cell	tsne1	tsne2	cluster_original	sample	diagnosis	stage	age	sex	region	Capbatch	Seqbatch	RIN	PMI	genes	UMIs	mito_perc	ribo_perc	lesion_stage	cluster	cell_type	DMGM_UL	DMGM_DL	DMWM
AAACCTGGTCCATGAT-1_5981_BA9	19.12104417	-20.54096003	3	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3674	9333	0.005143041	0.002357227	0	3	EN-L5-6	NA	NA	NA
AAACGGGAGTAGCCGA-1_5981_BA9	5.136135115	-13.75135082	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2407	4853	0.004945395	0.003709046	0	L2-3	EN-L2-3-MS	NA	NA	NA
AAACGGGCATCGGTTA-1_5981_BA9	-28.21075207	-20.76483656	6A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3593	7668	0.018518519	0.006129369	0	6A	IN-PV	NA	NA	NA
AAACGGGTCCATGAAC-1_5981_BA9	29.94612116	-15.72505561	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3288	6940	0.016426513	0.007060519	0	2	EN-L4	NA	NA	NA
AAAGATGCACGACTCG-1_5981_BA9	25.06527135	-19.42270353	3	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	4161	10297	0.007672138	0.003107701	0	3	EN-L5-6	NA	NA	NA
AAAGCAACACCGGAAA-1_5981_BA9	1.8820286	-17.25737198	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2759	5611	0.002138656	0.006415969	0	L2-3	EN-L2-3-MS	NA	NA	NA
AAAGCAACAGCTTCGG-1_5981_BA9	10.44686286	-1.904139985	12	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1632	2473	0.012939749	0.012939749	0	12	EN-MIX	NA	NA	NA
AAAGCAACATCGGACC-1_5981_BA9	27.43173236	-12.95194189	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	4611	12250	0.011755102	0.003755102	0	L2-3	EN-L2-3-MS	NA	NA	NA
AAAGTAGAGAGACTTA-1_5981_BA9	34.68073068	-4.080024739	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2373	4713	0.006789731	0.003182686	0	2	EN-L4	NA	NA	NA
AAAGTAGGTTATCGGT-1_5981_BA9	27.66646728	-17.55464753	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	5704	17769	0.042377174	0.006697057	0	2	EN-L4	NA	NA	NA
AAAGTAGTCGGACAAG-1_5981_BA9	4.916638048	-12.25342501	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2119	3676	0.004624592	0.006800871	0	L2-3	EN-L2-3-MS	NA	NA	NA
AAATGCCCAATGAAAC-1_5981_BA9	-26.35656288	-20.45555748	6A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2294	3984	0.02434739	0.006777108	0	6A	IN-PV	NA	NA	NA
AAATGCCCACGAAAGC-1_5981_BA9	-11.59133528	-11.02568567	6B	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1222	1916	0.001043841	0.004697286	0	6B	IN-SST	NA	NA	NA
AAATGCCCATGAACCT-1_5981_BA9	-18.214669	-4.908846377	13A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2880	5830	0.023327616	0.005145798	0	13A	IN-VIP	NA	NA	NA
AAATGCCCATGTAGTC-1_5981_BA9	-11.68518157	-5.203821878	13A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2050	3264	0.013786765	0.013480392	0	13A	IN-VIP	NA	NA	NA
AACACGTAGGACCACA-1_5981_BA9	23.96248188	-12.62328012	3	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3143	6206	0.005800838	0.00660651	0	3	EN-L5-6	NA	NA	NA
AACACGTCAGATCTGT-1_5981_BA9	26.17335876	7.398926657	15A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1374	1981	0.010600707	0.019687027	0	15A	Endo cells	NA	NA	NA
AACACGTGTATAGTAG-1_5981_BA9	-24.79966679	-8.164652597	9	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1031	1522	0.012483574	0.004599212	0	9	OPC	NA	NA	NA
AACACGTGTCTTCTCG-1_5981_BA9	1.028520349	-12.92109479	10	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2142	4114	0.000486145	0.006562956	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AACACGTTCGCCCTTA-1_5981_BA9	-28.07203951	-20.80299769	6A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	4337	11608	0.066333563	0.003876637	0	6A	IN-PV	NA	NA	NA
AACCATGAGTGGACGT-1_5981_BA9	-12.04526019	-13.525096	6B	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1338	2063	0.059137179	0.00484731	0	6B	IN-SST	NA	NA	NA
AACCATGCAGCTTCGG-1_5981_BA9	2.546633719	-18.88779444	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3278	7394	0.001622938	0.007438464	0	L2-3	EN-L2-3-MS	NA	NA	NA
AACCATGCATTGAGCT-1_5981_BA9	-21.37655131	-20.56594209	6A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2116	3634	0.038249862	0.003302146	0	6A	IN-PV	NA	NA	NA
AACCATGGTGGAAAGA-1_5981_BA9	-16.6480584	-14.85726165	6B	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1688	2794	0.008589835	0.005368647	0	6B	IN-SST	NA	NA	NA
AACCATGGTGTGGCTC-1_5981_BA9	-12.84904991	-9.230440069	13B	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2040	3617	0.011335361	0.002764722	0	13B	IN-SV2C	NA	NA	NA
AACCATGGTTTGACAC-1_5981_BA9	2.69650546	-17.38247165	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2775	5978	0.00117096	0.009534962	0	L2-3	EN-L2-3-MS	NA	NA	NA
AACCATGTCTAACTCT-1_5981_BA9	-32.19564756	-13.46044811	9	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	794	1078	0.000927644	0.001855288	0	9	OPC	NA	NA	NA
AACCATGTCTTCAACT-1_5981_BA9	6.15651253	-15.07179257	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2684	5245	0.003241182	0.014108675	0	L2-3	EN-L2-3-MS	NA	NA	NA
AACCGCGCACTTCGAA-1_5981_BA9	-9.663107935	-4.877319824	13A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1764	2997	0.009676343	0.006339673	0	13A	IN-VIP	NA	NA	NA
AACCGCGGTTCCACGG-1_5981_BA9	-22.1731124	-21.94712956	6A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2385	4684	0.047395389	0.002988898	0	6A	IN-PV	NA	NA	NA
AACGTTGGTCTCTCGT-1_5981_BA9	6.371384509	-28.79746978	10	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3319	8141	0.002579536	0.003316546	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AACTCAGAGAGCCTAG-1_5981_BA9	19.88116126	-3.434364252	12	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1407	2072	0.007239382	0.002413127	0	12	EN-MIX	NA	NA	NA
AACTCAGTCAAAGACA-1_5981_BA9	-13.22642722	-31.94821927	16	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1788	2975	0.061848739	0.005714286	0	16	EN-PYR	NA	NA	NA
AACTCCCAGAACAACT-1_5981_BA9	29.60661428	-3.849800636	10	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	4954	16147	0.00309655	0.00309655	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AACTCCCCAGCGATCC-1_5981_BA9	31.2345566	-8.709255121	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3838	9754	0.004716014	0.00399836	0	2	EN-L4	NA	NA	NA
AACTCCCTCCTTTCTC-1_5981_BA9	14.50164831	-20.86912513	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	4704	14163	0.007413684	0.003953965	0	L2-3	EN-L2-3-MS	NA	NA	NA
AACTCTTGTCTCCATC-1_5981_BA9	11.3326298	-8.703331385	10	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2653	6065	0.002143446	0.001483924	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AACTGGTCACGGACAA-1_5981_BA9	-14.07145442	-15.95745323	6A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1485	2452	0.019575856	0.004486134	0	6A	IN-PV	NA	NA	NA
AACTGGTGTCTCGTTC-1_5981_BA9	1.612109834	-18.19453676	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2418	5066	0.00493486	0.003355705	0	L2-3	EN-L2-3-MS	NA	NA	NA
AACTTTCAGTGAACAT-1_5981_BA9	-0.213000464	28.91129868	1	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	754	1018	0.007858546	0.001964637	0	oligos	OL-Cntl	NA	NA	NA
AACTTTCGTAGGCATG-1_5981_BA9	30.76771195	-12.62780041	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3422	7127	0.010242739	0.007857444	0	2	EN-L4	NA	NA	NA
AACTTTCGTCCTCTTG-1_5981_BA9	10.78278662	-20.40207301	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3017	6810	0.006461087	0.002936858	0	L2-3	EN-L2-3-MS	NA	NA	NA
AAGACCTGTCTCTCGT-1_5981_BA9	5.959330113	-12.87255323	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2339	4247	0.003531905	0.017424064	0	L2-3	EN-L2-3-MS	NA	NA	NA
AAGCCGCAGATACACA-1_5981_BA9	-29.90930068	-21.10150211	6A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	5442	15148	0.025944019	0.006931608	0	6A	IN-PV	NA	NA	NA
AAGCCGCAGCCCAATT-1_5981_BA9	18.99959798	0.27469756	12	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1046	1563	0.007677543	0.003198976	0	12	EN-MIX	NA	NA	NA
AAGCCGCAGGATGGAA-1_5981_BA9	-26.54500045	-17.62356093	13B	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	5096	12928	0.040764233	0.007116337	0	13B	IN-SV2C	NA	NA	NA
AAGCCGCCACCAGATT-1_5981_BA9	16.72273912	29.56059106	1	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	808	1133	0.000882613	0.004413063	0	oligos	OL-Cntl	NA	NA	NA
AAGCCGCCATGATCCA-1_5981_BA9	-13.27209896	7.398356995	8	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1177	1628	0.027027027	0.004299754	0	8	Astrocytes	NA	NA	NA
AAGCCGCTCGTTTAGG-1_5981_BA9	9.387272856	-6.94442866	10	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1848	3181	0.001571833	0.003458032	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AAGGAGCGTTATGTGC-1_5981_BA9	-16.50538652	-3.369152812	13A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2840	5251	0.011235955	0.007236717	0	13A	IN-VIP	NA	NA	NA
AAGGCAGAGTACTTGC-1_5981_BA9	-7.36386544	-32.63437984	16	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	820	1105	0.056108597	0.006334842	0	16	EN-PYR	NA	NA	NA
AAGGCAGAGTGTACGG-1_5981_BA9	30.23747244	-15.38998552	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2614	4794	0.013558615	0.009803922	0	2	EN-L4	NA	NA	NA
AAGGCAGGTCCAGTTA-1_5981_BA9	20.07941156	-11.17607498	3	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2524	4553	0.003294531	0.002415989	0	3	EN-L5-6	NA	NA	NA
AAGGCAGGTTGTGGCC-1_5981_BA9	-6.780002586	-33.7685986	16	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	722	1003	0.055832502	0.008973081	0	16	EN-PYR	NA	NA	NA
AAGGTTCAGGGAGTAA-1_5981_BA9	9.048599256	-13.31630486	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2774	5212	0.006139678	0.018610898	0	L2-3	EN-L2-3-MS	NA	NA	NA
AAGGTTCGTCAGAAGC-1_5981_BA9	-7.866371091	-33.17513975	16	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1001	1458	0.106310014	0.004115226	0	16	EN-PYR	NA	NA	NA
AAGGTTCGTGAGGGAG-1_5981_BA9	36.51307566	-13.38812478	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3349	6179	0.016669364	0.008415601	0	2	EN-L4	NA	NA	NA
AAGGTTCTCACTTACT-1_5981_BA9	-37.24083693	-4.658801362	9	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1284	2135	0.003278689	0.003747073	0	9	OPC	NA	NA	NA
AAGGTTCTCGATAGAA-1_5981_BA9	29.38417511	-16.25394401	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	4326	10952	0.023831264	0.006117604	0	2	EN-L4	NA	NA	NA
AAGTCTGAGTACGATA-1_5981_BA9	27.91606379	5.681609002	15A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	888	1116	0.007168459	0.012544803	0	15A	Endo cells	NA	NA	NA
AAGTCTGCACGTCTCT-1_5981_BA9	28.07856172	6.649684862	15A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	909	1167	0.013710368	0.022279349	0	15A	Endo cells	NA	NA	NA
AAGTCTGCAGCCTTTC-1_5981_BA9	13.59545007	-28.07094414	3	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2549	5419	0.002029895	0.003506182	0	3	EN-L5-6	NA	NA	NA
AAGTCTGCAGGGTACA-1_5981_BA9	-12.12073787	-21.87894901	6A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1103	1792	0.002232143	0.004464286	0	6A	IN-PV	NA	NA	NA
AAGTCTGTCTCTAAGG-1_5981_BA9	21.31650395	-12.90121202	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2812	5728	0.025663408	0.004539106	0	2	EN-L4	NA	NA	NA
AATCCAGAGAGTAATC-1_5981_BA9	23.33425658	-23.88932352	3	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3593	8607	0.008830022	0.005460672	0	3	EN-L5-6	NA	NA	NA
AATCCAGAGGCATGGT-1_5981_BA9	3.434893874	-11.85440885	12	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1948	3758	0.009313465	0.001596594	0	12	EN-MIX	NA	NA	NA
AATCCAGCATGGATGG-1_5981_BA9	20.27144809	-3.256855955	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1772	2802	0.011420414	0.003925767	0	2	EN-L4	NA	NA	NA
AATCCAGGTGTTTGGT-1_5981_BA9	16.57795151	-18.35689567	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	5337	17028	0.009983556	0.004521964	0	L2-3	EN-L2-3-MS	NA	NA	NA
AATCCAGTCTGTTTGT-1_5981_BA9	-0.277476677	31.29451152	17	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	938	1327	0.003767898	0.006028636	0	oligos	OL-MS-2	NA	NA	NA
AATCGGTAGTGTTTGC-1_5981_BA9	-7.798783719	-29.63148139	16	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	976	1281	0.035909446	0.010928962	0	16	EN-PYR	NA	NA	NA
AATCGGTTCGTCGTTC-1_5981_BA9	-11.8738082	-7.869937745	13B	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2104	3329	0.008110544	0.004806248	0	13B	IN-SV2C	NA	NA	NA
ACACCAACACCCTATC-1_5981_BA9	20.85269313	-3.513919257	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2072	3913	0.044722719	0.003577818	0	2	EN-L4	NA	NA	NA
ACACCAAGTAGGGACT-1_5981_BA9	-21.09966552	-21.14222055	6A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1854	3109	0.010935992	0.006754583	0	6A	IN-PV	NA	NA	NA
ACACCAAGTATGCTTG-1_5981_BA9	9.620716518	-17.74372979	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3705	7674	0.004430545	0.010294501	0	L2-3	EN-L2-3-MS	NA	NA	NA
ACACCAAGTCATCGGC-1_5981_BA9	20.15828941	-15.5533498	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	6730	23573	0.018665422	0.005429941	0	L2-3	EN-L2-3-MS	NA	NA	NA
ACACCAAGTCTCCATC-1_5981_BA9	-14.32567301	-15.41619967	6B	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1581	2596	0.013867488	0.008474576	0	6B	IN-SST	NA	NA	NA
ACACCAATCAGTCAGT-1_5981_BA9	29.97727597	-15.67122754	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3440	7496	0.009871932	0.00653682	0	2	EN-L4	NA	NA	NA
ACACCCTCAGAGTGTG-1_5981_BA9	7.726021762	-15.54788916	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3449	7707	0.004022317	0.015310756	0	L2-3	EN-L2-3-MS	NA	NA	NA
ACACCGGGTGTAATGA-1_5981_BA9	24.9073239	-18.01336533	3	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	4345	11019	0.020328523	0.004900626	0	3	EN-L5-6	NA	NA	NA
ACACCGGTCATTATCC-1_5981_BA9	18.51475546	-9.291094142	3	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2329	4791	0.009810061	0.00709664	0	3	EN-L5-6	NA	NA	NA
ACACTGAGTTACGCGC-1_5981_BA9	-10.64486964	-5.5269108	13A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1847	2998	0.013675784	0.006004003	0	13A	IN-VIP	NA	NA	NA
ACACTGATCACCAGGC-1_5981_BA9	5.219657422	-9.315428907	12	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1438	2339	0.015391193	0.005557931	0	12	EN-MIX	NA	NA	NA
ACAGCCGAGTCCGTAT-1_5981_BA9	-11.58334017	-34.67703323	16	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1241	2047	0.082559844	0.008793356	0	16	EN-PYR	NA	NA	NA
ACAGCCGCAAGTCTAC-1_5981_BA9	2.067416885	-18.2104646	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2734	5687	0.006506066	0.00492351	0	L2-3	EN-L2-3-MS	NA	NA	NA
ACAGCCGGTCACCCAG-1_5981_BA9	-33.79784581	-11.57409858	9	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	812	1203	0.000831255	0.00166251	0	9	OPC	NA	NA	NA
ACAGCCGGTGAGTATA-1_5981_BA9	-13.14313564	-21.84488887	6A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1172	1778	0.014623172	0.001687289	0	6A	IN-PV	NA	NA	NA
ACAGCTACATAGACTC-1_5981_BA9	-17.90510449	-24.96717948	6A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2452	4949	0.000606183	0.00404122	0	6A	IN-PV	NA	NA	NA
ACAGCTACATCACGTA-1_5981_BA9	23.02526984	-27.27634579	3	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2835	6620	0.002719033	0.004531722	0	3	EN-L5-6	NA	NA	NA
ACAGCTATCGCTTGTC-1_5981_BA9	28.83586326	-16.56925249	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	5438	17484	0.033230382	0.004346831	0	2	EN-L4	NA	NA	NA
ACATACGGTAGGCTGA-1_5981_BA9	-18.68883851	-5.489347739	13B	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2877	5578	0.035855145	0.005378272	0	13B	IN-SV2C	NA	NA	NA
ACATACGGTTCGCTAA-1_5981_BA9	11.88095827	-20.18052595	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3235	6997	0.007574675	0.004573389	0	L2-3	EN-L2-3-MS	NA	NA	NA
ACATCAGAGCGATTCT-1_5981_BA9	-13.14160626	-35.08311286	16	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1614	2735	0.063254113	0.004021938	0	16	EN-PYR	NA	NA	NA
ACATCAGCACGCGAAA-1_5981_BA9	-7.145299498	-32.98391197	16	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	786	1084	0.0599631	0.003690037	0	16	EN-PYR	NA	NA	NA
ACATCAGGTAAGTGGC-1_5981_BA9	26.69917045	-17.39096009	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	4841	13039	0.015875451	0.007976072	0	2	EN-L4	NA	NA	NA
ACATCAGGTATGGTTC-1_5981_BA9	24.26069825	-19.11135628	3	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	4846	13666	0.013244549	0.004463632	0	3	EN-L5-6	NA	NA	NA
ACATGGTAGGTAAACT-1_5981_BA9	-31.15119621	-13.22674209	9	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	794	1124	0.002669039	0.011565836	0	9	OPC	NA	NA	NA
ACATGGTGTCGCTTTC-1_5981_BA9	12.93482172	-20.57570615	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3867	9472	0.005384291	0.009818412	0	L2-3	EN-L2-3-MS	NA	NA	NA
ACCAGTAAGAGACTAT-1_5981_BA9	-9.098407261	-20.15877095	6B	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	716	1025	0.075121951	0.00097561	0	6B	IN-SST	NA	NA	NA
ACCAGTAAGCGAAGGG-1_5981_BA9	6.974092661	-15.08453316	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3025	6141	0.004233838	0.005210878	0	L2-3	EN-L2-3-MS	NA	NA	NA
ACCAGTAAGTGGTCCC-1_5981_BA9	-10.50900088	-5.467230412	13A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1824	3094	0.02133161	0.006464124	0	13A	IN-VIP	NA	NA	NA
ACCAGTAGTACAGTGG-1_5981_BA9	9.196117613	-4.491547724	12	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2155	3776	0.028601695	0.007150424	0	12	EN-MIX	NA	NA	NA
ACCCACTGTTCCACAA-1_5981_BA9	-27.07530491	-20.22315264	6A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2477	4550	0.04	0.004835165	0	6A	IN-PV	NA	NA	NA
ACCCACTGTTGTACAC-1_5981_BA9	28.64594716	-17.55292717	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	4760	13305	0.045847426	0.004058625	0	2	EN-L4	NA	NA	NA
ACCGTAACAAGGACAC-1_5981_BA9	22.958414	-0.530231004	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2109	4117	0.003157639	0.002428953	0	2	EN-L4	NA	NA	NA
ACCGTAACATTGAGCT-1_5981_BA9	19.12060049	-20.4830656	3	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3297	7390	0.013667118	0.003112314	0	3	EN-L5-6	NA	NA	NA
ACCGTAATCTGACCTC-1_5981_BA9	16.16465278	-18.27950772	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	6375	21649	0.003787704	0.003418172	0	L2-3	EN-L2-3-MS	NA	NA	NA
ACCTTTACAGGGTACA-1_5981_BA9	24.24469328	-17.50209082	3	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	6260	21166	0.016724936	0.005905698	0	3	EN-L5-6	NA	NA	NA
ACCTTTAGTGTTAAGA-1_5981_BA9	27.99968958	6.213066201	15A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	786	1014	0.00887574	0.019723866	0	15A	Endo cells	NA	NA	NA
ACCTTTATCACCCTCA-1_5981_BA9	8.746679549	-1.12194971	12	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	962	1370	0.005839416	0.006569343	0	12	EN-MIX	NA	NA	NA
ACCTTTATCATACGGT-1_5981_BA9	17.82757333	-17.64213009	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	4442	11503	0.016778232	0.003998957	0	L2-3	EN-L2-3-MS	NA	NA	NA
ACCTTTATCTCTAAGG-1_5981_BA9	-13.79334675	-36.32157915	16	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2027	3639	0.102775488	0.009343226	0	16	EN-PYR	NA	NA	NA
ACGAGCCAGCTGTCTA-1_5981_BA9	21.52613811	-2.550197592	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2099	3646	0.001919912	0.006308283	0	2	EN-L4	NA	NA	NA
ACGAGCCCACAGGCCT-1_5981_BA9	-11.45597779	-15.60697985	6B	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1113	1725	0.005797101	0.005217391	0	6B	IN-SST	NA	NA	NA
ACGAGCCCATGCTAGT-1_5981_BA9	9.019270406	-3.035833128	12	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1704	2770	0.049097473	0.001805054	0	12	EN-MIX	NA	NA	NA
ACGAGCCGTCGCATCG-1_5981_BA9	18.61895302	-7.188947607	3	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2045	4177	0.002394063	0.002872875	0	3	EN-L5-6	NA	NA	NA
ACGAGGAAGAAGCCCA-1_5981_BA9	20.48422919	-3.723983618	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2051	3335	0.022188906	0.006296852	0	2	EN-L4	NA	NA	NA
ACGATACAGAGTCTGG-1_5981_BA9	20.49219773	-11.97425408	3	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2814	5156	0.016873545	0.005818464	0	3	EN-L5-6	NA	NA	NA
ACGATACAGCACCGCT-1_5981_BA9	-16.44819936	-3.711096501	13A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2939	5896	0.013738128	0.004918589	0	13A	IN-VIP	NA	NA	NA
ACGATACCATCACCCT-1_5981_BA9	17.94703409	28.59635341	17	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	951	1369	0.00146092	0.003652301	0	oligos	OL-MS-2	NA	NA	NA
ACGATGTTCCAGAGGA-1_5981_BA9	-12.13041539	-4.933738288	13A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2387	4176	0.015565134	0.011733716	0	13A	IN-VIP	NA	NA	NA
ACGCAGCAGCCACTAT-1_5981_BA9	-26.50151989	-20.54875635	6A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2920	6271	0.064104609	0.003189284	0	6A	IN-PV	NA	NA	NA
ACGCAGCGTATAGGGC-1_5981_BA9	30.02495648	-6.768222318	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	4207	11079	0.004513043	0.004061738	0	2	EN-L4	NA	NA	NA
ACGCAGCGTCGCGAAA-1_5981_BA9	-22.05517256	-21.34806112	6A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2328	4120	0.009951456	0.011165049	0	6A	IN-PV	NA	NA	NA
ACGCAGCTCTAACGGT-1_5981_BA9	17.79988098	-17.76487178	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	4139	10132	0.016679826	0.00740229	0	L2-3	EN-L2-3-MS	NA	NA	NA
ACGCCAGAGAATCTCC-1_5981_BA9	30.17366594	-12.45363912	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3490	7984	0.008517034	0.006513026	0	2	EN-L4	NA	NA	NA
ACGCCAGAGCCTTGAT-1_5981_BA9	24.1665161	-25.21491499	3	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3359	8410	0.001070155	0.002259215	0	3	EN-L5-6	NA	NA	NA
ACGCCAGCATGGTCTA-1_5981_BA9	9.343979781	-7.82329901	10	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2602	6044	0.000661813	0.00198544	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACGCCAGGTGGTCCGT-1_5981_BA9	11.1778688	-20.79086239	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	4142	11329	0.003177686	0.00458999	0	L2-3	EN-L2-3-MS	NA	NA	NA
ACGCCAGTCAGTCCCT-1_5981_BA9	-7.443251872	-9.340263113	13A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	876	1143	0.007874016	0.012248469	0	13A	IN-VIP	NA	NA	NA
ACGCCGAGTGATGCCC-1_5981_BA9	20.57826786	-3.643733242	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1967	3330	0.014414414	0.004204204	0	2	EN-L4	NA	NA	NA
ACGCCGAGTGCACCAC-1_5981_BA9	23.95518759	-13.011026	3	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3176	6343	0.018760839	0.003626044	0	3	EN-L5-6	NA	NA	NA
ACGCCGAGTGTTGGGA-1_5981_BA9	-11.25004787	-5.546039416	13A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1813	2783	0.02012217	0.014732303	0	13A	IN-VIP	NA	NA	NA
ACGGAGACAGACTCGC-1_5981_BA9	-5.163333529	-8.003548438	13A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	877	1324	0.00755287	0.001510574	0	13A	IN-VIP	NA	NA	NA
ACGGAGATCACATAGC-1_5981_BA9	-0.02621817	30.77644301	1	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	869	1199	0.000834028	0.008340284	0	oligos	OL-Cntl	NA	NA	NA
ACGGCCAAGACGCACA-1_5981_BA9	-25.54984166	-22.06918554	6A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3226	6742	0.027439929	0.004004746	0	6A	IN-PV	NA	NA	NA
ACGGCCAAGCTACCTA-1_5981_BA9	-34.60358196	-5.859731589	9	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1254	1970	0.003045685	0.004568528	0	9	OPC	NA	NA	NA
ACGGCCATCCACGACG-1_5981_BA9	-12.78313354	-31.82480607	16	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1518	2393	0.025908901	0.007521939	0	16	EN-PYR	NA	NA	NA
ACGGGCTGTACAGCAG-1_5981_BA9	-7.029465396	-6.608611234	13A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1256	2065	0.023244552	0.004842615	0	13A	IN-VIP	NA	NA	NA
ACGGGTCAGTCGCCGT-1_5981_BA9	5.771567652	-13.45033636	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2295	4118	0.006070908	0.007042254	0	L2-3	EN-L2-3-MS	NA	NA	NA
ACGGGTCGTCCCGACA-1_5981_BA9	28.6732385	-17.00449766	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	5097	13833	0.021614979	0.006578472	0	2	EN-L4	NA	NA	NA
ACGGGTCTCGCACTCT-1_5981_BA9	28.60543204	-16.98627613	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	5552	17526	0.028471984	0.004108182	0	2	EN-L4	NA	NA	NA
ACGTCAAGTGGCGAAT-1_5981_BA9	-9.402631346	-2.243249566	13A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2127	3816	0.006551363	0.0028826	0	13A	IN-VIP	NA	NA	NA
ACGTCAATCTCCAACC-1_5981_BA9	30.04683083	-15.84669576	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3646	7764	0.022926327	0.009015971	0	2	EN-L4	NA	NA	NA
ACTATCTTCTGCGTAA-1_5981_BA9	24.60142997	-13.30097942	3	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3378	7022	0.007120478	0.006123612	0	3	EN-L5-6	NA	NA	NA
ACTGAACCATCCGGGT-1_5981_BA9	-8.433309098	-5.266952113	13A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1462	2274	0.00351803	0.006596306	0	13A	IN-VIP	NA	NA	NA
ACTGAACCATGGTCTA-1_5981_BA9	5.043724579	-15.72226349	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3188	7479	0.001604493	0.011899987	0	L2-3	EN-L2-3-MS	NA	NA	NA
ACTGAGTAGAAACCTA-1_5981_BA9	-13.28890697	7.350189587	8	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	974	1248	0.021634615	0.007211538	0	8	Astrocytes	NA	NA	NA
ACTGAGTAGCCGATTT-1_5981_BA9	-20.76158725	-20.65511457	6A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1822	3064	0.088772846	0.003263708	0	6A	IN-PV	NA	NA	NA
ACTGAGTAGCTGATAA-1_5981_BA9	27.59630362	-13.15137476	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3907	9384	0.020247229	0.003303495	0	2	EN-L4	NA	NA	NA
ACTGAGTCAACAACCT-1_5981_BA9	4.832041573	-11.72652762	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2046	3722	0.008060183	0.004298764	0	L2-3	EN-L2-3-MS	NA	NA	NA
ACTGATGAGTACGTAA-1_5981_BA9	-9.779703022	-5.827273927	13A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1613	2685	0.005959032	0.00744879	0	13A	IN-VIP	NA	NA	NA
ACTGCTCAGGAATGGA-1_5981_BA9	18.04031012	-17.34619891	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3426	7292	0.01769062	0.004936917	0	L2-3	EN-L2-3-MS	NA	NA	NA
ACTGCTCCAGGTCCAC-1_5981_BA9	17.68341904	-17.85860819	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	4492	11904	0.011592742	0.003780242	0	L2-3	EN-L2-3-MS	NA	NA	NA
ACTGCTCGTGGGTATG-1_5981_BA9	-4.526525864	-5.741581377	13A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1105	1718	0.001746217	0.001746217	0	13A	IN-VIP	NA	NA	NA
ACTTACTAGTCACGCC-1_5981_BA9	-0.639887594	31.74171117	17	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	972	1332	0.003003003	0.003753754	0	oligos	OL-MS-2	NA	NA	NA
ACTTACTCAGATCTGT-1_5981_BA9	5.287826928	-14.54756053	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2613	5296	0.004909366	0.006986405	0	L2-3	EN-L2-3-MS	NA	NA	NA
ACTTACTCAGTGAGTG-1_5981_BA9	-11.97585462	-10.26249351	13B	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1556	2627	0.001141987	0.006090598	0	13B	IN-SV2C	NA	NA	NA
ACTTGTTAGGGCTCTC-1_5981_BA9	31.21443775	-11.81265678	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2466	4776	0.00858459	0.008165829	0	2	EN-L4	NA	NA	NA
ACTTGTTCATCCGTGG-1_5981_BA9	11.35501952	-20.76529224	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3805	9519	0.003256645	0.002731379	0	L2-3	EN-L2-3-MS	NA	NA	NA
ACTTTCAAGCGCCTTG-1_5981_BA9	-11.20172105	-10.84455765	6B	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1221	1896	0.006329114	0.003164557	0	6B	IN-SST	NA	NA	NA
ACTTTCAAGTACCGGA-1_5981_BA9	29.99204355	-15.69222298	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3054	6238	0.047932029	0.005450465	0	2	EN-L4	NA	NA	NA
ACTTTCACATCGGACC-1_5981_BA9	28.28139727	-17.29475772	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	6008	20119	0.025796511	0.005666286	0	2	EN-L4	NA	NA	NA
ACTTTCATCCAGAGGA-1_5981_BA9	29.29762208	-16.02664354	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3942	9624	0.020157938	0.005818786	0	2	EN-L4	NA	NA	NA
AGAATAGGTAGCCTAT-1_5981_BA9	30.81851295	-13.43676773	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3655	8351	0.011854868	0.004430607	0	2	EN-L4	NA	NA	NA
AGAATAGTCTGGAGCC-1_5981_BA9	-10.82700098	-5.329659184	13A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1704	2695	0.012987013	0.006679035	0	13A	IN-VIP	NA	NA	NA
AGACGTTGTACGCACC-1_5981_BA9	-8.318852942	-5.957403715	13A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1483	2325	0.003870968	0.00516129	0	13A	IN-VIP	NA	NA	NA
AGACGTTGTCTCCCTA-1_5981_BA9	17.27404229	-18.09213528	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	4376	10527	0.011399259	0.009309395	0	L2-3	EN-L2-3-MS	NA	NA	NA
AGACGTTGTTAAAGAC-1_5981_BA9	-8.368659601	-6.051508789	13A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1503	2370	0.008860759	0.004219409	0	13A	IN-VIP	NA	NA	NA
AGAGCGAAGGGAAACA-1_5981_BA9	19.25592116	-11.06371665	3	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2740	5974	0.013558755	0.007365249	0	3	EN-L5-6	NA	NA	NA
AGAGCGAAGTGATCGG-1_5981_BA9	4.25615399	-13.61775071	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2204	4217	0.002608489	0.004268437	0	L2-3	EN-L2-3-MS	NA	NA	NA
AGAGCGACAGGAATGC-1_5981_BA9	30.44590596	-15.20007296	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2637	4749	0.01642451	0.006738261	0	2	EN-L4	NA	NA	NA
AGAGCTTCACCATCCT-1_5981_BA9	5.689824531	-11.50686682	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1999	3490	0.014040115	0.007163324	0	L2-3	EN-L2-3-MS	NA	NA	NA
AGAGCTTTCGTTTAGG-1_5981_BA9	10.30615536	-0.754960302	12	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1131	1569	0.008285532	0.008922881	0	12	EN-MIX	NA	NA	NA
AGAGTGGCACGTCAGC-1_5981_BA9	29.86168462	-15.65334219	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3995	9429	0.043694984	0.005408845	0	2	EN-L4	NA	NA	NA
AGAGTGGGTGTGACCC-1_5981_BA9	30.32700754	-14.96846956	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2598	4669	0.01863354	0.005354466	0	2	EN-L4	NA	NA	NA
AGAGTGGGTTGCGCAC-1_5981_BA9	1.933396358	-18.23809784	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2697	5573	0.005203661	0.001076619	0	L2-3	EN-L2-3-MS	NA	NA	NA
AGATCTGCATGCAATC-1_5981_BA9	12.50242646	-20.79319485	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3189	6707	0.007007604	0.003131057	0	L2-3	EN-L2-3-MS	NA	NA	NA
AGATCTGGTGATAAGT-1_5981_BA9	34.64601208	-3.485356061	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2629	5201	0.012305326	0.004422226	0	2	EN-L4	NA	NA	NA
AGATCTGGTTAAGACA-1_5981_BA9	1.639315144	-17.85988314	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2719	5667	0.002117522	0.004411505	0	L2-3	EN-L2-3-MS	NA	NA	NA
AGATCTGTCACAAACC-1_5981_BA9	27.59108454	5.188619914	15A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	804	1089	0.002754821	0.008264463	0	15A	Endo cells	NA	NA	NA
AGATCTGTCAGTACGT-1_5981_BA9	-21.93173571	-16.34849401	6A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3136	7190	0.00403338	0.00472879	0	6A	IN-PV	NA	NA	NA
AGATCTGTCCCTCTTT-1_5981_BA9	11.18054246	-20.94024892	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	4698	15411	0.004996431	0.002076439	0	L2-3	EN-L2-3-MS	NA	NA	NA
AGATTGCAGTCTCCTC-1_5981_BA9	-32.42527388	-13.5200151	9	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	712	1032	0.000968992	0.004844961	0	9	OPC	NA	NA	NA
AGATTGCGTTCTGAAC-1_5981_BA9	-11.6014697	-22.07459861	6A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1084	1761	0.002271437	0.002271437	0	6A	IN-PV	NA	NA	NA
AGATTGCTCGGAATCT-1_5981_BA9	20.39821985	-3.755557977	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1934	3212	0.02117061	0.004047323	0	2	EN-L4	NA	NA	NA
AGCAGCCCAACTTGAC-1_5981_BA9	-10.13208528	-6.470489851	13A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1480	2510	0.003984064	0.003984064	0	13A	IN-VIP	NA	NA	NA
AGCAGCCCAGGTCTCG-1_5981_BA9	30.28508437	-15.33917302	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2832	5531	0.036340626	0.003615983	0	2	EN-L4	NA	NA	NA
AGCATACAGATATGCA-1_5981_BA9	7.013818714	-14.63150007	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2935	5919	0.020273695	0.004730529	0	L2-3	EN-L2-3-MS	NA	NA	NA
AGCATACCACCGCTAG-1_5981_BA9	9.483900487	-3.119487446	12	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1953	3278	0.018303844	0.011592434	0	12	EN-MIX	NA	NA	NA
AGCATACCAGATCGGA-1_5981_BA9	17.79640836	-17.79387448	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	4918	12267	0.005787886	0.004075976	0	L2-3	EN-L2-3-MS	NA	NA	NA
AGCATACTCGGATGTT-1_5981_BA9	-12.62940618	-16.40525663	6A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1248	1950	0.008205128	0.004102564	0	6A	IN-PV	NA	NA	NA
AGCCTAAAGAATGTGT-1_5981_BA9	29.91771405	-3.378124757	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3159	7958	0.000628299	0.00439809	0	2	EN-L4	NA	NA	NA
AGCCTAAAGACACGAC-1_5981_BA9	30.48351964	-15.00546667	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2751	5162	0.010654785	0.006392871	0	2	EN-L4	NA	NA	NA
AGCCTAAAGGCAGGTT-1_5981_BA9	5.759264676	-13.38015687	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2463	4641	0.00280112	0.004309416	0	L2-3	EN-L2-3-MS	NA	NA	NA
AGCCTAAGTAGCGTGA-1_5981_BA9	27.83774029	-10.68533755	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3977	9397	0.008832606	0.00383101	0	2	EN-L4	NA	NA	NA
AGCCTAATCCGTAGTA-1_5981_BA9	24.28978387	-13.30446516	3	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3522	7407	0.012960713	0.005670312	0	3	EN-L5-6	NA	NA	NA
AGCCTAATCGCCTGTT-1_5981_BA9	20.29015738	-15.41832755	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	6414	22991	0.033926319	0.004914967	0	L2-3	EN-L2-3-MS	NA	NA	NA
AGCGGTCAGAGCCCAA-1_5981_BA9	-13.92079501	-15.11802272	6B	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1300	2164	0.006007394	0.00831793	0	6B	IN-SST	NA	NA	NA
AGCGGTCAGATCCCAT-1_5981_BA9	-6.264474964	-31.94793398	16	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	982	1345	0.05204461	0.011895911	0	16	EN-PYR	NA	NA	NA
AGCGGTCTCCGCGCAA-1_5981_BA9	29.13389629	-16.93682357	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	4992	13575	0.021952118	0.006556169	0	2	EN-L4	NA	NA	NA
AGCGTATTCAGCAACT-1_5981_BA9	19.98886759	-10.89302891	3	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2006	3408	0.003521127	0.002934272	0	3	EN-L5-6	NA	NA	NA
AGCGTATTCGGCCGAT-1_5981_BA9	-15.17547506	-36.82565367	16	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2713	5756	0.085476025	0.00886032	0	16	EN-PYR	NA	NA	NA
AGCGTCGAGGTCATCT-1_5981_BA9	3.188062926	-14.82050102	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2420	4746	0.003160556	0.011378003	0	L2-3	EN-L2-3-MS	NA	NA	NA
AGCGTCGCAGGATCGA-1_5981_BA9	-9.997224006	-6.236965724	13A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1626	2625	0.01447619	0.005714286	0	13A	IN-VIP	NA	NA	NA
AGCGTCGGTAAGAGGA-1_5981_BA9	24.46253498	-18.27580478	3	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	4012	10010	0.023476523	0.01038961	0	3	EN-L5-6	NA	NA	NA
AGCGTCGGTCGTGGCT-1_5981_BA9	19.97591658	-4.239834883	12	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2196	4047	0.035334816	0.005683222	0	12	EN-MIX	NA	NA	NA
AGCGTCGGTTGCTCCT-1_5981_BA9	-7.077103068	-7.960180996	13A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1073	1609	0.00621504	0.001864512	0	13A	IN-VIP	NA	NA	NA
AGCTCTCAGATACACA-1_5981_BA9	13.30977206	-21.01808493	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	4334	11142	0.016065338	0.004846527	0	L2-3	EN-L2-3-MS	NA	NA	NA
AGCTCTCAGGCTATCT-1_5981_BA9	1.056796083	-19.00947449	10	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3241	7717	0.002591681	0.005960866	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AGCTTGAAGTAAGTAC-1_5981_BA9	27.75815572	-18.1171836	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	7515	29902	0.030332419	0.005752124	0	2	EN-L4	NA	NA	NA
AGCTTGACACAGACTT-1_5981_BA9	-16.22696342	-3.511941413	13A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3055	6558	0.018450747	0.004727051	0	13A	IN-VIP	NA	NA	NA
AGCTTGACATGTAGTC-1_5981_BA9	25.24735458	-18.31435117	3	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	6594	23743	0.024849429	0.004590827	0	3	EN-L5-6	NA	NA	NA
AGCTTGATCGGCGCAT-1_5981_BA9	19.57898121	-3.335441889	12	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1200	1790	0.016201117	0.002234637	0	12	EN-MIX	NA	NA	NA
AGGCCACAGACTCGGA-1_5981_BA9	-11.11626702	29.2484552	17	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	931	1235	0.036437247	0.009716599	0	oligos	OL-MS-2	NA	NA	NA
AGGCCACAGTAGCGGT-1_5981_BA9	19.57143353	-11.21153329	3	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2490	4680	0.005982906	0.006837607	0	3	EN-L5-6	NA	NA	NA
AGGCCACGTCAACTGT-1_5981_BA9	31.32791488	-11.50648666	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2775	5519	0.010327958	0.004529806	0	2	EN-L4	NA	NA	NA
AGGCCACTCGAATGGG-1_5981_BA9	-28.98985244	10.24243975	8	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	770	1077	0.015784587	0.002785515	0	8	Astrocytes	NA	NA	NA
AGGCCGTAGACTCGGA-1_5981_BA9	29.33161817	-10.91655614	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	4993	13100	0.010610687	0.004656489	0	2	EN-L4	NA	NA	NA
AGGCCGTAGTGTCCAT-1_5981_BA9	-10.94142256	-4.741809011	13A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1988	3545	0.026234133	0.006205924	0	13A	IN-VIP	NA	NA	NA
AGGCCGTCATCTACGA-1_5981_BA9	23.77598491	-12.10767906	3	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3430	7880	0.002918782	0.004695431	0	3	EN-L5-6	NA	NA	NA
AGGCCGTGTGGTACAG-1_5981_BA9	9.608350717	-1.8461777	12	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1235	1701	0.021751911	0.01175779	0	12	EN-MIX	NA	NA	NA
AGGCCGTTCCCTCTTT-1_5981_BA9	27.56708636	-13.06504447	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	4375	11693	0.015393825	0.003506371	0	2	EN-L4	NA	NA	NA
AGGCCGTTCGTTTAGG-1_5981_BA9	9.930832176	-2.62940986	12	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1772	3039	0.012833169	0.008884501	0	12	EN-MIX	NA	NA	NA
AGGGAGTCACTTACGA-1_5981_BA9	-28.37749326	9.79900554	8	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	863	1223	0.003270646	0.006541292	0	8	Astrocytes	NA	NA	NA
AGGGAGTCAGTGGGAT-1_5981_BA9	-8.477370032	-6.180385935	13A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1410	2156	0.001855288	0.010204082	0	13A	IN-VIP	NA	NA	NA
AGGGAGTCATTAGCCA-1_5981_BA9	16.6389147	-14.88335416	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	6257	18946	0.007283859	0.006756043	0	L2-3	EN-L2-3-MS	NA	NA	NA
AGGGAGTGTGCACGAA-1_5981_BA9	28.51061527	-18.21433318	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	6581	23998	0.061796816	0.006750563	0	2	EN-L4	NA	NA	NA
AGGGAGTGTTCCACTC-1_5981_BA9	-33.49600781	-7.759373758	9	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1056	1509	0.003976143	0.003313453	0	9	OPC	NA	NA	NA
AGGGAGTTCATAAAGG-1_5981_BA9	-6.958779836	-7.236671703	13A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1150	1673	0.025104603	0.0041841	0	13A	IN-VIP	NA	NA	NA
AGGGAGTTCGGCTTGG-1_5981_BA9	9.426009033	-18.29897346	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3593	7542	0.002519226	0.010342084	0	L2-3	EN-L2-3-MS	NA	NA	NA
AGGGAGTTCTGTCTCG-1_5981_BA9	30.22780416	-12.63559528	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3576	7773	0.012736395	0.003988164	0	2	EN-L4	NA	NA	NA
AGGGATGAGCGTGAAC-1_5981_BA9	-12.58688828	-8.747614299	6B	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1802	2959	0.019263265	0.002365664	0	6B	IN-SST	NA	NA	NA
AGGGATGAGTTAGCGG-1_5981_BA9	29.95663166	-15.62465254	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2908	5667	0.023822128	0.005646727	0	2	EN-L4	NA	NA	NA
AGGGATGCACCCAGTG-1_5981_BA9	24.23279807	-13.14781268	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3317	6872	0.009167637	0.005093132	0	2	EN-L4	NA	NA	NA
AGGGATGGTCAACATC-1_5981_BA9	30.6219261	-12.34569248	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3224	6751	0.01599763	0.003555029	0	2	EN-L4	NA	NA	NA
AGGGTGAAGATGTGGC-1_5981_BA9	13.53876592	-28.14567917	3	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2687	5841	0.001883239	0.004622496	0	3	EN-L5-6	NA	NA	NA
AGGGTGAAGCGTAGTG-1_5981_BA9	27.83791064	-17.63393128	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	6074	17762	0.023983786	0.009965094	0	2	EN-L4	NA	NA	NA
AGGGTGACAGACACTT-1_5981_BA9	-8.966407652	-33.47092648	16	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1099	1601	0.107432854	0.004372267	0	16	EN-PYR	NA	NA	NA
AGGGTGATCCATTCTA-1_5981_BA9	28.45067541	-17.11416443	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	4593	12133	0.022253359	0.006016649	0	2	EN-L4	NA	NA	NA
AGGTCATGTGCAGTAG-1_5981_BA9	-27.62253326	-20.9342421	6A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3626	8024	0.036016949	0.005608175	0	6A	IN-PV	NA	NA	NA
AGGTCCGCAATCCAAC-1_5981_BA9	22.22749858	-3.454723031	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1769	3222	0.018621974	0.003103662	0	2	EN-L4	NA	NA	NA
AGGTCCGCACTGTTAG-1_5981_BA9	19.17064788	-20.54049867	3	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3778	9544	0.008172674	0.004295893	0	3	EN-L5-6	NA	NA	NA
AGGTCCGGTTCCTCCA-1_5981_BA9	18.08244043	-17.67314813	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	6329	22293	0.01157314	0.003319428	0	L2-3	EN-L2-3-MS	NA	NA	NA
AGTAGTCTCACAGTAC-1_5981_BA9	19.94364865	-3.459079652	12	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1501	2301	0.01781834	0.006084311	0	12	EN-MIX	NA	NA	NA
AGTAGTCTCGCACTCT-1_5981_BA9	-34.55051202	-10.40489525	9	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	890	1323	0.006046863	0.001511716	0	9	OPC	NA	NA	NA
AGTCTTTAGCGATCCC-1_5981_BA9	-17.0617483	-2.672734854	13A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2928	5610	0.014973262	0.009803922	0	13A	IN-VIP	NA	NA	NA
AGTCTTTAGGCTCTTA-1_5981_BA9	-25.82408855	-18.569799	6A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2544	4719	0.019283747	0.006993007	0	6A	IN-PV	NA	NA	NA
AGTCTTTCACGAGGTA-1_5981_BA9	19.6255219	-19.73521172	3	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2770	5226	0.003061615	0.012055109	0	3	EN-L5-6	NA	NA	NA
AGTCTTTGTGCGATAG-1_5981_BA9	16.34434008	-18.36431662	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	5907	19889	0.006687113	0.004072603	0	L2-3	EN-L2-3-MS	NA	NA	NA
AGTGAGGTCTCTGTCG-1_5981_BA9	24.90585026	-18.86245875	3	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	4038	9413	0.021672156	0.005524275	0	3	EN-L5-6	NA	NA	NA
AGTGGGAAGATGTGTA-1_5981_BA9	-26.75544948	-18.27668847	6B	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2731	5181	0.011580776	0.007141478	0	6B	IN-SST	NA	NA	NA
AGTGGGAGTCTCTCTG-1_5981_BA9	-11.32375825	-7.749857641	13B	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1708	2890	0.005536332	0.004152249	0	13B	IN-SV2C	NA	NA	NA
AGTGGGATCTGTCTCG-1_5981_BA9	5.033914888	-12.31849797	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1946	3490	0.007449857	0.006876791	0	L2-3	EN-L2-3-MS	NA	NA	NA
AGTGTCAAGTACGATA-1_5981_BA9	16.5426443	-18.18848872	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	4589	11828	0.03153534	0.004227257	0	L2-3	EN-L2-3-MS	NA	NA	NA
AGTGTCAAGTGACATA-1_5981_BA9	-12.34548915	-16.23892972	6A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1221	1962	0.018858308	0.004587156	0	6A	IN-PV	NA	NA	NA
AGTGTCAGTCTACCTC-1_5981_BA9	-1.724160926	36.43869792	17	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	758	1019	0.000981354	0.005888126	0	oligos	OL-MS-2	NA	NA	NA
AGTTGGTAGGGAACGG-1_5981_BA9	4.859087153	-13.74281714	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2167	4209	0.008315514	0.001663103	0	L2-3	EN-L2-3-MS	NA	NA	NA
AGTTGGTAGGTAAACT-1_5981_BA9	5.070114607	-10.20920856	12	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1542	2329	0.01459854	0.00729927	0	12	EN-MIX	NA	NA	NA
ATAACGCCAAAGTGCG-1_5981_BA9	17.84129396	-18.8594217	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2748	5577	0.016496324	0.002331002	0	L2-3	EN-L2-3-MS	NA	NA	NA
ATAACGCCATCCCACT-1_5981_BA9	-9.034309399	-34.20741662	16	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	957	1292	0.034055728	0.008513932	0	16	EN-PYR	NA	NA	NA
ATAACGCGTATATGAG-1_5981_BA9	19.03678395	-20.40987899	3	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3282	7407	0.005670312	0.004320238	0	3	EN-L5-6	NA	NA	NA
ATAAGAGAGTACTTGC-1_5981_BA9	21.27130313	-3.510412668	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2001	3743	0.017632915	0.001068662	0	2	EN-L4	NA	NA	NA
ATAAGAGGTGTGCCTG-1_5981_BA9	-31.78180801	-13.55277765	9	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	737	1066	0.001876173	0.003752345	0	9	OPC	NA	NA	NA
ATAGACCTCACCACCT-1_5981_BA9	-31.3329494	-10.75857178	9	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	865	1267	0.000789266	0.001578532	0	9	OPC	NA	NA	NA
ATAGACCTCACCTCGT-1_5981_BA9	2.72042703	-9.870318579	12	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1545	2728	0.004032258	0.005131965	0	12	EN-MIX	NA	NA	NA
ATAGACCTCAGTTCGA-1_5981_BA9	-3.729347213	-17.24335245	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2675	5613	0.000356316	0.009620524	0	L2-3	EN-L2-3-MS	NA	NA	NA
ATCACGAAGTCATCCA-1_5981_BA9	-11.83131996	-3.003828611	13A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2432	4522	0.004643963	0.005749668	0	13A	IN-VIP	NA	NA	NA
ATCACGAAGTGTTTGC-1_5981_BA9	-27.00970443	-20.37431405	6A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2588	4961	0.032453134	0.007458174	0	6A	IN-PV	NA	NA	NA
ATCATCTAGCGAGAAA-1_5981_BA9	6.602701388	-17.88352195	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3044	5534	0.001987712	0.014817492	0	L2-3	EN-L2-3-MS	NA	NA	NA
ATCATCTAGGCTATCT-1_5981_BA9	-9.614631842	-16.36807028	6B	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	905	1329	0.013544018	0.006772009	0	6B	IN-SST	NA	NA	NA
ATCATCTCAAAGCAAT-1_5981_BA9	10.24189957	-19.65001537	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	4898	14200	0.00443662	0.005211268	0	L2-3	EN-L2-3-MS	NA	NA	NA
ATCATCTCACGACGAA-1_5981_BA9	-28.33338252	8.769303405	8	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	817	1067	0.010309278	0.01968135	0	8	Astrocytes	NA	NA	NA
ATCATCTCAGATAATG-1_5981_BA9	20.24469188	-15.55053301	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	5771	17713	0.013097725	0.004516457	0	L2-3	EN-L2-3-MS	NA	NA	NA
ATCATCTCAGCCAGAA-1_5981_BA9	24.9227114	-18.82138971	3	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3850	9399	0.030960741	0.003617406	0	3	EN-L5-6	NA	NA	NA
ATCATGGCAGCTCGCA-1_5981_BA9	17.43130608	-17.72155223	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3691	8216	0.01533593	0.003894839	0	L2-3	EN-L2-3-MS	NA	NA	NA
ATCCACCAGCTACCGC-1_5981_BA9	-8.206158296	-2.505118196	13A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1864	3350	0.001791045	0.007462687	0	13A	IN-VIP	NA	NA	NA
ATCCGAAAGTTGAGAT-1_5981_BA9	26.63516947	5.308157877	15A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1073	1400	0.005714286	0.013571429	0	15A	Endo cells	NA	NA	NA
ATCCGAACACGAAGCA-1_5981_BA9	-7.859019756	-6.523481342	13A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1317	2019	0.012382368	0.004952947	0	13A	IN-VIP	NA	NA	NA
ATCCGAAGTCGTTGTA-1_5981_BA9	4.182699391	-8.735695747	12	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1465	2370	0.004219409	0.006329114	0	12	EN-MIX	NA	NA	NA
ATCGAGTAGAAAGTGG-1_5981_BA9	-12.07209938	-14.60971549	6A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1255	1990	0.026130653	0.007537688	0	6A	IN-PV	NA	NA	NA
ATCGAGTGTTTGACAC-1_5981_BA9	27.19322854	-17.468198	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	6517	24219	0.048309179	0.004789628	0	2	EN-L4	NA	NA	NA
ATCGAGTTCAACCATG-1_5981_BA9	-14.28100041	-21.50108519	6A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1369	2175	0.004597701	0.004137931	0	6A	IN-PV	NA	NA	NA
ATCGAGTTCAGTCAGT-1_5981_BA9	4.758879734	-8.706609485	12	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1284	1952	0.005635246	0.005635246	0	12	EN-MIX	NA	NA	NA
ATCGAGTTCCTCTAGC-1_5981_BA9	5.257495885	-14.38485103	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2554	4999	0.00320064	0.0040008	0	L2-3	EN-L2-3-MS	NA	NA	NA
ATCTACTCACATTAGC-1_5981_BA9	7.102242538	-14.90673386	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3039	6160	0.017857143	0.010714286	0	L2-3	EN-L2-3-MS	NA	NA	NA
ATCTACTCAGTAAGCG-1_5981_BA9	-11.27558937	-14.96796184	6B	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1114	1602	0.009363296	0.003121099	0	6B	IN-SST	NA	NA	NA
ATCTACTGTCTTGTCC-1_5981_BA9	27.90783234	-9.011651561	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3832	10008	0.009792166	0.002398082	0	2	EN-L4	NA	NA	NA
ATCTACTTCAACACAC-1_5981_BA9	-33.75346788	-13.33300401	9	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	738	1090	0.003669725	0.003669725	0	9	OPC	NA	NA	NA
ATCTGCCAGCCAACAG-1_5981_BA9	-7.244856856	-7.002474662	13A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1163	1701	0.005291005	0.004115226	0	13A	IN-VIP	NA	NA	NA
ATCTGCCCAGCCTTGG-1_5981_BA9	-26.82132312	-18.3379401	6A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3792	8769	0.037518531	0.003877295	0	6A	IN-PV	NA	NA	NA
ATCTGCCCAGCGATCC-1_5981_BA9	-9.099740733	-2.621247228	13A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1934	3325	0.000601504	0.006315789	0	13A	IN-VIP	NA	NA	NA
ATCTGCCCAGGGAGAG-1_5981_BA9	20.16636701	-3.7145442	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1807	3097	0.052308686	0.002583145	0	2	EN-L4	NA	NA	NA
ATCTGCCTCCGATATG-1_5981_BA9	-9.208796292	-18.69223429	6B	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	834	1265	0.009486166	0.003162055	0	6B	IN-SST	NA	NA	NA
ATCTGCCTCTTGGGTA-1_5981_BA9	-12.1111609	-13.40874197	6A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1449	2176	0.058823529	0.004136029	0	6A	IN-PV	NA	NA	NA
ATGAGGGTCGACAGCC-1_5981_BA9	26.74185173	7.520595959	15A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1269	1664	0.009014423	0.030649038	0	15A	Endo cells	NA	NA	NA
ATGCGATAGGACAGAA-1_5981_BA9	7.693368671	-1.384937781	12	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1143	1752	0.005136986	0.003995434	0	12	EN-MIX	NA	NA	NA
ATGGGAGAGAGTCTGG-1_5981_BA9	-26.71042553	-20.01595299	6A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1974	3142	0.028644176	0.010821133	0	6A	IN-PV	NA	NA	NA
ATGGGAGCAATCTGCA-1_5981_BA9	-21.08577406	-21.460149	6A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1961	3513	0.053515514	0.00284657	0	6A	IN-PV	NA	NA	NA
ATGGGAGGTGAAGGCT-1_5981_BA9	18.63692562	-10.9582162	3	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2671	5394	0.013718947	0.00945495	0	3	EN-L5-6	NA	NA	NA
ATGGGAGTCCGCAAGC-1_5981_BA9	27.10564119	4.886096262	15A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	929	1200	0.006666667	0.010833333	0	15A	Endo cells	NA	NA	NA
ATGGGAGTCGGATGGA-1_5981_BA9	30.02089658	-15.99716407	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3751	7927	0.013245869	0.009335184	0	2	EN-L4	NA	NA	NA
ATGTGTGAGAGAACAG-1_5981_BA9	24.66713646	7.102152874	15A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2181	3219	0.011494253	0.011494253	0	15A	Endo cells	NA	NA	NA
ATGTGTGAGTCAAGCG-1_5981_BA9	26.16735233	-17.68408353	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	5626	18119	0.03311441	0.00402892	0	2	EN-L4	NA	NA	NA
ATGTGTGCAATAGAGT-1_5981_BA9	5.396215253	-13.88385122	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2523	4920	0.012804878	0.006300813	0	L2-3	EN-L2-3-MS	NA	NA	NA
ATGTGTGCATGTTCCC-1_5981_BA9	30.78172845	-9.652862159	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2923	6384	0.013784461	0.003759398	0	2	EN-L4	NA	NA	NA
ATGTGTGGTATCAGTC-1_5981_BA9	20.40222324	-3.769927782	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1975	3331	0.019213449	0.003602522	0	2	EN-L4	NA	NA	NA
ATGTGTGTCGTTACGA-1_5981_BA9	-11.40931437	-15.02351264	6B	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1241	1905	0.033070866	0.005249344	0	6B	IN-SST	NA	NA	NA
ATTACTCAGTCTCAAC-1_5981_BA9	-8.984842552	-11.87620101	6B	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	906	1379	0.047860769	0.004350979	0	6B	IN-SST	NA	NA	NA
ATTACTCTCATGTCCC-1_5981_BA9	3.05190643	-7.470182448	12	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1280	2023	0.023727138	0.002965892	0	12	EN-MIX	NA	NA	NA
ATTATCCCAGGGCATA-1_5981_BA9	19.92469573	-11.48433614	3	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2866	5409	0.00314291	0.007764836	0	3	EN-L5-6	NA	NA	NA
ATTATCCGTACTTGAC-1_5981_BA9	-35.27847467	-12.78287027	9	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	815	1235	0.011336032	0.005668016	0	9	OPC	NA	NA	NA
ATTATCCTCGGGAGTA-1_5981_BA9	25.9228794	7.220276923	15A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1418	2000	0.0085	0.0175	0	15A	Endo cells	NA	NA	NA
ATTATCCTCTGTTGAG-1_5981_BA9	29.26397426	-17.09174336	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	5273	14863	0.022337348	0.008208302	0	2	EN-L4	NA	NA	NA
ATTCTACTCGGACAAG-1_5981_BA9	-19.17146553	-5.223353219	13B	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3074	6156	0.01137102	0.007797271	0	13B	IN-SV2C	NA	NA	NA
ATTGGACAGAATTCCC-1_5981_BA9	-19.13990737	-5.832707283	13B	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3503	7608	0.033123028	0.005651945	0	13B	IN-SV2C	NA	NA	NA
ATTGGACAGCGATCCC-1_5981_BA9	21.52162805	-2.708036744	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2158	3741	0.006148089	0.004009623	0	2	EN-L4	NA	NA	NA
ATTGGACCAGGACCCT-1_5981_BA9	-28.35605418	-20.71728537	6A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3966	9003	0.02365878	0.007553038	0	6A	IN-PV	NA	NA	NA
ATTGGTGCAACGATCT-1_5981_BA9	20.21376602	-4.165814187	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2177	3942	0.025621512	0.005327245	0	2	EN-L4	NA	NA	NA
ATTGGTGGTAGCACGA-1_5981_BA9	20.58259851	-3.518375152	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1846	2916	0.007544582	0.007887517	0	2	EN-L4	NA	NA	NA
ATTGGTGGTCTAAACC-1_5981_BA9	29.23392847	-16.445724	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	5474	16545	0.021456633	0.005862798	0	2	EN-L4	NA	NA	NA
ATTGGTGTCACTCCTG-1_5981_BA9	24.6093254	8.327560163	15A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2914	4909	0.009981666	0.02016704	0	15A	Endo cells	NA	NA	NA
ATTGGTGTCCCAACGG-1_5981_BA9	-11.74700093	-4.936618835	13A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2196	3654	0.009304871	0.006568144	0	13A	IN-VIP	NA	NA	NA
ATTTCTGAGCAGGCTA-1_5981_BA9	5.294601429	-12.33995152	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2069	3659	0.010385351	0.005465974	0	L2-3	EN-L2-3-MS	NA	NA	NA
ATTTCTGGTAACGCGA-1_5981_BA9	24.41415139	-27.36383	3	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3264	7878	0.001396293	0.003173394	0	3	EN-L5-6	NA	NA	NA
ATTTCTGTCACTGGGC-1_5981_BA9	30.70930462	-12.59785722	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2939	6016	0.018450798	0.004654255	0	2	EN-L4	NA	NA	NA
ATTTCTGTCAGTGTTG-1_5981_BA9	5.29586758	-13.66700995	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2300	4393	0.015479171	0.003186888	0	L2-3	EN-L2-3-MS	NA	NA	NA
ATTTCTGTCGTTGCCT-1_5981_BA9	26.21254251	-17.36803933	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	4737	13629	0.027588231	0.004769242	0	2	EN-L4	NA	NA	NA
ATTTCTGTCTATCCTA-1_5981_BA9	-11.55054115	-27.34661354	16	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	807	1197	0.170426065	0.006683375	0	16	EN-PYR	NA	NA	NA
ATTTCTGTCTCTTATG-1_5981_BA9	2.677168711	-20.36372692	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3310	8730	0.006414662	0.002863688	0	L2-3	EN-L2-3-MS	NA	NA	NA
CAACCAATCAACTCTT-1_5981_BA9	-5.613510643	-8.268082217	13A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	866	1175	0.007659574	0.007659574	0	13A	IN-VIP	NA	NA	NA
CAACCTCCACATGGGA-1_5981_BA9	-14.19638495	-15.43517452	6B	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1447	2464	0.039772727	0.003246753	0	6B	IN-SST	NA	NA	NA
CAACCTCGTTTGTTGG-1_5981_BA9	-34.87148925	-12.08748185	9	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	815	1179	0	0.003392706	0	9	OPC	NA	NA	NA
CAACCTCTCTGCAGTA-1_5981_BA9	18.71543089	-7.202347132	3	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2037	3943	0.000253614	0.005579508	0	3	EN-L5-6	NA	NA	NA
CAAGAAACAGCATGAG-1_5981_BA9	-6.49736614	-32.81348276	16	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	820	1095	0.048401826	0.010958904	0	16	EN-PYR	NA	NA	NA
CAAGAAACAGCCACCA-1_5981_BA9	3.900317766	-9.155473337	12	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1486	2246	0.00445236	0.00890472	0	12	EN-MIX	NA	NA	NA
CAAGAAACAGTCGTGC-1_5981_BA9	16.72800917	-18.24173251	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	5376	16049	0.00984485	0.004610879	0	L2-3	EN-L2-3-MS	NA	NA	NA
CAAGAAACATGGTAGG-1_5981_BA9	-31.70983878	-13.33266067	9	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	767	1023	0.000977517	0.002932551	0	9	OPC	NA	NA	NA
CAAGAAAGTAGGAGTC-1_5981_BA9	19.70570911	-3.441790009	12	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1403	2085	0.036930456	0.001918465	0	12	EN-MIX	NA	NA	NA
CAAGAAATCCACTCCA-1_5981_BA9	3.910302953	-13.94419725	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2323	4510	0.009756098	0.005764967	0	L2-3	EN-L2-3-MS	NA	NA	NA
CAAGAAATCGTTTGCC-1_5981_BA9	-36.69727937	-10.28710061	9	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	981	1559	0.002565747	0.003207184	0	9	OPC	NA	NA	NA
CAAGATCCACTGTCGG-1_5981_BA9	29.95893871	-3.441540874	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3403	8668	0.001153669	0.003230272	0	2	EN-L4	NA	NA	NA
CAAGATCTCGTGGGAA-1_5981_BA9	8.380972632	-10.95554246	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2447	4222	0.007105637	0.003079109	0	L2-3	EN-L2-3-MS	NA	NA	NA
CAAGGCCCACTTAACG-1_5981_BA9	28.54976894	-17.03576584	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	4943	12917	0.025625145	0.005419215	0	2	EN-L4	NA	NA	NA
CAAGGCCCAGTTCATG-1_5981_BA9	11.77944148	-20.18005233	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3849	9369	0.006404099	0.004589604	0	L2-3	EN-L2-3-MS	NA	NA	NA
CAAGTTGCAAGTAGTA-1_5981_BA9	-8.797475014	-31.62919135	16	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1088	1486	0.037012113	0.011440108	0	16	EN-PYR	NA	NA	NA
CAAGTTGCAAGTTAAG-1_5981_BA9	-7.096264452	-8.448451651	13A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	960	1308	0.010703364	0.010703364	0	13A	IN-VIP	NA	NA	NA
CAAGTTGCACTGCCAG-1_5981_BA9	-26.21368447	-20.09993271	6A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1899	3133	0.027130546	0.006064475	0	6A	IN-PV	NA	NA	NA
CAAGTTGGTAAAGTCA-1_5981_BA9	25.52765868	5.546535212	15A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1225	1596	0.008145363	0.005639098	0	15A	Endo cells	NA	NA	NA
CAAGTTGTCCGGCACA-1_5981_BA9	25.96516812	6.867596268	15A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1329	1905	0.019947507	0.015223097	0	15A	Endo cells	NA	NA	NA
CACAAACCAGATCTGT-1_5981_BA9	30.4039395	-10.26869373	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3666	9192	0.008050479	0.002175805	0	2	EN-L4	NA	NA	NA
CACAAACCATCCTTGC-1_5981_BA9	27.05002008	-13.69967289	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	5146	14695	0.017965294	0.005239878	0	L2-3	EN-L2-3-MS	NA	NA	NA
CACAAACTCCAACCAA-1_5981_BA9	-14.04825734	-15.20214157	6B	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1473	2380	0.012605042	0.004201681	0	6B	IN-SST	NA	NA	NA
CACAAACTCGCACTCT-1_5981_BA9	11.71018351	-20.6234348	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	5217	16735	0.003525545	0.00394383	0	L2-3	EN-L2-3-MS	NA	NA	NA
CACACAAAGCGAAGGG-1_5981_BA9	5.576235853	-10.29728755	12	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1695	2542	0.001573564	0.014555468	0	12	EN-MIX	NA	NA	NA
CACACAATCCAAACAC-1_5981_BA9	-32.95201201	-10.62788704	9	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	887	1326	0.002262443	0.003016591	0	9	OPC	NA	NA	NA
CACACCTCAGTTCATG-1_5981_BA9	-28.11073736	9.454383843	8	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	732	1000	0.002	0.004	0	8	Astrocytes	NA	NA	NA
CACACCTTCAACACTG-1_5981_BA9	31.23942245	-12.08703581	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3061	6052	0.014375413	0.00677462	0	2	EN-L4	NA	NA	NA
CACACCTTCCCAAGAT-1_5981_BA9	-19.98521777	-20.96679178	6A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1700	2930	0.027645051	0.00443686	0	6A	IN-PV	NA	NA	NA
CACACTCAGAACAACT-1_5981_BA9	17.49624971	0.866967275	12	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	981	1582	0.004424779	0.001264223	0	12	EN-MIX	NA	NA	NA
CACACTCGTACCGCTG-1_5981_BA9	23.18194627	-24.84535134	3	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3391	8312	0.004571704	0.006857555	0	3	EN-L5-6	NA	NA	NA
CACACTCTCCCTAATT-1_5981_BA9	-26.22315602	-23.90906107	6A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	5111	15132	0.03628073	0.003899022	0	6A	IN-PV	NA	NA	NA
CACAGGCGTAACGTTC-1_5981_BA9	19.91897298	-15.53239737	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	4666	12034	0.010470334	0.004819678	0	L2-3	EN-L2-3-MS	NA	NA	NA
CACAGGCGTAAGTGTA-1_5981_BA9	20.01922852	-11.79191731	12	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2363	3867	0.01939488	0.009050944	0	12	EN-MIX	NA	NA	NA
CACAGGCTCGCTTGTC-1_5981_BA9	-13.57169486	-36.38388455	16	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1722	2929	0.059747354	0.00990099	0	16	EN-PYR	NA	NA	NA
CACAGGCTCGTTGCCT-1_5981_BA9	17.94986359	-17.74386999	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	5520	16799	0.008750521	0.003571641	0	L2-3	EN-L2-3-MS	NA	NA	NA
CACAGTAAGATCGGGT-1_5981_BA9	-9.253187542	-15.71750813	6B	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	838	1181	0.00762066	0.008467401	0	6B	IN-SST	NA	NA	NA
CACAGTAAGGACATTA-1_5981_BA9	-13.95329634	-23.80179133	6A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1420	2478	0.00322841	0.004842615	0	6A	IN-PV	NA	NA	NA
CACAGTACACAACGTT-1_5981_BA9	-14.20611866	-6.096531145	13A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2584	5029	0.003778087	0.005567707	0	13A	IN-VIP	NA	NA	NA
CACAGTATCCCACTTG-1_5981_BA9	4.039705177	-13.63011795	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2208	4113	0.006807683	0.005348894	0	L2-3	EN-L2-3-MS	NA	NA	NA
CACATAGCACAAGCCC-1_5981_BA9	-28.98925141	9.748009956	8	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	768	1051	0.004757374	0.003805899	0	8	Astrocytes	NA	NA	NA
CACATAGCACGCATCG-1_5981_BA9	30.06022583	-15.63400165	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3842	8915	0.019517667	0.006618059	0	2	EN-L4	NA	NA	NA
CACATAGTCAAGCCTA-1_5981_BA9	-26.10775082	21.69154073	8	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1115	1553	0.01030264	0.00257566	0	8	Astrocytes	NA	NA	NA
CACATTTAGGGCTCTC-1_5981_BA9	-23.87291221	25.25735403	8	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1544	2532	0.00671406	0.005529226	0	8	Astrocytes	NA	NA	NA
CACATTTTCAGCTCTC-1_5981_BA9	30.98180108	-12.16927625	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3320	7461	0.014609302	0.00482509	0	2	EN-L4	NA	NA	NA
CACATTTTCTGTCCGT-1_5981_BA9	-9.168224734	-16.57722343	6B	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	790	1172	0.017064846	0.004266212	0	6B	IN-SST	NA	NA	NA
CACCACTAGGGTTTCT-1_5981_BA9	20.04794782	-15.49641698	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	4481	11595	0.027943079	0.006037085	0	L2-3	EN-L2-3-MS	NA	NA	NA
CACCACTAGTGTTTGC-1_5981_BA9	23.27726376	-24.95028812	3	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3108	7569	0.005945303	0.002906593	0	3	EN-L5-6	NA	NA	NA
CACCACTAGTTCCACA-1_5981_BA9	-22.68687648	-23.04475501	6A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2654	5753	0.010255519	0.004345559	0	6A	IN-PV	NA	NA	NA
CACCACTGTTGTACAC-1_5981_BA9	-0.722251517	36.41103059	1	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	790	1056	0.001893939	0.003787879	0	oligos	OL-Cntl	NA	NA	NA
CACCAGGAGGTAGCTG-1_5981_BA9	-8.462226289	-3.049097601	13A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1841	3426	0.004086398	0.006713368	0	13A	IN-VIP	NA	NA	NA
CACCAGGTCTATCCCG-1_5981_BA9	27.69948547	5.911828297	15A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	899	1222	0.004909984	0.012274959	0	15A	Endo cells	NA	NA	NA
CACCTTGGTCTGGTCG-1_5981_BA9	28.75386184	-17.04541481	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	6670	23866	0.014497612	0.00615939	0	2	EN-L4	NA	NA	NA
CACTCCAAGTCTCAAC-1_5981_BA9	-26.23464953	-20.52022332	6A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2560	5024	0.030453822	0.006170382	0	6A	IN-PV	NA	NA	NA
CACTCCACACAGAGGT-1_5981_BA9	20.21040481	-15.46229193	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	5102	14688	0.020288671	0.004221133	0	L2-3	EN-L2-3-MS	NA	NA	NA
CACTCCACACCATGTA-1_5981_BA9	-19.29176045	13.08820287	8	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1215	1784	0.007847534	0.003363229	0	8	Astrocytes	NA	NA	NA
CACTCCAGTCCAGTGC-1_5981_BA9	-16.48379224	-3.964502475	13A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2611	5295	0.013031161	0.004721435	0	13A	IN-VIP	NA	NA	NA
CACTCCAGTGAGTATA-1_5981_BA9	10.88303599	-21.02969404	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	4193	11698	0.002393572	0.003761327	0	L2-3	EN-L2-3-MS	NA	NA	NA
CACTCCAGTGATGTGG-1_5981_BA9	30.73604543	-14.55709814	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2601	4505	0.016204218	0.004661487	0	2	EN-L4	NA	NA	NA
CACTCCAGTGTAACGG-1_5981_BA9	-10.22232957	-10.40029752	6B	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1587	2525	0.076039604	0.003960396	0	6B	IN-SST	NA	NA	NA
CACTCCATCACTGGGC-1_5981_BA9	17.70592633	-17.81402472	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3656	9146	0.030723814	0.003280122	0	L2-3	EN-L2-3-MS	NA	NA	NA
CAGAATCCAGCTTCGG-1_5981_BA9	30.62913764	-14.68889927	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2970	6618	0.055303717	0.002719855	0	2	EN-L4	NA	NA	NA
CAGAATCTCCTTGACC-1_5981_BA9	17.63034273	-17.11701817	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	5011	13785	0.014363439	0.007544432	0	L2-3	EN-L2-3-MS	NA	NA	NA
CAGAATCTCTTCAACT-1_5981_BA9	-32.40908733	-9.591728147	9	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	942	1412	0.002124646	0.003541076	0	9	OPC	NA	NA	NA
CAGAGAGCACGAAACG-1_5981_BA9	-29.84454109	9.811523215	8	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	773	1017	0.008849558	0.004916421	0	8	Astrocytes	NA	NA	NA
CAGATCACAATAGCAA-1_5981_BA9	20.19184362	-27.08288384	3	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3062	6724	0.001338489	0.005800119	0	3	EN-L5-6	NA	NA	NA
CAGATCATCTCTTGAT-1_5981_BA9	24.21314989	-23.26915019	3	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	4165	10781	0.006400148	0.003802987	0	3	EN-L5-6	NA	NA	NA
CAGCAGCGTTGGGACA-1_5981_BA9	-8.877707093	-5.01380071	13A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1743	2968	0.005053908	0.007749326	0	13A	IN-VIP	NA	NA	NA
CAGCATAAGAATCTCC-1_5981_BA9	16.90594412	-16.29760299	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	7067	26838	0.022989791	0.014717937	0	L2-3	EN-L2-3-MS	NA	NA	NA
CAGCATAAGTGTGAAT-1_5981_BA9	-12.07923519	-13.40836186	6A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1414	2084	0.047984645	0.005278311	0	6A	IN-PV	NA	NA	NA
CAGCATACAAGCCATT-1_5981_BA9	-28.79114435	10.1480284	8	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	732	1023	0.002932551	0.004887586	0	8	Astrocytes	NA	NA	NA
CAGCATACATCAGTAC-1_5981_BA9	-6.85681032	-6.734139959	13A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1154	1819	0.004398021	0.003298516	0	13A	IN-VIP	NA	NA	NA
CAGCCGACAAGAGTCG-1_5981_BA9	28.55778858	-16.09923761	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	4324	11204	0.016601214	0.004819707	0	2	EN-L4	NA	NA	NA
CAGCCGATCTGGAGCC-1_5981_BA9	-14.21782789	-22.10708418	6A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1203	1749	0.008004574	0.002287021	0	6A	IN-PV	NA	NA	NA
CAGCCGATCTTCATGT-1_5981_BA9	27.53232062	-17.52881874	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	6677	24582	0.024896266	0.005695224	0	2	EN-L4	NA	NA	NA
CAGCGACAGCCACTAT-1_5981_BA9	-34.36721811	-12.66972084	9	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	904	1363	0.002201027	0.004402054	0	9	OPC	NA	NA	NA
CAGCTAATCTATCCCG-1_5981_BA9	22.36699047	17.74716744	1	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1121	1659	0.004822182	0.004219409	0	oligos	OL-Cntl	NA	NA	NA
CAGCTGGAGTCACGCC-1_5981_BA9	19.94044449	-11.24090015	3	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2256	4069	0.003440649	0.004177931	0	3	EN-L5-6	NA	NA	NA
CAGCTGGAGTGGGTTG-1_5981_BA9	25.71326555	7.038178288	15A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1473	2053	0.015586946	0.01899659	0	15A	Endo cells	NA	NA	NA
CAGCTGGCAAAGCAAT-1_5981_BA9	18.44222144	-18.46484925	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3792	8861	0.019410902	0.004401309	0	L2-3	EN-L2-3-MS	NA	NA	NA
CAGCTGGCAATGGACG-1_5981_BA9	-8.592102831	-15.9662613	6B	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	698	1089	0.117539027	0.000918274	0	6B	IN-SST	NA	NA	NA
CAGCTGGGTCGACTGC-1_5981_BA9	6.799038836	-11.99319245	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2323	4656	0.013530928	0.005154639	0	L2-3	EN-L2-3-MS	NA	NA	NA
CAGCTGGTCCGCGGTA-1_5981_BA9	16.78061539	-28.02618885	3	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3694	9426	0.007850626	0.003713134	0	3	EN-L5-6	NA	NA	NA
CAGCTGGTCTTGTTTG-1_5981_BA9	-31.5341595	-10.67787186	9	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	884	1283	0.001558846	0.003897116	0	9	OPC	NA	NA	NA
CAGGTGCAGATGAGAG-1_5981_BA9	7.492667704	-15.0075067	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3047	6480	0.018055556	0.007253086	0	L2-3	EN-L2-3-MS	NA	NA	NA
CAGGTGCAGTGAATTG-1_5981_BA9	-12.40397835	-34.83371878	16	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1372	2120	0.029716981	0.006603774	0	16	EN-PYR	NA	NA	NA
CAGGTGCGTGGGTCAA-1_5981_BA9	-15.56346656	-23.0187572	6A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1629	2775	0.00036036	0.002882883	0	6A	IN-PV	NA	NA	NA
CAGTAACAGATGTGGC-1_5981_BA9	5.048339794	-14.44431606	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2314	4365	0.009392898	0.002978236	0	L2-3	EN-L2-3-MS	NA	NA	NA
CAGTAACCAACACCTA-1_5981_BA9	32.12344244	-1.395440391	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2383	5113	0.003129278	0.005671817	0	2	EN-L4	NA	NA	NA
CAGTCCTAGTTGCAGG-1_5981_BA9	17.75806589	-17.62225	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	4330	11243	0.019300898	0.003468825	0	L2-3	EN-L2-3-MS	NA	NA	NA
CAGTCCTCAATACGCT-1_5981_BA9	-24.044406	-20.58728113	6A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2945	6335	0.01925809	0.004262036	0	6A	IN-PV	NA	NA	NA
CAGTCCTGTTCCGGCA-1_5981_BA9	-7.84098024	-34.48703041	16	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	834	1115	0.041255605	0.009865471	0	16	EN-PYR	NA	NA	NA
CATATGGCACGCATCG-1_5981_BA9	-18.31497554	-4.760855076	13A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2307	4111	0.01362199	0.006810995	0	13A	IN-VIP	NA	NA	NA
CATATGGTCCCACTTG-1_5981_BA9	24.39353838	-19.11199904	3	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	5057	14355	0.011424591	0.004667363	0	3	EN-L5-6	NA	NA	NA
CATATGGTCGCTTAGA-1_5981_BA9	31.17413619	-1.392754987	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2515	5454	0.000366703	0.004950495	0	2	EN-L4	NA	NA	NA
CATATTCAGCTCCCAG-1_5981_BA9	-34.80880133	-12.23149699	9	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	841	1242	0.000805153	0.003220612	0	9	OPC	NA	NA	NA
CATATTCCAAAGTCAA-1_5981_BA9	26.49094837	3.859643027	15BA	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	713	1086	0.001841621	0.002762431	0	15BA	Stromal cells	NA	NA	NA
CATATTCCAATGAATG-1_5981_BA9	10.83263888	-20.90316778	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3729	9132	0.005256242	0.002737626	0	L2-3	EN-L2-3-MS	NA	NA	NA
CATATTCCATAAAGGT-1_5981_BA9	29.62501814	-13.26722301	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3802	8396	0.010004764	0.007622677	0	2	EN-L4	NA	NA	NA
CATATTCGTAAGTGGC-1_5981_BA9	-10.99848715	-31.06340636	16	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1132	1644	0.027980535	0.007907543	0	16	EN-PYR	NA	NA	NA
CATATTCGTTGTTTGG-1_5981_BA9	25.02953158	-18.90770536	3	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	4242	11002	0.011088893	0.002908562	0	3	EN-L5-6	NA	NA	NA
CATCAAGAGGTGCACA-1_5981_BA9	6.162015193	-13.68767701	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2419	4521	0.01238664	0.01592568	0	L2-3	EN-L2-3-MS	NA	NA	NA
CATCAAGGTGAGGCTA-1_5981_BA9	-21.40263003	-24.49805424	6A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2643	5365	0.002795899	0.004473439	0	6A	IN-PV	NA	NA	NA
CATCAAGGTGCAGTAG-1_5981_BA9	-22.38897359	-22.07654857	6A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2627	5140	0.012840467	0.005836576	0	6A	IN-PV	NA	NA	NA
CATCAAGTCAAACGGG-1_5981_BA9	-24.93945895	-21.68341248	6A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3120	6392	0.015331665	0.005006258	0	6A	IN-PV	NA	NA	NA
CATCAAGTCGTACGGC-1_5981_BA9	4.2422658	-11.18170904	12	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1724	2869	0.006273963	0.007319624	0	12	EN-MIX	NA	NA	NA
CATCAAGTCTTGAGGT-1_5981_BA9	-11.79610668	-13.39987078	6B	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1454	2432	0.027138158	0.005756579	0	6B	IN-SST	NA	NA	NA
CATCAGACACAGTCGC-1_5981_BA9	23.03096607	-17.11583425	3	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3925	9365	0.012600107	0.011425521	0	3	EN-L5-6	NA	NA	NA
CATCCACAGCCAGGAT-1_5981_BA9	28.3821878	-18.18486264	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	8414	39907	0.033828652	0.010524469	0	2	EN-L4	NA	NA	NA
CATCCACCACTCTGTC-1_5981_BA9	-25.59778343	-18.14763215	6B	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2620	5231	0.005352705	0.005735041	0	6B	IN-SST	NA	NA	NA
CATCCACCATCATCCC-1_5981_BA9	30.7771781	-12.39445686	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2824	5747	0.00817818	0.006438142	0	2	EN-L4	NA	NA	NA
CATCCACCATGGTCTA-1_5981_BA9	-27.3404363	8.516744619	8	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	716	1023	0.00684262	0.005865103	0	8	Astrocytes	NA	NA	NA
CATCCACCATTTGCTT-1_5981_BA9	30.78996185	-14.96746727	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2976	6214	0.011908593	0.006919858	0	2	EN-L4	NA	NA	NA
CATCCACTCATGGTCA-1_5981_BA9	3.559930668	-26.92690443	10	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3320	8166	0.002694097	0.002571639	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CATCGAAAGAGGTTGC-1_5981_BA9	-12.12019595	-14.92959047	6B	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1347	2054	0.017039922	0.004868549	0	6B	IN-SST	NA	NA	NA
CATCGAAAGTCCATAC-1_5981_BA9	6.205890649	-14.68425609	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2933	6195	0.005488297	0.008071025	0	L2-3	EN-L2-3-MS	NA	NA	NA
CATCGAACACAGTCGC-1_5981_BA9	-8.579881511	-16.55975614	6B	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	730	1046	0.005736138	0.003824092	0	6B	IN-SST	NA	NA	NA
CATCGGGTCCCGGATG-1_5981_BA9	27.78655342	7.268641743	15A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	995	1377	0.012345679	0.026870007	0	15A	Endo cells	NA	NA	NA
CATGACACAGGGTTAG-1_5981_BA9	-8.755273739	-27.04966455	16	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	999	1534	0.037157757	0.002607562	0	16	EN-PYR	NA	NA	NA
CATGACAGTGCAGACA-1_5981_BA9	21.51534252	-2.475070785	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1927	3327	0.00270514	0.003606853	0	2	EN-L4	NA	NA	NA
CATGGCGAGCTAGGCA-1_5981_BA9	1.775266763	30.62033295	1	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	742	1030	0.001941748	0.004854369	0	oligos	OL-Cntl	NA	NA	NA
CATGGCGCAGTATGCT-1_5981_BA9	-7.216738661	-7.742830756	13A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1118	1631	0.00797057	0.006131208	0	13A	IN-VIP	NA	NA	NA
CATGGCGTCATGTCTT-1_5981_BA9	16.36087512	-18.36891444	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	5081	13466	0.00876281	0.0040101	0	L2-3	EN-L2-3-MS	NA	NA	NA
CATTATCAGGTAGCTG-1_5981_BA9	11.18871796	-20.55168523	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3064	6738	0.00593648	0.005788068	0	L2-3	EN-L2-3-MS	NA	NA	NA
CATTATCTCAGCTCGG-1_5981_BA9	24.22252596	-19.54182822	3	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	4559	12370	0.012934519	0.004042037	0	3	EN-L5-6	NA	NA	NA
CATTATCTCCACTCCA-1_5981_BA9	24.00621484	-19.64988472	3	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	5508	18305	0.012728763	0.004261131	0	3	EN-L5-6	NA	NA	NA
CATTCGCAGAAACCGC-1_5981_BA9	-3.159152145	23.97183197	1	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	917	1176	0.003401361	0.009353741	0	oligos	OL-Cntl	NA	NA	NA
CATTCGCAGGGATACC-1_5981_BA9	17.84636811	-17.68218767	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	5342	15633	0.014264696	0.003070428	0	L2-3	EN-L2-3-MS	NA	NA	NA
CATTCGCCACACATGT-1_5981_BA9	-13.53535598	-21.23605476	6A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1201	1863	0.015029522	0.003220612	0	6A	IN-PV	NA	NA	NA
CATTCGCTCAGTTAGC-1_5981_BA9	4.999543449	-13.79240341	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2272	4194	0.008345255	0.001430615	0	L2-3	EN-L2-3-MS	NA	NA	NA
CATTCGCTCGTCGTTC-1_5981_BA9	33.72467327	-3.205358325	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2281	4384	0.004105839	0.004562044	0	2	EN-L4	NA	NA	NA
CCAATCCGTCTCCATC-1_5981_BA9	-15.34583169	-37.11094948	16	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2829	5651	0.048840913	0.008317112	0	16	EN-PYR	NA	NA	NA
CCACCTAAGATGCCAG-1_5981_BA9	17.25940578	-17.93735283	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3996	9578	0.027667572	0.005742326	0	L2-3	EN-L2-3-MS	NA	NA	NA
CCACCTAAGGCATGGT-1_5981_BA9	-19.02343461	-5.609904172	13B	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3236	6906	0.012018535	0.005647263	0	13B	IN-SV2C	NA	NA	NA
CCACCTAGTTAGGGTG-1_5981_BA9	-8.567846065	-5.604117856	13A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1508	2324	0.008605852	0.007745267	0	13A	IN-VIP	NA	NA	NA
CCACCTATCACCAGGC-1_5981_BA9	11.0320918	-20.62914491	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3627	9021	0.005320918	0.002549606	0	L2-3	EN-L2-3-MS	NA	NA	NA
CCACGGAAGGCGCTCT-1_5981_BA9	-21.78493028	-24.519662	6A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2601	5391	0.00556483	0.00556483	0	6A	IN-PV	NA	NA	NA
CCACGGACAATGGACG-1_5981_BA9	22.22055006	-19.36418131	3	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	5414	16851	0.00551896	0.003679307	0	3	EN-L5-6	NA	NA	NA
CCACGGACACATGTGT-1_5981_BA9	30.67708427	-12.78636695	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2908	6168	0.019130999	0.002918288	0	2	EN-L4	NA	NA	NA
CCACGGACATCCCACT-1_5981_BA9	-27.80148185	-20.96732143	6A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3611	7871	0.02655317	0.008131114	0	6A	IN-PV	NA	NA	NA
CCACGGAGTATGGTTC-1_5981_BA9	-32.73730672	-10.54772611	9	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	899	1306	0.00229709	0.003828484	0	9	OPC	NA	NA	NA
CCACGGATCACCCTCA-1_5981_BA9	-0.141864697	28.51645443	1	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	757	1043	0.000958773	0.003835091	0	oligos	OL-Cntl	NA	NA	NA
CCACGGATCTTGCAAG-1_5981_BA9	-8.743855477	-15.84296123	6B	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	714	1002	0.013972056	0	0	6B	IN-SST	NA	NA	NA
CCACTACCACTGTTAG-1_5981_BA9	20.57097114	28.55087963	17	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	876	1226	0.004078303	0.000815661	0	oligos	OL-MS-2	NA	NA	NA
CCACTACGTTCGTCTC-1_5981_BA9	6.636656177	-15.13160994	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3139	6638	0.006025911	0.005122025	0	L2-3	EN-L2-3-MS	NA	NA	NA
CCAGCGAAGTCATCCA-1_5981_BA9	4.921028434	-11.75663457	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1914	3363	0.004460303	0.004757657	0	L2-3	EN-L2-3-MS	NA	NA	NA
CCAGCGACACCGCTAG-1_5981_BA9	-12.5783284	-35.23166971	16	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1618	2873	0.100939784	0.008353637	0	16	EN-PYR	NA	NA	NA
CCAGCGACATCGGACC-1_5981_BA9	6.161908349	-28.56894145	10	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3097	7111	0.001828154	0.00253129	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CCAGCGACATGCCCGA-1_5981_BA9	23.42834209	-24.33184756	3	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3654	9001	0.008665704	0.00266637	0	3	EN-L5-6	NA	NA	NA
CCAGCGAGTCAGAAGC-1_5981_BA9	4.994927486	-9.719944613	12	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1546	2508	0.010366826	0.002791069	0	12	EN-MIX	NA	NA	NA
CCATGTCAGTGCGTGA-1_5981_BA9	25.03665291	6.821019638	15A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1697	2469	0.011745646	0.013365735	0	15A	Endo cells	NA	NA	NA
CCATGTCGTAAACGCG-1_5981_BA9	-27.75682447	-20.09067948	6A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2717	5132	0.02650039	0.006430242	0	6A	IN-PV	NA	NA	NA
CCATGTCGTTACGACT-1_5981_BA9	-12.1877376	-8.49428492	13B	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2194	3813	0.008916863	0.006556517	0	13B	IN-SV2C	NA	NA	NA
CCATGTCTCGATGAGG-1_5981_BA9	-24.88362452	-21.31123293	6A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3678	7455	0.010328638	0.006304494	0	6A	IN-PV	NA	NA	NA
CCATTCGAGTAATCCC-1_5981_BA9	-9.172174232	-16.98268124	6B	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	752	1105	0.022624434	0.00361991	0	6B	IN-SST	NA	NA	NA
CCATTCGGTAAGTGGC-1_5981_BA9	5.165732635	-0.418745917	16	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1391	2153	0.026474686	0.011147236	0	16	EN-PYR	NA	NA	NA
CCATTCGGTACTCAAC-1_5981_BA9	-20.54592464	-25.82343614	6A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3043	6938	0.004324013	0.00230614	0	6A	IN-PV	NA	NA	NA
CCATTCGGTATCTGCA-1_5981_BA9	10.27049511	-1.372109038	12	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1256	1793	0.022866704	0.00501952	0	12	EN-MIX	NA	NA	NA
CCCAATCAGGCAGTCA-1_5981_BA9	-24.80079389	-19.90112731	6A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3318	7407	0.034156879	0.005130282	0	6A	IN-PV	NA	NA	NA
CCCAATCGTGCGAAAC-1_5981_BA9	-9.727966024	-4.137804302	13A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1774	2721	0.010290334	0.008085263	0	13A	IN-VIP	NA	NA	NA
CCCAGTTAGCCAGTAG-1_5981_BA9	-28.86996795	9.81763894	8	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	690	1007	0.004965243	0.004965243	0	8	Astrocytes	NA	NA	NA
CCCAGTTAGTACGCGA-1_5981_BA9	23.78842054	-21.24512057	3	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3855	10018	0.005889399	0.00319425	0	3	EN-L5-6	NA	NA	NA
CCCAGTTCAAGGGTCA-1_5981_BA9	27.2220485	4.823228608	15A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	862	1098	0.041894353	0.009107468	0	15A	Endo cells	NA	NA	NA
CCCAGTTCAATCCGAT-1_5981_BA9	-23.03107831	-24.13372965	6A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3226	7492	0.004004271	0.003203417	0	6A	IN-PV	NA	NA	NA
CCCAGTTGTATGAAAC-1_5981_BA9	-25.64626353	-24.61644933	6A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	4399	11151	0.018473679	0.003049054	0	6A	IN-PV	NA	NA	NA
CCCAGTTTCCTTTACA-1_5981_BA9	27.17547792	-17.28183127	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	8268	40476	0.021321277	0.005632968	0	2	EN-L4	NA	NA	NA
CCCATACTCCCTCTTT-1_5981_BA9	19.15557184	-19.84860153	3	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	4120	11116	0.013314142	0.003958258	0	3	EN-L5-6	NA	NA	NA
CCCTCCTAGAAAGTGG-1_5981_BA9	5.468719052	-8.718970772	12	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1410	2246	0.008459484	0.004007124	0	12	EN-MIX	NA	NA	NA
CCCTCCTAGCGTGAGT-1_5981_BA9	-11.47562819	-17.71707667	6B	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	964	1429	0.031490553	0.00349895	0	6B	IN-SST	NA	NA	NA
CCCTCCTTCTCAACTT-1_5981_BA9	28.68251792	-15.92814331	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2807	5259	0.025289979	0.004563605	0	2	EN-L4	NA	NA	NA
CCGGGATCATCACGTA-1_5981_BA9	-27.1540308	-20.79017753	6A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3124	6439	0.036806958	0.00341668	0	6A	IN-PV	NA	NA	NA
CCGGTAGCAGCGTTCG-1_5981_BA9	9.44346274	-2.549757698	12	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1488	2556	0.016040689	0.003521127	0	12	EN-MIX	NA	NA	NA
CCGGTAGGTCATATCG-1_5981_BA9	-13.51673736	-5.241352851	13A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2400	4841	0.004751084	0.008262756	0	13A	IN-VIP	NA	NA	NA
CCGTACTCACAGCCCA-1_5981_BA9	-28.31012809	-20.59842029	6A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3783	9075	0.078677686	0.005950413	0	6A	IN-PV	NA	NA	NA
CCGTGGACAAGCGTAG-1_5981_BA9	5.305998668	-9.260205862	12	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1444	2131	0.004692633	0.015016424	0	12	EN-MIX	NA	NA	NA
CCGTGGACACGAGAGT-1_5981_BA9	-5.187601023	-3.776873745	13A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1378	2260	0.003982301	0.005752212	0	13A	IN-VIP	NA	NA	NA
CCGTGGACACGCCAGT-1_5981_BA9	-10.28834279	-7.768886315	13A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1597	2574	0.008935509	0.002331002	0	13A	IN-VIP	NA	NA	NA
CCGTGGAGTAAGGATT-1_5981_BA9	19.78846813	-3.559090852	12	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1444	2218	0.020288548	0.00270514	0	12	EN-MIX	NA	NA	NA
CCGTGGAGTAGAAGGA-1_5981_BA9	27.92797066	-17.96437315	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	5783	17965	0.048260507	0.005844698	0	2	EN-L4	NA	NA	NA
CCGTGGATCGAACGGA-1_5981_BA9	17.5008904	-17.7681583	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	4368	11076	0.017515349	0.005146262	0	L2-3	EN-L2-3-MS	NA	NA	NA
CCGTTCATCCGGGTGT-1_5981_BA9	14.59504282	-30.79097663	3	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3439	8663	0.000923468	0.003232137	0	3	EN-L5-6	NA	NA	NA
CCGTTCATCTTCGGTC-1_5981_BA9	3.858570959	-9.653968847	12	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1500	2341	0.002990175	0.008543358	0	12	EN-MIX	NA	NA	NA
CCTAAAGAGGATTCGG-1_5981_BA9	17.93876642	-17.38634165	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3289	7125	0.039438596	0.004350877	0	L2-3	EN-L2-3-MS	NA	NA	NA
CCTACACCACCACCAG-1_5981_BA9	-35.73038855	-10.17226475	9	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	875	1381	0.005068791	0.005068791	0	9	OPC	NA	NA	NA
CCTACACCACGAAACG-1_5981_BA9	-33.78699202	-13.26836133	9	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	719	1060	0.008490566	0.000943396	0	9	OPC	NA	NA	NA
CCTACACTCCAAACAC-1_5981_BA9	25.97697029	7.349129982	15A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1497	2162	0.01480111	0.022201665	0	15A	Endo cells	NA	NA	NA
CCTACACTCTCGCTTG-1_5981_BA9	1.614601147	-18.26257294	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2840	6160	0.001298701	0.003733766	0	L2-3	EN-L2-3-MS	NA	NA	NA
CCTACCAGTACAAGTA-1_5981_BA9	-13.99351035	-5.39195838	13A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2922	6116	0.004905167	0.006376717	0	13A	IN-VIP	NA	NA	NA
CCTAGCTGTCGTTGTA-1_5981_BA9	4.162749021	-4.21356274	12	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1156	1694	0.001770956	0.014757969	0	12	EN-MIX	NA	NA	NA
CCTAGCTTCTAACTCT-1_5981_BA9	-17.00757545	-25.79804123	6A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2112	4378	0.001142074	0.000685244	0	6A	IN-PV	NA	NA	NA
CCTATTAAGCTGGAAC-1_5981_BA9	4.204501155	-3.506477838	12	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1037	1638	0.004273504	0.004273504	0	12	EN-MIX	NA	NA	NA
CCTATTAAGGCGATAC-1_5981_BA9	-17.21736662	-3.884091748	13A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2547	4659	0.021463833	0.01030264	0	13A	IN-VIP	NA	NA	NA
CCTATTACAGGAATGC-1_5981_BA9	6.015250617	-1.653996592	12	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	804	1051	0.019980971	0.024738344	0	12	EN-MIX	NA	NA	NA
CCTATTAGTTATTCTC-1_5981_BA9	-17.19666734	-21.84472725	6A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1723	2829	0.013432308	0.004595263	0	6A	IN-PV	NA	NA	NA
CCTCAGTAGCCAACAG-1_5981_BA9	3.596377995	27.96880939	1	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	719	1041	0	0.008645533	0	oligos	OL-Cntl	NA	NA	NA
CCTCAGTAGCGTGAGT-1_5981_BA9	-9.188192263	-8.169849018	13A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1468	2326	0.01805675	0.006018917	0	13A	IN-VIP	NA	NA	NA
CCTCAGTAGTGTTAGA-1_5981_BA9	29.45556349	-16.18096642	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	4077	9391	0.019912682	0.005430732	0	2	EN-L4	NA	NA	NA
CCTCAGTGTACCATCA-1_5981_BA9	-6.767867897	-9.172554238	13A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	774	1042	0.013435701	0.008637236	0	13A	IN-VIP	NA	NA	NA
CCTCTGACAAGAAAGG-1_5981_BA9	5.238114561	-13.70792907	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2352	4560	0.004605263	0.011184211	0	L2-3	EN-L2-3-MS	NA	NA	NA
CCTCTGACATTCTCAT-1_5981_BA9	13.42339553	-29.12266579	3	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3622	9550	0.001780105	0.005445026	0	3	EN-L5-6	NA	NA	NA
CCTTACGCAGATGGGT-1_5981_BA9	-10.1838813	-5.367168137	13A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1650	2705	0.005914972	0.008133087	0	13A	IN-VIP	NA	NA	NA
CCTTCCCAGGTACTCT-1_5981_BA9	21.71800062	-2.55042243	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1996	3562	0.008141494	0.005334082	0	2	EN-L4	NA	NA	NA
CCTTCCCCACACGCTG-1_5981_BA9	-11.47141978	-15.039466	6B	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1229	1993	0.020572002	0.004014049	0	6B	IN-SST	NA	NA	NA
CCTTCCCGTAATTGGA-1_5981_BA9	24.99946664	-18.73600317	3	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2999	5569	0.012569582	0.004848267	0	3	EN-L5-6	NA	NA	NA
CCTTCCCGTGAGGGAG-1_5981_BA9	-27.64744299	-21.06658209	6A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	4486	11642	0.089245834	0.003779419	0	6A	IN-PV	NA	NA	NA
CCTTCGAAGATGTCGG-1_5981_BA9	-1.365332377	30.74197635	17	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1026	1403	0.000712758	0.001425517	0	oligos	OL-MS-2	NA	NA	NA
CCTTCGACAGGCAGTA-1_5981_BA9	15.13409715	-30.66505579	3	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3396	8591	0.000698405	0.002560819	0	3	EN-L5-6	NA	NA	NA
CCTTCGACAGTGGGAT-1_5981_BA9	-23.27522844	-24.67022064	6A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3657	8589	0.005122832	0.003143556	0	6A	IN-PV	NA	NA	NA
CCTTCGAGTGCCTGGT-1_5981_BA9	30.74597166	-14.9624994	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2935	5750	0.011826087	0.004521739	0	2	EN-L4	NA	NA	NA
CCTTCGATCTGCCCTA-1_5981_BA9	21.00550246	-27.56676122	3	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2122	3892	0.001027749	0.003597122	0	3	EN-L5-6	NA	NA	NA
CCTTTCTGTGTGCGTC-1_5981_BA9	-11.54178063	-27.33773668	16	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	720	1166	0.196397942	0.007718696	0	16	EN-PYR	NA	NA	NA
CCTTTCTGTTGTCTTT-1_5981_BA9	27.90846357	-9.639046919	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3465	8721	0.011810572	0.002637312	0	2	EN-L4	NA	NA	NA
CGAACATAGCCGTCGT-1_5981_BA9	27.82563507	-17.74008099	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	8011	38062	0.060138721	0.005096947	0	2	EN-L4	NA	NA	NA
CGAACATAGCGTTCCG-1_5981_BA9	-12.14863292	-35.09574904	16	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1415	2197	0.089212563	0.010923987	0	16	EN-PYR	NA	NA	NA
CGAACATAGGGTTTCT-1_5981_BA9	-29.60669754	13.63981342	8	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	825	1262	0.003961965	0.005546751	0	8	Astrocytes	NA	NA	NA
CGAACATAGTGGACGT-1_5981_BA9	20.66855462	-2.447058033	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1612	2434	0.007395234	0.004930156	0	2	EN-L4	NA	NA	NA
CGAACATCATCTCCCA-1_5981_BA9	19.49332757	-19.66159311	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	4342	11226	0.004810262	0.007928024	0	L2-3	EN-L2-3-MS	NA	NA	NA
CGAACATGTTACCAGT-1_5981_BA9	8.333451791	-1.837501226	12	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1120	1628	0.019041769	0.001842752	0	12	EN-MIX	NA	NA	NA
CGAATGTAGGCGTACA-1_5981_BA9	19.04779551	-19.59971011	3	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3339	7074	0.009612666	0.005371784	0	3	EN-L5-6	NA	NA	NA
CGAATGTCAGATCTGT-1_5981_BA9	12.50494222	-3.736111382	12	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1337	1943	0.00257334	0.008749357	0	12	EN-MIX	NA	NA	NA
CGAATGTCATCATCCC-1_5981_BA9	-9.446241823	-0.231511037	13A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2258	4330	0.004387991	0.003464203	0	13A	IN-VIP	NA	NA	NA
CGAATGTGTGATAAGT-1_5981_BA9	4.955041895	-2.825704937	12	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	851	1189	0.035323802	0.002523129	0	12	EN-MIX	NA	NA	NA
CGACCTTGTGGCCCTA-1_5981_BA9	3.724901625	-12.98211422	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2060	3686	0.003526858	0.010851872	0	L2-3	EN-L2-3-MS	NA	NA	NA
CGACTTCAGCTAACTC-1_5981_BA9	16.38184391	-27.31415822	3	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3769	9251	0.01329586	0.004756243	0	3	EN-L5-6	NA	NA	NA
CGACTTCCATGTTCCC-1_5981_BA9	11.46532734	-20.82146485	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	4429	12030	0.003408146	0.005236908	0	L2-3	EN-L2-3-MS	NA	NA	NA
CGAGAAGCATCAGTCA-1_5981_BA9	8.946340262	-7.370335915	10	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1980	3908	0.004861822	0.001535312	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGAGAAGTCGAGAGCA-1_5981_BA9	8.943097703	-2.084242782	12	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1372	2111	0.041212695	0.007579346	0	12	EN-MIX	NA	NA	NA
CGAGAAGTCGGTGTCG-1_5981_BA9	-7.684168156	-34.08801209	16	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	794	1057	0.017975402	0.000946074	0	16	EN-PYR	NA	NA	NA
CGAGCACCACTTAACG-1_5981_BA9	20.25055546	-15.45949568	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	4700	11928	0.020959088	0.004443327	0	L2-3	EN-L2-3-MS	NA	NA	NA
CGAGCACGTAAATGTG-1_5981_BA9	30.87337987	-14.9506365	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3230	6667	0.01679916	0.007349633	0	2	EN-L4	NA	NA	NA
CGAGCACGTTTGCATG-1_5981_BA9	-1.428289064	30.97834323	17	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1055	1488	0.001344086	0.004032258	0	oligos	OL-MS-2	NA	NA	NA
CGAGCACTCCCTGACT-1_5981_BA9	-7.110874174	-5.979303084	13A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1245	1968	0.00152439	0.005081301	0	13A	IN-VIP	NA	NA	NA
CGAGCACTCTTCATGT-1_5981_BA9	11.98646905	-20.522285	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2816	5750	0.007826087	0.002434783	0	L2-3	EN-L2-3-MS	NA	NA	NA
CGAGCCAAGGGCATGT-1_5981_BA9	-14.12467434	-15.36087994	6B	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1485	2529	0.061289047	0.005140372	0	6B	IN-SST	NA	NA	NA
CGAGCCACAATCAGAA-1_5981_BA9	23.06457867	-10.07902912	3	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3125	7230	0.000829876	0.003042877	0	3	EN-L5-6	NA	NA	NA
CGAGCCAGTCGATTGT-1_5981_BA9	30.36452435	-15.39980949	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2867	5345	0.017025257	0.008980355	0	2	EN-L4	NA	NA	NA
CGAGCCAGTGGCGAAT-1_5981_BA9	-18.49579111	-7.934011868	13B	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3586	7988	0.005007511	0.004882323	0	13B	IN-SV2C	NA	NA	NA
CGAGCCATCACAATGC-1_5981_BA9	27.07362071	-15.30031843	3	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	5805	17078	0.011125425	0.005679822	0	3	EN-L5-6	NA	NA	NA
CGATCGGAGTGGGCTA-1_5981_BA9	8.224508197	-1.631950961	12	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1122	1685	0.106824926	0.005934718	0	12	EN-MIX	NA	NA	NA
CGATCGGGTCCAGTAT-1_5981_BA9	21.69052041	-3.845377055	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2511	4770	0.015932914	0.003563941	0	2	EN-L4	NA	NA	NA
CGATCGGTCCACGCAG-1_5981_BA9	27.05816354	5.056366104	15A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	929	1141	0.009640666	0.007887818	0	15A	Endo cells	NA	NA	NA
CGATGGCGTCCGTTAA-1_5981_BA9	-9.670582861	-6.724773383	13A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1686	2936	0.04359673	0.003065395	0	13A	IN-VIP	NA	NA	NA
CGATGGCGTTACGTCA-1_5981_BA9	25.0061528	-17.8105352	3	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	4776	13541	0.025404328	0.007754228	0	3	EN-L5-6	NA	NA	NA
CGATGGCGTTTGGCGC-1_5981_BA9	-12.15276462	-8.063222744	6B	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3027	5314	0.013549116	0.00696274	0	6B	IN-SST	NA	NA	NA
CGATGGCTCCGGCACA-1_5981_BA9	-13.28267598	-16.8521188	6B	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1153	1720	0.00872093	0.002325581	0	6B	IN-SST	NA	NA	NA
CGATGTACACCGTTGG-1_5981_BA9	24.2788825	-17.56535268	3	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3647	7801	0.022817587	0.00884502	0	3	EN-L5-6	NA	NA	NA
CGATTGAGTCTTCTCG-1_5981_BA9	-10.76387135	-6.890637633	13A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1603	2588	0.004250386	0.006568779	0	13A	IN-VIP	NA	NA	NA
CGCCAAGCACGCATCG-1_5981_BA9	-26.99677795	-18.25573417	6A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3842	8350	0.011616766	0.003832335	0	6A	IN-PV	NA	NA	NA
CGCCAAGCACTGTTAG-1_5981_BA9	25.02355112	-18.91923846	3	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	5692	16515	0.004359673	0.00599455	0	3	EN-L5-6	NA	NA	NA
CGCCAAGCATTGTGCA-1_5981_BA9	22.00477593	26.58399279	17	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1237	1771	0.001129305	0.004517222	0	oligos	OL-MS-2	NA	NA	NA
CGCCAAGGTGCCTGGT-1_5981_BA9	8.305171049	-10.92225775	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2009	3399	0.023536334	0.004707267	0	L2-3	EN-L2-3-MS	NA	NA	NA
CGCGGTACACTTAAGC-1_5981_BA9	10.44892389	-0.829345849	12	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1097	1653	0.015728978	0.004234725	0	12	EN-MIX	NA	NA	NA
CGCGGTAGTAAACGCG-1_5981_BA9	-7.25872613	-33.41426489	16	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	790	1015	0.049261084	0.01182266	0	16	EN-PYR	NA	NA	NA
CGCGGTATCAACGAAA-1_5981_BA9	-14.88672035	-16.47674516	6B	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1766	3203	0.010302841	0.002497658	0	6B	IN-SST	NA	NA	NA
CGCGGTATCCCGACTT-1_5981_BA9	-0.555611907	30.56386398	17	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	844	1217	0	0.004108463	0	oligos	OL-MS-2	NA	NA	NA
CGCGTTTAGGTTACCT-1_5981_BA9	-6.257665894	-5.429245469	13A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1305	2199	0.005457026	0.00636653	0	13A	IN-VIP	NA	NA	NA
CGCGTTTCAAGGTTCT-1_5981_BA9	21.29175224	-2.61284483	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1888	3146	0.010171647	0.005403687	0	2	EN-L4	NA	NA	NA
CGCGTTTCACGTTGGC-1_5981_BA9	24.2128092	-19.63597744	3	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	4975	13988	0.012010295	0.004432371	0	3	EN-L5-6	NA	NA	NA
CGCGTTTCATGCATGT-1_5981_BA9	20.76783207	-3.665942739	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2174	3928	0.011710794	0.00407332	0	2	EN-L4	NA	NA	NA
CGCGTTTTCTAACTTC-1_5981_BA9	23.30190239	-25.13345854	3	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2785	6048	0.004960317	0.005291005	0	3	EN-L5-6	NA	NA	NA
CGCTATCAGACTCGGA-1_5981_BA9	28.1405863	-18.55024398	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	8571	45853	0.062962074	0.005277735	0	2	EN-L4	NA	NA	NA
CGCTATCGTTCCACAA-1_5981_BA9	-12.57017636	-35.09976829	16	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1569	2483	0.081353202	0.006846557	0	16	EN-PYR	NA	NA	NA
CGCTATCTCGTCCGTT-1_5981_BA9	2.468770042	-20.43244282	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3306	7976	0.002507523	0.004889669	0	L2-3	EN-L2-3-MS	NA	NA	NA
CGCTGGACATGGATGG-1_5981_BA9	3.772146931	-20.26013567	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3423	7695	0.00402859	0.006107862	0	L2-3	EN-L2-3-MS	NA	NA	NA
CGCTGGAGTCTGGAGA-1_5981_BA9	4.893363536	-9.693858707	12	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1676	2723	0.004039662	0.01101726	0	12	EN-MIX	NA	NA	NA
CGCTTCACATCCTTGC-1_5981_BA9	-27.57709381	-20.82865615	6A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3497	8319	0.065512682	0.005289097	0	6A	IN-PV	NA	NA	NA
CGCTTCATCCATGAAC-1_5981_BA9	-29.18204885	11.15765473	8	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	884	1233	0.01216545	0.00324412	0	8	Astrocytes	NA	NA	NA
CGGACACCATGCCTAA-1_5981_BA9	34.54357947	-3.2223964	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2577	5556	0.016558675	0.001799856	0	2	EN-L4	NA	NA	NA
CGGACACGTCTACCTC-1_5981_BA9	-32.85905223	-13.46057296	9	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	709	1056	0.002840909	0.002840909	0	9	OPC	NA	NA	NA
CGGACACGTGAGTATA-1_5981_BA9	19.93849036	-3.882636185	12	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1753	2767	0.020238525	0.008312252	0	12	EN-MIX	NA	NA	NA
CGGACACGTTAAGAAC-1_5981_BA9	24.84722354	-14.54755568	3	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	4170	9707	0.038116823	0.007623365	0	3	EN-L5-6	NA	NA	NA
CGGACTGAGGACCACA-1_5981_BA9	-12.33438556	-35.06104313	16	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1531	2627	0.103159498	0.00647126	0	16	EN-PYR	NA	NA	NA
CGGACTGAGTTGAGAT-1_5981_BA9	20.70311554	-3.682443403	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1991	3257	0.007368744	0.008596868	0	2	EN-L4	NA	NA	NA
CGGACTGCACACCGAC-1_5981_BA9	-28.38503285	-20.70271907	6A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3696	8457	0.055575263	0.006266998	0	6A	IN-PV	NA	NA	NA
CGGACTGCACTCGACG-1_5981_BA9	19.30395291	-20.53773962	3	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3983	9730	0.006577595	0.005344296	0	3	EN-L5-6	NA	NA	NA
CGGACTGGTACTCGCG-1_5981_BA9	-16.19188481	-6.409423257	13B	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2359	4094	0.002931119	0.002198339	0	13B	IN-SV2C	NA	NA	NA
CGGAGCTAGTGAAGAG-1_5981_BA9	16.34723264	-18.41937492	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	4762	12554	0.004301418	0.003743827	0	L2-3	EN-L2-3-MS	NA	NA	NA
CGGAGCTTCAAGATCC-1_5981_BA9	19.3182278	-11.14721277	3	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2546	5146	0.020404197	0.007967353	0	3	EN-L5-6	NA	NA	NA
CGGAGTCAGCGATATA-1_5981_BA9	17.40594991	-17.65686099	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2613	4825	0.019481865	0.00373057	0	L2-3	EN-L2-3-MS	NA	NA	NA
CGGAGTCAGCTCCTCT-1_5981_BA9	-10.92199471	-2.928384483	13A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2054	3744	0.00267094	0.008814103	0	13A	IN-VIP	NA	NA	NA
CGGAGTCAGGACCACA-1_5981_BA9	20.30723983	-15.36427249	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	6234	20269	0.021214663	0.005772362	0	L2-3	EN-L2-3-MS	NA	NA	NA
CGGAGTCAGTGCCAGA-1_5981_BA9	27.94655932	-17.69151481	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	6616	24240	0.041419142	0.005115512	0	2	EN-L4	NA	NA	NA
CGGAGTCCATGCTGGC-1_5981_BA9	-28.85990613	10.37066059	8	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	958	1431	0.016072676	0.005590496	0	8	Astrocytes	NA	NA	NA
CGGAGTCGTTAAGTAG-1_5981_BA9	24.6101985	-20.84656967	3	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3249	6648	0.005264741	0.00767148	0	3	EN-L5-6	NA	NA	NA
CGGAGTCGTTACTGAC-1_5981_BA9	-10.70276058	29.71491109	17	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	742	1026	0.095516569	0.001949318	0	oligos	OL-MS-2	NA	NA	NA
CGGCTAGAGTGACATA-1_5981_BA9	30.43511646	-15.17616748	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2405	3978	0.019105078	0.00678733	0	2	EN-L4	NA	NA	NA
CGGCTAGCACTAGTAC-1_5981_BA9	24.53950972	8.464399303	15A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3821	7613	0.012215946	0.016550637	0	15A	Endo cells	NA	NA	NA
CGGTTAACATTCACTT-1_5981_BA9	30.53387181	-13.876931	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2924	5625	0.015466667	0.006577778	0	2	EN-L4	NA	NA	NA
CGGTTAAGTCAATACC-1_5981_BA9	11.93736748	-20.16722925	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3269	7031	0.007253591	0.004551273	0	L2-3	EN-L2-3-MS	NA	NA	NA
CGGTTAATCACTTCAT-1_5981_BA9	11.05887331	-8.987209902	10	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3164	7869	0.000635405	0.002414538	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGTAGCGAGTACGACG-1_5981_BA9	20.08588263	-10.98985191	3	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1870	3094	0.005171299	0.003232062	0	3	EN-L5-6	NA	NA	NA
CGTAGCGCAGCTGCTG-1_5981_BA9	30.30800648	-14.77821947	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3023	6215	0.012228479	0.00917136	0	2	EN-L4	NA	NA	NA
CGTAGGCAGTGTTGAA-1_5981_BA9	-11.47426456	-7.84410494	13B	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1829	3137	0.041122091	0.003825311	0	13B	IN-SV2C	NA	NA	NA
CGTAGGCCACCGGAAA-1_5981_BA9	17.53999459	-3.822919723	12	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1624	2629	0.004944846	0.006466337	0	12	EN-MIX	NA	NA	NA
CGTAGGCTCAACGCTA-1_5981_BA9	-31.50274439	-10.31948524	9	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	901	1288	0.005434783	0.00310559	0	9	OPC	NA	NA	NA
CGTAGGCTCTAACTCT-1_5981_BA9	19.90375224	-24.32143825	3	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3727	9490	0.004847208	0.013382508	0	3	EN-L5-6	NA	NA	NA
CGTCACTAGAGGTTGC-1_5981_BA9	-22.14846437	-21.77737584	6A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2106	3723	0.012624228	0.005372012	0	6A	IN-PV	NA	NA	NA
CGTCACTCACCCAGTG-1_5981_BA9	-9.557175509	-17.01562856	6B	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	893	1268	0.010252366	0.003154574	0	6B	IN-SST	NA	NA	NA
CGTCACTTCCAGAAGG-1_5981_BA9	6.987997622	-14.44973415	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2840	6091	0.006238713	0.011656542	0	L2-3	EN-L2-3-MS	NA	NA	NA
CGTCTACTCAACGCTA-1_5981_BA9	-11.74003356	-6.276820892	13A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2040	3482	0.005743825	0.006318208	0	13A	IN-VIP	NA	NA	NA
CGTGAGCTCAGCAACT-1_5981_BA9	34.66724716	-3.519368693	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2831	6164	0.018170019	0.004055808	0	2	EN-L4	NA	NA	NA
CGTGTAACATGCAACT-1_5981_BA9	-9.482720799	32.13034084	17	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	806	1002	0.011976048	0.005988024	0	oligos	OL-MS-2	NA	NA	NA
CGTGTAATCAACTCTT-1_5981_BA9	30.71193981	-14.87784627	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2545	4735	0.015205913	0.004646251	0	2	EN-L4	NA	NA	NA
CGTGTCTGTGTGAATA-1_5981_BA9	-9.888325477	-6.70728137	13A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1453	2255	0.003547672	0.003991131	0	13A	IN-VIP	NA	NA	NA
CGTTAGAAGACTAGGC-1_5981_BA9	5.930593273	-13.33255587	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2284	4076	0.003925417	0.016928361	0	L2-3	EN-L2-3-MS	NA	NA	NA
CGTTAGAAGTTACGGG-1_5981_BA9	-12.37041276	-14.06025929	6B	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1444	2183	0.019697664	0.008245534	0	6B	IN-SST	NA	NA	NA
CGTTAGATCCCATTTA-1_5981_BA9	20.13555755	-15.4504923	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	5547	17507	0.049523048	0.006054721	0	L2-3	EN-L2-3-MS	NA	NA	NA
CGTTGGGCACCAGGCT-1_5981_BA9	16.60225209	-18.12833108	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3560	8072	0.015113974	0.005079286	0	L2-3	EN-L2-3-MS	NA	NA	NA
CTAACTTAGACACTAA-1_5981_BA9	8.382886817	-11.21796615	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2230	4082	0.037481627	0.00832925	0	L2-3	EN-L2-3-MS	NA	NA	NA
CTAACTTCATTAACCG-1_5981_BA9	11.79377297	-20.61946873	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3999	10067	0.008344095	0.00556273	0	L2-3	EN-L2-3-MS	NA	NA	NA
CTAACTTGTTCAGGCC-1_5981_BA9	-7.197335798	-6.589638755	13A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1211	1871	0.003741315	0.005344735	0	13A	IN-VIP	NA	NA	NA
CTAAGACAGGAGTCTG-1_5981_BA9	10.70063383	-16.3913446	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3380	6938	0.012683771	0.012972038	0	L2-3	EN-L2-3-MS	NA	NA	NA
CTAAGACTCATTGCCC-1_5981_BA9	24.89207312	-19.18576318	3	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	4401	11650	0.008497854	0.004549356	0	3	EN-L5-6	NA	NA	NA
CTACACCGTACCATCA-1_5981_BA9	4.84093138	-14.41833311	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2459	4496	0.00155694	0.006672598	0	L2-3	EN-L2-3-MS	NA	NA	NA
CTACACCTCCTTTCTC-1_5981_BA9	-7.973930644	-2.583742377	13A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1902	3536	0.01300905	0.003959276	0	13A	IN-VIP	NA	NA	NA
CTACATTCACCCAGTG-1_5981_BA9	17.94118909	-18.1803304	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	4160	10608	0.023944193	0.003582202	0	L2-3	EN-L2-3-MS	NA	NA	NA
CTACATTGTCATGCAT-1_5981_BA9	-33.73007592	-10.30713727	9	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	932	1400	0	0.005714286	0	9	OPC	NA	NA	NA
CTACATTGTCTGATCA-1_5981_BA9	10.46567676	-20.32797607	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	4104	10701	0.003177273	0.006354546	0	L2-3	EN-L2-3-MS	NA	NA	NA
CTACCCAAGTTAGCGG-1_5981_BA9	-26.39718731	-19.61040977	6A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2595	4948	0.044462409	0.006063056	0	6A	IN-PV	NA	NA	NA
CTACCCAGTTACGCGC-1_5981_BA9	-34.25686026	-8.509440197	9	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1077	1639	0.013422819	0.003660769	0	9	OPC	NA	NA	NA
CTACGTCCAAACGCGA-1_5981_BA9	-11.28520049	-5.766670684	13A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2158	3884	0.007466529	0.002832132	0	13A	IN-VIP	NA	NA	NA
CTACGTCGTAAGAGAG-1_5981_BA9	5.443539047	-8.938076444	12	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1130	1603	0.008733624	0.002495321	0	12	EN-MIX	NA	NA	NA
CTACGTCGTAAGTAGT-1_5981_BA9	29.14762132	-15.5162345	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3322	7017	0.040615648	0.003990309	0	2	EN-L4	NA	NA	NA
CTAGAGTAGGAGCGTT-1_5981_BA9	25.13412313	-18.39932499	3	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	4612	11509	0.020245026	0.005213311	0	3	EN-L5-6	NA	NA	NA
CTAGAGTTCCCAGGTG-1_5981_BA9	-11.19337165	-15.37242482	6B	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1090	1617	0.01546073	0.004329004	0	6B	IN-SST	NA	NA	NA
CTAGCCTAGAAGAAGC-1_5981_BA9	10.49183572	-0.603890011	12	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1044	1493	0.023442733	0.005358339	0	12	EN-MIX	NA	NA	NA
CTAGCCTTCAATACCG-1_5981_BA9	-14.2934064	-21.64436555	6A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1365	2388	0.011725293	0.002931323	0	6A	IN-PV	NA	NA	NA
CTAGCCTTCGTGACAT-1_5981_BA9	20.05765636	-4.295857471	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2288	3836	0.028154327	0.005995829	0	2	EN-L4	NA	NA	NA
CTAGTGAAGTGCGTGA-1_5981_BA9	-6.835847996	-7.268819475	13A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1032	1505	0.011960133	0.005980066	0	13A	IN-VIP	NA	NA	NA
CTAGTGAGTATAAACG-1_5981_BA9	24.34052773	-20.98593816	3	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3835	8827	0.01019599	0.003058797	0	3	EN-L5-6	NA	NA	NA
CTCACACAGCCCTAAT-1_5981_BA9	16.17114316	-18.34941694	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	5741	18859	0.004401082	0.006044859	0	L2-3	EN-L2-3-MS	NA	NA	NA
CTCAGAAGTAAGTGTA-1_5981_BA9	27.93417042	-17.89537246	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	7188	28304	0.035684002	0.00660684	0	2	EN-L4	NA	NA	NA
CTCAGAAGTGACTCAT-1_5981_BA9	17.93754645	-17.49672257	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	5202	15022	0.013912928	0.008054853	0	L2-3	EN-L2-3-MS	NA	NA	NA
CTCAGAATCAGGTAAA-1_5981_BA9	-7.294675484	-33.27748644	16	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	861	1234	0.085089141	0.005672609	0	16	EN-PYR	NA	NA	NA
CTCATTAAGTCCGTAT-1_5981_BA9	31.39721805	-11.38621522	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2618	4794	0.006049228	0.003754693	0	2	EN-L4	NA	NA	NA
CTCATTACAGCGTTCG-1_5981_BA9	-18.69150038	-4.868425686	13B	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2609	4838	0.01302191	0.009508061	0	13B	IN-SV2C	NA	NA	NA
CTCATTATCAGAGACG-1_5981_BA9	2.731765874	0.231296864	16	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	930	1272	0.076257862	0.004716981	0	16	EN-PYR	NA	NA	NA
CTCATTATCTTACCTA-1_5981_BA9	2.892331487	-21.21994863	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	4043	11313	0.004950057	0.003977725	0	L2-3	EN-L2-3-MS	NA	NA	NA
CTCCTAGAGATGCCTT-1_5981_BA9	25.76357183	-17.41312634	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	6090	20405	0.01896594	0.004998775	0	2	EN-L4	NA	NA	NA
CTCCTAGGTATTAGCC-1_5981_BA9	-28.82263342	9.847366513	8	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	757	1053	0.010446344	0.00379867	0	8	Astrocytes	NA	NA	NA
CTCGAAAAGGGCTCTC-1_5981_BA9	30.77053589	-14.88723195	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2483	4648	0.018072289	0.007745267	0	2	EN-L4	NA	NA	NA
CTCGAAAGTCATACTG-1_5981_BA9	-0.816221589	29.2164912	1	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	809	1095	0.000913242	0.006392694	0	oligos	OL-Cntl	NA	NA	NA
CTCGAAATCATTTGGG-1_5981_BA9	5.204897753	-14.85212172	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3259	7657	0.006921771	0.003526185	0	L2-3	EN-L2-3-MS	NA	NA	NA
CTCGAGGAGTCATCCA-1_5981_BA9	6.449960517	-13.52273445	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2448	4587	0.006976237	0.00675823	0	L2-3	EN-L2-3-MS	NA	NA	NA
CTCGAGGGTTTGCATG-1_5981_BA9	29.11784491	-16.41951616	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	5325	16056	0.013016941	0.005979073	0	2	EN-L4	NA	NA	NA
CTCGAGGTCCGTTGCT-1_5981_BA9	24.79300695	-20.48390488	3	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3829	8958	0.006586292	0.005916499	0	3	EN-L5-6	NA	NA	NA
CTCGGAGGTAAATGTG-1_5981_BA9	-29.99259042	-12.10183768	9	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	820	1108	0.001805054	0.00631769	0	9	OPC	NA	NA	NA
CTCGGAGTCACCGTAA-1_5981_BA9	-12.70442969	-35.91147621	16	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1550	2561	0.074970715	0.006638032	0	16	EN-PYR	NA	NA	NA
CTCGGAGTCCCTGACT-1_5981_BA9	3.257824459	28.34229223	1	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	774	1100	0.008181818	0.002727273	0	oligos	OL-Cntl	NA	NA	NA
CTCGGGAAGCATGGCA-1_5981_BA9	6.492384724	-13.28157844	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2367	3888	0.002572016	0.007973251	0	L2-3	EN-L2-3-MS	NA	NA	NA
CTCGGGACAGGAATCG-1_5981_BA9	4.868822556	-9.574292599	12	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1641	2691	0.003716091	0.010405054	0	12	EN-MIX	NA	NA	NA
CTCGGGAGTTCCTCCA-1_5981_BA9	7.716015644	-12.40543716	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2379	4398	0.013187813	0.006139154	0	L2-3	EN-L2-3-MS	NA	NA	NA
CTCGTACGTGAAGGCT-1_5981_BA9	4.130185285	-11.09399152	12	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1762	2859	0.002098636	0.010493179	0	12	EN-MIX	NA	NA	NA
CTCGTACTCATCACCC-1_5981_BA9	-33.97544823	-12.76075557	9	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	870	1284	0.004672897	0.003115265	0	9	OPC	NA	NA	NA
CTCGTACTCGGGAGTA-1_5981_BA9	-11.36639278	-14.73064097	6B	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1066	1535	0.033876221	0.005863192	0	6B	IN-SST	NA	NA	NA
CTCGTCAAGTCTCCTC-1_5981_BA9	-7.220395742	-5.355139519	13A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1481	2476	0.011712439	0.006058158	0	13A	IN-VIP	NA	NA	NA
CTCGTCACAGGGATTG-1_5981_BA9	3.962187239	-12.96758972	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2164	3934	0.002033554	0.009405186	0	L2-3	EN-L2-3-MS	NA	NA	NA
CTCGTCAGTCTAGTGT-1_5981_BA9	-22.4216268	-22.20453232	6A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2573	5165	0.033107454	0.006582769	0	6A	IN-PV	NA	NA	NA
CTCGTCAGTTTCCACC-1_5981_BA9	-12.46854916	-13.6260615	6B	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1859	3476	0.070483314	0.003739931	0	6B	IN-SST	NA	NA	NA
CTCGTCATCTTCAACT-1_5981_BA9	-27.97309806	-21.0140988	6A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	4596	12182	0.02651453	0.005664095	0	6A	IN-PV	NA	NA	NA
CTCTACGCAGTCTTCC-1_5981_BA9	-3.52668256	-16.82197415	10	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2527	5320	0.00093985	0.008646617	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTCTACGGTGCTAGCC-1_5981_BA9	-19.71832334	-20.81693952	6A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1991	3901	0.017944117	0.003076134	0	6A	IN-PV	NA	NA	NA
CTCTACGTCGCGTAGC-1_5981_BA9	6.978248065	-1.679468496	12	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	796	1033	0.022265247	0.006776379	0	12	EN-MIX	NA	NA	NA
CTCTACGTCTATCCTA-1_5981_BA9	30.94737077	-11.9675245	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2943	6193	0.005328597	0.00613596	0	2	EN-L4	NA	NA	NA
CTCTGGTCAATTCCTT-1_5981_BA9	1.51891773	-18.22149164	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2907	6594	0.005762815	0.003942978	0	L2-3	EN-L2-3-MS	NA	NA	NA
CTCTGGTCATCACGTA-1_5981_BA9	29.75120454	-3.696421662	10	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3503	9415	0.001911843	0.002655337	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTCTGGTCATTGGCGC-1_5981_BA9	-26.64367529	-18.18899952	6A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	4028	9930	0.017724068	0.009164149	0	6A	IN-PV	NA	NA	NA
CTCTGGTGTAGCGCTC-1_5981_BA9	20.64350354	-3.577770695	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2027	3695	0.042489851	0.001894452	0	2	EN-L4	NA	NA	NA
CTCTGGTGTCGAACAG-1_5981_BA9	26.27362625	5.454699424	15A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1122	1636	0.031784841	0.014669927	0	15A	Endo cells	NA	NA	NA
CTCTGGTTCACAGTAC-1_5981_BA9	-11.35958893	-35.23266369	16	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1164	1675	0.030447761	0.008955224	0	16	EN-PYR	NA	NA	NA
CTCTGGTTCCTAGAAC-1_5981_BA9	-14.51226798	-22.74315976	6A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1288	2211	0.022614202	0.001809136	0	6A	IN-PV	NA	NA	NA
CTCTGGTTCTCTTGAT-1_5981_BA9	-8.920703121	-33.50332346	16	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	970	1256	0.034235669	0.00955414	0	16	EN-PYR	NA	NA	NA
CTGAAACGTCACACGC-1_5981_BA9	-17.89972663	-6.052508784	13B	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2837	5325	0.034741784	0.008638498	0	13B	IN-SV2C	NA	NA	NA
CTGATAGGTGATAAGT-1_5981_BA9	30.37466459	-15.24349979	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2588	4647	0.023455993	0.007316548	0	2	EN-L4	NA	NA	NA
CTGATCCAGGGAGTAA-1_5981_BA9	24.86767174	6.799452846	15A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2039	3002	0.021985343	0.013657562	0	15A	Endo cells	NA	NA	NA
CTGATCCCAGATAATG-1_5981_BA9	24.95190773	8.652139695	15A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2643	4322	0.006941231	0.02545118	0	15A	Endo cells	NA	NA	NA
CTGATCCCATGTAGTC-1_5981_BA9	-32.40535606	-13.65116256	9	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	728	1018	0.000982318	0.003929273	0	9	OPC	NA	NA	NA
CTGCCTATCACGCATA-1_5981_BA9	6.694706351	-14.83652266	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2886	5960	0.004362416	0.007885906	0	L2-3	EN-L2-3-MS	NA	NA	NA
CTGCCTATCGCGTTTC-1_5981_BA9	-16.91141197	-14.93568583	6B	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1860	3331	0.015010507	0.005403783	0	6B	IN-SST	NA	NA	NA
CTGCTGTCAACACGCC-1_5981_BA9	20.29286126	-15.31280442	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	7391	28505	0.011015611	0.006911068	0	L2-3	EN-L2-3-MS	NA	NA	NA
CTGCTGTCATTTGCCC-1_5981_BA9	-7.106056176	-33.18743507	16	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	750	1035	0.074396135	0.010628019	0	16	EN-PYR	NA	NA	NA
CTGCTGTGTACTCTCC-1_5981_BA9	12.04751074	-15.92553264	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	4588	12198	0.01631415	0.01262502	0	L2-3	EN-L2-3-MS	NA	NA	NA
CTGGTCTAGCCTATGT-1_5981_BA9	-8.030406703	-33.71126858	16	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	814	1081	0.037002775	0.009250694	0	16	EN-PYR	NA	NA	NA
CTGGTCTAGGTTCCTA-1_5981_BA9	-18.93372618	-5.902749032	13B	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3390	7511	0.013313806	0.004526694	0	13B	IN-SV2C	NA	NA	NA
CTGGTCTCATTGCGGC-1_5981_BA9	-11.7671333	-5.486525787	13A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1741	2667	0.011248594	0.023997	0	13A	IN-VIP	NA	NA	NA
CTGGTCTTCGTGACAT-1_5981_BA9	20.31520803	-15.42004345	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	4885	12712	0.023835746	0.006135935	0	L2-3	EN-L2-3-MS	NA	NA	NA
CTGTGCTAGTAATCCC-1_5981_BA9	-13.08580948	-35.75446884	16	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1683	3066	0.106979778	0.005218526	0	16	EN-PYR	NA	NA	NA
CTGTGCTTCTGCTTGC-1_5981_BA9	-11.20407406	-35.37111668	16	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1277	1853	0.04587156	0.005396654	0	16	EN-PYR	NA	NA	NA
CTGTTTAAGGCTCTTA-1_5981_BA9	22.35802473	-22.40924276	3	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3007	6501	0.005076142	0.016766651	0	3	EN-L5-6	NA	NA	NA
CTGTTTAAGGGTGTGT-1_5981_BA9	-13.56718009	-17.68554863	6B	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1264	1895	0.005277045	0.002110818	0	6B	IN-SST	NA	NA	NA
CTGTTTATCGTACCGG-1_5981_BA9	13.31281322	-28.68888186	3	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2448	5174	0.001739467	0.000773096	0	3	EN-L5-6	NA	NA	NA
CTTAACTAGCCAGGAT-1_5981_BA9	17.7537691	-17.99013787	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	4319	10452	0.007749713	0.0050708	0	L2-3	EN-L2-3-MS	NA	NA	NA
CTTAACTAGGCACATG-1_5981_BA9	-2.046804735	-35.47094295	16	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1667	2319	0.02414834	0.015955153	0	16	EN-PYR	NA	NA	NA
CTTAACTAGGTGATTA-1_5981_BA9	-6.719402871	-6.924109393	13A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1127	1668	0.001798561	0.003597122	0	13A	IN-VIP	NA	NA	NA
CTTACCGAGTCACGCC-1_5981_BA9	-27.45711076	-23.30624485	6A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	5891	17949	0.019165413	0.006518469	0	6A	IN-PV	NA	NA	NA
CTTACCGGTAAAGTCA-1_5981_BA9	-18.00340725	-5.08224523	13B	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2628	5204	0.018255188	0.004803997	0	13B	IN-SV2C	NA	NA	NA
CTTAGGACACGGTGTC-1_5981_BA9	-17.1708051	-7.232587585	13B	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2305	4162	0.028592023	0.003123498	0	13B	IN-SV2C	NA	NA	NA
CTTAGGAGTTTGCATG-1_5981_BA9	-11.82887132	-6.458778228	13B	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2083	4124	0.021338506	0.004122211	0	13B	IN-SV2C	NA	NA	NA
CTTCTCTCAGATCCAT-1_5981_BA9	-22.03737776	-24.36552034	6A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2800	6448	0.012096774	0.001861042	0	6A	IN-PV	NA	NA	NA
CTTCTCTGTTTGTTTC-1_5981_BA9	10.78719936	-20.54257543	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3184	7693	0.010399064	0.002599766	0	L2-3	EN-L2-3-MS	NA	NA	NA
CTTCTCTTCCGTCAAA-1_5981_BA9	11.32763853	-20.8739284	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	5440	18783	0.002289304	0.003939733	0	L2-3	EN-L2-3-MS	NA	NA	NA
CTTGGCTGTGTTTGTG-1_5981_BA9	5.577866073	-13.86876494	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2432	4695	0.003620873	0.009584665	0	L2-3	EN-L2-3-MS	NA	NA	NA
CTTGGCTTCTTGTCAT-1_5981_BA9	29.17867183	-16.37785798	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	4370	10450	0.024019139	0.004114833	0	2	EN-L4	NA	NA	NA
CTTTGCGTCGGGAGTA-1_5981_BA9	17.48617009	-17.79581807	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3955	9364	0.008222982	0.003951303	0	L2-3	EN-L2-3-MS	NA	NA	NA
GAAACTCAGTGGGTTG-1_5981_BA9	-18.62880755	-23.27214727	6A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2071	3670	0.001634877	0.002724796	0	6A	IN-PV	NA	NA	NA
GAACATCAGAGGTTGC-1_5981_BA9	8.305315626	18.92821107	1	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1293	1911	0.007326007	0.005756149	0	oligos	OL-Cntl	NA	NA	NA
GAACATCGTCATTAGC-1_5981_BA9	-0.046275691	30.09425383	1	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	908	1272	0.003144654	0.003930818	0	oligos	OL-Cntl	NA	NA	NA
GAACATCGTTACGCGC-1_5981_BA9	28.31795399	-17.57933991	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	5061	14424	0.022878536	0.005407654	0	2	EN-L4	NA	NA	NA
GAACCTACAACTGGCC-1_5981_BA9	23.67249736	-19.56100377	3	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	5282	17370	0.016810593	0.0054692	0	3	EN-L5-6	NA	NA	NA
GAACCTAGTGAAATCA-1_5981_BA9	-24.90214103	-21.79271644	6A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3572	8132	0.035538613	0.003566158	0	6A	IN-PV	NA	NA	NA
GAACGGAAGGCCCTTG-1_5981_BA9	29.78961845	-15.92196908	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3910	8874	0.016677936	0.006423259	0	2	EN-L4	NA	NA	NA
GAACGGAAGTGAACGC-1_5981_BA9	19.04200469	-16.52163741	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3792	8468	0.015233821	0.004133207	0	L2-3	EN-L2-3-MS	NA	NA	NA
GAACGGAAGTGGGCTA-1_5981_BA9	6.721047437	-10.5731995	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2005	3579	0.017602682	0.015646829	0	L2-3	EN-L2-3-MS	NA	NA	NA
GAACGGAGTATGAATG-1_5981_BA9	21.84829212	-2.378276613	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2203	3973	0.003523786	0.007550969	0	2	EN-L4	NA	NA	NA
GAACGGAGTCTAGCGC-1_5981_BA9	-24.41562679	-16.1706444	6A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2670	4664	0.021440823	0.00364494	0	6A	IN-PV	NA	NA	NA
GAAGCAGAGCCAGAAC-1_5981_BA9	-27.16065298	-18.37317123	6A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3809	8917	0.023438376	0.005831558	0	6A	IN-PV	NA	NA	NA
GAAGCAGAGGATTCGG-1_5981_BA9	20.69874907	-3.605388673	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1939	3169	0.012306721	0.002840013	0	2	EN-L4	NA	NA	NA
GAAGCAGCATAACCTG-1_5981_BA9	-8.248732931	-34.00001336	16	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	846	1178	0.020373514	0.003395586	0	16	EN-PYR	NA	NA	NA
GAAGCAGCATATACCG-1_5981_BA9	28.59894234	-18.32975548	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	7198	28820	0.033553088	0.008258154	0	2	EN-L4	NA	NA	NA
GAAGCAGGTAGCGCTC-1_5981_BA9	-27.15745631	-18.09165561	13A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3074	5956	0.03307589	0.006715917	0	13A	IN-VIP	NA	NA	NA
GAAGCAGGTAGGCATG-1_5981_BA9	-11.62914638	-27.35084425	16	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	805	1102	0.114337568	0.007259528	0	16	EN-PYR	NA	NA	NA
GAAGCAGTCTTCGAGA-1_5981_BA9	19.10472121	-19.69629998	3	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3861	9556	0.009522813	0.004604437	0	3	EN-L5-6	NA	NA	NA
GAATAAGAGTGAAGAG-1_5981_BA9	29.15988362	-16.50183676	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	4452	11224	0.022451889	0.004900214	0	2	EN-L4	NA	NA	NA
GAATAAGCACCACCAG-1_5981_BA9	30.24332491	-7.508195529	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	5422	18403	0.0041841	0.004129761	0	2	EN-L4	NA	NA	NA
GAATAAGGTCAGAATA-1_5981_BA9	16.29528	-28.94613063	3	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	4019	10305	0.002523047	0.003784571	0	3	EN-L5-6	NA	NA	NA
GAATAAGTCGCGGATC-1_5981_BA9	-28.81332882	9.936667985	8	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	799	1137	0.011433597	0.005277045	0	8	Astrocytes	NA	NA	NA
GAATGAAAGCCACGCT-1_5981_BA9	-28.04882212	-20.87482875	6A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3767	8247	0.018794713	0.008245423	0	6A	IN-PV	NA	NA	NA
GAATGAACACCCATGG-1_5981_BA9	21.93748265	-0.400648225	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1737	3157	0.000950269	0.002850808	0	2	EN-L4	NA	NA	NA
GAATGAAGTAGAAAGG-1_5981_BA9	8.19641389	-11.71258477	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2305	4190	0.011217184	0.005011933	0	L2-3	EN-L2-3-MS	NA	NA	NA
GACACGCGTAGATTAG-1_5981_BA9	25.031768	-18.8513842	3	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	4452	11234	0.008990564	0.005340929	0	3	EN-L5-6	NA	NA	NA
GACACGCGTCTCCCTA-1_5981_BA9	-16.82533833	-22.06646801	6A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1724	2990	0.010367893	0.004347826	0	6A	IN-PV	NA	NA	NA
GACAGAGAGACGCAAC-1_5981_BA9	12.57362186	-19.24060235	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	4493	11930	0.020871752	0.00804694	0	L2-3	EN-L2-3-MS	NA	NA	NA
GACAGAGAGTGGGCTA-1_5981_BA9	-28.71926506	-20.7844135	6A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	4148	9614	0.021635115	0.007281048	0	6A	IN-PV	NA	NA	NA
GACAGAGCATCGGAAG-1_5981_BA9	30.12952435	-15.16726853	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3323	7334	0.042677938	0.004499591	0	2	EN-L4	NA	NA	NA
GACCAATCAGGGAGAG-1_5981_BA9	-12.20346959	-4.864803245	13A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2394	4201	0.007855273	0.00999762	0	13A	IN-VIP	NA	NA	NA
GACCAATGTGAGGCTA-1_5981_BA9	11.75004177	-20.86590185	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3642	8745	0.005946255	0.003659234	0	L2-3	EN-L2-3-MS	NA	NA	NA
GACCAATTCTGTACGA-1_5981_BA9	-6.279055633	-32.82793903	16	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	778	1035	0.080193237	0.009661836	0	16	EN-PYR	NA	NA	NA
GACCTGGCAAGCCGCT-1_5981_BA9	7.470067138	-14.89761951	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2901	5671	0.007935108	0.004055722	0	L2-3	EN-L2-3-MS	NA	NA	NA
GACCTGGTCTCTGAGA-1_5981_BA9	-9.459569832	-16.09470374	6B	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	893	1295	0.005405405	0.003861004	0	6B	IN-SST	NA	NA	NA
GACCTGGTCTTGTACT-1_5981_BA9	17.47120422	-18.49120576	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	4182	10710	0.020168067	0.003174603	0	L2-3	EN-L2-3-MS	NA	NA	NA
GACGCGTAGCATGGCA-1_5981_BA9	30.42758905	-11.74109995	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3403	7389	0.017458384	0.004195426	0	2	EN-L4	NA	NA	NA
GACGCGTAGGCTAGCA-1_5981_BA9	-20.19449469	-4.824653175	13B	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3922	8152	0.012880275	0.009077527	0	13B	IN-SV2C	NA	NA	NA
GACGCGTAGTGGTCCC-1_5981_BA9	31.11177361	-14.7288362	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2730	5039	0.011708672	0.006548918	0	2	EN-L4	NA	NA	NA
GACGCGTTCGACGGAA-1_5981_BA9	24.68804519	-18.98729999	3	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	4899	13406	0.012680889	0.003729673	0	3	EN-L5-6	NA	NA	NA
GACGGCTAGCCCAGCT-1_5981_BA9	23.86083776	-12.26481106	3	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3292	6826	0.005273953	0.006592441	0	3	EN-L5-6	NA	NA	NA
GACGGCTAGGTGCAAC-1_5981_BA9	-9.488153261	-34.23046551	16	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1002	1452	0.067493113	0.005509642	0	16	EN-PYR	NA	NA	NA
GACGGCTCAGATCCAT-1_5981_BA9	28.15857842	-18.58054068	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	10234	75102	0.080463902	0.005818753	0	2	EN-L4	NA	NA	NA
GACGTGCAGCTGAACG-1_5981_BA9	5.23887572	-0.183500702	16	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1180	1809	0.017689331	0.006633499	0	16	EN-PYR	NA	NA	NA
GACGTGCCATCACCCT-1_5981_BA9	11.13648129	-20.69235064	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3797	9169	0.005344094	0.004253463	0	L2-3	EN-L2-3-MS	NA	NA	NA
GACGTGCCATCCGTGG-1_5981_BA9	-13.6215059	-36.23543502	16	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1865	3266	0.04654011	0.008573178	0	16	EN-PYR	NA	NA	NA
GACGTGCTCAGAAATG-1_5981_BA9	26.7324015	-17.43535478	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	5334	15653	0.022743244	0.004663643	0	2	EN-L4	NA	NA	NA
GACGTTAAGAAAGTGG-1_5981_BA9	4.176135482	-10.08433715	12	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1661	2804	0.0021398	0.012838802	0	12	EN-MIX	NA	NA	NA
GACGTTAGTACTCTCC-1_5981_BA9	30.75407317	-12.52397096	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2871	5484	0.009117433	0.004923414	0	2	EN-L4	NA	NA	NA
GACGTTAGTCTTCGTC-1_5981_BA9	-34.96258143	-12.29831581	9	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	859	1276	0.003918495	0.003918495	0	9	OPC	NA	NA	NA
GACGTTAGTGATAAGT-1_5981_BA9	9.385691652	-7.272116089	10	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1951	3517	0.006539664	0.001421666	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GACGTTATCATTATCC-1_5981_BA9	-28.01434582	-20.83248728	6A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3379	7246	0.031465636	0.008004416	0	6A	IN-PV	NA	NA	NA
GACGTTATCCCGACTT-1_5981_BA9	-35.12875228	-5.460141408	9	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1218	1879	0.001064396	0.00266099	0	9	OPC	NA	NA	NA
GACTAACAGCCACCTG-1_5981_BA9	-8.223174618	-2.670945331	13A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2171	4145	0.004101327	0.001688782	0	13A	IN-VIP	NA	NA	NA
GACTAACAGGACACCA-1_5981_BA9	2.850170425	-16.80059006	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2925	6357	0.002674217	0.009595721	0	L2-3	EN-L2-3-MS	NA	NA	NA
GACTAACGTCTTGCGG-1_5981_BA9	-7.95438329	-5.270876675	13A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1447	2440	0.00204918	0.006557377	0	13A	IN-VIP	NA	NA	NA
GACTAACGTTGTCTTT-1_5981_BA9	-31.97574506	-13.42333152	9	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	732	1094	0.000914077	0.001828154	0	9	OPC	NA	NA	NA
GACTACAAGCTGGAAC-1_5981_BA9	5.890856781	-13.1948434	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2378	4107	0.003165327	0.009982956	0	L2-3	EN-L2-3-MS	NA	NA	NA
GACTACACACTAAGTC-1_5981_BA9	-30.30580232	9.783848623	8	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	801	1115	0.013452915	0.008071749	0	8	Astrocytes	NA	NA	NA
GACTACACAGACAAGC-1_5981_BA9	29.23232895	-16.30025636	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3983	9252	0.025724168	0.004215305	0	2	EN-L4	NA	NA	NA
GACTACACATCCCACT-1_5981_BA9	-0.220059738	26.66775934	1	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	839	1153	0.003469211	0.005203816	0	oligos	OL-Cntl	NA	NA	NA
GACTACATCGAGAGCA-1_5981_BA9	-32.17196341	-13.36392811	9	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	768	1012	0.008893281	0.000988142	0	9	OPC	NA	NA	NA
GACTGCGAGAATTCCC-1_5981_BA9	29.65119245	-12.49643136	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	4121	10009	0.01208912	0.006993706	0	2	EN-L4	NA	NA	NA
GACTGCGAGGGCTTCC-1_5981_BA9	26.29345757	-17.38332876	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	4705	13218	0.024738992	0.003177485	0	2	EN-L4	NA	NA	NA
GACTGCGCAAAGTCAA-1_5981_BA9	-28.96090071	10.37097564	8	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	763	1085	0.012903226	0.00921659	0	8	Astrocytes	NA	NA	NA
GACTGCGCATAAGACA-1_5981_BA9	-6.776744633	-7.052740512	13A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1117	1659	0.002411091	0.001808318	0	13A	IN-VIP	NA	NA	NA
GACTGCGGTCTAAAGA-1_5981_BA9	13.42402604	-22.3825515	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	4580	12532	0.007740185	0.003590808	0	L2-3	EN-L2-3-MS	NA	NA	NA
GACTGCGTCTGGAGCC-1_5981_BA9	23.92974514	-19.23557497	3	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	4373	11702	0.012989233	0.013074688	0	3	EN-L5-6	NA	NA	NA
GAGCAGAGTACTCTCC-1_5981_BA9	-4.414919828	35.61518982	17	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	816	1085	0.002764977	0.003686636	0	oligos	OL-MS-2	NA	NA	NA
GAGCAGATCGTACCGG-1_5981_BA9	21.57769236	-9.079602057	3	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1869	3280	0.002439024	0.006097561	0	3	EN-L5-6	NA	NA	NA
GAGGTGAGTAAATGTG-1_5981_BA9	-12.07988251	-1.054593248	13A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2614	4871	0.009238349	0.004105933	0	13A	IN-VIP	NA	NA	NA
GAGGTGAGTCCGCTGA-1_5981_BA9	12.41079681	-14.90289773	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3206	6487	0.020348389	0.005549561	0	L2-3	EN-L2-3-MS	NA	NA	NA
GAGTCCGAGCTTATCG-1_5981_BA9	12.39297989	-19.52337749	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	4565	12144	0.004199605	0.004611331	0	L2-3	EN-L2-3-MS	NA	NA	NA
GAGTCCGCACAGGCCT-1_5981_BA9	-11.11480612	-15.60338767	6B	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1132	1875	0.0128	0.001066667	0	6B	IN-SST	NA	NA	NA
GATCGATAGCGCCTCA-1_5981_BA9	17.86085226	-6.006671191	3	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1449	2630	0.001140684	0.002661597	0	3	EN-L5-6	NA	NA	NA
GATCGATAGGCTAGAC-1_5981_BA9	7.709532676	-10.62221423	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1749	2904	0.019283747	0.005853994	0	L2-3	EN-L2-3-MS	NA	NA	NA
GATCGATCAAGGTTTC-1_5981_BA9	4.899276998	-14.77567252	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2785	5607	0.003210273	0.005528803	0	L2-3	EN-L2-3-MS	NA	NA	NA
GATCGATGTTCATGGT-1_5981_BA9	28.61430753	-17.68243437	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	7620	33523	0.023267607	0.005727411	0	2	EN-L4	NA	NA	NA
GATCGATTCTCTTATG-1_5981_BA9	-21.69920089	11.9727372	8	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	925	1241	0.010475423	0.003223207	0	8	Astrocytes	NA	NA	NA
GATCGCGAGAATTCCC-1_5981_BA9	-21.14521308	12.25961414	8	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	967	1403	0.027797577	0.002138275	0	8	Astrocytes	NA	NA	NA
GATCGCGAGGCATGGT-1_5981_BA9	-37.46209403	-1.358830432	9	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1441	2481	0.000806127	0.00362757	0	9	OPC	NA	NA	NA
GATCGCGCAAGCCATT-1_5981_BA9	-13.53723236	-17.1166588	6B	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1289	2142	0.004668534	0.007469655	0	6B	IN-SST	NA	NA	NA
GATCGCGCACACGCTG-1_5981_BA9	-14.24271824	-15.16383102	6B	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1569	2631	0.014063094	0.009122007	0	6B	IN-SST	NA	NA	NA
GATCGCGGTCATCCCT-1_5981_BA9	-12.32927741	-21.3711268	6A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1123	2044	0.001956947	0.000978474	0	6A	IN-PV	NA	NA	NA
GATCGCGGTGAGGGTT-1_5981_BA9	31.21747821	-2.896635584	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2985	6533	0.000612276	0.003520588	0	2	EN-L4	NA	NA	NA
GATCGCGTCCAAACAC-1_5981_BA9	29.31974682	-16.33980779	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	4809	13653	0.02358456	0.007251154	0	2	EN-L4	NA	NA	NA
GATCGCGTCTTACCTA-1_5981_BA9	-8.095247644	-2.733678016	13A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1859	3282	0.000914077	0.003351615	0	13A	IN-VIP	NA	NA	NA
GATCGTACAAGCGTAG-1_5981_BA9	18.62158536	-17.69691921	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	5317	14712	0.007340946	0.003670473	0	L2-3	EN-L2-3-MS	NA	NA	NA
GATCGTAGTGGTTTCA-1_5981_BA9	-11.96711294	-13.50211299	6B	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1195	1745	0.036676218	0.007449857	0	6B	IN-SST	NA	NA	NA
GATCGTATCCCGGATG-1_5981_BA9	-0.207190692	28.83208612	1	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	865	1168	0.001712329	0.005136986	0	oligos	OL-Cntl	NA	NA	NA
GATCTAGCACAAGACG-1_5981_BA9	11.28682627	-20.75921326	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3902	10432	0.011982362	0.004121933	0	L2-3	EN-L2-3-MS	NA	NA	NA
GATCTAGCACGAGAGT-1_5981_BA9	-9.184797722	-4.426476753	13A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1924	3421	0.003507746	0.006138556	0	13A	IN-VIP	NA	NA	NA
GATCTAGGTGTTGGGA-1_5981_BA9	-17.1716301	-7.827728453	13B	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2874	5843	0.010097553	0.006845798	0	13B	IN-SV2C	NA	NA	NA
GATGAAAAGAGCAATT-1_5981_BA9	-12.31226933	-14.26410696	6B	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1386	2203	0.038583749	0.004993191	0	6B	IN-SST	NA	NA	NA
GATGAAATCAAACCGT-1_5981_BA9	-18.86261058	-5.437051378	13B	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2988	6133	0.020544595	0.006359041	0	13B	IN-SV2C	NA	NA	NA
GATGAAATCGAACTGT-1_5981_BA9	-19.30298419	-4.41601747	13A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3397	7569	0.031972519	0.0073986	0	13A	IN-VIP	NA	NA	NA
GATGAGGTCCGATATG-1_5981_BA9	-20.61334746	-20.69756284	6A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1791	3164	0.020543616	0.004424779	0	6A	IN-PV	NA	NA	NA
GATGAGGTCCGTTGTC-1_5981_BA9	-25.14422889	8.023364187	8	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	908	1299	0.002309469	0.008468052	0	8	Astrocytes	NA	NA	NA
GATGCTAAGATAGGAG-1_5981_BA9	-6.729705516	-7.440068859	13A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	927	1275	0.01254902	0.003137255	0	13A	IN-VIP	NA	NA	NA
GATGCTATCGTCACGG-1_5981_BA9	27.94755862	-17.32114619	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	5412	16550	0.049244713	0.003927492	0	2	EN-L4	NA	NA	NA
GATTCAGAGTTGTCGT-1_5981_BA9	5.882841083	-10.77207699	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1856	3063	0.021221025	0.012406138	0	L2-3	EN-L2-3-MS	NA	NA	NA
GATTCAGTCGGCTACG-1_5981_BA9	-28.70106144	-20.73796839	6A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	4124	9981	0.037070434	0.004708947	0	6A	IN-PV	NA	NA	NA
GATTCAGTCTATGTGG-1_5981_BA9	21.91372446	-1.603240574	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2263	4546	0.002859657	0.005279366	0	2	EN-L4	NA	NA	NA
GCAAACTAGCGGATCA-1_5981_BA9	-28.89237588	9.641797739	8	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	782	1022	0.031311155	0.001956947	0	8	Astrocytes	NA	NA	NA
GCAAACTCAATACGCT-1_5981_BA9	21.4423073	-3.63049268	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2240	4116	0.020165209	0.003644315	0	2	EN-L4	NA	NA	NA
GCAATCAAGCAACGGT-1_5981_BA9	-15.03667687	-20.78723885	6A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1570	2689	0.003718855	0.001487542	0	6A	IN-PV	NA	NA	NA
GCAATCAGTCAGATAA-1_5981_BA9	-17.7331967	-14.79418838	6B	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2221	4135	0.003869407	0.007980653	0	6B	IN-SST	NA	NA	NA
GCACATAAGAGTACCG-1_5981_BA9	18.69989934	-11.1591349	3	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2631	5048	0.007329635	0.005744849	0	3	EN-L5-6	NA	NA	NA
GCACATATCATCTGTT-1_5981_BA9	31.32124852	-7.153029621	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3037	6809	0.004405933	0.002056102	0	2	EN-L4	NA	NA	NA
GCACTCTAGTGGAGAA-1_5981_BA9	17.32513268	-17.55675394	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3430	7165	0.034054431	0.004326588	0	L2-3	EN-L2-3-MS	NA	NA	NA
GCACTCTCAAACAACA-1_5981_BA9	-4.023895766	-32.80048955	16	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	685	1047	0.17860554	0.009551098	0	16	EN-PYR	NA	NA	NA
GCACTCTGTCATACTG-1_5981_BA9	-21.42267165	-20.51676498	6A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2153	3715	0.044952894	0.002960969	0	6A	IN-PV	NA	NA	NA
GCACTCTGTCCGTCAG-1_5981_BA9	16.91433878	-9.778486142	3	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1910	3266	0.002449479	0.009185548	0	3	EN-L5-6	NA	NA	NA
GCACTCTGTTCAGGCC-1_5981_BA9	16.50533156	-14.98163996	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	4445	11345	0.012604672	0.005288673	0	L2-3	EN-L2-3-MS	NA	NA	NA
GCAGCCAAGTTGAGTA-1_5981_BA9	17.35267564	-18.73957653	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	4469	11580	0.005440415	0.004145078	0	L2-3	EN-L2-3-MS	NA	NA	NA
GCAGCCACAAGCTGTT-1_5981_BA9	28.0456243	-18.46046305	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	9925	67964	0.057765876	0.005444059	0	2	EN-L4	NA	NA	NA
GCAGCCAGTGCCTGTG-1_5981_BA9	-5.067071555	-8.573972327	13A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	981	1485	0	0.003367003	0	13A	IN-VIP	NA	NA	NA
GCAGCCATCAGCGATT-1_5981_BA9	10.79340176	-20.85028737	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3191	7243	0.005936767	0.004279994	0	L2-3	EN-L2-3-MS	NA	NA	NA
GCAGTTAAGACAGAGA-1_5981_BA9	8.256680021	-11.69474298	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2321	4076	0.016192345	0.005888126	0	L2-3	EN-L2-3-MS	NA	NA	NA
GCAGTTACATCCGCGA-1_5981_BA9	18.6165097	-7.070383694	3	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1866	3661	0.000819448	0.013111172	0	3	EN-L5-6	NA	NA	NA
GCAGTTACATTGCGGC-1_5981_BA9	3.825432127	-5.437135725	12	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1023	1426	0.011220196	0.011220196	0	12	EN-MIX	NA	NA	NA
GCAGTTAGTCTAAAGA-1_5981_BA9	29.73563252	-15.94412227	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3240	6692	0.020322773	0.004781829	0	2	EN-L4	NA	NA	NA
GCAGTTATCTAACTGG-1_5981_BA9	21.14282032	-1.271430104	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1637	2687	0.002232974	0.00334946	0	2	EN-L4	NA	NA	NA
GCATACAAGTGGGTTG-1_5981_BA9	-26.86416115	-20.16086081	6A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2362	4381	0.065510157	0.007760785	0	6A	IN-PV	NA	NA	NA
GCATACACAATGAATG-1_5981_BA9	18.3239665	-6.849533189	3	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1601	2898	0.00621118	0.002070393	0	3	EN-L5-6	NA	NA	NA
GCATACACAGCTGTAT-1_5981_BA9	4.563238935	-11.07901752	12	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1875	3090	0.015533981	0.004530744	0	12	EN-MIX	NA	NA	NA
GCATACACAGGAATGC-1_5981_BA9	29.9801188	-15.67138783	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3047	5901	0.019657685	0.006609049	0	2	EN-L4	NA	NA	NA
GCATACATCTGATACG-1_5981_BA9	31.34715116	-11.91139466	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2700	5043	0.012294269	0.00594884	0	2	EN-L4	NA	NA	NA
GCATGATAGATGTTAG-1_5981_BA9	6.011908667	-13.28032428	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2370	4164	0.002881844	0.014889529	0	L2-3	EN-L2-3-MS	NA	NA	NA
GCATGATAGCTTATCG-1_5981_BA9	11.25601606	-15.65131968	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3328	6512	0.00291769	0.011056511	0	L2-3	EN-L2-3-MS	NA	NA	NA
GCATGATCATTATCTC-1_5981_BA9	-19.83387965	-27.37302054	6A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2903	6418	0.007167342	0.002337177	0	6A	IN-PV	NA	NA	NA
GCATGATGTCAACTGT-1_5981_BA9	-8.14018614	-5.967911338	13A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1452	2326	0.002579536	0.008598452	0	13A	IN-VIP	NA	NA	NA
GCATGCGAGGAATGGA-1_5981_BA9	4.981409474	-11.63153122	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1906	3142	0.004137492	0.014958625	0	L2-3	EN-L2-3-MS	NA	NA	NA
GCATGCGCACGTTGGC-1_5981_BA9	9.908245446	-1.129286648	12	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1178	1843	0.053716766	0.002712968	0	12	EN-MIX	NA	NA	NA
GCATGCGCAGTTAACC-1_5981_BA9	13.9134893	-31.20380378	3	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3040	6931	0.001587073	0.002597028	0	3	EN-L5-6	NA	NA	NA
GCATGCGCATAAAGGT-1_5981_BA9	-7.514566469	-34.16277362	16	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	973	1389	0.084953204	0.004319654	0	16	EN-PYR	NA	NA	NA
GCATGCGGTGGTGTAG-1_5981_BA9	-29.25310769	9.862414593	8	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	781	1073	0.017707363	0.001863933	0	8	Astrocytes	NA	NA	NA
GCATGCGTCAGAAATG-1_5981_BA9	11.60238061	-20.64375483	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	4092	10305	0.00349345	0.004949054	0	L2-3	EN-L2-3-MS	NA	NA	NA
GCATGTAAGCTTCGCG-1_5981_BA9	16.08464825	-18.40855076	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3326	7260	0.009366391	0.007162534	0	L2-3	EN-L2-3-MS	NA	NA	NA
GCATGTAGTACCATCA-1_5981_BA9	-17.1246111	-15.21864768	6B	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2019	3734	0.00776647	0.00776647	0	6B	IN-SST	NA	NA	NA
GCCAAATAGAAACGAG-1_5981_BA9	20.36030495	-3.160819031	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2029	3402	0.015579071	0.007348618	0	2	EN-L4	NA	NA	NA
GCCAAATCATCCGTGG-1_5981_BA9	30.05577439	-15.51602069	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2993	5955	0.01511335	0.006717045	0	2	EN-L4	NA	NA	NA
GCCAAATGTACCGAGA-1_5981_BA9	7.697781274	-12.31011252	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2286	3990	0.011027569	0.005764411	0	L2-3	EN-L2-3-MS	NA	NA	NA
GCCAAATTCAGCGATT-1_5981_BA9	-12.6864115	-14.26303213	6B	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1516	2456	0.049674267	0.002850163	0	6B	IN-SST	NA	NA	NA
GCCAAATTCGAGCCCA-1_5981_BA9	29.77408559	-15.76436857	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	4144	10137	0.022886456	0.004537832	0	2	EN-L4	NA	NA	NA
GCCTCTACACCTTGTC-1_5981_BA9	-27.01376355	-21.43854557	6A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3813	9009	0.038628039	0.002109002	0	6A	IN-PV	NA	NA	NA
GCCTCTACATTCCTCG-1_5981_BA9	-13.96738163	-24.44998935	6A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1451	2718	0.001103753	0.004415011	0	6A	IN-PV	NA	NA	NA
GCCTCTATCTTGCCGT-1_5981_BA9	27.7973936	-13.56880466	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	4598	12324	0.015173645	0.004543979	0	2	EN-L4	NA	NA	NA
GCGACCAAGCTGTTCA-1_5981_BA9	-6.572663655	-7.909409457	13A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	956	1332	0.01951952	0.006756757	0	13A	IN-VIP	NA	NA	NA
GCGACCATCCTCAACC-1_5981_BA9	-25.03637839	17.67198119	8	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1366	2155	0.007888631	0.001392111	0	8	Astrocytes	NA	NA	NA
GCGACCATCGCATGGC-1_5981_BA9	-30.37781607	9.68434064	8	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	802	1105	0.011764706	0.007239819	0	8	Astrocytes	NA	NA	NA
GCGAGAAGTTAAGACA-1_5981_BA9	1.64453382	-12.22822968	12	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2028	3775	0.00397351	0.001589404	0	12	EN-MIX	NA	NA	NA
GCGCAACAGGCTCATT-1_5981_BA9	23.62536472	-12.00280013	3	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3010	6544	0.001986553	0.005654034	0	3	EN-L5-6	NA	NA	NA
GCGCAACCACGAAATA-1_5981_BA9	11.09366087	-20.30127484	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3694	8849	0.006102384	0.005763363	0	L2-3	EN-L2-3-MS	NA	NA	NA
GCGCAACCATACTCTT-1_5981_BA9	-27.98510455	-20.75842503	6A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3529	7966	0.026362039	0.005272408	0	6A	IN-PV	NA	NA	NA
GCGCAACGTACAGTTC-1_5981_BA9	28.63637188	-18.01941153	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	7454	28965	0.036319696	0.005972726	0	2	EN-L4	NA	NA	NA
GCGCAACGTTAAAGTG-1_5981_BA9	25.00091807	-19.06880322	3	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3898	8766	0.006844627	0.003422313	0	3	EN-L5-6	NA	NA	NA
GCGCAGTAGACATAAC-1_5981_BA9	-28.5720264	-20.91943688	6A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	4923	12990	0.027636644	0.007852194	0	6A	IN-PV	NA	NA	NA
GCGCAGTCAGATCTGT-1_5981_BA9	-8.34074376	-6.203134818	13A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1607	2632	0.043693009	0.003419453	0	13A	IN-VIP	NA	NA	NA
GCGCAGTCAGTCGATT-1_5981_BA9	-26.15887779	-22.16033764	6A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3572	7760	0.029123711	0.005154639	0	6A	IN-PV	NA	NA	NA
GCGCAGTGTGGCCCTA-1_5981_BA9	-21.37269092	-21.30199683	6A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1975	3572	0.034994401	0.00643897	0	6A	IN-PV	NA	NA	NA
GCGCAGTTCATTTGGG-1_5981_BA9	-32.87882467	-13.57354942	9	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	701	1041	0.004803074	0.004803074	0	9	OPC	NA	NA	NA
GCGCAGTTCTTTACAC-1_5981_BA9	-18.90862514	-5.823535375	13B	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3051	6608	0.023002421	0.004993947	0	13B	IN-SV2C	NA	NA	NA
GCGCCAAGTCGAATCT-1_5981_BA9	-9.610263162	-34.18474366	16	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	985	1416	0.046610169	0.003531073	0	16	EN-PYR	NA	NA	NA
GCGCGATAGGCGATAC-1_5981_BA9	-0.335013976	29.02950387	1	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	739	1036	0.002895753	0.004826255	0	oligos	OL-Cntl	NA	NA	NA
GCGCGATAGTCCGTAT-1_5981_BA9	21.10189354	-1.173450028	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1590	2732	0.004392387	0.004026354	0	2	EN-L4	NA	NA	NA
GCGCGATGTCCAAGTT-1_5981_BA9	4.155355198	-11.0725636	12	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1782	3029	0.010234401	0.007263123	0	12	EN-MIX	NA	NA	NA
GCGCGATTCCCGACTT-1_5981_BA9	-11.9526728	-5.953954946	13A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2056	3589	0.006965729	0.006687099	0	13A	IN-VIP	NA	NA	NA
GCGCGATTCGGCGCAT-1_5981_BA9	-12.07893429	-7.299439462	13B	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1947	3390	0.016224189	0.004129794	0	13B	IN-SV2C	NA	NA	NA
GCGGGTTCAAACGCGA-1_5981_BA9	27.46867712	-18.76966137	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2822	5579	0.028141244	0.007707474	0	2	EN-L4	NA	NA	NA
GCGGGTTCAGTAAGCG-1_5981_BA9	6.326609958	-3.283090356	12	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1321	1858	0.008073197	0.013993541	0	12	EN-MIX	NA	NA	NA
GCGGGTTGTCGCTTCT-1_5981_BA9	5.123141391	-9.779446478	12	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1629	2868	0.011854951	0.006624826	0	12	EN-MIX	NA	NA	NA
GCTCCTAAGAGGTACC-1_5981_BA9	27.75488599	-17.52798404	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	6866	24793	0.026015408	0.007824789	0	2	EN-L4	NA	NA	NA
GCTCCTAAGGTGATTA-1_5981_BA9	-11.40735141	-34.3543283	16	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1259	2042	0.111165524	0.006856024	0	16	EN-PYR	NA	NA	NA
GCTCCTAGTACCGGCT-1_5981_BA9	-25.36879426	9.327497317	8	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	912	1315	0.000760456	0.004562738	0	8	Astrocytes	NA	NA	NA
GCTCCTAGTGCTTCTC-1_5981_BA9	-19.63111967	-5.81463614	13B	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3706	8198	0.015735545	0.006464991	0	13B	IN-SV2C	NA	NA	NA
GCTCTGTTCACCTTAT-1_5981_BA9	29.94469823	-15.82107747	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3278	6734	0.011434511	0.005940006	0	2	EN-L4	NA	NA	NA
GCTGCAGTCGCGATCG-1_5981_BA9	29.64923572	-16.03146389	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3492	7659	0.015928972	0.004700353	0	2	EN-L4	NA	NA	NA
GCTGCGACATGGATGG-1_5981_BA9	20.73470402	-3.652924145	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2040	3590	0.007520891	0.002506964	0	2	EN-L4	NA	NA	NA
GCTGCTTAGGACCACA-1_5981_BA9	-29.01519996	10.50188749	8	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	787	1093	0.004574565	0.004574565	0	8	Astrocytes	NA	NA	NA
GCTGCTTGTACCGCTG-1_5981_BA9	-10.2808316	-6.006997176	13A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1509	2365	0.005919662	0.005919662	0	13A	IN-VIP	NA	NA	NA
GCTGCTTGTGCAGACA-1_5981_BA9	-10.82805576	-8.674039978	13B	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1427	2300	0.004347826	0.003478261	0	13B	IN-SV2C	NA	NA	NA
GCTGCTTGTTATGCGT-1_5981_BA9	16.94277257	-26.54399807	3	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	4692	13380	0.005455904	0.006352765	0	3	EN-L5-6	NA	NA	NA
GCTTCCAAGACTACAA-1_5981_BA9	18.03863591	-18.96752599	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	4007	10196	0.022852099	0.004119262	0	L2-3	EN-L2-3-MS	NA	NA	NA
GCTTCCAGTGTGGTTT-1_5981_BA9	31.12027463	-10.47563664	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2434	4725	0.007830688	0.005714286	0	2	EN-L4	NA	NA	NA
GCTTGAACAAGCGCTC-1_5981_BA9	20.89917114	-3.835610566	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2118	3650	0.005205479	0.003287671	0	2	EN-L4	NA	NA	NA
GCTTGAAGTAAGGGAA-1_5981_BA9	-8.218204718	-10.73384499	6B	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	899	1306	0.073506891	0.004594181	0	6B	IN-SST	NA	NA	NA
GGAAAGCAGCACCGTC-1_5981_BA9	24.54097375	-19.97709165	3	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3699	8400	0.020833333	0.004642857	0	3	EN-L5-6	NA	NA	NA
GGAAAGCAGGACATTA-1_5981_BA9	30.03311056	-15.6436258	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3095	5950	0.017647059	0.007394958	0	2	EN-L4	NA	NA	NA
GGAAAGCAGGGCACTA-1_5981_BA9	-18.39228299	-5.830964637	13B	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2685	4952	0.006663974	0.007067851	0	13B	IN-SV2C	NA	NA	NA
GGAAAGCTCAATAAGG-1_5981_BA9	29.44382434	-15.58196766	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3147	6455	0.025871418	0.005731991	0	2	EN-L4	NA	NA	NA
GGAAAGCTCCCTAATT-1_5981_BA9	20.19339338	-15.50146052	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	4810	12839	0.024067295	0.00405016	0	L2-3	EN-L2-3-MS	NA	NA	NA
GGAACTTCATAGTAAG-1_5981_BA9	-9.463555204	-15.07212443	6B	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	879	1239	0.011299435	0.00645682	0	6B	IN-SST	NA	NA	NA
GGAACTTCATCCCATC-1_5981_BA9	-20.84489706	-20.83763524	6A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1981	3833	0.029741717	0.003913384	0	6A	IN-PV	NA	NA	NA
GGAACTTTCAACGGCC-1_5981_BA9	27.03980121	-13.74107606	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	6410	22806	0.020477067	0.003639393	0	2	EN-L4	NA	NA	NA
GGAATAAAGCAACGGT-1_5981_BA9	-8.582055563	-5.422415483	13A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1424	2205	0.00861678	0.004988662	0	13A	IN-VIP	NA	NA	NA
GGAATAACAGTCAGCC-1_5981_BA9	-22.94185156	-22.32986818	6A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2743	5354	0.020732163	0.005790064	0	6A	IN-PV	NA	NA	NA
GGAATAAGTCACAAGG-1_5981_BA9	28.40918138	-17.13032406	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	4786	12468	0.037536092	0.006015399	0	2	EN-L4	NA	NA	NA
GGAATAAGTTAGTGGG-1_5981_BA9	9.000242346	-3.376229959	12	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1648	2622	0.020976354	0.012204424	0	12	EN-MIX	NA	NA	NA
GGACAAGAGTCATGCT-1_5981_BA9	-13.02550823	-14.43769237	6B	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1559	2586	0.024361949	0.003480278	0	6B	IN-SST	NA	NA	NA
GGACAAGCAAGAAAGG-1_5981_BA9	-32.10459678	-13.56299775	9	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	794	1076	0.00464684	0.000929368	0	9	OPC	NA	NA	NA
GGACAAGTCGAGGTAG-1_5981_BA9	6.426541354	-11.05197565	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2022	3232	0.008663366	0.017636139	0	L2-3	EN-L2-3-MS	NA	NA	NA
GGACAGACATTCTCAT-1_5981_BA9	24.08076885	-19.40314103	3	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	4161	10347	0.009954576	0.015366773	0	3	EN-L5-6	NA	NA	NA
GGACATTCAAGCCATT-1_5981_BA9	7.573203693	23.9787955	1	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1055	1535	0.000651466	0.008469055	0	oligos	OL-Cntl	NA	NA	NA
GGACATTGTCGCCATG-1_5981_BA9	-10.61613541	-5.573067622	13A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1843	3140	0.007961783	0.015605096	0	13A	IN-VIP	NA	NA	NA
GGACATTTCAACACAC-1_5981_BA9	20.29584902	-15.33717868	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	5698	18625	0.015838926	0.005637584	0	L2-3	EN-L2-3-MS	NA	NA	NA
GGAGCAAAGACCCACC-1_5981_BA9	16.46089678	-18.19717798	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3692	9227	0.024818468	0.004768614	0	L2-3	EN-L2-3-MS	NA	NA	NA
GGAGCAAAGAGTCGGT-1_5981_BA9	-11.60926907	-27.38138455	16	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1037	1441	0.066620402	0.014573213	0	16	EN-PYR	NA	NA	NA
GGAGCAAAGTTCGATC-1_5981_BA9	18.01949593	-17.74443722	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	5595	17705	0.007455521	0.003162948	0	L2-3	EN-L2-3-MS	NA	NA	NA
GGAGCAAGTACTTGAC-1_5981_BA9	28.2513819	-17.2951609	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	5001	13969	0.017753597	0.006299664	0	2	EN-L4	NA	NA	NA
GGAGCAAGTGCACGAA-1_5981_BA9	3.797613327	-12.86644513	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2098	3789	0.003958828	0.01821061	0	L2-3	EN-L2-3-MS	NA	NA	NA
GGATGTTCAGGTTTCA-1_5981_BA9	16.2661724	-18.29652187	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	5275	14675	0.008381601	0.004633731	0	L2-3	EN-L2-3-MS	NA	NA	NA
GGATGTTGTAAGAGAG-1_5981_BA9	2.74088681	-7.021979569	12	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1398	2173	0	0.005982513	0	12	EN-MIX	NA	NA	NA
GGATGTTGTTGGTGGA-1_5981_BA9	-15.29345395	-22.68632265	6A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1541	2591	0.001157854	0.00270166	0	6A	IN-PV	NA	NA	NA
GGATGTTTCGATAGAA-1_5981_BA9	17.81588608	-17.63771836	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	4875	13055	0.007123707	0.004136346	0	L2-3	EN-L2-3-MS	NA	NA	NA
GGATTACCACTACAGT-1_5981_BA9	11.71185432	-20.53271868	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	4810	13499	0.002889103	0.005778206	0	L2-3	EN-L2-3-MS	NA	NA	NA
GGCAATTAGAAGGCCT-1_5981_BA9	30.03436018	-15.71205102	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3795	8868	0.027740189	0.007555255	0	2	EN-L4	NA	NA	NA
GGCAATTGTCCCTACT-1_5981_BA9	-7.186418847	-27.83396097	16	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	881	1181	0.029635902	0.008467401	0	16	EN-PYR	NA	NA	NA
GGCCGATGTAGCTCCG-1_5981_BA9	20.87646832	-21.80789624	3	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3825	8838	0.009843856	0.011541073	0	3	EN-L5-6	NA	NA	NA
GGCGACTCAGCCTTGG-1_5981_BA9	16.68621422	-28.07744264	3	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3708	8942	0.007828226	0.003354954	0	3	EN-L5-6	NA	NA	NA
GGCGACTTCTGCTTGC-1_5981_BA9	-5.644943742	-8.040291679	13A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	940	1436	0.004178273	0.007660167	0	13A	IN-VIP	NA	NA	NA
GGCGTGTCATGTCGAT-1_5981_BA9	-16.72564466	-6.725075125	13B	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2310	4181	0.032528103	0.004066013	0	13B	IN-SV2C	NA	NA	NA
GGCGTGTTCACGCATA-1_5981_BA9	-31.91206409	-13.40495279	9	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	740	1040	0.002884615	0.004807692	0	9	OPC	NA	NA	NA
GGCTCGAAGCTGTCTA-1_5981_BA9	19.88217759	-11.48951294	3	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2564	4931	0.016426688	0.004258771	0	3	EN-L5-6	NA	NA	NA
GGCTCGACAAGCCTAT-1_5981_BA9	5.157629856	-16.12975892	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3007	6741	0.002818573	0.011274292	0	L2-3	EN-L2-3-MS	NA	NA	NA
GGCTCGAGTTCACGGC-1_5981_BA9	11.40523977	-20.30376096	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	4301	10935	0.002743484	0.007864655	0	L2-3	EN-L2-3-MS	NA	NA	NA
GGCTCGATCATACGGT-1_5981_BA9	20.14869264	-4.276530727	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2227	3789	0.030087094	0.004486672	0	2	EN-L4	NA	NA	NA
GGCTCGATCGCGATCG-1_5981_BA9	-9.651510092	-17.05711159	6B	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	897	1372	0.006559767	0.002915452	0	6B	IN-SST	NA	NA	NA
GGCTGGTAGCTCCTCT-1_5981_BA9	28.15516645	-18.11057435	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	7694	31927	0.05283929	0.008174899	0	2	EN-L4	NA	NA	NA
GGCTGGTCATACCATG-1_5981_BA9	-9.616023896	22.20728672	8	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	926	1188	0.003367003	0.02020202	0	8	Astrocytes	NA	NA	NA
GGGAATGAGCTAAACA-1_5981_BA9	26.85306857	4.979806495	15A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	889	1182	0.011844332	0.011844332	0	15A	Endo cells	NA	NA	NA
GGGAATGGTACAAGTA-1_5981_BA9	-28.90637014	10.12878765	8	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	885	1182	0.012690355	0	0	8	Astrocytes	NA	NA	NA
GGGACCTCAGCCAGAA-1_5981_BA9	4.329527132	-11.30834291	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1898	3221	0.00124185	0.010866191	0	L2-3	EN-L2-3-MS	NA	NA	NA
GGGACCTCATGCAATC-1_5981_BA9	-11.09670632	-9.687583121	13B	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1335	2105	0.002375297	0.002850356	0	13B	IN-SV2C	NA	NA	NA
GGGACCTGTTTGGCGC-1_5981_BA9	-23.55697666	-20.78900915	6A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3594	7421	0.021829942	0.003099313	0	6A	IN-PV	NA	NA	NA
GGGAGATAGAATTCCC-1_5981_BA9	-17.83161413	-4.403138566	13A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3452	7153	0.013141339	0.006011464	0	13A	IN-VIP	NA	NA	NA
GGGAGATAGCCCAACC-1_5981_BA9	22.36130853	-21.87398848	3	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3360	7431	0.009150855	0.011034854	0	3	EN-L5-6	NA	NA	NA
GGGAGATAGCTAGGCA-1_5981_BA9	18.57065131	0.045771391	12	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1292	2141	0.001401214	0.003736572	0	12	EN-MIX	NA	NA	NA
GGGAGATAGTGAAGAG-1_5981_BA9	-17.59002692	-3.809155887	13A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2442	4178	0.060315941	0.00933461	0	13A	IN-VIP	NA	NA	NA
GGGAGATCAGTGGGAT-1_5981_BA9	24.90790223	-18.94028694	3	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3468	7297	0.020556393	0.003563108	0	3	EN-L5-6	NA	NA	NA
GGGAGATGTCGGCATC-1_5981_BA9	-16.56174818	-15.49474623	6B	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1840	3430	0.044023324	0.004081633	0	6B	IN-SST	NA	NA	NA
GGGAGATGTCGTTGTA-1_5981_BA9	-27.15468446	-18.27867069	6B	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3740	7757	0.015598814	0.010442181	0	6B	IN-SST	NA	NA	NA
GGGAGATTCCCATTAT-1_5981_BA9	25.33387675	-17.68942996	3	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	5242	16716	0.037808088	0.003529553	0	3	EN-L5-6	NA	NA	NA
GGGATGACACTCTGTC-1_5981_BA9	-12.12905275	-3.276969706	13A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2352	4196	0.0064347	0.0085796	0	13A	IN-VIP	NA	NA	NA
GGGCACTAGAGGGATA-1_5981_BA9	-27.30970239	-20.97546283	6A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3555	7712	0.017634855	0.007002075	0	6A	IN-PV	NA	NA	NA
GGGCACTAGAGGTTAT-1_5981_BA9	27.60891731	-17.53043867	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	7348	28614	0.02226183	0.007408961	0	2	EN-L4	NA	NA	NA
GGGCACTTCCTATGTT-1_5981_BA9	-24.39234896	10.50634168	8	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1056	1739	0.037377803	0.003450259	0	8	Astrocytes	NA	NA	NA
GGGCACTTCGCATGGC-1_5981_BA9	20.67421704	-14.12961391	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2746	5245	0.014871306	0.008198284	0	L2-3	EN-L2-3-MS	NA	NA	NA
GGGCATCGTGATGTCT-1_5981_BA9	28.26157392	-17.55072523	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	6701	24741	0.050765935	0.00416313	0	2	EN-L4	NA	NA	NA
GGGTTGCAGCAGGTCA-1_5981_BA9	-14.14394819	-15.4875119	6B	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1482	2371	0.009278785	0.002952341	0	6B	IN-SST	NA	NA	NA
GGGTTGCGTTAGTGGG-1_5981_BA9	8.180029842	-10.93151324	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1962	3193	0.020670216	0.002818666	0	L2-3	EN-L2-3-MS	NA	NA	NA
GGGTTGCTCAAACCGT-1_5981_BA9	4.988263994	-9.021270087	12	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1274	1998	0.012512513	0.006506507	0	12	EN-MIX	NA	NA	NA
GGTATTGCAAGAAGAG-1_5981_BA9	19.41177604	-20.57762733	3	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	4233	10791	0.014919841	0.003799463	0	3	EN-L5-6	NA	NA	NA
GGTATTGCACATTAGC-1_5981_BA9	9.063814108	-0.482830311	12	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	921	1224	0.024509804	0.005718954	0	12	EN-MIX	NA	NA	NA
GGTATTGGTTTGGGCC-1_5981_BA9	27.88339291	6.143671091	15A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	822	1036	0.005791506	0.011583012	0	15A	Endo cells	NA	NA	NA
GGTGAAGCACGACTCG-1_5981_BA9	19.55917843	-19.82571918	3	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3394	7072	0.013857466	0.009332579	0	3	EN-L5-6	NA	NA	NA
GGTGAAGTCTTGACGA-1_5981_BA9	-10.37138515	-5.536466973	13A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1973	3501	0.033704656	0.003427592	0	13A	IN-VIP	NA	NA	NA
GGTGCGTTCCTTTACA-1_5981_BA9	-18.58816432	-4.899242213	13A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3507	8122	0.02166954	0.007633588	0	13A	IN-VIP	NA	NA	NA
GGTGTTAAGCAGCGTA-1_5981_BA9	-9.640343468	-8.028157711	13A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1344	2097	0.006676204	0.001430615	0	13A	IN-VIP	NA	NA	NA
GGTGTTATCAGTTCGA-1_5981_BA9	-5.55997478	-7.277841698	13A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	977	1528	0.005890052	0.001963351	0	13A	IN-VIP	NA	NA	NA
GTAACGTAGTACTTGC-1_5981_BA9	11.07058679	-22.45445417	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	4829	14319	0.003142678	0.003212515	0	L2-3	EN-L2-3-MS	NA	NA	NA
GTAACGTAGTGAAGTT-1_5981_BA9	21.5801357	-22.01051586	3	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	4189	11502	0.004607894	0.005129543	0	3	EN-L5-6	NA	NA	NA
GTAACGTGTCGAAAGC-1_5981_BA9	5.254947375	-13.73065899	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2356	4560	0.009649123	0.004605263	0	L2-3	EN-L2-3-MS	NA	NA	NA
GTAACGTTCTGAGTGT-1_5981_BA9	5.499659001	-13.67402458	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2284	4224	0.002130682	0.012310606	0	L2-3	EN-L2-3-MS	NA	NA	NA
GTAACGTTCTTTCCTC-1_5981_BA9	17.69794818	26.19763153	1	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	951	1382	0.000723589	0.005065123	0	oligos	OL-Cntl	NA	NA	NA
GTAACTGAGAAGGCCT-1_5981_BA9	19.63543919	-11.31703775	3	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2750	5613	0.01407447	0.00498842	0	3	EN-L5-6	NA	NA	NA
GTAACTGGTCTCCCTA-1_5981_BA9	12.59468915	-19.85738301	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	5079	14620	0.006361149	0.00752394	0	L2-3	EN-L2-3-MS	NA	NA	NA
GTACGTAAGACTGTAA-1_5981_BA9	33.77645815	-5.062215391	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2726	5492	0.004552076	0.006554989	0	2	EN-L4	NA	NA	NA
GTACGTAAGCAATCTC-1_5981_BA9	24.15416171	-20.69427893	3	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	4163	10471	0.00716264	0.005252602	0	3	EN-L5-6	NA	NA	NA
GTACGTAAGCCTCGTG-1_5981_BA9	20.68307532	-2.293424674	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1590	2501	0.009596162	0.006397441	0	2	EN-L4	NA	NA	NA
GTACGTATCAGTTAGC-1_5981_BA9	10.67074935	-1.873741535	12	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1250	1932	0.02173913	0.00621118	0	12	EN-MIX	NA	NA	NA
GTACGTATCATATCGG-1_5981_BA9	-12.68267506	-34.86020359	16	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1487	2507	0.097327483	0.007179896	0	16	EN-PYR	NA	NA	NA
GTACGTATCTTTCCTC-1_5981_BA9	-12.05283433	-12.73496126	12	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1840	3235	0.039876352	0.00618238	0	12	EN-MIX	NA	NA	NA
GTACTCCCACGTCAGC-1_5981_BA9	-5.492052479	-8.850296275	13A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	925	1370	0.00729927	0.000729927	0	13A	IN-VIP	NA	NA	NA
GTACTCCCATGGATGG-1_5981_BA9	13.34165798	-28.23241326	3	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2073	4055	0.0027127	0.002219482	0	3	EN-L5-6	NA	NA	NA
GTACTCCGTACCGGCT-1_5981_BA9	-32.49687018	-13.593658	9	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	768	1051	0.002854424	0.004757374	0	9	OPC	NA	NA	NA
GTACTCCGTTCCATGA-1_5981_BA9	-7.437861093	-6.615509097	13A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1362	2291	0.012658228	0.001745962	0	13A	IN-VIP	NA	NA	NA
GTACTCCTCTGTCTAT-1_5981_BA9	-28.05076012	-20.84891441	6A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	4042	9895	0.038100051	0.005962607	0	6A	IN-PV	NA	NA	NA
GTACTTTAGCCGGTAA-1_5981_BA9	-10.19279971	-6.451343642	13A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1862	3250	0.005230769	0.004	0	13A	IN-VIP	NA	NA	NA
GTACTTTGTACTCGCG-1_5981_BA9	3.640757366	-12.8245737	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2022	3570	0.006442577	0.005602241	0	L2-3	EN-L2-3-MS	NA	NA	NA
GTACTTTGTATATCCG-1_5981_BA9	20.21134717	-3.800290679	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1790	2830	0.024381625	0.003533569	0	2	EN-L4	NA	NA	NA
GTACTTTGTTTGACAC-1_5981_BA9	4.324487435	-10.11532409	12	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1719	2965	0.002023609	0.013153457	0	12	EN-MIX	NA	NA	NA
GTACTTTTCACCTTAT-1_5981_BA9	5.86596701	-17.09976373	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3251	7176	0.003901895	0.019509476	0	L2-3	EN-L2-3-MS	NA	NA	NA
GTAGGCCGTCCGAACC-1_5981_BA9	26.95304331	-13.7175754	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	6116	20780	0.021222329	0.005149182	0	L2-3	EN-L2-3-MS	NA	NA	NA
GTATCTTCATCCCACT-1_5981_BA9	7.05888426	-24.78416089	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	5128	14778	0.00331574	0.002639058	0	L2-3	EN-L2-3-MS	NA	NA	NA
GTATCTTGTTATCACG-1_5981_BA9	17.34273195	-18.16707638	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	4389	11679	0.008648001	0.004366812	0	L2-3	EN-L2-3-MS	NA	NA	NA
GTATTCTCAAGCCTAT-1_5981_BA9	-28.08160099	-20.87388613	6A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	4273	10912	0.039772727	0.006231672	0	6A	IN-PV	NA	NA	NA
GTATTCTGTCCGACGT-1_5981_BA9	24.36566506	-24.22128515	3	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2619	5176	0.001738794	0.00637558	0	3	EN-L5-6	NA	NA	NA
GTATTCTTCTGCAGTA-1_5981_BA9	1.830999686	-7.585851025	12	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1398	2148	0.002793296	0.011638734	0	12	EN-MIX	NA	NA	NA
GTCAAGTAGCAATCTC-1_5981_BA9	-26.73261111	-18.3168755	6B	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3031	5905	0.010499577	0.012870449	0	6B	IN-SST	NA	NA	NA
GTCAAGTCAGCGTAAG-1_5981_BA9	4.450552027	1.747857713	16	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	828	1026	0.05165692	0.012670565	0	16	EN-PYR	NA	NA	NA
GTCAAGTTCACAAACC-1_5981_BA9	-11.66035309	-15.5452135	6B	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1131	1624	0.008004926	0.003078818	0	6B	IN-SST	NA	NA	NA
GTCACGGCAAATACAG-1_5981_BA9	-30.04430975	-11.33749727	9	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	943	1393	0.047379756	0.005025126	0	9	OPC	NA	NA	NA
GTCACGGCAAGCGATG-1_5981_BA9	11.27874401	-20.89476188	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	5032	13959	0.005301239	0.003868472	0	L2-3	EN-L2-3-MS	NA	NA	NA
GTCACGGGTAAGGGAA-1_5981_BA9	30.4489443	-14.37016572	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2885	5538	0.018237631	0.004153124	0	2	EN-L4	NA	NA	NA
GTCATTTCAAGGGTCA-1_5981_BA9	4.850317551	-15.44256287	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2493	4729	0.002537534	0.016493973	0	L2-3	EN-L2-3-MS	NA	NA	NA
GTCATTTCAATGGACG-1_5981_BA9	23.44345379	-4.384750869	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2780	6022	0.014779143	0.001992693	0	2	EN-L4	NA	NA	NA
GTCATTTCAGTAAGCG-1_5981_BA9	28.65553357	-17.84316757	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	7165	26909	0.028057527	0.005760155	0	2	EN-L4	NA	NA	NA
GTCCTCAAGAGACTAT-1_5981_BA9	-26.04150968	-17.2478069	6A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	6330	20187	0.03720216	0.004705999	0	6A	IN-PV	NA	NA	NA
GTCCTCACAATGGAGC-1_5981_BA9	17.00214166	-17.84083014	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3172	6949	0.035256871	0.004461074	0	L2-3	EN-L2-3-MS	NA	NA	NA
GTCCTCAGTAGCCTAT-1_5981_BA9	27.00377469	-13.68142592	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	5075	14532	0.030209194	0.00433526	0	L2-3	EN-L2-3-MS	NA	NA	NA
GTCCTCATCACTTACT-1_5981_BA9	31.10515128	-12.08818962	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3035	6190	0.018416801	0.004361874	0	2	EN-L4	NA	NA	NA
GTCGGGTAGAGGGCTT-1_5981_BA9	5.547251452	-14.42059492	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2796	5927	0.013160115	0.00286823	0	L2-3	EN-L2-3-MS	NA	NA	NA
GTCGGGTAGGCAGTCA-1_5981_BA9	-9.33974308	-15.99095896	6B	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	812	1188	0.002525253	0.006734007	0	6B	IN-SST	NA	NA	NA
GTCGGGTGTAATTGGA-1_5981_BA9	-7.272195337	-8.298465016	13A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1192	1654	0.019951632	0.012091898	0	13A	IN-VIP	NA	NA	NA
GTCGTAACAGGGTATG-1_5981_BA9	28.61706556	-18.47194618	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	7378	28897	0.029414818	0.010727757	0	2	EN-L4	NA	NA	NA
GTCGTAAGTGTTCTTT-1_5981_BA9	4.723719221	-11.71673786	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1851	3143	0.005727012	0.006363347	0	L2-3	EN-L2-3-MS	NA	NA	NA
GTCGTAATCGTCCGTT-1_5981_BA9	4.946449143	-10.43376862	12	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1647	2623	0.012581014	0.004574914	0	12	EN-MIX	NA	NA	NA
GTCTCGTAGGGAAACA-1_5981_BA9	-7.290764613	-6.803043284	13A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1177	1731	0.002888504	0.012131716	0	13A	IN-VIP	NA	NA	NA
GTCTCGTCAAAGTGCG-1_5981_BA9	-11.50236302	-27.31840407	16	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	686	1039	0.185755534	0.005774783	0	16	EN-PYR	NA	NA	NA
GTCTCGTTCTTAACCT-1_5981_BA9	3.175347182	-10.79020362	12	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1594	2782	0.004672897	0.007548526	0	12	EN-MIX	NA	NA	NA
GTCTTCGAGCCCAACC-1_5981_BA9	3.6776207	-12.49691251	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2051	3507	0.003136584	0.011690904	0	L2-3	EN-L2-3-MS	NA	NA	NA
GTCTTCGCACAACTGT-1_5981_BA9	27.92020049	-13.07675483	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	4089	10144	0.016561514	0.004238959	0	2	EN-L4	NA	NA	NA
GTCTTCGGTGTAAGTA-1_5981_BA9	5.527674285	-13.72569187	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2201	3824	0.003399582	0.008368201	0	L2-3	EN-L2-3-MS	NA	NA	NA
GTGAAGGCAGGACGTA-1_5981_BA9	-18.33378362	-5.938585324	13B	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2351	4264	0.037054409	0.001876173	0	13B	IN-SV2C	NA	NA	NA
GTGCAGCAGCCGCCTA-1_5981_BA9	-8.484508953	-3.320216214	13A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1784	3152	0.011738579	0.008883249	0	13A	IN-VIP	NA	NA	NA
GTGCAGCCACACCGAC-1_5981_BA9	-29.74948422	-21.06404505	6A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	5263	14650	0.012150171	0.005460751	0	6A	IN-PV	NA	NA	NA
GTGCAGCCATCCGCGA-1_5981_BA9	2.452117751	-12.84593537	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2360	4662	0.007507508	0.004504505	0	L2-3	EN-L2-3-MS	NA	NA	NA
GTGCAGCTCTTCTGGC-1_5981_BA9	25.04636	-28.94045693	3	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3335	8273	0.003384504	0.002417503	0	3	EN-L5-6	NA	NA	NA
GTGCATACATCTATGG-1_5981_BA9	-18.46131343	-5.530961923	13B	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2943	6267	0.039572363	0.006063507	0	13B	IN-SV2C	NA	NA	NA
GTGCATACATTACCTT-1_5981_BA9	18.63544012	-20.24257937	3	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2666	5672	0.008815233	0.005818054	0	3	EN-L5-6	NA	NA	NA
GTGCATAGTAAACGCG-1_5981_BA9	23.64521633	-24.17495171	3	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2894	6274	0.007331846	0.002709595	0	3	EN-L5-6	NA	NA	NA
GTGCATAGTCCGTGAC-1_5981_BA9	5.107045431	-14.10468365	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2592	5137	0.037765233	0.002919992	0	L2-3	EN-L2-3-MS	NA	NA	NA
GTGCATAGTTCGTCTC-1_5981_BA9	31.41093621	-11.21045151	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2673	5312	0.00753012	0.004329819	0	2	EN-L4	NA	NA	NA
GTGCATATCCTTGGTC-1_5981_BA9	-17.49916737	-14.83326873	6B	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2066	3748	0.00773746	0.00506937	0	6B	IN-SST	NA	NA	NA
GTGCGGTAGACAGGCT-1_5981_BA9	20.24309002	-15.31575792	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	7488	26306	0.00707063	0.008401125	0	L2-3	EN-L2-3-MS	NA	NA	NA
GTGCGGTCACGACTCG-1_5981_BA9	21.74426499	-19.402093	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	4954	14498	0.012967306	0.004345427	0	2	EN-L4	NA	NA	NA
GTGCGGTTCATGTGGT-1_5981_BA9	34.52181527	-3.167169366	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2216	4223	0.007340753	0.003551977	0	2	EN-L4	NA	NA	NA
GTGCGGTTCGACGGAA-1_5981_BA9	17.85411283	-6.705930999	3	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1588	2936	0.007833787	0.008174387	0	3	EN-L5-6	NA	NA	NA
GTGCTTCAGAACTGTA-1_5981_BA9	-0.679285767	34.52797059	17	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	768	1075	0.000930233	0.004651163	0	oligos	OL-MS-2	NA	NA	NA
GTGCTTCAGATGCCTT-1_5981_BA9	28.20248587	-17.70641726	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	5720	17553	0.022275395	0.007349171	0	2	EN-L4	NA	NA	NA
GTGCTTCGTTCAGGCC-1_5981_BA9	-18.30568654	-4.847797367	13A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2568	4804	0.011656953	0.007285595	0	13A	IN-VIP	NA	NA	NA
GTGCTTCGTTGGTGGA-1_5981_BA9	3.143833165	-10.87329341	12	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1697	2978	0.001343183	0.009066488	0	12	EN-MIX	NA	NA	NA
GTGCTTCTCTTCATGT-1_5981_BA9	-27.69579345	4.464254304	9	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1468	2324	0.00172117	0.005163511	0	9	OPC	NA	NA	NA
GTGGGTCAGCAGATCG-1_5981_BA9	31.5340463	-11.21826927	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2600	5055	0.006330366	0.006330366	0	2	EN-L4	NA	NA	NA
GTGGGTCAGCTGTTCA-1_5981_BA9	18.51809145	-20.54477845	3	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3093	6602	0.002574977	0.009088155	0	3	EN-L5-6	NA	NA	NA
GTGGGTCCAAACTGTC-1_5981_BA9	1.61447581	30.92327162	17	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	744	1011	0.003956479	0.007912957	0	oligos	OL-MS-2	NA	NA	NA
GTGGGTCGTCCAAGTT-1_5981_BA9	4.654398139	-8.961227092	12	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1553	2449	0.004899959	0.012658228	0	12	EN-MIX	NA	NA	NA
GTGTGCGAGTGGAGTC-1_5981_BA9	4.419623092	-11.19455317	12	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1703	2777	0.002520706	0.005401512	0	12	EN-MIX	NA	NA	NA
GTGTGCGCAGATGGGT-1_5981_BA9	-11.75134699	-14.41469756	6B	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1179	1758	0.013651877	0.010238908	0	6B	IN-SST	NA	NA	NA
GTGTGCGTCCTTTACA-1_5981_BA9	20.05259317	-15.72357685	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	6778	25374	0.02159691	0.003901632	0	L2-3	EN-L2-3-MS	NA	NA	NA
GTGTGCGTCGCACTCT-1_5981_BA9	-29.57288313	-12.9320388	9	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	807	1044	0.002873563	0.003831418	0	9	OPC	NA	NA	NA
GTGTTAGGTGCCTGCA-1_5981_BA9	-5.634452674	-8.695833451	13A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	751	1050	0.013333333	0.004761905	0	13A	IN-VIP	NA	NA	NA
GTGTTAGGTTACTGAC-1_5981_BA9	18.79015475	-9.997533956	3	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2335	4861	0.007611603	0.005142975	0	3	EN-L5-6	NA	NA	NA
GTTAAGCAGCCAGTAG-1_5981_BA9	-6.964061648	-7.140336023	13A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1115	1729	0.03470214	0.004626952	0	13A	IN-VIP	NA	NA	NA
GTTAAGCAGGATGTAT-1_5981_BA9	-14.29753313	-14.78860872	6B	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1487	2307	0.008669267	0.013003901	0	6B	IN-SST	NA	NA	NA
GTTAAGCAGTCCAGGA-1_5981_BA9	30.3005707	-6.384512662	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3057	6788	0.001915144	0.003241014	0	2	EN-L4	NA	NA	NA
GTTAAGCCAAGCGAGT-1_5981_BA9	-7.083618889	-8.06515564	13A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1033	1482	0.00877193	0.010796221	0	13A	IN-VIP	NA	NA	NA
GTTCATTCATCAGTCA-1_5981_BA9	31.33444196	-12.27261014	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2812	5744	0.009227019	0.005745125	0	2	EN-L4	NA	NA	NA
GTTCATTGTGACAAAT-1_5981_BA9	-27.75189552	-20.98145158	6A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3863	9175	0.030190736	0.003923706	0	6A	IN-PV	NA	NA	NA
GTTCTCGCAAGGCTCC-1_5981_BA9	26.03785879	-17.21891265	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	5925	19050	0.013858268	0.005616798	0	2	EN-L4	NA	NA	NA
GTTCTCGGTAAGTAGT-1_5981_BA9	12.7239422	-0.395262741	12	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	828	1092	0.006410256	0.009157509	0	12	EN-MIX	NA	NA	NA
GTTCTCGGTAATCGTC-1_5981_BA9	5.025830584	-8.934858184	12	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1279	1905	0.004724409	0.012598425	0	12	EN-MIX	NA	NA	NA
GTTCTCGGTAGTGAAT-1_5981_BA9	-7.255072346	-6.530294783	13A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1195	1783	0.002804262	0.007851935	0	13A	IN-VIP	NA	NA	NA
GTTTCTAAGTATCTCG-1_5981_BA9	3.018094377	-13.08137073	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2182	4296	0.005586592	0.002793296	0	L2-3	EN-L2-3-MS	NA	NA	NA
GTTTCTAAGTATGACA-1_5981_BA9	34.7484171	-3.672392078	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2764	5985	0.00952381	0.004678363	0	2	EN-L4	NA	NA	NA
TAAACCGAGAACTCGG-1_5981_BA9	30.6302511	-12.80913534	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2793	5334	0.010873641	0.006749156	0	2	EN-L4	NA	NA	NA
TAAACCGAGCAGACTG-1_5981_BA9	-11.6610234	-8.996361615	13B	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1798	2893	0.002073972	0.003456619	0	13B	IN-SV2C	NA	NA	NA
TAAACCGAGGCCCTCA-1_5981_BA9	-15.66495279	-2.934818469	13A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2547	5086	0.009437672	0.008651199	0	13A	IN-VIP	NA	NA	NA
TAAACCGAGTTACCCA-1_5981_BA9	-34.52273639	-13.21088264	9	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	754	1123	0	0.002671416	0	9	OPC	NA	NA	NA
TAAACCGAGTTACGGG-1_5981_BA9	-10.50126768	-15.41234854	6B	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	930	1287	0.013209013	0.006216006	0	6B	IN-SST	NA	NA	NA
TAAACCGCATAGAAAC-1_5981_BA9	30.72617394	-12.24926038	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3597	7830	0.020178799	0.002809706	0	2	EN-L4	NA	NA	NA
TAAACCGGTAGATTAG-1_5981_BA9	-10.50280343	-19.5237744	6B	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1064	1602	0.004369538	0.003121099	0	6B	IN-SST	NA	NA	NA
TAAACCGGTTACGACT-1_5981_BA9	3.072030136	-14.59089489	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2425	4590	0.001742919	0.013943355	0	L2-3	EN-L2-3-MS	NA	NA	NA
TAAACCGTCCACGACG-1_5981_BA9	-17.31022188	-8.819039421	6A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3103	6812	0.016881973	0.002495596	0	6A	IN-PV	NA	NA	NA
TAAACCGTCGAATGCT-1_5981_BA9	27.53089387	-15.77185667	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	6685	25246	0.019765507	0.003842193	0	2	EN-L4	NA	NA	NA
TAAGAGAAGCCTCGTG-1_5981_BA9	24.94366066	-20.51557328	3	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3329	6553	0.003967648	0.003967648	0	3	EN-L5-6	NA	NA	NA
TAAGAGAAGTCCAGGA-1_5981_BA9	-11.14019663	-5.313376568	13A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1751	2840	0.01056338	0.005985915	0	13A	IN-VIP	NA	NA	NA
TAAGAGACATCCAACA-1_5981_BA9	2.657876684	-20.37693287	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3474	8665	0.004154645	0.003346797	0	L2-3	EN-L2-3-MS	NA	NA	NA
TAAGAGATCGTAGATC-1_5981_BA9	3.943352591	-13.28965652	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2020	3813	0.004720692	0.001835825	0	L2-3	EN-L2-3-MS	NA	NA	NA
TAAGTGCCATCCAACA-1_5981_BA9	30.25420992	-15.37300229	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2780	5350	0.017009346	0.005233645	0	2	EN-L4	NA	NA	NA
TAAGTGCTCACGGTTA-1_5981_BA9	-9.305016566	-15.88695496	6B	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	851	1194	0.018425461	0.006700168	0	6B	IN-SST	NA	NA	NA
TACACGAGTTATCGGT-1_5981_BA9	-31.51176854	-12.63509179	9	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	795	1095	0.001826484	0.00456621	0	9	OPC	NA	NA	NA
TACCTATAGACGACGT-1_5981_BA9	-6.702355243	-7.534546914	13A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1058	1581	0.003795066	0.005060089	0	13A	IN-VIP	NA	NA	NA
TACCTATCAAGCTGAG-1_5981_BA9	18.60009086	-7.156973357	3	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1966	3407	0.000587027	0.002054593	0	3	EN-L5-6	NA	NA	NA
TACCTATCATGTCTCC-1_5981_BA9	-12.07858052	-0.372044423	13A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2845	6067	0.002802044	0.002802044	0	13A	IN-VIP	NA	NA	NA
TACCTATGTAGGGACT-1_5981_BA9	4.080474154	-12.77254963	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2079	3841	0.002603489	0.009893257	0	L2-3	EN-L2-3-MS	NA	NA	NA
TACCTATGTCACCTAA-1_5981_BA9	-15.12404431	-10.11825835	13B	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2297	4805	0.01082206	0.001873049	0	13B	IN-SV2C	NA	NA	NA
TACCTATTCCCATTAT-1_5981_BA9	-7.843656285	-31.94313314	16	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	778	1076	0.050185874	0.006505576	0	16	EN-PYR	NA	NA	NA
TACCTATTCTGCGACG-1_5981_BA9	-25.23966288	18.10833636	8	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1308	2022	0.006923838	0.005440158	0	8	Astrocytes	NA	NA	NA
TACGGATAGGCGTACA-1_5981_BA9	28.31850974	-17.74345748	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	6768	24227	0.021793866	0.007058241	0	2	EN-L4	NA	NA	NA
TACGGATAGGGCACTA-1_5981_BA9	21.1125116	-11.37350932	12	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2264	3875	0.034322581	0.005419355	0	12	EN-MIX	NA	NA	NA
TACGGATTCGCGGATC-1_5981_BA9	17.6089775	-17.46466159	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	4548	11680	0.016952055	0.003339041	0	L2-3	EN-L2-3-MS	NA	NA	NA
TACGGGCAGCACGCCT-1_5981_BA9	23.35450999	-24.13592141	3	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3480	7942	0.002518257	0.012843113	0	3	EN-L5-6	NA	NA	NA
TACGGGCAGCGTAGTG-1_5981_BA9	23.34010251	-24.93217203	3	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2748	6048	0.005621693	0.002810847	0	3	EN-L5-6	NA	NA	NA
TACGGGCTCAATAAGG-1_5981_BA9	-11.31419122	-6.874347533	13A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1759	2980	0.009060403	0.005369128	0	13A	IN-VIP	NA	NA	NA
TACGGGCTCCTTAATC-1_5981_BA9	-8.638489481	-5.198063303	13A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1600	2735	0.005850091	0.006215722	0	13A	IN-VIP	NA	NA	NA
TACGGTAGTCGCATCG-1_5981_BA9	8.988959318	-3.21822117	12	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1469	2403	0.033707865	0.009571369	0	12	EN-MIX	NA	NA	NA
TACGGTAGTCGCGTGT-1_5981_BA9	19.99945744	-3.874885863	12	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1709	2693	0.021537319	0.005941329	0	12	EN-MIX	NA	NA	NA
TACTCATAGGCTCATT-1_5981_BA9	34.69665979	-3.671422262	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2782	6208	0.005154639	0.004188144	0	2	EN-L4	NA	NA	NA
TACTCGCCATGGATGG-1_5981_BA9	16.71722357	-18.34207765	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	6417	22348	0.009799535	0.004295686	0	L2-3	EN-L2-3-MS	NA	NA	NA
TACTCGCTCAATACCG-1_5981_BA9	28.59738825	-17.88109273	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	6516	22933	0.025378276	0.006671609	0	2	EN-L4	NA	NA	NA
TACTTACCATCGTCGG-1_5981_BA9	2.707184191	-13.14976034	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2249	4462	0.004034065	0.006051098	0	L2-3	EN-L2-3-MS	NA	NA	NA
TACTTACGTCCAGTAT-1_5981_BA9	-8.050008018	-6.273864262	13A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1355	2015	0.004466501	0.006451613	0	13A	IN-VIP	NA	NA	NA
TAGACCAAGATCACGG-1_5981_BA9	-16.44415199	-3.803125844	13A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2650	5171	0.016824599	0.004447882	0	13A	IN-VIP	NA	NA	NA
TAGACCACAAGCTGGA-1_5981_BA9	5.070001162	-14.4508044	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2750	5752	0.00608484	0.002955494	0	L2-3	EN-L2-3-MS	NA	NA	NA
TAGAGCTAGGCATTGG-1_5981_BA9	-32.43626397	-12.15119552	9	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	755	1064	0.001879699	0.006578947	0	9	OPC	NA	NA	NA
TAGAGCTCATCACAAC-1_5981_BA9	-9.247343955	-34.71847199	16	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	916	1345	0.03866171	0.001486989	0	16	EN-PYR	NA	NA	NA
TAGCCGGCAGCTCGAC-1_5981_BA9	17.42727283	-18.00460654	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3944	8986	0.007344759	0.002448253	0	L2-3	EN-L2-3-MS	NA	NA	NA
TAGCCGGGTCAAACTC-1_5981_BA9	23.38020747	-4.353711623	10	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2626	5560	0.005755396	0.002158273	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TAGCCGGGTGAAGGCT-1_5981_BA9	18.42523385	-7.109850097	3	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1789	3303	0.002724796	0.004238571	0	3	EN-L5-6	NA	NA	NA
TAGCCGGTCGAGCCCA-1_5981_BA9	6.545086146	-14.5171877	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2752	5401	0.002592113	0.011109054	0	L2-3	EN-L2-3-MS	NA	NA	NA
TAGGCATAGTCCAGGA-1_5981_BA9	-27.45266351	10.64064787	8	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	883	1184	0.015202703	0.005067568	0	8	Astrocytes	NA	NA	NA
TAGGCATGTCATTAGC-1_5981_BA9	-25.20789039	-22.17234134	6A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2987	6185	0.022312045	0.004042037	0	6A	IN-PV	NA	NA	NA
TAGGCATGTGCACTTA-1_5981_BA9	-6.989462197	-6.825435663	13A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1219	1880	0.02393617	0.002659574	0	13A	IN-VIP	NA	NA	NA
TAGGCATGTGTGTGCC-1_5981_BA9	16.90533554	-18.62029948	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3792	8632	0.012164041	0.005908248	0	L2-3	EN-L2-3-MS	NA	NA	NA
TAGGCATTCAACCATG-1_5981_BA9	28.18074322	-15.97272704	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	5653	17949	0.018106858	0.006462756	0	2	EN-L4	NA	NA	NA
TAGGCATTCTTGCATT-1_5981_BA9	18.8631544	-0.136272518	10	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1532	3061	0.000653381	0.002613525	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TAGTGGTAGCTAGTGG-1_5981_BA9	-8.420429324	-6.427970486	13A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1367	2009	0.00298656	0.006968641	0	13A	IN-VIP	NA	NA	NA
TAGTGGTCAAGCTGGA-1_5981_BA9	11.87396063	-20.2084032	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3067	6641	0.019274206	0.002861015	0	L2-3	EN-L2-3-MS	NA	NA	NA
TAGTTGGTCAGTTAGC-1_5981_BA9	-11.42902314	-8.322692175	13B	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1716	2764	0.01845152	0.00397974	0	13B	IN-SV2C	NA	NA	NA
TATCAGGGTATAATGG-1_5981_BA9	-0.07429647	31.09678745	1	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	906	1267	0.010260458	0.002367798	0	oligos	OL-Cntl	NA	NA	NA
TATCAGGGTCACTTCC-1_5981_BA9	-13.77988814	-16.06414022	6B	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1226	1983	0.008572869	0.005042864	0	6B	IN-SST	NA	NA	NA
TATCAGGGTCCGAATT-1_5981_BA9	10.80006675	-33.82788921	3	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	4179	12947	0.000308952	0.001776473	0	3	EN-L5-6	NA	NA	NA
TATCAGGGTCGCCATG-1_5981_BA9	-9.403429878	-20.23940167	6B	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	811	1227	0	0.001629992	0	6B	IN-SST	NA	NA	NA
TATCAGGGTCTTGCGG-1_5981_BA9	29.26012504	-16.97140869	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	5029	13732	0.025633557	0.007646373	0	2	EN-L4	NA	NA	NA
TATCAGGTCATCATTC-1_5981_BA9	-8.44032234	-2.907965197	13B	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2020	3851	0.001558037	0.005453129	0	13B	IN-SV2C	NA	NA	NA
TATCTCAGTCGAATCT-1_5981_BA9	9.068466663	-4.300371187	12	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2155	4006	0.058662007	0.007738392	0	12	EN-MIX	NA	NA	NA
TATGCCCAGTGACTCT-1_5981_BA9	-11.14348649	-3.189897513	13A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2096	3683	0.007059462	0.00488732	0	13A	IN-VIP	NA	NA	NA
TATGCCCGTAAATACG-1_5981_BA9	-34.39903911	-13.04101619	9	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	744	1082	0	0.002772643	0	9	OPC	NA	NA	NA
TATTACCCAAGAGTCG-1_5981_BA9	29.94118426	-15.7455806	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3068	6075	0.016131687	0.007407407	0	2	EN-L4	NA	NA	NA
TATTACCCAGGGTACA-1_5981_BA9	24.45448364	-23.21138604	3	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3981	10338	0.00957632	0.00377249	0	3	EN-L5-6	NA	NA	NA
TCAACGAAGTTACGGG-1_5981_BA9	-1.878827762	36.54299091	17	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	847	1118	0.008050089	0.010733453	0	oligos	OL-MS-2	NA	NA	NA
TCAACGACAAACCTAC-1_5981_BA9	-22.24054252	-21.89559046	6A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2287	4625	0.023135135	0.003027027	0	6A	IN-PV	NA	NA	NA
TCAACGACAAGCGATG-1_5981_BA9	-7.990769616	-33.50285446	16	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	879	1155	0.019047619	0.007792208	0	16	EN-PYR	NA	NA	NA
TCAACGACACCCATTC-1_5981_BA9	19.91445207	-7.049367879	3	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2579	6068	0.000823995	0.004284773	0	3	EN-L5-6	NA	NA	NA
TCAACGAGTAGCCTCG-1_5981_BA9	-7.993814991	-34.7351869	16	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	901	1266	0.071879937	0.006319115	0	16	EN-PYR	NA	NA	NA
TCAACGATCCAAGTAC-1_5981_BA9	4.141521072	-8.006076846	12	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1362	2118	0.002360718	0.012747875	0	12	EN-MIX	NA	NA	NA
TCAACGATCTGTCCGT-1_5981_BA9	-29.40378449	13.80882285	8	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	858	1334	0.007496252	0.00149925	0	8	Astrocytes	NA	NA	NA
TCAATCTAGCCCAACC-1_5981_BA9	-11.20886707	-5.288826745	13A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1769	2861	0.012233485	0.004194338	0	13A	IN-VIP	NA	NA	NA
TCAATCTAGGCGTACA-1_5981_BA9	-7.202016145	-6.43112238	13A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1156	1773	0.001692047	0.00676819	0	13A	IN-VIP	NA	NA	NA
TCAATCTTCCTTGCCA-1_5981_BA9	0.956319485	-23.69247705	10	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3974	11247	0.002667378	0.001956077	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TCAATCTTCTAGAGTC-1_5981_BA9	11.32701756	-20.52973051	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3644	8919	0.00594237	0.002803005	0	L2-3	EN-L2-3-MS	NA	NA	NA
TCACAAGTCCAGAGGA-1_5981_BA9	29.29005539	-16.8696706	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	4845	12784	0.020494368	0.006414268	0	2	EN-L4	NA	NA	NA
TCACGAACACCACCAG-1_5981_BA9	-13.85192246	-6.319888796	13B	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2263	4409	0.012701293	0.002494897	0	13B	IN-SV2C	NA	NA	NA
TCACGAACACCATCCT-1_5981_BA9	16.42421057	-18.26622526	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3989	10844	0.010328292	0.004334194	0	L2-3	EN-L2-3-MS	NA	NA	NA
TCACGAAGTCATACTG-1_5981_BA9	23.84092027	-20.50619622	3	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	4687	13278	0.015740322	0.004669378	0	3	EN-L5-6	NA	NA	NA
TCACGAATCAACTCTT-1_5981_BA9	16.26721876	-18.28905397	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	4173	10811	0.012764777	0.005364906	0	L2-3	EN-L2-3-MS	NA	NA	NA
TCACGAATCTCACATT-1_5981_BA9	30.15406808	-15.55289582	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3489	7606	0.008282935	0.006836708	0	2	EN-L4	NA	NA	NA
TCAGATGAGAGACGAA-1_5981_BA9	-21.33359957	-21.32278246	6A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2169	3812	0.06112277	0.008394544	0	6A	IN-PV	NA	NA	NA
TCAGATGTCGGCTACG-1_5981_BA9	30.44984139	-15.2558268	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3147	6391	0.018619934	0.006258801	0	2	EN-L4	NA	NA	NA
TCAGCAATCCCTCAGT-1_5981_BA9	3.988969273	-12.79173995	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1945	3413	0.004980955	0.007617931	0	L2-3	EN-L2-3-MS	NA	NA	NA
TCAGCTCAGCCACTAT-1_5981_BA9	-17.71359903	-26.54865864	6A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2572	5989	0.001502755	0.002838537	0	6A	IN-PV	NA	NA	NA
TCAGCTCAGGCGCTCT-1_5981_BA9	-8.469562454	-4.81311215	13A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1576	2661	0.006012777	0.004885381	0	13A	IN-VIP	NA	NA	NA
TCAGCTCAGGGCTCTC-1_5981_BA9	30.45680036	-12.46297757	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3730	8993	0.016346047	0.005003892	0	2	EN-L4	NA	NA	NA
TCAGCTCGTCTTCTCG-1_5981_BA9	-12.85704833	-35.72051201	16	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1630	2698	0.07375834	0.009266123	0	16	EN-PYR	NA	NA	NA
TCAGCTCTCTGACCTC-1_5981_BA9	11.8684202	-20.21484793	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2798	5685	0.014599824	0.002110818	0	L2-3	EN-L2-3-MS	NA	NA	NA
TCAGGATTCCGAACGC-1_5981_BA9	-31.69025788	-12.69327624	9	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	806	1131	0.001768347	0.004420866	0	9	OPC	NA	NA	NA
TCAGGTACATACAGCT-1_5981_BA9	21.42223433	26.67629274	1	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1077	1582	0.000632111	0.001896334	0	oligos	OL-Cntl	NA	NA	NA
TCAGGTAGTAGTGAAT-1_5981_BA9	-9.333100209	-4.782710229	13A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1902	3185	0.003453689	0.00722135	0	13A	IN-VIP	NA	NA	NA
TCAGGTATCGTAGATC-1_5981_BA9	-13.1637133	-35.58191998	16	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1729	2793	0.066237021	0.008950949	0	16	EN-PYR	NA	NA	NA
TCATTACCAAGGTGTG-1_5981_BA9	-18.70383441	-5.973860117	13B	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3129	6347	0.031983614	0.006932409	0	13B	IN-SV2C	NA	NA	NA
TCATTACGTAACGTTC-1_5981_BA9	11.87140455	0.370534772	12	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	797	1260	0.011904762	0.003174603	0	12	EN-MIX	NA	NA	NA
TCATTTGAGATCCCGC-1_5981_BA9	-12.81826632	-16.48873212	6B	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1188	1941	0.010303967	0.005667182	0	6B	IN-SST	NA	NA	NA
TCATTTGCAATGAAAC-1_5981_BA9	-8.104998458	-33.99342407	16	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	986	1537	0.117111256	0.004554327	0	16	EN-PYR	NA	NA	NA
TCATTTGCACGTGAGA-1_5981_BA9	20.27407348	-15.36199324	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	5249	15274	0.019772162	0.00798743	0	L2-3	EN-L2-3-MS	NA	NA	NA
TCATTTGTCCCTTGCA-1_5981_BA9	-7.634803531	-2.800782627	13A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1717	3358	0.015485408	0.003871352	0	13A	IN-VIP	NA	NA	NA
TCATTTGTCTGATACG-1_5981_BA9	29.02500167	-16.67532342	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	4507	11656	0.019045985	0.007120796	0	2	EN-L4	NA	NA	NA
TCCACACCAAGTACCT-1_5981_BA9	27.86941232	1.177977172	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3143	7722	0.005698006	0.003367003	0	2	EN-L4	NA	NA	NA
TCCACACTCGAATGCT-1_5981_BA9	-1.087906516	29.73012333	1	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	819	1107	0.001806685	0.000903342	0	oligos	OL-Cntl	NA	NA	NA
TCGAGGCGTCGTGGCT-1_5981_BA9	-21.20398277	-21.27497889	6A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1954	3614	0.084117322	0.003873824	0	6A	IN-PV	NA	NA	NA
TCGCGAGCACATGTGT-1_5981_BA9	19.13835737	-10.04974172	3	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1815	3164	0.003160556	0.004108723	0	3	EN-L5-6	NA	NA	NA
TCGCGTTCACTAGTAC-1_5981_BA9	-8.155804534	-34.1690824	16	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	818	1098	0.033697632	0.007285974	0	16	EN-PYR	NA	NA	NA
TCGCGTTGTATGAAAC-1_5981_BA9	5.054275112	-10.00042724	12	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1821	2950	0.012881356	0.007457627	0	12	EN-MIX	NA	NA	NA
TCGGGACAGACAGGCT-1_5981_BA9	6.75195166	-14.81391226	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2835	5956	0.004533244	0.00721961	0	L2-3	EN-L2-3-MS	NA	NA	NA
TCGGGACCAATAGCGG-1_5981_BA9	27.91694628	-17.8721407	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	4901	13171	0.03970845	0.005162858	0	2	EN-L4	NA	NA	NA
TCGGGACCACCTCGGA-1_5981_BA9	-5.196544702	-7.956093898	13A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	898	1254	0.011164274	0.003189793	0	13A	IN-VIP	NA	NA	NA
TCGGGACCAGGGATTG-1_5981_BA9	8.94316751	-3.296564855	12	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1624	2699	0.017043349	0.00778066	0	12	EN-MIX	NA	NA	NA
TCGGGACTCGTAGGTT-1_5981_BA9	5.071982327	-14.70967632	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2963	6454	0.006197707	0.002943911	0	L2-3	EN-L2-3-MS	NA	NA	NA
TCGGTAAGTAGCGTGA-1_5981_BA9	15.01157127	1.695674765	12	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1099	1607	0.004355943	0.005600498	0	12	EN-MIX	NA	NA	NA
TCGGTAATCGGCGCAT-1_5981_BA9	-6.138890864	-32.44429137	16	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	792	1046	0.084130019	0.007648184	0	16	EN-PYR	NA	NA	NA
TCGTACCAGCGCTTAT-1_5981_BA9	-9.587697511	-34.69238502	16	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	987	1562	0.027528809	0.003841229	0	16	EN-PYR	NA	NA	NA
TCGTACCAGTCATCCA-1_5981_BA9	16.61060887	-18.23193342	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	5590	16435	0.007788257	0.006510496	0	L2-3	EN-L2-3-MS	NA	NA	NA
TCGTACCCACGTCAGC-1_5981_BA9	-7.202426674	-6.589295646	13A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1217	1953	0.005120328	0.006656426	0	13A	IN-VIP	NA	NA	NA
TCGTACCCACGTCTCT-1_5981_BA9	-18.5718688	-5.714360269	13B	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2731	5171	0.007928834	0.006768517	0	13B	IN-SV2C	NA	NA	NA
TCGTACCGTCAGAAGC-1_5981_BA9	4.766175875	0.996508231	16	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1020	1409	0.083747339	0.005677786	0	16	EN-PYR	NA	NA	NA
TCGTACCGTTCCCGAG-1_5981_BA9	-20.64705014	-21.00115692	6A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1849	3169	0.048911328	0.003786683	0	6A	IN-PV	NA	NA	NA
TCGTACCGTTGTGGCC-1_5981_BA9	-9.122245682	-17.091245	6B	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	828	1225	0.008163265	0.00244898	0	6B	IN-SST	NA	NA	NA
TCGTAGAAGGACAGCT-1_5981_BA9	17.44750089	-18.74959286	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	4152	10049	0.007264404	0.004378545	0	L2-3	EN-L2-3-MS	NA	NA	NA
TCGTAGACATTCACTT-1_5981_BA9	25.50657041	-17.53613608	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	6959	26299	0.029050534	0.006007833	0	2	EN-L4	NA	NA	NA
TCGTAGATCAGCTCGG-1_5981_BA9	23.4662514	-12.08205143	3	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2505	4460	0.004484305	0.004484305	0	3	EN-L5-6	NA	NA	NA
TCGTAGATCATTGCGA-1_5981_BA9	30.05992543	-15.78531332	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3772	8046	0.018891375	0.008948546	0	2	EN-L4	NA	NA	NA
TCTATTGGTACGCTGC-1_5981_BA9	-10.84696137	-33.37172074	16	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1214	1873	0.087026161	0.004271223	0	16	EN-PYR	NA	NA	NA
TCTATTGGTTTAAGCC-1_5981_BA9	-26.69852866	-18.23174604	6A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3422	7362	0.019831568	0.006927465	0	6A	IN-PV	NA	NA	NA
TCTATTGTCTTCTGGC-1_5981_BA9	-13.84801078	-15.86740804	6B	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1329	2356	0.013582343	0.003395586	0	6B	IN-SST	NA	NA	NA
TCTCATAAGTACTTGC-1_5981_BA9	-31.44271772	-11.2938855	9	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	888	1267	0.003157064	0.005524862	0	9	OPC	NA	NA	NA
TCTCATAAGTTCGATC-1_5981_BA9	6.200928793	-13.2167639	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2420	4301	0.002790049	0.018135317	0	L2-3	EN-L2-3-MS	NA	NA	NA
TCTCATACAGTATAAG-1_5981_BA9	24.73406514	7.639591465	15A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2235	3451	0.008403361	0.013619241	0	15A	Endo cells	NA	NA	NA
TCTCATACATGGGAAC-1_5981_BA9	16.1800063	-29.15404046	3	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	5610	19235	0.003223291	0.005354822	0	3	EN-L5-6	NA	NA	NA
TCTCTAAAGTGAACAT-1_5981_BA9	20.09979401	-3.964664945	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1982	3273	0.013443324	0.008554843	0	2	EN-L4	NA	NA	NA
TCTCTAAGTTGCTCCT-1_5981_BA9	28.54895519	-17.69824352	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3823	9244	0.034617049	0.006598875	0	2	EN-L4	NA	NA	NA
TCTGAGAAGGTTACCT-1_5981_BA9	29.6807523	-16.07792801	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	4160	10478	0.027295285	0.007157855	0	2	EN-L4	NA	NA	NA
TCTGGAAAGCGCTCCA-1_5981_BA9	28.49355234	-10.47328312	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3645	8755	0.019074814	0.003655054	0	2	EN-L4	NA	NA	NA
TCTGGAAAGTGTACCT-1_5981_BA9	12.17209516	-20.42704856	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	5479	15864	0.004286435	0.003782148	0	L2-3	EN-L2-3-MS	NA	NA	NA
TCTGGAACAGATAATG-1_5981_BA9	29.06118319	-16.69538561	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	4838	12619	0.025200095	0.005864173	0	2	EN-L4	NA	NA	NA
TCTGGAAGTCTAAACC-1_5981_BA9	16.66600503	-18.0907652	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	6505	22229	0.00845742	0.0045886	0	L2-3	EN-L2-3-MS	NA	NA	NA
TCTGGAAGTGTCCTCT-1_5981_BA9	20.31198843	-3.660208048	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1752	2825	0.017345133	0.002477876	0	2	EN-L4	NA	NA	NA
TCTGGAATCACCTCGT-1_5981_BA9	18.95345958	-7.383475067	3	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2253	4791	0.001878522	0.003339595	0	3	EN-L5-6	NA	NA	NA
TCTTCGGAGCTCCTCT-1_5981_BA9	22.69767497	-21.61013041	3	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3574	7992	0.004129129	0.009634635	0	3	EN-L5-6	NA	NA	NA
TCTTCGGAGGATGCGT-1_5981_BA9	20.40938816	-15.39246734	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	4173	9444	0.037801779	0.007094452	0	2	EN-L4	NA	NA	NA
TCTTCGGAGTCGATAA-1_5981_BA9	20.25609006	-15.29472453	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	6617	23226	0.013820718	0.005984672	0	L2-3	EN-L2-3-MS	NA	NA	NA
TCTTCGGGTAACGACG-1_5981_BA9	28.24740442	-17.53052653	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	5139	14139	0.034302284	0.008487163	0	2	EN-L4	NA	NA	NA
TCTTCGGGTTGTCGCG-1_5981_BA9	11.63377066	1.329202561	12	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	766	1199	0.00500417	0.012510425	0	12	EN-MIX	NA	NA	NA
TCTTTCCAGAAACGCC-1_5981_BA9	-13.08089177	-38.15057085	16	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2693	5725	0.107248908	0.010305677	0	16	EN-PYR	NA	NA	NA
TCTTTCCAGCGCCTTG-1_5981_BA9	25.33826661	-17.67232136	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	4385	11620	0.011015491	0.006884682	0	L2-3	EN-L2-3-MS	NA	NA	NA
TCTTTCCGTTCGTTGA-1_5981_BA9	1.150716308	-18.59702303	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2906	6259	0.001437929	0.002716089	0	L2-3	EN-L2-3-MS	NA	NA	NA
TCTTTCCTCAGTTTGG-1_5981_BA9	-11.4725381	-34.06172534	16	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1205	1801	0.081066074	0.006107718	0	16	EN-PYR	NA	NA	NA
TCTTTCCTCTAACTCT-1_5981_BA9	-4.321679797	-5.753685907	13A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1092	1761	0.005110733	0.00681431	0	13A	IN-VIP	NA	NA	NA
TGAAAGACACCGATAT-1_5981_BA9	-35.1951778	-9.808340956	9	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1025	1644	0.003041363	0.00243309	0	9	OPC	NA	NA	NA
TGACAACTCCTGCAGG-1_5981_BA9	27.69451442	-13.30763292	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	4870	13800	0.016231884	0.003550725	0	2	EN-L4	NA	NA	NA
TGACAACTCGTACCGG-1_5981_BA9	-9.407653867	-4.795446198	13A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1802	3107	0.006758931	0.008046347	0	13A	IN-VIP	NA	NA	NA
TGACGGCCACAACGTT-1_5981_BA9	-6.075537407	-7.36008352	13A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	903	1347	0.00074239	0.001484781	0	13A	IN-VIP	NA	NA	NA
TGACTAGCAGGGTACA-1_5981_BA9	-11.15803494	-35.06521135	16	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1113	1664	0.049879808	0.002403846	0	16	EN-PYR	NA	NA	NA
TGACTAGGTACGCTGC-1_5981_BA9	-21.11356406	-21.57209001	6A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2060	3587	0.015611932	0.006969612	0	6A	IN-PV	NA	NA	NA
TGACTAGGTATCAGTC-1_5981_BA9	-18.90871815	-5.387042242	13B	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3125	6218	0.005467996	0.006754583	0	13B	IN-SV2C	NA	NA	NA
TGACTAGGTCTAAAGA-1_5981_BA9	-7.401097417	-6.638992612	13A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1266	1985	0.004030227	0.003526448	0	13A	IN-VIP	NA	NA	NA
TGACTAGTCAAGCCTA-1_5981_BA9	-8.289579507	-17.20922466	6B	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	660	1031	0.03685742	0.000969932	0	6B	IN-SST	NA	NA	NA
TGACTAGTCACAAACC-1_5981_BA9	-0.542566285	31.86494973	17	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	863	1207	0.0008285	0.003314002	0	oligos	OL-MS-2	NA	NA	NA
TGACTTTGTAGAGGAA-1_5981_BA9	31.09178058	-11.03177357	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3233	7082	0.011296244	0.004094888	0	2	EN-L4	NA	NA	NA
TGAGAGGAGGATGCGT-1_5981_BA9	28.0871559	-17.76407248	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	6103	18787	0.013519987	0.005908341	0	2	EN-L4	NA	NA	NA
TGAGAGGGTGTGACGA-1_5981_BA9	-7.411649379	-33.91694488	16	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	900	1214	0.078253707	0.004942339	0	16	EN-PYR	NA	NA	NA
TGAGAGGTCTAACTGG-1_5981_BA9	16.29286068	-18.41736678	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	4766	12896	0.00566067	0.003489454	0	L2-3	EN-L2-3-MS	NA	NA	NA
TGAGCATCACATCTTT-1_5981_BA9	5.32105127	-0.159547524	16	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1268	1931	0.022786121	0.004142931	0	16	EN-PYR	NA	NA	NA
TGAGCATGTAAGTGGC-1_5981_BA9	29.35433109	-16.56701597	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	4828	13383	0.026003138	0.005977733	0	2	EN-L4	NA	NA	NA
TGAGCATGTCATGCAT-1_5981_BA9	-34.14925042	-10.04969784	9	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	914	1385	0.000722022	0.001444043	0	9	OPC	NA	NA	NA
TGAGCATGTGTGCGTC-1_5981_BA9	29.4735672	-16.21486147	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3899	8813	0.018268467	0.007602406	0	2	EN-L4	NA	NA	NA
TGAGCCGCAACTTGAC-1_5981_BA9	23.1972062	-23.70097567	3	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2953	6210	0.007407407	0.006763285	0	3	EN-L5-6	NA	NA	NA
TGAGCCGGTAAATGTG-1_5981_BA9	21.65479734	-3.535384237	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2160	3998	0.016258129	0.002501251	0	2	EN-L4	NA	NA	NA
TGAGCCGGTGCACTTA-1_5981_BA9	-32.71378393	-10.55187058	9	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	947	1407	0.004975124	0.002132196	0	9	OPC	NA	NA	NA
TGAGCCGTCATTCACT-1_5981_BA9	10.62344247	-0.613409531	12	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1137	1734	0.005767013	0.006343714	0	12	EN-MIX	NA	NA	NA
TGAGCCGTCGCTTAGA-1_5981_BA9	18.06462433	-17.31950878	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3367	7253	0.019302358	0.006755825	0	L2-3	EN-L2-3-MS	NA	NA	NA
TGAGGGAAGGCAGTCA-1_5981_BA9	-10.95422467	-14.43361144	6B	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1027	1504	0.037234043	0.003989362	0	6B	IN-SST	NA	NA	NA
TGATTTCGTGTAATGA-1_5981_BA9	29.2486006	-16.93172921	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	5485	15134	0.019360381	0.006277257	0	2	EN-L4	NA	NA	NA
TGATTTCTCACTCCTG-1_5981_BA9	18.0185204	27.56759135	1	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	995	1497	0.000668003	0.003340013	0	oligos	OL-Cntl	NA	NA	NA
TGCACCTGTGAGGGTT-1_5981_BA9	20.29009135	-15.52516072	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	4516	11801	0.037708669	0.002881112	0	2	EN-L4	NA	NA	NA
TGCCCATAGTACGTAA-1_5981_BA9	24.59538012	-19.02530857	3	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3406	7425	0.021683502	0.004713805	0	3	EN-L5-6	NA	NA	NA
TGCCCATCACGGCGTT-1_5981_BA9	-9.388717794	-3.882040106	13A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1796	3130	0.001916933	0.013099042	0	13A	IN-VIP	NA	NA	NA
TGCCCATTCTTCTGGC-1_5981_BA9	7.633923892	-15.21879799	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3357	7136	0.004204036	0.00896861	0	L2-3	EN-L2-3-MS	NA	NA	NA
TGCCCTAAGATCGATA-1_5981_BA9	27.09775794	-13.71354364	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	6259	21348	0.012788083	0.004122166	0	2	EN-L4	NA	NA	NA
TGCCCTAAGTCCAGGA-1_5981_BA9	23.66701773	-17.90220758	3	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3041	6041	0.02764443	0.012249628	0	3	EN-L5-6	NA	NA	NA
TGCCCTACACATCCAA-1_5981_BA9	-12.86090758	-21.75228906	6A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	992	1480	0.020945946	0.001351351	0	6A	IN-PV	NA	NA	NA
TGCCCTAGTAAAGTCA-1_5981_BA9	-27.05682563	-20.36121303	6A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3498	8200	0.118414634	0.002926829	0	6A	IN-PV	NA	NA	NA
TGCGCAGAGCGTGAGT-1_5981_BA9	-12.01751917	-13.53844387	6A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1437	2736	0.224049708	0.005116959	0	6A	IN-PV	NA	NA	NA
TGCGCAGAGCTTCGCG-1_5981_BA9	29.20613148	-15.59016055	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2971	5633	0.024320966	0.003550506	0	2	EN-L4	NA	NA	NA
TGCGCAGAGTGAACAT-1_5981_BA9	26.71951159	7.309597017	15A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1208	1598	0.001251564	0.021902378	0	15A	Endo cells	NA	NA	NA
TGCGCAGCAGCGTCCA-1_5981_BA9	20.12608607	-4.388632001	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2192	3980	0.032663317	0.006030151	0	2	EN-L4	NA	NA	NA
TGCGCAGCAGCTGGCT-1_5981_BA9	23.57829656	-26.57569687	3	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3256	7414	0.002158079	0.006069598	0	3	EN-L5-6	NA	NA	NA
TGCGCAGTCCTGTAGA-1_5981_BA9	20.20294071	-15.47322094	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	5150	14363	0.033279955	0.004943257	0	L2-3	EN-L2-3-MS	NA	NA	NA
TGCGGGTAGCGATATA-1_5981_BA9	5.17473818	-14.48407171	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2882	5857	0.007000171	0.003585453	0	L2-3	EN-L2-3-MS	NA	NA	NA
TGCGGGTGTAAACACA-1_5981_BA9	-28.8600498	9.842119466	8	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	778	1087	0.000919963	0.005519779	0	8	Astrocytes	NA	NA	NA
TGCGGGTGTGCGAAAC-1_5981_BA9	17.8879439	-17.4829451	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3949	9233	0.02209466	0.003357522	0	L2-3	EN-L2-3-MS	NA	NA	NA
TGCGGGTTCTGTCTCG-1_5981_BA9	-31.97315284	-13.36957151	9	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	780	1080	0	0.002777778	0	9	OPC	NA	NA	NA
TGCGTGGAGAATCTCC-1_5981_BA9	-8.2562733	-6.87831481	13A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1350	2222	0.063906391	0.00450045	0	13A	IN-VIP	NA	NA	NA
TGCGTGGAGACGCACA-1_5981_BA9	-15.92541533	-22.76384927	6A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1665	3000	0.005	0.003	0	6A	IN-PV	NA	NA	NA
TGCGTGGCATCCAACA-1_5981_BA9	-8.728164832	-15.23211389	6B	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	715	1015	0.007881773	0.004926108	0	6B	IN-SST	NA	NA	NA
TGCGTGGCATGCTAGT-1_5981_BA9	5.266589433	-14.21037425	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2455	4704	0.005314626	0.001913265	0	L2-3	EN-L2-3-MS	NA	NA	NA
TGCGTGGCATTGCGGC-1_5981_BA9	30.5995768	-15.08007284	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2520	4472	0.009838998	0.006708408	0	2	EN-L4	NA	NA	NA
TGCTACCCATCGGAAG-1_5981_BA9	16.58375488	-18.09889259	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2900	5855	0.014346712	0.002561913	0	L2-3	EN-L2-3-MS	NA	NA	NA
TGCTACCGTTCGTCTC-1_5981_BA9	7.834687524	-11.36265916	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2046	3698	0.014602488	0.005678745	0	L2-3	EN-L2-3-MS	NA	NA	NA
TGCTACCTCACGAAGG-1_5981_BA9	30.00311091	-6.745171515	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	4058	11226	0.006413683	0.004008552	0	2	EN-L4	NA	NA	NA
TGCTACCTCCAGAAGG-1_5981_BA9	26.68469049	5.424102976	15A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1039	1354	0.009601182	0.012555391	0	15A	Endo cells	NA	NA	NA
TGCTGCTAGGCTCTTA-1_5981_BA9	-7.586362494	-31.41353595	16	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	818	1118	0.037567084	0.008050089	0	16	EN-PYR	NA	NA	NA
TGCTGCTCACAAGCCC-1_5981_BA9	24.04298498	-18.51228079	3	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	4112	9373	0.004907714	0.009815427	0	3	EN-L5-6	NA	NA	NA
TGCTGCTTCGATCCCT-1_5981_BA9	21.77556921	-21.93177691	3	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	4232	10808	0.004718727	0.006476684	0	3	EN-L5-6	NA	NA	NA
TGGACGCCAAGTCTGT-1_5981_BA9	3.296201008	-13.46025505	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2181	3832	0.002087683	0.011221294	0	L2-3	EN-L2-3-MS	NA	NA	NA
TGGACGCGTCGACTAT-1_5981_BA9	8.967062428	-2.863936802	12	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1480	2107	0.024205031	0.005220693	0	12	EN-MIX	NA	NA	NA
TGGACGCGTTCCACAA-1_5981_BA9	4.793515906	-3.853794579	12	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1127	1657	0.018105009	0.002414001	0	12	EN-MIX	NA	NA	NA
TGGACGCTCATCTGCC-1_5981_BA9	12.12981976	-20.37707459	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	5312	15807	0.00468147	0.005061049	0	L2-3	EN-L2-3-MS	NA	NA	NA
TGGACGCTCTTCGAGA-1_5981_BA9	17.63175579	-17.84270483	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	5376	15747	0.00870007	0.003683241	0	L2-3	EN-L2-3-MS	NA	NA	NA
TGGCCAGAGCTCCTCT-1_5981_BA9	22.59780963	-21.84454713	3	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	4208	11331	0.008737093	0.009443121	0	3	EN-L5-6	NA	NA	NA
TGGCCAGCATCGACGC-1_5981_BA9	14.57178035	-30.84859256	3	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3306	7914	0.006444276	0.003538034	0	3	EN-L5-6	NA	NA	NA
TGGCCAGCATTGAGCT-1_5981_BA9	-7.867743759	-33.57590155	16	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	852	1174	0.053662692	0.004258944	0	16	EN-PYR	NA	NA	NA
TGGCGCACAGATGGCA-1_5981_BA9	4.546828482	-11.59658599	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1800	2942	0.004418763	0.009517335	0	L2-3	EN-L2-3-MS	NA	NA	NA
TGGCGCACATCCCACT-1_5981_BA9	-0.752765451	32.06251991	17	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	943	1335	0.005243446	0.002247191	0	oligos	OL-MS-2	NA	NA	NA
TGGCGCATCACCACCT-1_5981_BA9	-22.46265188	-23.89659138	6A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2543	4936	0.009724473	0.005267423	0	6A	IN-PV	NA	NA	NA
TGGCGCATCGATAGAA-1_5981_BA9	-7.882846693	-34.11826951	16	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	834	1147	0.040104621	0.005231037	0	16	EN-PYR	NA	NA	NA
TGGCTGGAGATCCGAG-1_5981_BA9	16.4671868	-18.19846313	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3302	6682	0.009129003	0.00463933	0	L2-3	EN-L2-3-MS	NA	NA	NA
TGGCTGGAGTAGCGGT-1_5981_BA9	-32.56234326	-13.53398856	9	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	742	1016	0.000984252	0.00492126	0	9	OPC	NA	NA	NA
TGGGAAGTCAACACTG-1_5981_BA9	-11.65371689	-6.62143479	13B	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2093	4014	0.012705531	0.005979073	0	13B	IN-SV2C	NA	NA	NA
TGGGCGTGTCTTCGTC-1_5981_BA9	30.46713867	-15.11725639	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2909	5523	0.008509868	0.009053051	0	2	EN-L4	NA	NA	NA
TGGTTAGTCACTATTC-1_5981_BA9	1.758444016	-18.48398094	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2841	6361	0.004087408	0.004873448	0	L2-3	EN-L2-3-MS	NA	NA	NA
TGGTTAGTCCTTCAAT-1_5981_BA9	-17.63581676	-21.15058785	6A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2030	3939	0.003046458	0.002284844	0	6A	IN-PV	NA	NA	NA
TGGTTAGTCGCAAGCC-1_5981_BA9	20.07433485	-3.297583672	12	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1491	2328	0.009020619	0.004725086	0	12	EN-MIX	NA	NA	NA
TGGTTCCAGCGATTCT-1_5981_BA9	-14.58197977	-6.006535027	13A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3399	8826	0.003965556	0.003965556	0	13A	IN-VIP	NA	NA	NA
TGGTTCCCACAGGTTT-1_5981_BA9	11.92393065	-20.31230731	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3057	6914	0.007376338	0.002603413	0	L2-3	EN-L2-3-MS	NA	NA	NA
TGGTTCCTCTACTCAT-1_5981_BA9	27.82979985	-17.38729219	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	5403	16905	0.019994085	0.00390417	0	2	EN-L4	NA	NA	NA
TGTATTCGTGTGGTTT-1_5981_BA9	18.32797371	-17.32602749	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	5150	14825	0.012816189	0.003102867	0	L2-3	EN-L2-3-MS	NA	NA	NA
TGTCCCAAGAAACCGC-1_5981_BA9	-20.0746627	-4.855927653	13B	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3749	7928	0.012108981	0.008829465	0	13B	IN-SV2C	NA	NA	NA
TGTCCCAAGAGTCTGG-1_5981_BA9	-27.22464791	-20.3354534	6A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2840	5518	0.038782167	0.007249003	0	6A	IN-PV	NA	NA	NA
TGTCCCAGTCGAATCT-1_5981_BA9	4.814225001	-11.65844375	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1871	3049	0.006231551	0.011479173	0	L2-3	EN-L2-3-MS	NA	NA	NA
TGTGGTAAGTTGAGTA-1_5981_BA9	21.13253754	-2.460712927	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1747	2792	0.002507163	0.005014327	0	2	EN-L4	NA	NA	NA
TGTGGTACAGCTGCAC-1_5981_BA9	-9.918853009	-4.1382871	13A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1817	2948	0.002035278	0.007123474	0	13A	IN-VIP	NA	NA	NA
TGTGGTAGTAGCAAAT-1_5981_BA9	-5.239055958	-31.876748	16	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	798	1007	0.022840119	0.016881827	0	16	EN-PYR	NA	NA	NA
TGTGTTTAGCTAGGCA-1_5981_BA9	-22.49175168	14.43697999	8	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1202	1721	0.008134805	0.002905288	0	8	Astrocytes	NA	NA	NA
TGTGTTTCAGCGTTCG-1_5981_BA9	-6.587426281	-9.150263489	13A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	866	1144	0.003496503	0.006993007	0	13A	IN-VIP	NA	NA	NA
TGTGTTTGTACATCCA-1_5981_BA9	-8.195957411	-34.41277167	16	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	779	1046	0.014340344	0.005736138	0	16	EN-PYR	NA	NA	NA
TGTGTTTTCATGCAAC-1_5981_BA9	6.175722284	-3.402501465	12	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1101	1617	0.025974026	0.002473717	0	12	EN-MIX	NA	NA	NA
TGTTCCGCACCATCCT-1_5981_BA9	-11.77676875	-21.65534798	6A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1007	1658	0.005428227	0.004221954	0	6A	IN-PV	NA	NA	NA
TGTTCCGGTATAATGG-1_5981_BA9	-9.200426307	-16.38120028	6B	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	912	1355	0.028782288	0.001476015	0	6B	IN-SST	NA	NA	NA
TGTTCCGGTTTGGGCC-1_5981_BA9	28.64637619	-15.84653003	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2855	5660	0.035865724	0.008127208	0	2	EN-L4	NA	NA	NA
TTAACTCAGCCGTCGT-1_5981_BA9	5.820260249	-14.26009005	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2623	5493	0.003640998	0.009466594	0	L2-3	EN-L2-3-MS	NA	NA	NA
TTAACTCGTATGAAAC-1_5981_BA9	-7.024500226	-7.833530102	13A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1015	1494	0.006024096	0.006024096	0	13A	IN-VIP	NA	NA	NA
TTAACTCGTCAGAAGC-1_5981_BA9	-29.77449589	-21.0192749	6A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	4890	12276	0.034864777	0.006028022	0	6A	IN-PV	NA	NA	NA
TTAACTCTCCTATGTT-1_5981_BA9	8.569520352	24.22463642	1	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	985	1438	0.001390821	0.004867872	0	oligos	OL-Cntl	NA	NA	NA
TTAGGACAGCCCAGCT-1_5981_BA9	-17.12479379	-15.26910768	6B	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2060	3885	0.024710425	0.003346203	0	6B	IN-SST	NA	NA	NA
TTAGGACTCTTTACAC-1_5981_BA9	21.83865946	-3.496209591	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2325	4719	0.022250477	0.005085823	0	2	EN-L4	NA	NA	NA
TTAGGCACACGAAAGC-1_5981_BA9	13.5288298	-23.29100172	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	4469	12159	0.004934616	0.003371988	0	L2-3	EN-L2-3-MS	NA	NA	NA
TTAGGCAGTAGAGTGC-1_5981_BA9	-12.08392162	-31.30078096	16	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1352	2028	0.036982249	0.004930966	0	16	EN-PYR	NA	NA	NA
TTAGGCATCAAACCGT-1_5981_BA9	26.94894623	-13.73306226	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	5517	17917	0.021655411	0.003125523	0	L2-3	EN-L2-3-MS	NA	NA	NA
TTAGTTCAGCCAGGAT-1_5981_BA9	-11.29863458	-14.65679787	6B	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1130	1768	0.071832579	0.001696833	0	6B	IN-SST	NA	NA	NA
TTAGTTCCAGACTCGC-1_5981_BA9	26.14584322	6.49913695	15A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1086	1431	0.01048218	0.018867925	0	15A	Endo cells	NA	NA	NA
TTAGTTCGTGCTCTTC-1_5981_BA9	-20.73036029	-20.91602443	6A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1597	2662	0.047332832	0.003380917	0	6A	IN-PV	NA	NA	NA
TTATGCTAGTATCTCG-1_5981_BA9	27.91306213	-9.287302414	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3174	7604	0.007759074	0.002367175	0	2	EN-L4	NA	NA	NA
TTATGCTTCAGTTCGA-1_5981_BA9	27.95419777	-17.66525284	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	7142	28238	0.040548197	0.006338976	0	2	EN-L4	NA	NA	NA
TTATGCTTCCTCAACC-1_5981_BA9	-28.41275919	9.22590911	8	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	785	1059	0.002832861	0.017941454	0	8	Astrocytes	NA	NA	NA
TTATGCTTCTGCGTAA-1_5981_BA9	20.65172574	-3.677504924	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2021	3469	0.017584318	0.004324013	0	2	EN-L4	NA	NA	NA
TTCCCAGCATATACGC-1_5981_BA9	-30.29850353	-13.18473082	9	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	765	1033	0.002904163	0.003872217	0	9	OPC	NA	NA	NA
TTCCCAGTCATACGGT-1_5981_BA9	-11.05458868	-15.82064175	6B	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	965	1376	0.006540698	0.005087209	0	6B	IN-SST	NA	NA	NA
TTCGAAGCATCGGAAG-1_5981_BA9	28.5528416	-16.94974645	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	4229	10194	0.029429076	0.005395331	0	2	EN-L4	NA	NA	NA
TTCGAAGGTCAGAATA-1_5981_BA9	-1.289510035	30.9407811	17	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	961	1323	0.003023432	0.004535147	0	oligos	OL-MS-2	NA	NA	NA
TTCGAAGGTCGAGATG-1_5981_BA9	-11.00258012	29.15932396	17	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	832	1099	0.053685168	0.010009099	0	oligos	OL-MS-2	NA	NA	NA
TTCGAAGTCAACCAAC-1_5981_BA9	30.0513916	-15.06253559	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3311	6940	0.01815562	0.005619597	0	2	EN-L4	NA	NA	NA
TTCGAAGTCGTTGACA-1_5981_BA9	12.80931608	-3.589062166	12	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1248	1975	0.010632911	0.002025316	0	12	EN-MIX	NA	NA	NA
TTCGGTCAGACTACAA-1_5981_BA9	18.83936367	-0.277085	12	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1255	2054	0.023855891	0.00194742	0	12	EN-MIX	NA	NA	NA
TTCGGTCAGGCTAGCA-1_5981_BA9	17.97713153	-17.74632702	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	4929	13692	0.014314928	0.003432661	0	L2-3	EN-L2-3-MS	NA	NA	NA
TTCGGTCGTTCGCTAA-1_5981_BA9	-10.42034554	-5.243291469	13A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1746	2735	0.009872029	0.009506399	0	13A	IN-VIP	NA	NA	NA
TTCGGTCTCCACGAAT-1_5981_BA9	20.6537351	-19.95697419	3	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3596	7736	0.009694933	0.009307135	0	3	EN-L5-6	NA	NA	NA
TTCTACATCAGAGCTT-1_5981_BA9	-9.475115251	-4.780889539	13A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1721	2959	0.004055424	0.007434944	0	13A	IN-VIP	NA	NA	NA
TTCTACATCTGTTGAG-1_5981_BA9	-28.54518488	9.509545954	8	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	774	1070	0.022429907	0.002803738	0	8	Astrocytes	NA	NA	NA
TTCTCAAAGCAGCGTA-1_5981_BA9	5.260031905	-9.775978255	12	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1763	2882	0.00277585	0.00832755	0	12	EN-MIX	NA	NA	NA
TTCTCAACACAAGCCC-1_5981_BA9	-14.72945561	-15.95693706	6B	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1818	3580	0.051396648	0.002513966	0	6B	IN-SST	NA	NA	NA
TTCTCAAGTAGCTAAA-1_5981_BA9	18.4455876	-20.24377315	3	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2250	4308	0.01810585	0.002785515	0	3	EN-L5-6	NA	NA	NA
TTCTCCTTCGTAGATC-1_5981_BA9	-21.64794298	-20.18388519	6A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2339	4502	0.014438028	0.002887606	0	6A	IN-PV	NA	NA	NA
TTCTTAGAGTCAATAG-1_5981_BA9	-28.30238402	22.83081262	8	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1259	1961	0.003059663	0.00254972	0	8	Astrocytes	NA	NA	NA
TTCTTAGCAAGCCATT-1_5981_BA9	-25.1343769	-22.55292511	6A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3244	7504	0.009861407	0.006396588	0	6A	IN-PV	NA	NA	NA
TTCTTAGGTTACTGAC-1_5981_BA9	-5.869182113	-5.589724274	13A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1250	2062	0.007274491	0.001454898	0	13A	IN-VIP	NA	NA	NA
TTGAACGGTGAGGCTA-1_5981_BA9	8.91556809	-1.714917669	16	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1203	1917	0.032342201	0.015127804	0	16	EN-PYR	NA	NA	NA
TTGAACGTCCATGCTC-1_5981_BA9	21.05551518	-1.296621661	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1627	2741	0.005472455	0.003648304	0	2	EN-L4	NA	NA	NA
TTGACTTTCCAGATCA-1_5981_BA9	30.92907717	-10.93372908	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3131	7341	0.012941016	0.002724424	0	2	EN-L4	NA	NA	NA
TTGCCGTCAGTCAGAG-1_5981_BA9	7.406980531	24.09861251	1	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	985	1372	0.002186589	0.005830904	0	oligos	OL-Cntl	NA	NA	NA
TTGCCGTGTCCGAATT-1_5981_BA9	27.5419174	1.194054071	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2437	5205	0.002881844	0.003842459	0	2	EN-L4	NA	NA	NA
TTGCGTCCAAAGAATC-1_5981_BA9	-11.01560444	-7.184490535	13A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1427	2031	0.012801576	0.007385524	0	13A	IN-VIP	NA	NA	NA
TTGCGTCCAAGACGTG-1_5981_BA9	-34.07254663	-12.29074255	9	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	814	1172	0	0.004266212	0	9	OPC	NA	NA	NA
TTGGAACAGCCGGTAA-1_5981_BA9	27.62108078	-18.85998996	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	4334	10411	0.042935357	0.007492076	0	2	EN-L4	NA	NA	NA
TTGGAACTCCAAATGC-1_5981_BA9	3.687184378	-16.23501271	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2965	6583	0.005012912	0.010481543	0	L2-3	EN-L2-3-MS	NA	NA	NA
TTGGCAAAGTGGAGAA-1_5981_BA9	29.88558283	-15.56103131	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3502	7296	0.025630482	0.004797149	0	2	EN-L4	NA	NA	NA
TTGGCAAGTACAGCAG-1_5981_BA9	6.815113745	-14.49503232	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2606	4670	0.00235546	0.0124197	0	L2-3	EN-L2-3-MS	NA	NA	NA
TTGGCAATCAAACAAG-1_5981_BA9	-10.94548344	-5.456947011	13A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1836	2879	0.035776311	0.009378256	0	13A	IN-VIP	NA	NA	NA
TTGTAGGCAACTGGCC-1_5981_BA9	-16.43284978	-6.413088861	13B	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2846	5838	0.015930113	0.002911956	0	13B	IN-SV2C	NA	NA	NA
TTGTAGGCATGGTCAT-1_5981_BA9	5.321998127	-14.51405873	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2745	5491	0.004370789	0.006738299	0	L2-3	EN-L2-3-MS	NA	NA	NA
TTTACTGGTTACGTCA-1_5981_BA9	-7.329431397	-6.206324018	13A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1248	2084	0.009117083	0.002879079	0	13A	IN-VIP	NA	NA	NA
TTTATGCAGTGGCACA-1_5981_BA9	5.699621413	-14.19778125	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	2436	4775	0.003769634	0.011308901	0	L2-3	EN-L2-3-MS	NA	NA	NA
TTTATGCTCGTAGGTT-1_5981_BA9	17.41090232	-17.21295498	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3488	7698	0.024681736	0.004286828	0	L2-3	EN-L2-3-MS	NA	NA	NA
TTTCCTCTCAATCACG-1_5981_BA9	20.88492893	-3.45720422	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1772	3206	0.020274485	0.002495321	0	2	EN-L4	NA	NA	NA
TTTGCGCAGGTCGGAT-1_5981_BA9	17.83974229	-17.54846761	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	5077	13416	0.010211688	0.005217651	0	L2-3	EN-L2-3-MS	NA	NA	NA
TTTGCGCAGTGGAGTC-1_5981_BA9	-12.52941292	-9.714643621	13B	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1904	3299	0.003637466	0.005456199	0	13B	IN-SV2C	NA	NA	NA
TTTGCGCGTATCACCA-1_5981_BA9	25.77128814	7.074682785	15A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1502	2103	0.011412268	0.016642891	0	15A	Endo cells	NA	NA	NA
TTTGCGCTCAGCATGT-1_5981_BA9	27.73988387	-17.6465484	2	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	6411	22963	0.03932413	0.006314506	0	2	EN-L4	NA	NA	NA
TTTGCGCTCTCGCATC-1_5981_BA9	-28.51901408	10.62241295	8	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	937	1360	0.0125	0.000735294	0	8	Astrocytes	NA	NA	NA
TTTGCGCTCTCTTGAT-1_5981_BA9	18.31002006	-17.27597555	4	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3482	8035	0.020908525	0.00360921	0	L2-3	EN-L2-3-MS	NA	NA	NA
TTTGTCAGTAAACCTC-1_5981_BA9	26.87058902	5.372806998	15A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	1014	1379	0.007251632	0.011602611	0	15A	Endo cells	NA	NA	NA
TTTGTCAGTTCCGTCT-1_5981_BA9	-16.6913255	-2.645484958	13A	5981_BA9	Control	Control	44	female	prefrontal	CAP7	SEQ5	7.8	19	3206	6566	0.009594883	0.009290283	0	13A	IN-VIP	NA	NA	NA
AAACCTGAGCAGGTCA-1_5787_BA9	18.06640981	-10.28566265	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2926	5482	0.00036483	0.018971178	0	3	EN-L5-6	NA	NA	NA
AAACCTGGTCTAGTGT-1_5787_BA9	-7.819595426	-34.98730716	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	910	1192	0.037751678	0.015100671	0	16	EN-PYR	NA	NA	NA
AAACCTGTCACAGGCC-1_5787_BA9	32.50544844	-1.942923555	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2662	4964	0.001007252	0.006849315	0	2	EN-L4	NA	NA	NA
AAACCTGTCAGGCCCA-1_5787_BA9	31.12110789	-7.76794754	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4342	10302	0.002135508	0.007668414	0	2	EN-L4	NA	NA	NA
AAACCTGTCCAGAGGA-1_5787_BA9	31.09108487	-6.296809618	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4017	8794	0.000454856	0.009551967	0	2	EN-L4	NA	NA	NA
AAACCTGTCTGGAGCC-1_5787_BA9	-14.61093186	-17.27823369	6B	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1659	2586	0.001160093	0.005800464	0	6B	IN-SST	NA	NA	NA
AAACGGGAGGCGCTCT-1_5787_BA9	-9.31060314	-5.899243482	13A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1948	3066	0.016960209	0.006523157	0	13A	IN-VIP	NA	NA	NA
AAACGGGTCAGCTCGG-1_5787_BA9	-16.83256155	-9.562666398	13B	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3271	6405	0.000468384	0.007181889	0	13B	IN-SV2C	NA	NA	NA
AAAGATGGTCTTCAAG-1_5787_BA9	18.32650085	-9.389259045	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2471	4761	0.00042008	0.010501995	0	3	EN-L5-6	NA	NA	NA
AAAGTAGAGATGGCGT-1_5787_BA9	-6.684613328	-34.54482963	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	882	1183	0.065088757	0.010143702	0	16	EN-PYR	NA	NA	NA
AAAGTAGCAAATCCGT-1_5787_BA9	25.96019897	-27.10821662	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5687	16406	0.000853346	0.004144825	0	3	EN-L5-6	NA	NA	NA
AAAGTAGTCTTCGGTC-1_5787_BA9	-6.675268056	-34.59112665	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	896	1254	0.096491228	0.01754386	0	16	EN-PYR	NA	NA	NA
AAATGCCAGACTAAGT-1_5787_BA9	21.81600393	-24.74156206	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4658	11466	0.001046572	0.014303157	0	3	EN-L5-6	NA	NA	NA
AAATGCCAGCTACCGC-1_5787_BA9	17.71144207	-5.745096318	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1432	2412	0.001243781	0.00787728	0	3	EN-L5-6	NA	NA	NA
AAATGCCAGTCCTCCT-1_5787_BA9	-7.008473908	-30.3898252	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	854	1148	0.031358885	0.013066202	0	16	EN-PYR	NA	NA	NA
AAATGCCCATTCTCAT-1_5787_BA9	-22.94848393	-9.23208609	9	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1502	2075	0.004819277	0.006746988	0	9	OPC	NA	NA	NA
AAATGCCTCGTAGATC-1_5787_BA9	-9.114096447	-6.189754297	13A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1726	2640	0.000757576	0.016287879	0	13A	IN-VIP	NA	NA	NA
AACCATGGTGAACCTT-1_5787_BA9	-7.672609866	-31.61884229	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	924	1327	0.100979653	0.009796534	0	16	EN-PYR	NA	NA	NA
AACCGCGCACATTTCT-1_5787_BA9	-1.320996753	36.29152106	17	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	957	1313	0.003808073	0.008377761	0	oligos	OL-MS-2	NA	NA	NA
AACCGCGGTAACGCGA-1_5787_BA9	16.12337969	-27.55276827	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	6168	18864	0.002226463	0.005089059	0	3	EN-L5-6	NA	NA	NA
AACGTTGCAAGGACTG-1_5787_BA9	-10.14818016	-10.80358214	6B	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1496	2094	0.023400191	0.013849093	0	6B	IN-SST	NA	NA	NA
AACGTTGCATATGGTC-1_5787_BA9	9.303249745	-26.9080929	10	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5021	12842	0.001245912	0.007163993	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AACGTTGGTTTAGGAA-1_5787_BA9	8.986863577	-28.63574836	10	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5263	13815	0.000868621	0.00412595	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AACGTTGTCTTATCTG-1_5787_BA9	6.995449778	-10.26371274	4	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1843	2824	0.004249292	0.018767705	0	L2-3	EN-L2-3-MS	NA	NA	NA
AACTCAGCATTCCTGC-1_5787_BA9	16.99273735	-29.7180747	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5521	16232	0.000800887	0.004374076	0	3	EN-L5-6	NA	NA	NA
AACTCAGTCACTGGGC-1_5787_BA9	8.350683757	-26.73414003	10	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5232	15236	0.000590706	0.003675505	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AACTCCCAGAGTGAGA-1_5787_BA9	-10.43269887	-7.336647886	13A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1744	2571	0.004667445	0.020225593	0	13A	IN-VIP	NA	NA	NA
AACTCCCAGTGTACGG-1_5787_BA9	30.42064701	-8.180854035	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4611	10795	0.003612784	0.006206577	0	2	EN-L4	NA	NA	NA
AACTCCCGTCGTCTTC-1_5787_BA9	-21.24483199	-25.09506795	6A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3816	8395	0.013103038	0.005241215	0	6A	IN-PV	NA	NA	NA
AACTCCCGTGACAAAT-1_5787_BA9	-6.166762285	-3.975333241	13A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1626	2533	0.001184366	0.010659297	0	13A	IN-VIP	NA	NA	NA
AACTCCCTCGGAAATA-1_5787_BA9	24.22669359	-11.88626431	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5055	12329	0.006407657	0.006083218	0	3	EN-L5-6	NA	NA	NA
AACTCCCTCTGGTATG-1_5787_BA9	-18.91337243	-21.76635698	6A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2929	6361	0.000943248	0.004401824	0	6A	IN-PV	NA	NA	NA
AACTCTTAGCGATGAC-1_5787_BA9	31.82188151	-1.513150301	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3002	5896	0.00050882	0.003222524	0	2	EN-L4	NA	NA	NA
AACTCTTCATTGGCGC-1_5787_BA9	27.46153717	6.076617483	15A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1018	1406	0.016358464	0.021337127	0	15A	Endo cells	NA	NA	NA
AACTCTTTCATTATCC-1_5787_BA9	13.84167235	-32.49233583	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3889	11121	0.00071936	0.003057279	0	3	EN-L5-6	NA	NA	NA
AACTGGTCACACAGAG-1_5787_BA9	-19.82183721	-17.20199167	6B	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3622	7911	0.000884844	0.006825939	0	6B	IN-SST	NA	NA	NA
AACTGGTCATGGTCAT-1_5787_BA9	-17.97937514	-17.50762778	6B	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2150	4174	0.004551989	0.00287494	0	6B	IN-SST	NA	NA	NA
AACTTTCCAGCATGAG-1_5787_BA9	-15.74778528	-9.706904167	13B	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2410	4227	0.01182872	0.006150934	0	13B	IN-SV2C	NA	NA	NA
AACTTTCGTGCGAAAC-1_5787_BA9	-15.78124187	-20.97430713	6A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1785	2839	0.000704473	0.014793942	0	6A	IN-PV	NA	NA	NA
AACTTTCTCAGTTGAC-1_5787_BA9	-9.921471398	-3.157055717	13A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2108	3558	0.001686341	0.019955031	0	13A	IN-VIP	NA	NA	NA
AAGACCTCAATGTAAG-1_5787_BA9	-12.42488126	-34.48068785	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1349	2002	0.010989011	0.012987013	0	16	EN-PYR	NA	NA	NA
AAGCCGCAGTGTCCAT-1_5787_BA9	-7.783666202	-33.37563359	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	921	1288	0.059006211	0.010093168	0	16	EN-PYR	NA	NA	NA
AAGCCGCCAATGGAAT-1_5787_BA9	11.49371236	-2.60637419	12	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1401	2319	0.004312204	0.007761966	0	12	EN-MIX	NA	NA	NA
AAGGAGCAGGATATAC-1_5787_BA9	-14.93000538	-14.43300235	6B	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1766	2651	0.005281026	0.014334214	0	6B	IN-SST	NA	NA	NA
AAGGAGCCACAGCGTC-1_5787_BA9	-33.66031154	-10.37706593	9	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	952	1397	0	0.006442377	0	9	OPC	NA	NA	NA
AAGGAGCCACCTGGTG-1_5787_BA9	24.40148442	-19.91438878	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	6738	19927	0.007678025	0.006373262	0	3	EN-L5-6	NA	NA	NA
AAGGAGCGTCCCTACT-1_5787_BA9	18.07529697	-10.18487416	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2514	4731	0.000634115	0.021771296	0	3	EN-L5-6	NA	NA	NA
AAGGAGCGTCTAAACC-1_5787_BA9	27.71729424	-5.977377428	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4664	13208	0.000605694	0.005602665	0	2	EN-L4	NA	NA	NA
AAGGAGCTCGCTGATA-1_5787_BA9	-11.67415332	-6.164627231	13A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2544	4178	0.004786979	0.016754428	0	13A	IN-VIP	NA	NA	NA
AAGGAGCTCGTTTGCC-1_5787_BA9	-29.278185	-12.34564092	9	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	946	1255	0	0.005577689	0	9	OPC	NA	NA	NA
AAGGCAGAGCGCTTAT-1_5787_BA9	-25.43728133	11.35929395	8	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	955	1412	0	0.007082153	0	8	Astrocytes	NA	NA	NA
AAGGCAGCATCGACGC-1_5787_BA9	5.920276597	-11.95624577	4	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2298	3602	0.000832871	0.018600777	0	L2-3	EN-L2-3-MS	NA	NA	NA
AAGGCAGGTTGGAGGT-1_5787_BA9	16.3320561	-30.18517716	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4547	11464	0.000785066	0.005844382	0	3	EN-L5-6	NA	NA	NA
AAGGTTCGTACGACCC-1_5787_BA9	24.03106693	-10.58867768	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4941	11886	0.000588928	0.00715127	0	3	EN-L5-6	NA	NA	NA
AAGGTTCGTTTGCATG-1_5787_BA9	33.23506018	-2.290467891	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2553	4672	0.001498288	0.004280822	0	2	EN-L4	NA	NA	NA
AAGGTTCGTTTGTTGG-1_5787_BA9	-7.627118477	-9.251935642	13A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1322	2418	0.00248139	0.009511993	0	13A	IN-VIP	NA	NA	NA
AAGGTTCTCGCTAGCG-1_5787_BA9	27.63011304	6.459138438	15A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1039	1330	0.007518797	0.028571429	0	15A	Endo cells	NA	NA	NA
AAGGTTCTCGTAGGTT-1_5787_BA9	3.480891616	-19.10188701	4	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3787	8034	0.000995768	0.006596963	0	L2-3	EN-L2-3-MS	NA	NA	NA
AAGGTTCTCTGAGGGA-1_5787_BA9	-23.12775333	-20.56326593	6A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3133	5913	0.050059192	0.007272112	0	6A	IN-PV	NA	NA	NA
AAGTCTGCAGTAAGCG-1_5787_BA9	9.409611269	-28.52254837	10	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5562	14960	0.001002674	0.004612299	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AAGTCTGGTTCCGGCA-1_5787_BA9	24.00777299	-26.10301746	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3337	6820	0.002639296	0.003372434	0	3	EN-L5-6	NA	NA	NA
AATCCAGAGTCGCCGT-1_5787_BA9	28.37393932	-5.388874083	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4234	10417	0.000959969	0.003839877	0	2	EN-L4	NA	NA	NA
AATCCAGGTACCGTAT-1_5787_BA9	-18.42169451	-21.47642227	6B	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2198	3735	0.000535475	0.012851406	0	6B	IN-SST	NA	NA	NA
AATCCAGGTAGCGCAA-1_5787_BA9	-7.283319992	-33.23684097	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	824	1066	0.030018762	0.009380863	0	16	EN-PYR	NA	NA	NA
AATCCAGTCGTAGGAG-1_5787_BA9	31.73851738	-3.028214993	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3073	6288	0.002226463	0.005566158	0	2	EN-L4	NA	NA	NA
AATCGGTCAAGCCATT-1_5787_BA9	25.51843149	-27.04033487	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5091	13838	0.002529267	0.006431565	0	3	EN-L5-6	NA	NA	NA
AATCGGTGTAGAGGAA-1_5787_BA9	-13.27862345	-17.55411843	6B	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1491	2334	0	0.010282776	0	6B	IN-SST	NA	NA	NA
ACACCAAAGTTAGCGG-1_5787_BA9	7.761370339	-16.49061307	4	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3387	6136	0.001303781	0.023956975	0	L2-3	EN-L2-3-MS	NA	NA	NA
ACACCAATCAGCGATT-1_5787_BA9	-9.804059151	-1.256662419	13A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2355	4153	0.00048158	0.006019745	0	13A	IN-VIP	NA	NA	NA
ACACCAATCCTATGTT-1_5787_BA9	25.45094636	-26.82548583	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4787	12572	0.001909004	0.004215717	0	3	EN-L5-6	NA	NA	NA
ACACCCTCAGCTGCTG-1_5787_BA9	-9.27331946	-32.95651873	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1115	1494	0.046854083	0.022088353	0	16	EN-PYR	NA	NA	NA
ACACCCTTCCAGTAGT-1_5787_BA9	-25.9299686	-10.23856333	9	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	849	1137	0.002638522	0.007915567	0	9	OPC	NA	NA	NA
ACACCCTTCTCAAACG-1_5787_BA9	-12.83112967	-2.571470916	13A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2944	5273	0.00246539	0.009102977	0	13A	IN-VIP	NA	NA	NA
ACACCGGAGTAGTGCG-1_5787_BA9	-15.95938608	-5.33868144	13A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3455	6985	0.011166786	0.009305655	0	13A	IN-VIP	NA	NA	NA
ACACTGACAAACAACA-1_5787_BA9	-9.558847988	-0.806804882	13A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2427	4689	0.003198976	0.010663254	0	13A	IN-VIP	NA	NA	NA
ACACTGAGTTATCACG-1_5787_BA9	17.48249539	-4.175702954	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1581	2432	0.002878289	0.009457237	0	3	EN-L5-6	NA	NA	NA
ACAGCCGAGAGACTTA-1_5787_BA9	18.73551898	-24.1064639	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4167	9170	0.000545256	0.029989095	0	3	EN-L5-6	NA	NA	NA
ACAGCCGAGCACCGCT-1_5787_BA9	-21.12271209	-27.33894786	6A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3872	8912	0.001346499	0.005722621	0	6A	IN-PV	NA	NA	NA
ACAGCCGGTCGTGGCT-1_5787_BA9	-7.771521313	-3.742968505	13A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1757	2897	0.003797031	0.007594063	0	13A	IN-VIP	NA	NA	NA
ACAGCTAGTCAACTGT-1_5787_BA9	-7.234585874	-33.45084213	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	774	1020	0.026470588	0.006862745	0	16	EN-PYR	NA	NA	NA
ACAGCTATCAAACGGG-1_5787_BA9	-15.36289136	-36.97684759	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2768	5156	0.024049651	0.015903801	0	16	EN-PYR	NA	NA	NA
ACATACGCAGATGGGT-1_5787_BA9	15.09837958	-4.283064495	12	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1520	2246	0.001335708	0.024042743	0	12	EN-MIX	NA	NA	NA
ACATACGGTTACGACT-1_5787_BA9	9.316645605	-23.68691066	4	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4298	9851	0.000304538	0.011369404	0	L2-3	EN-L2-3-MS	NA	NA	NA
ACATACGTCCATTCTA-1_5787_BA9	-13.78742598	-36.58706267	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1873	3221	0.053399565	0.012108041	0	16	EN-PYR	NA	NA	NA
ACATCAGCAATGCCAT-1_5787_BA9	-19.70979045	-17.25482264	6A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2989	6033	0.00298359	0.008121996	0	6A	IN-PV	NA	NA	NA
ACATCAGCATGCCCGA-1_5787_BA9	5.655436488	-17.69624783	4	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3682	7699	0.000389661	0.019742824	0	L2-3	EN-L2-3-MS	NA	NA	NA
ACATCAGGTCAAAGAT-1_5787_BA9	-16.19953164	-21.09161037	6A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1546	2373	0.004214075	0.00337126	0	6A	IN-PV	NA	NA	NA
ACATGGTAGGTAGCTG-1_5787_BA9	9.109796365	-30.83022703	10	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4183	9163	0.001527884	0.006329805	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACATGGTGTATTCGTG-1_5787_BA9	-19.75687177	-20.88597949	6A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1682	2607	0.003068661	0.013041811	0	6A	IN-PV	NA	NA	NA
ACATGGTTCTGCCAGG-1_5787_BA9	-15.74587505	-14.75464041	6B	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2031	3287	0.002129601	0.014298753	0	6B	IN-SST	NA	NA	NA
ACCAGTAAGCTAGCCC-1_5787_BA9	8.845925215	-27.71816765	10	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5421	14463	0.000483994	0.003941091	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACCAGTAAGGGCTCTC-1_5787_BA9	11.15486479	-26.78039903	10	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5858	15638	0.000767362	0.009847807	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACCAGTAAGGTGCTAG-1_5787_BA9	14.74552794	-29.00510406	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5605	15299	0.001438002	0.006732466	0	3	EN-L5-6	NA	NA	NA
ACCCACTCAGAGCCAA-1_5787_BA9	-9.433690459	-6.681080934	13A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1788	2618	0.00381971	0.011459129	0	13A	IN-VIP	NA	NA	NA
ACCCACTGTGGTGTAG-1_5787_BA9	-16.12686195	-16.97317276	6B	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1881	3264	0.004595588	0.007352941	0	6B	IN-SST	NA	NA	NA
ACCGTAAGTTAGAACA-1_5787_BA9	32.97800923	-3.150740504	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2834	5067	0.003157687	0.011841326	0	2	EN-L4	NA	NA	NA
ACCTTTACATATGCTG-1_5787_BA9	32.71846935	-3.563213579	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3524	7260	0.000826446	0.010192837	0	2	EN-L4	NA	NA	NA
ACCTTTATCAAAGACA-1_5787_BA9	16.25267456	-31.76693522	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5443	16681	0.000239794	0.004496133	0	3	EN-L5-6	NA	NA	NA
ACCTTTATCACCTCGT-1_5787_BA9	8.496432036	-31.70681514	10	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5821	19673	0.000762466	0.003304021	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACGAGCCCATACGCCG-1_5787_BA9	-7.002099546	-33.42520525	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	787	1071	0.060690943	0.016806723	0	16	EN-PYR	NA	NA	NA
ACGAGCCGTCAGATAA-1_5787_BA9	-20.97802136	-15.23975605	6A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3019	5715	0.009098863	0.007524059	0	6A	IN-PV	NA	NA	NA
ACGAGCCTCTTTAGTC-1_5787_BA9	-24.20753939	-21.92661649	6A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3408	6328	0.021017699	0.010745891	0	6A	IN-PV	NA	NA	NA
ACGAGGACATCTATGG-1_5787_BA9	5.900834909	-12.2925113	4	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2631	4366	0.00091617	0.016032982	0	L2-3	EN-L2-3-MS	NA	NA	NA
ACGAGGAGTTATTCTC-1_5787_BA9	9.851973457	-29.14592432	10	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	7398	24822	0.001732334	0.004391266	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACGATACTCACGCATA-1_5787_BA9	-14.58774958	-17.57990662	6B	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1630	2553	0.000783392	0.013317665	0	6B	IN-SST	NA	NA	NA
ACGATGTCATGCTGGC-1_5787_BA9	18.23299506	-23.49006654	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3841	8074	0.000371563	0.049913302	0	3	EN-L5-6	NA	NA	NA
ACGCAGCAGAGAGCTC-1_5787_BA9	2.626335332	-13.71261575	4	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2477	4499	0.001111358	0.010891309	0	L2-3	EN-L2-3-MS	NA	NA	NA
ACGCAGCAGCGCCTTG-1_5787_BA9	-18.31200991	-15.7515164	6B	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2298	3823	0.002354172	0.008108815	0	6B	IN-SST	NA	NA	NA
ACGCAGCAGTTTCCTT-1_5787_BA9	-20.72187881	-25.28080103	6A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3249	6719	0.003423128	0.002827802	0	6A	IN-PV	NA	NA	NA
ACGCAGCCAAGTTGTC-1_5787_BA9	17.33637489	-29.45890371	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	6398	19323	0.00201832	0.004812917	0	3	EN-L5-6	NA	NA	NA
ACGCAGCCATGAGCGA-1_5787_BA9	21.26023129	-2.751166425	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2318	4064	0.002706693	0.011318898	0	2	EN-L4	NA	NA	NA
ACGCAGCGTACTCGCG-1_5787_BA9	17.94917312	-8.022582429	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2022	3620	0.000552486	0.014088398	0	3	EN-L5-6	NA	NA	NA
ACGCAGCGTAGAAGGA-1_5787_BA9	9.627225932	-28.25930183	10	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4876	12033	0.000332419	0.004653869	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACGCCAGCATCACGTA-1_5787_BA9	9.219530003	-28.16522417	10	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5250	13163	0.000987617	0.006077642	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACGCCGAGTTGCGCAC-1_5787_BA9	17.81725148	-30.96694262	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	6345	20535	0.001753104	0.00331142	0	3	EN-L5-6	NA	NA	NA
ACGGAGAAGCGTCTAT-1_5787_BA9	20.92589961	-1.30638688	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1743	2688	0.001488095	0.007440476	0	2	EN-L4	NA	NA	NA
ACGGCCATCTCGGACG-1_5787_BA9	-8.121230195	-31.85751074	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	824	1074	0.014897579	0.00744879	0	16	EN-PYR	NA	NA	NA
ACGGGCTGTCCGAAGA-1_5787_BA9	-19.07209749	-17.39186947	6B	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2946	6163	0.000649035	0.009735518	0	6B	IN-SST	NA	NA	NA
ACGGGCTTCTCAACTT-1_5787_BA9	17.62152977	-31.38858194	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	6465	22398	0.001294758	0.003661041	0	3	EN-L5-6	NA	NA	NA
ACGGGCTTCTTGCATT-1_5787_BA9	-27.25113708	8.550645011	8	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	772	1053	0.001899335	0.002849003	0	8	Astrocytes	NA	NA	NA
ACGGGTCAGAGTCGGT-1_5787_BA9	-8.258324236	-36.22350974	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1017	1516	0.017150396	0.019129288	0	16	EN-PYR	NA	NA	NA
ACGGGTCAGGGCTTCC-1_5787_BA9	-12.32289739	-35.13061854	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1361	2046	0.032746823	0.01026393	0	16	EN-PYR	NA	NA	NA
ACGGGTCCAAGCCGCT-1_5787_BA9	-20.27585725	-16.13735682	6B	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2791	5397	0.006670372	0.005743932	0	6B	IN-SST	NA	NA	NA
ACGGGTCCAGCTGTAT-1_5787_BA9	16.93077994	-29.80423828	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5603	15006	0.00219912	0.005197921	0	3	EN-L5-6	NA	NA	NA
ACGTCAACACGGATAG-1_5787_BA9	27.29210622	-5.742315038	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5561	15540	0.000514801	0.004890605	0	2	EN-L4	NA	NA	NA
ACGTCAACATGCATGT-1_5787_BA9	5.898774404	-11.82439696	4	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2295	3682	0.000543183	0.013851168	0	L2-3	EN-L2-3-MS	NA	NA	NA
ACTATCTTCGTAGGTT-1_5787_BA9	-18.97637353	-20.96579874	6A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2338	4014	0.012456403	0.009217738	0	6A	IN-PV	NA	NA	NA
ACTGAACCAGAGCCAA-1_5787_BA9	28.81444865	-13.57761805	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	6679	19481	0.033057851	0.008367127	0	2	EN-L4	NA	NA	NA
ACTGAACTCTGTGCAA-1_5787_BA9	30.05205962	-5.888880043	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5363	14564	0.00391376	0.004943697	0	2	EN-L4	NA	NA	NA
ACTGAGTGTTACGCGC-1_5787_BA9	-8.584508521	-16.38166644	6B	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	816	1179	0.002544529	0.001696353	0	6B	IN-SST	NA	NA	NA
ACTGATGAGGCTAGAC-1_5787_BA9	12.7037943	-24.17435513	4	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5478	13488	0.003039739	0.017793594	0	L2-3	EN-L2-3-MS	NA	NA	NA
ACTGATGCATGCCTTC-1_5787_BA9	17.43419736	-32.07396845	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	6083	20864	0.000335506	0.004649156	0	3	EN-L5-6	NA	NA	NA
ACTGATGGTGCAACGA-1_5787_BA9	-7.472101356	-35.25038868	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	880	1154	0.021663778	0.01559792	0	16	EN-PYR	NA	NA	NA
ACTGCTCCAAGCCCAC-1_5787_BA9	12.18852234	-3.526944224	12	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1594	2659	0.002256487	0.006769462	0	12	EN-MIX	NA	NA	NA
ACTGTCCCAGGTCTCG-1_5787_BA9	33.65661293	-4.922349712	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3597	7719	0.001295505	0.010234486	0	2	EN-L4	NA	NA	NA
ACTGTCCTCCAGAAGG-1_5787_BA9	22.05417601	-24.61927514	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3493	7249	0.0008277	0.012967306	0	3	EN-L5-6	NA	NA	NA
ACTGTCCTCGCAAACT-1_5787_BA9	-9.171016793	-13.7440363	6B	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	884	1174	0.005962521	0.014480409	0	6B	IN-SST	NA	NA	NA
ACTTACTGTGACTCAT-1_5787_BA9	7.835405692	-30.98501823	10	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5933	20271	0.002022594	0.002959893	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACTTGTTGTCATGCAT-1_5787_BA9	10.77994944	-26.1471627	10	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	6421	20510	0.004095563	0.005948318	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACTTGTTTCCACGTTC-1_5787_BA9	-5.224494527	-36.68485174	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	891	1151	0.007819288	0.027801911	0	16	EN-PYR	NA	NA	NA
ACTTTCAAGAGCTTCT-1_5787_BA9	17.96281639	-7.874545872	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1834	3154	0.000634115	0.014267597	0	3	EN-L5-6	NA	NA	NA
ACTTTCAGTGCCTGCA-1_5787_BA9	-13.74513399	-3.621485652	13A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3258	6623	0.002113846	0.006643515	0	13A	IN-VIP	NA	NA	NA
ACTTTCATCCAGTAGT-1_5787_BA9	-14.12156574	-17.33231553	6A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1445	2151	0.0032543	0.0018596	0	6A	IN-PV	NA	NA	NA
AGAGCGAAGGTGCTTT-1_5787_BA9	9.622692784	-22.80042328	4	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5125	11556	0.003634476	0.016009	0	L2-3	EN-L2-3-MS	NA	NA	NA
AGAGCGAGTCAAACTC-1_5787_BA9	-7.158833276	-1.784615083	13A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2107	3538	0.000847937	0.008196721	0	13A	IN-VIP	NA	NA	NA
AGAGCGAGTGTGACCC-1_5787_BA9	9.645773246	-23.53406707	4	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4838	11231	0.000801353	0.020300953	0	L2-3	EN-L2-3-MS	NA	NA	NA
AGAGTGGAGGTGCACA-1_5787_BA9	-9.417855624	-6.652002824	13A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1759	2588	0.004250386	0.010046368	0	13A	IN-VIP	NA	NA	NA
AGATCTGAGCAATATG-1_5787_BA9	-21.58682919	-25.07339139	6A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2733	5357	0.001493373	0.010826955	0	6A	IN-PV	NA	NA	NA
AGATCTGGTCAGAAGC-1_5787_BA9	-14.32191142	-22.15770966	6A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1482	2248	0.001779359	0.004448399	0	6A	IN-PV	NA	NA	NA
AGCAGCCCACCAGCAC-1_5787_BA9	-17.91040203	-21.32858834	6A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2409	4614	0.003034244	0.004768097	0	6A	IN-PV	NA	NA	NA
AGCAGCCGTGCGATAG-1_5787_BA9	-12.74148013	-4.563958039	13A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2822	4908	0.003056235	0.008149959	0	13A	IN-VIP	NA	NA	NA
AGCAGCCTCACAACGT-1_5787_BA9	5.986221503	-11.78378039	4	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2374	3663	0.001638002	0.018291018	0	L2-3	EN-L2-3-MS	NA	NA	NA
AGCAGCCTCGTTGCCT-1_5787_BA9	5.884011865	-18.17911858	4	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3888	7930	0.00075662	0.01702396	0	L2-3	EN-L2-3-MS	NA	NA	NA
AGCATACAGGCGTACA-1_5787_BA9	-9.272528013	-9.310905741	13B	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1576	2421	0.002478315	0.007434944	0	13B	IN-SV2C	NA	NA	NA
AGCATACAGGGTCGAT-1_5787_BA9	21.55103384	-24.38327371	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4075	9600	0.001875	0.0228125	0	3	EN-L5-6	NA	NA	NA
AGCATACCAAGCTGGA-1_5787_BA9	28.01259154	-5.603155261	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5369	13396	0.000447895	0.005524037	0	2	EN-L4	NA	NA	NA
AGCATACGTAGGCTGA-1_5787_BA9	28.18784998	-5.576853142	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5414	14131	0.000283066	0.00431675	0	2	EN-L4	NA	NA	NA
AGCATACGTATTACCG-1_5787_BA9	-26.95356099	5.007748731	9	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1165	1621	0.000616903	0.008636644	0	9	OPC	NA	NA	NA
AGCATACGTCTCACCT-1_5787_BA9	6.156139373	-12.44630546	4	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2881	4997	0	0.016609966	0	L2-3	EN-L2-3-MS	NA	NA	NA
AGCATACTCGTTGCCT-1_5787_BA9	18.04520448	-31.50893425	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	7398	26900	0.000817844	0.00527881	0	3	EN-L5-6	NA	NA	NA
AGCCTAACAGTACACT-1_5787_BA9	12.42524396	1.306798385	12	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	768	1004	0.00498008	0.008964143	0	12	EN-MIX	NA	NA	NA
AGCCTAATCACCTTAT-1_5787_BA9	-16.51367384	-8.569776477	13B	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2907	5304	0.005656109	0.0086727	0	13B	IN-SV2C	NA	NA	NA
AGCCTAATCCACTCCA-1_5787_BA9	10.88548818	-25.88590157	10	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	6385	19100	0.000994764	0.007801047	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AGCCTAATCTCATTCA-1_5787_BA9	28.14597021	-11.57800559	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	6021	16817	0.006005827	0.007492418	0	2	EN-L4	NA	NA	NA
AGCGGTCAGGAATTAC-1_5787_BA9	7.204429587	-18.73581351	4	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4434	9410	0.001062699	0.018490967	0	L2-3	EN-L2-3-MS	NA	NA	NA
AGCGGTCAGGAGTCTG-1_5787_BA9	-29.36505825	-12.97135258	9	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	904	1184	0.001689189	0.004222973	0	9	OPC	NA	NA	NA
AGCGGTCCATCGGACC-1_5787_BA9	9.289928019	-23.28557783	4	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4337	9628	0.00166182	0.016929788	0	L2-3	EN-L2-3-MS	NA	NA	NA
AGCGGTCTCTCTGAGA-1_5787_BA9	19.82302129	-17.38124704	4	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	6846	18874	0.015365052	0.00937798	0	L2-3	EN-L2-3-MS	NA	NA	NA
AGCGTATAGTGGTAAT-1_5787_BA9	-21.54239173	-28.29616831	6A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5661	15477	0.001356852	0.00419978	0	6A	IN-PV	NA	NA	NA
AGCGTATGTCAAAGAT-1_5787_BA9	-18.18113789	-21.27731871	6A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2383	3905	0.007682458	0.003841229	0	6A	IN-PV	NA	NA	NA
AGCGTCGAGAGGTTGC-1_5787_BA9	-12.10800549	-34.30804864	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1333	2025	0.062222222	0.01037037	0	16	EN-PYR	NA	NA	NA
AGCGTCGCAAAGCAAT-1_5787_BA9	-12.69620172	-37.74048262	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1503	2321	0.028436019	0.027574321	0	16	EN-PYR	NA	NA	NA
AGCGTCGCAGCTTCGG-1_5787_BA9	6.984398414	-29.5776586	10	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5360	17193	0.000930611	0.002733671	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AGCGTCGGTTCTGAAC-1_5787_BA9	11.11186586	-14.5210446	4	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3468	6789	0.00456621	0.019001326	0	L2-3	EN-L2-3-MS	NA	NA	NA
AGCTCCTAGGCCGAAT-1_5787_BA9	-8.27483469	-1.882832755	13A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2108	3375	0.000592593	0.007407407	0	13A	IN-VIP	NA	NA	NA
AGCTCCTGTCTCGTTC-1_5787_BA9	-17.42491372	-21.99632605	6A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2527	4883	0.002252713	0.007782101	0	6A	IN-PV	NA	NA	NA
AGCTCCTTCGTAGGAG-1_5787_BA9	14.05089413	-4.338154281	12	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1631	2981	0.000670916	0.004696411	0	12	EN-MIX	NA	NA	NA
AGCTCCTTCTTGTATC-1_5787_BA9	5.311010682	-3.637147574	12	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	959	1512	0.012566138	0.001984127	0	12	EN-MIX	NA	NA	NA
AGCTCCTTCTTTACGT-1_5787_BA9	21.35794579	-27.48213496	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3120	7084	0.002258611	0.005364201	0	3	EN-L5-6	NA	NA	NA
AGCTCTCAGGAGCGTT-1_5787_BA9	17.62107622	-10.71014917	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2666	4800	0.000416667	0.022291667	0	3	EN-L5-6	NA	NA	NA
AGCTCTCCAAAGGTGC-1_5787_BA9	32.03944799	-7.455692683	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3325	6471	0.003399784	0.009735744	0	2	EN-L4	NA	NA	NA
AGCTCTCCACGGACAA-1_5787_BA9	15.28601466	-32.79063365	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5357	16232	0.000308034	0.002464268	0	3	EN-L5-6	NA	NA	NA
AGCTCTCGTCGCGAAA-1_5787_BA9	16.79203792	-6.735132072	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2227	4658	0.001073422	0.00536711	0	3	EN-L5-6	NA	NA	NA
AGCTCTCGTGAGCGAT-1_5787_BA9	-29.56152117	-12.98567601	9	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	793	1066	0	0.009380863	0	9	OPC	NA	NA	NA
AGCTCTCTCAAGAAGT-1_5787_BA9	14.34132501	-27.24184418	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4247	9961	0.000702741	0.004216444	0	3	EN-L5-6	NA	NA	NA
AGCTTGAAGGGAACGG-1_5787_BA9	-9.003563822	-12.42970505	6B	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1101	1497	0.023380094	0.039412158	0	6B	IN-SST	NA	NA	NA
AGCTTGACAATGGACG-1_5787_BA9	25.54473562	-27.25549667	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4623	11752	0.000255276	0.004339687	0	3	EN-L5-6	NA	NA	NA
AGCTTGACACAGTCGC-1_5787_BA9	24.76875326	6.373393879	15A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2187	3327	0.00841599	0.015329125	0	15A	Endo cells	NA	NA	NA
AGCTTGAGTCACCTAA-1_5787_BA9	8.418426606	-26.6894127	10	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5128	14591	0.002947022	0.001850456	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AGGCCACAGACAATAC-1_5787_BA9	32.28691578	-2.901432498	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3394	6709	0.001192428	0.006558354	0	2	EN-L4	NA	NA	NA
AGGCCACGTGGTTTCA-1_5787_BA9	19.48257528	-27.8403908	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4685	12220	0.000327332	0.006546645	0	3	EN-L5-6	NA	NA	NA
AGGCCGTAGCAAATCA-1_5787_BA9	17.24590184	-29.68526341	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	6212	18565	0.000915702	0.004632373	0	3	EN-L5-6	NA	NA	NA
AGGCCGTAGCGTGTCC-1_5787_BA9	-20.81576971	11.55205789	8	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	965	1363	0	0.008070433	0	8	Astrocytes	NA	NA	NA
AGGGAGTCATCCTAGA-1_5787_BA9	-29.18812934	-12.82628482	9	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	800	1049	0.000953289	0.009532888	0	9	OPC	NA	NA	NA
AGGGAGTGTAATCGTC-1_5787_BA9	-18.57830138	-21.58071443	6A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2462	4458	0.001345895	0.006056528	0	6A	IN-PV	NA	NA	NA
AGGGAGTTCAGCTCTC-1_5787_BA9	-20.10191658	-24.20192248	6A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2753	5024	0.001393312	0.006767516	0	6A	IN-PV	NA	NA	NA
AGGGAGTTCATCATTC-1_5787_BA9	-23.19795017	-24.96234115	6A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3923	8574	0.003265687	0.005131794	0	6A	IN-PV	NA	NA	NA
AGGGAGTTCTAACTTC-1_5787_BA9	-10.0746273	-6.044451391	13A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1900	2934	0.006816633	0.009543286	0	13A	IN-VIP	NA	NA	NA
AGGGATGAGCGATGAC-1_5787_BA9	-22.94852658	-22.15397098	6A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3517	6836	0.009069631	0.011117613	0	6A	IN-PV	NA	NA	NA
AGGGATGGTCAAAGAT-1_5787_BA9	25.46284839	-26.59704464	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4682	12563	0.001830773	0.004218738	0	3	EN-L5-6	NA	NA	NA
AGGTCATAGGCTATCT-1_5787_BA9	2.116204309	-17.92661907	4	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3323	6965	0.0005743	0.005455851	0	L2-3	EN-L2-3-MS	NA	NA	NA
AGGTCATCATGCGCAC-1_5787_BA9	-17.65133796	-17.58372509	6B	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2172	3904	0.000512295	0.008196721	0	6B	IN-SST	NA	NA	NA
AGGTCCGGTCGCGGTT-1_5787_BA9	-9.571872263	-13.45479322	6B	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1084	1493	0.000669792	0.020763563	0	6B	IN-SST	NA	NA	NA
AGTAGTCAGAAACGCC-1_5787_BA9	5.204736916	-2.086072692	12	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	776	1017	0.004916421	0.012782694	0	12	EN-MIX	NA	NA	NA
AGTAGTCAGCATGGCA-1_5787_BA9	-9.589934008	-36.21382953	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	981	1329	0.017306245	0.018058691	0	16	EN-PYR	NA	NA	NA
AGTAGTCGTTGTCTTT-1_5787_BA9	-8.680756575	-3.467873435	13A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1847	3034	0.002307185	0.012854318	0	13A	IN-VIP	NA	NA	NA
AGTAGTCTCTAACTGG-1_5787_BA9	-17.54033702	-21.81803804	6A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2140	3751	0.003732338	0.007464676	0	6A	IN-PV	NA	NA	NA
AGTCTTTCAACGATGG-1_5787_BA9	-17.41841704	-14.677887	6B	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2122	3473	0.002303484	0.010941549	0	6B	IN-SST	NA	NA	NA
AGTCTTTGTTTCCACC-1_5787_BA9	-18.84458806	-17.64230651	6A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2627	5182	0.000964878	0.005596295	0	6A	IN-PV	NA	NA	NA
AGTCTTTTCGTTACGA-1_5787_BA9	27.12080983	-16.88343136	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	7379	27386	0.032644417	0.010297232	0	2	EN-L4	NA	NA	NA
AGTGAGGCACGGATAG-1_5787_BA9	-7.978344779	-35.72040628	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	960	1289	0.041117145	0.013188518	0	16	EN-PYR	NA	NA	NA
AGTGAGGCAGCCACCA-1_5787_BA9	32.22505535	-6.247198992	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4052	8511	0.001057455	0.00657972	0	2	EN-L4	NA	NA	NA
AGTGAGGCATCGACGC-1_5787_BA9	9.850391366	-25.47664053	4	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5148	13306	0.008492409	0.002931009	0	L2-3	EN-L2-3-MS	NA	NA	NA
AGTGAGGGTCTTCGTC-1_5787_BA9	-19.33531691	-18.52768496	6A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2755	5205	0.004226705	0.003842459	0	6A	IN-PV	NA	NA	NA
AGTGGGAGTTAGAACA-1_5787_BA9	5.824004305	-11.94147284	4	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2350	3841	0.001041395	0.015360583	0	L2-3	EN-L2-3-MS	NA	NA	NA
AGTGTCACATGAACCT-1_5787_BA9	-12.25902103	-34.88277133	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1339	2078	0.040904716	0.012030799	0	16	EN-PYR	NA	NA	NA
AGTGTCAGTACAGCAG-1_5787_BA9	21.60231877	-24.15945027	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3771	7722	0.001295001	0.028619529	0	3	EN-L5-6	NA	NA	NA
AGTGTCAGTGCAACTT-1_5787_BA9	-12.3293976	-8.86905186	13B	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2301	3843	0.006765548	0.010408535	0	13B	IN-SV2C	NA	NA	NA
AGTGTCATCTCGGACG-1_5787_BA9	16.67917934	-29.85242019	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4968	12517	0.000719022	0.005192938	0	3	EN-L5-6	NA	NA	NA
AGTTGGTAGCTGGAAC-1_5787_BA9	-21.32268973	-16.12737053	6B	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3875	8375	0.000955224	0.00680597	0	6B	IN-SST	NA	NA	NA
AGTTGGTAGCTTCGCG-1_5787_BA9	-9.942175219	-37.16867715	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1197	1684	0.008907363	0.024346793	0	16	EN-PYR	NA	NA	NA
AGTTGGTGTCTAGCGC-1_5787_BA9	6.240605043	-3.725489616	12	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1450	2111	0.000473709	0.01657982	0	12	EN-MIX	NA	NA	NA
AGTTGGTTCGCAAACT-1_5787_BA9	-13.34868558	-10.99137956	13B	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2149	3814	0.000262192	0.004195071	0	13B	IN-SV2C	NA	NA	NA
AGTTGGTTCGGCGGTT-1_5787_BA9	17.55307423	-31.3736644	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4939	13585	0.00117777	0.004563857	0	3	EN-L5-6	NA	NA	NA
ATAACGCAGAGGACGG-1_5787_BA9	3.541974573	-16.52972451	4	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3314	6227	0.001124137	0.004335956	0	L2-3	EN-L2-3-MS	NA	NA	NA
ATAAGAGGTGCAGTAG-1_5787_BA9	8.554066127	-26.69278613	10	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4257	10122	0.000592768	0.003754199	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ATAGACCAGACATAAC-1_5787_BA9	0.991659183	-17.04469554	4	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2821	5463	0.000366099	0.005308439	0	L2-3	EN-L2-3-MS	NA	NA	NA
ATAGACCTCAGTCAGT-1_5787_BA9	-18.14630598	-14.25919796	6B	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2585	4484	0.011596789	0.011819804	0	6B	IN-SST	NA	NA	NA
ATCACGAAGTTGTCGT-1_5787_BA9	24.29805687	-20.20469941	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	7398	23080	0.010095321	0.005545927	0	3	EN-L5-6	NA	NA	NA
ATCACGACATGCCACG-1_5787_BA9	-11.89518721	-4.634398289	13A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2287	3914	0.001277466	0.007153807	0	13A	IN-VIP	NA	NA	NA
ATCACGATCTTTAGGG-1_5787_BA9	32.88021185	-2.994217478	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2817	5162	0.005230531	0.004068191	0	2	EN-L4	NA	NA	NA
ATCATCTGTGGTCTCG-1_5787_BA9	18.3518971	-9.286515017	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2281	3901	0.003076134	0.013073571	0	3	EN-L5-6	NA	NA	NA
ATCATGGGTGATGTGG-1_5787_BA9	-10.03638931	-36.8282743	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1286	1919	0.095362168	0.018759771	0	16	EN-PYR	NA	NA	NA
ATCATGGGTGGCGAAT-1_5787_BA9	-20.78987199	-24.97691307	6A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3276	6601	0.000757461	0.008332071	0	6A	IN-PV	NA	NA	NA
ATCCACCGTATAGGTA-1_5787_BA9	33.27807299	-3.398170502	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2908	5305	0.003770028	0.004147031	0	2	EN-L4	NA	NA	NA
ATCCACCGTTGGTAAA-1_5787_BA9	-7.956169594	-7.947630954	13A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1262	1752	0.001141553	0.006849315	0	13A	IN-VIP	NA	NA	NA
ATCCGAATCGAGCCCA-1_5787_BA9	-11.15340513	-6.747507576	13A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2437	4071	0.011299435	0.012036355	0	13A	IN-VIP	NA	NA	NA
ATCCGAATCTTTAGGG-1_5787_BA9	10.10357177	-26.13385636	10	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5217	14300	0.002097902	0.003846154	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ATCGAGTCAGATTGCT-1_5787_BA9	18.28897677	-25.32106832	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4604	10588	0.003777862	0.020306007	0	3	EN-L5-6	NA	NA	NA
ATCGAGTTCCCAACGG-1_5787_BA9	25.67590496	-27.42054024	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4811	12373	0.000484927	0.005253374	0	3	EN-L5-6	NA	NA	NA
ATCTACTAGCATCATC-1_5787_BA9	32.62750833	-2.868222542	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2881	5471	0.001279474	0.008407969	0	2	EN-L4	NA	NA	NA
ATCTACTCATCCGTGG-1_5787_BA9	-14.89033883	-14.7915102	6B	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1641	2572	0.00155521	0.010497667	0	6B	IN-SST	NA	NA	NA
ATCTACTTCACTTACT-1_5787_BA9	9.253898406	-23.22958824	4	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4604	11388	0.003073411	0.014401124	0	L2-3	EN-L2-3-MS	NA	NA	NA
ATCTGCCAGAGGGATA-1_5787_BA9	34.14260745	-4.23909908	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2767	5097	0.003139101	0.005885815	0	2	EN-L4	NA	NA	NA
ATCTGCCAGCAATCTC-1_5787_BA9	-19.45447551	-18.44944429	6A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3474	7713	0.000129651	0.002593025	0	6A	IN-PV	NA	NA	NA
ATCTGCCTCAACTCTT-1_5787_BA9	-10.0346616	-1.439262386	13A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2514	4591	0.004138532	0.004791984	0	13A	IN-VIP	NA	NA	NA
ATCTGCCTCTCGTATT-1_5787_BA9	12.70663279	1.762720948	12	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1045	1505	0.000664452	0.009966777	0	12	EN-MIX	NA	NA	NA
ATGAGGGAGTCCCACG-1_5787_BA9	11.3778273	-25.10295885	10	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4437	10052	0.004874652	0.008555511	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ATGAGGGCACATCCGG-1_5787_BA9	14.62484379	-5.027786646	12	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1985	2950	0.005423729	0.007457627	0	12	EN-MIX	NA	NA	NA
ATGAGGGCACATTTCT-1_5787_BA9	6.874391556	-2.437362683	12	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1059	1397	0.002863278	0.006442377	0	12	EN-MIX	NA	NA	NA
ATGAGGGGTGCTTCTC-1_5787_BA9	-10.24672426	-3.318959775	13A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2476	4151	0.003131775	0.023608769	0	13A	IN-VIP	NA	NA	NA
ATGCGATAGGAGTTTA-1_5787_BA9	29.3559695	-5.153368183	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3763	7891	0.001393993	0.007603599	0	2	EN-L4	NA	NA	NA
ATGCGATTCCACTCCA-1_5787_BA9	-17.03645028	-16.82638101	6B	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2093	3619	0.000552639	0.008013263	0	6B	IN-SST	NA	NA	NA
ATGGGAGCACAGACTT-1_5787_BA9	31.7558441	-3.436145257	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3535	7605	0.004076266	0.003813281	0	2	EN-L4	NA	NA	NA
ATGGGAGCATTTCAGG-1_5787_BA9	-6.583903703	-34.62940387	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	843	1072	0.03358209	0.012126866	0	16	EN-PYR	NA	NA	NA
ATGGGAGTCCGCGTTT-1_5787_BA9	-12.86778644	-36.79445372	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1364	2210	0.021719457	0.01719457	0	16	EN-PYR	NA	NA	NA
ATGTGTGAGCAGATCG-1_5787_BA9	-10.98412982	-6.353573982	13A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2262	3740	0.003743316	0.01684492	0	13A	IN-VIP	NA	NA	NA
ATGTGTGAGTGACTCT-1_5787_BA9	14.83401265	-31.15301385	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3890	9250	0.000216216	0.004540541	0	3	EN-L5-6	NA	NA	NA
ATGTGTGCAAATTGCC-1_5787_BA9	9.337607422	-23.67795768	4	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4619	10727	0.001398341	0.013144402	0	L2-3	EN-L2-3-MS	NA	NA	NA
ATGTGTGCACCTCGGA-1_5787_BA9	9.215609781	-23.38404944	4	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4227	9164	0.000872981	0.015058926	0	L2-3	EN-L2-3-MS	NA	NA	NA
ATGTGTGTCACTTCAT-1_5787_BA9	-7.158843068	-37.33439877	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	970	1308	0.029051988	0.017584098	0	16	EN-PYR	NA	NA	NA
ATTACTCTCCTTAATC-1_5787_BA9	-12.99840202	-17.42701802	6B	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1290	2040	0.001470588	0.009313725	0	6B	IN-SST	NA	NA	NA
ATTATCCAGTGTTGAA-1_5787_BA9	31.30698292	-3.383426631	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3355	7285	0.000549073	0.003980782	0	2	EN-L4	NA	NA	NA
ATTCTACCAGCTTAAC-1_5787_BA9	-8.412359228	-31.19094527	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1015	1457	0.06863418	0.014413178	0	16	EN-PYR	NA	NA	NA
ATTGGACAGCGTTTAC-1_5787_BA9	-16.46339629	-9.417665708	13B	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3132	6039	0.002649445	0.003974168	0	13B	IN-SV2C	NA	NA	NA
ATTGGACAGCTGTTCA-1_5787_BA9	27.44434764	-15.3688375	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	8252	31903	0.013258941	0.008463154	0	2	EN-L4	NA	NA	NA
ATTGGACCAGCGTCCA-1_5787_BA9	17.35238045	-30.09242729	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5885	17181	0.001687911	0.004074268	0	3	EN-L5-6	NA	NA	NA
ATTGGTGAGCAATCTC-1_5787_BA9	30.4991242	-1.066237042	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3859	8601	0.002209045	0.002674108	0	2	EN-L4	NA	NA	NA
ATTGGTGCATCACCCT-1_5787_BA9	-7.925983439	-2.397155531	13A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1936	3413	0.000585995	0.004980955	0	13A	IN-VIP	NA	NA	NA
ATTGGTGTCAAGAAGT-1_5787_BA9	4.347882591	-18.54242005	4	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3204	6417	0	0.013246065	0	L2-3	EN-L2-3-MS	NA	NA	NA
ATTTCTGCAACGCACC-1_5787_BA9	16.04398482	-29.88077238	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4167	10803	0.00148107	0.005739147	0	3	EN-L5-6	NA	NA	NA
ATTTCTGCAATGGACG-1_5787_BA9	16.23742568	-31.25939629	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4950	14536	0.000343974	0.003990094	0	3	EN-L5-6	NA	NA	NA
ATTTCTGCACAGGCCT-1_5787_BA9	-29.68290168	-12.53287623	9	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	819	1127	0	0.002661934	0	9	OPC	NA	NA	NA
CAACCAAAGGTGATTA-1_5787_BA9	-11.28252065	29.24620091	17	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1201	1723	0.049332559	0.004062681	0	oligos	OL-MS-2	NA	NA	NA
CAACCAAGTATAGGTA-1_5787_BA9	-10.44653129	-35.39938205	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1045	1471	0.029911625	0.014955812	0	16	EN-PYR	NA	NA	NA
CAACCAAGTGCCTGTG-1_5787_BA9	18.34395151	-30.65205396	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5823	16384	0.002624512	0.00402832	0	3	EN-L5-6	NA	NA	NA
CAACTAGGTCGCTTTC-1_5787_BA9	-9.039919085	-4.28576166	13A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2103	3769	0.000265322	0.005306447	0	13A	IN-VIP	NA	NA	NA
CAACTAGTCTCGTTTA-1_5787_BA9	-18.63925585	-17.35062377	6B	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2490	4608	0.001519097	0.004557292	0	6B	IN-SST	NA	NA	NA
CAAGAAAAGCGTAATA-1_5787_BA9	17.57192466	-29.86736689	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5871	16376	0.001404494	0.005740107	0	3	EN-L5-6	NA	NA	NA
CAAGAAATCAAAGTAG-1_5787_BA9	24.73443883	-26.54207965	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5200	12970	0.001464919	0.007864302	0	3	EN-L5-6	NA	NA	NA
CAAGGCCCATATGGTC-1_5787_BA9	28.3341825	-5.611387199	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4749	12448	0.00441838	0.003775707	0	2	EN-L4	NA	NA	NA
CAAGGCCGTAGCTCCG-1_5787_BA9	9.011462607	-31.39356732	10	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5094	13912	0.000862565	0.004097182	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CAAGGCCGTTATTCTC-1_5787_BA9	18.81035642	-17.57044683	4	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	7145	23753	0.001768198	0.005515093	0	L2-3	EN-L2-3-MS	NA	NA	NA
CAAGGCCTCATTGCGA-1_5787_BA9	28.0721995	-5.608421402	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5074	14166	0.000423549	0.00409431	0	2	EN-L4	NA	NA	NA
CAAGGCCTCTACGAGT-1_5787_BA9	33.33658182	-3.84701603	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3061	5454	0.008250825	0.006967363	0	2	EN-L4	NA	NA	NA
CAAGTTGGTCAGGACA-1_5787_BA9	32.17905081	-9.835091083	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3553	7190	0.017524339	0.013212796	0	2	EN-L4	NA	NA	NA
CAAGTTGGTGGTCTCG-1_5787_BA9	32.76256273	-3.126498802	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3219	6328	0.000790139	0.009007585	0	2	EN-L4	NA	NA	NA
CAAGTTGTCACTTACT-1_5787_BA9	-1.82266508	30.62665013	17	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	927	1275	0.001568627	0.004705882	0	oligos	OL-MS-2	NA	NA	NA
CACAAACAGTACGATA-1_5787_BA9	18.83778471	-27.79894743	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5033	12286	0.000895328	0.009930002	0	3	EN-L5-6	NA	NA	NA
CACAAACCATCACAAC-1_5787_BA9	7.234912105	-29.0780384	10	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5225	15062	0.000730315	0.003452397	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CACAAACCATCCGTGG-1_5787_BA9	16.78492904	-29.84024119	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4634	12058	0.012274009	0.003814895	0	3	EN-L5-6	NA	NA	NA
CACAAACCATTGTGCA-1_5787_BA9	8.885059901	-26.35494028	4	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	6001	16619	0.002527228	0.003068777	0	L2-3	EN-L2-3-MS	NA	NA	NA
CACACAACACGGATAG-1_5787_BA9	-13.97874196	-36.26201993	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2082	3525	0.028368794	0.013900709	0	16	EN-PYR	NA	NA	NA
CACACAATCCCAAGAT-1_5787_BA9	-17.16651998	-22.0128987	6A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1895	3249	0.000923361	0.004001231	0	6A	IN-PV	NA	NA	NA
CACACAATCCGTACAA-1_5787_BA9	-26.82699234	-6.330342239	9	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1178	1692	0	0.004728132	0	9	OPC	NA	NA	NA
CACACCTCAGTTCCCT-1_5787_BA9	26.13001352	-27.04301165	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5897	18777	0.00079885	0.003887735	0	3	EN-L5-6	NA	NA	NA
CACACCTGTCTAGTGT-1_5787_BA9	-19.17230376	-16.88480903	6B	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2536	4661	0.003218194	0.004290925	0	6B	IN-SST	NA	NA	NA
CACACCTTCAGTGTTG-1_5787_BA9	19.98245619	-11.19178049	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2982	6160	0.005357143	0.003896104	0	3	EN-L5-6	NA	NA	NA
CACACCTTCCGGGTGT-1_5787_BA9	7.891847288	-30.85937062	10	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	6162	21128	0.000662628	0.003644453	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CACACCTTCTAACTGG-1_5787_BA9	16.60646673	-29.93895318	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	6824	24503	0.000775415	0.007101171	0	3	EN-L5-6	NA	NA	NA
CACACTCAGCTTTGGT-1_5787_BA9	-8.321521628	-31.6604102	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	973	1374	0.045851528	0.010917031	0	16	EN-PYR	NA	NA	NA
CACACTCCAGTCTTCC-1_5787_BA9	9.019110173	-24.1503612	4	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5204	12776	0.002426425	0.005009393	0	L2-3	EN-L2-3-MS	NA	NA	NA
CACACTCGTACCCAAT-1_5787_BA9	22.71565548	-26.66405647	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4937	13025	0.00084453	0.009673704	0	3	EN-L5-6	NA	NA	NA
CACACTCGTTCGTCTC-1_5787_BA9	-15.18622868	-14.75719232	6B	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1766	2642	0.001892506	0.020439061	0	6B	IN-SST	NA	NA	NA
CACAGTATCTATCCCG-1_5787_BA9	31.24996779	-2.425656086	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3444	7472	0.000133833	0.003747323	0	2	EN-L4	NA	NA	NA
CACATAGCATCTCGCT-1_5787_BA9	32.54608158	-8.433397881	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3698	7725	0.001165049	0.008414239	0	2	EN-L4	NA	NA	NA
CACATAGCATTCACTT-1_5787_BA9	-16.58191152	-9.150234062	13B	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2925	5587	0.003400752	0.006622517	0	13B	IN-SV2C	NA	NA	NA
CACATAGGTGCAGACA-1_5787_BA9	30.70489062	-0.786810964	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3403	7087	0.000564414	0.005926344	0	2	EN-L4	NA	NA	NA
CACATAGGTTAAAGTG-1_5787_BA9	-27.53392501	9.61019313	8	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	819	1087	0.001839926	0.008279669	0	8	Astrocytes	NA	NA	NA
CACATTTAGTGGCACA-1_5787_BA9	24.00615607	-26.17754204	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3447	7910	0.000379267	0.003034134	0	3	EN-L5-6	NA	NA	NA
CACATTTTCAGCAACT-1_5787_BA9	-7.688656239	-34.77791894	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	966	1251	0.011990408	0.013589129	0	16	EN-PYR	NA	NA	NA
CACCACTCACAGACTT-1_5787_BA9	21.74199269	-24.55463147	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4608	11184	0.001072961	0.019492132	0	3	EN-L5-6	NA	NA	NA
CACCAGGAGGCATGTG-1_5787_BA9	18.25877394	-9.110844641	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2157	3828	0.000261233	0.012539185	0	3	EN-L5-6	NA	NA	NA
CACCAGGGTCAAGCGA-1_5787_BA9	16.98619102	-27.04909241	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4218	9649	0.001969116	0.007151	0	3	EN-L5-6	NA	NA	NA
CACCAGGGTCGCGTGT-1_5787_BA9	22.26426469	-19.07359617	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	6702	20710	0.018638339	0.006711733	0	3	EN-L5-6	NA	NA	NA
CACCAGGTCATGCATG-1_5787_BA9	-9.423713272	-14.10872191	6B	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1152	1569	0	0.008922881	0	6B	IN-SST	NA	NA	NA
CACCTTGGTCGACTGC-1_5787_BA9	-7.427539908	-33.94098195	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	965	1271	0.024390244	0.014162077	0	16	EN-PYR	NA	NA	NA
CACCTTGTCCCTAACC-1_5787_BA9	19.22548334	-28.25892672	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5090	15449	0.000970937	0.008997346	0	3	EN-L5-6	NA	NA	NA
CACCTTGTCGTTGCCT-1_5787_BA9	13.79681581	-4.677357432	12	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1910	3207	0.001247272	0.009042719	0	12	EN-MIX	NA	NA	NA
CACCTTGTCTCGAGTA-1_5787_BA9	27.71466282	-4.073429194	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3885	9193	0.000761449	0.005438921	0	2	EN-L4	NA	NA	NA
CACTCCACACTATCTT-1_5787_BA9	-8.633004625	-33.56292316	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1023	1489	0.089321692	0.013431833	0	16	EN-PYR	NA	NA	NA
CACTCCAGTTGGTAAA-1_5787_BA9	24.87730587	7.704439768	15A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2342	3618	0.016860144	0.017412935	0	15A	Endo cells	NA	NA	NA
CAGAATCCAATGAATG-1_5787_BA9	-20.75038157	-24.8686574	6A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2963	5660	0.002826855	0.006713781	0	6A	IN-PV	NA	NA	NA
CAGAATCCAATGGTCT-1_5787_BA9	8.614285512	-28.09709841	10	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	6405	20764	0.000915045	0.003900982	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CAGAATCGTACGAAAT-1_5787_BA9	-18.53020237	-17.16301675	6B	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2757	5531	0.000361598	0.003073585	0	6B	IN-SST	NA	NA	NA
CAGAATCGTTGTGGAG-1_5787_BA9	31.6123896	-3.577881328	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3705	7762	0.003349652	0.004766813	0	2	EN-L4	NA	NA	NA
CAGAGAGAGCAGCGTA-1_5787_BA9	29.27877704	-18.65198264	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	9564	43733	0.020350765	0.010929961	0	2	EN-L4	NA	NA	NA
CAGAGAGAGTAATCCC-1_5787_BA9	-6.674538638	-29.93851186	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	974	1460	0.156849315	0.009589041	0	16	EN-PYR	NA	NA	NA
CAGAGAGCACACCGCA-1_5787_BA9	18.30599982	-23.55493445	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4258	9479	0.000421985	0.045890917	0	3	EN-L5-6	NA	NA	NA
CAGAGAGCATCCTTGC-1_5787_BA9	21.75240508	-24.22517615	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4671	11428	0.001137557	0.02240112	0	3	EN-L5-6	NA	NA	NA
CAGATCACAGATAATG-1_5787_BA9	-15.32815027	-14.54305476	6B	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1925	3108	0.008043758	0.017052767	0	6B	IN-SST	NA	NA	NA
CAGATCAGTTACCGAT-1_5787_BA9	1.845169491	-17.90173624	4	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3012	6240	0.001442308	0.004967949	0	L2-3	EN-L2-3-MS	NA	NA	NA
CAGATCATCCTTTACA-1_5787_BA9	-18.67082154	-15.7426112	6B	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2390	4008	0.004241517	0.011976048	0	6B	IN-SST	NA	NA	NA
CAGCAGCCAAGCGCTC-1_5787_BA9	32.03019588	-1.605162088	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2953	5928	0.001012146	0.004723347	0	2	EN-L4	NA	NA	NA
CAGCAGCCAGATGAGC-1_5787_BA9	17.39083883	-29.21275517	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	6148	18167	0.001045852	0.005669621	0	3	EN-L5-6	NA	NA	NA
CAGCAGCTCGGCGCAT-1_5787_BA9	23.63423523	-10.13935073	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3882	8637	0.000810467	0.0048628	0	3	EN-L5-6	NA	NA	NA
CAGCATAGTGACGGTA-1_5787_BA9	26.50056194	5.330746177	15BA	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1188	1638	0.043956044	0.01953602	0	15BA	Stromal cells	NA	NA	NA
CAGCCGAAGAGGTACC-1_5787_BA9	16.46826133	-28.27352096	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4086	9369	0.001387555	0.006617569	0	3	EN-L5-6	NA	NA	NA
CAGCCGAAGCTACCTA-1_5787_BA9	5.75615199	-17.69459265	4	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3779	8042	0.002859985	0.011688635	0	L2-3	EN-L2-3-MS	NA	NA	NA
CAGCCGAGTCTAGCGC-1_5787_BA9	-11.29113068	-1.619386077	13A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2937	5004	0.002597922	0.007194245	0	13A	IN-VIP	NA	NA	NA
CAGCCGATCCATGAAC-1_5787_BA9	12.40898904	1.154030417	12	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	777	1033	0.003872217	0.001936108	0	12	EN-MIX	NA	NA	NA
CAGCCGATCTTCGGTC-1_5787_BA9	-21.0376302	-24.95809728	6A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3105	6217	0.003538684	0.005308026	0	6A	IN-PV	NA	NA	NA
CAGCGACGTCAACTGT-1_5787_BA9	8.431021414	-31.83977988	10	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4960	13617	0.00029375	0.002790629	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CAGCGACGTCCCGACA-1_5787_BA9	17.30859807	-4.193278046	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1558	2426	0.002061006	0.009480627	0	3	EN-L5-6	NA	NA	NA
CAGCGACGTGTAACGG-1_5787_BA9	28.09727945	-13.00605739	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5071	12365	0.022482814	0.00849171	0	2	EN-L4	NA	NA	NA
CAGCGACTCCAAACAC-1_5787_BA9	-21.06986608	-16.27759706	6A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3857	8144	0.002701375	0.006385069	0	6A	IN-PV	NA	NA	NA
CAGCTAATCGGAGGTA-1_5787_BA9	9.187247198	-23.88770388	4	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4626	10242	0.000781097	0.009568444	0	L2-3	EN-L2-3-MS	NA	NA	NA
CAGCTAATCTACCTGC-1_5787_BA9	12.07362016	-24.86145867	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5512	14091	0.001419346	0.022780498	0	3	EN-L5-6	NA	NA	NA
CAGCTGGAGAAGGCCT-1_5787_BA9	9.145852912	-26.3076287	10	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5122	13843	0.00325074	0.003900889	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CAGCTGGAGACTAAGT-1_5787_BA9	-10.15593176	-37.47847824	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1352	1958	0.072522983	0.020429009	0	16	EN-PYR	NA	NA	NA
CAGCTGGAGGTAGCTG-1_5787_BA9	33.3222555	-5.15279278	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3359	6667	0.002699865	0.010349483	0	2	EN-L4	NA	NA	NA
CAGCTGGGTCGACTGC-1_5787_BA9	-31.21444796	-10.48440786	9	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	988	1380	0.002898551	0.00942029	0	9	OPC	NA	NA	NA
CAGCTGGTCACGAAGG-1_5787_BA9	16.7312523	-27.96747107	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3634	8309	0.007100734	0.003851246	0	3	EN-L5-6	NA	NA	NA
CAGTAACAGCACCGTC-1_5787_BA9	32.55254319	-2.469766154	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3217	6600	0.001060606	0.012272727	0	2	EN-L4	NA	NA	NA
CAGTAACAGTCACGCC-1_5787_BA9	4.376804975	-16.22841127	4	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2738	4844	0.001445087	0.015895954	0	L2-3	EN-L2-3-MS	NA	NA	NA
CAGTAACGTCAATACC-1_5787_BA9	18.97964597	-7.410788596	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2354	4334	0.000461467	0.004153207	0	3	EN-L5-6	NA	NA	NA
CAGTAACGTGACGCCT-1_5787_BA9	-13.04787701	-35.9129022	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1548	2557	0.039499413	0.012514666	0	16	EN-PYR	NA	NA	NA
CAGTCCTAGTTCGCAT-1_5787_BA9	-14.84521812	-10.96728106	13B	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2379	4412	0.000679964	0.001586582	0	13B	IN-SV2C	NA	NA	NA
CAGTCCTGTCTCATCC-1_5787_BA9	33.23575264	-3.14926069	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2545	4481	0.004909618	0.012274046	0	2	EN-L4	NA	NA	NA
CAGTCCTGTGCACTTA-1_5787_BA9	31.40260756	-10.97106693	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3794	8081	0.003464918	0.009033535	0	2	EN-L4	NA	NA	NA
CAGTCCTTCAACGGCC-1_5787_BA9	-10.03812294	-35.49994977	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1051	1476	0.02100271	0.014905149	0	16	EN-PYR	NA	NA	NA
CAGTCCTTCGAACTGT-1_5787_BA9	24.43666465	-28.28053052	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3491	8056	0.000496524	0.004344588	0	3	EN-L5-6	NA	NA	NA
CATATGGTCCGTCATC-1_5787_BA9	-18.53154525	9.933791459	8	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	831	1094	0.00274223	0.006398537	0	8	Astrocytes	NA	NA	NA
CATATGGTCGAGCCCA-1_5787_BA9	17.82243145	-30.52777271	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	6724	21693	0.001843913	0.005116858	0	3	EN-L5-6	NA	NA	NA
CATATTCCACTTGGAT-1_5787_BA9	5.403316754	-17.82140252	4	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3351	6462	0.000464253	0.020272361	0	L2-3	EN-L2-3-MS	NA	NA	NA
CATATTCCATGGAATA-1_5787_BA9	3.351959671	-18.46417341	4	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3096	6282	0.000795925	0.007800064	0	L2-3	EN-L2-3-MS	NA	NA	NA
CATATTCGTCGCATCG-1_5787_BA9	25.4812155	-26.87939543	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4169	9875	0.001417722	0.005164557	0	3	EN-L5-6	NA	NA	NA
CATCAGAGTAAATGAC-1_5787_BA9	8.676397395	-27.92984692	10	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	6643	21350	0.000983607	0.003512881	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CATCAGAGTCAGGACA-1_5787_BA9	16.85849581	-29.70716658	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5541	14969	0.000601243	0.006680473	0	3	EN-L5-6	NA	NA	NA
CATCCACAGATGCGAC-1_5787_BA9	-12.54439631	-34.79418001	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1458	2204	0.046279492	0.013611615	0	16	EN-PYR	NA	NA	NA
CATCCACAGCAGATCG-1_5787_BA9	-15.01050655	-14.55452729	6B	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1687	2674	0.010845176	0.013836948	0	6B	IN-SST	NA	NA	NA
CATCCACCAGGGAGAG-1_5787_BA9	-14.09697348	-16.9380496	6B	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1588	2460	0.001219512	0.005691057	0	6B	IN-SST	NA	NA	NA
CATCCACGTGGTACAG-1_5787_BA9	29.02362948	-5.91544989	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5298	13546	0.000516758	0.005684335	0	2	EN-L4	NA	NA	NA
CATCCACTCGCGTTTC-1_5787_BA9	32.42260336	-6.153194582	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3542	6947	0.001295523	0.009068663	0	2	EN-L4	NA	NA	NA
CATCCACTCTTGTCAT-1_5787_BA9	7.587634959	-18.10362259	4	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4339	9521	0.000420124	0.024682281	0	L2-3	EN-L2-3-MS	NA	NA	NA
CATCGAAAGAACTGTA-1_5787_BA9	-5.884436502	-33.83989108	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	918	1159	0.012942192	0.019844694	0	16	EN-PYR	NA	NA	NA
CATCGAAAGGGAACGG-1_5787_BA9	31.14097496	-6.674865227	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4533	10397	0.000480908	0.007309801	0	2	EN-L4	NA	NA	NA
CATCGAACAAAGCAAT-1_5787_BA9	-17.51778565	-9.298427074	13B	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4040	8799	0.010228435	0.013296966	0	13B	IN-SV2C	NA	NA	NA
CATCGAATCTTGTCAT-1_5787_BA9	-13.47139289	7.261179595	8	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1028	1274	0.022762951	0.010204082	0	8	Astrocytes	NA	NA	NA
CATCGGGAGTCAAGGC-1_5787_BA9	25.55792913	-26.19431653	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5072	12819	0.00195023	0.0059287	0	3	EN-L5-6	NA	NA	NA
CATCGGGAGTGAACAT-1_5787_BA9	25.38242113	-26.63688017	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5415	14076	0.001349815	0.004759875	0	3	EN-L5-6	NA	NA	NA
CATCGGGCATCAGTAC-1_5787_BA9	31.72812802	-3.080549295	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3475	7002	0.002856327	0.004855755	0	2	EN-L4	NA	NA	NA
CATCGGGGTATTCGTG-1_5787_BA9	-20.51891034	-18.28968937	6A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4167	9437	0.001907386	0.005192328	0	6A	IN-PV	NA	NA	NA
CATCGGGGTCTTGCGG-1_5787_BA9	6.110988665	-13.23247974	4	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2748	4974	0.000804182	0.01628468	0	L2-3	EN-L2-3-MS	NA	NA	NA
CATCGGGGTGTGGCTC-1_5787_BA9	-9.147310782	-5.924172877	13A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1795	2685	0.001862197	0.006703911	0	13A	IN-VIP	NA	NA	NA
CATCGGGTCAAGGCTT-1_5787_BA9	28.7930892	-5.046981644	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4204	10076	0.002580389	0.006947201	0	2	EN-L4	NA	NA	NA
CATCGGGTCTCAACTT-1_5787_BA9	5.934336097	-12.25892836	4	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2440	4316	0.000695088	0.018072289	0	L2-3	EN-L2-3-MS	NA	NA	NA
CATGACACATGTCCTC-1_5787_BA9	23.08083467	-9.308391389	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3430	7886	0.000887649	0.00380421	0	3	EN-L5-6	NA	NA	NA
CATGACATCTGCTTGC-1_5787_BA9	17.8813682	-7.635790352	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1834	3029	0.00330142	0.003961704	0	3	EN-L5-6	NA	NA	NA
CATGGCGGTACTCGCG-1_5787_BA9	18.65191341	-10.31172474	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2273	3957	0.003538034	0.015415719	0	3	EN-L5-6	NA	NA	NA
CATTATCCAAGGCTCC-1_5787_BA9	-6.250978031	-31.38357426	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	825	1142	0.11295972	0.015761821	0	16	EN-PYR	NA	NA	NA
CATTATCGTGTGAAAT-1_5787_BA9	15.35170007	-4.319289113	12	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1453	2287	0.000874508	0.014429383	0	12	EN-MIX	NA	NA	NA
CATTATCGTTTAGGAA-1_5787_BA9	5.763385009	-9.890683043	12	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1765	2710	0.000738007	0.01697417	0	12	EN-MIX	NA	NA	NA
CATTATCTCGCATGGC-1_5787_BA9	-10.05590475	-1.892279545	13A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2127	3607	0.001108955	0.009703355	0	13A	IN-VIP	NA	NA	NA
CATTATCTCGTCACGG-1_5787_BA9	-22.29026344	-16.25990644	6B	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3468	6782	0.003096432	0.006340313	0	6B	IN-SST	NA	NA	NA
CATTCGCAGCTACCTA-1_5787_BA9	10.26650549	-27.18959129	4	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4655	11115	0.000359874	0.016464238	0	L2-3	EN-L2-3-MS	NA	NA	NA
CATTCGCAGTGCCAGA-1_5787_BA9	19.69695031	-17.42193063	4	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	7031	21116	0.003978026	0.006866831	0	L2-3	EN-L2-3-MS	NA	NA	NA
CATTCGCCAATAGAGT-1_5787_BA9	-28.13189623	10.60577826	8	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	953	1352	0	0.00147929	0	8	Astrocytes	NA	NA	NA
CATTCGCCAGTGACAG-1_5787_BA9	23.49457154	-25.90683268	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3110	7068	0.000990379	0.010469723	0	3	EN-L5-6	NA	NA	NA
CATTCGCGTACTTAGC-1_5787_BA9	30.42834443	-5.338355023	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3765	8058	0.000372301	0.010920824	0	2	EN-L4	NA	NA	NA
CATTCGCTCGCAAACT-1_5787_BA9	15.26704148	-27.33838731	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3955	9508	0.00252419	0.004417333	0	3	EN-L5-6	NA	NA	NA
CCAATCCGTTCCACTC-1_5787_BA9	-1.920370238	36.48985253	17	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	781	1021	0.001958864	0.003917728	0	oligos	OL-MS-2	NA	NA	NA
CCAATCCTCAGGTAAA-1_5787_BA9	9.321721333	-29.53182393	10	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	7630	25537	0.000978972	0.003132709	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CCACCTACAGTGAGTG-1_5787_BA9	17.13642929	-29.2900645	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4662	11383	0.001054204	0.004919617	0	3	EN-L5-6	NA	NA	NA
CCACGGATCTGTTTGT-1_5787_BA9	16.74374226	-31.53937188	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5461	17316	0.000981751	0.003522754	0	3	EN-L5-6	NA	NA	NA
CCACTACAGATCGGGT-1_5787_BA9	29.12813337	-17.70819694	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5096	12090	0.023325062	0.011000827	0	2	EN-L4	NA	NA	NA
CCACTACAGGAATCGC-1_5787_BA9	21.25694386	-26.89864389	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2961	5808	0.000688705	0.013085399	0	3	EN-L5-6	NA	NA	NA
CCAGCGAAGACTGGGT-1_5787_BA9	6.641528125	-16.29076516	4	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3187	5630	0.001598579	0.018117229	0	L2-3	EN-L2-3-MS	NA	NA	NA
CCAGCGACAAGTCATC-1_5787_BA9	-11.15691522	-5.927239783	13A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2482	4212	0.002611586	0.008547009	0	13A	IN-VIP	NA	NA	NA
CCAGCGATCCAGGGCT-1_5787_BA9	16.7132139	-29.52389489	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4689	11481	0.002438812	0.005922829	0	3	EN-L5-6	NA	NA	NA
CCATGTCAGACGCTTT-1_5787_BA9	8.470071101	-26.64460762	10	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5955	18311	0.002239091	0.003549779	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CCATGTCAGATGTAAC-1_5787_BA9	-10.37302973	-1.305510234	13A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2522	4328	0.005314233	0.008548983	0	13A	IN-VIP	NA	NA	NA
CCATGTCGTCAGCTAT-1_5787_BA9	-21.43796559	-28.40858657	6A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4533	10437	0.000287439	0.004790649	0	6A	IN-PV	NA	NA	NA
CCATGTCTCCTTAATC-1_5787_BA9	26.27295478	7.63813172	15A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1554	2230	0.018834081	0.028251121	0	15A	Endo cells	NA	NA	NA
CCATTCGCAAGCTGTT-1_5787_BA9	-15.17756654	-14.58849826	6B	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1825	2894	0.003800968	0.014512785	0	6B	IN-SST	NA	NA	NA
CCATTCGGTTCCGTCT-1_5787_BA9	28.90902118	-5.881600493	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4524	10566	0.001798221	0.005016089	0	2	EN-L4	NA	NA	NA
CCCAGTTAGAATTGTG-1_5787_BA9	24.60767396	8.161466871	15A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2999	5255	0.026260704	0.022074215	0	15A	Endo cells	NA	NA	NA
CCCAGTTAGAGTTGGC-1_5787_BA9	-17.57104737	-14.57874924	6B	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2398	4051	0.02443841	0.011848926	0	6B	IN-SST	NA	NA	NA
CCCAGTTAGGAATGGA-1_5787_BA9	-30.26645883	-11.7047533	9	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	870	1161	0.003445306	0.005167959	0	9	OPC	NA	NA	NA
CCCAGTTAGGTGGGTT-1_5787_BA9	17.23611528	-30.780856	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5625	16358	0.001344908	0.003178873	0	3	EN-L5-6	NA	NA	NA
CCCAGTTGTCATGCAT-1_5787_BA9	14.88470853	-4.867502723	12	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1705	2790	0.001433692	0.010752688	0	12	EN-MIX	NA	NA	NA
CCCATACAGTCAAGCG-1_5787_BA9	-10.08235006	-36.80036294	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1112	1644	0.035279805	0.013990268	0	16	EN-PYR	NA	NA	NA
CCCTCCTAGTACGTAA-1_5787_BA9	24.62964658	6.548668626	15A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1641	2409	0.02200083	0.01203819	0	15A	Endo cells	NA	NA	NA
CCCTCCTTCGTCCAGG-1_5787_BA9	17.57283401	-31.30211627	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	6156	21275	0.000893067	0.004606345	0	3	EN-L5-6	NA	NA	NA
CCCTCCTTCTTGTATC-1_5787_BA9	14.4574712	-21.86148406	4	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	8205	35836	0.017189418	0.004464784	0	L2-3	EN-L2-3-MS	NA	NA	NA
CCGGGATAGGATATAC-1_5787_BA9	-28.15588358	-12.69761729	9	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	832	1030	0.001941748	0.006796117	0	9	OPC	NA	NA	NA
CCGGGATGTTACGACT-1_5787_BA9	-9.654329509	-15.17506156	6B	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	849	1096	0.000912409	0.002737226	0	6B	IN-SST	NA	NA	NA
CCGGGATTCCTCCTAG-1_5787_BA9	3.764599287	-5.554995523	12	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1078	1640	0.007926829	0.001829268	0	12	EN-MIX	NA	NA	NA
CCGGTAGTCGTGGGAA-1_5787_BA9	-20.6905758	-25.4702476	6A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3607	7594	0.000263366	0.005267316	0	6A	IN-PV	NA	NA	NA
CCGTGGACATAACCTG-1_5787_BA9	-14.21744722	-22.2749391	6A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1386	2210	0.001809955	0.004072398	0	6A	IN-PV	NA	NA	NA
CCGTGGAGTGATAAGT-1_5787_BA9	-9.601850806	-35.87909127	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	958	1430	0.006993007	0.006293706	0	16	EN-PYR	NA	NA	NA
CCGTTCACACCACCAG-1_5787_BA9	-19.42683633	-17.35896118	6A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2746	4800	0.001041667	0.00875	0	6A	IN-PV	NA	NA	NA
CCGTTCATCAAAGACA-1_5787_BA9	-16.89052309	-9.717160591	13B	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3487	7249	0.004828252	0.004690302	0	13B	IN-SV2C	NA	NA	NA
CCGTTCATCAGTGTTG-1_5787_BA9	33.90311618	-8.200744347	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3912	7979	0.002882567	0.011906254	0	2	EN-L4	NA	NA	NA
CCGTTCATCGGTGTCG-1_5787_BA9	-7.351971745	-36.14236844	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	932	1432	0.019553073	0.012569832	0	16	EN-PYR	NA	NA	NA
CCTAAAGGTCAATGTC-1_5787_BA9	-27.65246745	-10.21516343	9	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	932	1216	0.001644737	0.009046053	0	9	OPC	NA	NA	NA
CCTACACAGCTGAAAT-1_5787_BA9	8.928326946	-24.58222414	4	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4946	12821	0.00077997	0.006239763	0	L2-3	EN-L2-3-MS	NA	NA	NA
CCTACCACAGCTGTAT-1_5787_BA9	-8.170376498	9.048429962	5	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1109	1475	0.021694915	0.010169492	0	oligos	OL-MS-1	NA	NA	NA
CCTACCATCCGATATG-1_5787_BA9	-26.84890136	11.86605759	8	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	949	1394	0.00071736	0.005738881	0	8	Astrocytes	NA	NA	NA
CCTAGCTAGTGTCCCG-1_5787_BA9	8.617107407	-29.89170697	10	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5008	13672	0.000585138	0.003437683	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CCTAGCTCAAGGCTCC-1_5787_BA9	27.64410406	-6.294986998	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5749	18396	0.000706675	0.002935421	0	2	EN-L4	NA	NA	NA
CCTAGCTCATTCGACA-1_5787_BA9	-16.83486505	-15.60130964	6B	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2001	3314	0.009957755	0.008147254	0	6B	IN-SST	NA	NA	NA
CCTCAGTCACCAGTTA-1_5787_BA9	-27.57442176	12.48397486	8	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	963	1445	0	0.003460208	0	8	Astrocytes	NA	NA	NA
CCTCAGTCATCGGAAG-1_5787_BA9	16.82242256	-29.90753716	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4874	12749	0.00094125	0.004627814	0	3	EN-L5-6	NA	NA	NA
CCTCTGAAGGCCCTCA-1_5787_BA9	-19.66374765	-18.95149544	6A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3504	7934	0.002142677	0.002394757	0	6A	IN-PV	NA	NA	NA
CCTCTGAGTAGCGTAG-1_5787_BA9	18.02767195	-10.3803873	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2495	4656	0.003865979	0.025343643	0	3	EN-L5-6	NA	NA	NA
CCTCTGATCGTCCAGG-1_5787_BA9	22.1260345	-24.03869348	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3870	8327	0.002281734	0.012609583	0	3	EN-L5-6	NA	NA	NA
CCTTACGAGTCGATAA-1_5787_BA9	-20.4815654	-24.78321458	6A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3804	8376	0.000835721	0.005850048	0	6A	IN-PV	NA	NA	NA
CCTTACGCATAGACTC-1_5787_BA9	25.9500825	-27.42456192	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5031	14203	0.000563261	0.002957122	0	3	EN-L5-6	NA	NA	NA
CCTTACGGTGATGTCT-1_5787_BA9	-29.93411091	-12.85485826	9	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	872	1166	0.000857633	0.005145798	0	9	OPC	NA	NA	NA
CCTTACGTCGCCAGCA-1_5787_BA9	21.49881211	-20.97168728	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	7440	24698	0.004656247	0.005627986	0	3	EN-L5-6	NA	NA	NA
CCTTCCCCAGCCAGAA-1_5787_BA9	-22.28676357	14.60437238	8	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1078	1606	0.00498132	0.00249066	0	8	Astrocytes	NA	NA	NA
CCTTCCCCAGCGAACA-1_5787_BA9	4.387332094	-19.03491056	4	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4270	10803	0.001110803	0.014440433	0	L2-3	EN-L2-3-MS	NA	NA	NA
CCTTCCCTCGAATGGG-1_5787_BA9	13.38844519	-28.48439719	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2570	5209	0.000383951	0.00211173	0	3	EN-L5-6	NA	NA	NA
CCTTCGAAGACTCGGA-1_5787_BA9	-25.85906529	-10.236581	9	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	900	1142	0.003502627	0.003502627	0	9	OPC	NA	NA	NA
CCTTCGAGTTCACGGC-1_5787_BA9	-23.71115764	-21.44303264	6A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3792	8005	0.019237976	0.009244222	0	6A	IN-PV	NA	NA	NA
CCTTTCTAGCTGAACG-1_5787_BA9	16.70949717	-30.16066141	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4761	12616	0.003249841	0.00554851	0	3	EN-L5-6	NA	NA	NA
CCTTTCTCATGAACCT-1_5787_BA9	-18.61699133	-21.13644142	6A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2454	4589	0.001961212	0.008716496	0	6A	IN-PV	NA	NA	NA
CCTTTCTGTCACTGGC-1_5787_BA9	31.10772735	-3.468088612	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3871	9314	0.001073653	0.005905089	0	2	EN-L4	NA	NA	NA
CCTTTCTGTCAGGACA-1_5787_BA9	25.51670044	-26.49768684	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4663	12339	0.000486263	0.004295324	0	3	EN-L5-6	NA	NA	NA
CGAACATCATCGTCGG-1_5787_BA9	-14.28403991	-20.30030096	6A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1761	3020	0.000662252	0.001655629	0	6A	IN-PV	NA	NA	NA
CGAACATGTCGCCATG-1_5787_BA9	9.389140448	-23.12629008	4	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5371	13585	0.002061097	0.013986014	0	L2-3	EN-L2-3-MS	NA	NA	NA
CGAACATGTTCCGGCA-1_5787_BA9	18.65661383	-0.126335328	12	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1268	1903	0.003678403	0.001576458	0	12	EN-MIX	NA	NA	NA
CGAATGTCAAGGTTCT-1_5787_BA9	9.615933618	-25.70217117	4	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5920	17574	0.001593263	0.008023216	0	L2-3	EN-L2-3-MS	NA	NA	NA
CGAATGTCATGCAATC-1_5787_BA9	17.9784058	-10.29054681	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2298	3837	0.001042481	0.029710711	0	3	EN-L5-6	NA	NA	NA
CGAATGTTCAGGCAAG-1_5787_BA9	24.68315194	-22.32742811	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4523	10491	0.006672386	0.006672386	0	3	EN-L5-6	NA	NA	NA
CGAATGTTCGAATCCA-1_5787_BA9	28.05635045	6.427328112	15A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	883	1172	0.027303754	0.045221843	0	15A	Endo cells	NA	NA	NA
CGACCTTTCTCTAAGG-1_5787_BA9	-16.13549674	-9.049947882	13B	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2833	5164	0.012006197	0.010650658	0	13B	IN-SV2C	NA	NA	NA
CGACTTCGTGCACTTA-1_5787_BA9	-15.35123951	-37.07240745	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2815	5731	0.028616297	0.012737742	0	16	EN-PYR	NA	NA	NA
CGAGAAGAGCTGAACG-1_5787_BA9	-15.05212992	-6.621201331	13A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3721	8357	0.013162618	0.006820629	0	13A	IN-VIP	NA	NA	NA
CGAGAAGCAGACTCGC-1_5787_BA9	19.22301334	-28.49846184	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5073	14328	0.001046901	0.003978224	0	3	EN-L5-6	NA	NA	NA
CGAGAAGGTTCGGGCT-1_5787_BA9	-15.99542749	-16.84192564	6B	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1854	2913	0.003089598	0.008238929	0	6B	IN-SST	NA	NA	NA
CGAGCACGTCACTTCC-1_5787_BA9	18.94170112	-0.254650366	12	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1255	1845	0.020596206	0.010840108	0	12	EN-MIX	NA	NA	NA
CGAGCCAAGACTAGAT-1_5787_BA9	-17.02459831	-8.393449695	13B	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3146	5811	0.00464636	0.014799518	0	13B	IN-SV2C	NA	NA	NA
CGAGCCACAGCGTCCA-1_5787_BA9	-8.408009655	-4.583468469	13A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1702	2717	0.001104159	0.004784689	0	13A	IN-VIP	NA	NA	NA
CGAGCCATCGGTTCGG-1_5787_BA9	-3.642170296	36.10834149	17	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	895	1179	0.002544529	0.009329941	0	oligos	OL-MS-2	NA	NA	NA
CGATCGGGTATCGCAT-1_5787_BA9	25.62375543	-27.56917458	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4574	11705	0.000341734	0.00358821	0	3	EN-L5-6	NA	NA	NA
CGATGGCTCCGTACAA-1_5787_BA9	30.44883417	-4.998293886	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3729	8293	0.008682021	0.010611359	0	2	EN-L4	NA	NA	NA
CGATGTAAGCGTGAGT-1_5787_BA9	17.40379283	-29.41989561	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	6026	17107	0.000759923	0.00531946	0	3	EN-L5-6	NA	NA	NA
CGATGTAGTTAGGGTG-1_5787_BA9	17.50593156	-30.10336003	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5751	17912	0.002903082	0.004354623	0	3	EN-L5-6	NA	NA	NA
CGATGTAGTTCCAACA-1_5787_BA9	-10.81443048	-37.46336621	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1395	1998	0.030530531	0.019019019	0	16	EN-PYR	NA	NA	NA
CGATGTAGTTTAGCTG-1_5787_BA9	12.657647	1.693644676	12	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	929	1242	0.002415459	0.005636071	0	12	EN-MIX	NA	NA	NA
CGATTGAAGCAGACTG-1_5787_BA9	17.20296684	-29.61508306	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5107	13687	0.000876744	0.006940893	0	3	EN-L5-6	NA	NA	NA
CGATTGAAGTGCGATG-1_5787_BA9	21.87503783	-24.43141207	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3831	8083	0.000371149	0.016825436	0	3	EN-L5-6	NA	NA	NA
CGCCAAGAGTGTCTCA-1_5787_BA9	-19.06586248	-16.80811313	6B	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2518	4392	0.001821494	0.010018215	0	6B	IN-SST	NA	NA	NA
CGCCAAGCACCCATTC-1_5787_BA9	14.95995354	-31.95107467	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4754	13523	0.000295792	0.003549508	0	3	EN-L5-6	NA	NA	NA
CGCCAAGTCAACGGGA-1_5787_BA9	-18.14495386	-13.98125482	6B	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2495	4187	0.015763076	0.016001911	0	6B	IN-SST	NA	NA	NA
CGCGGTAAGCTTATCG-1_5787_BA9	3.507100908	-19.02127101	4	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4200	9336	0.000535561	0.005355613	0	L2-3	EN-L2-3-MS	NA	NA	NA
CGCGGTACAAGGTTCT-1_5787_BA9	3.284017184	-13.93198861	4	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2511	4574	0.004591167	0.010056843	0	L2-3	EN-L2-3-MS	NA	NA	NA
CGCGTTTAGCACAGGT-1_5787_BA9	-19.76281216	-16.35816698	6B	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2805	5092	0.00392773	0.008837392	0	6B	IN-SST	NA	NA	NA
CGCGTTTTCTCGAGTA-1_5787_BA9	22.48426095	-1.129859031	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2270	4028	0.001737835	0.007696127	0	2	EN-L4	NA	NA	NA
CGCTATCAGACTGGGT-1_5787_BA9	29.62499615	-12.36075495	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4599	10168	0.008162864	0.013571991	0	2	EN-L4	NA	NA	NA
CGCTATCCACATGGGA-1_5787_BA9	18.10560046	-27.16551592	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5335	14226	0.00660762	0.00716997	0	3	EN-L5-6	NA	NA	NA
CGCTATCCACGAAATA-1_5787_BA9	-11.21990754	-27.34463108	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	853	1092	0.033882784	0.008241758	0	16	EN-PYR	NA	NA	NA
CGCTATCGTTCAGGCC-1_5787_BA9	-25.35986427	-9.731732032	9	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1006	1315	0.004562738	0.004562738	0	9	OPC	NA	NA	NA
CGCTTCACACGAAGCA-1_5787_BA9	-7.033733247	-37.51015245	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1047	1396	0.022206304	0.019340974	0	16	EN-PYR	NA	NA	NA
CGCTTCAGTGAACCTT-1_5787_BA9	17.39542848	-5.428038784	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2012	4079	0.001716107	0.004903163	0	3	EN-L5-6	NA	NA	NA
CGCTTCATCCATGAAC-1_5787_BA9	-16.7856043	-9.90960587	13B	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3488	7409	0.000944797	0.005263868	0	13B	IN-SV2C	NA	NA	NA
CGGACACAGCTGCGAA-1_5787_BA9	-10.59411677	-36.02896332	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1222	1768	0.043552036	0.009615385	0	16	EN-PYR	NA	NA	NA
CGGACGTCACTTACGA-1_5787_BA9	-10.3634542	28.21565213	17	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	858	1108	0.063176895	0.026173285	0	oligos	OL-MS-2	NA	NA	NA
CGGACGTCAGGACCCT-1_5787_BA9	31.79138711	-9.552084703	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4151	9272	0.00204918	0.008412425	0	2	EN-L4	NA	NA	NA
CGGACGTCATTCCTGC-1_5787_BA9	-9.119616001	-13.37238206	6B	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	830	1082	0.005545287	0.013863216	0	6B	IN-SST	NA	NA	NA
CGGACGTGTTGTCGCG-1_5787_BA9	10.88978584	-25.93731947	10	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5282	13386	0.004482295	0.004482295	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGGACGTTCAACTCTT-1_5787_BA9	27.58901453	-4.359868905	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4533	11682	0.000342407	0.005992125	0	2	EN-L4	NA	NA	NA
CGGACGTTCGACAGCC-1_5787_BA9	18.3263808	-30.77249176	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	6746	21761	0.000919075	0.00353844	0	3	EN-L5-6	NA	NA	NA
CGGACGTTCGTTTAGG-1_5787_BA9	-11.12830778	-14.38655893	6B	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1339	1958	0.007150153	0.014811032	0	6B	IN-SST	NA	NA	NA
CGGACTGAGCGCCTTG-1_5787_BA9	-6.538182525	-37.13682517	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	989	1305	0.061302682	0.022988506	0	16	EN-PYR	NA	NA	NA
CGGACTGAGTTTCCTT-1_5787_BA9	3.692259112	-16.00900049	4	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3182	6057	0.001155688	0.005448242	0	L2-3	EN-L2-3-MS	NA	NA	NA
CGGACTGTCTCGAGTA-1_5787_BA9	-9.369726256	-14.93276657	6B	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	913	1226	0	0.01223491	0	6B	IN-SST	NA	NA	NA
CGGAGTCCACCTATCC-1_5787_BA9	-12.58448005	-2.242877935	13A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2827	5345	0.001870907	0.012160898	0	13A	IN-VIP	NA	NA	NA
CGGAGTCGTGATGTGG-1_5787_BA9	28.04781127	-5.460783208	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4674	12449	0.000803277	0.005301631	0	2	EN-L4	NA	NA	NA
CGGAGTCGTGTTCTTT-1_5787_BA9	14.06046749	-32.0921606	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4004	12050	0.0006639	0.002904564	0	3	EN-L5-6	NA	NA	NA
CGGCTAGAGCTCTCGG-1_5787_BA9	-24.48895586	-12.50113072	9	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	790	1169	0.001710864	0.005132592	0	9	OPC	NA	NA	NA
CGGCTAGCACTAGTAC-1_5787_BA9	17.62420467	-30.08020535	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5998	17025	0.000763583	0.006578561	0	3	EN-L5-6	NA	NA	NA
CGGCTAGGTTACGTCA-1_5787_BA9	-11.31572278	-1.678705892	13A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2782	4875	0.003076923	0.005333333	0	13A	IN-VIP	NA	NA	NA
CGGCTAGTCGTTGCCT-1_5787_BA9	5.602723323	-17.88506393	4	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3379	6409	0.000624122	0.023716648	0	L2-3	EN-L2-3-MS	NA	NA	NA
CGGGTCACAACACCTA-1_5787_BA9	17.98671408	-28.0493715	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5969	18350	0.004032698	0.005667575	0	3	EN-L5-6	NA	NA	NA
CGGGTCATCATTTGGG-1_5787_BA9	18.98284101	-17.78434443	4	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5885	16583	0.013145993	0.007356932	0	L2-3	EN-L2-3-MS	NA	NA	NA
CGGTTAAAGAGACTAT-1_5787_BA9	-21.97731927	-22.39432562	6A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2699	5028	0.006165473	0.005568815	0	6A	IN-PV	NA	NA	NA
CGGTTAAAGGCAGGTT-1_5787_BA9	30.86756498	-17.37884067	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	6693	20244	0.027020352	0.010175855	0	2	EN-L4	NA	NA	NA
CGGTTAACATGCTAGT-1_5787_BA9	-9.670448659	-7.629542021	13A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1588	2350	0.002978723	0.007234043	0	13A	IN-VIP	NA	NA	NA
CGGTTAATCAGTCAGT-1_5787_BA9	17.54657795	-31.42655743	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5296	15690	0.000446144	0.003632887	0	3	EN-L5-6	NA	NA	NA
CGGTTAATCTCACATT-1_5787_BA9	-12.94462214	-10.78979986	13B	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1980	3254	0.000307314	0.005531653	0	13B	IN-SV2C	NA	NA	NA
CGTAGCGAGTGCGATG-1_5787_BA9	-0.582187163	-0.421209689	11	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1685	2490	0.002409639	0.008433735	0	11	Glia-MIX	NA	NA	NA
CGTAGCGCATTGTGCA-1_5787_BA9	-12.08513147	-34.61517846	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1288	1837	0.027218291	0.011431682	0	16	EN-PYR	NA	NA	NA
CGTAGGCCAGTATAAG-1_5787_BA9	-26.56509682	9.118206623	8	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	875	1211	0	0.007431874	0	8	Astrocytes	NA	NA	NA
CGTAGGCTCTGCTGCT-1_5787_BA9	6.42458102	-12.18694076	4	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2402	3915	0.002043423	0.032183908	0	L2-3	EN-L2-3-MS	NA	NA	NA
CGTCACTCAGGTCTCG-1_5787_BA9	-10.77145013	-36.82250698	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1284	1866	0.02733119	0.011254019	0	16	EN-PYR	NA	NA	NA
CGTCACTTCGACGGAA-1_5787_BA9	6.027130668	-12.5100011	4	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2951	5313	0.001693958	0.019198193	0	L2-3	EN-L2-3-MS	NA	NA	NA
CGTCCATAGGGCTCTC-1_5787_BA9	22.16502463	-22.2342804	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3182	6103	0.006554154	0.019334753	0	3	EN-L5-6	NA	NA	NA
CGTCCATCACAGGCCT-1_5787_BA9	16.28650275	1.740778042	12	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	752	1017	0.001966568	0.004916421	0	12	EN-MIX	NA	NA	NA
CGTCCATCAGCCACCA-1_5787_BA9	15.41762412	-30.35799748	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4325	11449	0.001048126	0.003930474	0	3	EN-L5-6	NA	NA	NA
CGTCCATTCTGCTTGC-1_5787_BA9	32.3602903	-2.15245744	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3202	6445	0.001241272	0.008688906	0	2	EN-L4	NA	NA	NA
CGTCTACAGGGAGTAA-1_5787_BA9	6.813385488	-2.767876038	12	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1343	1810	0.001657459	0.02320442	0	12	EN-MIX	NA	NA	NA
CGTCTACCAATAGCAA-1_5787_BA9	19.20940288	-18.21483962	4	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4674	10041	0.013046509	0.008266109	0	L2-3	EN-L2-3-MS	NA	NA	NA
CGTGAGCGTATGAAAC-1_5787_BA9	-16.87182312	-21.94072457	6A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2048	3477	0.001150417	0.004601668	0	6A	IN-PV	NA	NA	NA
CGTGTAACAACAACCT-1_5787_BA9	15.80915783	-30.82907634	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4170	11184	0.000625894	0.004649499	0	3	EN-L5-6	NA	NA	NA
CGTGTAAGTACGCTGC-1_5787_BA9	20.61217835	-26.65932651	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4789	12986	0.002541198	0.006699523	0	3	EN-L5-6	NA	NA	NA
CGTGTAAGTTTAGGAA-1_5787_BA9	21.38339624	-27.54746839	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3129	7264	0.000963656	0.005368943	0	3	EN-L5-6	NA	NA	NA
CGTGTCTAGATTACCC-1_5787_BA9	18.48025816	-8.939858297	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2488	4792	0.001460768	0.006051753	0	3	EN-L5-6	NA	NA	NA
CGTGTCTAGCCACCTG-1_5787_BA9	10.76847594	-25.71789826	10	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	6755	20981	0.00328869	0.01010438	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGTGTCTAGTGCGATG-1_5787_BA9	-12.96027984	0.044050201	13A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3249	6210	0.003381643	0.014009662	0	13A	IN-VIP	NA	NA	NA
CGTGTCTGTAAGTGTA-1_5787_BA9	-13.32779377	-36.4657039	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1813	3051	0.076368404	0.011471649	0	16	EN-PYR	NA	NA	NA
CGTGTCTTCGTTTATC-1_5787_BA9	-15.11101683	-36.90145485	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3268	7951	0.137592756	0.009181235	0	16	EN-PYR	NA	NA	NA
CGTTAGAAGCCACGTC-1_5787_BA9	18.26517108	-23.35195171	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4459	9457	0.001268901	0.046420641	0	3	EN-L5-6	NA	NA	NA
CGTTAGAAGCCATCGC-1_5787_BA9	8.17248879	-18.64107359	4	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4285	8769	0.001254419	0.021781275	0	L2-3	EN-L2-3-MS	NA	NA	NA
CGTTAGACACCGCTAG-1_5787_BA9	26.25158323	5.344856156	15A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1209	1591	0.017598994	0.016970459	0	15A	Endo cells	NA	NA	NA
CGTTAGACAGATGGCA-1_5787_BA9	-18.00267975	-17.17750078	6B	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2586	4895	0.001225741	0.002451481	0	6B	IN-SST	NA	NA	NA
CGTTAGAGTGCAACGA-1_5787_BA9	9.204956533	-21.75219475	4	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5177	12313	0.00129944	0.017055145	0	L2-3	EN-L2-3-MS	NA	NA	NA
CGTTAGATCCAAACTG-1_5787_BA9	0.886265731	-17.51273569	4	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3333	6676	0.001497903	0.004044338	0	L2-3	EN-L2-3-MS	NA	NA	NA
CGTTCTGGTACCAGTT-1_5787_BA9	-21.29673217	-17.1276489	6A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3671	7541	0.00079565	0.007426071	0	6A	IN-PV	NA	NA	NA
CGTTCTGGTAGCTTGT-1_5787_BA9	23.08591969	-0.229505255	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2362	4303	0.000464792	0.00813386	0	2	EN-L4	NA	NA	NA
CGTTCTGTCAAGGCTT-1_5787_BA9	-17.18755868	-21.86011762	6A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2063	3441	0.002615519	0.005231037	0	6A	IN-PV	NA	NA	NA
CGTTGGGAGGCAGGTT-1_5787_BA9	25.56744758	-27.27755535	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4628	11799	0.000678024	0.004915671	0	3	EN-L5-6	NA	NA	NA
CGTTGGGCAGCTGTAT-1_5787_BA9	5.913022944	-11.80397744	4	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2100	3322	0.000602047	0.021071644	0	L2-3	EN-L2-3-MS	NA	NA	NA
CGTTGGGGTGGTACAG-1_5787_BA9	-16.56751193	-15.767872	6B	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1926	3219	0.009009009	0.009009009	0	6B	IN-SST	NA	NA	NA
CTAACTTAGGCGATAC-1_5787_BA9	17.56738673	-31.7189283	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	6224	19994	0.003250975	0.00330099	0	3	EN-L5-6	NA	NA	NA
CTAACTTGTAGCGTCC-1_5787_BA9	-8.714772921	-15.37278787	6B	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	764	1115	0.001793722	0.003587444	0	6B	IN-SST	NA	NA	NA
CTAAGACCACGTAAGG-1_5787_BA9	18.84301531	-27.99572419	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5008	13041	0.001150219	0.008434936	0	3	EN-L5-6	NA	NA	NA
CTAAGACTCGCATGGC-1_5787_BA9	16.420384	-26.95773435	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4580	11044	0.001358204	0.00760594	0	3	EN-L5-6	NA	NA	NA
CTAAGACTCTGCTTGC-1_5787_BA9	31.17978816	-6.826639415	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4187	9596	0.003438933	0.01219258	0	2	EN-L4	NA	NA	NA
CTAATGGCATACGCTA-1_5787_BA9	15.36352069	-30.36214632	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3826	9122	0.001096251	0.005042754	0	3	EN-L5-6	NA	NA	NA
CTACACCCATTTGCTT-1_5787_BA9	15.32058016	-28.02442485	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3660	8610	0.008362369	0.005574913	0	3	EN-L5-6	NA	NA	NA
CTACATTTCCAGATCA-1_5787_BA9	8.284315339	-32.08661799	10	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3417	7764	0.002189593	0.00321999	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTACCCACATCGGAAG-1_5787_BA9	-7.010706649	-33.69449035	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	818	1074	0.025139665	0.015828678	0	16	EN-PYR	NA	NA	NA
CTACGTCCAGTCAGCC-1_5787_BA9	-9.695054159	-32.97222456	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1080	1496	0.023395722	0.016042781	0	16	EN-PYR	NA	NA	NA
CTACGTCGTGGGTATG-1_5787_BA9	19.20640413	-9.981863011	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2240	3716	0.007265877	0.006189451	0	3	EN-L5-6	NA	NA	NA
CTAGAGTAGCCGATTT-1_5787_BA9	27.23275333	-6.092588664	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	6521	20791	0.000577173	0.006974172	0	2	EN-L4	NA	NA	NA
CTAGAGTGTTCCAACA-1_5787_BA9	21.24947664	-2.495178441	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2252	3869	0.002067718	0.006203153	0	2	EN-L4	NA	NA	NA
CTAGAGTTCGGTCCGA-1_5787_BA9	18.07876188	-9.995001036	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2751	5627	0.000355429	0.020614892	0	3	EN-L5-6	NA	NA	NA
CTAGTGAAGGCCCTCA-1_5787_BA9	-9.58171301	-13.77234769	6B	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1263	1884	0.000530786	0.037685775	0	6B	IN-SST	NA	NA	NA
CTAGTGAAGTAGGCCA-1_5787_BA9	-24.55517514	6.939757138	8	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	781	1033	0.001936108	0.010648596	0	8	Astrocytes	NA	NA	NA
CTAGTGATCCCTAATT-1_5787_BA9	-6.936955168	-34.04491385	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	841	1124	0.010676157	0.012455516	0	16	EN-PYR	NA	NA	NA
CTAGTGATCCTCAACC-1_5787_BA9	25.98752685	-27.57916709	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5224	15603	0.000512722	0.003973595	0	3	EN-L5-6	NA	NA	NA
CTAGTGATCCTTAATC-1_5787_BA9	-14.06652977	-36.52429062	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1924	3142	0.019732654	0.017504774	0	16	EN-PYR	NA	NA	NA
CTCACACGTGAGGGAG-1_5787_BA9	-11.83361112	-2.920907232	13A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2485	4299	0.004884857	0.008141428	0	13A	IN-VIP	NA	NA	NA
CTCACACGTGCAACGA-1_5787_BA9	6.16166165	-12.24289819	4	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2627	4429	0.001354708	0.021675322	0	L2-3	EN-L2-3-MS	NA	NA	NA
CTCAGAACAACACCTA-1_5787_BA9	-6.770376119	-31.13213689	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	880	1149	0.041775457	0.015665796	0	16	EN-PYR	NA	NA	NA
CTCAGAATCCTTGACC-1_5787_BA9	8.919217161	-27.29831264	10	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	6159	19455	0.000719609	0.006476484	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTCATTAGTCTAGAGG-1_5787_BA9	16.56443694	-29.76003941	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3935	9127	0.000766955	0.005478251	0	3	EN-L5-6	NA	NA	NA
CTCATTATCATACGGT-1_5787_BA9	-6.161234712	-30.04518003	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	812	1038	0.060693642	0.016377649	0	16	EN-PYR	NA	NA	NA
CTCATTATCATGTGGT-1_5787_BA9	-20.3226443	-25.83748605	6A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3481	7729	0.001423211	0.00362272	0	6A	IN-PV	NA	NA	NA
CTCCTAGAGATATACG-1_5787_BA9	-9.815753236	-6.892897667	13A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1779	2744	0.001093294	0.008017493	0	13A	IN-VIP	NA	NA	NA
CTCCTAGTCCCTGACT-1_5787_BA9	-11.96787457	-34.41909567	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1381	1968	0.025406504	0.014735772	0	16	EN-PYR	NA	NA	NA
CTCGAAAAGGAACTGC-1_5787_BA9	17.33053877	-30.55576588	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5885	17263	0.000637201	0.004807971	0	3	EN-L5-6	NA	NA	NA
CTCGAAACAACTTGAC-1_5787_BA9	21.71889669	-24.04021142	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4749	11790	0.010178117	0.017811705	0	3	EN-L5-6	NA	NA	NA
CTCGAAACACACCGAC-1_5787_BA9	9.438212164	-26.44130396	10	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5696	17004	0.014878852	0.007762879	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTCGAAAGTACTCTCC-1_5787_BA9	28.11820765	-5.602055023	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5142	13996	0.000285796	0.006001715	0	2	EN-L4	NA	NA	NA
CTCGAGGAGTGTTTGC-1_5787_BA9	17.44581897	-32.03743426	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5454	16351	0.000672742	0.003791817	0	2	EN-L4	NA	NA	NA
CTCGGGACAGATCGGA-1_5787_BA9	6.364763338	-12.20579392	4	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2588	4171	0.001438504	0.031647087	0	L2-3	EN-L2-3-MS	NA	NA	NA
CTCGGGAGTGAGGCTA-1_5787_BA9	8.7516714	-27.34711269	10	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5987	17181	0.001047669	0.003841453	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTCGGGAGTTGCGCAC-1_5787_BA9	33.23003959	-2.791549563	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2686	4766	0.000629459	0.00923206	0	2	EN-L4	NA	NA	NA
CTCGTACAGGATGGTC-1_5787_BA9	9.570879462	-27.26398435	10	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4437	10324	0.000871755	0.0103642	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTCGTACGTGTCCTCT-1_5787_BA9	15.00558889	-30.36173199	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3434	7428	0.000403877	0.004308024	0	3	EN-L5-6	NA	NA	NA
CTCGTACTCGCTGATA-1_5787_BA9	-14.96543056	-14.69766438	6B	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1585	2324	0.006024096	0.016351119	0	6B	IN-SST	NA	NA	NA
CTCGTCAAGAAGGGTA-1_5787_BA9	30.60290643	-6.430381827	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4554	10663	0.000468911	0.004782894	0	2	EN-L4	NA	NA	NA
CTCGTCAAGAATTGTG-1_5787_BA9	-8.264194726	-33.44993563	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	898	1242	0.014492754	0.009661836	0	16	EN-PYR	NA	NA	NA
CTCGTCACAAAGGAAG-1_5787_BA9	18.44606581	-10.82623277	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2729	4764	0.002308984	0.024979009	0	3	EN-L5-6	NA	NA	NA
CTCGTCAGTGTTGGGA-1_5787_BA9	16.61779956	-29.86248905	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4419	10820	0.000369686	0.00702403	0	3	EN-L5-6	NA	NA	NA
CTCGTCATCCACTGGG-1_5787_BA9	32.92624814	-1.832490853	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2779	5189	0.000578146	0.007130468	0	2	EN-L4	NA	NA	NA
CTCGTCATCTGCGACG-1_5787_BA9	12.47138591	-24.11653155	4	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5305	13038	0.000613591	0.016643657	0	L2-3	EN-L2-3-MS	NA	NA	NA
CTCTAATAGTGACATA-1_5787_BA9	9.046511868	-27.10440487	10	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4414	10342	0.001933862	0.004544576	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTCTAATCATCATCCC-1_5787_BA9	22.09227698	-24.43566037	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4126	10247	0.001366254	0.014150483	0	3	EN-L5-6	NA	NA	NA
CTCTAATGTAGGCTGA-1_5787_BA9	-14.62825184	-14.80322318	6B	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1540	2306	0.017346054	0.011708586	0	6B	IN-SST	NA	NA	NA
CTCTAATTCACGACTA-1_5787_BA9	7.005192371	-16.0369949	4	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3094	5783	0.000864603	0.020750476	0	L2-3	EN-L2-3-MS	NA	NA	NA
CTCTAATTCCGCAGTG-1_5787_BA9	-7.501277947	-33.70606376	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	780	1015	0.004926108	0.014778325	0	16	EN-PYR	NA	NA	NA
CTCTACGCATGTCGAT-1_5787_BA9	-21.32037601	-28.10227651	6A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4929	13174	0.000303628	0.00417489	0	6A	IN-PV	NA	NA	NA
CTGAAACAGGAGCGTT-1_5787_BA9	15.22594781	-31.87053887	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4349	11297	0.000619634	0.005665221	0	3	EN-L5-6	NA	NA	NA
CTGAAACTCCTTGACC-1_5787_BA9	4.535085328	-15.55843581	4	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2959	5660	0.001590106	0.017667845	0	L2-3	EN-L2-3-MS	NA	NA	NA
CTGAAGTGTAAACACA-1_5787_BA9	17.11626107	-31.29920938	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	6031	18333	0.000381825	0.005891016	0	3	EN-L5-6	NA	NA	NA
CTGAAGTGTAGCGCAA-1_5787_BA9	33.35301533	-5.594048979	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3494	6844	0.00087668	0.009789597	0	2	EN-L4	NA	NA	NA
CTGAAGTGTCTGCCAG-1_5787_BA9	-13.76411752	-16.95539218	6A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1707	2790	0.001792115	0.003942652	0	6A	IN-PV	NA	NA	NA
CTGAAGTTCATCATTC-1_5787_BA9	8.68517431	-21.42619273	4	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4800	11325	0.001324503	0.01200883	0	L2-3	EN-L2-3-MS	NA	NA	NA
CTGATAGCAATCGAAA-1_5787_BA9	-8.785814384	-7.195902744	13A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1435	1975	0.004050633	0.004050633	0	13A	IN-VIP	NA	NA	NA
CTGATAGCACGAAAGC-1_5787_BA9	17.71508051	-31.87590552	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	6383	21451	0.00088574	0.004195609	0	3	EN-L5-6	NA	NA	NA
CTGATAGCATGCGCAC-1_5787_BA9	-10.11336412	-1.622234245	13A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2191	3867	0.000775795	0.008792345	0	13A	IN-VIP	NA	NA	NA
CTGATAGTCACTTACT-1_5787_BA9	-11.11582387	-9.72189445	13A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1559	2402	0.006244796	0.004579517	0	13A	IN-VIP	NA	NA	NA
CTGATAGTCGTAGGAG-1_5787_BA9	-15.3792501	-37.09548744	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3220	6883	0.055208485	0.012785123	0	16	EN-PYR	NA	NA	NA
CTGATCCGTCCAACTA-1_5787_BA9	-2.905145438	29.98101652	17	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	812	1060	0	0.006603774	0	oligos	OL-MS-2	NA	NA	NA
CTGCCTACACCGAATT-1_5787_BA9	8.472986121	-26.54515849	10	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	6038	18248	0.000657606	0.004438843	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTGCGGACACATTAGC-1_5787_BA9	-8.537649916	-10.1493585	6B	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1254	1772	0.002257336	0.014108352	0	6B	IN-SST	NA	NA	NA
CTGCGGAGTCTAAAGA-1_5787_BA9	-9.121043058	-5.141638584	13A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2030	3185	0.001255887	0.007849294	0	13A	IN-VIP	NA	NA	NA
CTGGTCTCAAACTGTC-1_5787_BA9	-9.808093064	28.27776044	17	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1011	1302	0.010752688	0.00921659	0	oligos	OL-MS-2	NA	NA	NA
CTGGTCTCACATCTTT-1_5787_BA9	-9.027689647	-6.323368345	13A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1696	2799	0.004644516	0.006073598	0	13A	IN-VIP	NA	NA	NA
CTGTGCTAGTCCAGGA-1_5787_BA9	-17.77770869	-7.724241227	13B	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3290	5860	0.004607509	0.009897611	0	13B	IN-SV2C	NA	NA	NA
CTGTGCTCACCCTATC-1_5787_BA9	16.65051217	-30.13875711	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5253	14823	0.000539702	0.004385077	0	3	EN-L5-6	NA	NA	NA
CTGTGCTCAGATGAGC-1_5787_BA9	7.50041781	-18.77113198	4	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4445	9514	0.00063065	0.020811436	0	L2-3	EN-L2-3-MS	NA	NA	NA
CTGTGCTTCCACGAAT-1_5787_BA9	-20.89898468	-25.32420811	6A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3762	8252	0.001090645	0.00618032	0	6A	IN-PV	NA	NA	NA
CTGTTTAAGCATCATC-1_5787_BA9	15.27631215	-30.43692652	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3956	9229	0	0.004117456	0	3	EN-L5-6	NA	NA	NA
CTTAACTCAGTCACTA-1_5787_BA9	6.930492509	22.6817412	1	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1014	1468	0.001362398	0.006811989	0	oligos	OL-Cntl	NA	NA	NA
CTTAACTGTCGCATAT-1_5787_BA9	26.84873665	4.509168214	15A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	879	1146	0.0008726	0.012216405	0	15A	Endo cells	NA	NA	NA
CTTAACTTCACGACTA-1_5787_BA9	-17.08714543	-10.17750561	13B	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3544	7852	0.002674478	0.006367804	0	13B	IN-SV2C	NA	NA	NA
CTTACCGAGACTTTCG-1_5787_BA9	-10.81824237	-33.61358921	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1090	1468	0.02520436	0.00613079	0	16	EN-PYR	NA	NA	NA
CTTACCGAGGCAGTCA-1_5787_BA9	-17.17912494	-14.56351009	6B	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2179	3558	0.005340079	0.012085441	0	6B	IN-SST	NA	NA	NA
CTTACCGAGGGTCTCC-1_5787_BA9	-12.81713365	-35.71602659	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1582	2415	0.03436853	0.016149068	0	16	EN-PYR	NA	NA	NA
CTTACCGCAGCGAACA-1_5787_BA9	-12.24921405	-34.81724949	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1334	2084	0.040786948	0.015834933	0	16	EN-PYR	NA	NA	NA
CTTACCGGTACACCGC-1_5787_BA9	27.75374389	-5.830233684	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5058	14238	0.000491642	0.003230791	0	2	EN-L4	NA	NA	NA
CTTACCGGTGCGCTTG-1_5787_BA9	-13.28475846	-35.52044179	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1656	2606	0.039140445	0.012663085	0	16	EN-PYR	NA	NA	NA
CTTAGGACAAGGACAC-1_5787_BA9	6.005730774	-10.76921759	12	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1908	2971	0.002692696	0.012790306	0	12	EN-MIX	NA	NA	NA
CTTAGGACAATGAAAC-1_5787_BA9	21.93043802	-13.65517071	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3278	5694	0.005795574	0.011064278	0	3	EN-L5-6	NA	NA	NA
CTTAGGACAGGCTGAA-1_5787_BA9	-10.23910286	-5.099528921	13A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2203	3559	0.003933689	0.009834223	0	13A	IN-VIP	NA	NA	NA
CTTCTCTCAAGACGTG-1_5787_BA9	-20.76383561	-25.62364595	6A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3794	8594	0.002327205	0.006748895	0	6A	IN-PV	NA	NA	NA
CTTCTCTCACCAGCAC-1_5787_BA9	8.403740872	-26.52552438	10	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	6064	20726	0.000482486	0.003570395	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTTCTCTGTCGGGTCT-1_5787_BA9	17.51479018	-5.927532141	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1858	3886	0.001029336	0.002058672	0	3	EN-L5-6	NA	NA	NA
CTTCTCTGTTATCGGT-1_5787_BA9	33.34477095	-3.857427656	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2922	5759	0.00277826	0.005209238	0	2	EN-L4	NA	NA	NA
CTTCTCTTCAACACAC-1_5787_BA9	-21.07653545	-16.76039079	6B	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3956	9733	0.003287784	0.005239905	0	6B	IN-SST	NA	NA	NA
CTTCTCTTCAGGCAAG-1_5787_BA9	-7.202778573	-32.51141618	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	847	1202	0.113976705	0.009983361	0	16	EN-PYR	NA	NA	NA
CTTTGCGAGAGGGATA-1_5787_BA9	-6.950349854	-9.001270593	13A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	935	1199	0.001668057	0.018348624	0	13A	IN-VIP	NA	NA	NA
CTTTGCGAGATTACCC-1_5787_BA9	-13.8329858	-10.12451353	13B	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2222	3960	0.000252525	0.009343434	0	13B	IN-SV2C	NA	NA	NA
CTTTGCGCATAGGATA-1_5787_BA9	22.4367329	-24.34624053	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3354	7120	0.00238764	0.018258427	0	3	EN-L5-6	NA	NA	NA
CTTTGCGTCCTCCTAG-1_5787_BA9	16.85413987	-28.54770169	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4065	9428	0.001909207	0.006257955	0	3	EN-L5-6	NA	NA	NA
CTTTGCGTCCTTGGTC-1_5787_BA9	4.918290888	-17.55179331	4	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3091	6139	0.000162893	0.021013194	0	L2-3	EN-L2-3-MS	NA	NA	NA
CTTTGCGTCTGGCGTG-1_5787_BA9	17.13852513	-29.72362109	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5587	15528	0.001287996	0.007148377	0	3	EN-L5-6	NA	NA	NA
GAAACTCCACATGGGA-1_5787_BA9	18.21229079	-23.48569625	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3073	6055	0.000660611	0.050867052	0	3	EN-L5-6	NA	NA	NA
GAAACTCCACTCGACG-1_5787_BA9	23.11347828	-24.86317726	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3289	6612	0.001361162	0.003176044	0	3	EN-L5-6	NA	NA	NA
GAAACTCCAGGTCTCG-1_5787_BA9	-16.16622657	-9.126432884	13B	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2784	4910	0.00101833	0.00712831	0	13B	IN-SV2C	NA	NA	NA
GAAATGATCTGGGCCA-1_5787_BA9	17.27425887	-29.74176984	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5798	16358	0.000122264	0.004279252	0	3	EN-L5-6	NA	NA	NA
GAACATCGTATATGAG-1_5787_BA9	-5.74312218	-34.29561624	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	891	1240	0.067741935	0.016129032	0	16	EN-PYR	NA	NA	NA
GAACATCGTGACTACT-1_5787_BA9	4.186222117	-7.808117103	12	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1267	1811	0.00496963	0.011043622	0	12	EN-MIX	NA	NA	NA
GAACATCTCCAAGTAC-1_5787_BA9	29.31919286	-11.97277125	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5866	16203	0.011355922	0.011541073	0	2	EN-L4	NA	NA	NA
GAACCTAAGAGCAATT-1_5787_BA9	-22.05797729	-20.57889671	6A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2736	4848	0.010519802	0.007838284	0	6A	IN-PV	NA	NA	NA
GAACCTAAGCCTTGAT-1_5787_BA9	9.087495571	-23.90881165	4	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5237	12660	0.002922591	0.005608215	0	L2-3	EN-L2-3-MS	NA	NA	NA
GAACCTAAGCGTTGCC-1_5787_BA9	-11.88053174	-4.624169529	13A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2483	4267	0.010546051	0.007968127	0	13A	IN-VIP	NA	NA	NA
GAACCTACACATGTGT-1_5787_BA9	-13.89534328	-5.668341185	13A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2854	5652	0.001415428	0.007607926	0	13A	IN-VIP	NA	NA	NA
GAACCTACATCGTCGG-1_5787_BA9	15.11128853	-4.330520278	12	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1646	2576	0.001164596	0.01552795	0	12	EN-MIX	NA	NA	NA
GAACGGAAGAGGTAGA-1_5787_BA9	-30.11301001	-12.63293975	9	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	803	1056	0.004734848	0.013257576	0	9	OPC	NA	NA	NA
GAACGGAGTACATCCA-1_5787_BA9	17.77197362	-7.534340833	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1812	3232	0.022586634	0.011757426	0	3	EN-L5-6	NA	NA	NA
GAACGGAGTCACAAGG-1_5787_BA9	-14.62412279	-22.92086698	6A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1674	2704	0.001109467	0.004807692	0	6A	IN-PV	NA	NA	NA
GAACGGAGTCCGAATT-1_5787_BA9	-5.761076459	-31.45845197	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	744	1016	0.077755906	0.018700787	0	16	EN-PYR	NA	NA	NA
GAACGGAGTCCGAGTC-1_5787_BA9	32.24536893	-8.899822344	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3111	5995	0.007172644	0.011676397	0	2	EN-L4	NA	NA	NA
GAACGGATCAGGTAAA-1_5787_BA9	7.695159302	-18.26592459	4	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4067	8411	0.001307811	0.02282725	0	L2-3	EN-L2-3-MS	NA	NA	NA
GAAGCAGCAAGCTGGA-1_5787_BA9	29.40058542	-12.48175141	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5039	12048	0.009960159	0.011205179	0	2	EN-L4	NA	NA	NA
GAAGCAGCAGATCGGA-1_5787_BA9	5.506173954	-2.618736457	12	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	925	1198	0.003338898	0.011686144	0	12	EN-MIX	NA	NA	NA
GAAGCAGGTGATGATA-1_5787_BA9	-16.68748931	-21.44752893	6A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1676	2624	0.012957317	0.005335366	0	6A	IN-PV	NA	NA	NA
GAATAAGGTGAGGCTA-1_5787_BA9	-13.29726455	14.42071148	8	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	857	1077	0.004642526	0.005571031	0	8	Astrocytes	NA	NA	NA
GAATGAAGTATGAATG-1_5787_BA9	-27.25765839	8.827030444	8	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	821	1102	0.000907441	0.006352087	0	8	Astrocytes	NA	NA	NA
GACACGCCAGCCAGAA-1_5787_BA9	-17.25603841	-15.73072628	6B	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2296	3995	0.003254068	0.006758448	0	6B	IN-SST	NA	NA	NA
GACACGCCAGGAATGC-1_5787_BA9	7.11040551	-18.09646282	4	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4262	8716	0.000573658	0.025011473	0	L2-3	EN-L2-3-MS	NA	NA	NA
GACACGCCATTTGCCC-1_5787_BA9	16.44357228	-31.77588178	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	6007	19834	0.000605022	0.004184733	0	3	EN-L5-6	NA	NA	NA
GACACGCGTGCTTCTC-1_5787_BA9	-20.70203147	-25.11036812	6A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2931	5763	0.003817456	0.004858581	0	6A	IN-PV	NA	NA	NA
GACACGCTCTGAGTGT-1_5787_BA9	32.22190877	-6.141275144	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3728	7665	0.007697326	0.005870841	0	2	EN-L4	NA	NA	NA
GACAGAGCAAACGCGA-1_5787_BA9	17.06895304	-31.01026396	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5931	18729	0.000480538	0.003470554	0	3	EN-L5-6	NA	NA	NA
GACAGAGCAGGCTCAC-1_5787_BA9	-16.28689971	-8.950213358	13B	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3016	5881	0.0039109	0.006971603	0	13B	IN-SV2C	NA	NA	NA
GACAGAGCATACGCCG-1_5787_BA9	13.96309001	-1.062629229	12	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	904	1246	0.028089888	0.003210273	0	12	EN-MIX	NA	NA	NA
GACAGAGTCGGCCGAT-1_5787_BA9	6.510287697	-12.76317215	4	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2888	4935	0.000810537	0.016818642	0	L2-3	EN-L2-3-MS	NA	NA	NA
GACCAATGTCGAATCT-1_5787_BA9	8.91106027	-22.86949722	4	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4661	10808	0.001572909	0.011380459	0	L2-3	EN-L2-3-MS	NA	NA	NA
GACCTGGAGACCCACC-1_5787_BA9	4.767962931	-18.89770124	4	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3674	7831	0.000383093	0.019665432	0	L2-3	EN-L2-3-MS	NA	NA	NA
GACGCGTAGATAGGAG-1_5787_BA9	25.94929751	7.240485777	15A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1490	2031	0.021664205	0.027572624	0	15A	Endo cells	NA	NA	NA
GACGCGTGTCGCTTTC-1_5787_BA9	-0.756168801	31.40048735	17	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	843	1151	0.00086881	0.003475239	0	oligos	OL-MS-2	NA	NA	NA
GACGGCTCAAGCGATG-1_5787_BA9	-30.37026019	-12.75311026	9	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	823	1086	0.004604052	0.006445672	0	9	OPC	NA	NA	NA
GACGGCTCAGACTCGC-1_5787_BA9	19.17446572	-17.45914005	4	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	9512	41894	0.020337041	0.004606865	0	L2-3	EN-L2-3-MS	NA	NA	NA
GACGGCTCATCCCACT-1_5787_BA9	6.669222723	-10.57837939	4	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2034	3120	0.001282051	0.025320513	0	L2-3	EN-L2-3-MS	NA	NA	NA
GACGGCTCATGCGCAC-1_5787_BA9	33.12374457	-4.562534637	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3116	6249	0.000640102	0.011681869	0	2	EN-L4	NA	NA	NA
GACGTGCCAATCCGAT-1_5787_BA9	33.27120683	-5.196768203	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3598	7063	0.001557412	0.007645476	0	2	EN-L4	NA	NA	NA
GACGTGCCAGTAACGG-1_5787_BA9	31.49150586	-7.143162293	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3926	8367	0.005617306	0.009202821	0	2	EN-L4	NA	NA	NA
GACGTGCGTCAAAGAT-1_5787_BA9	33.37302411	-2.614329147	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2898	5489	0.004372381	0.00783385	0	2	EN-L4	NA	NA	NA
GACGTGCTCAGATAAG-1_5787_BA9	16.69346059	-30.03802158	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4599	11582	0.00103609	0.005180452	0	3	EN-L5-6	NA	NA	NA
GACGTTAAGCTAGTCT-1_5787_BA9	6.19585196	-3.465874234	12	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1234	1696	0.006485849	0.02004717	0	12	EN-MIX	NA	NA	NA
GACGTTAAGGATGGTC-1_5787_BA9	-7.436389421	-33.69297312	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	908	1239	0.046811945	0.011299435	0	16	EN-PYR	NA	NA	NA
GACGTTAGTCATACTG-1_5787_BA9	31.88052803	-3.304904536	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3403	6881	0.001162622	0.003487865	0	2	EN-L4	NA	NA	NA
GACGTTAGTCGACTAT-1_5787_BA9	17.15649006	-30.40075317	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5978	18664	0.000857265	0.005036434	0	3	EN-L5-6	NA	NA	NA
GACTAACCATCGGAAG-1_5787_BA9	30.34251039	-7.682135744	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5295	13569	0.002726804	0.005601002	0	2	EN-L4	NA	NA	NA
GACTAACGTTAAGAAC-1_5787_BA9	-11.60324509	-27.35415146	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	916	1234	0.085089141	0.012155592	0	16	EN-PYR	NA	NA	NA
GACTACAGTGGAAAGA-1_5787_BA9	-4.979149084	-35.47512497	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	802	1026	0.030214425	0.01754386	0	16	EN-PYR	NA	NA	NA
GACTACATCGAATCCA-1_5787_BA9	17.68171308	-29.31497666	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	7205	23491	0.005832021	0.004342088	0	3	EN-L5-6	NA	NA	NA
GACTGCGGTTGGTAAA-1_5787_BA9	29.15007426	-12.7454802	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5509	14601	0.011780015	0.005890008	0	2	EN-L4	NA	NA	NA
GACTGCGTCGGTGTCG-1_5787_BA9	14.51424272	1.737711815	12	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	920	1168	0.000856164	0.006849315	0	12	EN-MIX	NA	NA	NA
GACTGCGTCTGCAGTA-1_5787_BA9	-12.06706107	-17.57788618	6B	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1111	1600	0.0025	0.003125	0	6B	IN-SST	NA	NA	NA
GACTGCGTCTGGCGAC-1_5787_BA9	21.93964296	-24.41079655	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3585	7383	0.001219017	0.019910605	0	3	EN-L5-6	NA	NA	NA
GAGCAGAAGAGGGATA-1_5787_BA9	29.8556342	-5.881637326	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5072	12855	0.004045119	0.005134189	0	2	EN-L4	NA	NA	NA
GAGCAGAAGAGTCTGG-1_5787_BA9	-24.25408474	-22.03702277	6A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3589	6842	0.019877229	0.010669395	0	6A	IN-PV	NA	NA	NA
GAGCAGAAGTGGAGAA-1_5787_BA9	-30.13977332	-6.846076616	9	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1318	1914	0.001567398	0.00261233	0	9	OPC	NA	NA	NA
GAGCAGACAACTGCGC-1_5787_BA9	-26.42061309	8.465478583	8	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	850	1163	0.00171969	0.003439381	0	8	Astrocytes	NA	NA	NA
GAGCAGACAGTCAGCC-1_5787_BA9	-10.71712943	-34.54177477	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1136	1596	0.046992481	0.013157895	0	16	EN-PYR	NA	NA	NA
GAGCAGAGTAGCTAAA-1_5787_BA9	21.48780651	-20.76181945	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	6225	18638	0.021515184	0.00547269	0	3	EN-L5-6	NA	NA	NA
GAGCAGAGTGCCTGTG-1_5787_BA9	-12.46156243	-35.18221497	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1446	2198	0.039581438	0.017743403	0	16	EN-PYR	NA	NA	NA
GAGCAGATCATGCATG-1_5787_BA9	5.921621401	-12.18208135	4	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2537	4213	0.001424163	0.015428436	0	L2-3	EN-L2-3-MS	NA	NA	NA
GAGGTGAAGTACGACG-1_5787_BA9	5.738570339	-12.3666456	4	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2670	4536	0.00154321	0.013227513	0	L2-3	EN-L2-3-MS	NA	NA	NA
GAGGTGAAGTGACTCT-1_5787_BA9	-23.94542909	-23.8293519	6A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3945	8445	0.005683837	0.006394316	0	6A	IN-PV	NA	NA	NA
GAGGTGAGTCGTCTTC-1_5787_BA9	13.41820107	-22.35453332	4	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5959	17635	0.005216898	0.003629147	0	L2-3	EN-L2-3-MS	NA	NA	NA
GAGGTGATCACTATTC-1_5787_BA9	21.88850673	-24.36810445	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3703	7623	0.007477371	0.017709563	0	3	EN-L5-6	NA	NA	NA
GAGTCCGAGATGGGTC-1_5787_BA9	-9.775512222	-15.67561991	6B	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1055	1365	0.003663004	0.004395604	0	6B	IN-SST	NA	NA	NA
GAGTCCGCACATTTCT-1_5787_BA9	-15.96014723	-9.234032692	13B	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2729	5142	0.000194477	0.005250875	0	13B	IN-SV2C	NA	NA	NA
GAGTCCGTCAAACAAG-1_5787_BA9	28.32645615	-18.835459	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	11179	62911	0.034095786	0.008980941	0	2	EN-L4	NA	NA	NA
GATCAGTTCATACGGT-1_5787_BA9	25.92256658	-27.04481163	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4945	13381	0.00052313	0.00448397	0	3	EN-L5-6	NA	NA	NA
GATCAGTTCTGGAGCC-1_5787_BA9	-15.77469615	-10.39788166	13B	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2974	6345	0.000945626	0.003309693	0	13B	IN-SV2C	NA	NA	NA
GATCGATCAGTCGATT-1_5787_BA9	-18.84537616	-8.382567025	13B	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4259	9666	0.003931306	0.007862611	0	13B	IN-SV2C	NA	NA	NA
GATCGCGAGAAGGCCT-1_5787_BA9	18.52908013	-4.6246341	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1763	2933	0.001704739	0.004091374	0	2	EN-L4	NA	NA	NA
GATCGCGAGACTGGGT-1_5787_BA9	32.94789513	-2.487193739	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2762	4889	0.008181632	0.00511352	0	2	EN-L4	NA	NA	NA
GATCGCGAGAGGTTAT-1_5787_BA9	-18.68353263	-15.49344289	6B	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2482	3992	0.005511022	0.014779559	0	6B	IN-SST	NA	NA	NA
GATCGCGGTATTACCG-1_5787_BA9	-7.294626908	-33.38967021	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	850	1110	0.022522523	0.017117117	0	16	EN-PYR	NA	NA	NA
GATCGCGGTGTTCTTT-1_5787_BA9	-11.13496396	-2.429166425	13A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2279	3911	0.006392227	0.006647916	0	13A	IN-VIP	NA	NA	NA
GATCGTAGTAACGTTC-1_5787_BA9	-12.46424773	-0.291995837	13A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3516	6869	0.002911632	0.007570243	0	13A	IN-VIP	NA	NA	NA
GATCGTAGTATAATGG-1_5787_BA9	-9.448548786	-15.31321934	6B	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1016	1353	0.007390983	0.014042868	0	6B	IN-SST	NA	NA	NA
GATCGTATCGCTGATA-1_5787_BA9	8.586198778	-27.43473345	10	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5219	15045	0.001395813	0.00292456	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GATCTAGTCAAACAAG-1_5787_BA9	27.12490139	-6.087947822	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	6001	17876	0.000223764	0.003915865	0	2	EN-L4	NA	NA	NA
GATCTAGTCTTGGGTA-1_5787_BA9	33.02534393	-4.60250026	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3360	6787	0.001768086	0.006925004	0	2	EN-L4	NA	NA	NA
GATGAAACACAAGTAA-1_5787_BA9	7.865477442	-30.76552987	10	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5864	18031	0.00038822	0.002551162	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GATGAAATCACGACTA-1_5787_BA9	32.89055886	-4.491949598	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3321	6917	0.003614284	0.00534914	0	2	EN-L4	NA	NA	NA
GATGAGGAGTGACATA-1_5787_BA9	17.75011451	-30.91084907	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	6912	23577	0.001866226	0.004029351	0	3	EN-L5-6	NA	NA	NA
GATGCTACACAGCGTC-1_5787_BA9	8.659761626	-27.18611988	10	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5095	13919	0.003592212	0.003232991	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GATGCTACATACAGCT-1_5787_BA9	-6.936757484	-37.40874508	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	957	1213	0.012366035	0.019785655	0	16	EN-PYR	NA	NA	NA
GATGCTAGTTCTGTTT-1_5787_BA9	16.61167181	-31.64481547	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5357	16035	0.000561272	0.003367633	0	3	EN-L5-6	NA	NA	NA
GATGCTATCTCGCATC-1_5787_BA9	5.956121499	-12.37571551	4	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2728	4755	0.00126183	0.01871714	0	L2-3	EN-L2-3-MS	NA	NA	NA
GATGCTATCTTAACCT-1_5787_BA9	-14.0351244	-35.77854779	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2138	4014	0.091679123	0.008470354	0	16	EN-PYR	NA	NA	NA
GATTCAGAGAATTGTG-1_5787_BA9	8.89749644	-27.75445685	10	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5173	12790	0.002032838	0.003205629	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GATTCAGAGATAGCAT-1_5787_BA9	30.94687441	-3.586827385	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3631	7759	0.001675474	0.005670834	0	2	EN-L4	NA	NA	NA
GATTCAGAGCCCGAAA-1_5787_BA9	-15.48776531	-17.1041275	6B	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1685	2800	0.003214286	0.003928571	0	6B	IN-SST	NA	NA	NA
GCAAACTTCCTCTAGC-1_5787_BA9	9.293862529	-24.03316093	4	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4548	10873	0.00395475	0.00984089	0	L2-3	EN-L2-3-MS	NA	NA	NA
GCAATCAAGCCGATTT-1_5787_BA9	23.05178669	-2.246083193	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2771	5287	0.000756573	0.003972007	0	2	EN-L4	NA	NA	NA
GCAATCACAACCGCCA-1_5787_BA9	-13.31284407	-35.74414551	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1700	2781	0.043509529	0.012225818	0	16	EN-PYR	NA	NA	NA
GCAATCACAAGTTAAG-1_5787_BA9	-1.34104564	36.62220295	17	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	816	1079	0.001853568	0.00463392	0	oligos	OL-MS-2	NA	NA	NA
GCAATCACATCACAAC-1_5787_BA9	-14.37310945	-6.051902831	13A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2792	5418	0.00147656	0.007013658	0	13A	IN-VIP	NA	NA	NA
GCAATCACATTCCTCG-1_5787_BA9	-8.365060145	-31.81570657	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	900	1198	0.030050083	0.012520868	0	16	EN-PYR	NA	NA	NA
GCAATCAGTGACGGTA-1_5787_BA9	13.78196508	-4.349585393	12	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1668	3188	0.001254705	0.004077792	0	12	EN-MIX	NA	NA	NA
GCAATCAGTTCCTCCA-1_5787_BA9	-10.75863127	-32.37682144	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1209	1637	0.010995724	0.007941356	0	16	EN-PYR	NA	NA	NA
GCACATAGTCTCTTAT-1_5787_BA9	4.350657632	-3.351324309	12	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	927	1317	0.009111617	0.006833713	0	12	EN-MIX	NA	NA	NA
GCACTCTCATTATCTC-1_5787_BA9	21.70452524	-24.6221499	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3821	8777	0.000797539	0.022217158	0	3	EN-L5-6	NA	NA	NA
GCACTCTTCATGCAAC-1_5787_BA9	-17.77796464	-14.79629862	6B	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2615	4781	0.002091613	0.009621418	0	6B	IN-SST	NA	NA	NA
GCAGCCATCATAACCG-1_5787_BA9	-20.22415552	-17.06113805	6B	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3925	9083	0.001211054	0.004844214	0	6B	IN-SST	NA	NA	NA
GCAGTTAGTACAGACG-1_5787_BA9	8.387824156	-26.71976623	10	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4428	11352	0.000616631	0.003083157	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCAGTTAGTCGAACAG-1_5787_BA9	27.79057095	5.463060848	15A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	863	1073	0.005591799	0.009319664	0	15A	Endo cells	NA	NA	NA
GCAGTTATCGCTTGTC-1_5787_BA9	22.58495504	-0.611469222	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2173	3949	0.000506457	0.006077488	0	2	EN-L4	NA	NA	NA
GCATACACAGGGATTG-1_5787_BA9	-7.411965956	-32.28823679	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	832	1074	0.017690875	0.012104283	0	16	EN-PYR	NA	NA	NA
GCATACAGTAGGCTGA-1_5787_BA9	15.11378082	-4.157128473	12	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1366	1958	0.002042901	0.019918284	0	12	EN-MIX	NA	NA	NA
GCATACAGTTGGTTTG-1_5787_BA9	8.739090886	-1.876633178	12	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1381	1929	0.011923276	0.005702436	0	12	EN-MIX	NA	NA	NA
GCATGATCAAGCGTAG-1_5787_BA9	-7.756966164	-33.40805316	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	981	1342	0.020119225	0.010432191	0	16	EN-PYR	NA	NA	NA
GCATGTAGTACACCGC-1_5787_BA9	-7.199367964	-34.06534446	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	806	1074	0.02886406	0.00744879	0	16	EN-PYR	NA	NA	NA
GCATGTAGTCAACTGT-1_5787_BA9	8.984289205	-26.90555348	10	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5151	13207	0.001968653	0.004315893	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCATGTATCTGCTGTC-1_5787_BA9	32.54495814	-8.364834247	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3553	6789	0.002356754	0.008690529	0	2	EN-L4	NA	NA	NA
GCCAAATAGCTATGCT-1_5787_BA9	32.92364643	-3.150454032	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2826	5334	0.000374953	0.010123735	0	2	EN-L4	NA	NA	NA
GCCAAATCAGCTGGCT-1_5787_BA9	-6.186824925	-34.04039388	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	890	1203	0.054031588	0.025768911	0	16	EN-PYR	NA	NA	NA
GCCAAATTCAGCTGGC-1_5787_BA9	-13.62890318	-36.37225686	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1797	2908	0.040921596	0.011691884	0	16	EN-PYR	NA	NA	NA
GCCTCTAAGAGGTAGA-1_5787_BA9	18.12852375	-9.940584124	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2932	5677	0.000176149	0.014796547	0	3	EN-L5-6	NA	NA	NA
GCCTCTACAGATTGCT-1_5787_BA9	5.938863053	-12.4771849	4	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2882	5028	0.002386635	0.019490851	0	L2-3	EN-L2-3-MS	NA	NA	NA
GCCTCTATCAGCCTAA-1_5787_BA9	27.23481654	-5.007585178	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5526	16215	0.000185014	0.003453592	0	2	EN-L4	NA	NA	NA
GCCTCTATCGCATGAT-1_5787_BA9	20.57110077	-26.72646893	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5503	15788	0.000760071	0.003610337	0	3	EN-L5-6	NA	NA	NA
GCCTCTATCTGTTGAG-1_5787_BA9	-15.43713147	-22.26975093	6A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1845	3265	0.001225115	0.004900459	0	6A	IN-PV	NA	NA	NA
GCGACCACATTAGCCA-1_5787_BA9	19.14902274	-24.56436691	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4444	10253	0.001072857	0.020189213	0	3	EN-L5-6	NA	NA	NA
GCGAGAACATCCGGGT-1_5787_BA9	-7.198192813	-33.14474861	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	802	1028	0.006809339	0.011673152	0	16	EN-PYR	NA	NA	NA
GCGAGAACATGCCACG-1_5787_BA9	18.47686477	-27.71058081	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4338	10187	0.000981643	0.011583391	0	3	EN-L5-6	NA	NA	NA
GCGAGAATCCGAGCCA-1_5787_BA9	31.19365185	-7.314309723	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4296	9708	0.001545117	0.009579728	0	2	EN-L4	NA	NA	NA
GCGCAACAGTGTTTGC-1_5787_BA9	15.00466638	-30.47954365	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3435	7105	0.001266714	0.003096411	0	3	EN-L5-6	NA	NA	NA
GCGCAACCAAGCGCTC-1_5787_BA9	16.4376933	-29.73527209	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4472	12052	0.002738135	0.006223034	0	3	EN-L5-6	NA	NA	NA
GCGCAACTCAACTCTT-1_5787_BA9	3.535241334	-13.59578295	4	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2274	3871	0.001033325	0.014466546	0	L2-3	EN-L2-3-MS	NA	NA	NA
GCGCAACTCGTTTAGG-1_5787_BA9	-20.93592102	-24.94476246	6A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3010	5580	0.001433692	0.008781362	0	6A	IN-PV	NA	NA	NA
GCGCAACTCTTGACGA-1_5787_BA9	-19.54290079	-16.89771565	6B	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2961	5613	0.003563157	0.009798682	0	6B	IN-SST	NA	NA	NA
GCGCAGTCATCAGTCA-1_5787_BA9	-10.91644102	-14.91823469	6B	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1225	1780	0.026404494	0.011235955	0	6B	IN-SST	NA	NA	NA
GCGCCAAAGTACTTGC-1_5787_BA9	5.930628895	-16.58863684	4	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3601	6990	0.001001431	0.014592275	0	L2-3	EN-L2-3-MS	NA	NA	NA
GCGCCAACAGGACGTA-1_5787_BA9	25.83079903	-27.38428184	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5306	15116	0.000860016	0.003572374	0	3	EN-L5-6	NA	NA	NA
GCGCCAAGTCTTCTCG-1_5787_BA9	-28.96326725	-12.95217381	9	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	771	1009	0.005946482	0.004955401	0	9	OPC	NA	NA	NA
GCGCCAATCATCTGCC-1_5787_BA9	3.739588879	-18.80535242	4	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3806	7624	0.001967471	0.006689402	0	L2-3	EN-L2-3-MS	NA	NA	NA
GCGCGATCACGCATCG-1_5787_BA9	-18.5921948	10.22535317	8	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	806	1041	0.007684918	0.006724304	0	8	Astrocytes	NA	NA	NA
GCGCGATGTGCACGAA-1_5787_BA9	-7.399989372	-33.82686819	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	891	1197	0.042606516	0.010025063	0	16	EN-PYR	NA	NA	NA
GCGCGATGTTCTGGTA-1_5787_BA9	-25.24551946	-12.17774656	9	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	928	1138	0.000878735	0.016695958	0	9	OPC	NA	NA	NA
GCGCGATGTTTCGCTC-1_5787_BA9	32.43634091	-2.196546811	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3338	6912	0.001157407	0.00708912	0	2	EN-L4	NA	NA	NA
GCGGGTTAGTCTCGGC-1_5787_BA9	-23.49200774	9.136433498	8	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1002	1427	0.007708479	0.007708479	0	8	Astrocytes	NA	NA	NA
GCGGGTTCAGGGTACA-1_5787_BA9	-14.53879628	-5.203523235	13A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2884	5120	0.004882813	0.011523438	0	13A	IN-VIP	NA	NA	NA
GCGGGTTTCAAACCAC-1_5787_BA9	-7.010590475	-32.88156215	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	771	1034	0.042553191	0.010638298	0	16	EN-PYR	NA	NA	NA
GCGGGTTTCTGCAAGT-1_5787_BA9	18.03013265	-30.97800712	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	7304	25747	0.001980813	0.004194663	0	3	EN-L5-6	NA	NA	NA
GCTCTGTGTGTATGGG-1_5787_BA9	24.97723083	-26.62627749	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5008	12742	0.000941767	0.010359441	0	3	EN-L5-6	NA	NA	NA
GCTCTGTGTTATGCGT-1_5787_BA9	33.08153503	-1.900140459	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2704	4867	0.001643723	0.005136634	0	2	EN-L4	NA	NA	NA
GCTGCAGGTTTGACAC-1_5787_BA9	-10.17276859	-15.2099299	6B	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1043	1415	0.002120141	0.004240283	0	6B	IN-SST	NA	NA	NA
GCTGCGACAAGGACAC-1_5787_BA9	-7.681485292	-37.789019	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1137	1520	0.019736842	0.015789474	0	16	EN-PYR	NA	NA	NA
GCTGCGACACCTCGTT-1_5787_BA9	-12.07135037	-34.84044612	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1268	1842	0.027687296	0.015200869	0	16	EN-PYR	NA	NA	NA
GCTGCGATCTTACCGC-1_5787_BA9	3.638807125	-2.770693576	12	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	791	1044	0.001915709	0.012452107	0	12	EN-MIX	NA	NA	NA
GCTGCTTAGTACGCCC-1_5787_BA9	-13.59804228	-17.33159975	6B	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1391	2222	0.004050405	0.00720072	0	6B	IN-SST	NA	NA	NA
GCTGCTTCAAACCTAC-1_5787_BA9	18.01711487	-9.993815747	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2074	3557	0.001405679	0.021928592	0	3	EN-L5-6	NA	NA	NA
GCTGCTTCATCACGTA-1_5787_BA9	-14.44579588	-17.37512184	6B	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1626	2886	0.001386001	0.003811504	0	6B	IN-SST	NA	NA	NA
GCTGGGTAGGCAAAGA-1_5787_BA9	9.723345549	-25.78196377	10	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5081	12762	0.002115656	0.003682808	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCTGGGTAGGTGCACA-1_5787_BA9	33.77521492	-3.326376194	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2561	4843	0.004336155	0.005368573	0	2	EN-L4	NA	NA	NA
GCTGGGTTCCCGGATG-1_5787_BA9	-6.126958031	-34.83147807	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	802	1072	0.015858209	0.014925373	0	16	EN-PYR	NA	NA	NA
GCTTCCACAAACGTGG-1_5787_BA9	24.73376112	6.82355496	15A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2298	3691	0.011108101	0.015713899	0	15A	Endo cells	NA	NA	NA
GCTTCCACAATCGGTT-1_5787_BA9	-19.93705281	-23.65567476	6A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2555	4725	0.001058201	0.004867725	0	6A	IN-PV	NA	NA	NA
GCTTCCAGTAGCGTCC-1_5787_BA9	3.529278171	-20.77573193	4	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5220	13646	0.001025942	0.004690019	0	L2-3	EN-L2-3-MS	NA	NA	NA
GCTTGAACACTGAAGG-1_5787_BA9	16.49367533	-28.4986348	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4340	10653	0.000938703	0.006383178	0	3	EN-L5-6	NA	NA	NA
GCTTGAAGTATATGGA-1_5787_BA9	9.489921254	-29.17619305	10	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	6642	20608	0.000873447	0.003979037	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCTTGAATCCCAAGAT-1_5787_BA9	8.791759697	-26.52127157	10	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5992	17662	0.001188993	0.004416261	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GGAAAGCAGCCAGTTT-1_5787_BA9	18.33932761	-23.63734202	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4375	9644	0.000518457	0.042306097	0	3	EN-L5-6	NA	NA	NA
GGAAAGCTCAGTACGT-1_5787_BA9	-8.245555515	-35.35699253	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	939	1253	0.019952115	0.017557861	0	16	EN-PYR	NA	NA	NA
GGAAAGCTCCTACAGA-1_5787_BA9	17.41599401	-7.255000038	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1904	3383	0.010937038	0.001773574	0	3	EN-L5-6	NA	NA	NA
GGAAAGCTCTAACGGT-1_5787_BA9	8.791898649	-11.6223971	4	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2604	4082	0.002694757	0.01788339	0	L2-3	EN-L2-3-MS	NA	NA	NA
GGAACTTAGACAATAC-1_5787_BA9	8.850452275	-26.19223621	10	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5385	14458	0.000968322	0.007815742	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GGAACTTGTCGCATAT-1_5787_BA9	28.54253415	-5.940095649	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4576	12182	0.000574618	0.004268593	0	2	EN-L4	NA	NA	NA
GGAATAAAGCTTATCG-1_5787_BA9	-9.06805329	-14.12563689	6B	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	901	1150	0.000869565	0.013043478	0	6B	IN-SST	NA	NA	NA
GGAATAAAGTATGACA-1_5787_BA9	11.45350277	-25.28819928	4	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5614	15185	0.003029305	0.006124465	0	L2-3	EN-L2-3-MS	NA	NA	NA
GGAATAACAGGAACGT-1_5787_BA9	9.348075231	-28.85740216	10	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	6053	17602	0.000738552	0.003579139	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GGAATAAGTATTAGCC-1_5787_BA9	5.849050305	-11.9638798	4	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2230	3484	0	0.016073479	0	L2-3	EN-L2-3-MS	NA	NA	NA
GGAATAATCATGTCCC-1_5787_BA9	17.34966642	-29.23835777	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5834	16683	0.002637415	0.008451717	0	3	EN-L5-6	NA	NA	NA
GGACAAGAGTGTACTC-1_5787_BA9	-14.01047587	-35.41760159	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2083	3748	0.052027748	0.006670224	0	16	EN-PYR	NA	NA	NA
GGACAAGCATAACCTG-1_5787_BA9	-6.797573643	35.97642446	17	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	852	1153	0.002601908	0.006071119	0	oligos	OL-MS-2	NA	NA	NA
GGACAGAAGCAGCGTA-1_5787_BA9	7.44262095	-16.09180894	4	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3272	5847	0.00239439	0.026851377	0	L2-3	EN-L2-3-MS	NA	NA	NA
GGACAGACACAACGTT-1_5787_BA9	22.21757383	-6.946417823	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2589	4613	0.004118795	0.011272491	0	3	EN-L5-6	NA	NA	NA
GGACAGACACAGATTC-1_5787_BA9	-24.26568575	-24.64616929	6A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4257	9547	0.002199644	0.008589086	0	6A	IN-PV	NA	NA	NA
GGACAGAGTTGGACCC-1_5787_BA9	-10.5577099	-35.8309942	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1308	1930	0.056476684	0.017098446	0	16	EN-PYR	NA	NA	NA
GGACATTCATGTAGTC-1_5787_BA9	20.77041276	-0.112861306	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1384	2046	0.00342131	0.005865103	0	2	EN-L4	NA	NA	NA
GGACATTTCAGAGACG-1_5787_BA9	-18.71820244	-21.16055865	6A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2790	5348	0.001308901	0.006170531	0	6A	IN-PV	NA	NA	NA
GGACGTCAGCGTTTAC-1_5787_BA9	-20.08719688	-24.41430674	6A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3205	6197	0.001936421	0.003872842	0	6A	IN-PV	NA	NA	NA
GGACGTCAGTCTCGGC-1_5787_BA9	12.14394625	1.140088297	12	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	808	1051	0.002854424	0.006660324	0	12	EN-MIX	NA	NA	NA
GGACGTCCAAGGTTCT-1_5787_BA9	16.33922544	-31.99807913	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	6326	21865	0.000411617	0.004024697	0	3	EN-L5-6	NA	NA	NA
GGACGTCCAGACTCGC-1_5787_BA9	-10.61400068	-36.7649932	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1253	1787	0.015109121	0.018466704	0	16	EN-PYR	NA	NA	NA
GGACGTCGTAGGCTGA-1_5787_BA9	21.68191881	-2.535311666	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2474	4687	0.000853424	0.007254107	0	2	EN-L4	NA	NA	NA
GGACGTCGTCGACTGC-1_5787_BA9	-10.52496828	-5.479517936	13A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1911	2966	0.002360081	0.016520566	0	13A	IN-VIP	NA	NA	NA
GGACGTCTCGGGAGTA-1_5787_BA9	27.26042959	4.726764657	15BA	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	797	1010	0.00990099	0.015841584	0	15BA	Stromal cells	NA	NA	NA
GGAGCAACAATCTGCA-1_5787_BA9	-18.2323372	-14.1493817	6A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2553	4355	0.014466131	0.01216992	0	6A	IN-PV	NA	NA	NA
GGAGCAACAGTCGTGC-1_5787_BA9	-8.462061862	-28.45910971	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	939	1190	0.013445378	0.019327731	0	16	EN-PYR	NA	NA	NA
GGAGCAACATACGCTA-1_5787_BA9	-13.14280316	-36.53350207	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1535	2528	0.011471519	0.012658228	0	16	EN-PYR	NA	NA	NA
GGAGCAAGTCAACTGT-1_5787_BA9	-22.43999634	-16.15394717	6A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4085	8710	0.001492537	0.007692308	0	6A	IN-PV	NA	NA	NA
GGAGCAAGTCACTTCC-1_5787_BA9	9.915551355	-29.20795083	10	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5348	14395	0.000694686	0.007502605	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GGAGCAAGTTCGCGAC-1_5787_BA9	-4.73468078	-34.40654867	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	731	1069	0.163704397	0.020579981	0	16	EN-PYR	NA	NA	NA
GGAGCAATCTACTCAT-1_5787_BA9	-29.49678211	-8.035243865	9	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1103	1555	0.004501608	0.009003215	0	9	OPC	NA	NA	NA
GGATGTTCACTTGGAT-1_5787_BA9	33.60822564	-5.208661007	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3432	7185	0.002087683	0.005845511	0	2	EN-L4	NA	NA	NA
GGATGTTTCCACGTTC-1_5787_BA9	8.715614373	-26.46938555	10	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5677	17118	0.001285197	0.004439771	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GGATGTTTCGAACTGT-1_5787_BA9	10.54353944	-26.34258952	10	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	6504	20104	0.001790688	0.004625945	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GGATTACAGGCATGGT-1_5787_BA9	7.165487141	-18.18376113	4	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4098	8179	0.001222643	0.019562294	0	L2-3	EN-L2-3-MS	NA	NA	NA
GGATTACCACAGTCGC-1_5787_BA9	-15.39977033	-37.03979854	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3325	7483	0.02311907	0.012962715	0	16	EN-PYR	NA	NA	NA
GGATTACGTTGGGACA-1_5787_BA9	-17.25345314	-17.05083764	6B	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2043	3697	0.000811469	0.009467136	0	6B	IN-SST	NA	NA	NA
GGCAATTCATCTGGTA-1_5787_BA9	-20.69392822	-24.86755761	6A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3408	6689	0.002989984	0.004185977	0	6A	IN-PV	NA	NA	NA
GGCAATTGTCAGGACA-1_5787_BA9	-11.78346953	0.467724965	13A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3327	6800	0.000147059	0.007352941	0	13A	IN-VIP	NA	NA	NA
GGCAATTTCAATCACG-1_5787_BA9	32.7544342	-5.826559598	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4184	9458	0.001480228	0.004229224	0	2	EN-L4	NA	NA	NA
GGCAATTTCAGCATGT-1_5787_BA9	-10.51074765	-0.279713038	13A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2554	4586	0.000654165	0.010466638	0	13A	IN-VIP	NA	NA	NA
GGCAATTTCCCTTGCA-1_5787_BA9	25.69869886	-27.39551193	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4770	13020	0.000844854	0.004915515	0	3	EN-L5-6	NA	NA	NA
GGCAATTTCTGGTATG-1_5787_BA9	-12.39252284	-34.68009663	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1303	1949	0.029758851	0.007183171	0	16	EN-PYR	NA	NA	NA
GGCGACTCAATCGAAA-1_5787_BA9	26.25574711	6.920525778	15A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1404	1917	0.023474178	0.03599374	0	15A	Endo cells	NA	NA	NA
GGCTCGAAGATATACG-1_5787_BA9	-30.55171604	-1.839297183	9	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1602	2479	0.001210165	0.006454215	0	9	OPC	NA	NA	NA
GGCTCGACAAGCCGCT-1_5787_BA9	-11.79441887	-33.41445499	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1397	2102	0.068030447	0.009990485	0	16	EN-PYR	NA	NA	NA
GGCTCGATCGTGACAT-1_5787_BA9	17.42017595	-32.06271818	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	6325	20828	0.000336086	0.003504897	0	3	EN-L5-6	NA	NA	NA
GGCTCGATCTTCAACT-1_5787_BA9	-17.74266393	-14.41018899	6B	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2351	3827	0.009668147	0.014894173	0	6B	IN-SST	NA	NA	NA
GGCTGGTAGACGCAAC-1_5787_BA9	-11.38265519	-29.54396461	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1342	1881	0.016480595	0.016480595	0	16	EN-PYR	NA	NA	NA
GGCTGGTAGGGTCTCC-1_5787_BA9	29.71705742	-11.05337614	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5196	13291	0.008802949	0.006169588	0	2	EN-L4	NA	NA	NA
GGCTGGTAGTACACCT-1_5787_BA9	27.37958374	-15.44564843	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	8609	32209	0.01375392	0.008506939	0	2	EN-L4	NA	NA	NA
GGCTGGTGTCGAATCT-1_5787_BA9	27.78571658	6.237285705	15BA	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	976	1292	0.006965944	0.020897833	0	15BA	Stromal cells	NA	NA	NA
GGCTGGTGTGCAACTT-1_5787_BA9	10.55322073	-26.22208169	10	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	6987	22215	0.00243079	0.00544677	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GGGAATGGTCTCACCT-1_5787_BA9	24.02199997	-25.86477229	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3259	7178	0.000278629	0.004040123	0	3	EN-L5-6	NA	NA	NA
GGGAATGGTTATCACG-1_5787_BA9	29.2674858	-12.26750841	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5876	15528	0.012042761	0.010110768	0	2	EN-L4	NA	NA	NA
GGGAATGTCGGCATCG-1_5787_BA9	-12.30421235	-13.25398015	6B	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1873	2715	0.002946593	0.020626151	0	6B	IN-SST	NA	NA	NA
GGGACCTAGTAGGCCA-1_5787_BA9	-20.55538097	-16.43543305	6B	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3214	6512	0.002457002	0.005528256	0	6B	IN-SST	NA	NA	NA
GGGACCTTCTTGCATT-1_5787_BA9	32.85110245	-2.919526878	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2961	5796	0.002070393	0.004485852	0	2	EN-L4	NA	NA	NA
GGGAGATGTTCATGGT-1_5787_BA9	-17.22499386	-22.03875217	6A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2083	3562	0.003088153	0.003930376	0	6A	IN-PV	NA	NA	NA
GGGAGATTCGGAAACG-1_5787_BA9	-8.692249088	-34.97961025	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	878	1189	0.017661901	0.011774601	0	16	EN-PYR	NA	NA	NA
GGGAGATTCTTCCTTC-1_5787_BA9	32.65158093	-2.929253378	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3042	5808	0.001721763	0.008780992	0	2	EN-L4	NA	NA	NA
GGGATGAAGCTACCTA-1_5787_BA9	31.82044023	-3.578627886	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3779	7994	0.000875657	0.009632224	0	2	EN-L4	NA	NA	NA
GGGATGAAGTGTTAGA-1_5787_BA9	-22.70897404	-16.48762805	6A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5016	12480	0.003846154	0.006730769	0	6A	IN-PV	NA	NA	NA
GGGATGACAACTGCGC-1_5787_BA9	17.89709211	-31.43316541	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	7696	27372	0.002813094	0.004603244	0	3	EN-L5-6	NA	NA	NA
GGGATGACAGCATGAG-1_5787_BA9	4.656697515	-17.1428049	4	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2809	5097	0.000196194	0.0127526	0	L2-3	EN-L2-3-MS	NA	NA	NA
GGGCACTTCTGAGGGA-1_5787_BA9	8.786302547	-25.95156863	4	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5229	12795	0.001094177	0.005158265	0	L2-3	EN-L2-3-MS	NA	NA	NA
GGGCATCAGCTCCTCT-1_5787_BA9	18.4481588	-23.66549404	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4231	9905	0.002120141	0.044422009	0	3	EN-L5-6	NA	NA	NA
GGGCATCCAAACTGCT-1_5787_BA9	5.606481756	-12.56284015	4	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2691	4853	0.000206058	0.016690707	0	L2-3	EN-L2-3-MS	NA	NA	NA
GGGTCTGCAGATAATG-1_5787_BA9	-16.95780571	-9.627722339	13B	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3346	6763	0.004879491	0.005618808	0	13B	IN-SV2C	NA	NA	NA
GGGTCTGCAGGACGTA-1_5787_BA9	17.88122402	-31.44036031	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	7331	26430	0.001021566	0.004653802	0	3	EN-L5-6	NA	NA	NA
GGGTCTGTCCTAGAAC-1_5787_BA9	27.1424465	6.381369364	15A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1266	1744	0.027522936	0.025229358	0	15A	Endo cells	NA	NA	NA
GGGTTGCGTTGGTTTG-1_5787_BA9	25.27561409	-26.31511146	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4818	11949	0.001757469	0.004435518	0	3	EN-L5-6	NA	NA	NA
GGGTTGCTCAGAAATG-1_5787_BA9	-24.87664744	-9.724176594	9	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1113	1473	0.006788866	0.004752206	0	9	OPC	NA	NA	NA
GGTATTGCATGCCACG-1_5787_BA9	16.81053764	-29.8360427	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5539	14989	0.001334312	0.004870238	0	3	EN-L5-6	NA	NA	NA
GGTATTGGTACATCCA-1_5787_BA9	31.54186595	-1.395916129	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3019	6120	0.000490196	0.006045752	0	2	EN-L4	NA	NA	NA
GGTGAAGAGCCAGAAC-1_5787_BA9	-16.6614139	-8.671062416	13B	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2869	5042	0.00198334	0.008528362	0	13B	IN-SV2C	NA	NA	NA
GGTGAAGCATCACGAT-1_5787_BA9	32.57526325	-2.388862735	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3066	5825	0.000686695	0.006180258	0	2	EN-L4	NA	NA	NA
GGTGAAGGTACCATCA-1_5787_BA9	18.0366298	-8.219259821	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2114	3669	0.000817661	0.010357046	0	3	EN-L5-6	NA	NA	NA
GGTGAAGGTGAAATCA-1_5787_BA9	-6.415725201	-30.95195433	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	957	1227	0.019559902	0.017114914	0	16	EN-PYR	NA	NA	NA
GGTGCGTAGTGAATTG-1_5787_BA9	-8.696073231	-5.736429749	13A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1568	2328	0.003436426	0.014604811	0	13A	IN-VIP	NA	NA	NA
GGTGCGTCACCACGTG-1_5787_BA9	-12.06915295	-9.102192501	13B	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1984	2980	0.002348993	0.005704698	0	13B	IN-SV2C	NA	NA	NA
GGTGCGTGTGCAGTAG-1_5787_BA9	-14.17922672	-18.01495426	6B	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1658	2691	0.000743218	0.005574136	0	6B	IN-SST	NA	NA	NA
GGTGCGTTCACGATGT-1_5787_BA9	31.09460722	-11.01450328	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3922	7823	0.003962674	0.007414036	0	2	EN-L4	NA	NA	NA
GGTGTTAAGATCCCGC-1_5787_BA9	32.50753797	-2.028248782	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3036	5766	0.000520291	0.005202914	0	2	EN-L4	NA	NA	NA
GGTGTTAAGCAGACTG-1_5787_BA9	12.18143209	-1.636567003	12	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1140	1518	0.004611331	0.011198946	0	12	EN-MIX	NA	NA	NA
GGTGTTAAGGCTAGAC-1_5787_BA9	-8.987202088	-35.41507122	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1000	1383	0.032537961	0.006507592	0	16	EN-PYR	NA	NA	NA
GGTGTTAAGTAGATGT-1_5787_BA9	29.73668909	-11.83497578	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4383	9384	0.003836317	0.014919011	0	2	EN-L4	NA	NA	NA
GGTGTTACACCACCAG-1_5787_BA9	-16.54547608	-17.96851006	6B	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2088	3964	0.00025227	0.005297679	0	6B	IN-SST	NA	NA	NA
GGTGTTAGTCCGAAGA-1_5787_BA9	19.84665867	-21.75442688	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5480	14334	0.024138412	0.006348542	0	3	EN-L5-6	NA	NA	NA
GGTGTTAGTCGAATCT-1_5787_BA9	21.60991078	-20.68246289	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	8263	31625	0.00515415	0.005596838	0	3	EN-L5-6	NA	NA	NA
GTAACGTCAAGAGGCT-1_5787_BA9	-21.12383749	-15.96682868	6B	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2994	5534	0.001445609	0.005059631	0	6B	IN-SST	NA	NA	NA
GTAACTGAGTCATCCA-1_5787_BA9	-9.428167731	-33.67775579	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	966	1298	0.005392912	0.009244992	0	16	EN-PYR	NA	NA	NA
GTAACTGCACAACGCC-1_5787_BA9	-8.17368057	-10.4913831	6B	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	867	1162	0.002581756	0.010327022	0	6B	IN-SST	NA	NA	NA
GTAACTGCATCCGGGT-1_5787_BA9	-20.83760209	-24.70109601	6A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3451	6714	0.002829908	0.004915103	0	6A	IN-PV	NA	NA	NA
GTAACTGGTCAATGTC-1_5787_BA9	-14.81641417	-14.42796597	6B	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1532	2338	0.013686912	0.015397776	0	6B	IN-SST	NA	NA	NA
GTACGTAAGGACAGAA-1_5787_BA9	8.217154109	-26.62218547	10	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	6580	21213	0.000424268	0.003205581	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GTACGTACACGGACAA-1_5787_BA9	-15.17284566	-23.34345579	6A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1573	2563	0.003901678	0.00702302	0	6A	IN-PV	NA	NA	NA
GTACGTACATATGGTC-1_5787_BA9	-10.45716594	-17.90659634	6B	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	996	1417	0.004940014	0.007762879	0	6B	IN-SST	NA	NA	NA
GTACGTACATCGGTTA-1_5787_BA9	-25.77162654	-10.35369932	9	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	821	1052	0.004752852	0.006653992	0	9	OPC	NA	NA	NA
GTACGTAGTAGAGGAA-1_5787_BA9	31.87308436	-10.63069049	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2739	4702	0.007868992	0.005529562	0	2	EN-L4	NA	NA	NA
GTACGTATCGGAGGTA-1_5787_BA9	8.725542929	-26.51854985	10	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4903	12137	0.001483068	0.005932273	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GTACTCCAGGCACATG-1_5787_BA9	32.83202493	-3.139387749	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3081	5870	0.001703578	0.0120954	0	2	EN-L4	NA	NA	NA
GTACTCCAGTGTTAGA-1_5787_BA9	22.27409344	-27.51572421	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	6091	17663	0.002321236	0.004416011	0	3	EN-L5-6	NA	NA	NA
GTACTCCCATGCAATC-1_5787_BA9	8.238140617	-18.44990335	4	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4067	8092	0.001730104	0.023232823	0	L2-3	EN-L2-3-MS	NA	NA	NA
GTACTTTAGATCACGG-1_5787_BA9	6.578318602	-15.31752113	4	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3160	6090	0.002791461	0.012972085	0	L2-3	EN-L2-3-MS	NA	NA	NA
GTACTTTCACTACAGT-1_5787_BA9	-9.465173913	-6.478622803	13A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1843	3006	0.001996008	0.009647372	0	13A	IN-VIP	NA	NA	NA
GTACTTTCATCACGTA-1_5787_BA9	-2.389492674	28.43777128	17	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	750	1009	0	0.007928642	0	oligos	OL-MS-2	NA	NA	NA
GTACTTTTCCGTCAAA-1_5787_BA9	14.42225446	-30.48695195	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3121	6952	0.010356732	0.0033084	0	3	EN-L5-6	NA	NA	NA
GTACTTTTCCTATTCA-1_5787_BA9	-17.69350381	-17.47683806	6B	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2047	3785	0.000792602	0.005812417	0	6B	IN-SST	NA	NA	NA
GTACTTTTCTAACTGG-1_5787_BA9	31.99590778	-3.245901222	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3111	6165	0.001459854	0.003730738	0	2	EN-L4	NA	NA	NA
GTAGGCCCACTTCTGC-1_5787_BA9	18.0809319	-10.19936004	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2174	3806	0.000525486	0.026537047	0	3	EN-L5-6	NA	NA	NA
GTAGGCCCAGATAATG-1_5787_BA9	-9.436574826	-34.8754191	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	997	1411	0.041105599	0.013465627	0	16	EN-PYR	NA	NA	NA
GTAGTCAAGTATCTCG-1_5787_BA9	17.97444116	-10.33985468	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2586	4484	0.000892061	0.029884032	0	3	EN-L5-6	NA	NA	NA
GTAGTCAAGTGATCGG-1_5787_BA9	12.63014366	-21.95652121	4	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	7343	23256	0.004514964	0.004901961	0	L2-3	EN-L2-3-MS	NA	NA	NA
GTAGTCACATGGTTGT-1_5787_BA9	13.62464016	-3.721243818	12	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1375	2091	0.00191296	0.004782401	0	12	EN-MIX	NA	NA	NA
GTAGTCAGTTGGAGGT-1_5787_BA9	-16.87262961	-23.3130228	6A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2095	3867	0	0.004396173	0	6A	IN-PV	NA	NA	NA
GTAGTCATCGCTTAGA-1_5787_BA9	-6.176098629	-35.8921514	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	898	1152	0.009548611	0.017361111	0	16	EN-PYR	NA	NA	NA
GTATCTTAGTGCGATG-1_5787_BA9	16.5349795	-29.78985353	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5105	13910	0.000431344	0.005751258	0	3	EN-L5-6	NA	NA	NA
GTATCTTCAATGTTGC-1_5787_BA9	21.75424203	-24.58108047	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4541	11100	0.00045045	0.018918919	0	3	EN-L5-6	NA	NA	NA
GTATCTTGTACCATCA-1_5787_BA9	-29.57657968	-11.18169681	9	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	973	1324	0.000755287	0.003021148	0	9	OPC	NA	NA	NA
GTATTCTGTGCACCAC-1_5787_BA9	-15.97970063	-9.257106727	13B	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2473	4317	0.004401205	0.006717628	0	13B	IN-SV2C	NA	NA	NA
GTCAAGTAGCTCAACT-1_5787_BA9	4.502603981	-27.79380568	10	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4028	9664	0.001655629	0.002793874	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GTCAAGTCAGATCGGA-1_5787_BA9	18.41033831	-4.493363121	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1593	2468	0	0.002836305	0	2	EN-L4	NA	NA	NA
GTCAAGTCATCCGCGA-1_5787_BA9	10.83016406	-17.72565341	4	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4476	9785	0.001430761	0.015840572	0	L2-3	EN-L2-3-MS	NA	NA	NA
GTCACAAGTCCAGTAT-1_5787_BA9	-6.766315021	-33.07736304	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	820	1094	0.046617916	0.006398537	0	16	EN-PYR	NA	NA	NA
GTCACAAGTCTCCACT-1_5787_BA9	-17.90208286	6.346248658	8	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	796	1024	0	0.004882813	0	8	Astrocytes	NA	NA	NA
GTCACAAGTTACGGAG-1_5787_BA9	-21.84818967	-24.49174444	6A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3856	7875	0.003936508	0.00584127	0	6A	IN-PV	NA	NA	NA
GTCACAATCATGTAGC-1_5787_BA9	30.33950404	-15.82407207	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3839	7838	0.026409798	0.013141107	0	2	EN-L4	NA	NA	NA
GTCACGGCATGCCTAA-1_5787_BA9	-10.58782436	-36.41384353	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1227	1702	0.028789659	0.012338425	0	16	EN-PYR	NA	NA	NA
GTCACGGTCCTAGTGA-1_5787_BA9	18.21589238	-23.42204424	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3025	5789	0.000518224	0.048713077	0	3	EN-L5-6	NA	NA	NA
GTCATTTCACGGCCAT-1_5787_BA9	16.73502563	-30.0779064	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4764	11808	0.001355014	0.005928184	0	3	EN-L5-6	NA	NA	NA
GTCCTCACACCCAGTG-1_5787_BA9	22.68546367	-2.088701474	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2459	5123	0.001366387	0.006441538	0	2	EN-L4	NA	NA	NA
GTCCTCATCGCTGATA-1_5787_BA9	-15.3182581	-36.86049475	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2804	5601	0.047670059	0.00785574	0	16	EN-PYR	NA	NA	NA
GTCCTCATCGGTTCGG-1_5787_BA9	25.75824196	-26.09474069	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4835	12267	0.001222793	0.006358523	0	3	EN-L5-6	NA	NA	NA
GTCCTCATCGTTACGA-1_5787_BA9	5.68210253	-1.738945373	12	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	818	1170	0.006837607	0.004273504	0	12	EN-MIX	NA	NA	NA
GTCGGGTGTATGCTTG-1_5787_BA9	5.603718276	-9.687332032	12	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1708	2473	0	0.021835827	0	12	EN-MIX	NA	NA	NA
GTCGTAAAGATCCGAG-1_5787_BA9	18.24588349	-23.35339249	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3256	6443	0.000931243	0.050597548	0	3	EN-L5-6	NA	NA	NA
GTCGTAACAGGAATGC-1_5787_BA9	-9.856647074	-15.58960974	6B	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1121	1514	0.001321004	0.013870542	0	6B	IN-SST	NA	NA	NA
GTCGTAAGTCAGAATA-1_5787_BA9	6.011928846	-12.13568536	4	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2304	3647	0	0.01617768	0	L2-3	EN-L2-3-MS	NA	NA	NA
GTCTTCGCATGCGCAC-1_5787_BA9	16.98915127	-30.30824749	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5937	19330	0.002741852	0.004345577	0	3	EN-L5-6	NA	NA	NA
GTGAAGGAGGACCACA-1_5787_BA9	-23.95967483	-23.25401632	6A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3663	7641	0.002879204	0.008637613	0	6A	IN-PV	NA	NA	NA
GTGAAGGAGGCATGGT-1_5787_BA9	31.87860893	-1.730309848	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3109	6143	0.001302295	0.005371968	0	2	EN-L4	NA	NA	NA
GTGAAGGAGTCCAGGA-1_5787_BA9	7.596692835	-18.76104046	4	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4424	9726	0.00071972	0.020357804	0	L2-3	EN-L2-3-MS	NA	NA	NA
GTGAAGGGTTCCAACA-1_5787_BA9	25.51342214	-27.1897417	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4511	11055	0.000361827	0.005698779	0	3	EN-L5-6	NA	NA	NA
GTGCAGCCAATGGACG-1_5787_BA9	-16.18917957	-9.155787275	13B	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2958	5460	0.001282051	0.004578755	0	13B	IN-SV2C	NA	NA	NA
GTGCATATCACCCGAG-1_5787_BA9	-2.59882066	0.646973781	11	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1765	2640	0.001515152	0.006060606	0	11	Glia-MIX	NA	NA	NA
GTGCATATCGTACCGG-1_5787_BA9	3.723999772	-17.28206348	4	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3112	6129	0.00130527	0.009626366	0	L2-3	EN-L2-3-MS	NA	NA	NA
GTGCGGTTCCACGACG-1_5787_BA9	-6.994831531	-34.36300578	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1052	1500	0.103333333	0.007333333	0	16	EN-PYR	NA	NA	NA
GTGCGGTTCTTTCCTC-1_5787_BA9	-15.11188656	-37.38093078	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2397	4910	0.054378819	0.010997963	0	16	EN-PYR	NA	NA	NA
GTGCTTCAGTTGAGAT-1_5787_BA9	17.96755619	-10.31496052	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2743	4848	0	0.025783828	0	3	EN-L5-6	NA	NA	NA
GTGCTTCCACGTCAGC-1_5787_BA9	33.88794681	-4.60222158	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2921	5518	0.003443277	0.007249003	0	2	EN-L4	NA	NA	NA
GTGCTTCGTCACTGGC-1_5787_BA9	-21.12728366	-15.66664363	6B	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3080	5937	0.008421762	0.009769244	0	6B	IN-SST	NA	NA	NA
GTGCTTCTCCCTCTTT-1_5787_BA9	-0.574264734	30.94113273	17	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	922	1320	0.000757576	0.010606061	0	oligos	OL-MS-2	NA	NA	NA
GTGCTTCTCGTCCAGG-1_5787_BA9	16.65444908	-30.13968062	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5184	14304	0.000769016	0.004893736	0	3	EN-L5-6	NA	NA	NA
GTGGGTCAGTAGGCCA-1_5787_BA9	11.62792569	-26.87608943	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	7414	23891	0.002050982	0.006320372	0	3	EN-L5-6	NA	NA	NA
GTGGGTCCACACCGAC-1_5787_BA9	-9.241230259	-15.49628542	6B	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	919	1254	0.000797448	0.010366826	0	6B	IN-SST	NA	NA	NA
GTGGGTCTCTAGAGTC-1_5787_BA9	10.83918216	-16.91448262	4	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4484	9673	0.00186085	0.016954409	0	L2-3	EN-L2-3-MS	NA	NA	NA
GTGTGCGAGAGAACAG-1_5787_BA9	-15.36707495	-4.852142841	13A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3845	7885	0.005326569	0.007736208	0	13A	IN-VIP	NA	NA	NA
GTGTGCGCAAGAAAGG-1_5787_BA9	-14.74600697	-14.49973667	6B	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1543	2147	0.002328831	0.010246856	0	6B	IN-SST	NA	NA	NA
GTGTGCGCATGTAGTC-1_5787_BA9	3.803747712	-8.92379944	12	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1634	2552	0.003134796	0.011363636	0	12	EN-MIX	NA	NA	NA
GTGTGCGGTTCCAACA-1_5787_BA9	-10.73969211	-32.99358594	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1116	1585	0.041009464	0.013249211	0	16	EN-PYR	NA	NA	NA
GTGTTAGGTCGAATCT-1_5787_BA9	13.10721292	-24.50532501	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	6216	17765	0.000619195	0.025612159	0	3	EN-L5-6	NA	NA	NA
GTGTTAGGTCGCATCG-1_5787_BA9	-10.1384861	-36.2858684	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1204	1745	0.055587393	0.011461318	0	16	EN-PYR	NA	NA	NA
GTTAAGCCAATCGAAA-1_5787_BA9	-7.525439594	-33.11764333	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	887	1209	0.065343259	0.013234078	0	16	EN-PYR	NA	NA	NA
GTTAAGCGTTCCACTC-1_5787_BA9	29.18393195	-3.162883664	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4930	12749	0.000784375	0.005569064	0	2	EN-L4	NA	NA	NA
GTTACAGCACTGTCGG-1_5787_BA9	18.71551838	-24.08421402	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4174	8870	0.000901917	0.024577227	0	3	EN-L5-6	NA	NA	NA
GTTACAGCATTCACTT-1_5787_BA9	27.15034776	-3.230630459	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3402	7351	0.000952251	0.005577472	0	2	EN-L4	NA	NA	NA
GTTCATTTCATACGGT-1_5787_BA9	5.756130912	-18.10929604	4	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3643	7361	0.000407553	0.017932346	0	L2-3	EN-L2-3-MS	NA	NA	NA
GTTCGGGGTGCATCTA-1_5787_BA9	-19.97776415	-20.79996954	6A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2236	3684	0.00597177	0.008414767	0	6A	IN-PV	NA	NA	NA
GTTCGGGGTGTGAATA-1_5787_BA9	6.067899988	-12.21433304	4	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2452	4103	0.000731172	0.020960273	0	L2-3	EN-L2-3-MS	NA	NA	NA
GTTCGGGTCACTTACT-1_5787_BA9	-12.17761558	-1.999276826	13A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2585	4494	0.001557632	0.010458389	0	13A	IN-VIP	NA	NA	NA
GTTCTCGGTGGTTTCA-1_5787_BA9	9.085142564	-22.90967702	4	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4332	9898	0.001818549	0.016872095	0	L2-3	EN-L2-3-MS	NA	NA	NA
GTTTCTAAGTATCGAA-1_5787_BA9	-16.24149519	-9.025388061	13B	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2364	4384	0.03854927	0.004333942	0	13B	IN-SV2C	NA	NA	NA
GTTTCTACAGTAACGG-1_5787_BA9	25.64246177	-26.59680347	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5252	14463	0.000829703	0.005254788	0	3	EN-L5-6	NA	NA	NA
TAAACCGAGTCCGTAT-1_5787_BA9	-24.30814607	6.279399842	8	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	745	1027	0.00097371	0.007789679	0	8	Astrocytes	NA	NA	NA
TAAACCGCATGGGACA-1_5787_BA9	32.36167175	-5.35703744	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4111	9313	0.003221304	0.006120477	0	2	EN-L4	NA	NA	NA
TAAACCGGTGTTCGAT-1_5787_BA9	-5.67737664	-6.48133763	13A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1136	1711	0.001753361	0.030391584	0	13A	IN-VIP	NA	NA	NA
TAAGAGAGTCTAGTGT-1_5787_BA9	-17.84354567	-16.77975807	6B	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2087	3510	0.006552707	0.003988604	0	6B	IN-SST	NA	NA	NA
TAAGCGTAGAAGGGTA-1_5787_BA9	-8.948905848	-6.004337559	13A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1644	2441	0.001638673	0.010651372	0	13A	IN-VIP	NA	NA	NA
TAAGCGTCAGAGTGTG-1_5787_BA9	11.08272983	-22.62081339	4	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5081	12836	0.005920848	0.006076659	0	L2-3	EN-L2-3-MS	NA	NA	NA
TAAGCGTGTAATAGCA-1_5787_BA9	16.62041529	-29.94122753	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4777	11728	0.001364256	0.005542292	0	3	EN-L5-6	NA	NA	NA
TAAGCGTGTTGAGGTG-1_5787_BA9	-9.267715457	-14.96790173	6B	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	955	1275	0.002352941	0.008627451	0	6B	IN-SST	NA	NA	NA
TAAGCGTTCAAACCAC-1_5787_BA9	-9.075662988	-7.05454473	13A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1494	2064	0.001453488	0.034883721	0	13A	IN-VIP	NA	NA	NA
TAAGTGCAGGGAGTAA-1_5787_BA9	5.409838144	-11.24675598	12	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1870	2860	0.001048951	0.016783217	0	12	EN-MIX	NA	NA	NA
TAAGTGCTCACTTATC-1_5787_BA9	-18.78853599	-18.24693112	6A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2501	4943	0.001213838	0.003439207	0	6A	IN-PV	NA	NA	NA
TACACGAAGAGTACCG-1_5787_BA9	-17.00578463	-8.322041342	13B	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3187	5485	0.002734731	0.009662716	0	13B	IN-SV2C	NA	NA	NA
TACACGAAGGCGCTCT-1_5787_BA9	32.42956303	-3.099943588	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2946	5563	0.002516628	0.004493978	0	2	EN-L4	NA	NA	NA
TACACGATCGTTTGCC-1_5787_BA9	-5.611029124	-32.11477534	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	849	1087	0.039558418	0.024839006	0	16	EN-PYR	NA	NA	NA
TACAGTGAGCCTTGAT-1_5787_BA9	-11.42584557	-36.01115471	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1369	1944	0.033950617	0.012345679	0	16	EN-PYR	NA	NA	NA
TACAGTGCACGGTTTA-1_5787_BA9	-21.09701443	-25.52688349	6A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3765	8826	0.008497621	0.004305461	0	6A	IN-PV	NA	NA	NA
TACAGTGGTATGAATG-1_5787_BA9	-12.9280334	-4.66355335	13A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2355	4043	0.002473411	0.010388326	0	13A	IN-VIP	NA	NA	NA
TACAGTGGTGTGCCTG-1_5787_BA9	16.62702074	-30.1657715	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5704	17878	0.000783085	0.002964537	0	3	EN-L5-6	NA	NA	NA
TACCTATAGCCTCGTG-1_5787_BA9	17.96445491	1.708111705	12	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1153	1750	0	0.005142857	0	12	EN-MIX	NA	NA	NA
TACCTATAGTAAGTAC-1_5787_BA9	-9.366558217	-33.9197789	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1087	1562	0.053777209	0.014084507	0	16	EN-PYR	NA	NA	NA
TACCTATAGTTAACGA-1_5787_BA9	-10.35365643	-1.890578973	13A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2159	3660	0.004371585	0.007650273	0	13A	IN-VIP	NA	NA	NA
TACCTATCAGGCGATA-1_5787_BA9	7.065843794	-16.71827493	4	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3792	7705	0.000778715	0.024269955	0	L2-3	EN-L2-3-MS	NA	NA	NA
TACCTATGTCGACTGC-1_5787_BA9	27.98678896	-5.592926497	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5100	14167	0.000705866	0.005576339	0	2	EN-L4	NA	NA	NA
TACCTATGTCTTTCAT-1_5787_BA9	29.42065347	-0.26973725	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3574	7966	0.003891539	0.005523475	0	2	EN-L4	NA	NA	NA
TACCTTAGTTGCTCCT-1_5787_BA9	1.974965806	5.177406042	14	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	822	1016	0.006889764	0.015748031	0	14	Microglia	NA	NA	NA
TACGGATAGACACGAC-1_5787_BA9	-15.52322202	-8.03170847	13B	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2980	5333	0.005062816	0.002250141	0	13B	IN-SV2C	NA	NA	NA
TACGGATTCCTAAGTG-1_5787_BA9	-4.820696508	-8.202338235	13A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	843	1120	0.003571429	0.003571429	0	13A	IN-VIP	NA	NA	NA
TACGGGCCACTTAACG-1_5787_BA9	-20.16534749	-21.24588867	6B	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2096	3403	0.004701734	0.009109609	0	6B	IN-SST	NA	NA	NA
TACGGGCTCTTACCTA-1_5787_BA9	6.903846084	-16.57179151	4	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3754	7550	0.001589404	0.018410596	0	L2-3	EN-L2-3-MS	NA	NA	NA
TACGGGCTCTTAGCCC-1_5787_BA9	18.84181218	-24.25903939	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3717	8469	0.001180777	0.032589444	0	3	EN-L5-6	NA	NA	NA
TACGGTAAGTTTAGGA-1_5787_BA9	-19.20817273	-19.24313989	6A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2843	5712	0.00140056	0.004026611	0	6A	IN-PV	NA	NA	NA
TACGGTAGTCCAGTGC-1_5787_BA9	18.64808319	-24.22419537	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5056	12535	0.001834862	0.024012764	0	3	EN-L5-6	NA	NA	NA
TACGGTAGTGCACGAA-1_5787_BA9	26.38002229	4.545910107	15A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1053	1413	0.002830856	0.008492569	0	15A	Endo cells	NA	NA	NA
TACGGTAGTGCGATAG-1_5787_BA9	28.45720875	-18.94866255	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	11001	61533	0.0371833	0.012188582	0	2	EN-L4	NA	NA	NA
TACTCGCAGAAACCGC-1_5787_BA9	10.88345171	-21.93775163	4	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5155	12864	0.002487562	0.008550995	0	L2-3	EN-L2-3-MS	NA	NA	NA
TACTTACAGAACTGTA-1_5787_BA9	24.45552847	-22.01686655	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4019	8645	0.002776171	0.007403123	0	3	EN-L5-6	NA	NA	NA
TACTTACAGTGTCCAT-1_5787_BA9	5.583850703	-18.12338766	4	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3578	7452	0.000670961	0.015968867	0	L2-3	EN-L2-3-MS	NA	NA	NA
TACTTACCAATACGCT-1_5787_BA9	8.921037429	-26.18313999	4	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4928	12534	0.000957396	0.008456997	0	L2-3	EN-L2-3-MS	NA	NA	NA
TACTTACTCAACGGGA-1_5787_BA9	28.63298115	-17.94010449	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	7280	25976	0.028603326	0.008392362	0	2	EN-L4	NA	NA	NA
TACTTACTCGCTAGCG-1_5787_BA9	6.200417343	-13.52057744	4	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2850	5013	0.000997407	0.016157989	0	L2-3	EN-L2-3-MS	NA	NA	NA
TAGACCAAGAGCCCAA-1_5787_BA9	19.90102595	-10.91981851	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2238	3779	0.005821646	0.006880127	0	3	EN-L5-6	NA	NA	NA
TAGACCAAGTTTCCTT-1_5787_BA9	18.00523883	-10.32322436	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2636	4985	0.000401204	0.025075226	0	3	EN-L5-6	NA	NA	NA
TAGAGCTAGATAGCAT-1_5787_BA9	21.23780341	-12.86728068	12	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2820	5102	0.011172089	0.010780086	0	12	EN-MIX	NA	NA	NA
TAGAGCTGTGGACGAT-1_5787_BA9	5.322448344	-3.622229719	12	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	967	1374	0.001455604	0.002183406	0	12	EN-MIX	NA	NA	NA
TAGAGCTTCACGATGT-1_5787_BA9	-10.1911918	-13.90529776	6B	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1085	1459	0.004112406	0.017820425	0	6B	IN-SST	NA	NA	NA
TAGCCGGCACGAAATA-1_5787_BA9	13.67691237	-23.09854499	4	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	6247	18870	0.003656598	0.004345522	0	L2-3	EN-L2-3-MS	NA	NA	NA
TAGCCGGCATGACGGA-1_5787_BA9	23.94375761	-1.436834167	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2297	4110	0.00243309	0.002189781	0	2	EN-L4	NA	NA	NA
TAGCCGGGTGACAAAT-1_5787_BA9	9.88061089	-13.20029175	4	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3138	5403	0.002035906	0.037756802	0	L2-3	EN-L2-3-MS	NA	NA	NA
TAGCCGGTCATTATCC-1_5787_BA9	-1.382066249	31.18836784	17	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1020	1451	0.00137836	0.008959338	0	oligos	OL-MS-2	NA	NA	NA
TAGGCATAGTTAACGA-1_5787_BA9	-7.53717069	-3.125696245	13A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1804	2914	0.00754976	0.007892931	0	13A	IN-VIP	NA	NA	NA
TAGGCATGTCATGCAT-1_5787_BA9	32.65838882	-2.003927279	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2703	5185	0.000578592	0.004628737	0	2	EN-L4	NA	NA	NA
TAGGCATGTCCCGACA-1_5787_BA9	18.95953807	-17.48529149	4	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	7397	25075	0.019022931	0.004187438	0	L2-3	EN-L2-3-MS	NA	NA	NA
TAGGCATTCCGTTGCT-1_5787_BA9	-29.54823322	-12.79476649	9	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	836	1139	0.000877963	0.007023705	0	9	OPC	NA	NA	NA
TAGTGGTAGCTCCTCT-1_5787_BA9	-20.2141396	-23.91340626	6A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2644	4758	0.002311896	0.008406894	0	6A	IN-PV	NA	NA	NA
TAGTGGTAGTTCCACA-1_5787_BA9	32.1462917	-7.7667955	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3756	7574	0	0.01043042	0	2	EN-L4	NA	NA	NA
TAGTGGTCAAACGTGG-1_5787_BA9	-13.68596583	-34.2096911	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1929	3136	0.037308673	0.006696429	0	16	EN-PYR	NA	NA	NA
TAGTGGTCATTGCGGC-1_5787_BA9	-9.392231179	-13.68277651	6B	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1002	1282	0.011700468	0.023400936	0	6B	IN-SST	NA	NA	NA
TAGTGGTGTTTCGCTC-1_5787_BA9	10.06038389	-29.32341167	10	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5870	16602	0.001686544	0.006023371	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TAGTGGTTCTCTAAGG-1_5787_BA9	-5.722725029	-33.69207359	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	810	1031	0.012609117	0.016488846	0	16	EN-PYR	NA	NA	NA
TAGTTGGAGAACAACT-1_5787_BA9	32.56492147	-8.276040662	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3515	7081	0.002259568	0.009038271	0	2	EN-L4	NA	NA	NA
TAGTTGGAGAGTGACC-1_5787_BA9	22.99751093	-0.025947103	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2288	4126	0.000484731	0.003393117	0	2	EN-L4	NA	NA	NA
TAGTTGGAGTACGCGA-1_5787_BA9	17.10262001	-4.6502201	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1597	2644	0.002269289	0.006429652	0	3	EN-L5-6	NA	NA	NA
TAGTTGGCAATGAATG-1_5787_BA9	-13.83675344	-36.57391327	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1905	3216	0.061256219	0.011504975	0	16	EN-PYR	NA	NA	NA
TAGTTGGGTGCACCAC-1_5787_BA9	-7.207678355	-37.45733077	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1041	1343	0.025316456	0.020848846	0	16	EN-PYR	NA	NA	NA
TATCAGGCAAGCCATT-1_5787_BA9	27.99315419	-5.768008206	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5657	15318	0.000652827	0.005810158	0	2	EN-L4	NA	NA	NA
TATCAGGCAAGCCGTC-1_5787_BA9	17.12525525	-29.88926121	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5090	13517	0.001701561	0.005844492	0	3	EN-L5-6	NA	NA	NA
TATCAGGCAGTCACTA-1_5787_BA9	-0.951944052	30.87017552	17	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	957	1340	0	0.005223881	0	oligos	OL-MS-2	NA	NA	NA
TATCAGGGTGTTTGTG-1_5787_BA9	5.209285813	-11.20715457	12	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1838	2885	0.001039861	0.013171577	0	12	EN-MIX	NA	NA	NA
TATCTCAAGTAACCCT-1_5787_BA9	-12.74584398	-33.80614029	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1483	2175	0.013793103	0.008275862	0	16	EN-PYR	NA	NA	NA
TATCTCACAATCCAAC-1_5787_BA9	-21.38800024	-28.51098647	6A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5162	15367	0.000260298	0.004164769	0	6A	IN-PV	NA	NA	NA
TATCTCAGTCTAGGTT-1_5787_BA9	-19.39177323	-18.49749667	6A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2796	5447	0.002753809	0.004589682	0	6A	IN-PV	NA	NA	NA
TATCTCATCTAGCACA-1_5787_BA9	6.222247398	-19.91578547	4	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4557	10371	0.000674959	0.008388776	0	L2-3	EN-L2-3-MS	NA	NA	NA
TATGCCCAGGACGAAA-1_5787_BA9	-13.26995409	-14.28484137	6B	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1643	2500	0.0132	0.0072	0	6B	IN-SST	NA	NA	NA
TATGCCCAGGTGCACA-1_5787_BA9	6.079713159	-12.87863861	4	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2602	4462	0.000896459	0.017256835	0	L2-3	EN-L2-3-MS	NA	NA	NA
TATGCCCGTTCACGGC-1_5787_BA9	-20.42969226	-24.3830027	6A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3027	5764	0.008674532	0.005031228	0	6A	IN-PV	NA	NA	NA
TATGCCCTCGAACTGT-1_5787_BA9	-15.23802659	-14.59591175	6B	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1857	2888	0.00900277	0.013157895	0	6B	IN-SST	NA	NA	NA
TATTACCAGTACGCCC-1_5787_BA9	-25.18943033	-10.2299017	9	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	867	1166	0.002572899	0.007718696	0	9	OPC	NA	NA	NA
TATTACCCAGCTGTTA-1_5787_BA9	-10.7650287	-33.5892915	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1169	1679	0.061346039	0.008338297	0	16	EN-PYR	NA	NA	NA
TATTACCCAGTTCATG-1_5787_BA9	-18.21314455	-23.53893275	6A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2203	3798	0.000789889	0.005265929	0	6A	IN-PV	NA	NA	NA
TATTACCTCCAAATGC-1_5787_BA9	32.17174296	-1.937525442	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3254	6917	0.00318057	0.008818852	0	2	EN-L4	NA	NA	NA
TCAACGACATACGCTA-1_5787_BA9	9.272330546	-28.99110313	10	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	6731	22827	0.000832348	0.004161738	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TCAACGACATCACGAT-1_5787_BA9	18.35069544	-9.594753097	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3259	7680	0.001041667	0.004557292	0	3	EN-L5-6	NA	NA	NA
TCAACGAGTTCGTTGA-1_5787_BA9	21.64444795	-20.64561559	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	6069	17814	0.003929494	0.004378579	0	3	EN-L5-6	NA	NA	NA
TCAATCTAGTGGGTTG-1_5787_BA9	23.23721027	-11.24032217	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3302	6389	0.004069494	0.008295508	0	3	EN-L5-6	NA	NA	NA
TCAATCTGTCTTGATG-1_5787_BA9	-10.48909419	-35.45816841	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1059	1539	0.007797271	0.012995452	0	16	EN-PYR	NA	NA	NA
TCACAAGGTACATCCA-1_5787_BA9	17.97980948	-9.840724795	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2321	4028	0.001241311	0.020854022	0	3	EN-L5-6	NA	NA	NA
TCACAAGGTCAGAGGT-1_5787_BA9	9.045444732	-26.38512799	10	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5189	13579	0.000883718	0.005965093	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TCACAAGTCTACTATC-1_5787_BA9	31.89013409	-2.705457212	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2985	6246	0.005123279	0.004162664	0	2	EN-L4	NA	NA	NA
TCACGAAAGGCAGGTT-1_5787_BA9	-19.7820175	-26.34719662	6A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3867	9249	0.006162828	0.002486755	0	6A	IN-PV	NA	NA	NA
TCACGAAGTCATCGGC-1_5787_BA9	-11.14346095	-33.88969072	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1500	2618	0.156226127	0.009167303	0	16	EN-PYR	NA	NA	NA
TCAGATGCACAACTGT-1_5787_BA9	-5.999987042	-33.85603054	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	832	1108	0.049638989	0.012635379	0	16	EN-PYR	NA	NA	NA
TCAGATGTCATCGATG-1_5787_BA9	-9.420963426	-32.9074752	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	978	1322	0.045385779	0.010590015	0	16	EN-PYR	NA	NA	NA
TCAGCAAAGAACTCGG-1_5787_BA9	13.92850234	-29.81886675	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4567	11623	0.000430182	0.005334251	0	3	EN-L5-6	NA	NA	NA
TCAGCAAAGGGAACGG-1_5787_BA9	26.83397457	-16.20699031	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	7695	26245	0.030253382	0.007353782	0	2	EN-L4	NA	NA	NA
TCAGCAACAACTTGAC-1_5787_BA9	-22.80395277	-1.517269318	9	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1185	1637	0.014660965	0.006108735	0	9	OPC	NA	NA	NA
TCAGCTCCAGCGTAAG-1_5787_BA9	5.918692729	-2.940095728	12	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1240	1829	0.001640241	0.013668671	0	12	EN-MIX	NA	NA	NA
TCAGCTCCATGTAGTC-1_5787_BA9	19.92850259	-34.04313132	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5904	16986	0.00058872	0.007476746	0	3	EN-L5-6	NA	NA	NA
TCAGGATAGCTTATCG-1_5787_BA9	17.19265885	-29.08187621	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5665	15382	0.009231569	0.007281238	0	3	EN-L5-6	NA	NA	NA
TCAGGATCATTCACTT-1_5787_BA9	-12.29454607	-8.665321191	13B	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2130	3661	0.003277793	0.007921333	0	13B	IN-SV2C	NA	NA	NA
TCAGGTACAGTGAGTG-1_5787_BA9	22.09398804	-2.233304915	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2166	3495	0.00286123	0.015164521	0	2	EN-L4	NA	NA	NA
TCAGGTAGTGGGTCAA-1_5787_BA9	-20.90798973	-25.32853088	6A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3376	7243	0.001242579	0.005522574	0	6A	IN-PV	NA	NA	NA
TCATTACAGAAACCTA-1_5787_BA9	33.42141051	-5.214442614	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3315	6786	0.002505158	0.008399646	0	2	EN-L4	NA	NA	NA
TCATTACGTCTAACGT-1_5787_BA9	21.70533117	-9.247556829	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2030	3225	0.000310078	0.008372093	0	3	EN-L5-6	NA	NA	NA
TCATTACGTGTGTGCC-1_5787_BA9	22.01009869	-9.485246471	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2260	4289	0.001398927	0.005129401	0	3	EN-L5-6	NA	NA	NA
TCATTTGAGCTGATAA-1_5787_BA9	31.76979582	-3.139022562	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3183	6589	0.00075884	0.005463652	0	2	EN-L4	NA	NA	NA
TCATTTGCATCATCCC-1_5787_BA9	-9.623127321	-32.61492933	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	943	1243	0.024939662	0.008045052	0	16	EN-PYR	NA	NA	NA
TCATTTGGTGCTCTTC-1_5787_BA9	-7.407066668	-33.6880776	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	937	1309	0.08250573	0.014514897	0	16	EN-PYR	NA	NA	NA
TCATTTGGTGGCTCCA-1_5787_BA9	-0.922977807	35.30411411	17	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	745	1042	0.002879079	0.004798464	0	oligos	OL-MS-2	NA	NA	NA
TCATTTGGTTCCATGA-1_5787_BA9	16.0822062	-31.81879384	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5349	16731	0.000537924	0.004064312	0	3	EN-L5-6	NA	NA	NA
TCCACACAGTACGTTC-1_5787_BA9	-15.18465456	-15.69387232	6B	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1837	2946	0.002376103	0.008825526	0	6B	IN-SST	NA	NA	NA
TCCACACGTCGATTGT-1_5787_BA9	29.33259936	-12.53779853	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5435	13823	0.00723432	0.010706793	0	2	EN-L4	NA	NA	NA
TCCACACGTTCTGAAC-1_5787_BA9	-9.978178593	-9.4444364	13B	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1304	1863	0.003757381	0.00805153	0	13B	IN-SV2C	NA	NA	NA
TCCCGATAGGCGATAC-1_5787_BA9	25.66508268	-26.32379651	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	6643	21050	0.000617577	0.004418052	0	3	EN-L5-6	NA	NA	NA
TCCCGATCACACCGCA-1_5787_BA9	8.766825751	-26.49310832	10	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5947	17388	0.001207729	0.005636071	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TCCCGATGTTAAGAAC-1_5787_BA9	-16.1731968	-8.640732937	13B	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2690	4622	0.007788836	0.015794029	0	13B	IN-SV2C	NA	NA	NA
TCGAGGCGTCGAAAGC-1_5787_BA9	31.86846381	-2.885194547	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2962	5997	0.000667	0.003001501	0	2	EN-L4	NA	NA	NA
TCGAGGCGTGATGCCC-1_5787_BA9	-9.522629336	-33.64748386	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1046	1424	0.014747191	0.010533708	0	16	EN-PYR	NA	NA	NA
TCGAGGCGTGTCCTCT-1_5787_BA9	28.65692074	-4.532228195	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4349	10691	0.00084183	0.005144514	0	2	EN-L4	NA	NA	NA
TCGAGGCTCCTTCAAT-1_5787_BA9	-13.53070464	-35.49474175	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1768	2900	0.043448276	0.012068966	0	16	EN-PYR	NA	NA	NA
TCGCGAGCACTATCTT-1_5787_BA9	30.50524948	-5.094581375	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3822	8138	0.000614402	0.008601622	0	2	EN-L4	NA	NA	NA
TCGCGTTAGCAATATG-1_5787_BA9	31.72763229	-3.064679689	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3364	7169	0.000836937	0.006556005	0	2	EN-L4	NA	NA	NA
TCGCGTTAGTTTAGGA-1_5787_BA9	-11.80320136	-6.407096125	13A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2319	3844	0.016909469	0.00780437	0	13A	IN-VIP	NA	NA	NA
TCGGGACAGTAGATGT-1_5787_BA9	-4.804149876	-7.899345102	13A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	858	1138	0.000878735	0.008787346	0	13A	IN-VIP	NA	NA	NA
TCGGGACCAATAGAGT-1_5787_BA9	-12.64516345	-34.89567467	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1436	2265	0.051214128	0.011479029	0	16	EN-PYR	NA	NA	NA
TCGGTAACAACCGCCA-1_5787_BA9	-13.11662002	-35.96215828	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1608	2536	0.030362776	0.016167192	0	16	EN-PYR	NA	NA	NA
TCGTACCCAGTCGATT-1_5787_BA9	9.14443398	-31.13141592	10	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4951	14616	0.001368363	0.003831418	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TCGTAGAGTGTTTGGT-1_5787_BA9	19.57700069	-17.53321235	4	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	6610	19082	0.016926947	0.006498271	0	L2-3	EN-L2-3-MS	NA	NA	NA
TCGTAGATCACAACGT-1_5787_BA9	-7.763976106	-33.22977896	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	851	1090	0.012844037	0.014678899	0	16	EN-PYR	NA	NA	NA
TCGTAGATCTAACGGT-1_5787_BA9	3.360227866	-13.7376	4	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2444	4314	0.001159017	0.006954103	0	L2-3	EN-L2-3-MS	NA	NA	NA
TCTATTGAGGCAGGTT-1_5787_BA9	12.1111446	-24.40207275	4	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5178	13295	0.000827379	0.018352764	0	L2-3	EN-L2-3-MS	NA	NA	NA
TCTCATAGTCGATTGT-1_5787_BA9	9.453974713	-27.33049217	10	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4848	12593	0.000476455	0.009052648	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TCTCTAAAGCGTCTAT-1_5787_BA9	27.71320722	-5.465495271	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4767	12669	0.000157866	0.006156761	0	2	EN-L4	NA	NA	NA
TCTCTAAAGGCAAAGA-1_5787_BA9	18.06568746	-9.91934698	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2370	4323	0.002081888	0.021744159	0	3	EN-L5-6	NA	NA	NA
TCTCTAAAGGTCATCT-1_5787_BA9	-10.5885679	-7.210908355	13A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2021	3235	0.01236476	0.007109737	0	13A	IN-VIP	NA	NA	NA
TCTCTAACACCACCAG-1_5787_BA9	12.82789901	1.928048898	12	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1118	1615	0.00123839	0.00371517	0	12	EN-MIX	NA	NA	NA
TCTCTAACAGCGTCCA-1_5787_BA9	32.97732932	-2.776952486	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3060	6374	0.001882648	0.003608409	0	2	EN-L4	NA	NA	NA
TCTCTAACAGGTGCCT-1_5787_BA9	-14.08977503	-20.15112852	6A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1540	2570	0.000389105	0.005447471	0	6A	IN-PV	NA	NA	NA
TCTCTAAGTCAACATC-1_5787_BA9	-26.28469216	-10.19151627	9	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	899	1248	0.001602564	0.009615385	0	9	OPC	NA	NA	NA
TCTCTAAGTTATCCGA-1_5787_BA9	7.966743851	-27.25088967	10	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5107	14908	0.000201234	0.005366246	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TCTGAGAGTCCGTGAC-1_5787_BA9	-17.78249232	-7.563199758	13B	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3342	6086	0.015609596	0.009858692	0	13B	IN-SV2C	NA	NA	NA
TCTGAGAGTTGATTGC-1_5787_BA9	-7.886921938	-30.05812101	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	905	1222	0.0400982	0.007364975	0	16	EN-PYR	NA	NA	NA
TCTGAGATCCCAAGTA-1_5787_BA9	2.275637965	-13.74845451	4	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2458	4451	0.00157268	0.002246686	0	L2-3	EN-L2-3-MS	NA	NA	NA
TCTGAGATCGCTAGCG-1_5787_BA9	10.1063322	-29.96099281	10	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4643	10996	0.000363769	0.010913059	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TCTGGAAGTGAACCTT-1_5787_BA9	-14.86790177	-21.47037718	6A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1650	2534	0.000789266	0.004340963	0	6A	IN-PV	NA	NA	NA
TCTTCGGAGAGATGAG-1_5787_BA9	-4.60624784	-33.20118143	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	759	1000	0.066	0.018	0	16	EN-PYR	NA	NA	NA
TCTTCGGGTATTCGTG-1_5787_BA9	-8.524221426	-4.431662467	13A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1763	2981	0.00167729	0.007044616	0	13A	IN-VIP	NA	NA	NA
TCTTCGGGTCTGGAGA-1_5787_BA9	9.621160849	-25.45472901	4	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4949	13756	0.004361733	0.003707473	0	L2-3	EN-L2-3-MS	NA	NA	NA
TCTTTCCAGGCTAGAC-1_5787_BA9	31.34297469	-1.366585979	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3253	6758	0.003551347	0.004883102	0	2	EN-L4	NA	NA	NA
TCTTTCCCAACCGCCA-1_5787_BA9	15.29787337	-31.87885908	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5475	18671	0.000589149	0.003106422	0	3	EN-L5-6	NA	NA	NA
TCTTTCCCAAGTCTGT-1_5787_BA9	-6.177840584	-34.65225147	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	800	1008	0.006944444	0.018849206	0	16	EN-PYR	NA	NA	NA
TCTTTCCCAGATGAGC-1_5787_BA9	1.016102557	-12.22725942	12	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2144	3956	0	0.002022245	0	12	EN-MIX	NA	NA	NA
TCTTTCCTCCACGAAT-1_5787_BA9	20.8522806	-0.540326262	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1545	2440	0.002868852	0.009836066	0	2	EN-L4	NA	NA	NA
TGAAAGAAGCTGAAAT-1_5787_BA9	4.801780268	-17.57239301	4	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2991	5325	0.00056338	0.014835681	0	L2-3	EN-L2-3-MS	NA	NA	NA
TGAAAGACACAGGAGT-1_5787_BA9	16.63336492	-29.53680839	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4627	11643	0.000171777	0.005582754	0	3	EN-L5-6	NA	NA	NA
TGAAAGAGTCTCTTTA-1_5787_BA9	16.47024134	-30.80428485	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4974	13895	0.001079525	0.003382512	0	3	EN-L5-6	NA	NA	NA
TGAAAGAGTTGACGTT-1_5787_BA9	-8.072431375	-3.572452097	13A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1826	3072	0.001953125	0.008789063	0	13A	IN-VIP	NA	NA	NA
TGACAACAGTACGTTC-1_5787_BA9	-25.33510376	-10.1045469	9	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	849	1128	0.003546099	0.005319149	0	9	OPC	NA	NA	NA
TGACAACAGTGGGTTG-1_5787_BA9	-10.11324898	-36.36337646	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1193	1698	0.034157833	0.011778563	0	16	EN-PYR	NA	NA	NA
TGACAACGTCGCTTTC-1_5787_BA9	25.94147982	-27.10178516	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5637	17399	0.00063222	0.004712915	0	3	EN-L5-6	NA	NA	NA
TGACGGCAGTACGTAA-1_5787_BA9	24.62392372	-19.99316551	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5100	12669	0.00363091	0.006630358	0	3	EN-L5-6	NA	NA	NA
TGACGGCGTAAACACA-1_5787_BA9	-14.78944214	-37.23219936	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2640	5109	0.082403601	0.014679977	0	16	EN-PYR	NA	NA	NA
TGACGGCGTCCAGTAT-1_5787_BA9	29.775127	-17.62323101	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	7315	24592	0.034767404	0.007360117	0	2	EN-L4	NA	NA	NA
TGACGGCGTGCAACTT-1_5787_BA9	18.19721453	-31.29217982	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5773	16640	0.003004808	0.004807692	0	3	EN-L5-6	NA	NA	NA
TGACGGCTCGGCTACG-1_5787_BA9	26.71222818	-2.565964819	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3232	6478	0.000926212	0.006946588	0	2	EN-L4	NA	NA	NA
TGACGGCTCTAACCGA-1_5787_BA9	-16.05603644	-17.06660742	6B	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2059	3457	0.00318195	0.005496095	0	6B	IN-SST	NA	NA	NA
TGACTAGCACTACAGT-1_5787_BA9	17.12287076	-19.00305799	4	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	6973	22436	0.019967909	0.006061687	0	L2-3	EN-L2-3-MS	NA	NA	NA
TGACTAGGTTGAACTC-1_5787_BA9	25.62392165	-26.32329064	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4935	12947	0.001776473	0.007183131	0	3	EN-L5-6	NA	NA	NA
TGACTTTCAAGGACAC-1_5787_BA9	3.511786485	-19.02266456	4	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3725	7977	0.001002883	0.007020183	0	L2-3	EN-L2-3-MS	NA	NA	NA
TGACTTTCAATTGCTG-1_5787_BA9	10.28592329	-28.48036286	10	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4630	12194	0.005412498	0.003362309	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TGAGAGGAGTCAATAG-1_5787_BA9	21.62975478	-26.42313492	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3545	7753	0.016509738	0.009028763	0	3	EN-L5-6	NA	NA	NA
TGAGCATAGAGTGACC-1_5787_BA9	25.16434726	-24.29257138	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4426	11482	0.0024386	0.003657899	0	3	EN-L5-6	NA	NA	NA
TGAGCATGTCCGAACC-1_5787_BA9	29.36783125	-3.169002257	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4262	10892	0.001928021	0.006059493	0	2	EN-L4	NA	NA	NA
TGAGCATTCGCTAGCG-1_5787_BA9	18.12046537	-31.40596086	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	7230	24121	0.003938477	0.005223664	0	3	EN-L5-6	NA	NA	NA
TGAGCCGGTGAGGGTT-1_5787_BA9	16.81722726	-26.49238777	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4680	11014	0.002723806	0.010804431	0	3	EN-L5-6	NA	NA	NA
TGAGCCGTCGCATGAT-1_5787_BA9	-7.152723733	-32.50510642	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	842	1064	0.033834586	0.010338346	0	16	EN-PYR	NA	NA	NA
TGAGGGAAGCTAGCCC-1_5787_BA9	17.38313282	-5.374544392	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1485	2331	0.001287001	0.004290004	0	3	EN-L5-6	NA	NA	NA
TGAGGGAAGGGATGGG-1_5787_BA9	7.409445907	-3.371552208	12	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1675	2367	0.001689903	0.025348542	0	12	EN-MIX	NA	NA	NA
TGAGGGACAGATGGGT-1_5787_BA9	31.53469664	-12.72714415	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3619	6828	0.005565319	0.009080258	0	2	EN-L4	NA	NA	NA
TGAGGGAGTGTCAATC-1_5787_BA9	-28.09066926	-5.360329766	9	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1372	1968	0.00050813	0.010162602	0	9	OPC	NA	NA	NA
TGAGGGATCTCGTTTA-1_5787_BA9	-15.2583976	-9.427764463	13B	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2535	4602	0.000869187	0.009343764	0	13B	IN-SV2C	NA	NA	NA
TGCACCTCATCCTTGC-1_5787_BA9	-27.7018028	-10.33416019	9	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	875	1112	0.000899281	0.006294964	0	9	OPC	NA	NA	NA
TGCCAAACATGCAATC-1_5787_BA9	-13.20590622	14.49903879	8	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	995	1296	0	0.005401235	0	8	Astrocytes	NA	NA	NA
TGCCCATCATGGATGG-1_5787_BA9	19.98730379	-11.16868981	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2525	4403	0.009538951	0.003861004	0	3	EN-L5-6	NA	NA	NA
TGCCCATGTACAGTTC-1_5787_BA9	16.63213185	-30.23510168	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5382	14702	0.002448646	0.004421167	0	3	EN-L5-6	NA	NA	NA
TGCCCATGTGACAAAT-1_5787_BA9	3.644672229	-18.73866562	4	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3953	8396	0.000476417	0.008932825	0	L2-3	EN-L2-3-MS	NA	NA	NA
TGCCCATTCATGCATG-1_5787_BA9	-17.81146599	-21.20528372	6A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1978	3453	0.004344049	0.005502462	0	6A	IN-PV	NA	NA	NA
TGCCCATTCATGCTCC-1_5787_BA9	5.184351424	-18.11627377	4	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3460	6969	0.000430478	0.015784187	0	L2-3	EN-L2-3-MS	NA	NA	NA
TGCCCTAAGGCGATAC-1_5787_BA9	11.62307975	-25.18755503	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	6697	19640	0.000916497	0.012525458	0	3	EN-L5-6	NA	NA	NA
TGCCCTAAGGTAGCCA-1_5787_BA9	17.41548669	-5.046441674	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1183	1847	0.001082837	0.004872767	0	3	EN-L5-6	NA	NA	NA
TGCCCTACAAGTAGTA-1_5787_BA9	-29.254328	-12.59727834	9	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	915	1242	0.001610306	0.00805153	0	9	OPC	NA	NA	NA
TGCCCTATCGGTTCGG-1_5787_BA9	32.06527628	-1.915180513	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3392	6714	0.001042598	0.010128091	0	2	EN-L4	NA	NA	NA
TGCGCAGAGAGGTTAT-1_5787_BA9	2.158809753	-18.61523216	4	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3520	7436	0.002017214	0.00295858	0	L2-3	EN-L2-3-MS	NA	NA	NA
TGCGCAGAGCACCGTC-1_5787_BA9	-25.54625249	-10.60746829	9	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	893	1200	0.005833333	0.02	0	9	OPC	NA	NA	NA
TGCGCAGAGCGTGAGT-1_5787_BA9	-7.451661187	-37.33656318	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1044	1384	0.033959538	0.016618497	0	16	EN-PYR	NA	NA	NA
TGCGCAGAGCTAGTGG-1_5787_BA9	18.39937242	-27.76799016	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5929	17406	0.001149029	0.007813398	0	3	EN-L5-6	NA	NA	NA
TGCGGGTGTCAGTGGA-1_5787_BA9	4.61840067	-17.16437598	4	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2847	5200	0.001153846	0.0125	0	L2-3	EN-L2-3-MS	NA	NA	NA
TGCGTGGTCAACACCA-1_5787_BA9	25.13681716	7.093499459	15A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1824	2723	0.025339699	0.016158649	0	15A	Endo cells	NA	NA	NA
TGCGTGGTCAGTCCCT-1_5787_BA9	9.641874231	-24.03569645	4	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5394	13888	0.000792051	0.013608871	0	L2-3	EN-L2-3-MS	NA	NA	NA
TGCTACCCAATGACCT-1_5787_BA9	-14.69599081	-16.90795926	6B	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1470	2344	0.001279863	0.010238908	0	6B	IN-SST	NA	NA	NA
TGCTACCCACATGTGT-1_5787_BA9	-14.26372245	-35.96509926	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2362	4611	0.090002169	0.010193017	0	16	EN-PYR	NA	NA	NA
TGCTACCCATCCGGGT-1_5787_BA9	-13.04517022	-35.27856163	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1658	2672	0.045658683	0.008607784	0	16	EN-PYR	NA	NA	NA
TGCTACCTCCCGGATG-1_5787_BA9	2.497793675	-18.3934005	4	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3615	7682	0.000390523	0.002473314	0	L2-3	EN-L2-3-MS	NA	NA	NA
TGCTACCTCCTTTCGG-1_5787_BA9	18.12056587	-10.67598597	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2963	5361	0.000373065	0.022570416	0	3	EN-L5-6	NA	NA	NA
TGCTACCTCGGATGGA-1_5787_BA9	18.10066549	-27.78319625	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5506	15435	0.002721088	0.007839326	0	3	EN-L5-6	NA	NA	NA
TGCTACCTCTAAGCCA-1_5787_BA9	19.23835475	-25.94467293	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2892	5082	0.002558048	0.018103109	0	3	EN-L5-6	NA	NA	NA
TGCTGCTAGTAGCCGA-1_5787_BA9	32.0571241	-8.539666274	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3601	7157	0.000978063	0.009221741	0	2	EN-L4	NA	NA	NA
TGGACGCAGTGGTCCC-1_5787_BA9	24.63679068	-21.19933096	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	6329	19046	0.00929329	0.004777906	0	3	EN-L5-6	NA	NA	NA
TGGACGCCACGAGGTA-1_5787_BA9	-6.323553261	-32.249157	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	786	1037	0.042430087	0.012536162	0	16	EN-PYR	NA	NA	NA
TGGACGCTCAATACCG-1_5787_BA9	14.73168495	-29.10436266	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5939	17047	0.001818502	0.004458262	0	3	EN-L5-6	NA	NA	NA
TGGCCAGCATCGGGTC-1_5787_BA9	-12.75161777	-2.484408508	13A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2745	5084	0.005900865	0.01140834	0	13A	IN-VIP	NA	NA	NA
TGGCCAGCATGCCTTC-1_5787_BA9	-26.55040468	-9.296708649	9	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1010	1367	0.005120702	0.008046818	0	9	OPC	NA	NA	NA
TGGCCAGTCAGCGATT-1_5787_BA9	3.676306105	-4.541408005	12	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1170	1793	0.002230898	0.007250418	0	12	EN-MIX	NA	NA	NA
TGGCGCAAGGAATGGA-1_5787_BA9	-11.25650799	-15.19382211	6B	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1204	1752	0.001712329	0.00913242	0	6B	IN-SST	NA	NA	NA
TGGCGCAGTCTTGCGG-1_5787_BA9	33.43974025	-3.540478016	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2702	5006	0.002996404	0.004594487	0	2	EN-L4	NA	NA	NA
TGGCGCATCCGCGTTT-1_5787_BA9	-10.32202889	-15.24050492	6B	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1038	1414	0.004243281	0.005657709	0	6B	IN-SST	NA	NA	NA
TGGCTGGAGACGCAAC-1_5787_BA9	-9.849440457	-33.20520075	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1136	1563	0.024952015	0.014715291	0	16	EN-PYR	NA	NA	NA
TGGGAAGCAGACGCAA-1_5787_BA9	-12.61264396	-2.354893066	13A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2897	5406	0.002404735	0.005734369	0	13A	IN-VIP	NA	NA	NA
TGGGCGTGTCAAAGAT-1_5787_BA9	-8.204958175	-38.05579658	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1253	1699	0.050618011	0.018834609	0	16	EN-PYR	NA	NA	NA
TGGTTAGGTACCATCA-1_5787_BA9	-12.10696528	-34.09943775	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1388	1977	0.028325746	0.010622155	0	16	EN-PYR	NA	NA	NA
TGGTTCCGTCACCTAA-1_5787_BA9	27.92027525	5.636674677	15A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	796	1018	0.020628684	0.020628684	0	15A	Endo cells	NA	NA	NA
TGGTTCCTCACAGGCC-1_5787_BA9	-12.11950978	-35.11213296	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1251	1850	0.019459459	0.012432432	0	16	EN-PYR	NA	NA	NA
TGTATTCAGCCTCGTG-1_5787_BA9	9.158659745	-30.69415022	10	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4190	9746	0.000513031	0.007490252	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TGTATTCAGGCGACAT-1_5787_BA9	6.520529067	-10.46759347	12	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1814	2510	0.001593625	0.026693227	0	12	EN-MIX	NA	NA	NA
TGTATTCCACAGTCGC-1_5787_BA9	21.14539447	-27.46295861	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3646	8703	0.000919223	0.004596116	0	3	EN-L5-6	NA	NA	NA
TGTATTCGTTGGAGGT-1_5787_BA9	4.061685652	-18.80349287	4	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3817	8094	0.001359031	0.011489993	0	L2-3	EN-L2-3-MS	NA	NA	NA
TGTATTCTCAAGATCC-1_5787_BA9	31.87761808	-1.653662831	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2976	5926	0.001856227	0.004893689	0	2	EN-L4	NA	NA	NA
TGTCCCAAGATGCGAC-1_5787_BA9	3.381973467	-13.64222795	4	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2374	4105	0.001948843	0.005359318	0	L2-3	EN-L2-3-MS	NA	NA	NA
TGTCCCAAGCAGGCTA-1_5787_BA9	16.89426198	-29.95219607	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5487	14907	0.000670826	0.005433689	0	3	EN-L5-6	NA	NA	NA
TGTCCCACAGTATAAG-1_5787_BA9	-11.55693085	-34.35839475	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1275	1869	0.027822365	0.009630819	0	16	EN-PYR	NA	NA	NA
TGTCCCAGTATGGTTC-1_5787_BA9	-24.05953379	6.370888512	8	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	786	1068	0	0.013108614	0	8	Astrocytes	NA	NA	NA
TGTCCCAGTCTGCAAT-1_5787_BA9	25.0187982	-1.075775014	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2624	5675	0.000704846	0.002290749	0	2	EN-L4	NA	NA	NA
TGTGGTAAGAGCTATA-1_5787_BA9	24.53726704	-19.92482311	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	6527	19350	0.007338501	0.005736434	0	3	EN-L5-6	NA	NA	NA
TGTGGTACATAGGATA-1_5787_BA9	-12.98123438	-17.05138235	6B	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1480	2111	0.001421127	0.017053529	0	6B	IN-SST	NA	NA	NA
TGTGGTAGTATCACCA-1_5787_BA9	25.86174001	-26.83133703	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5776	16854	0.00094933	0.003203987	0	3	EN-L5-6	NA	NA	NA
TGTGGTATCCGTTGCT-1_5787_BA9	-17.00162697	-25.266429	6A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2706	5517	0.004168932	0.004893964	0	6A	IN-PV	NA	NA	NA
TGTGTTTTCCGAAGAG-1_5787_BA9	11.48427356	-26.30176739	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5607	13959	0.001934236	0.007736944	0	3	EN-L5-6	NA	NA	NA
TGTTCCGCAATAGCGG-1_5787_BA9	16.10879795	-28.00903749	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4496	10768	0.001300149	0.005293462	0	3	EN-L5-6	NA	NA	NA
TGTTCCGCACTTCGAA-1_5787_BA9	2.55401573	-11.62854104	12	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1903	3122	0.000960922	0.00640615	0	12	EN-MIX	NA	NA	NA
TGTTCCGCATGTCTCC-1_5787_BA9	-20.30780251	-15.97264603	6B	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3275	6399	0.003594312	0.013283326	0	6B	IN-SST	NA	NA	NA
TGTTCCGGTAATCACC-1_5787_BA9	25.36545494	-27.3345748	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4968	13037	0.000383524	0.005676152	0	3	EN-L5-6	NA	NA	NA
TGTTCCGGTGCACTTA-1_5787_BA9	-11.91626669	-2.430282614	13A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2589	4597	0.002392865	0.011746791	0	13A	IN-VIP	NA	NA	NA
TGTTCCGGTTACGACT-1_5787_BA9	-15.08815182	-14.75868323	6B	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1793	2916	0.00308642	0.018518519	0	6B	IN-SST	NA	NA	NA
TGTTCCGTCTACCAGA-1_5787_BA9	-8.321868806	-35.05233423	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	920	1309	0.035905271	0.014514897	0	16	EN-PYR	NA	NA	NA
TTAACTCCAACAACCT-1_5787_BA9	29.21676063	-12.5085059	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5868	17049	0.024282949	0.007859699	0	2	EN-L4	NA	NA	NA
TTAGGACGTTAGAACA-1_5787_BA9	6.553106141	-11.2659705	4	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2396	3748	0.000533618	0.024813234	0	L2-3	EN-L2-3-MS	NA	NA	NA
TTAGGACTCTCCGGTT-1_5787_BA9	18.56018744	-0.470021992	12	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1411	2595	0.003853565	0.002697495	0	12	EN-MIX	NA	NA	NA
TTAGGCAAGACAATAC-1_5787_BA9	2.337532217	-20.35092887	4	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4559	11077	0.000451386	0.00379164	0	L2-3	EN-L2-3-MS	NA	NA	NA
TTAGGCACACTTACGA-1_5787_BA9	21.82458262	-24.02547765	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4712	11907	0.002099605	0.015873016	0	3	EN-L5-6	NA	NA	NA
TTAGGCACATAACCTG-1_5787_BA9	5.916967919	-11.54322231	4	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2031	3154	0.000634115	0.01934052	0	L2-3	EN-L2-3-MS	NA	NA	NA
TTAGGCAGTGCACTTA-1_5787_BA9	34.63073064	-5.583813759	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3394	6488	0.000462392	0.010172626	0	2	EN-L4	NA	NA	NA
TTAGGCATCTAACTCT-1_5787_BA9	-30.79805202	-11.20556099	9	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	899	1297	0.00154202	0.00462606	0	9	OPC	NA	NA	NA
TTAGTTCCAGTATAAG-1_5787_BA9	15.99747593	-4.571543834	12	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1492	2269	0.000881446	0.018069634	0	12	EN-MIX	NA	NA	NA
TTAGTTCGTATAAACG-1_5787_BA9	16.89484897	-29.21235334	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4886	12581	0.001192274	0.003179398	0	3	EN-L5-6	NA	NA	NA
TTAGTTCTCATCTGCC-1_5787_BA9	31.82932211	-1.283473166	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2708	5436	0.001287712	0.00459897	0	2	EN-L4	NA	NA	NA
TTAGTTCTCTGCAAGT-1_5787_BA9	-11.44006593	-33.73964658	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1178	1747	0.028620492	0.009158558	0	16	EN-PYR	NA	NA	NA
TTATGCTCATCACGTA-1_5787_BA9	24.39764026	-26.75474455	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4532	11214	0.000891742	0.008114856	0	3	EN-L5-6	NA	NA	NA
TTATGCTTCGGTTAAC-1_5787_BA9	32.32424498	-9.086133849	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3447	6826	0.00439496	0.014649868	0	2	EN-L4	NA	NA	NA
TTCCCAGAGACGCAAC-1_5787_BA9	-7.693676593	-3.660301496	13A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1815	3026	0.000330469	0.005948447	0	13A	IN-VIP	NA	NA	NA
TTCCCAGGTTAAGAAC-1_5787_BA9	5.838362903	-12.53412486	4	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2705	4906	0.000203832	0.016306563	0	L2-3	EN-L2-3-MS	NA	NA	NA
TTCCCAGTCCTTAATC-1_5787_BA9	17.14566163	-32.32011621	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	6419	24254	0.0013606	0.003215964	0	3	EN-L5-6	NA	NA	NA
TTCGAAGTCGCGCCAA-1_5787_BA9	17.62605609	-7.494493479	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1923	3023	0.002977175	0.009593119	0	3	EN-L5-6	NA	NA	NA
TTCGGTCCATTCCTGC-1_5787_BA9	34.04823452	-4.572531434	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2750	5126	0.004682013	0.007608272	0	2	EN-L4	NA	NA	NA
TTCTACAGTTATGTGC-1_5787_BA9	-14.55905138	-6.268526683	13B	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3278	7046	0.010502413	0.005393131	0	13B	IN-SV2C	NA	NA	NA
TTCTCAAAGGGCTTCC-1_5787_BA9	17.54018282	-31.08754951	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5650	16909	0.001951623	0.004021527	0	3	EN-L5-6	NA	NA	NA
TTCTCAAGTTATCGGT-1_5787_BA9	6.649969795	-28.99531254	10	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3286	7498	0.000133369	0.003867698	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TTCTCCTGTAAGAGGA-1_5787_BA9	25.03929921	-22.8976079	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4761	11859	0.003119993	0.004131883	0	3	EN-L5-6	NA	NA	NA
TTGAACGAGCCAGGAT-1_5787_BA9	27.53677047	7.259094233	15A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1059	1370	0.023357664	0.02919708	0	15A	Endo cells	NA	NA	NA
TTGAACGAGGCGATAC-1_5787_BA9	15.73933294	-30.06252566	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3594	7884	0.000761035	0.008371385	0	3	EN-L5-6	NA	NA	NA
TTGAACGTCAGTGCAT-1_5787_BA9	11.18790937	-0.177504293	12	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1094	1465	0.001365188	0.003412969	0	12	EN-MIX	NA	NA	NA
TTGCCGTCATGTAAGA-1_5787_BA9	-16.57408169	-9.15869822	13B	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3198	5992	0.002837116	0.01034713	0	13B	IN-SV2C	NA	NA	NA
TTGCCGTCATTATCTC-1_5787_BA9	-21.44549193	-25.60653791	6A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4243	9947	0.00140746	0.004926108	0	6A	IN-PV	NA	NA	NA
TTGCCGTGTTCCGGCA-1_5787_BA9	18.06191852	-10.24028218	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3174	6520	0.000153374	0.020398773	0	3	EN-L5-6	NA	NA	NA
TTGCGTCGTTATCACG-1_5787_BA9	19.63244621	1.344265727	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1489	2318	0.002588438	0.004314064	0	2	EN-L4	NA	NA	NA
TTGCGTCTCCATGAGT-1_5787_BA9	-7.178397878	-33.32274682	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	815	1064	0.058270677	0.010338346	0	16	EN-PYR	NA	NA	NA
TTGGAACGTGGTTTCA-1_5787_BA9	-19.91523495	-25.45879097	6A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2891	5943	0.000504796	0.006225812	0	6A	IN-PV	NA	NA	NA
TTGGAACTCACGACTA-1_5787_BA9	9.743363103	-24.27220699	4	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5348	13792	0.001232599	0.011165893	0	L2-3	EN-L2-3-MS	NA	NA	NA
TTGGAACTCTTTACGT-1_5787_BA9	21.7728527	-24.54485013	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4171	9311	0.000536999	0.017506175	0	3	EN-L5-6	NA	NA	NA
TTGGCAACAGTACACT-1_5787_BA9	10.20924578	-29.06968102	10	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	6256	18221	0.002195269	0.005488173	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TTGGCAACATCGATTG-1_5787_BA9	-19.40764939	-16.66807298	6B	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2761	4939	0.000809881	0.010933387	0	6B	IN-SST	NA	NA	NA
TTGTAGGAGAATGTTG-1_5787_BA9	11.41591424	-25.2544907	10	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5449	13869	0.00043262	0.014348547	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TTGTAGGTCACGCGGT-1_5787_BA9	30.33003582	-7.38751677	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5245	15599	0.005384961	0.005833707	0	2	EN-L4	NA	NA	NA
TTGTAGGTCAGATAAG-1_5787_BA9	17.27308111	-28.58939746	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4781	11537	0.003293751	0.004507238	0	3	EN-L5-6	NA	NA	NA
TTGTAGGTCCTGTAGA-1_5787_BA9	31.16219632	-6.834939658	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4910	12409	0.001853493	0.007655734	0	2	EN-L4	NA	NA	NA
TTGTAGGTCGTGGGAA-1_5787_BA9	17.60345042	-30.98292212	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	5817	16398	0.000487864	0.005976339	0	3	EN-L5-6	NA	NA	NA
TTTACTGCATTCTCAT-1_5787_BA9	-8.963076053	-5.110282508	13A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1781	2970	0.007744108	0.007070707	0	13A	IN-VIP	NA	NA	NA
TTTACTGTCAGTTAGC-1_5787_BA9	-14.03196074	-3.889679882	13A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3015	5839	0.004110293	0.007364275	0	13A	IN-VIP	NA	NA	NA
TTTATGCAGTAATCCC-1_5787_BA9	-25.35118345	-11.35273319	9	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	906	1206	0.002487562	0.004145937	0	9	OPC	NA	NA	NA
TTTATGCAGTTTGCGT-1_5787_BA9	-13.57411456	-9.134805006	13B	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2140	3529	0.001133466	0.010484557	0	13B	IN-SV2C	NA	NA	NA
TTTCCTCTCAACGCTA-1_5787_BA9	8.35587076	-26.2803463	10	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4957	14500	0.000827586	0.005241379	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TTTGCGCCACATCCGG-1_5787_BA9	18.412317	-6.885298162	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1775	3173	0.000630318	0.002206114	0	3	EN-L5-6	NA	NA	NA
TTTGCGCGTCTAGTGT-1_5787_BA9	-9.613301307	-6.494375212	13A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1756	2705	0.004066543	0.008502773	0	13A	IN-VIP	NA	NA	NA
TTTGCGCTCAGCACAT-1_5787_BA9	-18.55076798	-21.29690531	6A	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2585	5139	0.001556723	0.00486476	0	6A	IN-PV	NA	NA	NA
TTTGGTTAGACCGGAT-1_5787_BA9	-20.04741457	-21.04921334	6B	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1743	2579	0.009305933	0.016673129	0	6B	IN-SST	NA	NA	NA
TTTGGTTAGCAGCGTA-1_5787_BA9	21.00145375	-27.16969775	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3229	6960	0.001436782	0.00316092	0	3	EN-L5-6	NA	NA	NA
TTTGGTTCATCCTAGA-1_5787_BA9	-13.57806195	-35.95733428	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	1776	3026	0.038664904	0.005617978	0	16	EN-PYR	NA	NA	NA
TTTGGTTGTCCAGTTA-1_5787_BA9	-8.603681692	-31.66470942	16	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	955	1320	0.06969697	0.016666667	0	16	EN-PYR	NA	NA	NA
TTTGGTTGTGCAGACA-1_5787_BA9	25.64231581	-27.30889377	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4791	12825	0.000623782	0.00460039	0	3	EN-L5-6	NA	NA	NA
TTTGGTTTCCTCGCAT-1_5787_BA9	14.21853328	-32.16475078	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4883	14491	0.000138017	0.003036367	0	3	EN-L5-6	NA	NA	NA
TTTGGTTTCTTCTGGC-1_5787_BA9	31.58167932	-3.113045968	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	2922	6175	0.000323887	0.00582996	0	2	EN-L4	NA	NA	NA
TTTGTCAAGTAGGCCA-1_5787_BA9	16.23324313	-30.37370339	3	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	4505	11927	0.000670747	0.004779073	0	3	EN-L5-6	NA	NA	NA
TTTGTCAGTGCACCAC-1_5787_BA9	4.125244156	-16.3618089	4	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3063	5824	0.001888736	0.012362637	0	L2-3	EN-L2-3-MS	NA	NA	NA
TTTGTCATCGAATCCA-1_5787_BA9	33.06984946	-4.115130275	2	5787_BA9	Control	Control	39	male	prefrontal	CAP7	SEQ5	7.9	16	3473	7569	0.003831418	0.005681068	0	2	EN-L4	NA	NA	NA
AACACGTAGCGTAATA-1_5609_BA9	16.15054406	-30.34581822	3	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	4453	10881	0.0027571	0.003308519	0	3	EN-L5-6	NA	NA	NA
AACACGTGTGCTGTAT-1_5609_BA9	-13.15388515	-17.7333066	6B	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	1402	2199	0	0.010004548	0	6B	IN-SST	NA	NA	NA
AACACGTTCGTGGTCG-1_5609_BA9	-26.31635106	8.644565933	8	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	863	1165	0.000858369	0.002575107	0	8	Astrocytes	NA	NA	NA
AACCATGAGAAACGAG-1_5609_BA9	-19.95506806	-16.42934659	6A	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	2863	5286	0.009269769	0.005107832	0	6A	IN-PV	NA	NA	NA
AACCGCGAGGCCATAG-1_5609_BA9	20.65813663	-17.46647268	4	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	10229	43739	0.01273463	0.005647134	0	L2-3	EN-L2-3-MS	NA	NA	NA
AACCGCGGTTTCGCTC-1_5609_BA9	17.11644281	27.40518367	1	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	868	1214	0.000823723	0.00247117	0	oligos	OL-Cntl	NA	NA	NA
AACTCAGGTCCGTCAG-1_5609_BA9	1.172116327	30.93390997	17	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	839	1165	0.006008584	0.000858369	0	oligos	OL-MS-2	NA	NA	NA
AACTCCCAGACTAGGC-1_5609_BA9	-0.026678274	27.50205697	1	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	827	1133	0.000882613	0.0070609	0	oligos	OL-Cntl	NA	NA	NA
AACTCCCGTGTGACCC-1_5609_BA9	-11.61514284	29.97631422	17	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	2025	3041	0.007563302	0.007892141	0	oligos	OL-MS-2	NA	NA	NA
AACTGGTGTGAACCTT-1_5609_BA9	27.60462186	5.1188482	15A	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	812	1061	0.002827521	0.008482564	0	15A	Endo cells	NA	NA	NA
AACTTTCCAGCTCGAC-1_5609_BA9	-12.04317257	-3.278484096	13A	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	2615	4552	0.004393673	0.005052724	0	13A	IN-VIP	NA	NA	NA
AACTTTCCATTTGCTT-1_5609_BA9	20.29091922	-29.19660028	3	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	5403	16368	0.001282991	0.006414956	0	3	EN-L5-6	NA	NA	NA
AAGACCTTCAGCGATT-1_5609_BA9	13.27344168	-22.36593115	4	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	5021	12020	0.003826955	0.005074875	0	L2-3	EN-L2-3-MS	NA	NA	NA
AAGACCTTCCTCGCAT-1_5609_BA9	-11.18278427	-33.87828423	16	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	1176	1761	0.018739353	0.008517888	0	16	EN-PYR	NA	NA	NA
AAGGAGCCATCCGCGA-1_5609_BA9	-2.013472656	36.61779968	17	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	776	1029	0.005830904	0.008746356	0	oligos	OL-MS-2	NA	NA	NA
AAGGCAGCATTCCTGC-1_5609_BA9	-27.48096135	10.80636476	8	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	996	1441	0.001387925	0.004163775	0	8	Astrocytes	NA	NA	NA
ACACCAACAATGGAAT-1_5609_BA9	-5.447280396	-28.30612002	16	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	867	1163	0.048151333	0.007738607	0	16	EN-PYR	NA	NA	NA
ACACCAAGTACTTAGC-1_5609_BA9	27.60092395	5.883179861	15A	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	1075	1430	0.013286713	0.027972028	0	15A	Endo cells	NA	NA	NA
ACACCGGGTACTTAGC-1_5609_BA9	-26.50205651	8.404013687	8	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	877	1171	0.003415884	0.006831768	0	8	Astrocytes	NA	NA	NA
ACATACGAGAACTGTA-1_5609_BA9	7.727150049	23.95179137	1	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	1093	1557	0.001926782	0.008991651	0	oligos	OL-Cntl	NA	NA	NA
ACATACGCAGAAGCAC-1_5609_BA9	32.55191567	-7.949946634	2	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	3240	6109	0.001309543	0.006220331	0	2	EN-L4	NA	NA	NA
ACATACGCAGCTCGAC-1_5609_BA9	-16.0215253	-24.28982433	6A	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	2346	4474	0.002905677	0.004693786	0	6A	IN-PV	NA	NA	NA
ACATCAGCAGGGAGAG-1_5609_BA9	-11.90476325	-9.061216703	13B	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	2059	3306	0.000907441	0.005444646	0	13B	IN-SV2C	NA	NA	NA
ACATGGTTCCGAATGT-1_5609_BA9	8.392507439	-28.87506323	10	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	5998	17748	0.001070543	0.003662384	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACCCACTAGACTAAGT-1_5609_BA9	9.622561871	-28.9638253	3	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	6916	21513	0.00158044	0.003346814	0	3	EN-L5-6	NA	NA	NA
ACCCACTCATTTGCTT-1_5609_BA9	-7.780374107	-31.8854236	16	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	911	1240	0.017741935	0.010483871	0	16	EN-PYR	NA	NA	NA
ACCCACTGTCTCTTTA-1_5609_BA9	30.41766374	-5.598880276	2	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	4495	10825	0.001847575	0.00443418	0	2	EN-L4	NA	NA	NA
ACCCACTTCTTACCTA-1_5609_BA9	19.4449005	-10.38470776	3	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	2532	4797	0.004794663	0.00979779	0	3	EN-L5-6	NA	NA	NA
ACCGTAACATATGCTG-1_5609_BA9	-10.78467051	-33.07850295	16	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	1079	1514	0.018494055	0.007265522	0	16	EN-PYR	NA	NA	NA
ACGAGCCAGACTGTAA-1_5609_BA9	-10.38584103	-5.646016542	13A	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	2267	3716	0.004305705	0.010495156	0	13A	IN-VIP	NA	NA	NA
ACGAGCCCAATCAGAA-1_5609_BA9	-22.00358432	12.18579007	8	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	1063	1660	0.001204819	0.003012048	0	8	Astrocytes	NA	NA	NA
ACGAGCCGTTCCAACA-1_5609_BA9	8.857732672	-28.19583618	10	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	5023	12832	0.001558603	0.007091646	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACGAGCCTCGTACGGC-1_5609_BA9	21.85780124	-1.847786986	2	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	2333	4145	0.001206273	0.006272618	0	2	EN-L4	NA	NA	NA
ACGATGTCACATGGGA-1_5609_BA9	24.91768089	-19.43831594	3	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	5722	14532	0.019680705	0.00564272	0	3	EN-L5-6	NA	NA	NA
ACGCCAGCAATGTTGC-1_5609_BA9	13.94033703	-1.033059858	12	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	940	1303	0.002302379	0.006907137	0	12	EN-MIX	NA	NA	NA
ACGCCGAAGCGTTGCC-1_5609_BA9	9.341078253	-30.78565709	2	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	5200	12668	0.000552573	0.004025892	0	2	EN-L4	NA	NA	NA
ACGGAGAGTCCATGAT-1_5609_BA9	24.95048409	-20.39865669	3	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	3877	8028	0.006103637	0.007224714	0	3	EN-L5-6	NA	NA	NA
ACGGGCTTCTGCGGCA-1_5609_BA9	-11.58973205	-32.86605152	16	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	1256	1757	0.007968127	0.007968127	0	16	EN-PYR	NA	NA	NA
ACGTCAAGTTGGTGGA-1_5609_BA9	21.81368174	-21.94694531	3	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	3827	7175	0.008083624	0.004181185	0	3	EN-L5-6	NA	NA	NA
ACTATCTTCCCTTGCA-1_5609_BA9	32.31938507	-3.207814513	2	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	3310	6756	0.002368265	0.008732978	0	2	EN-L4	NA	NA	NA
ACTGAACAGATGTGGC-1_5609_BA9	33.32233895	-3.573718805	2	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	2920	5580	0.00125448	0.009139785	0	2	EN-L4	NA	NA	NA
ACTGAGTCAGCCAGAA-1_5609_BA9	-20.61940476	-24.16251786	6A	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	3140	5995	0.003336113	0.003169308	0	6A	IN-PV	NA	NA	NA
ACTTACTCACAAGCCC-1_5609_BA9	-27.72118604	10.03308253	8	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	865	1248	0.000801282	0.000801282	0	8	Astrocytes	NA	NA	NA
ACTTGTTGTCCGTCAG-1_5609_BA9	30.41440131	-7.19760534	2	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	4248	9638	0.001763851	0.004046483	0	2	EN-L4	NA	NA	NA
ACTTGTTTCGAGAACG-1_5609_BA9	15.60471906	-25.26321278	3	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	3343	6935	0.00331651	0.004902668	0	3	EN-L5-6	NA	NA	NA
AGAATAGCAGTAAGAT-1_5609_BA9	28.30685451	-5.098036812	2	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	4400	10528	0.000569909	0.003989362	0	2	EN-L4	NA	NA	NA
AGAGCGACAAGTTAAG-1_5609_BA9	21.69438595	-24.74177325	3	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	4157	8877	0.001464459	0.020502422	0	3	EN-L5-6	NA	NA	NA
AGAGCGATCACAATGC-1_5609_BA9	-7.758581946	-32.21592212	16	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	849	1154	0.027729636	0.002599653	0	16	EN-PYR	NA	NA	NA
AGAGCTTGTTAAGATG-1_5609_BA9	22.02062288	-22.76062111	3	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	4443	9950	0.004020101	0.004824121	0	3	EN-L5-6	NA	NA	NA
AGATTGCCACGACGAA-1_5609_BA9	-11.27914329	-33.09378207	16	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	1202	1852	0.048596112	0.009179266	0	16	EN-PYR	NA	NA	NA
AGATTGCTCGTCACGG-1_5609_BA9	-10.82993464	-15.51726623	6B	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	1137	1663	0.003006615	0.006013229	0	6B	IN-SST	NA	NA	NA
AGCAGCCCACTTAAGC-1_5609_BA9	-29.9869483	-13.36268127	9	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	820	1072	0.002798507	0.009328358	0	9	OPC	NA	NA	NA
AGCATACCACGGACAA-1_5609_BA9	-1.398350933	31.30215893	17	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	881	1199	0	0.007506255	0	oligos	OL-MS-2	NA	NA	NA
AGCCTAAAGAGATGAG-1_5609_BA9	9.194795046	-28.87380342	10	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	6812	19882	0.000855045	0.002766321	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AGCTCCTAGTGTCCCG-1_5609_BA9	21.94104406	-1.280976855	2	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	2113	3656	0.003282276	0.005196937	0	2	EN-L4	NA	NA	NA
AGCTCCTTCCCTAATT-1_5609_BA9	13.37721853	0.650936352	12	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	757	1036	0	0	0	12	EN-MIX	NA	NA	NA
AGCTCTCCACAGATTC-1_5609_BA9	-1.77364757	36.47395905	17	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	809	1106	0.000904159	0.005424955	0	oligos	OL-MS-2	NA	NA	NA
AGGCCGTGTCGGGTCT-1_5609_BA9	-29.86164786	-13.25532275	9	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	767	1023	0.004887586	0.003910068	0	9	OPC	NA	NA	NA
AGGGATGAGGCTATCT-1_5609_BA9	0.018537864	31.0820795	17	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	929	1299	0.004618938	0.003849115	0	oligos	OL-MS-2	NA	NA	NA
AGGGTGAGTACCTACA-1_5609_BA9	-26.5640941	9.118116825	8	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	861	1190	0.000840336	0.006722689	0	8	Astrocytes	NA	NA	NA
AGGTCATGTCATCGGC-1_5609_BA9	32.86658221	-5.897472757	2	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	3583	6995	0.003431022	0.003573981	0	2	EN-L4	NA	NA	NA
AGGTCCGAGGATCGCA-1_5609_BA9	-17.92221041	-20.95892437	6A	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	2282	3686	0.002170374	0.002712968	0	6A	IN-PV	NA	NA	NA
AGTAGTCTCTGTTGAG-1_5609_BA9	-5.766897816	-31.05815482	16	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	786	1046	0.04875717	0.007648184	0	16	EN-PYR	NA	NA	NA
AGTCTTTCATCGACGC-1_5609_BA9	18.2222225	-9.899808822	3	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	2781	5431	0.001657153	0.013809611	0	3	EN-L5-6	NA	NA	NA
AGTTGGTCACTTACGA-1_5609_BA9	-19.45578612	-16.95820819	6B	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	3023	5891	0.000339501	0.005092514	0	6B	IN-SST	NA	NA	NA
ATAGACCGTCCAGTAT-1_5609_BA9	-12.96318691	14.5643705	11	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	1021	1369	0	0.003652301	0	11	Glia-MIX	NA	NA	NA
ATCCGAACACCGCTAG-1_5609_BA9	-12.50909862	-35.06216917	16	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	1504	2805	0.103030303	0.004634581	0	16	EN-PYR	NA	NA	NA
ATGCGATTCTGAGGGA-1_5609_BA9	-1.919628255	36.31453932	17	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	789	1044	0.000957854	0.009578544	0	oligos	OL-MS-2	NA	NA	NA
ATGGGAGAGCACGCCT-1_5609_BA9	-20.38390765	-16.54782096	6B	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	3769	7912	0.001263903	0.007077856	0	6B	IN-SST	NA	NA	NA
ATTACTCAGCCGTCGT-1_5609_BA9	27.85639284	-13.31538359	2	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	5763	14698	0.006599537	0.006327391	0	2	EN-L4	NA	NA	NA
ATTACTCAGGATATAC-1_5609_BA9	17.15006738	-9.215749225	3	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	1887	3215	0.00155521	0.005598756	0	3	EN-L5-6	NA	NA	NA
ATTACTCGTCTCATCC-1_5609_BA9	9.514905188	-28.9417822	10	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	4991	13083	0.003210273	0.003363143	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ATTACTCTCTAACTGG-1_5609_BA9	-8.136005511	-2.612637694	13A	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	1856	3042	0.001643655	0.004930966	0	13A	IN-VIP	NA	NA	NA
ATTATCCGTTCCGGCA-1_5609_BA9	-18.87772817	-7.835249626	13B	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	4043	8537	0.006325407	0.004802624	0	13B	IN-SV2C	NA	NA	NA
ATTGGACCAACCGCCA-1_5609_BA9	29.23709602	-5.203852863	2	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	4371	10021	0.000698533	0.006486379	0	2	EN-L4	NA	NA	NA
ATTGGTGCAGATGGCA-1_5609_BA9	-15.32859091	-9.28081799	13B	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	2795	4760	0.001470588	0.005042017	0	13B	IN-SV2C	NA	NA	NA
ATTTCTGAGCACCGCT-1_5609_BA9	14.91889929	-31.72771469	3	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	4118	11007	0.000363405	0.003997456	0	3	EN-L5-6	NA	NA	NA
ATTTCTGTCAAGAAGT-1_5609_BA9	0.828647121	30.14627463	1	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	795	1055	0.003791469	0.006635071	0	oligos	OL-Cntl	NA	NA	NA
CAACCAAGTCTCCATC-1_5609_BA9	-30.36724	-13.20602635	9	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	740	1010	0.001980198	0.006930693	0	9	OPC	NA	NA	NA
CAACCTCAGGACAGAA-1_5609_BA9	1.514108681	30.6336025	1	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	882	1255	0.004780876	0.003984064	0	oligos	OL-Cntl	NA	NA	NA
CAACCTCTCGCCTGAG-1_5609_BA9	-6.351356226	31.94530137	17	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	1308	1838	0.006528836	0.007616975	0	oligos	OL-MS-2	NA	NA	NA
CAAGATCCACAGCCCA-1_5609_BA9	-1.302905763	30.76483909	1	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	968	1376	0.001453488	0.002906977	0	oligos	OL-Cntl	NA	NA	NA
CAAGATCTCTGCGACG-1_5609_BA9	-20.65106625	-25.38511796	6A	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	3059	6062	0.001979545	0.003299241	0	6A	IN-PV	NA	NA	NA
CAAGGCCAGAAGATTC-1_5609_BA9	21.93300737	-20.48642713	3	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	9399	38013	0.005050904	0.004366927	0	3	EN-L5-6	NA	NA	NA
CAAGTTGTCACAGTAC-1_5609_BA9	9.309107961	-30.80317992	2	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	4993	12311	0.001543335	0.004142637	0	2	EN-L4	NA	NA	NA
CACAAACTCAGGATCT-1_5609_BA9	-11.19871996	12.86534446	11	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	1051	1406	0.000711238	0.007112376	0	11	Glia-MIX	NA	NA	NA
CACACAAGTGCAACTT-1_5609_BA9	25.25803932	-22.33559382	3	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	7597	24732	0.003719877	0.004528546	0	3	EN-L5-6	NA	NA	NA
CACACCTCAGTCACTA-1_5609_BA9	-27.45925948	9.410670792	8	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	810	1129	0.00088574	0.007085917	0	8	Astrocytes	NA	NA	NA
CACAGTACAGCTGCTG-1_5609_BA9	-14.16245939	-18.01733335	6B	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	1506	2443	0.006549325	0.005730659	0	6B	IN-SST	NA	NA	NA
CACATAGGTCCGCTGA-1_5609_BA9	-15.21767511	-36.69632299	16	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	2845	5957	0.055061272	0.009568575	0	16	EN-PYR	NA	NA	NA
CACCTTGCAAATTGCC-1_5609_BA9	-16.505281	-16.81162171	6B	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	2033	3548	0.006764374	0.008737317	0	6B	IN-SST	NA	NA	NA
CACCTTGGTTCCGGCA-1_5609_BA9	-15.35810509	-37.09212006	16	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	3406	7662	0.025058731	0.010571652	0	16	EN-PYR	NA	NA	NA
CAGAATCAGCCCGAAA-1_5609_BA9	-8.783438672	-14.36126882	6B	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	819	1041	0.00192123	0.006724304	0	6B	IN-SST	NA	NA	NA
CAGCAGCGTCGATTGT-1_5609_BA9	32.72946136	-4.764052842	2	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	3744	8657	0.011666859	0.004042971	0	2	EN-L4	NA	NA	NA
CAGCAGCGTGAGGCTA-1_5609_BA9	-25.51181943	9.259653422	8	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	987	1367	0.000731529	0.008046818	0	8	Astrocytes	NA	NA	NA
CAGCGACGTAGCCTAT-1_5609_BA9	-13.37562918	-17.87054441	6B	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	1394	2128	0.000469925	0.005169173	0	6B	IN-SST	NA	NA	NA
CAGCGACGTCGATTGT-1_5609_BA9	31.68446876	-8.507139344	2	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	4020	8422	0.004511992	0.005105676	0	2	EN-L4	NA	NA	NA
CAGCTAAAGGATGGAA-1_5609_BA9	-8.626112409	-4.966094797	13A	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	1874	2999	0.004001334	0.008002668	0	13A	IN-VIP	NA	NA	NA
CAGCTGGTCCACGACG-1_5609_BA9	-0.17561541	30.11907191	1	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	754	1007	0.000993049	0.004965243	0	oligos	OL-Cntl	NA	NA	NA
CAGCTGGTCCCTAATT-1_5609_BA9	-33.69032958	-12.58127864	9	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	935	1338	0.000747384	0.005231689	0	9	OPC	NA	NA	NA
CAGGTGCCAACTGCGC-1_5609_BA9	-12.36488535	16.17383325	11	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	1736	2517	0.002781089	0.002781089	0	11	Glia-MIX	NA	NA	NA
CAGTAACAGCAGCGTA-1_5609_BA9	31.97699155	-1.767839497	2	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	3088	6361	0.008017607	0.004873448	0	2	EN-L4	NA	NA	NA
CAGTAACGTCTGCCAG-1_5609_BA9	-21.32029786	-16.21217964	6A	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	3942	8164	0.003429691	0.005022048	0	6A	IN-PV	NA	NA	NA
CATATTCGTATGAATG-1_5609_BA9	1.542941151	30.67195024	1	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	879	1202	0.001663894	0.009151414	0	oligos	OL-Cntl	NA	NA	NA
CATATTCGTCACAAGG-1_5609_BA9	14.97575871	-31.76256992	3	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	4374	10912	0.000733138	0.003940616	0	3	EN-L5-6	NA	NA	NA
CATATTCGTTGTACAC-1_5609_BA9	30.75547736	-5.104176753	2	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	4671	11332	0.002559125	0.00326509	0	2	EN-L4	NA	NA	NA
CATATTCTCCGGCACA-1_5609_BA9	10.00705996	-29.03899349	10	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	7088	23673	0.001393993	0.003168166	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CATCAAGGTAACGCGA-1_5609_BA9	18.64573856	-7.216631262	3	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	1932	3233	0.00061862	0.004021033	0	3	EN-L5-6	NA	NA	NA
CATGACAGTGGTAACG-1_5609_BA9	-11.20201933	12.59464916	11	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	1101	1463	0.002050581	0.003417635	0	11	Glia-MIX	NA	NA	NA
CATGACATCGCGTTTC-1_5609_BA9	-18.07451885	-6.577799194	13B	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	3213	5820	0.005498282	0.006701031	0	13B	IN-SV2C	NA	NA	NA
CCAATCCAGACTGGGT-1_5609_BA9	29.32931602	-4.170501755	2	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	4378	9981	0.001703236	0.004408376	0	2	EN-L4	NA	NA	NA
CCACCTAGTTCCATGA-1_5609_BA9	21.36095773	-12.85541277	2	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	2706	5111	0.008021914	0.007630601	0	2	EN-L4	NA	NA	NA
CCACCTAGTTCCGGCA-1_5609_BA9	-17.18333446	-21.36597501	6A	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	2145	3974	0.002013085	0.006794162	0	6A	IN-PV	NA	NA	NA
CCACGGACATGCCACG-1_5609_BA9	30.7398832	-6.745737625	2	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	4602	10822	0.000554426	0.004343005	0	2	EN-L4	NA	NA	NA
CCAGCGACACTTACGA-1_5609_BA9	31.53452021	-1.400034802	2	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	3296	6604	0.000151423	0.005299818	0	2	EN-L4	NA	NA	NA
CCAGCGAGTTGGTAAA-1_5609_BA9	1.798959572	-13.86327911	10	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	2560	4848	0.002062706	0.00330033	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CCATGTCTCCTTTACA-1_5609_BA9	13.40043997	-27.99945392	3	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	2649	5036	0.001985703	0.002978554	0	3	EN-L5-6	NA	NA	NA
CCCAATCAGACTTGAA-1_5609_BA9	18.29774156	-20.1674579	4	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	4246	9798	0.003368034	0.004694836	0	L2-3	EN-L2-3-MS	NA	NA	NA
CCCAATCTCATGTCTT-1_5609_BA9	-12.14089638	-34.48949982	16	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	1418	2090	0.021052632	0.014832536	0	16	EN-PYR	NA	NA	NA
CCCAGTTTCCCTAATT-1_5609_BA9	8.543023652	-27.67146453	10	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	7327	25991	0.002193067	0.003809011	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CCCATACTCAGCTTAG-1_5609_BA9	21.57486723	-3.407561405	2	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	2716	4691	0.011511405	0.005329354	0	2	EN-L4	NA	NA	NA
CCGTTCATCAGTGCAT-1_5609_BA9	-22.52302102	-23.06044841	6A	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	3576	7466	0.0049558	0.009375837	0	6A	IN-PV	NA	NA	NA
CCTAAAGGTCAGCTAT-1_5609_BA9	-8.931008641	-7.456255855	13A	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	1484	2243	0.005795809	0.010699955	0	13A	IN-VIP	NA	NA	NA
CCTCAGTCACGCATCG-1_5609_BA9	0.791713968	30.79897602	1	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	866	1210	0.011570248	0.001652893	0	oligos	OL-Cntl	NA	NA	NA
CCTCAGTGTTATCACG-1_5609_BA9	20.04359806	-11.10654293	3	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	2609	4995	0.002002002	0.005005005	0	3	EN-L5-6	NA	NA	NA
CCTCAGTTCCACTGGG-1_5609_BA9	-29.14037818	-12.94129675	9	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	804	1043	0.000958773	0.008628955	0	9	OPC	NA	NA	NA
CCTCAGTTCTTTAGTC-1_5609_BA9	-26.97609081	9.624210498	8	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	908	1289	0	0.006206362	0	8	Astrocytes	NA	NA	NA
CCTCTGACACAAGTAA-1_5609_BA9	30.39173013	-8.005350969	2	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	5264	12983	0.002079643	0.006778094	0	2	EN-L4	NA	NA	NA
CCTTTCTTCGGAATCT-1_5609_BA9	32.37441544	-7.998136744	2	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	3682	7448	0.012352309	0.007518797	0	2	EN-L4	NA	NA	NA
CGAATGTCAGTATAAG-1_5609_BA9	-1.48503384	-1.193593288	11	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	4177	8698	0.025982985	0.006553231	0	11	Glia-MIX	NA	NA	NA
CGACCTTTCGCTGATA-1_5609_BA9	27.94596525	5.73245257	15A	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	935	1236	0.018608414	0.021035599	0	15A	Endo cells	NA	NA	NA
CGACTTCCAAAGGAAG-1_5609_BA9	-13.08460483	-35.4766209	16	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	1754	2855	0.027670753	0.009457093	0	16	EN-PYR	NA	NA	NA
CGAGCCAAGACACGAC-1_5609_BA9	21.70792337	-18.16773536	3	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	10360	44206	0.01128806	0.005791069	0	3	EN-L5-6	NA	NA	NA
CGAGCCAAGCGTGAGT-1_5609_BA9	-1.980984832	29.41428716	17	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	785	1059	0.003777148	0.003777148	0	oligos	OL-MS-2	NA	NA	NA
CGATGGCAGGGCTTCC-1_5609_BA9	20.03489714	-17.46099458	4	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	7657	23220	0.008139535	0.005813953	0	L2-3	EN-L2-3-MS	NA	NA	NA
CGATGGCGTTAAGACA-1_5609_BA9	10.27202383	-28.97730554	10	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	5531	14305	0.004334149	0.004264243	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGATTGACAAATTGCC-1_5609_BA9	-10.4715072	-3.578560056	13A	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	2313	3942	0.003551497	0.00608828	0	13A	IN-VIP	NA	NA	NA
CGCCAAGCATGTTCCC-1_5609_BA9	33.20393712	-2.491906752	2	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	2736	5289	0.00113443	0.006050293	0	2	EN-L4	NA	NA	NA
CGCCAAGGTGCGAAAC-1_5609_BA9	8.880780532	-26.8255312	10	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	4752	11763	0.001190173	0.003315481	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGCGGTATCAAACCGT-1_5609_BA9	24.07793405	-10.62640631	3	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	5129	12674	0.002130346	0.007101152	0	3	EN-L5-6	NA	NA	NA
CGCGTTTGTTAGAACA-1_5609_BA9	-13.67565639	-5.269495721	13A	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	2728	4904	0.007137031	0.00632137	0	13A	IN-VIP	NA	NA	NA
CGCTGGATCGGTGTTA-1_5609_BA9	-1.776421111	29.51131006	17	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	867	1145	0.00349345	0.006113537	0	oligos	OL-MS-2	NA	NA	NA
CGGACACGTCTGCAAT-1_5609_BA9	31.34973827	-9.625074113	2	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	4611	10390	0.003946102	0.005678537	0	2	EN-L4	NA	NA	NA
CGGACTGGTTGACGTT-1_5609_BA9	-5.880446064	-31.0505406	16	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	788	1018	0.018664047	0.007858546	0	16	EN-PYR	NA	NA	NA
CGGAGTCAGCGCCTTG-1_5609_BA9	-23.22922556	-20.54560277	6A	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	3442	6539	0.021868787	0.0032115	0	6A	IN-PV	NA	NA	NA
CGGCTAGAGCCGTCGT-1_5609_BA9	20.89001748	-2.118424623	2	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	1872	3107	0.006437078	0.005471516	0	2	EN-L4	NA	NA	NA
CGGCTAGAGCGCCTCA-1_5609_BA9	-11.8757969	-34.26405619	16	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	1310	2042	0.047502449	0.007345739	0	16	EN-PYR	NA	NA	NA
CGGCTAGTCAACGGGA-1_5609_BA9	31.85878155	-8.907413861	2	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	3929	7982	0.008018041	0.011400651	0	2	EN-L4	NA	NA	NA
CGGGTCACAGGTGCCT-1_5609_BA9	32.78280325	-3.534941105	2	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	3739	7753	0.00167677	0.009802657	0	2	EN-L4	NA	NA	NA
CGGTTAAGTCAGCTAT-1_5609_BA9	7.245540457	24.27634624	1	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	1118	1501	0.006662225	0.007328448	0	oligos	OL-Cntl	NA	NA	NA
CGTAGGCAGGACCACA-1_5609_BA9	20.92385047	-27.86733484	3	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	3491	7561	0.000793546	0.003703214	0	3	EN-L5-6	NA	NA	NA
CGTCACTGTATAATGG-1_5609_BA9	29.28537416	-11.53722611	2	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	7358	21673	0.003645088	0.007474738	0	2	EN-L4	NA	NA	NA
CGTCACTTCTTCGAGA-1_5609_BA9	-1.581004726	29.09236567	1	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	751	1020	0	0.006862745	0	oligos	OL-Cntl	NA	NA	NA
CGTCAGGGTCTAGAGG-1_5609_BA9	13.38008571	-4.306840459	12	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	1727	2727	0.002933627	0.010267693	0	12	EN-MIX	NA	NA	NA
CGTGAGCCAGACGCCT-1_5609_BA9	-0.779635751	28.54466179	1	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	803	1069	0.000935454	0.003741815	0	oligos	OL-Cntl	NA	NA	NA
CGTGAGCTCTCCGGTT-1_5609_BA9	-2.101290672	29.35339635	17	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	755	1019	0.004906771	0.005888126	0	oligos	OL-MS-2	NA	NA	NA
CGTGTCTCATTCCTCG-1_5609_BA9	8.032792035	-27.0802286	10	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	4909	12540	0.000797448	0.004864434	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGTGTCTTCTAGCACA-1_5609_BA9	-14.70106515	-22.48560648	6A	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	1516	2269	0.002644337	0.004407228	0	6A	IN-PV	NA	NA	NA
CGTTAGAGTTGGAGGT-1_5609_BA9	-13.18278724	-31.92787035	16	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	1665	2620	0.019465649	0.008396947	0	16	EN-PYR	NA	NA	NA
CGTTAGATCCGAATGT-1_5609_BA9	8.750762016	-30.64323373	10	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	4226	9442	0.001588646	0.00455412	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGTTCTGGTGCACTTA-1_5609_BA9	17.74555966	28.5670886	1	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	893	1241	0.000805802	0.002417405	0	oligos	OL-Cntl	NA	NA	NA
CGTTGGGAGAAACGAG-1_5609_BA9	16.90728221	-19.60893905	4	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	6191	16344	0.005812531	0.004955947	0	L2-3	EN-L2-3-MS	NA	NA	NA
CGTTGGGGTTTAGCTG-1_5609_BA9	16.40790056	-26.84803129	3	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	4509	10078	0.003770589	0.00625124	0	3	EN-L5-6	NA	NA	NA
CTAACTTCAGACTCGC-1_5609_BA9	-7.39982805	-32.10513282	16	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	897	1202	0.021630616	0.006655574	0	16	EN-PYR	NA	NA	NA
CTAAGACTCGTCGTTC-1_5609_BA9	-17.53463706	-8.094011615	13B	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	3622	7561	0.005951594	0.005819336	0	13B	IN-SV2C	NA	NA	NA
CTAATGGAGCGAAGGG-1_5609_BA9	-2.150290639	29.49061432	17	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	805	1070	0.001869159	0.002803738	0	oligos	OL-MS-2	NA	NA	NA
CTAATGGCAAAGGAAG-1_5609_BA9	8.984942826	-31.01018855	10	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	4294	9654	0.00051792	0.00310752	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTACGTCCATAGAAAC-1_5609_BA9	-1.211133851	31.83328807	17	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	1013	1442	0.006934813	0.004160888	0	oligos	OL-MS-2	NA	NA	NA
CTACGTCGTGTTAAGA-1_5609_BA9	30.3571202	-8.329414839	2	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	5421	13892	0.005614742	0.002879355	0	2	EN-L4	NA	NA	NA
CTACGTCTCTCTTGAT-1_5609_BA9	17.29510087	1.655439131	12	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	1121	1561	0.008327995	0.004484305	0	12	EN-MIX	NA	NA	NA
CTAGAGTAGAGTGAGA-1_5609_BA9	31.44629772	-7.412294602	2	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	4015	8510	0.002585194	0.011045828	0	2	EN-L4	NA	NA	NA
CTAGAGTAGTACGTTC-1_5609_BA9	-23.57883845	12.3830754	8	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	1067	1555	0.000643087	0.005144695	0	8	Astrocytes	NA	NA	NA
CTAGCCTAGTTAACGA-1_5609_BA9	-10.054769	-7.010641287	13A	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	1995	3170	0.003785489	0.006309148	0	13A	IN-VIP	NA	NA	NA
CTCACACAGCGTAATA-1_5609_BA9	-10.5890664	-32.77405019	16	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	1231	1806	0.025470653	0.008305648	0	16	EN-PYR	NA	NA	NA
CTCACACCAGATAATG-1_5609_BA9	17.31315459	-31.21730705	3	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	6742	21418	0.000747035	0.004248763	0	3	EN-L5-6	NA	NA	NA
CTCAGAACAAGCCCAC-1_5609_BA9	19.40084392	-24.67199168	3	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	3452	7378	0.003117376	0.026294389	0	3	EN-L5-6	NA	NA	NA
CTCATTAAGGTAAACT-1_5609_BA9	-0.168378494	29.78822083	1	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	915	1313	0.001523229	0.003808073	0	oligos	OL-Cntl	NA	NA	NA
CTCCTAGTCACCCTCA-1_5609_BA9	-15.27035227	-9.440426517	13B	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	2483	4609	0.001735734	0.008678672	0	13B	IN-SV2C	NA	NA	NA
CTCCTAGTCAGTGCAT-1_5609_BA9	13.42977963	-27.42353315	3	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	3246	6854	0.002334403	0.002772104	0	3	EN-L5-6	NA	NA	NA
CTCGAAACAGTACACT-1_5609_BA9	19.76264509	-22.76763228	3	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	4909	11387	0.004215333	0.012997278	0	3	EN-L5-6	NA	NA	NA
CTCGAGGGTAGCGTCC-1_5609_BA9	-20.8668748	-24.96949206	6A	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	3188	6177	0.002266472	0.004694836	0	6A	IN-PV	NA	NA	NA
CTCGGGAGTTAAGGGC-1_5609_BA9	10.23447688	-28.65703575	10	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	5284	12866	0.001787657	0.00404166	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTCGGGATCTTTACGT-1_5609_BA9	-17.83273987	-8.433293639	13B	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	3693	7784	0.00192703	0.004367934	0	13B	IN-SV2C	NA	NA	NA
CTCGTACAGGCTATCT-1_5609_BA9	27.03118428	-15.10302212	3	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	6121	18098	0.008288209	0.0029285	0	3	EN-L5-6	NA	NA	NA
CTCGTACGTCGATTGT-1_5609_BA9	-2.220909266	31.51084687	17	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	986	1325	0.000754717	0.002264151	0	oligos	OL-MS-2	NA	NA	NA
CTCGTACTCGGCTACG-1_5609_BA9	-11.2223674	29.13205759	17	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	1092	1426	0.011921459	0.00911641	0	oligos	OL-MS-2	NA	NA	NA
CTCGTCAAGCCGGTAA-1_5609_BA9	-25.97086241	-9.797059669	9	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	1015	1404	0.005698006	0.004273504	0	9	OPC	NA	NA	NA
CTCGTCACAGTCTTCC-1_5609_BA9	30.81111472	-5.188951561	2	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	4101	9469	0.001795332	0.004646742	0	2	EN-L4	NA	NA	NA
CTCTGGTGTGAGTATA-1_5609_BA9	-27.29627334	12.00719966	8	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	957	1343	0.002978407	0.00446761	0	8	Astrocytes	NA	NA	NA
CTGAAACGTCTGATTG-1_5609_BA9	-27.10257445	8.508233136	8	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	770	1003	0.001994018	0.002991027	0	8	Astrocytes	NA	NA	NA
CTGAAGTCAAGGTTCT-1_5609_BA9	32.93814549	-4.647099199	2	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	3646	7463	0.004019831	0.008441645	0	2	EN-L4	NA	NA	NA
CTGATAGAGGTGACCA-1_5609_BA9	29.34445826	-10.80892731	2	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	6417	18186	0.012922028	0.004453976	0	2	EN-L4	NA	NA	NA
CTGATCCAGATCTGCT-1_5609_BA9	-19.79381473	-16.85496763	6A	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	3410	7116	0.003232153	0.009274874	0	6A	IN-PV	NA	NA	NA
CTGATCCCAGTGAGTG-1_5609_BA9	-6.128414618	-32.93812211	16	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	971	1362	0.060939794	0.013215859	0	16	EN-PYR	NA	NA	NA
CTGATCCTCAAGAAGT-1_5609_BA9	-15.34154313	-37.33460557	16	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	3129	6789	0.019737811	0.016644572	0	16	EN-PYR	NA	NA	NA
CTGCGGATCGTGGTCG-1_5609_BA9	13.32859674	-27.31352035	3	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	3124	6295	0.002859412	0.004447975	0	3	EN-L5-6	NA	NA	NA
CTGCTGTCACTGTTAG-1_5609_BA9	-11.25716692	-33.36495165	16	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	1369	2092	0.034894837	0.006214149	0	16	EN-PYR	NA	NA	NA
CTGGTCTTCAAAGTAG-1_5609_BA9	-14.12971532	-16.89975289	6B	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	1547	2456	0.002442997	0.006514658	0	6B	IN-SST	NA	NA	NA
CTGTTTACACTCTGTC-1_5609_BA9	-28.45014605	10.27253073	8	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	801	1116	0	0.005376344	0	8	Astrocytes	NA	NA	NA
CTTAGGAAGTAATCCC-1_5609_BA9	8.65899093	-31.1981839	10	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	4911	12256	0.000815927	0.0033453	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTTTGCGAGAATGTTG-1_5609_BA9	-16.0770501	-16.97336173	6B	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	1878	3094	0.002262443	0.005171299	0	6B	IN-SST	NA	NA	NA
CTTTGCGAGCCACGTC-1_5609_BA9	-1.602225926	28.77539736	1	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	766	1034	0.001934236	0.006769826	0	oligos	OL-Cntl	NA	NA	NA
CTTTGCGCAAAGCGGT-1_5609_BA9	-17.46306204	-16.83825304	6B	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	2227	3983	0.004017073	0.007783078	0	6B	IN-SST	NA	NA	NA
CTTTGCGGTCACAAGG-1_5609_BA9	30.83014856	-7.662736994	2	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	4935	11756	0.002636951	0.004678462	0	2	EN-L4	NA	NA	NA
CTTTGCGGTCACACGC-1_5609_BA9	-11.02389933	-34.04493354	16	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	1208	1798	0.04894327	0.014460512	0	16	EN-PYR	NA	NA	NA
GAAACTCAGGTTACCT-1_5609_BA9	29.66839874	-11.1531082	2	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	5173	11993	0.006170266	0.007671141	0	2	EN-L4	NA	NA	NA
GAACATCGTTATCACG-1_5609_BA9	8.707799862	-27.16232987	10	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	4405	10035	0.00328849	0.003089188	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GAAGCAGGTTTGACTG-1_5609_BA9	14.53761622	-21.92208277	4	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	6980	20863	0.008963236	0.004361789	0	L2-3	EN-L2-3-MS	NA	NA	NA
GAAGCAGTCCATGAAC-1_5609_BA9	15.78819896	-2.630235849	12	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	1116	1776	0	0.005067568	0	12	EN-MIX	NA	NA	NA
GAATAAGCAAGAAAGG-1_5609_BA9	-1.079001415	30.54635759	17	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	923	1250	8.00E-04	0.0048	0	oligos	OL-MS-2	NA	NA	NA
GACCAATGTGCGAAAC-1_5609_BA9	25.73129012	-24.43057482	3	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	5360	14138	0.011741406	0.005021927	0	3	EN-L5-6	NA	NA	NA
GACGCGTAGGGTGTTG-1_5609_BA9	3.275663622	-14.52905464	4	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	2573	4701	0.001701766	0.008934269	0	L2-3	EN-L2-3-MS	NA	NA	NA
GACGTGCAGCAGCGTA-1_5609_BA9	23.80410352	-19.83939682	3	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	5901	14942	0.009904966	0.006224066	0	3	EN-L5-6	NA	NA	NA
GACGTGCTCCCATTAT-1_5609_BA9	13.39608308	-22.34462605	4	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	6452	18681	0.005674214	0.003425941	0	L2-3	EN-L2-3-MS	NA	NA	NA
GACTACAGTTCAACCA-1_5609_BA9	-13.99096856	-21.93314304	6A	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	1485	2263	0.007954043	0.003977022	0	6A	IN-PV	NA	NA	NA
GACTACATCGTCACGG-1_5609_BA9	-1.474540597	23.31457137	1	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	773	1033	0.001936108	0.005808325	0	oligos	OL-Cntl	NA	NA	NA
GACTGCGCAAAGGTGC-1_5609_BA9	-16.44217093	-16.81282243	6B	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	1901	3259	0	0.007671065	0	6B	IN-SST	NA	NA	NA
GACTGCGGTACCTACA-1_5609_BA9	29.77035376	-4.979334013	2	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	4288	10216	0.000587314	0.007145654	0	2	EN-L4	NA	NA	NA
GAGCAGACACTTCGAA-1_5609_BA9	16.7090095	-4.636118873	12	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	1297	1961	0.009688934	0.006119327	0	12	EN-MIX	NA	NA	NA
GAGCAGACAGGAACGT-1_5609_BA9	-1.713651253	36.49094737	17	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	777	1072	0	0.006529851	0	oligos	OL-MS-2	NA	NA	NA
GAGGTGACAGTGGAGT-1_5609_BA9	32.65238846	-6.517169606	2	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	3453	6541	0.004127809	0.005503746	0	2	EN-L4	NA	NA	NA
GATCAGTGTAAGGGAA-1_5609_BA9	-17.22352589	-16.75926166	6B	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	2072	3551	0.001408054	0.0104196	0	6B	IN-SST	NA	NA	NA
GATCGTACAATGAATG-1_5609_BA9	-20.54491551	18.01610392	8	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	1628	2450	0.00122449	0.006530612	0	8	Astrocytes	NA	NA	NA
GATCTAGGTCATCGGC-1_5609_BA9	33.38413765	-5.392017961	2	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	3480	6817	0.001760305	0.006747836	0	2	EN-L4	NA	NA	NA
GATGCTACATCTACGA-1_5609_BA9	-1.635873926	29.14713492	1	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	747	1020	0.000980392	0.003921569	0	oligos	OL-Cntl	NA	NA	NA
GATTCAGAGGGTCTCC-1_5609_BA9	-1.305666191	29.42180761	1	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	848	1119	0.00714924	0.002680965	0	oligos	OL-Cntl	NA	NA	NA
GCAAACTGTCCGAGTC-1_5609_BA9	-28.15517472	10.30921912	8	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	937	1343	0.002233805	0.003723008	0	8	Astrocytes	NA	NA	NA
GCACATAAGTCTCGGC-1_5609_BA9	30.74640233	-7.129025886	2	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	4884	11495	0.003566768	0.003131796	0	2	EN-L4	NA	NA	NA
GCAGTTAAGCCAGTAG-1_5609_BA9	-7.195804082	-33.07750656	16	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	807	1097	0.012762078	0.015496809	0	16	EN-PYR	NA	NA	NA
GCATACAAGTGGAGAA-1_5609_BA9	23.96099086	-12.5099048	3	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	4072	8196	0.00829673	0.004514397	0	3	EN-L5-6	NA	NA	NA
GCATGATGTTAAGACA-1_5609_BA9	-13.36833791	-35.15004233	16	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	1836	3155	0.028843106	0.008557845	0	16	EN-PYR	NA	NA	NA
GCATGCGCACCAGGTC-1_5609_BA9	-7.178583733	36.07422961	17	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	779	1005	0.009950249	0.008955224	0	oligos	OL-MS-2	NA	NA	NA
GCATGCGTCCGTTGCT-1_5609_BA9	-21.57245959	-26.04876267	6A	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	3428	6858	0.010644503	0.00685331	0	6A	IN-PV	NA	NA	NA
GCATGTAAGGTGTGGT-1_5609_BA9	-16.62916004	-4.300314105	13A	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	2840	4908	0.013651182	0.008557457	0	13A	IN-VIP	NA	NA	NA
GCCTCTACATGAACCT-1_5609_BA9	22.40534351	-22.34438902	3	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	4332	10292	0.003595025	0.010007773	0	3	EN-L5-6	NA	NA	NA
GCCTCTATCAGTTTGG-1_5609_BA9	19.14949149	-9.614298879	3	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	1798	2878	0.004169562	0.007644197	0	3	EN-L5-6	NA	NA	NA
GCGACCAAGGAGCGTT-1_5609_BA9	-27.2670585	-9.926719273	9	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	926	1242	0.004025765	0.003220612	0	9	OPC	NA	NA	NA
GCGCAACGTGATAAGT-1_5609_BA9	20.1306919	-11.09549488	3	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	2971	5639	0.0019507	0.004256074	0	3	EN-L5-6	NA	NA	NA
GCGCAGTGTCTCATCC-1_5609_BA9	-1.642683029	-1.401748449	11	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	4505	8576	0.004314366	0.008162313	0	11	Glia-MIX	NA	NA	NA
GCGCCAACATAGGATA-1_5609_BA9	-13.3396888	16.46166169	11	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	1517	2209	0.004074242	0.002716161	0	11	Glia-MIX	NA	NA	NA
GCTCCTAAGGACAGCT-1_5609_BA9	1.24800274	30.96435544	1	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	778	1050	0.000952381	0.002857143	0	oligos	OL-Cntl	NA	NA	NA
GCTCCTACAGCGAACA-1_5609_BA9	12.95328613	-22.73142127	4	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	5440	15068	0.007963897	0.003981949	0	L2-3	EN-L2-3-MS	NA	NA	NA
GCTCTGTGTAGCGTCC-1_5609_BA9	24.50459457	-26.07266991	3	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	3515	7925	0.00126183	0.004037855	0	3	EN-L5-6	NA	NA	NA
GCTCTGTTCGCGTTTC-1_5609_BA9	-7.304029046	-31.05874771	16	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	925	1216	0.032072368	0.009868421	0	16	EN-PYR	NA	NA	NA
GCTGCGACAAGCGCTC-1_5609_BA9	-11.03704175	-1.963039114	13A	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	2464	4267	0.001640497	0.004687134	0	13A	IN-VIP	NA	NA	NA
GCTGCGACATGCCCGA-1_5609_BA9	24.07244326	-6.501629379	2	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	5192	12992	0.002155172	0.005080049	0	2	EN-L4	NA	NA	NA
GCTGGGTCATTGAGCT-1_5609_BA9	-18.18989372	-21.34917687	6A	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	2655	5127	0.002535596	0.006631558	0	6A	IN-PV	NA	NA	NA
GCTGGGTGTTCGTGAT-1_5609_BA9	28.71972303	-5.798001626	2	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	5481	13829	0.002747849	0.004266397	0	2	EN-L4	NA	NA	NA
GCTTCCAGTACCATCA-1_5609_BA9	33.04625391	-5.765694612	2	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	3545	6995	0.001286633	0.004002859	0	2	EN-L4	NA	NA	NA
GCTTCCAGTGCACGAA-1_5609_BA9	-27.74481538	9.208713729	8	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	775	1024	0.000976563	0.002929688	0	8	Astrocytes	NA	NA	NA
GCTTCCATCCGTCAAA-1_5609_BA9	-14.80818071	-17.20691323	6B	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	1532	2311	0.002163566	0.007356123	0	6B	IN-SST	NA	NA	NA
GCTTGAAGTACGCTGC-1_5609_BA9	26.88615793	-15.90429776	3	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	8488	31075	0.017280772	0.005760257	0	3	EN-L5-6	NA	NA	NA
GGAACTTCAAAGGCGT-1_5609_BA9	27.25380953	5.325205661	15A	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	996	1301	0.003843198	0.011529593	0	15A	Endo cells	NA	NA	NA
GGAATAAAGTTATCGC-1_5609_BA9	23.90076704	-12.60687055	3	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	3378	6424	0.008405978	0.006693649	0	3	EN-L5-6	NA	NA	NA
GGACAAGCATTGGGCC-1_5609_BA9	-26.1250972	9.056153411	8	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	946	1273	0.008641005	0.007069914	0	8	Astrocytes	NA	NA	NA
GGACATTAGTCCGGTC-1_5609_BA9	-13.23646429	-17.01518338	6B	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	1445	2307	0.00390117	0.012136974	0	6B	IN-SST	NA	NA	NA
GGACGTCTCAACGGGA-1_5609_BA9	29.31870594	-5.196926485	2	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	4087	9179	0.00076261	0.004139885	0	2	EN-L4	NA	NA	NA
GGATGTTCAGCTCGCA-1_5609_BA9	-8.549508796	-32.23062821	16	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	883	1189	0.008410429	0.008410429	0	16	EN-PYR	NA	NA	NA
GGATGTTGTCATATCG-1_5609_BA9	-29.85006474	-13.11343742	9	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	771	1076	0.002788104	0.005576208	0	9	OPC	NA	NA	NA
GGATTACGTGTAACGG-1_5609_BA9	9.697986688	-25.08289661	4	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	5902	16275	0.004608295	0.0040553	0	L2-3	EN-L2-3-MS	NA	NA	NA
GGCCGATCACTTACGA-1_5609_BA9	-13.27787631	-4.787750919	13A	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	2766	5296	0.013028701	0.006797583	0	13A	IN-VIP	NA	NA	NA
GGCCGATGTCTTCTCG-1_5609_BA9	18.00073821	-6.384711062	3	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	1747	3113	0.001284934	0.006103437	0	3	EN-L5-6	NA	NA	NA
GGCCGATGTTAAGAAC-1_5609_BA9	-29.56034003	-12.9788493	9	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	797	1036	0	0.008687259	0	9	OPC	NA	NA	NA
GGCGACTCAGCTGTAT-1_5609_BA9	27.15551022	-15.04839886	3	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	8451	30267	0.014372088	0.0055506	0	3	EN-L5-6	NA	NA	NA
GGCTCGAAGACACTAA-1_5609_BA9	-16.19150439	-9.658400178	13B	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	3296	6717	0.001339884	0.004764032	0	13B	IN-SV2C	NA	NA	NA
GGCTGGTAGATCGATA-1_5609_BA9	13.9380567	-22.01034462	4	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	8071	28170	0.007241747	0.003478878	0	L2-3	EN-L2-3-MS	NA	NA	NA
GGGATGACACAACGTT-1_5609_BA9	7.239272785	25.56797026	1	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	1023	1416	0.000706215	0.004943503	0	oligos	OL-Cntl	NA	NA	NA
GGGCACTAGTACGTAA-1_5609_BA9	19.08703101	-7.539222445	3	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	2590	4903	0.000815827	0.006526616	0	3	EN-L5-6	NA	NA	NA
GGGCACTTCGTTTGCC-1_5609_BA9	24.73214448	-23.98723779	3	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	3979	9016	0.003438332	0.005878438	0	3	EN-L5-6	NA	NA	NA
GGGCATCAGTGTGGCA-1_5609_BA9	-5.240528851	-32.84668405	16	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	800	1024	0.030273438	0.009765625	0	16	EN-PYR	NA	NA	NA
GGGCATCCATATACGC-1_5609_BA9	-26.65981269	10.13599457	8	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	946	1299	0	0.006158584	0	8	Astrocytes	NA	NA	NA
GGGCATCTCTGAGGGA-1_5609_BA9	-20.02646657	-16.42997139	6B	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	3122	6323	0.000790764	0.003321208	0	6B	IN-SST	NA	NA	NA
GGGTTGCGTTCAGTAC-1_5609_BA9	22.75260353	-0.96068192	2	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	2426	4073	0.000736558	0.004419347	0	2	EN-L4	NA	NA	NA
GGTATTGCAGAAGCAC-1_5609_BA9	-27.38994308	9.596157494	8	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	858	1169	0	0.002566296	0	8	Astrocytes	NA	NA	NA
GGTATTGTCTGACCTC-1_5609_BA9	6.425221061	-2.112936736	12	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	832	1028	0.002918288	0.002918288	0	12	EN-MIX	NA	NA	NA
GGTGAAGGTGTCGCTG-1_5609_BA9	-18.34242207	-15.78310407	6A	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	2375	4341	0.007141212	0.004837595	0	6A	IN-PV	NA	NA	NA
GGTGAAGGTTTACTCT-1_5609_BA9	-0.830430123	30.89829927	17	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	926	1270	0.001574803	0.006299213	0	oligos	OL-MS-2	NA	NA	NA
GGTGCGTGTTGCGCAC-1_5609_BA9	7.98188053	-28.03611284	10	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	6360	18993	0.001000369	0.004422682	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GGTGTTAAGAGGGCTT-1_5609_BA9	-20.06915284	-23.43542682	6A	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	2633	4790	0.00480167	0.003757829	0	6A	IN-PV	NA	NA	NA
GTAACGTGTCAGGACA-1_5609_BA9	8.855991566	-31.43898828	10	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	4853	12248	0.000571522	0.002612671	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GTAACTGCAAGGGTCA-1_5609_BA9	14.34208089	-21.92275932	4	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	6874	20425	0.010575275	0.004553244	0	L2-3	EN-L2-3-MS	NA	NA	NA
GTAACTGCACACCGCA-1_5609_BA9	-8.451140477	9.140116157	5	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	1005	1272	0.003144654	0.007075472	0	oligos	OL-MS-1	NA	NA	NA
GTACTCCCAGCTGTGC-1_5609_BA9	-10.85938971	-33.03964987	16	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	1197	1727	0.031268095	0.006948466	0	16	EN-PYR	NA	NA	NA
GTACTTTAGAAGGCCT-1_5609_BA9	-7.982132387	-31.92365001	16	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	998	1400	0.047142857	0.008571429	0	16	EN-PYR	NA	NA	NA
GTACTTTTCACCGGGT-1_5609_BA9	-9.503527503	-34.45598905	16	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	902	1343	0.026061057	0.011913626	0	16	EN-PYR	NA	NA	NA
GTAGGCCGTTACGGAG-1_5609_BA9	-15.74748845	-24.53836286	6A	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	1969	3500	0.001428571	0.005142857	0	6A	IN-PV	NA	NA	NA
GTATCTTCATCCCACT-1_5609_BA9	-11.76556481	-2.419156062	13A	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	2625	4717	0.006571974	0.005935976	0	13A	IN-VIP	NA	NA	NA
GTATTCTAGTCTCCTC-1_5609_BA9	-5.658844515	-9.958678995	13B	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	924	1289	0.00155159	0.004654771	0	13B	IN-SV2C	NA	NA	NA
GTCAAGTCATGCAACT-1_5609_BA9	-21.30443151	-15.91788632	6A	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	4023	8761	0.002511129	0.005707111	0	6A	IN-PV	NA	NA	NA
GTCCTCAGTCTGCAAT-1_5609_BA9	-1.809834987	29.20298858	17	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	802	1103	0.000906618	0.000906618	0	oligos	OL-MS-2	NA	NA	NA
GTCGTAAGTCACTTCC-1_5609_BA9	16.6110329	-29.44274867	3	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	5116	13795	0.004059442	0.005291772	0	3	EN-L5-6	NA	NA	NA
GTCTCGTCACAGACAG-1_5609_BA9	-6.526119384	-3.993323271	13A	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	1777	2926	0.005126452	0.007518797	0	13A	IN-VIP	NA	NA	NA
GTCTTCGCACAGTCGC-1_5609_BA9	29.11335946	-12.82898265	2	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	5972	16856	0.004627432	0.006288562	0	2	EN-L4	NA	NA	NA
GTGAAGGTCTGGCGTG-1_5609_BA9	21.36983704	28.9813426	17	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	1144	1677	0.002981515	0.002385212	0	oligos	OL-MS-2	NA	NA	NA
GTGCAGCTCTTCGAGA-1_5609_BA9	-18.72136349	-17.20049417	6B	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	2638	4993	0.000801122	0.006809533	0	6B	IN-SST	NA	NA	NA
GTGCGGTAGTATCTCG-1_5609_BA9	31.90453861	-10.88024342	2	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	3159	5639	0.005852101	0.009221493	0	2	EN-L4	NA	NA	NA
GTGCGGTGTCTTCTCG-1_5609_BA9	-11.67692986	-9.042509512	13B	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	1676	2588	0.001545595	0.00309119	0	13B	IN-SV2C	NA	NA	NA
GTGCTTCAGACTTGAA-1_5609_BA9	-1.862622855	36.44646219	17	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	901	1234	0.004051864	0.005672609	0	oligos	OL-MS-2	NA	NA	NA
GTGGGTCTCCTTAATC-1_5609_BA9	17.11038542	-32.21974759	3	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	5473	15320	0.001109661	0.003133159	0	3	EN-L5-6	NA	NA	NA
GTGTTAGGTGAGTGAC-1_5609_BA9	27.2211687	-15.74758566	2	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	7096	20417	0.02272616	0.009403928	0	2	EN-L4	NA	NA	NA
GTGTTAGTCCGTTGTC-1_5609_BA9	-21.75560002	-23.07313372	6A	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	3339	6669	0.004348478	0.005098216	0	6A	IN-PV	NA	NA	NA
GTGTTAGTCGCAAACT-1_5609_BA9	20.72842701	-12.02406416	12	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	2102	3167	0.007262393	0.005683612	0	12	EN-MIX	NA	NA	NA
GTTACAGCACACTGCG-1_5609_BA9	7.433199322	-28.87755201	10	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	5617	16331	0.003490295	0.003918927	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GTTCATTAGCAGCGTA-1_5609_BA9	-7.658383719	-33.35144056	16	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	919	1265	0.025296443	0.016600791	0	16	EN-PYR	NA	NA	NA
GTTCGGGAGCTAGTGG-1_5609_BA9	-13.07395644	14.61274534	11	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	977	1322	0.00075643	0.003025719	0	11	Glia-MIX	NA	NA	NA
GTTCTCGAGATGGGTC-1_5609_BA9	10.38713171	-28.75353133	4	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	5815	15131	0.003172295	0.004097548	0	L2-3	EN-L2-3-MS	NA	NA	NA
TAAACCGAGCTAGCCC-1_5609_BA9	25.1548085	-27.25111251	3	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	4305	10696	0.000560957	0.003272251	0	3	EN-L5-6	NA	NA	NA
TAAACCGCATTCCTGC-1_5609_BA9	-26.76292098	8.979350556	8	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	907	1308	0.000764526	0.004587156	0	8	Astrocytes	NA	NA	NA
TAAACCGTCGGATGTT-1_5609_BA9	-11.60557904	30.02254062	17	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	2386	3674	0.038649973	0.00843767	0	oligos	OL-MS-2	NA	NA	NA
TAAACCGTCTGCGACG-1_5609_BA9	-20.21929391	-23.73966815	6A	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	2752	5404	0.01572909	0.004256107	0	6A	IN-PV	NA	NA	NA
TAAGCGTAGAATCTCC-1_5609_BA9	17.81567277	-7.203353065	3	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	1805	2993	0.000334113	0.004009355	0	3	EN-L5-6	NA	NA	NA
TACACGAGTACATCCA-1_5609_BA9	-6.477228281	-10.17314844	13B	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	1336	1948	0.002566735	0.01026694	0	13B	IN-SV2C	NA	NA	NA
TACAGTGAGTGGGCTA-1_5609_BA9	-27.16757481	8.276879264	8	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	829	1073	0.000931966	0.003727866	0	8	Astrocytes	NA	NA	NA
TACCTATCAAGCTGGA-1_5609_BA9	-13.01492276	-35.70991784	16	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	1635	2542	0.019276161	0.012981904	0	16	EN-PYR	NA	NA	NA
TACGGGCAGTGCCAGA-1_5609_BA9	-11.86771895	0.099170055	13A	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	3215	6185	0.000485044	0.006790622	0	13A	IN-VIP	NA	NA	NA
TACGGTAAGGGTATCG-1_5609_BA9	-11.24578517	-10.11657348	13B	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	1529	2360	0.002966102	0.002966102	0	13B	IN-SV2C	NA	NA	NA
TACGGTAGTCCAGTAT-1_5609_BA9	-24.21593297	-22.02214753	6A	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	3813	7444	0.011552929	0.005507792	0	6A	IN-PV	NA	NA	NA
TACTCATCAATACGCT-1_5609_BA9	1.210486137	30.81992583	1	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	772	1029	0	0.002915452	0	oligos	OL-Cntl	NA	NA	NA
TACTCATTCACCTTAT-1_5609_BA9	24.23095391	-6.424539138	2	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	4316	10128	0.001086098	0.007010269	0	2	EN-L4	NA	NA	NA
TACTTACTCAGCATGT-1_5609_BA9	-23.9750533	-2.222324143	9	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	1057	1448	0.001381215	0.002762431	0	9	OPC	NA	NA	NA
TAGAGCTTCACAGGCC-1_5609_BA9	9.221496739	-1.349547365	12	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	1114	1555	0.006430868	0.003215434	0	12	EN-MIX	NA	NA	NA
TAGCCGGCACAGAGGT-1_5609_BA9	20.56475398	-0.854422008	2	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	1547	2394	0.002923977	0.003759398	0	2	EN-L4	NA	NA	NA
TAGCCGGCAGACGCAA-1_5609_BA9	32.05319084	-10.12463997	2	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	3606	7065	0.010757254	0.00905874	0	2	EN-L4	NA	NA	NA
TAGGCATTCTGCGTAA-1_5609_BA9	-2.600826912	29.86793183	17	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	867	1136	0	0.006161972	0	oligos	OL-MS-2	NA	NA	NA
TAGGCATTCTTAGAGC-1_5609_BA9	-26.11643511	9.05674809	8	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	976	1369	0.00073046	0.005843682	0	8	Astrocytes	NA	NA	NA
TAGTGGTTCACTTCAT-1_5609_BA9	0.441295537	30.04734383	1	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	851	1221	0.005733006	0.001638002	0	oligos	OL-Cntl	NA	NA	NA
TAGTTGGAGCTAACTC-1_5609_BA9	-27.75025202	8.958623795	8	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	773	1004	0.00498008	0	0	8	Astrocytes	NA	NA	NA
TAGTTGGCAGCTGGCT-1_5609_BA9	-20.41251196	-16.40261542	6B	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	3214	6508	0.002458513	0.005377996	0	6B	IN-SST	NA	NA	NA
TATCAGGAGAATTCCC-1_5609_BA9	-22.58343662	-1.557659827	9	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	1002	1337	0.003739716	0.005235602	0	9	OPC	NA	NA	NA
TATCAGGTCTGCGGCA-1_5609_BA9	16.46590572	-4.440520192	12	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	1509	2617	0.001146351	0.005731754	0	12	EN-MIX	NA	NA	NA
TATGCCCAGTCTCCTC-1_5609_BA9	17.6267149	27.76472018	1	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	1012	1455	0.002061856	0.002749141	0	oligos	OL-Cntl	NA	NA	NA
TATTACCGTTCAGACT-1_5609_BA9	-28.17359897	10.63187774	8	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	859	1175	0.000851064	0.006808511	0	8	Astrocytes	NA	NA	NA
TCAACGACACACTGCG-1_5609_BA9	2.83915478	7.216271266	1	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	1077	1554	0.001287001	0.005148005	0	oligos	OL-Cntl	NA	NA	NA
TCAATCTGTCCCTACT-1_5609_BA9	15.63840777	-5.305526376	12	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	1634	2555	0.002739726	0.003522505	0	12	EN-MIX	NA	NA	NA
TCACAAGCAGGACCCT-1_5609_BA9	3.289555587	-20.09112409	4	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	4376	10037	0.001095945	0.003586729	0	L2-3	EN-L2-3-MS	NA	NA	NA
TCACGAAGTATCAGTC-1_5609_BA9	-7.302157368	-31.9322424	16	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	749	1036	0.027992278	0.007722008	0	16	EN-PYR	NA	NA	NA
TCAGCAATCCCTCTTT-1_5609_BA9	-31.15651112	-12.45179756	9	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	938	1333	0.00300075	0.00300075	0	9	OPC	NA	NA	NA
TCAGCTCCAGACACTT-1_5609_BA9	29.39904499	-6.24569743	2	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	5636	15610	0.002370275	0.006021781	0	2	EN-L4	NA	NA	NA
TCAGCTCCAGGACCCT-1_5609_BA9	-14.2526522	-36.18227158	16	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	2130	3682	0.021455731	0.012764802	0	16	EN-PYR	NA	NA	NA
TCAGGATCAAGGACAC-1_5609_BA9	-12.41657008	-35.03362325	16	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	1378	2167	0.027226581	0.007844947	0	16	EN-PYR	NA	NA	NA
TCAGGATGTTTCCACC-1_5609_BA9	-26.17800738	9.534322696	8	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	1002	1504	0.000664894	0.003324468	0	8	Astrocytes	NA	NA	NA
TCAGGTACATGAACCT-1_5609_BA9	29.39231824	-5.734005904	2	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	4762	11615	0.001980198	0.003185536	0	2	EN-L4	NA	NA	NA
TCAGGTAGTCTGATTG-1_5609_BA9	23.94929352	-26.01696976	3	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	3340	7011	0.000998431	0.003280559	0	3	EN-L5-6	NA	NA	NA
TCAGGTATCGAACTGT-1_5609_BA9	-27.64257819	-21.2723722	6A	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	4500	9922	0.011187261	0.00493852	0	6A	IN-PV	NA	NA	NA
TCATTTGAGTGCGATG-1_5609_BA9	4.480239973	-15.87287256	4	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	3196	6228	0.001926782	0.007867694	0	L2-3	EN-L2-3-MS	NA	NA	NA
TCATTTGGTAGTGAAT-1_5609_BA9	18.01453306	-10.41739423	3	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	3099	6151	0.001138026	0.021459925	0	3	EN-L5-6	NA	NA	NA
TCATTTGTCATGTAGC-1_5609_BA9	-5.374077808	-34.37016897	16	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	782	1029	0.030126336	0.008746356	0	16	EN-PYR	NA	NA	NA
TCCCGATCAACACCTA-1_5609_BA9	-0.711381595	30.45754166	1	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	992	1383	0	0.005784526	0	oligos	OL-Cntl	NA	NA	NA
TCGGGACAGTCATCCA-1_5609_BA9	29.87007535	-8.734050229	2	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	7670	24905	0.003292512	0.006464565	0	2	EN-L4	NA	NA	NA
TCGGGACCAGGGTACA-1_5609_BA9	-19.07007624	-16.1871127	6B	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	2846	5429	0.003868116	0.008473015	0	6B	IN-SST	NA	NA	NA
TCGGTAACAAGTCTGT-1_5609_BA9	31.82901529	-3.068106612	2	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	3575	6998	0.00071449	0.006430409	0	2	EN-L4	NA	NA	NA
TCGTAGATCTCGATGA-1_5609_BA9	31.53623122	-9.537154668	2	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	3532	7087	0.002398758	0.004374206	0	2	EN-L4	NA	NA	NA
TCTATTGCACCAGATT-1_5609_BA9	30.99513204	-5.96486658	2	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	4356	10421	0.004414164	0.003934363	0	2	EN-L4	NA	NA	NA
TCTGAGAAGAAGGTTT-1_5609_BA9	-21.10800097	-23.3733785	6A	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	2896	5490	0.002367942	0.004553734	0	6A	IN-PV	NA	NA	NA
TCTGAGACACGCGAAA-1_5609_BA9	-9.644507682	-32.06545811	16	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	1126	1609	0.037290242	0.013051585	0	16	EN-PYR	NA	NA	NA
TCTTCGGGTCCAACTA-1_5609_BA9	-14.51212727	-18.31123606	6B	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	1491	2770	0.000361011	0.00433213	0	6B	IN-SST	NA	NA	NA
TCTTTCCCATTCTCAT-1_5609_BA9	29.36183266	-11.18210398	2	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	5675	16593	0.021394564	0.003736515	0	2	EN-L4	NA	NA	NA
TGAAAGAAGTGGTAAT-1_5609_BA9	-21.49908464	-23.0200455	6A	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	3166	5862	0.005970658	0.005800068	0	6A	IN-PV	NA	NA	NA
TGACGGCGTTCAACCA-1_5609_BA9	-9.563582189	-15.52903468	6B	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	1078	1502	0.014647137	0.007989348	0	6B	IN-SST	NA	NA	NA
TGAGAGGAGACGACGT-1_5609_BA9	33.12439617	-2.419860998	2	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	2708	4869	0.003080715	0.013144383	0	2	EN-L4	NA	NA	NA
TGAGAGGCACATTCGA-1_5609_BA9	13.57303053	-22.52381528	4	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	6913	21049	0.005320918	0.003990688	0	L2-3	EN-L2-3-MS	NA	NA	NA
TGAGCATCACGGCGTT-1_5609_BA9	-12.42544854	-8.680360319	13B	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	2674	4773	0.014665829	0.008589985	0	13B	IN-SV2C	NA	NA	NA
TGAGCATGTACGCACC-1_5609_BA9	9.209909833	-29.6491912	10	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	6938	21720	0.001058932	0.003499079	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TGAGCCGAGGTGACCA-1_5609_BA9	31.2697616	-7.090847004	2	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	4134	8921	0.001569331	0.004707992	0	2	EN-L4	NA	NA	NA
TGAGCCGTCCCGACTT-1_5609_BA9	33.12756985	-3.18078826	2	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	3125	6122	0.006043777	0.006860503	0	2	EN-L4	NA	NA	NA
TGAGCCGTCTCTAGGA-1_5609_BA9	23.61969409	-11.96682649	3	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	3594	7164	0.006839754	0.004606365	0	3	EN-L5-6	NA	NA	NA
TGCACCTCACTGTGTA-1_5609_BA9	24.68336903	-24.30712754	3	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	3907	8965	0.003346347	0.004907975	0	3	EN-L5-6	NA	NA	NA
TGCCCATCACCGGAAA-1_5609_BA9	-27.72592875	9.360860221	8	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	807	1117	0.000895255	0.00179051	0	8	Astrocytes	NA	NA	NA
TGCCCATGTTGAGGTG-1_5609_BA9	-15.09050875	-13.56881664	6B	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	2097	3383	0.00945906	0.007685486	0	6B	IN-SST	NA	NA	NA
TGCGCAGGTCCTCCAT-1_5609_BA9	13.73133821	1.978413735	12	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	714	1037	0.00192864	0.003857281	0	12	EN-MIX	NA	NA	NA
TGCGGGTGTCGTCTTC-1_5609_BA9	-17.1500612	-21.42317426	6B	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	1822	2935	0.003407155	0.013287905	0	6B	IN-SST	NA	NA	NA
TGCGTGGAGACAATAC-1_5609_BA9	14.07076923	-0.105315391	12	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	796	1102	0.013611615	0.004537205	0	12	EN-MIX	NA	NA	NA
TGCTACCTCAGCTTAG-1_5609_BA9	12.93687813	-22.53972159	4	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	5628	14863	0.002489403	0.003835027	0	L2-3	EN-L2-3-MS	NA	NA	NA
TGCTACCTCGCGTTTC-1_5609_BA9	32.39234188	-7.296658047	2	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	3422	6645	0.001354402	0.00662152	0	2	EN-L4	NA	NA	NA
TGCTGCTCATGACGGA-1_5609_BA9	-29.29435164	-13.08791485	9	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	787	1016	0.000984252	0.005905512	0	9	OPC	NA	NA	NA
TGCTGCTTCGGCTACG-1_5609_BA9	24.16774543	27.20248549	17	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	1401	2049	0.004880429	0.005368472	0	oligos	OL-MS-2	NA	NA	NA
TGGACGCTCACGGTTA-1_5609_BA9	17.67966631	-7.627249012	3	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	1905	3340	0.002095808	0.004191617	0	3	EN-L5-6	NA	NA	NA
TGGCCAGAGCGAGAAA-1_5609_BA9	-1.668079383	29.03029382	1	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	754	1048	0.001908397	0.006679389	0	oligos	OL-Cntl	NA	NA	NA
TGGCGCAAGACATAAC-1_5609_BA9	20.02415391	-11.02264541	3	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	2776	5133	0.004091175	0.003701539	0	3	EN-L5-6	NA	NA	NA
TGTCCCACACAGTCGC-1_5609_BA9	-1.868503329	29.27025081	17	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	711	1001	0.001998002	0	0	oligos	OL-MS-2	NA	NA	NA
TGTGTTTTCTTGCAAG-1_5609_BA9	17.26162141	-7.139741886	3	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	1844	3189	0.000940734	0.010661649	0	3	EN-L5-6	NA	NA	NA
TTAACTCTCTGCGGCA-1_5609_BA9	24.04115278	-12.46177743	3	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	5292	14289	0.01630625	0.003359227	0	3	EN-L5-6	NA	NA	NA
TTAACTCTCTTGTACT-1_5609_BA9	31.00749372	-9.985001449	2	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	3870	8671	0.010379426	0.004843732	0	2	EN-L4	NA	NA	NA
TTAGGCACAGTCAGAG-1_5609_BA9	12.22867549	-2.113407921	12	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	1225	1765	0.003966006	0.002266289	0	12	EN-MIX	NA	NA	NA
TTAGGCATCGCGTTTC-1_5609_BA9	20.63953942	-22.75256271	3	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	4049	8758	0.004453071	0.006622517	0	3	EN-L5-6	NA	NA	NA
TTAGGCATCTAAGCCA-1_5609_BA9	-11.95588435	-32.86486717	16	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	1251	1897	0.034264628	0.003690037	0	16	EN-PYR	NA	NA	NA
TTAGTTCCACACATGT-1_5609_BA9	24.26035376	-6.583478867	2	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	4501	10320	0.001841085	0.005426357	0	2	EN-L4	NA	NA	NA
TTCCCAGAGTTTAGGA-1_5609_BA9	-29.76242728	-13.21417034	9	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	740	1048	0	0.004770992	0	9	OPC	NA	NA	NA
TTCTACAAGGTAGCCA-1_5609_BA9	2.740644425	0.212509861	16	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	1099	1490	0.015436242	0.013422819	0	16	EN-PYR	NA	NA	NA
TTCTTAGTCTCTAAGG-1_5609_BA9	-8.149825424	-33.67508032	16	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	893	1179	0.038167939	0.009329941	0	16	EN-PYR	NA	NA	NA
TTGCGTCGTGAGGCTA-1_5609_BA9	6.725190199	-29.31119801	10	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	3750	8374	0.00214951	0.004537855	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TTTACTGAGAGTAATC-1_5609_BA9	-19.93443612	-24.01916514	6A	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	2424	4382	0.005933364	0.008443633	0	6A	IN-PV	NA	NA	NA
TTTACTGAGGATCGCA-1_5609_BA9	26.76250198	5.061984103	15A	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	1093	1433	0.00628053	0.016050244	0	15A	Endo cells	NA	NA	NA
TTTATGCCAAGTTGTC-1_5609_BA9	30.06018459	-9.22025136	2	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	4274	10411	0.003457881	0.003169724	0	2	EN-L4	NA	NA	NA
TTTGGTTCATAAAGGT-1_5609_BA9	13.56613407	-27.85213677	3	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	2800	5516	0.000725163	0.007251632	0	3	EN-L5-6	NA	NA	NA
TTTGTCAGTTCCACAA-1_5609_BA9	9.098570937	-1.464769143	12	5609_BA9	Control	Control	54	female	prefrontal	CAP7	SEQ5	8.5	6	1191	1869	0.006955591	0.005350455	0	12	EN-MIX	NA	NA	NA
AAACCTGAGGACGAAA-1_5546_BA9	32.57527168	-9.119409387	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3750	8353	0.004190111	0.012330899	0	2	EN-L4	NA	NA	NA
AAACCTGAGTAGCGGT-1_5546_BA9	-10.53506571	-36.22772619	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1103	1500	0.013333333	0.014666667	0	16	EN-PYR	NA	NA	NA
AAACCTGGTCATGCCG-1_5546_BA9	11.02984942	-25.72155461	10	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	5469	16797	0.001309758	0.004405549	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AAACCTGTCTCTTGAT-1_5546_BA9	-30.20126956	-21.79841938	6A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	5287	13931	0.017730242	0.01493073	0	6A	IN-PV	NA	NA	NA
AAACGGGAGGTAGCTG-1_5546_BA9	20.24253045	-20.28231184	3	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	5384	13556	0.00804072	0.007893184	0	3	EN-L5-6	NA	NA	NA
AAACGGGGTGAAATCA-1_5546_BA9	10.22729562	-19.30051421	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4808	12427	0.003540678	0.004989137	0	L2-3	EN-L2-3-MS	NA	NA	NA
AAACGGGTCGATCCCT-1_5546_BA9	20.08993885	-19.34370073	3	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	5597	15911	0.005656464	0.008233298	0	3	EN-L5-6	NA	NA	NA
AAAGATGAGATGTGGC-1_5546_BA9	-10.59504836	-36.41563643	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1200	1647	0.044323012	0.018214936	0	16	EN-PYR	NA	NA	NA
AAAGATGAGCGATAGC-1_5546_BA9	5.511304998	-13.41999724	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2553	4539	0.002864067	0.00462657	0	L2-3	EN-L2-3-MS	NA	NA	NA
AAAGATGAGTGTGAAT-1_5546_BA9	-9.59411695	-14.98422231	6B	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	968	1392	0.007902299	0.006465517	0	6B	IN-SST	NA	NA	NA
AAAGATGCAGTCACTA-1_5546_BA9	-15.2468499	-4.993215726	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3320	7883	0.011036407	0.007103894	0	13A	IN-VIP	NA	NA	NA
AAAGATGTCCATGCTC-1_5546_BA9	-30.43151947	-12.21965067	9	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	823	1144	0.001748252	0.004370629	0	9	OPC	NA	NA	NA
AAAGCAACAGCGTCCA-1_5546_BA9	-13.77950031	-36.50343118	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1727	2992	0.026403743	0.011697861	0	16	EN-PYR	NA	NA	NA
AAAGCAAGTCCAAGTT-1_5546_BA9	-10.95863775	-5.462908762	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1770	3032	0.007585752	0.012532982	0	13A	IN-VIP	NA	NA	NA
AAAGTAGTCAGCGACC-1_5546_BA9	29.09505518	6.985512152	15BA	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	850	1074	0.015828678	0.026070764	0	15BA	Stromal cells	NA	NA	NA
AAAGTAGTCGCCAAAT-1_5546_BA9	34.72462215	-12.60247705	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3338	6672	0.004196643	0.019484412	0	2	EN-L4	NA	NA	NA
AAATGCCCAATGGATA-1_5546_BA9	35.25929925	-11.03919626	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3878	8328	0.001681076	0.019572526	0	2	EN-L4	NA	NA	NA
AAATGCCCACTGCCAG-1_5546_BA9	-20.85128908	5.201292325	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1262	1793	0.011712214	0.005577245	0	8	Astrocytes	NA	NA	NA
AAATGCCCAGATTGCT-1_5546_BA9	-6.243114871	-35.46007673	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	816	1069	0.070159027	0.016838167	0	16	EN-PYR	NA	NA	NA
AAATGCCTCAACACGT-1_5546_BA9	34.64060169	-5.655778988	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3313	7002	0.002570694	0.005569837	0	2	EN-L4	NA	NA	NA
AACACGTGTGGTTTCA-1_5546_BA9	1.736793625	22.14047996	1	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	859	1135	0	0.004405286	0	oligos	OL-Cntl	NA	NA	NA
AACCATGAGAGTACCG-1_5546_BA9	-13.5961656	-1.747793771	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2556	4758	0.005044136	0.011559479	0	13A	IN-VIP	NA	NA	NA
AACCATGCACGTCTCT-1_5546_BA9	-11.29324738	-4.271047288	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2361	4296	0.004655493	0.013733706	0	13A	IN-VIP	NA	NA	NA
AACCATGTCAAGATCC-1_5546_BA9	-28.02873816	-5.180991837	9	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1260	1802	0.004439512	0.007214206	0	9	OPC	NA	NA	NA
AACCATGTCCTCAACC-1_5546_BA9	15.59164953	-21.2256258	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	6039	17730	0.006711788	0.008685843	0	L2-3	EN-L2-3-MS	NA	NA	NA
AACCATGTCGCCCTTA-1_5546_BA9	18.30429659	-9.523405517	3	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2330	4674	0.005134788	0.005348738	0	3	EN-L5-6	NA	NA	NA
AACCGCGCAGGCAGTA-1_5546_BA9	5.759176443	0.087471399	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1183	1813	0.015444015	0.013237728	0	16	EN-PYR	NA	NA	NA
AACCGCGGTAGGGACT-1_5546_BA9	-23.24637666	-15.7742313	6A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	5372	14674	0.004702194	0.009813275	0	6A	IN-PV	NA	NA	NA
AACCGCGTCCGCTGTT-1_5546_BA9	17.37963368	-9.804907024	3	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2012	3642	0.009610104	0.00686436	0	3	EN-L5-6	NA	NA	NA
AACGTTGAGAGCTGGT-1_5546_BA9	8.425293256	-15.35571252	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3419	7238	0.006079027	0.004282951	0	L2-3	EN-L2-3-MS	NA	NA	NA
AACGTTGAGTCAAGCG-1_5546_BA9	13.4892992	-23.82964732	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4917	13436	0.002679369	0.004763322	0	L2-3	EN-L2-3-MS	NA	NA	NA
AACTCAGCATGGGAAC-1_5546_BA9	14.67951962	-12.466607	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3505	7173	0.008504113	0.01491705	0	L2-3	EN-L2-3-MS	NA	NA	NA
AACTCAGTCTCTTATG-1_5546_BA9	12.46791392	-22.97540754	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4300	10436	0.000958222	0.007761594	0	L2-3	EN-L2-3-MS	NA	NA	NA
AACTCCCCACTACAGT-1_5546_BA9	-7.124635723	-35.55978569	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	918	1240	0.054032258	0.016935484	0	16	EN-PYR	NA	NA	NA
AACTCCCTCACCACCT-1_5546_BA9	-20.96451117	5.705239128	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1500	2194	0.001823154	0.010027347	0	8	Astrocytes	NA	NA	NA
AACTCCCTCGGAGGTA-1_5546_BA9	-21.70623101	5.811896361	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1203	1720	0.000581395	0.009883721	0	8	Astrocytes	NA	NA	NA
AACTCTTCACATCTTT-1_5546_BA9	-20.58579111	4.716210086	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	858	1108	0.004512635	0.002707581	0	8	Astrocytes	NA	NA	NA
AACTCTTCACGCCAGT-1_5546_BA9	-5.761905884	-2.506835812	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1728	3188	0.001254705	0.002823087	0	13A	IN-VIP	NA	NA	NA
AACTCTTGTAGCTTGT-1_5546_BA9	-14.07299102	3.327860942	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3577	6906	0.005647263	0.012597741	0	13A	IN-VIP	NA	NA	NA
AACTCTTGTCTCCATC-1_5546_BA9	-26.51187293	-21.06719029	6A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3625	8141	0.008721287	0.008229947	0	6A	IN-PV	NA	NA	NA
AACTGGTAGAATTGTG-1_5546_BA9	14.267668	-23.31277704	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4683	12145	0.012350762	0.004610951	0	L2-3	EN-L2-3-MS	NA	NA	NA
AACTGGTAGCTGCAAG-1_5546_BA9	-11.46227117	-15.30926205	6B	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1115	1626	0.038745387	0.006765068	0	6B	IN-SST	NA	NA	NA
AACTGGTCACGAAAGC-1_5546_BA9	12.80190912	-18.61568827	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	5953	16638	0.004207236	0.004026926	0	L2-3	EN-L2-3-MS	NA	NA	NA
AACTGGTCACTGTCGG-1_5546_BA9	10.44242272	-19.64405162	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	5543	15386	0.003379696	0.005459509	0	L2-3	EN-L2-3-MS	NA	NA	NA
AACTGGTCAGGGTACA-1_5546_BA9	15.51644807	-15.38901119	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	5657	15559	0.012404396	0.00694132	0	L2-3	EN-L2-3-MS	NA	NA	NA
AACTGGTGTCTCATCC-1_5546_BA9	-23.64998552	-11.05914297	9	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	860	1168	0.035958904	0.01369863	0	9	OPC	NA	NA	NA
AACTGGTGTGTTAAGA-1_5546_BA9	14.96286266	-17.40067713	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	5994	17186	0.013441173	0.006807867	0	L2-3	EN-L2-3-MS	NA	NA	NA
AACTGGTTCAACACCA-1_5546_BA9	-16.93355014	-14.96900295	6B	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1866	3248	0.010160099	0.002463054	0	6B	IN-SST	NA	NA	NA
AACTGGTTCACGATGT-1_5546_BA9	-22.79974058	8.395033943	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1183	1756	0.006833713	0.005694761	0	8	Astrocytes	NA	NA	NA
AACTTTCAGGGCTTCC-1_5546_BA9	7.183054764	0.092426377	12	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	833	1018	0.008840864	0.003929273	0	12	EN-MIX	NA	NA	NA
AACTTTCCAGCGTTCG-1_5546_BA9	10.69958897	-1.41017677	12	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1532	2149	0.002791996	0.021870638	0	12	EN-MIX	NA	NA	NA
AACTTTCGTCATGCCG-1_5546_BA9	33.31808983	-15.68151296	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3936	8711	0.008035817	0.010561359	0	2	EN-L4	NA	NA	NA
AACTTTCGTGCTCTTC-1_5546_BA9	6.203402295	-30.56715997	10	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	5493	19320	0.000672878	0.003778468	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AACTTTCGTTCTGGTA-1_5546_BA9	-23.30942672	5.542993937	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	794	1091	0.007332722	0.007332722	0	8	Astrocytes	NA	NA	NA
AACTTTCTCGAATCCA-1_5546_BA9	-8.981910524	-35.74658323	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	984	1362	0.015418502	0.008076358	0	16	EN-PYR	NA	NA	NA
AACTTTCTCGGCGCAT-1_5546_BA9	13.01818022	-4.381159127	12	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1743	2652	0.010180995	0.006410256	0	12	EN-MIX	NA	NA	NA
AACTTTCTCTCCGGTT-1_5546_BA9	33.6693817	-12.33515383	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4034	9395	0.006067057	0.008195849	0	2	EN-L4	NA	NA	NA
AAGACCTCACTATCTT-1_5546_BA9	4.800768204	0.468473843	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	820	1164	0.018041237	0.012886598	0	16	EN-PYR	NA	NA	NA
AAGACCTCACTCTGTC-1_5546_BA9	31.16114794	-12.75361571	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4483	10768	0.005479198	0.007986627	0	2	EN-L4	NA	NA	NA
AAGACCTGTCAATACC-1_5546_BA9	-11.49883032	-29.461882	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1374	2017	0.02131879	0.014377789	0	16	EN-PYR	NA	NA	NA
AAGCCGCAGTGAAGAG-1_5546_BA9	33.7356919	-16.73920488	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4238	8784	0.008196721	0.014344262	0	2	EN-L4	NA	NA	NA
AAGCCGCCAGATGGGT-1_5546_BA9	-21.03687296	5.492930814	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1098	1572	0.003180662	0.007633588	0	8	Astrocytes	NA	NA	NA
AAGCCGCCATCACGTA-1_5546_BA9	30.5727103	-16.9522895	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	5193	13649	0.012235329	0.008572057	0	2	EN-L4	NA	NA	NA
AAGCCGCGTCCTAGCG-1_5546_BA9	-13.61714212	-0.691277924	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3176	6456	0.003097893	0.011307311	0	13A	IN-VIP	NA	NA	NA
AAGGAGCCAGCTTAAC-1_5546_BA9	-10.67769041	-15.14911667	6B	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1061	1548	0.002583979	0.012273902	0	6B	IN-SST	NA	NA	NA
AAGGAGCGTCTCATCC-1_5546_BA9	-18.53365969	-21.66389735	6A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2045	3943	0.005325894	0.00634035	0	6A	IN-PV	NA	NA	NA
AAGGAGCTCAACTCTT-1_5546_BA9	9.495496282	-19.60218752	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3438	7828	0.003449157	0.006004088	0	L2-3	EN-L2-3-MS	NA	NA	NA
AAGGAGCTCCAGTATG-1_5546_BA9	-11.40633663	-4.995411248	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1979	3314	0.006035003	0.009957755	0	13A	IN-VIP	NA	NA	NA
AAGGCAGCATGCAATC-1_5546_BA9	24.76845815	-16.97599491	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	8436	32670	0.017569636	0.00835629	0	2	EN-L4	NA	NA	NA
AAGGTTCAGATCTGCT-1_5546_BA9	-30.00374963	-12.50915891	9	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	778	1071	0.000933707	0.004668534	0	9	OPC	NA	NA	NA
AAGGTTCAGTCAAGCG-1_5546_BA9	-21.32438884	4.517065481	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	908	1228	0.000814332	0.010586319	0	8	Astrocytes	NA	NA	NA
AAGGTTCGTATATGGA-1_5546_BA9	-28.70867011	-10.97187125	9	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	985	1415	0.002120141	0.008480565	0	9	OPC	NA	NA	NA
AAGGTTCGTTCCACAA-1_5546_BA9	-22.70935758	6.230185055	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1104	1603	0.004990643	0.003742982	0	8	Astrocytes	NA	NA	NA
AAGGTTCTCACTCTTA-1_5546_BA9	-24.91615922	-0.615164185	9	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1480	2223	0.003148898	0.013495277	0	9	OPC	NA	NA	NA
AAGGTTCTCGACGGAA-1_5546_BA9	-21.24774495	4.473420813	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1013	1371	0.004376368	0.008752735	0	8	Astrocytes	NA	NA	NA
AAGTCTGCAATGAAAC-1_5546_BA9	-29.69038976	-21.81669737	6A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4676	10819	0.021443756	0.010537018	0	6A	IN-PV	NA	NA	NA
AAGTCTGGTGTAACGG-1_5546_BA9	11.54915581	-12.50253429	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3443	7087	0.005079723	0.020883307	0	L2-3	EN-L2-3-MS	NA	NA	NA
AAGTCTGGTGTTGGGA-1_5546_BA9	24.26845036	-13.17701054	3	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3001	5328	0.00487988	0.01783033	0	3	EN-L5-6	NA	NA	NA
AAGTCTGTCTGCTTGC-1_5546_BA9	-29.58922081	-11.19000018	9	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	909	1297	0.00154202	0.01387818	0	9	OPC	NA	NA	NA
AATCCAGAGATATACG-1_5546_BA9	2.503108069	-21.31642331	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4077	10310	0.001648885	0.006401552	0	L2-3	EN-L2-3-MS	NA	NA	NA
AATCCAGAGCAGCCTC-1_5546_BA9	-18.14716977	-6.116872904	13B	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2783	5244	0.009344012	0.011060259	0	13B	IN-SV2C	NA	NA	NA
AATCCAGAGGTACTCT-1_5546_BA9	-28.51529258	-12.5790308	9	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	736	1036	0.004826255	0.010617761	0	9	OPC	NA	NA	NA
AATCCAGCAATACGCT-1_5546_BA9	5.772466004	17.23425899	1	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1045	1500	0.002	0.009333333	0	oligos	OL-Cntl	NA	NA	NA
AATCCAGCATTGGGCC-1_5546_BA9	32.55010854	-16.67238395	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4138	9514	0.007147362	0.016607105	0	2	EN-L4	NA	NA	NA
AATCGGTAGGTGACCA-1_5546_BA9	-11.57233586	-15.07012684	6B	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1272	1945	0.020051414	0.003598972	0	6B	IN-SST	NA	NA	NA
AATCGGTGTCATACTG-1_5546_BA9	8.783692081	-13.43238818	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2610	4984	0.011637239	0.011837881	0	L2-3	EN-L2-3-MS	NA	NA	NA
ACACCAAAGGGATGGG-1_5546_BA9	32.97766448	-16.31350514	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4210	9106	0.019877004	0.01197013	0	2	EN-L4	NA	NA	NA
ACACCAAGTCGAGTTT-1_5546_BA9	-9.082051812	-8.495241876	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1525	2341	0.005553182	0.003844511	0	13A	IN-VIP	NA	NA	NA
ACACCAAGTTAAGATG-1_5546_BA9	-22.09014051	5.574150397	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1083	1488	0.009408602	0.00672043	0	8	Astrocytes	NA	NA	NA
ACACCCTGTGAGGCTA-1_5546_BA9	-11.08477818	-2.179845995	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2411	4434	0.00383401	0.00744249	0	13A	IN-VIP	NA	NA	NA
ACACCCTGTGCACCAC-1_5546_BA9	17.98293001	-20.54224435	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3586	7647	0.004184648	0.006930823	0	L2-3	EN-L2-3-MS	NA	NA	NA
ACACCCTTCTCTAGGA-1_5546_BA9	-12.59291576	-1.886515646	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2495	4603	0.004562242	0.013903976	0	13A	IN-VIP	NA	NA	NA
ACACCGGAGAGACTTA-1_5546_BA9	28.61675186	-18.60081285	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	6383	19567	0.01758062	0.010170184	0	2	EN-L4	NA	NA	NA
ACACCGGCATTGGTAC-1_5546_BA9	12.79625516	-19.91279739	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4333	10035	0.008669656	0.004683607	0	L2-3	EN-L2-3-MS	NA	NA	NA
ACACCGGTCGAGAACG-1_5546_BA9	16.25557244	-16.91411224	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	5853	16731	0.01010101	0.007052776	0	L2-3	EN-L2-3-MS	NA	NA	NA
ACACCGGTCGGAAATA-1_5546_BA9	17.13282422	-14.97195333	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	6038	17274	0.008104666	0.008220447	0	L2-3	EN-L2-3-MS	NA	NA	NA
ACACTGACAATGACCT-1_5546_BA9	-28.65926415	-22.22901119	6A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	5594	15599	0.015000962	0.006667094	0	6A	IN-PV	NA	NA	NA
ACACTGAGTATGAAAC-1_5546_BA9	-18.19653627	-13.8984101	6A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2064	3300	0.018484848	0.004848485	0	6A	IN-PV	NA	NA	NA
ACACTGATCACTCCTG-1_5546_BA9	29.64539873	-18.75824853	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	7607	27653	0.015369038	0.014031027	0	2	EN-L4	NA	NA	NA
ACACTGATCGCCCTTA-1_5546_BA9	18.26496135	-10.8636257	3	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3039	6955	0.00992092	0.01480949	0	3	EN-L5-6	NA	NA	NA
ACAGCCGAGCCCAACC-1_5546_BA9	35.62050558	-11.5330729	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4291	10552	0.004833207	0.033074299	0	2	EN-L4	NA	NA	NA
ACAGCCGAGTAATCCC-1_5546_BA9	-22.52728945	-20.26731382	6A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2558	4881	0.002458513	0.013112067	0	6A	IN-PV	NA	NA	NA
ACAGCCGTCACCATAG-1_5546_BA9	10.1840723	-16.1244432	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4128	9463	0.004861038	0.004966712	0	L2-3	EN-L2-3-MS	NA	NA	NA
ACAGCCGTCGACGGAA-1_5546_BA9	6.716583039	0.324263903	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1047	1262	0.013470681	0.006339144	0	16	EN-PYR	NA	NA	NA
ACAGCTAAGCTGAAAT-1_5546_BA9	-14.83043543	-9.614594185	13B	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2342	4579	0.001528718	0.003930989	0	13B	IN-SV2C	NA	NA	NA
ACAGCTAAGTCGCCGT-1_5546_BA9	18.09496358	-10.82829135	3	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2694	5357	0.000560015	0.027627403	0	3	EN-L5-6	NA	NA	NA
ACAGCTACAAAGGTGC-1_5546_BA9	33.72733016	-11.57030937	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2137	3557	0.006184987	0.008996345	0	2	EN-L4	NA	NA	NA
ACAGCTATCAGTTCGA-1_5546_BA9	-7.292638899	-35.63975756	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	722	1006	0.007952286	0.014910537	0	16	EN-PYR	NA	NA	NA
ACAGCTATCCTTTCTC-1_5546_BA9	15.90805156	-28.78827959	3	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	5226	16408	0.000914188	0.00383959	0	3	EN-L5-6	NA	NA	NA
ACAGCTATCGAATGCT-1_5546_BA9	-27.67040624	-12.43404929	9	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	836	1094	0.000914077	0.016453382	0	9	OPC	NA	NA	NA
ACAGCTATCTTGTATC-1_5546_BA9	-28.34093742	-5.581776745	9	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1137	1771	0.000564653	0.005081875	0	9	OPC	NA	NA	NA
ACATACGCATAAGACA-1_5546_BA9	-15.28666687	-37.42354267	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2914	5451	0.031186938	0.015776922	0	16	EN-PYR	NA	NA	NA
ACATACGGTGGGTATG-1_5546_BA9	-20.28279008	-4.853986915	13B	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3818	7745	0.013040671	0.008521627	0	13B	IN-SV2C	NA	NA	NA
ACATACGTCCACGTGG-1_5546_BA9	-22.17046625	6.89331204	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1370	2223	0.00179937	0.006297796	0	8	Astrocytes	NA	NA	NA
ACATCAGAGGCCCTCA-1_5546_BA9	-15.16910155	-2.028647548	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2410	4227	0.004021765	0.011592146	0	13A	IN-VIP	NA	NA	NA
ACATCAGCAGTCTTCC-1_5546_BA9	-20.9185263	4.443781333	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	834	1337	0	0.006731488	0	8	Astrocytes	NA	NA	NA
ACATCAGGTACAGTTC-1_5546_BA9	28.14167129	6.587130593	15BA	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	742	1078	0.014842301	0.017625232	0	15BA	Stromal cells	NA	NA	NA
ACATCAGGTCGCCATG-1_5546_BA9	-24.5213106	-12.59424608	9	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	717	1005	0.000995025	0.010945274	0	9	OPC	NA	NA	NA
ACATGGTAGAAACCAT-1_5546_BA9	13.93673003	-24.18742738	10	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	5519	16841	0.00160323	0.007719257	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACATGGTAGGTCATCT-1_5546_BA9	-14.54034321	-16.25092035	6B	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1549	2652	0.006410256	0.007541478	0	6B	IN-SST	NA	NA	NA
ACATGGTAGTTAGGTA-1_5546_BA9	-10.95344669	-4.485975907	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2023	3216	0.003420398	0.01710199	0	13A	IN-VIP	NA	NA	NA
ACATGGTGTACCGTAT-1_5546_BA9	14.56250752	-13.95679313	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4731	11222	0.003653538	0.014614151	0	L2-3	EN-L2-3-MS	NA	NA	NA
ACATGGTTCGGATGGA-1_5546_BA9	27.00154184	7.431490974	15A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1198	1710	0.026315789	0.022222222	0	15A	Endo cells	NA	NA	NA
ACATGGTTCTTAGAGC-1_5546_BA9	-20.29546609	4.572735125	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	855	1103	0.001813237	0.014505893	0	8	Astrocytes	NA	NA	NA
ACCAGTACAATACGCT-1_5546_BA9	32.95711262	-16.55139825	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4754	11656	0.009780371	0.015271105	0	2	EN-L4	NA	NA	NA
ACCCACTGTTGAGGTG-1_5546_BA9	-27.03495775	-18.16470666	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3462	6935	0.023215573	0.010958904	0	13A	IN-VIP	NA	NA	NA
ACCCACTTCTGTTTGT-1_5546_BA9	-16.56365171	-0.181417592	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4606	11410	0.00762489	0.010604733	0	13A	IN-VIP	NA	NA	NA
ACCGTAATCGAACTGT-1_5546_BA9	-20.38554194	4.004077241	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	916	1200	0.003333333	0.0125	0	8	Astrocytes	NA	NA	NA
ACGAGCCCACCAGCAC-1_5546_BA9	10.97157581	-16.99829211	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4602	11518	0.005296058	0.007813857	0	L2-3	EN-L2-3-MS	NA	NA	NA
ACGAGCCCATCGGTTA-1_5546_BA9	-20.56962999	-20.727512	6A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1496	2401	0.024573095	0.009162849	0	6A	IN-PV	NA	NA	NA
ACGAGCCGTAAGTGTA-1_5546_BA9	18.82470552	-14.98816407	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	6411	17700	0.011073446	0.013276836	0	L2-3	EN-L2-3-MS	NA	NA	NA
ACGAGCCTCGGCTACG-1_5546_BA9	-28.02594528	-5.16888418	9	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1291	2015	0.004466501	0.008436725	0	9	OPC	NA	NA	NA
ACGAGGAGTCATCGGC-1_5546_BA9	2.705787066	19.00312449	5	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	996	1378	0.002177068	0.007982583	0	oligos	OL-MS-1	NA	NA	NA
ACGAGGAGTGACAAAT-1_5546_BA9	-26.64437916	-20.94561203	6A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2935	5511	0.009798585	0.009617129	0	6A	IN-PV	NA	NA	NA
ACGAGGAGTGCCTGTG-1_5546_BA9	9.885122213	-16.35986509	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3914	8719	0.008143136	0.006652139	0	L2-3	EN-L2-3-MS	NA	NA	NA
ACGAGGAGTGCTGTAT-1_5546_BA9	12.64342536	-17.18144368	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4955	13013	0.005148697	0.014370245	0	L2-3	EN-L2-3-MS	NA	NA	NA
ACGAGGATCAGAAATG-1_5546_BA9	-27.06062381	-11.1295331	9	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1103	1486	0.000672948	0.010094213	0	9	OPC	NA	NA	NA
ACGAGGATCCTTGACC-1_5546_BA9	-21.25558858	4.751256605	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	964	1319	0.006823351	0.006065201	0	8	Astrocytes	NA	NA	NA
ACGATACAGTTTCCTT-1_5546_BA9	9.254319858	-3.095961647	12	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1763	3053	0.011464134	0.00687848	0	12	EN-MIX	NA	NA	NA
ACGATACGTCGTTGTA-1_5546_BA9	-8.177163846	-3.030072323	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1721	2956	0.00744249	0.009133965	0	13A	IN-VIP	NA	NA	NA
ACGATACGTTCCACAA-1_5546_BA9	-26.07890642	-21.724751	6A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3653	7938	0.006676745	0.012471655	0	6A	IN-PV	NA	NA	NA
ACGATACGTTCGGCAC-1_5546_BA9	22.26800517	-19.0898858	3	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	6638	21693	0.006776379	0.005347347	0	3	EN-L5-6	NA	NA	NA
ACGATGTAGTACCGGA-1_5546_BA9	-21.98410888	5.22604693	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	887	1335	0.000749064	0.011985019	0	8	Astrocytes	NA	NA	NA
ACGATGTGTCGAGTTT-1_5546_BA9	11.03101086	-13.21494786	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3500	7375	0.002576271	0.017220339	0	L2-3	EN-L2-3-MS	NA	NA	NA
ACGATGTTCCGTACAA-1_5546_BA9	-26.6920927	-11.95926274	9	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	900	1243	0.00160901	0.01850362	0	9	OPC	NA	NA	NA
ACGCAGCCAAAGGAAG-1_5546_BA9	-14.34506003	-15.14335095	6B	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1582	2358	0.007633588	0.0072095	0	6B	IN-SST	NA	NA	NA
ACGCAGCCAACCGCCA-1_5546_BA9	-8.170209692	-35.12464285	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	913	1234	0.041329011	0.007293355	0	16	EN-PYR	NA	NA	NA
ACGCAGCCAGTCGATT-1_5546_BA9	9.960122199	-23.44949098	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	5251	14712	0.001699293	0.006525285	0	L2-3	EN-L2-3-MS	NA	NA	NA
ACGCAGCGTCTCAACA-1_5546_BA9	19.14469149	-14.2554359	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	8247	31314	0.013316727	0.016542122	0	L2-3	EN-L2-3-MS	NA	NA	NA
ACGCAGCTCTGGGCCA-1_5546_BA9	9.712045884	-16.1177267	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3549	7608	0.007229232	0.008543638	0	L2-3	EN-L2-3-MS	NA	NA	NA
ACGCCAGCATGCCCGA-1_5546_BA9	9.452609412	-29.28637349	10	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	6673	23626	0.002920511	0.004486583	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACGCCAGGTCTCTTTA-1_5546_BA9	-29.10463482	-11.76382916	9	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	821	1174	0.001703578	0.00681431	0	9	OPC	NA	NA	NA
ACGCCAGTCGGCATCG-1_5546_BA9	-12.36467656	-37.9502981	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1617	2397	0.045473509	0.018356279	0	16	EN-PYR	NA	NA	NA
ACGCCGACAAGTTCTG-1_5546_BA9	24.48523286	-17.28802141	3	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	6925	22813	0.00894227	0.010081971	0	3	EN-L5-6	NA	NA	NA
ACGCCGACAGCTGTGC-1_5546_BA9	-8.066534999	-6.380631551	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1325	2023	0.014829461	0.007909046	0	13A	IN-VIP	NA	NA	NA
ACGCCGACATGCAATC-1_5546_BA9	10.72682819	-19.28701121	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4265	10672	0.003841829	0.004685157	0	L2-3	EN-L2-3-MS	NA	NA	NA
ACGGAGAAGCCAGAAC-1_5546_BA9	12.71497266	-15.33636525	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4615	11195	0.004019652	0.007949978	0	L2-3	EN-L2-3-MS	NA	NA	NA
ACGGAGAAGCTCCCAG-1_5546_BA9	10.64698617	-13.34949932	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3393	6875	0.002763636	0.020218182	0	L2-3	EN-L2-3-MS	NA	NA	NA
ACGGAGACACTCAGGC-1_5546_BA9	-11.87451705	-36.81528006	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1297	1913	0.050182959	0.01881861	0	16	EN-PYR	NA	NA	NA
ACGGAGAGTCTGATCA-1_5546_BA9	29.87561812	-11.73218467	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4635	11009	0.005631756	0.008175129	0	2	EN-L4	NA	NA	NA
ACGGCCAAGTCACGCC-1_5546_BA9	-20.13853523	4.565552052	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1018	1354	0.007385524	0.007385524	0	8	Astrocytes	NA	NA	NA
ACGGCCACAATCCGAT-1_5546_BA9	-28.52378415	-21.96813239	6A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4172	9099	0.013517969	0.01153973	0	6A	IN-PV	NA	NA	NA
ACGGCCAGTCAACATC-1_5546_BA9	-13.33190749	-37.62927735	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1629	2602	0.020368947	0.01537279	0	16	EN-PYR	NA	NA	NA
ACGGCCAGTTGTACAC-1_5546_BA9	19.82192047	-22.23883436	3	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4516	11562	0.003373119	0.007005708	0	3	EN-L5-6	NA	NA	NA
ACGGCCATCACCACCT-1_5546_BA9	-13.03670285	-37.55136271	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1444	2196	0.019125683	0.016393443	0	16	EN-PYR	NA	NA	NA
ACGGGCTAGCACGCCT-1_5546_BA9	9.609952778	-28.67544269	10	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	7336	28901	0.000484412	0.003563891	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACGGGCTGTAAAGGAG-1_5546_BA9	14.59633264	-17.14756207	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	5710	14948	0.005753278	0.006823655	0	L2-3	EN-L2-3-MS	NA	NA	NA
ACGGGCTTCTGCTGTC-1_5546_BA9	-13.36254843	-37.05108599	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1681	2705	0.051016636	0.014787431	0	16	EN-PYR	NA	NA	NA
ACGGGTCAGCGATCCC-1_5546_BA9	16.35814759	-16.58455231	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	6867	21848	0.008055657	0.007140242	0	L2-3	EN-L2-3-MS	NA	NA	NA
ACGGGTCCAGACTCGC-1_5546_BA9	18.95493669	-22.99802461	3	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	6242	19261	0.002544001	0.012512331	0	3	EN-L5-6	NA	NA	NA
ACGGGTCCATTGGGCC-1_5546_BA9	-6.1907093	-34.70214355	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	808	1070	0.060747664	0.01588785	0	16	EN-PYR	NA	NA	NA
ACGGGTCGTTTGCATG-1_5546_BA9	-12.07899689	-36.5509381	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1269	1981	0.035840485	0.007067138	0	16	EN-PYR	NA	NA	NA
ACGGGTCTCGGTTCGG-1_5546_BA9	-11.50651198	-5.072709527	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2099	3530	0.009348442	0.011614731	0	13A	IN-VIP	NA	NA	NA
ACGGGTCTCTTAGAGC-1_5546_BA9	-7.693503528	-35.12975112	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	761	1009	0.015857284	0.014866204	0	16	EN-PYR	NA	NA	NA
ACGTCAAAGAGGTTAT-1_5546_BA9	18.20187636	-10.9391918	3	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2288	4126	0.005332041	0.020358701	0	3	EN-L5-6	NA	NA	NA
ACGTCAAAGGACATTA-1_5546_BA9	-14.73102606	-15.52992201	6B	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1628	2721	0.025358324	0.008820287	0	6B	IN-SST	NA	NA	NA
ACGTCAAAGTCATCCA-1_5546_BA9	-28.43539989	-11.37159362	9	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	999	1361	0.002939015	0.005878031	0	9	OPC	NA	NA	NA
ACGTCAACATGTCCTC-1_5546_BA9	-21.70269943	5.069875518	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1063	1537	0.003903709	0.007156799	0	8	Astrocytes	NA	NA	NA
ACGTCAATCTTGAGAC-1_5546_BA9	11.81370455	-22.30888726	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4901	13082	0.0033634	0.004510014	0	L2-3	EN-L2-3-MS	NA	NA	NA
ACTATCTAGACTGGGT-1_5546_BA9	-8.472903995	-36.23557468	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	943	1304	0.039877301	0.009969325	0	16	EN-PYR	NA	NA	NA
ACTATCTCAATAGAGT-1_5546_BA9	12.2436098	-22.26388429	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	5839	17349	0.003400772	0.005936942	0	L2-3	EN-L2-3-MS	NA	NA	NA
ACTATCTTCCGTAGTA-1_5546_BA9	-27.97643379	-4.626303665	9	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1500	2324	0	0.009466437	0	9	OPC	NA	NA	NA
ACTATCTTCTCTAGGA-1_5546_BA9	-17.8055921	-14.50126624	6B	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2104	3819	0.012568735	0.014925373	0	6B	IN-SST	NA	NA	NA
ACTGAACAGCAAATCA-1_5546_BA9	24.16539407	-11.54127994	3	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4558	10676	0.003465717	0.006463095	0	3	EN-L5-6	NA	NA	NA
ACTGAACGTGAAATCA-1_5546_BA9	-15.8814771	-1.923608745	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2843	5369	0.005773887	0.009871484	0	13A	IN-VIP	NA	NA	NA
ACTGAACGTTATGTGC-1_5546_BA9	6.975353576	0.487236357	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	907	1106	0.011754069	0.008137432	0	16	EN-PYR	NA	NA	NA
ACTGAACTCACGACTA-1_5546_BA9	-28.21135534	-5.345024471	9	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1206	1821	0.001647446	0.005491488	0	9	OPC	NA	NA	NA
ACTGAACTCGCGATCG-1_5546_BA9	28.50373127	-12.595575	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4688	12008	0.004663558	0.007328448	0	2	EN-L4	NA	NA	NA
ACTGAGTAGATATGCA-1_5546_BA9	-30.35193291	-12.8232425	9	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	748	1029	0.002915452	0.004859086	0	9	OPC	NA	NA	NA
ACTGAGTCACATTTCT-1_5546_BA9	35.46072857	-7.07374029	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4620	11763	0.007991159	0.008841282	0	2	EN-L4	NA	NA	NA
ACTGAGTTCCCTTGCA-1_5546_BA9	-14.2448725	0.319929307	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2988	5887	0.003737048	0.011720741	0	13A	IN-VIP	NA	NA	NA
ACTGAGTTCTAACGGT-1_5546_BA9	-26.11936997	-22.33438	6A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3448	7350	0.01414966	0.006394558	0	6A	IN-PV	NA	NA	NA
ACTGATGAGTCTCCTC-1_5546_BA9	13.05289643	-19.71164161	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4357	10858	0.002394548	0.015564561	0	L2-3	EN-L2-3-MS	NA	NA	NA
ACTGATGCAAGGTGTG-1_5546_BA9	31.85763034	-11.44790764	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3055	5759	0.007813857	0.009550269	0	2	EN-L4	NA	NA	NA
ACTGCTCAGCCACCTG-1_5546_BA9	-28.40505992	-21.92923897	6A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3639	7393	0.017584201	0.012444204	0	6A	IN-PV	NA	NA	NA
ACTGCTCAGCGATCCC-1_5546_BA9	-11.7547584	-27.3886766	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	982	1289	0.033359193	0.016291699	0	16	EN-PYR	NA	NA	NA
ACTGCTCAGCTGCCCA-1_5546_BA9	11.00693969	-24.40355017	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	6449	20342	0.002310491	0.010274309	0	L2-3	EN-L2-3-MS	NA	NA	NA
ACTGCTCCATCCGGGT-1_5546_BA9	22.93658982	-25.07795728	3	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4423	12114	0.003384514	0.003632161	0	3	EN-L5-6	NA	NA	NA
ACTGCTCGTCCCTTGT-1_5546_BA9	-20.19707859	4.875562114	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1018	1357	0.005895357	0.003684598	0	8	Astrocytes	NA	NA	NA
ACTGCTCTCCTCAACC-1_5546_BA9	-23.46860238	-24.83098644	6A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3709	8778	0.006607428	0.004556847	0	6A	IN-PV	NA	NA	NA
ACTGTCCCATCGATTG-1_5546_BA9	-21.00446455	4.678785426	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	837	1142	0.000875657	0.007005254	0	8	Astrocytes	NA	NA	NA
ACTGTCCTCTCCAGGG-1_5546_BA9	14.65740788	-21.96190431	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	7125	26600	0.004887218	0.006503759	0	L2-3	EN-L2-3-MS	NA	NA	NA
ACTTACTCAAGTAGTA-1_5546_BA9	9.228437662	-20.01688295	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4301	10416	0.002400154	0.003840246	0	L2-3	EN-L2-3-MS	NA	NA	NA
ACTTACTCAGCTATTG-1_5546_BA9	-22.14180084	5.221382884	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	935	1266	0.002369668	0.011848341	0	8	Astrocytes	NA	NA	NA
ACTTACTCATTTCAGG-1_5546_BA9	-6.080229211	-36.89618669	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	794	1014	0.015779093	0.015779093	0	16	EN-PYR	NA	NA	NA
ACTTACTTCCTCAATT-1_5546_BA9	34.22235269	-6.220558906	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3839	9125	0.003068493	0.005150685	0	2	EN-L4	NA	NA	NA
ACTTGTTAGAGATGAG-1_5546_BA9	-6.613715621	-35.72427164	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	859	1055	0.03507109	0.017061611	0	16	EN-PYR	NA	NA	NA
ACTTGTTGTACCGGCT-1_5546_BA9	-14.77341572	-15.23450681	6B	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1599	2569	0.011288439	0.010899183	0	6B	IN-SST	NA	NA	NA
ACTTGTTGTTATTCTC-1_5546_BA9	-29.84630163	-10.45234851	9	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	992	1439	0	0.003474635	0	9	OPC	NA	NA	NA
ACTTGTTTCAGCAACT-1_5546_BA9	10.58524366	-23.89754249	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	5318	17248	0.002493043	0.003478664	0	L2-3	EN-L2-3-MS	NA	NA	NA
ACTTTCACACCTGGTG-1_5546_BA9	-17.11845756	-0.700803038	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3415	6812	0.003082795	0.016294774	0	13A	IN-VIP	NA	NA	NA
ACTTTCAGTAAACACA-1_5546_BA9	-13.26856708	-37.34944738	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1727	2578	0.029480217	0.016679597	0	16	EN-PYR	NA	NA	NA
ACTTTCAGTGCCTGCA-1_5546_BA9	15.07022305	-21.26267424	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	5990	17894	0.005700235	0.006594389	0	L2-3	EN-L2-3-MS	NA	NA	NA
ACTTTCATCCGATATG-1_5546_BA9	14.94755899	-29.3919491	3	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	5412	17743	0.000563603	0.004565181	0	3	EN-L5-6	NA	NA	NA
ACTTTCATCTGATACG-1_5546_BA9	29.28583407	-18.75631439	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	8610	39310	0.025922157	0.013100992	0	2	EN-L4	NA	NA	NA
AGAATAGAGTGTTTGC-1_5546_BA9	-19.05758315	-3.712556568	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	5400	16486	0.007157588	0.012920053	0	13A	IN-VIP	NA	NA	NA
AGAATAGCAAATCCGT-1_5546_BA9	-22.48883714	7.434795404	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1142	1602	0.001248439	0.005617978	0	8	Astrocytes	NA	NA	NA
AGAATAGTCTCCAGGG-1_5546_BA9	16.79544607	-16.59712959	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	7581	27257	0.005319734	0.006713872	0	L2-3	EN-L2-3-MS	NA	NA	NA
AGACGTTTCCACTCCA-1_5546_BA9	13.01238445	-20.10704617	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	5994	19013	0.004523221	0.004681008	0	L2-3	EN-L2-3-MS	NA	NA	NA
AGACGTTTCCAGAAGG-1_5546_BA9	14.8966964	-21.22945281	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	6339	19357	0.005941003	0.006250969	0	L2-3	EN-L2-3-MS	NA	NA	NA
AGAGCGAAGTGAATTG-1_5546_BA9	-13.05107163	22.05568499	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2173	3462	0.011554015	0.008376661	0	8	Astrocytes	NA	NA	NA
AGAGCGACACCATGTA-1_5546_BA9	33.00490729	-17.90135518	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3247	6081	0.013813518	0.018418023	0	2	EN-L4	NA	NA	NA
AGAGCGAGTCTTCAAG-1_5546_BA9	8.999229256	-12.64669765	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2557	4676	0.00320787	0.027159966	0	L2-3	EN-L2-3-MS	NA	NA	NA
AGAGCGATCGAGAACG-1_5546_BA9	34.55202033	-12.22824777	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3289	6667	0.004949753	0.021898905	0	2	EN-L4	NA	NA	NA
AGAGCGATCTTGTACT-1_5546_BA9	-21.29187184	4.650883171	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1073	1456	0.000686813	0.018543956	0	8	Astrocytes	NA	NA	NA
AGAGCTTAGCTCAACT-1_5546_BA9	15.08555667	-21.48103389	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	7288	26915	0.005535946	0.005796025	0	L2-3	EN-L2-3-MS	NA	NA	NA
AGAGCTTGTCCAGTGC-1_5546_BA9	12.72611125	-19.06519642	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	5345	15055	0.004516772	0.003586848	0	L2-3	EN-L2-3-MS	NA	NA	NA
AGAGCTTTCATGCAAC-1_5546_BA9	30.16768732	-18.78458688	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	5451	13957	0.017697213	0.016335889	0	2	EN-L4	NA	NA	NA
AGAGCTTTCCGTAGTA-1_5546_BA9	33.66237862	-8.722616739	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3675	7295	0.003701165	0.009458533	0	2	EN-L4	NA	NA	NA
AGAGTGGGTCTTCTCG-1_5546_BA9	10.86815153	-20.02319085	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4849	13003	0.004537414	0.004306698	0	L2-3	EN-L2-3-MS	NA	NA	NA
AGAGTGGGTTCCTCCA-1_5546_BA9	-10.56264504	-15.28315822	6B	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1055	1523	0.018384767	0.003939593	0	6B	IN-SST	NA	NA	NA
AGAGTGGTCAAACCGT-1_5546_BA9	9.743579238	-11.87505961	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2662	4769	0.003355001	0.021807507	0	L2-3	EN-L2-3-MS	NA	NA	NA
AGATCTGAGTTATCGC-1_5546_BA9	-22.24212108	-24.68462836	6A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3014	6726	0.007731192	0.004311627	0	6A	IN-PV	NA	NA	NA
AGATCTGCAAATCCGT-1_5546_BA9	-31.5964036	-12.79184662	9	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	837	1239	0.001614205	0.005649718	0	9	OPC	NA	NA	NA
AGATCTGCAGCTGGCT-1_5546_BA9	-20.50863185	4.043514876	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	970	1278	0.007042254	0.006259781	0	8	Astrocytes	NA	NA	NA
AGATCTGTCAGCACAT-1_5546_BA9	17.02350657	-15.23208697	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	6622	21627	0.014888796	0.007768068	0	L2-3	EN-L2-3-MS	NA	NA	NA
AGATTGCCAGGCAGTA-1_5546_BA9	-13.97517009	9.334195429	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1718	2651	0.007167107	0.006035458	0	8	Astrocytes	NA	NA	NA
AGATTGCGTAAACGCG-1_5546_BA9	14.82580939	-13.62351623	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	5195	13080	0.006804281	0.010397554	0	L2-3	EN-L2-3-MS	NA	NA	NA
AGATTGCGTCAGCTAT-1_5546_BA9	-14.07561044	-16.09849611	6B	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1447	2395	0.004592902	0.003340292	0	6B	IN-SST	NA	NA	NA
AGATTGCTCACCCGAG-1_5546_BA9	-12.66347508	-14.17931997	6B	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1618	2695	0.018181818	0.009647495	0	6B	IN-SST	NA	NA	NA
AGATTGCTCCAAAGTC-1_5546_BA9	-7.151234282	-35.48208597	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	778	1012	0.027667984	0.017786561	0	16	EN-PYR	NA	NA	NA
AGATTGCTCGGTTAAC-1_5546_BA9	9.664524279	1.498659157	12	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	719	1025	0.006829268	0.007804878	0	12	EN-MIX	NA	NA	NA
AGCAGCCAGCATCATC-1_5546_BA9	-31.72309935	-6.40474618	9	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1121	1789	0.000558971	0.001117943	0	9	OPC	NA	NA	NA
AGCAGCCAGGGTCGAT-1_5546_BA9	-21.8678867	5.614990828	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1026	1498	0.00400534	0.009345794	0	8	Astrocytes	NA	NA	NA
AGCAGCCAGTACGCCC-1_5546_BA9	-27.61803499	-12.00385391	9	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1041	1412	0.002124646	0.003541076	0	9	OPC	NA	NA	NA
AGCAGCCCAGGGTTAG-1_5546_BA9	10.45032073	-14.13830362	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3691	7932	0.002521432	0.020801815	0	L2-3	EN-L2-3-MS	NA	NA	NA
AGCAGCCCATGCCTTC-1_5546_BA9	-5.467197699	-34.90576959	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	876	1165	0.035193133	0.012875536	0	16	EN-PYR	NA	NA	NA
AGCAGCCGTATAGGGC-1_5546_BA9	19.35809574	-14.19539167	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	7517	25054	0.016923445	0.009499481	0	2	EN-L4	NA	NA	NA
AGCAGCCTCACTTCAT-1_5546_BA9	12.41054853	-24.04973974	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	6208	20304	0.001822301	0.018814027	0	L2-3	EN-L2-3-MS	NA	NA	NA
AGCAGCCTCTACGAGT-1_5546_BA9	24.11373745	-17.68691555	3	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	6208	17978	0.010234731	0.009289131	0	3	EN-L5-6	NA	NA	NA
AGCATACAGAATTGTG-1_5546_BA9	-11.52027989	-36.76340087	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1285	1863	0.026838433	0.009125067	0	16	EN-PYR	NA	NA	NA
AGCATACAGCAATATG-1_5546_BA9	25.45978835	5.649081922	15A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1236	2282	0.000876424	0.006573181	0	15A	Endo cells	NA	NA	NA
AGCATACAGCTGATAA-1_5546_BA9	23.2726936	-16.22059998	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	7941	30968	0.014369672	0.009913459	0	2	EN-L4	NA	NA	NA
AGCATACAGTTTCCTT-1_5546_BA9	14.70748243	-20.78861186	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	8754	36958	0.003761026	0.009930191	0	L2-3	EN-L2-3-MS	NA	NA	NA
AGCATACCATCCGGGT-1_5546_BA9	-30.19174838	-21.78964247	6A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4582	10416	0.013056836	0.016993088	0	6A	IN-PV	NA	NA	NA
AGCATACTCGGGAGTA-1_5546_BA9	-28.25956478	-6.145611684	9	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1095	1585	0.000630915	0.006309148	0	9	OPC	NA	NA	NA
AGCCTAACAAGAGTCG-1_5546_BA9	-21.50273094	5.639922761	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1118	1598	0.002503129	0.013767209	0	8	Astrocytes	NA	NA	NA
AGCCTAACAGCTGCAC-1_5546_BA9	-7.310727264	-36.17616555	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	817	1146	0.018324607	0.014834206	0	16	EN-PYR	NA	NA	NA
AGCCTAATCAGGTTCA-1_5546_BA9	-8.240950257	-36.01240804	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1002	1269	0.026004728	0.011032309	0	16	EN-PYR	NA	NA	NA
AGCCTAATCTGAGGGA-1_5546_BA9	-13.43234549	-14.70088743	6B	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1422	2253	0.027962716	0.010208611	0	6B	IN-SST	NA	NA	NA
AGCGGTCGTCATGCCG-1_5546_BA9	34.07535781	-11.93565205	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2965	5817	0.003266288	0.017706722	0	2	EN-L4	NA	NA	NA
AGCGGTCTCGGAGCAA-1_5546_BA9	-26.35047084	-20.4844563	6A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2624	4801	0.020828994	0.009789627	0	6A	IN-PV	NA	NA	NA
AGCGTATAGAGCTGGT-1_5546_BA9	9.908742813	-19.76713163	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3449	7514	0.003593293	0.005323396	0	L2-3	EN-L2-3-MS	NA	NA	NA
AGCGTATAGCCGCCTA-1_5546_BA9	18.17046189	-10.50424277	3	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2293	4250	0.002352941	0.015058824	0	3	EN-L5-6	NA	NA	NA
AGCGTATAGTGTACTC-1_5546_BA9	-21.00603661	4.127998711	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	800	1053	0.02374169	0.005698006	0	8	Astrocytes	NA	NA	NA
AGCGTATCAGGTCTCG-1_5546_BA9	-28.66370679	-6.295545455	9	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1115	1649	0.001819284	0.004851425	0	9	OPC	NA	NA	NA
AGCGTATGTCTAAACC-1_5546_BA9	-8.041033482	-36.66338105	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	863	1143	0.020122485	0.018372703	0	16	EN-PYR	NA	NA	NA
AGCGTATTCCTGCCAT-1_5546_BA9	18.75593101	-14.83144006	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	7318	25372	0.005281413	0.009577487	0	L2-3	EN-L2-3-MS	NA	NA	NA
AGCGTCGCATACAGCT-1_5546_BA9	-27.50367709	-11.02546899	9	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	914	1373	0.001456664	0.012381646	0	9	OPC	NA	NA	NA
AGCTCCTAGCGTAATA-1_5546_BA9	-20.81727933	4.435030048	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	967	1277	0.003915427	0.006264683	0	8	Astrocytes	NA	NA	NA
AGCTCCTAGTCACGCC-1_5546_BA9	-12.54626789	-37.13157453	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1431	2054	0.027263875	0.014118793	0	16	EN-PYR	NA	NA	NA
AGCTCCTCACACAGAG-1_5546_BA9	12.54726207	-15.88068466	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4814	12369	0.004608295	0.00743795	0	L2-3	EN-L2-3-MS	NA	NA	NA
AGCTCCTGTGGGTCAA-1_5546_BA9	-28.12617543	-5.802452734	9	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1229	1869	0.002675227	0.005350455	0	9	OPC	NA	NA	NA
AGCTCCTTCAATCTCT-1_5546_BA9	16.09476554	-28.78420182	3	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	5677	19777	0.002781008	0.006573292	0	3	EN-L5-6	NA	NA	NA
AGCTCTCTCGCCCTTA-1_5546_BA9	-22.10703283	5.534753377	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1061	1523	0.001969796	0.006565988	0	8	Astrocytes	NA	NA	NA
AGCTTGACAGGGTTAG-1_5546_BA9	28.02792676	7.473480288	15BA	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	949	1312	0.022865854	0.041920732	0	15BA	Stromal cells	NA	NA	NA
AGCTTGAGTATATGGA-1_5546_BA9	-7.572142522	-34.59249016	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	993	1272	0.036163522	0.01572327	0	16	EN-PYR	NA	NA	NA
AGCTTGAGTGTGTGCC-1_5546_BA9	-20.0976353	6.155761585	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1062	1495	0.001337793	0.005351171	0	8	Astrocytes	NA	NA	NA
AGCTTGATCTCTGAGA-1_5546_BA9	-18.65449367	-0.444352325	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3402	6400	0.015	0.0296875	0	13A	IN-VIP	NA	NA	NA
AGGCCACAGAAACCAT-1_5546_BA9	-7.503448298	-35.00409996	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	884	1163	0.030954428	0.013757524	0	16	EN-PYR	NA	NA	NA
AGGCCACCAACTGGCC-1_5546_BA9	-21.55355645	6.195673865	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1245	1909	0.00471451	0.009952855	0	8	Astrocytes	NA	NA	NA
AGGCCACCAAGCTGAG-1_5546_BA9	-12.98322734	-4.656324235	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2546	4929	0.006492189	0.003854737	0	13A	IN-VIP	NA	NA	NA
AGGCCACTCAACACTG-1_5546_BA9	-15.81704968	-1.961687506	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2718	5112	0.002934272	0.012519562	0	13A	IN-VIP	NA	NA	NA
AGGCCACTCAGCGATT-1_5546_BA9	-20.51821585	-4.838394728	13B	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4239	9180	0.025163399	0.016230937	0	13B	IN-SV2C	NA	NA	NA
AGGCCGTAGAAACCAT-1_5546_BA9	-10.37513712	-36.3181923	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1140	1577	0.04692454	0.020925808	0	16	EN-PYR	NA	NA	NA
AGGCCGTAGCTACCGC-1_5546_BA9	-26.76143696	-22.09880809	6A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4091	9718	0.022741305	0.005865404	0	6A	IN-PV	NA	NA	NA
AGGCCGTAGGTCGGAT-1_5546_BA9	10.51882525	-13.11852128	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3320	6474	0.003552672	0.030738338	0	L2-3	EN-L2-3-MS	NA	NA	NA
AGGGAGTCAAAGGTGC-1_5546_BA9	9.157961525	-12.48586431	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2356	4123	0.004608295	0.025466893	0	L2-3	EN-L2-3-MS	NA	NA	NA
AGGGAGTCACCGTTGG-1_5546_BA9	-12.57134538	-2.698246179	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2697	5066	0.00493486	0.006316621	0	13A	IN-VIP	NA	NA	NA
AGGGAGTCAGCGTCCA-1_5546_BA9	-26.59903379	-20.59488103	6A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2711	4969	0.022942242	0.00623868	0	6A	IN-PV	NA	NA	NA
AGGGAGTCATCCGCGA-1_5546_BA9	-9.402566077	-36.20545469	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1059	1488	0.02688172	0.014784946	0	16	EN-PYR	NA	NA	NA
AGGGAGTGTAGCAAAT-1_5546_BA9	10.3687138	-16.65150983	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4297	10079	0.004365512	0.006349836	0	L2-3	EN-L2-3-MS	NA	NA	NA
AGGGAGTTCCGCATAA-1_5546_BA9	-26.76649663	-11.59284125	9	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1062	1471	0.00067981	0.016315432	0	9	OPC	NA	NA	NA
AGGGAGTTCTCATTCA-1_5546_BA9	9.345584345	-12.64529107	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2385	4180	0.003827751	0.018181818	0	L2-3	EN-L2-3-MS	NA	NA	NA
AGGGATGAGTACGTAA-1_5546_BA9	16.77211083	-15.91710303	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	6360	19072	0.017197987	0.007235738	0	L2-3	EN-L2-3-MS	NA	NA	NA
AGGGATGCAACTTGAC-1_5546_BA9	-19.26612149	-16.40409629	6B	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2554	5215	0.009395973	0.005369128	0	6B	IN-SST	NA	NA	NA
AGGGATGGTGTCTGAT-1_5546_BA9	22.6075485	-25.39603673	3	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3522	8037	0.001741944	0.006221227	0	3	EN-L5-6	NA	NA	NA
AGGGTGAAGGACAGCT-1_5546_BA9	-29.84682016	-21.65458414	6A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3892	8180	0.016625917	0.013814181	0	6A	IN-PV	NA	NA	NA
AGGGTGAGTCTAGCCG-1_5546_BA9	2.888051815	-12.83448934	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2132	3744	0.002136752	0.003739316	0	L2-3	EN-L2-3-MS	NA	NA	NA
AGGGTGAGTGCCTTGG-1_5546_BA9	16.79410914	-14.4373292	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	5991	15977	0.006634537	0.008136697	0	L2-3	EN-L2-3-MS	NA	NA	NA
AGGGTGATCATCGCTC-1_5546_BA9	32.31831082	-8.52610639	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4047	9100	0.003846154	0.007692308	0	2	EN-L4	NA	NA	NA
AGGTCATAGTCGCCGT-1_5546_BA9	15.40301881	-14.91655423	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	5538	14768	0.008057963	0.00494312	0	L2-3	EN-L2-3-MS	NA	NA	NA
AGGTCATCATCGGACC-1_5546_BA9	-8.556581624	-36.07014927	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	911	1236	0.030744337	0.014563107	0	16	EN-PYR	NA	NA	NA
AGGTCATGTGCGAAAC-1_5546_BA9	-16.53725283	-1.48649008	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2599	4438	0.004055881	0.021180712	0	13A	IN-VIP	NA	NA	NA
AGGTCATTCTAACCGA-1_5546_BA9	-19.21492387	-6.984387733	13B	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3996	9684	0.011255679	0.007434944	0	13B	IN-SV2C	NA	NA	NA
AGGTCCGAGAGGACGG-1_5546_BA9	9.546108167	-12.17733944	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2517	4462	0.002689377	0.025997311	0	L2-3	EN-L2-3-MS	NA	NA	NA
AGGTCCGAGCCCAGCT-1_5546_BA9	11.11903693	-22.33318691	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	5940	17541	0.002166353	0.00803831	0	L2-3	EN-L2-3-MS	NA	NA	NA
AGGTCCGGTCGCTTCT-1_5546_BA9	-26.41742079	-22.08414303	6A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4348	12703	0.046445721	0.003778635	0	6A	IN-PV	NA	NA	NA
AGTAGTCGTCCCTACT-1_5546_BA9	-17.77979144	-1.721329325	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3506	6874	0.006982834	0.010765202	0	13A	IN-VIP	NA	NA	NA
AGTCTTTAGATTACCC-1_5546_BA9	-29.51955347	-11.39921138	9	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	957	1409	0.001419446	0.005677786	0	9	OPC	NA	NA	NA
AGTCTTTGTGAGGGAG-1_5546_BA9	-22.39345223	-24.70940399	6A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3113	6707	0.007156702	0.005218429	0	6A	IN-PV	NA	NA	NA
AGTCTTTTCTGTCAAG-1_5546_BA9	34.73977567	-5.26040338	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2643	5231	0.000764672	0.008029058	0	2	EN-L4	NA	NA	NA
AGTGAGGAGATGTGGC-1_5546_BA9	10.34150923	-13.57787714	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3339	6600	0.001666667	0.018939394	0	L2-3	EN-L2-3-MS	NA	NA	NA
AGTGAGGTCAGCCTAA-1_5546_BA9	-20.11171674	-23.88005226	6A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2796	5747	0.002088046	0.004872107	0	6A	IN-PV	NA	NA	NA
AGTGGGAAGTAGCGGT-1_5546_BA9	-30.03920796	-20.95093198	6A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3807	7954	0.02074428	0.012195122	0	6A	IN-PV	NA	NA	NA
AGTGGGACATTTGCTT-1_5546_BA9	-15.89857948	17.77495997	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1565	2608	0.001150307	0.011886503	0	8	Astrocytes	NA	NA	NA
AGTGGGAGTGAACCTT-1_5546_BA9	26.78116063	7.570350706	15A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1382	2127	0.004231312	0.023037142	0	15A	Endo cells	NA	NA	NA
AGTGGGATCTGCAGTA-1_5546_BA9	35.23246653	-6.93792142	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3404	7063	0.002123743	0.007503894	0	2	EN-L4	NA	NA	NA
AGTGTCAAGTGACTCT-1_5546_BA9	-7.755170026	-35.35104357	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	912	1231	0.055239643	0.01056052	0	16	EN-PYR	NA	NA	NA
AGTGTCACAGATGGCA-1_5546_BA9	12.77331764	-20.34068646	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	5793	16623	0.004331348	0.004932924	0	L2-3	EN-L2-3-MS	NA	NA	NA
AGTGTCAGTACCGAGA-1_5546_BA9	15.52542124	-17.42997669	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	5020	13078	0.011010858	0.006193608	0	L2-3	EN-L2-3-MS	NA	NA	NA
AGTGTCAGTCTCTTTA-1_5546_BA9	-15.59912149	-1.987019721	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2496	4533	0.010809618	0.011471432	0	13A	IN-VIP	NA	NA	NA
AGTGTCATCATTCACT-1_5546_BA9	-20.589128	4.197117207	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	788	1028	0.011673152	0.009727626	0	8	Astrocytes	NA	NA	NA
AGTGTCATCCCTAACC-1_5546_BA9	-21.3148213	-21.78660155	6A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2220	4156	0.006256015	0.002646776	0	6A	IN-PV	NA	NA	NA
AGTTGGTAGATCTGAA-1_5546_BA9	-28.87597502	-21.27051776	6A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3232	6191	0.010014537	0.013729607	0	6A	IN-PV	NA	NA	NA
AGTTGGTAGTACGCCC-1_5546_BA9	9.767053644	-13.32787073	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3253	6196	0.003712072	0.012750161	0	L2-3	EN-L2-3-MS	NA	NA	NA
AGTTGGTCAGTGGAGT-1_5546_BA9	-30.4084096	-11.02494396	9	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	913	1338	0.001494768	0.002989537	0	9	OPC	NA	NA	NA
AGTTGGTGTACAGACG-1_5546_BA9	7.009255161	-2.554494805	12	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1348	1955	0.00511509	0.028132992	0	12	EN-MIX	NA	NA	NA
AGTTGGTGTAGCGTCC-1_5546_BA9	-21.35887591	4.834077698	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1116	1549	0.007746934	0.007746934	0	8	Astrocytes	NA	NA	NA
AGTTGGTTCCAAGCCG-1_5546_BA9	11.37104471	-21.36584534	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3835	8676	0.003688336	0.006224066	0	L2-3	EN-L2-3-MS	NA	NA	NA
ATAACGCAGACGCTTT-1_5546_BA9	8.88638549	-12.5060332	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2331	4184	0.005258126	0.011950287	0	L2-3	EN-L2-3-MS	NA	NA	NA
ATAACGCAGCACCGCT-1_5546_BA9	19.78744319	-20.01345693	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	5621	16572	0.005370504	0.007723872	0	L2-3	EN-L2-3-MS	NA	NA	NA
ATAACGCCACGGTAGA-1_5546_BA9	10.26275031	-20.20396184	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3595	8084	0.003958436	0.004453241	0	L2-3	EN-L2-3-MS	NA	NA	NA
ATAACGCGTCACACGC-1_5546_BA9	-26.94771419	-21.52620686	6A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3601	7750	0.019612903	0.008258065	0	6A	IN-PV	NA	NA	NA
ATAACGCGTGACGCCT-1_5546_BA9	-5.960728195	-36.00107676	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	853	1078	0.020408163	0.020408163	0	16	EN-PYR	NA	NA	NA
ATAACGCGTTAAGATG-1_5546_BA9	12.45791597	-19.31287858	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	5104	12967	0.002544922	0.009639855	0	L2-3	EN-L2-3-MS	NA	NA	NA
ATAAGAGCACGGACAA-1_5546_BA9	-18.18908234	-14.01824648	6B	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2176	3704	0.011069114	0.013228942	0	6B	IN-SST	NA	NA	NA
ATAAGAGGTCATCCCT-1_5546_BA9	-7.769975338	-36.67780528	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	946	1284	0.063862928	0.019470405	0	16	EN-PYR	NA	NA	NA
ATAAGAGGTGGCTCCA-1_5546_BA9	-19.43016911	-5.071737622	13B	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3059	5834	0.014741172	0.010627357	0	13B	IN-SV2C	NA	NA	NA
ATAAGAGGTTTCCACC-1_5546_BA9	-19.72938705	5.041484015	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	806	1175	0.001702128	0.001702128	0	8	Astrocytes	NA	NA	NA
ATAAGAGTCACTCCTG-1_5546_BA9	9.053388086	-10.84973641	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2096	3665	0.01255116	0.013369714	0	L2-3	EN-L2-3-MS	NA	NA	NA
ATAAGAGTCCTTGACC-1_5546_BA9	-22.79905706	-21.42672596	6A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2647	5401	0.019070542	0.005554527	0	6A	IN-PV	NA	NA	NA
ATAGACCAGACTGGGT-1_5546_BA9	12.03750141	-19.65756105	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	5471	15673	0.00287118	0.005933771	0	L2-3	EN-L2-3-MS	NA	NA	NA
ATAGACCAGAGACTTA-1_5546_BA9	23.94059755	-11.12534884	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4010	9062	0.003531229	0.006621055	0	2	EN-L4	NA	NA	NA
ATAGACCAGCTAACAA-1_5546_BA9	17.25736635	-14.76754973	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	7569	25198	0.009008651	0.006667196	0	L2-3	EN-L2-3-MS	NA	NA	NA
ATAGACCAGCTGAAAT-1_5546_BA9	9.769076643	-1.037235274	12	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1296	2016	0.012896825	0.018849206	0	12	EN-MIX	NA	NA	NA
ATAGACCCACGAGAGT-1_5546_BA9	-15.16863052	-2.05809878	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2448	4456	0.001795332	0.015709156	0	13A	IN-VIP	NA	NA	NA
ATAGACCGTGTGGCTC-1_5546_BA9	-28.10813713	-11.80535127	9	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	900	1273	0.00392773	0.006284368	0	9	OPC	NA	NA	NA
ATCACGAAGCTCCCAG-1_5546_BA9	34.24795671	-5.035635136	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2940	5861	0.003412387	0.00511858	0	2	EN-L4	NA	NA	NA
ATCACGACACTTAAGC-1_5546_BA9	-14.47936962	-37.70465204	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1879	2960	0.015540541	0.014189189	0	16	EN-PYR	NA	NA	NA
ATCACGATCAACCATG-1_5546_BA9	20.09836367	-21.020962	3	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	6515	22431	0.018010789	0.008247515	0	3	EN-L5-6	NA	NA	NA
ATCATCTAGCCATCGC-1_5546_BA9	-21.92856468	4.770652138	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	966	1327	0.003014318	0.005275057	0	8	Astrocytes	NA	NA	NA
ATCATCTTCCATGAAC-1_5546_BA9	-10.49831771	-36.25643644	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1272	1811	0.055770293	0.014356709	0	16	EN-PYR	NA	NA	NA
ATCATGGGTCTAGGTT-1_5546_BA9	-26.84738924	-18.52374902	6B	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2509	4632	0.013385147	0.009067358	0	6B	IN-SST	NA	NA	NA
ATCATGGTCTAACTTC-1_5546_BA9	-18.26073006	-6.243304527	13B	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3402	7092	0.004089114	0.009165257	0	13B	IN-SV2C	NA	NA	NA
ATCCACCAGAAACGAG-1_5546_BA9	-18.1119064	5.473035254	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	808	1213	0.002473207	0.009892828	0	8	Astrocytes	NA	NA	NA
ATCCACCAGACGACGT-1_5546_BA9	18.40709941	-9.512726997	3	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2540	4973	0.003217374	0.004222803	0	3	EN-L5-6	NA	NA	NA
ATCCACCAGGCGATAC-1_5546_BA9	13.79298145	-26.54629809	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2708	5232	0.00764526	0.002675841	0	L2-3	EN-L2-3-MS	NA	NA	NA
ATCCACCCAAGGCTCC-1_5546_BA9	17.59899986	-19.38961512	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4203	11262	0.006393181	0.004439709	0	L2-3	EN-L2-3-MS	NA	NA	NA
ATCCACCCATAACCTG-1_5546_BA9	-18.40256073	5.23940247	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	985	1326	0.000754148	0.003016591	0	8	Astrocytes	NA	NA	NA
ATCCACCGTACGCTGC-1_5546_BA9	16.50227047	-14.09413714	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	5658	15393	0.012668096	0.00961476	0	L2-3	EN-L2-3-MS	NA	NA	NA
ATCCACCGTGAGTGAC-1_5546_BA9	9.861780427	-19.45869445	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4500	10971	0.003828275	0.009297238	0	L2-3	EN-L2-3-MS	NA	NA	NA
ATCCACCTCAGGCAAG-1_5546_BA9	-22.41297767	6.002554544	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1103	1616	0.003094059	0.006806931	0	8	Astrocytes	NA	NA	NA
ATCCACCTCTGACCTC-1_5546_BA9	14.67457695	-21.77835693	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	6587	21336	0.002999625	0.005764904	0	L2-3	EN-L2-3-MS	NA	NA	NA
ATCCGAAAGATGCCTT-1_5546_BA9	-22.23654527	5.346037803	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1068	1529	0.003270111	0.006540222	0	8	Astrocytes	NA	NA	NA
ATCCGAACAGGTCGTC-1_5546_BA9	14.46705133	-14.25737825	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	5393	13962	0.005371723	0.008523134	0	L2-3	EN-L2-3-MS	NA	NA	NA
ATCCGAATCAAGAAGT-1_5546_BA9	-9.432931204	-3.725644554	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1846	3166	0.003790272	0.004106128	0	13A	IN-VIP	NA	NA	NA
ATCGAGTAGGGAGTAA-1_5546_BA9	9.961692129	-11.70956265	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2495	4350	0.009425287	0.016321839	0	L2-3	EN-L2-3-MS	NA	NA	NA
ATCGAGTAGTACGCCC-1_5546_BA9	-13.2877086	-37.18234409	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1591	2499	0.033213285	0.017607043	0	16	EN-PYR	NA	NA	NA
ATCGAGTAGTCCGTAT-1_5546_BA9	9.711388006	-13.40975519	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3222	6546	0.003666361	0.013443324	0	L2-3	EN-L2-3-MS	NA	NA	NA
ATCGAGTCAATGAATG-1_5546_BA9	19.59200462	-23.26597733	3	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	5728	17109	0.004675902	0.006896955	0	3	EN-L5-6	NA	NA	NA
ATCGAGTCATGTAGTC-1_5546_BA9	-13.73725464	-36.97942719	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1825	2844	0.021800281	0.016174402	0	16	EN-PYR	NA	NA	NA
ATCGAGTCATGTCCTC-1_5546_BA9	-17.28972042	-3.81234828	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2863	5579	0.003226385	0.011113103	0	13A	IN-VIP	NA	NA	NA
ATCGAGTGTGCATCTA-1_5546_BA9	19.0896139	-14.3615778	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	7079	24530	0.035059111	0.010436201	0	L2-3	EN-L2-3-MS	NA	NA	NA
ATCTACTCAGCTGGCT-1_5546_BA9	22.31614742	-16.99166786	3	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	6582	21537	0.00970423	0.008218415	0	3	EN-L5-6	NA	NA	NA
ATCTACTGTACTCAAC-1_5546_BA9	-6.485279817	-4.705341356	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1515	2657	0.008280015	0.003387279	0	13A	IN-VIP	NA	NA	NA
ATCTACTGTGGTCTCG-1_5546_BA9	15.53398461	-21.70426915	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	5767	16491	0.006730944	0.00909587	0	L2-3	EN-L2-3-MS	NA	NA	NA
ATCTACTTCTGCAAGT-1_5546_BA9	3.657373123	-7.416908594	12	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1177	1813	0.007722008	0.00275786	0	12	EN-MIX	NA	NA	NA
ATCTGCCAGTGGTAGC-1_5546_BA9	-16.28846906	-1.611471909	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2720	4783	0.003136107	0.016725904	0	13A	IN-VIP	NA	NA	NA
ATCTGCCCATTAGCCA-1_5546_BA9	17.38868278	-14.94908277	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	7463	24928	0.01283697	0.007581836	0	L2-3	EN-L2-3-MS	NA	NA	NA
ATCTGCCTCAGTTAGC-1_5546_BA9	-18.83972559	-17.57648863	6B	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2584	5459	0.001099102	0.004945961	0	6B	IN-SST	NA	NA	NA
ATGAGGGAGACTAAGT-1_5546_BA9	19.36915335	-21.63427007	3	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4652	10714	0.005413478	0.017827142	0	3	EN-L5-6	NA	NA	NA
ATGAGGGAGGGATCTG-1_5546_BA9	15.38259703	-27.02562794	3	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	5107	14303	0.001608054	0.007480948	0	3	EN-L5-6	NA	NA	NA
ATGAGGGCAAGGTTCT-1_5546_BA9	20.05802842	-19.75190296	3	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3008	6088	0.011662286	0.007555848	0	3	EN-L5-6	NA	NA	NA
ATGAGGGCAATTGCTG-1_5546_BA9	15.33865516	-16.46146724	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	5244	13839	0.007587253	0.017270034	0	L2-3	EN-L2-3-MS	NA	NA	NA
ATGAGGGCAGAAGCAC-1_5546_BA9	-24.47056588	-12.62797885	9	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	783	1217	0.006573541	0.004108463	0	9	OPC	NA	NA	NA
ATGAGGGGTCTAGTGT-1_5546_BA9	13.2199725	-23.83214966	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4547	10754	0.001487818	0.008461968	0	L2-3	EN-L2-3-MS	NA	NA	NA
ATGAGGGGTTTGTTGG-1_5546_BA9	-6.610383575	-10.36885145	13B	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1212	1818	0.002750275	0.002750275	0	13B	IN-SV2C	NA	NA	NA
ATGCGATAGGACACCA-1_5546_BA9	8.756808184	-15.40873862	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3139	6712	0.005214541	0.008194279	0	L2-3	EN-L2-3-MS	NA	NA	NA
ATGCGATCAATCTACG-1_5546_BA9	-8.737675246	-35.98267523	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1006	1324	0.024924471	0.009818731	0	16	EN-PYR	NA	NA	NA
ATGCGATGTCTAGCGC-1_5546_BA9	-14.48398224	-16.47076394	6B	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1564	2785	0.003949731	0.003949731	0	6B	IN-SST	NA	NA	NA
ATGGGAGAGGGTCTCC-1_5546_BA9	15.44199857	-17.89896443	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4981	12190	0.006562756	0.005742412	0	L2-3	EN-L2-3-MS	NA	NA	NA
ATGGGAGAGTGCCATT-1_5546_BA9	-22.26710119	4.468852135	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	757	1014	0.003944773	0.004930966	0	8	Astrocytes	NA	NA	NA
ATGGGAGCAGCTGGCT-1_5546_BA9	-27.19166679	-11.07155642	9	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1051	1419	0.000704722	0.019027484	0	9	OPC	NA	NA	NA
ATGGGAGCAGTGAGTG-1_5546_BA9	-6.611444573	-36.17427757	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	738	1014	0.006903353	0.020710059	0	16	EN-PYR	NA	NA	NA
ATGGGAGGTTGGTAAA-1_5546_BA9	-16.17484968	17.48065166	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1472	2249	0.001333926	0.012449978	0	8	Astrocytes	NA	NA	NA
ATGGGAGTCTGCGGCA-1_5546_BA9	-22.7650145	6.456794447	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1083	1506	0.001328021	0.007968127	0	8	Astrocytes	NA	NA	NA
ATTACTCAGTACTTGC-1_5546_BA9	9.654475501	-12.80533792	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2777	5151	0.001553096	0.028344011	0	L2-3	EN-L2-3-MS	NA	NA	NA
ATTACTCTCATTATCC-1_5546_BA9	-11.56302837	-6.546759803	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2078	3839	0.008856473	0.00520969	0	13A	IN-VIP	NA	NA	NA
ATTACTCTCGCAAGCC-1_5546_BA9	-8.604395734	-12.68409822	6B	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	699	1044	0.02394636	0.004789272	0	6B	IN-SST	NA	NA	NA
ATTATCCCACTTCTGC-1_5546_BA9	-28.12802903	-22.16362855	6A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4047	9431	0.03541512	0.010603329	0	6A	IN-PV	NA	NA	NA
ATTATCCGTCGCTTCT-1_5546_BA9	-12.96357424	7.181948155	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1294	1768	0.011312217	0.00678733	0	16	EN-PYR	NA	NA	NA
ATTATCCTCATGTCCC-1_5546_BA9	9.406866597	-16.05412944	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3659	8586	0.004192872	0.005008153	0	L2-3	EN-L2-3-MS	NA	NA	NA
ATTCTACCAGGGTTAG-1_5546_BA9	12.62778572	-23.5729584	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4527	11476	0.003921227	0.008103869	0	L2-3	EN-L2-3-MS	NA	NA	NA
ATTCTACGTCCAGTAT-1_5546_BA9	15.00743512	-17.40846935	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	7381	26336	0.004366646	0.005733597	0	L2-3	EN-L2-3-MS	NA	NA	NA
ATTCTACGTTCGTGAT-1_5546_BA9	-20.70282903	4.38200164	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	924	1219	0.004922067	0.006562756	0	8	Astrocytes	NA	NA	NA
ATTCTACGTTTGGCGC-1_5546_BA9	-12.80756597	-17.02133579	6B	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1214	1923	0.004160166	0.009360374	0	6B	IN-SST	NA	NA	NA
ATTCTACTCATGTCCC-1_5546_BA9	-28.05211616	-5.878894131	9	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1075	1607	0.001244555	0.00746733	0	9	OPC	NA	NA	NA
ATTGGACAGAGTAAGG-1_5546_BA9	13.71847332	-23.8021473	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4834	12142	0.002388404	0.005600395	0	L2-3	EN-L2-3-MS	NA	NA	NA
ATTGGACCAGTTCCCT-1_5546_BA9	-9.315244881	-4.9496493	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1790	2897	0.01104591	0.005868139	0	13A	IN-VIP	NA	NA	NA
ATTGGTGAGGCCCGTT-1_5546_BA9	34.43632289	-13.47599367	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4246	9470	0.005807814	0.016789863	0	2	EN-L4	NA	NA	NA
ATTGGTGCAGCTTAAC-1_5546_BA9	-10.6606811	-4.707684632	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2142	3644	0.01481888	0.012349067	0	13A	IN-VIP	NA	NA	NA
ATTGGTGTCATGTAGC-1_5546_BA9	-21.45569806	5.290686812	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	955	1341	0.008202834	0.005965697	0	8	Astrocytes	NA	NA	NA
ATTTCTGAGCGAGAAA-1_5546_BA9	-6.178610825	-35.74869588	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	807	1041	0.048991354	0.013448607	0	16	EN-PYR	NA	NA	NA
ATTTCTGTCAGCCTAA-1_5546_BA9	34.32167496	-11.7332237	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3036	6107	0.00376617	0.021450794	0	2	EN-L4	NA	NA	NA
CAACCAAAGGACAGCT-1_5546_BA9	-27.44679291	-12.52105471	9	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	800	1003	0.002991027	0.007976072	0	9	OPC	NA	NA	NA
CAACCAAAGTTCGATC-1_5546_BA9	-2.661694995	-34.54429162	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	834	1091	0.080659945	0.019248396	0	16	EN-PYR	NA	NA	NA
CAACCAACAACAACCT-1_5546_BA9	12.7526388	-16.24540398	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	5236	14078	0.00554056	0.008950135	0	L2-3	EN-L2-3-MS	NA	NA	NA
CAACCAACAATGCCAT-1_5546_BA9	-26.59621241	-2.299560602	9	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1288	2014	0.001489573	0.030784508	0	9	OPC	NA	NA	NA
CAACCAAGTATCGCAT-1_5546_BA9	-18.51943894	-1.276085183	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3298	6154	0.006987325	0.023074423	0	13A	IN-VIP	NA	NA	NA
CAACCAAGTATGCTTG-1_5546_BA9	-27.65160258	-12.6306588	9	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	858	1193	0.001676446	0.007544007	0	9	OPC	NA	NA	NA
CAACCAAGTGGCGAAT-1_5546_BA9	-27.72788776	-11.15925879	9	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	993	1393	0.00143575	0.009332376	0	9	OPC	NA	NA	NA
CAACCAATCAACACAC-1_5546_BA9	-21.09941844	4.585218567	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1069	1463	0.008885851	0.003417635	0	8	Astrocytes	NA	NA	NA
CAACCTCCAAGGACTG-1_5546_BA9	10.66442504	-16.53633928	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4037	8852	0.00666516	0.005535472	0	L2-3	EN-L2-3-MS	NA	NA	NA
CAACCTCCAGGAATGC-1_5546_BA9	11.33803346	-12.30649907	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2951	5434	0.005520795	0.019138756	0	L2-3	EN-L2-3-MS	NA	NA	NA
CAACCTCGTTATCCGA-1_5546_BA9	13.94582699	-17.52070899	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	5176	13802	0.005071729	0.012099696	0	L2-3	EN-L2-3-MS	NA	NA	NA
CAACCTCTCCACGTTC-1_5546_BA9	-5.811720083	-35.33436295	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	953	1380	0.080434783	0.013043478	0	16	EN-PYR	NA	NA	NA
CAACCTCTCTTCCTTC-1_5546_BA9	14.19754724	-20.29497679	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	5603	16945	0.008793154	0.00542933	0	L2-3	EN-L2-3-MS	NA	NA	NA
CAACTAGAGGCGCTCT-1_5546_BA9	-27.25882033	-11.11719653	9	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	988	1430	0.004895105	0.007692308	0	9	OPC	NA	NA	NA
CAACTAGAGTCATGCT-1_5546_BA9	-13.15185564	-15.47527712	6A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1604	2759	0.003986952	0.006161653	0	6A	IN-PV	NA	NA	NA
CAACTAGCAGTTTACG-1_5546_BA9	-6.83260938	-33.98874708	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	822	1083	0.069252078	0.01754386	0	16	EN-PYR	NA	NA	NA
CAACTAGGTACCCAAT-1_5546_BA9	14.77021097	-16.26664775	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	6522	20255	0.005430758	0.006023204	0	L2-3	EN-L2-3-MS	NA	NA	NA
CAACTAGTCCAAACAC-1_5546_BA9	11.36538619	0.689237752	12	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	864	1160	0.001724138	0.007758621	0	12	EN-MIX	NA	NA	NA
CAACTAGTCTGGCGTG-1_5546_BA9	27.64440724	8.797255011	15A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	913	1328	0.024849398	0.047439759	0	15A	Endo cells	NA	NA	NA
CAAGAAAAGACGCAAC-1_5546_BA9	-9.160784018	-16.11486358	6B	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	850	1172	0.028156997	0.005972696	0	6B	IN-SST	NA	NA	NA
CAAGAAAAGAGCTGGT-1_5546_BA9	24.68653152	-13.62710309	3	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4208	9150	0.009836066	0.010273224	0	3	EN-L5-6	NA	NA	NA
CAAGAAATCATCTGTT-1_5546_BA9	0.481722291	11.57297286	5	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	823	1134	0.014991182	0.02292769	0	oligos	OL-MS-1	NA	NA	NA
CAAGAAATCTGCTTGC-1_5546_BA9	30.40001235	-17.12848997	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4375	9778	0.010329311	0.010431581	0	2	EN-L4	NA	NA	NA
CAAGATCTCCATGAGT-1_5546_BA9	-10.92953658	-14.91004989	6B	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1166	1668	0.019784173	0.014388489	0	6B	IN-SST	NA	NA	NA
CAAGATCTCCGTCAAA-1_5546_BA9	-18.74436276	-1.78315459	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3934	8617	0.018451897	0.010328421	0	13A	IN-VIP	NA	NA	NA
CAAGATCTCGTTACGA-1_5546_BA9	34.390892	-12.37627394	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2962	5582	0.005553565	0.019706198	0	2	EN-L4	NA	NA	NA
CAAGATCTCGTTGCCT-1_5546_BA9	-15.17383983	-37.53184823	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2587	4931	0.044412898	0.017237883	0	16	EN-PYR	NA	NA	NA
CAAGGCCCAGGATTGG-1_5546_BA9	-28.40872576	-12.10572785	9	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	782	1045	0.005741627	0.021052632	0	9	OPC	NA	NA	NA
CAAGGCCGTCAAAGAT-1_5546_BA9	10.56678491	-13.5075003	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3457	7146	0.001959138	0.027427932	0	L2-3	EN-L2-3-MS	NA	NA	NA
CAAGTTGCAAGTCTGT-1_5546_BA9	-9.001076008	-12.44689971	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1019	1395	0.009318996	0.018637993	0	16	EN-PYR	NA	NA	NA
CAAGTTGCAATGGATA-1_5546_BA9	6.209190169	-15.27443042	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2929	5551	0.002161773	0.010448568	0	L2-3	EN-L2-3-MS	NA	NA	NA
CAAGTTGCAGTTCATG-1_5546_BA9	-20.15864213	-4.931791401	13B	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4066	8704	0.007123162	0.015280331	0	13B	IN-SV2C	NA	NA	NA
CAAGTTGTCTAACTTC-1_5546_BA9	18.46194257	-22.94919837	3	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4731	12710	0.013690008	0.017151849	0	3	EN-L5-6	NA	NA	NA
CACAAACAGATCTGCT-1_5546_BA9	35.75377172	-10.89534157	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4623	11263	0.002929948	0.016603036	0	2	EN-L4	NA	NA	NA
CACAAACGTACCAGTT-1_5546_BA9	17.27146289	-15.48307021	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	8280	34095	0.006188591	0.007596422	0	L2-3	EN-L2-3-MS	NA	NA	NA
CACAAACTCAGGCAAG-1_5546_BA9	-20.39862996	4.072457969	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	835	1065	0.003755869	0.004694836	0	8	Astrocytes	NA	NA	NA
CACAAACTCTTCGAGA-1_5546_BA9	27.79516804	8.433297969	15A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1423	2270	0.01938326	0.03876652	0	15A	Endo cells	NA	NA	NA
CACACAAAGATATGGT-1_5546_BA9	17.83194788	-21.94171783	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	5055	12848	0.005214819	0.009651308	0	L2-3	EN-L2-3-MS	NA	NA	NA
CACACAAAGTCTCCTC-1_5546_BA9	-18.06417183	-14.43431527	6B	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2478	4861	0.003497223	0.018514709	0	6B	IN-SST	NA	NA	NA
CACACAAGTCGAGATG-1_5546_BA9	-21.71899589	5.642196874	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1194	1734	0.000576701	0.015570934	0	8	Astrocytes	NA	NA	NA
CACACAATCCTTGGTC-1_5546_BA9	3.005351336	-3.786467889	12	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	898	1254	0.018341308	0.003987241	0	12	EN-MIX	NA	NA	NA
CACACAATCGACAGCC-1_5546_BA9	-20.92910586	4.509721642	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	991	1332	0.003753754	0.014264264	0	8	Astrocytes	NA	NA	NA
CACACAATCTCACATT-1_5546_BA9	10.42485844	-26.27588682	10	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	7628	33030	0.001089918	0.004056918	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CACACAATCTTGTACT-1_5546_BA9	31.03906245	-0.803847131	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3291	7077	0.001413028	0.006499929	0	2	EN-L4	NA	NA	NA
CACACCTAGATTACCC-1_5546_BA9	-24.54735766	-19.36922532	6A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3863	8490	0.01213192	0.006360424	0	6A	IN-PV	NA	NA	NA
CACACCTAGCCAGAAC-1_5546_BA9	11.39439689	-12.98488665	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3205	6467	0.00386578	0.01670017	0	L2-3	EN-L2-3-MS	NA	NA	NA
CACACTCTCGTGGACC-1_5546_BA9	-22.1330618	4.643926148	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	846	1136	0.004401408	0.003521127	0	8	Astrocytes	NA	NA	NA
CACAGGCCACAGCCCA-1_5546_BA9	-28.34549391	-20.37752817	6A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3189	6799	0.026915723	0.006030299	0	6A	IN-PV	NA	NA	NA
CACAGGCCACAGGCCT-1_5546_BA9	10.25816929	-14.33675004	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3484	7410	0.004453441	0.017408907	0	L2-3	EN-L2-3-MS	NA	NA	NA
CACAGGCGTGTGTGCC-1_5546_BA9	-6.140310222	-7.691766417	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	922	1346	0.013372957	0.005200594	0	13A	IN-VIP	NA	NA	NA
CACAGGCGTTCCACGG-1_5546_BA9	-28.9841129	-21.59719676	6A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3842	8563	0.024056989	0.013429873	0	6A	IN-PV	NA	NA	NA
CACAGTAAGTGAACGC-1_5546_BA9	14.72269567	-14.45922513	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	6442	18467	0.005306763	0.008934857	0	L2-3	EN-L2-3-MS	NA	NA	NA
CACAGTAGTCATCCCT-1_5546_BA9	-28.59143062	-22.19613847	6A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4581	11256	0.031538735	0.010749822	0	6A	IN-PV	NA	NA	NA
CACATAGAGATCGGGT-1_5546_BA9	-6.957526956	-36.5428743	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	846	1091	0.011915674	0.022914757	0	16	EN-PYR	NA	NA	NA
CACATAGCAGGGCATA-1_5546_BA9	18.51482963	-19.04939643	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3808	8262	0.008230453	0.007262164	0	L2-3	EN-L2-3-MS	NA	NA	NA
CACATAGTCGCGTTTC-1_5546_BA9	-14.19869205	-15.4306009	6B	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1491	2380	0.017226891	0.007563025	0	6B	IN-SST	NA	NA	NA
CACATAGTCGTACGGC-1_5546_BA9	-28.56992753	-5.905061637	9	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1077	1569	0.001274697	0.003824092	0	9	OPC	NA	NA	NA
CACATTTAGACACGAC-1_5546_BA9	-19.97539804	4.061940287	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	946	1210	0.007438017	0.009917355	0	8	Astrocytes	NA	NA	NA
CACATTTAGTGTACTC-1_5546_BA9	-29.0929994	-11.27770101	9	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	930	1311	0.003813883	0.003813883	0	9	OPC	NA	NA	NA
CACATTTCATAAAGGT-1_5546_BA9	27.28541394	-13.16774905	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	5893	16864	0.006404175	0.004684535	0	L2-3	EN-L2-3-MS	NA	NA	NA
CACATTTTCCACTCCA-1_5546_BA9	9.071122302	-14.41247806	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2949	5976	0.004685408	0.015227577	0	L2-3	EN-L2-3-MS	NA	NA	NA
CACATTTTCCTTTCGG-1_5546_BA9	-19.05584325	-3.114464528	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	5382	16408	0.002742565	0.012676743	0	L2-3	EN-L2-3-MS	NA	NA	NA
CACCACTAGAGGGCTT-1_5546_BA9	-21.25176217	4.578512546	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	990	1368	0.005847953	0.005847953	0	8	Astrocytes	NA	NA	NA
CACCACTAGCCCGAAA-1_5546_BA9	16.18073832	-18.06351629	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3528	7252	0.007032543	0.005929399	0	L2-3	EN-L2-3-MS	NA	NA	NA
CACCACTCACGGATAG-1_5546_BA9	-27.71849096	-4.451174128	9	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1426	2182	0.005041247	0.011915674	0	9	OPC	NA	NA	NA
CACCACTCATTTGCTT-1_5546_BA9	-15.4820371	-4.283048614	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2869	6270	0.003349282	0.010685805	0	13A	IN-VIP	NA	NA	NA
CACCACTGTCAGCTAT-1_5546_BA9	-20.18177456	-4.8565459	13B	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3989	8285	0.013639107	0.014725407	0	13B	IN-SV2C	NA	NA	NA
CACCAGGCAATCACAC-1_5546_BA9	-11.36273441	-14.2550178	6B	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1151	1882	0.026567481	0.004782147	0	6B	IN-SST	NA	NA	NA
CACCAGGCATACCATG-1_5546_BA9	-26.16495281	-10.95053422	9	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1039	1364	0.007331378	0.008797654	0	9	OPC	NA	NA	NA
CACCAGGGTTACCGAT-1_5546_BA9	-23.27821301	7.981490237	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1056	1689	0.000592066	0.008880995	0	8	Astrocytes	NA	NA	NA
CACCAGGTCGCCTGTT-1_5546_BA9	-11.6969193	12.88248619	11	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1179	1614	0.009913259	0.00929368	0	11	Glia-MIX	NA	NA	NA
CACCAGGTCGGCGCTA-1_5546_BA9	-17.38777135	24.09699669	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1671	2613	0.005740528	0.007654038	0	8	Astrocytes	NA	NA	NA
CACCTTGCACAGGTTT-1_5546_BA9	-27.24702403	-10.87837788	9	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1026	1456	0.004120879	0.006181319	0	9	OPC	NA	NA	NA
CACCTTGCAGGGTATG-1_5546_BA9	-25.37900349	-22.2934102	6A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3792	8909	0.023459423	0.004714334	0	6A	IN-PV	NA	NA	NA
CACCTTGGTTAAAGAC-1_5546_BA9	-25.50236202	-17.79282811	6A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4250	10212	0.006462985	0.012925969	0	6A	IN-PV	NA	NA	NA
CACCTTGGTTATCCGA-1_5546_BA9	9.165373324	-3.852388353	12	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1952	3436	0.011641444	0.010186263	0	12	EN-MIX	NA	NA	NA
CACTCCACATCCGCGA-1_5546_BA9	19.14380814	-14.13480765	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	8540	32404	0.009165535	0.013146525	0	2	EN-L4	NA	NA	NA
CACTCCAGTTAAGAAC-1_5546_BA9	-11.84902171	-27.39912217	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1078	1470	0.044897959	0.02585034	0	16	EN-PYR	NA	NA	NA
CAGAATCAGAAAGTGG-1_5546_BA9	-12.17223002	-15.14337248	6B	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1084	1462	0.014363885	0.004787962	0	6B	IN-SST	NA	NA	NA
CAGAATCCAATCCGAT-1_5546_BA9	10.56949186	-13.26003895	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3387	6685	0.00329095	0.023186238	0	L2-3	EN-L2-3-MS	NA	NA	NA
CAGAATCGTAGAAGGA-1_5546_BA9	15.23471149	-21.29116939	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	6229	17761	0.005461404	0.006474861	0	L2-3	EN-L2-3-MS	NA	NA	NA
CAGAATCGTCCAACTA-1_5546_BA9	-14.01695149	-32.02116468	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2668	5013	0.017953321	0.009575105	0	16	EN-PYR	NA	NA	NA
CAGAATCGTCTGATCA-1_5546_BA9	25.28416328	8.530922064	15A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2200	3853	0.009602907	0.017129509	0	15A	Endo cells	NA	NA	NA
CAGAATCGTGGACGAT-1_5546_BA9	14.28528379	-23.43206224	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3880	8758	0.003882165	0.005366522	0	L2-3	EN-L2-3-MS	NA	NA	NA
CAGAATCTCTTATCTG-1_5546_BA9	10.99681944	-24.44680097	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	6432	21355	0.001217513	0.009037696	0	L2-3	EN-L2-3-MS	NA	NA	NA
CAGAGAGAGGCCCGTT-1_5546_BA9	-10.17443448	-36.4996953	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1100	1565	0.021086262	0.011501597	0	16	EN-PYR	NA	NA	NA
CAGAGAGGTCTGGAGA-1_5546_BA9	11.03320951	-13.38787628	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3787	7765	0.008499678	0.022665808	0	L2-3	EN-L2-3-MS	NA	NA	NA
CAGAGAGGTGGTAACG-1_5546_BA9	-11.80334388	-13.08918145	6B	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1671	2624	0.046493902	0.013338415	0	6B	IN-SST	NA	NA	NA
CAGAGAGTCCTTCAAT-1_5546_BA9	-30.56004034	-21.48905008	6A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	6589	19462	0.016904737	0.014952215	0	6A	IN-PV	NA	NA	NA
CAGATCACAGTCAGAG-1_5546_BA9	12.15793094	-14.88129222	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3677	7363	0.004481869	0.015211191	0	L2-3	EN-L2-3-MS	NA	NA	NA
CAGATCATCAGGTTCA-1_5546_BA9	11.00716463	-16.79555922	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4180	9085	0.006494221	0.012328013	0	L2-3	EN-L2-3-MS	NA	NA	NA
CAGATCATCCAACCAA-1_5546_BA9	-8.812354103	-4.917836684	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1686	2890	0.01384083	0.007612457	0	13A	IN-VIP	NA	NA	NA
CAGATCATCCTAAGTG-1_5546_BA9	-21.93153837	4.394953563	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	838	1117	0.003581021	0.005371531	0	8	Astrocytes	NA	NA	NA
CAGATCATCTGATACG-1_5546_BA9	8.962253437	-11.43329991	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2040	3498	0.010291595	0.020297313	0	L2-3	EN-L2-3-MS	NA	NA	NA
CAGCAGCAGCTAGGCA-1_5546_BA9	6.999245897	-0.323199226	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1008	1436	0.014623955	0.014623955	0	16	EN-PYR	NA	NA	NA
CAGCAGCAGGTGCAAC-1_5546_BA9	10.77551721	-16.63452122	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4054	9142	0.003719099	0.010500984	0	L2-3	EN-L2-3-MS	NA	NA	NA
CAGCAGCTCCGTTGCT-1_5546_BA9	-11.81120961	-27.38371646	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	817	1016	0.030511811	0.032480315	0	16	EN-PYR	NA	NA	NA
CAGCATACACCATGTA-1_5546_BA9	-13.73463766	-36.91879655	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1818	2931	0.018764927	0.013306039	0	16	EN-PYR	NA	NA	NA
CAGCATACACGAAACG-1_5546_BA9	35.31875507	-6.923398832	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3523	7948	0.004906895	0.009310518	0	2	EN-L4	NA	NA	NA
CAGCATACACGGCCAT-1_5546_BA9	6.326324878	-29.91691375	10	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	5153	17026	0.000411136	0.006167039	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CAGCATACATCGACGC-1_5546_BA9	17.21823851	-15.96559286	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	7954	28957	0.010325655	0.008219083	0	L2-3	EN-L2-3-MS	NA	NA	NA
CAGCATAGTGACTCAT-1_5546_BA9	-27.20329342	-11.01121243	9	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1023	1462	0.002051984	0.008891929	0	9	OPC	NA	NA	NA
CAGCATAGTTGCGCAC-1_5546_BA9	-4.625004748	-36.27208477	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	798	1000	0.032	0.026	0	16	EN-PYR	NA	NA	NA
CAGCATATCTAACCGA-1_5546_BA9	22.28500395	-12.65896562	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3488	8304	0.003010597	0.0136079	0	2	EN-L4	NA	NA	NA
CAGCATATCTCTTGAT-1_5546_BA9	28.476129	-13.62960429	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	6776	23030	0.006513244	0.007598784	0	2	EN-L4	NA	NA	NA
CAGCATATCTTCGGTC-1_5546_BA9	34.07433701	-8.395748088	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4106	9654	0.000621504	0.012533665	0	2	EN-L4	NA	NA	NA
CAGCCGACAGCCACCA-1_5546_BA9	15.16731561	-17.50185482	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	6237	19503	0.005691432	0.006665641	0	L2-3	EN-L2-3-MS	NA	NA	NA
CAGCCGACAGTAACGG-1_5546_BA9	12.74571168	-19.07729342	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	5460	16158	0.003403887	0.005508107	0	L2-3	EN-L2-3-MS	NA	NA	NA
CAGCCGATCAACACCA-1_5546_BA9	13.27230352	-17.1835363	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	5821	16519	0.00581149	0.011078152	0	L2-3	EN-L2-3-MS	NA	NA	NA
CAGCCGATCAGATAAG-1_5546_BA9	-26.97593674	-18.61426417	6A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2244	3857	0.034742027	0.012444905	0	6A	IN-PV	NA	NA	NA
CAGCGACAGTCACGCC-1_5546_BA9	-19.55078072	4.587572962	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	860	1131	0.00265252	0.012378426	0	8	Astrocytes	NA	NA	NA
CAGCGACGTGTAACGG-1_5546_BA9	-8.079947423	-10.24447675	6B	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1032	1510	0.028476821	0.007284768	0	6B	IN-SST	NA	NA	NA
CAGCGACTCAGCCTAA-1_5546_BA9	31.6746457	-7.177855423	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	5053	14234	0.003793733	0.014542644	0	2	EN-L4	NA	NA	NA
CAGCTAAAGAGCCCAA-1_5546_BA9	26.78526774	8.337583281	15A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1434	2237	0.006258382	0.033527045	0	15A	Endo cells	NA	NA	NA
CAGCTGGAGCAGACTG-1_5546_BA9	-21.83528668	4.609135793	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	962	1355	0.004428044	0.003690037	0	8	Astrocytes	NA	NA	NA
CAGCTGGAGTTCGATC-1_5546_BA9	-26.83799654	-21.16836592	6A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3177	6373	0.025890475	0.005335007	0	6A	IN-PV	NA	NA	NA
CAGCTGGCACCTATCC-1_5546_BA9	24.00677103	-12.37308417	3	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3780	8281	0.007607777	0.00664171	0	3	EN-L5-6	NA	NA	NA
CAGCTGGGTCTAGCGC-1_5546_BA9	-6.148491936	-10.71913249	6B	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	786	1068	0.018726592	0.005617978	0	6B	IN-SST	NA	NA	NA
CAGCTGGTCAGTGCAT-1_5546_BA9	7.294398305	-10.04189693	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1497	2101	0.005711566	0.017134698	0	L2-3	EN-L2-3-MS	NA	NA	NA
CAGTAACAGCGTTGCC-1_5546_BA9	-29.61897604	-11.33701749	9	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	901	1218	0.001642036	0.009031199	0	9	OPC	NA	NA	NA
CAGTAACCAACACGCC-1_5546_BA9	-21.24121174	4.408493132	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	931	1315	0.008365019	0.007604563	0	8	Astrocytes	NA	NA	NA
CAGTAACCACACGCTG-1_5546_BA9	-7.182481936	-8.107663232	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1099	1525	0.026229508	0.00852459	0	13A	IN-VIP	NA	NA	NA
CAGTAACGTACCTACA-1_5546_BA9	-13.40809497	-36.98455732	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1625	2561	0.026161656	0.015228426	0	16	EN-PYR	NA	NA	NA
CAGTCCTAGCCAGTTT-1_5546_BA9	-7.957176372	-27.12452866	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	782	1058	0.018903592	0.014177694	0	16	EN-PYR	NA	NA	NA
CAGTCCTAGTCATGCT-1_5546_BA9	-21.54293506	4.806999585	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	945	1224	0.001633987	0.007352941	0	8	Astrocytes	NA	NA	NA
CAGTCCTCACTGTTAG-1_5546_BA9	9.501331876	-15.91661434	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3714	8406	0.005472282	0.007851535	0	L2-3	EN-L2-3-MS	NA	NA	NA
CAGTCCTGTAGGAGTC-1_5546_BA9	-13.24771051	-37.18456451	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1651	2657	0.060594656	0.012796387	0	16	EN-PYR	NA	NA	NA
CAGTCCTGTAGTAGTA-1_5546_BA9	-7.958071209	-36.94179815	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1022	1409	0.060326473	0.017033357	0	16	EN-PYR	NA	NA	NA
CAGTCCTTCATGCTCC-1_5546_BA9	9.466495235	-15.55243375	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3219	6748	0.002815649	0.014967398	0	L2-3	EN-L2-3-MS	NA	NA	NA
CAGTCCTTCTGGTTCC-1_5546_BA9	10.53230235	-18.98466757	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	5086	14106	0.002622997	0.003828158	0	L2-3	EN-L2-3-MS	NA	NA	NA
CAGTCCTTCTGTCCGT-1_5546_BA9	-13.91050982	-36.94389035	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1922	3081	0.036676404	0.010386238	0	16	EN-PYR	NA	NA	NA
CATATGGCACATCTTT-1_5546_BA9	9.438264892	-19.57228786	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4472	11426	0.001400315	0.008927009	0	L2-3	EN-L2-3-MS	NA	NA	NA
CATATGGGTACCCAAT-1_5546_BA9	35.68616707	-6.953797287	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4669	12589	0.005401541	0.00627532	0	2	EN-L4	NA	NA	NA
CATATGGGTTCGTGAT-1_5546_BA9	-27.70747787	-11.36309442	9	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	952	1316	0.002279635	0.011398176	0	9	OPC	NA	NA	NA
CATATTCAGTTTGCGT-1_5546_BA9	-6.618746974	-34.80816634	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	823	1074	0.044692737	0.015828678	0	16	EN-PYR	NA	NA	NA
CATATTCCAGATGAGC-1_5546_BA9	32.60042778	-16.78380026	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4680	10799	0.00953792	0.011852949	0	2	EN-L4	NA	NA	NA
CATATTCTCACATAGC-1_5546_BA9	14.33489292	-21.92852252	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	6056	20251	0.003259098	0.005530591	0	L2-3	EN-L2-3-MS	NA	NA	NA
CATATTCTCATGCAAC-1_5546_BA9	-11.91530381	13.09782874	11	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1158	1550	0.00516129	0.010322581	0	11	Glia-MIX	NA	NA	NA
CATCAAGAGATGAGAG-1_5546_BA9	-21.68268118	4.623641798	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	925	1261	0.002379064	0.006344171	0	8	Astrocytes	NA	NA	NA
CATCAAGAGCCTATGT-1_5546_BA9	17.57068795	-21.62575239	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	5230	15112	0.002249868	0.007278984	0	L2-3	EN-L2-3-MS	NA	NA	NA
CATCAAGAGCTATGCT-1_5546_BA9	16.27080417	-16.08080172	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	6171	17674	0.011542379	0.006789634	0	L2-3	EN-L2-3-MS	NA	NA	NA
CATCAAGCAACTTGAC-1_5546_BA9	10.15540804	-11.51351241	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2464	4186	0.01242236	0.012661252	0	L2-3	EN-L2-3-MS	NA	NA	NA
CATCAAGGTCTTCGTC-1_5546_BA9	-7.646647488	-35.25114693	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	954	1270	0.041732283	0.011023622	0	16	EN-PYR	NA	NA	NA
CATCAGAAGCATCATC-1_5546_BA9	9.475169651	-15.84073139	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3840	9388	0.002769493	0.014060503	0	L2-3	EN-L2-3-MS	NA	NA	NA
CATCCACCACCTTGTC-1_5546_BA9	-27.97444685	-2.912012367	9	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1547	2414	0.003728252	0.008285004	0	9	OPC	NA	NA	NA
CATCCACGTGGTACAG-1_5546_BA9	-28.40275308	-22.65377718	6A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	6465	20710	0.013954611	0.0098986	0	6A	IN-PV	NA	NA	NA
CATCCACGTTGTACAC-1_5546_BA9	-8.063461816	-7.186217067	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1171	1574	0.010165184	0.010165184	0	13A	IN-VIP	NA	NA	NA
CATCGAACACGGATAG-1_5546_BA9	-20.00486666	-4.125384504	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4043	8730	0.011569301	0.013860252	0	13A	IN-VIP	NA	NA	NA
CATCGAATCATGCATG-1_5546_BA9	-16.60683655	-0.725306249	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3569	7812	0.004480287	0.010880696	0	13A	IN-VIP	NA	NA	NA
CATCGAATCGAATGGG-1_5546_BA9	20.1001277	-19.70474371	3	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4130	9231	0.006608168	0.008883111	0	3	EN-L5-6	NA	NA	NA
CATCGGGAGATCCCAT-1_5546_BA9	-9.440206435	-36.00687791	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	999	1420	0.034507042	0.004929577	0	16	EN-PYR	NA	NA	NA
CATCGGGCAATAGAGT-1_5546_BA9	-20.33025783	-4.989804479	13B	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4247	9065	0.011362383	0.01279647	0	13B	IN-SV2C	NA	NA	NA
CATCGGGCACTGTCGG-1_5546_BA9	-16.3825961	-1.50375231	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2472	4463	0.004257226	0.020838001	0	13A	IN-VIP	NA	NA	NA
CATCGGGCAGCATGAG-1_5546_BA9	-20.62987718	4.179268323	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	782	1041	0.006724304	0.010566763	0	8	Astrocytes	NA	NA	NA
CATCGGGGTCAAACTC-1_5546_BA9	7.372231447	-13.17221249	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2268	4057	0.007641114	0.007148139	0	L2-3	EN-L2-3-MS	NA	NA	NA
CATGACACAATCTGCA-1_5546_BA9	9.703611636	-0.453225061	12	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1137	1854	0.008629989	0.010787487	0	12	EN-MIX	NA	NA	NA
CATGACACACTCAGGC-1_5546_BA9	-21.39310417	5.882241637	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1205	1890	0.000529101	0.005820106	0	8	Astrocytes	NA	NA	NA
CATGACACATGGTTGT-1_5546_BA9	-27.43889815	-11.06929278	9	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1004	1527	0.003274394	0.011787819	0	9	OPC	NA	NA	NA
CATGACAGTAACGACG-1_5546_BA9	-23.14043675	8.64953777	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1031	1483	0.001348618	0.008766015	0	8	Astrocytes	NA	NA	NA
CATGACATCAACACAC-1_5546_BA9	8.928378441	-15.3161363	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3015	6231	0.004493661	0.007542931	0	L2-3	EN-L2-3-MS	NA	NA	NA
CATGCCTCATCGACGC-1_5546_BA9	-9.528882402	-5.469769095	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1738	2920	0.007534247	0.009589041	0	13A	IN-VIP	NA	NA	NA
CATGCCTGTGGCTCCA-1_5546_BA9	30.1367087	-13.39767462	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4525	10984	0.005644574	0.013292061	0	2	EN-L4	NA	NA	NA
CATGCCTTCACGAAGG-1_5546_BA9	-8.259462111	-7.104918754	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1223	1945	0.003598972	0.010796915	0	13A	IN-VIP	NA	NA	NA
CATGCCTTCTGAGGGA-1_5546_BA9	-13.73532593	-36.67929321	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1824	3074	0.075146389	0.010735198	0	16	EN-PYR	NA	NA	NA
CATGCCTTCTGCAAGT-1_5546_BA9	-10.26379911	-3.170162175	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2019	3551	0.002252887	0.018304703	0	13A	IN-VIP	NA	NA	NA
CATGCCTTCTTCCTTC-1_5546_BA9	24.12574628	-10.86890568	3	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4935	13629	0.003888767	0.007410668	0	3	EN-L5-6	NA	NA	NA
CATGGCGCACGGTAAG-1_5546_BA9	15.06807857	-21.17670363	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	6400	19357	0.004391176	0.007077543	0	L2-3	EN-L2-3-MS	NA	NA	NA
CATGGCGCAGATCGGA-1_5546_BA9	20.61072009	-3.293747405	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1670	2701	0.008885598	0.006664198	0	2	EN-L4	NA	NA	NA
CATGGCGGTGCGATAG-1_5546_BA9	-29.66034141	-11.70741113	9	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	871	1217	0	0.013968776	0	9	OPC	NA	NA	NA
CATGGCGGTTCAACCA-1_5546_BA9	34.35358888	-5.26574865	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3058	6442	0.010555728	0.008848184	0	2	EN-L4	NA	NA	NA
CATGGCGGTTCGTCTC-1_5546_BA9	12.93139791	-19.41042654	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4734	11824	0.003890392	0.007949932	0	L2-3	EN-L2-3-MS	NA	NA	NA
CATTATCGTAAACGCG-1_5546_BA9	34.44284461	-12.64947531	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2913	5547	0.016946097	0.023616369	0	2	EN-L4	NA	NA	NA
CATTCGCCATTTCACT-1_5546_BA9	9.594443524	-20.0359318	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4761	13324	0.003377364	0.005178625	0	L2-3	EN-L2-3-MS	NA	NA	NA
CCAATCCAGCTAGCCC-1_5546_BA9	28.88127483	-17.66150447	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	8445	36276	0.009951483	0.007277539	0	2	EN-L4	NA	NA	NA
CCAATCCCAAGCTGAG-1_5546_BA9	20.66127618	-13.99544753	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3209	6597	0.010156132	0.009701379	0	L2-3	EN-L2-3-MS	NA	NA	NA
CCACCTAAGACAGAGA-1_5546_BA9	8.965936474	-12.67228243	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2481	4569	0.004815058	0.02232436	0	L2-3	EN-L2-3-MS	NA	NA	NA
CCACCTACAATCCGAT-1_5546_BA9	-6.237158477	-35.13996479	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	924	1165	0.038626609	0.016309013	0	16	EN-PYR	NA	NA	NA
CCACCTACAGATCTGT-1_5546_BA9	-8.10031056	-37.39294171	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	941	1254	0.016746411	0.026315789	0	16	EN-PYR	NA	NA	NA
CCACCTACAGGTCCAC-1_5546_BA9	-27.44280712	-21.68921808	6A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3444	7220	0.012188366	0.012742382	0	6A	IN-PV	NA	NA	NA
CCACCTATCTGTCTCG-1_5546_BA9	27.83045991	-14.02389388	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	5175	14449	0.011488684	0.005744342	0	2	EN-L4	NA	NA	NA
CCACGGACAATAGCGG-1_5546_BA9	-21.5868066	4.646532074	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1097	1496	0.005347594	0.010695187	0	8	Astrocytes	NA	NA	NA
CCACGGAGTTAGATGA-1_5546_BA9	7.506491478	-13.6253269	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2638	4928	0.006696429	0.008928571	0	L2-3	EN-L2-3-MS	NA	NA	NA
CCACTACAGATTACCC-1_5546_BA9	-20.66925094	-20.97117098	6A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1961	3502	0.01027984	0.005996573	0	6A	IN-PV	NA	NA	NA
CCACTACAGCCCAATT-1_5546_BA9	8.826904732	-13.55370134	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2643	4948	0.002425222	0.01738076	0	L2-3	EN-L2-3-MS	NA	NA	NA
CCACTACAGCGTGAGT-1_5546_BA9	-9.522558622	-36.45534519	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1110	1522	0.038764783	0.011826544	0	16	EN-PYR	NA	NA	NA
CCACTACCAAGCTGGA-1_5546_BA9	9.965956769	-16.72288058	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4227	10257	0.003802281	0.00887199	0	L2-3	EN-L2-3-MS	NA	NA	NA
CCACTACGTATGAAAC-1_5546_BA9	-6.772457976	14.95233638	5	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	844	1116	0.001792115	0.008960573	0	oligos	OL-MS-1	NA	NA	NA
CCAGCGACAGACAAGC-1_5546_BA9	-9.126834914	-12.83999484	6B	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	850	1090	0.021100917	0.009174312	0	6B	IN-SST	NA	NA	NA
CCAGCGACATGGATGG-1_5546_BA9	-21.42627201	4.832675225	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1064	1514	0.003963012	0.008586526	0	8	Astrocytes	NA	NA	NA
CCATGTCAGGACACCA-1_5546_BA9	-27.24111775	-9.895960412	9	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1237	1864	0.000536481	0.008583691	0	9	OPC	NA	NA	NA
CCATGTCCAGCAGTTT-1_5546_BA9	24.46816573	-17.34900966	3	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	7618	25337	0.012037731	0.008446146	0	3	EN-L5-6	NA	NA	NA
CCATGTCCATCGTCGG-1_5546_BA9	13.11282343	-20.13655842	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4823	12146	0.00304627	0.006257204	0	L2-3	EN-L2-3-MS	NA	NA	NA
CCATGTCGTAGCGATG-1_5546_BA9	27.20856027	-18.03934655	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4671	11560	0.015743945	0.009515571	0	2	EN-L4	NA	NA	NA
CCATGTCGTTACGTCA-1_5546_BA9	-24.29822557	-19.51891312	6A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2624	4973	0.008646692	0.014277096	0	6A	IN-PV	NA	NA	NA
CCATGTCTCAGGTAAA-1_5546_BA9	-21.28053463	7.873596949	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1041	1431	0.002096436	0.004891684	0	8	Astrocytes	NA	NA	NA
CCATGTCTCCAAGCCG-1_5546_BA9	-21.60227352	4.675801035	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1011	1348	0.004451039	0.005934718	0	8	Astrocytes	NA	NA	NA
CCATTCGAGACTCGGA-1_5546_BA9	-19.75829491	-3.156903611	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3063	5650	0.016283186	0.006725664	0	13A	IN-VIP	NA	NA	NA
CCATTCGGTGTGACCC-1_5546_BA9	10.94827438	-13.02609373	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3330	6894	0.003336234	0.025529446	0	L2-3	EN-L2-3-MS	NA	NA	NA
CCCAATCCAATCGAAA-1_5546_BA9	18.86098606	-17.05330236	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	5104	13333	0.010275257	0.008925223	0	L2-3	EN-L2-3-MS	NA	NA	NA
CCCAATCGTAGGACAC-1_5546_BA9	-22.96869473	-24.49685825	6A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3423	7681	0.014841817	0.005728421	0	6A	IN-PV	NA	NA	NA
CCCAATCTCCTGTACC-1_5546_BA9	-6.973293211	-33.729629	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	711	1016	0.046259843	0.008858268	0	16	EN-PYR	NA	NA	NA
CCCAATCTCGCAAGCC-1_5546_BA9	14.99254768	-17.95735782	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	5008	13382	0.007547452	0.006202361	0	L2-3	EN-L2-3-MS	NA	NA	NA
CCCAGTTAGAAGGCCT-1_5546_BA9	-19.5140014	-5.193151446	13B	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3471	7125	0.009684211	0.007157895	0	13B	IN-SV2C	NA	NA	NA
CCCAGTTAGCGTAATA-1_5546_BA9	9.99658256	-12.30247818	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2773	4880	0.005122951	0.023770492	0	L2-3	EN-L2-3-MS	NA	NA	NA
CCCAGTTAGCTGTCTA-1_5546_BA9	14.94011646	-17.43624492	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	5383	14963	0.006482657	0.007351467	0	L2-3	EN-L2-3-MS	NA	NA	NA
CCCAGTTCACCTCGTT-1_5546_BA9	33.35722629	-12.178216	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3797	8748	0.011431184	0.007315958	0	2	EN-L4	NA	NA	NA
CCCAGTTCAGCCAGAA-1_5546_BA9	-30.14028113	-21.78406047	6A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	5319	13612	0.014839847	0.014692918	0	6A	IN-PV	NA	NA	NA
CCCAGTTCATTCACTT-1_5546_BA9	14.18726287	-21.5767126	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	7722	34509	0.004114869	0.004549538	0	L2-3	EN-L2-3-MS	NA	NA	NA
CCCAGTTGTACCATCA-1_5546_BA9	8.552065156	-14.79896237	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2833	5515	0.003626473	0.008522212	0	L2-3	EN-L2-3-MS	NA	NA	NA
CCCAGTTTCGGTTAAC-1_5546_BA9	-20.15882178	-20.99033176	6A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1783	3180	0.00754717	0.005660377	0	6A	IN-PV	NA	NA	NA
CCCATACCAGGCGATA-1_5546_BA9	15.11364894	-21.7939707	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	5504	15065	0.004712911	0.005044806	0	L2-3	EN-L2-3-MS	NA	NA	NA
CCCTCCTAGCCACGCT-1_5546_BA9	12.62825516	-4.098688606	12	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1571	2498	0.006405124	0.007205765	0	12	EN-MIX	NA	NA	NA
CCCTCCTGTGCACTTA-1_5546_BA9	-11.68319103	-2.960564052	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2132	3826	0.002875065	0.008363826	0	13A	IN-VIP	NA	NA	NA
CCCTCCTGTTAAGTAG-1_5546_BA9	9.819330003	-16.03333813	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4162	10121	0.002074894	0.013239798	0	L2-3	EN-L2-3-MS	NA	NA	NA
CCCTCCTTCAGAAATG-1_5546_BA9	-27.4979686	-10.89108514	9	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1010	1540	0.002597403	0.008441558	0	9	OPC	NA	NA	NA
CCCTCCTTCGCTAGCG-1_5546_BA9	14.86931797	-15.68684496	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	5566	15688	0.009752677	0.007075472	0	L2-3	EN-L2-3-MS	NA	NA	NA
CCCTCCTTCGGACAAG-1_5546_BA9	-8.635704982	-6.606267718	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1442	2170	0.006912442	0.008294931	0	13A	IN-VIP	NA	NA	NA
CCGGGATAGAATGTTG-1_5546_BA9	32.81584949	-13.6303708	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3047	5574	0.01022605	0.009329028	0	2	EN-L4	NA	NA	NA
CCGGGATAGAATTCCC-1_5546_BA9	-15.72374359	-1.781728998	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2701	4862	0.001439737	0.018922254	0	13A	IN-VIP	NA	NA	NA
CCGGGATGTCAGTGGA-1_5546_BA9	13.25539714	-20.11190394	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4834	11759	0.001870907	0.009269496	0	L2-3	EN-L2-3-MS	NA	NA	NA
CCGGGATTCGTAGGTT-1_5546_BA9	-6.956917995	-36.23983146	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	901	1167	0.029991431	0.017137961	0	16	EN-PYR	NA	NA	NA
CCGGTAGGTAGCTCCG-1_5546_BA9	10.18194553	-19.88013502	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	5203	14687	0.003472459	0.005787431	0	L2-3	EN-L2-3-MS	NA	NA	NA
CCGGTAGGTGGTGTAG-1_5546_BA9	29.4661473	-17.5042818	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4918	12268	0.02266058	0.011085752	0	2	EN-L4	NA	NA	NA
CCGGTAGGTGTGTGCC-1_5546_BA9	16.35351992	-16.67513298	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	6674	21014	0.011658894	0.006567051	0	L2-3	EN-L2-3-MS	NA	NA	NA
CCGGTAGGTTGTGGAG-1_5546_BA9	-10.43053118	-37.13635368	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1246	1882	0.023379384	0.019659936	0	16	EN-PYR	NA	NA	NA
CCGTACTAGCTACCTA-1_5546_BA9	11.81312848	-12.54832329	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3734	8338	0.008155433	0.017630127	0	L2-3	EN-L2-3-MS	NA	NA	NA
CCGTACTAGGCTACGA-1_5546_BA9	27.28068878	8.889876017	15A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1304	2199	0.003638017	0.040472942	0	15A	Endo cells	NA	NA	NA
CCGTACTCAGTAAGAT-1_5546_BA9	9.653899373	-12.27390219	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2566	4403	0.008403361	0.026572791	0	L2-3	EN-L2-3-MS	NA	NA	NA
CCGTACTGTAAATGTG-1_5546_BA9	11.12305051	-16.92991378	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4416	10977	0.004828277	0.011114148	0	L2-3	EN-L2-3-MS	NA	NA	NA
CCGTACTGTCGGGTCT-1_5546_BA9	13.54456848	-20.06927808	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	5619	16240	0.005665025	0.006403941	0	L2-3	EN-L2-3-MS	NA	NA	NA
CCGTACTGTCTGCAAT-1_5546_BA9	-29.86609396	-11.5802949	9	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	878	1196	0.001672241	0.008361204	0	9	OPC	NA	NA	NA
CCGTACTTCAGAGACG-1_5546_BA9	-19.85548881	4.096268589	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	786	1033	0.001936108	0.007744434	0	8	Astrocytes	NA	NA	NA
CCGTACTTCAGCTTAG-1_5546_BA9	-18.40992191	-1.816350163	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3470	6810	0.00866373	0.018208517	0	13A	IN-VIP	NA	NA	NA
CCGTACTTCAGGCAAG-1_5546_BA9	-29.17534519	-21.10983372	6A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3380	6822	0.024772794	0.017883319	0	6A	IN-PV	NA	NA	NA
CCGTACTTCGGCGCAT-1_5546_BA9	-26.62164025	-18.34046298	6B	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2739	5183	0.012155123	0.017750338	0	6B	IN-SST	NA	NA	NA
CCGTACTTCGGTCTAA-1_5546_BA9	-28.72342575	-11.09305938	9	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	971	1387	0.002883922	0.004325883	0	9	OPC	NA	NA	NA
CCGTGGACAGGTCGTC-1_5546_BA9	-20.54326901	4.480736491	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	936	1271	0.00393391	0.011014949	0	8	Astrocytes	NA	NA	NA
CCGTGGACATCCCATC-1_5546_BA9	-28.09977489	-22.30074008	6A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4810	11867	0.013482767	0.009437937	0	6A	IN-PV	NA	NA	NA
CCGTGGAGTATATCCG-1_5546_BA9	-11.8938392	-14.22451641	6B	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1287	1992	0.025100402	0.009538153	0	6B	IN-SST	NA	NA	NA
CCGTGGAGTCTAGAGG-1_5546_BA9	3.197898232	-12.34266385	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2003	3307	0.001511944	0.003023889	0	L2-3	EN-L2-3-MS	NA	NA	NA
CCGTGGAGTCTTGCGG-1_5546_BA9	-30.23603166	-21.70862878	6A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4818	11145	0.033826828	0.015163751	0	6A	IN-PV	NA	NA	NA
CCGTGGATCTCGAGTA-1_5546_BA9	-27.0126532	-11.1355888	9	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	923	1294	0.002318393	0.016228748	0	9	OPC	NA	NA	NA
CCGTTCAAGGTGATAT-1_5546_BA9	-22.69457632	6.493155654	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1092	1637	0	0.003054368	0	8	Astrocytes	NA	NA	NA
CCGTTCAAGTGGTCCC-1_5546_BA9	34.66439031	-4.112058589	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2660	5396	0.012601927	0.005189029	0	2	EN-L4	NA	NA	NA
CCGTTCACACGAAGCA-1_5546_BA9	28.99857989	-17.73448747	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	8173	34475	0.030659898	0.006381436	0	2	EN-L4	NA	NA	NA
CCGTTCACAGACGCTC-1_5546_BA9	25.07918954	-16.19129379	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	6410	21588	0.008847508	0.01139522	0	2	EN-L4	NA	NA	NA
CCGTTCACATTTGCTT-1_5546_BA9	10.61272831	-11.52698419	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3226	6757	0.005475803	0.010211632	0	L2-3	EN-L2-3-MS	NA	NA	NA
CCGTTCAGTCGTGGCT-1_5546_BA9	35.77687296	-12.33872919	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4439	10653	0.002065146	0.036609406	0	2	EN-L4	NA	NA	NA
CCTAAAGAGGTGCTTT-1_5546_BA9	-21.62541823	4.789194018	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1035	1429	0.00139958	0.013995801	0	8	Astrocytes	NA	NA	NA
CCTAAAGCAAGCTGGA-1_5546_BA9	-22.38309068	5.530781488	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	976	1423	0.002810963	0.005621926	0	8	Astrocytes	NA	NA	NA
CCTAAAGGTCCAGTAT-1_5546_BA9	9.541727963	-19.64684188	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3981	9376	0.00383959	0.008425768	0	L2-3	EN-L2-3-MS	NA	NA	NA
CCTACACAGAATGTGT-1_5546_BA9	-17.17320814	-1.119915993	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3337	6660	0.006006006	0.01036036	0	13A	IN-VIP	NA	NA	NA
CCTACACAGAGTTGGC-1_5546_BA9	-20.68258032	4.085065464	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	972	1274	0.021193093	0.006279435	0	8	Astrocytes	NA	NA	NA
CCTACACCAATCAGAA-1_5546_BA9	4.19631666	-4.370533929	12	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1047	1517	0.00461437	0.006591958	0	12	EN-MIX	NA	NA	NA
CCTACACCAGCCAATT-1_5546_BA9	-20.47965366	4.815007459	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	970	1311	0.006102212	0.007627765	0	8	Astrocytes	NA	NA	NA
CCTACACCATCACGTA-1_5546_BA9	-10.8218889	-35.97461204	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1276	2039	0.105934282	0.009318293	0	16	EN-PYR	NA	NA	NA
CCTACACGTAAGAGGA-1_5546_BA9	8.978695655	-12.67171458	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2384	4253	0.00258641	0.019515636	0	L2-3	EN-L2-3-MS	NA	NA	NA
CCTACACGTCAACATC-1_5546_BA9	9.749429101	0.663600585	12	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1011	1683	0.004159239	0.012477718	0	12	EN-MIX	NA	NA	NA
CCTACCAAGTGGTAGC-1_5546_BA9	-10.44899167	-36.43469336	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1174	1690	0.049112426	0.011242604	0	16	EN-PYR	NA	NA	NA
CCTACCACACCGCTAG-1_5546_BA9	17.99510806	-14.89510496	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	7687	29237	0.012244758	0.00697746	0	L2-3	EN-L2-3-MS	NA	NA	NA
CCTACCAGTGAAATCA-1_5546_BA9	8.969632164	-3.614267177	12	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1877	3041	0.011509372	0.013811246	0	12	EN-MIX	NA	NA	NA
CCTACCAGTTCAGACT-1_5546_BA9	-9.406423258	-16.04440166	6B	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	827	1233	0.00405515	0.00648824	0	6B	IN-SST	NA	NA	NA
CCTACCAGTTCCACAA-1_5546_BA9	27.43919196	-12.14202341	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	6589	22851	0.007045644	0.006082885	0	L2-3	EN-L2-3-MS	NA	NA	NA
CCTACCAGTTGATTGC-1_5546_BA9	-20.32415487	3.984578987	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	808	1070	0.000934579	0.012149533	0	8	Astrocytes	NA	NA	NA
CCTACCATCCCATTTA-1_5546_BA9	-20.25219354	4.963912657	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	969	1330	0.003759398	0.012030075	0	8	Astrocytes	NA	NA	NA
CCTACCATCGTTGACA-1_5546_BA9	30.01162648	-11.14073657	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	5726	17416	0.002411576	0.010737253	0	2	EN-L4	NA	NA	NA
CCTAGCTAGAGCTTCT-1_5546_BA9	-21.37896212	-20.4416445	6A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2280	4355	0.01216992	0.007347876	0	6A	IN-PV	NA	NA	NA
CCTAGCTAGTACGATA-1_5546_BA9	-14.57614357	-37.6659629	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2034	3448	0.030742459	0.015081206	0	16	EN-PYR	NA	NA	NA
CCTAGCTCAAGAAGAG-1_5546_BA9	-27.56772488	-12.5123142	9	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	837	1146	0.003490401	0.009598604	0	9	OPC	NA	NA	NA
CCTAGCTCACCTCGGA-1_5546_BA9	-26.60927578	-11.50715351	9	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1050	1417	0.011291461	0.021877205	0	9	OPC	NA	NA	NA
CCTAGCTCACGTCTCT-1_5546_BA9	-11.25176349	-1.712595027	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2166	4018	0.00273768	0.017919363	0	13A	IN-VIP	NA	NA	NA
CCTAGCTCATCCGTGG-1_5546_BA9	9.39625422	-13.1382598	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2778	5278	0.003220917	0.013262599	0	L2-3	EN-L2-3-MS	NA	NA	NA
CCTAGCTCATGGGACA-1_5546_BA9	23.83877908	-18.61085904	3	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	5727	16992	0.012711864	0.007415254	0	3	EN-L5-6	NA	NA	NA
CCTAGCTTCGGTCTAA-1_5546_BA9	18.8894939	-10.95849925	3	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2602	5121	0.009568444	0.008201523	0	3	EN-L5-6	NA	NA	NA
CCTATTAAGGGATCTG-1_5546_BA9	-8.208187944	-8.675726268	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1151	1596	0.005012531	0.016917293	0	13A	IN-VIP	NA	NA	NA
CCTATTACACAAGTAA-1_5546_BA9	-10.02604311	-36.42879034	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1078	1454	0.021320495	0.010316369	0	16	EN-PYR	NA	NA	NA
CCTATTAGTAGCTTGT-1_5546_BA9	-12.06753682	-4.407568916	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2080	3672	0.006535948	0.012527233	0	13A	IN-VIP	NA	NA	NA
CCTATTAGTTACAGAA-1_5546_BA9	9.443079429	-13.16612335	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2787	5333	0.003375211	0.019126195	0	L2-3	EN-L2-3-MS	NA	NA	NA
CCTATTATCAGCTCTC-1_5546_BA9	-21.74130182	6.129410161	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1193	1783	0.015143017	0.003925967	0	8	Astrocytes	NA	NA	NA
CCTATTATCAGGCGAA-1_5546_BA9	-22.27469029	7.176982969	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1285	1820	0.003846154	0.004945055	0	8	Astrocytes	NA	NA	NA
CCTCAGTCAGAAGCAC-1_5546_BA9	-15.36697117	0.579247536	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3537	7052	0.006097561	0.013187748	0	13A	IN-VIP	NA	NA	NA
CCTCAGTGTCCAACTA-1_5546_BA9	-27.43956485	-11.10347042	9	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	899	1253	0.001596169	0.004788508	0	9	OPC	NA	NA	NA
CCTCAGTGTGAGTGAC-1_5546_BA9	15.250889	-13.71571419	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	6426	18481	0.009415075	0.012499324	0	L2-3	EN-L2-3-MS	NA	NA	NA
CCTCAGTTCTTACCGC-1_5546_BA9	-22.08282315	7.038127886	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1555	2340	0.001282051	0.005555556	0	8	Astrocytes	NA	NA	NA
CCTCTGACACAGCGTC-1_5546_BA9	5.980889823	-3.848369899	12	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1204	1747	0.007441328	0.013737836	0	12	EN-MIX	NA	NA	NA
CCTCTGACACTCAGGC-1_5546_BA9	-2.722880707	-34.66959797	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	888	1101	0.047229791	0.019981835	0	16	EN-PYR	NA	NA	NA
CCTCTGAGTCTAGAGG-1_5546_BA9	25.14813913	-16.16700187	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4213	9593	0.014281247	0.016261858	0	2	EN-L4	NA	NA	NA
CCTCTGAGTTCCCTTG-1_5546_BA9	8.306615832	-14.46692828	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2686	5107	0.001762287	0.014685725	0	L2-3	EN-L2-3-MS	NA	NA	NA
CCTCTGATCTTCGGTC-1_5546_BA9	-7.997851612	-35.47743994	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1057	1444	0.0533241	0.013850416	0	16	EN-PYR	NA	NA	NA
CCTTACGAGATCCCAT-1_5546_BA9	24.41927711	-11.99145314	3	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4184	9389	0.005538396	0.017147726	0	3	EN-L5-6	NA	NA	NA
CCTTACGCAAGTCATC-1_5546_BA9	15.16439639	-21.04776673	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	6006	18438	0.004718516	0.007538779	0	L2-3	EN-L2-3-MS	NA	NA	NA
CCTTACGTCGTTTATC-1_5546_BA9	24.4624295	-18.80931731	3	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	7286	27151	0.009281426	0.007955508	0	3	EN-L5-6	NA	NA	NA
CCTTACGTCTGTCAAG-1_5546_BA9	-15.85221188	-23.30691329	6A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1966	3795	0.000527009	0.007905138	0	6A	IN-PV	NA	NA	NA
CCTTCCCAGGGTGTGT-1_5546_BA9	9.940372343	-16.10009221	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3760	8370	0.002270012	0.008841099	0	L2-3	EN-L2-3-MS	NA	NA	NA
CCTTCCCGTATAGGGC-1_5546_BA9	11.75561299	-21.66159611	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	5784	17392	0.002357406	0.004599816	0	L2-3	EN-L2-3-MS	NA	NA	NA
CCTTCGAAGTGAAGAG-1_5546_BA9	-20.79987799	-20.59463575	6A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1914	3405	0.033480176	0.004698972	0	6A	IN-PV	NA	NA	NA
CCTTCGACAAGTCATC-1_5546_BA9	9.916047836	0.481225066	12	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	995	1585	0.005678233	0.012618297	0	12	EN-MIX	NA	NA	NA
CCTTCGACATGCCTTC-1_5546_BA9	10.46713515	-13.52282072	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3296	7103	0.00351964	0.020836266	0	L2-3	EN-L2-3-MS	NA	NA	NA
CCTTCGAGTATAGGTA-1_5546_BA9	-12.33851031	-38.09642502	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1605	2544	0.048349057	0.023584906	0	16	EN-PYR	NA	NA	NA
CCTTCGAGTGAGCGAT-1_5546_BA9	-20.09379379	-20.92035406	6A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1915	3244	0.003082614	0.009247842	0	6A	IN-PV	NA	NA	NA
CCTTTCTCAGGGATTG-1_5546_BA9	-20.17485553	-20.84422668	6B	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1431	2213	0.011296882	0.007230005	0	6B	IN-SST	NA	NA	NA
CCTTTCTGTTATGTGC-1_5546_BA9	7.684930577	-14.71660521	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2836	5800	0.005689655	0.010344828	0	L2-3	EN-L2-3-MS	NA	NA	NA
CCTTTCTTCGATAGAA-1_5546_BA9	18.15028408	-10.77367044	3	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2969	6373	0.004236623	0.017260317	0	3	EN-L5-6	NA	NA	NA
CCTTTCTTCTTCGGTC-1_5546_BA9	8.486985012	-12.98523299	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2446	4857	0.002058884	0.015853407	0	L2-3	EN-L2-3-MS	NA	NA	NA
CGAACATAGACAAAGG-1_5546_BA9	22.19553779	-18.1979932	3	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	8369	33076	0.011791027	0.006137381	0	3	EN-L5-6	NA	NA	NA
CGAACATGTGATGATA-1_5546_BA9	13.25617175	-18.12850695	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	6394	19527	0.002458135	0.006811082	0	L2-3	EN-L2-3-MS	NA	NA	NA
CGAACATGTTTGACAC-1_5546_BA9	-7.542924919	-35.52706557	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	919	1224	0.026960784	0.009803922	0	16	EN-PYR	NA	NA	NA
CGAACATTCAGGCCCA-1_5546_BA9	12.14913888	-20.21416876	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	5744	17673	0.008261189	0.004356929	0	L2-3	EN-L2-3-MS	NA	NA	NA
CGAACATTCTCTTATG-1_5546_BA9	-8.537835115	-36.11909725	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	947	1272	0.036163522	0.010220126	0	16	EN-PYR	NA	NA	NA
CGAATGTAGACTCGGA-1_5546_BA9	-13.58278037	-38.15648853	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1754	2751	0.037804435	0.018902217	0	16	EN-PYR	NA	NA	NA
CGAATGTAGGTGATAT-1_5546_BA9	12.31478645	-18.9978987	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	6210	19574	0.002554409	0.010881782	0	L2-3	EN-L2-3-MS	NA	NA	NA
CGACTTCAGCGCTCCA-1_5546_BA9	-15.18029935	-37.51012472	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2599	5008	0.034145367	0.013777955	0	16	EN-PYR	NA	NA	NA
CGACTTCAGCTGCCCA-1_5546_BA9	10.88334215	-19.55369931	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4286	11120	0.003147482	0.00647482	0	L2-3	EN-L2-3-MS	NA	NA	NA
CGACTTCCAGCTGTGC-1_5546_BA9	8.314020111	-11.57017693	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2226	3626	0.010479868	0.004688362	0	L2-3	EN-L2-3-MS	NA	NA	NA
CGACTTCGTATATCCG-1_5546_BA9	10.02854555	-12.74992398	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3053	5745	0.003655352	0.022454308	0	L2-3	EN-L2-3-MS	NA	NA	NA
CGAGAAGAGACTTTCG-1_5546_BA9	18.20008575	-23.12895569	3	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4465	10588	0.001511145	0.041839819	0	3	EN-L5-6	NA	NA	NA
CGAGAAGAGGGTGTGT-1_5546_BA9	12.35741628	-0.869819834	12	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1123	1692	0.008274232	0.006501182	0	12	EN-MIX	NA	NA	NA
CGAGAAGCACAGCCCA-1_5546_BA9	30.31558547	-18.66102374	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4935	11741	0.010135423	0.015586407	0	2	EN-L4	NA	NA	NA
CGAGAAGTCAAACCAC-1_5546_BA9	-8.865455895	-35.85486998	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	957	1265	0.02055336	0.007114625	0	16	EN-PYR	NA	NA	NA
CGAGCACCAAGGTTCT-1_5546_BA9	-10.96468909	-3.264397115	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2018	3621	0.007180337	0.009665838	0	13A	IN-VIP	NA	NA	NA
CGAGCACCAGTCAGAG-1_5546_BA9	-6.771063622	-35.70646343	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	861	1102	0.022686025	0.019056261	0	16	EN-PYR	NA	NA	NA
CGAGCCAAGGTAAACT-1_5546_BA9	33.94876489	-16.49274889	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4485	9510	0.006940063	0.019873817	0	2	EN-L4	NA	NA	NA
CGAGCCACAGTCAGCC-1_5546_BA9	-21.98258967	6.271615628	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1293	1879	0.005854178	0.010111762	0	8	Astrocytes	NA	NA	NA
CGAGCCAGTAATCGTC-1_5546_BA9	25.29751158	9.335042199	15A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2501	4766	0.004406211	0.033361309	0	15A	Endo cells	NA	NA	NA
CGAGCCAGTTCAGGCC-1_5546_BA9	12.7570349	-24.15502904	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	5046	14520	0.001584022	0.004752066	0	L2-3	EN-L2-3-MS	NA	NA	NA
CGATCGGAGACTGTAA-1_5546_BA9	-30.36390854	-10.37414657	9	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1006	1431	0.002096436	0.004891684	0	9	OPC	NA	NA	NA
CGATCGGGTATAATGG-1_5546_BA9	17.98496069	-10.43485845	3	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2008	3572	0.000839866	0.023236282	0	3	EN-L5-6	NA	NA	NA
CGATCGGGTTATCGGT-1_5546_BA9	-26.51172713	-10.44713479	9	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1307	1921	0.005205622	0.008849558	0	9	OPC	NA	NA	NA
CGATGGCCAAGAGGCT-1_5546_BA9	11.08052672	-23.86506265	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	5311	14877	0.000806614	0.004503596	0	L2-3	EN-L2-3-MS	NA	NA	NA
CGATGTAGTTCGGCAC-1_5546_BA9	4.780867488	-1.89473545	12	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	866	1377	0.000726216	0.005809731	0	12	EN-MIX	NA	NA	NA
CGATTGAAGACAGGCT-1_5546_BA9	-7.759222099	-36.36418036	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	901	1174	0.022998296	0.02044293	0	16	EN-PYR	NA	NA	NA
CGATTGAAGCCACTAT-1_5546_BA9	-16.11517494	-1.557173822	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3513	7433	0.008341181	0.008072111	0	13A	IN-VIP	NA	NA	NA
CGATTGAAGGATATAC-1_5546_BA9	5.310883907	-9.0471796	12	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1292	1955	0.008184143	0.017902813	0	12	EN-MIX	NA	NA	NA
CGATTGATCAACCATG-1_5546_BA9	-27.89030984	-19.120325	6A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2235	3696	0.015151515	0.016233766	0	6A	IN-PV	NA	NA	NA
CGATTGATCCGTTGTC-1_5546_BA9	33.66294209	-11.60109687	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2373	4022	0.003729488	0.017652909	0	2	EN-L4	NA	NA	NA
CGATTGATCTACTCAT-1_5546_BA9	16.01791791	-27.44788239	3	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4405	12161	0.003371433	0.006002796	0	3	EN-L5-6	NA	NA	NA
CGCCAAGAGAGCTGGT-1_5546_BA9	8.910076593	-12.67256481	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2575	4572	0.003062117	0.021216098	0	L2-3	EN-L2-3-MS	NA	NA	NA
CGCCAAGAGGCAATTA-1_5546_BA9	21.94324823	-17.7685206	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	6929	24806	0.011932597	0.007336935	0	L2-3	EN-L2-3-MS	NA	NA	NA
CGCCAAGCACAGACAG-1_5546_BA9	-19.86186357	-1.054940804	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	5031	12051	0.010206622	0.023234586	0	13A	IN-VIP	NA	NA	NA
CGCCAAGGTCTGGTCG-1_5546_BA9	29.69454094	-3.708184422	10	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3859	9725	0.003701799	0.004421594	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGCCAAGGTTCGAATC-1_5546_BA9	25.76279774	-17.35703006	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	6491	21961	0.011611493	0.006374937	0	2	EN-L4	NA	NA	NA
CGCCAAGGTTCTGGTA-1_5546_BA9	-16.33304082	-3.877858452	13B	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2940	6147	0.003090939	0.008134049	0	13B	IN-SV2C	NA	NA	NA
CGCCAAGTCATGCTCC-1_5546_BA9	4.077767654	-3.777147605	12	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1003	1475	0.019661017	0.01220339	0	12	EN-MIX	NA	NA	NA
CGCGGTAAGTGGACGT-1_5546_BA9	34.43270397	-11.99885923	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3211	6325	0.003794466	0.020711462	0	2	EN-L4	NA	NA	NA
CGCGGTACAGAAGCAC-1_5546_BA9	-20.14280569	4.287666429	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	820	1113	0.004492363	0.011680144	0	8	Astrocytes	NA	NA	NA
CGCGGTACATGGTAGG-1_5546_BA9	12.41327152	-23.13056193	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4287	10325	0.00377724	0.009200969	0	L2-3	EN-L2-3-MS	NA	NA	NA
CGCGGTAGTGCCTGTG-1_5546_BA9	7.289947801	-0.191592881	12	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	767	1053	0.007597341	0.015194682	0	12	EN-MIX	NA	NA	NA
CGCGGTATCATAACCG-1_5546_BA9	34.14207699	-12.0626121	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2757	4943	0.003236901	0.022051386	0	2	EN-L4	NA	NA	NA
CGCGGTATCCGCGGTA-1_5546_BA9	-14.24807463	-9.077384498	13B	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2321	4120	0.004368932	0.005825243	0	13B	IN-SV2C	NA	NA	NA
CGCGGTATCGCGTAGC-1_5546_BA9	-21.04814195	4.503703549	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	865	1165	0	0.006008584	0	8	Astrocytes	NA	NA	NA
CGCGTTTAGGGCACTA-1_5546_BA9	35.00990193	-11.87207757	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3381	7053	0.003261024	0.040266553	0	2	EN-L4	NA	NA	NA
CGCGTTTAGTTGCAGG-1_5546_BA9	20.07335303	-20.71097814	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	5871	18722	0.003578677	0.006249332	0	L2-3	EN-L2-3-MS	NA	NA	NA
CGCGTTTGTAGAGGAA-1_5546_BA9	-23.00991221	6.726917516	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	992	1305	0.003065134	0.003831418	0	8	Astrocytes	NA	NA	NA
CGCGTTTTCACTCTTA-1_5546_BA9	15.66797613	-25.49287301	3	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4226	10817	0.00379033	0.006748636	0	3	EN-L5-6	NA	NA	NA
CGCTATCAGACTTTCG-1_5546_BA9	21.8534973	-22.12966839	3	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4149	9750	0.004410256	0.006769231	0	3	EN-L5-6	NA	NA	NA
CGCTATCAGAGACGAA-1_5546_BA9	32.11988782	-15.84982429	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3708	7236	0.010226645	0.015063571	0	2	EN-L4	NA	NA	NA
CGCTATCAGAGCCTAG-1_5546_BA9	-21.53766391	4.787438798	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1070	1458	0.009602195	0.009602195	0	8	Astrocytes	NA	NA	NA
CGCTATCAGATCCTGT-1_5546_BA9	-11.87097423	-2.03594934	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2365	4266	0.003984998	0.009845288	0	13A	IN-VIP	NA	NA	NA
CGCTATCCACGTTGGC-1_5546_BA9	10.25374136	-19.68655144	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4898	13079	0.002140836	0.003822922	0	L2-3	EN-L2-3-MS	NA	NA	NA
CGCTATCCATGGGACA-1_5546_BA9	-19.96176232	4.10680473	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	824	1115	0.003587444	0.013452915	0	8	Astrocytes	NA	NA	NA
CGCTATCTCTTGACGA-1_5546_BA9	-8.283536576	-36.81402224	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	934	1288	0.041925466	0.017857143	0	16	EN-PYR	NA	NA	NA
CGCTGGATCAACTCTT-1_5546_BA9	4.960355659	-10.08368788	12	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1850	3128	0.010549872	0.001918159	0	12	EN-MIX	NA	NA	NA
CGCTTCACAGCTGCAC-1_5546_BA9	-23.80257312	5.949875919	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	848	1103	0.00543971	0.004533092	0	8	Astrocytes	NA	NA	NA
CGGACACAGACCGGAT-1_5546_BA9	-22.56547973	-19.68684446	6A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2748	5756	0.014246004	0.006254343	0	6A	IN-PV	NA	NA	NA
CGGACACCAAATTGCC-1_5546_BA9	-20.36562848	4.005521684	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1029	1336	0.008233533	0.009730539	0	8	Astrocytes	NA	NA	NA
CGGACACTCCAATGGT-1_5546_BA9	27.81688526	-15.09696658	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	7657	27518	0.00726797	0.00977542	0	2	EN-L4	NA	NA	NA
CGGACACTCCGGCACA-1_5546_BA9	12.64104707	-18.32266169	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	5274	14115	0.003684024	0.004959263	0	L2-3	EN-L2-3-MS	NA	NA	NA
CGGACGTGTGCGATAG-1_5546_BA9	-19.98714303	-4.84674451	13B	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3535	6838	0.007897046	0.017695233	0	13B	IN-SV2C	NA	NA	NA
CGGACGTTCATGTCTT-1_5546_BA9	-13.83708298	-36.24552372	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1842	2989	0.057209769	0.012378722	0	16	EN-PYR	NA	NA	NA
CGGACGTTCTAACTGG-1_5546_BA9	-22.75772023	-19.74775858	6A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3325	7335	0.00259032	0.005044308	0	6A	IN-PV	NA	NA	NA
CGGACTGCACAAGCCC-1_5546_BA9	-15.43196337	-5.023699766	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4064	10807	0.010548718	0.004719164	0	13A	IN-VIP	NA	NA	NA
CGGACTGTCCACGTGG-1_5546_BA9	-11.87970031	-12.71358509	6B	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2321	4228	0.015610218	0.008987701	0	6B	IN-SST	NA	NA	NA
CGGAGCTAGCTCCCAG-1_5546_BA9	8.24633102	-14.77398653	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3083	6284	0.004296626	0.011139402	0	L2-3	EN-L2-3-MS	NA	NA	NA
CGGAGCTAGTTCCACA-1_5546_BA9	-21.3200069	5.568975533	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1087	1533	0.009784736	0.006523157	0	8	Astrocytes	NA	NA	NA
CGGAGCTCAAGGCTCC-1_5546_BA9	-10.38111867	-4.394783328	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1825	3099	0.004194902	0.013230074	0	13A	IN-VIP	NA	NA	NA
CGGAGCTCACTATCTT-1_5546_BA9	-20.93413963	5.455388651	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1039	1524	0.000656168	0.005905512	0	8	Astrocytes	NA	NA	NA
CGGAGCTGTCTGATCA-1_5546_BA9	33.08302517	-12.440271	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3427	6765	0.006208426	0.009016999	0	2	EN-L4	NA	NA	NA
CGGAGTCAGTGCCATT-1_5546_BA9	-30.27177701	-21.30276405	6A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	5009	12256	0.015584204	0.008648825	0	6A	IN-PV	NA	NA	NA
CGGAGTCGTCGAACAG-1_5546_BA9	11.77234658	-16.81278179	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4819	11890	0.004289319	0.003784693	0	L2-3	EN-L2-3-MS	NA	NA	NA
CGGAGTCGTGAGCGAT-1_5546_BA9	-20.46885528	-20.62334788	6B	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1680	2669	0.008242788	0.020606969	0	6B	IN-SST	NA	NA	NA
CGGCTAGCAGATCCAT-1_5546_BA9	9.6541575	-11.74664993	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2465	4381	0.013695503	0.013695503	0	L2-3	EN-L2-3-MS	NA	NA	NA
CGGCTAGGTGAGGGAG-1_5546_BA9	10.0125343	-12.93664249	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3017	5811	0.006195147	0.015832043	0	L2-3	EN-L2-3-MS	NA	NA	NA
CGGCTAGGTTGCGCAC-1_5546_BA9	10.43509485	-13.43395221	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3227	6718	0.004316761	0.018309021	0	L2-3	EN-L2-3-MS	NA	NA	NA
CGGCTAGGTTTGACAC-1_5546_BA9	-28.39364715	-5.670894632	9	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1114	1669	0.001797484	0.004194128	0	9	OPC	NA	NA	NA
CGGCTAGTCCTACAGA-1_5546_BA9	-27.05156758	-11.37467781	9	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	938	1336	0.002245509	0.012724551	0	9	OPC	NA	NA	NA
CGGCTAGTCTAAGCCA-1_5546_BA9	-26.87908354	-21.89814517	6A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3705	8166	0.026940975	0.00722508	0	6A	IN-PV	NA	NA	NA
CGGGTCAGTATAGGTA-1_5546_BA9	-6.707762355	-37.23087971	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	952	1246	0.026484751	0.019261637	0	16	EN-PYR	NA	NA	NA
CGGGTCAGTGCAGTAG-1_5546_BA9	34.04585629	-14.73874877	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4823	11162	0.006271278	0.014603118	0	2	EN-L4	NA	NA	NA
CGGGTCAGTTTACTCT-1_5546_BA9	11.49611981	-12.67130693	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3387	6591	0.003337885	0.023668639	0	L2-3	EN-L2-3-MS	NA	NA	NA
CGGGTCATCCGCGGTA-1_5546_BA9	30.82823527	-12.86429143	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4214	9207	0.008254589	0.00792875	0	2	EN-L4	NA	NA	NA
CGGGTCATCCGTTGTC-1_5546_BA9	-8.912187948	-36.1293361	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	945	1331	0.026296018	0.019534185	0	16	EN-PYR	NA	NA	NA
CGTAGCGTCTCTGTCG-1_5546_BA9	-8.393663635	-35.67836738	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	852	1094	0.011882998	0.020109689	0	16	EN-PYR	NA	NA	NA
CGTAGGCCACGCCAGT-1_5546_BA9	18.19225413	-10.54055343	3	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2279	4087	0.003425495	0.009297773	0	3	EN-L5-6	NA	NA	NA
CGTAGGCCAGTAAGCG-1_5546_BA9	18.54460528	-15.44002404	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	5871	16695	0.011380653	0.006948188	0	L2-3	EN-L2-3-MS	NA	NA	NA
CGTAGGCTCCACTCCA-1_5546_BA9	13.01844407	-19.82483407	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	5382	15699	0.004904771	0.004586279	0	L2-3	EN-L2-3-MS	NA	NA	NA
CGTCACTAGGGTCTCC-1_5546_BA9	6.895179894	-14.13969934	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2641	5037	0.004367679	0.008536827	0	L2-3	EN-L2-3-MS	NA	NA	NA
CGTCACTCAAACCTAC-1_5546_BA9	-17.19602406	-3.032521508	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3038	5750	0.001913043	0.016869565	0	13A	IN-VIP	NA	NA	NA
CGTCACTGTGTGCCTG-1_5546_BA9	20.47861039	-20.02433682	3	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	6463	21293	0.006481003	0.008406519	0	3	EN-L5-6	NA	NA	NA
CGTCACTTCAACTCTT-1_5546_BA9	34.2397234	-12.26229895	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2534	4369	0.002059968	0.02105745	0	2	EN-L4	NA	NA	NA
CGTCAGGCAATACGCT-1_5546_BA9	-29.6658862	-21.49149105	6A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3717	7619	0.031893949	0.012993831	0	6A	IN-PV	NA	NA	NA
CGTCAGGCACAAGTAA-1_5546_BA9	22.94277226	-16.89705239	3	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3798	8259	0.013803124	0.016466885	0	3	EN-L5-6	NA	NA	NA
CGTCAGGCATGCCACG-1_5546_BA9	8.589172455	-14.30352582	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2820	5708	0.003503854	0.01874562	0	L2-3	EN-L2-3-MS	NA	NA	NA
CGTCAGGTCCGTTGTC-1_5546_BA9	10.95956208	-25.81937956	10	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	6419	22300	0.000762332	0.003408072	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGTCAGGTCGTTACGA-1_5546_BA9	-12.82638266	-37.10225965	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1458	2202	0.035422343	0.020435967	0	16	EN-PYR	NA	NA	NA
CGTCAGGTCGTTGACA-1_5546_BA9	5.527388594	-13.39589851	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2922	6293	0.003337041	0.003972668	0	L2-3	EN-L2-3-MS	NA	NA	NA
CGTCCATAGAAGATTC-1_5546_BA9	9.126790347	-19.81831761	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3699	8238	0.002549162	0.00461277	0	L2-3	EN-L2-3-MS	NA	NA	NA
CGTCCATCAAGGACAC-1_5546_BA9	-8.977791987	-35.87547954	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1015	1335	0.029213483	0.0082397	0	16	EN-PYR	NA	NA	NA
CGTCCATCACTGCCAG-1_5546_BA9	-21.01374977	4.296810346	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	832	1093	0.002744739	0.006404392	0	8	Astrocytes	NA	NA	NA
CGTCCATTCGTACCGG-1_5546_BA9	18.16877864	-22.94316149	3	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	5472	15356	0.004167752	0.050208388	0	3	EN-L5-6	NA	NA	NA
CGTCTACAGATCTGAA-1_5546_BA9	-30.05642638	-11.5732764	9	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	873	1228	0	0.004885993	0	9	OPC	NA	NA	NA
CGTCTACGTCGTCTTC-1_5546_BA9	30.87493808	-17.65392601	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	5533	14870	0.009213181	0.007666443	0	2	EN-L4	NA	NA	NA
CGTCTACGTGAAGGCT-1_5546_BA9	14.39775445	-15.45521841	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4848	11516	0.007815214	0.006512678	0	L2-3	EN-L2-3-MS	NA	NA	NA
CGTCTACTCATTATCC-1_5546_BA9	-20.70368132	4.750933371	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	873	1162	0.006884682	0.008605852	0	8	Astrocytes	NA	NA	NA
CGTGAGCGTTGATTCG-1_5546_BA9	14.38511601	-21.40690694	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	5815	17221	0.003658324	0.015388189	0	L2-3	EN-L2-3-MS	NA	NA	NA
CGTGTAACACGCATCG-1_5546_BA9	-28.17626723	-12.18802541	9	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	800	1118	0.000894454	0.009838998	0	9	OPC	NA	NA	NA
CGTGTAAGTTCGCGAC-1_5546_BA9	10.45539072	-15.79234311	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3313	7265	0.011424639	0.008947006	0	L2-3	EN-L2-3-MS	NA	NA	NA
CGTGTAATCAGAAATG-1_5546_BA9	10.18187872	-2.134143209	12	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1252	1917	0.037037037	0.00991132	0	12	EN-MIX	NA	NA	NA
CGTGTAATCAGTTAGC-1_5546_BA9	-9.37315804	-9.613080527	6B	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1359	2116	0.010396975	0.017958412	0	6B	IN-SST	NA	NA	NA
CGTGTCTAGAATTCCC-1_5546_BA9	8.665489388	-12.63857846	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2357	4266	0.00281294	0.019456165	0	L2-3	EN-L2-3-MS	NA	NA	NA
CGTGTCTAGGGCTTCC-1_5546_BA9	-7.470909256	-35.64314588	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	937	1198	0.032554257	0.015025042	0	16	EN-PYR	NA	NA	NA
CGTGTCTCAGTCCTTC-1_5546_BA9	-27.27015547	-11.07963092	9	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	923	1243	0.005631537	0.009654063	0	9	OPC	NA	NA	NA
CGTGTCTGTTGTGGCC-1_5546_BA9	-19.86417944	4.954328083	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	944	1294	0.000772798	0.015455951	0	8	Astrocytes	NA	NA	NA
CGTTAGAGTATAAACG-1_5546_BA9	-15.63119887	21.67806588	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1282	1888	0.002118644	0.004237288	0	8	Astrocytes	NA	NA	NA
CGTTAGAGTCACACGC-1_5546_BA9	15.22757976	-17.19168556	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	5475	14233	0.004918148	0.008079815	0	L2-3	EN-L2-3-MS	NA	NA	NA
CGTTAGAGTCTAGGTT-1_5546_BA9	12.33359371	-13.47311782	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4415	10440	0.006226054	0.016187739	0	L2-3	EN-L2-3-MS	NA	NA	NA
CGTTAGATCATACGGT-1_5546_BA9	-22.04722429	5.773075868	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1127	1657	0.004828002	0.007845504	0	8	Astrocytes	NA	NA	NA
CGTTCTGAGCTGTTCA-1_5546_BA9	-24.74419541	-19.78208952	6A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2641	4717	0.014415942	0.010599958	0	6A	IN-PV	NA	NA	NA
CGTTCTGCACTGAAGG-1_5546_BA9	-18.22734123	-14.02554401	6B	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2253	3921	0.014792145	0.01351696	0	6B	IN-SST	NA	NA	NA
CGTTCTGGTGCAGTAG-1_5546_BA9	-8.433954449	-6.759747684	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1298	2040	0.007843137	0.011764706	0	13A	IN-VIP	NA	NA	NA
CGTTGGGAGAGGTTGC-1_5546_BA9	-11.41689147	-2.908084187	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2223	3819	0.004189578	0.010473946	0	13A	IN-VIP	NA	NA	NA
CGTTGGGAGCTACCTA-1_5546_BA9	-22.27194815	-21.26563424	6A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2428	4481	0.016067842	0.008257085	0	6A	IN-PV	NA	NA	NA
CGTTGGGCAACACCTA-1_5546_BA9	-20.22798404	-20.52631508	6A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2147	3851	0.004414438	0.011944949	0	6A	IN-PV	NA	NA	NA
CGTTGGGGTCAAGCGA-1_5546_BA9	9.402534537	-3.908693374	12	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1641	2590	0.012355212	0.023552124	0	12	EN-MIX	NA	NA	NA
CGTTGGGGTCAGAGGT-1_5546_BA9	-7.53808475	-36.26104622	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	872	1134	0.018518519	0.021164021	0	16	EN-PYR	NA	NA	NA
CTAACTTAGGAGTTTA-1_5546_BA9	-29.46729352	-10.63003924	9	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	972	1320	0	0.00530303	0	9	OPC	NA	NA	NA
CTAACTTGTACCGTTA-1_5546_BA9	-27.0879754	-11.15740544	9	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1099	1609	0.001243008	0.016159105	0	9	OPC	NA	NA	NA
CTAACTTGTCTACCTC-1_5546_BA9	-12.08337036	-16.37972914	6B	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1052	1614	0.012391574	0.006815366	0	6B	IN-SST	NA	NA	NA
CTAAGACAGGGTGTGT-1_5546_BA9	35.0923118	-11.44393751	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3849	8174	0.003670174	0.01957426	0	2	EN-L4	NA	NA	NA
CTAAGACCACAAGACG-1_5546_BA9	9.848679056	-11.87995219	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2627	4411	0.004080707	0.028791657	0	L2-3	EN-L2-3-MS	NA	NA	NA
CTAAGACTCCTGCAGG-1_5546_BA9	-11.70469704	-29.32339336	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1789	3046	0.030531845	0.023309258	0	16	EN-PYR	NA	NA	NA
CTAAGACTCTCGATGA-1_5546_BA9	-20.72687716	4.037267909	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	812	1023	0.009775171	0.007820137	0	8	Astrocytes	NA	NA	NA
CTAATGGGTTCCATGA-1_5546_BA9	17.57023908	-15.73827323	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	8507	34155	0.007934417	0.008315034	0	L2-3	EN-L2-3-MS	NA	NA	NA
CTACACCCACAGACAG-1_5546_BA9	-23.02316745	8.520188123	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1019	1451	0.00068918	0.008270159	0	8	Astrocytes	NA	NA	NA
CTACACCCAGCCTTGG-1_5546_BA9	-27.76947153	-11.50213358	9	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1045	1515	0.002640264	0.007260726	0	9	OPC	NA	NA	NA
CTACACCCAGGATTGG-1_5546_BA9	-12.02724472	-5.567226481	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2002	3123	0.005123279	0.015690042	0	13A	IN-VIP	NA	NA	NA
CTACACCCAGTGGGAT-1_5546_BA9	-16.76731509	-2.91861434	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2739	5233	0.004586279	0.019682782	0	13A	IN-VIP	NA	NA	NA
CTACACCGTGACGCCT-1_5546_BA9	-19.62200809	5.387384982	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	971	1478	0.00135318	0.00879567	0	8	Astrocytes	NA	NA	NA
CTACACCGTTTCCACC-1_5546_BA9	18.42939527	-23.87826089	3	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	5846	18525	0.002483131	0.018299595	0	3	EN-L5-6	NA	NA	NA
CTACACCGTTTGGGCC-1_5546_BA9	-11.69686413	28.5088073	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1160	1572	0.024173028	0.013994911	0	16	EN-PYR	NA	NA	NA
CTACACCTCGATAGAA-1_5546_BA9	23.94149939	-10.82995367	3	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4052	9245	0.002920498	0.006598161	0	3	EN-L5-6	NA	NA	NA
CTACATTAGACAAGCC-1_5546_BA9	-17.15001643	-1.153534059	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3120	6206	0.007089913	0.016919111	0	13A	IN-VIP	NA	NA	NA
CTACATTAGGGATACC-1_5546_BA9	14.91698511	-22.78076421	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	5409	15989	0.006379386	0.005441241	0	L2-3	EN-L2-3-MS	NA	NA	NA
CTACATTCAGCCAATT-1_5546_BA9	-13.55284186	-37.1754425	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1810	2779	0.029147175	0.016192875	0	16	EN-PYR	NA	NA	NA
CTACATTCATCACGTA-1_5546_BA9	11.21486078	-23.68018403	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	6189	20810	0.001681884	0.004565113	0	L2-3	EN-L2-3-MS	NA	NA	NA
CTACATTCATTTGCTT-1_5546_BA9	-23.73687896	6.488818838	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	876	1240	0.001612903	0.00483871	0	8	Astrocytes	NA	NA	NA
CTACATTGTGCAGACA-1_5546_BA9	-9.532403209	-37.45566385	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1037	1486	0.026244953	0.020188425	0	16	EN-PYR	NA	NA	NA
CTACATTTCATGTAGC-1_5546_BA9	4.77633815	19.40165526	1	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	998	1411	0.002126152	0.014883062	0	oligos	OL-Cntl	NA	NA	NA
CTACCCAAGGCGATAC-1_5546_BA9	-13.53907343	22.21427322	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1870	2894	0.006219765	0.00552868	0	8	Astrocytes	NA	NA	NA
CTACCCAAGTAATCCC-1_5546_BA9	11.86048821	-13.72808392	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4586	10962	0.004834884	0.018244846	0	L2-3	EN-L2-3-MS	NA	NA	NA
CTACCCACAGTCCTTC-1_5546_BA9	-28.19798321	-22.21781542	6A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4325	10348	0.015558562	0.011306533	0	6A	IN-PV	NA	NA	NA
CTACCCAGTGAGTGAC-1_5546_BA9	-7.589190524	-34.10950426	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	823	1078	0.02690167	0.00742115	0	16	EN-PYR	NA	NA	NA
CTACCCAGTGTAAGTA-1_5546_BA9	10.36931212	-16.15230226	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3471	7401	0.00864748	0.009593298	0	L2-3	EN-L2-3-MS	NA	NA	NA
CTACCCAGTTACCAGT-1_5546_BA9	-14.09929864	-15.43248817	6B	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1508	2414	0.009942005	0.009113505	0	6B	IN-SST	NA	NA	NA
CTACCCAGTTCCAACA-1_5546_BA9	5.278282361	-8.40036154	12	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1246	2012	0.010437376	0.003479125	0	12	EN-MIX	NA	NA	NA
CTACCCATCCGCGGTA-1_5546_BA9	10.43067269	-19.63807253	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	5064	14111	0.004393735	0.003897668	0	L2-3	EN-L2-3-MS	NA	NA	NA
CTACGTCCACATTTCT-1_5546_BA9	13.27579516	-20.33034988	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	5746	17395	0.007300949	0.005231388	0	L2-3	EN-L2-3-MS	NA	NA	NA
CTACGTCCATGCAATC-1_5546_BA9	-27.8778973	-11.95753411	9	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	858	1131	0.000884173	0.029177719	0	9	OPC	NA	NA	NA
CTACGTCTCACCGGGT-1_5546_BA9	-21.22005808	-21.21932938	6A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1982	3538	0.013001696	0.005935557	0	6A	IN-PV	NA	NA	NA
CTAGAGTAGTCCGGTC-1_5546_BA9	-29.6758105	-21.5145738	6A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4426	10138	0.020023673	0.012132571	0	6A	IN-PV	NA	NA	NA
CTAGAGTGTAGCACGA-1_5546_BA9	29.72531431	-13.01383028	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4181	9598	0.004271723	0.011356533	0	2	EN-L4	NA	NA	NA
CTAGAGTTCCTGCTTG-1_5546_BA9	17.47442681	-14.83762106	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	6973	22846	0.00783507	0.009191981	0	L2-3	EN-L2-3-MS	NA	NA	NA
CTAGAGTTCGGTGTCG-1_5546_BA9	9.553116226	-12.30513666	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2516	4278	0.001870033	0.024076671	0	L2-3	EN-L2-3-MS	NA	NA	NA
CTAGCCTCACCGAAAG-1_5546_BA9	22.46540066	-18.33431525	3	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	6006	18640	0.009066524	0.006491416	0	3	EN-L5-6	NA	NA	NA
CTAGCCTCATTGGGCC-1_5546_BA9	-6.825002748	-35.99822861	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	768	1022	0.008806262	0.020547945	0	16	EN-PYR	NA	NA	NA
CTAGCCTGTTCCCTTG-1_5546_BA9	-20.11655135	4.591430371	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	858	1114	0.009874327	0.009874327	0	8	Astrocytes	NA	NA	NA
CTAGCCTGTTGCTCCT-1_5546_BA9	-7.500016889	-36.89637707	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	925	1241	0.017727639	0.016116035	0	16	EN-PYR	NA	NA	NA
CTAGCCTTCAAGGCTT-1_5546_BA9	-20.31742706	4.197883993	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	763	1007	0.004965243	0.006951341	0	8	Astrocytes	NA	NA	NA
CTAGCCTTCGCTAGCG-1_5546_BA9	9.7628095	-16.20723427	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3842	8039	0.003607414	0.005722105	0	L2-3	EN-L2-3-MS	NA	NA	NA
CTAGTGAAGAGGGATA-1_5546_BA9	9.070448115	-20.25235427	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4823	12132	0.003214639	0.004615892	0	L2-3	EN-L2-3-MS	NA	NA	NA
CTAGTGAAGATCGGGT-1_5546_BA9	-13.79091494	-1.058561488	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2979	5778	0.004845967	0.007095881	0	13A	IN-VIP	NA	NA	NA
CTAGTGACATCCTTGC-1_5546_BA9	-10.75089673	-4.299430735	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1950	3277	0.007018615	0.019530058	0	13A	IN-VIP	NA	NA	NA
CTAGTGACATGGGAAC-1_5546_BA9	-6.684210824	-9.083295608	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	845	1171	0.001707942	0.017079419	0	13A	IN-VIP	NA	NA	NA
CTCACACCAACTGCGC-1_5546_BA9	11.84526876	-14.53345297	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3501	7505	0.01065956	0.016522318	0	L2-3	EN-L2-3-MS	NA	NA	NA
CTCACACGTAGGGTAC-1_5546_BA9	-22.01312279	6.271992583	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1173	1705	0.002346041	0.007624633	0	8	Astrocytes	NA	NA	NA
CTCACACTCACGACTA-1_5546_BA9	15.01028802	-21.43396655	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	7646	28807	0.006213767	0.005762488	0	L2-3	EN-L2-3-MS	NA	NA	NA
CTCACACTCGAATGGG-1_5546_BA9	-8.918542011	-37.03456338	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1114	1627	0.018438844	0.009219422	0	16	EN-PYR	NA	NA	NA
CTCAGAAAGTGGAGTC-1_5546_BA9	34.3088757	-12.15498747	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2744	5023	0.004778021	0.020903842	0	2	EN-L4	NA	NA	NA
CTCAGAATCGTTGACA-1_5546_BA9	18.0433905	-16.60299882	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4171	10250	0.008682927	0.011804878	0	L2-3	EN-L2-3-MS	NA	NA	NA
CTCATTATCCAGATCA-1_5546_BA9	35.75156511	-10.11555026	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4012	8984	0.00333927	0.019256456	0	2	EN-L4	NA	NA	NA
CTCATTATCTGAAAGA-1_5546_BA9	-17.98865986	-15.22942637	6B	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2594	5213	0.011317859	0.006713984	0	6B	IN-SST	NA	NA	NA
CTCCTAGCAAACTGTC-1_5546_BA9	16.95473388	-15.71502922	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	7923	30396	0.007204895	0.00773128	0	L2-3	EN-L2-3-MS	NA	NA	NA
CTCCTAGCAAGGACTG-1_5546_BA9	25.34093159	9.969142031	15A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3138	5951	0.009410183	0.035960343	0	15A	Endo cells	NA	NA	NA
CTCCTAGCACAACTGT-1_5546_BA9	32.69609469	-12.5630894	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4165	9567	0.009720916	0.010557123	0	2	EN-L4	NA	NA	NA
CTCCTAGCACAGGCCT-1_5546_BA9	24.37600542	-19.10884801	3	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4168	11522	0.029769137	0.008158306	0	3	EN-L5-6	NA	NA	NA
CTCCTAGGTAGGGTAC-1_5546_BA9	22.28115403	-10.4910719	3	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2216	3990	0.001503759	0.009273183	0	3	EN-L5-6	NA	NA	NA
CTCCTAGGTCATGCAT-1_5546_BA9	-22.32287034	5.486128355	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	999	1733	0.001731102	0.006347374	0	8	Astrocytes	NA	NA	NA
CTCCTAGGTGCTTCTC-1_5546_BA9	17.86112569	-15.88817138	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	7499	27543	0.006898304	0.006571543	0	L2-3	EN-L2-3-MS	NA	NA	NA
CTCCTAGTCCTTTCTC-1_5546_BA9	5.721410953	-16.01043911	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3131	6804	0.004409171	0.008230453	0	L2-3	EN-L2-3-MS	NA	NA	NA
CTCGAAAAGGAGTCTG-1_5546_BA9	-6.430131978	-35.56669494	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	810	1021	0.051909892	0.020568071	0	16	EN-PYR	NA	NA	NA
CTCGAAACACAGATTC-1_5546_BA9	10.79386157	-16.45817159	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3960	8660	0.004849885	0.010623557	0	L2-3	EN-L2-3-MS	NA	NA	NA
CTCGAAAGTAGAAAGG-1_5546_BA9	9.383293068	-11.68964672	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2357	3915	0.006896552	0.016091954	0	L2-3	EN-L2-3-MS	NA	NA	NA
CTCGAAAGTTGCCTCT-1_5546_BA9	7.399989944	-1.160073398	12	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	969	1484	0.004043127	0.006738544	0	12	EN-MIX	NA	NA	NA
CTCGAGGAGGACACCA-1_5546_BA9	-26.30146922	-18.24169861	6A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3089	6055	0.015194055	0.003468208	0	6A	IN-PV	NA	NA	NA
CTCGAGGAGTGTACGG-1_5546_BA9	-30.77633709	-21.60436946	6A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	6314	17081	0.024296001	0.018792811	0	6A	IN-PV	NA	NA	NA
CTCGAGGCAAGGACAC-1_5546_BA9	33.58967477	-12.39195677	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3623	7584	0.006592827	0.009625527	0	2	EN-L4	NA	NA	NA
CTCGAGGTCCCAAGTA-1_5546_BA9	-17.2383274	-14.53353675	6B	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1808	2946	0.009504413	0.012559403	0	6B	IN-SST	NA	NA	NA
CTCGAGGTCCTTGCCA-1_5546_BA9	-26.74863637	-11.50092826	9	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1234	1794	0.002787068	0.017279822	0	9	OPC	NA	NA	NA
CTCGAGGTCGGAGGTA-1_5546_BA9	18.6703533	-11.14084087	3	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2936	5748	0.005219207	0.009916493	0	3	EN-L5-6	NA	NA	NA
CTCGGAGCATGCCACG-1_5546_BA9	15.27273877	-12.78181202	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4288	8740	0.011441648	0.017963387	0	L2-3	EN-L2-3-MS	NA	NA	NA
CTCGGAGGTGAGCGAT-1_5546_BA9	32.08791129	-16.16793526	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3613	7119	0.013204102	0.010675657	0	2	EN-L4	NA	NA	NA
CTCGGAGTCAGCTTAG-1_5546_BA9	8.598873152	-11.16335067	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1896	2954	0.005416385	0.01591063	0	L2-3	EN-L2-3-MS	NA	NA	NA
CTCGGAGTCCGAAGAG-1_5546_BA9	-21.667372	6.058327757	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1261	1770	0.002259887	0.006214689	0	8	Astrocytes	NA	NA	NA
CTCGGGAAGGAATTAC-1_5546_BA9	-20.87910962	4.146162402	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	893	1209	0.005789909	0.014888337	0	8	Astrocytes	NA	NA	NA
CTCGGGACAAGTTGTC-1_5546_BA9	-6.979108383	-35.70745152	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	891	1143	0.044619423	0.020122485	0	16	EN-PYR	NA	NA	NA
CTCGGGACACAGCCCA-1_5546_BA9	-25.64373588	-21.98224185	6A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3251	6833	0.011854237	0.008634568	0	6A	IN-PV	NA	NA	NA
CTCGGGACACGGCTAC-1_5546_BA9	21.48972539	-3.362274617	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2210	3816	0.034591195	0.004716981	0	2	EN-L4	NA	NA	NA
CTCGGGATCCAGATCA-1_5546_BA9	18.24605154	-23.06265666	3	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3401	6549	0.003206596	0.023973126	0	3	EN-L5-6	NA	NA	NA
CTCGTACAGACCCACC-1_5546_BA9	-28.06694478	-11.65135267	9	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	882	1286	0.000777605	0.023328149	0	9	OPC	NA	NA	NA
CTCGTACCATGTCGAT-1_5546_BA9	-29.18774128	-22.09848841	6A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4550	10697	0.011779003	0.01327475	0	6A	IN-PV	NA	NA	NA
CTCGTACGTGGGTCAA-1_5546_BA9	18.99546694	-14.34171054	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	6277	17751	0.017970819	0.007999549	0	L2-3	EN-L2-3-MS	NA	NA	NA
CTCGTACTCTTCATGT-1_5546_BA9	15.89392063	-28.52009954	3	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	6084	20399	0.001274572	0.006372861	0	3	EN-L5-6	NA	NA	NA
CTCGTCAAGATTACCC-1_5546_BA9	-11.86357163	-14.41678506	6B	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1224	1938	0.002063983	0.00877193	0	6B	IN-SST	NA	NA	NA
CTCGTCAAGTGGAGTC-1_5546_BA9	15.89205056	-10.93118533	12	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2520	4749	0.00968625	0.010107391	0	12	EN-MIX	NA	NA	NA
CTCGTCAGTTCGAATC-1_5546_BA9	9.767458932	-13.07922755	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2979	5788	0.008984105	0.011748445	0	L2-3	EN-L2-3-MS	NA	NA	NA
CTCGTCATCACCCTCA-1_5546_BA9	-28.67124463	-5.387001237	9	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1240	1909	0.000523834	0.00471451	0	9	OPC	NA	NA	NA
CTCTAATCACTGTCGG-1_5546_BA9	-27.78080574	-21.82342941	6A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3697	8287	0.018703994	0.010981055	0	6A	IN-PV	NA	NA	NA
CTCTAATGTGGTCCGT-1_5546_BA9	14.81700358	-17.41001826	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	5554	15717	0.004008399	0.008334924	0	L2-3	EN-L2-3-MS	NA	NA	NA
CTCTAATTCATATCGG-1_5546_BA9	-11.45246412	-35.53559141	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1265	1889	0.089465326	0.013234516	0	16	EN-PYR	NA	NA	NA
CTCTAATTCTCTGAGA-1_5546_BA9	-23.38606866	-9.44003717	9	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1332	1917	0.008868023	0.006781429	0	9	OPC	NA	NA	NA
CTCTACGGTAAACACA-1_5546_BA9	8.692197796	-12.90999118	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2543	4517	0.00376356	0.025016604	0	L2-3	EN-L2-3-MS	NA	NA	NA
CTCTGGTCACGGACAA-1_5546_BA9	-25.11505374	-19.19564259	6A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3795	8681	0.012325769	0.008409169	0	6A	IN-PV	NA	NA	NA
CTCTGGTCATGGTTGT-1_5546_BA9	8.424433415	-14.55408514	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2963	6284	0.002705283	0.016072565	0	L2-3	EN-L2-3-MS	NA	NA	NA
CTCTGGTGTAGCCTCG-1_5546_BA9	25.51376439	9.080383454	15A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2175	3917	0.007658923	0.025529742	0	15A	Endo cells	NA	NA	NA
CTCTGGTGTAGCTAAA-1_5546_BA9	-13.0379067	-36.37385098	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1529	2348	0.045570698	0.008517888	0	16	EN-PYR	NA	NA	NA
CTCTGGTGTAGGCATG-1_5546_BA9	5.162405843	-11.15058253	12	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1792	3069	0.005865103	0.011730205	0	12	EN-MIX	NA	NA	NA
CTCTGGTTCCTATTCA-1_5546_BA9	-27.36023568	-9.900177198	9	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1157	1821	0	0.006589786	0	9	OPC	NA	NA	NA
CTGAAGTAGCCCAATT-1_5546_BA9	-27.0863344	-21.17252646	6A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3445	7335	0.025494206	0.005725971	0	6A	IN-PV	NA	NA	NA
CTGAAGTTCGCAAGCC-1_5546_BA9	-17.4808417	-14.66370956	6B	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1790	2793	0.011099177	0.015395632	0	6B	IN-SST	NA	NA	NA
CTGATAGCATGTTGAC-1_5546_BA9	10.90899469	-14.14717395	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3254	6340	0.005678233	0.011671924	0	L2-3	EN-L2-3-MS	NA	NA	NA
CTGATAGGTAAGGATT-1_5546_BA9	34.05169295	-12.00429103	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3302	6618	0.003777576	0.015563614	0	2	EN-L4	NA	NA	NA
CTGATCCAGTGTGAAT-1_5546_BA9	8.54631372	-13.37200903	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2733	5210	0.00403071	0.014203455	0	L2-3	EN-L2-3-MS	NA	NA	NA
CTGATCCCAAATTGCC-1_5546_BA9	-21.81896039	5.045357234	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1095	1517	0.00461437	0.008569545	0	8	Astrocytes	NA	NA	NA
CTGATCCCAATCCGAT-1_5546_BA9	27.79631598	9.069242714	15A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	800	1169	0.009409752	0.062446536	0	15A	Endo cells	NA	NA	NA
CTGATCCGTAGCGTGA-1_5546_BA9	13.02095138	-19.47437268	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	6306	18717	0.002137095	0.006037292	0	L2-3	EN-L2-3-MS	NA	NA	NA
CTGATCCGTGTTTGGT-1_5546_BA9	-20.50681535	4.340759599	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	881	1127	0.005323869	0.003549246	0	8	Astrocytes	NA	NA	NA
CTGATCCTCAAGGCTT-1_5546_BA9	-22.14532117	6.945202064	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1261	1857	0.003769521	0.00538503	0	8	Astrocytes	NA	NA	NA
CTGATCCTCCCTAATT-1_5546_BA9	-20.82671947	-20.48118732	6A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2008	3668	0.019629226	0.006270447	0	6A	IN-PV	NA	NA	NA
CTGATCCTCGCGTAGC-1_5546_BA9	13.1952064	-19.72080464	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	5384	14596	0.005823513	0.007878871	0	L2-3	EN-L2-3-MS	NA	NA	NA
CTGCCTAAGACAGGCT-1_5546_BA9	-28.99159394	-21.73619726	6A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4218	9950	0.027537688	0.008241206	0	6A	IN-PV	NA	NA	NA
CTGCCTAAGATGTGGC-1_5546_BA9	33.57579178	-11.91763663	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3454	7048	0.005817253	0.006952327	0	2	EN-L4	NA	NA	NA
CTGCCTAAGCTTATCG-1_5546_BA9	-9.638862688	-36.69079504	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	993	1643	0.010955569	0.014607425	0	16	EN-PYR	NA	NA	NA
CTGCCTAAGTATTGGA-1_5546_BA9	-17.80656168	-0.534770016	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3543	6847	0.003651234	0.015919381	0	13A	IN-VIP	NA	NA	NA
CTGCCTACAAGCTGAG-1_5546_BA9	-16.69140163	-15.60883767	6B	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1933	3509	0.004844685	0.003419778	0	6B	IN-SST	NA	NA	NA
CTGCCTACACGGTAAG-1_5546_BA9	17.1159077	-9.642202821	12	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1786	3025	0.007603306	0.00661157	0	12	EN-MIX	NA	NA	NA
CTGCCTATCGTCTGAA-1_5546_BA9	-20.62536787	-20.53050727	6A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2087	3661	0.006555586	0.008194482	0	6A	IN-PV	NA	NA	NA
CTGCGGAAGACCTTTG-1_5546_BA9	33.44470594	-11.05221693	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3072	6214	0.002252977	0.011908593	0	2	EN-L4	NA	NA	NA
CTGCGGACAGGTGCCT-1_5546_BA9	-5.857645139	-35.37511417	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	919	1194	0.073701843	0.020938023	0	16	EN-PYR	NA	NA	NA
CTGCGGAGTAGTGAAT-1_5546_BA9	12.27563698	-19.65121593	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4567	11383	0.003953264	0.007642976	0	L2-3	EN-L2-3-MS	NA	NA	NA
CTGCGGAGTGTCGCTG-1_5546_BA9	-6.954130947	-35.98188879	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	797	1033	0.021297193	0.016456922	0	16	EN-PYR	NA	NA	NA
CTGCTGTAGGCTCTTA-1_5546_BA9	-12.58526786	-37.10217116	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1682	2700	0.087407407	0.014444444	0	16	EN-PYR	NA	NA	NA
CTGCTGTGTAAGAGAG-1_5546_BA9	18.95080268	-16.13379998	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3806	7733	0.010345274	0.008534851	0	L2-3	EN-L2-3-MS	NA	NA	NA
CTGCTGTGTGAGGGTT-1_5546_BA9	10.58180783	-15.521092	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3756	8148	0.005522828	0.016445754	0	L2-3	EN-L2-3-MS	NA	NA	NA
CTGGTCTGTAGGGTAC-1_5546_BA9	-20.20935176	4.277557693	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	898	1161	0.007751938	0.010335917	0	8	Astrocytes	NA	NA	NA
CTGGTCTTCCACGTGG-1_5546_BA9	24.8207341	-17.1404052	3	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	5249	14491	0.010834311	0.007245877	0	3	EN-L5-6	NA	NA	NA
CTGGTCTTCGTTGACA-1_5546_BA9	-19.71709195	5.331682677	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1065	1581	0.000632511	0.013915244	0	8	Astrocytes	NA	NA	NA
CTGTGCTGTGCTTCTC-1_5546_BA9	28.70359668	-18.75501845	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	6646	21908	0.014150082	0.013465401	0	2	EN-L4	NA	NA	NA
CTGTTTAAGCAGGTCA-1_5546_BA9	-30.26127222	-21.7811941	6A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	5143	12656	0.019437421	0.015723767	0	6A	IN-PV	NA	NA	NA
CTGTTTAAGCTAGTCT-1_5546_BA9	10.70892683	-11.38506969	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3231	7068	0.007498585	0.009903792	0	L2-3	EN-L2-3-MS	NA	NA	NA
CTGTTTAGTCAACTGT-1_5546_BA9	-24.29888075	6.327495847	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	774	1029	0.005830904	0.001943635	0	8	Astrocytes	NA	NA	NA
CTGTTTATCACCACCT-1_5546_BA9	-10.15928495	-35.34791626	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1023	1370	0.016058394	0.012408759	0	16	EN-PYR	NA	NA	NA
CTTAACTAGACTACAA-1_5546_BA9	-7.702577264	-36.71105476	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	984	1322	0.036308623	0.016641452	0	16	EN-PYR	NA	NA	NA
CTTAACTCAGCGTTCG-1_5546_BA9	-10.1319059	-36.79314805	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1074	1499	0.022681788	0.017344897	0	16	EN-PYR	NA	NA	NA
CTTAACTGTGCCTGCA-1_5546_BA9	-26.64972027	-11.63774566	9	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1273	1786	0.001119821	0.021836506	0	9	OPC	NA	NA	NA
CTTAACTGTTCGTTGA-1_5546_BA9	10.71641632	-23.81193715	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4696	12351	0.001781232	0.005505627	0	L2-3	EN-L2-3-MS	NA	NA	NA
CTTACCGAGACACTAA-1_5546_BA9	14.62312296	-16.9989499	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	6307	20104	0.006466375	0.00591922	0	L2-3	EN-L2-3-MS	NA	NA	NA
CTTACCGAGGCGATAC-1_5546_BA9	-10.79169187	-36.10309797	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1148	1622	0.020961776	0.007398274	0	16	EN-PYR	NA	NA	NA
CTTACCGCATCTCGCT-1_5546_BA9	-24.30003825	-19.49858576	6A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3862	9502	0.005051568	0.00631446	0	6A	IN-PV	NA	NA	NA
CTTACCGCATGCCTAA-1_5546_BA9	-9.606622263	27.87120328	17	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	850	1107	0.016260163	0.01535682	0	oligos	OL-MS-2	NA	NA	NA
CTTACCGGTGGTCCGT-1_5546_BA9	-27.56679738	-11.1382666	9	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	962	1326	0.002262443	0.005279035	0	9	OPC	NA	NA	NA
CTTAGGAAGAATTCCC-1_5546_BA9	-15.12506364	-1.791175275	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2589	4699	0.004256225	0.011704618	0	13A	IN-VIP	NA	NA	NA
CTTAGGAAGCAGATCG-1_5546_BA9	-26.81654268	4.996598991	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1718	2618	0.009549274	0.005347594	0	8	Astrocytes	NA	NA	NA
CTTAGGACACCACGTG-1_5546_BA9	-11.52974571	-14.35408992	6B	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1117	1662	0.033694344	0.004211793	0	6B	IN-SST	NA	NA	NA
CTTAGGATCACTTCAT-1_5546_BA9	10.47810902	-13.51852001	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3501	7498	0.001600427	0.022405975	0	L2-3	EN-L2-3-MS	NA	NA	NA
CTTAGGATCCGAATGT-1_5546_BA9	-10.46969765	-4.44468302	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1974	3332	0.00030012	0.007503001	0	13A	IN-VIP	NA	NA	NA
CTTAGGATCTGAGTGT-1_5546_BA9	2.639476919	-18.80313721	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3380	7331	0.003273769	0.004092211	0	L2-3	EN-L2-3-MS	NA	NA	NA
CTTCTCTCAATGGATA-1_5546_BA9	13.75298682	-15.89900565	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	5350	13970	0.004509664	0.007516106	0	L2-3	EN-L2-3-MS	NA	NA	NA
CTTCTCTCATAGACTC-1_5546_BA9	34.63974645	-7.444521227	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4118	9874	0.009216123	0.005975289	0	2	EN-L4	NA	NA	NA
CTTCTCTGTACCTACA-1_5546_BA9	-15.11986527	-37.43232039	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2334	4219	0.022517184	0.012799242	0	16	EN-PYR	NA	NA	NA
CTTCTCTGTTCCCGAG-1_5546_BA9	-28.7744121	-5.353831245	9	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1208	1855	0.003773585	0.009703504	0	9	OPC	NA	NA	NA
CTTCTCTTCCCTCAGT-1_5546_BA9	-21.61669851	4.729750876	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1156	1708	0.006440281	0.008782201	0	8	Astrocytes	NA	NA	NA
CTTCTCTTCCTTTCTC-1_5546_BA9	-16.56202771	-15.68578349	6B	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1846	3386	0.014471353	0.002953337	0	6B	IN-SST	NA	NA	NA
CTTGGCTCAAGCTGAG-1_5546_BA9	-18.11687166	-3.189659765	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2382	3941	0.027404212	0.013702106	0	13A	IN-VIP	NA	NA	NA
CTTGGCTGTAAGAGAG-1_5546_BA9	-29.6458148	-21.87347828	6A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4427	10507	0.026077853	0.011992005	0	6A	IN-PV	NA	NA	NA
CTTGGCTTCACGGTTA-1_5546_BA9	30.22586223	-8.540151192	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	5471	16691	0.004014139	0.005392127	0	2	EN-L4	NA	NA	NA
CTTGGCTTCACTGGGC-1_5546_BA9	-29.95994332	-12.60051397	9	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	796	1145	0	0.00349345	0	9	OPC	NA	NA	NA
CTTGGCTTCCCTCTTT-1_5546_BA9	-8.654283686	-27.08699806	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1057	1503	0.014637392	0.01330672	0	16	EN-PYR	NA	NA	NA
CTTTGCGAGTGACATA-1_5546_BA9	-24.78536343	-19.06023606	6B	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2642	4792	0.008764608	0.012103506	0	6B	IN-SST	NA	NA	NA
CTTTGCGCACATCCGG-1_5546_BA9	24.08164203	-18.85297768	3	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4182	10261	0.011694767	0.012084592	0	3	EN-L5-6	NA	NA	NA
CTTTGCGTCCTTAATC-1_5546_BA9	-20.46930663	-20.40467639	6A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2241	4175	0.011257485	0.006946108	0	6A	IN-PV	NA	NA	NA
GAAACTCCAAACTGCT-1_5546_BA9	12.44698468	-20.71620725	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	6113	20322	0.005363645	0.004428698	0	L2-3	EN-L2-3-MS	NA	NA	NA
GAAACTCCACCACCAG-1_5546_BA9	10.23024539	-18.8069476	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4368	10826	0.002678736	0.008128579	0	L2-3	EN-L2-3-MS	NA	NA	NA
GAAACTCGTAGAAGGA-1_5546_BA9	-16.1364088	-1.523238779	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2421	4004	0.009240759	0.018981019	0	13A	IN-VIP	NA	NA	NA
GAAACTCGTCTGATCA-1_5546_BA9	-13.93892605	-22.04246903	6A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1181	1767	0.013016412	0.007923033	0	6A	IN-PV	NA	NA	NA
GAAATGACAAGGTTTC-1_5546_BA9	-7.917859288	-37.68437089	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1110	1461	0.045859001	0.021218344	0	16	EN-PYR	NA	NA	NA
GAACATCAGATACACA-1_5546_BA9	-27.19227872	-10.88167016	9	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1048	1476	0.001355014	0.011517615	0	9	OPC	NA	NA	NA
GAACATCAGGATGGAA-1_5546_BA9	-28.4884926	-12.51306047	9	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	819	1094	0	0.011882998	0	9	OPC	NA	NA	NA
GAACCTAAGAGTACAT-1_5546_BA9	10.0216868	-14.47454488	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3471	7336	0.004907306	0.015267176	0	L2-3	EN-L2-3-MS	NA	NA	NA
GAACCTAAGTGAACAT-1_5546_BA9	-20.46332963	4.710906543	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1012	1359	0.008094187	0.008094187	0	8	Astrocytes	NA	NA	NA
GAACCTAGTTACTGAC-1_5546_BA9	9.035605997	-3.428731689	12	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1524	2510	0.008366534	0.009960159	0	12	EN-MIX	NA	NA	NA
GAACCTATCCGAACGC-1_5546_BA9	-20.45668116	4.393618612	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	877	1184	0.001689189	0.010135135	0	8	Astrocytes	NA	NA	NA
GAACGGACAAGGTTCT-1_5546_BA9	31.18636324	-17.62560193	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	5381	13963	0.010384588	0.012604741	0	2	EN-L4	NA	NA	NA
GAACGGACACATGTGT-1_5546_BA9	26.32641816	9.827548342	15A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1771	3066	0.000978474	0.062296151	0	15A	Endo cells	NA	NA	NA
GAACGGAGTAGTACCT-1_5546_BA9	33.78368839	-11.63088557	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2240	4142	0.009174312	0.012795751	0	2	EN-L4	NA	NA	NA
GAACGGAGTGAGGCTA-1_5546_BA9	17.43563745	-14.70904015	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	6454	19364	0.009605453	0.008056187	0	L2-3	EN-L2-3-MS	NA	NA	NA
GAACGGATCTCTGAGA-1_5546_BA9	-17.93470637	-21.36985005	6A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1932	3200	0.0021875	0.0059375	0	6A	IN-PV	NA	NA	NA
GAAGCAGAGATGGGTC-1_5546_BA9	-5.982548907	-36.81956398	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	896	1250	0.0496	0.0144	0	16	EN-PYR	NA	NA	NA
GAAGCAGCAATGGACG-1_5546_BA9	-9.750920635	-4.285278381	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1701	2819	0.005321036	0.007094714	0	13A	IN-VIP	NA	NA	NA
GAAGCAGGTTGCGCAC-1_5546_BA9	9.311071347	-4.104423846	12	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2163	3582	0.00921273	0.016192071	0	12	EN-MIX	NA	NA	NA
GAAGCAGTCATCGCTC-1_5546_BA9	-10.99278501	-5.405499626	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2169	3956	0.006572295	0.008088979	0	13A	IN-VIP	NA	NA	NA
GAATAAGAGTATTGGA-1_5546_BA9	-28.44822931	-11.54528932	9	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	970	1405	0.003558719	0.006405694	0	9	OPC	NA	NA	NA
GAATAAGAGTTATCGC-1_5546_BA9	-32.59216305	-11.39071403	9	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	886	1310	0.003053435	0.003816794	0	9	OPC	NA	NA	NA
GAATAAGGTAAGGATT-1_5546_BA9	-14.77191818	-37.63556787	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2103	3878	0.017792677	0.016245487	0	16	EN-PYR	NA	NA	NA
GAATGAAAGATCACGG-1_5546_BA9	-16.80662829	-2.655487483	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2887	5576	0.009505022	0.014167862	0	13A	IN-VIP	NA	NA	NA
GAATGAAGTATTCGTG-1_5546_BA9	-20.52066089	-5.090046198	13B	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4587	10383	0.014254069	0.011942598	0	13B	IN-SV2C	NA	NA	NA
GAATGAATCCTAAGTG-1_5546_BA9	34.07247219	-12.38860829	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4140	8988	0.004450378	0.010569648	0	2	EN-L4	NA	NA	NA
GAATGAATCGCGCCAA-1_5546_BA9	8.02156072	-11.04834922	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1786	2887	0.006927607	0.01073779	0	L2-3	EN-L2-3-MS	NA	NA	NA
GACACGCAGAGCTTCT-1_5546_BA9	15.39306251	-17.43341411	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	6612	20471	0.007473988	0.005813101	0	L2-3	EN-L2-3-MS	NA	NA	NA
GACACGCAGCTAGTCT-1_5546_BA9	14.81731664	-21.30492588	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	6732	23168	0.005093232	0.005740677	0	L2-3	EN-L2-3-MS	NA	NA	NA
GACACGCAGGTGCACA-1_5546_BA9	-10.4404362	-5.323410478	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1634	2689	0.005206396	0.005206396	0	13A	IN-VIP	NA	NA	NA
GACACGCAGTGGCACA-1_5546_BA9	-12.55473714	-16.26383246	6A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1353	2238	0.008489723	0.00714924	0	6A	IN-PV	NA	NA	NA
GACACGCCAGTAGAGC-1_5546_BA9	-26.75958804	-18.3367727	6B	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2445	4339	0.013367135	0.015902282	0	6B	IN-SST	NA	NA	NA
GACACGCGTCACCTAA-1_5546_BA9	-5.282438017	-36.45056998	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	917	1185	0.051476793	0.021940928	0	16	EN-PYR	NA	NA	NA
GACACGCGTTCCACTC-1_5546_BA9	9.446774655	-20.06057242	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4414	11452	0.00261963	0.004715334	0	L2-3	EN-L2-3-MS	NA	NA	NA
GACACGCTCTATCCTA-1_5546_BA9	-28.5112102	-1.543064147	9	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1533	2333	0.002571796	0.008144021	0	9	OPC	NA	NA	NA
GACAGAGCAATGGATA-1_5546_BA9	-10.85876781	-36.97052494	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1224	1875	0.013866667	0.013866667	0	16	EN-PYR	NA	NA	NA
GACAGAGCACAACTGT-1_5546_BA9	34.20870513	-11.34981015	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3310	6613	0.003326781	0.01512173	0	2	EN-L4	NA	NA	NA
GACAGAGCAGTCAGAG-1_5546_BA9	-11.20476423	-36.3070805	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1201	1707	0.026362039	0.016403046	0	16	EN-PYR	NA	NA	NA
GACAGAGCATCCCACT-1_5546_BA9	-23.0030604	6.378626038	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1045	1461	0.005475702	0.003422313	0	8	Astrocytes	NA	NA	NA
GACAGAGGTCTGATTG-1_5546_BA9	-21.30614762	5.942648634	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1237	1704	0.002347418	0.004107981	0	8	Astrocytes	NA	NA	NA
GACAGAGGTGCAGACA-1_5546_BA9	-22.0111562	6.364364169	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1244	1722	0.006387921	0.004645761	0	8	Astrocytes	NA	NA	NA
GACAGAGGTTGATTCG-1_5546_BA9	-10.32323454	-14.51985155	6B	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1273	2001	0.016491754	0.003498251	0	6B	IN-SST	NA	NA	NA
GACAGAGTCGTAGGAG-1_5546_BA9	-7.43626151	-36.59571431	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	985	1290	0.045736434	0.015503876	0	16	EN-PYR	NA	NA	NA
GACCAATAGCAGACTG-1_5546_BA9	-12.33324853	-14.18675235	6B	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1332	2056	0.008268482	0.004377432	0	6B	IN-SST	NA	NA	NA
GACCAATCACACTGCG-1_5546_BA9	16.60201804	-16.4366045	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	6418	19411	0.006491165	0.007469991	0	L2-3	EN-L2-3-MS	NA	NA	NA
GACCAATCAGGGAGAG-1_5546_BA9	-28.96777293	-10.90867326	9	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1045	1447	0.00414651	0.006219765	0	9	OPC	NA	NA	NA
GACCAATGTAATCACC-1_5546_BA9	19.02718592	-11.14734439	3	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2618	5282	0.007383567	0.007572889	0	3	EN-L5-6	NA	NA	NA
GACCAATGTCAAGCGA-1_5546_BA9	27.7476791	8.207604266	15A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1271	2070	0.015458937	0.037681159	0	15A	Endo cells	NA	NA	NA
GACCTGGAGATGCCTT-1_5546_BA9	-14.96044119	-2.538393226	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2533	4649	0.0027963	0.011185201	0	13A	IN-VIP	NA	NA	NA
GACCTGGCACAAGACG-1_5546_BA9	14.89049118	-17.51435072	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	5532	15120	0.007936508	0.006679894	0	L2-3	EN-L2-3-MS	NA	NA	NA
GACCTGGCACGAGAGT-1_5546_BA9	-19.43891301	-5.091408007	13B	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2875	5309	0.013938595	0.007911094	0	13B	IN-SV2C	NA	NA	NA
GACCTGGCACTAGTAC-1_5546_BA9	-8.709559436	-15.44833766	6B	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	683	1021	0.010773751	0.005876592	0	6B	IN-SST	NA	NA	NA
GACCTGGGTCAATGTC-1_5546_BA9	33.93204065	-14.72054902	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	5139	13528	0.008353046	0.012344766	0	2	EN-L4	NA	NA	NA
GACCTGGGTGTAATGA-1_5546_BA9	15.98862152	-17.14090196	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	6210	18493	0.005731899	0.005461526	0	L2-3	EN-L2-3-MS	NA	NA	NA
GACCTGGTCATCATTC-1_5546_BA9	-25.8805252	-21.6117635	6A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3116	6518	0.019177662	0.016722921	0	6A	IN-PV	NA	NA	NA
GACGCGTCAGCTGTTA-1_5546_BA9	7.218991986	0.911004689	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1677	2336	0.010273973	0.042808219	0	16	EN-PYR	NA	NA	NA
GACGCGTTCACAAACC-1_5546_BA9	20.01882363	-19.7624126	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	6068	18944	0.004328547	0.007601351	0	L2-3	EN-L2-3-MS	NA	NA	NA
GACGGCTAGAATCTCC-1_5546_BA9	-20.85070621	4.207836869	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	794	1027	0.005842259	0.003894839	0	8	Astrocytes	NA	NA	NA
GACGGCTAGGAGTCTG-1_5546_BA9	-10.52083234	-36.03093346	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1134	1677	0.038163387	0.013118664	0	16	EN-PYR	NA	NA	NA
GACGGCTAGGTAGCCA-1_5546_BA9	-23.51118451	6.372496626	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	983	1309	0.002291826	0.009167303	0	8	Astrocytes	NA	NA	NA
GACGGCTAGTCCCACG-1_5546_BA9	15.56648081	-26.62757808	3	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3424	7830	0.002426564	0.004597701	0	3	EN-L5-6	NA	NA	NA
GACGGCTCAATGGACG-1_5546_BA9	27.98784367	6.687558378	15A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	753	1041	0.006724304	0.027857829	0	15A	Endo cells	NA	NA	NA
GACGGCTCAGTTAACC-1_5546_BA9	10.941691	-16.74784712	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4357	10431	0.004793404	0.013229796	0	L2-3	EN-L2-3-MS	NA	NA	NA
GACGGCTGTTCGAATC-1_5546_BA9	-30.07745146	-21.79297653	6A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4470	9847	0.014319082	0.014217528	0	6A	IN-PV	NA	NA	NA
GACGTGCAGCTAAGAT-1_5546_BA9	-26.68279636	-11.16566611	9	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1094	1596	0.005012531	0.010025063	0	9	OPC	NA	NA	NA
GACGTGCGTCGAACAG-1_5546_BA9	34.20098202	-11.98647172	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2594	4956	0.006053269	0.020379338	0	2	EN-L4	NA	NA	NA
GACGTGCGTCGGGTCT-1_5546_BA9	-7.403253653	-35.06010088	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	854	1156	0.075259516	0.012975779	0	16	EN-PYR	NA	NA	NA
GACGTGCGTCTCTCGT-1_5546_BA9	-21.43659326	5.014879436	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1054	1352	0.002218935	0.00739645	0	8	Astrocytes	NA	NA	NA
GACGTTAAGCCCAGCT-1_5546_BA9	-10.95773015	-5.204920232	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1969	3440	0.015406977	0.006976744	0	13A	IN-VIP	NA	NA	NA
GACGTTACAGCTCCGA-1_5546_BA9	12.57429497	-19.14792478	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	5351	15643	0.005241961	0.004538771	0	L2-3	EN-L2-3-MS	NA	NA	NA
GACGTTACAGTCGATT-1_5546_BA9	15.04829366	-21.06425886	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	6237	22060	0.006165005	0.007706256	0	L2-3	EN-L2-3-MS	NA	NA	NA
GACTAACAGTATCTCG-1_5546_BA9	-17.23859498	-0.82575912	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3137	6478	0.004167953	0.032263044	0	13A	IN-VIP	NA	NA	NA
GACTAACGTAGGCTGA-1_5546_BA9	-17.38141168	-2.900997183	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3600	7453	0.003488528	0.007782101	0	13A	IN-VIP	NA	NA	NA
GACTAACTCGCCATAA-1_5546_BA9	-8.488395452	-12.17640257	6B	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	974	1465	0.032764505	0.009556314	0	6B	IN-SST	NA	NA	NA
GACTAACTCGTTTATC-1_5546_BA9	33.88929921	-11.74835196	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2501	4440	0.003378378	0.019594595	0	2	EN-L4	NA	NA	NA
GACTACAAGGCGACAT-1_5546_BA9	-21.55206288	5.437725751	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1228	1757	0.003984064	0.004553216	0	8	Astrocytes	NA	NA	NA
GACTACAAGTTAACGA-1_5546_BA9	-23.12344499	6.02452321	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	956	1306	0.000765697	0.006891271	0	8	Astrocytes	NA	NA	NA
GACTACACATATACCG-1_5546_BA9	2.797500289	-21.97252531	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4871	14132	0.002122842	0.003113501	0	L2-3	EN-L2-3-MS	NA	NA	NA
GACTACAGTGCCTGGT-1_5546_BA9	-23.5447891	-24.93473014	6A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4008	9575	0.003133159	0.004281984	0	6A	IN-PV	NA	NA	NA
GACTACAGTTATCACG-1_5546_BA9	24.98289888	8.439979249	15A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2358	4306	0.007199257	0.020668834	0	15A	Endo cells	NA	NA	NA
GACTACATCGATCCCT-1_5546_BA9	2.010812037	-18.91041975	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2936	6359	0.003931436	0.00613304	0	L2-3	EN-L2-3-MS	NA	NA	NA
GACTACATCGGTGTCG-1_5546_BA9	-22.15165268	5.905263764	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1059	1524	0.002624672	0.00656168	0	8	Astrocytes	NA	NA	NA
GACTGCGCACGGTTTA-1_5546_BA9	-17.24985779	-3.755938317	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2767	5289	0.01020987	0.009642655	0	13A	IN-VIP	NA	NA	NA
GACTGCGGTTCATGGT-1_5546_BA9	32.83942261	-8.298284516	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4034	9314	0.004187245	0.008803951	0	2	EN-L4	NA	NA	NA
GACTGCGTCAACTCTT-1_5546_BA9	-30.97864682	-7.817083762	9	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1034	1519	0.004608295	0.007899934	0	9	OPC	NA	NA	NA
GAGCAGAAGGAATCGC-1_5546_BA9	19.09593115	-18.18021875	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4481	10466	0.006210587	0.008121536	0	L2-3	EN-L2-3-MS	NA	NA	NA
GAGCAGAAGGGCTTCC-1_5546_BA9	11.63587381	-12.48905311	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3411	6767	0.008866558	0.023939707	0	L2-3	EN-L2-3-MS	NA	NA	NA
GAGCAGACACTGTGTA-1_5546_BA9	-9.385556903	-15.57747337	6B	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	880	1219	0.022969647	0.007383101	0	6B	IN-SST	NA	NA	NA
GAGCAGAGTTCGCTAA-1_5546_BA9	-30.50736225	-21.62094357	6A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	5756	15660	0.020178799	0.012260536	0	6A	IN-PV	NA	NA	NA
GAGCAGATCCCTGACT-1_5546_BA9	-11.81675675	-5.397305469	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2042	3568	0.00308296	0.011491031	0	13A	IN-VIP	NA	NA	NA
GAGGTGAAGGAGTCTG-1_5546_BA9	-7.496877842	-34.93397338	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	898	1151	0.049522155	0.018245004	0	16	EN-PYR	NA	NA	NA
GAGGTGACAGGACCCT-1_5546_BA9	31.64333486	-16.57548694	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	5068	12587	0.013505998	0.012552634	0	2	EN-L4	NA	NA	NA
GAGGTGACAGGCAGTA-1_5546_BA9	16.01820517	-14.66124373	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	6365	18154	0.00914399	0.007216041	0	L2-3	EN-L2-3-MS	NA	NA	NA
GAGGTGATCAGCTCGG-1_5546_BA9	-9.84754345	-3.414308867	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1859	3261	0.006746397	0.009199632	0	13A	IN-VIP	NA	NA	NA
GAGGTGATCTGACCTC-1_5546_BA9	27.57791817	-12.55832808	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	5066	13713	0.009844673	0.009844673	0	2	EN-L4	NA	NA	NA
GAGTCCGCACAGGTTT-1_5546_BA9	-6.732069265	-28.19170205	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	920	1224	0.031045752	0.02369281	0	16	EN-PYR	NA	NA	NA
GAGTCCGCACCAGATT-1_5546_BA9	-12.0784432	-5.172332354	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2255	4016	0.009213147	0.010707171	0	13A	IN-VIP	NA	NA	NA
GAGTCCGCACGCGAAA-1_5546_BA9	-0.712517645	10.25720998	5	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1086	1513	0.001982816	0.021810972	0	oligos	OL-MS-1	NA	NA	NA
GATCAGTGTTAAGTAG-1_5546_BA9	12.35045286	-18.7670017	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	5710	15853	0.004730966	0.005614079	0	L2-3	EN-L2-3-MS	NA	NA	NA
GATCGATGTCATATCG-1_5546_BA9	-27.15678684	-9.882014061	9	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1242	1755	0.000569801	0.005698006	0	9	OPC	NA	NA	NA
GATCGATGTTGTCGCG-1_5546_BA9	8.896155183	-15.40602493	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3242	6865	0.004806992	0.008302986	0	L2-3	EN-L2-3-MS	NA	NA	NA
GATCGATTCGTGGTCG-1_5546_BA9	-20.1088471	4.065679913	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	961	1262	0.005546751	0.019809826	0	8	Astrocytes	NA	NA	NA
GATCGATTCTAACTTC-1_5546_BA9	14.84085295	-21.6054034	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	7094	27470	0.004331999	0.004441209	0	L2-3	EN-L2-3-MS	NA	NA	NA
GATCGCGAGAGGTAGA-1_5546_BA9	-13.53398567	-15.91727737	6B	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1356	2155	0.02412993	0.00649652	0	6B	IN-SST	NA	NA	NA
GATCGCGCATGGAATA-1_5546_BA9	-12.87317082	-37.98633459	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1599	2371	0.024462252	0.0227752	0	16	EN-PYR	NA	NA	NA
GATCGCGTCTGACCTC-1_5546_BA9	33.64406623	-12.39133718	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3840	8627	0.007534485	0.013098412	0	2	EN-L4	NA	NA	NA
GATCGTACATGTTGAC-1_5546_BA9	-26.82635462	-11.31963151	9	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1133	1787	0.002238388	0.008393956	0	9	OPC	NA	NA	NA
GATCGTAGTCCCTACT-1_5546_BA9	11.72175326	-22.790401	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	6125	19827	0.002370505	0.005901044	0	L2-3	EN-L2-3-MS	NA	NA	NA
GATCGTAGTGGTAACG-1_5546_BA9	10.66093098	-1.099194427	12	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1417	2325	0.004301075	0.014623656	0	12	EN-MIX	NA	NA	NA
GATCTAGCAAGTTGTC-1_5546_BA9	15.72856039	-17.27679784	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	6591	21180	0.007176582	0.007648725	0	L2-3	EN-L2-3-MS	NA	NA	NA
GATCTAGCATTTCACT-1_5546_BA9	-6.510169822	-35.44120504	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	794	1001	0.033966034	0.012987013	0	16	EN-PYR	NA	NA	NA
GATCTAGGTAGGGACT-1_5546_BA9	-26.545208	-21.02741534	6A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3197	7047	0.02639421	0.005818079	0	6A	IN-PV	NA	NA	NA
GATCTAGGTAGTACCT-1_5546_BA9	-21.96003435	5.196349242	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	923	1209	0.00248139	0.015715467	0	8	Astrocytes	NA	NA	NA
GATGAAAAGATGGCGT-1_5546_BA9	-26.03906213	-18.31622757	6B	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2568	4848	0.010107261	0.00660066	0	6B	IN-SST	NA	NA	NA
GATGAAAAGCGTAGTG-1_5546_BA9	-10.34154487	-4.470659736	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1889	2990	0.003344482	0.008695652	0	13A	IN-VIP	NA	NA	NA
GATGAAAAGTCTCAAC-1_5546_BA9	27.14313791	7.558250913	15A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1083	1665	0.007807808	0.027627628	0	15A	Endo cells	NA	NA	NA
GATGAAACAGTAACGG-1_5546_BA9	19.72241023	-14.48439815	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	8525	34201	0.023508085	0.00833309	0	2	EN-L4	NA	NA	NA
GATGAAACAGTAAGCG-1_5546_BA9	13.44842009	-20.49288475	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	5884	16921	0.006382602	0.005968914	0	L2-3	EN-L2-3-MS	NA	NA	NA
GATGAAACATTCTCAT-1_5546_BA9	15.94179053	-16.11522964	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	6378	19069	0.004247732	0.030363417	0	L2-3	EN-L2-3-MS	NA	NA	NA
GATGAAAGTATGAAAC-1_5546_BA9	11.20468652	-22.55042151	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	6280	19226	0.002236555	0.007385832	0	L2-3	EN-L2-3-MS	NA	NA	NA
GATGAAAGTCCGAATT-1_5546_BA9	15.44161397	-16.92552421	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	6786	22082	0.009464722	0.009691151	0	L2-3	EN-L2-3-MS	NA	NA	NA
GATGAAAGTTCTCATT-1_5546_BA9	5.286183684	-9.847558447	12	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1619	2860	0.01013986	0.005594406	0	12	EN-MIX	NA	NA	NA
GATGAAATCGCGTAGC-1_5546_BA9	14.45523281	-12.37905364	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2735	4721	0.019911036	0.006990044	0	L2-3	EN-L2-3-MS	NA	NA	NA
GATGAGGGTCACTGGC-1_5546_BA9	33.54052152	-11.54755988	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2292	3770	0.011140584	0.010079576	0	2	EN-L4	NA	NA	NA
GATGAGGGTCCCTTGT-1_5546_BA9	16.36784915	-13.95341285	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	6119	17311	0.009647045	0.009184911	0	L2-3	EN-L2-3-MS	NA	NA	NA
GATGAGGGTCGACTAT-1_5546_BA9	28.8679708	-18.87063077	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	10166	54695	0.019965262	0.014571716	0	2	EN-L4	NA	NA	NA
GATGAGGGTGAGCGAT-1_5546_BA9	22.7103163	-25.8227568	3	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3272	7076	0.001978519	0.005935557	0	3	EN-L5-6	NA	NA	NA
GATGCTAAGACAGGCT-1_5546_BA9	-13.14610381	7.208819122	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1005	1256	0.018312102	0.012738854	0	8	Astrocytes	NA	NA	NA
GATGCTAAGACTGTAA-1_5546_BA9	-26.06345937	-12.01213605	9	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1002	1420	0.004929577	0.018309859	0	9	OPC	NA	NA	NA
GATGCTACAAGCCGTC-1_5546_BA9	-20.38090812	4.009487432	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	807	1014	0.00295858	0.006903353	0	8	Astrocytes	NA	NA	NA
GATGCTAGTCAATACC-1_5546_BA9	9.647244713	-19.6525694	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3783	8754	0.002398903	0.00685401	0	L2-3	EN-L2-3-MS	NA	NA	NA
GATGCTATCCTATTCA-1_5546_BA9	12.66160362	-18.92123282	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	6188	19496	0.005026672	0.004872794	0	L2-3	EN-L2-3-MS	NA	NA	NA
GATGCTATCCTCAACC-1_5546_BA9	15.31177507	-21.5253615	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	5478	14750	0.003661017	0.016542373	0	L2-3	EN-L2-3-MS	NA	NA	NA
GATTCAGAGGATGTAT-1_5546_BA9	-13.49789109	-37.22767936	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1793	2936	0.046662125	0.012942779	0	16	EN-PYR	NA	NA	NA
GATTCAGAGGCACATG-1_5546_BA9	10.63312783	-23.73391271	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4421	11581	0.001986012	0.003281237	0	L2-3	EN-L2-3-MS	NA	NA	NA
GATTCAGGTCATGCCG-1_5546_BA9	-18.29811593	-1.236508414	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3616	7026	0.005835468	0.019072018	0	13A	IN-VIP	NA	NA	NA
GCAAACTGTCGACTAT-1_5546_BA9	9.651649039	-12.4398724	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2768	5475	0.00109589	0.025388128	0	L2-3	EN-L2-3-MS	NA	NA	NA
GCAAACTTCTGTCAAG-1_5546_BA9	28.94212961	-16.94515224	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4594	11386	0.00895837	0.00772879	0	2	EN-L4	NA	NA	NA
GCAATCAAGGCTCTTA-1_5546_BA9	14.01083672	-17.01956289	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	6450	19619	0.004128651	0.011111677	0	L2-3	EN-L2-3-MS	NA	NA	NA
GCAATCAAGTTAGCGG-1_5546_BA9	-21.53455051	4.544402369	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	893	1156	0.00432526	0.010380623	0	8	Astrocytes	NA	NA	NA
GCAATCAGTTACGGAG-1_5546_BA9	-20.24062453	4.212959373	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	880	1149	0.006962576	0.00435161	0	8	Astrocytes	NA	NA	NA
GCAATCATCGGCATCG-1_5546_BA9	-22.17094744	5.809107682	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1107	1552	0.003221649	0.009664948	0	8	Astrocytes	NA	NA	NA
GCACATAAGATCTGAA-1_5546_BA9	-11.99689915	12.85258902	11	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	985	1254	0.003189793	0.010366826	0	11	Glia-MIX	NA	NA	NA
GCACATACAAACGTGG-1_5546_BA9	-20.8178848	4.724234662	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1099	1475	0.006101695	0.007457627	0	8	Astrocytes	NA	NA	NA
GCACATACATCTCGCT-1_5546_BA9	-27.24067367	-9.834897355	9	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1157	1785	0.001120448	0.008963585	0	9	OPC	NA	NA	NA
GCACTCTAGTTAGGTA-1_5546_BA9	-20.67295683	4.255086801	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	847	1068	0.014981273	0.011235955	0	8	Astrocytes	NA	NA	NA
GCACTCTCAATGTTGC-1_5546_BA9	-21.79876929	5.859637128	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1316	1979	0.001010611	0.01414856	0	8	Astrocytes	NA	NA	NA
GCACTCTCATGGGACA-1_5546_BA9	15.2829388	-21.63937973	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	7240	24807	0.006651348	0.009311888	0	L2-3	EN-L2-3-MS	NA	NA	NA
GCACTCTTCACCTCGT-1_5546_BA9	-15.24075823	-37.29415068	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2473	4352	0.026194853	0.011029412	0	16	EN-PYR	NA	NA	NA
GCACTCTTCCTCTAGC-1_5546_BA9	-22.99170525	8.726997393	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1208	1803	0.004437049	0.007210205	0	8	Astrocytes	NA	NA	NA
GCAGCCAAGGATCGCA-1_5546_BA9	15.60265131	-26.71216317	3	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3346	7620	0.003937008	0.008136483	0	3	EN-L5-6	NA	NA	NA
GCAGCCACAGCGATCC-1_5546_BA9	-19.77011253	4.439705231	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	927	1192	0.007550336	0.009228188	0	8	Astrocytes	NA	NA	NA
GCAGCCAGTGAGTGAC-1_5546_BA9	-9.152309617	-34.02637625	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1048	1436	0.057103064	0.010445682	0	16	EN-PYR	NA	NA	NA
GCAGCCAGTGCCTTGG-1_5546_BA9	-26.91675244	-11.32991494	9	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1200	1685	0.001780415	0.020178042	0	9	OPC	NA	NA	NA
GCAGCCAGTTCTGAAC-1_5546_BA9	9.838415788	-2.45993566	12	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1509	2147	0.040521658	0.011178388	0	12	EN-MIX	NA	NA	NA
GCAGTTAGTAACGCGA-1_5546_BA9	14.09016143	-23.67009744	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	5103	14719	0.002717576	0.006522182	0	L2-3	EN-L2-3-MS	NA	NA	NA
GCAGTTATCACGCATA-1_5546_BA9	-7.291610448	-37.35207669	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1007	1408	0.063920455	0.022727273	0	16	EN-PYR	NA	NA	NA
GCATACACAGATGGGT-1_5546_BA9	-15.7800585	18.12444851	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1677	2540	0.001968504	0.009448819	0	8	Astrocytes	NA	NA	NA
GCATGATGTCTAAACC-1_5546_BA9	10.59270866	-16.87273987	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4195	9659	0.00528005	0.010456569	0	L2-3	EN-L2-3-MS	NA	NA	NA
GCATGCGAGCCTTGAT-1_5546_BA9	10.13549332	-19.54600475	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	5811	18252	0.003232522	0.003725619	0	L2-3	EN-L2-3-MS	NA	NA	NA
GCATGCGCACGTCTCT-1_5546_BA9	32.37622164	-12.12418475	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3994	9443	0.004024145	0.012284232	0	2	EN-L4	NA	NA	NA
GCATGCGCAGCTGCAC-1_5546_BA9	28.11527699	7.106177205	15BA	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	969	1503	0.011976048	0.02994012	0	15BA	Stromal cells	NA	NA	NA
GCATGCGCAGGTCGTC-1_5546_BA9	-28.15546809	-11.2301414	9	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	984	1339	0.002240478	0.004480956	0	9	OPC	NA	NA	NA
GCATGCGGTAAACGCG-1_5546_BA9	-28.81468873	-11.77759654	9	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	868	1160	0.001724138	0.002586207	0	9	OPC	NA	NA	NA
GCATGCGTCAACTCTT-1_5546_BA9	20.43183241	-20.06025015	3	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	6303	21598	0.009399018	0.006945088	0	3	EN-L5-6	NA	NA	NA
GCATGTAAGTGTTGAA-1_5546_BA9	12.77454418	-23.91628038	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4719	11951	0.0023429	0.00552255	0	L2-3	EN-L2-3-MS	NA	NA	NA
GCATGTACAACTTGAC-1_5546_BA9	15.8387475	-28.72041436	3	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4597	12799	0.001484491	0.004453473	0	3	EN-L5-6	NA	NA	NA
GCATGTACAGCGTCCA-1_5546_BA9	-18.26429942	-15.10344212	6B	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2398	4271	0.019667525	0.006555842	0	6B	IN-SST	NA	NA	NA
GCATGTAGTTCCACTC-1_5546_BA9	32.46702943	-12.79813415	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4313	9598	0.005001042	0.01667014	0	2	EN-L4	NA	NA	NA
GCATGTAGTTTAGGAA-1_5546_BA9	9.310690258	-19.75904155	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4323	10803	0.001851338	0.005554013	0	L2-3	EN-L2-3-MS	NA	NA	NA
GCATGTATCCACGCAG-1_5546_BA9	33.38639532	-12.05195756	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3333	6625	0.006339623	0.006792453	0	2	EN-L4	NA	NA	NA
GCCAAATCACCATGTA-1_5546_BA9	8.782706624	-11.37092492	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2017	3388	0.012101535	0.013872491	0	L2-3	EN-L2-3-MS	NA	NA	NA
GCCAAATCACTGAAGG-1_5546_BA9	14.7659603	-17.06895629	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	6842	21280	0.00681391	0.007988722	0	L2-3	EN-L2-3-MS	NA	NA	NA
GCCAAATCATCTACGA-1_5546_BA9	-16.3716085	-1.608729563	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2856	5179	0.003861749	0.013902298	0	13A	IN-VIP	NA	NA	NA
GCCAAATGTACCTACA-1_5546_BA9	-12.52453831	-1.211707209	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2794	5442	0.006247703	0.007717751	0	13A	IN-VIP	NA	NA	NA
GCCAAATGTTCCAACA-1_5546_BA9	9.888564485	-2.411194733	12	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1441	2039	0.012260912	0.007356547	0	12	EN-MIX	NA	NA	NA
GCCAAATTCGCGCCAA-1_5546_BA9	9.452455998	-7.371980955	10	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2478	5341	0.001310616	0.005055233	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCCTCTACATTAGGCT-1_5546_BA9	-16.90819395	-1.519731487	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3060	5986	0.01369863	0.012362178	0	13A	IN-VIP	NA	NA	NA
GCCTCTATCCAGAGGA-1_5546_BA9	14.25807849	-20.86571002	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	5497	14615	0.004105371	0.009510777	0	L2-3	EN-L2-3-MS	NA	NA	NA
GCGACCACATTAGGCT-1_5546_BA9	-8.945489377	-9.123034278	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1385	2242	0.003568243	0.009366637	0	13A	IN-VIP	NA	NA	NA
GCGACCAGTACAGACG-1_5546_BA9	-27.27864652	-12.4954169	9	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	843	1141	0.004382121	0.021910605	0	9	OPC	NA	NA	NA
GCGACCAGTAGAAAGG-1_5546_BA9	-4.798964169	-35.64073551	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	797	1046	0.04875717	0.028680688	0	16	EN-PYR	NA	NA	NA
GCGACCATCCCAAGAT-1_5546_BA9	35.66562837	-7.480345707	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4303	10278	0.002335085	0.009632224	0	2	EN-L4	NA	NA	NA
GCGAGAAGTCCCTACT-1_5546_BA9	27.76743872	-12.66612713	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4674	11719	0.010922434	0.006826521	0	2	EN-L4	NA	NA	NA
GCGCAACAGAACAACT-1_5546_BA9	-16.9472902	-4.068777607	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3386	6981	0.009167741	0.009454233	0	13A	IN-VIP	NA	NA	NA
GCGCAGTAGGATGTAT-1_5546_BA9	23.31578199	-16.17383394	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	7543	29548	0.012285095	0.010728306	0	2	EN-L4	NA	NA	NA
GCGCAGTGTCTCACCT-1_5546_BA9	-22.23676773	5.392119568	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	951	1370	0.004379562	0.013138686	0	8	Astrocytes	NA	NA	NA
GCGCCAACAAGCGAGT-1_5546_BA9	-21.60534209	4.52666849	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	931	1261	0.007137193	0.010309278	0	8	Astrocytes	NA	NA	NA
GCGCCAACACATTTCT-1_5546_BA9	8.93575433	-3.412754169	12	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1528	2105	0.019477435	0.01567696	0	12	EN-MIX	NA	NA	NA
GCGCCAAGTTGATTCG-1_5546_BA9	-19.88816334	4.241875538	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	778	1056	0.021780303	0.016098485	0	8	Astrocytes	NA	NA	NA
GCGCCAATCTGTGCAA-1_5546_BA9	-21.67189697	4.477184271	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	900	1143	0.000874891	0.01312336	0	8	Astrocytes	NA	NA	NA
GCGCGATAGCTGATAA-1_5546_BA9	-29.39705314	-10.70806296	9	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1074	1584	0.001262626	0.005050505	0	9	OPC	NA	NA	NA
GCGCGATCACTGCCAG-1_5546_BA9	-12.04618652	-38.40995727	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1669	2471	0.050586807	0.028733306	0	16	EN-PYR	NA	NA	NA
GCGCGATGTGCGATAG-1_5546_BA9	9.798743266	-11.73997479	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2594	4644	0.013996555	0.011412575	0	L2-3	EN-L2-3-MS	NA	NA	NA
GCGCGATTCGAATGGG-1_5546_BA9	10.8298674	-16.41964319	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3965	8604	0.005113901	0.007322176	0	L2-3	EN-L2-3-MS	NA	NA	NA
GCGCGATTCGTCTGCT-1_5546_BA9	29.92322289	-13.04440038	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4094	9324	0.004826255	0.012333762	0	2	EN-L4	NA	NA	NA
GCGGGTTAGATGCCAG-1_5546_BA9	17.82033694	-20.96202709	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3471	7219	0.005263887	0.013436764	0	L2-3	EN-L2-3-MS	NA	NA	NA
GCGGGTTCACGAAAGC-1_5546_BA9	-8.749730767	-36.03118573	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	920	1293	0.018561485	0.013921114	0	16	EN-PYR	NA	NA	NA
GCGGGTTCATATACCG-1_5546_BA9	-12.88811871	-37.15697947	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1535	2182	0.021539872	0.015582035	0	16	EN-PYR	NA	NA	NA
GCGGGTTGTACTTAGC-1_5546_BA9	5.619886036	-9.74774222	12	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1605	2595	0.005009634	0.011560694	0	12	EN-MIX	NA	NA	NA
GCTCTGTAGATAGCAT-1_5546_BA9	-21.24533262	4.185353383	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	750	1003	0.003988036	0.006979063	0	8	Astrocytes	NA	NA	NA
GCTCTGTCAAGCTGTT-1_5546_BA9	-21.70984806	4.674569598	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	983	1335	0.003745318	0.005243446	0	8	Astrocytes	NA	NA	NA
GCTCTGTCAGTATAAG-1_5546_BA9	28.05689506	7.055536045	15A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1000	1362	0.013950073	0.016152717	0	15A	Endo cells	NA	NA	NA
GCTCTGTCATGGTCAT-1_5546_BA9	12.48667066	-15.99643491	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4402	10369	0.004050535	0.009354808	0	L2-3	EN-L2-3-MS	NA	NA	NA
GCTCTGTGTTTCCACC-1_5546_BA9	15.28569989	-17.13911455	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	5391	13504	0.007183057	0.007405213	0	L2-3	EN-L2-3-MS	NA	NA	NA
GCTGCAGAGGCCCTCA-1_5546_BA9	-20.60032054	4.527110618	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	941	1334	0	0.017991004	0	8	Astrocytes	NA	NA	NA
GCTGCAGCACCACCAG-1_5546_BA9	28.17208607	-18.30159295	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	9237	44048	0.021385761	0.008717762	0	2	EN-L4	NA	NA	NA
GCTGCAGCATCATCCC-1_5546_BA9	-12.22618923	-36.80683899	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1306	1937	0.014971606	0.014971606	0	16	EN-PYR	NA	NA	NA
GCTGCAGTCTCGTTTA-1_5546_BA9	-17.48071241	-14.57391873	6B	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2046	3522	0.009937535	0.016467916	0	6B	IN-SST	NA	NA	NA
GCTGCGACAACTGGCC-1_5546_BA9	-14.76073294	-2.075139034	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2378	4216	0.002134725	0.013282732	0	13A	IN-VIP	NA	NA	NA
GCTGCGACACTCAGGC-1_5546_BA9	-7.585912229	-35.642525	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	829	1115	0.022421525	0.01793722	0	16	EN-PYR	NA	NA	NA
GCTGCGAGTACCGAGA-1_5546_BA9	-15.8086903	-1.920549314	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2639	4658	0.008587377	0.012022327	0	13A	IN-VIP	NA	NA	NA
GCTGCGAGTCATGCCG-1_5546_BA9	15.02257423	-21.25412787	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	6552	20315	0.006940684	0.005217819	0	L2-3	EN-L2-3-MS	NA	NA	NA
GCTGCGAGTGACTCAT-1_5546_BA9	8.615554101	-14.14444395	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2797	5339	0.002060311	0.011987264	0	L2-3	EN-L2-3-MS	NA	NA	NA
GCTGCGATCTGCTGCT-1_5546_BA9	-7.350486425	-6.045981582	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1330	2195	0.00501139	0.007744875	0	13A	IN-VIP	NA	NA	NA
GCTGCTTAGGCTAGAC-1_5546_BA9	9.866255549	-16.21217734	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4058	9651	0.002383173	0.006113356	0	L2-3	EN-L2-3-MS	NA	NA	NA
GCTGCTTCACATTCGA-1_5546_BA9	-16.51359139	24.6297551	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1810	2852	0.002454418	0.008064516	0	8	Astrocytes	NA	NA	NA
GCTGCTTTCTTTCCTC-1_5546_BA9	-9.631962093	-36.11707943	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	977	1360	0.026470588	0.006617647	0	16	EN-PYR	NA	NA	NA
GCTTCCAAGACTAGAT-1_5546_BA9	-20.04190886	5.016273226	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1016	1412	0.001416431	0.006373938	0	8	Astrocytes	NA	NA	NA
GCTTCCAAGGAATTAC-1_5546_BA9	-21.53442376	4.81105761	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1078	1496	0.00868984	0.011363636	0	8	Astrocytes	NA	NA	NA
GCTTCCAGTCAACATC-1_5546_BA9	-21.80489058	4.383601506	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	840	1123	0.003561888	0.006233304	0	8	Astrocytes	NA	NA	NA
GCTTGAAAGATCCCAT-1_5546_BA9	-26.00738002	-9.605293147	9	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1269	1825	0.004383562	0.003835616	0	9	OPC	NA	NA	NA
GCTTGAAGTGTGGCTC-1_5546_BA9	9.109572533	-4.06874114	12	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1632	2346	0.031543052	0.02514919	0	12	EN-MIX	NA	NA	NA
GGAAAGCCAGTTCATG-1_5546_BA9	-13.75126341	-38.19814872	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2020	3299	0.04213398	0.02667475	0	16	EN-PYR	NA	NA	NA
GGAAAGCTCAGTGTTG-1_5546_BA9	-11.64869158	-13.67114746	6B	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1345	2092	0.007170172	0.01625239	0	6B	IN-SST	NA	NA	NA
GGAACTTAGACCGGAT-1_5546_BA9	7.169683948	-0.985478652	12	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1017	1449	0.011732229	0.020703934	0	12	EN-MIX	NA	NA	NA
GGAACTTAGTCTCAAC-1_5546_BA9	-14.4205465	-1.992596487	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2605	4805	0.003121748	0.011030177	0	13A	IN-VIP	NA	NA	NA
GGAACTTCACGAGAGT-1_5546_BA9	-20.3626544	4.057352873	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	946	1256	0.005573248	0.003184713	0	8	Astrocytes	NA	NA	NA
GGAACTTCAGGAATCG-1_5546_BA9	-16.47383957	24.82069963	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2027	3194	0.005635567	0.009079524	0	8	Astrocytes	NA	NA	NA
GGAACTTGTCTTCAAG-1_5546_BA9	-6.72771609	-35.33073501	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	847	1102	0.04446461	0.012704174	0	16	EN-PYR	NA	NA	NA
GGAACTTTCTGCTGTC-1_5546_BA9	24.05616871	-12.54919819	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3001	6085	0.003615448	0.011010682	0	2	EN-L4	NA	NA	NA
GGAATAACAAGACGTG-1_5546_BA9	9.075981503	-12.47968923	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2349	4102	0.004388103	0.019258898	0	L2-3	EN-L2-3-MS	NA	NA	NA
GGAATAACAGATGGCA-1_5546_BA9	28.00392072	6.405676561	15A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	803	1118	0.006261181	0.024150268	0	15A	Endo cells	NA	NA	NA
GGAATAACATAGAAAC-1_5546_BA9	17.39852496	-17.03956975	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	8295	31235	0.007459581	0.004226028	0	L2-3	EN-L2-3-MS	NA	NA	NA
GGACAAGAGGAGCGTT-1_5546_BA9	-16.35938794	-1.743234243	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2287	3697	0.008655667	0.015688396	0	13A	IN-VIP	NA	NA	NA
GGACAAGAGTGGTAGC-1_5546_BA9	14.29213281	-14.23226135	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4858	11291	0.006731025	0.011690727	0	L2-3	EN-L2-3-MS	NA	NA	NA
GGACAAGGTACAGCAG-1_5546_BA9	-8.125904531	-36.1032165	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	904	1227	0.033414833	0.010594947	0	16	EN-PYR	NA	NA	NA
GGACAAGGTCGTGGCT-1_5546_BA9	-22.65992103	7.678988597	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1239	1817	0.002201431	0.006604293	0	8	Astrocytes	NA	NA	NA
GGACAAGTCGCCCTTA-1_5546_BA9	35.06934053	-6.773703805	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3386	6970	0.001291248	0.013055954	0	2	EN-L4	NA	NA	NA
GGACAAGTCGGTGTTA-1_5546_BA9	16.33219797	-13.81951401	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4426	9938	0.008553029	0.010968002	0	L2-3	EN-L2-3-MS	NA	NA	NA
GGACAGAAGTGCCATT-1_5546_BA9	33.64450707	-15.86037527	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4340	9538	0.009855316	0.012161879	0	2	EN-L4	NA	NA	NA
GGACAGACACGACTCG-1_5546_BA9	26.46277483	9.312066	15A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1767	3114	0.015414258	0.03403982	0	15A	Endo cells	NA	NA	NA
GGACAGAGTAACGACG-1_5546_BA9	33.35792236	-17.03696246	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4447	9708	0.008240626	0.017305315	0	2	EN-L4	NA	NA	NA
GGACATTAGCTAACTC-1_5546_BA9	-16.67473362	-1.126086841	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3389	7308	0.004652436	0.011631089	0	13A	IN-VIP	NA	NA	NA
GGACATTTCCAGATCA-1_5546_BA9	30.56715293	-13.76097711	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4224	9454	0.011741062	0.011741062	0	2	EN-L4	NA	NA	NA
GGACATTTCTCAAACG-1_5546_BA9	-7.160428388	-9.495544617	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	830	1225	0.010612245	0.004897959	0	13A	IN-VIP	NA	NA	NA
GGACGTCAGAGAACAG-1_5546_BA9	-29.05892958	-21.41865826	6A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4310	9935	0.037342728	0.007146452	0	6A	IN-PV	NA	NA	NA
GGACGTCCACCGGAAA-1_5546_BA9	-14.43324124	21.56344834	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1292	1960	0.006632653	0.011734694	0	8	Astrocytes	NA	NA	NA
GGACGTCCACGAGAGT-1_5546_BA9	15.44593808	-17.08930126	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	5342	13739	0.006041197	0.006405124	0	L2-3	EN-L2-3-MS	NA	NA	NA
GGACGTCCAGCGTAAG-1_5546_BA9	12.19293731	-19.44033415	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	5369	13833	0.002241018	0.016193161	0	L2-3	EN-L2-3-MS	NA	NA	NA
GGACGTCCAGCGTTCG-1_5546_BA9	-25.87178901	-21.49516447	6A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3368	6885	0.011183733	0.009586057	0	6A	IN-PV	NA	NA	NA
GGAGCAAAGGATGGTC-1_5546_BA9	-15.12818687	-2.064330122	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2358	4056	0.00443787	0.008629191	0	13A	IN-VIP	NA	NA	NA
GGAGCAAAGTGAACGC-1_5546_BA9	10.95990377	-23.64257592	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4667	13051	0.002911654	0.006283043	0	L2-3	EN-L2-3-MS	NA	NA	NA
GGAGCAAGTACAGTTC-1_5546_BA9	-7.663480526	-34.33242096	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	791	1114	0.058348294	0.014362657	0	16	EN-PYR	NA	NA	NA
GGAGCAAGTACTTAGC-1_5546_BA9	21.3458285	-22.95045876	3	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	5231	14566	0.003707263	0.010503913	0	3	EN-L5-6	NA	NA	NA
GGAGCAAGTTTGGCGC-1_5546_BA9	-13.24862796	16.75727544	11	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1732	2573	0.003497862	0.008938982	0	11	Glia-MIX	NA	NA	NA
GGATGTTAGATCTGAA-1_5546_BA9	-14.19409864	8.735719912	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1609	2285	0.008752735	0.013129103	0	8	Astrocytes	NA	NA	NA
GGATGTTCATCTATGG-1_5546_BA9	-5.223883124	-32.70021087	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	777	1119	0.145665773	0.006255585	0	16	EN-PYR	NA	NA	NA
GGATTACAGGACGAAA-1_5546_BA9	9.170211805	-16.1614739	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3545	7543	0.003049185	0.003049185	0	L2-3	EN-L2-3-MS	NA	NA	NA
GGATTACAGTCGTTTG-1_5546_BA9	-20.19555097	4.240250147	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	792	1163	0.005159071	0.007738607	0	8	Astrocytes	NA	NA	NA
GGATTACTCTCTGAGA-1_5546_BA9	-21.72978364	4.442329738	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	889	1211	0.003303055	0.003303055	0	8	Astrocytes	NA	NA	NA
GGCAATTAGCCAGTAG-1_5546_BA9	-12.03140254	-13.48992899	6A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1503	2424	0.017739274	0.005363036	0	6A	IN-PV	NA	NA	NA
GGCAATTAGGACAGAA-1_5546_BA9	-7.594086168	-35.41651096	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	893	1127	0.025732032	0.00621118	0	16	EN-PYR	NA	NA	NA
GGCAATTGTATAGGTA-1_5546_BA9	28.43556374	7.263738916	15A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	967	1347	0.010393467	0.035634744	0	15A	Endo cells	NA	NA	NA
GGCAATTGTCCGTCAG-1_5546_BA9	-11.36713482	-36.13029141	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1422	2052	0.041910331	0.015107212	0	16	EN-PYR	NA	NA	NA
GGCAATTTCGCGGATC-1_5546_BA9	15.0862196	-17.62007218	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	5200	13350	0.006217228	0.005543071	0	L2-3	EN-L2-3-MS	NA	NA	NA
GGCGACTAGATGTTAG-1_5546_BA9	30.51109727	-18.27192254	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	5657	15690	0.009369025	0.012810707	0	2	EN-L4	NA	NA	NA
GGCGACTAGTACGCCC-1_5546_BA9	12.50425243	-15.16669753	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3469	7508	0.014517848	0.00945658	0	L2-3	EN-L2-3-MS	NA	NA	NA
GGCGACTCACCTCGTT-1_5546_BA9	30.20786094	-12.9374404	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4049	9192	0.00424282	0.016753699	0	2	EN-L4	NA	NA	NA
GGCGACTCAGTGGGAT-1_5546_BA9	9.687231017	-12.16868222	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2596	4616	0.005415945	0.023180243	0	L2-3	EN-L2-3-MS	NA	NA	NA
GGCGACTCATTGGTAC-1_5546_BA9	14.17956123	-20.60821151	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	5411	15112	0.00668343	0.005624669	0	L2-3	EN-L2-3-MS	NA	NA	NA
GGCGTGTGTATCACCA-1_5546_BA9	17.81788849	-15.62523589	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	6994	23499	0.00791523	0.00842589	0	L2-3	EN-L2-3-MS	NA	NA	NA
GGCGTGTGTTGGTAAA-1_5546_BA9	-20.49895608	-4.67199249	13B	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4234	8925	0.007619048	0.019831933	0	13B	IN-SV2C	NA	NA	NA
GGCTCGACAAAGCGGT-1_5546_BA9	-8.974114723	-36.01488709	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	937	1309	0.016806723	0.012223071	0	16	EN-PYR	NA	NA	NA
GGCTCGAGTTCGCTAA-1_5546_BA9	16.09652892	-14.43399801	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	5602	14869	0.008272244	0.006927164	0	L2-3	EN-L2-3-MS	NA	NA	NA
GGCTCGATCAACTCTT-1_5546_BA9	-16.79951488	-1.961954675	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2909	5403	0.0062928	0.012955765	0	13A	IN-VIP	NA	NA	NA
GGCTGGTAGATAGGAG-1_5546_BA9	-20.02753562	-20.55707891	6A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2358	4338	0.004840941	0.005301982	0	6A	IN-PV	NA	NA	NA
GGCTGGTAGTACTTGC-1_5546_BA9	-19.64820466	4.785555861	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	839	1173	0.00170503	0.005967604	0	8	Astrocytes	NA	NA	NA
GGCTGGTCAAAGTGCG-1_5546_BA9	-4.893585882	-37.10659207	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	984	1322	0.068835098	0.020423601	0	16	EN-PYR	NA	NA	NA
GGGAATGCAATGCCAT-1_5546_BA9	11.45100951	-16.43453592	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4535	10921	0.006501236	0.008149437	0	L2-3	EN-L2-3-MS	NA	NA	NA
GGGAATGCACGAAGCA-1_5546_BA9	-28.05340838	-4.8268562	9	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1291	1933	0.001551992	0.010863942	0	9	OPC	NA	NA	NA
GGGAATGGTAGTACCT-1_5546_BA9	-18.14182878	-15.08552667	6B	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2336	4173	0.003354901	0.008387251	0	6B	IN-SST	NA	NA	NA
GGGAATGGTCCCTACT-1_5546_BA9	-22.38070713	5.326449956	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	833	1187	0.00505476	0.0042123	0	8	Astrocytes	NA	NA	NA
GGGAATGTCTATCCTA-1_5546_BA9	9.988697645	-13.03410617	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2800	5112	0.001564945	0.024256651	0	L2-3	EN-L2-3-MS	NA	NA	NA
GGGACCTCACCTATCC-1_5546_BA9	-22.26033772	5.723457105	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1069	1501	0.00266489	0.014656895	0	8	Astrocytes	NA	NA	NA
GGGACCTGTTCCAACA-1_5546_BA9	8.125502564	-14.96049421	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3365	7012	0.002281803	0.00912721	0	L2-3	EN-L2-3-MS	NA	NA	NA
GGGACCTTCGGAGGTA-1_5546_BA9	9.274630979	0.672961618	12	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	955	1418	0.00493653	0.012693935	0	12	EN-MIX	NA	NA	NA
GGGACCTTCTGTTGAG-1_5546_BA9	-20.67269052	4.607533493	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	819	1095	0.00456621	0.005479452	0	8	Astrocytes	NA	NA	NA
GGGAGATCAGATCCAT-1_5546_BA9	23.48911338	-16.19972924	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	6857	21644	0.01335243	0.011504343	0	2	EN-L4	NA	NA	NA
GGGAGATGTCATATCG-1_5546_BA9	5.941763413	-18.28651728	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4116	9504	0.001578283	0.010521886	0	L2-3	EN-L2-3-MS	NA	NA	NA
GGGATGAAGGCTCTTA-1_5546_BA9	-7.659696739	-35.7663653	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	935	1229	0.036615134	0.010577705	0	16	EN-PYR	NA	NA	NA
GGGATGACAGGGATTG-1_5546_BA9	-20.51399789	-4.79147814	13B	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4351	9511	0.007359899	0.016086637	0	13B	IN-SV2C	NA	NA	NA
GGGATGAGTGACGGTA-1_5546_BA9	-9.588127994	-15.45539616	6B	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	973	1443	0.02009702	0.005544006	0	6B	IN-SST	NA	NA	NA
GGGATGAGTGAGGGTT-1_5546_BA9	17.20831038	-14.69280017	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	6905	21438	0.013993843	0.009235936	0	L2-3	EN-L2-3-MS	NA	NA	NA
GGGATGAGTGATGCCC-1_5546_BA9	10.61752144	-16.34624339	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3850	8182	0.005499878	0.008188707	0	L2-3	EN-L2-3-MS	NA	NA	NA
GGGATGAGTTAAGTAG-1_5546_BA9	27.98417839	7.660124449	15A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	956	1333	0.015753938	0.034508627	0	15A	Endo cells	NA	NA	NA
GGGCACTAGGAATCGC-1_5546_BA9	-10.74386526	-5.339132607	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1627	2686	0.006329114	0.006329114	0	13A	IN-VIP	NA	NA	NA
GGGCACTAGGTTCCTA-1_5546_BA9	-28.32138627	-22.35958768	6A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4847	11744	0.012091281	0.010132834	0	6A	IN-PV	NA	NA	NA
GGGCACTCACAGATTC-1_5546_BA9	14.1662842	-14.54536044	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	5465	13857	0.003969113	0.007072238	0	L2-3	EN-L2-3-MS	NA	NA	NA
GGGCACTGTTCCATGA-1_5546_BA9	20.31217618	-23.98737719	3	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3350	7369	0.001628443	0.033111684	0	3	EN-L5-6	NA	NA	NA
GGGCACTTCACCGTAA-1_5546_BA9	28.98707403	-14.21414368	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	5554	14934	0.008169278	0.01292353	0	2	EN-L4	NA	NA	NA
GGGCACTTCCATGCTC-1_5546_BA9	12.32423349	-19.70486644	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	5501	15798	0.002721864	0.008671984	0	L2-3	EN-L2-3-MS	NA	NA	NA
GGGCACTTCCTTGCCA-1_5546_BA9	-22.38336158	7.160754408	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1330	1931	0.002071466	0.004660798	0	8	Astrocytes	NA	NA	NA
GGGCATCAGACAGACC-1_5546_BA9	-25.24641638	-22.39838059	6A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4159	9847	0.009342947	0.009342947	0	6A	IN-PV	NA	NA	NA
GGGCATCCAGCGAACA-1_5546_BA9	11.26778792	-0.897720521	12	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1254	2116	0.007088847	0.008979206	0	12	EN-MIX	NA	NA	NA
GGGCATCGTTAGGGTG-1_5546_BA9	-5.142679933	-36.82948197	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	920	1178	0.039898132	0.024617997	0	16	EN-PYR	NA	NA	NA
GGGTCTGCAGATGAGC-1_5546_BA9	-20.79489502	4.159801446	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	835	1092	0.017399267	0.007326007	0	8	Astrocytes	NA	NA	NA
GGGTCTGCATCACGAT-1_5546_BA9	10.19485974	-24.56460219	10	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	5694	18262	0.000985653	0.004818749	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GGGTCTGGTCCATGAT-1_5546_BA9	-10.69779852	-6.362518837	13B	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1911	3375	0.007111111	0.00562963	0	13B	IN-SV2C	NA	NA	NA
GGGTCTGGTTATCACG-1_5546_BA9	13.74212779	-14.75115405	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4217	9446	0.007516409	0.011433411	0	L2-3	EN-L2-3-MS	NA	NA	NA
GGGTTGCAGAATGTTG-1_5546_BA9	6.415633412	-14.28323097	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2649	4837	0.003928055	0.006615671	0	L2-3	EN-L2-3-MS	NA	NA	NA
GGGTTGCAGTAGTGCG-1_5546_BA9	8.29090071	-14.33433471	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2726	5405	0.002960222	0.011655874	0	L2-3	EN-L2-3-MS	NA	NA	NA
GGGTTGCCAAGTAGTA-1_5546_BA9	-22.66533358	-16.41679884	6A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4347	11104	0.005403458	0.007114553	0	6A	IN-PV	NA	NA	NA
GGGTTGCCAGCGATCC-1_5546_BA9	12.49989129	-24.11534453	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	6718	21492	0.001721571	0.010934301	0	L2-3	EN-L2-3-MS	NA	NA	NA
GGTATTGAGGTTCCTA-1_5546_BA9	-11.19051469	-4.628621835	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2025	3406	0.007339988	0.007927187	0	13A	IN-VIP	NA	NA	NA
GGTATTGCACAGGTTT-1_5546_BA9	27.19066989	-18.22608149	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3397	7458	0.007910968	0.006301958	0	2	EN-L4	NA	NA	NA
GGTATTGCATGCTGGC-1_5546_BA9	-20.24805337	4.578409335	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	926	1249	0.000800641	0.012009608	0	8	Astrocytes	NA	NA	NA
GGTATTGTCCGGGTGT-1_5546_BA9	-8.350404323	-37.53673728	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1021	1366	0.049780381	0.019033675	0	16	EN-PYR	NA	NA	NA
GGTATTGTCCTATGTT-1_5546_BA9	-9.448926605	-2.754593046	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1980	3577	0.002795639	0.007548225	0	13A	IN-VIP	NA	NA	NA
GGTGAAGAGTACGCGA-1_5546_BA9	-6.835564433	-35.90219411	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	832	1075	0.030697674	0.012093023	0	16	EN-PYR	NA	NA	NA
GGTGAAGCAGGAATGC-1_5546_BA9	-21.80069981	-24.98723763	6A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2929	6116	0.003924133	0.004087639	0	6A	IN-PV	NA	NA	NA
GGTGCGTAGATCCGAG-1_5546_BA9	11.3006588	-23.83007103	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	5604	17419	0.001894483	0.00482232	0	L2-3	EN-L2-3-MS	NA	NA	NA
GGTGCGTAGGCCCTTG-1_5546_BA9	20.48086132	-20.06409974	3	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4003	9240	0.00952381	0.006277056	0	3	EN-L5-6	NA	NA	NA
GGTGCGTCACGGTAAG-1_5546_BA9	15.90911485	-17.1031619	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	5530	15286	0.007392385	0.005822321	0	L2-3	EN-L2-3-MS	NA	NA	NA
GGTGTTAAGAAGGTTT-1_5546_BA9	5.862493695	0.41313403	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	912	1245	0.020883534	0.015261044	0	16	EN-PYR	NA	NA	NA
GGTGTTAAGCCAGTAG-1_5546_BA9	10.59173189	-19.95434362	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4468	11232	0.00329416	0.005252849	0	L2-3	EN-L2-3-MS	NA	NA	NA
GGTGTTACATGCTAGT-1_5546_BA9	-29.70448331	-21.82591692	6A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4369	10229	0.036367191	0.014859713	0	6A	IN-PV	NA	NA	NA
GGTGTTAGTTAAAGTG-1_5546_BA9	16.02639404	-10.51483861	12	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2039	3500	0.036285714	0.005428571	0	12	EN-MIX	NA	NA	NA
GTAACGTAGTAGATGT-1_5546_BA9	34.69950685	-13.3061269	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3854	8160	0.00379902	0.019362745	0	2	EN-L4	NA	NA	NA
GTAACGTCAAGCTGAG-1_5546_BA9	-15.47140727	-1.977610826	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2638	4871	0.00554301	0.012523096	0	13A	IN-VIP	NA	NA	NA
GTAACGTCATTCCTCG-1_5546_BA9	29.0325168	-6.479787621	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	6046	19678	0.002896636	0.004573636	0	2	EN-L4	NA	NA	NA
GTAACTGCAGATAATG-1_5546_BA9	-15.47123541	-2.121576213	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2547	4770	0.022222222	0.008176101	0	13A	IN-VIP	NA	NA	NA
GTAACTGCATCTACGA-1_5546_BA9	17.29465875	-16.36830053	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	7068	24653	0.004948688	0.011317081	0	L2-3	EN-L2-3-MS	NA	NA	NA
GTAACTGGTGTGACCC-1_5546_BA9	33.28257293	-10.2352974	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3771	8427	0.005102646	0.00498398	0	2	EN-L4	NA	NA	NA
GTAACTGGTTAAGACA-1_5546_BA9	-19.51823883	-2.12829465	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3732	7651	0.010586851	0.012285976	0	13A	IN-VIP	NA	NA	NA
GTAACTGTCTACTATC-1_5546_BA9	9.416693366	-19.16149896	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4602	11815	0.001777402	0.010495133	0	L2-3	EN-L2-3-MS	NA	NA	NA
GTACGTAAGTTCGCAT-1_5546_BA9	-3.584679358	-6.072953493	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1053	1613	0.005579665	0.007439554	0	13A	IN-VIP	NA	NA	NA
GTACTCCAGAAGATTC-1_5546_BA9	-21.82892098	5.036701458	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	938	1235	0.0048583	0.010526316	0	8	Astrocytes	NA	NA	NA
GTACTCCAGCGATATA-1_5546_BA9	11.30082048	-21.47389076	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4597	11620	0.004561102	0.00404475	0	L2-3	EN-L2-3-MS	NA	NA	NA
GTACTCCAGGCGCTCT-1_5546_BA9	-21.07808497	5.779722296	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1491	2203	0.004993191	0.0154335	0	8	Astrocytes	NA	NA	NA
GTACTCCCACTATCTT-1_5546_BA9	-20.53036613	4.657011097	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	932	1249	0.003202562	0.010408327	0	8	Astrocytes	NA	NA	NA
GTACTCCTCTAACGGT-1_5546_BA9	-20.55816296	4.306622788	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	811	1011	0.00098912	0.008902077	0	8	Astrocytes	NA	NA	NA
GTACTTTAGAGTGACC-1_5546_BA9	-17.15222383	-1.362390953	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3244	6125	0.006857143	0.011102041	0	13A	IN-VIP	NA	NA	NA
GTACTTTAGGAGTAGA-1_5546_BA9	-22.39627268	7.347481136	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1311	1979	0.001515917	0.008084891	0	8	Astrocytes	NA	NA	NA
GTACTTTCAAGCGATG-1_5546_BA9	15.68172882	-17.2810878	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4740	11348	0.005551639	0.007666549	0	L2-3	EN-L2-3-MS	NA	NA	NA
GTACTTTTCAACGGGA-1_5546_BA9	-18.34334865	5.328302598	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	748	1106	0.000904159	0.00994575	0	8	Astrocytes	NA	NA	NA
GTACTTTTCACCGGGT-1_5546_BA9	9.74986925	-19.86581217	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4721	12057	0.002488181	0.008625695	0	L2-3	EN-L2-3-MS	NA	NA	NA
GTAGGCCCATTGTGCA-1_5546_BA9	16.2392412	-17.52173277	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4945	12153	0.007899284	0.005348474	0	L2-3	EN-L2-3-MS	NA	NA	NA
GTAGGCCGTCGCTTTC-1_5546_BA9	33.99960743	-13.81043714	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3814	8351	0.007903245	0.015926236	0	2	EN-L4	NA	NA	NA
GTAGGCCTCCCTAATT-1_5546_BA9	-23.07979758	-18.69532421	6B	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2742	5491	0.004006556	0.018029503	0	6B	IN-SST	NA	NA	NA
GTAGTCAAGAATAGGG-1_5546_BA9	-10.90983647	-4.109972246	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2292	3920	0.004336735	0.013010204	0	13A	IN-VIP	NA	NA	NA
GTAGTCAAGACCACGA-1_5546_BA9	-8.689582639	-37.31316692	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1159	1675	0.057313433	0.020298507	0	16	EN-PYR	NA	NA	NA
GTAGTCAAGGATTCGG-1_5546_BA9	-17.25688058	-14.6610941	6B	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1777	2892	0.005532503	0.007952974	0	6B	IN-SST	NA	NA	NA
GTAGTCACAATGAATG-1_5546_BA9	-12.16576942	-2.088361215	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2438	4356	0.003213958	0.004591368	0	13A	IN-VIP	NA	NA	NA
GTAGTCACACCGAATT-1_5546_BA9	33.54655757	-4.091708817	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3472	8156	0.004046101	0.005149583	0	2	EN-L4	NA	NA	NA
GTAGTCACACGGATAG-1_5546_BA9	-6.048515237	-36.5688933	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	887	1161	0.051679587	0.028423773	0	16	EN-PYR	NA	NA	NA
GTAGTCACAGTAGAGC-1_5546_BA9	-7.872138389	-34.88525874	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	856	1118	0.016994633	0.008944544	0	16	EN-PYR	NA	NA	NA
GTATCTTAGGAATGGA-1_5546_BA9	-22.0611832	5.443401703	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1195	1655	0.004229607	0.008459215	0	8	Astrocytes	NA	NA	NA
GTATCTTCACATCTTT-1_5546_BA9	-14.22716849	-36.80844067	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2169	3827	0.058270186	0.009145545	0	16	EN-PYR	NA	NA	NA
GTATCTTCATGCGCAC-1_5546_BA9	-5.180646452	-34.60395233	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	809	1050	0.075238095	0.013333333	0	16	EN-PYR	NA	NA	NA
GTATCTTGTCTTCTCG-1_5546_BA9	18.19039071	-10.86315168	3	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2852	6354	0.006767391	0.014951212	0	3	EN-L5-6	NA	NA	NA
GTATCTTTCCCAAGAT-1_5546_BA9	23.79469376	-10.88254577	3	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3298	6797	0.002206856	0.008974548	0	3	EN-L5-6	NA	NA	NA
GTATTCTAGTGCCATT-1_5546_BA9	13.33972561	-17.46566112	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	6082	17512	0.003940155	0.009821836	0	L2-3	EN-L2-3-MS	NA	NA	NA
GTATTCTCAGATGGGT-1_5546_BA9	9.465795774	-12.71476397	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2561	4548	0.002198769	0.027924362	0	L2-3	EN-L2-3-MS	NA	NA	NA
GTATTCTTCCATTCTA-1_5546_BA9	29.09029003	-4.759800528	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4295	11797	0.003644994	0.006696618	0	2	EN-L4	NA	NA	NA
GTCAAGTGTCTGGAGA-1_5546_BA9	11.15722051	-25.44274018	10	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4883	12743	0.000470847	0.007141176	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GTCAAGTGTGGGTATG-1_5546_BA9	19.8280919	-19.29184282	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	5205	13605	0.011613377	0.007203234	0	L2-3	EN-L2-3-MS	NA	NA	NA
GTCAAGTGTGGTACAG-1_5546_BA9	-12.94600776	-37.06474168	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1637	2505	0.0499002	0.017165669	0	16	EN-PYR	NA	NA	NA
GTCAAGTGTGGTGTAG-1_5546_BA9	17.09393718	-14.72622789	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	5649	15024	0.014709798	0.007121938	0	L2-3	EN-L2-3-MS	NA	NA	NA
GTCACAAAGTAGCGGT-1_5546_BA9	23.60120146	-16.22000574	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	5441	14679	0.011376797	0.011376797	0	2	EN-L4	NA	NA	NA
GTCACAACACTAAGTC-1_5546_BA9	-20.63294863	4.77112586	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	934	1325	0.003773585	0.010566038	0	8	Astrocytes	NA	NA	NA
GTCACAAGTCCGAACC-1_5546_BA9	34.8172525	-11.6091854	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3500	7518	0.003724395	0.022080341	0	2	EN-L4	NA	NA	NA
GTCACAATCCACGAAT-1_5546_BA9	34.13566161	-13.728314	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4257	9743	0.00882685	0.017243149	0	2	EN-L4	NA	NA	NA
GTCACAATCGCCAGCA-1_5546_BA9	-8.006391876	-35.47936561	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	824	1069	0.027128157	0.014031805	0	16	EN-PYR	NA	NA	NA
GTCACGGCAGACACTT-1_5546_BA9	-21.15947208	4.29540117	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	847	1133	0.001765225	0.007943513	0	8	Astrocytes	NA	NA	NA
GTCACGGCAGACGCCT-1_5546_BA9	-20.24505259	4.418490937	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	885	1158	0.003454231	0.011226252	0	8	Astrocytes	NA	NA	NA
GTCACGGTCACTTACT-1_5546_BA9	8.610255691	-14.30913301	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2916	5787	0.002764818	0.016761707	0	L2-3	EN-L2-3-MS	NA	NA	NA
GTCATTTAGAAGCCCA-1_5546_BA9	17.62975929	-7.454400165	3	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1775	3284	0.009744214	0.005785627	0	3	EN-L5-6	NA	NA	NA
GTCATTTAGGAATTAC-1_5546_BA9	11.59424166	-19.72518916	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4875	13207	0.005603089	0.004391611	0	L2-3	EN-L2-3-MS	NA	NA	NA
GTCATTTCACCGAATT-1_5546_BA9	15.37911958	-17.57263234	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	7072	26404	0.016058173	0.005491592	0	L2-3	EN-L2-3-MS	NA	NA	NA
GTCATTTGTTTGTTGG-1_5546_BA9	-15.00535118	-2.184561086	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2546	4762	0.005039899	0.01049979	0	13A	IN-VIP	NA	NA	NA
GTCATTTTCAACTCTT-1_5546_BA9	-21.61731649	6.0139741	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1172	1598	0.002503129	0.012515645	0	8	Astrocytes	NA	NA	NA
GTCCTCAAGCACAGGT-1_5546_BA9	27.8463057	6.644072041	15BA	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1151	1701	0.002351558	0.019400353	0	15BA	Stromal cells	NA	NA	NA
GTCCTCAAGCACCGTC-1_5546_BA9	-6.267605457	-34.99467939	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	782	1000	0.047	0.015	0	16	EN-PYR	NA	NA	NA
GTCCTCAGTTACGGAG-1_5546_BA9	-24.72426564	-19.34291528	6A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3334	6768	0.009160757	0.00679669	0	6A	IN-PV	NA	NA	NA
GTCGGGTGTCCAACTA-1_5546_BA9	-9.688436345	-37.0200572	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1041	1451	0.013783598	0.013783598	0	16	EN-PYR	NA	NA	NA
GTCGGGTTCCTGCAGG-1_5546_BA9	-21.41133411	5.171015808	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1099	1547	0.003878474	0.005817712	0	8	Astrocytes	NA	NA	NA
GTCGGGTTCCTTCAAT-1_5546_BA9	9.285227523	-19.49665425	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4279	10272	0.00194704	0.010319315	0	L2-3	EN-L2-3-MS	NA	NA	NA
GTCGGGTTCTTCCTTC-1_5546_BA9	-19.21331341	-5.484157094	13B	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3511	7127	0.005752771	0.012487723	0	13B	IN-SV2C	NA	NA	NA
GTCGTAAAGAGAGCTC-1_5546_BA9	-15.46894112	0.562615581	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3757	7811	0.004224811	0.013442581	0	13A	IN-VIP	NA	NA	NA
GTCGTAAGTACCGTAT-1_5546_BA9	-22.12337848	6.384881617	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1286	1828	0.004376368	0.007658643	0	8	Astrocytes	NA	NA	NA
GTCGTAAGTGCCTGTG-1_5546_BA9	-6.229730679	-35.11967116	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	818	1029	0.023323615	0.016520894	0	16	EN-PYR	NA	NA	NA
GTCGTAAGTTCCAACA-1_5546_BA9	-9.719076424	-33.34274345	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1047	1497	0.078824315	0.009352037	0	16	EN-PYR	NA	NA	NA
GTCGTAATCTTTAGTC-1_5546_BA9	-11.60176339	-13.55773889	6B	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1157	1648	0.026092233	0.009101942	0	6B	IN-SST	NA	NA	NA
GTCTCGTCACCAGGCT-1_5546_BA9	-20.94811055	5.932455562	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1084	1678	0.001787843	0.005959476	0	8	Astrocytes	NA	NA	NA
GTCTCGTGTTGTTTGG-1_5546_BA9	11.17790107	-1.674292538	12	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1587	2592	0.002314815	0.020833333	0	12	EN-MIX	NA	NA	NA
GTCTTCGAGGTACTCT-1_5546_BA9	13.54287642	-23.81492933	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	6411	21795	0.002844689	0.005781142	0	L2-3	EN-L2-3-MS	NA	NA	NA
GTCTTCGTCCAGATCA-1_5546_BA9	17.98152291	-15.46774305	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	7972	30143	0.007431244	0.007364894	0	L2-3	EN-L2-3-MS	NA	NA	NA
GTCTTCGTCCGAGCCA-1_5546_BA9	5.75997788	-18.09137361	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3703	8402	0.001071174	0.012616044	0	L2-3	EN-L2-3-MS	NA	NA	NA
GTCTTCGTCTACGAGT-1_5546_BA9	11.17282628	-25.65854306	10	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	7218	27567	0.001342184	0.004498132	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GTCTTCGTCTGAGGGA-1_5546_BA9	18.11349484	-10.87908453	3	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2957	5856	0.005122951	0.007342896	0	3	EN-L5-6	NA	NA	NA
GTGAAGGAGAGACTTA-1_5546_BA9	23.34590725	-16.26852899	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	6706	21634	0.034944994	0.009290931	0	2	EN-L4	NA	NA	NA
GTGAAGGCAAGAGTCG-1_5546_BA9	22.61601174	-22.75764725	3	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4302	10529	0.001234685	0.004748789	0	3	EN-L5-6	NA	NA	NA
GTGAAGGCATGTCCTC-1_5546_BA9	19.79329075	-3.54195187	12	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1399	2044	0.008806262	0.005381605	0	12	EN-MIX	NA	NA	NA
GTGAAGGTCTACTCAT-1_5546_BA9	-12.98806637	-16.25755661	6B	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1156	1734	0.00922722	0.004036909	0	6B	IN-SST	NA	NA	NA
GTGCAGCCACAGATTC-1_5546_BA9	-20.26083269	4.48703358	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	895	1210	0.001652893	0.003305785	0	8	Astrocytes	NA	NA	NA
GTGCAGCGTCGCGAAA-1_5546_BA9	8.59206056	-12.70743251	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2723	4606	0.001519757	0.021493704	0	L2-3	EN-L2-3-MS	NA	NA	NA
GTGCAGCGTGCCTTGG-1_5546_BA9	22.84256124	-21.83876155	3	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	5719	16886	0.002487268	0.006751155	0	3	EN-L5-6	NA	NA	NA
GTGCATAAGGAATCGC-1_5546_BA9	-8.891348284	-4.919823701	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1733	2755	0.005807623	0.008348457	0	13A	IN-VIP	NA	NA	NA
GTGCATAAGTTTAGGA-1_5546_BA9	-29.37521869	-11.61351185	9	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	924	1233	0	0.00486618	0	9	OPC	NA	NA	NA
GTGCATACACACATGT-1_5546_BA9	14.95545777	-20.95849279	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	6716	21863	0.004162283	0.011709281	0	L2-3	EN-L2-3-MS	NA	NA	NA
GTGCATAGTTCGGGCT-1_5546_BA9	5.730537159	0.303562306	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1053	1544	0.011010363	0.009067358	0	16	EN-PYR	NA	NA	NA
GTGCATAGTTCTGAAC-1_5546_BA9	-6.220906168	-36.08001584	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1028	1423	0.063246662	0.018973999	0	16	EN-PYR	NA	NA	NA
GTGCGGTCAATGACCT-1_5546_BA9	-6.24355813	16.11868611	5	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	741	1008	0.00297619	0.008928571	0	oligos	OL-MS-1	NA	NA	NA
GTGCGGTTCTAGAGTC-1_5546_BA9	22.12516546	-22.74448148	3	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3467	7539	0.004642526	0.010080913	0	3	EN-L5-6	NA	NA	NA
GTGCTTCAGATCCTGT-1_5546_BA9	-22.18334731	6.896360148	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1364	1998	0.006006006	0.008008008	0	8	Astrocytes	NA	NA	NA
GTGCTTCCACCATGTA-1_5546_BA9	-22.70639269	6.009395944	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	974	1292	0.00619195	0.007739938	0	8	Astrocytes	NA	NA	NA
GTGCTTCCACTTCGAA-1_5546_BA9	15.49907691	-7.564648126	3	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1952	3867	0.001034394	0.00646496	0	3	EN-L5-6	NA	NA	NA
GTGCTTCGTCCAGTGC-1_5546_BA9	-19.40901999	-3.759045228	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2607	4760	0.009663866	0.015756303	0	13A	IN-VIP	NA	NA	NA
GTGCTTCGTCGAGTTT-1_5546_BA9	33.86781552	-11.74931075	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2645	5113	0.007627616	0.022491688	0	2	EN-L4	NA	NA	NA
GTGCTTCTCTTAACCT-1_5546_BA9	8.977965185	-13.23232305	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2522	4718	0.00402713	0.012293345	0	L2-3	EN-L2-3-MS	NA	NA	NA
GTGGGTCAGTCATCCA-1_5546_BA9	-8.736348088	-10.80343016	6B	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	965	1332	0.057807808	0.009009009	0	6B	IN-SST	NA	NA	NA
GTGGGTCCAAGGTTTC-1_5546_BA9	9.530238558	-19.82358346	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4155	10035	0.001694071	0.004185351	0	L2-3	EN-L2-3-MS	NA	NA	NA
GTGGGTCCAGTTAACC-1_5546_BA9	34.47528768	-11.51724421	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3564	7581	0.003429627	0.010156971	0	2	EN-L4	NA	NA	NA
GTGGGTCTCAGAGCTT-1_5546_BA9	-19.71718853	-4.965517171	13B	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3243	6059	0.010727843	0.009407493	0	13B	IN-SV2C	NA	NA	NA
GTGGGTCTCCATTCTA-1_5546_BA9	8.984419036	-3.376228162	12	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1653	2703	0.013318535	0.010358861	0	12	EN-MIX	NA	NA	NA
GTGTGCGAGCCAGTAG-1_5546_BA9	17.44930919	-9.685316596	3	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1828	3196	0.006257822	0.005944931	0	3	EN-L5-6	NA	NA	NA
GTGTGCGCACATTTCT-1_5546_BA9	9.227334589	-19.63400578	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3835	9237	0.003356068	0.009959944	0	L2-3	EN-L2-3-MS	NA	NA	NA
GTGTGCGCACCAGGCT-1_5546_BA9	-22.35180873	6.258948608	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1043	1436	0.005571031	0.009749304	0	8	Astrocytes	NA	NA	NA
GTGTGCGGTTCGAATC-1_5546_BA9	35.11730749	-5.636557874	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2566	4826	0.000621633	0.01533361	0	2	EN-L4	NA	NA	NA
GTGTGCGTCTGCTGCT-1_5546_BA9	9.323030153	-1.982201254	12	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1458	2161	0.014807959	0.009717723	0	12	EN-MIX	NA	NA	NA
GTGTTAGAGTACATGA-1_5546_BA9	-20.28199236	4.612801045	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	943	1278	0.001564945	0.014084507	0	8	Astrocytes	NA	NA	NA
GTTAAGCCAGGTGGAT-1_5546_BA9	-6.669474138	-35.46932979	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	973	1324	0.067220544	0.01510574	0	16	EN-PYR	NA	NA	NA
GTTAAGCCATGGTCAT-1_5546_BA9	-29.15556692	-22.02321698	6A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4776	11320	0.013250883	0.011572438	0	6A	IN-PV	NA	NA	NA
GTTAAGCGTCCAAGTT-1_5546_BA9	-7.220878965	-37.34779512	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1008	1321	0.039364118	0.018168055	0	16	EN-PYR	NA	NA	NA
GTTACAGCATATACGC-1_5546_BA9	34.36802536	-14.43832828	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4536	11000	0.017090909	0.018454545	0	2	EN-L4	NA	NA	NA
GTTACAGTCAAACGGG-1_5546_BA9	-27.81838	-11.6915456	9	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	960	1453	0.000688231	0.008258775	0	9	OPC	NA	NA	NA
GTTACAGTCCTGTAGA-1_5546_BA9	8.608778232	-12.51030733	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2292	3918	0.005359877	0.008167432	0	L2-3	EN-L2-3-MS	NA	NA	NA
GTTCATTAGAATGTGT-1_5546_BA9	22.49877383	-27.03846684	3	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3047	7170	0.00111576	0.005020921	0	3	EN-L5-6	NA	NA	NA
GTTCATTAGGCGACAT-1_5546_BA9	-17.30629312	-2.118928814	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3299	6766	0.007981082	0.01285841	0	13A	IN-VIP	NA	NA	NA
GTTCATTCAACTGCTA-1_5546_BA9	-13.92137164	-15.19710412	6B	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1412	2232	0.009856631	0.003584229	0	6B	IN-SST	NA	NA	NA
GTTCATTCAATGTAAG-1_5546_BA9	-20.59998195	-27.69215451	6A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3878	10058	0.000397693	0.005070591	0	6A	IN-PV	NA	NA	NA
GTTCATTCAGTACACT-1_5546_BA9	10.42594336	-1.078526933	12	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1452	2371	0.008435259	0.008435259	0	12	EN-MIX	NA	NA	NA
GTTCATTGTGCTAGCC-1_5546_BA9	32.97664414	-9.042577425	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4511	10859	0.006262087	0.009024772	0	2	EN-L4	NA	NA	NA
GTTCATTTCACCGGGT-1_5546_BA9	8.724270515	0.050403318	12	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1330	2390	0.00460251	0.049790795	0	12	EN-MIX	NA	NA	NA
GTTCGGGAGGGTCTCC-1_5546_BA9	30.27344446	-18.46888133	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	5101	13366	0.021173126	0.013167739	0	2	EN-L4	NA	NA	NA
GTTCTCGAGCCAGTTT-1_5546_BA9	12.25713086	-23.90952203	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	6175	20104	0.002735774	0.003780342	0	L2-3	EN-L2-3-MS	NA	NA	NA
GTTCTCGGTTGCCTCT-1_5546_BA9	-20.89222557	4.431041814	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	971	1292	0.013931889	0.003095975	0	8	Astrocytes	NA	NA	NA
GTTCTCGTCCACTCCA-1_5546_BA9	-5.332461704	-36.50786223	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	897	1217	0.0673788	0.023829088	0	16	EN-PYR	NA	NA	NA
GTTCTCGTCCGCGGTA-1_5546_BA9	35.1148315	-11.15976192	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3423	7407	0.001080059	0.024571351	0	2	EN-L4	NA	NA	NA
GTTTCTAAGCTGCCCA-1_5546_BA9	-19.57567353	-5.366718064	13B	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3804	8583	0.009204241	0.007689619	0	13B	IN-SV2C	NA	NA	NA
GTTTCTACAAGCTGAG-1_5546_BA9	12.96960797	-19.41686856	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	6025	18392	0.003479774	0.00554589	0	L2-3	EN-L2-3-MS	NA	NA	NA
GTTTCTAGTATGCTTG-1_5546_BA9	4.382233876	0.452813057	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	845	1265	0.022924901	0.008695652	0	16	EN-PYR	NA	NA	NA
TAAACCGCACGGTGTC-1_5546_BA9	-14.62121759	13.61587067	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2205	3501	0.005427021	0.019994287	0	8	Astrocytes	NA	NA	NA
TAAACCGCACTTCGAA-1_5546_BA9	-11.39993884	-37.23767595	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1255	1757	0.011383039	0.015367103	0	16	EN-PYR	NA	NA	NA
TAAACCGTCGCCAAAT-1_5546_BA9	-9.085808227	-36.38543358	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1011	1412	0.014164306	0.016288952	0	16	EN-PYR	NA	NA	NA
TAAACCGTCGGAAATA-1_5546_BA9	21.94413417	-22.32630132	3	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3145	6568	0.006090134	0.012789281	0	3	EN-L5-6	NA	NA	NA
TAAACCGTCGTCACGG-1_5546_BA9	32.58260923	-12.37448984	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2618	4843	0.014247367	0.01610572	0	2	EN-L4	NA	NA	NA
TAAACCGTCTGCAGTA-1_5546_BA9	-12.91734748	-37.26376917	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1449	2213	0.018978762	0.018075011	0	16	EN-PYR	NA	NA	NA
TAAGAGAAGATATGGT-1_5546_BA9	15.04943651	-21.00163704	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	6149	18572	0.007269007	0.008938187	0	L2-3	EN-L2-3-MS	NA	NA	NA
TAAGAGAAGCACCGTC-1_5546_BA9	29.09619939	-13.62190205	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4779	11203	0.004998661	0.009015442	0	2	EN-L4	NA	NA	NA
TAAGAGAAGCGATAGC-1_5546_BA9	13.74457801	-17.11559312	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	5750	16477	0.007889786	0.006615282	0	L2-3	EN-L2-3-MS	NA	NA	NA
TAAGAGAAGTACGTAA-1_5546_BA9	-15.14108315	-0.101659453	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2646	4631	0.003023105	0.016843014	0	13A	IN-VIP	NA	NA	NA
TAAGAGAGTAGCCTCG-1_5546_BA9	-13.9533906	-5.328547016	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2350	4434	0.00608931	0.00563825	0	13A	IN-VIP	NA	NA	NA
TAAGAGATCTCAAGTG-1_5546_BA9	-14.78825403	-16.31663826	6B	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1637	2803	0.010346058	0.005351409	0	6B	IN-SST	NA	NA	NA
TAAGCGTAGTACTTGC-1_5546_BA9	9.369910838	-1.047315289	12	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1177	1504	0.025930851	0.006648936	0	12	EN-MIX	NA	NA	NA
TAAGCGTCAAGCCTAT-1_5546_BA9	-22.7061121	5.51966036	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	917	1271	0.003147128	0.006294256	0	8	Astrocytes	NA	NA	NA
TAAGCGTGTGTTTGTG-1_5546_BA9	-20.01324733	4.223369289	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	745	1000	0.002	0.006	0	8	Astrocytes	NA	NA	NA
TAAGTGCAGGCAGGTT-1_5546_BA9	-17.38736742	-2.660502916	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2708	4868	0.006778965	0.008627773	0	13A	IN-VIP	NA	NA	NA
TAAGTGCAGGGCTCTC-1_5546_BA9	-26.52376827	-10.92613703	9	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1004	1347	0.001484781	0.008166295	0	9	OPC	NA	NA	NA
TAAGTGCCAGGTGCCT-1_5546_BA9	-14.63933243	-37.5450749	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1947	3260	0.038650307	0.015030675	0	16	EN-PYR	NA	NA	NA
TAAGTGCGTACAAGTA-1_5546_BA9	10.83716287	-13.28026621	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3292	6841	0.002777372	0.027481362	0	L2-3	EN-L2-3-MS	NA	NA	NA
TAAGTGCGTAGCTAAA-1_5546_BA9	29.06302915	-17.85547217	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	6707	21883	0.026139012	0.009962071	0	2	EN-L4	NA	NA	NA
TAAGTGCTCGCTTAGA-1_5546_BA9	-20.29757439	4.445370766	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	976	1327	0.004521477	0.006028636	0	8	Astrocytes	NA	NA	NA
TACACGAAGTTTGCGT-1_5546_BA9	-29.37364285	-22.00788207	6A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	5188	13513	0.035151336	0.008436321	0	6A	IN-PV	NA	NA	NA
TACACGACAAGTAGTA-1_5546_BA9	-13.8495504	-15.82533728	6B	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1399	2283	0.016206746	0.007884363	0	6B	IN-SST	NA	NA	NA
TACACGACAGCTGCTG-1_5546_BA9	-20.44885114	4.174656057	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1102	1426	0.011921459	0.012622721	0	8	Astrocytes	NA	NA	NA
TACACGATCTTATCTG-1_5546_BA9	-15.36681848	-5.698712284	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4738	13913	0.007475023	0.006612521	0	13A	IN-VIP	NA	NA	NA
TACAGTGAGGACAGCT-1_5546_BA9	27.96506216	7.599154195	15A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1009	1449	0.039337474	0.033126294	0	15A	Endo cells	NA	NA	NA
TACAGTGAGTGTTTGC-1_5546_BA9	27.24034736	-18.05085309	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4345	10189	0.018843851	0.013544018	0	2	EN-L4	NA	NA	NA
TACAGTGCAGACGCTC-1_5546_BA9	5.389537414	-13.296865	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2656	5479	0.005292937	0.004197846	0	L2-3	EN-L2-3-MS	NA	NA	NA
TACAGTGCATCAGTCA-1_5546_BA9	-19.00481129	-1.66830697	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4514	10085	0.006246901	0.011403074	0	13A	IN-VIP	NA	NA	NA
TACAGTGGTTCACGGC-1_5546_BA9	-27.78738172	-11.05392118	9	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1058	1579	0.010132996	0.008233059	0	9	OPC	NA	NA	NA
TACAGTGTCGCCAAAT-1_5546_BA9	-20.24078571	4.937401872	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1007	1370	0.005839416	0.013138686	0	8	Astrocytes	NA	NA	NA
TACAGTGTCTCTAAGG-1_5546_BA9	12.63049373	-24.2667937	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	6168	18778	0.001171584	0.015869635	0	L2-3	EN-L2-3-MS	NA	NA	NA
TACCTATAGTAGTGCG-1_5546_BA9	29.93617987	-18.13454189	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	6543	20277	0.014844405	0.011638803	0	2	EN-L4	NA	NA	NA
TACCTATAGTGCTGCC-1_5546_BA9	-10.75290349	-35.45063408	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1109	1745	0.102005731	0.01260745	0	16	EN-PYR	NA	NA	NA
TACCTTACAATGGAGC-1_5546_BA9	23.61218676	-10.94869602	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3105	6741	0.002373535	0.008752411	0	2	EN-L4	NA	NA	NA
TACCTTACACGGTTTA-1_5546_BA9	19.9111418	-18.08275669	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4630	12005	0.007580175	0.008413161	0	L2-3	EN-L2-3-MS	NA	NA	NA
TACGGATAGGTGCACA-1_5546_BA9	-19.45734182	4.592733462	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	915	1190	0.012605042	0.01092437	0	8	Astrocytes	NA	NA	NA
TACGGATCACATCCGG-1_5546_BA9	-16.44968269	24.55883436	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1615	2648	0.001510574	0.010574018	0	8	Astrocytes	NA	NA	NA
TACGGATTCTGTCCGT-1_5546_BA9	-23.65655143	5.962519134	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	864	1194	0.001675042	0.004187605	0	8	Astrocytes	NA	NA	NA
TACGGGCAGATGGGTC-1_5546_BA9	16.76538085	-16.55880475	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	6273	18678	0.011189635	0.005675126	0	L2-3	EN-L2-3-MS	NA	NA	NA
TACGGGCTCAATCACG-1_5546_BA9	-26.57487627	-21.59041237	6A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3343	7027	0.026184716	0.005976946	0	6A	IN-PV	NA	NA	NA
TACGGTAAGATAGTCA-1_5546_BA9	-23.30397416	5.602280216	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	832	1090	0.001834862	0.000917431	0	8	Astrocytes	NA	NA	NA
TACGGTAGTCAGAAGC-1_5546_BA9	-7.745488529	-35.1983887	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	901	1225	0.047346939	0.013061224	0	16	EN-PYR	NA	NA	NA
TACTCATAGAACTGTA-1_5546_BA9	-8.574175402	-6.904959693	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1568	2613	0.008036739	0.00612323	0	13A	IN-VIP	NA	NA	NA
TACTCATCAAGCGCTC-1_5546_BA9	14.46458633	-17.38451431	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	5798	16836	0.006949394	0.006711808	0	L2-3	EN-L2-3-MS	NA	NA	NA
TACTCATCACGTCTCT-1_5546_BA9	35.02852024	-6.214597038	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3647	8241	0.00242689	0.004975124	0	2	EN-L4	NA	NA	NA
TACTCATCAGCGTCCA-1_5546_BA9	3.60103172	-20.94150952	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4111	10053	0.001094201	0.004774694	0	L2-3	EN-L2-3-MS	NA	NA	NA
TACTCATCAGGATTGG-1_5546_BA9	-17.67474739	5.561060873	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	831	1051	0.009514748	0.019980971	0	8	Astrocytes	NA	NA	NA
TACTCATGTAGAGGAA-1_5546_BA9	-20.00980997	4.746054176	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	997	1373	0.005098325	0.022578296	0	8	Astrocytes	NA	NA	NA
TACTCGCGTATAGGTA-1_5546_BA9	-28.41717392	-11.84045705	9	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	885	1229	0	0.004882018	0	9	OPC	NA	NA	NA
TACTCGCGTTCCACTC-1_5546_BA9	-30.33187656	-11.86171964	9	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	901	1282	0.002340094	0.007800312	0	9	OPC	NA	NA	NA
TACTTGTCAGATCCAT-1_5546_BA9	3.666948868	-12.91445276	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2222	4280	0.001869159	0.006775701	0	L2-3	EN-L2-3-MS	NA	NA	NA
TACTTGTGTGAGGCTA-1_5546_BA9	-29.03890301	-22.23985532	6A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4756	11555	0.018347036	0.011683254	0	6A	IN-PV	NA	NA	NA
TACTTGTGTGTGGCTC-1_5546_BA9	-29.05251864	-20.96303072	6A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4425	10767	0.019225411	0.010402155	0	6A	IN-PV	NA	NA	NA
TACTTGTTCAACTCTT-1_5546_BA9	-19.29360827	5.151311288	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	772	1018	0.008840864	0.009823183	0	8	Astrocytes	NA	NA	NA
TACTTGTTCACAAACC-1_5546_BA9	-28.74589554	-5.683042982	9	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1218	1779	0.002810568	0.008431703	0	9	OPC	NA	NA	NA
TAGACCAAGCTAGTTC-1_5546_BA9	-9.969194922	-36.83901091	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1121	1661	0.04756171	0.014449127	0	16	EN-PYR	NA	NA	NA
TAGACCACAATAACGA-1_5546_BA9	-22.46240319	7.280428042	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1218	1726	0.00405562	0.00811124	0	8	Astrocytes	NA	NA	NA
TAGACCAGTAATCACC-1_5546_BA9	17.28836941	-15.54793905	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	8989	39312	0.006486569	0.007376882	0	L2-3	EN-L2-3-MS	NA	NA	NA
TAGACCAGTGCGAAAC-1_5546_BA9	-16.47181134	-3.295867856	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2523	4480	0.008705357	0.011160714	0	13A	IN-VIP	NA	NA	NA
TAGACCATCCTGCTTG-1_5546_BA9	-28.8791906	-12.65281856	9	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	817	1099	0.004549591	0.012738854	0	9	OPC	NA	NA	NA
TAGAGCTGTACAGCAG-1_5546_BA9	-15.35100389	-37.46043238	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3290	6635	0.031650339	0.017483044	0	16	EN-PYR	NA	NA	NA
TAGAGCTTCTGCCAGG-1_5546_BA9	16.56865014	-16.52564323	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	6965	23690	0.011988181	0.007133812	0	L2-3	EN-L2-3-MS	NA	NA	NA
TAGCCGGCACGTTGGC-1_5546_BA9	19.71252596	-19.95489492	3	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3977	9629	0.007996677	0.00986603	0	3	EN-L5-6	NA	NA	NA
TAGCCGGGTACAAGTA-1_5546_BA9	-28.29352163	-5.819180193	9	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1059	1559	0.00192431	0.004490058	0	9	OPC	NA	NA	NA
TAGGCATAGAAACGCC-1_5546_BA9	20.20697713	-18.16909488	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4725	11951	0.011714501	0.009538951	0	L2-3	EN-L2-3-MS	NA	NA	NA
TAGGCATAGGAGCGTT-1_5546_BA9	-12.621129	-36.98136333	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1348	2025	0.040493827	0.012345679	0	16	EN-PYR	NA	NA	NA
TAGGCATGTCATCGGC-1_5546_BA9	-20.48950175	4.208545763	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	846	1092	0.001831502	0.009157509	0	8	Astrocytes	NA	NA	NA
TAGGCATTCAGAGCTT-1_5546_BA9	-25.96449765	-10.9334738	9	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1082	1455	0.008247423	0.004810997	0	9	OPC	NA	NA	NA
TAGGCATTCCTCTAGC-1_5546_BA9	-23.02098573	-19.66381748	6A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3646	8449	0.005681146	0.005207717	0	6A	IN-PV	NA	NA	NA
TAGTGGTCATTTGCTT-1_5546_BA9	-28.51771393	-6.271345464	9	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1126	1674	0.002389486	0.01135006	0	9	OPC	NA	NA	NA
TAGTGGTGTATAGGTA-1_5546_BA9	13.310513	-15.59061508	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4652	10793	0.008524043	0.009265265	0	L2-3	EN-L2-3-MS	NA	NA	NA
TAGTGGTGTATTCTCT-1_5546_BA9	-17.1394485	-2.084974539	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3294	6310	0.019175911	0.010618067	0	13A	IN-VIP	NA	NA	NA
TAGTGGTGTCAGTGGA-1_5546_BA9	15.87942308	-17.1950032	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	5398	14660	0.010436562	0.007639836	0	L2-3	EN-L2-3-MS	NA	NA	NA
TAGTGGTTCGCCTGTT-1_5546_BA9	-27.07611962	-11.38622449	9	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1016	1461	0	0.01779603	0	9	OPC	NA	NA	NA
TAGTGGTTCTAACTGG-1_5546_BA9	9.190827133	-3.114731056	12	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1675	2839	0.007044734	0.009862628	0	12	EN-MIX	NA	NA	NA
TAGTTGGCACTTAAGC-1_5546_BA9	14.92019266	-17.63075502	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	7125	25212	0.006663494	0.007179121	0	L2-3	EN-L2-3-MS	NA	NA	NA
TAGTTGGCATGGGAAC-1_5546_BA9	11.76638108	-22.3291714	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4897	13413	0.003802281	0.004547827	0	L2-3	EN-L2-3-MS	NA	NA	NA
TAGTTGGCATTCTTAC-1_5546_BA9	-27.26875753	-21.876572	6A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3932	9535	0.048557944	0.00650236	0	6A	IN-PV	NA	NA	NA
TAGTTGGTCAGCGACC-1_5546_BA9	-9.868007437	-36.53885903	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1159	1651	0.067837674	0.017565112	0	16	EN-PYR	NA	NA	NA
TAGTTGGTCGGCTTGG-1_5546_BA9	27.01346184	7.631798406	15A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1184	1806	0.008305648	0.029346622	0	15A	Endo cells	NA	NA	NA
TAGTTGGTCTTGTCAT-1_5546_BA9	15.00078285	-21.48254336	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	5882	18257	0.007723065	0.005641672	0	L2-3	EN-L2-3-MS	NA	NA	NA
TAGTTGGTCTTTACGT-1_5546_BA9	-20.52351561	5.925028293	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1068	1591	0.001257071	0.008170962	0	8	Astrocytes	NA	NA	NA
TATCAGGAGTGGTAAT-1_5546_BA9	27.94362647	7.326615087	15A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	810	1110	0.010810811	0.042342342	0	15A	Endo cells	NA	NA	NA
TATCAGGAGTTCGCGC-1_5546_BA9	9.075665457	-10.77653286	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2214	3698	0.010275825	0.014872904	0	L2-3	EN-L2-3-MS	NA	NA	NA
TATCAGGGTAGAAGGA-1_5546_BA9	7.103501731	-10.61229539	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1778	2855	0.003502627	0.024868651	0	L2-3	EN-L2-3-MS	NA	NA	NA
TATCAGGGTTCGGCAC-1_5546_BA9	-28.52173575	-21.79295434	6A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3668	8161	0.022178655	0.013233672	0	6A	IN-PV	NA	NA	NA
TATCTCATCTGATACG-1_5546_BA9	11.78328154	-14.93551045	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4113	9699	0.00422724	0.011238272	0	L2-3	EN-L2-3-MS	NA	NA	NA
TATGCCCAGGATGCGT-1_5546_BA9	-6.635727664	-9.224993546	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	815	1061	0.007540057	0.011310085	0	13A	IN-VIP	NA	NA	NA
TATGCCCAGTTGAGTA-1_5546_BA9	-29.8132172	-11.05601232	9	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	992	1426	0.000701262	0.004207574	0	9	OPC	NA	NA	NA
TATGCCCCACGTTGGC-1_5546_BA9	-27.29794216	-11.02275052	9	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1035	1484	0.002021563	0.00606469	0	9	OPC	NA	NA	NA
TATGCCCGTTCGTCTC-1_5546_BA9	10.10291888	-16.08526418	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3996	9437	0.003496874	0.013245735	0	L2-3	EN-L2-3-MS	NA	NA	NA
TATTACCAGAGAACAG-1_5546_BA9	20.1547415	-15.19689541	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4383	9760	0.01670082	0.006967213	0	L2-3	EN-L2-3-MS	NA	NA	NA
TATTACCAGGAGTTGC-1_5546_BA9	-21.98208651	6.456452529	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1589	2311	0.003461705	0.005192557	0	8	Astrocytes	NA	NA	NA
TATTACCTCCGCAGTG-1_5546_BA9	30.43880592	-8.924435664	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	5819	17546	0.003590562	0.007181124	0	2	EN-L4	NA	NA	NA
TATTACCTCTTCAACT-1_5546_BA9	-26.96281356	-22.67261445	6A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4892	13473	0.021598753	0.006531582	0	6A	IN-PV	NA	NA	NA
TCAACGAAGACATAAC-1_5546_BA9	11.28390688	-19.89886146	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	5453	15282	0.003206387	0.004973171	0	L2-3	EN-L2-3-MS	NA	NA	NA
TCAACGAAGAGTGACC-1_5546_BA9	-29.68235694	-21.38495206	6A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4465	11117	0.047135018	0.009894756	0	6A	IN-PV	NA	NA	NA
TCAACGACAACACGCC-1_5546_BA9	4.132740309	-7.642211273	12	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1197	1817	0.00495322	0.009906439	0	12	EN-MIX	NA	NA	NA
TCAACGACACAGCGTC-1_5546_BA9	-27.96424095	-19.10146449	6A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2035	3428	0.021295216	0.013710618	0	6A	IN-PV	NA	NA	NA
TCAACGATCGCACTCT-1_5546_BA9	10.1158864	-16.55614677	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4097	10161	0.003641374	0.008660565	0	L2-3	EN-L2-3-MS	NA	NA	NA
TCAACGATCTGCCAGG-1_5546_BA9	-8.197370633	-34.66430168	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	989	1371	0.080233406	0.006564551	0	16	EN-PYR	NA	NA	NA
TCAATCTAGGAATGGA-1_5546_BA9	-7.520646145	-6.195324293	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1362	2112	0.009943182	0.008522727	0	13A	IN-VIP	NA	NA	NA
TCAATCTAGTTAAGTG-1_5546_BA9	11.59406028	-12.21220739	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3058	5408	0.006286982	0.026072485	0	L2-3	EN-L2-3-MS	NA	NA	NA
TCAATCTGTCGACTGC-1_5546_BA9	-26.66418362	-11.12183969	9	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1345	1870	0.001604278	0.015508021	0	9	OPC	NA	NA	NA
TCAATCTTCACTTATC-1_5546_BA9	-10.48264716	-2.174675583	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2248	4411	0.004760825	0.017683065	0	13A	IN-VIP	NA	NA	NA
TCACAAGAGCGAAGGG-1_5546_BA9	14.58552445	-15.27514641	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4608	11002	0.008180331	0.011088893	0	L2-3	EN-L2-3-MS	NA	NA	NA
TCACAAGGTCAGTGGA-1_5546_BA9	10.01761985	-12.00509616	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2699	4939	0.006074104	0.021664305	0	L2-3	EN-L2-3-MS	NA	NA	NA
TCACAAGGTCCCTTGT-1_5546_BA9	-20.92245829	4.57911958	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	881	1148	0.013066202	0.005226481	0	8	Astrocytes	NA	NA	NA
TCACAAGTCCCATTTA-1_5546_BA9	-24.43121692	-19.34352592	6A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3762	8727	0.015010886	0.008250258	0	6A	IN-PV	NA	NA	NA
TCACGAACATCATCCC-1_5546_BA9	-21.21295936	5.92808064	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1428	2134	0.009840675	0.008903468	0	8	Astrocytes	NA	NA	NA
TCACGAAGTAGAGCTG-1_5546_BA9	22.60304482	-25.71294429	3	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4027	9724	0.00123406	0.007198684	0	3	EN-L5-6	NA	NA	NA
TCACGAAGTCTGGTCG-1_5546_BA9	-29.76880419	-10.50216458	9	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1012	1448	0.003453039	0.005524862	0	9	OPC	NA	NA	NA
TCACGAATCGAATCCA-1_5546_BA9	15.02493353	-17.33262132	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	5512	14552	0.00522265	0.00968939	0	L2-3	EN-L2-3-MS	NA	NA	NA
TCACGAATCTGTCTAT-1_5546_BA9	-16.55915328	-9.250634361	13B	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3022	7265	0.001651755	0.002615279	0	13B	IN-SV2C	NA	NA	NA
TCAGATGCACATCTTT-1_5546_BA9	-26.2361749	-20.57986569	6A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2567	4955	0.010898083	0.007669021	0	6A	IN-PV	NA	NA	NA
TCAGATGCACTGTGTA-1_5546_BA9	-8.335095621	-10.6405474	6B	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	936	1270	0.017322835	0.012598425	0	6B	IN-SST	NA	NA	NA
TCAGATGCATCTACGA-1_5546_BA9	-28.23565869	-11.92270737	9	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	772	1042	0.004798464	0.016314779	0	9	OPC	NA	NA	NA
TCAGATGGTATTACCG-1_5546_BA9	10.36182929	-19.89331134	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4765	12312	0.0041423	0.00462963	0	L2-3	EN-L2-3-MS	NA	NA	NA
TCAGATGTCAGGCAAG-1_5546_BA9	-8.225899081	-35.96516615	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	918	1251	0.050359712	0.024780176	0	16	EN-PYR	NA	NA	NA
TCAGCAAAGAATTCCC-1_5546_BA9	10.32666655	-15.69648685	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4536	11127	0.002606273	0.019322369	0	L2-3	EN-L2-3-MS	NA	NA	NA
TCAGCAAAGAGCTGGT-1_5546_BA9	33.74797181	-18.30540757	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3932	8220	0.014233577	0.013990268	0	2	EN-L4	NA	NA	NA
TCAGCAACAAGCGATG-1_5546_BA9	8.13214411	-10.34212216	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2473	4654	0.003867641	0.013321874	0	L2-3	EN-L2-3-MS	NA	NA	NA
TCAGCAACATGGGACA-1_5546_BA9	-8.140944809	-35.19252838	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	864	1170	0.020512821	0.015384615	0	16	EN-PYR	NA	NA	NA
TCAGCAACATTTCAGG-1_5546_BA9	10.21385079	-13.40131244	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3314	6728	0.003418549	0.021254459	0	L2-3	EN-L2-3-MS	NA	NA	NA
TCAGCAAGTGATGATA-1_5546_BA9	-28.66046991	-11.50473743	9	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	935	1280	0.00703125	0.01015625	0	9	OPC	NA	NA	NA
TCAGCAAGTGCCTTGG-1_5546_BA9	-17.51995771	-1.370928421	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3404	6704	0.008054893	0.013573986	0	13A	IN-VIP	NA	NA	NA
TCAGCAAGTTAAGACA-1_5546_BA9	-12.6021348	-3.939129503	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2461	4505	0.006437292	0.010876804	0	13A	IN-VIP	NA	NA	NA
TCAGCAATCTGCAAGT-1_5546_BA9	-11.8904763	-3.398108955	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2113	3841	0.014319188	0.006769071	0	13A	IN-VIP	NA	NA	NA
TCAGCTCAGATGAGAG-1_5546_BA9	14.99241746	-21.72425666	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4841	11846	0.002448084	0.012662502	0	L2-3	EN-L2-3-MS	NA	NA	NA
TCAGCTCAGCGCCTCA-1_5546_BA9	35.0359349	-6.353189982	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3385	6941	0.000864429	0.006051001	0	2	EN-L4	NA	NA	NA
TCAGCTCAGGTGACCA-1_5546_BA9	33.88985358	-12.54952987	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3504	7075	0.003250883	0.016678445	0	2	EN-L4	NA	NA	NA
TCAGCTCCATGAAGTA-1_5546_BA9	-12.75126017	-36.98651687	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1399	2155	0.03387471	0.014385151	0	16	EN-PYR	NA	NA	NA
TCAGCTCGTGTTAAGA-1_5546_BA9	-19.68298568	4.217986644	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1057	1367	0.002926116	0.010241405	0	8	Astrocytes	NA	NA	NA
TCAGGATAGAAGGACA-1_5546_BA9	-27.07261994	-18.58630557	6B	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3482	7009	0.01041518	0.017691539	0	6B	IN-SST	NA	NA	NA
TCAGGATAGTTCCACA-1_5546_BA9	-10.41442868	-36.32660097	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1313	2021	0.124690747	0.011875309	0	16	EN-PYR	NA	NA	NA
TCAGGATCAGGCTGAA-1_5546_BA9	20.12145232	-19.7404004	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	6451	20899	0.013158524	0.008517154	0	L2-3	EN-L2-3-MS	NA	NA	NA
TCAGGATCATTAGGCT-1_5546_BA9	10.84766449	-13.2671166	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3810	8697	0.003794412	0.030125331	0	L2-3	EN-L2-3-MS	NA	NA	NA
TCAGGATGTTTGGCGC-1_5546_BA9	31.79125257	-11.42777621	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3179	6478	0.011114542	0.008181538	0	2	EN-L4	NA	NA	NA
TCAGGATTCCAGTATG-1_5546_BA9	-10.39309029	-36.56203946	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1194	1676	0.042362768	0.019689737	0	16	EN-PYR	NA	NA	NA
TCAGGTAAGTGAAGTT-1_5546_BA9	-19.35548816	-6.140275725	13B	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3525	7156	0.01509223	0.006428172	0	13B	IN-SV2C	NA	NA	NA
TCAGGTACAAGTTCTG-1_5546_BA9	9.566835782	-13.24284498	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3033	6042	0.006951341	0.012744124	0	L2-3	EN-L2-3-MS	NA	NA	NA
TCAGGTACATATGGTC-1_5546_BA9	12.45509326	-19.07597245	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	5356	15350	0.003322476	0.004885993	0	L2-3	EN-L2-3-MS	NA	NA	NA
TCAGGTACATGGTAGG-1_5546_BA9	-26.93862779	-10.90327471	9	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	902	1239	0.004035513	0.008071025	0	9	OPC	NA	NA	NA
TCAGGTAGTAATAGCA-1_5546_BA9	12.29188023	-23.14078994	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	5145	13700	0.002043796	0.012262774	0	L2-3	EN-L2-3-MS	NA	NA	NA
TCAGGTAGTATAATGG-1_5546_BA9	-19.83926877	-15.74567827	6B	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3105	6272	0.000318878	0.012914541	0	6B	IN-SST	NA	NA	NA
TCAGGTAGTGTCCTCT-1_5546_BA9	33.90881665	-12.85471689	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3589	7986	0.006010518	0.012146256	0	2	EN-L4	NA	NA	NA
TCAGGTATCTACTTAC-1_5546_BA9	-17.93628024	-6.040466117	13B	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2753	4850	0.010721649	0.008659794	0	13B	IN-SV2C	NA	NA	NA
TCATTACAGAATAGGG-1_5546_BA9	-14.89816453	-37.23341837	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2251	4011	0.057840937	0.013462977	0	16	EN-PYR	NA	NA	NA
TCATTACAGATATGCA-1_5546_BA9	-17.37039548	-1.35621428	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3964	9224	0.004878578	0.011383348	0	13A	IN-VIP	NA	NA	NA
TCATTACAGGCTATCT-1_5546_BA9	7.083287378	-1.173072699	12	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1299	2062	0.005819593	0.004364694	0	12	EN-MIX	NA	NA	NA
TCATTACCAAACCCAT-1_5546_BA9	23.96947193	-12.74904736	3	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2982	5646	0.013106624	0.008678711	0	3	EN-L5-6	NA	NA	NA
TCATTACCACCCATGG-1_5546_BA9	-28.36421727	-5.320849049	9	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1331	2041	0.002939735	0.004899559	0	9	OPC	NA	NA	NA
TCATTACTCACATACG-1_5546_BA9	10.06769461	-21.40894509	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	6438	21293	0.002958719	0.004555488	0	L2-3	EN-L2-3-MS	NA	NA	NA
TCATTACTCCGAACGC-1_5546_BA9	9.288753813	-15.96757949	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3456	7476	0.006420546	0.005617978	0	L2-3	EN-L2-3-MS	NA	NA	NA
TCATTTGAGACACTAA-1_5546_BA9	-0.154381787	-10.74059853	12	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1686	3113	0.006745904	0.002248635	0	12	EN-MIX	NA	NA	NA
TCATTTGAGCCCAGCT-1_5546_BA9	-19.85504978	4.679825894	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	797	1128	0.000886525	0.007978723	0	8	Astrocytes	NA	NA	NA
TCCACACAGCCAGTAG-1_5546_BA9	18.72958803	-18.50885576	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4173	10175	0.007960688	0.005503686	0	L2-3	EN-L2-3-MS	NA	NA	NA
TCCACACAGGACAGAA-1_5546_BA9	19.41646471	-14.44287984	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	7786	29970	0.016449783	0.007640974	0	L2-3	EN-L2-3-MS	NA	NA	NA
TCCACACAGTTATCGC-1_5546_BA9	10.27042872	-20.44583002	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4081	10804	0.004165124	0.001943725	0	L2-3	EN-L2-3-MS	NA	NA	NA
TCCACACCACTCAGGC-1_5546_BA9	-18.42747594	-2.114407331	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3951	8584	0.011416589	0.00943616	0	13A	IN-VIP	NA	NA	NA
TCCACACCAGGCTGAA-1_5546_BA9	-11.20681678	-15.09255186	6B	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1133	1730	0.012716763	0.004624277	0	6B	IN-SST	NA	NA	NA
TCCACACCATAAAGGT-1_5546_BA9	-7.296208888	-6.74395924	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1343	1990	0.007537688	0.006030151	0	13A	IN-VIP	NA	NA	NA
TCCCGATAGGTTCCTA-1_5546_BA9	12.59239271	-23.87246613	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	6021	18342	0.003107622	0.014175117	0	L2-3	EN-L2-3-MS	NA	NA	NA
TCCCGATAGTGTTAGA-1_5546_BA9	-21.43344397	4.9261477	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	954	1274	0.010204082	0.006279435	0	8	Astrocytes	NA	NA	NA
TCCCGATTCCTCCTAG-1_5546_BA9	10.67057848	-14.76944212	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3892	8867	0.006653885	0.013082215	0	L2-3	EN-L2-3-MS	NA	NA	NA
TCCCGATTCGAATCCA-1_5546_BA9	-16.83201517	-3.521324102	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2966	6059	0.006436706	0.007592012	0	13A	IN-VIP	NA	NA	NA
TCGAGGCAGAGACTTA-1_5546_BA9	-25.26426657	-20.32803189	6A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4878	11072	0.011831647	0.009031792	0	6A	IN-PV	NA	NA	NA
TCGAGGCAGGAATCGC-1_5546_BA9	8.796307634	-11.18508184	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1994	3113	0.004176036	0.023128815	0	L2-3	EN-L2-3-MS	NA	NA	NA
TCGAGGCGTATTCTCT-1_5546_BA9	-11.2411463	-36.29792786	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1175	1658	0.012665862	0.010856454	0	16	EN-PYR	NA	NA	NA
TCGCGAGAGTCACGCC-1_5546_BA9	12.9139421	-14.82511383	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4074	9108	0.009991217	0.006807202	0	L2-3	EN-L2-3-MS	NA	NA	NA
TCGCGAGCACGGCCAT-1_5546_BA9	29.26744167	7.126626413	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	918	1193	0.025146689	0.03101425	0	16	EN-PYR	NA	NA	NA
TCGCGAGCAGCTGTTA-1_5546_BA9	18.44163092	-10.56292036	3	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2276	4215	0.00688019	0.013997628	0	3	EN-L5-6	NA	NA	NA
TCGCGAGCATCTCCCA-1_5546_BA9	33.82973049	-4.881520624	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3110	6773	0.003395836	0.005758157	0	2	EN-L4	NA	NA	NA
TCGCGAGGTATTCTCT-1_5546_BA9	-9.606314333	-16.82180231	6B	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	911	1407	0.017768301	0.004264392	0	6B	IN-SST	NA	NA	NA
TCGCGAGGTCTAGCGC-1_5546_BA9	33.49614652	-15.63261038	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3576	7042	0.007242261	0.015620562	0	2	EN-L4	NA	NA	NA
TCGCGTTGTCGCTTCT-1_5546_BA9	-14.98529299	-37.51826054	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2264	3929	0.036905065	0.016289132	0	16	EN-PYR	NA	NA	NA
TCGCGTTTCATCTGTT-1_5546_BA9	-16.53500253	24.49438411	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1637	2515	0.003976143	0.009940358	0	8	Astrocytes	NA	NA	NA
TCGCGTTTCTCTTGAT-1_5546_BA9	-6.498328445	-35.83241703	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	745	1000	0.02	0.023	0	16	EN-PYR	NA	NA	NA
TCGGGACCAATAACGA-1_5546_BA9	-13.30777694	-34.99583195	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1556	2378	0.047518923	0.011774601	0	16	EN-PYR	NA	NA	NA
TCGGGACGTGAACCTT-1_5546_BA9	-22.42568858	7.162992379	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1219	1787	0.002238388	0.009513151	0	8	Astrocytes	NA	NA	NA
TCGGGACTCTCTAAGG-1_5546_BA9	-20.95654666	5.05356103	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1177	1580	0.003797468	0.009493671	0	8	Astrocytes	NA	NA	NA
TCGGTAAGTACCCAAT-1_5546_BA9	-6.429298951	-7.913606937	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1003	1457	0.00754976	0.004118051	0	13A	IN-VIP	NA	NA	NA
TCGGTAAGTTCGTCTC-1_5546_BA9	-6.459741598	-7.309322996	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1067	1620	0.003703704	0.003703704	0	13A	IN-VIP	NA	NA	NA
TCGGTAATCCGAATGT-1_5546_BA9	14.38324362	-17.48396357	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	7328	24887	0.006147788	0.006308514	0	L2-3	EN-L2-3-MS	NA	NA	NA
TCGTACCTCAAAGACA-1_5546_BA9	9.490064865	-11.44518908	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2639	4750	0.004210526	0.008	0	L2-3	EN-L2-3-MS	NA	NA	NA
TCGTAGAAGGAACTGC-1_5546_BA9	-19.87701454	4.445695218	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	860	1142	0.008756567	0.006129597	0	8	Astrocytes	NA	NA	NA
TCGTAGACATCGATGT-1_5546_BA9	4.762649424	-2.930203443	12	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	927	1325	0.001509434	0.008301887	0	12	EN-MIX	NA	NA	NA
TCTATTGAGACTGTAA-1_5546_BA9	29.52362519	-3.796409284	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3433	8286	0.000362056	0.006758388	0	2	EN-L4	NA	NA	NA
TCTATTGAGCGGCTTC-1_5546_BA9	28.03320037	6.779557244	15A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	772	1087	0.005519779	0.021159154	0	15A	Endo cells	NA	NA	NA
TCTATTGAGTACGTAA-1_5546_BA9	-27.45790937	-21.69541593	6A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4122	9931	0.038062632	0.005538214	0	6A	IN-PV	NA	NA	NA
TCTATTGCAAGTCTGT-1_5546_BA9	14.86760154	-22.77837437	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	5780	17695	0.003899407	0.005538288	0	L2-3	EN-L2-3-MS	NA	NA	NA
TCTATTGCATGCCTAA-1_5546_BA9	8.492425259	-27.19945845	10	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3723	10496	0.001905488	0.004382622	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TCTATTGGTAAGAGAG-1_5546_BA9	13.00994422	-19.58389332	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	5947	17918	0.006306507	0.006697176	0	L2-3	EN-L2-3-MS	NA	NA	NA
TCTATTGGTCGCGAAA-1_5546_BA9	11.48116305	-14.19724804	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3495	7702	0.006621657	0.01012724	0	L2-3	EN-L2-3-MS	NA	NA	NA
TCTATTGGTTATCACG-1_5546_BA9	11.86676351	-15.70694805	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3809	8516	0.003053077	0.012799436	0	L2-3	EN-L2-3-MS	NA	NA	NA
TCTATTGTCTGCGTAA-1_5546_BA9	-12.9418005	14.92165342	11	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1056	1545	0.003236246	0.005177994	0	11	Glia-MIX	NA	NA	NA
TCTATTGTCTTTCCTC-1_5546_BA9	9.261094829	-4.320750546	12	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2393	4353	0.012175511	0.014243051	0	12	EN-MIX	NA	NA	NA
TCTCATACAATGTTGC-1_5546_BA9	32.78490728	-9.92936393	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4821	13076	0.005429795	0.013306822	0	2	EN-L4	NA	NA	NA
TCTCATACAGACGTAG-1_5546_BA9	-17.29348135	-3.901419744	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2557	4992	0.006410256	0.008814103	0	13A	IN-VIP	NA	NA	NA
TCTCTAAGTGTAATGA-1_5546_BA9	-9.198148912	-4.313276472	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1760	3097	0.002260252	0.006780756	0	13A	IN-VIP	NA	NA	NA
TCTGAGAAGATGTGTA-1_5546_BA9	33.03356415	-15.725296	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3920	8606	0.014408552	0.00697188	0	2	EN-L4	NA	NA	NA
TCTGAGACAATCGGTT-1_5546_BA9	26.39304834	8.447866338	15A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1471	2184	0.008699634	0.031135531	0	15A	Endo cells	NA	NA	NA
TCTGAGACATTAGCCA-1_5546_BA9	21.89931847	-15.59187626	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4819	12386	0.003310189	0.055304376	0	2	EN-L4	NA	NA	NA
TCTGAGATCGGTGTTA-1_5546_BA9	24.13581085	-12.91849729	3	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3079	5924	0.009453072	0.009284267	0	3	EN-L5-6	NA	NA	NA
TCTGGAACAATGGTCT-1_5546_BA9	-27.03818679	-12.1304406	9	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	905	1194	0.000837521	0.031825796	0	9	OPC	NA	NA	NA
TCTGGAATCAACACTG-1_5546_BA9	9.742077595	-16.14447082	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3566	7877	0.005839787	0.008251873	0	L2-3	EN-L2-3-MS	NA	NA	NA
TCTGGAATCATAGCAC-1_5546_BA9	-18.2158619	8.590505092	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	898	1244	0.013665595	0.008842444	0	8	Astrocytes	NA	NA	NA
TCTGGAATCTGATTCT-1_5546_BA9	33.57181177	-16.90904517	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	5020	12925	0.014313346	0.018723404	0	2	EN-L4	NA	NA	NA
TCTTCGGGTCTCAACA-1_5546_BA9	8.968877035	-3.607661737	12	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1669	2651	0.013579781	0.007921539	0	12	EN-MIX	NA	NA	NA
TCTTCGGTCGGTGTCG-1_5546_BA9	-22.84556241	-20.09024807	6A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2802	5683	0.00932606	0.005278902	0	6A	IN-PV	NA	NA	NA
TCTTTCCAGAGCTTCT-1_5546_BA9	19.85413998	-21.01009172	3	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3915	9105	0.007578254	0.0092257	0	3	EN-L5-6	NA	NA	NA
TCTTTCCCATACAGCT-1_5546_BA9	15.38458312	-21.62782073	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4925	13345	0.00659423	0.009366804	0	L2-3	EN-L2-3-MS	NA	NA	NA
TCTTTCCCATTTCACT-1_5546_BA9	-27.21745815	-10.95956059	9	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1024	1496	0.005347594	0.020053476	0	9	OPC	NA	NA	NA
TCTTTCCGTGACCAAG-1_5546_BA9	-6.64819329	-35.37779308	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	845	1046	0.029636711	0.009560229	0	16	EN-PYR	NA	NA	NA
TCTTTCCTCGCGTTTC-1_5546_BA9	10.19914937	-16.17543323	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3665	9004	0.005553088	0.008662817	0	L2-3	EN-L2-3-MS	NA	NA	NA
TCTTTCCTCTTCTGGC-1_5546_BA9	35.92686275	-9.321434355	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3916	9200	0.001086957	0.018043478	0	2	EN-L4	NA	NA	NA
TGAAAGAAGCCCAATT-1_5546_BA9	8.211675267	-14.96528596	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3225	6444	0.004345127	0.010242086	0	L2-3	EN-L2-3-MS	NA	NA	NA
TGAAAGACATGCCTAA-1_5546_BA9	-11.63377247	-27.36138544	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	870	1166	0.075471698	0.012864494	0	16	EN-PYR	NA	NA	NA
TGACAACAGTGGACGT-1_5546_BA9	-7.541514914	-37.64840662	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1038	1364	0.009530792	0.023460411	0	16	EN-PYR	NA	NA	NA
TGACAACCAGTCAGCC-1_5546_BA9	27.56548269	-15.33771561	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	7846	28388	0.010743976	0.009616739	0	2	EN-L4	NA	NA	NA
TGACGGCCAAGCCATT-1_5546_BA9	10.40094605	-13.47361527	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3527	7151	0.001678087	0.023912739	0	L2-3	EN-L2-3-MS	NA	NA	NA
TGACGGCTCCAGTATG-1_5546_BA9	-22.66660539	-24.31264471	6A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2866	5937	0.003200269	0.005389928	0	6A	IN-PV	NA	NA	NA
TGACTAGAGAGGGATA-1_5546_BA9	14.64122231	-17.20857713	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	5867	16322	0.006249234	0.006800637	0	L2-3	EN-L2-3-MS	NA	NA	NA
TGACTAGCAAGGGTCA-1_5546_BA9	6.888402765	-13.73019144	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2301	4081	0.003185494	0.013722127	0	L2-3	EN-L2-3-MS	NA	NA	NA
TGACTAGCAATCTGCA-1_5546_BA9	7.876450391	-3.254113079	12	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1439	1994	0.006519559	0.021564694	0	12	EN-MIX	NA	NA	NA
TGACTTTCACTCGACG-1_5546_BA9	27.73721581	-19.27793156	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3698	7430	0.017092867	0.013862719	0	2	EN-L4	NA	NA	NA
TGACTTTGTCCGTCAG-1_5546_BA9	-11.95400969	-4.848085308	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2054	3537	0.007633588	0.007633588	0	13A	IN-VIP	NA	NA	NA
TGACTTTGTCTAACGT-1_5546_BA9	-15.32624402	-37.45906834	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3099	6169	0.033230669	0.020262603	0	16	EN-PYR	NA	NA	NA
TGACTTTGTTCCATGA-1_5546_BA9	-10.18001422	-36.62604568	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1151	1603	0.016219588	0.013100437	0	16	EN-PYR	NA	NA	NA
TGACTTTTCACATACG-1_5546_BA9	-8.700306848	-35.88997095	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	901	1246	0.019261637	0.012038523	0	16	EN-PYR	NA	NA	NA
TGACTTTTCTCCAGGG-1_5546_BA9	-10.38463123	-36.38931628	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1103	1575	0.026666667	0.01015873	0	16	EN-PYR	NA	NA	NA
TGAGAGGAGTAGATGT-1_5546_BA9	-8.760086411	-6.639486938	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1491	2261	0.008403361	0.013710747	0	13A	IN-VIP	NA	NA	NA
TGAGAGGCAAGTCTAC-1_5546_BA9	-14.18018162	-15.2047026	6B	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1537	2370	0.015611814	0.002109705	0	6B	IN-SST	NA	NA	NA
TGAGAGGCACAAGTAA-1_5546_BA9	18.29411488	-14.88921371	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	6543	19683	0.017731037	0.010415079	0	L2-3	EN-L2-3-MS	NA	NA	NA
TGAGAGGCATATACGC-1_5546_BA9	-14.57071337	-37.54550259	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1986	3317	0.053964426	0.016882725	0	16	EN-PYR	NA	NA	NA
TGAGAGGGTTACGGAG-1_5546_BA9	13.69899844	-14.67055911	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4175	9310	0.010633727	0.006444683	0	L2-3	EN-L2-3-MS	NA	NA	NA
TGAGAGGGTTCACCTC-1_5546_BA9	-28.14995796	-22.24747203	6A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4760	11922	0.016607952	0.011071968	0	6A	IN-PV	NA	NA	NA
TGAGAGGGTTGTTTGG-1_5546_BA9	-11.90689289	-36.56957844	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1323	1930	0.024352332	0.011917098	0	16	EN-PYR	NA	NA	NA
TGAGAGGGTTTGTTGG-1_5546_BA9	28.89530416	-18.04044169	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	8777	39031	0.018728703	0.008429197	0	2	EN-L4	NA	NA	NA
TGAGCATAGTAGGCCA-1_5546_BA9	13.08701816	-19.41023096	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	6743	20903	0.005549443	0.006075683	0	L2-3	EN-L2-3-MS	NA	NA	NA
TGAGCATCAAGCCATT-1_5546_BA9	26.88732954	-13.63391443	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	6092	18639	0.010837491	0.006760019	0	L2-3	EN-L2-3-MS	NA	NA	NA
TGAGCATCACAGCGTC-1_5546_BA9	-8.581013943	-36.35768955	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	990	1394	0.065997131	0.012195122	0	16	EN-PYR	NA	NA	NA
TGAGCATTCGGATGTT-1_5546_BA9	12.4922137	-18.61465336	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	5565	15417	0.004605306	0.005124214	0	L2-3	EN-L2-3-MS	NA	NA	NA
TGAGCATTCTGAGGGA-1_5546_BA9	-10.26970669	-36.61495047	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1141	1611	0.036002483	0.016759777	0	16	EN-PYR	NA	NA	NA
TGAGCCGAGGCATGGT-1_5546_BA9	26.04410103	8.544805022	15A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1729	2845	0.008787346	0.024956063	0	15A	Endo cells	NA	NA	NA
TGAGCCGAGGGAACGG-1_5546_BA9	-16.98398515	-2.991611195	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2496	4368	0.006181319	0.012591575	0	13A	IN-VIP	NA	NA	NA
TGAGCCGCACAGAGGT-1_5546_BA9	-11.80225963	-36.80237003	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1229	1707	0.023432923	0.0152314	0	16	EN-PYR	NA	NA	NA
TGAGCCGCATCACGAT-1_5546_BA9	-21.03888454	5.696076326	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1240	1781	0.004491859	0.003930376	0	8	Astrocytes	NA	NA	NA
TGAGCCGCATCTCGCT-1_5546_BA9	-22.91890179	-25.46934288	6A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3631	8262	0.002420721	0.003873154	0	6A	IN-PV	NA	NA	NA
TGAGCCGGTACATGTC-1_5546_BA9	-12.14761825	-15.7216845	6B	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1147	1713	0.022767075	0.004086398	0	6B	IN-SST	NA	NA	NA
TGAGCCGGTGGTACAG-1_5546_BA9	19.57017307	-20.93683816	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	5456	15758	0.00387105	0.006663282	0	L2-3	EN-L2-3-MS	NA	NA	NA
TGAGCCGGTGTGCCTG-1_5546_BA9	-23.55180085	6.039273482	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	911	1217	0.000821693	0.007395234	0	8	Astrocytes	NA	NA	NA
TGAGGGACACAGGCCT-1_5546_BA9	8.996961488	-4.001996237	12	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1701	2718	0.058130979	0.013612951	0	12	EN-MIX	NA	NA	NA
TGAGGGACATATACCG-1_5546_BA9	7.141370835	-0.559235089	12	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	903	1282	0.010920437	0.020280811	0	12	EN-MIX	NA	NA	NA
TGAGGGATCATTTGGG-1_5546_BA9	10.44499043	-19.91535639	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4668	12133	0.004038572	0.004120992	0	L2-3	EN-L2-3-MS	NA	NA	NA
TGATTTCAGCAGACTG-1_5546_BA9	-6.127696299	-35.22216775	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	863	1063	0.022577611	0.021636877	0	16	EN-PYR	NA	NA	NA
TGATTTCGTGGTCCGT-1_5546_BA9	-5.925832673	-35.15763122	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	819	1022	0.029354207	0.017612524	0	16	EN-PYR	NA	NA	NA
TGATTTCTCAATCTCT-1_5546_BA9	28.87355454	-13.59453801	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	5116	13481	0.006008456	0.008827238	0	2	EN-L4	NA	NA	NA
TGCACCTAGATGTAAC-1_5546_BA9	-6.118570203	-35.3045213	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	817	1049	0.03336511	0.014299333	0	16	EN-PYR	NA	NA	NA
TGCACCTCAATGTAAG-1_5546_BA9	-7.212838586	-35.18904798	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	792	1033	0.025169409	0.014520813	0	16	EN-PYR	NA	NA	NA
TGCACCTTCAGGTAAA-1_5546_BA9	-15.30170122	-37.450316	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2987	5706	0.028040659	0.013845075	0	16	EN-PYR	NA	NA	NA
TGCACCTTCTACCAGA-1_5546_BA9	-23.22966547	-23.8650214	6A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3372	7437	0.004706199	0.008067769	0	6A	IN-PV	NA	NA	NA
TGCCAAAAGTCCCACG-1_5546_BA9	-28.12789089	0.218996852	9	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1705	2791	0.001074884	0.017914726	0	9	OPC	NA	NA	NA
TGCCAAAAGTTGAGTA-1_5546_BA9	-19.80237552	-6.500228725	13B	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4055	8201	0.009511035	0.009389099	0	13B	IN-SV2C	NA	NA	NA
TGCCCATCATTGGTAC-1_5546_BA9	-28.77892853	-6.028929998	9	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1096	1521	0.001972387	0.00591716	0	9	OPC	NA	NA	NA
TGCCCATCATTTGCCC-1_5546_BA9	-12.97891198	7.185769464	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1319	1756	0.031321185	0.014236902	0	16	EN-PYR	NA	NA	NA
TGCCCATGTAGCGATG-1_5546_BA9	-5.361078538	-28.96015348	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	832	1084	0.024907749	0.012915129	0	16	EN-PYR	NA	NA	NA
TGCCCATGTGTAACGG-1_5546_BA9	33.50423164	-10.27918418	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3605	7731	0.003363084	0.016944768	0	2	EN-L4	NA	NA	NA
TGCCCTAGTACCCAAT-1_5546_BA9	33.83400772	-12.43186072	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4127	9642	0.017942336	0.012860402	0	2	EN-L4	NA	NA	NA
TGCCCTAGTCGAATCT-1_5546_BA9	6.960967276	-3.173120067	12	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1431	2302	0.005212858	0.019548219	0	12	EN-MIX	NA	NA	NA
TGCCCTAGTTCGGCAC-1_5546_BA9	-28.19112163	-12.07356033	9	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	799	1159	0.000862813	0.006902502	0	9	OPC	NA	NA	NA
TGCCCTATCTACGAGT-1_5546_BA9	9.935921037	-2.517053303	12	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1546	2242	0.01382694	0.006690455	0	12	EN-MIX	NA	NA	NA
TGCGCAGAGAGCTATA-1_5546_BA9	-20.22770615	4.045147062	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1124	1586	0.015762926	0.007566204	0	8	Astrocytes	NA	NA	NA
TGCGCAGAGGCCGAAT-1_5546_BA9	-30.08712888	-12.58948376	9	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	735	1016	0.000984252	0.00492126	0	9	OPC	NA	NA	NA
TGCGCAGCACCAACCG-1_5546_BA9	-14.88698066	-37.62143854	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2099	3588	0.02006689	0.014492754	0	16	EN-PYR	NA	NA	NA
TGCGCAGCACCATCCT-1_5546_BA9	27.20962307	7.799032565	15A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1173	1842	0.017372421	0.029858849	0	15A	Endo cells	NA	NA	NA
TGCGCAGCATTGCGGC-1_5546_BA9	11.34903192	-13.90260353	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3839	8273	0.002780128	0.023933277	0	L2-3	EN-L2-3-MS	NA	NA	NA
TGCGCAGGTGCTCTTC-1_5546_BA9	-24.10451349	6.016839387	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	749	1056	0.003787879	0.002840909	0	8	Astrocytes	NA	NA	NA
TGCGCAGGTGGCGAAT-1_5546_BA9	-19.62877116	-4.955434305	13B	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3098	5609	0.004991977	0.011410234	0	13B	IN-SV2C	NA	NA	NA
TGCGCAGTCGACAGCC-1_5546_BA9	32.80402762	-16.5839949	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4282	10023	0.004988526	0.016262596	0	2	EN-L4	NA	NA	NA
TGCGGGTAGAAAGTGG-1_5546_BA9	19.31165806	-18.04990924	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3821	7931	0.012987013	0.011726138	0	L2-3	EN-L2-3-MS	NA	NA	NA
TGCGGGTAGCTAACAA-1_5546_BA9	-9.933510501	-8.118371319	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1466	2120	0.005660377	0.007075472	0	13A	IN-VIP	NA	NA	NA
TGCGGGTAGTGAAGTT-1_5546_BA9	-28.04394394	-2.185882599	9	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1779	2958	0.000338066	0.006085193	0	9	OPC	NA	NA	NA
TGCGGGTGTCACACGC-1_5546_BA9	5.490230168	-15.99374549	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3048	6372	0.002981795	0.006120527	0	L2-3	EN-L2-3-MS	NA	NA	NA
TGCGGGTGTCATGCAT-1_5546_BA9	-29.07599251	-11.39360062	9	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	944	1320	0	0.006060606	0	9	OPC	NA	NA	NA
TGCGTGGAGAGGTTAT-1_5546_BA9	-28.93631299	-11.50997261	9	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	920	1321	0.003785011	0.010598032	0	9	OPC	NA	NA	NA
TGCGTGGTCACAATGC-1_5546_BA9	-24.72089681	-19.66401978	6B	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2074	3584	0.010881696	0.023995536	0	6B	IN-SST	NA	NA	NA
TGCGTGGTCATGGTCA-1_5546_BA9	-28.6841227	-11.3044271	9	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	912	1277	0.003132341	0.004698512	0	9	OPC	NA	NA	NA
TGCTACCCATTTGCTT-1_5546_BA9	-16.70589291	-3.285510145	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2817	5304	0.005090498	0.012254902	0	13A	IN-VIP	NA	NA	NA
TGCTACCGTAACGACG-1_5546_BA9	-9.009072985	-36.13704987	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	954	1367	0.0329188	0.010241405	0	16	EN-PYR	NA	NA	NA
TGCTGCTAGCCGGTAA-1_5546_BA9	10.33467687	-23.51978718	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4699	12232	0.001553303	0.005967953	0	L2-3	EN-L2-3-MS	NA	NA	NA
TGCTGCTCACTGAAGG-1_5546_BA9	-26.93656584	-11.40932245	9	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1086	1480	0.001351351	0.030405405	0	9	OPC	NA	NA	NA
TGCTGCTGTCGGGTCT-1_5546_BA9	-10.57990351	-4.616891031	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1775	2782	0.002875629	0.011502516	0	13A	IN-VIP	NA	NA	NA
TGCTGCTGTTACGGAG-1_5546_BA9	-19.79306751	-5.111674262	13B	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3502	6947	0.008204981	0.010939974	0	13B	IN-SV2C	NA	NA	NA
TGCTGCTGTTATCGGT-1_5546_BA9	35.4454634	-11.55467142	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4213	9740	0.004312115	0.025462012	0	2	EN-L4	NA	NA	NA
TGCTGCTTCTTGTTTG-1_5546_BA9	9.565059373	-15.59121344	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3420	7541	0.003447819	0.017636918	0	L2-3	EN-L2-3-MS	NA	NA	NA
TGGACGCAGAAACCTA-1_5546_BA9	28.04377204	7.691820265	15A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	764	1129	0.003542958	0.038086802	0	15A	Endo cells	NA	NA	NA
TGGACGCAGATGGCGT-1_5546_BA9	5.934961019	-14.40906557	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2837	5456	0.00494868	0.005681818	0	L2-3	EN-L2-3-MS	NA	NA	NA
TGGACGCGTTCGTTGA-1_5546_BA9	6.141690843	0.577634079	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1196	1451	0.017918677	0.009648518	0	16	EN-PYR	NA	NA	NA
TGGCCAGAGAGTAAGG-1_5546_BA9	-11.49954675	-5.035480672	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2082	3487	0.008603384	0.012331517	0	13A	IN-VIP	NA	NA	NA
TGGCCAGAGCCACCTG-1_5546_BA9	34.39009748	-5.561406379	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3066	6100	0.001147541	0.008360656	0	2	EN-L4	NA	NA	NA
TGGCCAGGTTTACTCT-1_5546_BA9	16.68915777	-15.52666235	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	6360	19254	0.011010699	0.00758284	0	L2-3	EN-L2-3-MS	NA	NA	NA
TGGCCAGTCACCTTAT-1_5546_BA9	-20.7749095	4.206025272	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	787	1013	0.001974334	0.010858835	0	8	Astrocytes	NA	NA	NA
TGGCGCATCATGTAGC-1_5546_BA9	-15.3849145	-2.100561546	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2419	4121	0.006309148	0.015287552	0	13A	IN-VIP	NA	NA	NA
TGGCGCATCGCGGATC-1_5546_BA9	25.85301424	8.935930169	15A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1862	3275	0.004885496	0.029618321	0	15A	Endo cells	NA	NA	NA
TGGCTGGAGTAACCCT-1_5546_BA9	21.81716784	-25.141344	3	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	5154	14704	0.00210827	0.011085419	0	3	EN-L5-6	NA	NA	NA
TGGCTGGCACCAGCAC-1_5546_BA9	-27.55819844	-12.54853613	9	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	761	1019	0.009813543	0.014720314	0	9	OPC	NA	NA	NA
TGGGAAGCATCATCCC-1_5546_BA9	-5.133714572	-35.1557969	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	897	1131	0.038903625	0.018567639	0	16	EN-PYR	NA	NA	NA
TGGGAAGCATCTGGTA-1_5546_BA9	-26.28363483	-20.17509668	6A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2350	4265	0.016412661	0.007502931	0	6A	IN-PV	NA	NA	NA
TGGGAAGGTCAGATAA-1_5546_BA9	7.225230618	-10.11811626	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1585	2378	0.007148865	0.022708158	0	L2-3	EN-L2-3-MS	NA	NA	NA
TGGGCGTAGTCCGTAT-1_5546_BA9	14.15001569	-17.42451354	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	8278	31850	0.005054945	0.006028257	0	L2-3	EN-L2-3-MS	NA	NA	NA
TGGGCGTTCGCCTGAG-1_5546_BA9	9.30061036	-3.458046278	12	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1455	2269	0.011899515	0.016306743	0	12	EN-MIX	NA	NA	NA
TGGTTAGAGGCAGGTT-1_5546_BA9	7.277204613	-14.86100341	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2971	6387	0.012368874	0.005479881	0	L2-3	EN-L2-3-MS	NA	NA	NA
TGGTTAGCACATCCGG-1_5546_BA9	-17.0786788	-3.383485482	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3126	6217	0.005468876	0.009811806	0	13A	IN-VIP	NA	NA	NA
TGGTTAGGTAAACCTC-1_5546_BA9	-26.90450889	4.991057693	9	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1440	2014	0.004965243	0.004965243	0	9	OPC	NA	NA	NA
TGGTTAGGTTCACGGC-1_5546_BA9	-28.01751914	-5.689662316	9	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1202	1744	0.000573394	0.024082569	0	9	OPC	NA	NA	NA
TGGTTCCCAAGTTGTC-1_5546_BA9	-8.8067476	-36.33665937	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	922	1246	0.009630819	0.016051364	0	16	EN-PYR	NA	NA	NA
TGGTTCCCACGCGAAA-1_5546_BA9	-19.97517594	4.867611983	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	890	1388	0.000720461	0.012247839	0	8	Astrocytes	NA	NA	NA
TGGTTCCGTCATCGGC-1_5546_BA9	-16.73107594	24.94674537	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2289	4050	0.001975309	0.00617284	0	8	Astrocytes	NA	NA	NA
TGGTTCCTCCATGAAC-1_5546_BA9	13.04324682	-17.98821222	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4066	9590	0.006360792	0.003962461	0	L2-3	EN-L2-3-MS	NA	NA	NA
TGGTTCCTCGAATCCA-1_5546_BA9	-13.72431015	-36.78366267	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1714	3008	0.024268617	0.016954787	0	16	EN-PYR	NA	NA	NA
TGTATTCAGGTCGGAT-1_5546_BA9	-10.64442383	-35.9750416	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1130	1582	0.037926675	0.018331226	0	16	EN-PYR	NA	NA	NA
TGTATTCAGTTTCCTT-1_5546_BA9	-27.38987689	-10.12396986	9	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	950	1318	0.006069803	0.006069803	0	9	OPC	NA	NA	NA
TGTATTCTCAACTCTT-1_5546_BA9	-27.38581169	-21.44935545	6A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3740	8085	0.013358071	0.010142239	0	6A	IN-PV	NA	NA	NA
TGTCCCAGTATAAACG-1_5546_BA9	-18.37882236	-4.889976871	13B	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2495	4459	0.009194887	0.007625028	0	13B	IN-SV2C	NA	NA	NA
TGTCCCAGTGAGGCTA-1_5546_BA9	8.580063388	-14.9448152	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2977	5806	0.003272477	0.012400965	0	L2-3	EN-L2-3-MS	NA	NA	NA
TGTCCCATCGCCGTGA-1_5546_BA9	-24.38878032	-20.04351851	6A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2935	5670	0.025749559	0.00670194	0	6A	IN-PV	NA	NA	NA
TGTGGTAAGAGGTTAT-1_5546_BA9	-12.94010054	7.159448011	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1402	1880	0.018617021	0.007978723	0	16	EN-PYR	NA	NA	NA
TGTGGTATCAAGGTAA-1_5546_BA9	10.11526724	-23.43764788	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4317	10764	0.001858045	0.004459309	0	L2-3	EN-L2-3-MS	NA	NA	NA
TGTGTTTAGCGTAGTG-1_5546_BA9	9.637121313	-2.761415732	12	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1756	2847	0.006673692	0.008429926	0	12	EN-MIX	NA	NA	NA
TGTTCCGAGCTGCGAA-1_5546_BA9	17.14294487	-16.86845136	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	8029	30966	0.009235936	0.007750436	0	L2-3	EN-L2-3-MS	NA	NA	NA
TGTTCCGAGTGCTGCC-1_5546_BA9	-18.12602176	-14.16207944	6B	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2070	3508	0.011972634	0.0168187	0	6B	IN-SST	NA	NA	NA
TGTTCCGAGTGGTAAT-1_5546_BA9	15.51813127	-13.34640938	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	5609	15204	0.008155748	0.018153118	0	L2-3	EN-L2-3-MS	NA	NA	NA
TGTTCCGAGTTAACGA-1_5546_BA9	-21.89194537	5.49025169	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1129	1559	0.002565747	0.007055805	0	8	Astrocytes	NA	NA	NA
TGTTCCGCACACAGAG-1_5546_BA9	-25.98057631	-10.75480514	9	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1103	1555	0.005787781	0.008360129	0	9	OPC	NA	NA	NA
TTAACTCCAAGTACCT-1_5546_BA9	14.97260615	-17.45138679	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	6133	18754	0.008744801	0.00570545	0	L2-3	EN-L2-3-MS	NA	NA	NA
TTAACTCCACCTCGTT-1_5546_BA9	-15.41678976	-37.38867367	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4250	11045	0.077138977	0.012222725	0	16	EN-PYR	NA	NA	NA
TTAGGACAGAGTAATC-1_5546_BA9	-18.34626951	-1.17761069	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3135	5584	0.00519341	0.02023639	0	13A	IN-VIP	NA	NA	NA
TTAGGACCACTCTGTC-1_5546_BA9	13.6652614	-16.82486522	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	5619	15053	0.005115259	0.008968312	0	L2-3	EN-L2-3-MS	NA	NA	NA
TTAGGACGTCCTCCAT-1_5546_BA9	10.46487029	-19.22595942	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4312	11333	0.003264802	0.013853349	0	L2-3	EN-L2-3-MS	NA	NA	NA
TTAGGACGTTCAGACT-1_5546_BA9	10.59425759	-23.65877779	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4630	12500	0.00192	0.00736	0	L2-3	EN-L2-3-MS	NA	NA	NA
TTAGGACTCGGTCTAA-1_5546_BA9	-27.3321353	-20.35895123	6A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2794	5264	0.009878419	0.008928571	0	6A	IN-PV	NA	NA	NA
TTAGGCAAGTGCGATG-1_5546_BA9	10.79198793	-2.329807167	12	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1627	2481	0.008061266	0.018943974	0	12	EN-MIX	NA	NA	NA
TTAGGCACAGATGGGT-1_5546_BA9	9.73913196	-12.24681939	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2474	4319	0.002083816	0.032646446	0	L2-3	EN-L2-3-MS	NA	NA	NA
TTAGGCACATGTCGAT-1_5546_BA9	-13.38968156	-36.69989711	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1593	2387	0.028487641	0.013824885	0	16	EN-PYR	NA	NA	NA
TTAGGCAGTAGCCTCG-1_5546_BA9	3.153829439	-2.830008406	12	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	795	1100	0.002727273	0.000909091	0	12	EN-MIX	NA	NA	NA
TTAGGCATCGGGAGTA-1_5546_BA9	23.28363671	-16.12620466	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	6597	19813	0.014535911	0.013021753	0	2	EN-L4	NA	NA	NA
TTAGTTCCAAACCCAT-1_5546_BA9	-15.76669194	-3.828663275	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2738	5463	0.005125389	0.007138935	0	13A	IN-VIP	NA	NA	NA
TTAGTTCGTATCGCAT-1_5546_BA9	-28.27914103	-22.29003405	6A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4652	11454	0.014230836	0.009167103	0	6A	IN-PV	NA	NA	NA
TTAGTTCTCGCAAACT-1_5546_BA9	-14.80009025	-37.65341777	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2165	3637	0.012922739	0.014847402	0	16	EN-PYR	NA	NA	NA
TTAGTTCTCGGAAATA-1_5546_BA9	29.12338389	-18.76484622	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	8899	39811	0.026274145	0.012986361	0	2	EN-L4	NA	NA	NA
TTATGCTGTAAATGAC-1_5546_BA9	28.75506692	-18.10399608	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	9665	51428	0.014739053	0.008905655	0	2	EN-L4	NA	NA	NA
TTATGCTTCATGTGGT-1_5546_BA9	-29.32514334	-21.69585154	6A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4881	12704	0.032981738	0.00865869	0	6A	IN-PV	NA	NA	NA
TTATGCTTCCGTACAA-1_5546_BA9	2.477674383	-19.04458688	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3386	7716	0.004147227	0.003758424	0	L2-3	EN-L2-3-MS	NA	NA	NA
TTATGCTTCGCAAGCC-1_5546_BA9	-20.00934804	4.484719226	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	854	1143	0.005249344	0.006124234	0	8	Astrocytes	NA	NA	NA
TTCGAAGGTCTTGTCC-1_5546_BA9	-27.34354182	-12.49053011	9	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	865	1136	0.002640845	0.021126761	0	9	OPC	NA	NA	NA
TTCGAAGTCATTGCGA-1_5546_BA9	11.20403892	-16.65621686	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3974	9085	0.00429279	0.01210787	0	L2-3	EN-L2-3-MS	NA	NA	NA
TTCGAAGTCTGTCTAT-1_5546_BA9	-17.63993806	-2.131526908	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3201	5991	0.005508262	0.010849608	0	13A	IN-VIP	NA	NA	NA
TTCGAAGTCTTGTATC-1_5546_BA9	-27.15889413	-11.34773295	9	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	869	1176	0	0.005102041	0	9	OPC	NA	NA	NA
TTCGGTCCAAGAGTCG-1_5546_BA9	20.67252274	-12.3565756	3	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2654	4981	0.019474001	0.011041959	0	3	EN-L5-6	NA	NA	NA
TTCGGTCGTCTCACCT-1_5546_BA9	-21.69012757	4.486122417	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	958	1351	0.001480385	0.007401925	0	8	Astrocytes	NA	NA	NA
TTCTACAAGCAGACTG-1_5546_BA9	9.334502652	-12.85567724	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2488	4641	0.005602241	0.020900668	0	L2-3	EN-L2-3-MS	NA	NA	NA
TTCTACAAGCAGCCTC-1_5546_BA9	10.71300552	-13.54604952	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4125	9173	0.001853265	0.024310476	0	L2-3	EN-L2-3-MS	NA	NA	NA
TTCTACACAATAGAGT-1_5546_BA9	-20.34906645	4.254808686	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	841	1108	0.003610108	0.009025271	0	8	Astrocytes	NA	NA	NA
TTCTACACATCGACGC-1_5546_BA9	5.398242637	-13.09724129	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2227	3878	0.004383703	0.004641568	0	L2-3	EN-L2-3-MS	NA	NA	NA
TTCTACAGTAACGCGA-1_5546_BA9	-22.84910112	5.280616742	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	887	1191	0.003358522	0.012594458	0	8	Astrocytes	NA	NA	NA
TTCTACAGTCAGCTAT-1_5546_BA9	-7.888708329	-38.28948702	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1136	1655	0.03141994	0.014501511	0	16	EN-PYR	NA	NA	NA
TTCTACAGTCGCTTTC-1_5546_BA9	6.243901571	-10.25617814	12	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1747	3160	0.003797468	0.018987342	0	12	EN-MIX	NA	NA	NA
TTCTACAGTGCACTTA-1_5546_BA9	10.86335613	-25.97417569	10	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	6082	21343	0.002717519	0.00323291	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TTCTCAACAGCCAATT-1_5546_BA9	-21.90335556	4.492332942	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	936	1199	0.009174312	0.007506255	0	8	Astrocytes	NA	NA	NA
TTCTCAATCCCTAATT-1_5546_BA9	28.18964569	5.573942778	15BA	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	640	1121	0.000892061	0.020517395	0	15BA	Stromal cells	NA	NA	NA
TTCTCAATCCGTAGGC-1_5546_BA9	-21.65675841	4.53984317	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	957	1319	0.006823351	0.0030326	0	8	Astrocytes	NA	NA	NA
TTCTCAATCTGACCTC-1_5546_BA9	35.7228567	-9.667911292	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3797	9054	0.005191076	0.012812017	0	2	EN-L4	NA	NA	NA
TTCTCCTAGCCGGTAA-1_5546_BA9	8.388399644	-15.92890676	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3457	8106	0.003700962	0.005181347	0	L2-3	EN-L2-3-MS	NA	NA	NA
TTCTCCTCAGGATTGG-1_5546_BA9	34.83494812	-11.50338174	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3749	8489	0.003651785	0.017787725	0	2	EN-L4	NA	NA	NA
TTCTCCTCATTGAGCT-1_5546_BA9	-19.13924325	5.123027938	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	780	1172	0.000853242	0.012798635	0	8	Astrocytes	NA	NA	NA
TTCTCCTTCAAACCAC-1_5546_BA9	32.90386535	4.820428695	14	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1417	1945	0.02159383	0.005655527	0	14	Microglia	NA	NA	NA
TTCTCCTTCCAGAAGG-1_5546_BA9	-21.41791803	5.950747324	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1257	1860	0.001612903	0.010215054	0	8	Astrocytes	NA	NA	NA
TTCTTAGAGGGAAACA-1_5546_BA9	-29.099949	-10.54730678	9	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	942	1368	0	0.027046784	0	9	OPC	NA	NA	NA
TTCTTAGAGTGGAGTC-1_5546_BA9	10.31837499	-19.01824459	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4609	11858	0.003710575	0.006409175	0	L2-3	EN-L2-3-MS	NA	NA	NA
TTCTTAGCATCTCCCA-1_5546_BA9	25.59395471	8.79246715	15A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2028	3814	0.007603566	0.026481384	0	15A	Endo cells	NA	NA	NA
TTCTTAGGTCCTCCAT-1_5546_BA9	-19.59501157	4.695018457	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	889	1208	0.001655629	0.014900662	0	8	Astrocytes	NA	NA	NA
TTCTTAGGTTTCGCTC-1_5546_BA9	29.00915359	-19.01563962	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4637	11884	0.011528105	0.017334231	0	2	EN-L4	NA	NA	NA
TTCTTAGTCAAACGGG-1_5546_BA9	9.702718473	-16.20414978	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3714	8332	0.002760442	0.008041287	0	L2-3	EN-L2-3-MS	NA	NA	NA
TTGAACGAGCCACGCT-1_5546_BA9	12.24510943	-23.78176972	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4802	13143	0.001902153	0.005782546	0	L2-3	EN-L2-3-MS	NA	NA	NA
TTGAACGGTGCTCTTC-1_5546_BA9	-12.55876213	-4.239365876	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2367	4133	0.002661505	0.012823615	0	13A	IN-VIP	NA	NA	NA
TTGACTTAGACAATAC-1_5546_BA9	21.63584926	-15.01895441	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3006	6457	0.007433793	0.030974137	0	L2-3	EN-L2-3-MS	NA	NA	NA
TTGACTTTCTGATTCT-1_5546_BA9	-12.66708427	-36.92953782	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1447	2098	0.03336511	0.013822688	0	16	EN-PYR	NA	NA	NA
TTGCCGTAGGCTACGA-1_5546_BA9	-28.74554775	-11.39559235	9	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	925	1263	0.005542359	0.017418844	0	9	OPC	NA	NA	NA
TTGCCGTCAGTCCTTC-1_5546_BA9	-6.495809327	-34.75617069	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	796	1037	0.028929605	0.013500482	0	16	EN-PYR	NA	NA	NA
TTGCCGTGTTCGTTGA-1_5546_BA9	-13.09651706	-37.18448325	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1588	2410	0.036929461	0.014522822	0	16	EN-PYR	NA	NA	NA
TTGCCGTTCCGTCATC-1_5546_BA9	-17.48700669	-6.338574334	13B	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2704	5215	0.003835091	0.0105465	0	13B	IN-SV2C	NA	NA	NA
TTGCGTCAGAAGCCCA-1_5546_BA9	-7.890177433	-35.08368939	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	886	1150	0.037391304	0.002608696	0	16	EN-PYR	NA	NA	NA
TTGCGTCCAAACCTAC-1_5546_BA9	9.739106204	-16.20275129	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4162	9589	0.003128585	0.009698613	0	L2-3	EN-L2-3-MS	NA	NA	NA
TTGCGTCCACCAACCG-1_5546_BA9	10.75377341	14.08990738	1	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1300	2086	0.002876318	0.013902205	0	oligos	OL-Cntl	NA	NA	NA
TTGCGTCTCTGCTGTC-1_5546_BA9	21.60396454	-1.551120853	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1828	3056	0.003272251	0.011780105	0	2	EN-L4	NA	NA	NA
TTGGAACCAAGAAAGG-1_5546_BA9	9.078186082	-4.244783397	12	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1851	3007	0.02394413	0.013302295	0	12	EN-MIX	NA	NA	NA
TTGGAACCATGGAATA-1_5546_BA9	-27.35927464	-10.17261775	9	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1010	1410	0.00070922	0.009219858	0	9	OPC	NA	NA	NA
TTGGAACGTTGCTCCT-1_5546_BA9	-27.96163785	-5.109719662	9	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1325	2080	0.001923077	0.008653846	0	9	OPC	NA	NA	NA
TTGGAACGTTTACTCT-1_5546_BA9	-28.81223229	-11.35414718	9	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	845	1175	0.003404255	0.006808511	0	9	OPC	NA	NA	NA
TTGGCAATCAGAAATG-1_5546_BA9	33.09587622	-11.92311392	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3329	6449	0.00775314	0.009148705	0	2	EN-L4	NA	NA	NA
TTGGCAATCTCCGGTT-1_5546_BA9	19.49392858	-21.97676958	3	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	5246	15509	0.005609646	0.009607325	0	3	EN-L5-6	NA	NA	NA
TTGTAGGAGATGGCGT-1_5546_BA9	-17.08601166	-1.460728836	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3213	6086	0.008051265	0.01610253	0	13A	IN-VIP	NA	NA	NA
TTGTAGGGTACCATCA-1_5546_BA9	-27.9469571	-6.433861625	9	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1133	1693	0.003544005	0.00472534	0	9	OPC	NA	NA	NA
TTGTAGGGTAGCCTAT-1_5546_BA9	-7.625403358	-35.77271412	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	832	1080	0.015740741	0.016666667	0	16	EN-PYR	NA	NA	NA
TTGTAGGTCAGTTAGC-1_5546_BA9	-23.91618511	8.135741851	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	996	1364	0	0.008064516	0	8	Astrocytes	NA	NA	NA
TTGTAGGTCCAGTAGT-1_5546_BA9	-19.53046268	-2.189696064	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3726	7785	0.030057803	0.010789981	0	13A	IN-VIP	NA	NA	NA
TTTATGCAGACTAGAT-1_5546_BA9	7.670989045	-12.97441067	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2008	3487	0.002581015	0.013478635	0	L2-3	EN-L2-3-MS	NA	NA	NA
TTTATGCCATTAGCCA-1_5546_BA9	12.95593985	0.586922953	12	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	780	1200	0.003333333	0.005833333	0	12	EN-MIX	NA	NA	NA
TTTATGCTCAGTGCAT-1_5546_BA9	-26.90378401	-21.24673232	6A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	3538	8049	0.016523792	0.010684557	0	6A	IN-PV	NA	NA	NA
TTTATGCTCTAACTGG-1_5546_BA9	-5.954018656	-35.25214285	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	869	1081	0.047178538	0.011100833	0	16	EN-PYR	NA	NA	NA
TTTCCTCAGCGGCTTC-1_5546_BA9	-7.993600456	-6.747896027	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1286	1911	0.006279435	0.004709576	0	13A	IN-VIP	NA	NA	NA
TTTCCTCAGCTCCTTC-1_5546_BA9	18.99783843	-14.03225894	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	9195	47532	0.017651267	0.009341075	0	L2-3	EN-L2-3-MS	NA	NA	NA
TTTCCTCAGGGTGTGT-1_5546_BA9	-5.270344346	-36.80848532	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	828	1095	0.068493151	0.023744292	0	16	EN-PYR	NA	NA	NA
TTTCCTCAGGTGACCA-1_5546_BA9	-22.67906473	7.82558869	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1158	1721	0.004067403	0.001743173	0	8	Astrocytes	NA	NA	NA
TTTCCTCCAAGAAAGG-1_5546_BA9	9.481855287	-12.23898227	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2416	4130	0.003874092	0.022760291	0	L2-3	EN-L2-3-MS	NA	NA	NA
TTTCCTCCAGAGCCAA-1_5546_BA9	15.69805676	-25.34136556	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4100	11022	0.002177463	0.005625113	0	L2-3	EN-L2-3-MS	NA	NA	NA
TTTCCTCGTTATCACG-1_5546_BA9	-12.00023387	-16.27807195	6B	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1119	1857	0.038772213	0.007539041	0	6B	IN-SST	NA	NA	NA
TTTCCTCTCCCTCAGT-1_5546_BA9	-23.15426922	9.021145855	8	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1009	1494	0.001338688	0.000669344	0	8	Astrocytes	NA	NA	NA
TTTGCGCTCGACAGCC-1_5546_BA9	-13.11263867	-37.07702955	16	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1669	2599	0.043478261	0.025009619	0	16	EN-PYR	NA	NA	NA
TTTGGTTCATCTGGTA-1_5546_BA9	12.74230275	-19.02420942	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	5476	16136	0.003718394	0.007622707	0	L2-3	EN-L2-3-MS	NA	NA	NA
TTTGGTTGTCTACCTC-1_5546_BA9	-10.1951701	-2.430190765	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2068	3942	0.003297818	0.006849315	0	13A	IN-VIP	NA	NA	NA
TTTGGTTTCCCTAATT-1_5546_BA9	25.56452666	1.344778486	2	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2851	6510	0.001382488	0.004301075	0	2	EN-L4	NA	NA	NA
TTTGGTTTCTCCAGGG-1_5546_BA9	10.93799485	-23.76960844	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4842	13943	0.002797102	0.00372947	0	L2-3	EN-L2-3-MS	NA	NA	NA
TTTGGTTTCTCGTTTA-1_5546_BA9	15.53728742	-14.85215669	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	5722	16657	0.010446059	0.004742751	0	L2-3	EN-L2-3-MS	NA	NA	NA
TTTGTCAAGAAACGAG-1_5546_BA9	8.750578639	-11.24003581	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	2192	3684	0.008957655	0.016829533	0	L2-3	EN-L2-3-MS	NA	NA	NA
TTTGTCAAGCAGGCTA-1_5546_BA9	-7.332208838	-6.128952224	13A	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1319	2074	0.016875603	0.008678881	0	13A	IN-VIP	NA	NA	NA
TTTGTCAAGGACATTA-1_5546_BA9	-26.4901104	-10.73888628	9	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	1034	1457	0.006177076	0.006863418	0	9	OPC	NA	NA	NA
TTTGTCAGTTGGTGGA-1_5546_BA9	12.28557485	-18.08671855	4	5546_BA9	Control	Control	34	female	prefrontal	CAP7	SEQ5	8.3	27	4777	12173	0.003285961	0.006161176	0	L2-3	EN-L2-3-MS	NA	NA	NA
AAACCTGAGAACTCGG-1_1_A4	-33.82710869	-11.16510035	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	871	1284	0.003894081	0.014797508	1	9	OPC	26	7	7
AAACCTGAGAGTAAGG-1_1_A4	-1.966888713	18.336229	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	816	1264	0.002373418	0.016613924	1	oligos	OL-Cntl	26	7	7
AAACCTGAGCTAGCCC-1_1_A4	12.31399354	7.473180702	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1505	2494	0.008420209	0.014434643	1	oligos	OL-Cntl	26	7	7
AAACCTGCAACGATCT-1_1_A4	-34.77262717	-7.357482726	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1183	1993	0.000501756	0.003010537	1	9	OPC	26	7	7
AAACCTGCACCAGATT-1_1_A4	-16.62847013	14.45034912	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1456	2446	0.002452984	0.002861815	1	8	Astrocytes	26	7	7
AAACCTGCAGACGCCT-1_1_A4	-16.54101729	-25.93165974	6A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2294	5263	0.013870416	0.002280068	1	6A	IN-PV	26	7	7
AAACCTGCAGCTGTAT-1_1_A4	3.625941321	18.12038062	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	915	1430	0.012587413	0.009090909	1	oligos	OL-Cntl	26	7	7
AAACCTGGTATGGTTC-1_1_A4	3.109402007	25.55715033	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	775	1157	0.005185825	0.007778738	1	oligos	OL-Cntl	26	7	7
AAACCTGGTTAGAACA-1_1_A4	-36.71345399	-5.905818547	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1135	1921	0.002602811	0.001561687	1	9	OPC	26	7	7
AAACCTGTCTCTTATG-1_1_A4	12.49273957	29.91054228	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	759	1173	0.010230179	0.002557545	1	oligos	OL-Cntl	26	7	7
AAACGGGCATGGTCAT-1_1_A4	11.71637786	15.73761866	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1214	1975	0.012658228	0.007088608	1	oligos	OL-Cntl	26	7	7
AAACGGGGTCACAAGG-1_1_A4	-0.474859668	22.3347021	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	793	1154	0.019064125	0.012998267	1	oligos	OL-Cntl	26	7	7
AAACGGGTCGGACAAG-1_1_A4	5.807204429	24.44655239	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	883	1290	0.020930233	0.006976744	1	oligos	OL-Cntl	26	7	7
AAAGATGAGTCCCACG-1_1_A4	2.988038108	5.409503875	7	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	907	1312	0.004573171	0.006097561	1	7	Phagocytes	26	7	7
AAAGATGCAAACGCGA-1_1_A4	3.11076352	23.38055094	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	813	1200	0.009166667	0.008333333	1	oligos	OL-Cntl	26	7	7
AAAGATGCAATGACCT-1_1_A4	13.49285302	23.68882328	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	832	1233	0.01784266	0.00567721	1	oligos	OL-Cntl	26	7	7
AAAGATGGTAGCGTAG-1_1_A4	17.70246157	6.765985279	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2186	4407	0.019060585	0.007488087	1	oligos	OL-Cntl	26	7	7
AAAGATGGTGCCTGGT-1_1_A4	-23.5316732	0.971414755	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2391	4234	0.004723666	0.004959849	1	9	OPC	26	7	7
AAAGATGGTTTGTTTC-1_1_A4	-4.648759676	-8.004790308	13A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	821	1267	0.043409629	0.002367798	1	13A	IN-VIP	26	7	7
AAAGATGTCAATAAGG-1_1_A4	-7.337124895	-6.359408388	13A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1255	2184	0.026098901	0.003205128	1	13A	IN-VIP	26	7	7
AAAGCAAAGTGTTGAA-1_1_A4	-32.68496553	-12.73769759	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	822	1265	0.006324111	0.002371542	1	9	OPC	26	7	7
AAAGCAACACTACAGT-1_1_A4	17.99226872	12.77528645	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1398	2558	0.004691165	0.002736513	1	oligos	OL-Cntl	26	7	7
AAAGCAAGTTGAGTTC-1_1_A4	0.695963811	29.8651544	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	751	1071	0.012138189	0.008403361	1	oligos	OL-Cntl	26	7	7
AAAGCAAGTTGCGCAC-1_1_A4	-25.36659536	-11.5502062	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1200	1960	0.005612245	0.00255102	1	9	OPC	26	7	7
AAAGCAATCGTCCAGG-1_1_A4	-29.62539474	9.789280885	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	721	1093	0.007319305	0.004574565	1	8	Astrocytes	26	7	7
AAAGTAGAGCTGTTCA-1_1_A4	20.25010982	14.56760199	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1251	2083	0.006721075	0.004800768	1	oligos	OL-Cntl	26	7	7
AAAGTAGAGTCAAGCG-1_1_A4	-3.128016171	21.38460395	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	749	1032	0.022286822	0.015503876	1	oligos	OL-Cntl	26	7	7
AAAGTAGCACCAGGTC-1_1_A4	18.07290711	7.486478612	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2005	3873	0.014459076	0.005163956	1	oligos	OL-Cntl	26	7	7
AAAGTAGCACTATCTT-1_1_A4	-11.47164293	16.09247118	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1421	2398	0.002085071	0.002085071	1	11	Glia-MIX	26	7	7
AAAGTAGCAGCTGGCT-1_1_A4	-21.21426455	9.826552042	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	981	1418	0.003526093	0.002115656	1	8	Astrocytes	26	7	7
AAAGTAGCAGGGTATG-1_1_A4	4.424812968	19.27625893	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	892	1361	0.018368846	0.0095518	1	oligos	OL-Cntl	26	7	7
AAAGTAGGTCCCTTGT-1_1_A4	6.337237909	24.64528631	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	905	1328	0.012801205	0.002259036	1	oligos	OL-Cntl	26	7	7
AAAGTAGGTGAAATCA-1_1_A4	-36.87809276	-6.635160641	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1191	1920	0.0078125	0.003125	1	9	OPC	26	7	7
AAAGTAGGTTCGTTGA-1_1_A4	-0.305702895	23.12105998	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	799	1174	0.015332198	0.009369676	1	oligos	OL-Cntl	26	7	7
AAAGTAGTCCCTGACT-1_1_A4	10.29364084	23.05072469	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	814	1200	0.008333333	0.010833333	1	oligos	OL-Cntl	26	7	7
AAATGCCAGAACTCGG-1_1_A4	-35.79714581	-4.956013119	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1225	2051	0.001950268	0.001950268	1	9	OPC	26	7	7
AAATGCCAGATCGGGT-1_1_A4	-2.457775694	-0.857406991	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	3247	6359	0.009592703	0.01163705	1	11	Glia-MIX	26	7	7
AAATGCCAGGTCATCT-1_1_A4	39.79788037	12.21143748	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	941	1318	0.006069803	0.005311077	1	14	Microglia	26	7	7
AAATGCCAGTACGCCC-1_1_A4	-7.161094817	-3.733797851	13A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1962	3538	0.00254381	0.005652911	1	13A	IN-VIP	26	7	7
AAATGCCAGTGTCTCA-1_1_A4	-9.656472788	18.1142223	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	3367	7237	0.004698079	0.006218046	1	11	Glia-MIX	26	7	7
AAATGCCCAGCTCGCA-1_1_A4	3.229948342	19.74811154	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	867	1284	0.020249221	0.009345794	1	oligos	OL-Cntl	26	7	7
AAATGCCCATACCATG-1_1_A4	15.9813782	15.72741099	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1218	2032	0.006889764	0.005905512	1	oligos	OL-Cntl	26	7	7
AAATGCCGTCTAGTCA-1_1_A4	17.29429218	15.79309238	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1187	1961	0.009688934	0.008159102	1	oligos	OL-Cntl	26	7	7
AAATGCCGTTCGCTAA-1_1_A4	13.87396865	22.43542807	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	993	1609	0.004972032	0.004350528	1	oligos	OL-Cntl	26	7	7
AAATGCCTCGGACAAG-1_1_A4	-1.680979151	23.14714999	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	789	1132	0.006183746	0.006183746	1	oligos	OL-Cntl	26	7	7
AAATGCCTCGTCTGAA-1_1_A4	13.98721695	21.99543335	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	945	1532	0.005874674	0.002610966	1	oligos	OL-Cntl	26	7	7
AAATGCCTCTATCCCG-1_1_A4	13.46669025	16.3405844	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1148	1825	0.004383562	0.009863014	1	oligos	OL-Cntl	26	7	7
AACACGTAGGTCGGAT-1_1_A4	-22.70321061	-1.153246434	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1176	1840	0.016847826	0.008695652	1	9	OPC	26	7	7
AACACGTCAAGCGATG-1_1_A4	16.21189827	14.38441073	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1297	2214	0.003161698	0.004065041	1	oligos	OL-Cntl	26	7	7
AACACGTGTATTAGCC-1_1_A4	11.9102159	17.18735867	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1078	1691	0.010644589	0.008279125	1	oligos	OL-Cntl	26	7	7
AACACGTGTCTGCAAT-1_1_A4	3.358192643	21.57520372	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	816	1299	0.018475751	0.007698229	1	oligos	OL-Cntl	26	7	7
AACACGTGTGACGCCT-1_1_A4	38.61011316	14.35501171	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1129	1645	0.011550152	0.016413374	1	14	Microglia	26	7	7
AACACGTTCCGTAGGC-1_1_A4	17.14314007	10.60216587	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1506	2477	0.006863141	0.005651998	1	oligos	OL-Cntl	26	7	7
AACCATGAGGGTTCCC-1_1_A4	4.276137023	5.441617467	7	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1491	2280	0.017982456	0.009649123	1	7	Phagocytes	26	7	7
AACCATGCAGACAAAT-1_1_A4	3.414348198	5.039042787	7	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1154	1648	0.001213592	0.002427184	1	7	Phagocytes	26	7	7
AACCATGCATCTCGCT-1_1_A4	14.11295617	23.56014698	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	818	1275	0.000784314	0.003137255	1	oligos	OL-Cntl	26	7	7
AACCATGCATTACCTT-1_1_A4	-10.87564515	0.353877686	13A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2653	6587	0.01017155	0.001366328	1	13A	IN-VIP	26	7	7
AACCATGGTCCAGTAT-1_1_A4	-21.77335027	28.54672975	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1813	3600	0.001666667	0.008333333	1	8	Astrocytes	26	7	7
AACCATGGTGGTACAG-1_1_A4	10.38949712	14.89645884	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1079	1703	0.005871991	0.013505578	1	oligos	OL-Cntl	26	7	7
AACCATGTCATCTGCC-1_1_A4	10.94373569	14.51257879	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1131	1783	0.00897364	0.016264722	1	oligos	OL-Cntl	26	7	7
AACCATGTCATTTGGG-1_1_A4	-5.577763328	-10.66701956	6B	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1015	1654	0.004232164	0.00241838	1	6B	IN-SST	26	7	7
AACCGCGAGACCACGA-1_1_A4	0.395903829	24.21360281	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	731	1077	0.002785515	0.010213556	1	oligos	OL-Cntl	26	7	7
AACCGCGAGCCACGTC-1_1_A4	-0.25123892	11.5492535	5	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1051	1598	0.011889862	0.017521902	1	oligos	OL-MS-1	26	7	7
AACCGCGCAGCCTATA-1_1_A4	-32.73998324	-8.069127933	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1071	1717	0.012813046	0.009318579	1	9	OPC	26	7	7
AACCGCGCATGCAACT-1_1_A4	38.86368678	10.65948731	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	910	1271	0.009441385	0.010228167	1	14	Microglia	26	7	7
AACCGCGGTTGCCTCT-1_1_A4	16.4528314	16.19192894	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1122	2035	0.000982801	0.005896806	1	oligos	OL-Cntl	26	7	7
AACCGCGTCAGTCAGT-1_1_A4	18.38178638	8.945417764	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1687	3168	0.006313131	0.007260101	1	oligos	OL-Cntl	26	7	7
AACCGCGTCATTATCC-1_1_A4	-23.92354455	0.847858627	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2361	4377	0.008224812	0.010509481	1	9	OPC	26	7	7
AACCGCGTCCGTCATC-1_1_A4	17.19386693	-0.46202711	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	820	1267	0.000789266	0.001578532	1	12	EN-MIX	26	7	7
AACCGCGTCGAATGGG-1_1_A4	7.018360395	19.35992656	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1067	1710	0.004093567	0.014035088	1	oligos	OL-Cntl	26	7	7
AACGTTGAGATACACA-1_1_A4	-25.48501816	18.00027631	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1308	2414	0.006213753	0.002071251	1	8	Astrocytes	26	7	7
AACGTTGAGCCCGAAA-1_1_A4	-2.136399975	19.20180003	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	788	1175	0.003404255	0.008510638	1	oligos	OL-Cntl	26	7	7
AACGTTGAGGAACTGC-1_1_A4	-4.814695635	-1.363360978	13A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1449	2610	0.048275862	0.003065134	1	13A	IN-VIP	26	7	7
AACGTTGCAAGACGTG-1_1_A4	-10.05626501	23.16622285	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2492	4594	0.001088376	0.008924684	1	8	Astrocytes	26	7	7
AACGTTGCAAGTACCT-1_1_A4	-11.32459369	8.581854377	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	4127	9957	0.00431857	0.006427639	1	11	Glia-MIX	26	7	7
AACGTTGGTCGGATCC-1_1_A4	-15.14372746	-9.547648503	13B	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2446	5175	0.015652174	0.003864734	1	13B	IN-SV2C	26	7	7
AACGTTGGTTACGACT-1_1_A4	4.348845594	5.024905645	7	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1530	2235	0.002684564	0.0098434	1	7	Phagocytes	26	7	7
AACGTTGGTTTGTTGG-1_1_A4	-24.38312848	0.006090526	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2103	3752	0.009328358	0.003997868	1	9	OPC	26	7	7
AACGTTGTCCGCAAGC-1_1_A4	36.44324409	8.186435845	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	752	1003	0.007976072	0.004985045	1	14	Microglia	26	7	7
AACTCAGAGCCACGCT-1_1_A4	3.940488887	20.39461736	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	861	1422	0.021097046	0.008438819	1	oligos	OL-Cntl	26	7	7
AACTCAGCAATGAATG-1_1_A4	-2.071475227	21.95524498	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	755	1141	0.069237511	0.005258545	1	oligos	OL-Cntl	26	7	7
AACTCAGCACAGACTT-1_1_A4	6.105191946	26.36283444	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	869	1303	0.009209517	0.006907137	1	oligos	OL-Cntl	26	7	7
AACTCAGCACAGCGTC-1_1_A4	-29.54019101	13.33000475	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	766	1190	0.001680672	0.002521008	1	8	Astrocytes	26	7	7
AACTCAGCACCTTGTC-1_1_A4	4.669868999	21.10052165	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	962	1558	0.007060334	0.008344031	1	oligos	OL-Cntl	26	7	7
AACTCAGCAGCTGGCT-1_1_A4	13.28209947	1.451823072	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	692	1036	0	0.003861004	1	12	EN-MIX	26	7	7
AACTCAGCATCGACGC-1_1_A4	11.87566256	28.31589752	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	853	1353	0.001478197	0.001478197	1	oligos	OL-Cntl	26	7	7
AACTCAGGTACATCCA-1_1_A4	38.29845656	10.80605066	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	843	1209	0.007444169	0.017369727	1	14	Microglia	26	7	7
AACTCAGGTCGACTGC-1_1_A4	-11.60835071	-22.19016415	6B	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1044	1661	0.012040939	0.007224564	1	6B	IN-SST	26	7	7
AACTCAGGTCTAGGTT-1_1_A4	-4.123387493	-8.039330333	13A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	828	1293	0.034802784	0.003866976	1	13A	IN-VIP	26	7	7
AACTCCCAGAAGGGTA-1_1_A4	4.069369221	14.07085479	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1096	1779	0.01742552	0.012366498	1	oligos	OL-Cntl	26	7	7
AACTCCCCAAGTAGTA-1_1_A4	-34.7428114	-11.64959445	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	860	1320	0.024242424	0.003030303	1	9	OPC	26	7	7
AACTCCCCATGCTAGT-1_1_A4	14.21155125	2.133847202	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	725	1019	0.022571148	0.001962709	1	12	EN-MIX	26	7	7
AACTCTTAGAGTACAT-1_1_A4	39.90093284	11.2783504	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	836	1117	0	0.008057296	1	14	Microglia	26	7	7
AACTCTTAGCGTGAAC-1_1_A4	-2.966801784	21.3402578	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	919	1363	0.021276596	0.014673514	1	oligos	OL-Cntl	26	7	7
AACTCTTCAAAGTGCG-1_1_A4	17.33919119	14.82579891	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1241	2154	0.00185701	0.011606314	1	oligos	OL-Cntl	26	7	7
AACTCTTCAATTCCTT-1_1_A4	3.284053316	19.4541502	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	900	1390	0.008633094	0.010791367	1	oligos	OL-Cntl	26	7	7
AACTCTTCACACTGCG-1_1_A4	10.6707786	21.40214925	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	906	1347	0.005939124	0.005196733	1	oligos	OL-Cntl	26	7	7
AACTCTTCATTGGGCC-1_1_A4	6.070966848	22.43146079	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	772	1179	0.020356234	0.005937235	1	oligos	OL-Cntl	26	7	7
AACTCTTGTCAGAGGT-1_1_A4	2.556568331	23.1153523	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	744	1114	0.007181329	0.009874327	1	oligos	OL-Cntl	26	7	7
AACTCTTTCCGTCATC-1_1_A4	15.28528028	23.56561097	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	944	1515	0	0.00330033	1	oligos	OL-Cntl	26	7	7
AACTGGTCAGCGAACA-1_1_A4	8.551123809	6.618462358	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1864	3248	0.009852217	0.006157635	1	oligos	OL-Cntl	26	7	7
AACTGGTCAGGCTGAA-1_1_A4	-24.70761466	16.85054222	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1326	2261	0.007961079	0.007518797	1	8	Astrocytes	26	7	7
AACTGGTGTACAGTTC-1_1_A4	6.188069789	-5.911004994	10	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1369	2501	0.005197921	0.003198721	1	L2-3	EN-L2-3-Cntl	26	7	7
AACTGGTGTATCTGCA-1_1_A4	5.969111963	5.682167159	7	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	5509	15078	0.009948269	0.010279878	1	7	Phagocytes	26	7	7
AACTGGTGTTCCCTTG-1_1_A4	14.13197131	7.655727867	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1652	2779	0.007196833	0.013673983	1	oligos	OL-Cntl	26	7	7
AACTGGTTCGTCGTTC-1_1_A4	11.59372994	23.62499848	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	835	1247	0.01042502	0.008019246	1	oligos	OL-Cntl	26	7	7
AACTTTCAGACCGGAT-1_1_A4	10.88282	10.64257184	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1511	2585	0.024758221	0.008123791	1	oligos	OL-Cntl	26	7	7
AACTTTCGTCGGGTCT-1_1_A4	-10.70132104	9.626226964	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	4243	10103	0.006928635	0.005542908	1	11	Glia-MIX	26	7	7
AACTTTCGTTCTGGTA-1_1_A4	17.62143709	20.54687058	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	878	1464	0.006147541	0.00136612	1	oligos	OL-Cntl	26	7	7
AACTTTCTCAAACAAG-1_1_A4	4.144469317	5.449695846	7	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1373	2070	0.016425121	0.007729469	1	7	Phagocytes	26	7	7
AACTTTCTCCCAACGG-1_1_A4	-11.26201072	8.856374882	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	4630	11495	0.00861244	0.005915615	1	11	Glia-MIX	26	7	7
AACTTTCTCGGCTTGG-1_1_A4	-9.405806795	-16.69610262	6B	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	878	1468	0.029291553	0.004768392	1	6B	IN-SST	26	7	7
AACTTTCTCTTTACAC-1_1_A4	17.20076081	15.97726216	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1160	2049	0.005368472	0.006344558	1	oligos	OL-Cntl	26	7	7
AAGACCTCATATGAGA-1_1_A4	-26.42767062	23.57920545	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1472	2700	0.005555556	0.008888889	1	8	Astrocytes	26	7	7
AAGACCTCATTCTCAT-1_1_A4	38.20457029	10.29923753	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	806	1092	0.008241758	0.006410256	1	14	Microglia	26	7	7
AAGACCTGTTAAGAAC-1_1_A4	17.42061166	14.55328214	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1162	1921	0.003643935	0.005726184	1	oligos	OL-Cntl	26	7	7
AAGACCTGTTTCCACC-1_1_A4	-10.31937251	18.62657418	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	3461	8552	0.003157156	0.0047942	1	11	Glia-MIX	26	7	7
AAGCCGCAGTGACTCT-1_1_A4	-38.07339431	-8.239463724	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1180	2077	0.003851709	0.002888782	1	9	OPC	26	7	7
AAGCCGCCAAGCTGAG-1_1_A4	5.486904606	16.75715649	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	981	1575	0.015873016	0.012698413	1	oligos	OL-Cntl	26	7	7
AAGCCGCCACTAAGTC-1_1_A4	-4.267120503	26.48572202	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	891	1631	0.001226242	0.004291845	1	oligos	OL-Cntl	26	7	7
AAGCCGCTCAGAGACG-1_1_A4	-2.505078534	1.340954465	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1728	2983	0.008045592	0.004022796	1	11	Glia-MIX	26	7	7
AAGGAGCAGACGACGT-1_1_A4	15.32287142	14.46496355	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1278	2171	0.010133579	0.011976048	1	oligos	OL-Cntl	26	7	7
AAGGAGCAGACGCTTT-1_1_A4	-36.13958489	-8.349014025	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1017	1627	0.007990166	0.004917025	1	9	OPC	26	7	7
AAGGAGCAGACTAGGC-1_1_A4	-0.239249837	23.77358107	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	748	1075	0.008372093	0.013023256	1	oligos	OL-Cntl	26	7	7
AAGGAGCCAAGCTGGA-1_1_A4	-27.19595708	4.485519571	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2317	4243	0.002592505	0.008720245	1	11	Glia-MIX	26	7	7
AAGGAGCGTATCAGTC-1_1_A4	6.399550111	17.11116907	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1064	1649	0.007277138	0.014554275	1	oligos	OL-Cntl	26	7	7
AAGGAGCTCACCAGGC-1_1_A4	8.60674565	-7.575951956	10	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1940	4036	0.005698712	0.00173439	1	L2-3	EN-L2-3-Cntl	26	7	7
AAGGAGCTCATGTAGC-1_1_A4	-2.40293432	19.59538604	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	829	1202	0.022462562	0.004159734	1	oligos	OL-Cntl	26	7	7
AAGGAGCTCGCCATAA-1_1_A4	20.67885735	18.84601619	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1118	1772	0.005643341	0.001693002	1	oligos	OL-Cntl	26	7	7
AAGGAGCTCTACCTGC-1_1_A4	-2.316549079	-1.081439746	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2580	5386	0.013182325	0.002413665	1	11	Glia-MIX	26	7	7
AAGGCAGAGATAGCAT-1_1_A4	36.87025016	10.45571367	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	881	1197	0.007518797	0.022556391	1	14	Microglia	26	7	7
AAGGCAGCAAACGTGG-1_1_A4	6.576828861	6.259242703	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	3695	8320	0.022596154	0.008173077	1	oligos	OL-Cntl	26	7	7
AAGGCAGCACGAAAGC-1_1_A4	-21.9507892	24.97725731	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1744	3263	0.000919399	0.007968127	1	8	Astrocytes	26	7	7
AAGGCAGCAGAAGCAC-1_1_A4	4.847001099	5.3312265	7	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1983	3275	0.003664122	0.010076336	1	7	Phagocytes	26	7	7
AAGGCAGGTAAGTGGC-1_1_A4	-2.123869362	20.00427792	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	839	1211	0.003303055	0.02146986	1	oligos	OL-Cntl	26	7	7
AAGGCAGGTATGGTTC-1_1_A4	15.13585854	-1.141347509	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	772	1220	0.000819672	0.002459016	1	12	EN-MIX	26	7	7
AAGGCAGGTCAGATAA-1_1_A4	25.76497813	3.749528178	15BA	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	858	1305	0.003065134	0.000766284	1	15BA	Stromal cells	26	7	7
AAGGCAGTCTCGAGTA-1_1_A4	-4.01541365	19.79349753	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	734	1128	0.004432624	0.014184397	1	oligos	OL-Cntl	26	7	7
AAGGCAGTCTGGTATG-1_1_A4	2.798591437	25.27101796	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	783	1170	0.017948718	0.004273504	1	oligos	OL-Cntl	26	7	7
AAGGTTCAGTTCGCGC-1_1_A4	-27.93394557	22.80696583	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1100	1847	0.007038441	0.00378993	1	8	Astrocytes	26	7	7
AAGGTTCCAAACTGCT-1_1_A4	21.70593907	15.77068895	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1432	2412	0.009121061	0.008291874	1	oligos	OL-Cntl	26	7	7
AAGGTTCCACAAGCCC-1_1_A4	1.697586269	29.98061817	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	771	1118	0.016994633	0.007155635	1	oligos	OL-Cntl	26	7	7
AAGGTTCGTTCCTCCA-1_1_A4	-34.99360899	1.110316192	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1712	3064	0.002610966	0.004895561	1	9	OPC	26	7	7
AAGGTTCTCAGTTCGA-1_1_A4	-5.06654345	2.592823815	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	3636	8350	0.004071856	0.005628743	1	11	Glia-MIX	26	7	7
AAGTCTGAGCTACCTA-1_1_A4	-2.505096222	1.384904488	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1703	2937	0.005107252	0.002723868	1	11	Glia-MIX	26	7	7
AAGTCTGTCTCCAGGG-1_1_A4	-36.53011036	-5.608030884	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1178	1969	0.012188928	0.00253936	1	9	OPC	26	7	7
AAGTCTGTCTGATACG-1_1_A4	-23.65654276	-2.278095902	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	884	1327	0.006782216	0.002260739	1	9	OPC	26	7	7
AATCCAGAGCGCCTTG-1_1_A4	1.500481939	11.54163182	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	970	1491	0.01676727	0.018779343	1	oligos	OL-Cntl	26	7	7
AATCCAGAGGTGCACA-1_1_A4	6.035854358	6.571902701	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1873	3129	0.007350591	0.007670182	1	oligos	OL-Cntl	26	7	7
AATCCAGCACTGCCAG-1_1_A4	38.5661356	10.43004403	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	844	1151	0.017376195	0.006950478	1	14	Microglia	26	7	7
AATCCAGCAGTTTACG-1_1_A4	14.99058208	27.71627162	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	794	1381	0	0.003620565	1	oligos	OL-Cntl	26	7	7
AATCCAGCATGATCCA-1_1_A4	10.47610064	-19.20582664	4	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	3940	9965	0.011640743	0.00732564	1	L2-3	EN-L2-3-MS	26	7	7
AATCCAGGTGTCCTCT-1_1_A4	-20.22673731	8.274284123	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	874	1241	0.000805802	0.003223207	1	8	Astrocytes	26	7	7
AATCGGTAGACTAGGC-1_1_A4	-0.205867524	23.85333776	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	795	1175	0.029787234	0.008510638	1	oligos	OL-Cntl	26	7	7
AATCGGTAGGCCGAAT-1_1_A4	4.011986214	7.103619272	7	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1477	2264	0.020318021	0.01369258	1	7	Phagocytes	26	7	7
AATCGGTCACTGAAGG-1_1_A4	-9.351516602	-3.599843678	13A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1920	3440	0.024418605	0.008139535	1	13A	IN-VIP	26	7	7
AATCGGTGTAATCACC-1_1_A4	38.63849815	11.63368589	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	948	1285	0.008560311	0.007782101	1	14	Microglia	26	7	7
AATCGGTGTGTCTGAT-1_1_A4	14.84490554	22.52934022	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	881	1306	0.004594181	0.005359877	1	oligos	OL-Cntl	26	7	7
AATCGGTTCTGCGGCA-1_1_A4	10.42964502	16.60615208	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	965	1453	0.008947006	0.018582244	1	oligos	OL-Cntl	26	7	7
ACACCAAAGAAGCCCA-1_1_A4	-23.80867206	26.33320302	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1706	3464	0.005196305	0.004330254	1	8	Astrocytes	26	7	7
ACACCAAAGCAGGCTA-1_1_A4	22.55561322	13.21538456	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1384	2431	0.00370218	0.0061703	1	oligos	OL-Cntl	26	7	7
ACACCAAAGCCACGTC-1_1_A4	14.60353602	15.92717828	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1165	1815	0.01322314	0.012121212	1	oligos	OL-Cntl	26	7	7
ACACCAAAGTACTTGC-1_1_A4	-20.90346728	-24.5949576	6A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2723	6173	0.042118905	0.004373886	1	6A	IN-PV	26	7	7
ACACCAACACGCCAGT-1_1_A4	14.60270002	13.15425091	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1524	2684	0.029806259	0.007451565	1	oligos	OL-Cntl	26	7	7
ACACCAACACGTCAGC-1_1_A4	-29.17741628	20.88922639	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1146	2056	0.006809339	0.003891051	1	8	Astrocytes	26	7	7
ACACCAACATTATCTC-1_1_A4	17.67008126	8.671238473	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1720	3238	0.019456455	0.006794317	1	oligos	OL-Cntl	26	7	7
ACACCAAGTCCGTGAC-1_1_A4	-10.5344504	12.85764257	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	791	1118	0.002683363	0.004472272	1	11	Glia-MIX	26	7	7
ACACCAATCAGAGCTT-1_1_A4	-0.195680336	20.13337494	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	790	1235	0.019433198	0.012955466	1	oligos	OL-Cntl	26	7	7
ACACCAATCTCAAGTG-1_1_A4	14.85315515	14.53744429	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1307	2201	0.014538846	0.015447524	1	oligos	OL-Cntl	26	7	7
ACACCAATCTCCAACC-1_1_A4	-17.34449277	-26.46838428	6A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2518	6204	0.004190845	0.003223727	1	6A	IN-PV	26	7	7
ACACCAATCTTTACAC-1_1_A4	-38.93801926	-0.045754154	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1563	2905	0.001376936	0.003098107	1	9	OPC	26	7	7
ACACCCTAGTTACGGG-1_1_A4	-3.841197833	19.97665533	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	823	1224	0.015522876	0.022875817	1	oligos	OL-Cntl	26	7	7
ACACCCTCAAGCCCAC-1_1_A4	15.70463965	23.39038616	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	897	1465	0	0.004778157	1	oligos	OL-Cntl	26	7	7
ACACCCTCAAGTCATC-1_1_A4	-37.57591134	-1.755131937	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1499	2913	0.004119464	0.004119464	1	9	OPC	26	7	7
ACACCCTCACATTTCT-1_1_A4	-22.53580884	29.29348399	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2245	4990	0.001803607	0.005210421	1	8	Astrocytes	26	7	7
ACACCCTCATTCTCAT-1_1_A4	18.87094285	19.49638194	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1119	1949	0	0.004104669	1	oligos	OL-Cntl	26	7	7
ACACCCTTCCCAAGAT-1_1_A4	2.851737627	21.76352277	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	846	1303	0.017651573	0.006907137	1	oligos	OL-Cntl	26	7	7
ACACCCTTCGAGAACG-1_1_A4	0.365368255	22.33406666	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	871	1284	0.017912773	0.00623053	1	oligos	OL-Cntl	26	7	7
ACACCGGAGAATTCCC-1_1_A4	5.998335181	13.26455358	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1280	2014	0.028798411	0.01142006	1	oligos	OL-Cntl	26	7	7
ACACCGGAGCACCGCT-1_1_A4	-14.0627102	-21.39866925	6A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1537	2956	0.00947226	0.00405954	1	6A	IN-PV	26	7	7
ACACCGGAGCACGCCT-1_1_A4	-32.17863603	-12.90068009	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	765	1149	0.001740644	0.000870322	1	9	OPC	26	7	7
ACACCGGAGCGTGAGT-1_1_A4	14.80153186	20.37359702	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1151	1832	0.003275109	0.008733624	1	oligos	OL-Cntl	26	7	7
ACACCGGAGGATGGAA-1_1_A4	3.25926376	18.53609801	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	957	1481	0.008777853	0.007427414	1	oligos	OL-Cntl	26	7	7
ACACCGGAGTGCTGCC-1_1_A4	-22.8060093	28.07090702	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2036	4080	0.003431373	0.004166667	1	8	Astrocytes	26	7	7
ACACCGGCAATCCAAC-1_1_A4	7.340140306	-6.061786607	10	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1458	2766	0.000361533	0.001807664	1	L2-3	EN-L2-3-Cntl	26	7	7
ACACCGGCACAGCCCA-1_1_A4	4.814364766	12.0991938	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1167	1959	0.012761613	0.019908116	1	oligos	OL-Cntl	26	7	7
ACACCGGGTAATAGCA-1_1_A4	-38.37102527	-3.71371736	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1346	2491	0.006423123	0.003613007	1	9	OPC	26	7	7
ACACCGGTCAGTACGT-1_1_A4	0.418236695	25.79203887	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	803	1184	0.021959459	0.007601351	1	oligos	OL-Cntl	26	7	7
ACACTGAAGAAGGACA-1_1_A4	-9.481434336	15.89746539	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2122	3435	0.005531295	0.008442504	1	11	Glia-MIX	26	7	7
ACACTGAAGACTAAGT-1_1_A4	-23.03967341	-0.216287039	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1779	3054	0.013097577	0.007203667	1	9	OPC	26	7	7
ACACTGAAGATTACCC-1_1_A4	-2.265480644	20.19941153	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	869	1244	0.006430868	0.013665595	1	oligos	OL-Cntl	26	7	7
ACACTGAAGCACGCCT-1_1_A4	35.4885842	10.64299958	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	796	1019	0.018645731	0.02747792	1	14	Microglia	26	7	7
ACACTGACACGGCGTT-1_1_A4	39.1411441	15.02286397	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1241	1840	0.004347826	0.007608696	1	14	Microglia	26	7	7
ACACTGAGTGGCCCTA-1_1_A4	-33.68308262	-8.42664739	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1112	1747	0.006868918	0.005151689	1	9	OPC	26	7	7
ACACTGATCAACACCA-1_1_A4	-3.935247478	14.58052861	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	844	1309	0.039724981	0.018334607	1	oligos	OL-Cntl	26	7	7
ACACTGATCCACGTTC-1_1_A4	5.50966493	20.69548005	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1006	1485	0.005387205	0.007407407	1	oligos	OL-Cntl	26	7	7
ACACTGATCGAATCCA-1_1_A4	-20.60364685	8.51243609	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	816	1252	0.003194888	0.001597444	1	8	Astrocytes	26	7	7
ACAGCCGAGACTACAA-1_1_A4	3.480507855	30.66885193	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	790	1183	0.002535926	0.00591716	1	oligos	OL-Cntl	26	7	7
ACAGCCGAGGACCACA-1_1_A4	2.280692453	21.07986168	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	847	1238	0.015347334	0.010500808	1	oligos	OL-Cntl	26	7	7
ACAGCCGCATAGGATA-1_1_A4	14.68202018	27.21869862	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	832	1328	0	0.006024096	1	oligos	OL-Cntl	26	7	7
ACAGCCGGTAGCGTCC-1_1_A4	-17.40088187	13.20047039	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1271	1968	0.005589431	0.003556911	1	8	Astrocytes	26	7	7
ACAGCCGGTCATCCCT-1_1_A4	-1.756470789	28.42882663	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	685	1022	0.001956947	0.000978474	1	oligos	OL-Cntl	26	7	7
ACAGCCGGTCTGGTCG-1_1_A4	-1.42446649	24.67505094	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	722	1050	0.003809524	0.007619048	1	oligos	OL-Cntl	26	7	7
ACAGCCGGTTAAGTAG-1_1_A4	-4.962093808	2.801140133	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2848	5497	0.006730944	0.005093687	1	11	Glia-MIX	26	7	7
ACAGCCGTCACCACCT-1_1_A4	7.168534735	18.2261999	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1113	1750	0.006285714	0.013714286	1	oligos	OL-Cntl	26	7	7
ACAGCCGTCCCTTGTG-1_1_A4	-9.768575429	17.89113181	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2749	5645	0.012223206	0.00425155	1	11	Glia-MIX	26	7	7
ACAGCTAAGAAACGCC-1_1_A4	-4.92397634	13.23525376	5	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	835	1212	0.00990099	0.018976898	1	oligos	OL-MS-1	26	7	7
ACAGCTACACGGTGTC-1_1_A4	22.77215078	18.5147115	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1126	1724	0.007540603	0.004060325	1	oligos	OL-Cntl	26	7	7
ACAGCTACAGTCGATT-1_1_A4	-23.63090806	25.45912546	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1543	2743	0.00583303	0.002916515	1	8	Astrocytes	26	7	7
ACAGCTACATGGATGG-1_1_A4	7.427059043	22.60134194	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1123	1733	0.008655511	0.007501443	1	oligos	OL-Cntl	26	7	7
ACAGCTAGTGACTACT-1_1_A4	3.700386898	21.73669687	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	799	1191	0.008396306	0.010915197	1	oligos	OL-Cntl	26	7	7
ACAGCTATCAGGCCCA-1_1_A4	11.81059485	11.41317673	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1476	2519	0.007145693	0.014688368	1	oligos	OL-Cntl	26	7	7
ACATACGAGACACTAA-1_1_A4	-21.22888923	18.89648308	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1411	2496	0.003605769	0.006009615	1	8	Astrocytes	26	7	7
ACATACGAGGAATTAC-1_1_A4	3.130714632	16.97690885	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	921	1421	0.004926108	0.014778325	1	oligos	OL-Cntl	26	7	7
ACATACGAGGAGTAGA-1_1_A4	3.953988975	14.11696539	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	957	1495	0.018729097	0.016722408	1	oligos	OL-Cntl	26	7	7
ACATACGCACCACCAG-1_1_A4	18.18112351	12.67183597	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1418	2543	0.007078254	0.008257963	1	oligos	OL-Cntl	26	7	7
ACATACGCACTATCTT-1_1_A4	-25.553898	19.42084271	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1474	2588	0.002704791	0.002318393	1	8	Astrocytes	26	7	7
ACATACGCAGCTTCGG-1_1_A4	-2.054518689	20.33533761	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	687	1005	0.002985075	0.012935323	1	oligos	OL-Cntl	26	7	7
ACATACGGTTGACGTT-1_1_A4	-25.53338972	23.06221525	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1400	2580	0.007364341	0.002325581	1	8	Astrocytes	26	7	7
ACATACGTCATGTCCC-1_1_A4	17.39116893	8.5740888	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1777	3147	0.010168414	0.004448681	1	oligos	OL-Cntl	26	7	7
ACATACGTCTCTGAGA-1_1_A4	15.35477122	-5.011701604	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1284	2195	0.007289294	0.003644647	1	12	EN-MIX	26	7	7
ACATCAGAGACACTAA-1_1_A4	10.06008288	13.86827904	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1187	2047	0.006350757	0.005862237	1	oligos	OL-Cntl	26	7	7
ACATCAGAGCCACGTC-1_1_A4	17.43425692	6.966151306	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1980	3603	0.01582015	0.008881488	1	oligos	OL-Cntl	26	7	7
ACATCAGCAACACCTA-1_1_A4	12.34305076	22.4266565	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	957	1575	0.010793651	0.003174603	1	oligos	OL-Cntl	26	7	7
ACATCAGGTTGTACAC-1_1_A4	4.04033665	-14.50694909	4	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2717	5922	0.002532928	0.011482607	1	L2-3	EN-L2-3-MS	26	7	7
ACATGGTAGTCACGCC-1_1_A4	-0.099704613	24.46957041	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	692	1086	0.014732965	0.008287293	1	oligos	OL-Cntl	26	7	7
ACATGGTGTCTCTTAT-1_1_A4	11.3063349	17.9031902	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1001	1697	0.00117855	0.008839128	1	oligos	OL-Cntl	26	7	7
ACATGGTGTGTGCGTC-1_1_A4	40.66448483	14.42344259	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	958	1283	0.003117693	0.011691348	1	14	Microglia	26	7	7
ACATGGTTCAGCTTAG-1_1_A4	-15.23130797	-24.56184372	6A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1690	3387	0.001771479	0.002952465	1	6A	IN-PV	26	7	7
ACATGGTTCAGTGTTG-1_1_A4	39.80235458	15.99621903	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1476	2195	0.004555809	0.003644647	1	14	Microglia	26	7	7
ACATGGTTCATGCAAC-1_1_A4	39.50248352	14.07313681	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1023	1419	0.005637773	0.011980268	1	14	Microglia	26	7	7
ACATGGTTCTCGTATT-1_1_A4	2.221711074	21.19832652	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	853	1294	0.018547141	0.008500773	1	oligos	OL-Cntl	26	7	7
ACCAGTACAAACTGCT-1_1_A4	3.743725543	-5.165273099	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	881	1365	0.000732601	0.004395604	1	12	EN-MIX	26	7	7
ACCAGTACAATGCCAT-1_1_A4	2.945918109	25.50568265	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	776	1135	0.003524229	0.00969163	1	oligos	OL-Cntl	26	7	7
ACCAGTACACAACGCC-1_1_A4	8.906331225	21.31955416	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	881	1413	0.004246285	0.004953999	1	oligos	OL-Cntl	26	7	7
ACCAGTACACCTCGGA-1_1_A4	39.57130783	16.19925721	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1638	2486	0.012469831	0.017699115	1	14	Microglia	26	7	7
ACCAGTACACGAAATA-1_1_A4	3.976774873	22.57060379	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	896	1418	0.007757405	0.009873061	1	oligos	OL-Cntl	26	7	7
ACCAGTACAGTCGTGC-1_1_A4	-13.54119817	-17.75416971	6B	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1324	2320	0.007327586	0.001724138	1	6B	IN-SST	26	7	7
ACCAGTAGTCTCATCC-1_1_A4	14.55658389	-1.83138427	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1096	1817	0.002201431	0.006053935	1	12	EN-MIX	26	7	7
ACCAGTAGTTGGTAAA-1_1_A4	-25.92164279	22.5788199	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1306	2191	0.003194888	0.005933364	1	8	Astrocytes	26	7	7
ACCAGTATCCTCTAGC-1_1_A4	39.4927236	10.1612358	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	817	1110	0.010810811	0.007207207	1	14	Microglia	26	7	7
ACCAGTATCGCAAACT-1_1_A4	-9.893589933	22.83059934	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1716	2712	0.001106195	0.004056047	1	8	Astrocytes	26	7	7
ACCAGTATCTATCCCG-1_1_A4	-22.02188867	25.62025991	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1772	3417	0.002633889	0.004389816	1	8	Astrocytes	26	7	7
ACCCACTAGAGACGAA-1_1_A4	38.51272266	10.75059495	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	860	1141	0.004382121	0.014022787	1	14	Microglia	26	7	7
ACCCACTAGATGAGAG-1_1_A4	-10.66816006	15.81649203	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1683	2695	0.008534323	0.008534323	1	11	Glia-MIX	26	7	7
ACCCACTAGTTCGCAT-1_1_A4	39.75162504	16.15035341	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1818	2882	0.004857738	0.004510756	1	14	Microglia	26	7	7
ACCCACTCACGCATCG-1_1_A4	18.13997796	-0.042747768	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1147	1894	0.012671595	0.003167899	1	12	EN-MIX	26	7	7
ACCCACTCACGGCTAC-1_1_A4	-1.898360816	25.24189429	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	717	1028	0.007782101	0.010700389	1	oligos	OL-Cntl	26	7	7
ACCCACTCACTTCGAA-1_1_A4	-24.76822685	27.05874706	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1664	3181	0.004715498	0.004715498	1	8	Astrocytes	26	7	7
ACCCACTGTTCAGTAC-1_1_A4	16.94575333	-0.635383274	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	734	1058	0.002835539	0.003780718	1	12	EN-MIX	26	7	7
ACCGTAAAGCGGATCA-1_1_A4	13.11579639	15.3507465	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1152	1876	0.019189765	0.010127932	1	oligos	OL-Cntl	26	7	7
ACCGTAACACACAGAG-1_1_A4	-8.229299167	9.316215957	5	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	813	1220	0	0.012295082	1	oligos	OL-MS-1	26	7	7
ACCGTAACAGAAGCAC-1_1_A4	-11.85598647	13.29451269	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	795	1247	0.003207698	0.004811548	1	11	Glia-MIX	26	7	7
ACCGTAACAGAGCCAA-1_1_A4	-23.15909514	26.00701476	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1673	3110	0.002250804	0.008681672	1	8	Astrocytes	26	7	7
ACCGTAACAGTCTTCC-1_1_A4	12.88096399	27.4790529	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	806	1236	0.008899676	0.008090615	1	oligos	OL-Cntl	26	7	7
ACCGTAAGTCTTCAAG-1_1_A4	-33.61575806	4.726773864	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	3021	6040	0.004139073	0.00794702	1	9	OPC	26	7	7
ACCGTAATCACCAGGC-1_1_A4	1.741992882	-5.559174134	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	994	1639	0.004881025	0.002440513	1	12	EN-MIX	26	7	7
ACCGTAATCATACGGT-1_1_A4	-9.038814138	-1.854890823	13A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2246	4641	0.004955828	0.005171299	1	13A	IN-VIP	26	7	7
ACCTTTACAAAGTGCG-1_1_A4	-35.86551496	-6.35002882	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1164	1880	0.010638298	0.00212766	1	9	OPC	26	7	7
ACCTTTAGTCCTGCTT-1_1_A4	3.458856249	27.38631077	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	708	1037	0	0.005785921	1	oligos	OL-Cntl	26	7	7
ACCTTTAGTGATGTGG-1_1_A4	13.34997291	-27.52696712	3	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2767	6657	0.007510891	0.003905663	1	3	EN-L5-6	26	7	7
ACCTTTAGTTAAAGTG-1_1_A4	4.408853452	26.38892206	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	856	1297	0.00693909	0.00308404	1	oligos	OL-Cntl	26	7	7
ACCTTTATCGCCTGAG-1_1_A4	6.427739049	21.80691781	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	889	1334	0.009745127	0.010494753	1	oligos	OL-Cntl	26	7	7
ACCTTTATCTGTCTAT-1_1_A4	18.85750722	18.38923057	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1057	1710	0.004678363	0.010526316	1	oligos	OL-Cntl	26	7	7
ACGAGCCAGACCGGAT-1_1_A4	4.120029161	20.38576843	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	983	1449	0.009661836	0.008971705	1	oligos	OL-Cntl	26	7	7
ACGAGCCAGCGTTTAC-1_1_A4	-21.38457542	25.44694311	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1638	3128	0.004475703	0.007992327	1	8	Astrocytes	26	7	7
ACGAGCCAGTCGTACT-1_1_A4	10.603717	22.53513733	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	793	1225	0.009795918	0.009795918	1	oligos	OL-Cntl	26	7	7
ACGAGCCCAAAGGAAG-1_1_A4	5.618659582	12.08831097	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1401	2293	0.028347143	0.017880506	1	oligos	OL-Cntl	26	7	7
ACGAGCCCAAGCGCTC-1_1_A4	-0.215271479	28.80947601	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	943	1384	0.007947977	0.005780347	1	oligos	OL-Cntl	26	7	7
ACGAGCCCACTGAAGG-1_1_A4	-23.22440431	27.75473941	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1848	3335	0.00149925	0.003598201	1	8	Astrocytes	26	7	7
ACGAGCCGTCATCGGC-1_1_A4	-6.384998936	4.384646052	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	8044	30933	0.005043158	0.006303947	1	11	Glia-MIX	26	7	7
ACGAGCCGTCCGCTGA-1_1_A4	15.57474421	10.49831937	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1470	2613	0.007271336	0.00612323	1	oligos	OL-Cntl	26	7	7
ACGAGCCGTGGTCCGT-1_1_A4	14.42825576	15.07214887	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1199	1956	0.018404908	0.009202454	1	oligos	OL-Cntl	26	7	7
ACGAGCCTCCAGGGCT-1_1_A4	4.567056822	19.52916051	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1016	1534	0.003911343	0.020208605	1	oligos	OL-Cntl	26	7	7
ACGAGGAAGCTTTGGT-1_1_A4	23.02601198	18.82953473	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1075	1641	0.001218769	0.002437538	1	oligos	OL-Cntl	26	7	7
ACGAGGACAATCGGTT-1_1_A4	-0.554219485	21.35807175	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	745	1104	0.002717391	0.011775362	1	oligos	OL-Cntl	26	7	7
ACGAGGACAGCTTAAC-1_1_A4	-0.597666172	27.79490869	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	796	1220	0.056557377	0.001639344	1	oligos	OL-Cntl	26	7	7
ACGAGGACAGTAACGG-1_1_A4	15.22090273	6.161400602	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2330	4115	0.013365735	0.013608748	1	oligos	OL-Cntl	26	7	7
ACGAGGACATGTAAGA-1_1_A4	3.994370444	20.47311961	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	828	1192	0.015939597	0.007550336	1	oligos	OL-Cntl	26	7	7
ACGAGGAGTCGACTGC-1_1_A4	0.415662461	25.12602322	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	656	1045	0.01722488	0.000956938	1	oligos	OL-Cntl	26	7	7
ACGAGGAGTTGCTCCT-1_1_A4	0.318656294	28.86903757	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	841	1214	0.003294893	0.004942339	1	oligos	OL-Cntl	26	7	7
ACGAGGATCACCCTCA-1_1_A4	21.86348022	16.74881124	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1256	2150	0.004186047	0.001860465	1	oligos	OL-Cntl	26	7	7
ACGAGGATCCTAGAAC-1_1_A4	-23.62917734	19.23672168	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1496	2646	0.001511716	0.004157218	1	8	Astrocytes	26	7	7
ACGAGGATCTCCGGTT-1_1_A4	39.40247307	15.93875602	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1479	2339	0.003420265	0.008550663	1	14	Microglia	26	7	7
ACGATACGTCAACATC-1_1_A4	11.45655492	16.29222439	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1160	1922	0.008324662	0.00780437	1	oligos	OL-Cntl	26	7	7
ACGATACGTCCCGACA-1_1_A4	13.50908106	7.076487773	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1772	3017	0.010938018	0.008949287	1	oligos	OL-Cntl	26	7	7
ACGATACTCACGATGT-1_1_A4	21.27268859	11.00543617	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1675	3021	0.007282357	0.003972195	1	oligos	OL-Cntl	26	7	7
ACGATACTCATCGCTC-1_1_A4	5.37195748	5.040160315	7	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	3443	6830	0.007906296	0.005856515	1	7	Phagocytes	26	7	7
ACGATGTAGAGGGCTT-1_1_A4	-2.225055528	23.96062749	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	806	1178	0.058573854	0.004244482	1	oligos	OL-Cntl	26	7	7
ACGATGTAGGCATGTG-1_1_A4	14.68962198	22.84096245	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	857	1273	0.004713276	0.00392773	1	oligos	OL-Cntl	26	7	7
ACGATGTAGTCCCACG-1_1_A4	-1.938355411	23.86580311	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	801	1173	0.000852515	0.006820119	1	oligos	OL-Cntl	26	7	7
ACGATGTAGTGTACTC-1_1_A4	14.26218442	6.752625864	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1872	3361	0.011603689	0.007140732	1	oligos	OL-Cntl	26	7	7
ACGATGTCAGGTCCAC-1_1_A4	-23.62509561	25.9051568	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1724	3405	0.009104258	0.004698972	1	8	Astrocytes	26	7	7
ACGATGTCATAGAAAC-1_1_A4	5.799521687	16.68782541	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	998	1632	0.008578431	0.015931373	1	oligos	OL-Cntl	26	7	7
ACGATGTGTCCGTTAA-1_1_A4	15.59143536	16.17578307	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1173	1793	0.006134969	0.002230898	1	oligos	OL-Cntl	26	7	7
ACGATGTGTCGTGGCT-1_1_A4	5.608614957	17.35274122	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1129	1725	0.008695652	0.011014493	1	oligos	OL-Cntl	26	7	7
ACGATGTGTGAGTGAC-1_1_A4	-24.52883612	0.131240548	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2872	5519	0.024279761	0.007972459	1	9	OPC	26	7	7
ACGATGTTCTTAGCCC-1_1_A4	1.365565862	11.42601192	5	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	947	1489	0.015446608	0.012760242	1	oligos	OL-MS-1	26	7	7
ACGCAGCAGCCACCTG-1_1_A4	-22.96550021	-0.598350433	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1475	2293	0.011338857	0.003488879	1	9	OPC	26	7	7
ACGCAGCCAAGAAGAG-1_1_A4	4.920129015	24.14438923	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	944	1424	0.005617978	0.008426966	1	oligos	OL-Cntl	26	7	7
ACGCAGCCAATCCAAC-1_1_A4	4.598980528	11.44557557	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1208	1886	0.018557794	0.028632025	1	oligos	OL-Cntl	26	7	7
ACGCAGCCACTTAAGC-1_1_A4	-35.30515418	0.570503219	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1677	3009	0.004320372	0.010967099	1	9	OPC	26	7	7
ACGCAGCCAGGTCCAC-1_1_A4	18.62268554	0.794562387	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1055	1618	0.006798517	0.003708282	1	12	EN-MIX	26	7	7
ACGCAGCCATCCGGGT-1_1_A4	7.411605132	24.03655401	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1100	1647	0.007893139	0.005464481	1	oligos	OL-Cntl	26	7	7
ACGCAGCCATGACGGA-1_1_A4	-0.49803275	23.83935477	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	706	1043	0.011505273	0	1	oligos	OL-Cntl	26	7	7
ACGCAGCGTATATGAG-1_1_A4	11.06410554	25.0898356	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	901	1406	0.002133713	0.00284495	1	oligos	OL-Cntl	26	7	7
ACGCAGCGTCAAAGCG-1_1_A4	15.07541666	22.2967614	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	851	1235	0.007287449	0	1	oligos	OL-Cntl	26	7	7
ACGCAGCGTGTAACGG-1_1_A4	-2.551867955	22.74726595	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	753	1054	0.000948767	0.0056926	1	oligos	OL-Cntl	26	7	7
ACGCAGCGTTAGGGTG-1_1_A4	4.359700353	18.36710006	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1061	1612	0.024813896	0.008064516	1	oligos	OL-Cntl	26	7	7
ACGCAGCTCTCCCTGA-1_1_A4	40.4701292	14.508829	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1188	1697	0.005892752	0.026517384	1	14	Microglia	26	7	7
ACGCAGCTCTGGAGCC-1_1_A4	14.57104732	15.51079312	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1148	1763	0.008508225	0.012478729	1	oligos	OL-Cntl	26	7	7
ACGCAGCTCTGGCGAC-1_1_A4	-31.78467307	-12.90097662	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	765	1085	0.023041475	0.001843318	1	9	OPC	26	7	7
ACGCCAGAGGCTAGCA-1_1_A4	12.18728498	20.06206254	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1069	1769	0.006218202	0.008479367	1	oligos	OL-Cntl	26	7	7
ACGCCAGCATTCCTCG-1_1_A4	9.921674418	13.51471725	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1181	1878	0.002129925	0.018636848	1	oligos	OL-Cntl	26	7	7
ACGCCAGCATTGAGCT-1_1_A4	5.707152225	-11.02939445	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2018	3765	0.018326693	0.006640106	1	12	EN-MIX	26	7	7
ACGCCAGGTAGGGACT-1_1_A4	-35.88971528	-6.244047997	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1210	2040	0.002941176	0.00245098	1	9	OPC	26	7	7
ACGCCAGTCAAAGACA-1_1_A4	10.03199181	-8.399731574	10	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2027	4413	0.001133016	0.002039429	1	L2-3	EN-L2-3-Cntl	26	7	7
ACGCCGAAGCGCTCCA-1_1_A4	38.76693082	14.95221853	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1231	1778	0.001124859	0.01912261	1	14	Microglia	26	7	7
ACGCCGACAGGCTCAC-1_1_A4	14.84202225	15.51819577	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1236	2034	0.015732547	0.005899705	1	oligos	OL-Cntl	26	7	7
ACGCCGAGTCTCGTTC-1_1_A4	4.789116789	-4.748779313	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	722	1119	0.002680965	0.000893655	1	12	EN-MIX	26	7	7
ACGCCGAGTTGAACTC-1_1_A4	4.318157769	18.16680121	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	989	1538	0.014304291	0.016905072	1	oligos	OL-Cntl	26	7	7
ACGCCGAGTTGTGGCC-1_1_A4	6.118665448	22.56472228	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	844	1264	0.018987342	0.003955696	1	oligos	OL-Cntl	26	7	7
ACGCCGATCATGTAGC-1_1_A4	21.2950771	16.91522367	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1252	2012	0.00695825	0.003479125	1	oligos	OL-Cntl	26	7	7
ACGCCGATCCCAGGTG-1_1_A4	9.125969186	25.05449025	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	760	1150	0.012173913	0.004347826	1	oligos	OL-Cntl	26	7	7
ACGCCGATCCGCGTTT-1_1_A4	5.886382087	29.13447644	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	629	1009	0.017839445	0.006937562	1	oligos	OL-Cntl	26	7	7
ACGCCGATCCTGCTTG-1_1_A4	37.77422059	10.01631626	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	917	1269	0.012608353	0.007092199	1	14	Microglia	26	7	7
ACGCCGATCTTAACCT-1_1_A4	18.62371989	1.615109544	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1049	1736	0.003456221	0.001728111	1	12	EN-MIX	26	7	7
ACGGAGAAGGAGTAGA-1_1_A4	-6.545858955	11.74402009	5	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	826	1229	0.02278275	0.005695688	1	oligos	OL-MS-1	26	7	7
ACGGAGAGTACTTAGC-1_1_A4	15.81312998	-2.45777799	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1007	1596	0.002506266	0.001253133	1	12	EN-MIX	26	7	7
ACGGAGAGTGGCTCCA-1_1_A4	-0.641928457	25.33420352	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	740	1071	0.007469655	0.008403361	1	oligos	OL-Cntl	26	7	7
ACGGAGAGTGGTCTCG-1_1_A4	21.0457101	1.451907891	2	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1319	2274	0.007915567	0.002638522	1	2	EN-L4	26	7	7
ACGGAGAGTTGTGGAG-1_1_A4	-20.80737623	30.9429593	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2950	6708	0.004323196	0.003875969	1	8	Astrocytes	26	7	7
ACGGCCAAGACTAGAT-1_1_A4	21.7941863	10.20146137	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1594	2667	0.008248969	0.008998875	1	oligos	OL-Cntl	26	7	7
ACGGCCAAGACTTTCG-1_1_A4	-11.03203814	-10.44680491	13B	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1259	2093	0.010989011	0.002388915	1	13B	IN-SV2C	26	7	7
ACGGCCAAGCCGATTT-1_1_A4	-22.54867839	25.87006181	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1643	3122	0.003203075	0.004484305	1	8	Astrocytes	26	7	7
ACGGCCACAGACAAGC-1_1_A4	6.117990234	14.79542797	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1117	1780	0.006741573	0.012921348	1	oligos	OL-Cntl	26	7	7
ACGGCCACAGACGCTC-1_1_A4	27.1109816	5.368282378	15A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	849	1233	0.00162206	0.01378751	1	15A	Endo cells	26	7	7
ACGGCCACAGAGCCAA-1_1_A4	17.13661171	10.68194889	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1467	2596	0.001155624	0.007318952	1	oligos	OL-Cntl	26	7	7
ACGGCCAGTCTCTTAT-1_1_A4	-5.08155645	-10.5542345	6B	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	711	1002	0.010978044	0.010978044	1	6B	IN-SST	26	7	7
ACGGCCAGTGCAGACA-1_1_A4	-5.90373249	-5.031899836	13A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1295	2304	0.031684028	0.003038194	1	13A	IN-VIP	26	7	7
ACGGCCATCTACTATC-1_1_A4	6.240748933	19.00816214	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	981	1512	0.00462963	0.011243386	1	oligos	OL-Cntl	26	7	7
ACGGGCTAGTGGACGT-1_1_A4	-11.93585846	15.93544871	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1581	2744	0.006195335	0.005466472	1	11	Glia-MIX	26	7	7
ACGGGCTCACCTTGTC-1_1_A4	2.588254495	24.61957518	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	813	1301	0.022290546	0.006917756	1	oligos	OL-Cntl	26	7	7
ACGGGCTCACGGCTAC-1_1_A4	-3.741829742	-7.660029346	13A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	802	1260	0.00952381	0.003968254	1	13A	IN-VIP	26	7	7
ACGGGCTCATAAGACA-1_1_A4	16.67463582	5.731578037	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2791	5998	0.004834945	0.015338446	1	oligos	OL-Cntl	26	7	7
ACGGGCTGTACTTCTT-1_1_A4	-20.74677079	27.39447323	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1910	3602	0.003609106	0.012493059	1	8	Astrocytes	26	7	7
ACGGGCTGTTGTTTGG-1_1_A4	-9.600670614	-5.313750487	13A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1779	3055	0.022585925	0.011456628	1	13A	IN-VIP	26	7	7
ACGGGCTTCTCGAGTA-1_1_A4	11.01176613	14.69012891	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1201	2021	0.026719446	0.005937655	1	oligos	OL-Cntl	26	7	7
ACGGGTCAGAATCTCC-1_1_A4	-36.69135452	-4.332911372	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1413	2461	0.004876067	0.002031694	1	9	OPC	26	7	7
ACGGGTCAGCTCCTCT-1_1_A4	37.67248386	14.05189905	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1015	1414	0.016265912	0.016265912	1	14	Microglia	26	7	7
ACGGGTCAGGACGAAA-1_1_A4	1.750156332	26.66316216	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	753	1071	0.004668534	0.001867414	1	oligos	OL-Cntl	26	7	7
ACGGGTCCAATGCCAT-1_1_A4	14.20644516	6.134715137	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2302	4276	0.013330215	0.01707203	1	oligos	OL-Cntl	26	7	7
ACGGGTCGTAGAAAGG-1_1_A4	-11.60600595	17.35858181	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2058	3482	0.001148765	0.007466973	1	11	Glia-MIX	26	7	7
ACGGGTCGTCTTGTCC-1_1_A4	-26.5506062	1.774431186	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1962	3147	0.011757229	0.01398157	1	9	OPC	26	7	7
ACGGGTCGTGTGACGA-1_1_A4	8.186795712	18.99517986	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1325	2160	0.01712963	0.006481481	1	oligos	OL-Cntl	26	7	7
ACGGGTCTCCAAACAC-1_1_A4	23.42455422	17.777275	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1345	2115	0.005200946	0.004728132	1	oligos	OL-Cntl	26	7	7
ACGGGTCTCCTCTAGC-1_1_A4	37.8434233	10.10441244	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	828	1127	0.00621118	0.009760426	1	14	Microglia	26	7	7
ACGGGTCTCTCCAACC-1_1_A4	-1.91075044	22.07618278	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	715	1039	0.018286814	0.009624639	1	oligos	OL-Cntl	26	7	7
ACGGGTCTCTCTGCTG-1_1_A4	17.25090966	1.681249255	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	827	1248	0	0.000801282	1	12	EN-MIX	26	7	7
ACGTCAACATCATCCC-1_1_A4	6.559415084	21.5366678	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	854	1308	0.008409786	0.00382263	1	oligos	OL-Cntl	26	7	7
ACGTCAAGTCGAACAG-1_1_A4	-19.62957939	-28.3474188	6A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	3983	12036	0.008889997	0.002409438	1	6A	IN-PV	26	7	7
ACGTCAATCTAACGGT-1_1_A4	-10.8780809	9.549942162	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	4020	9264	0.005505181	0.004209845	1	11	Glia-MIX	26	7	7
ACTATCTAGCCATCGC-1_1_A4	-35.37769275	4.699765253	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2581	5761	0.004686686	0.00347162	1	9	OPC	26	7	7
ACTATCTAGCGTGAGT-1_1_A4	0.010152665	22.84010965	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	754	1157	0.005185825	0.004321521	1	oligos	OL-Cntl	26	7	7
ACTATCTAGTGGCACA-1_1_A4	11.6330098	22.12948379	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	936	1497	0.009352037	0.004008016	1	oligos	OL-Cntl	26	7	7
ACTATCTAGTGTCCAT-1_1_A4	-25.48051445	23.13815203	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1323	2472	0.00566343	0.004854369	1	8	Astrocytes	26	7	7
ACTATCTCAAAGCAAT-1_1_A4	-29.07107879	20.61734419	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1057	1928	0.003112033	0.001556017	1	8	Astrocytes	26	7	7
ACTATCTCAATGTAAG-1_1_A4	6.771031856	25.36647107	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	992	1539	0.015594542	0.007147498	1	oligos	OL-Cntl	26	7	7
ACTATCTCAGCCTATA-1_1_A4	12.59114684	26.32311951	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	685	1055	0.012322275	0.006635071	1	oligos	OL-Cntl	26	7	7
ACTATCTCATGCCCGA-1_1_A4	-10.16572621	-18.37162332	6B	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	887	1452	0.026859504	0.004132231	1	6B	IN-SST	26	7	7
ACTATCTGTGCACTTA-1_1_A4	-34.46302157	-8.341958004	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	992	1624	0.000615764	0.006157635	1	9	OPC	26	7	7
ACTATCTGTGTGAAAT-1_1_A4	-24.74447706	25.89748249	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1539	3020	0.004304636	0.002649007	1	8	Astrocytes	26	7	7
ACTGAACAGGAGCGAG-1_1_A4	2.725528917	25.05432538	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	732	1070	0.004672897	0.002803738	1	oligos	OL-Cntl	26	7	7
ACTGAACCACACCGCA-1_1_A4	38.70632009	13.62425417	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1042	1428	0.005602241	0.022408964	1	14	Microglia	26	7	7
ACTGAACCATATGCTG-1_1_A4	13.51110666	14.10663785	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1214	1907	0.014158364	0.010487677	1	oligos	OL-Cntl	26	7	7
ACTGAACCATCCAACA-1_1_A4	1.363325683	26.28753096	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	755	1114	0.003590664	0.008078995	1	oligos	OL-Cntl	26	7	7
ACTGAACGTAGAGGAA-1_1_A4	-13.60840731	-1.08405343	13A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2305	4102	0.00487567	0.015602145	1	13A	IN-VIP	26	7	7
ACTGAACGTATAGGGC-1_1_A4	-4.290992638	20.19013395	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	777	1084	0.009225092	0.024907749	1	oligos	OL-Cntl	26	7	7
ACTGAACGTTAAGTAG-1_1_A4	17.73882812	17.54924535	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1099	1896	0.007383966	0.007383966	1	oligos	OL-Cntl	26	7	7
ACTGAGTAGCACCGCT-1_1_A4	0.090160638	22.80922179	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	816	1194	0.008375209	0.005025126	1	oligos	OL-Cntl	26	7	7
ACTGAGTAGGCATTGG-1_1_A4	-5.178403158	-10.52475576	6B	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	867	1298	0.006933744	0.000770416	1	6B	IN-SST	26	7	7
ACTGAGTAGTGTGGCA-1_1_A4	-36.18897238	-5.704699787	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1182	2046	0.00684262	0.00342131	1	9	OPC	26	7	7
ACTGAGTGTAGGCTGA-1_1_A4	2.356241273	-4.099356	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	894	1353	0.010347376	0.001478197	1	12	EN-MIX	26	7	7
ACTGATGAGAGAACAG-1_1_A4	2.656263192	-4.879058637	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	923	1400	0.004285714	0.002142857	1	12	EN-MIX	26	7	7
ACTGATGAGTCGTACT-1_1_A4	13.00625826	19.8230099	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1024	1560	0.009615385	0.005128205	1	oligos	OL-Cntl	26	7	7
ACTGATGTCCGCAAGC-1_1_A4	2.553915219	27.38151735	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	805	1172	0.017064846	0.007679181	1	oligos	OL-Cntl	26	7	7
ACTGATGTCTCATTCA-1_1_A4	13.91930868	0.927780344	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	796	1236	0.034789644	0.002427184	1	12	EN-MIX	26	7	7
ACTGCTCAGAAACCTA-1_1_A4	-23.26135348	-4.762345796	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1549	2656	0.006400602	0.00376506	1	9	OPC	26	7	7
ACTGCTCAGACATAAC-1_1_A4	-26.43814873	3.472206649	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	4807	11433	0.005073034	0.013557247	1	9	OPC	26	7	7
ACTGCTCAGCTCCTCT-1_1_A4	-36.26949176	-3.179498488	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1420	2389	0.002511511	0.003348681	1	9	OPC	26	7	7
ACTGCTCAGTGGGTTG-1_1_A4	6.140484761	17.14737487	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1058	1659	0.007836046	0.008438819	1	oligos	OL-Cntl	26	7	7
ACTGCTCCAGTGAGTG-1_1_A4	-25.17719819	15.13363447	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1209	2077	0.010110737	0.0052961	1	8	Astrocytes	26	7	7
ACTGCTCTCAGCTCTC-1_1_A4	0.567784792	22.1706282	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	858	1208	0.004966887	0.016556291	1	oligos	OL-Cntl	26	7	7
ACTGCTCTCCGGCACA-1_1_A4	-10.99658034	9.508300871	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	6165	18443	0.004988342	0.007862061	1	11	Glia-MIX	26	7	7
ACTGTCCCATCGGTTA-1_1_A4	5.855390726	12.64121261	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1390	2239	0.02635105	0.012058955	1	oligos	OL-Cntl	26	7	7
ACTGTCCGTGGCAAAC-1_1_A4	0.227030068	24.12416652	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	688	1042	0.014395393	0.007677543	1	oligos	OL-Cntl	26	7	7
ACTTACTTCAAACCGT-1_1_A4	14.78699407	18.45611521	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1081	1649	0.012734991	0.003638569	1	oligos	OL-Cntl	26	7	7
ACTTACTTCTCAAGTG-1_1_A4	3.515529888	5.067511392	7	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	981	1373	0.008011653	0.014566642	1	7	Phagocytes	26	7	7
ACTTGTTAGAGGGCTT-1_1_A4	36.97626563	9.113000662	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	681	1008	0.00297619	0.006944444	1	14	Microglia	26	7	7
ACTTGTTAGCCGGTAA-1_1_A4	-28.63098441	10.04747348	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	868	1342	0.007451565	0.003725782	1	8	Astrocytes	26	7	7
ACTTGTTCACGGCGTT-1_1_A4	-1.404152682	20.66821772	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	770	1184	0.005067568	0.005912162	1	oligos	OL-Cntl	26	7	7
ACTTGTTCAGATTGCT-1_1_A4	-26.34394007	22.6469231	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1158	1980	0.00959596	0.005555556	1	8	Astrocytes	26	7	7
ACTTGTTCATCGGACC-1_1_A4	-26.49681386	23.52590235	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1333	2452	0.004486134	0.004893964	1	8	Astrocytes	26	7	7
ACTTGTTTCCACGCAG-1_1_A4	10.41314308	19.67813995	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	939	1443	0.015246015	0.00970201	1	oligos	OL-Cntl	26	7	7
ACTTTCACAATAAGCA-1_1_A4	14.79205251	16.61341606	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1170	1828	0.008205689	0.009299781	1	oligos	OL-Cntl	26	7	7
ACTTTCACAGATTGCT-1_1_A4	15.75512215	-5.796678832	10	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1427	2791	0.002866356	0.002866356	1	L2-3	EN-L2-3-Cntl	26	7	7
ACTTTCATCTGCTTGC-1_1_A4	-25.11105552	-0.724523406	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1945	4167	0.003599712	0.004559635	1	9	OPC	26	7	7
AGAATAGCAATGACCT-1_1_A4	-23.49997591	0.728768072	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1947	3482	0.004020678	0.010626077	1	9	OPC	26	7	7
AGAATAGGTCAGGACA-1_1_A4	6.564717339	20.25995207	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	972	1587	0.006931317	0.005040958	1	oligos	OL-Cntl	26	7	7
AGAATAGTCCCAAGAT-1_1_A4	-24.57554774	18.32986519	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1284	2333	0.008144021	0.003857694	1	8	Astrocytes	26	7	7
AGACGTTAGAGACTAT-1_1_A4	4.477854472	18.22433472	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1115	1745	0.0252149	0.01260745	1	oligos	OL-Cntl	26	7	7
AGACGTTCACATCTTT-1_1_A4	37.39548261	12.62865749	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1137	1613	0.016119033	0.00433974	1	14	Microglia	26	7	7
AGACGTTCACGAAACG-1_1_A4	-8.741112635	9.600747607	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	734	1026	0.012670565	0.001949318	1	11	Glia-MIX	26	7	7
AGACGTTCAGTATCTG-1_1_A4	-9.79346316	22.74201667	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1754	2638	0.004548901	0.007581501	1	8	Astrocytes	26	7	7
AGACGTTGTATAAACG-1_1_A4	-2.416501567	21.83959691	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	784	1124	0.015124555	0.013345196	1	oligos	OL-Cntl	26	7	7
AGACGTTTCAACCAAC-1_1_A4	-3.219705236	-6.112755135	13A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	875	1380	0.000724638	0.001449275	1	13A	IN-VIP	26	7	7
AGACGTTTCGAGAGCA-1_1_A4	-3.877945955	18.94839683	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	952	1401	0.014275517	0.010706638	1	oligos	OL-Cntl	26	7	7
AGAGCGAAGAAACCGC-1_1_A4	6.482123656	18.94289322	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1065	1700	0.017647059	0.006470588	1	oligos	OL-Cntl	26	7	7
AGAGCGAAGATCCGAG-1_1_A4	18.38631932	-6.916615872	3	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1911	3625	0.002206897	0.003586207	1	3	EN-L5-6	26	7	7
AGAGCGAAGCCAGGAT-1_1_A4	-2.110782038	24.15822197	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	702	1006	0.011928429	0.005964215	1	oligos	OL-Cntl	26	7	7
AGAGCGAAGCCCGAAA-1_1_A4	3.003814685	-2.925730649	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	712	1013	0.023692004	0.006910168	1	12	EN-MIX	26	7	7
AGAGCGACATCTGGTA-1_1_A4	-9.052934658	-20.11100473	6B	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	789	1279	0.06645817	0.007818608	1	6B	IN-SST	26	7	7
AGAGCGAGTCACCCAG-1_1_A4	3.014120571	20.92718989	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	950	1444	0.025623269	0.009695291	1	oligos	OL-Cntl	26	7	7
AGAGCGATCAGCTGGC-1_1_A4	12.01665917	15.1074516	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1225	2027	0.016773557	0.010853478	1	oligos	OL-Cntl	26	7	7
AGAGCTTAGGGTTTCT-1_1_A4	2.702521796	26.40770599	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	750	1162	0.010327022	0.006884682	1	oligos	OL-Cntl	26	7	7
AGAGCTTCAAGTACCT-1_1_A4	21.04108861	18.91398863	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	992	1454	0.002063274	0.00343879	1	oligos	OL-Cntl	26	7	7
AGAGCTTCACGGTAGA-1_1_A4	-2.753867525	23.84033107	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	764	1064	0.027255639	0.011278195	1	oligos	OL-Cntl	26	7	7
AGAGCTTTCTGAAAGA-1_1_A4	-8.902918271	15.74592376	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2508	4911	0.007330483	0.005701486	1	11	Glia-MIX	26	7	7
AGAGTGGCACGAAGCA-1_1_A4	5.124972641	22.26986729	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	930	1485	0.016835017	0.008080808	1	oligos	OL-Cntl	26	7	7
AGAGTGGCAGGTGCCT-1_1_A4	-7.241538768	-6.642691213	13A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1244	2020	0.021782178	0.007425743	1	13A	IN-VIP	26	7	7
AGAGTGGGTTTGTGTG-1_1_A4	-23.78031088	-1.397500878	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1291	2123	0.001413095	0.004710316	1	9	OPC	26	7	7
AGAGTGGTCAACTCTT-1_1_A4	6.250610197	20.09317062	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	932	1498	0.011348465	0.005340454	1	oligos	OL-Cntl	26	7	7
AGAGTGGTCGACCAGC-1_1_A4	-1.832484228	20.82067952	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	801	1137	0.014951627	0.013192612	1	oligos	OL-Cntl	26	7	7
AGAGTGGTCTAGCACA-1_1_A4	-35.0953995	-5.113447597	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1294	2049	0.000976086	0.005368472	1	9	OPC	26	7	7
AGAGTGGTCTCAAGTG-1_1_A4	38.66906432	15.83849604	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1361	1966	0.014750763	0.016276704	1	14	Microglia	26	7	7
AGATCTGAGCTGGAAC-1_1_A4	-10.84191697	9.79437281	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2958	6157	0.003735586	0.005359753	1	11	Glia-MIX	26	7	7
AGATCTGAGTCAATAG-1_1_A4	-10.72015355	12.85778637	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	720	1085	0.004608295	0.000921659	1	11	Glia-MIX	26	7	7
AGATCTGCAAGGTTCT-1_1_A4	34.60530487	14.16793892	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	942	1279	0.01876466	0.01876466	1	14	Microglia	26	7	7
AGATCTGCAGCTGCTG-1_1_A4	5.989281514	5.985837246	7	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	3062	6223	0.010927206	0.00996304	1	7	Phagocytes	26	7	7
AGATCTGGTAACGTTC-1_1_A4	-30.0027216	21.12553165	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	958	1547	0.000646412	0.003878474	1	8	Astrocytes	26	7	7
AGATCTGTCAACCATG-1_1_A4	40.10282431	11.10992461	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	779	1093	0.010064044	0.007319305	1	14	Microglia	26	7	7
AGATCTGTCGAGCCCA-1_1_A4	0.648682743	28.81852582	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	747	1104	0.005434783	0.005434783	1	oligos	OL-Cntl	26	7	7
AGATCTGTCGTTTGCC-1_1_A4	3.320569998	23.1970601	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	844	1291	0.007745933	0.007745933	1	oligos	OL-Cntl	26	7	7
AGATCTGTCTGGCGTG-1_1_A4	18.59866716	12.01434798	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1300	2430	0.008641975	0.002880658	1	oligos	OL-Cntl	26	7	7
AGATTGCAGATGGGTC-1_1_A4	3.777656633	6.246554731	7	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1253	1875	0.0096	0.008533333	1	7	Phagocytes	26	7	7
AGATTGCAGTGCCAGA-1_1_A4	-27.08807698	15.22402544	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	983	1699	0.002942908	0.005885815	1	8	Astrocytes	26	7	7
AGATTGCGTCCCTTGT-1_1_A4	-22.79638311	-0.489764855	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1429	2383	0.005455308	0.005035669	1	9	OPC	26	7	7
AGATTGCTCAACGAAA-1_1_A4	-23.7734903	26.10994004	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1548	2799	0.010718114	0.002858164	1	8	Astrocytes	26	7	7
AGATTGCTCACTCTTA-1_1_A4	16.33798369	18.39592423	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1060	1764	0.010204082	0.003968254	1	oligos	OL-Cntl	26	7	7
AGATTGCTCATGTCTT-1_1_A4	-35.2434161	-2.482277062	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1439	2724	0.005873715	0.00256975	1	9	OPC	26	7	7
AGATTGCTCCCATTAT-1_1_A4	14.78063302	17.45273929	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1074	1821	0.011532125	0.007688083	1	oligos	OL-Cntl	26	7	7
AGATTGCTCCGCAAGC-1_1_A4	-27.24560954	4.195709183	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	3402	6967	0.008037893	0.005454284	1	9	OPC	26	7	7
AGATTGCTCTAACCGA-1_1_A4	-6.398831577	-5.479807476	13A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1335	2416	0.009933775	0.003311258	1	13A	IN-VIP	26	7	7
AGCAGCCAGCCACGTC-1_1_A4	5.642608512	5.796739613	7	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2536	4689	0.007677543	0.004691832	1	7	Phagocytes	26	7	7
AGCAGCCAGCGATGAC-1_1_A4	3.647781697	-5.407607071	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	907	1299	0.005388761	0.006928406	1	12	EN-MIX	26	7	7
AGCAGCCAGGTGATTA-1_1_A4	8.606035754	-7.216687682	10	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1660	3141	0.011779688	0.00127348	1	L2-3	EN-L2-3-Cntl	26	7	7
AGCAGCCAGTTACGGG-1_1_A4	-33.26896309	-5.980073782	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1194	1941	0.004121587	0.002060793	1	9	OPC	26	7	7
AGCAGCCCACGGACAA-1_1_A4	14.63665884	0.369570805	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	649	1074	0	0.003724395	1	12	EN-MIX	26	7	7
AGCAGCCGTAATCACC-1_1_A4	3.024830498	-2.885121377	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	681	1016	0.012795276	0.002952756	1	12	EN-MIX	26	7	7
AGCAGCCGTGTCCTCT-1_1_A4	16.87292148	23.66872321	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	972	1523	0.003939593	0.004596192	1	oligos	OL-Cntl	26	7	7
AGCAGCCGTTCGTTGA-1_1_A4	40.05809368	11.07643304	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	962	1464	0.006830601	0.003415301	1	14	Microglia	26	7	7
AGCAGCCTCCGCTGTT-1_1_A4	21.5412581	1.691448923	2	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1636	3121	0.00128164	0.00096123	1	2	EN-L4	26	7	7
AGCATACAGTACATGA-1_1_A4	5.912630164	17.48503184	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1025	1569	0.00446144	0.010834927	1	oligos	OL-Cntl	26	7	7
AGCATACCACTTACGA-1_1_A4	2.060499259	28.54120044	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	832	1254	0.000797448	0.009569378	1	oligos	OL-Cntl	26	7	7
AGCATACGTACCATCA-1_1_A4	2.505742645	-3.861212231	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	745	1101	0.005449591	0.003633061	1	12	EN-MIX	26	7	7
AGCATACTCCTCATTA-1_1_A4	11.7884738	14.93169675	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1230	2075	0.017831325	0.004819277	1	oligos	OL-Cntl	26	7	7
AGCATACTCTGCGGCA-1_1_A4	6.924332622	19.88743106	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1060	1686	0.011269276	0.005931198	1	oligos	OL-Cntl	26	7	7
AGCCTAACAAAGGCGT-1_1_A4	4.604181943	24.7048218	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	771	1089	0.005509642	0.002754821	1	oligos	OL-Cntl	26	7	7
AGCCTAATCCTATTCA-1_1_A4	2.46458293	19.78356084	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	909	1395	0.009318996	0.018637993	1	oligos	OL-Cntl	26	7	7
AGCGGTCAGAGGGATA-1_1_A4	22.53735262	16.12047003	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1489	2248	0.004893238	0.009341637	1	oligos	OL-Cntl	26	7	7
AGCGGTCAGGCCGAAT-1_1_A4	-10.70599192	9.520542802	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	3604	7563	0.00595002	0.005817797	1	11	Glia-MIX	26	7	7
AGCGGTCAGTACGCGA-1_1_A4	5.654932922	21.68129952	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1008	1582	0.008217446	0.012642225	1	oligos	OL-Cntl	26	7	7
AGCGGTCAGTCGTTTG-1_1_A4	11.71569091	30.07271007	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	850	1318	0.000758725	0.003793627	1	oligos	OL-Cntl	26	7	7
AGCGGTCAGTGCGTGA-1_1_A4	4.153012992	-3.177493931	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	902	1291	0.037955074	0.00232378	1	12	EN-MIX	26	7	7
AGCGGTCCAAACTGCT-1_1_A4	-33.86809588	-11.96187766	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	724	1014	0.00295858	0.00295858	1	9	OPC	26	7	7
AGCGGTCCAAGCCCAC-1_1_A4	21.48456848	9.446307591	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1893	3330	0.006006006	0.006606607	1	oligos	OL-Cntl	26	7	7
AGCGGTCCAAGCTGGA-1_1_A4	-23.90391479	-0.656548808	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1703	2983	0.001340932	0.014750251	1	9	OPC	26	7	7
AGCGGTCCAGGCTCAC-1_1_A4	14.87405709	15.80288218	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1333	2275	0.02021978	0.008351648	1	oligos	OL-Cntl	26	7	7
AGCGGTCGTCCTCCAT-1_1_A4	11.2222857	15.0056376	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1193	1915	0.008355091	0.008877285	1	oligos	OL-Cntl	26	7	7
AGCGGTCTCACATGCA-1_1_A4	-10.93242253	0.204767865	13A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2868	6311	0.008081128	0.004753605	1	13A	IN-VIP	26	7	7
AGCGGTCTCCTTTCTC-1_1_A4	14.44740482	-8.158844691	3	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2086	4944	0.000404531	0.003236246	1	3	EN-L5-6	26	7	7
AGCGGTCTCTTACCGC-1_1_A4	5.377763408	21.85751037	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	957	1497	0.003340013	0.008684035	1	oligos	OL-Cntl	26	7	7
AGCGTATAGCGACGTA-1_1_A4	14.51935684	18.98695853	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1047	1578	0.010773131	0.003802281	1	oligos	OL-Cntl	26	7	7
AGCGTATAGGAATTAC-1_1_A4	-3.604084084	17.50969809	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	912	1317	0.017463933	0.01594533	1	oligos	OL-Cntl	26	7	7
AGCGTATAGGACCACA-1_1_A4	-25.2994473	13.55099909	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1093	1918	0.002606882	0.009906152	1	8	Astrocytes	26	7	7
AGCGTATGTAGCGTGA-1_1_A4	6.015327296	16.88808603	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1122	1773	0.038353074	0.008460237	1	oligos	OL-Cntl	26	7	7
AGCGTATGTAGCTGCC-1_1_A4	15.05097825	-6.583612316	10	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1657	3078	0.002923977	0.004223522	1	L2-3	EN-L2-3-Cntl	26	7	7
AGCGTATGTCGGCACT-1_1_A4	2.578424552	5.055508898	7	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	929	1270	0.006299213	0.011023622	1	7	Phagocytes	26	7	7
AGCGTATGTGCTGTAT-1_1_A4	2.882962203	21.26302072	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	842	1241	0.005640612	0.014504432	1	oligos	OL-Cntl	26	7	7
AGCGTATTCAGCGATT-1_1_A4	-0.567882212	-0.309456848	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1539	2599	0.022701039	0.007310504	1	11	Glia-MIX	26	7	7
AGCGTATTCCATTCTA-1_1_A4	-10.29615427	-20.46469836	6B	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	883	1475	0.050847458	0.002033898	1	6B	IN-SST	26	7	7
AGCGTCGAGAATGTTG-1_1_A4	3.581984113	26.70041041	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	772	1181	0.00084674	0.00338696	1	oligos	OL-Cntl	26	7	7
AGCGTCGAGATCACGG-1_1_A4	-36.22653486	-0.565188938	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1657	2743	0.003281079	0.005103901	1	9	OPC	26	7	7
AGCGTCGAGTGAACAT-1_1_A4	0.555299707	24.42836672	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	678	1003	0.008973081	0.00997009	1	oligos	OL-Cntl	26	7	7
AGCGTCGAGTTATCGC-1_1_A4	-28.43596764	16.60804565	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1082	1771	0.009599097	0.006775833	1	8	Astrocytes	26	7	7
AGCGTCGCACCACCAG-1_1_A4	18.75303945	7.679116519	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1868	3554	0.004783343	0.010410805	1	oligos	OL-Cntl	26	7	7
AGCGTCGCATCGGAAG-1_1_A4	3.67473173	5.197753418	7	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1197	1699	0.003531489	0.01177163	1	7	Phagocytes	26	7	7
AGCGTCGGTTTGACAC-1_1_A4	-33.92424001	-12.54718741	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	715	1042	0.001919386	0.002879079	1	9	OPC	26	7	7
AGCTCCTCAAATTGCC-1_1_A4	38.085273	10.10146222	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	773	1059	0.017941454	0.015108593	1	14	Microglia	26	7	7
AGCTCCTGTATATGAG-1_1_A4	5.441553762	6.431344526	7	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1895	3176	0.007871537	0.005352645	1	7	Phagocytes	26	7	7
AGCTCCTGTTAAAGTG-1_1_A4	0.101504368	22.93385953	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	805	1195	0.016736402	0.006694561	1	oligos	OL-Cntl	26	7	7
AGCTCCTTCCGCGTTT-1_1_A4	-8.93774969	-18.75263901	6B	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	719	1156	0.016435986	0.006920415	1	6B	IN-SST	26	7	7
AGCTCCTTCCTTTACA-1_1_A4	-10.67306385	9.501996506	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	3906	9082	0.009028848	0.008588417	1	11	Glia-MIX	26	7	7
AGCTCTCAGCCCAGCT-1_1_A4	2.168364409	-4.960744463	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1016	1745	0.003438395	0.002292264	1	12	EN-MIX	26	7	7
AGCTCTCAGCGATCCC-1_1_A4	-0.542843996	27.61918322	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	717	1059	0.024551464	0.001888574	1	oligos	OL-Cntl	26	7	7
AGCTCTCAGGATGCGT-1_1_A4	0.859180481	23.16171424	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	769	1089	0.016528926	0.008264463	1	oligos	OL-Cntl	26	7	7
AGCTCTCAGTATCTCG-1_1_A4	39.83306461	11.58126095	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	923	1319	0.007581501	0.003790751	1	14	Microglia	26	7	7
AGCTCTCCACATTAGC-1_1_A4	-37.8477792	2.442461167	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1653	3071	0.004233149	0.001302507	1	9	OPC	26	7	7
AGCTCTCCACTCGACG-1_1_A4	14.85555363	13.20673023	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1482	2574	0.024864025	0.006604507	1	oligos	OL-Cntl	26	7	7
AGCTCTCCATGGAATA-1_1_A4	15.4822057	21.19203245	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1011	1563	0.01087652	0.005758157	1	oligos	OL-Cntl	26	7	7
AGCTCTCTCGGCGCTA-1_1_A4	6.557211165	19.50365541	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1044	1590	0.018238994	0.011949686	1	oligos	OL-Cntl	26	7	7
AGCTTGAAGTACGTTC-1_1_A4	-19.3262933	-23.24411148	6A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2714	6383	0.028513238	0.002819991	1	6A	IN-PV	26	7	7
AGCTTGACAGCCTGTG-1_1_A4	12.5304369	6.4696562	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2054	3839	0.015368586	0.014066163	1	oligos	OL-Cntl	26	7	7
AGCTTGACAGCTGCTG-1_1_A4	-22.05357686	26.10047941	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1705	3113	0.002891102	0.007388371	1	8	Astrocytes	26	7	7
AGCTTGACAGTCTTCC-1_1_A4	-13.36141101	17.70386326	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1480	2511	0.006371963	0.010752688	1	11	Glia-MIX	26	7	7
AGCTTGACATGTAGTC-1_1_A4	11.66750366	-23.88124086	4	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	3973	9835	0.002033554	0.006710727	1	L2-3	EN-L2-3-MS	26	7	7
AGCTTGAGTCGGCTCA-1_1_A4	-17.49334692	13.20454443	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1126	1759	0	0.002274019	1	8	Astrocytes	26	7	7
AGGCCACAGCTCTCGG-1_1_A4	5.370388885	24.31488121	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	909	1411	0.004961021	0.007795889	1	oligos	OL-Cntl	26	7	7
AGGCCACAGTAGGCCA-1_1_A4	-10.0780131	17.61378115	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1930	3570	0.003081232	0.006722689	1	11	Glia-MIX	26	7	7
AGGCCACAGTTCGCAT-1_1_A4	39.98104415	10.92790422	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	913	1338	0.003736921	0.005979073	1	14	Microglia	26	7	7
AGGCCACCAAGTTCTG-1_1_A4	16.54747011	23.3304918	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	903	1357	0.016212233	0.002947679	1	oligos	OL-Cntl	26	7	7
AGGCCACCATATACGC-1_1_A4	-2.977471794	-9.045535106	6B	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	860	1189	0.030277544	0.001682086	1	6B	IN-SST	26	7	7
AGGCCACGTAGAAGGA-1_1_A4	-36.91575941	-1.097524703	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1516	2545	0.005108055	0.003143418	1	9	OPC	26	7	7
AGGCCACGTGCTGTAT-1_1_A4	-24.06735949	28.67351595	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1806	3434	0.000582411	0.004659289	1	8	Astrocytes	26	7	7
AGGCCACGTTACAGAA-1_1_A4	15.35943143	-6.030930631	10	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1448	2797	0.002860207	0.002145156	1	L2-3	EN-L2-3-Cntl	26	7	7
AGGCCACTCCTACAGA-1_1_A4	33.78634815	14.62517985	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	856	1184	0.01097973	0.032939189	1	14	Microglia	26	7	7
AGGCCACTCGTCTGAA-1_1_A4	-0.444086616	25.40042977	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	762	1099	0.007279345	0.005459509	1	oligos	OL-Cntl	26	7	7
AGGCCGTAGTATCGAA-1_1_A4	16.97038937	8.06210861	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1920	3605	0.005825243	0.005270458	1	oligos	OL-Cntl	26	7	7
AGGCCGTCACATGACT-1_1_A4	-14.74280488	-6.510582816	13A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	3320	8150	0.019141104	0.004294479	1	13A	IN-VIP	26	7	7
AGGCCGTCATTAGGCT-1_1_A4	-31.45234631	11.19339241	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	672	1015	0.001970443	0.004926108	1	8	Astrocytes	26	7	7
AGGCCGTGTATTCTCT-1_1_A4	20.4765896	18.24803706	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1132	1746	0.012027491	0.004581901	1	oligos	OL-Cntl	26	7	7
AGGCCGTGTCCATCCT-1_1_A4	-22.12244245	27.35775321	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1847	3631	0.001927844	0.007986781	1	8	Astrocytes	26	7	7
AGGCCGTGTTAAGAAC-1_1_A4	3.712377415	21.43508146	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	940	1445	0.010380623	0.009688581	1	oligos	OL-Cntl	26	7	7
AGGCCGTTCCTCATTA-1_1_A4	38.28532339	8.923656855	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	810	1116	0.008960573	0.004480287	1	14	Microglia	26	7	7
AGGGAGTAGCGTCTAT-1_1_A4	-33.10976945	-13.37228131	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	820	1233	0.01297648	0	1	9	OPC	26	7	7
AGGGAGTAGGGATACC-1_1_A4	30.61196108	9.462558689	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1240	1804	0.033259424	0.026053215	1	14	Microglia	26	7	7
AGGGAGTCACCTATCC-1_1_A4	8.664296977	-8.178382484	10	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1927	3819	0.001571092	0.002356638	1	L2-3	EN-L2-3-Cntl	26	7	7
AGGGAGTCACGGATAG-1_1_A4	-9.773014316	17.74231314	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2316	4453	0.003143948	0.006287896	1	11	Glia-MIX	26	7	7
AGGGAGTCATCCTAGA-1_1_A4	14.2722829	6.215036572	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2171	3935	0.021346887	0.009911055	1	oligos	OL-Cntl	26	7	7
AGGGAGTGTACAGCAG-1_1_A4	-1.249757128	25.37751817	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	711	1012	0.016798419	0.006916996	1	oligos	OL-Cntl	26	7	7
AGGGAGTGTACCTACA-1_1_A4	-9.147060733	18.94935437	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2553	4555	0.005708013	0.006805708	1	11	Glia-MIX	26	7	7
AGGGAGTGTAGCGTCC-1_1_A4	-24.77067259	16.94329793	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1439	2628	0.001902588	0.008371385	1	8	Astrocytes	26	7	7
AGGGAGTTCACCGGGT-1_1_A4	21.69667339	10.11362246	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1680	2859	0.004896817	0.005946135	1	oligos	OL-Cntl	26	7	7
AGGGAGTTCTCGTTTA-1_1_A4	2.608406309	7.058819844	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	917	1326	0.011312217	0.004524887	1	oligos	OL-Cntl	26	7	7
AGGGATGCACTAGTAC-1_1_A4	5.235175022	29.44601962	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	705	1062	0.008474576	0.003766478	1	oligos	OL-Cntl	26	7	7
AGGGATGCATATGGTC-1_1_A4	39.40062388	16.39685	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2769	5070	0.004142012	0.009270217	1	14	Microglia	26	7	7
AGGGATGCATTATCTC-1_1_A4	-9.091456448	-16.85453827	6B	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	746	1093	0.014638609	0.001829826	1	6B	IN-SST	26	7	7
AGGGATGGTCAGATAA-1_1_A4	-26.2128039	21.74604204	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1301	2125	0.008941176	0.005176471	1	8	Astrocytes	26	7	7
AGGGATGGTTCACGGC-1_1_A4	-22.56804053	18.17988713	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1636	2882	0.011450382	0.0055517	1	8	Astrocytes	26	7	7
AGGGATGTCACAGGCC-1_1_A4	5.838347367	6.408697636	7	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2015	3552	0.008164414	0.005630631	1	7	Phagocytes	26	7	7
AGGGATGTCAGAGGTG-1_1_A4	14.18973651	23.40406385	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	886	1273	0.003142184	0.003142184	1	oligos	OL-Cntl	26	7	7
AGGGTGAAGCCACCTG-1_1_A4	7.434284173	18.67770866	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1252	1992	0.011044177	0.010040161	1	oligos	OL-Cntl	26	7	7
AGGGTGACATCCAACA-1_1_A4	13.84163396	15.05398426	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1260	2013	0.007948336	0.012419275	1	oligos	OL-Cntl	26	7	7
AGGGTGACATCTGGTA-1_1_A4	-7.872817627	9.515304558	5	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	856	1284	0.010903427	0.012461059	1	oligos	OL-MS-1	26	7	7
AGGGTGACATTGTGCA-1_1_A4	12.61505092	26.81959273	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	807	1245	0.008032129	0.000803213	1	oligos	OL-Cntl	26	7	7
AGGGTGAGTGTAATGA-1_1_A4	7.380363967	19.5014005	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1118	1791	0.005025126	0.015633724	1	oligos	OL-Cntl	26	7	7
AGGGTGATCACTTACT-1_1_A4	5.276227399	12.7775015	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1074	1709	0.005851375	0.018139263	1	oligos	OL-Cntl	26	7	7
AGGGTGATCGACAGCC-1_1_A4	14.3695902	21.59255673	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1001	1620	0.00617284	0.009876543	1	oligos	OL-Cntl	26	7	7
AGGTCATAGTCATCCA-1_1_A4	17.54630002	6.444248469	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2309	4564	0.013146363	0.011174408	1	oligos	OL-Cntl	26	7	7
AGGTCATAGTCATGCT-1_1_A4	37.37512324	9.2181146	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	780	1034	0.007736944	0.008704062	1	14	Microglia	26	7	7
AGGTCATCAGCTCGCA-1_1_A4	7.350669848	14.37777111	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1067	1650	0.007878788	0.010909091	1	oligos	OL-Cntl	26	7	7
AGGTCATCATTATCTC-1_1_A4	14.56091568	14.90344071	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1211	1971	0.0152207	0.007102993	1	oligos	OL-Cntl	26	7	7
AGGTCATGTACGACCC-1_1_A4	16.28918064	-1.07385293	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	933	1475	0.016271186	0.000677966	1	12	EN-MIX	26	7	7
AGGTCCGAGATCGGGT-1_1_A4	-35.29236965	-7.033123899	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1173	1887	0.007949126	0.007419184	1	9	OPC	26	7	7
AGGTCCGCATACTACG-1_1_A4	-17.09830895	12.33229896	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1212	1776	0.005067568	0.003941441	1	8	Astrocytes	26	7	7
AGGTCCGGTTCGTCTC-1_1_A4	-16.35782901	-18.04692141	6B	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1883	3917	0.017104927	0.003318866	1	6B	IN-SST	26	7	7
AGGTCCGTCATTGCCC-1_1_A4	15.38557704	-1.544335614	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	825	1263	0.004750594	0.003958828	1	12	EN-MIX	26	7	7
AGGTCCGTCGGTTAAC-1_1_A4	5.295576251	4.952974017	7	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	3416	6918	0.006793871	0.011419485	1	7	Phagocytes	26	7	7
AGTAGTCAGCAATCTC-1_1_A4	-0.568722535	29.11452859	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	870	1340	0.001492537	0.002238806	1	oligos	OL-Cntl	26	7	7
AGTAGTCAGCGAGAAA-1_1_A4	-3.752264423	23.51253775	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	805	1168	0.011130137	0.006849315	1	oligos	OL-Cntl	26	7	7
AGTAGTCAGTAGCCGA-1_1_A4	-9.580462108	17.96070847	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	3273	6268	0.012603701	0.009412891	1	11	Glia-MIX	26	7	7
AGTAGTCAGTCAAGGC-1_1_A4	-1.719530673	19.7729346	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	791	1115	0.014349776	0.009865471	1	oligos	OL-Cntl	26	7	7
AGTAGTCAGTCCGTAT-1_1_A4	-5.317678002	-3.610144026	13A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1372	2316	0.024611399	0.007340242	1	13A	IN-VIP	26	7	7
AGTAGTCCAATTGCTG-1_1_A4	0.549972192	22.33760628	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	910	1521	0.038132807	0.003287311	1	oligos	OL-Cntl	26	7	7
AGTAGTCGTTACGACT-1_1_A4	12.98696014	26.96343675	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	722	1115	0.005381166	0.004484305	1	oligos	OL-Cntl	26	7	7
AGTAGTCTCGTTACAG-1_1_A4	1.184602406	20.72096492	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	774	1183	0.005071851	0.009298394	1	oligos	OL-Cntl	26	7	7
AGTAGTCTCTGCTGCT-1_1_A4	-25.98590563	23.37379563	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1328	2447	0.002860646	0.006947282	1	8	Astrocytes	26	7	7
AGTCTTTAGGCATGTG-1_1_A4	39.06503944	12.50402201	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	923	1274	0.003139717	0.015698587	1	14	Microglia	26	7	7
AGTCTTTAGTAGCGGT-1_1_A4	37.11610546	14.63317119	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1151	1544	0.007124352	0.014896373	1	14	Microglia	26	7	7
AGTCTTTAGTCGCCGT-1_1_A4	33.63564339	14.65570468	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	823	1132	0.005300353	0.020318021	1	14	Microglia	26	7	7
AGTCTTTCAGTCTTCC-1_1_A4	39.31026168	12.27727786	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	839	1202	0.009983361	0.008319468	1	14	Microglia	26	7	7
AGTCTTTCATATGAGA-1_1_A4	17.38148535	5.792242261	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2745	5934	0.013650152	0.009605662	1	oligos	OL-Cntl	26	7	7
AGTCTTTGTACACCGC-1_1_A4	3.578084503	5.146399691	7	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1128	1620	0.016049383	0.008641975	1	7	Phagocytes	26	7	7
AGTCTTTGTACCGTAT-1_1_A4	39.93184706	13.92490258	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1155	1644	0.012773723	0.010340633	1	14	Microglia	26	7	7
AGTCTTTGTACGAAAT-1_1_A4	15.60766541	27.65100282	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	810	1288	0	0.000776398	1	oligos	OL-Cntl	26	7	7
AGTCTTTGTGACGCCT-1_1_A4	-23.93879851	26.31238388	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1678	3169	0.00725781	0.002208899	1	8	Astrocytes	26	7	7
AGTCTTTTCGGATGGA-1_1_A4	21.04153529	-2.28382972	2	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1730	2924	0.004787962	0.003077975	1	2	EN-L4	26	7	7
AGTGAGGCAAAGCAAT-1_1_A4	-3.982024724	17.70063209	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	832	1228	0.016286645	0.017915309	1	oligos	OL-Cntl	26	7	7
AGTGAGGCAGCGATCC-1_1_A4	10.93039486	14.83757986	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1235	2054	0.022395326	0.015579357	1	oligos	OL-Cntl	26	7	7
AGTGAGGGTGGCTCCA-1_1_A4	5.442466578	5.886915264	7	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2203	3668	0.005452563	0.006270447	1	7	Phagocytes	26	7	7
AGTGAGGTCGGAGGTA-1_1_A4	-29.80311777	-13.00297361	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	745	1016	0.00492126	0.012795276	1	9	OPC	26	7	7
AGTGGGACAAACTGCT-1_1_A4	-18.69945534	6.711556014	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	735	1119	0.00893655	0.00357462	1	8	Astrocytes	26	7	7
AGTGGGACAAGCGATG-1_1_A4	0.758270316	10.57013647	5	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1140	1800	0.016111111	0.016111111	1	oligos	OL-MS-1	26	7	7
AGTGGGACACCTGGTG-1_1_A4	-29.76272877	13.0975253	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	766	1199	0.00500417	0.001668057	1	8	Astrocytes	26	7	7
AGTGGGACAGCTTAAC-1_1_A4	-3.483496179	21.12500172	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	835	1196	0.018394649	0.015886288	1	oligos	OL-Cntl	26	7	7
AGTGGGACATAAAGGT-1_1_A4	-23.78342682	-1.358532935	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1226	1815	0.007162534	0.006060606	1	9	OPC	26	7	7
AGTGGGAGTAAGGGCT-1_1_A4	19.95371726	13.81641295	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1408	2436	0.006157635	0.002873563	1	oligos	OL-Cntl	26	7	7
AGTGGGAGTTTGACTG-1_1_A4	-35.55273951	-4.845282557	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1230	2018	0.005450942	0.006442022	1	9	OPC	26	7	7
AGTGGGATCCATTCTA-1_1_A4	-5.520137301	16.50477731	5	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	685	1016	0.021653543	0.01476378	1	oligos	OL-MS-1	26	7	7
AGTGGGATCCCGGATG-1_1_A4	-23.32253932	2.234108249	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2913	5676	0.007047216	0.004756871	1	11	Glia-MIX	26	7	7
AGTGTCAAGCACGCCT-1_1_A4	-5.015455661	-8.357449633	13A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	831	1251	0.04636291	0.006394884	1	13A	IN-VIP	26	7	7
AGTGTCATCGCCAGCA-1_1_A4	7.492307863	19.12878737	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1166	1733	0.007501443	0.005193306	1	oligos	OL-Cntl	26	7	7
AGTTGGTCACCGTTGG-1_1_A4	-10.3202535	-19.989846	6B	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	935	1567	0.026802808	0.006381621	1	6B	IN-SST	26	7	7
AGTTGGTCAGGCTCAC-1_1_A4	-22.43289059	29.08682767	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1941	3775	0.003443709	0.004768212	1	8	Astrocytes	26	7	7
ATAACGCGTCAATACC-1_1_A4	-1.473050411	26.01072241	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	706	1056	0.00094697	0.005681818	1	oligos	OL-Cntl	26	7	7
ATAACGCGTGCAGACA-1_1_A4	-27.66600978	23.14840907	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1233	2217	0.00360848	0.00360848	1	8	Astrocytes	26	7	7
ATAACGCTCGAACGGA-1_1_A4	-5.208737788	-4.795698973	13A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1292	2254	0.026619343	0.002218279	1	13A	IN-VIP	26	7	7
ATAAGAGCACAGATTC-1_1_A4	-15.06774927	-21.67921628	6A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1939	4342	0.007830493	0.00161216	1	6A	IN-PV	26	7	7
ATAAGAGGTAACGACG-1_1_A4	-9.590182856	15.06546109	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1811	3221	0.00838249	0.003725551	1	11	Glia-MIX	26	7	7
ATAAGAGTCCTCAATT-1_1_A4	18.92559495	11.237391	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1449	2661	0.01841413	0.006012777	1	oligos	OL-Cntl	26	7	7
ATAGACCAGACCCACC-1_1_A4	17.1549616	-0.69348884	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	780	1273	0	0.001571092	1	12	EN-MIX	26	7	7
ATAGACCAGAGCTGCA-1_1_A4	-12.79564515	-1.007648947	13A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2855	5865	0.005967604	0.009548167	1	13A	IN-VIP	26	7	7
ATAGACCCAGCGTAAG-1_1_A4	-6.701078491	12.11929727	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	771	1112	0.023381295	0.017086331	1	oligos	OL-Cntl	26	7	7
ATAGACCCATCACCCT-1_1_A4	39.5809203	10.67846242	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	794	1130	0.007964602	0.003539823	1	14	Microglia	26	7	7
ATAGACCGTAGCGTGA-1_1_A4	-3.432276629	25.55072718	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	724	1155	0.004329004	0.006060606	1	oligos	OL-Cntl	26	7	7
ATAGACCTCAACACTG-1_1_A4	5.018883461	22.84250749	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	799	1194	0.008375209	0.005862647	1	oligos	OL-Cntl	26	7	7
ATAGACCTCATACGGT-1_1_A4	-26.09200216	22.64836688	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1228	2250	0.005333333	0.001777778	1	8	Astrocytes	26	7	7
ATCACGACACACAGAG-1_1_A4	6.130291492	6.107930179	7	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2908	5510	0.005807623	0.005263158	1	7	Phagocytes	26	7	7
ATCACGACATAGAAAC-1_1_A4	37.88993701	9.53617229	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	774	1025	0.003902439	0.013658537	1	14	Microglia	26	7	7
ATCACGAGTAAGTGGC-1_1_A4	38.28445285	9.625571295	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	896	1197	0.010025063	0.005012531	1	14	Microglia	26	7	7
ATCACGAGTTACGACT-1_1_A4	21.138969	8.473990235	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2163	4115	0.008262454	0.007047388	1	oligos	OL-Cntl	26	7	7
ATCACGAGTTCACGGC-1_1_A4	14.25737763	22.61261346	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	951	1450	0.005517241	0.009655172	1	oligos	OL-Cntl	26	7	7
ATCACGATCGCCATAA-1_1_A4	-11.45536713	17.16704717	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1769	2919	0.010962658	0.004796163	1	11	Glia-MIX	26	7	7
ATCACGATCTGCGGCA-1_1_A4	3.090591136	19.78866561	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	867	1299	0.022324865	0.007698229	1	oligos	OL-Cntl	26	7	7
ATCATCTAGAGGACGG-1_1_A4	-26.28176795	13.91728223	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1032	1671	0.001795332	0.004189108	1	8	Astrocytes	26	7	7
ATCATCTGTCCTAGCG-1_1_A4	-1.280665642	24.75108661	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	712	1028	0.019455253	0.007782101	1	oligos	OL-Cntl	26	7	7
ATCATCTGTCGGCTCA-1_1_A4	3.925263973	21.63390236	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	936	1496	0.015374332	0.009358289	1	oligos	OL-Cntl	26	7	7
ATCATGGAGAGATGAG-1_1_A4	4.959200379	19.08174451	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	954	1396	0.007163324	0.010028653	1	oligos	OL-Cntl	26	7	7
ATCATGGCAAGCCCAC-1_1_A4	-22.54470643	27.48570566	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1816	3416	0.005269321	0.006733021	1	8	Astrocytes	26	7	7
ATCATGGCACACAGAG-1_1_A4	-23.6253786	0.578514221	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2267	4293	0.006289308	0.00791987	1	9	OPC	26	7	7
ATCATGGGTAGAGCTG-1_1_A4	-24.93599596	16.7117056	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1282	2121	0.011315417	0.009429514	1	8	Astrocytes	26	7	7
ATCATGGGTCCGAACC-1_1_A4	12.32052616	12.00395921	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1329	2234	0.017457475	0.015666965	1	oligos	OL-Cntl	26	7	7
ATCATGGGTTGACGTT-1_1_A4	22.18896318	-9.071484641	3	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2375	5110	0.004109589	0.002348337	1	3	EN-L5-6	26	7	7
ATCATGGTCAACGGCC-1_1_A4	-0.870049438	25.41011963	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	726	1091	0.004582951	0.002749771	1	oligos	OL-Cntl	26	7	7
ATCATGGTCCGCGCAA-1_1_A4	-25.63810951	20.3825034	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1578	2870	0.001393728	0.004181185	1	8	Astrocytes	26	7	7
ATCCACCAGACGCAAC-1_1_A4	-34.17396208	-11.53743197	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	907	1500	0.006666667	0.003333333	1	9	OPC	26	7	7
ATCCACCAGCTTATCG-1_1_A4	-1.920175757	24.77269794	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	743	1037	0.008678881	0.011571842	1	oligos	OL-Cntl	26	7	7
ATCCACCAGTGATCGG-1_1_A4	-23.76203029	-2.190276775	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	999	1497	0.007348029	0.003340013	1	9	OPC	26	7	7
ATCCACCCAGGACCCT-1_1_A4	-25.22841286	20.10738765	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1520	2952	0.001693767	0.002710027	1	8	Astrocytes	26	7	7
ATCCACCCAGTATCTG-1_1_A4	-35.91554384	-4.620640153	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1325	2287	0.005684303	0.003060778	1	9	OPC	26	7	7
ATCCACCCATTGGCGC-1_1_A4	-26.39282019	2.053618576	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	3479	7354	0.003535491	0.007070982	1	9	OPC	26	7	7
ATCCACCGTACCATCA-1_1_A4	39.32522823	11.55644212	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	945	1365	0.002197802	0.008058608	1	14	Microglia	26	7	7
ATCCGAACAATGGAAT-1_1_A4	-35.05357035	-8.486184543	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1060	1628	0.002457002	0.003685504	1	9	OPC	26	7	7
ATCCGAACACATTCGA-1_1_A4	15.63133735	22.03186776	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1045	1587	0.006301197	0.006931317	1	oligos	OL-Cntl	26	7	7
ATCCGAACAGACGCAA-1_1_A4	-4.013301926	-7.900543419	13A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	779	1173	0.019607843	0.002557545	1	13A	IN-VIP	26	7	7
ATCCGAAGTCGACTGC-1_1_A4	7.394894152	19.02891499	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1136	1927	0.012454593	0.009859886	1	oligos	OL-Cntl	26	7	7
ATCCGAAGTTCGTCTC-1_1_A4	19.93919218	15.95295269	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1305	2153	0.002786809	0.004644682	1	oligos	OL-Cntl	26	7	7
ATCCGAATCTGGCGTG-1_1_A4	-25.42863711	18.70017697	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1384	2446	0.00572363	0.002452984	1	8	Astrocytes	26	7	7
ATCGAGTCAACGATGG-1_1_A4	-37.21694967	-0.713297396	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1520	2700	0.004074074	0.002962963	1	9	OPC	26	7	7
ATCGAGTGTACCGTAT-1_1_A4	8.408977093	-15.35396649	4	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	3012	5686	0.014773127	0.00615547	1	L2-3	EN-L2-3-MS	26	7	7
ATCGAGTTCAATCACG-1_1_A4	-23.45324312	2.417248771	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	4618	11231	0.009260084	0.003917728	1	11	Glia-MIX	26	7	7
ATCGAGTTCCTTAATC-1_1_A4	-9.703151657	22.73626905	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1327	1971	0.014713343	0.008625063	1	14	Microglia	26	7	7
ATCTACTAGACACGAC-1_1_A4	4.008844466	5.199384985	7	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1243	1818	0.010451045	0.00660066	1	7	Phagocytes	26	7	7
ATCTACTAGATGCGAC-1_1_A4	-28.45216312	20.80942733	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1130	1928	0.000518672	0.004149378	1	8	Astrocytes	26	7	7
ATCTACTAGTGAAGAG-1_1_A4	21.30856444	15.50742623	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1331	2213	0.012200633	0.005422503	1	oligos	OL-Cntl	26	7	7
ATCTACTCAAACCCAT-1_1_A4	6.936522249	17.25949637	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1087	1772	0.023137698	0.016365688	1	oligos	OL-Cntl	26	7	7
ATCTACTCAGTATCTG-1_1_A4	-11.19112855	15.14547302	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1422	2351	0.008081667	0.004253509	1	11	Glia-MIX	26	7	7
ATCTACTGTATGCTTG-1_1_A4	20.40773197	7.12420218	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2231	4470	0.014317673	0.004474273	1	oligos	OL-Cntl	26	7	7
ATCTACTGTTTGCATG-1_1_A4	4.526730396	5.074017189	7	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1616	2445	0.007361963	0.008179959	1	7	Phagocytes	26	7	7
ATCTGCCAGAACAATC-1_1_A4	-5.799491349	8.55097302	5	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1075	1763	0.009642655	0.027226319	1	oligos	OL-MS-1	26	7	7
ATCTGCCAGCTAAGAT-1_1_A4	28.86598059	0.613386899	2	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	3349	8175	0.000733945	0.005993884	1	2	EN-L4	26	7	7
ATCTGCCCACCAGGCT-1_1_A4	14.1598183	6.42164725	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1978	3623	0.01269666	0.014628761	1	oligos	OL-Cntl	26	7	7
ATCTGCCTCCCAGGTG-1_1_A4	4.340806157	18.22220062	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1127	1837	0.016330974	0.01034295	1	oligos	OL-Cntl	26	7	7
ATCTGCCTCCCTCTTT-1_1_A4	-12.55925026	-17.96812565	6B	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1205	2234	0.039391226	0.002685765	1	6B	IN-SST	26	7	7
ATCTGCCTCGGTGTTA-1_1_A4	15.88801797	15.81247108	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1163	1853	0.003777658	0.003237992	1	oligos	OL-Cntl	26	7	7
ATGAGGGAGACAGAGA-1_1_A4	6.629189348	19.9129791	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	996	1517	0.016479895	0.008569545	1	oligos	OL-Cntl	26	7	7
ATGAGGGCAAGCTGGA-1_1_A4	13.2896375	6.592829365	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1718	2943	0.014610941	0.011213048	1	oligos	OL-Cntl	26	7	7
ATGAGGGCACATGGGA-1_1_A4	-21.37217477	-26.36083001	6A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2838	6392	0.005788486	0.00422403	1	6A	IN-PV	26	7	7
ATGAGGGCAGGTGCCT-1_1_A4	12.84035213	10.60338862	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1460	2400	0.019583333	0.008333333	1	oligos	OL-Cntl	26	7	7
ATGAGGGCATGTTCCC-1_1_A4	37.13949701	10.67419266	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	989	1487	0.003362475	0.011432414	1	14	Microglia	26	7	7
ATGAGGGGTCAAAGCG-1_1_A4	17.59991807	19.06160363	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1101	1730	0.00867052	0.006936416	1	oligos	OL-Cntl	26	7	7
ATGAGGGTCTAGAGTC-1_1_A4	2.570407309	6.026140868	7	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1478	2272	0.007482394	0.008802817	1	7	Phagocytes	26	7	7
ATGCGATAGCAGCCTC-1_1_A4	4.321746843	26.7570834	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	799	1184	0.005912162	0.003378378	1	oligos	OL-Cntl	26	7	7
ATGCGATCAGATCCAT-1_1_A4	16.1829943	9.86225522	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1660	3159	0.006964229	0.003165559	1	oligos	OL-Cntl	26	7	7
ATGCGATCAGCCACCA-1_1_A4	-4.479659918	18.46714716	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	839	1237	0.008892482	0.013742926	1	oligos	OL-Cntl	26	7	7
ATGCGATCATAACCTG-1_1_A4	16.33452828	1.816442278	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	821	1173	0.00341006	0.00341006	1	12	EN-MIX	26	7	7
ATGCGATGTAATCACC-1_1_A4	-26.30660723	17.38926467	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1092	1784	0	0.006726457	1	8	Astrocytes	26	7	7
ATGCGATGTTCTCATT-1_1_A4	2.116520004	26.47081096	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	690	1012	0.003952569	0.002964427	1	oligos	OL-Cntl	26	7	7
ATGCGATGTTGAGTTC-1_1_A4	7.929010423	13.8557536	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1176	1894	0.005807814	0.010559662	1	oligos	OL-Cntl	26	7	7
ATGCGATTCACCAGGC-1_1_A4	-29.04039542	9.936767419	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	698	1023	0.008797654	0.004887586	1	8	Astrocytes	26	7	7
ATGCGATTCTACTCAT-1_1_A4	-21.77159293	26.18543375	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1818	3454	0.001158078	0.006658946	1	8	Astrocytes	26	7	7
ATGCGATTCTAGAGTC-1_1_A4	39.91400749	12.94021774	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1001	1401	0.001427552	0.007851535	1	14	Microglia	26	7	7
ATGCGATTCTTACCGC-1_1_A4	-1.85472845	19.67588661	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	789	1132	0.011484099	0.015017668	1	oligos	OL-Cntl	26	7	7
ATGGGAGAGGTAGCTG-1_1_A4	-31.8433802	-12.87581375	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	799	1208	0.004139073	0.018211921	1	9	OPC	26	7	7
ATGGGAGGTTCGCTAA-1_1_A4	-34.81842071	-12.05473864	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	797	1177	0.001699235	0.003398471	1	9	OPC	26	7	7
ATGGGAGTCGTGGACC-1_1_A4	-22.49543476	25.57925073	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1611	2919	0.004110997	0.006166495	1	8	Astrocytes	26	7	7
ATGTGTGTCATCTGCC-1_1_A4	-27.02177783	22.77356745	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1247	2082	0.004322767	0.002881844	1	8	Astrocytes	26	7	7
ATTACTCCATGCTGGC-1_1_A4	-38.04564859	-8.159655194	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1080	1865	0.005898123	0.001608579	1	9	OPC	26	7	7
ATTACTCGTCATATGC-1_1_A4	-0.240824247	23.29340791	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	693	1002	0.01497006	0.00998004	1	oligos	OL-Cntl	26	7	7
ATTACTCTCCGATATG-1_1_A4	-2.084322247	27.45765535	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	698	1148	0.003484321	0.004355401	1	oligos	OL-Cntl	26	7	7
ATTATCCGTCGCATCG-1_1_A4	-27.51080137	24.48794323	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1309	2522	0	0.003172086	1	8	Astrocytes	26	7	7
ATTCTACAGCATGGCA-1_1_A4	-26.04910736	22.79390624	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1308	2374	0.00463353	0.00294861	1	8	Astrocytes	26	7	7
ATTCTACTCAATACCG-1_1_A4	-16.39589501	-25.99635234	6A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2153	5216	0.011119632	0.002300613	1	6A	IN-PV	26	7	7
ATTCTACTCCTCAATT-1_1_A4	11.57553689	25.06865367	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	787	1207	0	0.003314002	1	oligos	OL-Cntl	26	7	7
ATTCTACTCGGTCTAA-1_1_A4	11.40434564	24.17958722	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	894	1407	0.008528785	0.007107321	1	oligos	OL-Cntl	26	7	7
ATTCTACTCTAACCGA-1_1_A4	-11.28181507	8.818782871	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	5458	15973	0.009578664	0.004131973	1	11	Glia-MIX	26	7	7
ATTGGACAGCCACCTG-1_1_A4	-1.256195353	-0.813086003	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2707	5883	0.009688934	0.005949346	1	11	Glia-MIX	26	7	7
ATTGGACAGCGTGAAC-1_1_A4	-30.83345181	11.35341521	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	774	1219	0.001640689	0.002461034	1	8	Astrocytes	26	7	7
ATTGGACGTTCCGGCA-1_1_A4	13.19402234	20.9283222	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	929	1484	0.003369272	0.005390836	1	oligos	OL-Cntl	26	7	7
ATTGGACTCCACGTTC-1_1_A4	-25.283054	18.70932552	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1445	2448	0.005310458	0.006127451	1	8	Astrocytes	26	7	7
ATTGGTGAGATGTTAG-1_1_A4	-7.392818062	-8.819033245	13A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1115	1746	0.019473081	0.009736541	1	13A	IN-VIP	26	7	7
ATTGGTGCACAGCGTC-1_1_A4	-5.71343098	-7.671184884	13A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	906	1397	0.052254832	0.005010737	1	13A	IN-VIP	26	7	7
ATTGGTGCACGGACAA-1_1_A4	-35.46409096	-1.755819417	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1443	2414	0.003728252	0.006213753	1	9	OPC	26	7	7
ATTGGTGGTAAGAGGA-1_1_A4	20.46946286	-27.48041228	3	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2828	6083	0.001643926	0.002465889	1	3	EN-L5-6	26	7	7
ATTGGTGGTAAGTAGT-1_1_A4	-21.56850821	29.22687162	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2218	4376	0.009369287	0.004341865	1	8	Astrocytes	26	7	7
ATTGGTGGTTCTGAAC-1_1_A4	-13.58647858	-24.22611874	6A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1281	2503	0.017978426	0.001598082	1	6A	IN-PV	26	7	7
ATTGGTGGTTTAGCTG-1_1_A4	3.528471435	28.8245453	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	697	1060	0.021698113	0.003773585	1	oligos	OL-Cntl	26	7	7
ATTGGTGGTTTGCATG-1_1_A4	-9.639417657	17.83138732	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2708	5244	0.004958047	0.006102212	1	11	Glia-MIX	26	7	7
ATTGGTGTCACAGGCC-1_1_A4	14.29142675	-1.783099394	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1032	1595	0.001880878	0.003134796	1	12	EN-MIX	26	7	7
ATTGGTGTCCCAAGAT-1_1_A4	16.04217387	-2.947630718	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1112	1842	0.008143322	0.002171553	1	12	EN-MIX	26	7	7
ATTGGTGTCTCTGCTG-1_1_A4	-10.49437414	9.968387536	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2645	5235	0.005157593	0.005348615	1	11	Glia-MIX	26	7	7
ATTTCTGAGTGAACAT-1_1_A4	-4.279493492	25.50372835	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	819	1363	0.012472487	0.00513573	1	oligos	OL-Cntl	26	7	7
ATTTCTGCAGCTGTTA-1_1_A4	4.751143134	5.504696193	7	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1643	2521	0.00396668	0.009123364	1	7	Phagocytes	26	7	7
ATTTCTGGTACTCAAC-1_1_A4	-0.945852726	24.88291505	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	702	1047	0	0.005730659	1	oligos	OL-Cntl	26	7	7
ATTTCTGGTATCACCA-1_1_A4	-0.589355281	22.9808058	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	747	1122	0.007130125	0.009803922	1	oligos	OL-Cntl	26	7	7
CAACCAAAGAGGTAGA-1_1_A4	32.62793951	14.52346147	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	773	1005	0	0.046766169	1	14	Microglia	26	7	7
CAACCAACACGCTTTC-1_1_A4	-19.61679594	8.479584386	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	967	1405	0.008540925	0.008540925	1	8	Astrocytes	26	7	7
CAACCAAGTGTTGGGA-1_1_A4	2.826104152	20.15859312	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	906	1347	0.004454343	0.012620638	1	oligos	OL-Cntl	26	7	7
CAACCAATCCGTAGTA-1_1_A4	6.251190877	6.287025864	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	3014	6503	0.00445948	0.007381209	1	oligos	OL-Cntl	26	7	7
CAACCAATCCTTAATC-1_1_A4	35.5170899	7.814342688	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	857	1190	0.000840336	0.005042017	1	14	Microglia	26	7	7
CAACCAATCTTAACCT-1_1_A4	-9.734343863	22.37790843	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1246	1775	0.005633803	0.002253521	1	8	Astrocytes	26	7	7
CAACCTCAGAGCCTAG-1_1_A4	-23.37681269	26.08589074	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1645	2933	0.004432322	0.008182748	1	8	Astrocytes	26	7	7
CAACCTCAGATCGGGT-1_1_A4	3.29934956	-3.957056993	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	827	1250	0.0152	0.0032	1	12	EN-MIX	26	7	7
CAACCTCAGCCTATGT-1_1_A4	-30.73904538	-13.28696877	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	733	1265	0.005533597	0.000790514	1	9	OPC	26	7	7
CAACCTCAGCGTCTAT-1_1_A4	-23.29233246	25.7347708	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1713	3394	0.000883913	0.001473188	1	8	Astrocytes	26	7	7
CAACCTCAGGGATACC-1_1_A4	24.49135402	-25.75520899	3	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2870	6882	0.001743679	0.002906132	1	3	EN-L5-6	26	7	7
CAACCTCAGGGTGTTG-1_1_A4	-10.51998043	16.62583526	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1995	3526	0.016165627	0.00794101	1	11	Glia-MIX	26	7	7
CAACCTCGTCAACTGT-1_1_A4	-22.59479645	29.40077596	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1993	4078	0.003433055	0.002452182	1	8	Astrocytes	26	7	7
CAACCTCTCCATGCTC-1_1_A4	16.62456629	17.8334593	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1130	1863	0.003220612	0.009125067	1	oligos	OL-Cntl	26	7	7
CAACCTCTCTACTCAT-1_1_A4	6.458640943	-5.796098918	10	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1151	1999	0.002501251	0.00150075	1	L2-3	EN-L2-3-Cntl	26	7	7
CAACTAGAGTGAAGAG-1_1_A4	-7.574470952	35.66273227	17	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	986	1463	0.015037594	0.00683527	1	oligos	OL-MS-2	26	7	7
CAACTAGAGTGTCCAT-1_1_A4	2.487691124	21.44666541	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	922	1369	0.005113221	0.008765522	1	oligos	OL-Cntl	26	7	7
CAACTAGCACCAGCAC-1_1_A4	16.00146142	24.87165876	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1001	1708	0.004098361	0.005269321	1	oligos	OL-Cntl	26	7	7
CAACTAGCATCAGTAC-1_1_A4	-38.19647054	-1.037208416	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1460	2765	0.007233273	0.0039783	1	9	OPC	26	7	7
CAACTAGGTATATGGA-1_1_A4	6.866929611	20.87239494	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	931	1405	0.014234875	0.010676157	1	oligos	OL-Cntl	26	7	7
CAACTAGGTGATGTGG-1_1_A4	-3.84573428	24.87861793	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	760	1151	0.003475239	0.012163336	1	oligos	OL-Cntl	26	7	7
CAACTAGGTGCTCTTC-1_1_A4	-12.0994796	-19.35498393	6B	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1022	1703	0.028772754	0.005871991	1	6B	IN-SST	26	7	7
CAACTAGTCGAATGCT-1_1_A4	5.672814678	12.39398083	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1388	2507	0.008376546	0.008376546	1	oligos	OL-Cntl	26	7	7
CAAGAAAGTATGAAAC-1_1_A4	6.144973237	13.28793976	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1184	1786	0.020156775	0.01287794	1	oligos	OL-Cntl	26	7	7
CAAGAAATCGCCATAA-1_1_A4	14.75052262	16.21758638	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1153	1896	0.009493671	0.007911392	1	oligos	OL-Cntl	26	7	7
CAAGATCAGTGGGATC-1_1_A4	2.827798189	25.0185429	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	747	1166	0.013722127	0.003430532	1	oligos	OL-Cntl	26	7	7
CAAGATCCAGGTGCCT-1_1_A4	0.789292659	0.891006622	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	926	1286	0.017107309	0.00466563	1	11	Glia-MIX	26	7	7
CAAGATCCATCGGAAG-1_1_A4	-11.63767387	18.08682425	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1945	3638	0.011269929	0.006871908	1	11	Glia-MIX	26	7	7
CAAGATCCATTGAGCT-1_1_A4	9.006597642	9.270733102	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1440	2468	0.002431118	0.012155592	1	oligos	OL-Cntl	26	7	7
CAAGATCTCGTACGGC-1_1_A4	11.52992231	15.36815508	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1109	1706	0.013481829	0.007620164	1	oligos	OL-Cntl	26	7	7
CAAGGCCAGATCTGCT-1_1_A4	-3.794227242	16.42623314	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	778	1116	0.011648746	0.019713262	1	oligos	OL-Cntl	26	7	7
CAAGGCCAGCTCCTTC-1_1_A4	7.274551338	19.86529534	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1019	1635	0.006116208	0.011009174	1	oligos	OL-Cntl	26	7	7
CAAGGCCGTCTAGTCA-1_1_A4	-7.182064108	-4.515794441	13A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1605	2775	0.027747748	0.002882883	1	13A	IN-VIP	26	7	7
CAAGGCCGTGGAAAGA-1_1_A4	4.637123561	-4.219862696	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1081	1698	0.007656066	0.010011779	1	12	EN-MIX	26	7	7
CAAGGCCGTGGTAACG-1_1_A4	2.50081834	6.297029746	7	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	850	1176	0.023809524	0.006802721	1	7	Phagocytes	26	7	7
CAAGGCCGTTCAACCA-1_1_A4	6.912056724	-6.03176079	10	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1472	2883	0.014221297	0.001387444	1	L2-3	EN-L2-3-Cntl	26	7	7
CAAGGCCGTTCGAATC-1_1_A4	38.30519615	13.49500137	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1047	1516	0.009234828	0.013852243	1	14	Microglia	26	7	7
CAAGGCCTCGTCTGCT-1_1_A4	39.81585923	11.44409837	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	895	1228	0.00732899	0.002442997	1	14	Microglia	26	7	7
CAAGGCCTCTCTGCTG-1_1_A4	22.34247041	10.51425886	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1584	2693	0.005198663	0.00482733	1	oligos	OL-Cntl	26	7	7
CAAGTTGAGGATTCGG-1_1_A4	-10.04190168	17.77160994	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2136	3925	0.006878981	0.004585987	1	11	Glia-MIX	26	7	7
CAAGTTGAGGGTTTCT-1_1_A4	6.168165097	5.973925751	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	4859	12159	0.009869233	0.009375771	1	11	Glia-MIX	26	7	7
CAAGTTGAGGTGCTAG-1_1_A4	3.942064274	11.79071395	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1204	1968	0.011178862	0.015243902	1	oligos	OL-Cntl	26	7	7
CAAGTTGAGGTTACCT-1_1_A4	38.31011425	10.08531505	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	818	1088	0.005514706	0.012867647	1	14	Microglia	26	7	7
CAAGTTGCATGGTAGG-1_1_A4	16.36594767	1.750909686	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	717	1028	0.024319066	0.000972763	1	12	EN-MIX	26	7	7
CAAGTTGCATTGCGGC-1_1_A4	-22.60260016	-0.356105719	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1463	2336	0.008989726	0.003424658	1	9	OPC	26	7	7
CAAGTTGTCAGCGACC-1_1_A4	4.463517193	17.34659153	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	990	1482	0.012820513	0.020917679	1	oligos	OL-Cntl	26	7	7
CACAAACAGAGTGAGA-1_1_A4	21.12041432	14.99034364	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1261	2056	0.009727626	0.004377432	1	oligos	OL-Cntl	26	7	7
CACAAACAGCTAACAA-1_1_A4	19.89726818	9.089569487	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1644	3018	0.003644798	0.001988072	1	oligos	OL-Cntl	26	7	7
CACAAACAGGACACCA-1_1_A4	-21.39891047	27.45663575	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1887	3535	0.00311174	0.011315417	1	8	Astrocytes	26	7	7
CACAAACAGTACTTGC-1_1_A4	4.097299754	5.368023801	7	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1470	2181	0.0174232	0.006419074	1	7	Phagocytes	26	7	7
CACAAACAGTCCAGGA-1_1_A4	2.985164228	-4.682238995	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	868	1403	0.001425517	0.003563792	1	12	EN-MIX	26	7	7
CACAAACAGTCCCACG-1_1_A4	15.55923274	15.01433737	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1279	2206	0.003626473	0.007252947	1	oligos	OL-Cntl	26	7	7
CACAAACCACCATCCT-1_1_A4	-33.11548146	-11.10353282	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	908	1404	0.007834758	0.007834758	1	9	OPC	26	7	7
CACAAACCATGTAAGA-1_1_A4	-22.49698917	29.20156873	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1963	3879	0.005155968	0.003093581	1	8	Astrocytes	26	7	7
CACAAACGTCCTCCAT-1_1_A4	-31.56807928	-1.195676174	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1607	2877	0.004518596	0.003128259	1	9	OPC	26	7	7
CACAAACGTCTACCTC-1_1_A4	15.33341405	29.30029622	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	773	1182	0.001692047	0.002538071	1	oligos	OL-Cntl	26	7	7
CACAAACGTTGATTCG-1_1_A4	-5.059771359	29.65386384	17	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1256	2015	0.02382134	0.004962779	1	oligos	OL-MS-2	26	7	7
CACAAACTCTCCAACC-1_1_A4	-37.27920366	-0.076584546	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1543	2839	0.002817894	0.001408947	1	9	OPC	26	7	7
CACACAAAGCCGTCGT-1_1_A4	-0.183678363	27.83150419	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	707	1016	0.003937008	0.005905512	1	oligos	OL-Cntl	26	7	7
CACACAAAGTACGCGA-1_1_A4	5.704382875	18.70736105	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1037	1600	0.003125	0.015	1	oligos	OL-Cntl	26	7	7
CACACAACACATTAGC-1_1_A4	6.158492589	26.29666775	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	834	1247	0.006415397	0.007217322	1	oligos	OL-Cntl	26	7	7
CACACAACAGCATGAG-1_1_A4	11.18895379	14.85064973	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1154	1832	0.004912664	0.008733624	1	oligos	OL-Cntl	26	7	7
CACACAAGTCCGCTGA-1_1_A4	3.246387388	31.64988281	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	710	1023	0.011730205	0.001955034	1	oligos	OL-Cntl	26	7	7
CACACAAGTCTCCCTA-1_1_A4	-23.32705022	28.43043737	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1966	3837	0.003388064	0.001042481	1	8	Astrocytes	26	7	7
CACACAAGTTGTCGCG-1_1_A4	-31.43898729	-12.82206287	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	833	1282	0.009360374	0.003900156	1	9	OPC	26	7	7
CACACAATCACCGGGT-1_1_A4	18.01874712	-0.063731021	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1086	1799	0.003335186	0.001667593	1	12	EN-MIX	26	7	7
CACACAATCGTTTATC-1_1_A4	-22.67641234	26.18678941	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1691	3271	0.004585754	0.003668603	1	8	Astrocytes	26	7	7
CACACCTCAAGTAGTA-1_1_A4	-8.329916572	-2.847679453	13A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2122	4384	0.013914234	0.004562044	1	13A	IN-VIP	26	7	7
CACACCTCATTATCTC-1_1_A4	12.7152524	15.22265926	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1244	2077	0.014925373	0.008184882	1	oligos	OL-Cntl	26	7	7
CACACCTGTCATCCCT-1_1_A4	20.01190318	15.99751377	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1284	2204	0.018602541	0.012250454	1	oligos	OL-Cntl	26	7	7
CACACCTGTCGCGAAA-1_1_A4	-8.180157768	-1.28991144	13A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2192	4525	0.00839779	0.00198895	1	13A	IN-VIP	26	7	7
CACACCTGTGTCAATC-1_1_A4	13.36243753	12.73074788	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1278	2092	0.013384321	0.011950287	1	oligos	OL-Cntl	26	7	7
CACACCTTCATCTGTT-1_1_A4	35.96746635	7.993079643	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	749	1012	0.001976285	0.009881423	1	14	Microglia	26	7	7
CACACTCAGAAGATTC-1_1_A4	-7.036347626	-5.613269214	13A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1491	2525	0.018613861	0.005544554	1	13A	IN-VIP	26	7	7
CACACTCCAATAGCGG-1_1_A4	4.477644104	-10.58521788	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1789	3178	0.013845186	0.007237256	1	12	EN-MIX	26	7	7
CACACTCCAGCCACCA-1_1_A4	-24.91945534	27.02169633	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1720	3338	0.003594967	0.001497903	1	8	Astrocytes	26	7	7
CACACTCCATACTCTT-1_1_A4	14.51304319	13.88154255	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1298	2152	0.008828996	0.012081784	1	oligos	OL-Cntl	26	7	7
CACACTCGTAAACACA-1_1_A4	-33.22774376	-8.726338188	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1110	1924	0.002598753	0.002079002	1	9	OPC	26	7	7
CACAGGCAGCGATAGC-1_1_A4	5.766622132	18.73594477	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1038	1660	0.013855422	0.015060241	1	oligos	OL-Cntl	26	7	7
CACAGGCAGTCTCCTC-1_1_A4	8.931341145	14.11965811	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1119	1808	0.01050885	0.011615044	1	oligos	OL-Cntl	26	7	7
CACAGGCAGTTAAGTG-1_1_A4	-4.108121077	-8.462356644	13A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	763	1137	0.030782762	0.000879507	1	13A	IN-VIP	26	7	7
CACAGGCCAGTAGAGC-1_1_A4	-1.445345066	19.77489413	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	876	1327	0.002260739	0.016578749	1	oligos	OL-Cntl	26	7	7
CACAGGCGTATATGAG-1_1_A4	5.503891333	21.1606567	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	951	1463	0.014354067	0.004784689	1	oligos	OL-Cntl	26	7	7
CACAGGCGTCGGCACT-1_1_A4	4.941324875	4.607781313	7	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2079	3426	0.010507881	0.010507881	1	7	Phagocytes	26	7	7
CACAGGCTCAATACCG-1_1_A4	19.97781102	16.8200526	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1187	1932	0.002070393	0.004658385	1	oligos	OL-Cntl	26	7	7
CACAGGCTCAGCCTAA-1_1_A4	-2.16294855	19.60534248	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	833	1253	0.005586592	0.011173184	1	oligos	OL-Cntl	26	7	7
CACAGGCTCCCATTTA-1_1_A4	5.756836677	12.43664884	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1312	2129	0.021136684	0.015030531	1	oligos	OL-Cntl	26	7	7
CACAGTAAGCTCCTCT-1_1_A4	-20.89187431	30.85719595	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2456	5413	0.005726954	0.005357473	1	8	Astrocytes	26	7	7
CACAGTAAGGCCCGTT-1_1_A4	-5.916611311	16.83768626	5	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	871	1294	0.021638331	0.00927357	1	oligos	OL-MS-1	26	7	7
CACAGTAAGGCTCATT-1_1_A4	-23.69286614	-1.020253741	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1600	2940	0.002721088	0.004081633	1	9	OPC	26	7	7
CACAGTAAGTGTTGAA-1_1_A4	-35.3453786	-4.758149377	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1293	2174	0.001839926	0.005979761	1	9	OPC	26	7	7
CACAGTACATCGGACC-1_1_A4	2.361233944	27.40693887	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	801	1172	0.007679181	0.005972696	1	oligos	OL-Cntl	26	7	7
CACAGTAGTAAGAGGA-1_1_A4	-4.430418472	14.94255979	5	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	820	1204	0.03654485	0.014119601	1	oligos	OL-MS-1	26	7	7
CACAGTAGTAGAAAGG-1_1_A4	-22.33686536	26.68988331	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1956	3577	0.003075203	0.00363433	1	8	Astrocytes	26	7	7
CACAGTAGTGTTCGAT-1_1_A4	-35.5762627	-4.857600509	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1260	2049	0.002928258	0.002440215	1	9	OPC	26	7	7
CACAGTAGTTACCAGT-1_1_A4	-9.336343628	-1.888666696	13A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2203	4227	0.022947717	0.00378519	1	13A	IN-VIP	26	7	7
CACAGTATCAACCAAC-1_1_A4	8.962514363	8.513015988	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1495	2679	0.008212019	0.010078387	1	oligos	OL-Cntl	26	7	7
CACAGTATCCACGAAT-1_1_A4	-0.496869219	27.49180159	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	739	1086	0.008287293	0.005524862	1	oligos	OL-Cntl	26	7	7
CACAGTATCCGCAGTG-1_1_A4	-25.24149419	17.99591913	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1352	2509	0.005181347	0.003188521	1	8	Astrocytes	26	7	7
CACATAGAGAAGGACA-1_1_A4	11.89655213	10.79824452	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1536	2744	0.014941691	0.012755102	1	oligos	OL-Cntl	26	7	7
CACATAGAGATGCCAG-1_1_A4	4.400273394	17.39439044	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1042	1602	0.011235955	0.009987516	1	oligos	OL-Cntl	26	7	7
CACATAGAGCCACGCT-1_1_A4	39.93529531	11.03058161	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	920	1378	0.001451379	0.004354136	1	14	Microglia	26	7	7
CACATAGAGTCAAGCG-1_1_A4	-8.255717397	-17.39869191	6B	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	739	1134	0.048500882	0.007054674	1	6B	IN-SST	26	7	7
CACATAGCAGCTGCTG-1_1_A4	17.09177353	22.34612331	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	915	1515	0.001980198	0.005940594	1	oligos	OL-Cntl	26	7	7
CACATAGGTCAGTGGA-1_1_A4	4.979901067	21.01639294	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	912	1372	0.008017493	0.00728863	1	oligos	OL-Cntl	26	7	7
CACATAGTCAAGAAGT-1_1_A4	5.204912614	25.15782426	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	845	1254	0.003987241	0.013556619	1	oligos	OL-Cntl	26	7	7
CACATAGTCGTATCAG-1_1_A4	6.446655026	26.20873371	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	879	1237	0.018593371	0.007275667	1	oligos	OL-Cntl	26	7	7
CACATAGTCTATCCCG-1_1_A4	22.5548885	15.78868412	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1556	3054	0.000982318	0.004584152	1	oligos	OL-Cntl	26	7	7
CACATTTCAGGTCCAC-1_1_A4	5.386394448	25.3021377	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	911	1346	0.016344725	0.010401189	1	oligos	OL-Cntl	26	7	7
CACATTTGTACAGTGG-1_1_A4	8.073277971	13.53449537	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1100	1734	0.013264129	0.014417532	1	oligos	OL-Cntl	26	7	7
CACATTTTCCTGCCAT-1_1_A4	6.868061158	14.37714439	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1153	1954	0.008700102	0.012282497	1	oligos	OL-Cntl	26	7	7
CACCACTAGAATAGGG-1_1_A4	23.15167505	13.66860464	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1318	2345	0.000852878	0.003411514	1	oligos	OL-Cntl	26	7	7
CACCACTAGCCTATGT-1_1_A4	-10.22140296	-1.96153296	13A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1981	3619	0.022658193	0.009947499	1	13A	IN-VIP	26	7	7
CACCACTCAGCCTGTG-1_1_A4	-20.90526913	28.07553806	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1924	3622	0.005797902	0.005797902	1	8	Astrocytes	26	7	7
CACCACTCAGGTTTCA-1_1_A4	-4.863514326	-10.56719919	6B	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	670	1015	0.020689655	0.004926108	1	6B	IN-SST	26	7	7
CACCACTGTATGAATG-1_1_A4	4.746574338	21.50830682	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	897	1361	0.008817046	0.006612785	1	oligos	OL-Cntl	26	7	7
CACCACTGTGACTACT-1_1_A4	7.218663717	13.30064149	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1284	2032	0.012795276	0.010334646	1	oligos	OL-Cntl	26	7	7
CACCACTGTGGCTCCA-1_1_A4	-25.35540582	19.45667197	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1474	2684	0.010804769	0.003353204	1	8	Astrocytes	26	7	7
CACCAGGAGACAGGCT-1_1_A4	14.7385367	18.38412183	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1136	1687	0.01007706	0.01007706	1	oligos	OL-Cntl	26	7	7
CACCAGGAGCACCGCT-1_1_A4	-3.603179798	23.80853869	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	724	1056	0.024621212	0.005681818	1	oligos	OL-Cntl	26	7	7
CACCAGGAGTACATGA-1_1_A4	6.065343891	6.40734126	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2130	3834	0.007042254	0.007042254	1	oligos	OL-Cntl	26	7	7
CACCAGGCACACCGCA-1_1_A4	30.91639939	15.55995164	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1152	1654	0.004232164	0.087061669	1	14	Microglia	26	7	7
CACCAGGCACCACCAG-1_1_A4	-21.95335358	27.04588867	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1844	3572	0.003639418	0.010078387	1	8	Astrocytes	26	7	7
CACCAGGCAGTCACTA-1_1_A4	38.78845905	11.76007549	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1020	1400	0.002142857	0.009285714	1	14	Microglia	26	7	7
CACCAGGGTAAACACA-1_1_A4	-3.333507101	17.81192706	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	719	1123	0.00445236	0.007123776	1	oligos	OL-Cntl	26	7	7
CACCAGGTCATATCGG-1_1_A4	-20.48240117	28.690992	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1992	3673	0.002178056	0.010073509	1	8	Astrocytes	26	7	7
CACCAGGTCTACGAGT-1_1_A4	-4.652937473	-9.211349235	13A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	723	1035	0.021256039	0.004830918	1	13A	IN-VIP	26	7	7
CACCAGGTCTCGCTTG-1_1_A4	-22.27242515	26.41105322	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1706	3210	0.002180685	0.00623053	1	8	Astrocytes	26	7	7
CACCTTGAGCGGCTTC-1_1_A4	-10.91062286	9.33250937	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	5970	14119	0.00757844	0.013882003	1	11	Glia-MIX	26	7	7
CACCTTGAGGGTTTCT-1_1_A4	34.57514711	14.25425053	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1096	1489	0.010745467	0.018804567	1	14	Microglia	26	7	7
CACCTTGCAAATCCGT-1_1_A4	19.70358664	12.72029039	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1383	2413	0.003315375	0.004144219	1	oligos	OL-Cntl	26	7	7
CACCTTGCACCGGAAA-1_1_A4	19.89449611	17.63872144	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1215	1919	0.026055237	0.005211047	1	oligos	OL-Cntl	26	7	7
CACCTTGCATTACGAC-1_1_A4	4.318690471	5.28901797	7	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1460	2231	0.003585836	0.005378754	1	7	Phagocytes	26	7	7
CACCTTGGTCGCATAT-1_1_A4	13.96429131	16.15981052	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1139	1821	0.012081274	0.006040637	1	oligos	OL-Cntl	26	7	7
CACCTTGTCACATACG-1_1_A4	-5.331748099	-5.057673687	13A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1134	2002	0.013486513	0.003996004	1	13A	IN-VIP	26	7	7
CACCTTGTCAGCGACC-1_1_A4	-9.023319905	19.10961785	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	5252	13636	0.002933412	0.007553535	1	11	Glia-MIX	26	7	7
CACCTTGTCAGCTTAG-1_1_A4	0.979195046	-7.943039965	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1418	2549	0.012553943	0.005100039	1	12	EN-MIX	26	7	7
CACCTTGTCCGTACAA-1_1_A4	-7.292981717	-8.669554798	13A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1404	2300	0.015217391	0.006521739	1	13A	IN-VIP	26	7	7
CACCTTGTCGGCTACG-1_1_A4	4.77685948	16.58643209	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1116	1733	0.018465089	0.012117715	1	oligos	OL-Cntl	26	7	7
CACTCCAAGAATGTGT-1_1_A4	-5.470861675	-9.804253961	13B	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	849	1202	0.009151414	0.003327787	1	13B	IN-SV2C	26	7	7
CACTCCAAGCTAACAA-1_1_A4	15.38356832	15.85146545	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1160	1884	0.011677282	0.003715499	1	oligos	OL-Cntl	26	7	7
CACTCCACAAAGGAAG-1_1_A4	-30.79307278	13.5678715	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1002	1531	0.013063357	0.005878511	1	8	Astrocytes	26	7	7
CACTCCACATAGAAAC-1_1_A4	21.28904754	18.4384868	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1127	1788	0.003355705	0.002796421	1	oligos	OL-Cntl	26	7	7
CACTCCAGTTCCAACA-1_1_A4	39.29621762	11.72374952	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1021	1410	0.010638298	0.003546099	1	14	Microglia	26	7	7
CACTCCATCCCTGACT-1_1_A4	4.40172062	5.701404238	7	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1608	2601	0.00307574	0.00461361	1	7	Phagocytes	26	7	7
CACTCCATCCTTTCGG-1_1_A4	-13.75034173	-5.45729436	13A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2938	7046	0.017740562	0.003548112	1	13A	IN-VIP	26	7	7
CACTCCATCGCTGATA-1_1_A4	16.26993604	1.413058523	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	709	1062	0.032015066	0.00094162	1	12	EN-MIX	26	7	7
CAGAATCAGCAGACTG-1_1_A4	-4.294297869	-4.929559803	13A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1092	1822	0.024698134	0.002744237	1	13A	IN-VIP	26	7	7
CAGAATCAGGACAGAA-1_1_A4	-36.61160572	-8.186424786	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	964	1568	0.004464286	0.003188776	1	9	OPC	26	7	7
CAGAATCAGTTCGCGC-1_1_A4	4.824150279	5.720543748	7	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1718	2880	0.020833333	0.009027778	1	7	Phagocytes	26	7	7
CAGAATCCAGTCAGCC-1_1_A4	3.636841013	-5.631787099	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1012	1572	0.010814249	0.001908397	1	12	EN-MIX	26	7	7
CAGAATCGTACTTCTT-1_1_A4	-3.680831879	25.10621706	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	771	1086	0.014732965	0.008287293	1	oligos	OL-Cntl	26	7	7
CAGAATCGTGAACCTT-1_1_A4	14.86010889	15.78459211	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1215	2048	0.006347656	0.005371094	1	oligos	OL-Cntl	26	7	7
CAGAATCTCACGCATA-1_1_A4	5.577850037	20.35606576	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	906	1446	0.009681881	0.006915629	1	oligos	OL-Cntl	26	7	7
CAGAATCTCCGTAGTA-1_1_A4	12.4240811	22.39242555	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	893	1375	0.004363636	0.007272727	1	oligos	OL-Cntl	26	7	7
CAGAATCTCGTGGGAA-1_1_A4	6.08921102	24.5933315	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	926	1397	0.003579098	0.001431639	1	oligos	OL-Cntl	26	7	7
CAGAGAGGTCAAACTC-1_1_A4	39.60054634	14.74577476	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1288	1963	0.001018849	0.007131941	1	14	Microglia	26	7	7
CAGAGAGGTTGGACCC-1_1_A4	2.577172514	20.82346812	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	888	1317	0.006074412	0.006074412	1	oligos	OL-Cntl	26	7	7
CAGAGAGTCCAGAAGG-1_1_A4	3.643621023	17.85007788	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	917	1417	0.000705716	0.01340861	1	oligos	OL-Cntl	26	7	7
CAGATCAAGAGTGAGA-1_1_A4	-12.46822493	-10.46272365	13B	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1576	2730	0.01978022	0.004029304	1	13B	IN-SV2C	26	7	7
CAGATCAAGGACATTA-1_1_A4	4.798943837	25.95984883	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	847	1266	0.003949447	0.006319115	1	oligos	OL-Cntl	26	7	7
CAGATCAAGGTCGGAT-1_1_A4	4.202163497	15.49156054	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1060	1575	0.011428571	0.010793651	1	oligos	OL-Cntl	26	7	7
CAGATCACAGGGAGAG-1_1_A4	2.189457436	22.06528033	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	949	1355	0.011808118	0.006642066	1	oligos	OL-Cntl	26	7	7
CAGATCACATCGGACC-1_1_A4	37.64871661	14.83143302	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1243	1828	0.00273523	0.020787746	1	14	Microglia	26	7	7
CAGATCAGTATCACCA-1_1_A4	-29.51624639	10.31041463	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	710	1041	0.005763689	0.006724304	1	8	Astrocytes	26	7	7
CAGATCAGTGTGACGA-1_1_A4	3.947024368	-2.895666208	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	856	1235	0.009716599	0.005668016	1	12	EN-MIX	26	7	7
CAGATCATCATCGGAT-1_1_A4	2.533677737	6.059024998	7	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1145	1668	0.002997602	0.007194245	1	7	Phagocytes	26	7	7
CAGATCATCTGCCAGG-1_1_A4	-15.53653682	-9.834148775	13B	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2748	6323	0.010121778	0.003004903	1	13B	IN-SV2C	26	7	7
CAGCAGCAGAACAATC-1_1_A4	15.07930673	15.58810963	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1333	2268	0.005291005	0.006613757	1	oligos	OL-Cntl	26	7	7
CAGCAGCAGAGCTGGT-1_1_A4	17.63569127	-3.863262568	3	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1497	2464	0.000405844	0.002435065	1	3	EN-L5-6	26	7	7
CAGCAGCAGCGATTCT-1_1_A4	11.78091921	3.101655154	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	981	1343	0.044676098	0.003723008	1	12	EN-MIX	26	7	7
CAGCAGCAGGAGCGAG-1_1_A4	-22.46191544	27.00434103	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1795	3294	0.010928962	0.00667881	1	8	Astrocytes	26	7	7
CAGCAGCGTACTTCTT-1_1_A4	14.38856013	-2.012921699	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	906	1349	0.015567087	0.007412898	1	12	EN-MIX	26	7	7
CAGCAGCGTGTAACGG-1_1_A4	16.87414716	8.693389987	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1924	3538	0.024307518	0.007348785	1	oligos	OL-Cntl	26	7	7
CAGCATAAGAGTCGGT-1_1_A4	-4.169984105	-6.577335899	13A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1069	1678	0.042908224	0.001787843	1	13A	IN-VIP	26	7	7
CAGCATAAGCGATTCT-1_1_A4	7.450597683	22.3280958	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	865	1360	0.000735294	0.011029412	1	oligos	OL-Cntl	26	7	7
CAGCATAAGCTAGTGG-1_1_A4	-19.43058606	15.76716474	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1584	2765	0.005786618	0.005424955	1	8	Astrocytes	26	7	7
CAGCATACATCTATGG-1_1_A4	-22.02978364	26.35083724	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1762	3238	0.006176652	0.004941322	1	8	Astrocytes	26	7	7
CAGCATATCAGCTTAG-1_1_A4	10.07441373	-7.933467216	10	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1925	4010	0.00074813	0.002743142	1	L2-3	EN-L2-3-Cntl	26	7	7
CAGCATATCCTTCAAT-1_1_A4	-23.25365429	2.086638942	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	3252	6789	0.012225659	0.013845927	1	11	Glia-MIX	26	7	7
CAGCCGAAGAGAGCTC-1_1_A4	5.649208703	13.07185809	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1185	1823	0.025233132	0.013713659	1	oligos	OL-Cntl	26	7	7
CAGCCGAAGCTAACAA-1_1_A4	15.35906158	-5.480099054	10	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1278	2453	0.001630656	0.00203832	1	L2-3	EN-L2-3-Cntl	26	7	7
CAGCCGAAGGATTCGG-1_1_A4	-23.6525902	0.432763386	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1899	3234	0.008348794	0.006493506	1	9	OPC	26	7	7
CAGCCGAAGTCGCCGT-1_1_A4	3.122192498	19.8823778	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	956	1473	0.031907671	0.009504413	1	oligos	OL-Cntl	26	7	7
CAGCCGACACATGACT-1_1_A4	18.78102584	8.954479846	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1844	3661	0.021032505	0.006282436	1	oligos	OL-Cntl	26	7	7
CAGCCGACACGTTGGC-1_1_A4	-3.804538314	23.3900098	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	704	1015	0.016748768	0.008866995	1	oligos	OL-Cntl	26	7	7
CAGCCGACAGACACTT-1_1_A4	16.90980609	1.694971263	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	799	1213	0.01071723	0.003297609	1	12	EN-MIX	26	7	7
CAGCCGACAGAGCCAA-1_1_A4	38.90749179	14.91409861	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1292	1953	0.00921659	0.011264721	1	14	Microglia	26	7	7
CAGCCGAGTCGTTGTA-1_1_A4	5.478763777	21.55877276	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	979	1510	0.013907285	0.01192053	1	oligos	OL-Cntl	26	7	7
CAGCCGAGTTGTCTTT-1_1_A4	-35.81844718	-5.056091018	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1221	2080	0.002884615	0.002884615	1	9	OPC	26	7	7
CAGCCGATCAACACCA-1_1_A4	6.596820443	21.88249981	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	955	1575	0.006984127	0.006349206	1	oligos	OL-Cntl	26	7	7
CAGCCGATCACCGTAA-1_1_A4	7.707820408	13.24347139	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1304	2185	0.00778032	0.010526316	1	oligos	OL-Cntl	26	7	7
CAGCCGATCACTTCAT-1_1_A4	-2.24604627	6.024470478	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1184	1868	0.006959315	0.008029979	1	11	Glia-MIX	26	7	7
CAGCCGATCAGTTGAC-1_1_A4	-34.81578321	-7.573303674	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1113	1795	0.001671309	0.004456825	1	9	OPC	26	7	7
CAGCCGATCTGATACG-1_1_A4	15.40026219	1.820858315	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	854	1236	0.009708738	0.003236246	1	12	EN-MIX	26	7	7
CAGCGACGTGCCTGGT-1_1_A4	-4.540233655	-8.417502977	13A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	975	1745	0.033237822	0.008595989	1	13A	IN-VIP	26	7	7
CAGCGACTCATATCGG-1_1_A4	13.33344408	12.37810274	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1299	2141	0.021952359	0.006071929	1	oligos	OL-Cntl	26	7	7
CAGCTAAAGCGACGTA-1_1_A4	-35.97611109	-0.997803813	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1531	2651	0.009053187	0.002263297	1	9	OPC	26	7	7
CAGCTAAAGGTCGGAT-1_1_A4	-3.303867536	21.45880608	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	756	1041	0.005763689	0.02401537	1	oligos	OL-Cntl	26	7	7
CAGCTAACACGGCGTT-1_1_A4	-1.89515003	-0.903426729	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2187	4052	0.030108588	0.012092794	1	11	Glia-MIX	26	7	7
CAGCTAAGTCGGGTCT-1_1_A4	-36.02676056	-2.581624046	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1460	2386	0.008801341	0.001676446	1	9	OPC	26	7	7
CAGCTAAGTTTGACTG-1_1_A4	17.37534817	7.831844246	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1959	3668	0.014176663	0.0087241	1	oligos	OL-Cntl	26	7	7
CAGCTAATCTTCGGTC-1_1_A4	17.08371443	-0.336670884	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	876	1313	0.006854532	0.002284844	1	12	EN-MIX	26	7	7
CAGCTGGAGAGGGCTT-1_1_A4	-33.94594013	-6.646935667	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1317	2266	0.00353045	0.0070609	1	9	OPC	26	7	7
CAGCTGGAGCCAGAAC-1_1_A4	5.302600384	25.30201739	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	860	1276	0.00862069	0.003134796	1	oligos	OL-Cntl	26	7	7
CAGCTGGCAAACAACA-1_1_A4	-4.71839252	-7.940138608	13A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	877	1454	0.071526823	0.001375516	1	13A	IN-VIP	26	7	7
CAGCTGGCATTTCACT-1_1_A4	4.071588163	27.08812554	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	766	1172	0.009385666	0.003412969	1	oligos	OL-Cntl	26	7	7
CAGCTGGGTAATAGCA-1_1_A4	7.76354957	17.78306865	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1200	1915	0.010443864	0.012010444	1	oligos	OL-Cntl	26	7	7
CAGCTGGGTTGGAGGT-1_1_A4	6.169609987	21.59549282	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	876	1320	0.009848485	0.012121212	1	oligos	OL-Cntl	26	7	7
CAGCTGGTCAATCTCT-1_1_A4	4.586410432	19.81373013	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1002	1531	0.011757022	0.008491182	1	oligos	OL-Cntl	26	7	7
CAGCTGGTCACCTCGT-1_1_A4	14.10829947	15.243706	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1173	1940	0.010309278	0.010309278	1	oligos	OL-Cntl	26	7	7
CAGCTGGTCACTTATC-1_1_A4	-37.11621935	2.684021324	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1797	3571	0.000280034	0.004200504	1	9	OPC	26	7	7
CAGCTGGTCCGCGTTT-1_1_A4	5.945815763	12.30883904	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1275	2143	0.004666356	0.014932338	1	oligos	OL-Cntl	26	7	7
CAGCTGGTCCTTCAAT-1_1_A4	13.89894606	15.24009331	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1266	2163	0.019879797	0.008321775	1	oligos	OL-Cntl	26	7	7
CAGCTGGTCTACCTGC-1_1_A4	15.60564853	17.1500412	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1120	1807	0.007747648	0.004980631	1	oligos	OL-Cntl	26	7	7
CAGGTGCCACCTATCC-1_1_A4	39.10864704	11.64056565	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	983	1385	0.003610108	0.010108303	1	14	Microglia	26	7	7
CAGGTGCCATATACGC-1_1_A4	-21.9608178	25.78826	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1610	2977	0.001007726	0.005710447	1	8	Astrocytes	26	7	7
CAGGTGCCATGCCTAA-1_1_A4	11.70981229	30.45749301	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	788	1173	0.007672634	0.002557545	1	oligos	OL-Cntl	26	7	7
CAGGTGCGTACTCAAC-1_1_A4	11.21462429	13.12708056	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1305	2098	0.025262154	0.019065777	1	oligos	OL-Cntl	26	7	7
CAGGTGCGTGAAATCA-1_1_A4	5.687347089	20.39415816	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	958	1476	0.012872629	0.004742547	1	oligos	OL-Cntl	26	7	7
CAGGTGCTCGGAAACG-1_1_A4	6.178273875	13.63743277	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1198	1887	0.010598834	0.011128776	1	oligos	OL-Cntl	26	7	7
CAGTAACAGAGCCCAA-1_1_A4	-29.60584084	19.69159312	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1046	1633	0.004898959	0.006123699	1	8	Astrocytes	26	7	7
CAGTAACAGCCAGAAC-1_1_A4	35.27472136	-6.644293307	2	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	4059	10535	0.00170859	0.006359753	1	2	EN-L4	26	7	7
CAGTAACCAAGGACTG-1_1_A4	39.58988795	10.08273355	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	853	1173	0.00170503	0.00511509	1	14	Microglia	26	7	7
CAGTAACTCAATACCG-1_1_A4	2.977152293	25.48059273	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	724	1144	0.004370629	0.005244755	1	oligos	OL-Cntl	26	7	7
CAGTAACTCTAACTCT-1_1_A4	16.43473585	10.42867211	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1641	2982	0.006036217	0.00804829	1	oligos	OL-Cntl	26	7	7
CAGTCCTAGAGTAAGG-1_1_A4	-1.692727479	19.98512522	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	921	1388	0.00648415	0.005763689	1	oligos	OL-Cntl	26	7	7
CAGTCCTAGTTAAGTG-1_1_A4	-9.016094227	19.20175726	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	3485	6768	0.005910165	0.010490544	1	11	Glia-MIX	26	7	7
CAGTCCTGTTACGTCA-1_1_A4	20.79075049	18.97013076	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1068	1730	0.001734104	0.004046243	1	oligos	OL-Cntl	26	7	7
CAGTCCTTCTTGTATC-1_1_A4	4.998611788	24.62036534	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	831	1283	0.010911925	0.003117693	1	oligos	OL-Cntl	26	7	7
CATATGGAGGACGAAA-1_1_A4	-3.061605487	24.02292727	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	734	1016	0.000984252	0.001968504	1	oligos	OL-Cntl	26	7	7
CATATGGAGGTCGGAT-1_1_A4	-20.58296146	30.99211623	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	3340	8411	0.005350137	0.003447866	1	8	Astrocytes	26	7	7
CATATGGCAGCTGTTA-1_1_A4	-31.15924473	12.47882341	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	918	1564	0.009590793	0.007033248	1	8	Astrocytes	26	7	7
CATATGGGTCGAGATG-1_1_A4	-22.01173959	26.29520086	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1881	3658	0.004647348	0.004920722	1	8	Astrocytes	26	7	7
CATATGGTCGCCTGTT-1_1_A4	-0.341436709	22.76230488	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	798	1210	0.017355372	0.009090909	1	oligos	OL-Cntl	26	7	7
CATATTCAGGGCTTCC-1_1_A4	-35.68899679	-11.83673297	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	838	1285	0.00155642	0.00233463	1	9	OPC	26	7	7
CATATTCCAATCCAAC-1_1_A4	-39.89099279	-0.548808462	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1408	2789	0.000717103	0.002151309	1	9	OPC	26	7	7
CATATTCGTTCATGGT-1_1_A4	39.92932149	11.36442195	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	767	1064	0.003759398	0.006578947	1	14	Microglia	26	7	7
CATATTCGTTGCGCAC-1_1_A4	6.803732383	14.67314584	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1174	1833	0.021276596	0.012002182	1	oligos	OL-Cntl	26	7	7
CATATTCGTTGTCTTT-1_1_A4	-37.81089451	-0.647002665	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1495	2817	0.001774938	0.00141995	1	9	OPC	26	7	7
CATCAAGAGGTCATCT-1_1_A4	-0.468910796	23.46814752	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	739	1047	0.00095511	0.006685769	1	oligos	OL-Cntl	26	7	7
CATCAAGCAAGCTGTT-1_1_A4	-24.47720214	22.43865983	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1446	2641	0.002271867	0.006058311	1	8	Astrocytes	26	7	7
CATCAAGCAAGGACAC-1_1_A4	4.220858801	21.0536863	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	976	1452	0.010330579	0.01584022	1	oligos	OL-Cntl	26	7	7
CATCAAGCACGCATCG-1_1_A4	20.65127481	18.40540391	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1122	1775	0.004507042	0.005633803	1	oligos	OL-Cntl	26	7	7
CATCAAGGTGAAGGCT-1_1_A4	1.14103784	21.91142852	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	833	1312	0.00304878	0.008384146	1	oligos	OL-Cntl	26	7	7
CATCAAGGTGTGCCTG-1_1_A4	-22.14327244	23.91165386	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1539	2862	0.003843466	0.008385744	1	8	Astrocytes	26	7	7
CATCAAGTCAGTACGT-1_1_A4	-5.032197823	29.62239755	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1249	2020	0.028217822	0.008910891	1	11	Glia-MIX	26	7	7
CATCAGAAGATCGATA-1_1_A4	-11.61507015	-22.19572376	6A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1082	1727	0.020266358	0.002316155	1	6A	IN-PV	26	7	7
CATCAGACACGGCTAC-1_1_A4	16.26542099	1.737435697	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	827	1260	0.01031746	0.001587302	1	12	EN-MIX	26	7	7
CATCAGAGTACTTCTT-1_1_A4	12.17788445	23.37082171	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	902	1373	0.005098325	0.003641661	1	oligos	OL-Cntl	26	7	7
CATCAGAGTAGCTCCG-1_1_A4	13.82099103	27.62777524	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	697	1065	0.003755869	0.004694836	1	oligos	OL-Cntl	26	7	7
CATCAGATCGTACGGC-1_1_A4	-23.86559352	-1.73338277	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1181	1848	0.003787879	0.008116883	1	9	OPC	26	7	7
CATCAGATCGTATCAG-1_1_A4	-0.018119761	35.94335584	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	782	1125	0.008888889	0.009777778	1	oligos	OL-Cntl	26	7	7
CATCCACAGCGAAGGG-1_1_A4	23.12963873	1.151164096	2	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1998	3803	0.00026295	0.001840652	1	2	EN-L4	26	7	7
CATCCACCACCCAGTG-1_1_A4	3.436908626	28.23910485	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	712	1091	0.002749771	0.001833181	1	oligos	OL-Cntl	26	7	7
CATCCACGTATATCCG-1_1_A4	7.107525311	-5.914063759	10	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1281	2270	0.004405286	0.0030837	1	L2-3	EN-L2-3-Cntl	26	7	7
CATCCACGTTCCTCCA-1_1_A4	16.05695066	27.43502642	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	869	1267	0.001578532	0.003157064	1	oligos	OL-Cntl	26	7	7
CATCCACGTTCGTTGA-1_1_A4	2.711144299	-3.832681238	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	840	1267	0.010260458	0.006314128	1	12	EN-MIX	26	7	7
CATCCACTCGTGGACC-1_1_A4	5.585038472	5.486979109	7	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	3080	5884	0.010707002	0.008157716	1	7	Phagocytes	26	7	7
CATCGAAAGCTACCTA-1_1_A4	17.97469539	8.01375032	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2005	3850	0.007012987	0.003636364	1	oligos	OL-Cntl	26	7	7
CATCGAAGTCTCGTTC-1_1_A4	37.2658349	10.92539334	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	872	1125	0.007111111	0.013333333	1	14	Microglia	26	7	7
CATCGAAGTGAGTGAC-1_1_A4	8.442300738	-6.869832053	10	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1498	2628	0.001141553	0.001141553	1	L2-3	EN-L2-3-Cntl	26	7	7
CATCGAATCACCCGAG-1_1_A4	-5.249526368	-10.2091953	13B	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	979	1591	0.02514142	0.003771213	1	13B	IN-SV2C	26	7	7
CATCGGGAGCGTTCCG-1_1_A4	-25.89300347	19.31346872	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1583	3025	0.014545455	0.004297521	1	8	Astrocytes	26	7	7
CATCGGGAGCTGAACG-1_1_A4	-4.952004477	-8.899805805	13A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	839	1299	0.076212471	0.006158584	1	13A	IN-VIP	26	7	7
CATCGGGAGCTGCAAG-1_1_A4	-9.214211183	-3.480465788	13A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2026	3706	0.010523475	0.005936319	1	13A	IN-VIP	26	7	7
CATCGGGAGTGGAGAA-1_1_A4	5.710014133	24.44925294	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	906	1339	0.000746826	0.008215086	1	oligos	OL-Cntl	26	7	7
CATCGGGCACGGCGTT-1_1_A4	19.26349021	-0.275905612	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1345	2377	0.021876315	0.007151872	1	12	EN-MIX	26	7	7
CATCGGGCATCGATGT-1_1_A4	-4.024538825	21.92947635	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	756	1131	0.019451813	0.014146773	1	oligos	OL-Cntl	26	7	7
CATCGGGTCAACTCTT-1_1_A4	-28.66765772	17.18080784	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1076	1786	0.001679731	0.006159015	1	8	Astrocytes	26	7	7
CATCGGGTCAGCTCTC-1_1_A4	22.62181092	18.39732055	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1143	1758	0.000568828	0.003412969	1	oligos	OL-Cntl	26	7	7
CATCGGGTCCAGTATG-1_1_A4	16.44784948	1.70207047	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	700	1026	0.004873294	0.002923977	1	12	EN-MIX	26	7	7
CATGACAAGATCTGCT-1_1_A4	-34.62637749	-11.81944528	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	816	1273	0.00392773	0.001571092	1	9	OPC	26	7	7
CATGACAAGTAAGTAC-1_1_A4	19.99330832	1.762658961	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1166	1954	0.001023541	0.002558854	1	12	EN-MIX	26	7	7
CATGACACAACGATGG-1_1_A4	-33.31948683	-12.72408008	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	772	1124	0.001779359	0.002669039	1	9	OPC	26	7	7
CATGACACACGAAAGC-1_1_A4	18.72793567	1.496427384	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1162	1857	0.002154012	0.003231018	1	12	EN-MIX	26	7	7
CATGACACACTTGGAT-1_1_A4	-24.98950587	16.5079711	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1182	2125	0.003764706	0.007058824	1	8	Astrocytes	26	7	7
CATGACACATATACCG-1_1_A4	-23.77272124	-0.165484744	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1876	3493	0.000572574	0.004294303	1	9	OPC	26	7	7
CATGACACATCCAACA-1_1_A4	14.16920023	15.10244867	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1262	2069	0.009666506	0.007733204	1	oligos	OL-Cntl	26	7	7
CATGACACATCCGTGG-1_1_A4	17.12357977	10.36666442	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1673	2884	0.008668516	0.006241331	1	oligos	OL-Cntl	26	7	7
CATGACAGTAAGGGAA-1_1_A4	5.955997378	12.91438316	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1303	2123	0.010833726	0.0089496	1	oligos	OL-Cntl	26	7	7
CATGACAGTCAAAGCG-1_1_A4	-16.65413962	13.09885332	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1547	2646	0.003401361	0.007936508	1	8	Astrocytes	26	7	7
CATGACAGTCTTCGTC-1_1_A4	5.787260617	24.06105096	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	921	1310	0.016030534	0.003816794	1	oligos	OL-Cntl	26	7	7
CATGACAGTGGGTCAA-1_1_A4	21.42765845	7.528175795	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2123	4155	0	0.006016847	1	oligos	OL-Cntl	26	7	7
CATGACAGTTACCAGT-1_1_A4	-10.03519374	23.14512964	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2532	4830	0.005383023	0.004347826	1	8	Astrocytes	26	7	7
CATGACATCAACCAAC-1_1_A4	-24.11572701	-0.413199714	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1910	3411	0.003811199	0.001759015	1	9	OPC	26	7	7
CATGCCTAGCCACGTC-1_1_A4	-22.29505871	29.4563718	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2195	4413	0.007704509	0.004078858	1	8	Astrocytes	26	7	7
CATGCCTCATGCGCAC-1_1_A4	3.031928262	-9.532156493	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1637	2813	0.006754355	0.006754355	1	12	EN-MIX	26	7	7
CATGCCTGTACCGGCT-1_1_A4	15.52088672	-5.421016907	10	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1266	2228	0.002244165	0.003141831	1	L2-3	EN-L2-3-Cntl	26	7	7
CATGCCTGTCATGCAT-1_1_A4	11.60485915	16.66975682	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1118	1828	0.002188184	0.012035011	1	oligos	OL-Cntl	26	7	7
CATGCCTGTTGGGACA-1_1_A4	22.55427655	20.3270017	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1080	1842	0.002171553	0.003257329	1	oligos	OL-Cntl	26	7	7
CATGCCTTCTTCGGTC-1_1_A4	-24.68615777	27.18280641	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1709	3547	0.004510854	0.003383141	1	8	Astrocytes	26	7	7
CATGGCGAGCGCTTAT-1_1_A4	-36.19346567	-9.61411248	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1037	1686	0.004744958	0.00059312	1	9	OPC	26	7	7
CATGGCGAGTGAACAT-1_1_A4	18.95697448	6.315484901	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2584	5453	0.006785256	0.006418485	1	oligos	OL-Cntl	26	7	7
CATGGCGCAAACCCAT-1_1_A4	15.40507204	-7.874935338	10	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2020	4085	0.012729498	0.003671971	1	L2-3	EN-L2-3-Cntl	26	7	7
CATGGCGGTGCGGTAA-1_1_A4	-35.18852556	-2.611236672	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1272	2033	0.002951303	0.001967536	1	9	OPC	26	7	7
CATGGCGGTGGACGAT-1_1_A4	18.57138638	-0.172737834	10	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1337	2218	0.015779982	0.001803427	1	L2-3	EN-L2-3-Cntl	26	7	7
CATGGCGTCACCACCT-1_1_A4	-11.69378089	13.61305497	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1077	1522	0.012483574	0.006570302	1	11	Glia-MIX	26	7	7
CATGGCGTCAGAGGTG-1_1_A4	-5.450425947	-7.471221878	13A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1059	1736	0.019009217	0.005760369	1	13A	IN-VIP	26	7	7
CATGGCGTCGTACCGG-1_1_A4	-25.93438234	22.58132165	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1262	2129	0.004697041	0.008924378	1	8	Astrocytes	26	7	7
CATTATCAGCACCGTC-1_1_A4	15.54080006	20.81590587	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	941	1516	0.013852243	0.005936675	1	oligos	OL-Cntl	26	7	7
CATTATCCAAGCGAGT-1_1_A4	0.625994799	22.12620937	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	998	1508	0.055702918	0.012599469	1	oligos	OL-Cntl	26	7	7
CATTATCCATCATCCC-1_1_A4	14.63657764	20.25962023	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	997	1586	0.027112232	0.009457755	1	oligos	OL-Cntl	26	7	7
CATTATCGTAAGTGGC-1_1_A4	4.709915324	21.5325242	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	871	1286	0.00933126	0.006998445	1	oligos	OL-Cntl	26	7	7
CATTATCTCCAGTAGT-1_1_A4	-13.79177897	-24.31013005	6A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1572	3297	0.011525629	0.000909918	1	6A	IN-PV	26	7	7
CATTATCTCCGCATAA-1_1_A4	4.047440961	19.69780163	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	871	1381	0.016654598	0.009413469	1	oligos	OL-Cntl	26	7	7
CATTCGCAGCGATGAC-1_1_A4	14.71120678	22.32353712	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	979	1605	0.002492212	0.00623053	1	oligos	OL-Cntl	26	7	7
CATTCGCCATGTTGAC-1_1_A4	21.43534237	10.77781421	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1621	2806	0.007127584	0.003920171	1	oligos	OL-Cntl	26	7	7
CATTCGCTCGGCATCG-1_1_A4	-9.116824007	19.08509876	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	3479	6871	0.003492941	0.007713579	1	11	Glia-MIX	26	7	7
CCAATCCAGATAGTCA-1_1_A4	11.72507703	23.63287645	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	891	1336	0.005239521	0.004491018	1	oligos	OL-Cntl	26	7	7
CCAATCCAGTCACGCC-1_1_A4	3.777530071	-15.52641536	4	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2947	6652	0.009771497	0.008117859	1	L2-3	EN-L2-3-MS	26	7	7
CCAATCCCAAATCCGT-1_1_A4	37.23229967	14.38711922	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1166	1685	0.008308605	0.016023739	1	14	Microglia	26	7	7
CCAATCCCAAGCGCTC-1_1_A4	-36.66070234	-4.088503826	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1308	2217	0.00135318	0.00541272	1	9	OPC	26	7	7
CCAATCCCAAGGCTCC-1_1_A4	22.28478745	18.77089768	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1197	2028	0.002465483	0.003451677	1	oligos	OL-Cntl	26	7	7
CCAATCCCAGCCTTTC-1_1_A4	3.169776215	5.436255729	7	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	957	1324	0.005287009	0.004531722	1	7	Phagocytes	26	7	7
CCAATCCCAGGAATCG-1_1_A4	-16.16935117	12.58385495	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1442	2256	0.004432624	0.007092199	1	8	Astrocytes	26	7	7
CCAATCCCATTTGCTT-1_1_A4	-0.950114131	24.70525795	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	672	1013	0.004935834	0.012833169	1	oligos	OL-Cntl	26	7	7
CCAATCCGTGTTGGGA-1_1_A4	23.50079491	-0.71437454	2	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2365	4693	0.000852333	0.004900916	1	2	EN-L4	26	7	7
CCAATCCTCTCTTATG-1_1_A4	6.110673133	19.78486644	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1072	1805	0.024930748	0.00498615	1	oligos	OL-Cntl	26	7	7
CCACCTACACATGGGA-1_1_A4	14.05456168	23.90358807	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	948	1428	0.00210084	0.004201681	1	oligos	OL-Cntl	26	7	7
CCACCTACACTTAACG-1_1_A4	-20.90175356	30.86636728	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2692	6056	0.00181638	0.002972259	1	8	Astrocytes	26	7	7
CCACCTACATCACAAC-1_1_A4	-32.20417102	1.502743857	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2138	4509	0.016189843	0.003104901	1	9	OPC	26	7	7
CCACCTAGTAACGTTC-1_1_A4	-36.08392302	2.446148661	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1972	3995	0.004755945	0.005006258	1	9	OPC	26	7	7
CCACCTAGTCCTCTTG-1_1_A4	-9.744048961	22.70280519	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1450	2258	0.00088574	0.002214349	1	8	Astrocytes	26	7	7
CCACCTAGTCGGCATC-1_1_A4	-23.668522	1.440280758	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	4149	9380	0.004904051	0.007249467	1	11	Glia-MIX	26	7	7
CCACCTAGTCTCATCC-1_1_A4	11.11184931	-8.052997883	10	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2133	4483	0.006691947	0.003122909	1	L2-3	EN-L2-3-Cntl	26	7	7
CCACCTAGTGAAAGAG-1_1_A4	-34.39881742	-2.870224073	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1570	2694	0.010764662	0.006310319	1	9	OPC	26	7	7
CCACCTATCCCTTGTG-1_1_A4	6.198135856	13.56849454	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1147	1749	0.008004574	0.009148085	1	oligos	OL-Cntl	26	7	7
CCACCTATCTCTGTCG-1_1_A4	18.63374045	16.39096544	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1228	2048	0.013183594	0.004882813	1	oligos	OL-Cntl	26	7	7
CCACGGAAGACTACAA-1_1_A4	-2.542888195	31.3265164	17	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	910	1358	0.002945508	0.000736377	1	oligos	OL-MS-2	26	7	7
CCACGGAAGGCATTGG-1_1_A4	3.700985241	22.95162714	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	894	1351	0.008142117	0.009622502	1	oligos	OL-Cntl	26	7	7
CCACGGAAGGGTCTCC-1_1_A4	-23.9031899	-1.430974892	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1353	2285	0.001750547	0.001750547	1	9	OPC	26	7	7
CCACGGAAGTAGCCGA-1_1_A4	-26.59189811	9.722079824	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	733	1060	0.005660377	0.000943396	1	8	Astrocytes	26	7	7
CCACGGAAGTTCGCAT-1_1_A4	5.990008567	-5.689798862	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1045	1667	0.01079784	0.00179964	1	12	EN-MIX	26	7	7
CCACGGACAGACGCAA-1_1_A4	38.0166456	10.53210556	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	979	1311	0.009916095	0.012204424	1	14	Microglia	26	7	7
CCACGGAGTTTACTCT-1_1_A4	-22.40705185	26.41942785	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1894	3676	0.004624592	0.005712731	1	8	Astrocytes	26	7	7
CCACTACAGTGGTAGC-1_1_A4	-25.83561057	22.89150461	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1384	2439	0.002050021	0.004920049	1	8	Astrocytes	26	7	7
CCACTACGTCAACTGT-1_1_A4	6.763454013	19.55052435	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1060	1712	0.009345794	0.011098131	1	oligos	OL-Cntl	26	7	7
CCACTACGTCAGTGGA-1_1_A4	4.350262872	4.017637227	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1795	2740	0.012773723	0.016788321	1	14	Microglia	26	7	7
CCACTACGTCGGATCC-1_1_A4	-0.281350224	0.098718992	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1281	2062	0.037827352	0.004364694	1	11	Glia-MIX	26	7	7
CCACTACGTCTCTCTG-1_1_A4	10.17297874	23.57915085	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	827	1303	0.004604758	0.003837299	1	oligos	OL-Cntl	26	7	7
CCACTACGTGCAACTT-1_1_A4	18.50668296	8.866474244	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1846	3426	0.006421483	0.004962055	1	oligos	OL-Cntl	26	7	7
CCACTACGTGCTGTAT-1_1_A4	39.49877881	16.28899771	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2104	3566	0.010936624	0.012338755	1	14	Microglia	26	7	7
CCACTACTCAGTTAGC-1_1_A4	5.378829708	23.63920565	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	916	1453	0.008258775	0.008947006	1	oligos	OL-Cntl	26	7	7
CCACTACTCCCTAATT-1_1_A4	8.568195188	-7.766442117	10	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1893	3982	0.003013561	0.002009041	1	L2-3	EN-L2-3-Cntl	26	7	7
CCAGCGACAAATCCGT-1_1_A4	2.984245297	-3.995113444	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	749	1167	0.011996572	0.000856898	1	12	EN-MIX	26	7	7
CCAGCGACAATCACAC-1_1_A4	-1.124068724	-0.429869964	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2087	3929	0.015271061	0.006871978	1	11	Glia-MIX	26	7	7
CCAGCGACACCTATCC-1_1_A4	-23.21581535	29.34986734	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2133	4396	0.001137398	0.004322111	1	8	Astrocytes	26	7	7
CCAGCGACATACTACG-1_1_A4	13.39014609	15.65487493	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1247	1992	0.004518072	0.007028112	1	oligos	OL-Cntl	26	7	7
CCAGCGAGTACAGACG-1_1_A4	8.80496302	-8.204248297	10	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2175	4829	0.00745496	0.003106233	1	L2-3	EN-L2-3-Cntl	26	7	7
CCAGCGATCGCCCTTA-1_1_A4	11.18331599	15.47765753	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1118	1793	0.007808143	0.005577245	1	oligos	OL-Cntl	26	7	7
CCAGCGATCGGCTTGG-1_1_A4	-26.00837551	16.58254666	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1117	1908	0.001048218	0.000524109	1	8	Astrocytes	26	7	7
CCAGCGATCGTTTAGG-1_1_A4	-0.530730641	17.67087058	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	902	1348	0.014836795	0.020029674	1	oligos	OL-Cntl	26	7	7
CCAGCGATCTCCAACC-1_1_A4	-9.011036715	19.25400863	7	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	3304	6266	0.005904883	0.007181615	1	7	Phagocytes	26	7	7
CCATGTCAGCCAGTTT-1_1_A4	22.8210109	13.30933759	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1393	2336	0.006849315	0.00385274	1	oligos	OL-Cntl	26	7	7
CCATGTCCAACACGCC-1_1_A4	7.045373172	13.47585769	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1244	2075	0.017831325	0.013975904	1	oligos	OL-Cntl	26	7	7
CCATGTCCATTCTTAC-1_1_A4	17.09398194	18.36610609	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1162	1910	0.009424084	0.006282723	1	oligos	OL-Cntl	26	7	7
CCATGTCGTCAGGACA-1_1_A4	5.013055897	-5.527445505	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1012	1536	0.005859375	0.003255208	1	12	EN-MIX	26	7	7
CCATTCGAGAGAGCTC-1_1_A4	2.998068695	26.78465422	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	713	1029	0.009718173	0.002915452	1	oligos	OL-Cntl	26	7	7
CCATTCGCAGGTGGAT-1_1_A4	2.500981974	24.68879396	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	752	1139	0.01404741	0.007901668	1	oligos	OL-Cntl	26	7	7
CCATTCGCATGCATGT-1_1_A4	14.70752442	12.49418792	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1541	2678	0.024645258	0.005974608	1	oligos	OL-Cntl	26	7	7
CCATTCGGTCTAGTGT-1_1_A4	3.479697499	25.32712005	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	785	1159	0.01553063	0.002588438	1	oligos	OL-Cntl	26	7	7
CCATTCGGTTCTGAAC-1_1_A4	23.73586028	-9.595295849	3	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	4681	14528	0.003854626	0.003028634	1	3	EN-L5-6	26	7	7
CCATTCGTCAAACCGT-1_1_A4	0.579080968	-7.803414296	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1336	2434	0.010271159	0.002054232	1	12	EN-MIX	26	7	7
CCATTCGTCGTCTGAA-1_1_A4	6.040401367	13.52645564	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1077	1728	0.011574074	0.013888889	1	oligos	OL-Cntl	26	7	7
CCCAATCAGACCTAGG-1_1_A4	0.370762091	23.32509412	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	821	1232	0.027597403	0.008928571	1	oligos	OL-Cntl	26	7	7
CCCAATCAGCACCGTC-1_1_A4	18.19735798	1.645396613	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1039	1654	0.010882709	0.004232164	1	12	EN-MIX	26	7	7
CCCAATCAGCTAGCCC-1_1_A4	-24.21726951	25.71706805	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1450	2628	0.001902588	0.004946728	1	8	Astrocytes	26	7	7
CCCAATCCACACAGAG-1_1_A4	39.69898665	10.74401137	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	866	1231	0.000812348	0.005686434	1	14	Microglia	26	7	7
CCCAATCCACGGTGTC-1_1_A4	20.76518716	11.75408599	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1397	2493	0.008824709	0.004412355	1	oligos	OL-Cntl	26	7	7
CCCAATCGTCTTTCAT-1_1_A4	7.545703703	-5.767553629	10	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1372	2614	0.000765111	0.003060444	1	L2-3	EN-L2-3-Cntl	26	7	7
CCCAATCGTGGGTATG-1_1_A4	-1.029968454	-0.626584049	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2004	3638	0.005772402	0.006322155	1	11	Glia-MIX	26	7	7
CCCAATCTCTGGCGTG-1_1_A4	-11.8117229	19.39651533	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2615	5350	0.005046729	0.003925234	1	11	Glia-MIX	26	7	7
CCCAGTTAGCAAATCA-1_1_A4	-23.17202417	27.27563797	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1914	3742	0.003206841	0.003206841	1	8	Astrocytes	26	7	7
CCCAGTTAGGATCGCA-1_1_A4	15.11829673	-0.317344432	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	781	1094	0.015539305	0.003656307	1	12	EN-MIX	26	7	7
CCCAGTTAGTAGGTGC-1_1_A4	-24.93014916	17.25310439	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1254	2140	0.010280374	0.006074766	1	8	Astrocytes	26	7	7
CCCAGTTCAACGATCT-1_1_A4	17.11897102	-4.635836747	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1094	1736	0.012672811	0.001728111	1	12	EN-MIX	26	7	7
CCCAGTTCAGCGAACA-1_1_A4	-37.3105466	0.225324849	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1649	3050	0.00295082	0.003278689	1	9	OPC	26	7	7
CCCAGTTGTCCTAGCG-1_1_A4	15.07687614	22.99942751	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	934	1537	0.000650618	0.010409889	1	oligos	OL-Cntl	26	7	7
CCCAGTTGTCTTGTCC-1_1_A4	15.24575128	3.007109588	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1045	1574	0	0.001905972	1	12	EN-MIX	26	7	7
CCCAGTTTCAAACGGG-1_1_A4	6.192034153	6.163130785	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	3395	7266	0.013487476	0.011010184	1	oligos	OL-Cntl	26	7	7
CCCAGTTTCGTAGGTT-1_1_A4	38.80661609	11.41575042	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	931	1301	0.002305919	0.004611837	1	14	Microglia	26	7	7
CCCAGTTTCTACCTGC-1_1_A4	-35.39471422	-12.71009204	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	785	1177	0	0.002548853	1	9	OPC	26	7	7
CCCATACAGAAGGTTT-1_1_A4	-23.98382521	19.24926424	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1557	2755	0.001814882	0.006896552	1	8	Astrocytes	26	7	7
CCCATACAGACAGGCT-1_1_A4	-10.77858786	-0.503309491	13A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2424	4909	0.015074353	0.003666735	1	13A	IN-VIP	26	7	7
CCCATACAGCCATCGC-1_1_A4	4.34961182	15.92735021	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1018	1660	0.009036145	0.009036145	1	oligos	OL-Cntl	26	7	7
CCCATACAGTATCTCG-1_1_A4	7.391669826	19.54358303	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1122	1696	0.013561321	0.007665094	1	oligos	OL-Cntl	26	7	7
CCCATACAGTCTCCTC-1_1_A4	-19.23033953	-26.73944372	6A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	3103	8143	0.001842073	0.001350853	1	6A	IN-PV	26	7	7
CCCATACAGTGAAGAG-1_1_A4	17.02350003	21.05475857	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1111	1769	0.003957038	0.005652911	1	oligos	OL-Cntl	26	7	7
CCCATACCAATGACCT-1_1_A4	17.2281338	0.254953989	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	749	1169	0.00855432	0.002566296	1	12	EN-MIX	26	7	7
CCCATACCACTGAAGG-1_1_A4	-24.50107439	-2.325127332	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1472	2815	0.003197158	0.004973357	1	9	OPC	26	7	7
CCCATACCATATGCTG-1_1_A4	-1.065064243	24.25681024	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	763	1118	0.007155635	0.009838998	1	oligos	OL-Cntl	26	7	7
CCCATACGTCTAAACC-1_1_A4	-23.26194732	2.221862294	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	3234	6835	0.004681785	0.004389173	1	11	Glia-MIX	26	7	7
CCCATACGTGATAAGT-1_1_A4	-22.23028106	24.4200827	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1728	3247	0.000615953	0.006467508	1	8	Astrocytes	26	7	7
CCCATACGTTGCGCAC-1_1_A4	39.71341685	14.50909643	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1250	1745	0.002292264	0.013180516	1	14	Microglia	26	7	7
CCCATACTCACCATAG-1_1_A4	1.650355355	25.48771574	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	742	1127	0.007098492	0.001774623	1	oligos	OL-Cntl	26	7	7
CCCATACTCACTGGGC-1_1_A4	40.09760504	13.74206079	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1062	1497	0.004008016	0.005344021	1	14	Microglia	26	7	7
CCCATACTCGAACGGA-1_1_A4	-3.639718817	-6.56169946	13A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1097	1753	0.054763263	0.006274957	1	13A	IN-VIP	26	7	7
CCCTCCTAGGACACCA-1_1_A4	14.68912426	8.351781949	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1996	3967	0.011595664	0.00756239	1	oligos	OL-Cntl	26	7	7
CCCTCCTAGGTTCCTA-1_1_A4	-29.85429962	13.10410669	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	713	1135	0.004405286	0.006167401	1	8	Astrocytes	26	7	7
CCCTCCTCAGCAGTTT-1_1_A4	6.629785834	20.7225844	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1027	1658	0.016887817	0.007237636	1	oligos	OL-Cntl	26	7	7
CCCTCCTCAGCTGCTG-1_1_A4	9.867398544	25.43787566	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	950	1628	0.00982801	0.001228501	1	oligos	OL-Cntl	26	7	7
CCCTCCTCAGGTGCCT-1_1_A4	36.47732297	8.12500159	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	729	1003	0.001994018	0.003988036	1	14	Microglia	26	7	7
CCCTCCTCAGTAGAGC-1_1_A4	-33.91107983	-5.147248251	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1336	2214	0.012195122	0.004516712	1	9	OPC	26	7	7
CCCTCCTGTACAGTGG-1_1_A4	-36.37123694	4.217192759	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2186	4552	0.00659051	0.001318102	1	9	OPC	26	7	7
CCCTCCTGTCTCTCTG-1_1_A4	13.98761486	6.850112149	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1763	3039	0.014807502	0.009871668	1	oligos	OL-Cntl	26	7	7
CCCTCCTTCGCGCCAA-1_1_A4	10.58472166	10.19748523	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1342	2322	0.012919897	0.012919897	1	oligos	OL-Cntl	26	7	7
CCCTCCTTCGGTCTAA-1_1_A4	-23.30684543	28.6503719	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2023	4051	0.001234263	0.004196495	1	8	Astrocytes	26	7	7
CCGGGATAGGTGCAAC-1_1_A4	7.636424334	13.23222718	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1186	1842	0.009771987	0.010857763	1	oligos	OL-Cntl	26	7	7
CCGGGATCACATGACT-1_1_A4	-3.485531494	-4.230350421	13A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1017	1639	0.001830384	0.000610128	1	13A	IN-VIP	26	7	7
CCGGGATCATTGGTAC-1_1_A4	-9.70413507	13.75554091	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1399	2068	0.003384913	0.005802708	1	11	Glia-MIX	26	7	7
CCGGGATTCGAATGGG-1_1_A4	-26.64395277	3.683433003	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	3426	6945	0.003743701	0.007199424	1	9	OPC	26	7	7
CCGGGATTCGGAATCT-1_1_A4	6.160610432	18.54405109	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1060	1658	0.014475271	0.009650181	1	oligos	OL-Cntl	26	7	7
CCGGTAGAGGAATGGA-1_1_A4	6.131551305	-6.1531136	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1220	2128	0.010338346	0.001409774	1	12	EN-MIX	26	7	7
CCGGTAGAGGGCTTGA-1_1_A4	7.297323953	19.30353138	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1160	1832	0.004912664	0.010371179	1	oligos	OL-Cntl	26	7	7
CCGGTAGAGTGGTCCC-1_1_A4	11.61212957	21.82871823	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	942	1513	0.013218771	0.002643754	1	oligos	OL-Cntl	26	7	7
CCGGTAGCAACCGCCA-1_1_A4	-3.238334305	23.95522713	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	761	1119	0.008042895	0.011617516	1	oligos	OL-Cntl	26	7	7
CCGGTAGGTGTAAGTA-1_1_A4	32.67279069	-2.233290748	2	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2863	5961	0.001342057	0.005535984	1	2	EN-L4	26	7	7
CCGGTAGGTTTGACTG-1_1_A4	8.209962269	27.56928584	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	952	1524	0.015091864	0.007217848	1	oligos	OL-Cntl	26	7	7
CCGGTAGTCAGCTTAG-1_1_A4	14.98375085	22.24363221	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	939	1420	0.008450704	0.003521127	1	oligos	OL-Cntl	26	7	7
CCGGTAGTCTTGAGAC-1_1_A4	1.693476309	23.23242456	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	829	1222	0.009001637	0.004091653	1	oligos	OL-Cntl	26	7	7
CCGTACTAGCAGGCTA-1_1_A4	-24.34456767	0.827266233	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2926	6658	0.017873235	0.006608591	1	9	OPC	26	7	7
CCGTACTAGCTAAACA-1_1_A4	35.95322935	11.03928812	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	818	1102	0.000907441	0.034482759	1	14	Microglia	26	7	7
CCGTACTAGGCTATCT-1_1_A4	16.40254101	1.979656802	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	727	1075	0.006511628	0.002790698	1	12	EN-MIX	26	7	7
CCGTACTAGGGTGTTG-1_1_A4	3.76402099	-5.14861972	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	934	1405	0.007117438	0.002135231	1	12	EN-MIX	26	7	7
CCGTACTGTACAGACG-1_1_A4	11.87197101	16.81974545	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1245	2101	0.03236554	0.00618753	1	oligos	OL-Cntl	26	7	7
CCGTACTGTGATGATA-1_1_A4	-24.92646793	22.5687512	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1378	2462	0.003655565	0.009341998	1	8	Astrocytes	26	7	7
CCGTACTGTTCAACCA-1_1_A4	-13.67632181	-24.24109342	6A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1181	1993	0.000501756	0.002508781	1	6A	IN-PV	26	7	7
CCGTACTGTTTAAGCC-1_1_A4	5.224869492	21.37113249	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	936	1464	0.015027322	0.005464481	1	oligos	OL-Cntl	26	7	7
CCGTACTTCTAACCGA-1_1_A4	14.5068915	13.02327774	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1405	2355	0.018683652	0.008492569	1	oligos	OL-Cntl	26	7	7
CCGTGGAAGCACAGGT-1_1_A4	-8.945695021	-16.04559554	6B	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	839	1275	0.064313725	0.005490196	1	6B	IN-SST	26	7	7
CCGTGGAAGCCACGCT-1_1_A4	-33.71046271	5.119683604	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2980	6395	0.002814699	0.006098514	1	9	OPC	26	7	7
CCGTGGACAGATAATG-1_1_A4	4.325088469	-3.518639123	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	915	1283	0.011691348	0.003117693	1	12	EN-MIX	26	7	7
CCGTGGAGTTCCCTTG-1_1_A4	6.862986921	19.80900469	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1073	1604	0.02244389	0.009351621	1	oligos	OL-Cntl	26	7	7
CCGTGGAGTTGCTCCT-1_1_A4	11.76043475	20.64437695	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1053	1624	0.009852217	0.008004926	1	oligos	OL-Cntl	26	7	7
CCGTGGATCAACACAC-1_1_A4	-23.67773437	0.550735358	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2365	4241	0.011082292	0.009195944	1	9	OPC	26	7	7
CCGTTCAAGCCGGTAA-1_1_A4	2.352742392	29.48061997	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	705	1038	0.011560694	0.00867052	1	oligos	OL-Cntl	26	7	7
CCGTTCAAGGTAGCCA-1_1_A4	37.92139499	10.12721993	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	839	1142	0.000875657	0.008756567	1	14	Microglia	26	7	7
CCGTTCAAGTGGGCTA-1_1_A4	-14.67474663	-11.30754341	13B	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2386	5261	0.018627637	0.001710701	1	13B	IN-SV2C	26	7	7
CCGTTCACATTGGGCC-1_1_A4	-28.25292635	9.545036188	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	760	1159	0.022433132	0.006039689	1	8	Astrocytes	26	7	7
CCGTTCAGTATAATGG-1_1_A4	14.96320955	21.32617287	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	988	1518	0.016469038	0.006587615	1	oligos	OL-Cntl	26	7	7
CCGTTCAGTCAGAAGC-1_1_A4	-28.24358381	22.82821956	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1335	2413	0.003729797	0.002900953	1	8	Astrocytes	26	7	7
CCGTTCAGTGATGCCC-1_1_A4	5.024340401	-2.198574873	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	718	1017	0.017699115	0.004916421	1	12	EN-MIX	26	7	7
CCGTTCAGTTCAGCGC-1_1_A4	2.726156727	-4.875415688	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1000	1578	0.005703422	0.001901141	1	12	EN-MIX	26	7	7
CCGTTCATCAGAGGTG-1_1_A4	-1.690362905	24.6774187	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	787	1107	0.009936766	0.012646793	1	oligos	OL-Cntl	26	7	7
CCTAAAGAGCGCCTCA-1_1_A4	3.468817337	20.14123174	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	896	1314	0.00608828	0.009893455	1	oligos	OL-Cntl	26	7	7
CCTAAAGAGGCGTACA-1_1_A4	4.720611088	20.93840637	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	817	1259	0.014297061	0.011119936	1	oligos	OL-Cntl	26	7	7
CCTACACAGCCCAATT-1_1_A4	13.96731993	-26.83662454	3	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2414	5211	0.019573978	0.003646133	1	3	EN-L5-6	26	7	7
CCTACACTCCGTAGTA-1_1_A4	-9.025885036	19.0997943	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	6298	19497	0.003487716	0.005641894	1	11	Glia-MIX	26	7	7
CCTACCAAGATGGGTC-1_1_A4	2.467908173	18.21982315	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	872	1361	0.017634093	0.006612785	1	oligos	OL-Cntl	26	7	7
CCTACCAAGTACTTGC-1_1_A4	8.939842207	-6.621040736	10	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1541	2999	0.003001	0.001000333	1	L2-3	EN-L2-3-Cntl	26	7	7
CCTACCACAATAGCGG-1_1_A4	20.08409669	15.67453409	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1300	2139	0.001402525	0.007012623	1	oligos	OL-Cntl	26	7	7
CCTACCACACGTTGGC-1_1_A4	39.98206587	14.33058109	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1175	1691	0.002365464	0.006505027	1	14	Microglia	26	7	7
CCTACCAGTATTACCG-1_1_A4	-23.50768979	0.359368704	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1911	3544	0.005361174	0.007054176	1	9	OPC	26	7	7
CCTACCAGTTCAGTAC-1_1_A4	7.172018215	-5.980234222	10	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1423	2734	0.009144111	0.002194587	1	L2-3	EN-L2-3-Cntl	26	7	7
CCTAGCTAGAAGATTC-1_1_A4	15.38525807	-6.580273493	10	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1738	3396	0.002944641	0.002944641	1	L2-3	EN-L2-3-Cntl	26	7	7
CCTAGCTAGGAGTACC-1_1_A4	15.03733613	10.1291584	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1596	2862	0.012578616	0.012578616	1	oligos	OL-Cntl	26	7	7
CCTAGCTAGTCTTGCA-1_1_A4	15.27512678	28.62528536	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	694	1010	0.010891089	0	1	oligos	OL-Cntl	26	7	7
CCTAGCTTCAATAAGG-1_1_A4	-13.4614117	18.96378595	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1765	3011	0.004981734	0.00597808	1	8	Astrocytes	26	7	7
CCTAGCTTCAGCGACC-1_1_A4	-36.11450148	2.058229316	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1803	3476	0.000575374	0.004602992	1	9	OPC	26	7	7
CCTAGCTTCATCATTC-1_1_A4	-10.01646062	23.14270678	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2814	5604	0.002498216	0.007851535	1	8	Astrocytes	26	7	7
CCTATTAAGCACGCCT-1_1_A4	4.936962254	19.83943752	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	991	1505	0.01461794	0.010631229	1	oligos	OL-Cntl	26	7	7
CCTATTAAGGGTCTCC-1_1_A4	-24.42656568	26.95724774	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1577	2995	0.003672788	0.002003339	1	8	Astrocytes	26	7	7
CCTATTACACGACGAA-1_1_A4	-9.630863848	0.18014455	13A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2380	5026	0.013927577	0.004377238	1	13A	IN-VIP	26	7	7
CCTATTAGTCTACCTC-1_1_A4	-25.36973278	27.63058263	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1702	3397	0.004121283	0.00117751	1	8	Astrocytes	26	7	7
CCTATTAGTTTGGCGC-1_1_A4	3.173300843	19.93999405	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	807	1234	0.004862237	0.009724473	1	oligos	OL-Cntl	26	7	7
CCTATTATCGGCCGAT-1_1_A4	17.97049372	19.70077619	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	999	1650	0.010909091	0.005454545	1	oligos	OL-Cntl	26	7	7
CCTATTATCTTTAGGG-1_1_A4	-9.319657128	-4.12567532	13A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1849	3559	0.008710312	0.009553245	1	13A	IN-VIP	26	7	7
CCTCAGTAGACGCTTT-1_1_A4	5.987226465	6.298161071	7	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2192	3934	0.004067107	0.003812913	1	7	Phagocytes	26	7	7
CCTCAGTCAATAAGCA-1_1_A4	15.36878706	13.54062104	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1323	2149	0.011167985	0.00511866	1	oligos	OL-Cntl	26	7	7
CCTCAGTCAATCTGCA-1_1_A4	-4.158427931	25.69974332	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	753	1138	0.008787346	0.003514938	1	oligos	OL-Cntl	26	7	7
CCTCAGTCACAACGTT-1_1_A4	-36.46970849	4.152939708	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1951	4009	0.001746071	0.003242704	1	9	OPC	26	7	7
CCTCAGTGTATGCTTG-1_1_A4	20.55945253	-27.72688178	3	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	3579	9603	0.002811621	0.003124024	1	3	EN-L5-6	26	7	7
CCTCAGTGTCGATTGT-1_1_A4	21.94731452	17.72505887	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1223	2057	0.01993194	0.004861449	1	oligos	OL-Cntl	26	7	7
CCTCAGTTCACGACTA-1_1_A4	11.2396645	24.08499802	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	820	1252	0.004792332	0.003194888	1	oligos	OL-Cntl	26	7	7
CCTCTGAAGCGTTGCC-1_1_A4	-0.370561446	1.092195532	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1538	2480	0.008064516	0.003629032	1	11	Glia-MIX	26	7	7
CCTCTGAAGGCTACGA-1_1_A4	-22.16952467	25.98909276	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1727	3232	0.00154703	0.007116337	1	8	Astrocytes	26	7	7
CCTCTGAAGTGTTAGA-1_1_A4	-26.04827818	-9.424400429	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	951	1574	0.048284625	0.005082592	1	9	OPC	26	7	7
CCTCTGACATCCCATC-1_1_A4	-16.66842988	14.86993264	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1650	2951	0.000677736	0.006099627	1	8	Astrocytes	26	7	7
CCTCTGAGTCGCGGTT-1_1_A4	13.28961177	12.2283378	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1380	2162	0.009713228	0.008788159	1	oligos	OL-Cntl	26	7	7
CCTCTGATCATAAAGG-1_1_A4	5.62021867	12.04833078	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1345	2164	0.01155268	0.01663586	1	oligos	OL-Cntl	26	7	7
CCTTACGAGAGAACAG-1_1_A4	15.39921154	20.20260213	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1039	1759	0.006253553	0.006253553	1	oligos	OL-Cntl	26	7	7
CCTTACGAGAGCCTAG-1_1_A4	21.7324345	16.88494763	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1226	2090	0.00430622	0.003827751	1	oligos	OL-Cntl	26	7	7
CCTTACGAGCCTATGT-1_1_A4	-16.40561299	-25.49386962	6A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2017	3944	0.009127789	0.002028398	1	6A	IN-PV	26	7	7
CCTTACGAGGCATGGT-1_1_A4	4.680441343	5.226042803	7	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1787	2738	0.020818115	0.010226443	1	7	Phagocytes	26	7	7
CCTTACGCATACGCCG-1_1_A4	-34.51686352	1.228125799	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2095	4543	0.005502972	0.002861545	1	9	OPC	26	7	7
CCTTACGGTAGCGCAA-1_1_A4	-37.37488523	-5.261829918	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1254	2105	0	0.003800475	1	9	OPC	26	7	7
CCTTACGGTTACCAGT-1_1_A4	15.14980565	2.947470332	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	916	1418	0	0.000705219	1	12	EN-MIX	26	7	7
CCTTACGGTTGTCGCG-1_1_A4	13.25525325	6.683429891	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1634	2813	0.018485603	0.014930679	1	oligos	OL-Cntl	26	7	7
CCTTACGTCACAGGCC-1_1_A4	3.201658585	25.93692521	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	781	1206	0.005804312	0.004975124	1	oligos	OL-Cntl	26	7	7
CCTTACGTCCAAGTAC-1_1_A4	7.311282584	20.67908077	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	991	1464	0.012295082	0.008196721	1	oligos	OL-Cntl	26	7	7
CCTTACGTCCTGCCAT-1_1_A4	25.24415441	0.310659067	2	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2390	5169	0.005997292	0.002708454	1	2	EN-L4	26	7	7
CCTTCCCAGGCATGGT-1_1_A4	-2.307761267	6.064683785	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1614	2732	0.005124451	0.003660322	1	oligos	OL-Cntl	26	7	7
CCTTCCCCAAAGTCAA-1_1_A4	3.080172778	21.45908842	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	772	1240	0.000806452	0.006451613	1	oligos	OL-Cntl	26	7	7
CCTTCCCCAATGGTCT-1_1_A4	-14.78996564	-3.541935543	13A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	5383	15663	0.021387984	0.008874417	1	13A	IN-VIP	26	7	7
CCTTCCCGTACTCTCC-1_1_A4	10.80784138	14.86206804	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1239	1963	0.018848701	0.013754457	1	oligos	OL-Cntl	26	7	7
CCTTCCCGTTACGGAG-1_1_A4	15.86804737	6.122337327	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2120	4096	0.013916016	0.014160156	1	oligos	OL-Cntl	26	7	7
CCTTCCCGTTATGTGC-1_1_A4	-23.39829971	2.423379952	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	5001	12634	0.005144847	0.007044483	1	11	Glia-MIX	26	7	7
CCTTCCCTCTCGAGTA-1_1_A4	10.25782974	-8.662113527	10	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2497	6124	0.000653168	0.003265839	1	L2-3	EN-L2-3-Cntl	26	7	7
CCTTCCCTCTGGGCCA-1_1_A4	-12.3218537	-10.6448642	13B	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1606	3055	0.019639935	0.002291326	1	13B	IN-SV2C	26	7	7
CCTTCGAAGACTAGGC-1_1_A4	0.487798151	23.06767377	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	832	1247	0.012830794	0.006415397	1	oligos	OL-Cntl	26	7	7
CCTTCGAAGCTCTCGG-1_1_A4	11.94537067	16.92872828	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1035	1626	0.006150062	0.006765068	1	oligos	OL-Cntl	26	7	7
CCTTCGAAGGACAGCT-1_1_A4	14.85208406	11.43600736	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1416	2332	0.006003431	0.01329331	1	oligos	OL-Cntl	26	7	7
CCTTCGAAGTCACGCC-1_1_A4	-11.87358851	14.30804797	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	905	1343	0.000744602	0.00446761	1	11	Glia-MIX	26	7	7
CCTTCGACAAAGTCAA-1_1_A4	12.96028908	16.1591451	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1218	2054	0.020934761	0.019474197	1	oligos	OL-Cntl	26	7	7
CCTTCGACACAGACTT-1_1_A4	1.152867206	20.81192778	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	864	1319	0.015921152	0.007581501	1	oligos	OL-Cntl	26	7	7
CCTTCGACAGGCTCAC-1_1_A4	-28.73222701	16.64770207	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1063	1825	0.000547945	0.002191781	1	8	Astrocytes	26	7	7
CCTTCGAGTCGTGGCT-1_1_A4	-25.22553992	16.27542929	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1211	2066	0.009680542	0.005808325	1	8	Astrocytes	26	7	7
CCTTCGATCACTTATC-1_1_A4	-6.319739486	4.238921459	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	5675	17220	0.005807201	0.004994193	1	11	Glia-MIX	26	7	7
CCTTCGATCTGTTGAG-1_1_A4	-24.9472225	17.07028366	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1166	1896	0.002637131	0.002637131	1	8	Astrocytes	26	7	7
CCTTTCTAGTCATGCT-1_1_A4	-9.889019015	11.73515288	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	923	1496	0.021390374	0.002673797	1	11	Glia-MIX	26	7	7
CCTTTCTAGTCCGGTC-1_1_A4	4.323840712	17.93568613	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	962	1464	0.017076503	0.008196721	1	oligos	OL-Cntl	26	7	7
CCTTTCTGTTGATTGC-1_1_A4	-0.074145166	23.90403739	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	763	1158	0.003454231	0.005181347	1	oligos	OL-Cntl	26	7	7
CCTTTCTTCACATGCA-1_1_A4	-11.49931501	-22.29050162	6A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1014	1899	0.039494471	0.003159558	1	6A	IN-PV	26	7	7
CCTTTCTTCGTAGGTT-1_1_A4	21.8267377	14.50089663	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1313	2185	0.001830664	0.003661327	1	oligos	OL-Cntl	26	7	7
CCTTTCTTCTCTTGAT-1_1_A4	22.21834392	9.999475169	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1652	3036	0.009881423	0.005599473	1	oligos	OL-Cntl	26	7	7
CGAACATAGACCTAGG-1_1_A4	14.81347229	16.54622025	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1082	1793	0.008923592	0.007250418	1	oligos	OL-Cntl	26	7	7
CGAACATAGTACGTAA-1_1_A4	9.225097476	8.427965843	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1720	3186	0.016949153	0.013496547	1	oligos	OL-Cntl	26	7	7
CGAACATAGTGTCTCA-1_1_A4	-9.050267215	17.35008238	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	4138	10379	0.00722613	0.005973601	1	11	Glia-MIX	26	7	7
CGAACATGTCAAGCGA-1_1_A4	-25.42570066	23.17046652	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1445	2628	0.003424658	0.004185693	1	8	Astrocytes	26	7	7
CGAACATGTCCAGTAT-1_1_A4	0.810400905	-7.948075711	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1412	2584	0.00619195	0.001547988	1	12	EN-MIX	26	7	7
CGAACATGTCCATCCT-1_1_A4	-22.65332374	-1.504348391	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	863	1261	0.002379064	0.001586043	1	9	OPC	26	7	7
CGAACATGTGTGGTTT-1_1_A4	-25.28225009	19.55582223	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1613	2848	0.001755618	0.003511236	1	8	Astrocytes	26	7	7
CGAACATTCCAAGCCG-1_1_A4	5.801321819	17.1385478	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1051	1781	0.023020775	0.009545199	1	oligos	OL-Cntl	26	7	7
CGAATGTAGGGAGTAA-1_1_A4	1.175419828	26.29101259	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	696	1045	0.010526316	0.009569378	1	oligos	OL-Cntl	26	7	7
CGAATGTCATTAACCG-1_1_A4	-32.62278369	-5.341895862	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1293	2125	0.004235294	0.012705882	1	9	OPC	26	7	7
CGAATGTGTATGGTTC-1_1_A4	5.58911163	13.51412745	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1187	1857	0.018309101	0.010231556	1	oligos	OL-Cntl	26	7	7
CGAATGTGTCATCCCT-1_1_A4	4.892826439	-5.018100247	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	777	1201	0.013322231	0.000832639	1	12	EN-MIX	26	7	7
CGAATGTTCAGTCCCT-1_1_A4	-36.21282676	-0.562634694	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1602	2794	0.002147459	0.005010737	1	9	OPC	26	7	7
CGAATGTTCGGAGGTA-1_1_A4	-31.82318759	-7.173707881	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1213	1860	0.007526882	0.008602151	1	9	OPC	26	7	7
CGAATGTTCTCGCTTG-1_1_A4	17.26217363	21.58772503	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	971	1544	0.000647668	0.00388601	1	oligos	OL-Cntl	26	7	7
CGACCTTAGAATGTTG-1_1_A4	14.74607274	22.34309059	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1000	1577	0.012682308	0.002536462	1	oligos	OL-Cntl	26	7	7
CGACCTTAGTGGGCTA-1_1_A4	-3.952472282	17.17997818	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	764	1147	0.013949433	0.012205754	1	oligos	OL-Cntl	26	7	7
CGACCTTCAGGATTGG-1_1_A4	4.611475544	18.78163943	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	956	1420	0.00915493	0.014084507	1	oligos	OL-Cntl	26	7	7
CGACCTTCAGGTGCCT-1_1_A4	-13.60333291	-21.51719449	6A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1367	2720	0.025735294	0.002573529	1	6A	IN-PV	26	7	7
CGACCTTCATGTCTCC-1_1_A4	14.69451945	17.2915406	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1090	1756	0.011958998	0.007403189	1	oligos	OL-Cntl	26	7	7
CGACCTTGTCGCGGTT-1_1_A4	15.72088731	20.82423625	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	955	1529	0.007194245	0.0058862	1	oligos	OL-Cntl	26	7	7
CGACCTTGTCGGCTCA-1_1_A4	20.94792205	10.47333776	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1559	2780	0.004316547	0.00971223	1	oligos	OL-Cntl	26	7	7
CGACCTTTCCCTTGTG-1_1_A4	-22.61063182	29.37586908	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2014	4115	0.002673147	0.005103281	1	8	Astrocytes	26	7	7
CGACCTTTCCGGCACA-1_1_A4	2.72114509	-3.548014597	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	831	1254	0.018341308	0.003189793	1	12	EN-MIX	26	7	7
CGACCTTTCCGTAGTA-1_1_A4	-0.063028727	28.70058331	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	748	1122	0.012477718	0.002673797	1	oligos	OL-Cntl	26	7	7
CGACCTTTCGAATCCA-1_1_A4	15.60852021	16.32081545	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1085	1726	0.001158749	0.007531866	1	oligos	OL-Cntl	26	7	7
CGACCTTTCGTGGACC-1_1_A4	-19.67691645	31.19550722	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2937	6543	0.003056702	0.004890723	1	8	Astrocytes	26	7	7
CGACCTTTCTACTATC-1_1_A4	-25.57541029	19.4032305	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1525	2973	0.004372688	0.005381769	1	8	Astrocytes	26	7	7
CGACCTTTCTATCCTA-1_1_A4	-37.38922159	-2.874667496	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1332	2522	0.001982554	0.003568596	1	9	OPC	26	7	7
CGACTTCAGACAGAGA-1_1_A4	15.59301837	1.892654308	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	937	1335	0.006741573	0.002996255	1	12	EN-MIX	26	7	7
CGACTTCAGCTCCTCT-1_1_A4	-10.96329276	18.01061968	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2251	4808	0.002911814	0.00374376	1	11	Glia-MIX	26	7	7
CGACTTCAGGGTTCCC-1_1_A4	35.46391733	7.78812252	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1022	1347	0.007423905	0.005939124	1	14	Microglia	26	7	7
CGACTTCAGTGAACGC-1_1_A4	4.431108679	26.08399436	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	803	1224	0.014705882	0.004901961	1	oligos	OL-Cntl	26	7	7
CGACTTCCATTTGCCC-1_1_A4	39.73836826	13.70950085	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1022	1463	0.000683527	0.001367054	1	14	Microglia	26	7	7
CGAGAAGAGTTTGCGT-1_1_A4	39.5634797	14.43393348	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1304	1962	0.008154944	0.009174312	1	14	Microglia	26	7	7
CGAGAAGCATAGACTC-1_1_A4	-26.15023716	1.688416491	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2326	4711	0.003396307	0.003608576	1	9	OPC	26	7	7
CGAGAAGGTAGAGTGC-1_1_A4	1.314222708	20.20708915	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	869	1283	0.014029618	0.012470772	1	oligos	OL-Cntl	26	7	7
CGAGAAGGTCTTCTCG-1_1_A4	-6.125543042	-10.56495074	6B	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1066	1767	0.073005093	0.002829655	1	6B	IN-SST	26	7	7
CGAGCACAGAGCCCAA-1_1_A4	8.792090331	13.46748843	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1285	2165	0.0073903	0.01108545	1	oligos	OL-Cntl	26	7	7
CGAGCACCAATCCAAC-1_1_A4	13.15574996	11.59811169	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1468	2443	0.011051985	0.009414654	1	oligos	OL-Cntl	26	7	7
CGAGCACCACACCGCA-1_1_A4	18.54186506	6.162443228	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2754	5830	0.00703259	0.006689537	1	oligos	OL-Cntl	26	7	7
CGAGCACCAGTCCTTC-1_1_A4	32.31354908	-2.950588038	2	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2705	5721	0.004195071	0.004894249	1	2	EN-L4	26	7	7
CGAGCACCATCAGTAC-1_1_A4	20.00197525	8.866139843	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1836	3564	0.002244669	0.00617284	1	oligos	OL-Cntl	26	7	7
CGAGCACGTCCATGAT-1_1_A4	-6.704524563	-2.054313572	13A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1910	3711	0.001886284	0.004042037	1	13A	IN-VIP	26	7	7
CGAGCACTCAGTACGT-1_1_A4	22.69725018	13.30078886	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1456	2510	0.006374502	0.005577689	1	oligos	OL-Cntl	26	7	7
CGAGCACTCCAGATCA-1_1_A4	14.24110344	6.80102904	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1771	3083	0.007460266	0.011676938	1	oligos	OL-Cntl	26	7	7
CGAGCACTCTATCGCC-1_1_A4	1.214991331	-17.91490224	4	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	3361	8673	0.001960106	0.004035513	1	L2-3	EN-L2-3-MS	26	7	7
CGAGCCATCGCTTAGA-1_1_A4	15.78234386	8.114998024	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1949	3779	0.007409368	0.008467849	1	oligos	OL-Cntl	26	7	7
CGAGCCATCTACGAGT-1_1_A4	15.88487511	19.17765456	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1080	1791	0.009491904	0.005025126	1	oligos	OL-Cntl	26	7	7
CGATCGGAGGCAGGTT-1_1_A4	14.13130461	-1.329010886	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	811	1167	0.003427592	0.003427592	1	12	EN-MIX	26	7	7
CGATCGGCATCACGTA-1_1_A4	-7.308726219	-6.349409512	13A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1377	2280	0.018421053	0.002192982	1	13A	IN-VIP	26	7	7
CGATCGGCATGGTAGG-1_1_A4	17.40552947	-0.432791526	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1036	1606	0.0124533	0.00249066	1	12	EN-MIX	26	7	7
CGATCGGGTCATCCCT-1_1_A4	13.8866435	19.74893062	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1019	1609	0.009322561	0.008079553	1	oligos	OL-Cntl	26	7	7
CGATCGGTCCTCAATT-1_1_A4	10.87083119	-7.335006142	10	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2024	3821	0.00157027	0.003663962	1	L2-3	EN-L2-3-Cntl	26	7	7
CGATCGGTCTTGTACT-1_1_A4	2.663046031	22.18971904	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	816	1197	0.012531328	0.005847953	1	oligos	OL-Cntl	26	7	7
CGATGGCAGACAAGCC-1_1_A4	-13.36212113	18.57978822	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1775	3372	0.011565836	0.002965599	1	8	Astrocytes	26	7	7
CGATGGCCACATGGGA-1_1_A4	18.50548534	1.606015527	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1081	1712	0.011682243	0.003504673	1	12	EN-MIX	26	7	7
CGATGGCGTGACAAAT-1_1_A4	21.30724339	17.58835374	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1176	1906	0.006295908	0.004197272	1	oligos	OL-Cntl	26	7	7
CGATGGCTCGCGGATC-1_1_A4	-35.47285227	-0.256203343	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1638	2807	0.004275027	0.003918774	1	9	OPC	26	7	7
CGATGTAAGAACAATC-1_1_A4	3.98377915	20.40407219	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	851	1271	0.005507474	0.005507474	1	oligos	OL-Cntl	26	7	7
CGATGTAAGAACTGTA-1_1_A4	6.737289437	-5.851476561	10	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1167	2079	0.000962001	0.000962001	1	L2-3	EN-L2-3-Cntl	26	7	7
CGATGTAAGACGCTTT-1_1_A4	7.126901301	19.83914673	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1140	1748	0.004576659	0.01201373	1	oligos	OL-Cntl	26	7	7
CGATGTAAGTCCCACG-1_1_A4	22.30906143	16.10537462	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1354	2154	0.006963788	0.010213556	1	oligos	OL-Cntl	26	7	7
CGATGTACATCTCCCA-1_1_A4	40.21170803	13.86054083	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1116	1545	0.004530744	0.005177994	1	14	Microglia	26	7	7
CGATGTAGTAAAGGAG-1_1_A4	-3.507368476	20.59051561	5	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	833	1159	0.000862813	0.017256255	1	oligos	OL-MS-1	26	7	7
CGATGTATCAATACCG-1_1_A4	15.30925662	-4.064207113	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1073	1737	0	0.003454231	1	12	EN-MIX	26	7	7
CGATGTATCGGCGCAT-1_1_A4	5.887578468	14.08171226	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1218	1925	0.01974026	0.015584416	1	oligos	OL-Cntl	26	7	7
CGATGTATCTGTCCGT-1_1_A4	4.458217117	17.8108751	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	992	1506	0.013280212	0.009960159	1	oligos	OL-Cntl	26	7	7
CGATTGAAGGCTAGAC-1_1_A4	10.25738706	13.73813702	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1234	2061	0.016982048	0.011644833	1	oligos	OL-Cntl	26	7	7
CGATTGACAACTGCTA-1_1_A4	-10.16538993	18.36029672	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2721	5587	0.005548595	0.003758726	1	11	Glia-MIX	26	7	7
CGATTGACACAGGTTT-1_1_A4	37.88266237	9.892293109	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	823	1109	0.000901713	0.009017133	1	14	Microglia	26	7	7
CGATTGAGTCCAACTA-1_1_A4	15.66588865	-2.357046094	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	943	1553	0	0.001931745	1	12	EN-MIX	26	7	7
CGATTGAGTCCATGAT-1_1_A4	13.01978628	11.7982224	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1466	2406	0.005403159	0.013300083	1	oligos	OL-Cntl	26	7	7
CGATTGATCAGTTGAC-1_1_A4	5.496751071	17.30993262	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1089	1782	0.013468013	0.009539843	1	oligos	OL-Cntl	26	7	7
CGATTGATCCGCTGTT-1_1_A4	0.230656936	0.918002519	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1318	2169	0.071000461	0.011065007	1	11	Glia-MIX	26	7	7
CGCCAAGTCACATACG-1_1_A4	9.17737703	-9.174145047	10	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2553	5866	0.002557109	0.002386635	1	L2-3	EN-L2-3-Cntl	26	7	7
CGCCAAGTCCTAGGGC-1_1_A4	-0.911362157	24.23663483	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	807	1182	0.002538071	0.007614213	1	oligos	OL-Cntl	26	7	7
CGCCAAGTCGTCCGTT-1_1_A4	-3.602766279	-7.39138686	13A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	825	1247	0.01042502	0.003207698	1	13A	IN-VIP	26	7	7
CGCCAAGTCTGCCAGG-1_1_A4	6.148959715	6.523565967	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2042	3673	0.003811598	0.004083855	1	oligos	OL-Cntl	26	7	7
CGCCAAGTCTTATCTG-1_1_A4	10.78948621	22.9369866	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	799	1265	0.009486166	0.008695652	1	oligos	OL-Cntl	26	7	7
CGCGGTAAGAAGGTGA-1_1_A4	-28.07015608	9.322268411	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	779	1225	0.001632653	0.006530612	1	8	Astrocytes	26	7	7
CGCGGTAAGACAGACC-1_1_A4	40.12896196	13.83337307	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1350	1948	0.02926078	0.011293634	1	14	Microglia	26	7	7
CGCGGTACAAAGCGGT-1_1_A4	22.69878604	10.7640243	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1728	3089	0.001294917	0.007769505	1	oligos	OL-Cntl	26	7	7
CGCGGTATCTGACCTC-1_1_A4	1.953324065	5.630762862	7	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	975	1362	0.013215859	0.01835536	1	7	Phagocytes	26	7	7
CGCGTTTAGCCGGTAA-1_1_A4	5.774686951	24.6419805	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	892	1306	0.009188361	0.009188361	1	oligos	OL-Cntl	26	7	7
CGCGTTTCAAAGCAAT-1_1_A4	2.47707462	21.91233438	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	902	1390	0.018705036	0.009352518	1	oligos	OL-Cntl	26	7	7
CGCGTTTCAAGGTTCT-1_1_A4	6.695576975	19.4627486	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1001	1490	0.006711409	0.010738255	1	oligos	OL-Cntl	26	7	7
CGCGTTTCACGACTCG-1_1_A4	14.67179559	18.49779984	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1053	1600	0.003125	0.00625	1	oligos	OL-Cntl	26	7	7
CGCGTTTGTAACGACG-1_1_A4	13.88185969	6.668642392	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1997	3728	0.01582618	0.010997854	1	oligos	OL-Cntl	26	7	7
CGCGTTTGTAATCGTC-1_1_A4	-11.85776611	16.27218466	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1659	2538	0.001182033	0.001970055	1	11	Glia-MIX	26	7	7
CGCGTTTGTAGCGTCC-1_1_A4	17.62216811	0.851365011	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	928	1516	0.006596306	0.003298153	1	12	EN-MIX	26	7	7
CGCGTTTGTCTGATCA-1_1_A4	38.03376065	9.6498546	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	928	1268	0.002365931	0.005520505	1	14	Microglia	26	7	7
CGCGTTTGTGAGGGTT-1_1_A4	3.602203865	20.59081696	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	887	1397	0.008589835	0.005726557	1	oligos	OL-Cntl	26	7	7
CGCGTTTTCAAGGTAA-1_1_A4	-37.29634027	0.397391589	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1622	2734	0.005120702	0.005120702	1	9	OPC	26	7	7
CGCGTTTTCACGCATA-1_1_A4	-8.909793858	16.09563697	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	3310	7160	0.00726257	0.006145251	1	11	Glia-MIX	26	7	7
CGCGTTTTCCCTGACT-1_1_A4	11.59219995	14.92707457	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1217	1853	0.016189962	0.011332974	1	oligos	OL-Cntl	26	7	7
CGCGTTTTCGCTTGTC-1_1_A4	-23.18576151	28.59832188	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2018	4167	0.002639789	0.001439885	1	8	Astrocytes	26	7	7
CGCGTTTTCTGATTCT-1_1_A4	-36.48422905	-1.127965583	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1473	2701	0.002221399	0.003702332	1	9	OPC	26	7	7
CGCTATCAGGTCGGAT-1_1_A4	-26.64118229	1.790442598	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2295	3903	0.002562132	0.012042019	1	9	OPC	26	7	7
CGCTATCCACGAAAGC-1_1_A4	14.35775731	6.175570747	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2297	4224	0.012310606	0.013257576	1	oligos	OL-Cntl	26	7	7
CGCTATCCATGTAGTC-1_1_A4	-24.1985583	17.97752258	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1343	2289	0.001747488	0.003058104	1	8	Astrocytes	26	7	7
CGCTATCTCCACTCCA-1_1_A4	15.03238018	12.51818244	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1443	2516	0.008744038	0.009538951	1	oligos	OL-Cntl	26	7	7
CGCTATCTCTACCTGC-1_1_A4	11.66691635	30.71058675	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	723	1046	0.011472275	0.004780115	1	oligos	OL-Cntl	26	7	7
CGCTGGAAGTTATCGC-1_1_A4	13.44664361	6.650859334	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1867	3311	0.013893084	0.020839625	1	oligos	OL-Cntl	26	7	7
CGCTGGACAAGGTGTG-1_1_A4	-0.250608595	27.03706744	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	765	1125	0.007111111	0.005333333	1	oligos	OL-Cntl	26	7	7
CGCTGGACAATGGAAT-1_1_A4	-35.27661437	-4.85977903	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1321	2196	0.005009107	0.00273224	1	9	OPC	26	7	7
CGCTGGAGTCACTTCC-1_1_A4	4.880228903	5.503604658	7	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1995	3221	0.021732381	0.005898789	1	7	Phagocytes	26	7	7
CGCTGGAGTCCGTGAC-1_1_A4	6.7827196	19.86817079	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	996	1497	0.007348029	0.007348029	1	oligos	OL-Cntl	26	7	7
CGCTGGAGTTACGTCA-1_1_A4	6.854257359	23.80821178	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	949	1371	0.008023341	0.004376368	1	oligos	OL-Cntl	26	7	7
CGCTGGATCCCAGGTG-1_1_A4	3.762586936	12.73247964	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1113	1703	0.01233118	0.015854375	1	oligos	OL-Cntl	26	7	7
CGCTGGATCCTGTACC-1_1_A4	13.78458405	11.70949847	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1424	2444	0.014320786	0.013502455	1	oligos	OL-Cntl	26	7	7
CGCTTCAAGACTTGAA-1_1_A4	6.573215432	6.25293277	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2876	5921	0.012328998	0.010471204	1	oligos	OL-Cntl	26	7	7
CGCTTCACATGACATC-1_1_A4	-24.04043679	18.95777009	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1452	2510	0.000796813	0.003585657	1	8	Astrocytes	26	7	7
CGCTTCAGTACATGTC-1_1_A4	19.20374702	10.85803315	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1620	2880	0.001388889	0.002430556	1	oligos	OL-Cntl	26	7	7
CGCTTCAGTCTCGTTC-1_1_A4	5.064973846	-5.263503971	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	824	1345	0.002973978	0.002230483	1	12	EN-MIX	26	7	7
CGCTTCATCAATCTCT-1_1_A4	5.590339447	17.85872342	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	980	1504	0.009308511	0.013962766	1	oligos	OL-Cntl	26	7	7
CGCTTCATCACTCTTA-1_1_A4	-22.44372733	29.66225181	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2298	4790	0.003757829	0.007098121	1	8	Astrocytes	26	7	7
CGCTTCATCATTGCGA-1_1_A4	2.250392138	-5.152787977	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1129	1922	0	0.004682622	1	12	EN-MIX	26	7	7
CGGACACAGCATCATC-1_1_A4	1.788740712	20.05803053	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	835	1312	0.004573171	0.020579268	1	oligos	OL-Cntl	26	7	7
CGGACACAGGGAACGG-1_1_A4	4.739787814	4.660709498	7	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1941	3060	0.003267974	0.012091503	1	7	Phagocytes	26	7	7
CGGACACGTACACCGC-1_1_A4	-35.46446549	-4.012624924	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1341	2277	0.012736056	0.006148441	1	9	OPC	26	7	7
CGGACACGTCAGGACA-1_1_A4	-21.99624329	-26.57140675	6A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	3161	6966	0.004163078	0.002727534	1	6A	IN-PV	26	7	7
CGGACACGTCGCCATG-1_1_A4	-1.697853658	27.86992475	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	729	1014	0.003944773	0.00295858	1	oligos	OL-Cntl	26	7	7
CGGACACGTGACGCCT-1_1_A4	-36.12145479	-1.087983289	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1586	2738	0.00109569	0.004017531	1	9	OPC	26	7	7
CGGACACTCAAACCAC-1_1_A4	14.38177924	15.51448585	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1338	2217	0.00857014	0.00496166	1	oligos	OL-Cntl	26	7	7
CGGACACTCCCTTGTG-1_1_A4	18.56931346	1.470536204	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1184	1838	0.019586507	0.004352557	1	12	EN-MIX	26	7	7
CGGACACTCCTAGTGA-1_1_A4	19.01520055	17.51434496	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1155	1841	0.003259098	0.004888647	1	oligos	OL-Cntl	26	7	7
CGGACGTAGATGGGTC-1_1_A4	13.966431	7.789574875	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1695	2895	0.016925734	0.011744387	1	oligos	OL-Cntl	26	7	7
CGGACGTAGGATGGTC-1_1_A4	11.69702988	20.87654431	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	994	1641	0.009750152	0.009750152	1	oligos	OL-Cntl	26	7	7
CGGACGTAGGCGACAT-1_1_A4	14.58888401	14.26601791	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1284	2058	0.009718173	0.013605442	1	oligos	OL-Cntl	26	7	7
CGGACGTAGTTCGCGC-1_1_A4	-20.13449515	30.85626767	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2906	6284	0.004137492	0.005887969	1	8	Astrocytes	26	7	7
CGGACGTCAGCATGAG-1_1_A4	13.05551166	-0.455165736	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	856	1210	0.014876033	0.00661157	1	12	EN-MIX	26	7	7
CGGACGTCATTTCAGG-1_1_A4	13.13075502	14.44496534	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1251	2068	0.006286267	0.010154739	1	oligos	OL-Cntl	26	7	7
CGGACGTGTAGGCTGA-1_1_A4	36.71549459	14.75352301	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1233	1774	0.012401353	0.016910936	1	14	Microglia	26	7	7
CGGACGTGTTACAGAA-1_1_A4	3.593828955	18.05139218	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	926	1395	0.007168459	0.012903226	1	oligos	OL-Cntl	26	7	7
CGGACGTTCCCACTTG-1_1_A4	16.96970571	-0.683723871	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	671	1071	0.000933707	0.003734827	1	12	EN-MIX	26	7	7
CGGACTGAGCAAATCA-1_1_A4	-35.09401673	-9.019350564	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1027	1606	0.015566625	0.003113325	1	9	OPC	26	7	7
CGGACTGAGCGTGTCC-1_1_A4	18.99799518	1.685295497	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1065	1690	0.002366864	0.002366864	1	12	EN-MIX	26	7	7
CGGACTGAGTGACTCT-1_1_A4	-35.2706219	-4.512241021	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1326	2187	0.005486968	0.002743484	1	9	OPC	26	7	7
CGGACTGAGTGCTGCC-1_1_A4	0.897120592	25.32612933	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	849	1289	0.008533747	0.008533747	1	oligos	OL-Cntl	26	7	7
CGGACTGCACATTAGC-1_1_A4	-22.25030993	29.09285249	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2344	5108	0.002349256	0.003915427	1	8	Astrocytes	26	7	7
CGGACTGCAGGGTATG-1_1_A4	-35.15997882	-6.803378509	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1118	1650	0.011515152	0.004242424	1	9	OPC	26	7	7
CGGACTGGTGATAAGT-1_1_A4	4.657952608	-5.201698635	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	799	1199	0.000834028	0.006672227	1	12	EN-MIX	26	7	7
CGGACTGGTTTCCACC-1_1_A4	14.66374946	-7.54766748	10	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1835	4024	0.003727634	0.004473161	1	L2-3	EN-L2-3-Cntl	26	7	7
CGGACTGTCACTGGGC-1_1_A4	22.33416731	13.53880845	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1526	2700	0.014074074	0.004444444	1	oligos	OL-Cntl	26	7	7
CGGACTGTCAGTTCGA-1_1_A4	6.571089537	13.02717815	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1335	2308	0.009532062	0.012564991	1	oligos	OL-Cntl	26	7	7
CGGAGCTAGCTCCCAG-1_1_A4	-9.82862682	17.81164623	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2610	5080	0.006692913	0.004330709	1	11	Glia-MIX	26	7	7
CGGAGCTAGGCGATAC-1_1_A4	4.441692882	26.16227103	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	768	1161	0.002583979	0.006890612	1	oligos	OL-Cntl	26	7	7
CGGAGCTCAGAGCCAA-1_1_A4	-4.13150144	-6.439348138	13A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1077	1672	0.024521531	0.003588517	1	13A	IN-VIP	26	7	7
CGGAGCTGTAATCACC-1_1_A4	8.575346805	-7.079296451	10	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1636	2996	0.006341789	0.003337784	1	L2-3	EN-L2-3-Cntl	26	7	7
CGGAGCTGTAGCGCAA-1_1_A4	-24.47561355	16.64549814	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1344	2256	0.001329787	0.007978723	1	8	Astrocytes	26	7	7
CGGAGCTTCTACTTAC-1_1_A4	-8.54594471	8.833993304	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	884	1380	0.006521739	0.008695652	1	11	Glia-MIX	26	7	7
CGGAGTCAGAAGGGTA-1_1_A4	-32.0917854	-1.022907456	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1512	2385	0.007127883	0.007966457	1	9	OPC	26	7	7
CGGAGTCAGAGTGACC-1_1_A4	-3.441324058	20.9204554	5	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	745	1061	0.001885014	0.015080113	1	oligos	OL-MS-1	26	7	7
CGGAGTCAGTATCGAA-1_1_A4	-0.412499765	24.66976684	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	744	1073	0.002795899	0.009319664	1	oligos	OL-Cntl	26	7	7
CGGAGTCGTTCTCATT-1_1_A4	17.42563586	19.92496722	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1078	1769	0.00508762	0.006218202	1	oligos	OL-Cntl	26	7	7
CGGAGTCTCTACCAGA-1_1_A4	6.904054362	17.35983211	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1109	1726	0.015643105	0.01622248	1	oligos	OL-Cntl	26	7	7
CGGCTAGCACATTAGC-1_1_A4	38.28652238	8.710626764	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	742	1023	0.019550342	0.001955034	1	14	Microglia	26	7	7
CGGCTAGGTCATGCAT-1_1_A4	21.54773697	-1.523636992	2	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2045	3936	0.030995935	0.004319106	1	2	EN-L4	26	7	7
CGGCTAGTCACATACG-1_1_A4	21.24173737	9.546351549	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1737	3197	0.001251173	0.014075696	1	oligos	OL-Cntl	26	7	7
CGGCTAGTCACATGCA-1_1_A4	12.25214686	15.57827978	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1282	2138	0.015434986	0.00748363	1	oligos	OL-Cntl	26	7	7
CGGCTAGTCGCCCTTA-1_1_A4	39.23196617	14.37997716	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1217	1786	0.015677492	0.008398656	1	14	Microglia	26	7	7
CGGCTAGTCTCTTATG-1_1_A4	3.978273173	5.358844575	7	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1362	2000	0.0075	0.0075	1	7	Phagocytes	26	7	7
CGGGTCAAGCTAAGAT-1_1_A4	-24.59031606	-1.673050644	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1672	3312	0.001811594	0.002113527	1	9	OPC	26	7	7
CGGGTCACAGCGATCC-1_1_A4	8.493198039	13.28699056	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1281	2075	0.009156627	0.015903614	1	oligos	OL-Cntl	26	7	7
CGGGTCATCAACTCTT-1_1_A4	-4.284317067	-7.379969008	13A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	953	1520	0.029605263	0.006578947	1	13A	IN-VIP	26	7	7
CGGGTCATCACGGTTA-1_1_A4	6.310145157	-7.164015724	10	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1653	2791	0.004299534	0.006091007	1	L2-3	EN-L2-3-Cntl	26	7	7
CGGGTCATCCAGAGGA-1_1_A4	-1.560545322	20.80482798	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	828	1225	0.007346939	0.012244898	1	oligos	OL-Cntl	26	7	7
CGGTTAAAGACACGAC-1_1_A4	1.967314115	27.27181851	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	807	1181	0.016088061	0.00508044	1	oligos	OL-Cntl	26	7	7
CGGTTAAAGAGCTATA-1_1_A4	14.11906222	-1.323560048	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	924	1429	0.013296011	0.005598321	1	12	EN-MIX	26	7	7
CGGTTAACAGGGATTG-1_1_A4	-9.585218749	-17.2621458	6B	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	919	1521	0.046022354	0.002629849	1	6B	IN-SST	26	7	7
CGGTTAAGTCGCGTGT-1_1_A4	-5.396055655	-9.868403085	13B	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	966	1522	0.049277267	0.002628121	1	13B	IN-SV2C	26	7	7
CGGTTAAGTGTCGCTG-1_1_A4	-25.00309901	15.67736049	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1196	2078	0.008180943	0.003849856	1	8	Astrocytes	26	7	7
CGGTTAAGTGTTTGTG-1_1_A4	-5.146657519	2.618182501	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	3754	7861	0.010304033	0.007378196	1	11	Glia-MIX	26	7	7
CGGTTAAGTTCAGGCC-1_1_A4	-27.60146013	8.501911168	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	758	1264	0.001582278	0.01028481	1	8	Astrocytes	26	7	7
CGGTTAATCATGCAAC-1_1_A4	13.17026756	12.02205055	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1414	2322	0.021963824	0.009474591	1	oligos	OL-Cntl	26	7	7
CGGTTAATCCCTCAGT-1_1_A4	38.71440419	10.8102581	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	834	1175	0.001702128	0.010212766	1	14	Microglia	26	7	7
CGTAGCGAGGATATAC-1_1_A4	-2.306423818	22.15854446	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	890	1257	0.003977725	0.007159905	1	oligos	OL-Cntl	26	7	7
CGTAGCGAGTCCGGTC-1_1_A4	2.231625971	23.48536695	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	810	1215	0.002469136	0.01399177	1	oligos	OL-Cntl	26	7	7
CGTAGCGCACCAGGTC-1_1_A4	22.14762598	17.24819013	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1360	2091	0.006217121	0.003825921	1	oligos	OL-Cntl	26	7	7
CGTAGCGTCAACACGT-1_1_A4	-24.25241813	17.33212864	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1119	1862	0.001074114	0.005370569	1	8	Astrocytes	26	7	7
CGTAGGCAGCTAACAA-1_1_A4	-20.68446253	25.72269296	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1637	2891	0.002767209	0.005188516	1	8	Astrocytes	26	7	7
CGTAGGCAGGAACTGC-1_1_A4	-0.737124833	23.36481726	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	838	1212	0.004125413	0.00660066	1	oligos	OL-Cntl	26	7	7
CGTAGGCAGGGTCTCC-1_1_A4	-0.018169236	0.298355295	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1075	1680	0.041071429	0.004761905	1	11	Glia-MIX	26	7	7
CGTAGGCAGTGACTCT-1_1_A4	12.15768903	14.76604178	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1141	1862	0.005370569	0.016648765	1	oligos	OL-Cntl	26	7	7
CGTAGGCCACAGGAGT-1_1_A4	-9.120979113	19.0332854	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	3039	5699	0.005088612	0.00579049	1	11	Glia-MIX	26	7	7
CGTAGGCCACAGGTTT-1_1_A4	-13.27669943	4.520965121	13B	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2237	3905	0.023303457	0.004353393	1	13B	IN-SV2C	26	7	7
CGTAGGCCATCGATGT-1_1_A4	-1.291313543	-0.87221699	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2643	5213	0.020909265	0.0061385	1	11	Glia-MIX	26	7	7
CGTAGGCGTAAGGGCT-1_1_A4	37.86965318	10.64623033	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	918	1240	0.006451613	0.018548387	1	14	Microglia	26	7	7
CGTAGGCGTGCACTTA-1_1_A4	16.25340715	10.99398879	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1385	2289	0.00436872	0.005679336	1	oligos	OL-Cntl	26	7	7
CGTAGGCTCACGATGT-1_1_A4	13.84979344	9.707085529	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1533	2652	0.014328808	0.010180995	1	oligos	OL-Cntl	26	7	7
CGTAGGCTCCTAGGGC-1_1_A4	-22.11493276	24.04311465	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1705	3089	0.005827129	0.004208482	1	8	Astrocytes	26	7	7
CGTAGGCTCTGGAGCC-1_1_A4	7.037130374	23.63965379	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1091	1726	0.007531866	0.007531866	1	oligos	OL-Cntl	26	7	7
CGTCACTAGATGCCTT-1_1_A4	19.43079608	-7.240895531	3	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2602	6113	0.00196303	0.002617373	1	3	EN-L5-6	26	7	7
CGTCACTAGATTACCC-1_1_A4	23.39829215	18.49259406	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1268	2107	0.002847651	0.004271476	1	oligos	OL-Cntl	26	7	7
CGTCACTAGCTCTCGG-1_1_A4	-0.78390182	22.88387581	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	762	1069	0.009354537	0.008419083	1	oligos	OL-Cntl	26	7	7
CGTCACTAGCTGAAAT-1_1_A4	20.15205137	16.07893273	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1356	2211	0.003165988	0.008141113	1	oligos	OL-Cntl	26	7	7
CGTCACTCAGACGCCT-1_1_A4	-24.85167719	16.86380162	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1298	2130	0.007042254	0.005164319	1	8	Astrocytes	26	7	7
CGTCACTGTAGGCTGA-1_1_A4	-3.458023198	25.3770622	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	828	1228	0.017915309	0.00732899	1	oligos	OL-Cntl	26	7	7
CGTCACTGTGATGTGG-1_1_A4	2.77602371	15.23606651	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1014	1585	0.003785489	0.013880126	1	oligos	OL-Cntl	26	7	7
CGTCACTTCTCACATT-1_1_A4	22.43191119	15.66790558	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1397	2263	0.003093239	0.008837826	1	oligos	OL-Cntl	26	7	7
CGTCAGGAGAATAGGG-1_1_A4	-25.66403653	22.75871552	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1403	2452	0.005709625	0.005301794	1	8	Astrocytes	26	7	7
CGTCAGGAGTATTGGA-1_1_A4	-28.712817	12.15942383	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	877	1306	0.009188361	0.001531394	1	8	Astrocytes	26	7	7
CGTCAGGCAAATCCGT-1_1_A4	15.2791606	23.25765612	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	797	1162	0.003442341	0.004302926	1	oligos	OL-Cntl	26	7	7
CGTCAGGCACAAGACG-1_1_A4	-3.190518046	11.64974924	5	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	836	1260	0.001587302	0.007142857	1	oligos	OL-MS-1	26	7	7
CGTCAGGGTCTACCTC-1_1_A4	39.45191735	14.965158	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1299	1924	0.003638254	0.006756757	1	14	Microglia	26	7	7
CGTCCATAGAGGGATA-1_1_A4	0.684876919	22.18090965	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	890	1292	0.011609907	0.007739938	1	oligos	OL-Cntl	26	7	7
CGTCCATAGGCACATG-1_1_A4	4.286351058	17.55683838	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1083	1642	0.013398295	0.014007308	1	oligos	OL-Cntl	26	7	7
CGTCCATCAAGTTGTC-1_1_A4	15.13292665	2.875059662	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	763	1102	0.013611615	0.000907441	1	12	EN-MIX	26	7	7
CGTCCATCAGACGTAG-1_1_A4	15.78447452	9.430476023	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1553	2693	0.002970665	0.005941329	1	oligos	OL-Cntl	26	7	7
CGTCCATCAGTCTTCC-1_1_A4	-34.2543058	4.864782338	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2565	5483	0.005653839	0.004924312	1	9	OPC	26	7	7
CGTCCATTCCCAAGTA-1_1_A4	4.572597347	5.094633268	7	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1883	2952	0.015582656	0.017615176	1	7	Phagocytes	26	7	7
CGTCCATTCCGTAGTA-1_1_A4	-34.78436611	-9.834851986	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	937	1565	0.017252396	0.005750799	1	9	OPC	26	7	7
CGTCTACAGCGTTCCG-1_1_A4	-4.253799983	-8.816528251	13A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	929	1380	0.04057971	0.002898551	1	13A	IN-VIP	26	7	7
CGTCTACAGTCATCCA-1_1_A4	15.16857981	20.23985376	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	988	1497	0.007348029	0.010688043	1	oligos	OL-Cntl	26	7	7
CGTCTACCAACGCACC-1_1_A4	4.409741152	16.60099598	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1059	1623	0.008009858	0.012939002	1	oligos	OL-Cntl	26	7	7
CGTCTACGTCTTCGTC-1_1_A4	-23.65046063	28.11970667	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1829	3604	0.001109878	0.005826859	1	8	Astrocytes	26	7	7
CGTGAGCCAAGTCATC-1_1_A4	3.794712483	22.50434482	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	911	1390	0.016546763	0.012230216	1	oligos	OL-Cntl	26	7	7
CGTGAGCCACGGACAA-1_1_A4	-34.00626289	-9.792625728	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1105	1646	0.010935601	0.004860267	1	9	OPC	26	7	7
CGTGAGCGTATGCTTG-1_1_A4	6.694078911	20.08347968	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1041	1534	0.009778357	0.005867014	1	oligos	OL-Cntl	26	7	7
CGTGAGCGTGTAATGA-1_1_A4	-35.89706233	-5.859382369	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1225	1948	0.004106776	0.005646817	1	9	OPC	26	7	7
CGTGAGCTCCTTGGTC-1_1_A4	14.07253545	9.274586104	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1533	2690	0.008921933	0.00669145	1	oligos	OL-Cntl	26	7	7
CGTGTAAAGGTGCTTT-1_1_A4	-7.704969538	7.960694241	5	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	787	1204	0.01910299	0.042358804	1	oligos	OL-MS-1	26	7	7
CGTGTAACAAGGTTTC-1_1_A4	-23.00870975	2.110039672	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2415	4194	0.014306152	0.009298999	1	11	Glia-MIX	26	7	7
CGTGTAACAGTATGCT-1_1_A4	-14.91526296	-20.64972855	6B	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1779	3799	0.035798894	0.005264543	1	6B	IN-SST	26	7	7
CGTGTAAGTTCCCTTG-1_1_A4	-23.6253648	19.27641141	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1519	2706	0.001478197	0.002586844	1	8	Astrocytes	26	7	7
CGTGTAATCATGGTCA-1_1_A4	1.461514922	22.60849347	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	812	1180	0.009322034	0.012711864	1	oligos	OL-Cntl	26	7	7
CGTGTAATCCAATGGT-1_1_A4	-29.41950079	20.49209143	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1102	1761	0.002271437	0.005110733	1	8	Astrocytes	26	7	7
CGTGTCTAGTAGGTGC-1_1_A4	16.81454712	1.636952887	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	727	1063	0.001881468	0.003762935	1	12	EN-MIX	26	7	7
CGTGTCTCACCGAAAG-1_1_A4	7.103692934	24.81448505	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	865	1262	0.003169572	0.003169572	1	oligos	OL-Cntl	26	7	7
CGTGTCTCAGGAACGT-1_1_A4	8.5803692	-7.510734772	10	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1872	3554	0.004220597	0.002813731	1	L2-3	EN-L2-3-Cntl	26	7	7
CGTGTCTCAGTCGATT-1_1_A4	-24.19700139	24.09302762	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1483	2703	0.000369959	0.004439512	1	8	Astrocytes	26	7	7
CGTGTCTTCAGCAACT-1_1_A4	-37.60803062	-6.908064973	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1142	1942	0.000514933	0.001544799	1	9	OPC	26	7	7
CGTGTCTTCCAAACTG-1_1_A4	17.17756408	6.004356252	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2418	4786	0.014208107	0.009611366	1	oligos	OL-Cntl	26	7	7
CGTTAGACAAACGTGG-1_1_A4	-34.82940215	-11.50754918	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	905	1403	0.007127584	0.002851033	1	9	OPC	26	7	7
CGTTAGACATGACGGA-1_1_A4	23.11432936	13.1995169	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1299	2315	0	0.002591793	1	oligos	OL-Cntl	26	7	7
CGTTAGATCACTTCAT-1_1_A4	-9.244827566	-2.905995403	13A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2157	4308	0.009517177	0.005106778	1	13A	IN-VIP	26	7	7
CGTTAGATCCAATGGT-1_1_A4	-9.684484164	11.5868674	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	719	1118	0.004472272	0.009838998	1	11	Glia-MIX	26	7	7
CGTTCTGAGCACAGGT-1_1_A4	22.01706034	17.24196945	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1199	1886	0.000530223	0.004241782	1	oligos	OL-Cntl	26	7	7
CGTTCTGGTGACTCAT-1_1_A4	6.316563112	13.69695079	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1220	1956	0.018916155	0.007668712	1	oligos	OL-Cntl	26	7	7
CGTTCTGTCAAACCGT-1_1_A4	-34.3780919	-4.728435848	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1220	2084	0.002879079	0.011036468	1	9	OPC	26	7	7
CGTTCTGTCATGCTCC-1_1_A4	21.14093911	17.49122563	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1248	1930	0.00984456	0.006217617	1	oligos	OL-Cntl	26	7	7
CGTTCTGTCGTACGGC-1_1_A4	5.291207171	13.3148898	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1164	1891	0.016922263	0.013749339	1	oligos	OL-Cntl	26	7	7
CGTTGGGAGCCACGTC-1_1_A4	1.536515834	22.04425484	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	947	1318	0.006069803	0.016691958	1	oligos	OL-Cntl	26	7	7
CGTTGGGCACCACCAG-1_1_A4	35.79799266	10.67969002	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	849	1162	0.030981067	0.024956971	1	14	Microglia	26	7	7
CGTTGGGCAGACAAGC-1_1_A4	14.27105087	-1.036950659	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	840	1239	0.008878128	0.001614205	1	12	EN-MIX	26	7	7
CGTTGGGGTCAGATAA-1_1_A4	9.247706663	10.11584422	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1312	2112	0.018939394	0.008522727	1	oligos	OL-Cntl	26	7	7
CTAACTTAGAACTGTA-1_1_A4	15.12381665	21.7441685	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	875	1372	0.014577259	0.004373178	1	oligos	OL-Cntl	26	7	7
CTAACTTAGGCCCTCA-1_1_A4	-9.768046865	11.64116707	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	902	1563	0.003838772	0.001279591	1	11	Glia-MIX	26	7	7
CTAACTTAGGTGTGGT-1_1_A4	-7.219982454	-13.57517673	6A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1511	2386	0.020536463	0.005029338	1	6A	IN-PV	26	7	7
CTAACTTCAATAGAGT-1_1_A4	-0.080691473	27.21404337	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	659	1000	0.008	0.007	1	oligos	OL-Cntl	26	7	7
CTAACTTCAGCGTTCG-1_1_A4	2.006564365	27.64147649	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	810	1206	0.006633499	0.000829187	1	oligos	OL-Cntl	26	7	7
CTAACTTTCGGTCCGA-1_1_A4	15.01932146	12.91969637	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1385	2400	0.007083333	0.010416667	1	oligos	OL-Cntl	26	7	7
CTAAGACAGACCTAGG-1_1_A4	-36.91670797	-8.475890126	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1032	1754	0.001140251	0.003420753	1	9	OPC	26	7	7
CTAAGACAGCACGCCT-1_1_A4	-3.510162013	-6.485885468	13A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	954	1543	0.031108231	0.005184705	1	13A	IN-VIP	26	7	7
CTAAGACCACCGAATT-1_1_A4	12.9118504	21.19868996	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	955	1468	0.000681199	0.006811989	1	oligos	OL-Cntl	26	7	7
CTAAGACCAGCTCGAC-1_1_A4	35.79976704	11.25352023	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	938	1273	0.010997643	0.012568735	1	14	Microglia	26	7	7
CTAAGACGTAGCGCTC-1_1_A4	6.72283187	-27.02428119	4	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	5059	15166	0.01259396	0.005340894	1	L2-3	EN-L2-3-MS	26	7	7
CTAAGACTCATTTGGG-1_1_A4	15.70220888	23.56391096	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	862	1299	0	0.003079292	1	oligos	OL-Cntl	26	7	7
CTAAGACTCCTCAATT-1_1_A4	20.71183024	15.76033368	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1148	1851	0.003241491	0.004862237	1	oligos	OL-Cntl	26	7	7
CTAAGACTCTTGCATT-1_1_A4	14.74990105	17.64610532	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1071	1787	0.008393956	0.007274762	1	oligos	OL-Cntl	26	7	7
CTAATGGAGTGCCATT-1_1_A4	-19.66402362	7.592044602	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	837	1288	0.010093168	0.007763975	1	8	Astrocytes	26	7	7
CTAATGGCACAAGACG-1_1_A4	-27.51927078	4.404016174	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2716	5432	0.004418262	0.007179676	1	9	OPC	26	7	7
CTAATGGGTCGTCTTC-1_1_A4	3.453953925	20.58276087	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	870	1357	0.015475313	0.006632277	1	oligos	OL-Cntl	26	7	7
CTAATGGTCCCTTGCA-1_1_A4	11.56088481	16.60915706	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1057	1673	0.003586372	0.012552301	1	oligos	OL-Cntl	26	7	7
CTACACCAGGTACTCT-1_1_A4	-10.62302859	18.48069585	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2430	4810	0.005405405	0.006860707	1	11	Glia-MIX	26	7	7
CTACACCCACTACAGT-1_1_A4	-3.907321167	-8.61218309	13A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	754	1147	0.012205754	0.002615519	1	13A	IN-VIP	26	7	7
CTACACCGTCGTGGCT-1_1_A4	13.79443159	21.08806887	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	964	1519	0.004608295	0.004608295	1	oligos	OL-Cntl	26	7	7
CTACACCGTGAAATCA-1_1_A4	-6.218922155	-9.591033656	13A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1166	1822	0.01701427	0.002744237	1	13A	IN-VIP	26	7	7
CTACACCTCCAGATCA-1_1_A4	-12.19289641	16.34460316	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1768	2986	0.005358339	0.004018754	1	11	Glia-MIX	26	7	7
CTACACCTCCCAAGTA-1_1_A4	-5.244451238	-10.58819304	6B	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	901	1335	0.011235955	0.002996255	1	6B	IN-SST	26	7	7
CTACATTCACGGTTTA-1_1_A4	39.77020611	11.1833628	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	851	1174	0.002555366	0.005110733	1	14	Microglia	26	7	7
CTACATTCAGGACGTA-1_1_A4	15.90543875	21.42023324	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1004	1613	0.007439554	0.006819591	1	oligos	OL-Cntl	26	7	7
CTACATTTCTAACTTC-1_1_A4	-23.30797253	2.198609546	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2876	5986	0.004844637	0.003675242	1	11	Glia-MIX	26	7	7
CTACCCAAGACTAGAT-1_1_A4	3.654631013	20.67523921	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	877	1339	0.016430172	0.012696042	1	oligos	OL-Cntl	26	7	7
CTACCCAAGCATCATC-1_1_A4	17.08706922	-0.622265529	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	798	1297	0.00154202	0.00385505	1	12	EN-MIX	26	7	7
CTACCCAAGTATCGAA-1_1_A4	-22.62711524	25.23662717	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1587	2917	0.002056908	0.00342818	1	8	Astrocytes	26	7	7
CTACCCACAAGGCTCC-1_1_A4	6.269515962	6.254401033	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2821	5626	0.01350871	0.009242801	1	oligos	OL-Cntl	26	7	7
CTACCCACATGCATGT-1_1_A4	10.21498821	20.15976277	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	909	1445	0.004152249	0.007612457	1	oligos	OL-Cntl	26	7	7
CTACCCAGTTGCGTTA-1_1_A4	4.978962327	25.64700834	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	788	1191	0.001679261	0.006717045	1	oligos	OL-Cntl	26	7	7
CTACCCATCCAATGGT-1_1_A4	-9.13349739	-20.19454967	6B	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	827	1420	0.073943662	0.004929577	1	6B	IN-SST	26	7	7
CTACCCATCCCACTTG-1_1_A4	14.18932198	6.636144879	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2091	4259	0.019253346	0.010800657	1	oligos	OL-Cntl	26	7	7
CTACCCATCTACGAGT-1_1_A4	-4.238080149	21.45168592	5	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	701	1019	0.026496565	0.01373896	1	oligos	OL-MS-1	26	7	7
CTACGTCAGATGGGTC-1_1_A4	-7.987530137	-6.102022639	13A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1503	2598	0.011932256	0.004234026	1	13A	IN-VIP	26	7	7
CTACGTCAGCGGCTTC-1_1_A4	11.68214119	16.58848677	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1120	1869	0.017121455	0.004815409	1	oligos	OL-Cntl	26	7	7
CTACGTCCATGCAATC-1_1_A4	-24.73158484	16.86395751	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1293	2320	0.003448276	0.005172414	1	8	Astrocytes	26	7	7
CTACGTCCATTTCAGG-1_1_A4	6.26841384	-15.50843263	4	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	3045	7060	0.010623229	0.012322946	1	L2-3	EN-L2-3-MS	26	7	7
CTACGTCTCCTAAGTG-1_1_A4	-13.46074731	-17.14970711	6B	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1319	2215	0.020316027	0.00496614	1	6B	IN-SST	26	7	7
CTACGTCTCGGTGTTA-1_1_A4	16.23246609	9.638857396	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1603	2885	0.006239168	0.010398614	1	oligos	OL-Cntl	26	7	7
CTAGAGTAGCCAGTAG-1_1_A4	-25.91311151	22.48854644	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1164	1875	0.008	0.005866667	1	8	Astrocytes	26	7	7
CTAGAGTCAATGGATA-1_1_A4	3.994042118	23.5899747	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	799	1120	0.00625	0.0125	1	oligos	OL-Cntl	26	7	7
CTAGAGTCACGTCAGC-1_1_A4	13.89014147	15.9498531	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1136	1806	0.014396456	0.008305648	1	oligos	OL-Cntl	26	7	7
CTAGAGTCAGTCGTGC-1_1_A4	38.34866021	11.84765275	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	945	1292	0.012383901	0.009287926	1	14	Microglia	26	7	7
CTAGAGTGTTGTGGAG-1_1_A4	-12.31139487	15.88358221	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1315	2130	0.008920188	0.010798122	1	11	Glia-MIX	26	7	7
CTAGCCTCAGCTCCGA-1_1_A4	-24.47989262	26.65657751	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1670	3282	0.003656307	0.003656307	1	8	Astrocytes	26	7	7
CTAGCCTCATGAACCT-1_1_A4	-33.38170363	-12.76336072	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	717	1051	0.004757374	0	1	9	OPC	26	7	7
CTAGCCTTCAACGCTA-1_1_A4	12.19469449	17.22531846	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1147	1987	0.008555611	0.007045798	1	oligos	OL-Cntl	26	7	7
CTAGCCTTCTCTAGGA-1_1_A4	-0.121938316	23.40059196	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	768	1166	0.002572899	0.009433962	1	oligos	OL-Cntl	26	7	7
CTAGTGAAGATGTGGC-1_1_A4	-2.344048819	24.84963536	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	871	1312	0.022103659	0.004573171	1	oligos	OL-Cntl	26	7	7
CTAGTGACAAAGAATC-1_1_A4	4.230220762	12.25825915	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1133	1825	0.024109589	0.007671233	1	oligos	OL-Cntl	26	7	7
CTAGTGACAAGCCCAC-1_1_A4	2.528899192	-3.57538314	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	719	1064	0.009398496	0.003759398	1	12	EN-MIX	26	7	7
CTAGTGACACGTGAGA-1_1_A4	-22.09332653	25.95019226	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1610	2841	0.000703977	0.008799718	1	8	Astrocytes	26	7	7
CTAGTGATCCTGCAGG-1_1_A4	-18.73461117	-21.57016935	6A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	3053	7890	0.014448669	0.003295311	1	6A	IN-PV	26	7	7
CTAGTGATCTTAACCT-1_1_A4	17.97522738	16.30413238	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1087	1791	0.000558347	0.006700168	1	oligos	OL-Cntl	26	7	7
CTAGTGATCTTGCATT-1_1_A4	5.063884455	4.858488405	7	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2382	4128	0.009205426	0.016715116	1	7	Phagocytes	26	7	7
CTCACACAGCCCAATT-1_1_A4	3.100789278	33.82651818	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	712	1055	0.003791469	0.007582938	1	oligos	OL-Cntl	26	7	7
CTCACACAGTGGAGAA-1_1_A4	3.208821015	24.74960356	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	750	1062	0.002824859	0.007532957	1	oligos	OL-Cntl	26	7	7
CTCACACAGTTTAGGA-1_1_A4	-38.23218271	-3.133965848	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1238	2122	0.002827521	0.003298775	1	9	OPC	26	7	7
CTCACACCAATGGACG-1_1_A4	26.04855201	3.173636078	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	509	1365	0.001465201	0.000732601	1	8	Astrocytes	26	7	7
CTCACACCACTCGACG-1_1_A4	14.43917833	15.08868769	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1165	1971	0.007102993	0.011669203	1	oligos	OL-Cntl	26	7	7
CTCACACCATCAGTCA-1_1_A4	18.53976166	7.51603047	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2048	4003	0.003497377	0.004996253	1	oligos	OL-Cntl	26	7	7
CTCACACGTGACAAAT-1_1_A4	0.52425059	23.72556662	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	809	1253	0.011173184	0.011173184	1	oligos	OL-Cntl	26	7	7
CTCACACGTGCTAGCC-1_1_A4	-23.86462897	28.53947979	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1899	4178	0.004786979	0.002872188	1	8	Astrocytes	26	7	7
CTCACACTCAGCATGT-1_1_A4	-23.58736518	0.832182346	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	3249	7705	0.006489293	0.002465931	1	9	OPC	26	7	7
CTCACACTCTTTAGGG-1_1_A4	4.285882153	18.89431066	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	963	1537	0.008458035	0.01691607	1	oligos	OL-Cntl	26	7	7
CTCAGAAAGCGATAGC-1_1_A4	-16.71189823	-17.56239595	6B	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1975	4043	0.004204798	0.004204798	1	6B	IN-SST	26	7	7
CTCAGAACATTACGAC-1_1_A4	12.9725516	-9.235816466	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1525	2672	0.001497006	0.003368263	1	12	EN-MIX	26	7	7
CTCAGAAGTCGCGAAA-1_1_A4	14.40369074	6.100857839	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2385	4523	0.020782666	0.010833518	1	oligos	OL-Cntl	26	7	7
CTCAGAATCCAGGGCT-1_1_A4	-3.165834313	-8.869617097	13A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	923	1347	0.022271715	0.002969562	1	13A	IN-VIP	26	7	7
CTCAGAATCGCTAGCG-1_1_A4	37.61005247	9.673865333	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	842	1149	0.006092254	0.010443864	1	14	Microglia	26	7	7
CTCATTAAGACCTAGG-1_1_A4	5.641550687	16.98178427	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1079	1692	0.010638298	0.012411348	1	oligos	OL-Cntl	26	7	7
CTCATTACAATGGAAT-1_1_A4	19.08712338	6.577509396	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2345	4920	0.00995935	0.003455285	1	oligos	OL-Cntl	26	7	7
CTCATTAGTAAGTAGT-1_1_A4	17.01228058	12.23207584	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1331	2208	0.00317029	0.004981884	1	oligos	OL-Cntl	26	7	7
CTCATTAGTCATCCCT-1_1_A4	-24.48372906	26.53983378	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1576	3194	0.004070131	0.004696306	1	8	Astrocytes	26	7	7
CTCATTATCAGCGATT-1_1_A4	-34.34506057	-11.42876997	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	857	1266	0.007898894	0.002369668	1	9	OPC	26	7	7
CTCATTATCAGTGCAT-1_1_A4	-28.12969661	23.01327772	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1212	2229	0.009421265	0.004934948	1	8	Astrocytes	26	7	7
CTCATTATCCGCGGTA-1_1_A4	6.595150833	-13.30852624	4	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2532	5146	0.019626895	0.010104936	1	L2-3	EN-L2-3-MS	26	7	7
CTCCTAGAGAAACGCC-1_1_A4	19.67341216	17.3215558	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1114	1761	0.010789324	0.007950028	1	oligos	OL-Cntl	26	7	7
CTCCTAGAGAGTACCG-1_1_A4	5.098170702	20.84177596	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	932	1458	0.011659808	0.00617284	1	oligos	OL-Cntl	26	7	7
CTCCTAGCAAGACACG-1_1_A4	39.37623939	16.38470494	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2711	5138	0.002530167	0.006228104	1	14	Microglia	26	7	7
CTCCTAGCACCTTGTC-1_1_A4	8.452976042	22.06902003	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1034	1635	0.009785933	0.006727829	1	oligos	OL-Cntl	26	7	7
CTCCTAGCAGACGCAA-1_1_A4	0.066572808	23.17243492	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	782	1155	0.016450216	0.011255411	1	oligos	OL-Cntl	26	7	7
CTCCTAGGTAAATGTG-1_1_A4	5.18749608	17.42382955	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	940	1402	0.007132668	0.015691869	1	oligos	OL-Cntl	26	7	7
CTCCTAGGTATAGGGC-1_1_A4	4.748565363	6.292464968	7	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1529	2567	0.001558239	0.004674718	1	7	Phagocytes	26	7	7
CTCCTAGGTGCAGACA-1_1_A4	-21.2549461	26.00894652	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1829	3371	0.00415307	0.005339662	1	8	Astrocytes	26	7	7
CTCCTAGTCCAGTAGT-1_1_A4	-15.83045253	14.92967154	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2019	3847	0.000519886	0.009357941	1	8	Astrocytes	26	7	7
CTCGAAACAAGTTCTG-1_1_A4	13.36504834	21.18744787	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	999	1459	0.002056203	0.00685401	1	oligos	OL-Cntl	26	7	7
CTCGAAACACGGCCAT-1_1_A4	-4.968035542	29.18432593	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1199	2001	0.028985507	0.004997501	1	11	Glia-MIX	26	7	7
CTCGAAACATGCATGT-1_1_A4	35.57582626	7.81673705	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	902	1245	0.014457831	0.012048193	1	14	Microglia	26	7	7
CTCGAAAGTACCGCTG-1_1_A4	2.398033934	28.29728935	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	763	1121	0.000892061	0.003568243	1	oligos	OL-Cntl	26	7	7
CTCGAAAGTGTGCCTG-1_1_A4	13.30593553	16.73102712	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1173	1831	0.009830694	0.007099945	1	oligos	OL-Cntl	26	7	7
CTCGAAATCCTGTACC-1_1_A4	-9.854541536	18.0290966	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2761	5941	0.004376368	0.004376368	1	11	Glia-MIX	26	7	7
CTCGAGGAGCTGCCCA-1_1_A4	13.29843091	14.98238573	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1220	1976	0.014676113	0.009109312	1	oligos	OL-Cntl	26	7	7
CTCGAGGAGGTGTTAA-1_1_A4	1.297979633	25.27496591	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	818	1217	0.018898932	0.01232539	1	oligos	OL-Cntl	26	7	7
CTCGAGGAGTGCTGCC-1_1_A4	6.128623197	-5.72513508	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1093	1739	0.000575043	0.003450259	1	12	EN-MIX	26	7	7
CTCGAGGCAATGGAGC-1_1_A4	-32.38022072	-7.886768695	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1186	1957	0.004598876	0.009708738	1	9	OPC	26	7	7
CTCGAGGCACAGGTTT-1_1_A4	20.74750614	18.02765578	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1104	1784	0.007286996	0.001121076	1	oligos	OL-Cntl	26	7	7
CTCGAGGCACTGTGTA-1_1_A4	3.457771718	-2.730308411	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	728	1026	0.006822612	0.001949318	1	12	EN-MIX	26	7	7
CTCGAGGGTCAAGCGA-1_1_A4	39.86811814	13.0412877	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1035	1454	0.000687758	0.00343879	1	14	Microglia	26	7	7
CTCGGAGCATCTCGCT-1_1_A4	13.31903635	6.744691064	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1723	3043	0.015445284	0.01610253	1	oligos	OL-Cntl	26	7	7
CTCGGAGGTCCAGTGC-1_1_A4	14.20936401	19.1254236	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1029	1624	0.016009852	0.008004926	1	oligos	OL-Cntl	26	7	7
CTCGGAGTCTTTAGTC-1_1_A4	-23.54773888	19.70290949	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1641	2990	0.004347826	0.008026756	1	8	Astrocytes	26	7	7
CTCGGGAAGAGTACAT-1_1_A4	-36.77411764	-10.790153	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	958	1548	0.001937984	0.002583979	1	9	OPC	26	7	7
CTCGGGAAGCCCTAAT-1_1_A4	15.22592962	-1.130899157	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	797	1231	0.025182778	0.004061738	1	12	EN-MIX	26	7	7
CTCGGGAAGCTGAACG-1_1_A4	3.736102194	6.469939506	7	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1378	2096	0.007633588	0.00620229	1	7	Phagocytes	26	7	7
CTCGGGACAATGACCT-1_1_A4	15.80568198	15.67974657	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1302	2238	0.006255585	0.008042895	1	oligos	OL-Cntl	26	7	7
CTCGGGACATCCGTGG-1_1_A4	-12.58255524	-21.94788175	6A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1109	1682	0.013674197	0.004756243	1	6A	IN-PV	26	7	7
CTCGGGACATGGTTGT-1_1_A4	11.66207611	11.70196268	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1416	2334	0.008140531	0.011139674	1	oligos	OL-Cntl	26	7	7
CTCGGGAGTCCTCCAT-1_1_A4	-24.86180531	27.0699636	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1708	3374	0.001185536	0.002074689	1	8	Astrocytes	26	7	7
CTCGGGAGTGGGTATG-1_1_A4	-1.33190746	24.27452227	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	714	1036	0.011583012	0.001930502	1	oligos	OL-Cntl	26	7	7
CTCGTACAGACAGAGA-1_1_A4	15.49002236	-6.319726706	10	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1504	2715	0.002209945	0.003683241	1	L2-3	EN-L2-3-Cntl	26	7	7
CTCGTACAGCCAGTAG-1_1_A4	-10.91095905	17.87688975	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2697	5386	0.007240995	0.005569996	1	11	Glia-MIX	26	7	7
CTCGTACAGCCGTCGT-1_1_A4	19.04297101	1.67125105	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1223	2105	0.019952494	0.001900238	1	12	EN-MIX	26	7	7
CTCGTACAGTTAACGA-1_1_A4	-0.483242161	22.84071729	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	793	1181	0.011007621	0.013547841	1	oligos	OL-Cntl	26	7	7
CTCGTACCAAGGACAC-1_1_A4	5.754652647	11.39567162	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1481	2458	0.010577705	0.01098454	1	oligos	OL-Cntl	26	7	7
CTCGTACCACCAGGCT-1_1_A4	-6.823607325	-0.532196546	13A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2095	4266	0.001640881	0.004688233	1	13A	IN-VIP	26	7	7
CTCGTACCATGCTAGT-1_1_A4	20.45661589	1.538518916	2	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1526	2702	0.003700962	0.000740192	1	2	EN-L4	26	7	7
CTCGTACCATTCCTGC-1_1_A4	14.4654798	20.48373253	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1065	1767	0.003961517	0.002263724	1	oligos	OL-Cntl	26	7	7
CTCGTACGTACAGACG-1_1_A4	-3.813070605	25.27526437	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	781	1243	0.011263073	0.006436042	1	oligos	OL-Cntl	26	7	7
CTCGTACGTAGAGGAA-1_1_A4	10.41922689	14.03226025	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1273	2141	0.020084073	0.013545072	1	oligos	OL-Cntl	26	7	7
CTCGTCAAGACACGAC-1_1_A4	-21.69986564	28.70238888	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2035	4238	0.003303445	0.005427088	1	8	Astrocytes	26	7	7
CTCGTCAAGGCCGAAT-1_1_A4	39.98338038	11.30131965	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	831	1138	0.002636204	0.003514938	1	14	Microglia	26	7	7
CTCGTCAAGTACGATA-1_1_A4	1.762913712	21.37675826	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	830	1144	0.020104895	0.013986014	1	oligos	OL-Cntl	26	7	7
CTCGTCAAGTGGGATC-1_1_A4	-16.09307344	14.42492904	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1739	2947	0.001357313	0.006786563	1	8	Astrocytes	26	7	7
CTCGTCACACCAGCAC-1_1_A4	13.3626677	23.16501105	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	946	1542	0.005836576	0.006485084	1	oligos	OL-Cntl	26	7	7
CTCGTCACATCCCACT-1_1_A4	4.123423832	-3.530736733	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	861	1194	0.011725293	0.004187605	1	12	EN-MIX	26	7	7
CTCGTCAGTGCAACTT-1_1_A4	21.17236104	16.87381128	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1185	2022	0.008407517	0.005440158	1	oligos	OL-Cntl	26	7	7
CTCGTCATCAGTTCGA-1_1_A4	11.06359998	20.75149149	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	966	1570	0.001273885	0.010191083	1	oligos	OL-Cntl	26	7	7
CTCGTCATCGCGTTTC-1_1_A4	7.542210719	12.72501024	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1224	1959	0.012251149	0.011230219	1	oligos	OL-Cntl	26	7	7
CTCTAATAGCGTGAGT-1_1_A4	-23.64093049	2.335164045	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	4771	11879	0.00580857	0.006650391	1	9	OPC	26	7	7
CTCTAATAGCTCAACT-1_1_A4	-11.08550435	9.344158904	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	5292	14793	0.005475563	0.005205165	1	11	Glia-MIX	26	7	7
CTCTAATCACGGTTTA-1_1_A4	23.59622321	-7.279864617	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	4000	10115	0.004251112	0.002768166	1	11	Glia-MIX	26	7	7
CTCTAATGTATAGGTA-1_1_A4	12.31517769	25.36340603	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	807	1253	0.012769354	0.005586592	1	oligos	OL-Cntl	26	7	7
CTCTAATGTCTTGTCC-1_1_A4	-35.273876	-12.75917591	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	810	1305	0.005363985	0.003065134	1	9	OPC	26	7	7
CTCTAATGTTCCCTTG-1_1_A4	-3.45678342	-5.993767019	13A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1082	1868	0.034796574	0.002141328	1	13A	IN-VIP	26	7	7
CTCTAATTCATCGATG-1_1_A4	13.27119418	22.91981114	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	932	1502	0.001997337	0.003328895	1	oligos	OL-Cntl	26	7	7
CTCTAATTCTGCTGCT-1_1_A4	-3.427396454	-6.341773406	13A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	925	1515	0.013861386	0.002640264	1	13A	IN-VIP	26	7	7
CTCTACGCAGTGACAG-1_1_A4	-22.96899259	-4.652675887	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1968	3665	0.027830832	0.003274216	1	9	OPC	26	7	7
CTCTACGTCAACGGGA-1_1_A4	-18.45886539	-17.52866596	6B	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2309	5132	0.004286828	0.004871395	1	6B	IN-SST	26	7	7
CTCTACGTCCGGCACA-1_1_A4	-11.508395	18.35042383	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2077	3811	0.008134348	0.009708738	1	11	Glia-MIX	26	7	7
CTCTACGTCCGTAGTA-1_1_A4	7.241386484	19.68383563	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1008	1550	0.013548387	0.008387097	1	oligos	OL-Cntl	26	7	7
CTCTACGTCTCACATT-1_1_A4	15.80487793	6.320091715	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2206	4342	0.005988024	0.00990327	1	oligos	OL-Cntl	26	7	7
CTCTGGTCAGACGCCT-1_1_A4	3.396436077	18.49958445	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	955	1471	0.006118287	0.007477906	1	oligos	OL-Cntl	26	7	7
CTCTGGTCATACAGCT-1_1_A4	39.07768139	12.41939459	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1015	1406	0.003556188	0.012802276	1	14	Microglia	26	7	7
CTCTGGTGTAAGAGGA-1_1_A4	15.49730894	-1.250720244	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	776	1166	0.000857633	0.002572899	1	12	EN-MIX	26	7	7
CTCTGGTGTCATATGC-1_1_A4	11.49017948	-3.081592091	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1466	2352	0.022534014	0.004676871	1	12	EN-MIX	26	7	7
CTCTGGTGTGGCTCCA-1_1_A4	-8.960682329	15.39354279	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2331	4545	0.00330033	0.00440044	1	11	Glia-MIX	26	7	7
CTCTGGTTCCCAAGTA-1_1_A4	4.164431423	-5.50981802	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1036	1635	0.008562691	0.002446483	1	12	EN-MIX	26	7	7
CTGAAACCATATGGTC-1_1_A4	11.52972072	16.2772482	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1140	1804	0.003325942	0.007206208	1	oligos	OL-Cntl	26	7	7
CTGAAGTAGAGGTACC-1_1_A4	4.403695573	20.39013683	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	930	1452	0.002066116	0.007575758	1	oligos	OL-Cntl	26	7	7
CTGAAGTAGGTAGCTG-1_1_A4	6.158321966	21.28074082	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	916	1315	0.012927757	0.006844106	1	oligos	OL-Cntl	26	7	7
CTGAAGTCAACGCACC-1_1_A4	12.61980955	21.01930558	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1008	1507	0.00530856	0.00995355	1	oligos	OL-Cntl	26	7	7
CTGAAGTCACCTTGTC-1_1_A4	16.30095587	-1.276986565	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	727	1087	0.011959522	0.001839926	1	12	EN-MIX	26	7	7
CTGAAGTCAGCCAGAA-1_1_A4	-5.994127171	-5.080426092	13A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1228	1906	0.026232949	0.004721931	1	13A	IN-VIP	26	7	7
CTGAAGTGTAGATTAG-1_1_A4	-0.326993082	22.78158758	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	738	1031	0.005819593	0.008729389	1	oligos	OL-Cntl	26	7	7
CTGAAGTGTGCCTGTG-1_1_A4	13.80702785	6.755961934	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1862	3423	0.018112767	0.009348525	1	oligos	OL-Cntl	26	7	7
CTGAAGTGTTGCGCAC-1_1_A4	13.07548941	22.89098683	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	908	1374	0.008733624	0.005094614	1	oligos	OL-Cntl	26	7	7
CTGATAGAGATGTGTA-1_1_A4	-34.84227393	-12.22832477	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	732	1168	0.001712329	0.000856164	1	9	OPC	26	7	7
CTGATAGAGCGTGAAC-1_1_A4	-2.817755199	21.47867729	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	800	1101	0.015440509	0.011807448	1	oligos	OL-Cntl	26	7	7
CTGATAGAGTTCCACA-1_1_A4	0.777735939	13.94697818	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1048	1598	0.008760951	0.011889862	1	oligos	OL-Cntl	26	7	7
CTGATAGCAGATGAGC-1_1_A4	-0.788829844	20.55425875	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	866	1222	0.011456628	0.014729951	1	oligos	OL-Cntl	26	7	7
CTGATAGCATGTTGAC-1_1_A4	-13.28213016	4.748788558	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2505	5046	0.021601268	0.002972652	1	8	Astrocytes	26	7	7
CTGATAGGTAGCGTGA-1_1_A4	-31.33521923	12.69545194	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	876	1418	0.002115656	0.002820874	1	8	Astrocytes	26	7	7
CTGATAGTCAGTACGT-1_1_A4	-9.916052223	-20.65843736	6A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	804	1276	0.017241379	0.002351097	1	6A	IN-PV	26	7	7
CTGATAGTCCCATTAT-1_1_A4	3.982428999	12.8395725	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1107	1793	0.025655326	0.021751255	1	oligos	OL-Cntl	26	7	7
CTGATAGTCGAATGGG-1_1_A4	-25.14029307	17.61886783	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1339	2237	0.0098346	0.002235136	1	8	Astrocytes	26	7	7
CTGATAGTCTCCTATA-1_1_A4	1.542935488	21.69260621	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	835	1214	0.009884679	0.009884679	1	oligos	OL-Cntl	26	7	7
CTGATCCAGTCACGCC-1_1_A4	4.260042998	19.81557321	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	968	1482	0.011470985	0.006747638	1	oligos	OL-Cntl	26	7	7
CTGATCCGTGTGCCTG-1_1_A4	-34.68484857	-9.475448431	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1024	1803	0.001663894	0.002773156	1	9	OPC	26	7	7
CTGATCCGTTCAGGCC-1_1_A4	3.997856805	18.42237003	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	947	1473	0.010862186	0.008825526	1	oligos	OL-Cntl	26	7	7
CTGATCCTCCTTCAAT-1_1_A4	-0.432015086	27.6684942	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	703	1054	0.018975332	0.0056926	1	oligos	OL-Cntl	26	7	7
CTGATCCTCGCAAACT-1_1_A4	12.95637485	15.34093082	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1238	2013	0.007948336	0.008941878	1	oligos	OL-Cntl	26	7	7
CTGATCCTCGGCATCG-1_1_A4	3.870546975	-5.393996971	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	997	1519	0.008558262	0.001974984	1	12	EN-MIX	26	7	7
CTGCCTAAGTACGCCC-1_1_A4	-21.77731093	26.82856593	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1909	3792	0.002637131	0.005537975	1	8	Astrocytes	26	7	7
CTGCCTAAGTCGAGTG-1_1_A4	-9.646863002	-5.157749644	13A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1677	2968	0.010781671	0.010781671	1	13A	IN-VIP	26	7	7
CTGCCTACAAAGGTGC-1_1_A4	5.847216032	16.59931086	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1073	1731	0.016175621	0.012709417	1	oligos	OL-Cntl	26	7	7
CTGCCTACAAAGTCAA-1_1_A4	-13.88327878	-21.21867133	6A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1409	2736	0.013888889	0.001827485	1	6A	IN-PV	26	7	7
CTGCCTACACATGGGA-1_1_A4	-2.141570535	22.70985659	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	822	1200	0.011666667	0.013333333	1	oligos	OL-Cntl	26	7	7
CTGCCTACATGAGCGA-1_1_A4	-35.17094075	-4.912229661	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1264	2058	0.005830904	0.005344995	1	9	OPC	26	7	7
CTGCCTAGTATGAAAC-1_1_A4	-15.16340984	-18.35818558	6B	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1669	3228	0.025402726	0.002168525	1	6B	IN-SST	26	7	7
CTGCCTATCAATACCG-1_1_A4	15.5435429	17.4273061	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1098	1823	0.005485464	0.00603401	1	oligos	OL-Cntl	26	7	7
CTGCCTATCGAGCCCA-1_1_A4	2.886611272	23.38019612	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	911	1407	0.012082445	0.012082445	1	oligos	OL-Cntl	26	7	7
CTGCCTATCGATAGAA-1_1_A4	9.912698558	-8.898561413	10	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2398	5851	0.000683644	0.001196377	1	L2-3	EN-L2-3-Cntl	26	7	7
CTGCCTATCGCGCCAA-1_1_A4	-2.467047775	24.61541213	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	699	1055	0.020853081	0.008530806	1	oligos	OL-Cntl	26	7	7
CTGCCTATCTACGAGT-1_1_A4	16.68464503	-0.696413984	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	676	1061	0.003770028	0.000942507	1	12	EN-MIX	26	7	7
CTGCGGACAGATCCAT-1_1_A4	39.93718873	11.4978681	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	963	1339	0.013442868	0.008215086	1	14	Microglia	26	7	7
CTGCGGACATACGCTA-1_1_A4	-36.80127175	-7.836692105	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1107	1778	0.001124859	0.001687289	1	9	OPC	26	7	7
CTGCGGACATGCAACT-1_1_A4	5.970174954	20.8338529	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	969	1582	0.01517067	0.010745891	1	oligos	OL-Cntl	26	7	7
CTGCGGAGTCTAGTGT-1_1_A4	-9.699088553	-7.684042866	13A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1514	2714	0.04642594	0.004789978	1	13A	IN-VIP	26	7	7
CTGCGGATCATGCAAC-1_1_A4	-36.92147847	-4.245097054	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1275	2119	0.002359604	0.002831524	1	9	OPC	26	7	7
CTGCGGATCGAACGGA-1_1_A4	2.93700661	4.837364936	7	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	933	1268	0.007097792	0.007097792	1	7	Phagocytes	26	7	7
CTGCTGTCACCACCAG-1_1_A4	-25.58528473	22.87452192	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1421	2430	0.011522634	0.005349794	1	8	Astrocytes	26	7	7
CTGCTGTCACGGCCAT-1_1_A4	-36.38728751	-0.745332744	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1548	2655	0.002636535	0.004896422	1	9	OPC	26	7	7
CTGCTGTCATCCCATC-1_1_A4	17.33222223	5.684714527	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	3575	8616	0.008008357	0.010793872	1	oligos	OL-Cntl	26	7	7
CTGCTGTTCACTATTC-1_1_A4	-14.7124665	-21.53063764	6A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1550	2846	0.063246662	0.004216444	1	6A	IN-PV	26	7	7
CTGCTGTTCATAACCG-1_1_A4	-25.7555303	19.30496248	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1544	2669	0.002997377	0.004121394	1	8	Astrocytes	26	7	7
CTGCTGTTCCAAGCCG-1_1_A4	2.622264309	-3.555410618	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	815	1223	0.003270646	0.004088307	1	12	EN-MIX	26	7	7
CTGCTGTTCTAGAGTC-1_1_A4	3.398361523	26.36002288	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	784	1216	0	0.002467105	1	oligos	OL-Cntl	26	7	7
CTGGTCTCAAACCTAC-1_1_A4	-13.49981465	19.09482032	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1897	3460	0.003468208	0.009248555	1	8	Astrocytes	26	7	7
CTGGTCTCACAGAGGT-1_1_A4	38.69303825	9.510000021	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	840	1136	0.014964789	0.011443662	1	14	Microglia	26	7	7
CTGGTCTCATTGCGGC-1_1_A4	16.57249844	-4.020203058	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1098	1738	0.007479862	0.006904488	1	12	EN-MIX	26	7	7
CTGGTCTGTACCGTAT-1_1_A4	-16.37845963	-25.41329701	6A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2150	4670	0.011349036	0.003426124	1	6A	IN-PV	26	7	7
CTGGTCTGTCTTCGTC-1_1_A4	12.54694054	21.11218617	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	982	1563	0.001279591	0.007677543	1	oligos	OL-Cntl	26	7	7
CTGGTCTTCTTGAGGT-1_1_A4	-3.59881572	-7.568551611	13A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	741	1109	0.017132552	0.00541028	1	13A	IN-VIP	26	7	7
CTGTGCTAGCGAAGGG-1_1_A4	-21.51965302	24.69487097	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1633	3000	0.002666667	0.007666667	1	8	Astrocytes	26	7	7
CTGTGCTCACCCTATC-1_1_A4	10.84631359	13.77052873	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1388	2322	0.01464255	0.01335056	1	oligos	OL-Cntl	26	7	7
CTGTGCTCATCGTCGG-1_1_A4	17.15092426	6.562431291	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2150	4117	0.01190187	0.007043964	1	oligos	OL-Cntl	26	7	7
CTGTGCTGTACTCTCC-1_1_A4	38.26156813	8.667872272	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	759	1006	0.007952286	0.004970179	1	14	Microglia	26	7	7
CTGTGCTGTCAAAGCG-1_1_A4	38.76373921	16.18993332	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1642	2517	0.010329758	0.025824394	1	14	Microglia	26	7	7
CTGTGCTTCATGCAAC-1_1_A4	-35.83266629	-11.38262374	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	910	1433	0.007676204	0.00209351	1	9	OPC	26	7	7
CTGTGCTTCATGCATG-1_1_A4	6.448335295	-5.847727573	10	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1156	1975	0.002531646	0.003037975	1	L2-3	EN-L2-3-Cntl	26	7	7
CTGTGCTTCGAGCCCA-1_1_A4	-17.12140576	12.4297615	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1272	1925	0.001038961	0.002597403	1	8	Astrocytes	26	7	7
CTGTTTAAGAACAATC-1_1_A4	-0.466462599	24.5965792	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	744	1081	0.005550416	0.005550416	1	oligos	OL-Cntl	26	7	7
CTGTTTAGTACCGTTA-1_1_A4	17.16858076	5.692591	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	3252	7326	0.015834016	0.010510511	1	oligos	OL-Cntl	26	7	7
CTGTTTAGTCTTTCAT-1_1_A4	1.837711706	23.12425924	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	747	1151	0.010425717	0.006081668	1	oligos	OL-Cntl	26	7	7
CTGTTTATCACAAACC-1_1_A4	14.45333597	15.33829563	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1211	2084	0.007197697	0.005278311	1	oligos	OL-Cntl	26	7	7
CTGTTTATCCGTTGCT-1_1_A4	-34.55063261	3.94714252	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2143	4017	0.005476724	0.005476724	1	9	OPC	26	7	7
CTGTTTATCTAACTGG-1_1_A4	13.89053094	6.729040624	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1805	3336	0.012589928	0.010191847	1	oligos	OL-Cntl	26	7	7
CTTAACTAGGGATGGG-1_1_A4	20.95513397	-2.288952963	2	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1736	2948	0.003731343	0.003731343	1	2	EN-L4	26	7	7
CTTAACTAGTTCCACA-1_1_A4	21.19556529	17.18787675	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1186	1917	0.002086594	0.004173187	1	oligos	OL-Cntl	26	7	7
CTTAACTCAATGACCT-1_1_A4	-37.48117322	-0.680443031	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1460	2696	0.003338279	0.004080119	1	9	OPC	26	7	7
CTTAACTGTGAGTATA-1_1_A4	-14.03913648	-10.98613125	13B	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2277	5159	0.005233572	0.002326032	1	13B	IN-SV2C	26	7	7
CTTAACTGTTCGGGCT-1_1_A4	14.44212245	10.04446541	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1426	2462	0.013809911	0.011372868	1	oligos	OL-Cntl	26	7	7
CTTAACTTCAGTTAGC-1_1_A4	-0.801908023	21.00794355	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	827	1326	0.009803922	0.013574661	1	oligos	OL-Cntl	26	7	7
CTTAACTTCCACGACG-1_1_A4	-23.53672244	25.92600217	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1661	3141	0.004775549	0.005093919	1	8	Astrocytes	26	7	7
CTTACCGAGCACGCCT-1_1_A4	4.681791373	26.13865129	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	814	1195	0.005857741	0.005857741	1	oligos	OL-Cntl	26	7	7
CTTACCGAGCGATGAC-1_1_A4	15.37307754	19.96432025	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1168	1893	0.020602219	0.002113048	1	oligos	OL-Cntl	26	7	7
CTTACCGCACAGGCCT-1_1_A4	-24.09626046	25.98355114	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1497	2586	0.005027069	0.00154679	1	8	Astrocytes	26	7	7
CTTACCGCAGCTCGAC-1_1_A4	-37.23787863	-5.546099442	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1170	1997	0.002503756	0.001502253	1	9	OPC	26	7	7
CTTACCGCATAGGATA-1_1_A4	-3.127347178	24.98838634	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	800	1098	0.020947177	0.005464481	1	oligos	OL-Cntl	26	7	7
CTTACCGGTCTGCCAG-1_1_A4	12.19065911	20.85640747	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	914	1460	0.006164384	0.014383562	1	oligos	OL-Cntl	26	7	7
CTTACCGGTTCCTCCA-1_1_A4	30.7728783	-5.357440497	2	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	4354	12780	0.007042254	0.00312989	1	2	EN-L4	26	7	7
CTTACCGTCACCTCGT-1_1_A4	-37.90350378	-0.560297411	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1566	3027	0.004625041	0.003964321	1	9	OPC	26	7	7
CTTACCGTCACCTTAT-1_1_A4	12.65499798	15.8278493	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1210	2115	0.005200946	0.005200946	1	oligos	OL-Cntl	26	7	7
CTTACCGTCACTTACT-1_1_A4	39.8158285	12.24342626	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	940	1365	0.008791209	0.006593407	1	14	Microglia	26	7	7
CTTACCGTCTGCGGCA-1_1_A4	3.791245802	19.65171035	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	914	1417	0.014114326	0.008468596	1	oligos	OL-Cntl	26	7	7
CTTAGGAAGAAGCCCA-1_1_A4	9.375317951	20.13763166	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1054	1763	0.056721497	0.01020987	1	oligos	OL-Cntl	26	7	7
CTTAGGAAGCAGCGTA-1_1_A4	-9.179273114	-19.93784215	6B	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	815	1404	0.06980057	0.001424501	1	6B	IN-SST	26	7	7
CTTAGGAAGGGTTTCT-1_1_A4	4.988512933	28.99986922	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	691	1035	0.005797101	0.002898551	1	oligos	OL-Cntl	26	7	7
CTTAGGAAGGTCATCT-1_1_A4	-33.68654309	-11.83918919	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	807	1257	0.00318218	0.002386635	1	9	OPC	26	7	7
CTTAGGAAGTGGTAAT-1_1_A4	-4.947732917	-9.681721532	13B	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	868	1306	0.046707504	0.004594181	1	13B	IN-SV2C	26	7	7
CTTAGGACAGAAGCAC-1_1_A4	-1.642639885	20.16247143	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	869	1269	0.01891253	0.011820331	1	oligos	OL-Cntl	26	7	7
CTTAGGACATCCCATC-1_1_A4	18.82433916	-6.917655858	3	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2156	4876	0.000205086	0.002871206	1	3	EN-L5-6	26	7	7
CTTAGGACATTTGCCC-1_1_A4	19.03760548	19.98462966	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1046	1734	0.000576701	0.002306805	1	oligos	OL-Cntl	26	7	7
CTTAGGATCCAGATCA-1_1_A4	15.331492	22.21170346	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	941	1474	0.002713704	0.004748982	1	oligos	OL-Cntl	26	7	7
CTTAGGATCTTATCTG-1_1_A4	1.180513423	23.74942971	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	762	1236	0.012135922	0.008899676	1	oligos	OL-Cntl	26	7	7
CTTCTCTAGACAGGCT-1_1_A4	-22.99905327	23.88943424	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1548	2763	0.002171553	0.002533478	1	8	Astrocytes	26	7	7
CTTCTCTAGCAAATCA-1_1_A4	6.228076896	13.91375447	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1088	1642	0.009135201	0.009135201	1	oligos	OL-Cntl	26	7	7
CTTCTCTAGGCCATAG-1_1_A4	-37.16078488	-6.454792275	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1102	1915	0.003133159	0.003655352	1	9	OPC	26	7	7
CTTCTCTAGGCTCATT-1_1_A4	37.48126022	10.91480666	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	945	1467	0.014996592	0.011588275	1	14	Microglia	26	7	7
CTTCTCTAGTGACATA-1_1_A4	13.71049023	21.18336848	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	890	1461	0.003422313	0.004106776	1	oligos	OL-Cntl	26	7	7
CTTCTCTCAGTAAGCG-1_1_A4	-8.220202419	9.188302272	5	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1100	1670	0.008383234	0.007784431	1	oligos	OL-MS-1	26	7	7
CTTCTCTTCAACTCTT-1_1_A4	0.314788548	-0.612643732	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	948	1446	0.009681881	0.004840941	1	11	Glia-MIX	26	7	7
CTTGGCTAGCTTATCG-1_1_A4	-23.37008287	2.258870419	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	4146	9640	0.010373444	0.006950207	1	11	Glia-MIX	26	7	7
CTTGGCTAGTATCTCG-1_1_A4	4.285455952	14.8605057	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1033	1622	0.013563502	0.01541307	1	oligos	OL-Cntl	26	7	7
CTTGGCTAGTTGTAGA-1_1_A4	-35.85040668	-4.563871123	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1251	1986	0.002517623	0.004028197	1	9	OPC	26	7	7
CTTGGCTCACAGGTTT-1_1_A4	15.41551717	21.18321532	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1002	1601	0.018113679	0.004996877	1	oligos	OL-Cntl	26	7	7
CTTGGCTCACTCTGTC-1_1_A4	10.4405766	23.90906865	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	878	1495	0.002675585	0.005351171	1	oligos	OL-Cntl	26	7	7
CTTGGCTCATCCCATC-1_1_A4	17.30139563	23.71839543	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	879	1412	0.013456091	0.004249292	1	oligos	OL-Cntl	26	7	7
CTTGGCTCATGGATGG-1_1_A4	-24.12437366	26.31044943	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1578	2905	0.002065404	0.002409639	1	8	Astrocytes	26	7	7
CTTGGCTGTAGAGCTG-1_1_A4	6.620162977	13.5043216	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1336	2048	0.009765625	0.012207031	1	oligos	OL-Cntl	26	7	7
CTTGGCTGTCTGGTCG-1_1_A4	-12.11859538	-2.817860424	13A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2698	5333	0.021188824	0.009188074	1	13A	IN-VIP	26	7	7
CTTTGCGAGCTGTCTA-1_1_A4	2.89100139	-3.11728586	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	729	1059	0.004721435	0.002832861	1	12	EN-MIX	26	7	7
CTTTGCGCAACACCCG-1_1_A4	-25.02680937	27.21541789	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1834	3742	0.004543025	0.004810262	1	8	Astrocytes	26	7	7
CTTTGCGGTCTAAACC-1_1_A4	-34.3244406	-10.51580952	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1089	1850	0.011351351	0.002702703	1	9	OPC	26	7	7
GAAACTCAGAGTGAGA-1_1_A4	-14.23215724	-24.6099133	6A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1620	3219	0.049083566	0.002485244	1	6A	IN-PV	26	7	7
GAAACTCAGGCGATAC-1_1_A4	-18.00876566	13.4964476	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1062	1614	0.007434944	0.00929368	1	8	Astrocytes	26	7	7
GAAACTCGTCCTCTTG-1_1_A4	-23.67792534	1.949904935	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	3898	9664	0.008174669	0.003932119	1	11	Glia-MIX	26	7	7
GAAACTCGTTAGATGA-1_1_A4	-22.14879118	26.16861387	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1665	3230	0.00247678	0.00495356	1	8	Astrocytes	26	7	7
GAAACTCTCACTCCTG-1_1_A4	19.58938786	20.71958461	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1008	1744	0.009174312	0.002293578	1	oligos	OL-Cntl	26	7	7
GAAACTCTCACTTATC-1_1_A4	-9.379149886	14.58683309	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1744	2915	0.004116638	0.005831904	1	11	Glia-MIX	26	7	7
GAAACTCTCTATCCTA-1_1_A4	-24.43910842	26.32856982	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1671	3431	0.004080443	0.002914602	1	8	Astrocytes	26	7	7
GAAACTCTCTTTACAC-1_1_A4	-17.73111905	13.07080047	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1114	1597	0.000626174	0.004383219	1	8	Astrocytes	26	7	7
GAAATGAAGGTTACCT-1_1_A4	35.86272113	11.02858501	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	800	1028	0.008754864	0.037937743	1	14	Microglia	26	7	7
GAAATGACAAGGTTTC-1_1_A4	23.0287553	18.88985055	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1083	1705	0.003519062	0.001173021	1	oligos	OL-Cntl	26	7	7
GAAATGACAGCTATTG-1_1_A4	3.095474388	25.76066099	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	830	1235	0.009716599	0.0048583	1	oligos	OL-Cntl	26	7	7
GAAATGAGTCCCTACT-1_1_A4	-25.75193309	16.4005988	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1048	1623	0.009858287	0.005545287	1	8	Astrocytes	26	7	7
GAAATGATCACAGGCC-1_1_A4	-13.39133936	19.0008302	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1763	3180	0.004402516	0.004402516	1	8	Astrocytes	26	7	7
GAACATCAGGTGCTTT-1_1_A4	4.191981066	27.38692906	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	720	1104	0.000905797	0.00634058	1	oligos	OL-Cntl	26	7	7
GAACATCAGTCCCACG-1_1_A4	35.60880203	7.775781013	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	890	1167	0.00856898	0.006855184	1	14	Microglia	26	7	7
GAACATCAGTGGGATC-1_1_A4	39.24227031	10.29055753	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	827	1102	0.021778584	0.004537205	1	14	Microglia	26	7	7
GAACATCCAATAAGCA-1_1_A4	1.570473593	28.98608122	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	736	1113	0.017070979	0.005390836	1	oligos	OL-Cntl	26	7	7
GAACATCCACGGTAAG-1_1_A4	-27.33367371	12.96614451	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1026	1624	0.003694581	0.004926108	1	8	Astrocytes	26	7	7
GAACATCCATTAGCCA-1_1_A4	25.56559654	3.816325786	15BA	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1013	1504	0.003324468	0.005319149	1	15BA	Stromal cells	26	7	7
GAACATCCATTCGACA-1_1_A4	3.835961139	19.30494096	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	884	1348	0.013353116	0.005934718	1	oligos	OL-Cntl	26	7	7
GAACATCGTAGCGCAA-1_1_A4	2.232485403	26.77150266	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	753	1075	0.002790698	0.006511628	1	oligos	OL-Cntl	26	7	7
GAACATCTCATGCAAC-1_1_A4	4.37209186	18.29424955	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	916	1413	0.016985138	0.007784855	1	oligos	OL-Cntl	26	7	7
GAACATCTCGTGGGAA-1_1_A4	-5.461572045	14.61008413	5	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	880	1282	0.028081123	0.016380655	1	oligos	OL-MS-1	26	7	7
GAACCTAAGATATGGT-1_1_A4	-30.57509709	9.682945249	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	672	1008	0.012896825	0.004960317	1	8	Astrocytes	26	7	7
GAACCTACACATGACT-1_1_A4	4.606368577	26.15220198	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	819	1185	0.012658228	0.005907173	1	oligos	OL-Cntl	26	7	7
GAACCTAGTCACCCAG-1_1_A4	40.09985946	11.75475849	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	846	1192	0.005033557	0.012583893	1	14	Microglia	26	7	7
GAACCTAGTCGAGATG-1_1_A4	-3.594441033	-7.584000937	13A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	763	1169	0.022241232	0.001710864	1	13A	IN-VIP	26	7	7
GAACGGAAGAGTACAT-1_1_A4	-6.952554132	-4.327898023	13A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1818	3232	0.012685644	0.003094059	1	13A	IN-VIP	26	7	7
GAACGGAAGCAATCTC-1_1_A4	-35.56101588	-4.76498962	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1433	2469	0.012960713	0.005670312	1	9	OPC	26	7	7
GAACGGACACTCGACG-1_1_A4	14.78624943	14.60053467	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1241	2078	0.012030799	0.006737247	1	oligos	OL-Cntl	26	7	7
GAACGGACAGGACGTA-1_1_A4	14.34776653	15.39763362	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1193	1934	0.001034126	0.007755946	1	oligos	OL-Cntl	26	7	7
GAACGGAGTCGCCATG-1_1_A4	-1.326300219	25.38314138	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	710	1090	0.002752294	0.001834862	1	oligos	OL-Cntl	26	7	7
GAACGGATCAACTCTT-1_1_A4	-22.56056615	23.87928461	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1461	2600	0.003076923	0.008076923	1	8	Astrocytes	26	7	7
GAACGGATCCTGCTTG-1_1_A4	14.60742532	15.50037908	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1301	2196	0.005009107	0.005009107	1	oligos	OL-Cntl	26	7	7
GAACGGATCGCGATCG-1_1_A4	13.96846739	6.656119953	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1912	3338	0.019173158	0.008987418	1	oligos	OL-Cntl	26	7	7
GAAGCAGAGCTACCGC-1_1_A4	-23.26817397	2.235884762	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	4279	10244	0.00673565	0.003904725	1	11	Glia-MIX	26	7	7
GAAGCAGAGTGGCACA-1_1_A4	-20.83162516	8.486132849	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	796	1105	0.005429864	0.006334842	1	8	Astrocytes	26	7	7
GAAGCAGCAGATGAGC-1_1_A4	14.6012272	17.44992942	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1063	1683	0.01010101	0.006535948	1	oligos	OL-Cntl	26	7	7
GAAGCAGCAGCTATTG-1_1_A4	-21.58922979	27.51598227	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1977	3612	0.004706534	0.005813953	1	8	Astrocytes	26	7	7
GAAGCAGTCGGAGGTA-1_1_A4	-25.98240353	22.53361583	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1269	2165	0.002309469	0.006466513	1	8	Astrocytes	26	7	7
GAAGCAGTCTCTTGAT-1_1_A4	-23.25792456	2.215707956	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	3606	8051	0.007949323	0.0060862	1	11	Glia-MIX	26	7	7
GAATAAGAGACAGGCT-1_1_A4	-24.64260337	17.36830934	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1232	2047	0.001954079	0.006839277	1	8	Astrocytes	26	7	7
GAATAAGCAAGCTGTT-1_1_A4	12.87543454	22.06588847	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	918	1474	0.002713704	0.006784261	1	oligos	OL-Cntl	26	7	7
GAATAAGCATTGCGGC-1_1_A4	6.206515843	21.63660799	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	861	1367	0.021214338	0.008778347	1	oligos	OL-Cntl	26	7	7
GAATAAGGTCACCTAA-1_1_A4	-37.97088325	-5.321073002	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1216	2223	0.000899685	0.001349528	1	9	OPC	26	7	7
GAATGAAGTACGACCC-1_1_A4	1.34420566	22.54593742	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	837	1293	0.018561485	0.010827533	1	oligos	OL-Cntl	26	7	7
GAATGAAGTCCGAGTC-1_1_A4	39.53805508	14.80671126	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1197	1792	0.013392857	0.007254464	1	14	Microglia	26	7	7
GAATGAATCGTCACGG-1_1_A4	15.19429006	14.59991932	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1274	2082	0.003362152	0.012007685	1	oligos	OL-Cntl	26	7	7
GACACGCCAACTGGCC-1_1_A4	6.138594707	13.64994408	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1128	1750	0.015428571	0.009714286	1	oligos	OL-Cntl	26	7	7
GACACGCCAATTCCTT-1_1_A4	-22.87826587	27.77547984	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1818	3488	0.006880734	0.004300459	1	8	Astrocytes	26	7	7
GACACGCCACCAGTTA-1_1_A4	-22.29161086	28.96607372	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2082	4435	0.000901917	0.003833145	1	8	Astrocytes	26	7	7
GACACGCGTTCCAACA-1_1_A4	4.469618354	9.829061039	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1340	2174	0.00873965	0.023919043	1	oligos	OL-Cntl	26	7	7
GACACGCGTTCGTTGA-1_1_A4	13.37427448	12.12684578	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1519	2507	0.025129637	0.011168728	1	oligos	OL-Cntl	26	7	7
GACACGCTCAATAAGG-1_1_A4	-31.68041263	-11.43648354	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	876	1271	0.014162077	0.002360346	1	9	OPC	26	7	7
GACACGCTCAGGCCCA-1_1_A4	15.30300855	15.32174866	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1321	2306	0.00954033	0.004770165	1	oligos	OL-Cntl	26	7	7
GACACGCTCATATCGG-1_1_A4	16.85020102	0.931858374	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	730	1031	0.006789525	0.004849661	1	12	EN-MIX	26	7	7
GACACGCTCTCTTGAT-1_1_A4	16.40856226	10.0257149	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1437	2532	0.010268562	0.010663507	1	oligos	OL-Cntl	26	7	7
GACAGAGAGACAAAGG-1_1_A4	-4.083544648	19.61485292	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	815	1170	0.035897436	0.017094017	1	oligos	OL-Cntl	26	7	7
GACAGAGAGCAATCTC-1_1_A4	-10.10719784	12.24106736	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	733	1042	0.005758157	0.003838772	1	11	Glia-MIX	26	7	7
GACAGAGAGTTGTAGA-1_1_A4	-25.46878732	22.51486267	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1234	2188	0.001371115	0.008683729	1	8	Astrocytes	26	7	7
GACAGAGAGTTTGCGT-1_1_A4	16.08879961	25.13497997	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	906	1367	0.015362107	0.002926116	1	oligos	OL-Cntl	26	7	7
GACAGAGCAAGGCTCC-1_1_A4	-25.06838181	15.88221646	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1221	2089	0.009573959	0.005265677	1	8	Astrocytes	26	7	7
GACAGAGCACATCTTT-1_1_A4	-10.1644741	-20.76896705	6A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	760	1102	0.009981851	0.004537205	1	6A	IN-PV	26	7	7
GACAGAGCACCATCCT-1_1_A4	35.47086663	7.884766135	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	966	1306	0.012251149	0.012251149	1	14	Microglia	26	7	7
GACAGAGCACCTATCC-1_1_A4	3.0751208	-5.414656039	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	977	1521	0.003287311	0.003287311	1	12	EN-MIX	26	7	7
GACAGAGGTAGCAAAT-1_1_A4	21.53768724	1.170221868	2	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1335	2266	0.000441306	0.000441306	1	2	EN-L4	26	7	7
GACAGAGGTAGGCTGA-1_1_A4	8.310794043	18.86655832	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1280	2066	0.005808325	0.008228461	1	oligos	OL-Cntl	26	7	7
GACAGAGGTGTCCTCT-1_1_A4	6.357241035	17.68951434	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1074	1716	0.007575758	0.012820513	1	oligos	OL-Cntl	26	7	7
GACAGAGGTGTGTGCC-1_1_A4	3.220526057	18.44223596	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	919	1475	0.008135593	0.004745763	1	oligos	OL-Cntl	26	7	7
GACAGAGGTTAAGTAG-1_1_A4	38.35374057	10.53071466	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	889	1202	0.004991681	0.009983361	1	14	Microglia	26	7	7
GACAGAGGTTGGTTTG-1_1_A4	3.151844919	6.988646446	7	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1122	1593	0.009416196	0.013810421	1	7	Phagocytes	26	7	7
GACAGAGTCAGTCAGT-1_1_A4	2.903360451	-4.342684919	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	866	1260	0.01031746	0.007142857	1	12	EN-MIX	26	7	7
GACAGAGTCCATGAAC-1_1_A4	-36.10625087	0.005829616	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1661	2967	0.012133468	0.007077856	1	9	OPC	26	7	7
GACCAATAGTAGATGT-1_1_A4	5.659800579	19.34510516	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	888	1266	0.009478673	0.008688784	1	oligos	OL-Cntl	26	7	7
GACCAATCAAAGGCGT-1_1_A4	-3.489087879	11.45685154	5	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	884	1283	0.027279813	0.033515199	1	oligos	OL-MS-1	26	7	7
GACCAATCAGTATAAG-1_1_A4	-22.30082799	29.36732899	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2184	4553	0.00285526	0.004392708	1	8	Astrocytes	26	7	7
GACCAATGTCCAGTAT-1_1_A4	-26.42820961	19.07073341	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1449	2695	0.002597403	0.00296846	1	8	Astrocytes	26	7	7
GACCAATGTCCGTCAG-1_1_A4	39.44863586	16.00030998	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1587	2520	0.012698413	0.004761905	1	14	Microglia	26	7	7
GACCAATGTGAACCTT-1_1_A4	-22.27551186	29.29317765	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2186	4632	0.000647668	0.003022453	1	8	Astrocytes	26	7	7
GACCAATGTGCTGTAT-1_1_A4	14.23110334	15.95159316	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1226	1986	0.010574018	0.006545821	1	oligos	OL-Cntl	26	7	7
GACCAATGTTACAGAA-1_1_A4	0.04458391	22.98478902	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	790	1122	0.010695187	0.00802139	1	oligos	OL-Cntl	26	7	7
GACCAATTCGCCTGTT-1_1_A4	-36.59539783	-5.984797461	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1183	2008	0.000996016	0.002988048	1	9	OPC	26	7	7
GACCAATTCTTGTATC-1_1_A4	-15.28888548	-11.10420702	13B	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	3007	7999	0.001625203	0.002375297	1	13B	IN-SV2C	26	7	7
GACCTGGGTAATTGGA-1_1_A4	9.146780701	-6.904058658	10	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1779	3426	0.011675423	0.001751313	1	L2-3	EN-L2-3-Cntl	26	7	7
GACCTGGGTATATGGA-1_1_A4	1.054005507	16.34461353	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	776	1110	0.007207207	0.00990991	1	oligos	OL-Cntl	26	7	7
GACGCGTAGGCAGTCA-1_1_A4	36.39469412	10.39834813	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	834	1097	0.010027347	0.018231541	1	14	Microglia	26	7	7
GACGCGTCAATCACAC-1_1_A4	3.062016965	-3.009338053	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	775	1139	0.012291484	0.005267779	1	12	EN-MIX	26	7	7
GACGCGTCACGGTTTA-1_1_A4	-27.33482925	8.540303998	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	698	1016	0.006889764	0.008858268	1	8	Astrocytes	26	7	7
GACGCGTCATGCCTAA-1_1_A4	16.76070338	15.98809244	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1218	2107	0.005220693	0.005695301	1	oligos	OL-Cntl	26	7	7
GACGCGTCATTTCAGG-1_1_A4	-24.53982826	27.55919636	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1781	3431	0.007577966	0.007577966	1	8	Astrocytes	26	7	7
GACGCGTGTATTAGCC-1_1_A4	15.90550348	-0.855643388	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	710	1017	0	0.002949853	1	12	EN-MIX	26	7	7
GACGCGTGTCAATACC-1_1_A4	3.037666863	-4.811050552	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	985	1551	0.010315925	0.003223727	1	12	EN-MIX	26	7	7
GACGCGTGTTATGCGT-1_1_A4	-23.56871445	-0.885087445	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1527	2550	0.006666667	0.005098039	1	9	OPC	26	7	7
GACGGCTAGCGTGAAC-1_1_A4	-3.699554088	25.3300488	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	919	1487	0.00403497	0.004707465	1	oligos	OL-Cntl	26	7	7
GACGGCTAGGAGCGAG-1_1_A4	5.941105008	5.660160462	7	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	4373	9460	0.011310782	0.008350951	1	7	Phagocytes	26	7	7
GACGGCTCAGGACGTA-1_1_A4	-35.52007553	-6.479768226	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1135	1851	0.002160994	0.00378174	1	9	OPC	26	7	7
GACGGCTCATAACCTG-1_1_A4	33.90287542	14.66354127	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	980	1318	0.015933232	0.065250379	1	14	Microglia	26	7	7
GACGGCTCATCACGTA-1_1_A4	9.609404693	23.97567277	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	918	1419	0.00845666	0.007047216	1	oligos	OL-Cntl	26	7	7
GACGGCTCATTCACTT-1_1_A4	3.266812585	-11.00543513	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1760	3269	0.015601101	0.006118079	1	12	EN-MIX	26	7	7
GACGGCTGTAAGTTCC-1_1_A4	14.36246955	-2.42529247	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1051	1746	0.026345934	0	1	12	EN-MIX	26	7	7
GACGGCTGTGTGACGA-1_1_A4	4.522720514	13.19859023	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1080	1606	0.016811955	0.018057285	1	oligos	OL-Cntl	26	7	7
GACGTGCAGAGACTTA-1_1_A4	5.740892513	20.7158981	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	971	1463	0.00683527	0.006151743	1	oligos	OL-Cntl	26	7	7
GACGTGCCAAACTGCT-1_1_A4	32.28342028	-10.11496272	2	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2846	5766	0.010405827	0.008844953	1	2	EN-L4	26	7	7
GACGTGCCAGCTGCAC-1_1_A4	-22.59905305	27.81572821	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1943	3853	0.003373994	0.005450298	1	8	Astrocytes	26	7	7
GACGTGCGTAGCGTCC-1_1_A4	-21.90560764	27.99285342	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2087	4205	0.00451843	0.004994055	1	8	Astrocytes	26	7	7
GACGTGCGTCCGTTAA-1_1_A4	10.95423818	6.828065441	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1766	3103	0.010312601	0.021592008	1	oligos	OL-Cntl	26	7	7
GACGTGCGTTAAAGTG-1_1_A4	4.00457878	20.24866833	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	943	1478	0.01150203	0.00270636	1	oligos	OL-Cntl	26	7	7
GACGTGCGTTGTACAC-1_1_A4	17.27913797	9.990189607	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1620	2899	0.001724733	0.008623663	1	oligos	OL-Cntl	26	7	7
GACGTGCGTTTACTCT-1_1_A4	5.934395681	13.84566677	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1283	1988	0.012072435	0.013581489	1	oligos	OL-Cntl	26	7	7
GACGTGCTCAACGGGA-1_1_A4	-0.51422041	29.14130241	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	922	1344	0.002232143	0.003720238	1	oligos	OL-Cntl	26	7	7
GACGTGCTCAGAAATG-1_1_A4	20.24431072	18.428277	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1168	1920	0.003125	0.003645833	1	oligos	OL-Cntl	26	7	7
GACGTTAAGTACGACG-1_1_A4	-11.33129528	8.86756848	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	4667	10798	0.004260048	0.005927024	1	11	Glia-MIX	26	7	7
GACGTTACAATACGCT-1_1_A4	38.7921039	11.15902586	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	925	1265	0.001581028	0.012648221	1	14	Microglia	26	7	7
GACGTTACACGCATCG-1_1_A4	-20.72310516	30.80263859	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2574	5260	0.001520913	0.007794677	1	8	Astrocytes	26	7	7
GACGTTACATTTCACT-1_1_A4	-7.432680051	-6.640675959	13A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1316	2077	0.032739528	0.0105922	1	13A	IN-VIP	26	7	7
GACGTTAGTCGCATAT-1_1_A4	-0.376642316	0.756378839	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1308	2165	0.032794457	0.005542725	1	11	Glia-MIX	26	7	7
GACGTTATCAAGCCTA-1_1_A4	7.523555542	-7.028679855	10	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1487	2846	0.003513703	0.001405481	1	L2-3	EN-L2-3-Cntl	26	7	7
GACGTTATCAAGGCTT-1_1_A4	13.9917954	12.68661287	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1432	2398	0.008757298	0.005838198	1	oligos	OL-Cntl	26	7	7
GACTAACCACCGATAT-1_1_A4	17.77987282	7.528918847	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2200	4333	0.004846527	0.006231249	1	oligos	OL-Cntl	26	7	7
GACTAACGTCGTTGTA-1_1_A4	-10.45510244	-9.342839921	13A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1397	2407	0.027420025	0.002908184	1	13A	IN-VIP	26	7	7
GACTAACGTGCTCTTC-1_1_A4	-37.87384316	-0.599970993	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1575	2946	0.00509165	0.002376103	1	9	OPC	26	7	7
GACTAACTCAGCGACC-1_1_A4	16.0803962	12.1344287	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1453	2465	0.006896552	0.006896552	1	oligos	OL-Cntl	26	7	7
GACTAACTCATAAAGG-1_1_A4	1.982746518	12.47456043	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	971	1395	0.015053763	0.013620072	1	oligos	OL-Cntl	26	7	7
GACTAACTCCTTTACA-1_1_A4	5.450776167	23.98241208	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	894	1397	0.013600573	0.002863278	1	oligos	OL-Cntl	26	7	7
GACTAACTCGCATGGC-1_1_A4	-26.10411135	19.35930531	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1541	2743	0.005103901	0.004010208	1	8	Astrocytes	26	7	7
GACTAACTCGTTTATC-1_1_A4	5.717782497	16.78223284	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1053	1678	0.017282479	0.007747318	1	oligos	OL-Cntl	26	7	7
GACTAACTCTGGCGTG-1_1_A4	-1.476396943	23.32507151	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	709	1020	0.012745098	0.009803922	1	oligos	OL-Cntl	26	7	7
GACTACAAGGCGTACA-1_1_A4	21.12511115	18.00476368	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1162	1921	0.00468506	0.005726184	1	oligos	OL-Cntl	26	7	7
GACTACACAACACCTA-1_1_A4	5.762032264	13.14516707	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1122	1783	0.00897364	0.014021312	1	oligos	OL-Cntl	26	7	7
GACTACACAATGACCT-1_1_A4	22.09480433	-0.748191403	2	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1911	3526	0.007090187	0.00567215	1	2	EN-L4	26	7	7
GACTACACACCATCCT-1_1_A4	-0.239132577	20.9558278	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	700	1065	0.007511737	0.016901408	1	oligos	OL-Cntl	26	7	7
GACTACACAGGGAGAG-1_1_A4	32.9305853	-2.431218314	2	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2912	5983	0.001002841	0.00752131	1	2	EN-L4	26	7	7
GACTACACAGGGTATG-1_1_A4	-22.69635775	-0.237006962	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1626	2716	0.004786451	0.004050074	1	9	OPC	26	7	7
GACTACAGTAGGGTAC-1_1_A4	8.419698628	24.11570569	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1199	2033	0.006394491	0.001475652	1	oligos	OL-Cntl	26	7	7
GACTACATCAATCACG-1_1_A4	3.187404961	29.70336726	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	672	1034	0.006769826	0	1	oligos	OL-Cntl	26	7	7
GACTGCGAGCCATCGC-1_1_A4	-35.12775885	-8.120986942	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1092	1800	0.005	0.002222222	1	9	OPC	26	7	7
GACTGCGGTACAAGTA-1_1_A4	10.69540876	-33.98878024	3	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	5218	18111	0.001269946	0.001601237	1	3	EN-L5-6	26	7	7
GACTGCGTCGGACAAG-1_1_A4	15.00443515	20.19795772	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	975	1534	0.005215124	0.007822686	1	oligos	OL-Cntl	26	7	7
GACTGCGTCGTTACGA-1_1_A4	5.87040871	16.88219991	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1094	1671	0.023339318	0.008976661	1	oligos	OL-Cntl	26	7	7
GACTGCGTCTCCAACC-1_1_A4	39.22275643	15.96084684	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1408	2081	0.013935608	0.008649688	1	14	Microglia	26	7	7
GACTGCGTCTCCGGTT-1_1_A4	-34.24986985	-9.362817483	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	970	1497	0.002004008	0.001336005	1	9	OPC	26	7	7
GAGCAGAAGGACATTA-1_1_A4	-27.05209862	4.070491908	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	5033	13051	0.00183894	0.006053176	1	11	Glia-MIX	26	7	7
GAGCAGAAGGAGTAGA-1_1_A4	15.30824866	-0.099178993	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	765	1095	0.005479452	0.000913242	1	12	EN-MIX	26	7	7
GAGCAGAAGTGAATTG-1_1_A4	36.32416712	8.905128574	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	777	1060	0.006603774	0.020754717	1	14	Microglia	26	7	7
GAGCAGACAAGTACCT-1_1_A4	14.25311673	14.80808493	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1313	2183	0.021530005	0.012826386	1	oligos	OL-Cntl	26	7	7
GAGCAGAGTCATGCAT-1_1_A4	20.17081685	17.83443981	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1063	1697	0.002357101	0.007660577	1	oligos	OL-Cntl	26	7	7
GAGCAGATCAGTTTGG-1_1_A4	38.72090422	11.52169381	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	971	1329	0.004514673	0.010534236	1	14	Microglia	26	7	7
GAGCAGATCGGTTAAC-1_1_A4	14.81701531	1.66404227	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1145	1853	0.017269293	0.00701565	1	12	EN-MIX	26	7	7
GAGGTGAAGGACTGGT-1_1_A4	-1.770321847	22.97606298	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	847	1244	0.013665595	0.008038585	1	oligos	OL-Cntl	26	7	7
GAGGTGAAGGCTACGA-1_1_A4	-34.02124608	-9.610425279	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1083	1627	0.012907191	0.003687769	1	9	OPC	26	7	7
GAGGTGAAGTGTGAAT-1_1_A4	16.91811939	1.491742332	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	799	1293	0.005413766	0.000773395	1	12	EN-MIX	26	7	7
GAGGTGACACCACGTG-1_1_A4	-21.83776893	27.73134586	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2218	4383	0.004563085	0.006616473	1	8	Astrocytes	26	7	7
GAGGTGAGTGGTAACG-1_1_A4	4.619304978	31.28775418	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	812	1249	0.017614091	0.002401922	1	oligos	OL-Cntl	26	7	7
GAGGTGAGTGTTCGAT-1_1_A4	-0.1451234	24.16437335	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	782	1180	0.018644068	0.008474576	1	oligos	OL-Cntl	26	7	7
GAGGTGAGTTCGCTAA-1_1_A4	7.718331378	29.9404318	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	675	1044	0.002873563	0.005747126	1	oligos	OL-Cntl	26	7	7
GAGGTGATCATCGATG-1_1_A4	-23.79941088	2.071609854	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	5328	15111	0.008338297	0.006286811	1	11	Glia-MIX	26	7	7
GAGGTGATCATTTGGG-1_1_A4	-17.28332177	12.98236845	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1183	1812	0.001103753	0.002759382	1	8	Astrocytes	26	7	7
GAGGTGATCTGATTCT-1_1_A4	10.34260535	-18.70145148	4	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	5360	16957	0.00766645	0.008374123	1	L2-3	EN-L2-3-MS	26	7	7
GAGTCCGAGCTTATCG-1_1_A4	2.55566299	4.489171045	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	868	1191	0.010075567	0.006717045	1	14	Microglia	26	7	7
GAGTCCGAGTGACTCT-1_1_A4	1.805731	29.91961894	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	757	1109	0.014427412	0.007213706	1	oligos	OL-Cntl	26	7	7
GAGTCCGAGTTCGCGC-1_1_A4	13.04279729	31.03572059	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	857	1358	0.025773196	0.008836524	1	oligos	OL-Cntl	26	7	7
GAGTCCGTCTCGCTTG-1_1_A4	15.69270881	10.13904709	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1547	2846	0.008432888	0.005973296	1	oligos	OL-Cntl	26	7	7
GATCAGTAGGAATTAC-1_1_A4	15.91760345	18.14743087	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1094	1865	0.01233244	0.009115282	1	oligos	OL-Cntl	26	7	7
GATCAGTCAACTGCGC-1_1_A4	17.35802721	13.0329289	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1303	2374	0.00547599	0.01010952	1	oligos	OL-Cntl	26	7	7
GATCAGTCACGCATCG-1_1_A4	-19.18283556	-26.49919605	6A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2656	6066	0.009231784	0.005110452	1	6A	IN-PV	26	7	7
GATCAGTGTACCGTAT-1_1_A4	-36.07800813	-1.775376067	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1433	2524	0.006339144	0.007527734	1	9	OPC	26	7	7
GATCAGTGTACGCTGC-1_1_A4	3.020411161	18.19118461	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	975	1478	0.01488498	0.00811908	1	oligos	OL-Cntl	26	7	7
GATCAGTGTCTAACGT-1_1_A4	-9.424704092	15.8268804	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2175	3754	0.002663825	0.006925946	1	11	Glia-MIX	26	7	7
GATCAGTGTGTGCGTC-1_1_A4	39.41059768	15.81289379	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1395	2131	0.00140779	0.006100422	1	14	Microglia	26	7	7
GATCAGTTCATCGGAT-1_1_A4	4.828985306	14.78534114	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	911	1455	0.016494845	0.006872852	1	oligos	OL-Cntl	26	7	7
GATCAGTTCATGTAGC-1_1_A4	-1.963310405	26.7269127	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	691	1013	0.017769003	0.012833169	1	oligos	OL-Cntl	26	7	7
GATCAGTTCATTGCCC-1_1_A4	15.42110556	20.5037929	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1066	1714	0.009334889	0.006417736	1	oligos	OL-Cntl	26	7	7
GATCAGTTCCACGTTC-1_1_A4	2.677803319	-3.395771413	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	762	1118	0.007155635	0.006261181	1	12	EN-MIX	26	7	7
GATCAGTTCCATGAGT-1_1_A4	10.54007159	8.847737328	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1343	2171	0.015200368	0.012436665	1	oligos	OL-Cntl	26	7	7
GATCAGTTCTGGCGAC-1_1_A4	8.584125793	24.79311811	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	797	1226	0.004078303	0.007340946	1	oligos	OL-Cntl	26	7	7
GATCAGTTCTGTTGAG-1_1_A4	-36.29170768	-3.306899669	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1389	2393	0.004178855	0.003343084	1	9	OPC	26	7	7
GATCGATAGCAGCCTC-1_1_A4	21.5210128	11.54934636	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1467	2549	0.003138486	0.005884661	1	oligos	OL-Cntl	26	7	7
GATCGATCAAGGACAC-1_1_A4	-6.293444172	-1.752647671	13A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1690	3104	0.013853093	0.00257732	1	13A	IN-VIP	26	7	7
GATCGATCATACTCTT-1_1_A4	14.90899914	28.02834896	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	762	1104	0.002717391	0.000905797	1	oligos	OL-Cntl	26	7	7
GATCGATCATCGATGT-1_1_A4	-10.99059549	7.26049533	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	3951	9905	0.011206461	0.007874811	1	oligos	OL-Cntl	26	7	7
GATCGATTCCACGTTC-1_1_A4	-6.687485126	0.41639027	13A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2190	5044	0.010705789	0.003568596	1	13A	IN-VIP	26	7	7
GATCGCGAGACTAGAT-1_1_A4	-9.237030505	18.49166781	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	4383	10290	0.004373178	0.004275996	1	11	Glia-MIX	26	7	7
GATCGCGAGTAACCCT-1_1_A4	14.43926419	6.439432277	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1938	3495	0.00658083	0.012589413	1	oligos	OL-Cntl	26	7	7
GATCGCGCACGAGAGT-1_1_A4	-23.82148618	-1.06285661	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1530	2851	0.002104525	0.004559804	1	9	OPC	26	7	7
GATCGCGTCCACTGGG-1_1_A4	-23.64021718	28.89490766	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1962	4137	0.000966884	0.004350979	1	8	Astrocytes	26	7	7
GATCGTAAGAAACCAT-1_1_A4	26.07294373	3.649385757	15BA	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	718	1030	0.004854369	0.001941748	1	15BA	Stromal cells	26	7	7
GATCGTAAGATGCGAC-1_1_A4	3.734390031	7.286909475	7	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1025	1502	0.004660453	0.001997337	1	7	Phagocytes	26	7	7
GATCGTAAGTCATCCA-1_1_A4	-22.49251014	28.62208362	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2008	3930	0.003816794	0.006361323	1	8	Astrocytes	26	7	7
GATCGTACATTTGCCC-1_1_A4	5.434185863	26.89530512	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	813	1208	0.007450331	0.006622517	1	oligos	OL-Cntl	26	7	7
GATCGTAGTAAATACG-1_1_A4	8.259669441	-7.128370335	10	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1585	3104	0.003865979	0.00193299	1	L2-3	EN-L2-3-Cntl	26	7	7
GATCGTAGTAAGGGCT-1_1_A4	5.472232117	30.54797757	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	795	1284	0.021028037	0.003115265	1	oligos	OL-Cntl	26	7	7
GATCGTATCCAAAGTC-1_1_A4	11.72588334	16.30841439	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1148	1915	0.017754569	0.010443864	1	oligos	OL-Cntl	26	7	7
GATCGTATCGTCCGTT-1_1_A4	37.80036926	9.516522057	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	803	1104	0.003623188	0.008152174	1	14	Microglia	26	7	7
GATCGTATCTGTCTAT-1_1_A4	14.93740986	-1.108964141	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	883	1448	0.010359116	0.002071823	1	12	EN-MIX	26	7	7
GATCGTATCTTCTGGC-1_1_A4	-34.46554545	0.212756755	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1729	3534	0.003678551	0.005376344	1	9	OPC	26	7	7
GATCTAGAGATCCCAT-1_1_A4	5.147858903	24.59246294	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	861	1301	0.026133743	0.003074558	1	oligos	OL-Cntl	26	7	7
GATCTAGGTACCGAGA-1_1_A4	-24.47879301	26.50579498	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1517	2896	0.004834254	0.005870166	1	8	Astrocytes	26	7	7
GATCTAGGTATGGTTC-1_1_A4	5.503786917	24.05151164	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	911	1348	0.004451039	0.003709199	1	oligos	OL-Cntl	26	7	7
GATCTAGGTCTCTTTA-1_1_A4	-0.38376231	20.87833404	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	740	1137	0.000879507	0.004397537	1	oligos	OL-Cntl	26	7	7
GATCTAGTCAGTCCCT-1_1_A4	38.15200976	11.07098114	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	901	1230	0.008943089	0.010569106	1	14	Microglia	26	7	7
GATCTAGTCCTCGCAT-1_1_A4	-22.41219636	26.37471678	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1786	3456	0.000289352	0.006076389	1	8	Astrocytes	26	7	7
GATGAAAAGAGTGAGA-1_1_A4	4.067519645	31.0026795	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	698	1021	0.020568071	0.000979432	1	oligos	OL-Cntl	26	7	7
GATGAAAAGATGTCGG-1_1_A4	-1.469525381	22.84900408	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	825	1198	0.010851419	0.006677796	1	oligos	OL-Cntl	26	7	7
GATGAAAAGTTCGCAT-1_1_A4	11.643005	24.04216818	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	867	1377	0.003631082	0.005809731	1	oligos	OL-Cntl	26	7	7
GATGAAACAACACCTA-1_1_A4	7.232065699	13.93588188	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1190	1890	0.016402116	0.014285714	1	oligos	OL-Cntl	26	7	7
GATGAAACACAACTGT-1_1_A4	3.559641447	-9.538219017	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2017	4398	0.002273761	0.005684402	1	12	EN-MIX	26	7	7
GATGAAAGTAAACGCG-1_1_A4	-11.68233565	-22.32424801	6A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1051	1737	0.027633851	0.003454231	1	6A	IN-PV	26	7	7
GATGAAAGTCGGCACT-1_1_A4	0.947316568	21.9574785	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	823	1332	0.001501502	0.011261261	1	oligos	OL-Cntl	26	7	7
GATGAAAGTCTGCGGT-1_1_A4	38.18259563	10.55805631	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	906	1209	0.004135649	0.014061208	1	14	Microglia	26	7	7
GATGAAATCAGCTCGG-1_1_A4	-34.5549317	-13.22471827	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	678	1021	0.001958864	0	1	9	OPC	26	7	7
GATGAAATCCCAGGTG-1_1_A4	35.61819508	10.86660837	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	809	1132	0.007067138	0.017667845	1	14	Microglia	26	7	7
GATGAGGCATGCAACT-1_1_A4	22.72789167	14.91381584	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1392	2324	0.001290878	0.007314974	1	oligos	OL-Cntl	26	7	7
GATGAGGGTGCGATAG-1_1_A4	33.151056	14.42925763	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	970	1304	0.017638037	0.053680982	1	14	Microglia	26	7	7
GATGAGGTCAGTACGT-1_1_A4	-36.81826118	-4.506029261	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1322	2289	0.008300568	0.003931848	1	9	OPC	26	7	7
GATGAGGTCCTCGCAT-1_1_A4	-12.15361487	-10.90304744	13B	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1460	2793	0.005370569	0.001432152	1	13B	IN-SV2C	26	7	7
GATGAGGTCGTAGGAG-1_1_A4	-0.369867464	27.58740061	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	758	1041	0.025936599	0.003842459	1	oligos	OL-Cntl	26	7	7
GATGAGGTCTCCGGTT-1_1_A4	16.66549854	21.66946613	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1060	1836	0.022331155	0.003267974	1	oligos	OL-Cntl	26	7	7
GATGAGGTCTTGCCGT-1_1_A4	-28.94633548	13.59057422	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	859	1389	0.003599712	0.00287977	1	8	Astrocytes	26	7	7
GATGCTAAGTCAAGCG-1_1_A4	20.15427112	18.53780859	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1039	1626	0.004305043	0.006150062	1	oligos	OL-Cntl	26	7	7
GATGCTACAAGCCGTC-1_1_A4	8.194815566	-6.367345908	10	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1436	2631	0.003800836	0.001140251	1	L2-3	EN-L2-3-Cntl	26	7	7
GATGCTACAGTAAGAT-1_1_A4	15.18180007	22.36871013	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	960	1420	0.007746479	0.004929577	1	oligos	OL-Cntl	26	7	7
GATGCTAGTTAAGATG-1_1_A4	-8.353005829	-2.745952801	13A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2000	3841	0.010934652	0.007550117	1	13A	IN-VIP	26	7	7
GATGCTAGTTACTGAC-1_1_A4	0.362708113	23.6787137	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	689	1054	0.016129032	0.004743833	1	oligos	OL-Cntl	26	7	7
GATGCTAGTTCCAACA-1_1_A4	6.133394593	-6.098707338	10	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1285	2131	0.009385265	0.002346316	1	L2-3	EN-L2-3-Cntl	26	7	7
GATGCTATCAACGGCC-1_1_A4	7.512839997	22.99170127	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1019	1540	0.002597403	0.003896104	1	oligos	OL-Cntl	26	7	7
GATTCAGAGCTAGCCC-1_1_A4	3.419715848	22.04407264	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	816	1243	0.014481094	0.006436042	1	oligos	OL-Cntl	26	7	7
GATTCAGCAAGACACG-1_1_A4	3.949900982	5.603589482	7	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1380	2059	0.009713453	0.011656144	1	7	Phagocytes	26	7	7
GATTCAGCACGGTTTA-1_1_A4	-34.6392657	-11.94924528	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	785	1242	0.000805153	0.002415459	1	9	OPC	26	7	7
GATTCAGCAGACACTT-1_1_A4	22.57786763	11.86978022	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1710	3223	0.00124108	0.003102699	1	oligos	OL-Cntl	26	7	7
GATTCAGGTAGCGTAG-1_1_A4	-9.35939421	18.50708945	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2909	5286	0.006242906	0.006242906	1	11	Glia-MIX	26	7	7
GATTCAGGTATCACCA-1_1_A4	15.58601716	6.144838507	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2160	4416	0.008378623	0.009057971	1	oligos	OL-Cntl	26	7	7
GATTCAGGTGATGTGG-1_1_A4	-11.28566666	16.13921352	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1625	2552	0.002351097	0.003134796	1	11	Glia-MIX	26	7	7
GATTCAGTCCTCAATT-1_1_A4	-38.2633845	-0.873800582	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1462	2637	0.001896094	0.002275313	1	9	OPC	26	7	7
GATTCAGTCGTTGCCT-1_1_A4	35.89280094	8.015609182	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	781	1079	0.000926784	0.006487488	1	14	Microglia	26	7	7
GCAAACTAGGCCGAAT-1_1_A4	-3.265933958	-6.681378284	13A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	897	1385	0.002888087	0.005776173	1	13A	IN-VIP	26	7	7
GCAAACTAGTGCCAGA-1_1_A4	0.862693437	29.7199367	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	760	1079	0.000926784	0.003707136	1	oligos	OL-Cntl	26	7	7
GCAAACTCAACTGCGC-1_1_A4	39.39463278	16.16615244	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1735	2744	0.011661808	0.008381924	1	14	Microglia	26	7	7
GCAAACTCAGCCTTTC-1_1_A4	-11.00238293	0.048562228	13A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2811	6294	0.002065459	0.005560852	1	13A	IN-VIP	26	7	7
GCAAACTCAGGTCCAC-1_1_A4	3.468596546	26.11432137	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	794	1231	0.006498781	0.004061738	1	oligos	OL-Cntl	26	7	7
GCAAACTGTAAAGGAG-1_1_A4	-12.67403771	15.70462026	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1300	1932	0.004140787	0.00621118	1	11	Glia-MIX	26	7	7
GCAAACTGTACCGAGA-1_1_A4	-22.35923915	27.17529356	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1924	3543	0.006209427	0.003669207	1	8	Astrocytes	26	7	7
GCAAACTGTACCGCTG-1_1_A4	-37.11060738	0.055251493	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1599	2746	0.001456664	0.002184996	1	9	OPC	26	7	7
GCAAACTGTCAACTGT-1_1_A4	-3.337251851	-7.381146572	13A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	727	1071	0.006535948	0.001867414	1	13A	IN-VIP	26	7	7
GCAAACTGTGTAATGA-1_1_A4	4.561208147	20.5951691	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	960	1492	0.030160858	0.012734584	1	oligos	OL-Cntl	26	7	7
GCAAACTGTTCCACGG-1_1_A4	38.46852002	13.1865785	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1071	1508	0.00397878	0.00994695	1	14	Microglia	26	7	7
GCAATCAAGCCCGAAA-1_1_A4	18.09131783	1.498530178	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1020	1573	0.017800381	0.005721551	1	12	EN-MIX	26	7	7
GCAATCAAGCTAAGAT-1_1_A4	12.29326709	11.88509781	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1324	2156	0.003710575	0.013914657	1	oligos	OL-Cntl	26	7	7
GCAATCAAGGGTGTTG-1_1_A4	6.200356752	21.8992744	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	931	1473	0.007467753	0.011541073	1	oligos	OL-Cntl	26	7	7
GCAATCACACAAGTAA-1_1_A4	-10.09282056	18.13278038	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2574	5169	0.008512285	0.006771136	1	11	Glia-MIX	26	7	7
GCAATCACATGCTGGC-1_1_A4	5.522244617	17.28446714	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1072	1673	0.013747759	0.014345487	1	oligos	OL-Cntl	26	7	7
GCAATCAGTCATCCCT-1_1_A4	-24.74708588	19.27263578	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1580	2932	0.005457026	0.004433834	1	8	Astrocytes	26	7	7
GCAATCAGTCCGTTAA-1_1_A4	20.19540983	1.297821882	10	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1492	2748	0.014919942	0.001455604	1	L2-3	EN-L2-3-Cntl	26	7	7
GCAATCAGTGGCCCTA-1_1_A4	2.22344946	-5.146142641	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1030	1659	0.009644364	0.002411091	1	12	EN-MIX	26	7	7
GCACATAAGCCCAACC-1_1_A4	14.52307368	17.41672826	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1126	1734	0.012110727	0.009803922	1	oligos	OL-Cntl	26	7	7
GCACATAAGCGTTTAC-1_1_A4	11.50812328	11.41673161	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1376	2141	0.024287716	0.015413358	1	oligos	OL-Cntl	26	7	7
GCACATAGTAATCGTC-1_1_A4	-36.36105492	-1.805227954	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1441	2613	0.002296211	0.007654038	1	9	OPC	26	7	7
GCACATAGTCGATTGT-1_1_A4	-12.57683424	15.53554838	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1204	1986	0.002014099	0.006042296	1	11	Glia-MIX	26	7	7
GCACATAGTGGCAAAC-1_1_A4	5.330913935	12.99209133	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1178	1899	0.027909426	0.016850974	1	oligos	OL-Cntl	26	7	7
GCACATATCCCATTTA-1_1_A4	39.95265143	12.65184432	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	979	1379	0.008701958	0.009427121	1	14	Microglia	26	7	7
GCACATATCTCTTATG-1_1_A4	-25.32599025	27.22691535	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1748	3518	0.000852757	0.004263786	1	8	Astrocytes	26	7	7
GCACATATCTGCCCTA-1_1_A4	38.39654676	14.43121102	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1150	1690	0.007692308	0.009467456	1	14	Microglia	26	7	7
GCACTCTAGACACGAC-1_1_A4	-21.76945421	19.75274449	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1733	3128	0.002557545	0.00415601	1	8	Astrocytes	26	7	7
GCACTCTAGACAGGCT-1_1_A4	-1.04639901	23.98669866	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	782	1152	0.012152778	0.0078125	1	oligos	OL-Cntl	26	7	7
GCACTCTAGTCCAGGA-1_1_A4	-22.84549245	24.997024	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1624	3054	0.003929273	0.007531107	1	8	Astrocytes	26	7	7
GCACTCTCACGCGAAA-1_1_A4	-6.196447671	-7.135507894	13A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	917	1301	0.020753267	0.002305919	1	13A	IN-VIP	26	7	7
GCACTCTGTCCGAACC-1_1_A4	-14.71570376	-15.70395806	6B	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1653	3073	0.024406118	0.007484543	1	6B	IN-SST	26	7	7
GCACTCTGTCTCGTTC-1_1_A4	2.620752532	6.314470374	7	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	979	1385	0.015162455	0.006498195	1	7	Phagocytes	26	7	7
GCACTCTTCGGTGTTA-1_1_A4	-21.23874433	23.77594632	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1541	2708	0.008862629	0.006277696	1	8	Astrocytes	26	7	7
GCAGCCAAGAACAACT-1_1_A4	17.30615161	-4.225577175	3	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2180	4982	0.000401445	0.002007226	1	3	EN-L5-6	26	7	7
GCAGCCAGTAAGTTCC-1_1_A4	10.18259275	11.3128164	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1333	2221	0.029266096	0.01710941	1	oligos	OL-Cntl	26	7	7
GCAGCCAGTCGGCACT-1_1_A4	19.39597407	17.65953466	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1115	1824	0.004934211	0.003837719	1	oligos	OL-Cntl	26	7	7
GCAGCCAGTCGGGTCT-1_1_A4	10.38180299	14.05240285	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1183	1996	0.002004008	0.009018036	1	oligos	OL-Cntl	26	7	7
GCAGCCAGTTACGGAG-1_1_A4	3.873071845	-5.58356761	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1065	1606	0.019302615	0.001867995	1	12	EN-MIX	26	7	7
GCAGCCATCAGTTGAC-1_1_A4	13.844594	6.7655854	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1886	3501	0.011425307	0.013710368	1	oligos	OL-Cntl	26	7	7
GCAGTTAAGCCCGAAA-1_1_A4	-9.129540151	19.14527778	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	3229	6272	0.005899235	0.011639031	1	11	Glia-MIX	26	7	7
GCAGTTAAGTACACCT-1_1_A4	-0.225993617	27.40573075	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	788	1193	0.016764459	0.004191115	1	oligos	OL-Cntl	26	7	7
GCAGTTAGTAGCCTAT-1_1_A4	4.752542267	21.75040305	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	909	1340	0.007462687	0.008208955	1	oligos	OL-Cntl	26	7	7
GCAGTTAGTATCACCA-1_1_A4	27.72285671	1.098177832	2	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	3140	7805	0.009096733	0.002306214	1	2	EN-L4	26	7	7
GCAGTTAGTCATATGC-1_1_A4	-3.712427515	-7.516151756	13A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	818	1236	0.007281553	0.003236246	1	13A	IN-VIP	26	7	7
GCAGTTATCACAAACC-1_1_A4	-22.50071405	29.13342785	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2082	4185	0.000955795	0.002867384	1	8	Astrocytes	26	7	7
GCATACAAGAAACGCC-1_1_A4	-16.69311063	-26.26294141	6A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2175	4938	0.007897934	0.003037667	1	6A	IN-PV	26	7	7
GCATACAAGAAGCCCA-1_1_A4	-0.843435291	-0.48592061	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1582	2598	0.012317167	0.004234026	1	11	Glia-MIX	26	7	7
GCATACACACCAGATT-1_1_A4	-35.41371244	-4.625604469	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1270	2130	0.002816901	0.005164319	1	9	OPC	26	7	7
GCATACACACCAGGCT-1_1_A4	-10.2296646	16.08546631	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2153	3909	0.015860834	0.006395498	1	11	Glia-MIX	26	7	7
GCATACAGTCATGCAT-1_1_A4	-1.428771724	27.88464238	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	678	1062	0.001883239	0.002824859	1	oligos	OL-Cntl	26	7	7
GCATACAGTGAGGGTT-1_1_A4	4.961976061	13.65883849	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1158	1765	0.013031161	0.011898017	1	oligos	OL-Cntl	26	7	7
GCATGATGTAAGGATT-1_1_A4	16.87626513	24.71760572	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	975	1484	0.006738544	0.002695418	1	oligos	OL-Cntl	26	7	7
GCATGATGTTTGCATG-1_1_A4	14.10568582	16.06676184	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1176	1911	0.006279435	0.009419152	1	oligos	OL-Cntl	26	7	7
GCATGATTCAAGGTAA-1_1_A4	3.1082	11.45693727	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1166	1790	0.012849162	0.018994413	1	oligos	OL-Cntl	26	7	7
GCATGATTCATGGTCA-1_1_A4	31.46243521	16.17962915	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1175	1681	0.007138608	0.081499108	1	14	Microglia	26	7	7
GCATGCGAGAGTAATC-1_1_A4	15.42093481	12.83389839	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1597	2655	0.004896422	0.006779661	1	oligos	OL-Cntl	26	7	7
GCATGCGCAGCCTATA-1_1_A4	18.35686396	9.411622655	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1663	2931	0.009553054	0.006141249	1	oligos	OL-Cntl	26	7	7
GCATGCGGTACCGTAT-1_1_A4	-1.532114557	27.41229596	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	722	1066	0.008442777	0.005628518	1	oligos	OL-Cntl	26	7	7
GCATGCGTCATACGGT-1_1_A4	5.87787064	13.03616404	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1272	2022	0.023738872	0.020276954	1	oligos	OL-Cntl	26	7	7
GCATGTAAGATGAGAG-1_1_A4	-9.898479734	22.98389657	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2525	4333	0.009000692	0.008769905	1	8	Astrocytes	26	7	7
GCATGTAGTCGCGGTT-1_1_A4	12.79292521	7.009754298	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1700	3045	0.020689655	0.012151067	1	oligos	OL-Cntl	26	7	7
GCATGTAGTTAGTGGG-1_1_A4	-12.64196273	-18.06714699	6B	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1192	2164	0.036968577	0.004158965	1	6B	IN-SST	26	7	7
GCATGTATCAGGTAAA-1_1_A4	2.83491103	21.32702781	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	871	1338	0.002989537	0.007473842	1	oligos	OL-Cntl	26	7	7
GCATGTATCATCTGTT-1_1_A4	20.27645448	14.53406569	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1292	2195	0.004555809	0.006378132	1	oligos	OL-Cntl	26	7	7
GCATGTATCTCCAGGG-1_1_A4	-2.293925307	-1.605242622	13A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1471	2550	0.035294118	0.002745098	1	13A	IN-VIP	26	7	7
GCCAAATAGATGGGTC-1_1_A4	4.023568298	26.42401455	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	805	1193	0.027661358	0.003352892	1	oligos	OL-Cntl	26	7	7
GCCAAATAGTCTTGCA-1_1_A4	12.5430472	11.5143086	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1372	2163	0.01063338	0.014794267	1	oligos	OL-Cntl	26	7	7
GCCAAATCATCATCCC-1_1_A4	-1.815988787	27.28639972	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	685	1021	0.011753183	0.009794319	1	oligos	OL-Cntl	26	7	7
GCCAAATCATTTCAGG-1_1_A4	4.855924503	5.51970917	7	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1957	3339	0.014675052	0.005690326	1	7	Phagocytes	26	7	7
GCCAAATGTAGCACGA-1_1_A4	40.63137501	14.54160497	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1236	1842	0.017915309	0.019001086	1	14	Microglia	26	7	7
GCCAAATGTATAGGGC-1_1_A4	5.197645512	-13.67519372	4	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2659	5663	0.012714109	0.003531697	1	L2-3	EN-L2-3-MS	26	7	7
GCCAAATGTCAAACTC-1_1_A4	-22.2320577	28.88106566	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2312	5223	0.009764503	0.002871913	1	8	Astrocytes	26	7	7
GCCAAATGTTTAAGCC-1_1_A4	15.54929984	-6.278924415	10	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1527	2851	0.002455279	0.003858295	1	L2-3	EN-L2-3-Cntl	26	7	7
GCCAAATTCCTCAACC-1_1_A4	18.09074119	0.024300613	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1163	1870	0.003208556	0.004278075	1	12	EN-MIX	26	7	7
GCCAAATTCCTGCCAT-1_1_A4	13.94197054	6.390269601	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2136	4226	0.011594889	0.010411737	1	oligos	OL-Cntl	26	7	7
GCCTCTAAGAAACCGC-1_1_A4	-1.327994559	-1.01600152	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2752	6063	0.020616856	0.005277915	1	11	Glia-MIX	26	7	7
GCCTCTAAGGGATACC-1_1_A4	-6.005225269	-7.858866254	13A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1109	1680	0.020238095	0.005357143	1	13A	IN-VIP	26	7	7
GCCTCTAAGGGCTTGA-1_1_A4	-23.35224098	2.12613528	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	3373	6799	0.008089425	0.00661862	1	9	OPC	26	7	7
GCCTCTAAGTGGAGAA-1_1_A4	9.901340324	9.098876889	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1367	2220	0.013063063	0.018018018	1	oligos	OL-Cntl	26	7	7
GCCTCTACAACTGCTA-1_1_A4	13.49553068	21.24460042	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	892	1345	0.017100372	0.005947955	1	oligos	OL-Cntl	26	7	7
GCCTCTACACCTCGTT-1_1_A4	-36.15449426	-1.050014873	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1469	2643	0.00908059	0.005297011	1	9	OPC	26	7	7
GCCTCTAGTACTCTCC-1_1_A4	-22.37065515	23.74116171	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1454	2449	0.003266639	0.008166599	1	8	Astrocytes	26	7	7
GCCTCTAGTCAAGCGA-1_1_A4	14.03691212	6.784489872	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1802	3283	0.021017362	0.01096558	1	oligos	OL-Cntl	26	7	7
GCCTCTAGTCGAGTTT-1_1_A4	-11.01067764	9.415080576	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	3898	8024	0.008100698	0.004985045	1	11	Glia-MIX	26	7	7
GCCTCTAGTGGTACAG-1_1_A4	3.652517707	20.40600197	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	943	1438	0.011821975	0.010431154	1	oligos	OL-Cntl	26	7	7
GCCTCTATCAACACCA-1_1_A4	-9.769673448	22.74029238	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1528	2279	0.004826678	0.00833699	1	8	Astrocytes	26	7	7
GCGACCAAGCGTTGCC-1_1_A4	-24.22685547	0.316271307	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2258	4107	0.008765522	0.009982956	1	9	OPC	26	7	7
GCGACCACACCGAATT-1_1_A4	13.35480387	11.97920437	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1491	2422	0.007431874	0.012386457	1	oligos	OL-Cntl	26	7	7
GCGACCACATTAACCG-1_1_A4	-11.27562354	-22.03883731	6A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	913	1471	0.01903467	0.003399048	1	6A	IN-PV	26	7	7
GCGACCAGTATATCCG-1_1_A4	-9.136616677	19.1011391	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	3418	6977	0.008743013	0.004729827	1	11	Glia-MIX	26	7	7
GCGACCATCATGTCCC-1_1_A4	14.92807573	14.88010773	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1348	2236	0.004472272	0.005366726	1	oligos	OL-Cntl	26	7	7
GCGACCATCTTATCTG-1_1_A4	-31.8730502	-13.08262478	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	761	1164	0.006013746	0.001718213	1	9	OPC	26	7	7
GCGAGAAAGGAGTCTG-1_1_A4	-27.42810062	4.439258725	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2995	6303	0.00412502	0.003649056	1	9	OPC	26	7	7
GCGAGAAAGTTACCCA-1_1_A4	27.02851401	4.417214088	15BA	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	664	1031	0	0.004849661	1	15BA	Stromal cells	26	7	7
GCGAGAACAACTGGCC-1_1_A4	-20.8164068	30.85462512	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2857	6563	0.003199756	0.004418711	1	8	Astrocytes	26	7	7
GCGAGAACAGACGCTC-1_1_A4	16.09109096	17.15693862	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1073	1635	0.005504587	0.004892966	1	oligos	OL-Cntl	26	7	7
GCGAGAACAGCTGTTA-1_1_A4	-33.99826741	-13.32090538	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	790	1270	0.001574803	0.005511811	1	9	OPC	26	7	7
GCGAGAACAGTGGAGT-1_1_A4	-10.82501343	9.440713562	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	6676	20571	0.009965485	0.00709737	1	11	Glia-MIX	26	7	7
GCGAGAAGTATATGGA-1_1_A4	4.617235085	21.04841904	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	929	1432	0.01047486	0.005586592	1	oligos	OL-Cntl	26	7	7
GCGAGAAGTGAACCTT-1_1_A4	-9.409014712	17.4100636	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	3030	6302	0.012853063	0.008886068	1	11	Glia-MIX	26	7	7
GCGAGAATCATATCGG-1_1_A4	1.970731017	18.70811874	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	920	1442	0.009015257	0.013176144	1	oligos	OL-Cntl	26	7	7
GCGCAACAGACGCAAC-1_1_A4	15.18849757	20.99784865	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1057	1691	0.018332348	0.005322295	1	oligos	OL-Cntl	26	7	7
GCGCAACAGCGTTCCG-1_1_A4	15.7188403	-1.210238579	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	696	1054	0.008538899	0	1	12	EN-MIX	26	7	7
GCGCAACAGGGATCTG-1_1_A4	-37.1149637	1.434246188	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1672	3067	0.002934464	0.003260515	1	9	OPC	26	7	7
GCGCAACAGTGGAGTC-1_1_A4	12.8288062	20.28141721	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1094	1730	0.024277457	0.005202312	1	oligos	OL-Cntl	26	7	7
GCGCAACCAAGGGTCA-1_1_A4	7.123398128	25.33732448	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1031	1634	0.006731946	0.007343941	1	oligos	OL-Cntl	26	7	7
GCGCAACCACGAAACG-1_1_A4	19.75589369	18.95625109	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1040	1690	0.020710059	0.004733728	1	oligos	OL-Cntl	26	7	7
GCGCAACCACGTTGGC-1_1_A4	40.03054386	13.88813175	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1114	1627	0.005531653	0.005531653	1	14	Microglia	26	7	7
GCGCAACTCCCACTTG-1_1_A4	24.28734149	0.566936073	2	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1948	3975	0.000503145	0.003018868	1	2	EN-L4	26	7	7
GCGCAACTCCTGCAGG-1_1_A4	2.580456689	21.81765254	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	856	1254	0.003189793	0.009569378	1	oligos	OL-Cntl	26	7	7
GCGCAACTCTCTTGAT-1_1_A4	1.89073042	-5.570182859	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1068	1644	0.007907543	0.004257908	1	12	EN-MIX	26	7	7
GCGCAGTCACGAAAGC-1_1_A4	2.287711645	-6.281487352	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1091	1794	0.020624303	0.005016722	1	12	EN-MIX	26	7	7
GCGCAGTCACGTCTCT-1_1_A4	4.893979164	-5.220746	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	824	1294	0.01236476	0.00309119	1	12	EN-MIX	26	7	7
GCGCAGTGTCATATGC-1_1_A4	-23.08923052	26.00950831	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1713	3176	0.006297229	0.005352645	1	8	Astrocytes	26	7	7
GCGCAGTGTCGAGTTT-1_1_A4	16.56819157	1.794030032	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	829	1247	0.016038492	0.002405774	1	12	EN-MIX	26	7	7
GCGCAGTTCAAGGTAA-1_1_A4	0.659089449	29.28235978	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	705	1129	0.002657219	0.004428698	1	oligos	OL-Cntl	26	7	7
GCGCAGTTCACAATGC-1_1_A4	5.71765535	-14.86591379	4	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	3058	6742	0.00904776	0.004746366	1	L2-3	EN-L2-3-MS	26	7	7
GCGCAGTTCGAGAACG-1_1_A4	0.733666149	29.23881354	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	742	1071	0.010270775	0.001867414	1	oligos	OL-Cntl	26	7	7
GCGCAGTTCGTAGATC-1_1_A4	5.602688666	22.7939386	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	912	1385	0.015162455	0.007220217	1	oligos	OL-Cntl	26	7	7
GCGCCAAAGCAATCTC-1_1_A4	2.491701952	11.71060094	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1088	1865	0.011796247	0.009651475	1	oligos	OL-Cntl	26	7	7
GCGCCAAAGCTGAAAT-1_1_A4	14.47852964	18.10822623	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1101	1803	0.004991681	0.006655574	1	oligos	OL-Cntl	26	7	7
GCGCCAAAGGGAGTAA-1_1_A4	6.274261203	-8.538336708	4	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2220	4264	0.013602251	0.003517824	1	L2-3	EN-L2-3-MS	26	7	7
GCGCCAACACAGACTT-1_1_A4	16.26234113	6.312940384	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2246	4335	0.010380623	0.010841984	1	oligos	OL-Cntl	26	7	7
GCGCCAACACATTCGA-1_1_A4	21.01246101	10.92004003	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1702	2968	0.002021563	0.005727763	1	oligos	OL-Cntl	26	7	7
GCGCCAACACGGTTTA-1_1_A4	35.51624996	7.837233731	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1028	1503	0.013972056	0.008649368	1	14	Microglia	26	7	7
GCGCCAACACTTCGAA-1_1_A4	8.523177328	19.52992922	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1157	1807	0.011068069	0.006640841	1	oligos	OL-Cntl	26	7	7
GCGCCAACAGCAGTTT-1_1_A4	-21.4990501	27.72159976	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2189	4529	0.004857584	0.005961581	1	8	Astrocytes	26	7	7
GCGCCAACATTAGCCA-1_1_A4	6.863980651	-5.649925327	10	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1156	1940	0.013917526	0.002061856	1	L2-3	EN-L2-3-Cntl	26	7	7
GCGCCAAGTTACGTCA-1_1_A4	-10.9962791	7.474378791	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	5659	17126	0.004320916	0.00624781	1	11	Glia-MIX	26	7	7
GCGCCAAGTTCAGCGC-1_1_A4	6.41691639	-6.207996853	10	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1474	2568	0.007398754	0.004283489	1	L2-3	EN-L2-3-Cntl	26	7	7
GCGCCAATCAACACTG-1_1_A4	-10.04264089	23.10480308	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2117	3901	0.005895924	0.00563958	1	8	Astrocytes	26	7	7
GCGCCAATCACATGCA-1_1_A4	-2.380516	18.61892863	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1012	1648	0.012135922	0.005461165	1	oligos	OL-Cntl	26	7	7
GCGCCAATCAGCGACC-1_1_A4	0.135888859	24.61753295	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	719	1053	0.014245014	0.004748338	1	oligos	OL-Cntl	26	7	7
GCGCCAATCTCCGGTT-1_1_A4	-25.2532105	16.34423718	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1145	1847	0.011369789	0.007038441	1	8	Astrocytes	26	7	7
GCGCGATCAGCGATCC-1_1_A4	21.16306756	9.698881761	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1688	2902	0.00241213	0.007580979	1	oligos	OL-Cntl	26	7	7
GCGCGATGTCGCTTCT-1_1_A4	-6.773745586	11.83690591	5	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	653	1017	0.009832842	0.025565388	1	oligos	OL-MS-1	26	7	7
GCGGGTTAGATAGCAT-1_1_A4	0.442834101	28.55035019	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	710	1029	0	0.001943635	1	oligos	OL-Cntl	26	7	7
GCGGGTTAGTGTTAGA-1_1_A4	-5.010869727	2.829906303	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2800	5388	0.008166295	0.004268745	1	11	Glia-MIX	26	7	7
GCGGGTTCAATCCGAT-1_1_A4	39.14489586	16.17051269	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1712	2748	0.010917031	0.016375546	1	14	Microglia	26	7	7
GCGGGTTCACCATCCT-1_1_A4	7.251475639	-7.141991423	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1470	2728	0.000733138	0.002565982	1	12	EN-MIX	26	7	7
GCGGGTTGTGCATCTA-1_1_A4	15.25378789	19.9882227	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1079	1719	0.007562536	0.005235602	1	oligos	OL-Cntl	26	7	7
GCGGGTTTCACGCGGT-1_1_A4	18.44320326	9.093479833	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1702	3010	0.009966777	0.006312292	1	oligos	OL-Cntl	26	7	7
GCGGGTTTCTCGATGA-1_1_A4	21.84565534	-9.33069708	3	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1979	3936	0.011941057	0.003556911	1	3	EN-L5-6	26	7	7
GCTCCTAAGATCGATA-1_1_A4	-34.42279221	-11.20414913	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	864	1344	0.004464286	0.005952381	1	9	OPC	26	7	7
GCTCCTAAGGCCATAG-1_1_A4	20.4878396	14.02786042	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1381	2529	0.006722025	0.003558719	1	oligos	OL-Cntl	26	7	7
GCTCCTACACGGTTTA-1_1_A4	1.404662973	16.63369377	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1016	1582	0.003792668	0.013274336	1	oligos	OL-Cntl	26	7	7
GCTCCTAGTCAACATC-1_1_A4	20.05047358	1.49457959	2	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1300	2297	0.004788855	0.001741402	1	2	EN-L4	26	7	7
GCTCCTAGTTCGTTGA-1_1_A4	-24.54254888	17.47053399	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1521	2763	0.007238509	0.007238509	1	8	Astrocytes	26	7	7
GCTCCTATCCGCTGTT-1_1_A4	15.08604086	12.54248124	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1487	2561	0.010933229	0.008199922	1	oligos	OL-Cntl	26	7	7
GCTCCTATCTGAAAGA-1_1_A4	8.127525795	18.64930466	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1319	2298	0.006092254	0.006092254	1	oligos	OL-Cntl	26	7	7
GCTCTGTGTTCGGCAC-1_1_A4	-27.63684311	4.337663682	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2898	5695	0.001755926	0.004741001	1	9	OPC	26	7	7
GCTCTGTTCACGAAGG-1_1_A4	14.88252593	15.55517622	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1331	2140	0.014018692	0.010280374	1	oligos	OL-Cntl	26	7	7
GCTGCAGCAAGGACTG-1_1_A4	4.980419878	18.95095416	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	989	1545	0.012297735	0.013592233	1	oligos	OL-Cntl	26	7	7
GCTGCAGCACGAGGTA-1_1_A4	37.99323836	9.761043575	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	858	1162	0.00172117	0.006884682	1	14	Microglia	26	7	7
GCTGCAGGTAAATGTG-1_1_A4	-1.052664508	-0.511331839	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1985	3484	0.018082664	0.010907003	1	11	Glia-MIX	26	7	7
GCTGCAGGTTCCGGCA-1_1_A4	11.84418268	21.3619262	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	923	1440	0.004861111	0.011805556	1	oligos	OL-Cntl	26	7	7
GCTGCAGGTTCTGAAC-1_1_A4	12.2503737	10.06487315	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1509	2543	0.014549744	0.012583563	1	oligos	OL-Cntl	26	7	7
GCTGCAGTCACTTATC-1_1_A4	-23.29601785	26.33640015	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1677	3106	0.00257566	0.004185448	1	8	Astrocytes	26	7	7
GCTGCAGTCGCCTGTT-1_1_A4	4.116312404	20.1131108	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	897	1371	0.006564551	0.007293946	1	oligos	OL-Cntl	26	7	7
GCTGCGAAGATCCCGC-1_1_A4	12.38999732	15.53353716	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1215	1955	0.007672634	0.011253197	1	oligos	OL-Cntl	26	7	7
GCTGCGAAGGATGGAA-1_1_A4	-9.375333348	-20.41730672	6B	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	876	1501	0.051965356	0.00266489	1	6B	IN-SST	26	7	7
GCTGCGAAGTCAATAG-1_1_A4	4.045324969	-7.998492278	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1277	2034	0.006882989	0.005408063	1	12	EN-MIX	26	7	7
GCTGCGACAACGATGG-1_1_A4	14.25705839	19.70137494	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1096	1777	0.001688239	0.006752954	1	oligos	OL-Cntl	26	7	7
GCTGCGACATCGATGT-1_1_A4	-8.986756445	16.92329955	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	3370	7596	0.005265929	0.005924171	1	11	Glia-MIX	26	7	7
GCTGCGAGTCTGGTCG-1_1_A4	38.7754931	11.51349141	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	947	1305	0.009195402	0.010727969	1	14	Microglia	26	7	7
GCTGCGATCTCTGAGA-1_1_A4	-9.470730599	15.88060538	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2180	3810	0.005249344	0.008136483	1	11	Glia-MIX	26	7	7
GCTGCTTAGACTAGGC-1_1_A4	-1.171951349	28.61069598	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	748	1057	0.025543992	0.006622517	1	oligos	OL-Cntl	26	7	7
GCTGCTTAGTAACCCT-1_1_A4	38.52391051	9.62453654	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	770	1015	0.00591133	0.009852217	1	14	Microglia	26	7	7
GCTGCTTGTAAATACG-1_1_A4	-0.837741541	23.41078431	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	811	1164	0.006013746	0.004295533	1	oligos	OL-Cntl	26	7	7
GCTGCTTGTTCCGGCA-1_1_A4	14.34477858	6.18771043	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2099	3795	0.016073781	0.014229249	1	oligos	OL-Cntl	26	7	7
GCTGGGTAGCGCCTTG-1_1_A4	-20.97227952	30.71478575	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2502	5385	0.003528319	0.007056639	1	8	Astrocytes	26	7	7
GCTGGGTAGGATCGCA-1_1_A4	12.48808517	21.10108698	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1000	1572	0.003180662	0.013358779	1	oligos	OL-Cntl	26	7	7
GCTGGGTCATCACGTA-1_1_A4	-36.88545884	-0.445428708	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1405	2398	0.012093411	0.004170142	1	9	OPC	26	7	7
GCTGGGTGTAAATGTG-1_1_A4	6.115067981	19.63370109	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	999	1437	0.016005567	0.006263048	1	oligos	OL-Cntl	26	7	7
GCTGGGTGTTGTTTGG-1_1_A4	37.50444816	10.82217106	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	957	1324	0.009818731	0.015861027	1	14	Microglia	26	7	7
GCTGGGTTCCTAAGTG-1_1_A4	10.66341996	24.7131977	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	810	1274	0.007064364	0.006279435	1	oligos	OL-Cntl	26	7	7
GCTGGGTTCTTAACCT-1_1_A4	-19.80248608	31.31217391	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	4520	11406	0.005961775	0.004383658	1	8	Astrocytes	26	7	7
GCTTCCAAGACTCGGA-1_1_A4	21.58589624	18.1523881	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1153	1793	0.003346347	0.002788622	1	oligos	OL-Cntl	26	7	7
GCTTCCACAAGTACCT-1_1_A4	-25.52658646	19.08395852	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1603	2998	0.003002001	0.005336891	1	8	Astrocytes	26	7	7
GCTTCCACAGCCTTGG-1_1_A4	-8.129459946	-17.74108614	6B	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	703	1047	0.037249284	0.005730659	1	6B	IN-SST	26	7	7
GCTTCCACAGGTCGTC-1_1_A4	3.180782313	18.43289688	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	929	1358	0.008836524	0.013991163	1	oligos	OL-Cntl	26	7	7
GCTTCCACATACGCCG-1_1_A4	6.711645162	14.39355779	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1267	2084	0.019193858	0.011036468	1	oligos	OL-Cntl	26	7	7
GCTTCCATCAACACCA-1_1_A4	-5.118335759	-10.43384226	13B	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	839	1332	0.002252252	0.002252252	1	13B	IN-SV2C	26	7	7
GCTTCCATCCGTACAA-1_1_A4	12.28712828	21.86428693	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1021	1577	0.001268231	0.006975269	1	oligos	OL-Cntl	26	7	7
GCTTCCATCTGTCTCG-1_1_A4	-2.264925288	23.63388874	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	774	1058	0.017013233	0.007561437	1	oligos	OL-Cntl	26	7	7
GCTTGAAAGCAATATG-1_1_A4	15.29764379	-4.510585105	10	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1060	1738	0.004027618	0.003452244	1	L2-3	EN-L2-3-Cntl	26	7	7
GCTTGAAAGCCCAACC-1_1_A4	5.152812981	25.31147485	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	766	1175	0.004255319	0.005957447	1	oligos	OL-Cntl	26	7	7
GCTTGAAAGCGATCCC-1_1_A4	4.88171213	13.52890232	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1046	1599	0.003752345	0.02126329	1	oligos	OL-Cntl	26	7	7
GCTTGAACACTGTCGG-1_1_A4	5.456833801	24.29887522	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	860	1287	0.007770008	0.003885004	1	oligos	OL-Cntl	26	7	7
GCTTGAACATACTACG-1_1_A4	-18.62121642	24.68517854	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1990	3882	0.001030397	0.005924781	1	8	Astrocytes	26	7	7
GCTTGAAGTCCAACTA-1_1_A4	-4.639375974	21.73551652	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	690	1051	0.025689819	0.004757374	1	oligos	OL-Cntl	26	7	7
GCTTGAAGTTAAGACA-1_1_A4	15.3071328	17.86039181	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1046	1643	0.001217285	0.007303713	1	oligos	OL-Cntl	26	7	7
GCTTGAATCCAATGGT-1_1_A4	12.83976508	11.854299	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1335	2157	0.01483542	0.016689847	1	oligos	OL-Cntl	26	7	7
GCTTGAATCCGCTGTT-1_1_A4	36.75645399	11.98182497	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	959	1307	0.003060444	0.023718439	1	14	Microglia	26	7	7
GCTTGAATCGTGACAT-1_1_A4	15.75150465	-3.353547755	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1113	1931	0.002589332	0.002071466	1	12	EN-MIX	26	7	7
GGAAAGCCAACGCACC-1_1_A4	6.303570889	19.43503267	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1080	1617	0.01546073	0.011750155	1	oligos	OL-Cntl	26	7	7
GGAAAGCGTGTGTGCC-1_1_A4	-24.47516188	17.98580904	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1255	2144	0.005130597	0.006063433	1	8	Astrocytes	26	7	7
GGAAAGCTCAAAGTAG-1_1_A4	17.61271588	0.098961117	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	963	1603	0.001871491	0.001871491	1	12	EN-MIX	26	7	7
GGAAAGCTCAAGGTAA-1_1_A4	21.64479207	-8.854670598	3	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1812	3356	0.015196663	0.003277712	1	3	EN-L5-6	26	7	7
GGAAAGCTCTGCAAGT-1_1_A4	-25.87926951	22.74907139	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1333	2428	0.001235585	0.007413509	1	8	Astrocytes	26	7	7
GGAACTTAGAGTCGGT-1_1_A4	-28.12021672	9.15055332	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	799	1298	0.005392912	0.006933744	1	8	Astrocytes	26	7	7
GGAACTTAGATCCGAG-1_1_A4	-8.08105267	-5.404869865	13A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1672	2850	0.008421053	0.004210526	1	13A	IN-VIP	26	7	7
GGAACTTCAACTTGAC-1_1_A4	5.907141432	6.044271763	7	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2673	5056	0.006526899	0.006724684	1	7	Phagocytes	26	7	7
GGAACTTCACATGGGA-1_1_A4	16.70780448	15.62315101	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1158	1908	0.002620545	0.004716981	1	oligos	OL-Cntl	26	7	7
GGAACTTCACCCAGTG-1_1_A4	37.77055716	10.05212874	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	802	1110	0	0.010810811	1	14	Microglia	26	7	7
GGAACTTCAGTCAGCC-1_1_A4	21.44193562	17.81350331	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1218	1993	0.000501756	0.00652283	1	oligos	OL-Cntl	26	7	7
GGAACTTGTGTGGTTT-1_1_A4	35.69517172	7.794360431	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	904	1227	0.012224939	0.004889976	1	14	Microglia	26	7	7
GGAATAAAGAAGGCCT-1_1_A4	11.26340052	15.83069488	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1060	1742	0.007462687	0.008610792	1	oligos	OL-Cntl	26	7	7
GGAATAAAGATGTGGC-1_1_A4	7.134838204	19.79129265	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1103	1742	0.008610792	0.008036739	1	oligos	OL-Cntl	26	7	7
GGAATAAAGTGGACGT-1_1_A4	6.838475427	19.75434649	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	959	1417	0.011997177	0.009174312	1	oligos	OL-Cntl	26	7	7
GGAATAAAGTGGGTTG-1_1_A4	14.98204317	22.33930002	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	971	1524	0.002624672	0.002624672	1	oligos	OL-Cntl	26	7	7
GGAATAACACAGGCCT-1_1_A4	12.34903948	16.38118338	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1183	1910	0.015706806	0.006282723	1	oligos	OL-Cntl	26	7	7
GGAATAAGTCCAAGTT-1_1_A4	10.28193419	19.93444084	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	970	1492	0.002680965	0.006032172	1	oligos	OL-Cntl	26	7	7
GGAATAAGTCTCTCGT-1_1_A4	4.212440469	18.98261463	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	938	1407	0.010660981	0.017057569	1	oligos	OL-Cntl	26	7	7
GGAATAAGTGTCTGAT-1_1_A4	-4.448399866	-7.060347747	13A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	966	1484	0.028301887	0.008086253	1	13A	IN-VIP	26	7	7
GGAATAAGTTGTTTGG-1_1_A4	5.446402567	-3.224906967	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	968	1402	0.015691869	0.004279601	1	12	EN-MIX	26	7	7
GGACAAGAGTCACGCC-1_1_A4	-5.38414416	-10.14416211	13B	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	894	1314	0.023592085	0.002283105	1	13B	IN-SV2C	26	7	7
GGACAAGCACGAAAGC-1_1_A4	39.16248691	15.03189987	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1269	1836	0.005446623	0.008169935	1	14	Microglia	26	7	7
GGACAAGCATTTCAGG-1_1_A4	5.314886745	24.65933843	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	892	1340	0.023134328	0.005223881	1	oligos	OL-Cntl	26	7	7
GGACAAGTCTACTCAT-1_1_A4	-23.68146944	-0.191867348	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1897	3640	0.00521978	0.006043956	1	9	OPC	26	7	7
GGACAAGTCTGACCTC-1_1_A4	-18.5187571	6.672619221	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	839	1530	0.001960784	0.001960784	1	8	Astrocytes	26	7	7
GGACAGAAGTACACCT-1_1_A4	5.542904825	23.87031249	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	887	1380	0.014492754	0.007971014	1	oligos	OL-Cntl	26	7	7
GGACAGAGTCAATACC-1_1_A4	-4.345150778	17.94492235	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	883	1281	0.009367681	0.012490242	1	oligos	OL-Cntl	26	7	7
GGACAGATCGCTGATA-1_1_A4	-8.918084027	16.11233602	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2611	5159	0.010467145	0.006784261	1	11	Glia-MIX	26	7	7
GGACATTAGCTGTCTA-1_1_A4	3.156387556	-2.963358712	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	760	1111	0.01170117	0.00360036	1	12	EN-MIX	26	7	7
GGACATTCAGTTAACC-1_1_A4	6.283421589	13.60181548	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1272	2099	0.013339686	0.011434016	1	oligos	OL-Cntl	26	7	7
GGACATTGTATATGGA-1_1_A4	6.104740269	6.151204309	7	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	3053	6294	0.00651414	0.007308548	1	7	Phagocytes	26	7	7
GGACATTGTGGTAACG-1_1_A4	18.11644414	15.97444299	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1173	1928	0.004149378	0.005705394	1	oligos	OL-Cntl	26	7	7
GGACATTGTTATCACG-1_1_A4	0.864313737	25.72890276	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	894	1331	0.012772352	0.006010518	1	oligos	OL-Cntl	26	7	7
GGACATTTCCCAACGG-1_1_A4	-25.59410103	22.96908704	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1479	2731	0.004760161	0.003661662	1	8	Astrocytes	26	7	7
GGACATTTCTACTCAT-1_1_A4	-14.71558842	-21.45022785	6A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1719	3709	0.025613373	0.00485306	1	6A	IN-PV	26	7	7
GGACGTCCAAGTAATG-1_1_A4	13.68991799	20.15292913	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1035	1636	0.011613692	0.009168704	1	oligos	OL-Cntl	26	7	7
GGACGTCCACAAGTAA-1_1_A4	-16.76821718	5.031071601	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	900	2438	0.49466776	0.034864643	1	8	Astrocytes	26	7	7
GGACGTCCACCCATGG-1_1_A4	-11.09943518	-21.69545533	6A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	903	1581	0.04743833	0.001897533	1	6A	IN-PV	26	7	7
GGACGTCTCAACCAAC-1_1_A4	-10.76111308	-9.585236386	13B	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1316	2085	0.013429257	0.00383693	1	13B	IN-SV2C	26	7	7
GGACGTCTCTTATCTG-1_1_A4	-22.59616089	26.99681435	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1745	3323	0.005115859	0.004513993	1	8	Astrocytes	26	7	7
GGAGCAAAGTTACCCA-1_1_A4	6.039437162	24.97819141	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	953	1395	0.01218638	0.005734767	1	oligos	OL-Cntl	26	7	7
GGAGCAACAATCTGCA-1_1_A4	2.474248771	5.874378243	7	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1562	2369	0.008442381	0.010130857	1	7	Phagocytes	26	7	7
GGAGCAACACAACTGT-1_1_A4	-35.8702899	-4.985924457	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1250	2047	0.001465559	0.003908158	1	9	OPC	26	7	7
GGAGCAACAGCGTCCA-1_1_A4	15.5706719	12.78047961	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1436	2389	0.003348681	0.01046463	1	oligos	OL-Cntl	26	7	7
GGAGCAACATTACCTT-1_1_A4	-11.59719666	-22.44509	6A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1036	1758	0.001706485	0.001137656	1	6A	IN-PV	26	7	7
GGAGCAATCTCCCTGA-1_1_A4	-23.33545479	25.9113351	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1668	3232	0.004331683	0.006188119	1	8	Astrocytes	26	7	7
GGATGTTAGCCGTCGT-1_1_A4	3.024474274	-2.87303256	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	750	1096	0.010948905	0.004562044	1	12	EN-MIX	26	7	7
GGATGTTCAAGCTGTT-1_1_A4	-25.85248636	22.54389797	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1530	2772	0.007215007	0.007575758	1	8	Astrocytes	26	7	7
GGATGTTCACAGACAG-1_1_A4	37.65594388	8.998356999	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	760	1026	0.001949318	0.010721248	1	14	Microglia	26	7	7
GGATGTTGTCACAAGG-1_1_A4	-25.42893043	23.23888681	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1487	2585	0.007736944	0.007736944	1	8	Astrocytes	26	7	7
GGATGTTTCAAGCCTA-1_1_A4	2.60861105	6.195873088	7	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	982	1457	0.002059025	0.004804393	1	7	Phagocytes	26	7	7
GGATGTTTCCGAAGAG-1_1_A4	18.89270799	15.45389452	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1131	1915	0.006788512	0.00156658	1	oligos	OL-Cntl	26	7	7
GGATGTTTCTGCTGCT-1_1_A4	15.04406456	17.2771332	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1082	1769	0.009609949	0.005652911	1	oligos	OL-Cntl	26	7	7
GGATTACAGCCACGTC-1_1_A4	5.571312235	28.8399924	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	692	1026	0.000974659	0.003898635	1	oligos	OL-Cntl	26	7	7
GGATTACAGCCGCCTA-1_1_A4	17.50804239	0.596866171	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	873	1437	0.020876827	0.001391788	1	12	EN-MIX	26	7	7
GGATTACAGGAACTGC-1_1_A4	-34.07468696	-10.96181365	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	892	1351	0.00296077	0.002220577	1	9	OPC	26	7	7
GGATTACCACTGAAGG-1_1_A4	-1.132073579	24.72988694	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	731	1013	0.005923001	0.005923001	1	oligos	OL-Cntl	26	7	7
GGATTACGTCGTCTTC-1_1_A4	21.16844256	17.82794966	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1209	1990	0.005527638	0.005527638	1	oligos	OL-Cntl	26	7	7
GGATTACTCACCCTCA-1_1_A4	-25.65096504	20.70550534	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1687	3313	0.001207365	0.001811047	1	8	Astrocytes	26	7	7
GGATTACTCAGCGACC-1_1_A4	-24.71652889	26.59884467	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1760	3596	0.002780868	0.006395996	1	8	Astrocytes	26	7	7
GGCAATTCAGACGCCT-1_1_A4	-37.58111268	-5.114494453	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1248	2127	0.002820874	0.005641749	1	9	OPC	26	7	7
GGCAATTCAGTTAACC-1_1_A4	18.02903825	18.96195414	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1050	1704	0.007629108	0.004694836	1	oligos	OL-Cntl	26	7	7
GGCAATTGTCATACTG-1_1_A4	-27.61165143	18.12573112	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1168	2156	0.001855288	0.003246753	1	8	Astrocytes	26	7	7
GGCAATTGTCTAACGT-1_1_A4	18.94468143	14.91564017	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1282	2254	0.008873114	0.004880213	1	oligos	OL-Cntl	26	7	7
GGCAATTGTTATCCGA-1_1_A4	39.51864324	10.49748097	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	772	1101	0	0.007266122	1	14	Microglia	26	7	7
GGCAATTGTTCAGTAC-1_1_A4	37.91340322	8.891557378	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	740	1037	0.010607522	0.018322083	1	14	Microglia	26	7	7
GGCAATTTCACGATGT-1_1_A4	9.67900356	-14.5659943	4	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	3703	9224	0.012033825	0.018647008	1	L2-3	EN-L2-3-MS	26	7	7
GGCAATTTCGCAAACT-1_1_A4	16.7400285	27.53151459	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	851	1309	0.003055768	0.004583652	1	oligos	OL-Cntl	26	7	7
GGCAATTTCGGTGTCG-1_1_A4	12.25331923	8.432032588	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1688	3098	0.008069722	0.011297611	1	oligos	OL-Cntl	26	7	7
GGCCGATAGTCATGCT-1_1_A4	15.52743259	-4.263909564	10	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1105	1993	0.002007025	0.001505268	1	L2-3	EN-L2-3-Cntl	26	7	7
GGCCGATAGTCTCGGC-1_1_A4	38.44670957	11.55888405	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	925	1279	0.007818608	0.021110242	1	14	Microglia	26	7	7
GGCCGATCAAGCGCTC-1_1_A4	14.63158276	23.22532651	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	832	1193	0.005867561	0.004191115	1	oligos	OL-Cntl	26	7	7
GGCCGATGTATGCTTG-1_1_A4	-23.11246618	26.49531543	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1850	3386	0.005611341	0.005020673	1	8	Astrocytes	26	7	7
GGCCGATGTGGTCTCG-1_1_A4	-23.04807739	25.73256233	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1816	3411	0.001172677	0.003811199	1	8	Astrocytes	26	7	7
GGCCGATTCAAAGACA-1_1_A4	39.83126249	12.96514591	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1012	1399	0.002859185	0.013581129	1	14	Microglia	26	7	7
GGCCGATTCATAACCG-1_1_A4	-11.47291227	-3.289622275	13A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2472	4979	0.021289416	0.008636272	1	13A	IN-VIP	26	7	7
GGCCGATTCGAATGGG-1_1_A4	-13.82968739	-10.75803571	13B	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2096	4332	0.005540166	0.001154201	1	13B	IN-SV2C	26	7	7
GGCGACTAGAATCTCC-1_1_A4	14.76627036	16.55925708	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1155	1804	0.003325942	0.007760532	1	oligos	OL-Cntl	26	7	7
GGCGACTAGAGTACAT-1_1_A4	15.93385347	16.57622966	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1317	2229	0.011664424	0.00807537	1	oligos	OL-Cntl	26	7	7
GGCGACTAGATAGGAG-1_1_A4	-0.637000424	22.62493749	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	783	1155	0.006060606	0.006060606	1	oligos	OL-Cntl	26	7	7
GGCGACTAGCATGGCA-1_1_A4	17.76931419	0.926192919	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	922	1393	0.00143575	0.003589375	1	12	EN-MIX	26	7	7
GGCGACTCAACTGCTA-1_1_A4	15.52875216	-7.789616942	10	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1981	4239	0.004718094	0.00802076	1	L2-3	EN-L2-3-Cntl	26	7	7
GGCGACTGTACAAGTA-1_1_A4	6.225838813	25.45325591	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	867	1302	0.005376344	0.004608295	1	oligos	OL-Cntl	26	7	7
GGCGACTGTCCCTTGT-1_1_A4	-1.266101198	25.08660353	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	692	1003	0.032901296	0.004985045	1	oligos	OL-Cntl	26	7	7
GGCGACTGTCGAATCT-1_1_A4	2.862759793	4.582536389	7	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1252	1828	0.010393873	0.008205689	1	7	Phagocytes	26	7	7
GGCGACTTCGGGAGTA-1_1_A4	13.51525545	28.54029926	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	812	1229	0.00081367	0.013832384	1	oligos	OL-Cntl	26	7	7
GGCGTGTGTCTCTTAT-1_1_A4	2.102565557	24.55824051	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	810	1229	0.005695688	0.004882018	1	oligos	OL-Cntl	26	7	7
GGCGTGTGTGCACGAA-1_1_A4	-11.09868778	9.147187311	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	4806	11794	0.011616076	0.007122266	1	11	Glia-MIX	26	7	7
GGCGTGTGTTCCGTCT-1_1_A4	37.42559483	9.308197944	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	745	1000	0.002	0.012	1	14	Microglia	26	7	7
GGCGTGTTCATAACCG-1_1_A4	-10.48573099	18.64624618	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	3010	6459	0.002941632	0.002786809	1	11	Glia-MIX	26	7	7
GGCGTGTTCCACGTGG-1_1_A4	4.452675209	-3.7591471	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	962	1371	0.008752735	0.006564551	1	12	EN-MIX	26	7	7
GGCTCGAAGCTAGTCT-1_1_A4	-26.51369345	23.36355295	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1359	2342	0.002988898	0.009820666	1	8	Astrocytes	26	7	7
GGCTCGAAGTAGGTGC-1_1_A4	-2.839850757	25.17613469	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	891	1430	0.004195804	0.00979021	1	oligos	OL-Cntl	26	7	7
GGCTCGACACTCGACG-1_1_A4	11.51494502	17.06958736	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1042	1660	0.005421687	0.007228916	1	oligos	OL-Cntl	26	7	7
GGCTCGAGTAGCGTCC-1_1_A4	-0.446070813	28.29083839	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	787	1126	0.007104796	0.008880995	1	oligos	OL-Cntl	26	7	7
GGCTCGATCAACGAAA-1_1_A4	17.0170514	-5.159189834	3	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1322	2359	0.000423908	0.003391267	1	3	EN-L5-6	26	7	7
GGCTCGATCAGTTGAC-1_1_A4	-4.91767175	-4.57700204	13A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1264	2183	0.029775538	0.004122767	1	13A	IN-VIP	26	7	7
GGCTCGATCCCATTAT-1_1_A4	-36.13248781	1.523408441	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1715	3222	0.001862197	0.005276226	1	9	OPC	26	7	7
GGCTGGTAGAATTGTG-1_1_A4	5.335322502	23.92191649	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	914	1325	0.00754717	0.00754717	1	oligos	OL-Cntl	26	7	7
GGCTGGTAGTTGAGAT-1_1_A4	-11.1212524	-4.596659751	13A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2061	3771	0.020153805	0.010076903	1	13A	IN-VIP	26	7	7
GGCTGGTCAAGCTGTT-1_1_A4	-11.18749882	-0.76408638	13A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2657	5532	0.002169197	0.007772957	1	13A	IN-VIP	26	7	7
GGCTGGTCACACCGCA-1_1_A4	-10.03155629	23.09581215	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2275	4214	0.005695301	0.01067869	1	8	Astrocytes	26	7	7
GGCTGGTCATCCAACA-1_1_A4	14.3505278	7.959765417	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1696	2915	0.005145798	0.010977702	1	oligos	OL-Cntl	26	7	7
GGCTGGTCATGCAACT-1_1_A4	4.920921488	31.2188625	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	727	1083	0.014773777	0.002770083	1	oligos	OL-Cntl	26	7	7
GGCTGGTGTAGCGCTC-1_1_A4	3.034633587	-3.035187022	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	828	1225	0.007346939	0	1	12	EN-MIX	26	7	7
GGCTGGTGTATAATGG-1_1_A4	11.50818494	11.86853622	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1272	2026	0.01727542	0.011846002	1	oligos	OL-Cntl	26	7	7
GGCTGGTGTGATGATA-1_1_A4	14.04102798	20.16765407	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1003	1522	0.008541393	0.009855453	1	oligos	OL-Cntl	26	7	7
GGCTGGTTCTAACCGA-1_1_A4	-2.18194988	19.12573988	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	834	1324	0.006042296	0.006797583	1	oligos	OL-Cntl	26	7	7
GGGAATGAGAGGGCTT-1_1_A4	15.95330699	14.0837418	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1329	2146	0.011649581	0.010251631	1	oligos	OL-Cntl	26	7	7
GGGAATGAGTACCGGA-1_1_A4	-23.54151407	0.646571038	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2138	3875	0.001290323	0.005935484	1	9	OPC	26	7	7
GGGAATGCAGTGGAGT-1_1_A4	-2.355104278	23.31733767	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	875	1288	0.007763975	0.013198758	1	oligos	OL-Cntl	26	7	7
GGGAATGGTGATGCCC-1_1_A4	-22.26564479	26.08595182	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1695	3134	0.00319081	0.006381621	1	8	Astrocytes	26	7	7
GGGAATGTCTCGTATT-1_1_A4	-0.511502603	22.23478407	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	726	1100	0.002727273	0.011818182	1	oligos	OL-Cntl	26	7	7
GGGACCTAGAGGTTGC-1_1_A4	0.130141892	2.186515797	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	901	1297	0.01464919	0.00539707	1	11	Glia-MIX	26	7	7
GGGACCTAGGAGTACC-1_1_A4	-28.21755028	9.252779224	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	787	1149	0.002610966	0.006092254	1	8	Astrocytes	26	7	7
GGGACCTCACGCTTTC-1_1_A4	6.444040815	6.361995097	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2644	5461	0.009155832	0.007507782	1	oligos	OL-Cntl	26	7	7
GGGACCTCACTCAGGC-1_1_A4	16.77418358	-0.489871835	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	841	1277	0.002349256	0.003132341	1	12	EN-MIX	26	7	7
GGGACCTCAGGGAGAG-1_1_A4	32.97087776	13.522278	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1422	1988	0.006036217	0.016599598	1	14	Microglia	26	7	7
GGGACCTCATAAAGGT-1_1_A4	4.795491128	5.334029696	7	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1793	2965	0.006745363	0.005733558	1	7	Phagocytes	26	7	7
GGGACCTGTCATATGC-1_1_A4	18.02922114	14.98820659	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1305	2258	0.006200177	0.005314438	1	oligos	OL-Cntl	26	7	7
GGGACCTGTCATCGGC-1_1_A4	3.47470177	28.90736747	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	708	1068	0.002808989	0.002808989	1	oligos	OL-Cntl	26	7	7
GGGACCTGTGTTGAGG-1_1_A4	37.34645382	10.90283371	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	860	1204	0.01744186	0.01744186	1	14	Microglia	26	7	7
GGGACCTTCGGTTCGG-1_1_A4	38.10036109	8.8592803	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	742	1012	0.000988142	0.005928854	1	14	Microglia	26	7	7
GGGACCTTCTAACGGT-1_1_A4	-13.24928035	-23.95767614	6A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1281	2461	0.011783828	0.002844372	1	6A	IN-PV	26	7	7
GGGAGATCACCAGCAC-1_1_A4	16.96985434	14.62117343	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1250	2026	0.003948667	0.005923001	1	oligos	OL-Cntl	26	7	7
GGGAGATCAGGAATCG-1_1_A4	-23.77005468	26.22049112	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1551	2683	0.008199776	0.002236303	1	8	Astrocytes	26	7	7
GGGAGATGTCCGAATT-1_1_A4	15.01367926	12.21869865	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1561	2505	0.004790419	0.009580838	1	oligos	OL-Cntl	26	7	7
GGGAGATGTCTAGTCA-1_1_A4	21.45205007	15.75218083	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1344	2197	0.007737824	0.009103323	1	oligos	OL-Cntl	26	7	7
GGGAGATGTTCATGGT-1_1_A4	1.782870198	10.92328572	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1133	1856	0.021012931	0.016702586	1	oligos	OL-Cntl	26	7	7
GGGATGAAGTAGCCGA-1_1_A4	-23.33998838	19.75759675	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1713	3174	0.006931317	0.006616257	1	8	Astrocytes	26	7	7
GGGATGAAGTTATCGC-1_1_A4	17.5495863	1.464431649	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	947	1442	0.014563107	0.001386963	1	12	EN-MIX	26	7	7
GGGATGATCAACACGT-1_1_A4	-23.72652352	19.61038631	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1659	3097	0.004843397	0.006780756	1	8	Astrocytes	26	7	7
GGGATGATCCTTGACC-1_1_A4	37.69594803	9.767795478	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	848	1176	0.008503401	0.008503401	1	14	Microglia	26	7	7
GGGATGATCGACCAGC-1_1_A4	6.389373735	20.32914569	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	945	1490	0.009395973	0.006711409	1	oligos	OL-Cntl	26	7	7
GGGCACTAGCACAGGT-1_1_A4	-0.550308307	27.39467908	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	763	1139	0.012291484	0.004389816	1	oligos	OL-Cntl	26	7	7
GGGCACTCACGAAGCA-1_1_A4	13.6619969	16.33374305	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1147	1889	0.003705664	0.012175754	1	oligos	OL-Cntl	26	7	7
GGGCACTGTACCGGCT-1_1_A4	2.960448408	6.506040695	7	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1207	1782	0.005050505	0.002244669	1	7	Phagocytes	26	7	7
GGGCACTGTCCGTTAA-1_1_A4	-25.03478623	16.71618403	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1200	1987	0.001006543	0.003019628	1	8	Astrocytes	26	7	7
GGGCACTGTGACCAAG-1_1_A4	-21.12965929	23.65921232	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1578	3012	0.002988048	0.006640106	1	8	Astrocytes	26	7	7
GGGCACTGTTATCACG-1_1_A4	-27.35621542	4.283953014	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2825	6019	0.003655092	0.003987373	1	9	OPC	26	7	7
GGGCACTTCATTATCC-1_1_A4	15.15741173	2.938133702	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	890	1436	0.003481894	0.002089136	1	12	EN-MIX	26	7	7
GGGCACTTCCTTTCTC-1_1_A4	15.69786831	12.66079185	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1377	2369	0.007598143	0.003799071	1	oligos	OL-Cntl	26	7	7
GGGCACTTCTCCTATA-1_1_A4	19.33843686	20.11540184	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1078	1814	0	0.004410143	1	oligos	OL-Cntl	26	7	7
GGGCATCAGTACCGGA-1_1_A4	32.95827004	-16.78106379	2	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	6050	17123	0.020732348	0.009168954	1	2	EN-L4	26	7	7
GGGCATCAGTCCGTAT-1_1_A4	19.61893108	17.62401647	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1215	1977	0.02276176	0.009104704	1	oligos	OL-Cntl	26	7	7
GGGCATCAGTTACCCA-1_1_A4	38.08198239	9.502200246	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	774	1069	0.000935454	0.008419083	1	14	Microglia	26	7	7
GGGCATCAGTTACGGG-1_1_A4	-35.62360201	-4.919162889	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1308	2105	0.003800475	0.003800475	1	9	OPC	26	7	7
GGGCATCCACCGAAAG-1_1_A4	1.146498592	-7.513324185	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1308	2136	0.001872659	0.002808989	1	12	EN-MIX	26	7	7
GGGCATCCATACGCCG-1_1_A4	-4.41231666	25.38226124	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	709	1144	0.007867133	0.006118881	1	oligos	OL-Cntl	26	7	7
GGGCATCCATGCGCAC-1_1_A4	4.011100814	27.31999993	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	774	1156	0.002595156	0.00432526	1	oligos	OL-Cntl	26	7	7
GGGCATCGTTCGGGCT-1_1_A4	-0.671883054	23.74925277	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	733	1105	0.004524887	0.009049774	1	oligos	OL-Cntl	26	7	7
GGGCATCTCAGCAACT-1_1_A4	17.2127618	10.5319551	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1730	3130	0.010223642	0.006709265	1	oligos	OL-Cntl	26	7	7
GGGCATCTCTTTAGGG-1_1_A4	-11.12970581	19.02606693	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	3060	6596	0.002728927	0.006519102	1	11	Glia-MIX	26	7	7
GGGTCTGAGTCCGGTC-1_1_A4	4.090043938	20.70303312	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	915	1394	0.017216643	0.005738881	1	oligos	OL-Cntl	26	7	7
GGGTCTGAGTGTGAAT-1_1_A4	-25.04117731	15.74621916	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1073	1677	0.011329756	0.004770423	1	8	Astrocytes	26	7	7
GGGTCTGGTCCGTCAG-1_1_A4	39.05780959	14.1733528	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1090	1519	0.004608295	0.01843318	1	14	Microglia	26	7	7
GGGTCTGGTGAGGCTA-1_1_A4	5.684320194	24.78724673	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	842	1259	0.006354249	0.007148531	1	oligos	OL-Cntl	26	7	7
GGGTCTGGTGCTTCTC-1_1_A4	6.077488692	-5.725396694	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1005	1689	0.005328597	0.000592066	1	12	EN-MIX	26	7	7
GGGTTGCAGTAGGCCA-1_1_A4	4.438859625	5.506943217	7	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1675	2650	0.024150943	0.005283019	1	7	Phagocytes	26	7	7
GGGTTGCCAAGCGAGT-1_1_A4	7.481173345	23.84101478	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1094	1672	0.009569378	0.003588517	1	oligos	OL-Cntl	26	7	7
GGGTTGCGTTACAGAA-1_1_A4	2.345573843	21.9945572	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	995	1482	0.011470985	0.014844804	1	oligos	OL-Cntl	26	7	7
GGGTTGCGTTCGCTAA-1_1_A4	6.903761202	15.32989056	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1147	1938	0.01496388	0.009287926	1	oligos	OL-Cntl	26	7	7
GGGTTGCTCATGTCTT-1_1_A4	-23.44676683	19.64615896	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1413	2386	0.001257334	0.011735122	1	8	Astrocytes	26	7	7
GGTATTGAGACAATAC-1_1_A4	15.94174613	1.613226108	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	761	1081	0.011100833	0.002775208	1	12	EN-MIX	26	7	7
GGTATTGCAACTGCGC-1_1_A4	20.08270896	17.73854504	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1151	1839	0.007069059	0.002175095	1	oligos	OL-Cntl	26	7	7
GGTATTGCACCCTATC-1_1_A4	11.36041494	23.19850387	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	916	1459	0.015078821	0.005483208	1	oligos	OL-Cntl	26	7	7
GGTATTGCATTGAGCT-1_1_A4	-3.534701496	-6.298602148	13A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1054	1856	0.026939655	0.003232759	1	13A	IN-VIP	26	7	7
GGTATTGTCCGTCATC-1_1_A4	4.230594502	-5.187830252	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	869	1321	0.008327025	0.001514005	1	12	EN-MIX	26	7	7
GGTATTGTCTTATCTG-1_1_A4	7.645475498	14.28427945	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1150	1927	0.026466009	0.013492475	1	oligos	OL-Cntl	26	7	7
GGTGAAGAGAAGGCCT-1_1_A4	18.09183667	1.716733892	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	992	1480	0	0.004054054	1	12	EN-MIX	26	7	7
GGTGAAGAGCACCGTC-1_1_A4	17.34735442	0.293146815	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	864	1355	0.007380074	0.002214022	1	12	EN-MIX	26	7	7
GGTGAAGAGGGTTTCT-1_1_A4	-6.856605886	-4.097043873	13A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1772	3335	0.029685157	0.005997001	1	13A	IN-VIP	26	7	7
GGTGAAGCAATCCAAC-1_1_A4	8.349730431	18.8567476	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1277	2048	0.006835938	0.004394531	1	oligos	OL-Cntl	26	7	7
GGTGAAGCATAACCTG-1_1_A4	14.07180086	20.29169787	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1024	1602	0.003745318	0.008739076	1	oligos	OL-Cntl	26	7	7
GGTGAAGCATTGGCGC-1_1_A4	14.59201137	20.22649684	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1066	1648	0.013349515	0.005461165	1	oligos	OL-Cntl	26	7	7
GGTGCGTAGAAGATTC-1_1_A4	-3.858724522	22.95538773	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	705	1088	0.007352941	0.009191176	1	oligos	OL-Cntl	26	7	7
GGTGCGTAGCATCATC-1_1_A4	7.785599084	-7.266450748	10	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1496	2790	0.002867384	0.001792115	1	L2-3	EN-L2-3-Cntl	26	7	7
GGTGCGTCAACTGCTA-1_1_A4	-26.60240978	1.787656347	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1265	1876	0.005863539	0.007462687	1	9	OPC	26	7	7
GGTGCGTCATCATCCC-1_1_A4	2.929603248	19.04989739	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	857	1298	0.006163328	0.00770416	1	oligos	OL-Cntl	26	7	7
GGTGCGTGTCAGGACA-1_1_A4	2.228147777	21.04926159	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	976	1518	0.0085639	0.009222661	1	oligos	OL-Cntl	26	7	7
GGTGCGTGTCTAGAGG-1_1_A4	-7.670382904	8.845426807	5	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	791	1376	0.01744186	0.010901163	1	oligos	OL-MS-1	26	7	7
GGTGCGTGTGTCCTCT-1_1_A4	4.474045311	25.61257625	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	811	1167	0.016281063	0.005141388	1	oligos	OL-Cntl	26	7	7
GGTGCGTTCAACACCA-1_1_A4	15.36900907	-7.832497596	10	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1917	3768	0.009819533	0.005042463	1	L2-3	EN-L2-3-Cntl	26	7	7
GGTGCGTTCGAGAACG-1_1_A4	6.132959568	19.50771397	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1096	1637	0.021380574	0.012217471	1	oligos	OL-Cntl	26	7	7
GGTGCGTTCGGTTAAC-1_1_A4	38.16924877	10.61692854	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	763	1020	0.011764706	0.016666667	1	14	Microglia	26	7	7
GGTGTTAAGCGTCTAT-1_1_A4	-36.98485647	-6.489862514	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1238	2026	0.004935834	0.000493583	1	9	OPC	26	7	7
GGTGTTAAGGATGTAT-1_1_A4	-4.478947451	19.36456139	5	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	790	1094	0.020109689	0.008226691	1	oligos	OL-MS-1	26	7	7
GGTGTTAAGGGAAACA-1_1_A4	17.31822566	1.684656572	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	906	1368	0.010964912	0.005116959	1	12	EN-MIX	26	7	7
GGTGTTAAGGTGTGGT-1_1_A4	-23.22083684	2.332127604	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	4489	10634	0.007334963	0.009121685	1	11	Glia-MIX	26	7	7
GGTGTTACAAGCCGTC-1_1_A4	15.0904297	15.89499829	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1214	1912	0.004707113	0.007322176	1	oligos	OL-Cntl	26	7	7
GGTGTTATCAAACCGT-1_1_A4	5.708208572	16.60087824	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1099	1686	0.020759193	0.008303677	1	oligos	OL-Cntl	26	7	7
GGTGTTATCCAGATCA-1_1_A4	4.349593945	5.198969149	7	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1569	2399	0.021675698	0.010004168	1	7	Phagocytes	26	7	7
GGTGTTATCGTAGGAG-1_1_A4	33.22051492	-4.161957592	2	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	3000	6291	0.006040375	0.005245589	1	2	EN-L4	26	7	7
GGTGTTATCTGCCCTA-1_1_A4	-2.539039676	25.14386898	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	767	1197	0.008354219	0.010025063	1	oligos	OL-Cntl	26	7	7
GTAACGTCACTACAGT-1_1_A4	0.358216178	29.11726966	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	703	1011	0.003956479	0.002967359	1	oligos	OL-Cntl	26	7	7
GTAACGTCATGATCCA-1_1_A4	13.80639175	6.675212732	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1796	3252	0.018450185	0.012300123	1	oligos	OL-Cntl	26	7	7
GTAACGTTCCCAAGTA-1_1_A4	18.47971568	12.33228306	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1283	2034	0.004916421	0.003933137	1	oligos	OL-Cntl	26	7	7
GTAACTGAGAGATGAG-1_1_A4	-27.84665116	18.12760601	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1172	1991	0.004520342	0.005022602	1	8	Astrocytes	26	7	7
GTAACTGAGTACGCGA-1_1_A4	5.329272867	17.52363311	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	954	1438	0.006954103	0.016689847	1	oligos	OL-Cntl	26	7	7
GTAACTGCACTCAGGC-1_1_A4	-10.01242825	23.00657102	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2073	3663	0.004641005	0.004095004	1	8	Astrocytes	26	7	7
GTAACTGGTCGCTTCT-1_1_A4	15.54391187	-6.01559678	10	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1410	2642	0.008705526	0.002649508	1	L2-3	EN-L2-3-Cntl	26	7	7
GTAACTGTCAACCATG-1_1_A4	-10.87937126	9.304570934	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	7829	30541	0.00753086	0.006548574	1	11	Glia-MIX	26	7	7
GTAACTGTCTGTTTGT-1_1_A4	-9.470168278	15.97096486	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2015	3277	0.0042722	0.006103143	1	11	Glia-MIX	26	7	7
GTAACTGTCTTAACCT-1_1_A4	-23.21141556	1.903122206	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	3507	7975	0.007899687	0.004890282	1	11	Glia-MIX	26	7	7
GTACGTAAGCCACTAT-1_1_A4	5.79190831	21.4332029	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	873	1339	0.005974608	0.008961912	1	oligos	OL-Cntl	26	7	7
GTACGTAAGCTTCGCG-1_1_A4	-3.193381151	21.07742829	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	734	1019	0.014720314	0.021589794	1	oligos	OL-Cntl	26	7	7
GTACGTAAGGGTTTCT-1_1_A4	38.36306294	10.58354791	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	760	1046	0.01625239	0.01625239	1	14	Microglia	26	7	7
GTACGTAAGTGCAAGC-1_1_A4	-0.065463855	22.20379868	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	810	1201	0.01582015	0.009991674	1	oligos	OL-Cntl	26	7	7
GTACGTACAAATTGCC-1_1_A4	5.891246086	15.41007224	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1116	1783	0.005047672	0.012338755	1	oligos	OL-Cntl	26	7	7
GTACGTACAATGTTGC-1_1_A4	-24.45508683	26.31158918	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1486	2668	0.004122939	0.004872564	1	8	Astrocytes	26	7	7
GTACGTACACCAGGCT-1_1_A4	-1.38418185	-1.314738223	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1883	3561	0.02302724	0.00393148	1	11	Glia-MIX	26	7	7
GTACGTACAGATGGCA-1_1_A4	5.022781317	17.28407426	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	886	1327	0.008289375	0.009042954	1	oligos	OL-Cntl	26	7	7
GTACGTACAGCGTAAG-1_1_A4	6.070287786	6.324326178	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2377	4188	0.010506208	0.004297994	1	oligos	OL-Cntl	26	7	7
GTACGTACAGCTTAAC-1_1_A4	-26.32303955	18.09396638	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1197	2079	0.003848004	0.002405002	1	8	Astrocytes	26	7	7
GTACGTACATCTCGCT-1_1_A4	-11.31691964	-22.09053222	6A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	914	1532	0.018929504	0.001958225	1	6A	IN-PV	26	7	7
GTACGTAGTACAGTTC-1_1_A4	-10.34317946	15.94474405	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2000	3347	0.005676725	0.00537795	1	11	Glia-MIX	26	7	7
GTACGTAGTACGCACC-1_1_A4	15.6156335	-2.016526134	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	879	1391	0.003594536	0.003594536	1	12	EN-MIX	26	7	7
GTACGTAGTTACGTCA-1_1_A4	4.562042358	20.8851005	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	845	1278	0.024256651	0.003912363	1	oligos	OL-Cntl	26	7	7
GTACGTATCGGTTCGG-1_1_A4	22.28702417	13.39533171	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1433	2401	0.011661808	0.002915452	1	oligos	OL-Cntl	26	7	7
GTACGTATCGTTGCCT-1_1_A4	-32.17214131	-12.37361462	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	925	1371	0.003646973	0.007293946	1	9	OPC	26	7	7
GTACGTATCTTCGAGA-1_1_A4	-11.63003609	17.97363965	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1787	3233	0.000927931	0.004948964	1	11	Glia-MIX	26	7	7
GTACTCCAGAAACCAT-1_1_A4	-8.994156027	-19.98304896	6B	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	798	1346	0.03268945	0.002228826	1	6B	IN-SST	26	7	7
GTACTCCAGCTGTTCA-1_1_A4	5.606901558	23.77505565	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	882	1357	0.010316875	0.011053795	1	oligos	OL-Cntl	26	7	7
GTACTCCAGTGTCTCA-1_1_A4	-9.191544674	15.64879968	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2220	3818	0.005500262	0.01231011	1	11	Glia-MIX	26	7	7
GTACTCCCAAAGTCAA-1_1_A4	7.027451736	21.05820978	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	990	1533	0.006523157	0.00456621	1	oligos	OL-Cntl	26	7	7
GTACTCCGTAAAGGAG-1_1_A4	-33.36777086	-11.33523442	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	943	1492	0.003351206	0.004021448	1	9	OPC	26	7	7
GTACTCCTCGAATCCA-1_1_A4	2.868818712	25.5445018	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	813	1201	0.010824313	0.007493755	1	oligos	OL-Cntl	26	7	7
GTACTCCTCTTTAGTC-1_1_A4	14.83392767	16.85032596	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1140	1799	0.009449694	0.010005559	1	oligos	OL-Cntl	26	7	7
GTACTTTAGACTAGAT-1_1_A4	7.86219313	13.78475168	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1064	1625	0.002461538	0.007384615	1	oligos	OL-Cntl	26	7	7
GTACTTTAGCTAACAA-1_1_A4	21.11108773	10.94249338	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1563	2745	0.002185792	0.004007286	1	oligos	OL-Cntl	26	7	7
GTACTTTAGTTACGGG-1_1_A4	6.161327748	21.80002537	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	794	1201	0.016652789	0.012489592	1	oligos	OL-Cntl	26	7	7
GTACTTTGTTGTACAC-1_1_A4	1.553451621	11.81314963	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1021	1590	0.01572327	0.013836478	1	oligos	OL-Cntl	26	7	7
GTAGGCCAGAGAGCTC-1_1_A4	-23.5585434	0.770701918	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2404	4536	0.01366843	0.010141093	1	9	OPC	26	7	7
GTAGGCCCATCTACGA-1_1_A4	14.23974029	15.75799622	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1179	1892	0.003699789	0.006871036	1	oligos	OL-Cntl	26	7	7
GTAGGCCTCAATCTCT-1_1_A4	7.507458984	23.91141729	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1012	1489	0.006044325	0.00402955	1	oligos	OL-Cntl	26	7	7
GTAGGCCTCCACGCAG-1_1_A4	-1.684919412	27.22160871	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	748	1083	0.021237304	0.010156971	1	oligos	OL-Cntl	26	7	7
GTAGGCCTCCCAAGTA-1_1_A4	-0.953713955	27.76951477	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	769	1093	0.006404392	0.004574565	1	oligos	OL-Cntl	26	7	7
GTAGGCCTCTCAAACG-1_1_A4	-21.60373132	25.67541006	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1575	2859	0.001049318	0.008744316	1	8	Astrocytes	26	7	7
GTAGTCAAGACTGGGT-1_1_A4	23.16023675	20.42460876	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	992	1483	0.002022927	0.004045853	1	oligos	OL-Cntl	26	7	7
GTAGTCACATTTCACT-1_1_A4	5.689246794	13.00101334	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1184	1889	0.025939651	0.017469561	1	oligos	OL-Cntl	26	7	7
GTAGTCAGTGGCAAAC-1_1_A4	6.445393298	24.35974135	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	938	1432	0.00349162	0.009078212	1	oligos	OL-Cntl	26	7	7
GTATCTTCAGCCAATT-1_1_A4	15.33541876	28.07294283	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	789	1262	0.001584786	0.002377179	1	oligos	OL-Cntl	26	7	7
GTATCTTGTTTGGCGC-1_1_A4	39.65170775	9.909695015	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	751	1036	0	0.005791506	1	14	Microglia	26	7	7
GTATCTTTCAATCACG-1_1_A4	10.73165068	20.79585087	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1014	1610	0.025465839	0.004347826	1	oligos	OL-Cntl	26	7	7
GTATCTTTCGCAAGCC-1_1_A4	-4.703852516	25.13441558	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	885	1284	0.020249221	0.007009346	1	11	Glia-MIX	26	7	7
GTATTCTAGCCGTCGT-1_1_A4	-4.286408175	13.40014557	5	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	923	1341	0.01715138	0.024608501	1	oligos	OL-MS-1	26	7	7
GTATTCTGTACAGCAG-1_1_A4	1.601738657	22.4788355	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	745	1149	0.000870322	0.005221932	1	oligos	OL-Cntl	26	7	7
GTATTCTGTACTTAGC-1_1_A4	39.53335813	11.654605	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	836	1076	0.001858736	0.008364312	1	14	Microglia	26	7	7
GTATTCTGTCGACTGC-1_1_A4	-14.76280913	-19.13346501	6B	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1424	2540	0.014173228	0.002755906	1	6B	IN-SST	26	7	7
GTATTCTTCAGAAATG-1_1_A4	-5.118925973	-4.218366327	13A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1299	2252	0.015541741	0.005328597	1	13A	IN-VIP	26	7	7
GTCAAGTCAATGGAGC-1_1_A4	6.53597873	21.64407076	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	958	1444	0.012465374	0.008310249	1	oligos	OL-Cntl	26	7	7
GTCAAGTCACATCTTT-1_1_A4	-37.74846337	0.161673667	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1496	2699	0.004446091	0.002964061	1	9	OPC	26	7	7
GTCAAGTCACCGTTGG-1_1_A4	-2.986365241	23.21592205	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	766	1095	0.028310502	0.010045662	1	oligos	OL-Cntl	26	7	7
GTCAAGTGTAGAGTGC-1_1_A4	-21.78209885	25.47685555	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1665	3073	0.002277904	0.004230394	1	8	Astrocytes	26	7	7
GTCAAGTGTAGATTAG-1_1_A4	-30.10776476	-13.41091529	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	672	1008	0.027777778	0.00297619	1	9	OPC	26	7	7
GTCAAGTGTTAGGGTG-1_1_A4	36.44695498	9.991502636	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	754	1050	0.008571429	0.014285714	1	14	Microglia	26	7	7
GTCAAGTTCAAGGTAA-1_1_A4	-5.738407835	-9.965613776	13B	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	744	1021	0.021547502	0.005876592	1	13B	IN-SV2C	26	7	7
GTCAAGTTCCTAGAAC-1_1_A4	-16.25613199	13.47226916	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1483	2343	0.004694836	0.012377294	1	8	Astrocytes	26	7	7
GTCACAAAGAGCTGGT-1_1_A4	-0.088905205	23.11497469	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	867	1250	0.0072	0.0064	1	oligos	OL-Cntl	26	7	7
GTCACAACACAACGTT-1_1_A4	11.78657636	15.64014564	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1187	1900	0.013684211	0.007894737	1	oligos	OL-Cntl	26	7	7
GTCACAACACGCATCG-1_1_A4	20.30450385	-0.699072846	2	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1531	2498	0.006004804	0.006004804	1	2	EN-L4	26	7	7
GTCACAAGTAGATTAG-1_1_A4	5.686682052	13.58443584	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1088	1726	0.010428737	0.013325608	1	oligos	OL-Cntl	26	7	7
GTCACAATCCGAACGC-1_1_A4	-11.23689978	-22.21127859	6A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	849	1363	0.002201027	0.006603081	1	6A	IN-PV	26	7	7
GTCACAATCTCTGAGA-1_1_A4	0.404394481	26.69060047	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	697	1027	0.003894839	0.004868549	1	oligos	OL-Cntl	26	7	7
GTCACGGAGCAGGCTA-1_1_A4	5.069045141	6.504440572	7	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1757	2811	0.013874066	0.010316613	1	7	Phagocytes	26	7	7
GTCACGGAGCATGGCA-1_1_A4	18.78699181	10.65798564	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1398	2359	0.010173802	0.004662993	1	oligos	OL-Cntl	26	7	7
GTCACGGGTTGAACTC-1_1_A4	-11.49766807	16.24613153	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1664	2685	0.002979516	0.004841713	1	11	Glia-MIX	26	7	7
GTCACGGTCGCCTGAG-1_1_A4	-34.86305551	4.594164334	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2416	4666	0.003643378	0.004286327	1	9	OPC	26	7	7
GTCATTTAGCACCGCT-1_1_A4	-26.56750199	1.780625016	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1286	1884	0.00477707	0.003184713	1	9	OPC	26	7	7
GTCATTTAGCGATATA-1_1_A4	-20.30829593	9.275003558	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1078	1596	0.001253133	0.005012531	1	8	Astrocytes	26	7	7
GTCATTTCATGCCTTC-1_1_A4	13.60903717	31.04947676	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	832	1239	0.00645682	0.000807103	1	oligos	OL-Cntl	26	7	7
GTCATTTCATTGCGGC-1_1_A4	7.493079241	12.60038173	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1191	1921	0.01405518	0.01405518	1	oligos	OL-Cntl	26	7	7
GTCATTTGTCTCTTAT-1_1_A4	-37.72482192	-2.583484597	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1346	2450	0.000408163	0.00244898	1	9	OPC	26	7	7
GTCATTTTCAGTGTTG-1_1_A4	-26.46932206	12.74300836	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	984	1717	0.002329645	0.006988934	1	8	Astrocytes	26	7	7
GTCATTTTCTCGCTTG-1_1_A4	-23.33225659	-4.837111564	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1377	2497	0.043251902	0.001601922	1	9	OPC	26	7	7
GTCCTCAAGCTTTGGT-1_1_A4	-12.8762325	-23.41764916	6A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1356	2576	0.025232919	0.001552795	1	6A	IN-PV	26	7	7
GTCCTCACAGTTAACC-1_1_A4	17.20083345	-0.499534064	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	904	1478	0.00879567	0.00135318	1	12	EN-MIX	26	7	7
GTCCTCACATACGCCG-1_1_A4	-37.07151475	-4.74337484	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1362	2308	0.000433276	0.004766031	1	9	OPC	26	7	7
GTCCTCAGTCAGAAGC-1_1_A4	-12.33255763	17.43302928	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1800	2978	0.00402955	0.007051713	1	11	Glia-MIX	26	7	7
GTCCTCAGTGGCAAAC-1_1_A4	-22.05949657	25.76495905	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1799	3505	0.005420827	0.006276748	1	8	Astrocytes	26	7	7
GTCCTCATCAGCTTAG-1_1_A4	-27.99047483	9.467181069	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	777	1178	0.003395586	0.002546689	1	8	Astrocytes	26	7	7
GTCCTCATCTCACATT-1_1_A4	35.84047339	7.871650697	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	858	1233	0.00567721	0.00243309	1	14	Microglia	26	7	7
GTCGGGTAGATAGCAT-1_1_A4	2.565641058	29.61301952	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	724	1029	0.011661808	0.003887269	1	oligos	OL-Cntl	26	7	7
GTCGGGTAGCGGCTTC-1_1_A4	-26.09825446	22.7221357	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1350	2495	0.002004008	0.006412826	1	8	Astrocytes	26	7	7
GTCGGGTCAAGCTGAG-1_1_A4	-16.58968941	-5.204359571	13A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	4379	10162	0.028340878	0.008758118	1	13A	IN-VIP	26	7	7
GTCGGGTCATGCTGGC-1_1_A4	15.40390535	-2.288946127	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	920	1365	0.000732601	0.003663004	1	12	EN-MIX	26	7	7
GTCGGGTGTCCAACTA-1_1_A4	16.90837523	-0.749358139	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	684	1039	0.000962464	0	1	12	EN-MIX	26	7	7
GTCGGGTTCCGCAAGC-1_1_A4	-16.56340631	13.05513641	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1369	2083	0.003360538	0.007201152	1	8	Astrocytes	26	7	7
GTCGGGTTCGAGAGCA-1_1_A4	-32.29668876	-13.64558712	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	720	1023	0.008797654	0.002932551	1	9	OPC	26	7	7
GTCGGGTTCTGGTGTA-1_1_A4	21.8943048	15.62148745	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1423	2407	0.010386373	0.004154549	1	oligos	OL-Cntl	26	7	7
GTCGTAAAGGGAGTAA-1_1_A4	3.855702044	20.27118899	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	867	1271	0.006294256	0.011014949	1	oligos	OL-Cntl	26	7	7
GTCGTAATCTTCAACT-1_1_A4	-12.4411856	-10.75846239	13B	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1586	2846	0.001756852	0.001756852	1	13B	IN-SV2C	26	7	7
GTCTCGTCAAGCCGCT-1_1_A4	-32.43500418	-12.75666296	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	802	1317	0.001518603	0.003037206	1	9	OPC	26	7	7
GTCTCGTCAGGGTATG-1_1_A4	7.896892911	-6.253486528	10	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1342	2413	0.004558641	0.002486531	1	L2-3	EN-L2-3-Cntl	26	7	7
GTCTCGTGTACGCTGC-1_1_A4	4.739897846	17.07455616	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1043	1538	0.006501951	0.014304291	1	oligos	OL-Cntl	26	7	7
GTCTCGTTCACTTCAT-1_1_A4	-23.87523975	-1.62799963	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1228	2022	0.006429278	0.006429278	1	9	OPC	26	7	7
GTCTTCGAGAAACCAT-1_1_A4	-0.979306176	20.35358521	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	768	1168	0.005136986	0.015410959	1	oligos	OL-Cntl	26	7	7
GTCTTCGAGCCGTCGT-1_1_A4	33.9614655	14.71309767	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	774	1026	0	0.04288499	1	14	Microglia	26	7	7
GTCTTCGAGGTGATTA-1_1_A4	2.625486281	-3.535705867	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	738	1091	0.00091659	0.004582951	1	12	EN-MIX	26	7	7
GTCTTCGCACGAAACG-1_1_A4	3.76378928	4.818704957	7	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1274	1846	0.009750813	0.010292524	1	7	Phagocytes	26	7	7
GTCTTCGGTAGGCTGA-1_1_A4	-0.500507217	22.73500831	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	791	1181	0.00762066	0.010160881	1	oligos	OL-Cntl	26	7	7
GTCTTCGGTTCCACAA-1_1_A4	11.07742769	16.0518603	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1095	1765	0.014164306	0.009065156	1	oligos	OL-Cntl	26	7	7
GTCTTCGTCATGCATG-1_1_A4	38.47932152	15.13923044	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1221	1825	0.005479452	0.014246575	1	14	Microglia	26	7	7
GTGAAGGAGATCACGG-1_1_A4	-28.98994224	11.95088923	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	865	1316	0.000759878	0.003799392	1	8	Astrocytes	26	7	7
GTGAAGGAGCTAGTCT-1_1_A4	16.23357424	12.39181895	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1416	2274	0.010114336	0.008355321	1	oligos	OL-Cntl	26	7	7
GTGAAGGAGGAATCGC-1_1_A4	-34.47293946	-6.963845692	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1179	1910	0.003141361	0.005759162	1	9	OPC	26	7	7
GTGAAGGAGTCAATAG-1_1_A4	-5.998550643	2.970221224	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	4238	9734	0.005033902	0.00380111	1	11	Glia-MIX	26	7	7
GTGAAGGAGTTGTCGT-1_1_A4	3.708390234	25.41969196	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	762	1105	0.005429864	0.005429864	1	oligos	OL-Cntl	26	7	7
GTGAAGGCATGCCACG-1_1_A4	-3.213113603	-6.255680885	13A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	885	1320	0.010606061	0.003787879	1	13A	IN-VIP	26	7	7
GTGAAGGGTATGAAAC-1_1_A4	15.28299118	2.978057224	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1193	1901	0.002104156	0.003682272	1	12	EN-MIX	26	7	7
GTGAAGGGTGTGCCTG-1_1_A4	1.460358274	25.49981415	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	823	1215	0.009876543	0.004938272	1	oligos	OL-Cntl	26	7	7
GTGAAGGTCTTGGGTA-1_1_A4	35.0594907	10.51409336	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	793	1037	0.007714561	0.023143684	1	14	Microglia	26	7	7
GTGCAGCAGACACGAC-1_1_A4	4.699562301	17.8462736	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1155	1851	0.000540249	0.009184225	1	oligos	OL-Cntl	26	7	7
GTGCAGCAGCACGCCT-1_1_A4	16.78209673	0.749776001	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	683	1011	0.047477745	0.004945598	1	12	EN-MIX	26	7	7
GTGCAGCAGCTAAGAT-1_1_A4	-23.43962784	2.451110624	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	3802	7577	0.014253662	0.005015178	1	11	Glia-MIX	26	7	7
GTGCAGCAGTGCCAGA-1_1_A4	5.582246671	18.87415016	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1096	1716	0.007575758	0.007575758	1	oligos	OL-Cntl	26	7	7
GTGCAGCAGTGGTAAT-1_1_A4	-10.54402864	16.62688139	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2251	4056	0.009368836	0.00295858	1	11	Glia-MIX	26	7	7
GTGCAGCCAGACAAAT-1_1_A4	-11.19520948	-21.90702369	6A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	860	1322	0.007564297	0.003025719	1	6A	IN-PV	26	7	7
GTGCAGCCAGTCCTTC-1_1_A4	-20.99688153	9.346655499	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	984	1403	0.009265859	0.002851033	1	8	Astrocytes	26	7	7
GTGCAGCGTAAACCTC-1_1_A4	-7.058853729	-3.898960894	13A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1725	2939	0.002041511	0.005103777	1	13A	IN-VIP	26	7	7
GTGCAGCTCAATCACG-1_1_A4	-4.199795564	20.65294507	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	830	1217	0.018077239	0.015612161	1	oligos	OL-Cntl	26	7	7
GTGCAGCTCTTGTTTG-1_1_A4	-24.93802702	-0.17228428	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2836	6539	0.010246215	0.005658358	1	9	OPC	26	7	7
GTGCATACAACTTGAC-1_1_A4	-11.57041122	14.69823679	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1299	2122	0.012252592	0.003770028	1	11	Glia-MIX	26	7	7
GTGCATATCATTCACT-1_1_A4	5.287322243	25.49491228	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	882	1385	0.019494585	0.003610108	1	oligos	OL-Cntl	26	7	7
GTGCATATCGGATGTT-1_1_A4	-23.85434396	2.603557924	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	3553	6936	0.007208766	0.009659746	1	11	Glia-MIX	26	7	7
GTGCGGTAGACCACGA-1_1_A4	4.196691428	5.33765674	7	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1488	2180	0.011926606	0.008715596	1	7	Phagocytes	26	7	7
GTGCGGTAGATCTGCT-1_1_A4	35.6081745	7.809197911	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	958	1242	0.001610306	0.001610306	1	14	Microglia	26	7	7
GTGCGGTAGCTATGCT-1_1_A4	-4.832467069	-9.883322124	13B	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	822	1224	0.007352941	0.003267974	1	13B	IN-SV2C	26	7	7
GTGCGGTAGTGTTTGC-1_1_A4	13.97952792	7.075032906	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1684	2979	0.01611279	0.012084592	1	oligos	OL-Cntl	26	7	7
GTGCTTCAGACTAAGT-1_1_A4	4.209231811	22.29074987	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	935	1444	0.026315789	0.00900277	1	oligos	OL-Cntl	26	7	7
GTGCTTCAGCAGCGTA-1_1_A4	19.0330883	-10.60861411	3	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2450	4816	0.037583056	0.0035299	1	3	EN-L5-6	26	7	7
GTGCTTCAGCGATATA-1_1_A4	2.955560141	6.494489991	7	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1189	1758	0.017633675	0.008532423	1	7	Phagocytes	26	7	7
GTGCTTCCAGCGTCCA-1_1_A4	4.355778382	-5.063806552	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	997	1885	0.01061008	0.002122016	1	12	EN-MIX	26	7	7
GTGCTTCCAGGGATTG-1_1_A4	-35.54053166	-8.61796889	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1010	1670	0.003592814	0.008383234	1	9	OPC	26	7	7
GTGCTTCCATGCTAGT-1_1_A4	-9.193363335	-20.25780546	6A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	743	1070	0.029906542	0.001869159	1	6A	IN-PV	26	7	7
GTGCTTCGTGGTCTCG-1_1_A4	-2.4007907	19.93674851	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	809	1198	0.010016694	0.024207012	1	oligos	OL-Cntl	26	7	7
GTGCTTCTCACTTCAT-1_1_A4	4.994649291	19.77993298	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	968	1496	0.004010695	0.002005348	1	oligos	OL-Cntl	26	7	7
GTGGGTCAGAGCCTAG-1_1_A4	5.007141155	-5.280398366	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	881	1288	0.000776398	0	1	12	EN-MIX	26	7	7
GTGGGTCAGCCAGTAG-1_1_A4	0.710451444	23.99392778	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	761	1163	0.049011178	0.006878762	1	oligos	OL-Cntl	26	7	7
GTGGGTCAGGCCCTTG-1_1_A4	14.4510119	14.93538242	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1271	2120	0.010377358	0.005660377	1	oligos	OL-Cntl	26	7	7
GTGGGTCCATTAGCCA-1_1_A4	20.68417081	17.13815687	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1156	1885	0.007427056	0.004244032	1	oligos	OL-Cntl	26	7	7
GTGGGTCGTATCACCA-1_1_A4	-25.08033899	22.53849014	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1362	2363	0.008040626	0.005501481	1	8	Astrocytes	26	7	7
GTGGGTCGTCACTTCC-1_1_A4	21.83941836	-3.224668699	2	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2601	5242	0.018122854	0.005150706	1	2	EN-L4	26	7	7
GTGGGTCGTCGTGGCT-1_1_A4	-4.107501503	-7.989874668	13A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	945	1496	0.058823529	0.004010695	1	13A	IN-VIP	26	7	7
GTGGGTCGTGTTGGGA-1_1_A4	-9.16931891	-20.14670921	6B	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	852	1383	0.096890817	0.005784526	1	6B	IN-SST	26	7	7
GTGGGTCGTTAAGATG-1_1_A4	-33.10081698	-1.482571521	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1609	2706	0.009608278	0.004065041	1	9	OPC	26	7	7
GTGGGTCTCGTTTATC-1_1_A4	-4.601637805	-7.920137845	13A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	924	1425	0.032280702	0.004912281	1	13A	IN-VIP	26	7	7
GTGGGTCTCTGTACGA-1_1_A4	-9.103121182	19.056685	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	4400	9850	0.00680203	0.007918782	1	11	Glia-MIX	26	7	7
GTGTGCGAGGTGCTAG-1_1_A4	13.44988452	15.00369989	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1241	1940	0.007216495	0.010824742	1	oligos	OL-Cntl	26	7	7
GTGTGCGCATGATCCA-1_1_A4	-1.811167434	20.53265029	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	862	1292	0.018575851	0.011609907	1	oligos	OL-Cntl	26	7	7
GTGTGCGGTGCACTTA-1_1_A4	15.62088488	29.41381722	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	756	1105	0.001809955	0.00361991	1	oligos	OL-Cntl	26	7	7
GTGTGCGTCACTATTC-1_1_A4	-2.337404283	22.90453913	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	776	1122	0.00802139	0.012477718	1	oligos	OL-Cntl	26	7	7
GTGTGCGTCACTGGGC-1_1_A4	-6.959030654	9.789379125	5	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	884	1296	0.007716049	0.023148148	1	oligos	OL-MS-1	26	7	7
GTGTGCGTCATCACCC-1_1_A4	-22.13961653	26.33660352	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1770	3391	0.000884695	0.007962253	1	8	Astrocytes	26	7	7
GTGTGCGTCCACTGGG-1_1_A4	0.159975686	22.8722042	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	790	1174	0.02044293	0.004258944	1	oligos	OL-Cntl	26	7	7
GTGTGCGTCCGCGTTT-1_1_A4	39.89627923	10.90818632	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	906	1271	0.006294256	0.010228167	1	14	Microglia	26	7	7
GTGTGCGTCCTAGTGA-1_1_A4	11.55842687	16.99795654	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1152	1824	0.010416667	0.003289474	1	oligos	OL-Cntl	26	7	7
GTGTGCGTCTGTGCAA-1_1_A4	6.066888663	18.90310483	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1055	1692	0.002955083	0.008274232	1	oligos	OL-Cntl	26	7	7
GTGTTAGAGTTGCAGG-1_1_A4	10.51013613	13.84747027	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1247	1911	0.019884877	0.013082156	1	oligos	OL-Cntl	26	7	7
GTGTTAGGTTGGAGGT-1_1_A4	21.59273982	-1.473423038	2	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1906	3503	0.000570939	0.008564088	1	2	EN-L4	26	7	7
GTGTTAGTCGCCATAA-1_1_A4	-21.42609065	24.35468913	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1637	2916	0.005486968	0.009259259	1	8	Astrocytes	26	7	7
GTTAAGCCATGCATGT-1_1_A4	-23.88786519	1.072933644	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	3815	9591	0.008236889	0.005213221	1	9	OPC	26	7	7
GTTAAGCGTTGATTGC-1_1_A4	38.66808667	11.23285988	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	945	1333	0.0060015	0.010502626	1	14	Microglia	26	7	7
GTTAAGCTCGGCGCAT-1_1_A4	0.437501003	25.95094723	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	695	1065	0.014084507	0.008450704	1	oligos	OL-Cntl	26	7	7
GTTACAGCAAGCTGAG-1_1_A4	-10.34408704	18.32093331	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2339	4600	0.003695652	0.002826087	1	11	Glia-MIX	26	7	7
GTTACAGCAAGTAATG-1_1_A4	-21.96149072	23.50035755	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1474	2707	0.000738825	0.009235316	1	8	Astrocytes	26	7	7
GTTACAGTCACGATGT-1_1_A4	14.42044907	15.36342994	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1267	2069	0.008699855	0.010149831	1	oligos	OL-Cntl	26	7	7
GTTCATTAGGAGCGTT-1_1_A4	-35.57454318	-6.749428124	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1088	1777	0.001688239	0.003939223	1	9	OPC	26	7	7
GTTCATTCAAGCTGAG-1_1_A4	-10.97972313	9.396198204	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	5674	15779	0.016414221	0.008048672	1	11	Glia-MIX	26	7	7
GTTCATTCAAGTAATG-1_1_A4	3.994942116	14.55160941	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1076	1772	0.007336343	0.011851016	1	oligos	OL-Cntl	26	7	7
GTTCATTCACGTAAGG-1_1_A4	-23.67672361	-1.202097213	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1322	2226	0.017969452	0.002695418	1	9	OPC	26	7	7
GTTCATTCACTTGGAT-1_1_A4	15.93322643	-7.354992401	3	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2246	4629	0.009937351	0.00345647	1	3	EN-L5-6	26	7	7
GTTCATTCAGTCAGAG-1_1_A4	17.02343312	22.14324321	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1018	1663	0.019242333	0.003006615	1	oligos	OL-Cntl	26	7	7
GTTCATTGTAGCGCTC-1_1_A4	15.23209541	10.45981709	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1517	2769	0.013362225	0.006861683	1	oligos	OL-Cntl	26	7	7
GTTCATTGTGGGTATG-1_1_A4	5.734786507	12.3764187	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1390	2486	0.011665326	0.013676589	1	oligos	OL-Cntl	26	7	7
GTTCATTTCAAACCGT-1_1_A4	15.15549074	6.426967727	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2071	3895	0.011296534	0.010012837	1	oligos	OL-Cntl	26	7	7
GTTCATTTCCGAATGT-1_1_A4	15.77399861	15.34673388	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1212	2062	0.005819593	0.005819593	1	oligos	OL-Cntl	26	7	7
GTTCATTTCTACTCAT-1_1_A4	17.78407407	19.46932437	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1036	1715	0.013411079	0.004081633	1	oligos	OL-Cntl	26	7	7
GTTCGGGAGCCCTAAT-1_1_A4	2.473239346	4.417689944	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	976	1319	0.011372252	0.010614102	1	14	Microglia	26	7	7
GTTCGGGAGGTTCCTA-1_1_A4	6.900330394	-6.048068173	10	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1390	2430	0.005761317	0.002057613	1	L2-3	EN-L2-3-Cntl	26	7	7
GTTCGGGCAGGCTGAA-1_1_A4	15.17067992	18.25252918	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1109	1726	0.006373117	0.00405562	1	oligos	OL-Cntl	26	7	7
GTTCGGGTCCGCGGTA-1_1_A4	12.80304275	15.23334072	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1173	1958	0.004085802	0.013789581	1	oligos	OL-Cntl	26	7	7
GTTCGGGTCGTCGTTC-1_1_A4	6.280467037	13.07517595	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1306	2083	0.008641383	0.01056169	1	oligos	OL-Cntl	26	7	7
GTTCGGGTCTCGAGTA-1_1_A4	0.68252656	21.87588178	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	753	1123	0.000890472	0.011576135	1	oligos	OL-Cntl	26	7	7
GTTCTCGAGAGAACAG-1_1_A4	12.33772053	16.37574217	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1161	1855	0.008086253	0.004312668	1	oligos	OL-Cntl	26	7	7
GTTCTCGAGATGTAAC-1_1_A4	-23.6884747	2.441990802	7	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2261	3874	0.005937016	0.008002065	1	7	Phagocytes	26	7	7
GTTCTCGCAATGAAAC-1_1_A4	-10.34153295	18.46177627	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2687	5078	0.010634108	0.005317054	1	11	Glia-MIX	26	7	7
GTTCTCGCAGGGTATG-1_1_A4	6.798236793	13.46192673	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1369	2144	0.006996269	0.014458955	1	oligos	OL-Cntl	26	7	7
GTTCTCGCATTGTGCA-1_1_A4	20.97273309	-5.669470353	3	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1843	3104	0.004832474	0.00257732	1	3	EN-L5-6	26	7	7
GTTCTCGGTGAAGGCT-1_1_A4	11.22445631	15.26488854	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1195	1850	0.008648649	0.014594595	1	oligos	OL-Cntl	26	7	7
GTTCTCGGTGATGATA-1_1_A4	-25.72643554	22.80218439	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1379	2382	0.005457599	0.00713686	1	8	Astrocytes	26	7	7
GTTTCTACAGATGGGT-1_1_A4	37.45103817	9.545885705	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	800	1133	0.011473963	0.012356575	1	14	Microglia	26	7	7
TAAACCGAGAAGCCCA-1_1_A4	-1.247638497	26.99859482	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	687	1036	0.004826255	0.003861004	1	oligos	OL-Cntl	26	7	7
TAAACCGAGCCCAGCT-1_1_A4	11.70259617	26.51365425	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	862	1298	0.008474576	0.004622496	1	oligos	OL-Cntl	26	7	7
TAAACCGAGTGCGTGA-1_1_A4	3.170087492	18.41782529	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	932	1562	0.007682458	0.002560819	1	oligos	OL-Cntl	26	7	7
TAAACCGCAAGAGTCG-1_1_A4	15.30579448	20.44501724	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1065	1656	0.004830918	0.003623188	1	oligos	OL-Cntl	26	7	7
TAAACCGCACATGGGA-1_1_A4	-22.19580571	26.11794125	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1792	3556	0.002249719	0.003093363	1	8	Astrocytes	26	7	7
TAAACCGCACTCGACG-1_1_A4	21.12512327	15.18394039	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1260	2093	0.001433349	0.001911132	1	oligos	OL-Cntl	26	7	7
TAAACCGCATCCGGGT-1_1_A4	14.79259579	15.20477057	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1198	1942	0.003089598	0.005149331	1	oligos	OL-Cntl	26	7	7
TAAACCGGTAGAGGAA-1_1_A4	3.718818422	7.230387026	7	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1260	1835	0.007629428	0.009809264	1	7	Phagocytes	26	7	7
TAAACCGGTTAAGATG-1_1_A4	-10.79369294	9.726953243	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	3594	7939	0.005164378	0.005038418	1	11	Glia-MIX	26	7	7
TAAGAGAAGGACCACA-1_1_A4	-0.76263497	-0.497594072	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1520	2529	0.023724792	0.004349545	1	11	Glia-MIX	26	7	7
TAAGAGAAGTGGCACA-1_1_A4	-35.44319808	-6.540460943	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1126	1740	0.006896552	0.006321839	1	9	OPC	26	7	7
TAAGCGTAGTGCTGCC-1_1_A4	4.243512901	18.34314014	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1027	1678	0.02205006	0.009535161	1	oligos	OL-Cntl	26	7	7
TAAGCGTCAAGCGCTC-1_1_A4	38.60093727	11.16140373	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	929	1290	0.00620155	0.010852713	1	14	Microglia	26	7	7
TAAGCGTCACAGACAG-1_1_A4	-1.00649722	27.79683105	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	727	1102	0	0.003629764	1	oligos	OL-Cntl	26	7	7
TAAGCGTCACGTCTCT-1_1_A4	-2.849061482	21.58830267	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	882	1284	0.01635514	0.01635514	1	oligos	OL-Cntl	26	7	7
TAAGCGTGTCAGCTAT-1_1_A4	4.698475725	18.81830571	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	965	1479	0.017579446	0.010141988	1	oligos	OL-Cntl	26	7	7
TAAGCGTGTTCCTCCA-1_1_A4	20.48635421	-1.230340716	2	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1523	2531	0.039114974	0.003160806	1	2	EN-L4	26	7	7
TAAGCGTTCGTTTATC-1_1_A4	22.2424801	16.36780618	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1316	2237	0.000447027	0.006705409	1	oligos	OL-Cntl	26	7	7
TAAGTGCAGCGTTTAC-1_1_A4	-24.96427341	16.69535108	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1188	1980	0.004545455	0.003535354	1	8	Astrocytes	26	7	7
TAAGTGCGTAAGCACG-1_1_A4	10.42616719	23.45214818	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	806	1294	0.003863988	0.00618238	1	oligos	OL-Cntl	26	7	7
TAAGTGCGTGCCTGCA-1_1_A4	-1.365882657	21.56385334	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	711	1052	0.014258555	0.005703422	1	oligos	OL-Cntl	26	7	7
TAAGTGCGTTATCCGA-1_1_A4	3.969451383	5.419694519	7	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1152	1711	0.004091175	0.004091175	1	7	Phagocytes	26	7	7
TAAGTGCTCACCACCT-1_1_A4	14.40955943	20.35726851	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	902	1408	0.008522727	0.009943182	1	oligos	OL-Cntl	26	7	7
TAAGTGCTCCAAACTG-1_1_A4	21.02408986	10.39586087	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1609	2836	0.003878702	0.007052186	1	oligos	OL-Cntl	26	7	7
TAAGTGCTCCGTAGGC-1_1_A4	0.512204401	22.30629549	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	762	1113	0.005390836	0.008984726	1	oligos	OL-Cntl	26	7	7
TAAGTGCTCTGTACGA-1_1_A4	-22.95337799	26.13706474	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1895	3679	0.008426203	0.004349008	1	8	Astrocytes	26	7	7
TACACGAAGCCCTAAT-1_1_A4	22.79036346	12.03974763	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1591	2903	0.002066827	0.004822597	1	oligos	OL-Cntl	26	7	7
TACACGAAGGTAGCTG-1_1_A4	15.91337089	1.821413691	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	802	1191	0.006717045	0.004198153	1	12	EN-MIX	26	7	7
TACACGACAGGGTACA-1_1_A4	-23.11393099	-1.884205736	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	994	1490	0.001342282	0.002684564	1	9	OPC	26	7	7
TACACGACATTTGCCC-1_1_A4	-21.88823678	28.00657114	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1947	4048	0.00222332	0.005681818	1	8	Astrocytes	26	7	7
TACACGAGTAAGCACG-1_1_A4	-36.20104866	-6.543499265	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1208	2073	0.005306319	0.002411963	1	9	OPC	26	7	7
TACACGAGTGACAAAT-1_1_A4	17.99171198	1.504067044	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	950	1517	0.001977587	0	1	12	EN-MIX	26	7	7
TACACGAGTTTCGCTC-1_1_A4	13.44637081	18.21364828	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1039	1697	0.012964054	0.011785504	1	oligos	OL-Cntl	26	7	7
TACACGATCACCCTCA-1_1_A4	16.31171542	1.742589587	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	876	1306	0.016079632	0.003062787	1	12	EN-MIX	26	7	7
TACAGTGAGTACACCT-1_1_A4	34.27226036	-3.456724694	2	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2546	5520	0.017028986	0.005253623	1	2	EN-L4	26	7	7
TACAGTGAGTCGATAA-1_1_A4	3.944157678	22.10151013	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	851	1252	0.019968051	0.011980831	1	oligos	OL-Cntl	26	7	7
TACAGTGAGTCTCCTC-1_1_A4	15.53498211	9.317612221	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1608	2888	0.006232687	0.011772853	1	oligos	OL-Cntl	26	7	7
TACAGTGCAATGGACG-1_1_A4	16.43277819	20.24121838	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	991	1586	0.004413619	0.005674653	1	oligos	OL-Cntl	26	7	7
TACAGTGCACTACAGT-1_1_A4	15.38553084	15.36323241	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1144	1956	0.018916155	0.006646217	1	oligos	OL-Cntl	26	7	7
TACAGTGCAGAGTGTG-1_1_A4	17.83334412	1.889870388	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	911	1283	0.007794232	0.001558846	1	12	EN-MIX	26	7	7
TACAGTGGTTACCAGT-1_1_A4	16.51750465	9.637911538	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1640	2830	0.013780919	0.004240283	1	oligos	OL-Cntl	26	7	7
TACAGTGTCAAGGCTT-1_1_A4	-24.70782228	26.15617508	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1624	3183	0.003455859	0.005969211	1	8	Astrocytes	26	7	7
TACCTATAGTTGAGTA-1_1_A4	11.85312239	15.68892181	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1181	2025	0.005432099	0.005432099	1	oligos	OL-Cntl	26	7	7
TACCTATCAGGAATGC-1_1_A4	15.9387343	6.175054508	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2261	4576	0.017701049	0.009615385	1	oligos	OL-Cntl	26	7	7
TACCTATGTATGAATG-1_1_A4	-2.680918568	19.03888372	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	969	1678	0.011323004	0.007747318	1	oligos	OL-Cntl	26	7	7
TACCTATGTCTAAACC-1_1_A4	-37.01648942	1.27812878	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1600	3041	0.002959553	0.002959553	1	9	OPC	26	7	7
TACCTATGTTACCGAT-1_1_A4	-36.47079271	-5.025726676	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1220	2100	0.000952381	0.003809524	1	9	OPC	26	7	7
TACCTATTCACTATTC-1_1_A4	5.470144885	22.1756887	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	860	1327	0.008289375	0.006782216	1	oligos	OL-Cntl	26	7	7
TACCTATTCGTGGACC-1_1_A4	2.759743715	26.91163861	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	702	1083	0.01754386	0.003693444	1	oligos	OL-Cntl	26	7	7
TACCTATTCTACCTGC-1_1_A4	-25.09466387	17.89850432	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1249	2275	0.003956044	0.003516484	1	8	Astrocytes	26	7	7
TACCTTAAGCCAGTAG-1_1_A4	-29.03729742	21.43390234	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1141	1978	0.003538928	0.004044489	1	8	Astrocytes	26	7	7
TACCTTAAGGGTATCG-1_1_A4	3.5542298	22.15089688	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	778	1149	0.009573542	0.009573542	1	oligos	OL-Cntl	26	7	7
TACCTTACACCTCGTT-1_1_A4	16.22963976	15.81293117	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1244	2180	0.009174312	0.004587156	1	oligos	OL-Cntl	26	7	7
TACCTTATCCAGGGCT-1_1_A4	-10.15640588	12.54919858	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	918	1324	0.012084592	0.003776435	1	11	Glia-MIX	26	7	7
TACCTTATCCCTAATT-1_1_A4	-23.34830271	1.88592627	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	5240	16158	0.006622107	0.004889219	1	11	Glia-MIX	26	7	7
TACCTTATCGATGAGG-1_1_A4	-27.88543819	12.91536591	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	881	1408	0.003551136	0.002130682	1	8	Astrocytes	26	7	7
TACCTTATCTCACATT-1_1_A4	18.95294865	20.11606902	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1112	1806	0.018272425	0.004429679	1	oligos	OL-Cntl	26	7	7
TACGGATCAGATGGGT-1_1_A4	3.148263246	7.078331368	7	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	977	1352	0.00887574	0.016272189	1	7	Phagocytes	26	7	7
TACGGATCAGCTGCAC-1_1_A4	-25.88387862	16.7291561	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1234	2264	0.011042403	0.003091873	1	8	Astrocytes	26	7	7
TACGGATCATAAAGGT-1_1_A4	3.337222302	18.31941318	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	999	1435	0.019512195	0.013240418	1	oligos	OL-Cntl	26	7	7
TACGGATGTCATGCAT-1_1_A4	11.513929	16.25363207	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1163	1991	0.00100452	0.009542943	1	oligos	OL-Cntl	26	7	7
TACGGGCAGCAATCTC-1_1_A4	13.12605457	2.763902927	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	998	1362	0.014684288	0.002936858	1	14	Microglia	26	7	7
TACGGGCAGTATTGGA-1_1_A4	-35.31019924	-3.899403172	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1421	2377	0.005469079	0.004627682	1	9	OPC	26	7	7
TACGGGCCACTTACGA-1_1_A4	0.13442689	28.5653636	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	787	1115	0.007174888	0.005381166	1	oligos	OL-Cntl	26	7	7
TACGGGCCAGACGCAA-1_1_A4	-24.4815945	-1.429169138	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1567	2982	0.006706908	0.007042254	1	9	OPC	26	7	7
TACGGGCTCGAACTGT-1_1_A4	13.04411455	28.33548049	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	834	1242	0.006441224	0.004025765	1	oligos	OL-Cntl	26	7	7
TACGGTAAGGATGCGT-1_1_A4	-33.27128019	-12.16665158	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	771	1077	0.00185701	0.00185701	1	9	OPC	26	7	7
TACGGTACACCGATAT-1_1_A4	8.806681805	24.7548852	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	828	1209	0.007444169	0.004962779	1	oligos	OL-Cntl	26	7	7
TACGGTAGTAGAAGGA-1_1_A4	5.92233192	12.97508234	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1257	1922	0.01925078	0.017169615	1	oligos	OL-Cntl	26	7	7
TACGGTAGTATATCCG-1_1_A4	-0.613118284	22.30187711	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	749	1069	0.002806361	0.012160898	1	oligos	OL-Cntl	26	7	7
TACGGTAGTCCCTACT-1_1_A4	-24.70305275	17.48403192	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1272	2065	0.001937046	0.00968523	1	8	Astrocytes	26	7	7
TACGGTAGTCGATTGT-1_1_A4	-36.67130396	-10.06325791	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1017	1628	0.006142506	0.003685504	1	9	OPC	26	7	7
TACTCATAGCAATCTC-1_1_A4	-4.805040273	-10.16369228	13B	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	748	1129	0.023029229	0.004428698	1	13B	IN-SV2C	26	7	7
TACTCATAGTAGGTGC-1_1_A4	14.08071946	11.72872916	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1252	2083	0.006240999	0.009121459	1	oligos	OL-Cntl	26	7	7
TACTCATCACCGAAAG-1_1_A4	-27.72131623	18.29065711	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1193	2058	0.003887269	0.004859086	1	8	Astrocytes	26	7	7
TACTCATTCAAGCCTA-1_1_A4	39.29363594	12.65508759	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1024	1467	0.006134969	0.008179959	1	14	Microglia	26	7	7
TACTCGCAGAATGTTG-1_1_A4	10.81841398	14.45674098	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1245	2080	0.022596154	0.009615385	1	oligos	OL-Cntl	26	7	7
TACTCGCAGTATTGGA-1_1_A4	4.886815644	24.59711624	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	871	1313	0.004569688	0.006092917	1	oligos	OL-Cntl	26	7	7
TACTCGCCATCCCATC-1_1_A4	-20.79490362	30.84328586	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2860	6756	0.002220249	0.006364713	1	8	Astrocytes	26	7	7
TACTCGCGTGCTAGCC-1_1_A4	6.666617169	24.22780094	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	953	1394	0.008608321	0.003586801	1	oligos	OL-Cntl	26	7	7
TACTCGCTCCAAACAC-1_1_A4	-9.621676325	16.19820251	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2440	4556	0.007901668	0.004609306	1	11	Glia-MIX	26	7	7
TACTCGCTCTCAAACG-1_1_A4	6.949292913	12.70162331	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1217	2069	0.00821653	0.012566457	1	oligos	OL-Cntl	26	7	7
TACTTACCACAGCCCA-1_1_A4	-24.89135266	17.21817441	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1259	2263	0.003093239	0.003093239	1	8	Astrocytes	26	7	7
TACTTACCATGACGGA-1_1_A4	11.01718591	16.3158176	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1064	1741	0.004020678	0.009764503	1	oligos	OL-Cntl	26	7	7
TACTTACTCACGCATA-1_1_A4	-10.53439895	9.289353152	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	4913	14034	0.008978196	0.004560353	1	11	Glia-MIX	26	7	7
TACTTACTCAGTTCGA-1_1_A4	-19.68643027	7.502475112	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	744	1078	0	0.001855288	1	8	Astrocytes	26	7	7
TACTTGTAGAAGGTGA-1_1_A4	-30.38677877	9.478371555	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	741	1105	0.016289593	0.009049774	1	8	Astrocytes	26	7	7
TACTTGTAGACTTTCG-1_1_A4	-29.29956366	12.84411022	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	790	1196	0.001672241	0.002508361	1	8	Astrocytes	26	7	7
TACTTGTAGCGACGTA-1_1_A4	-19.49575636	31.16182568	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2879	5592	0.006795422	0.008762518	1	8	Astrocytes	26	7	7
TACTTGTAGTCTCCTC-1_1_A4	-1.135511059	-0.761280851	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2015	3849	0.010911925	0.004416732	1	11	Glia-MIX	26	7	7
TACTTGTCAAAGAATC-1_1_A4	-23.64086791	26.0492701	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1564	2923	0.004105371	0.004447485	1	8	Astrocytes	26	7	7
TACTTGTGTAGGGACT-1_1_A4	-20.50394567	8.155637075	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	788	1145	0.002620087	0.005240175	1	8	Astrocytes	26	7	7
TAGACCACAACAACCT-1_1_A4	-28.00468352	17.94897344	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1129	1891	0.000528821	0.005288207	1	8	Astrocytes	26	7	7
TAGACCACACGGTAAG-1_1_A4	-24.53642245	16.31801168	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1313	2224	0.001798561	0.006294964	1	8	Astrocytes	26	7	7
TAGACCACACTGAAGG-1_1_A4	18.46610367	9.074623295	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1485	2613	0.009184845	0.007271336	1	oligos	OL-Cntl	26	7	7
TAGACCACAGCAGTTT-1_1_A4	15.5385757	28.65235664	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	803	1179	0.004240882	0.007633588	1	oligos	OL-Cntl	26	7	7
TAGACCAGTAGCGCAA-1_1_A4	0.876555767	25.70247893	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	869	1280	0.0171875	0.00859375	1	oligos	OL-Cntl	26	7	7
TAGACCAGTCTCTTTA-1_1_A4	-13.00977761	18.0603826	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1787	3435	0.009315866	0.0069869	1	11	Glia-MIX	26	7	7
TAGACCAGTGTTAAGA-1_1_A4	5.809398394	13.19275804	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1183	1860	0.00483871	0.014516129	1	oligos	OL-Cntl	26	7	7
TAGACCATCGCGCCAA-1_1_A4	-36.16402475	-0.526508547	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1514	2543	0.001966182	0.0043256	1	9	OPC	26	7	7
TAGACCATCTGGTATG-1_1_A4	-11.49423684	16.91127569	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1802	3076	0.009102731	0.008452536	1	11	Glia-MIX	26	7	7
TAGAGCTAGATATGGT-1_1_A4	-1.703980419	19.53651352	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	908	1314	0.008371385	0.015981735	1	oligos	OL-Cntl	26	7	7
TAGAGCTAGCACAGGT-1_1_A4	-35.80443748	-6.835882731	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1029	1678	0.003575685	0.002979738	1	9	OPC	26	7	7
TAGAGCTAGTCTTGCA-1_1_A4	6.510516071	20.79363437	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	910	1318	0.005311077	0.009104704	1	oligos	OL-Cntl	26	7	7
TAGAGCTCAGTAAGCG-1_1_A4	15.00491692	12.09803008	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1732	2858	0.018894332	0.009447166	1	oligos	OL-Cntl	26	7	7
TAGAGCTGTCCGCTGA-1_1_A4	18.49037683	12.28201838	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1328	2296	0.010888502	0.004790941	1	oligos	OL-Cntl	26	7	7
TAGAGCTGTGTGCGTC-1_1_A4	15.84780165	16.74425339	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1064	1747	0.002862049	0.006296508	1	oligos	OL-Cntl	26	7	7
TAGAGCTGTTCCTCCA-1_1_A4	-28.66628351	9.279903227	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	734	1088	0.008272059	0.003676471	1	8	Astrocytes	26	7	7
TAGCCGGAGAAGATTC-1_1_A4	-22.0587159	25.27351976	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1727	3350	0.002089552	0.004477612	1	8	Astrocytes	26	7	7
TAGCCGGAGCACCGTC-1_1_A4	21.47670003	16.55677003	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1347	2233	0	0.008956561	1	oligos	OL-Cntl	26	7	7
TAGCCGGAGGTGCAAC-1_1_A4	-25.38442034	14.69326831	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1042	1616	0.008044554	0.005569307	1	8	Astrocytes	26	7	7
TAGCCGGAGTTTAGGA-1_1_A4	11.14814316	29.9999533	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	719	1088	0.011948529	0.006433824	1	oligos	OL-Cntl	26	7	7
TAGCCGGCACGGCGTT-1_1_A4	-27.95771112	23.30604665	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1332	2447	0.008173273	0.002860646	1	8	Astrocytes	26	7	7
TAGCCGGCAGTCTTCC-1_1_A4	14.05848357	20.79087691	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	961	1507	0.0066357	0.00597213	1	oligos	OL-Cntl	26	7	7
TAGCCGGCATACGCTA-1_1_A4	13.00246419	16.86058972	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1037	1633	0.011635028	0.011635028	1	oligos	OL-Cntl	26	7	7
TAGCCGGCATTTGCCC-1_1_A4	17.58137058	8.687873547	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1692	3112	0.005784062	0.006105398	1	oligos	OL-Cntl	26	7	7
TAGCCGGGTAGAGTGC-1_1_A4	4.18661782	12.99216309	5	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1042	1575	0.013333333	0.017142857	1	oligos	OL-MS-1	26	7	7
TAGCCGGGTGTCAATC-1_1_A4	5.883518282	13.33574479	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1027	1602	0.011235955	0.018726592	1	oligos	OL-Cntl	26	7	7
TAGCCGGTCTGTCAAG-1_1_A4	5.640448829	10.01045053	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1558	2586	0.007733952	0.018948183	1	oligos	OL-Cntl	26	7	7
TAGGCATAGAAGGTGA-1_1_A4	-28.93788242	11.2547517	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	784	1228	0.027687296	0.002442997	1	8	Astrocytes	26	7	7
TAGGCATCAACAACCT-1_1_A4	-37.33741017	-4.652380337	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1186	2037	0.001472754	0.004418262	1	9	OPC	26	7	7
TAGGCATCAATTGCTG-1_1_A4	4.348377038	17.24497623	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	976	1517	0.029004614	0.015161503	1	oligos	OL-Cntl	26	7	7
TAGGCATCACTGAAGG-1_1_A4	-26.05340133	22.87736353	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1224	2034	0.000983284	0.005899705	1	8	Astrocytes	26	7	7
TAGGCATCAGGGAGAG-1_1_A4	22.43317584	16.04891682	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1420	2268	0.008818342	0.004850088	1	oligos	OL-Cntl	26	7	7
TAGGCATGTCGTTGTA-1_1_A4	2.666664166	-3.523972022	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	871	1313	0.004569688	0.006092917	1	12	EN-MIX	26	7	7
TAGGCATTCTCGGACG-1_1_A4	-29.72660839	17.89368186	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1008	1742	0.002870264	0.005740528	1	8	Astrocytes	26	7	7
TAGGCATTCTCGTATT-1_1_A4	-37.18350015	-5.090449556	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1162	1971	0.002029427	0.004058853	1	9	OPC	26	7	7
TAGTGGTAGCTGCGAA-1_1_A4	-32.16500469	-12.99715226	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	704	1038	0.004816956	0.006743738	1	9	OPC	26	7	7
TAGTGGTCAAGCTGAG-1_1_A4	-9.867071856	-5.303230109	13A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1701	2827	0.027591086	0.009197029	1	13A	IN-VIP	26	7	7
TAGTGGTGTGTTTGGT-1_1_A4	17.48580286	-5.027409497	3	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1601	2827	0.001768659	0.003183587	1	3	EN-L5-6	26	7	7
TAGTTGGCAGCTCGCA-1_1_A4	0.542746931	25.05898468	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	705	1033	0.010648596	0.003872217	1	oligos	OL-Cntl	26	7	7
TAGTTGGTCGGAAACG-1_1_A4	37.7807243	10.00880185	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	797	1082	0.011090573	0.020332717	1	14	Microglia	26	7	7
TATCAGGGTGATGTCT-1_1_A4	39.22536732	16.1005531	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1490	2331	0.008151008	0.007722008	1	14	Microglia	26	7	7
TATCAGGTCATCTGTT-1_1_A4	-23.76617913	-2.59675075	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	868	1246	0.004815409	0.004012841	1	9	OPC	26	7	7
TATCTCAGTACTTAGC-1_1_A4	-9.135193652	15.02711409	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1990	3551	0.005632216	0.00675866	1	11	Glia-MIX	26	7	7
TATCTCAGTTGATTGC-1_1_A4	-19.07435798	27.62180228	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1998	3816	0.005765199	0.003668763	1	8	Astrocytes	26	7	7
TATCTCATCTACCAGA-1_1_A4	3.785457433	7.346365841	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1124	1767	0.013016412	0.005093379	1	oligos	OL-Cntl	26	7	7
TATCTCATCTTCCTTC-1_1_A4	11.80634807	26.08248818	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	874	1376	0.010901163	0.005087209	1	oligos	OL-Cntl	26	7	7
TATGCCCAGAAGGTTT-1_1_A4	5.213490426	6.549708773	7	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1721	2812	0.016714083	0.0056899	1	7	Phagocytes	26	7	7
TATGCCCAGTCGCCGT-1_1_A4	11.42929374	13.3010907	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1400	2278	0.012291484	0.012730465	1	oligos	OL-Cntl	26	7	7
TATGCCCCAACACCCG-1_1_A4	-22.26158868	28.85795115	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2095	4302	0.005578801	0.005113901	1	8	Astrocytes	26	7	7
TATGCCCCACATGACT-1_1_A4	2.87013555	6.367611077	7	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1112	1648	0.009708738	0.002427184	1	7	Phagocytes	26	7	7
TATGCCCCATTCTCAT-1_1_A4	-2.318573639	23.7937318	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	844	1280	0.00546875	0.00625	1	oligos	OL-Cntl	26	7	7
TATGCCCGTTACGGAG-1_1_A4	19.31987918	1.369295969	2	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1270	2042	0.001469148	0.005386876	1	2	EN-L4	26	7	7
TATGCCCTCCCGGATG-1_1_A4	9.170849769	30.03711016	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	810	1239	0.013720743	0.00322841	1	oligos	OL-Cntl	26	7	7
TATGCCCTCCCTTGCA-1_1_A4	12.89082653	20.10953357	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1024	1634	0.004895961	0.004895961	1	oligos	OL-Cntl	26	7	7
TATGCCCTCCGCGCAA-1_1_A4	4.415286109	5.331263242	7	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1540	2320	0.00387931	0.020258621	1	7	Phagocytes	26	7	7
TATTACCAGCGGCTTC-1_1_A4	-1.486172685	1.250943979	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1668	2661	0.008643367	0.002254791	1	11	Glia-MIX	26	7	7
TATTACCAGTGGTAGC-1_1_A4	13.32338744	12.29515345	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1340	2162	0.012025902	0.008788159	1	oligos	OL-Cntl	26	7	7
TATTACCCAGGTCGTC-1_1_A4	-2.106928693	19.5371091	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	855	1252	0.023961661	0.005591054	1	oligos	OL-Cntl	26	7	7
TATTACCGTATGAAAC-1_1_A4	18.14827969	12.3194037	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1288	2172	0.017034991	0.004143646	1	oligos	OL-Cntl	26	7	7
TATTACCGTTCAGCGC-1_1_A4	6.223856265	6.405528687	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2142	4225	0.010650888	0.007100592	1	oligos	OL-Cntl	26	7	7
TCAACGAAGCTCCTTC-1_1_A4	4.977254028	26.4072361	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	795	1103	0.018132366	0.003626473	1	oligos	OL-Cntl	26	7	7
TCAACGAGTCTCGTTC-1_1_A4	16.40520537	15.2291491	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1297	2189	0.001370489	0.003197807	1	oligos	OL-Cntl	26	7	7
TCAACGATCATCGCTC-1_1_A4	-0.594980056	25.17654571	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	715	1136	0.00528169	0.004401408	1	oligos	OL-Cntl	26	7	7
TCAACGATCATCTGTT-1_1_A4	-15.55538548	-24.37451538	6A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1850	3910	0.023785166	0.002046036	1	6A	IN-PV	26	7	7
TCAACGATCATTGCGA-1_1_A4	5.812388947	21.58784847	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	937	1421	0.018296974	0.004926108	1	oligos	OL-Cntl	26	7	7
TCAATCTAGCGGCTTC-1_1_A4	-10.87477775	9.400468683	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	5348	14463	0.01099357	0.008020466	1	11	Glia-MIX	26	7	7
TCAATCTCAACACCCG-1_1_A4	6.146833998	6.174145555	7	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	3011	6235	0.007698476	0.01138733	1	7	Phagocytes	26	7	7
TCAATCTCATACGCTA-1_1_A4	14.15756975	7.07289833	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1568	2815	0.013143872	0.008880995	1	oligos	OL-Cntl	26	7	7
TCAATCTTCCCTCTTT-1_1_A4	14.07303041	14.74809215	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1221	1938	0.005159959	0.006707946	1	oligos	OL-Cntl	26	7	7
TCACAAGAGCAGCGTA-1_1_A4	-37.61449743	-0.93003709	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1545	2698	0.00148258	0.00222387	1	9	OPC	26	7	7
TCACAAGAGCTCCTCT-1_1_A4	31.46696309	-13.65728675	2	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	4088	9570	0.02737722	0.009404389	1	2	EN-L4	26	7	7
TCACAAGAGTGTGAAT-1_1_A4	13.81622368	24.80476649	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	873	1339	0.005227782	0.000746826	1	oligos	OL-Cntl	26	7	7
TCACAAGCAAGTTAAG-1_1_A4	7.561648902	20.26137788	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1090	1718	0.011641444	0.009895227	1	oligos	OL-Cntl	26	7	7
TCACAAGCACATCTTT-1_1_A4	2.265704331	22.4657539	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	799	1202	0.001663894	0.004991681	1	oligos	OL-Cntl	26	7	7
TCACAAGCATGTCCTC-1_1_A4	-37.42790225	0.611922393	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1682	3324	0.002707581	0.001805054	1	9	OPC	26	7	7
TCACAAGGTATGAAAC-1_1_A4	-8.992058909	16.53205628	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2624	5176	0.011785162	0.007148377	1	11	Glia-MIX	26	7	7
TCACAAGGTCATCCCT-1_1_A4	5.609037262	6.4105651	7	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2018	3600	0.006111111	0.006666667	1	7	Phagocytes	26	7	7
TCACAAGTCCACGCAG-1_1_A4	10.90095524	25.23078176	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	862	1383	0.009399855	0.002169197	1	oligos	OL-Cntl	26	7	7
TCACAAGTCTACCAGA-1_1_A4	9.623200619	17.51565236	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1070	1672	0.013157895	0.00777512	1	oligos	OL-Cntl	26	7	7
TCACGAAAGAATAGGG-1_1_A4	-8.265285649	-17.6932348	6B	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	635	1000	0.044	0.005	1	6B	IN-SST	26	7	7
TCACGAAGTAAGGGAA-1_1_A4	5.465699951	13.4220211	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1027	1538	0.011053316	0.016254876	1	oligos	OL-Cntl	26	7	7
TCACGAAGTAATAGCA-1_1_A4	16.96754005	15.44110225	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1237	2098	0.011916111	0.004766444	1	oligos	OL-Cntl	26	7	7
TCACGAAGTGTGACGA-1_1_A4	2.350593541	21.2336237	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1009	1522	0.011169514	0.011826544	1	oligos	OL-Cntl	26	7	7
TCACGAAGTTGGACCC-1_1_A4	-2.378840528	20.07427109	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	910	1316	0.003799392	0.019756839	1	oligos	OL-Cntl	26	7	7
TCAGATGAGAAGCCCA-1_1_A4	21.09631781	16.75159782	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1239	2008	0.00498008	0.00498008	1	oligos	OL-Cntl	26	7	7
TCAGATGAGCTTCGCG-1_1_A4	-0.691362032	22.53560421	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	671	1015	0.008866995	0.006896552	1	oligos	OL-Cntl	26	7	7
TCAGATGCAAGCCGTC-1_1_A4	3.090586081	21.24304076	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	852	1262	0.017432647	0.00792393	1	oligos	OL-Cntl	26	7	7
TCAGATGCAAGCTGAG-1_1_A4	33.45666527	14.75848256	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	874	1206	0.006633499	0.049751244	1	14	Microglia	26	7	7
TCAGATGCAGACACTT-1_1_A4	-2.847249339	21.83102911	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	850	1317	0.011389522	0.012148823	1	oligos	OL-Cntl	26	7	7
TCAGATGGTACGAAAT-1_1_A4	3.807907489	-14.3830117	4	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2612	5591	0.005008049	0.005365766	1	L2-3	EN-L2-3-MS	26	7	7
TCAGATGGTACGACCC-1_1_A4	2.781014177	20.97046191	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	860	1239	0.014527845	0.012106538	1	oligos	OL-Cntl	26	7	7
TCAGATGGTTCTGGTA-1_1_A4	19.8387646	11.36153691	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1419	2428	0.013179572	0.009472817	1	oligos	OL-Cntl	26	7	7
TCAGATGTCAGCTGGC-1_1_A4	-11.35544789	8.501574756	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	4093	10107	0.005441773	0.003462946	1	11	Glia-MIX	26	7	7
TCAGATGTCATGTAGC-1_1_A4	-21.05431474	23.77557531	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1634	2892	0.01417704	0.003457815	1	8	Astrocytes	26	7	7
TCAGATGTCGCCAGCA-1_1_A4	-12.00456418	14.46218022	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	956	1382	0.011577424	0.002894356	1	11	Glia-MIX	26	7	7
TCAGCAACACACCGAC-1_1_A4	-31.59039423	-11.93411893	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	818	1221	0.004095004	0.007371007	1	9	OPC	26	7	7
TCAGCAACACGAGGTA-1_1_A4	-19.0825654	7.085590316	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	855	1282	0.003900156	0.011700468	1	8	Astrocytes	26	7	7
TCAGCAAGTAAGAGGA-1_1_A4	12.89072872	-3.632252238	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1111	1759	0.009664582	0.003979534	1	12	EN-MIX	26	7	7
TCAGCAAGTGCACCAC-1_1_A4	-4.513285085	-8.623117765	13A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	884	1397	0.073013601	0.003579098	1	13A	IN-VIP	26	7	7
TCAGCAATCACTCCTG-1_1_A4	12.95766761	27.02593679	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	780	1242	0.004830918	0.004830918	1	oligos	OL-Cntl	26	7	7
TCAGCAATCTGACCTC-1_1_A4	14.53160539	17.3589507	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1093	1819	0.015393073	0.007146784	1	oligos	OL-Cntl	26	7	7
TCAGCTCAGCTGTCTA-1_1_A4	-9.33252104	18.3943804	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	3032	6327	0.004109373	0.004425478	1	11	Glia-MIX	26	7	7
TCAGCTCAGGCTCAGA-1_1_A4	-9.861676633	17.73416317	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2165	4046	0.004448838	0.005190311	1	11	Glia-MIX	26	7	7
TCAGCTCCACGAAACG-1_1_A4	-23.30292354	-0.215347299	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1854	3284	0.006394641	0.00365408	1	9	OPC	26	7	7
TCAGCTCCACGTCTCT-1_1_A4	19.87600327	14.59146277	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1391	2300	0.014347826	0.005652174	1	oligos	OL-Cntl	26	7	7
TCAGCTCCAGATCCAT-1_1_A4	19.89185304	19.25051257	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1078	1805	0.000554017	0.004432133	1	oligos	OL-Cntl	26	7	7
TCAGCTCCAGTATCTG-1_1_A4	4.041818582	-5.057833385	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	869	1388	0.001440922	0.001440922	1	12	EN-MIX	26	7	7
TCAGCTCGTACCGTTA-1_1_A4	37.33886303	9.657740221	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	764	1043	0.004793864	0.014381592	1	14	Microglia	26	7	7
TCAGCTCGTAGAGGAA-1_1_A4	-8.021698521	9.144855361	5	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	905	1461	0.003422313	0.011635866	1	oligos	OL-MS-1	26	7	7
TCAGCTCGTGTTCTTT-1_1_A4	-35.332466	-11.98567173	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	861	1356	0.004424779	0.002949853	1	9	OPC	26	7	7
TCAGCTCTCATAGCAC-1_1_A4	-2.072281677	24.00970109	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	680	1042	0.001919386	0.009596929	1	oligos	OL-Cntl	26	7	7
TCAGCTCTCCGCATCT-1_1_A4	17.28109812	1.784905384	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	928	1403	0.000712758	0.003563792	1	12	EN-MIX	26	7	7
TCAGGATCATGCCACG-1_1_A4	2.859749637	-6.945017942	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1273	2114	0.005203406	0.003311258	1	12	EN-MIX	26	7	7
TCAGGATCATTTGCTT-1_1_A4	20.46064254	-27.53847497	3	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	3567	10039	0.008168144	0.002689511	1	3	EN-L5-6	26	7	7
TCAGGATTCGACCAGC-1_1_A4	2.62409547	4.4492279	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	996	1363	0.008070433	0.005869406	1	14	Microglia	26	7	7
TCAGGATTCGGCTACG-1_1_A4	14.5014368	15.64733705	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1189	1932	0.003623188	0.009834369	1	oligos	OL-Cntl	26	7	7
TCAGGTAAGTTTCCTT-1_1_A4	5.624070162	13.10812912	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1108	1770	0.010734463	0.011299435	1	oligos	OL-Cntl	26	7	7
TCAGGTACAATGTAAG-1_1_A4	5.245933041	-5.386363215	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	974	1511	0.004632694	0.00198544	1	12	EN-MIX	26	7	7
TCAGGTACACACAGAG-1_1_A4	-26.3511447	22.75351391	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1305	2220	0.013063063	0.002252252	1	8	Astrocytes	26	7	7
TCAGGTACATGCATGT-1_1_A4	14.53737757	13.36841237	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1344	2179	0.008719596	0.010096374	1	oligos	OL-Cntl	26	7	7
TCAGGTAGTCACCCAG-1_1_A4	4.290707872	25.08615351	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	867	1303	0.012279355	0.006139678	1	oligos	OL-Cntl	26	7	7
TCATTACAGAACTGTA-1_1_A4	14.60853838	14.13799216	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1300	2196	0.008196721	0.007285974	1	oligos	OL-Cntl	26	7	7
TCATTACAGAGTTGGC-1_1_A4	20.91992619	-2.366239905	2	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1841	3144	0.014631043	0.007633588	1	2	EN-L4	26	7	7
TCATTACAGATAGTCA-1_1_A4	38.66842391	10.88535607	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	818	1121	0	0.018733274	1	14	Microglia	26	7	7
TCATTACAGTACGCCC-1_1_A4	-36.21350913	-7.077196817	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1083	1759	0.010233087	0.002274019	1	9	OPC	26	7	7
TCATTACCACACTGCG-1_1_A4	16.43575712	20.73210775	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1032	1670	0.007185629	0.00239521	1	oligos	OL-Cntl	26	7	7
TCATTACCACAGACAG-1_1_A4	19.5687359	16.32067161	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1245	1989	0.008547009	0.007038713	1	oligos	OL-Cntl	26	7	7
TCATTACCACCCATTC-1_1_A4	-9.468917376	13.22383956	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	975	1412	0.004957507	0.001416431	1	11	Glia-MIX	26	7	7
TCATTACCAGACAAGC-1_1_A4	-22.79818246	28.84243613	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2049	4118	0.000728509	0.003885381	1	8	Astrocytes	26	7	7
TCATTACTCCTTGCCA-1_1_A4	5.969818326	20.25866672	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	954	1443	0.012474012	0.011781012	1	oligos	OL-Cntl	26	7	7
TCATTACTCGCTGATA-1_1_A4	-16.23326057	-25.37530812	6A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2208	4878	0.02296023	0.003075031	1	6A	IN-PV	26	7	7
TCATTACTCGGTGTCG-1_1_A4	-17.49993105	-14.56944688	6B	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2150	4129	0.016226689	0.009929765	1	6B	IN-SST	26	7	7
TCATTTGCACAGACTT-1_1_A4	38.71724995	14.86787066	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1213	1786	0.006159015	0.012318029	1	14	Microglia	26	7	7
TCATTTGCATATGAGA-1_1_A4	4.329700496	5.175523171	7	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1522	2436	0.013136289	0.003694581	1	7	Phagocytes	26	7	7
TCATTTGTCCCAAGAT-1_1_A4	14.62484514	24.60056445	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	798	1191	0.000839631	0.007556675	1	oligos	OL-Cntl	26	7	7
TCCACACAGTATCGAA-1_1_A4	-23.48012613	1.175687862	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2810	5583	0.001612037	0.005731685	1	9	OPC	26	7	7
TCCACACAGTTAGCGG-1_1_A4	2.976018194	26.24618124	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	695	1079	0.017608897	0.007414272	1	oligos	OL-Cntl	26	7	7
TCCACACCAAACCCAT-1_1_A4	15.91965301	-5.970465759	3	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1548	3049	0.008527386	0.006231551	1	3	EN-L5-6	26	7	7
TCCACACCACTGTCGG-1_1_A4	-22.41361913	25.64640383	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1816	3631	0.004681906	0.006334343	1	8	Astrocytes	26	7	7
TCCACACCAGTATAAG-1_1_A4	3.887282209	15.28859939	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	937	1441	0.006245663	0.0111034	1	oligos	OL-Cntl	26	7	7
TCCACACCATGACATC-1_1_A4	38.98841815	10.8693835	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	895	1146	0.001745201	0.012216405	1	14	Microglia	26	7	7
TCCCGATAGCCGATTT-1_1_A4	8.077730816	29.99693503	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	668	1067	0.000937207	0.003748828	1	oligos	OL-Cntl	26	7	7
TCCCGATAGGTGCAAC-1_1_A4	-3.122805492	33.12093123	17	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1064	1711	0.036820573	0.004091175	1	oligos	OL-MS-2	26	7	7
TCCCGATCAGTAAGAT-1_1_A4	-3.972680521	-6.368090239	13A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1113	1796	0.016703786	0.006124722	1	13A	IN-VIP	26	7	7
TCCCGATCAGTTAACC-1_1_A4	14.51938571	-7.721001915	10	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1703	3516	0.003412969	0.003412969	1	L2-3	EN-L2-3-Cntl	26	7	7
TCCCGATCATCGGGTC-1_1_A4	25.98745043	3.207087666	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	798	2230	0.001793722	0.004932735	1	8	Astrocytes	26	7	7
TCCCGATGTGTGAATA-1_1_A4	14.59749236	-0.978896135	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	806	1249	0.001601281	0.002401922	1	12	EN-MIX	26	7	7
TCCCGATGTTCACCTC-1_1_A4	-13.24634122	-18.2749273	6B	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1241	2150	0.02744186	0.006046512	1	6B	IN-SST	26	7	7
TCCCGATTCCGTAGGC-1_1_A4	17.37084649	18.97126739	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1036	1703	0.002935995	0.003523194	1	oligos	OL-Cntl	26	7	7
TCCCGATTCTTAGAGC-1_1_A4	-26.57423985	1.736899527	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1709	2744	0.003644315	0.01712828	1	9	OPC	26	7	7
TCGAGGCCACAGCCCA-1_1_A4	15.86465354	19.45486704	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	979	1602	0.011235955	0.005617978	1	oligos	OL-Cntl	26	7	7
TCGAGGCGTATCTGCA-1_1_A4	39.95974284	13.54843576	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1085	1456	0.011675824	0.004807692	1	14	Microglia	26	7	7
TCGAGGCGTCCTCCAT-1_1_A4	-9.256307025	13.45364575	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1576	2529	0.009489917	0.014630289	1	11	Glia-MIX	26	7	7
TCGAGGCGTCGGGTCT-1_1_A4	6.893046655	17.60772253	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1193	1868	0.02248394	0.009100642	1	oligos	OL-Cntl	26	7	7
TCGAGGCTCAACGCTA-1_1_A4	5.607076371	5.490796338	7	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	3251	6171	0.009398801	0.015232539	1	7	Phagocytes	26	7	7
TCGAGGCTCCTTTCGG-1_1_A4	-35.74927141	-5.361612165	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1284	2151	0.004649	0.0032543	1	9	OPC	26	7	7
TCGAGGCTCGGCGGTT-1_1_A4	12.80475056	11.96608502	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1454	2364	0.007614213	0.019458545	1	oligos	OL-Cntl	26	7	7
TCGCGAGCAGATTGCT-1_1_A4	-33.78992465	-11.75045131	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	850	1306	0.009954058	0.00229709	1	9	OPC	26	7	7
TCGCGAGCAGTAGAGC-1_1_A4	-3.940993192	21.50823307	5	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	788	1146	0.006108202	0.016579407	1	oligos	OL-MS-1	26	7	7
TCGCGAGGTGAGGCTA-1_1_A4	-3.999449777	-6.792470232	13A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1025	1584	0.006944444	0.005050505	1	13A	IN-VIP	26	7	7
TCGCGAGGTTCGCTAA-1_1_A4	3.685142825	7.24652839	7	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1249	1958	0.002553626	0.011235955	1	7	Phagocytes	26	7	7
TCGCGAGTCGATGAGG-1_1_A4	-27.12515266	4.178666304	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2402	4457	0.01054521	0.010769576	1	9	OPC	26	7	7
TCGCGAGTCGTCCGTT-1_1_A4	6.232120969	-13.55584043	4	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2619	5538	0.032502709	0.003611412	1	L2-3	EN-L2-3-MS	26	7	7
TCGCGTTAGACCTAGG-1_1_A4	-36.92577156	-1.346333697	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1427	2452	0.002854812	0.005301794	1	9	OPC	26	7	7
TCGCGTTAGCTGAAAT-1_1_A4	2.18246145	-4.192040529	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	893	1435	0.022996516	0.000696864	1	12	EN-MIX	26	7	7
TCGCGTTAGGATCGCA-1_1_A4	0.099969526	27.96417343	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	775	1175	0.002553191	0.003404255	1	oligos	OL-Cntl	26	7	7
TCGCGTTAGTGGAGTC-1_1_A4	4.754012183	25.25513728	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	814	1192	0.011744966	0.007550336	1	oligos	OL-Cntl	26	7	7
TCGCGTTCAGCTGCTG-1_1_A4	7.917187937	12.43565567	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1255	2037	0.014236622	0.016200295	1	oligos	OL-Cntl	26	7	7
TCGCGTTGTCTCCACT-1_1_A4	5.327944813	24.99162883	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	841	1181	0.00762066	0.00677392	1	oligos	OL-Cntl	26	7	7
TCGCGTTGTGGCCCTA-1_1_A4	37.27382577	11.01320177	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	833	1114	0.006283662	0.012567325	1	14	Microglia	26	7	7
TCGCGTTTCCCTCTTT-1_1_A4	0.928973099	21.95891347	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	919	1385	0.007220217	0.01299639	1	oligos	OL-Cntl	26	7	7
TCGCGTTTCGCCAAAT-1_1_A4	16.25907338	13.41794528	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1449	2459	0.005286702	0.003660024	1	oligos	OL-Cntl	26	7	7
TCGGGACAGAAGGACA-1_1_A4	5.801658977	5.794864623	7	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	3044	5659	0.013960064	0.009719032	1	7	Phagocytes	26	7	7
TCGGGACAGAGCTGCA-1_1_A4	19.85164616	17.59334186	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1180	1969	0.01015744	0.007110208	1	oligos	OL-Cntl	26	7	7
TCGGGACAGCGATCCC-1_1_A4	2.928915121	25.90649182	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	722	1036	0.006756757	0.006756757	1	oligos	OL-Cntl	26	7	7
TCGGGACAGTAATCCC-1_1_A4	-0.843560529	27.04616453	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	652	1006	0.027833002	0.001988072	1	oligos	OL-Cntl	26	7	7
TCGGGACCAAGAAAGG-1_1_A4	12.92778818	15.63427526	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1244	1989	0.001508296	0.006033183	1	oligos	OL-Cntl	26	7	7
TCGGGACCAGAGCCAA-1_1_A4	-33.01131448	-8.55168367	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1156	1800	0.006666667	0.002777778	1	9	OPC	26	7	7
TCGGGACCATAGAAAC-1_1_A4	3.461026797	4.884584198	7	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1158	1543	0.008425146	0.025923526	1	7	Phagocytes	26	7	7
TCGGGACGTGACGGTA-1_1_A4	-25.75102945	14.58741864	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1061	1690	0.00295858	0.007692308	1	8	Astrocytes	26	7	7
TCGGTAACACTGTCGG-1_1_A4	39.28165712	10.84228139	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	897	1201	0.013322231	0.008326395	1	14	Microglia	26	7	7
TCGGTAACAGTAAGAT-1_1_A4	14.25679338	17.55172367	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1079	1627	0.008604794	0.004917025	1	oligos	OL-Cntl	26	7	7
TCGGTAAGTAATTGGA-1_1_A4	11.54762631	22.84356836	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	939	1460	0.00890411	0.005479452	1	oligos	OL-Cntl	26	7	7
TCGGTAAGTAGCCTAT-1_1_A4	-9.389097414	15.96319285	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2530	4575	0.005901639	0.010710383	1	11	Glia-MIX	26	7	7
TCGGTAAGTTACCAGT-1_1_A4	-25.38477465	23.48244249	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1367	2337	0.002567394	0.009841677	1	8	Astrocytes	26	7	7
TCGGTAATCGCTTGTC-1_1_A4	-27.45746291	23.23145892	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1233	2142	0.006069094	0.002334267	1	8	Astrocytes	26	7	7
TCGTACCAGACACGAC-1_1_A4	-4.557057992	-4.344270154	13A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1293	2221	0.025664115	0.002701486	1	13A	IN-VIP	26	7	7
TCGTACCAGCGATAGC-1_1_A4	15.77342325	-2.3512626	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	965	1613	0.002479851	0.001859888	1	12	EN-MIX	26	7	7
TCGTACCAGGAGTACC-1_1_A4	3.411588104	25.45432362	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	758	1142	0.010507881	0.008756567	1	oligos	OL-Cntl	26	7	7
TCGTACCGTGTGCGTC-1_1_A4	-22.29009393	28.14092887	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2161	4437	0.00360604	0.00360604	1	8	Astrocytes	26	7	7
TCGTACCTCCGTTGTC-1_1_A4	4.997829105	-5.457661532	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1027	1636	0.009168704	0.004889976	1	12	EN-MIX	26	7	7
TCGTAGACACATCCGG-1_1_A4	13.32160102	29.65497361	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	834	1326	0.027903469	0.002262443	1	oligos	OL-Cntl	26	7	7
TCGTAGATCTGCCAGG-1_1_A4	-3.080271866	20.17627839	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	801	1180	0.022033898	0.007627119	1	oligos	OL-Cntl	26	7	7
TCTATTGAGCCAGTTT-1_1_A4	0.216730698	-0.533930439	6B	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1009	1522	0.0282523	0.004599212	1	6B	IN-SST	26	7	7
TCTATTGAGCCCAATT-1_1_A4	-11.08147483	7.143818492	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	4327	11669	0.011140629	0.006341589	1	11	Glia-MIX	26	7	7
TCTATTGAGCGATATA-1_1_A4	-26.76313155	18.42537736	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1270	2227	0.001347104	0.004041311	1	8	Astrocytes	26	7	7
TCTATTGAGGCATGGT-1_1_A4	-5.021730199	-3.596881031	13A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1331	2380	0.018487395	0.002941176	1	13A	IN-VIP	26	7	7
TCTATTGCATGCTGGC-1_1_A4	11.4882973	16.34492304	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1112	1838	0.016322089	0.013057671	1	oligos	OL-Cntl	26	7	7
TCTATTGGTAGGGACT-1_1_A4	-0.52160661	23.20691102	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	715	1091	0.018331806	0.010999083	1	oligos	OL-Cntl	26	7	7
TCTATTGGTCCTCTTG-1_1_A4	4.619526701	4.835139559	7	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1528	2411	0.001244297	0.004147657	1	7	Phagocytes	26	7	7
TCTATTGGTTCATGGT-1_1_A4	3.845702273	29.16534456	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	667	1051	0.010466223	0.002854424	1	oligos	OL-Cntl	26	7	7
TCTATTGTCGAACGGA-1_1_A4	2.526533834	23.37068152	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	784	1127	0.007985803	0.01242236	1	oligos	OL-Cntl	26	7	7
TCTATTGTCTAGCACA-1_1_A4	-24.37266563	15.19396674	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1001	1630	0.000613497	0.005521472	1	8	Astrocytes	26	7	7
TCTATTGTCTCAACTT-1_1_A4	7.621849189	29.94331272	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	644	1035	0	0.005797101	1	oligos	OL-Cntl	26	7	7
TCTATTGTCTGCCAGG-1_1_A4	2.326454632	-19.6165365	4	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	3861	10966	0.006109794	0.002735729	1	L2-3	EN-L2-3-MS	26	7	7
TCTATTGTCTTGAGAC-1_1_A4	3.552364969	20.2785102	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	839	1296	0.022376543	0.015432099	1	oligos	OL-Cntl	26	7	7
TCTCATAAGGCTCAGA-1_1_A4	-23.03859857	23.29042157	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1522	2700	0.004444444	0.003333333	1	8	Astrocytes	26	7	7
TCTCATACATACAGCT-1_1_A4	-23.85047241	27.99079312	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1745	3422	0.011689071	0.004675628	1	8	Astrocytes	26	7	7
TCTCATAGTGAAAGAG-1_1_A4	6.346057733	14.56636531	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1142	1723	0.022054556	0.015089959	1	oligos	OL-Cntl	26	7	7
TCTCATATCAGCATGT-1_1_A4	19.04832145	16.55797217	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1143	1815	0.007713499	0.00661157	1	oligos	OL-Cntl	26	7	7
TCTCATATCGATAGAA-1_1_A4	4.698729281	6.985033707	7	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1453	2422	0.006606111	0.003715937	1	7	Phagocytes	26	7	7
TCTCATATCGTCGTTC-1_1_A4	5.592561357	28.33939521	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	717	1060	0.016037736	0.000943396	1	oligos	OL-Cntl	26	7	7
TCTCTAACAAGAAGAG-1_1_A4	2.529416407	4.418525114	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	936	1259	0.003177125	0.008737093	1	14	Microglia	26	7	7
TCTCTAACAGTGAGTG-1_1_A4	-28.58934898	9.873608901	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	798	1282	0.001560062	0.003120125	1	8	Astrocytes	26	7	7
TCTCTAATCAATCTCT-1_1_A4	6.359507416	19.86518186	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	963	1570	0.014649682	0.008280255	1	oligos	OL-Cntl	26	7	7
TCTCTAATCCTTCAAT-1_1_A4	4.056597496	18.32070904	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	905	1465	0.005460751	0.012969283	1	oligos	OL-Cntl	26	7	7
TCTGAGAAGAGGGATA-1_1_A4	-11.21180864	-10.24594496	13B	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1324	2091	0.012434242	0.00095648	1	13B	IN-SV2C	26	7	7
TCTGAGACATCGATGT-1_1_A4	15.07998843	19.47951383	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1124	1799	0.007226237	0.007782101	1	oligos	OL-Cntl	26	7	7
TCTGAGAGTAGTAGTA-1_1_A4	3.329701111	23.11122001	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	840	1240	0.008870968	0.008064516	1	oligos	OL-Cntl	26	7	7
TCTGAGAGTGACCAAG-1_1_A4	-37.00278276	0.285165213	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1738	3238	0.004941322	0.003397159	1	9	OPC	26	7	7
TCTGAGAGTGATGATA-1_1_A4	-36.49337714	-5.553787277	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1195	1907	0.003670687	0.002621919	1	9	OPC	26	7	7
TCTGAGATCCGCGCAA-1_1_A4	13.43537378	22.32664748	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	891	1317	0.011389522	0.004555809	1	oligos	OL-Cntl	26	7	7
TCTGAGATCTCTGTCG-1_1_A4	-32.08425977	1.279306978	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2035	3982	0.02812657	0.004018081	1	9	OPC	26	7	7
TCTGGAAAGCGTCTAT-1_1_A4	32.85608523	9.242127143	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	878	1236	0.115695793	0.021035599	1	14	Microglia	26	7	7
TCTGGAAAGCGTGTCC-1_1_A4	-35.59091073	-6.923177112	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1047	1672	0.004186603	0.004186603	1	9	OPC	26	7	7
TCTGGAACAGCCTGTG-1_1_A4	7.091011473	25.46291678	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1067	1737	0.00115141	0.004605642	1	oligos	OL-Cntl	26	7	7
TCTGGAAGTGACCAAG-1_1_A4	5.01574608	27.8111688	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	873	1281	0.00156128	0.005464481	1	oligos	OL-Cntl	26	7	7
TCTGGAAGTTGGGACA-1_1_A4	-5.803608799	16.50059275	5	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	785	1097	0.020966272	0.008204193	1	oligos	OL-MS-1	26	7	7
TCTGGAATCAGTTGAC-1_1_A4	5.506872685	13.40317544	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1157	1742	0.009184845	0.012629162	1	oligos	OL-Cntl	26	7	7
TCTGGAATCCCATTTA-1_1_A4	39.02727159	15.73847932	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1303	1972	0.009127789	0.013691684	1	14	Microglia	26	7	7
TCTGGAATCCGTTGTC-1_1_A4	6.109249783	19.84327054	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	975	1587	0.018273472	0.011342155	1	oligos	OL-Cntl	26	7	7
TCTGGAATCCTGTACC-1_1_A4	17.33620769	0.119185693	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	866	1433	0.000697837	0.003489184	1	12	EN-MIX	26	7	7
TCTGGAATCTGTCCGT-1_1_A4	2.542740912	6.051836718	7	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	887	1187	0.0168492	0.01095198	1	7	Phagocytes	26	7	7
TCTTCGGAGGCCATAG-1_1_A4	-11.29054637	8.707590954	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	4114	9659	0.010042447	0.009110674	1	11	Glia-MIX	26	7	7
TCTTCGGAGTAGTGCG-1_1_A4	-28.90200421	10.74216868	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	762	1124	0.001779359	0.001779359	1	8	Astrocytes	26	7	7
TCTTCGGGTGCACGAA-1_1_A4	-22.35621703	26.53780254	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1748	3354	0.002385212	0.005664878	1	8	Astrocytes	26	7	7
TCTTCGGGTTCCCTTG-1_1_A4	6.363973698	25.07683926	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	914	1429	0.012596221	0.00489853	1	oligos	OL-Cntl	26	7	7
TCTTCGGTCCTGCAGG-1_1_A4	16.36555787	17.08129319	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1161	1962	0.009683996	0.009174312	1	oligos	OL-Cntl	26	7	7
TCTTCGGTCGCGCCAA-1_1_A4	5.81421677	20.81967256	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	878	1308	0.010703364	0.01146789	1	oligos	OL-Cntl	26	7	7
TCTTTCCAGAGTGACC-1_1_A4	-10.19813287	14.54465631	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1582	2585	0.010058027	0.007350097	1	11	Glia-MIX	26	7	7
TCTTTCCCAGCTCGAC-1_1_A4	-38.54664552	-2.725871551	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1284	2281	0.003507234	0.003068829	1	9	OPC	26	7	7
TCTTTCCCATGCGCAC-1_1_A4	-33.33766359	-11.86705896	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	854	1290	0.004651163	0.005426357	1	9	OPC	26	7	7
TCTTTCCGTAGTGAAT-1_1_A4	20.87174222	-0.420376072	2	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1504	2659	0.004889056	0.010906356	1	2	EN-L4	26	7	7
TGAAAGAAGGCCCGTT-1_1_A4	-1.686566283	11.26020196	5	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	925	1390	0.003597122	0.015107914	1	oligos	OL-MS-1	26	7	7
TGAAAGACAATGTTGC-1_1_A4	6.673121724	-1.740182624	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1079	1917	0.008346375	0.008346375	1	12	EN-MIX	26	7	7
TGAAAGACAGGTTTCA-1_1_A4	39.42592948	14.4245547	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1107	1604	0.016209476	0.003740648	1	14	Microglia	26	7	7
TGAAAGAGTTAAGAAC-1_1_A4	0.68140203	-15.97911769	4	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2494	5468	0.015544989	0.003840527	1	L2-3	EN-L2-3-MS	26	7	7
TGAAAGATCCGAATGT-1_1_A4	-23.20827294	26.19388203	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1689	3270	0.002752294	0.003669725	1	8	Astrocytes	26	7	7
TGACAACAGAATGTGT-1_1_A4	3.169292837	-2.925218869	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	790	1146	0.006980803	0.004363002	1	12	EN-MIX	26	7	7
TGACAACAGGACCACA-1_1_A4	-13.52935462	18.73585843	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1564	2653	0.003392386	0.004523181	1	8	Astrocytes	26	7	7
TGACAACCACAACGTT-1_1_A4	15.16725871	18.74796278	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1087	1840	0.002717391	0.004347826	1	oligos	OL-Cntl	26	7	7
TGACAACCATCAGTCA-1_1_A4	14.87585172	12.9155144	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1387	2251	0.001776988	0.00888494	1	oligos	OL-Cntl	26	7	7
TGACAACGTAGCGTGA-1_1_A4	0.060923298	-11.28312185	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1701	3165	0.017693523	0.005687204	1	12	EN-MIX	26	7	7
TGACAACGTGACGGTA-1_1_A4	4.033892476	20.2818336	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	941	1425	0.007719298	0.007017544	1	oligos	OL-Cntl	26	7	7
TGACAACGTGCGCTTG-1_1_A4	-23.91310875	26.46014541	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1673	3384	0.005023641	0.005614657	1	8	Astrocytes	26	7	7
TGACAACGTTTGGCGC-1_1_A4	-28.19347372	16.62867682	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1064	1773	0.003948111	0.003384095	1	8	Astrocytes	26	7	7
TGACGGCAGATCGATA-1_1_A4	14.68555339	-1.906837545	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	887	1343	0.005956813	0.002978407	1	12	EN-MIX	26	7	7
TGACGGCAGTCTTGCA-1_1_A4	12.34721967	17.17480776	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1162	1797	0.016138008	0.008347245	1	oligos	OL-Cntl	26	7	7
TGACGGCCAAATACAG-1_1_A4	18.64889442	16.21079217	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1315	2175	0.020689655	0.005977011	1	oligos	OL-Cntl	26	7	7
TGACGGCGTCCAAGTT-1_1_A4	15.00424709	-7.51924445	10	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1636	3069	0.004235907	0.003584229	1	L2-3	EN-L2-3-Cntl	26	7	7
TGACGGCTCAGTTCGA-1_1_A4	6.436918945	-5.584955797	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1059	1750	0.004571429	0.002857143	1	12	EN-MIX	26	7	7
TGACGGCTCGCTGATA-1_1_A4	13.16326931	27.85934218	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	905	1363	0.008070433	0.004402054	1	oligos	OL-Cntl	26	7	7
TGACGGCTCGGAGGTA-1_1_A4	5.337480651	19.60680793	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1051	1545	0.014886731	0.012297735	1	oligos	OL-Cntl	26	7	7
TGACGGCTCTCGCTTG-1_1_A4	1.859235868	21.63440723	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	923	1468	0.003405995	0.008855586	1	oligos	OL-Cntl	26	7	7
TGACTAGAGTAACCCT-1_1_A4	15.07947402	13.88301277	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1233	1995	0.007017544	0.004511278	1	oligos	OL-Cntl	26	7	7
TGACTAGAGTAGCCGA-1_1_A4	5.389308573	23.65064559	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	897	1368	0.012426901	0.008040936	1	oligos	OL-Cntl	26	7	7
TGACTAGCAGACGCTC-1_1_A4	-4.343181501	-8.529474493	13A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	777	1139	0.043020193	0.007901668	1	13A	IN-VIP	26	7	7
TGACTAGCAGCGAACA-1_1_A4	14.35367142	14.47741078	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1307	2086	0.004793864	0.00527325	1	oligos	OL-Cntl	26	7	7
TGACTAGGTCAAAGCG-1_1_A4	1.630611258	22.42866176	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	893	1306	0.008422665	0.008422665	1	oligos	OL-Cntl	26	7	7
TGACTAGGTGTCCTCT-1_1_A4	21.86510061	0.900301955	2	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1553	2775	0.007927928	0.002882883	1	2	EN-L4	26	7	7
TGACTAGGTTGTACAC-1_1_A4	-31.48648975	13.01480032	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	840	1353	0.002217295	0.00443459	1	8	Astrocytes	26	7	7
TGACTAGTCAGTGTTG-1_1_A4	21.31548301	16.18108801	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1255	2097	0.006676204	0.001907487	1	oligos	OL-Cntl	26	7	7
TGACTAGTCCGAACGC-1_1_A4	9.013187768	34.17328547	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	982	1573	0.043229498	0.00317864	1	oligos	OL-Cntl	26	7	7
TGACTAGTCGCTTAGA-1_1_A4	4.559842216	6.151229047	7	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1592	2567	0.008570316	0.009738995	1	7	Phagocytes	26	7	7
TGACTTTAGTCCTCCT-1_1_A4	15.92543584	17.6466089	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1068	1683	0.005941771	0.005941771	1	oligos	OL-Cntl	26	7	7
TGACTTTAGTCTTGCA-1_1_A4	-33.47642285	-4.18074276	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1434	2525	0.00990099	0.004356436	1	9	OPC	26	7	7
TGACTTTCATGACATC-1_1_A4	-10.83843633	8.693140192	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	6588	22791	0.007108069	0.006932561	1	11	Glia-MIX	26	7	7
TGACTTTGTACTTGAC-1_1_A4	-24.26476705	27.05191149	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1788	3648	0.002741228	0.00877193	1	8	Astrocytes	26	7	7
TGACTTTGTCCTAGCG-1_1_A4	4.93363785	13.41620011	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1106	1657	0.010863005	0.015691008	1	oligos	OL-Cntl	26	7	7
TGACTTTGTTAGGGTG-1_1_A4	13.49512188	21.74712534	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	907	1463	0.006151743	0.008885851	1	oligos	OL-Cntl	26	7	7
TGACTTTTCACAATGC-1_1_A4	5.026396153	20.40550332	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	868	1342	0.000745156	0.006706408	1	oligos	OL-Cntl	26	7	7
TGACTTTTCTTGACGA-1_1_A4	-32.72076881	-12.77527604	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	739	1126	0	0.017761989	1	9	OPC	26	7	7
TGAGAGGCAACTGGCC-1_1_A4	-1.055617899	-0.482265678	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1963	3680	0.003804348	0.003804348	1	11	Glia-MIX	26	7	7
TGAGAGGCACTTAACG-1_1_A4	-4.126706219	-7.025780219	13A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	891	1322	0.006807867	0.004538578	1	13A	IN-VIP	26	7	7
TGAGAGGGTCCATCCT-1_1_A4	3.732946672	5.378673464	7	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1113	1574	0.00635324	0.007623888	1	7	Phagocytes	26	7	7
TGAGAGGGTGTAACGG-1_1_A4	-1.003319554	21.14519862	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	847	1285	0.00311284	0.014785992	1	oligos	OL-Cntl	26	7	7
TGAGAGGGTGTCCTCT-1_1_A4	12.87319089	15.50514076	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1301	2147	0.006986493	0.012575687	1	oligos	OL-Cntl	26	7	7
TGAGAGGGTTAAGAAC-1_1_A4	2.684086689	6.020041901	7	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1148	1591	0.023884349	0.015713388	1	7	Phagocytes	26	7	7
TGAGAGGGTTAAGGGC-1_1_A4	3.26091314	21.3029225	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	913	1361	0.0286554	0.0095518	1	oligos	OL-Cntl	26	7	7
TGAGAGGTCAGCTCGG-1_1_A4	-24.60853564	17.38856052	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1385	2348	0.004258944	0.007240204	1	8	Astrocytes	26	7	7
TGAGAGGTCATTATCC-1_1_A4	-22.74549321	-1.538395695	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	848	1165	0.006008584	0.003433476	1	9	OPC	26	7	7
TGAGAGGTCCCTCAGT-1_1_A4	12.7922826	19.298133	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	990	1503	0.010645376	0.007318696	1	oligos	OL-Cntl	26	7	7
TGAGAGGTCGCGGATC-1_1_A4	-0.81058754	23.10145775	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	757	1094	0.011882998	0.010968921	1	oligos	OL-Cntl	26	7	7
TGAGCATAGAACAATC-1_1_A4	12.12773556	24.61861004	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	856	1414	0.003536068	0.009193777	1	oligos	OL-Cntl	26	7	7
TGAGCATAGCTAGCCC-1_1_A4	-33.81684559	-8.37718696	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1091	1677	0.008944544	0.001192606	1	9	OPC	26	7	7
TGAGCATAGGTCATCT-1_1_A4	8.019749206	-7.409654369	10	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1760	3535	0.004809052	0.002263083	1	L2-3	EN-L2-3-Cntl	26	7	7
TGAGCATCAATGAATG-1_1_A4	-32.26094086	-13.24708279	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	798	1159	0.006039689	0.002588438	1	9	OPC	26	7	7
TGAGCATCAGTAAGCG-1_1_A4	-9.240557154	-5.615587876	13A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1487	2427	0.013597033	0.00947672	1	13A	IN-VIP	26	7	7
TGAGCATGTAAGGATT-1_1_A4	12.48334981	-1.626829625	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1034	1627	0.007990166	0.006146281	1	12	EN-MIX	26	7	7
TGAGCATGTCGCGTGT-1_1_A4	-4.523510207	-8.216801959	13A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	741	1125	0.031111111	0.005333333	1	13A	IN-VIP	26	7	7
TGAGCATGTGCGAAAC-1_1_A4	-3.111632845	19.09081511	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	787	1131	0.030946065	0.006189213	1	oligos	OL-Cntl	26	7	7
TGAGCATGTGTCCTCT-1_1_A4	7.352273892	20.31247753	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1010	1580	0.009493671	0.008860759	1	oligos	OL-Cntl	26	7	7
TGAGCATTCGGCGCTA-1_1_A4	-2.458446431	22.47896022	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	681	1000	0.02	0.008	1	oligos	OL-Cntl	26	7	7
TGAGCATTCTTTAGGG-1_1_A4	2.501743452	26.49257437	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	723	1115	0.007174888	0.004484305	1	oligos	OL-Cntl	26	7	7
TGAGCCGAGACTCGGA-1_1_A4	-22.31797121	27.85378045	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1910	3416	0.004098361	0.005562061	1	8	Astrocytes	26	7	7
TGAGCCGAGATATACG-1_1_A4	6.041651321	19.8500986	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	951	1429	0.016095171	0.010496851	1	oligos	OL-Cntl	26	7	7
TGAGCCGAGCTGTTCA-1_1_A4	22.65014244	10.52072688	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1553	2587	0.001546193	0.003478933	1	oligos	OL-Cntl	26	7	7
TGAGCCGAGGAACTGC-1_1_A4	-35.51504374	-4.778238326	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1316	2181	0.002751032	0.003209537	1	9	OPC	26	7	7
TGAGCCGCAGACTCGC-1_1_A4	35.86347314	7.979583249	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	777	1005	0	0.007960199	1	14	Microglia	26	7	7
TGAGCCGCATCAGTCA-1_1_A4	3.997423903	23.44237349	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	860	1343	0.020848846	0.005212211	1	oligos	OL-Cntl	26	7	7
TGAGCCGGTCTCGTTC-1_1_A4	1.492439618	23.31953555	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	805	1225	0.014693878	0.006530612	1	oligos	OL-Cntl	26	7	7
TGAGGGAAGCTAGTTC-1_1_A4	6.374001686	14.13831278	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1183	1912	0.016213389	0.012552301	1	oligos	OL-Cntl	26	7	7
TGAGGGACACAGCGTC-1_1_A4	19.20721785	-26.82556843	3	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	3815	9656	0.013359569	0.003521127	1	3	EN-L5-6	26	7	7
TGAGGGACAGATGGGT-1_1_A4	4.753556264	18.40637974	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	979	1449	0.011732229	0.013802622	1	oligos	OL-Cntl	26	7	7
TGAGGGAGTTCAGGCC-1_1_A4	-2.845426805	24.13778822	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	791	1215	0.027160494	0.008230453	1	oligos	OL-Cntl	26	7	7
TGAGGGATCACTCTTA-1_1_A4	-10.6818712	9.636472701	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	4996	14544	0.006050605	0.004056656	1	11	Glia-MIX	26	7	7
TGATTTCCAGAGCCAA-1_1_A4	3.195683157	24.7947653	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	819	1269	0.011032309	0.007092199	1	oligos	OL-Cntl	26	7	7
TGATTTCTCATTCACT-1_1_A4	11.72893062	29.49247273	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	759	1193	0.000838223	0.002514669	1	oligos	OL-Cntl	26	7	7
TGCACCTCAAGCCCAC-1_1_A4	6.110536327	6.221771251	7	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2494	4720	0.026694915	0.011652542	1	7	Phagocytes	26	7	7
TGCACCTCAGACGCCT-1_1_A4	39.02751219	16.15314599	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1522	2271	0.001761339	0.024658741	1	14	Microglia	26	7	7
TGCACCTGTAACGCGA-1_1_A4	15.34553995	23.53527801	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	931	1463	0.00683527	0.002050581	1	oligos	OL-Cntl	26	7	7
TGCACCTGTAAGGGCT-1_1_A4	-4.319436506	-7.817377987	13A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	811	1153	0.012142238	0.006071119	1	13A	IN-VIP	26	7	7
TGCACCTGTAAGTTCC-1_1_A4	-31.55007125	-13.14698952	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	675	1041	0.003842459	0.002881844	1	9	OPC	26	7	7
TGCACCTTCCCATTTA-1_1_A4	-9.359471899	-20.17823892	6B	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	878	1656	0.004830918	0.000603865	1	6B	IN-SST	26	7	7
TGCACCTTCCTCGCAT-1_1_A4	5.581392307	22.56135194	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	906	1453	0.006194081	0.006882312	1	oligos	OL-Cntl	26	7	7
TGCACCTTCGTCGTTC-1_1_A4	14.63772794	17.36449556	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1062	1745	0.006303725	0.008022923	1	oligos	OL-Cntl	26	7	7
TGCCAAAAGAGTAAGG-1_1_A4	5.954141536	19.47216198	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1056	1636	0.007334963	0.007334963	1	oligos	OL-Cntl	26	7	7
TGCCAAACAACAACCT-1_1_A4	-24.23963573	19.29598323	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1661	3118	0.002245029	0.005452213	1	8	Astrocytes	26	7	7
TGCCAAACAGCTGGCT-1_1_A4	11.86848964	16.34907456	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1125	1841	0.010320478	0.010320478	1	oligos	OL-Cntl	26	7	7
TGCCAAACATAAGACA-1_1_A4	-16.14209195	14.17270965	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1461	2422	0	0.016515277	1	8	Astrocytes	26	7	7
TGCCAAAGTTTAAGCC-1_1_A4	39.89185194	13.67533707	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1047	1525	0.003278689	0.011803279	1	14	Microglia	26	7	7
TGCCAAATCAAAGTAG-1_1_A4	2.741069458	-11.91399381	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1810	3084	0.004863813	0.007133593	1	12	EN-MIX	26	7	7
TGCCAAATCCGTCAAA-1_1_A4	4.548270416	17.46965153	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1099	1746	0.021191294	0.008018328	1	oligos	OL-Cntl	26	7	7
TGCCCATAGAGTAAGG-1_1_A4	-36.32684053	-5.412202233	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1214	2027	0.0024667	0.002960039	1	9	OPC	26	7	7
TGCCCATAGCTAGGCA-1_1_A4	4.154486659	18.49730308	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1030	1557	0.00834939	0.005138086	1	oligos	OL-Cntl	26	7	7
TGCCCATCACATGACT-1_1_A4	0.223800639	28.79712285	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	843	1229	0.004882018	0.007323027	1	oligos	OL-Cntl	26	7	7
TGCCCATCAGATCCAT-1_1_A4	17.1997589	0.382415523	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	829	1288	0	0.001552795	1	12	EN-MIX	26	7	7
TGCCCATGTTGTCGCG-1_1_A4	38.65148743	14.0804541	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1130	1658	0.001206273	0.017490953	1	14	Microglia	26	7	7
TGCCCATTCAGCAACT-1_1_A4	15.7069244	14.2228395	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1396	2232	0.003136201	0.012544803	1	oligos	OL-Cntl	26	7	7
TGCCCATTCTTCGAGA-1_1_A4	-5.094386852	-10.27898499	13B	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	865	1381	0	0.003620565	1	13B	IN-SV2C	26	7	7
TGCCCTAAGAACAATC-1_1_A4	-32.75846691	-3.457387448	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1443	2457	0.004070004	0.021164021	1	9	OPC	26	7	7
TGCCCTACAGCATACT-1_1_A4	0.631877312	-8.075018427	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1480	2944	0.000339674	0.00169837	1	12	EN-MIX	26	7	7
TGCCCTACAGGCTCAC-1_1_A4	2.286330309	-4.809851305	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	891	1454	0.0130674	0.002063274	1	12	EN-MIX	26	7	7
TGCCCTACAGTCAGCC-1_1_A4	-38.97255702	-0.006364291	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1500	2845	0.007732865	0.003514938	1	9	OPC	26	7	7
TGCCCTAGTAGCACGA-1_1_A4	-22.2807455	29.02103975	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2088	4045	0.003213844	0.005438813	1	8	Astrocytes	26	7	7
TGCCCTAGTATAATGG-1_1_A4	-22.39729318	27.57962162	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1924	3625	0.003034483	0.006896552	1	8	Astrocytes	26	7	7
TGCCCTAGTGCAACGA-1_1_A4	39.92243245	11.44305028	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	902	1309	0.002291826	0.005347594	1	14	Microglia	26	7	7
TGCCCTAGTTAAAGAC-1_1_A4	3.51941576	25.08382356	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	780	1173	0.007672634	0.007672634	1	oligos	OL-Cntl	26	7	7
TGCCCTATCATGCAAC-1_1_A4	-10.45907848	18.33522147	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2578	5463	0.010250778	0.003660992	1	11	Glia-MIX	26	7	7
TGCCCTATCCCTTGCA-1_1_A4	19.28322561	20.03349297	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1101	1865	0.004825737	0.004289544	1	oligos	OL-Cntl	26	7	7
TGCCCTATCTGCTTGC-1_1_A4	36.64721911	10.65424323	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	891	1215	0.010699588	0.018106996	1	14	Microglia	26	7	7
TGCGCAGAGAGACGAA-1_1_A4	-36.16852125	-6.91084677	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1205	2063	0.001938924	0.002423655	1	9	OPC	26	7	7
TGCGCAGAGCACACAG-1_1_A4	21.52539684	10.44107653	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1634	2678	0.003360717	0.004854369	1	oligos	OL-Cntl	26	7	7
TGCGCAGAGGTCATCT-1_1_A4	20.49979921	14.04026219	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1426	2506	0.007581804	0.004788508	1	oligos	OL-Cntl	26	7	7
TGCGCAGCATAACCTG-1_1_A4	7.722679439	-28.329047	10	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	6381	21799	0.001422084	0.003165283	1	L2-3	EN-L2-3-Cntl	26	7	7
TGCGCAGGTAGGAGTC-1_1_A4	5.915789108	13.09336661	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1272	2081	0.021624219	0.010091302	1	oligos	OL-Cntl	26	7	7
TGCGCAGGTATCGCAT-1_1_A4	2.565049293	6.360467199	7	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	956	1332	0.012012012	0.005255255	1	7	Phagocytes	26	7	7
TGCGCAGGTGCACTTA-1_1_A4	-24.33672	27.34995251	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1851	3694	0.002977802	0.005955604	1	8	Astrocytes	26	7	7
TGCGCAGGTGTTGGGA-1_1_A4	1.137889888	29.42542844	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	818	1242	0.001610306	0.004025765	1	oligos	OL-Cntl	26	7	7
TGCGCAGTCTCAAGTG-1_1_A4	-23.03201842	2.025834586	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2244	3777	0.007148531	0.00688377	1	11	Glia-MIX	26	7	7
TGCGCAGTCTCGCATC-1_1_A4	9.36091663	23.92147867	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	946	1425	0.007017544	0.001403509	1	oligos	OL-Cntl	26	7	7
TGCGCAGTCTCGGACG-1_1_A4	14.27691202	15.51310024	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1259	2080	0.013942308	0.003846154	1	oligos	OL-Cntl	26	7	7
TGCGGGTCACGAAATA-1_1_A4	-21.66164576	23.98065645	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1541	2890	0.003460208	0.00899654	1	8	Astrocytes	26	7	7
TGCGGGTCAGCTCGAC-1_1_A4	-6.219063191	-10.82536448	6B	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	995	1583	0.008843967	0.00315856	1	6B	IN-SST	26	7	7
TGCGGGTCATGACATC-1_1_A4	0.436970637	22.40597619	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	781	1211	0.009083402	0.012386457	1	oligos	OL-Cntl	26	7	7
TGCGGGTGTACCAGTT-1_1_A4	13.31272355	12.21639639	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1446	2465	0.012170385	0.011359026	1	oligos	OL-Cntl	26	7	7
TGCGGGTGTCGTGGCT-1_1_A4	-16.69890726	12.47826332	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1232	1954	0.004094166	0.004605937	1	8	Astrocytes	26	7	7
TGCGGGTGTTCGTGAT-1_1_A4	-0.310864901	29.15420741	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	882	1262	0.004754358	0.003169572	1	oligos	OL-Cntl	26	7	7
TGCGGGTTCACTTATC-1_1_A4	7.190769317	25.36895459	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1005	1611	0.006828057	0.009931719	1	oligos	OL-Cntl	26	7	7
TGCGTGGAGAAGGTGA-1_1_A4	12.20695816	-11.59419391	4	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	4621	10413	0.012004225	0.0136368	1	L2-3	EN-L2-3-MS	26	7	7
TGCGTGGAGGGTTTCT-1_1_A4	-4.538438747	-4.604970349	13A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1240	2209	0.034857402	0.00769579	1	13A	IN-VIP	26	7	7
TGCGTGGCAAAGCAAT-1_1_A4	16.45838414	11.5195068	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1407	2573	0.029537505	0.006607073	1	oligos	OL-Cntl	26	7	7
TGCGTGGCATAAGACA-1_1_A4	-25.43101838	27.4481967	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1744	3204	0.003745318	0.005617978	1	8	Astrocytes	26	7	7
TGCGTGGGTAGCTCCG-1_1_A4	5.29459644	22.76642217	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	869	1342	0.005961252	0.006706408	1	oligos	OL-Cntl	26	7	7
TGCGTGGGTTCAGTAC-1_1_A4	-22.32949121	25.59509994	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1700	3138	0.001274697	0.008285532	1	8	Astrocytes	26	7	7
TGCGTGGTCACCCGAG-1_1_A4	-26.13291236	22.55213019	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1299	2261	0.005307386	0.003095975	1	8	Astrocytes	26	7	7
TGCGTGGTCACCGTAA-1_1_A4	-0.709944072	29.22156633	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1022	1697	0.001767826	0.005303477	1	oligos	OL-Cntl	26	7	7
TGCGTGGTCATTGCCC-1_1_A4	12.88116785	15.19361255	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1270	2112	0.004261364	0.009469697	1	oligos	OL-Cntl	26	7	7
TGCTACCCAGCTGGCT-1_1_A4	11.81270046	11.16212795	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1667	2745	0.006557377	0.013479053	1	oligos	OL-Cntl	26	7	7
TGCTACCGTACATGTC-1_1_A4	14.85357104	20.75187227	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1047	1701	0.002939447	0.009994121	1	oligos	OL-Cntl	26	7	7
TGCTACCGTATAGTAG-1_1_A4	-18.40143738	-21.40034282	6A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2904	6685	0.037845924	0.003739716	1	6A	IN-PV	26	7	7
TGCTACCTCACCGGGT-1_1_A4	5.460520784	17.43704059	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1043	1570	0.007006369	0.008917197	1	oligos	OL-Cntl	26	7	7
TGCTACCTCGGTCCGA-1_1_A4	18.6075779	7.627419972	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2052	3935	0.013722999	0.007623888	1	oligos	OL-Cntl	26	7	7
TGCTACCTCTGGAGCC-1_1_A4	-11.04002805	9.516125021	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	4507	9966	0.007324905	0.004816376	1	11	Glia-MIX	26	7	7
TGCTGCTAGAGGACGG-1_1_A4	22.22600498	9.919814755	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1832	3222	0.003103662	0.006517691	1	oligos	OL-Cntl	26	7	7
TGCTGCTAGCACGCCT-1_1_A4	13.30981704	16.33633156	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1173	1951	0.010763711	0.009738596	1	oligos	OL-Cntl	26	7	7
TGCTGCTAGGCAGTCA-1_1_A4	20.35235714	-0.754045975	2	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1366	2223	0.009896536	0.008097166	1	2	EN-L4	26	7	7
TGCTGCTAGGCTAGCA-1_1_A4	-21.89087304	29.39468639	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2309	4803	0.003747658	0.005621487	1	8	Astrocytes	26	7	7
TGCTGCTCAAGGCTCC-1_1_A4	13.23736095	11.9285014	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1576	2716	0.004786451	0.012886598	1	oligos	OL-Cntl	26	7	7
TGCTGCTCATCCGCGA-1_1_A4	11.97153089	16.01654063	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1266	2048	0.004394531	0.0078125	1	oligos	OL-Cntl	26	7	7
TGCTGCTGTAGCTCCG-1_1_A4	18.18659771	1.433414078	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1033	1674	0.001194743	0.000597372	1	12	EN-MIX	26	7	7
TGCTGCTGTTGTCGCG-1_1_A4	18.93457653	1.728795524	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1011	1622	0	0.002466091	1	12	EN-MIX	26	7	7
TGCTGCTTCTCAAACG-1_1_A4	11.93736941	15.90059616	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1214	2002	0.008991009	0.013486513	1	oligos	OL-Cntl	26	7	7
TGCTGCTTCTGCAAGT-1_1_A4	14.80398212	-1.155291434	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	846	1318	0.006069803	0.001517451	1	12	EN-MIX	26	7	7
TGGACGCAGCGCCTCA-1_1_A4	14.65795007	10.19544679	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1601	2714	0.015475313	0.010685335	1	oligos	OL-Cntl	26	7	7
TGGACGCCACATCCAA-1_1_A4	-15.16904802	-25.18579806	6A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1803	3608	0.000554324	0.003603104	1	6A	IN-PV	26	7	7
TGGACGCCACGGACAA-1_1_A4	-34.36517508	-11.72302476	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	780	1115	0.001793722	0.002690583	1	9	OPC	26	7	7
TGGACGCCAGATGGCA-1_1_A4	4.506223357	18.94802382	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	916	1442	0.0110957	0.009015257	1	oligos	OL-Cntl	26	7	7
TGGACGCCATAGACTC-1_1_A4	-27.48247207	4.367285702	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	3072	6560	0.001981707	0.003658537	1	9	OPC	26	7	7
TGGACGCGTACAGTTC-1_1_A4	38.71619343	10.44468862	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	851	1198	0.002504174	0.014190317	1	14	Microglia	26	7	7
TGGACGCGTCAGCTAT-1_1_A4	13.41878191	6.524144117	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1840	3341	0.032026339	0.012870398	1	oligos	OL-Cntl	26	7	7
TGGCCAGAGACACGAC-1_1_A4	-5.834722751	2.63196258	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	3691	7835	0.006253989	0.005488194	1	11	Glia-MIX	26	7	7
TGGCCAGAGCTAACTC-1_1_A4	0.221363025	22.22683825	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	793	1189	0.016820858	0.006728343	1	oligos	OL-Cntl	26	7	7
TGGCCAGCACCAGGTC-1_1_A4	5.735998142	12.19850791	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1240	2043	0.018110622	0.015173764	1	oligos	OL-Cntl	26	7	7
TGGCCAGCACGAAGCA-1_1_A4	4.129162378	7.373453009	7	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1330	2146	0.013979497	0.008853681	1	7	Phagocytes	26	7	7
TGGCCAGCATGTAAGA-1_1_A4	10.82046782	-7.964606404	10	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2194	4699	0.002766546	0.001276867	1	L2-3	EN-L2-3-Cntl	26	7	7
TGGCCAGGTAGCGTAG-1_1_A4	4.972452339	22.55699842	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	906	1429	0.009797061	0.006997901	1	oligos	OL-Cntl	26	7	7
TGGCCAGGTCAAACTC-1_1_A4	-5.664972263	-5.32896531	13A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1168	2074	0.034715526	0.00289296	1	13A	IN-VIP	26	7	7
TGGCCAGGTCATGCAT-1_1_A4	-4.435578925	26.03600805	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	885	1443	0.009009009	0.006930007	1	11	Glia-MIX	26	7	7
TGGCCAGGTTGTGGCC-1_1_A4	-13.93235199	-23.88139177	6A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1651	3606	0.08291736	0.001386578	1	6A	IN-PV	26	7	7
TGGCGCAAGAATTGTG-1_1_A4	7.694914316	22.4205031	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1215	1869	0.012841091	0.006420546	1	oligos	OL-Cntl	26	7	7
TGGCGCAAGAGACTTA-1_1_A4	-0.174939609	26.7555159	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	869	1276	0.015673981	0.004702194	1	oligos	OL-Cntl	26	7	7
TGGCGCAAGCGTTCCG-1_1_A4	38.13038904	10.5193711	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	862	1172	0.018771331	0.017918089	1	14	Microglia	26	7	7
TGGCGCAAGTTGTCGT-1_1_A4	-10.52989849	18.58420376	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	3017	5916	0.008789723	0.005240027	1	11	Glia-MIX	26	7	7
TGGCGCACAAACCTAC-1_1_A4	20.66778688	0.522780669	2	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1327	2158	0.013901761	0.002780352	1	2	EN-L4	26	7	7
TGGCGCACACGGCTAC-1_1_A4	-0.162604774	28.59183851	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	847	1247	0.004009623	0.001603849	1	oligos	OL-Cntl	26	7	7
TGGCGCACAGATCCAT-1_1_A4	14.56305063	13.01754159	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1228	2152	0.013011152	0.007434944	1	oligos	OL-Cntl	26	7	7
TGGCGCAGTAGCTTGT-1_1_A4	1.599006001	10.73371593	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1114	1751	0.031981725	0.017704169	1	oligos	OL-Cntl	26	7	7
TGGCGCATCACTCCTG-1_1_A4	-8.483428344	-17.99071426	6B	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	811	1342	0.037257824	0.001490313	1	6B	IN-SST	26	7	7
TGGCGCATCGTGACAT-1_1_A4	-31.77652189	0.191537257	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1742	3016	0.00198939	0.004973475	1	9	OPC	26	7	7
TGGCTGGAGACGACGT-1_1_A4	-4.343239571	25.9549016	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	841	1221	0.006552007	0.006552007	1	oligos	OL-Cntl	26	7	7
TGGCTGGAGCCGCCTA-1_1_A4	-13.9910057	-10.52012891	13B	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2252	4644	0.001076658	0.003229974	1	13B	IN-SV2C	26	7	7
TGGCTGGAGTTTAGGA-1_1_A4	13.17581643	1.694118238	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	900	1510	0.002649007	0.001324503	1	12	EN-MIX	26	7	7
TGGCTGGCAGAAGCAC-1_1_A4	-1.841073481	2.849810115	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1850	3733	0.00241093	0.001875167	1	11	Glia-MIX	26	7	7
TGGCTGGCATAGTAAG-1_1_A4	3.127929467	-26.89575784	10	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	3585	8972	0.001114579	0.002563531	1	L2-3	EN-L2-3-Cntl	26	7	7
TGGGAAGAGCAGCCTC-1_1_A4	-22.91623731	25.61957217	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1571	2898	0.007246377	0.006556246	1	8	Astrocytes	26	7	7
TGGGAAGCATACTACG-1_1_A4	20.41744329	19.56102707	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1179	1945	0.001542416	0.006169666	1	oligos	OL-Cntl	26	7	7
TGGGAAGGTAGCTGCC-1_1_A4	-3.244220228	-6.815370515	13A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	849	1268	0.025236593	0.004731861	1	13A	IN-VIP	26	7	7
TGGGAAGGTGCCTTGG-1_1_A4	-34.82658398	-12.17531955	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	798	1303	0.006139678	0.003837299	1	9	OPC	26	7	7
TGGGAAGGTTACGACT-1_1_A4	-2.182837602	25.44980917	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	688	1007	0.006951341	0.005958292	1	oligos	OL-Cntl	26	7	7
TGGGAAGTCAACGAAA-1_1_A4	4.507091856	17.27957355	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	978	1436	0.016713092	0.009052925	1	oligos	OL-Cntl	26	7	7
TGGGAAGTCTCACATT-1_1_A4	16.43342323	-6.672421092	3	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1823	3613	0.00332134	0.001937448	1	3	EN-L5-6	26	7	7
TGGGCGTCAATAAGCA-1_1_A4	-6.828926254	-6.001612761	13A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1337	2142	0.028011204	0.007002801	1	13A	IN-VIP	26	7	7
TGGGCGTCACCGGAAA-1_1_A4	15.20988322	2.968829211	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1172	2006	0.052342971	0.002492522	1	12	EN-MIX	26	7	7
TGGGCGTCAGCCTTTC-1_1_A4	-36.99925697	-6.487125792	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1176	2129	0.005166745	0.000939408	1	9	OPC	26	7	7
TGGGCGTGTATCGCAT-1_1_A4	0.324176396	25.73481621	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	785	1166	0.013722127	0.009433962	1	oligos	OL-Cntl	26	7	7
TGGGCGTTCACCCGAG-1_1_A4	19.74788819	-0.712273096	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1315	2012	0.014413519	0.003976143	1	12	EN-MIX	26	7	7
TGGGCGTTCGGGAGTA-1_1_A4	3.640740704	17.54009314	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	975	1447	0.017277125	0.01105736	1	oligos	OL-Cntl	26	7	7
TGGGCGTTCGTATCAG-1_1_A4	4.969087102	25.55791934	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	836	1258	0.011923688	0.007949126	1	oligos	OL-Cntl	26	7	7
TGGGCGTTCTGAGTGT-1_1_A4	-5.037491735	16.78715542	5	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	829	1156	0.023356401	0.01384083	1	oligos	OL-MS-1	26	7	7
TGGTTAGAGATCGGGT-1_1_A4	16.36838509	-0.750929557	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	758	1138	0.004393673	0.001757469	1	12	EN-MIX	26	7	7
TGGTTAGCAATCAGAA-1_1_A4	5.478981799	18.75809255	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	971	1455	0.004810997	0.010996564	1	oligos	OL-Cntl	26	7	7
TGGTTAGTCTAACCGA-1_1_A4	17.08052159	12.75301875	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1286	2190	0.002739726	0.005022831	1	oligos	OL-Cntl	26	7	7
TGGTTCCCAAGTAATG-1_1_A4	-23.04482816	27.90662014	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1782	3171	0.003468937	0.004099653	1	8	Astrocytes	26	7	7
TGGTTCCCAGGAACGT-1_1_A4	14.66724992	13.71709872	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1331	2165	0.0147806	0.005080831	1	oligos	OL-Cntl	26	7	7
TGGTTCCGTAAATACG-1_1_A4	-11.27090876	-21.79216628	6B	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	961	1652	0.036319613	0.006053269	1	6B	IN-SST	26	7	7
TGGTTCCGTCTACCTC-1_1_A4	18.67815951	19.89242048	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1096	1818	0.00880088	0.00220022	1	oligos	OL-Cntl	26	7	7
TGGTTCCGTTCCAACA-1_1_A4	6.397684128	16.3590698	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1085	1821	0.008237232	0.011532125	1	oligos	OL-Cntl	26	7	7
TGGTTCCTCTTTACGT-1_1_A4	0.857306737	-7.644857505	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1317	2294	0.003487358	0.003051439	1	12	EN-MIX	26	7	7
TGTATTCAGCCATCGC-1_1_A4	35.41129198	11.1114834	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	813	1069	0.016838167	0.021515435	1	14	Microglia	26	7	7
TGTATTCAGCTACCGC-1_1_A4	4.917416609	4.969977713	7	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2124	3519	0.017618642	0.025575448	1	7	Phagocytes	26	7	7
TGTATTCCAGGATTGG-1_1_A4	-26.33097192	14.01952244	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	985	1628	0.006142506	0.008599509	1	8	Astrocytes	26	7	7
TGTATTCCATGCTAGT-1_1_A4	-3.993566777	-7.877091322	13A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	771	1168	0.041952055	0.003424658	1	13A	IN-VIP	26	7	7
TGTATTCTCACTTATC-1_1_A4	18.31423858	-0.208244864	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1306	2384	0.107802013	0.002936242	1	12	EN-MIX	26	7	7
TGTATTCTCTTTACAC-1_1_A4	-35.91126348	-10.26923938	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	917	1492	0.002010724	0.002010724	1	9	OPC	26	7	7
TGTCCCACATGCTAGT-1_1_A4	6.594966644	20.52500072	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1017	1630	0.011656442	0.004907975	1	oligos	OL-Cntl	26	7	7
TGTCCCATCACCCTCA-1_1_A4	0.756906049	29.33914988	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	801	1211	0.003303055	0.003303055	1	oligos	OL-Cntl	26	7	7
TGTCCCATCCCATTTA-1_1_A4	38.30058096	9.521998465	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	983	1399	0.007862759	0.006433167	1	14	Microglia	26	7	7
TGTGGTAAGATCTGCT-1_1_A4	6.554366544	13.35891553	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1252	1938	0.011867905	0.009803922	1	oligos	OL-Cntl	26	7	7
TGTGGTACAATGAAAC-1_1_A4	-33.73317677	-12.2494227	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	808	1187	0.00252738	0.00168492	1	9	OPC	26	7	7
TGTGGTAGTATAGGGC-1_1_A4	6.346279922	13.65136608	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1315	2114	0.005676443	0.009460738	1	oligos	OL-Cntl	26	7	7
TGTGGTAGTATATGAG-1_1_A4	6.485451077	18.41052959	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1022	1613	0.000619963	0.017978921	1	oligos	OL-Cntl	26	7	7
TGTGGTAGTCGATTGT-1_1_A4	-10.14235837	-4.298556999	13A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2008	3624	0.017108168	0.007726269	1	13A	IN-VIP	26	7	7
TGTGTTTAGCTAGTCT-1_1_A4	17.66125908	6.214145987	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2315	4671	0.015414258	0.007493042	1	oligos	OL-Cntl	26	7	7
TGTGTTTCAATGTTGC-1_1_A4	-0.76185876	22.99008899	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	704	1022	0.005870841	0.011741683	1	oligos	OL-Cntl	26	7	7
TGTGTTTCACACCGCA-1_1_A4	-1.172459393	24.10723078	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	686	1027	0.010710808	0.004868549	1	oligos	OL-Cntl	26	7	7
TGTGTTTCACCCAGTG-1_1_A4	-0.44137729	25.37658384	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	700	1003	0.000997009	0.00997009	1	oligos	OL-Cntl	26	7	7
TGTGTTTCATTGGTAC-1_1_A4	-2.889502252	24.05267813	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	711	1019	0.005888126	0.002944063	1	oligos	OL-Cntl	26	7	7
TGTGTTTGTCAAAGAT-1_1_A4	-1.822867962	22.27082716	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	791	1175	0.008510638	0.009361702	1	oligos	OL-Cntl	26	7	7
TGTGTTTGTCTTGCGG-1_1_A4	-1.428604928	23.30484104	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	764	1094	0.007312614	0.004570384	1	oligos	OL-Cntl	26	7	7
TGTGTTTGTTAAGAAC-1_1_A4	-26.15973438	22.96583326	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1264	2180	0.004587156	0.003211009	1	8	Astrocytes	26	7	7
TGTGTTTGTTCCCTTG-1_1_A4	20.84859963	11.13581099	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1531	2595	0.001926782	0.008477842	1	oligos	OL-Cntl	26	7	7
TGTGTTTTCCCATTAT-1_1_A4	-9.925328763	35.35839431	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	886	1149	0.020017406	0.006092254	1	11	Glia-MIX	26	7	7
TGTTCCGCAGCTCCGA-1_1_A4	-14.39678688	-24.91816281	6A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1610	3090	0.014886731	0.001618123	1	6A	IN-PV	26	7	7
TTAACTCAGCAGCGTA-1_1_A4	-4.590205837	-4.031120935	13A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1359	2421	0.001239157	0.00330442	1	13A	IN-VIP	26	7	7
TTAACTCAGCTCAACT-1_1_A4	10.2371479	15.98303537	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1047	1744	0.021215596	0.017775229	1	oligos	OL-Cntl	26	7	7
TTAACTCAGGAGTCTG-1_1_A4	19.70385855	17.12346001	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1146	1799	0.005558644	0.007226237	1	oligos	OL-Cntl	26	7	7
TTAACTCAGTGAAGTT-1_1_A4	14.15342277	24.24087903	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	853	1286	0.00777605	0.00622084	1	oligos	OL-Cntl	26	7	7
TTAGGACCAAATTGCC-1_1_A4	11.06833318	15.01336807	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1220	2171	0.020267158	0.00829111	1	oligos	OL-Cntl	26	7	7
TTAGGACCAAGCCATT-1_1_A4	38.89932926	10.53123785	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	790	1036	0.003861004	0.006756757	1	14	Microglia	26	7	7
TTAGGACCAAGGTTCT-1_1_A4	3.345667737	-8.131657776	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1472	2491	0.006021678	0.004415897	1	12	EN-MIX	26	7	7
TTAGGACCAGACAGGT-1_1_A4	-23.16954216	25.8885348	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1601	2924	0.005471956	0.004445964	1	8	Astrocytes	26	7	7
TTAGGACCATGTCCTC-1_1_A4	13.86554457	6.458614207	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2043	3828	0.010971787	0.014106583	1	oligos	OL-Cntl	26	7	7
TTAGGACCATGTTGAC-1_1_A4	-16.43407611	13.0832669	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1371	2155	0.001392111	0.004176334	1	8	Astrocytes	26	7	7
TTAGGACTCACTTACT-1_1_A4	10.78139376	19.74445482	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	877	1365	0.001465201	0.007326007	1	oligos	OL-Cntl	26	7	7
TTAGGACTCTGGTGTA-1_1_A4	14.0039665	20.11406763	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1028	1545	0.010355987	0.003236246	1	oligos	OL-Cntl	26	7	7
TTAGGCAAGGGAACGG-1_1_A4	-4.941050847	-7.799359376	13A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	884	1350	0.046666667	0.008148148	1	13A	IN-VIP	26	7	7
TTAGGCACACGACTCG-1_1_A4	1.801896302	26.13506052	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	725	1063	0.011288805	0.00752587	1	oligos	OL-Cntl	26	7	7
TTAGGCACAGTGGGAT-1_1_A4	-13.27923914	4.752041269	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2059	3585	0.012273361	0.005299861	1	8	Astrocytes	26	7	7
TTAGGCACATCTGGTA-1_1_A4	14.85345243	17.66865821	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1055	1659	0.0066305	0.008438819	1	oligos	OL-Cntl	26	7	7
TTAGGCATCCCTAACC-1_1_A4	39.49096698	11.98194456	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	964	1335	0.012734082	0.007490637	1	14	Microglia	26	7	7
TTAGTTCAGAGATGAG-1_1_A4	-9.572059427	-6.737003368	13A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1717	3097	0.014853084	0.003228931	1	13A	IN-VIP	26	7	7
TTAGTTCCAAGGACAC-1_1_A4	-24.04941711	26.06797058	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1530	2959	0.001013856	0.005407232	1	8	Astrocytes	26	7	7
TTAGTTCCATAGAAAC-1_1_A4	-29.54189836	20.42747953	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1039	1679	0.001786778	0.005955926	1	8	Astrocytes	26	7	7
TTAGTTCGTTTCCACC-1_1_A4	1.136488661	23.97818767	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	686	1101	0.009082652	0.012715713	1	oligos	OL-Cntl	26	7	7
TTAGTTCTCATACGGT-1_1_A4	4.438858923	18.01640873	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1070	1683	0.008318479	0.009506833	1	oligos	OL-Cntl	26	7	7
TTAGTTCTCCTCAATT-1_1_A4	17.41211011	14.46496995	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1266	2155	0.00649652	0.004176334	1	oligos	OL-Cntl	26	7	7
TTATGCTAGACTGGGT-1_1_A4	4.077561889	27.32588131	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	702	1083	0.014773777	0.002770083	1	oligos	OL-Cntl	26	7	7
TTATGCTAGCAGCCTC-1_1_A4	-38.5952988	-2.211968822	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1349	2488	0.002009646	0.003215434	1	9	OPC	26	7	7
TTATGCTAGGCTCAGA-1_1_A4	12.79844474	17.75649389	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1023	1591	0.00565682	0.011942175	1	oligos	OL-Cntl	26	7	7
TTATGCTCAAATACAG-1_1_A4	17.46658631	9.539024859	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1567	2922	0.015400411	0.005475702	1	oligos	OL-Cntl	26	7	7
TTATGCTCAAGAAAGG-1_1_A4	-26.95625345	23.1286636	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1292	2237	0.002235136	0.002235136	1	8	Astrocytes	26	7	7
TTATGCTGTATGGTTC-1_1_A4	14.19588683	23.39130298	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	875	1287	0.010878011	0.001554002	1	oligos	OL-Cntl	26	7	7
TTATGCTGTTGCCTCT-1_1_A4	12.751735	25.27279614	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	696	1097	0.003646308	0.002734731	1	oligos	OL-Cntl	26	7	7
TTCCCAGAGACATAAC-1_1_A4	-22.53903661	-4.509333536	13A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	3361	8205	0.013893967	0.002925046	1	13A	IN-VIP	26	7	7
TTCCCAGCACATCTTT-1_1_A4	15.79835155	23.95968083	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1059	1763	0.00453772	0.00453772	1	oligos	OL-Cntl	26	7	7
TTCCCAGCATGCATGT-1_1_A4	-22.71628675	25.31237531	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1650	3305	0.006354009	0.004236006	1	8	Astrocytes	26	7	7
TTCCCAGCATTAGCCA-1_1_A4	-9.664442628	17.99883871	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2950	6568	0.003349574	0.0045676	1	11	Glia-MIX	26	7	7
TTCCCAGGTAACGTTC-1_1_A4	-36.58037981	-2.761454469	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1377	2493	0.004813478	0.001604493	1	9	OPC	26	7	7
TTCCCAGGTTGCGCAC-1_1_A4	10.4614646	10.09820037	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1381	2367	0.024503591	0.010561893	1	oligos	OL-Cntl	26	7	7
TTCGAAGCAAGTACCT-1_1_A4	-34.87870985	-7.728773608	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1107	1841	0.001086366	0.00706138	1	9	OPC	26	7	7
TTCGAAGCACATCTTT-1_1_A4	14.47431968	6.139640587	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2240	4315	0.022479722	0.016685979	1	oligos	OL-Cntl	26	7	7
TTCGAAGGTAGCGTGA-1_1_A4	-25.64349428	22.28514706	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1270	2136	0.007022472	0.013108614	1	8	Astrocytes	26	7	7
TTCGAAGGTGGGTCAA-1_1_A4	15.6448379	16.00945678	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1199	1947	0.011813046	0.006163328	1	oligos	OL-Cntl	26	7	7
TTCGAAGGTTACCGAT-1_1_A4	6.118403319	6.241434833	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2644	5099	0.008629143	0.007648559	1	oligos	OL-Cntl	26	7	7
TTCGAAGTCCTATGTT-1_1_A4	30.20174832	13.78868653	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1054	1511	0.037723362	0.05493051	1	14	Microglia	26	7	7
TTCGAAGTCCTTCAAT-1_1_A4	-10.02324293	23.08471933	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2112	3921	0.004590666	0.006375925	1	8	Astrocytes	26	7	7
TTCGAAGTCTCCAACC-1_1_A4	-11.01201442	9.34125323	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	9006	38690	0.00535022	0.007676402	1	11	Glia-MIX	26	7	7
TTCGGTCAGCTCCTCT-1_1_A4	13.05720389	15.52341573	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1123	1759	0.004548039	0.013075611	1	oligos	OL-Cntl	26	7	7
TTCGGTCCACTTCGAA-1_1_A4	4.305297374	26.42240249	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	737	1079	0.003707136	0.002780352	1	oligos	OL-Cntl	26	7	7
TTCGGTCCAGGACCCT-1_1_A4	19.50054883	19.23241908	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1101	1835	0.004359673	0.004904632	1	oligos	OL-Cntl	26	7	7
TTCGGTCGTAGCTGCC-1_1_A4	21.81195517	16.16903794	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1284	2075	0.003855422	0.005301205	1	oligos	OL-Cntl	26	7	7
TTCGGTCGTTACGACT-1_1_A4	6.777443615	19.42372359	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	983	1572	0.006997455	0.007633588	1	oligos	OL-Cntl	26	7	7
TTCGGTCTCGGTTAAC-1_1_A4	-34.8277458	-11.68169142	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	830	1365	0.008058608	0.002930403	1	9	OPC	26	7	7
TTCGGTCTCTCTGAGA-1_1_A4	-36.18669078	-4.784940308	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1214	2147	0	0.005589194	1	9	OPC	26	7	7
TTCGGTCTCTGGTGTA-1_1_A4	18.05665073	7.347016689	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2019	4040	0.008910891	0.005940594	1	oligos	OL-Cntl	26	7	7
TTCTACAAGGAATCGC-1_1_A4	14.56387843	17.25471737	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1016	1566	0.012132822	0.006385696	1	oligos	OL-Cntl	26	7	7
TTCTACAAGGTAGCTG-1_1_A4	7.904732199	13.765649	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1031	1603	0.016843419	0.018091079	1	oligos	OL-Cntl	26	7	7
TTCTACACAGGAATCG-1_1_A4	-20.69612466	9.092486713	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1006	1538	0	0.003250975	1	8	Astrocytes	26	7	7
TTCTACACATCGGACC-1_1_A4	-35.05909771	-11.88332873	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	828	1238	0.008077544	0.004846527	1	9	OPC	26	7	7
TTCTACACATGGTCAT-1_1_A4	23.54633647	-9.434485916	3	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	4116	12147	0.00255207	0.001728822	1	3	EN-L5-6	26	7	7
TTCTACAGTGTTTGTG-1_1_A4	4.480345601	4.703509526	7	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1563	2404	0.00374376	0.005407654	1	7	Phagocytes	26	7	7
TTCTACATCCACGAAT-1_1_A4	-27.7463047	23.94047106	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1294	2233	0.006717421	0.002686968	1	8	Astrocytes	26	7	7
TTCTACATCTTTACAC-1_1_A4	-8.487458834	-18.12140165	6B	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	678	1061	0.041470311	0.002827521	1	6B	IN-SST	26	7	7
TTCTCAACAACACGCC-1_1_A4	15.46129792	-2.361342379	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	925	1487	0.00268998	0.00134499	1	12	EN-MIX	26	7	7
TTCTCAACAACCGCCA-1_1_A4	-38.71338161	-2.968384178	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1290	2400	0.00375	0.00125	1	9	OPC	26	7	7
TTCTCAAGTCGGCACT-1_1_A4	13.15963425	15.94124237	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1116	1711	0.010520164	0.009351257	1	oligos	OL-Cntl	26	7	7
TTCTCAATCGTAGATC-1_1_A4	-38.25801922	-5.338563159	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1197	2018	0.002477701	0.00148662	1	9	OPC	26	7	7
TTCTCCTAGCGATTCT-1_1_A4	11.12580138	20.86660142	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	947	1595	0.009404389	0.006896552	1	oligos	OL-Cntl	26	7	7
TTCTCCTAGGACCACA-1_1_A4	18.45612876	6.685375474	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2351	4930	0.010547667	0.006693712	1	oligos	OL-Cntl	26	7	7
TTCTCCTCAGTCAGAG-1_1_A4	-9.319065097	17.75251001	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	3262	7294	0.007951741	0.00671785	1	11	Glia-MIX	26	7	7
TTCTCCTGTAACGACG-1_1_A4	8.536805533	16.08773228	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	903	1485	0.010774411	0.007407407	1	oligos	OL-Cntl	26	7	7
TTCTCCTGTAAGGGCT-1_1_A4	11.85227719	28.34383001	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	865	1356	0.008112094	0.007374631	1	oligos	OL-Cntl	26	7	7
TTCTCCTGTACACCGC-1_1_A4	3.15132267	25.45591511	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	727	1065	0.012206573	0.008450704	1	oligos	OL-Cntl	26	7	7
TTCTCCTGTGTAACGG-1_1_A4	-9.887282922	17.08952678	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2296	4419	0.023987327	0.005431093	1	11	Glia-MIX	26	7	7
TTCTCCTGTGTGCGTC-1_1_A4	-26.58047376	1.780848825	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1312	1868	0.001070664	0.006959315	1	9	OPC	26	7	7
TTCTCCTTCACTTACT-1_1_A4	-27.5399578	4.399631107	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2611	5904	0.001693767	0.002371274	1	9	OPC	26	7	7
TTCTCCTTCCTATTCA-1_1_A4	20.84459866	14.66847737	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1251	2116	0.002835539	0.002835539	1	oligos	OL-Cntl	26	7	7
TTCTTAGCAACCGCCA-1_1_A4	16.4671926	-0.623349407	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	779	1260	0.000793651	0.001587302	1	12	EN-MIX	26	7	7
TTCTTAGGTCGAGTTT-1_1_A4	-35.2948634	-9.739670822	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	889	1415	0.002120141	0.004240283	1	9	OPC	26	7	7
TTGAACGAGGGATACC-1_1_A4	2.834228287	21.98773063	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	894	1313	0.00990099	0.008377761	1	oligos	OL-Cntl	26	7	7
TTGAACGAGTAGCGGT-1_1_A4	13.63612702	16.96500323	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1091	1704	0.00528169	0.013497653	1	oligos	OL-Cntl	26	7	7
TTGAACGCACATCCAA-1_1_A4	-22.22443319	26.63525847	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1566	2807	0.001781261	0.007837549	1	8	Astrocytes	26	7	7
TTGAACGCACCATGTA-1_1_A4	-5.960051368	-4.535475273	13A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1425	2626	0.051789794	0.004950495	1	13A	IN-VIP	26	7	7
TTGAACGCAGGTTTCA-1_1_A4	16.55774125	1.76033752	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	721	1044	0.009578544	0.000957854	1	12	EN-MIX	26	7	7
TTGAACGCATCCTTGC-1_1_A4	9.972316408	23.78199455	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	865	1420	0.013380282	0.00915493	1	oligos	OL-Cntl	26	7	7
TTGAACGCATGTCGAT-1_1_A4	4.596631992	22.13992593	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	919	1461	0.020533881	0.00752909	1	oligos	OL-Cntl	26	7	7
TTGAACGGTCCAGTAT-1_1_A4	-7.34939837	-0.192242768	13A	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2189	4441	0.019590182	0.001576222	1	13A	IN-VIP	26	7	7
TTGAACGGTCTGATCA-1_1_A4	2.113370452	23.05195662	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	806	1222	0.016366612	0.004091653	1	oligos	OL-Cntl	26	7	7
TTGAACGTCTCACATT-1_1_A4	3.944370757	23.21928767	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	817	1247	0.003207698	0.004811548	1	oligos	OL-Cntl	26	7	7
TTGAACGTCTCCAACC-1_1_A4	15.44172802	-0.931988432	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	694	1022	0.007827789	0.002935421	1	12	EN-MIX	26	7	7
TTGACTTAGGTGATAT-1_1_A4	-24.7309413	26.78049414	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1699	3406	0.002935995	0.003523194	1	8	Astrocytes	26	7	7
TTGACTTCATAGAAAC-1_1_A4	-25.85608057	22.51606972	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1325	2261	0.002211411	0.007076515	1	8	Astrocytes	26	7	7
TTGACTTCATGTAGTC-1_1_A4	11.86181053	13.40453144	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1349	2141	0.009808501	0.003736572	1	oligos	OL-Cntl	26	7	7
TTGACTTGTGATAAGT-1_1_A4	5.04688415	23.52903542	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	891	1320	0.012121212	0.011363636	1	oligos	OL-Cntl	26	7	7
TTGCCGTAGATCCGAG-1_1_A4	5.12042074	19.28553703	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	991	1520	0.025	0.009868421	1	oligos	OL-Cntl	26	7	7
TTGCCGTCAGGACCCT-1_1_A4	18.09478039	15.94817385	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1326	2213	0.014008134	0.006326254	1	oligos	OL-Cntl	26	7	7
TTGCCGTGTGCTTCTC-1_1_A4	-0.770105636	21.2205012	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	768	1213	0.013190437	0.007419621	1	oligos	OL-Cntl	26	7	7
TTGCCGTTCACCGTAA-1_1_A4	1.574966324	21.77503403	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	823	1293	0.004640371	0.013147718	1	oligos	OL-Cntl	26	7	7
TTGCGTCAGAGTACCG-1_1_A4	3.896776368	5.108339116	7	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1371	2016	0.005952381	0.012400794	1	7	Phagocytes	26	7	7
TTGCGTCAGCCAGTAG-1_1_A4	-36.13334556	-4.557093401	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1294	2198	0.006824386	0.003184713	1	9	OPC	26	7	7
TTGCGTCAGTGGAGTC-1_1_A4	-23.82305458	-1.211074719	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1326	2151	0.004649	0.0032543	1	9	OPC	26	7	7
TTGCGTCGTAGGGTAC-1_1_A4	3.528572023	21.18287759	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	833	1233	0.01703163	0.00729927	1	oligos	OL-Cntl	26	7	7
TTGCGTCGTCTTCTCG-1_1_A4	18.22431995	-4.987759557	3	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1615	3015	0.011276949	0.00199005	1	3	EN-L5-6	26	7	7
TTGCGTCTCCTAGAAC-1_1_A4	-32.63363717	-4.015416816	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1465	2763	0.005790807	0.008686211	1	9	OPC	26	7	7
TTGGAACCATGACGGA-1_1_A4	35.50082545	8.994063955	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	989	1462	0.025307798	0.008891929	1	14	Microglia	26	7	7
TTGGAACGTCAAAGCG-1_1_A4	38.1726737	10.49055359	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	816	1076	0.008364312	0.013011152	1	14	Microglia	26	7	7
TTGGAACGTGCCTTGG-1_1_A4	5.828556135	20.73313435	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	906	1324	0.005287009	0.01510574	1	oligos	OL-Cntl	26	7	7
TTGGAACGTTTCGCTC-1_1_A4	-9.165312972	18.87739841	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2985	6298	0.005239759	0.003651953	1	11	Glia-MIX	26	7	7
TTGGAACTCGGAGGTA-1_1_A4	-2.985766115	21.34759607	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	910	1418	0.005641749	0.016925247	1	oligos	OL-Cntl	26	7	7
TTGGCAAAGTCATCCA-1_1_A4	17.69381219	16.04161675	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1097	1804	0.00886918	0.004988914	1	oligos	OL-Cntl	26	7	7
TTGGCAAAGTTAACGA-1_1_A4	11.38370428	24.04546182	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	865	1375	0.010181818	0.008	1	oligos	OL-Cntl	26	7	7
TTGGCAACAGCGAACA-1_1_A4	5.072486124	13.28206506	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1036	1658	0.025331725	0.02291918	1	oligos	OL-Cntl	26	7	7
TTGGCAACAGTGAGTG-1_1_A4	34.28732754	14.56179202	14	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1012	1446	0.003457815	0.025587828	1	14	Microglia	26	7	7
TTGGCAAGTCTTTCAT-1_1_A4	-8.290746227	-17.06975291	6B	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	639	1003	0.046859422	0.005982054	1	6B	IN-SST	26	7	7
TTGGCAAGTGAGGGAG-1_1_A4	-12.82495721	15.30105728	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1182	1742	0.015499426	0.009184845	1	11	Glia-MIX	26	7	7
TTGTAGGAGAAACCTA-1_1_A4	-36.05428736	-9.013349224	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	968	1518	0.0085639	0.004611331	1	9	OPC	26	7	7
TTGTAGGAGGAGCGAG-1_1_A4	-33.26767012	-12.02209942	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	902	1377	0.009440813	0.005809731	1	9	OPC	26	7	7
TTGTAGGAGGCTAGCA-1_1_A4	-10.81384016	9.632480506	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	3512	7452	0.009661836	0.005636071	1	11	Glia-MIX	26	7	7
TTGTAGGCATCACGTA-1_1_A4	23.32338514	18.50030066	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1199	2050	0.00097561	0.004878049	1	oligos	OL-Cntl	26	7	7
TTTACTGAGATCCCGC-1_1_A4	-26.29316877	15.64097241	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1252	2065	0.020338983	0.002421308	1	8	Astrocytes	26	7	7
TTTACTGAGTGAAGTT-1_1_A4	4.046884928	-4.277128066	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1032	1633	0.003061849	0.006123699	1	12	EN-MIX	26	7	7
TTTACTGCACGAAAGC-1_1_A4	2.815812726	-7.52876665	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1340	2289	0.001310616	0.003931848	1	12	EN-MIX	26	7	7
TTTACTGCATCCTTGC-1_1_A4	9.643191261	15.56433404	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	886	1338	0.002989537	0.011958146	1	oligos	OL-Cntl	26	7	7
TTTACTGCATGAAGTA-1_1_A4	3.331405959	26.59992794	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	732	1114	0.006283662	0.005385996	1	oligos	OL-Cntl	26	7	7
TTTACTGGTTGCGCAC-1_1_A4	20.01462141	14.05933026	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1279	2366	0.001690617	0.004226543	1	oligos	OL-Cntl	26	7	7
TTTATGCCAGCTGGCT-1_1_A4	15.15272944	-1.20868883	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	744	1116	0.000896057	0	1	12	EN-MIX	26	7	7
TTTATGCGTAGCGCTC-1_1_A4	-23.5053042	0.846914835	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2227	4236	0.00802644	0.004485364	1	9	OPC	26	7	7
TTTCCTCAGAGCTGCA-1_1_A4	5.542498456	17.61680278	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1001	1583	0.015161087	0.013265951	1	oligos	OL-Cntl	26	7	7
TTTCCTCCACCACCAG-1_1_A4	-24.88891147	26.40790585	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1651	3391	0.002064288	0.001474491	1	8	Astrocytes	26	7	7
TTTCCTCCACTAGTAC-1_1_A4	-23.11151443	-0.460382238	9	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1520	2682	0.002237136	0.004847129	1	9	OPC	26	7	7
TTTCCTCGTCGAAAGC-1_1_A4	15.03620805	2.726033288	12	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	725	1104	0.043478261	0.003623188	1	12	EN-MIX	26	7	7
TTTGCGCCACGAAAGC-1_1_A4	3.901525456	27.85878395	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	748	1112	0.003597122	0.005395683	1	oligos	OL-Cntl	26	7	7
TTTGCGCGTAAACGCG-1_1_A4	5.511654622	20.68381168	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	874	1295	0.006949807	0.010810811	1	oligos	OL-Cntl	26	7	7
TTTGCGCGTACTCGCG-1_1_A4	4.21029007	20.29531134	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	858	1314	0.01217656	0.01065449	1	oligos	OL-Cntl	26	7	7
TTTGCGCGTTCCTCCA-1_1_A4	-15.00913523	-11.37568644	13B	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2485	5562	0.008450198	0.002337289	1	13B	IN-SV2C	26	7	7
TTTGCGCTCCTGCTTG-1_1_A4	11.3884651	16.27346959	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1102	1815	0.020385675	0.008264463	1	oligos	OL-Cntl	26	7	7
TTTGCGCTCCTTGACC-1_1_A4	5.795359181	24.07014266	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	900	1377	0.003631082	0.004357298	1	oligos	OL-Cntl	26	7	7
TTTGCGCTCGCACTCT-1_1_A4	-24.05174796	26.05978794	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1555	2987	0.004686977	0.004017409	1	8	Astrocytes	26	7	7
TTTGGTTCAAAGAATC-1_1_A4	14.97714757	27.8615124	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	842	1290	0.002325581	0.003875969	1	oligos	OL-Cntl	26	7	7
TTTGGTTGTACGAAAT-1_1_A4	5.98379713	22.30444593	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	814	1224	0.016339869	0.007352941	1	oligos	OL-Cntl	26	7	7
TTTGGTTTCGGCTTGG-1_1_A4	-13.47466567	-19.01159661	6B	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1303	2374	0.02485257	0.00084246	1	6B	IN-SST	26	7	7
TTTGGTTTCGGTTAAC-1_1_A4	-10.55825501	9.397476901	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	3829	9497	0.003685374	0.004948931	1	11	Glia-MIX	26	7	7
TTTGTCAAGAGCCTAG-1_1_A4	6.169494923	14.03512323	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1081	1659	0.019288728	0.011452682	1	oligos	OL-Cntl	26	7	7
TTTGTCAAGCTGAACG-1_1_A4	-25.67811711	19.45887733	8	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1536	2872	0.000696379	0.005571031	1	8	Astrocytes	26	7	7
TTTGTCAGTGCAACGA-1_1_A4	4.237140813	5.358631383	7	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	1459	2264	0.006625442	0.007067138	1	7	Phagocytes	26	7	7
TTTGTCATCTGTCCGT-1_1_A4	-8.91515096	16.3617133	11	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	2741	5764	0.005725191	0.004857738	1	11	Glia-MIX	26	7	7
TTTGTCATCTTCTGGC-1_1_A4	14.97202376	22.62218452	1	1_A4	MS	Acute/Chronic active	35	female	motor-premotor	CAP1	SEQ1	7	9	926	1456	0.004807692	0.003434066	1	oligos	OL-Cntl	26	7	7
AAACCTGAGAAGGACA-1_1_A9	-6.29942553	-30.26659393	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	835	1210	0.133884298	0.009090909	11	16	EN-PYR	64	21	21
AAACCTGAGAATGTTG-1_1_A9	-11.87904526	16.22974205	11	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1633	2654	0.005651846	0.004521477	11	11	Glia-MIX	64	21	21
AAACCTGAGAGGTAGA-1_1_A9	-12.34838116	-34.55189268	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1215	1950	0.054358974	0.009230769	11	16	EN-PYR	64	21	21
AAACCTGAGCAGATCG-1_1_A9	-5.038864813	35.70435383	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	798	1103	0.015412511	0.006346328	11	oligos	OL-MS-2	64	21	21
AAACCTGAGCCAGTTT-1_1_A9	18.75179928	-32.33281228	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6928	28255	0.005202619	0.003928508	11	3	EN-L5-6	64	21	21
AAACCTGGTCATTAGC-1_1_A9	-24.27526587	-1.628413797	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1245	1995	0.019548872	0.005513784	11	9	OPC	64	21	21
AAACCTGGTCGAACAG-1_1_A9	-20.46574492	12.05129551	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	957	1424	0.006320225	0.006320225	11	8	Astrocytes	64	21	21
AAACCTGGTTTAGGAA-1_1_A9	4.857871736	-23.69724061	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3826	10366	0.017750338	0.006077561	11	L2-3	EN-L2-3-MS	64	21	21
AAACCTGTCAAGGCTT-1_1_A9	-26.10210243	-24.21639843	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5067	14374	0.028941144	0.005356894	11	6A	IN-PV	64	21	21
AAACCTGTCCGCGCAA-1_1_A9	-11.5241311	31.76149034	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	911	1216	0.032894737	0.004934211	11	oligos	OL-MS-2	64	21	21
AAACGGGAGGAGTACC-1_1_A9	33.16580956	4.819215764	14	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1162	1522	0.042049934	0.009198423	11	14	Microglia	64	21	21
AAACGGGAGTCAAGGC-1_1_A9	-1.090650473	34.88503665	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	847	1112	0.013489209	0.003597122	11	oligos	OL-MS-2	64	21	21
AAACGGGCAGTCTTCC-1_1_A9	-22.78364426	-8.535249165	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1561	2305	0.025596529	0.034273319	11	9	OPC	64	21	21
AAACGGGGTTCCATGA-1_1_A9	15.96051165	-25.32680679	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3803	8578	0.009326183	0.005129401	11	3	EN-L5-6	64	21	21
AAACGGGTCAACGGGA-1_1_A9	-25.6791122	-7.900567763	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1121	1631	0.009809933	0.008583691	11	9	OPC	64	21	21
AAACGGGTCAGGCAAG-1_1_A9	-9.106751657	-31.2018057	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	812	1144	0.049825175	0.011363636	11	16	EN-PYR	64	21	21
AAACGGGTCAGTACGT-1_1_A9	-7.31793796	-30.28002744	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	768	1020	0.034313725	0.005882353	11	16	EN-PYR	64	21	21
AAACGGGTCGCATGGC-1_1_A9	8.369621823	-23.11384283	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5514	17572	0.006259959	0.01553608	11	L2-3	EN-L2-3-MS	64	21	21
AAAGATGCACCTATCC-1_1_A9	-8.358326676	-27.20878151	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	892	1217	0.095316352	0.006573541	11	16	EN-PYR	64	21	21
AAAGATGGTAGCCTAT-1_1_A9	27.90328802	-25.44965126	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5256	18874	0.008318322	0.003496874	11	3	EN-L5-6	64	21	21
AAAGCAAAGCCAGTAG-1_1_A9	-7.869931569	-29.63613439	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	794	1047	0.043935053	0.004775549	11	16	EN-PYR	64	21	21
AAAGCAAAGGACACCA-1_1_A9	7.540626561	-23.20026407	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6956	28475	0.018683055	0.009095698	11	L2-3	EN-L2-3-MS	64	21	21
AAAGCAAAGTCTCGGC-1_1_A9	2.651979867	0.194820793	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	860	1130	0.04159292	0.007079646	11	16	EN-PYR	64	21	21
AAAGCAACAAGCTGAG-1_1_A9	23.56214577	26.55624465	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1288	2070	0.007246377	0.005797101	11	oligos	OL-MS-2	64	21	21
AAAGCAACAGACAGGT-1_1_A9	-18.85842099	14.34786551	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1488	2284	0.014448336	0.00262697	11	8	Astrocytes	64	21	21
AAAGCAACATACGCTA-1_1_A9	-11.57445072	30.88288043	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	897	1138	0.029876977	0.005272408	11	oligos	OL-MS-2	64	21	21
AAAGCAAGTGGCGAAT-1_1_A9	5.475910413	-24.018981	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5522	18938	0.010349562	0.007867779	11	L2-3	EN-L2-3-MS	64	21	21
AAAGTAGAGGACAGAA-1_1_A9	-15.97753451	-9.627201956	13B	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2578	5114	0.007235041	0.003715291	11	13B	IN-SV2C	64	21	21
AAAGTAGCAACGCACC-1_1_A9	-10.78112067	-30.01807148	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1136	1635	0.051987768	0.011009174	11	16	EN-PYR	64	21	21
AAAGTAGGTCCTGCTT-1_1_A9	-14.54101889	9.86222812	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1234	1884	0.012738854	0.008492569	11	8	Astrocytes	64	21	21
AAAGTAGGTGGTCCGT-1_1_A9	-2.398443444	32.35790965	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	944	1323	0.013605442	0.001511716	11	oligos	OL-MS-2	64	21	21
AAAGTAGGTTGAACTC-1_1_A9	-22.4785598	15.05181405	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1157	1829	0.003827228	0.006014215	11	8	Astrocytes	64	21	21
AAAGTAGTCGGTTCGG-1_1_A9	-6.837389834	-30.00447007	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	838	1248	0.149839744	0.006410256	11	16	EN-PYR	64	21	21
AAAGTAGTCTTCCTTC-1_1_A9	-34.57274497	-9.592487158	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	895	1387	0.006488825	0.001441961	11	9	OPC	64	21	21
AAATGCCAGTGGCACA-1_1_A9	-14.36114983	-4.25253333	13A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3818	9498	0.027584755	0.004421984	11	13A	IN-VIP	64	21	21
AAATGCCCAGGTGCCT-1_1_A9	-5.83858411	31.04812546	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1288	2002	0.037962038	0.003496503	11	oligos	OL-MS-2	64	21	21
AAATGCCGTACGACCC-1_1_A9	-8.12371499	34.42655555	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	887	1230	0.009756098	0.003252033	11	oligos	OL-MS-2	64	21	21
AAATGCCGTATCGCAT-1_1_A9	-14.09912137	8.620048231	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1178	1779	0.01742552	0.004496908	11	8	Astrocytes	64	21	21
AAATGCCGTGAAAGAG-1_1_A9	-24.13892366	-6.370232201	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1476	2171	0.019345924	0.003224321	11	9	OPC	64	21	21
AAATGCCTCAATCACG-1_1_A9	-19.22838595	15.35062611	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1747	3023	0.011247106	0.001984783	11	8	Astrocytes	64	21	21
AAATGCCTCTATCCTA-1_1_A9	20.54865706	-33.45764407	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4518	14284	0.004060487	0.003640437	11	3	EN-L5-6	64	21	21
AACACGTCAAACCCAT-1_1_A9	-18.15805328	9.920857554	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	853	1140	0.021052632	0.005263158	11	8	Astrocytes	64	21	21
AACACGTGTTGAACTC-1_1_A9	6.305302697	-25.60080129	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6241	23460	0.004987212	0.005967604	11	L2-3	EN-L2-3-MS	64	21	21
AACACGTTCGGCGCTA-1_1_A9	-21.34028098	14.64561877	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1235	1911	0.012035583	0.002093145	11	8	Astrocytes	64	21	21
AACACGTTCTGAAAGA-1_1_A9	-26.16102935	-24.16969484	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5383	15230	0.034734077	0.007025607	11	6A	IN-PV	64	21	21
AACCATGAGTTAGGTA-1_1_A9	-7.021357985	32.20994888	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1001	1381	0.018102824	0.005792904	11	oligos	OL-MS-2	64	21	21
AACCATGCACAGGAGT-1_1_A9	-5.309605867	33.82763032	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1022	1403	0.017106201	0.002138275	11	oligos	OL-MS-2	64	21	21
AACCATGGTAGAGGAA-1_1_A9	5.347726829	-24.49524784	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5252	16580	0.007599517	0.002895054	11	L2-3	EN-L2-3-MS	64	21	21
AACCATGGTTCCGGCA-1_1_A9	-13.64110184	-34.14282165	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1599	2767	0.079147091	0.007589447	11	16	EN-PYR	64	21	21
AACCATGGTTTGGCGC-1_1_A9	27.08767477	-25.26915534	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5610	20352	0.012480346	0.002702437	11	3	EN-L5-6	64	21	21
AACCATGTCAGCTCGG-1_1_A9	-18.59375519	-7.96881204	13B	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3523	7521	0.011567611	0.003988831	11	13B	IN-SV2C	64	21	21
AACCGCGAGATGTGGC-1_1_A9	-23.72328422	-9.313273944	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1159	1698	0.018256773	0.010600707	11	9	OPC	64	21	21
AACCGCGAGCCAACAG-1_1_A9	-9.629450675	33.39867704	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	813	1067	0.017806935	0.005623243	11	oligos	OL-MS-2	64	21	21
AACCGCGCAGAGCCAA-1_1_A9	-19.58430288	13.40535457	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1312	1900	0.008947368	0.007894737	11	8	Astrocytes	64	21	21
AACCGCGTCCGGGTGT-1_1_A9	6.851398445	-26.06209941	10	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4888	14885	0.006852536	0.009136715	11	L2-3	EN-L2-3-Cntl	64	21	21
AACGTTGAGACCCACC-1_1_A9	-10.06478088	32.9823123	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	904	1201	0.024979184	0.004163197	11	oligos	OL-MS-2	64	21	21
AACGTTGCAATAACGA-1_1_A9	-9.544183678	-31.22739015	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1088	1940	0.203092784	0.006185567	11	16	EN-PYR	64	21	21
AACGTTGGTCACCCAG-1_1_A9	-22.75419363	-15.90318517	6B	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5069	15053	0.015611506	0.005646715	11	6B	IN-SST	64	21	21
AACGTTGTCACCCTCA-1_1_A9	-24.93515664	-5.445762927	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1515	2419	0.008267879	0.005787516	11	9	OPC	64	21	21
AACGTTGTCCTAGAAC-1_1_A9	19.19247982	-32.95645684	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	7362	30464	0.003840599	0.005252101	11	3	EN-L5-6	64	21	21
AACTCAGAGTGAATTG-1_1_A9	24.82104953	-19.63847284	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6744	23065	0.030565792	0.00711034	11	3	EN-L5-6	64	21	21
AACTCAGAGTGACTCT-1_1_A9	33.21673704	5.24436264	14	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	869	1094	0.041133455	0.010054845	11	14	Microglia	64	21	21
AACTCAGCACGGCGTT-1_1_A9	-7.290765537	-30.93946376	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	788	1050	0.064761905	0.01047619	11	16	EN-PYR	64	21	21
AACTCAGGTCTACCTC-1_1_A9	-25.1764314	-5.840196214	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1340	2059	0.011170471	0.007770763	11	9	OPC	64	21	21
AACTCAGGTGACGGTA-1_1_A9	25.6512563	-22.4093231	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4713	13657	0.038954382	0.007395475	11	3	EN-L5-6	64	21	21
AACTCAGGTTAAGACA-1_1_A9	-2.213214307	35.81824286	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	763	1036	0.007722008	0.008687259	11	oligos	OL-MS-2	64	21	21
AACTCAGTCCGCATCT-1_1_A9	-14.48884112	-4.284966091	13A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3749	8967	0.008587041	0.006245121	11	13A	IN-VIP	64	21	21
AACTCCCCAATCGAAA-1_1_A9	-2.956537639	34.71340808	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	857	1185	0.021097046	0.005063291	11	oligos	OL-MS-2	64	21	21
AACTCCCCATCACGAT-1_1_A9	5.327270191	1.682596207	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	902	1208	0.040562914	0.013245033	11	16	EN-PYR	64	21	21
AACTCCCCATTGAGCT-1_1_A9	-11.29257114	15.45264381	11	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1625	2460	0.011788618	0.005691057	11	11	Glia-MIX	64	21	21
AACTCCCGTTGTACAC-1_1_A9	-5.778647761	33.18846229	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	965	1315	0.014448669	0.003041825	11	oligos	OL-MS-2	64	21	21
AACTCCCTCCAGAGGA-1_1_A9	-21.12610992	10.54122837	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	916	1412	0.009915014	0.006373938	11	8	Astrocytes	64	21	21
AACTCTTAGCATGGCA-1_1_A9	22.89298052	-19.06290459	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	8230	36257	0.019582425	0.005130044	11	3	EN-L5-6	64	21	21
AACTCTTAGCGATGAC-1_1_A9	-21.22281624	12.59990932	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	944	1444	0.009695291	0.007617729	11	8	Astrocytes	64	21	21
AACTCTTAGGCCATAG-1_1_A9	22.87365149	-22.14444952	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3657	8975	0.01270195	0.004679666	11	3	EN-L5-6	64	21	21
AACTCTTCAAACTGCT-1_1_A9	12.18329053	0.312819698	12	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	851	1181	0.062658764	0.0042337	11	12	EN-MIX	64	21	21
AACTCTTCACCCAGTG-1_1_A9	-25.03871709	-6.681916422	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1187	1692	0.007092199	0.004728132	11	9	OPC	64	21	21
AACTCTTGTCAACTGT-1_1_A9	-21.4026862	-16.22951797	6B	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3249	7367	0.007465726	0.005158138	11	6B	IN-SST	64	21	21
AACTCTTGTTACGCGC-1_1_A9	18.79945427	-31.7548674	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6096	21938	0.004786216	0.00319081	11	3	EN-L5-6	64	21	21
AACTCTTTCGAATGCT-1_1_A9	-18.97381049	10.91699419	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	896	1219	0.020508614	0.000820345	11	8	Astrocytes	64	21	21
AACTGGTAGCTGTTCA-1_1_A9	-8.202798224	33.69211938	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	768	1025	0.014634146	0.007804878	11	oligos	OL-MS-2	64	21	21
AACTGGTAGGCCCTCA-1_1_A9	-21.22187953	16.12941549	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1275	2046	0.009775171	0.004398827	11	8	Astrocytes	64	21	21
AACTGGTCACAGGCCT-1_1_A9	-8.727534084	33.29215728	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	873	1171	0.010247652	0.004269855	11	oligos	OL-MS-2	64	21	21
AACTGGTGTAAGGGCT-1_1_A9	-7.321293787	-29.25694089	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	794	1082	0.094269871	0.005545287	11	16	EN-PYR	64	21	21
AACTGGTTCAGGTTCA-1_1_A9	18.68092952	-25.67316237	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3237	6759	0.005918035	0.019677467	11	3	EN-L5-6	64	21	21
AACTGGTTCCTCATTA-1_1_A9	-19.09225249	16.19547853	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1676	2609	0.016098122	0.005749329	11	8	Astrocytes	64	21	21
AACTGGTTCTAACCGA-1_1_A9	33.18615737	4.646348234	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1024	1317	0.041002278	0.014426727	11	16	EN-PYR	64	21	21
AACTTTCGTACATGTC-1_1_A9	-18.51136817	-20.99242001	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2304	5134	0.012076354	0.002921698	11	6A	IN-PV	64	21	21
AACTTTCGTCAGGACA-1_1_A9	-2.218302682	36.22098152	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	779	1076	0.020446097	0.00464684	11	oligos	OL-MS-2	64	21	21
AAGACCTCACAGGAGT-1_1_A9	-5.745159819	35.14498327	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	850	1164	0.018900344	0.004295533	11	oligos	OL-MS-2	64	21	21
AAGACCTCATGCATGT-1_1_A9	-7.736581617	34.67468415	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	890	1200	0.018333333	0.0075	11	oligos	OL-MS-2	64	21	21
AAGACCTGTCCTGCTT-1_1_A9	-22.84687768	-21.67642186	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2845	6610	0.052950076	0.003025719	11	6A	IN-PV	64	21	21
AAGACCTGTTAGTGGG-1_1_A9	22.60337107	-19.47314958	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5455	16418	0.010354489	0.007613595	11	3	EN-L5-6	64	21	21
AAGCCGCAGATATGCA-1_1_A9	-14.89716041	10.83511899	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1758	2909	0.025094534	0.006875215	11	8	Astrocytes	64	21	21
AAGCCGCAGCCTATGT-1_1_A9	4.274604715	1.406931659	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	801	1008	0.054563492	0.009920635	11	16	EN-PYR	64	21	21
AAGCCGCAGCTTTGGT-1_1_A9	-3.860552113	32.98204159	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	986	1373	0.013109978	0.004369993	11	oligos	OL-MS-2	64	21	21
AAGCCGCAGTAGATGT-1_1_A9	-19.37101977	17.30541115	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1565	2546	0.00392773	0.009426551	11	8	Astrocytes	64	21	21
AAGCCGCCAGGTCCAC-1_1_A9	6.866657575	-24.07668204	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6129	22293	0.009195712	0.005248284	11	L2-3	EN-L2-3-MS	64	21	21
AAGCCGCGTAGCACGA-1_1_A9	20.29331291	-31.93771386	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	8699	40027	0.012641467	0.004097234	11	3	EN-L5-6	64	21	21
AAGCCGCGTATGCTTG-1_1_A9	-12.59085475	16.840094	11	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1620	2614	0.006885998	0.005355777	11	11	Glia-MIX	64	21	21
AAGCCGCGTTGTTTGG-1_1_A9	31.14118239	-2.661570303	2	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2891	6143	0.008464919	0.003255738	11	2	EN-L4	64	21	21
AAGCCGCTCGGTTAAC-1_1_A9	3.106676286	-24.39943858	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3783	8529	0.009731504	0.00433814	11	L2-3	EN-L2-3-MS	64	21	21
AAGCCGCTCTCCAACC-1_1_A9	20.52821034	27.33036777	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	988	1487	0.015467384	0.00403497	11	oligos	OL-MS-2	64	21	21
AAGGAGCAGTACGTAA-1_1_A9	-16.17095635	-17.05333712	6B	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1775	3368	0.027909739	0.005344418	11	6B	IN-SST	64	21	21
AAGGAGCCACATTCGA-1_1_A9	-8.46850897	-29.96782661	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	877	1208	0.072019868	0.006622517	11	16	EN-PYR	64	21	21
AAGGAGCCAGTGAGTG-1_1_A9	5.260876541	-23.64220284	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4829	13630	0.004108584	0.004695525	11	L2-3	EN-L2-3-MS	64	21	21
AAGGAGCCATATGAGA-1_1_A9	-20.84115276	16.77314492	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1674	2863	0.006287111	0.005937827	11	8	Astrocytes	64	21	21
AAGGAGCGTACCGGCT-1_1_A9	23.46236454	26.61058099	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1258	1922	0.005723205	0.008324662	11	oligos	OL-MS-2	64	21	21
AAGGCAGAGAAACCGC-1_1_A9	-7.405172378	-30.71877076	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	825	1109	0.051397656	0.008115419	11	16	EN-PYR	64	21	21
AAGGCAGAGGGTATCG-1_1_A9	30.15381999	-8.171624082	2	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4722	12743	0.009416935	0.005650161	11	2	EN-L4	64	21	21
AAGGCAGAGGGTCTCC-1_1_A9	-1.70800873	36.37036584	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	813	1079	0.012974977	0.010194625	11	oligos	OL-MS-2	64	21	21
AAGGCAGCAATGTAAG-1_1_A9	22.54632638	-21.94500178	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5078	14701	0.018502143	0.007482484	11	3	EN-L5-6	64	21	21
AAGGCAGGTAGCGTCC-1_1_A9	-10.51523475	-27.43448119	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	809	1060	0.072641509	0.009433962	11	16	EN-PYR	64	21	21
AAGGCAGGTTAGATGA-1_1_A9	-12.4672029	17.26567223	11	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1763	2797	0.009295674	0.007508044	11	11	Glia-MIX	64	21	21
AAGGCAGGTTTAGGAA-1_1_A9	-6.08824081	35.88260131	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	830	1123	0.024042743	0.00890472	11	oligos	OL-MS-2	64	21	21
AAGGCAGTCGGAATCT-1_1_A9	-5.055202104	36.07126249	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	718	1017	0.010816126	0.001966568	11	oligos	OL-MS-2	64	21	21
AAGGCAGTCGTTTAGG-1_1_A9	-13.11997001	7.189552038	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	969	1291	0.02556158	0.00929512	11	16	EN-PYR	64	21	21
AAGGTTCAGGATCGCA-1_1_A9	23.13608288	-10.47028484	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2888	5796	0.01552795	0.003968254	11	3	EN-L5-6	64	21	21
AAGGTTCAGTTCGATC-1_1_A9	-21.7793516	14.48090551	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1230	1944	0.007201646	0.006687243	11	8	Astrocytes	64	21	21
AAGGTTCGTATGAATG-1_1_A9	-19.40888562	10.63902363	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	882	1212	0.015676568	0.008250825	11	8	Astrocytes	64	21	21
AAGTCTGAGGAATGGA-1_1_A9	16.78788502	-27.27589181	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4667	12114	0.010979033	0.007594519	11	3	EN-L5-6	64	21	21
AAGTCTGGTATGGTTC-1_1_A9	-2.746225191	34.99660852	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	789	1071	0.019607843	0.005602241	11	oligos	OL-MS-2	64	21	21
AAGTCTGGTTCGTGAT-1_1_A9	-11.65031966	-33.33295015	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1096	1644	0.035279805	0.004257908	11	16	EN-PYR	64	21	21
AAGTCTGTCACCGGGT-1_1_A9	-12.28872605	17.31432983	11	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1835	3026	0.0042961	0.00462657	11	11	Glia-MIX	64	21	21
AAGTCTGTCAGCTCTC-1_1_A9	28.37260737	-26.07733699	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5589	21018	0.005804548	0.002616805	11	3	EN-L5-6	64	21	21
AAGTCTGTCCTTTCTC-1_1_A9	-24.31943839	-1.288372718	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1501	2308	0.008232236	0.005199307	11	9	OPC	64	21	21
AATCCAGCAAATTGCC-1_1_A9	-11.22872323	-30.39881163	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1277	1754	0.031927024	0.009122007	11	16	EN-PYR	64	21	21
AATCCAGCAGGTGGAT-1_1_A9	20.67826812	-31.92500616	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5828	21994	0.026598163	0.003364554	11	3	EN-L5-6	64	21	21
AATCCAGCATCCGGGT-1_1_A9	-21.23107758	16.24814246	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1367	2259	0.006197432	0.005312085	11	8	Astrocytes	64	21	21
AATCCAGCATGTAGTC-1_1_A9	17.69487382	-27.67424993	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3228	7300	0.004383562	0.014931507	11	3	EN-L5-6	64	21	21
AATCCAGGTAGTAGTA-1_1_A9	28.184681	-25.82699376	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5330	18288	0.012521872	0.002843395	11	3	EN-L5-6	64	21	21
AATCCAGGTCCGAATT-1_1_A9	-18.67156851	-8.182937154	13B	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3947	9594	0.011778195	0.007921618	11	13B	IN-SV2C	64	21	21
AATCGGTAGAAAGTGG-1_1_A9	-7.134033385	-32.11892617	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	836	1221	0.108108108	0.017199017	11	16	EN-PYR	64	21	21
AATCGGTAGAGGACGG-1_1_A9	-20.42819512	12.70842278	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1092	1680	0.017857143	0.004166667	11	8	Astrocytes	64	21	21
AATCGGTAGATCTGCT-1_1_A9	19.84296392	-34.07257534	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3686	10495	0.003430205	0.00686041	11	3	EN-L5-6	64	21	21
AATCGGTAGTGCTGCC-1_1_A9	19.18516196	-34.29220353	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4232	11361	0.008626001	0.003432796	11	3	EN-L5-6	64	21	21
AATCGGTCACTTACGA-1_1_A9	20.1712211	-33.71135027	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4318	12579	0.008267748	0.006598299	11	3	EN-L5-6	64	21	21
AATCGGTGTAAGTGTA-1_1_A9	-20.21942865	10.82288559	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	998	1459	0.006168609	0.00685401	11	8	Astrocytes	64	21	21
AATCGGTGTGACGGTA-1_1_A9	7.304082866	-24.36717109	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6084	21080	0.007210626	0.00313093	11	L2-3	EN-L2-3-MS	64	21	21
AATCGGTGTTATGTGC-1_1_A9	26.99868122	-26.65400332	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5298	17104	0.003917212	0.003449486	11	3	EN-L5-6	64	21	21
ACACCAAAGCATCATC-1_1_A9	3.840165831	0.871641372	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	800	1025	0.07804878	0.005853659	11	16	EN-PYR	64	21	21
ACACCAAAGGATGGTC-1_1_A9	5.951996206	-23.83714002	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5658	17928	0.00713967	0.00502008	11	L2-3	EN-L2-3-MS	64	21	21
ACACCAAAGTCCTCCT-1_1_A9	4.821357914	1.805014206	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	800	1022	0.057729941	0.004892368	11	16	EN-PYR	64	21	21
ACACCAAAGTGTTTGC-1_1_A9	-12.1506084	-32.84841538	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1361	2174	0.073597056	0.011039558	11	16	EN-PYR	64	21	21
ACACCAACAGGTTTCA-1_1_A9	23.09780796	-19.58750955	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6515	24049	0.032558526	0.00399185	11	3	EN-L5-6	64	21	21
ACACCAAGTATGCTTG-1_1_A9	-8.299059242	33.31454047	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	972	1281	0.014051522	0.006245121	11	oligos	OL-MS-2	64	21	21
ACACCAAGTGTGACCC-1_1_A9	-11.11913985	31.68758375	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1233	1723	0.029599536	0.004643064	11	oligos	OL-MS-2	64	21	21
ACACCAATCAAACCGT-1_1_A9	-9.854243703	-31.21956986	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	972	1415	0.028975265	0.007067138	11	16	EN-PYR	64	21	21
ACACCAATCATCTGTT-1_1_A9	33.01738588	5.199659248	14	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1180	1487	0.016812374	0.008742434	11	14	Microglia	64	21	21
ACACCAATCCGCATAA-1_1_A9	-13.94021695	8.486241534	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1441	2120	0.035377358	0.00754717	11	8	Astrocytes	64	21	21
ACACCCTCAAAGAATC-1_1_A9	-8.813389011	-27.69197659	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	945	1278	0.031298905	0.017214397	11	16	EN-PYR	64	21	21
ACACCCTCAGAGCCAA-1_1_A9	-11.36559239	31.7370214	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	989	1358	0.028718704	0.00736377	11	oligos	OL-MS-2	64	21	21
ACACCCTCAGATAATG-1_1_A9	-9.173331147	-28.21899148	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	906	1250	0.0528	0.004	11	16	EN-PYR	64	21	21
ACACCCTCAGATCCAT-1_1_A9	-21.48168935	-16.61211999	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5516	18483	0.007736839	0.003570849	11	6A	IN-PV	64	21	21
ACACCCTCAGTAACGG-1_1_A9	5.397036488	-24.32706221	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6154	23192	0.009399793	0.005087961	11	L2-3	EN-L2-3-MS	64	21	21
ACACCCTGTACTTGAC-1_1_A9	-13.68001262	-34.21202404	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1710	2857	0.04900245	0.00840042	11	16	EN-PYR	64	21	21
ACACCCTGTGCAGGTA-1_1_A9	-14.9138095	9.243626272	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1256	1814	0.02646086	0.005512679	11	8	Astrocytes	64	21	21
ACACCCTTCTAACTTC-1_1_A9	-24.4715455	-1.044130228	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1704	2731	0.012449652	0.004760161	11	9	OPC	64	21	21
ACACCCTTCTCTAAGG-1_1_A9	-10.27302758	32.279959	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1089	1394	0.035868006	0.015064562	11	oligos	OL-MS-2	64	21	21
ACACCCTTCTTAACCT-1_1_A9	-7.167894411	-28.60628127	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	761	1017	0.05899705	0.004916421	11	16	EN-PYR	64	21	21
ACACCGGAGCAGGTCA-1_1_A9	-19.13878521	10.75744539	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	853	1160	0.012068966	0.003448276	11	8	Astrocytes	64	21	21
ACACCGGAGCGTCTAT-1_1_A9	5.641273996	-23.88258641	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5391	18354	0.006265664	0.006701536	11	L2-3	EN-L2-3-MS	64	21	21
ACACCGGAGCTCTCGG-1_1_A9	22.93014028	-24.10166035	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2706	5610	0.018894831	0.0057041	11	3	EN-L5-6	64	21	21
ACACCGGCAATGGACG-1_1_A9	7.423041677	-0.473295854	12	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	920	1418	0.021861777	0.014809591	11	12	EN-MIX	64	21	21
ACACCGGCAATGTAAG-1_1_A9	-8.809004945	33.64395236	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	850	1102	0.015426497	0.002722323	11	oligos	OL-MS-2	64	21	21
ACACCGGCACGTTGGC-1_1_A9	-6.970656741	32.0739803	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1134	1591	0.011313639	0.004399749	11	oligos	OL-MS-2	64	21	21
ACACCGGCATGACGGA-1_1_A9	19.20606373	-32.69128392	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	7007	26251	0.004799817	0.007009257	11	3	EN-L5-6	64	21	21
ACACCGGGTCCGTGAC-1_1_A9	-5.097811982	35.37548112	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	831	1123	0.021371327	0.006233304	11	oligos	OL-MS-2	64	21	21
ACACCGGGTGCGGTAA-1_1_A9	-25.88536247	-9.595339181	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1007	1442	0.022884882	0.004160888	11	9	OPC	64	21	21
ACACCGGTCTGACCTC-1_1_A9	11.82921613	-2.908929128	12	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1516	2763	0.014115092	0.009048136	11	12	EN-MIX	64	21	21
ACACTGAAGTGGTCCC-1_1_A9	3.994809516	0.773843567	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1048	1600	0.00625	0.01	11	16	EN-PYR	64	21	21
ACACTGACACCCATGG-1_1_A9	9.129102338	-1.244590879	12	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1263	2043	0.018110622	0.005873715	11	12	EN-MIX	64	21	21
ACACTGACACCCATTC-1_1_A9	5.173214852	1.822913083	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	898	1137	0.051011434	0.007915567	11	16	EN-PYR	64	21	21
ACACTGACACGGTAGA-1_1_A9	-11.4083461	30.11792904	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1680	2445	0.039263804	0.008179959	11	oligos	OL-MS-2	64	21	21
ACACTGACATGCCTTC-1_1_A9	-7.682305537	31.78077385	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1130	1634	0.025703794	0.004895961	11	oligos	OL-MS-2	64	21	21
ACACTGAGTCTAGTCA-1_1_A9	-18.87029668	10.50421313	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	811	1080	0.014814815	0.00462963	11	8	Astrocytes	64	21	21
ACACTGAGTTAGTGGG-1_1_A9	-0.039002249	-15.75169665	10	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2408	5047	0.002575788	0.00396275	11	L2-3	EN-L2-3-Cntl	64	21	21
ACACTGAGTTTGGGCC-1_1_A9	-26.32366561	-23.95371843	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5096	14086	0.048061905	0.0066023	11	6A	IN-PV	64	21	21
ACAGCCGAGCGTGAGT-1_1_A9	-11.51921083	14.2203501	11	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1314	1939	0.008251676	0.004641568	11	11	Glia-MIX	64	21	21
ACAGCCGAGTACGACG-1_1_A9	22.08193499	26.44731139	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1105	1693	0.011222682	0.007678677	11	oligos	OL-MS-2	64	21	21
ACAGCCGAGTGTTGAA-1_1_A9	-17.40006068	-9.077772463	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3292	6853	0.008609368	0.007296075	11	6A	IN-PV	64	21	21
ACAGCCGCAAACCTAC-1_1_A9	6.272944436	-25.39456492	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5767	19698	0.005025891	0.002538329	11	L2-3	EN-L2-3-MS	64	21	21
ACAGCCGCATACGCCG-1_1_A9	5.275143219	1.498694941	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1086	1721	0.027890761	0.005810575	11	16	EN-PYR	64	21	21
ACAGCCGGTAGAGCTG-1_1_A9	20.1793133	-31.95845419	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	7574	32142	0.008400224	0.004573455	11	3	EN-L5-6	64	21	21
ACAGCCGGTTACCGAT-1_1_A9	-24.57409372	-6.547758013	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1291	1890	0.014285714	0.002645503	11	9	OPC	64	21	21
ACAGCCGGTTGCCTCT-1_1_A9	-19.41719675	12.38751069	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1067	1570	0.012101911	0.004458599	11	8	Astrocytes	64	21	21
ACAGCCGTCATGGTCA-1_1_A9	-8.080235776	-29.44291806	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	926	1252	0.084664537	0.012779553	11	16	EN-PYR	64	21	21
ACAGCCGTCCTCATTA-1_1_A9	-7.188235883	34.17340898	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	883	1190	0.023529412	0.006722689	11	oligos	OL-MS-2	64	21	21
ACAGCCGTCTTATCTG-1_1_A9	-10.44305088	22.27269838	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1596	2428	0.007413509	0.00247117	11	8	Astrocytes	64	21	21
ACAGCTAAGCGTAATA-1_1_A9	-9.644670555	-31.24218079	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	927	1256	0.015923567	0.008757962	11	16	EN-PYR	64	21	21
ACAGCTACAAACAACA-1_1_A9	4.502152628	1.138235811	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1057	1460	0.073972603	0.010273973	11	16	EN-PYR	64	21	21
ACAGCTACACCTCGTT-1_1_A9	9.447147445	-23.15954063	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6112	20540	0.006669912	0.015287244	11	L2-3	EN-L2-3-MS	64	21	21
ACAGCTACAGATGGGT-1_1_A9	8.669493616	-23.52931996	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5175	15469	0.005882733	0.014221992	11	L2-3	EN-L2-3-MS	64	21	21
ACAGCTACATCTCGCT-1_1_A9	9.901802973	-2.28039503	12	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1536	2608	0.023773006	0.009202454	11	12	EN-MIX	64	21	21
ACAGCTACATTAGGCT-1_1_A9	-14.61227456	7.163433423	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	769	1029	0.041788144	0.008746356	11	8	Astrocytes	64	21	21
ACAGCTAGTCATATCG-1_1_A9	19.2484998	-32.49640569	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6095	20564	0.006370356	0.005932698	11	3	EN-L5-6	64	21	21
ACAGCTAGTGTGTGCC-1_1_A9	2.363463405	5.249363674	7	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1111	1434	0.006973501	0.013947001	11	7	Phagocytes	64	21	21
ACAGCTATCGTGACAT-1_1_A9	-20.1054038	12.07167491	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	997	1417	0.016231475	0.006351447	11	8	Astrocytes	64	21	21
ACAGCTATCGTTGCCT-1_1_A9	-7.175770285	-29.7481455	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	754	1082	0.091497227	0.007393715	11	16	EN-PYR	64	21	21
ACAGCTATCTTTACAC-1_1_A9	-6.081638451	32.51183394	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	955	1371	0.021152443	0.004376368	11	oligos	OL-MS-2	64	21	21
ACATACGAGCCGCCTA-1_1_A9	-12.01181401	-32.48503365	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1329	2046	0.087487781	0.005376344	11	16	EN-PYR	64	21	21
ACATACGTCTTGTCAT-1_1_A9	27.74473373	-24.63890429	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6027	21636	0.011508597	0.003189129	11	3	EN-L5-6	64	21	21
ACATCAGAGCGATATA-1_1_A9	-25.37285326	-8.899021758	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1023	1402	0.007132668	0.003566334	11	9	OPC	64	21	21
ACATCAGCATCGGAAG-1_1_A9	-20.21923697	16.35667585	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1421	2269	0.006610842	0.004407228	11	8	Astrocytes	64	21	21
ACATCAGGTCGCCATG-1_1_A9	7.394866671	-24.60627904	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5755	19118	0.00831677	0.005178366	11	L2-3	EN-L2-3-MS	64	21	21
ACATCAGGTCGTCTTC-1_1_A9	-11.0955675	-32.95882091	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1164	1805	0.099722992	0.004432133	11	16	EN-PYR	64	21	21
ACATCAGTCACTGGGC-1_1_A9	6.860441715	-2.571809216	12	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1171	2055	0.010705596	0.005352798	11	12	EN-MIX	64	21	21
ACATCAGTCGTAGATC-1_1_A9	-3.090753919	34.91774348	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	846	1124	0.020462633	0.004448399	11	oligos	OL-MS-2	64	21	21
ACATCAGTCGTTGACA-1_1_A9	-13.47977965	-5.000484579	13A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2345	4494	0.026257232	0.003782822	11	13A	IN-VIP	64	21	21
ACATCAGTCTACTCAT-1_1_A9	-12.04087131	31.12666788	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	958	1266	0.04028436	0.006319115	11	oligos	OL-MS-2	64	21	21
ACATCAGTCTCCAGGG-1_1_A9	-3.202285488	35.22519903	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	751	1028	0.01459144	0.002918288	11	oligos	OL-MS-2	64	21	21
ACATGGTCACACGCTG-1_1_A9	10.4950096	0.525507712	12	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	907	1328	0.009789157	0.002259036	11	12	EN-MIX	64	21	21
ACATGGTGTATTCTCT-1_1_A9	-9.038692511	33.26572505	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	834	1142	0.064798599	0.003502627	11	oligos	OL-MS-2	64	21	21
ACATGGTGTGTTGGGA-1_1_A9	-8.644630175	-27.31654016	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	943	1360	0.027205882	0.005147059	11	16	EN-PYR	64	21	21
ACATGGTTCACAAACC-1_1_A9	4.775738918	1.483860624	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	875	1156	0.073529412	0.008650519	11	16	EN-PYR	64	21	21
ACATGGTTCGTAGGTT-1_1_A9	-8.428255555	-29.84312538	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	926	1238	0.045234249	0.008077544	11	16	EN-PYR	64	21	21
ACCAGTACAAGCTGTT-1_1_A9	-25.56082431	-7.850316379	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1065	1507	0.00729927	0.01592568	11	9	OPC	64	21	21
ACCAGTACAGACGTAG-1_1_A9	-11.43832216	31.54632874	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1152	1528	0.035994764	0.009162304	11	oligos	OL-MS-2	64	21	21
ACCAGTACATGGTAGG-1_1_A9	-12.58839286	-3.34926963	13A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2711	5185	0.015814851	0.006171649	11	13A	IN-VIP	64	21	21
ACCAGTAGTAGCAAAT-1_1_A9	-6.411232779	-29.78720797	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	767	1084	0.123616236	0.010147601	11	16	EN-PYR	64	21	21
ACCAGTAGTAGGGACT-1_1_A9	5.405167667	-23.90611131	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5151	15354	0.005080109	0.004168295	11	L2-3	EN-L2-3-MS	64	21	21
ACCAGTAGTATAAACG-1_1_A9	-25.42934867	-10.20330932	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	791	1071	0.01774043	0.005602241	11	9	OPC	64	21	21
ACCAGTAGTCATATCG-1_1_A9	-31.19966927	-10.37104073	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	958	1384	0.007225434	0.00433526	11	9	OPC	64	21	21
ACCAGTAGTTCTGTTT-1_1_A9	21.17055648	27.35129836	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1014	1531	0.018941868	0.007838014	11	oligos	OL-MS-2	64	21	21
ACCAGTATCAACACTG-1_1_A9	6.000071576	-22.38701654	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3217	7282	0.00700357	0.00810217	11	L2-3	EN-L2-3-MS	64	21	21
ACCAGTATCAGCATGT-1_1_A9	28.87938225	-7.033386038	2	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3996	10251	0.007023705	0.00399961	11	2	EN-L4	64	21	21
ACCAGTATCTAGCACA-1_1_A9	-18.26730344	10.1420354	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1047	1584	0.016414141	0.002525253	11	8	Astrocytes	64	21	21
ACCAGTATCTATGTGG-1_1_A9	-16.94409761	11.22856084	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1299	1967	0.014234875	0.007625826	11	8	Astrocytes	64	21	21
ACCAGTATCTGGCGTG-1_1_A9	7.116821665	-24.20162027	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6812	25555	0.007826257	0.004460967	11	L2-3	EN-L2-3-MS	64	21	21
ACCCACTAGGGCTTGA-1_1_A9	-19.07348317	15.08106735	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1632	2762	0.010861694	0.013034033	11	8	Astrocytes	64	21	21
ACCCACTCAATAGAGT-1_1_A9	-17.09504634	-7.467816062	13B	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2922	5929	0.024962051	0.002192613	11	13B	IN-SV2C	64	21	21
ACCCACTCAATGACCT-1_1_A9	-8.058680435	-29.82223043	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	810	1093	0.064958829	0.004574565	11	16	EN-PYR	64	21	21
ACCCACTCAGCCAGAA-1_1_A9	4.480387208	1.067533134	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1016	1346	0.05794948	0.008915305	11	16	EN-PYR	64	21	21
ACCCACTGTACCGTTA-1_1_A9	-17.7785336	10.0505958	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1125	1640	0.017073171	0.007317073	11	8	Astrocytes	64	21	21
ACCCACTGTAGCGTAG-1_1_A9	-15.14100276	-6.175955114	13A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4611	11873	0.007832898	0.009938516	11	13A	IN-VIP	64	21	21
ACCCACTGTCGGGTCT-1_1_A9	-1.824781585	33.30889592	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1006	1447	0.007601935	0.01105736	11	oligos	OL-MS-2	64	21	21
ACCCACTGTCTGATCA-1_1_A9	-19.07695273	16.42251733	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1788	2990	0.005351171	0.006020067	11	8	Astrocytes	64	21	21
ACCCACTGTGCGGTAA-1_1_A9	18.84530419	-31.38644992	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5823	19380	0.00505676	0.004540764	11	3	EN-L5-6	64	21	21
ACCCACTGTGGACGAT-1_1_A9	-25.01416366	-5.856897179	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1267	1835	0.010354223	0.003814714	11	9	OPC	64	21	21
ACCCACTGTGGTACAG-1_1_A9	-8.84113752	-31.04100574	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	934	1272	0.062106918	0.010220126	11	16	EN-PYR	64	21	21
ACCCACTGTTTCCACC-1_1_A9	-9.091421103	33.5737388	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	808	1061	0.02262017	0.001885014	11	oligos	OL-MS-2	64	21	21
ACCCACTGTTTCGCTC-1_1_A9	-8.194810556	-27.41777344	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	825	1090	0.080733945	0.00733945	11	16	EN-PYR	64	21	21
ACCGTAAAGGTGACCA-1_1_A9	7.060097508	2.330113745	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	865	1051	0.016175071	0.006660324	11	16	EN-PYR	64	21	21
ACCGTAAAGTCGTACT-1_1_A9	-5.490603695	-28.43062541	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	761	1004	0.028884462	0.010956175	11	16	EN-PYR	64	21	21
ACCGTAACAAAGGCGT-1_1_A9	-7.293934726	-29.613968	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	743	1015	0.032512315	0.003940887	11	16	EN-PYR	64	21	21
ACCGTAACAAGGTGTG-1_1_A9	-20.40304722	15.12651313	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1435	2295	0.005664488	0.006100218	11	8	Astrocytes	64	21	21
ACCGTAACAATACGCT-1_1_A9	-10.53604839	33.10968254	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	867	1119	0.023235031	0.00714924	11	oligos	OL-MS-2	64	21	21
ACCGTAACAGACACTT-1_1_A9	4.969410211	1.660320487	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	813	1040	0.048076923	0.0125	11	16	EN-PYR	64	21	21
ACCGTAAGTCAAACTC-1_1_A9	-7.509599024	-28.87035607	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	864	1143	0.048993876	0.007874016	11	16	EN-PYR	64	21	21
ACCGTAAGTCAACTGT-1_1_A9	-9.780104745	32.63783006	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	807	1055	0.020853081	0.009478673	11	oligos	OL-MS-2	64	21	21
ACCGTAATCAGCTCGG-1_1_A9	-21.109	16.43411988	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1553	2521	0.013486712	0.005156684	11	8	Astrocytes	64	21	21
ACCGTAATCTACCAGA-1_1_A9	-8.31404374	-29.87974177	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	885	1218	0.068965517	0.00410509	11	16	EN-PYR	64	21	21
ACCTTTAAGTGGGATC-1_1_A9	-6.378168808	-30.58807615	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	759	1023	0.070381232	0.009775171	11	16	EN-PYR	64	21	21
ACCTTTAGTTTGTTGG-1_1_A9	-26.85298101	12.49641773	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	970	1443	0.007623008	0.001386001	11	8	Astrocytes	64	21	21
ACGAGCCCACAACGCC-1_1_A9	4.775071132	1.208078331	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1066	1418	0.045133992	0.008462623	11	16	EN-PYR	64	21	21
ACGAGCCGTAAACCTC-1_1_A9	-18.65029359	-8.181886212	13B	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3991	9075	0.005619835	0.007052342	11	13B	IN-SV2C	64	21	21
ACGAGGAAGGTAAACT-1_1_A9	-9.025515096	35.17756075	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	920	1183	0.018596788	0.003381234	11	oligos	OL-MS-2	64	21	21
ACGAGGACAACTGCGC-1_1_A9	24.93395017	-19.97755619	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	8713	41614	0.023045129	0.0070409	11	3	EN-L5-6	64	21	21
ACGAGGATCACAATGC-1_1_A9	-1.891384705	34.06191782	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	872	1301	0.01537279	0.003074558	11	oligos	OL-MS-2	64	21	21
ACGAGGATCTCGCATC-1_1_A9	31.60660709	-5.721303751	2	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2651	4945	0.008493428	0.00364004	11	2	EN-L4	64	21	21
ACGATACAGCTAAGAT-1_1_A9	-2.22539924	35.34214905	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	827	1135	0.014977974	0.006167401	11	oligos	OL-MS-2	64	21	21
ACGATACCAGCTTCGG-1_1_A9	9.551405816	-1.567239061	12	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1258	2123	0.018841262	0.0089496	11	12	EN-MIX	64	21	21
ACGATACTCAAGAAGT-1_1_A9	26.14154808	-27.11954755	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4190	11386	0.01018795	0.002898296	11	3	EN-L5-6	64	21	21
ACGATACTCCACGACG-1_1_A9	-8.490141924	34.40629291	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	942	1257	0.023070804	0.002386635	11	oligos	OL-MS-2	64	21	21
ACGATACTCCGTCAAA-1_1_A9	-17.59459373	9.633455157	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1278	2095	0.012410501	0.008591885	11	8	Astrocytes	64	21	21
ACGATACTCTAAGCCA-1_1_A9	-25.41384041	-24.77404545	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5061	14112	0.015022676	0.006802721	11	6A	IN-PV	64	21	21
ACGATACTCTCTGCTG-1_1_A9	24.38660406	8.371226758	15A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5215	12826	0.018634025	0.019569624	11	15A	Endo cells	64	21	21
ACGATGTAGGGTTCCC-1_1_A9	28.45817533	-26.07022655	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5742	20405	0.001911296	0.003283509	11	3	EN-L5-6	64	21	21
ACGATGTAGTAGCCGA-1_1_A9	-13.72664837	17.4174632	11	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1564	2426	0.003297609	0.009068425	11	11	Glia-MIX	64	21	21
ACGATGTCACAGACTT-1_1_A9	-12.27708958	-32.97771659	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1272	1990	0.03718593	0.007035176	11	16	EN-PYR	64	21	21
ACGATGTCACGGATAG-1_1_A9	26.75996415	-25.33253612	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4412	12164	0.00830319	0.003370602	11	3	EN-L5-6	64	21	21
ACGATGTCATCACGTA-1_1_A9	-6.22265661	35.2887098	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	843	1161	0.018949182	0.002583979	11	oligos	OL-MS-2	64	21	21
ACGATGTGTTAAGACA-1_1_A9	-11.34050175	16.17048166	11	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2384	4008	0.013473054	0.004241517	11	11	Glia-MIX	64	21	21
ACGATGTGTTGAGTTC-1_1_A9	-24.79770549	-10.96869767	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1077	1389	0.019438445	0.01511879	11	9	OPC	64	21	21
ACGATGTTCCGCAAGC-1_1_A9	19.68523906	-32.996992	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6936	27212	0.004703807	0.003785095	11	3	EN-L5-6	64	21	21
ACGCAGCAGCCAGAAC-1_1_A9	-18.91432939	-15.9119863	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2294	4443	0.010803511	0.00427639	11	6A	IN-PV	64	21	21
ACGCAGCCATGCCTAA-1_1_A9	-12.64425522	-33.22296078	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1410	2175	0.044597701	0.008275862	11	16	EN-PYR	64	21	21
ACGCAGCTCACTTACT-1_1_A9	-25.60914981	-24.66977574	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4812	13055	0.017234776	0.003600153	11	6A	IN-PV	64	21	21
ACGCAGCTCAGCTCGG-1_1_A9	-25.77740354	-10.53604487	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	980	1286	0.017107309	0.020995334	11	9	OPC	64	21	21
ACGCAGCTCCAACCAA-1_1_A9	-21.01982922	-15.7831221	6B	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2884	5760	0.021180556	0.005555556	11	6B	IN-SST	64	21	21
ACGCAGCTCTCGCTTG-1_1_A9	22.35309208	25.6465275	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1185	1824	0.011513158	0.006578947	11	oligos	OL-MS-2	64	21	21
ACGCCAGAGGCCCTTG-1_1_A9	-9.397457048	32.68234303	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	846	1122	0.024955437	0.004456328	11	oligos	OL-MS-2	64	21	21
ACGCCAGCAATGCCAT-1_1_A9	-18.84707103	-8.108206808	13B	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4300	10282	0.010114764	0.007294301	11	13B	IN-SV2C	64	21	21
ACGCCAGCAGGTCCAC-1_1_A9	-6.981624109	-30.06756936	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	839	1134	0.038800705	0.011463845	11	16	EN-PYR	64	21	21
ACGCCAGCATGTCTCC-1_1_A9	-14.16249325	-3.752850884	13A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3641	8305	0.009753161	0.006863335	11	13A	IN-VIP	64	21	21
ACGCCAGGTCACACGC-1_1_A9	30.0949912	-7.076703354	2	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4369	10836	0.007290513	0.003691399	11	2	EN-L4	64	21	21
ACGCCAGGTCGTGGCT-1_1_A9	20.25560891	-31.96665826	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	7082	26934	0.010470038	0.006534492	11	3	EN-L5-6	64	21	21
ACGCCAGTCCACGTTC-1_1_A9	-6.464518216	34.18135534	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	896	1258	0.025437202	0.005564388	11	oligos	OL-MS-2	64	21	21
ACGCCAGTCCTCGCAT-1_1_A9	6.497482305	-23.4365938	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4716	13168	0.011087485	0.004252734	11	L2-3	EN-L2-3-MS	64	21	21
ACGCCAGTCTGTCTAT-1_1_A9	-14.29291405	9.389612274	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1632	2641	0.006436956	0.006436956	11	8	Astrocytes	64	21	21
ACGCCGAAGAAACGCC-1_1_A9	-8.313712148	-27.45887125	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	841	1113	0.061096137	0.008984726	11	16	EN-PYR	64	21	21
ACGCCGAAGAGAGCTC-1_1_A9	-17.82172797	9.173191426	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1152	1872	0.005876068	0.003205128	11	8	Astrocytes	64	21	21
ACGCCGAAGAGGGCTT-1_1_A9	-13.87698576	-14.95990492	6B	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1480	2303	0.019973947	0.004342162	11	6B	IN-SST	64	21	21
ACGCCGAAGCACCGTC-1_1_A9	-18.6179579	10.49727366	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	770	1046	0.022944551	0.004780115	11	8	Astrocytes	64	21	21
ACGCCGAAGTAGCGGT-1_1_A9	-7.710717162	-31.28001489	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	825	1087	0.04323827	0.011039558	11	16	EN-PYR	64	21	21
ACGCCGACAGGTTTCA-1_1_A9	-11.0507362	31.39544943	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	923	1238	0.012116317	0.006462036	11	oligos	OL-MS-2	64	21	21
ACGCCGAGTCCTCCAT-1_1_A9	-16.94958703	8.927901021	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1124	1558	0.01283697	0.006418485	11	8	Astrocytes	64	21	21
ACGCCGAGTGATAAAC-1_1_A9	-5.348052908	34.79104212	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	958	1327	0.03089676	0.004521477	11	oligos	OL-MS-2	64	21	21
ACGGAGAAGTAAGTAC-1_1_A9	-21.34514042	16.5266707	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1470	2532	0.004739336	0.002369668	11	8	Astrocytes	64	21	21
ACGGAGAAGTCACGCC-1_1_A9	-33.71626322	-7.517994624	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1112	1675	0.005373134	0.00238806	11	9	OPC	64	21	21
ACGGAGAGTATTCGTG-1_1_A9	26.87122367	-23.4568457	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6488	23867	0.013994218	0.003477605	11	3	EN-L5-6	64	21	21
ACGGAGAGTCTAGTCA-1_1_A9	27.07363898	-24.88663829	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4251	11536	0.007108183	0.004247573	11	3	EN-L5-6	64	21	21
ACGGAGAGTGCGAAAC-1_1_A9	-18.88885211	-7.921260257	13B	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4220	10082	0.009621107	0.00862924	11	13B	IN-SV2C	64	21	21
ACGGAGATCCAAATGC-1_1_A9	-10.80805825	32.45445174	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	997	1350	0.021481481	0.007407407	11	oligos	OL-MS-2	64	21	21
ACGGAGATCTGGAGCC-1_1_A9	-1.917903495	36.01134052	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	802	1135	0.011453744	0.003524229	11	oligos	OL-MS-2	64	21	21
ACGGCCAAGAAGCCCA-1_1_A9	-7.764813018	-27.7324409	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	771	1037	0.078109932	0.007714561	11	16	EN-PYR	64	21	21
ACGGCCAAGCAGCGTA-1_1_A9	-11.54576136	32.03529811	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	769	1000	0.024	0.006	11	oligos	OL-MS-2	64	21	21
ACGGCCAAGGCTCATT-1_1_A9	7.650291031	-23.17908973	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5095	15584	0.007571869	0.00513347	11	L2-3	EN-L2-3-MS	64	21	21
ACGGCCACACGGACAA-1_1_A9	-14.50874208	9.984379294	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1628	2462	0.010154346	0.00528026	11	8	Astrocytes	64	21	21
ACGGCCACAGCGATCC-1_1_A9	-7.679060211	-30.19205988	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	788	1068	0.037453184	0.008426966	11	16	EN-PYR	64	21	21
ACGGCCACAGTAAGAT-1_1_A9	7.030907984	-24.4307773	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6592	23176	0.009492579	0.00405592	11	L2-3	EN-L2-3-MS	64	21	21
ACGGCCACATTCCTCG-1_1_A9	-9.042838841	-28.16699405	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	893	1189	0.037005887	0.006728343	11	16	EN-PYR	64	21	21
ACGGCCAGTAGCTGCC-1_1_A9	-10.54579967	31.96902376	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	905	1156	0.019031142	0.009515571	11	oligos	OL-MS-2	64	21	21
ACGGCCAGTGACCAAG-1_1_A9	-17.0107144	-7.912485875	13B	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2607	5182	0.033770745	0.004438441	11	13B	IN-SV2C	64	21	21
ACGGCCAGTTCACCTC-1_1_A9	-13.12887534	-33.63476748	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1389	2221	0.061233679	0.005402972	11	16	EN-PYR	64	21	21
ACGGCCATCACAGTAC-1_1_A9	-8.815380224	-27.76768908	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	901	1254	0.074162679	0.003189793	11	16	EN-PYR	64	21	21
ACGGCCATCTGAGGGA-1_1_A9	25.80629557	7.041402953	15A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1350	1817	0.015960374	0.028068244	11	15A	Endo cells	64	21	21
ACGGGCTAGTTTAGGA-1_1_A9	27.43095165	-24.47509597	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6356	22195	0.010362694	0.00468574	11	3	EN-L5-6	64	21	21
ACGGGCTCACCACCAG-1_1_A9	-7.931477778	-27.27558795	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	770	1003	0.076769691	0.005982054	11	16	EN-PYR	64	21	21
ACGGGCTCAGGTCTCG-1_1_A9	-9.701892997	-32.87113413	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	949	1277	0.04385278	0.017227878	11	16	EN-PYR	64	21	21
ACGGGCTCATGCTGGC-1_1_A9	-2.11129948	32.23193237	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	892	1221	0.014742015	0.009009009	11	oligos	OL-MS-2	64	21	21
ACGGGCTGTCACCCAG-1_1_A9	-19.48607673	16.67398028	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1895	3169	0.010097823	0.005680025	11	8	Astrocytes	64	21	21
ACGGGCTGTCATTAGC-1_1_A9	4.945374731	-24.54524948	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3953	10899	0.010184421	0.002936049	11	L2-3	EN-L2-3-MS	64	21	21
ACGGGCTGTTCCTCCA-1_1_A9	-21.21288242	13.36329099	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1153	1773	0.011844332	0.002820079	11	8	Astrocytes	64	21	21
ACGGGCTTCACCTCGT-1_1_A9	33.20328646	5.89370824	14	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	963	1178	0.020373514	0.007640068	11	14	Microglia	64	21	21
ACGGGCTTCGCGGATC-1_1_A9	18.72795652	-32.15451273	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	7093	28328	0.003530076	0.007130754	11	3	EN-L5-6	64	21	21
ACGGGCTTCGTCACGG-1_1_A9	-25.29854337	-24.44689469	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4862	13901	0.030069779	0.005323358	11	6A	IN-PV	64	21	21
ACGGGTCAGCTAAACA-1_1_A9	-23.19520216	-8.175392992	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1456	2135	0.020608899	0.004215457	11	9	OPC	64	21	21
ACGGGTCCAAGGCTCC-1_1_A9	7.769067924	-24.82357438	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	7158	27342	0.011118426	0.005303197	11	L2-3	EN-L2-3-MS	64	21	21
ACGGGTCCAGCCTTTC-1_1_A9	-17.90189396	10.14730112	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1117	1644	0.013990268	0.004257908	11	8	Astrocytes	64	21	21
ACGGGTCGTCGTGGCT-1_1_A9	15.631716	-27.33297897	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3028	6289	0.006996343	0.011925584	11	3	EN-L5-6	64	21	21
ACGTCAAAGGTGCTTT-1_1_A9	-5.212105792	33.1874435	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	966	1418	0.021156559	0.010578279	11	oligos	OL-MS-2	64	21	21
ACGTCAACACCCATTC-1_1_A9	-23.54586114	-7.400170867	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1522	2430	0.011934156	0.005761317	11	9	OPC	64	21	21
ACGTCAACAGTCTTCC-1_1_A9	19.26105781	-33.61844503	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6864	27731	0.005264866	0.004002741	11	3	EN-L5-6	64	21	21
ACGTCAAGTCAGAGGT-1_1_A9	15.2763053	-27.72228807	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3445	7209	0.014287696	0.003606603	11	3	EN-L5-6	64	21	21
ACGTCAATCATGTGGT-1_1_A9	-16.15198199	-5.470500923	13A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4086	9953	0.01718075	0.007937305	11	13A	IN-VIP	64	21	21
ACTATCTAGCTAGTGG-1_1_A9	24.09906033	-10.26829977	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4320	11548	0.003377208	0.004243159	11	3	EN-L5-6	64	21	21
ACTATCTCACATTCGA-1_1_A9	-9.938631888	33.26845929	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	885	1190	0.021008403	0.010084034	11	oligos	OL-MS-2	64	21	21
ACTATCTCAGTAAGAT-1_1_A9	7.578947289	-23.30223163	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4627	13331	0.020478584	0.002625459	11	L2-3	EN-L2-3-MS	64	21	21
ACTATCTGTCAGATAA-1_1_A9	21.94789708	-20.68872328	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4875	13637	0.012172765	0.004179805	11	3	EN-L5-6	64	21	21
ACTATCTGTTACCGAT-1_1_A9	-10.68250558	-27.50326861	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1018	1465	0.107849829	0.017064846	11	16	EN-PYR	64	21	21
ACTATCTGTTCAACCA-1_1_A9	-19.34696461	11.80005055	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1031	1442	0.014563107	0.004854369	11	8	Astrocytes	64	21	21
ACTATCTTCTGCAAGT-1_1_A9	-11.55723288	-32.481375	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1100	1670	0.056886228	0.005988024	11	16	EN-PYR	64	21	21
ACTGAACCATTCACTT-1_1_A9	-7.880453397	32.80578221	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1012	1391	0.020129403	0.006470165	11	oligos	OL-MS-2	64	21	21
ACTGAACGTTCTCATT-1_1_A9	18.66922047	-33.55301485	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	7159	31865	0.003483446	0.002290915	11	3	EN-L5-6	64	21	21
ACTGAACTCCGAATGT-1_1_A9	-10.47763077	30.64140154	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1293	1825	0.031232877	0.007123288	11	oligos	OL-MS-2	64	21	21
ACTGAACTCCGCAGTG-1_1_A9	-10.95868378	12.11521216	11	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	846	1157	0.020743302	0.00605013	11	11	Glia-MIX	64	21	21
ACTGAACTCCTCGCAT-1_1_A9	-8.000285231	-29.64035656	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	870	1140	0.025438596	0.015789474	11	16	EN-PYR	64	21	21
ACTGAACTCTCAAGTG-1_1_A9	17.07581492	-32.61764635	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6313	23583	0.003901115	0.00309545	11	3	EN-L5-6	64	21	21
ACTGAGTAGACACGAC-1_1_A9	-9.026118314	-27.84466242	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	956	1293	0.069605568	0.013147718	11	16	EN-PYR	64	21	21
ACTGAGTAGAGCCCAA-1_1_A9	26.20576869	-27.49834676	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3898	9904	0.003231018	0.004442649	11	3	EN-L5-6	64	21	21
ACTGAGTAGAGCTGCA-1_1_A9	-20.28248214	17.38604257	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1505	2424	0.012376238	0.004537954	11	8	Astrocytes	64	21	21
ACTGAGTAGCTCCCAG-1_1_A9	-17.56819957	-7.883464304	13B	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2846	5724	0.016946191	0.006464011	11	13B	IN-SV2C	64	21	21
ACTGAGTAGGCCGAAT-1_1_A9	-25.74469862	-7.875380776	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1204	1719	0.013379872	0.012216405	11	9	OPC	64	21	21
ACTGAGTCAGACAGGT-1_1_A9	-23.10671901	-7.167480516	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1988	3384	0.013888889	0.013002364	11	9	OPC	64	21	21
ACTGAGTCAGTTAACC-1_1_A9	-4.219035683	34.85419709	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	848	1145	0.018340611	0.004366812	11	oligos	OL-MS-2	64	21	21
ACTGAGTCATTGAGCT-1_1_A9	-21.06764416	12.84745073	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1050	1517	0.011865524	0.003955175	11	8	Astrocytes	64	21	21
ACTGAGTGTAGGACAC-1_1_A9	-18.91455003	10.82374855	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	930	1321	0.012112036	0.00681302	11	8	Astrocytes	64	21	21
ACTGAGTTCGTCACGG-1_1_A9	-9.940991048	33.36682716	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	852	1050	0.028571429	0.005714286	11	oligos	OL-MS-2	64	21	21
ACTGATGAGCGACGTA-1_1_A9	-21.82187925	14.97564561	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1215	1856	0.010237069	0.010775862	11	8	Astrocytes	64	21	21
ACTGATGCAACACCCG-1_1_A9	-12.11790826	30.74513447	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	931	1184	0.039695946	0.005912162	11	oligos	OL-MS-2	64	21	21
ACTGATGTCAAGGTAA-1_1_A9	28.17666058	-25.79547297	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5812	20510	0.006192101	0.005168211	11	3	EN-L5-6	64	21	21
ACTGATGTCATGCATG-1_1_A9	-5.887002072	32.42288368	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1035	1494	0.021419009	0.006024096	11	oligos	OL-MS-2	64	21	21
ACTGATGTCATGGTCA-1_1_A9	7.595254067	-22.98036164	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5312	16179	0.011125533	0.012670746	11	L2-3	EN-L2-3-MS	64	21	21
ACTGATGTCTGTTGAG-1_1_A9	-18.66978561	-8.124138114	13B	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3797	8846	0.01390459	0.006556636	11	13B	IN-SV2C	64	21	21
ACTGCTCAGCGCCTCA-1_1_A9	-11.15237403	31.55949323	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	911	1166	0.013722127	0.010291595	11	oligos	OL-MS-2	64	21	21
ACTGCTCCAATGACCT-1_1_A9	-20.09482872	13.14395146	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1239	1948	0.023100616	0.006160164	11	8	Astrocytes	64	21	21
ACTGCTCCACCAACCG-1_1_A9	-7.708403232	33.05072919	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1105	1515	0.02640264	0.004620462	11	oligos	OL-MS-2	64	21	21
ACTGCTCCAGCCTATA-1_1_A9	4.831363192	1.373242163	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	891	1129	0.051372896	0.007971656	11	16	EN-PYR	64	21	21
ACTGCTCTCACTTACT-1_1_A9	-19.15253172	16.01134176	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1941	3291	0.008508052	0.006988757	11	8	Astrocytes	64	21	21
ACTGCTCTCCGTTGTC-1_1_A9	19.11375344	-34.13181877	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5103	16401	0.004572892	0.003902201	11	3	EN-L5-6	64	21	21
ACTGTCCAGAATCTCC-1_1_A9	-10.27219657	-29.63821852	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1161	1720	0.077325581	0.009883721	11	16	EN-PYR	64	21	21
ACTGTCCAGCAGGCTA-1_1_A9	33.40204466	7.554201552	14	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	876	1179	0.039016115	0.006785411	11	14	Microglia	64	21	21
ACTGTCCAGGAATCGC-1_1_A9	-29.37681891	-13.22418199	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	750	1010	0.010891089	0.010891089	11	9	OPC	64	21	21
ACTGTCCAGTGAACGC-1_1_A9	-11.38040569	29.25078257	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1423	2125	0.066352941	0.006117647	11	oligos	OL-MS-2	64	21	21
ACTGTCCCACGACGAA-1_1_A9	-12.73259041	-33.13741528	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1510	2716	0.118188513	0.006627393	11	16	EN-PYR	64	21	21
ACTGTCCCAGCGAACA-1_1_A9	-10.67727029	32.1476911	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	906	1175	0.02212766	0.006808511	11	oligos	OL-MS-2	64	21	21
ACTGTCCCATGTAGTC-1_1_A9	11.75047379	3.042814348	12	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1112	1562	0.043533931	0.007042254	11	12	EN-MIX	64	21	21
ACTGTCCGTCCAAGTT-1_1_A9	20.15009926	-33.55694235	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5060	15039	0.006516391	0.005385996	11	3	EN-L5-6	64	21	21
ACTGTCCGTCTCATCC-1_1_A9	-10.58276908	-27.30466092	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	907	1187	0.072451559	0.01179444	11	16	EN-PYR	64	21	21
ACTGTCCGTGATAAGT-1_1_A9	-8.066756665	32.10606316	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1196	1790	0.036871508	0.000558659	11	oligos	OL-MS-2	64	21	21
ACTGTCCTCGAGAGCA-1_1_A9	23.00245697	-20.25753145	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	8152	32196	0.013231457	0.005311219	11	3	EN-L5-6	64	21	21
ACTGTCCTCTACTCAT-1_1_A9	-7.959011164	31.89919325	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1122	1547	0.023270847	0.004524887	11	oligos	OL-MS-2	64	21	21
ACTGTCCTCTTAACCT-1_1_A9	-19.7615543	16.21493531	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1503	2447	0.008581937	0.002451982	11	8	Astrocytes	64	21	21
ACTTACTCACCTTGTC-1_1_A9	-13.82682019	-34.33539742	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1949	3552	0.053490991	0.004786036	11	16	EN-PYR	64	21	21
ACTTACTGTAGCGCAA-1_1_A9	5.103810104	-18.3624128	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3337	7859	0.008525258	0.013487721	11	L2-3	EN-L2-3-MS	64	21	21
ACTTACTGTGATGTCT-1_1_A9	11.39782208	-29.17344554	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5102	14625	0.006700855	0.00765812	11	3	EN-L5-6	64	21	21
ACTTACTTCCATGAAC-1_1_A9	6.040040923	-25.18254129	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6033	22128	0.006326826	0.002666305	11	L2-3	EN-L2-3-MS	64	21	21
ACTTGTTAGCAGATCG-1_1_A9	-11.35949287	-33.11645758	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1271	2001	0.109945027	0.010994503	11	16	EN-PYR	64	21	21
ACTTGTTAGTGAACGC-1_1_A9	-9.879643181	-31.16453241	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1033	1473	0.052953157	0.009504413	11	16	EN-PYR	64	21	21
ACTTGTTCACGTGAGA-1_1_A9	-7.072001891	-29.58819475	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	865	1231	0.084484159	0.008123477	11	16	EN-PYR	64	21	21
ACTTGTTCACTTAACG-1_1_A9	-5.351378027	35.31368005	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	904	1241	0.015310234	0.002417405	11	oligos	OL-MS-2	64	21	21
ACTTGTTCAGTAAGAT-1_1_A9	-25.09301511	-11.15875221	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1109	1743	0.008605852	0.009753299	11	9	OPC	64	21	21
ACTTGTTGTCTAGCCG-1_1_A9	-19.62533556	17.4347078	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1342	2136	0.007022472	0.006554307	11	8	Astrocytes	64	21	21
ACTTGTTGTGGTAACG-1_1_A9	22.67801086	-19.58411097	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6532	22958	0.016464849	0.006620786	11	3	EN-L5-6	64	21	21
ACTTGTTTCGAGAACG-1_1_A9	20.32638967	-33.60192468	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4404	12011	0.003496795	0.015652319	11	3	EN-L5-6	64	21	21
ACTTGTTTCGTAGATC-1_1_A9	-7.122748552	-30.41701744	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	829	1186	0.10455312	0.009274874	11	16	EN-PYR	64	21	21
ACTTTCAAGGATATAC-1_1_A9	-32.55727877	-9.586628008	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	956	1444	0.008310249	0.002077562	11	9	OPC	64	21	21
ACTTTCACACGCCAGT-1_1_A9	-8.190596931	-26.97777612	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	871	1131	0.051282051	0.011494253	11	16	EN-PYR	64	21	21
ACTTTCACAGTAAGCG-1_1_A9	-5.419051298	34.8630022	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	925	1268	0.014195584	0.009463722	11	oligos	OL-MS-2	64	21	21
ACTTTCACAGTACACT-1_1_A9	-12.38971647	16.40193453	11	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1570	2380	0.007983193	0.005042017	11	11	Glia-MIX	64	21	21
ACTTTCATCCGCTGTT-1_1_A9	-11.52664196	-32.29544991	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1278	1940	0.084536082	0.012371134	11	16	EN-PYR	64	21	21
AGAATAGAGATGGCGT-1_1_A9	-28.27477495	21.64995449	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1198	2052	0.003411306	0.004873294	11	8	Astrocytes	64	21	21
AGAATAGAGTACGATA-1_1_A9	-21.72181173	-28.23090922	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4291	12369	0.01455251	0.004689142	11	6A	IN-PV	64	21	21
AGAATAGCATGCATGT-1_1_A9	-20.32789585	19.08497239	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2088	3923	0.005098139	0.004588325	11	8	Astrocytes	64	21	21
AGAATAGGTCGAATCT-1_1_A9	5.224555344	1.439696176	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	902	1393	0.030150754	0.005743001	11	16	EN-PYR	64	21	21
AGAATAGGTTGAGGTG-1_1_A9	-29.25554455	-12.35695558	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	840	1171	0.00853971	0.005977797	11	9	OPC	64	21	21
AGACGTTAGCTAACTC-1_1_A9	-10.87676032	30.78291852	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1038	1400	0.025714286	0.007142857	11	oligos	OL-MS-2	64	21	21
AGACGTTAGGCGCTCT-1_1_A9	19.34727419	-33.17175739	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	7799	34937	0.004808656	0.004035836	11	3	EN-L5-6	64	21	21
AGACGTTCAAGAAGAG-1_1_A9	27.58312787	-24.48876946	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5595	18875	0.023258278	0.002860927	11	3	EN-L5-6	64	21	21
AGACGTTTCAAGAAGT-1_1_A9	-31.29700104	-10.31358237	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	928	1336	0.004491018	0.008982036	11	9	OPC	64	21	21
AGAGCGAAGCGCTTAT-1_1_A9	-5.629260339	35.74843908	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	832	1187	0.01347936	0.00505476	11	oligos	OL-MS-2	64	21	21
AGAGCGAAGCGTTCCG-1_1_A9	2.676114912	-20.59863059	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3628	8573	0.004549166	0.01038143	11	L2-3	EN-L2-3-MS	64	21	21
AGAGCGAAGCTCAACT-1_1_A9	-26.19010596	-6.48029077	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1309	1929	0.00933126	0.00622084	11	9	OPC	64	21	21
AGAGCGAAGGAGCGAG-1_1_A9	24.14124609	-12.71883	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4927	12882	0.010169228	0.004890545	11	3	EN-L5-6	64	21	21
AGAGCGACAGTAAGCG-1_1_A9	-23.3578054	-9.570534951	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1082	1474	0.037991859	0.006105834	11	9	OPC	64	21	21
AGAGCGACATGCAATC-1_1_A9	-18.12155886	9.41606064	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	889	1333	0.012003001	0.005251313	11	8	Astrocytes	64	21	21
AGAGCGAGTGAGTGAC-1_1_A9	29.89207615	-10.86232359	2	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4169	9420	0.017197452	0.008704883	11	2	EN-L4	64	21	21
AGAGCGAGTTGTCTTT-1_1_A9	19.12648469	-24.80496961	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3485	7989	0.007510327	0.025284767	11	3	EN-L5-6	64	21	21
AGAGCGATCGCACTCT-1_1_A9	-9.59423657	32.65216149	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	751	1018	0.02848723	0.008840864	11	oligos	OL-MS-2	64	21	21
AGAGCTTAGTGTTGAA-1_1_A9	24.3592956	-27.27101569	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2458	5079	0.010041347	0.002756448	11	3	EN-L5-6	64	21	21
AGAGCTTCAATGTAAG-1_1_A9	-29.60174425	-12.52067855	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	778	1092	0.008241758	0.000915751	11	9	OPC	64	21	21
AGAGCTTCACACTGCG-1_1_A9	-13.8907234	7.943045976	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1212	1606	0.035491905	0.00747198	11	8	Astrocytes	64	21	21
AGAGCTTCATGCCACG-1_1_A9	-16.51669233	-25.67486349	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2046	3922	0.004844467	0.003314635	11	6A	IN-PV	64	21	21
AGAGCTTGTAGCTGCC-1_1_A9	20.19521564	-32.24258868	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	8629	41493	0.008820765	0.007374738	11	3	EN-L5-6	64	21	21
AGAGCTTGTCTCTCGT-1_1_A9	-21.60453848	15.05317041	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1344	2182	0.023831347	0.005957837	11	8	Astrocytes	64	21	21
AGAGCTTGTTCCGTCT-1_1_A9	-8.798042927	-7.235539077	13A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1213	1856	0.017780172	0.009159483	11	13A	IN-VIP	64	21	21
AGAGCTTTCTCCAGGG-1_1_A9	-3.173333617	35.55512885	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	751	1043	0.0105465	0.005752637	11	oligos	OL-MS-2	64	21	21
AGAGCTTTCTGCGGCA-1_1_A9	-22.49415316	-15.770919	6B	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3821	8531	0.01312859	0.006212636	11	6B	IN-SST	64	21	21
AGAGTGGAGCAGATCG-1_1_A9	-19.46905777	16.58495071	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1734	2725	0.00587156	0.005504587	11	8	Astrocytes	64	21	21
AGAGTGGCAAGACACG-1_1_A9	27.21021979	-25.07917712	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5553	17642	0.006405169	0.003060877	11	3	EN-L5-6	64	21	21
AGAGTGGCAATCGAAA-1_1_A9	20.29441716	-31.84373534	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6295	20691	0.00763617	0.006814557	11	3	EN-L5-6	64	21	21
AGAGTGGCAGTAGAGC-1_1_A9	-3.700602288	32.55016815	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1003	1480	0.012162162	0.005405405	11	oligos	OL-MS-2	64	21	21
AGAGTGGCATCCCATC-1_1_A9	4.725637624	-24.93523656	10	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3481	9172	0.005124291	0.004143044	11	L2-3	EN-L2-3-Cntl	64	21	21
AGAGTGGGTACAAGTA-1_1_A9	-11.74293202	19.31139169	11	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2821	5292	0.005102041	0.006613757	11	11	Glia-MIX	64	21	21
AGAGTGGGTCCAGTAT-1_1_A9	-9.673412	33.45546753	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	814	1034	0.03384913	0.008704062	11	oligos	OL-MS-2	64	21	21
AGAGTGGTCACTTCAT-1_1_A9	12.88374215	-30.86570306	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2721	6518	0.00705738	0.004142375	11	3	EN-L5-6	64	21	21
AGAGTGGTCTTACCGC-1_1_A9	17.6622135	-26.46015074	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4714	13446	0.005652239	0.020526551	11	3	EN-L5-6	64	21	21
AGATCTGAGGCGATAC-1_1_A9	-12.0710206	-34.65235003	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1192	1835	0.040326975	0.013079019	11	16	EN-PYR	64	21	21
AGATCTGAGTACGCCC-1_1_A9	-0.86851493	35.39771656	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	797	1097	0.010938924	0.011850501	11	oligos	OL-MS-2	64	21	21
AGATCTGCACGGCCAT-1_1_A9	-18.23656769	9.310498552	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	744	1010	0.025742574	0.006930693	11	8	Astrocytes	64	21	21
AGATCTGCACTGCCAG-1_1_A9	-6.72945739	36.06844432	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	760	1012	0.013833992	0.009881423	11	oligos	OL-MS-2	64	21	21
AGATCTGCATTAACCG-1_1_A9	-8.297326181	-31.99388428	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	830	1109	0.03336339	0.010820559	11	16	EN-PYR	64	21	21
AGATCTGTCTGCAGTA-1_1_A9	29.73725686	-8.864770427	2	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4722	12758	0.006819251	0.004702931	11	2	EN-L4	64	21	21
AGATCTGTCTGCTGCT-1_1_A9	-26.58297116	-8.048537681	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1171	1742	0.008036739	0.005740528	11	9	OPC	64	21	21
AGATTGCAGCCCAATT-1_1_A9	22.73439577	-20.31501457	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	7325	29492	0.01790316	0.003628103	11	3	EN-L5-6	64	21	21
AGATTGCAGCTGTCTA-1_1_A9	-26.16328158	-24.1376031	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5189	14934	0.022097228	0.006093478	11	6A	IN-PV	64	21	21
AGATTGCTCAGGTAAA-1_1_A9	-14.44536361	-4.000445567	13A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3478	8657	0.0120134	0.006122213	11	13A	IN-VIP	64	21	21
AGATTGCTCGGAGGTA-1_1_A9	6.033345099	-2.532872209	12	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	923	1295	0.086486486	0.004633205	11	12	EN-MIX	64	21	21
AGATTGCTCGTCCGTT-1_1_A9	-11.79869297	13.5187273	11	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	992	1398	0.007153076	0.006437768	11	11	Glia-MIX	64	21	21
AGCAGCCAGGAATTAC-1_1_A9	-5.673502262	32.38813755	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1080	1613	0.012399256	0.004959702	11	oligos	OL-MS-2	64	21	21
AGCAGCCAGGCACATG-1_1_A9	-9.48293666	31.37595848	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1050	1458	0.023319616	0.005486968	11	oligos	OL-MS-2	64	21	21
AGCAGCCCATTGGCGC-1_1_A9	-2.523350623	34.83638082	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	869	1214	0.018121911	0.004942339	11	oligos	OL-MS-2	64	21	21
AGCAGCCGTAGGACAC-1_1_A9	20.32094859	-33.03067107	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	8483	37136	0.006085739	0.008536191	11	3	EN-L5-6	64	21	21
AGCAGCCGTATAGTAG-1_1_A9	-24.56674901	-1.843081372	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1245	1891	0.011105235	0.004759387	11	9	OPC	64	21	21
AGCAGCCGTGTTAAGA-1_1_A9	-21.20084148	14.22032052	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1188	1853	0.00701565	0.008634647	11	8	Astrocytes	64	21	21
AGCAGCCTCATGTCCC-1_1_A9	-19.45100304	12.81921483	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1181	1648	0.012742718	0.004247573	11	8	Astrocytes	64	21	21
AGCAGCCTCCCTCTTT-1_1_A9	23.93820954	-22.09226784	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3537	8581	0.009789069	0.003496096	11	3	EN-L5-6	64	21	21
AGCAGCCTCGCGATCG-1_1_A9	-18.25777854	10.06228276	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	907	1269	0.024428684	0.006304177	11	8	Astrocytes	64	21	21
AGCAGCCTCTGATTCT-1_1_A9	4.777809976	1.682167169	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	799	1086	0.038674033	0.012891344	11	16	EN-PYR	64	21	21
AGCAGCCTCTTAGAGC-1_1_A9	-9.245282979	-31.24315007	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	915	1232	0.030032468	0.008928571	11	16	EN-PYR	64	21	21
AGCATACAGATGTGGC-1_1_A9	28.61641221	-5.099432096	2	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3697	9295	0.004948897	0.002904788	11	2	EN-L4	64	21	21
AGCATACAGTAGGCCA-1_1_A9	-25.53349065	-7.418275156	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1154	1684	0.010095012	0.005938242	11	9	OPC	64	21	21
AGCATACCAATGACCT-1_1_A9	-19.57918238	16.04258241	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1629	2656	0.012048193	0.007153614	11	8	Astrocytes	64	21	21
AGCATACCATGCGCAC-1_1_A9	7.275864172	-24.5550562	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6285	22517	0.017586712	0.004130213	11	L2-3	EN-L2-3-MS	64	21	21
AGCATACCATTAGCCA-1_1_A9	-19.44706701	11.98103142	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1103	1623	0.012939002	0.007393715	11	8	Astrocytes	64	21	21
AGCATACGTAGCTAAA-1_1_A9	-14.61524755	-4.032107595	13A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3591	7933	0.011975293	0.008571789	11	13A	IN-VIP	64	21	21
AGCATACTCATTGCCC-1_1_A9	-10.08234392	33.39664595	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	785	1000	0.021	0.006	11	oligos	OL-MS-2	64	21	21
AGCATACTCGCCAGCA-1_1_A9	24.85558544	8.346511765	15A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2197	3472	0.016129032	0.040610599	11	15A	Endo cells	64	21	21
AGCATACTCTTGCATT-1_1_A9	4.881422588	-23.83866725	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4214	11965	0.022064354	0.003593815	11	L2-3	EN-L2-3-MS	64	21	21
AGCCTAAAGACATAAC-1_1_A9	-14.50808218	9.378407792	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1415	2108	0.017552182	0.004743833	11	8	Astrocytes	64	21	21
AGCCTAACACAAGCCC-1_1_A9	-10.68195168	-29.92025064	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1126	1542	0.046044099	0.00843061	11	16	EN-PYR	64	21	21
AGCCTAACAGCGTCCA-1_1_A9	17.72765829	-32.30721263	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5032	16269	0.008052124	0.003933862	11	3	EN-L5-6	64	21	21
AGCCTAAGTAAGAGAG-1_1_A9	-11.2950548	-31.25383463	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1330	2000	0.0725	0.0105	11	16	EN-PYR	64	21	21
AGCCTAAGTATTACCG-1_1_A9	6.718226366	-23.82854433	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4431	11769	0.010281247	0.003908573	11	L2-3	EN-L2-3-MS	64	21	21
AGCCTAAGTGCAACTT-1_1_A9	-11.91824974	-32.37801754	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1098	1586	0.063051702	0.010088272	11	16	EN-PYR	64	21	21
AGCGGTCAGGTGTGGT-1_1_A9	-16.98698686	11.1061607	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1313	1905	0.014698163	0.006299213	11	8	Astrocytes	64	21	21
AGCGGTCGTGCCTTGG-1_1_A9	-10.76094888	16.97183884	11	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2190	4064	0.003444882	0.003937008	11	11	Glia-MIX	64	21	21
AGCGGTCTCGGCGCTA-1_1_A9	-21.22555389	15.27357323	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1357	2153	0.011611705	0.006038086	11	8	Astrocytes	64	21	21
AGCGTATAGACGCAAC-1_1_A9	-29.16664711	-12.6722878	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	813	1093	0.017383349	0.002744739	11	9	OPC	64	21	21
AGCGTATAGGTGACCA-1_1_A9	26.39685644	-25.45120728	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3935	9858	0.0090282	0.003753297	11	3	EN-L5-6	64	21	21
AGCGTATCATCGGAAG-1_1_A9	-21.59214692	-16.59835056	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2751	5470	0.023583181	0.006581353	11	6A	IN-PV	64	21	21
AGCGTATGTCGTCTTC-1_1_A9	22.78850681	-20.22724347	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	8561	42551	0.026462363	0.0038777	11	3	EN-L5-6	64	21	21
AGCGTATTCAGAGCTT-1_1_A9	-10.29059845	32.84297748	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	820	1032	0.024224806	0.004844961	11	oligos	OL-MS-2	64	21	21
AGCGTATTCCCATTAT-1_1_A9	5.184736404	2.003396698	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	781	1010	0.048514851	0.004950495	11	16	EN-PYR	64	21	21
AGCGTATTCGCGATCG-1_1_A9	-3.103109926	32.73389096	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	953	1334	0.011994003	0.003748126	11	oligos	OL-MS-2	64	21	21
AGCGTATTCTGGTGTA-1_1_A9	21.48397482	13.33693104	1	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1295	2081	0.006246997	0.003844306	11	oligos	OL-Cntl	64	21	21
AGCGTCGAGTGGTAGC-1_1_A9	-0.291439272	-0.107325974	11	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1144	1801	0.002220988	0.00388673	11	11	Glia-MIX	64	21	21
AGCGTCGCACATTCGA-1_1_A9	27.8208656	-24.46541124	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6217	22057	0.012785057	0.003853652	11	3	EN-L5-6	64	21	21
AGCGTCGTCTCGGACG-1_1_A9	2.48930494	6.21364456	7	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	977	1266	0.015797788	0.011058452	11	7	Phagocytes	64	21	21
AGCTCCTAGCGATCCC-1_1_A9	-5.708620007	34.59386814	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	841	1170	0.013675214	0.002564103	11	oligos	OL-MS-2	64	21	21
AGCTCCTAGCTGAAAT-1_1_A9	-20.60787011	13.1360151	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1242	1967	0.013726487	0.005592272	11	8	Astrocytes	64	21	21
AGCTCCTAGGCAAAGA-1_1_A9	-24.55499356	-10.25095534	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	820	1068	0.024344569	0.003745318	11	9	OPC	64	21	21
AGCTCCTCAATCACAC-1_1_A9	26.24079373	-24.34848556	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5342	16610	0.006742926	0.005117399	11	3	EN-L5-6	64	21	21
AGCTCCTCATTCCTGC-1_1_A9	-20.49438063	18.49813682	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2022	3685	0.007055631	0.003799186	11	8	Astrocytes	64	21	21
AGCTCCTGTGTGACGA-1_1_A9	7.501749057	-23.1688692	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5798	18670	0.015425817	0.010391002	11	L2-3	EN-L2-3-MS	64	21	21
AGCTCCTTCTATCCCG-1_1_A9	-6.184229916	35.48784062	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	798	1132	0.025618375	0.005300353	11	oligos	OL-MS-2	64	21	21
AGCTCTCCAGACGCAA-1_1_A9	5.04864059	1.511782849	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	993	1311	0.044241037	0.010678871	11	16	EN-PYR	64	21	21
AGCTCTCCATCTGGTA-1_1_A9	29.31162946	-6.504514398	2	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4636	13394	0.005524862	0.012990891	11	2	EN-L4	64	21	21
AGCTCTCGTACCATCA-1_1_A9	-4.119668285	33.62558326	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	896	1323	0.017384732	0.008314437	11	oligos	OL-MS-2	64	21	21
AGCTCTCGTCTAGTGT-1_1_A9	19.90805516	-31.45919478	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6042	20129	0.013413483	0.004222763	11	3	EN-L5-6	64	21	21
AGCTTGACATATGCTG-1_1_A9	29.63267271	-6.302067277	2	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4139	10790	0.006116775	0.007970343	11	2	EN-L4	64	21	21
AGCTTGAGTTCAGGCC-1_1_A9	26.81324714	-25.15253356	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5251	17102	0.011343702	0.003274471	11	3	EN-L5-6	64	21	21
AGCTTGAGTTCCCTTG-1_1_A9	20.28440183	-33.7089335	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5593	18618	0.002148458	0.015576324	11	3	EN-L5-6	64	21	21
AGCTTGATCCATGAGT-1_1_A9	6.986524084	-24.30082338	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6938	27228	0.009181725	0.003489055	11	L2-3	EN-L2-3-MS	64	21	21
AGGCCACAGCCCTAAT-1_1_A9	-7.489874664	34.19601894	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	900	1220	0.018852459	0.007377049	11	oligos	OL-MS-2	64	21	21
AGGCCACCAGCTGCAC-1_1_A9	-8.129991832	-27.08155808	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	882	1147	0.053182214	0.010462075	11	16	EN-PYR	64	21	21
AGGCCACGTCACTGGC-1_1_A9	-7.634872038	34.44065137	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	801	1049	0.009532888	0.006673022	11	oligos	OL-MS-2	64	21	21
AGGCCACTCCCTCTTT-1_1_A9	-6.27377629	34.50051519	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	838	1130	0.014159292	0.002654867	11	oligos	OL-MS-2	64	21	21
AGGCCACTCCTATGTT-1_1_A9	5.798938201	-23.71683654	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5598	18367	0.005226765	0.007077911	11	L2-3	EN-L2-3-MS	64	21	21
AGGCCACTCCTATTCA-1_1_A9	-11.30392875	30.75390884	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1375	1966	0.034079349	0.007121058	11	oligos	OL-MS-2	64	21	21
AGGCCGTAGCCCAGCT-1_1_A9	-19.86388618	11.35917186	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	868	1269	0.01891253	0.00394011	11	8	Astrocytes	64	21	21
AGGCCGTAGCCGCCTA-1_1_A9	-8.490484693	33.76031964	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	794	1083	0.021237304	0.004616805	11	oligos	OL-MS-2	64	21	21
AGGCCGTAGCTGCCCA-1_1_A9	-12.11813106	31.06813089	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	799	1015	0.034482759	0.008866995	11	oligos	OL-MS-2	64	21	21
AGGCCGTCAGGGAGAG-1_1_A9	-21.57044002	-16.05682253	6B	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2657	5045	0.016253717	0.00753221	11	6B	IN-SST	64	21	21
AGGCCGTCATCCGGGT-1_1_A9	-8.374760336	-30.62057232	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	845	1162	0.060240964	0.004302926	11	16	EN-PYR	64	21	21
AGGCCGTGTAAGGATT-1_1_A9	22.59037562	-19.06038445	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5493	16224	0.010539941	0.011156312	11	3	EN-L5-6	64	21	21
AGGCCGTGTAGGCTGA-1_1_A9	12.47050435	-1.713905897	12	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1039	1420	0.01971831	0.004225352	11	12	EN-MIX	64	21	21
AGGCCGTGTTAAAGTG-1_1_A9	5.497788188	-22.76095751	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6275	22079	0.003713936	0.00878663	11	L2-3	EN-L2-3-MS	64	21	21
AGGCCGTTCAAACGGG-1_1_A9	-14.63889159	9.681834391	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1432	2148	0.010242086	0.004655493	11	8	Astrocytes	64	21	21
AGGCCGTTCCAAACTG-1_1_A9	-3.707378335	32.74590121	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	961	1463	0.01367054	0.005468216	11	oligos	OL-MS-2	64	21	21
AGGGAGTAGATGAGAG-1_1_A9	-25.59476913	-9.842071444	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	905	1174	0.007666099	0.010221465	11	9	OPC	64	21	21
AGGGAGTAGGCAGTCA-1_1_A9	-18.7608018	-8.152051075	13B	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3792	8613	0.014745153	0.007430628	11	13B	IN-SV2C	64	21	21
AGGGAGTCACCACGTG-1_1_A9	-10.51453891	-13.10216358	6B	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1139	1636	0.040953545	0.006112469	11	6B	IN-SST	64	21	21
AGGGAGTCACCATGTA-1_1_A9	-9.576822261	32.55548607	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	863	1177	0.031435854	0.000849618	11	oligos	OL-MS-2	64	21	21
AGGGAGTCAGCGAACA-1_1_A9	-23.11861322	-8.428787398	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1700	2658	0.05944319	0.003386005	11	9	OPC	64	21	21
AGGGAGTGTTACGTCA-1_1_A9	15.03149066	-27.9156175	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3484	8685	0.00333909	0.004605642	11	3	EN-L5-6	64	21	21
AGGGAGTTCAACCATG-1_1_A9	-19.35724409	16.37345152	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1522	2397	0.006257822	0.008760951	11	8	Astrocytes	64	21	21
AGGGATGAGATGGGTC-1_1_A9	-9.319962979	32.7568495	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	774	1007	0.019860973	0.004965243	11	oligos	OL-MS-2	64	21	21
AGGGATGCAGCCAATT-1_1_A9	-14.0756256	8.621434377	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1083	1520	0.014473684	0.005263158	11	8	Astrocytes	64	21	21
AGGGATGGTATATGAG-1_1_A9	24.34443076	-25.65146497	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2806	5899	0.007967452	0.002881844	11	3	EN-L5-6	64	21	21
AGGGATGGTTAAGACA-1_1_A9	2.078742859	-13.22304521	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2034	3977	0.007543374	0.005028916	11	L2-3	EN-L2-3-MS	64	21	21
AGGGATGTCAGCTTAG-1_1_A9	6.491770782	-23.78217239	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5317	16421	0.014189148	0.006698739	11	L2-3	EN-L2-3-MS	64	21	21
AGGGTGAAGCAGCCTC-1_1_A9	-0.444169533	33.73317764	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	778	1083	0.013850416	0.003693444	11	oligos	OL-MS-2	64	21	21
AGGGTGACACCATCCT-1_1_A9	-5.811357438	31.34923762	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1234	1776	0.011261261	0.005630631	11	oligos	OL-MS-2	64	21	21
AGGGTGAGTAAAGGAG-1_1_A9	6.987973997	-23.99576856	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6283	21560	0.01609462	0.003153989	11	L2-3	EN-L2-3-MS	64	21	21
AGGGTGAGTACTTCTT-1_1_A9	26.63370065	-25.28995025	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4949	16029	0.004741406	0.00324412	11	3	EN-L5-6	64	21	21
AGGGTGAGTTAAAGTG-1_1_A9	18.6769382	-31.39600489	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5796	18594	0.008282242	0.006615037	11	3	EN-L5-6	64	21	21
AGGTCATAGGATGCGT-1_1_A9	32.42427652	-7.933734309	2	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3691	7996	0.007253627	0.014632316	11	2	EN-L4	64	21	21
AGGTCATAGTGAACGC-1_1_A9	5.378495746	-24.24095022	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5303	17571	0.009561209	0.005292812	11	L2-3	EN-L2-3-MS	64	21	21
AGGTCATCACTACAGT-1_1_A9	-17.1140065	-7.501237652	13B	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2838	5632	0.011541193	0.005149148	11	13B	IN-SV2C	64	21	21
AGGTCATCATGAACCT-1_1_A9	-11.91768527	32.03322414	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1174	1825	0.024657534	0.004383562	11	oligos	OL-MS-2	64	21	21
AGGTCATGTCTCTTTA-1_1_A9	19.90005285	-31.99440088	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4944	13886	0.007417543	0.005617168	11	3	EN-L5-6	64	21	21
AGGTCATGTGTGCCTG-1_1_A9	-28.55306731	-12.56316663	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	809	1099	0.006369427	0.007279345	11	9	OPC	64	21	21
AGGTCATTCAACACCA-1_1_A9	28.74446852	-6.843993475	2	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4395	12067	0.00389492	0.004392144	11	2	EN-L4	64	21	21
AGGTCATTCATCGATG-1_1_A9	-21.02697616	-17.06384728	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2907	6646	0.028438158	0.003310262	11	6A	IN-PV	64	21	21
AGGTCATTCCCTCAGT-1_1_A9	-24.81067498	-7.607332339	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1146	1627	0.004302397	0.004302397	11	9	OPC	64	21	21
AGGTCCGAGGATGCGT-1_1_A9	27.00469845	-24.8802863	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5202	16101	0.009254084	0.004658096	11	3	EN-L5-6	64	21	21
AGGTCCGAGTAGGTGC-1_1_A9	-8.249853051	33.85386239	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	823	1107	0.021680217	0.005420054	11	oligos	OL-MS-2	64	21	21
AGGTCCGAGTCTTGCA-1_1_A9	-11.65364786	13.6050059	11	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1196	1635	0.00733945	0.006727829	11	11	Glia-MIX	64	21	21
AGGTCCGGTATAATGG-1_1_A9	-7.074384061	34.58697483	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	891	1224	0.026143791	0.004901961	11	oligos	OL-MS-2	64	21	21
AGGTCCGTCATAGCAC-1_1_A9	-13.98506368	-4.500696907	13A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2807	5345	0.009541628	0.008231993	11	13A	IN-VIP	64	21	21
AGTAGTCAGACATAAC-1_1_A9	-24.86744444	-10.49032763	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	819	1097	0.026435734	0.003646308	11	9	OPC	64	21	21
AGTAGTCCAAGTACCT-1_1_A9	7.709851332	-22.54504488	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4563	11845	0.013845504	0.015449557	11	L2-3	EN-L2-3-MS	64	21	21
AGTAGTCCAGCTGCTG-1_1_A9	7.165041971	-24.26230848	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	7195	28486	0.008425191	0.003264762	11	L2-3	EN-L2-3-MS	64	21	21
AGTAGTCGTTGTGGAG-1_1_A9	-9.786260162	30.98369062	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1154	1536	0.029947917	0.003255208	11	oligos	OL-MS-2	64	21	21
AGTCTTTAGGTAGCCA-1_1_A9	-21.87824632	14.25137191	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1060	1543	0.009721322	0.004536617	11	8	Astrocytes	64	21	21
AGTCTTTGTTACAGAA-1_1_A9	-6.702709136	36.31394805	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	768	1022	0.018590998	0.003913894	11	oligos	OL-MS-2	64	21	21
AGTCTTTTCAAACAAG-1_1_A9	-24.24336777	-10.1124188	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	904	1242	0.071658615	0.006441224	11	9	OPC	64	21	21
AGTCTTTTCCGCTGTT-1_1_A9	-21.01500075	12.14557789	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	975	1467	0.005453306	0.006816633	11	8	Astrocytes	64	21	21
AGTCTTTTCGCTTGTC-1_1_A9	-33.76234126	-7.547037875	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1128	1688	0.013033175	0.005331754	11	9	OPC	64	21	21
AGTGAGGAGAGGGCTT-1_1_A9	-19.62674042	16.00049135	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1690	2672	0.007110778	0.008982036	11	8	Astrocytes	64	21	21
AGTGAGGAGATAGTCA-1_1_A9	-25.37108518	-5.912566822	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1355	2023	0.011369254	0.004448838	11	9	OPC	64	21	21
AGTGAGGCATACGCCG-1_1_A9	19.48107623	-30.89858295	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5052	13987	0.007578466	0.004003718	11	3	EN-L5-6	64	21	21
AGTGAGGGTACAGCAG-1_1_A9	-14.18538411	-4.195596147	13A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2944	5625	0.008	0.007644444	11	13A	IN-VIP	64	21	21
AGTGAGGGTAGTAGTA-1_1_A9	-11.7731092	-32.68896264	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1299	1894	0.057550158	0.014255544	11	16	EN-PYR	64	21	21
AGTGAGGTCACATGCA-1_1_A9	25.5608049	5.611343053	15BA	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1343	1851	0.015667207	0.019989195	11	15BA	Stromal cells	64	21	21
AGTGGGACAAACCTAC-1_1_A9	-21.06169899	14.87904745	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1335	2058	0.007774538	0.005830904	11	8	Astrocytes	64	21	21
AGTGGGATCTTGGGTA-1_1_A9	-31.44600734	-10.5218733	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	940	1348	0.008160237	0.007418398	11	9	OPC	64	21	21
AGTGTCAAGCTCCCAG-1_1_A9	-17.01406724	11.1887287	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1350	2099	0.015721772	0.002382087	11	8	Astrocytes	64	21	21
AGTGTCAAGTAAGTAC-1_1_A9	-26.26328086	-7.199213324	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1168	1673	0.013747759	0.007172744	11	9	OPC	64	21	21
AGTGTCAGTACCATCA-1_1_A9	-17.16964116	10.2795174	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1371	2068	0.01450677	0.010638298	11	8	Astrocytes	64	21	21
AGTGTCATCGCGGATC-1_1_A9	-7.643180854	-32.23495849	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	838	1168	0.073630137	0.006849315	11	16	EN-PYR	64	21	21
AGTTGGTCAAAGTGCG-1_1_A9	-2.83884532	36.32067673	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	719	1002	0.007984032	0.000998004	11	oligos	OL-MS-2	64	21	21
AGTTGGTCATGGGAAC-1_1_A9	-19.87909931	14.27765094	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1404	2211	0.010402533	0.007688829	11	8	Astrocytes	64	21	21
AGTTGGTGTAGATTAG-1_1_A9	-22.41907363	-15.34338628	6B	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4066	9591	0.013137316	0.009279533	11	6B	IN-SST	64	21	21
AGTTGGTGTCATGCAT-1_1_A9	18.51480201	-7.463170629	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1651	2922	0.021560575	0.001368925	11	3	EN-L5-6	64	21	21
AGTTGGTGTGTCCTCT-1_1_A9	-25.67630084	-5.986174599	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1233	1865	0.008579088	0.001608579	11	9	OPC	64	21	21
AGTTGGTTCAGTCCCT-1_1_A9	-31.51417659	-10.01399878	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	921	1312	0.012957317	0.006859756	11	9	OPC	64	21	21
AGTTGGTTCGATCCCT-1_1_A9	-17.26290531	9.079549559	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1057	1516	0.017810026	0.005936675	11	8	Astrocytes	64	21	21
AGTTGGTTCTCTGTCG-1_1_A9	-20.79034335	12.0840821	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	966	1449	0.01863354	0.009661836	11	8	Astrocytes	64	21	21
ATAACGCAGACTAGGC-1_1_A9	-14.16918327	-3.974426743	13A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2866	5818	0.019078721	0.007390856	11	13A	IN-VIP	64	21	21
ATAACGCAGATATGGT-1_1_A9	-27.01607377	-9.820933985	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	896	1270	0.008661417	0.012598425	11	9	OPC	64	21	21
ATAACGCAGCCGCCTA-1_1_A9	4.299442753	1.594836906	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	780	1009	0.046580773	0.005946482	11	16	EN-PYR	64	21	21
ATAACGCCAGGAACGT-1_1_A9	-20.26529834	11.16120154	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1023	1553	0.00772698	0.004507405	11	8	Astrocytes	64	21	21
ATAACGCGTTCCCTTG-1_1_A9	5.592668611	-24.65217155	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5506	19022	0.006361056	0.004415939	11	L2-3	EN-L2-3-MS	64	21	21
ATAACGCTCACGCATA-1_1_A9	-6.452419956	33.40189566	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	930	1340	0.02238806	0.003731343	11	oligos	OL-MS-2	64	21	21
ATAACGCTCGTGACAT-1_1_A9	13.60911999	-4.371462499	12	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1515	2677	0.020918939	0.001867762	11	12	EN-MIX	64	21	21
ATAAGAGAGTACTTGC-1_1_A9	27.78663013	-26.24675802	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3877	10988	0.015471423	0.003094285	11	3	EN-L5-6	64	21	21
ATAAGAGCACATAACC-1_1_A9	6.668810597	-24.28108356	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5337	17859	0.012094742	0.003863598	11	L2-3	EN-L2-3-MS	64	21	21
ATAAGAGCATGGGAAC-1_1_A9	-12.1787636	31.00279405	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	895	1142	0.041155867	0.007005254	11	oligos	OL-MS-2	64	21	21
ATAAGAGTCAAGATCC-1_1_A9	4.259202996	-15.96122342	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2663	5237	0.01546687	0.015275921	11	L2-3	EN-L2-3-MS	64	21	21
ATAGACCAGAGCCCAA-1_1_A9	-20.60873467	16.62301456	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1556	2571	0.010890704	0.005445352	11	8	Astrocytes	64	21	21
ATAGACCAGAGTACAT-1_1_A9	33.28173562	6.466778358	14	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	851	1064	0.022556391	0.014097744	11	14	Microglia	64	21	21
ATAGACCCAACAACCT-1_1_A9	-23.13885109	-7.948911129	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1674	2502	0.023181455	0.009592326	11	9	OPC	64	21	21
ATAGACCCAGGAACGT-1_1_A9	-12.99117968	-33.55800657	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1421	2325	0.072688172	0.003870968	11	16	EN-PYR	64	21	21
ATAGACCCATGCAACT-1_1_A9	-14.1503282	-3.889386751	13A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3465	7861	0.010049612	0.006233304	11	13A	IN-VIP	64	21	21
ATAGACCTCGGTCTAA-1_1_A9	8.892133441	1.659771736	12	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	619	1008	0.020833333	0.004960317	11	12	EN-MIX	64	21	21
ATCACGACAAAGTGCG-1_1_A9	-26.08729514	-24.27984638	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5163	14814	0.028689078	0.003847712	11	6A	IN-PV	64	21	21
ATCACGAGTCTAGTGT-1_1_A9	-21.34871329	12.93219853	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1025	1487	0.011432414	0.007397445	11	8	Astrocytes	64	21	21
ATCACGAGTTACGTCA-1_1_A9	19.1414009	-34.13465492	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4832	15579	0.010847936	0.003337827	11	3	EN-L5-6	64	21	21
ATCACGAGTTCCACAA-1_1_A9	-9.004288248	-29.990406	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1021	1433	0.089323098	0.009769714	11	16	EN-PYR	64	21	21
ATCACGATCAGCACAT-1_1_A9	-11.06980844	32.46598776	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	895	1238	0.033925687	0.008077544	11	oligos	OL-MS-2	64	21	21
ATCACGATCGACAGCC-1_1_A9	-21.21422254	15.88121957	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1351	2287	0.005684303	0.003498032	11	8	Astrocytes	64	21	21
ATCACGATCGGTCTAA-1_1_A9	-19.1536808	14.62525456	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1374	2077	0.014925373	0.006740491	11	8	Astrocytes	64	21	21
ATCATCTAGACCGGAT-1_1_A9	-15.54724344	-6.92873065	13A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3189	7038	0.020602444	0.005257175	11	13A	IN-VIP	64	21	21
ATCATCTAGAGGTTAT-1_1_A9	6.177528854	-22.38358498	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2917	6210	0.020128824	0.004347826	11	L2-3	EN-L2-3-MS	64	21	21
ATCATCTGTCCTCTTG-1_1_A9	-2.325177553	33.73153626	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	850	1211	0.009909166	0.004128819	11	oligos	OL-MS-2	64	21	21
ATCATCTGTCTCACCT-1_1_A9	23.85861834	-23.07958582	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4733	14354	0.013724397	0.004110353	11	3	EN-L5-6	64	21	21
ATCATCTTCCTTGACC-1_1_A9	-7.849699288	-27.51146739	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	833	1161	0.111972438	0.007751938	11	16	EN-PYR	64	21	21
ATCATGGAGGTTACCT-1_1_A9	24.65029214	-24.66524756	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3213	8046	0.014665672	0.003231419	11	3	EN-L5-6	64	21	21
ATCATGGGTAGCTGCC-1_1_A9	5.422119928	-23.42485617	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5616	18672	0.009318766	0.010443445	11	L2-3	EN-L2-3-MS	64	21	21
ATCATGGGTTCCATGA-1_1_A9	5.367134661	-24.93012751	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6018	23490	0.004427416	0.003788846	11	L2-3	EN-L2-3-MS	64	21	21
ATCATGGTCATGTGGT-1_1_A9	-6.932566608	-30.98545608	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	860	1190	0.1	0.013445378	11	16	EN-PYR	64	21	21
ATCATGGTCCCTCTTT-1_1_A9	27.66689087	-24.81208719	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5508	21104	0.020138362	0.00227445	11	3	EN-L5-6	64	21	21
ATCATGGTCGTTGCCT-1_1_A9	20.6061423	-32.17545737	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4945	15144	0.019347596	0.003961965	11	3	EN-L5-6	64	21	21
ATCCACCAGATCGGGT-1_1_A9	-12.1395101	-8.7390525	13B	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1885	3277	0.02258163	0.007323772	11	13B	IN-SV2C	64	21	21
ATCCACCAGATCTGCT-1_1_A9	22.39917845	27.03988337	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1109	1633	0.007960808	0.005511329	11	oligos	OL-MS-2	64	21	21
ATCCACCAGGTACTCT-1_1_A9	-10.3258877	-31.63086056	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1113	1553	0.063747585	0.005795235	11	16	EN-PYR	64	21	21
ATCCACCAGGTGGGTT-1_1_A9	-25.27155278	-9.009881114	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1164	1627	0.014751076	0.007375538	11	9	OPC	64	21	21
ATCCACCAGTCAATAG-1_1_A9	-23.57710799	-9.403395751	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1133	1551	0.014829142	0.013539652	11	9	OPC	64	21	21
ATCCACCCACCGAATT-1_1_A9	21.36100463	-20.28280961	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6516	22422	0.008295424	0.009142806	11	L2-3	EN-L2-3-MS	64	21	21
ATCCACCCAGCTGCAC-1_1_A9	-10.12953568	33.4032491	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	934	1252	0.017571885	0.009584665	11	oligos	OL-MS-2	64	21	21
ATCCACCTCACGACTA-1_1_A9	-7.788929401	-27.35581378	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	851	1184	0.107263514	0.01097973	11	16	EN-PYR	64	21	21
ATCCACCTCCACGTTC-1_1_A9	-11.67858328	30.76046351	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1028	1340	0.037313433	0.011940299	11	oligos	OL-MS-2	64	21	21
ATCCACCTCCTCAATT-1_1_A9	14.07999802	-5.035265283	12	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1501	2386	0.04526404	0.003352892	11	12	EN-MIX	64	21	21
ATCCACCTCGTCACGG-1_1_A9	-7.638528695	-28.36691954	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	903	1245	0.117269076	0.009638554	11	16	EN-PYR	64	21	21
ATCCACCTCTGCCCTA-1_1_A9	6.235775724	-25.70926322	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	7002	29241	0.004172224	0.002975274	11	3	EN-L5-6	64	21	21
ATCCGAAAGACGACGT-1_1_A9	11.34094921	-29.14245274	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6169	20744	0.003326263	0.009014655	11	3	EN-L5-6	64	21	21
ATCCGAACATGGGAAC-1_1_A9	20.53887762	-32.17018364	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5356	16901	0.01863795	0.002721732	11	3	EN-L5-6	64	21	21
ATCCGAACATGTCTCC-1_1_A9	25.06595245	5.96782757	15A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1550	2223	0.031938821	0.014394962	11	15A	Endo cells	64	21	21
ATCCGAAGTCTTGTCC-1_1_A9	24.45052979	8.501342161	15A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4269	9002	0.019217952	0.033992446	11	15A	Endo cells	64	21	21
ATCCGAAGTGCCTTGG-1_1_A9	-19.86345127	15.07126096	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1336	2094	0.010983763	0.002387775	11	8	Astrocytes	64	21	21
ATCCGAAGTGGTCTCG-1_1_A9	-19.30495418	10.79399835	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	849	1159	0.014667817	0.011216566	11	8	Astrocytes	64	21	21
ATCCGAAGTTCGCTAA-1_1_A9	-21.63162384	-28.44996255	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4661	13310	0.007137491	0.004282494	11	6A	IN-PV	64	21	21
ATCCGAATCACGACTA-1_1_A9	3.899131367	0.425001829	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1159	1565	0.053674121	0.009584665	11	16	EN-PYR	64	21	21
ATCCGAATCTGGAGCC-1_1_A9	8.521435401	-28.12363505	10	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5773	19927	0.002860441	0.007276559	11	L2-3	EN-L2-3-Cntl	64	21	21
ATCGAGTAGCTGATAA-1_1_A9	18.74845976	-32.00174474	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6432	22489	0.005158077	0.004402152	11	3	EN-L5-6	64	21	21
ATCGAGTCATTTGCTT-1_1_A9	-18.60722076	16.12795287	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1612	2777	0.005761613	0.006841916	11	8	Astrocytes	64	21	21
ATCGAGTGTAAACACA-1_1_A9	-4.669536181	32.37033275	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1145	1652	0.018765133	0.004237288	11	oligos	OL-MS-2	64	21	21
ATCGAGTGTCATGCCG-1_1_A9	-21.04550073	16.68270221	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1520	2605	0.007677543	0.00806142	11	8	Astrocytes	64	21	21
ATCGAGTGTCGGGTCT-1_1_A9	28.35793117	-25.86874952	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5980	21257	0.003904596	0.004704333	11	3	EN-L5-6	64	21	21
ATCGAGTTCAATCTCT-1_1_A9	-24.44282145	-9.278836981	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1115	1548	0.01873385	0.006459948	11	9	OPC	64	21	21
ATCTACTAGAAACGAG-1_1_A9	-7.608016067	-30.29082421	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	868	1218	0.08045977	0.010673235	11	16	EN-PYR	64	21	21
ATCTACTAGGACTGGT-1_1_A9	4.938028941	-25.05747484	10	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4418	14098	0.00276635	0.003333806	11	L2-3	EN-L2-3-Cntl	64	21	21
ATCTACTTCCTACAGA-1_1_A9	-2.74664625	35.77310378	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	813	1163	0.011177988	0.008598452	11	oligos	OL-MS-2	64	21	21
ATCTACTTCTGGTGTA-1_1_A9	18.75995517	-34.61465975	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4730	16460	0.004495747	0.003827461	11	3	EN-L5-6	64	21	21
ATCTGCCAGCACACAG-1_1_A9	-19.96623916	16.62836947	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1724	2854	0.013314646	0.008058865	11	8	Astrocytes	64	21	21
ATCTGCCAGCGTTCCG-1_1_A9	-20.86092258	16.75791115	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1445	2419	0.004960728	0.001240182	11	8	Astrocytes	64	21	21
ATCTGCCAGTGGCACA-1_1_A9	-12.19148068	-32.69715725	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1321	1998	0.055055055	0.006506507	11	16	EN-PYR	64	21	21
ATCTGCCAGTTCGCAT-1_1_A9	-17.90344383	9.45085084	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	957	1305	0.019923372	0.003065134	11	8	Astrocytes	64	21	21
ATCTGCCGTCCCTTGT-1_1_A9	-11.21984944	32.36138842	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	779	1025	0.037073171	0.010731707	11	oligos	OL-MS-2	64	21	21
ATCTGCCGTCTAGTGT-1_1_A9	-24.77354644	-7.606560403	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1207	1714	0.011668611	0.004667445	11	9	OPC	64	21	21
ATCTGCCGTGCCTGCA-1_1_A9	29.70607157	-6.478729271	2	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3832	9737	0.005648557	0.009448495	11	2	EN-L4	64	21	21
ATCTGCCGTTAAGTAG-1_1_A9	22.87538114	-22.2161067	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3311	6977	0.009316325	0.003296546	11	3	EN-L5-6	64	21	21
ATCTGCCTCAAGCCTA-1_1_A9	-7.909417024	33.79707035	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	861	1146	0.013961606	0.002617801	11	oligos	OL-MS-2	64	21	21
ATCTGCCTCATCGCTC-1_1_A9	-19.02492347	-9.077037637	13B	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4954	13319	0.00840904	0.00630678	11	13B	IN-SV2C	64	21	21
ATGAGGGAGTGTCTCA-1_1_A9	-7.988680377	-29.82678754	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	830	1080	0.048148148	0.006481481	11	16	EN-PYR	64	21	21
ATGAGGGCAACACGCC-1_1_A9	-11.21807967	-33.13235869	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1103	1608	0.024875622	0.009328358	11	16	EN-PYR	64	21	21
ATGAGGGCACCTGGTG-1_1_A9	-10.80871237	-27.35118219	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	765	1041	0.080691643	0.003842459	11	16	EN-PYR	64	21	21
ATGAGGGCAGCTCGAC-1_1_A9	-23.6858934	24.75938392	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1537	2569	0.004671078	0.004281822	11	8	Astrocytes	64	21	21
ATGAGGGCAGGATTGG-1_1_A9	-21.15353271	16.29700611	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1478	2523	0.00673801	0.003170828	11	8	Astrocytes	64	21	21
ATGAGGGCATTATCTC-1_1_A9	22.82799441	26.60903833	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1153	1794	0.010033445	0.005016722	11	oligos	OL-MS-2	64	21	21
ATGAGGGCATTCTTAC-1_1_A9	-11.15826531	29.88263845	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	821	1058	0.039697543	0.004725898	11	oligos	OL-MS-2	64	21	21
ATGAGGGGTATCTGCA-1_1_A9	22.42929309	-19.50976645	2	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5645	18290	0.008693275	0.00606889	11	2	EN-L4	64	21	21
ATGAGGGGTCATTAGC-1_1_A9	33.29459913	5.395800689	14	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	919	1121	0.016949153	0.010704728	11	14	Microglia	64	21	21
ATGAGGGTCATTCACT-1_1_A9	6.030096038	-25.6045732	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5488	19331	0.005069577	0.002638249	11	L2-3	EN-L2-3-MS	64	21	21
ATGAGGGTCCACGCAG-1_1_A9	18.85663636	-10.46354671	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2237	4364	0.012603116	0.007103575	11	3	EN-L5-6	64	21	21
ATGCGATAGACTAGGC-1_1_A9	-23.76950128	-22.41091824	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2974	5869	0.018572159	0.008689726	11	6A	IN-PV	64	21	21
ATGCGATAGTGTTTGC-1_1_A9	-8.719993343	-29.73765479	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	881	1243	0.065164924	0.009654063	11	16	EN-PYR	64	21	21
ATGCGATCAGACAAAT-1_1_A9	-2.674850152	32.25687464	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	971	1426	0.014025245	0.004207574	11	oligos	OL-MS-2	64	21	21
ATGCGATTCACCGTAA-1_1_A9	-8.585108509	-29.95416836	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	892	1228	0.085504886	0.00732899	11	16	EN-PYR	64	21	21
ATGCGATTCTACGAGT-1_1_A9	6.902575396	-23.80193375	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4626	13333	0.017550439	0.001725043	11	L2-3	EN-L2-3-MS	64	21	21
ATGGGAGAGCGCTTAT-1_1_A9	5.119632836	-2.745036055	12	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	823	1084	0.012915129	0.010147601	11	12	EN-MIX	64	21	21
ATGGGAGAGTACGTAA-1_1_A9	-5.638467653	35.7687659	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	731	1025	0.037073171	0.00097561	11	oligos	OL-MS-2	64	21	21
ATGGGAGCAATAACGA-1_1_A9	-21.05223521	16.48451507	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1384	2243	0.008470798	0.004904146	11	8	Astrocytes	64	21	21
ATGGGAGCAGATAATG-1_1_A9	-14.21629649	-3.901038956	13A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3353	7237	0.006494404	0.008290728	11	13A	IN-VIP	64	21	21
ATGGGAGTCTACGAGT-1_1_A9	-22.74090023	12.30639705	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1143	1824	0.007127193	0.006030702	11	8	Astrocytes	64	21	21
ATGTGTGAGCTAACTC-1_1_A9	24.24241648	-10.37951127	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5278	15454	0.004853112	0.004400155	11	3	EN-L5-6	64	21	21
ATGTGTGGTCCCTACT-1_1_A9	-2.452965549	36.13743099	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	800	1075	0.009302326	0.006511628	11	oligos	OL-MS-2	64	21	21
ATGTGTGGTGTTAAGA-1_1_A9	-25.62622696	-7.570748	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1058	1521	0.008547009	0.003287311	11	9	OPC	64	21	21
ATGTGTGTCTACTCAT-1_1_A9	5.555337705	-25.7374284	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4556	14508	0.007030604	0.002963882	11	L2-3	EN-L2-3-MS	64	21	21
ATGTGTGTCTTCGAGA-1_1_A9	-2.063462828	36.38833205	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	856	1175	0.008510638	0.006808511	11	oligos	OL-MS-2	64	21	21
ATTACTCCACGTTGGC-1_1_A9	-21.21926406	13.17146808	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1172	1767	0.013016412	0.005093379	11	8	Astrocytes	64	21	21
ATTACTCCAGACGCTC-1_1_A9	-24.90079831	-24.7270072	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4337	12149	0.033253766	0.002798584	11	6A	IN-PV	64	21	21
ATTACTCCAGGGCATA-1_1_A9	22.9099574	-24.31288159	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2931	7053	0.010491989	0.002977456	11	3	EN-L5-6	64	21	21
ATTACTCGTGACGGTA-1_1_A9	-19.38657494	9.597842171	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	899	1297	0.01464919	0.00462606	11	8	Astrocytes	64	21	21
ATTACTCTCAACGGGA-1_1_A9	3.198670229	-16.38420646	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3089	7059	0.009208103	0.008499788	11	L2-3	EN-L2-3-MS	64	21	21
ATTACTCTCGATGAGG-1_1_A9	-27.33848392	13.56605941	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	899	1376	0.002906977	0.006540698	11	8	Astrocytes	64	21	21
ATTATCCCACATCCAA-1_1_A9	1.889970717	6.422872751	7	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	945	1229	0.017087063	0.002441009	11	7	Phagocytes	64	21	21
ATTATCCCACGGCCAT-1_1_A9	17.70454322	-19.67988803	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3217	6855	0.021444201	0.003646973	11	L2-3	EN-L2-3-MS	64	21	21
ATTCTACAGTGTTGAA-1_1_A9	25.669351	3.951854785	15BA	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1133	1575	0.012063492	0.001269841	11	15BA	Stromal cells	64	21	21
ATTCTACAGTTCCACA-1_1_A9	-22.40002628	-20.33971148	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2671	5710	0.070052539	0.005604203	11	6A	IN-PV	64	21	21
ATTCTACGTCATCCCT-1_1_A9	-23.86550814	-25.00889788	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4096	10707	0.006537779	0.00354908	11	6A	IN-PV	64	21	21
ATTCTACGTGCGAAAC-1_1_A9	-1.978680744	35.93304559	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	785	1108	0.010830325	0.004512635	11	oligos	OL-MS-2	64	21	21
ATTCTACTCGAGAGCA-1_1_A9	19.89850025	-34.03722373	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4070	11310	0.005923961	0.009106985	11	3	EN-L5-6	64	21	21
ATTGGACAGCGTAGTG-1_1_A9	-29.55197687	-11.50627347	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	850	1120	0.011607143	0.011607143	11	9	OPC	64	21	21
ATTGGACCACTTCGAA-1_1_A9	-20.11021617	16.38639343	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1772	3211	0.012768608	0.006540019	11	8	Astrocytes	64	21	21
ATTGGACCAGATAATG-1_1_A9	-20.9497715	14.62752698	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1236	1969	0.007110208	0.005586592	11	8	Astrocytes	64	21	21
ATTGGACCATCCGGGT-1_1_A9	25.22094171	-8.469061189	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3983	9739	0.005031317	0.004312558	11	3	EN-L5-6	64	21	21
ATTGGACGTATGAATG-1_1_A9	-29.76967451	-1.360237719	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1509	2468	0.006077796	0.020259319	11	9	OPC	64	21	21
ATTGGACGTTACCGAT-1_1_A9	-5.362375722	32.70726984	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	945	1369	0.016800584	0.006574142	11	oligos	OL-MS-2	64	21	21
ATTGGACTCAAGATCC-1_1_A9	3.130035137	-10.66041561	12	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1698	2995	0.07278798	0.005008347	11	12	EN-MIX	64	21	21
ATTGGACTCATCGATG-1_1_A9	-5.909481418	-29.93157773	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	760	1034	0.070599613	0.01450677	11	16	EN-PYR	64	21	21
ATTGGACTCGGTGTCG-1_1_A9	-8.610685281	-31.73077032	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	842	1177	0.052676296	0.005947324	11	16	EN-PYR	64	21	21
ATTGGTGAGTAGGCCA-1_1_A9	-14.02507322	-3.971002445	13A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3038	6294	0.014299333	0.008102955	11	13A	IN-VIP	64	21	21
ATTGGTGAGTCCGGTC-1_1_A9	-9.314595912	32.73213943	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	800	1074	0.011173184	0.009310987	11	oligos	OL-MS-2	64	21	21
ATTGGTGCATGCATGT-1_1_A9	33.69947144	7.197941264	14	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1015	1299	0.024634334	0.006928406	11	14	Microglia	64	21	21
ATTGGTGGTACCATCA-1_1_A9	-14.16590472	8.510838366	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1231	1795	0.02005571	0.005013928	11	8	Astrocytes	64	21	21
ATTGGTGGTGGACGAT-1_1_A9	7.14886128	-21.05728272	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4120	10298	0.005729268	0.014371723	11	L2-3	EN-L2-3-MS	64	21	21
ATTGGTGGTTGTGGAG-1_1_A9	7.548108692	-23.19468251	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4781	13789	0.023787077	0.004568859	11	L2-3	EN-L2-3-MS	64	21	21
ATTGGTGTCCCAACGG-1_1_A9	5.185960927	-23.43421203	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6009	21671	0.00729085	0.008029163	11	L2-3	EN-L2-3-MS	64	21	21
ATTTCTGCACATAACC-1_1_A9	-10.74743292	-9.095132911	13B	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1335	2211	0.014925373	0.00452284	11	13B	IN-SV2C	64	21	21
ATTTCTGGTGTCCTCT-1_1_A9	-36.67156471	-7.133869411	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1066	1735	0.006916427	0.00518732	11	9	OPC	64	21	21
CAACCAAAGACCGGAT-1_1_A9	5.972548877	-24.68410705	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5799	19247	0.005299527	0.003013457	11	L2-3	EN-L2-3-MS	64	21	21
CAACCAAAGCGTTCCG-1_1_A9	-11.18423568	-32.20650573	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1115	1698	0.066548881	0.002944641	11	16	EN-PYR	64	21	21
CAACCAACAAACCCAT-1_1_A9	22.86161553	-19.81430871	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	8240	37359	0.013196285	0.006584759	11	3	EN-L5-6	64	21	21
CAACCAACACGTGAGA-1_1_A9	-11.2512976	31.75566968	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	853	1200	0.031666667	0.01	11	oligos	OL-MS-2	64	21	21
CAACCAATCCATGCTC-1_1_A9	4.4004679	1.306898009	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	793	1036	0.048262548	0.003861004	11	16	EN-PYR	64	21	21
CAACCTCAGGAATTAC-1_1_A9	-6.632434166	31.11375949	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1381	2118	0.026440038	0.008498584	11	oligos	OL-MS-2	64	21	21
CAACCTCCACACGCTG-1_1_A9	4.010815837	1.098913627	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	868	1119	0.046470063	0.00893655	11	16	EN-PYR	64	21	21
CAACCTCCAGGTGCCT-1_1_A9	-14.31984548	9.000900028	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1333	1859	0.019903174	0.009144701	11	8	Astrocytes	64	21	21
CAACCTCGTCAATACC-1_1_A9	-19.6326762	15.14183205	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1499	2290	0.008733624	0.004366812	11	8	Astrocytes	64	21	21
CAACCTCGTCAGAATA-1_1_A9	-12.36650163	-2.438502365	13A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2473	4690	0.009594883	0.013219616	11	13A	IN-VIP	64	21	21
CAACCTCGTTAAAGTG-1_1_A9	-7.295633233	-28.97126651	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	751	1007	0.048659384	0.003972195	11	16	EN-PYR	64	21	21
CAACCTCTCTACTATC-1_1_A9	-7.925795293	-27.36463868	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	818	1083	0.084949215	0.005540166	11	16	EN-PYR	64	21	21
CAACTAGAGACACTAA-1_1_A9	29.77949872	-6.494472752	2	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4113	10702	0.012427584	0.003083536	11	2	EN-L4	64	21	21
CAACTAGAGACTCGGA-1_1_A9	-7.281384382	-28.73079189	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	808	1045	0.066028708	0.006698565	11	16	EN-PYR	64	21	21
CAACTAGAGATGCCTT-1_1_A9	-7.907453468	-27.44303331	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	793	1051	0.063748811	0.009514748	11	16	EN-PYR	64	21	21
CAACTAGAGCAGACTG-1_1_A9	-18.36581394	10.07353005	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	795	1090	0.008256881	0.012844037	11	8	Astrocytes	64	21	21
CAACTAGAGTGCCAGA-1_1_A9	-7.461874782	-29.59484352	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	858	1263	0.135391924	0.007917656	11	16	EN-PYR	64	21	21
CAACTAGCAGATGGCA-1_1_A9	-21.88971755	-16.29555987	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3407	7630	0.020838794	0.008519004	11	6A	IN-PV	64	21	21
CAACTAGGTCTAGTCA-1_1_A9	-4.301155871	34.69494262	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	820	1098	0.014571949	0.007285974	11	oligos	OL-MS-2	64	21	21
CAACTAGGTCTGCCAG-1_1_A9	-3.51780859	33.82587547	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	867	1196	0.016722408	0.011705686	11	oligos	OL-MS-2	64	21	21
CAACTAGGTTTGACTG-1_1_A9	-8.277038138	32.77387159	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	932	1249	0.021617294	0.004003203	11	oligos	OL-MS-2	64	21	21
CAAGAAAAGCCGATTT-1_1_A9	-12.55177757	16.29198868	11	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1859	2812	0.019203414	0.006756757	11	11	Glia-MIX	64	21	21
CAAGAAAAGTGCAAGC-1_1_A9	-6.48205841	33.91624891	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	894	1251	0.011990408	0.003197442	11	oligos	OL-MS-2	64	21	21
CAAGAAACACACTGCG-1_1_A9	27.00703839	-26.11383276	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4440	12873	0.004660918	0.003418007	11	3	EN-L5-6	64	21	21
CAAGAAACATCTGGTA-1_1_A9	-10.15783608	-16.55063132	6B	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	973	1434	0.041841004	0.00209205	11	6B	IN-SST	64	21	21
CAAGAAATCGCCATAA-1_1_A9	0.165302095	0.886242996	11	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1294	1997	0.060090135	0.003505258	11	11	Glia-MIX	64	21	21
CAAGAAATCTGCTGTC-1_1_A9	-12.31941464	-13.24269542	6B	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1647	2670	0.038951311	0.003370787	11	6B	IN-SST	64	21	21
CAAGATCAGCGTAATA-1_1_A9	26.46766447	-27.0357761	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4282	11558	0.007527254	0.003028206	11	3	EN-L5-6	64	21	21
CAAGATCAGGCCCTCA-1_1_A9	-24.97777602	-5.67232957	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1403	2308	0.009532062	0.003466205	11	9	OPC	64	21	21
CAAGATCAGTCATCCA-1_1_A9	27.50822422	-24.96003999	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6377	23528	0.011475689	0.002975179	11	3	EN-L5-6	64	21	21
CAAGATCAGTGGTAGC-1_1_A9	19.75643142	-32.1471254	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6434	21721	0.013949634	0.005616684	11	3	EN-L5-6	64	21	21
CAAGATCCACTGTGTA-1_1_A9	-20.02781655	15.08963203	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1371	2144	0.012593284	0.006529851	11	8	Astrocytes	64	21	21
CAAGATCCACTGTTAG-1_1_A9	1.839604061	5.999880774	7	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	912	1232	0.01461039	0.006493506	11	7	Phagocytes	64	21	21
CAAGATCCAGTAGAGC-1_1_A9	25.00353883	-20.05602119	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6493	22839	0.019002583	0.004903892	11	3	EN-L5-6	64	21	21
CAAGATCGTATAAACG-1_1_A9	-18.59833669	-7.933287563	13B	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3554	7663	0.012527731	0.005872374	11	13B	IN-SV2C	64	21	21
CAAGATCGTCAATACC-1_1_A9	-14.87749627	8.224830837	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1026	1362	0.03010279	0.007342144	11	8	Astrocytes	64	21	21
CAAGATCGTCGAACAG-1_1_A9	18.70669428	-31.39448171	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5598	17647	0.005383351	0.005326684	11	3	EN-L5-6	64	21	21
CAAGATCGTTGCGCAC-1_1_A9	-6.26944578	34.74250297	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	790	1048	0.022900763	0.008587786	11	oligos	OL-MS-2	64	21	21
CAAGATCTCACAGTAC-1_1_A9	-19.55246251	14.95713886	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1379	2128	0.010808271	0.009398496	11	8	Astrocytes	64	21	21
CAAGATCTCCTAGAAC-1_1_A9	-12.74157521	16.82071457	11	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1538	2527	0.007123071	0.003561535	11	11	Glia-MIX	64	21	21
CAAGATCTCCTATGTT-1_1_A9	-7.851974437	-28.64460628	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	778	1062	0.037664783	0.009416196	11	16	EN-PYR	64	21	21
CAAGGCCCAGGCGATA-1_1_A9	-10.26558244	-33.02797159	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1107	1607	0.057249533	0.010578718	11	16	EN-PYR	64	21	21
CAAGGCCCAGGTGGAT-1_1_A9	5.605491239	-24.25340385	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5461	17080	0.002810304	0.005035129	11	L2-3	EN-L2-3-MS	64	21	21
CAAGGCCGTAGCCTAT-1_1_A9	-10.14042882	22.39007985	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1651	2541	0.0094451	0.015348288	11	8	Astrocytes	64	21	21
CAAGGCCTCGTTGCCT-1_1_A9	-6.060682961	32.8059313	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	959	1359	0.016188374	0.005150846	11	oligos	OL-MS-2	64	21	21
CAAGGCCTCTGCAAGT-1_1_A9	-9.789279537	-31.44631615	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1025	1461	0.055441478	0.004791239	11	16	EN-PYR	64	21	21
CAAGTTGAGGTACTCT-1_1_A9	-8.113632033	-30.54791398	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	896	1379	0.137055838	0.005801305	11	16	EN-PYR	64	21	21
CAAGTTGCAGGTGGAT-1_1_A9	27.9846102	-25.29291004	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5206	17362	0.012383366	0.004550167	11	3	EN-L5-6	64	21	21
CAAGTTGGTGCTCTTC-1_1_A9	-10.78496743	-27.36868522	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	888	1129	0.04340124	0.012400354	11	16	EN-PYR	64	21	21
CAAGTTGGTGTTCTTT-1_1_A9	-19.73300039	15.3166286	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1492	2372	0.015598651	0.005902192	11	8	Astrocytes	64	21	21
CAAGTTGGTTCGCGAC-1_1_A9	-32.11228311	-0.23022996	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1870	3468	0.007208766	0.002306805	11	9	OPC	64	21	21
CAAGTTGGTTTGCATG-1_1_A9	-4.34233937	35.61007736	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	784	1029	0.032069971	0.003887269	11	oligos	OL-MS-2	64	21	21
CACAAACAGAGCCCAA-1_1_A9	-23.93907292	-9.672254038	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1033	1425	0.016842105	0.007719298	11	9	OPC	64	21	21
CACAAACAGCTATGCT-1_1_A9	33.04107505	5.89263545	14	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1016	1268	0.02444795	0.011829653	11	14	Microglia	64	21	21
CACAAACAGGCTACGA-1_1_A9	-11.3365354	-13.91639388	6B	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1126	1505	0.035215947	0.003322259	11	6B	IN-SST	64	21	21
CACAAACAGGCTAGGT-1_1_A9	-9.43095132	-28.07806154	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1156	1597	0.025046963	0.009392611	11	16	EN-PYR	64	21	21
CACAAACAGGGTTTCT-1_1_A9	-19.27022529	13.66120121	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1427	2128	0.01362782	0.003289474	11	8	Astrocytes	64	21	21
CACAAACCAAGCTGAG-1_1_A9	-10.27342367	32.84478185	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	891	1244	0.032958199	0.00562701	11	oligos	OL-MS-2	64	21	21
CACAAACCACGGTTTA-1_1_A9	-7.885227771	-27.35457129	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	757	1018	0.067779961	0.007858546	11	16	EN-PYR	64	21	21
CACAAACCAGATTGCT-1_1_A9	4.905059332	1.855327285	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	809	1034	0.055125725	0.005802708	11	16	EN-PYR	64	21	21
CACAAACCATACGCCG-1_1_A9	-23.18573251	-7.705208121	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1789	2866	0.021981856	0.012212142	11	9	OPC	64	21	21
CACAAACCATGTCTCC-1_1_A9	5.211691937	1.934009187	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	792	1010	0.053465347	0.00990099	11	16	EN-PYR	64	21	21
CACAAACGTATAATGG-1_1_A9	19.35046479	-33.45415355	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	7270	29610	0.005775076	0.002499156	11	3	EN-L5-6	64	21	21
CACAAACTCGCGCCAA-1_1_A9	19.33635001	-33.14790928	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	8412	39687	0.006979615	0.004787462	11	3	EN-L5-6	64	21	21
CACAAACTCGTGGACC-1_1_A9	-23.19367703	-16.43505567	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3985	8544	0.025163858	0.006086142	11	6A	IN-PV	64	21	21
CACACAAAGCGATATA-1_1_A9	-11.67519591	31.75792334	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	837	1062	0.04613936	0.004708098	11	oligos	OL-MS-2	64	21	21
CACACAAAGCTTCGCG-1_1_A9	-9.452372046	-30.46445553	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1075	1532	0.086814621	0.00848564	11	16	EN-PYR	64	21	21
CACACAAAGTCCAGGA-1_1_A9	-6.416397093	34.19720481	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	904	1258	0.013513514	0.005564388	11	oligos	OL-MS-2	64	21	21
CACACAACAAACGCGA-1_1_A9	-9.863502292	33.21218626	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	865	1134	0.022045855	0.009700176	11	oligos	OL-MS-2	64	21	21
CACACAACAGATCTGT-1_1_A9	-11.37541924	15.49706415	11	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1766	2825	0.011327434	0.005309735	11	11	Glia-MIX	64	21	21
CACACAACATGCAACT-1_1_A9	19.37341524	-32.8270259	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	8265	38923	0.010045474	0.003571153	11	3	EN-L5-6	64	21	21
CACACAAGTCTCTCGT-1_1_A9	19.33309159	-31.01695627	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6337	23239	0.009725031	0.005120702	11	3	EN-L5-6	64	21	21
CACACAAGTTAAGAAC-1_1_A9	-19.95276124	14.94964588	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1438	2249	0.01067141	0.004446421	11	8	Astrocytes	64	21	21
CACACAATCAGATAAG-1_1_A9	-12.77108279	7.267942887	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2724	4944	0.059061489	0.00566343	11	16	EN-PYR	64	21	21
CACACAATCCGCAAGC-1_1_A9	-8.822225168	33.67540171	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	873	1151	0.020851434	0.004344049	11	oligos	OL-MS-2	64	21	21
CACACAATCGGTGTTA-1_1_A9	-19.94346572	14.83744935	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1300	2014	0.01142006	0.00347567	11	8	Astrocytes	64	21	21
CACACAATCTGGCGTG-1_1_A9	-14.12209885	-4.003048736	13A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3001	5980	0.009197324	0.005183946	11	13A	IN-VIP	64	21	21
CACACCTAGATGAGAG-1_1_A9	31.06061261	5.016198032	15DA	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	913	1120	0.021428571	0.023214286	11	15DA	T cells	64	21	21
CACACCTAGCGGCTTC-1_1_A9	-14.61411003	-4.002023645	13A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3638	8111	0.006164468	0.011835779	11	13A	IN-VIP	64	21	21
CACACCTAGGGTTCCC-1_1_A9	-8.075495747	-26.80040871	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	772	1001	0.063936064	0.00999001	11	16	EN-PYR	64	21	21
CACACCTCAAACGCGA-1_1_A9	4.593521068	-26.27731559	10	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3716	10023	0.004489674	0.004489674	11	L2-3	EN-L2-3-Cntl	64	21	21
CACACCTCAAAGTCAA-1_1_A9	8.517244665	-1.966845967	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1434	2458	0.02278275	0.009357201	11	16	EN-PYR	64	21	21
CACACCTCAACACCTA-1_1_A9	-22.03182387	-15.88723738	6B	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3669	8664	0.016851339	0.007040628	11	6B	IN-SST	64	21	21
CACACCTCAACGATCT-1_1_A9	-9.7537217	-31.65715608	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	992	1339	0.035847647	0.010455564	11	16	EN-PYR	64	21	21
CACACCTCAATGCCAT-1_1_A9	-12.08587476	-30.7767205	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1666	2517	0.079856973	0.006356774	11	16	EN-PYR	64	21	21
CACACCTCACCGAATT-1_1_A9	4.049149708	0.895664626	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	925	1229	0.04719284	0.007323027	11	16	EN-PYR	64	21	21
CACACCTCACTATCTT-1_1_A9	-14.32594236	9.461914361	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1285	1966	0.018311292	0.007121058	11	8	Astrocytes	64	21	21
CACACCTCAGGTCTCG-1_1_A9	3.925220626	1.072471868	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	773	1020	0.08627451	0.011764706	11	16	EN-PYR	64	21	21
CACACCTCATCGGAAG-1_1_A9	-24.98962227	-9.852491353	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	925	1272	0.011006289	0.019654088	11	9	OPC	64	21	21
CACACCTGTCCATCCT-1_1_A9	-13.77811061	-34.34416474	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1750	2975	0.024537815	0.008067227	11	16	EN-PYR	64	21	21
CACACCTTCCTCAATT-1_1_A9	-8.739045975	-27.66170344	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1022	1406	0.076813656	0.007112376	11	16	EN-PYR	64	21	21
CACACCTTCGTTGACA-1_1_A9	-18.89807292	13.81541762	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1401	2081	0.012493993	0.009610764	11	8	Astrocytes	64	21	21
CACACTCAGAGACGAA-1_1_A9	-5.942529662	34.29657731	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	938	1271	0.021243116	0.00393391	11	oligos	OL-MS-2	64	21	21
CACACTCAGGGTCGAT-1_1_A9	-8.933237054	31.59278525	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1134	1622	0.027743527	0.008014797	11	oligos	OL-MS-2	64	21	21
CACACTCAGGTGCTAG-1_1_A9	-14.15316027	-35.53698192	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2137	4145	0.072858866	0.012303981	11	16	EN-PYR	64	21	21
CACACTCAGTAAGTAC-1_1_A9	-20.4224436	18.57034463	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2572	5035	0.006156902	0.005561072	11	8	Astrocytes	64	21	21
CACACTCAGTGGTCCC-1_1_A9	-11.50085153	31.45446438	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1296	1759	0.025582717	0.005116543	11	oligos	OL-MS-2	64	21	21
CACACTCAGTGTGGCA-1_1_A9	-6.701541744	31.97619028	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1235	1787	0.015109121	0.006155568	11	oligos	OL-MS-2	64	21	21
CACACTCAGTTATCGC-1_1_A9	-6.430734262	-29.71133669	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	779	1006	0.02584493	0.010934394	11	16	EN-PYR	64	21	21
CACACTCCAAGCGTAG-1_1_A9	-23.27497599	-7.66200097	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1518	2255	0.0172949	0.005764967	11	9	OPC	64	21	21
CACACTCCAAGTTCTG-1_1_A9	32.87473627	4.838524573	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1181	1581	0.07084124	0.0056926	11	16	EN-PYR	64	21	21
CACACTCCACAGGTTT-1_1_A9	-19.61888193	12.95019122	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1202	1774	0.009019166	0.002818489	11	8	Astrocytes	64	21	21
CACACTCCACTACAGT-1_1_A9	4.988791381	1.710161498	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	799	1038	0.058766859	0.011560694	11	16	EN-PYR	64	21	21
CACACTCCATGTCTCC-1_1_A9	5.795485334	1.795587309	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1160	1545	0.049838188	0.00776699	11	16	EN-PYR	64	21	21
CACAGGCAGATATGCA-1_1_A9	11.4948088	-28.96469533	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6224	20907	0.005022241	0.004496102	11	3	EN-L5-6	64	21	21
CACAGGCAGATCCGAG-1_1_A9	-10.92567736	-32.578957	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1218	2015	0.129032258	0.00942928	11	16	EN-PYR	64	21	21
CACAGGCAGTTACGGG-1_1_A9	-25.61903831	-10.09107732	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	916	1263	0.021377672	0.011084719	11	9	OPC	64	21	21
CACAGGCCAAATCCGT-1_1_A9	-11.74341792	32.8734747	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1207	1705	0.023460411	0.008211144	11	oligos	OL-MS-2	64	21	21
CACAGGCCACCATCCT-1_1_A9	19.19640462	-34.11111667	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6419	26022	0.005226347	0.003881331	11	3	EN-L5-6	64	21	21
CACAGGCCAGTTCCCT-1_1_A9	-9.638279917	-29.12477971	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1010	1391	0.061107117	0.007189073	11	16	EN-PYR	64	21	21
CACAGGCGTCGCATAT-1_1_A9	22.84907383	-20.24282698	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	8015	37594	0.020269192	0.005905198	11	3	EN-L5-6	64	21	21
CACAGGCTCCCACTTG-1_1_A9	17.92321565	-25.03884846	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5874	20092	0.005723671	0.019161855	11	3	EN-L5-6	64	21	21
CACAGGCTCCCTTGTG-1_1_A9	-25.4757996	-7.247657702	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1116	1598	0.009386733	0.005006258	11	9	OPC	64	21	21
CACAGTAAGCAATCTC-1_1_A9	4.939861597	1.535629963	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	935	1194	0.051926298	0.008375209	11	16	EN-PYR	64	21	21
CACAGTAAGGAGTCTG-1_1_A9	4.714133225	1.383006854	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	862	1112	0.054856115	0.009892086	11	16	EN-PYR	64	21	21
CACAGTAAGTACTTGC-1_1_A9	-10.23500963	30.77183794	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	996	1346	0.033432392	0.004457652	11	oligos	OL-MS-2	64	21	21
CACAGTACAAGCGATG-1_1_A9	19.08964391	-33.41223304	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6407	23388	0.003506071	0.003377801	11	3	EN-L5-6	64	21	21
CACAGTACAGCCACCA-1_1_A9	3.680915815	0.34816616	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1004	1314	0.04414003	0.008371385	11	16	EN-PYR	64	21	21
CACAGTACATGCCTTC-1_1_A9	-13.80294807	-34.29027141	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1932	3646	0.076247943	0.006582556	11	16	EN-PYR	64	21	21
CACAGTACATTCACTT-1_1_A9	-7.111732449	32.06424336	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1155	1674	0.021505376	0.010155317	11	oligos	OL-MS-2	64	21	21
CACAGTAGTTTGACTG-1_1_A9	28.1022948	-25.92995837	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4856	15167	0.008505308	0.001912046	11	3	EN-L5-6	64	21	21
CACAGTATCCAGAAGG-1_1_A9	7.319860436	-24.22349823	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5517	17603	0.014315742	0.009146168	11	L2-3	EN-L2-3-MS	64	21	21
CACATAGCACATGGGA-1_1_A9	5.375623116	1.832339133	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	828	1071	0.063492063	0.010270775	11	16	EN-PYR	64	21	21
CACATAGCAGACGTAG-1_1_A9	5.264669898	1.745706291	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	820	1015	0.030541872	0.012807882	11	16	EN-PYR	64	21	21
CACATAGCAGATCGGA-1_1_A9	27.77596194	-24.35679297	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5764	18489	0.012061226	0.003137	11	3	EN-L5-6	64	21	21
CACATAGCATTCTTAC-1_1_A9	5.244062072	1.804052074	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	898	1151	0.06429192	0.012163336	11	16	EN-PYR	64	21	21
CACATAGGTAAGTTCC-1_1_A9	5.366961331	-24.40245424	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	7056	28047	0.003565444	0.006096909	11	L2-3	EN-L2-3-MS	64	21	21
CACATAGTCCCAAGAT-1_1_A9	-8.780046265	-27.38016205	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	996	1349	0.054855448	0.008895478	11	16	EN-PYR	64	21	21
CACATAGTCGGCCGAT-1_1_A9	20.39773392	-23.92795036	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5593	17050	0.012316716	0.01026393	11	3	EN-L5-6	64	21	21
CACATAGTCTCAACTT-1_1_A9	20.64442482	-31.81130975	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	9343	49367	0.014260538	0.004112059	11	3	EN-L5-6	64	21	21
CACATAGTCTTGAGAC-1_1_A9	-18.87964486	14.90431754	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1640	2674	0.018324607	0.005983545	11	8	Astrocytes	64	21	21
CACATTTAGACCACGA-1_1_A9	-5.443274656	32.37505844	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1048	1541	0.023361454	0.006489293	11	oligos	OL-MS-2	64	21	21
CACATTTAGAGGACGG-1_1_A9	1.860357616	6.405346363	7	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1269	1781	0.019090399	0.00729927	11	7	Phagocytes	64	21	21
CACATTTAGCTAACTC-1_1_A9	6.596749922	-25.28688301	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6359	23121	0.00536309	0.004281822	11	L2-3	EN-L2-3-MS	64	21	21
CACATTTAGTGGACGT-1_1_A9	-1.462753698	36.40413073	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	814	1140	0.013157895	0.010526316	11	oligos	OL-MS-2	64	21	21
CACATTTAGTGTACTC-1_1_A9	4.920413724	1.769220789	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	828	1072	0.043843284	0.009328358	11	16	EN-PYR	64	21	21
CACATTTCAAGGGTCA-1_1_A9	19.60172941	-33.57700299	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5442	18861	0.00683951	0.002491915	11	3	EN-L5-6	64	21	21
CACATTTCACAAGTAA-1_1_A9	-5.784019147	31.79445468	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1107	1610	0.026086957	0.004347826	11	oligos	OL-MS-2	64	21	21
CACATTTGTAAGTTCC-1_1_A9	-11.45083458	30.73123042	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1197	1749	0.028016009	0.006861063	11	oligos	OL-MS-2	64	21	21
CACATTTGTAATCACC-1_1_A9	-11.07065874	32.49383729	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	987	1359	0.026490066	0.005150846	11	oligos	OL-MS-2	64	21	21
CACATTTGTACGACCC-1_1_A9	8.098240463	-0.046589822	12	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	829	1057	0.048249763	0.006622517	11	12	EN-MIX	64	21	21
CACATTTGTCACCCAG-1_1_A9	-6.436968011	33.18595465	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	982	1381	0.015930485	0.00724113	11	oligos	OL-MS-2	64	21	21
CACATTTTCCACGCAG-1_1_A9	6.393488316	-25.28040166	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	7000	27811	0.005717162	0.004818237	11	L2-3	EN-L2-3-MS	64	21	21
CACATTTTCCCATTAT-1_1_A9	20.93627083	-12.303209	12	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2209	3642	0.049423394	0.006315211	11	12	EN-MIX	64	21	21
CACATTTTCCCTTGTG-1_1_A9	8.555297455	-1.857803304	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1216	1702	0.042890717	0.009988249	11	16	EN-PYR	64	21	21
CACCACTAGTGAACAT-1_1_A9	-18.73678322	14.89751906	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1989	3322	0.012040939	0.005117399	11	8	Astrocytes	64	21	21
CACCACTCACTTAACG-1_1_A9	32.00479145	4.984132075	15DA	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1069	1536	0.038411458	0.0234375	11	15DA	T cells	64	21	21
CACCACTCAGACGCTC-1_1_A9	3.980606308	0.831496387	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	918	1168	0.038527397	0.011130137	11	16	EN-PYR	64	21	21
CACCACTCATAACCTG-1_1_A9	-19.3162795	15.36375827	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1662	2817	0.008164714	0.004614838	11	8	Astrocytes	64	21	21
CACCACTCATTCGACA-1_1_A9	-7.689838346	-29.28544896	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	779	1025	0.052682927	0.007804878	11	16	EN-PYR	64	21	21
CACCACTGTCAACTGT-1_1_A9	4.850872253	1.502532078	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	979	1254	0.039872408	0.002392344	11	16	EN-PYR	64	21	21
CACCACTGTCTTGATG-1_1_A9	7.456260118	-23.22081662	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6291	22042	0.021096089	0.007258869	11	L2-3	EN-L2-3-MS	64	21	21
CACCACTGTTACCGAT-1_1_A9	-11.88277379	30.27664989	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	848	1043	0.022051774	0.003835091	11	16	EN-PYR	64	21	21
CACCACTGTTAGGGTG-1_1_A9	-19.62735401	12.57782473	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1231	1845	0.009214092	0.003252033	11	8	Astrocytes	64	21	21
CACCACTTCACATGCA-1_1_A9	-18.98371522	-8.14822967	13B	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5407	15518	0.013274907	0.006250806	11	13B	IN-SV2C	64	21	21
CACCACTTCAGCCTAA-1_1_A9	-8.056116998	-27.64569109	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	857	1161	0.047372954	0.007751938	11	16	EN-PYR	64	21	21
CACCACTTCCACGTTC-1_1_A9	4.515739053	1.226821625	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	916	1192	0.045302013	0.015100671	11	16	EN-PYR	64	21	21
CACCACTTCGCCAAAT-1_1_A9	4.986378336	1.646361913	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	872	1146	0.052356021	0.009598604	11	16	EN-PYR	64	21	21
CACCAGGAGGCAATTA-1_1_A9	-6.834839497	32.3090044	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1012	1364	0.014662757	0.005865103	11	oligos	OL-MS-2	64	21	21
CACCAGGCAGATGAGC-1_1_A9	-7.287855211	-30.36893961	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	814	1051	0.029495718	0.010466223	11	16	EN-PYR	64	21	21
CACCAGGCAGGCTGAA-1_1_A9	3.772790768	-10.52237369	12	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2060	4118	0.00728509	0.003642545	11	12	EN-MIX	64	21	21
CACCAGGCATCCTTGC-1_1_A9	-5.018295753	31.45257189	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1153	1803	0.010537992	0.004991681	11	oligos	OL-MS-2	64	21	21
CACCAGGGTCCTGCTT-1_1_A9	-9.293836861	-28.00320022	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1032	1399	0.047891351	0.011436741	11	16	EN-PYR	64	21	21
CACCAGGGTGAAGGCT-1_1_A9	-23.46743297	0.226787815	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2161	3705	0.011875843	0.004048583	11	9	OPC	64	21	21
CACCAGGGTTCCTCCA-1_1_A9	-11.16055299	31.33298422	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1228	1733	0.026543566	0.00577034	11	oligos	OL-MS-2	64	21	21
CACCAGGGTTTGACTG-1_1_A9	13.30380584	-22.44348989	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6441	21483	0.006563329	0.008378718	11	L2-3	EN-L2-3-MS	64	21	21
CACCAGGTCAGATAAG-1_1_A9	26.29068736	-22.73140703	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	7326	30838	0.017964849	0.004021013	11	3	EN-L5-6	64	21	21
CACCTTGAGAAACCAT-1_1_A9	-5.723904157	31.54640231	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1081	1524	0.007874016	0.011154856	11	oligos	OL-MS-2	64	21	21
CACCTTGCATCACAAC-1_1_A9	5.068227823	1.792224868	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	833	1029	0.04664723	0.006802721	11	16	EN-PYR	64	21	21
CACCTTGCATCGTCGG-1_1_A9	-19.93663489	10.80456185	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	864	1191	0.010915197	0.004198153	11	8	Astrocytes	64	21	21
CACCTTGGTCTCCCTA-1_1_A9	-14.00400338	8.681162359	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1342	1932	0.018115942	0.009834369	11	8	Astrocytes	64	21	21
CACCTTGTCAATCTCT-1_1_A9	-7.967226241	-27.55740475	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	783	1026	0.053606238	0.007797271	11	16	EN-PYR	64	21	21
CACCTTGTCCGCGGTA-1_1_A9	33.11109365	5.866077896	14	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	907	1137	0.019349164	0.008795075	11	14	Microglia	64	21	21
CACCTTGTCGTACGGC-1_1_A9	-16.42180333	10.97005823	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1224	1788	0.010067114	0.006152125	11	8	Astrocytes	64	21	21
CACTCCAAGAGCTGCA-1_1_A9	-7.94636346	-27.35879185	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	829	1058	0.043478261	0.013232514	11	16	EN-PYR	64	21	21
CACTCCAAGCCCAATT-1_1_A9	-6.955511406	31.1785159	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1359	1985	0.016120907	0.00604534	11	oligos	OL-MS-2	64	21	21
CACTCCACACGTGAGA-1_1_A9	-20.35938861	11.88419234	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	922	1276	0.012539185	0.005485893	11	8	Astrocytes	64	21	21
CACTCCACATTATCTC-1_1_A9	32.49900656	4.69691107	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1232	1628	0.047911548	0.00982801	11	16	EN-PYR	64	21	21
CACTCCAGTATATGAG-1_1_A9	-8.129186185	-29.40065492	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	823	1059	0.033994334	0.005665722	11	16	EN-PYR	64	21	21
CACTCCAGTATCACCA-1_1_A9	-8.874843969	-27.73269325	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	989	1323	0.050642479	0.009070295	11	16	EN-PYR	64	21	21
CAGAATCAGCTAGCCC-1_1_A9	-17.89535843	10.07511562	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1009	1490	0.014765101	0.001342282	11	8	Astrocytes	64	21	21
CAGAATCAGGAATGGA-1_1_A9	-8.608707725	33.21290745	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1004	1390	0.028776978	0.005035971	11	oligos	OL-MS-2	64	21	21
CAGAATCAGGTACTCT-1_1_A9	31.01382345	-8.284251202	2	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4541	11844	0.00717663	0.006670044	11	2	EN-L4	64	21	21
CAGAATCCAACCGCCA-1_1_A9	-5.700080539	32.37589006	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1055	1538	0.014304291	0.00390117	11	oligos	OL-MS-2	64	21	21
CAGAATCCAAGGCTCC-1_1_A9	27.73245857	-24.87874952	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6307	25596	0.01539303	0.004180341	11	3	EN-L5-6	64	21	21
CAGAATCCAATGTTGC-1_1_A9	-25.76144619	-6.118136274	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1159	1836	0.005446623	0.003812636	11	9	OPC	64	21	21
CAGAATCCAGATCTGT-1_1_A9	-21.20145371	15.31180358	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1305	2062	0.009699321	0.006304559	11	8	Astrocytes	64	21	21
CAGAGAGAGGGTGTGT-1_1_A9	-24.16588002	-10.23250538	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	883	1141	0.014899211	0.013146363	11	9	OPC	64	21	21
CAGAGAGAGTATGACA-1_1_A9	27.72846288	-24.69644817	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6277	23444	0.008360348	0.004094864	11	3	EN-L5-6	64	21	21
CAGAGAGCAGTCGTGC-1_1_A9	-12.80001266	16.82089068	11	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1685	2751	0.01126863	0.003635042	11	11	Glia-MIX	64	21	21
CAGAGAGCATCGTCGG-1_1_A9	18.72801191	-31.9048324	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5513	17394	0.005921582	0.004426814	11	3	EN-L5-6	64	21	21
CAGAGAGCATGCGCAC-1_1_A9	-8.115268048	-27.05390663	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	840	1072	0.052238806	0.012126866	11	16	EN-PYR	64	21	21
CAGAGAGCATGGGAAC-1_1_A9	24.91433823	-19.358487	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5222	13386	0.015015688	0.009935754	11	3	EN-L5-6	64	21	21
CAGAGAGTCCCAACGG-1_1_A9	-25.75055568	-7.751837251	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1054	1524	0.00984252	0.003937008	11	9	OPC	64	21	21
CAGAGAGTCTTCAACT-1_1_A9	-18.44293783	-7.956433561	13B	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3536	7996	0.00837919	0.00837919	11	13B	IN-SV2C	64	21	21
CAGATCAAGTTTCCTT-1_1_A9	-15.67688293	11.30245688	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1527	2436	0.013957307	0.003284072	11	8	Astrocytes	64	21	21
CAGATCACAGCCAGAA-1_1_A9	20.43785362	-33.39482101	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4690	12356	0.005017805	0.010683069	11	3	EN-L5-6	64	21	21
CAGATCATCGTTGCCT-1_1_A9	7.248004593	-10.19652799	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1962	4081	0.015437393	0.007106101	11	L2-3	EN-L2-3-MS	64	21	21
CAGCAGCAGGATTCGG-1_1_A9	-4.762026471	34.95127686	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	820	1148	0.013937282	0.004355401	11	oligos	OL-MS-2	64	21	21
CAGCAGCCACCTCGTT-1_1_A9	-4.238257133	32.60825107	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	991	1445	0.015916955	0.006920415	11	oligos	OL-MS-2	64	21	21
CAGCAGCCACTAGTAC-1_1_A9	-8.115627269	-27.54574315	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	812	1069	0.039289055	0.009354537	11	16	EN-PYR	64	21	21
CAGCAGCCAGCGTCCA-1_1_A9	-10.84919954	31.95786743	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	950	1255	0.027091633	0.00876494	11	oligos	OL-MS-2	64	21	21
CAGCAGCCAGGTCCAC-1_1_A9	-22.90570102	-16.24728944	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6192	20116	0.019238417	0.006561941	11	6A	IN-PV	64	21	21
CAGCAGCCATTCTCAT-1_1_A9	-8.230294411	34.39401996	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	909	1254	0.011961722	0.007974482	11	oligos	OL-MS-2	64	21	21
CAGCAGCGTAAGTGTA-1_1_A9	19.67447492	-31.22702469	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6093	19820	0.011301715	0.006710394	11	3	EN-L5-6	64	21	21
CAGCAGCGTCAGGACA-1_1_A9	-15.72323142	-5.156273319	13A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4976	12718	0.017534203	0.005661267	11	13A	IN-VIP	64	21	21
CAGCAGCGTCCGAAGA-1_1_A9	-15.42968384	-6.61635384	13A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5136	14982	0.007408891	0.005940462	11	13A	IN-VIP	64	21	21
CAGCAGCGTGATGTCT-1_1_A9	-24.5852913	-12.16093111	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1015	1651	0.010902483	0.004845548	11	9	OPC	64	21	21
CAGCAGCGTTATCCGA-1_1_A9	-5.141335027	32.43587591	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1015	1436	0.01183844	0.005571031	11	oligos	OL-MS-2	64	21	21
CAGCAGCTCATCACCC-1_1_A9	7.33227345	1.623660653	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1032	1340	0.030597015	0.018656716	11	16	EN-PYR	64	21	21
CAGCAGCTCCTTAATC-1_1_A9	-10.81470252	22.21182415	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2414	4257	0.005637773	0.006812309	11	8	Astrocytes	64	21	21
CAGCATAAGAACAATC-1_1_A9	18.7500485	-31.52592749	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5826	19668	0.005796217	0.003609925	11	3	EN-L5-6	64	21	21
CAGCATAAGAGATGAG-1_1_A9	-15.85172894	-6.625134391	13A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1968	3370	0.013946588	0.005341246	11	13A	IN-VIP	64	21	21
CAGCATAAGGGTTTCT-1_1_A9	-24.00975207	24.90778497	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1486	2484	0.007648953	0.005636071	11	8	Astrocytes	64	21	21
CAGCATAAGTTGCAGG-1_1_A9	-19.69862005	15.5486602	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1389	2255	0.006651885	0.009312639	11	8	Astrocytes	64	21	21
CAGCATACACCATCCT-1_1_A9	-9.343937832	-28.35917772	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1124	1720	0.135465116	0.004651163	11	16	EN-PYR	64	21	21
CAGCATACAGGATCGA-1_1_A9	-25.97107014	-7.41908558	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1126	1648	0.006067961	0.003033981	11	9	OPC	64	21	21
CAGCATAGTAGGGACT-1_1_A9	-24.20923461	-7.488139865	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1239	1805	0.021052632	0.007202216	11	9	OPC	64	21	21
CAGCATAGTGACTCAT-1_1_A9	-20.61963918	16.84420639	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1641	2817	0.007809727	0.006744764	11	8	Astrocytes	64	21	21
CAGCATAGTGGGTATG-1_1_A9	30.6035686	-9.213130346	2	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3754	9325	0.006112601	0.00847185	11	2	EN-L4	64	21	21
CAGCATAGTTACGTCA-1_1_A9	15.9272086	-27.5161004	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4199	11051	0.003529092	0.013482943	11	3	EN-L5-6	64	21	21
CAGCATAGTTCCATGA-1_1_A9	30.04326908	8.536456755	15DA	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	824	1012	0.015810277	0.023715415	11	15DA	T cells	64	21	21
CAGCATAGTTGAGTTC-1_1_A9	-11.72646936	-32.38803671	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	974	1411	0.046066619	0.008504607	11	16	EN-PYR	64	21	21
CAGCATATCATTATCC-1_1_A9	-11.84632968	30.73131235	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	846	1131	0.034482759	0.00795756	11	oligos	OL-MS-2	64	21	21
CAGCATATCGCATGGC-1_1_A9	18.74572444	-31.68864083	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5355	17699	0.006610543	0.004350528	11	3	EN-L5-6	64	21	21
CAGCCGAAGGTGACCA-1_1_A9	-16.22072662	-6.518696924	13A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4107	10197	0.010395214	0.005001471	11	13A	IN-VIP	64	21	21
CAGCCGACACCAACCG-1_1_A9	-8.677306891	33.80718908	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	870	1184	0.021959459	0.005067568	11	oligos	OL-MS-2	64	21	21
CAGCCGACACTTCTGC-1_1_A9	27.12227503	-15.40047681	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6938	24285	0.017871114	0.010088532	11	3	EN-L5-6	64	21	21
CAGCCGAGTACCGGCT-1_1_A9	-8.933295948	-29.93952244	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	949	1336	0.084580838	0.003742515	11	16	EN-PYR	64	21	21
CAGCCGATCTCGTTTA-1_1_A9	-5.835127105	30.92345996	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1332	2038	0.014229637	0.00686948	11	oligos	OL-MS-2	64	21	21
CAGCCGATCTGCGGCA-1_1_A9	-21.32765458	16.57738614	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1532	2710	0.006642066	0.003690037	11	8	Astrocytes	64	21	21
CAGCGACAGGACGAAA-1_1_A9	2.741785857	0.219031547	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1083	1456	0.024725275	0.012362637	11	16	EN-PYR	64	21	21
CAGCGACCACACCGAC-1_1_A9	4.166306506	1.104435742	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	913	1181	0.055038103	0.00592718	11	16	EN-PYR	64	21	21
CAGCGACCAGGCGATA-1_1_A9	-11.70276375	13.45557601	11	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1229	1702	0.022326675	0.005287897	11	11	Glia-MIX	64	21	21
CAGCGACCATGGTCAT-1_1_A9	-8.898538671	33.63604639	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	888	1183	0.023668639	0.005071851	11	oligos	OL-MS-2	64	21	21
CAGCGACGTCAATACC-1_1_A9	22.78516838	-19.15444062	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	8586	40479	0.028310976	0.0071148	11	3	EN-L5-6	64	21	21
CAGCGACTCCAGTATG-1_1_A9	-8.651532672	-30.69391719	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	859	1212	0.043729373	0.007425743	11	16	EN-PYR	64	21	21
CAGCTAAAGCTAAACA-1_1_A9	-23.55440192	-7.950294842	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1296	1849	0.018388318	0.005408329	11	9	OPC	64	21	21
CAGCTAAAGTGTACGG-1_1_A9	-19.68981134	13.26644463	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1205	1733	0.010386613	0.008078477	11	8	Astrocytes	64	21	21
CAGCTAACAGCGATCC-1_1_A9	-24.74779697	-10.48055497	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	834	1089	0.016528926	0.008264463	11	9	OPC	64	21	21
CAGCTAACATCACCCT-1_1_A9	-15.35568149	-5.254448039	13A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3721	8682	0.015434232	0.006680488	11	13A	IN-VIP	64	21	21
CAGCTAAGTAAACGCG-1_1_A9	27.59939697	-25.01305379	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6048	19729	0.008971565	0.003091895	11	3	EN-L5-6	64	21	21
CAGCTAAGTAGGCTGA-1_1_A9	22.80828278	-19.24645723	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	7363	28309	0.01974637	0.003603094	11	3	EN-L5-6	64	21	21
CAGCTAAGTATCGCAT-1_1_A9	-25.92011236	-23.86886809	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4183	10534	0.032751092	0.003037782	11	6A	IN-PV	64	21	21
CAGCTAAGTCACCTAA-1_1_A9	-9.330437746	-30.1440547	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1028	1483	0.066756575	0.009440324	11	16	EN-PYR	64	21	21
CAGCTAATCAGCGATT-1_1_A9	22.35463314	27.28443507	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1006	1518	0.015151515	0.004611331	11	oligos	OL-MS-2	64	21	21
CAGCTAATCGTTGACA-1_1_A9	23.04703071	-20.06268582	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5946	17894	0.010785738	0.006426735	11	3	EN-L5-6	64	21	21
CAGCTGGAGAAGAAGC-1_1_A9	-20.89697292	11.56710841	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1014	1560	0.008333333	0.005769231	11	8	Astrocytes	64	21	21
CAGCTGGAGTACGACG-1_1_A9	-10.25308296	32.39722283	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	838	1090	0.023853211	0.011926606	11	oligos	OL-MS-2	64	21	21
CAGCTGGCAATTGCTG-1_1_A9	28.35237219	-25.99387489	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5749	22002	0.002090719	0.00327243	11	3	EN-L5-6	64	21	21
CAGCTGGCACCAGATT-1_1_A9	-11.24006841	15.42980152	11	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1605	2418	0.006617039	0.009511993	11	11	Glia-MIX	64	21	21
CAGCTGGGTACGCACC-1_1_A9	20.3655263	-31.79088767	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	8303	38133	0.01132877	0.003540241	11	3	EN-L5-6	64	21	21
CAGCTGGGTATCAGTC-1_1_A9	-8.273039675	-30.1630909	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	962	1388	0.113832853	0.007204611	11	16	EN-PYR	64	21	21
CAGCTGGGTCTGCAAT-1_1_A9	5.314769748	-24.85995778	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6595	26984	0.005151201	0.004039431	11	L2-3	EN-L2-3-MS	64	21	21
CAGCTGGGTTATCGGT-1_1_A9	-26.06835378	-5.182989656	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1292	1940	0.009278351	0.015463918	11	9	OPC	64	21	21
CAGCTGGTCATTATCC-1_1_A9	-8.50944501	-28.13473717	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	902	1182	0.050761421	0.008460237	11	16	EN-PYR	64	21	21
CAGCTGGTCCTAGGGC-1_1_A9	22.02729055	-19.52083255	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5802	18002	0.017386957	0.008665704	11	3	EN-L5-6	64	21	21
CAGCTGGTCCTTAATC-1_1_A9	-4.203206489	32.19141383	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1052	1571	0.01145767	0.00700191	11	oligos	OL-MS-2	64	21	21
CAGCTGGTCTGGTGTA-1_1_A9	16.12363267	-24.92422875	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3873	9034	0.036417977	0.010294443	11	3	EN-L5-6	64	21	21
CAGGTGCAGTCGTTTG-1_1_A9	-20.38098037	16.91404153	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1741	2830	0.008127208	0.004946996	11	8	Astrocytes	64	21	21
CAGGTGCCACTTAACG-1_1_A9	3.669834566	0.966629629	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	979	1273	0.036135114	0.012568735	11	16	EN-PYR	64	21	21
CAGGTGCCAGATCTGT-1_1_A9	-7.607341767	-30.07014312	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	807	1019	0.044160942	0.008832188	11	16	EN-PYR	64	21	21
CAGGTGCCAGTAGAGC-1_1_A9	-23.4751726	-7.363665564	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1694	2664	0.021021021	0.00487988	11	9	OPC	64	21	21
CAGGTGCCATCATCCC-1_1_A9	-6.338539803	34.43857318	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	861	1164	0.01975945	0.006013746	11	oligos	OL-MS-2	64	21	21
CAGGTGCCATCGATGT-1_1_A9	5.360359939	-24.87519685	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5600	19108	0.003087712	0.003663387	11	L2-3	EN-L2-3-MS	64	21	21
CAGGTGCCATGCAACT-1_1_A9	-9.427854638	-30.64314503	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1005	1443	0.068607069	0.004851005	11	16	EN-PYR	64	21	21
CAGGTGCCATTTCACT-1_1_A9	1.985099158	5.057430415	14	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	980	1224	0.022058824	0.04248366	11	14	Microglia	64	21	21
CAGGTGCGTAGGACAC-1_1_A9	9.432127249	1.412279156	12	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	789	1229	0.007323027	0.006509357	11	12	EN-MIX	64	21	21
CAGGTGCGTTTAGGAA-1_1_A9	21.8805415	-19.957041	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6239	19505	0.012099462	0.004409126	11	3	EN-L5-6	64	21	21
CAGGTGCTCACCAGGC-1_1_A9	-8.146602533	-26.90431494	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	898	1167	0.024850043	0.00856898	11	16	EN-PYR	64	21	21
CAGGTGCTCCACGAAT-1_1_A9	-9.435178529	-30.49918339	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	928	1309	0.043544691	0.004583652	11	16	EN-PYR	64	21	21
CAGTAACAGACCTAGG-1_1_A9	-5.900371402	31.187849	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1239	1837	0.015786609	0.005443658	11	oligos	OL-MS-2	64	21	21
CAGTAACCAATCTGCA-1_1_A9	-9.160339207	-13.26518946	6B	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	811	1184	0.032939189	0.005067568	11	6B	IN-SST	64	21	21
CAGTAACCAATGGAGC-1_1_A9	-23.11050702	-8.649349375	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1434	2177	0.029857602	0.005052825	11	9	OPC	64	21	21
CAGTAACCAGACAAGC-1_1_A9	-8.900973376	-27.62742944	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	995	1348	0.056379822	0.002225519	11	16	EN-PYR	64	21	21
CAGTAACCAGCATACT-1_1_A9	3.8947493	0.893134801	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	911	1169	0.049615056	0.013686912	11	16	EN-PYR	64	21	21
CAGTAACCAGGTCTCG-1_1_A9	-10.08977112	33.31611847	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	738	1003	0.03888335	0.003988036	11	oligos	OL-MS-2	64	21	21
CAGTAACCATGTTCCC-1_1_A9	-24.06099847	-7.429528729	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1270	1771	0.013551666	0.005081875	11	9	OPC	64	21	21
CAGTAACCATTCTCAT-1_1_A9	4.025243505	0.947057524	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	890	1158	0.050949914	0.006908463	11	16	EN-PYR	64	21	21
CAGTAACGTAAGTTCC-1_1_A9	19.19167662	-33.95755755	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5779	20470	0.006741573	0.004152418	11	3	EN-L5-6	64	21	21
CAGTAACGTAGCTAAA-1_1_A9	-8.775283461	31.67418085	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1095	1478	0.01826793	0.00338295	11	oligos	OL-MS-2	64	21	21
CAGTAACGTCACCCAG-1_1_A9	-8.036676217	35.09447568	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	809	1044	0.018199234	0.000957854	11	oligos	OL-MS-2	64	21	21
CAGTAACGTCTCAACA-1_1_A9	7.432997765	-23.15272305	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5117	14503	0.012273323	0.005378198	11	L2-3	EN-L2-3-MS	64	21	21
CAGTAACTCAGAGACG-1_1_A9	-6.195593537	35.88848815	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	746	1016	0.012795276	0.00492126	11	oligos	OL-MS-2	64	21	21
CAGTAACTCATCATTC-1_1_A9	-10.11773954	33.0959979	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	759	1012	0.030632411	0.004940711	11	oligos	OL-MS-2	64	21	21
CAGTAACTCCTGTACC-1_1_A9	33.51800084	7.329133687	14	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1050	1383	0.028922632	0.015907448	11	14	Microglia	64	21	21
CAGTCCTAGACCTAGG-1_1_A9	-1.218760505	33.42169026	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	846	1238	0.011308562	0.004846527	11	oligos	OL-MS-2	64	21	21
CAGTCCTAGATATGGT-1_1_A9	-20.48554537	-18.20747463	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4062	10869	0.006900359	0.003496182	11	6A	IN-PV	64	21	21
CAGTCCTAGGCGACAT-1_1_A9	23.11654388	26.37083926	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1177	1893	0.00792393	0.00528262	11	oligos	OL-MS-2	64	21	21
CAGTCCTAGTGTTAGA-1_1_A9	-15.25688551	7.938342849	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1047	1438	0.027121001	0.005563282	11	8	Astrocytes	64	21	21
CAGTCCTCAAGGCTCC-1_1_A9	-18.17290451	-8.258321541	13B	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3782	8861	0.010721138	0.006771245	11	13B	IN-SV2C	64	21	21
CAGTCCTCAATCACAC-1_1_A9	-12.53543807	-32.58971731	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1412	2297	0.092294297	0.013060514	11	16	EN-PYR	64	21	21
CAGTCCTGTGGCTCCA-1_1_A9	-11.41740137	29.24388901	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1308	1857	0.017770598	0.005923533	11	oligos	OL-MS-2	64	21	21
CAGTCCTTCCCAAGAT-1_1_A9	-27.88111086	4.245209603	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1909	3236	0.006798517	0.002163164	11	9	OPC	64	21	21
CAGTCCTTCCTCCTAG-1_1_A9	-18.5841239	14.65520696	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2120	3613	0.019097703	0.008856906	11	8	Astrocytes	64	21	21
CAGTCCTTCCTTCAAT-1_1_A9	-8.307454458	-27.50585202	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	887	1228	0.085504886	0.009771987	11	16	EN-PYR	64	21	21
CAGTCCTTCTCAAACG-1_1_A9	-5.495287804	34.88777278	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	809	1073	0.020503262	0.006523765	11	oligos	OL-MS-2	64	21	21
CATATGGCATACTCTT-1_1_A9	-6.479224351	33.68956354	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	935	1356	0.022861357	0.002949853	11	oligos	OL-MS-2	64	21	21
CATATGGCATATACCG-1_1_A9	-8.888553361	-27.57455149	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	982	1314	0.040334855	0.00456621	11	16	EN-PYR	64	21	21
CATATGGCATGGGAAC-1_1_A9	-19.69779054	14.53237728	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1417	2227	0.017512348	0.002694207	11	8	Astrocytes	64	21	21
CATATGGGTTCAACCA-1_1_A9	-17.23760435	-8.250523593	13B	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2769	5510	0.012704174	0.003448276	11	13B	IN-SV2C	64	21	21
CATATGGTCCATTCTA-1_1_A9	22.2409922	26.81935511	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	960	1439	0.013898541	0.001389854	11	oligos	OL-MS-2	64	21	21
CATATGGTCGTAGGAG-1_1_A9	17.42260988	-10.11042472	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2076	3531	0.002265647	0.017558765	11	3	EN-L5-6	64	21	21
CATATTCAGGAGCGTT-1_1_A9	-22.8070764	-16.13045476	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4792	12084	0.01795763	0.005958292	11	6A	IN-PV	64	21	21
CATATTCAGTAAGTAC-1_1_A9	27.97382062	-6.011061954	2	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4379	12473	0.006093161	0.008097491	11	2	EN-L4	64	21	21
CATATTCCATACGCCG-1_1_A9	-19.84475052	15.93534261	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1472	2374	0.00968829	0.00252738	11	8	Astrocytes	64	21	21
CATATTCCATCCCATC-1_1_A9	-13.81081803	-34.37536374	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1857	3526	0.034316506	0.006239365	11	16	EN-PYR	64	21	21
CATATTCCATGCTAGT-1_1_A9	18.97079651	8.531410363	1	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1789	3254	0.007068224	0.004302397	11	oligos	OL-Cntl	64	21	21
CATATTCGTAGGACAC-1_1_A9	4.971541756	-24.3170648	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4160	11484	0.006182515	0.004266806	11	L2-3	EN-L2-3-MS	64	21	21
CATATTCGTCCGTCAG-1_1_A9	28.05762428	-25.97060953	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5548	20935	0.011129687	0.001910676	11	3	EN-L5-6	64	21	21
CATATTCGTGAGGGTT-1_1_A9	-23.34015381	-7.206296598	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1757	2890	0.013148789	0.008650519	11	9	OPC	64	21	21
CATATTCGTTGTACAC-1_1_A9	-20.05724206	-18.13086064	6B	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3431	9129	0.011939972	0.001643115	11	6B	IN-SST	64	21	21
CATATTCTCAATCTCT-1_1_A9	-23.90850695	-9.620450667	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	972	1352	0.022189349	0.005177515	11	9	OPC	64	21	21
CATATTCTCATTGCGA-1_1_A9	-7.397196465	33.36928634	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	905	1253	0.019952115	0.008778931	11	oligos	OL-MS-2	64	21	21
CATATTCTCCTACAGA-1_1_A9	-9.222361563	18.80807815	11	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3300	6877	0.00450778	0.003780718	11	11	Glia-MIX	64	21	21
CATATTCTCGCATGAT-1_1_A9	-22.3038996	-19.68518592	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3343	7949	0.029815071	0.004277268	11	6A	IN-PV	64	21	21
CATCAAGAGAGGTTAT-1_1_A9	-20.45413972	18.79601227	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2143	3733	0.00750067	0.005625502	11	8	Astrocytes	64	21	21
CATCAAGCAACTTGAC-1_1_A9	7.64387618	-22.89652394	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5148	14879	0.016130116	0.009946905	11	L2-3	EN-L2-3-MS	64	21	21
CATCAAGCACGGTAAG-1_1_A9	-10.79438461	-27.57869652	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1129	1617	0.079777365	0.010513296	11	16	EN-PYR	64	21	21
CATCAAGCACGTCTCT-1_1_A9	-22.84919529	-16.29337159	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4377	11104	0.025216138	0.003242075	11	6A	IN-PV	64	21	21
CATCAAGCAGCTCGCA-1_1_A9	-6.227585194	35.58753591	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	790	1023	0.019550342	0.00684262	11	oligos	OL-MS-2	64	21	21
CATCAAGGTCAAAGCG-1_1_A9	-11.60906924	30.52500857	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	906	1174	0.022998296	0.010221465	11	oligos	OL-MS-2	64	21	21
CATCAAGGTCATGCAT-1_1_A9	4.386729466	1.152443323	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	994	1383	0.039768619	0.005061461	11	16	EN-PYR	64	21	21
CATCAAGGTCGCGTGT-1_1_A9	26.94255493	-25.9153975	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4572	12964	0.004859611	0.004011108	11	3	EN-L5-6	64	21	21
CATCAAGGTCGCTTTC-1_1_A9	-18.05349056	9.724944348	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	925	1369	0.011687363	0.002191381	11	8	Astrocytes	64	21	21
CATCAAGTCCGCGTTT-1_1_A9	26.39691552	-22.93317471	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5063	16443	0.027245636	0.00237183	11	3	EN-L5-6	64	21	21
CATCAGAAGATGCCAG-1_1_A9	-18.84080421	14.81944349	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1751	2946	0.012559403	0.003733876	11	8	Astrocytes	64	21	21
CATCAGAAGCCTCGTG-1_1_A9	29.20052145	-6.601904503	2	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4266	10648	0.006667919	0.007231405	11	2	EN-L4	64	21	21
CATCAGAGTAAACCTC-1_1_A9	21.52146615	-20.11516363	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6042	19334	0.010241026	0.002948174	11	3	EN-L5-6	64	21	21
CATCAGAGTACCAGTT-1_1_A9	-25.88636074	-7.222325548	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1005	1493	0.010716678	0.005358339	11	9	OPC	64	21	21
CATCAGAGTACCTACA-1_1_A9	-9.494553662	-30.2604715	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	955	1349	0.041512231	0.008154188	11	16	EN-PYR	64	21	21
CATCAGATCGTTACAG-1_1_A9	-12.93729056	-1.959404631	13A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2903	5784	0.004322268	0.008644537	11	13A	IN-VIP	64	21	21
CATCCACAGCCAGTTT-1_1_A9	20.08536687	-31.67896046	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	8295	39061	0.00729628	0.004761783	11	3	EN-L5-6	64	21	21
CATCCACAGGAGTTTA-1_1_A9	-9.980945471	-27.36710575	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	976	1354	0.074593796	0.008862629	11	16	EN-PYR	64	21	21
CATCCACAGTGACATA-1_1_A9	-20.42393672	18.52505886	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2635	5100	0.008235294	0.003137255	11	8	Astrocytes	64	21	21
CATCCACCACGAAAGC-1_1_A9	-4.821318473	32.80526057	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	991	1399	0.0192995	0.002859185	11	oligos	OL-MS-2	64	21	21
CATCCACCAGACAGGT-1_1_A9	-8.513854773	33.57181664	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	865	1166	0.016295026	0.003430532	11	oligos	OL-MS-2	64	21	21
CATCCACGTACCAGTT-1_1_A9	-13.76593664	-34.2701507	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1919	3502	0.080239863	0.009708738	11	16	EN-PYR	64	21	21
CATCCACGTAGGCTGA-1_1_A9	6.071228778	-24.01374754	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5941	20526	0.005407776	0.004433402	11	L2-3	EN-L2-3-MS	64	21	21
CATCCACTCACCACCT-1_1_A9	-23.48627524	-9.237030092	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1300	1822	0.023600439	0.006037322	11	9	OPC	64	21	21
CATCGAAAGATCTGCT-1_1_A9	16.07069157	-18.93605343	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6452	22064	0.018944888	0.007025018	11	L2-3	EN-L2-3-MS	64	21	21
CATCGAAAGTCTCAAC-1_1_A9	-7.502347936	-30.34668304	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	810	1098	0.084699454	0.015482696	11	16	EN-PYR	64	21	21
CATCGAACAACCGCCA-1_1_A9	-9.217211412	-27.83110861	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1128	1688	0.065165877	0.004739336	11	16	EN-PYR	64	21	21
CATCGAACAAGTCTAC-1_1_A9	-9.228171081	-30.19273933	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	997	1359	0.049300957	0.008094187	11	16	EN-PYR	64	21	21
CATCGAACATCGATGT-1_1_A9	-25.62835988	-10.96324258	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	928	1286	0.013219285	0.037325039	11	9	OPC	64	21	21
CATCGAACATCTCCCA-1_1_A9	4.108073036	0.219214122	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1239	1725	0.060289855	0.012753623	11	16	EN-PYR	64	21	21
CATCGAAGTATATGAG-1_1_A9	5.18215133	-24.21701604	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5675	18660	0.003215434	0.003697749	11	L2-3	EN-L2-3-MS	64	21	21
CATCGAAGTCTAGAGG-1_1_A9	1.936248883	6.960514482	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	848	1142	0.010507881	0.006129597	11	oligos	OL-MS-2	64	21	21
CATCGAAGTTCGCTAA-1_1_A9	27.8921292	-24.5400871	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5841	19331	0.008690704	0.003310744	11	3	EN-L5-6	64	21	21
CATCGAAGTTGCGTTA-1_1_A9	-21.01150961	15.70295937	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1377	2202	0.00862852	0.003633061	11	8	Astrocytes	64	21	21
CATCGAATCAGTCAGT-1_1_A9	-24.26581429	-8.529227082	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1184	1683	0.021984551	0.008912656	11	9	OPC	64	21	21
CATCGGGAGATCCCAT-1_1_A9	6.556515579	-13.76888857	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3127	6906	0.011873733	0.007095279	11	L2-3	EN-L2-3-MS	64	21	21
CATCGGGAGCTCTCGG-1_1_A9	-6.406424458	32.18338419	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1077	1567	0.028717294	0.003828973	11	oligos	OL-MS-2	64	21	21
CATCGGGCAAGTCTAC-1_1_A9	33.52440026	7.260042003	14	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	796	1040	0.043269231	0.011538462	11	14	Microglia	64	21	21
CATCGGGCACGAAGCA-1_1_A9	-8.827078519	-30.51860599	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	883	1187	0.027801179	0.00758214	11	16	EN-PYR	64	21	21
CATCGGGCATACTACG-1_1_A9	-18.74143739	17.56223141	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1886	3337	0.006892418	0.005693737	11	8	Astrocytes	64	21	21
CATCGGGCATTCGACA-1_1_A9	-20.7284556	15.59242524	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1432	2287	0.011805859	0.003060778	11	8	Astrocytes	64	21	21
CATCGGGTCCAAATGC-1_1_A9	-21.82484086	12.02077383	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	919	1322	0.008320726	0.006807867	11	8	Astrocytes	64	21	21
CATGACAAGAGTGACC-1_1_A9	-9.195394317	-31.44771454	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	907	1276	0.047805643	0.014890282	11	16	EN-PYR	64	21	21
CATGACAAGTCAATAG-1_1_A9	-7.281491076	-31.36727254	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	838	1124	0.059608541	0.008007117	11	16	EN-PYR	64	21	21
CATGACAAGTCTCGGC-1_1_A9	-11.87304139	32.03394693	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	968	1268	0.018138801	0.003943218	11	oligos	OL-MS-2	64	21	21
CATGACACACACCGCA-1_1_A9	-18.73197358	14.85291611	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2059	3409	0.014080375	0.004693458	11	8	Astrocytes	64	21	21
CATGACACAGATCCAT-1_1_A9	-11.65294443	-31.37174916	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1373	2108	0.103889943	0.008064516	11	16	EN-PYR	64	21	21
CATGACACAGCTCCGA-1_1_A9	-18.70042462	-8.493656307	13B	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4022	9956	0.015568501	0.005524307	11	13B	IN-SV2C	64	21	21
CATGACACAGGCGATA-1_1_A9	-16.26031857	-6.739463656	13A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2559	4530	0.030684327	0.005518764	11	13A	IN-VIP	64	21	21
CATGACAGTCAGGACA-1_1_A9	-18.72599024	14.93912199	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1972	3043	0.01610253	0.008872823	11	8	Astrocytes	64	21	21
CATGACATCACCATAG-1_1_A9	28.35803362	-25.41273883	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6916	28755	0.00535559	0.002608242	11	3	EN-L5-6	64	21	21
CATGACATCAGCAACT-1_1_A9	4.634938047	1.374457096	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	875	1137	0.054529464	0.00703606	11	16	EN-PYR	64	21	21
CATGACATCTATCCTA-1_1_A9	3.951142532	1.481106979	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	740	1057	0.138126774	0.016083254	11	16	EN-PYR	64	21	21
CATGCCTAGAATTGTG-1_1_A9	-4.292056517	36.23590722	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	740	1016	0.018700787	0.00984252	11	oligos	OL-MS-2	64	21	21
CATGCCTAGATGGCGT-1_1_A9	-22.85441155	-16.13187503	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5395	15063	0.018256655	0.005111864	11	6A	IN-PV	64	21	21
CATGCCTAGTGTACCT-1_1_A9	-12.62696685	-13.88562739	6B	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1623	2798	0.018942102	0.001072194	11	6B	IN-SST	64	21	21
CATGCCTCAAAGGTGC-1_1_A9	-7.499653338	-28.32331469	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	831	1098	0.071038251	0.009107468	11	16	EN-PYR	64	21	21
CATGCCTCACGAGAGT-1_1_A9	22.57806671	-18.40939561	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6397	20370	0.009769269	0.007412862	11	3	EN-L5-6	64	21	21
CATGCCTCAGCTGTTA-1_1_A9	19.19392366	-22.81654684	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6308	19979	0.011011562	0.034736473	11	3	EN-L5-6	64	21	21
CATGCCTCATCGGAAG-1_1_A9	-20.77275769	14.06107159	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1353	1982	0.008072654	0.00554995	11	8	Astrocytes	64	21	21
CATGCCTCATTCGACA-1_1_A9	-23.7378457	-7.397452267	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1400	2108	0.012808349	0.00711575	11	9	OPC	64	21	21
CATGCCTGTGGTAACG-1_1_A9	30.27988962	-7.702561723	2	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4415	11238	0.004805125	0.006851753	11	2	EN-L4	64	21	21
CATGCCTTCTTCTGGC-1_1_A9	-26.05710346	-7.023638929	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1106	1582	0.008217446	0.008849558	11	9	OPC	64	21	21
CATGGCGAGGCGACAT-1_1_A9	-6.293130508	35.24023684	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	793	1128	0.022163121	0.00177305	11	oligos	OL-MS-2	64	21	21
CATGGCGAGGTAGCTG-1_1_A9	24.8949534	-19.99205192	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6402	21877	0.019426795	0.006033734	11	3	EN-L5-6	64	21	21
CATGGCGAGTAGTGCG-1_1_A9	-8.953555589	-31.87177498	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	846	1230	0.044715447	0.003252033	11	16	EN-PYR	64	21	21
CATGGCGCAAGAAAGG-1_1_A9	-20.77307101	16.4212769	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1486	2432	0.008634868	0.006990132	11	8	Astrocytes	64	21	21
CATGGCGCACATGGGA-1_1_A9	5.104531491	1.749469834	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	864	1072	0.043843284	0.009328358	11	16	EN-PYR	64	21	21
CATGGCGCACGGTAAG-1_1_A9	10.7839293	-2.426979075	12	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1440	2494	0.022854852	0.01042502	11	12	EN-MIX	64	21	21
CATGGCGCATCGATTG-1_1_A9	7.477523626	-22.02713086	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5453	16076	0.007340134	0.013684996	11	L2-3	EN-L2-3-MS	64	21	21
CATGGCGGTAATTGGA-1_1_A9	-26.30386149	-9.368898832	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	876	1253	0.014365523	0.002394254	11	9	OPC	64	21	21
CATGGCGGTGAGGGTT-1_1_A9	11.36095099	-28.94695413	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5985	19676	0.003710104	0.004065867	11	3	EN-L5-6	64	21	21
CATGGCGGTGTAATGA-1_1_A9	22.52175748	-18.6349514	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6229	18879	0.017903491	0.007203771	11	3	EN-L5-6	64	21	21
CATGGCGGTGTCGCTG-1_1_A9	18.43752627	-9.328589463	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2549	6019	0.007642466	0.005814919	11	3	EN-L5-6	64	21	21
CATTATCAGAAGGGTA-1_1_A9	17.36534448	-7.722814423	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1761	3130	0.005750799	0.000638978	11	3	EN-L5-6	64	21	21
CATTATCAGGAGTTGC-1_1_A9	-21.68106098	-16.39606616	6B	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2769	5670	0.017283951	0.008289242	11	6B	IN-SST	64	21	21
CATTATCAGGGCTCTC-1_1_A9	-1.96858265	31.44176302	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	876	1253	0.007980846	0.001596169	11	oligos	OL-MS-2	64	21	21
CATTATCCACAGGTTT-1_1_A9	-18.14498808	9.650157369	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	872	1233	0.01216545	0.01054339	11	8	Astrocytes	64	21	21
CATTATCGTGTAACGG-1_1_A9	22.90932116	-19.03108665	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	7899	34271	0.018820577	0.003764115	11	3	EN-L5-6	64	21	21
CATTATCGTTACTGAC-1_1_A9	-2.983612173	33.76970038	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	936	1353	0.015521064	0.00443459	11	oligos	OL-MS-2	64	21	21
CATTATCGTTCTGTTT-1_1_A9	-2.082461639	35.80142456	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	780	1101	0.007266122	0.007266122	11	oligos	OL-MS-2	64	21	21
CATTATCTCACCATAG-1_1_A9	-25.00334829	-7.174077975	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1120	1643	0.008520998	0.002434571	11	9	OPC	64	21	21
CATTCGCAGTCTCGGC-1_1_A9	5.321418045	-23.32729796	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6137	21722	0.002946322	0.008977074	11	L2-3	EN-L2-3-MS	64	21	21
CATTCGCCACTGTCGG-1_1_A9	-27.29440247	4.48157426	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3599	7727	0.004917821	0.008800311	11	8	Astrocytes	64	21	21
CATTCGCGTCGCATAT-1_1_A9	-11.09704758	31.48892174	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1087	1493	0.036168788	0.006697924	11	oligos	OL-MS-2	64	21	21
CATTCGCGTCGGCACT-1_1_A9	19.82682124	-34.04939716	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4982	15348	0.005994266	0.00951264	11	3	EN-L5-6	64	21	21
CATTCGCGTCGGCTCA-1_1_A9	-18.71580532	8.841243484	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	804	1212	0.018976898	0.00660066	11	8	Astrocytes	64	21	21
CATTCGCGTTTGTTTC-1_1_A9	5.209597949	-23.6296575	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4977	14467	0.005184212	0.006635792	11	L2-3	EN-L2-3-MS	64	21	21
CATTCGCTCACCATAG-1_1_A9	-24.95921507	-5.57598089	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1368	2103	0.007608179	0.009034712	11	9	OPC	64	21	21
CATTCGCTCACCTTAT-1_1_A9	24.4451071	-24.31925927	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4049	11199	0.007232789	0.005357621	11	3	EN-L5-6	64	21	21
CATTCGCTCATCGATG-1_1_A9	-25.34415675	-10.1871361	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	941	1254	0.010366826	0.012759171	11	9	OPC	64	21	21
CATTCGCTCCTTTCGG-1_1_A9	-7.407307912	-30.82524627	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	829	1167	0.078834619	0.005141388	11	16	EN-PYR	64	21	21
CCAATCCAGACCTTTG-1_1_A9	-22.40930382	-15.86870751	6B	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4018	10137	0.022787807	0.002860807	11	6B	IN-SST	64	21	21
CCAATCCAGACTAGGC-1_1_A9	-14.76372238	10.04142213	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1560	2508	0.007974482	0.002791069	11	8	Astrocytes	64	21	21
CCAATCCAGGGTATCG-1_1_A9	5.101497948	1.752867419	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	799	1091	0.087992667	0.006416132	11	16	EN-PYR	64	21	21
CCAATCCCATCCTTGC-1_1_A9	-19.87467119	16.00289925	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1684	2712	0.009587021	0.003318584	11	8	Astrocytes	64	21	21
CCAATCCGTAGCCTCG-1_1_A9	-18.76975853	10.70470686	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	792	1046	0.018164436	0.003824092	11	8	Astrocytes	64	21	21
CCAATCCGTCACCCAG-1_1_A9	-13.13814331	15.77924394	11	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1308	1892	0.014799154	0.008985201	11	11	Glia-MIX	64	21	21
CCAATCCGTCTCGTTC-1_1_A9	-21.17217786	-16.53040659	6B	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3367	8102	0.011478647	0.002838805	11	6B	IN-SST	64	21	21
CCAATCCGTCTTCTCG-1_1_A9	-27.820608	4.262664388	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2048	3487	0.006309148	0.01089762	11	9	OPC	64	21	21
CCAATCCGTGTAACGG-1_1_A9	-2.668403095	32.0947764	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	959	1384	0.011560694	0.00216763	11	oligos	OL-MS-2	64	21	21
CCAATCCGTTGCGTTA-1_1_A9	-24.01889513	-2.32142485	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1304	1892	0.022727273	0.007399577	11	oligos	OL-MS-2	64	21	21
CCAATCCTCGCATGAT-1_1_A9	-24.35289447	-6.278685589	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1373	2129	0.013621419	0.002818225	11	9	OPC	64	21	21
CCACCTAAGCCAACAG-1_1_A9	-24.28296652	0.362509868	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2690	4479	0.010046885	0.004018754	11	9	OPC	64	21	21
CCACCTAAGTACGATA-1_1_A9	-9.665024344	-29.96260881	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	996	1409	0.070262598	0.005677786	11	16	EN-PYR	64	21	21
CCACCTAAGTAGATGT-1_1_A9	-6.487953587	-30.8187213	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	850	1170	0.094871795	0.014529915	11	16	EN-PYR	64	21	21
CCACCTACAACTGCTA-1_1_A9	24.33668098	-25.18817965	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3249	8068	0.006197323	0.003222608	11	3	EN-L5-6	64	21	21
CCACCTACAAGGACAC-1_1_A9	-12.56976249	-31.80956781	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1446	2261	0.048651039	0.008845644	11	16	EN-PYR	64	21	21
CCACCTACAGTAAGCG-1_1_A9	-20.22326241	-16.36527151	6B	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2645	4902	0.016523868	0.002039984	11	6B	IN-SST	64	21	21
CCACCTAGTCAATACC-1_1_A9	18.8937728	-34.51606585	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3959	11604	0.006980352	0.00275767	11	3	EN-L5-6	64	21	21
CCACCTAGTCTAAACC-1_1_A9	21.27607088	-20.06709213	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5807	18816	0.011054422	0.008290816	11	L2-3	EN-L2-3-MS	64	21	21
CCACCTATCAGCCTAA-1_1_A9	-12.27569625	-32.09759407	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1330	1993	0.058705469	0.009031611	11	16	EN-PYR	64	21	21
CCACCTATCATCACCC-1_1_A9	-9.944348945	32.48194565	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	827	1055	0.025592417	0.005687204	11	oligos	OL-MS-2	64	21	21
CCACCTATCGCACTCT-1_1_A9	4.861894918	1.611303876	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	988	1289	0.056633049	0.009309542	11	16	EN-PYR	64	21	21
CCACGGACAAGCGCTC-1_1_A9	-9.155287992	-31.70265585	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	880	1176	0.022108844	0.016156463	11	16	EN-PYR	64	21	21
CCACGGACACCCATGG-1_1_A9	-24.5940913	-6.802252658	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1326	1894	0.012143611	0.004223865	11	9	OPC	64	21	21
CCACGGACACTTCTGC-1_1_A9	-6.120764096	31.09500348	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1345	2091	0.014825442	0.003347681	11	oligos	OL-MS-2	64	21	21
CCACGGACATCACGAT-1_1_A9	-11.23881387	30.8652243	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1078	1465	0.034812287	0.004778157	11	oligos	OL-MS-2	64	21	21
CCACGGATCACAATGC-1_1_A9	-6.091195378	34.46299929	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	828	1119	0.011617516	0.00357462	11	oligos	OL-MS-2	64	21	21
CCACGGATCAGGCGAA-1_1_A9	-24.85391167	-7.27020915	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1163	1686	0.015421115	0.004744958	11	9	OPC	64	21	21
CCACTACAGCCACCTG-1_1_A9	2.128675675	5.895056738	7	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1605	2276	0.015817223	0.00659051	11	7	Phagocytes	64	21	21
CCACTACCAAATACAG-1_1_A9	4.484340116	0.092033496	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1328	1815	0.038016529	0.00661157	11	16	EN-PYR	64	21	21
CCACTACCACTTCTGC-1_1_A9	3.648299931	0.461795425	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	987	1407	0.123667377	0.010660981	11	16	EN-PYR	64	21	21
CCACTACGTTAAGACA-1_1_A9	5.996177201	-24.51746094	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6192	21851	0.008832548	0.003935747	11	L2-3	EN-L2-3-MS	64	21	21
CCACTACTCAGGTTCA-1_1_A9	-8.462920034	-27.45906107	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	890	1157	0.039757995	0.008643042	11	16	EN-PYR	64	21	21
CCACTACTCATTCACT-1_1_A9	-9.026080391	32.88197153	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1018	1432	0.018854749	0.007681564	11	oligos	OL-MS-2	64	21	21
CCACTACTCTCTGAGA-1_1_A9	-9.439567981	31.09638632	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1172	1606	0.02739726	0.006849315	11	oligos	OL-MS-2	64	21	21
CCACTACTCTGGTTCC-1_1_A9	20.46515666	-24.15913927	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5349	15125	0.008528926	0.007603306	11	3	EN-L5-6	64	21	21
CCAGCGAAGGGTCGAT-1_1_A9	-25.25571406	-8.876859216	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1141	1601	0.011867583	0.018738289	11	9	OPC	64	21	21
CCAGCGACAAGGACTG-1_1_A9	7.245508839	-24.89129196	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	8731	39618	0.008809127	0.00504821	11	L2-3	EN-L2-3-MS	64	21	21
CCAGCGACATGTCTCC-1_1_A9	-8.609943096	34.70688688	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	777	1018	0.031434185	0.010805501	11	oligos	OL-MS-2	64	21	21
CCAGCGATCACCACCT-1_1_A9	4.821538995	1.59054637	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	911	1186	0.05227656	0.015177066	11	16	EN-PYR	64	21	21
CCAGCGATCTGCGTAA-1_1_A9	21.07570817	12.82995845	1	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1775	3098	0.013557134	0.004519045	11	oligos	OL-Cntl	64	21	21
CCATGTCAGATACACA-1_1_A9	-11.52936629	31.73234913	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1070	1458	0.030178326	0.004115226	11	oligos	OL-MS-2	64	21	21
CCATGTCAGGCCGAAT-1_1_A9	-7.427185007	33.66126389	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	961	1313	0.014470678	0.006092917	11	oligos	OL-MS-2	64	21	21
CCATGTCAGGTGTGGT-1_1_A9	-20.35128813	15.4425045	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1362	2157	0.010199351	0.003245248	11	8	Astrocytes	64	21	21
CCATGTCAGTGTACTC-1_1_A9	-0.215874884	35.27674805	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	853	1146	0.012216405	0.005235602	11	oligos	OL-MS-2	64	21	21
CCATGTCCAAGTTAAG-1_1_A9	28.21988382	-25.64129454	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6018	21209	0.006176623	0.002593239	11	3	EN-L5-6	64	21	21
CCATGTCCACGAAGCA-1_1_A9	-16.5606453	-15.75978399	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1768	2943	0.058103976	0.001698947	11	6A	IN-PV	64	21	21
CCATGTCCAGTATGCT-1_1_A9	-24.23698009	-6.338604732	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1533	2270	0.012334802	0.004845815	11	9	OPC	64	21	21
CCATGTCCATACCATG-1_1_A9	-9.052050663	-30.07239278	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	978	1334	0.036731634	0.006746627	11	16	EN-PYR	64	21	21
CCATGTCCATCACGAT-1_1_A9	-8.81544768	-27.63621293	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1065	1571	0.103119032	0.010821133	11	16	EN-PYR	64	21	21
CCATGTCGTCCCTACT-1_1_A9	33.2813539	5.343331121	14	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	816	1106	0.033453888	0.01084991	11	14	Microglia	64	21	21
CCATGTCGTGGCTCCA-1_1_A9	26.43202356	-22.97313056	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	7428	29950	0.010183639	0.00427379	11	3	EN-L5-6	64	21	21
CCATGTCTCCTCAATT-1_1_A9	-9.313635874	-28.93303359	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1050	1466	0.082537517	0.013642565	11	16	EN-PYR	64	21	21
CCATTCGAGAAACGAG-1_1_A9	-11.7839391	-14.85741848	6B	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1135	1747	0.026330853	0.005151689	11	6B	IN-SST	64	21	21
CCATTCGAGAACAATC-1_1_A9	-11.11229322	-31.83930469	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1194	1873	0.093432995	0.005872931	11	16	EN-PYR	64	21	21
CCATTCGAGCGTGAGT-1_1_A9	-21.90053239	13.40940414	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	997	1449	0.003450656	0.002070393	11	8	Astrocytes	64	21	21
CCATTCGAGGAGTCTG-1_1_A9	-8.354406358	33.65032272	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	889	1196	0.02090301	0.010033445	11	oligos	OL-MS-2	64	21	21
CCATTCGAGTGGGTTG-1_1_A9	-21.38232596	15.45035867	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1396	2142	0.005602241	0.004201681	11	8	Astrocytes	64	21	21
CCATTCGGTAACGCGA-1_1_A9	-11.72384885	17.25378984	11	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1957	3219	0.005902454	0.004970488	11	11	Glia-MIX	64	21	21
CCATTCGGTCGATTGT-1_1_A9	21.63109757	-20.14744358	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6308	20808	0.009083045	0.008842753	11	3	EN-L5-6	64	21	21
CCATTCGTCCTTAATC-1_1_A9	-20.51080291	15.39516502	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1397	2204	0.007259528	0.005898367	11	8	Astrocytes	64	21	21
CCATTCGTCCTTTCGG-1_1_A9	7.857967488	-24.23304585	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6022	20501	0.012731086	0.004097361	11	L2-3	EN-L2-3-MS	64	21	21
CCATTCGTCTGGCGTG-1_1_A9	-3.621945756	34.14150192	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	871	1266	0.011848341	0.007109005	11	oligos	OL-MS-2	64	21	21
CCATTCGTCTGTTGAG-1_1_A9	-20.57765753	18.05217832	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1874	3435	0.009024745	0.002911208	11	8	Astrocytes	64	21	21
CCCAATCAGATTACCC-1_1_A9	-6.112491764	31.9572531	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1197	1740	0.023563218	0.00862069	11	oligos	OL-MS-2	64	21	21
CCCAATCAGGCCCTCA-1_1_A9	-14.42990175	-3.919054067	13A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3630	8462	0.007208698	0.00638147	11	13A	IN-VIP	64	21	21
CCCAATCAGTGAAGTT-1_1_A9	-0.592765173	34.82869575	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	944	1366	0.028550512	0.004392387	11	oligos	OL-MS-2	64	21	21
CCCAATCAGTGCTGCC-1_1_A9	4.084725473	1.121027447	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	848	1082	0.047134935	0.005545287	11	16	EN-PYR	64	21	21
CCCAATCCAATAACGA-1_1_A9	-18.81755309	-8.544039954	13B	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4669	13259	0.015989139	0.004298967	11	13B	IN-SV2C	64	21	21
CCCAATCCAGGCTCAC-1_1_A9	22.59288516	-20.56163965	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	7668	34724	0.017135123	0.005327727	11	3	EN-L5-6	64	21	21
CCCAATCGTAGGACAC-1_1_A9	-12.11197143	-33.46774761	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1151	1710	0.031578947	0.00994152	11	16	EN-PYR	64	21	21
CCCAATCGTCCCGACA-1_1_A9	-11.25911046	-30.49081593	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1189	1729	0.076923077	0.009253904	11	16	EN-PYR	64	21	21
CCCAATCGTCTAAACC-1_1_A9	4.300891867	1.277813313	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	933	1182	0.053299492	0.010998308	11	16	EN-PYR	64	21	21
CCCAATCGTGACGGTA-1_1_A9	-22.87426761	-16.05355916	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4039	9028	0.007421356	0.010855117	11	6A	IN-PV	64	21	21
CCCAATCGTGAGTATA-1_1_A9	-10.37769211	31.07560043	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	793	1018	0.030451866	0.006876228	11	oligos	OL-MS-2	64	21	21
CCCAATCGTTATGTGC-1_1_A9	-21.53720343	-20.04514376	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2579	5265	0.018043685	0.006077873	11	6A	IN-PV	64	21	21
CCCAATCGTTCTGTTT-1_1_A9	-9.98762219	32.67150197	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	920	1238	0.037964459	0.002423263	11	oligos	OL-MS-2	64	21	21
CCCAATCGTTTGTTTC-1_1_A9	-19.41672025	16.0860255	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1994	3657	0.015586546	0.003554826	11	8	Astrocytes	64	21	21
CCCAATCTCACCTCGT-1_1_A9	-7.396981231	-28.39828733	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	779	1006	0.040755467	0.008946322	11	16	EN-PYR	64	21	21
CCCAATCTCGGCTACG-1_1_A9	27.92896147	-25.46234211	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4094	10396	0.008176222	0.002597153	11	3	EN-L5-6	64	21	21
CCCAGTTAGACTCGGA-1_1_A9	-15.28433583	-36.41143483	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2564	5715	0.032370954	0.004199475	11	16	EN-PYR	64	21	21
CCCAGTTAGATGTGGC-1_1_A9	-24.20637375	-8.107925253	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1229	1797	0.016694491	0.012242627	11	9	OPC	64	21	21
CCCAGTTCAATCCGAT-1_1_A9	-9.795376939	-31.14563973	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	996	1445	0.06366782	0.008304498	11	16	EN-PYR	64	21	21
CCCAGTTCACAAGCCC-1_1_A9	-5.706889946	34.33113873	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	869	1148	0.020905923	0.005226481	11	oligos	OL-MS-2	64	21	21
CCCAGTTCAGACGCTC-1_1_A9	-17.58038384	-16.42251583	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2120	4064	0.018454724	0.003444882	11	6A	IN-PV	64	21	21
CCCAGTTTCCCATTAT-1_1_A9	8.431292852	-2.063200032	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1477	2166	0.057248384	0.007848569	11	16	EN-PYR	64	21	21
CCCATACAGAGGTACC-1_1_A9	4.008189829	1.055651958	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	843	1078	0.038961039	0.009276438	11	16	EN-PYR	64	21	21
CCCATACAGCACCGTC-1_1_A9	-5.714586953	32.17062967	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1051	1514	0.020475561	0.005284016	11	oligos	OL-MS-2	64	21	21
CCCATACAGCTAACAA-1_1_A9	-11.30459654	31.45874254	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1195	1684	0.020783848	0.005344418	11	oligos	OL-MS-2	64	21	21
CCCATACAGTGCCATT-1_1_A9	5.102185253	1.469363715	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	969	1283	0.040530008	0.007014809	11	16	EN-PYR	64	21	21
CCCATACAGTGCTGCC-1_1_A9	19.32993832	-34.12651041	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4955	15681	0.004145144	0.004272687	11	3	EN-L5-6	64	21	21
CCCATACCAAGTCATC-1_1_A9	-24.31107052	-10.19344148	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	891	1209	0.028949545	0.018196857	11	9	OPC	64	21	21
CCCATACCAGTTCCCT-1_1_A9	32.67307175	4.88321536	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1018	1307	0.036725325	0.011476664	11	16	EN-PYR	64	21	21
CCCATACGTGAGGGTT-1_1_A9	3.887931344	1.164638248	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	844	1112	0.057553957	0.008992806	11	16	EN-PYR	64	21	21
CCCATACTCACCATAG-1_1_A9	24.41516212	-24.74601423	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2383	4402	0.017719219	0.002726034	11	3	EN-L5-6	64	21	21
CCCTCCTAGCTGGAAC-1_1_A9	19.03707566	-32.63201988	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	7632	34630	0.005977476	0.004620271	11	3	EN-L5-6	64	21	21
CCCTCCTAGTGGTAAT-1_1_A9	-7.932393169	33.98706881	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	785	1018	0.019646365	0.002946955	11	oligos	OL-MS-2	64	21	21
CCCTCCTCAAGCCGTC-1_1_A9	-6.182344116	36.1049105	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	749	1006	0.016898608	0.008946322	11	oligos	OL-MS-2	64	21	21
CCCTCCTCATCGATTG-1_1_A9	-7.184672834	34.66569552	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	812	1100	0.017272727	0.005454545	11	oligos	OL-MS-2	64	21	21
CCCTCCTGTCTAAACC-1_1_A9	-23.48193059	-9.796898625	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1130	1509	0.026507621	0.005964215	11	9	OPC	64	21	21
CCCTCCTTCACAAACC-1_1_A9	-7.919901827	-27.36806035	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	806	1110	0.1	0.007207207	11	16	EN-PYR	64	21	21
CCCTCCTTCCTACAGA-1_1_A9	-11.72206406	-32.22689652	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1167	1724	0.017981439	0.00638051	11	16	EN-PYR	64	21	21
CCCTCCTTCGAACTGT-1_1_A9	24.17598718	26.28550835	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1493	2362	0.00719729	0.00338696	11	oligos	OL-MS-2	64	21	21
CCGGGATAGACCGGAT-1_1_A9	33.61718642	7.05428863	14	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	851	1096	0.020985401	0.013686131	11	14	Microglia	64	21	21
CCGGGATAGCTAAGAT-1_1_A9	18.86113301	-34.22286125	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5086	15279	0.004581452	0.003665161	11	3	EN-L5-6	64	21	21
CCGGGATCACACCGCA-1_1_A9	12.1347234	-3.366211913	12	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1232	1698	0.017667845	0.00647821	11	12	EN-MIX	64	21	21
CCGGGATCACCAGCAC-1_1_A9	-7.930900252	35.11418915	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	755	1039	0.032723773	0.003849856	11	oligos	OL-MS-2	64	21	21
CCGGGATCAGGTTTCA-1_1_A9	-13.81784166	-4.164835368	13A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2931	6406	0.007961286	0.007180768	11	13A	IN-VIP	64	21	21
CCGGGATGTCAATACC-1_1_A9	27.99641376	-24.76271541	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6036	23553	0.010911561	0.003056935	11	3	EN-L5-6	64	21	21
CCGGGATGTCCAGTTA-1_1_A9	-25.56978256	-7.826300447	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1296	1884	0.016454352	0.013800425	11	9	OPC	64	21	21
CCGGGATTCGCAAGCC-1_1_A9	-24.36679915	-7.448569875	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1258	1881	0.014354067	0.006379585	11	9	OPC	64	21	21
CCGGGATTCTATCCTA-1_1_A9	24.9867593	-19.98765954	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	7492	32045	0.024652832	0.005086597	11	3	EN-L5-6	64	21	21
CCGGTAGCACCCTATC-1_1_A9	-15.09478183	-6.543979131	13A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2948	5762	0.009371746	0.004685873	11	13A	IN-VIP	64	21	21
CCGGTAGCAGACGCTC-1_1_A9	-10.42310198	32.3211219	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	981	1308	0.021406728	0.004587156	11	oligos	OL-MS-2	64	21	21
CCGGTAGCAGCTGGCT-1_1_A9	18.9309196	-33.18403962	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6099	22541	0.003637816	0.003859634	11	3	EN-L5-6	64	21	21
CCGGTAGGTCATGCAT-1_1_A9	-10.33429483	-27.67392789	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1100	1695	0.072566372	0.010029499	11	16	EN-PYR	64	21	21
CCGGTAGTCCGATATG-1_1_A9	-19.50875297	11.80283907	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	956	1301	0.019984627	0.003074558	11	8	Astrocytes	64	21	21
CCGGTAGTCTGCTGTC-1_1_A9	-21.24796407	-16.42833941	6B	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3654	8536	0.020501406	0.002928772	11	6B	IN-SST	64	21	21
CCGGTAGTCTTCGAGA-1_1_A9	-18.03364385	-7.925554865	13B	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3207	6459	0.007276668	0.009444186	11	13B	IN-SV2C	64	21	21
CCGTACTAGCCGTCGT-1_1_A9	-15.62086107	-16.44494079	6B	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1585	2691	0.029357116	0.005202527	11	6B	IN-SST	64	21	21
CCGTACTAGGCATGGT-1_1_A9	-5.800269068	35.95706742	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	795	1048	0.008587786	0.006679389	11	oligos	OL-MS-2	64	21	21
CCGTACTCAATCCAAC-1_1_A9	-9.606795035	-28.9691531	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1209	1815	0.109090909	0.007162534	11	16	EN-PYR	64	21	21
CCGTACTCAGCTTAAC-1_1_A9	-5.216007245	34.43156922	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	903	1191	0.010915197	0.005877414	11	oligos	OL-MS-2	64	21	21
CCGTACTGTATCACCA-1_1_A9	-8.994108261	-29.71834066	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1009	1415	0.083392226	0.004946996	11	16	EN-PYR	64	21	21
CCGTGGAAGAGTTGGC-1_1_A9	-19.448025	10.28744923	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	979	1375	0.008727273	0.006545455	11	8	Astrocytes	64	21	21
CCGTGGAAGATCGGGT-1_1_A9	-21.80819909	-19.31286161	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2928	6717	0.036027989	0.00297752	11	6A	IN-PV	64	21	21
CCGTGGAAGCCACGTC-1_1_A9	-9.56245744	-9.478874841	13B	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1177	1663	0.027660854	0.004810583	11	13B	IN-SV2C	64	21	21
CCGTGGAAGGATGGTC-1_1_A9	33.21858051	7.503261738	14	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	874	1199	0.026688907	0.021684737	11	14	Microglia	64	21	21
CCGTGGAAGTCTCGGC-1_1_A9	-25.09125891	-1.717151416	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1784	2925	0.006495726	0.005811966	11	9	OPC	64	21	21
CCGTGGACAAAGCGGT-1_1_A9	26.98802447	-24.69323898	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5857	18437	0.012529153	0.004230623	11	3	EN-L5-6	64	21	21
CCGTGGACAAGTCTGT-1_1_A9	-1.212260684	33.61348989	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	911	1325	0.018113208	0.002264151	11	oligos	OL-MS-2	64	21	21
CCGTGGAGTGGCGAAT-1_1_A9	-1.673045503	33.38480213	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	869	1204	0.011627907	0.004152824	11	oligos	OL-MS-2	64	21	21
CCGTGGATCAAGATCC-1_1_A9	6.421217481	-25.64696718	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	7050	27310	0.004210912	0.004027829	11	L2-3	EN-L2-3-MS	64	21	21
CCGTGGATCCGCATCT-1_1_A9	17.99537507	-32.26762594	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4905	16374	0.006229388	0.003969708	11	3	EN-L5-6	64	21	21
CCGTTCACACTACAGT-1_1_A9	-7.37108359	31.06931985	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1440	2269	0.02688409	0.007492287	11	oligos	OL-MS-2	64	21	21
CCGTTCACAGGAATCG-1_1_A9	-14.89074345	-7.427155817	13A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3086	6990	0.018168813	0.002575107	11	13A	IN-VIP	64	21	21
CCGTTCACATTTGCTT-1_1_A9	-7.625094465	35.46801018	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	850	1147	0.026155187	0.004359198	11	oligos	OL-MS-2	64	21	21
CCGTTCAGTCGTTGTA-1_1_A9	-3.936425645	35.09086571	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	785	1092	0.036630037	0.004578755	11	oligos	OL-MS-2	64	21	21
CCGTTCAGTGGCCCTA-1_1_A9	14.94509969	-27.80720624	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3423	8866	0.00530115	0.006316264	11	3	EN-L5-6	64	21	21
CCGTTCAGTTGATTGC-1_1_A9	-12.42004173	-13.27594041	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1935	3348	0.031362007	0.009557945	11	6A	IN-PV	64	21	21
CCGTTCATCAGATAAG-1_1_A9	-8.381205853	-32.48849705	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	910	1248	0.068108974	0.005608974	11	16	EN-PYR	64	21	21
CCTAAAGAGACTAGGC-1_1_A9	-7.519373764	-30.86715542	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	914	1261	0.08406027	0.011895321	11	16	EN-PYR	64	21	21
CCTAAAGAGCGATCCC-1_1_A9	-9.931820806	31.0901592	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	992	1336	0.032185629	0.009730539	11	oligos	OL-MS-2	64	21	21
CCTAAAGAGTGAACAT-1_1_A9	20.55741081	-30.05318646	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5792	20993	0.003334445	0.006716525	11	3	EN-L5-6	64	21	21
CCTAAAGCATACGCTA-1_1_A9	-10.88074051	-0.421595581	13A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2701	5740	0.009930314	0.003135889	11	13A	IN-VIP	64	21	21
CCTAAAGCATGCCCGA-1_1_A9	27.7901415	-25.75475597	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6087	25027	0.003915771	0.003356375	11	3	EN-L5-6	64	21	21
CCTAAAGGTAGCGTGA-1_1_A9	6.903646204	-23.49284083	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4095	10086	0.014574658	0.003767599	11	L2-3	EN-L2-3-MS	64	21	21
CCTAAAGGTGGTAACG-1_1_A9	-13.71136238	-34.34131156	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1757	3201	0.058419244	0.004373633	11	16	EN-PYR	64	21	21
CCTACACAGGAATTAC-1_1_A9	3.958890658	0.513416106	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1035	1343	0.0454207	0.006701415	11	16	EN-PYR	64	21	21
CCTACACAGTCTCGGC-1_1_A9	-24.97024844	-5.703934377	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1426	2350	0.00893617	0.003829787	11	9	OPC	64	21	21
CCTACACCAAACCCAT-1_1_A9	-7.919929644	-27.47946081	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	812	1072	0.059701493	0.008395522	11	16	EN-PYR	64	21	21
CCTACACCATCAGTAC-1_1_A9	7.967665118	-1.285328511	12	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	963	1302	0.035330261	0.006912442	11	12	EN-MIX	64	21	21
CCTACACCATGCCTTC-1_1_A9	-13.57271759	-34.06249342	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1552	2468	0.042949757	0.006888169	11	16	EN-PYR	64	21	21
CCTACACTCACCACCT-1_1_A9	4.301235405	1.167265208	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	920	1217	0.063270337	0.009860312	11	16	EN-PYR	64	21	21
CCTACACTCCACTGGG-1_1_A9	10.04258434	0.732936797	12	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	926	1591	0.020741672	0.004399749	11	12	EN-MIX	64	21	21
CCTACACTCGATCCCT-1_1_A9	-10.33750392	-27.29689246	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	861	1323	0.069538927	0.005291005	11	16	EN-PYR	64	21	21
CCTACACTCGTTTATC-1_1_A9	-17.53274424	-7.884204107	13B	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3020	6324	0.014073371	0.009013283	11	13B	IN-SV2C	64	21	21
CCTACCAAGGCATTGG-1_1_A9	26.81364134	-25.09539874	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5286	17242	0.012469551	0.003073889	11	3	EN-L5-6	64	21	21
CCTACCACAACTGCGC-1_1_A9	-11.19816363	32.09579997	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	998	1355	0.01697417	0.005904059	11	oligos	OL-MS-2	64	21	21
CCTACCACACTAGTAC-1_1_A9	-19.95541693	16.72435624	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1963	3548	0.011273957	0.003100338	11	8	Astrocytes	64	21	21
CCTACCACAGGACGTA-1_1_A9	-8.271270921	34.6026992	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	770	1038	0.021194605	0.004816956	11	oligos	OL-MS-2	64	21	21
CCTACCACATGGTCTA-1_1_A9	-17.73934622	-8.179528399	13B	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3249	7040	0.015767045	0.003125	11	13B	IN-SV2C	64	21	21
CCTACCAGTCTAAAGA-1_1_A9	-7.675140698	35.17256186	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	796	1078	0.015769944	0.005565863	11	oligos	OL-MS-2	64	21	21
CCTACCAGTGCGCTTG-1_1_A9	-20.26332578	15.49978303	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1387	2061	0.013100437	0.007763222	11	8	Astrocytes	64	21	21
CCTACCAGTGCGGTAA-1_1_A9	-23.9533133	-21.22133777	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3336	6639	0.014610634	0.00768188	11	6A	IN-PV	64	21	21
CCTAGCTAGTTGTAGA-1_1_A9	19.01471332	-31.40172931	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6599	24294	0.00407508	0.003828106	11	3	EN-L5-6	64	21	21
CCTAGCTCAAGACACG-1_1_A9	6.547225547	-23.89374726	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5895	19678	0.010061998	0.003963817	11	L2-3	EN-L2-3-MS	64	21	21
CCTAGCTCACGTCTCT-1_1_A9	-7.71368433	34.35556067	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	895	1240	0.017741935	0.006451613	11	oligos	OL-MS-2	64	21	21
CCTAGCTCAGCATACT-1_1_A9	-23.6661737	-6.925618271	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1580	2579	0.017448623	0.006591702	11	9	OPC	64	21	21
CCTAGCTCAGCCTTTC-1_1_A9	11.38493805	-28.85546517	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	7401	31582	0.008992464	0.004812868	11	3	EN-L5-6	64	21	21
CCTAGCTCAGTCTTCC-1_1_A9	-11.88607759	-32.84999508	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1246	1896	0.044831224	0.007383966	11	16	EN-PYR	64	21	21
CCTAGCTGTCGCGAAA-1_1_A9	-6.519492635	-29.90171991	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	780	1233	0.197891322	0.00729927	11	16	EN-PYR	64	21	21
CCTAGCTTCTCTGTCG-1_1_A9	-13.61682354	-4.541116069	13A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2670	5282	0.009844756	0.008330178	11	13A	IN-VIP	64	21	21
CCTATTAAGAAGGTTT-1_1_A9	-20.72513555	11.79850651	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	950	1411	0.009922041	0.002834869	11	8	Astrocytes	64	21	21
CCTATTACACTTAACG-1_1_A9	-14.33802391	-3.959075053	13A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3543	8139	0.007740509	0.004791743	11	13A	IN-VIP	64	21	21
CCTATTACAGACGTAG-1_1_A9	-22.8574333	-16.27412811	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4648	12836	0.014724213	0.006154565	11	6A	IN-PV	64	21	21
CCTATTAGTATAGTAG-1_1_A9	-21.71673225	15.79205613	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1384	2253	0.011096316	0.004438526	11	8	Astrocytes	64	21	21
CCTATTAGTATCAGTC-1_1_A9	-14.83843116	-3.937496786	13A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3938	9913	0.014021991	0.008171088	11	13A	IN-VIP	64	21	21
CCTATTAGTCCATGAT-1_1_A9	2.573634777	-10.56358091	12	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1473	2344	0.0221843	0.003412969	11	12	EN-MIX	64	21	21
CCTATTAGTCGCGGTT-1_1_A9	-20.10718575	12.16063837	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1015	1501	0.005996003	0.01065956	11	8	Astrocytes	64	21	21
CCTATTAGTGTAAGTA-1_1_A9	25.93019825	-25.35741043	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3404	8365	0.014225941	0.002032277	11	3	EN-L5-6	64	21	21
CCTATTAGTTGCGCAC-1_1_A9	-24.93003249	-6.108736292	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1269	1849	0.012439156	0.004867496	11	9	OPC	64	21	21
CCTATTATCTTTCCTC-1_1_A9	4.238928054	-22.91478443	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5071	17115	0.005200117	0.009114812	11	L2-3	EN-L2-3-MS	64	21	21
CCTCAGTAGATGTTAG-1_1_A9	-12.94398482	-34.01170386	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1260	1931	0.038322113	0.010357328	11	16	EN-PYR	64	21	21
CCTCAGTAGGAGCGTT-1_1_A9	22.79720344	-20.30776286	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	7053	27476	0.015722813	0.00640559	11	3	EN-L5-6	64	21	21
CCTCAGTAGTATCTCG-1_1_A9	-26.54453878	-7.041675685	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1038	1500	0.008	0.008	11	9	OPC	64	21	21
CCTCAGTAGTCGAGTG-1_1_A9	-6.535779428	33.95042765	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	941	1277	0.022709475	0.009397024	11	oligos	OL-MS-2	64	21	21
CCTCAGTCAGATGAGC-1_1_A9	-23.71440817	-9.678075755	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1071	1463	0.028024607	0.00683527	11	9	OPC	64	21	21
CCTCAGTCATGGATGG-1_1_A9	6.39931655	-25.27252171	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6358	24176	0.004756784	0.004425877	11	L2-3	EN-L2-3-MS	64	21	21
CCTCAGTGTAAATGAC-1_1_A9	-6.87114025	32.20108534	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1039	1472	0.012228261	0.004755435	11	oligos	OL-MS-2	64	21	21
CCTCAGTGTCTCTTTA-1_1_A9	-31.70987372	-10.01489473	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1004	1489	0.008730692	0.00402955	11	9	OPC	64	21	21
CCTCAGTGTTCACCTC-1_1_A9	19.35531724	-33.13854016	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6985	27339	0.007132668	0.004864845	11	3	EN-L5-6	64	21	21
CCTCAGTTCAACGAAA-1_1_A9	-12.90716317	7.275167437	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1657	2440	0.054098361	0.007786885	11	16	EN-PYR	64	21	21
CCTCTGACAATAAGCA-1_1_A9	-24.40860715	-6.317948083	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1339	2032	0.006397638	0.00246063	11	9	OPC	64	21	21
CCTCTGACACATCTTT-1_1_A9	17.49441021	-10.15206513	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2375	4520	0.013716814	0.007964602	11	3	EN-L5-6	64	21	21
CCTCTGACACTGTGTA-1_1_A9	-6.728299214	31.18815602	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1241	1839	0.01576944	0.009244154	11	oligos	OL-MS-2	64	21	21
CCTCTGAGTGATGTCT-1_1_A9	-7.562840929	-30.98628004	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	774	1034	0.040618956	0.005802708	11	16	EN-PYR	64	21	21
CCTCTGATCCAATGGT-1_1_A9	-8.556601157	33.88141261	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	779	1012	0.014822134	0.002964427	11	oligos	OL-MS-2	64	21	21
CCTCTGATCGTATCAG-1_1_A9	20.37538264	-32.00379743	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6996	26867	0.010198385	0.003312614	11	3	EN-L5-6	64	21	21
CCTTACGAGATGTAAC-1_1_A9	9.661774331	-0.592020763	12	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	983	1296	0.039351852	0.00617284	11	12	EN-MIX	64	21	21
CCTTACGCAATCTGCA-1_1_A9	-15.15101439	-5.210469794	13A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2933	5344	0.007672156	0.017215569	11	13A	IN-VIP	64	21	21
CCTTACGCACAGGCCT-1_1_A9	-7.507209974	35.10090599	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	819	1105	0.027149321	0.00361991	11	oligos	OL-MS-2	64	21	21
CCTTACGCACATAACC-1_1_A9	-11.34814151	-31.44764106	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1245	1815	0.05785124	0.009366391	11	16	EN-PYR	64	21	21
CCTTACGGTGTGAATA-1_1_A9	-22.92471602	-16.10806694	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5810	18251	0.011834968	0.005479152	11	6A	IN-PV	64	21	21
CCTTACGGTTATTCTC-1_1_A9	-7.881438041	-29.95140205	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	797	1038	0.047206166	0.00867052	11	16	EN-PYR	64	21	21
CCTTACGGTTCCCTTG-1_1_A9	-8.224396686	-29.59872343	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	847	1117	0.026857654	0.008952551	11	16	EN-PYR	64	21	21
CCTTACGGTTGAGTTC-1_1_A9	-13.42836686	-4.472928754	13A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2616	5008	0.012380192	0.005790735	11	13A	IN-VIP	64	21	21
CCTTCCCAGCTAAACA-1_1_A9	-11.65392081	30.74221429	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1048	1420	0.043661972	0.011267606	11	oligos	OL-MS-2	64	21	21
CCTTCCCAGCTGTTCA-1_1_A9	33.50191841	6.953584803	14	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	929	1175	0.011914894	0.017021277	11	14	Microglia	64	21	21
CCTTCCCCAGATGAGC-1_1_A9	-24.54705014	-5.880910107	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1411	2106	0.009021842	0.00379867	11	9	OPC	64	21	21
CCTTCCCTCAAAGTAG-1_1_A9	-26.21174259	-24.24007325	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5271	15066	0.016261781	0.007433957	11	6A	IN-PV	64	21	21
CCTTCGAAGTATCTCG-1_1_A9	-26.66692872	-12.11986098	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1032	1393	0.010768126	0.045944006	11	9	OPC	64	21	21
CCTTCGACACCAACCG-1_1_A9	-9.174763811	-28.05764461	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1017	1373	0.067734887	0.008739985	11	16	EN-PYR	64	21	21
CCTTCGACACGTAAGG-1_1_A9	-7.309824255	-28.38795904	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	762	1020	0.076470588	0.01372549	11	16	EN-PYR	64	21	21
CCTTCGAGTTTGACAC-1_1_A9	-9.641670047	31.71282251	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	853	1123	0.025823687	0.007123776	11	oligos	OL-MS-2	64	21	21
CCTTCGATCCGCAGTG-1_1_A9	-21.13290192	14.60211595	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1312	2046	0.008308895	0.00684262	11	8	Astrocytes	64	21	21
CCTTCGATCTATCCTA-1_1_A9	26.81681517	-15.72237193	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	8102	37624	0.014698065	0.004651286	11	3	EN-L5-6	64	21	21
CCTTTCTAGACAGACC-1_1_A9	10.02320602	-26.00513721	10	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6137	21275	0.003055229	0.010622797	11	L2-3	EN-L2-3-Cntl	64	21	21
CCTTTCTAGCTCCTTC-1_1_A9	-19.88789691	-25.78123601	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3554	10492	0.0053374	0.003145254	11	6A	IN-PV	64	21	21
CCTTTCTCACCTGGTG-1_1_A9	7.112078159	-26.06058521	10	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6396	24830	0.004349577	0.005436971	11	L2-3	EN-L2-3-Cntl	64	21	21
CCTTTCTCAGATCGGA-1_1_A9	15.40002008	-27.92865265	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3974	10671	0.005997563	0.005435292	11	3	EN-L5-6	64	21	21
CCTTTCTCATGGGAAC-1_1_A9	7.370318481	-24.48981823	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6978	28264	0.005979338	0.005130201	11	L2-3	EN-L2-3-MS	64	21	21
CCTTTCTGTATAGGGC-1_1_A9	-17.66475699	-16.45441181	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2298	4518	0.044046038	0.003984064	11	6A	IN-PV	64	21	21
CCTTTCTTCCCAAGAT-1_1_A9	-19.77332726	14.59861824	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1331	2142	0.010737628	0.005602241	11	8	Astrocytes	64	21	21
CCTTTCTTCCGGCACA-1_1_A9	-2.455426116	33.34046108	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	886	1296	0.014660494	0.00462963	11	oligos	OL-MS-2	64	21	21
CGAACATAGAAGAAGC-1_1_A9	-10.21573882	32.67626002	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	816	1061	0.034872762	0.004712535	11	oligos	OL-MS-2	64	21	21
CGAACATAGCGATGAC-1_1_A9	7.402743926	-24.59097594	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	7015	24707	0.010199539	0.004897397	11	L2-3	EN-L2-3-MS	64	21	21
CGAACATAGCGCCTCA-1_1_A9	-25.84100182	-7.412180346	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1128	1651	0.012719564	0.01029679	11	9	OPC	64	21	21
CGAACATAGGATTCGG-1_1_A9	18.62136853	-32.09534988	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5136	16922	0.007918686	0.002600165	11	3	EN-L5-6	64	21	21
CGAACATCACATCCAA-1_1_A9	-23.625621	-9.111655366	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1245	1796	0.013919822	0.008351893	11	9	OPC	64	21	21
CGAACATCAGTTAACC-1_1_A9	28.08651606	-25.99479415	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5689	21421	0.00634891	0.00177396	11	3	EN-L5-6	64	21	21
CGAACATGTTCTGTTT-1_1_A9	-23.6457589	-9.542919154	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1121	1517	0.029004614	0.011206328	11	9	OPC	64	21	21
CGAACATTCACTTATC-1_1_A9	-15.41572543	-5.057545834	13A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3315	7227	0.01273004	0.00774872	11	13A	IN-VIP	64	21	21
CGAACATTCTTATCTG-1_1_A9	-10.17828585	-29.58725254	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1134	1604	0.086034913	0.00872818	11	16	EN-PYR	64	21	21
CGAATGTAGAGTACAT-1_1_A9	-9.40086198	-30.78413868	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	932	1429	0.075577327	0.00419874	11	16	EN-PYR	64	21	21
CGAATGTAGTGTACTC-1_1_A9	5.092122821	1.51504753	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	966	1319	0.059135709	0.009855951	11	16	EN-PYR	64	21	21
CGAATGTAGTTGAGAT-1_1_A9	22.38640683	-19.99407509	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6644	22820	0.012620508	0.005696757	11	3	EN-L5-6	64	21	21
CGAATGTCACAACGCC-1_1_A9	22.92116148	-17.84668883	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	8014	31916	0.014099511	0.007551072	11	3	EN-L5-6	64	21	21
CGAATGTGTCTTCTCG-1_1_A9	-21.41631175	17.463777	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1595	2590	0.005791506	0.005019305	11	8	Astrocytes	64	21	21
CGAATGTGTTAGATGA-1_1_A9	-25.49709477	-7.422009191	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1205	1750	0.009714286	0.007428571	11	9	OPC	64	21	21
CGAATGTTCCGGCACA-1_1_A9	-21.99358456	-16.45561728	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4537	12527	0.023788617	0.003751896	11	6A	IN-PV	64	21	21
CGAATGTTCTGTTGAG-1_1_A9	-20.32188846	15.60729686	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1443	2262	0.004862953	0.003536693	11	8	Astrocytes	64	21	21
CGACCTTAGTCCGGTC-1_1_A9	-10.81559511	-33.0917737	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1084	1587	0.071833648	0.008821676	11	16	EN-PYR	64	21	21
CGACCTTCAACTGCGC-1_1_A9	18.16882898	-24.85844078	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6530	23317	0.009435176	0.018870352	11	3	EN-L5-6	64	21	21
CGACCTTGTTAAGTAG-1_1_A9	-20.88264156	14.17847088	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1233	1866	0.006430868	0.003215434	11	8	Astrocytes	64	21	21
CGACCTTTCACAAACC-1_1_A9	-23.53694723	-10.19897923	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	902	1176	0.029761905	0.007653061	11	16	EN-PYR	64	21	21
CGACCTTTCACCAGGC-1_1_A9	-25.58823067	-7.475366609	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1136	1668	0.012589928	0.001798561	11	9	OPC	64	21	21
CGACTTCCAATAGCGG-1_1_A9	-9.97880199	32.6144958	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	954	1311	0.016781083	0.006864989	11	oligos	OL-MS-2	64	21	21
CGACTTCCAATCAGAA-1_1_A9	-3.666958127	32.37271033	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1067	1543	0.012313675	0.006480881	11	oligos	OL-MS-2	64	21	21
CGACTTCCACCAGTTA-1_1_A9	-18.69846991	10.89023845	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	973	1315	0.0121673	0.006844106	11	8	Astrocytes	64	21	21
CGACTTCCATAACCTG-1_1_A9	-8.436682198	-27.43458217	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	777	1016	0.037401575	0.003937008	11	16	EN-PYR	64	21	21
CGACTTCCATGGGAAC-1_1_A9	9.576025658	0.005640885	12	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1006	1514	0.032364597	0.007926024	11	12	EN-MIX	64	21	21
CGACTTCGTAGGCTGA-1_1_A9	-21.06903786	-16.25427828	6B	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2802	6145	0.021643613	0.004068348	11	6B	IN-SST	64	21	21
CGACTTCGTCCGTTAA-1_1_A9	-14.88092811	7.767529123	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	992	1368	0.030701754	0.010233918	11	8	Astrocytes	64	21	21
CGACTTCTCACCCTCA-1_1_A9	24.42384115	8.314252088	15A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3785	7163	0.021080553	0.026245986	11	15A	Endo cells	64	21	21
CGACTTCTCACTGGGC-1_1_A9	-15.20475846	-6.613657916	13A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3480	8103	0.014068863	0.005800321	11	13A	IN-VIP	64	21	21
CGACTTCTCCAGTAGT-1_1_A9	-3.508369571	32.39059144	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1023	1475	0.011525424	0.009491525	11	oligos	OL-MS-2	64	21	21
CGAGAAGAGTACACCT-1_1_A9	-24.50416406	-6.602212521	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1326	1962	0.013761468	0.003567788	11	9	OPC	64	21	21
CGAGAAGCAGCTGGCT-1_1_A9	4.243341615	0.424901432	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1224	1952	0.032786885	0.005122951	11	16	EN-PYR	64	21	21
CGAGAAGCATCTGGTA-1_1_A9	6.317949496	-25.36677617	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5634	18819	0.006217121	0.003453956	11	L2-3	EN-L2-3-MS	64	21	21
CGAGAAGCATGCAACT-1_1_A9	-6.834474049	34.64453271	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	864	1163	0.01977644	0.006878762	11	oligos	OL-MS-2	64	21	21
CGAGAAGGTCCAGTGC-1_1_A9	6.827132989	-23.14271604	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5605	16983	0.010657717	0.008891244	11	L2-3	EN-L2-3-MS	64	21	21
CGAGAAGGTCGAGATG-1_1_A9	-7.587804876	-28.73611559	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	868	1188	0.104377104	0.011784512	11	16	EN-PYR	64	21	21
CGAGAAGTCCTTAATC-1_1_A9	-14.51088294	-4.290882913	13A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3473	7732	0.006466632	0.009053285	11	13A	IN-VIP	64	21	21
CGAGCACAGAATGTGT-1_1_A9	-8.221180272	33.66866074	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	950	1269	0.020488574	0.007092199	11	oligos	OL-MS-2	64	21	21
CGAGCACAGGAATGGA-1_1_A9	-21.54774339	-16.61742174	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4413	10979	0.007742053	0.004918481	11	6A	IN-PV	64	21	21
CGAGCACCACAGTCGC-1_1_A9	-9.006745215	33.15729939	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	894	1196	0.023411371	0.007525084	11	oligos	OL-MS-2	64	21	21
CGAGCACGTAGCGATG-1_1_A9	-11.19029457	30.01458008	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1206	1697	0.041838539	0.007660577	11	oligos	OL-MS-2	64	21	21
CGAGCACGTGATGCCC-1_1_A9	27.01625095	-23.79898708	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5229	16823	0.020150984	0.002853237	11	3	EN-L5-6	64	21	21
CGAGCACGTGCTCTTC-1_1_A9	-2.785426051	36.20429182	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	799	1096	0.011861314	0.002737226	11	oligos	OL-MS-2	64	21	21
CGAGCACGTTGAACTC-1_1_A9	-13.78868946	-3.117948296	13A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3356	7481	0.004678519	0.006148911	11	13A	IN-VIP	64	21	21
CGAGCACTCTTATCTG-1_1_A9	-14.60239186	-4.064380427	13A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3964	9825	0.009770992	0.006310433	11	13A	IN-VIP	64	21	21
CGAGCCAAGTACGACG-1_1_A9	-24.01586124	-21.18161403	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4664	12560	0.025398089	0.005175159	11	6A	IN-PV	64	21	21
CGAGCCACAAATACAG-1_1_A9	-11.2160591	31.53913719	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1119	1524	0.030839895	0.004593176	11	oligos	OL-MS-2	64	21	21
CGAGCCACAAGACACG-1_1_A9	19.12135368	-34.12398011	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5536	18238	0.004002632	0.003289834	11	3	EN-L5-6	64	21	21
CGAGCCACAGGATCGA-1_1_A9	-8.546056039	-29.61754366	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	920	1256	0.054936306	0.006369427	11	16	EN-PYR	64	21	21
CGAGCCACATAGACTC-1_1_A9	9.775451473	0.657260281	12	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	958	1553	0.02060528	0.004507405	11	12	EN-MIX	64	21	21
CGAGCCAGTAGCCTCG-1_1_A9	5.168930094	-23.55082675	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5422	17072	0.005330366	0.006267573	11	L2-3	EN-L2-3-MS	64	21	21
CGAGCCATCATCACCC-1_1_A9	-9.13594972	-27.87982766	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1070	1450	0.043448276	0.010344828	11	16	EN-PYR	64	21	21
CGAGCCATCCTACAGA-1_1_A9	7.184147562	-21.78223186	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5997	19929	0.005770485	0.016910031	11	L2-3	EN-L2-3-MS	64	21	21
CGAGCCATCTACTATC-1_1_A9	27.74739554	-24.60213656	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	7253	29589	0.009902329	0.003616209	11	3	EN-L5-6	64	21	21
CGATCGGAGCCACTAT-1_1_A9	7.225810166	-23.27851913	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4560	12153	0.0125072	0.006089032	11	L2-3	EN-L2-3-MS	64	21	21
CGATCGGAGGCAGTCA-1_1_A9	-24.58480426	-9.903296464	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	896	1226	0.010603589	0.009787928	11	9	OPC	64	21	21
CGATCGGAGGTAGCCA-1_1_A9	16.58684216	-19.41302868	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4529	11280	0.028191489	0.007092199	11	L2-3	EN-L2-3-MS	64	21	21
CGATCGGAGTTAAGTG-1_1_A9	-9.839663646	32.61985531	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	862	1123	0.044523598	0.00445236	11	oligos	OL-MS-2	64	21	21
CGATCGGCACAGGAGT-1_1_A9	-20.47198764	15.24040903	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1348	1983	0.008572869	0.009077156	11	8	Astrocytes	64	21	21
CGATCGGCACTTCGAA-1_1_A9	-7.387116325	-29.30545422	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	790	1067	0.060918463	0.005623243	11	16	EN-PYR	64	21	21
CGATCGGCAGCTGGCT-1_1_A9	-25.85533864	-24.03384822	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3627	7685	0.018087183	0.004814574	11	6A	IN-PV	64	21	21
CGATCGGCATGCCACG-1_1_A9	4.635966904	-23.15992439	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4179	10890	0.005509642	0.006152433	11	L2-3	EN-L2-3-MS	64	21	21
CGATCGGCATTCTTAC-1_1_A9	19.00764445	-34.223902	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5736	19928	0.004415897	0.002659574	11	3	EN-L5-6	64	21	21
CGATGGCAGAAACCGC-1_1_A9	-9.677231537	-31.46462773	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1013	1377	0.037037037	0.010893246	11	16	EN-PYR	64	21	21
CGATGGCAGCAATCTC-1_1_A9	-6.835242636	-30.00331242	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	831	1076	0.039033457	0.00929368	11	16	EN-PYR	64	21	21
CGATGGCAGCGGCTTC-1_1_A9	-25.95917163	-7.622329151	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1242	1849	0.018929151	0.004326663	11	9	OPC	64	21	21
CGATGGCCAAACCCAT-1_1_A9	-23.04707287	-16.23883792	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6132	18572	0.026114581	0.00586905	11	6A	IN-PV	64	21	21
CGATGGCCACATGGGA-1_1_A9	-8.4998493	34.28434926	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	834	1054	0.017077799	0.007590133	11	oligos	OL-MS-2	64	21	21
CGATGGCCACGAGAGT-1_1_A9	-16.59912717	-6.999806563	13B	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2466	4721	0.016310104	0.004024571	11	13B	IN-SV2C	64	21	21
CGATGGCCAGTTAACC-1_1_A9	-9.229587081	-28.20013555	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	949	1275	0.043137255	0.007843137	11	16	EN-PYR	64	21	21
CGATGGCCATCGGACC-1_1_A9	-21.46777198	-16.47061064	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3643	8913	0.012117132	0.009200045	11	6A	IN-PV	64	21	21
CGATGGCGTAATTGGA-1_1_A9	27.53160966	-24.39711323	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6675	24036	0.015934432	0.00478449	11	3	EN-L5-6	64	21	21
CGATGGCGTCAAGCGA-1_1_A9	-4.444606583	36.22758095	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	778	1060	0.01509434	0.008490566	11	oligos	OL-MS-2	64	21	21
CGATGGCGTGGACGAT-1_1_A9	-4.408299104	32.68212616	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	940	1258	0.007154213	0.011128776	11	oligos	OL-MS-2	64	21	21
CGATGGCGTTCGAATC-1_1_A9	4.753829746	-23.24096587	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4192	10903	0.004402458	0.008162891	11	L2-3	EN-L2-3-MS	64	21	21
CGATGGCGTTTGGGCC-1_1_A9	26.68744176	-17.5083206	2	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5246	14652	0.025320775	0.007098007	11	2	EN-L4	64	21	21
CGATGGCTCATGCAAC-1_1_A9	19.2880906	-33.96757946	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4831	14470	0.015342087	0.003662751	11	3	EN-L5-6	64	21	21
CGATGTAAGAGGGCTT-1_1_A9	-19.0308814	16.56740891	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1864	3069	0.006190942	0.007494298	11	8	Astrocytes	64	21	21
CGATGTAGTCCCTTGT-1_1_A9	-22.66532142	-9.023668901	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2319	3712	0.016702586	0.011853448	11	9	OPC	64	21	21
CGATGTAGTGCACTTA-1_1_A9	26.1555012	-22.68481375	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6269	21385	0.011924246	0.004489128	11	3	EN-L5-6	64	21	21
CGATGTAGTTATGCGT-1_1_A9	21.96331034	26.28105816	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1014	1587	0.013862634	0.006931317	11	oligos	OL-MS-2	64	21	21
CGATGTATCCTGTACC-1_1_A9	-16.23452719	-6.488131088	13A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3485	7939	0.026829576	0.004786497	11	13A	IN-VIP	64	21	21
CGATGTATCGGATGGA-1_1_A9	6.217918293	-9.862267421	12	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1805	3236	0.012360939	0.009270705	11	12	EN-MIX	64	21	21
CGATGTATCTGCTTGC-1_1_A9	-19.8604633	15.37732658	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1536	2484	0.008454106	0.003623188	11	8	Astrocytes	64	21	21
CGATTGAAGGCTCTTA-1_1_A9	5.230585782	-23.63276314	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4293	11280	0.004166667	0.005762411	11	L2-3	EN-L2-3-MS	64	21	21
CGATTGACAATTCCTT-1_1_A9	5.925346779	-2.856137205	12	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1092	1731	0.00751011	0.004621606	11	12	EN-MIX	64	21	21
CGATTGACATTTGCCC-1_1_A9	6.928870658	-25.85047282	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6593	25236	0.003764463	0.009232842	11	L2-3	EN-L2-3-MS	64	21	21
CGATTGAGTAGCTGCC-1_1_A9	-12.34224333	-33.26304083	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1245	1946	0.050359712	0.004624872	11	16	EN-PYR	64	21	21
CGATTGAGTAGGACAC-1_1_A9	-3.811131411	35.63863564	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	762	1006	0.024850895	0.004970179	11	oligos	OL-MS-2	64	21	21
CGATTGATCAGCCTAA-1_1_A9	-19.70573747	12.40379939	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1130	1711	0.010520164	0.001753361	11	8	Astrocytes	64	21	21
CGCCAAGAGACAATAC-1_1_A9	4.076474007	0.678966272	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	832	1085	0.06359447	0.011981567	11	16	EN-PYR	64	21	21
CGCCAAGCACCCATGG-1_1_A9	4.645185631	1.366205951	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	932	1248	0.048076923	0.010416667	11	16	EN-PYR	64	21	21
CGCCAAGCATACGCCG-1_1_A9	-15.04323339	-7.179753653	13A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2986	6267	0.015158768	0.004148715	11	13A	IN-VIP	64	21	21
CGCCAAGCATTTGCCC-1_1_A9	19.44859651	-34.2134519	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5750	19632	0.004533415	0.007538712	11	3	EN-L5-6	64	21	21
CGCCAAGGTCGCTTTC-1_1_A9	-9.664998677	22.27561847	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1037	1436	0.01183844	0.003481894	11	8	Astrocytes	64	21	21
CGCCAAGGTGTAATGA-1_1_A9	3.789430166	0.935427208	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	797	1025	0.044878049	0.006829268	11	16	EN-PYR	64	21	21
CGCCAAGGTGTATGGG-1_1_A9	-7.294571117	-32.63102412	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	754	1018	0.048133595	0.006876228	11	16	EN-PYR	64	21	21
CGCCAAGGTTCAGCGC-1_1_A9	-2.778462965	32.70815456	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	906	1299	0.005388761	0.007698229	11	oligos	OL-MS-2	64	21	21
CGCCAAGTCTACTCAT-1_1_A9	-19.33448693	15.96378906	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1873	3166	0.008528111	0.004106128	11	8	Astrocytes	64	21	21
CGCGGTAAGCTGATAA-1_1_A9	-11.1600349	29.55467272	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	913	1226	0.037520392	0.008156607	11	oligos	OL-MS-2	64	21	21
CGCGGTACAAATACAG-1_1_A9	-23.36759063	-16.41528858	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4336	9665	0.031039834	0.005897569	11	6A	IN-PV	64	21	21
CGCGGTACACTGCCAG-1_1_A9	-20.7864639	12.36414229	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	988	1371	0.00948213	0.004376368	11	8	Astrocytes	64	21	21
CGCGGTACATGCCTAA-1_1_A9	-7.65665079	-32.17263071	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	839	1142	0.050788091	0.013134851	11	16	EN-PYR	64	21	21
CGCGGTAGTTCCGTCT-1_1_A9	26.78137443	-25.68982839	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5119	14435	0.005888466	0.003740908	11	3	EN-L5-6	64	21	21
CGCGGTAGTTTACTCT-1_1_A9	-6.571182577	35.50123776	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	761	1014	0.00887574	0.003944773	11	oligos	OL-MS-2	64	21	21
CGCGGTATCACAGGCC-1_1_A9	-10.70244643	-27.44346077	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	989	1285	0.051361868	0.014007782	11	16	EN-PYR	64	21	21
CGCGGTATCGCCCTTA-1_1_A9	-24.66298827	-6.126354694	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1352	1980	0.007070707	0.004545455	11	9	OPC	64	21	21
CGCGTTTAGTACGATA-1_1_A9	-19.07366408	-16.22475572	6B	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2190	4196	0.010486177	0.003574833	11	6B	IN-SST	64	21	21
CGCGTTTCAGACAGGT-1_1_A9	-28.39104703	-12.72070913	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	775	1014	0.015779093	0.004930966	11	9	OPC	64	21	21
CGCGTTTCAGACTCGC-1_1_A9	-10.93824723	32.0296488	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	956	1273	0.035349568	0.005498822	11	oligos	OL-MS-2	64	21	21
CGCGTTTGTGTTCGAT-1_1_A9	30.27372781	-8.293940402	2	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4697	11257	0.008616861	0.013058541	11	2	EN-L4	64	21	21
CGCGTTTGTTGTCGCG-1_1_A9	-21.05386405	16.80413419	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1577	2556	0.009780908	0.004694836	11	8	Astrocytes	64	21	21
CGCGTTTTCCTATGTT-1_1_A9	8.543995275	-2.082313425	12	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1553	2342	0.058070026	0.005977797	11	12	EN-MIX	64	21	21
CGCGTTTTCGTCGTTC-1_1_A9	24.70646375	26.84526516	1	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1556	2532	0.007503949	0.003554502	11	oligos	OL-Cntl	64	21	21
CGCTATCAGGCTCAGA-1_1_A9	-11.34713985	-32.47065248	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1222	1834	0.07306434	0.0087241	11	16	EN-PYR	64	21	21
CGCTATCAGTACACCT-1_1_A9	-10.87704598	-29.96308085	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1236	1943	0.112197633	0.006176016	11	16	EN-PYR	64	21	21
CGCTATCCAAGCCCAC-1_1_A9	-10.72209495	-27.33688563	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	871	1132	0.074204947	0.009717314	11	16	EN-PYR	64	21	21
CGCTATCCAATGGAGC-1_1_A9	20.41422277	-24.15552548	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6142	20046	0.012620972	0.005287838	11	L2-3	EN-L2-3-MS	64	21	21
CGCTATCCACGACGAA-1_1_A9	27.1283186	-26.06812484	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5412	17772	0.00624578	0.003713707	11	3	EN-L5-6	64	21	21
CGCTATCCATGGGAAC-1_1_A9	24.96533788	-19.88780413	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6781	22227	0.008638143	0.008773114	11	3	EN-L5-6	64	21	21
CGCTATCGTACTCTCC-1_1_A9	-5.377890554	33.73314484	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	903	1293	0.013921114	0.006187162	11	oligos	OL-MS-2	64	21	21
CGCTATCGTTCACGGC-1_1_A9	33.23841907	6.459196422	14	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	840	1027	0.012658228	0.007789679	11	14	Microglia	64	21	21
CGCTATCTCCACGAAT-1_1_A9	-8.152692819	-27.0317616	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	785	1026	0.048732943	0.013645224	11	16	EN-PYR	64	21	21
CGCTATCTCTACTATC-1_1_A9	-11.44659865	31.97050555	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	891	1165	0.03776824	0.002575107	11	oligos	OL-MS-2	64	21	21
CGCTGGAAGCAAATCA-1_1_A9	-19.73416678	15.46413595	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1451	2306	0.011274935	0.003902862	11	8	Astrocytes	64	21	21
CGCTGGAAGCCACGTC-1_1_A9	7.727618012	-23.21435901	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5809	19180	0.020698644	0.003388947	11	L2-3	EN-L2-3-MS	64	21	21
CGCTGGAAGCGCCTCA-1_1_A9	26.07776728	5.60007318	15A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1083	1454	0.039889959	0.015818432	11	15A	Endo cells	64	21	21
CGCTGGACACCGAAAG-1_1_A9	-23.81106118	-10.6251618	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	828	1065	0.036619718	0.014084507	11	9	OPC	64	21	21
CGCTGGACACTTCTGC-1_1_A9	-6.527769926	30.9749316	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1474	2231	0.01748095	0.002241147	11	oligos	OL-MS-2	64	21	21
CGCTGGACAGTAAGAT-1_1_A9	19.93217363	-33.7639708	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5021	15215	0.008412751	0.005323694	11	3	EN-L5-6	64	21	21
CGCTGGACATTGGCGC-1_1_A9	-11.03875392	-9.169674194	13B	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1498	2547	0.012171182	0.001963094	11	13B	IN-SV2C	64	21	21
CGCTTCAAGAGCCCAA-1_1_A9	29.40279017	-11.40158871	2	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4214	9771	0.011769522	0.010643742	11	2	EN-L4	64	21	21
CGCTTCAAGCACGCCT-1_1_A9	-3.317986816	32.7937563	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1051	1564	0.019820972	0.007033248	11	oligos	OL-MS-2	64	21	21
CGCTTCACAAGTAGTA-1_1_A9	-8.895389783	34.24382461	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	764	1027	0.014605648	0.007789679	11	oligos	OL-MS-2	64	21	21
CGCTTCACATGCCACG-1_1_A9	-7.69978922	34.8072344	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	817	1111	0.02070207	0.00540054	11	oligos	OL-MS-2	64	21	21
CGCTTCAGTGGCAAAC-1_1_A9	-25.75429713	-7.648800402	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1171	1738	0.008055236	0.005178366	11	9	OPC	64	21	21
CGCTTCAGTGGTACAG-1_1_A9	6.62568267	-24.91394981	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6477	23888	0.011219022	0.003600134	11	L2-3	EN-L2-3-MS	64	21	21
CGCTTCAGTTTGACAC-1_1_A9	-4.922895928	33.82441335	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	931	1314	0.01217656	0.00761035	11	oligos	OL-MS-2	64	21	21
CGCTTCATCTATGTGG-1_1_A9	-13.47609672	-34.12636132	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1490	2637	0.064087979	0.00303375	11	16	EN-PYR	64	21	21
CGGACACAGCATCATC-1_1_A9	28.11125918	-25.88635029	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5430	17654	0.005381217	0.003455308	11	3	EN-L5-6	64	21	21
CGGACACCAGGAACGT-1_1_A9	-8.11252244	-26.94331501	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	865	1109	0.064021641	0.013525699	11	16	EN-PYR	64	21	21
CGGACACCATGTCTCC-1_1_A9	22.38745588	-19.87375794	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	7399	26817	0.010851326	0.009956371	11	3	EN-L5-6	64	21	21
CGGACACGTAGCTGCC-1_1_A9	-12.42653765	-32.6987438	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1387	2142	0.053688142	0.008870215	11	16	EN-PYR	64	21	21
CGGACACGTGCCTGCA-1_1_A9	20.52680411	-33.55547015	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4139	10385	0.005681271	0.006162735	11	3	EN-L5-6	64	21	21
CGGACACTCACGGTTA-1_1_A9	18.43811609	-8.726510658	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2577	5660	0.005477032	0.002473498	11	3	EN-L5-6	64	21	21
CGGACACTCAGAGCTT-1_1_A9	-14.98659272	11.09301249	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1688	2853	0.005257624	0.004556607	11	8	Astrocytes	64	21	21
CGGACACTCCCAACGG-1_1_A9	-8.380049723	-27.32113214	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	922	1174	0.038330494	0.012776831	11	16	EN-PYR	64	21	21
CGGACACTCTGGGCCA-1_1_A9	-11.02711041	31.68992826	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	966	1272	0.025157233	0.002358491	11	oligos	OL-MS-2	64	21	21
CGGACGTAGAGTCTGG-1_1_A9	-21.49386107	-16.13990697	6B	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2991	5961	0.011239725	0.002516356	11	6B	IN-SST	64	21	21
CGGACGTAGGCAATTA-1_1_A9	5.278749625	-24.65811207	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5189	16248	0.007570162	0.00418513	11	L2-3	EN-L2-3-MS	64	21	21
CGGACGTAGGTCATCT-1_1_A9	-11.89142902	-32.22577739	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1208	1830	0.043715847	0.008743169	11	16	EN-PYR	64	21	21
CGGACGTAGTCTTGCA-1_1_A9	-26.14544212	-8.988610452	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	999	1376	0.014534884	0.004360465	11	9	OPC	64	21	21
CGGACGTCACCAGGTC-1_1_A9	-7.264488974	31.07774762	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1412	2080	0.031730769	0.002884615	11	oligos	OL-MS-2	64	21	21
CGGACGTCACCCATTC-1_1_A9	-14.71561964	10.22553585	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1453	2242	0.006690455	0.001784121	11	8	Astrocytes	64	21	21
CGGACGTCAGACACTT-1_1_A9	-8.450024347	-27.33110196	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	954	1263	0.055423595	0.007125891	11	16	EN-PYR	64	21	21
CGGACGTGTACTCTCC-1_1_A9	6.930590006	-25.71133105	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6773	23675	0.006673706	0.004435058	11	L2-3	EN-L2-3-MS	64	21	21
CGGACGTTCAACACAC-1_1_A9	-14.07166882	8.517435223	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1193	1654	0.024183797	0.006650544	11	8	Astrocytes	64	21	21
CGGACTGAGGCCGAAT-1_1_A9	27.88907051	4.228087622	15BA	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	941	1300	0.021538462	0.021538462	11	15BA	Stromal cells	64	21	21
CGGACTGAGTGGTAGC-1_1_A9	-27.45102108	-5.105041209	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1204	1756	0.003986333	0.01309795	11	9	OPC	64	21	21
CGGACTGCACAGACAG-1_1_A9	-11.51011816	29.97578841	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	996	1332	0.043543544	0.006756757	11	oligos	OL-MS-2	64	21	21
CGGACTGCACAGACTT-1_1_A9	-11.51903154	31.25106971	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	830	1040	0.029807692	0.004807692	11	oligos	OL-MS-2	64	21	21
CGGACTGGTACGAAAT-1_1_A9	20.39486201	-24.3210798	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6102	19744	0.007344003	0.008002431	11	3	EN-L5-6	64	21	21
CGGACTGGTGATGCCC-1_1_A9	-24.70648706	-6.256396714	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1470	2354	0.012319456	0.00722175	11	9	OPC	64	21	21
CGGACTGGTTAAGAAC-1_1_A9	-9.493949316	-31.38583175	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	916	1233	0.04379562	0.01135442	11	16	EN-PYR	64	21	21
CGGAGCTAGAGACTAT-1_1_A9	-12.08877166	14.28181144	11	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1188	1742	0.012055109	0.00401837	11	11	Glia-MIX	64	21	21
CGGAGCTAGCGTAATA-1_1_A9	22.4916836	-19.74579942	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6435	20793	0.008464387	0.007213966	11	3	EN-L5-6	64	21	21
CGGAGCTAGGAGCGTT-1_1_A9	-9.782220787	31.77211303	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	944	1227	0.016299919	0.012224939	11	oligos	OL-MS-2	64	21	21
CGGAGCTCAACGATGG-1_1_A9	19.15302274	-33.44516317	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6472	23923	0.004138277	0.005308699	11	3	EN-L5-6	64	21	21
CGGAGCTCAGCTGCTG-1_1_A9	-21.44416176	14.9957391	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1238	1975	0.004556962	0.006075949	11	8	Astrocytes	64	21	21
CGGAGCTCATGGATGG-1_1_A9	-11.11071814	12.38020708	11	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1074	1478	0.01894452	0.00541272	11	11	Glia-MIX	64	21	21
CGGAGCTGTGTGACCC-1_1_A9	-12.59491661	-9.119934913	6B	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1584	2720	0.053676471	0.002205882	11	6B	IN-SST	64	21	21
CGGAGCTGTTCCACAA-1_1_A9	-9.387025724	-27.61164418	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1237	1747	0.032627361	0.012593017	11	16	EN-PYR	64	21	21
CGGAGCTGTTTACTCT-1_1_A9	28.15266544	-25.65873372	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6138	22198	0.006937562	0.002702946	11	3	EN-L5-6	64	21	21
CGGAGCTTCGCCTGTT-1_1_A9	-21.04850432	-16.74765887	6B	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4879	14618	0.00519907	0.005404296	11	6B	IN-SST	64	21	21
CGGAGTCAGAAGAAGC-1_1_A9	-20.69035927	16.06928425	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1414	2217	0.00315742	0.00180424	11	8	Astrocytes	64	21	21
CGGAGTCAGACAGGCT-1_1_A9	26.38050122	-24.20296893	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3795	9601	0.029163629	0.002708051	11	3	EN-L5-6	64	21	21
CGGAGTCAGCTGATAA-1_1_A9	-11.06080418	-1.524042975	13A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2248	4244	0.012959472	0.005183789	11	13A	IN-VIP	64	21	21
CGGAGTCAGCTGCAAG-1_1_A9	-13.5754044	-34.58271124	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1621	2708	0.028064993	0.009231905	11	16	EN-PYR	64	21	21
CGGAGTCAGGGCTTCC-1_1_A9	-25.08289376	-10.27402503	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	847	1064	0.008458647	0.008458647	11	9	OPC	64	21	21
CGGAGTCAGGTCATCT-1_1_A9	-24.81065276	-2.102060561	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1490	2588	0.007727975	0.005409583	11	9	OPC	64	21	21
CGGAGTCCACGCCAGT-1_1_A9	-25.79451536	-7.368340666	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1262	1790	0.008938547	0.003351955	11	9	OPC	64	21	21
CGGAGTCCATCCAACA-1_1_A9	25.30160853	6.564833274	15A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1480	2096	0.012881679	0.024332061	11	15A	Endo cells	64	21	21
CGGAGTCTCTCCGGTT-1_1_A9	-4.949525282	36.44877664	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	784	1039	0.01732435	0.008662175	11	oligos	OL-MS-2	64	21	21
CGGAGTCTCTTTAGTC-1_1_A9	-0.494555784	30.11213886	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	751	1078	0.010204082	0.009276438	11	oligos	OL-MS-2	64	21	21
CGGCTAGAGTCAAGCG-1_1_A9	-8.262431566	31.93926774	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1080	1494	0.02811245	0.010709505	11	oligos	OL-MS-2	64	21	21
CGGCTAGCATCAGTCA-1_1_A9	-11.77994102	31.92025931	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1239	1789	0.02235886	0.009502515	11	oligos	OL-MS-2	64	21	21
CGGCTAGCATCATCCC-1_1_A9	-24.93273907	-8.81744767	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1054	1466	0.015006821	0.006821282	11	9	OPC	64	21	21
CGGCTAGGTCGCATCG-1_1_A9	6.975271542	-23.75957073	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6287	20142	0.009135141	0.005659815	11	L2-3	EN-L2-3-MS	64	21	21
CGGCTAGTCAGCTCTC-1_1_A9	-19.63309186	15.45322805	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1642	2674	0.010845176	0.001869858	11	8	Astrocytes	64	21	21
CGGGTCAAGCGTGTCC-1_1_A9	7.406676207	-23.12418931	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5173	14741	0.016213283	0.006987314	11	L2-3	EN-L2-3-MS	64	21	21
CGGGTCAAGGAGCGAG-1_1_A9	-25.01880288	-7.293235114	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1174	1725	0.004637681	0.00173913	11	9	OPC	64	21	21
CGGGTCAAGGATATAC-1_1_A9	2.020829442	5.476416673	7	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	989	1262	0.00792393	0.010301109	11	7	Phagocytes	64	21	21
CGGGTCAAGGATGGAA-1_1_A9	28.6834661	-6.786130921	2	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4821	12779	0.004460443	0.003364896	11	2	EN-L4	64	21	21
CGGGTCAAGGCTCAGA-1_1_A9	-5.815614432	35.20203107	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	888	1203	0.028262677	0.005818786	11	oligos	OL-MS-2	64	21	21
CGGGTCAAGTTTCCTT-1_1_A9	-25.08438627	-5.474643814	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1490	2347	0.01022582	0.003408607	11	9	OPC	64	21	21
CGGGTCACAGACAGGT-1_1_A9	-18.36581478	10.15807052	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	879	1167	0.030848329	0.003427592	11	8	Astrocytes	64	21	21
CGGGTCACAGCGAACA-1_1_A9	-15.75466404	-5.281400731	13A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4136	9927	0.007454417	0.005842651	11	13A	IN-VIP	64	21	21
CGGGTCACAGCGTCCA-1_1_A9	26.18943035	-22.64725583	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	7708	31791	0.020508949	0.00427794	11	3	EN-L5-6	64	21	21
CGGGTCACAGGGATTG-1_1_A9	-11.31144195	15.39848666	11	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1570	2402	0.007493755	0.007077435	11	11	Glia-MIX	64	21	21
CGGGTCACATTACCTT-1_1_A9	16.018786	-18.97616001	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6256	20355	0.011299435	0.005158438	11	L2-3	EN-L2-3-MS	64	21	21
CGGGTCAGTCGAACAG-1_1_A9	-8.041253721	-30.42947997	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	791	1059	0.061378659	0.002832861	11	16	EN-PYR	64	21	21
CGGGTCATCACGATGT-1_1_A9	-6.091435191	32.10241643	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1126	1558	0.016046213	0.008344031	11	oligos	OL-MS-2	64	21	21
CGGTTAAAGATTACCC-1_1_A9	18.99018974	-34.60847384	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5139	15934	0.005334505	0.004769675	11	3	EN-L5-6	64	21	21
CGGTTAAAGCGGATCA-1_1_A9	7.348189725	-25.19466486	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	7047	24833	0.005879274	0.006201426	11	L2-3	EN-L2-3-MS	64	21	21
CGGTTAATCCTATGTT-1_1_A9	-7.491579866	-28.49418208	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	849	1195	0.085355649	0.009205021	11	16	EN-PYR	64	21	21
CGGTTAATCCTGTAGA-1_1_A9	26.2175647	-24.74016211	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5108	15734	0.014872251	0.003559171	11	3	EN-L5-6	64	21	21
CGGTTAATCGGATGGA-1_1_A9	26.2351351	-22.73788216	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	7196	26943	0.019077311	0.004416732	11	3	EN-L5-6	64	21	21
CGTAGCGAGCAGGCTA-1_1_A9	-24.96016016	-5.569655157	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1425	2222	0.004950495	0.006750675	11	9	OPC	64	21	21
CGTAGCGAGTGAATTG-1_1_A9	-15.10936141	-34.38639365	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1775	2731	0.020871476	0.009154156	11	16	EN-PYR	64	21	21
CGTAGCGAGTGGGCTA-1_1_A9	27.9779427	-25.75385481	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4330	12927	0.007735747	0.002552796	11	3	EN-L5-6	64	21	21
CGTAGCGCACATCTTT-1_1_A9	19.36716356	-33.1144913	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	7185	29567	0.007880407	0.003585078	11	3	EN-L5-6	64	21	21
CGTAGCGCAGGGATTG-1_1_A9	-23.8503516	-7.349276255	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1329	1941	0.018031942	0.009788769	11	9	OPC	64	21	21
CGTAGCGGTGATGTGG-1_1_A9	-25.41025301	-8.625250359	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1020	1423	0.009135629	0.00983837	11	9	OPC	64	21	21
CGTAGCGGTTCAGGCC-1_1_A9	-13.61183932	-34.17648733	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1643	2681	0.042894442	0.008951884	11	16	EN-PYR	64	21	21
CGTAGCGTCTATCCCG-1_1_A9	-13.28383007	8.004210032	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1861	2857	0.035701785	0.004900245	11	8	Astrocytes	64	21	21
CGTAGGCCAAAGAATC-1_1_A9	-15.54876446	-4.333576325	13A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2999	5818	0.016156755	0.010312822	11	13A	IN-VIP	64	21	21
CGTAGGCCAACTGCTA-1_1_A9	-21.82038458	14.86730189	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1223	1864	0.011802575	0.00804721	11	8	Astrocytes	64	21	21
CGTAGGCCAAGGACAC-1_1_A9	-8.076175434	-30.42239904	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	886	1207	0.086164043	0.005799503	11	16	EN-PYR	64	21	21
CGTAGGCCAGCTGGCT-1_1_A9	-13.94939908	-3.602027094	13A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3458	7606	0.006047857	0.009466211	11	13A	IN-VIP	64	21	21
CGTAGGCGTATATCCG-1_1_A9	-5.265859382	36.06915759	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	739	1004	0.021912351	0.009960159	11	oligos	OL-MS-2	64	21	21
CGTAGGCGTTTACTCT-1_1_A9	-24.79857256	-9.184545901	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1080	1469	0.014295439	0.015656909	11	9	OPC	64	21	21
CGTAGGCTCACTCTTA-1_1_A9	12.06201332	0.812952697	12	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	784	1204	0.02076412	0.007475083	11	12	EN-MIX	64	21	21
CGTAGGCTCAGGCGAA-1_1_A9	3.93363802	0.745668642	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	803	1084	0.08302583	0.007380074	11	16	EN-PYR	64	21	21
CGTAGGCTCCCAAGTA-1_1_A9	-7.535264914	-29.21712236	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	870	1185	0.084388186	0.005907173	11	16	EN-PYR	64	21	21
CGTAGGCTCGCATGAT-1_1_A9	-8.4143337	31.96840073	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1083	1457	0.019903912	0.012354152	11	oligos	OL-MS-2	64	21	21
CGTCACTAGTTGCAGG-1_1_A9	6.022186941	-25.34605336	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6325	22605	0.006016368	0.00287547	11	L2-3	EN-L2-3-MS	64	21	21
CGTCACTCAAGGACTG-1_1_A9	-5.397138455	32.22112231	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1104	1564	0.010869565	0.00511509	11	oligos	OL-MS-2	64	21	21
CGTCACTCAATCCAAC-1_1_A9	-11.32785718	30.58858552	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	985	1321	0.050719152	0.00984103	11	oligos	OL-MS-2	64	21	21
CGTCACTCACCGCTAG-1_1_A9	4.062788665	1.212872563	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	773	1007	0.05163853	0.006951341	11	16	EN-PYR	64	21	21
CGTCACTCAGTCACTA-1_1_A9	-9.03452726	32.51956924	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	940	1317	0.025816249	0.009870919	11	oligos	OL-MS-2	64	21	21
CGTCACTCAGTTAACC-1_1_A9	-18.98998261	14.77791378	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1450	2260	0.012831858	0.003982301	11	8	Astrocytes	64	21	21
CGTCACTGTCCTCCAT-1_1_A9	-4.918767169	33.56384591	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	922	1290	0.01627907	0.003875969	11	oligos	OL-MS-2	64	21	21
CGTCACTGTCTACCTC-1_1_A9	-9.733835976	-31.19366152	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	915	1317	0.051632498	0.004555809	11	16	EN-PYR	64	21	21
CGTCACTTCTGTCCGT-1_1_A9	-25.87963109	-24.00666992	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4597	12356	0.020233085	0.00485594	11	6A	IN-PV	64	21	21
CGTCAGGAGGCAATTA-1_1_A9	25.92800413	7.622691256	15A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1578	2233	0.018808777	0.044334975	11	15A	Endo cells	64	21	21
CGTCAGGCAAGTCATC-1_1_A9	-22.11603106	16.06493914	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1321	2168	0.004151292	0.003690037	11	8	Astrocytes	64	21	21
CGTCAGGCACACGCTG-1_1_A9	17.64903554	-32.39179861	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4313	12027	0.005820238	0.002993265	11	3	EN-L5-6	64	21	21
CGTCAGGCATGAACCT-1_1_A9	-6.079640979	35.77864681	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	828	1133	0.015004413	0.00353045	11	oligos	OL-MS-2	64	21	21
CGTCAGGGTAGGGTAC-1_1_A9	-7.001926728	31.10882778	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1443	2137	0.02292934	0.004211511	11	oligos	OL-MS-2	64	21	21
CGTCAGGGTGACTACT-1_1_A9	-25.60043105	-10.17707188	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	848	1178	0.004244482	0.017826825	11	9	OPC	64	21	21
CGTCAGGGTGTAAGTA-1_1_A9	25.83420492	-23.38159982	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5428	15273	0.01538663	0.006874877	11	3	EN-L5-6	64	21	21
CGTCAGGGTTCCGTCT-1_1_A9	-17.44480257	9.414584113	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1072	1592	0.005653266	0.009422111	11	8	Astrocytes	64	21	21
CGTCCATCACGACGAA-1_1_A9	-21.34520118	-16.58876389	6B	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3987	9213	0.005861283	0.00379898	11	6B	IN-SST	64	21	21
CGTCCATCATTCCTGC-1_1_A9	-31.85615744	0.035647387	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2018	3463	0.00664164	0.008374242	11	9	OPC	64	21	21
CGTCCATGTCTAAAGA-1_1_A9	-7.607608647	-29.45070443	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	801	1021	0.048971596	0.003917728	11	16	EN-PYR	64	21	21
CGTCCATGTGAACCTT-1_1_A9	4.568984768	-26.34039973	10	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3144	7332	0.003000546	0.004773595	11	L2-3	EN-L2-3-Cntl	64	21	21
CGTCCATTCCAAACTG-1_1_A9	-25.72989968	-7.719129823	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1182	1780	0.01011236	0.016853933	11	9	OPC	64	21	21
CGTCCATTCGTAGGTT-1_1_A9	-1.318755671	34.06865358	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	921	1293	0.020881671	0.003866976	11	oligos	OL-MS-2	64	21	21
CGTCCATTCGTGGGAA-1_1_A9	27.01730342	-15.17629929	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6417	19924	0.016261795	0.012798635	11	3	EN-L5-6	64	21	21
CGTCTACAGACCTTTG-1_1_A9	-31.59840013	-9.879150688	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	990	1469	0.006807352	0.00136147	11	9	OPC	64	21	21
CGTCTACAGACTACAA-1_1_A9	-7.535286915	-28.03807587	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	749	1055	0.121327014	0.007582938	11	16	EN-PYR	64	21	21
CGTCTACAGATCCTGT-1_1_A9	34.00252336	7.075613978	14	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1255	1729	0.022556391	0.024869867	11	14	Microglia	64	21	21
CGTCTACAGCTCCTTC-1_1_A9	-16.04229921	-6.102975759	13A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5607	18685	0.023334225	0.006261707	11	13A	IN-VIP	64	21	21
CGTCTACAGGTGCTTT-1_1_A9	-21.61371647	15.52870559	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1235	2028	0.008382643	0.003944773	11	8	Astrocytes	64	21	21
CGTCTACCAAACCCAT-1_1_A9	-9.192074486	-15.19262433	6B	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	857	1186	0.02698145	0.00084317	11	6B	IN-SST	64	21	21
CGTCTACTCCACGCAG-1_1_A9	28.87136603	-7.014234505	2	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4540	12966	0.005784359	0.004396113	11	2	EN-L4	64	21	21
CGTCTACTCGTGGACC-1_1_A9	-10.49161113	30.11504579	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	894	1184	0.026182432	0.004222973	11	oligos	OL-MS-2	64	21	21
CGTCTACTCTGCCCTA-1_1_A9	-17.38939688	-8.094246559	13B	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2986	5967	0.008547009	0.006368359	11	13B	IN-SV2C	64	21	21
CGTGAGCAGTAAGTAC-1_1_A9	22.26674116	-18.691361	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5315	14549	0.015808647	0.009210255	11	3	EN-L5-6	64	21	21
CGTGAGCCACATGTGT-1_1_A9	-3.562816105	32.76633699	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	890	1200	0.013333333	0.003333333	11	oligos	OL-MS-2	64	21	21
CGTGAGCCAGGCAGTA-1_1_A9	-25.37822307	-9.385139551	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	882	1257	0.011933174	0.005568815	11	9	OPC	64	21	21
CGTGAGCGTAAGTGGC-1_1_A9	9.36490872	-2.387314222	12	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1838	3252	0.023062731	0.005535055	11	12	EN-MIX	64	21	21
CGTGAGCGTGGTAACG-1_1_A9	-14.23087601	-16.26266766	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1421	2161	0.04349838	0.005552985	11	6A	IN-PV	64	21	21
CGTGAGCTCACTTCAT-1_1_A9	5.136680977	-23.4257583	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5092	15501	0.007934972	0.007160828	11	L2-3	EN-L2-3-MS	64	21	21
CGTGTAACAGAGTGTG-1_1_A9	-7.578087782	-32.93481767	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	862	1155	0.027705628	0.01038961	11	16	EN-PYR	64	21	21
CGTGTAACAGCCTGTG-1_1_A9	7.16615128	-23.5268729	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5308	16078	0.013807688	0.004229382	11	L2-3	EN-L2-3-MS	64	21	21
CGTGTAAGTGACCAAG-1_1_A9	27.46540764	-24.27108135	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4696	12827	0.012317767	0.005067436	11	3	EN-L5-6	64	21	21
CGTGTCTAGACAGAGA-1_1_A9	-8.610841587	-30.20604396	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	925	1267	0.045777427	0.013417522	11	16	EN-PYR	64	21	21
CGTGTCTCAGGAATCG-1_1_A9	7.457962907	-18.1938476	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3378	7355	0.008973487	0.025016995	11	L2-3	EN-L2-3-MS	64	21	21
CGTGTCTGTAAGCACG-1_1_A9	-11.12208662	29.47435029	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1091	1526	0.014416776	0.008519004	11	oligos	OL-MS-2	64	21	21
CGTGTCTGTTCGCTAA-1_1_A9	-17.6255492	8.954547968	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1050	1471	0.008837525	0.010876954	11	8	Astrocytes	64	21	21
CGTTAGAAGAAACGAG-1_1_A9	19.04701513	-34.32318651	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5123	16113	0.002048036	0.006082046	11	3	EN-L5-6	64	21	21
CGTTAGAAGCGCTCCA-1_1_A9	-21.68161226	-16.42360166	6B	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2496	4650	0.02344086	0.004946237	11	6B	IN-SST	64	21	21
CGTTAGACACAACGCC-1_1_A9	-7.242270053	36.00768764	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	796	1003	0.020937188	0.005982054	11	oligos	OL-MS-2	64	21	21
CGTTAGACAGAAGCAC-1_1_A9	-14.976716	10.54695764	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1400	2127	0.004231312	0.003761166	11	8	Astrocytes	64	21	21
CGTTAGAGTATGCTTG-1_1_A9	26.21756212	-22.67321988	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6390	23581	0.011322675	0.003519783	11	3	EN-L5-6	64	21	21
CGTTAGAGTCATCGGC-1_1_A9	16.03919062	-18.88264578	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6427	21070	0.015472235	0.009587091	11	L2-3	EN-L2-3-MS	64	21	21
CGTTAGATCCGTCAAA-1_1_A9	24.55287487	8.240758455	15A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3107	5487	0.013486422	0.020229634	11	15A	Endo cells	64	21	21
CGTTAGATCCGTCATC-1_1_A9	-2.450329232	36.08048636	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	859	1264	0.02056962	0.007120253	11	oligos	OL-MS-2	64	21	21
CGTTAGATCTAGCACA-1_1_A9	6.327119927	-25.45610863	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4517	11882	0.004797172	0.003113954	11	L2-3	EN-L2-3-MS	64	21	21
CGTTCTGAGAACTGTA-1_1_A9	-8.889355731	-29.80861	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	960	1331	0.045078888	0.011269722	11	16	EN-PYR	64	21	21
CGTTCTGCAAACTGCT-1_1_A9	19.27776436	-30.73188362	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6487	22938	0.00279013	0.013253117	11	3	EN-L5-6	64	21	21
CGTTCTGGTACTCGCG-1_1_A9	-12.39467541	17.0367703	11	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1909	3156	0.006337136	0.003168568	11	11	Glia-MIX	64	21	21
CGTTCTGGTCTAGCGC-1_1_A9	29.12755657	-11.51297531	2	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4821	12631	0.020346766	0.009421265	11	2	EN-L4	64	21	21
CGTTCTGGTCTGATTG-1_1_A9	7.161964608	-21.8817096	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4520	12434	0.001608493	0.011420299	11	L2-3	EN-L2-3-MS	64	21	21
CGTTCTGGTGCTAGCC-1_1_A9	19.83958487	-11.48532763	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2840	6355	0.0061369	0.007395751	11	3	EN-L5-6	64	21	21
CGTTCTGTCGCGGATC-1_1_A9	33.15013906	4.748605328	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	882	1098	0.039162113	0.008196721	11	16	EN-PYR	64	21	21
CGTTGGGAGAGGACGG-1_1_A9	19.78152575	-33.87951641	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4302	10840	0.006088561	0.004335793	11	3	EN-L5-6	64	21	21
CGTTGGGAGGACTGGT-1_1_A9	-18.86220095	-21.039159	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2528	5421	0.01180594	0.003504888	11	6A	IN-PV	64	21	21
CGTTGGGGTATTCGTG-1_1_A9	28.31042757	-25.80471734	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5772	19011	0.0046815	0.003208669	11	3	EN-L5-6	64	21	21
CGTTGGGTCACGACTA-1_1_A9	-18.91275119	-8.103884175	13B	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4124	9716	0.013482915	0.00648415	11	13B	IN-SV2C	64	21	21
CGTTGGGTCCTCGCAT-1_1_A9	-5.045735831	34.54204223	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	886	1223	0.020441537	0.00572363	11	oligos	OL-MS-2	64	21	21
CGTTGGGTCTCTGTCG-1_1_A9	30.41684631	-7.889487324	2	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5111	14179	0.007193737	0.010226391	11	2	EN-L4	64	21	21
CTAACTTCACCGAAAG-1_1_A9	-17.93776495	9.833244941	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	932	1309	0.016806723	0.009167303	11	8	Astrocytes	64	21	21
CTAACTTGTAGCTAAA-1_1_A9	6.129739213	-24.17230699	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5699	19076	0.010327113	0.003407423	11	L2-3	EN-L2-3-MS	64	21	21
CTAACTTGTGTGGCTC-1_1_A9	5.44001038	-25.17633006	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5026	16997	0.002647526	0.005295052	11	L2-3	EN-L2-3-MS	64	21	21
CTAACTTGTTCAGTAC-1_1_A9	-25.21813505	-5.842008474	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1338	2129	0.009863786	0.009394082	11	9	OPC	64	21	21
CTAACTTGTTCGTTGA-1_1_A9	-34.02127049	-8.65992139	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	993	1493	0.005358339	0.005358339	11	9	OPC	64	21	21
CTAACTTTCCATGAGT-1_1_A9	-3.567758931	35.65181241	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	752	1027	0.011684518	0.005842259	11	oligos	OL-MS-2	64	21	21
CTAAGACAGGGCTTGA-1_1_A9	2.534893216	-17.73880539	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3203	7939	0.013099887	0.007557627	11	L2-3	EN-L2-3-MS	64	21	21
CTAAGACAGTGGAGAA-1_1_A9	-27.62196305	4.396296757	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1909	3069	0.008145976	0.007820137	11	9	OPC	64	21	21
CTAAGACCAGTCCTTC-1_1_A9	-19.05511735	10.76331187	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	824	1076	0.024163569	0.00929368	11	8	Astrocytes	64	21	21
CTAAGACCATTCACTT-1_1_A9	6.892373499	-25.68276888	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	7137	28914	0.006052431	0.008888428	11	L2-3	EN-L2-3-MS	64	21	21
CTAAGACCATTTCACT-1_1_A9	5.275531055	1.748009072	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	903	1156	0.05017301	0.01384083	11	16	EN-PYR	64	21	21
CTAAGACGTGACCAAG-1_1_A9	31.21551207	-6.955407366	2	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4283	10889	0.005050969	0.012581504	11	2	EN-L4	64	21	21
CTAAGACTCACAAACC-1_1_A9	19.05656387	-32.77742947	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6554	24985	0.006403842	0.007284371	11	3	EN-L5-6	64	21	21
CTAAGACTCGGTTCGG-1_1_A9	-18.85861596	-5.773419979	13B	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3250	6681	0.014219428	0.011225864	11	13B	IN-SV2C	64	21	21
CTAAGACTCTCAAACG-1_1_A9	-19.38520311	11.07476041	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	899	1216	0.018092105	0.004111842	11	8	Astrocytes	64	21	21
CTAATGGCATTAACCG-1_1_A9	19.67000781	-32.9470209	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	7246	29709	0.008751557	0.006260729	11	3	EN-L5-6	64	21	21
CTAATGGGTAAGGGAA-1_1_A9	-21.39035614	13.09543245	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1158	1729	0.012724118	0.003470214	11	8	Astrocytes	64	21	21
CTAATGGGTCCAACTA-1_1_A9	-6.193507913	34.54146256	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	857	1124	0.018683274	0.009786477	11	oligos	OL-MS-2	64	21	21
CTAATGGGTCTCCATC-1_1_A9	-0.740770573	33.01316496	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	807	1108	0.017148014	0.007220217	11	oligos	OL-MS-2	64	21	21
CTAATGGTCGTTACGA-1_1_A9	-11.3591135	-33.4998233	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1172	1735	0.042651297	0.004034582	11	16	EN-PYR	64	21	21
CTAATGGTCTATCCCG-1_1_A9	-22.2679542	-16.02045601	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4705	13579	0.009868179	0.004050372	11	6A	IN-PV	64	21	21
CTAATGGTCTGCTGTC-1_1_A9	-10.30999741	30.81571339	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1100	1496	0.034759358	0.007352941	11	oligos	OL-MS-2	64	21	21
CTACACCAGGTGCACA-1_1_A9	7.837042642	-0.359187873	12	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	874	1173	0.071611253	0.00511509	11	12	EN-MIX	64	21	21
CTACACCCAAGACACG-1_1_A9	20.51690919	-31.88069428	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	9046	45302	0.019491413	0.004304446	11	3	EN-L5-6	64	21	21
CTACACCCATGCATGT-1_1_A9	6.872497402	-25.75924511	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	7022	29085	0.008733024	0.007770328	11	L2-3	EN-L2-3-MS	64	21	21
CTACACCCATGGATGG-1_1_A9	19.05192746	-33.40088142	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6088	21960	0.004781421	0.003460838	11	3	EN-L5-6	64	21	21
CTACACCCATGGGAAC-1_1_A9	5.428909607	1.934416654	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	950	1232	0.044642857	0.008116883	11	16	EN-PYR	64	21	21
CTACACCGTACCTACA-1_1_A9	-5.68161869	31.20741843	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1218	1781	0.022459293	0.005614823	11	oligos	OL-MS-2	64	21	21
CTACACCGTTCAGGCC-1_1_A9	-8.118882539	34.72561058	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	855	1197	0.023391813	0.003341688	11	oligos	OL-MS-2	64	21	21
CTACACCTCGTATCAG-1_1_A9	-14.0320224	-4.429595011	13A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3082	6620	0.018126888	0.007099698	11	13A	IN-VIP	64	21	21
CTACACCTCTGGCGAC-1_1_A9	-24.50331877	-6.524336019	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1279	2029	0.017249877	0.002957122	11	9	OPC	64	21	21
CTACATTAGTAGATGT-1_1_A9	-9.079277526	-12.025054	6B	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	869	1275	0.04	0.002352941	11	6B	IN-SST	64	21	21
CTACATTGTACGACCC-1_1_A9	18.98478765	-34.48301681	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4842	13957	0.005946837	0.005445296	11	3	EN-L5-6	64	21	21
CTACATTGTCAAAGAT-1_1_A9	26.08278289	-24.14002985	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3279	7910	0.06852086	0.002022756	11	3	EN-L5-6	64	21	21
CTACATTGTCTCCATC-1_1_A9	5.288738199	-23.13527205	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5709	18893	0.005769333	0.009686127	11	L2-3	EN-L2-3-MS	64	21	21
CTACATTTCGAGAGCA-1_1_A9	-21.56683976	14.49199604	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1188	1796	0.011135857	0.005567929	11	8	Astrocytes	64	21	21
CTACATTTCTGCTGTC-1_1_A9	-11.86870871	13.59780902	11	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	862	1221	0.005733006	0.000819001	11	11	Glia-MIX	64	21	21
CTACCCAAGGAGTTTA-1_1_A9	26.70002976	-27.18352496	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4651	14187	0.004652146	0.003453866	11	3	EN-L5-6	64	21	21
CTACCCAAGGCATGGT-1_1_A9	26.64759313	-23.60999201	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	7452	30450	0.018981938	0.00410509	11	3	EN-L5-6	64	21	21
CTACCCAAGGGCTTCC-1_1_A9	-6.335790832	-30.14887403	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	803	1059	0.09631728	0.004721435	11	16	EN-PYR	64	21	21
CTACCCAAGGGTTCCC-1_1_A9	-3.77356553	32.38468821	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1068	1614	0.013011152	0.003097893	11	oligos	OL-MS-2	64	21	21
CTACCCACACACATGT-1_1_A9	-11.65324805	30.27742584	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1042	1405	0.051245552	0.002846975	11	oligos	OL-MS-2	64	21	21
CTACCCAGTATTCGTG-1_1_A9	-18.31981924	10.37688553	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	967	1269	0.023640662	0.005516154	11	8	Astrocytes	64	21	21
CTACCCAGTGCACCAC-1_1_A9	-13.5287594	-34.00484937	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1649	2662	0.059729527	0.010518407	11	16	EN-PYR	64	21	21
CTACCCAGTGTTAAGA-1_1_A9	6.923509702	-20.99591465	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5295	16331	0.003306595	0.023513563	11	L2-3	EN-L2-3-MS	64	21	21
CTACCCATCAGCCTAA-1_1_A9	-9.44903021	33.39176161	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	840	1090	0.018348624	0.010091743	11	oligos	OL-MS-2	64	21	21
CTACCCATCCGTAGTA-1_1_A9	32.83447551	5.465803592	14	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	971	1225	0.013061224	0.004897959	11	14	Microglia	64	21	21
CTACCCATCCTATGTT-1_1_A9	-15.37191784	-36.69944209	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3275	7886	0.058077606	0.007988841	11	16	EN-PYR	64	21	21
CTACCCATCCTTCAAT-1_1_A9	-25.2437499	-8.899507314	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1064	1460	0.012328767	0.006849315	11	9	OPC	64	21	21
CTACGTCCACGAGGTA-1_1_A9	27.61455185	4.041275979	15BA	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1008	1360	0.007352941	0.004411765	11	15BA	Stromal cells	64	21	21
CTACGTCCATACGCTA-1_1_A9	-26.20197255	-9.233990615	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	939	1320	0.013636364	0.013636364	11	9	OPC	64	21	21
CTACGTCCATGTTCCC-1_1_A9	3.594974257	0.285449324	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1089	1496	0.060828877	0.011363636	11	16	EN-PYR	64	21	21
CTACGTCGTAATAGCA-1_1_A9	-20.29387639	12.42854127	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1130	1634	0.006119951	0.007955936	11	8	Astrocytes	64	21	21
CTACGTCGTCAAACTC-1_1_A9	26.91146031	-25.37739214	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4520	12571	0.012250418	0.002943282	11	3	EN-L5-6	64	21	21
CTACGTCGTCATCGGC-1_1_A9	7.008249207	-24.15104182	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6822	25414	0.010663414	0.004957897	11	L2-3	EN-L2-3-MS	64	21	21
CTACGTCGTGACTCAT-1_1_A9	6.10183334	-21.87462032	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3321	7445	0.006715917	0.00886501	11	L2-3	EN-L2-3-MS	64	21	21
CTAGAGTAGGCACATG-1_1_A9	-25.40634738	-10.04995667	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	856	1128	0.008865248	0.003546099	11	9	OPC	64	21	21
CTAGAGTAGGTTACCT-1_1_A9	18.7646926	-32.87182742	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6518	26976	0.005412218	0.003632859	11	3	EN-L5-6	64	21	21
CTAGAGTAGTTAGGTA-1_1_A9	-15.04945657	-16.71137144	6B	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1397	2235	0.012080537	0.003131991	11	6B	IN-SST	64	21	21
CTAGAGTGTGCGATAG-1_1_A9	22.63152804	-20.5297035	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6401	21619	0.009621167	0.004070494	11	3	EN-L5-6	64	21	21
CTAGAGTGTGTATGGG-1_1_A9	27.73321769	-24.49775188	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5943	20133	0.009238564	0.00496697	11	3	EN-L5-6	64	21	21
CTAGCCTAGCGAGAAA-1_1_A9	-9.470807121	-31.25217435	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	970	1364	0.063782991	0.00659824	11	16	EN-PYR	64	21	21
CTAGCCTAGTCGATAA-1_1_A9	-20.67199818	16.37108889	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1462	2376	0.007154882	0.002946128	11	8	Astrocytes	64	21	21
CTAGCCTAGTGGGTTG-1_1_A9	-17.81430542	9.799511487	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1021	1403	0.023521026	0.009265859	11	8	Astrocytes	64	21	21
CTAGCCTAGTTGAGTA-1_1_A9	-21.69024167	13.80633791	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1074	1603	0.006238303	0.001247661	11	8	Astrocytes	64	21	21
CTAGCCTCAACGATCT-1_1_A9	-13.23735773	-16.70542326	6B	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1212	1881	0.028176502	0.002658161	11	6B	IN-SST	64	21	21
CTAGCCTGTGTTAAGA-1_1_A9	-24.82990389	-5.651817951	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1638	2582	0.013555383	0.00697134	11	9	OPC	64	21	21
CTAGCCTGTTGTGGAG-1_1_A9	-10.00531576	32.03416284	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	877	1157	0.023336214	0.006914434	11	oligos	OL-MS-2	64	21	21
CTAGTGAAGAAGCCCA-1_1_A9	-11.75918299	16.84489651	11	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2220	4054	0.012826838	0.003946719	11	11	Glia-MIX	64	21	21
CTAGTGACAGGTGGAT-1_1_A9	-16.49579641	-9.141376829	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2344	4410	0.018367347	0.006802721	11	6A	IN-PV	64	21	21
CTAGTGAGTCAGCTAT-1_1_A9	-26.7479228	-9.220529171	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	918	1305	0.011494253	0.007662835	11	9	OPC	64	21	21
CTAGTGAGTTTCCACC-1_1_A9	-21.1067843	14.93190203	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1382	2446	0.00572363	0.002452984	11	8	Astrocytes	64	21	21
CTAGTGATCTGATTCT-1_1_A9	-18.93982958	10.34685032	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	739	1033	0.006776379	0.004840271	11	8	Astrocytes	64	21	21
CTCACACAGCTGCAAG-1_1_A9	-9.743009405	33.05185776	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	768	1012	0.017786561	0.007905138	11	oligos	OL-MS-2	64	21	21
CTCACACCAGTTCATG-1_1_A9	28.26696351	-25.72190221	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6809	28110	0.006403415	0.002134472	11	3	EN-L5-6	64	21	21
CTCACACCATATACGC-1_1_A9	-10.64135144	-29.68768972	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1288	1923	0.095683827	0.007280291	11	16	EN-PYR	64	21	21
CTCACACCATCACGTA-1_1_A9	18.04543632	-20.19665315	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3584	8350	0.007904192	0.004550898	11	L2-3	EN-L2-3-MS	64	21	21
CTCACACGTGAAATCA-1_1_A9	-7.769291578	35.13199523	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	783	1026	0.015594542	0.005847953	11	oligos	OL-MS-2	64	21	21
CTCACACGTTGACGTT-1_1_A9	-12.01516671	30.82582977	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	966	1304	0.047546012	0.004601227	11	oligos	OL-MS-2	64	21	21
CTCACACGTTGTGGAG-1_1_A9	-31.75058768	-10.15347659	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	885	1248	0.008814103	0.00400641	11	9	OPC	64	21	21
CTCACACTCCCTCTTT-1_1_A9	-22.99589467	-16.22267946	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6995	26524	0.025410949	0.005391344	11	6A	IN-PV	64	21	21
CTCACACTCCGGCACA-1_1_A9	-9.09244824	34.38185065	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	811	1083	0.015697138	0.003693444	11	oligos	OL-MS-2	64	21	21
CTCACACTCCTTAATC-1_1_A9	5.013978409	1.755381099	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	808	1063	0.061147695	0.014111007	11	16	EN-PYR	64	21	21
CTCACACTCTGCGACG-1_1_A9	-11.29371608	30.64688054	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1195	1635	0.028134557	0.004892966	11	oligos	OL-MS-2	64	21	21
CTCAGAAAGTCCCACG-1_1_A9	-9.067241967	-27.87757477	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1052	1416	0.069915254	0.008474576	11	16	EN-PYR	64	21	21
CTCAGAAAGTGACATA-1_1_A9	4.176423948	1.341312147	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1130	1745	0.050429799	0.00286533	11	16	EN-PYR	64	21	21
CTCAGAAGTCATATCG-1_1_A9	-25.58423463	-7.590065746	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1057	1527	0.01113294	0.003274394	11	9	OPC	64	21	21
CTCAGAATCTTGAGAC-1_1_A9	-18.76808241	-8.521795391	13B	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3637	8097	0.01753736	0.006422132	11	13B	IN-SV2C	64	21	21
CTCAGAATCTTGAGGT-1_1_A9	-9.202167185	-29.91643296	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	952	1303	0.069838833	0.008442057	11	16	EN-PYR	64	21	21
CTCATTACAAACCTAC-1_1_A9	-10.5251901	-27.50300619	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1095	1484	0.034366577	0.008760108	11	16	EN-PYR	64	21	21
CTCATTAGTAGCGTAG-1_1_A9	-25.20000999	-9.962213337	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	953	1312	0.006859756	0.008384146	11	9	OPC	64	21	21
CTCATTAGTTACCGAT-1_1_A9	-18.58911231	10.55429529	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	869	1223	0.021259199	0.006541292	11	8	Astrocytes	64	21	21
CTCATTATCAGCTGGC-1_1_A9	25.42001429	-23.23739954	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4903	14240	0.006390449	0.014957865	11	3	EN-L5-6	64	21	21
CTCATTATCTGCAGTA-1_1_A9	11.7593545	-2.693833712	12	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1424	2472	0.017394822	0.004045307	11	12	EN-MIX	64	21	21
CTCCTAGAGAGCTTCT-1_1_A9	-4.706787813	32.4359687	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1124	1604	0.00872818	0.009975062	11	oligos	OL-MS-2	64	21	21
CTCCTAGCAATGACCT-1_1_A9	-8.45018262	33.21992121	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	878	1193	0.023470243	0.007544007	11	oligos	OL-MS-2	64	21	21
CTCCTAGCACCAGTTA-1_1_A9	22.51280062	-19.1680268	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6197	20391	0.016674023	0.009317836	11	3	EN-L5-6	64	21	21
CTCCTAGCAGAGCCAA-1_1_A9	-10.58460143	30.86927975	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	823	1088	0.027573529	0.010110294	11	oligos	OL-MS-2	64	21	21
CTCCTAGCAGCCTTGG-1_1_A9	-32.55310203	4.425458308	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2753	5583	0.00483611	0.010926025	11	9	OPC	64	21	21
CTCCTAGGTGTGCCTG-1_1_A9	28.21569591	-25.55419695	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6609	25567	0.004732663	0.004106856	11	3	EN-L5-6	64	21	21
CTCCTAGTCAACACTG-1_1_A9	-20.09664289	14.50590733	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1345	2158	0.012511585	0.005560704	11	8	Astrocytes	64	21	21
CTCCTAGTCACATGCA-1_1_A9	-14.46530239	9.541788781	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1313	2028	0.017751479	0.005424063	11	8	Astrocytes	64	21	21
CTCCTAGTCAGCCTAA-1_1_A9	28.2897506	-25.55312308	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	7112	31562	0.00560801	0.003833724	11	3	EN-L5-6	64	21	21
CTCCTAGTCTTGGGTA-1_1_A9	20.246415	-32.11961842	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6709	24937	0.007057786	0.004130409	11	3	EN-L5-6	64	21	21
CTCGAAACACGTCTCT-1_1_A9	-14.42982425	-3.78856028	13A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4699	12754	0.006899796	0.006821389	11	13A	IN-VIP	64	21	21
CTCGAAACAGTATCTG-1_1_A9	20.63981315	-26.61434941	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4166	11123	0.003506248	0.005034613	11	3	EN-L5-6	64	21	21
CTCGAAACATAGGATA-1_1_A9	-5.086161205	32.47334579	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1048	1443	0.019404019	0.004851005	11	oligos	OL-MS-2	64	21	21
CTCGAAAGTACGCTGC-1_1_A9	27.96559091	-24.58433507	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6806	25559	0.010368168	0.004499394	11	3	EN-L5-6	64	21	21
CTCGAAAGTTAAGACA-1_1_A9	-25.46414754	-9.974944385	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	868	1160	0.012931034	0.007758621	11	9	OPC	64	21	21
CTCGAAATCATGCAAC-1_1_A9	-25.23909795	-6.161037448	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1339	2067	0.011127238	0.009192066	11	9	OPC	64	21	21
CTCGAGGAGGCAATTA-1_1_A9	-6.89935897	-29.03583144	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	813	1038	0.075144509	0.012524085	11	16	EN-PYR	64	21	21
CTCGAGGAGGCATGGT-1_1_A9	-21.97213996	15.60192726	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1357	2207	0.005890349	0.006796556	11	8	Astrocytes	64	21	21
CTCGAGGAGTCCATAC-1_1_A9	-7.68509666	-29.25296494	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	791	1037	0.029893925	0.008678881	11	16	EN-PYR	64	21	21
CTCGAGGGTAGCTTGT-1_1_A9	19.34704531	-34.09463423	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5265	18008	0.004886717	0.003553976	11	3	EN-L5-6	64	21	21
CTCGAGGGTCCGACGT-1_1_A9	-19.02483951	15.12179567	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1810	3028	0.020475561	0.007595773	11	8	Astrocytes	64	21	21
CTCGAGGGTGCGCTTG-1_1_A9	-29.57406654	-13.21939134	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	806	1096	0.015510949	0.001824818	11	9	OPC	64	21	21
CTCGGAGGTTATCGGT-1_1_A9	-10.06232823	-17.28950659	6B	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	890	1329	0.009781791	0.003009782	11	6B	IN-SST	64	21	21
CTCGGAGTCTGGAGCC-1_1_A9	20.39263439	-11.88572326	12	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2195	4118	0.018455561	0.005342399	11	12	EN-MIX	64	21	21
CTCGGGAAGACCGGAT-1_1_A9	22.37015702	-18.51185951	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6218	19432	0.019658296	0.00648415	11	3	EN-L5-6	64	21	21
CTCGGGACAATAGAGT-1_1_A9	29.85712909	-7.98186495	2	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6040	18842	0.010030782	0.005095001	11	2	EN-L4	64	21	21
CTCGGGACACATCCGG-1_1_A9	26.33979544	-25.00443167	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5186	19274	0.005966587	0.002905469	11	3	EN-L5-6	64	21	21
CTCGGGAGTGGTTTCA-1_1_A9	5.187517399	-23.78324298	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4713	13253	0.005357278	0.003320003	11	L2-3	EN-L2-3-MS	64	21	21
CTCGGGAGTTAAGAAC-1_1_A9	-6.174484378	-29.84685346	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	766	1041	0.087415946	0.016330451	11	16	EN-PYR	64	21	21
CTCGGGATCCCAAGTA-1_1_A9	-25.27211279	-6.661783837	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1271	1895	0.012664908	0.006860158	11	9	OPC	64	21	21
CTCGGGATCTACTCAT-1_1_A9	-23.46765922	-7.648014897	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1392	2120	0.019339623	0.014150943	11	9	OPC	64	21	21
CTCGTACAGCGTCTAT-1_1_A9	-23.20008648	-20.44637595	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3200	6905	0.01897176	0.006661839	11	6A	IN-PV	64	21	21
CTCGTACAGCTTATCG-1_1_A9	-16.50830262	6.867917015	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	931	1426	0.004908836	0.009817672	11	8	Astrocytes	64	21	21
CTCGTACGTTCACCTC-1_1_A9	24.68875382	-2.69918037	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3040	7455	0.005633803	0.003487592	11	3	EN-L5-6	64	21	21
CTCGTCAAGATCCCAT-1_1_A9	-8.565683869	34.44634699	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	856	1132	0.018551237	0.005300353	11	oligos	OL-MS-2	64	21	21
CTCGTCAAGTTACGGG-1_1_A9	28.23471286	-25.97896082	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4484	14062	0.003057887	0.002062296	11	3	EN-L5-6	64	21	21
CTCGTCACAGTCCTTC-1_1_A9	-11.00249841	-30.12854135	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1284	1837	0.05334785	0.010887316	11	16	EN-PYR	64	21	21
CTCGTCACATATACCG-1_1_A9	-24.26343394	-6.207300143	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1522	2467	0.015403324	0.004053506	11	9	OPC	64	21	21
CTCGTCAGTTGTCGCG-1_1_A9	5.647791898	-23.97902141	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5413	16887	0.004500503	0.00373068	11	L2-3	EN-L2-3-MS	64	21	21
CTCGTCATCCTAGGGC-1_1_A9	33.35457192	7.2664203	14	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	824	1007	0.02979146	0.013902681	11	14	Microglia	64	21	21
CTCGTCATCGAGAGCA-1_1_A9	-25.92255464	-7.217884059	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1165	1680	0.005357143	0.006547619	11	9	OPC	64	21	21
CTCGTCATCGTCCGTT-1_1_A9	-8.150618459	32.64507494	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	928	1250	0.0152	0.0024	11	oligos	OL-MS-2	64	21	21
CTCGTCATCTGAGGGA-1_1_A9	-10.05731435	30.82872768	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1041	1463	0.030758715	0.007518797	11	oligos	OL-MS-2	64	21	21
CTCTAATAGCTAACTC-1_1_A9	-7.89789231	34.8866039	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	865	1172	0.023037543	0.008532423	11	oligos	OL-MS-2	64	21	21
CTCTAATAGCTTATCG-1_1_A9	-14.69129374	-16.15544749	6B	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1457	2576	0.059782609	0.004658385	11	6B	IN-SST	64	21	21
CTCTAATAGTGGCACA-1_1_A9	-5.597495969	35.22040467	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	852	1162	0.007745267	0.003442341	11	oligos	OL-MS-2	64	21	21
CTCTAATCACTTGGAT-1_1_A9	4.766328829	-23.71575209	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4065	10915	0.006779661	0.003573065	11	L2-3	EN-L2-3-MS	64	21	21
CTCTAATCAGCATACT-1_1_A9	-8.580797877	-29.67499411	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	871	1167	0.040274207	0.006855184	11	16	EN-PYR	64	21	21
CTCTAATCAGTATGCT-1_1_A9	5.427516249	-24.0810257	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5230	17653	0.006231235	0.002775732	11	L2-3	EN-L2-3-MS	64	21	21
CTCTAATCATCAGTAC-1_1_A9	-16.79087756	-9.77334991	13B	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3316	8002	0.008747813	0.003999	11	13B	IN-SV2C	64	21	21
CTCTAATCATTAACCG-1_1_A9	6.735879525	-3.164452731	12	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1338	2348	0.18483816	0.004258944	11	12	EN-MIX	64	21	21
CTCTAATGTTACCGAT-1_1_A9	-15.1714489	-9.224631433	13A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2460	5296	0.013406344	0.002643505	11	13A	IN-VIP	64	21	21
CTCTAATGTTGGTTTG-1_1_A9	-23.07840391	-15.9620378	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	7100	26795	0.038066804	0.005859302	11	6A	IN-PV	64	21	21
CTCTAATTCCGCAAGC-1_1_A9	25.19379768	5.570344349	15A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1319	1808	0.01880531	0.013274336	11	15A	Endo cells	64	21	21
CTCTAATTCGCGGATC-1_1_A9	5.496971688	-24.17499141	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5353	18651	0.006809286	0.003860383	11	L2-3	EN-L2-3-MS	64	21	21
CTCTAATTCTGAGTGT-1_1_A9	16.58432656	-27.37675774	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4860	14404	0.008469869	0.009858373	11	3	EN-L5-6	64	21	21
CTCTACGAGAGGGCTT-1_1_A9	19.50355769	-30.8437622	2	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5787	18346	0.007358552	0.011174098	11	2	EN-L4	64	21	21
CTCTACGAGGTTACCT-1_1_A9	-18.71590603	-20.90192686	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2158	4161	0.012016342	0.006969478	11	6A	IN-PV	64	21	21
CTCTACGCACATGACT-1_1_A9	-10.53708458	32.7513056	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	912	1219	0.019688269	0.009844135	11	oligos	OL-MS-2	64	21	21
CTCTACGCACGGATAG-1_1_A9	-22.54297999	-15.69746383	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4685	12848	0.025373599	0.005603985	11	6A	IN-PV	64	21	21
CTCTACGCATAGAAAC-1_1_A9	-8.206118931	34.06740755	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	848	1173	0.025575448	0.009377664	11	oligos	OL-MS-2	64	21	21
CTCTACGGTAGCGTCC-1_1_A9	-20.97055447	16.70265675	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1502	2399	0.004585244	0.003334723	11	8	Astrocytes	64	21	21
CTCTACGGTATGAATG-1_1_A9	-11.73486692	13.92987611	11	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1280	1853	0.009174312	0.004856989	11	11	Glia-MIX	64	21	21
CTCTACGGTTTGTTTC-1_1_A9	22.47961595	-19.67386387	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6466	24270	0.010671611	0.002925422	11	3	EN-L5-6	64	21	21
CTCTACGTCAAAGACA-1_1_A9	15.9575764	-25.26476479	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4179	10106	0.008311894	0.004254898	11	3	EN-L5-6	64	21	21
CTCTACGTCCGCTGTT-1_1_A9	27.1038036	-26.32405795	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4270	11404	0.004822869	0.002718344	11	3	EN-L5-6	64	21	21
CTCTACGTCGAGCCCA-1_1_A9	-10.1014552	31.67252344	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	924	1261	0.017446471	0.004758128	11	oligos	OL-MS-2	64	21	21
CTCTACGTCTCCAGGG-1_1_A9	-18.82854963	-8.258301399	13B	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4522	11738	0.014738456	0.006133924	11	13B	IN-SV2C	64	21	21
CTCTGGTCAGTCCTTC-1_1_A9	19.0653532	-34.39664674	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4712	14767	0.005417485	0.004537144	11	3	EN-L5-6	64	21	21
CTCTGGTCATGCAATC-1_1_A9	4.676979154	-24.70642792	10	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4305	13054	0.0062816	0.001761912	11	L2-3	EN-L2-3-Cntl	64	21	21
CTCTGGTGTGTAATGA-1_1_A9	-12.78299643	-33.7572187	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1288	2009	0.027874564	0.007964161	11	16	EN-PYR	64	21	21
CTCTGGTGTTGAACTC-1_1_A9	-9.660234423	32.40139092	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	785	1013	0.014807502	0.010858835	11	oligos	OL-MS-2	64	21	21
CTGAAACAGGGTTCCC-1_1_A9	-8.611604516	31.87655587	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1022	1376	0.033430233	0.005813953	11	oligos	OL-MS-2	64	21	21
CTGAAACCATTCCTCG-1_1_A9	-9.408132079	-29.48997178	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	966	1370	0.083941606	0.005839416	11	16	EN-PYR	64	21	21
CTGAAACGTCAGCTAT-1_1_A9	27.64861514	-24.508609	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	7117	27068	0.006576031	0.004322447	11	3	EN-L5-6	64	21	21
CTGAAACGTTCAGTAC-1_1_A9	17.71453082	-31.91541829	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6652	25329	0.003158435	0.009317383	11	3	EN-L5-6	64	21	21
CTGAAACGTTCCCTTG-1_1_A9	-7.790828053	33.41651426	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	964	1286	0.024883359	0.00311042	11	oligos	OL-MS-2	64	21	21
CTGAAACTCGGCGCAT-1_1_A9	22.30206431	-20.02039374	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	7486	27618	0.0096314	0.007096821	11	3	EN-L5-6	64	21	21
CTGAAGTAGATCGGGT-1_1_A9	-21.81198506	14.39713264	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1183	1951	0.006150692	0.003587904	11	8	Astrocytes	64	21	21
CTGAAGTCAATGAAAC-1_1_A9	6.637983546	-25.84593472	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5964	20697	0.006474368	0.00430014	11	3	EN-L5-6	64	21	21
CTGAAGTCAGGGTATG-1_1_A9	27.7928474	-6.52123409	2	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4054	10695	0.004768583	0.002618046	11	2	EN-L4	64	21	21
CTGAAGTGTTTAGGAA-1_1_A9	25.20365387	7.441624571	15A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1811	2640	0.027272727	0.030681818	11	15A	Endo cells	64	21	21
CTGAAGTTCAAGCCTA-1_1_A9	-19.57351291	14.65386834	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1318	2082	0.013448607	0.003842459	11	8	Astrocytes	64	21	21
CTGAAGTTCATCTGTT-1_1_A9	18.70348751	-31.22354962	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6524	25405	0.006179886	0.007793741	11	3	EN-L5-6	64	21	21
CTGAAGTTCGCTTAGA-1_1_A9	-11.68235116	29.03125286	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1391	1975	0.040506329	0.007594937	11	16	EN-PYR	64	21	21
CTGATAGCAAGAGTCG-1_1_A9	-21.7516802	15.30959482	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1361	2299	0.006959548	0.005219661	11	8	Astrocytes	64	21	21
CTGATAGCACAGCCCA-1_1_A9	-14.46767566	7.357480111	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	894	1139	0.017559263	0.004389816	11	8	Astrocytes	64	21	21
CTGATAGCACTACAGT-1_1_A9	-10.71504499	-31.50887472	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1244	1864	0.094957082	0.011802575	11	16	EN-PYR	64	21	21
CTGATAGCATGCCTTC-1_1_A9	-24.06456719	-6.492515537	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1572	2611	0.009574876	0.00612792	11	9	OPC	64	21	21
CTGATAGCATGGTCTA-1_1_A9	-11.99020927	-13.53159183	6B	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1363	2152	0.028345725	0.0116171	11	6B	IN-SST	64	21	21
CTGATAGGTCTCGTTC-1_1_A9	-14.44763289	-4.085059832	13A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3635	8196	0.012689117	0.008052709	11	13A	IN-VIP	64	21	21
CTGATAGGTGACGCCT-1_1_A9	-17.15487894	6.070142371	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	740	1004	0.007968127	0.005976096	11	8	Astrocytes	64	21	21
CTGATAGTCGGCGCTA-1_1_A9	-13.96943181	-3.755625053	13A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3115	6273	0.012593655	0.004622987	11	13A	IN-VIP	64	21	21
CTGATAGTCTTGACGA-1_1_A9	-22.06444629	14.75301103	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1111	1733	0.009809579	0.005193306	11	8	Astrocytes	64	21	21
CTGATCCCACAGTCGC-1_1_A9	-9.061921326	-27.85884021	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1032	1474	0.093622795	0.008141113	11	16	EN-PYR	64	21	21
CTGATCCCACGACTCG-1_1_A9	-6.017294708	34.03473992	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	895	1241	0.023368251	0.002417405	11	oligos	OL-MS-2	64	21	21
CTGATCCCATCCGTGG-1_1_A9	-10.85668543	-32.32568057	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1211	1745	0.061318052	0.007449857	11	16	EN-PYR	64	21	21
CTGATCCCATTCTTAC-1_1_A9	-14.32876107	-3.724430026	13A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4444	11696	0.005642955	0.006839945	11	13A	IN-VIP	64	21	21
CTGATCCGTGACTACT-1_1_A9	-25.83586176	-7.644687788	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1052	1466	0.01159618	0.010231924	11	9	OPC	64	21	21
CTGATCCTCGCCAAAT-1_1_A9	19.85493339	-34.02892364	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4282	11239	0.00649524	0.007029095	11	3	EN-L5-6	64	21	21
CTGATCCTCTCTTGAT-1_1_A9	18.26581741	-17.83827156	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	8350	40087	0.021802579	0.004590017	11	L2-3	EN-L2-3-MS	64	21	21
CTGCCTAAGCCTATGT-1_1_A9	4.680531269	-23.47211037	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3687	9768	0.006961507	0.00522113	11	L2-3	EN-L2-3-MS	64	21	21
CTGCCTAAGTGAACGC-1_1_A9	-2.694207512	33.27341132	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	954	1392	0.01795977	0.005747126	11	oligos	OL-MS-2	64	21	21
CTGCCTACACAGATTC-1_1_A9	-19.33225666	11.06186804	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	898	1265	0.012648221	0.007114625	11	8	Astrocytes	64	21	21
CTGCCTAGTTAGGGTG-1_1_A9	-1.63286131	36.43235861	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	863	1157	0.008643042	0.012964564	11	oligos	OL-MS-2	64	21	21
CTGCCTATCAAAGTAG-1_1_A9	-14.44977197	-4.022676113	13A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3467	7721	0.007382463	0.009972801	11	13A	IN-VIP	64	21	21
CTGCGGAAGCTTATCG-1_1_A9	7.334466884	-24.37764339	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	7364	28695	0.006203171	0.003659174	11	L2-3	EN-L2-3-MS	64	21	21
CTGCGGAAGGTAAACT-1_1_A9	-20.47086275	18.69452502	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2195	4069	0.009093143	0.005652494	11	8	Astrocytes	64	21	21
CTGCGGAAGGTCATCT-1_1_A9	-34.04549576	-7.351153732	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1111	1678	0.00476758	0.007151371	11	9	OPC	64	21	21
CTGCGGAAGTAGATGT-1_1_A9	-24.00150259	20.22912736	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1815	3216	0.002487562	0.002487562	11	8	Astrocytes	64	21	21
CTGCGGACAGACGCTC-1_1_A9	28.00562418	-26.04765917	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3991	11126	0.011864102	0.003505303	11	3	EN-L5-6	64	21	21
CTGCGGATCCAGGGCT-1_1_A9	28.79876498	7.071348062	15DA	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	926	1246	0.032905297	0.064205457	11	15DA	T cells	64	21	21
CTGCTGTAGACTAGAT-1_1_A9	-24.94270337	-7.039353105	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1271	1877	0.009057006	0.003729355	11	9	OPC	64	21	21
CTGCTGTAGCACACAG-1_1_A9	8.024173545	3.445949876	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	995	1441	0.018043026	0.009021513	11	oligos	OL-MS-2	64	21	21
CTGCTGTAGGCAGGTT-1_1_A9	19.97999353	-10.89586845	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2212	4633	0.019857544	0.004316857	11	3	EN-L5-6	64	21	21
CTGCTGTGTACCGAGA-1_1_A9	-9.423911035	-30.18164123	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1025	1470	0.069387755	0.003401361	11	16	EN-PYR	64	21	21
CTGCTGTGTCGTTGTA-1_1_A9	29.0942445	-11.36682943	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4682	11340	0.007583774	0.008553792	11	3	EN-L5-6	64	21	21
CTGCTGTGTGCCTGTG-1_1_A9	-22.38811777	-15.88477606	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3957	9605	0.010515357	0.004893285	11	6A	IN-PV	64	21	21
CTGCTGTTCACAGGCC-1_1_A9	-32.28773587	3.966457814	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2420	4528	0.004637809	0.003975265	11	9	OPC	64	21	21
CTGGTCTAGGGTATCG-1_1_A9	-22.50976444	-20.05303575	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3056	6829	0.020061502	0.006589545	11	6A	IN-PV	64	21	21
CTGGTCTCATCGATGT-1_1_A9	-21.14607732	-16.57331055	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4179	11593	0.007159493	0.005434314	11	6A	IN-PV	64	21	21
CTGGTCTGTGCTTCTC-1_1_A9	-17.15909653	-9.890324791	13B	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4021	10734	0.009782001	0.005589715	11	13B	IN-SV2C	64	21	21
CTGGTCTTCATAGCAC-1_1_A9	-8.304118845	-27.21749039	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	922	1224	0.047385621	0.007352941	11	16	EN-PYR	64	21	21
CTGGTCTTCATGGTCA-1_1_A9	-25.52040097	-24.68776132	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5600	17315	0.015189142	0.003522957	11	6A	IN-PV	64	21	21
CTGGTCTTCTTCCTTC-1_1_A9	18.73429428	-32.92741955	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	8471	44793	0.004487308	0.008505793	11	3	EN-L5-6	64	21	21
CTGTGCTAGGTGGGTT-1_1_A9	-11.39410425	-32.28511484	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1197	1738	0.045454545	0.009205984	11	16	EN-PYR	64	21	21
CTGTGCTGTACCGTTA-1_1_A9	16.02777857	-19.00072226	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6457	21158	0.014746195	0.009216372	11	L2-3	EN-L2-3-MS	64	21	21
CTGTGCTGTAGGCTGA-1_1_A9	26.52749662	-27.42938322	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4480	12462	0.005456588	0.002808538	11	3	EN-L5-6	64	21	21
CTGTGCTGTCCCTACT-1_1_A9	24.45741905	-27.60970122	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2699	6204	0.019503546	0.002578981	11	3	EN-L5-6	64	21	21
CTGTGCTGTCTGGAGA-1_1_A9	8.95712898	1.496658172	12	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	661	1013	0.020730503	0.005923001	11	12	EN-MIX	64	21	21
CTGTGCTTCGAGCCCA-1_1_A9	-4.873457362	34.76905508	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	831	1139	0.019315189	0.004389816	11	oligos	OL-MS-2	64	21	21
CTGTTTACAAACTGTC-1_1_A9	-15.29435271	11.10193106	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1540	2446	0.0053148	0.003679477	11	8	Astrocytes	64	21	21
CTGTTTACAACGCACC-1_1_A9	20.6123483	8.369287862	1	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1931	3339	0.013477089	0.005989817	11	oligos	OL-Cntl	64	21	21
CTGTTTACAGACGCCT-1_1_A9	9.274819117	1.61070952	12	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	690	1020	0.169607843	0.006862745	11	12	EN-MIX	64	21	21
CTGTTTACATTTGCCC-1_1_A9	28.26225328	-25.6901526	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6932	30264	0.006410256	0.003965107	11	3	EN-L5-6	64	21	21
CTGTTTAGTACCGTAT-1_1_A9	5.620115411	-24.22477353	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5534	19155	0.005586009	0.008196293	11	L2-3	EN-L2-3-MS	64	21	21
CTGTTTAGTGGTAACG-1_1_A9	19.52605222	-33.12042953	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6139	22094	0.008192269	0.005702906	11	3	EN-L5-6	64	21	21
CTGTTTATCTCAACTT-1_1_A9	-0.642127591	34.08936318	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	788	1147	0.012205754	0.00087184	11	oligos	OL-MS-2	64	21	21
CTTAACTAGCTGTCTA-1_1_A9	-32.05341865	-0.447582411	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1619	2666	0.015378845	0.00300075	11	9	OPC	64	21	21
CTTAACTAGGCAATTA-1_1_A9	-1.257647297	34.17349332	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	872	1279	0.024237686	0.005473026	11	oligos	OL-MS-2	64	21	21
CTTAACTAGGTGCACA-1_1_A9	-8.223063919	33.86314308	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	852	1123	0.020480855	0.010685663	11	oligos	OL-MS-2	64	21	21
CTTAACTCACAAGTAA-1_1_A9	-7.487546408	31.39415271	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1243	1827	0.024083196	0.00711549	11	oligos	OL-MS-2	64	21	21
CTTAACTCACGGACAA-1_1_A9	-7.572123327	-29.94389788	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	805	1123	0.0730187	0.005342832	11	16	EN-PYR	64	21	21
CTTAACTCAGGGCATA-1_1_A9	-7.777726058	34.81460345	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	896	1208	0.014072848	0.007450331	11	oligos	OL-MS-2	64	21	21
CTTAACTGTCTCTCGT-1_1_A9	-11.24233665	29.68806102	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1433	2087	0.019166267	0.01006229	11	oligos	OL-MS-2	64	21	21
CTTAACTGTGATGTGG-1_1_A9	-3.126787994	32.82490814	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	992	1392	0.011494253	0.00862069	11	oligos	OL-MS-2	64	21	21
CTTAACTGTGTAACGG-1_1_A9	-21.06207756	11.93972039	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1070	1578	0.00887199	0.004435995	11	8	Astrocytes	64	21	21
CTTAACTTCGCCAGCA-1_1_A9	-25.33762443	-24.78713281	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5010	14793	0.036909349	0.003041979	11	6A	IN-PV	64	21	21
CTTAACTTCGCCTGAG-1_1_A9	-7.489120025	-31.46285775	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	732	1006	0.0944334	0.005964215	11	16	EN-PYR	64	21	21
CTTACCGAGCTTCGCG-1_1_A9	-13.86839219	-4.735934246	13A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3026	6880	0.006976744	0.006976744	11	13A	IN-VIP	64	21	21
CTTACCGAGTCAAGCG-1_1_A9	19.758723	-31.14331793	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6569	23788	0.018622835	0.00399361	11	3	EN-L5-6	64	21	21
CTTACCGCACAGTCGC-1_1_A9	-7.577871647	-28.37521493	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	787	1061	0.097078228	0.006597549	11	16	EN-PYR	64	21	21
CTTACCGGTCTAGAGG-1_1_A9	27.6054728	-24.76787144	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5088	16431	0.016493214	0.002677865	11	3	EN-L5-6	64	21	21
CTTACCGGTCTCAACA-1_1_A9	-23.73012946	-7.451024272	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1414	2074	0.016875603	0.003375121	11	9	OPC	64	21	21
CTTACCGGTTAAGAAC-1_1_A9	-20.90710875	-16.81458857	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2823	5987	0.013028228	0.005344914	11	6A	IN-PV	64	21	21
CTTACCGGTTCGCTAA-1_1_A9	18.83850388	-34.58241488	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4414	13360	0.004191617	0.002694611	11	3	EN-L5-6	64	21	21
CTTACCGGTTCTGTTT-1_1_A9	-20.40044868	12.51646423	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1101	1643	0.01339014	0.009738284	11	8	Astrocytes	64	21	21
CTTACCGTCGTTTATC-1_1_A9	-6.237159594	35.79403505	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	764	1043	0.009587728	0.004793864	11	oligos	OL-MS-2	64	21	21
CTTAGGAAGGATGGTC-1_1_A9	5.279628489	-24.85885689	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5354	17448	0.005788629	0.0021779	11	L2-3	EN-L2-3-MS	64	21	21
CTTAGGACACTTCTGC-1_1_A9	-16.41552977	8.18406035	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1414	2280	0.00745614	0.003070175	11	8	Astrocytes	64	21	21
CTTAGGAGTGCAGGTA-1_1_A9	24.22419463	-10.84392388	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4797	12493	0.00680381	0.005923317	11	3	EN-L5-6	64	21	21
CTTAGGATCCCTAATT-1_1_A9	-6.575238269	-30.59401985	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	870	1189	0.085786375	0.018502944	11	16	EN-PYR	64	21	21
CTTCTCTGTAGCGTAG-1_1_A9	-13.9830419	8.62564959	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1355	1933	0.010346611	0.008277289	11	8	Astrocytes	64	21	21
CTTCTCTGTGCCTGGT-1_1_A9	6.170329783	-25.9062314	10	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5721	21412	0.004997198	0.00284887	11	L2-3	EN-L2-3-Cntl	64	21	21
CTTCTCTGTTCCCTTG-1_1_A9	-9.703834652	31.57810853	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	883	1176	0.028911565	0.009353741	11	oligos	OL-MS-2	64	21	21
CTTCTCTTCGAGAACG-1_1_A9	2.171015355	6.348978652	7	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1208	1619	0.014823965	0.009882644	11	7	Phagocytes	64	21	21
CTTCTCTTCGCCAGCA-1_1_A9	15.34846856	-27.52283254	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3189	7392	0.013257576	0.005546537	11	3	EN-L5-6	64	21	21
CTTGGCTAGAGCTTCT-1_1_A9	-15.84864873	-5.201508091	13A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4261	10206	0.012149716	0.009406232	11	13A	IN-VIP	64	21	21
CTTGGCTAGGATCGCA-1_1_A9	-14.12653233	8.672749006	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1071	1536	0.022786458	0.006510417	11	8	Astrocytes	64	21	21
CTTGGCTAGGGTCGAT-1_1_A9	-24.749335	-7.026000382	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1313	2011	0.010442566	0.001491795	11	9	OPC	64	21	21
CTTGGCTCAGTATGCT-1_1_A9	-20.31558438	17.52637085	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1465	2400	0.0075	0.005	11	8	Astrocytes	64	21	21
CTTGGCTCATGTTCCC-1_1_A9	-19.87806898	16.05088369	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1477	2458	0.010577705	0.002847844	11	8	Astrocytes	64	21	21
CTTGGCTGTCGTGGCT-1_1_A9	27.05184528	7.144632845	15A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1096	1431	0.015373864	0.030747729	11	15A	Endo cells	64	21	21
CTTGGCTGTTCATGGT-1_1_A9	-23.17154508	-8.691764377	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1419	2070	0.047342995	0.002898551	11	9	OPC	64	21	21
CTTGGCTTCACGCGGT-1_1_A9	33.71079397	7.211688337	14	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	876	1135	0.010572687	0.011453744	11	14	Microglia	64	21	21
CTTGGCTTCGGTCTAA-1_1_A9	23.74200272	-22.87795288	2	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5356	15832	0.006758464	0.00511622	11	2	EN-L4	64	21	21
CTTTGCGAGATAGCAT-1_1_A9	-13.26522079	16.53312647	11	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1434	2231	0.007171672	0.005826983	11	11	Glia-MIX	64	21	21
CTTTGCGAGGGTCGAT-1_1_A9	-23.55656167	-9.732846239	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1189	1574	0.024777637	0.010165184	11	9	OPC	64	21	21
CTTTGCGCAAACGCGA-1_1_A9	-7.551574885	-29.35709262	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	821	1078	0.080705009	0.010204082	11	16	EN-PYR	64	21	21
CTTTGCGCAAGCTGGA-1_1_A9	7.23248441	-22.96073102	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4125	10740	0.018901304	0.006331471	11	L2-3	EN-L2-3-MS	64	21	21
CTTTGCGCATGGTAGG-1_1_A9	-25.5601926	-9.777530419	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	854	1162	0.022375215	0.002581756	11	9	OPC	64	21	21
CTTTGCGGTACTCGCG-1_1_A9	-13.47394709	-34.04703833	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1391	2464	0.038961039	0.002840909	11	16	EN-PYR	64	21	21
GAAACTCCACAAGTAA-1_1_A9	-7.930205688	-29.55759389	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	790	1065	0.075117371	0.002816901	11	16	EN-PYR	64	21	21
GAAACTCCACCGATAT-1_1_A9	-9.582253184	-29.34526686	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	996	1330	0.045112782	0.009022556	11	16	EN-PYR	64	21	21
GAAACTCCACGACTCG-1_1_A9	-10.23125403	-29.6689593	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1033	1459	0.084304318	0.012337217	11	16	EN-PYR	64	21	21
GAAACTCCACTTCGAA-1_1_A9	-7.45073073	-28.81986991	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	817	1072	0.036380597	0.004664179	11	16	EN-PYR	64	21	21
GAAATGACAATAACGA-1_1_A9	28.31532937	-25.83440446	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5918	19820	0.005499495	0.004742684	11	3	EN-L5-6	64	21	21
GAAATGACAGCTGTTA-1_1_A9	33.73756892	7.175721357	14	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1016	1315	0.009125475	0.009885932	11	14	Microglia	64	21	21
GAAATGAGTCGGCATC-1_1_A9	24.53955964	-25.75731994	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2547	5153	0.01474869	0.002910926	11	3	EN-L5-6	64	21	21
GAAATGAGTCTAGCCG-1_1_A9	-11.60049297	-0.275806346	13A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2716	5598	0.010896749	0.005001786	11	13A	IN-VIP	64	21	21
GAACATCAGTCCATAC-1_1_A9	-25.50070467	-8.425375165	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	958	1314	0.009893455	0.009893455	11	9	OPC	64	21	21
GAACATCCAGATGGGT-1_1_A9	-19.03658528	15.14974162	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1611	2622	0.009534706	0.00877193	11	8	Astrocytes	64	21	21
GAACATCCAGCGTTCG-1_1_A9	24.85555486	-27.45880843	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3094	7587	0.010676157	0.002504284	11	3	EN-L5-6	64	21	21
GAACATCCATCGGGTC-1_1_A9	11.48702828	-29.16319105	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4642	12704	0.008894836	0.00220403	11	3	EN-L5-6	64	21	21
GAACATCGTATTAGCC-1_1_A9	-14.98495347	7.3609467	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	978	1300	0.033076923	0.006153846	11	8	Astrocytes	64	21	21
GAACATCGTGTTAAGA-1_1_A9	6.834849144	-23.63132316	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4776	15246	0.025186934	0.002951594	11	L2-3	EN-L2-3-MS	64	21	21
GAACATCTCGTACCGG-1_1_A9	-2.085677139	32.65730219	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1029	1517	0.008569545	0.003295979	11	oligos	OL-MS-2	64	21	21
GAACATCTCTCGAGTA-1_1_A9	-9.764766913	32.20251922	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	847	1096	0.02189781	0.005474453	11	oligos	OL-MS-2	64	21	21
GAACCTAAGATGCGAC-1_1_A9	18.92024471	-34.57082301	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4106	10936	0.002011704	0.006309437	11	3	EN-L5-6	64	21	21
GAACCTAAGGACACCA-1_1_A9	-10.04671466	32.97936168	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	819	1057	0.024597919	0.005676443	11	oligos	OL-MS-2	64	21	21
GAACCTAAGGCTATCT-1_1_A9	-19.74467155	11.5059381	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1057	1536	0.016276042	0.006510417	11	8	Astrocytes	64	21	21
GAACCTAGTCGTGGCT-1_1_A9	6.699753315	-24.75148394	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6902	27902	0.01035768	0.004049889	11	L2-3	EN-L2-3-MS	64	21	21
GAACCTAGTGTTTGGT-1_1_A9	-6.965671342	-30.77700393	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	942	1272	0.067610063	0.02672956	11	16	EN-PYR	64	21	21
GAACCTAGTTGAGGTG-1_1_A9	26.71582463	-25.16161184	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5003	14554	0.007008383	0.002679676	11	3	EN-L5-6	64	21	21
GAACGGAAGAGTGAGA-1_1_A9	-11.34369198	16.68903064	11	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2923	5590	0.012701252	0.008765653	11	11	Glia-MIX	64	21	21
GAACGGAAGCTGCCCA-1_1_A9	-3.501190705	35.82988939	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	797	1079	0.010194625	0.008341057	11	oligos	OL-MS-2	64	21	21
GAACGGAAGGTGCTTT-1_1_A9	21.57023332	-20.37769183	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6670	21936	0.014815828	0.01317469	11	3	EN-L5-6	64	21	21
GAACGGAAGTGTCTCA-1_1_A9	17.98075208	-32.20882474	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4606	13424	0.007002384	0.004246126	11	3	EN-L5-6	64	21	21
GAACGGACAAGTTCTG-1_1_A9	-10.72764575	-2.633677654	13A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2098	3635	0.008528198	0.007427785	11	13A	IN-VIP	64	21	21
GAACGGACATGCAACT-1_1_A9	33.29550887	6.41108804	14	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	949	1164	0.012886598	0.008591065	11	14	Microglia	64	21	21
GAACGGAGTGGCCCTA-1_1_A9	-16.06303629	-6.646300251	13A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2324	4191	0.010260081	0.004294918	11	13A	IN-VIP	64	21	21
GAACGGAGTTGATTGC-1_1_A9	22.22011373	25.83927074	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1210	1762	0.010215664	0.006242906	11	oligos	OL-MS-2	64	21	21
GAACGGATCAAAGACA-1_1_A9	-11.02222752	16.09970223	11	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1915	3035	0.009555189	0.007248764	11	11	Glia-MIX	64	21	21
GAACGGATCCGCATAA-1_1_A9	-10.08269717	32.73917158	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	765	1015	0.025615764	0.013793103	11	oligos	OL-MS-2	64	21	21
GAACGGATCGCAGGCT-1_1_A9	-19.93842842	17.43733852	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1511	2350	0.001276596	0.005531915	11	8	Astrocytes	64	21	21
GAAGCAGAGAATCTCC-1_1_A9	-18.83374888	-8.298881155	13B	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4930	13210	0.009386828	0.005071915	11	13B	IN-SV2C	64	21	21
GAAGCAGAGACAGACC-1_1_A9	-5.687074238	33.25398848	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	995	1418	0.010578279	0.003526093	11	oligos	OL-MS-2	64	21	21
GAAGCAGAGGAATCGC-1_1_A9	11.82912688	-2.822339585	12	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1495	2727	0.01540154	0.00550055	11	12	EN-MIX	64	21	21
GAAGCAGAGGGTATCG-1_1_A9	29.52672748	-5.681634411	2	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4196	10093	0.007232736	0.005944714	11	2	EN-L4	64	21	21
GAAGCAGCAGCTGCAC-1_1_A9	-8.16320188	-11.90493916	6B	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	682	1005	0.168159204	0.005970149	11	6B	IN-SST	64	21	21
GAAGCAGGTGCCTTGG-1_1_A9	29.19411641	-11.23181434	2	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5007	13058	0.013172002	0.008806862	11	2	EN-L4	64	21	21
GAAGCAGTCAACACTG-1_1_A9	-14.64389557	10.47424563	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1642	2613	0.008419441	0.004209721	11	8	Astrocytes	64	21	21
GAAGCAGTCAATACCG-1_1_A9	-3.227687683	35.468519	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	813	1133	0.015887026	0.00353045	11	oligos	OL-MS-2	64	21	21
GAAGCAGTCCGAGCCA-1_1_A9	19.89906176	-31.9671106	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6589	23249	0.006365865	0.007871306	11	3	EN-L5-6	64	21	21
GAAGCAGTCCGCAAGC-1_1_A9	7.014534608	-25.63411641	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6230	20772	0.004525323	0.004140189	11	L2-3	EN-L2-3-MS	64	21	21
GAAGCAGTCGATCCCT-1_1_A9	-8.732520085	34.22824208	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	774	1027	0.010710808	0.005842259	11	oligos	OL-MS-2	64	21	21
GAATGAAAGAACAACT-1_1_A9	-9.624384749	-28.02272171	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1396	2022	0.070227498	0.009891197	11	16	EN-PYR	64	21	21
GAATGAAAGAACAATC-1_1_A9	-23.93546382	-9.994072601	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	907	1148	0.018292683	0.006097561	11	9	OPC	64	21	21
GAATGAAAGACAAAGG-1_1_A9	-17.55985023	10.17981464	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1089	1618	0.010506799	0.003090235	11	8	Astrocytes	64	21	21
GAATGAAGTAGCGTAG-1_1_A9	-24.53674736	-10.40248662	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	869	1111	0.00810081	0.01890189	11	9	OPC	64	21	21
GAATGAATCATCACCC-1_1_A9	-7.966512903	-27.81677707	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	787	1005	0.032835821	0.012935323	11	16	EN-PYR	64	21	21
GAATGAATCCTAGGGC-1_1_A9	9.215925801	-2.128181912	12	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1355	2173	0.076852278	0.005982513	11	12	EN-MIX	64	21	21
GACACGCAGAATAGGG-1_1_A9	32.91142049	4.878598177	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1021	1270	0.037007874	0.014173228	11	16	EN-PYR	64	21	21
GACACGCAGCCCAACC-1_1_A9	-8.824673439	33.57133413	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	943	1272	0.029874214	0.001572327	11	oligos	OL-MS-2	64	21	21
GACACGCAGCCCGAAA-1_1_A9	-7.196884946	-30.05874525	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	809	1094	0.071297989	0.010054845	11	16	EN-PYR	64	21	21
GACACGCAGCGTCAAG-1_1_A9	-7.50741663	-30.25937045	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	869	1215	0.10781893	0.009053498	11	16	EN-PYR	64	21	21
GACACGCAGGAGTACC-1_1_A9	5.041053211	1.831533483	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	788	1017	0.062930187	0.007866273	11	16	EN-PYR	64	21	21
GACACGCCAGTTCATG-1_1_A9	18.7450331	-24.93770594	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3581	7741	0.005942385	0.026224002	11	3	EN-L5-6	64	21	21
GACACGCCATCCTTGC-1_1_A9	15.1403588	-30.44150232	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3688	9294	0.013234345	0.001829137	11	3	EN-L5-6	64	21	21
GACACGCGTACGACCC-1_1_A9	-7.72266864	33.28613277	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	929	1261	0.018239492	0.007137193	11	oligos	OL-MS-2	64	21	21
GACACGCGTCTTCTCG-1_1_A9	-20.89325311	16.03226193	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1300	2098	0.011439466	0.005719733	11	8	Astrocytes	64	21	21
GACACGCGTGTCCTCT-1_1_A9	-21.62312234	-28.41194389	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5173	16683	0.009890307	0.003716358	11	6A	IN-PV	64	21	21
GACACGCGTTAAGGGC-1_1_A9	-20.41158056	16.02808416	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1466	2323	0.004304778	0.005596212	11	8	Astrocytes	64	21	21
GACACGCTCACAGTAC-1_1_A9	4.089571559	0.88785645	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	995	1320	0.054545455	0.00530303	11	16	EN-PYR	64	21	21
GACACGCTCAGCTCTC-1_1_A9	-27.60171472	4.219491256	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3345	6656	0.004657452	0.01156851	11	9	OPC	64	21	21
GACACGCTCTGGGCCA-1_1_A9	-24.70709136	-10.36777485	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	907	1176	0.026360544	0.005952381	11	9	OPC	64	21	21
GACAGAGAGAGTAATC-1_1_A9	-11.82136385	-32.83307154	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1216	1894	0.060190074	0.004751848	11	16	EN-PYR	64	21	21
GACAGAGAGGTGCTTT-1_1_A9	-19.42735187	11.90747787	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	996	1400	0.035	0.007857143	11	8	Astrocytes	64	21	21
GACAGAGAGGTTACCT-1_1_A9	-16.53956888	-9.065747112	13B	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2664	5338	0.01386287	0.004496066	11	13B	IN-SV2C	64	21	21
GACAGAGCATCTATGG-1_1_A9	-9.501284757	-31.321879	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	950	1365	0.020512821	0.003663004	11	16	EN-PYR	64	21	21
GACAGAGGTACACCGC-1_1_A9	-18.60198404	10.20484228	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	765	1002	0.015968064	0.006986028	11	8	Astrocytes	64	21	21
GACAGAGGTTCGCGAC-1_1_A9	-25.63899398	-7.822646708	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1029	1446	0.01175657	0.008990318	11	9	OPC	64	21	21
GACAGAGGTTTACTCT-1_1_A9	-17.2192783	10.27198389	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1197	1803	0.009983361	0.006655574	11	8	Astrocytes	64	21	21
GACAGAGTCGTACCGG-1_1_A9	-20.55402583	18.29493985	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1894	3392	0.004716981	0.003537736	11	8	Astrocytes	64	21	21
GACCAATAGGAATTAC-1_1_A9	-24.34683961	-5.964537496	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1598	2584	0.009287926	0.005417957	11	9	OPC	64	21	21
GACCAATAGGCAAAGA-1_1_A9	-21.60870192	13.32160457	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1060	1542	0.00843061	0.001297017	11	8	Astrocytes	64	21	21
GACCAATCAAGTCATC-1_1_A9	-6.486742868	-29.3158374	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	692	1010	0.13960396	0.000990099	11	16	EN-PYR	64	21	21
GACCAATCACCGCTAG-1_1_A9	20.31999427	-33.56999124	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5179	16105	0.009003415	0.007947842	11	3	EN-L5-6	64	21	21
GACCAATCATATGAGA-1_1_A9	-7.825539305	-29.71318486	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	796	1043	0.041227229	0.01725791	11	16	EN-PYR	64	21	21
GACCAATCATCCTAGA-1_1_A9	23.22918973	-20.90448829	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4246	11085	0.026071267	0.005593144	11	3	EN-L5-6	64	21	21
GACCAATCATGGATGG-1_1_A9	-18.74713511	10.52110311	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	843	1159	0.011216566	0.006039689	11	8	Astrocytes	64	21	21
GACCAATTCACTTATC-1_1_A9	-25.54879933	-24.72719998	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6028	20939	0.037442094	0.003390802	11	6A	IN-PV	64	21	21
GACCAATTCAGTCAGT-1_1_A9	20.578689	-32.8300066	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4018	10108	0.014345073	0.005935892	11	3	EN-L5-6	64	21	21
GACCAATTCATTATCC-1_1_A9	5.69203662	-24.45251673	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5985	20986	0.005193939	0.003812065	11	L2-3	EN-L2-3-MS	64	21	21
GACCAATTCCAGTATG-1_1_A9	-14.22276177	8.756839061	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1312	1961	0.019887812	0.00254972	11	8	Astrocytes	64	21	21
GACCAATTCCTGCCAT-1_1_A9	33.21595639	6.428360291	14	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	873	1061	0.024505184	0.013195099	11	14	Microglia	64	21	21
GACCAATTCTCGCTTG-1_1_A9	-25.05183499	-7.845465346	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1241	1907	0.038804405	0.007865758	11	9	OPC	64	21	21
GACCTGGAGGACCACA-1_1_A9	4.059906702	1.139911881	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	825	1032	0.033914729	0.006782946	11	16	EN-PYR	64	21	21
GACCTGGCAAAGCAAT-1_1_A9	-21.22110668	14.30382865	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1407	2216	0.011281588	0.003158845	11	8	Astrocytes	64	21	21
GACCTGGCACTTACGA-1_1_A9	-11.19942926	30.7043048	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1138	1594	0.033877039	0.009410289	11	oligos	OL-MS-2	64	21	21
GACCTGGCAGTAAGAT-1_1_A9	-9.762481916	33.10202977	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	835	1129	0.02125775	0.010628875	11	oligos	OL-MS-2	64	21	21
GACCTGGCATTTGCTT-1_1_A9	19.4495837	-32.4504163	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	8069	34722	0.00786245	0.009907263	11	3	EN-L5-6	64	21	21
GACCTGGGTGCGATAG-1_1_A9	-17.26663625	11.02834375	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1231	1875	0.011733333	0.004266667	11	8	Astrocytes	64	21	21
GACCTGGTCCTTTACA-1_1_A9	22.61685619	25.96824468	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1228	1924	0.011434511	0.004677755	11	oligos	OL-MS-2	64	21	21
GACCTGGTCGTATCAG-1_1_A9	-6.090821658	34.95287427	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	817	1085	0.016589862	0.006451613	11	oligos	OL-MS-2	64	21	21
GACGCGTAGAGACGAA-1_1_A9	-8.086914555	-27.53366204	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	860	1101	0.059037239	0.009990917	11	16	EN-PYR	64	21	21
GACGCGTAGAGGGATA-1_1_A9	-9.560965658	32.28407326	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	837	1077	0.019498607	0.005571031	11	oligos	OL-MS-2	64	21	21
GACGCGTAGGCCGAAT-1_1_A9	22.70713751	-20.34861254	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5682	16596	0.011569053	0.008435768	11	3	EN-L5-6	64	21	21
GACGCGTCAAGGGTCA-1_1_A9	-14.23516195	8.232499202	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1315	1823	0.013713659	0.002194185	11	8	Astrocytes	64	21	21
GACGCGTCACGAGGTA-1_1_A9	-29.09594714	-12.48948096	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	866	1178	0.009337861	0.005093379	11	9	OPC	64	21	21
GACGCGTCAGAAGCAC-1_1_A9	-20.32567916	15.50298785	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1474	2293	0.009158308	0.010466638	11	8	Astrocytes	64	21	21
GACGCGTCAGAGTGTG-1_1_A9	-21.5092616	16.32403834	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1302	2040	0.003431373	0.004901961	11	8	Astrocytes	64	21	21
GACGCGTGTCAACTGT-1_1_A9	7.400772734	-23.34418638	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6345	21918	0.019025459	0.004653709	11	L2-3	EN-L2-3-MS	64	21	21
GACGCGTGTTCATGGT-1_1_A9	19.75260573	-31.17327954	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6961	23750	0.008589474	0.008168421	11	3	EN-L5-6	64	21	21
GACGGCTAGGAGTTTA-1_1_A9	-3.626905768	35.5173585	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	772	1018	0.012770138	0.006876228	11	oligos	OL-MS-2	64	21	21
GACGGCTCAGCCAGAA-1_1_A9	-8.163055128	-29.68488079	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	817	1104	0.069746377	0.011775362	11	16	EN-PYR	64	21	21
GACGGCTGTATCAGTC-1_1_A9	-7.845521136	32.46042026	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1011	1398	0.018597997	0.009298999	11	oligos	OL-MS-2	64	21	21
GACGGCTGTCTAGTGT-1_1_A9	-20.88834635	13.28187642	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1151	1794	0.009476031	0.008918618	11	8	Astrocytes	64	21	21
GACGGCTGTGTCGCTG-1_1_A9	-25.51754179	-9.936293478	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	910	1209	0.004962779	0.009925558	11	9	OPC	64	21	21
GACGGCTTCAAACAAG-1_1_A9	-9.304888614	31.61501388	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	949	1303	0.020721412	0.003837299	11	oligos	OL-MS-2	64	21	21
GACGGCTTCTCGCATC-1_1_A9	-32.03637869	-0.608600799	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1617	2815	0.011012433	0.003552398	11	9	OPC	64	21	21
GACGTGCAGACAAAGG-1_1_A9	-20.79568432	11.94295537	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	918	1275	0.010196078	0.008627451	11	8	Astrocytes	64	21	21
GACGTGCAGACTAGAT-1_1_A9	-18.09413655	-8.284117423	13B	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3203	6831	0.015810277	0.004391744	11	13B	IN-SV2C	64	21	21
GACGTGCAGGAGTTTA-1_1_A9	-8.129067636	-31.75782159	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	820	1205	0.077178423	0.003319502	11	16	EN-PYR	64	21	21
GACGTGCAGTTGTAGA-1_1_A9	-10.56488082	15.69069073	11	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1747	2779	0.0043181	0.007916517	11	11	Glia-MIX	64	21	21
GACGTGCCAAAGGCGT-1_1_A9	-5.723616954	-31.76860659	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	915	1240	0.064516129	0.013709677	11	16	EN-PYR	64	21	21
GACGTGCGTCCAGTAT-1_1_A9	7.572953198	-23.08139213	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5784	17803	0.009661293	0.010391507	11	L2-3	EN-L2-3-MS	64	21	21
GACGTGCGTGAAAGAG-1_1_A9	-11.07630356	-2.614978904	13A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2158	4034	0.007932573	0.014377789	11	13A	IN-VIP	64	21	21
GACGTTAAGCTAGGCA-1_1_A9	26.15291278	-25.07769298	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3835	9560	0.007635983	0.006066946	11	3	EN-L5-6	64	21	21
GACGTTAAGCTGAAAT-1_1_A9	-10.19865283	30.49297414	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1190	1636	0.022616137	0.004889976	11	oligos	OL-MS-2	64	21	21
GACGTTACATCGACGC-1_1_A9	-11.56707251	30.61173698	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	795	1021	0.040156709	0.006856024	11	oligos	OL-MS-2	64	21	21
GACGTTATCACTTCAT-1_1_A9	-11.06587003	-30.08316543	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1280	1886	0.071049841	0.009013786	11	16	EN-PYR	64	21	21
GACGTTATCAGGCCCA-1_1_A9	-10.26889011	30.87901101	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	832	1062	0.02165725	0.00094162	11	oligos	OL-MS-2	64	21	21
GACGTTATCCTGTAGA-1_1_A9	-20.58340318	8.585638232	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	880	1261	0.009516257	0.015067407	11	8	Astrocytes	64	21	21
GACTAACAGAAGAAGC-1_1_A9	-6.064087095	34.37494255	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	869	1188	0.013468013	0.002525253	11	oligos	OL-MS-2	64	21	21
GACTAACCAAATTGCC-1_1_A9	-25.86145399	-6.186338924	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1208	1795	0.007799443	0.001114206	11	9	OPC	64	21	21
GACTAACCAATCGGTT-1_1_A9	24.13012702	26.36214218	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1428	2249	0.008003557	0.006224989	11	oligos	OL-MS-2	64	21	21
GACTAACCACCTATCC-1_1_A9	27.74055274	-26.57490498	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6728	25002	0.003559715	0.003959683	11	3	EN-L5-6	64	21	21
GACTAACGTAAACCTC-1_1_A9	4.776620669	1.839371864	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	798	1020	0.050980392	0.008823529	11	16	EN-PYR	64	21	21
GACTAACGTCATCGGC-1_1_A9	-25.10449684	-24.8957301	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5391	15101	0.014767234	0.007019403	11	6A	IN-PV	64	21	21
GACTAACGTTAAAGTG-1_1_A9	-23.97132139	-7.341449622	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1289	1941	0.017001546	0.012879959	11	9	OPC	64	21	21
GACTAACTCCTATGTT-1_1_A9	-24.67582905	-9.097420851	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1165	1586	0.014501892	0.009457755	11	9	OPC	64	21	21
GACTAACTCGTGACAT-1_1_A9	-19.70510253	16.29994013	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1588	2579	0.011632416	0.004265219	11	8	Astrocytes	64	21	21
GACTACAAGCCACTAT-1_1_A9	-19.26708728	13.68420975	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1417	2095	0.016706444	0.003818616	11	8	Astrocytes	64	21	21
GACTACACAGCCAATT-1_1_A9	4.971863432	1.70050047	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	847	1093	0.052150046	0.004574565	11	16	EN-PYR	64	21	21
GACTACACAGCTGCAC-1_1_A9	17.00533411	-9.718762715	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1798	2797	0.032534859	0.005720415	11	3	EN-L5-6	64	21	21
GACTACACAGGAATCG-1_1_A9	20.34864072	-31.55158031	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6828	25658	0.008184582	0.004715878	11	3	EN-L5-6	64	21	21
GACTACACATTAGCCA-1_1_A9	27.84885592	4.23827568	15BA	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	851	1117	0.022381379	0.026857654	11	15BA	Stromal cells	64	21	21
GACTACAGTAAGCACG-1_1_A9	5.133990447	1.636403009	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	830	1033	0.047434656	0.008712488	11	16	EN-PYR	64	21	21
GACTACAGTCAAACTC-1_1_A9	-5.760284973	31.46700519	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1194	1707	0.015817223	0.006444054	11	oligos	OL-MS-2	64	21	21
GACTACAGTCTCCATC-1_1_A9	22.57373956	-19.51539033	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6965	25119	0.011664477	0.008001911	11	3	EN-L5-6	64	21	21
GACTACATCCCACTTG-1_1_A9	-23.57438201	-8.959372493	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1216	1788	0.025727069	0.007829978	11	9	OPC	64	21	21
GACTGCGCATCTGGTA-1_1_A9	-24.44865622	-1.619793041	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1352	1995	0.011027569	0.003007519	11	9	OPC	64	21	21
GACTGCGGTAGCTAAA-1_1_A9	18.93043928	-34.26889636	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5397	18261	0.005366628	0.003011883	11	3	EN-L5-6	64	21	21
GACTGCGGTCGCTTTC-1_1_A9	27.46355567	-25.9951047	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5541	19209	0.008902077	0.004112656	11	3	EN-L5-6	64	21	21
GACTGCGGTTGGAGGT-1_1_A9	6.20410483	-25.93314939	10	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4768	14428	0.005267535	0.003188245	11	L2-3	EN-L2-3-Cntl	64	21	21
GACTGCGTCACAAACC-1_1_A9	-7.476406244	33.93903749	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	915	1222	0.016366612	0.006546645	11	oligos	OL-MS-2	64	21	21
GACTGCGTCACATAGC-1_1_A9	-17.23262277	10.74505448	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1171	1750	0.016	0.004	11	8	Astrocytes	64	21	21
GACTGCGTCGCGATCG-1_1_A9	-26.84547756	-8.989856296	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	892	1229	0.004882018	0.014646054	11	9	OPC	64	21	21
GACTGCGTCTTAGCCC-1_1_A9	-20.37379277	16.84157532	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1672	2743	0.007291287	0.005103901	11	8	Astrocytes	64	21	21
GAGCAGAAGAAACGCC-1_1_A9	-20.83621877	15.29635094	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1345	2116	0.010869565	0.005671078	11	8	Astrocytes	64	21	21
GAGCAGAAGGCCCTTG-1_1_A9	-18.96596987	-8.204564679	13B	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5256	15029	0.012908377	0.007385721	11	13B	IN-SV2C	64	21	21
GAGCAGACATTTGCTT-1_1_A9	-11.95663544	-32.67852423	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1246	1943	0.076685538	0.009264025	11	16	EN-PYR	64	21	21
GAGCAGAGTATGAAAC-1_1_A9	26.64455372	-24.93747103	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5497	16249	0.007138901	0.006154225	11	3	EN-L5-6	64	21	21
GAGCAGATCGTATCAG-1_1_A9	25.98017904	-23.68457982	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6288	21558	0.017023843	0.004638649	11	3	EN-L5-6	64	21	21
GAGGTGAAGGCGCTCT-1_1_A9	-28.65519079	-12.37149615	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	842	1156	0.020761246	0.002595156	11	9	OPC	64	21	21
GAGGTGACAAGTCTAC-1_1_A9	27.94115601	-25.25830407	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6315	23862	0.005615623	0.004023133	11	3	EN-L5-6	64	21	21
GAGGTGACACAACTGT-1_1_A9	-6.553463182	33.97538109	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	940	1289	0.023273856	0.002327386	11	oligos	OL-MS-2	64	21	21
GAGGTGACACCGTTGG-1_1_A9	-14.39416072	9.62426768	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1797	2858	0.037088873	0.004548635	11	8	Astrocytes	64	21	21
GAGGTGAGTAACGTTC-1_1_A9	-7.339193116	-29.50548601	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	753	1007	0.047666336	0.008937438	11	16	EN-PYR	64	21	21
GAGGTGAGTGCTCTTC-1_1_A9	-8.53510325	-29.81831592	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	908	1198	0.042570952	0.007512521	11	16	EN-PYR	64	21	21
GAGGTGATCCAGATCA-1_1_A9	5.613313908	-24.18327138	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5422	17350	0.006974063	0.004956772	11	L2-3	EN-L2-3-MS	64	21	21
GAGGTGATCCGGCACA-1_1_A9	-13.96829132	-4.347692504	13A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2827	5589	0.006977992	0.007335838	11	13A	IN-VIP	64	21	21
GAGGTGATCGGATGTT-1_1_A9	11.60104224	-2.949781518	12	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1772	3379	0.014501332	0.002367564	11	12	EN-MIX	64	21	21
GAGTCCGAGTTCGCGC-1_1_A9	5.977066095	-25.29310355	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6808	27350	0.006179159	0.00369287	11	L2-3	EN-L2-3-MS	64	21	21
GAGTCCGCAAAGTGCG-1_1_A9	-14.36594706	-4.130302113	13A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3008	6222	0.006268081	0.007393121	11	13A	IN-VIP	64	21	21
GAGTCCGCACCAGGCT-1_1_A9	-18.77610925	14.95563268	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1996	3284	0.013093788	0.005176614	11	8	Astrocytes	64	21	21
GAGTCCGGTCCATCCT-1_1_A9	-13.00265272	-33.39067681	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1611	2607	0.069812044	0.007288071	11	16	EN-PYR	64	21	21
GAGTCCGTCGTCTGCT-1_1_A9	-18.67513628	14.65953904	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1799	2977	0.01713134	0.006046355	11	8	Astrocytes	64	21	21
GAGTCCGTCTGCTGTC-1_1_A9	19.22291548	-32.28704595	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	7073	27909	0.012397435	0.005016303	11	3	EN-L5-6	64	21	21
GATCAGTAGAAACCAT-1_1_A9	19.11703757	-34.30750834	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4665	14208	0.004011824	0.005278716	11	3	EN-L5-6	64	21	21
GATCAGTAGTTCGCAT-1_1_A9	26.69259266	-26.76361199	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4796	15767	0.004883618	0.003805416	11	3	EN-L5-6	64	21	21
GATCAGTCATAAGACA-1_1_A9	-20.31557484	16.9413742	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1794	3109	0.008362818	0.004824702	11	8	Astrocytes	64	21	21
GATCAGTGTGTTTGGT-1_1_A9	-7.966906286	-30.30154824	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	869	1191	0.057094878	0.010075567	11	16	EN-PYR	64	21	21
GATCAGTTCGGGAGTA-1_1_A9	-20.88736269	16.56868034	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1496	2476	0.014135703	0.004846527	11	8	Astrocytes	64	21	21
GATCAGTTCTTTAGGG-1_1_A9	-9.408046087	33.89020228	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	779	1031	0.021338506	0.004849661	11	oligos	OL-MS-2	64	21	21
GATCGATAGAGGTAGA-1_1_A9	-11.64854294	-33.82851935	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1173	1730	0.024855491	0.013872832	11	16	EN-PYR	64	21	21
GATCGATAGCGATTCT-1_1_A9	14.77662773	-27.9449028	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2859	6751	0.001777514	0.009776329	11	3	EN-L5-6	64	21	21
GATCGATGTACTCAAC-1_1_A9	-11.88486786	-32.50882122	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1178	1844	0.062906725	0.007592191	11	16	EN-PYR	64	21	21
GATCGATGTAGCCTCG-1_1_A9	-28.67803187	-12.81195375	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	712	1012	0.031620553	0.001976285	11	9	OPC	64	21	21
GATCGATGTTAGAACA-1_1_A9	-5.310068315	34.45983147	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	883	1241	0.006446414	0.00886382	11	oligos	OL-MS-2	64	21	21
GATCGATTCACAACGT-1_1_A9	-26.08911321	-24.14726196	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4637	12168	0.01808021	0.006903353	11	6A	IN-PV	64	21	21
GATCGCGCACCAGCAC-1_1_A9	-8.331926661	33.76085241	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	871	1173	0.020460358	0.00511509	11	oligos	OL-MS-2	64	21	21
GATCGCGCAGACAGGT-1_1_A9	25.00954167	-19.64054214	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	8616	40366	0.028365456	0.004855572	11	3	EN-L5-6	64	21	21
GATCGCGGTAGCGATG-1_1_A9	-9.169253115	-29.96065169	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1028	1405	0.058362989	0.006405694	11	16	EN-PYR	64	21	21
GATCGCGTCACCCGAG-1_1_A9	28.11505472	-25.86378019	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5369	18818	0.017695823	0.003294718	11	3	EN-L5-6	64	21	21
GATCGCGTCATGTGGT-1_1_A9	14.98731442	-29.41978723	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4470	12950	0.002702703	0.007104247	11	3	EN-L5-6	64	21	21
GATCGTAAGAACAATC-1_1_A9	-5.660427931	31.41928039	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1128	1573	0.01525747	0.008264463	11	oligos	OL-MS-2	64	21	21
GATCGTAAGCAACGGT-1_1_A9	-10.1413669	33.22430817	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	802	1050	0.015238095	0.006666667	11	oligos	OL-MS-2	64	21	21
GATCGTACAAATTGCC-1_1_A9	-17.13621414	11.24391162	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1320	2124	0.012241055	0.004237288	11	8	Astrocytes	64	21	21
GATCGTACAGTTCCCT-1_1_A9	-14.4673992	10.41783375	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1978	3298	0.012128563	0.006064281	11	8	Astrocytes	64	21	21
GATCGTATCAGGATCT-1_1_A9	4.196236802	0.879945047	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1003	1520	0.026973684	0.005263158	11	16	EN-PYR	64	21	21
GATCGTATCATGTGGT-1_1_A9	-24.33159207	-7.507072964	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1327	1954	0.017911975	0.004094166	11	9	OPC	64	21	21
GATCTAGCAAAGTGCG-1_1_A9	6.887694478	-15.34559757	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3261	7609	0.008279669	0.006571166	11	L2-3	EN-L2-3-MS	64	21	21
GATCTAGCAAGCTGTT-1_1_A9	-11.29820584	30.47275338	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1178	1662	0.028279182	0.004813478	11	oligos	OL-MS-2	64	21	21
GATCTAGGTTTAGGAA-1_1_A9	19.06549439	-34.10782809	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5019	15936	0.003953313	0.005710341	11	3	EN-L5-6	64	21	21
GATCTAGTCCTCCTAG-1_1_A9	-7.898685137	-27.51606888	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	781	1037	0.06075217	0.008678881	11	16	EN-PYR	64	21	21
GATCTAGTCTGTTTGT-1_1_A9	-3.887609034	36.25314147	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	828	1160	0.024137931	0.006896552	11	oligos	OL-MS-2	64	21	21
GATGAAAAGACACGAC-1_1_A9	28.38762084	-25.99237605	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5789	20863	0.003355222	0.003451086	11	3	EN-L5-6	64	21	21
GATGAAACACATGGGA-1_1_A9	-9.451890495	32.85818762	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	922	1263	0.030087094	0.003167063	11	oligos	OL-MS-2	64	21	21
GATGAAACATCACGAT-1_1_A9	-7.423242147	35.31435734	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	909	1176	0.017857143	0.007653061	11	oligos	OL-MS-2	64	21	21
GATGAAACATGATCCA-1_1_A9	-25.37384073	-24.8548469	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5568	18600	0.012688172	0.003655914	11	6A	IN-PV	64	21	21
GATGAAAGTAAACACA-1_1_A9	-9.318792219	33.1443319	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	909	1189	0.02607233	0.010933558	11	oligos	OL-MS-2	64	21	21
GATGAAAGTAGAAAGG-1_1_A9	22.5373915	14.24766483	1	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1201	1804	0.007760532	0.00443459	11	oligos	OL-Cntl	64	21	21
GATGAAAGTAGCGTGA-1_1_A9	-21.48418345	-17.71361429	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3150	6013	0.011974056	0.006153334	11	6A	IN-PV	64	21	21
GATGAAAGTCATATCG-1_1_A9	-29.41424947	-12.4506403	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	778	1075	0.017674419	0.001860465	11	9	OPC	64	21	21
GATGAAATCGGAAATA-1_1_A9	-25.01734326	-7.087353503	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1163	1763	0.015314804	0.00113443	11	9	OPC	64	21	21
GATGAAATCTCGCTTG-1_1_A9	-20.68197343	11.64592248	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	926	1285	0.004669261	0.004669261	11	8	Astrocytes	64	21	21
GATGAGGAGAAGAAGC-1_1_A9	-10.8801452	-27.31297173	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	797	1148	0.140243902	0.006097561	11	16	EN-PYR	64	21	21
GATGAGGAGAGTAATC-1_1_A9	27.8015258	-25.39168266	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5091	15370	0.010735198	0.004554327	11	3	EN-L5-6	64	21	21
GATGAGGAGAGTCGGT-1_1_A9	6.124711656	-22.248186	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3153	6498	0.011542013	0.005847953	11	L2-3	EN-L2-3-MS	64	21	21
GATGAGGAGTCCAGGA-1_1_A9	-11.17870135	-33.21055326	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1079	1586	0.05296343	0.013871375	11	16	EN-PYR	64	21	21
GATGAGGAGTTTCCTT-1_1_A9	-12.09042934	31.55393349	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	933	1247	0.048917402	0.006415397	11	oligos	OL-MS-2	64	21	21
GATGAGGCAATCGAAA-1_1_A9	1.726699333	6.783682459	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	989	1343	0.017125838	0.010424423	11	oligos	OL-MS-2	64	21	21
GATGAGGCATGGGAAC-1_1_A9	5.062451396	1.825926955	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	891	1137	0.051011434	0.01055409	11	16	EN-PYR	64	21	21
GATGAGGGTAGGCATG-1_1_A9	-8.829440972	-31.90190883	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	848	1146	0.055846422	0.010471204	11	16	EN-PYR	64	21	21
GATGAGGGTGACCAAG-1_1_A9	24.96039774	4.529714034	15BA	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1448	2153	0.008360427	0.004644682	11	15BA	Stromal cells	64	21	21
GATGAGGTCACCGTAA-1_1_A9	22.93013844	-20.34865575	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6299	21163	0.029768936	0.007891131	11	3	EN-L5-6	64	21	21
GATGAGGTCAGCAACT-1_1_A9	22.37432969	26.04347189	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1200	1851	0.009184225	0.007023231	11	oligos	OL-MS-2	64	21	21
GATGAGGTCCCTAATT-1_1_A9	-3.188621318	35.93473322	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	775	1077	0.009285051	0.00185701	11	oligos	OL-MS-2	64	21	21
GATGAGGTCGCCAAAT-1_1_A9	-14.5223	10.4178973	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1697	2896	0.014502762	0.005524862	11	8	Astrocytes	64	21	21
GATGAGGTCTCAACTT-1_1_A9	-14.3396862	-16.00255664	6B	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1454	2563	0.036285603	0.002341007	11	6B	IN-SST	64	21	21
GATGCTAAGAATAGGG-1_1_A9	-32.68966219	-9.540223775	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1067	1592	0.006909548	0.001256281	11	9	OPC	64	21	21
GATGCTAAGAGATGAG-1_1_A9	-17.32247033	9.883858153	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1174	1667	0.0119976	0.00779844	11	8	Astrocytes	64	21	21
GATGCTAAGCCGCCTA-1_1_A9	20.41598643	-31.85884609	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6170	22740	0.015831135	0.004353562	11	3	EN-L5-6	64	21	21
GATGCTAAGTACGACG-1_1_A9	19.18116568	-34.40763076	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5081	15499	0.004129299	0.005484225	11	3	EN-L5-6	64	21	21
GATGCTACACCAGATT-1_1_A9	-23.81423614	-7.393252836	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1405	2177	0.016995866	0.008727607	11	9	OPC	64	21	21
GATGCTACAGACACTT-1_1_A9	-10.97430217	31.34791961	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1118	1528	0.031413613	0.007198953	11	oligos	OL-MS-2	64	21	21
GATGCTACAGACAGGT-1_1_A9	-22.42135534	-4.481192398	13A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3767	8144	0.006630648	0.008963654	11	13A	IN-VIP	64	21	21
GATGCTACATCCGGGT-1_1_A9	-11.29128945	30.05833132	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	839	1126	0.046181172	0.005328597	11	oligos	OL-MS-2	64	21	21
GATGCTAGTAGTACCT-1_1_A9	9.951556547	-21.89044521	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	7104	26326	0.009686242	0.014472385	11	L2-3	EN-L2-3-MS	64	21	21
GATGCTATCAGAGGTG-1_1_A9	-24.56293071	-6.882054133	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1191	1786	0.009518477	0.002239642	11	9	OPC	64	21	21
GATGCTATCTGATACG-1_1_A9	-14.64796216	7.458111185	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	949	1263	0.030087094	0.001583531	11	8	Astrocytes	64	21	21
GATTCAGAGAAAGTGG-1_1_A9	-9.070709373	-4.425234667	13A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1888	3269	0.007647599	0.005200367	11	13A	IN-VIP	64	21	21
GATTCAGAGCCAACAG-1_1_A9	-8.741799835	32.25214967	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1039	1406	0.019914651	0.010668563	11	oligos	OL-MS-2	64	21	21
GATTCAGCAAGGGTCA-1_1_A9	22.82297952	-20.4546895	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6867	25045	0.013296067	0.006109004	11	3	EN-L5-6	64	21	21
GATTCAGCACCAGCAC-1_1_A9	7.149645518	-23.59400553	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6357	22738	0.017679655	0.003694256	11	L2-3	EN-L2-3-MS	64	21	21
GATTCAGCAGCCAGAA-1_1_A9	34.17460809	-4.223688052	2	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2708	5067	0.008880995	0.012630748	11	2	EN-L4	64	21	21
GATTCAGCAGGTTTCA-1_1_A9	-11.58566434	30.29855681	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	933	1249	0.03202562	0.008006405	11	oligos	OL-MS-2	64	21	21
GATTCAGCATCACGTA-1_1_A9	-11.24469612	30.73769917	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1106	1537	0.031880286	0.007156799	11	oligos	OL-MS-2	64	21	21
GATTCAGGTAAGGGCT-1_1_A9	20.68311238	-22.67705293	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4596	11138	0.016071108	0.005835877	11	3	EN-L5-6	64	21	21
GATTCAGGTTATGTGC-1_1_A9	-7.339392398	-29.25884322	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	839	1106	0.058770344	0.011754069	11	16	EN-PYR	64	21	21
GATTCAGTCCGGCACA-1_1_A9	-22.62254622	-15.82617736	6B	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5109	14677	0.01696532	0.00374736	11	6B	IN-SST	64	21	21
GATTCAGTCGCTTGTC-1_1_A9	20.38416257	-24.11503292	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5193	15594	0.014941644	0.006156214	11	3	EN-L5-6	64	21	21
GCAAACTAGCTATGCT-1_1_A9	5.9824427	-19.97014124	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3865	9572	0.004387798	0.018073548	11	L2-3	EN-L2-3-MS	64	21	21
GCAAACTAGGATGCGT-1_1_A9	28.01631314	4.537752902	15DA	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	813	1016	0.015748031	0.006889764	11	15DA	T cells	64	21	21
GCAAACTAGGTTCCTA-1_1_A9	-6.282662199	35.03936127	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	905	1218	0.013957307	0.007389163	11	oligos	OL-MS-2	64	21	21
GCAAACTCAGACACTT-1_1_A9	5.391975888	2.163929256	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	976	1273	0.037706206	0.012568735	11	16	EN-PYR	64	21	21
GCAAACTCATAGAAAC-1_1_A9	-24.57697017	-7.346464053	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1251	1825	0.016438356	0.002191781	11	9	OPC	64	21	21
GCAAACTGTCGCATCG-1_1_A9	-5.331183716	35.53150174	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	849	1146	0.015706806	0.0008726	11	oligos	OL-MS-2	64	21	21
GCAAACTGTTCCATGA-1_1_A9	-8.123327258	-27.38652717	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	831	1090	0.050458716	0.010091743	11	16	EN-PYR	64	21	21
GCAAACTTCGCAGGCT-1_1_A9	-21.13535789	-16.970801	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3195	7036	0.014070495	0.003268903	11	6A	IN-PV	64	21	21
GCAATCAAGCAATCTC-1_1_A9	-9.462017607	-28.10001696	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1193	1651	0.061780739	0.011508177	11	16	EN-PYR	64	21	21
GCAATCACAAGGACTG-1_1_A9	-18.46503907	10.23834324	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	846	1099	0.021838035	0.006369427	11	8	Astrocytes	64	21	21
GCAATCACAAGTTCTG-1_1_A9	19.89885721	-34.01590401	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3701	9162	0.00556647	0.007312814	11	3	EN-L5-6	64	21	21
GCAATCACAGCTTCGG-1_1_A9	7.583491939	-1.462510402	12	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	937	1190	0.017647059	0.010084034	11	12	EN-MIX	64	21	21
GCAATCAGTCACCCAG-1_1_A9	23.93800138	26.91633292	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1258	1815	0.01046832	0.002203857	11	oligos	OL-MS-2	64	21	21
GCAATCAGTGCAGGTA-1_1_A9	-25.55710274	-7.960555974	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1157	1624	0.00862069	0.017857143	11	9	OPC	64	21	21
GCAATCAGTGGTACAG-1_1_A9	-25.51965973	-6.120502296	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1279	1926	0.007268951	0.001557632	11	9	OPC	64	21	21
GCAATCAGTGTCAATC-1_1_A9	-19.67607263	16.27698224	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1656	2623	0.0133435	0.014487228	11	8	Astrocytes	64	21	21
GCACATAAGATAGTCA-1_1_A9	4.428191685	1.372546867	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	806	1005	0.057711443	0.012935323	11	16	EN-PYR	64	21	21
GCACATAAGTTGTAGA-1_1_A9	-15.29353546	-3.987959521	13A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3333	6763	0.013011977	0.007688895	11	13A	IN-VIP	64	21	21
GCACATACAACACCCG-1_1_A9	-18.75802346	-8.658106181	13B	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4192	10679	0.010581515	0.005056653	11	13B	IN-SV2C	64	21	21
GCACATACACGTTGGC-1_1_A9	5.00254924	1.814850071	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	857	1099	0.046405823	0.018198362	11	16	EN-PYR	64	21	21
GCACATACAGGGTATG-1_1_A9	16.77178058	-26.83014686	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4604	12812	0.008897908	0.007727131	11	3	EN-L5-6	64	21	21
GCACATAGTCTCACCT-1_1_A9	4.093756876	1.030711522	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	840	1109	0.073038774	0.015329125	11	16	EN-PYR	64	21	21
GCACATATCCCAACGG-1_1_A9	3.936650952	0.943332305	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	797	1010	0.079207921	0.010891089	11	16	EN-PYR	64	21	21
GCACATATCCCATTAT-1_1_A9	5.352788101	1.030318982	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1261	1768	0.044683258	0.007918552	11	16	EN-PYR	64	21	21
GCACATATCCTGCAGG-1_1_A9	7.454138537	-19.21791589	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4293	10588	0.009539101	0.023706082	11	L2-3	EN-L2-3-MS	64	21	21
GCACATATCGGTCCGA-1_1_A9	6.520222531	-25.33619184	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5991	19242	0.003118179	0.006184388	11	L2-3	EN-L2-3-MS	64	21	21
GCACTCTGTAGCGATG-1_1_A9	33.05914911	5.113289569	14	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	918	1107	0.019873532	0.019873532	11	14	Microglia	64	21	21
GCACTCTGTCTCCACT-1_1_A9	-9.074141196	34.01496149	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	803	1085	0.021198157	0.003686636	11	oligos	OL-MS-2	64	21	21
GCACTCTTCTCACATT-1_1_A9	-14.67349508	10.72382177	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1865	3109	0.015760695	0.002894821	11	8	Astrocytes	64	21	21
GCAGCCAAGCCTTGAT-1_1_A9	-9.815734243	-0.999744956	13A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2384	4778	0.004395144	0.006697363	11	13A	IN-VIP	64	21	21
GCAGCCAAGGGAAACA-1_1_A9	-25.63489094	-10.45309955	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	952	1262	0.006339144	0.022187005	11	9	OPC	64	21	21
GCAGCCACAAAGAATC-1_1_A9	20.16402226	-33.56360072	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5575	17667	0.003848984	0.010980925	11	3	EN-L5-6	64	21	21
GCAGCCACAAGTAGTA-1_1_A9	18.72596762	-31.42481828	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6208	21743	0.005978936	0.005978936	11	3	EN-L5-6	64	21	21
GCAGCCACACGTAAGG-1_1_A9	-23.76137988	-9.344140356	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1154	1560	0.018589744	0.005769231	11	9	OPC	64	21	21
GCAGCCACATCCTAGA-1_1_A9	4.393736499	0.5547968	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	865	1099	0.054595086	0.010009099	11	16	EN-PYR	64	21	21
GCAGCCACATTACGAC-1_1_A9	-8.034074934	-29.55217582	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	844	1228	0.100977199	0.004885993	11	16	EN-PYR	64	21	21
GCAGCCAGTGGGTATG-1_1_A9	-9.766015937	-9.55010644	13B	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1396	2324	0.024956971	0.007314974	11	13B	IN-SV2C	64	21	21
GCAGCCAGTTGCCTCT-1_1_A9	-10.28426183	18.4678872	11	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3037	6128	0.004079634	0.003916449	11	11	Glia-MIX	64	21	21
GCAGCCATCCAAGCCG-1_1_A9	7.134816607	-22.02182005	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4977	14098	0.0055327	0.009221166	11	L2-3	EN-L2-3-MS	64	21	21
GCAGCCATCCTTAATC-1_1_A9	-10.20288483	-31.48981483	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1103	1632	0.09129902	0.012254902	11	16	EN-PYR	64	21	21
GCAGCCATCCTTGGTC-1_1_A9	-2.733658911	36.05482827	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	774	1088	0.027573529	0.008272059	11	oligos	OL-MS-2	64	21	21
GCAGCCATCGGACAAG-1_1_A9	19.00874591	-31.49984037	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6249	22832	0.011037141	0.006394534	11	3	EN-L5-6	64	21	21
GCAGCCATCTCAACTT-1_1_A9	-19.20241658	11.43970672	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1039	1551	0.019987105	0.003868472	11	8	Astrocytes	64	21	21
GCAGTTAAGACAAGCC-1_1_A9	-10.78483749	30.47637747	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1064	1448	0.035911602	0.004834254	11	oligos	OL-MS-2	64	21	21
GCAGTTAAGGCACATG-1_1_A9	-19.67010116	11.54978456	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	880	1260	0.019047619	0.005555556	11	8	Astrocytes	64	21	21
GCAGTTAAGTGTCCAT-1_1_A9	7.605712945	-23.14360004	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5966	17720	0.01027088	0.006602709	11	L2-3	EN-L2-3-MS	64	21	21
GCAGTTACACCCATTC-1_1_A9	-7.805860839	-27.77669121	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	812	1036	0.041505792	0.008687259	11	16	EN-PYR	64	21	21
GCAGTTACAGTCCTTC-1_1_A9	-11.3957879	29.39094969	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1423	2071	0.023660068	0.007725736	11	oligos	OL-MS-2	64	21	21
GCAGTTACATGCAATC-1_1_A9	7.653428829	-23.18355171	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6980	25971	0.009164068	0.009741635	11	L2-3	EN-L2-3-MS	64	21	21
GCAGTTAGTGCAACTT-1_1_A9	-24.62808099	-10.06005819	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	948	1377	0.024691358	0.004357298	11	9	OPC	64	21	21
GCAGTTATCCTTAATC-1_1_A9	-18.83684488	-8.283800992	13B	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4581	12218	0.010885579	0.008839417	11	13B	IN-SV2C	64	21	21
GCAGTTATCTGCAAGT-1_1_A9	22.92221589	-17.17946898	2	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6616	20909	0.011239179	0.018987039	11	2	EN-L4	64	21	21
GCATACACACCACCAG-1_1_A9	3.853259762	1.046570606	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	846	1080	0.042592593	0.019444444	11	16	EN-PYR	64	21	21
GCATACAGTACTCTCC-1_1_A9	6.075501991	2.886594685	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	872	1156	0.035467128	0.00432526	11	16	EN-PYR	64	21	21
GCATACAGTCTCTCGT-1_1_A9	-6.228535496	35.79203277	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	782	1015	0.01773399	0.004926108	11	oligos	OL-MS-2	64	21	21
GCATACATCCATGAAC-1_1_A9	5.125921327	1.822178085	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	802	1050	0.060952381	0.01047619	11	16	EN-PYR	64	21	21
GCATACATCCCACTTG-1_1_A9	-19.57156925	12.12556636	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	995	1425	0.01122807	0.004210526	11	8	Astrocytes	64	21	21
GCATACATCTCTGTCG-1_1_A9	25.34617635	-28.71939546	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3603	9321	0.005471516	0.003111254	11	3	EN-L5-6	64	21	21
GCATGATAGCCAACAG-1_1_A9	6.295310479	2.792079541	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	914	1120	0.033035714	0.004464286	11	16	EN-PYR	64	21	21
GCATGATAGCGTAGTG-1_1_A9	19.50783033	-30.7886525	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4601	11632	0.00644773	0.009284732	11	3	EN-L5-6	64	21	21
GCATGATAGGCGCTCT-1_1_A9	5.598377561	-24.1652023	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5658	19563	0.011654654	0.005673976	11	L2-3	EN-L2-3-MS	64	21	21
GCATGATAGTTTCCTT-1_1_A9	-6.25195926	34.63530038	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	816	1161	0.012919897	0.004306632	11	oligos	OL-MS-2	64	21	21
GCATGATGTCCATCCT-1_1_A9	-6.124905495	35.33055427	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	800	1081	0.016651249	0.009250694	11	oligos	OL-MS-2	64	21	21
GCATGATTCACCTCGT-1_1_A9	-24.74763133	-8.197864665	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	963	1369	0.012417823	0.005113221	11	9	OPC	64	21	21
GCATGCGAGTATCTCG-1_1_A9	-6.027508822	34.5408723	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	863	1187	0.02190396	0.00252738	11	oligos	OL-MS-2	64	21	21
GCATGCGAGTCGAGTG-1_1_A9	-8.260675575	-30.81242426	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	776	1041	0.038424592	0.008645533	11	16	EN-PYR	64	21	21
GCATGCGCATGCCACG-1_1_A9	-6.97254065	-29.39347868	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	854	1235	0.119838057	0.010526316	11	16	EN-PYR	64	21	21
GCATGCGGTTACCGAT-1_1_A9	33.21702937	6.387603101	14	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	787	1000	0.018	0.005	11	14	Microglia	64	21	21
GCATGCGGTTACTGAC-1_1_A9	19.34088235	-32.91242446	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6146	23204	0.007240131	0.005128426	11	3	EN-L5-6	64	21	21
GCATGCGTCACGATGT-1_1_A9	-7.57060996	-30.53127107	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	863	1181	0.080440305	0.011854361	11	16	EN-PYR	64	21	21
GCATGCGTCGCAGGCT-1_1_A9	33.28616004	7.562101387	14	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	992	1306	0.054364472	0.016845329	11	14	Microglia	64	21	21
GCATGCGTCTAAGCCA-1_1_A9	5.834498646	-20.53122696	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3400	7400	0.007432432	0.012432432	11	L2-3	EN-L2-3-MS	64	21	21
GCATGTAAGCCGTCGT-1_1_A9	-26.15735062	-24.02601092	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4973	13510	0.031754256	0.010288675	11	6A	IN-PV	64	21	21
GCATGTAAGCGTAGTG-1_1_A9	-18.40647964	10.38878013	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	949	1221	0.008190008	0.005733006	11	8	Astrocytes	64	21	21
GCATGTACAAGCTGAG-1_1_A9	-11.55921845	-33.39385655	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1150	1690	0.031360947	0.00887574	11	16	EN-PYR	64	21	21
GCATGTACATCACAAC-1_1_A9	4.944265601	1.685343964	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	882	1148	0.054006969	0.009581882	11	16	EN-PYR	64	21	21
GCATGTACATCCCATC-1_1_A9	4.994742572	1.70175678	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	795	1026	0.048732943	0.005847953	11	16	EN-PYR	64	21	21
GCATGTACATCTATGG-1_1_A9	19.24349346	-33.95925947	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4391	13222	0.007714415	0.001890788	11	3	EN-L5-6	64	21	21
GCATGTAGTCCCTTGT-1_1_A9	-6.546789723	33.97595416	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	928	1234	0.015397083	0.010534846	11	oligos	OL-MS-2	64	21	21
GCATGTAGTGTCGCTG-1_1_A9	-20.65955415	11.58570007	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	937	1385	0.006498195	0.003610108	11	8	Astrocytes	64	21	21
GCATGTAGTTTAGGAA-1_1_A9	-15.37072884	-16.79568034	6B	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1652	2911	0.010305737	0.002748196	11	6B	IN-SST	64	21	21
GCATGTATCAGCTCGG-1_1_A9	1.952588389	5.450307271	7	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	900	1127	0.023957409	0.011535049	11	7	Phagocytes	64	21	21
GCATGTATCATTCACT-1_1_A9	-8.169524172	-26.81445195	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	872	1141	0.062226117	0.004382121	11	16	EN-PYR	64	21	21
GCATGTATCTGGGCCA-1_1_A9	-31.81415728	-1.897647407	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1390	2166	0.006463527	0.004155125	11	9	OPC	64	21	21
GCCAAATAGAGATGAG-1_1_A9	30.21384242	-8.215608784	2	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4578	11201	0.007320775	0.005267387	11	2	EN-L4	64	21	21
GCCAAATCATTACGAC-1_1_A9	-8.388614002	31.85959444	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1001	1364	0.021260997	0.00659824	11	oligos	OL-MS-2	64	21	21
GCCAAATGTTCTGGTA-1_1_A9	-17.5623901	10.9079233	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1229	1844	0.00867679	0.005422993	11	8	Astrocytes	64	21	21
GCCAAATTCCTAGTGA-1_1_A9	-19.68773934	13.4821679	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1307	1930	0.011917098	0.005699482	11	8	Astrocytes	64	21	21
GCCTCTAAGACTGGGT-1_1_A9	-20.69321087	14.87490816	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1361	2199	0.006821282	0.004547522	11	8	Astrocytes	64	21	21
GCCTCTAAGTAGTGCG-1_1_A9	26.75046093	-25.43839332	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4869	14220	0.012447257	0.003727145	11	3	EN-L5-6	64	21	21
GCCTCTAAGTATCGAA-1_1_A9	7.37042956	-23.34184064	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5933	19268	0.011365995	0.006072244	11	L2-3	EN-L2-3-MS	64	21	21
GCCTCTAAGTTCGCAT-1_1_A9	-6.137661129	34.8059753	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	801	1098	0.011839709	0.007285974	11	oligos	OL-MS-2	64	21	21
GCCTCTACACTTACGA-1_1_A9	-11.02656986	31.25511915	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1268	1787	0.03077784	0.007274762	11	oligos	OL-MS-2	64	21	21
GCCTCTACAGCTCCGA-1_1_A9	-7.892851339	-27.37674179	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	809	1129	0.137289637	0.007085917	11	16	EN-PYR	64	21	21
GCCTCTAGTCAGCTAT-1_1_A9	1.869376259	5.536340853	7	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	922	1191	0.016792611	0.010075567	11	7	Phagocytes	64	21	21
GCCTCTATCCCATTTA-1_1_A9	-25.21523873	-8.852223266	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1104	1665	0.014414414	0.007807808	11	9	OPC	64	21	21
GCCTCTATCTCCAACC-1_1_A9	25.22751453	-8.423670981	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4374	10302	0.004173947	0.003882741	11	3	EN-L5-6	64	21	21
GCGACCAAGCTAGCCC-1_1_A9	-21.46967503	14.2643606	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1197	1945	0.002570694	0.002570694	11	8	Astrocytes	64	21	21
GCGACCAAGCTGCGAA-1_1_A9	-7.910259853	34.26004292	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	901	1193	0.01424979	0.004191115	11	oligos	OL-MS-2	64	21	21
GCGACCAAGTGCGATG-1_1_A9	-27.78421043	-21.88769791	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4867	11756	0.036236815	0.008676421	11	6A	IN-PV	64	21	21
GCGACCACAAGCTGAG-1_1_A9	23.8937713	-30.29731245	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4279	12756	0.009877705	0.002430229	11	3	EN-L5-6	64	21	21
GCGACCAGTTATCGGT-1_1_A9	19.21280284	-34.02103831	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5630	18000	0.003388889	0.006277778	11	3	EN-L5-6	64	21	21
GCGACCAGTTGCGTTA-1_1_A9	3.905477678	1.007866069	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	821	1045	0.053588517	0.005741627	11	16	EN-PYR	64	21	21
GCGACCATCATCGGAT-1_1_A9	-24.29693301	-7.834140188	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1182	1727	0.016792125	0.00463231	11	9	OPC	64	21	21
GCGACCATCGAGAGCA-1_1_A9	-6.381199922	-29.91324348	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	811	1062	0.060263653	0.007532957	11	16	EN-PYR	64	21	21
GCGACCATCTATCGCC-1_1_A9	-8.239033306	-27.26302715	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	828	1089	0.082644628	0.011937557	11	16	EN-PYR	64	21	21
GCGAGAAAGTAAGTAC-1_1_A9	-25.18710574	-10.02058928	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	780	1063	0.013170273	0.006585136	11	9	OPC	64	21	21
GCGAGAACAAACCCAT-1_1_A9	18.06137983	-8.094970967	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2138	3826	0.007318348	0.005488761	11	3	EN-L5-6	64	21	21
GCGAGAACAAAGAATC-1_1_A9	-9.045762796	33.23416307	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	891	1197	0.027568922	0.008354219	11	oligos	OL-MS-2	64	21	21
GCGAGAACACCGCTAG-1_1_A9	7.615853674	-22.30547712	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5228	14537	0.005228039	0.011763087	11	L2-3	EN-L2-3-MS	64	21	21
GCGAGAACAGTGAGTG-1_1_A9	6.40494247	-22.73873453	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3956	9092	0.006379234	0.006159261	11	L2-3	EN-L2-3-MS	64	21	21
GCGAGAACATACGCTA-1_1_A9	-3.332301405	34.80012752	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	844	1132	0.013250883	0.009717314	11	oligos	OL-MS-2	64	21	21
GCGAGAAGTATGAAAC-1_1_A9	-21.24852403	12.70385762	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1219	1776	0.007882883	0.006756757	11	8	Astrocytes	64	21	21
GCGAGAAGTCCGACGT-1_1_A9	21.10120587	25.92581946	1	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	985	1424	0.009129213	0.005617978	11	oligos	OL-Cntl	64	21	21
GCGAGAAGTTCGCGAC-1_1_A9	-9.451810875	-7.826211047	13A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1485	2623	0.007243614	0.008387343	11	13A	IN-VIP	64	21	21
GCGCAACAGACAGACC-1_1_A9	4.0236433	0.865436404	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	867	1138	0.049209139	0.015817223	11	16	EN-PYR	64	21	21
GCGCAACAGCTGCAAG-1_1_A9	-18.64635336	-8.295896935	13B	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3969	9703	0.017623415	0.004431619	11	13B	IN-SV2C	64	21	21
GCGCAACAGTAGCGGT-1_1_A9	-6.10176785	-30.06989512	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	819	1063	0.075258702	0.012229539	11	16	EN-PYR	64	21	21
GCGCAACCACAGTCGC-1_1_A9	-24.42593457	-8.882913539	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1141	1599	0.017510944	0.005628518	11	9	OPC	64	21	21
GCGCAACCAGCCTGTG-1_1_A9	-32.07825534	-0.229585701	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1863	3303	0.004844081	0.004541326	11	9	OPC	64	21	21
GCGCAACCATTCTTAC-1_1_A9	-16.0088705	-6.350790912	13A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6072	21616	0.028589933	0.005181347	11	13A	IN-VIP	64	21	21
GCGCAACGTAGCGCTC-1_1_A9	-10.22048795	32.93441694	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	828	1060	0.023584906	0.001886792	11	oligos	OL-MS-2	64	21	21
GCGCAACGTCAGAGGT-1_1_A9	-22.72283283	-16.36299346	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4402	11383	0.019942019	0.003426162	11	6A	IN-PV	64	21	21
GCGCAACGTCTGCCAG-1_1_A9	-16.90556412	10.20190128	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1336	1969	0.0126968	0.004570848	11	8	Astrocytes	64	21	21
GCGCAACGTGATGTCT-1_1_A9	-7.356320967	-30.83789714	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	893	1269	0.107959023	0.011820331	11	16	EN-PYR	64	21	21
GCGCAACTCAGCTGGC-1_1_A9	-19.78395364	15.96051634	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1543	2485	0.011267606	0.004024145	11	8	Astrocytes	64	21	21
GCGCAACTCGCACTCT-1_1_A9	27.95424667	-24.96119823	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5669	19061	0.015791407	0.002046063	11	3	EN-L5-6	64	21	21
GCGCAACTCTGCGGCA-1_1_A9	-6.808803846	33.79887985	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	917	1223	0.017170891	0.004905969	11	oligos	OL-MS-2	64	21	21
GCGCAGTAGGTCATCT-1_1_A9	33.41524009	7.209350811	14	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	790	1030	0.013592233	0.009708738	11	14	Microglia	64	21	21
GCGCAGTAGTACGCGA-1_1_A9	15.94547605	-18.67285717	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	7226	25441	0.015644039	0.012696042	11	L2-3	EN-L2-3-MS	64	21	21
GCGCAGTCACGAAAGC-1_1_A9	-15.40518758	-6.199843133	13A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3726	7699	0.012079491	0.008442655	11	13A	IN-VIP	64	21	21
GCGCAGTGTCCAACTA-1_1_A9	-21.22991616	-15.75892819	6B	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2782	5384	0.009286776	0.013001486	11	6B	IN-SST	64	21	21
GCGCAGTGTCGCGGTT-1_1_A9	27.61052883	-24.75183368	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5229	17467	0.008816626	0.003664052	11	3	EN-L5-6	64	21	21
GCGCCAAAGACTGTAA-1_1_A9	3.578368353	-10.55208505	12	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1901	4003	0.010741944	0.006245316	11	12	EN-MIX	64	21	21
GCGCCAAAGCTGCGAA-1_1_A9	28.04041941	-25.46169099	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	7162	28386	0.004227436	0.003311492	11	3	EN-L5-6	64	21	21
GCGCCAAGTACCGTTA-1_1_A9	16.3803744	-19.45022125	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4173	10088	0.017644726	0.011201427	11	L2-3	EN-L2-3-MS	64	21	21
GCGCCAAGTCTAAACC-1_1_A9	-27.70417185	4.290062167	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2662	4862	0.004524887	0.013368984	11	9	OPC	64	21	21
GCGCCAAGTGTGGTTT-1_1_A9	-7.040444825	-29.91210548	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	858	1220	0.116393443	0.006557377	11	16	EN-PYR	64	21	21
GCGCCAATCACCGTAA-1_1_A9	31.17418441	12.29451912	14	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1210	1792	0.012276786	0.086495536	11	14	Microglia	64	21	21
GCGCCAATCCAAACTG-1_1_A9	19.75145541	-22.49307182	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4171	10388	0.01800154	0.013765884	11	3	EN-L5-6	64	21	21
GCGCGATAGCATCATC-1_1_A9	22.41689572	-18.47401026	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6234	19000	0.012	0.006684211	11	3	EN-L5-6	64	21	21
GCGCGATAGCTAGTCT-1_1_A9	26.47771238	-27.42860506	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4816	14787	0.002299317	0.006356935	11	3	EN-L5-6	64	21	21
GCGCGATGTAATCGTC-1_1_A9	-5.671490172	33.33260829	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	910	1312	0.012957317	0.003810976	11	oligos	OL-MS-2	64	21	21
GCGGGTTAGAGCTTCT-1_1_A9	-21.42367614	12.85400963	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1063	1699	0.007062978	0.005885815	11	8	Astrocytes	64	21	21
GCGGGTTAGCACGCCT-1_1_A9	-8.021767866	-31.58485982	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	782	1046	0.02581262	0.014340344	11	16	EN-PYR	64	21	21
GCGGGTTAGGCAGGTT-1_1_A9	-25.03911733	-6.202000037	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1262	1909	0.010476689	0.003143007	11	9	OPC	64	21	21
GCGGGTTAGGCTCTTA-1_1_A9	-24.48477837	-7.370159068	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1304	1921	0.008328995	0.005205622	11	9	OPC	64	21	21
GCGGGTTCAAGTCATC-1_1_A9	-11.71470348	-32.70356687	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1156	1659	0.027124774	0.012055455	11	16	EN-PYR	64	21	21
GCGGGTTCAGCTTCGG-1_1_A9	19.08942248	-32.8451139	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6555	22472	0.004316483	0.006496974	11	3	EN-L5-6	64	21	21
GCGGGTTCATGTAGTC-1_1_A9	-21.23656991	-16.57399962	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5768	18067	0.012730392	0.006807992	11	6A	IN-PV	64	21	21
GCGGGTTGTAAGGGAA-1_1_A9	-20.07620042	14.24644663	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1369	2038	0.007360157	0.00686948	11	8	Astrocytes	64	21	21
GCGGGTTGTACGCTGC-1_1_A9	4.764559427	1.595777264	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	921	1190	0.055462185	0.006722689	11	16	EN-PYR	64	21	21
GCGGGTTGTGACCAAG-1_1_A9	-10.13148898	31.15818034	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	858	1122	0.018716578	0.006238859	11	oligos	OL-MS-2	64	21	21
GCGGGTTTCATCACCC-1_1_A9	18.9298124	-34.16343496	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5251	17217	0.002846024	0.002671778	11	3	EN-L5-6	64	21	21
GCGGGTTTCCAAATGC-1_1_A9	-6.246582093	34.36633106	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	939	1297	0.01387818	0.00462606	11	oligos	OL-MS-2	64	21	21
GCGGGTTTCCCATTAT-1_1_A9	21.00061723	-12.39646279	12	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2451	4065	0.052890529	0.004674047	11	12	EN-MIX	64	21	21
GCGGGTTTCCTTTCTC-1_1_A9	22.57842607	-19.56873315	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6695	25268	0.015157511	0.006450847	11	3	EN-L5-6	64	21	21
GCGGGTTTCGTCTGAA-1_1_A9	7.860821161	-23.14356538	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6123	21073	0.020500166	0.007972287	11	L2-3	EN-L2-3-MS	64	21	21
GCTCCTAAGTGATCGG-1_1_A9	-19.95015392	16.58694215	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1635	2859	0.004197272	0.002448409	11	8	Astrocytes	64	21	21
GCTCCTACACGGCTAC-1_1_A9	-9.026878455	-27.77492582	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	977	1310	0.046564885	0.011450382	11	16	EN-PYR	64	21	21
GCTCCTACATGACATC-1_1_A9	27.24150626	-25.88056433	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5248	18112	0.017667845	0.004361749	11	3	EN-L5-6	64	21	21
GCTCCTAGTCAATGTC-1_1_A9	-24.17143281	-6.453616731	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1457	2298	0.016971279	0.00435161	11	9	OPC	64	21	21
GCTCTGTAGATGCCTT-1_1_A9	-22.16120101	-14.51880849	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2973	5745	0.019669278	0.002610966	11	6A	IN-PV	64	21	21
GCTCTGTAGCTAACAA-1_1_A9	-5.655480715	35.07878263	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	914	1291	0.048024787	0.00697134	11	oligos	OL-MS-2	64	21	21
GCTGCAGAGATCCCGC-1_1_A9	4.67750677	-24.12463426	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4403	13394	0.003733015	0.004703599	11	L2-3	EN-L2-3-MS	64	21	21
GCTGCAGAGGCTCATT-1_1_A9	-15.14010574	6.940440607	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	780	1014	0.01183432	0.006903353	11	8	Astrocytes	64	21	21
GCTGCAGAGTACGACG-1_1_A9	-24.14343904	-9.687689973	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1079	1444	0.019390582	0.011080332	11	9	OPC	64	21	21
GCTGCAGAGTGTCCCG-1_1_A9	27.74420444	-24.44415206	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5989	19342	0.018664047	0.004032675	11	3	EN-L5-6	64	21	21
GCTGCAGCATTCTTAC-1_1_A9	-19.17586156	15.54095238	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1679	2781	0.011147069	0.007910823	11	8	Astrocytes	64	21	21
GCTGCAGGTAAGGATT-1_1_A9	-24.51997151	-22.15369369	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3834	8695	0.016101208	0.004255319	11	6A	IN-PV	64	21	21
GCTGCAGGTGGACGAT-1_1_A9	18.89259391	-31.28959367	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4803	13019	0.009370919	0.004992703	11	3	EN-L5-6	64	21	21
GCTGCAGGTGTGCCTG-1_1_A9	33.05564056	4.926107709	14	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1068	1365	0.013186813	0.008058608	11	14	Microglia	64	21	21
GCTGCAGGTTGTGGCC-1_1_A9	-9.761362828	-29.64130586	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1052	1450	0.053793103	0.010344828	11	16	EN-PYR	64	21	21
GCTGCAGTCACCTCGT-1_1_A9	20.55390921	-33.3833133	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4385	11568	0.010805671	0.006656293	11	3	EN-L5-6	64	21	21
GCTGCAGTCATCGATG-1_1_A9	-24.94975276	-5.363317061	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1548	2466	0.006893755	0.004460665	11	9	OPC	64	21	21
GCTGCAGTCCTTTACA-1_1_A9	-14.70869287	9.510777151	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1336	2068	0.010638298	0.007253385	11	8	Astrocytes	64	21	21
GCTGCAGTCTACTCAT-1_1_A9	-13.7814243	-3.38816523	13A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3347	8024	0.007352941	0.00772682	11	13A	IN-VIP	64	21	21
GCTGCAGTCTCAACTT-1_1_A9	-7.73028913	-29.51461373	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	874	1157	0.052722558	0.006914434	11	16	EN-PYR	64	21	21
GCTGCAGTCTGCAAGT-1_1_A9	-9.604591198	32.64059465	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	876	1158	0.032815199	0.005181347	11	oligos	OL-MS-2	64	21	21
GCTGCGAAGAGGGATA-1_1_A9	-20.38123467	12.57434723	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1187	1840	0.013043478	0.005978261	11	8	Astrocytes	64	21	21
GCTGCGAAGGCGCTCT-1_1_A9	-20.764147	17.20460383	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1743	3044	0.007227332	0.003613666	11	8	Astrocytes	64	21	21
GCTGCGACAAGACACG-1_1_A9	-6.062493641	31.16951926	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1263	1899	0.016850974	0.003686151	11	oligos	OL-MS-2	64	21	21
GCTGCGACAAGTTAAG-1_1_A9	28.41624927	-26.13719396	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6106	22437	0.001693631	0.003832954	11	3	EN-L5-6	64	21	21
GCTGCGACATACCATG-1_1_A9	-18.81322356	-7.999317734	13B	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3511	7311	0.007796471	0.006155109	11	13B	IN-SV2C	64	21	21
GCTGCGACATCCAACA-1_1_A9	4.508375028	1.454704041	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	922	1184	0.054054054	0.012668919	11	16	EN-PYR	64	21	21
GCTGCGACATTCACTT-1_1_A9	4.81098668	1.59606569	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	917	1190	0.056302521	0.003361345	11	16	EN-PYR	64	21	21
GCTGCGAGTGGACGAT-1_1_A9	-9.777492108	32.17049996	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	986	1269	0.037037037	0.009456265	11	oligos	OL-MS-2	64	21	21
GCTGCGAGTGTAACGG-1_1_A9	-6.252643509	35.325584	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	779	1042	0.017274472	0.00671785	11	oligos	OL-MS-2	64	21	21
GCTGCGATCATAGCAC-1_1_A9	-13.14217065	-32.9115555	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1624	2528	0.036392405	0.01028481	11	16	EN-PYR	64	21	21
GCTGCGATCCATGCTC-1_1_A9	-5.694935049	31.11037762	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1330	1932	0.023291925	0.006728778	11	oligos	OL-MS-2	64	21	21
GCTGCGATCTCGTTTA-1_1_A9	7.823460715	-0.741424921	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1047	1601	0.031855091	0.008744535	11	16	EN-PYR	64	21	21
GCTGCGATCTGGCGTG-1_1_A9	-5.720529587	32.1299855	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1110	1643	0.012172855	0.001825928	11	oligos	OL-MS-2	64	21	21
GCTGCTTAGTCAATAG-1_1_A9	-25.66598812	-7.76672584	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1166	1668	0.007793765	0.018585132	11	9	OPC	64	21	21
GCTGCTTCAGCTGTGC-1_1_A9	7.582641445	-24.63231861	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5481	16431	0.005234009	0.007911874	11	L2-3	EN-L2-3-MS	64	21	21
GCTGCTTCATTTGCCC-1_1_A9	5.240205998	1.944196738	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	815	1056	0.049242424	0.005681818	11	16	EN-PYR	64	21	21
GCTGCTTGTGTTTGTG-1_1_A9	-7.630845179	-27.99783418	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	845	1179	0.091603053	0.009329941	11	16	EN-PYR	64	21	21
GCTGCTTGTTCCACTC-1_1_A9	-18.82733926	10.59868593	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	778	1101	0.015440509	0.009990917	11	8	Astrocytes	64	21	21
GCTGCTTTCCGCGGTA-1_1_A9	6.499184663	-12.73278193	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2471	4603	0.009776233	0.013034977	11	L2-3	EN-L2-3-MS	64	21	21
GCTGCTTTCCGTCAAA-1_1_A9	4.1080222	0.960339609	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	853	1116	0.056451613	0.016129032	11	16	EN-PYR	64	21	21
GCTGCTTTCTTACCTA-1_1_A9	-10.8402834	30.6890049	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1034	1395	0.031541219	0.005734767	11	oligos	OL-MS-2	64	21	21
GCTGGGTCAGACAGGT-1_1_A9	5.943509208	-25.22266939	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6099	21469	0.004657879	0.004052355	11	L2-3	EN-L2-3-MS	64	21	21
GCTGGGTCAGGAACGT-1_1_A9	19.86103464	-34.04416039	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4920	13154	0.005245553	0.008362475	11	3	EN-L5-6	64	21	21
GCTGGGTCAGTCAGAG-1_1_A9	-21.00979888	-16.59654085	6B	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3358	7391	0.005953186	0.00446489	11	6B	IN-SST	64	21	21
GCTGGGTGTGGCTCCA-1_1_A9	27.89007218	4.093841584	15DA	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	978	1257	0.023070804	0.007955449	11	15DA	T cells	64	21	21
GCTGGGTGTTACGACT-1_1_A9	-19.46306554	12.44049038	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1308	1990	0.012060302	0.005025126	11	8	Astrocytes	64	21	21
GCTGGGTTCGGATGGA-1_1_A9	-15.60160222	-9.516459283	13B	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2453	4903	0.00815827	0.002039568	11	13B	IN-SV2C	64	21	21
GCTTCCAAGATTACCC-1_1_A9	5.280447386	-23.01904666	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4483	12300	0.004634146	0.01097561	11	L2-3	EN-L2-3-MS	64	21	21
GCTTCCACATCCCACT-1_1_A9	-8.227590408	-27.09410856	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	856	1118	0.062611807	0.010733453	11	16	EN-PYR	64	21	21
GCTTCCACATGCAATC-1_1_A9	-8.978461312	-29.70585125	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	865	1156	0.05017301	0.006920415	11	16	EN-PYR	64	21	21
GCTTCCAGTAGCGATG-1_1_A9	23.30534693	-20.39256898	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5052	13272	0.015672092	0.013562387	11	3	EN-L5-6	64	21	21
GCTTCCATCACCATAG-1_1_A9	-24.0215148	-9.586878716	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	987	1369	0.013148283	0.007304602	11	9	OPC	64	21	21
GCTTCCATCCTTAATC-1_1_A9	32.84910893	5.86869446	14	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	878	1104	0.041666667	0.024456522	11	14	Microglia	64	21	21
GCTTCCATCTTGGGTA-1_1_A9	-24.33311638	-12.22893558	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1066	1510	0.02781457	0.01192053	11	9	OPC	64	21	21
GCTTGAAAGGAGCGTT-1_1_A9	-15.37985786	-36.73069426	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3119	7341	0.06906416	0.007900831	11	16	EN-PYR	64	21	21
GCTTGAACAGGTCTCG-1_1_A9	-21.85844824	-16.29529616	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3391	7523	0.016881563	0.004785325	11	6A	IN-PV	64	21	21
GCTTGAAGTGACTACT-1_1_A9	-11.34509704	-31.79478243	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1082	1503	0.035928144	0.007984032	11	16	EN-PYR	64	21	21
GCTTGAAGTTCGCTAA-1_1_A9	-8.825400913	14.56128159	1	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1833	2852	0.007012623	0.005259467	11	oligos	OL-Cntl	64	21	21
GCTTGAATCGCAAGCC-1_1_A9	-24.48303387	-1.445154097	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1544	2397	0.009178139	0.007926575	11	9	OPC	64	21	21
GGAAAGCAGAGCTTCT-1_1_A9	-4.23608317	34.57081905	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	832	1110	0.015315315	0.002702703	11	oligos	OL-MS-2	64	21	21
GGAAAGCGTCTCCACT-1_1_A9	-9.488527117	-4.744935262	13A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1765	2998	0.017344897	0.006337558	11	13A	IN-VIP	64	21	21
GGAAAGCGTTCGAATC-1_1_A9	21.75542606	26.15391166	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1026	1559	0.007055805	0.005131495	11	oligos	OL-MS-2	64	21	21
GGAAAGCGTTCGCGAC-1_1_A9	-18.90259433	-8.29564283	13B	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3591	8239	0.017599223	0.007525185	11	13B	IN-SV2C	64	21	21
GGAACTTAGTGTGAAT-1_1_A9	-27.02922653	-6.089224864	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1297	1932	0.006728778	0.01242236	11	9	OPC	64	21	21
GGAACTTCAAGAAAGG-1_1_A9	-8.004408885	34.51665133	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	835	1103	0.017225748	0.011786038	11	oligos	OL-MS-2	64	21	21
GGAACTTCAGATCGGA-1_1_A9	-24.55233505	-8.231880071	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1102	1546	0.01228978	0.003234153	11	9	OPC	64	21	21
GGAACTTGTGATAAGT-1_1_A9	9.987886616	-0.360627967	12	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	984	1420	0.070422535	0.003521127	11	12	EN-MIX	64	21	21
GGAACTTGTGCTAGCC-1_1_A9	19.81848017	-33.82103368	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3656	8749	0.010629786	0.007543719	11	3	EN-L5-6	64	21	21
GGAACTTGTGTTGGGA-1_1_A9	22.84735597	-18.58630922	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	7878	33030	0.024704814	0.007114744	11	3	EN-L5-6	64	21	21
GGAACTTTCCTTTCTC-1_1_A9	-9.702797407	31.66725919	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	878	1198	0.01836394	0.004173623	11	oligos	OL-MS-2	64	21	21
GGAACTTTCTCTTATG-1_1_A9	5.494521376	-24.51896975	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5843	19746	0.004608528	0.006330396	11	L2-3	EN-L2-3-MS	64	21	21
GGAATAAAGACGCACA-1_1_A9	-8.782545841	33.6850615	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	843	1108	0.020758123	0.002707581	11	oligos	OL-MS-2	64	21	21
GGAATAAAGACTAGGC-1_1_A9	-25.77219057	-7.290111747	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1168	1729	0.00578369	0.002891845	11	9	OPC	64	21	21
GGAATAAAGCCATCGC-1_1_A9	-9.514454031	-30.42613117	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	926	1260	0.043650794	0.007142857	11	16	EN-PYR	64	21	21
GGAATAACAACGATGG-1_1_A9	25.97863502	-22.70692801	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4229	10724	0.01156285	0.004289444	11	3	EN-L5-6	64	21	21
GGAATAAGTCCGCTGA-1_1_A9	-7.214894478	-30.43121248	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	912	1290	0.115503876	0.010077519	11	16	EN-PYR	64	21	21
GGAATAATCGGATGGA-1_1_A9	15.62377895	-8.245260929	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1802	3238	0.004632489	0.004632489	11	3	EN-L5-6	64	21	21
GGACAAGCAAGGGTCA-1_1_A9	22.23691852	26.00015958	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1126	1659	0.005424955	0.015069319	11	oligos	OL-MS-2	64	21	21
GGACAAGCACAACGCC-1_1_A9	-24.48237952	-8.952233443	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1328	1882	0.01381509	0.030286929	11	9	OPC	64	21	21
GGACAAGCACGCTTTC-1_1_A9	-22.0187638	-16.11994854	6B	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4208	10203	0.009016956	0.003528374	11	6B	IN-SST	64	21	21
GGACAAGCAGAAGCAC-1_1_A9	-8.769889627	-27.5531188	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1015	1404	0.051994302	0.00997151	11	16	EN-PYR	64	21	21
GGACAAGGTAGAGCTG-1_1_A9	-27.13515523	-9.231303545	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1225	1723	0.00754498	0.005223447	11	9	OPC	64	21	21
GGACAAGGTAGAGGAA-1_1_A9	-8.118377511	33.68990711	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	804	1102	0.014519056	0.006352087	11	oligos	OL-MS-2	64	21	21
GGACAAGGTCCTCTTG-1_1_A9	28.2583878	-25.72363553	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	7104	29506	0.004134752	0.004338101	11	3	EN-L5-6	64	21	21
GGACAAGTCTCAAACG-1_1_A9	-6.130374913	31.26561466	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1469	2176	0.011948529	0.006893382	11	oligos	OL-MS-2	64	21	21
GGACAGAAGAGCCTAG-1_1_A9	-9.433756934	32.2413148	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	890	1195	0.044351464	0.006694561	11	oligos	OL-MS-2	64	21	21
GGACAGAAGTCCGTAT-1_1_A9	37.08839728	8.928010534	14	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	873	1105	0.016289593	0.011764706	11	14	Microglia	64	21	21
GGACAGACATTAGGCT-1_1_A9	0.048154253	-22.66848095	10	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4576	14649	0.001570073	0.005665916	11	L2-3	EN-L2-3-Cntl	64	21	21
GGACAGAGTCCGCTGA-1_1_A9	-25.27371988	-10.03646497	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	889	1159	0.021570319	0.002588438	11	9	OPC	64	21	21
GGACATTAGGCGCTCT-1_1_A9	-21.96968378	-19.70749358	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2803	6001	0.011331445	0.004832528	11	6A	IN-PV	64	21	21
GGACATTCACTCTGTC-1_1_A9	-26.01749948	-24.18987117	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4421	10715	0.013999067	0.006719552	11	6A	IN-PV	64	21	21
GGACATTCATACTCTT-1_1_A9	3.788997367	0.286619589	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1069	1397	0.052970651	0.009305655	11	16	EN-PYR	64	21	21
GGACATTCATCGACGC-1_1_A9	-23.43842506	-7.627339933	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1518	2143	0.015398973	0.006066262	11	9	OPC	64	21	21
GGACATTCATCTCCCA-1_1_A9	5.086607786	1.867317651	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	831	1059	0.053824363	0.011331445	11	16	EN-PYR	64	21	21
GGACATTGTAAATGAC-1_1_A9	6.266027575	-25.18126534	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6650	26013	0.011994003	0.003421366	11	L2-3	EN-L2-3-MS	64	21	21
GGACATTGTCATCCCT-1_1_A9	5.529149188	-25.07605552	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5973	21513	0.006135825	0.003904616	11	L2-3	EN-L2-3-MS	64	21	21
GGACATTTCAACCATG-1_1_A9	-22.60297837	-16.50502249	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4595	12767	0.022009869	0.004542962	11	6A	IN-PV	64	21	21
GGACATTTCAAGGCTT-1_1_A9	-33.06515939	-9.490310584	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1000	1441	0.0055517	0.004163775	11	9	OPC	64	21	21
GGACATTTCCATTCTA-1_1_A9	-0.979520518	35.93304324	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	750	1002	0.01497006	0.006986028	11	oligos	OL-MS-2	64	21	21
GGACATTTCCCAAGTA-1_1_A9	-11.37052859	30.09524371	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1122	1495	0.044816054	0.012040134	11	oligos	OL-MS-2	64	21	21
GGACATTTCCTGCCAT-1_1_A9	-13.82904536	-3.670136348	13A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3300	7580	0.005408971	0.007124011	11	13A	IN-VIP	64	21	21
GGACATTTCTATCCCG-1_1_A9	10.18595921	0.35640194	12	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	882	1254	0.033492823	0.005582137	11	12	EN-MIX	64	21	21
GGACGTCAGGCATTGG-1_1_A9	-33.88058028	-7.619321594	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1212	1912	0.005753138	0.003138075	11	9	OPC	64	21	21
GGACGTCCAAACGCGA-1_1_A9	-5.183534652	35.38466618	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	905	1237	0.025060631	0.014551334	11	oligos	OL-MS-2	64	21	21
GGACGTCCAATCTGCA-1_1_A9	3.706217353	-10.82855919	12	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1608	2562	0.007806401	0.008587041	11	12	EN-MIX	64	21	21
GGACGTCGTACCGGCT-1_1_A9	-6.023352079	35.49018609	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	758	1013	0.019743337	0.004935834	11	oligos	OL-MS-2	64	21	21
GGACGTCGTGTCAATC-1_1_A9	-17.75895265	-17.22738378	6B	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1909	3469	0.006341885	0.00230614	11	6B	IN-SST	64	21	21
GGACGTCTCTCGATGA-1_1_A9	-21.1656183	16.83923092	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1528	2614	0.003442999	0.003060444	11	8	Astrocytes	64	21	21
GGAGCAAAGCGTGAAC-1_1_A9	-1.804700395	34.30794458	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	827	1141	0.008764242	0.002629273	11	oligos	OL-MS-2	64	21	21
GGAGCAACATGTAGTC-1_1_A9	-15.83957363	-6.533016543	13A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2751	5348	0.01776365	0.005422588	11	13A	IN-VIP	64	21	21
GGAGCAACATTTGCTT-1_1_A9	27.78404509	-24.3766895	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6554	25272	0.011158594	0.003363406	11	3	EN-L5-6	64	21	21
GGAGCAAGTCGGCATC-1_1_A9	-26.32434628	-8.663066776	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	973	1408	0.016335227	0.004261364	11	9	OPC	64	21	21
GGAGCAAGTTCTGTTT-1_1_A9	30.16656346	-7.268609118	2	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4859	13819	0.00542731	0.016426659	11	2	EN-L4	64	21	21
GGAGCAATCAGAAATG-1_1_A9	5.135899575	-23.33583855	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4191	10507	0.007042924	0.006281527	11	L2-3	EN-L2-3-MS	64	21	21
GGAGCAATCCAAAGTC-1_1_A9	-14.82628593	13.78860065	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2214	3763	0.018602179	0.010895562	11	8	Astrocytes	64	21	21
GGAGCAATCCACGCAG-1_1_A9	-22.51578099	-15.46639273	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3879	8892	0.011695906	0.00528565	11	6A	IN-PV	64	21	21
GGATGTTAGAGCAATT-1_1_A9	-14.56028457	9.634191781	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1406	2141	0.020551144	0.007473143	11	8	Astrocytes	64	21	21
GGATGTTAGTCCTCCT-1_1_A9	7.875824024	-23.17333507	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5839	19909	0.014716962	0.004621026	11	L2-3	EN-L2-3-MS	64	21	21
GGATGTTCAAACGCGA-1_1_A9	29.22953852	-13.29309966	2	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4556	11207	0.013027572	0.011153743	11	2	EN-L4	64	21	21
GGATGTTCAATCTGCA-1_1_A9	-9.646022166	-29.07393208	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1032	1410	0.058865248	0.010638298	11	16	EN-PYR	64	21	21
GGATGTTCAGCTGGCT-1_1_A9	-25.23231987	-7.681123114	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1078	1571	0.015276894	0.001909612	11	9	OPC	64	21	21
GGATGTTGTACCATCA-1_1_A9	-18.09167538	9.451641636	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	846	1159	0.016393443	0.006039689	11	8	Astrocytes	64	21	21
GGATGTTTCTTGCCGT-1_1_A9	-19.77740862	13.96562131	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1292	2051	0.011701609	0.006338372	11	8	Astrocytes	64	21	21
GGATTACAGACAAAGG-1_1_A9	15.93715017	-19.16243761	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6827	23881	0.023365856	0.004187429	11	L2-3	EN-L2-3-MS	64	21	21
GGATTACAGTACGTTC-1_1_A9	-10.08792077	-31.43516101	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1041	1465	0.049829352	0.017064846	11	16	EN-PYR	64	21	21
GGATTACCACATCCGG-1_1_A9	-9.052283101	-29.93283262	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	847	1137	0.050131926	0.004397537	11	16	EN-PYR	64	21	21
GGATTACGTTCATGGT-1_1_A9	26.72234762	-24.37683344	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4085	10945	0.022384651	0.001827318	11	3	EN-L5-6	64	21	21
GGATTACTCCAGAGGA-1_1_A9	2.352814109	6.419360112	7	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1023	1387	0.010814708	0.005767844	11	7	Phagocytes	64	21	21
GGCAATTAGAAAGTGG-1_1_A9	-18.81691079	-8.199421768	13B	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3287	6532	0.018677281	0.006736069	11	13B	IN-SV2C	64	21	21
GGCAATTAGCTAAGAT-1_1_A9	-25.88384858	-7.495112642	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1061	1495	0.010033445	0.010033445	11	9	OPC	64	21	21
GGCAATTTCAGATAAG-1_1_A9	-19.94739348	15.63415926	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1478	2301	0.009126467	0.00478053	11	8	Astrocytes	64	21	21
GGCAATTTCCCATTAT-1_1_A9	8.5145976	-2.063031287	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1469	2114	0.05487228	0.007095553	11	16	EN-PYR	64	21	21
GGCAATTTCGTCTGAA-1_1_A9	-6.481518155	33.54366689	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	989	1391	0.010064702	0.004313444	11	oligos	OL-MS-2	64	21	21
GGCCGATAGAATTCCC-1_1_A9	-5.727374158	33.9673611	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	963	1413	0.012031139	0.004246285	11	oligos	OL-MS-2	64	21	21
GGCCGATGTAGCAAAT-1_1_A9	15.35513671	-27.89910072	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3548	8364	0.004304161	0.009684362	11	3	EN-L5-6	64	21	21
GGCCGATGTGCGCTTG-1_1_A9	-20.22126863	18.62761285	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2022	3532	0.008493771	0.005379388	11	8	Astrocytes	64	21	21
GGCCGATTCCCAAGTA-1_1_A9	-19.9111469	-16.19536466	6B	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2573	4959	0.008267796	0.004839685	11	6B	IN-SST	64	21	21
GGCGACTAGAAGGGTA-1_1_A9	-10.98555475	29.52915581	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	777	1000	0.052	0.013	11	oligos	OL-MS-2	64	21	21
GGCGACTCAGACACTT-1_1_A9	-21.51836079	-16.10503662	6B	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3670	8542	0.014984781	0.005385156	11	6B	IN-SST	64	21	21
GGCGACTGTCTCCCTA-1_1_A9	-17.59217454	10.04361022	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1104	1562	0.02368758	0.007042254	11	8	Astrocytes	64	21	21
GGCGACTTCACCATAG-1_1_A9	-8.291416615	-27.4619308	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	885	1127	0.057675244	0.005323869	11	16	EN-PYR	64	21	21
GGCGTGTCACATGGGA-1_1_A9	-8.588047143	-31.33419239	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	920	1297	0.073245952	0.00616808	11	16	EN-PYR	64	21	21
GGCGTGTCACCATGTA-1_1_A9	-4.169628382	36.17681197	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	785	1034	0.00967118	0.00483559	11	oligos	OL-MS-2	64	21	21
GGCGTGTCATAGACTC-1_1_A9	-18.72149401	-8.195135156	13B	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3596	8396	0.018461172	0.002977608	11	13B	IN-SV2C	64	21	21
GGCGTGTTCAGGCAAG-1_1_A9	7.409846679	-21.08575175	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3963	9301	0.004945705	0.020750457	11	L2-3	EN-L2-3-MS	64	21	21
GGCGTGTTCTCACATT-1_1_A9	25.05361516	-24.87341033	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2943	6313	0.006969745	0.002376049	11	3	EN-L5-6	64	21	21
GGCTCGAAGATCCCGC-1_1_A9	25.44662973	6.698970722	15A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1409	1964	0.023930754	0.035641548	11	15A	Endo cells	64	21	21
GGCTCGAAGCCCAATT-1_1_A9	-23.73972215	-6.774949279	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1627	2550	0.01254902	0.005098039	11	9	OPC	64	21	21
GGCTCGACACCTCGTT-1_1_A9	-11.60384892	28.84117259	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1243	1725	0.031884058	0.008115942	11	oligos	OL-MS-2	64	21	21
GGCTCGACATATGAGA-1_1_A9	-5.357721877	36.21129487	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	743	1016	0.013779528	0.00492126	11	oligos	OL-MS-2	64	21	21
GGCTCGAGTACAAGTA-1_1_A9	-2.492398199	31.76423631	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	985	1502	0.008655126	0.00665779	11	oligos	OL-MS-2	64	21	21
GGCTCGAGTCCTAGCG-1_1_A9	-9.559322526	-30.9221256	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	943	1329	0.055680963	0.006772009	11	16	EN-PYR	64	21	21
GGCTCGAGTCCTGCTT-1_1_A9	-25.36172318	-8.704874235	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1022	1464	0.016393443	0.00273224	11	9	OPC	64	21	21
GGCTCGAGTGATGCCC-1_1_A9	28.04858868	-25.26531656	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6087	20822	0.006387475	0.003169724	11	3	EN-L5-6	64	21	21
GGCTCGAGTTCAACCA-1_1_A9	-2.159879803	34.27110234	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	903	1270	0.015748031	0.004724409	11	oligos	OL-MS-2	64	21	21
GGCTCGAGTTCTGGTA-1_1_A9	-17.06879802	11.02245984	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1422	2213	0.008133755	0.004518753	11	8	Astrocytes	64	21	21
GGCTCGATCACCGGGT-1_1_A9	-15.90041527	-5.307732	13A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4791	12766	0.009791634	0.006501645	11	13A	IN-VIP	64	21	21
GGCTCGATCACGCATA-1_1_A9	-11.14462772	31.26241558	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1076	1455	0.029553265	0.006872852	11	oligos	OL-MS-2	64	21	21
GGCTCGATCTCCTATA-1_1_A9	-6.124866609	35.17154856	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	780	1079	0.019462465	0.006487488	11	oligos	OL-MS-2	64	21	21
GGCTGGTAGAAGATTC-1_1_A9	-9.920441203	35.15458397	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	814	1027	0.012658228	0.007789679	11	oligos	OL-MS-2	64	21	21
GGCTGGTAGTGGGCTA-1_1_A9	18.92074883	-34.37371765	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4868	15503	0.005547313	0.00335419	11	3	EN-L5-6	64	21	21
GGCTGGTCAATAAGCA-1_1_A9	13.53516937	-24.21631459	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6276	20422	0.00474978	0.022084027	11	3	EN-L5-6	64	21	21
GGCTGGTCACACCGCA-1_1_A9	-19.57433387	15.52716699	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1624	2694	0.006681514	0.005939124	11	8	Astrocytes	64	21	21
GGCTGGTCACCACGTG-1_1_A9	-11.30874692	30.88777597	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1087	1462	0.034883721	0.003419973	11	oligos	OL-MS-2	64	21	21
GGCTGGTCACGTCAGC-1_1_A9	24.93374806	6.71820998	15A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1730	2566	0.012860483	0.014809041	11	15A	Endo cells	64	21	21
GGCTGGTCATGACGGA-1_1_A9	-22.87662311	21.34725185	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1305	2036	0.009332024	0.00589391	11	8	Astrocytes	64	21	21
GGCTGGTCATGTTCCC-1_1_A9	7.989452661	-0.189009521	12	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	833	1082	0.019408503	0.010166359	11	12	EN-MIX	64	21	21
GGCTGGTCATTAACCG-1_1_A9	-7.429649363	-30.10919106	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	817	1076	0.065055762	0.00929368	11	16	EN-PYR	64	21	21
GGCTGGTTCCCTCAGT-1_1_A9	27.35655062	-25.84246064	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5058	16205	0.008207343	0.004319654	11	3	EN-L5-6	64	21	21
GGCTGGTTCGAGAGCA-1_1_A9	-15.62647631	-4.96811238	13A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3795	8215	0.012781497	0.008155813	11	13A	IN-VIP	64	21	21
GGCTGGTTCGGATGGA-1_1_A9	-12.08860575	-32.95363993	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1311	2093	0.065456283	0.008122312	11	16	EN-PYR	64	21	21
GGCTGGTTCGTGGTCG-1_1_A9	-26.1548244	-24.18013034	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5368	14600	0.020890411	0.00609589	11	6A	IN-PV	64	21	21
GGGAATGCATAAAGGT-1_1_A9	7.271311649	-24.43060264	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6841	24798	0.007661908	0.007823212	11	L2-3	EN-L2-3-MS	64	21	21
GGGAATGGTACAGTGG-1_1_A9	-24.69613739	-22.14214732	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3057	6037	0.023355972	0.005466291	11	6A	IN-PV	64	21	21
GGGAATGGTTAGAACA-1_1_A9	-25.55050045	-8.107249902	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1151	1578	0.015842839	0.009505703	11	9	OPC	64	21	21
GGGAATGGTTCCACAA-1_1_A9	-3.66858349	32.5879117	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1030	1518	0.014492754	0.0085639	11	oligos	OL-MS-2	64	21	21
GGGAATGGTTTGACTG-1_1_A9	-12.64624731	-2.401198694	13A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2580	4946	0.01860089	0.012737566	11	13A	IN-VIP	64	21	21
GGGAATGTCCACTGGG-1_1_A9	-14.69828235	10.39220807	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1917	3471	0.014981273	0.003169116	11	8	Astrocytes	64	21	21
GGGACCTAGCATCATC-1_1_A9	-7.50658295	35.42885125	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	779	1076	0.019516729	0.008364312	11	oligos	OL-MS-2	64	21	21
GGGACCTAGTCGATAA-1_1_A9	27.85444854	4.251948853	15A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	863	1196	0.086120401	0.013377926	11	15A	Endo cells	64	21	21
GGGACCTCACATGGGA-1_1_A9	5.054856167	1.802270963	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	839	1104	0.048913043	0.004528986	11	16	EN-PYR	64	21	21
GGGACCTCACGCATCG-1_1_A9	-21.88185095	-18.93148138	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3635	9297	0.011293966	0.003549532	11	6A	IN-PV	64	21	21
GGGACCTCAGACGCTC-1_1_A9	-27.49719275	4.355465623	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2508	4668	0.005998286	0.008997429	11	9	OPC	64	21	21
GGGACCTGTATTCTCT-1_1_A9	23.78898859	27.33704818	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1170	1819	0.010995052	0.003298516	11	oligos	OL-MS-2	64	21	21
GGGACCTGTTCCGTCT-1_1_A9	-20.0664639	15.1366199	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1450	2243	0.010699955	0.003566652	11	8	Astrocytes	64	21	21
GGGACCTTCCGTTGCT-1_1_A9	18.81556547	-34.28333473	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4795	15253	0.00222907	0.002753557	11	3	EN-L5-6	64	21	21
GGGACCTTCGCCAGCA-1_1_A9	-18.86509771	10.45977713	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	704	1037	0.018322083	0.00192864	11	8	Astrocytes	64	21	21
GGGACCTTCTCAAACG-1_1_A9	-3.076514951	35.91048459	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	786	1073	0.014911463	0.002795899	11	oligos	OL-MS-2	64	21	21
GGGACCTTCTCGCTTG-1_1_A9	-18.93075227	17.24368351	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1596	2804	0.005349501	0.009629101	11	8	Astrocytes	64	21	21
GGGAGATAGACAGGCT-1_1_A9	-6.518488949	-29.88841223	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	796	1055	0.068246445	0.015165877	11	16	EN-PYR	64	21	21
GGGAGATAGGACAGCT-1_1_A9	-20.99257839	15.91569368	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1397	2163	0.008321775	0.005085529	11	8	Astrocytes	64	21	21
GGGAGATAGGGCTCTC-1_1_A9	-7.852022717	35.68824693	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	734	1016	0.027559055	0.00492126	11	oligos	OL-MS-2	64	21	21
GGGAGATGTCTAGAGG-1_1_A9	-9.738625989	22.25393885	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1232	1694	0.011806375	0.0094451	11	8	Astrocytes	64	21	21
GGGAGATGTCTCACCT-1_1_A9	-9.930705826	31.24380569	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	930	1226	0.022838499	0.013866232	11	oligos	OL-MS-2	64	21	21
GGGAGATTCACCGGGT-1_1_A9	-18.30509825	9.908096332	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	873	1140	0.013157895	0.003508772	11	8	Astrocytes	64	21	21
GGGAGATTCCAAGTAC-1_1_A9	-5.610952668	32.52806274	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1028	1476	0.012195122	0.008130081	11	oligos	OL-MS-2	64	21	21
GGGATGAAGACTAAGT-1_1_A9	-14.05010192	8.714098217	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1290	1876	0.030383795	0.007995736	11	8	Astrocytes	64	21	21
GGGATGAAGTGATCGG-1_1_A9	6.886431951	-22.97969191	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3502	7937	0.013355172	0.00289782	11	L2-3	EN-L2-3-MS	64	21	21
GGGATGACATACTACG-1_1_A9	5.196221999	-23.75368029	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4133	10808	0.006754256	0.003330866	11	L2-3	EN-L2-3-MS	64	21	21
GGGATGACATCTCCCA-1_1_A9	4.472823535	1.707226899	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	781	1003	0.039880359	0.012961117	11	16	EN-PYR	64	21	21
GGGATGAGTGGAAAGA-1_1_A9	-20.03903943	16.11136754	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1500	2368	0.006334459	0.009290541	11	8	Astrocytes	64	21	21
GGGATGAGTTCACGGC-1_1_A9	22.71872341	-20.31597132	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6082	19582	0.018843836	0.005311	11	3	EN-L5-6	64	21	21
GGGATGAGTTCAGACT-1_1_A9	26.70038546	-25.43668517	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4704	13634	0.007554643	0.004034033	11	3	EN-L5-6	64	21	21
GGGATGAGTTGGTTTG-1_1_A9	-23.74298683	-21.22678968	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4220	11461	0.034115697	0.004362621	11	6A	IN-PV	64	21	21
GGGATGATCCACTGGG-1_1_A9	-19.81285859	-18.64530944	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3237	8119	0.007636408	0.001970686	11	6A	IN-PV	64	21	21
GGGATGATCTGTGCAA-1_1_A9	6.490940364	-24.57882998	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6846	26396	0.005341718	0.004318836	11	L2-3	EN-L2-3-MS	64	21	21
GGGCACTAGCAATATG-1_1_A9	5.30341706	-23.26213672	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4856	13944	0.00580895	0.00989673	11	L2-3	EN-L2-3-MS	64	21	21
GGGCACTAGGACAGCT-1_1_A9	6.180600078	-24.69033633	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6109	21735	0.007177364	0.003588682	11	L2-3	EN-L2-3-MS	64	21	21
GGGCACTGTATAGGTA-1_1_A9	-7.07488997	35.1503229	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	823	1093	0.028362306	0.010064044	11	oligos	OL-MS-2	64	21	21
GGGCACTGTCTCCATC-1_1_A9	13.50647763	-2.043818515	12	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1135	1564	0.019181586	0.007672634	11	12	EN-MIX	64	21	21
GGGCACTGTGCAACTT-1_1_A9	-14.21568198	8.360702993	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1221	1705	0.015835777	0.007624633	11	8	Astrocytes	64	21	21
GGGCACTGTGTTGGGA-1_1_A9	-11.7059693	-32.18345139	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1080	1645	0.039513678	0.009118541	11	16	EN-PYR	64	21	21
GGGCACTTCAACACTG-1_1_A9	-7.125193985	31.40532541	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1180	1665	0.024024024	0.004204204	11	oligos	OL-MS-2	64	21	21
GGGCACTTCGCGTTTC-1_1_A9	6.508170866	-23.60528734	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5976	20509	0.007703935	0.008630357	11	L2-3	EN-L2-3-MS	64	21	21
GGGCACTTCGGCTACG-1_1_A9	-5.633858102	34.77627814	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	927	1347	0.011878248	0.004454343	11	oligos	OL-MS-2	64	21	21
GGGCACTTCTACTCAT-1_1_A9	-25.12117043	-6.45704072	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1354	2089	0.011010053	0.005744375	11	9	OPC	64	21	21
GGGCACTTCTGCTTGC-1_1_A9	-23.35242726	-8.885306171	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1320	1874	0.014941302	0.006403415	11	9	OPC	64	21	21
GGGCATCAGCAATATG-1_1_A9	5.91447233	-24.4915185	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4237	11537	0.008581087	0.002860362	11	L2-3	EN-L2-3-MS	64	21	21
GGGCATCAGCCAGGAT-1_1_A9	-25.85982341	-24.12471137	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4236	10520	0.021102662	0.003136882	11	6A	IN-PV	64	21	21
GGGCATCAGTACGCCC-1_1_A9	24.1993282	26.40729969	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1506	2515	0.009940358	0.007952286	11	oligos	OL-MS-2	64	21	21
GGGCATCAGTAGTGCG-1_1_A9	-21.22846841	16.5050633	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1462	2484	0.003623188	0.002415459	11	8	Astrocytes	64	21	21
GGGCATCAGTTTCCTT-1_1_A9	-20.69715111	16.97183689	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1639	2823	0.008501594	0.004250797	11	8	Astrocytes	64	21	21
GGGCATCCACCATGTA-1_1_A9	-6.357548083	-29.59482882	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	791	1032	0.076550388	0.013565891	11	16	EN-PYR	64	21	21
GGGCATCCAGCCTATA-1_1_A9	-25.18669603	-7.272371588	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1130	1716	0.015151515	0.003496503	11	9	OPC	64	21	21
GGGCATCCATTCGACA-1_1_A9	-14.53250097	-4.603673462	13A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2853	5735	0.010985179	0.007672188	11	13A	IN-VIP	64	21	21
GGGCATCGTCCAAGTT-1_1_A9	19.30342229	-32.88927144	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6615	24954	0.006812535	0.004087521	11	3	EN-L5-6	64	21	21
GGGCATCGTGGGTCAA-1_1_A9	11.41259574	-28.87100995	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5595	17840	0.00661435	0.004091928	11	3	EN-L5-6	64	21	21
GGGCATCTCTAACGGT-1_1_A9	-10.01510129	32.56140794	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	839	1113	0.026954178	0.011680144	11	oligos	OL-MS-2	64	21	21
GGGCATCTCTCGTTTA-1_1_A9	26.57152444	-23.13688417	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	7382	31505	0.01980638	0.003269322	11	3	EN-L5-6	64	21	21
GGGCATCTCTGTCCGT-1_1_A9	27.91649033	-25.16108627	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6100	22882	0.00830347	0.002796958	11	3	EN-L5-6	64	21	21
GGGTCTGAGCGATAGC-1_1_A9	21.65186257	25.97456947	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1070	1626	0.004920049	0.007380074	11	oligos	OL-MS-2	64	21	21
GGGTCTGAGCTAACTC-1_1_A9	-24.81192396	-6.955927456	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1149	1658	0.014475271	0.002412545	11	9	OPC	64	21	21
GGGTCTGCAACACGCC-1_1_A9	-18.56589218	-16.0518595	6B	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2248	4140	0.016666667	0.005555556	11	6B	IN-SST	64	21	21
GGGTCTGCAGCAGTTT-1_1_A9	-19.17670078	-6.484722775	13B	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3428	7587	0.017529986	0.00448135	11	13B	IN-SV2C	64	21	21
GGGTCTGGTCTCCATC-1_1_A9	5.349194091	-24.57702621	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6252	24397	0.004139853	0.003688978	11	L2-3	EN-L2-3-MS	64	21	21
GGGTCTGGTTCAGGCC-1_1_A9	-24.4971704	-12.34478351	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	839	1174	0.02044293	0.004258944	11	9	OPC	64	21	21
GGGTCTGTCACTCCTG-1_1_A9	-20.38632329	11.30193722	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	919	1408	0.006392045	0.004261364	11	8	Astrocytes	64	21	21
GGGTTGCCAAATTGCC-1_1_A9	-19.81060995	13.0715917	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1301	2047	0.007327797	0.008304836	11	8	Astrocytes	64	21	21
GGGTTGCTCGCATGGC-1_1_A9	20.25721814	-33.6896194	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4981	14898	0.003960263	0.011880789	11	3	EN-L5-6	64	21	21
GGTATTGAGCAATCTC-1_1_A9	-24.95040039	-5.497352678	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1461	2267	0.012351125	0.006616674	11	9	OPC	64	21	21
GGTATTGAGGAGTTTA-1_1_A9	-10.48418162	-5.414952939	13A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1754	2880	0.030208333	0.008333333	11	13A	IN-VIP	64	21	21
GGTATTGCACTAGTAC-1_1_A9	-11.96557557	-33.16108459	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1180	1787	0.031897034	0.00391718	11	16	EN-PYR	64	21	21
GGTATTGCAGCTTAAC-1_1_A9	5.289200414	1.853894929	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	756	1112	0.022482014	0.005395683	11	16	EN-PYR	64	21	21
GGTATTGGTATAAACG-1_1_A9	-12.58696423	16.74920875	11	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1607	2478	0.007263923	0.004035513	11	11	Glia-MIX	64	21	21
GGTATTGGTTCCTCCA-1_1_A9	5.027943556	-23.67508376	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4642	13991	0.007147452	0.004788793	11	L2-3	EN-L2-3-MS	64	21	21
GGTATTGTCATACGGT-1_1_A9	-22.07213084	-16.98569655	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3858	9869	0.031715473	0.003546459	11	6A	IN-PV	64	21	21
GGTATTGTCATGTAGC-1_1_A9	-21.59724248	14.83508645	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1246	1896	0.004746835	0.003691983	11	8	Astrocytes	64	21	21
GGTATTGTCCCTCAGT-1_1_A9	-11.97471361	-32.5675807	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1188	1714	0.049008168	0.011085181	11	16	EN-PYR	64	21	21
GGTGAAGAGAACTCGG-1_1_A9	-13.87199193	8.500688807	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1346	2002	0.018481518	0.007992008	11	8	Astrocytes	64	21	21
GGTGAAGAGATTACCC-1_1_A9	-23.65601417	-9.322228907	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1112	1596	0.021303258	0.009398496	11	9	OPC	64	21	21
GGTGAAGCAAACCCAT-1_1_A9	-11.56328234	15.75105677	11	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2244	3635	0.019807428	0.005777166	11	11	Glia-MIX	64	21	21
GGTGAAGCAAGGTTTC-1_1_A9	26.73746362	-26.44615338	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4645	13008	0.006073186	0.003151907	11	3	EN-L5-6	64	21	21
GGTGAAGGTATCGCAT-1_1_A9	-8.564363641	33.34656785	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	828	1110	0.01981982	0.00990991	11	oligos	OL-MS-2	64	21	21
GGTGAAGTCATCACCC-1_1_A9	-24.74461421	-7.660817014	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1202	1775	0.012394366	0.003380282	11	9	OPC	64	21	21
GGTGCGTAGAAACCTA-1_1_A9	27.48892395	-24.53640059	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	7486	32692	0.021350789	0.003487092	11	3	EN-L5-6	64	21	21
GGTGCGTAGAACTCGG-1_1_A9	-10.37989759	-32.69457044	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1164	1702	0.082256169	0.011750881	11	16	EN-PYR	64	21	21
GGTGCGTAGAACTGTA-1_1_A9	-14.58011847	-4.66880415	13A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2849	5442	0.013414186	0.008269019	11	13A	IN-VIP	64	21	21
GGTGCGTAGACTCGGA-1_1_A9	-24.79692668	-7.348486714	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1198	1780	0.012921348	0.006741573	11	9	OPC	64	21	21
GGTGCGTAGATGAGAG-1_1_A9	-11.63578276	-32.57331838	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1150	1700	0.061764706	0.002941176	11	16	EN-PYR	64	21	21
GGTGCGTAGCTGCCCA-1_1_A9	-8.417007317	-31.95613892	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	796	1130	0.04159292	0.009734513	11	16	EN-PYR	64	21	21
GGTGCGTCAAATACAG-1_1_A9	1.738976148	6.539995793	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	957	1238	0.010500808	0.005654281	11	oligos	OL-MS-2	64	21	21
GGTGCGTCAAGTTGTC-1_1_A9	-20.43942602	12.60986569	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1222	1791	0.007258515	0.010050251	11	8	Astrocytes	64	21	21
GGTGCGTCAGCATGAG-1_1_A9	-2.8856357	36.1357791	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	878	1207	0.009942005	0.005799503	11	oligos	OL-MS-2	64	21	21
GGTGCGTGTAGTACCT-1_1_A9	4.76773115	-23.6567742	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3702	8991	0.004226449	0.003892782	11	L2-3	EN-L2-3-MS	64	21	21
GGTGCGTGTCATATGC-1_1_A9	22.39948217	-19.72244318	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5036	13655	0.01398755	0.005346027	11	3	EN-L5-6	64	21	21
GGTGCGTGTCTCGTTC-1_1_A9	28.35401359	-25.97513992	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6066	21720	0.005202578	0.002209945	11	3	EN-L5-6	64	21	21
GGTGCGTGTTCCACTC-1_1_A9	-1.896987224	33.6841529	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	894	1228	0.013843648	0.003257329	11	oligos	OL-MS-2	64	21	21
GGTGCGTTCATGTGGT-1_1_A9	34.11197479	12.50753562	14	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1304	1892	0.031712474	0.016384778	11	14	Microglia	64	21	21
GGTGTTACACCCATGG-1_1_A9	33.04890764	4.947638263	14	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1254	1665	0.028828829	0.014414414	11	14	Microglia	64	21	21
GGTGTTAGTGCAGACA-1_1_A9	-16.54423547	11.33784204	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1449	2175	0.023448276	0.005057471	11	8	Astrocytes	64	21	21
GGTGTTAGTGGGTATG-1_1_A9	33.52422001	7.387622727	14	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	837	1040	0.013461538	0.014423077	11	14	Microglia	64	21	21
GGTGTTAGTGGTCTCG-1_1_A9	27.53255758	-25.25371966	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6574	27806	0.005826081	0.004351579	11	3	EN-L5-6	64	21	21
GGTGTTAGTTCGTTGA-1_1_A9	-25.14254192	-9.511956665	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	905	1203	0.004156276	0.002493766	11	9	OPC	64	21	21
GTAACGTAGGTAAACT-1_1_A9	-28.15489011	-5.855958813	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1105	1574	0.010165184	0.022871665	11	9	OPC	64	21	21
GTAACGTGTACAGTGG-1_1_A9	-26.71472791	-11.32071006	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1061	1430	0.006293706	0.037062937	11	9	OPC	64	21	21
GTAACGTGTGACTCAT-1_1_A9	32.90222092	10.77491744	14	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	862	1208	0.04718543	0.042218543	11	14	Microglia	64	21	21
GTAACGTTCTGGGCCA-1_1_A9	5.605387973	-25.13860993	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5241	19132	0.00538365	0.003397449	11	L2-3	EN-L2-3-MS	64	21	21
GTAACTGAGCACACAG-1_1_A9	4.457747457	1.78584138	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	846	1072	0.070895522	0.005597015	11	16	EN-PYR	64	21	21
GTAACTGCAAGCCCAC-1_1_A9	33.26905794	6.269271966	14	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1018	1364	0.035923754	0.007331378	11	14	Microglia	64	21	21
GTAACTGCAATGGACG-1_1_A9	22.74044557	-20.7039186	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	7437	30500	0.026852459	0.003344262	11	3	EN-L5-6	64	21	21
GTAACTGCATCTGGTA-1_1_A9	-26.27601468	-6.798129239	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1031	1498	0.004672897	0.000667557	11	9	OPC	64	21	21
GTAACTGGTTCCATGA-1_1_A9	22.8484574	-20.32285818	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	7789	34423	0.029253697	0.004386602	11	3	EN-L5-6	64	21	21
GTAACTGTCAAGATCC-1_1_A9	24.48841609	-26.00598297	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2432	5396	0.008710156	0.00222387	11	3	EN-L5-6	64	21	21
GTAACTGTCAGAGGTG-1_1_A9	8.641391334	-24.62441358	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4000	9883	0.007689973	0.007689973	11	L2-3	EN-L2-3-MS	64	21	21
GTACGTAAGCCAGTTT-1_1_A9	2.871333895	-16.7483498	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3126	7146	0.015253289	0.005177722	11	L2-3	EN-L2-3-MS	64	21	21
GTACGTAAGCGCCTCA-1_1_A9	-20.72653066	16.69931439	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1634	2692	0.008543834	0.002228826	11	8	Astrocytes	64	21	21
GTACGTAAGTATCGAA-1_1_A9	26.24366562	-24.0028276	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5085	14706	0.012987896	0.003467972	11	3	EN-L5-6	64	21	21
GTACGTAAGTGGTAAT-1_1_A9	33.12444406	5.058228123	14	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	881	1062	0.016007533	0.014124294	11	14	Microglia	64	21	21
GTACGTACAATCCGAT-1_1_A9	5.408620569	-23.60997912	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4830	13919	0.006465982	0.006753359	11	L2-3	EN-L2-3-MS	64	21	21
GTACGTACACAACGTT-1_1_A9	-7.438188304	-28.73602545	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	855	1126	0.041740675	0.007104796	11	16	EN-PYR	64	21	21
GTACGTACACGCTTTC-1_1_A9	22.35068431	26.44202215	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1143	1737	0.010362694	0.006908463	11	oligos	OL-MS-2	64	21	21
GTACTCCAGTAGATGT-1_1_A9	7.081541814	-23.28626102	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5107	13842	0.012136974	0.006935414	11	L2-3	EN-L2-3-MS	64	21	21
GTACTCCAGTGTTGAA-1_1_A9	4.281903193	1.132997118	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	880	1126	0.047069272	0.013321492	11	16	EN-PYR	64	21	21
GTACTCCCATAGAAAC-1_1_A9	-18.56424586	10.46131279	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	881	1142	0.020140105	0.00525394	11	8	Astrocytes	64	21	21
GTACTCCTCCGTACAA-1_1_A9	-14.08641098	-5.743829567	13A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2470	4594	0.007400958	0.006965607	11	13A	IN-VIP	64	21	21
GTACTTTCAAGCGCTC-1_1_A9	-18.6956031	-8.025328878	13B	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3706	8451	0.008519702	0.006508106	11	13B	IN-SV2C	64	21	21
GTACTTTCAGTCTTCC-1_1_A9	17.96402405	-29.27145363	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6145	21392	0.012294316	0.016922214	11	3	EN-L5-6	64	21	21
GTACTTTCATAGTAAG-1_1_A9	-25.09702769	-9.011316487	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	993	1385	0.013718412	0.003610108	11	9	OPC	64	21	21
GTACTTTGTGTCTGAT-1_1_A9	-25.28749459	-9.231425274	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	933	1316	0.003799392	0.009118541	11	9	OPC	64	21	21
GTACTTTTCCAGTAGT-1_1_A9	-7.567695138	-30.53457017	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	947	1329	0.070729872	0.015048909	11	16	EN-PYR	64	21	21
GTACTTTTCTGTCTAT-1_1_A9	6.884350893	-23.61783229	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4933	15385	0.012349691	0.003249919	11	L2-3	EN-L2-3-MS	64	21	21
GTAGGCCAGGCATTGG-1_1_A9	-14.21838883	9.089575297	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1645	2457	0.013024013	0.015873016	11	8	Astrocytes	64	21	21
GTAGGCCAGGCGTACA-1_1_A9	-18.67631458	10.59298119	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	921	1293	0.013921114	0.004640371	11	8	Astrocytes	64	21	21
GTAGGCCCACGCGAAA-1_1_A9	-11.14296506	16.15521708	11	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2210	3710	0.008086253	0.003504043	11	11	Glia-MIX	64	21	21
GTAGGCCCATGTCGAT-1_1_A9	-25.82823733	-9.181926516	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1082	1469	0.010891763	0.011572498	11	9	OPC	64	21	21
GTAGGCCGTCACTGGC-1_1_A9	-21.42920897	16.00053017	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1398	2236	0.009391771	0.004472272	11	8	Astrocytes	64	21	21
GTAGGCCGTTCCAACA-1_1_A9	-19.01341242	11.23962904	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1008	1483	0.010114633	0.009440324	11	8	Astrocytes	64	21	21
GTAGGCCTCCAAACAC-1_1_A9	-19.74705514	12.67154774	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1235	1849	0.009734992	0.005949162	11	8	Astrocytes	64	21	21
GTAGTCAAGGCTACGA-1_1_A9	-21.85738868	15.03409391	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1260	1974	0.006079027	0.005572442	11	8	Astrocytes	64	21	21
GTAGTCACATCAGTCA-1_1_A9	-25.66725708	-7.682535665	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1206	1757	0.013659647	0.014228799	11	9	OPC	64	21	21
GTATCTTCAAGCCGCT-1_1_A9	-23.98317184	-0.96107669	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1513	2445	0.006543967	0.007361963	11	9	OPC	64	21	21
GTATCTTCAATCGGTT-1_1_A9	-6.507589167	34.21865828	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	867	1221	0.032760033	0.001638002	11	oligos	OL-MS-2	64	21	21
GTATCTTCAGCATACT-1_1_A9	-23.73786478	-22.32373769	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3066	6189	0.015834545	0.004524156	11	6A	IN-PV	64	21	21
GTATCTTGTATGAAAC-1_1_A9	20.22671143	-31.46991321	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	8273	39829	0.010042934	0.003640563	11	3	EN-L5-6	64	21	21
GTATCTTGTTATCCGA-1_1_A9	-9.451551022	31.82632878	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	832	1133	0.026478376	0.005295675	11	oligos	OL-MS-2	64	21	21
GTATCTTTCCTGTAGA-1_1_A9	-12.82143194	7.097455862	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	975	1317	0.050873197	0.006833713	11	16	EN-PYR	64	21	21
GTATCTTTCGAACTGT-1_1_A9	-27.12727516	-11.27707743	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	859	1108	0.009025271	0.035198556	11	9	OPC	64	21	21
GTATCTTTCTTGAGAC-1_1_A9	0.447351406	33.05749694	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	802	1161	0.009474591	0.005167959	11	oligos	OL-MS-2	64	21	21
GTATTCTGTCTCCACT-1_1_A9	-5.898399603	35.27971235	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	804	1096	0.013686131	0.004562044	11	oligos	OL-MS-2	64	21	21
GTATTCTGTTTGACTG-1_1_A9	3.954180233	-11.31442387	12	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2090	3776	0.005826271	0.010063559	11	12	EN-MIX	64	21	21
GTATTCTTCCTCAATT-1_1_A9	5.463318547	-24.57131664	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5677	20040	0.003892216	0.00508982	11	L2-3	EN-L2-3-MS	64	21	21
GTCAAGTAGCGCCTCA-1_1_A9	-18.3380201	10.22519262	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	870	1163	0.01977644	0.004299226	11	8	Astrocytes	64	21	21
GTCAAGTCAAAGGTGC-1_1_A9	15.14180956	-27.74826854	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3218	7531	0.005045811	0.007037578	11	3	EN-L5-6	64	21	21
GTCAAGTCAGTCAGAG-1_1_A9	11.549339	-28.85690283	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5237	15944	0.008843452	0.005644757	11	3	EN-L5-6	64	21	21
GTCAAGTCATACAGCT-1_1_A9	-7.965928022	31.4798077	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1257	1844	0.027114967	0.007049892	11	oligos	OL-MS-2	64	21	21
GTCAAGTCATAGACTC-1_1_A9	-19.28245661	15.93721766	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1929	3241	0.009873496	0.003394014	11	8	Astrocytes	64	21	21
GTCAAGTCATGAGCGA-1_1_A9	-6.377692193	30.92382451	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1486	2152	0.014869888	0.004182156	11	oligos	OL-MS-2	64	21	21
GTCAAGTCATGCCACG-1_1_A9	15.4138418	-27.57232938	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3146	6821	0.007770122	0.006157455	11	3	EN-L5-6	64	21	21
GTCAAGTCATGGTCAT-1_1_A9	-21.1463054	-16.65569353	6B	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5050	16675	0.021289355	0.002278861	11	6B	IN-SST	64	21	21
GTCAAGTGTGAGCGAT-1_1_A9	32.81030751	9.989456969	14	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	835	1064	0.010338346	0.038533835	11	14	Microglia	64	21	21
GTCAAGTGTGTGGTTT-1_1_A9	-15.66865743	11.42673585	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1646	2763	0.006514658	0.004705031	11	8	Astrocytes	64	21	21
GTCAAGTTCTGCAAGT-1_1_A9	-12.57446748	16.94173683	11	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1859	3140	0.010191083	0.007324841	11	11	Glia-MIX	64	21	21
GTCAAGTTCTTAGAGC-1_1_A9	20.88079343	-33.38532032	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3942	10130	0.006712734	0.003948667	11	3	EN-L5-6	64	21	21
GTCACAACAGGTGGAT-1_1_A9	-27.07642257	-6.885907985	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1053	1547	0.008403361	0.019392372	11	9	OPC	64	21	21
GTCACAATCACTTACT-1_1_A9	4.805530724	1.587920534	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	791	1026	0.049707602	0.011695906	11	16	EN-PYR	64	21	21
GTCACAATCCCAACGG-1_1_A9	-10.69485927	-27.34040792	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	865	1123	0.053428317	0.014247551	11	16	EN-PYR	64	21	21
GTCACGGAGCTACCTA-1_1_A9	-7.763404021	-27.7450342	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	844	1132	0.108657244	0.007067138	11	16	EN-PYR	64	21	21
GTCACGGAGTCCAGGA-1_1_A9	19.25610461	-10.49384167	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2097	3839	0.01041938	0.008335504	11	3	EN-L5-6	64	21	21
GTCACGGCAAGCTGTT-1_1_A9	-25.77813946	-10.02254499	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	829	1128	0.011524823	0.009751773	11	9	OPC	64	21	21
GTCACGGGTACAGACG-1_1_A9	-20.14200458	16.48875599	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1414	2216	0.009476534	0.002256318	11	8	Astrocytes	64	21	21
GTCACGGGTAGCGCAA-1_1_A9	-12.43173085	16.58659979	11	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1740	2891	0.008301626	0.004150813	11	11	Glia-MIX	64	21	21
GTCACGGGTCATACTG-1_1_A9	28.21093622	-25.84320675	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5837	21386	0.006125503	0.00533059	11	3	EN-L5-6	64	21	21
GTCACGGTCAGCTTAG-1_1_A9	28.09032809	-25.67890532	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4822	14889	0.018604339	0.002686547	11	3	EN-L5-6	64	21	21
GTCATTTAGATACACA-1_1_A9	24.04444494	-10.52703329	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3961	9621	0.014447563	0.005196965	11	3	EN-L5-6	64	21	21
GTCATTTCAAGCCTAT-1_1_A9	6.842194483	-22.94067697	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4655	13641	0.008137233	0.004765047	11	L2-3	EN-L2-3-MS	64	21	21
GTCATTTCAAGCTGTT-1_1_A9	-9.645604039	-32.01160275	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	948	1318	0.036418816	0.006069803	11	16	EN-PYR	64	21	21
GTCATTTTCGCGATCG-1_1_A9	28.23020218	-25.94279163	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4962	15772	0.009637332	0.002662947	11	3	EN-L5-6	64	21	21
GTCATTTTCTCTGAGA-1_1_A9	-8.170536526	33.80929876	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	792	1044	0.029693487	0.004789272	11	oligos	OL-MS-2	64	21	21
GTCCTCAAGCGTCTAT-1_1_A9	15.07153654	-27.8399457	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3312	7696	0.015852391	0.004677755	11	3	EN-L5-6	64	21	21
GTCCTCACAAAGCAAT-1_1_A9	26.91968904	-24.6485542	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4407	12608	0.014355964	0.003965736	11	3	EN-L5-6	64	21	21
GTCCTCACAACACGCC-1_1_A9	-13.87105623	-34.14490099	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2033	3597	0.047817626	0.006672227	11	16	EN-PYR	64	21	21
GTCCTCACACAGGTTT-1_1_A9	-23.21496043	-7.810369629	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1587	2308	0.022097054	0.00779896	11	9	OPC	64	21	21
GTCCTCACAGGGTACA-1_1_A9	27.70150757	-24.60960687	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6879	26384	0.014061552	0.003297453	11	3	EN-L5-6	64	21	21
GTCCTCACATCCCATC-1_1_A9	-23.88278991	-21.22633251	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4418	11989	0.023521561	0.005254817	11	6A	IN-PV	64	21	21
GTCCTCAGTGATGATA-1_1_A9	-25.48471329	-8.690828883	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1080	1560	0.010897436	0.005128205	11	9	OPC	64	21	21
GTCCTCAGTGCCTGTG-1_1_A9	-25.99644848	-23.95103812	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3907	9083	0.013761973	0.008257184	11	6A	IN-PV	64	21	21
GTCCTCATCACCGTAA-1_1_A9	-26.20090834	-24.26510748	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6550	23311	0.028312814	0.003989533	11	6A	IN-PV	64	21	21
GTCCTCATCACGCATA-1_1_A9	28.01596494	-24.43054421	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5806	19143	0.005171603	0.00297759	11	3	EN-L5-6	64	21	21
GTCCTCATCATAGCAC-1_1_A9	-24.80385379	-8.550570551	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1077	1567	0.016592214	0.003828973	11	9	OPC	64	21	21
GTCCTCATCCACTCCA-1_1_A9	-10.30125086	33.87604747	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	956	1281	0.016393443	0.00312256	11	oligos	OL-MS-2	64	21	21
GTCCTCATCTACCTGC-1_1_A9	-21.13318962	-16.85304572	6B	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3573	8417	0.011524296	0.003564215	11	6B	IN-SST	64	21	21
GTCCTCATCTCTAAGG-1_1_A9	21.89721967	-20.27359036	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5903	18232	0.015522159	0.006417288	11	3	EN-L5-6	64	21	21
GTCGGGTAGATCTGCT-1_1_A9	2.206699877	-7.859131679	12	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1371	2555	0.010176125	0.004305284	11	12	EN-MIX	64	21	21
GTCGTAAAGAGGTTAT-1_1_A9	-26.13711545	-7.451713644	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1149	1677	0.005963029	0.007155635	11	9	OPC	64	21	21
GTCGTAAAGCTATGCT-1_1_A9	25.97181245	-22.2587581	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5711	16732	0.012849629	0.006753526	11	3	EN-L5-6	64	21	21
GTCGTAACAATGGAGC-1_1_A9	-12.79159962	-4.894144339	13A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2249	3678	0.011691136	0.013594345	11	13A	IN-VIP	64	21	21
GTCGTAACACCCAGTG-1_1_A9	19.64693802	-33.76807567	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5686	17655	0.007646559	0.004531294	11	3	EN-L5-6	64	21	21
GTCGTAACAGCTTAAC-1_1_A9	-20.56139628	12.23046339	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1032	1519	0.01514154	0.005266623	11	8	Astrocytes	64	21	21
GTCGTAAGTCGACTAT-1_1_A9	-18.86576608	10.52038297	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	756	1012	0.008893281	0.002964427	11	8	Astrocytes	64	21	21
GTCGTAAGTTCGCGAC-1_1_A9	16.10724739	-8.949399505	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2185	4307	0.022753657	0.004875784	11	3	EN-L5-6	64	21	21
GTCGTAATCTCCAGGG-1_1_A9	22.1700751	26.14747006	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1147	1743	0.012621916	0.003442341	11	oligos	OL-MS-2	64	21	21
GTCTCGTAGTGTTTGC-1_1_A9	-1.916234508	36.17909967	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	789	1118	0.009838998	0.009838998	11	oligos	OL-MS-2	64	21	21
GTCTCGTCAAGCCATT-1_1_A9	-6.216408432	35.00960404	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	743	1035	0.024154589	0.002898551	11	oligos	OL-MS-2	64	21	21
GTCTCGTCAGGGAGAG-1_1_A9	-29.14406588	-11.77220316	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	858	1139	0.012291484	0.01404741	11	9	OPC	64	21	21
GTCTCGTCATAACCTG-1_1_A9	-19.41209114	11.23988811	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	856	1215	0.018106996	0.004938272	11	8	Astrocytes	64	21	21
GTCTCGTGTCGGCTCA-1_1_A9	-1.890978574	36.05455606	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	767	1042	0.013435701	0.003838772	11	oligos	OL-MS-2	64	21	21
GTCTCGTTCATCACCC-1_1_A9	-9.46134941	-28.12070627	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1204	1722	0.042973287	0.009291521	11	16	EN-PYR	64	21	21
GTCTCGTTCTACCTGC-1_1_A9	-24.27644527	-7.486738646	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1186	1722	0.017421603	0.012775842	11	9	OPC	64	21	21
GTCTCGTTCTTGAGAC-1_1_A9	-26.42730005	-6.995126745	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	982	1431	0.00698812	0.004192872	11	9	OPC	64	21	21
GTCTTCGCAAACAACA-1_1_A9	-23.27455645	-7.844744527	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1504	2274	0.014951627	0.014951627	11	9	OPC	64	21	21
GTCTTCGCACAACGTT-1_1_A9	19.03915109	-34.5211581	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3766	9648	0.005078773	0.006737148	11	3	EN-L5-6	64	21	21
GTCTTCGCACTCGACG-1_1_A9	-25.594865	-9.286443186	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	800	1084	0.014760148	0.001845018	11	9	OPC	64	21	21
GTCTTCGCAGGCGATA-1_1_A9	-1.256271044	35.60183794	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	789	1072	0.006529851	0.004664179	11	oligos	OL-MS-2	64	21	21
GTCTTCGGTCCAGTTA-1_1_A9	-11.650652	30.08086913	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	983	1314	0.03196347	0.005327245	11	oligos	OL-MS-2	64	21	21
GTCTTCGTCCGTACAA-1_1_A9	18.88702476	-31.45775064	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5061	15054	0.008037731	0.003852797	11	3	EN-L5-6	64	21	21
GTCTTCGTCTGCTTGC-1_1_A9	-5.286643916	32.48348354	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1010	1406	0.017780939	0.009957326	11	oligos	OL-MS-2	64	21	21
GTGAAGGGTACTTGAC-1_1_A9	-24.66607645	-9.371467023	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1063	1519	0.014483213	0.007241606	11	9	OPC	64	21	21
GTGAAGGGTCAACATC-1_1_A9	-6.436433961	34.45510233	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	800	1099	0.010009099	0.002729754	11	oligos	OL-MS-2	64	21	21
GTGAAGGGTCGGCACT-1_1_A9	-21.99423458	-15.36719735	6B	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3524	7732	0.036083808	0.004785308	11	6B	IN-SST	64	21	21
GTGAAGGGTTACTGAC-1_1_A9	22.37252252	26.87340245	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1097	1678	0.010727056	0.004171633	11	oligos	OL-MS-2	64	21	21
GTGCAGCCATTACGAC-1_1_A9	-21.49644254	14.50986452	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1229	1907	0.005768222	0.002097535	11	8	Astrocytes	64	21	21
GTGCAGCGTAGCGCAA-1_1_A9	25.81385533	-17.3582488	2	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	10520	67340	0.024680725	0.006266706	11	2	EN-L4	64	21	21
GTGCAGCTCAACTCTT-1_1_A9	-26.08597233	-24.25288145	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5871	18832	0.020125319	0.006000425	11	6A	IN-PV	64	21	21
GTGCAGCTCACATACG-1_1_A9	-15.4254725	-4.78718643	13A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4700	11645	0.008243881	0.00729927	11	13A	IN-VIP	64	21	21
GTGCATAAGTACACCT-1_1_A9	16.18958414	-8.970082084	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1964	3781	0.006612007	0.006347527	11	3	EN-L5-6	64	21	21
GTGCATACACAGACTT-1_1_A9	-15.01030389	-6.344420555	13A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2828	5543	0.01028324	0.008839978	11	13A	IN-VIP	64	21	21
GTGCATATCCCATTAT-1_1_A9	-24.60115381	-7.226615989	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1261	1850	0.009189189	0.003783784	11	9	OPC	64	21	21
GTGCGGTCAATGGACG-1_1_A9	-18.7156077	-8.612456516	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3626	8255	0.023016354	0.007268322	11	6A	IN-PV	64	21	21
GTGCGGTCACCAACCG-1_1_A9	18.8628719	-31.07075151	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5947	18953	0.008283649	0.011343851	11	3	EN-L5-6	64	21	21
GTGCGGTCAGCCTGTG-1_1_A9	19.13784543	-34.25513056	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5453	17352	0.004034117	0.005013831	11	3	EN-L5-6	64	21	21
GTGCGGTGTATTCTCT-1_1_A9	-10.54915752	32.02217595	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	874	1096	0.018248175	0.010948905	11	oligos	OL-MS-2	64	21	21
GTGCGGTGTCTTGTCC-1_1_A9	-13.68090957	-33.72183558	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2015	3216	0.057524876	0.01119403	11	16	EN-PYR	64	21	21
GTGCGGTTCAGGCCCA-1_1_A9	-14.4030102	-3.853312999	13A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3321	6910	0.00723589	0.006512301	11	13A	IN-VIP	64	21	21
GTGCGGTTCATGTCTT-1_1_A9	-15.27470197	-7.210679182	13A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4232	11889	0.014551266	0.004037345	11	13A	IN-VIP	64	21	21
GTGCGGTTCCCACTTG-1_1_A9	-23.09285155	-22.14570023	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2683	4889	0.018817754	0.005931683	11	6A	IN-PV	64	21	21
GTGCGGTTCCTAAGTG-1_1_A9	20.4083249	-23.89734888	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5660	17207	0.010983902	0.011797524	11	3	EN-L5-6	64	21	21
GTGCGGTTCGTGGTCG-1_1_A9	18.1274451	-31.37740886	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5655	18066	0.003376508	0.008026126	11	3	EN-L5-6	64	21	21
GTGCTTCCACGAAAGC-1_1_A9	-9.480869915	-30.79616858	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	932	1322	0.06580938	0.006807867	11	16	EN-PYR	64	21	21
GTGCTTCGTTCATGGT-1_1_A9	-22.0905268	13.32989315	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1125	1686	0.011269276	0.002965599	11	8	Astrocytes	64	21	21
GTGCTTCGTTCTGAAC-1_1_A9	18.6967731	-7.646385163	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2250	4855	0.045108136	0.002471679	11	3	EN-L5-6	64	21	21
GTGCTTCTCAAAGACA-1_1_A9	-24.92392666	-6.488413361	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1215	1746	0.011454754	0.004581901	11	9	OPC	64	21	21
GTGCTTCTCCCAAGTA-1_1_A9	18.98761285	-34.18943916	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5559	19268	0.004463359	0.00326967	11	3	EN-L5-6	64	21	21
GTGCTTCTCCTGTACC-1_1_A9	18.59234639	-31.45125606	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5901	21092	0.005736772	0.006779822	11	3	EN-L5-6	64	21	21
GTGGGTCCAAGGTTCT-1_1_A9	30.98883615	-8.496265037	2	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3861	8949	0.008716058	0.007151637	11	2	EN-L4	64	21	21
GTGGGTCCACAGGAGT-1_1_A9	-2.964833503	33.23856306	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	979	1368	0.012426901	0.006578947	11	oligos	OL-MS-2	64	21	21
GTGGGTCCAGTAAGAT-1_1_A9	-9.651718397	-30.91980742	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	976	1431	0.088749126	0.01048218	11	16	EN-PYR	64	21	21
GTGGGTCCATTGGCGC-1_1_A9	-12.52241036	-34.14321363	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1316	1940	0.05	0.012371134	11	16	EN-PYR	64	21	21
GTGGGTCGTTCGAATC-1_1_A9	13.91882383	-4.581036379	12	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1737	3309	0.004533092	0.007555153	11	12	EN-MIX	64	21	21
GTGGGTCTCAACTCTT-1_1_A9	-20.74568416	16.69177783	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1548	2628	0.008371385	0.002663623	11	8	Astrocytes	64	21	21
GTGGGTCTCTAACTTC-1_1_A9	27.55553826	-25.1704927	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6637	26451	0.007523345	0.00374277	11	3	EN-L5-6	64	21	21
GTGGGTCTCTACCAGA-1_1_A9	-21.42876641	14.77010803	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1279	1950	0.006666667	0.004615385	11	8	Astrocytes	64	21	21
GTGGGTCTCTTGTCAT-1_1_A9	-26.87216795	-7.624780669	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1047	1468	0.00613079	0.005449591	11	9	OPC	64	21	21
GTGTGCGAGCAGACTG-1_1_A9	-17.31026824	-17.16869279	6B	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1787	3487	0.00516203	0.002867795	11	6B	IN-SST	64	21	21
GTGTGCGAGCTTCGCG-1_1_A9	-18.26880468	9.323011744	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	883	1168	0.011130137	0.011986301	11	8	Astrocytes	64	21	21
GTGTGCGCACATCCGG-1_1_A9	-23.67258695	-7.443791862	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1432	2146	0.01444548	0.003727866	11	9	OPC	64	21	21
GTGTGCGCACCATCCT-1_1_A9	-15.00179727	8.049425056	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	964	1555	0.023794212	0.003858521	11	8	Astrocytes	64	21	21
GTGTGCGCAGGCTGAA-1_1_A9	20.09044167	-31.66265091	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6486	22168	0.008751353	0.007127391	11	3	EN-L5-6	64	21	21
GTGTGCGCATAAAGGT-1_1_A9	26.16508819	-22.55421332	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5319	15163	0.021895403	0.00309965	11	3	EN-L5-6	64	21	21
GTGTGCGGTAGCCTAT-1_1_A9	24.97208983	-21.81542004	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3739	8868	0.020861525	0.00315742	11	3	EN-L5-6	64	21	21
GTGTGCGGTATTCTCT-1_1_A9	-1.922573588	33.59729034	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	916	1331	0.009015778	0.006010518	11	oligos	OL-MS-2	64	21	21
GTGTGCGTCACTCCTG-1_1_A9	-11.52812531	-33.0030035	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1060	1527	0.038637852	0.007858546	11	16	EN-PYR	64	21	21
GTGTGCGTCCGTTGCT-1_1_A9	-25.35426079	-5.617488047	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1347	2128	0.003759398	0.005169173	11	9	OPC	64	21	21
GTGTGCGTCTCCCTGA-1_1_A9	-16.8712264	-10.9540539	13B	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3553	8589	0.011060659	0.004191408	11	13B	IN-SV2C	64	21	21
GTGTTAGAGACAGAGA-1_1_A9	19.30515072	-33.68065754	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5755	18910	0.006557377	0.005076679	11	3	EN-L5-6	64	21	21
GTGTTAGAGGAATTAC-1_1_A9	17.50409027	-8.886523948	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2454	5767	0.009710421	0.006069013	11	3	EN-L5-6	64	21	21
GTGTTAGAGGGATACC-1_1_A9	-10.83920251	-32.79954941	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	993	1410	0.030496454	0.008510638	11	16	EN-PYR	64	21	21
GTGTTAGCAAGGTTCT-1_1_A9	-14.0353864	-4.121325044	13A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2896	5885	0.009855565	0.003738318	11	13A	IN-VIP	64	21	21
GTGTTAGCACTGTGTA-1_1_A9	-8.783441297	-31.66633308	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	913	1225	0.054693878	0.009795918	11	16	EN-PYR	64	21	21
GTGTTAGCAGCCACCA-1_1_A9	-19.82308872	11.40562486	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	970	1374	0.018195051	0.002911208	11	8	Astrocytes	64	21	21
GTGTTAGCATAGACTC-1_1_A9	-25.15172281	-6.05128524	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1198	1878	0.00798722	0.002662407	11	9	OPC	64	21	21
GTGTTAGGTATAAACG-1_1_A9	-11.58893273	-33.65063359	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1092	1645	0.056534954	0.005471125	11	16	EN-PYR	64	21	21
GTGTTAGTCCAGTATG-1_1_A9	22.73063207	-20.0227789	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5382	15969	0.017220865	0.005761162	11	3	EN-L5-6	64	21	21
GTGTTAGTCTGTCTAT-1_1_A9	-13.40611433	-4.063392665	13A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2591	5173	0.00405954	0.007152523	11	13A	IN-VIP	64	21	21
GTTAAGCAGCCTTGAT-1_1_A9	-25.17055886	-6.794898372	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1161	1738	0.012658228	0.006329114	11	9	OPC	64	21	21
GTTAAGCAGCGTGTCC-1_1_A9	-18.5111379	8.826319657	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	862	1253	0.015961692	0.005586592	11	8	Astrocytes	64	21	21
GTTAAGCAGGACACCA-1_1_A9	-19.53617522	16.27813325	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1653	2907	0.008943928	0.004127967	11	8	Astrocytes	64	21	21
GTTAAGCCAGCTTCGG-1_1_A9	-12.82318758	7.234604907	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1869	2919	0.032545392	0.006851662	11	16	EN-PYR	64	21	21
GTTAAGCCAGGACCCT-1_1_A9	17.48932503	-26.62810716	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3668	8765	0.002852253	0.016086708	11	3	EN-L5-6	64	21	21
GTTAAGCGTACTCTCC-1_1_A9	-7.934234293	35.68800322	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	767	1022	0.029354207	0.004892368	11	oligos	OL-MS-2	64	21	21
GTTAAGCGTGCTGTAT-1_1_A9	11.65249104	-2.174004145	12	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1280	2118	0.00802644	0.004721435	11	12	EN-MIX	64	21	21
GTTAAGCGTGGCTCCA-1_1_A9	-22.72692915	-15.56019573	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6316	22033	0.063994917	0.007171062	11	6A	IN-PV	64	21	21
GTTAAGCGTGTGCCTG-1_1_A9	-3.381070771	36.53717834	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	733	1016	0.011811024	0.006889764	11	oligos	OL-MS-2	64	21	21
GTTAAGCGTGTTCTTT-1_1_A9	-7.090045559	-30.13936696	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	763	1010	0.061386139	0.021782178	11	16	EN-PYR	64	21	21
GTTAAGCTCCTTGCCA-1_1_A9	-23.16800986	-7.777902813	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1673	2617	0.01490256	0.003056935	11	9	OPC	64	21	21
GTTACAGAGAAGGTGA-1_1_A9	-21.97013081	-15.31106686	6B	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3640	8334	0.023638109	0.005039597	11	6B	IN-SST	64	21	21
GTTACAGAGTTAGCGG-1_1_A9	-24.83760759	-22.9324383	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3223	6997	0.013863084	0.005145062	11	6A	IN-PV	64	21	21
GTTACAGCACAGGTTT-1_1_A9	-23.10059094	-21.96955619	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2781	6145	0.039707079	0.005207486	11	6A	IN-PV	64	21	21
GTTACAGCATGACATC-1_1_A9	-5.73244668	35.53686764	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	724	1010	0.014851485	0.00990099	11	oligos	OL-MS-2	64	21	21
GTTACAGTCACGGTTA-1_1_A9	-25.87821542	-7.310574529	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1077	1582	0.011378003	0.005689001	11	9	OPC	64	21	21
GTTCATTAGTTAACGA-1_1_A9	-13.04062051	-33.57284799	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1338	2069	0.042049299	0.007249879	11	16	EN-PYR	64	21	21
GTTCATTCAGCGATCC-1_1_A9	-17.69291468	10.24749683	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1065	1476	0.017615176	0.004065041	11	8	Astrocytes	64	21	21
GTTCATTCATAACCTG-1_1_A9	-21.01518322	-15.87496342	6B	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2850	6013	0.019125229	0.006153334	11	6B	IN-SST	64	21	21
GTTCATTGTCTTCTCG-1_1_A9	18.48772093	-7.617249231	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1736	3444	0.069105691	0.003193961	11	3	EN-L5-6	64	21	21
GTTCATTTCCTATGTT-1_1_A9	-24.49084095	-6.168278809	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1416	2237	0.016092982	0.003129191	11	9	OPC	64	21	21
GTTCGGGAGATTACCC-1_1_A9	-20.3360612	-16.56132341	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2679	5140	0.007587549	0.004863813	11	6A	IN-PV	64	21	21
GTTCGGGAGCACACAG-1_1_A9	-19.70415158	15.70204844	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1553	2464	0.006493506	0.005275974	11	8	Astrocytes	64	21	21
GTTCGGGAGTACGTTC-1_1_A9	-18.9613574	14.92979153	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1733	2805	0.032798574	0.002139037	11	8	Astrocytes	64	21	21
GTTCGGGGTGATGTGG-1_1_A9	-11.06909772	30.97906114	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1068	1391	0.025161754	0.012221423	11	oligos	OL-MS-2	64	21	21
GTTCGGGTCAAACCAC-1_1_A9	-19.73065285	15.69946441	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1583	2523	0.007134364	0.00554895	11	8	Astrocytes	64	21	21
GTTCGGGTCACCCTCA-1_1_A9	-12.24413196	16.50368208	11	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1541	2485	0.004828974	0.004024145	11	11	Glia-MIX	64	21	21
GTTCGGGTCCCTTGCA-1_1_A9	26.50271509	-23.1938571	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5391	17132	0.010098062	0.004436143	11	3	EN-L5-6	64	21	21
GTTCTCGCAACACGCC-1_1_A9	-24.89196839	-8.8929017	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1103	1522	0.009855453	0.009198423	11	9	OPC	64	21	21
GTTCTCGGTAAGTGTA-1_1_A9	7.213526221	-24.45600418	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6083	19199	0.005416949	0.009531746	11	L2-3	EN-L2-3-MS	64	21	21
GTTCTCGGTATCACCA-1_1_A9	-9.419582429	32.5940979	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	832	1100	0.020909091	0.007272727	11	oligos	OL-MS-2	64	21	21
GTTCTCGGTTATCCGA-1_1_A9	-6.941227116	-30.20000606	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	774	1001	0.057942058	0.012987013	11	16	EN-PYR	64	21	21
GTTCTCGTCGTAGATC-1_1_A9	-26.89363155	-7.791229672	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	948	1364	0.005865103	0.008797654	11	9	OPC	64	21	21
GTTCTCGTCGTGGACC-1_1_A9	-21.23892417	15.36309653	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1298	2074	0.009161041	0.004339441	11	8	Astrocytes	64	21	21
GTTTCTAAGCCCAACC-1_1_A9	5.115704946	-11.22206265	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2266	5156	0.016291699	0.005042669	11	L2-3	EN-L2-3-MS	64	21	21
GTTTCTACATCTACGA-1_1_A9	-27.36096928	15.58568574	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1076	1681	0.005353956	0.003569304	11	8	Astrocytes	64	21	21
GTTTCTAGTCCGTTAA-1_1_A9	-25.79873939	-7.775198768	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1058	1513	0.011896894	0.003965631	11	9	OPC	64	21	21
GTTTCTAGTGACGGTA-1_1_A9	-27.34870902	10.92897766	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	931	1349	0.011119348	0.005930319	11	8	Astrocytes	64	21	21
GTTTCTATCAGCTCGG-1_1_A9	6.305441675	-23.84251539	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5077	15607	0.009098481	0.003267764	11	L2-3	EN-L2-3-MS	64	21	21
GTTTCTATCATCTGCC-1_1_A9	-26.75558162	13.65360346	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1018	1612	0.008064516	0.00248139	11	8	Astrocytes	64	21	21
TAAACCGAGTTAAGTG-1_1_A9	-9.654916945	31.82011529	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	823	1051	0.028544244	0.005708849	11	oligos	OL-MS-2	64	21	21
TAAACCGCAGACAGGT-1_1_A9	-24.82886846	-6.067951948	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1389	2073	0.010130246	0.005788712	11	9	OPC	64	21	21
TAAACCGGTTCAGACT-1_1_A9	-10.72484937	-29.90012153	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1158	1680	0.061904762	0.010714286	11	16	EN-PYR	64	21	21
TAAACCGGTTGGTAAA-1_1_A9	18.50340139	-4.594061009	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1644	3151	0.004760394	0.002856236	11	3	EN-L5-6	64	21	21
TAAACCGTCCAAAGTC-1_1_A9	-9.841749278	31.14035496	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	970	1285	0.024902724	0.005447471	11	oligos	OL-MS-2	64	21	21
TAAACCGTCCTTCAAT-1_1_A9	-24.74099809	-5.799138521	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1420	2299	0.012179208	0.006524576	11	9	OPC	64	21	21
TAAACCGTCGGTTAAC-1_1_A9	19.6610479	-34.15091707	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5326	16755	0.005908684	0.00811698	11	3	EN-L5-6	64	21	21
TAAGAGAAGACGACGT-1_1_A9	5.282030617	-24.02372726	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4671	14395	0.005418548	0.005835359	11	L2-3	EN-L2-3-MS	64	21	21
TAAGAGACACCTATCC-1_1_A9	-8.278247419	-27.34870854	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	868	1149	0.075718016	0.009573542	11	16	EN-PYR	64	21	21
TAAGAGACATTGGGCC-1_1_A9	-9.75546024	-30.49832168	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1139	1662	0.093261131	0.005415162	11	16	EN-PYR	64	21	21
TAAGAGAGTCAACATC-1_1_A9	-20.00675949	17.06855603	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1644	2835	0.008818342	0.005643739	11	8	Astrocytes	64	21	21
TAAGAGATCACCTCGT-1_1_A9	19.03946784	-32.37849802	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5885	20546	0.004137058	0.00953957	11	3	EN-L5-6	64	21	21
TAAGAGATCGCAAGCC-1_1_A9	-22.37178164	-20.17039584	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2542	4961	0.017335215	0.006047168	11	6A	IN-PV	64	21	21
TAAGCGTAGAACAACT-1_1_A9	-6.989660482	-33.00608713	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	763	1008	0.033730159	0.018849206	11	16	EN-PYR	64	21	21
TAAGCGTCAGTGGAGT-1_1_A9	-22.93319964	15.08822999	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1143	1783	0.003925967	0.009534492	11	8	Astrocytes	64	21	21
TAAGCGTCATACGCCG-1_1_A9	-24.81098009	-8.275644803	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1106	1601	0.018738289	0.006870706	11	9	OPC	64	21	21
TAAGCGTTCAACTCTT-1_1_A9	17.52164404	-32.22368143	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5784	21585	0.006393329	0.004401205	11	3	EN-L5-6	64	21	21
TAAGCGTTCAAGAAGT-1_1_A9	5.197460286	-24.4778218	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4883	15218	0.006308319	0.002957025	11	L2-3	EN-L2-3-MS	64	21	21
TAAGCGTTCTCCTATA-1_1_A9	-11.7627516	13.61220924	11	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1168	1638	0.013431013	0.004273504	11	11	Glia-MIX	64	21	21
TAAGTGCAGGTGCAAC-1_1_A9	28.35776759	-25.51107251	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6126	21993	0.004774246	0.002227982	11	3	EN-L5-6	64	21	21
TAAGTGCAGTCAATAG-1_1_A9	22.5374758	-19.72896302	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6322	22028	0.01361903	0.005583802	11	3	EN-L5-6	64	21	21
TAAGTGCAGTTTGCGT-1_1_A9	-21.18169756	12.92502222	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1223	1947	0.005136107	0.005649718	11	8	Astrocytes	64	21	21
TAAGTGCCACTTAACG-1_1_A9	-12.22294778	-0.501568681	13A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3015	6211	0.005474159	0.005635163	11	13A	IN-VIP	64	21	21
TAAGTGCGTATGAAAC-1_1_A9	-0.568837712	33.75823892	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	862	1205	0.011618257	0.004149378	11	oligos	OL-MS-2	64	21	21
TAAGTGCGTGCTCTTC-1_1_A9	19.42395425	-21.91002869	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5448	16639	0.012080053	0.020734419	11	3	EN-L5-6	64	21	21
TAAGTGCTCCTTTACA-1_1_A9	-19.10603489	11.02299799	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	968	1390	0.015827338	0.005755396	11	8	Astrocytes	64	21	21
TACACGAAGATGGCGT-1_1_A9	18.99588287	-34.60260422	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4002	10235	0.005862237	0.00420127	11	3	EN-L5-6	64	21	21
TACACGAAGCCACGCT-1_1_A9	-8.366016502	-29.53151489	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	939	1355	0.101845018	0.005166052	11	16	EN-PYR	64	21	21
TACACGAAGGGTCTCC-1_1_A9	-12.49364606	-34.52660905	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1366	2194	0.044667274	0.01230629	11	16	EN-PYR	64	21	21
TACACGAGTACCGAGA-1_1_A9	33.13448418	4.983258836	14	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1203	1609	0.049098819	0.011808577	11	14	Microglia	64	21	21
TACACGAGTCCAAGTT-1_1_A9	-13.08363947	14.70862696	11	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	996	1407	0.008528785	0.006396588	11	11	Glia-MIX	64	21	21
TACACGAGTGCTTCTC-1_1_A9	-4.31443592	34.41006453	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	759	1047	0.024832856	0.010506208	11	oligos	OL-MS-2	64	21	21
TACACGAGTGGCTCCA-1_1_A9	-8.185236053	-29.66337274	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	877	1194	0.07118928	0.007537688	11	16	EN-PYR	64	21	21
TACACGATCCACGTTC-1_1_A9	-7.359370687	-27.99884703	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	807	1030	0.047572816	0.009708738	11	16	EN-PYR	64	21	21
TACACGATCTCGTATT-1_1_A9	-26.24241089	-24.21437075	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6403	21693	0.027336007	0.004932467	11	6A	IN-PV	64	21	21
TACAGTGAGGCGTACA-1_1_A9	14.72899359	-27.30884409	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2681	6021	0.010961634	0.006145159	11	3	EN-L5-6	64	21	21
TACAGTGAGTAAGTAC-1_1_A9	-26.9180122	4.980340813	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1569	2355	0.01358811	0.016135881	11	8	Astrocytes	64	21	21
TACAGTGAGTATCGAA-1_1_A9	-21.7029987	-28.27595651	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4569	13493	0.016378863	0.0041503	11	6A	IN-PV	64	21	21
TACAGTGCAGGGTACA-1_1_A9	28.27652472	-6.50992451	2	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4896	14527	0.004267915	0.005231638	11	2	EN-L4	64	21	21
TACAGTGCAGGTCCAC-1_1_A9	20.2629702	-24.28203956	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4768	13630	0.014086574	0.004035216	11	3	EN-L5-6	64	21	21
TACAGTGCAGTATGCT-1_1_A9	5.196479876	1.011171462	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1151	1622	0.049938348	0.00431566	11	16	EN-PYR	64	21	21
TACAGTGGTAGTAGTA-1_1_A9	-24.64229271	-7.233316912	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1291	1942	0.015447992	0.003604531	11	9	OPC	64	21	21
TACAGTGGTTCCCTTG-1_1_A9	-25.69004468	-6.09669273	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1212	1857	0.006462036	0.001615509	11	9	OPC	64	21	21
TACAGTGTCCACGACG-1_1_A9	-10.05700142	31.55546765	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	853	1150	0.033913043	0.007826087	11	oligos	OL-MS-2	64	21	21
TACAGTGTCGGAGGTA-1_1_A9	7.920494948	-23.16917381	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	7311	27738	0.020982046	0.003785421	11	L2-3	EN-L2-3-MS	64	21	21
TACAGTGTCGGTGTCG-1_1_A9	-9.617634191	32.98802575	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	752	1001	0.01998002	0.008991009	11	oligos	OL-MS-2	64	21	21
TACCTATAGGACACCA-1_1_A9	-24.52028401	-6.953874507	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1281	1968	0.019817073	0.004573171	11	9	OPC	64	21	21
TACCTATAGGGCTCTC-1_1_A9	-24.19040444	-9.455932138	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1151	1550	0.027096774	0.010322581	11	9	OPC	64	21	21
TACCTATAGTGAAGAG-1_1_A9	-15.92584857	-5.365379607	13A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3460	7267	0.013898445	0.008531719	11	13A	IN-VIP	64	21	21
TACCTATAGTTGTCGT-1_1_A9	-18.29885078	8.517333089	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	826	1208	0.005794702	0.003311258	11	8	Astrocytes	64	21	21
TACCTATCACAACGCC-1_1_A9	-11.06850026	32.42224569	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	980	1327	0.020346647	0.004521477	11	oligos	OL-MS-2	64	21	21
TACCTATCATAGAAAC-1_1_A9	-19.74888048	13.01133818	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1111	1645	0.015805471	0.00668693	11	8	Astrocytes	64	21	21
TACCTATCATATGCTG-1_1_A9	19.27866089	-31.82714787	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5839	20386	0.00569018	0.005641126	11	3	EN-L5-6	64	21	21
TACCTATCATGCAATC-1_1_A9	28.02022693	-25.50122596	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5974	22153	0.006455108	0.004694624	11	3	EN-L5-6	64	21	21
TACCTATGTCAGGACA-1_1_A9	5.650006508	-23.8398142	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4352	11743	0.012518096	0.004768798	11	L2-3	EN-L2-3-MS	64	21	21
TACCTATGTTTCCACC-1_1_A9	26.41260605	-22.90328116	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6891	30704	0.020257947	0.002996352	11	3	EN-L5-6	64	21	21
TACCTATTCCTTAATC-1_1_A9	-23.13243762	-8.688488178	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1515	2316	0.069516408	0.00388601	11	9	OPC	64	21	21
TACCTATTCGGACAAG-1_1_A9	-20.21571428	11.58837446	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	900	1238	0.008077544	0.004846527	11	8	Astrocytes	64	21	21
TACCTTAAGAATTGTG-1_1_A9	-7.178176231	-30.68891641	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	860	1128	0.063829787	0.007978723	11	16	EN-PYR	64	21	21
TACCTTAAGCGCTTAT-1_1_A9	7.59625076	-21.99049801	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4174	10742	0.009216161	0.012102029	11	L2-3	EN-L2-3-MS	64	21	21
TACCTTACACATCTTT-1_1_A9	5.502090217	-23.84776623	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4855	15639	0.01087026	0.003133193	11	L2-3	EN-L2-3-MS	64	21	21
TACCTTACACGACTCG-1_1_A9	-23.36777013	-7.84649302	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1403	2144	0.016324627	0.014458955	11	9	OPC	64	21	21
TACCTTAGTCTAACGT-1_1_A9	27.16763899	-26.280942	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5081	16988	0.005356722	0.002648929	11	3	EN-L5-6	64	21	21
TACCTTAGTCTCATCC-1_1_A9	-23.02501809	-9.226699549	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1459	2181	0.022008253	0.010087116	11	9	OPC	64	21	21
TACCTTAGTCTGGTCG-1_1_A9	18.79459052	-34.46056342	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4956	16087	0.007521601	0.004227016	11	3	EN-L5-6	64	21	21
TACGGATCACAACGCC-1_1_A9	-18.83125825	-8.183098068	13B	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4490	11773	0.023783233	0.004841587	11	13B	IN-SV2C	64	21	21
TACGGATCACGGTAGA-1_1_A9	-23.9830977	24.9193798	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1743	2910	0.005498282	0.006872852	11	8	Astrocytes	64	21	21
TACGGATCAGACGCCT-1_1_A9	-23.67209896	-9.578645621	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1135	1498	0.015353805	0.015353805	11	9	OPC	64	21	21
TACGGATGTACGAAAT-1_1_A9	-25.02117075	-6.130846278	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1248	1879	0.003725386	0.001596594	11	9	OPC	64	21	21
TACGGATGTCACCCAG-1_1_A9	28.14726038	-6.604279523	2	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5172	16107	0.007512262	0.001738375	11	2	EN-L4	64	21	21
TACGGATGTTCTGGTA-1_1_A9	-21.36056893	-16.65748208	6B	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5395	17339	0.015283465	0.003691101	11	6B	IN-SST	64	21	21
TACGGATTCACTTATC-1_1_A9	-11.23016026	32.49051721	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	890	1139	0.027216857	0.008779631	11	oligos	OL-MS-2	64	21	21
TACGGATTCATCTGTT-1_1_A9	-10.78865733	-33.57146318	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1060	1467	0.038173142	0.017723245	11	16	EN-PYR	64	21	21
TACGGATTCATTGCCC-1_1_A9	-21.29091171	15.79692108	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1324	2031	0.005908419	0.003938946	11	8	Astrocytes	64	21	21
TACGGATTCTAACTCT-1_1_A9	-8.547880416	33.63334125	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	869	1150	0.01826087	0.006956522	11	oligos	OL-MS-2	64	21	21
TACGGGCCATAGTAAG-1_1_A9	2.507445156	-17.3445756	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3095	6910	0.01186686	0.003762663	11	L2-3	EN-L2-3-MS	64	21	21
TACGGGCCATGTCTCC-1_1_A9	-21.53652529	16.31359608	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1356	2142	0.011204482	0.005135387	11	8	Astrocytes	64	21	21
TACGGGCCATTAGGCT-1_1_A9	29.96439879	-8.501395541	2	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4510	11661	0.005574136	0.010719492	11	2	EN-L4	64	21	21
TACGGGCTCGTCACGG-1_1_A9	6.205650153	-25.41147812	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6414	23148	0.003326421	0.004017626	11	L2-3	EN-L2-3-MS	64	21	21
TACGGTACACGTTGGC-1_1_A9	-3.349901318	33.37783611	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	860	1152	0.006944444	0.011284722	11	oligos	OL-MS-2	64	21	21
TACGGTACAGATCTGT-1_1_A9	-7.323685384	-29.14372142	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	782	1059	0.084985836	0.010387158	11	16	EN-PYR	64	21	21
TACGGTACAGTCTTCC-1_1_A9	-20.67778098	10.9182581	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1006	1571	0.006365372	0.009548059	11	8	Astrocytes	64	21	21
TACGGTAGTAAGAGGA-1_1_A9	19.86107462	-31.57249478	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	7477	30128	0.013276686	0.004680032	11	3	EN-L5-6	64	21	21
TACGGTAGTCGAATCT-1_1_A9	-21.29512515	-17.27885601	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5280	16203	0.005616244	0.003641301	11	6A	IN-PV	64	21	21
TACGGTATCAGTCCCT-1_1_A9	5.045163506	-24.82866596	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4935	16460	0.004617254	0.002490887	11	L2-3	EN-L2-3-MS	64	21	21
TACTCATAGACTGGGT-1_1_A9	-23.23528015	30.22851715	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2059	3869	0.0043939	0.00491083	11	8	Astrocytes	64	21	21
TACTCATCAACTTGAC-1_1_A9	19.12099387	-34.13891093	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5382	18439	0.006507945	0.003904767	11	3	EN-L5-6	64	21	21
TACTCATGTAGCAAAT-1_1_A9	-20.53024091	17.25525649	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1595	2463	0.005684125	0.009338205	11	8	Astrocytes	64	21	21
TACTCATGTGCCTGTG-1_1_A9	19.07672532	-34.16059665	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5341	17789	0.005396593	0.004047445	11	3	EN-L5-6	64	21	21
TACTCGCAGCTGTCTA-1_1_A9	-2.262832214	34.1526609	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	835	1159	0.012079379	0.005176877	11	oligos	OL-MS-2	64	21	21
TACTCGCCACTCAGGC-1_1_A9	3.670896865	0.328638229	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1115	1597	0.088916719	0.009392611	11	16	EN-PYR	64	21	21
TACTCGCCAGCTCGAC-1_1_A9	29.29918728	-11.45903639	2	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5049	13345	0.007418509	0.009666542	11	2	EN-L4	64	21	21
TACTCGCTCTTGCAAG-1_1_A9	33.13977296	5.206442745	14	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	860	1025	0.021463415	0.013658537	11	14	Microglia	64	21	21
TACTTACAGAGTGACC-1_1_A9	-22.008317	14.30607376	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1166	1863	0.011272142	0.003220612	11	8	Astrocytes	64	21	21
TACTTACAGCTAGTGG-1_1_A9	3.253217534	-14.64479925	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2392	4660	0.005364807	0.012017167	11	L2-3	EN-L2-3-MS	64	21	21
TACTTACAGTACATGA-1_1_A9	27.33079696	-25.79330182	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6007	21573	0.016177629	0.003152088	11	3	EN-L5-6	64	21	21
TACTTACGTCACCTAA-1_1_A9	-8.139916321	-29.66863612	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	900	1178	0.049235993	0.001697793	11	16	EN-PYR	64	21	21
TACTTACGTTAAGGGC-1_1_A9	26.78260728	-26.19764202	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4805	13746	0.00560163	0.004946894	11	3	EN-L5-6	64	21	21
TACTTACTCAGCACAT-1_1_A9	-11.66147403	31.70276148	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	983	1309	0.037433155	0.003055768	11	oligos	OL-MS-2	64	21	21
TACTTACTCGGCCGAT-1_1_A9	-18.17208644	9.887952786	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	826	1186	0.031197302	0.003372681	11	8	Astrocytes	64	21	21
TACTTACTCTGTTGAG-1_1_A9	-18.61176618	9.900935886	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	747	1013	0.046396841	0.006910168	11	8	Astrocytes	64	21	21
TACTTACTCTTGCAAG-1_1_A9	-24.54680792	-8.199447563	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	988	1393	0.010768126	0.007896626	11	9	OPC	64	21	21
TACTTGTAGACGCAAC-1_1_A9	-13.39229046	-16.5008661	6B	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1245	1922	0.024973985	0.005202914	11	6B	IN-SST	64	21	21
TACTTGTAGGCGTACA-1_1_A9	-10.04066398	-16.14743333	6B	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	913	1331	0.041322314	0.003756574	11	6B	IN-SST	64	21	21
TACTTGTCAAGGGTCA-1_1_A9	-10.95917454	31.36318392	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	946	1250	0.0304	0.0112	11	oligos	OL-MS-2	64	21	21
TACTTGTCACAGACAG-1_1_A9	-6.01094638	34.6649432	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	893	1190	0.013445378	0.006722689	11	oligos	OL-MS-2	64	21	21
TACTTGTCATATGAGA-1_1_A9	-3.980203663	32.03381795	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1097	1512	0.013888889	0.009920635	11	oligos	OL-MS-2	64	21	21
TACTTGTTCACCCTCA-1_1_A9	-3.503610257	34.56021314	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	767	1054	0.010436433	0.009487666	11	oligos	OL-MS-2	64	21	21
TACTTGTTCCAAACTG-1_1_A9	-20.93161884	14.63042827	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1313	2113	0.010884998	0.002366304	11	8	Astrocytes	64	21	21
TAGACCAAGCCATCGC-1_1_A9	4.213103231	0.165700271	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1104	1542	0.033722438	0.015564202	11	16	EN-PYR	64	21	21
TAGACCAAGGGATACC-1_1_A9	-10.91917683	-30.59047275	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1224	1667	0.025794841	0.01139772	11	16	EN-PYR	64	21	21
TAGACCACACGGTTTA-1_1_A9	-24.47672344	-10.03575926	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	857	1139	0.021071115	0.007901668	11	9	OPC	64	21	21
TAGACCACATGTTGAC-1_1_A9	-18.50704437	10.17340979	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	815	1102	0.026315789	0.001814882	11	8	Astrocytes	64	21	21
TAGACCAGTCCCGACA-1_1_A9	-5.265821168	34.66757357	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	918	1306	0.019908116	0.006891271	11	oligos	OL-MS-2	64	21	21
TAGACCAGTCTCCCTA-1_1_A9	-8.277060467	-27.5063756	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	846	1094	0.054844607	0.005484461	11	16	EN-PYR	64	21	21
TAGAGCTCACAGATTC-1_1_A9	-13.61839232	-34.19523458	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1608	2765	0.06835443	0.006871609	11	16	EN-PYR	64	21	21
TAGAGCTCATTCTCAT-1_1_A9	-10.59746887	22.27670619	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1858	2992	0.00868984	0.005347594	11	8	Astrocytes	64	21	21
TAGAGCTGTAGCGCTC-1_1_A9	-7.639818151	-33.24483773	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	760	1077	0.042711235	0.010213556	11	16	EN-PYR	64	21	21
TAGAGCTGTGATGTCT-1_1_A9	19.22600548	-34.31184467	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5096	15575	0.002247191	0.004044944	11	3	EN-L5-6	64	21	21
TAGAGCTTCACTTATC-1_1_A9	26.0329484	-25.90415813	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4967	14704	0.001360174	0.005508705	11	3	EN-L5-6	64	21	21
TAGCCGGAGATCACGG-1_1_A9	20.03809011	-33.89056757	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4380	11953	0.007613152	0.00585627	11	3	EN-L5-6	64	21	21
TAGCCGGAGCTGTTCA-1_1_A9	-20.34857928	16.87605772	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1587	2528	0.003560127	0.003560127	11	8	Astrocytes	64	21	21
TAGCCGGAGGACCACA-1_1_A9	4.407019286	-8.688565616	12	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1474	2152	0.014869888	0.012546468	11	12	EN-MIX	64	21	21
TAGCCGGCACCACGTG-1_1_A9	32.93731889	5.008689948	14	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	920	1211	0.022295623	0.015689513	11	14	Microglia	64	21	21
TAGCCGGCACGGACAA-1_1_A9	-22.92013665	-16.3040909	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4984	13523	0.025659987	0.007025068	11	6A	IN-PV	64	21	21
TAGCCGGCAGCTGGCT-1_1_A9	-2.360573794	33.19380307	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	932	1367	0.032187271	0.00658376	11	oligos	OL-MS-2	64	21	21
TAGCCGGGTAAGAGGA-1_1_A9	6.680137722	-23.76873412	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4277	11163	0.024097465	0.003045776	11	L2-3	EN-L2-3-MS	64	21	21
TAGCCGGGTACGCACC-1_1_A9	-6.859027742	35.35915988	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	784	1027	0.014605648	0.007789679	11	oligos	OL-MS-2	64	21	21
TAGCCGGGTCTAAAGA-1_1_A9	5.495495226	-24.67313553	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4870	15403	0.008894371	0.003635655	11	L2-3	EN-L2-3-MS	64	21	21
TAGCCGGGTCTAGCGC-1_1_A9	-14.18774758	-6.08352053	13B	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2286	4290	0.007692308	0.006759907	11	13B	IN-SV2C	64	21	21
TAGCCGGTCCACGACG-1_1_A9	-5.902259077	30.99475634	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1280	1983	0.013615734	0.006051437	11	oligos	OL-MS-2	64	21	21
TAGGCATAGCCCAACC-1_1_A9	5.769946225	-22.68891245	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5910	19508	0.00451097	0.012456428	11	L2-3	EN-L2-3-MS	64	21	21
TAGGCATCAATAGCGG-1_1_A9	-29.06885254	-12.15977686	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	874	1161	0.013781223	0.01205857	11	9	OPC	64	21	21
TAGGCATCAGGTGGAT-1_1_A9	-18.1747884	10.01123313	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	968	1274	0.025117739	0.000784929	11	8	Astrocytes	64	21	21
TAGGCATCAGTTCATG-1_1_A9	-8.73512697	-2.930607488	13A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1875	3425	0.010218978	0.007007299	11	13A	IN-VIP	64	21	21
TAGGCATGTGTAAGTA-1_1_A9	26.45429505	-26.93061811	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3929	10184	0.00392773	0.004124116	11	3	EN-L5-6	64	21	21
TAGGCATTCTGGAGCC-1_1_A9	-7.466746283	34.28011694	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	848	1161	0.022394488	0.007751938	11	oligos	OL-MS-2	64	21	21
TAGTGGTAGCGAGAAA-1_1_A9	-11.49946768	-2.476918012	13A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2229	4084	0.011018609	0.009059745	11	13A	IN-VIP	64	21	21
TAGTGGTAGGAGTACC-1_1_A9	-20.42425304	11.59709475	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	910	1261	0.013481364	0.008723236	11	8	Astrocytes	64	21	21
TAGTGGTGTACATCCA-1_1_A9	19.31393437	-34.06872269	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4598	13413	0.005964363	0.004398718	11	3	EN-L5-6	64	21	21
TAGTGGTTCTTAGCCC-1_1_A9	8.874486355	-4.104034732	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1766	3047	0.026255333	0.004594683	11	16	EN-PYR	64	21	21
TAGTTGGCATGCCACG-1_1_A9	-33.67701319	-7.700717859	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1094	1660	0.010240964	0.003012048	11	9	OPC	64	21	21
TAGTTGGGTACGCTGC-1_1_A9	18.0779761	-33.01412061	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6529	24766	0.007106517	0.007510296	11	3	EN-L5-6	64	21	21
TAGTTGGTCACGATGT-1_1_A9	-24.05401583	24.97787905	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1540	2659	0.010154193	0.00300865	11	8	Astrocytes	64	21	21
TAGTTGGTCTCGCATC-1_1_A9	19.13548691	-34.14889556	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5187	17466	0.00629795	0.003435246	11	3	EN-L5-6	64	21	21
TAGTTGGTCTGGAGCC-1_1_A9	4.827025204	1.695416772	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	804	1100	0.029090909	0.003636364	11	16	EN-PYR	64	21	21
TATCAGGCACTGTCGG-1_1_A9	-6.728084985	-31.07069821	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	822	1040	0.053846154	0.015384615	11	16	EN-PYR	64	21	21
TATCAGGGTCATCCCT-1_1_A9	-7.596968783	-29.62734026	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	765	1007	0.058589871	0.005958292	11	16	EN-PYR	64	21	21
TATCAGGGTGCAACTT-1_1_A9	-19.82833646	13.74071369	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1288	1873	0.013347571	0.004805125	11	8	Astrocytes	64	21	21
TATCAGGTCAACACTG-1_1_A9	-7.023005781	32.2147316	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1059	1524	0.038057743	0.005905512	11	oligos	OL-MS-2	64	21	21
TATCAGGTCTCGCATC-1_1_A9	-19.77020963	13.38264745	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1281	1975	0.023797468	0.002025316	11	8	Astrocytes	64	21	21
TATCTCACAAACAACA-1_1_A9	-11.69704761	30.86326303	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	947	1206	0.029850746	0.004975124	11	oligos	OL-MS-2	64	21	21
TATCTCACAATGGAAT-1_1_A9	-18.12382394	-8.154562305	13B	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3270	6937	0.014847917	0.004324636	11	13B	IN-SV2C	64	21	21
TATCTCACAGCGATCC-1_1_A9	-7.010547182	-30.24697388	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	773	1088	0.087316176	0.009191176	11	16	EN-PYR	64	21	21
TATCTCAGTACATCCA-1_1_A9	12.34481441	-1.378459506	12	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1107	1922	0.011966701	0.00364204	11	12	EN-MIX	64	21	21
TATCTCAGTTCCACTC-1_1_A9	-19.71141141	11.00312857	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	816	1102	0.011796733	0.007259528	11	8	Astrocytes	64	21	21
TATCTCATCATGCTCC-1_1_A9	-13.58439134	-34.08754237	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1553	2452	0.033034258	0.006525285	11	16	EN-PYR	64	21	21
TATCTCATCGGAAACG-1_1_A9	28.41827373	-26.00955643	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5616	19181	0.005630572	0.003075961	11	3	EN-L5-6	64	21	21
TATGCCCAGACCTAGG-1_1_A9	-26.15606643	-7.335878432	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1095	1575	0.012063492	0.01015873	11	9	OPC	64	21	21
TATGCCCAGACCTTTG-1_1_A9	-26.04487049	-24.21014065	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5313	15068	0.022431643	0.004778338	11	6A	IN-PV	64	21	21
TATGCCCAGAGGACGG-1_1_A9	-25.58125068	-7.80923528	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1052	1496	0.010695187	0.006016043	11	9	OPC	64	21	21
TATGCCCCAGGTCTCG-1_1_A9	-10.4855459	-32.69417382	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1051	1502	0.022636485	0.016644474	11	16	EN-PYR	64	21	21
TATGCCCCATAACCTG-1_1_A9	28.15557635	-25.874614	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4658	13795	0.013773106	0.002972091	11	3	EN-L5-6	64	21	21
TATGCCCGTGATAAAC-1_1_A9	29.15497751	-6.785585709	2	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3980	10085	0.007040159	0.006445216	11	2	EN-L4	64	21	21
TATGCCCTCACAAACC-1_1_A9	12.09938463	-3.427055301	12	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1768	3550	0.007323944	0.006760563	11	12	EN-MIX	64	21	21
TATGCCCTCCAGATCA-1_1_A9	-18.73913711	14.77786274	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1970	3412	0.013188746	0.004689332	11	8	Astrocytes	64	21	21
TATGCCCTCTGTCTAT-1_1_A9	-18.87728727	14.40115478	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1537	2404	0.019966722	0.008319468	11	8	Astrocytes	64	21	21
TATTACCAGTGCCAGA-1_1_A9	18.48086601	-33.5641314	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6024	23616	0.010331978	0.004530827	11	3	EN-L5-6	64	21	21
TATTACCCAGGTCCAC-1_1_A9	-25.75764503	-10.06097455	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	793	1074	0.014897579	0.004655493	11	9	OPC	64	21	21
TATTACCGTGACTACT-1_1_A9	-8.858033766	-29.70963931	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	994	1444	0.113573407	0.004847645	11	16	EN-PYR	64	21	21
TATTACCTCCATGCTC-1_1_A9	-7.798196536	-29.10025989	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	788	1044	0.037356322	0.002873563	11	16	EN-PYR	64	21	21
TATTACCTCCCGGATG-1_1_A9	-20.72290773	11.78552806	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	910	1344	0.003720238	0.001488095	11	8	Astrocytes	64	21	21
TATTACCTCCGGGTGT-1_1_A9	-20.66319382	11.5004836	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	876	1251	0.021582734	0.007993605	11	8	Astrocytes	64	21	21
TATTACCTCGGCTTGG-1_1_A9	20.72943192	-29.34819542	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5068	18102	0.004750856	0.006408132	11	3	EN-L5-6	64	21	21
TCAACGACACTAAGTC-1_1_A9	26.19522029	-22.728292	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	7288	29800	0.014395973	0.004127517	11	3	EN-L5-6	64	21	21
TCAACGACAGGTCCAC-1_1_A9	-7.209367953	-29.34993162	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	729	1019	0.036310108	0.009813543	11	16	EN-PYR	64	21	21
TCAACGAGTACACCGC-1_1_A9	-8.471180364	-9.591330326	12	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1120	1624	0.016625616	0.006773399	11	12	EN-MIX	64	21	21
TCAACGAGTCGCGAAA-1_1_A9	-17.42211738	-14.66797531	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2233	4176	0.049329502	0.004070881	11	6A	IN-PV	64	21	21
TCAACGATCGCTAGCG-1_1_A9	5.434570833	-24.88087705	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5316	17312	0.008086876	0.004447782	11	L2-3	EN-L2-3-MS	64	21	21
TCAATCTAGCCCAACC-1_1_A9	5.619855654	-23.98669523	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5367	17299	0.005491647	0.004624545	11	L2-3	EN-L2-3-MS	64	21	21
TCAATCTCACGAGGTA-1_1_A9	-9.778621452	31.76958614	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	877	1149	0.028720627	0.013925152	11	oligos	OL-MS-2	64	21	21
TCAATCTGTCAATGTC-1_1_A9	-6.445513628	-29.7619462	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	766	1038	0.134874759	0.004816956	11	16	EN-PYR	64	21	21
TCAATCTGTCTGGAGA-1_1_A9	-22.14373234	-27.9487271	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3937	10779	0.018183505	0.003154281	11	6A	IN-PV	64	21	21
TCAATCTGTGAGTATA-1_1_A9	-17.6162239	11.07090002	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1110	1748	0.008009153	0.010297483	11	8	Astrocytes	64	21	21
TCAATCTTCATAACCG-1_1_A9	15.68277022	-27.35017735	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3597	8404	0.009043313	0.00999524	11	3	EN-L5-6	64	21	21
TCAATCTTCTATCGCC-1_1_A9	-21.87291377	-28.29581447	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5779	21433	0.018009611	0.003312649	11	6A	IN-PV	64	21	21
TCACAAGAGAGTGACC-1_1_A9	-11.31783919	29.41203016	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1237	1764	0.039115646	0.006235828	11	oligos	OL-MS-2	64	21	21
TCACAAGCAAACTGCT-1_1_A9	-10.24833569	32.92422496	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	812	1117	0.02775291	0.007162041	11	oligos	OL-MS-2	64	21	21
TCACAAGCAAGGACTG-1_1_A9	-8.247059578	-29.63449464	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	973	1303	0.077513431	0.008442057	11	16	EN-PYR	64	21	21
TCACAAGCATCCCACT-1_1_A9	-11.3388141	31.89200221	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1125	1566	0.027458493	0.004469987	11	oligos	OL-MS-2	64	21	21
TCACAAGGTGTAACGG-1_1_A9	-1.824994734	33.60723435	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	987	1460	0.01369863	0.009589041	11	oligos	OL-MS-2	64	21	21
TCACAAGTCGATGAGG-1_1_A9	27.69007579	-24.65082597	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5872	20719	0.012790193	0.00386119	11	3	EN-L5-6	64	21	21
TCACGAAAGACACGAC-1_1_A9	-10.06246267	33.19381892	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	805	1057	0.03500473	0.009460738	11	oligos	OL-MS-2	64	21	21
TCACGAAAGACCTTTG-1_1_A9	-21.26265996	16.29793345	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1303	2196	0.005009107	0.003642987	11	8	Astrocytes	64	21	21
TCACGAACACATCCGG-1_1_A9	-20.52846314	-17.29880496	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4975	15001	0.007666156	0.005666289	11	6A	IN-PV	64	21	21
TCACGAACAGTTTACG-1_1_A9	-14.66179153	9.754537548	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1461	2164	0.014787431	0.006469501	11	8	Astrocytes	64	21	21
TCACGAACATCCCATC-1_1_A9	-12.00146187	-32.41120317	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1215	1910	0.061780105	0.003664921	11	16	EN-PYR	64	21	21
TCACGAATCCCTGACT-1_1_A9	-21.89433782	-20.02987686	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2635	5502	0.011632134	0.007088332	11	6A	IN-PV	64	21	21
TCACGAATCGTTACGA-1_1_A9	8.835109829	-2.049131928	12	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1521	2688	0.01264881	0.004464286	11	12	EN-MIX	64	21	21
TCAGATGAGATCCTGT-1_1_A9	22.13743154	26.24600717	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1116	1675	0.016716418	0.007164179	11	oligos	OL-MS-2	64	21	21
TCAGATGAGCATCATC-1_1_A9	-13.1441185	-31.6494035	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2006	3427	0.040560257	0.00700321	11	16	EN-PYR	64	21	21
TCAGATGAGCCGTCGT-1_1_A9	-25.61677644	-10.21881924	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	823	1139	0.01404741	0.004389816	11	9	OPC	64	21	21
TCAGATGAGTTACCCA-1_1_A9	25.79818381	-8.281900094	2	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3763	8430	0.008540925	0.004033215	11	2	EN-L4	64	21	21
TCAGATGCACACCGAC-1_1_A9	-8.302996864	33.72918533	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	940	1293	0.025522042	0.006960557	11	oligos	OL-MS-2	64	21	21
TCAGATGCAGATGAGC-1_1_A9	18.68423063	-6.940516119	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1907	4030	0.00248139	0.001488834	11	3	EN-L5-6	64	21	21
TCAGATGGTGGTTTCA-1_1_A9	-17.51781276	9.746067416	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1109	1644	0.006082725	0.00243309	11	8	Astrocytes	64	21	21
TCAGATGGTTGGTAAA-1_1_A9	-8.231062309	-32.16768796	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	867	1164	0.045532646	0.006013746	11	16	EN-PYR	64	21	21
TCAGATGTCAGCGACC-1_1_A9	-8.105240905	32.66412236	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1015	1336	0.024700599	0.006736527	11	oligos	OL-MS-2	64	21	21
TCAGCAAAGATGTAAC-1_1_A9	5.781399717	-24.74083088	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4879	14592	0.006167763	0.004180373	11	L2-3	EN-L2-3-MS	64	21	21
TCAGCAAAGTCCTCCT-1_1_A9	5.871944817	-25.32047056	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6797	28216	0.006166714	0.00361497	11	L2-3	EN-L2-3-MS	64	21	21
TCAGCAACACCTTGTC-1_1_A9	-12.14018991	31.0401743	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	909	1154	0.034662045	0.008665511	11	oligos	OL-MS-2	64	21	21
TCAGCAACATCAGTCA-1_1_A9	19.31609054	-34.25132824	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4652	13551	0.005829828	0.007305734	11	3	EN-L5-6	64	21	21
TCAGCAAGTAACGACG-1_1_A9	-17.51365964	9.854884388	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1124	1654	0.025392987	0.005441354	11	8	Astrocytes	64	21	21
TCAGCAAGTATTAGCC-1_1_A9	27.32016751	-25.2597935	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5550	18617	0.010205726	0.003598861	11	3	EN-L5-6	64	21	21
TCAGCAAGTGGTCTCG-1_1_A9	-20.67603165	-24.74092405	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3369	8324	0.017659779	0.003483902	11	6A	IN-PV	64	21	21
TCAGCTCAGACTAGGC-1_1_A9	28.23888633	-25.9687028	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5715	21085	0.003035333	0.003272469	11	3	EN-L5-6	64	21	21
TCAGCTCCACTCTGTC-1_1_A9	-7.465524547	33.42780554	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	936	1322	0.024962179	0.003782148	11	oligos	OL-MS-2	64	21	21
TCAGCTCCAGCCACCA-1_1_A9	4.359257127	1.195188333	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	919	1192	0.062080537	0.01090604	11	16	EN-PYR	64	21	21
TCAGCTCGTGCTGTAT-1_1_A9	-31.08083703	-12.13061255	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	816	1111	0.00540054	0	11	9	OPC	64	21	21
TCAGCTCTCACTTATC-1_1_A9	-14.04158285	-4.127898689	13A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3367	8084	0.009524988	0.005690252	11	13A	IN-VIP	64	21	21
TCAGCTCTCCCTAATT-1_1_A9	22.76776577	25.73881661	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1277	1956	0.013292434	0.007668712	11	oligos	OL-MS-2	64	21	21
TCAGCTCTCGAGCCCA-1_1_A9	-21.28569821	-17.52817024	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3537	8352	0.01592433	0.006345785	11	6A	IN-PV	64	21	21
TCAGCTCTCGCAAGCC-1_1_A9	-8.525817003	-27.53358555	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	912	1227	0.069274654	0.010594947	11	16	EN-PYR	64	21	21
TCAGGATAGTTGAGTA-1_1_A9	-10.61111113	-27.48831862	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1078	1646	0.027946537	0.012150668	11	16	EN-PYR	64	21	21
TCAGGATCAAGACACG-1_1_A9	-4.210668771	34.50861865	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	840	1180	0.021186441	0.004237288	11	oligos	OL-MS-2	64	21	21
TCAGGATCAGCTGTAT-1_1_A9	-13.11940885	14.6149898	11	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	825	1145	0.0069869	0.006113537	11	11	Glia-MIX	64	21	21
TCAGGATCATTCTCAT-1_1_A9	-22.58799021	-20.24703729	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3253	8085	0.017687075	0.003339518	11	6A	IN-PV	64	21	21
TCAGGATTCAGCCTAA-1_1_A9	9.573747575	0.566960981	12	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	926	1270	0.029133858	0.01023622	11	12	EN-MIX	64	21	21
TCAGGATTCATAAAGG-1_1_A9	-9.478834214	32.15691869	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	819	1056	0.021780303	0.001893939	11	oligos	OL-MS-2	64	21	21
TCAGGATTCCAAACAC-1_1_A9	-17.19793239	7.55934558	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	912	1292	0.01006192	0.002321981	11	8	Astrocytes	64	21	21
TCAGGATTCCCATTAT-1_1_A9	4.881447844	1.289885325	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1168	1603	0.052401747	0.004366812	11	16	EN-PYR	64	21	21
TCAGGATTCCTCTAGC-1_1_A9	5.193850853	-23.30639787	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5406	17016	0.003584861	0.009344147	11	L2-3	EN-L2-3-MS	64	21	21
TCAGGTAAGCAGACTG-1_1_A9	-19.63755067	13.12829086	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1297	1947	0.011299435	0.002568053	11	8	Astrocytes	64	21	21
TCAGGTAAGCTGTTCA-1_1_A9	-25.91584355	-7.87474225	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	995	1387	0.01369863	0.003604903	11	9	OPC	64	21	21
TCAGGTACAAGCCCAC-1_1_A9	24.67565677	6.851152509	15A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1905	2853	0.018927445	0.018226428	11	15A	Endo cells	64	21	21
TCAGGTACAAGCCGTC-1_1_A9	-25.81304842	-24.05787709	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4185	10382	0.025524947	0.006164516	11	6A	IN-PV	64	21	21
TCAGGTAGTAAGAGAG-1_1_A9	-18.96986255	-8.100964853	13B	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4462	10521	0.016538352	0.005988024	11	13B	IN-SV2C	64	21	21
TCAGGTAGTGGAAAGA-1_1_A9	-21.25569844	-16.5798288	6B	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4679	12942	0.021325916	0.003631587	11	6B	IN-SST	64	21	21
TCAGGTATCAGAGGTG-1_1_A9	-24.53408554	-10.24267974	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	842	1073	0.010251631	0.007455732	11	9	OPC	64	21	21
TCAGGTATCAGGCCCA-1_1_A9	-5.401233057	-8.990217132	13A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	960	1440	0.025	0.004861111	11	13A	IN-VIP	64	21	21
TCAGGTATCGCTGATA-1_1_A9	-25.10904618	-9.146605299	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	906	1265	0.009486166	0.005533597	11	9	OPC	64	21	21
TCAGGTATCTTGTATC-1_1_A9	18.36254428	-33.7547173	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5997	23614	0.00605573	0.002117388	11	3	EN-L5-6	64	21	21
TCATTACAGATGGGTC-1_1_A9	-31.94407304	-9.839614995	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	983	1407	0.007818053	0.005685856	11	9	OPC	64	21	21
TCATTACAGTCGTACT-1_1_A9	-15.67512754	11.46621778	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1504	2495	0.003607214	0.005611222	11	8	Astrocytes	64	21	21
TCATTACCACACGCTG-1_1_A9	-10.76792088	30.72764987	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1238	1759	0.030130756	0.003411029	11	oligos	OL-MS-2	64	21	21
TCATTACGTCCGAATT-1_1_A9	5.4260063	-24.3821104	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4899	16064	0.00560259	0.002863546	11	L2-3	EN-L2-3-MS	64	21	21
TCATTACTCCGATATG-1_1_A9	-12.82611357	7.276483218	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2131	3592	0.01642539	0.009187082	11	16	EN-PYR	64	21	21
TCATTTGAGTGTCCAT-1_1_A9	-31.62867947	-12.30546796	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	812	1129	0.012400354	0.00088574	11	9	OPC	64	21	21
TCATTTGCAATCACAC-1_1_A9	19.91232541	-32.53109832	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6452	25638	0.014314689	0.002691318	11	3	EN-L5-6	64	21	21
TCATTTGCATAAGACA-1_1_A9	-24.83936007	-7.298998623	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1195	1856	0.016702586	0.003771552	11	9	OPC	64	21	21
TCATTTGGTGCGCTTG-1_1_A9	-32.07005471	-0.368602127	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1720	2891	0.004496714	0.003459011	11	9	OPC	64	21	21
TCATTTGGTTCAGCGC-1_1_A9	6.264435656	-25.32254239	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5670	20391	0.004707959	0.004658918	11	L2-3	EN-L2-3-MS	64	21	21
TCCACACAGAACTCGG-1_1_A9	-10.59903764	32.49367546	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	842	1044	0.026819923	0.00862069	11	oligos	OL-MS-2	64	21	21
TCCACACAGAAGGACA-1_1_A9	-10.19107431	33.27908828	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	791	1012	0.018774704	0.003952569	11	oligos	OL-MS-2	64	21	21
TCCACACAGGTGCACA-1_1_A9	4.054650559	1.057293763	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	773	1017	0.054080629	0.010816126	11	16	EN-PYR	64	21	21
TCCACACCAAGGTTTC-1_1_A9	-24.94053367	-5.293482627	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1620	2624	0.012195122	0.004954268	11	9	OPC	64	21	21
TCCACACCACATTAGC-1_1_A9	-8.174699348	-29.54439078	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	828	1056	0.036931818	0.001893939	11	16	EN-PYR	64	21	21
TCCACACCAGGGTTAG-1_1_A9	-9.680030365	-6.341190223	13A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1740	3049	0.021646441	0.007543457	11	13A	IN-VIP	64	21	21
TCCACACTCCAGGGCT-1_1_A9	-11.2703077	31.60196965	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1128	1594	0.030112923	0.003764115	11	oligos	OL-MS-2	64	21	21
TCCACACTCGCACTCT-1_1_A9	-10.05657064	33.87616406	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	842	1105	0.023529412	0.005429864	11	oligos	OL-MS-2	64	21	21
TCCACACTCTAGCACA-1_1_A9	-18.91485186	-8.268519741	13B	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4447	11414	0.011739968	0.005519537	11	13B	IN-SV2C	64	21	21
TCCACACTCTGGTATG-1_1_A9	-23.16472433	-7.785733116	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1786	2998	0.008338893	0.006337558	11	9	OPC	64	21	21
TCCCGATAGAGGACGG-1_1_A9	-18.43224746	9.140997554	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	847	1160	0.012931034	0.012931034	11	8	Astrocytes	64	21	21
TCCCGATAGGTGACCA-1_1_A9	-18.34548572	10.03131231	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	913	1232	0.026785714	0.007305195	11	8	Astrocytes	64	21	21
TCCCGATAGTACGCGA-1_1_A9	-19.94690764	11.73478628	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	894	1247	0.008821171	0.012028869	11	8	Astrocytes	64	21	21
TCCCGATGTTCATGGT-1_1_A9	-26.76670194	-4.948171959	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1446	2234	0.01656222	0.010743062	11	9	OPC	64	21	21
TCCCGATTCTTACCTA-1_1_A9	-14.8499027	-6.608666737	13A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3167	7069	0.006507285	0.005941434	11	13A	IN-VIP	64	21	21
TCGAGGCCAATCGGTT-1_1_A9	16.00017006	-19.0198647	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6695	23580	0.010008482	0.004071247	11	L2-3	EN-L2-3-MS	64	21	21
TCGAGGCCACATAACC-1_1_A9	-24.35539929	-6.08355135	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1524	2431	0.012751954	0.006581654	11	9	OPC	64	21	21
TCGAGGCCATAGAAAC-1_1_A9	-8.4375512	-31.85259063	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1050	1618	0.124227441	0.008034611	11	16	EN-PYR	64	21	21
TCGAGGCGTCTCCATC-1_1_A9	26.16523351	-22.64040296	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6557	24967	0.022149237	0.003164177	11	3	EN-L5-6	64	21	21
TCGAGGCTCAGAAATG-1_1_A9	-18.02663684	-8.194687352	13B	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3432	7920	0.020580808	0.002146465	11	13B	IN-SV2C	64	21	21
TCGAGGCTCCAGAGGA-1_1_A9	6.41951514	-23.73145983	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5772	18363	0.0081686	0.005227904	11	L2-3	EN-L2-3-MS	64	21	21
TCGAGGCTCTTGTCAT-1_1_A9	-16.54007058	7.792594053	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	966	1294	0.014683153	0.005409583	11	8	Astrocytes	64	21	21
TCGCGAGAGTCCAGGA-1_1_A9	-17.67610324	8.654212541	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	937	1232	0.011363636	0.008116883	11	8	Astrocytes	64	21	21
TCGCGAGAGTGTACTC-1_1_A9	5.308912065	1.820269439	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1008	1386	0.090909091	0.019480519	11	16	EN-PYR	64	21	21
TCGCGAGCAAACCTAC-1_1_A9	-12.09744491	-12.92250201	6B	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1683	2650	0.031320755	0.00754717	11	6B	IN-SST	64	21	21
TCGCGAGCATGGGACA-1_1_A9	-7.889484607	-29.45894904	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	831	1121	0.075825156	0.007136485	11	16	EN-PYR	64	21	21
TCGCGAGGTAGATTAG-1_1_A9	-26.03959757	-9.111325262	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	989	1308	0.012232416	0.00382263	11	9	OPC	64	21	21
TCGCGAGGTTACTGAC-1_1_A9	-12.77274013	16.3650126	11	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2117	3337	0.008690441	0.012885826	11	11	Glia-MIX	64	21	21
TCGCGTTAGAGAGCTC-1_1_A9	-24.31947387	-7.38904531	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1256	1860	0.019892473	0.003763441	11	9	OPC	64	21	21
TCGCGTTAGCCACTAT-1_1_A9	-22.63730754	-16.23164485	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5443	16687	0.015401211	0.003355906	11	6A	IN-PV	64	21	21
TCGCGTTCAAGGCTCC-1_1_A9	-14.09398003	8.382135122	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1361	1941	0.039670273	0.006697579	11	8	Astrocytes	64	21	21
TCGCGTTCACGCATCG-1_1_A9	-25.41425658	-6.292793178	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1119	1696	0.009433962	0.001768868	11	9	OPC	64	21	21
TCGCGTTCAGCCAATT-1_1_A9	-12.1607841	11.59484085	11	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1049	1340	0.011940299	0.003731343	11	11	Glia-MIX	64	21	21
TCGCGTTGTCGGATCC-1_1_A9	-7.668374286	-31.5052966	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	832	1098	0.0428051	0.009107468	11	16	EN-PYR	64	21	21
TCGCGTTTCCTACAGA-1_1_A9	-26.15671799	-24.15702792	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5013	13604	0.025727727	0.005219053	11	6A	IN-PV	64	21	21
TCGCGTTTCCTATGTT-1_1_A9	5.019334166	1.672133541	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	938	1203	0.049875312	0.011637573	11	16	EN-PYR	64	21	21
TCGGGACAGAGACGAA-1_1_A9	30.09239525	-6.495854864	2	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3506	8799	0.011592226	0.008182748	11	2	EN-L4	64	21	21
TCGGGACAGATCCTGT-1_1_A9	-25.59091798	-5.954981601	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1284	2000	0.0125	0.005	11	9	OPC	64	21	21
TCGGGACAGCCGCCTA-1_1_A9	19.36369056	-33.02770295	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	7298	29630	0.005669929	0.005231185	11	3	EN-L5-6	64	21	21
TCGGGACAGGCGTACA-1_1_A9	-9.813626107	22.39886151	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1763	2712	0.015486726	0.008112094	11	8	Astrocytes	64	21	21
TCGGGACAGGTAAACT-1_1_A9	-7.253973945	-28.41994823	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	721	1001	0.125874126	0.001998002	11	16	EN-PYR	64	21	21
TCGGGACAGTAGTGCG-1_1_A9	-25.70849975	-7.545958892	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1082	1539	0.014944769	0.005198181	11	9	OPC	64	21	21
TCGGGACCACGTAAGG-1_1_A9	-25.6025981	-5.288611361	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1505	2305	0.00824295	0.005206074	11	9	OPC	64	21	21
TCGGGACCATGTTGAC-1_1_A9	15.15266988	-27.56118659	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2881	6405	0.005464481	0.006401249	11	3	EN-L5-6	64	21	21
TCGGGACGTAAGAGAG-1_1_A9	-12.85611626	7.146214301	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1343	1925	0.043636364	0.004675325	11	16	EN-PYR	64	21	21
TCGGGACGTACAAGTA-1_1_A9	20.04441416	-4.121940551	12	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2364	4589	0.011331445	0.014818043	11	12	EN-MIX	64	21	21
TCGGGACGTTAAAGTG-1_1_A9	28.10587015	-25.43614028	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6088	20457	0.003568461	0.004741653	11	3	EN-L5-6	64	21	21
TCGGGACTCGATCCCT-1_1_A9	-17.20027481	9.663846202	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1142	1818	0.015951595	0.004950495	11	8	Astrocytes	64	21	21
TCGGTAAAGGAACTGC-1_1_A9	7.48703276	-23.17752965	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5819	19626	0.021196372	0.008305309	11	L2-3	EN-L2-3-MS	64	21	21
TCGGTAAAGGAGCGAG-1_1_A9	-26.11608041	-8.104961142	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	989	1376	0.005813953	0.005087209	11	9	OPC	64	21	21
TCGGTAACAGATGGGT-1_1_A9	-15.747331	-9.136286135	13B	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2397	4708	0.016992353	0.002124044	11	13B	IN-SV2C	64	21	21
TCGGTAAGTAAATACG-1_1_A9	1.829331736	6.673168124	7	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	973	1324	0.00755287	0.005287009	11	7	Phagocytes	64	21	21
TCGGTAAGTAATCACC-1_1_A9	20.07485943	-33.09167328	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5097	15739	0.016328865	0.00285914	11	3	EN-L5-6	64	21	21
TCGGTAAGTCACAAGG-1_1_A9	6.31222688	-25.38681125	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5067	16159	0.004641376	0.002599171	11	L2-3	EN-L2-3-MS	64	21	21
TCGTACCAGCTAACTC-1_1_A9	12.36824875	-1.595962338	12	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1168	2405	0.008731809	0.002494802	11	12	EN-MIX	64	21	21
TCGTACCAGTCCCACG-1_1_A9	-25.79045455	-24.33501427	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4362	10918	0.022256824	0.003572083	11	6A	IN-PV	64	21	21
TCGTACCCACGTTGGC-1_1_A9	22.48637227	26.01672539	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1154	1647	0.017607772	0.003035823	11	oligos	OL-MS-2	64	21	21
TCGTACCGTATAGGTA-1_1_A9	19.12280838	-31.61586944	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6138	22499	0.008400373	0.005778035	11	3	EN-L5-6	64	21	21
TCGTACCTCAGTGCAT-1_1_A9	-23.60258231	-21.00127819	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3780	9249	0.017191048	0.003892313	11	6A	IN-PV	64	21	21
TCGTAGAAGATCACGG-1_1_A9	-10.69718975	32.89138667	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	792	1010	0.037623762	0.001980198	11	oligos	OL-MS-2	64	21	21
TCGTAGACACACTGCG-1_1_A9	-10.65599172	-27.5406136	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1057	1510	0.056291391	0.01192053	11	16	EN-PYR	64	21	21
TCGTAGACATAGAAAC-1_1_A9	22.93654462	-20.37185979	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6136	19313	0.023869932	0.007922125	11	3	EN-L5-6	64	21	21
TCGTAGAGTACCGCTG-1_1_A9	-2.008534855	36.28709458	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	789	1132	0.014134276	0.007067138	11	oligos	OL-MS-2	64	21	21
TCGTAGAGTCTCTTTA-1_1_A9	-15.73920834	8.134627291	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1259	1755	0.010826211	0.004558405	11	8	Astrocytes	64	21	21
TCGTAGAGTGCTAGCC-1_1_A9	18.8350211	-31.31059696	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4715	12915	0.008749516	0.004955478	11	3	EN-L5-6	64	21	21
TCGTAGAGTTCAACCA-1_1_A9	-19.69223113	12.25250829	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1078	1667	0.00659868	0.00479904	11	8	Astrocytes	64	21	21
TCGTAGAGTTTACTCT-1_1_A9	27.0323118	-25.11078225	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5310	18227	0.012947825	0.003785593	11	3	EN-L5-6	64	21	21
TCTATTGCAAGACGTG-1_1_A9	-4.700255382	32.49428439	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1131	1584	0.015782828	0.008207071	11	oligos	OL-MS-2	64	21	21
TCTATTGCACTACAGT-1_1_A9	14.08802218	-4.851624308	12	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1455	2226	0.019317161	0.004941599	11	12	EN-MIX	64	21	21
TCTATTGCAGACAAAT-1_1_A9	-8.31229976	31.57080984	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1133	1632	0.025735294	0.007352941	11	oligos	OL-MS-2	64	21	21
TCTATTGGTCAACATC-1_1_A9	15.9420307	-27.43864169	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3876	10540	0.006356736	0.009203036	11	3	EN-L5-6	64	21	21
TCTATTGTCAACGAAA-1_1_A9	21.25413306	26.09820918	1	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	970	1454	0.017881706	0.006189821	11	oligos	OL-Cntl	64	21	21
TCTCATAAGTGACATA-1_1_A9	23.89177917	-23.13308728	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4243	11627	0.008772684	0.001548121	11	3	EN-L5-6	64	21	21
TCTCATACAAAGTGCG-1_1_A9	6.300701884	-24.21900401	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5782	20241	0.008645818	0.002717257	11	L2-3	EN-L2-3-MS	64	21	21
TCTCATACACCAACCG-1_1_A9	-9.636636759	32.47422513	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	936	1350	0.028148148	0.004444444	11	oligos	OL-MS-2	64	21	21
TCTCATACATTGTGCA-1_1_A9	-11.38433176	32.47246173	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1038	1434	0.023012552	0.008368201	11	oligos	OL-MS-2	64	21	21
TCTCATATCTCTAGGA-1_1_A9	-26.49462508	9.115396397	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	764	1104	0.014492754	0.002717391	11	8	Astrocytes	64	21	21
TCTCTAAGTGCGATAG-1_1_A9	-7.516097106	-31.878074	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	827	1108	0.051444043	0.00631769	11	16	EN-PYR	64	21	21
TCTCTAATCAGCGATT-1_1_A9	-6.55251868	-29.79064693	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	802	1070	0.069158879	0.008411215	11	16	EN-PYR	64	21	21
TCTCTAATCGCGATCG-1_1_A9	-20.8884611	-16.64230516	6B	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2674	5645	0.009920283	0.00425155	11	6B	IN-SST	64	21	21
TCTCTAATCTGAGGGA-1_1_A9	-20.6331159	13.82127306	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1249	1997	0.006009014	0.004006009	11	8	Astrocytes	64	21	21
TCTGAGAAGAAAGTGG-1_1_A9	26.97867417	-23.76265	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4934	15166	0.019319531	0.002439668	11	3	EN-L5-6	64	21	21
TCTGAGAAGAGCCTAG-1_1_A9	-17.15928602	9.124661182	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1040	1528	0.011780105	0.004581152	11	8	Astrocytes	64	21	21
TCTGAGAAGCTCTCGG-1_1_A9	-29.00487079	-11.67480344	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	888	1234	0.0089141	0.022690438	11	9	OPC	64	21	21
TCTGAGAAGTCTCCTC-1_1_A9	7.210098465	-21.21529031	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4346	11553	0.006578378	0.016705618	11	L2-3	EN-L2-3-MS	64	21	21
TCTGAGACACATTTCT-1_1_A9	-24.28095921	-1.924939968	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1113	1542	0.019455253	0.010376135	11	9	OPC	64	21	21
TCTGAGACACTATCTT-1_1_A9	-11.3735528	-32.14903048	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1199	1734	0.038062284	0.016724337	11	16	EN-PYR	64	21	21
TCTGAGAGTCATGCCG-1_1_A9	-17.3538626	10.87255316	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1150	1679	0.010720667	0.01131626	11	8	Astrocytes	64	21	21
TCTGAGAGTCGAATCT-1_1_A9	-18.86208861	-18.29929343	6B	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2563	5831	0.004973418	0.003258446	11	6B	IN-SST	64	21	21
TCTGAGATCTCCGGTT-1_1_A9	-25.54564885	-10.69158795	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1125	1468	0.015667575	0.025885559	11	9	OPC	64	21	21
TCTGGAAAGACACGAC-1_1_A9	-21.47712891	-28.51780989	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5003	15502	0.004580054	0.004838085	11	6A	IN-PV	64	21	21
TCTGGAAGTCTAGTCA-1_1_A9	-10.31954709	-32.20640559	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	922	1315	0.063878327	0.007604563	11	16	EN-PYR	64	21	21
TCTGGAAGTGAGCGAT-1_1_A9	-25.24856996	-24.79632733	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4487	12560	0.00955414	0.003901274	11	6A	IN-PV	64	21	21
TCTGGAAGTTCATGGT-1_1_A9	-20.08203768	9.91572282	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	915	1401	0.007851535	0.005710207	11	8	Astrocytes	64	21	21
TCTGGAATCTGATACG-1_1_A9	-26.24907267	-24.12358692	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5286	15456	0.038431677	0.005111284	11	6A	IN-PV	64	21	21
TCTGGAATCTGCGACG-1_1_A9	-24.35137648	-1.518966646	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1225	1833	0.012547736	0.009819967	11	9	OPC	64	21	21
TCTGGAATCTTGCATT-1_1_A9	3.747003548	0.08569153	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1237	1746	0.027491409	0.004581901	11	16	EN-PYR	64	21	21
TCTTCGGCATCTCCCA-1_1_A9	4.072575833	0.855612247	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	901	1161	0.048234281	0.015503876	11	16	EN-PYR	64	21	21
TCTTCGGGTTACCGAT-1_1_A9	-18.64055475	9.586160086	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	867	1228	0.013029316	0.002442997	11	8	Astrocytes	64	21	21
TCTTTCCAGCCACCTG-1_1_A9	-25.06965565	-5.728647494	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1379	2333	0.009858551	0.001714531	11	9	OPC	64	21	21
TCTTTCCAGGGAGTAA-1_1_A9	-18.3037526	9.392890419	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	988	1471	0.005438477	0.00067981	11	8	Astrocytes	64	21	21
TCTTTCCCAAGACGTG-1_1_A9	-8.245811537	-6.426893435	13A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1488	2535	0.01183432	0.003550296	11	13A	IN-VIP	64	21	21
TCTTTCCCAGATCCAT-1_1_A9	26.92873315	-25.1093873	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5563	19229	0.009048832	0.003536325	11	3	EN-L5-6	64	21	21
TCTTTCCCAGCTGTGC-1_1_A9	-13.4541934	-34.04338972	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1529	2425	0.038762887	0.007835052	11	16	EN-PYR	64	21	21
TCTTTCCCATGCGCAC-1_1_A9	5.073570235	1.940613183	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	911	1198	0.05509182	0.010016694	11	16	EN-PYR	64	21	21
TCTTTCCGTTGTCGCG-1_1_A9	-21.85599536	13.00629501	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1023	1522	0.008541393	0.002628121	11	8	Astrocytes	64	21	21
TCTTTCCTCTCCCTGA-1_1_A9	26.40289474	-28.18383439	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5796	24857	0.003218409	0.001931046	11	3	EN-L5-6	64	21	21
TCTTTCCTCTGGTTCC-1_1_A9	-28.49000532	14.4750726	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1038	1672	0.015550239	0.001794258	11	8	Astrocytes	64	21	21
TCTTTCCTCTTTCCTC-1_1_A9	25.30720476	-29.36320725	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3763	11035	0.002265519	0.003081106	11	3	EN-L5-6	64	21	21
TGAAAGAAGCTGAAAT-1_1_A9	-20.02837014	15.07459054	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1426	2205	0.009977324	0.001360544	11	8	Astrocytes	64	21	21
TGAAAGAAGGGATACC-1_1_A9	-0.07072517	-22.66847935	10	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4344	12263	0.001386284	0.00293566	11	L2-3	EN-L2-3-Cntl	64	21	21
TGAAAGACAATTGCTG-1_1_A9	-17.08511924	6.926415464	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	916	1271	0.022029898	0.009441385	11	8	Astrocytes	64	21	21
TGAAAGAGTCAATACC-1_1_A9	25.66215569	-8.373267305	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4654	11683	0.013010357	0.004536506	11	3	EN-L5-6	64	21	21
TGAAAGATCCAAATGC-1_1_A9	-5.300493581	35.32052826	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	879	1237	0.016168149	0.004850445	11	oligos	OL-MS-2	64	21	21
TGACAACCACACTGCG-1_1_A9	-10.94292519	-28.17632795	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1981	3695	0.075778078	0.017861976	11	16	EN-PYR	64	21	21
TGACAACCATTTGCTT-1_1_A9	6.195839743	-25.33777191	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6228	24490	0.006492446	0.002654145	11	L2-3	EN-L2-3-MS	64	21	21
TGACAACGTAGGAGTC-1_1_A9	-21.25589471	16.48084041	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1582	2790	0.008243728	0.005017921	11	8	Astrocytes	64	21	21
TGACAACGTAGGCTGA-1_1_A9	22.62943451	25.82021809	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1213	1809	0.013266998	0.011055832	11	oligos	OL-MS-2	64	21	21
TGACAACGTATCAGTC-1_1_A9	22.62006569	26.34704581	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1143	1727	0.008685582	0.005790388	11	oligos	OL-MS-2	64	21	21
TGACAACGTCATGCAT-1_1_A9	-11.38594905	32.18888001	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	848	1097	0.022789426	0.010938924	11	oligos	OL-MS-2	64	21	21
TGACAACGTCTTCGTC-1_1_A9	-7.859803843	33.97332908	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	838	1130	0.027433628	0.004424779	11	oligos	OL-MS-2	64	21	21
TGACAACTCGCCAAAT-1_1_A9	7.07615773	-24.15987184	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	7721	33305	0.008407146	0.003332833	11	L2-3	EN-L2-3-MS	64	21	21
TGACAACTCTAACCGA-1_1_A9	-11.44425353	16.39640678	11	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2576	4518	0.006861443	0.001549358	11	11	Glia-MIX	64	21	21
TGACGGCAGATGTGTA-1_1_A9	17.73867234	-29.3450316	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5112	13861	0.00295794	0.004400837	11	3	EN-L5-6	64	21	21
TGACGGCGTTCCCTTG-1_1_A9	-24.97970708	-7.947237674	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1189	1738	0.01726122	0.008055236	11	9	OPC	64	21	21
TGACGGCGTTCTGTTT-1_1_A9	-11.13389068	29.81227083	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1048	1392	0.056752874	0.005028736	11	oligos	OL-MS-2	64	21	21
TGACGGCTCGCGCCAA-1_1_A9	3.094054698	7.041258082	7	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1581	2404	0.018718802	0.041181364	11	7	Phagocytes	64	21	21
TGACTAGAGCACGCCT-1_1_A9	-14.09700361	-3.432415483	13A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3101	6233	0.005454837	0.008663565	11	13A	IN-VIP	64	21	21
TGACTAGCACAAGACG-1_1_A9	-9.648585817	32.72914137	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	757	1000	0.031	0.013	11	oligos	OL-MS-2	64	21	21
TGACTAGCACGCATCG-1_1_A9	-10.82588497	-29.82568554	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1124	1568	0.056122449	0.010841837	11	16	EN-PYR	64	21	21
TGACTAGCACGGTAGA-1_1_A9	-12.17207213	-33.09684413	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1272	1910	0.058638743	0.008376963	11	16	EN-PYR	64	21	21
TGACTAGCACGGTTTA-1_1_A9	-9.349322985	-30.43372196	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1009	1515	0.081848185	0.007260726	11	16	EN-PYR	64	21	21
TGACTAGGTCCATCCT-1_1_A9	29.79700386	-6.305867543	2	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4879	13064	0.007348438	0.010410288	11	2	EN-L4	64	21	21
TGACTAGGTGCTCTTC-1_1_A9	-11.69469117	30.07047471	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	915	1216	0.036184211	0.010690789	11	oligos	OL-MS-2	64	21	21
TGACTAGGTGTGAAAT-1_1_A9	-13.6425285	8.37270012	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1282	1837	0.021230267	0.007076756	11	8	Astrocytes	64	21	21
TGACTAGTCCGAAGAG-1_1_A9	-18.51001794	9.240924999	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	798	1069	0.010289991	0.001870907	11	8	Astrocytes	64	21	21
TGACTTTAGTAGGCCA-1_1_A9	-24.56638472	-9.239196377	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	994	1394	0.012912482	0.004304161	11	9	OPC	64	21	21
TGACTTTCATGTCCTC-1_1_A9	-5.978668126	35.99275216	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	784	1068	0.020599251	0.009363296	11	oligos	OL-MS-2	64	21	21
TGACTTTGTCTCTCGT-1_1_A9	-17.37926247	10.38426798	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1103	1644	0.00973236	0.005474453	11	8	Astrocytes	64	21	21
TGACTTTGTCTGCGGT-1_1_A9	-21.28709616	15.01391803	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1352	2137	0.005615349	0.001403837	11	8	Astrocytes	64	21	21
TGACTTTTCAGGCCCA-1_1_A9	5.46740258	-25.05814858	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6494	26724	0.003255501	0.003854213	11	L2-3	EN-L2-3-MS	64	21	21
TGACTTTTCCTATGTT-1_1_A9	7.274344594	-24.28909391	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	7150	28010	0.008568368	0.007747233	11	L2-3	EN-L2-3-MS	64	21	21
TGACTTTTCCTCAACC-1_1_A9	22.83753688	26.64417454	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1170	1827	0.006020799	0.011494253	11	oligos	OL-MS-2	64	21	21
TGACTTTTCTATCCCG-1_1_A9	-20.37619562	15.67889653	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1282	1947	0.009244992	0.005136107	11	8	Astrocytes	64	21	21
TGAGAGGAGAAAGTGG-1_1_A9	26.78750856	-26.27736319	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4359	11999	0.006833903	0.005500458	11	3	EN-L5-6	64	21	21
TGAGAGGAGATCGGGT-1_1_A9	-16.14600647	-6.617716479	13A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3003	6299	0.021749484	0.004762661	11	13A	IN-VIP	64	21	21
TGAGAGGCAACACCTA-1_1_A9	27.94397009	3.910809862	15BA	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1008	1289	0.017843289	0.008533747	11	15BA	Stromal cells	64	21	21
TGAGAGGCAACTGGCC-1_1_A9	4.619649113	-23.54761327	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4417	12498	0.005680909	0.008881421	11	L2-3	EN-L2-3-MS	64	21	21
TGAGAGGGTCTAAACC-1_1_A9	30.01355344	-6.612476057	2	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3666	8396	0.009051929	0.002977608	11	2	EN-L4	64	21	21
TGAGAGGGTGTTCTTT-1_1_A9	20.06945434	-33.73741159	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5328	18095	0.007515888	0.003205305	11	3	EN-L5-6	64	21	21
TGAGAGGTCGCGTTTC-1_1_A9	-21.08832659	12.59316125	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	928	1417	0.009174312	0.004234298	11	8	Astrocytes	64	21	21
TGAGCATAGGCTCTTA-1_1_A9	-18.66790122	-5.705057003	13B	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3499	8122	0.018837725	0.004555528	11	13B	IN-SV2C	64	21	21
TGAGCATCATTGTGCA-1_1_A9	6.030587259	-25.91945541	10	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5816	20956	0.001861042	0.003006299	11	L2-3	EN-L2-3-Cntl	64	21	21
TGAGCATGTCAATGTC-1_1_A9	-7.810743703	-31.48897246	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	808	1143	0.084864392	0.006124234	11	16	EN-PYR	64	21	21
TGAGCATGTCGCATCG-1_1_A9	-9.684591489	22.23429708	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1281	1796	0.008351893	0.007238307	11	8	Astrocytes	64	21	21
TGAGCATGTCTAAACC-1_1_A9	24.91527959	-21.42877318	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3710	8691	0.024853297	0.003797031	11	3	EN-L5-6	64	21	21
TGAGCATTCGTCCAGG-1_1_A9	-20.64055886	12.01905091	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	927	1320	0.006060606	0.002272727	11	8	Astrocytes	64	21	21
TGAGCCGCACGAGGTA-1_1_A9	-7.591407689	-29.41779984	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	797	1078	0.067717996	0.005565863	11	16	EN-PYR	64	21	21
TGAGCCGGTAAATACG-1_1_A9	-21.926458	14.67992689	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1189	1933	0.00931195	0.003621314	11	8	Astrocytes	64	21	21
TGAGCCGGTTCACGGC-1_1_A9	20.12326968	-32.20077582	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6854	27399	0.009379904	0.003321289	11	3	EN-L5-6	64	21	21
TGAGCCGGTTTGACAC-1_1_A9	-14.91040678	10.92181284	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1703	3082	0.008111616	0.00486697	11	8	Astrocytes	64	21	21
TGAGCCGTCCTCGCAT-1_1_A9	-25.39630927	-7.305573273	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1145	1666	0.007803121	0.007803121	11	9	OPC	64	21	21
TGAGGGAAGAGGGATA-1_1_A9	-11.74360811	28.75723782	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1257	1728	0.028935185	0.007523148	11	16	EN-PYR	64	21	21
TGAGGGAAGGGCATGT-1_1_A9	29.88720531	-10.49291087	2	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4202	9617	0.013517729	0.010294271	11	2	EN-L4	64	21	21
TGAGGGACAAGTAATG-1_1_A9	-5.974225362	36.29068732	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	734	1009	0.027750248	0.005946482	11	oligos	OL-MS-2	64	21	21
TGAGGGAGTTGTCTTT-1_1_A9	-17.92017012	8.666596244	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1031	1383	0.010122921	0.010845987	11	8	Astrocytes	64	21	21
TGAGGGATCCTTGCCA-1_1_A9	-27.23505052	-4.0537068	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1457	2343	0.013657704	0.011950491	11	9	OPC	64	21	21
TGAGGGATCTTGGGTA-1_1_A9	-20.98952976	-19.48461929	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2451	4979	0.016268327	0.005422776	11	6A	IN-PV	64	21	21
TGATTTCAGATTACCC-1_1_A9	-20.55261757	17.33438703	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1694	2922	0.004791239	0.004449008	11	8	Astrocytes	64	21	21
TGATTTCAGTACGTAA-1_1_A9	-26.62723338	12.87437499	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	985	1518	0.007246377	0.003952569	11	8	Astrocytes	64	21	21
TGATTTCTCACTCTTA-1_1_A9	-13.25204912	-9.357037609	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1854	3480	0.049712644	0.004885057	11	6A	IN-PV	64	21	21
TGATTTCTCGGCTACG-1_1_A9	-12.02727367	-32.95440271	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1190	1851	0.085899514	0.008103728	11	16	EN-PYR	64	21	21
TGATTTCTCTCGTATT-1_1_A9	2.432631657	6.756176083	7	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1073	1487	0.010087424	0.004707465	11	7	Phagocytes	64	21	21
TGCACCTCAAGAGGCT-1_1_A9	-27.16390599	-19.47873181	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3355	7022	0.034605525	0.005126745	11	6A	IN-PV	64	21	21
TGCACCTCATAAGACA-1_1_A9	-7.491191153	-28.8717058	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	777	1005	0.026865672	0.011940299	11	16	EN-PYR	64	21	21
TGCACCTCATGATCCA-1_1_A9	-12.85334092	7.225895155	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1468	2073	0.031355523	0.005306319	11	16	EN-PYR	64	21	21
TGCACCTGTCGGCTCA-1_1_A9	-6.989763815	31.95152461	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1129	1613	0.019218847	0.006199628	11	oligos	OL-MS-2	64	21	21
TGCACCTTCGTCCAGG-1_1_A9	15.58979063	-8.102945317	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2219	4522	0.005970809	0.004865104	11	3	EN-L5-6	64	21	21
TGCACCTTCTCGATGA-1_1_A9	-12.65351719	-33.59493236	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1243	1960	0.033673469	0.006122449	11	16	EN-PYR	64	21	21
TGCCAAAAGAGCTTCT-1_1_A9	-26.13145274	-24.11791228	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4689	12035	0.032239302	0.003489821	11	6A	IN-PV	64	21	21
TGCCAAAAGTACGCGA-1_1_A9	-16.77309349	-14.9224651	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2068	4114	0.022605737	0.007292173	11	6A	IN-PV	64	21	21
TGCCAAACAACACCTA-1_1_A9	-5.935289189	31.02954945	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1361	2075	0.014457831	0.009638554	11	oligos	OL-MS-2	64	21	21
TGCCAAACATCCGGGT-1_1_A9	-18.75287892	14.77586394	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1781	2845	0.019332162	0.005272408	11	8	Astrocytes	64	21	21
TGCCAAACATTTGCCC-1_1_A9	8.585368594	2.956756053	12	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1151	1671	0.020945542	0.004787552	11	12	EN-MIX	64	21	21
TGCCAAAGTCGCTTCT-1_1_A9	-14.13147777	-4.203664646	13A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2929	6068	0.007415953	0.007251154	11	13A	IN-VIP	64	21	21
TGCCAAAGTTGGAGGT-1_1_A9	-27.46662502	4.307656997	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2266	3816	0.004716981	0.00812369	11	9	OPC	64	21	21
TGCCAAATCAATCTCT-1_1_A9	32.46363991	8.388300436	14	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1253	1622	0.016029593	0.065351418	11	14	Microglia	64	21	21
TGCCAAATCGCAGGCT-1_1_A9	27.71325013	-26.19254451	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4431	11817	0.007023779	0.002961835	11	3	EN-L5-6	64	21	21
TGCCCATAGGGCTTGA-1_1_A9	-14.71100764	9.973252463	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1497	2346	0.010656436	0.006820119	11	8	Astrocytes	64	21	21
TGCCCATCACAGATTC-1_1_A9	-21.58395051	-16.17718883	6B	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3656	8565	0.008756567	0.003619381	11	6B	IN-SST	64	21	21
TGCCCATGTAGCGCTC-1_1_A9	-7.236851293	-31.89938505	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	902	1312	0.112042683	0.012957317	11	16	EN-PYR	64	21	21
TGCCCATGTCTCACCT-1_1_A9	5.052465083	1.65447206	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	836	1039	0.034648701	0.01732435	11	16	EN-PYR	64	21	21
TGCCCATGTCTCATCC-1_1_A9	-24.6533608	-6.103720102	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1491	2214	0.007226739	0.005420054	11	9	OPC	64	21	21
TGCCCATGTGTCGCTG-1_1_A9	-6.175993027	35.14949571	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	821	1139	0.011413521	0.008779631	11	oligos	OL-MS-2	64	21	21
TGCCCATTCGCCGTGA-1_1_A9	-20.34387172	-24.70014903	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3120	6568	0.015225335	0.005633374	11	6A	IN-PV	64	21	21
TGCCCATTCTAACTCT-1_1_A9	-18.25988295	9.614871541	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	850	1156	0.011245675	0.005190311	11	8	Astrocytes	64	21	21
TGCCCTACATCTCCCA-1_1_A9	6.562213695	-3.440545783	12	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1161	1641	0.039609994	0.007312614	11	12	EN-MIX	64	21	21
TGCCCTAGTCTTCTCG-1_1_A9	-6.030957712	35.24077823	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	853	1195	0.015062762	0.005020921	11	oligos	OL-MS-2	64	21	21
TGCCCTATCAAAGACA-1_1_A9	-6.174190994	33.14778593	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	966	1294	0.013137558	0.005409583	11	oligos	OL-MS-2	64	21	21
TGCGCAGAGCCCTAAT-1_1_A9	-14.21040431	8.873729012	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1609	2514	0.011535402	0.00477327	11	8	Astrocytes	64	21	21
TGCGCAGAGGCGACAT-1_1_A9	7.668929706	-23.11283277	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4964	13403	0.020741625	0.005371932	11	L2-3	EN-L2-3-MS	64	21	21
TGCGCAGCAGCCACCA-1_1_A9	-6.352538557	33.63190497	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	978	1303	0.023023791	0.002302379	11	oligos	OL-MS-2	64	21	21
TGCGCAGCAGCTCCGA-1_1_A9	-10.4041626	31.93729041	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	996	1303	0.023791251	0.008442057	11	oligos	OL-MS-2	64	21	21
TGCGCAGGTCCAACTA-1_1_A9	17.00268907	-32.63550269	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5665	20858	0.002636878	0.002349219	11	3	EN-L5-6	64	21	21
TGCGCAGTCCACTCCA-1_1_A9	33.10003377	5.840200182	14	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	817	1009	0.017839445	0.010901883	11	14	Microglia	64	21	21
TGCGCAGTCTTGCATT-1_1_A9	27.93350892	-24.11969974	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6091	20019	0.003746441	0.00549478	11	3	EN-L5-6	64	21	21
TGCGGGTAGAAGGACA-1_1_A9	23.67254504	-20.60244027	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4587	12195	0.030832308	0.004510045	11	3	EN-L5-6	64	21	21
TGCGGGTAGGGCTTGA-1_1_A9	17.04400042	-19.46532306	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4159	9789	0.018592297	0.007763817	11	L2-3	EN-L2-3-MS	64	21	21
TGCGGGTCAAGCGCTC-1_1_A9	-10.14283863	30.76213373	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	949	1291	0.03718048	0.00697134	11	oligos	OL-MS-2	64	21	21
TGCGGGTCAAGGTGTG-1_1_A9	-17.11163761	7.441204449	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	936	1359	0.006622517	0.005150846	11	8	Astrocytes	64	21	21
TGCGGGTGTGCCTTGG-1_1_A9	21.47786259	25.55141632	1	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1035	1524	0.00656168	0.005905512	11	oligos	OL-Cntl	64	21	21
TGCGGGTTCCATTCTA-1_1_A9	18.90961992	-34.07179307	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5736	18831	0.004779353	0.004726249	11	3	EN-L5-6	64	21	21
TGCGTGGAGCTTTGGT-1_1_A9	-11.51959115	13.29374683	11	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1329	1813	0.016547159	0.00551572	11	11	Glia-MIX	64	21	21
TGCGTGGAGGAGCGTT-1_1_A9	19.83681896	-33.4086	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5116	15273	0.006351077	0.001767826	11	3	EN-L5-6	64	21	21
TGCGTGGCAATGTTGC-1_1_A9	-0.41457324	31.99003201	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1024	1541	0.027255029	0.005840363	11	oligos	OL-MS-2	64	21	21
TGCGTGGCACCTTGTC-1_1_A9	5.319704253	-2.435083246	12	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	809	1192	0.104026846	0.005872483	11	12	EN-MIX	64	21	21
TGCGTGGCACTACAGT-1_1_A9	-24.47369466	-10.26400685	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	906	1166	0.01457976	0.002572899	11	9	OPC	64	21	21
TGCGTGGCAGAGTGTG-1_1_A9	-5.905173683	32.72882675	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1031	1527	0.01702685	0.005239031	11	oligos	OL-MS-2	64	21	21
TGCGTGGCAGGTCGTC-1_1_A9	11.90031625	-2.632877627	12	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1531	2565	0.009746589	0.003508772	11	12	EN-MIX	64	21	21
TGCGTGGGTTCCACGG-1_1_A9	-9.046731542	-30.40915905	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	906	1234	0.02917342	0.005672609	11	16	EN-PYR	64	21	21
TGCGTGGGTTGAACTC-1_1_A9	30.4322658	-7.765684006	2	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4739	11778	0.009594159	0.009254542	11	2	EN-L4	64	21	21
TGCGTGGTCTGAGGGA-1_1_A9	6.601751775	-23.82163551	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4697	13512	0.012729426	0.005106572	11	L2-3	EN-L2-3-MS	64	21	21
TGCTACCAGCACACAG-1_1_A9	-11.86596077	-32.52373705	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1165	1733	0.058857473	0.007501443	11	16	EN-PYR	64	21	21
TGCTACCAGCAGGCTA-1_1_A9	33.88836661	8.101978479	14	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1217	1611	0.028553693	0.018001241	11	14	Microglia	64	21	21
TGCTACCAGCTAAGAT-1_1_A9	-14.69680699	7.866859165	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	978	1310	0.020610687	0.009160305	11	8	Astrocytes	64	21	21
TGCTACCAGCTAGTCT-1_1_A9	-18.94465342	-8.141505529	13B	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4808	12785	0.013609699	0.007508799	11	13B	IN-SV2C	64	21	21
TGCTACCAGTGGACGT-1_1_A9	18.34392156	-31.13390359	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5098	15289	0.005624959	0.007260122	11	3	EN-L5-6	64	21	21
TGCTACCCACAAGTAA-1_1_A9	-19.44596688	15.89659945	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1495	2407	0.004985459	0.006647279	11	8	Astrocytes	64	21	21
TGCTACCCAGTAACGG-1_1_A9	-10.82817739	-32.98204631	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1094	1589	0.062303335	0.015733166	11	16	EN-PYR	64	21	21
TGCTACCCATTCCTCG-1_1_A9	-19.95258752	11.99346209	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1052	1479	0.01081812	0.006085193	11	8	Astrocytes	64	21	21
TGCTACCGTCAGAAGC-1_1_A9	-20.55556895	15.3637923	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1510	2541	0.012987013	0.003148367	11	8	Astrocytes	64	21	21
TGCTACCGTGATAAAC-1_1_A9	20.19533682	-31.73064052	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	7167	27410	0.007187158	0.010251733	11	3	EN-L5-6	64	21	21
TGCTACCGTGGTCTCG-1_1_A9	-2.759601231	35.92527088	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	750	1057	0.009460738	0.003784295	11	oligos	OL-MS-2	64	21	21
TGCTACCGTTTAAGCC-1_1_A9	4.992830618	-23.75348978	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4615	13574	0.006556652	0.007588036	11	L2-3	EN-L2-3-MS	64	21	21
TGCTACCTCTTTACAC-1_1_A9	-9.934889834	34.703194	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	910	1214	0.017298188	0.009884679	11	oligos	OL-MS-2	64	21	21
TGCTGCTAGGGTCGAT-1_1_A9	-26.88016602	-9.538752557	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1470	2021	0.016823355	0.016823355	11	9	OPC	64	21	21
TGCTGCTAGGTGATAT-1_1_A9	-6.639380202	-30.46867705	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	786	1057	0.080416272	0.008514664	11	16	EN-PYR	64	21	21
TGCTGCTAGTATCTCG-1_1_A9	24.92407731	-19.88040273	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	7242	29823	0.01264125	0.00603561	11	3	EN-L5-6	64	21	21
TGCTGCTAGTGGCACA-1_1_A9	22.72138077	26.57097314	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1203	1787	0.007274762	0.001678791	11	oligos	OL-MS-2	64	21	21
TGCTGCTCAAACAACA-1_1_A9	-8.089098526	32.03462913	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1081	1446	0.013831259	0.006224066	11	oligos	OL-MS-2	64	21	21
TGCTGCTCACGTCAGC-1_1_A9	2.807547147	-19.4044137	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3452	8228	0.006076811	0.008507535	11	L2-3	EN-L2-3-MS	64	21	21
TGCTGCTCAGCTGCAC-1_1_A9	-13.19678867	7.312579288	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1324	1774	0.020856821	0.003382187	11	8	Astrocytes	64	21	21
TGCTGCTCATTAGCCA-1_1_A9	-11.12987661	16.55834437	11	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2027	3463	0.007507941	0.00288767	11	11	Glia-MIX	64	21	21
TGCTGCTGTAACGTTC-1_1_A9	-11.1037327	-32.71332764	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1139	1695	0.07079646	0.008849558	11	16	EN-PYR	64	21	21
TGCTGCTGTATTCTCT-1_1_A9	7.682006709	-23.04093403	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4837	13149	0.013689254	0.007833295	11	L2-3	EN-L2-3-MS	64	21	21
TGCTGCTTCCCACTTG-1_1_A9	-11.11783593	30.0383794	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	854	1127	0.05501331	0.009760426	11	oligos	OL-MS-2	64	21	21
TGCTGCTTCGGCGCAT-1_1_A9	18.75405218	-34.67490688	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3707	9949	0.004020505	0.00693537	11	3	EN-L5-6	64	21	21
TGGACGCCACAAGCCC-1_1_A9	-24.09640211	-6.742715351	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1462	2244	0.010249554	0.00802139	11	9	OPC	64	21	21
TGGACGCGTAGGAGTC-1_1_A9	-19.522183	12.2376775	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1122	1658	0.009650181	0.010856454	11	8	Astrocytes	64	21	21
TGGACGCGTCCGAAGA-1_1_A9	-21.2463329	12.90938592	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1105	1650	0.011515152	0.004848485	11	8	Astrocytes	64	21	21
TGGCCAGAGAGCTGGT-1_1_A9	-18.32230225	10.07109727	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	753	1027	0.019474197	0.006815969	11	8	Astrocytes	64	21	21
TGGCCAGAGCAAATCA-1_1_A9	28.80181019	-6.98653218	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4807	13229	0.007407967	0.006954418	11	3	EN-L5-6	64	21	21
TGGCCAGAGCTTCGCG-1_1_A9	-26.75182179	-7.483157099	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1121	1574	0.010800508	0.011435832	11	9	OPC	64	21	21
TGGCCAGCAATGCCAT-1_1_A9	-14.5760789	10.095691	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1475	2221	0.011706439	0.006303467	11	8	Astrocytes	64	21	21
TGGCCAGCATCTCCCA-1_1_A9	-25.33052048	-24.89673032	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5516	17984	0.013678826	0.002947064	11	6A	IN-PV	64	21	21
TGGCCAGGTAACGACG-1_1_A9	28.1603392	-25.6951323	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6364	23572	0.006745291	0.002078737	11	3	EN-L5-6	64	21	21
TGGCCAGGTAAGTGTA-1_1_A9	-21.24189341	-17.29638329	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4886	13432	0.002159023	0.005583681	11	6A	IN-PV	64	21	21
TGGCCAGGTAGTACCT-1_1_A9	-25.43866696	-9.667858892	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	975	1348	0.012611276	0.002967359	11	9	OPC	64	21	21
TGGCCAGGTATAGGGC-1_1_A9	-20.65992477	16.94684236	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1626	2779	0.005037783	0.005397625	11	8	Astrocytes	64	21	21
TGGCCAGGTCGAGATG-1_1_A9	-19.78114192	11.21467881	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	736	1071	0.007469655	0.006535948	11	8	Astrocytes	64	21	21
TGGCCAGGTTGAACTC-1_1_A9	-9.050166444	33.53193327	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	889	1178	0.031409168	0.006791171	11	oligos	OL-MS-2	64	21	21
TGGCCAGTCGAACTGT-1_1_A9	26.1043149	-22.68929616	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5296	16699	0.019222708	0.00359303	11	3	EN-L5-6	64	21	21
TGGCCAGTCGAGCCCA-1_1_A9	-22.96857164	-16.25861801	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5342	14359	0.015112473	0.00584999	11	6A	IN-PV	64	21	21
TGGCCAGTCGGTGTCG-1_1_A9	18.94100605	-33.97348286	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6195	22763	0.003646268	0.005491368	11	3	EN-L5-6	64	21	21
TGGCGCAAGGTGCTTT-1_1_A9	-8.852930797	-29.98011367	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	963	1277	0.057948316	0.01018011	11	16	EN-PYR	64	21	21
TGGCGCACAATGTTGC-1_1_A9	-19.85420801	19.08275272	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1795	3000	0.009333333	0.008	11	8	Astrocytes	64	21	21
TGGCGCACAGTATGCT-1_1_A9	-22.5128051	-15.82838267	6B	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4613	12704	0.014404912	0.004093199	11	6B	IN-SST	64	21	21
TGGCGCAGTCTGATCA-1_1_A9	-10.8610016	-7.47160193	13A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1758	2674	0.016828721	0.006731488	11	13A	IN-VIP	64	21	21
TGGCGCAGTTTCCACC-1_1_A9	-8.296715152	31.59491586	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1132	1601	0.021861337	0.007495315	11	oligos	OL-MS-2	64	21	21
TGGCGCATCAGTTAGC-1_1_A9	-7.435710809	34.43412207	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	930	1238	0.009693053	0.009693053	11	oligos	OL-MS-2	64	21	21
TGGCTGGCAAACTGTC-1_1_A9	-14.65408077	9.786420174	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1187	1734	0.013264129	0.003460208	11	8	Astrocytes	64	21	21
TGGCTGGCAAAGGAAG-1_1_A9	19.33606591	-32.54209167	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6021	18343	0.012484326	0.004197787	11	3	EN-L5-6	64	21	21
TGGCTGGCACGAAACG-1_1_A9	-25.31923382	-10.23949101	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	894	1171	0.012809564	0.010247652	11	9	OPC	64	21	21
TGGCTGGCATCATCCC-1_1_A9	-7.837779116	-31.27769676	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1036	1509	0.108018555	0.009940358	11	16	EN-PYR	64	21	21
TGGCTGGGTCTACCTC-1_1_A9	-19.88936252	12.33893625	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1085	1619	0.008647313	0.005558987	11	8	Astrocytes	64	21	21
TGGCTGGTCCCATTAT-1_1_A9	33.18743207	6.366744253	14	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	819	1045	0.01722488	0.010526316	11	14	Microglia	64	21	21
TGGCTGGTCGAGAGCA-1_1_A9	-19.27847201	-16.26329825	6B	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2430	4456	0.009201077	0.002468582	11	6B	IN-SST	64	21	21
TGGCTGGTCTTACCGC-1_1_A9	-17.39879361	11.2987763	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1274	1910	0.013089005	0.012565445	11	8	Astrocytes	64	21	21
TGGCTGGTCTTTAGGG-1_1_A9	27.68884988	-6.170657272	2	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4304	12697	0.002126487	0.006300701	11	2	EN-L4	64	21	21
TGGGAAGAGAGGTTAT-1_1_A9	-22.00304769	14.3342421	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1192	1871	0.008551577	0.003206841	11	8	Astrocytes	64	21	21
TGGGAAGGTACTCGCG-1_1_A9	-8.663971642	-30.52321078	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	840	1101	0.044504995	0.005449591	11	16	EN-PYR	64	21	21
TGGGAAGGTTCGTCTC-1_1_A9	-2.233841133	33.02519854	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	944	1370	0.013138686	0.005109489	11	oligos	OL-MS-2	64	21	21
TGGGAAGTCAACGGCC-1_1_A9	-25.46809415	-24.7364192	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5450	16417	0.026192362	0.003289273	11	6A	IN-PV	64	21	21
TGGGCGTAGATATACG-1_1_A9	-25.51975851	-6.691021972	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1177	1721	0.005229518	0.00464846	11	9	OPC	64	21	21
TGGGCGTAGTCCAGGA-1_1_A9	-7.865599243	33.03920914	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1030	1349	0.016308377	0.002965159	11	oligos	OL-MS-2	64	21	21
TGGGCGTAGTTATCGC-1_1_A9	-22.09181297	14.86795517	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1193	1845	0.006504065	0.006504065	11	8	Astrocytes	64	21	21
TGGGCGTCAGATCGGA-1_1_A9	20.43113144	-31.89632872	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6855	24781	0.016464227	0.003107219	11	3	EN-L5-6	64	21	21
TGGGCGTTCGGTGTCG-1_1_A9	-33.63992324	-8.323479115	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1060	1538	0.009102731	0.006501951	11	9	OPC	64	21	21
TGGTTAGAGACCACGA-1_1_A9	-23.47229294	-17.83729797	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3833	8252	0.024236549	0.007755696	11	6A	IN-PV	64	21	21
TGGTTAGAGTCCGGTC-1_1_A9	2.40154417	5.805547141	7	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1073	1415	0.009187279	0.004946996	11	7	Phagocytes	64	21	21
TGGTTAGAGTTCGCAT-1_1_A9	-20.77651803	15.48984603	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1552	2486	0.008849558	0.004022526	11	8	Astrocytes	64	21	21
TGGTTAGCAATTGCTG-1_1_A9	-25.34295187	-5.869412401	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1302	2100	0.017619048	0.004285714	11	9	OPC	64	21	21
TGGTTAGCACACTGCG-1_1_A9	26.14470641	-25.17268627	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3817	9223	0.018757454	0.002168492	11	3	EN-L5-6	64	21	21
TGGTTAGCACCAGTTA-1_1_A9	-22.35258642	-15.84301946	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3771	9387	0.022690956	0.003941621	11	6A	IN-PV	64	21	21
TGGTTAGGTTCAGCGC-1_1_A9	23.02202275	26.65948231	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1198	1715	0.011661808	0.006997085	11	oligos	OL-MS-2	64	21	21
TGGTTAGTCCCATTTA-1_1_A9	19.00932435	-33.40258869	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5124	16033	0.004802595	0.002931454	11	3	EN-L5-6	64	21	21
TGGTTAGTCTTAACCT-1_1_A9	5.988694504	-25.6278389	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5915	21736	0.001932278	0.008833272	11	L2-3	EN-L2-3-MS	64	21	21
TGGTTCCAGACACGAC-1_1_A9	-7.744345812	-27.52237064	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	763	1013	0.082922014	0.008884501	11	16	EN-PYR	64	21	21
TGGTTCCAGAGAGCTC-1_1_A9	6.817472123	-22.54081088	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4491	12144	0.008810935	0.006752306	11	L2-3	EN-L2-3-MS	64	21	21
TGGTTCCCAAACAACA-1_1_A9	-10.20893583	-29.57843728	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1169	1617	0.050092764	0.017316017	11	16	EN-PYR	64	21	21
TGGTTCCCAGATGGGT-1_1_A9	-24.2039444	-7.844719094	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1176	1660	0.012650602	0.00060241	11	9	OPC	64	21	21
TGGTTCCCATGGGAAC-1_1_A9	5.523971465	1.889126809	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	778	1013	0.066140178	0.006910168	11	16	EN-PYR	64	21	21
TGGTTCCGTACCGTAT-1_1_A9	-26.2236248	-7.540613784	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1048	1501	0.01598934	0.013990673	11	9	OPC	64	21	21
TGGTTCCGTTACAGAA-1_1_A9	-6.875181431	-29.81995372	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	796	1097	0.086599818	0.007292616	11	16	EN-PYR	64	21	21
TGGTTCCGTTACCAGT-1_1_A9	22.82818268	26.87430342	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1134	1747	0.012020607	0.002289639	11	oligos	OL-MS-2	64	21	21
TGGTTCCTCAGGTAAA-1_1_A9	-11.1132657	31.67551409	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	919	1177	0.021240442	0.005947324	11	oligos	OL-MS-2	64	21	21
TGGTTCCTCATTGCCC-1_1_A9	-6.22904644	36.19163518	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	763	1006	0.017892644	0.013916501	11	oligos	OL-MS-2	64	21	21
TGGTTCCTCCACGTTC-1_1_A9	-21.98337978	-16.40068933	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4334	10552	0.005686126	0.004548901	11	6A	IN-PV	64	21	21
TGTATTCCACCAACCG-1_1_A9	6.278250435	-25.34283316	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5698	20021	0.007192448	0.002697168	11	L2-3	EN-L2-3-MS	64	21	21
TGTATTCCACTTAAGC-1_1_A9	-26.78591928	8.830633445	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	759	1016	0.015748031	0.013779528	11	8	Astrocytes	64	21	21
TGTATTCGTACCTACA-1_1_A9	-10.81751416	-32.48412099	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1020	1454	0.036451169	0.012379642	11	16	EN-PYR	64	21	21
TGTATTCGTTCCACTC-1_1_A9	-6.370496268	-29.59846075	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	754	1019	0.105004907	0.009813543	11	16	EN-PYR	64	21	21
TGTATTCTCAGGTTCA-1_1_A9	-9.429013536	-30.50973953	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1011	1408	0.058948864	0.006392045	11	16	EN-PYR	64	21	21
TGTCCCAAGGCCATAG-1_1_A9	6.61052435	-23.51004369	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5655	17453	0.011917722	0.005901564	11	L2-3	EN-L2-3-MS	64	21	21
TGTCCCAGTCACCCAG-1_1_A9	22.83498332	-19.41154214	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	7181	27562	0.029134315	0.007800595	11	3	EN-L5-6	64	21	21
TGTCCCAGTCCTGCTT-1_1_A9	-15.42897689	11.27053134	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1515	2337	0.008985879	0.005562687	11	8	Astrocytes	64	21	21
TGTCCCATCAGAGCTT-1_1_A9	-7.86023186	-30.80159393	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	758	1054	0.066413662	0.0028463	11	16	EN-PYR	64	21	21
TGTCCCATCGCTGATA-1_1_A9	-6.570233566	-29.47968458	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	768	1019	0.074582924	0.007850834	11	16	EN-PYR	64	21	21
TGTCCCATCGGTTCGG-1_1_A9	-9.640119862	-31.49662993	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	942	1331	0.046581518	0.007513148	11	16	EN-PYR	64	21	21
TGTCCCATCTCCTATA-1_1_A9	27.82366852	-24.79038847	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6247	21597	0.004445062	0.004120943	11	3	EN-L5-6	64	21	21
TGTGGTAAGGCGACAT-1_1_A9	-21.92218709	14.45712368	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1272	1942	0.005664264	0.002574665	11	8	Astrocytes	64	21	21
TGTGGTAAGTAACCCT-1_1_A9	28.06858104	-26.20778055	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5248	19190	0.002761855	0.002397082	11	3	EN-L5-6	64	21	21
TGTGGTAAGTTAACGA-1_1_A9	4.228774618	-22.95445126	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3594	8210	0.003288672	0.008769793	11	L2-3	EN-L2-3-MS	64	21	21
TGTGGTACAAGTCTAC-1_1_A9	-25.31011257	-6.772586806	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1222	1777	0.010692178	0.008441193	11	9	OPC	64	21	21
TGTGGTAGTAAGCACG-1_1_A9	-20.83961611	14.85637676	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1351	2118	0.003777148	0.007082153	11	8	Astrocytes	64	21	21
TGTGGTAGTATTAGCC-1_1_A9	-18.92909004	14.97687747	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1718	2615	0.016826004	0.008795411	11	8	Astrocytes	64	21	21
TGTGGTATCAACACTG-1_1_A9	-25.68690741	-10.37593625	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1017	1366	0.010248902	0.019033675	11	9	OPC	64	21	21
TGTGGTATCGTCTGAA-1_1_A9	-18.9180155	-8.160885527	13B	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4417	10997	0.019096117	0.006183505	11	13B	IN-SV2C	64	21	21
TGTGTTTCAACTGGCC-1_1_A9	20.92140334	27.62759487	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1105	1596	0.011278195	0.00877193	11	oligos	OL-MS-2	64	21	21
TGTGTTTGTACTTGAC-1_1_A9	-18.77493813	-8.22099438	13B	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3775	9063	0.032549928	0.005627276	11	13B	IN-SV2C	64	21	21
TGTGTTTGTCTAAACC-1_1_A9	-24.93800294	-10.05973763	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	963	1280	0.02578125	0.00546875	11	9	OPC	64	21	21
TGTTCCGCAGGGTATG-1_1_A9	-9.288518006	32.99445153	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	851	1212	0.030528053	0.005775578	11	oligos	OL-MS-2	64	21	21
TGTTCCGCATCACGTA-1_1_A9	-21.71926492	-15.96818828	6B	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3321	7012	0.00912721	0.004706218	11	6B	IN-SST	64	21	21
TGTTCCGGTGTGAATA-1_1_A9	-9.646353523	-31.55937505	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	906	1271	0.031471282	0.007081039	11	16	EN-PYR	64	21	21
TGTTCCGGTTCAGCGC-1_1_A9	5.696738222	-25.27550147	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5138	16830	0.003505645	0.003327392	11	L2-3	EN-L2-3-MS	64	21	21
TGTTCCGGTTCTGGTA-1_1_A9	-31.022183	-10.81480826	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	924	1306	0.010719755	0.006891271	11	9	OPC	64	21	21
TTAACTCCACCACCAG-1_1_A9	-19.67104157	15.5077199	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1589	2610	0.011494253	0.004214559	11	8	Astrocytes	64	21	21
TTAACTCTCCCTCAGT-1_1_A9	-1.940889201	36.17848392	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	841	1160	0.009482759	0.006034483	11	oligos	OL-MS-2	64	21	21
TTAACTCTCCTCAACC-1_1_A9	-9.886178345	22.37250133	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1332	1879	0.013304949	0.00532198	11	8	Astrocytes	64	21	21
TTAACTCTCTGTCCGT-1_1_A9	7.132467576	-25.91174593	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6601	24064	0.008602061	0.005443816	11	L2-3	EN-L2-3-MS	64	21	21
TTAGGACAGATCCTGT-1_1_A9	-2.633438907	35.86981617	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	771	1104	0.019927536	0.003623188	11	oligos	OL-MS-2	64	21	21
TTAGGACAGCCCAACC-1_1_A9	-7.379646439	-28.66706125	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	803	1040	0.043269231	0.009615385	11	16	EN-PYR	64	21	21
TTAGGACCACGGTTTA-1_1_A9	-8.710604724	-29.84429824	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	878	1215	0.051851852	0.006584362	11	16	EN-PYR	64	21	21
TTAGGACCACTACAGT-1_1_A9	-18.86254746	14.89798309	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1716	2931	0.009894234	0.005117707	11	8	Astrocytes	64	21	21
TTAGGACTCCACGTTC-1_1_A9	27.82093688	-24.54304203	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6935	26252	0.008380314	0.004190157	11	3	EN-L5-6	64	21	21
TTAGGACTCTGGCGAC-1_1_A9	-26.06198282	-6.969249383	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	974	1454	0.008253095	0.00343879	11	9	OPC	64	21	21
TTAGGCAAGCCGCCTA-1_1_A9	-14.53312526	9.866894149	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1517	2391	0.011710581	0.007946466	11	8	Astrocytes	64	21	21
TTAGGCACACAGATTC-1_1_A9	-15.54163473	-5.161461877	13A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3899	9486	0.015074847	0.008328062	11	13A	IN-VIP	64	21	21
TTAGGCACACGGCGTT-1_1_A9	24.9899033	-19.66747313	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	7042	26030	0.033269305	0.005800999	11	3	EN-L5-6	64	21	21
TTAGGCAGTCTAGGTT-1_1_A9	-17.35472162	11.16642602	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1209	1818	0.0110011	0.004950495	11	8	Astrocytes	64	21	21
TTAGTTCAGCTGTCTA-1_1_A9	-26.20333806	-24.0495973	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5278	14780	0.044384303	0.006901218	11	6A	IN-PV	64	21	21
TTAGTTCAGTACGTTC-1_1_A9	-23.90235938	-24.19507091	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3407	7517	0.011307703	0.003591858	11	6A	IN-PV	64	21	21
TTAGTTCAGTGGAGTC-1_1_A9	4.859469676	-23.70027735	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3998	10705	0.007006072	0.004764129	11	L2-3	EN-L2-3-MS	64	21	21
TTAGTTCCAAGAGGCT-1_1_A9	-7.678889091	-30.23054886	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	739	1034	0.080270793	0.002901354	11	16	EN-PYR	64	21	21
TTATGCTCAGCTTCGG-1_1_A9	-18.63270378	-20.17656064	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2725	6570	0.021613394	0.001826484	11	6A	IN-PV	64	21	21
TTATGCTGTATAGTAG-1_1_A9	-21.22958525	-16.77390154	6B	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4278	11834	0.00591516	0.003126584	11	6B	IN-SST	64	21	21
TTATGCTGTGCATCTA-1_1_A9	-17.66466197	-8.690542002	13B	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3195	7398	0.021492295	0.00324412	11	13B	IN-SV2C	64	21	21
TTATGCTTCAGTTTGG-1_1_A9	15.71627544	-10.69344577	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2197	4130	0.005326877	0.004358354	11	L2-3	EN-L2-3-MS	64	21	21
TTATGCTTCCGTCAAA-1_1_A9	-22.23952634	14.76761588	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1149	1857	0.011847065	0.00538503	11	8	Astrocytes	64	21	21
TTCCCAGAGAATGTTG-1_1_A9	-23.89219853	-7.712981872	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1394	2107	0.027052682	0.004271476	11	9	OPC	64	21	21
TTCCCAGAGCTTTGGT-1_1_A9	-0.711536899	32.56118949	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	901	1274	0.013343799	0.007064364	11	oligos	OL-MS-2	64	21	21
TTCCCAGAGTCATCCA-1_1_A9	-19.55269863	12.91382292	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1228	1775	0.010704225	0.004507042	11	8	Astrocytes	64	21	21
TTCCCAGCAAACAACA-1_1_A9	-14.48654046	7.002114401	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	785	1027	0.030185005	0.005842259	11	8	Astrocytes	64	21	21
TTCCCAGCACAACTGT-1_1_A9	-10.97771124	31.00609205	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1118	1511	0.039708802	0.00595632	11	oligos	OL-MS-2	64	21	21
TTCCCAGCACATGACT-1_1_A9	-8.282892652	-27.31345506	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	910	1212	0.048679868	0.009075908	11	16	EN-PYR	64	21	21
TTCCCAGCATATACCG-1_1_A9	-13.63376659	-2.912687176	13A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3445	8702	0.005401057	0.005171225	11	13A	IN-VIP	64	21	21
TTCCCAGGTACAAGTA-1_1_A9	-5.353491655	32.76079138	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	955	1298	0.016178737	0.009244992	11	oligos	OL-MS-2	64	21	21
TTCCCAGGTGATAAGT-1_1_A9	-25.99523338	-9.402651597	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	960	1332	0.007507508	0.012012012	11	9	OPC	64	21	21
TTCCCAGTCAATACCG-1_1_A9	-12.69056724	16.32070746	11	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1810	2794	0.010021475	0.007516106	11	11	Glia-MIX	64	21	21
TTCCCAGTCGCTAGCG-1_1_A9	17.22161662	-4.833588122	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1748	3667	0.008726479	0.002454322	11	3	EN-L5-6	64	21	21
TTCCCAGTCTTTACAC-1_1_A9	25.04613694	-28.12919435	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3342	9381	0.009487261	0.002131969	11	3	EN-L5-6	64	21	21
TTCGAAGCAATAGAGT-1_1_A9	-4.778178189	36.33440723	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	749	1005	0.011940299	0.006965174	11	oligos	OL-MS-2	64	21	21
TTCGAAGCAGATCCAT-1_1_A9	30.05710173	-8.129906996	2	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5004	13666	0.010171228	0.003805064	11	2	EN-L4	64	21	21
TTCGAAGTCTCCAACC-1_1_A9	7.483527686	-23.32658661	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6471	23103	0.017357053	0.005194131	11	L2-3	EN-L2-3-MS	64	21	21
TTCGGTCAGAGGGATA-1_1_A9	6.459733674	-10.84395846	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1937	3211	0.016194332	0.018062909	11	L2-3	EN-L2-3-MS	64	21	21
TTCGGTCAGAGGTTGC-1_1_A9	27.07512056	-26.22010686	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5181	15920	0.00540201	0.003329146	11	3	EN-L5-6	64	21	21
TTCGGTCAGCGCTTAT-1_1_A9	-11.38349942	16.58539068	11	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2170	3841	0.010153606	0.005988024	11	11	Glia-MIX	64	21	21
TTCGGTCAGCTAGTTC-1_1_A9	-20.93424422	-25.62618156	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3225	7334	0.011453504	0.005044996	11	6A	IN-PV	64	21	21
TTCGGTCCAGACAAAT-1_1_A9	-6.276845118	33.95926254	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	897	1235	0.012145749	0.007287449	11	oligos	OL-MS-2	64	21	21
TTCGGTCCATGCAATC-1_1_A9	-24.89595581	-6.047492886	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1314	1959	0.011740684	0.002041858	11	9	OPC	64	21	21
TTCGGTCGTCGTCTTC-1_1_A9	-8.209991264	-31.79876897	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	833	1192	0.089765101	0.01090604	11	16	EN-PYR	64	21	21
TTCGGTCGTTCTGGTA-1_1_A9	12.69638423	-30.73404912	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2991	7793	0.003208007	0.002566406	11	3	EN-L5-6	64	21	21
TTCGGTCTCATGGTCA-1_1_A9	22.48317138	-19.38728911	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	8797	41329	0.011565729	0.012775533	11	3	EN-L5-6	64	21	21
TTCGGTCTCCAAGTAC-1_1_A9	-8.934795973	-29.85025506	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	952	1329	0.045146727	0.006772009	11	16	EN-PYR	64	21	21
TTCGGTCTCCGCTGTT-1_1_A9	30.29627058	-8.180894926	2	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4311	11105	0.009185052	0.005312922	11	2	EN-L4	64	21	21
TTCGGTCTCGTGGTCG-1_1_A9	-24.52657649	-21.567146	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4129	9253	0.014914082	0.006592457	11	6A	IN-PV	64	21	21
TTCGGTCTCTAAGCCA-1_1_A9	26.22169023	-22.8834552	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4436	12487	0.016016657	0.004164331	11	3	EN-L5-6	64	21	21
TTCTACAAGCGCCTTG-1_1_A9	-5.433341256	-27.97913551	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	868	1083	0.037857802	0.015697138	11	16	EN-PYR	64	21	21
TTCTACACAGCGTAAG-1_1_A9	-2.107280046	33.29845422	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	921	1311	0.010678871	0.001525553	11	oligos	OL-MS-2	64	21	21
TTCTACACAGGCAGTA-1_1_A9	-4.619736611	32.24720441	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1087	1535	0.01237785	0.003908795	11	oligos	OL-MS-2	64	21	21
TTCTACACAGTACACT-1_1_A9	-18.96065847	-8.047714869	13B	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4314	11042	0.017931534	0.008331824	11	13B	IN-SV2C	64	21	21
TTCTACAGTATTCGTG-1_1_A9	-24.71651713	-8.02761276	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1055	1533	0.007175473	0.005218526	11	9	OPC	64	21	21
TTCTACATCAACACAC-1_1_A9	6.628520015	-25.22526555	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6217	21239	0.006262065	0.004661236	11	L2-3	EN-L2-3-MS	64	21	21
TTCTACATCCTATTCA-1_1_A9	-6.559515019	-30.63536668	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	852	1179	0.099236641	0.014418999	11	16	EN-PYR	64	21	21
TTCTACATCTGATTCT-1_1_A9	-27.08871548	8.747421482	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	694	1047	0.005730659	0.007640879	11	8	Astrocytes	64	21	21
TTCTACATCTGTACGA-1_1_A9	7.619096661	-23.01304466	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5616	18329	0.018058814	0.00960227	11	L2-3	EN-L2-3-MS	64	21	21
TTCTCAAAGGTCATCT-1_1_A9	-19.83710694	11.20068041	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	839	1173	0.009377664	0.00341006	11	8	Astrocytes	64	21	21
TTCTCAAAGGTTCCTA-1_1_A9	-27.83638574	9.168630007	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	755	1137	0.006156552	0.01055409	11	8	Astrocytes	64	21	21
TTCTCAAAGTTACGGG-1_1_A9	2.199538248	-17.86277809	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2766	5962	0.00318685	0.007883261	11	L2-3	EN-L2-3-MS	64	21	21
TTCTCAACAAGGTTTC-1_1_A9	-19.45254859	12.03454724	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1111	1601	0.01623985	0.004996877	11	8	Astrocytes	64	21	21
TTCTCAACAATAACGA-1_1_A9	33.90594959	7.337152535	14	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	777	1026	0.026315789	0.005847953	11	14	Microglia	64	21	21
TTCTCAACACGACTCG-1_1_A9	-25.02815932	-6.29443828	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1241	1886	0.011664899	0.004241782	11	9	OPC	64	21	21
TTCTCAACACTGTGTA-1_1_A9	-4.352148949	35.09447191	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	774	1045	0.012440191	0.002870813	11	oligos	OL-MS-2	64	21	21
TTCTCAACAGACTCGC-1_1_A9	-25.12054562	-5.703758287	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1313	2019	0.009905894	0.006934126	11	9	OPC	64	21	21
TTCTCAACATCGGACC-1_1_A9	-29.1084829	-12.46055997	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	817	1134	0.014109347	0.007936508	11	9	OPC	64	21	21
TTCTCAAGTGACGCCT-1_1_A9	-33.94699716	-7.729559513	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1151	1833	0.009819967	0.003818876	11	9	OPC	64	21	21
TTCTCAATCACAATGC-1_1_A9	27.84960431	-6.472845452	2	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4197	11629	0.006879353	0.006019434	11	2	EN-L4	64	21	21
TTCTCAATCGTAGATC-1_1_A9	-29.30768889	-12.95308249	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	815	1109	0.007213706	0.00541028	11	9	OPC	64	21	21
TTCTCCTAGACTAGGC-1_1_A9	-21.33066271	16.14345581	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1332	2151	0.007903301	0.0027894	11	8	Astrocytes	64	21	21
TTCTCCTAGACTTGAA-1_1_A9	-24.95218261	-24.82508152	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4846	14716	0.014609948	0.005300353	11	6A	IN-PV	64	21	21
TTCTCCTAGGAGTAGA-1_1_A9	-26.08509681	-24.18620694	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4688	12561	0.018469867	0.006209697	11	6A	IN-PV	64	21	21
TTCTCCTAGGGCATGT-1_1_A9	-21.09129862	12.67213857	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1011	1556	0.005141388	0.007069409	11	8	Astrocytes	64	21	21
TTCTCCTCAATTGCTG-1_1_A9	28.3217214	-25.85019645	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6414	27703	0.015377396	0.002707288	11	3	EN-L5-6	64	21	21
TTCTCCTCAGCTTAAC-1_1_A9	-24.21516475	-9.767060635	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	895	1233	0.01865369	0.00405515	11	9	OPC	64	21	21
TTCTCCTGTAAGGATT-1_1_A9	5.056487792	-23.63645287	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5483	18819	0.004038472	0.006589085	11	L2-3	EN-L2-3-MS	64	21	21
TTCTCCTGTAGCTAAA-1_1_A9	7.829142109	-23.1762318	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5731	18598	0.017636305	0.004892999	11	L2-3	EN-L2-3-MS	64	21	21
TTCTTAGAGCCAGGAT-1_1_A9	14.82971879	-27.52058169	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2358	4637	0.006685357	0.01035152	11	3	EN-L5-6	64	21	21
TTCTTAGAGGACCACA-1_1_A9	-19.33516448	11.20167697	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	837	1113	0.010781671	0.00359389	11	8	Astrocytes	64	21	21
TTCTTAGAGGCCGAAT-1_1_A9	-22.47384554	12.19209999	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1062	1632	0.011029412	0.005514706	11	8	Astrocytes	64	21	21
TTCTTAGCACCACGTG-1_1_A9	28.04212124	-25.71578505	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4614	12597	0.006827022	0.003095975	11	3	EN-L5-6	64	21	21
TTCTTAGGTAAACACA-1_1_A9	-15.29948139	-7.36032875	13A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2810	5588	0.00984252	0.003937008	11	13A	IN-VIP	64	21	21
TTCTTAGTCAGAAATG-1_1_A9	-18.24803356	-8.111231322	13B	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3652	8186	0.008184706	0.005130711	11	13B	IN-SV2C	64	21	21
TTCTTAGTCTACTTAC-1_1_A9	-13.82970553	8.232657543	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1211	1752	0.054223744	0.003995434	11	8	Astrocytes	64	21	21
TTGAACGAGGCTACGA-1_1_A9	-8.580430852	-5.475574852	13A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1517	2548	0.01844584	0.003924647	11	13A	IN-VIP	64	21	21
TTGAACGCACTTACGA-1_1_A9	-10.801976	-27.91286626	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1339	2069	0.057999033	0.00918318	11	16	EN-PYR	64	21	21
TTGAACGCAGCGTAAG-1_1_A9	17.34410037	10.59086025	1	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1552	2519	0.010321556	0.010321556	11	oligos	OL-Cntl	64	21	21
TTGAACGTCATTCACT-1_1_A9	-23.63915487	-6.863884332	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1670	2661	0.022547914	0.003757986	11	9	OPC	64	21	21
TTGACTTCAATGGTCT-1_1_A9	-31.63488086	-10.25688941	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	843	1196	0.010869565	0.003344482	11	9	OPC	64	21	21
TTGACTTCACTTAAGC-1_1_A9	5.663205222	-23.87611811	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5399	18938	0.016897244	0.005280389	11	L2-3	EN-L2-3-MS	64	21	21
TTGACTTCATATGAGA-1_1_A9	5.082709976	-24.01757444	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5186	16840	0.006472684	0.005285036	11	L2-3	EN-L2-3-MS	64	21	21
TTGACTTGTCAGATAA-1_1_A9	-18.99456888	10.68601986	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	728	1033	0.020329138	0.003872217	11	8	Astrocytes	64	21	21
TTGACTTGTTACGCGC-1_1_A9	-11.4019643	-0.614729463	13A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2702	5612	0.015680684	0.007662153	11	13A	IN-VIP	64	21	21
TTGACTTGTTGGTTTG-1_1_A9	-19.29081325	11.57258331	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1010	1415	0.009187279	0.007773852	11	8	Astrocytes	64	21	21
TTGCCGTAGATAGCAT-1_1_A9	-12.04230587	31.58479076	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	951	1225	0.03755102	0.008163265	11	oligos	OL-MS-2	64	21	21
TTGCCGTAGATCCTGT-1_1_A9	-27.69584358	4.351984495	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2028	3328	0.003605769	0.008112981	11	9	OPC	64	21	21
TTGCCGTAGCGATGAC-1_1_A9	-2.290496251	32.92034688	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1021	1486	0.009421265	0.006729475	11	oligos	OL-MS-2	64	21	21
TTGCCGTCAATAGCAA-1_1_A9	-10.97847121	-27.44437591	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	997	1445	0.103114187	0.010380623	11	16	EN-PYR	64	21	21
TTGCGTCAGCGCTTAT-1_1_A9	-7.270516166	35.19553997	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	891	1191	0.019311503	0.008396306	11	oligos	OL-MS-2	64	21	21
TTGCGTCCAACAACCT-1_1_A9	-1.881782076	33.68023653	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	971	1336	0.011227545	0.003742515	11	oligos	OL-MS-2	64	21	21
TTGCGTCCACCAGCAC-1_1_A9	-18.62457699	-8.06622224	13B	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3625	8100	0.012716049	0.005061728	11	13B	IN-SV2C	64	21	21
TTGCGTCGTCACTTCC-1_1_A9	-6.756415195	-33.64243712	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	809	1148	0.088850174	0.014808362	11	16	EN-PYR	64	21	21
TTGCGTCGTCTGCCAG-1_1_A9	5.657463179	-24.16310565	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4982	16502	0.015452672	0.00375712	11	L2-3	EN-L2-3-MS	64	21	21
TTGGAACAGAGGTACC-1_1_A9	-16.22246129	-6.318450783	13A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2975	5997	0.021010505	0.007170252	11	13A	IN-VIP	64	21	21
TTGGAACAGCTGAAAT-1_1_A9	-25.85849126	-7.437448647	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1047	1528	0.006544503	0.003272251	11	9	OPC	64	21	21
TTGGAACAGGAGTCTG-1_1_A9	-11.33235131	-31.74622944	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1166	1673	0.050209205	0.008368201	11	16	EN-PYR	64	21	21
TTGGAACAGGCACATG-1_1_A9	-18.88205572	-8.066836583	13B	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4151	9887	0.010114291	0.008394862	11	13B	IN-SV2C	64	21	21
TTGGAACCAAGCCATT-1_1_A9	-25.61964185	-24.66377946	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5652	17474	0.01350578	0.005493877	11	6A	IN-PV	64	21	21
TTGGAACCACATGACT-1_1_A9	5.803060071	2.2273068	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	835	1058	0.039697543	0.013232514	11	16	EN-PYR	64	21	21
TTGGAACGTGTTTGGT-1_1_A9	-18.80881913	-8.150770723	13B	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3911	9217	0.025821851	0.005316263	11	13B	IN-SV2C	64	21	21
TTGGAACTCGATCCCT-1_1_A9	-23.63679957	-8.820816272	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1148	1699	0.017068864	0.002354326	11	9	OPC	64	21	21
TTGGAACTCGGCGCAT-1_1_A9	-8.033245688	32.82814562	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	955	1280	0.0171875	0.00390625	11	oligos	OL-MS-2	64	21	21
TTGGCAAAGAATTCCC-1_1_A9	-7.861821902	32.39188673	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	949	1353	0.016999261	0.003695492	11	oligos	OL-MS-2	64	21	21
TTGGCAACATATACGC-1_1_A9	-9.215910973	-14.73773214	6B	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	859	1197	0.055137845	0.004177109	11	6B	IN-SST	64	21	21
TTGGCAATCACAATGC-1_1_A9	7.872046043	-23.138202	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5771	18297	0.012898289	0.003661802	11	L2-3	EN-L2-3-MS	64	21	21
TTGGCAATCCCATTAT-1_1_A9	4.512688886	1.525063753	16	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	816	1022	0.052837573	0.004892368	11	16	EN-PYR	64	21	21
TTGGCAATCTTGACGA-1_1_A9	23.20062237	-18.22319428	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	9308	48842	0.026206953	0.005814668	11	3	EN-L5-6	64	21	21
TTGTAGGAGAGGTTGC-1_1_A9	-4.694300167	35.26028152	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	776	1083	0.010156971	0.003693444	11	oligos	OL-MS-2	64	21	21
TTGTAGGAGGTACTCT-1_1_A9	26.7601384	-25.32331738	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5595	20179	0.006045889	0.004559195	11	3	EN-L5-6	64	21	21
TTGTAGGCACTGTGTA-1_1_A9	20.52537563	-3.932588176	2	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1948	3020	0.011258278	0.009602649	11	2	EN-L4	64	21	21
TTGTAGGCAGGGAGAG-1_1_A9	18.62595004	-7.187728897	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2042	4078	0.007111329	0.001961746	11	3	EN-L5-6	64	21	21
TTGTAGGGTAAAGTCA-1_1_A9	5.909275544	-24.58010829	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5587	17674	0.006336992	0.004583003	11	L2-3	EN-L2-3-MS	64	21	21
TTGTAGGGTGCCTGTG-1_1_A9	-25.62584522	-6.126040194	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1245	1929	0.00622084	0.003628823	11	9	OPC	64	21	21
TTGTAGGGTGCGCTTG-1_1_A9	-0.659538965	35.77089411	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	747	1009	0.008919722	0.007928642	11	oligos	OL-MS-2	64	21	21
TTTACTGAGTCTCGGC-1_1_A9	-26.27573325	-9.420635206	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	894	1186	0.010118044	0.008431703	11	9	OPC	64	21	21
TTTACTGAGTGTGAAT-1_1_A9	-25.48326346	8.699414103	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	879	1290	0.00620155	0.004651163	11	8	Astrocytes	64	21	21
TTTACTGCATAGACTC-1_1_A9	19.17874426	-34.0611471	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4691	14779	0.010420191	0.003856824	11	3	EN-L5-6	64	21	21
TTTACTGGTTACGTCA-1_1_A9	34.2399407	-2.86610593	2	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	2090	3903	0.012298232	0.002305919	11	2	EN-L4	64	21	21
TTTATGCAGAAGGTTT-1_1_A9	25.89906301	-27.16079342	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3685	9453	0.006347191	0.003385169	11	3	EN-L5-6	64	21	21
TTTATGCCAAGCTGGA-1_1_A9	-15.12713396	-6.749954685	13A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4133	10876	0.010022067	0.006160353	11	13A	IN-VIP	64	21	21
TTTATGCCACCTCGGA-1_1_A9	23.74475342	-22.96814439	2	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4144	10608	0.008201357	0.002828054	11	2	EN-L4	64	21	21
TTTATGCCATGCGCAC-1_1_A9	-20.89372185	16.1182347	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1479	2359	0.006782535	0.003815176	11	8	Astrocytes	64	21	21
TTTATGCCATTTCACT-1_1_A9	-26.38681932	8.617588563	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	832	1207	0.011599006	0.003314002	11	8	Astrocytes	64	21	21
TTTATGCGTGAGGCTA-1_1_A9	-26.28893477	-6.887694082	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1049	1575	0.004444444	0.001904762	11	9	OPC	64	21	21
TTTATGCGTTACGGAG-1_1_A9	30.21714889	-7.730097349	2	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4912	14148	0.011309019	0.015337857	11	2	EN-L4	64	21	21
TTTATGCTCACATAGC-1_1_A9	-21.06237028	12.24028607	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1020	1559	0.008338679	0.003848621	11	8	Astrocytes	64	21	21
TTTATGCTCAGCCTAA-1_1_A9	-21.96999749	12.89625051	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1116	1757	0.007398976	0.00284576	11	8	Astrocytes	64	21	21
TTTATGCTCGCTAGCG-1_1_A9	-21.20901794	14.5993372	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1241	2102	0.003805899	0.004281637	11	8	Astrocytes	64	21	21
TTTATGCTCTTAGAGC-1_1_A9	18.85122481	-20.49091017	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4475	12104	0.026272307	0.005122274	11	L2-3	EN-L2-3-MS	64	21	21
TTTCCTCCACAACGCC-1_1_A9	25.31167541	5.502713691	15A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1237	1675	0.013731343	0.011940299	11	15A	Endo cells	64	21	21
TTTCCTCCATGACATC-1_1_A9	-21.11756352	-16.97082869	6A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3158	6884	0.022806508	0.003195816	11	6A	IN-PV	64	21	21
TTTCCTCGTCAGAATA-1_1_A9	-14.69778541	9.923430399	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1196	1869	0.009630819	0.004815409	11	8	Astrocytes	64	21	21
TTTCCTCGTCGAAAGC-1_1_A9	18.61926196	-26.3998347	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3721	9535	0.00356581	0.014682748	11	3	EN-L5-6	64	21	21
TTTCCTCGTCGCCATG-1_1_A9	-24.24362466	-1.141620741	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1447	2207	0.016311735	0.012233802	11	9	OPC	64	21	21
TTTCCTCTCAACGGCC-1_1_A9	-2.722909511	34.70963056	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	773	1112	0.022482014	0.004496403	11	oligos	OL-MS-2	64	21	21
TTTGCGCAGATATACG-1_1_A9	-21.52278338	-16.05338606	6B	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	3012	6524	0.011955855	0.010729614	11	6B	IN-SST	64	21	21
TTTGCGCAGTACGACG-1_1_A9	-19.2379442	14.74533379	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1450	2320	0.006896552	0.006465517	11	8	Astrocytes	64	21	21
TTTGCGCCAAAGAATC-1_1_A9	-5.867661007	36.14792938	17	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	801	1070	0.026168224	0.007476636	11	oligos	OL-MS-2	64	21	21
TTTGCGCCACAGGCCT-1_1_A9	-20.2838943	16.13948102	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1428	2344	0.011945392	0.006399317	11	8	Astrocytes	64	21	21
TTTGCGCTCGTCGTTC-1_1_A9	-32.75297418	-11.52776842	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	806	1180	0.013559322	0.010169492	11	9	OPC	64	21	21
TTTGGTTCACTGTCGG-1_1_A9	-22.00489795	14.90104566	8	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1241	2003	0.002995507	0.003994009	11	8	Astrocytes	64	21	21
TTTGGTTCATCCGGGT-1_1_A9	19.05886641	-31.3975405	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5752	21129	0.014482465	0.004354205	11	3	EN-L5-6	64	21	21
TTTGGTTCATCGATGT-1_1_A9	28.27135771	-26.02831699	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	5176	18622	0.00708839	0.003544195	11	3	EN-L5-6	64	21	21
TTTGGTTGTCAACTGT-1_1_A9	-15.59496039	-6.578390433	13A	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	6547	27824	0.012004025	0.004240943	11	13A	IN-VIP	64	21	21
TTTGTCAAGGCTACGA-1_1_A9	19.2578122	-34.36408669	3	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4790	14338	0.004951876	0.010670944	11	3	EN-L5-6	64	21	21
TTTGTCAGTTAGGGTG-1_1_A9	5.439432472	-23.93612339	4	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	4679	13342	0.01109279	0.003972418	11	L2-3	EN-L2-3-MS	64	21	21
TTTGTCATCGACCAGC-1_1_A9	-33.97632988	-7.615124729	9	1_A9	MS	Chronic inactive	55	male	temporal	CAP3	SEQ2	7.1	16	1092	1681	0.008328376	0.004164188	11	9	OPC	64	21	21
AAACCTGAGCTACCGC-1_25G_P3C1	4.162710193	-30.19448693	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3734	11527	8.68E-05	0.002255574	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AAACCTGAGTAGTGCG-1_25G_P3C1	-0.158789974	-8.347481795	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1645	3020	0.000993377	0.004304636	0	12	EN-MIX	NA	NA	NA
AAACCTGCACAAGTAA-1_25G_P3C1	-5.271152365	-1.852068121	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1674	3149	0.008256589	0.004128295	0	13A	IN-VIP	NA	NA	NA
AAACCTGTCCGTTGCT-1_25G_P3C1	-3.751646678	-16.39881721	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2532	5838	0.006509078	0.003425831	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AAACCTGTCGTATCAG-1_25G_P3C1	-2.594273788	-15.7710075	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2368	5158	0.000969368	0.002520357	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AAACGGGAGGGATCTG-1_25G_P3C1	-27.82228249	24.84209388	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1330	2371	0.008013496	0.00421763	0	8	Astrocytes	NA	NA	NA
AAACGGGAGGGTCTCC-1_25G_P3C1	-34.94069416	-4.079635056	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1291	2102	0.003330162	0.003330162	0	9	OPC	NA	NA	NA
AAACGGGAGTACGTAA-1_25G_P3C1	-5.261396719	-10.53994475	13B	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	931	1379	0.006526468	0.004350979	0	13B	IN-SV2C	NA	NA	NA
AAACGGGCACGAAAGC-1_25G_P3C1	-25.83299339	27.21020357	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1612	2989	0.008029441	0.004349281	0	8	Astrocytes	NA	NA	NA
AAACGGGCAGTTCCCT-1_25G_P3C1	-27.83796549	25.2695497	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1135	2035	0.0004914	0.003439803	0	8	Astrocytes	NA	NA	NA
AAACGGGCATCTGGTA-1_25G_P3C1	-3.994669705	-21.15507621	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3803	10553	0.001989955	0.008054582	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AAACGGGTCCAAATGC-1_25G_P3C1	1.52155812	-5.448946446	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	990	1673	0	0.003586372	0	12	EN-MIX	NA	NA	NA
AAAGATGAGTCTCAAC-1_25G_P3C1	-4.453897072	-9.592808533	13B	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	675	1010	0.017821782	0	0	13B	IN-SV2C	NA	NA	NA
AAAGATGCATAGTAAG-1_25G_P3C1	-2.529701084	-14.65574753	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2124	4072	0.001227898	0.000982318	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AAAGATGGTAAATGAC-1_25G_P3C1	-0.772520253	-10.79815802	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1710	3366	0.003862151	0.004159239	0	12	EN-MIX	NA	NA	NA
AAAGATGGTCTGATCA-1_25G_P3C1	-37.43625303	-9.77249875	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	940	1532	0.005874674	0.001305483	0	9	OPC	NA	NA	NA
AAAGATGTCGACCAGC-1_25G_P3C1	-29.54490742	14.67157206	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	879	1414	0	0.004243281	0	8	Astrocytes	NA	NA	NA
AAAGCAAAGCTACCGC-1_25G_P3C1	-9.395446726	1.789447017	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2688	6031	0.005969159	0.00348201	0	13A	IN-VIP	NA	NA	NA
AAAGCAACACGTAAGG-1_25G_P3C1	-10.35546876	2.558002805	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3267	8680	0.000345622	0.004147465	0	13A	IN-VIP	NA	NA	NA
AAAGCAACATGTTCCC-1_25G_P3C1	23.80708178	-29.53259219	3	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2916	7797	0.001539053	0.008464794	0	3	EN-L5-6	NA	NA	NA
AAAGCAAGTACATCCA-1_25G_P3C1	-0.563653958	-10.51709855	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1737	3517	0.000568666	0.004833665	0	12	EN-MIX	NA	NA	NA
AAAGCAAGTCATTAGC-1_25G_P3C1	-13.96022006	-10.51226448	13B	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2075	4122	0.011402232	0.002668607	0	13B	IN-SV2C	NA	NA	NA
AAAGCAAGTCTGGTCG-1_25G_P3C1	0.76697609	-14.75964842	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2500	5114	0.004693	0.004888541	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AAAGCAAGTGAGCGAT-1_25G_P3C1	-0.65571914	-29.68637848	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4190	12316	0.006008444	0.003653784	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AAAGCAAGTGGTAACG-1_25G_P3C1	-25.1574115	24.78163147	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1484	2655	0.001129944	0.007909605	0	8	Astrocytes	NA	NA	NA
AAATGCCCAGGTGCCT-1_25G_P3C1	-24.1411746	-1.641210026	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1591	3720	0.001344086	0.001612903	0	9	OPC	NA	NA	NA
AAATGCCGTCGATTGT-1_25G_P3C1	-2.437691988	-11.97118577	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1867	3402	0.0111699	0.007642563	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AAATGCCTCGCAAACT-1_25G_P3C1	-3.479318911	-24.79517959	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3862	11612	0.001464003	0.003272477	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AACACGTAGCGTCAAG-1_25G_P3C1	-3.577873252	-14.05630913	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2360	4984	0.002407705	0.006621188	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AACACGTGTCAACATC-1_25G_P3C1	-0.303774979	-8.43097797	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1514	2481	0.000403063	0.012898025	0	12	EN-MIX	NA	NA	NA
AACACGTTCGTTTAGG-1_25G_P3C1	-5.01779523	-20.20881563	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2882	6872	0.002910361	0.004074505	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AACACGTTCTCTTGAT-1_25G_P3C1	-19.7431866	-28.08042894	6A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3699	10692	0.010942761	0.001683502	0	6A	IN-PV	NA	NA	NA
AACACGTTCTTGGGTA-1_25G_P3C1	-15.17767159	-10.51678561	13B	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2889	6673	0.001498576	0.004046156	0	13B	IN-SV2C	NA	NA	NA
AACCATGCAACGATGG-1_25G_P3C1	25.55220952	0.551612986	2	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2425	5500	0.004727273	0.002909091	0	2	EN-L4	NA	NA	NA
AACCATGCAGTATCTG-1_25G_P3C1	1.654013829	-7.087513428	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1308	2049	0.001952172	0.013665203	0	12	EN-MIX	NA	NA	NA
AACCATGTCCCAGGTG-1_25G_P3C1	-8.972801873	-18.50871822	6B	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	773	1198	0.000834725	0.003338898	0	6B	IN-SST	NA	NA	NA
AACCATGTCGGTTAAC-1_25G_P3C1	-3.378888259	-13.09630189	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2265	4730	0.013742072	0.009725159	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AACCGCGCACAAGCCC-1_25G_P3C1	-4.261863126	-3.269719848	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1266	2343	0.003414426	0.00128041	0	13A	IN-VIP	NA	NA	NA
AACCGCGCACCGATAT-1_25G_P3C1	-4.269054613	-17.02440043	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2535	5386	0.002784998	0.007426662	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AACCGCGTCGCCAAAT-1_25G_P3C1	-39.33242672	-2.094361574	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1252	2223	0.008097166	0.002249213	0	9	OPC	NA	NA	NA
AACGTTGCAGGCTGAA-1_25G_P3C1	28.35284441	0.318593283	2	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3159	7792	0.000898357	0.00436345	0	2	EN-L4	NA	NA	NA
AACGTTGCATTACCTT-1_25G_P3C1	-2.688171249	-25.36634055	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4032	11848	0.000759622	0.00312289	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AACTCAGAGGACATTA-1_25G_P3C1	-29.28565077	22.64909754	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1068	1756	0.001138952	0.007403189	0	8	Astrocytes	NA	NA	NA
AACTCAGCAAGCCATT-1_25G_P3C1	9.851892581	29.31494265	1	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	737	1064	0.002819549	0.007518797	0	oligos	OL-Cntl	NA	NA	NA
AACTCAGCAGAGTGTG-1_25G_P3C1	-1.250379223	-23.55440954	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4838	14551	0.004398323	0.005566628	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AACTCAGGTCGACTGC-1_25G_P3C1	-8.222870822	-0.069223331	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2460	5374	0.007815408	0.001860811	0	13A	IN-VIP	NA	NA	NA
AACTCAGTCCTTCAAT-1_25G_P3C1	-26.36518443	27.79808258	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1586	3201	0.003748828	0.004998438	0	8	Astrocytes	NA	NA	NA
AACTCAGTCGTTGACA-1_25G_P3C1	-1.61902051	-24.44768009	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	5035	16558	0.00320087	0.00736804	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AACTCAGTCGTTTAGG-1_25G_P3C1	-4.973952227	-2.558223198	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1470	2691	0.004830918	0.004459309	0	13A	IN-VIP	NA	NA	NA
AACTCCCGTAAACGCG-1_25G_P3C1	-27.96228981	12.15081525	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	763	1298	0.00770416	0.003081664	0	8	Astrocytes	NA	NA	NA
AACTCCCGTCGGGTCT-1_25G_P3C1	-37.27836749	-9.296889797	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	971	1603	0.001247661	0.001871491	0	9	OPC	NA	NA	NA
AACTCCCGTGGCTCCA-1_25G_P3C1	-9.629200945	2.353035483	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2918	6984	0.005870561	0.003865979	0	13A	IN-VIP	NA	NA	NA
AACTCCCTCCATGAGT-1_25G_P3C1	-1.029064508	-27.90365106	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	5375	20043	0.004440453	0.005039166	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AACTCTTAGACGCACA-1_25G_P3C1	-7.197992295	-1.041594456	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1888	3875	0.003354839	0.002064516	0	13A	IN-VIP	NA	NA	NA
AACTCTTCACGTCTCT-1_25G_P3C1	-2.424152919	-14.72307065	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2275	5177	0.000579486	0.00463589	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AACTCTTCATGAAGTA-1_25G_P3C1	-15.51845544	-25.9545883	6A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1895	4370	0.004805492	0.001830664	0	6A	IN-PV	NA	NA	NA
AACTCTTGTATGCTTG-1_25G_P3C1	-29.61142972	13.93816946	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	773	1267	0.001578532	0.00789266	0	8	Astrocytes	NA	NA	NA
AACTCTTGTGTCGCTG-1_25G_P3C1	-29.54357802	22.23636856	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1013	1684	0.003562945	0.00415677	0	8	Astrocytes	NA	NA	NA
AACTGGTCAATAACGA-1_25G_P3C1	-1.765613407	-17.7303583	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2823	6895	0.003190718	0.00275562	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AACTGGTCATTCGACA-1_25G_P3C1	-35.74635129	4.559598668	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2258	4908	0.001629992	0.004278729	0	9	OPC	NA	NA	NA
AACTGGTGTCCAGTTA-1_25G_P3C1	-39.48429407	-0.248804364	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1512	2782	0.004672897	0.002516175	0	9	OPC	NA	NA	NA
AACTGGTTCTTTACGT-1_25G_P3C1	-6.564559768	0.636709274	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1891	4180	0	0.000956938	0	13A	IN-VIP	NA	NA	NA
AACTTTCAGACACTAA-1_25G_P3C1	-4.090631171	-24.35141298	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4784	18393	0.002011635	0.003370848	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AACTTTCAGTTCGCGC-1_25G_P3C1	13.19670871	-31.38541846	3	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2946	7577	0.000395935	0.005939026	0	3	EN-L5-6	NA	NA	NA
AACTTTCGTGAAATCA-1_25G_P3C1	0.99423269	-6.197243193	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1100	1786	0.00055991	0.003919373	0	12	EN-MIX	NA	NA	NA
AACTTTCGTGGTCTCG-1_25G_P3C1	-39.6899706	0.092806951	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1472	2798	0.000714796	0.003216583	0	9	OPC	NA	NA	NA
AACTTTCTCATACGGT-1_25G_P3C1	-5.66843425	-23.28202924	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2903	7642	0.001439414	0.002617116	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AACTTTCTCATCGATG-1_25G_P3C1	0.39084734	-6.774446145	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1152	2117	0	0.004723666	0	12	EN-MIX	NA	NA	NA
AAGACCTAGAGAACAG-1_25G_P3C1	32.48181149	-4.072505319	2	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3274	7603	0.013415757	0.006313297	0	2	EN-L4	NA	NA	NA
AAGACCTAGCATCATC-1_25G_P3C1	-5.379507107	-22.70834393	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3163	8182	0.001344415	0.003788805	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AAGCCGCAGCGTAATA-1_25G_P3C1	-4.433089113	-23.57477855	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4164	12160	0.001973684	0.005016447	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AAGCCGCAGTTTGCGT-1_25G_P3C1	-28.46102349	16.96851545	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1011	1610	0.002484472	0.004347826	0	8	Astrocytes	NA	NA	NA
AAGCCGCTCATAGCAC-1_25G_P3C1	19.25968002	22.13009618	1	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	957	1540	0.001298701	0.001298701	0	oligos	OL-Cntl	NA	NA	NA
AAGCCGCTCGCAGGCT-1_25G_P3C1	5.874379754	-12.34101229	4	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2116	3694	0.008662696	0.015701137	0	L2-3	EN-L2-3-MS	NA	NA	NA
AAGCCGCTCGTTACAG-1_25G_P3C1	2.378545201	-26.56446552	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3673	10017	0.004492363	0.005490666	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AAGGAGCAGGCGATAC-1_25G_P3C1	-4.973241585	-23.20070113	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3494	9592	0	0.003127606	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AAGGAGCGTGTGTGCC-1_25G_P3C1	-38.34817376	-8.453633669	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1029	1785	0	0.001680672	0	9	OPC	NA	NA	NA
AAGGAGCTCAAGATCC-1_25G_P3C1	-4.461222497	-14.99169947	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2545	5342	0.001871958	0.005615874	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AAGGAGCTCGCAAGCC-1_25G_P3C1	-1.552381563	-27.50255704	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4338	13867	0.00216341	0.005480637	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AAGGAGCTCGGCCGAT-1_25G_P3C1	-30.23481369	12.88423457	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	797	1215	0.005761317	0.007407407	0	8	Astrocytes	NA	NA	NA
AAGGAGCTCTGATACG-1_25G_P3C1	-24.81310085	26.32756933	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1565	3026	0.003304693	0.0042961	0	8	Astrocytes	NA	NA	NA
AAGGCAGAGGACGAAA-1_25G_P3C1	5.887875105	-32.14722425	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4994	16006	0.001062102	0.002561539	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AAGGCAGCAGTCAGCC-1_25G_P3C1	-29.48563005	12.42715592	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	695	1116	0	0.003584229	0	8	Astrocytes	NA	NA	NA
AAGGCAGCATTTGCCC-1_25G_P3C1	-0.021909209	-8.175692891	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1490	2803	0	0.007135212	0	12	EN-MIX	NA	NA	NA
AAGGTTCAGATAGGAG-1_25G_P3C1	1.520989831	-6.095052709	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1190	1811	0.004417449	0.006626173	0	12	EN-MIX	NA	NA	NA
AAGGTTCAGGAGTTGC-1_25G_P3C1	23.56466754	1.207240859	2	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1905	3673	0.006261911	0.004356112	0	2	EN-L4	NA	NA	NA
AAGGTTCAGGGCTTGA-1_25G_P3C1	-2.416772091	-16.03807984	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2316	4841	0.00371824	0.001652551	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AAGGTTCAGTGCGTGA-1_25G_P3C1	-1.602660812	-29.07553395	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3038	7721	0.003885507	0.002719855	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AAGGTTCCAGACGCTC-1_25G_P3C1	-27.52244722	25.40638462	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1360	2470	0.002834008	0.002024291	0	8	Astrocytes	NA	NA	NA
AAGGTTCGTAGGAGTC-1_25G_P3C1	-13.68065118	-24.26261214	6A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1299	2157	0.001854427	0.003708855	0	6A	IN-PV	NA	NA	NA
AAGGTTCGTTCCATGA-1_25G_P3C1	-17.83413249	-27.07798415	6A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2597	6540	0.003669725	0.002599388	0	6A	IN-PV	NA	NA	NA
AAGGTTCTCATATCGG-1_25G_P3C1	-17.71853501	-26.52289264	6A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2373	5015	0.009571286	0.002592223	0	6A	IN-PV	NA	NA	NA
AAGGTTCTCCAATGGT-1_25G_P3C1	-2.949797223	-25.85169986	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4158	12706	0.000629624	0.003620337	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AAGGTTCTCCAGAGGA-1_25G_P3C1	10.52855941	29.28506136	1	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	734	1129	0.005314438	0.003542958	0	oligos	OL-Cntl	NA	NA	NA
AAGTCTGAGAGACTTA-1_25G_P3C1	-4.319474238	-15.802651	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2583	6011	0.003160872	0.005656297	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AATCCAGAGAGGACGG-1_25G_P3C1	-4.078966787	-5.14629537	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1094	1822	0.00219539	0.001646542	0	13A	IN-VIP	NA	NA	NA
AATCCAGAGCCATCGC-1_25G_P3C1	-4.038093401	-14.421444	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2387	5068	0.004340963	0.007498027	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AATCCAGAGCGCCTCA-1_25G_P3C1	-2.820367678	-13.99063266	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2125	4468	0.004476276	0.005819158	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AATCCAGAGGGATCTG-1_25G_P3C1	2.269514271	-26.64904652	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2878	6867	0.004514344	0.006116208	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AATCCAGCACCATCCT-1_25G_P3C1	-39.26628866	-1.862013664	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1332	2471	0.006475111	0.001214083	0	9	OPC	NA	NA	NA
AATCCAGGTAAATGTG-1_25G_P3C1	-28.03566847	18.06203096	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1078	1876	0.004797441	0.004264392	0	8	Astrocytes	NA	NA	NA
AATCCAGGTCTCTCTG-1_25G_P3C1	-4.377228984	-9.568665584	13B	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	694	1096	0.010036496	0.000912409	0	13B	IN-SV2C	NA	NA	NA
AATCCAGTCGCGTAGC-1_25G_P3C1	-6.310509207	-0.535153506	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1733	3156	0.00095057	0.002534854	0	13A	IN-VIP	NA	NA	NA
AATCGGTAGATCGATA-1_25G_P3C1	-0.805168286	-29.4581527	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3572	10151	9.85E-05	0.005319673	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AATCGGTAGCGCTCCA-1_25G_P3C1	26.78705175	0.572528511	2	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2622	5972	0.000334896	0.002176825	0	2	EN-L4	NA	NA	NA
AATCGGTAGCTCCTTC-1_25G_P3C1	-2.912876381	-13.51434609	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2173	4524	0.00331565	0.005083996	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AATCGGTAGTGTACGG-1_25G_P3C1	5.778355551	-32.11149484	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	5376	19774	0.004197431	0.003034287	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AATCGGTCAGTCACTA-1_25G_P3C1	-3.890688114	-20.93041158	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3641	9221	0.005422405	0.007049127	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AATCGGTGTATCACCA-1_25G_P3C1	-4.267837996	-23.90998199	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3977	12029	0.000914457	0.004156621	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AATCGGTGTTGGACCC-1_25G_P3C1	-17.54276786	-23.98201499	6A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2217	5014	0.007179896	0.001994416	0	6A	IN-PV	NA	NA	NA
ACACCAACACAGGAGT-1_25G_P3C1	-19.37472202	-27.73774293	6A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3629	10743	0.002047845	0.003071768	0	6A	IN-PV	NA	NA	NA
ACACCAACAGCTGGCT-1_25G_P3C1	-6.901067779	0.702732368	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2154	4681	0.003631703	0.004058962	0	13A	IN-VIP	NA	NA	NA
ACACCAAGTGGGTATG-1_25G_P3C1	-4.129529694	-13.77230887	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2356	4728	0.001692047	0.010786802	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACACCCTAGAGGGATA-1_25G_P3C1	6.157007995	30.89847411	1	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	732	1026	0.001949318	0.005847953	0	oligos	OL-Cntl	NA	NA	NA
ACACCCTAGGCATGGT-1_25G_P3C1	-4.356447678	-16.21286038	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2507	5459	0.011723759	0.005861879	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACACCCTCACAGGAGT-1_25G_P3C1	-39.06123762	-1.310849141	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1439	2694	0.002227171	0.005196733	0	9	OPC	NA	NA	NA
ACACCCTGTTTGTTGG-1_25G_P3C1	0.094530853	-8.104047435	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1436	2545	0.008644401	0.0043222	0	12	EN-MIX	NA	NA	NA
ACACCCTTCAACGGCC-1_25G_P3C1	-39.73445656	0.436809285	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1616	3304	0.001210654	0.000605327	0	9	OPC	NA	NA	NA
ACACCCTTCAGTGTTG-1_25G_P3C1	-4.044362523	-25.33056133	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3448	8732	0.001259734	0.007100321	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACACCCTTCGCGGATC-1_25G_P3C1	-7.641026545	-16.24164437	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	845	1154	0.006065858	0.003466205	0	13A	IN-VIP	NA	NA	NA
ACACCCTTCTGTTTGT-1_25G_P3C1	0.101526668	-7.808140369	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1430	2604	0.003456221	0.003072197	0	12	EN-MIX	NA	NA	NA
ACACCGGAGCCTTGAT-1_25G_P3C1	-16.43189134	-10.81101342	13B	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2975	6762	0.004140787	0.004436557	0	13B	IN-SV2C	NA	NA	NA
ACACCGGCAAGACACG-1_25G_P3C1	-10.26090201	-0.065737344	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2403	4846	0.009905076	0.00536525	0	13A	IN-VIP	NA	NA	NA
ACACCGGCAAGCGCTC-1_25G_P3C1	-27.8396119	18.64934619	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1204	2110	0.009478673	0.008056872	0	8	Astrocytes	NA	NA	NA
ACACCGGCAGGACGTA-1_25G_P3C1	-16.20016804	-19.1881538	6B	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1898	3602	0.016102165	0.008051083	0	6B	IN-SST	NA	NA	NA
ACACCGGTCCTATTCA-1_25G_P3C1	-3.368342778	-26.41862522	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3498	11217	0.000445752	0.004724971	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACACCGGTCGCCGTGA-1_25G_P3C1	-22.97765338	31.3382637	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2091	4330	0.001154734	0.003464203	0	8	Astrocytes	NA	NA	NA
ACACCGGTCTCCCTGA-1_25G_P3C1	-9.355354105	-18.78587975	6B	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	734	1225	0.001632653	0.000816327	0	6B	IN-SST	NA	NA	NA
ACACTGAGTTAAAGAC-1_25G_P3C1	-27.35666405	25.32355454	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1278	2200	0.005909091	0.001818182	0	8	Astrocytes	NA	NA	NA
ACACTGATCTGGAGCC-1_25G_P3C1	-38.04696309	-5.739618489	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1143	1960	0.003571429	0.001530612	0	9	OPC	NA	NA	NA
ACAGCCGCACCCATGG-1_25G_P3C1	-0.672454639	-29.42936185	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4178	11944	0.001004689	0.002176825	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACAGCCGCACCTTGTC-1_25G_P3C1	-7.902891849	-0.433772406	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2351	5778	0.002076843	0.002249913	0	13A	IN-VIP	NA	NA	NA
ACAGCCGTCAACACAC-1_25G_P3C1	26.81938118	4.669491892	15BA	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	821	1016	0.029527559	0.020669291	0	15BA	Stromal cells	NA	NA	NA
ACAGCTACACAGCCCA-1_25G_P3C1	-39.57622705	-0.465951	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1463	2750	0.002181818	0.002181818	0	9	OPC	NA	NA	NA
ACAGCTAGTCTACCTC-1_25G_P3C1	-27.44931019	17.80652329	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1028	1684	0.000593824	0.005344418	0	8	Astrocytes	NA	NA	NA
ACAGCTATCCTAAGTG-1_25G_P3C1	-28.46726307	12.95789922	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	797	1179	0.010178117	0.006785411	0	8	Astrocytes	NA	NA	NA
ACATACGAGCCCAATT-1_25G_P3C1	0.108494916	-30.03578847	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	5944	22372	0.002056142	0.004291078	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACATACGAGCTACCTA-1_25G_P3C1	-11.71694332	-11.22343037	6B	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1168	2027	0.008386778	0.002960039	0	6B	IN-SST	NA	NA	NA
ACATACGAGTACGATA-1_25G_P3C1	32.86334113	-2.015398055	2	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3062	6883	0.004213279	0.005666134	0	2	EN-L4	NA	NA	NA
ACATACGCAGCTGCAC-1_25G_P3C1	-9.62388469	2.018633792	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3013	7326	0.003003003	0.003549004	0	13A	IN-VIP	NA	NA	NA
ACATACGCAGGAATCG-1_25G_P3C1	-29.22504294	22.37866836	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1137	2026	0.004442251	0.001974334	0	8	Astrocytes	NA	NA	NA
ACATACGTCGTGACAT-1_25G_P3C1	2.922126485	-28.90066502	3	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3351	9021	0.001441082	0.003658131	0	3	EN-L5-6	NA	NA	NA
ACATCAGCACAGAGGT-1_25G_P3C1	15.80190192	-7.592013224	3	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2585	6201	0.000967586	0.007901951	0	3	EN-L5-6	NA	NA	NA
ACATCAGCAGGTGGAT-1_25G_P3C1	-19.28172312	-28.41161949	6A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3355	9086	0.000880475	0.002311248	0	6A	IN-PV	NA	NA	NA
ACATCAGCATAGACTC-1_25G_P3C1	-17.55435512	-23.96931375	6A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2282	5670	0.007760141	0.001763668	0	6A	IN-PV	NA	NA	NA
ACATCAGCATTTCACT-1_25G_P3C1	-0.554799774	-9.445575807	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1710	3515	0.017638691	0.003698435	0	12	EN-MIX	NA	NA	NA
ACATCAGTCAGATAAG-1_25G_P3C1	-12.43627355	-19.79564833	6B	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1096	1962	0.001529052	0.004587156	0	6B	IN-SST	NA	NA	NA
ACATCAGTCATGCTCC-1_25G_P3C1	-37.31004728	-3.212808435	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1367	2342	0.002561913	0.001707942	0	9	OPC	NA	NA	NA
ACATCAGTCATGTAGC-1_25G_P3C1	5.901815342	-31.77109231	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3538	9755	0.001640185	0.004305484	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACATGGTAGATGTTAG-1_25G_P3C1	11.52121948	25.55426458	1	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	756	1115	0	0.002690583	0	oligos	OL-Cntl	NA	NA	NA
ACATGGTAGTTTCCTT-1_25G_P3C1	-38.2105805	-8.010701675	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1036	1825	0	0.003835616	0	9	OPC	NA	NA	NA
ACATGGTCAGGTCGTC-1_25G_P3C1	31.37292655	-1.281564014	2	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3066	7264	0.01032489	0.007709251	0	2	EN-L4	NA	NA	NA
ACATGGTTCCCTCAGT-1_25G_P3C1	28.48585554	0.727330605	2	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3256	8350	0.00251497	0.003712575	0	2	EN-L4	NA	NA	NA
ACATGGTTCGGATGTT-1_25G_P3C1	-5.676792267	-1.026354512	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1921	4142	0.005070014	0.002414293	0	13A	IN-VIP	NA	NA	NA
ACCAGTAAGCGATCCC-1_25G_P3C1	-27.15264516	19.42321906	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1233	2121	0.000471476	0.004714757	0	8	Astrocytes	NA	NA	NA
ACCAGTAAGGACTGGT-1_25G_P3C1	-3.672266463	-7.705766752	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	719	1026	0.006822612	0.006822612	0	13A	IN-VIP	NA	NA	NA
ACCAGTACACGGTTTA-1_25G_P3C1	-39.49434432	-1.54279527	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1343	2662	0.001126972	0.001878287	0	9	OPC	NA	NA	NA
ACCAGTACATCAGTCA-1_25G_P3C1	11.57760548	13.26034618	1	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1259	2055	0.006812652	0.006812652	0	oligos	OL-Cntl	NA	NA	NA
ACCAGTACATGTCCTC-1_25G_P3C1	-3.088074347	-21.955991	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3660	9538	0.006500315	0.004298595	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACCAGTAGTACCGAGA-1_25G_P3C1	27.07428778	-4.041594087	2	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3685	10336	0.002031734	0.004160217	0	2	EN-L4	NA	NA	NA
ACCAGTAGTCTTGCGG-1_25G_P3C1	-0.280944665	-8.48553192	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1648	3111	0.00257152	0.009000321	0	12	EN-MIX	NA	NA	NA
ACCAGTATCCGCAGTG-1_25G_P3C1	-5.430289618	-10.13958489	13B	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1082	1639	0.010372178	0.001830384	0	13B	IN-SV2C	NA	NA	NA
ACCAGTATCGCGCCAA-1_25G_P3C1	-3.490830549	-22.11665969	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4407	14840	0.003908356	0.005390836	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACCAGTATCTGATACG-1_25G_P3C1	-1.781491339	-21.62448037	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3285	7924	0.003785967	0.004038364	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACCCACTAGTCTCAAC-1_25G_P3C1	23.42710527	-9.09039936	3	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3446	9333	0.000535733	0.003214401	0	3	EN-L5-6	NA	NA	NA
ACCCACTAGTTGAGTA-1_25G_P3C1	-13.6983273	-10.8824383	13B	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1964	3908	0.002302968	0.002558854	0	13B	IN-SV2C	NA	NA	NA
ACCCACTCAGCAGTTT-1_25G_P3C1	-26.6683753	27.44678473	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1487	2808	0.000356125	0.00462963	0	8	Astrocytes	NA	NA	NA
ACCCACTGTGCGATAG-1_25G_P3C1	-4.146235594	-4.57137767	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1248	1929	0.005702436	0.004147227	0	13A	IN-VIP	NA	NA	NA
ACCCACTGTTCGTTGA-1_25G_P3C1	-27.92861223	24.71386513	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1351	2394	0.009189641	0.006683375	0	8	Astrocytes	NA	NA	NA
ACCCACTTCACAACGT-1_25G_P3C1	-4.35016041	-21.81227625	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3621	10260	0.001267057	0.004093567	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACCCACTTCATAGCAC-1_25G_P3C1	-13.10130623	-19.7066571	6B	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1254	2275	0.003956044	0.004395604	0	6B	IN-SST	NA	NA	NA
ACCCACTTCTACCTGC-1_25G_P3C1	20.12739424	-0.411324704	2	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1368	2073	0.008200675	0.00723589	0	2	EN-L4	NA	NA	NA
ACCCACTTCTTTCCTC-1_25G_P3C1	-9.612866147	3.08847047	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3636	9826	0.006004478	0.002238958	0	13A	IN-VIP	NA	NA	NA
ACCGTAAAGAGACTAT-1_25G_P3C1	18.99016959	25.12424289	1	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	885	1314	0.00456621	0.003805175	0	oligos	OL-Cntl	NA	NA	NA
ACCGTAAAGTTAGGTA-1_25G_P3C1	-25.67595142	27.66206743	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1795	3537	0.001413627	0.006502686	0	8	Astrocytes	NA	NA	NA
ACCGTAACAGGCAGTA-1_25G_P3C1	-38.93989869	-1.577860546	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1353	2330	0.000429185	0.001287554	0	9	OPC	NA	NA	NA
ACCGTAAGTTCGGCAC-1_25G_P3C1	-2.465556141	-14.82537921	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2253	5182	0.00135083	0.004245465	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACCTTTAAGATATACG-1_25G_P3C1	-28.97975336	17.20845203	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	975	1721	0	0.00464846	0	8	Astrocytes	NA	NA	NA
ACCTTTAAGGCTCTTA-1_25G_P3C1	-27.81161367	18.88647019	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1209	2314	0	0.003025065	0	8	Astrocytes	NA	NA	NA
ACCTTTACAAATACAG-1_25G_P3C1	-5.696435506	-4.97333036	13B	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1312	2388	0.013400335	0.003350084	0	13B	IN-SV2C	NA	NA	NA
ACCTTTAGTGTAAGTA-1_25G_P3C1	-2.25866437	-14.19480353	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1993	4107	0.002921841	0.003165327	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACCTTTATCAGTTGAC-1_25G_P3C1	-6.618972346	-2.069022668	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1640	3002	0.004663558	0.005996003	0	13A	IN-VIP	NA	NA	NA
ACCTTTATCCATGAGT-1_25G_P3C1	-27.9557577	24.41620718	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1272	2314	0.004321521	0.003025065	0	8	Astrocytes	NA	NA	NA
ACGAGCCAGATCCTGT-1_25G_P3C1	-27.22518172	19.43457056	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1294	2196	0.001821494	0.005464481	0	8	Astrocytes	NA	NA	NA
ACGAGCCCAACCGCCA-1_25G_P3C1	-5.322237817	-21.78374297	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3198	7956	0.001759678	0.003393665	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACGAGCCCATACCATG-1_25G_P3C1	18.93882861	23.89784676	1	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1009	1630	0.000613497	0.003067485	0	oligos	OL-Cntl	NA	NA	NA
ACGAGCCTCCCAAGTA-1_25G_P3C1	-4.577935038	-18.43436074	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2892	6701	0.002686166	0.006715416	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACGAGGACACATGTGT-1_25G_P3C1	-4.380832662	-16.52011149	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2480	5325	0.006197183	0.006384977	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACGAGGACATCCCATC-1_25G_P3C1	39.44172851	9.655290148	14	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	719	1072	0.003731343	0.002798507	0	14	Microglia	NA	NA	NA
ACGAGGAGTAATCACC-1_25G_P3C1	3.484192906	-17.66514567	4	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2947	6611	0.008319468	0.008016941	0	L2-3	EN-L2-3-MS	NA	NA	NA
ACGAGGAGTTAAGGGC-1_25G_P3C1	-3.933265225	-16.45538185	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2512	5404	0.003145818	0.00388601	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACGAGGAGTTGCGCAC-1_25G_P3C1	-4.380571933	-16.26466944	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2462	4930	0.004665314	0.007099391	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACGAGGATCACAACGT-1_25G_P3C1	13.08428152	31.07671798	1	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	877	1313	0.003046458	0.003046458	0	oligos	OL-Cntl	NA	NA	NA
ACGAGGATCTCGAGTA-1_25G_P3C1	-28.09691982	24.10206397	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1210	2069	0.001933301	0.001933301	0	8	Astrocytes	NA	NA	NA
ACGAGGATCTTGCAAG-1_25G_P3C1	-4.436170121	-16.6578614	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2607	5881	0.010032307	0.006461486	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACGATACCACGGCGTT-1_25G_P3C1	-6.892234471	0.517117114	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2078	4030	0.005210918	0.003970223	0	13A	IN-VIP	NA	NA	NA
ACGATACGTCAACTGT-1_25G_P3C1	-3.798642808	-20.95418577	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3093	7654	0.002743663	0.003788869	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACGATACTCTAACCGA-1_25G_P3C1	-5.690924256	-23.17772706	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3223	8620	0.001740139	0.002320186	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACGATACTCTGCTGTC-1_25G_P3C1	-4.840105167	-1.974574044	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1458	2625	0.002666667	0.003047619	0	13A	IN-VIP	NA	NA	NA
ACGATGTAGAGTACAT-1_25G_P3C1	-2.105271291	-12.04060513	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2020	4013	0.005980563	0.005482183	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACGATGTAGCGTGAAC-1_25G_P3C1	5.394489521	-27.15803094	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4341	11503	0.005042163	0.006520038	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACGATGTCAGCCACCA-1_25G_P3C1	-37.38071593	-4.766097403	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1183	1967	0.002541942	0.002541942	0	9	OPC	NA	NA	NA
ACGATGTCATCCTTGC-1_25G_P3C1	-27.7217254	24.42311545	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1235	2116	0.003780718	0.007561437	0	8	Astrocytes	NA	NA	NA
ACGCAGCCAAGTTAAG-1_25G_P3C1	-26.83695164	10.25767143	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	800	1243	0.003218021	0.003218021	0	8	Astrocytes	NA	NA	NA
ACGCAGCCACGTGAGA-1_25G_P3C1	29.12327247	0.241385016	2	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3211	7442	0.000671862	0.006046762	0	2	EN-L4	NA	NA	NA
ACGCAGCGTATCACCA-1_25G_P3C1	-2.014601383	-23.48668134	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4696	13588	0.00507801	0.006402708	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACGCAGCGTCAATACC-1_25G_P3C1	9.548252161	27.93818881	1	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	856	1287	0.002331002	0.003885004	0	oligos	OL-Cntl	NA	NA	NA
ACGCAGCGTCAGCTAT-1_25G_P3C1	-3.315085907	-13.03472188	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2320	4629	0.007993087	0.005832793	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACGCAGCGTTATGCGT-1_25G_P3C1	11.06252475	29.81143121	1	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	693	1018	0	0.002946955	0	oligos	OL-Cntl	NA	NA	NA
ACGCCAGAGTCTCAAC-1_25G_P3C1	-26.72116622	19.37911879	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1341	2300	0.005652174	0.006956522	0	8	Astrocytes	NA	NA	NA
ACGCCAGCAGGGTTAG-1_25G_P3C1	25.60111397	-4.716289818	2	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4324	12386	8.07E-05	0.002664298	0	2	EN-L4	NA	NA	NA
ACGCCAGGTAGGGTAC-1_25G_P3C1	-4.97167282	-22.97897874	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3708	10549	0.000853161	0.003791829	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACGCCAGTCAATACCG-1_25G_P3C1	-0.817749461	-26.19159151	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4580	14002	0.003285245	0.009498643	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACGCCAGTCCTAAGTG-1_25G_P3C1	40.04324769	11.04189433	14	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	888	1241	0.004029009	0.004834811	0	14	Microglia	NA	NA	NA
ACGCCAGTCTGAAAGA-1_25G_P3C1	8.955744334	27.39508986	1	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	782	1219	0.000820345	0.003281378	0	oligos	OL-Cntl	NA	NA	NA
ACGCCGAAGTACGACG-1_25G_P3C1	-3.826515577	-6.471010154	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	926	1441	0.0055517	0.0055517	0	13A	IN-VIP	NA	NA	NA
ACGCCGACAGGGTATG-1_25G_P3C1	29.12178269	0.424353635	2	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2980	7041	0.003408607	0.006817213	0	2	EN-L4	NA	NA	NA
ACGCCGAGTATCACCA-1_25G_P3C1	-4.22634286	-15.12821614	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2724	5760	0.001909722	0.007291667	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACGCCGAGTTCTGGTA-1_25G_P3C1	10.47414159	26.9757358	1	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	887	1286	0.000777605	0.005443235	0	oligos	OL-Cntl	NA	NA	NA
ACGCCGATCACTGGGC-1_25G_P3C1	-26.00435831	26.13729155	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1497	2734	0.00658376	0.008412582	0	8	Astrocytes	NA	NA	NA
ACGCCGATCTAAGCCA-1_25G_P3C1	-5.096870658	-5.625711055	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1052	1681	0.018441404	0.001784652	0	13A	IN-VIP	NA	NA	NA
ACGCCGATCTAGCACA-1_25G_P3C1	24.22862283	-6.363614196	2	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4295	11638	0.000171851	0.004038495	0	2	EN-L4	NA	NA	NA
ACGGAGAAGCGCTCCA-1_25G_P3C1	-4.546901022	-18.81333465	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3245	8076	0.001857355	0.008667657	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACGGAGACAGCCTATA-1_25G_P3C1	-9.807966012	3.269454817	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3375	8288	0.003740347	0.004946911	0	13A	IN-VIP	NA	NA	NA
ACGGAGACATGCGCAC-1_25G_P3C1	-14.94094191	-24.90893789	6A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1631	2996	0.011014686	0.004339119	0	6A	IN-PV	NA	NA	NA
ACGGAGAGTTGTACAC-1_25G_P3C1	-1.642527619	-29.11456905	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3268	7747	0.000258164	0.004388796	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACGGAGAGTTGTCGCG-1_25G_P3C1	-3.797731821	-5.051897847	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1112	1893	0.011093502	0.003169572	0	13A	IN-VIP	NA	NA	NA
ACGGAGATCACCGTAA-1_25G_P3C1	-8.90470595	2.88331317	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2856	6897	0.001014934	0.003479774	0	13A	IN-VIP	NA	NA	NA
ACGGCCAAGACACTAA-1_25G_P3C1	-26.62541388	27.2168046	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1534	2935	0.001022147	0.002725724	0	8	Astrocytes	NA	NA	NA
ACGGCCAAGCAATATG-1_25G_P3C1	1.756066726	-21.36654455	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4055	11096	0.00630858	0.004145638	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACGGCCACAAGACGTG-1_25G_P3C1	29.06505651	1.047981761	2	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2731	5600	0.005535714	0.005357143	0	2	EN-L4	NA	NA	NA
ACGGCCAGTAATCGTC-1_25G_P3C1	-37.76668112	-2.689061329	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1286	2239	0.003126396	0.003573024	0	9	OPC	NA	NA	NA
ACGGCCAGTAGGAGTC-1_25G_P3C1	-39.42450101	-1.577742873	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1245	2088	0.000478927	0.000957854	0	9	OPC	NA	NA	NA
ACGGCCAGTTCCCTTG-1_25G_P3C1	39.82393402	13.37941145	14	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1107	1587	0.003150599	0.009451796	0	14	Microglia	NA	NA	NA
ACGGCCATCATCGATG-1_25G_P3C1	-26.60258282	26.66313733	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1539	2932	0.001705321	0.004092769	0	8	Astrocytes	NA	NA	NA
ACGGCCATCCAGTATG-1_25G_P3C1	-7.396551619	-0.138356569	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1943	4053	0.007155194	0.003207501	0	13A	IN-VIP	NA	NA	NA
ACGGGCTAGAAGGCCT-1_25G_P3C1	7.214052665	-33.3032894	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	5223	17844	0.003866846	0.001849361	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACGGGCTCAGCCACCA-1_25G_P3C1	-2.541267919	-23.33593668	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4077	11488	0.003568942	0.005222841	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACGGGCTGTTGCCTCT-1_25G_P3C1	-13.03481013	-19.76862687	6B	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1349	2586	0.007347254	0.004253674	0	6B	IN-SST	NA	NA	NA
ACGGGCTTCACTCCTG-1_25G_P3C1	11.37241439	28.10249466	1	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	860	1275	0.003921569	0.002352941	0	oligos	OL-Cntl	NA	NA	NA
ACGGGCTTCATGCTCC-1_25G_P3C1	-8.905041481	2.864474252	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2837	6739	0.00163229	0.00103873	0	13A	IN-VIP	NA	NA	NA
ACGGGCTTCCTTGACC-1_25G_P3C1	-16.92969289	-23.43480655	6A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1984	4436	0.00541028	0.001127142	0	6A	IN-PV	NA	NA	NA
ACGGGTCCAAGTTGTC-1_25G_P3C1	-3.759225717	-21.57861528	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3539	9077	0.001872865	0.003635562	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACGGGTCGTATATCCG-1_25G_P3C1	-2.749496355	-14.29049037	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2258	4588	0.001089799	0.005013078	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACGGGTCTCAGATAAG-1_25G_P3C1	3.402804365	-5.433344703	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1056	1595	0.00815047	0.011912226	0	12	EN-MIX	NA	NA	NA
ACGTCAAAGCGCCTTG-1_25G_P3C1	-2.795341721	-12.63223374	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2074	3908	0.009467758	0.010747185	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACGTCAACAGGGCATA-1_25G_P3C1	-28.95198803	22.38700396	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1054	1835	0.003814714	0.004359673	0	8	Astrocytes	NA	NA	NA
ACGTCAAGTCACTGGC-1_25G_P3C1	0.052764686	-7.894038514	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1444	2564	0.001170047	0.005850234	0	12	EN-MIX	NA	NA	NA
ACGTCAAGTGATAAAC-1_25G_P3C1	30.527966	-0.877015629	2	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3288	7655	0.008229915	0.003135206	0	2	EN-L4	NA	NA	NA
ACTATCTGTCTGGTCG-1_25G_P3C1	-3.186151638	-5.946340025	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	976	1579	0.00569981	0.001266624	0	13A	IN-VIP	NA	NA	NA
ACTATCTTCCCGACTT-1_25G_P3C1	-9.130027682	2.560546262	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2559	6254	0.001758874	0.001598977	0	13A	IN-VIP	NA	NA	NA
ACTATCTTCGAGCCCA-1_25G_P3C1	-2.515189297	-16.98326676	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2852	7162	0.001256632	0.001954761	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACTGAACAGATCGGGT-1_25G_P3C1	-5.380516612	-22.98575036	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3428	9558	0.000418498	0.00355723	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACTGAACAGCCAGAAC-1_25G_P3C1	-12.70218	-10.94795327	13B	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1555	2926	0	0.002734108	0	13B	IN-SV2C	NA	NA	NA
ACTGAACAGTTGTAGA-1_25G_P3C1	-37.03335054	-9.169039964	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	982	1595	0.001880878	0.003134796	0	9	OPC	NA	NA	NA
ACTGAACCAAACGTGG-1_25G_P3C1	-5.423180145	-4.511220393	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1262	2467	0.00648561	0.001216052	0	13A	IN-VIP	NA	NA	NA
ACTGAACCACAACGCC-1_25G_P3C1	-28.48478848	17.36005703	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1025	1806	0.00055371	0.004983389	0	8	Astrocytes	NA	NA	NA
ACTGAACTCGGCTACG-1_25G_P3C1	11.57125753	31.25825077	1	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	690	1040	0.002884615	0.010576923	0	oligos	OL-Cntl	NA	NA	NA
ACTGAACTCTAACGGT-1_25G_P3C1	-4.360059161	-16.63860322	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2543	5599	0.00214324	0.002857653	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACTGAGTCAAGCGATG-1_25G_P3C1	-3.965060933	-25.1458445	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3688	9901	0.000605999	0.003635996	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACTGAGTCAGCCAATT-1_25G_P3C1	-29.67703584	13.63538222	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	842	1346	0	0.005943536	0	8	Astrocytes	NA	NA	NA
ACTGAGTCAGCTGTGC-1_25G_P3C1	21.93028181	-29.04220586	3	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2823	6497	0.001847006	0.002462675	0	3	EN-L5-6	NA	NA	NA
ACTGAGTGTGTCAATC-1_25G_P3C1	-29.27487802	22.77856671	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1122	1924	0.001559252	0.003638254	0	8	Astrocytes	NA	NA	NA
ACTGATGCACATGTGT-1_25G_P3C1	4.963647253	-27.84742421	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2963	7283	0.000823836	0.003295345	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACTGATGGTTAGATGA-1_25G_P3C1	-3.867723892	-25.03947324	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3463	8734	0.001946416	0.004121823	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACTGATGGTTCGTCTC-1_25G_P3C1	-37.4813552	-9.368875186	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1001	1627	0.000614628	0.004302397	0	9	OPC	NA	NA	NA
ACTGATGGTTGCGTTA-1_25G_P3C1	-4.035432257	-16.09340488	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2385	5239	0.005726284	0.00591716	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACTGATGTCGAACTGT-1_25G_P3C1	26.60351223	-0.397160478	2	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2885	6963	0.003015941	0.004452104	0	2	EN-L4	NA	NA	NA
ACTGATGTCGGTCTAA-1_25G_P3C1	-0.084487634	-8.229099161	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1428	2246	0.000890472	0.005788068	0	12	EN-MIX	NA	NA	NA
ACTGCTCCACCAGGCT-1_25G_P3C1	-39.24012529	-2.46610743	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1241	2183	0	0.001832341	0	9	OPC	NA	NA	NA
ACTGCTCCACCTGGTG-1_25G_P3C1	-4.537833559	-23.10849747	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4005	12108	0.00016518	0.005037991	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACTGCTCGTACATGTC-1_25G_P3C1	-26.41812315	28.01041213	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1669	3421	0.001169249	0.002046185	0	8	Astrocytes	NA	NA	NA
ACTGCTCGTTGTCTTT-1_25G_P3C1	18.77251885	22.83766557	1	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	868	1405	0.001423488	0.000711744	0	oligos	OL-Cntl	NA	NA	NA
ACTGCTCTCTGCTGCT-1_25G_P3C1	-4.668830393	-16.47641344	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2732	6436	0.006681168	0.007924177	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACTGTCCCAGCCTGTG-1_25G_P3C1	-18.93428267	-28.15041936	6A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3085	8016	0.000249501	0.003493014	0	6A	IN-PV	NA	NA	NA
ACTGTCCTCACAGGCC-1_25G_P3C1	-3.941474258	-21.4804523	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3801	10856	0.002947679	0.003592483	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACTTACTCAAGCCGTC-1_25G_P3C1	-2.299030043	-14.89681028	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2226	5231	0.001147008	0.003632193	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACTTACTCATTACGAC-1_25G_P3C1	26.63234097	4.319321484	15BA	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	791	1189	0.008410429	0.011774601	0	15BA	Stromal cells	NA	NA	NA
ACTTACTCATTCCTGC-1_25G_P3C1	-3.915242373	-15.54321283	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2525	6072	0.00428195	0.003129117	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACTTACTTCATGTAGC-1_25G_P3C1	-38.38066307	-7.528488862	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1015	1685	0	0.001186944	0	9	OPC	NA	NA	NA
ACTTACTTCCTCATTA-1_25G_P3C1	-5.475688767	-20.18429297	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2635	6358	0.003460208	0.002831079	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACTTGTTAGTACGCCC-1_25G_P3C1	-4.877034894	-20.5619627	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2949	7146	0.006017352	0.002938707	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACTTGTTGTCATCCCT-1_25G_P3C1	-5.502459017	-22.63088441	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2970	7759	0.002835417	0.003093182	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACTTGTTGTCTAAAGA-1_25G_P3C1	-4.969202642	-20.8464715	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3131	7791	0.000641766	0.003722244	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACTTGTTTCAAAGTAG-1_25G_P3C1	-6.923916214	0.666314293	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1988	3886	0.011837365	0.003602676	0	13A	IN-VIP	NA	NA	NA
ACTTGTTTCACCGTAA-1_25G_P3C1	26.94293884	0.480092669	2	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2844	7041	0.002556455	0.002556455	0	2	EN-L4	NA	NA	NA
ACTTTCAAGAAGGTTT-1_25G_P3C1	-11.96985585	-10.54359215	13B	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1348	2408	0.002491694	0.002906977	0	13B	IN-SV2C	NA	NA	NA
ACTTTCAAGAGTTGGC-1_25G_P3C1	-2.425805421	-14.56789796	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2439	5586	0.000895095	0.00877193	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACTTTCAAGATGCCAG-1_25G_P3C1	-4.130858763	-4.83126643	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1140	1861	0.009672219	0.003224073	0	13A	IN-VIP	NA	NA	NA
ACTTTCAAGCGATAGC-1_25G_P3C1	-28.56257174	22.87178	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1083	1700	0.000588235	0.001764706	0	8	Astrocytes	NA	NA	NA
ACTTTCAAGCGCTTAT-1_25G_P3C1	-3.796704579	-24.70340084	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3884	12099	0.004463179	0.003636664	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACTTTCACAGCGTCCA-1_25G_P3C1	-37.38741588	-9.666395929	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	926	1603	0.00062383	0.002495321	0	9	OPC	NA	NA	NA
ACTTTCAGTAGCGTAG-1_25G_P3C1	-15.43386428	-25.84604463	6A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1902	3932	0.012716175	0.003051882	0	6A	IN-PV	NA	NA	NA
ACTTTCAGTCTAAAGA-1_25G_P3C1	-5.552475989	-22.57527571	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2895	7435	0.000806994	0.004169469	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACTTTCAGTGTAACGG-1_25G_P3C1	-0.798174534	-10.41839692	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1712	3315	0.002714932	0.005731523	0	12	EN-MIX	NA	NA	NA
ACTTTCATCGAGGTAG-1_25G_P3C1	-5.866005828	-22.31740643	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2942	7473	0.002141041	0.003345377	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AGAATAGCACCTCGTT-1_25G_P3C1	-3.280278715	-25.62075539	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3706	10124	0.001086527	0.004148558	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AGAATAGGTCTAGCCG-1_25G_P3C1	-30.53710888	20.48791984	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	899	1496	0.001336898	0.002005348	0	8	Astrocytes	NA	NA	NA
AGAATAGTCCAATGGT-1_25G_P3C1	-1.959406382	-28.68584898	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3444	9570	0.000208986	0.002194357	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AGACGTTAGTGTACCT-1_25G_P3C1	1.180630607	-6.376313785	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1129	1873	0.006406834	0.006406834	0	12	EN-MIX	NA	NA	NA
AGACGTTCAATGGAGC-1_25G_P3C1	-4.255877746	-18.30754097	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3053	6940	0.002305476	0.006051873	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AGACGTTGTTATGCGT-1_25G_P3C1	-28.51511055	16.41156285	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	918	1382	0.002894356	0.004341534	0	8	Astrocytes	NA	NA	NA
AGAGCGAAGCTGGAAC-1_25G_P3C1	-4.158075636	-24.16475775	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4014	11766	0.002294748	0.004419514	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AGAGCGATCAATAAGG-1_25G_P3C1	-2.574308934	-12.98765209	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2265	4738	0.003799071	0.003799071	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AGAGCGATCCTATTCA-1_25G_P3C1	-17.77556556	-24.29099712	6A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2717	7170	0.00292887	0.00251046	0	6A	IN-PV	NA	NA	NA
AGAGCTTAGTGCCAGA-1_25G_P3C1	19.98155616	1.523510454	2	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1636	2976	0.002352151	0.004032258	0	2	EN-L4	NA	NA	NA
AGAGTGGAGCTAACTC-1_25G_P3C1	-11.967191	-10.98423846	13B	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1228	2033	0.005410723	0.00245942	0	13B	IN-SV2C	NA	NA	NA
AGAGTGGGTATAGGGC-1_25G_P3C1	11.32242855	28.78388255	1	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	767	1179	0.000848176	0.001696353	0	oligos	OL-Cntl	NA	NA	NA
AGATCTGAGTACATGA-1_25G_P3C1	-15.752298	-18.79276421	6B	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1743	3608	0.031873614	0.002494457	0	6B	IN-SST	NA	NA	NA
AGATCTGCACGGTTTA-1_25G_P3C1	-3.951870751	-22.85815771	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4310	14834	0.004314413	0.004584064	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AGATCTGCATGGGACA-1_25G_P3C1	25.82546994	1.080706609	2	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2465	5037	0.010522136	0.002977963	0	2	EN-L4	NA	NA	NA
AGATCTGGTACGACCC-1_25G_P3C1	31.34206082	-6.338395893	2	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3446	8369	0.00932011	0.005615964	0	2	EN-L4	NA	NA	NA
AGATCTGGTATCGCAT-1_25G_P3C1	-2.334146884	-14.43868446	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2192	4821	0.000414852	0.00497822	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AGATCTGTCCTCGCAT-1_25G_P3C1	18.29792914	1.226743005	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1079	1750	0.008	0.002857143	0	12	EN-MIX	NA	NA	NA
AGATCTGTCCTTGACC-1_25G_P3C1	-39.45563273	-1.196618889	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1329	2576	0.001164596	0.004270186	0	9	OPC	NA	NA	NA
AGATTGCCAGCTGTGC-1_25G_P3C1	-5.348068944	-21.27727891	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2825	7333	0.000818219	0.005318424	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AGATTGCCAGCTTCGG-1_25G_P3C1	-0.254096193	-8.333308432	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1559	2618	0.000763942	0.007639419	0	12	EN-MIX	NA	NA	NA
AGATTGCGTGGTAACG-1_25G_P3C1	-4.040777469	-22.74487133	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3797	11171	0.001969385	0.005281533	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AGATTGCTCCCTTGTG-1_25G_P3C1	-13.20996521	-19.77009668	6B	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1297	2358	0.011450382	0.002968617	0	6B	IN-SST	NA	NA	NA
AGATTGCTCCTCAATT-1_25G_P3C1	-3.242604239	-24.24129289	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4540	15032	0.003858435	0.00405801	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AGATTGCTCCTCCTAG-1_25G_P3C1	12.51390287	-33.03649644	2	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2803	7393	0.000135263	0.002028946	0	2	EN-L4	NA	NA	NA
AGATTGCTCGTAGGAG-1_25G_P3C1	-12.34159966	-10.72401564	13B	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1504	2552	0.014890282	0.001959248	0	13B	IN-SV2C	NA	NA	NA
AGCAGCCAGACTAGAT-1_25G_P3C1	-1.227379806	-27.58116137	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4762	14781	0.001082471	0.003653339	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AGCAGCCCAATGGAGC-1_25G_P3C1	-4.660084262	-19.23942187	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2910	6802	0.001911203	0.006027639	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AGCAGCCCATGTAAGA-1_25G_P3C1	-0.473998128	-27.87517579	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4991	15056	0.001062699	0.003453773	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AGCAGCCGTTAGATGA-1_25G_P3C1	-4.458208637	-17.10313874	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2752	6058	0.000990426	0.005447342	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AGCAGCCGTTTAGCTG-1_25G_P3C1	-0.860127918	-25.81165301	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3958	10248	0.00087822	0.005171741	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AGCAGCCTCCATGAAC-1_25G_P3C1	-27.29432365	25.20756915	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1258	2261	0.002211411	0.002653693	0	8	Astrocytes	NA	NA	NA
AGCATACCACGTCTCT-1_25G_P3C1	-2.07162282	-25.56365267	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	5252	18727	0.001281572	0.002883537	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AGCATACCAGGACGTA-1_25G_P3C1	-2.407740278	-24.64919206	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4437	14165	0.001906107	0.002470879	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AGCATACTCTAGAGTC-1_25G_P3C1	-38.28417579	-2.954274673	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1349	2394	0.001670844	0.002088555	0	9	OPC	NA	NA	NA
AGCCTAAAGCCAGTAG-1_25G_P3C1	28.74072432	0.703081536	2	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2698	5895	0.001187447	0.0057676	0	2	EN-L4	NA	NA	NA
AGCCTAACACAAGTAA-1_25G_P3C1	-2.59170344	-14.58035436	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2413	4847	0.002475758	0.00515783	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AGCCTAACACTTCGAA-1_25G_P3C1	-0.784125927	-29.06965393	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	5974	23844	0.001006543	0.006626405	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AGCCTAACAGTCGTGC-1_25G_P3C1	-0.712554527	-26.45809158	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	5282	16516	0.00387503	0.00478324	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AGCCTAATCCCGGATG-1_25G_P3C1	-5.078473186	-22.12423866	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3353	9044	0.003317116	0.006634233	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AGCGGTCAGAAGGACA-1_25G_P3C1	22.273465	-0.873046916	2	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1888	3342	0.007480551	0.008078995	0	2	EN-L4	NA	NA	NA
AGCGGTCAGGCAGGTT-1_25G_P3C1	-14.14526362	-10.49377478	13B	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2250	4580	0.005676856	0.002183406	0	13B	IN-SV2C	NA	NA	NA
AGCGGTCCACATGTGT-1_25G_P3C1	29.43427169	-0.436378524	2	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4021	10742	0.004561534	0.006051015	0	2	EN-L4	NA	NA	NA
AGCGGTCCAGCCAGAA-1_25G_P3C1	28.71174775	-4.039417377	2	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3854	10023	0.003292427	0.009278659	0	2	EN-L4	NA	NA	NA
AGCGGTCGTATTACCG-1_25G_P3C1	-16.21833514	-19.15154723	6B	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1961	3935	0.006099111	0.00660737	0	6B	IN-SST	NA	NA	NA
AGCGGTCGTGTCGCTG-1_25G_P3C1	-31.65461275	13.53107682	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	795	1410	0	0.002836879	0	8	Astrocytes	NA	NA	NA
AGCGGTCGTTACGTCA-1_25G_P3C1	-0.569480082	-26.46953878	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4216	10708	0.003735525	0.003642137	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AGCGGTCTCCGCGTTT-1_25G_P3C1	-5.096845138	-22.28942503	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3554	10605	9.43E-05	0.003866101	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AGCGGTCTCTTCGAGA-1_25G_P3C1	-25.23812655	25.65539368	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1482	2702	0.004441155	0.005551443	0	8	Astrocytes	NA	NA	NA
AGCGTATCACAAGCCC-1_25G_P3C1	-36.70328088	-3.268557646	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1342	2249	0.001333926	0.003557137	0	9	OPC	NA	NA	NA
AGCGTATCAGATGGCA-1_25G_P3C1	-4.573463835	-17.02281201	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2744	5890	0.004244482	0.007640068	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AGCGTCGGTTACGACT-1_25G_P3C1	-2.735537486	-14.10011701	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2111	4306	0.002554575	0.005341384	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AGCTCCTAGGCCATAG-1_25G_P3C1	-12.58354206	-10.86707839	13B	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1632	2866	0.000697837	0.002442428	0	13B	IN-SV2C	NA	NA	NA
AGCTCCTAGTTTGCGT-1_25G_P3C1	-3.795711718	-16.44602865	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2599	5704	0.001051893	0.004207574	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AGCTCCTCAATCCGAT-1_25G_P3C1	-25.7930735	20.25739091	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1281	2169	0.000922084	0.003688336	0	8	Astrocytes	NA	NA	NA
AGCTCCTCAGCCACCA-1_25G_P3C1	-2.989359052	-23.04450466	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3844	11048	0.00307748	0.002986966	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AGCTCCTTCCGTAGGC-1_25G_P3C1	-1.932052745	-26.7660533	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	5095	17595	0.002784882	0.002841716	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AGCTCCTTCCTAGAAC-1_25G_P3C1	-12.7016412	-11.02898551	13B	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1674	3192	0	0.002506266	0	13B	IN-SV2C	NA	NA	NA
AGCTCCTTCGCTTAGA-1_25G_P3C1	-10.51228389	2.469111032	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3241	7942	0.000503651	0.002392344	0	13A	IN-VIP	NA	NA	NA
AGCTCCTTCGGCTACG-1_25G_P3C1	2.486442803	-27.98736832	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3113	7767	0.000643749	0.004248745	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AGCTCTCAGAGATGAG-1_25G_P3C1	-4.829594896	-16.64939545	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2723	5969	0.002010387	0.008879209	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AGCTCTCAGTTACGGG-1_25G_P3C1	-10.17311007	2.073577386	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2556	5794	0.001898516	0.00742147	0	13A	IN-VIP	NA	NA	NA
AGCTCTCGTCCGCTGA-1_25G_P3C1	-3.864540924	-18.32880793	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2821	6301	0.005713379	0.007300429	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AGCTCTCTCATTTGGG-1_25G_P3C1	-1.259818468	-10.02929349	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1761	3352	0.002386635	0.005369928	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AGCTTGAAGTACATGA-1_25G_P3C1	-3.924757572	-6.377482427	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	947	1428	0.009803922	0.004901961	0	13A	IN-VIP	NA	NA	NA
AGCTTGACACAGGTTT-1_25G_P3C1	-2.991942484	-23.01868787	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3731	9951	0.003215757	0.004522159	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AGCTTGAGTCAGTGGA-1_25G_P3C1	-0.770554466	-26.38752593	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	5411	17908	0.004858164	0.003294617	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AGCTTGAGTCGCATAT-1_25G_P3C1	29.65584671	-0.089924979	2	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2902	6875	0.006254545	0.003636364	0	2	EN-L4	NA	NA	NA
AGCTTGAGTGCTTCTC-1_25G_P3C1	38.5247243	9.610517899	14	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	743	1005	0.016915423	0.010945274	0	14	Microglia	NA	NA	NA
AGCTTGATCACCCGAG-1_25G_P3C1	-6.942616133	0.391540779	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2069	4253	0.003056666	0.003291794	0	13A	IN-VIP	NA	NA	NA
AGGCCACAGAGCCTAG-1_25G_P3C1	-4.640525398	-17.24594218	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2943	6642	0.000602228	0.005269497	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AGGCCACCATGAAGTA-1_25G_P3C1	-5.399891217	-22.38717173	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2909	6615	0	0.003476946	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AGGCCACTCATTCACT-1_25G_P3C1	-2.638471739	-26.80781498	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4541	15019	0.001664558	0.002663293	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AGGCCGTAGATGCCTT-1_25G_P3C1	-1.159643781	-12.22089386	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1994	3885	0.001029601	0.003603604	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AGGCCGTAGTTTGCGT-1_25G_P3C1	-22.1915011	-24.35135957	6A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2833	6576	0.038625304	0.003649635	0	6A	IN-PV	NA	NA	NA
AGGCCGTCATGACGGA-1_25G_P3C1	26.3069551	0.4066195	2	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2724	6488	0.00431566	0.004778052	0	2	EN-L4	NA	NA	NA
AGGCCGTTCACTTACT-1_25G_P3C1	-2.662252695	-15.44962145	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2706	6888	0.003919861	0.005081301	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AGGGAGTCAAGACGTG-1_25G_P3C1	-35.12031139	-12.68787625	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	739	1258	0.002384738	0.001589825	0	9	OPC	NA	NA	NA
AGGGAGTCATATGCTG-1_25G_P3C1	12.16378701	26.65050244	1	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	829	1297	0.00231303	0.00308404	0	oligos	OL-Cntl	NA	NA	NA
AGGGATGAGCGAGAAA-1_25G_P3C1	-9.41615165	2.961121199	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3217	7490	0.006542056	0.00493992	0	13A	IN-VIP	NA	NA	NA
AGGGATGAGGAGCGTT-1_25G_P3C1	14.50911395	-33.48081601	3	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4727	14757	0.003794809	0.004404689	0	3	EN-L5-6	NA	NA	NA
AGGGATGAGGAGTTGC-1_25G_P3C1	-5.02978005	-20.73785447	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2926	6765	0.003399852	0.00413895	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AGGGATGAGTCCAGGA-1_25G_P3C1	0.531320542	-7.559222358	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1375	2312	0.004757785	0.008650519	0	12	EN-MIX	NA	NA	NA
AGGGATGCATCGGAAG-1_25G_P3C1	-29.43838421	12.23237648	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	683	1063	0.003762935	0.006585136	0	8	Astrocytes	NA	NA	NA
AGGGATGCATGATCCA-1_25G_P3C1	-10.99611214	-19.18936231	6B	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	991	1709	0.001755413	0.005851375	0	6B	IN-SST	NA	NA	NA
AGGGATGGTCCAAGTT-1_25G_P3C1	-16.695767	-25.33085923	6A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2283	4988	0.004811548	0.002806736	0	6A	IN-PV	NA	NA	NA
AGGGATGGTTGGTGGA-1_25G_P3C1	-4.140745403	-21.1503908	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3468	9368	0.001601196	0.003842869	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AGGGATGTCTTAGCCC-1_25G_P3C1	-27.50515356	25.35190152	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1350	2572	0.002332815	0.002332815	0	8	Astrocytes	NA	NA	NA
AGGGTGAAGGCTATCT-1_25G_P3C1	-1.04898263	-9.472726315	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1865	3369	0.003265064	0.004155536	0	12	EN-MIX	NA	NA	NA
AGGGTGACACACATGT-1_25G_P3C1	-38.16684687	-8.531531088	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1008	1654	0.00120919	0.001813785	0	9	OPC	NA	NA	NA
AGGGTGAGTCGAGTTT-1_25G_P3C1	-0.013819913	-8.29549923	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1665	3033	0.005275305	0.004615892	0	12	EN-MIX	NA	NA	NA
AGGGTGAGTCTGCCAG-1_25G_P3C1	-28.7895973	22.75054197	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1092	1757	0.007398976	0.005122368	0	8	Astrocytes	NA	NA	NA
AGGGTGATCGAACTGT-1_25G_P3C1	8.638836342	31.26855993	1	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	664	1030	0.000970874	0.003883495	0	oligos	OL-Cntl	NA	NA	NA
AGGGTGATCTTACCGC-1_25G_P3C1	19.78451748	-28.81181983	3	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3527	9592	0.001876564	0.011050876	0	3	EN-L5-6	NA	NA	NA
AGGTCATCACAACGTT-1_25G_P3C1	-26.65012914	27.20337436	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1510	2918	0.004455106	0.006168609	0	8	Astrocytes	NA	NA	NA
AGGTCATCATTATCTC-1_25G_P3C1	-16.43891969	-18.9882616	6B	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2141	4959	0.011494253	0.003024803	0	6B	IN-SST	NA	NA	NA
AGGTCATGTTAGAACA-1_25G_P3C1	-29.68199067	21.9968706	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1066	1815	0.009366391	0.004407713	0	8	Astrocytes	NA	NA	NA
AGGTCATGTTCACGGC-1_25G_P3C1	-29.45513854	13.36967267	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	811	1252	0	0.004792332	0	8	Astrocytes	NA	NA	NA
AGGTCATTCAAAGACA-1_25G_P3C1	5.483479334	-27.33053967	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3722	10260	0.001364522	0.003996101	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AGGTCATTCCGAGCCA-1_25G_P3C1	-2.471406106	-13.89982139	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2049	4339	0.003457018	0.002996082	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AGGTCCGAGAAGGTGA-1_25G_P3C1	24.36380369	0.067387053	2	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2152	4520	0.003982301	0.002876106	0	2	EN-L4	NA	NA	NA
AGGTCCGAGAGCTGGT-1_25G_P3C1	7.894272121	31.86448114	1	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	787	1143	0	0.003499563	0	oligos	OL-Cntl	NA	NA	NA
AGGTCCGCAATCGGTT-1_25G_P3C1	8.134622565	32.14355798	1	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	688	1044	0.005747126	0.003831418	0	oligos	OL-Cntl	NA	NA	NA
AGGTCCGCAATGTTGC-1_25G_P3C1	10.60547349	26.5598937	1	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	792	1143	0.001749781	0.005249344	0	oligos	OL-Cntl	NA	NA	NA
AGGTCCGCAGATTGCT-1_25G_P3C1	-15.08901796	-7.297016696	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3095	7724	0.011263594	0.002589332	0	13A	IN-VIP	NA	NA	NA
AGGTCCGGTAAGAGGA-1_25G_P3C1	17.62999578	0.936514281	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	962	1400	0	0.004285714	0	12	EN-MIX	NA	NA	NA
AGGTCCGGTACCTACA-1_25G_P3C1	-2.979801977	-14.79299793	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2269	4976	0.003617363	0.004823151	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AGGTCCGGTGTGACGA-1_25G_P3C1	-19.9255389	-29.10498828	6A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4489	14915	0.001273885	0.002614817	0	6A	IN-PV	NA	NA	NA
AGTAGTCCAAACAACA-1_25G_P3C1	31.4057451	-1.189869403	2	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2482	5300	0.007358491	0.004716981	0	2	EN-L4	NA	NA	NA
AGTAGTCGTACATGTC-1_25G_P3C1	-27.07746853	26.66257592	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1319	2431	0.002056767	0.004113534	0	8	Astrocytes	NA	NA	NA
AGTAGTCGTCATGCCG-1_25G_P3C1	8.519381324	-7.949708702	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1896	3766	0.00212427	0.003717472	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AGTAGTCGTTAAGACA-1_25G_P3C1	6.62890382	-6.010216004	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1399	2487	0.003618818	0.002814636	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AGTCTTTAGTTAACGA-1_25G_P3C1	-15.10524498	-25.72090659	6A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1767	3839	0.003907268	0.001302423	0	6A	IN-PV	NA	NA	NA
AGTCTTTCAATAACGA-1_25G_P3C1	-0.751886835	-29.65078152	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3898	10983	0.000728398	0.003459893	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AGTGAGGGTAAGGATT-1_25G_P3C1	-4.59807045	-20.90542901	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3140	7859	0.003690037	0.004580735	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AGTGAGGGTCCATGAT-1_25G_P3C1	-2.151342792	-25.53270301	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4334	12807	0.001405481	0.002264387	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AGTGAGGTCACGAAGG-1_25G_P3C1	0.539900645	-18.35446845	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2869	6629	0.009201991	0.003469603	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AGTGGGAAGAGACTTA-1_25G_P3C1	-2.776989261	-14.2809912	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2130	4333	0.000230787	0.006000462	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AGTGGGAAGCATCATC-1_25G_P3C1	-4.667042822	-16.59928918	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2768	6138	0.002606712	0.005376344	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AGTGGGAAGGATCGCA-1_25G_P3C1	-5.210495281	-2.773624844	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1467	2426	0.007419621	0.006183017	0	13A	IN-VIP	NA	NA	NA
AGTGGGAAGTATTGGA-1_25G_P3C1	-38.15426629	-8.266696598	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1009	1574	0.005082592	0.005082592	0	9	OPC	NA	NA	NA
AGTGGGACAAGCCCAC-1_25G_P3C1	-7.647435922	1.424377436	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2530	5740	0.009233449	0.004006969	0	13A	IN-VIP	NA	NA	NA
AGTGGGACAAGTTCTG-1_25G_P3C1	-3.402301782	-23.13787699	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3761	10649	0.001972016	0.002629355	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AGTGGGACACCACCAG-1_25G_P3C1	-8.999111564	-18.62835066	6B	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	726	1214	0.028830313	0.004942339	0	6B	IN-SST	NA	NA	NA
AGTGGGACACTCTGTC-1_25G_P3C1	25.11559302	-4.257783374	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4313	13763	0.00050861	0.00406888	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AGTGGGAGTGCATCTA-1_25G_P3C1	29.59061634	-0.752872405	2	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3446	8597	0.007444457	0.003489589	0	2	EN-L4	NA	NA	NA
AGTGGGAGTTTGGGCC-1_25G_P3C1	-2.748913945	-12.76313867	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2074	4220	0.004739336	0.003554502	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AGTGGGATCCACGTGG-1_25G_P3C1	-13.66521547	-24.32269102	6A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1402	2469	0.006075334	0.003240178	0	6A	IN-PV	NA	NA	NA
AGTGGGATCTTAGCCC-1_25G_P3C1	-3.71077291	-4.594583512	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1137	1844	0.00867679	0.005422993	0	13A	IN-VIP	NA	NA	NA
AGTGTCAAGAGCTATA-1_25G_P3C1	2.527627567	-7.195988101	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1425	2286	0.018810149	0.012248469	0	12	EN-MIX	NA	NA	NA
AGTGTCACACGGTAAG-1_25G_P3C1	-34.672499	-12.87787969	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	783	1133	0.004413063	0.001765225	0	9	OPC	NA	NA	NA
AGTGTCACAGCTCGAC-1_25G_P3C1	-4.718845559	-20.09283988	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2993	7150	0.003216783	0.003496503	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AGTGTCAGTTACGACT-1_25G_P3C1	-7.374548408	-1.402739975	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1831	3486	0.014629948	0.004876649	0	13A	IN-VIP	NA	NA	NA
AGTGTCATCAAGCCTA-1_25G_P3C1	-4.154243779	-14.06869087	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2518	5380	0.001301115	0.012267658	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AGTTGGTAGAGGGATA-1_25G_P3C1	30.11696927	-0.388227567	2	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3012	6384	0.006735589	0.004699248	0	2	EN-L4	NA	NA	NA
AGTTGGTAGTGTTTGC-1_25G_P3C1	17.85625901	1.327542701	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	911	1398	0.00286123	0.002145923	0	12	EN-MIX	NA	NA	NA
AGTTGGTCAGCTGTGC-1_25G_P3C1	-0.864184342	-28.747327	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	5244	18104	0.003977022	0.007291206	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AGTTGGTTCGTACGGC-1_25G_P3C1	-35.20751541	-12.74857463	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	735	1123	0.001780944	0.00445236	0	9	OPC	NA	NA	NA
AGTTGGTTCTGCCCTA-1_25G_P3C1	-28.76616181	17.81646047	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1051	1813	0.007170436	0.001654716	0	8	Astrocytes	NA	NA	NA
ATAACGCAGACAATAC-1_25G_P3C1	-2.53116925	-12.84306092	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2007	4164	0.002641691	0.006243996	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ATAACGCAGCGATCCC-1_25G_P3C1	26.06354834	-5.652061269	2	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	5008	18114	0.006790328	0.002373854	0	2	EN-L4	NA	NA	NA
ATAACGCAGGACATTA-1_25G_P3C1	-28.04172586	22.73215575	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1057	1706	0.007033998	0.004103165	0	8	Astrocytes	NA	NA	NA
ATAACGCAGTTATCGC-1_25G_P3C1	-29.99545111	20.92895014	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	943	1729	0.001735107	0.004626952	0	8	Astrocytes	NA	NA	NA
ATAACGCCACCCATTC-1_25G_P3C1	-5.348342286	-20.29268191	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2584	6189	0.005655195	0.004685733	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ATAACGCGTCTCCACT-1_25G_P3C1	-29.23311657	13.36099217	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	780	1231	0	0.004874086	0	8	Astrocytes	NA	NA	NA
ATAACGCGTGTCAATC-1_25G_P3C1	-4.167807539	-15.91619401	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2413	5395	0.005189991	0.005746061	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ATAACGCGTTCACCTC-1_25G_P3C1	-0.74403112	-29.49611533	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	5379	21928	0.000319227	0.003237869	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ATAACGCGTTCGGCAC-1_25G_P3C1	-2.173248629	-16.42136911	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2509	5785	0.001555748	0.002592913	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ATAAGAGAGAAACCGC-1_25G_P3C1	24.57495056	0.021647472	2	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2340	5237	0.001336643	0.003055184	0	2	EN-L4	NA	NA	NA
ATAAGAGCACGTAAGG-1_25G_P3C1	-38.05715446	-8.56158347	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	958	1573	0.003814367	0.005085823	0	9	OPC	NA	NA	NA
ATAAGAGGTCATACTG-1_25G_P3C1	-2.29098785	-14.03695673	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2090	4549	0.00901297	0.003737085	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ATAAGAGTCATGCATG-1_25G_P3C1	1.690378532	-5.023233966	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	919	1410	0	0.003546099	0	12	EN-MIX	NA	NA	NA
ATAGACCAGCCGATTT-1_25G_P3C1	-4.343040413	-17.08625278	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2573	5585	0.00519248	0.007699194	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ATAGACCCACATTCGA-1_25G_P3C1	-5.41946096	-22.07640008	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3054	7653	0.002221351	0.003789364	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ATAGACCGTACAGCAG-1_25G_P3C1	-5.489406672	-22.8068468	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3339	9151	0.000109278	0.004589662	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ATAGACCGTATAATGG-1_25G_P3C1	-16.234307	-10.62340582	13B	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2732	6225	0.007550201	0.004658635	0	13B	IN-SV2C	NA	NA	NA
ATCACGAAGCTAGTTC-1_25G_P3C1	-3.212120352	-13.93793127	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2229	4653	0.004513217	0.005372878	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ATCACGAAGGAACTGC-1_25G_P3C1	13.98289298	31.12061865	1	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	861	1409	0.001419446	0.002838893	0	oligos	OL-Cntl	NA	NA	NA
ATCACGAAGTTGTCGT-1_25G_P3C1	25.42201072	1.172827157	2	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2334	4910	0.003869654	0.004276986	0	2	EN-L4	NA	NA	NA
ATCACGACAGCTATTG-1_25G_P3C1	-37.54099851	-1.696245118	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1521	3280	0.002439024	0.00152439	0	9	OPC	NA	NA	NA
ATCACGACAGTAAGAT-1_25G_P3C1	9.86542227	26.33518515	1	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	834	1335	0.001498127	0.001498127	0	oligos	OL-Cntl	NA	NA	NA
ATCACGACATCATCCC-1_25G_P3C1	-1.104692191	-28.52715868	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4831	16340	0.002264382	0.00869033	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ATCACGAGTCATGCCG-1_25G_P3C1	-4.264542521	-16.85479649	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2650	5738	0.008016731	0.009933775	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ATCACGAGTTTGCATG-1_25G_P3C1	-8.470428217	-31.62375181	16	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	902	1536	0.1953125	0.006510417	0	16	EN-PYR	NA	NA	NA
ATCACGATCCTTCAAT-1_25G_P3C1	-14.55951535	-21.65959984	6A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1558	3058	0.0147155	0.004251145	0	6A	IN-PV	NA	NA	NA
ATCATCTAGCCATCGC-1_25G_P3C1	-9.861385666	1.787872945	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2747	5903	0.010841945	0.005759783	0	13A	IN-VIP	NA	NA	NA
ATCATCTAGCTTCGCG-1_25G_P3C1	-3.743249819	-25.55189881	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3755	11208	0	0.006870093	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ATCATCTAGGCCCTTG-1_25G_P3C1	-3.520068426	-24.83808156	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3949	12872	0.002408328	0.006292728	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ATCATCTCACACGCTG-1_25G_P3C1	-29.84774524	13.47816373	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	825	1370	0	0.003649635	0	8	Astrocytes	NA	NA	NA
ATCATCTTCTGCCCTA-1_25G_P3C1	8.789434087	31.41338649	1	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	650	1036	0.001930502	0.003861004	0	oligos	OL-Cntl	NA	NA	NA
ATCATGGAGACGCAAC-1_25G_P3C1	-2.341363019	-11.67488332	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1885	3628	0.007442117	0.003307607	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ATCATGGCAGCCAATT-1_25G_P3C1	-39.40948096	-1.474373745	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1205	2127	0.000940291	0.001880583	0	9	OPC	NA	NA	NA
ATCATGGCATAGAAAC-1_25G_P3C1	12.37029026	31.24648199	1	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	686	1025	0.00097561	0.00195122	0	oligos	OL-Cntl	NA	NA	NA
ATCATGGCATCGGTTA-1_25G_P3C1	-13.71773438	-10.54341332	13B	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1850	3394	0.00618739	0.001767826	0	13B	IN-SV2C	NA	NA	NA
ATCATGGGTAGGAGTC-1_25G_P3C1	14.42111028	-33.35349612	3	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4642	15339	0.005867397	0.003716018	0	3	EN-L5-6	NA	NA	NA
ATCATGGTCTGAAAGA-1_25G_P3C1	-17.70981044	-24.04267255	6A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2495	6021	0.010795549	0.001993024	0	6A	IN-PV	NA	NA	NA
ATCCACCAGCTAACTC-1_25G_P3C1	-2.207692862	-24.47870228	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4915	16823	0.006182013	0.004577067	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ATCCACCAGCTACCGC-1_25G_P3C1	39.35020309	10.33176621	14	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	818	1150	0.008695652	0.005217391	0	14	Microglia	NA	NA	NA
ATCCACCCACTAAGTC-1_25G_P3C1	-4.154117082	-21.74245765	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3394	8952	0.004915103	0.006702413	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ATCCACCGTAGTGAAT-1_25G_P3C1	9.472777706	31.20543795	1	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	755	1131	0	0.004420866	0	oligos	OL-Cntl	NA	NA	NA
ATCCACCGTTAAAGAC-1_25G_P3C1	8.730842592	31.24802891	1	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	700	1035	0.000966184	0.007729469	0	oligos	OL-Cntl	NA	NA	NA
ATCCACCGTTAAGAAC-1_25G_P3C1	-27.98904062	18.43443883	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1184	2082	0.001440922	0.005763689	0	8	Astrocytes	NA	NA	NA
ATCCACCGTTCCACTC-1_25G_P3C1	-26.65052535	26.74130419	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1475	2836	0.002115656	0.007052186	0	8	Astrocytes	NA	NA	NA
ATCCACCTCACCCGAG-1_25G_P3C1	-4.261349305	-20.55844692	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3299	8429	0.003559141	0.006287816	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ATCCACCTCTGATTCT-1_25G_P3C1	-2.403005419	-25.14256769	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4087	12120	0.001567657	0.005115512	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ATCCGAACACGTTGGC-1_25G_P3C1	-0.056195224	-8.386915829	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1528	2786	0.010050251	0.007178751	0	12	EN-MIX	NA	NA	NA
ATCCGAACAGATGAGC-1_25G_P3C1	-4.611254437	-22.81385214	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3640	9132	0.00043802	0.003942181	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ATCCGAACAGGAATCG-1_25G_P3C1	-2.283512488	-24.85343947	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4238	12841	0.001012382	0.004049529	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ATCCGAAGTCTAGTCA-1_25G_P3C1	-1.774686516	-23.1725401	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3924	11224	0.001603706	0.003831076	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ATCCGAAGTCTTGCGG-1_25G_P3C1	-24.95380203	19.28873448	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1339	2594	0.00154202	0.00308404	0	8	Astrocytes	NA	NA	NA
ATCCGAAGTGACAAAT-1_25G_P3C1	-17.03199996	-23.36161745	6A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1900	4123	0.001455251	0.002425418	0	6A	IN-PV	NA	NA	NA
ATCCGAATCTTGCATT-1_25G_P3C1	-3.675193787	-21.66179803	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3647	10360	0.004247104	0.004054054	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ATCGAGTAGAAGGGTA-1_25G_P3C1	-7.174151285	-2.782807221	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1801	3424	0.004088785	0.002920561	0	13A	IN-VIP	NA	NA	NA
ATCGAGTAGAGCCCAA-1_25G_P3C1	-15.17034762	-25.34674551	6A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1567	2839	0.004579077	0.00211342	0	6A	IN-PV	NA	NA	NA
ATCGAGTGTGACGGTA-1_25G_P3C1	-32.92188238	-13.31193848	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	673	1008	0.000992063	0.001984127	0	9	OPC	NA	NA	NA
ATCTACTAGTGAAGAG-1_25G_P3C1	-2.330749571	-27.45716605	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4561	15535	6.44E-05	0.003476022	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ATCTACTAGTTGTCGT-1_25G_P3C1	-3.90313233	-23.09498928	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3753	10092	0.002774475	0.007332541	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ATCTACTCAGGAATGC-1_25G_P3C1	-37.97135258	-9.005975638	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	970	1607	0.003733665	0.00248911	0	9	OPC	NA	NA	NA
ATCTACTCATACAGCT-1_25G_P3C1	1.230986978	-6.407366607	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1213	2317	0.005610703	0.006473889	0	12	EN-MIX	NA	NA	NA
ATCTACTCATATGAGA-1_25G_P3C1	-28.87448892	16.48582296	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	906	1491	0	0.002012072	0	8	Astrocytes	NA	NA	NA
ATCTACTGTCCGTCAG-1_25G_P3C1	-9.447358086	-0.46294417	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2066	4107	0.005600195	0.004139274	0	13A	IN-VIP	NA	NA	NA
ATCTGCCCAGCAGTTT-1_25G_P3C1	0.853784484	-6.372109312	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1190	1911	0.002093145	0.006279435	0	12	EN-MIX	NA	NA	NA
ATCTGCCGTATGGTTC-1_25G_P3C1	-36.81622828	-9.238544977	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	920	1441	0.000693963	0.000693963	0	9	OPC	NA	NA	NA
ATCTGCCGTCGCCATG-1_25G_P3C1	-1.137511075	-9.409720496	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1811	3582	0.001395868	0.00921273	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ATCTGCCGTTATTCTC-1_25G_P3C1	-9.323839867	2.857633443	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2942	7015	0.006557377	0.00342124	0	13A	IN-VIP	NA	NA	NA
ATCTGCCTCCAAGCCG-1_25G_P3C1	-39.57621631	-1.81668124	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1330	2336	0.001712329	0.002996575	0	9	OPC	NA	NA	NA
ATCTGCCTCGCTTAGA-1_25G_P3C1	-5.471338954	-21.51384443	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2864	7220	0.000415512	0.002216066	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ATGAGGGAGGCAATTA-1_25G_P3C1	-4.622332335	-2.042057908	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1276	2117	0.000472367	0.006140765	0	13A	IN-VIP	NA	NA	NA
ATGAGGGAGTGCCAGA-1_25G_P3C1	-1.10346001	-28.82562895	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4615	14052	0.000142328	0.008397381	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ATGAGGGCAGGGTTAG-1_25G_P3C1	39.03730567	9.648049208	14	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	741	1027	0.00097371	0.00292113	0	14	Microglia	NA	NA	NA
ATGAGGGCATGAAGTA-1_25G_P3C1	-9.609126378	3.022993113	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2896	6497	0.001385255	0.005694936	0	13A	IN-VIP	NA	NA	NA
ATGAGGGGTGCGATAG-1_25G_P3C1	-3.250664525	-12.74204037	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2114	4340	0.009447005	0.011981567	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ATGAGGGGTTTAGCTG-1_25G_P3C1	-4.138962149	-23.79476151	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3624	9906	0.002523723	0.003432263	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ATGAGGGTCTGACCTC-1_25G_P3C1	29.18703634	0.463601842	2	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3003	7055	0.003827073	0.003401843	0	2	EN-L4	NA	NA	NA
ATGCGATAGATGGGTC-1_25G_P3C1	6.467233133	-27.41323603	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4997	13827	0.008027772	0.004339336	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ATGCGATAGCGTAGTG-1_25G_P3C1	29.57925592	0.864328903	2	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2432	4971	0.004023335	0.010058338	0	2	EN-L4	NA	NA	NA
ATGCGATAGGAATTAC-1_25G_P3C1	-3.678478287	-21.07148954	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3550	8956	0.003014739	0.00703439	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ATGCGATAGGATCGCA-1_25G_P3C1	-2.246881051	-28.60763481	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2904	7007	0.001141715	0.002426145	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ATGCGATAGTAATCCC-1_25G_P3C1	0.125763255	-7.720605172	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1463	2634	0.000379651	0.002277904	0	12	EN-MIX	NA	NA	NA
ATGCGATAGTAGGCCA-1_25G_P3C1	-4.332318429	-15.7474109	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2811	6877	0.007706849	0.004216955	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ATGCGATAGTGAACAT-1_25G_P3C1	-16.40157866	-18.95856985	6A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2018	4192	0.015505725	0.001431298	0	6A	IN-PV	NA	NA	NA
ATGCGATGTCTCTTTA-1_25G_P3C1	-4.656374584	-23.6454652	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3890	11809	0.001524261	0.003980015	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ATGCGATGTGACGGTA-1_25G_P3C1	-2.577224217	-15.10819023	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2379	5500	0.001272727	0.004545455	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ATGCGATTCATGCATG-1_25G_P3C1	-4.883834888	-17.90188803	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2871	6531	0.000612464	0.003674782	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ATGCGATTCATGTCTT-1_25G_P3C1	-0.454348004	-9.470244744	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1621	3193	0.002818666	0.004384591	0	12	EN-MIX	NA	NA	NA
ATGCGATTCTCCCTGA-1_25G_P3C1	-35.14170284	-8.262950178	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1097	1877	0.000532765	0.00213106	0	9	OPC	NA	NA	NA
ATGGGAGAGACTCGGA-1_25G_P3C1	-3.783343851	-24.71429994	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3884	11020	0.000453721	0.003357532	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ATGGGAGGTCAGAATA-1_25G_P3C1	-2.989715371	-13.15667716	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2001	3896	0.001540041	0.00949692	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ATGGGAGGTTAGGGTG-1_25G_P3C1	-37.58090611	-8.942683873	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	969	1542	0.001297017	0.003891051	0	9	OPC	NA	NA	NA
ATGGGAGGTTGATTCG-1_25G_P3C1	10.75338268	-7.96298546	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2143	4289	0.000932618	0.002331546	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ATGGGAGTCACCCGAG-1_25G_P3C1	-8.579258751	2.450265951	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2809	6612	0.001966122	0.002873563	0	13A	IN-VIP	NA	NA	NA
ATGGGAGTCAGAGACG-1_25G_P3C1	-2.699361047	-12.68696952	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1919	3752	0.001865672	0.009594883	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ATGGGAGTCGCGTAGC-1_25G_P3C1	-3.77477848	-23.52819243	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3762	9957	0.000200864	0.003414683	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ATGGGAGTCGCTTAGA-1_25G_P3C1	-34.80962365	-12.11091472	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	828	1278	0.001564945	0.004694836	0	9	OPC	NA	NA	NA
ATGGGAGTCTTGAGAC-1_25G_P3C1	-30.03134924	20.78301069	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	967	1466	0.004774898	0.004092769	0	8	Astrocytes	NA	NA	NA
ATGTGTGAGCCAGGAT-1_25G_P3C1	0.411272891	-7.803396311	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1374	2539	0.009846396	0.003150847	0	12	EN-MIX	NA	NA	NA
ATGTGTGAGGCTATCT-1_25G_P3C1	-4.095190332	-16.36920997	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2630	6443	0.000931243	0.00388018	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ATGTGTGCACCTCGGA-1_25G_P3C1	-3.23222145	-13.0958406	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2005	3899	0.003077712	0.007181329	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ATGTGTGCAGGAATCG-1_25G_P3C1	-13.66202653	-24.17373164	6A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1460	2634	0.006454062	0.002657555	0	6A	IN-PV	NA	NA	NA
ATGTGTGGTCGGATCC-1_25G_P3C1	-39.59907297	-0.035486151	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1448	2653	0.001507727	0.003392386	0	9	OPC	NA	NA	NA
ATGTGTGGTGCCTGGT-1_25G_P3C1	29.32052177	0.477998528	2	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2642	5841	0.0047937	0.0047937	0	2	EN-L4	NA	NA	NA
ATGTGTGTCTTGGGTA-1_25G_P3C1	-15.13208667	-25.84757508	6A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1592	3460	0.005202312	0.002023121	0	6A	IN-PV	NA	NA	NA
ATTACTCAGACTAAGT-1_25G_P3C1	-5.581816461	-0.779957049	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1631	3018	0.009277667	0.004970179	0	13A	IN-VIP	NA	NA	NA
ATTACTCAGAGCAATT-1_25G_P3C1	-36.27777972	-11.35337697	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	805	1347	0.00074239	0.002227171	0	9	OPC	NA	NA	NA
ATTACTCAGGGTGTTG-1_25G_P3C1	-10.22644809	22.60026869	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1177	1935	0.002583979	0.005684755	0	8	Astrocytes	NA	NA	NA
ATTACTCTCAACGCTA-1_25G_P3C1	-1.644496259	-10.37692812	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1897	3818	0.006286014	0.005762179	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ATTATCCAGAAAGTGG-1_25G_P3C1	1.619726437	-5.755213822	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1040	1674	0.006571087	0.008960573	0	12	EN-MIX	NA	NA	NA
ATTATCCAGCTCCTCT-1_25G_P3C1	-3.067343489	-6.443777406	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	934	1445	0.018685121	0.000692042	0	13A	IN-VIP	NA	NA	NA
ATTATCCAGTTCCACA-1_25G_P3C1	29.59335547	0.479560099	2	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2673	6019	0.008140887	0.003655092	0	2	EN-L4	NA	NA	NA
ATTATCCCACTGAAGG-1_25G_P3C1	-18.19521618	-27.25576346	6A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2548	6192	0.001453488	0.003229974	0	6A	IN-PV	NA	NA	NA
ATTATCCCAGTTCCCT-1_25G_P3C1	-4.474235546	-2.426393551	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1327	2505	0.007185629	0.00239521	0	13A	IN-VIP	NA	NA	NA
ATTATCCTCATAGCAC-1_25G_P3C1	0.638100168	-18.5617378	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3057	7367	0.008415909	0.005293878	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ATTATCCTCCAGAGGA-1_25G_P3C1	-37.48163144	-10.0841224	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	878	1406	0.003556188	0.00284495	0	9	OPC	NA	NA	NA
ATTATCCTCGCACTCT-1_25G_P3C1	-29.89180328	14.35321508	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	791	1268	0	0.003943218	0	8	Astrocytes	NA	NA	NA
ATTATCCTCGTACCGG-1_25G_P3C1	-7.876236526	-0.362102589	13B	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2121	4372	0.002516011	0.002516011	0	13B	IN-SV2C	NA	NA	NA
ATTATCCTCTTGTACT-1_25G_P3C1	-14.18667435	-24.86703708	6A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1484	2904	0.007575758	0.004476584	0	6A	IN-PV	NA	NA	NA
ATTCTACAGATCCCAT-1_25G_P3C1	0.317530383	-7.62998831	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1380	2532	0.001974724	0.001579779	0	12	EN-MIX	NA	NA	NA
ATTCTACAGGGATACC-1_25G_P3C1	-2.747985218	-13.53179625	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1996	4093	0.002443196	0.008062546	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ATTCTACCAAAGTCAA-1_25G_P3C1	-5.089606141	-22.92312192	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3646	10713	0.000933445	0.005413983	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ATTCTACCATTTCACT-1_25G_P3C1	-38.79915395	-6.194525678	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1071	1858	0.003767492	0.002152853	0	9	OPC	NA	NA	NA
ATTCTACGTATAAACG-1_25G_P3C1	-35.36152319	-12.90287795	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	732	1174	0.005962521	0.003407155	0	9	OPC	NA	NA	NA
ATTCTACGTCGAACAG-1_25G_P3C1	15.53151797	-6.106756604	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1546	2728	0.000733138	0.004398827	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ATTCTACTCGCACTCT-1_25G_P3C1	-5.582462732	-22.67075384	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3249	9628	0.001350229	0.002181138	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ATTCTACTCTTCCTTC-1_25G_P3C1	-14.72264279	-22.16786341	6A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1541	3425	0.000291971	0.002043796	0	6A	IN-PV	NA	NA	NA
ATTGGACAGCTGGAAC-1_25G_P3C1	-5.154432136	-20.91805964	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2951	7283	0.0045311	0.004256488	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ATTGGACAGTACGCCC-1_25G_P3C1	-3.52706102	-13.32518938	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2196	4475	0.003351955	0.006480447	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ATTGGACTCACGCATA-1_25G_P3C1	-9.176657608	-18.65187599	6B	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	830	1371	0.028446389	0.003646973	0	6B	IN-SST	NA	NA	NA
ATTGGACTCTACTCAT-1_25G_P3C1	-8.257601928	1.93303122	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2401	5697	0.005792522	0.002106372	0	13A	IN-VIP	NA	NA	NA
ATTGGACTCTTCGGTC-1_25G_P3C1	-9.515968312	-1.439761952	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2195	4416	0.008378623	0.007019928	0	13A	IN-VIP	NA	NA	NA
ATTGGTGAGCACAGGT-1_25G_P3C1	-1.376954659	-10.01670687	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1886	3625	0.001655172	0.00662069	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ATTGGTGCACAACGTT-1_25G_P3C1	-2.754492181	-16.87011765	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2626	6222	0.00064288	0.003214401	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ATTGGTGTCCATGAGT-1_25G_P3C1	2.185907862	-6.786025893	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1207	1979	0.00353714	0.005053057	0	12	EN-MIX	NA	NA	NA
ATTGGTGTCCCTTGCA-1_25G_P3C1	-12.17588426	-10.81083668	13B	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1425	2666	0.007876969	0.00300075	0	13B	IN-SV2C	NA	NA	NA
ATTTCTGAGGAATGGA-1_25G_P3C1	-1.863991732	-16.29674403	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2265	5354	0.00149421	0.002801644	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ATTTCTGCATGCCCGA-1_25G_P3C1	-1.980149375	-16.05508662	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2079	4737	0.001266624	0.002533249	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ATTTCTGTCAGCTCGG-1_25G_P3C1	-5.728768527	-23.14958068	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3091	8151	0.000613422	0.002331002	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CAACCAAGTTCGAATC-1_25G_P3C1	1.335068578	-5.892917543	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1081	1697	0.001767826	0.007660577	0	12	EN-MIX	NA	NA	NA
CAACCTCAGCAACGGT-1_25G_P3C1	19.58216632	22.23654933	1	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	998	1685	0	0.002967359	0	oligos	OL-Cntl	NA	NA	NA
CAACCTCAGTGCCATT-1_25G_P3C1	-1.632703845	-14.20631884	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2082	4205	0.000237812	0.007609988	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CAACCTCCAGCTGTAT-1_25G_P3C1	-4.151939784	-20.51279793	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3317	8464	0.003426276	0.005198488	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CAACCTCCATGCCTTC-1_25G_P3C1	-15.3996033	-25.82283313	6A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1917	4120	0.004126214	0.003398058	0	6A	IN-PV	NA	NA	NA
CAACCTCGTATAGGGC-1_25G_P3C1	-3.798815704	-21.94909984	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4068	11787	0.004496479	0.005429711	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CAACCTCGTATAGTAG-1_25G_P3C1	-1.191883014	-25.89165006	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	5336	18196	0.005385799	0.006100242	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CAACCTCTCCTCATTA-1_25G_P3C1	-2.445462144	-15.08792951	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2332	5786	0.000172831	0.001382648	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CAACTAGAGCCCAACC-1_25G_P3C1	-9.448963973	3.189040249	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2956	6683	0.003890468	0.004040102	0	13A	IN-VIP	NA	NA	NA
CAACTAGCACGGTAAG-1_25G_P3C1	5.835150296	-30.91057994	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4441	13440	0.001116071	0.005580357	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CAACTAGCATTCACTT-1_25G_P3C1	19.14730679	24.2200472	1	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	950	1439	0.000694927	0.004169562	0	oligos	OL-Cntl	NA	NA	NA
CAACTAGGTACATGTC-1_25G_P3C1	19.10767479	21.5749965	1	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	926	1491	0.000670691	0.005365526	0	oligos	OL-Cntl	NA	NA	NA
CAACTAGGTAGGCATG-1_25G_P3C1	6.115127122	30.61072236	1	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	809	1173	0.00511509	0.007672634	0	oligos	OL-Cntl	NA	NA	NA
CAACTAGGTTAGGGTG-1_25G_P3C1	-36.99338385	-4.284221836	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1239	2211	0.001809136	0.001356852	0	9	OPC	NA	NA	NA
CAACTAGTCATTGCCC-1_25G_P3C1	-2.614216456	-25.12235248	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4701	15549	0.001672133	0.002250949	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CAAGAAAGTTGACGTT-1_25G_P3C1	-2.182887628	-16.52181645	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2409	5329	0.00150122	0.001688872	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CAAGATCAGCAGGCTA-1_25G_P3C1	3.792871826	-3.006303667	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	903	1202	0.010815308	0.014975042	0	12	EN-MIX	NA	NA	NA
CAAGATCCAAGCCTAT-1_25G_P3C1	-3.793376212	-23.27758113	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3758	10312	0.00242436	0.006012413	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CAAGATCCAATAGCGG-1_25G_P3C1	-1.848745999	-14.22794986	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2162	4359	0.002982335	0.003441156	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CAAGGCCGTAATAGCA-1_25G_P3C1	9.462251192	26.007164	1	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	859	1381	0.000724113	0.00724113	0	oligos	OL-Cntl	NA	NA	NA
CAAGGCCGTGTTTGGT-1_25G_P3C1	-26.66651523	19.31411064	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1341	2284	0.010507881	0.004378284	0	8	Astrocytes	NA	NA	NA
CAAGTTGAGGCGCTCT-1_25G_P3C1	19.98981444	-6.88193486	3	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2384	5765	0.001734605	0.007805724	0	3	EN-L5-6	NA	NA	NA
CAAGTTGAGGTGCTAG-1_25G_P3C1	-8.594576623	1.265011726	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2175	4524	0.00331565	0.00530504	0	13A	IN-VIP	NA	NA	NA
CAAGTTGCAGCATACT-1_25G_P3C1	-26.7731649	26.90227454	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1514	3056	0.001636126	0.005562827	0	8	Astrocytes	NA	NA	NA
CAAGTTGCATGGGAAC-1_25G_P3C1	-2.562250362	-24.42491798	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4173	11953	0.000501966	0.002258847	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CAAGTTGGTCAAACTC-1_25G_P3C1	-2.58724467	-12.99220028	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2160	4582	0.001964208	0.002400698	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CAAGTTGGTGTGTGCC-1_25G_P3C1	14.7669207	31.25162208	1	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	867	1283	0.003117693	0.000779423	0	oligos	OL-Cntl	NA	NA	NA
CAAGTTGTCGTCGTTC-1_25G_P3C1	-3.82370856	-23.45660199	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3793	10386	0.001155402	0.003755055	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CAAGTTGTCTTGGGTA-1_25G_P3C1	-4.234264312	-17.10409498	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2810	6682	0.002993116	0.004040706	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CACAAACGTGATGTCT-1_25G_P3C1	-25.85416499	19.14900834	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1456	2547	0.000785238	0.005104044	0	8	Astrocytes	NA	NA	NA
CACAAACGTTCGGGCT-1_25G_P3C1	-0.672404825	-8.881513693	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1679	3152	0.001586294	0.006979695	0	12	EN-MIX	NA	NA	NA
CACAAACTCACCGGGT-1_25G_P3C1	-2.119632818	-26.51671442	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4804	16018	0.001435885	0.003183918	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CACAAACTCTGGTTCC-1_25G_P3C1	-3.243373446	-12.90956986	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2262	4666	0.012001715	0.005143592	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CACACAAAGCGTCAAG-1_25G_P3C1	-9.238498705	2.760369048	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2930	6984	0.004438717	0.003150057	0	13A	IN-VIP	NA	NA	NA
CACACAAAGCTGTTCA-1_25G_P3C1	-4.716447754	-20.47142371	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2771	6509	0.002611768	0.003840836	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CACACAAAGGTAAACT-1_25G_P3C1	-4.940990947	-16.9207146	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2738	6201	0.000967586	0.006450572	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CACACAAAGTGGGTTG-1_25G_P3C1	29.83859124	-0.689156459	2	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3665	8789	0.007850722	0.004778701	0	2	EN-L4	NA	NA	NA
CACACAATCTTTCCTC-1_25G_P3C1	-22.263339	31.6735159	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3068	8078	0.003218618	0.003837584	0	8	Astrocytes	NA	NA	NA
CACACCTCAACGATGG-1_25G_P3C1	5.559340809	-32.33614831	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4960	17669	0.000735752	0.002490237	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CACACTCAGATGTAAC-1_25G_P3C1	-37.48610604	-9.923469554	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	889	1446	0.001383126	0.000691563	0	9	OPC	NA	NA	NA
CACACTCAGTCCATAC-1_25G_P3C1	-4.378568391	-23.43355248	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3876	11271	0.000709786	0.003726377	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CACACTCCAAAGTGCG-1_25G_P3C1	-27.30922904	19.25987676	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1258	2130	0.003286385	0.001408451	0	8	Astrocytes	NA	NA	NA
CACACTCCACATGACT-1_25G_P3C1	-0.302546806	-8.802930835	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1556	2732	0.000366032	0.006222548	0	12	EN-MIX	NA	NA	NA
CACACTCCATGAACCT-1_25G_P3C1	-4.653288893	-17.25904626	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2653	6003	0.004997501	0.006163585	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CACACTCGTATTCGTG-1_25G_P3C1	-10.98331566	1.46418874	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2896	7395	0.011088573	0.002839757	0	13A	IN-VIP	NA	NA	NA
CACACTCTCATGCTCC-1_25G_P3C1	-19.31200714	-27.37797531	6A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3175	8043	0.014422479	0.002113639	0	6A	IN-PV	NA	NA	NA
CACACTCTCGAGCCCA-1_25G_P3C1	-26.61726372	27.79909758	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1595	3154	0.000634115	0.002853519	0	8	Astrocytes	NA	NA	NA
CACAGGCAGTCAATAG-1_25G_P3C1	-2.5022001	-15.46543138	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2608	5696	0.001404494	0.004037921	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CACAGGCCATTACGAC-1_25G_P3C1	-1.70744982	-26.14069077	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4915	16627	0.003969447	0.002766584	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CACAGGCCATTCACTT-1_25G_P3C1	-4.254642447	-22.75666533	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3553	9792	0.001940359	0.006229575	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CACAGGCGTTGTGGCC-1_25G_P3C1	-3.327629367	-23.80294886	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4923	16541	0.002115954	0.005924672	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CACAGGCTCAAGATCC-1_25G_P3C1	-4.693475359	-20.84846178	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2677	6153	0.005038193	0.003412969	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CACAGGCTCATCACCC-1_25G_P3C1	0.401829225	-29.6391034	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	5251	19820	0.000605449	0.00221998	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CACAGGCTCATCGCTC-1_25G_P3C1	29.22035187	-0.401917268	2	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3490	8887	0.003825813	0.004050861	0	2	EN-L4	NA	NA	NA
CACAGGCTCCGCAGTG-1_25G_P3C1	-16.81615066	-10.65090283	13B	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3213	7175	0.007526132	0.003763066	0	13B	IN-SV2C	NA	NA	NA
CACAGGCTCGAACTGT-1_25G_P3C1	18.93042778	24.50469602	1	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	958	1443	0.003465003	0.006930007	0	oligos	OL-Cntl	NA	NA	NA
CACAGGCTCTCAACTT-1_25G_P3C1	-9.438402718	0.51495639	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2785	6796	0.009123014	0.002942908	0	13A	IN-VIP	NA	NA	NA
CACAGGCTCTTGTATC-1_25G_P3C1	-2.588950715	-23.90916326	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4043	12094	0.003555482	0.002893997	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CACAGTATCAGCACAT-1_25G_P3C1	5.944707575	-31.0020533	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	5134	17201	0.002034765	0.003488169	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CACAGTATCATGTGGT-1_25G_P3C1	19.1356709	21.53176002	1	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	934	1518	0.001317523	0.001317523	0	oligos	OL-Cntl	NA	NA	NA
CACAGTATCGGTGTTA-1_25G_P3C1	-4.651763409	-23.34994905	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3735	10235	0.000293112	0.004494382	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CACAGTATCTGGTATG-1_25G_P3C1	-6.67248855	-2.446790509	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1761	3145	0.007949126	0.004769475	0	13A	IN-VIP	NA	NA	NA
CACATAGAGCTGATAA-1_25G_P3C1	-3.663711178	-23.3498175	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4379	13296	0.000676895	0.007145006	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CACATAGAGGGTATCG-1_25G_P3C1	-1.630346235	-25.5224185	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4824	15855	0.003721224	0.004162725	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CACATAGGTAGTAGTA-1_25G_P3C1	-0.690951633	-29.44076705	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4432	12989	0.000615906	0.003772423	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CACATAGGTCTCAACA-1_25G_P3C1	-2.648645606	-14.05309395	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2122	4490	0.007572383	0.005567929	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CACATAGGTGGCCCTA-1_25G_P3C1	-19.37175591	-28.09191909	6A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3569	10190	0.004023553	0.003729146	0	6A	IN-PV	NA	NA	NA
CACATTTAGCTCAACT-1_25G_P3C1	-39.26237337	-1.027968926	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1426	2669	0.004496066	0.002622705	0	9	OPC	NA	NA	NA
CACATTTCAATAACGA-1_25G_P3C1	-7.231996155	-0.165316509	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2004	4142	0.001931434	0.003621439	0	13A	IN-VIP	NA	NA	NA
CACATTTCAGGCAGTA-1_25G_P3C1	19.97877285	-6.897810633	3	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2283	5608	0.001783167	0.001783167	0	3	EN-L5-6	NA	NA	NA
CACATTTTCGCTGATA-1_25G_P3C1	-19.3323643	-28.01417151	6A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3148	8368	0.004660612	0.004063098	0	6A	IN-PV	NA	NA	NA
CACCACTAGTCCATAC-1_25G_P3C1	-11.65236056	-19.77611906	6B	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1044	1851	0.01458671	0	0	6B	IN-SST	NA	NA	NA
CACCACTAGTGTCTCA-1_25G_P3C1	-9.851048846	2.45191089	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3198	7925	0.003280757	0.002649842	0	13A	IN-VIP	NA	NA	NA
CACCACTCATCATCCC-1_25G_P3C1	-16.88472022	-26.64098243	6A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2278	4890	0.004294479	0.003885481	0	6A	IN-PV	NA	NA	NA
CACCACTTCAACTCTT-1_25G_P3C1	18.98063614	13.15230489	1	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1269	2247	0.000890076	0.003115265	0	oligos	OL-Cntl	NA	NA	NA
CACCAGGCACTGTGTA-1_25G_P3C1	-0.747200882	-11.07396636	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1853	3677	0.000271961	0.002447648	0	12	EN-MIX	NA	NA	NA
CACCAGGGTCCTCCAT-1_25G_P3C1	-2.930180935	-14.19449009	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2283	4673	0	0.006419859	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CACCAGGGTGCCTTGG-1_25G_P3C1	-2.977273733	-26.38421662	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4251	12945	7.72E-05	0.002471997	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CACCAGGTCCTCATTA-1_25G_P3C1	-2.049168986	-27.3234356	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4322	13586	0.001692919	0.002870602	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CACCTTGAGAATGTGT-1_25G_P3C1	9.315032646	27.6384377	1	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	844	1316	0.000759878	0.004559271	0	oligos	OL-Cntl	NA	NA	NA
CACCTTGCATGGGAAC-1_25G_P3C1	38.7113084	9.189042085	14	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	763	1027	0.00194742	0.004868549	0	14	Microglia	NA	NA	NA
CACCTTGGTTCAGCGC-1_25G_P3C1	-2.660890768	-24.42685352	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4433	13350	0.000749064	0.003370787	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CACCTTGTCGATAGAA-1_25G_P3C1	-3.209283094	-13.08198438	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2187	4508	0.001996451	0.007542147	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CACCTTGTCTACGAGT-1_25G_P3C1	-10.91294104	1.445795444	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2915	7624	0.008001049	0.00249213	0	13A	IN-VIP	NA	NA	NA
CACTCCAAGAGGGATA-1_25G_P3C1	-28.44532775	17.94858244	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1087	1817	0.00495322	0.003302146	0	8	Astrocytes	NA	NA	NA
CACTCCAAGGGTGTTG-1_25G_P3C1	25.47755679	-29.32515117	3	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4893	16508	0.00018173	0.003028835	0	3	EN-L5-6	NA	NA	NA
CACTCCAAGTCCTCCT-1_25G_P3C1	-27.98593814	18.39655836	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1153	2003	0.002496256	0.002995507	0	8	Astrocytes	NA	NA	NA
CACTCCACAACTGCGC-1_25G_P3C1	-38.91483611	0.076571836	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1536	2924	0.002735978	0.002051984	0	9	OPC	NA	NA	NA
CACTCCACAAGTTGTC-1_25G_P3C1	-2.370717129	-25.86924323	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4549	14061	0.000284475	0.00654292	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CACTCCACAGATGAGC-1_25G_P3C1	0.201904508	-8.003009934	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1533	2640	0.001893939	0.006060606	0	12	EN-MIX	NA	NA	NA
CACTCCACATACCATG-1_25G_P3C1	-26.12180674	28.07528409	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1647	3484	0.000861079	0.003731343	0	8	Astrocytes	NA	NA	NA
CACTCCATCAACCAAC-1_25G_P3C1	39.20268329	9.357532772	14	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	806	1098	0.001821494	0.007285974	0	14	Microglia	NA	NA	NA
CACTCCATCAGCGATT-1_25G_P3C1	8.982084545	33.05887002	1	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	883	1297	0	0.00462606	0	oligos	OL-Cntl	NA	NA	NA
CACTCCATCAGTTCGA-1_25G_P3C1	-28.11084472	18.73707199	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1177	2145	0.000932401	0.007459207	0	8	Astrocytes	NA	NA	NA
CACTCCATCCTGCCAT-1_25G_P3C1	-16.49164343	-10.99474941	13B	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3259	8073	0.00396383	0.00383996	0	13B	IN-SV2C	NA	NA	NA
CAGAATCAGAATTGTG-1_25G_P3C1	-3.356187278	-6.511268996	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	952	1492	0.009383378	0.002680965	0	13A	IN-VIP	NA	NA	NA
CAGAATCCACCGAAAG-1_25G_P3C1	-2.235426758	-28.7220276	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2776	5708	0.000525578	0.004029432	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CAGAATCCATCACGAT-1_25G_P3C1	-25.54068076	25.65964122	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1390	2491	0.000401445	0.003613007	0	8	Astrocytes	NA	NA	NA
CAGAATCGTACGACCC-1_25G_P3C1	-4.537653835	-22.696864	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3589	9995	0.00150075	0.007303652	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CAGAATCGTAGCTAAA-1_25G_P3C1	10.73424981	-33.92382417	3	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	6196	23583	0.004791587	0.006021287	0	3	EN-L5-6	NA	NA	NA
CAGAATCGTCGATTGT-1_25G_P3C1	-18.0449648	-27.10235188	6A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2578	6036	0.008117959	0.003644798	0	6A	IN-PV	NA	NA	NA
CAGAATCGTGAGGGAG-1_25G_P3C1	-0.507935329	-26.45177563	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3607	7816	0.004605937	0.007804504	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CAGAGAGAGCGGCTTC-1_25G_P3C1	-2.446743154	-16.85334031	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2500	5780	0.002595156	0.003979239	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CAGAGAGTCTCGTTTA-1_25G_P3C1	-4.500020605	-17.29092385	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2714	5956	0.000335796	0.010913365	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CAGATCAGTATATGGA-1_25G_P3C1	-33.65034637	-11.4648556	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	848	1238	0	0.002423263	0	9	OPC	NA	NA	NA
CAGATCATCCATGAAC-1_25G_P3C1	-38.58548631	-2.294563242	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1292	2284	0.000437828	0.001751313	0	9	OPC	NA	NA	NA
CAGATCATCGCGTAGC-1_25G_P3C1	-3.54737373	-4.651529538	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1200	1979	0.012632643	0.00707428	0	13A	IN-VIP	NA	NA	NA
CAGCAGCAGGCACATG-1_25G_P3C1	-2.043872704	-24.1792076	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4773	14916	0.004625905	0.004424779	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CAGCAGCCACGTTGGC-1_25G_P3C1	-0.939882738	-29.3007146	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3427	7669	0.001043161	0.007823706	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CAGCAGCCAGACAGGT-1_25G_P3C1	-2.390406765	-26.42474437	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4112	12065	0.00132615	0.002983838	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CAGCAGCGTATAGTAG-1_25G_P3C1	6.373561571	-8.37668521	4	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2142	3841	0.009372559	0.007810466	0	L2-3	EN-L2-3-MS	NA	NA	NA
CAGCAGCTCACGCGGT-1_25G_P3C1	13.76331232	29.98877959	1	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	887	1312	0.003810976	0.00304878	0	oligos	OL-Cntl	NA	NA	NA
CAGCAGCTCTTGCAAG-1_25G_P3C1	-30.45322921	20.51535643	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	891	1505	0.000664452	0.003322259	0	8	Astrocytes	NA	NA	NA
CAGCATAAGATGGGTC-1_25G_P3C1	-37.81361036	-9.872330565	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1060	1805	0.00498615	0.002216066	0	9	OPC	NA	NA	NA
CAGCATAAGTCGTACT-1_25G_P3C1	26.39110169	3.851966643	15BA	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	705	1058	0.006616257	0.008506616	0	15BA	Stromal cells	NA	NA	NA
CAGCATAGTCATCCCT-1_25G_P3C1	-8.79596075	2.332502245	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2755	6825	0.004542125	0.002637363	0	13A	IN-VIP	NA	NA	NA
CAGCATAGTGATAAGT-1_25G_P3C1	-0.93739277	-28.12539742	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4350	12652	0.002055011	0.003003478	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CAGCATAGTTGCGTTA-1_25G_P3C1	25.47036635	-4.770728144	2	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4947	16728	0.00053802	0.004005261	0	2	EN-L4	NA	NA	NA
CAGCATATCAGATAAG-1_25G_P3C1	0.873911595	-6.048573247	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1020	1646	0.000607533	0.006075334	0	12	EN-MIX	NA	NA	NA
CAGCCGAAGCGATCCC-1_25G_P3C1	25.54140086	-29.28881167	3	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4767	16776	0	0.002205532	0	3	EN-L5-6	NA	NA	NA
CAGCCGACACCACGTG-1_25G_P3C1	25.26893996	-1.880851815	2	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2959	7789	0.000128386	0.003209655	0	2	EN-L4	NA	NA	NA
CAGCCGACATTACGAC-1_25G_P3C1	-5.035257009	-23.42011705	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3657	9790	0.00102145	0.002553626	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CAGCCGATCCGCAAGC-1_25G_P3C1	-4.692831506	-17.02704538	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2635	5626	0.001421969	0.008176324	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CAGCCGATCCGTCAAA-1_25G_P3C1	37.99562643	9.283300978	14	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	737	1016	0.003937008	0.008858268	0	14	Microglia	NA	NA	NA
CAGCCGATCGCACTCT-1_25G_P3C1	-6.543600001	0.138959673	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2070	4425	0.009039548	0.002033898	0	13A	IN-VIP	NA	NA	NA
CAGCGACAGCTAAACA-1_25G_P3C1	25.52317873	-3.925192655	2	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3587	10316	0.002229546	0.002229546	0	2	EN-L4	NA	NA	NA
CAGCGACGTTATCCGA-1_25G_P3C1	24.50402045	0.086763127	2	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2183	4396	0.002502275	0.001819836	0	2	EN-L4	NA	NA	NA
CAGCGACTCCATGCTC-1_25G_P3C1	-10.90382123	0.69665488	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2934	6480	0.014351852	0.005401235	0	13A	IN-VIP	NA	NA	NA
CAGCGACTCCGATATG-1_25G_P3C1	7.637648709	-31.83180472	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4076	12439	0.003858831	0.002733339	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CAGCGACTCTTGCATT-1_25G_P3C1	2.403494214	-6.447155095	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1174	1814	0.000551268	0.009922822	0	12	EN-MIX	NA	NA	NA
CAGCTAACACGGCTAC-1_25G_P3C1	36.50101237	11.24570503	14	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	741	1062	0	0.020715631	0	14	Microglia	NA	NA	NA
CAGCTAAGTCAGCTAT-1_25G_P3C1	7.983754284	32.38117459	1	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	675	1007	0.003972195	0.006951341	0	oligos	OL-Cntl	NA	NA	NA
CAGCTAAGTCCCTTGT-1_25G_P3C1	-12.57152345	-11.0438502	13B	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1671	3304	0.00090799	0.003934625	0	13B	IN-SV2C	NA	NA	NA
CAGCTAATCGTAGATC-1_25G_P3C1	-2.696747142	-23.91452368	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4716	14934	0.002209723	0.005624749	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CAGCTGGAGAGTAAGG-1_25G_P3C1	-3.315015012	-6.770757117	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	861	1341	0.000745712	0.004474273	0	13A	IN-VIP	NA	NA	NA
CAGCTGGAGTGAACAT-1_25G_P3C1	-19.63550663	-28.19564309	6A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3854	10962	0.002463054	0.00410509	0	6A	IN-PV	NA	NA	NA
CAGCTGGGTACATCCA-1_25G_P3C1	29.73938689	-0.814826225	2	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4047	11446	0.004979906	0.007251442	0	2	EN-L4	NA	NA	NA
CAGCTGGGTCAATGTC-1_25G_P3C1	-4.359196408	-15.5373545	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2591	5805	0.000689061	0.006029285	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CAGCTGGGTCGACTAT-1_25G_P3C1	-1.549538512	-27.38344508	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	5296	19469	0.002105912	0.004263188	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CAGCTGGTCACAGTAC-1_25G_P3C1	-2.34310638	-24.81608653	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	5408	20950	0.002147971	0.004343675	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CAGGTGCAGAGCTTCT-1_25G_P3C1	-4.170156887	-15.28505752	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2642	5865	0.000341006	0.007161125	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CAGGTGCCATACTACG-1_25G_P3C1	-1.724142604	-25.15049464	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	5645	20346	0.00167109	0.003637079	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CAGGTGCGTTAGGGTG-1_25G_P3C1	5.574055669	-31.84554612	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4082	10477	0.003149757	0.003149757	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CAGGTGCTCAGCACAT-1_25G_P3C1	-4.579547562	-16.14602642	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2521	5716	0.000524843	0.005773268	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CAGGTGCTCGAATGCT-1_25G_P3C1	-34.73833753	-10.93057421	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	835	1345	0.002230483	0	0	9	OPC	NA	NA	NA
CAGTAACAGGAATCGC-1_25G_P3C1	-38.30511215	-7.813433742	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1141	2006	0.006480558	0.001495513	0	9	OPC	NA	NA	NA
CAGTAACCAGACACTT-1_25G_P3C1	-0.737377564	-29.58536829	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	6002	24663	0.001135304	0.005271054	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CAGTAACTCACGCGGT-1_25G_P3C1	-9.10635435	0.203659326	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2241	4380	0.008447489	0.005479452	0	13A	IN-VIP	NA	NA	NA
CAGTCCTAGTTCCACA-1_25G_P3C1	-27.78303366	25.88484643	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1378	2706	0.002217295	0.002217295	0	8	Astrocytes	NA	NA	NA
CAGTCCTCATGACATC-1_25G_P3C1	24.47665299	-29.65873915	3	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3488	10144	0.00216877	0.002858833	0	3	EN-L5-6	NA	NA	NA
CAGTCCTCATTCCTGC-1_25G_P3C1	27.82396437	-0.534511668	2	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3899	10386	0.001733102	0.003369921	0	2	EN-L4	NA	NA	NA
CAGTCCTGTAAAGGAG-1_25G_P3C1	-11.0902009	2.580065749	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3566	9103	0.008678458	0.006920795	0	13A	IN-VIP	NA	NA	NA
CAGTCCTGTACGCACC-1_25G_P3C1	-4.363947231	-23.91362053	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3694	9741	0.001950518	0.004209013	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CAGTCCTGTATTCTCT-1_25G_P3C1	-14.31504128	-10.8368071	13B	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2200	4888	0.000204583	0.004091653	0	13B	IN-SV2C	NA	NA	NA
CAGTCCTTCAAGATCC-1_25G_P3C1	-11.95785408	-19.95475586	6B	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1029	1725	0.020289855	0.002318841	0	6B	IN-SST	NA	NA	NA
CAGTCCTTCCGAACGC-1_25G_P3C1	-4.540244573	-18.35207299	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2856	6545	0.00565317	0.006111536	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CATATGGGTACAAGTA-1_25G_P3C1	-37.75686577	-8.287333092	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1053	1807	0.004980631	0.002213614	0	9	OPC	NA	NA	NA
CATATGGTCTACCAGA-1_25G_P3C1	-5.502331317	-20.98855606	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2626	6142	0.001790948	0.002442201	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CATATGGTCTCTAAGG-1_25G_P3C1	26.79784391	0.869075811	2	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2339	5392	0.00055638	0.00129822	0	2	EN-L4	NA	NA	NA
CATATGGTCTTAGCCC-1_25G_P3C1	-29.39159509	12.03809299	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	703	1033	0.004840271	0.006776379	0	8	Astrocytes	NA	NA	NA
CATATTCGTTCGCTAA-1_25G_P3C1	-38.90153613	-6.119338767	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1103	2021	0.003463632	0.001979218	0	9	OPC	NA	NA	NA
CATATTCTCACGCATA-1_25G_P3C1	5.997308975	-32.43514698	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4415	14540	0.000343879	0.00213205	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CATCAAGCATGTTCCC-1_25G_P3C1	-27.86587335	25.54598611	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1280	2141	0.002802429	0.002802429	0	8	Astrocytes	NA	NA	NA
CATCAAGGTAAGTAGT-1_25G_P3C1	1.335606138	-6.762578899	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1147	1887	0.002119767	0.002649709	0	12	EN-MIX	NA	NA	NA
CATCAAGGTACATGTC-1_25G_P3C1	-1.916886681	-15.52558842	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2377	4718	0.002755405	0.003179313	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CATCAAGGTGCAGTAG-1_25G_P3C1	-5.155151774	-21.534546	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3137	7755	0.001031593	0.003352676	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CATCAAGGTTTGCATG-1_25G_P3C1	-2.056905034	-28.69010923	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3230	8636	0.000347383	0.002547476	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CATCAAGTCGCTAGCG-1_25G_P3C1	-32.64685342	-0.84221365	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1490	2561	0.00468567	0.002733307	0	9	OPC	NA	NA	NA
CATCAGACACATGTGT-1_25G_P3C1	-23.86624012	29.6924351	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1849	3769	0.001326612	0.003979836	0	8	Astrocytes	NA	NA	NA
CATCAGAGTCGCCATG-1_25G_P3C1	11.04569176	28.46582181	1	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	719	1228	0	0.000814332	0	oligos	OL-Cntl	NA	NA	NA
CATCAGAGTTCCACTC-1_25G_P3C1	10.54877784	22.44782808	1	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	863	1360	0.000735294	0.007352941	0	oligos	OL-Cntl	NA	NA	NA
CATCAGAGTTCGTGAT-1_25G_P3C1	0.790078793	-14.30608023	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2155	3999	0.002250563	0.004501125	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CATCCACAGGTGACCA-1_25G_P3C1	10.97717958	27.04583653	1	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	833	1255	0.002390438	0.002390438	0	oligos	OL-Cntl	NA	NA	NA
CATCCACGTACAAGTA-1_25G_P3C1	9.173833194	31.048052	1	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	812	1345	0.000743494	0.003717472	0	oligos	OL-Cntl	NA	NA	NA
CATCCACGTCTAAACC-1_25G_P3C1	-3.403066907	-7.651575711	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	675	1015	0.037438424	0.000985222	0	13A	IN-VIP	NA	NA	NA
CATCCACGTCTGGAGA-1_25G_P3C1	-18.90133981	-27.60162036	6A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3168	8346	0.008267434	0.003714354	0	6A	IN-PV	NA	NA	NA
CATCCACGTGCAGGTA-1_25G_P3C1	-26.6555098	1.821577011	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1824	3181	0.000628733	0.005029865	0	9	OPC	NA	NA	NA
CATCCACTCAATAAGG-1_25G_P3C1	14.36192137	-8.260047336	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2128	4818	0.000622665	0.003113325	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CATCGAAAGACTTTCG-1_25G_P3C1	4.890027905	-30.43218225	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3167	7211	0.000832062	0.00374428	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CATCGAAAGATATACG-1_25G_P3C1	-18.14728585	-26.91124756	6A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2513	5806	0.006200482	0.00430589	0	6A	IN-PV	NA	NA	NA
CATCGAACACGAAAGC-1_25G_P3C1	-3.533076251	-13.35285408	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2265	4537	0.00286533	0.010138858	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CATCGAAGTCACCCAG-1_25G_P3C1	1.35213729	-21.95960862	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4172	11692	0.005815943	0.004533014	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CATCGAATCGCCAAAT-1_25G_P3C1	-37.3136519	-5.807269764	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1140	1875	0.000533333	0.002666667	0	9	OPC	NA	NA	NA
CATCGAATCTTATCTG-1_25G_P3C1	-38.03663477	-8.659509531	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1035	1694	0.001770956	0.002361275	0	9	OPC	NA	NA	NA
CATCGGGAGAAGGGTA-1_25G_P3C1	-27.25765149	19.06409529	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1279	2116	0.003780718	0.005671078	0	8	Astrocytes	NA	NA	NA
CATCGGGCACCCATGG-1_25G_P3C1	-14.0725247	-8.323908382	13B	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2724	6318	0.000633112	0.00379867	0	13B	IN-SV2C	NA	NA	NA
CATCGGGTCCAAGCCG-1_25G_P3C1	-2.376628783	-23.86714235	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4370	13178	0.001821217	0.002959478	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CATCGGGTCCTTGCCA-1_25G_P3C1	-5.163614818	-21.28833393	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3399	9189	0.001958864	0.004244205	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CATCGGGTCTCCAGGG-1_25G_P3C1	-2.682584501	-22.67516111	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3702	9419	0.00456524	0.002017199	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CATCGGGTCTGTCCGT-1_25G_P3C1	-26.37175788	23.58816301	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1315	2179	0.006424966	0.003671409	0	8	Astrocytes	NA	NA	NA
CATGACAAGGGAAACA-1_25G_P3C1	-4.463009549	-23.56898568	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3780	11302	0.002300478	0.002035038	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CATGACAAGTTAACGA-1_25G_P3C1	-5.073308189	-21.40869646	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3437	9181	0.001198127	0.004030062	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CATGACAAGTTCGATC-1_25G_P3C1	-26.80152898	25.93571718	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1397	2493	0.001604493	0.000802246	0	8	Astrocytes	NA	NA	NA
CATGACACACGACTCG-1_25G_P3C1	-39.56752233	-0.942253751	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1443	2651	0.002263297	0.002640513	0	9	OPC	NA	NA	NA
CATGACAGTATAAACG-1_25G_P3C1	-26.014677	27.25853377	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1668	3260	0.003680982	0.00797546	0	8	Astrocytes	NA	NA	NA
CATGACAGTTAAGAAC-1_25G_P3C1	-5.26917107	-4.571921198	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1435	2713	0.013638039	0.001474383	0	13A	IN-VIP	NA	NA	NA
CATGCCTAGTGCCATT-1_25G_P3C1	39.51095539	9.683411188	14	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	799	1099	0.000909918	0.005459509	0	14	Microglia	NA	NA	NA
CATGCCTCACAGACAG-1_25G_P3C1	-15.40727041	-26.02844584	6A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1973	4366	0.00091617	0.002061383	0	6A	IN-PV	NA	NA	NA
CATGCCTGTGATAAGT-1_25G_P3C1	-4.09890778	-23.2104284	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4082	12097	0.00305861	0.004463917	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CATGCCTGTTCTCATT-1_25G_P3C1	-17.80863501	-24.31989528	6A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2815	7454	0	0.002012342	0	6A	IN-PV	NA	NA	NA
CATGCCTTCGTTGACA-1_25G_P3C1	-5.566905685	-1.468143904	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1904	3843	0.006505334	0.002862347	0	13A	IN-VIP	NA	NA	NA
CATGGCGAGAATAGGG-1_25G_P3C1	-27.65910029	23.6651799	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1257	2271	0.005284016	0.005284016	0	8	Astrocytes	NA	NA	NA
CATGGCGAGCACCGTC-1_25G_P3C1	-3.221506524	-23.52417337	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4300	12196	0.0013939	0.004837652	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CATGGCGGTCTCTTTA-1_25G_P3C1	11.99051664	32.23111618	1	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	714	1033	0.000968054	0.001936108	0	oligos	OL-Cntl	NA	NA	NA
CATGGCGTCTGAGGGA-1_25G_P3C1	-14.09536283	-8.277501399	13B	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2620	5953	0.006215354	0.004703511	0	13B	IN-SV2C	NA	NA	NA
CATGGCGTCTGGTATG-1_25G_P3C1	-4.402081104	-17.32262433	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2696	5789	0.006736915	0.007773363	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CATTATCAGCACACAG-1_25G_P3C1	-35.61317631	-11.85736362	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	814	1236	0.002427184	0.004854369	0	9	OPC	NA	NA	NA
CATTATCCAGCTGCTG-1_25G_P3C1	5.35948666	-27.27404276	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3178	8380	0.005011933	0.003699284	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CATTATCCATCACCCT-1_25G_P3C1	-27.59750604	24.96478398	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1313	2462	0.000406174	0.003655565	0	8	Astrocytes	NA	NA	NA
CATTATCTCGCTAGCG-1_25G_P3C1	-2.396420109	-12.62924692	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1956	4017	0.000746826	0.005227782	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CATTATCTCTCAAGTG-1_25G_P3C1	-2.344489488	-25.47761912	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4492	15241	0.001443475	0.00341185	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CATTCGCAGATCCCGC-1_25G_P3C1	-4.080880814	-18.07424964	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2940	6645	0.007674944	0.008878856	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CATTCGCGTCGGCTCA-1_25G_P3C1	29.66357507	0.085706115	2	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2785	6346	0.005200126	0.005042546	0	2	EN-L4	NA	NA	NA
CATTCGCGTCTAAAGA-1_25G_P3C1	37.28711178	8.867950024	14	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	779	1041	0.014409222	0.008645533	0	14	Microglia	NA	NA	NA
CCAATCCGTTAAGACA-1_25G_P3C1	-4.222848934	-15.93083591	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2588	6054	0.002642881	0.006442022	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CCAATCCTCATTCACT-1_25G_P3C1	18.8385462	22.64384023	1	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	806	1282	0.001560062	0.001560062	0	oligos	OL-Cntl	NA	NA	NA
CCACCTAAGCGATAGC-1_25G_P3C1	-26.58427708	27.36727209	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1563	3186	0.000627746	0.006591337	0	8	Astrocytes	NA	NA	NA
CCACCTACAATTGCTG-1_25G_P3C1	39.2695976	9.915665003	14	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	864	1213	0.000824402	0.004122012	0	14	Microglia	NA	NA	NA
CCACCTACATAGAAAC-1_25G_P3C1	-2.076148729	-25.40730605	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4713	15263	0.000982769	0.002882788	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CCACCTAGTAAATGTG-1_25G_P3C1	-4.147780837	-17.56257749	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2875	6489	0.010171059	0.010479273	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CCACCTAGTTCACGGC-1_25G_P3C1	-2.588284601	-27.1035102	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4327	13690	0.001168736	0.003360117	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CCACGGAAGCTGATAA-1_25G_P3C1	5.557153032	33.43841523	1	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	730	1007	0.006951341	0.007944389	0	oligos	OL-Cntl	NA	NA	NA
CCACGGATCATCTGTT-1_25G_P3C1	-3.859395665	-23.90927421	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4073	12539	0.000957014	0.00406731	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CCACGGATCGTCCAGG-1_25G_P3C1	-17.104861	-25.99250073	6A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2120	4377	0.006168609	0.003883939	0	6A	IN-PV	NA	NA	NA
CCACTACAGCGTAATA-1_25G_P3C1	-14.44715897	-24.75302969	6A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1522	2613	0.010332951	0.004209721	0	6A	IN-PV	NA	NA	NA
CCACTACAGGGTATCG-1_25G_P3C1	-0.964182602	-28.7236846	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3914	9719	0.00164626	0.006996605	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CCACTACCACCAACCG-1_25G_P3C1	39.12446224	9.172866027	14	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	738	1019	0.004906771	0.002944063	0	14	Microglia	NA	NA	NA
CCACTACCATGGGAAC-1_25G_P3C1	13.81167944	-32.94238957	3	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4234	13285	0.000677456	0.006774558	0	3	EN-L5-6	NA	NA	NA
CCACTACGTAGCACGA-1_25G_P3C1	39.41010911	9.555084355	14	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	808	1117	0	0.007162041	0	14	Microglia	NA	NA	NA
CCAGCGAAGCCAACAG-1_25G_P3C1	-5.155957155	-2.330115525	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1676	3323	0.006620524	0.003310262	0	13A	IN-VIP	NA	NA	NA
CCAGCGACATGAAGTA-1_25G_P3C1	5.934956488	31.1758314	1	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	779	1176	0.004251701	0.007653061	0	oligos	OL-Cntl	NA	NA	NA
CCAGCGAGTCCGAAGA-1_25G_P3C1	-4.406846376	-8.699496973	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	974	1503	0.013972056	0.002661344	0	13A	IN-VIP	NA	NA	NA
CCAGCGAGTTTGGCGC-1_25G_P3C1	6.671849267	-27.42341881	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4851	14713	0.001359342	0.002786651	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CCATGTCAGACAGAGA-1_25G_P3C1	-4.890744698	-1.475602556	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1475	2804	0.0032097	0.0021398	0	13A	IN-VIP	NA	NA	NA
CCATGTCCAGCTGTAT-1_25G_P3C1	-3.903892491	-14.02877298	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2364	5063	0.004937784	0.005530318	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CCATGTCGTAGCGTCC-1_25G_P3C1	13.86316762	-31.72938711	3	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3257	7421	0.000539011	0.004177335	0	3	EN-L5-6	NA	NA	NA
CCATGTCTCAACCATG-1_25G_P3C1	-4.534416175	-3.232958847	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1361	2312	0.00432526	0.003892734	0	13A	IN-VIP	NA	NA	NA
CCATTCGCAAGCCGCT-1_25G_P3C1	-8.7475866	1.168951993	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2534	5522	0.000724375	0.004527345	0	13A	IN-VIP	NA	NA	NA
CCATTCGGTACCAGTT-1_25G_P3C1	-11.75782967	-19.42705127	6B	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	978	1670	0.001796407	0.003592814	0	6B	IN-SST	NA	NA	NA
CCATTCGGTCTAGCGC-1_25G_P3C1	-27.60374457	24.49491591	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1301	2212	0.000904159	0.004068716	0	8	Astrocytes	NA	NA	NA
CCATTCGGTGCACCAC-1_25G_P3C1	9.689527209	-25.43434327	4	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3996	10275	0.00973236	0.003892944	0	L2-3	EN-L2-3-MS	NA	NA	NA
CCATTCGTCTTGTACT-1_25G_P3C1	-4.977109468	-24.18064669	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3170	8126	0.000861432	0.005414718	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CCCAATCAGAGTGACC-1_25G_P3C1	-29.48596594	14.32915154	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	865	1500	0.002	0.002666667	0	8	Astrocytes	NA	NA	NA
CCCAATCCAGACGCAA-1_25G_P3C1	-26.3872494	9.805007908	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	828	1290	0.001550388	0.005426357	0	8	Astrocytes	NA	NA	NA
CCCAATCGTCCGAAGA-1_25G_P3C1	-8.537914112	2.273050052	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2575	5679	0.006339144	0.002465223	0	13A	IN-VIP	NA	NA	NA
CCCAATCTCAAAGTAG-1_25G_P3C1	-2.680331998	-12.98393825	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2011	4134	0.001451379	0.006289308	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CCCAATCTCACAATGC-1_25G_P3C1	-3.272439308	-25.4971014	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4115	12605	0.001269338	0.003808013	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CCCAGTTAGAATAGGG-1_25G_P3C1	-2.164073041	-25.93582111	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4574	14186	0.000916396	0.004440998	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CCCAGTTAGACAATAC-1_25G_P3C1	16.32021027	1.436467766	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	786	1181	0.0042337	0.00592718	0	12	EN-MIX	NA	NA	NA
CCCAGTTAGACTGGGT-1_25G_P3C1	-35.54922914	1.842070423	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1768	3415	0.002928258	0.002635432	0	9	OPC	NA	NA	NA
CCCAGTTCACCGCTAG-1_25G_P3C1	-2.376415021	-1.62718105	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1749	3274	0.007025046	0.001832621	0	13A	IN-VIP	NA	NA	NA
CCCAGTTCAGGCAGTA-1_25G_P3C1	29.68781673	-1.224977721	2	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3419	7814	0.002175582	0.004607115	0	2	EN-L4	NA	NA	NA
CCCAGTTCAGTAAGAT-1_25G_P3C1	39.31415751	9.427648128	14	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	768	1033	0	0.009680542	0	14	Microglia	NA	NA	NA
CCCAGTTTCCGCGCAA-1_25G_P3C1	-0.701641937	-10.13459857	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1670	3109	0.003538115	0.005146349	0	12	EN-MIX	NA	NA	NA
CCCATACAGATATGGT-1_25G_P3C1	-36.94087917	-6.861856192	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1032	1617	0.003710575	0.004947434	0	9	OPC	NA	NA	NA
CCCATACCACAGACTT-1_25G_P3C1	-30.08365542	21.35434495	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	967	1676	0.002386635	0.008949881	0	8	Astrocytes	NA	NA	NA
CCCATACCACGTCAGC-1_25G_P3C1	-25.80309333	27.21906487	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1748	3378	0.004144464	0.004440497	0	8	Astrocytes	NA	NA	NA
CCCATACCAGGCGATA-1_25G_P3C1	-27.00441218	17.77924441	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1161	1835	0.001634877	0.001089918	0	8	Astrocytes	NA	NA	NA
CCCATACGTACGCACC-1_25G_P3C1	9.174756936	-31.05685842	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3788	10864	0.006259205	0.005983063	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CCCTCCTAGAACAACT-1_25G_P3C1	-39.08248755	-2.44067813	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1194	2184	0	0.002289377	0	9	OPC	NA	NA	NA
CCCTCCTAGAGAGCTC-1_25G_P3C1	10.55112919	30.7124539	1	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	741	1111	0.00270027	0.00270027	0	oligos	OL-Cntl	NA	NA	NA
CCCTCCTCACTTCTGC-1_25G_P3C1	3.560668746	-28.35993132	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4411	15803	0.001139024	0.002721002	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CCCTCCTCAGGACCCT-1_25G_P3C1	-37.72533889	-4.734973628	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1267	2199	0.002728513	0.007276035	0	9	OPC	NA	NA	NA
CCCTCCTGTAATAGCA-1_25G_P3C1	-39.70876001	0.252785963	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1555	3025	0.000661157	0.000991736	0	9	OPC	NA	NA	NA
CCCTCCTGTCGGCTCA-1_25G_P3C1	-11.16618564	1.557595347	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3144	7348	0.004627109	0.004627109	0	13A	IN-VIP	NA	NA	NA
CCGGGATAGGCAATTA-1_25G_P3C1	-4.861748149	-22.74060413	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3548	9780	0.000204499	0.003680982	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CCGGGATCATCCCATC-1_25G_P3C1	20.10199133	-29.05632849	3	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	5121	19584	0.003727533	0.004340278	0	3	EN-L5-6	NA	NA	NA
CCGGGATGTTAGAACA-1_25G_P3C1	-14.09854241	-7.867694675	13B	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3035	7481	0.00815399	0.002138752	0	13B	IN-SV2C	NA	NA	NA
CCGGGATTCCTTTCGG-1_25G_P3C1	-11.04225817	1.50392473	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2949	7079	0.005933041	0.003249046	0	13A	IN-VIP	NA	NA	NA
CCGGGATTCTTCGAGA-1_25G_P3C1	-13.0715598	-11.11355011	13B	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1575	3033	0.005275305	0.000659413	0	13B	IN-SV2C	NA	NA	NA
CCGGTAGAGACACTAA-1_25G_P3C1	28.17574627	0.628134087	2	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2818	6303	0.000793273	0.004442329	0	2	EN-L4	NA	NA	NA
CCGGTAGCACACAGAG-1_25G_P3C1	-0.582099372	-8.783030257	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1713	2967	0.00438153	0.00876306	0	12	EN-MIX	NA	NA	NA
CCGGTAGGTCTAGCGC-1_25G_P3C1	-2.201777748	-23.63085636	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4792	14509	0.00503136	0.005169205	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CCGGTAGTCTAACTCT-1_25G_P3C1	2.811957066	-28.90959381	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3471	9595	0.000833768	0.004481501	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CCGTACTGTCTAGTGT-1_25G_P3C1	-2.833323955	-12.86454467	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2195	4342	0.005527407	0.002763703	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CCGTACTGTTCCGTCT-1_25G_P3C1	-39.85149991	0.415542493	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1631	3505	0	0.00171184	0	9	OPC	NA	NA	NA
CCGTACTTCTTTACGT-1_25G_P3C1	-35.24107867	-0.546282151	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1415	2486	0.005631537	0.008045052	0	9	OPC	NA	NA	NA
CCGTGGACACACGCTG-1_25G_P3C1	-37.52351608	-9.718702733	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1068	1712	0.002920561	0.002336449	0	9	OPC	NA	NA	NA
CCGTGGAGTAGAGGAA-1_25G_P3C1	-0.851645887	-9.409256201	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1672	2971	0.003702457	0.008078088	0	12	EN-MIX	NA	NA	NA
CCGTGGAGTCTAGCGC-1_25G_P3C1	-4.778773713	-22.53259601	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3802	10473	0.002196123	0.004296763	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CCGTGGATCCGCATAA-1_25G_P3C1	22.06457852	-8.571694038	2	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2179	4774	0.001256808	0.002513615	0	2	EN-L4	NA	NA	NA
CCGTTCAAGGCTCAGA-1_25G_P3C1	10.62882306	28.96947729	1	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	758	1199	0.008340284	0.002502085	0	oligos	OL-Cntl	NA	NA	NA
CCGTTCACAGGTCTCG-1_25G_P3C1	-4.492250823	-18.45531813	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3004	6879	0.002616659	0.012065707	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CCTAAAGAGACACGAC-1_25G_P3C1	-4.21249196	-21.70590072	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3943	12060	0.000912106	0.006467662	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CCTAAAGCACTGTGTA-1_25G_P3C1	-2.887510086	-26.20105539	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3819	10028	0.00129637	0.002692461	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CCTAAAGCAGCTATTG-1_25G_P3C1	-5.194753846	-21.77597678	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3330	9076	0.005068312	0.002313795	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CCTAAAGCATTATCTC-1_25G_P3C1	-3.209336829	-16.97833677	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2693	6119	0.003758784	0.006210165	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CCTAAAGGTCATATCG-1_25G_P3C1	-27.3670531	18.77112539	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1119	1869	0.002140182	0.003745318	0	8	Astrocytes	NA	NA	NA
CCTACACAGCGAGAAA-1_25G_P3C1	-4.121578646	-23.86804186	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4578	14769	0.000203128	0.004739657	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CCTACACCAATAACGA-1_25G_P3C1	-39.46863576	-0.006383192	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1515	2812	0.001066856	0.004267425	0	9	OPC	NA	NA	NA
CCTACACGTGTCTGAT-1_25G_P3C1	28.18168672	0.334500013	2	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3010	7469	0.002276074	0.005489356	0	2	EN-L4	NA	NA	NA
CCTACACTCACCTTAT-1_25G_P3C1	20.23513771	20.6469718	1	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1032	1710	0	0.006432749	0	oligos	OL-Cntl	NA	NA	NA
CCTACACTCATGGTCA-1_25G_P3C1	-5.685872614	-21.92135403	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2939	7619	0.000787505	0.00315002	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CCTACCAAGAGCTTCT-1_25G_P3C1	-1.895944618	-17.70974426	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2977	7632	0.002227463	0.004454927	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CCTACCACAGTCTTCC-1_25G_P3C1	-24.48287207	30.07881015	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1847	3895	0.000256739	0.002053915	0	8	Astrocytes	NA	NA	NA
CCTACCAGTGATGTGG-1_25G_P3C1	-9.336674265	2.564674008	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2740	6186	0.005172971	0.002909796	0	13A	IN-VIP	NA	NA	NA
CCTACCAGTTAGATGA-1_25G_P3C1	1.295613215	-13.57538601	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2565	7371	0.00298467	0.009089676	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CCTACCATCAGCTCGG-1_25G_P3C1	-22.03438643	9.822847764	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	961	1476	0	0.002710027	0	8	Astrocytes	NA	NA	NA
CCTACCATCATGCTCC-1_25G_P3C1	-0.994036967	-27.93400231	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	5202	18224	0.001262072	0.003127744	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CCTACCATCGTTGCCT-1_25G_P3C1	-5.381932592	-1.484478476	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1731	3455	0.00260492	0.00260492	0	13A	IN-VIP	NA	NA	NA
CCTAGCTAGAGCTGGT-1_25G_P3C1	-26.8352249	18.90655904	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1178	2071	0	0.002897151	0	8	Astrocytes	NA	NA	NA
CCTAGCTAGCAGCCTC-1_25G_P3C1	-2.884746883	-13.01996722	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2178	4556	0.000877963	0.009438104	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CCTAGCTCAACGCACC-1_25G_P3C1	-4.469230081	-17.17856573	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2866	6611	0.004386628	0.010285887	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CCTAGCTCATCGGTTA-1_25G_P3C1	-18.71515907	-23.08085583	6A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2299	4944	0.03802589	0.002831715	0	6A	IN-PV	NA	NA	NA
CCTAGCTCATGCATGT-1_25G_P3C1	25.34687584	5.330989825	15A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1158	1953	0.002048131	0.007168459	0	15A	Endo cells	NA	NA	NA
CCTAGCTGTCATCGGC-1_25G_P3C1	0.648252365	-7.540400937	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1285	2235	0.002237136	0.0049217	0	12	EN-MIX	NA	NA	NA
CCTAGCTTCACTCTTA-1_25G_P3C1	-26.53891576	27.91976608	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1730	3839	0.000260485	0.00286533	0	8	Astrocytes	NA	NA	NA
CCTAGCTTCACTTATC-1_25G_P3C1	-14.8373408	-11.20798394	13B	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2482	6099	0.00245942	0.004099033	0	13B	IN-SV2C	NA	NA	NA
CCTAGCTTCAGCAACT-1_25G_P3C1	2.956449748	-4.565031582	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	875	1317	0.006074412	0.002277904	0	12	EN-MIX	NA	NA	NA
CCTATTAAGGCAGTCA-1_25G_P3C1	-4.285965818	-16.76436615	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2554	5303	0.00905148	0.00528003	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CCTATTAAGGCTCTTA-1_25G_P3C1	-4.947996124	-23.19652485	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3351	9112	0.001207199	0.006584723	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CCTATTAGTGTGAATA-1_25G_P3C1	-3.709862384	-5.479112668	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1089	1976	0.009109312	0.00354251	0	13A	IN-VIP	NA	NA	NA
CCTATTATCTACCAGA-1_25G_P3C1	-27.06053167	25.57046729	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1320	2546	0.005498822	0.005498822	0	8	Astrocytes	NA	NA	NA
CCTCAGTAGAGCTATA-1_25G_P3C1	-3.195256351	-15.01653165	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2566	5586	0.001432152	0.005012531	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CCTCAGTAGATGCGAC-1_25G_P3C1	-39.44480633	-1.333984832	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1435	2698	0.001853225	0.004447739	0	9	OPC	NA	NA	NA
CCTCAGTAGCCACTAT-1_25G_P3C1	-32.01829789	-13.27515223	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	648	1058	0.004725898	0	0	9	OPC	NA	NA	NA
CCTCAGTCAATGTAAG-1_25G_P3C1	-19.61010717	-28.07701809	6A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3700	9990	0.003603604	0.002202202	0	6A	IN-PV	NA	NA	NA
CCTCAGTCATTTGCTT-1_25G_P3C1	8.935290129	30.46241688	1	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	668	1033	0.017424976	0.001936108	0	oligos	OL-Cntl	NA	NA	NA
CCTCAGTGTTTGTTGG-1_25G_P3C1	-4.683533748	-24.43837174	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3405	9535	0.001992659	0.00293655	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CCTCTGACAACACGCC-1_25G_P3C1	-39.37932416	-0.636590617	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1461	2867	0.002790373	0.001395187	0	9	OPC	NA	NA	NA
CCTCTGAGTCGCGGTT-1_25G_P3C1	-7.846532594	-0.281901164	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2364	5529	0.017724724	0.003255562	0	13A	IN-VIP	NA	NA	NA
CCTCTGAGTTAGATGA-1_25G_P3C1	-5.264549243	-21.45202539	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3085	7644	0.000654108	0.003532182	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CCTCTGATCCATTCTA-1_25G_P3C1	-8.375776969	2.472427105	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2458	5453	0.006418485	0.002017238	0	13A	IN-VIP	NA	NA	NA
CCTCTGATCGGTTCGG-1_25G_P3C1	-28.75770035	17.14878135	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	974	1633	0.004286589	0.00183711	0	8	Astrocytes	NA	NA	NA
CCTTACGAGCTGAACG-1_25G_P3C1	10.11445169	25.98654534	1	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	912	1360	0.016911765	0.005882353	0	oligos	OL-Cntl	NA	NA	NA
CCTTACGCATCTCCCA-1_25G_P3C1	9.052086135	33.37326465	1	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	814	1332	0.000750751	0.003003003	0	oligos	OL-Cntl	NA	NA	NA
CCTTACGGTGCTAGCC-1_25G_P3C1	-2.405530125	-16.29006049	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2410	5445	0.003856749	0.003856749	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CCTTACGGTTCCATGA-1_25G_P3C1	-26.03052976	28.26549951	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1678	3210	0.013707165	0.001557632	0	8	Astrocytes	NA	NA	NA
CCTTACGTCATTATCC-1_25G_P3C1	-0.827210374	-29.35588392	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4844	16591	0.000120547	0.003556145	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CCTTACGTCTTAACCT-1_25G_P3C1	-28.11613737	17.64713751	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1002	1812	0.001103753	0.005518764	0	8	Astrocytes	NA	NA	NA
CCTTACGTCTTCTGGC-1_25G_P3C1	-2.27382604	-14.57980082	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2036	4698	0.000425713	0.003618561	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CCTTCCCAGCAACGGT-1_25G_P3C1	19.20956509	22.32388732	1	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	920	1433	0.001395673	0.001395673	0	oligos	OL-Cntl	NA	NA	NA
CCTTCCCAGCTCTCGG-1_25G_P3C1	-28.54629841	23.51362915	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1191	2075	0	0.005783133	0	8	Astrocytes	NA	NA	NA
CCTTCCCAGGGTCGAT-1_25G_P3C1	6.559262035	-31.88275076	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	5644	21525	0.002369338	0.003530778	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CCTTCCCCACGAAAGC-1_25G_P3C1	-2.189291844	-19.01996962	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2997	7119	0.001123753	0.002247507	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CCTTCCCCATAACCTG-1_25G_P3C1	0.062926933	-7.930550091	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1495	2604	0	0.006912442	0	12	EN-MIX	NA	NA	NA
CCTTCCCCATACAGCT-1_25G_P3C1	-2.515000587	-15.35669443	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2541	6024	0.010292165	0.003320053	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CCTTCCCGTGGTCTCG-1_25G_P3C1	-4.219999993	-18.87240925	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3317	8153	0.008831105	0.007727217	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CCTTCCCTCTCTTGAT-1_25G_P3C1	-39.32178912	-1.455756053	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1305	2478	0.000807103	0.001210654	0	9	OPC	NA	NA	NA
CCTTCGAAGGGATCTG-1_25G_P3C1	-4.344538468	-14.30701667	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2615	5692	0.001581167	0.014054814	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CCTTCGAAGTCGTTTG-1_25G_P3C1	28.23222831	0.86647992	2	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2537	5457	0.000916254	0.009529045	0	2	EN-L4	NA	NA	NA
CCTTCGAAGTGAACAT-1_25G_P3C1	-26.60604168	27.58475241	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1592	3239	0.000617475	0.004322322	0	8	Astrocytes	NA	NA	NA
CCTTCGACACACTGCG-1_25G_P3C1	-1.839426848	-25.494652	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	5307	18263	0.003340087	0.003230575	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CCTTCGAGTACCTACA-1_25G_P3C1	-2.584670457	-23.34196344	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3684	9743	0.002565945	0.004208149	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CCTTCGATCTATGTGG-1_25G_P3C1	-3.847689415	-16.58478888	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2573	5581	0.00268769	0.003583587	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CCTTTCTAGACTAGAT-1_25G_P3C1	-2.342916637	-12.7443093	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2122	4138	0.007008217	0.006524891	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CCTTTCTAGTGAATTG-1_25G_P3C1	-6.616729213	0.351186334	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1833	3542	0.006775833	0.006493506	0	13A	IN-VIP	NA	NA	NA
CCTTTCTAGTGGGCTA-1_25G_P3C1	-5.132814615	-21.85732502	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3247	8422	0.000593683	0.003205889	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CCTTTCTGTGAGGCTA-1_25G_P3C1	26.72796834	0.06082286	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2857	7046	0.000283849	0.001845018	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CCTTTCTGTTTAAGCC-1_25G_P3C1	-2.970325915	-25.83091189	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4383	15560	0.00096401	0.002313625	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CCTTTCTTCATATCGG-1_25G_P3C1	-31.53478404	12.93620119	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	804	1414	0.001414427	0.007779349	0	8	Astrocytes	NA	NA	NA
CCTTTCTTCGGAATCT-1_25G_P3C1	-15.43146132	-25.88362008	6A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1767	3665	0.000818554	0.00218281	0	6A	IN-PV	NA	NA	NA
CCTTTCTTCTCCAACC-1_25G_P3C1	-9.634159071	3.063934107	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3072	7178	0.00975202	0.005572583	0	13A	IN-VIP	NA	NA	NA
CCTTTCTTCTTATCTG-1_25G_P3C1	8.673912066	31.75692464	1	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	769	1219	0.000820345	0.004101723	0	oligos	OL-Cntl	NA	NA	NA
CGAACATAGGCTAGAC-1_25G_P3C1	-2.514448973	-12.0733223	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2120	4174	0.00718735	0.009103977	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGAACATAGTGTCCAT-1_25G_P3C1	-10.67601423	-32.80778623	16	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1087	1693	0.104548139	0.011222682	0	16	EN-PYR	NA	NA	NA
CGAACATGTCTCACCT-1_25G_P3C1	-4.730084454	-16.77245011	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2698	6114	0.003107622	0.005888126	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGAACATTCAGATAAG-1_25G_P3C1	-28.86268381	16.55405567	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	911	1449	0.002760524	0.003450656	0	8	Astrocytes	NA	NA	NA
CGAATGTGTCGAAAGC-1_25G_P3C1	-2.406596161	-12.03784304	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2040	3781	0.010579212	0.00872785	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGAATGTGTCGTCTTC-1_25G_P3C1	-3.45925013	-23.65570923	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4358	13840	0.002890173	0.00382948	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGAATGTGTGCATCTA-1_25G_P3C1	-0.136428902	-11.47028885	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1955	3535	0.004243281	0.005374823	0	12	EN-MIX	NA	NA	NA
CGAATGTTCCAAGTAC-1_25G_P3C1	-37.29732418	-9.053960584	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	946	1461	0.001368925	0.002053388	0	9	OPC	NA	NA	NA
CGAATGTTCGGCTACG-1_25G_P3C1	-3.09935459	-23.92248094	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3984	11283	0.000974918	0.003899672	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGACCTTGTTGCCTCT-1_25G_P3C1	28.41240536	0.020564804	2	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3599	9673	0.00186085	0.002894655	0	2	EN-L4	NA	NA	NA
CGACCTTTCAAACCGT-1_25G_P3C1	0.486023061	-8.147002553	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1400	2314	0.002592913	0.003889369	0	12	EN-MIX	NA	NA	NA
CGACTTCAGTACCGGA-1_25G_P3C1	-2.685441761	-15.77434705	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2503	5638	0.002305782	0.003547357	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGACTTCGTCAGTGGA-1_25G_P3C1	19.84410988	0.964538429	2	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1524	2835	0.000705467	0.007054674	0	2	EN-L4	NA	NA	NA
CGACTTCGTGACCAAG-1_25G_P3C1	-3.041022446	-14.39623311	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2493	5115	0.001564027	0.00684262	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGACTTCGTTGTGGAG-1_25G_P3C1	-4.275718081	-17.42762436	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2873	6167	0.010215664	0.007134749	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGACTTCTCACGCGGT-1_25G_P3C1	9.823151914	20.97504029	1	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	897	1420	0.000704225	0.002816901	0	oligos	OL-Cntl	NA	NA	NA
CGAGAAGAGAGGGATA-1_25G_P3C1	-4.699676791	-18.57372499	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2979	5977	0.00334616	0.005186548	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGAGAAGAGAGTCTGG-1_25G_P3C1	-0.554343588	-8.764492739	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1642	2916	0.011316872	0.015089163	0	12	EN-MIX	NA	NA	NA
CGAGAAGAGCACCGCT-1_25G_P3C1	8.591437266	28.67900938	1	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	800	1198	0.010016694	0.005008347	0	oligos	OL-Cntl	NA	NA	NA
CGAGAAGAGGGAGTAA-1_25G_P3C1	-38.61900424	-6.31442757	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1168	1952	0.001536885	0.00204918	0	9	OPC	NA	NA	NA
CGAGAAGGTAAGGGAA-1_25G_P3C1	0.867503014	-21.95457874	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3875	9949	0.002010252	0.005226656	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGAGAAGGTGGACGAT-1_25G_P3C1	0.524856457	-6.745581038	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1231	2083	0.003360538	0.002880461	0	12	EN-MIX	NA	NA	NA
CGAGAAGTCGGAATCT-1_25G_P3C1	-9.510230597	2.977612615	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3315	8244	0.01067443	0.004124212	0	13A	IN-VIP	NA	NA	NA
CGAGCACAGCATCATC-1_25G_P3C1	10.45851806	-33.9619788	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	5812	23672	0.000295708	0.001816492	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGAGCACAGCTGCAAG-1_25G_P3C1	2.147122206	-21.12655377	4	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4208	12488	0.015134529	0.004804612	0	L2-3	EN-L2-3-MS	NA	NA	NA
CGAGCACAGTGACTCT-1_25G_P3C1	-25.70609031	27.85013341	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1654	3326	0.002705953	0.004509922	0	8	Astrocytes	NA	NA	NA
CGAGCACCACAGACAG-1_25G_P3C1	-2.91182704	-23.19637792	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3758	10393	0.001731935	0.003752526	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGAGCACGTAAGCACG-1_25G_P3C1	12.89873611	29.35308664	1	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	757	1170	0.000854701	0.002564103	0	oligos	OL-Cntl	NA	NA	NA
CGAGCACGTGTTTGGT-1_25G_P3C1	19.32395568	-25.84053369	3	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2702	5987	0.005010857	0.024887256	0	3	EN-L5-6	NA	NA	NA
CGAGCACTCTGCGGCA-1_25G_P3C1	-5.128679272	-21.07657761	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3118	7501	0.001066524	0.004532729	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGAGCCAAGGAGTTTA-1_25G_P3C1	-2.417477749	-24.60843071	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4621	14199	0.00253539	0.0028171	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGAGCCAAGTCTTGCA-1_25G_P3C1	-29.75248328	21.64349976	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	985	1593	0.001255493	0.007532957	0	8	Astrocytes	NA	NA	NA
CGAGCCACAATCTGCA-1_25G_P3C1	-3.999126856	-20.31617649	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3896	10339	0.008704904	0.006770481	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGAGCCACAATGGACG-1_25G_P3C1	-14.58651111	-19.65287847	6B	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1369	2477	0.014129996	0.002018571	0	6B	IN-SST	NA	NA	NA
CGAGCCAGTTGTTTGG-1_25G_P3C1	3.609296117	-16.97582669	4	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2698	5489	0.003825833	0.00856258	0	L2-3	EN-L2-3-MS	NA	NA	NA
CGAGCCATCAATACCG-1_25G_P3C1	-3.898302633	-20.8102895	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4175	12683	0.005519199	0.007726878	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGAGCCATCCGTAGTA-1_25G_P3C1	-2.147633525	-23.70085863	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4426	13064	0.00528169	0.005434783	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGAGCCATCCGTCATC-1_25G_P3C1	-2.119167603	-13.60382576	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2186	5170	0.000967118	0.00483559	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGAGCCATCCTGCAGG-1_25G_P3C1	-37.22741729	-8.976112755	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	933	1490	0.002013423	0.002013423	0	9	OPC	NA	NA	NA
CGATCGGAGCCTATGT-1_25G_P3C1	-11.65694546	-19.13886969	6B	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1079	1763	0.023255814	0.005104935	0	6B	IN-SST	NA	NA	NA
CGATCGGCACCAGGTC-1_25G_P3C1	-17.95322757	-24.2800663	6A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2922	7356	0.008972268	0.002446982	0	6A	IN-PV	NA	NA	NA
CGATCGGCAGGAACGT-1_25G_P3C1	-14.14684996	-7.957245742	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2922	6529	0.003982233	0.004594884	0	13A	IN-VIP	NA	NA	NA
CGATCGGCATATACCG-1_25G_P3C1	-0.150793246	-29.89510603	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	5088	18512	0.004861711	0.002376837	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGATCGGGTTACAGAA-1_25G_P3C1	34.4764621	15.41434506	14	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	968	1385	0.003610108	0.045487365	0	14	Microglia	NA	NA	NA
CGATCGGTCTGTCTAT-1_25G_P3C1	32.69945772	15.19033962	14	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	774	1014	0.000986193	0.060157791	0	14	Microglia	NA	NA	NA
CGATGGCAGAAGGGTA-1_25G_P3C1	-4.27128416	-16.50929468	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2791	6219	0.000321595	0.004823927	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGATGGCGTAATTGGA-1_25G_P3C1	-26.12096887	20.70976844	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1590	2967	0.005729693	0.005392653	0	8	Astrocytes	NA	NA	NA
CGATGGCGTTTGACTG-1_25G_P3C1	-19.85681982	-29.06880512	6A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4304	13564	0.001327042	0.00258036	0	6A	IN-PV	NA	NA	NA
CGATGGCGTTTGCATG-1_25G_P3C1	39.4589594	9.772361635	14	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	725	1020	0.005882353	0	0	14	Microglia	NA	NA	NA
CGATGGCTCTTGTTTG-1_25G_P3C1	-3.504030023	-5.918234873	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	976	1686	0.013048636	0.003558719	0	13A	IN-VIP	NA	NA	NA
CGATGTATCCGATATG-1_25G_P3C1	-37.50081039	-10.11850264	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	908	1528	0.001963351	0.003926702	0	9	OPC	NA	NA	NA
CGATTGAAGCGATTCT-1_25G_P3C1	-4.044386775	-20.10735918	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3421	8474	0.005428369	0.005074345	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGATTGACAGATAATG-1_25G_P3C1	-2.046831803	-11.8193542	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1953	3714	0.004577275	0.003769521	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGATTGAGTACGAAAT-1_25G_P3C1	-39.86753859	0.544662692	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1654	3300	0.003333333	0.003030303	0	9	OPC	NA	NA	NA
CGCCAAGAGGGATCTG-1_25G_P3C1	-31.39997018	12.30999225	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	730	1026	0	0.003898635	0	8	Astrocytes	NA	NA	NA
CGCCAAGAGTCGATAA-1_25G_P3C1	-29.09091044	9.901875836	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	723	1053	0.000949668	0.007597341	0	8	Astrocytes	NA	NA	NA
CGCCAAGCACGTCTCT-1_25G_P3C1	-29.38678918	22.86288408	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1130	2023	0.000988631	0.002965892	0	8	Astrocytes	NA	NA	NA
CGCCAAGCAGCCTATA-1_25G_P3C1	8.670284767	31.68343809	1	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	770	1187	0.00336984	0.00336984	0	oligos	OL-Cntl	NA	NA	NA
CGCCAAGTCTTACCGC-1_25G_P3C1	-15.79776364	-25.95306925	6A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1977	4242	0.000235738	0.003064592	0	6A	IN-PV	NA	NA	NA
CGCGGTAAGACCTAGG-1_25G_P3C1	-26.13992912	26.78320369	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1477	2962	0.00033761	0.004051317	0	8	Astrocytes	NA	NA	NA
CGCGGTAAGTACGCGA-1_25G_P3C1	-3.385043624	-23.62156458	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4598	13912	0.002372053	0.005319149	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGCGGTAGTGTTTGTG-1_25G_P3C1	-27.27683063	10.73572943	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	761	1136	0.003521127	0.004401408	0	8	Astrocytes	NA	NA	NA
CGCGGTATCTACTTAC-1_25G_P3C1	-16.36136914	-26.28181848	6A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2018	4148	0.00168756	0.004821601	0	6A	IN-PV	NA	NA	NA
CGCGTTTAGACAGAGA-1_25G_P3C1	-15.80814027	-25.92422939	6A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1907	4096	0.012695313	0.002929688	0	6A	IN-PV	NA	NA	NA
CGCGTTTAGCTAGTCT-1_25G_P3C1	-11.00579554	-21.63264795	6B	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	871	1310	0.000763359	0.003053435	0	6B	IN-SST	NA	NA	NA
CGCGTTTCACACCGAC-1_25G_P3C1	11.89974586	27.3504164	1	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	801	1191	0.001679261	0.001679261	0	oligos	OL-Cntl	NA	NA	NA
CGCGTTTCACTCGACG-1_25G_P3C1	-29.18770638	12.08992522	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	724	1051	0.00190295	0.006660324	0	8	Astrocytes	NA	NA	NA
CGCGTTTCAGCTGCAC-1_25G_P3C1	-4.207889737	-15.91914686	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2465	4866	0.002260584	0.00431566	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGCGTTTCATATGGTC-1_25G_P3C1	-4.24990997	-20.2245208	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3190	8234	0.006436726	0.006436726	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGCGTTTGTACCGAGA-1_25G_P3C1	10.6792717	-9.057412627	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2970	7179	0.000975066	0.003064494	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGCGTTTGTCCGTGAC-1_25G_P3C1	6.770255565	-33.03685907	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4908	17268	0.000173732	0.002258513	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGCGTTTTCCTCAACC-1_25G_P3C1	-14.72751318	-21.60323303	6A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1648	3102	0.002256609	0.002256609	0	6A	IN-PV	NA	NA	NA
CGCGTTTTCTTAACCT-1_25G_P3C1	-10.89957818	1.561220135	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3301	9248	0.000540657	0.001946367	0	13A	IN-VIP	NA	NA	NA
CGCTATCAGCGGATCA-1_25G_P3C1	-3.7100636	-14.40537017	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2275	4643	0.000861512	0.007322852	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGCTATCAGGAGTACC-1_25G_P3C1	-26.47578868	26.58639106	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1567	3067	0.00423867	0.005868927	0	8	Astrocytes	NA	NA	NA
CGCTATCAGGCAGTCA-1_25G_P3C1	-26.17260746	26.68471764	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1495	2718	0.00147167	0.006990434	0	8	Astrocytes	NA	NA	NA
CGCTATCAGTGGCACA-1_25G_P3C1	19.93140879	21.46095185	1	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1079	1767	0	0.003395586	0	oligos	OL-Cntl	NA	NA	NA
CGCTATCCAGCGAACA-1_25G_P3C1	-27.88026932	18.12925337	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1132	1867	0.002678093	0.003213712	0	8	Astrocytes	NA	NA	NA
CGCTATCGTTAAGTAG-1_25G_P3C1	-16.40977566	-23.23026361	6A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1571	2788	0.006097561	0.00286944	0	6A	IN-PV	NA	NA	NA
CGCTGGACACGGTAGA-1_25G_P3C1	11.19146599	29.22755683	1	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	817	1248	0.006410256	0.001602564	0	oligos	OL-Cntl	NA	NA	NA
CGCTGGACACTTACGA-1_25G_P3C1	7.191996958	-33.2159898	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	5221	18286	0.0008203	0.002789019	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGCTGGATCCGATATG-1_25G_P3C1	4.157086658	-32.13206477	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	5702	21062	0.000474789	0.002991169	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGCTGGATCGGAATCT-1_25G_P3C1	-4.918953292	-20.47746647	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2965	6987	0.002289967	0.004293688	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGCTGGATCGTTGACA-1_25G_P3C1	2.629309878	-6.877603414	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1253	1903	0.002101944	0.007356805	0	12	EN-MIX	NA	NA	NA
CGCTTCACACCCATTC-1_25G_P3C1	-20.02168306	-28.45659927	6A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4014	12341	0.007535856	0.002917106	0	6A	IN-PV	NA	NA	NA
CGCTTCAGTAGGACAC-1_25G_P3C1	-5.265193008	-21.81210225	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3051	7256	0.000689085	0.002067255	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGCTTCAGTCCGTGAC-1_25G_P3C1	-8.241765916	1.290395114	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2241	4835	0.005997932	0.004550155	0	13A	IN-VIP	NA	NA	NA
CGCTTCAGTTTCCACC-1_25G_P3C1	-1.102465271	-27.68476462	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	6253	23934	0.001921952	0.004094593	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGCTTCATCCAAAGTC-1_25G_P3C1	-2.59116046	-24.56755474	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4463	13818	0.001664496	0.002677667	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGCTTCATCCACGACG-1_25G_P3C1	-1.824974441	-27.03300659	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	5897	23673	0.001351751	0.002619017	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGGACACAGAGGGCTT-1_25G_P3C1	-3.383720219	-13.15251037	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2294	4558	0.004607284	0.006143045	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGGACACAGCTAAGAT-1_25G_P3C1	-18.51778535	-24.74571791	6A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3233	8388	0.008822127	0.000953743	0	6A	IN-PV	NA	NA	NA
CGGACACAGGGTTTCT-1_25G_P3C1	-0.588010743	-27.02958208	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4926	15356	0.002474603	0.003646783	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGGACACCATTACGAC-1_25G_P3C1	24.81182305	-29.22249879	3	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3634	9761	0.00276611	0.002561213	0	3	EN-L5-6	NA	NA	NA
CGGACACGTGTGACCC-1_25G_P3C1	23.5510598	-9.225317154	3	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3929	10749	0.000744255	0.002790957	0	3	EN-L5-6	NA	NA	NA
CGGACACTCACTCCTG-1_25G_P3C1	-4.231507735	-23.76499988	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4669	15943	0.00018817	0.003324343	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGGACGTAGAAACCAT-1_25G_P3C1	-2.447815074	-12.64108504	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2094	3938	0.00126968	0.002793296	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGGACGTAGCGTCTAT-1_25G_P3C1	-3.250404105	-25.55568666	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4220	11381	0.000351463	0.005271944	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGGACGTAGGGCTTCC-1_25G_P3C1	-13.6834602	-10.73427196	13B	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1935	3625	0.003586207	0.002206897	0	13B	IN-SV2C	NA	NA	NA
CGGACGTCACCTATCC-1_25G_P3C1	-2.408144564	-24.81071602	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4632	15017	0.002330692	0.004661384	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGGACTGAGCCAACAG-1_25G_P3C1	39.19478586	9.34476415	14	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	796	1095	0.00913242	0.007305936	0	14	Microglia	NA	NA	NA
CGGACTGAGCCAGAAC-1_25G_P3C1	31.226248	-1.107908517	2	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2787	5996	0.006837892	0.004002668	0	2	EN-L4	NA	NA	NA
CGGACTGTCGGCGGTT-1_25G_P3C1	-15.15570674	-10.51887233	13B	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2896	6604	0.001665657	0.002725621	0	13B	IN-SV2C	NA	NA	NA
CGGAGCTCAATACGCT-1_25G_P3C1	8.652834757	30.41999896	1	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	710	1058	0.00094518	0.004725898	0	oligos	OL-Cntl	NA	NA	NA
CGGAGCTGTCTGGAGA-1_25G_P3C1	-3.321622083	-23.96491878	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4499	12956	0.000926212	0.003627663	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGGAGCTTCATGGTCA-1_25G_P3C1	-28.42274219	17.03438687	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	990	1618	0	0.006798517	0	8	Astrocytes	NA	NA	NA
CGGAGCTTCCGTAGGC-1_25G_P3C1	-27.58789435	19.14482611	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1272	2133	0.00140647	0.003281763	0	8	Astrocytes	NA	NA	NA
CGGAGTCAGTACGATA-1_25G_P3C1	-2.702059777	-13.54977727	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2010	4123	0.000485084	0.004608295	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGGAGTCCATCGATGT-1_25G_P3C1	10.45719094	-8.917082342	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2903	7286	0.001372495	0.004254735	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGGAGTCGTCTCTTAT-1_25G_P3C1	3.085479965	-3.2817848	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	892	1440	0	0.005555556	0	12	EN-MIX	NA	NA	NA
CGGAGTCTCGCATGAT-1_25G_P3C1	-39.68645113	0.039719066	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1445	2633	0.001139385	0.002278769	0	9	OPC	NA	NA	NA
CGGCTAGAGACTAGGC-1_25G_P3C1	3.084551532	-2.878480876	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	782	1149	0.046127067	0.00435161	0	12	EN-MIX	NA	NA	NA
CGGCTAGAGGCAGGTT-1_25G_P3C1	-9.492227792	3.053409499	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2812	5767	0.005375412	0.00433501	0	13A	IN-VIP	NA	NA	NA
CGGCTAGAGTGCCAGA-1_25G_P3C1	-1.773340136	-12.91858615	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2428	4679	0.001709767	0.003846976	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGGCTAGAGTGCCATT-1_25G_P3C1	-26.75101309	26.71309529	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1404	2637	0.000379219	0.004929845	0	8	Astrocytes	NA	NA	NA
CGGCTAGTCAACCATG-1_25G_P3C1	4.630848428	-32.34107316	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	5871	22595	0.000531091	0.003009515	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGGCTAGTCTTACCTA-1_25G_P3C1	-26.47595525	27.19580207	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1517	2888	0.00034626	0.004501385	0	8	Astrocytes	NA	NA	NA
CGGTTAAAGGCTAGGT-1_25G_P3C1	-26.64657316	27.2614138	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1596	2948	0.001696065	0.006105834	0	8	Astrocytes	NA	NA	NA
CGGTTAAAGGTGCTAG-1_25G_P3C1	-3.513596246	-21.92972719	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4052	11956	0.005102041	0.003345601	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGGTTAACAATGAATG-1_25G_P3C1	-0.844118654	-28.68060196	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	5699	20967	0.001812372	0.005103257	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGGTTAACAATGTAAG-1_25G_P3C1	-25.94258008	25.7328146	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1497	2744	0.005466472	0.005830904	0	8	Astrocytes	NA	NA	NA
CGGTTAACACAGTCGC-1_25G_P3C1	-4.189275259	-14.07858612	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2447	5133	0.006428989	0.00993571	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGGTTAAGTCTCACCT-1_25G_P3C1	-1.561981686	-25.61160773	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	5933	21172	0.001558662	0.006281882	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGGTTAATCCCTAATT-1_25G_P3C1	-3.408989101	-24.22384268	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3296	8327	0.001681278	0.005163925	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGGTTAATCGGCTACG-1_25G_P3C1	-4.292457904	-20.23293082	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3333	8470	0.002125148	0.004604486	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGTAGCGAGCGATATA-1_25G_P3C1	-4.060163005	-20.31784509	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3488	8830	0.003624009	0.006908267	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGTAGCGAGCTCCTCT-1_25G_P3C1	-2.801519671	-23.14853484	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4012	11649	0.004635591	0.003519615	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGTAGCGCAAACCCAT-1_25G_P3C1	23.4027607	1.157617487	2	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1955	3652	0.012322015	0.004107338	0	2	EN-L4	NA	NA	NA
CGTAGCGCAGATGGCA-1_25G_P3C1	-0.997034774	-9.353819127	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1729	3332	0.00120048	0.005102041	0	12	EN-MIX	NA	NA	NA
CGTAGCGGTAAATGAC-1_25G_P3C1	-4.612451512	-2.313085018	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1394	2459	0.008133388	0.002440016	0	13A	IN-VIP	NA	NA	NA
CGTAGCGGTAGAAGGA-1_25G_P3C1	-14.55858338	-10.7504122	13B	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2402	5084	0	0.002753737	0	13B	IN-SV2C	NA	NA	NA
CGTAGGCAGCCGCCTA-1_25G_P3C1	-1.617042192	-27.61208184	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4606	14047	0.001423792	0.005908735	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGTAGGCAGCGAAGGG-1_25G_P3C1	-2.702356132	-12.10453613	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2029	3705	0.005128205	0.007287449	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGTAGGCCATGCCCGA-1_25G_P3C1	0.357070725	-6.922183821	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1255	2168	0.000461255	0.00599631	0	12	EN-MIX	NA	NA	NA
CGTAGGCGTCTGGTCG-1_25G_P3C1	-15.42358727	-25.9233775	6A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1881	4088	0	0.00146771	0	6A	IN-PV	NA	NA	NA
CGTAGGCTCACCACCT-1_25G_P3C1	-13.87682297	-10.76070555	13B	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1944	4095	0.003907204	0.001953602	0	13B	IN-SV2C	NA	NA	NA
CGTAGGCTCTGGTGTA-1_25G_P3C1	-5.421052665	-3.25993892	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1522	2441	0.012290045	0.004096682	0	13A	IN-VIP	NA	NA	NA
CGTCACTAGCGTAGTG-1_25G_P3C1	-4.142296385	-14.37176502	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2271	4753	0.000841574	0.006311803	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGTCACTTCAAACAAG-1_25G_P3C1	12.74789657	-32.92893108	3	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2998	7738	0.000646162	0.002067718	0	3	EN-L5-6	NA	NA	NA
CGTCACTTCATACGGT-1_25G_P3C1	12.97500447	1.321011053	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	585	1086	0.00092081	0.003683241	0	12	EN-MIX	NA	NA	NA
CGTCACTTCCCGGATG-1_25G_P3C1	-6.816451035	0.632560021	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1873	3676	0.000272035	0.003536453	0	13A	IN-VIP	NA	NA	NA
CGTCACTTCGGTCCGA-1_25G_P3C1	-2.461649429	-15.32193354	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2638	6270	0.001275917	0.00446571	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGTCACTTCTGTTTGT-1_25G_P3C1	-2.25294008	-12.60011556	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1949	3896	0.01026694	0.003336756	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGTCAGGAGACAATAC-1_25G_P3C1	28.10237626	0.343832636	2	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3051	7435	0.002017485	0.004303968	0	2	EN-L4	NA	NA	NA
CGTCAGGAGAGAGCTC-1_25G_P3C1	-28.72995731	16.97903568	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	981	1699	0.000588582	0.005885815	0	8	Astrocytes	NA	NA	NA
CGTCAGGAGCGATTCT-1_25G_P3C1	-25.80334232	25.05653178	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1437	2802	0.001070664	0.006780871	0	8	Astrocytes	NA	NA	NA
CGTCAGGAGCTATGCT-1_25G_P3C1	-3.780596938	-13.79426318	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2291	4775	0.002094241	0.006073298	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGTCAGGAGGATATAC-1_25G_P3C1	-0.632549095	-29.37359933	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3324	7520	0.002792553	0.002659574	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGTCAGGCACAGACTT-1_25G_P3C1	6.311574522	-30.12901912	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4436	13122	0.005639384	0.005868008	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGTCAGGCACATCTTT-1_25G_P3C1	-4.969409927	-17.95528226	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2959	6642	0.001957242	0.012044565	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGTCAGGCACGGTGTC-1_25G_P3C1	-2.701395276	-13.56897816	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2236	4622	0.000216357	0.003461705	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGTCCATAGGCCCGTT-1_25G_P3C1	-4.337351173	-17.42075461	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3022	7351	0.007481975	0.00598558	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGTCCATGTGTGAAAT-1_25G_P3C1	-37.78418189	-4.990807646	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1284	2125	0.007529412	0.001882353	0	9	OPC	NA	NA	NA
CGTCCATGTTCGTGAT-1_25G_P3C1	-4.035514418	-17.20047777	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2827	6002	0.005664778	0.005998001	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGTCCATTCCGAGCCA-1_25G_P3C1	-9.468984228	1.454441769	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2701	5772	0.006583507	0.004504505	0	13A	IN-VIP	NA	NA	NA
CGTCTACCAACTGCTA-1_25G_P3C1	8.190293583	33.05666582	1	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	883	1418	0.000705219	0.004231312	0	oligos	OL-Cntl	NA	NA	NA
CGTCTACCACACCGAC-1_25G_P3C1	-39.58885114	-0.579357453	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1401	2582	0.004260263	0.00580945	0	9	OPC	NA	NA	NA
CGTCTACCACTTGGAT-1_25G_P3C1	14.30012984	1.852773143	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	786	1266	0.012638231	0.002369668	0	12	EN-MIX	NA	NA	NA
CGTCTACGTGTTCGAT-1_25G_P3C1	22.10217808	-8.628579512	2	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2153	4494	0.000890076	0.002447708	0	2	EN-L4	NA	NA	NA
CGTCTACTCACGCGGT-1_25G_P3C1	0.87025621	-7.609931917	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1337	2328	0.000429553	0.005584192	0	12	EN-MIX	NA	NA	NA
CGTCTACTCGCTAGCG-1_25G_P3C1	-11.66814655	-11.18097039	6B	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1170	2087	0.009103977	0.003354097	0	6B	IN-SST	NA	NA	NA
CGTGAGCAGACTAGAT-1_25G_P3C1	-12.13851212	0.955656906	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3107	6715	0.008190618	0.008190618	0	13A	IN-VIP	NA	NA	NA
CGTGAGCCAATCCAAC-1_25G_P3C1	0.738785674	-26.94601139	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3795	9774	0.001023123	0.003273992	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGTGAGCCAGCCTTTC-1_25G_P3C1	-2.487864597	-24.3516966	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4695	14588	0.00267343	0.00411297	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGTGAGCGTTGCCTCT-1_25G_P3C1	8.854374389	31.17037433	1	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	775	1258	0.00317965	0.004769475	0	oligos	OL-Cntl	NA	NA	NA
CGTGAGCTCAACGAAA-1_25G_P3C1	-1.782825939	-24.81062957	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	5167	16678	0.003597554	0.002997961	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGTGAGCTCACCCTCA-1_25G_P3C1	-17.97996721	-24.38234719	6A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2977	7328	0.002456332	0.003684498	0	6A	IN-PV	NA	NA	NA
CGTGAGCTCGTTGACA-1_25G_P3C1	-1.905860282	-26.14405689	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4112	10609	0.001508153	0.002922047	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGTGTAACACTTGGAT-1_25G_P3C1	-29.07480193	18.833361	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1021	1660	0.007228916	0.006024096	0	8	Astrocytes	NA	NA	NA
CGTGTAACATCTATGG-1_25G_P3C1	-8.513386808	0.74019576	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2040	4261	0.005632481	0.002581554	0	13A	IN-VIP	NA	NA	NA
CGTGTAAGTTAGTGGG-1_25G_P3C1	-38.71974928	-2.507538967	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1237	2208	0	0.002264493	0	9	OPC	NA	NA	NA
CGTGTAATCCAACCAA-1_25G_P3C1	-3.59487576	-7.423766755	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	809	1181	0.0042337	0.00508044	0	13A	IN-VIP	NA	NA	NA
CGTGTCTAGCTGATAA-1_25G_P3C1	24.84538743	-0.28569463	2	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2531	5893	0.00118785	0.001866621	0	2	EN-L4	NA	NA	NA
CGTGTCTCAATAGAGT-1_25G_P3C1	-4.733813599	-4.142379816	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1256	1903	0.009458749	0.004729375	0	13A	IN-VIP	NA	NA	NA
CGTGTCTCAATCACAC-1_25G_P3C1	-7.377623431	0.976355801	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2057	4076	0.012266928	0.00515211	0	13A	IN-VIP	NA	NA	NA
CGTGTCTCATCCGGGT-1_25G_P3C1	-29.1052393	22.6471398	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1085	1815	0	0.003305785	0	8	Astrocytes	NA	NA	NA
CGTGTCTCATGCCTAA-1_25G_P3C1	16.73667924	22.67128709	1	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	886	1345	0.000743494	0.001486989	0	oligos	OL-Cntl	NA	NA	NA
CGTGTCTGTACGCACC-1_25G_P3C1	-4.141031158	-14.25023965	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2422	5031	0.000596303	0.008149473	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGTGTCTGTTCTGGTA-1_25G_P3C1	-4.15815807	-24.71816327	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3166	7851	0.005222265	0.004840148	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGTGTCTTCCGTCAAA-1_25G_P3C1	9.323906805	31.5555172	1	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	794	1225	0.000816327	0.000816327	0	oligos	OL-Cntl	NA	NA	NA
CGTTAGAAGCTGCGAA-1_25G_P3C1	-5.657966883	-22.34929827	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3062	7736	0.00090486	0.003877973	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGTTAGACAAGTTAAG-1_25G_P3C1	-2.600353768	-20.71398475	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3439	8406	0.007613609	0.002736141	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGTTAGAGTCTCCACT-1_25G_P3C1	-2.570688907	-26.95487244	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3948	11075	0.001173815	0.003702032	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGTTAGAGTGGCAAAC-1_25G_P3C1	-36.91124554	-10.2876054	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	909	1335	0.001498127	0.002247191	0	9	OPC	NA	NA	NA
CGTTAGATCAGTCCCT-1_25G_P3C1	0.643401544	-7.44620519	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1380	2159	0.009726725	0.011116258	0	12	EN-MIX	NA	NA	NA
CGTTAGATCTGTCCGT-1_25G_P3C1	-5.001925807	-22.91218856	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3553	9701	0.000103082	0.005566436	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGTTCTGAGAGGTTAT-1_25G_P3C1	-29.60554171	13.53222002	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	717	1069	0.001870907	0.002806361	0	8	Astrocytes	NA	NA	NA
CGTTCTGCAGTAGAGC-1_25G_P3C1	-9.649025852	0.048692663	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2409	5026	0.006764823	0.006764823	0	13A	IN-VIP	NA	NA	NA
CGTTCTGTCACAACGT-1_25G_P3C1	28.3620166	0.451328283	2	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3166	7627	0.000524453	0.006031205	0	2	EN-L4	NA	NA	NA
CGTTCTGTCTGGTGTA-1_25G_P3C1	-39.53390431	-0.4279464	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1424	2715	0.004051565	0.002209945	0	9	OPC	NA	NA	NA
CGTTCTGTCTTGCCGT-1_25G_P3C1	-5.41667709	-1.04188383	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1689	3308	0.004232164	0.002116082	0	13A	IN-VIP	NA	NA	NA
CGTTGGGAGCTCCTCT-1_25G_P3C1	-0.861147996	-29.25446135	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4858	15299	0.001503366	0.005555919	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGTTGGGCAAGTTGTC-1_25G_P3C1	4.577023547	-17.30613921	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2491	5075	0.003940887	0.013399015	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGTTGGGCACAAGACG-1_25G_P3C1	26.65020026	-0.976691447	2	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3197	8120	0.000738916	0.00455665	0	2	EN-L4	NA	NA	NA
CGTTGGGCAGGTCTCG-1_25G_P3C1	-8.713981503	2.554011937	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2638	5715	0.005949256	0.002974628	0	13A	IN-VIP	NA	NA	NA
CGTTGGGGTAGGACAC-1_25G_P3C1	-4.409310356	-21.98408858	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3443	9049	0.00198917	0.002431208	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGTTGGGGTCAGTGGA-1_25G_P3C1	-14.22248835	-10.56218598	13B	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2166	4611	0.001734982	0.003469963	0	13B	IN-SV2C	NA	NA	NA
CGTTGGGGTCGCGAAA-1_25G_P3C1	-16.17728399	-19.13860939	6B	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1950	3910	0.007161125	0.006138107	0	6B	IN-SST	NA	NA	NA
CGTTGGGGTTATCCGA-1_25G_P3C1	-3.233412115	-22.73500268	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3647	9123	0.005042201	0.003726844	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGTTGGGTCGAGAACG-1_25G_P3C1	-8.995526351	0.593734049	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2365	4760	0.010504202	0.003991597	0	13A	IN-VIP	NA	NA	NA
CGTTGGGTCTTCTGGC-1_25G_P3C1	29.57733239	-0.30365395	2	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3580	8567	0.00385199	0.004785806	0	2	EN-L4	NA	NA	NA
CTAACTTAGTTACGGG-1_25G_P3C1	-3.444923899	-13.8209132	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2161	4359	0.011470521	0.003670567	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTAACTTCAAGCTGAG-1_25G_P3C1	-10.17773816	3.215137567	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3570	9022	0.009532254	0.003436045	0	13A	IN-VIP	NA	NA	NA
CTAACTTCAATAACGA-1_25G_P3C1	-37.40871244	-9.631006311	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	988	1598	0.001251564	0.003754693	0	9	OPC	NA	NA	NA
CTAACTTCAGTCTTCC-1_25G_P3C1	-10.15490398	3.103462312	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3350	9377	0.005332196	0.003732537	0	13A	IN-VIP	NA	NA	NA
CTAACTTGTCCGTGAC-1_25G_P3C1	22.47040089	-8.924959546	3	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2386	5358	0.006905562	0.001493094	0	3	EN-L5-6	NA	NA	NA
CTAACTTGTGTCTGAT-1_25G_P3C1	-9.16021684	0.667704742	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2107	4277	0.010989011	0.004909984	0	13A	IN-VIP	NA	NA	NA
CTAACTTTCGTAGGAG-1_25G_P3C1	-5.385848379	-21.84779236	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2992	7547	0.005830131	0.004505101	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTAACTTTCTAACTTC-1_25G_P3C1	-1.053105278	-10.44828019	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1704	3308	0.001813785	0.005139057	0	12	EN-MIX	NA	NA	NA
CTAAGACGTACAGCAG-1_25G_P3C1	19.73049303	-28.82686713	3	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4013	11877	0.000168393	0.010440347	0	3	EN-L5-6	NA	NA	NA
CTAAGACGTGTTCGAT-1_25G_P3C1	20.03341577	-28.81665465	3	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3503	9228	0.001517122	0.006827048	0	3	EN-L5-6	NA	NA	NA
CTAATGGAGCAACGGT-1_25G_P3C1	1.005319058	-6.865808955	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1188	1887	0.000529942	0.010068892	0	12	EN-MIX	NA	NA	NA
CTAATGGAGGGAAACA-1_25G_P3C1	-10.33029741	-0.362812166	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2517	5597	0.008397356	0.006789351	0	13A	IN-VIP	NA	NA	NA
CTAATGGAGTCCCACG-1_25G_P3C1	-29.05998229	22.85529619	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1193	2088	0.001436782	0.001915709	0	8	Astrocytes	NA	NA	NA
CTAATGGCACGGCGTT-1_25G_P3C1	-3.81721654	-24.84562074	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3628	9994	0.00080048	0.003502101	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTAATGGCAGTATGCT-1_25G_P3C1	-8.136833887	0.169416287	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2076	4516	0.002214349	0.004207263	0	13A	IN-VIP	NA	NA	NA
CTAATGGCATGCCTTC-1_25G_P3C1	-16.41726133	-19.38333234	6B	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2081	4894	0.004290969	0.00224765	0	6B	IN-SST	NA	NA	NA
CTAATGGCATTCGACA-1_25G_P3C1	-4.129564614	-14.48855031	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2595	5830	0.002915952	0.004974271	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTAATGGCATTGAGCT-1_25G_P3C1	-9.632795654	-19.39371989	6A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	914	1568	0.010204082	0	0	6A	IN-PV	NA	NA	NA
CTAATGGGTCATACTG-1_25G_P3C1	-11.76257857	-10.93599156	13B	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1151	1823	0.001645639	0.001645639	0	13B	IN-SV2C	NA	NA	NA
CTAATGGGTTGAGTTC-1_25G_P3C1	-9.455018605	-1.836735275	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2026	3860	0.023056995	0.005958549	0	13A	IN-VIP	NA	NA	NA
CTAATGGTCTCCAACC-1_25G_P3C1	7.306654167	30.15199005	1	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	667	1038	0.000963391	0.013487476	0	oligos	OL-Cntl	NA	NA	NA
CTACACCAGACCACGA-1_25G_P3C1	-24.38630455	30.02605489	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1915	4063	0.000984494	0.005660842	0	8	Astrocytes	NA	NA	NA
CTACACCAGTCCATAC-1_25G_P3C1	2.838543475	-24.87747429	4	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3818	10245	0.00068326	0.003611518	0	L2-3	EN-L2-3-MS	NA	NA	NA
CTACACCTCGTTACAG-1_25G_P3C1	-14.13948942	-8.072347677	13B	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3459	10207	0.006760067	0.001861468	0	13B	IN-SV2C	NA	NA	NA
CTACATTAGCCAGGAT-1_25G_P3C1	-3.197251804	-13.13500582	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2156	4307	0.003018342	0.007429765	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTACATTAGGCGATAC-1_25G_P3C1	-2.796120217	-13.15478308	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2096	4345	0.003912543	0.00598389	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTACATTTCGAGAACG-1_25G_P3C1	7.35528733	-33.07077114	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4018	12951	0.001698711	0.003242993	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTACCCAAGAGACTAT-1_25G_P3C1	-26.63963268	26.62449865	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1436	2715	0.001841621	0.003683241	0	8	Astrocytes	NA	NA	NA
CTACCCAAGCGGCTTC-1_25G_P3C1	-37.52892592	-6.48184213	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1187	2050	0.002439024	0.00195122	0	9	OPC	NA	NA	NA
CTACCCACATAGAAAC-1_25G_P3C1	-4.44791727	-16.90781396	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2859	6412	0.005302558	0.005926388	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTACCCATCACTCCTG-1_25G_P3C1	-3.710208069	-5.202387532	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1102	1798	0.005561735	0.002780868	0	13A	IN-VIP	NA	NA	NA
CTACCCATCTACTCAT-1_25G_P3C1	-17.59827864	-25.83284325	6A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2377	4933	0.000202716	0.00222988	0	6A	IN-PV	NA	NA	NA
CTACGTCAGCGATATA-1_25G_P3C1	-2.575781472	-13.28843182	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1883	3948	0.000253293	0.004812563	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTACGTCAGTGGACGT-1_25G_P3C1	-4.556150963	-19.73780277	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3339	8685	0.00437536	0.006678181	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTACGTCGTCCATGAT-1_25G_P3C1	-9.086618896	1.949317686	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2413	5514	0.006528836	0.003264418	0	13A	IN-VIP	NA	NA	NA
CTACGTCGTGTTAAGA-1_25G_P3C1	-1.203204127	-9.6137082	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1771	3061	0.004246978	0.006860503	0	12	EN-MIX	NA	NA	NA
CTACGTCTCACAATGC-1_25G_P3C1	-8.773311431	2.709324261	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2520	5612	0.003385602	0.003741981	0	13A	IN-VIP	NA	NA	NA
CTACGTCTCCCTAATT-1_25G_P3C1	-2.414966153	-15.09256394	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2278	4869	0.005134525	0.003902239	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTACGTCTCTCGCTTG-1_25G_P3C1	-2.561002441	-23.39456971	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4406	13046	0.001686341	0.004062548	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTAGAGTAGGACACCA-1_25G_P3C1	-4.290654048	-14.73825737	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2572	5468	0.006400878	0.007315289	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTAGAGTGTAGCGCTC-1_25G_P3C1	0.49216519	-6.62889221	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1090	1778	0.006186727	0.001687289	0	12	EN-MIX	NA	NA	NA
CTAGAGTTCAAAGTAG-1_25G_P3C1	-5.278061403	-10.61844389	13B	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	906	1446	0.005532503	0.001383126	0	13B	IN-SV2C	NA	NA	NA
CTAGAGTTCGATCCCT-1_25G_P3C1	-1.23303756	-26.54508903	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	5068	17387	0.00149537	0.003335826	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTAGAGTTCTTGTATC-1_25G_P3C1	-2.291222845	-11.66571319	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1904	3743	0.010152284	0.008014961	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTAGCCTGTTCCCGAG-1_25G_P3C1	-8.010837664	-0.376190823	13B	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2108	4578	0.008300568	0.001529052	0	13B	IN-SV2C	NA	NA	NA
CTAGCCTTCGCCATAA-1_25G_P3C1	23.76491144	-9.060093663	3	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3972	11756	0.002722014	0.004168084	0	3	EN-L5-6	NA	NA	NA
CTAGTGAAGTATGACA-1_25G_P3C1	0.301962717	-8.311344079	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1541	2712	0.0070059	0.008480826	0	12	EN-MIX	NA	NA	NA
CTAGTGACAGCATACT-1_25G_P3C1	-4.361038427	-16.43512867	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2448	5303	0.004148595	0.004902885	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTAGTGATCAGTCAGT-1_25G_P3C1	-9.378968016	3.117023431	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2982	6956	0.003881541	0.004887867	0	13A	IN-VIP	NA	NA	NA
CTCACACAGGCCATAG-1_25G_P3C1	2.726617574	-31.43189839	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	7150	33688	0.002879364	0.004897886	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTCACACAGTCGATAA-1_25G_P3C1	-27.23388007	18.60841616	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1199	2200	0.001818182	0.005454545	0	8	Astrocytes	NA	NA	NA
CTCACACCAAGTAATG-1_25G_P3C1	-5.127667438	-21.18774295	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3180	8316	0.003727754	0.002886003	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTCACACCATCACGTA-1_25G_P3C1	20.03727485	-29.12552785	3	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	5225	20410	0.001861832	0.005291524	0	3	EN-L5-6	NA	NA	NA
CTCACACGTACTTCTT-1_25G_P3C1	-39.20250823	0.111439457	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1624	3186	0.003138732	0.001255493	0	9	OPC	NA	NA	NA
CTCACACGTATGAAAC-1_25G_P3C1	-26.48755114	27.77709467	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1617	3131	0.000638774	0.005429575	0	8	Astrocytes	NA	NA	NA
CTCACACGTCGAACAG-1_25G_P3C1	-2.958934381	-25.60254781	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4827	16606	0.00150548	0.004275563	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTCACACTCACTTACT-1_25G_P3C1	-38.1597903	2.673479942	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1792	3800	0.000526316	0.002368421	0	9	OPC	NA	NA	NA
CTCACACTCCACGAAT-1_25G_P3C1	19.86887854	21.39990365	1	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	924	1551	0.001934236	0.000644745	0	oligos	OL-Cntl	NA	NA	NA
CTCAGAACAATGAATG-1_25G_P3C1	1.375122408	-27.48439697	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3557	9466	0.001267695	0.002218466	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTCAGAACATCAGTCA-1_25G_P3C1	-17.99216963	-24.76846097	6A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2778	6978	0.000143308	0.002006306	0	6A	IN-PV	NA	NA	NA
CTCAGAATCAATCACG-1_25G_P3C1	-1.263826883	-27.74511605	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	6062	24165	0.001034554	0.00306228	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTCATTAAGCGATATA-1_25G_P3C1	-4.452267405	-17.0201379	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2730	5971	0.002847094	0.006531569	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTCATTACACCAACCG-1_25G_P3C1	-6.323616761	0.074594175	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1781	3479	0.002874389	0.005461339	0	13A	IN-VIP	NA	NA	NA
CTCATTAGTAAGGATT-1_25G_P3C1	-4.217746975	-16.64120069	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2384	5006	0.008389932	0.00719137	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTCATTATCTTGCATT-1_25G_P3C1	-4.607256736	-2.362003692	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1307	2307	0.007802341	0.002167317	0	13A	IN-VIP	NA	NA	NA
CTCCTAGGTAAAGGAG-1_25G_P3C1	19.36982534	20.83781506	1	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	944	1491	0.003353454	0.004694836	0	oligos	OL-Cntl	NA	NA	NA
CTCCTAGGTCAGAAGC-1_25G_P3C1	-1.445399172	-29.06663917	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3254	7753	0.002579647	0.002837611	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTCCTAGTCAGTTGAC-1_25G_P3C1	-1.873090699	-25.2132993	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	5419	19328	0.004139073	0.005225579	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTCCTAGTCGCCCTTA-1_25G_P3C1	-3.00977894	-25.95804948	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4555	16105	0.000186278	0.002669978	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTCGAAACAATGACCT-1_25G_P3C1	-13.63667923	-24.17739118	6A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1287	2359	0.008902077	0.004239084	0	6A	IN-PV	NA	NA	NA
CTCGAAAGTCGATTGT-1_25G_P3C1	16.35086399	23.40982895	1	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	899	1348	0.00148368	0.002225519	0	oligos	OL-Cntl	NA	NA	NA
CTCGAAAGTTTGACAC-1_25G_P3C1	10.8394234	21.13960987	1	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	937	1494	0.00669344	0.004016064	0	oligos	OL-Cntl	NA	NA	NA
CTCGAAATCTGTACGA-1_25G_P3C1	-8.9639489	0.907866486	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2355	4824	0.008499171	0.002902156	0	13A	IN-VIP	NA	NA	NA
CTCGAGGAGAGGTAGA-1_25G_P3C1	-3.138266466	-23.25517956	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3744	9722	0.001440033	0.007714462	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTCGAGGAGATGGGTC-1_25G_P3C1	0.360732365	-9.678904316	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1528	2784	0.001436782	0.007902299	0	12	EN-MIX	NA	NA	NA
CTCGAGGAGGCGATAC-1_25G_P3C1	-2.150745225	-21.3020307	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4259	11170	0.005013429	0.004655327	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTCGAGGTCAGCCTAA-1_25G_P3C1	10.79827432	25.77368995	1	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	866	1338	0.002989537	0.007473842	0	oligos	OL-Cntl	NA	NA	NA
CTCGAGGTCTGCGTAA-1_25G_P3C1	-4.628608746	-17.39823305	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2965	6923	0.004477828	0.005633396	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTCGGAGAGGCATGGT-1_25G_P3C1	-26.32141933	26.82569722	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1489	2848	0.001755618	0.008426966	0	8	Astrocytes	NA	NA	NA
CTCGGAGCACTTAACG-1_25G_P3C1	-11.01092672	2.271290779	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3055	7305	0.012457221	0.003969884	0	13A	IN-VIP	NA	NA	NA
CTCGGGAAGCGCCTTG-1_25G_P3C1	-0.775742022	-10.6570565	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1768	3105	0.000644122	0.003864734	0	12	EN-MIX	NA	NA	NA
CTCGGGACAGCCAGAA-1_25G_P3C1	-10.59948543	-19.47426951	6B	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	916	1382	0.023878437	0.002894356	0	6B	IN-SST	NA	NA	NA
CTCGGGACATCACGTA-1_25G_P3C1	-7.706406835	-0.270344573	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2193	4699	0.009363694	0.002766546	0	13A	IN-VIP	NA	NA	NA
CTCGGGATCAGCTGGC-1_25G_P3C1	-0.886097955	-26.49630994	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4819	14364	0.001949318	0.007518797	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTCGTACCACACAGAG-1_25G_P3C1	-3.205533438	-13.0629558	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2013	4041	0.001237317	0.00569166	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTCGTACTCTATCGCC-1_25G_P3C1	7.390680789	-33.12519277	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4035	12146	0.00049399	0.002058291	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTCGTCAAGCTAACAA-1_25G_P3C1	-3.668122413	-21.85711715	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3706	10445	0.004404021	0.004116802	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTCGTCAAGCTCCTTC-1_25G_P3C1	-9.524087316	3.032587165	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2942	6592	0.002730583	0.004399272	0	13A	IN-VIP	NA	NA	NA
CTCGTCAAGGCCGAAT-1_25G_P3C1	-0.352809015	-8.800504883	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1499	3003	0.001332001	0.002664003	0	12	EN-MIX	NA	NA	NA
CTCGTCAAGGTACTCT-1_25G_P3C1	-29.47849538	15.842487	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	910	1445	0.000692042	0.004844291	0	8	Astrocytes	NA	NA	NA
CTCGTCAAGTTATCGC-1_25G_P3C1	-8.743456139	2.863464802	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2510	5604	0.000178444	0.003211991	0	13A	IN-VIP	NA	NA	NA
CTCGTCACATAGACTC-1_25G_P3C1	0.229121391	-7.82018765	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1448	2521	0.000396668	0.005156684	0	12	EN-MIX	NA	NA	NA
CTCGTCACATGGTCAT-1_25G_P3C1	5.880889814	-32.2612438	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4981	17536	0.001824818	0.00256615	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTCGTCAGTCGGCTCA-1_25G_P3C1	31.57004182	15.21392922	14	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	842	1161	0.005167959	0.06546081	0	14	Microglia	NA	NA	NA
CTCTAATAGGCCCTTG-1_25G_P3C1	-9.768190153	2.070722786	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2803	6679	0.009133104	0.003144183	0	13A	IN-VIP	NA	NA	NA
CTCTAATCACAACGCC-1_25G_P3C1	-5.211364141	-21.14272013	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3164	8127	0.003445306	0.003076166	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTCTAATCACATCCGG-1_25G_P3C1	-2.013267932	-25.66638183	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4748	15971	0.000375681	0.003694196	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTCTAATGTTGGTTTG-1_25G_P3C1	6.805853898	-33.27464254	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3244	9003	0.003110074	0.002110408	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTCTAATTCGCACTCT-1_25G_P3C1	-28.26015529	17.37259538	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1079	1932	0	0.003623188	0	8	Astrocytes	NA	NA	NA
CTCTAATTCGCCGTGA-1_25G_P3C1	-2.140365053	-13.60477574	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1722	3384	0.003250591	0.004137116	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTCTACGAGACCACGA-1_25G_P3C1	5.736265577	32.15824735	1	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	726	1057	0.000946074	0.003784295	0	oligos	OL-Cntl	NA	NA	NA
CTCTACGCAAAGGCGT-1_25G_P3C1	-28.48154738	16.95408174	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	968	1610	0.004347826	0.00621118	0	8	Astrocytes	NA	NA	NA
CTCTACGCACCTTGTC-1_25G_P3C1	-4.828465804	-20.91189929	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3089	7913	0.003664855	0.00556047	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTCTACGCAGGGTATG-1_25G_P3C1	-5.672800337	-21.7366083	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2693	6466	0.000154655	0.002474482	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTCTACGGTCCAGTGC-1_25G_P3C1	22.85754778	-9.001903443	3	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2826	6687	0.000598176	0.003439509	0	3	EN-L5-6	NA	NA	NA
CTCTACGGTTCGTTGA-1_25G_P3C1	11.77413781	-8.536458077	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3071	7258	0.00275558	0.002480022	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTCTGGTAGAAACGCC-1_25G_P3C1	-16.71717474	-26.22703531	6A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2137	4368	0.003663004	0.005494505	0	6A	IN-PV	NA	NA	NA
CTCTGGTAGTGATCGG-1_25G_P3C1	-29.51206959	12.36709243	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	717	1092	0.001831502	0.002747253	0	8	Astrocytes	NA	NA	NA
CTCTGGTCAATAACGA-1_25G_P3C1	-7.988572969	-1.664287213	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2095	4402	0.016810541	0.001363017	0	13A	IN-VIP	NA	NA	NA
CTCTGGTCACTGCCAG-1_25G_P3C1	25.84000748	-3.154301282	2	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3387	8482	0.000589484	0.005541146	0	2	EN-L4	NA	NA	NA
CTCTGGTCATGGGAAC-1_25G_P3C1	-2.608674739	-23.69747775	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4175	12109	0.000908415	0.003633661	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTGAAACAGGTGGGTT-1_25G_P3C1	-29.2672142	13.2877044	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	749	1145	0	0.001746725	0	8	Astrocytes	NA	NA	NA
CTGAAACCACGGCTAC-1_25G_P3C1	-20.92803352	9.719655554	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	997	1632	0.003676471	0.004901961	0	8	Astrocytes	NA	NA	NA
CTGAAACGTAGGGACT-1_25G_P3C1	-39.49594528	-0.286705017	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1486	2742	0.002552881	0.00401167	0	9	OPC	NA	NA	NA
CTGAAACGTCGACTGC-1_25G_P3C1	-4.524514535	-22.40137284	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3335	8309	0.003730894	0.004814057	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTGAAACGTTCATGGT-1_25G_P3C1	1.108925866	-28.88837343	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4133	12143	0.002141151	0.003047023	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTGAAACGTTTGGGCC-1_25G_P3C1	-3.929029899	-20.03132065	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3467	8836	0.010072431	0.004866455	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTGAAGTAGCGTCAAG-1_25G_P3C1	-2.750885343	-22.53395685	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3844	9110	0.006915477	0.00428101	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTGAAGTAGTGGGATC-1_25G_P3C1	-5.192753086	-22.20482283	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3059	7133	0.000280387	0.004626384	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTGAAGTCATCAGTCA-1_25G_P3C1	-29.67559986	13.96002517	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	739	1164	0.003436426	0.001718213	0	8	Astrocytes	NA	NA	NA
CTGAAGTCATTAGCCA-1_25G_P3C1	-2.681758567	-25.43053452	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4144	12291	0.001871288	0.004312098	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTGAAGTGTTAGAACA-1_25G_P3C1	23.54806007	-29.43983312	3	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3148	8238	0.001335276	0.006312212	0	3	EN-L5-6	NA	NA	NA
CTGAAGTTCATTGCGA-1_25G_P3C1	-3.885351952	-15.52198503	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2451	5641	0.002481829	0.005318206	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTGATAGCAGACAAAT-1_25G_P3C1	-2.574717416	-14.5826652	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2292	4711	0.002971768	0.003184037	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTGATAGGTACACCGC-1_25G_P3C1	-3.765585586	-17.09692099	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2631	5665	0.007943513	0.007237423	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTGATCCAGTGAATTG-1_25G_P3C1	-7.364205208	0.673150389	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2104	4216	0.013282732	0.004506641	0	13A	IN-VIP	NA	NA	NA
CTGATCCGTAGCTGCC-1_25G_P3C1	-4.412715996	-17.95999288	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2900	6665	0.003900975	0.009002251	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTGATCCGTGACAAAT-1_25G_P3C1	-26.57916876	26.86047077	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1570	2927	0.002733174	0.003758114	0	8	Astrocytes	NA	NA	NA
CTGATCCTCCAAATGC-1_25G_P3C1	-39.37049202	-1.610604073	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1276	2257	0.000443066	0.00221533	0	9	OPC	NA	NA	NA
CTGCCTAAGACAATAC-1_25G_P3C1	-29.18106031	22.57325451	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1014	1843	0.001085187	0.00596853	0	8	Astrocytes	NA	NA	NA
CTGCCTAAGAGTTGGC-1_25G_P3C1	-7.333031276	-3.688937789	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1620	2802	0.019985724	0.00178444	0	13A	IN-VIP	NA	NA	NA
CTGCCTAAGCGTGTCC-1_25G_P3C1	-29.96033157	20.58765328	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1094	1811	0.001656543	0.004417449	0	8	Astrocytes	NA	NA	NA
CTGCCTACACCGCTAG-1_25G_P3C1	-0.460693754	-8.862427013	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1700	3177	0.003147624	0.007869059	0	12	EN-MIX	NA	NA	NA
CTGCCTACAGGTTTCA-1_25G_P3C1	-4.439308588	-18.73864879	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2921	6592	0.002427184	0.006371359	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTGCCTAGTAAATGTG-1_25G_P3C1	26.50206801	-6.090935339	2	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	5722	21317	0.003002299	0.003987428	0	2	EN-L4	NA	NA	NA
CTGCCTAGTGTTGAGG-1_25G_P3C1	-2.726854792	-15.1207828	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2421	5278	0.002084123	0.005494505	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTGCCTAGTTTCCACC-1_25G_P3C1	28.23215283	0.306321192	2	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3347	8251	0.000605987	0.003878318	0	2	EN-L4	NA	NA	NA
CTGCCTATCGACCAGC-1_25G_P3C1	-26.5112426	27.5323822	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1569	3072	0.001953125	0.006835938	0	8	Astrocytes	NA	NA	NA
CTGCCTATCTGAAAGA-1_25G_P3C1	-27.82675006	24.67273732	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1258	2221	0.001350743	0.004502476	0	8	Astrocytes	NA	NA	NA
CTGCGGAAGATGTAAC-1_25G_P3C1	-3.964778528	-13.96049175	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2476	5381	0.005389333	0.006318528	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTGCGGAAGCACAGGT-1_25G_P3C1	26.71420688	-0.808864854	2	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3165	7989	0.000625861	0.003129303	0	2	EN-L4	NA	NA	NA
CTGCGGACACCAGATT-1_25G_P3C1	-39.62024262	-1.283251227	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1334	2463	0.002842063	0.002436054	0	9	OPC	NA	NA	NA
CTGCGGAGTATGGTTC-1_25G_P3C1	-4.370814157	-16.54383736	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2464	5305	0.005655042	0.007540057	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTGCGGAGTTAAAGAC-1_25G_P3C1	-27.68446205	24.63196998	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1223	2213	0.000903751	0.004518753	0	8	Astrocytes	NA	NA	NA
CTGCGGATCCTAGAAC-1_25G_P3C1	-9.357468053	3.062327004	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2995	6973	0.004589129	0.004445719	0	13A	IN-VIP	NA	NA	NA
CTGCGGATCGTGGACC-1_25G_P3C1	0.319612776	-7.257966814	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1286	2210	0.004072398	0.005429864	0	12	EN-MIX	NA	NA	NA
CTGCTGTAGGATGGTC-1_25G_P3C1	0.827039065	-30.19698483	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	5846	21789	0.001330947	0.002615999	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTGCTGTCAGGCTCAC-1_25G_P3C1	28.29116841	0.848813192	2	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2920	6835	0.00277981	0.005120702	0	2	EN-L4	NA	NA	NA
CTGCTGTGTAAGGGCT-1_25G_P3C1	-4.484269927	-16.43340742	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2717	6067	0.003296522	0.005274435	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTGCTGTGTGCCTGCA-1_25G_P3C1	23.87672597	-8.490343521	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4162	12158	0.001727258	0.003043264	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTGCTGTTCATCTGTT-1_25G_P3C1	-3.160009687	-13.39971998	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2080	4111	0.004621747	0.003891997	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTGGTCTAGATGTGTA-1_25G_P3C1	28.11011331	0.030196768	2	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3018	6799	0.00338285	0.005589057	0	2	EN-L4	NA	NA	NA
CTGGTCTCACTTCTGC-1_25G_P3C1	-9.135036026	-0.284499721	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2035	3732	0.004287245	0.008038585	0	13A	IN-VIP	NA	NA	NA
CTGTGCTAGAGGTTGC-1_25G_P3C1	26.17635771	-4.387863172	2	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4403	13122	0.000609663	0.003505563	0	2	EN-L4	NA	NA	NA
CTGTGCTCAAACCCAT-1_25G_P3C1	-2.74468566	-12.9669417	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2175	4229	0.0018917	0.007803263	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTGTGCTGTCCGACGT-1_25G_P3C1	-2.616475342	-15.44494109	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2409	5408	0.000554734	0.004252959	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTGTGCTGTCTGGTCG-1_25G_P3C1	-29.38916271	13.10627825	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	742	1232	0.001623377	0.003246753	0	8	Astrocytes	NA	NA	NA
CTGTGCTTCTGCGTAA-1_25G_P3C1	1.514574914	-6.093388087	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1184	1883	0.004779607	0.009559214	0	12	EN-MIX	NA	NA	NA
CTGTGCTTCTGGAGCC-1_25G_P3C1	-4.394624256	-16.05097403	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2553	5623	0.003912502	0.008002845	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTGTTTAAGGCTCAGA-1_25G_P3C1	-13.82024444	-24.55896733	6A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1385	2684	0	0.001862891	0	6A	IN-PV	NA	NA	NA
CTGTTTACAAGCTGTT-1_25G_P3C1	-20.08001387	-29.11794689	6A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4818	17384	0.003221353	0.002473539	0	6A	IN-PV	NA	NA	NA
CTGTTTACACAGGCCT-1_25G_P3C1	-2.70245753	-12.87007199	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2116	4739	0.001899135	0.005697405	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTGTTTACACATTAGC-1_25G_P3C1	7.035659797	-33.1399384	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4235	14120	0.002124646	0.002266289	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTGTTTACAGGGAGAG-1_25G_P3C1	-37.15705668	-9.211193148	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1023	1643	0.003651856	0.004260499	0	9	OPC	NA	NA	NA
CTGTTTACATATGAGA-1_25G_P3C1	-35.54904974	-12.54289458	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	831	1261	0.003965107	0.001586043	0	9	OPC	NA	NA	NA
CTTAACTAGAGCCCAA-1_25G_P3C1	-2.879165207	-12.14557811	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1860	3582	0.000837521	0.008654383	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTTAACTAGTAGTGCG-1_25G_P3C1	28.89277688	0.59650551	2	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2778	6415	0.005144193	0.006079501	0	2	EN-L4	NA	NA	NA
CTTAACTCACGTCTCT-1_25G_P3C1	-2.53462646	-14.65783102	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2081	4325	0.000462428	0.003930636	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTTAACTGTAAGTAGT-1_25G_P3C1	-31.34389911	12.76675543	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	873	1350	0.019259259	0.003703704	0	8	Astrocytes	NA	NA	NA
CTTAACTTCAGAAATG-1_25G_P3C1	-9.553527485	-0.313922857	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2434	4900	0.007755102	0.006734694	0	13A	IN-VIP	NA	NA	NA
CTTAACTTCCTTGGTC-1_25G_P3C1	-1.981148416	-27.59107983	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4823	18069	0.001604959	0.002877857	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTTACCGAGATCCCGC-1_25G_P3C1	-3.663492165	-5.204229223	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1142	1963	0.004584819	0.004075395	0	13A	IN-VIP	NA	NA	NA
CTTACCGAGGCCATAG-1_25G_P3C1	-26.55850202	9.900442786	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	832	1245	0.000803213	0.003212851	0	8	Astrocytes	NA	NA	NA
CTTACCGAGTCAATAG-1_25G_P3C1	-4.204278365	-23.8903574	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3856	11101	0.00135123	0.003693361	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTTACCGCAATTGCTG-1_25G_P3C1	-2.049078142	-27.34223418	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	5698	24551	0.000285121	0.00370657	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTTACCGCACAGCCCA-1_25G_P3C1	-24.28546362	29.77144099	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1664	3164	0.004108723	0.005372946	0	8	Astrocytes	NA	NA	NA
CTTACCGCACGTGAGA-1_25G_P3C1	-18.57296453	-25.29762275	6A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2987	7781	0.002698882	0.002313327	0	6A	IN-PV	NA	NA	NA
CTTACCGTCACAACGT-1_25G_P3C1	-4.384406371	-23.1144963	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3745	11074	0.000180603	0.005959906	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTTAGGAAGTAGGCCA-1_25G_P3C1	14.35369254	-8.398467958	3	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2286	4828	0.000207125	0.003728252	0	3	EN-L5-6	NA	NA	NA
CTTAGGACAAGGTTCT-1_25G_P3C1	20.48253156	20.62435687	1	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	929	1464	0.00204918	0.008196721	0	oligos	OL-Cntl	NA	NA	NA
CTTAGGACACGGATAG-1_25G_P3C1	-37.15991854	-9.830320671	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	995	1588	0.010075567	0.002518892	0	9	OPC	NA	NA	NA
CTTAGGACAGCTCGAC-1_25G_P3C1	-14.1818728	-10.61358919	13B	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2264	4932	0.003852393	0.003041363	0	13B	IN-SV2C	NA	NA	NA
CTTAGGACAGGTCTCG-1_25G_P3C1	-4.199805831	-14.45411551	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2445	5062	0.00019755	0.009679968	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTTAGGAGTGAGGGTT-1_25G_P3C1	2.665253726	-13.83835059	4	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2110	3969	0.007306626	0.010582011	0	L2-3	EN-L2-3-MS	NA	NA	NA
CTTAGGAGTGCAGACA-1_25G_P3C1	-37.80339168	-8.387639333	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	976	1547	0.000646412	0.001939237	0	9	OPC	NA	NA	NA
CTTAGGAGTTCTGGTA-1_25G_P3C1	-29.53085049	15.99321981	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	890	1415	0.000706714	0.002826855	0	8	Astrocytes	NA	NA	NA
CTTAGGATCCGTTGCT-1_25G_P3C1	-15.14925313	-25.47503637	6A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1826	3854	0.000259471	0.001816295	0	6A	IN-PV	NA	NA	NA
CTTCTCTCACTACAGT-1_25G_P3C1	-2.211872693	-19.32537338	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2911	8302	0.002409058	0.002168152	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTTCTCTCATTGGTAC-1_25G_P3C1	-28.88474181	17.64877003	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1042	1867	0.002678093	0.00374933	0	8	Astrocytes	NA	NA	NA
CTTCTCTGTAACGTTC-1_25G_P3C1	-24.93832912	17.54050815	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1111	1814	0.001653804	0.00275634	0	8	Astrocytes	NA	NA	NA
CTTCTCTGTACGACCC-1_25G_P3C1	-36.68242896	-11.10384036	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	806	1338	0.000747384	0.002242152	0	9	OPC	NA	NA	NA
CTTCTCTTCCATGCTC-1_25G_P3C1	-14.12112859	-8.410028874	13B	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2713	6706	0.004473606	0.002087683	0	13B	IN-SV2C	NA	NA	NA
CTTGGCTCAGCTATTG-1_25G_P3C1	-26.64696017	27.55434151	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1535	3269	0.002141328	0.002753136	0	8	Astrocytes	NA	NA	NA
CTTGGCTCATAAAGGT-1_25G_P3C1	-3.749395855	-15.31911571	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2483	5809	0.003787227	0.005508693	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTTGGCTCATGTAGTC-1_25G_P3C1	-37.58336101	-9.677391741	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	938	1539	0.00259909	0.001949318	0	9	OPC	NA	NA	NA
CTTGGCTTCAGTTTGG-1_25G_P3C1	-0.829311321	-10.85783424	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1696	3275	0.000610687	0.001221374	0	12	EN-MIX	NA	NA	NA
CTTTGCGCACCGTTGG-1_25G_P3C1	-27.83020766	18.61832838	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1096	1869	0.001070091	0.002675227	0	8	Astrocytes	NA	NA	NA
CTTTGCGCATTGGCGC-1_25G_P3C1	-0.680465855	-26.35546956	4	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	5393	18495	0.006001622	0.00567721	0	L2-3	EN-L2-3-MS	NA	NA	NA
CTTTGCGGTCTAAAGA-1_25G_P3C1	-4.823017896	-2.230382889	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1504	2696	0	0.004821958	0	13A	IN-VIP	NA	NA	NA
CTTTGCGGTGTAACGG-1_25G_P3C1	-4.9796639	-19.57043712	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2736	6310	0.007765452	0.005546751	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTTTGCGGTTATCGGT-1_25G_P3C1	28.20246446	0.840370611	2	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2755	6343	0.000788271	0.005833202	0	2	EN-L4	NA	NA	NA
GAAACTCAGAAAGTGG-1_25G_P3C1	-1.54462041	-13.11237378	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2147	4245	0.002826855	0.006595995	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GAAACTCAGAGTGAGA-1_25G_P3C1	-3.562606993	-15.08725591	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2404	4986	0.004011231	0.0026073	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GAAACTCCACTTAAGC-1_25G_P3C1	-3.946453555	-13.76750827	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2430	5229	0.003633582	0.007458405	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GAAACTCCATTAACCG-1_25G_P3C1	-5.865387345	-1.233651654	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1658	3404	0.006169213	0.002056404	0	13A	IN-VIP	NA	NA	NA
GAAACTCCATTCTTAC-1_25G_P3C1	-0.744413129	-29.42764825	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4567	15785	0.001773836	0.003991131	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GAAACTCGTGATGCCC-1_25G_P3C1	-17.91340389	-24.45733067	6A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2864	7558	0.004366234	0.001455411	0	6A	IN-PV	NA	NA	NA
GAAACTCGTTTGTTTC-1_25G_P3C1	-3.360978907	-6.251261201	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	855	1345	0.00669145	0.000743494	0	13A	IN-VIP	NA	NA	NA
GAAACTCTCGTTTGCC-1_25G_P3C1	-27.78477215	24.70659955	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1303	2463	0.00365408	0.005278116	0	8	Astrocytes	NA	NA	NA
GAAATGAGTAACGACG-1_25G_P3C1	-8.95513869	-19.01970404	6B	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	687	1064	0.003759398	0.004699248	0	6B	IN-SST	NA	NA	NA
GAAATGAGTAAGAGGA-1_25G_P3C1	1.090086013	-18.9274012	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3212	7663	0.001826961	0.006394363	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GAAATGAGTACTTGAC-1_25G_P3C1	5.909715579	-32.03325672	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4298	14131	0.000141533	0.004175218	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GAAATGAGTGAGCGAT-1_25G_P3C1	-9.040863714	1.203783966	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2399	5082	0.015741834	0.002558048	0	13A	IN-VIP	NA	NA	NA
GAACATCAGTAATCCC-1_25G_P3C1	-27.6869033	17.82718813	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1143	1980	0.001010101	0.004040404	0	8	Astrocytes	NA	NA	NA
GAACATCCACGAGAGT-1_25G_P3C1	-9.118421503	1.345075441	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2631	6381	0.00955963	0.003761166	0	13A	IN-VIP	NA	NA	NA
GAACATCCACGAGGTA-1_25G_P3C1	-25.8500728	20.45302908	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1430	2611	0.00076599	0.003446955	0	8	Astrocytes	NA	NA	NA
GAACATCGTGTATGGG-1_25G_P3C1	-27.43800178	18.63718031	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1215	2010	0.00199005	0.002985075	0	8	Astrocytes	NA	NA	NA
GAACATCTCGGCTACG-1_25G_P3C1	-3.864796336	-20.45796657	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3061	8030	0.003362391	0.003362391	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GAACCTAAGGATGTAT-1_25G_P3C1	-19.71798953	-28.24711127	6A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3417	9261	0.002483533	0.004751107	0	6A	IN-PV	NA	NA	NA
GAACCTACACATCTTT-1_25G_P3C1	-2.687365644	-13.506471	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1939	4096	0.001464844	0.002685547	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GAACCTAGTTATCCGA-1_25G_P3C1	11.12395838	28.5046235	1	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	778	1223	0.006541292	0.002452984	0	oligos	OL-Cntl	NA	NA	NA
GAACCTAGTTATTCTC-1_25G_P3C1	-2.170155034	-11.61196311	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1796	3222	0.011483551	0.010242086	0	12	EN-MIX	NA	NA	NA
GAACGGACACGACGAA-1_25G_P3C1	-11.99915002	-19.7331596	6B	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	969	1668	0.00059952	0.002398082	0	6B	IN-SST	NA	NA	NA
GAACGGACATGCCCGA-1_25G_P3C1	-26.20743997	27.74751042	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1699	3419	0.00087745	0.005849664	0	8	Astrocytes	NA	NA	NA
GAACGGAGTGCAACGA-1_25G_P3C1	-9.844523812	-0.338615716	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2436	4709	0.005946061	0.007432576	0	13A	IN-VIP	NA	NA	NA
GAACGGATCCAAATGC-1_25G_P3C1	-2.500749019	-23.94696403	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4308	12581	0.003815277	0.002861458	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GAACGGATCTGAGGGA-1_25G_P3C1	-8.757986027	-0.084845922	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2437	5164	0.015879163	0.002711077	0	13A	IN-VIP	NA	NA	NA
GAAGCAGAGTGGGCTA-1_25G_P3C1	-39.37618308	-1.005708437	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1483	2611	0.001148985	0.004978935	0	9	OPC	NA	NA	NA
GAAGCAGAGTTGAGAT-1_25G_P3C1	-30.1088411	21.16190599	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	995	1641	0.001218769	0.003656307	0	8	Astrocytes	NA	NA	NA
GAAGCAGCACTCGACG-1_25G_P3C1	-38.19499367	-7.914825027	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1063	1817	0.000550358	0.000550358	0	9	OPC	NA	NA	NA
GAAGCAGCAGGGTACA-1_25G_P3C1	-2.75289846	-23.8906772	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4451	14147	0.002544709	0.002686082	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GAAGCAGGTAAACACA-1_25G_P3C1	-4.006413563	-17.79005535	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2887	6311	0.005704326	0.010933291	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GAAGCAGGTATGAATG-1_25G_P3C1	-3.602189288	-23.67457938	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4222	12513	0.002157756	0.003516343	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GAAGCAGTCAGTGTTG-1_25G_P3C1	-9.496680083	3.065967131	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3014	6955	0.004169662	0.002875629	0	13A	IN-VIP	NA	NA	NA
GAAGCAGTCCCGGATG-1_25G_P3C1	7.544138969	-33.00288196	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3514	10218	0.00195733	0.003033862	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GAATAAGAGGAATGGA-1_25G_P3C1	18.01854427	1.419403341	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1139	1643	0.004260499	0.003651856	0	12	EN-MIX	NA	NA	NA
GAATAAGAGGAGTTGC-1_25G_P3C1	-26.36548416	20.10711939	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1472	2568	0.00194704	0.005451713	0	8	Astrocytes	NA	NA	NA
GAATAAGAGGCTAGAC-1_25G_P3C1	2.034022376	-4.314378698	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	910	1418	0.002820874	0.00493653	0	12	EN-MIX	NA	NA	NA
GAATAAGCAGTAACGG-1_25G_P3C1	25.7521391	-7.173986332	2	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3779	9276	0.005605865	0.004420009	0	2	EN-L4	NA	NA	NA
GAATAAGGTGAAGGCT-1_25G_P3C1	8.255680282	31.98592177	1	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	692	1069	0.002806361	0.001870907	0	oligos	OL-Cntl	NA	NA	NA
GAATAAGTCGAGAACG-1_25G_P3C1	-12.52765419	-1.157615692	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2400	4626	0.012970169	0.010808474	0	13A	IN-VIP	NA	NA	NA
GAATGAAAGAAGGGTA-1_25G_P3C1	-37.30999605	-10.01302928	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	907	1440	0.001388889	0.003472222	0	9	OPC	NA	NA	NA
GAATGAACAACTTGAC-1_25G_P3C1	-2.842382892	-19.31886261	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2840	6449	0.003101256	0.004806947	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GACACGCAGAAACGAG-1_25G_P3C1	-0.409210459	-27.23798142	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4891	14872	0.003765465	0.003899946	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GACACGCAGAGTAAGG-1_25G_P3C1	-25.06430693	-2.012306537	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1379	2468	0.003646677	0.006077796	0	9	OPC	NA	NA	NA
GACACGCAGCTCCCAG-1_25G_P3C1	-26.03217522	20.55403839	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1515	2924	0.004103967	0.006497948	0	8	Astrocytes	NA	NA	NA
GACACGCAGTCGATAA-1_25G_P3C1	-2.287031947	-11.96331408	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2096	3898	0.004617753	0.010774756	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GACACGCCATCCCACT-1_25G_P3C1	-2.543773224	-14.93531354	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2272	4871	0.000410593	0.004721823	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GACACGCGTCCGCTGA-1_25G_P3C1	-26.40784052	27.90135686	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1652	3274	0.001832621	0.004581552	0	8	Astrocytes	NA	NA	NA
GACAGAGAGCACCGCT-1_25G_P3C1	-29.01480045	16.60795226	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	944	1482	0.002699055	0.004048583	0	8	Astrocytes	NA	NA	NA
GACAGAGAGCGGATCA-1_25G_P3C1	25.13728965	-9.046494985	2	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4042	11111	0.000450005	0.002700027	0	2	EN-L4	NA	NA	NA
GACAGAGAGGCAGGTT-1_25G_P3C1	-0.960107944	-10.96239207	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1803	3093	0.003556418	0.002909796	0	12	EN-MIX	NA	NA	NA
GACAGAGGTGACCAAG-1_25G_P3C1	2.74577354	-28.9107798	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3996	11812	0.001523874	0.004740941	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GACAGAGGTGTGAAAT-1_25G_P3C1	-14.07413236	-24.81335656	6A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1490	2786	0.001794688	0.003948313	0	6A	IN-PV	NA	NA	NA
GACAGAGTCGCCATAA-1_25G_P3C1	39.23537085	9.301903543	14	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	733	1023	0.001955034	0.000977517	0	14	Microglia	NA	NA	NA
GACAGAGTCGTCGTTC-1_25G_P3C1	-28.71569197	17.52358619	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1034	1765	0.009065156	0.005665722	0	8	Astrocytes	NA	NA	NA
GACAGAGTCTACTCAT-1_25G_P3C1	-10.87885026	2.074315861	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3384	9617	0.01601331	0.004783196	0	13A	IN-VIP	NA	NA	NA
GACCAATCAGAGTGTG-1_25G_P3C1	-16.87560898	-25.09399664	6A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2177	4569	0.00175093	0.003939593	0	6A	IN-PV	NA	NA	NA
GACCAATGTCAGAGGT-1_25G_P3C1	5.934369921	-31.04553026	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4480	12594	0.000158806	0.003890742	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GACCAATTCAATACCG-1_25G_P3C1	-3.257927856	-25.85381689	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4465	14784	0.000473485	0.003517316	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GACCAATTCGTGGGAA-1_25G_P3C1	0.793866486	-14.60984757	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2212	4302	0.00441655	0.005346351	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GACCAATTCGTTACAG-1_25G_P3C1	-4.115654743	-17.26787344	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2647	5708	0.004555011	0.007533287	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GACCTGGGTATTCGTG-1_25G_P3C1	-9.048951489	0.492305231	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2253	4971	0.005230336	0.00683967	0	13A	IN-VIP	NA	NA	NA
GACCTGGTCGGCTTGG-1_25G_P3C1	-38.16240067	-8.65322477	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	987	1646	0.000607533	0.0018226	0	9	OPC	NA	NA	NA
GACGCGTAGGCCATAG-1_25G_P3C1	-4.71982247	-1.723913213	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1341	2367	0.000844951	0.005492184	0	13A	IN-VIP	NA	NA	NA
GACGCGTGTACAGTGG-1_25G_P3C1	-25.08967596	26.35680991	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1566	3046	0.001313198	0.00558109	0	8	Astrocytes	NA	NA	NA
GACGCGTTCATGCATG-1_25G_P3C1	19.10596354	13.45333674	1	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1241	2211	0.004975124	0.001809136	0	oligos	OL-Cntl	NA	NA	NA
GACGGCTAGTCCGGTC-1_25G_P3C1	-28.32128757	18.05917576	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1160	1832	0.006004367	0.004912664	0	8	Astrocytes	NA	NA	NA
GACGGCTCACTACAGT-1_25G_P3C1	-17.30409893	-23.85447765	6A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1796	3471	0.000288101	0.002304811	0	6A	IN-PV	NA	NA	NA
GACGGCTCAGATCGGA-1_25G_P3C1	4.668292039	-17.67230446	4	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3224	6983	0.006873836	0.014034083	0	L2-3	EN-L2-3-MS	NA	NA	NA
GACGGCTTCAAGGCTT-1_25G_P3C1	-0.950586108	-25.87132755	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	5610	19072	0.002569211	0.002883809	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GACGGCTTCCAAAGTC-1_25G_P3C1	-3.233150881	-25.26838192	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4225	12477	0.00128236	0.004007374	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GACGGCTTCCCTTGCA-1_25G_P3C1	-29.5705237	14.01588272	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	828	1382	0.002170767	0.002170767	0	8	Astrocytes	NA	NA	NA
GACGGCTTCTGAAAGA-1_25G_P3C1	-7.771351903	-2.271042932	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1820	3168	0.016414141	0.003787879	0	13A	IN-VIP	NA	NA	NA
GACGTGCAGACAGACC-1_25G_P3C1	25.39699638	-29.02372144	3	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4733	14816	0.000404968	0.003644708	0	3	EN-L5-6	NA	NA	NA
GACGTGCAGCATCATC-1_25G_P3C1	-5.407399089	-21.71915627	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3097	8093	0.001482763	0.004201161	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GACGTGCAGTAGGTGC-1_25G_P3C1	19.3856342	22.0551054	1	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1011	1538	0.00390117	0.00390117	0	oligos	OL-Cntl	NA	NA	NA
GACGTGCCAAAGTGCG-1_25G_P3C1	-2.7296097	-22.38628516	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4067	10309	0.004656126	0.007178194	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GACGTGCCACAGATTC-1_25G_P3C1	-4.688168089	-18.05807542	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3124	7440	0.005913978	0.005510753	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GACGTGCCATGACGGA-1_25G_P3C1	-9.398991799	2.935113552	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2757	5810	0.006196213	0.003442341	0	13A	IN-VIP	NA	NA	NA
GACGTGCTCATAACCG-1_25G_P3C1	-3.904248589	-20.40503589	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3844	9918	0.001714055	0.005142166	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GACGTGCTCCTAGGGC-1_25G_P3C1	39.34427601	9.58949429	14	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	799	1109	0.00270514	0.00270514	0	14	Microglia	NA	NA	NA
GACGTTAAGAATGTGT-1_25G_P3C1	-27.51771732	18.83314044	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1176	1905	0.004724409	0.003149606	0	8	Astrocytes	NA	NA	NA
GACGTTAAGATCGATA-1_25G_P3C1	0.348103189	-8.065323205	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1528	2807	0.003918774	0.005700036	0	12	EN-MIX	NA	NA	NA
GACGTTAGTCTAGGTT-1_25G_P3C1	8.08254665	-31.74098584	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3797	9521	0.007247138	0.003255961	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GACGTTAGTTCAGTAC-1_25G_P3C1	-4.833352779	-2.816597581	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1372	2426	0.012778236	0.002473207	0	13A	IN-VIP	NA	NA	NA
GACTAACAGGCAGTCA-1_25G_P3C1	-4.255073601	-15.30254263	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2425	4817	0.001245589	0.003529168	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GACTAACAGGGCACTA-1_25G_P3C1	-1.206035435	-9.876906993	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1769	3220	0.00310559	0.008385093	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GACTAACAGTCACGCC-1_25G_P3C1	-36.3793761	-11.23213133	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	823	1219	0.000820345	0.001640689	0	9	OPC	NA	NA	NA
GACTAACAGTCGTTTG-1_25G_P3C1	4.123781037	-2.140151192	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	789	1140	0.003508772	0.009649123	0	12	EN-MIX	NA	NA	NA
GACTAACCAGCCTTTC-1_25G_P3C1	-3.5738631	-23.47454793	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4273	13432	0.001786778	0.004318046	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GACTAACGTCTCCCTA-1_25G_P3C1	-8.982596193	1.292741007	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2636	6406	0.007180768	0.005151421	0	13A	IN-VIP	NA	NA	NA
GACTAACGTTCAGCGC-1_25G_P3C1	-4.228045149	-15.2643385	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2542	5487	0.000182249	0.006560962	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GACTAACTCAACCAAC-1_25G_P3C1	-4.109775024	-14.69274737	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2460	5274	0.00303375	0.004550626	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GACTACAAGCGATTCT-1_25G_P3C1	1.202280225	-30.90713296	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	5861	23373	0.00106961	0.002780987	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GACTACACAAGTCTAC-1_25G_P3C1	39.47390563	12.25501042	14	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	904	1303	0.003837299	0.003069839	0	14	Microglia	NA	NA	NA
GACTACACAATAAGCA-1_25G_P3C1	-0.191180991	-8.43571646	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1525	2702	0.001110289	0.003700962	0	12	EN-MIX	NA	NA	NA
GACTGCGAGCTGTTCA-1_25G_P3C1	-38.37154156	-5.762207535	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1172	1906	0.001573977	0.002098636	0	9	OPC	NA	NA	NA
GACTGCGCAAGCTGGA-1_25G_P3C1	33.09522929	15.17037328	14	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	802	1095	0.003652968	0.056621005	0	14	Microglia	NA	NA	NA
GACTGCGCAGTCACTA-1_25G_P3C1	8.372026245	32.15702269	1	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	693	1076	0.005576208	0.001858736	0	oligos	OL-Cntl	NA	NA	NA
GACTGCGGTGCACTTA-1_25G_P3C1	-3.281671662	-5.732870334	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1077	1754	0.009122007	0.003420753	0	13A	IN-VIP	NA	NA	NA
GACTGCGGTTTGACAC-1_25G_P3C1	-4.969416735	-1.286792852	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1569	2917	0.005142269	0.002056908	0	13A	IN-VIP	NA	NA	NA
GAGCAGAAGTCCGGTC-1_25G_P3C1	-0.728682725	-26.58160195	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	6458	24868	0.004342931	0.007760978	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GAGCAGAAGTGTCCCG-1_25G_P3C1	-2.409364725	-12.50026519	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2108	3871	0.004133299	0.004649961	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GAGCAGACAAGAGGCT-1_25G_P3C1	-0.132701163	-8.196966426	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1517	2533	0.006316621	0.010264508	0	12	EN-MIX	NA	NA	NA
GAGCAGACAAGCCGTC-1_25G_P3C1	8.679686555	32.43551463	1	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	809	1204	0.005813953	0.004152824	0	oligos	OL-Cntl	NA	NA	NA
GAGCAGACATATGCTG-1_25G_P3C1	-2.39412558	-17.0993893	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2694	6548	0.001221747	0.003207086	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GAGCAGACATCGATTG-1_25G_P3C1	-8.05331304	-0.078888217	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2117	4403	0.005450829	0.001816943	0	13A	IN-VIP	NA	NA	NA
GAGCAGAGTTCTGAAC-1_25G_P3C1	28.08466539	-0.027729579	2	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3630	9500	0.002315789	0.002842105	0	2	EN-L4	NA	NA	NA
GAGCAGAGTTGTCGCG-1_25G_P3C1	-4.774418006	-21.37761947	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3375	9091	0.000219998	0.005059949	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GAGCAGATCATTATCC-1_25G_P3C1	20.02615121	22.30690888	1	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	982	1661	0	0.001204094	0	oligos	OL-Cntl	NA	NA	NA
GAGGTGAAGCGAAGGG-1_25G_P3C1	-27.21903948	19.001503	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1291	2174	0.003679853	0.006439742	0	8	Astrocytes	NA	NA	NA
GAGGTGAAGCGTGAAC-1_25G_P3C1	-28.78177619	17.27449794	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1061	1692	0.002955083	0.008865248	0	8	Astrocytes	NA	NA	NA
GAGGTGAAGGCACATG-1_25G_P3C1	-36.7642049	-4.219436083	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1320	2321	0.002585093	0.003877639	0	9	OPC	NA	NA	NA
GAGGTGACAAAGGCGT-1_25G_P3C1	-2.619919429	-21.42561789	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3326	8658	0.001848002	0.003234003	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GAGGTGAGTAGAAAGG-1_25G_P3C1	25.52401775	-3.464973315	2	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3445	8941	0.000111844	0.004361928	0	2	EN-L4	NA	NA	NA
GAGGTGAGTTCCTCCA-1_25G_P3C1	-4.508506381	-8.395649177	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	903	1486	0.00269179	0.00269179	0	13A	IN-VIP	NA	NA	NA
GAGTCCGAGGCGACAT-1_25G_P3C1	-19.70667156	-28.44075664	6A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3689	10427	0.002109907	0.00335667	0	6A	IN-PV	NA	NA	NA
GAGTCCGCACGAAATA-1_25G_P3C1	-4.736836705	-2.897350079	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1419	2554	0.003523884	0.005481597	0	13A	IN-VIP	NA	NA	NA
GAGTCCGCACTTACGA-1_25G_P3C1	-31.15340375	13.02840237	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	768	1164	0.001718213	0.006013746	0	8	Astrocytes	NA	NA	NA
GAGTCCGCAGTATAAG-1_25G_P3C1	-37.43974088	-9.896803127	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	909	1567	0.001276324	0.001914486	0	9	OPC	NA	NA	NA
GAGTCCGGTCCTCCAT-1_25G_P3C1	27.012121	0.231525769	2	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2995	7724	0	0.003107198	0	2	EN-L4	NA	NA	NA
GAGTCCGTCGGCATCG-1_25G_P3C1	-4.782933117	-18.33861942	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3093	7338	0.001090215	0.00926683	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GATCAGTAGAAGGTGA-1_25G_P3C1	5.319302996	-31.27843383	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	5167	18350	0.002561308	0.002125341	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GATCAGTAGTTGTAGA-1_25G_P3C1	6.880250967	-33.18622866	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4028	12072	0	0.002485089	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GATCAGTCAAGTCTAC-1_25G_P3C1	-28.00228339	18.59612761	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1105	2166	0	0.005078486	0	8	Astrocytes	NA	NA	NA
GATCAGTGTCTTGTCC-1_25G_P3C1	1.163712609	-18.92234214	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3085	7308	0.006978654	0.00410509	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GATCAGTGTGTGGCTC-1_25G_P3C1	-1.135504857	-29.29311866	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4005	12192	0.002132546	0.002706693	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GATCAGTTCGGCGGTT-1_25G_P3C1	30.91321828	-6.155902557	2	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4293	11848	0.015952059	0.003798109	0	2	EN-L4	NA	NA	NA
GATCAGTTCGGGAGTA-1_25G_P3C1	-3.422451925	-7.06114777	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	935	1421	0.021111893	0.00070373	0	13A	IN-VIP	NA	NA	NA
GATCGATCATCCTTGC-1_25G_P3C1	40.01917535	11.37980192	14	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	782	1200	0	0.006666667	0	14	Microglia	NA	NA	NA
GATCGATGTAATAGCA-1_25G_P3C1	-22.82613076	31.35838261	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2295	5425	0.002764977	0.00202765	0	8	Astrocytes	NA	NA	NA
GATCGATGTCCTCTTG-1_25G_P3C1	11.88394314	26.43050373	1	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	801	1253	0.003192338	0.001596169	0	oligos	OL-Cntl	NA	NA	NA
GATCGATTCATTATCC-1_25G_P3C1	-16.270081	-19.25428338	6B	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2047	4441	0.000900698	0.00698041	0	6B	IN-SST	NA	NA	NA
GATCGATTCCAGAAGG-1_25G_P3C1	11.20669778	30.62458814	1	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	662	1013	0.003948667	0.003948667	0	oligos	OL-Cntl	NA	NA	NA
GATCGATTCGGCTACG-1_25G_P3C1	-4.823088642	-18.64741732	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3159	7901	0.001771928	0.006328313	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GATCGCGCAGAAGCAC-1_25G_P3C1	19.0627165	22.92742474	1	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	963	1608	0.002487562	0.003109453	0	oligos	OL-Cntl	NA	NA	NA
GATCGCGCAGGAATGC-1_25G_P3C1	-4.613530942	-24.7275787	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3383	8501	0.002587931	0.004352429	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GATCGCGGTAAATGTG-1_25G_P3C1	-20.67093171	16.67871747	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1395	2322	0.003014643	0.005167959	0	8	Astrocytes	NA	NA	NA
GATCGCGTCAGATAAG-1_25G_P3C1	-2.91111763	-13.1450902	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2144	4158	0.006493506	0.003367003	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GATCGCGTCAGCATGT-1_25G_P3C1	13.94762517	-33.88662726	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4740	16091	0.000807905	0.005344603	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GATCGCGTCCCATTTA-1_25G_P3C1	-3.229491894	-25.80256102	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4158	13892	0	0.002375468	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GATCGTAAGACCCACC-1_25G_P3C1	-2.516108774	-22.51674711	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3518	9502	0.003999158	0.00420964	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GATCGTACAAACAACA-1_25G_P3C1	7.108406356	-33.38851835	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3814	11735	0.001363443	0.001022582	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GATCGTACATGCTAGT-1_25G_P3C1	-4.720120801	-22.54471909	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3508	9798	0.000510308	0.004082466	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GATCGTAGTGGGTATG-1_25G_P3C1	0.256231552	-7.40945698	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1294	2247	0.000445038	0.00400534	0	12	EN-MIX	NA	NA	NA
GATCGTAGTGGTTTCA-1_25G_P3C1	-0.892606429	-26.01274088	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4566	13249	0.00203789	0.005585327	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GATCTAGAGCTAAGAT-1_25G_P3C1	-39.50009561	0.105815435	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1515	2807	0.003918774	0.005700036	0	9	OPC	NA	NA	NA
GATCTAGAGTCATCCA-1_25G_P3C1	-5.37389735	-21.17591452	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3091	8197	0.002683909	0.003415884	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GATCTAGAGTCCGTAT-1_25G_P3C1	-4.218427431	-23.26987108	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3701	10764	0.001021925	0.00287997	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GATCTAGCAGCGTCCA-1_25G_P3C1	2.293118011	-6.292933795	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1256	2403	0.000832293	0.002496879	0	12	EN-MIX	NA	NA	NA
GATCTAGTCGGCTTGG-1_25G_P3C1	-3.084136258	-25.73536096	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3695	9548	0.00104734	0.002618349	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GATGAAATCCCATTTA-1_25G_P3C1	-0.618390257	-8.856424404	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1556	2888	0.001385042	0.007617729	0	12	EN-MIX	NA	NA	NA
GATGAGGCAGCTGTTA-1_25G_P3C1	-3.243989729	-26.16198677	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3586	10078	0.000893034	0.002579877	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GATGAGGCAGCTTCGG-1_25G_P3C1	-37.74271202	-8.000897065	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1090	1789	0.002235886	0.000558971	0	9	OPC	NA	NA	NA
GATGAGGCAGGATCGA-1_25G_P3C1	-4.144546856	-19.34230177	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3504	8629	0.004519643	0.006953297	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GATGAGGTCAACGAAA-1_25G_P3C1	-11.55992885	0.963782584	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3098	7214	0.002772387	0.005544774	0	13A	IN-VIP	NA	NA	NA
GATGAGGTCAGGTAAA-1_25G_P3C1	-5.812024012	-22.60200594	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2961	7411	0.000944542	0.005127513	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GATGAGGTCTCTTATG-1_25G_P3C1	-2.663657593	-26.86881759	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4057	11869	0.00134805	0.003117365	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GATGCTAAGAGCCCAA-1_25G_P3C1	-25.51165329	27.81472048	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1680	3151	0.002538877	0.008251349	0	8	Astrocytes	NA	NA	NA
GATGCTAAGAGGTAGA-1_25G_P3C1	-2.4005155	-24.34731867	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4036	11322	0.002649709	0.003709592	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GATGCTAAGATACACA-1_25G_P3C1	-4.127834143	-14.57639373	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2332	4957	0.001815614	0.01190236	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GATGCTAAGGGATCTG-1_25G_P3C1	-1.852403878	-16.25560682	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2378	5095	0.001373896	0.003140334	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GATGCTAAGTTCGCGC-1_25G_P3C1	6.761806105	-32.80698664	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3639	9442	0.00021182	0.004024571	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GATGCTACATGCTAGT-1_25G_P3C1	36.4601053	11.73784331	14	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	790	1051	0.00190295	0.033301618	0	14	Microglia	NA	NA	NA
GATGCTAGTTCCTCCA-1_25G_P3C1	-14.14342497	-10.5421963	13B	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2154	4376	0.005941499	0.001371115	0	13B	IN-SV2C	NA	NA	NA
GATGCTATCATCGCTC-1_25G_P3C1	-3.932779639	-23.00491972	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3789	10757	0.002788882	0.003253695	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GATTCAGAGCACAGGT-1_25G_P3C1	9.237983181	-20.53813058	4	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4870	13842	0.005273804	0.008452536	0	L2-3	EN-L2-3-MS	NA	NA	NA
GATTCAGCACCCATGG-1_25G_P3C1	-38.63656694	-7.948674063	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1085	2069	0.001933301	0.003383277	0	9	OPC	NA	NA	NA
GATTCAGGTATATCCG-1_25G_P3C1	-36.0927018	4.591932384	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2168	4850	0.001649485	0.002268041	0	9	OPC	NA	NA	NA
GATTCAGGTGCGGTAA-1_25G_P3C1	-2.669391997	-21.12556976	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3030	7102	0.00183047	0.004928189	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCAAACTAGAGGTTGC-1_25G_P3C1	2.400451794	-21.29156876	4	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3692	9255	0.012317666	0.006050783	0	L2-3	EN-L2-3-MS	NA	NA	NA
GCAAACTAGCATCATC-1_25G_P3C1	-24.88768934	18.90840012	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1450	2600	0.002307692	0.005384615	0	8	Astrocytes	NA	NA	NA
GCAAACTAGCGACGTA-1_25G_P3C1	-8.587541861	1.874588055	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2681	6145	0.004882018	0.003580146	0	13A	IN-VIP	NA	NA	NA
GCAAACTAGTATCTCG-1_25G_P3C1	-3.964928267	-24.00473739	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3593	9408	0.001913265	0.002338435	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCAAACTCAGACTCGC-1_25G_P3C1	-4.718919243	-18.28669379	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2954	6608	0.000756659	0.008928571	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCAAACTCAGTATGCT-1_25G_P3C1	-9.505272655	2.76809349	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3083	7100	0.005211268	0.003521127	0	13A	IN-VIP	NA	NA	NA
GCAAACTCATATGAGA-1_25G_P3C1	-2.683241604	-15.39900057	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2433	5169	0.000580383	0.006384214	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCAAACTCATGCCTAA-1_25G_P3C1	2.467729203	-31.6502254	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	6372	25216	0.001031091	0.002974302	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCAAACTGTACCAGTT-1_25G_P3C1	-1.66723567	-24.86631788	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4824	15461	0.004656879	0.003363301	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCAAACTGTCACTGGC-1_25G_P3C1	-2.161627622	-24.40966886	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4916	15662	0.003383987	0.003703231	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCAAACTGTCTAAACC-1_25G_P3C1	-22.49501879	31.48719399	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2606	6189	0.008402004	0.002100501	0	8	Astrocytes	NA	NA	NA
GCAAACTGTTAAGTAG-1_25G_P3C1	38.88892684	12.98887157	14	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	947	1324	0.00755287	0.005287009	0	14	Microglia	NA	NA	NA
GCAAACTTCCCATTAT-1_25G_P3C1	-2.033050605	-28.72502081	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3198	8055	0.002731223	0.002731223	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCAAACTTCCCTCTTT-1_25G_P3C1	25.53686173	-3.680687844	2	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4028	12185	0.002051703	0.006811654	0	2	EN-L4	NA	NA	NA
GCAAACTTCTTCGGTC-1_25G_P3C1	2.344040832	-27.90561392	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3413	9400	0.001382979	0.004574468	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCAATCAGTCGTGGCT-1_25G_P3C1	-2.512432219	-23.58871294	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4337	13032	0.002685697	0.002302026	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCAATCATCGTGGGAA-1_25G_P3C1	2.229534558	-26.63393441	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3098	6488	0.005548705	0.00662762	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCAATCATCTGCTGCT-1_25G_P3C1	-4.106399111	-17.91317624	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3097	7217	0.009006512	0.006512401	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCACATAAGCTCCTCT-1_25G_P3C1	1.979501258	-31.26210893	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	6019	24792	0.001452081	0.002339464	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCACATACAGGGTACA-1_25G_P3C1	-4.733838327	-3.167795682	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1384	2354	0.007646559	0.002124044	0	13A	IN-VIP	NA	NA	NA
GCACATAGTAATCGTC-1_25G_P3C1	-28.7774484	17.06261203	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	980	1601	0.002498438	0.003123048	0	8	Astrocytes	NA	NA	NA
GCACATAGTAGCGTCC-1_25G_P3C1	-13.8159537	-10.68317866	13B	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2049	4302	0.010460251	0.00255695	0	13B	IN-SV2C	NA	NA	NA
GCACATAGTGCAGGTA-1_25G_P3C1	-1.559126505	-10.38823935	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1919	3745	0.007476636	0.006408545	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCACATAGTTCTGAAC-1_25G_P3C1	-26.15004298	27.19948662	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1615	2993	0.002338791	0.00801871	0	8	Astrocytes	NA	NA	NA
GCACATAGTTCTGTTT-1_25G_P3C1	-2.725765783	-14.10119225	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2269	4747	0.002949231	0.004634506	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCACATAGTTGCTCCT-1_25G_P3C1	-26.67787129	27.00903172	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1497	2885	0.001039861	0.004506066	0	8	Astrocytes	NA	NA	NA
GCACATATCTTGAGAC-1_25G_P3C1	-1.087055186	-18.54604777	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2689	6070	0.004118616	0.004118616	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCACATATCTTGGGTA-1_25G_P3C1	-0.484325534	-28.49612532	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	5255	17383	0.003566703	0.003451648	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCACTCTAGATCGATA-1_25G_P3C1	-0.04641759	-8.003708655	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1415	2393	0.007521939	0.010865023	0	12	EN-MIX	NA	NA	NA
GCACTCTCAGGAATGC-1_25G_P3C1	-0.57390098	-28.88904203	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	7228	30795	0.002565352	0.007111544	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCACTCTCATCACAAC-1_25G_P3C1	-39.20218299	-2.257108618	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1186	2230	0.001345291	0.002242152	0	9	OPC	NA	NA	NA
GCACTCTGTCGTTGTA-1_25G_P3C1	-1.805921638	-24.65182963	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	5016	15970	0.004007514	0.00363181	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCACTCTTCCCTAATT-1_25G_P3C1	-5.551569864	-22.57846249	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2962	7413	0.000674491	0.005395926	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCAGCCAAGGACAGAA-1_25G_P3C1	-0.259435377	-8.462488605	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1582	2768	0.003251445	0.01083815	0	12	EN-MIX	NA	NA	NA
GCAGCCACACGGTAAG-1_25G_P3C1	-4.16890605	-13.77472219	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2299	4477	0.003350458	0.016082198	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCAGCCACACGGTTTA-1_25G_P3C1	-3.186805985	-12.98496209	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2155	4417	0.000679194	0.007697532	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCAGCCACAGCGAACA-1_25G_P3C1	-32.94234312	-12.80230349	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	762	1254	0.003189793	0.003987241	0	9	OPC	NA	NA	NA
GCAGCCATCCTAGGGC-1_25G_P3C1	26.84656159	-4.188777339	2	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3875	10464	0.00382263	0.004109327	0	2	EN-L4	NA	NA	NA
GCAGTTAAGATCTGAA-1_25G_P3C1	-4.72480467	-17.75527402	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2720	6045	0.001323408	0.006782465	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCAGTTAAGCCACGTC-1_25G_P3C1	0.26898878	-11.23154214	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1666	3114	0.003853565	0.004495825	0	12	EN-MIX	NA	NA	NA
GCAGTTACAAGTTAAG-1_25G_P3C1	-2.396984027	-25.40084229	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4373	12871	0.00038847	0.004195478	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCAGTTACACCGAATT-1_25G_P3C1	-3.569022822	-24.22596767	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4744	15681	0.000382629	0.005675658	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCAGTTACACTTCGAA-1_25G_P3C1	39.36806967	9.563444258	14	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	897	1222	0.006546645	0.006546645	0	14	Microglia	NA	NA	NA
GCAGTTACAGATGGGT-1_25G_P3C1	-4.17311411	-14.99104371	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2515	5044	0.000991277	0.009912768	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCAGTTACATCAGTAC-1_25G_P3C1	-15.19781617	-25.53097692	6A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1731	3335	0.0005997	0.002998501	0	6A	IN-PV	NA	NA	NA
GCAGTTACATCCCATC-1_25G_P3C1	-4.529703428	-24.31652698	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3645	10110	0.001285856	0.002769535	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCAGTTATCCAACCAA-1_25G_P3C1	-2.635450561	-23.71246094	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4835	16098	0.00515592	0.005342279	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCATACACACATCTTT-1_25G_P3C1	-13.66693196	-24.4882189	6A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1257	2226	0	0.000898473	0	6A	IN-PV	NA	NA	NA
GCATACAGTTCCCGAG-1_25G_P3C1	-2.761594027	-23.43287078	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4045	11755	0.006975755	0.00459379	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCATACATCGAGCCCA-1_25G_P3C1	38.89136967	9.35401581	14	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	818	1102	0.006352087	0.008166969	0	14	Microglia	NA	NA	NA
GCATACATCGTCCGTT-1_25G_P3C1	10.54314628	28.70653412	1	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	849	1378	0	0.006531205	0	oligos	OL-Cntl	NA	NA	NA
GCATACATCTCGAGTA-1_25G_P3C1	-2.512279207	-14.05764022	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2211	4422	0.002487562	0.008141113	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCATGATAGCTGCGAA-1_25G_P3C1	-24.74347629	29.78858098	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1647	3111	0.00032144	0.004821601	0	8	Astrocytes	NA	NA	NA
GCATGATCAGACGCAA-1_25G_P3C1	-3.552884714	-22.64947226	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3531	8474	0.000472032	0.006018409	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCATGATCAGTGACAG-1_25G_P3C1	2.738978959	-31.28468917	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	5735	22080	0.001856884	0.002536232	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCATGATCATCCCATC-1_25G_P3C1	-26.30194327	27.58853249	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1686	3460	0.001445087	0.004913295	0	8	Astrocytes	NA	NA	NA
GCATGATGTATATGGA-1_25G_P3C1	-35.35685014	-12.23720116	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	792	1188	0.003367003	0.003367003	0	9	OPC	NA	NA	NA
GCATGCGAGCTACCGC-1_25G_P3C1	-35.12425771	4.923460233	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2569	5513	0.002539452	0.003083621	0	9	OPC	NA	NA	NA
GCATGCGAGCTGCGAA-1_25G_P3C1	39.33021897	9.438152369	14	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	828	1156	0.000865052	0.002595156	0	14	Microglia	NA	NA	NA
GCATGCGGTCGTCTTC-1_25G_P3C1	-4.483033598	-18.85501272	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2862	6426	0.001556178	0.009337068	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCATGCGGTGGCAAAC-1_25G_P3C1	-3.252067737	-22.04543358	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4095	11828	0.004649983	0.002874535	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCATGCGGTTGTCGCG-1_25G_P3C1	-3.414195422	-5.350191696	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1101	1868	0.018736617	0.003211991	0	13A	IN-VIP	NA	NA	NA
GCATGCGTCTGGCGAC-1_25G_P3C1	-3.57847419	-25.19159669	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3874	10155	0.000787789	0.004234367	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCATGCGTCTTCAACT-1_25G_P3C1	14.66525702	31.27753413	1	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	866	1279	0.001563722	0.003909304	0	oligos	OL-Cntl	NA	NA	NA
GCATGTAAGTTAACGA-1_25G_P3C1	27.63872047	1.098424785	2	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2551	5753	0.003824092	0.005388493	0	2	EN-L4	NA	NA	NA
GCATGTACAAGCCTAT-1_25G_P3C1	19.43157631	21.84103187	1	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1029	1761	0.001135718	0.003407155	0	oligos	OL-Cntl	NA	NA	NA
GCATGTACAATAAGCA-1_25G_P3C1	9.458114302	29.12496869	1	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	725	1085	0	0.001843318	0	oligos	OL-Cntl	NA	NA	NA
GCATGTACACATCTTT-1_25G_P3C1	-9.327305351	2.710712629	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2831	6430	0.005287714	0.002643857	0	13A	IN-VIP	NA	NA	NA
GCATGTACAGGTCCAC-1_25G_P3C1	-19.44367117	-27.51606539	6A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3392	8845	0.00192199	0.002600339	0	6A	IN-PV	NA	NA	NA
GCATGTAGTATAGGGC-1_25G_P3C1	28.6595423	0.744473165	2	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3173	7520	0.004654255	0.006382979	0	2	EN-L4	NA	NA	NA
GCATGTAGTTTGCATG-1_25G_P3C1	-4.046218513	-17.33199133	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2672	5625	0.007288889	0.008533333	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCCAAATAGTACGCGA-1_25G_P3C1	-2.158708024	-23.29095024	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4344	12762	0.005563391	0.00493653	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCCAAATCAAGAGGCT-1_25G_P3C1	-0.18286135	-8.466681963	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1648	2929	0.002731308	0.005121202	0	12	EN-MIX	NA	NA	NA
GCCAAATCAAGCCCAC-1_25G_P3C1	-9.106909062	0.861748383	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2436	5115	0.016226784	0.00684262	0	13A	IN-VIP	NA	NA	NA
GCCAAATCATGAAGTA-1_25G_P3C1	-4.340661501	-8.715809059	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1006	1912	0.000523013	0.00209205	0	13A	IN-VIP	NA	NA	NA
GCCAAATTCAACCATG-1_25G_P3C1	3.783619687	-32.66852386	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	6037	24558	0.001425197	0.002565355	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCCAAATTCCTATGTT-1_25G_P3C1	-15.28670148	-25.93559239	6A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1798	3856	0.004408714	0.002074689	0	6A	IN-PV	NA	NA	NA
GCCTCTACAAGAGTCG-1_25G_P3C1	9.783472289	27.84445118	1	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	873	1342	0.008196721	0.005216095	0	oligos	OL-Cntl	NA	NA	NA
GCCTCTACAATACGCT-1_25G_P3C1	-5.403907323	-21.46325456	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3284	9387	0.000532652	0.002769788	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCCTCTAGTCATGCCG-1_25G_P3C1	-5.210631121	-21.79894424	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3310	9306	0.001826778	0.002578981	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCCTCTAGTCGAGATG-1_25G_P3C1	1.914602482	-27.17524506	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3123	7698	0.001299039	0.005066251	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCCTCTAGTGCCTGTG-1_25G_P3C1	-2.154023396	-14.24895629	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2089	4417	0	0.00226398	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCCTCTATCAGTACGT-1_25G_P3C1	-2.971261503	-13.8222364	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2170	4568	0	0.006129597	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCGACCATCGGCTTGG-1_25G_P3C1	-1.829306754	-24.20771591	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4910	15941	0.006398595	0.003763879	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCGAGAAAGCCATCGC-1_25G_P3C1	38.55213266	9.630309834	14	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	792	1048	0.000954198	0.01240458	0	14	Microglia	NA	NA	NA
GCGAGAAAGCCCGAAA-1_25G_P3C1	-3.78588795	-13.69625951	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2534	5261	0.008553507	0.005702338	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCGAGAAAGGACGAAA-1_25G_P3C1	-35.86727913	-4.534323405	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1192	1848	0.002164502	0.011904762	0	9	OPC	NA	NA	NA
GCGAGAAGTGGACGAT-1_25G_P3C1	-1.139669988	-9.35028762	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1743	3008	0.005984043	0.010638298	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCGAGAATCAAGAAGT-1_25G_P3C1	-29.42517905	13.77167429	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	863	1431	0.002096436	0.004891684	0	8	Astrocytes	NA	NA	NA
GCGAGAATCCCTCTTT-1_25G_P3C1	-27.85028111	24.59965845	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1231	2241	0.008478358	0.002677376	0	8	Astrocytes	NA	NA	NA
GCGCAACAGAATGTTG-1_25G_P3C1	-3.401517285	-6.368413202	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	878	1373	0.007283321	0.002913328	0	13A	IN-VIP	NA	NA	NA
GCGCAACAGCCCAGCT-1_25G_P3C1	-8.509301491	-18.30405881	6B	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	766	1166	0.048027444	0.001715266	0	6B	IN-SST	NA	NA	NA
GCGCAACCAATAGAGT-1_25G_P3C1	-3.839763817	-21.06914699	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3281	8125	0.002215385	0.0032	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCGCAACGTCAGATAA-1_25G_P3C1	1.862731926	-14.76560942	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2255	4267	0.007265057	0.013358331	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCGCAACGTGTTGAGG-1_25G_P3C1	-2.386835879	-15.54898072	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2571	5168	0.001934985	0.007352941	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCGCAACTCGCCAGCA-1_25G_P3C1	-4.208784731	-15.06294274	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2531	5511	0.007258211	0.005625113	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCGCAGTAGATGTAAC-1_25G_P3C1	-3.683661512	-25.03501989	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3879	10614	0.001224797	0.005558696	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCGCAGTCAACTTGAC-1_25G_P3C1	-4.413837396	-16.52139106	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2557	5489	0.007469484	0.006558572	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCGCAGTGTCTGGTCG-1_25G_P3C1	-11.02972454	0.706619293	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2874	6259	0.015657453	0.008308036	0	13A	IN-VIP	NA	NA	NA
GCGCAGTTCCTAAGTG-1_25G_P3C1	27.22525433	-4.003304784	2	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3729	10013	0.001797663	0.004494158	0	2	EN-L4	NA	NA	NA
GCGCAGTTCGCCCTTA-1_25G_P3C1	-5.345311192	-21.2981232	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2851	7219	0.00249342	0.00374013	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCGCCAAAGACTAGGC-1_25G_P3C1	-4.650115179	-20.08251339	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3112	7584	0.003164557	0.007647679	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCGCCAAAGGTGTGGT-1_25G_P3C1	-7.782209865	-0.168106172	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2203	4737	0.003799873	0.002744353	0	13A	IN-VIP	NA	NA	NA
GCGCCAACAAGGCTCC-1_25G_P3C1	-3.900928578	-13.87361869	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2120	4071	0.003193319	0.010316875	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCGCCAACAGACGCCT-1_25G_P3C1	-19.92864201	-28.73452895	6A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4124	12195	0.002542025	0.004264043	0	6A	IN-PV	NA	NA	NA
GCGCCAAGTTACGACT-1_25G_P3C1	-9.921407292	2.809999051	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3241	7448	0.015574651	0.004833512	0	13A	IN-VIP	NA	NA	NA
GCGCCAAGTTATGTGC-1_25G_P3C1	-7.189178471	-1.151751366	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1917	3783	0.002907745	0.001057362	0	13A	IN-VIP	NA	NA	NA
GCGCCAATCCACTGGG-1_25G_P3C1	-15.41210758	-19.17513012	6B	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1549	3003	0.001998002	0.003330003	0	6B	IN-SST	NA	NA	NA
GCGCCAATCGTGGACC-1_25G_P3C1	-28.64244286	23.07081991	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1340	2418	0.019437552	0.005376344	0	8	Astrocytes	NA	NA	NA
GCGCGATAGGACAGAA-1_25G_P3C1	-4.282176907	-17.39015277	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2703	5934	0.006403775	0.006909336	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCGCGATCATCGGGTC-1_25G_P3C1	7.47120196	-31.92100033	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3829	10066	0.003278363	0.003377707	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCGCGATGTATAGTAG-1_25G_P3C1	-28.22190999	12.45243052	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	839	1210	0.01322314	0.002479339	0	8	Astrocytes	NA	NA	NA
GCGGGTTAGCTGATAA-1_25G_P3C1	-27.15688406	8.35314267	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	710	1016	0.005905512	0.003937008	0	8	Astrocytes	NA	NA	NA
GCGGGTTAGGCGCTCT-1_25G_P3C1	-4.032531298	-16.56392893	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2474	5563	0.008448679	0.002336869	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCGGGTTCAAGCTGAG-1_25G_P3C1	-6.774355436	-2.09346122	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1763	3272	0.008251834	0.006112469	0	13A	IN-VIP	NA	NA	NA
GCGGGTTCATCAGTAC-1_25G_P3C1	-18.44060927	-28.06933869	6A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2697	6537	0.001376778	0.00397736	0	6A	IN-PV	NA	NA	NA
GCGGGTTGTGACTACT-1_25G_P3C1	-1.043621885	-25.7329343	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	5374	16908	0.003075467	0.002838893	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCGGGTTGTGGCAAAC-1_25G_P3C1	-29.54825317	12.77530341	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	672	1020	0.000980392	0.002941176	0	8	Astrocytes	NA	NA	NA
GCGGGTTTCATTTGGG-1_25G_P3C1	-25.9163457	20.2613428	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1351	2487	0.002814636	0.005227181	0	8	Astrocytes	NA	NA	NA
GCGGGTTTCGTACGGC-1_25G_P3C1	9.166110097	30.72010441	1	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	733	1140	0.004385965	0.001754386	0	oligos	OL-Cntl	NA	NA	NA
GCTCCTACACGAAAGC-1_25G_P3C1	1.118895518	-18.99067416	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3047	6982	0.009166428	0.003867087	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCTCCTACAGCAGTTT-1_25G_P3C1	-1.494325065	-10.03430796	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1914	3619	0.000828958	0.008289583	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCTCCTACATCACGAT-1_25G_P3C1	26.6493899	4.8472401	15A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	898	1174	0.024701874	0.009369676	0	15A	Endo cells	NA	NA	NA
GCTCCTACATGCCTAA-1_25G_P3C1	-2.731730507	-24.89724862	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4319	13706	0.001167372	0.002991391	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCTCCTATCCAAATGC-1_25G_P3C1	1.894417258	-31.28915225	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	5726	21935	0.000638249	0.00360155	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCTCCTATCGTCTGAA-1_25G_P3C1	-31.56695142	12.83042841	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	772	1304	0.003067485	0.005368098	0	8	Astrocytes	NA	NA	NA
GCTCCTATCTTCAACT-1_25G_P3C1	-25.30490399	27.61266821	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1623	3285	0.00761035	0.004870624	0	8	Astrocytes	NA	NA	NA
GCTCTGTGTAAGCACG-1_25G_P3C1	-4.357073664	-19.61694777	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3136	7252	0.005239934	0.006756757	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCTCTGTTCACATACG-1_25G_P3C1	-5.108313555	-22.00288549	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3883	11566	0.000778143	0.003112571	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCTCTGTTCATATCGG-1_25G_P3C1	-4.683781141	-3.120884841	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1388	2510	0.001593625	0.005577689	0	13A	IN-VIP	NA	NA	NA
GCTCTGTTCTTACCGC-1_25G_P3C1	-9.356405615	-3.355168117	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1776	3091	0.013911356	0.008735037	0	13A	IN-VIP	NA	NA	NA
GCTGCAGAGATATACG-1_25G_P3C1	-2.141017988	-12.55466238	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1984	3969	0.008818342	0.003779289	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCTGCAGCAATCCAAC-1_25G_P3C1	-2.207182088	-12.34162953	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1844	3560	0.004213483	0.007022472	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCTGCAGGTCCAGTGC-1_25G_P3C1	-39.57078964	-0.045614737	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1451	2795	0.001073345	0.002862254	0	9	OPC	NA	NA	NA
GCTGCAGTCAGTTCGA-1_25G_P3C1	39.27343683	9.38004794	14	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	820	1122	0.001782531	0.001782531	0	14	Microglia	NA	NA	NA
GCTGCGAAGTGTGGCA-1_25G_P3C1	0.005270529	-8.432536579	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1588	2840	0.002112676	0.006338028	0	12	EN-MIX	NA	NA	NA
GCTGCGACACCATGTA-1_25G_P3C1	25.07223324	0.978667654	2	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2243	4607	0.001085305	0.003690037	0	2	EN-L4	NA	NA	NA
GCTGCGACACTATCTT-1_25G_P3C1	-6.628862959	-0.374155045	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1757	3611	0.001938521	0.003046248	0	13A	IN-VIP	NA	NA	NA
GCTGCGAGTACCGGCT-1_25G_P3C1	-27.84236914	18.36956002	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1149	1830	0.001092896	0.007650273	0	8	Astrocytes	NA	NA	NA
GCTGCGAGTCCCTACT-1_25G_P3C1	-5.036041732	-20.72278077	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2965	6586	0.000759186	0.006225326	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCTGCGATCTGTCTCG-1_25G_P3C1	-8.815891128	1.751508307	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2481	5745	0.001392515	0.003829417	0	13A	IN-VIP	NA	NA	NA
GCTGCTTGTATTCTCT-1_25G_P3C1	-25.72972316	27.36422883	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1470	2498	0	0.003602882	0	8	Astrocytes	NA	NA	NA
GCTGCTTTCAGTGCAT-1_25G_P3C1	-4.483642631	-22.49748424	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3190	8347	0.00407332	0.003234695	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCTGCTTTCTGCTTGC-1_25G_P3C1	0.185706117	-7.944971965	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1488	2633	0.000379795	0.003797949	0	12	EN-MIX	NA	NA	NA
GCTGGGTAGGACACCA-1_25G_P3C1	-18.22182074	-27.65224845	6A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2666	6073	0.001646633	0.003457929	0	6A	IN-PV	NA	NA	NA
GCTGGGTCACGCATCG-1_25G_P3C1	-4.737051356	-18.10376877	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2807	6598	0.002728099	0.005304638	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCTGGGTGTACAAGTA-1_25G_P3C1	-3.041670195	-8.975579874	6B	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	870	1344	0.005208333	0.002232143	0	6B	IN-SST	NA	NA	NA
GCTGGGTGTCAACATC-1_25G_P3C1	-3.457637642	-4.801853974	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1144	1940	0.003608247	0.001546392	0	13A	IN-VIP	NA	NA	NA
GCTGGGTGTCTTGCGG-1_25G_P3C1	-4.819294194	-16.61167198	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2842	6534	0.003367003	0.005968779	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCTGGGTGTGGTTTCA-1_25G_P3C1	-3.687896463	-21.87615904	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3742	10593	0.002643255	0.005380912	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCTGGGTGTTACCAGT-1_25G_P3C1	-2.428928253	-16.7166374	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2547	5338	0.001498689	0.003372049	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCTGGGTTCATACGGT-1_25G_P3C1	-1.531050354	-23.36418035	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4171	12357	0.003803512	0.002751477	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCTGGGTTCGCAAACT-1_25G_P3C1	-36.82693757	1.745249904	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1660	3291	0.001519295	0.003646308	0	9	OPC	NA	NA	NA
GCTGGGTTCGCTTGTC-1_25G_P3C1	19.90697457	9.417196819	1	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1544	2978	0	0.003693754	0	oligos	OL-Cntl	NA	NA	NA
GCTTCCAAGACTTTCG-1_25G_P3C1	-25.80192096	26.86978446	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1517	2884	0.005894591	0.003467406	0	8	Astrocytes	NA	NA	NA
GCTTCCACAAACGTGG-1_25G_P3C1	-17.00584805	-23.40198262	6A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1751	3262	0.008277131	0.002759044	0	6A	IN-PV	NA	NA	NA
GCTTCCACAACACCTA-1_25G_P3C1	-8.710093204	1.151765149	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2643	6485	0.009868928	0.00231303	0	13A	IN-VIP	NA	NA	NA
GCTTCCAGTGTTAAGA-1_25G_P3C1	29.37927428	0.520024593	2	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2728	5672	0.006170663	0.006346968	0	2	EN-L4	NA	NA	NA
GCTTGAAGTCCAGTTA-1_25G_P3C1	5.767628679	-31.18802776	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4535	13801	0.000724585	0.00340555	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCTTGAAGTCCGAGTC-1_25G_P3C1	-26.14041345	19.34383828	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1470	2536	0.001577287	0.005914826	0	8	Astrocytes	NA	NA	NA
GCTTGAAGTCGTCTTC-1_25G_P3C1	-38.66520965	-0.119768571	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1549	2707	0.002955301	0.002585888	0	9	OPC	NA	NA	NA
GCTTGAATCATGCTCC-1_25G_P3C1	-2.271275594	-24.96633596	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4678	15204	0.001249671	0.003814786	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCTTGAATCGAATGGG-1_25G_P3C1	-29.6918991	13.91206891	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	729	1056	0	0.002840909	0	8	Astrocytes	NA	NA	NA
GGAAAGCAGGCTAGAC-1_25G_P3C1	-26.78056963	25.43648315	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1388	2480	0.009274194	0.002822581	0	8	Astrocytes	NA	NA	NA
GGAAAGCAGTACGTTC-1_25G_P3C1	-4.641811592	-21.86829521	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3705	10678	0.003558719	0.004120622	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GGAAAGCCAAAGTCAA-1_25G_P3C1	-17.74785516	-24.08478271	6A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2505	5959	0.005202215	0.001845947	0	6A	IN-PV	NA	NA	NA
GGAAAGCCAGGAACGT-1_25G_P3C1	2.430905864	-12.49260105	4	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1941	3526	0.00340329	0.006522972	0	L2-3	EN-L2-3-MS	NA	NA	NA
GGAAAGCGTACATCCA-1_25G_P3C1	-28.41178438	16.38823629	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	990	1574	0	0.006988564	0	8	Astrocytes	NA	NA	NA
GGAAAGCTCAGTACGT-1_25G_P3C1	-4.114776113	-19.40652	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3170	7249	0.003586702	0.006621603	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GGAAAGCTCTAGAGTC-1_25G_P3C1	-1.248319858	-9.679267169	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1840	3257	0.007675775	0.014430457	0	12	EN-MIX	NA	NA	NA
GGAACTTAGGAGCGTT-1_25G_P3C1	-6.960024164	0.684899313	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1946	4250	0.000470588	0.002117647	0	13A	IN-VIP	NA	NA	NA
GGAACTTGTGATGATA-1_25G_P3C1	1.091420975	-6.115317539	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1114	1764	0	0.012471655	0	12	EN-MIX	NA	NA	NA
GGAACTTGTTCCACGG-1_25G_P3C1	-2.709349685	-12.93682739	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2041	3916	0.001532176	0.007660878	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GGAACTTTCCTTTACA-1_25G_P3C1	12.15814192	32.19325616	1	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	690	1013	0.000987167	0.004935834	0	oligos	OL-Cntl	NA	NA	NA
GGAATAAAGTATGACA-1_25G_P3C1	-2.674935689	-23.07952716	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4056	11689	0.002908718	0.005988536	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GGAATAACACCCATGG-1_25G_P3C1	-33.02688212	-12.38911232	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	808	1164	0.004295533	0.004295533	0	9	OPC	NA	NA	NA
GGAATAAGTAAGTGGC-1_25G_P3C1	14.79876242	30.09992785	1	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	842	1298	0.000770416	0.006163328	0	oligos	OL-Cntl	NA	NA	NA
GGAATAAGTCAACTGT-1_25G_P3C1	10.65781602	-34.08472275	3	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	6534	29476	0.001458814	0.001798073	0	3	EN-L5-6	NA	NA	NA
GGAATAAGTCATATCG-1_25G_P3C1	-1.164281454	-11.44246017	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1799	3687	0.00678058	0.003797125	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GGAATAAGTCTACCTC-1_25G_P3C1	-4.098718513	-15.81365637	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2611	5817	0.008595496	0.003094379	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GGAATAATCACTCCTG-1_25G_P3C1	-8.525196945	-18.32748207	6B	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	802	1192	0.024328859	0.005033557	0	6B	IN-SST	NA	NA	NA
GGAATAATCCAGAAGG-1_25G_P3C1	-27.3409039	19.14505438	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1181	2058	0.000485909	0.003401361	0	8	Astrocytes	NA	NA	NA
GGAATAATCTAACTGG-1_25G_P3C1	-10.11559248	0.160440447	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2371	4792	0.00918197	0.011477462	0	13A	IN-VIP	NA	NA	NA
GGACAAGGTAAGCACG-1_25G_P3C1	-9.308745529	2.802302553	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2915	6663	0.006903797	0.003902146	0	13A	IN-VIP	NA	NA	NA
GGACAAGGTACTTGAC-1_25G_P3C1	13.39340028	17.31470926	1	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1096	1718	0.001746217	0.00523865	0	oligos	OL-Cntl	NA	NA	NA
GGACAAGGTATAGGGC-1_25G_P3C1	-28.55249416	17.32983843	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1147	1917	0	0.004173187	0	8	Astrocytes	NA	NA	NA
GGACAGAAGAGGTACC-1_25G_P3C1	25.16597329	-29.57499261	3	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3910	12155	0.000246812	0.001974496	0	3	EN-L5-6	NA	NA	NA
GGACAGAAGTGACATA-1_25G_P3C1	-4.934636974	-2.484863277	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1454	2281	0.000438404	0.006576063	0	13A	IN-VIP	NA	NA	NA
GGACAGAAGTTCGCAT-1_25G_P3C1	-38.20242826	-1.955063468	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1365	2577	0.000776096	0.002716337	0	9	OPC	NA	NA	NA
GGACAGAGTCAGGACA-1_25G_P3C1	31.95221442	-1.395317924	2	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2376	4619	0.007577398	0.005412427	0	2	EN-L4	NA	NA	NA
GGACAGAGTCTCAACA-1_25G_P3C1	19.78835461	-28.57427791	3	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3098	7691	0.002600442	0.011051879	0	3	EN-L5-6	NA	NA	NA
GGACAGATCGTTACGA-1_25G_P3C1	12.29862245	26.94788734	1	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	784	1212	0.004950495	0.004950495	0	oligos	OL-Cntl	NA	NA	NA
GGACATTAGTCTCAAC-1_25G_P3C1	-4.051807381	-21.77057655	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3775	10365	0.001447178	0.005788712	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GGACATTAGTGAAGTT-1_25G_P3C1	-5.135673029	-20.14172358	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2744	6764	0.0078356	0.003991721	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GGACATTCAGGAATCG-1_25G_P3C1	-35.06539312	-13.01662161	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	705	1062	0.00094162	0.002824859	0	9	OPC	NA	NA	NA
GGACATTCAGGGATTG-1_25G_P3C1	-2.491609446	-22.27762232	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3616	9311	0.005047793	0.004081194	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GGACATTGTAACGTTC-1_25G_P3C1	5.508235049	-27.30452392	3	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2779	6500	0.004307692	0.003384615	0	3	EN-L5-6	NA	NA	NA
GGACATTGTTTACTCT-1_25G_P3C1	-2.049393313	-25.35437941	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4430	13969	0.002433961	0.005082683	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GGACATTTCAGTTAGC-1_25G_P3C1	19.83028761	-28.95143263	3	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4246	13316	0.000150195	0.014268549	0	3	EN-L5-6	NA	NA	NA
GGACATTTCTCAAACG-1_25G_P3C1	-8.159607585	-0.19061461	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2390	5677	0.010568962	0.003346838	0	13A	IN-VIP	NA	NA	NA
GGACATTTCTTGAGGT-1_25G_P3C1	-14.32636833	-7.488594281	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3869	11732	0.010484146	0.002727583	0	13A	IN-VIP	NA	NA	NA
GGACGTCCACGGCGTT-1_25G_P3C1	-9.453859251	2.096975231	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2752	6474	0.006641952	0.005869632	0	13A	IN-VIP	NA	NA	NA
GGACGTCGTTAAGTAG-1_25G_P3C1	-3.487447981	-23.1198308	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3922	11416	0.002365102	0.005255781	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GGACGTCTCCTTTCGG-1_25G_P3C1	-37.47810193	-9.695489026	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1015	1707	0.000585823	0.004686585	0	9	OPC	NA	NA	NA
GGACGTCTCGTCTGAA-1_25G_P3C1	11.226157	27.40967595	1	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	942	1508	0.00132626	0.00265252	0	oligos	OL-Cntl	NA	NA	NA
GGAGCAAAGCCAGGAT-1_25G_P3C1	-38.81973292	-2.429962526	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1201	2145	0.001398601	0.001864802	0	9	OPC	NA	NA	NA
GGAGCAAAGCGACGTA-1_25G_P3C1	-1.802705959	-26.13526496	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4154	12072	0.001076872	0.003396289	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GGAGCAAAGCGGATCA-1_25G_P3C1	5.896995996	-32.01136168	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4659	14773	0.00060922	0.002098423	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GGAGCAACACGGACAA-1_25G_P3C1	-4.068393333	-17.13186539	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2683	5926	0.009449882	0.006749916	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GGATGTTAGTGGGATC-1_25G_P3C1	-17.51598339	-23.94983934	6A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2120	4756	0.003153911	0.001892347	0	6A	IN-PV	NA	NA	NA
GGATGTTGTACAGACG-1_25G_P3C1	10.89462991	-9.044801568	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2881	7259	0.00055104	0.0020664	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GGATGTTGTACCGCTG-1_25G_P3C1	-4.99587544	-20.53621771	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2935	7627	0	0.005506752	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GGATTACAGCTGCCCA-1_25G_P3C1	-13.49393774	-11.38070408	13B	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1822	3680	0.001086957	0.002445652	0	13B	IN-SV2C	NA	NA	NA
GGATTACCAAGGGTCA-1_25G_P3C1	-4.534444693	-16.48993729	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2752	6036	0.007952286	0.006461233	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GGATTACGTCGGGTCT-1_25G_P3C1	-14.60225851	-10.24173516	13B	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2417	5163	0.000774743	0.003873717	0	13B	IN-SV2C	NA	NA	NA
GGATTACTCCCTAACC-1_25G_P3C1	-9.061320985	-19.27539966	6B	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	692	1042	0.004798464	0.003838772	0	6B	IN-SST	NA	NA	NA
GGATTACTCCTGCCAT-1_25G_P3C1	-5.069004595	-23.1601605	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3702	10670	0.000281162	0.004686036	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GGATTACTCGCACTCT-1_25G_P3C1	-28.04859788	14.76867157	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	952	1490	0.002684564	0.000671141	0	8	Astrocytes	NA	NA	NA
GGCAATTAGCGTAATA-1_25G_P3C1	29.98812974	15.93622186	14	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1477	2330	0.003862661	0.120171674	0	14	Microglia	NA	NA	NA
GGCAATTCACAGACAG-1_25G_P3C1	-3.426112615	-7.613839181	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	719	1132	0.001766784	0.002650177	0	13A	IN-VIP	NA	NA	NA
GGCAATTCACCTTGTC-1_25G_P3C1	-1.07110568	-10.73011817	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1850	3424	0.005841121	0.002920561	0	12	EN-MIX	NA	NA	NA
GGCAATTCATGGAATA-1_25G_P3C1	11.69946133	13.36747152	1	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1141	2023	0	0.000988631	0	oligos	OL-Cntl	NA	NA	NA
GGCAATTCATTGTGCA-1_25G_P3C1	-4.635376264	-24.4364093	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3203	8174	0	0.003303156	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GGCAATTGTGAGGGTT-1_25G_P3C1	24.89829389	-0.166305274	2	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2383	5173	0.006959211	0.00270636	0	2	EN-L4	NA	NA	NA
GGCCGATAGAACTGTA-1_25G_P3C1	-4.363403316	-17.13638957	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2473	5218	0.002108087	0.006132618	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GGCCGATAGAGGTTGC-1_25G_P3C1	-7.879561776	-0.012372194	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2422	5367	0.0039128	0.002608534	0	13A	IN-VIP	NA	NA	NA
GGCCGATAGCAGATCG-1_25G_P3C1	-4.561710628	-3.052773494	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1193	2116	0.012759924	0.004253308	0	13A	IN-VIP	NA	NA	NA
GGCCGATAGTCCTCCT-1_25G_P3C1	39.67227858	10.36023063	14	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	931	1328	0.004518072	0.005271084	0	14	Microglia	NA	NA	NA
GGCCGATTCATGTCTT-1_25G_P3C1	26.47774886	0.511184194	2	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2568	6015	0.001496259	0.003657523	0	2	EN-L4	NA	NA	NA
GGCCGATTCGCAGGCT-1_25G_P3C1	-2.246830287	-24.94173418	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4773	14517	0.003995316	0.002617621	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GGCCGATTCGCCAGCA-1_25G_P3C1	18.73620444	21.87445996	1	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	907	1436	0	0.003481894	0	oligos	OL-Cntl	NA	NA	NA
GGCGACTAGGAGTAGA-1_25G_P3C1	19.9762188	-6.89507859	3	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2305	5575	0.002690583	0.002152466	0	3	EN-L5-6	NA	NA	NA
GGCGACTAGTAGTGCG-1_25G_P3C1	14.57628552	-33.58244341	3	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4676	15271	0.000785803	0.004780303	0	3	EN-L5-6	NA	NA	NA
GGCGACTAGTGATCGG-1_25G_P3C1	-2.519936715	-23.51787059	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4258	11760	0.002295918	0.005697279	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GGCGACTCAATTCCTT-1_25G_P3C1	-10.49503133	0.700458867	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2551	5257	0.012744912	0.006277344	0	13A	IN-VIP	NA	NA	NA
GGCGACTCACGCGAAA-1_25G_P3C1	-5.33191991	-22.17306026	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3077	7368	0.000542888	0.003257329	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GGCGACTCACTGTGTA-1_25G_P3C1	-2.590335908	-25.01754971	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4303	12791	0.001407239	0.003049019	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GGCGACTCAGCTGTAT-1_25G_P3C1	-2.824280126	-15.5280881	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2791	6762	0.000443656	0.004584442	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GGCGACTGTAATCACC-1_25G_P3C1	-17.36820587	-23.67301649	6A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2081	4487	0.020280811	0.003788723	0	6A	IN-PV	NA	NA	NA
GGCGACTGTCGCGGTT-1_25G_P3C1	-25.5749217	27.52132558	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1534	2840	0.000352113	0.005633803	0	8	Astrocytes	NA	NA	NA
GGCGACTGTGCCTGCA-1_25G_P3C1	-12.369761	-19.41115815	6B	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1091	1809	0.014372582	0.002211166	0	6B	IN-SST	NA	NA	NA
GGCGACTGTGGTACAG-1_25G_P3C1	-37.56320458	-9.147346836	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1046	1687	0.003556609	0.001778305	0	9	OPC	NA	NA	NA
GGCGTGTAGAGGGATA-1_25G_P3C1	-4.65093169	-23.79808735	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3587	9530	0.000104932	0.005351522	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GGCGTGTCAAGACGTG-1_25G_P3C1	28.42292901	6.977296685	15A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	919	1205	0.057261411	0.023236515	0	15A	Endo cells	NA	NA	NA
GGCGTGTCACCGAAAG-1_25G_P3C1	-0.125289829	-8.223836589	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1564	2629	0.002282237	0.012552301	0	12	EN-MIX	NA	NA	NA
GGCGTGTCATGGAATA-1_25G_P3C1	-0.114450077	-9.790090504	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1686	3330	0.003003003	0.001201201	0	12	EN-MIX	NA	NA	NA
GGCGTGTGTGCAGACA-1_25G_P3C1	1.623263734	-11.10984714	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1718	2898	0.001380262	0.00621118	0	12	EN-MIX	NA	NA	NA
GGCGTGTTCAGATAAG-1_25G_P3C1	-5.48087838	-22.35313664	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3308	8442	0.000947643	0.003790571	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GGCGTGTTCTATGTGG-1_25G_P3C1	-5.639419005	-2.624413242	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1593	2644	0.013237519	0.006807867	0	13A	IN-VIP	NA	NA	NA
GGCTCGAAGCTGAAAT-1_25G_P3C1	-5.872658763	-3.982421681	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1480	2511	0.006371963	0.003982477	0	13A	IN-VIP	NA	NA	NA
GGCTCGAGTAGATTAG-1_25G_P3C1	19.10946755	-17.38803193	4	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	7781	32642	0.037804056	0.00529992	0	L2-3	EN-L2-3-MS	NA	NA	NA
GGCTCGAGTGATGTCT-1_25G_P3C1	-2.429346972	-28.4676861	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2851	6954	0.000575209	0.004889272	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GGCTCGATCATTCACT-1_25G_P3C1	-2.648815329	-26.92296418	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4579	15833	0.000126318	0.002652687	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GGCTCGATCCGGGTGT-1_25G_P3C1	-11.55068033	-20.65352512	6B	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	902	1410	0.007092199	0.00212766	0	6B	IN-SST	NA	NA	NA
GGCTCGATCCTTTACA-1_25G_P3C1	10.56948438	31.51538116	1	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	764	1137	0	0.004397537	0	oligos	OL-Cntl	NA	NA	NA
GGCTGGTCACTGCCAG-1_25G_P3C1	-15.29052872	-11.10424073	13B	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2522	5433	0.008834898	0.004049328	0	13B	IN-SV2C	NA	NA	NA
GGCTGGTCAGTGAGTG-1_25G_P3C1	19.16523047	23.99889817	1	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	938	1534	0.001303781	0.002607562	0	oligos	OL-Cntl	NA	NA	NA
GGCTGGTGTATCACCA-1_25G_P3C1	6.404169093	-31.16334805	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4586	13689	0.002629849	0.006501571	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GGCTGGTTCAAACCGT-1_25G_P3C1	-38.32168819	-6.486666728	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1158	1945	0	0.002570694	0	9	OPC	NA	NA	NA
GGCTGGTTCATACGGT-1_25G_P3C1	2.440118942	-31.03556675	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	5209	17360	0.000518433	0.00328341	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GGGAATGAGCTAGGCA-1_25G_P3C1	-9.228618788	2.021202667	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2847	6819	0.00307963	0.004106174	0	13A	IN-VIP	NA	NA	NA
GGGAATGCAACACCTA-1_25G_P3C1	-4.878350659	-16.88746652	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2661	5849	0.002393572	0.004274235	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GGGAATGCATCAGTCA-1_25G_P3C1	-13.75955851	-19.52539113	6B	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1311	2498	0.00040032	0.003602882	0	6B	IN-SST	NA	NA	NA
GGGAATGTCATCGGAT-1_25G_P3C1	-1.379690945	-27.82343831	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	5006	16384	0.001708984	0.004943848	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GGGACCTAGTGGACGT-1_25G_P3C1	21.26902538	-8.064959659	3	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1375	2485	0.000804829	0.00362173	0	3	EN-L5-6	NA	NA	NA
GGGACCTTCCTAGAAC-1_25G_P3C1	-19.15436277	-27.81559389	6A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3172	8379	0.001432152	0.002625612	0	6A	IN-PV	NA	NA	NA
GGGACCTTCGAGAACG-1_25G_P3C1	-0.956675557	-29.00418795	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4252	12518	0.001997124	0.003914363	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GGGAGATAGGGTTCCC-1_25G_P3C1	-3.619332555	-14.90646504	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2394	5563	0.002696387	0.003055905	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GGGAGATCAGATGAGC-1_25G_P3C1	-28.83664534	13.25952815	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	829	1186	0.001686341	0.006745363	0	8	Astrocytes	NA	NA	NA
GGGAGATCATGGGACA-1_25G_P3C1	-4.928026288	-22.0173406	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3416	8833	0.003849202	0.002943507	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GGGAGATCATTTGCTT-1_25G_P3C1	26.35694518	-2.449635478	2	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3151	7522	0.003456528	0.004254188	0	2	EN-L4	NA	NA	NA
GGGAGATGTGACGGTA-1_25G_P3C1	-6.483776405	0.158753426	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1927	3743	0.000267165	0.002137323	0	13A	IN-VIP	NA	NA	NA
GGGAGATTCCCTTGTG-1_25G_P3C1	-4.991847303	-2.168971411	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1447	2501	0.00159936	0.005197921	0	13A	IN-VIP	NA	NA	NA
GGGATGAAGAGTCGGT-1_25G_P3C1	8.432881734	32.1084544	1	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	721	1060	0.001886792	0.002830189	0	oligos	OL-Cntl	NA	NA	NA
GGGATGAAGGACAGAA-1_25G_P3C1	-27.6148007	24.67096139	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1331	2337	0.003851091	0.005562687	0	8	Astrocytes	NA	NA	NA
GGGATGACACCCAGTG-1_25G_P3C1	-2.307545733	-14.85638782	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2550	6160	0.000487013	0.002272727	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GGGATGAGTCCGACGT-1_25G_P3C1	-4.886980734	-2.929914579	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1383	2425	0.006185567	0.005773196	0	13A	IN-VIP	NA	NA	NA
GGGATGAGTTCTGAAC-1_25G_P3C1	-4.871594901	-21.75322839	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3256	7962	0.002888721	0.002763125	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GGGATGATCGCAAACT-1_25G_P3C1	-4.388078377	-17.08160899	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2771	6511	0.003225311	0.003225311	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GGGCACTAGAAACCTA-1_25G_P3C1	-3.205284593	-23.39836021	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4591	14246	0.004843465	0.005966587	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GGGCACTAGGGAAACA-1_25G_P3C1	-27.12925091	25.94460792	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1395	2714	0.00073692	0.009211496	0	8	Astrocytes	NA	NA	NA
GGGCACTCACCTCGGA-1_25G_P3C1	-8.16774665	1.857394968	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2455	5454	0.003483682	0.004033737	0	13A	IN-VIP	NA	NA	NA
GGGCACTCACTCGACG-1_25G_P3C1	-15.42946304	-25.99971515	6A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1804	3787	0	0.003432796	0	6A	IN-PV	NA	NA	NA
GGGCACTCAGGATTGG-1_25G_P3C1	-1.600602509	-12.4053298	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1920	3656	0.004923414	0.006017505	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GGGCACTGTCTCGTTC-1_25G_P3C1	0.743487126	-27.70785242	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4100	11581	0.002331405	0.003885675	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GGGCACTTCTTAGCCC-1_25G_P3C1	-1.335009498	-28.25120249	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4142	12384	0.000161499	0.002987726	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GGGCATCGTCATCCCT-1_25G_P3C1	-0.865874996	-26.5624078	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	5429	18719	0.006196912	0.007959827	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GGGCATCGTGACTCAT-1_25G_P3C1	28.96517582	1.168712274	2	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2291	4566	0.002628121	0.003066141	0	2	EN-L4	NA	NA	NA
GGGCATCGTGTCCTCT-1_25G_P3C1	-28.30449033	23.94397337	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1268	2240	0.004017857	0.004910714	0	8	Astrocytes	NA	NA	NA
GGGCATCTCACTGGGC-1_25G_P3C1	6.963059617	-33.04573676	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4512	14417	0.001248526	0.002150239	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GGGTCTGCAGATGAGC-1_25G_P3C1	-26.28472503	25.8249974	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1379	2508	0.006778309	0.007177033	0	8	Astrocytes	NA	NA	NA
GGGTCTGCATGGTAGG-1_25G_P3C1	-15.45036476	-25.86728554	6A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1764	3499	0.000857388	0.003715347	0	6A	IN-PV	NA	NA	NA
GGGTCTGGTCTTGTCC-1_25G_P3C1	17.38402256	24.37438011	1	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	923	1373	0.003641661	0.002913328	0	oligos	OL-Cntl	NA	NA	NA
GGGTTGCAGACAAAGG-1_25G_P3C1	-2.652080823	-22.76771348	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3562	8582	0.001631321	0.005360056	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GGGTTGCCAAACGCGA-1_25G_P3C1	-8.328210269	1.705917378	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2319	5017	0.001594578	0.004385091	0	13A	IN-VIP	NA	NA	NA
GGGTTGCCAATCACAC-1_25G_P3C1	-29.56608499	22.35648315	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1040	1856	0.001077586	0.005926724	0	8	Astrocytes	NA	NA	NA
GGGTTGCCACAGGAGT-1_25G_P3C1	-4.308329649	-16.53779589	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2792	6331	0.007265835	0.006002211	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GGGTTGCCATCGGAAG-1_25G_P3C1	28.95458276	0.497790337	2	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2673	5612	0.002316465	0.005167498	0	2	EN-L4	NA	NA	NA
GGGTTGCGTACAGCAG-1_25G_P3C1	-26.74483242	27.32403355	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1643	3476	0	0.004027618	0	8	Astrocytes	NA	NA	NA
GGGTTGCGTAGGAGTC-1_25G_P3C1	-3.815430911	-22.74028933	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3639	9399	0.000851154	0.004894138	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GGGTTGCGTCTGATCA-1_25G_P3C1	-0.514665186	-8.691614544	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1678	2976	0.004032258	0.006048387	0	12	EN-MIX	NA	NA	NA
GGGTTGCGTTCCACTC-1_25G_P3C1	-1.143137748	-28.99027778	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4584	14433	0.000485	0.004434283	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GGGTTGCTCGTTTGCC-1_25G_P3C1	-38.97614986	-0.602314274	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1379	2378	0.00294365	0.002523129	0	9	OPC	NA	NA	NA
GGGTTGCTCTGAAAGA-1_25G_P3C1	-5.034063332	-21.88423523	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3220	8218	0.001703578	0.003407155	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GGTATTGAGTGACATA-1_25G_P3C1	2.154383127	-27.7785663	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3075	7285	0.000411805	0.005765271	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GGTATTGAGTTACCCA-1_25G_P3C1	-36.12340515	4.741988512	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2138	4812	0.000831255	0.001454697	0	9	OPC	NA	NA	NA
GGTATTGGTATCGCAT-1_25G_P3C1	29.64351946	-0.075218721	2	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3301	8177	0.004647181	0.004158004	0	2	EN-L4	NA	NA	NA
GGTATTGGTCCCTACT-1_25G_P3C1	-28.5273907	17.91875707	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1035	1657	0.0006035	0.004828002	0	8	Astrocytes	NA	NA	NA
GGTGAAGAGAGTAAGG-1_25G_P3C1	-4.225894542	-14.02721841	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2489	5255	0.000570885	0.011607992	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GGTGAAGAGTTAACGA-1_25G_P3C1	-10.28423608	0.616290198	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2518	5038	0.023620484	0.006947201	0	13A	IN-VIP	NA	NA	NA
GGTGAAGCAATTCCTT-1_25G_P3C1	-4.155404884	-15.71841326	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2369	5075	0.002364532	0.005123153	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GGTGAAGCACCAACCG-1_25G_P3C1	-39.09762118	-0.74083043	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1514	2731	0.001098499	0.007323325	0	9	OPC	NA	NA	NA
GGTGAAGGTTCAGCGC-1_25G_P3C1	-27.86071416	24.08229919	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1231	2043	0.000489476	0.001957905	0	8	Astrocytes	NA	NA	NA
GGTGCGTAGCAAATCA-1_25G_P3C1	-38.03762158	3.131374427	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1749	3414	0.001757469	0.004100762	0	9	OPC	NA	NA	NA
GGTGCGTGTAGTGAAT-1_25G_P3C1	9.404499124	21.95274645	1	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	748	1221	0.005733006	0.005733006	0	oligos	OL-Cntl	NA	NA	NA
GGTGCGTGTGCGATAG-1_25G_P3C1	-17.28503832	-25.93681738	6A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2419	5679	0.00264131	0.001056524	0	6A	IN-PV	NA	NA	NA
GGTGCGTTCTGCTTGC-1_25G_P3C1	25.23318781	-4.22265299	2	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4482	14132	0.004882536	0.003184263	0	2	EN-L4	NA	NA	NA
GGTGTTAAGCCAGGAT-1_25G_P3C1	-27.90507051	18.43223789	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1129	1852	0.002159827	0.008639309	0	8	Astrocytes	NA	NA	NA
GGTGTTACACCCTATC-1_25G_P3C1	-8.40311408	1.434998977	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2274	4692	0.008738278	0.003836317	0	13A	IN-VIP	NA	NA	NA
GGTGTTACACGAGAGT-1_25G_P3C1	-37.0363714	-2.734619123	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1312	2203	0.002269632	0.004539265	0	9	OPC	NA	NA	NA
GTAACGTAGAGGACGG-1_25G_P3C1	10.37731754	28.40140787	1	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	777	1191	0.002518892	0.001679261	0	oligos	OL-Cntl	NA	NA	NA
GTAACGTAGGTAAACT-1_25G_P3C1	-11.02396003	1.460342979	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2915	6912	0.005353009	0.003038194	0	13A	IN-VIP	NA	NA	NA
GTAACGTGTAAAGGAG-1_25G_P3C1	-9.227997279	-18.12126542	6B	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	768	1152	0.033854167	0.000868056	0	6B	IN-SST	NA	NA	NA
GTAACGTTCCGTACAA-1_25G_P3C1	-4.020514384	-18.07053847	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3171	7423	0.011181463	0.006062239	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GTAACGTTCGCCATAA-1_25G_P3C1	11.40868784	28.91641935	1	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	719	1132	0	0.005300353	0	oligos	OL-Cntl	NA	NA	NA
GTAACTGAGACTAGGC-1_25G_P3C1	-5.757547842	-20.92915579	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2618	6214	0.000643708	0.003862247	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GTAACTGAGCCACGCT-1_25G_P3C1	30.00622252	-1.359132269	2	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3798	9923	0.006046559	0.004837247	0	2	EN-L4	NA	NA	NA
GTAACTGCAACAACCT-1_25G_P3C1	9.313563329	28.20741945	1	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	825	1290	0.004651163	0.003875969	0	oligos	OL-Cntl	NA	NA	NA
GTAACTGCATGTAAGA-1_25G_P3C1	-2.701567721	-24.86893667	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3631	10051	0.003382748	0.003681226	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GTAACTGGTCTCCATC-1_25G_P3C1	39.31647248	9.368117294	14	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	770	1064	0.004699248	0.003759398	0	14	Microglia	NA	NA	NA
GTAACTGGTTAAGTAG-1_25G_P3C1	-4.692718864	-3.685711166	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1200	1968	0.007113821	0.00254065	0	13A	IN-VIP	NA	NA	NA
GTAACTGGTTATCGGT-1_25G_P3C1	-1.281135876	-11.01040889	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1864	3521	0.001136041	0.004260153	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GTAACTGGTTCTGAAC-1_25G_P3C1	-3.18627056	-13.90741564	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2165	4657	0.003650419	0.00407988	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GTAACTGTCGATGAGG-1_25G_P3C1	-28.34906475	17.41115388	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	988	1575	0.006984127	0.002539683	0	8	Astrocytes	NA	NA	NA
GTAACTGTCTATCCCG-1_25G_P3C1	-2.525849986	-12.77922646	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2161	4475	0.005586592	0.004692737	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GTACGTAAGCATCATC-1_25G_P3C1	-4.29291691	-19.02267705	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3071	7395	0.002569304	0.010547667	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GTACGTAAGTTAGCGG-1_25G_P3C1	3.222279305	-9.417188243	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1590	2640	0.007954545	0.007954545	0	12	EN-MIX	NA	NA	NA
GTACGTACAAGGACAC-1_25G_P3C1	-28.00810407	25.0075383	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1319	2402	0.001248959	0.006244796	0	8	Astrocytes	NA	NA	NA
GTACGTACACACAGAG-1_25G_P3C1	-1.571356757	-26.32695336	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	5421	19357	0.00113654	0.003409619	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GTACGTAGTAGCGCTC-1_25G_P3C1	-1.672531792	-24.05195893	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4991	15773	0.004691562	0.004057567	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GTACGTAGTAGGACAC-1_25G_P3C1	37.97504947	9.29352583	14	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	769	1048	0.000954198	0.005725191	0	14	Microglia	NA	NA	NA
GTACTCCAGACCCACC-1_25G_P3C1	-16.32928595	-23.10377236	6A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1694	3601	0.000555401	0.001943904	0	6A	IN-PV	NA	NA	NA
GTACTCCCATTAGCCA-1_25G_P3C1	-3.519698678	-24.16506385	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4335	13020	0.001766513	0.003149002	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GTACTCCGTGAGGGAG-1_25G_P3C1	-4.442692332	-17.14751201	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2837	6446	0.007446478	0.005274589	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GTACTCCTCACTTACT-1_25G_P3C1	-17.622871	-24.08589709	6A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2334	5360	0.002052239	0.003544776	0	6A	IN-PV	NA	NA	NA
GTACTTTCAGTCCTTC-1_25G_P3C1	-38.51213576	-4.785308671	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1208	2024	0.000988142	0.002964427	0	9	OPC	NA	NA	NA
GTACTTTCATCCAACA-1_25G_P3C1	-5.860899643	-22.51827366	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2701	6461	0.000154775	0.003714595	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GTACTTTGTAGGCATG-1_25G_P3C1	12.98020679	-31.66163149	3	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3062	8503	0.001176056	0.003763378	0	3	EN-L5-6	NA	NA	NA
GTACTTTGTCAGTGGA-1_25G_P3C1	-29.23864406	13.44904448	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	792	1160	0.005172414	0.001724138	0	8	Astrocytes	NA	NA	NA
GTAGGCCAGGAATTAC-1_25G_P3C1	-8.390291477	2.403537639	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2466	5361	0.009513151	0.004663309	0	13A	IN-VIP	NA	NA	NA
GTAGGCCAGGATGTAT-1_25G_P3C1	-8.503528469	1.246750783	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2157	4522	0.005970809	0.007297656	0	13A	IN-VIP	NA	NA	NA
GTAGGCCAGTTCGCAT-1_25G_P3C1	-39.4289578	-2.210892831	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1189	2125	0.000941176	0.003294118	0	9	OPC	NA	NA	NA
GTAGGCCCAATGACCT-1_25G_P3C1	-38.84597851	-1.181729773	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1322	2324	0.006024096	0.003012048	0	9	OPC	NA	NA	NA
GTAGGCCGTCTACCTC-1_25G_P3C1	-4.934207708	-2.144055368	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1428	2710	0.000738007	0.003321033	0	13A	IN-VIP	NA	NA	NA
GTAGGCCTCGGTCCGA-1_25G_P3C1	-1.979406114	-27.75357503	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3546	9826	0.001424791	0.002646041	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GTAGTCAAGTCGTTTG-1_25G_P3C1	-28.1685643	18.1203167	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1095	1838	0.002720348	0.009249184	0	8	Astrocytes	NA	NA	NA
GTAGTCAAGTGCCAGA-1_25G_P3C1	9.387223789	31.50338355	1	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	772	1128	0.006205674	0.003546099	0	oligos	OL-Cntl	NA	NA	NA
GTAGTCAGTAATCACC-1_25G_P3C1	-38.27034738	-0.939902876	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1331	2309	0.005197055	0.001732352	0	9	OPC	NA	NA	NA
GTAGTCAGTATCAGTC-1_25G_P3C1	17.05275971	23.33349501	1	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	853	1397	0	0.00071582	0	oligos	OL-Cntl	NA	NA	NA
GTAGTCAGTATTCGTG-1_25G_P3C1	-19.64976298	-28.14095304	6A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3500	9999	0.00410041	0.0040004	0	6A	IN-PV	NA	NA	NA
GTAGTCATCGTACCGG-1_25G_P3C1	-4.719190573	-1.938855424	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1347	2393	0.006686168	0.005850397	0	13A	IN-VIP	NA	NA	NA
GTATCTTAGCTAGTTC-1_25G_P3C1	-2.331800361	-16.5416156	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2555	6476	0.000617665	0.001852996	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GTATCTTAGGTCATCT-1_25G_P3C1	-23.38329768	31.08112272	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1847	4020	0.004477612	0.003731343	0	8	Astrocytes	NA	NA	NA
GTATCTTCAGTATAAG-1_25G_P3C1	-0.303432622	-9.500278533	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1574	2833	0.000705965	0.004941758	0	12	EN-MIX	NA	NA	NA
GTATCTTGTAAGTGGC-1_25G_P3C1	-3.70539234	-13.1367784	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2137	4015	0.005479452	0.010958904	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GTATTCTAGGATGTAT-1_25G_P3C1	-4.965391053	-24.23886243	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3100	8438	0.001303626	0.004621948	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GTATTCTAGGTGATTA-1_25G_P3C1	-2.226815755	-12.60540783	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2120	4323	0.007170946	0.004626417	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GTATTCTAGTATCGAA-1_25G_P3C1	-13.75535058	-10.7135592	13B	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1995	3783	0.003436426	0.003436426	0	13B	IN-SV2C	NA	NA	NA
GTATTCTCACGGACAA-1_25G_P3C1	-11.39385945	1.948116887	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2899	6211	0.007889229	0.003864112	0	13A	IN-VIP	NA	NA	NA
GTATTCTCATATGCTG-1_25G_P3C1	-5.093922718	-22.47471649	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2946	6692	0.004034668	0.002390915	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GTATTCTCATCCCACT-1_25G_P3C1	-4.530134288	-24.06205649	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4406	15731	0.000572119	0.00457695	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GTATTCTCATTCCTCG-1_25G_P3C1	-37.65945847	-9.674871836	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	994	1663	0.004810583	0.002405292	0	9	OPC	NA	NA	NA
GTATTCTGTCTTGATG-1_25G_P3C1	-8.877111737	0.730907226	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2533	5820	0.008419244	0.001546392	0	13A	IN-VIP	NA	NA	NA
GTATTCTTCCCTCAGT-1_25G_P3C1	-3.979962997	-5.095744376	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1066	1870	0.002673797	0.001604278	0	13A	IN-VIP	NA	NA	NA
GTCAAGTAGCAGGCTA-1_25G_P3C1	-18.84152776	-25.44784383	6A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3023	7152	0.00139821	0.004334452	0	6A	IN-PV	NA	NA	NA
GTCAAGTCACTGAAGG-1_25G_P3C1	-3.913455681	-20.77216314	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4001	11417	0.004904966	0.004379434	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GTCAAGTTCAGCAACT-1_25G_P3C1	-5.081660184	-1.300233469	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1545	2756	0.005442671	0.004354136	0	13A	IN-VIP	NA	NA	NA
GTCACAAAGCTAAACA-1_25G_P3C1	-9.135938375	0.58399988	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2319	4705	0.01381509	0.007013815	0	13A	IN-VIP	NA	NA	NA
GTCACAACATCCTTGC-1_25G_P3C1	-0.992436503	-28.96189167	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3871	10836	0.001199705	0.002307124	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GTCACAAGTCTGATCA-1_25G_P3C1	1.811821589	-6.382779568	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1202	1855	0.002156334	0.002695418	0	12	EN-MIX	NA	NA	NA
GTCACAATCTGGAGCC-1_25G_P3C1	-8.151045052	0.222501036	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2068	4078	0.007111329	0.002452182	0	13A	IN-VIP	NA	NA	NA
GTCACAATCTGGTTCC-1_25G_P3C1	-2.579581359	-23.31294236	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4493	13695	0.003870026	0.002774735	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GTCACGGAGAAACGCC-1_25G_P3C1	-2.211642843	-26.9017327	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4250	12587	0.00079447	0.002462859	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GTCACGGAGAGGTAGA-1_25G_P3C1	-3.483383983	-15.78633094	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2430	5224	0.004402757	0.003828484	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GTCACGGAGTGCCATT-1_25G_P3C1	-2.894569273	-14.25188924	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2321	4895	0.00020429	0.004290092	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GTCACGGGTAATCACC-1_25G_P3C1	-4.971521841	-22.18111296	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3368	8720	0.001720183	0.004472477	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GTCACGGGTCTCTTTA-1_25G_P3C1	28.25451876	0.411354453	2	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3061	7024	0.003274487	0.004128702	0	2	EN-L4	NA	NA	NA
GTCACGGGTTAGATGA-1_25G_P3C1	-19.86852668	-28.63090978	6A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3679	9746	0.002052124	0.002257336	0	6A	IN-PV	NA	NA	NA
GTCACGGGTTCAGTAC-1_25G_P3C1	-4.628298706	-21.31726155	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3355	8672	0.000115314	0.002652214	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GTCATTTAGCTAAGAT-1_25G_P3C1	-1.867960689	-28.72045468	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3412	9241	0.000541067	0.004112109	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GTCATTTAGTGGAGAA-1_25G_P3C1	-0.711850051	-26.84670482	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4960	15764	0.003552398	0.002093377	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GTCATTTCACATCCAA-1_25G_P3C1	8.931657961	31.08983724	1	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	682	1027	0	0.00292113	0	oligos	OL-Cntl	NA	NA	NA
GTCATTTGTACCCAAT-1_25G_P3C1	-23.29753318	27.89424815	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1627	2960	0.003378378	0.004391892	0	8	Astrocytes	NA	NA	NA
GTCATTTTCATTGCCC-1_25G_P3C1	-5.561458318	-22.98321457	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3237	9233	0.00075815	0.001949529	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GTCATTTTCCGGGTGT-1_25G_P3C1	-22.60127668	31.53560009	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2661	6284	0.001591343	0.002068746	0	8	Astrocytes	NA	NA	NA
GTCATTTTCTGGTGTA-1_25G_P3C1	28.19045932	0.751398214	2	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3132	7819	0.002429978	0.003708914	0	2	EN-L4	NA	NA	NA
GTCCTCAAGCCAGAAC-1_25G_P3C1	-1.465543903	-27.75452755	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	5818	23408	0.00102529	0.002776828	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GTCCTCAAGGGTCTCC-1_25G_P3C1	-36.58559101	-11.20042847	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	855	1328	0.00376506	0	0	9	OPC	NA	NA	NA
GTCCTCACAGGCAGTA-1_25G_P3C1	26.14805083	-2.512053938	2	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3124	7585	0.000791035	0.002636783	0	2	EN-L4	NA	NA	NA
GTCCTCAGTACCTACA-1_25G_P3C1	-2.886722158	-24.18077623	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3884	10933	0.003201317	0.004024513	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GTCCTCAGTGCAGGTA-1_25G_P3C1	-29.52240311	12.42273082	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	679	1077	0	0.00185701	0	8	Astrocytes	NA	NA	NA
GTCCTCATCTACTTAC-1_25G_P3C1	-8.334206412	1.33056425	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2247	4796	0.008965805	0.005421184	0	13A	IN-VIP	NA	NA	NA
GTCCTCATCTCTAAGG-1_25G_P3C1	-29.10553512	13.03796088	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	816	1270	0.003149606	0.002362205	0	8	Astrocytes	NA	NA	NA
GTCGGGTCAGGCTGAA-1_25G_P3C1	-1.126480295	-10.9257392	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1796	3426	0.003210741	0.007880911	0	12	EN-MIX	NA	NA	NA
GTCGGGTGTAAGGGCT-1_25G_P3C1	1.984820367	-6.706316787	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1246	1935	0.000516796	0.005167959	0	12	EN-MIX	NA	NA	NA
GTCGGGTGTTAAGAAC-1_25G_P3C1	1.616183381	-8.327487856	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1521	2661	0.009394964	0.006012777	0	12	EN-MIX	NA	NA	NA
GTCGTAAAGATAGGAG-1_25G_P3C1	-1.788019816	-26.5662348	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4149	11644	0.002318791	0.003263483	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GTCGTAACACAAGTAA-1_25G_P3C1	-37.844794	-6.093554401	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1174	1975	0.001518987	0.001518987	0	9	OPC	NA	NA	NA
GTCGTAACATGGATGG-1_25G_P3C1	-4.181362572	-19.59070247	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3204	7541	0.00583477	0.008221721	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GTCTCGTAGACCACGA-1_25G_P3C1	8.877346336	31.78762848	1	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	737	1121	0.002676182	0.003568243	0	oligos	OL-Cntl	NA	NA	NA
GTCTCGTAGGCTACGA-1_25G_P3C1	39.62192486	9.951153059	14	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	716	1019	0	0.007850834	0	14	Microglia	NA	NA	NA
GTCTCGTCACTGTCGG-1_25G_P3C1	-19.23104241	-26.66073336	6A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2877	6766	0.009606858	0.003842743	0	6A	IN-PV	NA	NA	NA
GTCTCGTCAGGCTGAA-1_25G_P3C1	-1.067875777	-27.69613555	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	5197	16383	0.002136361	0.005005188	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GTCTCGTTCTTGTATC-1_25G_P3C1	-29.02670922	13.70849141	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	769	1198	0.001669449	0.003338898	0	8	Astrocytes	NA	NA	NA
GTCTTCGGTCTAAACC-1_25G_P3C1	-4.057161509	-21.85591383	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3399	8902	0.001011009	0.006852393	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GTCTTCGGTGTGGCTC-1_25G_P3C1	-5.040913297	-2.524508447	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1399	2528	0.013844937	0.002768987	0	13A	IN-VIP	NA	NA	NA
GTCTTCGTCAAGGTAA-1_25G_P3C1	-14.41987274	-21.3598949	6A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1487	2800	0.007857143	0.001785714	0	6A	IN-PV	NA	NA	NA
GTCTTCGTCCAATGGT-1_25G_P3C1	-5.311384083	-1.82127976	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1619	3261	0.014106102	0.003986507	0	13A	IN-VIP	NA	NA	NA
GTCTTCGTCGCCATAA-1_25G_P3C1	-14.44065125	-24.829409	6A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1557	3005	0	0.00765391	0	6A	IN-PV	NA	NA	NA
GTCTTCGTCTGTCCGT-1_25G_P3C1	-3.335021296	-5.288591276	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1037	1656	0.003019324	0.007246377	0	13A	IN-VIP	NA	NA	NA
GTGAAGGCAAAGGAAG-1_25G_P3C1	24.72009061	-29.29000541	3	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3612	9769	0.001228375	0.003685126	0	3	EN-L5-6	NA	NA	NA
GTGAAGGCAAGCTGTT-1_25G_P3C1	-1.260886042	-27.74625257	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4895	15608	0.000704767	0.003908252	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GTGAAGGCAGGATTGG-1_25G_P3C1	-4.768966943	-9.858265687	13B	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	786	1171	0.000853971	0.001707942	0	13B	IN-SV2C	NA	NA	NA
GTGAAGGCATGTCGAT-1_25G_P3C1	-7.641742642	1.420595354	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2199	4546	0.007699076	0.002639683	0	13A	IN-VIP	NA	NA	NA
GTGAAGGGTGAGTGAC-1_25G_P3C1	2.828375335	-14.45680917	4	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2275	4334	0.005999077	0.005999077	0	L2-3	EN-L2-3-MS	NA	NA	NA
GTGAAGGTCTCTGCTG-1_25G_P3C1	-4.14558998	-20.38256467	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3092	7337	0.005315524	0.004906638	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GTGCAGCCACCATCCT-1_25G_P3C1	-28.11755401	17.3286452	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1078	1848	0.000541126	0.003246753	0	8	Astrocytes	NA	NA	NA
GTGCAGCCACTACAGT-1_25G_P3C1	-10.95203015	1.455221799	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3371	9356	0.004702864	0.002030782	0	13A	IN-VIP	NA	NA	NA
GTGCAGCCATCAGTCA-1_25G_P3C1	-5.708049226	-1.998305702	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1665	2932	0.011937244	0.002387449	0	13A	IN-VIP	NA	NA	NA
GTGCAGCTCATCTGCC-1_25G_P3C1	-1.056397418	-28.84549441	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4287	12548	0.002470513	0.003028371	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GTGCAGCTCTCACATT-1_25G_P3C1	1.136139662	-7.30568633	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1273	2103	0	0.006657156	0	12	EN-MIX	NA	NA	NA
GTGCAGCTCTCGTATT-1_25G_P3C1	37.32053356	9.63555586	14	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	764	1000	0.01	0.003	0	14	Microglia	NA	NA	NA
GTGCATAAGATAGGAG-1_25G_P3C1	-31.47813077	12.25136666	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	726	1101	0.004541326	0.003633061	0	8	Astrocytes	NA	NA	NA
GTGCATAAGCTCAACT-1_25G_P3C1	25.83997186	3.685045945	15BA	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	746	1121	0.005352364	0.002676182	0	15BA	Stromal cells	NA	NA	NA
GTGCATAAGTCCATAC-1_25G_P3C1	-29.57516412	12.57395816	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	726	1194	0.003350084	0.006700168	0	8	Astrocytes	NA	NA	NA
GTGCATACAGAGCCAA-1_25G_P3C1	8.015819493	-15.83285665	4	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3122	6724	0.009220702	0.011451517	0	L2-3	EN-L2-3-MS	NA	NA	NA
GTGCATACATGGTCTA-1_25G_P3C1	-38.49856325	-3.946303508	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1252	2113	0.001419782	0.002366304	0	9	OPC	NA	NA	NA
GTGCATAGTCTCTTTA-1_25G_P3C1	9.789288042	28.59010054	1	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	799	1241	0.005640612	0.001611604	0	oligos	OL-Cntl	NA	NA	NA
GTGCGGTAGTCCGTAT-1_25G_P3C1	5.401118919	-27.2630508	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	5137	17117	0.001402115	0.002453701	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GTGCGGTCACTAGTAC-1_25G_P3C1	-4.33670117	-18.41512618	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3186	7223	0.004707185	0.007614565	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GTGCGGTCACTATCTT-1_25G_P3C1	-4.168363319	-21.22458256	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3439	8993	0.004336706	0.002891138	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GTGCGGTGTCCAGTTA-1_25G_P3C1	-28.09996117	25.47137534	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1370	2507	0.007578779	0.005185481	0	8	Astrocytes	NA	NA	NA
GTGCGGTGTCTCGTTC-1_25G_P3C1	5.45171691	26.90932753	1	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	763	1070	0.002803738	0.000934579	0	oligos	OL-Cntl	NA	NA	NA
GTGCTTCAGAACTCGG-1_25G_P3C1	-4.071350499	-15.41686324	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2530	5427	0.00239543	0.005896444	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GTGCTTCCACCACCAG-1_25G_P3C1	-4.131959593	-15.13905337	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2413	4942	0.010522056	0.00586807	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GTGCTTCCAGGATCGA-1_25G_P3C1	-8.78459469	2.427269469	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2386	5279	0.001136579	0.003030877	0	13A	IN-VIP	NA	NA	NA
GTGCTTCTCTGTCTAT-1_25G_P3C1	-5.15343275	-20.81362223	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2940	7471	0.000535404	0.003881676	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GTGGGTCAGATCACGG-1_25G_P3C1	-4.239662313	-24.60169654	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4222	13159	0.00083593	0.005091572	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GTGGGTCAGGAGTACC-1_25G_P3C1	-3.306130617	-22.33812092	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3715	9547	0.001780664	0.006389442	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GTGGGTCAGGTGATTA-1_25G_P3C1	2.777842625	-16.70630604	4	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2745	5634	0.001952432	0.004969826	0	L2-3	EN-L2-3-MS	NA	NA	NA
GTGGGTCAGGTTCCTA-1_25G_P3C1	-8.51502976	1.743162211	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2609	6117	0.003760013	0.002452182	0	13A	IN-VIP	NA	NA	NA
GTGGGTCCAAAGTCAA-1_25G_P3C1	-26.3104699	26.27079183	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1426	2459	0.002033347	0.003253355	0	8	Astrocytes	NA	NA	NA
GTGGGTCGTCCCGACA-1_25G_P3C1	-26.91052138	26.850623	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1373	2428	0.000823723	0.007001647	0	8	Astrocytes	NA	NA	NA
GTGTGCGCACACCGCA-1_25G_P3C1	-0.309703255	-29.26496706	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	6191	27180	0.002354673	0.003568801	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GTGTGCGCAGACGCCT-1_25G_P3C1	-18.27372928	-27.66960445	6A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2605	6139	0.001954716	0.002769181	0	6A	IN-PV	NA	NA	NA
GTGTGCGGTAAGAGAG-1_25G_P3C1	5.054955765	31.76604575	1	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	757	1088	0.009191176	0.005514706	0	oligos	OL-Cntl	NA	NA	NA
GTGTTAGAGGTAAACT-1_25G_P3C1	-0.48152147	-9.007132342	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1618	2695	0.003339518	0.013729128	0	12	EN-MIX	NA	NA	NA
GTGTTAGCAGCCTATA-1_25G_P3C1	-4.984933776	-22.16844011	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3756	10586	0.003400718	0.00387304	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GTGTTAGTCGCAAGCC-1_25G_P3C1	-2.115000008	-23.90058891	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4882	15129	0.004428581	0.007931787	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GTTAAGCCAAGTAATG-1_25G_P3C1	-7.90380929	-0.306190911	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2091	4495	0	0.002892102	0	13A	IN-VIP	NA	NA	NA
GTTAAGCCACTTCGAA-1_25G_P3C1	-3.532184121	-5.897958406	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1012	1534	0.004563233	0.002607562	0	13A	IN-VIP	NA	NA	NA
GTTAAGCTCCAATGGT-1_25G_P3C1	-11.05752828	1.639631611	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3306	8796	0.008981355	0.003524329	0	13A	IN-VIP	NA	NA	NA
GTTAAGCTCCTGCTTG-1_25G_P3C1	-34.1534854	-12.43807988	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	762	1151	0.00086881	0.002606429	0	9	OPC	NA	NA	NA
GTTAAGCTCTTGCATT-1_25G_P3C1	-13.43335049	-19.55775558	6B	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1295	2403	0.001248439	0.002913025	0	6B	IN-SST	NA	NA	NA
GTTACAGAGACTACAA-1_25G_P3C1	-35.17072147	-12.14425374	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	825	1251	0.003197442	0.002398082	0	9	OPC	NA	NA	NA
GTTACAGAGCGATCCC-1_25G_P3C1	20.24155226	-28.93766799	3	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3886	11478	0.001829587	0.005401638	0	3	EN-L5-6	NA	NA	NA
GTTACAGCACAAGACG-1_25G_P3C1	-25.97362957	26.26482664	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1638	3153	0.000317158	0.005074532	0	8	Astrocytes	NA	NA	NA
GTTACAGCACGCTTTC-1_25G_P3C1	-6.276277398	-1.005038405	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1983	4583	0.008727907	0.001963779	0	13A	IN-VIP	NA	NA	NA
GTTACAGGTCATATCG-1_25G_P3C1	-1.000978306	-9.356156576	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1657	3105	0.009983897	0.00547504	0	12	EN-MIX	NA	NA	NA
GTTACAGTCCTGTACC-1_25G_P3C1	-10.20500002	3.238560187	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3689	9466	0.002957955	0.003591802	0	13A	IN-VIP	NA	NA	NA
GTTCATTAGGCTCTTA-1_25G_P3C1	-1.381732309	-27.94938913	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	5086	19476	0.000924214	0.002618608	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GTTCATTAGTTCGCAT-1_25G_P3C1	-28.1763601	18.59911732	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1143	2057	0.004375304	0.004375304	0	8	Astrocytes	NA	NA	NA
GTTCATTCATCCTTGC-1_25G_P3C1	-5.457464913	-21.86854607	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2891	7185	0.003757829	0.003897008	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GTTCATTCATGCGCAC-1_25G_P3C1	2.530261006	-8.450367451	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1464	2468	0.009724473	0.009724473	0	12	EN-MIX	NA	NA	NA
GTTCATTCATTTGCTT-1_25G_P3C1	-2.152153607	-28.77582837	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2926	7419	0.001078312	0.002560992	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GTTCATTGTGATGATA-1_25G_P3C1	-4.231519563	-24.31304359	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3356	8122	0.002216203	0.00307806	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GTTCATTTCCGCTGTT-1_25G_P3C1	-5.62993145	-5.173594111	13B	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1184	1961	0.009688934	0.003059663	0	13B	IN-SV2C	NA	NA	NA
GTTCATTTCGTGTAGT-1_25G_P3C1	0.078430874	-7.751974649	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1437	2809	0.000355999	0.003915984	0	12	EN-MIX	NA	NA	NA
GTTCGGGAGCGTGTCC-1_25G_P3C1	1.167427365	-26.89132238	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3577	9307	0.003330826	0.002471258	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GTTCGGGGTCCGACGT-1_25G_P3C1	10.96455728	29.45883951	1	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	701	1057	0.002838221	0.001892148	0	oligos	OL-Cntl	NA	NA	NA
GTTCGGGGTGTGGCTC-1_25G_P3C1	-4.522444438	-20.70070494	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3561	9623	0.001558765	0.003637119	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GTTCTCGAGCCTCGTG-1_25G_P3C1	-2.871007284	-22.38538629	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3844	10072	0.004567117	0.005361398	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GTTCTCGAGGCCCGTT-1_25G_P3C1	-5.34371718	-21.32776425	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2978	7102	0.00183047	0.002393692	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GTTCTCGCAGAGTGTG-1_25G_P3C1	3.622491949	-19.08202558	4	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3461	8043	0.007832898	0.004724605	0	L2-3	EN-L2-3-MS	NA	NA	NA
GTTCTCGCATAACCTG-1_25G_P3C1	14.88617696	31.25873104	1	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	962	1557	0.001284522	0.002569043	0	oligos	OL-Cntl	NA	NA	NA
GTTCTCGGTGAAAGAG-1_25G_P3C1	-3.881142322	-20.65428293	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3744	9581	0.005218662	0.00417493	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GTTCTCGGTTACGCGC-1_25G_P3C1	-37.47144475	-9.474426393	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1031	1755	0.001139601	0.001709402	0	9	OPC	NA	NA	NA
GTTTCTAAGCGGATCA-1_25G_P3C1	-27.85139301	18.91128301	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1236	2408	0	0.005813953	0	8	Astrocytes	NA	NA	NA
GTTTCTAGTGCGATAG-1_25G_P3C1	-0.629414539	-10.01951943	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1740	3215	0.007465008	0.00622084	0	12	EN-MIX	NA	NA	NA
TAAACCGAGGATCGCA-1_25G_P3C1	-4.968013025	-5.353521437	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1143	1862	0.004833512	0.002148228	0	13A	IN-VIP	NA	NA	NA
TAAACCGAGGTGCAAC-1_25G_P3C1	-27.55020081	25.53282562	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1375	2627	0	0.004187286	0	8	Astrocytes	NA	NA	NA
TAAACCGGTAGCCTCG-1_25G_P3C1	1.500937362	-13.60859084	4	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2295	4290	0.009324009	0.002331002	0	L2-3	EN-L2-3-MS	NA	NA	NA
TAAACCGGTAGGGTAC-1_25G_P3C1	-3.457803604	-5.150668191	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1044	1794	0.004459309	0.002229654	0	13A	IN-VIP	NA	NA	NA
TAAACCGTCAGGATCT-1_25G_P3C1	-6.62047388	-1.040407565	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1836	3292	0.009416768	0.004556501	0	13A	IN-VIP	NA	NA	NA
TAAACCGTCTGTCTAT-1_25G_P3C1	21.37955322	1.620164191	2	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1421	2586	0	0.003480278	0	2	EN-L4	NA	NA	NA
TAAGAGAAGGTCATCT-1_25G_P3C1	12.70617004	-31.51187395	3	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2621	6835	0.001316752	0.002340892	0	3	EN-L5-6	NA	NA	NA
TAAGAGAGTACATGTC-1_25G_P3C1	-5.923767221	-4.787283871	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1504	2663	0.003004131	0.003755163	0	13A	IN-VIP	NA	NA	NA
TAAGAGAGTCAGAATA-1_25G_P3C1	33.74177426	-2.194120485	2	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2436	4912	0.018118893	0.004275244	0	2	EN-L4	NA	NA	NA
TAAGAGAGTGCACCAC-1_25G_P3C1	-4.287775315	-15.26072691	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2640	6220	0.000321543	0.009967846	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TAAGAGAGTTAGGGTG-1_25G_P3C1	-11.42655424	-22.11925169	6A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	918	1371	0.002917578	0.003646973	0	6A	IN-PV	NA	NA	NA
TAAGAGATCACTGGGC-1_25G_P3C1	-9.128772654	-19.32475954	6B	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	806	1409	0.016323634	0.004258339	0	6B	IN-SST	NA	NA	NA
TAAGAGATCTGGCGAC-1_25G_P3C1	-35.16663635	-12.85269802	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	779	1141	0.001752848	0.001752848	0	9	OPC	NA	NA	NA
TAAGCGTGTGACTCAT-1_25G_P3C1	10.20965101	-28.42990317	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	5297	17483	0.002230738	0.006635017	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TAAGCGTTCCGAAGAG-1_25G_P3C1	2.427817726	-27.39726431	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2888	5828	0.001715854	0.003260124	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TAAGTGCAGGTAAACT-1_25G_P3C1	-37.20504218	-10.04361	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1099	1815	0.007713499	0.001652893	0	9	OPC	NA	NA	NA
TAAGTGCCACAGACTT-1_25G_P3C1	24.29228969	1.15325327	2	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2005	3878	0.002320784	0.002062919	0	2	EN-L4	NA	NA	NA
TAAGTGCGTATCGCAT-1_25G_P3C1	-5.537854704	-1.029073103	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1695	3235	0.003709428	0.001854714	0	13A	IN-VIP	NA	NA	NA
TAAGTGCGTTCCACGG-1_25G_P3C1	5.654609219	-32.35016134	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	5798	23950	0.00125261	0.003340292	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TAAGTGCGTTTGTTTC-1_25G_P3C1	-4.033934821	-15.11416664	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2583	5716	0.000874738	0.006822953	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TACACGAAGGATGTAT-1_25G_P3C1	-4.117932131	-25.06354798	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3150	7871	0.002668022	0.003176216	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TACACGAAGTGCAAGC-1_25G_P3C1	-29.5109803	13.84962441	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	746	1122	0.000891266	0.007130125	0	8	Astrocytes	NA	NA	NA
TACACGACAATGAAAC-1_25G_P3C1	-18.78061676	-27.60412882	6A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3174	8861	0.005078434	0.002369936	0	6A	IN-PV	NA	NA	NA
TACACGAGTGCGGTAA-1_25G_P3C1	29.32195101	0.430988308	2	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2994	6811	0.005726031	0.004698282	0	2	EN-L4	NA	NA	NA
TACACGAGTGTTCTTT-1_25G_P3C1	-2.403113326	-27.19603619	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4283	13906	0.000791025	0.00309219	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TACAGTGAGAGCTGGT-1_25G_P3C1	-0.779431637	-9.867269406	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1745	3049	0.003935717	0.006887504	0	12	EN-MIX	NA	NA	NA
TACAGTGAGCCGTCGT-1_25G_P3C1	5.821415562	-31.5936221	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4161	11584	0.001985497	0.00448895	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TACAGTGGTAATCACC-1_25G_P3C1	-2.485364065	-23.84271993	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4539	14470	0.005183138	0.002902557	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TACAGTGTCCACTGGG-1_25G_P3C1	-2.315726542	-27.30391218	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3788	10818	0.001663894	0.004621926	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TACCTATAGAAACGCC-1_25G_P3C1	-2.928004851	-15.95102535	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2487	5341	0.001872309	0.003182925	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TACCTATAGAGACGAA-1_25G_P3C1	-36.90700239	-10.24372039	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	921	1494	0.002677376	0.002677376	0	9	OPC	NA	NA	NA
TACCTATAGTCAATAG-1_25G_P3C1	-28.69668057	16.56446588	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	925	1499	0.001334223	0.003335557	0	8	Astrocytes	NA	NA	NA
TACCTATAGTGGAGAA-1_25G_P3C1	-28.06527176	18.59656201	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1273	2245	0.014253898	0.00311804	0	8	Astrocytes	NA	NA	NA
TACCTATCAGATTGCT-1_25G_P3C1	-27.5452109	19.08835674	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1215	2173	0	0.001840773	0	8	Astrocytes	NA	NA	NA
TACCTATCAGGCTCAC-1_25G_P3C1	-7.131788851	0.558629485	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2241	4676	0.004704876	0.004704876	0	13A	IN-VIP	NA	NA	NA
TACCTATGTGAGTATA-1_25G_P3C1	-1.047846602	-27.78688319	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	5320	19071	0.002831524	0.003251009	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TACCTATGTTGGAGGT-1_25G_P3C1	-37.43760754	-8.182467744	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1016	1721	0.00232423	0.00232423	0	9	OPC	NA	NA	NA
TACCTATTCCTGCAGG-1_25G_P3C1	12.74034645	29.83249679	1	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	708	1066	0.001876173	0	0	oligos	OL-Cntl	NA	NA	NA
TACCTATTCTCGGACG-1_25G_P3C1	-3.849594439	-21.77095689	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3983	10990	0.003730664	0.004549591	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TACCTTATCCAGTAGT-1_25G_P3C1	-2.589518966	-15.65437926	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2650	6670	0.00029985	0.002998501	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TACCTTATCGCAAGCC-1_25G_P3C1	8.748904737	31.53612184	1	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	718	1126	0.002664298	0.002664298	0	oligos	OL-Cntl	NA	NA	NA
TACGGATAGATCACGG-1_25G_P3C1	-8.298827256	2.199155594	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2397	5047	0.009114325	0.002179513	0	13A	IN-VIP	NA	NA	NA
TACGGATAGATCGATA-1_25G_P3C1	-27.57471556	24.16114902	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1336	2363	0.002539145	0.003385527	0	8	Astrocytes	NA	NA	NA
TACGGATGTCGCGGTT-1_25G_P3C1	-4.288333938	-18.26891093	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2897	6765	0.004582409	0.009312639	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TACGGATGTGATAAAC-1_25G_P3C1	-34.38640238	-13.21528796	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	684	1007	0.003972195	0.000993049	0	9	OPC	NA	NA	NA
TACGGATTCCGCGCAA-1_25G_P3C1	-3.939585486	-17.88241	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2760	6136	0.005378096	0.007007823	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TACGGGCCAGTCAGAG-1_25G_P3C1	-4.273507293	-20.08243094	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3169	7668	0.001564945	0.006129369	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TACGGGCCATACTCTT-1_25G_P3C1	-28.6227477	17.17302716	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1035	1823	0.000548546	0.00603401	0	8	Astrocytes	NA	NA	NA
TACGGGCCATATGGTC-1_25G_P3C1	-28.17201147	17.10263575	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	990	1659	0.001808318	0.001808318	0	8	Astrocytes	NA	NA	NA
TACGGGCTCCCTCAGT-1_25G_P3C1	0.757357778	-21.79015154	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3868	9964	0.005118426	0.007527098	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TACGGTAAGATGGGTC-1_25G_P3C1	19.73950428	-28.66633128	3	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3029	7480	0.00040107	0.015508021	0	3	EN-L5-6	NA	NA	NA
TACGGTACACTTACGA-1_25G_P3C1	-3.929143209	-24.03222361	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4495	14640	0.002800546	0.004644809	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TACGGTATCTGTCCGT-1_25G_P3C1	-38.42162517	-6.317426651	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1164	2056	0.000972763	0.000972763	0	9	OPC	NA	NA	NA
TACTCATAGCAATCTC-1_25G_P3C1	-5.166491827	-21.22516599	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2935	7271	0.003438317	0.004538578	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TACTCATAGCCTCGTG-1_25G_P3C1	-9.362568354	0.479442036	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2489	5595	0.006255585	0.004647006	0	13A	IN-VIP	NA	NA	NA
TACTCATAGCTAGTCT-1_25G_P3C1	-10.3377033	14.24783857	11	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1086	1658	0.004221954	0.001206273	0	11	Glia-MIX	NA	NA	NA
TACTCATAGGAGCGAG-1_25G_P3C1	-2.691915032	-15.93270732	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2485	6115	0.003434178	0.003107114	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TACTCATAGTAGGTGC-1_25G_P3C1	13.86397929	-32.99053464	3	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3841	11720	0.002474403	0.002986348	0	3	EN-L5-6	NA	NA	NA
TACTCATCACGCGAAA-1_25G_P3C1	-0.688450904	-8.85509698	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1580	2756	0.000725689	0.010885341	0	12	EN-MIX	NA	NA	NA
TACTCATGTCAAACTC-1_25G_P3C1	19.7707738	-28.71534697	3	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3308	9460	0.000105708	0.009196617	0	3	EN-L5-6	NA	NA	NA
TACTCGCAGACAATAC-1_25G_P3C1	-4.553366053	-23.75474203	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4838	17666	0.000226424	0.003679384	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TACTCGCAGCTAAACA-1_25G_P3C1	31.12309894	-3.390804079	2	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3035	7269	0.001375705	0.003714404	0	2	EN-L4	NA	NA	NA
TACTCGCAGCTAGGCA-1_25G_P3C1	5.443102187	30.07024845	1	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	743	1058	0.001890359	0.008506616	0	oligos	OL-Cntl	NA	NA	NA
TACTCGCGTTCAGGCC-1_25G_P3C1	-3.08806682	-24.36191803	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4013	10934	0.001554783	0.002743735	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TACTCGCGTTCCCGAG-1_25G_P3C1	23.42860692	1.130426471	2	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2057	4072	0.010559921	0.003192534	0	2	EN-L4	NA	NA	NA
TACTCGCGTTGGTTTG-1_25G_P3C1	-4.373560753	-16.18409237	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2611	5805	0.008613264	0.003962102	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TACTCGCTCCTCAATT-1_25G_P3C1	-4.712010815	-9.675694979	13B	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	923	1513	0.001321877	0.00462657	0	13B	IN-SV2C	NA	NA	NA
TACTTACAGATCCGAG-1_25G_P3C1	-0.57565614	-9.190698209	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1620	2697	0.001853912	0.008157212	0	12	EN-MIX	NA	NA	NA
TACTTACAGGTGCAAC-1_25G_P3C1	-14.10165668	-8.300743715	13B	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2922	7152	0.003775168	0.003215884	0	13B	IN-SV2C	NA	NA	NA
TACTTACGTTACCGAT-1_25G_P3C1	7.012062511	-33.28323612	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3441	10234	0	0.003029119	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TACTTACTCCGGGTGT-1_25G_P3C1	25.02086566	-4.282229189	2	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3962	12619	0.00071321	0.001822648	0	2	EN-L4	NA	NA	NA
TACTTGTCAACACCCG-1_25G_P3C1	-36.11800955	4.574443284	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2177	5058	0.000395413	0.001383946	0	9	OPC	NA	NA	NA
TACTTGTGTCCATCCT-1_25G_P3C1	-9.044944796	2.594448867	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2756	6743	0.003855851	0.002076227	0	13A	IN-VIP	NA	NA	NA
TACTTGTGTTGCCTCT-1_25G_P3C1	-10.94033767	2.9831366	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3772	9894	0.00747928	0.004346068	0	13A	IN-VIP	NA	NA	NA
TACTTGTTCGCCGTGA-1_25G_P3C1	-4.383450373	-17.0132718	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2874	6709	0.008645104	0.003428231	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TAGACCACAAATCCGT-1_25G_P3C1	-5.018563382	-22.42915496	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3499	10148	0.001478124	0.002759164	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TAGACCACAACAACCT-1_25G_P3C1	-39.76274415	0.255410509	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1550	3009	0	0.002326354	0	9	OPC	NA	NA	NA
TAGACCACACCAGGCT-1_25G_P3C1	-3.002327645	-24.34460167	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3465	8787	0.001593263	0.001479458	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TAGACCACACGGTAGA-1_25G_P3C1	-8.942051721	2.980204562	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2394	4674	0.003851091	0.003851091	0	13A	IN-VIP	NA	NA	NA
TAGACCATCTGCGACG-1_25G_P3C1	24.77485647	0.719463361	2	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2101	3946	0.001773948	0.00430816	0	2	EN-L4	NA	NA	NA
TAGACCATCTTAGAGC-1_25G_P3C1	12.66192802	-33.02575403	2	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2913	7063	0.000141583	0.002265326	0	2	EN-L4	NA	NA	NA
TAGAGCTGTCAGTGGA-1_25G_P3C1	-38.40617441	-5.677876043	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1138	1925	0.001558442	0.002077922	0	9	OPC	NA	NA	NA
TAGAGCTGTCCAGTGC-1_25G_P3C1	-4.21751687	-18.78876323	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3409	8730	0.006071019	0.007101947	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TAGAGCTGTTCGTCTC-1_25G_P3C1	-4.497724443	-16.10767793	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2615	5904	0.003556911	0.004911924	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TAGAGCTTCACAATGC-1_25G_P3C1	-0.871870111	-28.15633486	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4790	15509	0.002772584	0.003288413	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TAGAGCTTCGGCGCTA-1_25G_P3C1	-34.59635261	-12.7222631	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	694	1025	0.00195122	0.00195122	0	9	OPC	NA	NA	NA
TAGAGCTTCTTATCTG-1_25G_P3C1	-22.67822191	31.47840044	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2350	5315	0.005079962	0.003010348	0	8	Astrocytes	NA	NA	NA
TAGCCGGCAAGGCTCC-1_25G_P3C1	-39.12780305	0.595721182	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1676	3337	0.002097693	0.002097693	0	9	OPC	NA	NA	NA
TAGCCGGGTTACTGAC-1_25G_P3C1	0.507978551	-6.69165334	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1237	2162	0.008325624	0.002312673	0	12	EN-MIX	NA	NA	NA
TAGGCATAGCGTCAAG-1_25G_P3C1	8.366252209	-26.1593821	4	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4441	11988	0.021604938	0.004421088	0	L2-3	EN-L2-3-MS	NA	NA	NA
TAGGCATAGCTAGCCC-1_25G_P3C1	8.655989895	-7.523007729	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1953	3906	0.005376344	0.00281618	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TAGGCATAGTTGAGAT-1_25G_P3C1	-1.272555769	-9.640294978	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1901	3593	0.002504871	0.012524353	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TAGGCATCATAGACTC-1_25G_P3C1	-22.7110956	31.54266939	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2693	6713	0.004171011	0.002383435	0	8	Astrocytes	NA	NA	NA
TAGGCATCATCGATGT-1_25G_P3C1	5.05222247	-32.31278512	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4489	15029	0.00099807	0.002129217	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TAGGCATCATCGGTTA-1_25G_P3C1	-22.43909825	31.61756144	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2796	7278	0.000549602	0.004396812	0	8	Astrocytes	NA	NA	NA
TAGGCATGTCCGAAGA-1_25G_P3C1	-39.86564926	0.503969493	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1720	3448	0.000290023	0.002030162	0	9	OPC	NA	NA	NA
TAGGCATGTCTAGTGT-1_25G_P3C1	-19.0835811	-28.2614738	6A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3305	9224	0.002710321	0.00151778	0	6A	IN-PV	NA	NA	NA
TAGGCATTCCAGTATG-1_25G_P3C1	-2.411217645	-26.02283927	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	5129	19991	0.002801261	0.00180081	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TAGTGGTTCACTTACT-1_25G_P3C1	-4.396004931	-16.88196645	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2878	7060	0.000991501	0.003966006	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TAGTGGTTCTGATACG-1_25G_P3C1	-4.63526498	-2.932986149	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1294	2275	0.009230769	0.003076923	0	13A	IN-VIP	NA	NA	NA
TAGTTGGCAGTCAGCC-1_25G_P3C1	-8.556032305	0.283192681	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2196	4505	0.008213097	0.005327414	0	13A	IN-VIP	NA	NA	NA
TAGTTGGGTGAAGGCT-1_25G_P3C1	-17.24080962	-26.37538193	6A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2452	5529	0.003798155	0.003074697	0	6A	IN-PV	NA	NA	NA
TAGTTGGGTGGTCCGT-1_25G_P3C1	-3.170861046	-24.16090897	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3600	9923	0.00151164	0.003224831	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TAGTTGGTCAGCGATT-1_25G_P3C1	1.746273889	-14.78145057	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2382	4966	0.00583971	0.00865888	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TAGTTGGTCCAGGGCT-1_25G_P3C1	-18.11101107	-27.12991353	6A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2585	6164	0.006489293	0.001946788	0	6A	IN-PV	NA	NA	NA
TAGTTGGTCCAGTATG-1_25G_P3C1	25.45424274	1.196328634	2	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2312	4710	0.003609342	0.00552017	0	2	EN-L4	NA	NA	NA
TAGTTGGTCTCGCTTG-1_25G_P3C1	26.39200075	-0.368876517	2	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2978	7979	0.000375987	0.002130593	0	2	EN-L4	NA	NA	NA
TATCAGGCACGACTCG-1_25G_P3C1	-4.288396181	-21.4696289	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3518	9777	0.000818247	0.003784392	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TATCAGGCAGTCTTCC-1_25G_P3C1	-2.60091723	-15.94082543	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2822	6455	0.002168861	0.003253292	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TATCAGGCATTACGAC-1_25G_P3C1	-9.105822492	0.561368329	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2337	5116	0.015050821	0.003713839	0	13A	IN-VIP	NA	NA	NA
TATCAGGGTAAGTTCC-1_25G_P3C1	-4.36724262	-22.80440317	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3660	10193	0.002452664	0.00765231	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TATCAGGGTCAGGACA-1_25G_P3C1	2.462929573	-27.42550047	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3699	10663	0.002156991	0.002813467	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TATCAGGGTGCACTTA-1_25G_P3C1	-10.96624203	-20.26030625	6A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1010	1737	0.020149683	0.00115141	0	6A	IN-PV	NA	NA	NA
TATCAGGTCGCATGAT-1_25G_P3C1	-1.631641566	-27.17592316	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4708	15378	0.002015867	0.003576538	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TATCTCAAGATAGTCA-1_25G_P3C1	-3.276990607	-25.76093366	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4020	11935	0.002513615	0.003770423	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TATCTCAAGGCTAGAC-1_25G_P3C1	25.82702104	0.750353457	2	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2396	5329	0.002439482	0.003565397	0	2	EN-L4	NA	NA	NA
TATCTCATCCGCGGTA-1_25G_P3C1	14.53383878	30.78235365	1	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	757	1131	0.000884173	0.00530504	0	oligos	OL-Cntl	NA	NA	NA
TATGCCCAGGCTATCT-1_25G_P3C1	-4.238260709	-21.64810735	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3660	9576	0.005952381	0.003132832	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TATGCCCCAAACCCAT-1_25G_P3C1	-4.83802775	-22.73752248	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3675	10731	0.000186376	0.004938962	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TATGCCCCAGACAAGC-1_25G_P3C1	-2.800831582	-12.93795689	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2070	4446	0.003148898	0.007197481	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TATGCCCCAGCCAGAA-1_25G_P3C1	-5.043430462	-21.08517171	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3171	8607	0.00592541	0.002788428	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TATTACCAGTTACGGG-1_25G_P3C1	27.93747455	0.73691347	2	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2657	6092	0.002298096	0.003611293	0	2	EN-L4	NA	NA	NA
TATTACCCAGGCAGTA-1_25G_P3C1	-8.622946708	2.582471874	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2629	6181	0.001294289	0.003235722	0	13A	IN-VIP	NA	NA	NA
TATTACCCATACCATG-1_25G_P3C1	-3.141023565	-26.00847331	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3844	11177	0.000626286	0.003399839	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TATTACCGTAAGAGAG-1_25G_P3C1	-3.144006782	-13.79623805	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2230	4862	0.00308515	0.005347594	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TATTACCGTCTCGTTC-1_25G_P3C1	-3.915398108	-14.77473409	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2349	5032	0.000794913	0.006756757	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TCAACGAAGACAATAC-1_25G_P3C1	-2.661058013	-15.2342126	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2560	5872	0.001021798	0.004768392	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TCAACGAAGGACAGAA-1_25G_P3C1	0.465353778	-8.212693972	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1603	2680	0.000746269	0.004477612	0	12	EN-MIX	NA	NA	NA
TCAACGAAGTAGCCGA-1_25G_P3C1	-5.232452263	-3.131798813	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1505	2628	0.019025875	0.00456621	0	13A	IN-VIP	NA	NA	NA
TCAACGACAGGCTCAC-1_25G_P3C1	-5.257330543	-21.67979997	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3016	8060	0.002853598	0.004466501	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TCAACGACAGGTCGTC-1_25G_P3C1	19.42389495	-28.40577404	3	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4034	11593	0.001552661	0.019494523	0	3	EN-L5-6	NA	NA	NA
TCAACGAGTCAATACC-1_25G_P3C1	4.52957711	-30.37421387	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3596	9496	0.001579612	0.002632687	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TCAATCTAGTAGGCCA-1_25G_P3C1	18.69530748	9.141447485	1	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1548	2834	0.002822865	0.004587156	0	oligos	OL-Cntl	NA	NA	NA
TCAATCTCACTGTTAG-1_25G_P3C1	-5.417937347	-22.83642686	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3283	8677	0.000691483	0.002535439	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TCAATCTTCCATGCTC-1_25G_P3C1	-38.10926657	2.43329389	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1756	3393	0.000884173	0.008252284	0	9	OPC	NA	NA	NA
TCACAAGCAAGCCCAC-1_25G_P3C1	1.017400395	-7.62217726	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1424	2346	0.000852515	0.00341006	0	12	EN-MIX	NA	NA	NA
TCACAAGCAGGAACGT-1_25G_P3C1	-2.790042102	-23.10538343	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4017	10872	0.00303532	0.004231052	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TCACAAGTCCTGCAGG-1_25G_P3C1	-0.697052668	-29.68773028	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4909	18262	0.002683167	0.002135582	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TCACGAAAGTATCGAA-1_25G_P3C1	3.717757397	30.54816084	1	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	787	1145	0.011353712	0.012227074	0	oligos	OL-Cntl	NA	NA	NA
TCACGAACATCATCCC-1_25G_P3C1	-10.88899247	1.602037615	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2858	7100	0.002112676	0.002112676	0	13A	IN-VIP	NA	NA	NA
TCACGAAGTGTCTGAT-1_25G_P3C1	-4.313640142	-15.8002423	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2715	5749	0.003130979	0.005914072	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TCACGAATCCGATATG-1_25G_P3C1	-38.21543212	-8.621490879	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	944	1594	0.003764115	0.004391468	0	9	OPC	NA	NA	NA
TCACGAATCCTCCTAG-1_25G_P3C1	-17.33775113	-23.71230749	6A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2050	4734	0.009928179	0.001267427	0	6A	IN-PV	NA	NA	NA
TCAGATGAGTAGGCCA-1_25G_P3C1	-0.57131973	-29.57534942	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4649	15187	0.000263383	0.004411668	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TCAGATGGTCGCTTCT-1_25G_P3C1	9.517287591	32.20249618	1	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	755	1081	0.003700278	0.005550416	0	oligos	OL-Cntl	NA	NA	NA
TCAGATGGTTCGTTGA-1_25G_P3C1	-3.643163473	-14.95953993	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2421	4967	0.009462452	0.00483189	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TCAGATGTCGTCTGCT-1_25G_P3C1	-19.57868915	-18.0716431	6B	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3214	8094	0.001235483	0.003459353	0	6B	IN-SST	NA	NA	NA
TCAGATGTCGTTTGCC-1_25G_P3C1	-29.42605789	14.13421351	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	865	1359	0.012509198	0.002943341	0	8	Astrocytes	NA	NA	NA
TCAGCAACACCGAATT-1_25G_P3C1	-2.387809928	-23.95121539	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	5669	21434	0.002939255	0.006624988	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TCAGCAACATATACCG-1_25G_P3C1	-9.56309604	2.74808407	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3217	8362	0.001913418	0.003707247	0	13A	IN-VIP	NA	NA	NA
TCAGCAAGTGTCCTCT-1_25G_P3C1	-2.661660964	-12.20222256	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2183	4147	0.009645527	0.010127803	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TCAGCAATCAGTACGT-1_25G_P3C1	-4.226578501	-20.17285162	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3287	8038	0.00398109	0.007091316	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TCAGCTCAGCGTGAAC-1_25G_P3C1	38.1129881	9.137984215	14	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	770	1019	0.001962709	0.008832188	0	14	Microglia	NA	NA	NA
TCAGCTCAGGTGTTAA-1_25G_P3C1	-0.316087293	-8.428871133	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1464	2410	0.006224066	0.011618257	0	12	EN-MIX	NA	NA	NA
TCAGCTCCATAGTAAG-1_25G_P3C1	19.25979422	-26.14684054	3	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2921	6807	0.001469076	0.014396944	0	3	EN-L5-6	NA	NA	NA
TCAGCTCGTCCCTTGT-1_25G_P3C1	-19.71283523	-28.47368691	6A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3415	9490	0.009167545	0.003582719	0	6A	IN-PV	NA	NA	NA
TCAGCTCTCAACACAC-1_25G_P3C1	-28.89993779	17.04698906	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	916	1598	0.000625782	0.003128911	0	8	Astrocytes	NA	NA	NA
TCAGGATAGCGCTTAT-1_25G_P3C1	-2.186557002	-25.59738395	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4020	10908	0.002658599	0.00440044	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TCAGGATAGTCCCACG-1_25G_P3C1	-0.016718125	-7.882583958	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1423	2554	0.000391543	0.007439311	0	12	EN-MIX	NA	NA	NA
TCAGGATCATTGGCGC-1_25G_P3C1	-24.30102274	26.39619313	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1510	2774	0.003965393	0.001802451	0	8	Astrocytes	NA	NA	NA
TCAGGATTCCTCATTA-1_25G_P3C1	-4.321109943	-20.02830648	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3412	9057	0.006293475	0.004968533	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TCAGGATTCGTATCAG-1_25G_P3C1	-7.387317744	0.920915024	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2042	3945	0.002027883	0.004309252	0	13A	IN-VIP	NA	NA	NA
TCAGGTAAGACAGAGA-1_25G_P3C1	-3.654981627	-13.38619035	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2274	4419	0.010862186	0.008372935	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TCAGGTAGTGATGTGG-1_25G_P3C1	-0.812902841	-10.50058041	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1798	3434	0.003785673	0.006697729	0	12	EN-MIX	NA	NA	NA
TCAGGTATCCAGTAGT-1_25G_P3C1	5.900443467	-30.97881198	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4074	11681	0.003081928	0.005907029	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TCATTACAGCGATGAC-1_25G_P3C1	-3.262646911	-12.73586819	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2128	4125	0.005818182	0.011151515	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TCATTACAGTTTCCTT-1_25G_P3C1	0.393281787	-6.919149175	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1237	2308	0.000433276	0.00389948	0	12	EN-MIX	NA	NA	NA
TCATTACCATAACCTG-1_25G_P3C1	-2.710511266	-15.93940612	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3037	8879	0.000225251	0.004505012	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TCATTACCATACTACG-1_25G_P3C1	-3.796055766	-14.94315079	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2473	5894	0.001187648	0.00458093	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TCATTACGTAGCTGCC-1_25G_P3C1	-4.153433001	-17.53356828	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2948	6780	0.009882006	0.008112094	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TCATTACGTCTTCTCG-1_25G_P3C1	-18.3544976	-27.69951448	6A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2713	7549	0	0.002251954	0	6A	IN-PV	NA	NA	NA
TCATTACTCACGACTA-1_25G_P3C1	-0.943887668	-29.0949744	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4955	17238	0.000928182	0.006265228	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TCATTACTCAGAGCTT-1_25G_P3C1	-1.207323831	-9.580437531	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1758	3133	0.003511012	0.007979572	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TCATTACTCCGTAGGC-1_25G_P3C1	-3.358331684	-25.57093388	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4209	12832	0.000389651	0.004052369	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TCATTTGAGTCCGGTC-1_25G_P3C1	-3.202902962	-13.89068263	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2216	4741	0.005062223	0.007171483	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TCATTTGCAGTGAGTG-1_25G_P3C1	-26.39617628	27.45528269	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1554	2899	0.010003449	0.003794412	0	8	Astrocytes	NA	NA	NA
TCATTTGCATCCGGGT-1_25G_P3C1	-5.528224457	-3.390925175	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1350	2319	0.008193187	0.006468305	0	13A	IN-VIP	NA	NA	NA
TCATTTGTCTAGAGTC-1_25G_P3C1	-29.7121291	14.95192869	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	780	1311	0.001525553	0.006102212	0	8	Astrocytes	NA	NA	NA
TCATTTGTCTCCAACC-1_25G_P3C1	-9.529488906	2.260305233	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2851	6642	0.007979524	0.003763927	0	13A	IN-VIP	NA	NA	NA
TCCACACAGGCTCTTA-1_25G_P3C1	11.28671363	28.04521564	1	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	858	1348	0.002225519	0.00148368	0	oligos	OL-Cntl	NA	NA	NA
TCCACACCATCACCCT-1_25G_P3C1	-1.438350007	-27.64837444	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	5949	24998	0.001240099	0.003200256	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TCCACACGTCTGCCAG-1_25G_P3C1	-4.615616085	-20.19252122	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3129	7969	0.003262643	0.007529176	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TCCACACGTTCGTTGA-1_25G_P3C1	-28.279618	17.62141922	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1043	1770	0.001694915	0.004519774	0	8	Astrocytes	NA	NA	NA
TCCCGATCAAGTCTGT-1_25G_P3C1	36.11561538	12.19503212	14	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	817	1097	0.000911577	0.031905196	0	14	Microglia	NA	NA	NA
TCCCGATCAGATAATG-1_25G_P3C1	13.98528127	-33.21429893	3	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3754	11372	0.000175871	0.003693282	0	3	EN-L5-6	NA	NA	NA
TCCCGATCAGGTGCCT-1_25G_P3C1	-4.83199156	-9.983997886	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	835	1241	0.020145044	0.002417405	0	13A	IN-VIP	NA	NA	NA
TCCCGATGTAGCGCAA-1_25G_P3C1	4.481056162	29.40066966	1	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	707	1106	0.000904159	0.004520796	0	oligos	OL-Cntl	NA	NA	NA
TCCCGATTCGGCGGTT-1_25G_P3C1	-3.542730013	-15.3465308	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2356	5120	0.000390625	0.004101563	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TCGAGGCGTTCAGACT-1_25G_P3C1	-2.6743422	-18.83452144	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2830	6238	0.001282462	0.002725232	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TCGAGGCTCAAACGGG-1_25G_P3C1	-4.859273484	-17.57452153	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2874	6497	0.004155764	0.006926274	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TCGAGGCTCAATACCG-1_25G_P3C1	-15.26954259	-24.52313524	6A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1858	3995	0.00350438	0.003254068	0	6A	IN-PV	NA	NA	NA
TCGCGAGAGAAACCAT-1_25G_P3C1	-4.243731115	-14.06602478	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2459	4979	0.001807592	0.014661579	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TCGCGAGAGGATATAC-1_25G_P3C1	4.763630119	32.12762158	1	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	769	1153	0.004336513	0.006938422	0	oligos	OL-Cntl	NA	NA	NA
TCGCGAGCAAGAGGCT-1_25G_P3C1	-11.50672308	-9.810301382	13B	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1511	2405	0.002494802	0.006237006	0	13B	IN-SV2C	NA	NA	NA
TCGCGAGCAGGGAGAG-1_25G_P3C1	25.73834399	0.585522344	2	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2274	4410	0	0.003628118	0	2	EN-L4	NA	NA	NA
TCGCGAGTCACTTCAT-1_25G_P3C1	-24.32910988	29.92674775	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1762	3448	0.002320186	0.002320186	0	8	Astrocytes	NA	NA	NA
TCGCGAGTCTTGTTTG-1_25G_P3C1	24.29747096	0.81105243	2	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2181	4151	0.006022645	0.004336305	0	2	EN-L4	NA	NA	NA
TCGCGTTAGAATCTCC-1_25G_P3C1	-4.548114514	-23.31901962	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3643	10093	9.91E-05	0.006539186	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TCGCGTTCACGTGAGA-1_25G_P3C1	-3.078361861	-13.22858437	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2100	4116	0.003887269	0.003887269	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TCGCGTTGTAAGCACG-1_25G_P3C1	-1.552890624	-25.62258362	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	5571	19114	0.00156953	0.002354295	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TCGCGTTGTATCAGTC-1_25G_P3C1	-12.90195825	-17.72230118	6B	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1233	2080	0.011057692	0.005288462	0	6B	IN-SST	NA	NA	NA
TCGCGTTGTGCGAAAC-1_25G_P3C1	-4.226112963	-17.88873135	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2736	5916	0.006592292	0.006254226	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TCGCGTTTCTCGTATT-1_25G_P3C1	28.43106294	0.211922763	2	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3181	8238	0.001213887	0.002913328	0	2	EN-L4	NA	NA	NA
TCGGGACCAAGCCCAC-1_25G_P3C1	-12.35219078	-11.02583798	13B	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1398	2450	0.00122449	0.00244898	0	13B	IN-SV2C	NA	NA	NA
TCGGGACCATCACGTA-1_25G_P3C1	-25.62214542	27.80055039	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1614	3024	0.001653439	0.00297619	0	8	Astrocytes	NA	NA	NA
TCGGGACCATCTCGCT-1_25G_P3C1	-39.48572418	-0.715914508	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1448	2746	0	0.002184996	0	9	OPC	NA	NA	NA
TCGGGACGTTGCGCAC-1_25G_P3C1	-0.426353215	-9.115992194	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1678	2820	0.006737589	0.005673759	0	12	EN-MIX	NA	NA	NA
TCGGTAAAGAAACGAG-1_25G_P3C1	-5.003183803	-20.1451293	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3159	7562	0.001454642	0.006083047	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TCGGTAAAGGGTTTCT-1_25G_P3C1	-2.383891278	-14.78143622	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2359	5351	0.002242571	0.003737619	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TCGGTAAAGTAATCCC-1_25G_P3C1	-4.895939183	-21.4776579	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3146	7716	0.002592017	0.002592017	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TCGGTAAGTCAGATAA-1_25G_P3C1	-9.33338833	-18.93354611	6B	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	833	1345	0.026765799	0.005204461	0	6B	IN-SST	NA	NA	NA
TCGGTAAGTTAAGTAG-1_25G_P3C1	-2.704768083	-14.6897371	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2309	4639	0.001077818	0.004742401	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TCGGTAATCCAAAGTC-1_25G_P3C1	-4.231977298	-15.35332976	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2609	5621	0.002846469	0.006048746	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TCGGTAATCGCCTGTT-1_25G_P3C1	-3.585302113	-24.40872018	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4447	13952	0.000430046	0.005447248	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TCGTACCAGAATTCCC-1_25G_P3C1	-4.240264238	-15.14934773	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2583	5831	0.000171497	0.00908935	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TCGTACCCAATAACGA-1_25G_P3C1	-1.515089179	-12.66252146	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2069	3874	0.008260196	0.006711409	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TCGTACCCATCTCGCT-1_25G_P3C1	4.334425323	-29.92284568	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3150	7457	0.00120692	0.00308435	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TCGTACCGTCGAGTTT-1_25G_P3C1	-38.04180985	-2.153828152	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1318	2365	0.006765328	0.002114165	0	9	OPC	NA	NA	NA
TCGTACCGTTACCGAT-1_25G_P3C1	-26.61383031	27.38190092	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1433	2771	0.001443522	0.004330567	0	8	Astrocytes	NA	NA	NA
TCGTACCTCAGCTCGG-1_25G_P3C1	-7.366368903	-2.099086593	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1765	3260	0.007361963	0.005214724	0	13A	IN-VIP	NA	NA	NA
TCGTACCTCAGTTTGG-1_25G_P3C1	-28.08749286	22.64112078	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1129	1924	0.000519751	0.007796258	0	8	Astrocytes	NA	NA	NA
TCGTAGACAGCCTATA-1_25G_P3C1	-29.67066959	13.03804067	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	728	1185	0.016033755	0.001687764	0	8	Astrocytes	NA	NA	NA
TCGTAGAGTTGGAGGT-1_25G_P3C1	-5.507445393	-1.614728206	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1467	2687	0.012653517	0.00334946	0	13A	IN-VIP	NA	NA	NA
TCGTAGATCTTCCTTC-1_25G_P3C1	8.884413645	-8.941931022	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2365	5562	0.000719166	0.003416037	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TCTATTGGTCTCGTTC-1_25G_P3C1	0.458956544	-6.651454225	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1199	2043	0.005384239	0.004405286	0	12	EN-MIX	NA	NA	NA
TCTCATAAGTGCCATT-1_25G_P3C1	-8.932882398	1.319442223	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2406	5186	0.005399152	0.003278056	0	13A	IN-VIP	NA	NA	NA
TCTCATACACCCATTC-1_25G_P3C1	-13.89828935	-11.10669891	13B	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2063	4301	0.000232504	0.002557545	0	13B	IN-SV2C	NA	NA	NA
TCTCATACATCCCACT-1_25G_P3C1	-5.611370499	-22.97727639	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3066	8379	0	0.001909536	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TCTCTAAAGTCACGCC-1_25G_P3C1	-37.8130805	-9.459931116	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	909	1492	0.006702413	0.001340483	0	9	OPC	NA	NA	NA
TCTCTAAAGTGGTAGC-1_25G_P3C1	-4.922468088	-16.35102006	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2882	7030	0.000853485	0.006543385	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TCTCTAACAGGACCCT-1_25G_P3C1	7.946078129	31.69341299	1	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	743	1196	0.005016722	0.002508361	0	oligos	OL-Cntl	NA	NA	NA
TCTGAGAAGACTAAGT-1_25G_P3C1	-14.8275704	-25.35921345	6A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1574	3012	0.003320053	0.001992032	0	6A	IN-PV	NA	NA	NA
TCTGAGAAGGATGGTC-1_25G_P3C1	-9.593264871	-17.56053441	6B	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	890	1353	0.015521064	0.005173688	0	6B	IN-SST	NA	NA	NA
TCTGAGAAGTCAAGGC-1_25G_P3C1	-24.86232849	25.95960107	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1502	2652	0.001508296	0.007541478	0	8	Astrocytes	NA	NA	NA
TCTGAGACAGACGCCT-1_25G_P3C1	-37.73343341	-0.986006466	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1421	2440	0.006557377	0.001229508	0	9	OPC	NA	NA	NA
TCTGAGAGTCCAGTTA-1_25G_P3C1	6.321242592	-33.24922578	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4450	12792	0.000703565	0.00343965	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TCTGAGAGTCCGTGAC-1_25G_P3C1	-2.741435432	-14.80014858	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2326	5025	0.00318408	0.004776119	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TCTGAGAGTTAGAACA-1_25G_P3C1	-6.869441304	-32.901465	16	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	806	1148	0.082752613	0.006097561	0	16	EN-PYR	NA	NA	NA
TCTGAGATCCGAATGT-1_25G_P3C1	-5.877077553	-1.777848452	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1671	3258	0.01043585	0.005831799	0	13A	IN-VIP	NA	NA	NA
TCTGAGATCCTACAGA-1_25G_P3C1	-3.803832244	-7.801480334	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	739	1070	0.017757009	0.003738318	0	13A	IN-VIP	NA	NA	NA
TCTGAGATCTAACTTC-1_25G_P3C1	-26.30364032	27.16683086	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1428	2772	0.00036075	0.005411255	0	8	Astrocytes	NA	NA	NA
TCTGGAACATGCTAGT-1_25G_P3C1	-4.749917895	-23.42930327	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3344	8783	0.001821701	0.004212684	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TCTGGAATCATGGTCA-1_25G_P3C1	-28.10416272	23.6226243	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1069	1819	0.008246289	0.004398021	0	8	Astrocytes	NA	NA	NA
TCTTCGGAGAGTTGGC-1_25G_P3C1	-28.78133422	22.81682661	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1108	2004	0.00748503	0.005988024	0	8	Astrocytes	NA	NA	NA
TCTTCGGAGTCGCCGT-1_25G_P3C1	14.63624512	-31.67996686	2	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3426	8981	0.002449616	0.004342501	0	2	EN-L4	NA	NA	NA
TCTTCGGGTCTTCTCG-1_25G_P3C1	25.56204022	1.121856483	2	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2370	5094	0.002748331	0.006085591	0	2	EN-L4	NA	NA	NA
TCTTCGGGTTCACCTC-1_25G_P3C1	13.26566666	-33.31457917	3	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3925	12155	0.000164541	0.002961744	0	3	EN-L5-6	NA	NA	NA
TCTTCGGGTTTGTTTC-1_25G_P3C1	-3.005909915	-13.72096394	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2145	4673	0.005563878	0.004493901	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TCTTCGGTCCGCAAGC-1_25G_P3C1	-3.563595227	-21.66606499	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3718	10433	0.005750982	0.003738139	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TCTTTCCAGTGGGCTA-1_25G_P3C1	-26.89677743	26.49288165	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1435	2709	0.003691399	0.00036914	0	8	Astrocytes	NA	NA	NA
TCTTTCCGTGAGGCTA-1_25G_P3C1	-3.327443536	-14.30200574	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2304	4945	0.004044489	0.005055612	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TCTTTCCTCGCGGATC-1_25G_P3C1	-35.89813654	-11.86019668	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	820	1304	0.001533742	0.002300613	0	9	OPC	NA	NA	NA
TCTTTCCTCTATCCTA-1_25G_P3C1	-4.738322071	-23.80752854	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3214	8410	0	0.007134364	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TCTTTCCTCTCTGTCG-1_25G_P3C1	23.22288451	1.410339516	2	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1707	3308	0	0.002720677	0	2	EN-L4	NA	NA	NA
TGAAAGAAGCGCCTCA-1_25G_P3C1	-25.63784708	25.56946373	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1505	2846	0.008432888	0.003865074	0	8	Astrocytes	NA	NA	NA
TGAAAGACAGAAGCAC-1_25G_P3C1	-31.39231845	11.97127791	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	730	1172	0.003412969	0.003412969	0	8	Astrocytes	NA	NA	NA
TGAAAGAGTACCGTAT-1_25G_P3C1	-1.245237554	-9.615685391	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1737	3199	0.001250391	0.009377931	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TGAAAGATCGTAGGAG-1_25G_P3C1	-14.15338041	-10.31171448	13B	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2143	4096	0.006347656	0.001953125	0	13B	IN-SV2C	NA	NA	NA
TGACAACAGGACGAAA-1_25G_P3C1	-37.42805662	-8.821686969	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1005	1635	0.005504587	0.001223242	0	9	OPC	NA	NA	NA
TGACAACAGGATATAC-1_25G_P3C1	-2.410220779	-12.10129926	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2065	3857	0.000518538	0.009333679	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TGACAACAGTCCGTAT-1_25G_P3C1	-2.552685687	-27.06313638	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4290	13689	0.000219154	0.003725619	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TGACAACCAGGCAGTA-1_25G_P3C1	-39.75096424	0.013057462	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1506	3028	0.004623514	0.00330251	0	9	OPC	NA	NA	NA
TGACAACGTAGAAGGA-1_25G_P3C1	-3.156552392	-6.627400895	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	885	1378	0.002177068	0.000725689	0	13A	IN-VIP	NA	NA	NA
TGACAACGTCAGAATA-1_25G_P3C1	39.1321678	9.2680778	14	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	863	1134	0.002645503	0.00617284	0	14	Microglia	NA	NA	NA
TGACAACGTCCCGACA-1_25G_P3C1	-0.665685751	-28.56223758	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	5875	21775	0.001331803	0.003903559	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TGACAACTCTCAAGTG-1_25G_P3C1	13.14040226	-33.92185352	3	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	6426	27926	0.002076918	0.003580892	0	3	EN-L5-6	NA	NA	NA
TGACGGCCATCCGTGG-1_25G_P3C1	-1.29246	-15.32294655	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2253	4630	0.003671706	0.004103672	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TGACGGCTCAGGCAAG-1_25G_P3C1	-4.108709506	-20.29501609	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3887	10570	0.003878903	0.005392621	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TGACGGCTCGAACTGT-1_25G_P3C1	27.98702185	0.594196728	2	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2648	5948	0.002353732	0.003530599	0	2	EN-L4	NA	NA	NA
TGACGGCTCTCTTATG-1_25G_P3C1	-26.19991791	9.715848197	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	785	1189	0.000841043	0.004205214	0	8	Astrocytes	NA	NA	NA
TGACTAGAGCCAGTAG-1_25G_P3C1	-27.44272219	19.06304556	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1277	2168	0.000922509	0.002306273	0	8	Astrocytes	NA	NA	NA
TGACTAGAGGACTGGT-1_25G_P3C1	-0.094452884	-9.856179061	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1609	3162	0.006641366	0.003162555	0	12	EN-MIX	NA	NA	NA
TGACTAGAGTGTACGG-1_25G_P3C1	-2.155130124	-28.91965352	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2625	5914	0.000338181	0.003043625	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TGACTAGGTAGGAGTC-1_25G_P3C1	-12.57088923	-0.805457801	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2396	4457	0.010993942	0.008525914	0	13A	IN-VIP	NA	NA	NA
TGACTAGGTTGCCTCT-1_25G_P3C1	8.12893193	30.1337103	1	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	649	1005	0	0	0	oligos	OL-Cntl	NA	NA	NA
TGACTAGTCTATCCTA-1_25G_P3C1	-1.545552698	-27.6010889	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	5610	22819	0.00070117	0.00210351	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TGACTTTGTATGCTTG-1_25G_P3C1	-19.32227489	-28.53041546	6A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4086	13159	0.00083593	0.00273577	0	6A	IN-PV	NA	NA	NA
TGACTTTGTCGCATCG-1_25G_P3C1	-2.219024283	-23.72603178	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4113	11253	0.003821203	0.007375811	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TGAGAGGAGGTAAACT-1_25G_P3C1	-28.56283648	16.89341266	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	968	1516	0.007255937	0.001978892	0	8	Astrocytes	NA	NA	NA
TGAGAGGCACAACTGT-1_25G_P3C1	-3.288856877	-5.723364658	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1049	1692	0.006501182	0.002364066	0	13A	IN-VIP	NA	NA	NA
TGAGAGGCATCCCATC-1_25G_P3C1	25.70371123	-4.843284126	2	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4725	14905	0.000201275	0.003153304	0	2	EN-L4	NA	NA	NA
TGAGAGGGTCGCTTTC-1_25G_P3C1	-38.41983991	-7.362910487	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1128	1971	0	0.002536783	0	9	OPC	NA	NA	NA
TGAGAGGTCCTTTCGG-1_25G_P3C1	-15.08542686	-25.59212272	6A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1599	3376	0.001481043	0.001777251	0	6A	IN-PV	NA	NA	NA
TGAGCATAGCTAACTC-1_25G_P3C1	11.96398501	3.210235328	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	886	1370	0.001459854	0.005109489	0	12	EN-MIX	NA	NA	NA
TGAGCATTCCAAGTAC-1_25G_P3C1	-7.807520798	-0.731138535	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2116	4034	0.003470501	0.006941001	0	13A	IN-VIP	NA	NA	NA
TGAGCATTCGAATGCT-1_25G_P3C1	-27.9608464	18.64629743	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1158	2160	0	0.004166667	0	8	Astrocytes	NA	NA	NA
TGAGCCGAGAGCCTAG-1_25G_P3C1	-26.70727138	18.90767988	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1237	2059	0.003885381	0.003885381	0	8	Astrocytes	NA	NA	NA
TGAGCCGCACCACGTG-1_25G_P3C1	-2.188273685	-12.7215639	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2004	4262	0.003050211	0.003519474	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TGAGCCGGTCGAAAGC-1_25G_P3C1	24.45262481	0.085801492	2	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2305	4623	0.000648929	0.002812027	0	2	EN-L4	NA	NA	NA
TGAGCCGGTCTCCCTA-1_25G_P3C1	-38.73719387	-1.119354402	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1442	2758	0.002175489	0.002175489	0	9	OPC	NA	NA	NA
TGAGGGAAGGGATACC-1_25G_P3C1	1.519786954	-5.20361171	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	919	1531	0.008491182	0.004572175	0	12	EN-MIX	NA	NA	NA
TGAGGGAAGTTTCCTT-1_25G_P3C1	-2.463321476	-24.72493325	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4593	15291	0.000523184	0.004250867	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TGAGGGAGTCTAGTGT-1_25G_P3C1	-8.921544646	0.21881978	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2202	4299	0.007908816	0.004419632	0	13A	IN-VIP	NA	NA	NA
TGAGGGAGTGGCTCCA-1_25G_P3C1	39.41453738	9.556447824	14	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	792	1101	0.00181653	0.007266122	0	14	Microglia	NA	NA	NA
TGATTTCAGAAACCTA-1_25G_P3C1	-16.68042543	-23.21967379	6A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1847	3879	0.00644496	0.001031194	0	6A	IN-PV	NA	NA	NA
TGATTTCAGACACTAA-1_25G_P3C1	4.769764049	-31.80645985	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4017	13039	0.001227088	0.00230079	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TGATTTCGTCCCTACT-1_25G_P3C1	-0.091662737	-8.270491832	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1563	2717	0.00736106	0.009201325	0	12	EN-MIX	NA	NA	NA
TGATTTCTCGTGGTCG-1_25G_P3C1	-4.910777547	-10.29780775	13B	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	752	1132	0	0.002650177	0	13B	IN-SV2C	NA	NA	NA
TGCACCTAGAAACGAG-1_25G_P3C1	25.23352796	-4.272576961	2	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3916	11493	0.005307579	0.002436266	0	2	EN-L4	NA	NA	NA
TGCACCTAGTATCTCG-1_25G_P3C1	9.563895909	28.91483783	1	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	911	1371	0.00948213	0.005105762	0	oligos	OL-Cntl	NA	NA	NA
TGCACCTCAGCTGTAT-1_25G_P3C1	-9.988114817	-0.358659302	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2407	5179	0.006371886	0.004441012	0	13A	IN-VIP	NA	NA	NA
TGCACCTCAGTTTACG-1_25G_P3C1	13.74120008	31.08265515	1	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	798	1230	0.001626016	0.001626016	0	oligos	OL-Cntl	NA	NA	NA
TGCACCTGTACCGTTA-1_25G_P3C1	-0.464138835	-8.753159938	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1631	3067	0.000978155	0.006847082	0	12	EN-MIX	NA	NA	NA
TGCACCTGTCCGAATT-1_25G_P3C1	-4.935061306	-2.239873149	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1474	2695	0.003710575	0.002597403	0	13A	IN-VIP	NA	NA	NA
TGCACCTGTGTTCTTT-1_25G_P3C1	-3.355232106	-4.441123727	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1209	2192	0.002737226	0.002281022	0	13A	IN-VIP	NA	NA	NA
TGCACCTTCAGGTTCA-1_25G_P3C1	-0.22151507	-8.450487578	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1532	2557	0.005084083	0.006257333	0	12	EN-MIX	NA	NA	NA
TGCACCTTCCCTAATT-1_25G_P3C1	27.35937039	-1.429097937	2	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3926	11317	0.002209066	0.006627198	0	2	EN-L4	NA	NA	NA
TGCACCTTCTGGGCCA-1_25G_P3C1	-27.88705249	18.25272596	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1169	2128	0.001409774	0.004229323	0	8	Astrocytes	NA	NA	NA
TGCCAAAAGCGCTCCA-1_25G_P3C1	-36.25894422	-11.70850258	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	765	1154	0.001733102	0.001733102	0	9	OPC	NA	NA	NA
TGCCAAAAGCGGCTTC-1_25G_P3C1	-15.2217521	-25.80522827	6A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1766	3569	0.003082096	0.003642477	0	6A	IN-PV	NA	NA	NA
TGCCAAAAGCTACCTA-1_25G_P3C1	19.82515778	22.41188455	1	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	974	1426	0	0.002805049	0	oligos	OL-Cntl	NA	NA	NA
TGCCAAACACGAAAGC-1_25G_P3C1	30.19001273	-2.045600072	2	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3994	9862	0.012776313	0.003853174	0	2	EN-L4	NA	NA	NA
TGCCAAACATTGGGCC-1_25G_P3C1	24.77055165	-0.199807764	2	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2510	5755	0.010251955	0.003822763	0	2	EN-L4	NA	NA	NA
TGCCAAAGTACCGAGA-1_25G_P3C1	-6.278902872	-1.626352577	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1742	2859	0.007345226	0.00524659	0	13A	IN-VIP	NA	NA	NA
TGCCAAAGTAGAGCTG-1_25G_P3C1	-17.67918053	-18.97152173	13B	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2244	4676	0.009837468	0.001710864	0	13B	IN-SV2C	NA	NA	NA
TGCCAAAGTCCGAATT-1_25G_P3C1	39.18311833	9.609013187	14	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	855	1143	0.005249344	0.009623797	0	14	Microglia	NA	NA	NA
TGCCAAAGTGTCAATC-1_25G_P3C1	14.47806817	-33.73524461	3	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	5201	17395	0.000344927	0.004484047	0	3	EN-L5-6	NA	NA	NA
TGCCAAATCACAATGC-1_25G_P3C1	-0.934143633	-29.00363233	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	5180	18300	0.000163934	0.006612022	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TGCCAAATCATGTGGT-1_25G_P3C1	-8.483927477	2.463175302	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2341	4791	0.004174494	0.003339595	0	13A	IN-VIP	NA	NA	NA
TGCCAAATCTATCGCC-1_25G_P3C1	-1.828048326	-27.80104334	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4212	13378	0.000373748	0.003139483	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TGCCCATGTATTCGTG-1_25G_P3C1	-28.42708507	23.12597291	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1228	2094	0.00191022	0.005730659	0	8	Astrocytes	NA	NA	NA
TGCCCATGTTAGATGA-1_25G_P3C1	-0.410250297	-27.90928005	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4985	16416	0.000670078	0.003106725	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TGCCCTACAATGAATG-1_25G_P3C1	-12.94248919	-19.59476598	6B	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1264	2277	0.02722881	0.001756697	0	6B	IN-SST	NA	NA	NA
TGCCCTACACCATCCT-1_25G_P3C1	-39.67894471	0.320215574	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1574	3038	0.002633311	0.001316656	0	9	OPC	NA	NA	NA
TGCCCTAGTCTCTCTG-1_25G_P3C1	-1.915271448	-22.30321304	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3992	11233	0.004896288	0.002403632	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TGCCCTAGTGTAATGA-1_25G_P3C1	-11.47197586	-19.06465484	6B	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	997	1692	0.016548463	0.004728132	0	6B	IN-SST	NA	NA	NA
TGCCCTAGTTCAGACT-1_25G_P3C1	-8.688494122	1.616332459	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2378	5278	0.002084123	0.002463054	0	13A	IN-VIP	NA	NA	NA
TGCCCTATCTACCTGC-1_25G_P3C1	-26.47864848	26.17755233	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1486	2905	0.002409639	0.005163511	0	8	Astrocytes	NA	NA	NA
TGCCCTATCTTCTGGC-1_25G_P3C1	28.7081367	-0.358041267	2	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3502	8563	0.003036319	0.006072638	0	2	EN-L4	NA	NA	NA
TGCGCAGAGAGACGAA-1_25G_P3C1	-9.950418074	-0.868936523	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2465	5056	0.011273734	0.006329114	0	13A	IN-VIP	NA	NA	NA
TGCGCAGAGGAATTAC-1_25G_P3C1	-5.92696725	-1.28079287	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1782	3206	0.003431067	0.002807236	0	13A	IN-VIP	NA	NA	NA
TGCGCAGAGGTGTTAA-1_25G_P3C1	-4.326038704	-18.28028169	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3222	7560	0.009391534	0.006084656	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TGCGCAGCAACACCTA-1_25G_P3C1	-4.136065283	-21.7014843	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3852	10974	0.004373975	0.004556224	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TGCGCAGGTGCATCTA-1_25G_P3C1	9.363860134	30.9911564	1	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	813	1331	0.00150263	0.004507889	0	oligos	OL-Cntl	NA	NA	NA
TGCGCAGTCCATGAAC-1_25G_P3C1	-3.068691389	-22.10529299	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3789	10332	0.006387921	0.006194348	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TGCGCAGTCTAACCGA-1_25G_P3C1	19.71655404	-27.88649108	3	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2744	6459	0.009908655	0.009289364	0	3	EN-L5-6	NA	NA	NA
TGCGGGTGTAGCGCAA-1_25G_P3C1	-5.913437248	-0.707120617	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1937	3611	0.014677375	0.001938521	0	13A	IN-VIP	NA	NA	NA
TGCGGGTGTAGTACCT-1_25G_P3C1	-10.2331002	3.256034288	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3793	9244	0.002163566	0.004976201	0	13A	IN-VIP	NA	NA	NA
TGCGGGTTCATCGATG-1_25G_P3C1	-3.383244023	-26.25561544	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3959	12932	0.000154655	0.004098361	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TGCGTGGAGCCTCGTG-1_25G_P3C1	-16.44715269	-10.75049557	13B	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2969	6862	0.004809094	0.003934713	0	13B	IN-SV2C	NA	NA	NA
TGCGTGGCAGCCACCA-1_25G_P3C1	19.73223815	22.16241875	1	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	909	1609	0	0.001864512	0	oligos	OL-Cntl	NA	NA	NA
TGCGTGGCAGCCTTTC-1_25G_P3C1	-0.748251149	-25.85129285	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4128	11184	0.002414163	0.00545422	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TGCGTGGCAGGTCCAC-1_25G_P3C1	26.90966256	-3.970440633	2	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3954	11052	0.000361925	0.003800217	0	2	EN-L4	NA	NA	NA
TGCGTGGCATGAAGTA-1_25G_P3C1	-1.958767531	-12.79799346	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2022	3767	0.000530926	0.004247412	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TGCGTGGTCGGAAACG-1_25G_P3C1	-32.78289466	-13.00400246	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	736	1067	0.000937207	0.004686036	0	9	OPC	NA	NA	NA
TGCGTGGTCGTCTGCT-1_25G_P3C1	23.81965203	-29.51651954	3	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2402	5138	0.002919424	0.006811989	0	3	EN-L5-6	NA	NA	NA
TGCTACCCACTCTGTC-1_25G_P3C1	-38.44448403	-5.632344402	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1167	2043	0.002936858	0.001957905	0	9	OPC	NA	NA	NA
TGCTACCCATGCGCAC-1_25G_P3C1	-4.356072932	-19.29414898	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3096	7068	0.003961517	0.004102999	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TGCTACCGTCGCGGTT-1_25G_P3C1	-4.493769197	-15.30477237	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2458	5127	0.003120733	0.0093622	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TGCTACCGTTGGACCC-1_25G_P3C1	-35.89614371	-8.895044899	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	955	1510	0.003311258	0.003311258	0	9	OPC	NA	NA	NA
TGCTGCTAGACACGAC-1_25G_P3C1	-3.595566597	-15.91924998	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2416	5489	0.002368373	0.003279286	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TGCTGCTAGTCAATAG-1_25G_P3C1	-4.650309038	-21.0368042	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3108	7831	0.004597114	0.002170859	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TGCTGCTAGTGGACGT-1_25G_P3C1	38.78868057	8.975309711	14	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	870	1152	0.019097222	0.004340278	0	14	Microglia	NA	NA	NA
TGCTGCTAGTGTTTGC-1_25G_P3C1	14.47909902	-7.995490428	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1925	3829	0.000783494	0.002872813	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TGCTGCTCAATGCCAT-1_25G_P3C1	-38.93873914	-0.880306615	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1397	2446	0.000408831	0.003679477	0	9	OPC	NA	NA	NA
TGCTGCTCACAGGAGT-1_25G_P3C1	-4.937995216	-17.85836349	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2889	6685	0.000448766	0.009723261	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TGCTGCTCATGAAGTA-1_25G_P3C1	-4.049400153	-18.37212844	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3110	6771	0.006350613	0.009599764	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TGCTGCTGTAGCCTAT-1_25G_P3C1	-39.23845385	-1.0068872	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1377	2501	0.00159936	0.00119952	0	9	OPC	NA	NA	NA
TGCTGCTGTAGGAGTC-1_25G_P3C1	-3.634079895	-23.71443576	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	5416	18723	0.001335256	0.006302409	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TGCTGCTGTCAGCTAT-1_25G_P3C1	-2.86961881	-21.13736259	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3437	8815	0.005218378	0.001928531	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TGCTGCTGTCGAAAGC-1_25G_P3C1	-17.77854139	-23.5618358	6A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2375	5465	0.01116194	0.004391583	0	6A	IN-PV	NA	NA	NA
TGGACGCAGACGCACA-1_25G_P3C1	-29.51371392	22.22878683	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1110	1710	0.003508772	0.005847953	0	8	Astrocytes	NA	NA	NA
TGGACGCAGAGTACCG-1_25G_P3C1	5.355928107	-31.01951704	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4683	14258	0.001753402	0.002805443	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TGGACGCAGATATGCA-1_25G_P3C1	-29.38756109	14.0793811	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	782	1328	0	0.00376506	0	8	Astrocytes	NA	NA	NA
TGGACGCAGATGTGTA-1_25G_P3C1	-10.3056676	12.60596669	11	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	837	1161	0.001722653	0.001722653	0	11	Glia-MIX	NA	NA	NA
TGGACGCAGTTGAGTA-1_25G_P3C1	-30.31100011	14.00188535	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	861	1339	0.001493652	0.005974608	0	8	Astrocytes	NA	NA	NA
TGGCCAGAGAGTAATC-1_25G_P3C1	-28.9706046	22.82016243	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1096	2096	0.000954198	0.001908397	0	8	Astrocytes	NA	NA	NA
TGGCCAGAGGAGCGAG-1_25G_P3C1	-3.683182785	-23.7134249	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4406	13893	0.000287915	0.003958828	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TGGCCAGAGTAAGTAC-1_25G_P3C1	-2.292367798	-12.451518	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2006	3845	0.00390117	0.005981795	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TGGCCAGCATCCGGGT-1_25G_P3C1	-26.72278922	26.63073798	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1428	2676	0.004110613	0.002989537	0	8	Astrocytes	NA	NA	NA
TGGCCAGGTCATATCG-1_25G_P3C1	-37.96828673	-0.43296475	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1613	3182	0.002514142	0.001571339	0	9	OPC	NA	NA	NA
TGGCCAGGTGATGTGG-1_25G_P3C1	-5.150258813	-1.583862401	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1515	2847	0.008781173	0.003863716	0	13A	IN-VIP	NA	NA	NA
TGGCCAGGTGCTGTAT-1_25G_P3C1	27.03472878	0.267892848	2	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2829	6636	0	0.002712477	0	2	EN-L4	NA	NA	NA
TGGCCAGTCAACGCTA-1_25G_P3C1	-8.18041513	-3.094452369	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1927	3861	0.014504015	0.003367003	0	13A	IN-VIP	NA	NA	NA
TGGCGCAAGTGTACGG-1_25G_P3C1	-2.593124427	-16.27070147	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2599	5637	0.001596594	0.003547987	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TGGCGCAAGTTGTCGT-1_25G_P3C1	-26.15596281	25.54062441	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1353	2392	0.006688963	0.002926421	0	8	Astrocytes	NA	NA	NA
TGGCGCAGTATATGAG-1_25G_P3C1	-30.00700103	21.31347859	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	924	1514	0	0.003963012	0	8	Astrocytes	NA	NA	NA
TGGCGCAGTCCGTGAC-1_25G_P3C1	-39.4304627	-0.151051658	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1477	2680	0.004850746	0.001865672	0	9	OPC	NA	NA	NA
TGGCGCAGTCTGGAGA-1_25G_P3C1	-2.235520211	-24.92144063	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4320	12406	0.001128486	0.004272126	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TGGCGCATCCTCGCAT-1_25G_P3C1	0.599824453	-7.816533124	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1411	2491	0.006824568	0.002007226	0	12	EN-MIX	NA	NA	NA
TGGCTGGCACTCGACG-1_25G_P3C1	-32.56036964	-12.68495393	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	720	1031	0.004849661	0.001939864	0	9	OPC	NA	NA	NA
TGGCTGGTCAGCTGGC-1_25G_P3C1	-13.56660155	-11.54544055	13B	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1919	3929	0.001781624	0.001527106	0	13B	IN-SV2C	NA	NA	NA
TGGCTGGTCATTATCC-1_25G_P3C1	8.713481893	27.09558477	1	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	822	1211	0.002477291	0.008257638	0	oligos	OL-Cntl	NA	NA	NA
TGGGAAGAGGATGGTC-1_25G_P3C1	-11.80942604	-10.52246318	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1524	2475	0.003232323	0.002020202	0	13A	IN-VIP	NA	NA	NA
TGGGAAGGTAACGACG-1_25G_P3C1	-4.161456204	-20.97219507	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3488	8987	0.002114165	0.003671971	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TGGGAAGGTAACGTTC-1_25G_P3C1	7.131033217	-33.31631216	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3335	9222	0.002277163	0.002927781	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TGGGAAGGTAGGCTGA-1_25G_P3C1	31.48439103	-1.113342592	2	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2656	5599	0.002321843	0.00428648	0	2	EN-L4	NA	NA	NA
TGGGAAGGTCCGTGAC-1_25G_P3C1	38.29377798	15.27881213	14	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1208	1792	0.004464286	0.013950893	0	14	Microglia	NA	NA	NA
TGGGAAGTCTTACCGC-1_25G_P3C1	2.705455524	-28.91023026	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3966	11476	0.000697107	0.004356919	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TGGGCGTGTTCGTGAT-1_25G_P3C1	-2.373324689	-24.51178667	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4226	12193	0.002050357	0.003280571	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TGGGCGTTCGCGATCG-1_25G_P3C1	-37.25832634	-10.04642065	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	978	1632	0.003676471	0.001838235	0	9	OPC	NA	NA	NA
TGGTTAGAGATGTGTA-1_25G_P3C1	-2.041545803	-23.76955511	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4607	14231	0.003443187	0.004637763	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TGGTTAGAGGCAGTCA-1_25G_P3C1	-5.779393385	-22.54072332	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3037	7800	0.000384615	0.001794872	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TGGTTCCGTGAGTGAC-1_25G_P3C1	5.503404307	-27.31000054	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3168	7298	0.004384763	0.003699644	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TGGTTCCGTGGAAAGA-1_25G_P3C1	19.19668103	22.90728115	1	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	991	1545	0.000647249	0.003883495	0	oligos	OL-Cntl	NA	NA	NA
TGGTTCCGTGTTCGAT-1_25G_P3C1	-9.020966315	2.47162267	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2853	7591	0.00079041	0.001976024	0	13A	IN-VIP	NA	NA	NA
TGGTTCCTCTTCTGGC-1_25G_P3C1	-5.544134851	-20.89149337	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2632	6243	0.000160179	0.006407176	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TGTATTCAGAAACGCC-1_25G_P3C1	-2.643433159	-15.19374337	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2353	4776	0.001884422	0.004187605	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TGTATTCAGGGAACGG-1_25G_P3C1	-2.733341516	-14.4242705	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2275	4834	0.000620604	0.004344228	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TGTATTCCATCCGGGT-1_25G_P3C1	8.862681871	-8.912432531	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2387	5229	0.000191241	0.001529929	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TGTATTCGTAAACGCG-1_25G_P3C1	-24.97407466	-2.313105884	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1108	1796	0.00389755	0.008351893	0	9	OPC	NA	NA	NA
TGTATTCGTCGTGGCT-1_25G_P3C1	-12.22002478	-11.00978489	13B	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1272	2178	0.002295684	0.00137741	0	13B	IN-SV2C	NA	NA	NA
TGTATTCGTGCCTGTG-1_25G_P3C1	6.707989223	-32.11764452	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3446	8601	0.001395187	0.002674108	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TGTATTCTCAATACCG-1_25G_P3C1	-0.822875806	-9.376313412	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1809	3358	0.00565813	0.004169148	0	12	EN-MIX	NA	NA	NA
TGTATTCTCGCGTAGC-1_25G_P3C1	-7.013398829	0.157878138	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1900	3686	0.002441671	0.007867607	0	13A	IN-VIP	NA	NA	NA
TGTCCCAAGTCAAGGC-1_25G_P3C1	2.370515345	-6.680129826	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1220	1953	0.013824885	0.003072197	0	12	EN-MIX	NA	NA	NA
TGTCCCACACCAGATT-1_25G_P3C1	19.0096861	23.1642829	1	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	927	1408	0.002840909	0.004261364	0	oligos	OL-Cntl	NA	NA	NA
TGTCCCATCGTGACAT-1_25G_P3C1	-1.680776789	-24.34880652	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	5084	16745	0.002687369	0.005673335	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TGTCCCATCTAAGCCA-1_25G_P3C1	-38.67085734	-2.379765001	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1326	2307	0.004768097	0.003034244	0	9	OPC	NA	NA	NA
TGTGGTACACTCGACG-1_25G_P3C1	-8.510647406	2.360439552	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2464	5443	0.002020944	0.004409333	0	13A	IN-VIP	NA	NA	NA
TGTGGTAGTCCCTACT-1_25G_P3C1	-9.685087097	0.836202	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2433	4998	0.009403762	0.006002401	0	13A	IN-VIP	NA	NA	NA
TGTGGTATCATGCATG-1_25G_P3C1	12.4842573	27.4640511	1	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	797	1230	0.004065041	0.002439024	0	oligos	OL-Cntl	NA	NA	NA
TGTGGTATCCTCGCAT-1_25G_P3C1	-5.30112014	-20.95843383	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2717	6513	0.000614156	0.003684938	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TGTGTTTGTCAGAGGT-1_25G_P3C1	-5.195376877	-2.28160216	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1583	2836	0.006346968	0.002468265	0	13A	IN-VIP	NA	NA	NA
TGTTCCGAGTCATCCA-1_25G_P3C1	4.358011505	-17.53999213	4	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3063	6653	0.007665715	0.011573726	0	L2-3	EN-L2-3-MS	NA	NA	NA
TGTTCCGCAACACCTA-1_25G_P3C1	-27.78354258	24.51299894	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1301	2345	0.008528785	0.005970149	0	8	Astrocytes	NA	NA	NA
TGTTCCGCATGCCTAA-1_25G_P3C1	-27.98372085	24.30942623	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1209	2020	0.005445545	0.003465347	0	8	Astrocytes	NA	NA	NA
TGTTCCGTCTTACCTA-1_25G_P3C1	-15.64025282	-19.1824421	6B	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1618	3127	0.000639591	0.002558363	0	6B	IN-SST	NA	NA	NA
TTAACTCAGAGCTGCA-1_25G_P3C1	8.994805114	30.99242129	1	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	706	1102	0	0.002722323	0	oligos	OL-Cntl	NA	NA	NA
TTAACTCAGGCATTGG-1_25G_P3C1	18.72354735	1.45464081	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1210	1932	0.010351967	0.002587992	0	12	EN-MIX	NA	NA	NA
TTAACTCCATACTACG-1_25G_P3C1	13.08536342	-33.16495362	3	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3515	10618	0.000282539	0.002731211	0	3	EN-L5-6	NA	NA	NA
TTAACTCGTGCAACTT-1_25G_P3C1	-4.319425546	-20.54901478	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2910	7121	0.010251369	0.002949024	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TTAACTCGTGCGATAG-1_25G_P3C1	-2.591656288	-14.89449771	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2502	6457	0.000619483	0.003716896	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TTAACTCTCGTTTAGG-1_25G_P3C1	-2.392282006	-13.93422441	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1910	3985	0.006273526	0.00250941	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TTAACTCTCTTGTCAT-1_25G_P3C1	-2.589445746	-12.9881621	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2016	4374	0.01303155	0.002057613	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TTAGGACAGGCAGTCA-1_25G_P3C1	-25.91208588	30.10025143	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1730	3207	0.000623636	0.004053633	0	8	Astrocytes	NA	NA	NA
TTAGGACGTCTAGGTT-1_25G_P3C1	-6.967397923	-1.389959968	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2019	3841	0.006769071	0.004165582	0	13A	IN-VIP	NA	NA	NA
TTAGGACGTCTCTCTG-1_25G_P3C1	-0.929647231	-11.0863077	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1738	3429	0.001458151	0.002333042	0	12	EN-MIX	NA	NA	NA
TTAGGCACAATAACGA-1_25G_P3C1	-11.12566228	-21.78788833	6A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	892	1485	0.005387205	0.004713805	0	6A	IN-PV	NA	NA	NA
TTAGGCACAGCTCGCA-1_25G_P3C1	-2.275716259	-12.67070362	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1935	3807	0	0.005516154	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TTAGGCATCGCAAACT-1_25G_P3C1	-4.273099347	-18.30141516	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3046	7422	0.003637833	0.007275667	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TTAGTTCAGGTGCAAC-1_25G_P3C1	-5.125964324	-10.31396813	13B	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	951	1504	0.005319149	0.002659574	0	13B	IN-SV2C	NA	NA	NA
TTAGTTCGTTTAGCTG-1_25G_P3C1	2.140141685	-6.243907026	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1101	1718	0.011059371	0.004074505	0	12	EN-MIX	NA	NA	NA
TTAGTTCTCAAAGACA-1_25G_P3C1	-0.550150146	-29.68334659	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4524	15112	0.001985177	0.003705664	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TTAGTTCTCATCTGTT-1_25G_P3C1	-2.07182457	-11.94371205	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1796	3417	0.002341235	0.006438396	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TTAGTTCTCGGCATCG-1_25G_P3C1	-5.371232762	-21.53087106	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2805	7072	0.001414027	0.004100679	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TTAGTTCTCTGCGACG-1_25G_P3C1	-36.12815145	-12.06907713	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	771	1226	0.000815661	0.004893964	0	9	OPC	NA	NA	NA
TTATGCTAGAGGTTGC-1_25G_P3C1	-11.93046338	-19.40858098	6B	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	993	1678	0.017878427	0.001787843	0	6B	IN-SST	NA	NA	NA
TTATGCTGTCTCATCC-1_25G_P3C1	-17.82284493	-26.55972001	6A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2515	5899	0.023563316	0.002034243	0	6A	IN-PV	NA	NA	NA
TTATGCTTCGGCGGTT-1_25G_P3C1	20.04697861	-6.941133298	3	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2326	5726	0.000174642	0.002270346	0	3	EN-L5-6	NA	NA	NA
TTATGCTTCTGTTTGT-1_25G_P3C1	-0.633034083	-8.959821306	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1757	3514	0.000284576	0.0071144	0	12	EN-MIX	NA	NA	NA
TTCCCAGAGGAGCGTT-1_25G_P3C1	-26.61767192	1.781456922	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1005	1452	0.000688705	0.002066116	0	9	OPC	NA	NA	NA
TTCCCAGAGGAGTTGC-1_25G_P3C1	-29.37819745	13.89915551	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	822	1303	0.004604758	0.001534919	0	8	Astrocytes	NA	NA	NA
TTCCCAGGTTGGACCC-1_25G_P3C1	-36.12452888	-4.699306906	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1177	2002	0.000999001	0.003496503	0	9	OPC	NA	NA	NA
TTCCCAGTCGGCGCAT-1_25G_P3C1	-27.08254554	26.43818094	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1326	2454	0.000407498	0.004889976	0	8	Astrocytes	NA	NA	NA
TTCGAAGAGATGTAAC-1_25G_P3C1	6.973825754	-33.04608837	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3362	8888	0.001125113	0.001237624	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TTCGAAGCATCCAACA-1_25G_P3C1	2.805084758	-31.25201992	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4945	16482	0.001577478	0.004429074	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TTCGAAGGTATCTGCA-1_25G_P3C1	-25.87973975	25.84359361	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1453	2727	0.005133847	0.005133847	0	8	Astrocytes	NA	NA	NA
TTCGAAGTCTGGCGTG-1_25G_P3C1	-28.2930897	24.11901503	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1184	2135	0.001405152	0.007025761	0	8	Astrocytes	NA	NA	NA
TTCGGTCAGCGGCTTC-1_25G_P3C1	-5.475004576	-1.301613319	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1710	3196	0.007196496	0.005006258	0	13A	IN-VIP	NA	NA	NA
TTCGGTCAGTCCAGGA-1_25G_P3C1	-4.372959411	-20.70693357	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3607	9992	0.004803843	0.005304243	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TTCGGTCCAGCATACT-1_25G_P3C1	-3.222549797	-23.23443482	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4189	12697	0.004016697	0.003071592	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TTCGGTCCATATGCTG-1_25G_P3C1	-7.724212729	-0.26492392	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2087	4397	0.006822834	0.00204685	0	13A	IN-VIP	NA	NA	NA
TTCGGTCGTGAGGGAG-1_25G_P3C1	4.878959778	-17.57794551	4	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2834	5927	0.005399021	0.015353467	0	L2-3	EN-L2-3-MS	NA	NA	NA
TTCGGTCTCACCGTAA-1_25G_P3C1	-9.12078528	-1.267432257	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2272	4583	0.013528257	0.003927558	0	13A	IN-VIP	NA	NA	NA
TTCGGTCTCGGTGTTA-1_25G_P3C1	36.20124521	11.61451307	14	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	815	1141	0.001752848	0.041191937	0	14	Microglia	NA	NA	NA
TTCGGTCTCTACTTAC-1_25G_P3C1	-13.70699675	-10.69847656	13B	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1893	3724	0.006176155	0.002148228	0	13B	IN-SV2C	NA	NA	NA
TTCTACAAGACTAGAT-1_25G_P3C1	3.476478528	-28.42045544	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3098	8383	0.007634498	0.002743648	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TTCTACAAGCAACGGT-1_25G_P3C1	-13.48615307	-21.08668179	6A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1173	1906	0.016264428	0.002098636	0	6A	IN-PV	NA	NA	NA
TTCTACAAGCTAGCCC-1_25G_P3C1	-3.946892855	-15.61022655	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2583	5814	0.001547988	0.003611971	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TTCTACACAGACGCTC-1_25G_P3C1	0.157485645	-8.073989009	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1485	2512	0.002388535	0.005971338	0	12	EN-MIX	NA	NA	NA
TTCTACATCACCCTCA-1_25G_P3C1	-39.7084512	0.377667786	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1646	3327	0.000300571	0.002103998	0	9	OPC	NA	NA	NA
TTCTACATCCAAACAC-1_25G_P3C1	-8.933310696	-18.5052927	6B	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	736	1139	0.033362599	0.004389816	0	6B	IN-SST	NA	NA	NA
TTCTCAAAGATATGCA-1_25G_P3C1	2.409371619	-27.62468058	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3202	8119	0.003079197	0.009114423	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TTCTCAAAGTACGTTC-1_25G_P3C1	4.988203327	-27.83270591	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2649	6546	0.001069355	0.002597006	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TTCTCAAGTGTGCCTG-1_25G_P3C1	-0.666995738	-10.25346382	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1707	3108	0.00032175	0.005469755	0	12	EN-MIX	NA	NA	NA
TTCTCAAGTTGTACAC-1_25G_P3C1	-4.753736452	-23.63737497	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3391	9492	0.001790982	0.002949853	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TTCTCAATCCACGACG-1_25G_P3C1	23.24357862	12.25149701	1	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1519	2826	0.002123142	0.002123142	0	oligos	OL-Cntl	NA	NA	NA
TTCTCCTAGCTCCTCT-1_25G_P3C1	-2.186241331	-14.20054565	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2025	4478	0.001339884	0.002679768	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TTCTCCTCACAAGACG-1_25G_P3C1	-28.04075743	17.49311595	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1024	1673	0.002390915	0.004781829	0	8	Astrocytes	NA	NA	NA
TTCTCCTCACGGTGTC-1_25G_P3C1	-10.00517403	-18.78837951	6B	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	885	1520	0.001973684	0.001315789	0	6B	IN-SST	NA	NA	NA
TTCTCCTCAGTTCCCT-1_25G_P3C1	-0.680325904	-29.57859245	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4918	18246	0.00126055	0.005809492	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TTCTTAGTCAAACAAG-1_25G_P3C1	-5.281935668	-1.708179639	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1498	2659	0.010154193	0.006393381	0	13A	IN-VIP	NA	NA	NA
TTGAACGAGGGTCTCC-1_25G_P3C1	-4.619973785	-23.56302343	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4014	12221	0.000409132	0.002454791	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TTGAACGCAACTGCTA-1_25G_P3C1	4.045131059	-16.86587486	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2261	4227	0.000473149	0.017269931	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TTGAACGCACGCGAAA-1_25G_P3C1	3.416387565	-5.219993673	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	998	1452	0.002754821	0.004820937	0	12	EN-MIX	NA	NA	NA
TTGAACGGTATAATGG-1_25G_P3C1	-3.322920509	-23.9114417	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3159	7260	0.003030303	0.00399449	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TTGAACGGTCAATGTC-1_25G_P3C1	-37.80238949	-8.127823288	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	999	1648	0.002427184	0.003033981	0	9	OPC	NA	NA	NA
TTGAACGGTCTACCTC-1_25G_P3C1	-26.86898203	27.06223782	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1514	3216	0.002798507	0.003109453	0	8	Astrocytes	NA	NA	NA
TTGAACGGTCTAGAGG-1_25G_P3C1	1.51704434	-14.73686649	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2290	4540	0.003744493	0.009911894	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TTGAACGTCGTAGGAG-1_25G_P3C1	4.532396269	-5.429530488	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1082	1657	0.0006035	0.002414001	0	12	EN-MIX	NA	NA	NA
TTGAACGTCGTTTAGG-1_25G_P3C1	4.642226959	-1.886735912	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	716	1215	0.002469136	0.005761317	0	12	EN-MIX	NA	NA	NA
TTGACTTAGTGTCCAT-1_25G_P3C1	-36.69444751	-5.464561684	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1094	1790	0.001675978	0.003910615	0	9	OPC	NA	NA	NA
TTGACTTCATATACGC-1_25G_P3C1	-17.44818658	-24.0023029	6A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1932	4395	0.003640501	0.002502844	0	6A	IN-PV	NA	NA	NA
TTGACTTGTTGAACTC-1_25G_P3C1	-9.214527267	-19.49924898	6B	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	696	1075	0.001860465	0.002790698	0	6B	IN-SST	NA	NA	NA
TTGACTTTCCGAGCCA-1_25G_P3C1	-10.33610592	1.03009449	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2828	6995	0.004717655	0.002573267	0	13A	IN-VIP	NA	NA	NA
TTGACTTTCTTAGCCC-1_25G_P3C1	-29.35024572	23.04503685	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1029	1994	0.000501505	0.003009027	0	8	Astrocytes	NA	NA	NA
TTGCCGTAGAGGTTAT-1_25G_P3C1	1.023525333	-8.039547188	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1350	2411	0	0.00953961	0	12	EN-MIX	NA	NA	NA
TTGCCGTAGCAGCGTA-1_25G_P3C1	-37.48580231	-9.859940397	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	963	1595	0.003761755	0	0	9	OPC	NA	NA	NA
TTGCCGTGTAAGTTCC-1_25G_P3C1	-1.319022035	-29.13648092	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3538	9598	0.000833507	0.001667014	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TTGCCGTGTGCACTTA-1_25G_P3C1	-23.04844751	29.73053587	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1906	3960	0.002525253	0.005555556	0	8	Astrocytes	NA	NA	NA
TTGCCGTGTGTTGAGG-1_25G_P3C1	-4.279040845	-14.89571759	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2495	5577	0.002331002	0.01183432	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TTGCCGTGTTCCAACA-1_25G_P3C1	-38.70840034	-5.844982336	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1143	2076	0.003853565	0.002890173	0	9	OPC	NA	NA	NA
TTGCGTCAGATGCCAG-1_25G_P3C1	-37.12064067	-9.312943792	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	998	1653	0.003629764	0.003024803	0	9	OPC	NA	NA	NA
TTGCGTCAGCGGATCA-1_25G_P3C1	23.89500592	-6.717076681	3	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4170	11296	0.000619688	0.002744334	0	3	EN-L5-6	NA	NA	NA
TTGCGTCAGCTAACAA-1_25G_P3C1	-1.414986807	-10.09337814	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1937	3911	0.001278445	0.003835336	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TTGCGTCCAAGCCGCT-1_25G_P3C1	27.2006597	-4.166219197	2	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4125	11856	0.004132928	0.00447031	0	2	EN-L4	NA	NA	NA
TTGCGTCCATGAGCGA-1_25G_P3C1	18.86912955	1.504303349	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1152	1802	0.002219756	0.002774695	0	12	EN-MIX	NA	NA	NA
TTGCGTCCATTAACCG-1_25G_P3C1	-28.53060516	16.22241691	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	948	1483	0.004720162	0.002022927	0	8	Astrocytes	NA	NA	NA
TTGCGTCTCCCACTTG-1_25G_P3C1	-4.270697965	-21.09036124	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3373	8542	0.007609459	0.003980332	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TTGCGTCTCCTCCTAG-1_25G_P3C1	3.30810617	-31.65038377	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	6077	26081	0.000766842	0.002453894	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TTGGAACAGCCTATGT-1_25G_P3C1	18.78046646	23.1010721	1	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	872	1354	0	0.004431315	0	oligos	OL-Cntl	NA	NA	NA
TTGGAACAGGACATTA-1_25G_P3C1	-1.488671784	-26.17730025	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	5176	17951	0.002005459	0.003732383	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TTGGAACAGTCAAGCG-1_25G_P3C1	-2.741019096	-12.34802545	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2028	3740	0.005614973	0.010962567	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TTGGAACAGTGCAAGC-1_25G_P3C1	-11.16168186	0.20290491	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2545	4928	0.007913961	0.007305195	0	13A	IN-VIP	NA	NA	NA
TTGGAACCACTTAACG-1_25G_P3C1	-1.906783007	-26.82550481	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	5146	17752	0.000394322	0.003154574	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TTGGAACCAGGAATGC-1_25G_P3C1	-19.19356744	-27.50398425	6A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3058	7488	0.005208333	0.004407051	0	6A	IN-PV	NA	NA	NA
TTGGAACCATGAAGTA-1_25G_P3C1	25.22636872	-3.94170896	2	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3712	10669	0.000281188	0.002624426	0	2	EN-L4	NA	NA	NA
TTGGAACTCTGCAAGT-1_25G_P3C1	-9.194608238	-1.806036231	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2024	3807	0.002889414	0.007354873	0	13A	IN-VIP	NA	NA	NA
TTGGCAACACCCATGG-1_25G_P3C1	-28.47853346	22.57563784	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1101	1828	0	0.003282276	0	8	Astrocytes	NA	NA	NA
TTGGCAATCTCCAGGG-1_25G_P3C1	-4.388221057	-22.99640605	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3512	9495	0.003264876	0.004634018	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TTGTAGGCAATGACCT-1_25G_P3C1	-24.93320246	26.55572955	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1496	2867	0.00209278	0.004883153	0	8	Astrocytes	NA	NA	NA
TTGTAGGGTAACGTTC-1_25G_P3C1	-2.061882806	-26.34451307	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	4481	14349	0.002439194	0.003972402	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TTGTAGGTCGACGGAA-1_25G_P3C1	-27.85423445	25.28577202	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1313	2368	0.002956081	0.004222973	0	8	Astrocytes	NA	NA	NA
TTGTAGGTCGATAGAA-1_25G_P3C1	-15.39332851	-19.42902475	6B	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1642	3296	0.005764563	0.003337379	0	6B	IN-SST	NA	NA	NA
TTTACTGAGACCACGA-1_25G_P3C1	-2.659183819	-13.43401034	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2022	4280	0.002570093	0.005140187	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TTTACTGGTAGCACGA-1_25G_P3C1	-29.54259544	16.29128538	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	934	1548	0.003229974	0.003229974	0	8	Astrocytes	NA	NA	NA
TTTACTGGTCAGGACA-1_25G_P3C1	-18.10592343	-28.92061371	6A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2574	5974	0.004686977	0.003013057	0	6A	IN-PV	NA	NA	NA
TTTATGCAGAGACTTA-1_25G_P3C1	-0.193564426	-8.389422494	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1574	2881	0.00208261	0.005553627	0	12	EN-MIX	NA	NA	NA
TTTATGCAGCATGGCA-1_25G_P3C1	-36.02661562	-10.91733968	9	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	934	1471	0.004078858	0.00067981	0	9	OPC	NA	NA	NA
TTTATGCCAATCGAAA-1_25G_P3C1	-4.085155488	-14.05098255	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2260	4788	0.001670844	0.008354219	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TTTATGCGTAGCAAAT-1_25G_P3C1	-5.542259854	-1.445401392	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1612	2990	0.001672241	0.003344482	0	13A	IN-VIP	NA	NA	NA
TTTATGCGTATAAACG-1_25G_P3C1	-6.435858867	0.289715592	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1872	3991	0.005762967	0.003006765	0	13A	IN-VIP	NA	NA	NA
TTTATGCTCGTTGCCT-1_25G_P3C1	-12.31953386	-11.0387969	13B	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1500	2956	0.01826793	0.00202977	0	13B	IN-SV2C	NA	NA	NA
TTTCCTCCACCGCTAG-1_25G_P3C1	2.500048109	-3.691967195	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	997	1864	0	0.003755365	0	12	EN-MIX	NA	NA	NA
TTTCCTCCACGACTCG-1_25G_P3C1	-0.095464073	-30.05156096	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	5673	23677	0.000464586	0.003421042	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TTTCCTCCATTAGGCT-1_25G_P3C1	0.466812672	-7.772287464	12	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1399	2493	0.004412355	0.005214601	0	12	EN-MIX	NA	NA	NA
TTTCCTCCATTCTTAC-1_25G_P3C1	19.88272251	-28.50145349	3	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2512	6119	0.000817127	0.005719889	0	3	EN-L5-6	NA	NA	NA
TTTCCTCGTCACCCAG-1_25G_P3C1	-6.76041944	0.640636139	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2099	4753	0.001051967	0.003576688	0	13A	IN-VIP	NA	NA	NA
TTTGCGCAGAGGGATA-1_25G_P3C1	-4.916146261	-20.45176143	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2871	6687	0.003439509	0.004486317	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TTTGCGCAGTCATCCA-1_25G_P3C1	-5.521614652	-0.464179677	13A	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1703	3471	0.000288101	0.001440507	0	13A	IN-VIP	NA	NA	NA
TTTGCGCCAAATTGCC-1_25G_P3C1	25.12365969	-4.96806026	2	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	5621	24735	0.00165757	0.001697999	0	2	EN-L4	NA	NA	NA
TTTGCGCCATGCTGGC-1_25G_P3C1	-28.79807254	22.84555069	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1051	1691	0.00295683	0.005913661	0	8	Astrocytes	NA	NA	NA
TTTGCGCTCTTGCATT-1_25G_P3C1	-4.47936573	-16.85447969	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	2904	6786	0.006189213	0.005599764	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TTTGGTTCACAGACTT-1_25G_P3C1	-5.643017898	-22.37062895	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3020	8043	0.000497327	0.002610966	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TTTGGTTGTCTAGGTT-1_25G_P3C1	-28.95530338	13.76370679	8	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	872	1470	0	0.005442177	0	8	Astrocytes	NA	NA	NA
TTTGGTTTCCGGGTGT-1_25G_P3C1	19.79429228	21.40878682	1	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1014	1635	0.003669725	0.001834862	0	oligos	OL-Cntl	NA	NA	NA
TTTGTCAAGCGTCTAT-1_25G_P3C1	-12.4944278	-10.97713085	13B	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	1417	2537	0.000394166	0.002364998	0	13B	IN-SV2C	NA	NA	NA
TTTGTCATCTTGTCAT-1_25G_P3C1	-4.121019791	-25.11194163	10	25G_P3C1	Control	Control	35	male	parietal	CAP5	SEQ3	6.8	22	3419	9635	0.000207577	0.003113648	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AAACCTGAGTTAACGA-1_2_B4	-0.241691967	0.108661426	11	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1090	1601	0.009369144	0.006246096	0	11	Glia-MIX	NA	NA	NA
AAACCTGTCAGTTGAC-1_2_B4	-24.68126648	17.98587466	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1203	2127	0.011753644	0.004701457	0	8	Astrocytes	NA	NA	NA
AAACCTGTCCGAATGT-1_2_B4	15.92461818	19.42924494	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	943	1524	0	0.003937008	0	oligos	OL-Cntl	NA	NA	NA
AAACGGGAGACAAGCC-1_2_B4	20.96836117	-2.243145352	2	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1825	2763	0.007238509	0.005428882	0	2	EN-L4	NA	NA	NA
AAACGGGAGCGGCTTC-1_2_B4	8.381503035	27.94169065	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	895	1340	0.008955224	0.004477612	0	oligos	OL-Cntl	NA	NA	NA
AAACGGGCAAATTGCC-1_2_B4	-37.82903111	-1.318995885	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1444	2584	0.000773994	0.003869969	0	9	OPC	NA	NA	NA
AAACGGGCACGAGAGT-1_2_B4	-0.246392977	-12.77779054	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1897	3898	0.013083633	0.002565418	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AAACGGGTCAACTCTT-1_2_B4	-28.40723365	21.67396254	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1121	1801	0.003331483	0.001110494	0	8	Astrocytes	NA	NA	NA
AAACGGGTCAGGTTCA-1_2_B4	4.286693174	28.05236939	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	790	1093	0.001829826	0.007319305	0	oligos	OL-Cntl	NA	NA	NA
AAACGGGTCCTCGCAT-1_2_B4	2.878818472	26.421822	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	695	1132	0.003533569	0.013250883	0	oligos	OL-Cntl	NA	NA	NA
AAAGATGAGCGTCTAT-1_2_B4	-2.623007267	1.191068613	11	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1622	2621	0.009919878	0.006867608	0	11	Glia-MIX	NA	NA	NA
AAAGATGAGTGGCACA-1_2_B4	19.03583492	-26.84148118	3	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3318	8416	0.010931559	0.008673954	0	3	EN-L5-6	NA	NA	NA
AAAGATGGTCCATGAT-1_2_B4	10.93876764	-9.048617701	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2914	7097	0.011695082	0.001690855	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AAAGATGGTTGTGGAG-1_2_B4	0.372436924	-11.19350685	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1723	3226	0.011779293	0.001859888	0	12	EN-MIX	NA	NA	NA
AAAGATGTCGTAGATC-1_2_B4	15.6874732	1.736539841	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	922	1280	0.0109375	0.00234375	0	12	EN-MIX	NA	NA	NA
AAAGCAACAGACGTAG-1_2_B4	7.498839531	23.03957405	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1034	1541	0.003244646	0.007138222	0	oligos	OL-Cntl	NA	NA	NA
AAAGTAGGTCACCTAA-1_2_B4	14.35630382	-8.19168089	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2023	4515	0.002657807	0.004208195	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AAAGTAGGTGCACCAC-1_2_B4	6.012371755	31.16267029	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	770	1128	0.004432624	0.004432624	0	oligos	OL-Cntl	NA	NA	NA
AAAGTAGGTTGCTCCT-1_2_B4	1.086984757	-7.672539148	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1351	2255	0.003991131	0.000886918	0	12	EN-MIX	NA	NA	NA
AAATGCCAGGACTGGT-1_2_B4	-7.561186454	-2.700546133	13A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1593	2946	0.068228106	0.00203666	0	13A	IN-VIP	NA	NA	NA
AAATGCCAGGCGCTCT-1_2_B4	23.13454834	18.52176624	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1140	1814	0.00275634	0.00275634	0	oligos	OL-Cntl	NA	NA	NA
AAATGCCAGGTCGGAT-1_2_B4	-34.64168099	-2.961526197	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1412	2511	0.00517722	0.002389486	0	9	OPC	NA	NA	NA
AAATGCCCACAGTCGC-1_2_B4	16.03399124	27.65183966	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	815	1161	0.004306632	0.001722653	0	oligos	OL-Cntl	NA	NA	NA
AAATGCCCACCGAAAG-1_2_B4	16.99949015	15.54310462	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1130	1822	0.001097695	0.009330406	0	oligos	OL-Cntl	NA	NA	NA
AAATGCCCAGGACCCT-1_2_B4	-20.631976	9.29655464	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	957	1434	0.0013947	0.00488145	0	8	Astrocytes	NA	NA	NA
AAATGCCCAGGCTGAA-1_2_B4	11.83527725	24.70936661	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	811	1255	0.006374502	0.002390438	0	oligos	OL-Cntl	NA	NA	NA
AAATGCCCATCCAACA-1_2_B4	18.37286948	-5.833913572	3	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1494	2773	0.006491165	0.002884962	0	3	EN-L5-6	NA	NA	NA
AAATGCCGTGATGTCT-1_2_B4	15.87518464	22.8282469	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	917	1360	0.002941176	0.005147059	0	oligos	OL-Cntl	NA	NA	NA
AAATGCCTCAGGCGAA-1_2_B4	25.93982904	4.046937007	15BA	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	957	1387	0.01369863	0.007930786	0	15BA	Stromal cells	NA	NA	NA
AAATGCCTCTATCCTA-1_2_B4	22.57427152	-6.219365435	2	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1771	3096	0.016472868	0.002260982	0	2	EN-L4	NA	NA	NA
AAATGCCTCTTCGGTC-1_2_B4	2.308243936	-6.419043851	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1154	1891	0.051824432	0.004230566	0	12	EN-MIX	NA	NA	NA
AACACGTAGCAGACTG-1_2_B4	-5.522972437	-9.205755765	13A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1041	1733	0.00577034	0.001731102	0	13A	IN-VIP	NA	NA	NA
AACACGTAGCGATTCT-1_2_B4	-37.98810925	-0.200484213	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1348	2301	0.008257279	0.003911343	0	9	OPC	NA	NA	NA
AACACGTAGTGTACGG-1_2_B4	16.46496709	24.5206575	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	826	1203	0.00166251	0.003325021	0	oligos	OL-Cntl	NA	NA	NA
AACACGTGTATTAGCC-1_2_B4	22.89514788	18.96668837	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	977	1415	0.002826855	0.004240283	0	oligos	OL-Cntl	NA	NA	NA
AACACGTGTTCGTCTC-1_2_B4	19.80531993	6.970141857	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2021	3880	0.005927835	0.005927835	0	oligos	OL-Cntl	NA	NA	NA
AACACGTTCCGCGTTT-1_2_B4	20.43477883	1.253444758	2	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1613	3056	0.006871728	0.002617801	0	2	EN-L4	NA	NA	NA
AACACGTTCGATGAGG-1_2_B4	-10.27028362	18.58411171	11	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3005	6301	0.004285034	0.005872084	0	11	Glia-MIX	NA	NA	NA
AACACGTTCGCGTAGC-1_2_B4	-22.0648725	10.0881066	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	859	1257	0.002386635	0.00477327	0	8	Astrocytes	NA	NA	NA
AACCATGCATATACGC-1_2_B4	-15.90117868	-17.43161527	6B	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1727	3019	0.008280888	0.00662471	0	6B	IN-SST	NA	NA	NA
AACCATGTCACGCATA-1_2_B4	14.17773645	0.177258174	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	710	1155	0.001731602	0.000865801	0	12	EN-MIX	NA	NA	NA
AACCATGTCGCAGGCT-1_2_B4	16.48013806	23.75718459	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	881	1344	0.001488095	0.003720238	0	oligos	OL-Cntl	NA	NA	NA
AACCGCGCAGATCCAT-1_2_B4	2.546716072	-10.9169016	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1727	3054	0.003601834	0.003601834	0	12	EN-MIX	NA	NA	NA
AACCGCGCAGCTCGCA-1_2_B4	-5.553344692	35.35889386	17	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	809	1151	0.039965248	0.002606429	0	oligos	OL-MS-2	NA	NA	NA
AACCGCGCAGTTAACC-1_2_B4	11.48232961	25.8958782	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	884	1422	0.003516174	0.004922644	0	oligos	OL-Cntl	NA	NA	NA
AACCGCGCATCATCCC-1_2_B4	-3.497653582	-6.323362491	13A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	882	1377	0.010893246	0.004357298	0	13A	IN-VIP	NA	NA	NA
AACCGCGCATCCTAGA-1_2_B4	17.44568623	12.19529034	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1331	2253	0.001331558	0.007101642	0	oligos	OL-Cntl	NA	NA	NA
AACCGCGGTATCAGTC-1_2_B4	17.07483182	17.43889531	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1161	1973	0.006588951	0.007602636	0	oligos	OL-Cntl	NA	NA	NA
AACCGCGGTGACGGTA-1_2_B4	-30.32825145	12.90750713	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	724	1104	0	0.004528986	0	8	Astrocytes	NA	NA	NA
AACCGCGTCACGCGGT-1_2_B4	19.39845975	14.32984789	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1241	2084	0.001439539	0.005278311	0	oligos	OL-Cntl	NA	NA	NA
AACCGCGTCCATGAGT-1_2_B4	2.429650381	29.87741973	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	796	1125	0.002666667	0.004444444	0	oligos	OL-Cntl	NA	NA	NA
AACCGCGTCCGTCATC-1_2_B4	11.15419047	-9.007248271	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2979	6903	0.00159351	0.001738375	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AACCGCGTCTACTCAT-1_2_B4	10.69517829	25.34408257	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	865	1324	0.004531722	0.003776435	0	oligos	OL-Cntl	NA	NA	NA
AACGTTGAGATATGGT-1_2_B4	18.40172843	21.18822905	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	937	1505	0.011295681	0.003986711	0	oligos	OL-Cntl	NA	NA	NA
AACGTTGAGTACGACG-1_2_B4	16.15548933	17.12403317	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1075	1688	0.004146919	0.006516588	0	oligos	OL-Cntl	NA	NA	NA
AACGTTGCAAGGGTCA-1_2_B4	15.58115529	-1.814032343	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1060	1852	0.006479482	0.002159827	0	12	EN-MIX	NA	NA	NA
AACGTTGCAGACGTAG-1_2_B4	4.467464884	25.65590761	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	758	1020	0.001960784	0.007843137	0	oligos	OL-Cntl	NA	NA	NA
AACGTTGGTCTGGTCG-1_2_B4	1.71891079	-7.291369593	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1279	2223	0.028340081	0.000899685	0	12	EN-MIX	NA	NA	NA
AACTCAGAGGGAGTAA-1_2_B4	4.092230904	-28.86306223	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3175	7330	0.00218281	0.003274216	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AACTCAGAGTGTTTGC-1_2_B4	-30.80021994	13.0155117	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	896	1388	0.002881844	0.005043228	0	8	Astrocytes	NA	NA	NA
AACTCAGGTCGAATCT-1_2_B4	-9.090764584	-20.09555869	6B	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	691	1140	0.10877193	0.006140351	0	6B	IN-SST	NA	NA	NA
AACTCAGGTCGACTGC-1_2_B4	-21.54419071	-28.0439695	6A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	4501	12550	0.009243028	0.006932271	0	6A	IN-PV	NA	NA	NA
AACTCAGGTTTCCACC-1_2_B4	-5.536205855	-3.512507188	13A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1481	2473	0.015365952	0.00283057	0	13A	IN-VIP	NA	NA	NA
AACTCAGTCTGGCGTG-1_2_B4	17.43439008	13.66677516	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1201	1848	0.012445887	0.003787879	0	oligos	OL-Cntl	NA	NA	NA
AACTCCCCATGCTAGT-1_2_B4	23.53018276	-9.818029739	3	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3180	7394	0.014876927	0.003245875	0	3	EN-L5-6	NA	NA	NA
AACTCCCCATTAACCG-1_2_B4	19.19092949	19.16447778	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1036	1635	0.001223242	0.010397554	0	oligos	OL-Cntl	NA	NA	NA
AACTCCCGTCGAATCT-1_2_B4	21.9341603	17.65757241	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1128	1720	0.004651163	0.008139535	0	oligos	OL-Cntl	NA	NA	NA
AACTCCCTCCCATTTA-1_2_B4	-22.9317992	22.96050407	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1389	2180	0.000458716	0.009174312	0	8	Astrocytes	NA	NA	NA
AACTCCCTCCTGTACC-1_2_B4	8.475240025	-6.744971235	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1658	3158	0.024382521	0.002849905	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AACTCCCTCTTGCCGT-1_2_B4	-23.29191172	21.80914854	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1238	2216	0.005415162	0.003610108	0	8	Astrocytes	NA	NA	NA
AACTCTTAGAAGGTGA-1_2_B4	17.40548662	22.96654843	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	945	1436	0.016713092	0.001392758	0	oligos	OL-Cntl	NA	NA	NA
AACTCTTAGATATACG-1_2_B4	20.47459372	1.69353346	2	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1460	2792	0.014684814	0.001074499	0	2	EN-L4	NA	NA	NA
AACTCTTAGGGTCTCC-1_2_B4	37.90191215	13.32469406	14	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	988	1330	0.001503759	0.011278195	0	14	Microglia	NA	NA	NA
AACTCTTCACCGATAT-1_2_B4	-37.25450698	3.088984245	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1852	3774	0.000529942	0.00317965	0	9	OPC	NA	NA	NA
AACTGGTCACGCCAGT-1_2_B4	-16.88225735	-26.44428077	6A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2227	5014	0.004387714	0.004387714	0	6A	IN-PV	NA	NA	NA
AACTGGTCAGTATAAG-1_2_B4	2.064540186	26.6377397	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	696	1024	0.008789063	0.013671875	0	oligos	OL-Cntl	NA	NA	NA
AACTGGTCATACAGCT-1_2_B4	-3.810507452	27.33688095	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	811	1231	0.004061738	0.003249391	0	oligos	OL-Cntl	NA	NA	NA
AACTGGTGTACAGTTC-1_2_B4	7.945101374	-27.05104844	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	4814	14570	0.005490734	0.004255319	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AACTGGTTCAGAGACG-1_2_B4	11.26483924	25.58188085	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	831	1253	0.003192338	0.005586592	0	oligos	OL-Cntl	NA	NA	NA
AACTGGTTCCCAACGG-1_2_B4	-26.59506814	15.47991087	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	979	1491	0.000670691	0.006036217	0	8	Astrocytes	NA	NA	NA
AACTTTCGTCTAGTCA-1_2_B4	3.213800073	-29.78914582	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3362	9019	0.001330524	0.003548065	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AACTTTCTCTCAAACG-1_2_B4	1.418629905	-6.268633144	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1163	1934	0.003102378	0.005170631	0	12	EN-MIX	NA	NA	NA
AAGACCTAGCCACGCT-1_2_B4	-3.829898669	-6.124285919	13A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	955	1417	0.004940014	0.004234298	0	13A	IN-VIP	NA	NA	NA
AAGACCTTCCACGACG-1_2_B4	18.5672961	-6.792085803	3	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1843	3581	0.001117006	0.001117006	0	3	EN-L5-6	NA	NA	NA
AAGACCTTCTAACGGT-1_2_B4	22.69871337	12.23657992	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1413	2598	0.001924557	0.003849115	0	oligos	OL-Cntl	NA	NA	NA
AAGCCGCAGAACAATC-1_2_B4	18.74415672	14.97660673	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1153	1875	0.002666667	0.005866667	0	oligos	OL-Cntl	NA	NA	NA
AAGCCGCCAAACTGCT-1_2_B4	18.80482762	14.94396814	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1140	1838	0.002176279	0.006528836	0	oligos	OL-Cntl	NA	NA	NA
AAGCCGCCATTTGCTT-1_2_B4	-10.54355383	18.16394271	11	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1918	3479	0.00258695	0.003161828	0	11	Glia-MIX	NA	NA	NA
AAGCCGCGTCCAGTTA-1_2_B4	9.281724557	-7.496902295	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1832	3560	0.003651685	0.003651685	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AAGCCGCGTGATGTCT-1_2_B4	23.2142442	18.71246782	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1064	1584	0.001893939	0.008207071	0	oligos	OL-Cntl	NA	NA	NA
AAGGAGCAGAGTCGGT-1_2_B4	3.517418316	5.086501469	7	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1133	1583	0.00315856	0.01958307	0	7	Phagocytes	NA	NA	NA
AAGGAGCCAATTCCTT-1_2_B4	10.1400026	-7.967341747	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1971	3952	0.005819838	0.001012146	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AAGGAGCTCACCAGGC-1_2_B4	2.710839348	-32.05216648	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	6125	23596	0.003898966	0.002415664	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AAGGAGCTCTACTCAT-1_2_B4	-4.801482941	-3.980009851	13A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1267	2051	0.017064846	0.004388103	0	13A	IN-VIP	NA	NA	NA
AAGGAGCTCTCGTTTA-1_2_B4	-9.167343212	-18.44855786	6B	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	870	1318	0.007587253	0.002276176	0	6B	IN-SST	NA	NA	NA
AAGGCAGAGCTAACTC-1_2_B4	12.64627172	0.33650216	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	937	1415	0.004946996	0.004240283	0	12	EN-MIX	NA	NA	NA
AAGGCAGGTATGGTTC-1_2_B4	24.76786351	-29.48743993	3	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3214	7963	0.001255808	0.002260455	0	3	EN-L5-6	NA	NA	NA
AAGGCAGGTTTGACAC-1_2_B4	-9.921464201	-19.43612374	6B	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	930	1323	0.026455026	0.003779289	0	6B	IN-SST	NA	NA	NA
AAGGCAGTCCGTAGGC-1_2_B4	-8.121301373	-1.917625206	13A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1963	3387	0.013876587	0.005609684	0	13A	IN-VIP	NA	NA	NA
AAGGTTCAGCTAGTTC-1_2_B4	-5.255670383	-10.10565016	13B	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	797	1132	0.003533569	0.002650177	0	13B	IN-SV2C	NA	NA	NA
AAGGTTCAGGGTTCCC-1_2_B4	22.19948334	0.63453414	2	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1721	3085	0.010048622	0.000972447	0	2	EN-L4	NA	NA	NA
AAGGTTCAGGTGTGGT-1_2_B4	11.9489608	26.37543483	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	842	1293	0.00154679	0.006187162	0	oligos	OL-Cntl	NA	NA	NA
AAGGTTCCAACGATGG-1_2_B4	-14.76393591	-25.06382579	6A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1628	3074	0.03057905	0.001301236	0	6A	IN-PV	NA	NA	NA
AAGGTTCCAAGCGTAG-1_2_B4	36.84525616	14.09678624	14	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1045	1414	0.004950495	0.016973126	0	14	Microglia	NA	NA	NA
AAGGTTCCAGTATCTG-1_2_B4	9.213175167	-7.368177332	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1805	3452	0.006373117	0.000579374	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AAGGTTCGTTCCCTTG-1_2_B4	15.98388713	21.68201272	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	935	1425	0.004210526	0.006315789	0	oligos	OL-Cntl	NA	NA	NA
AAGGTTCTCAAACCAC-1_2_B4	0.520088236	-16.15968289	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2257	4722	0.001905972	0.004023719	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AAGGTTCTCAACACTG-1_2_B4	-9.178244423	-1.087717151	13A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2106	4098	0.022938019	0.004636408	0	13A	IN-VIP	NA	NA	NA
AAGGTTCTCGAATGGG-1_2_B4	15.86846478	28.52124293	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	776	1120	0.005357143	0.008035714	0	oligos	OL-Cntl	NA	NA	NA
AAGTCTGAGAGTACAT-1_2_B4	11.14796667	21.76893362	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	849	1323	0.006046863	0.008314437	0	oligos	OL-Cntl	NA	NA	NA
AAGTCTGCAAGTTCTG-1_2_B4	4.100722957	26.6114775	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	793	1151	0.003475239	0.004344049	0	oligos	OL-Cntl	NA	NA	NA
AAGTCTGCAGTCTTCC-1_2_B4	-12.34927871	0.806058027	13A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3264	7040	0.011505682	0.005681818	0	13A	IN-VIP	NA	NA	NA
AAGTCTGGTAGCAAAT-1_2_B4	37.98164999	10.19360263	14	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	784	1035	0.012560386	0.01352657	0	14	Microglia	NA	NA	NA
AAGTCTGTCTGAGGGA-1_2_B4	3.026784216	-7.793165771	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1264	2072	0.02027027	0.003378378	0	12	EN-MIX	NA	NA	NA
AAGTCTGTCTTGCCGT-1_2_B4	-1.705780481	22.74933342	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	738	1084	0.013837638	0.011070111	0	oligos	OL-Cntl	NA	NA	NA
AATCCAGAGAGTAAGG-1_2_B4	13.15845434	27.7124287	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	763	1100	0.003636364	0.004545455	0	oligos	OL-Cntl	NA	NA	NA
AATCCAGAGTGCAAGC-1_2_B4	10.15493643	-8.82490955	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2608	6077	0.010531512	0.001645549	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AATCCAGCACTTACGA-1_2_B4	-12.23855209	-22.92172325	6A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1242	2333	0.018002572	0.003000429	0	6A	IN-PV	NA	NA	NA
AATCCAGCAGATGGGT-1_2_B4	-15.8620208	-25.06974777	6A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1889	3862	0.058259969	0.002848265	0	6A	IN-PV	NA	NA	NA
AATCCAGCAGTGACAG-1_2_B4	3.039256756	-3.48943536	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	788	1091	0.009165903	0.006416132	0	12	EN-MIX	NA	NA	NA
AATCCAGGTCAAAGCG-1_2_B4	23.86154997	0.185314604	2	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1945	3775	0.006887417	0.002119205	0	2	EN-L4	NA	NA	NA
AATCCAGGTGAGGGTT-1_2_B4	18.59278287	9.075093395	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1438	2661	0.001878993	0.007140173	0	oligos	OL-Cntl	NA	NA	NA
AATCCAGTCAGTCAGT-1_2_B4	2.286356806	-20.65576176	4	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3195	7944	0.00213998	0.00427996	0	L2-3	EN-L2-3-MS	NA	NA	NA
AATCGGTAGGGTCGAT-1_2_B4	-25.58404616	11.29329225	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	904	1362	0.005873715	0.008076358	0	8	Astrocytes	NA	NA	NA
AATCGGTAGTCTCAAC-1_2_B4	15.14737096	22.97258877	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	929	1385	0.002888087	0.007942238	0	oligos	OL-Cntl	NA	NA	NA
AATCGGTCAGACAGGT-1_2_B4	6.386008189	21.14094475	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	887	1317	0.006074412	0.012908125	0	oligos	OL-Cntl	NA	NA	NA
AATCGGTGTTGTGGAG-1_2_B4	30.29433387	-0.57160792	2	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3570	9121	0.009538428	0.004385484	0	2	EN-L4	NA	NA	NA
AATCGGTTCCGTAGTA-1_2_B4	18.72332796	8.889986423	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1559	2762	0.005430847	0.004706734	0	oligos	OL-Cntl	NA	NA	NA
ACACCAACAATAAGCA-1_2_B4	2.463279049	30.42745359	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	738	1107	0.009033424	0.005420054	0	oligos	OL-Cntl	NA	NA	NA
ACACCAACACCACCAG-1_2_B4	17.56037123	19.28913349	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1032	1609	0.001243008	0.005593536	0	oligos	OL-Cntl	NA	NA	NA
ACACCAAGTAAGCACG-1_2_B4	-34.35654969	-12.83703779	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	700	1048	0.001908397	0	0	9	OPC	NA	NA	NA
ACACCAAGTCCGTGAC-1_2_B4	-8.898199385	16.38410628	11	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2943	6191	0.002907446	0.004199645	0	11	Glia-MIX	NA	NA	NA
ACACCCTCACAGCCCA-1_2_B4	12.33697363	20.71489798	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	987	1566	0.007024266	0.004469987	0	oligos	OL-Cntl	NA	NA	NA
ACACCCTCACCAGCAC-1_2_B4	0.761362737	29.08691312	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	784	1094	0.001828154	0.004570384	0	oligos	OL-Cntl	NA	NA	NA
ACACCCTCACGGCTAC-1_2_B4	21.53939884	20.19931174	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	993	1483	0.002022927	0.005394471	0	oligos	OL-Cntl	NA	NA	NA
ACACCCTCAGCTCGCA-1_2_B4	0.010932652	-10.29709966	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1460	2549	0.003138486	0.003923107	0	12	EN-MIX	NA	NA	NA
ACACCCTTCTCCTATA-1_2_B4	15.26390145	27.67314942	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	784	1168	0.004280822	0.005136986	0	oligos	OL-Cntl	NA	NA	NA
ACACCGGAGAAGGTGA-1_2_B4	11.05172271	25.31374057	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	837	1235	0.010526316	0.000809717	0	oligos	OL-Cntl	NA	NA	NA
ACACCGGCAATCCAAC-1_2_B4	5.092837832	-31.11108912	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	4373	13338	0.00119958	0.002549108	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACACCGGCATCCGTGG-1_2_B4	0.553382216	-16.45674889	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2372	4940	0.006275304	0.00465587	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACACCGGGTCACCTAA-1_2_B4	-1.476940166	23.77271456	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	714	1009	0.004955401	0.006937562	0	oligos	OL-Cntl	NA	NA	NA
ACACCGGGTCTTCAAG-1_2_B4	15.13451367	-0.694793177	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	654	1016	0.000984252	0.001968504	0	12	EN-MIX	NA	NA	NA
ACACCGGTCTAACTGG-1_2_B4	18.09145175	21.89810136	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	852	1319	0.005307051	0.0030326	0	oligos	OL-Cntl	NA	NA	NA
ACACTGAAGACACTAA-1_2_B4	-0.69166406	-15.86216038	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2355	4916	0.013222132	0.0046786	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACACTGAAGTCGCCGT-1_2_B4	-34.66971842	-7.070091392	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1139	1773	0.002256063	0.00676819	0	9	OPC	NA	NA	NA
ACACTGAGTCCATGAT-1_2_B4	20.75670336	15.92922327	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1105	1596	0.002506266	0.006265664	0	oligos	OL-Cntl	NA	NA	NA
ACACTGAGTTGTCTTT-1_2_B4	0.048748448	29.15521649	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	767	1006	0.001988072	0.003976143	0	oligos	OL-Cntl	NA	NA	NA
ACACTGATCAGGTAAA-1_2_B4	2.610319499	24.25277361	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	792	1137	0.004397537	0.007915567	0	oligos	OL-Cntl	NA	NA	NA
ACACTGATCGATAGAA-1_2_B4	3.902984664	18.88336959	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	838	1197	0.003341688	0.014202172	0	oligos	OL-Cntl	NA	NA	NA
ACACTGATCTGGGCCA-1_2_B4	-36.56006025	-9.213953232	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	969	1525	0.00852459	0.002622951	0	9	OPC	NA	NA	NA
ACAGCCGAGGCACATG-1_2_B4	39.80007472	12.52934651	14	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	991	1408	0.008522727	0.0078125	0	14	Microglia	NA	NA	NA
ACAGCCGCACGGCCAT-1_2_B4	-16.1571379	11.73643966	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1185	1836	0.003812636	0.006535948	0	8	Astrocytes	NA	NA	NA
ACAGCCGCATCGACGC-1_2_B4	-25.24040628	17.33771194	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1115	1665	0.002402402	0.004804805	0	8	Astrocytes	NA	NA	NA
ACAGCCGGTCCTGCTT-1_2_B4	-10.51788977	16.55042955	11	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1804	3100	0.002903226	0.003225806	0	11	Glia-MIX	NA	NA	NA
ACAGCCGGTTAAGTAG-1_2_B4	-6.34881001	4.107201959	11	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	8307	31463	0.006229539	0.006038839	0	11	Glia-MIX	NA	NA	NA
ACAGCCGGTTACAGAA-1_2_B4	38.02454015	11.4087622	14	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	950	1331	0.00150263	0.009767092	0	14	Microglia	NA	NA	NA
ACAGCCGGTTGGGACA-1_2_B4	20.38123411	18.21217389	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1146	1726	0.003476246	0.005214368	0	oligos	OL-Cntl	NA	NA	NA
ACAGCCGTCCAAACTG-1_2_B4	-28.23825809	11.00185913	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	753	1147	0.013949433	0.002615519	0	8	Astrocytes	NA	NA	NA
ACAGCCGTCTTACCTA-1_2_B4	15.14228305	25.74311419	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	850	1375	0.000727273	0.000727273	0	oligos	OL-Cntl	NA	NA	NA
ACAGCTAAGATCACGG-1_2_B4	-31.86652355	12.25570629	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	846	1224	0.00245098	0.00245098	0	8	Astrocytes	NA	NA	NA
ACAGCTAAGGCGATAC-1_2_B4	-35.59505295	-3.807391915	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1311	2189	0.005938785	0.003654637	0	9	OPC	NA	NA	NA
ACAGCTAAGTCCATAC-1_2_B4	19.0068654	14.16171546	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1215	2097	0.00286123	0.001907487	0	oligos	OL-Cntl	NA	NA	NA
ACAGCTACAGGCGATA-1_2_B4	-12.86168391	14.75170601	11	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	943	1309	0.002291826	0.007639419	0	11	Glia-MIX	NA	NA	NA
ACAGCTAGTAGGGTAC-1_2_B4	5.103044535	-9.419060528	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1498	2450	0.023265306	0.006122449	0	12	EN-MIX	NA	NA	NA
ACAGCTATCTTTAGGG-1_2_B4	17.82652344	21.55420727	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	928	1487	0.002017485	0.00134499	0	oligos	OL-Cntl	NA	NA	NA
ACATACGAGAGACTTA-1_2_B4	13.89521469	28.54905	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	769	1132	0.001766784	0.005300353	0	oligos	OL-Cntl	NA	NA	NA
ACATACGAGCCACCTG-1_2_B4	-5.204464414	-6.734496935	13A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1074	1691	0.011235955	0.004730928	0	13A	IN-VIP	NA	NA	NA
ACATACGGTGTGCGTC-1_2_B4	-1.706730965	26.13456943	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	784	1112	0.002697842	0.009892086	0	oligos	OL-Cntl	NA	NA	NA
ACATCAGGTAAGTAGT-1_2_B4	18.48890461	14.28608175	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1101	1788	0.001118568	0.008389262	0	oligos	OL-Cntl	NA	NA	NA
ACATCAGGTAGGGTAC-1_2_B4	14.23595924	27.47819648	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	749	1046	0.000956023	0.001912046	0	oligos	OL-Cntl	NA	NA	NA
ACATCAGGTGCTCTTC-1_2_B4	-10.49362454	9.845319741	11	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2854	6164	0.002433485	0.007300454	0	11	Glia-MIX	NA	NA	NA
ACATGGTAGCCAACAG-1_2_B4	4.557406346	-5.133499006	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	852	1252	0.047124601	0.000798722	0	12	EN-MIX	NA	NA	NA
ACATGGTGTGTGCGTC-1_2_B4	22.59113698	18.64553061	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1085	1552	0.005798969	0.005798969	0	oligos	OL-Cntl	NA	NA	NA
ACATGGTTCAACGGCC-1_2_B4	25.08337031	0.539776916	2	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2482	5206	0.009412217	0.002497119	0	2	EN-L4	NA	NA	NA
ACCAGTAAGGCCCTTG-1_2_B4	21.02578061	7.284386733	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2533	4893	0.000817494	0.006744329	0	oligos	OL-Cntl	NA	NA	NA
ACCAGTACAAACTGCT-1_2_B4	1.91458495	-20.86566467	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3269	8106	0.001110289	0.004811251	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACCAGTACAAGCGAGT-1_2_B4	16.63567755	21.91751719	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	992	1513	0.003965631	0.006609385	0	oligos	OL-Cntl	NA	NA	NA
ACCAGTAGTCAGAAGC-1_2_B4	-34.1878574	-6.713185679	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1219	1843	0.001627781	0.002170374	0	9	OPC	NA	NA	NA
ACCAGTAGTCTCATCC-1_2_B4	18.87417982	-26.25011857	3	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	4060	11172	0.002953813	0.013157895	0	3	EN-L5-6	NA	NA	NA
ACCAGTATCGTCACGG-1_2_B4	-4.122654878	-3.709295636	13A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1353	2302	0.018245004	0.004778454	0	13A	IN-VIP	NA	NA	NA
ACCAGTATCGTCGTTC-1_2_B4	18.94465005	8.225664796	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1638	2934	0.00408998	0.007157464	0	oligos	OL-Cntl	NA	NA	NA
ACCCACTAGAGTCGGT-1_2_B4	2.851052016	23.86916781	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	813	1134	0.009700176	0.007054674	0	oligos	OL-Cntl	NA	NA	NA
ACCCACTAGGCCATAG-1_2_B4	4.840582465	5.494172921	7	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1691	2621	0.004578405	0.006486074	0	7	Phagocytes	NA	NA	NA
ACCCACTCACAAGACG-1_2_B4	-22.19539019	10.41708303	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	878	1297	0.00385505	0.00462606	0	8	Astrocytes	NA	NA	NA
ACCCACTCACAGGAGT-1_2_B4	1.002683908	-7.387798996	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1283	2104	0.006178707	0.003326996	0	12	EN-MIX	NA	NA	NA
ACCCACTCACGCATCG-1_2_B4	8.003762758	-32.17637667	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3658	9808	0.008972268	0.003262643	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACCCACTCACGCTTTC-1_2_B4	-6.726819526	-9.760199143	6B	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1251	2201	0.024534303	0.001363017	0	6B	IN-SST	NA	NA	NA
ACCCACTCATGTTGAC-1_2_B4	8.843724613	29.18296891	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	858	1247	0.004009623	0.006415397	0	oligos	OL-Cntl	NA	NA	NA
ACCCACTGTGCGCTTG-1_2_B4	6.125831359	28.82750589	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	661	1012	0	0	0	oligos	OL-Cntl	NA	NA	NA
ACCCACTGTGTGACGA-1_2_B4	-9.052155358	16.78971525	11	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2480	4749	0.005264266	0.006948831	0	11	Glia-MIX	NA	NA	NA
ACCCACTGTTCAGTAC-1_2_B4	11.06869315	-8.806712301	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2619	5359	0.003545438	0.005598059	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACCGTAAAGCCAGGAT-1_2_B4	2.227984345	-7.954565692	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1486	2469	0.027946537	0.004050223	0	12	EN-MIX	NA	NA	NA
ACCGTAAAGGCAAAGA-1_2_B4	-11.29843864	-22.20789402	6A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	917	1506	0.024568393	0.001328021	0	6A	IN-PV	NA	NA	NA
ACCGTAACACAGGAGT-1_2_B4	19.77411617	17.47273601	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1084	1712	0.003504673	0.007593458	0	oligos	OL-Cntl	NA	NA	NA
ACCGTAAGTCTCTCGT-1_2_B4	14.43067252	-8.123431794	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2040	4111	0.003162248	0.003405497	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACCGTAAGTGGTCCGT-1_2_B4	19.43817315	0.146328361	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1342	2150	0.042325581	0.00372093	0	12	EN-MIX	NA	NA	NA
ACCGTAATCACCAGGC-1_2_B4	-1.464226601	-22.19792664	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3542	9206	0.003693244	0.003475994	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACCGTAATCTGTACGA-1_2_B4	3.023618669	27.18853014	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	701	1035	0	0.009661836	0	oligos	OL-Cntl	NA	NA	NA
ACCTTTAAGCCAGAAC-1_2_B4	-32.74448342	-12.09600579	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	896	1382	0.004341534	0.003617945	0	9	OPC	NA	NA	NA
ACCTTTAAGTCATGCT-1_2_B4	14.5184253	27.31444204	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	707	1083	0.000923361	0.002770083	0	oligos	OL-Cntl	NA	NA	NA
ACCTTTACATTTGCTT-1_2_B4	-25.43922654	12.13614771	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	977	1537	0.004554327	0.004554327	0	8	Astrocytes	NA	NA	NA
ACCTTTAGTCCATCCT-1_2_B4	-35.36242717	5.180265176	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2664	6105	0.002293202	0.002457002	0	9	OPC	NA	NA	NA
ACGAGCCAGCGATATA-1_2_B4	21.60646011	12.68843634	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1383	2276	0.001757469	0.003075571	0	oligos	OL-Cntl	NA	NA	NA
ACGAGCCAGGAATCGC-1_2_B4	-14.57343495	-24.32625256	6A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1603	3009	0.002658691	0.002326354	0	6A	IN-PV	NA	NA	NA
ACGAGCCCACATGGGA-1_2_B4	-24.81927105	19.50504643	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1560	2717	0.001840265	0.002944424	0	8	Astrocytes	NA	NA	NA
ACGAGCCCATCGGGTC-1_2_B4	-1.316146804	-16.31020557	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2208	4425	0.006553672	0.002711864	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACGAGCCCATGCGCAC-1_2_B4	5.500272456	19.18528181	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	970	1413	0.006369427	0.013446568	0	oligos	OL-Cntl	NA	NA	NA
ACGAGCCGTCATCGGC-1_2_B4	-1.147125099	3.261007186	11	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1153	1558	0.005134788	0.005134788	0	11	Glia-MIX	NA	NA	NA
ACGAGCCGTCCAGTAT-1_2_B4	7.476111458	22.93190677	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	982	1290	0.004651163	0.01627907	0	oligos	OL-Cntl	NA	NA	NA
ACGAGCCGTGGTGTAG-1_2_B4	14.74728982	-8.207535252	3	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2202	4130	0.002905569	0.002663438	0	3	EN-L5-6	NA	NA	NA
ACGAGGACAGCATGAG-1_2_B4	5.828626988	21.37687972	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	831	1163	0.009458298	0.011177988	0	oligos	OL-Cntl	NA	NA	NA
ACGAGGAGTACATCCA-1_2_B4	10.84028775	30.51771758	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	718	1017	0.001966568	0.001966568	0	oligos	OL-Cntl	NA	NA	NA
ACGAGGAGTTGTCGCG-1_2_B4	-32.66359375	-12.49716846	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	797	1204	0.000830565	0.002491694	0	9	OPC	NA	NA	NA
ACGAGGATCAGTGTTG-1_2_B4	22.0375408	17.45278148	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1246	1873	0.005339028	0.005339028	0	oligos	OL-Cntl	NA	NA	NA
ACGAGGATCCGTCATC-1_2_B4	-20.52402725	8.397399714	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	803	1155	0.008658009	0.005194805	0	8	Astrocytes	NA	NA	NA
ACGAGGATCTCAAACG-1_2_B4	9.85639715	20.59106019	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	869	1337	0.003739716	0.009723261	0	oligos	OL-Cntl	NA	NA	NA
ACGAGGATCTTGCCGT-1_2_B4	9.173324587	-6.412730344	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1568	3239	0.037357209	0.001543686	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACGATACCACTTACGA-1_2_B4	1.016334731	28.71693803	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	780	1154	0.002599653	0.000866551	0	oligos	OL-Cntl	NA	NA	NA
ACGATACCAGGACCCT-1_2_B4	11.31630003	23.39130702	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	873	1313	0.002284844	0.001523229	0	oligos	OL-Cntl	NA	NA	NA
ACGATACCATTGGGCC-1_2_B4	-9.064484271	-19.68597023	6B	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	720	1086	0.066298343	0.003683241	0	6B	IN-SST	NA	NA	NA
ACGATACGTAGGCTGA-1_2_B4	9.812998437	30.20634371	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	721	1061	0.003770028	0.005655042	0	oligos	OL-Cntl	NA	NA	NA
ACGATACGTCACCCAG-1_2_B4	5.667699933	20.81365996	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	869	1173	0.006820119	0.007672634	0	oligos	OL-Cntl	NA	NA	NA
ACGATACTCCAACCAA-1_2_B4	21.45944767	12.98060279	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1326	2163	0.004623209	0.00554785	0	oligos	OL-Cntl	NA	NA	NA
ACGATGTAGCTGTCTA-1_2_B4	-35.72777666	-4.400631824	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1267	2082	0.002401537	0.003842459	0	9	OPC	NA	NA	NA
ACGATGTCAACACCTA-1_2_B4	3.619281518	-9.679043754	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1688	3148	0.012071156	0.00476493	0	12	EN-MIX	NA	NA	NA
ACGATGTCAAGAGTCG-1_2_B4	-0.413454922	-15.92096798	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2189	4331	0.008773955	0.003001616	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACGATGTTCAATAAGG-1_2_B4	11.48861541	29.51766834	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	718	1054	0.003795066	0.001897533	0	oligos	OL-Cntl	NA	NA	NA
ACGATGTTCGACGGAA-1_2_B4	14.61859274	-1.157856447	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	875	1369	0.007304602	0.002921841	0	12	EN-MIX	NA	NA	NA
ACGATGTTCTCCCTGA-1_2_B4	3.99235735	26.82920543	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	733	1044	0.001915709	0.00862069	0	oligos	OL-Cntl	NA	NA	NA
ACGATGTTCTTTCCTC-1_2_B4	2.145453011	-16.22982651	4	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2403	4939	0.01457785	0.004656813	0	L2-3	EN-L2-3-MS	NA	NA	NA
ACGCAGCAGACTCGGA-1_2_B4	18.72151762	8.489363243	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1711	3094	0.005817712	0.008726568	0	oligos	OL-Cntl	NA	NA	NA
ACGCAGCAGAGGTACC-1_2_B4	-5.018069136	-6.836688198	13A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1018	1425	0.021754386	0.007719298	0	13A	IN-VIP	NA	NA	NA
ACGCAGCGTCAAAGCG-1_2_B4	19.04228803	6.250340187	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2852	5996	0.008005337	0.004002668	0	oligos	OL-Cntl	NA	NA	NA
ACGCAGCGTCACAAGG-1_2_B4	-0.202950033	27.55500912	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	843	1201	0.004163197	0.004995837	0	oligos	OL-Cntl	NA	NA	NA
ACGCAGCGTTCTGTTT-1_2_B4	38.04582228	9.346777323	14	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	898	1139	0.004389816	0.009657594	0	14	Microglia	NA	NA	NA
ACGCAGCTCAGCTGGC-1_2_B4	-23.23432339	0.566331133	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2072	3882	0.004894384	0.003606388	0	9	OPC	NA	NA	NA
ACGCAGCTCCGTCAAA-1_2_B4	17.05766147	-4.748594117	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1191	2005	0.005486284	0.003990025	0	12	EN-MIX	NA	NA	NA
ACGCCAGCAGCGTAAG-1_2_B4	-22.84244263	-0.449803996	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1446	2258	0.00044287	0.004871568	0	9	OPC	NA	NA	NA
ACGCCAGGTCTTGATG-1_2_B4	22.4916108	13.75210976	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1265	2096	0.004770992	0.00620229	0	oligos	OL-Cntl	NA	NA	NA
ACGCCAGTCAAAGACA-1_2_B4	3.126042939	-32.59482526	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	5647	20001	0.001049948	0.001849908	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACGCCGAAGACGACGT-1_2_B4	9.766551879	26.48569689	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	783	1210	0.001652893	0.008264463	0	oligos	OL-Cntl	NA	NA	NA
ACGCCGAAGCCCTAAT-1_2_B4	19.95360793	-6.942902918	3	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2285	4701	0.005743459	0.001914486	0	3	EN-L5-6	NA	NA	NA
ACGCCGACATGCCTTC-1_2_B4	2.483282175	29.47851237	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	734	1050	0.002857143	0.003809524	0	oligos	OL-Cntl	NA	NA	NA
ACGCCGAGTCTCGTTC-1_2_B4	3.331918114	-28.14306887	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3076	7773	0.002573009	0.002573009	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACGCCGAGTGGGTATG-1_2_B4	3.95131644	-15.02520418	4	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2387	4675	0.009625668	0.004705882	0	L2-3	EN-L2-3-MS	NA	NA	NA
ACGCCGATCACTCCTG-1_2_B4	8.369463159	28.16940547	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	930	1380	0.005072464	0.002898551	0	oligos	OL-Cntl	NA	NA	NA
ACGCCGATCTTAACCT-1_2_B4	26.81451271	-3.700197517	2	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3629	9342	0.001926782	0.003746521	0	2	EN-L4	NA	NA	NA
ACGGAGAAGATGTAAC-1_2_B4	13.84862581	24.72609144	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	823	1207	0.003314002	0.0008285	0	oligos	OL-Cntl	NA	NA	NA
ACGGAGAAGTGTTTGC-1_2_B4	0.294922319	23.95424655	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	767	1042	0	0.004798464	0	oligos	OL-Cntl	NA	NA	NA
ACGGAGACACTGAAGG-1_2_B4	-0.131592804	23.44017667	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	714	1018	0.003929273	0.007858546	0	oligos	OL-Cntl	NA	NA	NA
ACGGAGAGTACTTAGC-1_2_B4	12.73860629	-33.02480626	3	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3775	10387	0.001540387	0.00182921	0	3	EN-L5-6	NA	NA	NA
ACGGAGAGTCAGGACA-1_2_B4	10.568588	25.19784666	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	879	1369	0.002191381	0.013878744	0	oligos	OL-Cntl	NA	NA	NA
ACGGAGAGTGGTCTCG-1_2_B4	27.15908119	-5.754005921	2	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	4423	12303	0.004714297	0.00414533	0	2	EN-L4	NA	NA	NA
ACGGAGAGTTCCTCCA-1_2_B4	2.338691413	27.695955	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	865	1245	0.007228916	0.007228916	0	oligos	OL-Cntl	NA	NA	NA
ACGGAGATCTTCTGGC-1_2_B4	8.127348856	35.02060918	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	915	1333	0.013503376	0.0060015	0	oligos	OL-Cntl	NA	NA	NA
ACGGCCACAATGTAAG-1_2_B4	4.921254261	26.40934461	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	814	1167	0.001713796	0.00428449	0	oligos	OL-Cntl	NA	NA	NA
ACGGCCAGTCTCTTAT-1_2_B4	-15.68695593	-11.25569217	13B	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2651	6134	0.007825236	0.003260515	0	13B	IN-SV2C	NA	NA	NA
ACGGCCATCGTCTGAA-1_2_B4	-27.83446784	-12.9503942	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	749	1042	0.009596929	0.003838772	0	9	OPC	NA	NA	NA
ACGGCCATCTCCGGTT-1_2_B4	4.036530041	26.49626546	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	778	1137	0.007915567	0.009674582	0	oligos	OL-Cntl	NA	NA	NA
ACGGCCATCTGACCTC-1_2_B4	3.524601154	-5.827376193	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	989	1614	0.011152416	0.001858736	0	12	EN-MIX	NA	NA	NA
ACGGGCTAGACAATAC-1_2_B4	18.38229393	12.70702206	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1316	1972	0.003042596	0.005578093	0	oligos	OL-Cntl	NA	NA	NA
ACGGGCTAGAGGACGG-1_2_B4	-1.199029866	28.16765086	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	794	1090	0.001834862	0.003669725	0	oligos	OL-Cntl	NA	NA	NA
ACGGGCTAGTCCGTAT-1_2_B4	-20.73186159	9.087043341	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	929	1362	0.003671072	0.008076358	0	8	Astrocytes	NA	NA	NA
ACGGGCTCACGGCTAC-1_2_B4	-8.801647121	1.179395226	13A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2699	5785	0.00622299	0.003457217	0	13A	IN-VIP	NA	NA	NA
ACGGGCTGTCGACTGC-1_2_B4	19.14460858	21.87161636	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	986	1575	0.001904762	0.006349206	0	oligos	OL-Cntl	NA	NA	NA
ACGGGCTGTGAGCGAT-1_2_B4	-2.307538583	-1.077775119	13A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2614	4933	0.030002027	0.004054328	0	13A	IN-VIP	NA	NA	NA
ACGGGCTTCTCAAACG-1_2_B4	18.15858195	18.93020567	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1024	1604	0.00436409	0.003117207	0	oligos	OL-Cntl	NA	NA	NA
ACGGGTCAGCTAGCCC-1_2_B4	-23.56346309	22.5730269	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1303	2298	0.001740644	0.00435161	0	8	Astrocytes	NA	NA	NA
ACGGGTCCACAACTGT-1_2_B4	18.98100761	9.052595681	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1659	3137	0.009882053	0.003506535	0	oligos	OL-Cntl	NA	NA	NA
ACGGGTCGTATTACCG-1_2_B4	20.97289348	12.33719147	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1286	2273	0.008798944	0.001759789	0	oligos	OL-Cntl	NA	NA	NA
ACGGGTCGTCGTCTTC-1_2_B4	10.53246835	20.54908945	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	886	1315	0.002281369	0.009125475	0	oligos	OL-Cntl	NA	NA	NA
ACGGGTCTCAACACCA-1_2_B4	23.08226881	12.24204026	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1509	2628	0.00152207	0.00608828	0	oligos	OL-Cntl	NA	NA	NA
ACGGGTCTCATATCGG-1_2_B4	-1.329403209	22.05552952	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	745	1029	0.005830904	0.004859086	0	oligos	OL-Cntl	NA	NA	NA
ACGGGTCTCGTTTAGG-1_2_B4	0.755256908	27.42425361	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	746	1016	0	0.001968504	0	oligos	OL-Cntl	NA	NA	NA
ACGGGTCTCTCTGCTG-1_2_B4	25.68507429	-3.196972059	2	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3227	8289	0.000603209	0.001447702	0	2	EN-L4	NA	NA	NA
ACGGGTCTCTGCAGTA-1_2_B4	21.02911451	18.25401442	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1159	1840	0.00326087	0.005978261	0	oligos	OL-Cntl	NA	NA	NA
ACGTCAAAGCATGGCA-1_2_B4	-36.34229476	4.297749952	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2138	3919	0.00535851	0.002551671	0	9	OPC	NA	NA	NA
ACGTCAACACGCGAAA-1_2_B4	6.334784326	24.23232264	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	922	1384	0.002890173	0.007947977	0	oligos	OL-Cntl	NA	NA	NA
ACGTCAAGTCTGCCAG-1_2_B4	11.29787689	21.20815083	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	894	1348	0.002967359	0.011127596	0	oligos	OL-Cntl	NA	NA	NA
ACGTCAATCAAAGACA-1_2_B4	4.697888728	-7.42309854	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1314	1994	0.003009027	0.007021063	0	12	EN-MIX	NA	NA	NA
ACGTCAATCTCCCTGA-1_2_B4	26.96220157	0.350277562	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2921	7477	0.002139896	0.001337435	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACTATCTCAATACGCT-1_2_B4	20.51921096	15.42901387	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1168	1928	0.001556017	0.004149378	0	oligos	OL-Cntl	NA	NA	NA
ACTATCTTCGAACGGA-1_2_B4	-14.49143555	-16.68874939	6B	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1400	2366	0.035080304	0.009298394	0	6B	IN-SST	NA	NA	NA
ACTGAACAGTGCGTGA-1_2_B4	-29.51212011	19.01908733	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	931	1444	0.001385042	0.002077562	0	8	Astrocytes	NA	NA	NA
ACTGAACCAGGCTCAC-1_2_B4	19.23751697	14.24465729	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1195	1993	0.006021074	0.007526342	0	oligos	OL-Cntl	NA	NA	NA
ACTGAACGTCCCGACA-1_2_B4	37.93163825	13.77516758	14	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1063	1474	0.002035278	0.011533243	0	14	Microglia	NA	NA	NA
ACTGAGTGTAGGCTGA-1_2_B4	1.129706243	-19.38347801	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3203	7339	0.010083118	0.002997684	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACTGAGTTCACGAAGG-1_2_B4	-4.641381041	-8.292999066	13A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	766	1114	0.010771993	0.002692998	0	13A	IN-VIP	NA	NA	NA
ACTGAGTTCGTGACAT-1_2_B4	5.22908554	-15.3436859	4	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2754	5726	0.012574223	0.007160321	0	L2-3	EN-L2-3-MS	NA	NA	NA
ACTGATGAGAGAACAG-1_2_B4	0.776861383	-27.37265676	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3800	10368	0.003858025	0.001832562	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACTGATGCAATAGCAA-1_2_B4	9.182676117	-8.869348789	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2525	5733	0.005407291	0.002267574	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACTGATGCACGTGAGA-1_2_B4	-23.28364017	-2.190636543	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	949	1338	0.002989537	0.003736921	0	9	OPC	NA	NA	NA
ACTGATGGTAAGCACG-1_2_B4	19.77504568	20.02709454	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	991	1506	0.001992032	0.001992032	0	oligos	OL-Cntl	NA	NA	NA
ACTGCTCAGCTAGGCA-1_2_B4	-36.77417204	-0.827257475	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1462	2551	0.003136025	0.004312034	0	9	OPC	NA	NA	NA
ACTGCTCCACGAGAGT-1_2_B4	-31.994784	11.97691988	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	755	1134	0.012345679	0.00617284	0	8	Astrocytes	NA	NA	NA
ACTGCTCGTAAGGGCT-1_2_B4	13.93855842	28.27808928	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	742	1069	0	0.006548176	0	oligos	OL-Cntl	NA	NA	NA
ACTGCTCGTTAAAGAC-1_2_B4	15.84495996	23.13096856	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	911	1370	0.011678832	0.003649635	0	oligos	OL-Cntl	NA	NA	NA
ACTGCTCTCCCTTGCA-1_2_B4	13.42707646	29.64952594	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	799	1275	0.003137255	0.00627451	0	oligos	OL-Cntl	NA	NA	NA
ACTGCTCTCGGTCCGA-1_2_B4	14.11843001	28.10075052	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	788	1183	0.00591716	0.006762468	0	oligos	OL-Cntl	NA	NA	NA
ACTGTCCAGCCTCGTG-1_2_B4	-1.354018399	29.67743734	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	914	1257	0.00159109	0.007159905	0	oligos	OL-Cntl	NA	NA	NA
ACTGTCCAGCGATATA-1_2_B4	2.602198527	-7.648876369	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1414	2469	0.010125557	0.004860267	0	12	EN-MIX	NA	NA	NA
ACTGTCCCAATACGCT-1_2_B4	40.10865733	14.02542363	14	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1092	1581	0.001897533	0.003795066	0	14	Microglia	NA	NA	NA
ACTGTCCCATACGCTA-1_2_B4	-25.21884168	17.49922144	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1071	1623	0.01047443	0.004313001	0	8	Astrocytes	NA	NA	NA
ACTGTCCCATCGTCGG-1_2_B4	19.49348097	8.607092985	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1832	3331	0.00090063	0.006904833	0	oligos	OL-Cntl	NA	NA	NA
ACTGTCCGTACTCTCC-1_2_B4	19.40064079	10.11736787	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1468	2621	0.008012209	0.00305227	0	oligos	OL-Cntl	NA	NA	NA
ACTGTCCGTAGGAGTC-1_2_B4	5.814492881	31.41934292	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	789	1164	0.001718213	0.00257732	0	oligos	OL-Cntl	NA	NA	NA
ACTGTCCGTCAGATAA-1_2_B4	0.772193569	28.75773426	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	790	1123	0.003561888	0.003561888	0	oligos	OL-Cntl	NA	NA	NA
ACTGTCCGTCTTGTCC-1_2_B4	19.27025281	17.21829143	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1102	1761	0.002839296	0.00681431	0	oligos	OL-Cntl	NA	NA	NA
ACTGTCCTCAAACGGG-1_2_B4	10.09465169	21.0605715	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	913	1348	0.003709199	0.010385757	0	oligos	OL-Cntl	NA	NA	NA
ACTGTCCTCTCGTATT-1_2_B4	-35.21185676	-5.745769292	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1238	1937	0.008776458	0.002065049	0	9	OPC	NA	NA	NA
ACTGTCCTCTGAAAGA-1_2_B4	-23.89868678	23.77301643	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1429	2753	0.004722121	0.002905921	0	8	Astrocytes	NA	NA	NA
ACTTACTCAGGTGCCT-1_2_B4	-22.23923837	10.01945543	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	846	1218	0	0.00410509	0	8	Astrocytes	NA	NA	NA
ACTTACTGTTGTCGCG-1_2_B4	5.361726933	-2.103641153	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	715	1021	0.003917728	0.005876592	0	12	EN-MIX	NA	NA	NA
ACTTGTTAGCCACGCT-1_2_B4	-29.20853387	19.69404843	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1023	1669	0.001797484	0.002396645	0	8	Astrocytes	NA	NA	NA
ACTTGTTCATGTAAGA-1_2_B4	21.23672333	-8.02206199	3	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1240	1962	0.012232416	0.003058104	0	3	EN-L5-6	NA	NA	NA
ACTTGTTGTACACCGC-1_2_B4	22.60180169	0.086684737	2	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1765	3075	0.006504065	0.003252033	0	2	EN-L4	NA	NA	NA
ACTTGTTTCGGCATCG-1_2_B4	25.88570701	3.777788848	15BA	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	833	1119	0.011617516	0.00357462	0	15BA	Stromal cells	NA	NA	NA
ACTTTCACATTTCACT-1_2_B4	17.85482331	20.0761804	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	934	1581	0.001897533	0.003795066	0	oligos	OL-Cntl	NA	NA	NA
ACTTTCAGTTTCCACC-1_2_B4	-28.23931599	13.51158126	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	814	1278	0.007824726	0.000782473	0	8	Astrocytes	NA	NA	NA
ACTTTCATCCCTTGTG-1_2_B4	10.56298125	23.32636994	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	777	1210	0.000826446	0.009917355	0	oligos	OL-Cntl	NA	NA	NA
ACTTTCATCGCTAGCG-1_2_B4	-22.96599749	22.90522261	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1420	2489	0.004419446	0.005624749	0	8	Astrocytes	NA	NA	NA
AGAATAGAGATCACGG-1_2_B4	10.63799465	-7.445243297	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2329	4641	0.006895066	0.002370179	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AGAATAGGTATAGGGC-1_2_B4	14.99682648	23.56202204	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	856	1297	0.00616808	0.0077101	0	oligos	OL-Cntl	NA	NA	NA
AGAATAGTCCTCTAGC-1_2_B4	-3.543587336	-7.66790428	13A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	735	1080	0.028703704	0.005555556	0	13A	IN-VIP	NA	NA	NA
AGACGTTCAGGGAGAG-1_2_B4	21.42232458	17.53866665	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1167	1797	0.000556483	0.006677796	0	oligos	OL-Cntl	NA	NA	NA
AGACGTTGTAGTGAAT-1_2_B4	-16.82300373	14.39701287	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1476	2360	0.003813559	0.005084746	0	8	Astrocytes	NA	NA	NA
AGACGTTTCCAAGCCG-1_2_B4	16.07308658	18.31007879	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	991	1693	0.001181335	0.006497342	0	oligos	OL-Cntl	NA	NA	NA
AGACGTTTCCTAGAAC-1_2_B4	14.53284179	21.51680619	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	895	1280	0.0015625	0.00859375	0	oligos	OL-Cntl	NA	NA	NA
AGAGCGAAGCCCGAAA-1_2_B4	2.783250934	-19.5292018	4	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3184	7307	0.012727522	0.007527029	0	L2-3	EN-L2-3-MS	NA	NA	NA
AGAGCGAAGGGCTTCC-1_2_B4	26.74361493	0.135919729	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2971	7173	0.00167294	0.00083647	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AGAGCGACAGTAGAGC-1_2_B4	22.38142686	-6.380424847	11	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1888	3377	0.009475866	0.001480604	0	11	Glia-MIX	NA	NA	NA
AGAGCGACATGAGCGA-1_2_B4	17.39746667	15.49036857	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1114	1797	0.002782415	0.008347245	0	oligos	OL-Cntl	NA	NA	NA
AGAGCGACATGTCCTC-1_2_B4	21.40863149	10.75019399	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1361	2265	0.00397351	0.00397351	0	oligos	OL-Cntl	NA	NA	NA
AGAGCGAGTGACTACT-1_2_B4	23.13366449	-9.219620159	3	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2952	6374	0.000156887	0.002667085	0	3	EN-L5-6	NA	NA	NA
AGAGCGAGTTACGACT-1_2_B4	1.671959228	25.63636516	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	762	1085	0.010138249	0.013824885	0	oligos	OL-Cntl	NA	NA	NA
AGAGCGATCACCATAG-1_2_B4	0.5887605	26.03373936	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	774	1092	0.011904762	0.001831502	0	oligos	OL-Cntl	NA	NA	NA
AGAGCTTAGATCGATA-1_2_B4	21.85166447	15.85476598	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1363	2214	0.012646793	0.006323397	0	oligos	OL-Cntl	NA	NA	NA
AGAGCTTAGTGAACAT-1_2_B4	20.18247184	17.80925964	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1082	1605	0.003738318	0.009968847	0	oligos	OL-Cntl	NA	NA	NA
AGAGCTTCATGAGCGA-1_2_B4	-36.35187475	-9.452473549	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	895	1299	0.006928406	0.001539646	0	9	OPC	NA	NA	NA
AGAGCTTGTCAACTGT-1_2_B4	-35.65408437	-7.476585725	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1111	1760	0.001704545	0.001704545	0	9	OPC	NA	NA	NA
AGAGTGGAGCTGCAAG-1_2_B4	-15.50146371	-10.08305759	13B	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2293	4595	0.015669206	0.001088139	0	13B	IN-SV2C	NA	NA	NA
AGAGTGGTCCGAACGC-1_2_B4	15.09414908	18.13372815	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1079	1599	0.005003127	0.003752345	0	oligos	OL-Cntl	NA	NA	NA
AGATCTGCAGGAATGC-1_2_B4	22.82037406	1.135209513	2	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1705	3288	0.02189781	0.00243309	0	2	EN-L4	NA	NA	NA
AGATCTGTCGATCCCT-1_2_B4	30.62414197	-1.391181277	2	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2830	6406	0.004058695	0.004995317	0	2	EN-L4	NA	NA	NA
AGATCTGTCGTTACAG-1_2_B4	19.9260319	-6.87167801	3	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1995	4349	0.002069441	0.001379628	0	3	EN-L5-6	NA	NA	NA
AGATCTGTCTAGCACA-1_2_B4	-22.8020671	-1.019802577	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1092	1636	0.003056235	0.001222494	0	9	OPC	NA	NA	NA
AGATTGCAGAACAACT-1_2_B4	-12.76245073	14.89465272	11	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	998	1429	0.00349895	0.006997901	0	11	Glia-MIX	NA	NA	NA
AGATTGCCACATTCGA-1_2_B4	17.985786	1.553070367	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	985	1542	0.022697795	0.001297017	0	12	EN-MIX	NA	NA	NA
AGATTGCGTTGTGGCC-1_2_B4	36.65468466	15.00236747	14	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1160	1580	0.005063291	0.019620253	0	14	Microglia	NA	NA	NA
AGCAGCCAGCGATGAC-1_2_B4	3.110233149	-20.82857463	4	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3293	7487	0.003339121	0.005743288	0	L2-3	EN-L2-3-MS	NA	NA	NA
AGCAGCCAGGATGGTC-1_2_B4	18.64686968	22.22733428	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1080	1631	0.002452483	0.003678725	0	oligos	OL-Cntl	NA	NA	NA
AGCAGCCAGGTGATTA-1_2_B4	2.87894876	-25.9209143	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	5020	15030	0.01237525	0.001996008	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AGCAGCCAGTTGAGTA-1_2_B4	-0.212773956	29.45040003	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	741	1042	0.002879079	0.005758157	0	oligos	OL-Cntl	NA	NA	NA
AGCAGCCCACGGACAA-1_2_B4	18.45331257	-4.849565203	3	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2089	4855	0.001441813	0.002471679	0	3	EN-L5-6	NA	NA	NA
AGCAGCCCAGCTGTAT-1_2_B4	21.97530476	11.97941562	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1382	2200	0.002272727	0.007727273	0	oligos	OL-Cntl	NA	NA	NA
AGCAGCCCAGTGACAG-1_2_B4	-36.20025057	-5.637961769	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1228	1967	0.00305033	0.007625826	0	9	OPC	NA	NA	NA
AGCAGCCCATGCCCGA-1_2_B4	20.77820731	11.02698155	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1552	2643	0.009837306	0.004918653	0	oligos	OL-Cntl	NA	NA	NA
AGCAGCCGTAATCACC-1_2_B4	1.581644071	-16.7534182	4	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2528	5211	0.007484168	0.003070428	0	L2-3	EN-L2-3-MS	NA	NA	NA
AGCAGCCGTTCCCGAG-1_2_B4	14.7240863	22.85750132	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	906	1404	0.003561254	0.006410256	0	oligos	OL-Cntl	NA	NA	NA
AGCAGCCGTTCGGGCT-1_2_B4	18.53441445	25.64248554	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	979	1439	0.004864489	0.00694927	0	oligos	OL-Cntl	NA	NA	NA
AGCAGCCTCAAAGACA-1_2_B4	-4.221352834	26.68629227	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	972	1429	0.007697691	0.006298111	0	oligos	OL-Cntl	NA	NA	NA
AGCAGCCTCCGCTGTT-1_2_B4	25.59460035	-4.251576825	2	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	4822	13786	0.001233135	0.002031046	0	2	EN-L4	NA	NA	NA
AGCATACAGCGACGTA-1_2_B4	16.15503331	25.37111975	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	806	1098	0.000910747	0.005464481	0	oligos	OL-Cntl	NA	NA	NA
AGCATACAGGATGCGT-1_2_B4	-30.69501478	-13.16089663	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	774	1069	0.004677268	0.003741815	0	9	OPC	NA	NA	NA
AGCATACAGTCATGCT-1_2_B4	6.916588994	25.5547855	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	933	1353	0.005173688	0.006651885	0	oligos	OL-Cntl	NA	NA	NA
AGCATACAGTGTACTC-1_2_B4	23.70602772	17.93020151	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1298	2166	0.002308403	0.005078486	0	oligos	OL-Cntl	NA	NA	NA
AGCATACCACGGCGTT-1_2_B4	13.95571318	30.12632236	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	850	1224	0.004901961	0.000816993	0	oligos	OL-Cntl	NA	NA	NA
AGCATACCAGATTGCT-1_2_B4	16.59056016	21.096585	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	926	1368	0.005847953	0.005116959	0	oligos	OL-Cntl	NA	NA	NA
AGCATACGTACCATCA-1_2_B4	-1.553093146	-16.40408656	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2528	5625	0.004977778	0.002488889	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AGCATACGTGGTCTCG-1_2_B4	3.567421195	27.58417773	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	797	1147	0.00087184	0.006974717	0	oligos	OL-Cntl	NA	NA	NA
AGCCTAAAGATGTAAC-1_2_B4	22.85572595	12.61411321	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1407	2260	0.001769912	0.001769912	0	oligos	OL-Cntl	NA	NA	NA
AGCCTAACAAAGGCGT-1_2_B4	18.83964397	6.202996815	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2646	5417	0.005353517	0.004799705	0	oligos	OL-Cntl	NA	NA	NA
AGCCTAACAAGGCTCC-1_2_B4	1.686839069	23.35638245	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	716	1021	0.009794319	0.007835455	0	oligos	OL-Cntl	NA	NA	NA
AGCCTAACAGACAAGC-1_2_B4	3.30837322	30.61654066	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	711	1006	0.001988072	0.005964215	0	oligos	OL-Cntl	NA	NA	NA
AGCCTAAGTCCCTTGT-1_2_B4	-20.66384923	9.18163315	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	964	1361	0.004408523	0.005878031	0	8	Astrocytes	NA	NA	NA
AGCGGTCAGGTGCACA-1_2_B4	15.30017442	20.08202481	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	991	1558	0.002567394	0.007702182	0	oligos	OL-Cntl	NA	NA	NA
AGCGGTCAGTGCGTGA-1_2_B4	7.507629992	-15.37843797	4	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3313	7228	0.027255119	0.005672385	0	L2-3	EN-L2-3-MS	NA	NA	NA
AGCGGTCAGTGGTAGC-1_2_B4	-20.85125261	8.148448774	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	713	1016	0.025590551	0.005905512	0	8	Astrocytes	NA	NA	NA
AGCGGTCCAAACTGCT-1_2_B4	-35.111636	5.040766432	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2425	4733	0.001267695	0.002112825	0	9	OPC	NA	NA	NA
AGCGGTCCACCTTGTC-1_2_B4	-28.38221577	10.75451866	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	733	1065	0.015962441	0.001877934	0	8	Astrocytes	NA	NA	NA
AGCGGTCGTTGCTCCT-1_2_B4	21.43907188	8.041001913	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1767	3061	0.001633453	0.00522705	0	oligos	OL-Cntl	NA	NA	NA
AGCGGTCTCACGACTA-1_2_B4	4.882770216	26.77637836	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	803	1131	0.00530504	0.008841733	0	oligos	OL-Cntl	NA	NA	NA
AGCGGTCTCAGCCTAA-1_2_B4	6.876506709	23.96201355	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	942	1327	0.005275057	0.007535795	0	oligos	OL-Cntl	NA	NA	NA
AGCGGTCTCCTTTCTC-1_2_B4	15.036839	-33.65739948	3	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	5797	23099	0.000649379	0.003506645	0	3	EN-L5-6	NA	NA	NA
AGCGGTCTCTTTACGT-1_2_B4	12.94491157	21.01246847	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	961	1440	0.004861111	0.006944444	0	oligos	OL-Cntl	NA	NA	NA
AGCGTATCACATTCGA-1_2_B4	4.23847203	29.98344416	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	717	1044	0.005747126	0.004789272	0	oligos	OL-Cntl	NA	NA	NA
AGCGTATCACCATCCT-1_2_B4	-13.16079425	-23.72291191	6A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1181	1988	0.023138833	0.004024145	0	6A	IN-PV	NA	NA	NA
AGCGTATCATCCTTGC-1_2_B4	3.040166764	25.35007971	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	729	1002	0.001996008	0.006986028	0	oligos	OL-Cntl	NA	NA	NA
AGCGTATTCACTCTTA-1_2_B4	25.77987955	-0.742264509	2	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2589	5642	0.000886211	0.004431053	0	2	EN-L4	NA	NA	NA
AGCGTATTCAGAGCTT-1_2_B4	7.47303113	20.1196512	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	931	1311	0.003813883	0.009153318	0	oligos	OL-Cntl	NA	NA	NA
AGCGTATTCCAAGTAC-1_2_B4	19.63529681	12.08813806	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1406	2360	0.005508475	0.005508475	0	oligos	OL-Cntl	NA	NA	NA
AGCGTATTCCTTGCCA-1_2_B4	3.233261632	-2.712448336	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	682	1153	0.004336513	0.003469211	0	12	EN-MIX	NA	NA	NA
AGCGTCGAGCTCCTTC-1_2_B4	22.12111412	12.42564422	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1332	2047	0.002931119	0.006350757	0	oligos	OL-Cntl	NA	NA	NA
AGCGTCGGTCCTCTTG-1_2_B4	-27.10141414	24.74386596	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1309	2342	0.001280956	0.003415884	0	8	Astrocytes	NA	NA	NA
AGCGTCGTCCGTTGCT-1_2_B4	8.833499823	-7.455587772	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1728	2945	0.013921902	0.003395586	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AGCTCCTAGGTGTGGT-1_2_B4	6.154228904	-8.185430051	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1594	2554	0.018402506	0.005481597	0	12	EN-MIX	NA	NA	NA
AGCTCCTAGTGAAGTT-1_2_B4	-0.297110058	29.10516887	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	809	1139	0.004389816	0.005267779	0	oligos	OL-Cntl	NA	NA	NA
AGCTCCTCAAGCCCAC-1_2_B4	-11.5162222	14.51040725	11	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1105	1612	0.006203474	0.008064516	0	11	Glia-MIX	NA	NA	NA
AGCTCCTCACCAGGCT-1_2_B4	22.12831563	11.65440091	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1522	2682	0.005592841	0.003728561	0	oligos	OL-Cntl	NA	NA	NA
AGCTCCTCAGTCACTA-1_2_B4	-0.4863188	0.87094917	11	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1312	2116	0.020321361	0.004725898	0	11	Glia-MIX	NA	NA	NA
AGCTCCTTCTCTGCTG-1_2_B4	39.6557506	13.4309998	14	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1076	1652	0.004842615	0.013922518	0	14	Microglia	NA	NA	NA
AGCTCCTTCTGGCGTG-1_2_B4	-28.36896731	21.74305683	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1145	1756	0.003986333	0.002277904	0	8	Astrocytes	NA	NA	NA
AGCTCCTTCTTCGGTC-1_2_B4	-16.84207387	-18.17221215	6B	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1963	3675	0.021496599	0.008979592	0	6B	IN-SST	NA	NA	NA
AGCTCTCAGACAGAGA-1_2_B4	-11.80225728	-21.89585708	6A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1072	1861	0.010209565	0.001612037	0	6A	IN-PV	NA	NA	NA
AGCTCTCAGCCCAGCT-1_2_B4	-1.870379475	-21.36983243	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3802	9626	0.00176605	0.002597133	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AGCTCTCAGGAACTGC-1_2_B4	17.3875705	23.55392203	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	911	1339	0.00746826	0.002987304	0	oligos	OL-Cntl	NA	NA	NA
AGCTCTCAGGGTTTCT-1_2_B4	-23.8365994	22.14790675	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1271	2062	0.003394762	0.004849661	0	8	Astrocytes	NA	NA	NA
AGCTCTCAGTTAACGA-1_2_B4	25.04433148	-0.483117788	2	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2616	5489	0.001275278	0.003097103	0	2	EN-L4	NA	NA	NA
AGCTCTCCAAAGTGCG-1_2_B4	0.213628877	28.80635462	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	728	1020	0.007843137	0.007843137	0	oligos	OL-Cntl	NA	NA	NA
AGCTCTCCAATTCCTT-1_2_B4	-0.146582371	25.5035657	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	718	1012	0.007905138	0.009881423	0	oligos	OL-Cntl	NA	NA	NA
AGCTCTCCATACGCCG-1_2_B4	6.585019183	24.17100014	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	941	1369	0.002921841	0.010226443	0	oligos	OL-Cntl	NA	NA	NA
AGCTCTCGTGTGGCTC-1_2_B4	-39.33187931	-0.953244526	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1346	2395	0.00125261	0.002922756	0	9	OPC	NA	NA	NA
AGCTCTCTCGCACTCT-1_2_B4	-19.02194854	-18.32224778	6A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2400	5060	0.004347826	0.003162055	0	6A	IN-PV	NA	NA	NA
AGCTCTCTCTTGCCGT-1_2_B4	16.301305	21.1754293	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	974	1504	0.003324468	0.001994681	0	oligos	OL-Cntl	NA	NA	NA
AGCTTGACAGCCAGAA-1_2_B4	23.55603687	0.480380446	2	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1873	3661	0.012564873	0.001912046	0	2	EN-L4	NA	NA	NA
AGCTTGAGTGAGGGTT-1_2_B4	13.46560698	-28.55769415	3	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2641	5735	0.004882302	0.002441151	0	3	EN-L5-6	NA	NA	NA
AGCTTGAGTTAAAGAC-1_2_B4	39.46388152	12.98638458	14	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1078	1535	0.000651466	0.005863192	0	14	Microglia	NA	NA	NA
AGCTTGATCATTTGGG-1_2_B4	4.34317065	-5.099595666	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	813	1337	0.000747943	0.002991773	0	12	EN-MIX	NA	NA	NA
AGGCCACAGCCACGCT-1_2_B4	13.70905236	26.71087505	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	705	1045	0.012440191	0.007655502	0	oligos	OL-Cntl	NA	NA	NA
AGGCCACAGCGTTCCG-1_2_B4	13.56488981	27.84446012	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	707	1038	0	0.007707129	0	oligos	OL-Cntl	NA	NA	NA
AGGCCACGTGTTCGAT-1_2_B4	23.47907895	12.45371269	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1456	2413	0.002486531	0.002072109	0	oligos	OL-Cntl	NA	NA	NA
AGGCCACGTTACAGAA-1_2_B4	14.64731275	-29.52087952	3	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	4662	13946	0.002151154	0.004374014	0	3	EN-L5-6	NA	NA	NA
AGGCCGTAGAGTGACC-1_2_B4	18.75998477	7.419065636	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2056	3625	0.008551724	0.004689655	0	oligos	OL-Cntl	NA	NA	NA
AGGCCGTAGCACCGTC-1_2_B4	-36.91428506	-4.074098906	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1332	2262	0.003536693	0.00265252	0	9	OPC	NA	NA	NA
AGGCCGTAGTACATGA-1_2_B4	13.27299178	16.44661423	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1088	1672	0.002392344	0.010167464	0	oligos	OL-Cntl	NA	NA	NA
AGGCCGTGTAGAAAGG-1_2_B4	14.12902962	28.57908412	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	731	1071	0.003734827	0	0	oligos	OL-Cntl	NA	NA	NA
AGGCCGTTCATTTGGG-1_2_B4	15.97342776	28.14037777	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	913	1374	0.004366812	0.004366812	0	oligos	OL-Cntl	NA	NA	NA
AGGGAGTCACCCATTC-1_2_B4	17.51140697	15.53783167	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1129	1870	0.003208556	0.00802139	0	oligos	OL-Cntl	NA	NA	NA
AGGGAGTCACCTATCC-1_2_B4	1.896508738	-31.55167714	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	5949	21628	0.001664509	0.0030516	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AGGGAGTGTTAGAACA-1_2_B4	17.71509134	1.735337384	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	935	1388	0.007204611	0.004322767	0	12	EN-MIX	NA	NA	NA
AGGGAGTTCACCCTCA-1_2_B4	0.489553588	26.38786478	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	749	1053	0.004748338	0.010446344	0	oligos	OL-Cntl	NA	NA	NA
AGGGATGAGGCAAAGA-1_2_B4	16.24431259	22.2074466	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	931	1379	0.002175489	0.002900653	0	oligos	OL-Cntl	NA	NA	NA
AGGGATGAGTGGTAGC-1_2_B4	-1.867045589	22.66735687	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	766	1106	0.008137432	0.004520796	0	oligos	OL-Cntl	NA	NA	NA
AGGGATGCACTTGGAT-1_2_B4	3.678824354	-7.001309286	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1169	1749	0.014865638	0.002287021	0	12	EN-MIX	NA	NA	NA
AGGGATGCATTATCTC-1_2_B4	-20.78793527	-16.57644319	6B	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3090	7150	0.017902098	0.005594406	0	6B	IN-SST	NA	NA	NA
AGGGATGGTTATGTGC-1_2_B4	3.815231981	-3.121394021	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	872	1234	0.026742301	0.006482982	0	12	EN-MIX	NA	NA	NA
AGGGATGTCTTGTATC-1_2_B4	2.182144249	29.44440833	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	748	1019	0.003925417	0.004906771	0	oligos	OL-Cntl	NA	NA	NA
AGGGTGAGTCATTAGC-1_2_B4	-35.67185966	-6.62061057	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1104	1701	0.013521458	0.001763668	0	9	OPC	NA	NA	NA
AGGGTGATCCCATTTA-1_2_B4	-0.398657066	24.60062781	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	721	1006	0.002982107	0.005964215	0	oligos	OL-Cntl	NA	NA	NA
AGGGTGATCCGAACGC-1_2_B4	40.61698046	14.55990147	14	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1116	1548	0.003875969	0.010335917	0	14	Microglia	NA	NA	NA
AGGTCATAGCCGGTAA-1_2_B4	-23.83902153	18.52783008	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1290	2043	0.001957905	0.004894763	0	8	Astrocytes	NA	NA	NA
AGGTCATAGCGATTCT-1_2_B4	32.57247863	14.83734447	14	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	766	1040	0	0.065384615	0	14	Microglia	NA	NA	NA
AGGTCATAGCTAAACA-1_2_B4	18.18941507	16.74376247	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1031	1516	0.004617414	0.006596306	0	oligos	OL-Cntl	NA	NA	NA
AGGTCATCAACTGCTA-1_2_B4	12.56180732	27.56613019	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	770	1166	0.003430532	0.007718696	0	oligos	OL-Cntl	NA	NA	NA
AGGTCATCAAGACACG-1_2_B4	-4.50049997	-8.202024331	13A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	848	1220	0.018032787	0.000819672	0	13A	IN-VIP	NA	NA	NA
AGGTCATGTACGACCC-1_2_B4	6.724985755	-29.00600215	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3665	9349	0.010696331	0.002139266	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AGGTCCGAGTAATCCC-1_2_B4	0.448985689	28.90358563	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	726	1006	0.000994036	0.007952286	0	oligos	OL-Cntl	NA	NA	NA
AGGTCCGGTACATCCA-1_2_B4	-28.35765828	20.69666658	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1105	1674	0.003584229	0.009557945	0	8	Astrocytes	NA	NA	NA
AGGTCCGGTCGATTGT-1_2_B4	-12.21884169	15.22616778	11	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1074	1630	0.002453988	0.006134969	0	11	Glia-MIX	NA	NA	NA
AGGTCCGGTGCACGAA-1_2_B4	5.221242612	26.1889939	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	793	1166	0.000857633	0.008576329	0	oligos	OL-Cntl	NA	NA	NA
AGGTCCGTCATTGCCC-1_2_B4	15.26902666	-30.802329	3	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3479	8771	0.002622278	0.003990423	0	3	EN-L5-6	NA	NA	NA
AGGTCCGTCCGCTGTT-1_2_B4	-23.96947496	-2.832434367	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	992	1573	0.004450095	0.004450095	0	9	OPC	NA	NA	NA
AGGTCCGTCGAGAACG-1_2_B4	22.48157012	19.30265225	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1128	1781	0.003930376	0.002245929	0	oligos	OL-Cntl	NA	NA	NA
AGTAGTCAGCGAGAAA-1_2_B4	-4.283067341	-8.396367989	13A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	754	1111	0.01350135	0.00450045	0	13A	IN-VIP	NA	NA	NA
AGTAGTCAGTGAAGAG-1_2_B4	19.61972013	0.447417254	2	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1290	2129	0.030530766	0.00234852	0	2	EN-L4	NA	NA	NA
AGTAGTCAGTTCCACA-1_2_B4	2.966351484	-28.11662267	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3294	8868	0.00067659	0.001917005	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AGTAGTCCAATCTGCA-1_2_B4	-18.72561601	-23.20724542	6A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2261	4514	0.04120514	0.003322995	0	6A	IN-PV	NA	NA	NA
AGTAGTCCATCACAAC-1_2_B4	21.60985614	18.10778	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1049	1567	0.010210593	0.002552648	0	oligos	OL-Cntl	NA	NA	NA
AGTAGTCTCACATGCA-1_2_B4	-3.51755403	-7.614601462	13A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	797	1194	0.011725293	0.002512563	0	13A	IN-VIP	NA	NA	NA
AGTCTTTAGAGGTTGC-1_2_B4	0.396324195	0.883660664	11	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1108	1682	0.034482759	0.005350773	0	11	Glia-MIX	NA	NA	NA
AGTCTTTTCGCAAGCC-1_2_B4	22.22237055	13.4443531	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1246	2039	0.000980873	0.004904365	0	oligos	OL-Cntl	NA	NA	NA
AGTGAGGAGTCCTCCT-1_2_B4	23.10960379	12.27426673	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1494	2469	0.004455245	0.004050223	0	oligos	OL-Cntl	NA	NA	NA
AGTGGGAAGATGCCTT-1_2_B4	16.16620735	27.68629861	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	771	1102	0.002722323	0.003629764	0	oligos	OL-Cntl	NA	NA	NA
AGTGGGAAGCTATGCT-1_2_B4	31.68316919	-1.105553976	2	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2478	4727	0.002961709	0.003596361	0	2	EN-L4	NA	NA	NA
AGTGGGACATGCCTAA-1_2_B4	-9.048103666	-16.39971406	6B	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	785	1107	0.018066847	0.002710027	0	6B	IN-SST	NA	NA	NA
AGTGGGAGTGACGCCT-1_2_B4	0.469825776	29.03823776	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	840	1148	0.006097561	0.007839721	0	oligos	OL-Cntl	NA	NA	NA
AGTGTCAAGCTGTCTA-1_2_B4	2.464621413	-8.278357785	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1447	2438	0.006562756	0.004101723	0	12	EN-MIX	NA	NA	NA
AGTGTCAGTATGGTTC-1_2_B4	0.049007799	30.95601725	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	904	1270	0.002362205	0.012598425	0	oligos	OL-Cntl	NA	NA	NA
AGTGTCAGTGCACCAC-1_2_B4	-9.02617723	16.27242934	11	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2493	4550	0.002197802	0.004175824	0	11	Glia-MIX	NA	NA	NA
AGTGTCATCACTTCAT-1_2_B4	-35.1177245	-3.618464776	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1336	2287	0.006121557	0.006996065	0	9	OPC	NA	NA	NA
AGTTGGTAGCTACCTA-1_2_B4	-10.80980614	17.89333946	11	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1615	2950	0.000338983	0.003728814	0	11	Glia-MIX	NA	NA	NA
AGTTGGTAGTCCTCCT-1_2_B4	22.88256083	12.00486637	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1525	2749	0.002910149	0.003637686	0	oligos	OL-Cntl	NA	NA	NA
AGTTGGTCATTAGCCA-1_2_B4	2.478487151	-6.67027037	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1190	1992	0.010542169	0.003514056	0	12	EN-MIX	NA	NA	NA
AGTTGGTGTTAGATGA-1_2_B4	15.58065267	-2.070563118	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	882	1394	0.003586801	0	0	12	EN-MIX	NA	NA	NA
ATAACGCGTATAATGG-1_2_B4	-0.476132101	26.02479797	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	698	1011	0.013847676	0.002967359	0	oligos	OL-Cntl	NA	NA	NA
ATAACGCTCCCTTGCA-1_2_B4	14.78890767	27.78622786	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	716	1044	0.003831418	0.002873563	0	oligos	OL-Cntl	NA	NA	NA
ATAACGCTCTTGTCAT-1_2_B4	0.663039488	-13.8036606	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2037	3969	0.030234316	0.003023432	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ATAAGAGCAGCGTCCA-1_2_B4	16.7899985	19.3986678	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1048	1678	0.001787843	0.008939213	0	oligos	OL-Cntl	NA	NA	NA
ATAAGAGGTTGTGGAG-1_2_B4	1.988662749	-12.77762712	4	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1792	3194	0.009079524	0.004696306	0	L2-3	EN-L2-3-MS	NA	NA	NA
ATAGACCAGACCCACC-1_2_B4	4.401631372	-30.2730719	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3388	9622	0.000415714	0.001974641	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ATAGACCAGCGATCCC-1_2_B4	18.16300276	18.4687507	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1062	1692	0.002364066	0.005319149	0	oligos	OL-Cntl	NA	NA	NA
ATAGACCAGGTACTCT-1_2_B4	-23.49844987	23.13590325	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1356	2503	0.001598082	0.003196165	0	8	Astrocytes	NA	NA	NA
ATAGACCCACTTACGA-1_2_B4	7.558077382	-7.176191771	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1387	2381	0.00251995	0.004199916	0	12	EN-MIX	NA	NA	NA
ATAGACCCATATACCG-1_2_B4	14.01518621	27.01457115	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	698	1062	0.003766478	0.002824859	0	oligos	OL-Cntl	NA	NA	NA
ATAGACCGTTCATGGT-1_2_B4	9.374220192	-6.796985854	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1592	3129	0.006391818	0.001917546	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ATCACGAAGATGAGAG-1_2_B4	-23.19709256	-2.120656652	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	866	1123	0.007123776	0.00445236	0	9	OPC	NA	NA	NA
ATCACGAGTCTTGATG-1_2_B4	-26.33070135	11.03438687	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	739	1058	0	0.002835539	0	8	Astrocytes	NA	NA	NA
ATCACGATCAGAGCTT-1_2_B4	-7.484191847	-6.956060403	13A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1205	1851	0.016747704	0.007023231	0	13A	IN-VIP	NA	NA	NA
ATCACGATCCCATTAT-1_2_B4	13.66443403	26.50445155	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	805	1320	0.001515152	0.00530303	0	oligos	OL-Cntl	NA	NA	NA
ATCACGATCCGTTGTC-1_2_B4	6.513349241	-5.8332735	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1279	2205	0.010884354	0.003628118	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ATCACGATCTTGCAAG-1_2_B4	-30.0140288	20.67808121	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	913	1496	0.001336898	0.007352941	0	8	Astrocytes	NA	NA	NA
ATCATCTAGACCGGAT-1_2_B4	19.08597231	16.1153358	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1239	1913	0.001568217	0.005750131	0	oligos	OL-Cntl	NA	NA	NA
ATCATCTCAAGAGTCG-1_2_B4	25.09258543	-28.49208841	3	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3387	8503	0.001764083	0.002469717	0	3	EN-L5-6	NA	NA	NA
ATCATCTCACCACGTG-1_2_B4	17.2533591	21.7635526	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	945	1383	0.006507592	0.003615329	0	oligos	OL-Cntl	NA	NA	NA
ATCATCTCACGGTTTA-1_2_B4	14.68886632	27.40752146	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	794	1221	0.003276003	0.003276003	0	oligos	OL-Cntl	NA	NA	NA
ATCATCTGTAGCTAAA-1_2_B4	32.04113422	-1.638915145	2	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2282	4529	0.009052771	0.003753588	0	2	EN-L4	NA	NA	NA
ATCATCTTCCTTTCTC-1_2_B4	21.34410535	19.62727131	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	952	1482	0.000674764	0	0	oligos	OL-Cntl	NA	NA	NA
ATCATGGAGAGGACGG-1_2_B4	-5.629952521	-4.978045901	13A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1138	1740	0.042528736	0.003448276	0	13A	IN-VIP	NA	NA	NA
ATCATGGAGTCATGCT-1_2_B4	2.885136112	-25.92454171	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3657	9653	0.007251632	0.002279084	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ATCCACCAGACCCACC-1_2_B4	12.45976347	31.82716717	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	675	1015	0.003940887	0.001970443	0	oligos	OL-Cntl	NA	NA	NA
ATCCACCAGCTAGTCT-1_2_B4	21.35142591	7.538337183	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1945	3403	0.002350867	0.004114017	0	oligos	OL-Cntl	NA	NA	NA
ATCCACCCACCGAAAG-1_2_B4	20.45672695	22.58323627	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1042	1603	0.003742982	0.003742982	0	oligos	OL-Cntl	NA	NA	NA
ATCCACCCATCGTCGG-1_2_B4	20.87168417	7.164239964	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2583	5299	0.004906586	0.003963012	0	oligos	OL-Cntl	NA	NA	NA
ATCCACCGTAGCGTCC-1_2_B4	-1.557427621	-15.91245895	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2015	3890	0.003856041	0.002056555	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ATCCACCGTCAATGTC-1_2_B4	-23.83663203	-1.35547689	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1291	1997	0.005007511	0.00450676	0	9	OPC	NA	NA	NA
ATCCACCGTCTCCACT-1_2_B4	-6.315036929	-7.319813103	13A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	944	1356	0.011061947	0.005899705	0	13A	IN-VIP	NA	NA	NA
ATCCACCGTGACCAAG-1_2_B4	9.898844441	29.04099809	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	701	1071	0.008403361	0.006535948	0	oligos	OL-Cntl	NA	NA	NA
ATCCACCGTTACGCGC-1_2_B4	-13.89943246	-17.97342999	6B	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1396	2577	0.026387272	0.004656577	0	6B	IN-SST	NA	NA	NA
ATCCACCTCACCTCGT-1_2_B4	6.096724344	-5.462668625	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1137	2116	0.003308129	0.00047259	0	12	EN-MIX	NA	NA	NA
ATCCGAAAGACAATAC-1_2_B4	15.25603085	28.72376381	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	772	1117	0.004476276	0.00179051	0	oligos	OL-Cntl	NA	NA	NA
ATCCGAAAGTCATCCA-1_2_B4	-11.83610953	-2.891931571	13A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2150	3688	0.012472885	0.011388286	0	13A	IN-VIP	NA	NA	NA
ATCCGAACAATGGAGC-1_2_B4	-24.28808832	18.18044141	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1189	2079	0.002405002	0.006734007	0	8	Astrocytes	NA	NA	NA
ATCCGAACACCAGCAC-1_2_B4	-22.9415255	27.12590986	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1679	3190	0.002821317	0.004702194	0	8	Astrocytes	NA	NA	NA
ATCCGAATCCACGAAT-1_2_B4	2.949781178	23.92661798	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	795	1150	0.008695652	0.003478261	0	oligos	OL-Cntl	NA	NA	NA
ATCGAGTAGATGTCGG-1_2_B4	-5.093732815	-7.569919816	13A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	957	1381	0.024619841	0.002896452	0	13A	IN-VIP	NA	NA	NA
ATCGAGTAGCGGCTTC-1_2_B4	2.647286666	-7.970611775	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1335	2159	0.005094951	0.002779064	0	12	EN-MIX	NA	NA	NA
ATCGAGTAGTCAAGGC-1_2_B4	15.91161133	15.90200681	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1132	1690	0.007692308	0.007100592	0	oligos	OL-Cntl	NA	NA	NA
ATCGAGTCAAAGGAAG-1_2_B4	-2.268929902	-1.113692733	11	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2220	4015	0.037858032	0.003237858	0	11	Glia-MIX	NA	NA	NA
ATCGAGTCACCAGGTC-1_2_B4	-0.758089606	25.16865408	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	724	1065	0.007511737	0.004694836	0	oligos	OL-Cntl	NA	NA	NA
ATCGAGTCATCTCGCT-1_2_B4	-20.881963	9.251512657	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	990	1514	0.002642008	0.003963012	0	8	Astrocytes	NA	NA	NA
ATCGAGTGTCACCTAA-1_2_B4	17.35979749	19.53433686	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1007	1565	0.002555911	0.005111821	0	oligos	OL-Cntl	NA	NA	NA
ATCGAGTGTCCATGAT-1_2_B4	1.569626083	25.00426599	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	722	1043	0.004793864	0.009587728	0	oligos	OL-Cntl	NA	NA	NA
ATCGAGTTCAGTACGT-1_2_B4	1.837512754	-5.316154322	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1046	1644	0.01216545	0.003649635	0	12	EN-MIX	NA	NA	NA
ATCGAGTTCATTATCC-1_2_B4	-35.92372295	-0.331158253	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1677	3031	0.000989772	0.001649621	0	9	OPC	NA	NA	NA
ATCGAGTTCCGGGTGT-1_2_B4	-28.15336993	21.4923205	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1120	1823	0.008228195	0.003291278	0	8	Astrocytes	NA	NA	NA
ATCGAGTTCTTGTATC-1_2_B4	32.61918028	15.32055033	14	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	928	1281	0.00312256	0.067135051	0	14	Microglia	NA	NA	NA
ATCTACTCAATAAGCA-1_2_B4	24.77584807	0.856677575	2	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2317	4592	0.014155052	0.0021777	0	2	EN-L4	NA	NA	NA
ATCTACTCAATCCAAC-1_2_B4	-15.06895413	-21.17451419	6A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1586	2872	0.013231198	0.004526462	0	6A	IN-PV	NA	NA	NA
ATCTACTCATCCAACA-1_2_B4	11.57668697	29.69865506	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	708	1080	0.002777778	0.003703704	0	oligos	OL-Cntl	NA	NA	NA
ATCTACTGTAAATGAC-1_2_B4	21.40394558	17.29995884	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1124	1819	0.005497526	0.007146784	0	oligos	OL-Cntl	NA	NA	NA
ATCTACTGTCAGGACA-1_2_B4	-0.42926862	27.43394229	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	755	1048	0.003816794	0.007633588	0	oligos	OL-Cntl	NA	NA	NA
ATCTACTGTCGGCATC-1_2_B4	38.19843247	10.65371387	14	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	869	1210	0.001652893	0.01322314	0	14	Microglia	NA	NA	NA
ATCTGCCAGCCGCCTA-1_2_B4	15.14076014	1.838161626	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	873	1285	0.013229572	0.00311284	0	12	EN-MIX	NA	NA	NA
ATCTGCCAGGATTCGG-1_2_B4	6.659525434	24.62315883	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	864	1279	0.008600469	0.006254887	0	oligos	OL-Cntl	NA	NA	NA
ATCTGCCAGGCGCTCT-1_2_B4	-23.6876394	18.78238977	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1347	2429	0.000823384	0.001646768	0	8	Astrocytes	NA	NA	NA
ATCTGCCAGGCTCTTA-1_2_B4	-0.29126482	29.09052467	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	788	1117	0.008952551	0.002685765	0	oligos	OL-Cntl	NA	NA	NA
ATCTGCCGTAAATACG-1_2_B4	-13.74137071	-24.47361755	6A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1245	2156	0.018089054	0.002782931	0	6A	IN-PV	NA	NA	NA
ATCTGCCGTAGAGTGC-1_2_B4	17.08914828	29.02835267	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	836	1159	0.003451251	0	0	oligos	OL-Cntl	NA	NA	NA
ATCTGCCGTCTCCATC-1_2_B4	15.30080945	2.357137891	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	751	1104	0.009963768	0.00634058	0	12	EN-MIX	NA	NA	NA
ATCTGCCTCCAGGGCT-1_2_B4	20.72920204	18.47991007	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	994	1502	0.003994674	0.005326232	0	oligos	OL-Cntl	NA	NA	NA
ATCTGCCTCCCATTAT-1_2_B4	20.14304081	17.6531844	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1171	1857	0.002692515	0.007000539	0	oligos	OL-Cntl	NA	NA	NA
ATCTGCCTCTTGTCAT-1_2_B4	-36.63252703	-7.794550794	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1037	1742	0.000574053	0.001148106	0	9	OPC	NA	NA	NA
ATGAGGGCAATAACGA-1_2_B4	-21.3314322	27.78670968	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1813	3697	0.002704896	0.00622126	0	8	Astrocytes	NA	NA	NA
ATGAGGGGTCCCTACT-1_2_B4	-31.42675582	10.95530747	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	706	1077	0.007428041	0.00185701	0	8	Astrocytes	NA	NA	NA
ATGAGGGGTTCCTCCA-1_2_B4	-17.43139788	13.91372517	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1221	1787	0.002797985	0.005036374	0	8	Astrocytes	NA	NA	NA
ATGAGGGTCCGTTGTC-1_2_B4	-14.60337119	-22.93475828	6A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1507	3128	0.14673913	0.003196931	0	6A	IN-PV	NA	NA	NA
ATGAGGGTCGCCAAAT-1_2_B4	27.71952969	1.028811893	2	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2727	6447	0.007910656	0.002016442	0	2	EN-L4	NA	NA	NA
ATGCGATCACAGCCCA-1_2_B4	1.978708788	20.5797166	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	883	1325	0.009811321	0.01509434	0	oligos	OL-Cntl	NA	NA	NA
ATGCGATCATAACCTG-1_2_B4	32.1762371	-4.740725373	2	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3371	7373	0.00393327	0.00420453	0	2	EN-L4	NA	NA	NA
ATGCGATCATTCTCAT-1_2_B4	14.9013594	19.66444462	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	986	1562	0.001920615	0.011523688	0	oligos	OL-Cntl	NA	NA	NA
ATGCGATTCGTATCAG-1_2_B4	-2.56049313	-1.002475868	13A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2609	5087	0.013957146	0.004717908	0	13A	IN-VIP	NA	NA	NA
ATGCGATTCGTTTGCC-1_2_B4	22.72286972	27.63096736	17	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1151	1775	0.001690141	0.004507042	0	oligos	OL-MS-2	NA	NA	NA
ATGGGAGAGTGGGATC-1_2_B4	22.76413711	13.64405429	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1286	2050	0.003902439	0.00195122	0	oligos	OL-Cntl	NA	NA	NA
ATGGGAGGTCGCTTTC-1_2_B4	-22.9427674	-1.105446454	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1158	1746	0.025773196	0.002290951	0	9	OPC	NA	NA	NA
ATGTGTGAGAGCAATT-1_2_B4	34.78066208	15.43022995	14	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1156	1579	0.000633312	0.044965168	0	14	Microglia	NA	NA	NA
ATGTGTGAGATCACGG-1_2_B4	5.775190851	-13.19234378	4	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2189	3817	0.004191774	0.010217448	0	L2-3	EN-L2-3-MS	NA	NA	NA
ATGTGTGAGATCTGCT-1_2_B4	4.813888433	-6.204385187	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1212	1840	0.014130435	0.004347826	0	12	EN-MIX	NA	NA	NA
ATGTGTGCACATGTGT-1_2_B4	9.824286601	-8.791995511	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2262	5162	0.009298721	0.001937234	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ATGTGTGCACGGTAAG-1_2_B4	13.43570568	19.70828159	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	954	1446	0.007607192	0.005532503	0	oligos	OL-Cntl	NA	NA	NA
ATGTGTGCATACAGCT-1_2_B4	23.42174425	-9.958226913	3	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3285	7310	0.006703146	0.002872777	0	3	EN-L5-6	NA	NA	NA
ATGTGTGGTAGCGCAA-1_2_B4	-24.27096454	18.17839846	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1209	2011	0.00198906	0.003480855	0	8	Astrocytes	NA	NA	NA
ATTACTCAGTAGTGCG-1_2_B4	-10.74816881	-7.298175846	13A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1612	2556	0.020344288	0.005477308	0	13A	IN-VIP	NA	NA	NA
ATTACTCAGTGAACGC-1_2_B4	-31.34246631	12.93706748	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	928	1425	0.000701754	0.004210526	0	8	Astrocytes	NA	NA	NA
ATTACTCCAGGTCGTC-1_2_B4	-18.69304194	-17.53760977	6B	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2236	4554	0.005489679	0.004611331	0	6B	IN-SST	NA	NA	NA
ATTACTCGTCCCGACA-1_2_B4	-13.63128685	-5.636121614	13A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2391	5037	0.01588247	0.003772087	0	13A	IN-VIP	NA	NA	NA
ATTACTCGTCGGGTCT-1_2_B4	20.37454982	-27.54343446	3	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2673	5741	0.004528828	0.00766417	0	3	EN-L5-6	NA	NA	NA
ATTACTCGTGGAAAGA-1_2_B4	-22.17003324	9.584197043	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	823	1258	0.003974563	0.00317965	0	8	Astrocytes	NA	NA	NA
ATTATCCGTACTTAGC-1_2_B4	12.91106394	-32.85123468	3	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3380	9504	0.002630471	0.002630471	0	3	EN-L5-6	NA	NA	NA
ATTCTACAGAGACTTA-1_2_B4	6.76382472	-30.13339985	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3795	10831	0.003508448	0.002215862	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ATTCTACAGCGTCTAT-1_2_B4	22.52555999	13.96638305	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1257	2020	0.004455446	0.004950495	0	oligos	OL-Cntl	NA	NA	NA
ATTCTACAGGTGCTAG-1_2_B4	-37.2308339	-6.452930027	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	988	1637	0.004276115	0.003054368	0	9	OPC	NA	NA	NA
ATTCTACCACGCATCG-1_2_B4	2.883187197	-11.94133679	4	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1933	3653	0.018614837	0.007938681	0	L2-3	EN-L2-3-MS	NA	NA	NA
ATTCTACCAGGTCCAC-1_2_B4	-28.78691304	13.67289869	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	827	1333	0	0.004501125	0	8	Astrocytes	NA	NA	NA
ATTCTACTCGTCTGAA-1_2_B4	1.564030102	-5.862121149	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1015	1649	0.011522135	0.00667071	0	12	EN-MIX	NA	NA	NA
ATTGGACAGCACACAG-1_2_B4	3.244618471	28.13469033	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	787	1113	0.009883199	0.008086253	0	oligos	OL-Cntl	NA	NA	NA
ATTGGACCACCGCTAG-1_2_B4	22.98048617	12.42313823	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1350	2147	0.001397299	0.006520727	0	oligos	OL-Cntl	NA	NA	NA
ATTGGACCACCTCGTT-1_2_B4	-23.06082935	22.59261654	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1392	2444	0.000409165	0.008183306	0	8	Astrocytes	NA	NA	NA
ATTGGACCATCTACGA-1_2_B4	-23.81185579	-1.638513597	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1189	1856	0.010237069	0.005926724	0	9	OPC	NA	NA	NA
ATTGGACGTGCCTGGT-1_2_B4	20.62687968	-27.60319905	3	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2497	5168	0.003482972	0.006772446	0	3	EN-L5-6	NA	NA	NA
ATTGGTGAGACGCTTT-1_2_B4	1.187937109	19.77456345	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	823	1154	0.008665511	0.017331023	0	oligos	OL-Cntl	NA	NA	NA
ATTGGTGCAAGTACCT-1_2_B4	23.25003891	18.88349724	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1029	1485	0.000673401	0.004040404	0	oligos	OL-Cntl	NA	NA	NA
ATTGGTGCACTCGACG-1_2_B4	3.135794846	-2.787518373	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	695	1110	0.001801802	0.004504505	0	12	EN-MIX	NA	NA	NA
ATTGGTGCAGGGTACA-1_2_B4	23.17146045	13.86086543	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1247	1924	0.002079002	0.005197505	0	oligos	OL-Cntl	NA	NA	NA
ATTGGTGCATGGAATA-1_2_B4	13.55295477	23.81398932	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	891	1336	0.002994012	0.008982036	0	oligos	OL-Cntl	NA	NA	NA
ATTGGTGCATTCTCAT-1_2_B4	23.1344321	18.33980049	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1129	1647	0.000607165	0.004857316	0	oligos	OL-Cntl	NA	NA	NA
ATTGGTGGTACTCTCC-1_2_B4	-37.84721606	-0.200322456	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1364	2430	0.002469136	0.002469136	0	9	OPC	NA	NA	NA
ATTGGTGGTTTGACTG-1_2_B4	-0.118397408	28.6408858	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	789	1136	0.001760563	0.003521127	0	oligos	OL-Cntl	NA	NA	NA
ATTGGTGTCACAGGCC-1_2_B4	20.36777531	-29.38171273	3	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	4756	14644	0.001775471	0.004780115	0	3	EN-L5-6	NA	NA	NA
ATTGGTGTCCCAAGAT-1_2_B4	16.27142243	-32.79498945	3	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	4855	16344	0.006546745	0.002630935	0	3	EN-L5-6	NA	NA	NA
ATTGGTGTCCGCGTTT-1_2_B4	39.0540169	15.06488675	14	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1205	1769	0.016393443	0.013001696	0	14	Microglia	NA	NA	NA
ATTGGTGTCTTAGCCC-1_2_B4	17.92369457	12.85207781	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1219	2074	0.005785921	0.005303761	0	oligos	OL-Cntl	NA	NA	NA
ATTTCTGGTGGAAAGA-1_2_B4	10.08140758	-8.511668256	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2267	4937	0.002430626	0.002633178	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CAACCAATCCATGCTC-1_2_B4	2.620940229	4.70757641	7	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	857	1074	0.002793296	0.003724395	0	7	Phagocytes	NA	NA	NA
CAACCTCAGATCGGGT-1_2_B4	2.93929991	-27.36832239	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3097	7719	0.012566395	0.002591009	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CAACCTCAGGTGGGTT-1_2_B4	-11.92643882	15.97773364	11	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1305	2004	0.001497006	0.003493014	0	11	Glia-MIX	NA	NA	NA
CAACCTCGTGCAGACA-1_2_B4	6.911474056	-5.701177785	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1335	2579	0.012795657	0.000775494	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CAACCTCTCTACTCAT-1_2_B4	3.504358705	-30.11720964	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	4184	13183	0.002427369	0.002048092	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CAACCTCTCTTGCAAG-1_2_B4	11.32679642	23.39144728	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	873	1361	0.004408523	0.008817046	0	oligos	OL-Cntl	NA	NA	NA
CAACTAGAGGCAATTA-1_2_B4	-4.174500323	-8.421123317	13A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	766	1139	0.026338894	0.000877963	0	13A	IN-VIP	NA	NA	NA
CAACTAGCAATCCAAC-1_2_B4	11.81436533	30.18742613	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	670	1030	0	0.004854369	0	oligos	OL-Cntl	NA	NA	NA
CAACTAGCATGAACCT-1_2_B4	15.00811337	18.863073	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	970	1577	0.001902346	0.005072923	0	oligos	OL-Cntl	NA	NA	NA
CAAGAAACAGCGTCCA-1_2_B4	-31.36022234	11.09985914	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	684	1019	0.002944063	0.003925417	0	8	Astrocytes	NA	NA	NA
CAAGAAACATGCAACT-1_2_B4	-24.35260657	17.57947892	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1109	1697	0.00117855	0.002357101	0	8	Astrocytes	NA	NA	NA
CAAGAAAGTGACAAAT-1_2_B4	-7.375117539	-1.397889055	13A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1923	3720	0.031989247	0.003763441	0	13A	IN-VIP	NA	NA	NA
CAAGATCCAGGTGCCT-1_2_B4	23.02177252	-6.761294343	11	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3739	8448	0.011008523	0.005681818	0	11	Glia-MIX	NA	NA	NA
CAAGATCGTAGTACCT-1_2_B4	16.80993199	22.94493786	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	850	1303	0.006139678	0.00076746	0	oligos	OL-Cntl	NA	NA	NA
CAAGATCTCACAATGC-1_2_B4	21.62630513	17.63340956	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1077	1648	0.001213592	0.00788835	0	oligos	OL-Cntl	NA	NA	NA
CAAGATCTCCCTGACT-1_2_B4	-8.577279385	-18.26110815	6B	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	721	1085	0.017511521	0.000921659	0	6B	IN-SST	NA	NA	NA
CAAGGCCAGGATTCGG-1_2_B4	12.58028874	26.25279234	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	826	1252	0	0.000798722	0	oligos	OL-Cntl	NA	NA	NA
CAAGGCCAGTACCGGA-1_2_B4	17.46038152	10.5827809	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1610	2651	0.003017729	0.004149378	0	oligos	OL-Cntl	NA	NA	NA
CAAGGCCGTAAACACA-1_2_B4	4.667152588	23.5061246	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	874	1261	0.01665345	0.009516257	0	oligos	OL-Cntl	NA	NA	NA
CAAGGCCGTAAATACG-1_2_B4	-15.40608537	12.05293597	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1513	2618	0.002673797	0.002291826	0	8	Astrocytes	NA	NA	NA
CAAGGCCGTGGAAAGA-1_2_B4	6.300094825	-16.19384593	4	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3435	7736	0.006334023	0.009824199	0	L2-3	EN-L2-3-MS	NA	NA	NA
CAAGGCCGTGGGTCAA-1_2_B4	-0.00165623	28.20736731	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	785	1101	0.002724796	0.010899183	0	oligos	OL-Cntl	NA	NA	NA
CAAGGCCGTTCAACCA-1_2_B4	2.923896728	-29.22165247	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	4434	13219	0.010212573	0.001815568	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CAAGGCCTCAACCAAC-1_2_B4	19.23655539	8.229624878	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1725	3156	0.001267427	0.004119138	0	oligos	OL-Cntl	NA	NA	NA
CAAGGCCTCAGAGGTG-1_2_B4	10.58375308	30.11244943	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	771	1131	0.001768347	0.001768347	0	oligos	OL-Cntl	NA	NA	NA
CAAGTTGAGCAGCGTA-1_2_B4	12.82326246	28.9274258	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	786	1160	0.000862069	0.006896552	0	oligos	OL-Cntl	NA	NA	NA
CAAGTTGAGGCGACAT-1_2_B4	20.22003323	15.21716155	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1112	1809	0.002763958	0.004975124	0	oligos	OL-Cntl	NA	NA	NA
CAAGTTGCAGTATGCT-1_2_B4	-8.00191298	-1.216175543	13A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2016	4155	0.016847172	0.000722022	0	13A	IN-VIP	NA	NA	NA
CAAGTTGCATGGTAGG-1_2_B4	30.97270538	-3.245673295	2	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3113	7084	0.016374929	0.002258611	0	2	EN-L4	NA	NA	NA
CAAGTTGGTAACGACG-1_2_B4	23.12137486	-3.129227034	2	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2132	4280	0.017056075	0.003738318	0	2	EN-L4	NA	NA	NA
CAAGTTGTCTTTCCTC-1_2_B4	-11.50851625	-20.85098441	6B	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	971	1547	0.027795734	0.001939237	0	6B	IN-SST	NA	NA	NA
CACAAACAGAAGGTGA-1_2_B4	-13.04176481	-17.59313796	6B	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1210	1953	0.034306196	0.007168459	0	6B	IN-SST	NA	NA	NA
CACAAACAGCTGAAAT-1_2_B4	3.829552654	22.3815179	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	848	1235	0.0048583	0.005668016	0	oligos	OL-Cntl	NA	NA	NA
CACAAACAGGCTATCT-1_2_B4	-36.69204663	-5.041678169	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1273	2105	0.007125891	0.002375297	0	9	OPC	NA	NA	NA
CACAAACAGTCCAGGA-1_2_B4	-1.100207136	-19.04132129	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2889	6789	0.001178377	0.002798645	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CACAAACCACTACAGT-1_2_B4	20.46314455	18.15336997	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1090	1628	0.000614251	0.011056511	0	oligos	OL-Cntl	NA	NA	NA
CACAAACGTGCAACTT-1_2_B4	7.682690735	-7.355259698	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1766	3632	0.00688326	0.001651982	0	12	EN-MIX	NA	NA	NA
CACAAACTCAGGCCCA-1_2_B4	2.760458934	-5.872389311	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1030	1859	0.000537924	0.004841313	0	12	EN-MIX	NA	NA	NA
CACAAACTCTAACTCT-1_2_B4	19.55108372	-6.927445869	3	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2082	4409	0.007031073	0.003628941	0	3	EN-L5-6	NA	NA	NA
CACACAAAGGATGGTC-1_2_B4	5.157962397	27.1763261	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	803	1118	0.005366726	0.012522361	0	oligos	OL-Cntl	NA	NA	NA
CACACAACAAACCCAT-1_2_B4	-20.83530207	8.336612582	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	775	1089	0.000918274	0.002754821	0	8	Astrocytes	NA	NA	NA
CACACAAGTGCCTGTG-1_2_B4	-28.14561224	21.84302718	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1098	1776	0.002815315	0.009009009	0	8	Astrocytes	NA	NA	NA
CACACAAGTTCTGAAC-1_2_B4	7.392286517	25.40788644	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	922	1410	0.00141844	0.008510638	0	oligos	OL-Cntl	NA	NA	NA
CACACAATCACCCTCA-1_2_B4	19.61623595	20.7425881	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1033	1705	0.001173021	0.001759531	0	oligos	OL-Cntl	NA	NA	NA
CACACAATCACCGGGT-1_2_B4	7.126320945	-33.02933311	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3618	9433	0.001802184	0.003392346	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CACACAATCCAGATCA-1_2_B4	7.672505887	-7.145852559	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1436	2600	0.017692308	0.001923077	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CACACAATCCTGCCAT-1_2_B4	-27.70819733	16.56710093	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1051	1688	0.013625592	0.001777251	0	8	Astrocytes	NA	NA	NA
CACACCTAGGAGCGAG-1_2_B4	-36.06846532	-7.344988081	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1046	1685	0.016023739	0.003560831	0	9	OPC	NA	NA	NA
CACACCTAGGATCGCA-1_2_B4	13.72334769	29.32650529	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	764	1139	0.006145742	0.003511853	0	oligos	OL-Cntl	NA	NA	NA
CACACCTAGTACGTTC-1_2_B4	-11.01406742	14.4832216	11	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1177	1731	0.003466205	0.004621606	0	11	Glia-MIX	NA	NA	NA
CACACCTCAAGAGTCG-1_2_B4	3.26265004	22.46379706	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	854	1236	0.00566343	0.012135922	0	oligos	OL-Cntl	NA	NA	NA
CACACCTTCAGTCCCT-1_2_B4	18.66297712	7.64696974	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1931	3717	0.002690342	0.00645682	0	oligos	OL-Cntl	NA	NA	NA
CACACCTTCTGGCGAC-1_2_B4	12.54652444	16.26785805	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1140	1789	0.002794857	0.008943544	0	oligos	OL-Cntl	NA	NA	NA
CACACCTTCTTGAGGT-1_2_B4	-34.99777235	-12.61015964	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	706	1090	0.000917431	0.002752294	0	9	OPC	NA	NA	NA
CACACTCAGAAACGAG-1_2_B4	15.56020761	-2.433468955	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1059	1830	0.052459016	0.003825137	0	12	EN-MIX	NA	NA	NA
CACACTCAGGGAACGG-1_2_B4	-25.70415312	10.75079476	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	819	1182	0.011844332	0.009306261	0	8	Astrocytes	NA	NA	NA
CACACTCCAAGCTGGA-1_2_B4	-16.29256463	14.65372601	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1744	2982	0.000670691	0.003018109	0	8	Astrocytes	NA	NA	NA
CACACTCCAGATGAGC-1_2_B4	21.18085758	16.88512489	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1197	1878	0.005324814	0.002662407	0	oligos	OL-Cntl	NA	NA	NA
CACACTCGTCACAAGG-1_2_B4	3.052073039	-11.92369221	4	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1873	3201	0.025616995	0.004998438	0	L2-3	EN-L2-3-MS	NA	NA	NA
CACACTCGTCGAGATG-1_2_B4	6.636985626	35.32094618	11	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	915	1323	0.037792895	0.009070295	0	11	Glia-MIX	NA	NA	NA
CACACTCGTTACTGAC-1_2_B4	13.88799174	20.38266713	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	891	1397	0.005726557	0.008589835	0	oligos	OL-Cntl	NA	NA	NA
CACAGGCAGTCCAGGA-1_2_B4	0.548304692	-8.855423872	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1530	2790	0.003942652	0.003225806	0	12	EN-MIX	NA	NA	NA
CACAGGCCAGCTGTGC-1_2_B4	13.55849535	30.25872302	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	837	1260	0.004761905	0.006349206	0	oligos	OL-Cntl	NA	NA	NA
CACAGGCCATCAGTCA-1_2_B4	0.175768618	28.53791541	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	900	1310	0.005343511	0.008396947	0	oligos	OL-Cntl	NA	NA	NA
CACAGGCCATTACCTT-1_2_B4	15.06563328	-7.363559717	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1738	3493	0.002290295	0.003721729	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CACAGGCGTACAGACG-1_2_B4	1.602839079	28.45318185	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	810	1219	0.004101723	0.004101723	0	oligos	OL-Cntl	NA	NA	NA
CACAGGCTCCTTTACA-1_2_B4	-33.24196602	-11.99751104	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	830	1274	0.001569859	0.004709576	0	9	OPC	NA	NA	NA
CACAGTAAGATGTGGC-1_2_B4	20.4696548	15.9821953	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1159	1747	0.002862049	0.004006869	0	oligos	OL-Cntl	NA	NA	NA
CACAGTAAGCCCGAAA-1_2_B4	16.16081309	28.33138889	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	749	1047	0.011461318	0.003820439	0	oligos	OL-Cntl	NA	NA	NA
CACAGTAAGGAGCGAG-1_2_B4	4.516876841	29.4368882	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	729	1012	0.001976285	0.006916996	0	oligos	OL-Cntl	NA	NA	NA
CACAGTAGTCTCCCTA-1_2_B4	13.08302603	27.18985193	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	716	1055	0.005687204	0.003791469	0	oligos	OL-Cntl	NA	NA	NA
CACAGTAGTTACTGAC-1_2_B4	-23.23030277	23.22163305	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1477	2564	0.001170047	0.004680187	0	8	Astrocytes	NA	NA	NA
CACAGTAGTTGCGCAC-1_2_B4	15.34499171	22.65062097	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	882	1307	0.006885998	0.003825555	0	oligos	OL-Cntl	NA	NA	NA
CACAGTATCACTCTTA-1_2_B4	10.68727373	32.45982574	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	776	1108	0.007220217	0.005415162	0	oligos	OL-Cntl	NA	NA	NA
CACATAGAGATCGATA-1_2_B4	23.52984187	12.9153311	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1305	2183	0.000458085	0.005955108	0	oligos	OL-Cntl	NA	NA	NA
CACATAGAGCCACTAT-1_2_B4	4.574330647	25.01538908	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	794	1093	0.010064044	0.009149131	0	oligos	OL-Cntl	NA	NA	NA
CACATAGAGGACAGAA-1_2_B4	-34.01873758	-12.16380285	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	770	1115	0.011659193	0.002690583	0	9	OPC	NA	NA	NA
CACATAGAGTAGATGT-1_2_B4	-31.08478398	12.13252777	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	898	1334	0.000749625	0.002998501	0	8	Astrocytes	NA	NA	NA
CACATAGCAGACGCAA-1_2_B4	3.232711235	-5.782368872	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1027	1559	0.012828736	0.003207184	0	12	EN-MIX	NA	NA	NA
CACATAGCATTATCTC-1_2_B4	8.845965089	21.24279097	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	787	1124	0.002669039	0.008007117	0	oligos	OL-Cntl	NA	NA	NA
CACATAGCATTGGGCC-1_2_B4	-24.9413615	11.17587709	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	946	1353	0.001478197	0.002217295	0	8	Astrocytes	NA	NA	NA
CACATAGGTCATATGC-1_2_B4	-20.18425499	8.27630667	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	777	1091	0.002749771	0.001833181	0	8	Astrocytes	NA	NA	NA
CACATAGTCAAACAAG-1_2_B4	6.588194659	19.38776477	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	909	1388	0.003602305	0.012247839	0	oligos	OL-Cntl	NA	NA	NA
CACATAGTCGGAAACG-1_2_B4	7.807963886	20.01689386	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1046	1471	0.004758668	0.010197145	0	oligos	OL-Cntl	NA	NA	NA
CACATTTAGACCTTTG-1_2_B4	-28.14680567	-13.05395764	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	700	1097	0.00911577	0.001823154	0	9	OPC	NA	NA	NA
CACATTTAGTGGACGT-1_2_B4	-31.2799997	11.45345172	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	803	1180	0.006779661	0.005084746	0	8	Astrocytes	NA	NA	NA
CACATTTCACAGACTT-1_2_B4	12.63178014	25.34215814	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	697	1024	0	0.008789063	0	oligos	OL-Cntl	NA	NA	NA
CACATTTCACCAGTTA-1_2_B4	27.74776006	1.093558685	2	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2650	6010	0.00515807	0.002828619	0	2	EN-L4	NA	NA	NA
CACATTTCAGTTTACG-1_2_B4	0.266383159	28.45825803	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	796	1149	0.000870322	0.006962576	0	oligos	OL-Cntl	NA	NA	NA
CACATTTTCAACCATG-1_2_B4	13.22278564	25.5992246	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	837	1301	0	0.002305919	0	oligos	OL-Cntl	NA	NA	NA
CACATTTTCTTGTATC-1_2_B4	-11.32635803	18.30216296	11	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1748	2940	0.004421769	0.004761905	0	11	Glia-MIX	NA	NA	NA
CACCACTAGCAACGGT-1_2_B4	12.27245974	25.4965191	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	777	1196	0.003344482	0.003344482	0	oligos	OL-Cntl	NA	NA	NA
CACCACTAGCACACAG-1_2_B4	21.62086145	9.297626278	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1783	3007	0.001995344	0.005986033	0	oligos	OL-Cntl	NA	NA	NA
CACCACTAGCCAGAAC-1_2_B4	2.694115102	-3.229773754	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	675	1057	0.02743614	0.006622517	0	12	EN-MIX	NA	NA	NA
CACCACTAGCCCAGCT-1_2_B4	23.08401711	16.86890789	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1432	2308	0.003466205	0.013431542	0	oligos	OL-Cntl	NA	NA	NA
CACCACTCAGGTTTCA-1_2_B4	-15.45017473	-11.27052323	13B	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2526	5632	0.011541193	0.00337358	0	13B	IN-SV2C	NA	NA	NA
CACCACTCATATGAGA-1_2_B4	1.453742798	-16.92326413	4	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2657	5730	0.015357766	0.002094241	0	L2-3	EN-L2-3-MS	NA	NA	NA
CACCACTGTCACTTCC-1_2_B4	20.13087254	14.05843831	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1409	2410	0.004979253	0.006224066	0	oligos	OL-Cntl	NA	NA	NA
CACCACTGTCTAGCGC-1_2_B4	23.41182171	26.31331665	17	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1178	1882	0.001594049	0.003719447	0	oligos	OL-MS-2	NA	NA	NA
CACCACTTCATCATTC-1_2_B4	20.02645196	20.58138385	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	969	1620	0.001851852	0.002469136	0	oligos	OL-Cntl	NA	NA	NA
CACCACTTCCTCTAGC-1_2_B4	19.63198518	23.58370935	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1037	1695	0.005899705	0.002949853	0	oligos	OL-Cntl	NA	NA	NA
CACCACTTCTAGAGTC-1_2_B4	13.70935457	26.69952063	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	849	1319	0.004548901	0.015163002	0	oligos	OL-Cntl	NA	NA	NA
CACCAGGCACAGACAG-1_2_B4	-20.33554229	8.506088692	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	863	1204	0.004983389	0.006644518	0	8	Astrocytes	NA	NA	NA
CACCAGGGTAAGAGGA-1_2_B4	5.710888173	26.98576338	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	864	1259	0.002382844	0.015885624	0	oligos	OL-Cntl	NA	NA	NA
CACCAGGTCTACGAGT-1_2_B4	-14.41219593	-6.635871937	13A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2683	5621	0.015477673	0.006582459	0	13A	IN-VIP	NA	NA	NA
CACCTTGAGAGGTTGC-1_2_B4	10.40348789	29.40349492	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	754	1087	0.001839926	0.004599816	0	oligos	OL-Cntl	NA	NA	NA
CACCTTGAGCAACGGT-1_2_B4	11.30408355	27.39984911	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	847	1236	0.001618123	0.002427184	0	oligos	OL-Cntl	NA	NA	NA
CACCTTGAGCGCCTTG-1_2_B4	21.18440058	17.30525755	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1121	1734	0.002306805	0.010380623	0	oligos	OL-Cntl	NA	NA	NA
CACCTTGGTTTCGCTC-1_2_B4	-28.94165313	21.71275652	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	931	1428	0.012605042	0.004901961	0	8	Astrocytes	NA	NA	NA
CACCTTGTCAGCTTAG-1_2_B4	4.064642519	-23.32966442	4	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	4832	14860	0.011170929	0.005248991	0	L2-3	EN-L2-3-MS	NA	NA	NA
CACCTTGTCATTTGGG-1_2_B4	14.41793176	28.19015821	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	762	1223	0	0.004905969	0	oligos	OL-Cntl	NA	NA	NA
CACTCCAAGAAACCTA-1_2_B4	13.73185218	29.23188609	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	842	1276	0.001567398	0.002351097	0	oligos	OL-Cntl	NA	NA	NA
CACTCCAAGAACTGTA-1_2_B4	-14.79081925	-25.11379198	6A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1556	3020	0.013907285	0.002317881	0	6A	IN-PV	NA	NA	NA
CACTCCAAGAATGTGT-1_2_B4	-16.81864809	-9.52883173	13B	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3155	6735	0.00861173	0.002969562	0	13B	IN-SV2C	NA	NA	NA
CACTCCACAGGCGATA-1_2_B4	-20.35379213	8.468866801	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	855	1217	0.009860312	0.004108463	0	8	Astrocytes	NA	NA	NA
CACTCCAGTACATCCA-1_2_B4	11.79282287	20.62438768	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	964	1566	0.002554278	0.011494253	0	oligos	OL-Cntl	NA	NA	NA
CACTCCAGTATTAGCC-1_2_B4	-1.677657338	-15.88640811	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2254	4891	0.004906972	0.001226743	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CACTCCAGTCGGCTCA-1_2_B4	-5.13919671	-9.070762897	13A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1098	2018	0.016352825	0.00099108	0	13A	IN-VIP	NA	NA	NA
CACTCCAGTCTCTCGT-1_2_B4	2.390537277	29.75442402	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	771	1097	0.00911577	0.003646308	0	oligos	OL-Cntl	NA	NA	NA
CACTCCAGTTACGGAG-1_2_B4	15.23646517	21.94011825	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	915	1370	0.002189781	0.00729927	0	oligos	OL-Cntl	NA	NA	NA
CACTCCAGTTATCACG-1_2_B4	15.43452816	23.29697278	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	820	1243	0.008045052	0.009654063	0	oligos	OL-Cntl	NA	NA	NA
CACTCCAGTTATGCGT-1_2_B4	14.95323311	27.71735287	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	797	1177	0.003398471	0.005097706	0	oligos	OL-Cntl	NA	NA	NA
CACTCCATCCCTAATT-1_2_B4	21.0736328	10.92725774	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1532	2673	0.00748223	0.005237561	0	oligos	OL-Cntl	NA	NA	NA
CACTCCATCCGTTGTC-1_2_B4	-29.18300215	20.31724874	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1020	1504	0.006648936	0.003989362	0	8	Astrocytes	NA	NA	NA
CACTCCATCGCTGATA-1_2_B4	31.78537168	-3.137158377	2	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2874	6311	0.017112977	0.002059895	0	2	EN-L4	NA	NA	NA
CAGAATCAGGATCGCA-1_2_B4	15.8692478	22.46593187	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	935	1428	0.003501401	0.009103641	0	oligos	OL-Cntl	NA	NA	NA
CAGAATCAGTGGTAGC-1_2_B4	-20.78196269	9.436131384	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1074	1506	0.000664011	0.002656042	0	8	Astrocytes	NA	NA	NA
CAGAATCCACATGTGT-1_2_B4	7.539630878	-7.121288727	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1492	2776	0.004322767	0.006123919	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CAGAATCCAGTCAGCC-1_2_B4	3.579262671	-21.48764509	4	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	4031	10485	0.01163567	0.004196471	0	L2-3	EN-L2-3-MS	NA	NA	NA
CAGAATCCAGTTAACC-1_2_B4	11.55105065	23.57693046	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	742	1111	0.00090009	0.00810081	0	oligos	OL-Cntl	NA	NA	NA
CAGAATCCATTCTTAC-1_2_B4	16.22965796	24.57864006	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	853	1265	0	0.002371542	0	oligos	OL-Cntl	NA	NA	NA
CAGAATCTCATAAAGG-1_2_B4	4.392733695	27.44269713	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	808	1198	0.005843072	0.005008347	0	oligos	OL-Cntl	NA	NA	NA
CAGAATCTCCCAAGAT-1_2_B4	19.66508359	10.63617611	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1457	2495	0.004008016	0.005611222	0	oligos	OL-Cntl	NA	NA	NA
CAGAGAGAGACGCACA-1_2_B4	8.680609086	-7.544181593	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1808	3113	0.002891102	0.002248635	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CAGAGAGAGCAATCTC-1_2_B4	13.11363611	20.24869824	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	966	1450	0.004137931	0.007586207	0	oligos	OL-Cntl	NA	NA	NA
CAGAGAGAGCCACCTG-1_2_B4	17.35121852	17.70535055	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1144	1829	0.007107709	0.009841443	0	oligos	OL-Cntl	NA	NA	NA
CAGAGAGGTCGTGGCT-1_2_B4	4.347994782	25.23041437	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	720	1019	0.00686948	0.00686948	0	oligos	OL-Cntl	NA	NA	NA
CAGAGAGTCTAGAGTC-1_2_B4	20.57249823	19.49668595	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1031	1668	0.002398082	0.002997602	0	oligos	OL-Cntl	NA	NA	NA
CAGATCACAGCTCGAC-1_2_B4	22.07146657	14.58050125	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1280	2141	0.001401214	0.003736572	0	oligos	OL-Cntl	NA	NA	NA
CAGATCAGTCAATGTC-1_2_B4	-23.51553297	-2.114148653	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	863	1207	0.009113505	0.004971002	0	9	OPC	NA	NA	NA
CAGATCAGTCCGAACC-1_2_B4	18.11365249	23.22426955	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	836	1317	0.003796507	0.001518603	0	oligos	OL-Cntl	NA	NA	NA
CAGATCAGTGTGACGA-1_2_B4	5.376119124	-21.39163008	4	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3464	7669	0.009388447	0.005215804	0	L2-3	EN-L2-3-MS	NA	NA	NA
CAGCAGCCAAAGCAAT-1_2_B4	-17.19770279	-26.4599655	6A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2259	4825	0.005388601	0.002072539	0	6A	IN-PV	NA	NA	NA
CAGCAGCGTAAACCTC-1_2_B4	-37.20973435	0.048553666	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1472	2461	0.00365705	0.000812678	0	9	OPC	NA	NA	NA
CAGCAGCGTACAAGTA-1_2_B4	-0.383863344	29.0859552	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	735	1031	0.003879728	0.004849661	0	oligos	OL-Cntl	NA	NA	NA
CAGCAGCGTACCGCTG-1_2_B4	20.62188673	16.54652799	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1230	1872	0.004807692	0.010149573	0	oligos	OL-Cntl	NA	NA	NA
CAGCAGCGTACTTCTT-1_2_B4	20.5676166	-28.12367813	3	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2815	6034	0.009943653	0.005634736	0	3	EN-L5-6	NA	NA	NA
CAGCAGCTCTATCCCG-1_2_B4	6.248899195	30.43489179	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	731	1074	0.000931099	0.003724395	0	oligos	OL-Cntl	NA	NA	NA
CAGCATAAGAAAGTGG-1_2_B4	2.731839511	27.75289113	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	724	1004	0.011952191	0.005976096	0	oligos	OL-Cntl	NA	NA	NA
CAGCATAGTTGGACCC-1_2_B4	-6.257970878	-8.923673829	13A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	683	1026	0.019493177	0.004873294	0	13A	IN-VIP	NA	NA	NA
CAGCATATCAGATAAG-1_2_B4	17.0356522	0.70408042	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	779	1207	0.002485501	0.001657001	0	12	EN-MIX	NA	NA	NA
CAGCATATCAGCTTAG-1_2_B4	4.161592563	-32.85718223	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	5716	21421	0.000653564	0.002287475	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CAGCATATCCTTAATC-1_2_B4	-36.34008862	-0.176006232	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1628	3009	0.001329345	0.001661682	0	9	OPC	NA	NA	NA
CAGCCGAAGACTACAA-1_2_B4	-25.12032443	11.0345031	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	865	1263	0.002375297	0.006334125	0	8	Astrocytes	NA	NA	NA
CAGCCGAAGCTAACAA-1_2_B4	13.76241552	-32.92081511	3	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	4056	11994	0.00150075	0.001584125	0	3	EN-L5-6	NA	NA	NA
CAGCCGACAGACACTT-1_2_B4	25.43555333	-0.713671952	2	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2827	6119	0.0102958	0.002941657	0	2	EN-L4	NA	NA	NA
CAGCCGAGTTCTGGTA-1_2_B4	2.699510573	23.28673348	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	790	1127	0.008873114	0.004436557	0	oligos	OL-Cntl	NA	NA	NA
CAGCCGATCTGATACG-1_2_B4	33.35333077	-5.20951402	2	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3084	6271	0.010843566	0.005421783	0	2	EN-L4	NA	NA	NA
CAGCGACAGAAGGCCT-1_2_B4	-36.40328436	-0.237857452	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1409	2124	0.002354049	0.004237288	0	9	OPC	NA	NA	NA
CAGCGACAGGCAAAGA-1_2_B4	18.73070758	12.11710462	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1449	2376	0.001262626	0.001262626	0	oligos	OL-Cntl	NA	NA	NA
CAGCGACCAACACCTA-1_2_B4	11.07882881	24.92818263	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	834	1265	0.01027668	0.003952569	0	oligos	OL-Cntl	NA	NA	NA
CAGCGACGTTCAGGCC-1_2_B4	13.37529148	16.47414202	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1186	1793	0.002230898	0.010039041	0	oligos	OL-Cntl	NA	NA	NA
CAGCGACTCAGCGATT-1_2_B4	-13.18692445	-21.37811308	6A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1158	1830	0.01420765	0.003825137	0	6A	IN-PV	NA	NA	NA
CAGCGACTCGAACGGA-1_2_B4	10.00403063	-8.560293188	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2493	5103	0.002939447	0.001175779	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CAGCGACTCGCGGATC-1_2_B4	14.92299782	19.94122657	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	960	1464	0	0.006147541	0	oligos	OL-Cntl	NA	NA	NA
CAGCGACTCTTGTACT-1_2_B4	13.9139021	22.10178326	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	873	1338	0	0.012705531	0	oligos	OL-Cntl	NA	NA	NA
CAGCTAAAGACTAAGT-1_2_B4	-36.91196516	-0.866881581	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1477	2624	0.002667683	0.002667683	0	9	OPC	NA	NA	NA
CAGCTAACAACAACCT-1_2_B4	-8.974507995	-19.65935616	6B	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	735	1138	0.03602812	0.005272408	0	6B	IN-SST	NA	NA	NA
CAGCTAACAAGGGTCA-1_2_B4	13.87774243	23.0237162	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	894	1392	0.003591954	0.00933908	0	oligos	OL-Cntl	NA	NA	NA
CAGCTAAGTCAAACTC-1_2_B4	1.563689447	28.78083541	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	742	1092	0.003663004	0.01007326	0	oligos	OL-Cntl	NA	NA	NA
CAGCTAATCAATAAGG-1_2_B4	-27.77025012	4.342445536	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2047	3618	0.004422333	0.001934771	0	9	OPC	NA	NA	NA
CAGCTAATCGGATGTT-1_2_B4	21.37908541	-8.236154185	3	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1562	2602	0.001921599	0.003074558	0	3	EN-L5-6	NA	NA	NA
CAGCTAATCTTCGGTC-1_2_B4	7.933040678	-31.98663973	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3467	9004	0.00699689	0.002776544	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CAGCTGGAGACAAAGG-1_2_B4	21.44487224	13.94620374	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1388	2204	0.007713249	0.003629764	0	oligos	OL-Cntl	NA	NA	NA
CAGCTGGCACGTAAGG-1_2_B4	14.8292927	29.32287226	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	828	1299	0.002309469	0.005388761	0	oligos	OL-Cntl	NA	NA	NA
CAGCTGGTCACGCATA-1_2_B4	15.31284786	30.63182995	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	819	1234	0.001620746	0.002431118	0	oligos	OL-Cntl	NA	NA	NA
CAGCTGGTCGAGAACG-1_2_B4	7.362588402	23.05949371	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1025	1456	0.001373626	0.009615385	0	oligos	OL-Cntl	NA	NA	NA
CAGGTGCCAAGTTAAG-1_2_B4	-26.64335787	1.794345624	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1496	2412	0.005389718	0.005389718	0	9	OPC	NA	NA	NA
CAGGTGCCAGGGATTG-1_2_B4	3.123101044	26.77065945	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	679	1036	0.006756757	0.007722008	0	oligos	OL-Cntl	NA	NA	NA
CAGGTGCGTGAGGGAG-1_2_B4	11.23690925	22.90000364	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	829	1237	0.002425222	0.008892482	0	oligos	OL-Cntl	NA	NA	NA
CAGTAACAGTTGAGAT-1_2_B4	-17.26422499	-26.23958733	6A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2122	4225	0.00260355	0.004023669	0	6A	IN-PV	NA	NA	NA
CAGTAACGTCAAACTC-1_2_B4	3.267049859	-2.760184694	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	713	1049	0.025738799	0.007626311	0	12	EN-MIX	NA	NA	NA
CAGTAACGTCGCTTCT-1_2_B4	-23.27722442	23.51780838	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1470	2671	0.001871958	0.00224635	0	8	Astrocytes	NA	NA	NA
CAGTAACGTCTTGATG-1_2_B4	2.850038933	25.94568439	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	722	1038	0.009633911	0.007707129	0	oligos	OL-Cntl	NA	NA	NA
CAGTAACTCTGCTGCT-1_2_B4	-10.29108155	1.184676268	13A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2180	4174	0.003593675	0.004072832	0	13A	IN-VIP	NA	NA	NA
CAGTCCTAGGTGTTAA-1_2_B4	22.29086417	17.46605228	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1249	1916	0.002087683	0.006784969	0	oligos	OL-Cntl	NA	NA	NA
CAGTCCTCAAGAAAGG-1_2_B4	-23.5018906	23.38906177	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1411	2434	0.002054232	0.005341002	0	8	Astrocytes	NA	NA	NA
CAGTCCTCACTCAGGC-1_2_B4	16.02193731	19.27296024	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	953	1557	0.005780347	0.004495825	0	oligos	OL-Cntl	NA	NA	NA
CAGTCCTCAGTCAGAG-1_2_B4	-11.4745371	-22.28027098	6A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1012	1889	0.069878242	0.002117522	0	6A	IN-PV	NA	NA	NA
CAGTCCTTCATTGCGA-1_2_B4	-14.62109029	-18.64892943	6B	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1385	2492	0.038523274	0.001605136	0	6B	IN-SST	NA	NA	NA
CAGTCCTTCCCAAGTA-1_2_B4	-20.86374346	9.97605549	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1152	1827	0.003831418	0.004378763	0	8	Astrocytes	NA	NA	NA
CAGTCCTTCTGAGTGT-1_2_B4	16.41670487	19.15781004	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1005	1558	0.003851091	0.003851091	0	oligos	OL-Cntl	NA	NA	NA
CATATGGAGACGCACA-1_2_B4	-1.744056015	-17.58494899	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2504	5445	0.005142332	0.002571166	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CATATGGCACTTAAGC-1_2_B4	-37.28828897	2.713071601	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1676	3028	0.001321004	0.002642008	0	9	OPC	NA	NA	NA
CATATGGGTGATGTCT-1_2_B4	18.15902155	20.76945099	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	949	1508	0.00265252	0.00596817	0	oligos	OL-Cntl	NA	NA	NA
CATATGGTCAAAGTAG-1_2_B4	-23.80967299	-1.039904461	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1342	2080	0.006730769	0.001923077	0	9	OPC	NA	NA	NA
CATATGGTCGTTTATC-1_2_B4	-33.93532245	-12.17641605	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	759	1161	0.006029285	0.000861326	0	9	OPC	NA	NA	NA
CATATGGTCTCAAGTG-1_2_B4	-23.55327782	22.45866887	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1253	2030	0.001970443	0.007389163	0	8	Astrocytes	NA	NA	NA
CATATTCCAGCTCGCA-1_2_B4	16.82029855	20.29322733	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	979	1509	0.007952286	0.007952286	0	oligos	OL-Cntl	NA	NA	NA
CATATTCCAGGAACGT-1_2_B4	13.09261242	28.08803196	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	755	1101	0.002724796	0.008174387	0	oligos	OL-Cntl	NA	NA	NA
CATATTCCATCACGTA-1_2_B4	20.43534478	20.67334184	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	958	1521	0.000657462	0.000657462	0	oligos	OL-Cntl	NA	NA	NA
CATATTCTCGTCCAGG-1_2_B4	0.32486097	26.88340991	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	712	1027	0.00097371	0.00292113	0	oligos	OL-Cntl	NA	NA	NA
CATCAAGAGGCATTGG-1_2_B4	16.61699761	27.69456396	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	817	1138	0.006151142	0.001757469	0	oligos	OL-Cntl	NA	NA	NA
CATCAAGCATGCATGT-1_2_B4	-13.64888449	-24.43762392	6A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1210	2249	0.003557137	0.006669631	0	6A	IN-PV	NA	NA	NA
CATCAAGTCAAACCAC-1_2_B4	18.80903985	13.06833798	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1326	2178	0.005968779	0.007805326	0	oligos	OL-Cntl	NA	NA	NA
CATCAAGTCGCATGGC-1_2_B4	-27.36888321	14.21173598	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1008	1557	0.000642261	0.003853565	0	8	Astrocytes	NA	NA	NA
CATCAGAAGCTCAACT-1_2_B4	14.58642729	-2.451262764	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1131	2058	0.006316812	0.002915452	0	12	EN-MIX	NA	NA	NA
CATCAGACACGGCTAC-1_2_B4	33.30755254	-4.392003963	2	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3083	6703	0.009100403	0.004475608	0	2	EN-L4	NA	NA	NA
CATCAGACACGTTGGC-1_2_B4	-20.78993131	8.460076186	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	875	1313	0.006854532	0.006092917	0	8	Astrocytes	NA	NA	NA
CATCAGACAGCCTTGG-1_2_B4	-18.94695224	-18.20450598	6A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2262	4516	0.003985828	0.005978742	0	6A	IN-PV	NA	NA	NA
CATCAGAGTAGATTAG-1_2_B4	-23.71642349	22.67917821	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1319	2213	0.002259376	0.001807501	0	8	Astrocytes	NA	NA	NA
CATCCACGTATATCCG-1_2_B4	5.269357706	-31.64627797	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	4451	13492	0.003038838	0.002742366	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CATCCACGTCAATGTC-1_2_B4	-38.57707234	-0.912026893	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1456	2591	0.004631416	0.00270166	0	9	OPC	NA	NA	NA
CATCCACGTTATCCGA-1_2_B4	13.28805635	30.14940599	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	755	1143	0.003499563	0.001749781	0	oligos	OL-Cntl	NA	NA	NA
CATCCACGTTCGGCAC-1_2_B4	21.55689145	18.99073756	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1118	1798	0	0.006674082	0	oligos	OL-Cntl	NA	NA	NA
CATCCACGTTCGTTGA-1_2_B4	1.03414775	-19.84639174	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3212	7800	0.006794872	0.003589744	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CATCCACTCCGTCATC-1_2_B4	16.31248911	28.70038857	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	756	1108	0.000902527	0.004512635	0	oligos	OL-Cntl	NA	NA	NA
CATCCACTCTGAAAGA-1_2_B4	-32.73603432	-13.00968633	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	730	1039	0.001924928	0.000962464	0	9	OPC	NA	NA	NA
CATCGAACAGGTGCCT-1_2_B4	-32.12318958	-6.631802529	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1271	1913	0.008886566	0.002613696	0	9	OPC	NA	NA	NA
CATCGAAGTCTCCATC-1_2_B4	5.950830744	24.59719334	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	888	1274	0.008634223	0.005494505	0	oligos	OL-Cntl	NA	NA	NA
CATCGAAGTGAGTGAC-1_2_B4	1.966522632	-30.26045872	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	4868	14326	0.00132626	0.002931733	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CATCGAATCTGGAGCC-1_2_B4	23.16730231	20.3121216	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1017	1470	0.004081633	0.007482993	0	oligos	OL-Cntl	NA	NA	NA
CATCGGGAGAACAATC-1_2_B4	22.76346501	10.66333271	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1507	2546	0.001963865	0.00785546	0	oligos	OL-Cntl	NA	NA	NA
CATCGGGCATTGGGCC-1_2_B4	11.56213638	28.06187307	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	817	1176	0.005102041	0.009353741	0	oligos	OL-Cntl	NA	NA	NA
CATCGGGGTCGGCATC-1_2_B4	6.120321433	22.11943619	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	894	1310	0.010687023	0.007633588	0	oligos	OL-Cntl	NA	NA	NA
CATCGGGGTTCACCTC-1_2_B4	1.765766933	-7.524597858	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1314	2394	0.005430242	0.001670844	0	12	EN-MIX	NA	NA	NA
CATCGGGTCCACTGGG-1_2_B4	12.77721775	16.77122212	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1197	1888	0.002118644	0.005826271	0	oligos	OL-Cntl	NA	NA	NA
CATCGGGTCCAGTATG-1_2_B4	30.61679168	-2.897064543	2	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2908	6555	0.003813883	0.003203661	0	2	EN-L4	NA	NA	NA
CATGACAAGACTCGGA-1_2_B4	3.857109412	-5.600767343	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1102	1775	0.009577465	0.003943662	0	12	EN-MIX	NA	NA	NA
CATGACAAGCGTGAAC-1_2_B4	-21.07308098	8.086184502	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	884	1227	0.008964955	0.00407498	0	8	Astrocytes	NA	NA	NA
CATGACAAGTAAGTAC-1_2_B4	27.05504172	-5.332889262	2	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	4076	10837	0.00129187	0.002399188	0	2	EN-L4	NA	NA	NA
CATGACACAAAGCAAT-1_2_B4	7.765824061	23.67688035	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	927	1399	0.000714796	0.004288778	0	oligos	OL-Cntl	NA	NA	NA
CATGACACACGAAAGC-1_2_B4	29.32932063	-1.958247864	2	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3751	8596	0.003606329	0.004420661	0	2	EN-L4	NA	NA	NA
CATGACATCACTTCAT-1_2_B4	0.131731737	28.64135628	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	817	1169	0.000855432	0.005132592	0	oligos	OL-Cntl	NA	NA	NA
CATGACATCCAGTATG-1_2_B4	40.09281868	14.03265055	14	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1143	1554	0.001930502	0.007722008	0	14	Microglia	NA	NA	NA
CATGACATCTCAACTT-1_2_B4	2.603379512	-3.458737604	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	808	1209	0.011579818	0.005789909	0	12	EN-MIX	NA	NA	NA
CATGCCTAGTACGTAA-1_2_B4	15.65524493	-2.512861048	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1108	1789	0.005030743	0.002235886	0	12	EN-MIX	NA	NA	NA
CATGCCTCACCGAATT-1_2_B4	4.942853221	5.469115203	7	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1946	3282	0.005179768	0.007007922	0	7	Phagocytes	NA	NA	NA
CATGCCTCATGCGCAC-1_2_B4	8.352535568	-27.0722263	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	4854	13341	0.005996552	0.005022112	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CATGCCTGTACCGGCT-1_2_B4	14.87436722	-31.69079731	3	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3841	10136	0.001381215	0.004143646	0	3	EN-L5-6	NA	NA	NA
CATGCCTGTTCTGGTA-1_2_B4	15.95738625	21.03068829	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	921	1342	0.008196721	0.008941878	0	oligos	OL-Cntl	NA	NA	NA
CATGCCTTCACTATTC-1_2_B4	22.43523952	12.02268606	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1482	2673	0.002244669	0.003367003	0	oligos	OL-Cntl	NA	NA	NA
CATGCCTTCAGCAACT-1_2_B4	-36.51372933	1.422866525	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1737	3276	0.003052503	0.004884005	0	9	OPC	NA	NA	NA
CATGCCTTCAGCTCGG-1_2_B4	4.00679955	26.3467533	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	762	1102	0.007259528	0.005444646	0	oligos	OL-Cntl	NA	NA	NA
CATGCCTTCGCCGTGA-1_2_B4	-34.45547586	-7.399676072	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1007	1448	0.007596685	0.008287293	0	9	OPC	NA	NA	NA
CATGCCTTCTTTAGTC-1_2_B4	3.906537826	28.88583209	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	765	1104	0.001811594	0.005434783	0	oligos	OL-Cntl	NA	NA	NA
CATGGCGGTCTAAACC-1_2_B4	-6.904921559	-8.151224744	13A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	904	1343	0.031273269	0.003723008	0	13A	IN-VIP	NA	NA	NA
CATGGCGGTGGACGAT-1_2_B4	8.873924635	-30.37790364	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	4075	9704	0.010098928	0.003812861	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CATGGCGTCAAAGACA-1_2_B4	-23.06282724	18.36454567	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1196	1904	0.00052521	0.003676471	0	8	Astrocytes	NA	NA	NA
CATTATCAGAACAACT-1_2_B4	14.44880899	26.74607255	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	793	1199	0.003336113	0.004170142	0	oligos	OL-Cntl	NA	NA	NA
CATTATCAGTACCGGA-1_2_B4	2.348430215	27.47506575	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	692	1015	0.000985222	0.008866995	0	oligos	OL-Cntl	NA	NA	NA
CATTATCAGTGACTCT-1_2_B4	-10.3661494	18.42448587	11	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2585	5299	0.002453293	0.003774297	0	11	Glia-MIX	NA	NA	NA
CATTATCCAAACCTAC-1_2_B4	11.57669136	28.41162277	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	864	1294	0.000772798	0.002318393	0	oligos	OL-Cntl	NA	NA	NA
CATTATCCACAGAGGT-1_2_B4	25.9087382	0.863629599	2	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2399	5163	0.011040093	0.003292659	0	2	EN-L4	NA	NA	NA
CATTATCCAGCTTAAC-1_2_B4	0.232709244	-8.05719925	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1407	2575	0.00815534	0.000776699	0	12	EN-MIX	NA	NA	NA
CATTATCGTAAGGGCT-1_2_B4	37.07563997	9.469442037	14	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	756	1025	0.005853659	0.012682927	0	14	Microglia	NA	NA	NA
CATTATCGTACTTAGC-1_2_B4	-14.42492211	-5.326777953	13A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2833	6096	0.007545932	0.006397638	0	13A	IN-VIP	NA	NA	NA
CATTATCGTAGTGAAT-1_2_B4	-20.98117882	10.05223157	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1039	1607	0	0.003733665	0	8	Astrocytes	NA	NA	NA
CATTATCGTTCGCGAC-1_2_B4	-8.218302141	-1.200556157	13A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2050	4121	0.002669255	0.002911915	0	13A	IN-VIP	NA	NA	NA
CATTCGCAGCCAGGAT-1_2_B4	-4.130007251	-6.207549396	13A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1004	1524	0.008530184	0.004593176	0	13A	IN-VIP	NA	NA	NA
CATTCGCCACGACTCG-1_2_B4	12.14842078	24.38769596	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	801	1190	0.000840336	0.005042017	0	oligos	OL-Cntl	NA	NA	NA
CATTCGCCATAAAGGT-1_2_B4	23.50576905	12.64397448	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1356	2308	0.000433276	0.000866551	0	oligos	OL-Cntl	NA	NA	NA
CATTCGCGTGAGGCTA-1_2_B4	15.72543072	-1.10460907	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	758	1259	0.001588562	0.001588562	0	12	EN-MIX	NA	NA	NA
CATTCGCGTGCCTGTG-1_2_B4	32.1530582	10.6390884	14	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	955	1266	0.001579779	0.06793049	0	14	Microglia	NA	NA	NA
CCAATCCAGACTGGGT-1_2_B4	-12.86485453	-23.08512831	6A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1498	2550	0.002745098	0.001568627	0	6A	IN-PV	NA	NA	NA
CCAATCCAGAGGTTAT-1_2_B4	21.03852641	9.489912615	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1703	3000	0.006333333	0.007333333	0	oligos	OL-Cntl	NA	NA	NA
CCAATCCCACGGCCAT-1_2_B4	7.138895421	24.73460837	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	954	1442	0.003467406	0.006241331	0	oligos	OL-Cntl	NA	NA	NA
CCAATCCCACGTGAGA-1_2_B4	15.76507529	26.13727689	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	880	1349	0.004447739	0.00148258	0	oligos	OL-Cntl	NA	NA	NA
CCAATCCGTCTTCTCG-1_2_B4	18.9661203	7.478547624	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2027	4094	0.006595017	0.007083537	0	oligos	OL-Cntl	NA	NA	NA
CCACCTAAGACACTAA-1_2_B4	21.46433986	10.62435557	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1592	2728	0.001099707	0.011363636	0	oligos	OL-Cntl	NA	NA	NA
CCACCTAAGGCTCAGA-1_2_B4	-32.05929434	12.03807551	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	778	1188	0.005892256	0.004208754	0	8	Astrocytes	NA	NA	NA
CCACCTAAGGGATCTG-1_2_B4	39.63293808	13.32475527	14	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	996	1351	0.006661732	0.009622502	0	14	Microglia	NA	NA	NA
CCACCTACAGTCCTTC-1_2_B4	15.00871386	28.28103459	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	714	1102	0.004537205	0.003629764	0	oligos	OL-Cntl	NA	NA	NA
CCACCTACATCCCACT-1_2_B4	16.67925469	18.16220007	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1055	1746	0.001145475	0.006300115	0	oligos	OL-Cntl	NA	NA	NA
CCACCTAGTCTCATCC-1_2_B4	8.967438146	-30.21095459	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	6130	23231	0.006112522	0.002625802	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CCACCTAGTCTTCGTC-1_2_B4	14.09755176	-2.645745926	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1088	1914	0.000522466	0.003134796	0	12	EN-MIX	NA	NA	NA
CCACCTATCCACTGGG-1_2_B4	-10.56152545	15.79249817	11	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1780	2777	0.003240907	0.005401512	0	11	Glia-MIX	NA	NA	NA
CCACGGAAGACTACAA-1_2_B4	3.177682302	-4.517483296	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	837	1185	0.010126582	0.000843882	0	12	EN-MIX	NA	NA	NA
CCACGGAAGGTGATTA-1_2_B4	-36.95284848	-5.464869092	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1274	2222	0.00450045	0.00450045	0	9	OPC	NA	NA	NA
CCACGGAAGTTCGCAT-1_2_B4	1.37220045	-27.9938936	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3846	10835	0.008121827	0.002307337	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CCACGGACAAGCCGTC-1_2_B4	-36.33683378	-0.551477864	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1567	2683	0.005963474	0.004845322	0	9	OPC	NA	NA	NA
CCACGGACAATGTTGC-1_2_B4	-26.98155035	13.17755636	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	915	1364	0.008797654	0.008064516	0	8	Astrocytes	NA	NA	NA
CCACGGAGTATCAGTC-1_2_B4	-28.26300437	10.66323375	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	679	1037	0.003857281	0.004821601	0	8	Astrocytes	NA	NA	NA
CCACGGATCAGGCCCA-1_2_B4	18.66093033	13.37996716	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1284	2085	0.002877698	0.007194245	0	oligos	OL-Cntl	NA	NA	NA
CCACGGATCTTCTGGC-1_2_B4	39.82820136	11.3353549	14	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	878	1192	0.000838926	0.005033557	0	14	Microglia	NA	NA	NA
CCACTACCAATGTAAG-1_2_B4	2.660944603	29.76958254	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	685	1017	0.015732547	0.000983284	0	oligos	OL-Cntl	NA	NA	NA
CCACTACTCCCTAATT-1_2_B4	2.140349463	-31.38028876	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	5529	19878	0.002465037	0.003119026	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CCACTACTCGAACTGT-1_2_B4	16.56559965	1.581853447	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	815	1284	0.052959502	0.000778816	0	12	EN-MIX	NA	NA	NA
CCACTACTCTGTCCGT-1_2_B4	-11.88848052	13.49389032	11	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	924	1292	0.00619195	0.00619195	0	11	Glia-MIX	NA	NA	NA
CCAGCGAAGGCGACAT-1_2_B4	22.11226329	11.16202368	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1554	2462	0.002030869	0.010154346	0	oligos	OL-Cntl	NA	NA	NA
CCAGCGACAAATCCGT-1_2_B4	-0.004675719	-17.34982802	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2643	6118	0.011114743	0.002942138	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CCAGCGACATTTCAGG-1_2_B4	15.37669634	28.49933665	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	723	1057	0.004730369	0.005676443	0	oligos	OL-Cntl	NA	NA	NA
CCAGCGAGTACAGACG-1_2_B4	2.567308541	-31.96958633	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	6159	22018	0.007039695	0.00295213	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CCAGCGAGTCCATCCT-1_2_B4	21.31302886	10.63507665	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1458	2321	0.008616975	0.00689358	0	oligos	OL-Cntl	NA	NA	NA
CCATGTCAGCTCCTCT-1_2_B4	17.47239449	20.440519	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	988	1604	0.008104738	0.005610973	0	oligos	OL-Cntl	NA	NA	NA
CCATGTCCAAGGCTCC-1_2_B4	7.93774475	27.49775527	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	898	1381	0.005068791	0.006517017	0	oligos	OL-Cntl	NA	NA	NA
CCATGTCCACAGGAGT-1_2_B4	11.22497374	32.57166629	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	732	1046	0.005736138	0.006692161	0	oligos	OL-Cntl	NA	NA	NA
CCATGTCCATTCCTGC-1_2_B4	-0.681720072	-13.13094617	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2086	4249	0.007295834	0.002353495	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CCATGTCGTCAAAGAT-1_2_B4	-35.8833749	-4.482455394	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1247	1949	0.002565418	0.005130836	0	9	OPC	NA	NA	NA
CCATGTCGTCAGGACA-1_2_B4	0.961825735	-27.23688268	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3612	9009	0.004218004	0.002442002	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CCATTCGAGGTCGGAT-1_2_B4	15.0979136	-0.464773102	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	732	1091	0.004582951	0.003666361	0	12	EN-MIX	NA	NA	NA
CCATTCGAGTTTCCTT-1_2_B4	10.27379246	28.64874727	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	755	1115	0.000896861	0.002690583	0	oligos	OL-Cntl	NA	NA	NA
CCATTCGCAATAACGA-1_2_B4	1.698980917	28.89500553	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	783	1120	0.003571429	0.002678571	0	oligos	OL-Cntl	NA	NA	NA
CCATTCGCAATCCGAT-1_2_B4	-27.80483519	13.4263468	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	850	1315	0.001520913	0	0	8	Astrocytes	NA	NA	NA
CCATTCGCAATGGAGC-1_2_B4	16.99704567	16.56590074	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1143	1777	0.007878447	0.009566685	0	oligos	OL-Cntl	NA	NA	NA
CCATTCGCACAGCCCA-1_2_B4	20.52313905	7.281384593	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1930	3636	0.002475248	0.006050605	0	oligos	OL-Cntl	NA	NA	NA
CCATTCGCACCCAGTG-1_2_B4	16.67516187	15.96534985	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1098	1817	0.001651073	0.009906439	0	oligos	OL-Cntl	NA	NA	NA
CCATTCGTCAAACCGT-1_2_B4	-1.639139558	-24.87830799	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	4480	13780	0.00616836	0.002467344	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CCATTCGTCTGGTGTA-1_2_B4	-23.55267101	-0.913483304	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1256	2007	0.002989537	0.005480817	0	9	OPC	NA	NA	NA
CCCAATCAGCACCGTC-1_2_B4	30.20789236	-3.552578106	2	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3496	8388	0.010014306	0.00286123	0	2	EN-L4	NA	NA	NA
CCCAATCAGCGGCTTC-1_2_B4	-0.127282469	-11.64137833	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1880	3592	0.009465479	0.002227171	0	12	EN-MIX	NA	NA	NA
CCCAATCGTAGGGACT-1_2_B4	12.36019685	30.17206154	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	721	1064	0.003759398	0.002819549	0	oligos	OL-Cntl	NA	NA	NA
CCCAATCGTCTTTCAT-1_2_B4	5.880919938	-32.29200914	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	4506	15025	0.001198003	0.002063228	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CCCAATCGTTACTGAC-1_2_B4	14.60841541	18.85269791	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1067	1705	0.002346041	0.007038123	0	oligos	OL-Cntl	NA	NA	NA
CCCAATCTCAAACCAC-1_2_B4	-16.63670995	14.61798355	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1627	2712	0.003687316	0.002581121	0	8	Astrocytes	NA	NA	NA
CCCAGTTAGATCTGAA-1_2_B4	34.20667893	14.68602401	14	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	956	1258	0.001589825	0.039745628	0	14	Microglia	NA	NA	NA
CCCAGTTAGCATCATC-1_2_B4	-38.44263067	-2.723155131	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1229	2056	0.003891051	0.003404669	0	9	OPC	NA	NA	NA
CCCAGTTAGCTGATAA-1_2_B4	6.631283007	24.88747854	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	842	1212	0.001650165	0.004125413	0	oligos	OL-Cntl	NA	NA	NA
CCCAGTTAGGATCGCA-1_2_B4	20.73414663	-28.13423921	3	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3001	6744	0.011714116	0.004596679	0	3	EN-L5-6	NA	NA	NA
CCCAGTTAGGGCACTA-1_2_B4	1.216685648	0.983737846	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	920	1302	0.019201229	0.003840246	0	12	EN-MIX	NA	NA	NA
CCCAGTTAGTGGAGTC-1_2_B4	15.61585737	19.93126345	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	885	1352	0.002218935	0.008136095	0	oligos	OL-Cntl	NA	NA	NA
CCCAGTTCAACGATCT-1_2_B4	24.92282528	-27.32850903	3	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3481	8533	0.007148717	0.003515762	0	3	EN-L5-6	NA	NA	NA
CCCAGTTCACATCTTT-1_2_B4	-16.80338607	-25.91917912	6A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2189	4597	0.01305199	0.002827931	0	6A	IN-PV	NA	NA	NA
CCCAGTTCACGAGAGT-1_2_B4	3.457882828	-9.816250696	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1545	2540	0.014173228	0.003149606	0	12	EN-MIX	NA	NA	NA
CCCAGTTGTCTTGTCC-1_2_B4	23.5140486	-9.250448353	3	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3693	9300	0.001290323	0.001935484	0	3	EN-L5-6	NA	NA	NA
CCCAGTTGTTCAACCA-1_2_B4	-27.14790053	23.42125946	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1262	2167	0.002307337	0.005999077	0	8	Astrocytes	NA	NA	NA
CCCAGTTTCTAACGGT-1_2_B4	15.96787198	-7.381364956	3	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2078	4213	0.000474721	0.009019701	0	3	EN-L5-6	NA	NA	NA
CCCAGTTTCTACCTGC-1_2_B4	-35.38189812	5.187274658	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2867	6676	0.000748951	0.002097064	0	9	OPC	NA	NA	NA
CCCATACAGAACAATC-1_2_B4	7.884976639	35.2004762	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1085	1682	0.039833532	0.003567182	0	oligos	OL-Cntl	NA	NA	NA
CCCATACAGCCCAGCT-1_2_B4	2.872982399	-11.29522999	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2032	4366	0.005038937	0.003206596	0	12	EN-MIX	NA	NA	NA
CCCATACCAAACAACA-1_2_B4	15.55225536	-2.346585092	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	983	1612	0.013027295	0.005583127	0	12	EN-MIX	NA	NA	NA
CCCATACCAATGACCT-1_2_B4	26.70092758	0.127446515	2	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2852	7146	0.004897845	0.002518892	0	2	EN-L4	NA	NA	NA
CCCATACCACCAGTTA-1_2_B4	6.680267461	24.65641299	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	897	1331	0.003756574	0.006010518	0	oligos	OL-Cntl	NA	NA	NA
CCCATACCACGGACAA-1_2_B4	16.60078351	13.5831573	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1174	1841	0.002715915	0.004345464	0	oligos	OL-Cntl	NA	NA	NA
CCCATACCAGCGATCC-1_2_B4	20.86517626	14.22467721	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1314	2181	0.003209537	0.003209537	0	oligos	OL-Cntl	NA	NA	NA
CCCATACGTTGACGTT-1_2_B4	-19.32048629	8.361132459	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	920	1256	0.002388535	0.003980892	0	8	Astrocytes	NA	NA	NA
CCCATACTCCACGTTC-1_2_B4	-13.22538425	16.13518584	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1280	1965	0.007124682	0.002035623	0	8	Astrocytes	NA	NA	NA
CCCATACTCTCTGCTG-1_2_B4	-11.33624731	-0.638645972	13A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2554	4641	0.010127128	0.008834303	0	13A	IN-VIP	NA	NA	NA
CCCATACTCTTCTGGC-1_2_B4	10.93371503	1.325629027	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	800	1091	0.03208066	0	0	12	EN-MIX	NA	NA	NA
CCCATACTCTTTAGGG-1_2_B4	6.288373724	-8.438989062	4	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1966	3345	0.004783259	0.007473842	0	L2-3	EN-L2-3-MS	NA	NA	NA
CCCTCCTAGACTACAA-1_2_B4	18.88780463	16.29590814	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1149	1850	0.004324324	0.002702703	0	oligos	OL-Cntl	NA	NA	NA
CCCTCCTAGCGCCTCA-1_2_B4	20.35693772	18.94395269	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1059	1751	0	0.011993147	0	oligos	OL-Cntl	NA	NA	NA
CCCTCCTAGGGTATCG-1_2_B4	18.07018787	16.6722504	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1097	1745	0.003438395	0.006876791	0	oligos	OL-Cntl	NA	NA	NA
CCCTCCTAGTGAATTG-1_2_B4	-37.86528568	-0.173594347	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1326	2247	0.000890076	0.003560303	0	9	OPC	NA	NA	NA
CCCTCCTCATTACCTT-1_2_B4	15.02543777	-3.399075622	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1145	2128	0.015037594	0.002819549	0	12	EN-MIX	NA	NA	NA
CCCTCCTGTAACGTTC-1_2_B4	3.120047095	28.23945666	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	724	1074	0.003724395	0.005586592	0	oligos	OL-Cntl	NA	NA	NA
CCCTCCTGTACAGCAG-1_2_B4	-0.122877278	-16.86265637	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2459	4883	0.007577309	0.002047921	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CCGGGATAGCCATCGC-1_2_B4	2.997882814	22.23882767	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	863	1220	0.007377049	0.01147541	0	oligos	OL-Cntl	NA	NA	NA
CCGGGATAGGTGGGTT-1_2_B4	20.38873227	22.5222896	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1047	1660	0.007228916	0.006626506	0	oligos	OL-Cntl	NA	NA	NA
CCGGGATAGTGCGTGA-1_2_B4	-11.01023226	0.048437187	13A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2683	5471	0.010601353	0.005117894	0	13A	IN-VIP	NA	NA	NA
CCGGGATCACATGACT-1_2_B4	-19.80547266	-18.31019239	13A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3693	9813	0.002038113	0.002751452	0	13A	IN-VIP	NA	NA	NA
CCGGGATCAGGTCCAC-1_2_B4	-12.15999042	-10.75509204	13B	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1430	2521	0.001586672	0.003570012	0	13B	IN-SV2C	NA	NA	NA
CCGGGATGTGACGGTA-1_2_B4	-6.084436316	-0.928141892	13A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1675	2973	0.000336361	0.006727212	0	13A	IN-VIP	NA	NA	NA
CCGGTAGAGGAATGGA-1_2_B4	8.143401427	-26.55113552	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	4180	11233	0.00729992	0.002848749	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CCGGTAGAGGAGTAGA-1_2_B4	12.10893669	18.90029254	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1040	1508	0.00198939	0.00862069	0	oligos	OL-Cntl	NA	NA	NA
CCGGTAGAGTGGGATC-1_2_B4	21.51278956	10.97780537	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1571	2612	0.007656968	0.005359877	0	oligos	OL-Cntl	NA	NA	NA
CCGGTAGCAGTAAGAT-1_2_B4	4.172456051	-7.321307433	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1226	1956	0.020961145	0.006646217	0	12	EN-MIX	NA	NA	NA
CCGGTAGGTCTCCATC-1_2_B4	-22.88080398	22.05552537	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1340	2159	0.000926355	0.004168597	0	8	Astrocytes	NA	NA	NA
CCGGTAGTCGCAAACT-1_2_B4	-21.50627542	9.814397757	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	935	1396	0.001432665	0.006446991	0	8	Astrocytes	NA	NA	NA
CCGGTAGTCTCCAACC-1_2_B4	13.37309498	23.31132066	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	901	1422	0.007735584	0.00281294	0	oligos	OL-Cntl	NA	NA	NA
CCGTACTAGGCTATCT-1_2_B4	22.86739826	-9.002378338	3	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2783	6347	0.004569088	0.001733102	0	3	EN-L5-6	NA	NA	NA
CCGTACTAGGGTGTTG-1_2_B4	3.151647881	-20.51686778	4	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3579	8267	0.007015846	0.005201403	0	L2-3	EN-L2-3-MS	NA	NA	NA
CCGTACTCATTTGCTT-1_2_B4	4.09321819	4.076822822	7	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1968	3122	0.00384369	0.068866111	0	7	Phagocytes	NA	NA	NA
CCGTACTGTAGCGTCC-1_2_B4	-23.32096109	22.73629936	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1425	2372	0.004637437	0.005902192	0	8	Astrocytes	NA	NA	NA
CCGTACTGTATAATGG-1_2_B4	6.381087719	26.93086722	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	815	1161	0.003445306	0.010335917	0	oligos	OL-Cntl	NA	NA	NA
CCGTACTGTTCAACCA-1_2_B4	-20.29481119	-29.05684199	6A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3805	10241	0.000488234	0.002343521	0	6A	IN-PV	NA	NA	NA
CCGTACTTCCAACCAA-1_2_B4	11.70151108	23.71822529	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	853	1304	0.001533742	0.006134969	0	oligos	OL-Cntl	NA	NA	NA
CCGTACTTCCTTCAAT-1_2_B4	21.03984954	7.610971352	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2076	3872	0.003615702	0.003873967	0	oligos	OL-Cntl	NA	NA	NA
CCGTACTTCTCAAGTG-1_2_B4	14.74637075	21.08281701	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	992	1479	0.006761325	0.008789723	0	oligos	OL-Cntl	NA	NA	NA
CCGTGGACAGATAATG-1_2_B4	3.817833542	-19.68255404	4	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3398	7398	0.007434442	0.006758583	0	L2-3	EN-L2-3-MS	NA	NA	NA
CCGTGGACAGATGAGC-1_2_B4	1.277733606	22.07933882	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	841	1223	0.010629599	0.014717907	0	oligos	OL-Cntl	NA	NA	NA
CCGTGGATCACCCTCA-1_2_B4	-2.089196947	-1.205501864	13B	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1977	3718	0.005379236	0.002420656	0	13B	IN-SV2C	NA	NA	NA
CCGTGGATCGCCCTTA-1_2_B4	14.65130343	20.18086017	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	943	1441	0.002081888	0.006245663	0	oligos	OL-Cntl	NA	NA	NA
CCGTGGATCGGCGCAT-1_2_B4	11.67171121	29.23783154	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	825	1226	0.000815661	0.004078303	0	oligos	OL-Cntl	NA	NA	NA
CCGTGGATCTGGGCCA-1_2_B4	19.08170342	8.267546822	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1741	3152	0.000951777	0.003489848	0	oligos	OL-Cntl	NA	NA	NA
CCGTTCAAGATCCTGT-1_2_B4	-24.4848706	-1.585424489	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1857	4354	0.001378043	0.002296739	0	9	OPC	NA	NA	NA
CCGTTCAAGCCGGTAA-1_2_B4	14.497943	1.29414587	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	733	1078	0.038033395	0.000927644	0	12	EN-MIX	NA	NA	NA
CCGTTCACACCAACCG-1_2_B4	20.41950912	15.12666204	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1171	1987	0.002013085	0.005535984	0	oligos	OL-Cntl	NA	NA	NA
CCGTTCACATCGGACC-1_2_B4	12.25650822	25.08061043	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	870	1364	0.007331378	0.001466276	0	oligos	OL-Cntl	NA	NA	NA
CCGTTCACATCGGGTC-1_2_B4	-3.793302642	22.56982958	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	768	1058	0.007561437	0.016068053	0	oligos	OL-Cntl	NA	NA	NA
CCGTTCAGTGATGCCC-1_2_B4	3.154310308	-15.54643062	4	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2587	5072	0.00887224	0.008477918	0	L2-3	EN-L2-3-MS	NA	NA	NA
CCGTTCAGTGCACGAA-1_2_B4	18.37789999	14.98048181	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1168	2007	0.014449427	0.005979073	0	oligos	OL-Cntl	NA	NA	NA
CCGTTCAGTGTTCGAT-1_2_B4	40.52806579	14.88804657	14	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1430	2090	0.025837321	0.017703349	0	14	Microglia	NA	NA	NA
CCGTTCAGTTATCACG-1_2_B4	-0.224700561	24.97181415	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	790	1195	0.00167364	0.006694561	0	oligos	OL-Cntl	NA	NA	NA
CCGTTCAGTTCAGCGC-1_2_B4	0.691905629	-23.34648837	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3706	9602	0.005415538	0.002916059	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CCGTTCATCCAAAGTC-1_2_B4	20.93488203	19.18407433	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	949	1420	0.002816901	0.003521127	0	oligos	OL-Cntl	NA	NA	NA
CCGTTCATCCTCCTAG-1_2_B4	20.50217937	8.710878219	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1716	3084	0.000648508	0.008106355	0	oligos	OL-Cntl	NA	NA	NA
CCTAAAGAGGTGCAAC-1_2_B4	-14.50240248	-24.87305465	6A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1535	2824	0.003541076	0.002124646	0	6A	IN-PV	NA	NA	NA
CCTAAAGAGTGAACGC-1_2_B4	2.742998836	26.67256605	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	716	1042	0.007677543	0.00671785	0	oligos	OL-Cntl	NA	NA	NA
CCTAAAGCAGTATGCT-1_2_B4	-9.214124279	14.41774279	11	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1771	2968	0.001684636	0.001684636	0	11	Glia-MIX	NA	NA	NA
CCTAAAGTCAGGTAAA-1_2_B4	16.77508069	20.11561989	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1017	1516	0.001319261	0.003298153	0	oligos	OL-Cntl	NA	NA	NA
CCTAAAGTCTCCAGGG-1_2_B4	15.39400523	21.57725745	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	868	1283	0.00233827	0.004676539	0	oligos	OL-Cntl	NA	NA	NA
CCTAAAGTCTTTACAC-1_2_B4	-37.51363171	2.944397732	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1732	3421	0.002338498	0.001753873	0	9	OPC	NA	NA	NA
CCTACACAGCCCAATT-1_2_B4	21.31760541	-20.42924481	3	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	6637	25419	0.018057359	0.006373185	0	3	EN-L5-6	NA	NA	NA
CCTACACCAGGTCTCG-1_2_B4	-11.79668273	18.17330894	11	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1613	2813	0.001777462	0.002843939	0	11	Glia-MIX	NA	NA	NA
CCTACACCATCTCCCA-1_2_B4	-27.05570423	12.30742902	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	882	1344	0.008184524	0.001488095	0	8	Astrocytes	NA	NA	NA
CCTACACGTAAATGTG-1_2_B4	-28.3545481	15.89088319	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1000	1626	0.001845018	0.003690037	0	8	Astrocytes	NA	NA	NA
CCTACACGTCTTGATG-1_2_B4	16.51285404	20.56207421	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1020	1633	0.014084507	0.003061849	0	oligos	OL-Cntl	NA	NA	NA
CCTACCAAGTACTTGC-1_2_B4	4.137161861	-32.89418249	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	5213	17909	0.00234519	0.001898487	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CCTACCAAGTCCCACG-1_2_B4	16.65216221	26.05845396	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	930	1406	0.000711238	0.009957326	0	oligos	OL-Cntl	NA	NA	NA
CCTACCACACCAGCAC-1_2_B4	22.65895601	14.06627197	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1283	2144	0.001399254	0.005130597	0	oligos	OL-Cntl	NA	NA	NA
CCTACCAGTCGGGTCT-1_2_B4	21.33789282	17.33051939	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1138	1744	0.002866972	0.006880734	0	oligos	OL-Cntl	NA	NA	NA
CCTACCAGTCTAAAGA-1_2_B4	-28.66469171	12.16454418	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	788	1270	0.01023622	0.002362205	0	8	Astrocytes	NA	NA	NA
CCTACCAGTTCAGTAC-1_2_B4	4.012693879	-31.06290896	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	4791	17279	0.005266508	0.001851959	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CCTACCAGTTGGAGGT-1_2_B4	8.909550911	-8.717002699	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2321	5109	0.005480525	0.000978665	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CCTAGCTAGAAGATTC-1_2_B4	15.12209921	-32.06631339	3	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	5538	19439	0.002212048	0.003858223	0	3	EN-L5-6	NA	NA	NA
CCTAGCTAGAATTCCC-1_2_B4	16.33394427	19.71446585	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1024	1704	0.008802817	0.009389671	0	oligos	OL-Cntl	NA	NA	NA
CCTAGCTGTACTCAAC-1_2_B4	5.343233919	30.64770162	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	707	1055	0.019905213	0.008530806	0	oligos	OL-Cntl	NA	NA	NA
CCTAGCTGTCGACTAT-1_2_B4	-1.393217947	-1.119274354	11	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2020	3694	0.005143476	0.010286952	0	11	Glia-MIX	NA	NA	NA
CCTAGCTTCAACACCA-1_2_B4	-19.73994865	-24.37219204	6A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2521	5110	0.011741683	0.005283757	0	6A	IN-PV	NA	NA	NA
CCTATTAAGAGAACAG-1_2_B4	-28.27547527	20.73464445	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1203	2040	0.009313725	0.004411765	0	8	Astrocytes	NA	NA	NA
CCTATTAAGAGTTGGC-1_2_B4	1.367452453	22.04727341	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	742	1095	0.015525114	0.00913242	0	oligos	OL-Cntl	NA	NA	NA
CCTATTAAGATCTGCT-1_2_B4	15.40432783	-6.187733747	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1724	3415	0.001171303	0.00556369	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CCTATTAGTGATGTGG-1_2_B4	37.94181226	10.20501825	14	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	799	1086	0.006445672	0.007366483	0	14	Microglia	NA	NA	NA
CCTATTATCGCTTAGA-1_2_B4	-28.01626415	22.00887936	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1121	1931	0.004660798	0.003107198	0	8	Astrocytes	NA	NA	NA
CCTCAGTAGGACAGCT-1_2_B4	3.161848947	-4.865529193	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	878	1281	0.010148322	0.00312256	0	12	EN-MIX	NA	NA	NA
CCTCAGTCAACTGGCC-1_2_B4	-1.197114287	-0.221388529	11	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2175	3968	0.003780242	0.003780242	0	11	Glia-MIX	NA	NA	NA
CCTCAGTCAACTTGAC-1_2_B4	-35.8394594	-9.232645405	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	966	1506	0.005976096	0.000664011	0	9	OPC	NA	NA	NA
CCTCAGTCATGTCCTC-1_2_B4	18.01765195	19.57542494	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1039	1663	0.001202646	0.007215875	0	oligos	OL-Cntl	NA	NA	NA
CCTCAGTTCGAACTGT-1_2_B4	11.08876442	0.355744955	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1090	1680	0.017261905	0.004761905	0	12	EN-MIX	NA	NA	NA
CCTCTGAAGCGTTGCC-1_2_B4	-1.533375606	-18.41843999	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2985	7337	0.007768843	0.002862205	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CCTCTGACATCAGTAC-1_2_B4	15.01239082	2.90910684	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	869	1261	0.004758128	0	0	12	EN-MIX	NA	NA	NA
CCTCTGAGTAACGACG-1_2_B4	1.696762205	-18.15504073	4	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2560	5142	0.009529366	0.005056398	0	L2-3	EN-L2-3-MS	NA	NA	NA
CCTCTGAGTGTGCCTG-1_2_B4	11.98754832	-8.593716006	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2288	4302	0.0032543	0.0027894	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CCTCTGATCGCCAAAT-1_2_B4	15.45917007	-1.047479239	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	732	1155	0.005194805	0.003463203	0	12	EN-MIX	NA	NA	NA
CCTCTGATCTTAGAGC-1_2_B4	39.27230494	16.34745104	14	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2133	3637	0.009073412	0.012097883	0	14	Microglia	NA	NA	NA
CCTTACGAGGAATCGC-1_2_B4	10.84191842	20.9238808	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	927	1486	0.004710633	0.007402423	0	oligos	OL-Cntl	NA	NA	NA
CCTTACGCACGCATCG-1_2_B4	2.833195298	-6.313385545	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1129	1747	0.014310246	0.004579279	0	12	EN-MIX	NA	NA	NA
CCTTACGCAGCTGCAC-1_2_B4	4.148702529	-7.994894822	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1297	2115	0.008037825	0.008037825	0	12	EN-MIX	NA	NA	NA
CCTTACGCATGGGACA-1_2_B4	14.12145078	28.49427314	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	700	1007	0.001986097	0.008937438	0	oligos	OL-Cntl	NA	NA	NA
CCTTACGGTCAATGTC-1_2_B4	-17.48435261	14.13094793	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1302	2062	0	0.004849661	0	8	Astrocytes	NA	NA	NA
CCTTACGGTCCAGTGC-1_2_B4	5.71558442	-5.71528331	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1002	1609	0.001243008	0.000621504	0	12	EN-MIX	NA	NA	NA
CCTTACGGTTACCAGT-1_2_B4	23.53399262	-9.289651058	3	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3626	9367	0.00096082	0.002348671	0	3	EN-L5-6	NA	NA	NA
CCTTACGTCTAACTCT-1_2_B4	-26.14184378	16.37721119	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1106	1683	0.000594177	0.000594177	0	8	Astrocytes	NA	NA	NA
CCTTACGTCTTTACAC-1_2_B4	20.72033012	7.263781639	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2143	4241	0.000471587	0.004715869	0	oligos	OL-Cntl	NA	NA	NA
CCTTCCCAGCGACGTA-1_2_B4	-38.6689411	-1.314286309	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1357	2376	0.001262626	0.002104377	0	9	OPC	NA	NA	NA
CCTTCCCAGCTGCAAG-1_2_B4	16.68056914	20.25173922	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	958	1471	0.001359619	0.011556764	0	oligos	OL-Cntl	NA	NA	NA
CCTTCCCAGTCTCCTC-1_2_B4	4.919037541	23.57331896	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	858	1258	0.002384738	0.014308426	0	oligos	OL-Cntl	NA	NA	NA
CCTTCCCTCAACGAAA-1_2_B4	20.9467725	-0.222714515	2	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1498	2644	0.042738275	0.002647504	0	2	EN-L4	NA	NA	NA
CCTTCCCTCAGCACAT-1_2_B4	21.74720929	17.13509195	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1343	2105	0.003800475	0.003800475	0	oligos	OL-Cntl	NA	NA	NA
CCTTCCCTCAGGTTCA-1_2_B4	-1.742121733	26.70709621	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	759	1052	0.003802281	0.006653992	0	oligos	OL-Cntl	NA	NA	NA
CCTTCCCTCGGCATCG-1_2_B4	16.50770722	28.89643739	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	802	1140	0.000877193	0.003508772	0	oligos	OL-Cntl	NA	NA	NA
CCTTCCCTCGTCCAGG-1_2_B4	-21.05975545	9.95956668	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	963	1415	0.009893993	0.004240283	0	8	Astrocytes	NA	NA	NA
CCTTCCCTCTCGAGTA-1_2_B4	4.151408167	-32.91199751	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	7135	34801	0.000574696	0.002327519	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CCTTCGAAGAGGTACC-1_2_B4	-28.92595334	12.18364518	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	758	1114	0	0.001795332	0	8	Astrocytes	NA	NA	NA
CCTTCGAAGCCGCCTA-1_2_B4	18.24460983	8.454291789	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1643	2888	0.004847645	0.005540166	0	oligos	OL-Cntl	NA	NA	NA
CCTTCGAAGTCACGCC-1_2_B4	-9.17095938	17.60954499	11	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3622	8433	0.002134472	0.005691925	0	11	Glia-MIX	NA	NA	NA
CCTTCGACACCGTTGG-1_2_B4	18.90141709	7.130438486	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2033	4176	0.006944444	0.005268199	0	oligos	OL-Cntl	NA	NA	NA
CCTTCGAGTACCGGCT-1_2_B4	-4.258390264	-8.489926436	13A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	794	1107	0.019873532	0.002710027	0	13A	IN-VIP	NA	NA	NA
CCTTCGAGTATAAACG-1_2_B4	21.14785088	-5.570239431	2	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2536	4752	0.010732323	0.003998316	0	2	EN-L4	NA	NA	NA
CCTTCGATCACTTATC-1_2_B4	25.1110848	-27.87738751	3	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3603	9616	0.006655574	0.002287854	0	3	EN-L5-6	NA	NA	NA
CCTTCGATCGGCTACG-1_2_B4	17.97688506	-5.663026334	3	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1363	2259	0.000885347	0.002656042	0	3	EN-L5-6	NA	NA	NA
CCTTCGATCTTGTTTG-1_2_B4	9.535181218	19.51455815	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	845	1260	0.004761905	0.01031746	0	oligos	OL-Cntl	NA	NA	NA
CCTTTCTCAAACTGCT-1_2_B4	-10.22639125	12.62628533	11	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	903	1284	0.009345794	0.007009346	0	11	Glia-MIX	NA	NA	NA
CCTTTCTGTCGCATAT-1_2_B4	19.79637225	21.85047986	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1017	1732	0.001154734	0.002886836	0	oligos	OL-Cntl	NA	NA	NA
CCTTTCTTCTAGAGTC-1_2_B4	2.25837257	26.68246942	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	674	1001	0.006993007	0.007992008	0	oligos	OL-Cntl	NA	NA	NA
CGAACATAGATGTTAG-1_2_B4	-15.90558126	-19.13517386	6B	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1852	3914	0.015074093	0.005365355	0	6B	IN-SST	NA	NA	NA
CGAACATAGTACGCGA-1_2_B4	17.70717339	27.32723391	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	976	1417	0.007762879	0.007762879	0	oligos	OL-Cntl	NA	NA	NA
CGAACATAGTGACATA-1_2_B4	14.02244826	30.48848918	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	838	1187	0.00252738	0.00084246	0	oligos	OL-Cntl	NA	NA	NA
CGAACATAGTGCAAGC-1_2_B4	2.118193091	27.64932906	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	742	1100	0.002727273	0.003636364	0	oligos	OL-Cntl	NA	NA	NA
CGAACATAGTGCTGCC-1_2_B4	3.539373327	27.51851732	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	738	1020	0.002941176	0.001960784	0	oligos	OL-Cntl	NA	NA	NA
CGAACATCAAAGTGCG-1_2_B4	38.3938793	11.29300235	14	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	844	1140	0.009649123	0.011403509	0	14	Microglia	NA	NA	NA
CGAACATCAGACGTAG-1_2_B4	15.64028148	27.007003	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	812	1173	0.000852515	0.00341006	0	oligos	OL-Cntl	NA	NA	NA
CGAACATCAGGACGTA-1_2_B4	-28.35677297	10.64089303	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	724	1008	0.004960317	0.001984127	0	8	Astrocytes	NA	NA	NA
CGAACATGTCCAGTAT-1_2_B4	0.736447931	-27.61165158	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	4458	13458	0.003863873	0.001931936	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGAACATGTCCATCCT-1_2_B4	-23.30365619	1.236274761	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2837	6030	0.003482587	0.006467662	0	9	OPC	NA	NA	NA
CGAACATGTGACGCCT-1_2_B4	-4.389860073	-4.477846763	13A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1123	1816	0.011013216	0.001101322	0	13A	IN-VIP	NA	NA	NA
CGAATGTAGTGTACTC-1_2_B4	-12.01629493	19.68557007	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2110	4035	0.006443618	0.005947955	0	8	Astrocytes	NA	NA	NA
CGAATGTGTCATCCCT-1_2_B4	3.511280441	-28.4457883	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3107	7713	0.008686633	0.002204071	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGAATGTGTCGCGGTT-1_2_B4	2.867841063	28.15954	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	718	1021	0.000979432	0.007835455	0	oligos	OL-Cntl	NA	NA	NA
CGAATGTTCAACACGT-1_2_B4	17.18055677	26.97579359	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	886	1255	0.002390438	0.003984064	0	oligos	OL-Cntl	NA	NA	NA
CGACCTTAGTCGCCGT-1_2_B4	-9.165728023	-19.82485326	6B	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	701	1036	0.017374517	0.001930502	0	6B	IN-SST	NA	NA	NA
CGACCTTCACTTCTGC-1_2_B4	-23.09019625	24.39294522	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1501	2652	0.003770739	0.007541478	0	8	Astrocytes	NA	NA	NA
CGACCTTCATCGGACC-1_2_B4	12.07886371	23.5061025	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	854	1290	0.000775194	0.00620155	0	oligos	OL-Cntl	NA	NA	NA
CGACCTTGTATAAACG-1_2_B4	-18.63468304	-27.05415199	6A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2430	5207	0.007681967	0.004801229	0	6A	IN-PV	NA	NA	NA
CGACCTTTCACCTCGT-1_2_B4	3.397617454	-6.430549664	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1140	1809	0.022111664	0.007739082	0	12	EN-MIX	NA	NA	NA
CGACCTTTCCATGAGT-1_2_B4	-9.557660811	13.61068191	11	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1148	1674	0.004778973	0.005376344	0	11	Glia-MIX	NA	NA	NA
CGACCTTTCCGGCACA-1_2_B4	1.694110325	-18.81901398	4	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3072	6874	0.013238289	0.003636893	0	L2-3	EN-L2-3-MS	NA	NA	NA
CGACTTCAGACAGAGA-1_2_B4	24.17845345	-6.465408922	2	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3248	6464	0.00572401	0.006961634	0	2	EN-L4	NA	NA	NA
CGACTTCAGACGCACA-1_2_B4	1.225937648	0.984954459	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1027	1505	0.022591362	0.002657807	0	12	EN-MIX	NA	NA	NA
CGACTTCAGATGGGTC-1_2_B4	19.34407062	8.730670473	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1678	3110	0.003858521	0.007073955	0	oligos	OL-Cntl	NA	NA	NA
CGACTTCAGCGTTGCC-1_2_B4	1.89322911	-10.4401514	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1480	2558	0.035574668	0.004300235	0	12	EN-MIX	NA	NA	NA
CGACTTCAGGAACTGC-1_2_B4	18.5684882	1.524319922	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1148	1765	0.003966006	0.001133144	0	12	EN-MIX	NA	NA	NA
CGACTTCAGTGGGCTA-1_2_B4	11.34150485	28.9857614	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	760	1099	0.009099181	0.003639672	0	oligos	OL-Cntl	NA	NA	NA
CGACTTCCAAAGCAAT-1_2_B4	19.12916725	25.12653932	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	955	1480	0.011486486	0.00472973	0	oligos	OL-Cntl	NA	NA	NA
CGACTTCCAGATCCAT-1_2_B4	-7.833111055	-5.823599795	13A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1351	2217	0.0090212	0.00857014	0	13A	IN-VIP	NA	NA	NA
CGACTTCCATATACGC-1_2_B4	17.35897159	12.17389356	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1320	2285	0.003063457	0.015754923	0	oligos	OL-Cntl	NA	NA	NA
CGACTTCCATGGTCTA-1_2_B4	3.800848222	-4.965621434	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	967	1585	0.022712934	0.002523659	0	12	EN-MIX	NA	NA	NA
CGACTTCGTCTTGATG-1_2_B4	3.740130188	23.44706431	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	782	1099	0.001819836	0.010009099	0	oligos	OL-Cntl	NA	NA	NA
CGACTTCTCCTGCTTG-1_2_B4	0.236431982	-11.44936563	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1637	2929	0.005121202	0.002731308	0	12	EN-MIX	NA	NA	NA
CGAGAAGAGAGTCTGG-1_2_B4	22.75873308	10.58868568	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1405	2159	0.006947661	0.004631774	0	oligos	OL-Cntl	NA	NA	NA
CGAGAAGAGATAGCAT-1_2_B4	-27.75148246	23.6082794	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1260	2041	0.000489956	0.004899559	0	8	Astrocytes	NA	NA	NA
CGAGAAGAGGAGTTGC-1_2_B4	17.26330267	23.01122879	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	931	1440	0.007638889	0.003472222	0	oligos	OL-Cntl	NA	NA	NA
CGAGAAGAGGAGTTTA-1_2_B4	15.29204463	21.22965669	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1023	1543	0.003240441	0.00712897	0	oligos	OL-Cntl	NA	NA	NA
CGAGAAGAGGCCGAAT-1_2_B4	3.303593088	23.28859867	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	781	1072	0.001865672	0.013992537	0	oligos	OL-Cntl	NA	NA	NA
CGAGAAGAGGTGTGGT-1_2_B4	33.8338324	-2.883089732	2	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2524	5060	0.00770751	0.003754941	0	2	EN-L4	NA	NA	NA
CGAGAAGCAAATCCGT-1_2_B4	24.47403296	-29.07169962	3	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2516	5283	0.006057164	0.002839296	0	3	EN-L5-6	NA	NA	NA
CGAGAAGCACCAGCAC-1_2_B4	4.623143372	28.7370858	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	742	1074	0.002793296	0.003724395	0	oligos	OL-Cntl	NA	NA	NA
CGAGAAGGTAAGGGCT-1_2_B4	14.31376386	27.2745287	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	778	1124	0.00088968	0.011565836	0	oligos	OL-Cntl	NA	NA	NA
CGAGAAGGTTCCACAA-1_2_B4	21.01442122	7.487383935	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2060	3774	0.00609433	0.005034446	0	oligos	OL-Cntl	NA	NA	NA
CGAGAAGGTTCTGGTA-1_2_B4	9.548104303	24.55657747	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	841	1234	0.004051864	0.006482982	0	oligos	OL-Cntl	NA	NA	NA
CGAGAAGTCCCGGATG-1_2_B4	2.896449912	26.99008432	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	716	1062	0.004708098	0.005649718	0	oligos	OL-Cntl	NA	NA	NA
CGAGCACAGATATACG-1_2_B4	22.38661697	10.82700654	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1846	3201	0.017494533	0.008122462	0	oligos	OL-Cntl	NA	NA	NA
CGAGCACCAATCCGAT-1_2_B4	32.38276664	14.47049244	14	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1195	1644	0.01459854	0.057785888	0	14	Microglia	NA	NA	NA
CGAGCACCACATTAGC-1_2_B4	-4.82819054	-3.938849362	13A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1356	2288	0.011363636	0.001748252	0	13A	IN-VIP	NA	NA	NA
CGAGCACTCTGATACG-1_2_B4	3.806643775	25.24566363	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	812	1265	0.002371542	0.002371542	0	oligos	OL-Cntl	NA	NA	NA
CGAGCCAAGTCCATAC-1_2_B4	15.08204404	23.26719456	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	911	1352	0.005177515	0.00591716	0	oligos	OL-Cntl	NA	NA	NA
CGAGCCACATGTCTCC-1_2_B4	21.35361089	25.56798112	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1111	1646	0.003037667	0.003037667	0	oligos	OL-Cntl	NA	NA	NA
CGATCGGAGGCAGGTT-1_2_B4	14.14761527	-27.3566915	3	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2844	6047	0.001984455	0.004465024	0	3	EN-L5-6	NA	NA	NA
CGATCGGCATGGTAGG-1_2_B4	7.419518139	-29.37329506	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3556	8466	0.01015828	0.001771793	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGATCGGGTGTAAGTA-1_2_B4	-0.055463999	25.60064667	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	759	1108	0.001805054	0.004512635	0	oligos	OL-Cntl	NA	NA	NA
CGATCGGTCCTCAATT-1_2_B4	24.20739895	-6.412856815	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	6003	20748	0.001204935	0.004048583	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGATCGGTCTAGAGTC-1_2_B4	-3.730583437	-7.889716659	13A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	751	1112	0.026978417	0.001798561	0	13A	IN-VIP	NA	NA	NA
CGATCGGTCTGCCCTA-1_2_B4	14.71996852	28.02136895	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	780	1095	0.001826484	0.00456621	0	oligos	OL-Cntl	NA	NA	NA
CGATCGGTCTGCGTAA-1_2_B4	-24.5496272	17.73155051	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1237	1916	0.002087683	0.003653445	0	8	Astrocytes	NA	NA	NA
CGATGGCAGTACATGA-1_2_B4	-28.15780611	22.35263809	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1250	2184	0.004120879	0.003205128	0	8	Astrocytes	NA	NA	NA
CGATGGCCAAGTACCT-1_2_B4	10.14981124	32.07323245	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	927	1359	0.011037528	0.006622517	0	oligos	OL-Cntl	NA	NA	NA
CGATGGCCACATGGGA-1_2_B4	30.96521753	-3.746903932	2	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3652	8504	0.010583255	0.005291627	0	2	EN-L4	NA	NA	NA
CGATGGCCACTCTGTC-1_2_B4	7.778723439	23.11885233	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	956	1430	0.004195804	0.00979021	0	oligos	OL-Cntl	NA	NA	NA
CGATGGCGTGGTCCGT-1_2_B4	17.17274753	-4.823265471	3	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1670	3013	0.013275805	0.00132758	0	3	EN-L5-6	NA	NA	NA
CGATGGCTCACAGTAC-1_2_B4	-10.18030165	-21.06780506	6B	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	665	1048	0.008587786	0	0	6B	IN-SST	NA	NA	NA
CGATGTAAGAACTGTA-1_2_B4	6.164024937	-29.45278602	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3991	11008	0.002634448	0.003452035	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGATGTAAGAATCTCC-1_2_B4	3.682685545	25.7149939	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	729	1054	0.0028463	0.001897533	0	oligos	OL-Cntl	NA	NA	NA
CGATGTAAGATATGCA-1_2_B4	4.520321649	28.76477032	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	736	1073	0.011183597	0.013979497	0	oligos	OL-Cntl	NA	NA	NA
CGATGTAAGCAAATCA-1_2_B4	-31.5364663	11.7212532	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	771	1173	0.00170503	0.004262575	0	8	Astrocytes	NA	NA	NA
CGATGTAAGGGAAACA-1_2_B4	13.22482061	0.883623322	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	688	1004	0.020916335	0.001992032	0	12	EN-MIX	NA	NA	NA
CGATGTAAGGTGGGTT-1_2_B4	7.232518606	20.13273618	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	943	1349	0.002965159	0.010378058	0	oligos	OL-Cntl	NA	NA	NA
CGATGTAAGTTAACGA-1_2_B4	-37.51585632	1.872593615	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1685	3265	0.001837672	0.003062787	0	9	OPC	NA	NA	NA
CGATGTACAATGACCT-1_2_B4	4.101596024	5.334643606	7	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1430	2119	0.000943841	0.007550731	0	7	Phagocytes	NA	NA	NA
CGATGTACACATTCGA-1_2_B4	12.28530778	23.14679443	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	820	1187	0.0042123	0.00505476	0	oligos	OL-Cntl	NA	NA	NA
CGATGTACACCCATTC-1_2_B4	-19.27258008	8.518553796	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1025	1543	0	0.003240441	0	8	Astrocytes	NA	NA	NA
CGATGTATCAATACCG-1_2_B4	13.50031181	-30.73415926	3	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3775	9887	0.001112572	0.003843431	0	3	EN-L5-6	NA	NA	NA
CGATGTATCCTGCCAT-1_2_B4	5.066410979	-10.54258068	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1856	3321	0.01023788	0.007226739	0	12	EN-MIX	NA	NA	NA
CGATTGAAGCACCGCT-1_2_B4	13.50549621	26.43746118	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	799	1173	0.006820119	0.006820119	0	oligos	OL-Cntl	NA	NA	NA
CGATTGACAAACAACA-1_2_B4	22.125917	12.02361005	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1611	2859	0.003847499	0.006295908	0	oligos	OL-Cntl	NA	NA	NA
CGATTGACAATCACAC-1_2_B4	19.49310804	12.08967839	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1351	2380	0.006722689	0.003361345	0	oligos	OL-Cntl	NA	NA	NA
CGATTGACAGCCTATA-1_2_B4	-26.08867243	12.07032419	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	935	1434	0.007670851	0.00488145	0	8	Astrocytes	NA	NA	NA
CGATTGAGTAATCGTC-1_2_B4	-12.79863371	-1.52064092	13A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2614	4904	0.024469821	0.010807504	0	13A	IN-VIP	NA	NA	NA
CGATTGAGTCCAACTA-1_2_B4	21.16126116	-28.66701892	3	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3315	7966	0.000753201	0.003138338	0	3	EN-L5-6	NA	NA	NA
CGATTGATCCAGTATG-1_2_B4	-5.765180133	-9.992986053	13B	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	852	1173	0.004262575	0.00341006	0	13B	IN-SV2C	NA	NA	NA
CGATTGATCGCACTCT-1_2_B4	1.65176318	29.05888021	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	712	1011	0.003956479	0.010880317	0	oligos	OL-Cntl	NA	NA	NA
CGCCAAGAGAGGGCTT-1_2_B4	3.18926279	-11.06390361	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1639	2755	0.007985481	0.009800363	0	12	EN-MIX	NA	NA	NA
CGCCAAGAGCCACCTG-1_2_B4	2.527507878	22.33521511	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	851	1169	0.005988024	0.00427716	0	oligos	OL-Cntl	NA	NA	NA
CGCCAAGAGTCGAGTG-1_2_B4	-22.99129645	24.65592605	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1665	2959	0.009124704	0.007096992	0	8	Astrocytes	NA	NA	NA
CGCCAAGAGTCGATAA-1_2_B4	21.20683442	7.417941503	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2025	3531	0.002548853	0.005097706	0	oligos	OL-Cntl	NA	NA	NA
CGCCAAGGTAGAGTGC-1_2_B4	21.5613515	9.281252972	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1792	2932	0.004092769	0.004774898	0	oligos	OL-Cntl	NA	NA	NA
CGCCAAGTCACATACG-1_2_B4	1.962509813	-31.77286399	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	6546	24879	0.00176856	0.002733229	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGCGGTACAATGGACG-1_2_B4	-24.71167988	17.44046387	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1233	2041	0.01077903	0.006369427	0	8	Astrocytes	NA	NA	NA
CGCGGTACAGCCACCA-1_2_B4	-33.83388634	-7.065210213	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1111	1693	0.004134672	0.007088009	0	9	OPC	NA	NA	NA
CGCGGTAGTAGCTGCC-1_2_B4	23.37539368	12.18727593	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1719	2896	0.000690608	0.003453039	0	oligos	OL-Cntl	NA	NA	NA
CGCGGTAGTCCAAGTT-1_2_B4	21.54377749	17.11331396	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1315	2085	0.002398082	0.004796163	0	oligos	OL-Cntl	NA	NA	NA
CGCGGTAGTCTAGTGT-1_2_B4	18.27840754	-8.32397026	3	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1678	2836	0.010578279	0.003878702	0	3	EN-L5-6	NA	NA	NA
CGCGGTATCGTTACGA-1_2_B4	-12.54024956	15.69989395	11	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1192	1784	0.001681614	0.010089686	0	11	Glia-MIX	NA	NA	NA
CGCGGTATCTTGCATT-1_2_B4	12.15282646	21.11511291	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	937	1473	0.001357773	0.014935506	0	oligos	OL-Cntl	NA	NA	NA
CGCGTTTAGGTCGGAT-1_2_B4	-16.69806143	12.97019373	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1276	1955	0.001534527	0.002557545	0	8	Astrocytes	NA	NA	NA
CGCGTTTCACAGACAG-1_2_B4	-0.0586382	27.20971281	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	927	1364	0.016129032	0.012463343	0	oligos	OL-Cntl	NA	NA	NA
CGCGTTTCAGGCTCAC-1_2_B4	15.94134855	-6.447896551	3	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1659	3264	0.002757353	0.003370098	0	3	EN-L5-6	NA	NA	NA
CGCGTTTGTAAACGCG-1_2_B4	-11.01525787	7.150087332	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2454	4909	0.002037075	0.005092687	0	oligos	OL-Cntl	NA	NA	NA
CGCGTTTGTAGCGTCC-1_2_B4	27.89111366	0.707613446	2	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2928	7014	0.003992016	0.002994012	0	2	EN-L4	NA	NA	NA
CGCGTTTGTCCGAACC-1_2_B4	1.420340169	28.43159951	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	764	1045	0.006698565	0.00861244	0	oligos	OL-Cntl	NA	NA	NA
CGCGTTTGTGTAATGA-1_2_B4	-36.35105894	-3.451647118	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1398	2254	0.003992902	0.003992902	0	9	OPC	NA	NA	NA
CGCGTTTTCCCATTAT-1_2_B4	0.963252611	1.008205542	11	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1168	1538	0.014304291	0.010403121	0	11	Glia-MIX	NA	NA	NA
CGCGTTTTCGGATGGA-1_2_B4	21.28681516	0.855553392	2	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1432	2314	0.00605013	0.001728608	0	2	EN-L4	NA	NA	NA
CGCGTTTTCTTCGGTC-1_2_B4	39.79789848	10.98951542	14	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	799	1146	0	0.002617801	0	14	Microglia	NA	NA	NA
CGCTATCCAAGCCGCT-1_2_B4	-31.90825356	-12.72074725	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	843	1180	0.004237288	0.001694915	0	9	OPC	NA	NA	NA
CGCTATCCAATCAGAA-1_2_B4	-5.041408219	-7.315147182	13A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	906	1267	0.011049724	0.006314128	0	13A	IN-VIP	NA	NA	NA
CGCTATCGTAAACCTC-1_2_B4	9.232536746	23.94048429	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	927	1387	0.002883922	0.007930786	0	oligos	OL-Cntl	NA	NA	NA
CGCTATCTCCCAACGG-1_2_B4	0.276409755	28.2060075	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	978	1354	0.004431315	0.010339734	0	oligos	OL-Cntl	NA	NA	NA
CGCTATCTCGGCTACG-1_2_B4	18.5300021	17.40570928	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1084	1595	0.005642633	0.008777429	0	oligos	OL-Cntl	NA	NA	NA
CGCTATCTCGGTGTTA-1_2_B4	3.680471756	-13.97692778	4	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2324	4171	0.011987533	0.009829777	0	L2-3	EN-L2-3-MS	NA	NA	NA
CGCTGGAAGTCACGCC-1_2_B4	-12.85765156	-23.1089127	6A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1470	2439	0.001230012	0.002460025	0	6A	IN-PV	NA	NA	NA
CGCTGGAAGTTTCCTT-1_2_B4	22.41594455	19.50120851	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1048	1604	0.003740648	0.003740648	0	oligos	OL-Cntl	NA	NA	NA
CGCTGGACATGCCCGA-1_2_B4	16.80055382	21.69091859	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	994	1519	0.001974984	0.006583278	0	oligos	OL-Cntl	NA	NA	NA
CGCTGGAGTCTGATTG-1_2_B4	33.50209336	14.59562409	14	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	947	1221	0.001638002	0.056511057	0	14	Microglia	NA	NA	NA
CGCTGGATCTATGTGG-1_2_B4	18.62062576	14.71569915	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1208	1911	0.004709576	0.004709576	0	oligos	OL-Cntl	NA	NA	NA
CGCTGGATCTCGATGA-1_2_B4	-6.347011441	-10.82472506	6B	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	796	1124	0.019572954	0.007117438	0	6B	IN-SST	NA	NA	NA
CGCTTCAAGCTATGCT-1_2_B4	3.347976247	30.01917641	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	730	1055	0.009478673	0.004739336	0	oligos	OL-Cntl	NA	NA	NA
CGCTTCACAAGTCATC-1_2_B4	5.088808156	4.923710268	7	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2136	3669	0.00572363	0.007904061	0	7	Phagocytes	NA	NA	NA
CGCTTCACAGCGATCC-1_2_B4	5.985268601	25.33898794	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	879	1277	0.003915427	0.008613939	0	oligos	OL-Cntl	NA	NA	NA
CGCTTCACATGTCCTC-1_2_B4	15.35169722	28.51443124	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	792	1194	0.001675042	0.004187605	0	oligos	OL-Cntl	NA	NA	NA
CGCTTCAGTCTCGTTC-1_2_B4	9.419790848	-9.188018677	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2744	6712	0.00238379	0.00238379	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGCTTCATCATTGCGA-1_2_B4	1.255324587	-27.93421844	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3700	9569	0.001149545	0.002821611	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGGACACAGGACGAAA-1_2_B4	-33.57500475	-13.47376761	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	761	1035	0.006763285	0.000966184	0	9	OPC	NA	NA	NA
CGGACACCATCATCCC-1_2_B4	14.8104388	31.20459281	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	857	1251	0.002398082	0.001598721	0	oligos	OL-Cntl	NA	NA	NA
CGGACACGTAGGGACT-1_2_B4	3.972733408	-9.071219778	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1568	2840	0.008450704	0.002816901	0	12	EN-MIX	NA	NA	NA
CGGACACTCACTGGGC-1_2_B4	21.95705783	1.07689031	2	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1618	3041	0.007563302	0.001644196	0	2	EN-L4	NA	NA	NA
CGGACACTCATCGATG-1_2_B4	20.688899	18.83970574	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1111	1689	0.001184133	0.008288928	0	oligos	OL-Cntl	NA	NA	NA
CGGACGTAGGTGTTAA-1_2_B4	-22.68059043	1.286672009	11	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2455	4307	0.006965405	0.007197585	0	11	Glia-MIX	NA	NA	NA
CGGACGTAGTGGAGAA-1_2_B4	-0.716983157	25.82137565	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	695	1008	0.018849206	0.005952381	0	oligos	OL-Cntl	NA	NA	NA
CGGACGTAGTGGTCCC-1_2_B4	4.757410478	-15.26658476	4	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2729	5615	0.01175423	0.003918077	0	L2-3	EN-L2-3-MS	NA	NA	NA
CGGACGTCACGAGAGT-1_2_B4	15.25917668	21.38237895	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	944	1416	0.000706215	0.004943503	0	oligos	OL-Cntl	NA	NA	NA
CGGACGTCAGCATGAG-1_2_B4	18.40330385	-10.98703221	3	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2946	5792	0.013984807	0.009323204	0	3	EN-L5-6	NA	NA	NA
CGGACGTGTCGCTTTC-1_2_B4	-19.58058153	27.88935429	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2078	4026	0.001987084	0.007203179	0	8	Astrocytes	NA	NA	NA
CGGACGTGTCTAGGTT-1_2_B4	11.03667759	0.469288349	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1025	1406	0.017780939	0.007112376	0	12	EN-MIX	NA	NA	NA
CGGACGTTCCCACTTG-1_2_B4	10.35563849	-8.950503725	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2699	6476	0.000308833	0.00293391	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGGACTGAGCGTGTCC-1_2_B4	27.34825099	-5.616846055	2	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3876	10054	0.003580664	0.002188184	0	2	EN-L4	NA	NA	NA
CGGACTGCAAACCTAC-1_2_B4	13.19698205	31.04734618	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	785	1067	0.014058107	0.003748828	0	oligos	OL-Cntl	NA	NA	NA
CGGACTGCAAGCGTAG-1_2_B4	-1.398291815	24.83802293	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	769	1063	0.003762935	0.013170273	0	oligos	OL-Cntl	NA	NA	NA
CGGACTGCAAGTCTGT-1_2_B4	-13.06802678	3.150368133	13A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2461	4711	0.004882191	0.005731267	0	13A	IN-VIP	NA	NA	NA
CGGACTGCAGCTCGAC-1_2_B4	5.799894364	24.00623584	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	933	1320	0.006818182	0.00530303	0	oligos	OL-Cntl	NA	NA	NA
CGGACTGGTCATACTG-1_2_B4	13.71559694	25.02119679	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	849	1262	0.003961965	0.005546751	0	oligos	OL-Cntl	NA	NA	NA
CGGACTGGTGATAAGT-1_2_B4	3.499735027	-28.17602347	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2865	6170	0.001458671	0.005510535	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGGACTGGTTGATTCG-1_2_B4	-17.89393122	9.291986261	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	884	1180	0.003389831	0.002542373	0	8	Astrocytes	NA	NA	NA
CGGACTGGTTTCCACC-1_2_B4	15.51254188	-32.88922917	3	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	5447	18848	0.003289474	0.003713922	0	3	EN-L5-6	NA	NA	NA
CGGACTGTCTCTGTCG-1_2_B4	3.806327936	26.01910625	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	792	1131	0.008841733	0.004420866	0	oligos	OL-Cntl	NA	NA	NA
CGGAGCTAGGGATACC-1_2_B4	-9.577240047	13.58673023	11	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1318	2065	0.002905569	0.002421308	0	11	Glia-MIX	NA	NA	NA
CGGAGCTCAGCATACT-1_2_B4	15.03614652	25.20085724	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	860	1307	0.006120888	0.006120888	0	oligos	OL-Cntl	NA	NA	NA
CGGAGCTCATAGTAAG-1_2_B4	-26.14507954	12.95588929	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1010	1518	0.000658762	0.002635046	0	8	Astrocytes	NA	NA	NA
CGGAGCTGTAATCACC-1_2_B4	7.482595802	-29.49681134	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	4749	13420	0.004918033	0.003055142	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGGAGCTGTTGACGTT-1_2_B4	-14.10750618	-22.04995359	6A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1335	2006	0.011465603	0.004985045	0	6A	IN-PV	NA	NA	NA
CGGAGTCAGTACCGGA-1_2_B4	19.15433208	19.09903366	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1003	1546	0.004527814	0.001940492	0	oligos	OL-Cntl	NA	NA	NA
CGGAGTCCAGCTCGAC-1_2_B4	0.325116294	29.28094388	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	806	1147	0	0.003487358	0	oligos	OL-Cntl	NA	NA	NA
CGGAGTCGTCCGCTGA-1_2_B4	-16.15228171	-25.68333296	6A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1937	3672	0.001089325	0.004357298	0	6A	IN-PV	NA	NA	NA
CGGAGTCGTTCCCTTG-1_2_B4	14.96511466	30.41799128	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	951	1395	0.001433692	0.006451613	0	oligos	OL-Cntl	NA	NA	NA
CGGCTAGAGATCCGAG-1_2_B4	16.35543907	13.65385431	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1093	1670	0.001197605	0.009580838	0	oligos	OL-Cntl	NA	NA	NA
CGGCTAGAGTTAGGTA-1_2_B4	-2.249363504	24.93806387	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	822	1119	0.004468275	0.008042895	0	oligos	OL-Cntl	NA	NA	NA
CGGCTAGCATGCATGT-1_2_B4	3.049164151	-6.756799368	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1160	1891	0.013749339	0.002115283	0	12	EN-MIX	NA	NA	NA
CGGCTAGGTAATTGGA-1_2_B4	23.84046125	0.291141624	2	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2028	3753	0.003730349	0.002664535	0	2	EN-L4	NA	NA	NA
CGGCTAGGTCGACTGC-1_2_B4	15.93559864	28.02127234	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	732	1079	0.002780352	0.002780352	0	oligos	OL-Cntl	NA	NA	NA
CGGGTCAAGTCGTTTG-1_2_B4	-27.14574372	11.33471106	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	910	1370	0.035036496	0.005839416	0	8	Astrocytes	NA	NA	NA
CGGGTCAGTAGCTTGT-1_2_B4	2.931064209	-10.69171917	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1730	3290	0.004559271	0.003647416	0	12	EN-MIX	NA	NA	NA
CGGGTCATCACGGTTA-1_2_B4	7.829268636	-28.27809108	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	5111	13703	0.004743487	0.00510837	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGGGTCATCGCTTGTC-1_2_B4	10.45789204	30.15264947	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	747	1072	0.000932836	0.003731343	0	oligos	OL-Cntl	NA	NA	NA
CGGTTAAAGAGCTATA-1_2_B4	23.28795796	-25.14243404	3	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3356	7982	0.015534954	0.009396141	0	3	EN-L5-6	NA	NA	NA
CGGTTAAGTGTTTGTG-1_2_B4	9.076659432	-29.90493775	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	5657	17964	0.007849031	0.003451347	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGGTTAAGTTAAGATG-1_2_B4	19.7100341	18.07630535	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1135	1737	0.008635579	0.006908463	0	oligos	OL-Cntl	NA	NA	NA
CGGTTAATCTGACCTC-1_2_B4	-23.44891447	24.69287551	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1528	2727	0.00550055	0.00440044	0	8	Astrocytes	NA	NA	NA
CGTAGCGAGGACCACA-1_2_B4	-5.044744939	-4.267213149	13A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1290	2061	0.01795245	0.002911208	0	13A	IN-VIP	NA	NA	NA
CGTAGGCAGGACCACA-1_2_B4	-32.93159048	-10.88567849	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	905	1343	0.001489203	0.007446016	0	9	OPC	NA	NA	NA
CGTAGGCGTACCGCTG-1_2_B4	22.77201173	-0.144840259	2	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1741	2999	0.006335445	0.001667222	0	2	EN-L4	NA	NA	NA
CGTAGGCGTTTGACTG-1_2_B4	-24.23479736	22.89834062	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1413	2539	0.011815675	0.008664829	0	8	Astrocytes	NA	NA	NA
CGTAGGCTCCATGAAC-1_2_B4	3.779794075	-15.05600151	4	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2382	4569	0.013788575	0.003064128	0	L2-3	EN-L2-3-MS	NA	NA	NA
CGTCACTAGCACGCCT-1_2_B4	-28.93635317	21.62799274	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1010	1693	0.000590667	0.00472534	0	8	Astrocytes	NA	NA	NA
CGTCACTCATATACGC-1_2_B4	13.58533309	26.30311011	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	837	1275	0.004705882	0.007843137	0	oligos	OL-Cntl	NA	NA	NA
CGTCACTGTTCAGCGC-1_2_B4	4.349280296	26.47854911	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	766	1098	0.007285974	0.012750455	0	oligos	OL-Cntl	NA	NA	NA
CGTCACTTCATTTGGG-1_2_B4	4.719695369	28.81355113	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	756	1089	0.002754821	0.005509642	0	oligos	OL-Cntl	NA	NA	NA
CGTCACTTCTACTCAT-1_2_B4	3.362295753	-3.350205864	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	807	1179	0.027141645	0.005089059	0	12	EN-MIX	NA	NA	NA
CGTCAGGCAAATCCGT-1_2_B4	19.32222305	6.278887725	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2835	5829	0.002916452	0.006176016	0	oligos	OL-Cntl	NA	NA	NA
CGTCAGGCAGATGAGC-1_2_B4	16.66014063	10.01922199	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1625	2754	0.005446623	0.008351489	0	oligos	OL-Cntl	NA	NA	NA
CGTCCATAGAGCTATA-1_2_B4	5.260633561	23.78946345	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	863	1217	0.003286771	0.001643385	0	oligos	OL-Cntl	NA	NA	NA
CGTCCATAGCGTTGCC-1_2_B4	-17.77442795	13.60091471	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1162	1779	0.007307476	0.005059022	0	8	Astrocytes	NA	NA	NA
CGTCCATAGTACGTTC-1_2_B4	-4.891224069	-3.953499177	13A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1242	1946	0.010791367	0.004624872	0	13A	IN-VIP	NA	NA	NA
CGTCCATCAAGTTGTC-1_2_B4	23.34640831	-8.99525116	3	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2921	6571	0.008978846	0.002587125	0	3	EN-L5-6	NA	NA	NA
CGTCCATCACATCCGG-1_2_B4	20.99464272	-5.676548069	3	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2114	3517	0.003980665	0.008529997	0	3	EN-L5-6	NA	NA	NA
CGTCCATGTAAATACG-1_2_B4	0.875777246	-11.72711961	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1989	3577	0.007827789	0.004752586	0	12	EN-MIX	NA	NA	NA
CGTCCATGTATAGGGC-1_2_B4	-12.15764242	19.60018099	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2140	3921	0.000765111	0.005355777	0	8	Astrocytes	NA	NA	NA
CGTCCATGTTTGTTTC-1_2_B4	15.44027058	22.87941238	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	871	1283	0.005455963	0.003117693	0	oligos	OL-Cntl	NA	NA	NA
CGTCCATTCCTCAATT-1_2_B4	6.870043299	-5.897940977	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1393	2757	0.044976424	0.002176279	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGTCCATTCTGCGTAA-1_2_B4	-29.90135219	-13.18173243	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	722	1022	0.000978474	0.003913894	0	9	OPC	NA	NA	NA
CGTCTACGTAACGACG-1_2_B4	-23.0747374	28.40778293	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1848	3348	0.001792115	0.0020908	0	8	Astrocytes	NA	NA	NA
CGTCTACTCCGATATG-1_2_B4	6.045179499	26.78502383	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	834	1189	0.010092515	0.003364172	0	oligos	OL-Cntl	NA	NA	NA
CGTCTACTCTTGTTTG-1_2_B4	13.68189542	28.08768354	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	795	1197	0.002506266	0.002506266	0	oligos	OL-Cntl	NA	NA	NA
CGTGAGCCAATCTACG-1_2_B4	-37.25887768	-4.485881714	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1277	1994	0.007522568	0.001003009	0	9	OPC	NA	NA	NA
CGTGAGCCAGGAATCG-1_2_B4	-4.17554826	-7.988408261	13A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	762	1150	0.071304348	0.00173913	0	13A	IN-VIP	NA	NA	NA
CGTGAGCTCTGGTTCC-1_2_B4	6.008482245	30.29108973	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	772	1072	0.008395522	0.007462687	0	oligos	OL-Cntl	NA	NA	NA
CGTGTAAAGCACCGTC-1_2_B4	21.66944949	17.3632005	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1140	1664	0.006009615	0.004206731	0	oligos	OL-Cntl	NA	NA	NA
CGTGTAAAGGTGACCA-1_2_B4	-22.90035272	24.63692128	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1638	2973	0.002018163	0.004709048	0	8	Astrocytes	NA	NA	NA
CGTGTAAGTCCTCCAT-1_2_B4	4.679104743	-3.712692963	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1043	1628	0.011056511	0.004299754	0	12	EN-MIX	NA	NA	NA
CGTGTCTAGTAGGTGC-1_2_B4	25.48407421	-2.371574264	2	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2782	6074	0.000987817	0.002469542	0	2	EN-L4	NA	NA	NA
CGTGTCTCAAACTGCT-1_2_B4	5.405133859	-13.95429595	4	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2177	3992	0.020541082	0.006262525	0	L2-3	EN-L2-3-MS	NA	NA	NA
CGTGTCTCACAAGACG-1_2_B4	12.78257253	16.5699799	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1209	1846	0.001083424	0.009750813	0	oligos	OL-Cntl	NA	NA	NA
CGTGTCTCACCTCGGA-1_2_B4	22.69761377	16.3737444	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1352	2112	0.003787879	0.007102273	0	oligos	OL-Cntl	NA	NA	NA
CGTGTCTCAGGAACGT-1_2_B4	7.638414846	-28.25114387	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	5656	17221	0.004761628	0.003251844	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGTGTCTTCTTATCTG-1_2_B4	33.11963085	14.79508679	14	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	833	1078	0.002782931	0.060296846	0	14	Microglia	NA	NA	NA
CGTTAGAAGACATAAC-1_2_B4	21.88111293	0.679248764	2	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1583	2746	0.00182083	0.002913328	0	2	EN-L4	NA	NA	NA
CGTTAGAAGAGGGATA-1_2_B4	14.12674352	19.99018928	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	986	1496	0.011363636	0.01671123	0	oligos	OL-Cntl	NA	NA	NA
CGTTAGACAAGCGCTC-1_2_B4	4.561221251	26.57422221	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	797	1158	0.003454231	0.006044905	0	oligos	OL-Cntl	NA	NA	NA
CGTTAGACACACTGCG-1_2_B4	-3.897218601	-8.768869651	13A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	801	1106	0.023508137	0.004520796	0	13A	IN-VIP	NA	NA	NA
CGTTAGACATATGCTG-1_2_B4	1.554008347	28.31661072	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	688	1006	0.008946322	0.001988072	0	oligos	OL-Cntl	NA	NA	NA
CGTTAGAGTAGCTCCG-1_2_B4	14.54021845	29.05668821	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	792	1154	0.004332756	0.004332756	0	oligos	OL-Cntl	NA	NA	NA
CGTTAGAGTCCTCCAT-1_2_B4	22.54470044	18.20146669	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1123	1719	0.004653869	0.005817336	0	oligos	OL-Cntl	NA	NA	NA
CGTTAGATCAGAAATG-1_2_B4	3.211555774	-10.12454104	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1589	2587	0.011596444	0.005411674	0	12	EN-MIX	NA	NA	NA
CGTTAGATCATTGCGA-1_2_B4	-7.440126869	-6.773231888	13A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1371	2165	0.057736721	0.011547344	0	13A	IN-VIP	NA	NA	NA
CGTTAGATCGGTGTCG-1_2_B4	14.76996105	0.96017253	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	757	1075	0.014883721	0.005581395	0	12	EN-MIX	NA	NA	NA
CGTTAGATCGTATCAG-1_2_B4	-26.03909635	11.51524993	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	883	1354	0.00295421	0.002215657	0	8	Astrocytes	NA	NA	NA
CGTTCTGAGAAACGCC-1_2_B4	-28.2522368	13.04478917	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	812	1159	0.003451251	0.006039689	0	8	Astrocytes	NA	NA	NA
CGTTCTGAGATCACGG-1_2_B4	-23.25101132	-2.090459141	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	759	1044	0.005747126	0.004789272	0	9	OPC	NA	NA	NA
CGTTCTGAGATCGATA-1_2_B4	3.291466929	-26.51497234	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2546	4823	0.006427535	0.004768816	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGTTCTGAGATGCCAG-1_2_B4	7.357939218	35.28102546	17	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	975	1374	0.010189229	0.006550218	0	oligos	OL-MS-2	NA	NA	NA
CGTTCTGAGCCCTAAT-1_2_B4	-11.41356143	15.89085536	11	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1397	2301	0.000869187	0.002172968	0	11	Glia-MIX	NA	NA	NA
CGTTCTGCACCGCTAG-1_2_B4	20.97608301	7.751258698	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2043	3655	0.001915185	0.00629275	0	oligos	OL-Cntl	NA	NA	NA
CGTTCTGCAGCTGTGC-1_2_B4	-10.24745163	-18.64412119	6B	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	914	1556	0.024421594	0.005141388	0	6B	IN-SST	NA	NA	NA
CGTTCTGCAGGAACGT-1_2_B4	-28.20217342	11.74664619	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	775	1166	0.002572899	0.004288165	0	8	Astrocytes	NA	NA	NA
CGTTCTGGTTGATTCG-1_2_B4	18.92203622	14.25278905	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1256	2107	0.005220693	0.004271476	0	oligos	OL-Cntl	NA	NA	NA
CGTTGGGAGTCCTCCT-1_2_B4	4.254382132	25.31255111	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	775	1156	0.00432526	0.006920415	0	oligos	OL-Cntl	NA	NA	NA
CGTTGGGCAGACAAGC-1_2_B4	23.24731541	-25.98429044	3	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3034	6316	0.005224826	0.004591514	0	3	EN-L5-6	NA	NA	NA
CGTTGGGCATGCCTTC-1_2_B4	11.576912	23.10879339	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	814	1203	0.006650042	0.009143807	0	oligos	OL-Cntl	NA	NA	NA
CTAACTTAGATATGGT-1_2_B4	-4.773073082	-10.41011156	6B	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	718	1069	0.01777362	0.002806361	0	6B	IN-SST	NA	NA	NA
CTAACTTAGCTACCTA-1_2_B4	15.81462369	-1.14633515	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	806	1318	0.013657056	0.001517451	0	12	EN-MIX	NA	NA	NA
CTAACTTCAACACCCG-1_2_B4	22.67625957	19.47755669	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1015	1546	0.003880983	0.003880983	0	oligos	OL-Cntl	NA	NA	NA
CTAACTTGTGCAGGTA-1_2_B4	22.43205056	18.87111607	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	971	1381	0.004344678	0.002172339	0	oligos	OL-Cntl	NA	NA	NA
CTAACTTTCACTATTC-1_2_B4	12.98817799	22.4038184	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	804	1219	0.003281378	0.004922067	0	oligos	OL-Cntl	NA	NA	NA
CTAACTTTCGTCCGTT-1_2_B4	-26.74555716	10.04008806	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	698	1058	0	0.00094518	0	8	Astrocytes	NA	NA	NA
CTAAGACAGCGAGAAA-1_2_B4	-30.71512515	10.96463244	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	714	1064	0.001879699	0.002819549	0	8	Astrocytes	NA	NA	NA
CTAAGACAGGCTCTTA-1_2_B4	13.27588898	25.62238955	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	768	1142	0.003502627	0.008756567	0	oligos	OL-Cntl	NA	NA	NA
CTAAGACAGGGTATCG-1_2_B4	-9.795811517	-1.48850748	13A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2073	3892	0.012076053	0.007708119	0	13A	IN-VIP	NA	NA	NA
CTAATGGAGACCACGA-1_2_B4	9.785160508	-9.026878879	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2541	6066	0.005769865	0.002802506	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTAATGGAGGTAGCCA-1_2_B4	-24.92102213	15.58091511	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1028	1644	0.005474453	0.006690998	0	8	Astrocytes	NA	NA	NA
CTAATGGCACCAGGTC-1_2_B4	5.880886356	24.61415599	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	843	1188	0.005050505	0.007575758	0	oligos	OL-Cntl	NA	NA	NA
CTAATGGCACTTCGAA-1_2_B4	10.12023944	-8.776001011	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2375	5432	0.005338733	0.002761414	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTACACCGTAGCAAAT-1_2_B4	22.31345227	12.09792548	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1459	2529	0.005140372	0.003954132	0	oligos	OL-Cntl	NA	NA	NA
CTACACCTCCAGATCA-1_2_B4	-6.404750709	3.001790594	11	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	5440	16214	0.004625632	0.003638831	0	11	Glia-MIX	NA	NA	NA
CTACACCTCCCAAGTA-1_2_B4	-16.30505502	-11.17245206	13B	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3311	7905	0.011005693	0.002909551	0	13B	IN-SV2C	NA	NA	NA
CTACACCTCTTGCAAG-1_2_B4	11.04074342	24.09774172	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	754	1138	0.007908612	0.005272408	0	oligos	OL-Cntl	NA	NA	NA
CTACATTAGATCGATA-1_2_B4	-29.43711562	18.72974733	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	928	1491	0.004024145	0.001341382	0	8	Astrocytes	NA	NA	NA
CTACATTCAAGCTGAG-1_2_B4	4.510672106	26.45661672	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	789	1110	0.016216216	0.007207207	0	oligos	OL-Cntl	NA	NA	NA
CTACATTCAAGTTAAG-1_2_B4	-23.10322112	23.26517977	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1450	2493	0.005615724	0.004813478	0	8	Astrocytes	NA	NA	NA
CTACATTCACACCGCA-1_2_B4	12.87784946	30.01325664	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	668	1079	0.003707136	0.006487488	0	oligos	OL-Cntl	NA	NA	NA
CTACATTTCGTGACAT-1_2_B4	1.584319987	-8.145170238	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1417	2572	0.016329705	0.001166407	0	12	EN-MIX	NA	NA	NA
CTACCCAAGATCTGCT-1_2_B4	5.661852475	30.97200825	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	815	1214	0.008237232	0.004118616	0	oligos	OL-Cntl	NA	NA	NA
CTACCCAAGCATCATC-1_2_B4	10.26385905	-8.927125419	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2823	7056	0.001984127	0.001842404	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTACCCAAGGTTCCTA-1_2_B4	20.54681269	10.852915	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1476	2556	0.007042254	0.004694836	0	oligos	OL-Cntl	NA	NA	NA
CTACCCAGTAACGTTC-1_2_B4	-36.58536546	-2.62043612	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1287	2182	0.003208066	0.002749771	0	9	OPC	NA	NA	NA
CTACCCATCAGTCAGT-1_2_B4	18.78190569	14.85138673	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1195	1909	0.004190676	0.008381351	0	oligos	OL-Cntl	NA	NA	NA
CTACCCATCGCTGATA-1_2_B4	1.230549878	0.798785952	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1212	1832	0.006550218	0.00709607	0	12	EN-MIX	NA	NA	NA
CTACCCATCTTGCCGT-1_2_B4	-8.292167722	-17.89084135	6B	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	686	1071	0.036414566	0.000933707	0	6B	IN-SST	NA	NA	NA
CTACGTCCACAAGACG-1_2_B4	16.38846197	19.2552366	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1012	1556	0.003213368	0.008354756	0	oligos	OL-Cntl	NA	NA	NA
CTACGTCCACTAGTAC-1_2_B4	-23.88514057	23.84398519	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1417	2647	0.001888931	0.004533434	0	8	Astrocytes	NA	NA	NA
CTACGTCCAGACACTT-1_2_B4	-24.1293704	17.42132582	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1247	2020	0.003465347	0.005445545	0	8	Astrocytes	NA	NA	NA
CTACGTCGTCTCCCTA-1_2_B4	38.77729552	15.80470316	14	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1366	2075	0.003373494	0.01686747	0	14	Microglia	NA	NA	NA
CTACGTCGTTAAGAAC-1_2_B4	13.1380818	27.15958499	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	758	1111	0.00360036	0.00810081	0	oligos	OL-Cntl	NA	NA	NA
CTACGTCTCAGCAACT-1_2_B4	15.63482718	16.61512283	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1048	1667	0.00059988	0.00539892	0	oligos	OL-Cntl	NA	NA	NA
CTACGTCTCATACGGT-1_2_B4	-29.09690901	21.04887371	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	975	1551	0.007736944	0.000644745	0	8	Astrocytes	NA	NA	NA
CTACGTCTCTGACCTC-1_2_B4	18.17821678	20.26895279	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	879	1412	0.001416431	0.002124646	0	oligos	OL-Cntl	NA	NA	NA
CTAGAGTAGTCAATAG-1_2_B4	1.345303424	28.48399881	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	721	1002	0.013972056	0.00499002	0	oligos	OL-Cntl	NA	NA	NA
CTAGAGTCAGGGATTG-1_2_B4	1.467141211	30.22060772	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	756	1045	0.005741627	0.005741627	0	oligos	OL-Cntl	NA	NA	NA
CTAGAGTCATCCAACA-1_2_B4	-23.61541948	-1.900597204	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	896	1282	0.001560062	0.000780031	0	9	OPC	NA	NA	NA
CTAGAGTTCACGCATA-1_2_B4	36.6300795	11.73658347	14	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	809	1044	0.000957854	0.028735632	0	14	Microglia	NA	NA	NA
CTAGAGTTCCGCGTTT-1_2_B4	14.19980436	22.47284472	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	920	1386	0.002886003	0.004329004	0	oligos	OL-Cntl	NA	NA	NA
CTAGAGTTCGCCTGTT-1_2_B4	1.126101826	-25.73802806	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3304	8173	0.007585954	0.004160039	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTAGCCTAGATGTGGC-1_2_B4	-7.683863343	-1.752883889	13A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1793	3181	0.003143666	0.005972964	0	13A	IN-VIP	NA	NA	NA
CTAGCCTCAAGCCGCT-1_2_B4	15.0254182	24.10180439	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	887	1339	0.005974608	0.005227782	0	oligos	OL-Cntl	NA	NA	NA
CTAGCCTCAGTGAGTG-1_2_B4	14.48171134	26.48838416	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	838	1289	0.00155159	0.008533747	0	oligos	OL-Cntl	NA	NA	NA
CTAGCCTGTGCCTGCA-1_2_B4	2.327309793	-4.269853454	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	948	1461	0.008213552	0.003422313	0	12	EN-MIX	NA	NA	NA
CTAGCCTGTGTGCCTG-1_2_B4	-2.390749673	-1.104358722	13B	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2771	5328	0.01295045	0.005818318	0	13B	IN-SV2C	NA	NA	NA
CTAGCCTTCTGCGTAA-1_2_B4	13.84844571	29.220325	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	755	1159	0.000862813	0.001725626	0	oligos	OL-Cntl	NA	NA	NA
CTAGTGAAGCTAGGCA-1_2_B4	23.36573607	12.26880865	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1472	2504	0.004392971	0.004792332	0	oligos	OL-Cntl	NA	NA	NA
CTAGTGACAAGCCCAC-1_2_B4	-1.622256064	-17.98535953	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2992	7387	0.006091783	0.00230134	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTAGTGACACAACGTT-1_2_B4	1.690673461	-11.2964582	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1707	3013	0.000995685	0.006637902	0	12	EN-MIX	NA	NA	NA
CTAGTGACAGATTGCT-1_2_B4	3.316825441	27.17419077	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	734	1069	0	0.004677268	0	oligos	OL-Cntl	NA	NA	NA
CTAGTGACAGTGAGTG-1_2_B4	-23.97891911	22.19489336	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1352	2162	0.003237743	0.004625347	0	8	Astrocytes	NA	NA	NA
CTAGTGACATCCTAGA-1_2_B4	14.16474155	23.65527956	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	833	1243	0.006436042	0.006436042	0	oligos	OL-Cntl	NA	NA	NA
CTAGTGATCAATAAGG-1_2_B4	-15.98424924	-25.49869318	6A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1824	3572	0.027995521	0.001959686	0	6A	IN-PV	NA	NA	NA
CTAGTGATCTTGAGAC-1_2_B4	23.00093539	11.99634477	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1560	2643	0.002648505	0.002648505	0	oligos	OL-Cntl	NA	NA	NA
CTCACACAGGACAGCT-1_2_B4	7.115460156	24.30532289	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	997	1478	0.00338295	0.00608931	0	oligos	OL-Cntl	NA	NA	NA
CTCACACAGGGCTTGA-1_2_B4	13.73435194	22.76927162	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	931	1380	0.011594203	0.010144928	0	oligos	OL-Cntl	NA	NA	NA
CTCACACTCACGGTTA-1_2_B4	-23.18322479	24.84816794	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1598	2928	0.005122951	0.007172131	0	8	Astrocytes	NA	NA	NA
CTCACACTCGGTGTTA-1_2_B4	16.00769445	-6.057379003	3	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1710	3079	0.012016889	0.000974342	0	3	EN-L5-6	NA	NA	NA
CTCAGAAAGAAACCGC-1_2_B4	-24.1797633	23.05676765	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1341	2229	0.001794527	0.004934948	0	8	Astrocytes	NA	NA	NA
CTCAGAAAGCCACGCT-1_2_B4	-34.6853719	-11.11316216	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	872	1352	0.002218935	0	0	9	OPC	NA	NA	NA
CTCAGAAAGCGCTTAT-1_2_B4	2.752485938	-4.884463418	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1001	1524	0.015091864	0.000656168	0	12	EN-MIX	NA	NA	NA
CTCAGAACACTAGTAC-1_2_B4	15.11632234	20.87863711	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1018	1595	0.006269592	0.006896552	0	oligos	OL-Cntl	NA	NA	NA
CTCAGAACATCTACGA-1_2_B4	39.41499049	14.38171279	14	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1235	1746	0.002863688	0.006300115	0	14	Microglia	NA	NA	NA
CTCAGAACATTACGAC-1_2_B4	6.674619838	-27.39918954	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	5264	16581	0.00253302	0.00410108	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTCAGAAGTGGAAAGA-1_2_B4	23.27623998	-0.058314066	2	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2147	3908	0.001535312	0.002302968	0	2	EN-L4	NA	NA	NA
CTCAGAAGTGTGGTTT-1_2_B4	14.76992785	29.51318599	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	791	1096	0.006386861	0.001824818	0	oligos	OL-Cntl	NA	NA	NA
CTCAGAATCATGTAGC-1_2_B4	37.20806657	11.41946414	14	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	885	1255	0.003984064	0.019920319	0	14	Microglia	NA	NA	NA
CTCAGAATCCAGGGCT-1_2_B4	-13.46609613	3.719735666	13A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	4054	9402	0.019038502	0.007338864	0	13A	IN-VIP	NA	NA	NA
CTCAGAATCCCATTAT-1_2_B4	4.288880924	-2.286971654	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	771	1107	0.073170732	0.001806685	0	12	EN-MIX	NA	NA	NA
CTCCTAGCACAACGTT-1_2_B4	-26.77071416	16.90745361	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1084	1755	0.003988604	0.003988604	0	8	Astrocytes	NA	NA	NA
CTCCTAGGTACTCAAC-1_2_B4	6.289772497	25.94766918	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	857	1200	0.005833333	0.0025	0	oligos	OL-Cntl	NA	NA	NA
CTCCTAGGTCACACGC-1_2_B4	-16.50358748	-26.38126626	6A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2089	4603	0.011079731	0.004562242	0	6A	IN-PV	NA	NA	NA
CTCCTAGGTCGGCATC-1_2_B4	3.128341847	-14.76434905	4	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2297	4249	0.003294893	0.00941398	0	L2-3	EN-L2-3-MS	NA	NA	NA
CTCCTAGTCCACGACG-1_2_B4	16.9067965	27.94370587	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	836	1291	0.00464756	0.000774593	0	oligos	OL-Cntl	NA	NA	NA
CTCCTAGTCTGCGGCA-1_2_B4	8.862358182	-8.826582788	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2277	4490	0.010022272	0.002004454	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTCGAAAAGACATAAC-1_2_B4	13.80724235	-0.777532495	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	822	1198	0.02754591	0.003338898	0	12	EN-MIX	NA	NA	NA
CTCGAAACAATCACAC-1_2_B4	14.75600035	30.26191341	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	800	1153	0.004336513	0.000867303	0	oligos	OL-Cntl	NA	NA	NA
CTCGAAACACTTACGA-1_2_B4	-13.29934746	14.56628758	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	861	1225	0.001632653	0.004081633	0	8	Astrocytes	NA	NA	NA
CTCGAAACATTATCTC-1_2_B4	14.20530639	29.37302474	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	801	1159	0.006902502	0.002588438	0	oligos	OL-Cntl	NA	NA	NA
CTCGAAACATTTCAGG-1_2_B4	16.70894457	21.18015657	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	921	1428	0.007703081	0.007703081	0	oligos	OL-Cntl	NA	NA	NA
CTCGAAAGTACTCAAC-1_2_B4	12.37669472	26.51552121	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	790	1176	0.003401361	0.006802721	0	oligos	OL-Cntl	NA	NA	NA
CTCGAAAGTAGCGTAG-1_2_B4	-23.00780655	24.77917817	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1636	2948	0.000678426	0.004748982	0	8	Astrocytes	NA	NA	NA
CTCGAAATCTCATTCA-1_2_B4	16.30721355	14.06831088	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1246	1920	0.0015625	0.005208333	0	oligos	OL-Cntl	NA	NA	NA
CTCGAGGAGATGTAAC-1_2_B4	18.82313536	13.75385669	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1215	1932	0.011387164	0.005175983	0	oligos	OL-Cntl	NA	NA	NA
CTCGAGGAGTGCTGCC-1_2_B4	3.605874152	-29.75206835	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3695	9690	0.001444788	0.002270382	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTCGAGGCACTGTGTA-1_2_B4	2.146889331	-17.07002243	4	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2745	5649	0.006018764	0.00424854	0	L2-3	EN-L2-3-MS	NA	NA	NA
CTCGAGGCAGACGTAG-1_2_B4	18.16840548	-0.126188292	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1201	1944	0.008230453	0.00154321	0	12	EN-MIX	NA	NA	NA
CTCGAGGGTAGGCTGA-1_2_B4	-24.47147503	19.2101819	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1389	2337	0.005990586	0.00427899	0	8	Astrocytes	NA	NA	NA
CTCGAGGGTGGCAAAC-1_2_B4	-22.97613248	-0.536345598	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1450	2342	0.001707942	0.001707942	0	9	OPC	NA	NA	NA
CTCGAGGTCACGATGT-1_2_B4	17.75211182	24.31829313	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	923	1328	0.003012048	0.010542169	0	oligos	OL-Cntl	NA	NA	NA
CTCGAGGTCCGAATGT-1_2_B4	13.54998331	17.02599502	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1093	1685	0.003560831	0.010682493	0	oligos	OL-Cntl	NA	NA	NA
CTCGGAGAGCAGCGTA-1_2_B4	-23.41229116	21.69792505	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1120	1805	0.00166205	0.006094183	0	8	Astrocytes	NA	NA	NA
CTCGGAGAGGTAGCCA-1_2_B4	6.687704211	25.89435987	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	885	1260	0.003174603	0.01031746	0	oligos	OL-Cntl	NA	NA	NA
CTCGGAGCATTCCTGC-1_2_B4	-24.33986803	18.05768018	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1219	1860	0.002150538	0.004301075	0	8	Astrocytes	NA	NA	NA
CTCGGAGGTAACGCGA-1_2_B4	17.10276634	-4.834079541	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1171	1769	0.006783493	0.004522329	0	12	EN-MIX	NA	NA	NA
CTCGGGAAGCCCTAAT-1_2_B4	24.40623927	-29.50827741	3	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2861	6989	0.022463872	0.001716984	0	3	EN-L5-6	NA	NA	NA
CTCGGGACAAAGTGCG-1_2_B4	25.2577146	-1.361443329	2	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2691	5846	0.005473828	0.001881628	0	2	EN-L4	NA	NA	NA
CTCGGGACATCCGTGG-1_2_B4	-21.7142382	-26.45528357	6A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3940	9192	0.010987815	0.0044604	0	6A	IN-PV	NA	NA	NA
CTCGGGAGTTTGGGCC-1_2_B4	-5.065539784	-9.015693711	13A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1027	1639	0.029896278	0.002440513	0	13A	IN-VIP	NA	NA	NA
CTCGTACAGACAGAGA-1_2_B4	15.02466296	-32.08597373	3	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	4397	12333	0.001216249	0.003405497	0	3	EN-L5-6	NA	NA	NA
CTCGTACAGCCGTCGT-1_2_B4	26.41852718	-5.370517463	2	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	4322	11869	0.013311989	0.002696099	0	2	EN-L4	NA	NA	NA
CTCGTACAGCGATCCC-1_2_B4	15.71245844	21.33603242	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	977	1462	0.00752394	0.003419973	0	oligos	OL-Cntl	NA	NA	NA
CTCGTACAGGGAAACA-1_2_B4	39.40754859	14.76773246	14	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1171	1655	0.006646526	0.011480363	0	14	Microglia	NA	NA	NA
CTCGTACCAAGTCTAC-1_2_B4	3.980828226	-5.771031139	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1330	2423	0.016095749	0.000825423	0	12	EN-MIX	NA	NA	NA
CTCGTACCATGCTAGT-1_2_B4	29.40552173	-3.366607203	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	4871	13739	0.004949414	0.006113982	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTCGTCAAGAGTGACC-1_2_B4	0.178771561	25.21136537	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	766	1058	0.009451796	0.009451796	0	oligos	OL-Cntl	NA	NA	NA
CTCGTCACAATCTACG-1_2_B4	-31.38516833	11.2394151	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	730	1046	0.012428298	0.001912046	0	8	Astrocytes	NA	NA	NA
CTCGTCACATCCCACT-1_2_B4	4.238334184	-18.12580751	4	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3025	6191	0.006784041	0.010983686	0	L2-3	EN-L2-3-MS	NA	NA	NA
CTCGTCAGTAGCCTCG-1_2_B4	6.789105474	23.90383561	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	986	1475	0.000677966	0.008813559	0	oligos	OL-Cntl	NA	NA	NA
CTCGTCATCAACACAC-1_2_B4	-22.95682428	-1.883027142	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	688	1035	0.002898551	0.001932367	0	9	OPC	NA	NA	NA
CTCGTCATCAGTTCGA-1_2_B4	15.52157479	1.366882346	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	687	1004	0.008964143	0.000996016	0	12	EN-MIX	NA	NA	NA
CTCGTCATCGTTACAG-1_2_B4	23.46318495	0.451503514	2	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2105	4040	0.023267327	0.002227723	0	2	EN-L4	NA	NA	NA
CTCTAATGTCCATCCT-1_2_B4	1.915204623	-16.93038124	4	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2561	5528	0.022431259	0.005426918	0	L2-3	EN-L2-3-MS	NA	NA	NA
CTCTAATGTGCAGTAG-1_2_B4	2.697709782	-7.534333854	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1310	2082	0.007684918	0.004803074	0	12	EN-MIX	NA	NA	NA
CTCTACGAGCGATCCC-1_2_B4	15.6507439	-8.020737966	3	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1947	3382	0.013010053	0.005617978	0	3	EN-L5-6	NA	NA	NA
CTCTACGCAGATCTGT-1_2_B4	-37.33006204	-5.519051942	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1094	1882	0.004782147	0.001594049	0	9	OPC	NA	NA	NA
CTCTACGCATTGCGGC-1_2_B4	13.92531963	29.3689428	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	776	1166	0.004288165	0.003430532	0	oligos	OL-Cntl	NA	NA	NA
CTCTACGGTCGTGGCT-1_2_B4	19.34650274	11.86068253	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1340	2256	0.003546099	0.006648936	0	oligos	OL-Cntl	NA	NA	NA
CTCTGGTCAGATTGCT-1_2_B4	4.618377265	-5.66511558	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1171	1957	0.002554931	0.002043945	0	12	EN-MIX	NA	NA	NA
CTCTGGTGTAAGAGGA-1_2_B4	13.2980909	-31.32848653	3	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2993	6790	0.002798233	0.003092784	0	3	EN-L5-6	NA	NA	NA
CTCTGGTGTACTCTCC-1_2_B4	25.42284638	-2.459777188	2	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2778	6700	0.008059701	0.001791045	0	2	EN-L4	NA	NA	NA
CTCTGGTGTCATATGC-1_2_B4	23.89997792	-18.61655927	3	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	5392	14690	0.02089857	0.012321307	0	3	EN-L5-6	NA	NA	NA
CTCTGGTGTCTAGGTT-1_2_B4	10.1999843	-8.869816099	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2681	6616	0.015568319	0.001964933	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTCTGGTGTCTGCGGT-1_2_B4	15.77173078	25.89581718	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	862	1296	0.010802469	0.003858025	0	oligos	OL-Cntl	NA	NA	NA
CTCTGGTGTGTATGGG-1_2_B4	34.68433384	6.546147194	14	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	960	1348	0.020029674	0.004451039	0	14	Microglia	NA	NA	NA
CTCTGGTGTTCGCTAA-1_2_B4	0.003886852	28.116751	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	737	1067	0.012183693	0.010309278	0	oligos	OL-Cntl	NA	NA	NA
CTCTGGTTCCAGAGGA-1_2_B4	12.98444237	-31.62984214	3	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2456	5587	0.001252909	0.004474673	0	3	EN-L5-6	NA	NA	NA
CTCTGGTTCCCAAGTA-1_2_B4	0.997882605	-26.92950264	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	4189	11583	0.007165674	0.002503669	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTGAAACAGTCACGCC-1_2_B4	-28.3120716	22.01600505	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1085	1794	0.000557414	0.002229654	0	8	Astrocytes	NA	NA	NA
CTGAAACCACGGCTAC-1_2_B4	16.97538177	21.85717396	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	978	1527	0.004584152	0.001964637	0	oligos	OL-Cntl	NA	NA	NA
CTGAAACCATCCAACA-1_2_B4	36.26702138	11.7945703	14	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	870	1202	0.003327787	0.040765391	0	14	Microglia	NA	NA	NA
CTGAAACCATTGAGCT-1_2_B4	10.4509253	-7.916394957	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2008	3913	0.010477894	0.00153335	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTGAAACGTGGGTCAA-1_2_B4	5.077317379	25.69305848	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	819	1124	0.003558719	0.006227758	0	oligos	OL-Cntl	NA	NA	NA
CTGAAGTAGGCTAGCA-1_2_B4	20.42480495	19.53104466	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1007	1559	0	0.006414368	0	oligos	OL-Cntl	NA	NA	NA
CTGAAGTCAAGGACAC-1_2_B4	15.12216631	21.94906469	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	895	1344	0.007440476	0.005952381	0	oligos	OL-Cntl	NA	NA	NA
CTGAAGTCACCTTGTC-1_2_B4	2.740162198	-25.48963654	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3525	8897	0.007418231	0.002472744	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTGAAGTTCAGTGCAT-1_2_B4	-19.54635923	7.608517076	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	737	1018	0.006876228	0.004911591	0	8	Astrocytes	NA	NA	NA
CTGAAGTTCCTTTCGG-1_2_B4	-22.75026268	-1.026418527	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1165	1766	0.001132503	0.004530011	0	9	OPC	NA	NA	NA
CTGAAGTTCGTGGTCG-1_2_B4	-18.1923036	-19.21681208	6A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2076	4267	0.034450434	0.003046637	0	6A	IN-PV	NA	NA	NA
CTGATAGAGACGCACA-1_2_B4	19.52512343	10.08059139	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1597	3029	0.008913833	0.002641136	0	oligos	OL-Cntl	NA	NA	NA
CTGATAGCACCAGGCT-1_2_B4	-24.51074819	27.99555178	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1695	2963	0.002699966	0.003712454	0	8	Astrocytes	NA	NA	NA
CTGATAGGTGCACCAC-1_2_B4	-3.730982994	-6.667597997	13A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1044	1541	0.015574302	0.001297859	0	13A	IN-VIP	NA	NA	NA
CTGATAGTCAGTACGT-1_2_B4	-20.46872451	-27.62991763	6A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3465	8966	0.013383895	0.004126701	0	6A	IN-PV	NA	NA	NA
CTGATAGTCCATGAGT-1_2_B4	0.676374191	26.48328311	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	904	1272	0.011006289	0.017295597	0	oligos	OL-Cntl	NA	NA	NA
CTGATCCAGACATAAC-1_2_B4	11.83304883	25.79016985	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	904	1464	0.008879781	0.010245902	0	oligos	OL-Cntl	NA	NA	NA
CTGATCCCACACTGCG-1_2_B4	16.82394696	24.25634926	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	953	1464	0.003415301	0.00273224	0	oligos	OL-Cntl	NA	NA	NA
CTGATCCCATTGGTAC-1_2_B4	6.407881081	26.07096495	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	831	1173	0.00341006	0.00511509	0	oligos	OL-Cntl	NA	NA	NA
CTGATCCGTCATATCG-1_2_B4	-11.60138919	-22.19783398	6A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1022	1744	0.052178899	0.002866972	0	6A	IN-PV	NA	NA	NA
CTGATCCGTGCTAGCC-1_2_B4	16.53887671	27.73171805	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	889	1345	0.005947955	0.005204461	0	oligos	OL-Cntl	NA	NA	NA
CTGATCCGTGGCTCCA-1_2_B4	15.39742384	26.12465887	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	803	1155	0.002597403	0.001731602	0	oligos	OL-Cntl	NA	NA	NA
CTGATCCGTTTGTTTC-1_2_B4	-23.09084067	22.1913236	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1314	2104	0.005228137	0.009505703	0	8	Astrocytes	NA	NA	NA
CTGATCCTCATCGGAT-1_2_B4	14.51570098	23.99049039	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	870	1235	0.000809717	0.008097166	0	oligos	OL-Cntl	NA	NA	NA
CTGATCCTCGGCATCG-1_2_B4	10.93927982	-22.77470437	4	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3908	9585	0.006885759	0.004277517	0	L2-3	EN-L2-3-MS	NA	NA	NA
CTGCCTAAGATGCGAC-1_2_B4	4.406474178	-4.104613857	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1028	1503	0.037924152	0.005322688	0	12	EN-MIX	NA	NA	NA
CTGCCTAAGCAGACTG-1_2_B4	15.27411279	30.56296175	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	782	1144	0.006118881	0.000874126	0	oligos	OL-Cntl	NA	NA	NA
CTGCCTAAGCGTTGCC-1_2_B4	-17.9145301	-28.90939322	6A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1959	3424	0.005841121	0.004088785	0	6A	IN-PV	NA	NA	NA
CTGCCTACATATGCTG-1_2_B4	16.4332442	24.39704968	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	842	1289	0.002327386	0.004654771	0	oligos	OL-Cntl	NA	NA	NA
CTGCCTATCACTCTTA-1_2_B4	-3.391362262	-5.49458788	13A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1069	1864	0.011266094	0.005364807	0	13A	IN-VIP	NA	NA	NA
CTGCCTATCGATAGAA-1_2_B4	3.339187939	-32.58465734	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	6781	30737	0.001203761	0.002277386	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTGCCTATCGGCGCTA-1_2_B4	14.27183637	16.40152686	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1041	1557	0.003853565	0.013487476	0	oligos	OL-Cntl	NA	NA	NA
CTGCCTATCTACGAGT-1_2_B4	9.797678785	-8.958738248	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2570	5687	0.003340953	0.002285915	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTGCGGAAGGCTCAGA-1_2_B4	0.482467534	-11.57475687	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1838	3288	0.007907543	0.002128954	0	12	EN-MIX	NA	NA	NA
CTGCGGAAGTGTTAGA-1_2_B4	-0.54765517	27.60127171	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	754	1062	0.014124294	0.009416196	0	oligos	OL-Cntl	NA	NA	NA
CTGCGGACAATGGTCT-1_2_B4	21.2028442	11.03842069	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1565	2642	0.001514005	0.004542014	0	oligos	OL-Cntl	NA	NA	NA
CTGCGGACACCATCCT-1_2_B4	4.557530045	-5.177943695	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	890	1519	0.001974984	0.002633311	0	12	EN-MIX	NA	NA	NA
CTGCGGACACTTAAGC-1_2_B4	4.817577432	22.37339266	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	864	1241	0.004834811	0.008058018	0	oligos	OL-Cntl	NA	NA	NA
CTGCGGACAGCCAATT-1_2_B4	15.61340982	23.85887489	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	819	1206	0.001658375	0.00331675	0	oligos	OL-Cntl	NA	NA	NA
CTGCGGACATAGTAAG-1_2_B4	20.83341436	15.52303054	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1198	1953	0.009728623	0.004608295	0	oligos	OL-Cntl	NA	NA	NA
CTGCGGAGTCGCTTCT-1_2_B4	-5.17199394	-7.398892381	13A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	878	1335	0.007490637	0.002247191	0	13A	IN-VIP	NA	NA	NA
CTGCGGAGTGTCAATC-1_2_B4	-26.25044768	12.28373273	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1049	1540	0.006493506	0.003246753	0	8	Astrocytes	NA	NA	NA
CTGCGGATCAGCTCGG-1_2_B4	17.63614655	8.095966379	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1709	2996	0.00200267	0.008344459	0	oligos	OL-Cntl	NA	NA	NA
CTGCGGATCCGCATCT-1_2_B4	21.0029581	14.17426095	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1204	2023	0.000988631	0.002471577	0	oligos	OL-Cntl	NA	NA	NA
CTGCTGTAGTGGAGAA-1_2_B4	-0.833713195	23.74054812	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	724	1015	0.00591133	0.009852217	0	oligos	OL-Cntl	NA	NA	NA
CTGCTGTCATACTCTT-1_2_B4	-37.34446441	2.768633462	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1755	3019	0.002649884	0.002649884	0	9	OPC	NA	NA	NA
CTGCTGTCATCGTCGG-1_2_B4	0.477044795	25.6372309	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	739	1042	0.000959693	0.008637236	0	oligos	OL-Cntl	NA	NA	NA
CTGCTGTGTAAATGAC-1_2_B4	-25.60699681	12.29590526	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1027	1520	0.006578947	0.009210526	0	8	Astrocytes	NA	NA	NA
CTGCTGTGTACTCTCC-1_2_B4	3.370162354	-4.296375574	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	911	1492	0.001340483	0.003351206	0	12	EN-MIX	NA	NA	NA
CTGCTGTGTAGAGTGC-1_2_B4	1.14812032	28.82020114	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	735	1024	0.006835938	0.005859375	0	oligos	OL-Cntl	NA	NA	NA
CTGCTGTGTCGAGATG-1_2_B4	-4.374575599	-7.90322967	13A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	804	1089	0.009182736	0.001836547	0	13A	IN-VIP	NA	NA	NA
CTGCTGTGTGTTCGAT-1_2_B4	21.2059104	17.8103083	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1100	1617	0.003092146	0.00742115	0	oligos	OL-Cntl	NA	NA	NA
CTGCTGTTCCAAGCCG-1_2_B4	-1.599002048	-19.08040085	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3010	6810	0.003817915	0.003230543	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTGGTCTAGACGCAAC-1_2_B4	16.64294882	23.11780746	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	866	1331	0.00150263	0	0	oligos	OL-Cntl	NA	NA	NA
CTGGTCTAGCTCCTTC-1_2_B4	-36.75598663	-4.694579232	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1248	2110	0.002843602	0.001895735	0	9	OPC	NA	NA	NA
CTGGTCTCATTGCGGC-1_2_B4	23.07849915	-24.36308643	3	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3929	9913	0.007969333	0.006859679	0	3	EN-L5-6	NA	NA	NA
CTGGTCTGTACAGACG-1_2_B4	-11.07713498	-20.60255747	6A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	988	1601	0.021236727	0.001873829	0	6A	IN-PV	NA	NA	NA
CTGGTCTGTACCCAAT-1_2_B4	13.81131583	26.30057177	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	762	1089	0.002754821	0.005509642	0	oligos	OL-Cntl	NA	NA	NA
CTGGTCTGTCCGAACC-1_2_B4	14.37564642	21.32369434	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	986	1393	0.007178751	0.003589375	0	oligos	OL-Cntl	NA	NA	NA
CTGGTCTTCACTCCTG-1_2_B4	8.63304235	30.60193925	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	708	1097	0.000911577	0.002734731	0	oligos	OL-Cntl	NA	NA	NA
CTGGTCTTCCAGAGGA-1_2_B4	23.21952598	12.74059365	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1389	2215	0.003160271	0.003160271	0	oligos	OL-Cntl	NA	NA	NA
CTGGTCTTCTGCGGCA-1_2_B4	-38.06483675	2.324966227	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1619	2980	0.00033557	0.001006711	0	9	OPC	NA	NA	NA
CTGTGCTAGGAGTAGA-1_2_B4	1.907919675	24.74038336	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	719	1023	0.003910068	0.00684262	0	oligos	OL-Cntl	NA	NA	NA
CTGTGCTAGGTGACCA-1_2_B4	7.443438725	23.48260109	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	926	1353	0.011086475	0.008130081	0	oligos	OL-Cntl	NA	NA	NA
CTGTGCTCAAGTCTGT-1_2_B4	-16.01673561	-26.03620489	6A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1817	3445	0.000290276	0.000870827	0	6A	IN-PV	NA	NA	NA
CTGTGCTCAGACGCAA-1_2_B4	-12.05569434	-10.96804677	13B	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1256	2097	0.004768717	0.005245589	0	13B	IN-SV2C	NA	NA	NA
CTGTGCTCAGCGTAAG-1_2_B4	-28.58495261	12.12289356	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	766	1080	0.001851852	0.00462963	0	8	Astrocytes	NA	NA	NA
CTGTGCTGTAGCTCCG-1_2_B4	11.4641394	24.5708257	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	835	1192	0.006711409	0.001677852	0	oligos	OL-Cntl	NA	NA	NA
CTGTGCTTCATGCATG-1_2_B4	2.716100305	-29.39149894	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3867	10617	0.00197796	0.00263728	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTGTGCTTCTGGCGTG-1_2_B4	38.2138624	10.18104411	14	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	793	1023	0.001955034	0.004887586	0	14	Microglia	NA	NA	NA
CTGTTTAAGAACAACT-1_2_B4	15.91530225	27.70567424	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	714	1070	0.001869159	0.010280374	0	oligos	OL-Cntl	NA	NA	NA
CTGTTTAAGCTAGCCC-1_2_B4	14.37702082	-0.657035819	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	793	1277	0.085356304	0.003132341	0	12	EN-MIX	NA	NA	NA
CTGTTTAAGTGACTCT-1_2_B4	-27.81933294	15.44997423	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	904	1375	0.003636364	0.002909091	0	8	Astrocytes	NA	NA	NA
CTGTTTACACGACGAA-1_2_B4	-24.39361894	22.02258213	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1224	2090	0.002870813	0.004784689	0	8	Astrocytes	NA	NA	NA
CTGTTTACATCTACGA-1_2_B4	10.79564429	28.76142139	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	776	1132	0.005300353	0.005300353	0	oligos	OL-Cntl	NA	NA	NA
CTGTTTACATTTCACT-1_2_B4	13.96611661	25.62849212	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	753	1169	0.000855432	0.003421728	0	oligos	OL-Cntl	NA	NA	NA
CTGTTTAGTTAGATGA-1_2_B4	-15.62372415	-25.93479742	6A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1782	3510	0.012820513	0.003418803	0	6A	IN-PV	NA	NA	NA
CTGTTTATCATAACCG-1_2_B4	16.96360471	9.736010288	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1495	2634	0.009491268	0.004555809	0	oligos	OL-Cntl	NA	NA	NA
CTGTTTATCCTTGGTC-1_2_B4	2.482820916	26.76714795	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	696	1064	0.003759398	0.006578947	0	oligos	OL-Cntl	NA	NA	NA
CTTAACTAGAAACGCC-1_2_B4	14.49859248	26.90537278	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	706	1006	0.002982107	0.001988072	0	oligos	OL-Cntl	NA	NA	NA
CTTAACTAGGCATTGG-1_2_B4	-23.35943758	24.00833026	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1401	2475	0.004444444	0.004444444	0	8	Astrocytes	NA	NA	NA
CTTAACTAGTGTACTC-1_2_B4	-31.47465831	11.39344342	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	747	1160	0.001724138	0.001724138	0	8	Astrocytes	NA	NA	NA
CTTAACTGTAGCGTGA-1_2_B4	21.48425732	10.33875624	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1582	2691	0.004830918	0.005202527	0	oligos	OL-Cntl	NA	NA	NA
CTTAACTTCAGGCCCA-1_2_B4	18.28121966	20.31097601	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	935	1476	0.003387534	0.004742547	0	oligos	OL-Cntl	NA	NA	NA
CTTACCGAGAAGGTTT-1_2_B4	16.01612036	15.78803889	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1071	1605	0.002492212	0.004361371	0	oligos	OL-Cntl	NA	NA	NA
CTTAGGAAGCTACCTA-1_2_B4	11.51087912	24.73092098	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	724	1031	0.000969932	0.012609117	0	oligos	OL-Cntl	NA	NA	NA
CTTAGGACACATAACC-1_2_B4	-0.718832573	28.19351435	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	744	1057	0	0.004730369	0	oligos	OL-Cntl	NA	NA	NA
CTTAGGACATGGATGG-1_2_B4	8.267373584	19.60293078	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1067	1690	0.00591716	0.00887574	0	oligos	OL-Cntl	NA	NA	NA
CTTAGGAGTGCGCTTG-1_2_B4	14.25351459	-0.397835273	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	681	1034	0.006769826	0.002901354	0	12	EN-MIX	NA	NA	NA
CTTAGGAGTTCAACCA-1_2_B4	-38.89173787	-1.766323226	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1250	2215	0.004063205	0.004063205	0	9	OPC	NA	NA	NA
CTTCTCTGTACCGAGA-1_2_B4	-14.87755633	-18.97586699	6B	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1375	2305	0.002603037	0.005206074	0	6B	IN-SST	NA	NA	NA
CTTCTCTGTACCGCTG-1_2_B4	21.33141514	11.22968418	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1424	2329	0.000429369	0.003864319	0	oligos	OL-Cntl	NA	NA	NA
CTTCTCTTCACATGCA-1_2_B4	-37.73995579	-0.602745608	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1444	2735	0.004387569	0.003290676	0	9	OPC	NA	NA	NA
CTTCTCTTCGGAGCAA-1_2_B4	3.144762073	-11.08921883	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1715	2918	0.008224812	0.005825908	0	12	EN-MIX	NA	NA	NA
CTTGGCTAGCGCCTTG-1_2_B4	0.679565838	28.29423542	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	771	1075	0.006511628	0.005581395	0	oligos	OL-Cntl	NA	NA	NA
CTTGGCTAGGTAGCTG-1_2_B4	6.794588356	19.1348119	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	945	1424	0.004213483	0.016151685	0	oligos	OL-Cntl	NA	NA	NA
CTTGGCTGTCAGGACA-1_2_B4	-9.063102325	-19.44143996	6B	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	741	1231	0.023558083	0.001624695	0	6B	IN-SST	NA	NA	NA
CTTGGCTGTCTTGTCC-1_2_B4	4.924426026	24.42422125	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	863	1315	0.002281369	0.009885932	0	oligos	OL-Cntl	NA	NA	NA
CTTGGCTTCCTACAGA-1_2_B4	1.871671031	-16.8605599	4	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2590	5578	0.010218716	0.005916099	0	L2-3	EN-L2-3-MS	NA	NA	NA
CTTGGCTTCCTTGACC-1_2_B4	19.7260354	21.87861186	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	930	1420	0.002816901	0.003521127	0	oligos	OL-Cntl	NA	NA	NA
CTTTGCGAGCTGTCTA-1_2_B4	0.544349874	-20.23724935	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3173	7422	0.004446241	0.002964161	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTTTGCGCAAGCTGTT-1_2_B4	4.260566794	-3.394256234	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	926	1486	0.006056528	0.004037685	0	12	EN-MIX	NA	NA	NA
CTTTGCGGTGGTCTCG-1_2_B4	-36.64898359	-4.17719872	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1273	2084	0.002879079	0.004318618	0	9	OPC	NA	NA	NA
CTTTGCGGTGTTTGTG-1_2_B4	-1.18678366	-16.42322994	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2609	5987	0.010021714	0.002171371	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTTTGCGTCCTTGCCA-1_2_B4	-3.191724901	-6.359208565	13A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	869	1291	0.0116189	0.001549187	0	13A	IN-VIP	NA	NA	NA
GAAACTCAGAAACCTA-1_2_B4	16.981753	20.06785344	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	957	1480	0.004054054	0.007432432	0	oligos	OL-Cntl	NA	NA	NA
GAAACTCAGTTAGCGG-1_2_B4	0.272826071	-11.3493511	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1700	3219	0.006834421	0.002174588	0	12	EN-MIX	NA	NA	NA
GAAACTCCAAATCCGT-1_2_B4	11.57064436	29.18434597	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	693	1067	0.003748828	0.001874414	0	oligos	OL-Cntl	NA	NA	NA
GAAACTCCATGTAAGA-1_2_B4	0.531556532	-11.08793551	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1712	3124	0.018565941	0.003201024	0	12	EN-MIX	NA	NA	NA
GAAACTCGTCGCGAAA-1_2_B4	1.87783135	-7.303846508	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1265	2206	0.024932004	0.002266546	0	12	EN-MIX	NA	NA	NA
GAAATGACACCGGAAA-1_2_B4	8.829360713	-7.860778472	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2028	4270	0.003747073	0.001873536	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GAAATGACAGTATAAG-1_2_B4	-36.82802015	-1.002241905	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1454	2573	0.001943257	0.003109211	0	9	OPC	NA	NA	NA
GAAATGACAGTCAGAG-1_2_B4	7.377060631	-7.181528638	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1606	3054	0.000654879	0.002946955	0	12	EN-MIX	NA	NA	NA
GAAATGACATCTACGA-1_2_B4	4.246376905	29.61509991	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	744	1077	0.009285051	0.00371402	0	oligos	OL-Cntl	NA	NA	NA
GAAATGAGTAGCACGA-1_2_B4	9.905164104	19.71760936	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	855	1293	0.004640371	0.007733952	0	oligos	OL-Cntl	NA	NA	NA
GAAATGATCACTGGGC-1_2_B4	-10.96216032	7.296992341	11	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2718	5172	0.006960557	0.007927301	0	11	Glia-MIX	NA	NA	NA
GAAATGATCGTTGACA-1_2_B4	4.467844002	4.488616898	7	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1547	2324	0.015920826	0.012478485	0	7	Phagocytes	NA	NA	NA
GAAATGATCTACTATC-1_2_B4	-4.366862098	-4.547265902	13A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1155	1842	0.023887079	0.002714441	0	13A	IN-VIP	NA	NA	NA
GAAATGATCTTGGGTA-1_2_B4	-23.41884546	-2.112727331	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	835	1165	0.006008584	0.004291845	0	9	OPC	NA	NA	NA
GAACATCAGGGATGGG-1_2_B4	4.625993864	-11.21222989	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1896	3186	0.016321406	0.006277464	0	12	EN-MIX	NA	NA	NA
GAACATCGTACCAGTT-1_2_B4	12.44245937	29.69278809	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	775	1130	0.015044248	0.005309735	0	oligos	OL-Cntl	NA	NA	NA
GAACATCTCCATGAGT-1_2_B4	13.75097573	27.70171764	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	726	1039	0.006737247	0.001924928	0	oligos	OL-Cntl	NA	NA	NA
GAACATCTCTTCATGT-1_2_B4	-8.47287345	-4.17254397	13A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1654	2904	0.042699725	0.003443526	0	13A	IN-VIP	NA	NA	NA
GAACCTAAGAAACGCC-1_2_B4	-0.764194563	29.76511145	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	825	1140	0.002631579	0.006140351	0	oligos	OL-Cntl	NA	NA	NA
GAACCTAAGCGTAGTG-1_2_B4	21.96645569	17.74315897	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1109	1643	0.001825928	0.008520998	0	oligos	OL-Cntl	NA	NA	NA
GAACCTACAACTGCTA-1_2_B4	-27.9313777	13.35347905	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	880	1294	0.003863988	0.00309119	0	8	Astrocytes	NA	NA	NA
GAACCTACAAGTAGTA-1_2_B4	14.52236393	-1.792831467	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1224	2522	0.012688343	0.000396511	0	12	EN-MIX	NA	NA	NA
GAACCTACATAGGATA-1_2_B4	17.82075924	14.48282846	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1252	2097	0.007629948	0.006199332	0	oligos	OL-Cntl	NA	NA	NA
GAACCTACATTCCTGC-1_2_B4	12.62006782	20.63547067	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	957	1533	0.003261579	0.008480104	0	oligos	OL-Cntl	NA	NA	NA
GAACCTAGTAACGACG-1_2_B4	14.68898805	30.23529668	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	723	1021	0.000979432	0.005876592	0	oligos	OL-Cntl	NA	NA	NA
GAACCTAGTACTCAAC-1_2_B4	15.48685879	-1.036870087	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	673	1019	0	0.002944063	0	12	EN-MIX	NA	NA	NA
GAACCTAGTTGATTGC-1_2_B4	-1.966837676	26.90719777	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	741	1019	0.010794897	0.014720314	0	oligos	OL-Cntl	NA	NA	NA
GAACCTATCTACTCAT-1_2_B4	38.15644855	11.43909995	14	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	919	1201	0.008326395	0.01498751	0	14	Microglia	NA	NA	NA
GAACCTATCTTCGGTC-1_2_B4	-28.47022296	11.11710365	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	696	1020	0.007843137	0.006862745	0	8	Astrocytes	NA	NA	NA
GAACGGAAGAAGGGTA-1_2_B4	18.79913118	7.718088745	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1867	3397	0.00677068	0.005004416	0	oligos	OL-Cntl	NA	NA	NA
GAACGGAAGGTCATCT-1_2_B4	1.200049047	24.80651629	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	721	1011	0.003956479	0.004945598	0	oligos	OL-Cntl	NA	NA	NA
GAACGGATCGGAGGTA-1_2_B4	-11.10627682	-15.88710602	6B	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1085	1686	0.047449585	0.003558719	0	6B	IN-SST	NA	NA	NA
GAAGCAGGTTTCCACC-1_2_B4	-9.259506072	17.608482	11	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2872	6073	0.001811296	0.003293265	0	11	Glia-MIX	NA	NA	NA
GAAGCAGTCCGTCATC-1_2_B4	-14.30336003	-21.33461943	6A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1406	2664	0.013513514	0.003003003	0	6A	IN-PV	NA	NA	NA
GAAGCAGTCGTAGGTT-1_2_B4	12.97110684	27.76904155	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	787	1179	0.005937235	0.005937235	0	oligos	OL-Cntl	NA	NA	NA
GAATAAGAGAACAATC-1_2_B4	29.76048818	-0.025738608	2	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2810	6335	0.010891871	0.002367798	0	2	EN-L4	NA	NA	NA
GAATAAGAGACATAAC-1_2_B4	12.49792448	25.48261166	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	809	1237	0.004042037	0.004850445	0	oligos	OL-Cntl	NA	NA	NA
GAATAAGAGACCCACC-1_2_B4	-36.09584881	-4.343578769	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1189	2010	0.00199005	0.001492537	0	9	OPC	NA	NA	NA
GAATAAGCATTCTTAC-1_2_B4	22.94000828	18.27637621	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1084	1814	0.001653804	0.003307607	0	oligos	OL-Cntl	NA	NA	NA
GAATAAGGTCCGACGT-1_2_B4	18.94585914	8.794792725	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1659	3106	0.00515132	0.004829363	0	oligos	OL-Cntl	NA	NA	NA
GAATAAGTCTCAAACG-1_2_B4	15.69056214	21.06660903	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	874	1305	0.003065134	0.005363985	0	oligos	OL-Cntl	NA	NA	NA
GAATGAACATACTCTT-1_2_B4	11.22051804	29.30872986	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	775	1214	0.004942339	0.005766063	0	oligos	OL-Cntl	NA	NA	NA
GACACGCAGGAGCGAG-1_2_B4	-3.23771983	-7.122294078	13A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	845	1241	0.008058018	0.002417405	0	13A	IN-VIP	NA	NA	NA
GACACGCCACGAAAGC-1_2_B4	-7.611927202	-2.274835715	13A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1785	3184	0.016645729	0.004396985	0	13A	IN-VIP	NA	NA	NA
GACACGCGTTGGAGGT-1_2_B4	-6.601390584	-31.37149715	16	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	807	1123	0.081032947	0.006233304	0	16	EN-PYR	NA	NA	NA
GACACGCTCAACACAC-1_2_B4	23.18955221	18.74190129	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1091	1700	0.001764706	0.003529412	0	oligos	OL-Cntl	NA	NA	NA
GACACGCTCATATCGG-1_2_B4	28.40426971	0.672829767	2	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2631	5362	0.003543454	0.003543454	0	2	EN-L4	NA	NA	NA
GACAGAGAGCAATCTC-1_2_B4	-8.846340625	15.79158157	11	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2710	5373	0.004652894	0.005397357	0	11	Glia-MIX	NA	NA	NA
GACAGAGAGCTAGGCA-1_2_B4	-4.840432498	-8.248326699	13A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	844	1177	0.028887001	0.007646559	0	13A	IN-VIP	NA	NA	NA
GACAGAGCACATCTTT-1_2_B4	-21.51688125	-26.51270915	6A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2706	6077	0.008885963	0.003126543	0	6A	IN-PV	NA	NA	NA
GACAGAGCACCTATCC-1_2_B4	1.488544769	-26.1440454	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3698	9654	0.002796768	0.003314688	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GACAGAGGTAGCAAAT-1_2_B4	24.26839655	-6.348603628	2	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	4413	12511	0.001358804	0.002957397	0	2	EN-L4	NA	NA	NA
GACAGAGTCAGTCAGT-1_2_B4	1.624965957	-20.62858187	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3116	6998	0.008145184	0.006144613	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GACAGAGTCTACTCAT-1_2_B4	23.32620483	12.19742457	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1554	2617	0.002292702	0.003821169	0	oligos	OL-Cntl	NA	NA	NA
GACCAATAGATGCCTT-1_2_B4	2.541844355	26.19721269	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	764	1089	0.011019284	0.016528926	0	oligos	OL-Cntl	NA	NA	NA
GACCAATCACAACGCC-1_2_B4	-9.05088628	0.604265453	13A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2306	4521	0.01459854	0.00309666	0	13A	IN-VIP	NA	NA	NA
GACCAATCATCACGAT-1_2_B4	-20.48193423	9.194709643	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	982	1469	0.003403676	0.007488087	0	8	Astrocytes	NA	NA	NA
GACCAATCATGCCCGA-1_2_B4	8.926564559	26.40593834	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	924	1347	0.002227171	0.005196733	0	oligos	OL-Cntl	NA	NA	NA
GACCAATGTAGAGCTG-1_2_B4	-28.1755213	13.01810523	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	850	1300	0.007692308	0.006153846	0	8	Astrocytes	NA	NA	NA
GACCAATTCATGTCTT-1_2_B4	11.81507479	16.59638147	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1045	1649	0.008489994	0.008489994	0	oligos	OL-Cntl	NA	NA	NA
GACCAATTCCCTCAGT-1_2_B4	-0.796380039	25.84475712	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	724	1010	0	0.004950495	0	oligos	OL-Cntl	NA	NA	NA
GACCAATTCGCAGGCT-1_2_B4	3.503171348	-2.541936765	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	672	1000	0.019	0.003	0	12	EN-MIX	NA	NA	NA
GACCAATTCTAACCGA-1_2_B4	2.703636823	-3.176896139	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	735	1211	0.019818332	0.005780347	0	12	EN-MIX	NA	NA	NA
GACCTGGCACCAGATT-1_2_B4	7.704769264	-7.352025336	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1711	3352	0.010441527	0.001789976	0	12	EN-MIX	NA	NA	NA
GACCTGGGTAATTGGA-1_2_B4	8.20638406	-30.21953288	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	5499	18513	0.011397396	0.002268676	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GACCTGGGTGCCTGCA-1_2_B4	17.77191052	13.73583849	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1331	2281	0.006576063	0.001315213	0	oligos	OL-Cntl	NA	NA	NA
GACCTGGGTTCACGGC-1_2_B4	23.32781544	12.33357634	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1442	2491	0.004415897	0.002007226	0	oligos	OL-Cntl	NA	NA	NA
GACCTGGTCAGAGGTG-1_2_B4	15.8065274	27.94623986	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	774	1123	0.001780944	0.005342832	0	oligos	OL-Cntl	NA	NA	NA
GACCTGGTCGCGATCG-1_2_B4	-1.238556655	28.38929956	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	713	1003	0.004985045	0.003988036	0	oligos	OL-Cntl	NA	NA	NA
GACGCGTCAATCACAC-1_2_B4	13.37166818	-28.65403282	4	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2786	6086	0.008708511	0.002957608	0	L2-3	EN-L2-3-MS	NA	NA	NA
GACGCGTCACATCTTT-1_2_B4	12.48327501	27.09671938	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	827	1311	0.009916095	0.003051106	0	oligos	OL-Cntl	NA	NA	NA
GACGCGTGTATTAGCC-1_2_B4	14.54915711	-8.186495481	3	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2288	4797	0.001876173	0.002918491	0	3	EN-L5-6	NA	NA	NA
GACGCGTGTCAATACC-1_2_B4	0.749439667	-23.33423054	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3335	7987	0.007637411	0.004382121	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GACGCGTGTTGCGCAC-1_2_B4	-10.44106083	15.88461953	11	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1675	2684	0.002608048	0.004098361	0	11	Glia-MIX	NA	NA	NA
GACGCGTTCAAGAAGT-1_2_B4	14.74783601	25.87728926	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	755	1090	0.005504587	0.001834862	0	oligos	OL-Cntl	NA	NA	NA
GACGCGTTCAGGCCCA-1_2_B4	10.78348536	31.10525597	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	777	1159	0.004314064	0.005176877	0	oligos	OL-Cntl	NA	NA	NA
GACGGCTAGTCCATAC-1_2_B4	-8.90896607	-2.660466119	13A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2096	4329	0.041118041	0.002772003	0	13A	IN-VIP	NA	NA	NA
GACGGCTAGTGAAGTT-1_2_B4	6.067485445	24.55328412	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	904	1279	0.003127443	0.008600469	0	oligos	OL-Cntl	NA	NA	NA
GACGGCTAGTGCCATT-1_2_B4	5.09311222	16.10386005	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	989	1488	0.002016129	0.012768817	0	oligos	OL-Cntl	NA	NA	NA
GACGGCTGTAAGTTCC-1_2_B4	13.30723401	-29.60129929	3	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3402	8681	0.016357562	0.003225435	0	3	EN-L5-6	NA	NA	NA
GACGGCTGTCGCTTCT-1_2_B4	19.04494595	7.862185172	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1854	3459	0.003469211	0.005492917	0	oligos	OL-Cntl	NA	NA	NA
GACGGCTTCTGATACG-1_2_B4	12.96247987	28.7874271	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	711	1034	0.000967118	0.001934236	0	oligos	OL-Cntl	NA	NA	NA
GACGTGCAGAGCTTCT-1_2_B4	26.93351411	4.571825841	15BA	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	922	1312	0.022103659	0.014481707	0	15BA	Stromal cells	NA	NA	NA
GACGTGCAGAGTGACC-1_2_B4	20.86834448	14.35161276	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1234	2070	0.005797101	0.005797101	0	oligos	OL-Cntl	NA	NA	NA
GACGTGCAGCTCCCAG-1_2_B4	-22.38727868	0.961190048	11	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1818	2998	0.010673783	0.002001334	0	11	Glia-MIX	NA	NA	NA
GACGTGCAGTGCTGCC-1_2_B4	-11.30624337	-10.31908283	13B	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1315	2168	0.022601476	0.002767528	0	13B	IN-SV2C	NA	NA	NA
GACGTGCCAGTCGTGC-1_2_B4	18.35201787	19.86072337	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	992	1588	0.001259446	0.005037783	0	oligos	OL-Cntl	NA	NA	NA
GACGTGCCATGCGCAC-1_2_B4	14.0791897	26.39821749	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	866	1328	0.00376506	0.010542169	0	oligos	OL-Cntl	NA	NA	NA
GACGTGCTCACGATGT-1_2_B4	19.2081415	11.39636758	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1405	2359	0.004239084	0.008902077	0	oligos	OL-Cntl	NA	NA	NA
GACGTGCTCAGGCCCA-1_2_B4	-17.62283055	13.50566334	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1182	1779	0.003934795	0.006745363	0	8	Astrocytes	NA	NA	NA
GACGTGCTCATGGTCA-1_2_B4	-0.650163656	25.32621727	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	749	1070	0.002803738	0.009345794	0	oligos	OL-Cntl	NA	NA	NA
GACGTGCTCGCCTGAG-1_2_B4	22.00910215	11.84046095	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1537	2516	0.005564388	0.003974563	0	oligos	OL-Cntl	NA	NA	NA
GACGTTAGTCTCTTAT-1_2_B4	-9.043835497	-2.958255923	13A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1782	3021	0.005958292	0.006620324	0	13A	IN-VIP	NA	NA	NA
GACGTTATCAAGCCTA-1_2_B4	2.714589935	-25.93422957	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	4732	14756	0.003591759	0.002236378	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GACTAACCAAGTAATG-1_2_B4	19.74990635	9.230062751	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1574	2824	0.009206799	0.002478754	0	oligos	OL-Cntl	NA	NA	NA
GACTAACCAGATCGGA-1_2_B4	-11.54679641	15.95366735	11	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1452	2276	0.002636204	0.008347979	0	11	Glia-MIX	NA	NA	NA
GACTAACCAGCTCCGA-1_2_B4	17.90182063	13.66937616	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1191	1929	0.002592017	0.00933126	0	oligos	OL-Cntl	NA	NA	NA
GACTAACGTACCGTAT-1_2_B4	15.53844226	0.166406747	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	785	1349	0.015567087	0.002965159	0	12	EN-MIX	NA	NA	NA
GACTAACGTTGGGACA-1_2_B4	3.494245169	30.21940734	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	756	1108	0.003610108	0.004512635	0	oligos	OL-Cntl	NA	NA	NA
GACTAACTCGTTGCCT-1_2_B4	9.9881452	29.29379277	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	772	1185	0.001687764	0.007594937	0	oligos	OL-Cntl	NA	NA	NA
GACTACAAGCGATAGC-1_2_B4	-37.01858102	-1.108176556	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1440	2508	0.005183413	0.003189793	0	9	OPC	NA	NA	NA
GACTACAAGTACGCCC-1_2_B4	18.29099377	10.12251714	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1442	2534	0.001578532	0.007103394	0	oligos	OL-Cntl	NA	NA	NA
GACTACACAAGCCCAC-1_2_B4	20.57025323	-1.838313721	2	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1504	2421	0.012391574	0.006195787	0	2	EN-L4	NA	NA	NA
GACTACACAGCCAATT-1_2_B4	1.024786032	28.6802743	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	806	1152	0.003472222	0.0078125	0	oligos	OL-Cntl	NA	NA	NA
GACTACACAGCTTAAC-1_2_B4	14.58485037	19.74531808	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	941	1455	0.003436426	0.013058419	0	oligos	OL-Cntl	NA	NA	NA
GACTACAGTCGATTGT-1_2_B4	-15.44773601	-11.83710839	13B	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2421	4948	0.013338723	0.003031528	0	13B	IN-SV2C	NA	NA	NA
GACTGCGAGACTGGGT-1_2_B4	19.92585498	21.15429861	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1015	1501	0.004663558	0.00532978	0	oligos	OL-Cntl	NA	NA	NA
GACTGCGAGCCCAGCT-1_2_B4	0.30335445	29.09673999	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	803	1115	0.021524664	0.002690583	0	oligos	OL-Cntl	NA	NA	NA
GACTGCGAGTTAGGTA-1_2_B4	4.894043238	24.48643809	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	875	1227	0.006519967	0.013039935	0	oligos	OL-Cntl	NA	NA	NA
GACTGCGCAGTAACGG-1_2_B4	-22.50531595	27.24668912	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1854	3601	0.003332408	0.006664815	0	8	Astrocytes	NA	NA	NA
GACTGCGCATGACGGA-1_2_B4	20.73752877	18.29377243	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1088	1716	0.001165501	0.005827506	0	oligos	OL-Cntl	NA	NA	NA
GACTGCGCATTCTCAT-1_2_B4	9.809833444	26.94241652	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	852	1241	0.005640612	0.003223207	0	oligos	OL-Cntl	NA	NA	NA
GACTGCGGTAAGTAGT-1_2_B4	-10.47109533	-17.39586923	6B	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1048	1667	0.036592681	0.0029994	0	6B	IN-SST	NA	NA	NA
GACTGCGGTGCGATAG-1_2_B4	21.48657249	18.50338247	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1067	1587	0.003780718	0.005671078	0	oligos	OL-Cntl	NA	NA	NA
GACTGCGGTTGGTTTG-1_2_B4	-1.008031018	-0.438905433	11	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1860	3111	0.021215043	0.003214401	0	11	Glia-MIX	NA	NA	NA
GACTGCGTCCGTCATC-1_2_B4	-15.10839583	-25.09572699	6A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1708	3395	0.037997054	0.003829161	0	6A	IN-PV	NA	NA	NA
GAGCAGAAGGAGTAGA-1_2_B4	4.029872171	-28.69551804	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2837	5825	0.002575107	0.001888412	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GAGCAGAAGTGACTCT-1_2_B4	-24.08345743	21.99727011	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1301	2075	0.003855422	0.009638554	0	8	Astrocytes	NA	NA	NA
GAGCAGACAATGGAGC-1_2_B4	19.0858897	13.16671749	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1263	2126	0.003292568	0.006585136	0	oligos	OL-Cntl	NA	NA	NA
GAGCAGACAGATGGGT-1_2_B4	6.525050216	23.69095298	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	975	1372	0.003644315	0.011661808	0	oligos	OL-Cntl	NA	NA	NA
GAGCAGACAGCTCGAC-1_2_B4	14.15164916	-2.530662727	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1194	1950	0.014358974	0.002564103	0	12	EN-MIX	NA	NA	NA
GAGCAGACAGTAAGAT-1_2_B4	11.42828993	26.08827909	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	828	1199	0.00500417	0.012510425	0	oligos	OL-Cntl	NA	NA	NA
GAGCAGACATCTACGA-1_2_B4	-1.275331635	30.49747287	17	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	867	1174	0.008517888	0.004258944	0	oligos	OL-MS-2	NA	NA	NA
GAGCAGATCAGAGACG-1_2_B4	19.44672853	8.879927017	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1714	2998	0.004002668	0.00700467	0	oligos	OL-Cntl	NA	NA	NA
GAGGTGAAGTGTGAAT-1_2_B4	25.47581419	-2.709884095	2	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3177	7773	0.007075775	0.002187058	0	2	EN-L4	NA	NA	NA
GAGGTGACACGCCAGT-1_2_B4	27.75991822	-9.766924999	2	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2704	6106	0.042908614	0.003111693	0	2	EN-L4	NA	NA	NA
GAGGTGATCCGAATGT-1_2_B4	14.92377257	30.10130484	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	832	1280	0.0078125	0.00234375	0	oligos	OL-Cntl	NA	NA	NA
GAGGTGATCCTTGACC-1_2_B4	6.886059537	23.7315796	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	995	1447	0.00829302	0.01105736	0	oligos	OL-Cntl	NA	NA	NA
GAGGTGATCGACGGAA-1_2_B4	3.798737281	26.10984604	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	742	1058	0.004725898	0.004725898	0	oligos	OL-Cntl	NA	NA	NA
GAGGTGATCGCAAGCC-1_2_B4	3.829995528	-7.901206881	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1302	2155	0.011600928	0.001392111	0	12	EN-MIX	NA	NA	NA
GAGTCCGAGAAGGGTA-1_2_B4	12.9382045	19.87680551	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1001	1516	0.003957784	0.009894459	0	oligos	OL-Cntl	NA	NA	NA
GAGTCCGAGCGGCTTC-1_2_B4	18.13680222	14.23477282	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1205	1865	0.000536193	0.004289544	0	oligos	OL-Cntl	NA	NA	NA
GAGTCCGAGCTCCCAG-1_2_B4	19.65452362	11.85679019	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1336	2187	0.000914495	0.002286237	0	oligos	OL-Cntl	NA	NA	NA
GAGTCCGAGGCCCTCA-1_2_B4	14.92068822	20.88122319	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1005	1576	0.001903553	0.003807107	0	oligos	OL-Cntl	NA	NA	NA
GAGTCCGAGGGCATGT-1_2_B4	20.57589601	19.10693475	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	987	1527	0.007858546	0.007203667	0	oligos	OL-Cntl	NA	NA	NA
GAGTCCGAGTCTCCTC-1_2_B4	-20.41801698	8.02960014	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	787	1128	0.008865248	0.002659574	0	8	Astrocytes	NA	NA	NA
GAGTCCGCAGGAACGT-1_2_B4	2.7387072	29.52472017	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	707	1024	0.005859375	0.005859375	0	oligos	OL-Cntl	NA	NA	NA
GAGTCCGCAGGACGTA-1_2_B4	32.68173288	-1.575542831	2	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2668	5435	0.00349586	0.008463661	0	2	EN-L4	NA	NA	NA
GAGTCCGCATTGGTAC-1_2_B4	-37.63076665	-0.093896579	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1534	2819	0.000354736	0.001773679	0	9	OPC	NA	NA	NA
GAGTCCGGTCCGAGTC-1_2_B4	-4.671474238	-6.821193224	13A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1056	1532	0.017624021	0.004569191	0	13A	IN-VIP	NA	NA	NA
GATCAGTAGGATCGCA-1_2_B4	-35.59279183	4.925476549	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2505	5691	0.000175716	0.002811457	0	9	OPC	NA	NA	NA
GATCAGTCAGGTCCAC-1_2_B4	18.00670981	9.970083495	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1554	2544	0.003930818	0.006289308	0	oligos	OL-Cntl	NA	NA	NA
GATCAGTCAGTAACGG-1_2_B4	21.43881106	0.973596094	2	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1400	2378	0.006728343	0.002523129	0	2	EN-L4	NA	NA	NA
GATCAGTCAGTATGCT-1_2_B4	-17.62565718	13.99804052	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1237	2056	0.001459144	0.002431907	0	8	Astrocytes	NA	NA	NA
GATCAGTGTGCAACTT-1_2_B4	0.374863413	28.32647191	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	960	1376	0.005813953	0.006540698	0	oligos	OL-Cntl	NA	NA	NA
GATCAGTGTGGTGTAG-1_2_B4	17.19250935	-4.485684838	3	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1375	2230	0.012556054	0.006278027	0	3	EN-L5-6	NA	NA	NA
GATCAGTGTGTTTGGT-1_2_B4	13.40929288	28.18092764	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	778	1085	0.001843318	0.004608295	0	oligos	OL-Cntl	NA	NA	NA
GATCAGTTCCACGTTC-1_2_B4	1.04384269	-20.23564128	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3229	8110	0.005918619	0.003945746	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GATCAGTTCCCACTTG-1_2_B4	-0.050614618	28.25479386	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	682	1000	0.009	0.002	0	oligos	OL-Cntl	NA	NA	NA
GATCAGTTCCCAGGTG-1_2_B4	2.9418657	-2.894586601	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	665	1004	0.001992032	0.003984064	0	12	EN-MIX	NA	NA	NA
GATCGATAGTGGGATC-1_2_B4	13.69319745	29.91840239	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	862	1291	0.006196747	0.00232378	0	oligos	OL-Cntl	NA	NA	NA
GATCGATCACCGGAAA-1_2_B4	18.38808585	22.08009707	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	965	1521	0	0.005259698	0	oligos	OL-Cntl	NA	NA	NA
GATCGATCAGCTCCGA-1_2_B4	17.36634787	12.49314505	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1326	2308	0.000866551	0.008232236	0	oligos	OL-Cntl	NA	NA	NA
GATCGATCATGCGCAC-1_2_B4	35.37028844	13.76392875	14	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1039	1368	0.001461988	0.040935673	0	14	Microglia	NA	NA	NA
GATCGATCATTCTTAC-1_2_B4	-20.40721349	8.450249073	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	857	1246	0.001605136	0.006420546	0	8	Astrocytes	NA	NA	NA
GATCGATGTGAGGGTT-1_2_B4	11.69079269	24.41359789	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	763	1143	0.003499563	0.008748906	0	oligos	OL-Cntl	NA	NA	NA
GATCGATGTGGAAAGA-1_2_B4	-31.61649692	12.5481244	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	892	1352	0.00887574	0.00591716	0	8	Astrocytes	NA	NA	NA
GATCGATGTGGTACAG-1_2_B4	-0.417603413	29.53067622	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	798	1095	0.006392694	0.000913242	0	oligos	OL-Cntl	NA	NA	NA
GATCGATGTTCATGGT-1_2_B4	2.433760561	-8.004618058	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1334	2201	0.019082235	0.003634711	0	12	EN-MIX	NA	NA	NA
GATCGATGTTCTGTTT-1_2_B4	12.09640212	27.59413757	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	758	1121	0.001784121	0.008920607	0	oligos	OL-Cntl	NA	NA	NA
GATCGATGTTGAACTC-1_2_B4	12.74493128	25.32475592	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	715	1047	0.00286533	0.00191022	0	oligos	OL-Cntl	NA	NA	NA
GATCGATTCATCATTC-1_2_B4	6.013851541	-3.439421829	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1054	1594	0.005646173	0.016938519	0	12	EN-MIX	NA	NA	NA
GATCGCGCACAACTGT-1_2_B4	21.743768	21.20317902	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1011	1593	0.005649718	0.005649718	0	oligos	OL-Cntl	NA	NA	NA
GATCGCGCACCTGGTG-1_2_B4	19.79741055	21.98657599	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	977	1545	0.003236246	0.001941748	0	oligos	OL-Cntl	NA	NA	NA
GATCGCGGTCACTGGC-1_2_B4	-28.23139692	22.61096937	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1193	1989	0.002513826	0.007541478	0	8	Astrocytes	NA	NA	NA
GATCGCGGTTATGCGT-1_2_B4	2.54698527	29.77212799	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	761	1123	0.000890472	0.009795191	0	oligos	OL-Cntl	NA	NA	NA
GATCGCGTCACAAACC-1_2_B4	4.007346416	28.10906253	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	756	1126	0.007992895	0.003552398	0	oligos	OL-Cntl	NA	NA	NA
GATCGCGTCGTCTGAA-1_2_B4	-31.21200824	13.1847273	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	843	1304	0.00690184	0.002300613	0	8	Astrocytes	NA	NA	NA
GATCGTAAGGTGACCA-1_2_B4	3.02498876	-6.760835603	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1272	2230	0.006726457	0.004932735	0	12	EN-MIX	NA	NA	NA
GATCGTAGTAAATACG-1_2_B4	3.15568666	-31.98902181	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	5402	19133	0.002979146	0.002770083	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GATCGTAGTCCTCTTG-1_2_B4	-23.51357315	-0.214878912	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1663	2843	0.007738305	0.004220893	0	9	OPC	NA	NA	NA
GATCGTATCCATGAAC-1_2_B4	-37.43526545	-1.022004657	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1324	2423	0.001650846	0.004127115	0	9	OPC	NA	NA	NA
GATCGTATCTGTCTAT-1_2_B4	23.95118234	-27.61406013	3	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3694	10310	0.006498545	0.003588749	0	3	EN-L5-6	NA	NA	NA
GATCTAGCAAACTGCT-1_2_B4	21.90742853	18.67477447	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1100	1754	0.00627138	0.004561003	0	oligos	OL-Cntl	NA	NA	NA
GATCTAGCATGCCTTC-1_2_B4	-5.160318637	-2.600369602	13A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1412	2634	0.01556568	0.003796507	0	13A	IN-VIP	NA	NA	NA
GATCTAGCATGGAATA-1_2_B4	-0.79045789	28.88259533	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	825	1187	0	0.00673968	0	oligos	OL-Cntl	NA	NA	NA
GATCTAGGTCCGTGAC-1_2_B4	17.51754845	15.8892877	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1136	1840	0.00326087	0.005978261	0	oligos	OL-Cntl	NA	NA	NA
GATCTAGGTTGGTTTG-1_2_B4	18.70828356	1.376321697	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1116	1701	0.001175779	0.002939447	0	12	EN-MIX	NA	NA	NA
GATCTAGTCAGGTAAA-1_2_B4	14.72962964	22.01547894	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	860	1292	0.001547988	0.012383901	0	oligos	OL-Cntl	NA	NA	NA
GATGAAAAGATCCCGC-1_2_B4	11.90206856	25.43558735	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	669	1039	0.000962464	0.00481232	0	oligos	OL-Cntl	NA	NA	NA
GATGAAACATGGTTGT-1_2_B4	33.86526742	14.49734176	14	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	944	1263	0.000791766	0.030087094	0	14	Microglia	NA	NA	NA
GATGAAAGTATTAGCC-1_2_B4	7.810435129	27.07353561	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	904	1320	0.002272727	0.006060606	0	oligos	OL-Cntl	NA	NA	NA
GATGAAATCCATTCTA-1_2_B4	22.14115589	13.74982239	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1267	2065	0.002421308	0.005326877	0	oligos	OL-Cntl	NA	NA	NA
GATGAGGAGCACAGGT-1_2_B4	-1.667241468	28.36829241	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	723	1016	0.003937008	0.005905512	0	oligos	OL-Cntl	NA	NA	NA
GATGAGGAGGAGTCTG-1_2_B4	-4.124043289	-8.85359295	13A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	784	1010	0.001980198	0.005940594	0	13A	IN-VIP	NA	NA	NA
GATGAGGCAGACAGGT-1_2_B4	22.65056152	16.03694903	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1407	2204	0.001361162	0.010435572	0	oligos	OL-Cntl	NA	NA	NA
GATGAGGCAGCGATCC-1_2_B4	15.31543218	-6.206401765	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1950	4626	0.007565932	0.001297017	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GATGAGGGTTCTCATT-1_2_B4	38.03278675	13.38822492	14	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1037	1450	0.006896552	0.02137931	0	14	Microglia	NA	NA	NA
GATGAGGTCAGCTCGG-1_2_B4	14.73528236	27.06121408	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	733	1013	0.0029615	0.0029615	0	oligos	OL-Cntl	NA	NA	NA
GATGAGGTCCTTGACC-1_2_B4	3.298437647	18.66474676	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	878	1316	0.004559271	0.008358663	0	oligos	OL-Cntl	NA	NA	NA
GATGCTACAAGCCGTC-1_2_B4	7.520319676	-29.66644672	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	4678	13591	0.002795968	0.001913031	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GATGCTAGTCAGAGGT-1_2_B4	15.54182009	24.95750327	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	875	1300	0.011538462	0.000769231	0	oligos	OL-Cntl	NA	NA	NA
GATGCTAGTGACGCCT-1_2_B4	-37.31026825	0.286510763	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1485	2623	0.0053374	0.0026687	0	9	OPC	NA	NA	NA
GATGCTAGTTCCAACA-1_2_B4	2.757378573	-25.62555059	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	4617	14050	0.00683274	0.002918149	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GATGCTAGTTTGTTGG-1_2_B4	-1.309057493	-1.2235963	11	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1788	3277	0.020445529	0.001525786	0	11	Glia-MIX	NA	NA	NA
GATGCTATCAGTCAGT-1_2_B4	-12.42044787	-21.97604523	6A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1056	1739	0.021851639	0.007475561	0	6A	IN-PV	NA	NA	NA
GATGCTATCGGCGCTA-1_2_B4	12.87871328	-31.48117123	3	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2594	5702	0.001578394	0.003858295	0	3	EN-L5-6	NA	NA	NA
GATTCAGAGACGACGT-1_2_B4	1.61358591	27.00361252	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	716	1003	0.000997009	0.011964108	0	oligos	OL-Cntl	NA	NA	NA
GATTCAGAGCCGTCGT-1_2_B4	5.102126031	24.95781316	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	846	1251	0.003197442	0.003197442	0	oligos	OL-Cntl	NA	NA	NA
GATTCAGAGTTAGGTA-1_2_B4	-5.058870508	-3.116433673	13A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1442	2495	0.014028056	0.004408818	0	13A	IN-VIP	NA	NA	NA
GATTCAGCAGATCCAT-1_2_B4	-35.73934052	-6.709119797	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1073	1726	0.001738123	0.002317497	0	9	OPC	NA	NA	NA
GCAAACTAGAGCTGGT-1_2_B4	22.50435884	15.55796675	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1513	2407	0.015371832	0.007478189	0	oligos	OL-Cntl	NA	NA	NA
GCAAACTAGCAATATG-1_2_B4	3.75730312	-5.634143882	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1071	1694	0.002361275	0.001180638	0	12	EN-MIX	NA	NA	NA
GCAAACTAGGCCGAAT-1_2_B4	-10.29079231	2.207584566	13A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2832	6149	0.005854611	0.005366726	0	13A	IN-VIP	NA	NA	NA
GCAAACTCAAGTCATC-1_2_B4	2.389845957	-7.885957356	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1366	2465	0.00851927	0.004056795	0	12	EN-MIX	NA	NA	NA
GCAAACTCACGACGAA-1_2_B4	17.46771395	23.79299013	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	959	1444	0.002077562	0.006925208	0	oligos	OL-Cntl	NA	NA	NA
GCAAACTCAGCGAACA-1_2_B4	-15.34351006	-24.98776864	6A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1641	2914	0.014413178	0.001715854	0	6A	IN-PV	NA	NA	NA
GCAAACTGTCAACTGT-1_2_B4	-8.315862818	0.964178014	13A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2530	5269	0.004934523	0.002277472	0	13A	IN-VIP	NA	NA	NA
GCAAACTTCATGCAAC-1_2_B4	16.99049848	27.4774423	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	847	1191	0.011754828	0.000839631	0	oligos	OL-Cntl	NA	NA	NA
GCAAACTTCTTGTCAT-1_2_B4	-7.594255936	-1.186409533	13A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1806	3323	0.003310262	0.005717725	0	13A	IN-VIP	NA	NA	NA
GCAATCAAGAATTGTG-1_2_B4	-8.311352236	2.663034426	13A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2240	4709	0.003610108	0.001911234	0	13A	IN-VIP	NA	NA	NA
GCAATCAAGCCCGAAA-1_2_B4	31.02221828	-3.259371304	2	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3344	7413	0.009847565	0.002967759	0	2	EN-L4	NA	NA	NA
GCAATCAAGTGAATTG-1_2_B4	5.365676213	24.13699078	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	888	1308	0	0.003058104	0	oligos	OL-Cntl	NA	NA	NA
GCAATCACACAGGTTT-1_2_B4	-16.23774236	-23.35114558	6A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1936	3849	0.01039231	0.004416732	0	6A	IN-PV	NA	NA	NA
GCAATCACACCCATGG-1_2_B4	-1.562112416	27.30430744	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	874	1242	0.006441224	0.00805153	0	oligos	OL-Cntl	NA	NA	NA
GCAATCACACTCGACG-1_2_B4	-11.06940034	12.99909036	11	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	728	1065	0.004694836	0	0	11	Glia-MIX	NA	NA	NA
GCAATCAGTCAAACTC-1_2_B4	8.529439674	24.25410286	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	927	1260	0.001587302	0.004761905	0	oligos	OL-Cntl	NA	NA	NA
GCAATCAGTCCGTTAA-1_2_B4	7.015505623	-31.60024182	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	4469	13368	0.009799521	0.002094554	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCAATCAGTGGCCCTA-1_2_B4	-1.185428425	-23.96500815	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3472	8995	0.006670372	0.001889939	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCAATCATCCAGTAGT-1_2_B4	13.9852044	27.99946736	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	788	1173	0.004262575	0.00341006	0	oligos	OL-Cntl	NA	NA	NA
GCAATCATCCCACTTG-1_2_B4	3.455753852	28.39258599	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	703	1006	0.002982107	0.005964215	0	oligos	OL-Cntl	NA	NA	NA
GCACATAAGCCTTGAT-1_2_B4	2.334900276	-10.50576152	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1525	2532	0.014612954	0.002764613	0	12	EN-MIX	NA	NA	NA
GCACATAAGTGAAGTT-1_2_B4	0.397675419	29.68521328	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	840	1197	0.000835422	0.003341688	0	oligos	OL-Cntl	NA	NA	NA
GCACATACAGGAATGC-1_2_B4	-32.18948232	-12.85331484	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	761	1004	0.00498008	0.000996016	0	9	OPC	NA	NA	NA
GCACATACATAAGACA-1_2_B4	14.19405046	15.11922855	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1164	1808	0.002212389	0.008849558	0	oligos	OL-Cntl	NA	NA	NA
GCACATAGTACGCACC-1_2_B4	2.856005456	29.59579736	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	736	1030	0.005825243	0.006796117	0	oligos	OL-Cntl	NA	NA	NA
GCACATAGTATAATGG-1_2_B4	19.26737202	9.039299394	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1536	2700	0.002222222	0.01037037	0	oligos	OL-Cntl	NA	NA	NA
GCACATATCATGCATG-1_2_B4	18.2631291	-6.869609707	3	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1652	2936	0.004427793	0.005449591	0	3	EN-L5-6	NA	NA	NA
GCACTCTAGAGACGAA-1_2_B4	0.603815604	29.98250595	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	729	1038	0.006743738	0.001926782	0	oligos	OL-Cntl	NA	NA	NA
GCACTCTAGCCATCGC-1_2_B4	24.656237	-0.119421553	2	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2204	4458	0.000672948	0.002916106	0	2	EN-L4	NA	NA	NA
GCACTCTCAATGGTCT-1_2_B4	39.08215785	15.89882306	14	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1394	2153	0.006967023	0.01532745	0	14	Microglia	NA	NA	NA
GCACTCTCACGCGAAA-1_2_B4	-12.16815575	-0.470697512	13A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2903	5819	0.015466575	0.004639973	0	13A	IN-VIP	NA	NA	NA
GCACTCTCACTATCTT-1_2_B4	22.28652057	12.48561907	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1365	2454	0.000407498	0.005704971	0	oligos	OL-Cntl	NA	NA	NA
GCACTCTTCACTCTTA-1_2_B4	-24.05800739	28.81539993	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1729	3299	0.002728099	0.001818733	0	8	Astrocytes	NA	NA	NA
GCAGCCAAGAGCCTAG-1_2_B4	1.899544154	25.93784452	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	736	1024	0.001953125	0.004882813	0	oligos	OL-Cntl	NA	NA	NA
GCAGCCACAAGTAGTA-1_2_B4	21.99243693	11.28885559	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1603	2834	0.00388144	0.008821454	0	oligos	OL-Cntl	NA	NA	NA
GCAGCCACAGGACGTA-1_2_B4	-7.580053874	-6.552159148	13A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1277	2094	0.009073543	0.008595989	0	13A	IN-VIP	NA	NA	NA
GCAGCCAGTAGTAGTA-1_2_B4	-18.2333826	7.180890907	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	958	1424	0.002106742	0.003511236	0	8	Astrocytes	NA	NA	NA
GCAGCCAGTGGTACAG-1_2_B4	31.93465174	-2.606743089	2	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2494	4992	0.009214744	0.004807692	0	2	EN-L4	NA	NA	NA
GCAGCCAGTTACGGAG-1_2_B4	3.430736567	-20.68849116	4	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3683	8606	0.01452475	0.0058099	0	L2-3	EN-L2-3-MS	NA	NA	NA
GCAGCCATCCGCGTTT-1_2_B4	-11.44778268	-32.8537432	16	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1194	1850	0.085405405	0.005945946	0	16	EN-PYR	NA	NA	NA
GCAGCCATCCGGGTGT-1_2_B4	-13.31558728	-19.31772677	6B	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1262	2178	0.028466483	0.002754821	0	6B	IN-SST	NA	NA	NA
GCAGCCATCCTTTACA-1_2_B4	19.63273365	12.50593561	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1349	2301	0.005215124	0.008691873	0	oligos	OL-Cntl	NA	NA	NA
GCAGCCATCGTGGTCG-1_2_B4	-4.128112354	-8.426392663	13A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	831	1117	0.011638317	0.005371531	0	13A	IN-VIP	NA	NA	NA
GCAGTTAAGGCTAGAC-1_2_B4	2.528069827	-7.673944614	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1277	2024	0.009881423	0.006422925	0	12	EN-MIX	NA	NA	NA
GCAGTTAGTCATATGC-1_2_B4	-12.31038219	0.530242747	13A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3071	6592	0.010467233	0.007433252	0	13A	IN-VIP	NA	NA	NA
GCAGTTAGTCTCCACT-1_2_B4	19.66430277	20.44054894	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1031	1670	0.001197605	0.005988024	0	oligos	OL-Cntl	NA	NA	NA
GCAGTTAGTGGTAACG-1_2_B4	-5.522369913	-9.063552437	13A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1043	1892	0.005285412	0.004756871	0	13A	IN-VIP	NA	NA	NA
GCAGTTAGTTATCCGA-1_2_B4	15.80463792	19.65857105	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1031	1673	0.020920502	0.006575015	0	oligos	OL-Cntl	NA	NA	NA
GCAGTTATCGAGGTAG-1_2_B4	16.13738271	21.13240883	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	911	1368	0.002192982	0.009502924	0	oligos	OL-Cntl	NA	NA	NA
GCAGTTATCGCTGATA-1_2_B4	10.67375975	29.79887155	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	725	1061	0.001885014	0.004712535	0	oligos	OL-Cntl	NA	NA	NA
GCATACAAGCAGGCTA-1_2_B4	14.24686099	22.30566231	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	943	1290	0.002325581	0.012403101	0	oligos	OL-Cntl	NA	NA	NA
GCATACAAGCCATCGC-1_2_B4	17.02349365	28.94200523	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	857	1190	0.001680672	0.004201681	0	oligos	OL-Cntl	NA	NA	NA
GCATACAAGTACACCT-1_2_B4	19.36165754	8.75092661	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1687	3230	0.002786378	0.008668731	0	oligos	OL-Cntl	NA	NA	NA
GCATACACAAGTCTAC-1_2_B4	9.651577648	26.63887163	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	857	1318	0.001517451	0.006069803	0	oligos	OL-Cntl	NA	NA	NA
GCATACACAGCTTCGG-1_2_B4	-12.09964575	19.63151876	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1795	3230	0.003095975	0.006501548	0	8	Astrocytes	NA	NA	NA
GCATACATCAGGTTCA-1_2_B4	-6.732117606	-9.021681427	13A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	940	1459	0.017820425	0.007539411	0	13A	IN-VIP	NA	NA	NA
GCATACATCCGGCACA-1_2_B4	20.41690575	13.61129959	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1298	2177	0.01423978	0.003215434	0	oligos	OL-Cntl	NA	NA	NA
GCATACATCGGAGGTA-1_2_B4	-27.28204566	4.620747748	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1936	3432	0.007284382	0.007575758	0	9	OPC	NA	NA	NA
GCATGATAGAAACGCC-1_2_B4	11.95617024	28.49440762	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	775	1136	0.009683099	0.000880282	0	oligos	OL-Cntl	NA	NA	NA
GCATGATAGCGATTCT-1_2_B4	0.162744623	-15.75993699	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2555	5498	0.009639869	0.003092033	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCATGATCAAAGTCAA-1_2_B4	7.348879195	24.06817605	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	910	1335	0	0.004494382	0	oligos	OL-Cntl	NA	NA	NA
GCATGATGTAACGACG-1_2_B4	4.970670134	26.24999412	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	741	1004	0.008964143	0.010956175	0	oligos	OL-Cntl	NA	NA	NA
GCATGATGTACTCGCG-1_2_B4	3.660968004	-8.21853024	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1318	2010	0.011442786	0.005472637	0	12	EN-MIX	NA	NA	NA
GCATGATGTGATGCCC-1_2_B4	-14.33775761	-24.80582719	6A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1514	2697	0.011123471	0.002224694	0	6A	IN-PV	NA	NA	NA
GCATGATGTGCACGAA-1_2_B4	9.293730057	-7.62481845	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2117	3890	0.003856041	0.002313625	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCATGATGTGGCAAAC-1_2_B4	-36.38689891	4.183413573	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2009	3857	0.00466684	0.00233342	0	9	OPC	NA	NA	NA
GCATGATTCGCGGATC-1_2_B4	-8.182873872	-17.6943389	6B	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	662	1016	0.012795276	0.001968504	0	6B	IN-SST	NA	NA	NA
GCATGCGAGATCACGG-1_2_B4	9.819672073	27.82369152	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	837	1360	0.002941176	0.001470588	0	oligos	OL-Cntl	NA	NA	NA
GCATGCGAGATGCCAG-1_2_B4	-37.96704343	0.371799636	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1593	2794	0.003579098	0.003579098	0	9	OPC	NA	NA	NA
GCATGCGCAAGCTGTT-1_2_B4	-36.17936385	-7.169735465	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1149	1855	0.002156334	0.000539084	0	9	OPC	NA	NA	NA
GCATGCGTCCCATTTA-1_2_B4	22.67938109	19.29213171	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1052	1619	0.003088326	0.003088326	0	oligos	OL-Cntl	NA	NA	NA
GCATGCGTCTTGCAAG-1_2_B4	3.745127225	29.42019498	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	790	1145	0.004366812	0.006113537	0	oligos	OL-Cntl	NA	NA	NA
GCATGTAGTGGTCCGT-1_2_B4	22.64518739	12.37451051	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1387	2288	0.006993007	0.002185315	0	oligos	OL-Cntl	NA	NA	NA
GCATGTATCACCATAG-1_2_B4	15.97727891	16.47977517	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1113	1690	0.007100592	0.004142012	0	oligos	OL-Cntl	NA	NA	NA
GCATGTATCGTCACGG-1_2_B4	21.72652104	0.530589422	2	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1502	2421	0.002478315	0.002478315	0	2	EN-L4	NA	NA	NA
GCCAAATAGGTCATCT-1_2_B4	16.25662462	22.44377869	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	969	1513	0.003965631	0.010575017	0	oligos	OL-Cntl	NA	NA	NA
GCCAAATAGTACGTAA-1_2_B4	3.580092968	-7.329327347	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1290	2072	0.007239382	0.004343629	0	12	EN-MIX	NA	NA	NA
GCCAAATAGTCGATAA-1_2_B4	23.1071525	19.41426559	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1053	1652	0.003631961	0.002421308	0	oligos	OL-Cntl	NA	NA	NA
GCCAAATCACATGTGT-1_2_B4	17.5220312	-5.348950752	3	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1361	2407	0.008724553	0.004985459	0	3	EN-L5-6	NA	NA	NA
GCCAAATCATCCCATC-1_2_B4	5.492793293	26.15600132	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	819	1183	0.000845309	0.007607777	0	oligos	OL-Cntl	NA	NA	NA
GCCAAATGTGATGATA-1_2_B4	37.11333736	13.88747771	14	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1174	1594	0.003136763	0.016311167	0	14	Microglia	NA	NA	NA
GCCAAATTCCTCAACC-1_2_B4	8.515000914	-31.49301656	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3645	8734	0.003663842	0.006182734	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCCAAATTCGTAGGAG-1_2_B4	-0.639347753	-17.43423758	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2588	5294	0.007744617	0.002833396	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCCTCTAAGTGTGGCA-1_2_B4	3.796204187	-2.748354402	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	722	1011	0.020771513	0.007912957	0	12	EN-MIX	NA	NA	NA
GCCTCTACAGTATCTG-1_2_B4	6.383413135	24.1744006	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	932	1352	0.000739645	0.014053254	0	oligos	OL-Cntl	NA	NA	NA
GCCTCTACATCCCATC-1_2_B4	-13.46269001	-24.02273181	6A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1274	2527	0.000395726	0.003165809	0	6A	IN-PV	NA	NA	NA
GCCTCTATCAACACCA-1_2_B4	-23.86015134	23.30612202	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1280	2236	0.007155635	0.007155635	0	8	Astrocytes	NA	NA	NA
GCGACCAAGACAGGCT-1_2_B4	7.944306561	-8.051320504	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1761	3202	0.004684572	0.003123048	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCGACCACATTAACCG-1_2_B4	-20.24399742	-27.45859875	6A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3154	7682	0.015751106	0.003644884	0	6A	IN-PV	NA	NA	NA
GCGACCAGTGAACCTT-1_2_B4	12.30292508	21.44807922	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	902	1371	0.000729395	0.006564551	0	oligos	OL-Cntl	NA	NA	NA
GCGACCATCTTGCAAG-1_2_B4	-14.80766858	-9.339655305	13A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2409	4748	0.00968829	0.002737995	0	13A	IN-VIP	NA	NA	NA
GCGAGAACAAGTCATC-1_2_B4	-1.076442178	29.53698522	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	909	1257	0.007159905	0.005568815	0	oligos	OL-Cntl	NA	NA	NA
GCGAGAACACCCTATC-1_2_B4	-28.71750318	22.63495656	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	982	1555	0.002572347	0.00192926	0	8	Astrocytes	NA	NA	NA
GCGAGAACAGTGGAGT-1_2_B4	-10.39630332	12.54356952	11	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	887	1166	0.005145798	0.003430532	0	11	Glia-MIX	NA	NA	NA
GCGAGAAGTCTCATCC-1_2_B4	0.12496577	28.40985517	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	901	1287	0.003108003	0.006993007	0	oligos	OL-Cntl	NA	NA	NA
GCGAGAATCAACACCA-1_2_B4	20.3172273	19.53104341	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1029	1593	0.006277464	0.003138732	0	oligos	OL-Cntl	NA	NA	NA
GCGAGAATCATGCTCC-1_2_B4	21.68261773	17.59894628	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1093	1671	0.001795332	0.009575105	0	oligos	OL-Cntl	NA	NA	NA
GCGAGAATCGCCTGAG-1_2_B4	7.874552903	24.74338335	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	989	1427	0.007007708	0.010511563	0	oligos	OL-Cntl	NA	NA	NA
GCGAGAATCTGCCCTA-1_2_B4	-11.97001878	-10.8289229	13B	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1415	2423	0.011555922	0.003301692	0	13B	IN-SV2C	NA	NA	NA
GCGCAACAGCGTTCCG-1_2_B4	14.44546876	-8.266884501	3	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2360	4785	0.004388715	0.001671891	0	3	EN-L5-6	NA	NA	NA
GCGCAACCAATAGCGG-1_2_B4	2.128173678	-8.994418743	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1425	2300	0.013043478	0.002173913	0	12	EN-MIX	NA	NA	NA
GCGCAACTCACCCGAG-1_2_B4	-26.59853816	17.15685	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1223	2022	0.002472799	0.005440158	0	8	Astrocytes	NA	NA	NA
GCGCAACTCCCACTTG-1_2_B4	26.65393304	-3.924282118	2	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	5150	15756	0.000761615	0.002475248	0	2	EN-L4	NA	NA	NA
GCGCAACTCCCTTGCA-1_2_B4	4.498333444	32.33831368	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	716	1025	0.003902439	0.004878049	0	oligos	OL-Cntl	NA	NA	NA
GCGCAACTCTCTTGAT-1_2_B4	3.07344953	-19.66337459	4	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3439	8038	0.004478726	0.00796218	0	L2-3	EN-L2-3-MS	NA	NA	NA
GCGCAACTCTGCCAGG-1_2_B4	14.2896147	26.42098986	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	840	1251	0.003197442	0.007194245	0	oligos	OL-Cntl	NA	NA	NA
GCGCAGTAGATCTGAA-1_2_B4	4.3108388	-4.088894328	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1085	1490	0.005369128	0.006040268	0	12	EN-MIX	NA	NA	NA
GCGCAGTAGCGAGAAA-1_2_B4	3.026988508	-15.07928662	4	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2221	4239	0.021939137	0.004246285	0	L2-3	EN-L2-3-MS	NA	NA	NA
GCGCAGTCACCGCTAG-1_2_B4	4.553869972	6.964482601	7	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1471	2298	0.001740644	0.005221932	0	7	Phagocytes	NA	NA	NA
GCGCAGTCACGAAAGC-1_2_B4	1.881563755	-20.73438463	4	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3541	8573	0.015397177	0.004432521	0	L2-3	EN-L2-3-MS	NA	NA	NA
GCGCAGTCACGTCTCT-1_2_B4	3.749391233	-28.19897832	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2758	6929	0.002597777	0.002453456	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCGCAGTCATAGGATA-1_2_B4	16.16958803	27.74795484	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	874	1305	0.016091954	0.003831418	0	oligos	OL-Cntl	NA	NA	NA
GCGCAGTGTCATGCCG-1_2_B4	20.76888132	11.07141493	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1527	2697	0.001853912	0.004449388	0	oligos	OL-Cntl	NA	NA	NA
GCGCAGTGTCGAGTTT-1_2_B4	31.78131823	-2.681744722	2	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3028	6364	0.012413576	0.002357008	0	2	EN-L4	NA	NA	NA
GCGCAGTGTGAAAGAG-1_2_B4	4.348196993	-10.06559	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1739	2963	0.009787378	0.006074924	0	12	EN-MIX	NA	NA	NA
GCGCAGTTCAGAGACG-1_2_B4	-27.11200152	13.81167858	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	882	1454	0.002751032	0.002063274	0	8	Astrocytes	NA	NA	NA
GCGCAGTTCATACGGT-1_2_B4	-17.23047768	14.26464974	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1501	2761	0.002173126	0.003984064	0	8	Astrocytes	NA	NA	NA
GCGCAGTTCCGTTGTC-1_2_B4	22.54785304	17.08593306	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1167	1718	0.006402794	0.00814901	0	oligos	OL-Cntl	NA	NA	NA
GCGCAGTTCTTAGAGC-1_2_B4	-15.28356506	-25.6527197	6A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1730	3355	0.005663189	0.003874814	0	6A	IN-PV	NA	NA	NA
GCGCCAAAGCAGACTG-1_2_B4	13.52408841	26.90272732	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	763	1128	0.002659574	0.005319149	0	oligos	OL-Cntl	NA	NA	NA
GCGCCAAAGGGAGTAA-1_2_B4	1.230660004	34.52287774	17	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	941	1444	0.004847645	0.007617729	0	oligos	OL-MS-2	NA	NA	NA
GCGCCAACAACACCCG-1_2_B4	22.30874602	16.40685519	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1246	1863	0.003757381	0.010735373	0	oligos	OL-Cntl	NA	NA	NA
GCGCCAACATTAGCCA-1_2_B4	4.896243736	-31.32672082	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3855	11151	0.009595552	0.002152273	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCGCCAAGTAAACGCG-1_2_B4	14.71242697	-1.772471217	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	920	1526	0.007208388	0.00327654	0	12	EN-MIX	NA	NA	NA
GCGCCAAGTGAGTATA-1_2_B4	23.17217242	18.82551576	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1012	1469	0.00136147	0.002042206	0	oligos	OL-Cntl	NA	NA	NA
GCGCCAAGTGATGATA-1_2_B4	22.71867227	13.62581064	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1335	2121	0.002357379	0.002828854	0	oligos	OL-Cntl	NA	NA	NA
GCGCCAAGTTCAGCGC-1_2_B4	9.013086415	-26.16397441	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	4539	12499	0.005840467	0.003680294	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCGCCAATCCAGTATG-1_2_B4	1.616292249	28.68266334	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	788	1147	0.006102877	0.014821273	0	oligos	OL-Cntl	NA	NA	NA
GCGCCAATCGGCTTGG-1_2_B4	3.860600536	-9.690515311	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1747	3260	0.008588957	0.00398773	0	12	EN-MIX	NA	NA	NA
GCGCGATCAACCGCCA-1_2_B4	15.88871745	27.89235691	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	801	1200	0.0075	0.001666667	0	oligos	OL-Cntl	NA	NA	NA
GCGCGATCAAGTCTAC-1_2_B4	35.54150615	7.769921926	14	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	837	1079	0.016682113	0.005560704	0	14	Microglia	NA	NA	NA
GCGCGATCAGTGACAG-1_2_B4	2.676766495	28.34131637	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	784	1098	0	0.007285974	0	oligos	OL-Cntl	NA	NA	NA
GCGCGATTCCCATTAT-1_2_B4	12.07550524	33.13135222	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	768	1088	0.008272059	0.000919118	0	oligos	OL-Cntl	NA	NA	NA
GCGCGATTCCCTGACT-1_2_B4	15.53463833	28.08995389	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	787	1141	0.001752848	0.001752848	0	oligos	OL-Cntl	NA	NA	NA
GCGCGATTCGCGGATC-1_2_B4	-17.87153484	13.75238168	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1161	1733	0.000577034	0.004039238	0	8	Astrocytes	NA	NA	NA
GCGCGATTCGGGAGTA-1_2_B4	14.2566042	31.11870392	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	771	1109	0.00541028	0.004508566	0	oligos	OL-Cntl	NA	NA	NA
GCGCGATTCTACTATC-1_2_B4	-7.89017762	-6.532006817	13A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1370	2239	0.033050469	0.00446628	0	13A	IN-VIP	NA	NA	NA
GCGGGTTAGAAACCGC-1_2_B4	2.549033367	-7.698750692	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1357	2463	0.006090134	0.00365408	0	12	EN-MIX	NA	NA	NA
GCGGGTTAGTGTTAGA-1_2_B4	-6.334057622	4.082791237	11	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	7844	28506	0.005507612	0.005332211	0	11	Glia-MIX	NA	NA	NA
GCGGGTTCACCATCCT-1_2_B4	0.586269916	-27.34862397	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	4373	12710	0.000550747	0.003697876	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCGGGTTGTTGAACTC-1_2_B4	14.55638449	-7.776679704	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1821	3399	0.001765225	0.002942042	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCGGGTTTCAATAAGG-1_2_B4	-9.649068168	-19.53873581	6B	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	857	1280	0.04609375	0.003125	0	6B	IN-SST	NA	NA	NA
GCGGGTTTCAGTGTTG-1_2_B4	-2.806802971	23.87901608	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	757	1051	0.002854424	0.006660324	0	oligos	OL-Cntl	NA	NA	NA
GCGGGTTTCGCACTCT-1_2_B4	7.703507229	23.81209889	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	978	1434	0.0013947	0.010460251	0	oligos	OL-Cntl	NA	NA	NA
GCGGGTTTCGCTAGCG-1_2_B4	-24.08087416	23.61675416	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1393	2418	0.00165426	0.003308519	0	8	Astrocytes	NA	NA	NA
GCTCCTAAGAGCTATA-1_2_B4	15.40760075	18.93903051	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	963	1474	0.001356852	0.008141113	0	oligos	OL-Cntl	NA	NA	NA
GCTCCTAAGTTACCCA-1_2_B4	-27.51646617	13.86338973	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	928	1501	0.012658228	0.004663558	0	8	Astrocytes	NA	NA	NA
GCTCCTAGTCAACATC-1_2_B4	7.400099461	-32.90575312	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	4134	12243	0.004002287	0.001633587	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCTCCTAGTGATGTCT-1_2_B4	-5.204916159	-3.62005714	13A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1519	2701	0.016290263	0.001851166	0	13A	IN-VIP	NA	NA	NA
GCTCCTATCGGCGGTT-1_2_B4	0.165859095	-16.32701315	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2323	4795	0.008550574	0.001251303	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCTCCTATCTCTGAGA-1_2_B4	12.39326525	30.24047197	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	681	1035	0	0.007729469	0	oligos	OL-Cntl	NA	NA	NA
GCTCCTATCTCTGCTG-1_2_B4	21.19632545	7.871221592	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1798	3135	0.002551834	0.006379585	0	oligos	OL-Cntl	NA	NA	NA
GCTCTGTAGACCACGA-1_2_B4	20.99398328	16.88965853	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1187	1831	0.001092299	0.003276898	0	oligos	OL-Cntl	NA	NA	NA
GCTCTGTAGGGTCTCC-1_2_B4	18.65589652	8.391126747	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1866	3421	0.002923122	0.005553932	0	oligos	OL-Cntl	NA	NA	NA
GCTCTGTCATCCAACA-1_2_B4	-5.313595188	-8.378326017	13A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	693	1021	0.017629775	0.006856024	0	13A	IN-VIP	NA	NA	NA
GCTCTGTGTTATGCGT-1_2_B4	34.40085409	-3.146531751	2	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2388	4674	0.023962345	0.002139495	0	2	EN-L4	NA	NA	NA
GCTCTGTTCCAAGCCG-1_2_B4	-14.30641722	-25.01486595	6A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1514	2840	0.015140845	0.003873239	0	6A	IN-PV	NA	NA	NA
GCTCTGTTCTCTAAGG-1_2_B4	-13.30857292	-10.83207231	13B	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1801	3553	0.017731495	0.00365888	0	13B	IN-SV2C	NA	NA	NA
GCTGCAGAGGAATGGA-1_2_B4	-26.70237909	9.926641531	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	721	1026	0.000974659	0.002923977	0	8	Astrocytes	NA	NA	NA
GCTGCAGCAAACCTAC-1_2_B4	-0.116825308	-0.875621201	13A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	949	1469	0.015656909	0.004765146	0	13A	IN-VIP	NA	NA	NA
GCTGCAGCAAGGGTCA-1_2_B4	2.053124135	29.99450991	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	785	1136	0.00528169	0.008802817	0	oligos	OL-Cntl	NA	NA	NA
GCTGCAGCACTAGTAC-1_2_B4	19.37706909	19.75436718	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1142	1794	0.005016722	0.003344482	0	oligos	OL-Cntl	NA	NA	NA
GCTGCAGCACTTAAGC-1_2_B4	14.21272081	-1.365185357	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1099	1843	0.007053717	0.002712968	0	12	EN-MIX	NA	NA	NA
GCTGCAGCATAAAGGT-1_2_B4	1.915178191	29.21162227	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	768	1132	0.00795053	0.00795053	0	oligos	OL-Cntl	NA	NA	NA
GCTGCAGCATTTGCTT-1_2_B4	-15.50846341	-11.95927744	6A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2454	5299	0.01283261	0.005472731	0	6A	IN-PV	NA	NA	NA
GCTGCAGTCCCAACGG-1_2_B4	-5.020706152	-2.22352797	13A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1585	2775	0.001081081	0.003603604	0	13A	IN-VIP	NA	NA	NA
GCTGCAGTCTTAACCT-1_2_B4	17.97686047	26.15919444	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	933	1397	0.005010737	0.005726557	0	oligos	OL-Cntl	NA	NA	NA
GCTGCGAAGAGTGAGA-1_2_B4	-1.31287246	25.428647	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	765	1063	0.001881468	0.010348071	0	oligos	OL-Cntl	NA	NA	NA
GCTGCGAAGCGTGAAC-1_2_B4	18.32212307	13.66054331	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1261	2077	0.000481464	0.003370246	0	oligos	OL-Cntl	NA	NA	NA
GCTGCGAAGTCAATAG-1_2_B4	7.066333583	-17.26806862	4	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3791	8779	0.006378859	0.008998747	0	L2-3	EN-L2-3-MS	NA	NA	NA
GCTGCGAGTAAGTTCC-1_2_B4	-0.654345732	27.60694246	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	728	1014	0.003944773	0.009861933	0	oligos	OL-Cntl	NA	NA	NA
GCTGCGATCCTTGCCA-1_2_B4	-3.659839136	-7.85895802	13A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	757	1155	0.070995671	0.001731602	0	13A	IN-VIP	NA	NA	NA
GCTGCGATCGCATGGC-1_2_B4	20.474723	20.23950816	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1067	1776	0.000563063	0.004504505	0	oligos	OL-Cntl	NA	NA	NA
GCTGCTTCAGAGTGTG-1_2_B4	17.64607406	22.47688096	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	870	1293	0.000773395	0.004640371	0	oligos	OL-Cntl	NA	NA	NA
GCTGCTTGTACCGGCT-1_2_B4	11.8480711	25.88226743	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	934	1441	0.002081888	0.003469813	0	oligos	OL-Cntl	NA	NA	NA
GCTGCTTGTTACTGAC-1_2_B4	19.81949766	12.23939636	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1346	2433	0.000411015	0.004521167	0	oligos	OL-Cntl	NA	NA	NA
GCTGCTTTCAGTGCAT-1_2_B4	18.03875316	-9.304120348	3	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2222	4352	0.016773897	0.004595588	0	3	EN-L5-6	NA	NA	NA
GCTGCTTTCATTCACT-1_2_B4	-23.70335707	29.12699334	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1917	3734	0.002678093	0.005356186	0	8	Astrocytes	NA	NA	NA
GCTGCTTTCGGAAACG-1_2_B4	6.874977444	26.88210558	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	913	1305	0.003065134	0.003065134	0	oligos	OL-Cntl	NA	NA	NA
GCTGCTTTCGGAATCT-1_2_B4	15.43707464	-0.849140484	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	722	1121	0.000892061	0.001784121	0	12	EN-MIX	NA	NA	NA
GCTGGGTAGCTAAGAT-1_2_B4	37.2766748	11.95913621	14	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	949	1292	0.004643963	0.026315789	0	14	Microglia	NA	NA	NA
GCTGGGTAGGCCCTCA-1_2_B4	-22.89297822	-0.85845605	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1220	1837	0.001088732	0.005988024	0	9	OPC	NA	NA	NA
GCTGGGTCAGATTGCT-1_2_B4	15.80992798	21.72792752	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	895	1348	0.003709199	0.006676558	0	oligos	OL-Cntl	NA	NA	NA
GCTGGGTGTAGCCTAT-1_2_B4	0.044996018	31.11541916	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	950	1340	0.008955224	0.005970149	0	oligos	OL-Cntl	NA	NA	NA
GCTGGGTGTGCACGAA-1_2_B4	-23.01707356	-2.003708483	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	703	1178	0.005093379	0.001697793	0	9	OPC	NA	NA	NA
GCTGGGTTCAGCACAT-1_2_B4	12.26395689	22.39326906	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	918	1365	0.008058608	0.01025641	0	oligos	OL-Cntl	NA	NA	NA
GCTGGGTTCAGCATGT-1_2_B4	-27.11508611	14.6923898	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1017	1626	0.002460025	0.002460025	0	8	Astrocytes	NA	NA	NA
GCTGGGTTCCTAGTGA-1_2_B4	11.24116883	20.89061566	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	949	1433	0.009071877	0.00837404	0	oligos	OL-Cntl	NA	NA	NA
GCTTCCAAGACGCAAC-1_2_B4	7.429898527	24.00817559	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	943	1377	0.000726216	0.006535948	0	oligos	OL-Cntl	NA	NA	NA
GCTTCCAAGCGATTCT-1_2_B4	21.76317641	11.15856766	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1697	3028	0.003632761	0.006935271	0	oligos	OL-Cntl	NA	NA	NA
GCTTCCAAGTCTCAAC-1_2_B4	11.89540668	29.18749479	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	682	1062	0.016007533	0.00094162	0	oligos	OL-Cntl	NA	NA	NA
GCTTCCACATACTCTT-1_2_B4	7.647802209	-8.272768835	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2156	4319	0.021301227	0.002546886	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCTTCCAGTATAGGTA-1_2_B4	6.870832511	-5.876306667	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1350	2291	0.008293322	0.001745962	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCTTCCAGTCGCGTGT-1_2_B4	15.16942439	21.41283662	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1011	1613	0.001239926	0.007439554	0	oligos	OL-Cntl	NA	NA	NA
GCTTCCAGTGCTCTTC-1_2_B4	22.60163312	19.82152558	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1154	1768	0.003393665	0.005090498	0	oligos	OL-Cntl	NA	NA	NA
GCTTCCATCAACACCA-1_2_B4	-15.75713571	-11.22317377	13B	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2958	7164	0.005164712	0.002233389	0	13B	IN-SV2C	NA	NA	NA
GCTTCCATCGACAGCC-1_2_B4	-34.07491959	-11.93700259	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	795	1136	0.004401408	0.000880282	0	9	OPC	NA	NA	NA
GCTTGAAAGATGGCGT-1_2_B4	2.124785955	28.00656166	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	763	1094	0.003656307	0.008226691	0	oligos	OL-Cntl	NA	NA	NA
GCTTGAAAGCAATATG-1_2_B4	15.50666526	-30.00794565	3	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3664	9527	0.005982996	0.004198593	0	3	EN-L5-6	NA	NA	NA
GCTTGAAAGTAGGCCA-1_2_B4	4.229014694	-11.06052883	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1671	2832	0.014830508	0.007768362	0	12	EN-MIX	NA	NA	NA
GCTTGAACAAGGCTCC-1_2_B4	39.01231739	16.12581239	14	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1453	2105	0.000475059	0.016627078	0	14	Microglia	NA	NA	NA
GCTTGAATCACTCCTG-1_2_B4	-8.174731211	-2.573579807	13A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1817	3083	0.012974376	0.00551411	0	13A	IN-VIP	NA	NA	NA
GCTTGAATCAGTTGAC-1_2_B4	-28.53172389	21.64250446	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1069	1657	0.003621002	0.006035003	0	8	Astrocytes	NA	NA	NA
GCTTGAATCCGCGCAA-1_2_B4	-21.93386217	10.22332181	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1032	1501	0.00266489	0.001998668	0	8	Astrocytes	NA	NA	NA
GCTTGAATCGTGACAT-1_2_B4	14.156608	-32.79114485	3	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3928	10847	0.002765742	0.002120402	0	3	EN-L5-6	NA	NA	NA
GGAAAGCAGCGAAGGG-1_2_B4	-0.0987231	28.49483395	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	837	1183	0.006762468	0.005071851	0	oligos	OL-Cntl	NA	NA	NA
GGAAAGCCAAGGTTTC-1_2_B4	16.99615012	24.06188065	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	989	1464	0.00136612	0.006147541	0	oligos	OL-Cntl	NA	NA	NA
GGAAAGCGTCTAGTCA-1_2_B4	7.29461136	-7.140061774	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1503	2802	0.007137759	0.005710207	0	12	EN-MIX	NA	NA	NA
GGAAAGCTCAAAGTAG-1_2_B4	26.43452923	-1.10036431	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3611	9339	0.001927401	0.002141557	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GGAAAGCTCGGATGGA-1_2_B4	-23.94641571	22.75470771	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1224	1959	0.001531394	0.005104645	0	8	Astrocytes	NA	NA	NA
GGAACTTCAATGAAAC-1_2_B4	24.56806128	-29.52463475	3	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2975	7518	0.002394254	0.001729183	0	3	EN-L5-6	NA	NA	NA
GGAACTTCAGGACCCT-1_2_B4	20.98609608	8.09830648	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1788	3294	0.001214329	0.007589557	0	oligos	OL-Cntl	NA	NA	NA
GGAACTTCAGTATCTG-1_2_B4	4.163297136	-15.04675376	4	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2512	4886	0.004502661	0.005935325	0	L2-3	EN-L2-3-MS	NA	NA	NA
GGAACTTGTGCGATAG-1_2_B4	5.579804345	24.62743922	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	867	1243	0.00160901	0.008849558	0	oligos	OL-Cntl	NA	NA	NA
GGAACTTGTGGGTCAA-1_2_B4	-1.654841573	-17.60608267	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2506	5413	0.005542213	0.001847404	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GGAACTTTCTACTCAT-1_2_B4	9.773710024	23.08739068	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	754	1098	0.007285974	0.008196721	0	oligos	OL-Cntl	NA	NA	NA
GGAATAAAGGTGATAT-1_2_B4	-10.96037635	-21.81258956	6A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	862	1453	0.051617343	0.001376462	0	6A	IN-PV	NA	NA	NA
GGAATAACACTCAGGC-1_2_B4	3.073476516	26.80290989	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	707	1007	0.005958292	0.003972195	0	oligos	OL-Cntl	NA	NA	NA
GGAATAACAGCCTATA-1_2_B4	20.07503629	1.58085692	2	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1500	2625	0.042666667	0.003809524	0	2	EN-L4	NA	NA	NA
GGAATAAGTCGCTTTC-1_2_B4	12.70911399	28.03736426	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	698	1053	0.00379867	0.002849003	0	oligos	OL-Cntl	NA	NA	NA
GGAATAATCGGCCGAT-1_2_B4	9.999162124	21.25366497	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	844	1398	0	0.006437768	0	oligos	OL-Cntl	NA	NA	NA
GGAATAATCTGGCGTG-1_2_B4	9.592107834	23.94298712	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	761	1097	0.001823154	0.005469462	0	oligos	OL-Cntl	NA	NA	NA
GGAATAATCTTTCCTC-1_2_B4	12.51910004	25.28863738	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	722	1096	0	0.004562044	0	oligos	OL-Cntl	NA	NA	NA
GGACAAGAGGATATAC-1_2_B4	8.243459139	24.16601738	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	915	1250	0.004	0.004	0	oligos	OL-Cntl	NA	NA	NA
GGACAAGAGTCACGCC-1_2_B4	-17.21941625	-8.446059578	13B	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3029	6397	0.021103642	0.003751759	0	13B	IN-SV2C	NA	NA	NA
GGACAAGGTCATCGGC-1_2_B4	21.4158742	19.52439646	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1147	1825	0.001643836	0.003835616	0	oligos	OL-Cntl	NA	NA	NA
GGACAAGGTTACGACT-1_2_B4	15.63968541	29.47965106	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	830	1216	0.001644737	0.005756579	0	oligos	OL-Cntl	NA	NA	NA
GGACAAGTCAACGAAA-1_2_B4	17.79632727	20.19690196	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	978	1642	0.004872107	0.004263094	0	oligos	OL-Cntl	NA	NA	NA
GGACAGAAGGTGCTAG-1_2_B4	13.43076028	-2.534001986	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1154	1925	0.004155844	0.003116883	0	12	EN-MIX	NA	NA	NA
GGACAGAGTGTGAAAT-1_2_B4	22.16070214	20.23941299	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1110	1696	0.001179245	0.004127358	0	oligos	OL-Cntl	NA	NA	NA
GGACAGAGTTCCAACA-1_2_B4	-34.20124656	-6.57552429	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1191	1828	0.001641138	0.002188184	0	9	OPC	NA	NA	NA
GGACAGATCAAGCCTA-1_2_B4	2.544637804	-16.33777947	4	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2413	4736	0.009923986	0.00464527	0	L2-3	EN-L2-3-MS	NA	NA	NA
GGACATTAGCTGTCTA-1_2_B4	3.994444461	-26.56309633	3	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2927	6200	0.011290323	0.00483871	0	3	EN-L5-6	NA	NA	NA
GGACATTAGGATTCGG-1_2_B4	12.98216982	21.32676002	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	840	1245	0.001606426	0.007228916	0	oligos	OL-Cntl	NA	NA	NA
GGACATTAGTAACCCT-1_2_B4	-11.46905967	-19.241289	6B	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	973	1568	0.024872449	0.004464286	0	6B	IN-SST	NA	NA	NA
GGACATTAGTTAGGTA-1_2_B4	-23.09094846	18.68079084	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1253	2074	0.00048216	0.004821601	0	8	Astrocytes	NA	NA	NA
GGACATTCATGTCCTC-1_2_B4	-19.53084826	7.973065947	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	873	1208	0.004139073	0.005794702	0	8	Astrocytes	NA	NA	NA
GGACATTTCACGGTTA-1_2_B4	15.76692905	24.08625173	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	807	1194	0.000837521	0.006700168	0	oligos	OL-Cntl	NA	NA	NA
GGACGTCAGATGTGTA-1_2_B4	1.794846354	30.21110921	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	774	1066	0.005628518	0.015009381	0	oligos	OL-Cntl	NA	NA	NA
GGACGTCAGTCGAGTG-1_2_B4	17.81240576	20.35588205	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	953	1506	0.002656042	0.008632138	0	oligos	OL-Cntl	NA	NA	NA
GGACGTCAGTGAATTG-1_2_B4	3.631847887	4.944041672	7	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1258	1669	0.008987418	0.02576393	0	7	Phagocytes	NA	NA	NA
GGACGTCCACAAGTAA-1_2_B4	-23.26578063	18.16884841	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1270	2172	0.033149171	0.006445672	0	8	Astrocytes	NA	NA	NA
GGACGTCCAGCTCGAC-1_2_B4	15.22991973	26.22378228	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	752	1169	0.002566296	0.001710864	0	oligos	OL-Cntl	NA	NA	NA
GGACGTCGTATATGAG-1_2_B4	17.67558467	-3.613212191	3	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1300	2133	0.030004688	0.004219409	0	3	EN-L5-6	NA	NA	NA
GGACGTCGTATTCGTG-1_2_B4	-31.74911806	11.91503053	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	816	1187	0.0042123	0.0042123	0	8	Astrocytes	NA	NA	NA
GGACGTCGTCGACTGC-1_2_B4	3.450029165	27.11059263	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	711	1021	0.007835455	0.011753183	0	oligos	OL-Cntl	NA	NA	NA
GGACGTCTCTGCGACG-1_2_B4	13.49129266	-27.29077548	3	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2431	4465	0.007166853	0.006494961	0	3	EN-L5-6	NA	NA	NA
GGAGCAAAGAGGGATA-1_2_B4	13.75941818	26.29129339	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	850	1304	0.003067485	0.003834356	0	oligos	OL-Cntl	NA	NA	NA
GGAGCAAAGTGGGCTA-1_2_B4	-22.22604386	10.66692136	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	964	1451	0.00275672	0.008959338	0	8	Astrocytes	NA	NA	NA
GGAGCAACATTACCTT-1_2_B4	-19.58100695	-28.75321191	6A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3509	9521	0.001890558	0.002730806	0	6A	IN-PV	NA	NA	NA
GGAGCAAGTACGCACC-1_2_B4	-7.70866024	-2.418748724	13A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1844	3162	0.009487666	0.003162555	0	13A	IN-VIP	NA	NA	NA
GGAGCAATCGTCGTTC-1_2_B4	2.460163199	21.26984557	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	819	1174	0.003407155	0.009369676	0	oligos	OL-Cntl	NA	NA	NA
GGAGCAATCTTGAGAC-1_2_B4	1.827695067	28.79582665	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	781	1103	0.002719855	0.00543971	0	oligos	OL-Cntl	NA	NA	NA
GGATGTTAGAGACGAA-1_2_B4	-18.39733128	-23.74778674	6A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1988	3369	0.001780944	0.00296824	0	6A	IN-PV	NA	NA	NA
GGATGTTAGCCGTCGT-1_2_B4	1.151214123	-19.27616685	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3092	6925	0.004909747	0.004187726	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GGATGTTAGTGGGTTG-1_2_B4	12.14943638	24.79058078	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	744	1084	0.006457565	0.009225092	0	oligos	OL-Cntl	NA	NA	NA
GGATGTTGTCGAGATG-1_2_B4	-0.811389792	24.14934093	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	745	1079	0.005560704	0.00463392	0	oligos	OL-Cntl	NA	NA	NA
GGATGTTGTTATCCGA-1_2_B4	-22.18097869	10.14548457	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	839	1268	0.002365931	0.006309148	0	8	Astrocytes	NA	NA	NA
GGATGTTTCAATAAGG-1_2_B4	-28.8402205	20.731546	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1003	1622	0.00431566	0.008631319	0	8	Astrocytes	NA	NA	NA
GGATGTTTCATCGGAT-1_2_B4	-14.44011407	-21.32365894	6A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1504	2890	0.028027682	0.001384083	0	6A	IN-PV	NA	NA	NA
GGATGTTTCTCTGCTG-1_2_B4	12.53909792	25.02763337	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	867	1414	0.002828854	0.004950495	0	oligos	OL-Cntl	NA	NA	NA
GGATTACAGCCAGGAT-1_2_B4	-13.800629	-10.58519082	13B	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1892	3425	0.009635036	0.00350365	0	13B	IN-SV2C	NA	NA	NA
GGATTACAGCCGCCTA-1_2_B4	30.22771189	-0.384374026	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3555	9064	0.017210944	0.002096205	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GGATTACAGCTAGTTC-1_2_B4	14.17894232	26.10419285	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	806	1224	0.00245098	0.005718954	0	oligos	OL-Cntl	NA	NA	NA
GGATTACAGGAACTGC-1_2_B4	12.48536184	31.24299368	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	706	1050	0	0.002857143	0	oligos	OL-Cntl	NA	NA	NA
GGATTACAGTGTCCAT-1_2_B4	28.52521671	0.765592902	2	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2441	5067	0.000592066	0.004933886	0	2	EN-L4	NA	NA	NA
GGATTACTCAAACCGT-1_2_B4	-0.850838264	26.40420404	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	790	1182	0.005922166	0.00676819	0	oligos	OL-Cntl	NA	NA	NA
GGATTACTCACGCATA-1_2_B4	-22.97504661	24.92815386	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1602	2895	0.002072539	0.00552677	0	8	Astrocytes	NA	NA	NA
GGATTACTCTAACTCT-1_2_B4	16.48951609	24.05200218	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	834	1274	0.000784929	0.005494505	0	oligos	OL-Cntl	NA	NA	NA
GGATTACTCTCGTTTA-1_2_B4	-1.6580221	-15.80794307	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2263	4862	0.001439737	0.002879473	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GGCAATTAGCGTTCCG-1_2_B4	0.785754881	22.0919127	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	786	1097	0.006381039	0.010938924	0	oligos	OL-Cntl	NA	NA	NA
GGCAATTCACCTATCC-1_2_B4	20.07180531	19.0079018	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1104	1782	0.003928171	0.008417508	0	oligos	OL-Cntl	NA	NA	NA
GGCAATTCACTGAAGG-1_2_B4	11.49977331	-8.534329004	2	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2485	5226	0.002678913	0.002870264	0	2	EN-L4	NA	NA	NA
GGCAATTGTAGATTAG-1_2_B4	14.87106766	25.86264947	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	774	1091	0	0.002749771	0	oligos	OL-Cntl	NA	NA	NA
GGCAATTGTTATCGGT-1_2_B4	-23.46979978	22.70051645	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1372	2507	0.000797766	0.003191065	0	8	Astrocytes	NA	NA	NA
GGCAATTTCGGTCTAA-1_2_B4	35.75616564	15.61264326	14	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1177	1689	0.003552398	0.034339846	0	14	Microglia	NA	NA	NA
GGCCGATAGTCATGCT-1_2_B4	13.59150184	-32.60848887	3	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3514	9828	0.001729752	0.001933252	0	3	EN-L5-6	NA	NA	NA
GGCCGATCAAGCGCTC-1_2_B4	19.3166581	6.332577377	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2853	5992	0.005340454	0.003671562	0	oligos	OL-Cntl	NA	NA	NA
GGCCGATGTAAGTGGC-1_2_B4	0.915129638	-10.45701326	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1599	2795	0.004293381	0.003935599	0	12	EN-MIX	NA	NA	NA
GGCCGATGTCAACATC-1_2_B4	19.04649926	-6.626434246	3	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1918	4108	0.02775073	0.001217137	0	3	EN-L5-6	NA	NA	NA
GGCCGATTCCACGTTC-1_2_B4	-23.03525008	25.30366529	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1672	2998	0.003669113	0.005003336	0	8	Astrocytes	NA	NA	NA
GGCGACTAGACCTTTG-1_2_B4	11.26880521	24.82572863	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	758	1166	0.008576329	0.000857633	0	oligos	OL-Cntl	NA	NA	NA
GGCGACTAGCATGGCA-1_2_B4	28.54545046	0.643357059	2	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2726	5776	0.001731302	0.003289474	0	2	EN-L4	NA	NA	NA
GGCGACTCAACTGCTA-1_2_B4	20.02390557	-29.28083657	3	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	5259	16614	0.0030697	0.012338991	0	3	EN-L5-6	NA	NA	NA
GGCGACTCACCGAAAG-1_2_B4	-7.394294654	-13.75621358	6B	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	898	1276	0.012539185	0.003918495	0	6B	IN-SST	NA	NA	NA
GGCGACTGTACTCTCC-1_2_B4	-15.72303894	-24.5430211	6A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1740	3155	0.013946117	0.003169572	0	6A	IN-PV	NA	NA	NA
GGCGACTGTCCAACTA-1_2_B4	0.30093829	28.44533592	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	911	1260	0.006349206	0.003968254	0	oligos	OL-Cntl	NA	NA	NA
GGCGACTTCACCAGGC-1_2_B4	-11.25751562	-0.049050211	13A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2310	3989	0.009776886	0.007771371	0	13A	IN-VIP	NA	NA	NA
GGCGTGTCAAAGGAAG-1_2_B4	0.659192917	28.16078869	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	917	1281	0	0.010928962	0	oligos	OL-Cntl	NA	NA	NA
GGCGTGTCAACTGCGC-1_2_B4	36.95564301	12.83539434	14	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	991	1293	0.010827533	0.008507347	0	14	Microglia	NA	NA	NA
GGCGTGTGTATCAGTC-1_2_B4	9.177284616	-7.677560917	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1985	3727	0.003756372	0.001609874	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GGCGTGTGTTCGGCAC-1_2_B4	4.173460125	-3.849692041	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	973	1449	0.024154589	0.002760524	0	12	EN-MIX	NA	NA	NA
GGCGTGTTCCACGTGG-1_2_B4	4.391410552	-18.48879864	4	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3181	6900	0.005507246	0.006376812	0	L2-3	EN-L2-3-MS	NA	NA	NA
GGCTCGAAGAACAACT-1_2_B4	20.50775163	11.42958729	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1507	2546	0.001963865	0.003142184	0	oligos	OL-Cntl	NA	NA	NA
GGCTCGAAGCGCTCCA-1_2_B4	15.60107943	29.96343801	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	857	1191	0.009235936	0.003358522	0	oligos	OL-Cntl	NA	NA	NA
GGCTCGACACCATCCT-1_2_B4	12.35287032	28.14711233	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	752	1047	0.00286533	0.008595989	0	oligos	OL-Cntl	NA	NA	NA
GGCTCGAGTCTAACGT-1_2_B4	8.09886881	-7.842859164	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1958	3811	0.003673576	0.002623983	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GGCTCGAGTTACGCGC-1_2_B4	23.0294983	18.62663847	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1102	1662	0.009025271	0.003610108	0	oligos	OL-Cntl	NA	NA	NA
GGCTCGATCAACGAAA-1_2_B4	22.83973246	-26.7081027	3	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3883	9684	0.000516316	0.006712102	0	3	EN-L5-6	NA	NA	NA
GGCTCGATCACATGCA-1_2_B4	19.10844543	16.20026648	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1280	1996	0.003006012	0.00751503	0	oligos	OL-Cntl	NA	NA	NA
GGCTCGATCACGAAGG-1_2_B4	-14.96118377	-1.060950061	13A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2434	4191	0.016463851	0.028871391	0	13A	IN-VIP	NA	NA	NA
GGCTCGATCCTGCTTG-1_2_B4	-20.88545507	9.353772879	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	855	1187	0.0084246	0.00252738	0	8	Astrocytes	NA	NA	NA
GGCTCGATCTTCATGT-1_2_B4	21.26819797	10.50579104	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1533	2585	0.001934236	0.00696325	0	oligos	OL-Cntl	NA	NA	NA
GGCTGGTAGTCCGTAT-1_2_B4	-16.832364	12.07061887	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1229	1697	0.009428403	0.012374779	0	8	Astrocytes	NA	NA	NA
GGCTGGTGTAGCGCTC-1_2_B4	3.589117281	-15.73811579	4	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2730	5504	0.006177326	0.003633721	0	L2-3	EN-L2-3-MS	NA	NA	NA
GGCTGGTTCAGTACGT-1_2_B4	20.90763681	18.40309335	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1048	1597	0.023168441	0.00313087	0	oligos	OL-Cntl	NA	NA	NA
GGCTGGTTCGGAATCT-1_2_B4	21.4800378	-8.326410467	3	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1475	2544	0.001179245	0.003144654	0	3	EN-L5-6	NA	NA	NA
GGCTGGTTCTGGTGTA-1_2_B4	15.56348485	-2.516534621	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1094	1919	0.015112038	0.001563314	0	12	EN-MIX	NA	NA	NA
GGGAATGCACAGTCGC-1_2_B4	7.131072812	27.17747395	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	857	1244	0.001607717	0.007234727	0	oligos	OL-Cntl	NA	NA	NA
GGGAATGCAGACTCGC-1_2_B4	14.04721754	22.41831103	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	900	1329	0.006772009	0.007524454	0	oligos	OL-Cntl	NA	NA	NA
GGGAATGCATTTGCTT-1_2_B4	3.140457045	-25.98017437	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2659	5770	0.002426343	0.002946274	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GGGAATGGTATGAAAC-1_2_B4	10.47317418	23.01794696	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	800	1128	0.002659574	0.005319149	0	oligos	OL-Cntl	NA	NA	NA
GGGAATGGTCTAAAGA-1_2_B4	3.942367382	24.39120945	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	798	1084	0.002767528	0.016605166	0	oligos	OL-Cntl	NA	NA	NA
GGGAATGGTTAAGAAC-1_2_B4	-0.317188489	26.16914799	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	673	1002	0	0.00499002	0	oligos	OL-Cntl	NA	NA	NA
GGGAATGTCCGCGGTA-1_2_B4	20.81764195	20.15306107	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1087	1662	0.005415162	0.002406739	0	oligos	OL-Cntl	NA	NA	NA
GGGACCTAGAGGTTGC-1_2_B4	18.3362109	0.285504418	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1370	2415	0.00621118	0.001656315	0	12	EN-MIX	NA	NA	NA
GGGACCTAGCGATGAC-1_2_B4	39.20214694	16.2520629	14	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1726	2545	0	0.017288802	0	14	Microglia	NA	NA	NA
GGGACCTAGGTCGGAT-1_2_B4	2.443891964	-8.014310126	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1331	2196	0.007741348	0.00273224	0	12	EN-MIX	NA	NA	NA
GGGACCTAGTATCGAA-1_2_B4	4.819100045	25.21310893	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	785	1162	0.029259897	0.005163511	0	oligos	OL-Cntl	NA	NA	NA
GGGACCTAGTCACGCC-1_2_B4	22.61680223	12.35472412	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1497	2456	0.003664495	0.005700326	0	oligos	OL-Cntl	NA	NA	NA
GGGACCTCACTCAGGC-1_2_B4	11.169814	-8.921806938	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2831	6276	0.002071383	0.002071383	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GGGACCTCAGCCTTGG-1_2_B4	-20.9843964	7.538707088	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	860	1261	0.006344171	0.009516257	0	8	Astrocytes	NA	NA	NA
GGGACCTGTAGCAAAT-1_2_B4	6.30791851	23.99743761	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	904	1248	0.008012821	0.009615385	0	oligos	OL-Cntl	NA	NA	NA
GGGACCTGTAGTACCT-1_2_B4	-15.46908055	-19.85344408	6B	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1590	2781	0.012585401	0.004674577	0	6B	IN-SST	NA	NA	NA
GGGACCTTCATAACCG-1_2_B4	16.76664959	24.11023027	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	915	1366	0.000732064	0.005856515	0	oligos	OL-Cntl	NA	NA	NA
GGGAGATAGAGTCTGG-1_2_B4	-21.76700742	9.64190212	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	803	1132	0.007067138	0.001766784	0	8	Astrocytes	NA	NA	NA
GGGAGATAGGCCGAAT-1_2_B4	3.18908038	-10.65978803	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1563	2601	0.016532103	0.008458285	0	12	EN-MIX	NA	NA	NA
GGGAGATGTGACGGTA-1_2_B4	-8.875705681	-18.39849196	6B	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	764	1201	0.052456286	0.005828476	0	6B	IN-SST	NA	NA	NA
GGGAGATGTTTAAGCC-1_2_B4	11.40651193	25.54380383	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	788	1141	0.003505697	0.002629273	0	oligos	OL-Cntl	NA	NA	NA
GGGATGAAGCCACCTG-1_2_B4	-35.09624952	-8.025569599	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1140	1747	0.008013738	0.011448197	0	9	OPC	NA	NA	NA
GGGATGAAGTTATCGC-1_2_B4	30.59571222	-4.22654092	2	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3863	9523	0.016066366	0.003150268	0	2	EN-L4	NA	NA	NA
GGGATGACAAACCTAC-1_2_B4	3.420313534	-2.72851237	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	809	1288	0.002329193	0.005434783	0	12	EN-MIX	NA	NA	NA
GGGATGACATTTCAGG-1_2_B4	4.201073409	24.98481707	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	850	1227	0.003259984	0.004889976	0	oligos	OL-Cntl	NA	NA	NA
GGGATGAGTCAAACTC-1_2_B4	17.25726407	14.82154075	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1086	1766	0.004530011	0.004530011	0	oligos	OL-Cntl	NA	NA	NA
GGGCACTAGCTCCCAG-1_2_B4	20.96880459	-0.774251294	2	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1911	4026	0.002235469	0.002483855	0	2	EN-L4	NA	NA	NA
GGGCACTAGTCTCCTC-1_2_B4	21.85424961	19.52012455	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	985	1468	0.002043597	0.00613079	0	oligos	OL-Cntl	NA	NA	NA
GGGCACTCATGGTAGG-1_2_B4	21.53400198	-8.325879704	3	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1733	3214	0.003422526	0.003422526	0	3	EN-L5-6	NA	NA	NA
GGGCACTTCATTATCC-1_2_B4	22.95389405	-9.096890846	3	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2955	7144	0.002519597	0.001959686	0	3	EN-L5-6	NA	NA	NA
GGGCACTTCCATGAAC-1_2_B4	16.12277514	27.73636495	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	821	1184	0.007601351	0.007601351	0	oligos	OL-Cntl	NA	NA	NA
GGGCACTTCGCCCTTA-1_2_B4	-15.49860203	-9.76105876	13B	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2162	4142	0.020280058	0.002897151	0	13B	IN-SV2C	NA	NA	NA
GGGCACTTCGCTGATA-1_2_B4	6.134139137	28.01225004	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	885	1305	0.009195402	0.003065134	0	oligos	OL-Cntl	NA	NA	NA
GGGCATCAGCTGCGAA-1_2_B4	-6.262784992	-3.197849414	13A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1593	2681	0.011189855	0.004102947	0	13A	IN-VIP	NA	NA	NA
GGGCATCCACCGAAAG-1_2_B4	0.002743854	-27.20110765	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	4124	10812	0.001849797	0.003329634	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GGGCATCGTAGCGCAA-1_2_B4	13.4646426	27.29778717	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	770	1113	0.007187781	0.008984726	0	oligos	OL-Cntl	NA	NA	NA
GGGCATCGTCAACTGT-1_2_B4	13.05003937	1.879917428	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	946	1401	0.010706638	0.002855103	0	12	EN-MIX	NA	NA	NA
GGGCATCGTCACAAGG-1_2_B4	11.1178989	24.14832562	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	883	1315	0.005323194	0.007604563	0	oligos	OL-Cntl	NA	NA	NA
GGGCATCGTTGACGTT-1_2_B4	19.87582138	19.34418387	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	989	1496	0.001336898	0.005347594	0	oligos	OL-Cntl	NA	NA	NA
GGGCATCTCCCTAATT-1_2_B4	22.16917056	9.989421997	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1826	3241	0.007405122	0.004319654	0	oligos	OL-Cntl	NA	NA	NA
GGGCATCTCCTGTAGA-1_2_B4	-11.45432231	-22.19950633	6A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1015	1657	0.046469523	0.001810501	0	6A	IN-PV	NA	NA	NA
GGGTCTGAGTAATCCC-1_2_B4	2.992841693	29.25690612	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	756	1077	0.002785515	0.004642526	0	oligos	OL-Cntl	NA	NA	NA
GGGTCTGCAGTCCTTC-1_2_B4	2.913121302	-15.08030298	4	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2365	4796	0.00646372	0.006255213	0	L2-3	EN-L2-3-MS	NA	NA	NA
GGGTCTGCATTCGACA-1_2_B4	12.38137546	20.70598693	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	969	1495	0.003344482	0.014715719	0	oligos	OL-Cntl	NA	NA	NA
GGGTCTGGTGCTTCTC-1_2_B4	0.80032624	-27.41661229	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3852	10848	0.004424779	0.002212389	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GGGTTGCCACAAGCCC-1_2_B4	2.233579824	-6.987806346	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1176	2053	0.012664394	0.001948368	0	12	EN-MIX	NA	NA	NA
GGGTTGCGTACTCAAC-1_2_B4	3.264599416	-2.908077893	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	758	1112	0.017086331	0.003597122	0	12	EN-MIX	NA	NA	NA
GGGTTGCGTGGTCTCG-1_2_B4	-23.54183803	22.61669358	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1253	2002	0.002497502	0.009490509	0	8	Astrocytes	NA	NA	NA
GGGTTGCTCATCTGCC-1_2_B4	13.59766751	28.39249993	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	775	1141	0.008764242	0.008764242	0	oligos	OL-Cntl	NA	NA	NA
GGTATTGAGACAATAC-1_2_B4	30.67009268	-5.015931141	2	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3358	7481	0.011763133	0.004411175	0	2	EN-L4	NA	NA	NA
GGTATTGCACGAAATA-1_2_B4	21.27685123	7.643601106	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1822	3482	0.00229753	0.003446295	0	oligos	OL-Cntl	NA	NA	NA
GGTATTGGTATATGGA-1_2_B4	35.92401496	13.42674236	14	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	988	1340	0.01119403	0.023880597	0	14	Microglia	NA	NA	NA
GGTATTGGTTTCCACC-1_2_B4	15.93622311	28.01055055	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	741	1075	0.001860465	0	0	oligos	OL-Cntl	NA	NA	NA
GGTATTGTCCGTCATC-1_2_B4	0.951036969	-25.33142688	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3425	8819	0.00442227	0.003174963	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GGTGAAGAGAAGGCCT-1_2_B4	24.08483488	-6.170331803	2	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3112	7022	0.000284819	0.002563372	0	2	EN-L4	NA	NA	NA
GGTGAAGAGCACCGTC-1_2_B4	8.313288291	-32.08982227	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3216	7766	0.008241051	0.002832861	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GGTGAAGCAGATCGGA-1_2_B4	-23.88444822	21.92485396	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1160	1766	0.00396376	0.005662514	0	8	Astrocytes	NA	NA	NA
GGTGAAGGTTCGCGAC-1_2_B4	6.23184562	24.83002706	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	828	1160	0.002586207	0.004310345	0	oligos	OL-Cntl	NA	NA	NA
GGTGCGTAGCATCATC-1_2_B4	1.569004654	-28.83319886	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	4439	12209	0.00253911	0.003521992	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GGTGCGTGTTCAGTAC-1_2_B4	-26.61810809	11.00821523	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	795	1169	0.014542344	0.001710864	0	8	Astrocytes	NA	NA	NA
GGTGCGTTCAACACCA-1_2_B4	15.877725	-28.41805213	3	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	5127	15208	0.008745397	0.006378222	0	3	EN-L5-6	NA	NA	NA
GGTGCGTTCACATGCA-1_2_B4	-11.43198532	16.43807831	11	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1567	2627	0.002664636	0.007232585	0	11	Glia-MIX	NA	NA	NA
GGTGCGTTCTACGAGT-1_2_B4	14.89181465	28.20284594	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	779	1128	0.002659574	0.007092199	0	oligos	OL-Cntl	NA	NA	NA
GGTGTTAAGGGAAACA-1_2_B4	31.15391098	-3.453089059	2	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3269	7234	0.012579486	0.003594139	0	2	EN-L4	NA	NA	NA
GGTGTTACAGATTGCT-1_2_B4	10.99357534	22.38695528	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	880	1277	0.014095536	0.01018011	0	oligos	OL-Cntl	NA	NA	NA
GGTGTTACATCCGTGG-1_2_B4	16.59252773	29.36625213	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	846	1203	0.006650042	0.003325021	0	oligos	OL-Cntl	NA	NA	NA
GGTGTTATCAGGCCCA-1_2_B4	3.067055274	-6.49904805	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1201	2158	0.001853568	0.003243744	0	12	EN-MIX	NA	NA	NA
GTAACGTCATCGTCGG-1_2_B4	-1.441843656	-16.04971337	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2266	4869	0.016019717	0.003286096	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GTAACGTCATTGTGCA-1_2_B4	-35.7894448	-6.701889228	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1105	1867	0.001071237	0.005356186	0	9	OPC	NA	NA	NA
GTAACTGAGCTCAACT-1_2_B4	17.6598004	22.08570184	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	789	1247	0.001603849	0.008821171	0	oligos	OL-Cntl	NA	NA	NA
GTAACTGCAAAGGCGT-1_2_B4	5.569308287	-2.041335696	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	838	1146	0.007853403	0.001745201	0	12	EN-MIX	NA	NA	NA
GTAACTGCAGGAACGT-1_2_B4	32.92699908	-4.749040303	2	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3191	6869	0.006842335	0.006114427	0	2	EN-L4	NA	NA	NA
GTAACTGGTCCAAGTT-1_2_B4	11.01446163	25.25715384	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	769	1122	0.007130125	0.004456328	0	oligos	OL-Cntl	NA	NA	NA
GTAACTGGTCGCTTCT-1_2_B4	16.21552095	-32.45222831	3	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	5639	21766	0.006799596	0.002480934	0	3	EN-L5-6	NA	NA	NA
GTAACTGGTCTGATCA-1_2_B4	12.25452441	24.66253408	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	809	1260	0.003968254	0.003174603	0	oligos	OL-Cntl	NA	NA	NA
GTAACTGGTGACGCCT-1_2_B4	15.91645207	-1.062681081	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	724	1165	0.000858369	0.001716738	0	12	EN-MIX	NA	NA	NA
GTAACTGTCAACCATG-1_2_B4	-9.493317863	13.50414425	11	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1092	1550	0.003225806	0.00516129	0	11	Glia-MIX	NA	NA	NA
GTACGTAAGCCACCTG-1_2_B4	-11.13580719	-20.49913908	6B	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	931	1369	0.002191381	0.003652301	0	6B	IN-SST	NA	NA	NA
GTACGTACAAGCCCAC-1_2_B4	39.91790285	13.0431426	14	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	951	1387	0.000720981	0.003604903	0	14	Microglia	NA	NA	NA
GTACGTACATCTCGCT-1_2_B4	-19.77551289	-28.08955675	6A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3444	9201	0.016954679	0.002499728	0	6A	IN-PV	NA	NA	NA
GTACGTAGTACGCACC-1_2_B4	14.07560089	-32.04790354	3	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3237	7832	0.003702758	0.003702758	0	3	EN-L5-6	NA	NA	NA
GTACGTAGTGCACGAA-1_2_B4	4.171108499	-14.77466544	4	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2437	4845	0.01878225	0.004540764	0	L2-3	EN-L2-3-MS	NA	NA	NA
GTACGTAGTGCAGTAG-1_2_B4	24.5154897	-25.88483308	3	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2369	4684	0.004056362	0.002561913	0	3	EN-L5-6	NA	NA	NA
GTACGTATCTGCAAGT-1_2_B4	19.52299965	1.438460393	2	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1340	2183	0.016491067	0.002748511	0	2	EN-L4	NA	NA	NA
GTACTCCCACACGCTG-1_2_B4	16.8512238	23.38535518	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1003	1524	0.00656168	0.002624672	0	oligos	OL-Cntl	NA	NA	NA
GTACTCCCAGGGAGAG-1_2_B4	5.410151515	-2.51294113	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	852	1156	0.014705882	0.006920415	0	12	EN-MIX	NA	NA	NA
GTACTCCCAGTGACAG-1_2_B4	4.333486916	-2.366633735	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	726	1070	0.008411215	0.003738318	0	12	EN-MIX	NA	NA	NA
GTACTCCGTAAGTTCC-1_2_B4	3.844744825	30.21080567	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	738	1061	0.004712535	0.007540057	0	oligos	OL-Cntl	NA	NA	NA
GTACTCCTCATTATCC-1_2_B4	22.66932048	18.95961861	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	995	1500	0.003333333	0.010666667	0	oligos	OL-Cntl	NA	NA	NA
GTACTTTCATCGATTG-1_2_B4	-4.684447535	-2.018036149	13A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1264	2034	0.005408063	0.002949853	0	13A	IN-VIP	NA	NA	NA
GTACTTTTCTGTCCGT-1_2_B4	19.98786162	15.31334185	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1059	1711	0.001753361	0.001753361	0	oligos	OL-Cntl	NA	NA	NA
GTAGGCCAGTACGATA-1_2_B4	15.53730931	14.36184007	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1177	1760	0.011931818	0.014772727	0	oligos	OL-Cntl	NA	NA	NA
GTAGGCCCAAGCTGAG-1_2_B4	19.19542677	22.30416278	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1053	1612	0.008064516	0.004342432	0	oligos	OL-Cntl	NA	NA	NA
GTAGGCCCATAAGACA-1_2_B4	-8.619340315	-18.23339498	6B	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	697	1034	0.042553191	0.000967118	0	6B	IN-SST	NA	NA	NA
GTAGGCCGTACGCTGC-1_2_B4	17.21040489	7.087887528	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1810	3095	0.003231018	0.01098546	0	oligos	OL-Cntl	NA	NA	NA
GTAGGCCGTTACTGAC-1_2_B4	14.84439527	1.716723043	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	883	1254	0.019936204	0.003987241	0	12	EN-MIX	NA	NA	NA
GTAGGCCTCTAGCACA-1_2_B4	14.03261351	26.67460321	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	717	1101	0.005449591	0.010899183	0	oligos	OL-Cntl	NA	NA	NA
GTAGGCCTCTTCGGTC-1_2_B4	18.25045646	8.306782918	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1850	3555	0.007313643	0.007876231	0	oligos	OL-Cntl	NA	NA	NA
GTAGTCATCAGGCGAA-1_2_B4	-11.64214675	13.33079988	11	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	967	1330	0.007518797	0.002255639	0	11	Glia-MIX	NA	NA	NA
GTATCTTCAATGTTGC-1_2_B4	16.0499332	24.17351341	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	900	1355	0.005904059	0.003690037	0	oligos	OL-Cntl	NA	NA	NA
GTATCTTTCATTATCC-1_2_B4	1.999762192	-5.011578882	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	922	1540	0.032467532	0.002597403	0	12	EN-MIX	NA	NA	NA
GTATTCTCATAGACTC-1_2_B4	-27.96445668	21.54211702	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1107	1750	0.008	0.006285714	0	8	Astrocytes	NA	NA	NA
GTATTCTCATCGGACC-1_2_B4	25.5717582	-3.288399915	2	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3284	8934	0.006492053	0.001678979	0	2	EN-L4	NA	NA	NA
GTATTCTGTTAGATGA-1_2_B4	4.674063795	-5.18270024	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	842	1345	0.014869888	0.000743494	0	12	EN-MIX	NA	NA	NA
GTCAAGTAGTGAAGTT-1_2_B4	-35.23107516	5.041866497	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2582	5255	0.006279734	0.003805899	0	9	OPC	NA	NA	NA
GTCAAGTCACAGTCGC-1_2_B4	12.70313503	29.80278797	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	838	1243	0.009654063	0.004827031	0	oligos	OL-Cntl	NA	NA	NA
GTCAAGTCACCTATCC-1_2_B4	7.417786255	20.84852172	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	992	1485	0.002693603	0.009427609	0	oligos	OL-Cntl	NA	NA	NA
GTCAAGTCAGACGCCT-1_2_B4	15.44633567	-2.40138833	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1032	1792	0.001674107	0.001674107	0	12	EN-MIX	NA	NA	NA
GTCAAGTGTAGCACGA-1_2_B4	7.656522866	23.94158276	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1109	1681	0.019631172	0.005353956	0	oligos	OL-Cntl	NA	NA	NA
GTCAAGTGTGGTAACG-1_2_B4	-36.02356588	-3.341129191	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1364	2233	0.001791312	0.001791312	0	9	OPC	NA	NA	NA
GTCAAGTTCAAGGTAA-1_2_B4	-17.47020539	-7.647250726	13B	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2945	6007	0.02313967	0.006325953	0	13B	IN-SV2C	NA	NA	NA
GTCAAGTTCGTTTAGG-1_2_B4	4.651569057	26.95377442	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	754	1082	0.000924214	0.010166359	0	oligos	OL-Cntl	NA	NA	NA
GTCACAACAAGCGTAG-1_2_B4	22.19938593	10.14478053	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1632	2622	0.0064836	0.007627765	0	oligos	OL-Cntl	NA	NA	NA
GTCACAACATGGTAGG-1_2_B4	21.67593492	10.23221519	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1612	2659	0.005641219	0.005641219	0	oligos	OL-Cntl	NA	NA	NA
GTCACAAGTTGGTTTG-1_2_B4	-36.19620495	-7.253348737	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1141	1838	0.003264418	0.004352557	0	9	OPC	NA	NA	NA
GTCACAAGTTTAGGAA-1_2_B4	3.541999943	-4.508038992	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	823	1267	0.016574586	0.002367798	0	12	EN-MIX	NA	NA	NA
GTCACAATCATCGATG-1_2_B4	19.60977492	12.25544655	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1381	2346	0.005541347	0.002131287	0	oligos	OL-Cntl	NA	NA	NA
GTCACAATCCGAACGC-1_2_B4	-19.27442269	-28.82655646	6A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3079	7411	0.004722709	0.003238429	0	6A	IN-PV	NA	NA	NA
GTCACAATCGTATCAG-1_2_B4	18.90404055	6.605690901	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2180	4357	0.004360799	0.007114987	0	oligos	OL-Cntl	NA	NA	NA
GTCACGGAGCTACCGC-1_2_B4	3.792262719	-4.96763341	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	946	1491	0.008718981	0.001341382	0	12	EN-MIX	NA	NA	NA
GTCACGGAGTTAGGTA-1_2_B4	1.69022437	29.57435871	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	796	1159	0.005176877	0.003451251	0	oligos	OL-Cntl	NA	NA	NA
GTCACGGGTCATGCAT-1_2_B4	15.25287969	29.29663976	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	836	1219	0.001640689	0.001640689	0	oligos	OL-Cntl	NA	NA	NA
GTCACGGTCCTCGCAT-1_2_B4	4.222967353	24.97192929	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	822	1220	0.005737705	0.009016393	0	oligos	OL-Cntl	NA	NA	NA
GTCATTTAGAGCAATT-1_2_B4	19.87391226	19.50538686	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1004	1533	0.000652316	0.008480104	0	oligos	OL-Cntl	NA	NA	NA
GTCATTTCAAGCGATG-1_2_B4	6.199108363	18.37443595	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	991	1410	0.002836879	0.013475177	0	oligos	OL-Cntl	NA	NA	NA
GTCATTTCACCGAAAG-1_2_B4	-26.60142406	9.925772304	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	739	1065	0.002816901	0.009389671	0	8	Astrocytes	NA	NA	NA
GTCATTTGTCGGGTCT-1_2_B4	19.90729637	6.795117982	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2329	4698	0.003831418	0.006811409	0	oligos	OL-Cntl	NA	NA	NA
GTCATTTTCATCGATG-1_2_B4	-1.799002251	-15.9539069	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2196	4809	0.003119152	0.001455604	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GTCCTCAAGAACAACT-1_2_B4	-12.70753716	-23.39124536	6A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1147	1956	0.011758691	0.004601227	0	6A	IN-PV	NA	NA	NA
GTCCTCAAGGTGCAAC-1_2_B4	20.899114	16.44260214	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1312	2112	0.001420455	0.007575758	0	oligos	OL-Cntl	NA	NA	NA
GTCCTCAAGTCCTCCT-1_2_B4	6.383046977	-8.408791433	4	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2402	4881	0.025609506	0.003687769	0	L2-3	EN-L2-3-MS	NA	NA	NA
GTCCTCACACAACTGT-1_2_B4	-37.46674131	0.771914205	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1598	3095	0.00355412	0.003231018	0	9	OPC	NA	NA	NA
GTCCTCACACATCTTT-1_2_B4	13.28047022	23.8023462	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	919	1498	0.000667557	0.003337784	0	oligos	OL-Cntl	NA	NA	NA
GTCCTCACAGTTAACC-1_2_B4	4.721449918	-30.24137355	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3438	8794	0.005685695	0.001705708	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GTCCTCACATCTACGA-1_2_B4	15.47148994	-6.264429413	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1956	4130	0.004358354	0.001210654	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GTCCTCATCTTAGAGC-1_2_B4	23.23683631	12.07861264	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1525	2542	0.001573564	0.00393391	0	oligos	OL-Cntl	NA	NA	NA
GTCGGGTAGCGTTTAC-1_2_B4	13.75615076	26.96499692	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	776	1099	0.002729754	0.010009099	0	oligos	OL-Cntl	NA	NA	NA
GTCGGGTAGTCCTCCT-1_2_B4	-22.13909841	10.02805914	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	846	1313	0.000761615	0.007616146	0	8	Astrocytes	NA	NA	NA
GTCGGGTCATGCTGGC-1_2_B4	24.43148127	-28.26792309	3	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3058	6663	0.002551403	0.006153384	0	3	EN-L5-6	NA	NA	NA
GTCGGGTGTAGCGCTC-1_2_B4	13.33537158	25.75742979	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	885	1282	0.003120125	0.007800312	0	oligos	OL-Cntl	NA	NA	NA
GTCGGGTGTCCAACTA-1_2_B4	10.10190666	-8.829875022	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2435	5157	0.000193911	0.001163467	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GTCGGGTTCACTGGGC-1_2_B4	-23.62972892	0.220139206	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2117	3828	0.005485893	0.006792059	0	9	OPC	NA	NA	NA
GTCGTAAAGTACGTTC-1_2_B4	11.44780032	21.01029622	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	861	1279	0.001563722	0.007818608	0	oligos	OL-Cntl	NA	NA	NA
GTCGTAAGTTTGGCGC-1_2_B4	-4.230768361	-7.921169971	13A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	798	1098	0.026411658	0.003642987	0	13A	IN-VIP	NA	NA	NA
GTCGTAATCGCCTGAG-1_2_B4	15.68383388	-1.053746062	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	751	1164	0.00257732	0.003436426	0	12	EN-MIX	NA	NA	NA
GTCGTAATCTCAACTT-1_2_B4	-24.63202948	17.27078078	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1165	1978	0.002022245	0.006066734	0	8	Astrocytes	NA	NA	NA
GTCGTAATCTGGCGAC-1_2_B4	-18.05931132	-26.75491069	6A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2534	5479	0.009125753	0.002920241	0	6A	IN-PV	NA	NA	NA
GTCTCGTAGAGTACCG-1_2_B4	3.870537746	-5.330138999	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1061	1811	0.007178355	0.008282717	0	12	EN-MIX	NA	NA	NA
GTCTCGTCAAGCCGTC-1_2_B4	-3.40232806	-7.699664579	13A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	685	1014	0.031558185	0.000986193	0	13A	IN-VIP	NA	NA	NA
GTCTCGTCAGGGTATG-1_2_B4	4.663419769	-31.09729072	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	4705	14155	0.003391028	0.002119392	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GTCTCGTCATACTACG-1_2_B4	21.45950371	10.24322467	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1589	2624	0.00152439	0.011051829	0	oligos	OL-Cntl	NA	NA	NA
GTCTCGTCATGCTAGT-1_2_B4	12.62167541	26.1415692	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	690	1011	0	0.006923838	0	oligos	OL-Cntl	NA	NA	NA
GTCTTCGAGGTGATTA-1_2_B4	-2.062403957	-21.38645558	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3078	7262	0.002065547	0.003167172	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GTCTTCGAGTCAAGGC-1_2_B4	8.513918992	24.27641858	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	896	1255	0.002390438	0.000796813	0	oligos	OL-Cntl	NA	NA	NA
GTCTTCGCAGTATGCT-1_2_B4	10.87359982	-9.035015326	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2798	7122	0.01572592	0.00238697	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GTCTTCGCATCTCCCA-1_2_B4	32.7234723	16.84998352	14	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1901	3069	0.001303356	0.064841968	0	14	Microglia	NA	NA	NA
GTCTTCGGTGCGATAG-1_2_B4	-23.81774509	23.48863228	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1353	2272	0.007922535	0.003080986	0	8	Astrocytes	NA	NA	NA
GTCTTCGTCAGTTAGC-1_2_B4	18.31152641	-6.96494766	3	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1946	3651	0.007121337	0.002738976	0	3	EN-L5-6	NA	NA	NA
GTCTTCGTCCTACAGA-1_2_B4	5.07896718	30.94005809	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	727	1032	0.007751938	0.006782946	0	oligos	OL-Cntl	NA	NA	NA
GTGAAGGCAAACCTAC-1_2_B4	-1.413626856	0.923072738	11	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2504	4850	0.004329897	0.005154639	0	11	Glia-MIX	NA	NA	NA
GTGAAGGCATCCCATC-1_2_B4	12.90263769	28.11493764	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	716	1071	0.004668534	0.005602241	0	oligos	OL-Cntl	NA	NA	NA
GTGAAGGCATGCCACG-1_2_B4	-10.95159975	2.790557489	13A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3340	7763	0.009532397	0.003349221	0	13A	IN-VIP	NA	NA	NA
GTGAAGGGTCGATTGT-1_2_B4	1.847333129	-13.03193995	4	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2092	4102	0.006338372	0.003656753	0	L2-3	EN-L2-3-MS	NA	NA	NA
GTGAAGGGTTATTCTC-1_2_B4	11.83491145	30.19248924	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	730	1098	0.000910747	0.008196721	0	oligos	OL-Cntl	NA	NA	NA
GTGAAGGGTTCCTCCA-1_2_B4	16.0598415	24.81919632	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	824	1289	0.002327386	0.00155159	0	oligos	OL-Cntl	NA	NA	NA
GTGAAGGTCTACTATC-1_2_B4	33.3307408	-4.0970798	2	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2696	5659	0.013960064	0.00512458	0	2	EN-L4	NA	NA	NA
GTGCAGCAGCACGCCT-1_2_B4	27.75289	1.154845619	2	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2794	6850	0.02189781	0.003941606	0	2	EN-L4	NA	NA	NA
GTGCAGCAGTCGCCGT-1_2_B4	18.49275684	16.91261698	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1158	1791	0.002791736	0.005583473	0	oligos	OL-Cntl	NA	NA	NA
GTGCAGCCAGACAAAT-1_2_B4	-19.04898761	-27.77784964	6A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2783	6266	0.007022024	0.00223428	0	6A	IN-PV	NA	NA	NA
GTGCAGCGTCTAAACC-1_2_B4	-23.37760795	28.92121874	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1962	3981	0	0.002511932	0	8	Astrocytes	NA	NA	NA
GTGCAGCGTTGGTGGA-1_2_B4	3.544219041	-3.953875778	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	999	1544	0.004533679	0.00388601	0	12	EN-MIX	NA	NA	NA
GTGCATAAGTGACATA-1_2_B4	21.85312305	1.074622952	2	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1669	2916	0.010288066	0.004115226	0	2	EN-L4	NA	NA	NA
GTGCATAGTCACTGGC-1_2_B4	14.7474704	25.57139652	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	813	1199	0.004170142	0.002502085	0	oligos	OL-Cntl	NA	NA	NA
GTGCATATCAGGTTCA-1_2_B4	22.7766345	-9.124245004	3	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2600	5410	0.00961183	0.001848429	0	3	EN-L5-6	NA	NA	NA
GTGCATATCCAAGCCG-1_2_B4	9.782355621	22.1092708	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	787	1188	0.001683502	0.012626263	0	oligos	OL-Cntl	NA	NA	NA
GTGCATATCGTTACGA-1_2_B4	38.9095928	15.90431621	14	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1478	2208	0.013586957	0.015851449	0	14	Microglia	NA	NA	NA
GTGCGGTAGCTATGCT-1_2_B4	-15.27775182	-8.595200153	13B	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2729	5686	0.004396764	0.0029898	0	13B	IN-SV2C	NA	NA	NA
GTGCGGTCAAGTTAAG-1_2_B4	0.63421744	27.92182606	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	770	1061	0.006597549	0.003770028	0	oligos	OL-Cntl	NA	NA	NA
GTGCGGTCATACAGCT-1_2_B4	1.733696407	-17.55116988	4	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2612	5480	0.007664234	0.004744526	0	L2-3	EN-L2-3-MS	NA	NA	NA
GTGCGGTCATCGTCGG-1_2_B4	15.3475795	28.20468402	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	753	1122	0.003565062	0.005347594	0	oligos	OL-Cntl	NA	NA	NA
GTGCGGTGTAGCGCTC-1_2_B4	22.32602778	-0.096512865	2	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1731	3109	0.002573175	0.004824702	0	2	EN-L4	NA	NA	NA
GTGCGGTGTCTAGAGG-1_2_B4	23.27545941	12.29096793	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1456	2330	0.004291845	0.003862661	0	oligos	OL-Cntl	NA	NA	NA
GTGCGGTTCGTTGACA-1_2_B4	-8.109542044	-10.68192947	6B	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	870	1323	0.019652305	0.008314437	0	6B	IN-SST	NA	NA	NA
GTGCTTCAGCAGCGTA-1_2_B4	23.78804667	-20.59913843	3	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	6732	21775	0.034259472	0.006475316	0	3	EN-L5-6	NA	NA	NA
GTGCTTCAGCGTGAAC-1_2_B4	2.099764756	32.10601915	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	802	1137	0.000879507	0.005277045	0	oligos	OL-Cntl	NA	NA	NA
GTGCTTCAGTATCGAA-1_2_B4	35.8800489	15.45878996	14	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1210	1664	0.004206731	0.027644231	0	14	Microglia	NA	NA	NA
GTGCTTCCAGCGTCCA-1_2_B4	0.330104334	-17.47521243	4	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3201	8334	0.007679386	0.00287977	0	L2-3	EN-L2-3-MS	NA	NA	NA
GTGCTTCCATGCTAGT-1_2_B4	-19.85622639	-26.12964939	6A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2621	5521	0.024814345	0.001992393	0	6A	IN-PV	NA	NA	NA
GTGCTTCGTACCCAAT-1_2_B4	3.462465429	-3.333655357	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	859	1232	0.021103896	0.003246753	0	12	EN-MIX	NA	NA	NA
GTGGGTCAGAGCCTAG-1_2_B4	3.696166314	-28.49182137	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3048	6720	0.000595238	0.001339286	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GTGGGTCAGCTGTCTA-1_2_B4	14.69930754	28.94038835	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	703	1024	0.00390625	0.000976563	0	oligos	OL-Cntl	NA	NA	NA
GTGGGTCCACGGTGTC-1_2_B4	7.500355249	29.17603326	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	706	1097	0	0.005469462	0	oligos	OL-Cntl	NA	NA	NA
GTGGGTCCATCCGGGT-1_2_B4	39.97783346	11.66789933	14	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	906	1268	0.006309148	0.003154574	0	14	Microglia	NA	NA	NA
GTGGGTCGTAATTGGA-1_2_B4	15.08979824	21.88556937	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	913	1302	0.003072197	0.003840246	0	oligos	OL-Cntl	NA	NA	NA
GTGGGTCGTCGACTGC-1_2_B4	2.418435027	27.56040478	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	756	1103	0.002719855	0.003626473	0	oligos	OL-Cntl	NA	NA	NA
GTGGGTCGTGCTCTTC-1_2_B4	22.89262877	18.68766127	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1123	1678	0.002979738	0.001191895	0	oligos	OL-Cntl	NA	NA	NA
GTGGGTCTCAACGAAA-1_2_B4	-36.87685489	-0.251595721	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1438	2310	0.002164502	0.003896104	0	9	OPC	NA	NA	NA
GTGGGTCTCCCAGGTG-1_2_B4	0.385587565	-15.22455796	4	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2333	4566	0.011169514	0.003942181	0	L2-3	EN-L2-3-MS	NA	NA	NA
GTGTGCGAGTGGACGT-1_2_B4	7.869775309	23.77168307	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1047	1575	0.003809524	0.004444444	0	oligos	OL-Cntl	NA	NA	NA
GTGTGCGCAATGACCT-1_2_B4	21.65050185	10.13902653	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1652	2709	0.003691399	0.004429679	0	oligos	OL-Cntl	NA	NA	NA
GTGTGCGGTCGGGTCT-1_2_B4	10.82761567	18.84722873	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	945	1408	0.001420455	0.009232955	0	oligos	OL-Cntl	NA	NA	NA
GTGTGCGGTTGGACCC-1_2_B4	17.54604646	15.77042614	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1122	1761	0.003407155	0.00681431	0	oligos	OL-Cntl	NA	NA	NA
GTGTGCGTCAATACCG-1_2_B4	-36.59972554	-4.637875468	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1284	2181	0.001834021	0.001375516	0	9	OPC	NA	NA	NA
GTGTGCGTCTGGCGTG-1_2_B4	13.41068885	19.25316064	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1099	1693	0.005316007	0.007678677	0	oligos	OL-Cntl	NA	NA	NA
GTTAAGCAGGGCTTGA-1_2_B4	-9.572360358	13.64879904	11	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1260	1823	0.004936917	0.004936917	0	11	Glia-MIX	NA	NA	NA
GTTAAGCGTACAGACG-1_2_B4	0.726649758	-12.47267225	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1881	3758	0.001330495	0.005055881	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GTTAAGCGTATGAAAC-1_2_B4	-27.68518564	15.59063413	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	941	1493	0.001339585	0.002679169	0	8	Astrocytes	NA	NA	NA
GTTAAGCTCTTTAGTC-1_2_B4	-17.88822684	13.4926423	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1150	1870	0.003208556	0.002139037	0	8	Astrocytes	NA	NA	NA
GTTACAGAGAGAGCTC-1_2_B4	19.22786553	14.59741406	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1122	1856	0.003771552	0.005926724	0	oligos	OL-Cntl	NA	NA	NA
GTTACAGAGCTGCGAA-1_2_B4	-35.90237822	4.323410868	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2061	3832	0.003914405	0.002348643	0	9	OPC	NA	NA	NA
GTTCATTAGGCATGTG-1_2_B4	-26.31685737	16.46125209	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1144	1857	0.003769521	0.007000539	0	8	Astrocytes	NA	NA	NA
GTTCATTCATTGGGCC-1_2_B4	-17.25945839	-26.14572872	6A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2171	4716	0.003180662	0.003180662	0	6A	IN-PV	NA	NA	NA
GTTCGGGAGCGGCTTC-1_2_B4	3.801055343	7.301403109	7	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1108	1660	0.003012048	0.007228916	0	7	Phagocytes	NA	NA	NA
GTTCGGGAGGTTCCTA-1_2_B4	2.263614268	-30.85161053	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	4694	13699	0.005620848	0.003211913	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GTTCGGGCACGAAATA-1_2_B4	-36.97903888	-5.03998648	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1118	1813	0.001103144	0.004964148	0	9	OPC	NA	NA	NA
GTTCGGGTCAGAGACG-1_2_B4	14.19086654	16.44902156	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1091	1711	0.003506721	0.006428989	0	oligos	OL-Cntl	NA	NA	NA
GTTCGGGTCATCGGAT-1_2_B4	5.189735107	22.97028908	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	845	1242	0.000805153	0.006441224	0	oligos	OL-Cntl	NA	NA	NA
GTTCGGGTCTGATTCT-1_2_B4	15.79734125	24.08090454	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	815	1163	0	0.003439381	0	oligos	OL-Cntl	NA	NA	NA
GTTCTCGAGAGAACAG-1_2_B4	15.59059616	20.00415276	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	941	1438	0.002086231	0.004867872	0	oligos	OL-Cntl	NA	NA	NA
GTTCTCGAGATATACG-1_2_B4	20.43910811	-27.87815752	3	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2550	5751	0.002782125	0.003651539	0	3	EN-L5-6	NA	NA	NA
GTTCTCGAGTGCCATT-1_2_B4	-35.73900686	-8.976122983	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	861	1321	0.001514005	0.003028009	0	9	OPC	NA	NA	NA
GTTCTCGCATGCCTTC-1_2_B4	20.06901399	11.66996325	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1314	2185	0.002745995	0.005491991	0	oligos	OL-Cntl	NA	NA	NA
GTTCTCGCATTGTGCA-1_2_B4	17.8795094	-31.58652882	3	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	4298	13054	0.004902712	0.007354068	0	3	EN-L5-6	NA	NA	NA
GTTCTCGGTGGCCCTA-1_2_B4	-2.293949742	24.95716995	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	769	1094	0.00274223	0.007312614	0	oligos	OL-Cntl	NA	NA	NA
GTTCTCGTCAGCACAT-1_2_B4	2.929458212	27.66317983	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	839	1230	0.001626016	0.003252033	0	oligos	OL-Cntl	NA	NA	NA
GTTCTCGTCTCTTATG-1_2_B4	12.66240346	30.04431807	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	687	1027	0.004868549	0.00292113	0	oligos	OL-Cntl	NA	NA	NA
GTTTCTACACAAGCCC-1_2_B4	3.516174617	27.55761283	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	717	1024	0	0.004882813	0	oligos	OL-Cntl	NA	NA	NA
GTTTCTATCAACACGT-1_2_B4	-16.21279171	-26.00435425	6A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1897	3829	0.003133978	0.003917472	0	6A	IN-PV	NA	NA	NA
GTTTCTATCGAGGTAG-1_2_B4	-19.85919421	-25.77377535	6A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2606	6041	0.018374441	0.003641781	0	6A	IN-PV	NA	NA	NA
TAAACCGAGAGACTAT-1_2_B4	1.342822271	-8.809601978	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1505	2706	0.024390244	0.002586844	0	12	EN-MIX	NA	NA	NA
TAAACCGAGGCTAGGT-1_2_B4	0.897231459	0.931540602	11	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1043	1460	0.012328767	0.004794521	0	11	Glia-MIX	NA	NA	NA
TAAACCGAGTGGGCTA-1_2_B4	-3.5516513	-7.699060801	13A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	728	1131	0.030946065	0.000884173	0	13A	IN-VIP	NA	NA	NA
TAAACCGCAGATCCAT-1_2_B4	-10.94180452	18.25226405	11	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2016	3730	0.001340483	0.004021448	0	11	Glia-MIX	NA	NA	NA
TAAACCGCATAGAAAC-1_2_B4	15.35174872	25.97041858	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	840	1294	0.000772798	0.004636785	0	oligos	OL-Cntl	NA	NA	NA
TAAACCGTCTTGACGA-1_2_B4	24.82823214	-28.28362701	3	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3311	8331	0.006721882	0.004081143	0	3	EN-L5-6	NA	NA	NA
TAAGAGAAGAACAACT-1_2_B4	14.00268416	26.16136142	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	743	1107	0.011743451	0.005420054	0	oligos	OL-Cntl	NA	NA	NA
TAAGAGAAGAATCTCC-1_2_B4	-17.86331025	-27.50178828	6A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2125	4780	0.00251046	0.001882845	0	6A	IN-PV	NA	NA	NA
TAAGAGACACAGATTC-1_2_B4	39.99396683	12.03833859	14	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	900	1320	0.010606061	0.00530303	0	14	Microglia	NA	NA	NA
TAAGAGACATGCCTAA-1_2_B4	4.035246342	-29.68347915	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3529	10836	0.002214839	0.002030269	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TAAGAGAGTCCATCCT-1_2_B4	22.45937232	13.42862063	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1280	2173	0.00138058	0.003681546	0	oligos	OL-Cntl	NA	NA	NA
TAAGAGATCGCAGGCT-1_2_B4	-28.52740538	21.31243906	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1132	1901	0.002630195	0.007364545	0	8	Astrocytes	NA	NA	NA
TAAGAGATCTCTAGGA-1_2_B4	5.607601667	-8.583960019	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1315	2290	0.010480349	0.003056769	0	12	EN-MIX	NA	NA	NA
TAAGCGTGTAGCCTCG-1_2_B4	-31.96721154	-12.8368133	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	738	1025	0.009756098	0.005853659	0	9	OPC	NA	NA	NA
TAAGCGTGTCAATGTC-1_2_B4	33.78140277	14.55852609	14	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1015	1319	0.003790751	0.042456406	0	14	Microglia	NA	NA	NA
TAAGCGTGTGATGTCT-1_2_B4	16.84648256	20.77686647	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1008	1522	0.007227332	0.010512484	0	oligos	OL-Cntl	NA	NA	NA
TAAGCGTTCTCGATGA-1_2_B4	-0.681170312	-15.67458857	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2272	4842	0.006608839	0.002684841	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TAAGTGCAGTGTTTGC-1_2_B4	5.962934462	6.158532219	7	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2411	4370	0.002059497	0.012128146	0	7	Phagocytes	NA	NA	NA
TAAGTGCCATCACAAC-1_2_B4	2.845375926	25.83049726	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	714	1054	0.008538899	0.011385199	0	oligos	OL-Cntl	NA	NA	NA
TAAGTGCTCCAGATCA-1_2_B4	-23.76328883	-1.681249785	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1116	1628	0.002457002	0.005528256	0	9	OPC	NA	NA	NA
TAAGTGCTCGACAGCC-1_2_B4	-13.04398772	-21.9579824	6A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1173	2053	0.002922552	0.003896736	0	6A	IN-PV	NA	NA	NA
TAAGTGCTCTTATCTG-1_2_B4	15.90228141	22.46342632	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	808	1262	0.003169572	0.002377179	0	oligos	OL-Cntl	NA	NA	NA
TACACGAAGAGCCCAA-1_2_B4	-27.88522621	15.77776574	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	973	1473	0.009504413	0.004752206	0	8	Astrocytes	NA	NA	NA
TACACGAAGCGTTGCC-1_2_B4	5.428517735	31.05281565	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	796	1094	0.011882998	0.007312614	0	oligos	OL-Cntl	NA	NA	NA
TACACGAAGGTAGCTG-1_2_B4	32.52978173	-4.50387234	2	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3363	7535	0.00597213	0.006370272	0	2	EN-L4	NA	NA	NA
TACACGAAGTAGCCGA-1_2_B4	-22.05753907	10.30975131	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	915	1360	0.000735294	0.008088235	0	8	Astrocytes	NA	NA	NA
TACACGACACTCAGGC-1_2_B4	13.01759516	31.00622907	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	835	1265	0.000790514	0.004743083	0	oligos	OL-Cntl	NA	NA	NA
TACACGAGTGACAAAT-1_2_B4	26.1045463	-3.602571348	2	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3728	10229	0.001368658	0.002248509	0	2	EN-L4	NA	NA	NA
TACACGATCACCCTCA-1_2_B4	35.43806588	7.654698545	14	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	796	1033	0.003872217	0.004840271	0	14	Microglia	NA	NA	NA
TACACGATCATGCTCC-1_2_B4	15.34476424	21.12710873	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	886	1381	0.002896452	0.007965243	0	oligos	OL-Cntl	NA	NA	NA
TACACGATCCGGCACA-1_2_B4	-22.18120883	29.91113889	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2058	4079	0.004167688	0.003677372	0	8	Astrocytes	NA	NA	NA
TACACGATCTTCGGTC-1_2_B4	-27.13853796	17.08424928	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1116	1924	0.005717256	0.004158004	0	8	Astrocytes	NA	NA	NA
TACAGTGAGGACCACA-1_2_B4	3.314395126	-4.785614564	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	917	1377	0.009440813	0.003631082	0	12	EN-MIX	NA	NA	NA
TACAGTGAGGGATGGG-1_2_B4	-37.13241664	-6.828389828	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1083	1688	0.005924171	0.004146919	0	9	OPC	NA	NA	NA
TACAGTGCAGAGTGTG-1_2_B4	24.20445561	-6.30649215	2	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3585	8029	0.006351974	0.002615519	0	2	EN-L4	NA	NA	NA
TACAGTGGTAAACGCG-1_2_B4	-36.32667969	4.451569989	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2062	3994	0.00450676	0.005257887	0	9	OPC	NA	NA	NA
TACAGTGGTCAATACC-1_2_B4	-0.528368375	25.75348134	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	756	1106	0.003616637	0.007233273	0	oligos	OL-Cntl	NA	NA	NA
TACAGTGTCCAGAAGG-1_2_B4	5.148420737	24.54987608	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	817	1148	0.006097561	0.007839721	0	oligos	OL-Cntl	NA	NA	NA
TACCTATAGCGATAGC-1_2_B4	0.871000293	22.91576163	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	761	1068	0.007490637	0.005617978	0	oligos	OL-Cntl	NA	NA	NA
TACCTATAGTACGTAA-1_2_B4	-36.91401059	-9.402341653	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	953	1629	0.003069368	0.003069368	0	9	OPC	NA	NA	NA
TACCTATCAATCGAAA-1_2_B4	25.13616213	-1.01041579	2	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2417	5070	0.00591716	0.00295858	0	2	EN-L4	NA	NA	NA
TACCTATCACATTTCT-1_2_B4	-23.1616088	24.23306782	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1540	2875	0.000347826	0.005217391	0	8	Astrocytes	NA	NA	NA
TACCTATCATCACGTA-1_2_B4	-5.402946677	-9.475389923	13A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	811	1280	0.00703125	0.0015625	0	13A	IN-VIP	NA	NA	NA
TACCTATCATCGTCGG-1_2_B4	14.58080094	21.0013761	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	978	1469	0.006126617	0.009530293	0	oligos	OL-Cntl	NA	NA	NA
TACCTATTCACGAAGG-1_2_B4	-11.08680189	7.147424983	11	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3408	8015	0.007111666	0.003119152	0	11	Glia-MIX	NA	NA	NA
TACCTATTCCCACTTG-1_2_B4	-34.15542628	-1.102467802	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1567	2720	0.002573529	0.004779412	0	9	OPC	NA	NA	NA
TACCTTAAGTGGACGT-1_2_B4	2.657391083	-12.53279864	4	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2019	3759	0.014365523	0.005320564	0	L2-3	EN-L2-3-MS	NA	NA	NA
TACCTTATCCAGGGCT-1_2_B4	-10.3616718	9.127966371	11	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	4380	11632	0.00988652	0.005416094	0	11	Glia-MIX	NA	NA	NA
TACCTTATCCCACTTG-1_2_B4	11.45507313	22.4178434	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	865	1360	0.002205882	0.004411765	0	oligos	OL-Cntl	NA	NA	NA
TACGGATAGACCTTTG-1_2_B4	-18.59187924	-28.16729788	6A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2756	6745	0.003113417	0.002816901	0	6A	IN-PV	NA	NA	NA
TACGGATAGACTCGGA-1_2_B4	16.35177604	24.42940679	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	913	1369	0.00073046	0.007304602	0	oligos	OL-Cntl	NA	NA	NA
TACGGATCACACATGT-1_2_B4	-1.202623598	-0.863673691	11	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2040	3813	0.002884868	0.008392342	0	11	Glia-MIX	NA	NA	NA
TACGGATCATGCCTAA-1_2_B4	17.87718128	16.61692652	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1047	1619	0.001852996	0.003088326	0	oligos	OL-Cntl	NA	NA	NA
TACGGGCAGACCCACC-1_2_B4	-13.31497809	-24.18939284	6A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1031	1745	0.00286533	0.00286533	0	6A	IN-PV	NA	NA	NA
TACGGGCAGCAATCTC-1_2_B4	23.39776131	-7.183090855	11	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3533	7428	0.009289176	0.006058158	0	11	Glia-MIX	NA	NA	NA
TACGGGCCATGGATGG-1_2_B4	-17.03352282	14.25273822	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1388	2230	0.000896861	0.004932735	0	8	Astrocytes	NA	NA	NA
TACGGGCGTCAAACTC-1_2_B4	20.62118156	21.3454459	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1086	1659	0.000602773	0.003616637	0	oligos	OL-Cntl	NA	NA	NA
TACGGTAAGCTCAACT-1_2_B4	21.75576551	10.95930179	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1591	2652	0.003016591	0.002639517	0	oligos	OL-Cntl	NA	NA	NA
TACGGTAGTGAAGGCT-1_2_B4	-11.85774711	0.058904881	13A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2651	5008	0.01178115	0.008586262	0	13A	IN-VIP	NA	NA	NA
TACGGTAGTTCGTCTC-1_2_B4	18.15626926	9.47505034	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1548	2631	0.007981756	0.006461422	0	oligos	OL-Cntl	NA	NA	NA
TACTCATCAAAGGTGC-1_2_B4	21.1562503	10.9642305	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1427	2372	0.011804384	0.002951096	0	oligos	OL-Cntl	NA	NA	NA
TACTCATCAGTCACTA-1_2_B4	1.64443915	-7.986434984	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1382	2575	0.033786408	0.002718447	0	12	EN-MIX	NA	NA	NA
TACTCATTCAACCATG-1_2_B4	1.829610005	-28.20159259	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3480	9743	0.007492559	0.002565945	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TACTCGCAGAGGTTAT-1_2_B4	3.105460222	-11.47547154	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1874	3342	0.021244764	0.004787552	0	12	EN-MIX	NA	NA	NA
TACTCGCCAGTTCCCT-1_2_B4	-36.96286767	3.885147372	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1828	3464	0.005484988	0.004618938	0	9	OPC	NA	NA	NA
TACTCGCTCCCTAATT-1_2_B4	-27.94764569	22.06066185	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1160	2044	0.001956947	0.004403131	0	8	Astrocytes	NA	NA	NA
TACTCGCTCGTAGATC-1_2_B4	-28.22899173	20.66575226	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1084	1704	0.002934272	0.001760563	0	8	Astrocytes	NA	NA	NA
TACTTACCACGAAAGC-1_2_B4	3.096101967	-19.98561872	4	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3235	7139	0.002661437	0.008544614	0	L2-3	EN-L2-3-MS	NA	NA	NA
TACTTACCAGATTGCT-1_2_B4	19.03920545	14.64324688	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1130	1777	0.002250985	0.005627462	0	oligos	OL-Cntl	NA	NA	NA
TACTTACCAGCCTTGG-1_2_B4	15.83180432	27.49268452	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	840	1259	0.001588562	0.004765687	0	oligos	OL-Cntl	NA	NA	NA
TACTTACGTCCGAACC-1_2_B4	16.40033296	20.92103047	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1026	1493	0.009377093	0.006028131	0	oligos	OL-Cntl	NA	NA	NA
TACTTACGTTTACTCT-1_2_B4	18.0381099	-5.529071275	3	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1241	2209	0.027614305	0.003168855	0	3	EN-L5-6	NA	NA	NA
TACTTGTAGCGCTTAT-1_2_B4	1.338689175	-8.063068502	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1401	2322	0.014211886	0.001722653	0	12	EN-MIX	NA	NA	NA
TACTTGTGTACTTGAC-1_2_B4	-36.71655455	-6.987936723	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1130	1806	0.003322259	0.00166113	0	9	OPC	NA	NA	NA
TACTTGTGTAGATTAG-1_2_B4	-31.07543394	10.141096	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	867	1295	0.001544402	0.011583012	0	8	Astrocytes	NA	NA	NA
TACTTGTGTGCCTGGT-1_2_B4	30.41664424	-0.70328068	2	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2629	5900	0.002033898	0.006440678	0	2	EN-L4	NA	NA	NA
TACTTGTTCAACGGGA-1_2_B4	2.094351148	-8.789615191	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1525	2678	0.011949216	0.00373413	0	12	EN-MIX	NA	NA	NA
TACTTGTTCTTGCCGT-1_2_B4	-29.25404357	21.57745342	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1049	1785	0.003921569	0.003361345	0	8	Astrocytes	NA	NA	NA
TAGACCACAAGTTGTC-1_2_B4	38.80014328	11.17394195	14	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	944	1321	0.005299016	0.015140045	0	14	Microglia	NA	NA	NA
TAGACCAGTCCGAATT-1_2_B4	21.12271201	19.25193203	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	987	1465	0.001365188	0.004778157	0	oligos	OL-Cntl	NA	NA	NA
TAGACCATCGAATCCA-1_2_B4	21.06894797	7.30333954	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2231	4360	0.001605505	0.005733945	0	oligos	OL-Cntl	NA	NA	NA
TAGAGCTAGTGAACAT-1_2_B4	3.674405463	-3.539519571	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	821	1181	0.00084674	0.00338696	0	12	EN-MIX	NA	NA	NA
TAGAGCTCATCTCGCT-1_2_B4	3.953755761	25.28082638	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	718	1015	0.001970443	0.003940887	0	oligos	OL-Cntl	NA	NA	NA
TAGAGCTGTGGGTATG-1_2_B4	2.637600814	-26.61678535	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3290	7971	0.010412746	0.003010915	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TAGCCGGAGACATAAC-1_2_B4	-10.06108447	13.75634215	11	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1125	1706	0.004103165	0.006447831	0	11	Glia-MIX	NA	NA	NA
TAGCCGGAGTTATCGC-1_2_B4	-23.19105987	25.31723267	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1606	2929	0.00102424	0.006145442	0	8	Astrocytes	NA	NA	NA
TAGCCGGCAAGGACAC-1_2_B4	-28.44929682	12.42457156	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	795	1203	0.009975062	0.00166251	0	8	Astrocytes	NA	NA	NA
TAGCCGGCACCACCAG-1_2_B4	3.734321419	-9.435390599	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1905	3564	0.008417508	0.002805836	0	12	EN-MIX	NA	NA	NA
TAGCCGGCAGCGTAAG-1_2_B4	-25.08656146	15.14892863	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1069	1650	0.007878788	0.003636364	0	8	Astrocytes	NA	NA	NA
TAGCCGGCAGCTATTG-1_2_B4	2.60100444	27.31252813	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	710	1019	0.001962709	0.005888126	0	oligos	OL-Cntl	NA	NA	NA
TAGCCGGCAGGTCGTC-1_2_B4	-10.31907655	12.64538061	11	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	996	1461	0.009582478	0.004791239	0	11	Glia-MIX	NA	NA	NA
TAGCCGGCATAAGACA-1_2_B4	5.901337022	24.30317199	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	890	1348	0.002967359	0.002967359	0	oligos	OL-Cntl	NA	NA	NA
TAGCCGGCATACTACG-1_2_B4	-23.67319837	22.81915414	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1347	2370	0.003375527	0.002953586	0	8	Astrocytes	NA	NA	NA
TAGCCGGCATCGTCGG-1_2_B4	9.987377044	-7.729185717	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1871	3718	0.007799892	0.002420656	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TAGCCGGGTAGAAAGG-1_2_B4	3.002421602	25.72408314	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	803	1145	0.00349345	0.000873362	0	oligos	OL-Cntl	NA	NA	NA
TAGCCGGGTAGCCTCG-1_2_B4	-4.015152496	-4.509471562	13A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1118	1878	0.010649627	0.001597444	0	13A	IN-VIP	NA	NA	NA
TAGGCATAGCCAACAG-1_2_B4	-24.04042914	22.54789449	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1217	2022	0.00148368	0.008902077	0	8	Astrocytes	NA	NA	NA
TAGGCATAGCCGATTT-1_2_B4	18.93675066	12.22945098	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1265	2171	0.000460617	0.002303086	0	oligos	OL-Cntl	NA	NA	NA
TAGGCATGTCGTTGTA-1_2_B4	2.004204465	-20.97310209	4	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3416	8035	0.006845053	0.004480398	0	L2-3	EN-L2-3-MS	NA	NA	NA
TAGGCATGTTATCACG-1_2_B4	-36.08994447	4.660516786	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2092	4268	0.002108716	0.003045923	0	9	OPC	NA	NA	NA
TAGGCATTCAGCACAT-1_2_B4	16.82791021	11.43104912	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1363	2317	0.005610703	0.009495037	0	oligos	OL-Cntl	NA	NA	NA
TAGGCATTCGTTACGA-1_2_B4	3.981901942	-2.356835654	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	735	1090	0.008256881	0.008256881	0	12	EN-MIX	NA	NA	NA
TAGTGGTCATTGGCGC-1_2_B4	22.07982591	11.83328214	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1492	2527	0.001187178	0.005540166	0	oligos	OL-Cntl	NA	NA	NA
TAGTGGTGTGTGACGA-1_2_B4	-35.70108604	-5.704343305	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1246	2097	0.006199332	0.002384359	0	9	OPC	NA	NA	NA
TAGTTGGAGCAGGTCA-1_2_B4	3.203403452	28.8990702	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	753	1099	0.002729754	0.005459509	0	oligos	OL-Cntl	NA	NA	NA
TAGTTGGTCGGTGTCG-1_2_B4	2.640787991	27.29501369	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	694	1017	0.003933137	0.001966568	0	oligos	OL-Cntl	NA	NA	NA
TATCAGGAGCTCAACT-1_2_B4	24.08532922	-0.978514553	2	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2428	5110	0.028375734	0.003131115	0	2	EN-L4	NA	NA	NA
TATCAGGCATCAGTAC-1_2_B4	-28.67713978	13.02888036	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	780	1172	0.003412969	0.004266212	0	8	Astrocytes	NA	NA	NA
TATCAGGCATTGAGCT-1_2_B4	20.90349212	1.731901494	2	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1257	2182	0	0.001374885	0	2	EN-L4	NA	NA	NA
TATCAGGGTGTAATGA-1_2_B4	19.59407001	-6.861950999	3	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2023	3926	0.013499745	0.00356597	0	3	EN-L5-6	NA	NA	NA
TATCAGGGTTTGACAC-1_2_B4	14.11939202	26.27143902	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	732	1125	0.001777778	0.009777778	0	oligos	OL-Cntl	NA	NA	NA
TATCAGGTCGCCATAA-1_2_B4	21.30519217	16.96465018	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1200	1908	0.007861635	0.005765199	0	oligos	OL-Cntl	NA	NA	NA
TATCAGGTCGTAGGTT-1_2_B4	2.676421003	-27.80770073	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3185	8463	0.005671748	0.001536098	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TATCTCAAGCCACGTC-1_2_B4	-3.199607064	-7.162511745	13A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	802	1209	0.031430935	0.00165426	0	13A	IN-VIP	NA	NA	NA
TATCTCAAGGAGCGAG-1_2_B4	14.54805064	21.49202344	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	937	1470	0.004081633	0.002721088	0	oligos	OL-Cntl	NA	NA	NA
TATCTCACAGGGTACA-1_2_B4	17.99888686	15.10341266	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1046	1742	0.001722158	0.006314581	0	oligos	OL-Cntl	NA	NA	NA
TATCTCACATACAGCT-1_2_B4	14.50987439	27.14367766	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	735	1096	0.009124088	0.003649635	0	oligos	OL-Cntl	NA	NA	NA
TATCTCAGTGTGCGTC-1_2_B4	3.428949584	-28.4767669	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3299	8824	0.010312783	0.001813237	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TATCTCAGTTTGGGCC-1_2_B4	19.79024898	15.08919986	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1143	1901	0.002104156	0.005260389	0	oligos	OL-Cntl	NA	NA	NA
TATCTCATCTGCGGCA-1_2_B4	-36.25314246	4.223472192	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2118	4333	0.003923379	0.002077083	0	9	OPC	NA	NA	NA
TATGCCCGTCTCCCTA-1_2_B4	18.23491003	19.16218989	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1066	1732	0.000577367	0.005773672	0	oligos	OL-Cntl	NA	NA	NA
TATGCCCGTTACGGAG-1_2_B4	29.36009707	-2.237769798	2	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	4585	11882	0.004881333	0.004292207	0	2	EN-L4	NA	NA	NA
TATGCCCGTTCTCATT-1_2_B4	8.23819283	-7.562278459	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1736	3430	0.001457726	0.001457726	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TATGCCCTCAAGAAGT-1_2_B4	-31.96771828	12.16861907	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	844	1320	0.002272727	0.004545455	0	8	Astrocytes	NA	NA	NA
TATGCCCTCGGTTAAC-1_2_B4	17.02502429	22.23741914	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	867	1294	0.001545595	0.00309119	0	oligos	OL-Cntl	NA	NA	NA
TATTACCAGCGGCTTC-1_2_B4	-6.312590794	4.033419118	11	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	7653	31607	0.005093808	0.004113013	0	11	Glia-MIX	NA	NA	NA
TATTACCGTCATGCCG-1_2_B4	1.080707153	-20.54035564	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3086	7648	0.003530335	0.005360879	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TATTACCGTTCCACTC-1_2_B4	21.56548438	-8.339040139	3	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1629	3034	0.015161503	0.001977587	0	3	EN-L5-6	NA	NA	NA
TCAACGAGTTCGAATC-1_2_B4	15.93183383	-7.43347226	3	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2121	4223	0.000236798	0.009945536	0	3	EN-L5-6	NA	NA	NA
TCAATCTAGTTAACGA-1_2_B4	-0.172787889	-11.47509242	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1733	3328	0.010216346	0.003305288	0	12	EN-MIX	NA	NA	NA
TCAATCTCATCCAACA-1_2_B4	24.32795905	-29.59972414	3	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2572	5952	0.002688172	0.002352151	0	3	EN-L5-6	NA	NA	NA
TCAATCTGTGCCTGTG-1_2_B4	-36.02921911	-8.153655066	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	996	1529	0.004578156	0.001962067	0	9	OPC	NA	NA	NA
TCAATCTTCCCAAGTA-1_2_B4	14.55230275	25.05979402	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	775	1198	0.001669449	0.007512521	0	oligos	OL-Cntl	NA	NA	NA
TCAATCTTCGCCTGTT-1_2_B4	18.56451515	19.82948444	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	989	1630	0.001226994	0.005521472	0	oligos	OL-Cntl	NA	NA	NA
TCACAAGAGACATAAC-1_2_B4	3.041265297	23.95033377	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	913	1286	0.00466563	0.006998445	0	oligos	OL-Cntl	NA	NA	NA
TCACAAGAGGCAATTA-1_2_B4	3.654377285	-13.36399017	4	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2049	3809	0.022315568	0.009188763	0	L2-3	EN-L2-3-MS	NA	NA	NA
TCACAAGAGTGACATA-1_2_B4	5.115538481	25.24323654	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	859	1238	0.003231018	0.004846527	0	oligos	OL-Cntl	NA	NA	NA
TCACAAGCAAGGACAC-1_2_B4	-16.90129284	10.88245756	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1108	1589	0.001258653	0.007551919	0	8	Astrocytes	NA	NA	NA
TCACAAGGTAAAGGAG-1_2_B4	-11.76481803	-19.07137428	6B	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1034	1633	0.017758726	0.004898959	0	6B	IN-SST	NA	NA	NA
TCACGAAAGACTAGAT-1_2_B4	-36.2427112	-8.054741352	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1004	1503	0.005988024	0.004657352	0	9	OPC	NA	NA	NA
TCACGAACAAAGGTGC-1_2_B4	-21.04426137	9.206954134	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1104	1751	0.002284409	0.006853227	0	8	Astrocytes	NA	NA	NA
TCACGAACAGGGATTG-1_2_B4	2.885132709	-11.04224736	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1629	2849	0.010530011	0.004212004	0	12	EN-MIX	NA	NA	NA
TCACGAAGTACAGTTC-1_2_B4	13.62250526	19.36919644	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1021	1494	0.005354752	0.005354752	0	oligos	OL-Cntl	NA	NA	NA
TCACGAAGTGCGATAG-1_2_B4	6.002993519	21.74547301	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	802	1154	0.002599653	0.008665511	0	oligos	OL-Cntl	NA	NA	NA
TCAGATGAGGAGTTGC-1_2_B4	0.249607618	-11.53396465	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1946	3892	0.030318602	0.002055498	0	12	EN-MIX	NA	NA	NA
TCAGATGAGTGTCTCA-1_2_B4	5.727935211	24.05405376	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	858	1276	0.010188088	0.009404389	0	oligos	OL-Cntl	NA	NA	NA
TCAGATGTCACCCTCA-1_2_B4	18.48476766	14.24506879	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1178	2033	0.000983768	0.007870143	0	oligos	OL-Cntl	NA	NA	NA
TCAGATGTCAGCACAT-1_2_B4	4.705655033	25.6360519	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	766	1123	0.003561888	0.00445236	0	oligos	OL-Cntl	NA	NA	NA
TCAGATGTCGCCAGCA-1_2_B4	-9.16633603	17.64978492	11	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3776	8747	0.005944895	0.005487596	0	11	Glia-MIX	NA	NA	NA
TCAGATGTCTTTAGGG-1_2_B4	15.42328699	13.35099554	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1284	2075	0.007710843	0.004337349	0	oligos	OL-Cntl	NA	NA	NA
TCAGCAACAGGCTCAC-1_2_B4	17.24233767	26.8328491	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	910	1369	0.002921841	0.002921841	0	oligos	OL-Cntl	NA	NA	NA
TCAGCAACATCCGCGA-1_2_B4	-23.26454033	22.59765507	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1276	2343	0.00128041	0.002987623	0	8	Astrocytes	NA	NA	NA
TCAGCAAGTAAGAGGA-1_2_B4	19.00887506	-20.90818595	4	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	4220	10273	0.007300691	0.006716636	0	L2-3	EN-L2-3-MS	NA	NA	NA
TCAGCAAGTTCTGAAC-1_2_B4	3.729535136	-7.515486052	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1217	1908	0.004716981	0.004716981	0	12	EN-MIX	NA	NA	NA
TCAGCTCAGGACTGGT-1_2_B4	16.31234194	17.04153593	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1016	1673	0.005977286	0.007770472	0	oligos	OL-Cntl	NA	NA	NA
TCAGCTCCAATGGATA-1_2_B4	9.66292892	-7.035639122	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1836	3084	0.016212711	0.003242542	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TCAGCTCCAGTATCTG-1_2_B4	0.976130135	-25.42815394	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3347	8696	0.002644894	0.002184913	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TCAGCTCGTACTTCTT-1_2_B4	-10.23847241	12.50181065	11	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	819	1093	0.005489478	0.004574565	0	11	Glia-MIX	NA	NA	NA
TCAGCTCGTCAGGACA-1_2_B4	4.995365302	22.19578467	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	877	1290	0.004651163	0.00620155	0	oligos	OL-Cntl	NA	NA	NA
TCAGCTCGTCCTCCAT-1_2_B4	21.07044041	7.312258868	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2156	3952	0.001012146	0.003795547	0	oligos	OL-Cntl	NA	NA	NA
TCAGCTCTCAATAAGG-1_2_B4	14.9445853	23.51566532	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1017	1510	0.001324503	0.005960265	0	oligos	OL-Cntl	NA	NA	NA
TCAGCTCTCATAACCG-1_2_B4	13.80652717	26.98040025	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	686	1047	0.00095511	0.003820439	0	oligos	OL-Cntl	NA	NA	NA
TCAGCTCTCCGCATCT-1_2_B4	29.39531763	-2.055399579	2	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3455	7907	0.000632351	0.007461743	0	2	EN-L4	NA	NA	NA
TCAGGATAGTTGAGTA-1_2_B4	-20.54321532	8.234357612	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	804	1092	0.001831502	0.001831502	0	8	Astrocytes	NA	NA	NA
TCAGGATCATGCCACG-1_2_B4	8.937644127	-24.60624977	4	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	4638	12895	0.006126406	0.005428461	0	L2-3	EN-L2-3-MS	NA	NA	NA
TCAGGATTCATCATTC-1_2_B4	-22.07977161	29.88958895	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2110	3961	0.002019692	0.003281999	0	8	Astrocytes	NA	NA	NA
TCAGGATTCATGTAGC-1_2_B4	13.11695354	-30.91483732	3	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3118	7808	0.006147541	0.002305328	0	3	EN-L5-6	NA	NA	NA
TCAGGATTCTAGAGTC-1_2_B4	11.59195241	29.34004442	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	801	1174	0.000851789	0.00681431	0	oligos	OL-Cntl	NA	NA	NA
TCAGGTACAATGTAAG-1_2_B4	1.136230731	-28.62432662	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3991	11024	0.003447025	0.002177068	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TCAGGTACACACATGT-1_2_B4	12.63649062	32.07445229	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	657	1008	0	0.00297619	0	oligos	OL-Cntl	NA	NA	NA
TCAGGTACAGCTGGCT-1_2_B4	22.98315189	12.24560475	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1483	2513	0	0.002785515	0	oligos	OL-Cntl	NA	NA	NA
TCAGGTACATCTATGG-1_2_B4	32.52753508	14.95046776	14	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	886	1172	0.006825939	0.067406143	0	14	Microglia	NA	NA	NA
TCAGGTATCAGTCCCT-1_2_B4	21.61119873	17.18002019	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1128	1725	0.012173913	0.009275362	0	oligos	OL-Cntl	NA	NA	NA
TCAGGTATCCAAATGC-1_2_B4	4.217498677	23.55330888	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	896	1228	0.009771987	0.00732899	0	oligos	OL-Cntl	NA	NA	NA
TCAGGTATCCTGCCAT-1_2_B4	3.111160219	-7.608921725	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1424	2640	0.002651515	0.002272727	0	12	EN-MIX	NA	NA	NA
TCATTACCACCCATTC-1_2_B4	-10.5766422	9.656590654	11	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	4215	10575	0.003498818	0.004349882	0	11	Glia-MIX	NA	NA	NA
TCATTACCAGTTCCCT-1_2_B4	16.02338592	21.88813068	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	893	1321	0.002271007	0.006056018	0	oligos	OL-Cntl	NA	NA	NA
TCATTACTCTCTTGAT-1_2_B4	-0.619228387	-15.93805584	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2085	4139	0.010630587	0.002416043	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TCATTTGAGAGACGAA-1_2_B4	9.279306414	-8.224832386	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2191	4549	0.009232798	0.002637942	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TCATTTGAGCTGCAAG-1_2_B4	23.30286749	1.195492989	2	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1830	3595	0.000834492	0.003337969	0	2	EN-L4	NA	NA	NA
TCATTTGCACGTAAGG-1_2_B4	2.579233423	-4.139489145	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	819	1192	0.012583893	0.001677852	0	12	EN-MIX	NA	NA	NA
TCATTTGGTTCCGTCT-1_2_B4	-8.791658744	-17.99458068	6B	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	729	1128	0.030141844	0.002659574	0	6B	IN-SST	NA	NA	NA
TCATTTGTCCAATGGT-1_2_B4	2.621690274	-3.252659126	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	708	1056	0.044507576	0.006628788	0	12	EN-MIX	NA	NA	NA
TCCACACAGCAGCCTC-1_2_B4	15.32889148	20.5927529	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1016	1562	0.010883483	0.008962868	0	oligos	OL-Cntl	NA	NA	NA
TCCACACAGGAACTGC-1_2_B4	-0.68818413	23.61258807	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	718	1005	0.004975124	0.013930348	0	oligos	OL-Cntl	NA	NA	NA
TCCACACAGTAACCCT-1_2_B4	5.414508665	25.84615049	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	823	1209	0.00082713	0.003308519	0	oligos	OL-Cntl	NA	NA	NA
TCCACACCAAACCCAT-1_2_B4	20.57599614	-29.26180195	3	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	4729	13995	0.00664523	0.008931761	0	3	EN-L5-6	NA	NA	NA
TCCACACGTAACGACG-1_2_B4	3.655730113	5.151311196	7	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1275	1855	0.002695418	0.005390836	0	7	Phagocytes	NA	NA	NA
TCCACACGTCATCCCT-1_2_B4	-37.01542053	-0.214898834	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1528	2762	0.005792904	0.004344678	0	9	OPC	NA	NA	NA
TCCACACGTTGAGGTG-1_2_B4	18.977602	11.98476373	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1409	2405	0.007484407	0.003326403	0	oligos	OL-Cntl	NA	NA	NA
TCCACACTCGGCATCG-1_2_B4	16.556191	20.39012705	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	957	1457	0.004804393	0.009608785	0	oligos	OL-Cntl	NA	NA	NA
TCCCGATAGAGCAATT-1_2_B4	14.12338237	0.152078696	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	760	1148	0.017421603	0.004355401	0	12	EN-MIX	NA	NA	NA
TCCCGATAGGAATGGA-1_2_B4	15.1690797	13.37489703	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1386	2215	0.013544018	0.010835214	0	oligos	OL-Cntl	NA	NA	NA
TCCCGATCACACCGCA-1_2_B4	0.369962918	-11.60817177	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1882	3487	0.008603384	0.003154574	0	12	EN-MIX	NA	NA	NA
TCCCGATCACTACAGT-1_2_B4	-12.47693055	13.19714948	11	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	888	1294	0.00309119	0.00618238	0	11	Glia-MIX	NA	NA	NA
TCCCGATCAGTTAACC-1_2_B4	14.98025154	-33.34605091	3	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	5278	18818	0.002338187	0.003666702	0	3	EN-L5-6	NA	NA	NA
TCCCGATGTAAACGCG-1_2_B4	-23.96368628	23.15976239	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1386	2521	0.002776676	0.004760016	0	8	Astrocytes	NA	NA	NA
TCCCGATGTACTTAGC-1_2_B4	20.9017874	19.3334645	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	929	1279	0.005473026	0.006254887	0	oligos	OL-Cntl	NA	NA	NA
TCCCGATGTGTGAATA-1_2_B4	24.15550732	-29.39566965	3	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2914	6350	0.000944882	0.002677165	0	3	EN-L5-6	NA	NA	NA
TCGAGGCCATGGTCTA-1_2_B4	15.20029817	30.17995937	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	796	1180	0	0.001694915	0	oligos	OL-Cntl	NA	NA	NA
TCGAGGCGTTCCAACA-1_2_B4	-23.97848446	22.49366135	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1414	2459	0.004066694	0.004473363	0	8	Astrocytes	NA	NA	NA
TCGAGGCTCAACACGT-1_2_B4	-11.5983718	-10.96674114	6B	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1197	1911	0.015698587	0.002093145	0	6B	IN-SST	NA	NA	NA
TCGAGGCTCTACCAGA-1_2_B4	14.03537852	27.47884371	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	686	1011	0	0.008902077	0	oligos	OL-Cntl	NA	NA	NA
TCGAGGCTCTGCCCTA-1_2_B4	2.439090896	-13.6553982	4	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1995	3632	0.009085903	0.007709251	0	L2-3	EN-L2-3-MS	NA	NA	NA
TCGAGGCTCTTGCAAG-1_2_B4	1.252487724	26.49426019	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	710	1063	0	0.008466604	0	oligos	OL-Cntl	NA	NA	NA
TCGCGAGAGTATTGGA-1_2_B4	-9.639756724	22.27665062	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1134	1704	0.002934272	0.01056338	0	8	Astrocytes	NA	NA	NA
TCGCGAGCATACGCCG-1_2_B4	12.24665018	22.460657	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	806	1158	0	0.006044905	0	oligos	OL-Cntl	NA	NA	NA
TCGCGAGGTACTCGCG-1_2_B4	23.33187064	19.09880508	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1046	1575	0.001904762	0.002539683	0	oligos	OL-Cntl	NA	NA	NA
TCGCGAGGTGAGGCTA-1_2_B4	-11.82949183	0.728795966	13A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3384	7571	0.005679567	0.00673623	0	13A	IN-VIP	NA	NA	NA
TCGCGAGGTTCAGACT-1_2_B4	-6.198487047	-6.291356715	13A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1070	1750	0.008571429	0.005714286	0	13A	IN-VIP	NA	NA	NA
TCGCGAGTCCAAACTG-1_2_B4	-12.84743753	-20.9031695	6A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1220	2045	0.015647922	0.001466993	0	6A	IN-PV	NA	NA	NA
TCGCGTTAGAAACCAT-1_2_B4	-6.07968806	-4.943844345	13A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1415	2558	0.039874902	0.000781861	0	13A	IN-VIP	NA	NA	NA
TCGCGTTAGCTGAAAT-1_2_B4	1.080991668	-19.71613048	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3273	7973	0.01517622	0.002759313	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TCGCGTTGTCGAATCT-1_2_B4	20.22382388	11.56107496	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1401	2269	0.006170119	0.003966505	0	oligos	OL-Cntl	NA	NA	NA
TCGCGTTGTGATGTCT-1_2_B4	-0.092351863	0.016711549	11	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	879	1262	0.004754358	0.001584786	0	11	Glia-MIX	NA	NA	NA
TCGGGACAGCTAGCCC-1_2_B4	6.6359227	25.88857207	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	861	1240	0.000806452	0.004032258	0	oligos	OL-Cntl	NA	NA	NA
TCGGGACGTCCCTTGT-1_2_B4	20.14566489	20.12273636	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	987	1561	0.000640615	0.00384369	0	oligos	OL-Cntl	NA	NA	NA
TCGGGACTCAACTCTT-1_2_B4	4.610162081	26.94479276	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	738	1062	0.014124294	0.005649718	0	oligos	OL-Cntl	NA	NA	NA
TCGGTAAGTGATGTGG-1_2_B4	1.484303071	-10.88700383	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1743	2872	0.002089136	0.003133705	0	12	EN-MIX	NA	NA	NA
TCGTACCAGATACACA-1_2_B4	14.61144386	19.92280807	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	949	1434	0.00069735	0.009762901	0	oligos	OL-Cntl	NA	NA	NA
TCGTACCAGCGATAGC-1_2_B4	13.25309172	-32.63849491	3	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3577	10312	0.005139643	0.001939488	0	3	EN-L5-6	NA	NA	NA
TCGTACCAGTATCGAA-1_2_B4	-36.52187633	-1.222901147	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1320	2124	0.002354049	0.002824859	0	9	OPC	NA	NA	NA
TCGTACCTCCGTTGTC-1_2_B4	0.954352721	-27.57322609	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3711	10196	0.007061593	0.002059631	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TCGTACCTCGCCTGTT-1_2_B4	-11.80522312	-20.98436019	6A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1115	1932	0.022774327	0.003623188	0	6A	IN-PV	NA	NA	NA
TCGTAGACAGGTCGTC-1_2_B4	38.73469382	12.00492064	14	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	891	1184	0.001689189	0.008445946	0	14	Microglia	NA	NA	NA
TCGTAGAGTAGCGATG-1_2_B4	4.652996573	-10.92469235	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1807	2948	0.023405699	0.009837178	0	12	EN-MIX	NA	NA	NA
TCGTAGAGTCACACGC-1_2_B4	-37.56248218	-5.86190449	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1191	1871	0.004275788	0	0	9	OPC	NA	NA	NA
TCGTAGAGTCTCTCTG-1_2_B4	-35.18478931	-7.375974516	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1104	1793	0.002788622	0.003346347	0	9	OPC	NA	NA	NA
TCTATTGAGTTCGCAT-1_2_B4	22.85379251	18.80531543	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1014	1471	0.00067981	0.006798097	0	oligos	OL-Cntl	NA	NA	NA
TCTATTGCACACCGAC-1_2_B4	14.89221781	27.76883438	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	688	1043	0	0.000958773	0	oligos	OL-Cntl	NA	NA	NA
TCTATTGCAGAGCCAA-1_2_B4	3.64080144	-28.24933084	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3092	7729	0.010091862	0.002199508	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TCTATTGCATGTCTCC-1_2_B4	15.70796038	27.86820427	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	707	1018	0.012770138	0.006876228	0	oligos	OL-Cntl	NA	NA	NA
TCTATTGGTTATTCTC-1_2_B4	18.30075623	20.07555573	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	928	1605	0.003738318	0.003115265	0	oligos	OL-Cntl	NA	NA	NA
TCTATTGTCAACACAC-1_2_B4	8.219226198	28.84239213	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	829	1235	0.000809717	0.010526316	0	oligos	OL-Cntl	NA	NA	NA
TCTATTGTCGAATCCA-1_2_B4	1.857692288	-28.60901542	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3907	11603	0.006291476	0.002757907	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TCTATTGTCGGCGCTA-1_2_B4	-9.031273349	14.34139873	11	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1549	2435	0.005338809	0.004106776	0	11	Glia-MIX	NA	NA	NA
TCTATTGTCGTGACAT-1_2_B4	33.27770864	-2.12041266	2	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2225	4258	0.03452325	0.002818225	0	2	EN-L4	NA	NA	NA
TCTCATAAGAGATGAG-1_2_B4	32.16748893	15.22251358	14	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	852	1174	0.000851789	0.10306644	0	14	Microglia	NA	NA	NA
TCTCATACATGTTCCC-1_2_B4	8.977956754	23.95113082	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	770	1107	0.001806685	0.009033424	0	oligos	OL-Cntl	NA	NA	NA
TCTCATATCAGCGACC-1_2_B4	1.845742709	24.20956507	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	724	1036	0.008687259	0.003861004	0	oligos	OL-Cntl	NA	NA	NA
TCTCTAACAACTGCTA-1_2_B4	-36.47094618	-8.169225231	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	929	1404	0.004985755	0.002136752	0	9	OPC	NA	NA	NA
TCTGAGAAGAATGTTG-1_2_B4	-35.849937	-9.373558222	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	952	1432	0.006284916	0.000698324	0	9	OPC	NA	NA	NA
TCTGAGAAGCCCAACC-1_2_B4	11.27713645	24.01528332	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	931	1377	0.001452433	0.002178649	0	oligos	OL-Cntl	NA	NA	NA
TCTGAGAAGTAATCCC-1_2_B4	0.756902237	22.77593295	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	806	1153	0.008673027	0.01300954	0	oligos	OL-Cntl	NA	NA	NA
TCTGAGACATTTGCTT-1_2_B4	18.9897299	9.367656859	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1430	2751	0.001090513	0.005089059	0	oligos	OL-Cntl	NA	NA	NA
TCTGAGAGTGCAGACA-1_2_B4	10.79244088	1.563999505	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	725	1012	0.023715415	0.001976285	0	12	EN-MIX	NA	NA	NA
TCTGAGATCAACCATG-1_2_B4	-11.19906456	15.88218776	11	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1367	2277	0.003952569	0.002635046	0	11	Glia-MIX	NA	NA	NA
TCTGAGATCTATCCCG-1_2_B4	-23.16799938	22.72500455	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1434	2589	0.001931248	0.005021244	0	8	Astrocytes	NA	NA	NA
TCTGGAAAGATGTGTA-1_2_B4	-5.442697873	-9.752612203	13A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	848	1209	0.023159636	0.00248139	0	13A	IN-VIP	NA	NA	NA
TCTGGAAAGCGTTCCG-1_2_B4	2.303147525	-7.116593008	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1259	2020	0.016831683	0.003465347	0	12	EN-MIX	NA	NA	NA
TCTGGAAAGGATGTAT-1_2_B4	21.59247098	18.77885053	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1015	1600	0.0025	0.003125	0	oligos	OL-Cntl	NA	NA	NA
TCTGGAAAGTCCTCCT-1_2_B4	0.390617345	28.39691314	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	800	1118	0.001788909	0.002683363	0	oligos	OL-Cntl	NA	NA	NA
TCTGGAAAGTCTCGGC-1_2_B4	21.43911475	10.90497645	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1672	2850	0.004561404	0.004561404	0	oligos	OL-Cntl	NA	NA	NA
TCTGGAACAGACACTT-1_2_B4	9.693444257	-9.013169125	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2518	5944	0.002355316	0.000672948	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TCTGGAACATACTCTT-1_2_B4	-36.64193045	1.865741416	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1694	3014	0.000331785	0.001658925	0	9	OPC	NA	NA	NA
TCTGGAAGTGCAGGTA-1_2_B4	12.8891706	24.11519009	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	836	1241	0.012087027	0.006446414	0	oligos	OL-Cntl	NA	NA	NA
TCTGGAATCCTGCCAT-1_2_B4	-23.68578431	-0.932431778	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1446	2566	0.003507405	0.00233827	0	9	OPC	NA	NA	NA
TCTGGAATCCTGTACC-1_2_B4	27.40604098	0.382089794	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3937	11344	0.001763047	0.003702398	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TCTGGAATCGAGCCCA-1_2_B4	23.32491687	0.573159319	2	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2056	3857	0.002074151	0.001555613	0	2	EN-L4	NA	NA	NA
TCTTCGGAGTCAATAG-1_2_B4	-3.267018895	-6.719283447	13A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	890	1326	0.028657617	0.003016591	0	13A	IN-VIP	NA	NA	NA
TCTTCGGCACAAGCCC-1_2_B4	23.08804501	12.10498036	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1497	2572	0.001944012	0.003888025	0	oligos	OL-Cntl	NA	NA	NA
TCTTCGGGTAAGTTCC-1_2_B4	-27.38398174	14.55441231	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	854	1346	0.00371471	0.002971768	0	8	Astrocytes	NA	NA	NA
TCTTTCCAGTCCGTAT-1_2_B4	-12.07108706	14.74605714	11	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	959	1446	0	0.003457815	0	11	Glia-MIX	NA	NA	NA
TCTTTCCCACTTCGAA-1_2_B4	25.10852958	-4.072500334	2	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3723	11160	0.000537634	0.002508961	0	2	EN-L4	NA	NA	NA
TCTTTCCCAGCCACCA-1_2_B4	-31.63949141	11.69248673	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	787	1135	0.002643172	0.001762115	0	8	Astrocytes	NA	NA	NA
TCTTTCCCAGTCACTA-1_2_B4	26.26413953	0.099743365	2	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2507	5822	0.003607008	0.001545861	0	2	EN-L4	NA	NA	NA
TCTTTCCCATTTGCTT-1_2_B4	0.162265434	-12.86395646	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1889	3679	0.009785268	0.002446317	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TCTTTCCGTGCGGTAA-1_2_B4	27.5505899	-0.499826358	2	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2884	6701	0.00208924	0.001492315	0	2	EN-L4	NA	NA	NA
TCTTTCCTCACTGGGC-1_2_B4	-20.57022317	-26.89627392	6A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3229	8300	0.013493976	0.003855422	0	6A	IN-PV	NA	NA	NA
TCTTTCCTCATGCATG-1_2_B4	20.84487798	15.57786128	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1096	1840	0.001630435	0.002717391	0	oligos	OL-Cntl	NA	NA	NA
TCTTTCCTCTTCCTTC-1_2_B4	-32.60993393	-11.71556247	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	792	1250	0	0.0024	0	9	OPC	NA	NA	NA
TGAAAGAAGACAGACC-1_2_B4	38.42642987	8.757713771	14	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	732	1016	0.000984252	0.002952756	0	14	Microglia	NA	NA	NA
TGAAAGAAGCATGGCA-1_2_B4	10.91012683	31.8802195	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	798	1238	0.008885299	0.004846527	0	oligos	OL-Cntl	NA	NA	NA
TGAAAGACAAGGACTG-1_2_B4	33.31631531	14.72244046	14	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	849	1130	0.003539823	0.066371681	0	14	Microglia	NA	NA	NA
TGAAAGAGTCAGTGGA-1_2_B4	15.94500192	25.54055181	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	856	1297	0.00308404	0.00462606	0	oligos	OL-Cntl	NA	NA	NA
TGACAACAGAATGTGT-1_2_B4	3.016858893	-19.31363495	4	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2994	6501	0.006306722	0.005076142	0	L2-3	EN-L2-3-MS	NA	NA	NA
TGACAACCAAGCCGCT-1_2_B4	15.11181993	26.29607357	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	773	1164	0.00257732	0.001718213	0	oligos	OL-Cntl	NA	NA	NA
TGACAACCAATGGTCT-1_2_B4	9.575526925	21.64294755	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	814	1255	0.007968127	0.001593625	0	oligos	OL-Cntl	NA	NA	NA
TGACAACCAGCGAACA-1_2_B4	-24.88090855	29.40411148	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1939	3320	0.005120482	0.002409639	0	8	Astrocytes	NA	NA	NA
TGACAACCATGACGGA-1_2_B4	-36.08976692	-4.368806612	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1257	2090	0.002392344	0.005263158	0	9	OPC	NA	NA	NA
TGACAACGTAGCGTGA-1_2_B4	1.72412168	-22.88415496	4	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	5150	16908	0.010054412	0.004199196	0	L2-3	EN-L2-3-MS	NA	NA	NA
TGACAACGTTGATTGC-1_2_B4	21.00071552	17.81174961	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1092	1650	0.004242424	0.004848485	0	oligos	OL-Cntl	NA	NA	NA
TGACAACTCGTGGGAA-1_2_B4	14.92051495	28.56096086	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	786	1135	0	0.004405286	0	oligos	OL-Cntl	NA	NA	NA
TGACAACTCTACTTAC-1_2_B4	39.261487	14.65034088	14	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1226	1760	0.023295455	0.006818182	0	14	Microglia	NA	NA	NA
TGACGGCAGAGTACCG-1_2_B4	6.709243849	24.57285983	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	933	1382	0.005788712	0.002894356	0	oligos	OL-Cntl	NA	NA	NA
TGACGGCAGATCGATA-1_2_B4	22.48845171	-26.11374346	3	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3023	6561	0.006249047	0.005334553	0	3	EN-L5-6	NA	NA	NA
TGACGGCAGGCAATTA-1_2_B4	6.378344456	-6.261353068	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1342	2311	0.0263955	0.001730852	0	12	EN-MIX	NA	NA	NA
TGACGGCCACCAGATT-1_2_B4	0.218188245	28.76550529	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	868	1199	0.020850709	0.003336113	0	oligos	OL-Cntl	NA	NA	NA
TGACGGCCACGAAGCA-1_2_B4	-23.15508615	22.71831331	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1286	2222	0.001350135	0.00450045	0	8	Astrocytes	NA	NA	NA
TGACGGCCAGCGTCCA-1_2_B4	-14.4207571	-21.43530123	6A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1405	2462	0.009341998	0.002437043	0	6A	IN-PV	NA	NA	NA
TGACGGCGTATAAACG-1_2_B4	12.08884669	24.49225799	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	836	1220	0.002459016	0.008196721	0	oligos	OL-Cntl	NA	NA	NA
TGACGGCGTCCAAGTT-1_2_B4	16.33421553	-31.55378221	3	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	4660	13564	0.005086995	0.003981127	0	3	EN-L5-6	NA	NA	NA
TGACGGCGTCTGATTG-1_2_B4	15.02330468	-0.682026303	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	691	1034	0.008704062	0.00483559	0	12	EN-MIX	NA	NA	NA
TGACGGCTCAGTTCGA-1_2_B4	5.717643132	-32.10216593	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3586	9026	0.003323731	0.001883448	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TGACTAGAGGATATAC-1_2_B4	18.92087259	18.01295306	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1109	1723	0.002901915	0.004062681	0	oligos	OL-Cntl	NA	NA	NA
TGACTAGCATGTTGAC-1_2_B4	16.69533295	21.7518216	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	909	1419	0.011275546	0.002114165	0	oligos	OL-Cntl	NA	NA	NA
TGACTAGGTCAATGTC-1_2_B4	21.87607525	17.46134417	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1213	1851	0.001080497	0.006482982	0	oligos	OL-Cntl	NA	NA	NA
TGACTAGGTGTCCTCT-1_2_B4	27.47611173	-5.450241423	2	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	5001	14921	0.007573219	0.00361906	0	2	EN-L4	NA	NA	NA
TGACTTTAGAGACTAT-1_2_B4	24.51235231	-25.87958258	3	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2506	5155	0.009505335	0.003491756	0	3	EN-L5-6	NA	NA	NA
TGACTTTAGGACAGCT-1_2_B4	2.149179107	-10.75100897	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1611	2873	0.024364775	0.002784546	0	12	EN-MIX	NA	NA	NA
TGACTTTAGTGCGTGA-1_2_B4	-14.32584133	-18.9639019	6B	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1449	2636	0.036418816	0.003034901	0	6B	IN-SST	NA	NA	NA
TGACTTTCATGACATC-1_2_B4	0.306745385	5.984680677	11	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	889	1169	0.006843456	0.006843456	0	11	Glia-MIX	NA	NA	NA
TGACTTTGTGCAGACA-1_2_B4	13.80386089	24.84475427	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	826	1175	0.006808511	0.005106383	0	oligos	OL-Cntl	NA	NA	NA
TGACTTTTCTAACTGG-1_2_B4	-16.11382581	-18.85052156	6B	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1746	3301	0.01423811	0.006664647	0	6B	IN-SST	NA	NA	NA
TGACTTTTCTTTAGGG-1_2_B4	21.16501192	-5.516915088	2	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2042	3644	0.003567508	0.007958288	0	2	EN-L4	NA	NA	NA
TGAGAGGAGGCTAGCA-1_2_B4	-0.354389808	25.54843668	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	758	1052	0.003802281	0.011406844	0	oligos	OL-Cntl	NA	NA	NA
TGAGAGGCACAGCGTC-1_2_B4	15.68053286	-7.957996829	3	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2544	4651	0.004300151	0.004515158	0	3	EN-L5-6	NA	NA	NA
TGAGAGGCACTCGACG-1_2_B4	-13.4115656	-23.74390394	6A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1216	2098	0.04528122	0.003336511	0	6A	IN-PV	NA	NA	NA
TGAGAGGCACTTAACG-1_2_B4	-12.42096402	0.799926856	13A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3246	6916	0.006795836	0.009109312	0	13A	IN-VIP	NA	NA	NA
TGAGAGGGTAACGTTC-1_2_B4	-36.30004387	-5.546830949	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1232	1931	0.001553599	0.003625065	0	9	OPC	NA	NA	NA
TGAGAGGGTACCGTTA-1_2_B4	-3.195615175	-5.76857607	13A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1064	1823	0.016456391	0.002742732	0	13A	IN-VIP	NA	NA	NA
TGAGAGGTCAGAAATG-1_2_B4	4.099365274	-3.411589592	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	896	1246	0.020866774	0.007223114	0	12	EN-MIX	NA	NA	NA
TGAGAGGTCATTATCC-1_2_B4	-23.33815957	1.384860247	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3442	7716	0.004276827	0.003628823	0	9	OPC	NA	NA	NA
TGAGAGGTCCGCGCAA-1_2_B4	-17.4349842	-17.68097831	6B	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2172	4561	0.020390265	0.004165753	0	6B	IN-SST	NA	NA	NA
TGAGCATAGGTCATCT-1_2_B4	0.887625706	-28.58170004	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	5668	19723	0.004918116	0.003904071	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TGAGCATCACATCTTT-1_2_B4	-0.553693072	28.38412817	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	768	1081	0.000925069	0.002775208	0	oligos	OL-Cntl	NA	NA	NA
TGAGCATCAGCTATTG-1_2_B4	31.22128717	14.34265992	14	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	812	1094	0.00274223	0.077696527	0	14	Microglia	NA	NA	NA
TGAGCATGTAAGGATT-1_2_B4	24.66697657	-21.98153414	3	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3683	8492	0.007418747	0.005181347	0	3	EN-L5-6	NA	NA	NA
TGAGCATTCCATGAAC-1_2_B4	4.477589245	30.2713904	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	806	1163	0.004299226	0.006878762	0	oligos	OL-Cntl	NA	NA	NA
TGAGCCGAGAGTTGGC-1_2_B4	-0.15861478	28.54646423	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	784	1086	0.002762431	0.006445672	0	oligos	OL-Cntl	NA	NA	NA
TGAGCCGCATGGATGG-1_2_B4	3.459967381	32.0633849	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	758	1042	0.013435701	0.00671785	0	oligos	OL-Cntl	NA	NA	NA
TGAGCCGGTGCTAGCC-1_2_B4	2.723634902	28.47800354	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	784	1143	0.015748031	0.006999125	0	oligos	OL-Cntl	NA	NA	NA
TGAGCCGGTGGTCTCG-1_2_B4	-4.88623789	-10.52697314	6B	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	661	1004	0.006972112	0.00498008	0	6B	IN-SST	NA	NA	NA
TGAGCCGGTTGGTGGA-1_2_B4	-1.001739793	24.458841	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	764	1065	0.005633803	0.011267606	0	oligos	OL-Cntl	NA	NA	NA
TGAGCCGTCGTGGGAA-1_2_B4	1.027114068	-17.11870028	4	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2481	4620	0.004112554	0.003896104	0	L2-3	EN-L2-3-MS	NA	NA	NA
TGAGGGAGTCAGTGGA-1_2_B4	-12.09963537	-0.347494886	13A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2766	5365	0.010624418	0.005032619	0	13A	IN-VIP	NA	NA	NA
TGAGGGATCGCATGGC-1_2_B4	-9.751829331	13.59710448	11	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1266	1814	0.003858875	0.003307607	0	11	Glia-MIX	NA	NA	NA
TGATTTCAGCTAGTTC-1_2_B4	-36.26200771	-8.416218378	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	972	1551	0.001289491	0.004513217	0	9	OPC	NA	NA	NA
TGATTTCCAAGCGTAG-1_2_B4	-23.21148042	-0.720797285	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1412	2062	0.006304559	0.006304559	0	9	OPC	NA	NA	NA
TGATTTCTCAACACTG-1_2_B4	-37.01048232	-9.218732928	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	898	1405	0.000711744	0.004982206	0	9	OPC	NA	NA	NA
TGATTTCTCAACGGGA-1_2_B4	19.28408773	20.73182479	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1016	1558	0.003851091	0.003209243	0	oligos	OL-Cntl	NA	NA	NA
TGCACCTCACGACGAA-1_2_B4	-27.77664237	13.02318253	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	833	1240	0.004032258	0.00483871	0	8	Astrocytes	NA	NA	NA
TGCACCTGTAAGGGCT-1_2_B4	-11.63173556	-0.780093326	13A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2652	4887	0.011049724	0.007775732	0	13A	IN-VIP	NA	NA	NA
TGCACCTGTCACACGC-1_2_B4	4.275751094	-4.282845591	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1185	1914	0.008359457	0.006792059	0	12	EN-MIX	NA	NA	NA
TGCACCTGTCAGAAGC-1_2_B4	11.82207948	14.68777812	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1164	1777	0.001125492	0.019133371	0	oligos	OL-Cntl	NA	NA	NA
TGCACCTGTCTAGAGG-1_2_B4	20.28932985	20.41586381	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1040	1546	0.001940492	0.003880983	0	oligos	OL-Cntl	NA	NA	NA
TGCACCTTCAGTACGT-1_2_B4	15.34027667	8.803159404	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1691	2947	0.006447234	0.0108585	0	oligos	OL-Cntl	NA	NA	NA
TGCACCTTCCTGTACC-1_2_B4	17.42876113	22.83111246	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1016	1631	0.003678725	0.004291845	0	oligos	OL-Cntl	NA	NA	NA
TGCACCTTCGCGGATC-1_2_B4	18.58247074	8.46950838	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1704	3050	0.001639344	0.004918033	0	oligos	OL-Cntl	NA	NA	NA
TGCCAAAAGAAGATTC-1_2_B4	-3.287705511	-8.822140104	13A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	945	1266	0.018167457	0.003949447	0	13A	IN-VIP	NA	NA	NA
TGCCAAAAGCAACGGT-1_2_B4	4.616805602	-4.152804806	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1040	1600	0.035625	0.005625	0	12	EN-MIX	NA	NA	NA
TGCCAAAAGGTAGCTG-1_2_B4	2.987726304	-4.58488086	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	882	1343	0.018615041	0.002978407	0	12	EN-MIX	NA	NA	NA
TGCCAAATCAAACAAG-1_2_B4	6.478023861	25.75659098	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	919	1282	0.004680187	0.004680187	0	oligos	OL-Cntl	NA	NA	NA
TGCCAAATCAAAGTAG-1_2_B4	8.727101663	-23.77536078	4	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	5275	14097	0.003972476	0.008796198	0	L2-3	EN-L2-3-MS	NA	NA	NA
TGCCAAATCTTCTGGC-1_2_B4	17.53025099	23.51979774	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	843	1287	0.001554002	0.002331002	0	oligos	OL-Cntl	NA	NA	NA
TGCCCATAGGGCACTA-1_2_B4	-15.93650061	-25.33360453	6A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1998	4081	0.029894634	0.001715266	0	6A	IN-PV	NA	NA	NA
TGCCCATAGTACGTAA-1_2_B4	35.65489588	7.878937674	14	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	930	1276	0.021159875	0.009404389	0	14	Microglia	NA	NA	NA
TGCCCATCAAAGGTGC-1_2_B4	3.318413948	-14.02893069	4	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2218	3858	0.007516848	0.00933126	0	L2-3	EN-L2-3-MS	NA	NA	NA
TGCCCATCAGATCCAT-1_2_B4	24.89669108	-0.323898396	2	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2561	5310	0.000753296	0.003578154	0	2	EN-L4	NA	NA	NA
TGCCCATGTACATGTC-1_2_B4	20.04486551	17.57143185	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1201	1705	0.001759531	0.008797654	0	oligos	OL-Cntl	NA	NA	NA
TGCCCATGTCGCTTTC-1_2_B4	7.584790742	23.76850339	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	949	1356	0.002212389	0.005162242	0	oligos	OL-Cntl	NA	NA	NA
TGCCCATGTGCAGGTA-1_2_B4	-4.853050944	-2.313459028	13A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1508	2713	0.003317361	0.001842978	0	13A	IN-VIP	NA	NA	NA
TGCCCATTCTTCGAGA-1_2_B4	-16.08606432	-11.16646268	13B	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3062	7138	0.000560381	0.002801905	0	13B	IN-SV2C	NA	NA	NA
TGCCCTAAGGAGTTGC-1_2_B4	14.42154285	-0.631554309	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	752	1192	0.016778523	0.004194631	0	12	EN-MIX	NA	NA	NA
TGCCCTAAGGTGGGTT-1_2_B4	-19.65291052	8.921379488	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1144	1644	0.003041363	0.006082725	0	8	Astrocytes	NA	NA	NA
TGCCCTACAGCATACT-1_2_B4	1.153566232	-27.9246534	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	4209	12502	0.001359782	0.002719565	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TGCCCTACAGGCTCAC-1_2_B4	-1.650758885	-17.91095099	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3021	7511	0.009452803	0.002130209	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TGCCCTACATCAGTAC-1_2_B4	19.59173376	11.00862966	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1471	2582	0.001936483	0.00464756	0	oligos	OL-Cntl	NA	NA	NA
TGCCCTATCAGGTTCA-1_2_B4	-37.44023317	0.291469146	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1604	3091	0.004852798	0.002264639	0	9	OPC	NA	NA	NA
TGCCCTATCCGTACAA-1_2_B4	16.33044056	1.685462847	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	792	1223	0.008994276	0.000817661	0	12	EN-MIX	NA	NA	NA
TGCGCAGAGTGGAGTC-1_2_B4	14.34644541	27.25468804	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	702	1047	0.003820439	0.005730659	0	oligos	OL-Cntl	NA	NA	NA
TGCGCAGCATAACCTG-1_2_B4	15.33643436	-0.07112394	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	796	1177	0.003398471	0.005947324	0	12	EN-MIX	NA	NA	NA
TGCGCAGGTCCAGTAT-1_2_B4	20.24071926	18.03692127	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1073	1605	0.001869159	0.009968847	0	oligos	OL-Cntl	NA	NA	NA
TGCGCAGGTGTGTGCC-1_2_B4	-0.691531244	28.68154097	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	795	1124	0.001779359	0.007117438	0	oligos	OL-Cntl	NA	NA	NA
TGCGCAGTCTGCGGCA-1_2_B4	-13.67365426	-24.35984587	6A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1200	2137	0.002807674	0.000935891	0	6A	IN-PV	NA	NA	NA
TGCGGGTAGGGCTTCC-1_2_B4	16.28970695	17.02868683	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1074	1716	0.002913753	0.004662005	0	oligos	OL-Cntl	NA	NA	NA
TGCGGGTCAGCTCGAC-1_2_B4	-16.64794752	-9.802573891	13B	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3174	7379	0.005691828	0.003116954	0	13B	IN-SV2C	NA	NA	NA
TGCGGGTCAGCTGCTG-1_2_B4	13.65526119	17.79300724	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1066	1740	0.002298851	0.006896552	0	oligos	OL-Cntl	NA	NA	NA
TGCGGGTTCGTCTGAA-1_2_B4	3.477967751	-8.185696149	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1285	1867	0.012854847	0.001606856	0	12	EN-MIX	NA	NA	NA
TGCGTGGAGGTGATTA-1_2_B4	10.05129014	31.38793858	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	834	1143	0.005249344	0.003499563	0	oligos	OL-Cntl	NA	NA	NA
TGCGTGGCACTGTGTA-1_2_B4	11.07159687	1.476620378	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	816	1124	0.014234875	0.009786477	0	12	EN-MIX	NA	NA	NA
TGCGTGGGTAGCGTAG-1_2_B4	16.34098593	1.767915651	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	796	1190	0.068907563	0.001680672	0	12	EN-MIX	NA	NA	NA
TGCGTGGTCAACACAC-1_2_B4	2.468241879	-9.063648266	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1530	2808	0.011039886	0.002849003	0	12	EN-MIX	NA	NA	NA
TGCGTGGTCGACGGAA-1_2_B4	-0.318646295	28.11971503	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	776	1089	0.006427916	0.01010101	0	oligos	OL-Cntl	NA	NA	NA
TGCTACCAGAGATGAG-1_2_B4	4.521108716	27.54559291	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	834	1200	0.0025	0.009166667	0	oligos	OL-Cntl	NA	NA	NA
TGCTACCGTATGGTTC-1_2_B4	15.06634603	-2.212903046	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1059	1985	0.006549118	0.004534005	0	12	EN-MIX	NA	NA	NA
TGCTACCGTGGAAAGA-1_2_B4	-25.70810109	17.68483934	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1221	1947	0.002054443	0.002568053	0	8	Astrocytes	NA	NA	NA
TGCTACCTCACCATAG-1_2_B4	20.36860121	20.06995979	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1086	1767	0.003395586	0.001131862	0	oligos	OL-Cntl	NA	NA	NA
TGCTACCTCATAACCG-1_2_B4	0.510340619	26.31516682	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	884	1277	0.002349256	0.005481597	0	oligos	OL-Cntl	NA	NA	NA
TGCTGCTAGAGTACCG-1_2_B4	-2.865302733	22.47282064	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	773	1018	0.006876228	0.008840864	0	oligos	OL-Cntl	NA	NA	NA
TGCTGCTAGGCAGTCA-1_2_B4	31.4630329	-7.521092965	2	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3966	9066	0.010037503	0.011250827	0	2	EN-L4	NA	NA	NA
TGCTGCTGTAGCTCCG-1_2_B4	27.23254247	-0.974355902	2	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3236	7420	0.001347709	0.002560647	0	2	EN-L4	NA	NA	NA
TGCTGCTGTCGCATCG-1_2_B4	15.71397744	15.16863709	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1188	1859	0.003227542	0.00591716	0	oligos	OL-Cntl	NA	NA	NA
TGCTGCTGTGTCCTCT-1_2_B4	21.29824882	7.592130558	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2028	3712	0.001616379	0.003502155	0	oligos	OL-Cntl	NA	NA	NA
TGCTGCTGTTGTCGCG-1_2_B4	30.19625773	-3.05940559	2	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3311	8037	0.000995396	0.002364066	0	2	EN-L4	NA	NA	NA
TGCTGCTTCATGCATG-1_2_B4	37.41468583	9.159162098	14	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	798	1034	0.01934236	0.008704062	0	14	Microglia	NA	NA	NA
TGCTGCTTCCCAAGAT-1_2_B4	35.5162348	7.891114219	14	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	838	1073	0.005591799	0.021435228	0	14	Microglia	NA	NA	NA
TGCTGCTTCGACGGAA-1_2_B4	-18.79568062	6.492508871	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	599	1024	0.000976563	0.005859375	0	8	Astrocytes	NA	NA	NA
TGCTGCTTCTGCAAGT-1_2_B4	20.43070053	-27.66398878	3	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2846	5822	0.004637582	0.00377877	0	3	EN-L5-6	NA	NA	NA
TGGACGCAGGCTACGA-1_2_B4	-17.93983215	6.680857463	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	754	1063	0.003762935	0.002822201	0	8	Astrocytes	NA	NA	NA
TGGACGCGTACCGTTA-1_2_B4	14.51085508	22.80978834	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	872	1239	0.002421308	0.00645682	0	oligos	OL-Cntl	NA	NA	NA
TGGACGCGTCATTAGC-1_2_B4	15.27055962	-0.455599909	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	864	1614	0.001239157	0.002478315	0	12	EN-MIX	NA	NA	NA
TGGCCAGAGAACTGTA-1_2_B4	17.69046376	27.36370927	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	896	1294	0.00927357	0.00927357	0	oligos	OL-Cntl	NA	NA	NA
TGGCCAGAGAGTACAT-1_2_B4	15.38700692	20.80867714	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1016	1553	0.005795235	0.00772698	0	oligos	OL-Cntl	NA	NA	NA
TGGCCAGAGGCTACGA-1_2_B4	22.42930953	15.53651901	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1503	2481	0.003224506	0.012898025	0	oligos	OL-Cntl	NA	NA	NA
TGGCCAGCAGAAGCAC-1_2_B4	8.075132303	-7.665767994	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1914	3653	0.0057487	0.001368738	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TGGCCAGCAGACACTT-1_2_B4	13.36598013	2.371529462	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	735	1000	0.017	0.004	0	12	EN-MIX	NA	NA	NA
TGGCCAGCAGATCGGA-1_2_B4	5.703872893	-5.635977702	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1137	1865	0.009115282	0.002144772	0	12	EN-MIX	NA	NA	NA
TGGCCAGCATGTAAGA-1_2_B4	7.002552995	-32.13428235	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	5828	19984	0.003002402	0.002451962	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TGGCCAGGTCAAACTC-1_2_B4	-14.71718513	-7.104264853	13A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3731	10073	0.026109401	0.003176809	0	13A	IN-VIP	NA	NA	NA
TGGCCAGGTGCGGTAA-1_2_B4	-0.930476535	27.94585794	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	841	1239	0.001614205	0.00322841	0	oligos	OL-Cntl	NA	NA	NA
TGGCCAGGTTCCCTTG-1_2_B4	4.555347819	27.68467155	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	821	1166	0.015437393	0.006861063	0	oligos	OL-Cntl	NA	NA	NA
TGGCCAGTCGGCGCAT-1_2_B4	23.67318233	13.68134907	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1144	1832	0.000545852	0.002729258	0	oligos	OL-Cntl	NA	NA	NA
TGGCGCAAGGCTAGGT-1_2_B4	6.740704739	26.62853572	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	941	1355	0.004428044	0.005904059	0	oligos	OL-Cntl	NA	NA	NA
TGGCGCACAAACCTAC-1_2_B4	30.17108857	-5.808217537	2	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	4010	10030	0.009670987	0.003888335	0	2	EN-L4	NA	NA	NA
TGGCGCACACGCATCG-1_2_B4	13.89075856	26.55427217	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	756	1164	0.001718213	0.005154639	0	oligos	OL-Cntl	NA	NA	NA
TGGCGCACACGGTAAG-1_2_B4	15.55374569	23.3386131	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	875	1262	0.004754358	0.001584786	0	oligos	OL-Cntl	NA	NA	NA
TGGCGCACAGACACTT-1_2_B4	4.463064293	4.258292558	7	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1903	2798	0.008934954	0.038241601	0	7	Phagocytes	NA	NA	NA
TGGCGCAGTCTCTCGT-1_2_B4	27.26514512	5.108183058	15A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	781	1086	0.001841621	0.007366483	0	15A	Endo cells	NA	NA	NA
TGGCGCATCAAGGCTT-1_2_B4	-11.325803	-8.064549945	13B	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1550	2508	0.012759171	0.006379585	0	13B	IN-SV2C	NA	NA	NA
TGGCTGGAGACAAGCC-1_2_B4	18.01816498	16.27352531	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1159	1791	0.005025126	0.011166946	0	oligos	OL-Cntl	NA	NA	NA
TGGCTGGAGAGAACAG-1_2_B4	-21.99647045	10.11098039	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	879	1219	0.009844135	0.003281378	0	8	Astrocytes	NA	NA	NA
TGGCTGGAGAGTACCG-1_2_B4	15.41107571	17.08852982	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1099	1680	0.00297619	0.008333333	0	oligos	OL-Cntl	NA	NA	NA
TGGCTGGAGCCAACAG-1_2_B4	18.9134694	7.830027219	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1947	3666	0.003273322	0.006273868	0	oligos	OL-Cntl	NA	NA	NA
TGGCTGGCACATTTCT-1_2_B4	20.71535396	12.46474417	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1338	2253	0.000887705	0.007545495	0	oligos	OL-Cntl	NA	NA	NA
TGGCTGGGTCGGCTCA-1_2_B4	11.32365914	25.16011928	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	811	1172	0.005119454	0.003412969	0	oligos	OL-Cntl	NA	NA	NA
TGGCTGGGTGAAGGCT-1_2_B4	-22.44780299	23.82877042	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1390	2140	0.009813084	0.005140187	0	8	Astrocytes	NA	NA	NA
TGGCTGGGTTACTGAC-1_2_B4	17.20136233	15.37256801	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1133	1804	0.003325942	0.007206208	0	oligos	OL-Cntl	NA	NA	NA
TGGCTGGGTTCATGGT-1_2_B4	-37.08563869	1.945693819	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1667	2951	0.003049814	0.002033209	0	9	OPC	NA	NA	NA
TGGCTGGTCCCAGGTG-1_2_B4	21.02541731	14.74022904	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1185	1750	0.000571429	0.008	0	oligos	OL-Cntl	NA	NA	NA
TGGCTGGTCCTGTAGA-1_2_B4	21.48252365	10.11678439	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1619	2617	0.004585403	0.008788689	0	oligos	OL-Cntl	NA	NA	NA
TGGCTGGTCTCCTATA-1_2_B4	14.67393101	27.86360777	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	697	1045	0.000956938	0.002870813	0	oligos	OL-Cntl	NA	NA	NA
TGGGAAGAGAAGGGTA-1_2_B4	-5.515688374	-10.41148307	6B	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	783	1089	0.043158861	0.003673095	0	6B	IN-SST	NA	NA	NA
TGGGAAGCACTACAGT-1_2_B4	-31.88938608	11.99608782	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	814	1207	0	0.003314002	0	8	Astrocytes	NA	NA	NA
TGGGAAGCATGGGACA-1_2_B4	19.07791047	6.245577674	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2519	4893	0.004087472	0.005313713	0	oligos	OL-Cntl	NA	NA	NA
TGGGAAGGTAGCTGCC-1_2_B4	-11.21906565	-0.002737949	13A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2780	5678	0.019373019	0.007749207	0	13A	IN-VIP	NA	NA	NA
TGGGAAGTCGTCGTTC-1_2_B4	18.88474368	25.42888904	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1024	1557	0.002569043	0.006422608	0	oligos	OL-Cntl	NA	NA	NA
TGGGAAGTCTCACATT-1_2_B4	10.75328626	-34.103662	3	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	5459	18029	0.003050641	0.003272505	0	3	EN-L5-6	NA	NA	NA
TGGGCGTAGTACGCGA-1_2_B4	2.203451465	-8.14237317	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1384	2268	0.007936508	0.005291005	0	12	EN-MIX	NA	NA	NA
TGGGCGTGTAAATACG-1_2_B4	9.662094587	26.62248107	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	729	1070	0	0.005607477	0	oligos	OL-Cntl	NA	NA	NA
TGGGCGTGTAGCGATG-1_2_B4	-24.18689215	22.29948148	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1218	1967	0.004067107	0.004067107	0	8	Astrocytes	NA	NA	NA
TGGGCGTGTCCGAATT-1_2_B4	18.3183884	7.282615985	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1990	3602	0.003053859	0.010272071	0	oligos	OL-Cntl	NA	NA	NA
TGGGCGTTCACCCGAG-1_2_B4	32.08842004	-9.583960181	2	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	4121	9228	0.013437365	0.00704378	0	2	EN-L4	NA	NA	NA
TGGGCGTTCTGTCTAT-1_2_B4	2.49832064	-10.65017557	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1416	2339	0.013253527	0.005985464	0	12	EN-MIX	NA	NA	NA
TGGTTAGAGATCGGGT-1_2_B4	4.125595926	-28.92485578	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3211	7727	0.001941245	0.00245891	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TGGTTAGCACCTCGTT-1_2_B4	-9.047535288	16.6827513	11	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2676	5046	0.004359889	0.005152596	0	11	Glia-MIX	NA	NA	NA
TGGTTAGCATAGACTC-1_2_B4	22.58605576	18.46327011	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1177	1809	0.011608624	0.004422333	0	oligos	OL-Cntl	NA	NA	NA
TGGTTAGGTTACCAGT-1_2_B4	14.12305987	2.452124582	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	754	1014	0.006903353	0.00591716	0	12	EN-MIX	NA	NA	NA
TGGTTAGTCAGCGACC-1_2_B4	14.07211986	26.26401848	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	746	1032	0.003875969	0.006782946	0	oligos	OL-Cntl	NA	NA	NA
TGGTTCCAGGTAGCTG-1_2_B4	7.26625774	20.47382862	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	945	1387	0.003604903	0.01297765	0	oligos	OL-Cntl	NA	NA	NA
TGGTTCCAGTCTCAAC-1_2_B4	-4.886196408	-5.21922987	13A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1199	2009	0.028372325	0.004479841	0	13A	IN-VIP	NA	NA	NA
TGGTTCCGTCCTCCAT-1_2_B4	39.79651212	14.55920821	14	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1209	1830	0.008743169	0.004918033	0	14	Microglia	NA	NA	NA
TGGTTCCTCTTTACGT-1_2_B4	-1.188600126	-24.94539348	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	4679	14676	0.004497138	0.002521123	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TGTATTCCAATCAGAA-1_2_B4	26.1818258	0.367045664	2	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2712	6506	0.000153704	0.002305564	0	2	EN-L4	NA	NA	NA
TGTATTCGTCGCATAT-1_2_B4	-4.219706758	-8.971849693	13A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	747	1096	0.046532847	0.000912409	0	13A	IN-VIP	NA	NA	NA
TGTATTCGTCTACCTC-1_2_B4	-5.971476715	-4.514288038	13A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1409	2687	0.041310011	0.002605136	0	13A	IN-VIP	NA	NA	NA
TGTATTCGTCTCTCTG-1_2_B4	4.674175829	24.8511266	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	799	1166	0.004288165	0.002572899	0	oligos	OL-Cntl	NA	NA	NA
TGTATTCTCCGCGCAA-1_2_B4	11.23178464	23.05987825	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	777	1088	0.000919118	0.011029412	0	oligos	OL-Cntl	NA	NA	NA
TGTATTCTCTTGTCAT-1_2_B4	11.98932193	25.33521486	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	762	1111	0.00270027	0.00270027	0	oligos	OL-Cntl	NA	NA	NA
TGTCCCAAGGATGGTC-1_2_B4	23.15778635	18.49047027	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1226	1775	0.004507042	0.005070423	0	oligos	OL-Cntl	NA	NA	NA
TGTCCCAAGTCAATAG-1_2_B4	2.996717023	-11.74492527	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1804	3053	0.010153947	0.009171307	0	12	EN-MIX	NA	NA	NA
TGTCCCACATATACCG-1_2_B4	10.75911045	2.406554191	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	765	1050	0.03047619	0.002857143	0	12	EN-MIX	NA	NA	NA
TGTCCCAGTCTCTTTA-1_2_B4	2.790445259	-3.449246487	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	817	1198	0.011686144	0.005843072	0	12	EN-MIX	NA	NA	NA
TGTCCCAGTCTGGTCG-1_2_B4	4.623787784	-3.510929171	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	949	1498	0.020026702	0.003337784	0	12	EN-MIX	NA	NA	NA
TGTCCCAGTTCATGGT-1_2_B4	0.524755674	27.58134888	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	775	1079	0	0.007414272	0	oligos	OL-Cntl	NA	NA	NA
TGTGGTACAACCGCCA-1_2_B4	-37.62540234	-4.586417517	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1248	2092	0.003824092	0.006692161	0	9	OPC	NA	NA	NA
TGTGGTAGTCTACCTC-1_2_B4	14.01645241	21.74392786	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	889	1281	0.00156128	0.005464481	0	oligos	OL-Cntl	NA	NA	NA
TGTGTTTAGACCGGAT-1_2_B4	-26.28566314	15.8439786	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	975	1415	0.001413428	0.006360424	0	8	Astrocytes	NA	NA	NA
TGTGTTTGTGCCTGGT-1_2_B4	-36.33581349	-6.282611437	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1016	1608	0.004975124	0.003109453	0	9	OPC	NA	NA	NA
TGTGTTTTCTTATCTG-1_2_B4	0.416323681	27.26411485	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	689	1005	0.0039801	0.009950249	0	oligos	OL-Cntl	NA	NA	NA
TGTTCCGAGAGTCGGT-1_2_B4	4.997741917	29.46738041	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	739	1088	0	0.007352941	0	oligos	OL-Cntl	NA	NA	NA
TGTTCCGCAGTAACGG-1_2_B4	2.439883305	29.16685491	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	718	1012	0.008893281	0.001976285	0	oligos	OL-Cntl	NA	NA	NA
TGTTCCGGTCTAAAGA-1_2_B4	4.836702995	-5.226459937	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	868	1323	0.0287226	0.003023432	0	12	EN-MIX	NA	NA	NA
TGTTCCGTCCTCATTA-1_2_B4	22.91283209	1.063174325	2	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1712	2991	0.002006018	0.003343363	0	2	EN-L4	NA	NA	NA
TGTTCCGTCTGAGGGA-1_2_B4	-1.106662034	25.07375727	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	693	1001	0.002997003	0.00999001	0	oligos	OL-Cntl	NA	NA	NA
TTAACTCAGATCCCGC-1_2_B4	-36.29786444	-7.577079175	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1046	1790	0.006703911	0.002234637	0	9	OPC	NA	NA	NA
TTAACTCTCATGCATG-1_2_B4	18.73209031	14.40592469	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1154	1982	0.01160444	0.005045409	0	oligos	OL-Cntl	NA	NA	NA
TTAACTCTCTAACTTC-1_2_B4	-29.83591205	20.85605094	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	863	1541	0.003893576	0.005191434	0	8	Astrocytes	NA	NA	NA
TTAGGACAGCAGGTCA-1_2_B4	2.759776063	-3.382960309	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	735	1043	0.004793864	0.003835091	0	12	EN-MIX	NA	NA	NA
TTAGGACAGGGCACTA-1_2_B4	3.077448142	-3.240390683	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	786	1129	0.012400354	0.007085917	0	12	EN-MIX	NA	NA	NA
TTAGGCAAGTGGGCTA-1_2_B4	12.04451189	25.83965405	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	764	1117	0.005371531	0.003581021	0	oligos	OL-Cntl	NA	NA	NA
TTAGGCACAAGTTAAG-1_2_B4	9.604211808	-8.574242328	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2340	4746	0.000421408	0.002317741	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TTAGGCAGTATAGGGC-1_2_B4	16.70824514	1.629978962	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	873	1339	0.035847647	0.000746826	0	12	EN-MIX	NA	NA	NA
TTAGTTCAGCGTGAAC-1_2_B4	16.1170739	22.98443201	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	871	1292	0.008513932	0.003869969	0	oligos	OL-Cntl	NA	NA	NA
TTAGTTCAGGCCCTCA-1_2_B4	19.55802705	1.624564555	2	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1276	2064	0.003391473	0.003391473	0	2	EN-L4	NA	NA	NA
TTAGTTCAGTACACCT-1_2_B4	12.04866889	24.56091903	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	801	1264	0.001582278	0.004746835	0	oligos	OL-Cntl	NA	NA	NA
TTATGCTAGCATGGCA-1_2_B4	-10.89329896	-21.56316224	6A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	843	1461	0.066392882	0.003422313	0	6A	IN-PV	NA	NA	NA
TTATGCTAGCGATGAC-1_2_B4	13.86233926	-32.36238664	3	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3522	9722	0.000308578	0.001851471	0	3	EN-L5-6	NA	NA	NA
TTATGCTCATACCATG-1_2_B4	20.87939952	1.719257752	2	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1677	3187	0.005647945	0.000941324	0	2	EN-L4	NA	NA	NA
TTATGCTCATTCGACA-1_2_B4	-0.313318331	-0.388621131	11	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1213	1975	0.044556962	0.004050633	0	11	Glia-MIX	NA	NA	NA
TTATGCTGTCGAGTTT-1_2_B4	0.250077793	32.55788791	17	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	793	1133	0.013239188	0.002647838	0	oligos	OL-MS-2	NA	NA	NA
TTCCCAGAGTATCTCG-1_2_B4	-11.58393831	-21.23093257	6A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1162	2120	0.102830189	0.003773585	0	6A	IN-PV	NA	NA	NA
TTCCCAGCAGATCCAT-1_2_B4	23.10394643	-9.088447571	3	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2951	6883	0.009443557	0.002615139	0	3	EN-L5-6	NA	NA	NA
TTCCCAGCATGCAACT-1_2_B4	39.96732149	11.94123725	14	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	942	1359	0.014716703	0.004415011	0	14	Microglia	NA	NA	NA
TTCCCAGGTCATATGC-1_2_B4	-17.59707095	-11.48313831	13B	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3037	6695	0.005974608	0.005377147	0	13B	IN-SV2C	NA	NA	NA
TTCCCAGTCCGCGGTA-1_2_B4	21.07720072	14.30013724	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1265	2116	0.002362949	0.004725898	0	oligos	OL-Cntl	NA	NA	NA
TTCGAAGAGTGGACGT-1_2_B4	7.724795996	23.91406307	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	997	1435	0.012543554	0.011149826	0	oligos	OL-Cntl	NA	NA	NA
TTCGAAGGTTACGCGC-1_2_B4	17.32942738	27.08570816	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	904	1346	0.004457652	0.002971768	0	oligos	OL-Cntl	NA	NA	NA
TTCGAAGTCACGCGGT-1_2_B4	-35.58025267	-2.458995666	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1364	2262	0	0.001768347	0	9	OPC	NA	NA	NA
TTCGAAGTCATGTGGT-1_2_B4	15.79999984	22.46186404	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	861	1304	0.000766871	0.004601227	0	oligos	OL-Cntl	NA	NA	NA
TTCGAAGTCATTCACT-1_2_B4	15.97347128	22.4803607	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	834	1257	0	0.005568815	0	oligos	OL-Cntl	NA	NA	NA
TTCGAAGTCTCCAACC-1_2_B4	-9.662286454	14.47794118	11	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1442	2127	0.007992478	0.004701457	0	11	Glia-MIX	NA	NA	NA
TTCGGTCAGCCATCGC-1_2_B4	12.18943887	23.35668855	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	950	1498	0.002670227	0.003337784	0	oligos	OL-Cntl	NA	NA	NA
TTCGGTCAGTTAAGTG-1_2_B4	31.48519004	15.45223131	14	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1112	1498	0.000667557	0.080106809	0	14	Microglia	NA	NA	NA
TTCGGTCCAGTGAGTG-1_2_B4	16.80247954	16.05170575	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1178	1855	0.005390836	0.005929919	0	oligos	OL-Cntl	NA	NA	NA
TTCGGTCGTGCACTTA-1_2_B4	19.2195803	14.52714954	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1072	1709	0.001755413	0.004095963	0	oligos	OL-Cntl	NA	NA	NA
TTCGGTCGTTATGCGT-1_2_B4	9.925092669	-8.332235209	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2058	4215	0.001423488	0.001897983	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TTCGGTCGTTCCACAA-1_2_B4	-28.52903711	22.52864459	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1083	1813	0.002206288	0.004412576	0	8	Astrocytes	NA	NA	NA
TTCGGTCTCATATCGG-1_2_B4	4.252447423	-29.31876123	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3028	7376	0.001898048	0.002033623	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TTCGGTCTCCAGAGGA-1_2_B4	12.07982981	25.64525772	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	728	1047	0.00286533	0.004775549	0	oligos	OL-Cntl	NA	NA	NA
TTCGGTCTCCCTTGTG-1_2_B4	-23.18548807	25.08316933	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1476	2642	0.006056018	0.004163512	0	8	Astrocytes	NA	NA	NA
TTCTACACAGCCTGTG-1_2_B4	4.570068696	19.61337614	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1033	1476	0.025745257	0.013550136	0	oligos	OL-Cntl	NA	NA	NA
TTCTACACAGCCTTGG-1_2_B4	-0.280718374	0.517110886	11	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1114	1668	0.040767386	0.004796163	0	11	Glia-MIX	NA	NA	NA
TTCTACAGTCTAGTCA-1_2_B4	-31.00416893	12.92451613	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	795	1211	0.001651528	0.003303055	0	8	Astrocytes	NA	NA	NA
TTCTCAAAGAAGGACA-1_2_B4	12.25982259	27.72823259	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	697	1028	0.000972763	0.008754864	0	oligos	OL-Cntl	NA	NA	NA
TTCTCAAAGAATTCCC-1_2_B4	20.17852957	15.58024681	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1091	1805	0.017174515	0.002216066	0	oligos	OL-Cntl	NA	NA	NA
TTCTCAACAACACGCC-1_2_B4	25.703487	-28.67411744	3	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	4350	13661	0.001390821	0.002928043	0	3	EN-L5-6	NA	NA	NA
TTCTCAACAAGCGAGT-1_2_B4	20.46009128	19.38373219	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1004	1589	0.00188798	0.004405286	0	oligos	OL-Cntl	NA	NA	NA
TTCTCAACACATCCAA-1_2_B4	22.68897924	18.16467538	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1113	1748	0.007437071	0.007437071	0	oligos	OL-Cntl	NA	NA	NA
TTCTCAAGTGTTTGGT-1_2_B4	3.341947839	-3.192459425	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	807	1180	0.013559322	0.007627119	0	12	EN-MIX	NA	NA	NA
TTCTCAAGTTCTGAAC-1_2_B4	-8.994768836	13.64941769	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1194	1882	0.002125399	0.003719447	0	oligos	OL-Cntl	NA	NA	NA
TTCTCAATCTATCCCG-1_2_B4	3.213082652	25.05257861	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	756	1080	0.010185185	0.002777778	0	oligos	OL-Cntl	NA	NA	NA
TTCTCCTAGGACAGCT-1_2_B4	12.11661678	27.48236612	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	783	1209	0.004135649	0.003308519	0	oligos	OL-Cntl	NA	NA	NA
TTCTCCTCATCGATTG-1_2_B4	-31.52966406	13.0643056	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	749	1173	0.000852515	0.004262575	0	8	Astrocytes	NA	NA	NA
TTCTCCTGTGAAGGCT-1_2_B4	3.708709878	-2.988953811	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	757	1089	0.01010101	0.001836547	0	12	EN-MIX	NA	NA	NA
TTCTCCTGTTCCACAA-1_2_B4	38.20033435	14.05375706	14	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1020	1408	0.002130682	0.020596591	0	14	Microglia	NA	NA	NA
TTCTCCTTCATCACCC-1_2_B4	13.99937546	22.80741846	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	846	1305	0.003065134	0.004597701	0	oligos	OL-Cntl	NA	NA	NA
TTCTTAGCAACCGCCA-1_2_B4	10.60437105	-33.95508875	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	4084	13211	0.001059723	0.001816668	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TTCTTAGCACAAGCCC-1_2_B4	-9.552685576	17.95780373	11	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2612	5524	0.003258508	0.003620565	0	11	Glia-MIX	NA	NA	NA
TTGAACGCAGGTTTCA-1_2_B4	30.52830926	-3.134882541	2	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3306	7801	0.010511473	0.002563774	0	2	EN-L4	NA	NA	NA
TTGAACGTCATGCATG-1_2_B4	3.432308636	26.67123917	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	751	1058	0.009451796	0.006616257	0	oligos	OL-Cntl	NA	NA	NA
TTGAACGTCTCCAACC-1_2_B4	12.72126301	-33.03419032	2	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3339	8736	0.006295788	0.00206044	0	2	EN-L4	NA	NA	NA
TTGACTTAGTCAAGCG-1_2_B4	3.346947967	-5.232884154	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1003	1603	0.018091079	0.002495321	0	12	EN-MIX	NA	NA	NA
TTGACTTGTAAGTGGC-1_2_B4	1.035272011	-16.8644355	4	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2503	5317	0.005266128	0.006206507	0	L2-3	EN-L2-3-MS	NA	NA	NA
TTGACTTGTACCGCTG-1_2_B4	-14.92288045	-6.81565119	13A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2640	5489	0.006740754	0.006558572	0	13A	IN-VIP	NA	NA	NA
TTGACTTTCAAACGGG-1_2_B4	16.62233487	24.78841207	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	857	1278	0.004694836	0.002347418	0	oligos	OL-Cntl	NA	NA	NA
TTGACTTTCCCTTGTG-1_2_B4	0.034360959	-15.80605605	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2380	5103	0.004899079	0.004115226	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TTGCCGTTCACAATGC-1_2_B4	2.784572368	4.605055486	7	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1067	1466	0.006821282	0.007503411	0	7	Phagocytes	NA	NA	NA
TTGCCGTTCGGATGTT-1_2_B4	5.608448777	22.09467859	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	803	1105	0.009049774	0.006334842	0	oligos	OL-Cntl	NA	NA	NA
TTGCCGTTCTAAGCCA-1_2_B4	15.25091513	30.45359949	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	769	1080	0.000925926	0.003703704	0	oligos	OL-Cntl	NA	NA	NA
TTGCGTCAGGTGGGTT-1_2_B4	-35.91033813	-3.948487751	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1402	2245	0.001781737	0.004454343	0	9	OPC	NA	NA	NA
TTGCGTCGTAGCACGA-1_2_B4	4.6799065	-10.93629021	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1695	2633	0.008355488	0.006456513	0	12	EN-MIX	NA	NA	NA
TTGCGTCTCAGTACGT-1_2_B4	-20.92340228	8.343151503	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	826	1245	0	0.002409639	0	8	Astrocytes	NA	NA	NA
TTGGAACCACACAGAG-1_2_B4	23.26880372	18.39579731	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1177	1760	0.000568182	0.007386364	0	oligos	OL-Cntl	NA	NA	NA
TTGGAACTCAGAAATG-1_2_B4	21.56808776	-8.504100302	3	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1716	3173	0.013551844	0.004097069	0	3	EN-L5-6	NA	NA	NA
TTGGCAAAGACTACAA-1_2_B4	3.497105709	25.42129791	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	775	1188	0.001683502	0.004208754	0	oligos	OL-Cntl	NA	NA	NA
TTGGCAACAAGCGTAG-1_2_B4	22.11101996	15.07147781	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1163	1766	0.001132503	0.002831257	0	oligos	OL-Cntl	NA	NA	NA
TTGGCAACACAGCCCA-1_2_B4	1.004315925	21.58243632	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	753	1072	0.008395522	0.012126866	0	oligos	OL-Cntl	NA	NA	NA
TTGGCAACAGGCGATA-1_2_B4	12.86305581	20.77626193	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	994	1443	0.006237006	0.002079002	0	oligos	OL-Cntl	NA	NA	NA
TTGGCAACAGGGTACA-1_2_B4	15.08531336	22.60501764	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	884	1315	0.008365019	0.003041825	0	oligos	OL-Cntl	NA	NA	NA
TTGTAGGAGTTATCGC-1_2_B4	15.4983874	27.78356007	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	756	1096	0.002737226	0.004562044	0	oligos	OL-Cntl	NA	NA	NA
TTGTAGGCAGCGAACA-1_2_B4	-29.34336216	19.32787133	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	931	1412	0.009206799	0.004249292	0	8	Astrocytes	NA	NA	NA
TTGTAGGCAGTACACT-1_2_B4	24.84905121	-0.181799156	2	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2359	4859	0.00226384	0.002881251	0	2	EN-L4	NA	NA	NA
TTGTAGGCATCACCCT-1_2_B4	9.921159371	26.477244	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	754	1094	0.001828154	0.006398537	0	oligos	OL-Cntl	NA	NA	NA
TTGTAGGCATGCCCGA-1_2_B4	7.019834311	-6.938477098	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1387	2513	0.027457222	0.001193792	0	12	EN-MIX	NA	NA	NA
TTGTAGGCATTCTTAC-1_2_B4	16.08142226	22.88982834	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	886	1318	0.010622155	0.008345979	0	oligos	OL-Cntl	NA	NA	NA
TTGTAGGGTCCGCTGA-1_2_B4	22.67051233	12.92292197	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1238	2076	0.00433526	0.001926782	0	oligos	OL-Cntl	NA	NA	NA
TTGTAGGTCGTAGATC-1_2_B4	-7.314010326	-2.887968096	13A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1708	3277	0.030210558	0.002441257	0	13A	IN-VIP	NA	NA	NA
TTTACTGAGAAGATTC-1_2_B4	15.94582998	27.70679695	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	765	1204	0.002491694	0.004983389	0	oligos	OL-Cntl	NA	NA	NA
TTTACTGCAAGGTTTC-1_2_B4	14.42260192	22.70505242	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	862	1303	0.002302379	0.006907137	0	oligos	OL-Cntl	NA	NA	NA
TTTACTGGTGCGCTTG-1_2_B4	15.6768864	27.84650944	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	798	1261	0.000793021	0.006344171	0	oligos	OL-Cntl	NA	NA	NA
TTTATGCAGGCGACAT-1_2_B4	4.336485616	-29.51514045	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3178	9329	0.001822275	0.001500697	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TTTATGCCAGATCTGT-1_2_B4	1.617394077	26.96220053	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	672	1005	0.000995025	0.004975124	0	oligos	OL-Cntl	NA	NA	NA
TTTATGCCAGCTGGCT-1_2_B4	25.80437792	-29.14137499	3	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	4653	16443	0.000668978	0.002189381	0	3	EN-L5-6	NA	NA	NA
TTTATGCGTAGCTAAA-1_2_B4	3.036443837	-27.4240689	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3086	7780	0.004755784	0.003727506	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TTTATGCGTCGAATCT-1_2_B4	14.85372284	27.51690642	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	720	1015	0.003940887	0.004926108	0	oligos	OL-Cntl	NA	NA	NA
TTTATGCGTGAGCGAT-1_2_B4	0.630199026	-12.70383587	10	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1921	3886	0.017241379	0.002316006	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TTTATGCGTGTCGCTG-1_2_B4	-8.086479539	-0.983424938	13A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2003	4004	0.015484515	0.000999001	0	13A	IN-VIP	NA	NA	NA
TTTATGCGTTGTGGCC-1_2_B4	20.94601713	1.714415035	2	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1626	3000	0.022666667	0.002666667	0	2	EN-L4	NA	NA	NA
TTTCCTCAGTTAAGTG-1_2_B4	-31.86241715	12.25014059	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	861	1349	0.009636768	0.003706449	0	8	Astrocytes	NA	NA	NA
TTTCCTCCAAAGGTGC-1_2_B4	-27.57794912	17.06178759	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1122	1881	0.004253057	0.004784689	0	8	Astrocytes	NA	NA	NA
TTTCCTCGTACAGTTC-1_2_B4	14.3245878	-3.70064718	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1231	2093	0.011944577	0.002388915	0	12	EN-MIX	NA	NA	NA
TTTCCTCTCGACAGCC-1_2_B4	23.30409374	17.98490974	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1115	1775	0	0.002253521	0	oligos	OL-Cntl	NA	NA	NA
TTTGCGCAGGAGTTGC-1_2_B4	-8.357699002	-16.98190903	6B	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	729	1049	0.030505243	0.010486177	0	6B	IN-SST	NA	NA	NA
TTTGCGCAGGCAGTCA-1_2_B4	-35.54524539	-0.750920828	9	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1570	2884	0.004507628	0.007281553	0	9	OPC	NA	NA	NA
TTTGCGCAGTCAAGGC-1_2_B4	-9.517971866	-0.202408065	13A	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2276	4403	0.004769475	0.005905065	0	13A	IN-VIP	NA	NA	NA
TTTGCGCCAGCTTCGG-1_2_B4	16.10480343	22.89458232	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	989	1524	0.00328084	0.005905512	0	oligos	OL-Cntl	NA	NA	NA
TTTGCGCCATGGGACA-1_2_B4	15.3774601	18.28159699	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	927	1499	0.004002668	0.010673783	0	oligos	OL-Cntl	NA	NA	NA
TTTGCGCGTTTCGCTC-1_2_B4	-5.754872739	-10.29920371	13B	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1113	1713	0.033274956	0.004086398	0	13B	IN-SV2C	NA	NA	NA
TTTGGTTAGGGTTTCT-1_2_B4	2.188382271	27.20551997	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	728	1023	0.003910068	0.002932551	0	oligos	OL-Cntl	NA	NA	NA
TTTGGTTCAAGAGGCT-1_2_B4	-31.59040328	11.95198675	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	795	1284	0.001557632	0.003894081	0	8	Astrocytes	NA	NA	NA
TTTGGTTCATCCGCGA-1_2_B4	-27.84422439	10.83403772	8	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	728	1121	0.001784121	0.001784121	0	8	Astrocytes	NA	NA	NA
TTTGGTTGTAATCACC-1_2_B4	22.86950653	12.25951936	1	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1365	2430	0.000411523	0.002469136	0	oligos	OL-Cntl	NA	NA	NA
TTTGGTTTCTCACATT-1_2_B4	3.856488151	-5.221518682	12	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	1048	1640	0.064634146	0.001829268	0	12	EN-MIX	NA	NA	NA
TTTGTCAGTACCCAAT-1_2_B4	17.81161379	-28.03660925	3	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	3661	9391	0.010329038	0.003301033	0	3	EN-L5-6	NA	NA	NA
TTTGTCATCTAACCGA-1_2_B4	25.77453149	0.514096326	2	2_B4	Control	Control	82	male	motor-premotor	CAP1	SEQ1	8.5	21	2207	4601	0.008259074	0.002173441	0	2	EN-L4	NA	NA	NA
AAACCTGCACCCAGTG-1_2_B9	-8.202796907	-38.63116124	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1326	1961	0.061703213	0.017338093	9	16	EN-PYR	31	7	7
AAACCTGCATCTATGG-1_2_B9	-28.71562484	-4.245710343	9	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1193	1825	0.004383562	0.005479452	9	9	OPC	31	7	7
AAACCTGCATCTCCCA-1_2_B9	31.27023506	-17.69807878	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	7007	25913	0.018909428	0.019951376	9	2	EN-L4	31	7	7
AAACCTGGTAGAAAGG-1_2_B9	13.95777891	-17.99560706	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	5404	14483	0.006628461	0.01270455	9	L2-3	EN-L2-3-MS	31	7	7
AAACCTGTCATGCAAC-1_2_B9	-31.75795585	-11.33942868	9	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	864	1272	0.01572327	0.002358491	9	9	OPC	31	7	7
AAACCTGTCATGGTCA-1_2_B9	36.74610285	13.7928029	14	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1131	1507	0.00862641	0.01260783	9	14	Microglia	31	7	7
AAACCTGTCGCGCCAA-1_2_B9	34.62563922	-16.09768563	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4667	11149	0.009776662	0.012826262	9	2	EN-L4	31	7	7
AAACGGGAGATCCTGT-1_2_B9	-26.78141101	-1.906044564	9	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1374	1985	0.017128463	0.029219144	9	9	OPC	31	7	7
AAACGGGAGCGAAGGG-1_2_B9	-28.40865914	-4.230432469	9	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1183	1695	0.008259587	0.002949853	9	9	OPC	31	7	7
AAACGGGCACACCGAC-1_2_B9	-23.35940137	-17.65649628	6A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3417	7492	0.029097704	0.0093433	9	6A	IN-PV	31	7	7
AAACGGGGTCGCGTGT-1_2_B9	-26.73883516	-11.55970397	9	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1096	1667	0.00479904	0.032993401	9	9	OPC	31	7	7
AAAGATGAGCTAGTGG-1_2_B9	32.2986079	-12.56891697	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3597	7597	0.013426353	0.010398842	9	2	EN-L4	31	7	7
AAAGATGAGTACGATA-1_2_B9	18.86088807	-15.40799278	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	6423	21752	0.02707797	0.009148584	9	L2-3	EN-L2-3-MS	31	7	7
AAAGATGAGTCGCCGT-1_2_B9	16.29932601	-13.52526771	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	5601	15129	0.015136493	0.020027761	9	L2-3	EN-L2-3-MS	31	7	7
AAAGATGAGTGTCCAT-1_2_B9	32.53385	8.738280186	14	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	767	1001	0.085914086	0.013986014	9	14	Microglia	31	7	7
AAAGATGCATCTCGCT-1_2_B9	25.69192366	6.817466122	15A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1282	1926	0.010384216	0.011422638	9	15A	Endo cells	31	7	7
AAAGATGTCCAGAAGG-1_2_B9	37.76613198	13.39728893	14	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1098	1591	0.023884349	0.005028284	9	14	Microglia	31	7	7
AAAGCAAAGTACGTTC-1_2_B9	26.63231075	7.7945045	15A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1313	2142	0.029878618	0.019607843	9	15A	Endo cells	31	7	7
AAAGCAAGTATCTGCA-1_2_B9	-12.90269938	-1.361498627	13A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2631	5028	0.027048528	0.006165473	9	13A	IN-VIP	31	7	7
AAAGCAATCGTTTAGG-1_2_B9	33.91783015	-18.52524041	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3688	7398	0.019194377	0.020816437	9	2	EN-L4	31	7	7
AAAGCAATCTAACTCT-1_2_B9	9.501310279	1.385628101	12	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	764	1334	0.027736132	0.010494753	9	12	EN-MIX	31	7	7
AAAGTAGAGCGTTGCC-1_2_B9	-28.21757018	-4.31509269	9	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1178	1823	0.004936917	0.008228195	9	9	OPC	31	7	7
AAAGTAGAGCTAGTTC-1_2_B9	14.9893143	12.5850671	1	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1296	1968	0.007621951	0.010670732	9	oligos	OL-Cntl	31	7	7
AAAGTAGAGGATCGCA-1_2_B9	25.12737746	-16.04969781	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4886	12605	0.034510115	0.01190004	9	2	EN-L4	31	7	7
AAAGTAGCACCCTATC-1_2_B9	-28.44377424	-3.489034017	9	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1364	2098	0.007626311	0.012392755	9	9	OPC	31	7	7
AAATGCCAGCAGACTG-1_2_B9	4.87086861	4.845568698	7	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2021	3213	0.021164021	0.009648304	9	7	Phagocytes	31	7	7
AAATGCCAGTCCCACG-1_2_B9	32.78043281	8.613901143	14	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	859	1269	0.100866824	0.017336485	9	14	Microglia	31	7	7
AAATGCCGTGACCAAG-1_2_B9	-4.072743639	-35.13427259	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	756	1108	0.11101083	0.028880866	9	16	EN-PYR	31	7	7
AAATGCCTCCCATTAT-1_2_B9	7.28011363	2.159167833	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	777	1035	0.104347826	0.017391304	9	16	EN-PYR	31	7	7
AAATGCCTCGCATGGC-1_2_B9	-24.18342541	0.979949935	9	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2311	4012	0.006729811	0.015952144	9	9	OPC	31	7	7
AACACGTCATGCTAGT-1_2_B9	10.55202987	-12.00056962	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2559	4676	0.027159966	0.01283148	9	L2-3	EN-L2-3-MS	31	7	7
AACACGTGTAGAGCTG-1_2_B9	-25.26165798	11.05477673	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	995	1522	0.003942181	0.010512484	9	8	Astrocytes	31	7	7
AACACGTGTCCGTCAG-1_2_B9	11.64367455	-13.13153385	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3116	6153	0.012839265	0.016089712	9	L2-3	EN-L2-3-MS	31	7	7
AACACGTGTTCAGTAC-1_2_B9	-20.28647951	8.357016238	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	896	1254	0.022328549	0.007177033	9	8	Astrocytes	31	7	7
AACACGTTCCCTTGCA-1_2_B9	34.06573643	8.020323534	14	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1189	1663	0.030066146	0.015033073	9	14	Microglia	31	7	7
AACACGTTCCTATGTT-1_2_B9	-13.71505711	-32.31556241	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1762	2907	0.072583419	0.015479876	9	16	EN-PYR	31	7	7
AACCATGAGTGAACAT-1_2_B9	11.01817225	-27.24870642	10	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	6941	26317	0.002773872	0.004027815	9	L2-3	EN-L2-3-Cntl	31	7	7
AACCATGCACTTCGAA-1_2_B9	-17.07266507	17.73448025	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1484	2414	0.011184756	0.013670257	9	8	Astrocytes	31	7	7
AACCATGGTAGCAAAT-1_2_B9	-27.82339194	-2.914696408	9	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1389	2189	0.009593422	0.019643673	9	9	OPC	31	7	7
AACCATGGTCAATGTC-1_2_B9	10.38586023	-12.34179627	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2592	4745	0.022971549	0.006743941	9	L2-3	EN-L2-3-MS	31	7	7
AACCGCGAGACCCACC-1_2_B9	16.83895668	-14.99446494	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	6659	21302	0.016477326	0.015726223	9	L2-3	EN-L2-3-MS	31	7	7
AACCGCGAGGCAGTCA-1_2_B9	15.9441568	-16.67280681	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	5112	13585	0.017960986	0.011556864	9	L2-3	EN-L2-3-MS	31	7	7
AACGTTGTCCACGAAT-1_2_B9	-15.88912206	-0.153896838	13A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3599	7586	0.013841287	0.006591089	9	13A	IN-VIP	31	7	7
AACGTTGTCCATTCTA-1_2_B9	-5.074160842	-31.08935786	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	761	1200	0.198333333	0.016666667	9	16	EN-PYR	31	7	7
AACGTTGTCTTTAGGG-1_2_B9	-16.05656733	0.503132899	13A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3648	8054	0.012912838	0.018003477	9	13A	IN-VIP	31	7	7
AACTCAGAGAAACCTA-1_2_B9	-9.036650294	-27.87319143	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1153	1798	0.144605117	0.010011123	9	16	EN-PYR	31	7	7
AACTCAGAGCAGATCG-1_2_B9	-3.406989483	-34.30760931	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	848	1158	0.102763385	0.021588946	9	16	EN-PYR	31	7	7
AACTCAGCAGCGTTCG-1_2_B9	-11.58770312	18.02998417	11	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2264	3993	0.008765339	0.011269722	9	11	Glia-MIX	31	7	7
AACTCAGTCCAACCAA-1_2_B9	-17.47268501	28.929473	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2692	5924	0.00590817	0.011141121	9	8	Astrocytes	31	7	7
AACTCAGTCGCAAGCC-1_2_B9	-7.779926052	-38.47625095	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1143	1719	0.095404305	0.01628854	9	16	EN-PYR	31	7	7
AACTCAGTCGTCTGCT-1_2_B9	-5.765935557	-37.54671424	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	979	1348	0.049703264	0.027448071	9	16	EN-PYR	31	7	7
AACTCCCCACCAGCAC-1_2_B9	32.25830313	-12.53786383	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4447	10421	0.012666731	0.009596008	9	2	EN-L4	31	7	7
AACTCCCCAGACGTAG-1_2_B9	-2.982729754	-34.38597864	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1039	1456	0.096840659	0.01717033	9	16	EN-PYR	31	7	7
AACTCCCGTAATCGTC-1_2_B9	-12.86949284	-1.385419857	13A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2536	5035	0.038530288	0.005561072	9	13A	IN-VIP	31	7	7
AACTCCCGTGACGGTA-1_2_B9	26.99936204	9.233821833	15A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1343	1936	0.026859504	0.036673554	9	15A	Endo cells	31	7	7
AACTCCCGTGCGCTTG-1_2_B9	16.20039437	-13.42587163	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	5427	14529	0.016862826	0.013903228	9	L2-3	EN-L2-3-MS	31	7	7
AACTCCCGTTTACTCT-1_2_B9	-28.30617127	-3.993578997	9	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1359	2099	0.022391615	0.005717008	9	9	OPC	31	7	7
AACTCTTAGAAGAAGC-1_2_B9	24.3612177	-12.01316428	3	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3421	7054	0.004536433	0.015026935	9	3	EN-L5-6	31	7	7
AACTCTTAGACACTAA-1_2_B9	-6.867523348	-37.3386463	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	937	1370	0.076642336	0.019708029	9	16	EN-PYR	31	7	7
AACTCTTAGCCAGAAC-1_2_B9	-24.45365059	-16.16090282	6A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3009	5959	0.035744252	0.005705655	9	6A	IN-PV	31	7	7
AACTCTTAGTGGAGAA-1_2_B9	-5.729840901	-34.04454535	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	781	1143	0.100612423	0.01399825	9	16	EN-PYR	31	7	7
AACTCTTCAGTCGTGC-1_2_B9	29.22038283	7.055373608	15DA	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	747	1007	0.032770606	0.06653426	9	15DA	T cells	31	7	7
AACTCTTCATGGGAAC-1_2_B9	25.56751129	7.555018191	15A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1646	2636	0.030728376	0.022382398	9	15A	Endo cells	31	7	7
AACTCTTGTACAGTGG-1_2_B9	-12.50275294	17.58118533	11	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1694	2797	0.018233822	0.0096532	9	11	Glia-MIX	31	7	7
AACTCTTTCAGAGACG-1_2_B9	-19.34945277	13.19771024	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1242	1992	0.02811245	0.005522088	9	8	Astrocytes	31	7	7
AACTGGTAGCCGATTT-1_2_B9	16.63598042	-15.3367879	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	5715	15978	0.016647891	0.008198773	9	L2-3	EN-L2-3-MS	31	7	7
AACTGGTGTCCGAATT-1_2_B9	-17.86473596	16.19526676	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1142	1793	0.008365867	0.004461796	9	8	Astrocytes	31	7	7
AACTGGTTCTCGCTTG-1_2_B9	-17.23598893	-8.714234835	13B	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2819	5899	0.009832175	0.004407527	9	13B	IN-SV2C	31	7	7
AACTTTCCACACATGT-1_2_B9	-3.538344657	-34.97955846	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	897	1381	0.167270094	0.028964518	9	16	EN-PYR	31	7	7
AACTTTCCAGGTGGAT-1_2_B9	-11.54105729	-37.86914522	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1502	2618	0.097020626	0.014132926	9	16	EN-PYR	31	7	7
AACTTTCTCGAATCCA-1_2_B9	15.84564641	-16.64532509	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	6658	24445	0.017017795	0.012845163	9	L2-3	EN-L2-3-MS	31	7	7
AACTTTCTCGAGAGCA-1_2_B9	-17.44542226	28.84179851	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2422	4689	0.005331627	0.006184688	9	8	Astrocytes	31	7	7
AAGACCTCAAGAAAGG-1_2_B9	25.55914783	5.705636557	15A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1281	2098	0.009056244	0.012392755	9	15A	Endo cells	31	7	7
AAGACCTGTCAGTGGA-1_2_B9	18.37821178	-14.98277994	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4350	10303	0.014655925	0.01203533	9	L2-3	EN-L2-3-MS	31	7	7
AAGACCTGTGCGATAG-1_2_B9	-10.9427524	14.11951723	11	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1663	2800	0.100714286	0.013214286	9	11	Glia-MIX	31	7	7
AAGACCTTCCGATATG-1_2_B9	11.68975566	-15.74649497	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3847	8895	0.008206858	0.007307476	9	L2-3	EN-L2-3-MS	31	7	7
AAGCCGCCATTCTTAC-1_2_B9	-27.13624182	-23.33169824	6A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	5444	15999	0.026189137	0.008875555	9	6A	IN-PV	31	7	7
AAGCCGCTCAAACGGG-1_2_B9	-3.956503269	-35.82733589	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	923	1303	0.086722947	0.019953952	9	16	EN-PYR	31	7	7
AAGGAGCAGGAATGGA-1_2_B9	-28.41477953	-4.454276132	9	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1129	1627	0.012292563	0.004917025	9	9	OPC	31	7	7
AAGGAGCAGTGGAGAA-1_2_B9	-15.80526511	8.68391769	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1042	1492	0.012734584	0.024798928	9	8	Astrocytes	31	7	7
AAGGAGCTCCTAAGTG-1_2_B9	-23.58954208	11.55563119	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1230	1978	0.025278059	0.00859454	9	8	Astrocytes	31	7	7
AAGGCAGAGGCAGTCA-1_2_B9	26.13702996	-17.6408161	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	7940	39073	0.131446267	0.003327106	9	2	EN-L4	31	7	7
AAGGCAGAGGGTTCCC-1_2_B9	20.04755076	-17.98873954	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3866	8467	0.00909413	0.019369316	9	L2-3	EN-L2-3-MS	31	7	7
AAGGCAGCAATCCGAT-1_2_B9	32.92249925	13.46150356	14	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1308	1864	0.019849785	0.032725322	9	14	Microglia	31	7	7
AAGGCAGCACTTGGAT-1_2_B9	-18.58251143	23.40730727	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1347	2287	0.013117621	0.010494097	9	8	Astrocytes	31	7	7
AAGGCAGCAGACAAAT-1_2_B9	-20.64026475	-4.990091581	13B	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4932	13117	0.034611573	0.014332546	9	13B	IN-SV2C	31	7	7
AAGGTTCAGTGATCGG-1_2_B9	18.9085226	-22.44264465	3	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4695	13490	0.002965159	0.00874722	9	3	EN-L5-6	31	7	7
AAGGTTCCACGGTAAG-1_2_B9	33.98985841	-18.49140489	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3675	7598	0.018031061	0.02461174	9	2	EN-L4	31	7	7
AAGGTTCCACTATCTT-1_2_B9	34.50163191	-17.64679729	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4840	12450	0.014698795	0.018955823	9	2	EN-L4	31	7	7
AAGGTTCCATAGACTC-1_2_B9	25.33663193	-15.2708718	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	5163	13025	0.027946257	0.017888676	9	2	EN-L4	31	7	7
AAGTCTGCAGCTGTTA-1_2_B9	-28.71792599	-4.165719687	9	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1273	2162	0.007400555	0.007400555	9	9	OPC	31	7	7
AATCCAGAGCCGCCTA-1_2_B9	-24.75275133	-19.26908758	6B	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2365	4441	0.020265706	0.023868498	9	6B	IN-SST	31	7	7
AATCCAGTCAAGGCTT-1_2_B9	-1.905142373	2.836101061	11	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2113	4127	0.026653744	0.003634601	9	11	Glia-MIX	31	7	7
AATCGGTAGTGCTGCC-1_2_B9	-11.61080518	28.39901123	17	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1932	3168	0.045770202	0.012626263	9	oligos	OL-MS-2	31	7	7
AATCGGTGTCTAGGTT-1_2_B9	-14.17634469	-6.051780136	13A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2244	4232	0.014177694	0.004489603	9	13A	IN-VIP	31	7	7
AATCGGTTCTGTGCAA-1_2_B9	37.52980374	9.522204162	14	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	860	1148	0.027003484	0.011324042	9	14	Microglia	31	7	7
ACACCAACAAGTTGTC-1_2_B9	34.14773771	12.92655526	14	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1019	1436	0.013231198	0.036211699	9	14	Microglia	31	7	7
ACACCAATCAAGGCTT-1_2_B9	13.55356517	-14.91847408	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3961	9477	0.016460905	0.004853857	9	L2-3	EN-L2-3-MS	31	7	7
ACACCCTAGACAGAGA-1_2_B9	33.82237888	8.864307485	14	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1133	1515	0.029042904	0.019141914	9	14	Microglia	31	7	7
ACACCCTAGTTCGCGC-1_2_B9	24.19660893	-17.7575178	3	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	5371	15387	0.02690583	0.011113277	9	3	EN-L5-6	31	7	7
ACACCCTCAGCCTATA-1_2_B9	-16.00998661	16.64648595	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1994	3802	0.012098895	0.009205681	9	8	Astrocytes	31	7	7
ACACCCTGTTCGTTGA-1_2_B9	31.97857043	-19.09740689	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4761	11681	0.019775704	0.028593442	9	2	EN-L4	31	7	7
ACACCGGAGTGTGAAT-1_2_B9	13.17022234	-14.57392548	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3840	8278	0.012684223	0.01304663	9	L2-3	EN-L2-3-MS	31	7	7
ACACCGGGTTACGCGC-1_2_B9	-18.5716712	-1.735832569	13A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3662	8313	0.015517864	0.009984362	9	13A	IN-VIP	31	7	7
ACACCGGTCACATAGC-1_2_B9	-16.13964691	0.018964936	13A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4679	11982	0.017108997	0.009931564	9	13A	IN-VIP	31	7	7
ACACCGGTCGAATGCT-1_2_B9	-29.25131319	-3.991818668	9	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1309	1974	0.014690983	0.006585613	9	9	OPC	31	7	7
ACACTGAAGCTAACAA-1_2_B9	-15.14918328	13.77725046	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1743	3118	0.02629891	0.010262989	9	8	Astrocytes	31	7	7
ACACTGAAGCTGTCTA-1_2_B9	31.71500667	-1.399323682	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2762	5678	0.004402959	0.007396971	9	2	EN-L4	31	7	7
ACACTGAAGTACATGA-1_2_B9	-17.45339882	17.36851846	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1471	2332	0.012435678	0.007718696	9	8	Astrocytes	31	7	7
ACACTGAGTAAAGTCA-1_2_B9	25.43874451	9.931360767	15A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2577	4538	0.029308065	0.052666373	9	15A	Endo cells	31	7	7
ACACTGAGTAGGCTGA-1_2_B9	-20.84927626	-5.100318062	13B	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	6842	22225	0.022182227	0.01655793	9	13B	IN-SV2C	31	7	7
ACACTGATCCGCAGTG-1_2_B9	-17.02130861	17.71670367	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1630	2648	0.013595166	0.010951662	9	8	Astrocytes	31	7	7
ACAGCCGAGAAACGAG-1_2_B9	14.18820959	-14.63692733	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4201	9739	0.013759113	0.013348393	9	L2-3	EN-L2-3-MS	31	7	7
ACAGCCGGTACCTACA-1_2_B9	-29.33437771	-2.0162791	9	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1452	2231	0.012550426	0.005826983	9	9	OPC	31	7	7
ACAGCCGGTGCTGTAT-1_2_B9	-15.65394778	9.509081792	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1533	2666	0.012003001	0.013503376	9	8	Astrocytes	31	7	7
ACAGCTACAGCTCGCA-1_2_B9	-11.86472633	-5.615456894	13A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1993	3129	0.016938319	0.023969319	9	13A	IN-VIP	31	7	7
ACAGCTAGTACACCGC-1_2_B9	25.01823099	-16.87398032	3	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	5966	19117	0.042318355	0.008160276	9	3	EN-L5-6	31	7	7
ACAGCTAGTTAAAGTG-1_2_B9	-15.90876351	7.935470121	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1140	1644	0.018856448	0.013381995	9	8	Astrocytes	31	7	7
ACATACGGTTCAGACT-1_2_B9	32.76106717	12.29742405	14	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1044	1486	0.040376851	0.034320323	9	14	Microglia	31	7	7
ACATCAGAGGGTGTTG-1_2_B9	27.29597954	7.700112132	15A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1072	1488	0.023521505	0.04905914	9	15A	Endo cells	31	7	7
ACATCAGAGTTTAGGA-1_2_B9	-9.173409628	-37.87322262	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1097	1754	0.12713797	0.027936146	9	16	EN-PYR	31	7	7
ACATCAGCAGGGTTAG-1_2_B9	-18.11431474	-1.271493876	13A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2877	5078	0.022252855	0.021465144	9	13A	IN-VIP	31	7	7
ACATCAGCATCCGTGG-1_2_B9	9.014922302	-14.34614646	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2781	5122	0.002928544	0.016985553	9	L2-3	EN-L2-3-MS	31	7	7
ACATGGTAGCAGATCG-1_2_B9	-15.95887453	16.49477603	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2151	4113	0.007537078	0.007293946	9	8	Astrocytes	31	7	7
ACATGGTAGCGATTCT-1_2_B9	36.63075969	13.75897761	14	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1155	1639	0.008541794	0.009151922	9	14	Microglia	31	7	7
ACATGGTCATCCAACA-1_2_B9	32.81524411	-7.762884475	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3978	10988	0.007917728	0.006461594	9	2	EN-L4	31	7	7
ACATGGTTCTCACATT-1_2_B9	12.43330554	-12.58931558	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3673	7998	0.021255314	0.023005751	9	L2-3	EN-L2-3-MS	31	7	7
ACATGGTTCTCCTATA-1_2_B9	-17.45866348	17.36001589	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1727	3064	0.039490862	0.009791123	9	8	Astrocytes	31	7	7
ACCAGTACATCCCATC-1_2_B9	7.273272647	2.158374747	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	791	1028	0.091439689	0.01848249	9	16	EN-PYR	31	7	7
ACCCACTAGCCTTGAT-1_2_B9	-19.73294957	17.89302987	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1305	2255	0.010199557	0.005321508	9	8	Astrocytes	31	7	7
ACCCACTAGTTAGCGG-1_2_B9	-15.24630425	-14.96744793	6B	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1656	2642	0.017411052	0.019682059	9	6B	IN-SST	31	7	7
ACCCACTCACATCTTT-1_2_B9	24.52782017	-18.71217451	3	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	5570	18118	0.013136108	0.009658903	9	3	EN-L5-6	31	7	7
ACCCACTCACGCGAAA-1_2_B9	-2.885823979	-34.05959447	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	908	1325	0.142641509	0.010566038	9	16	EN-PYR	31	7	7
ACCCACTGTCATTAGC-1_2_B9	31.37433951	-17.34674238	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	6092	19536	0.03281122	0.00793407	9	2	EN-L4	31	7	7
ACCCACTGTCTTTCAT-1_2_B9	34.42761841	-16.37086294	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4061	9029	0.024144424	0.013733525	9	2	EN-L4	31	7	7
ACCCACTTCTATCCTA-1_2_B9	-22.97138673	-18.35630258	6B	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2411	4523	0.021667035	0.014370993	9	6B	IN-SST	31	7	7
ACCCACTTCTGCGACG-1_2_B9	17.93056309	-27.44526839	3	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3962	9820	0.004887984	0.007637475	9	3	EN-L5-6	31	7	7
ACCGTAAAGTACCGGA-1_2_B9	-19.01837725	24.03728584	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1594	2876	0.003477051	0.007649513	9	8	Astrocytes	31	7	7
ACCGTAAGTCCCGACA-1_2_B9	-15.61998815	12.69773776	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1463	2353	0.007224819	0.006374841	9	8	Astrocytes	31	7	7
ACCGTAAGTTAGAACA-1_2_B9	-28.33497514	-3.305152972	9	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1388	2101	0.010947168	0.007615421	9	9	OPC	31	7	7
ACCGTAATCAGTCCCT-1_2_B9	-20.53582883	-26.92157818	6A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3012	6871	0.044535002	0.002474167	9	6A	IN-PV	31	7	7
ACCTTTATCATGCATG-1_2_B9	21.91573955	-16.32559093	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	5194	14564	0.023551222	0.026435045	9	2	EN-L4	31	7	7
ACGAGCCAGCGTAATA-1_2_B9	19.47720499	-10.33262153	3	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1792	2802	0.017130621	0.007851535	9	3	EN-L5-6	31	7	7
ACGAGCCCAGCTGTAT-1_2_B9	-17.48557373	-0.778429262	13A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2816	5289	0.012667801	0.022877671	9	13A	IN-VIP	31	7	7
ACGAGCCGTCGCTTTC-1_2_B9	30.99666206	-18.69721828	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	6801	22172	0.024670756	0.017228937	9	2	EN-L4	31	7	7
ACGAGCCGTGGCCCTA-1_2_B9	-28.2258285	-4.388324008	9	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1243	1795	0.012256267	0.006128134	9	9	OPC	31	7	7
ACGAGCCGTTACTGAC-1_2_B9	24.70995981	-17.30613249	3	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	5220	14822	0.023478613	0.006814195	9	3	EN-L5-6	31	7	7
ACGAGCCTCTTCGGTC-1_2_B9	22.10956573	-16.78456602	3	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	6803	20658	0.01878207	0.016264885	9	3	EN-L5-6	31	7	7
ACGAGGACAGTCGTGC-1_2_B9	24.85853118	-15.30176379	3	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4208	9763	0.012291304	0.016490833	9	3	EN-L5-6	31	7	7
ACGAGGATCTCCTATA-1_2_B9	-2.865677137	-33.96007406	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	849	1285	0.179766537	0.024902724	9	16	EN-PYR	31	7	7
ACGAGGATCTGAGTGT-1_2_B9	-5.217927047	-32.94551333	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	770	1133	0.112974404	0.007943513	9	16	EN-PYR	31	7	7
ACGAGGATCTGGCGAC-1_2_B9	7.826175075	1.065890298	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1028	1382	0.035455861	0.026772793	9	16	EN-PYR	31	7	7
ACGATACAGTCATGCT-1_2_B9	34.86297535	12.91276975	14	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1085	1520	0.010526316	0.014473684	9	14	Microglia	31	7	7
ACGATACGTTCCATGA-1_2_B9	5.925486977	-0.016217877	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1257	1784	0.019618834	0.035313901	9	16	EN-PYR	31	7	7
ACGATACGTTGACGTT-1_2_B9	21.76872893	-17.52078101	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4624	11213	0.022117185	0.010791046	9	L2-3	EN-L2-3-MS	31	7	7
ACGATGTAGAATGTGT-1_2_B9	29.96626589	13.82269659	14	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	911	1244	0.038585209	0.082797428	9	14	Microglia	31	7	7
ACGATGTCATACAGCT-1_2_B9	28.55113048	-14.02237458	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	5701	16288	0.018664047	0.009147839	9	2	EN-L4	31	7	7
ACGATGTCATGGGAAC-1_2_B9	-12.20163558	-37.94673325	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1786	3208	0.110972569	0.01340399	9	16	EN-PYR	31	7	7
ACGATGTGTCTCGTTC-1_2_B9	-18.23165398	6.537407696	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	850	1248	0.016826923	0.007211538	9	8	Astrocytes	31	7	7
ACGCAGCAGAGATGAG-1_2_B9	-15.9996835	-0.240317501	13A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2660	4625	0.025297297	0.015135135	9	13A	IN-VIP	31	7	7
ACGCAGCCAGCTTAAC-1_2_B9	28.10077322	6.029983148	15A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	801	1034	0.051257253	0.017408124	9	15A	Endo cells	31	7	7
ACGCAGCGTACAGTGG-1_2_B9	-11.79450579	17.96478494	11	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2394	4318	0.008568782	0.012042612	9	11	Glia-MIX	31	7	7
ACGCAGCGTCCAAGTT-1_2_B9	-19.77001745	-6.120232753	13B	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3890	8935	0.024622272	0.006267487	9	13B	IN-SV2C	31	7	7
ACGCCAGCAAGAAAGG-1_2_B9	-14.90446684	-5.209265427	13A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2960	5839	0.010618257	0.007878061	9	13A	IN-VIP	31	7	7
ACGCCAGCAAGCGTAG-1_2_B9	15.84023911	-16.85297563	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	5154	14127	0.013732569	0.008211227	9	L2-3	EN-L2-3-MS	31	7	7
ACGCCAGCATATACCG-1_2_B9	33.5484622	-16.62644493	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4814	11622	0.013422819	0.017552917	9	2	EN-L4	31	7	7
ACGCCAGCATCACCCT-1_2_B9	8.467598345	-15.26960815	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2770	5257	0.013696024	0.004565341	9	L2-3	EN-L2-3-MS	31	7	7
ACGCCAGGTGAAATCA-1_2_B9	-26.91970596	-18.71843476	6B	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2918	5615	0.019234194	0.022261799	9	6B	IN-SST	31	7	7
ACGCCAGTCGTCTGAA-1_2_B9	-20.49884084	-5.068237417	13B	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3966	8461	0.016428318	0.016428318	9	13B	IN-SV2C	31	7	7
ACGCCGAAGAAACCGC-1_2_B9	-5.498306064	-34.56376729	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1037	1665	0.171171171	0.009009009	9	16	EN-PYR	31	7	7
ACGCCGACACACTGCG-1_2_B9	28.24969143	5.94794362	15DA	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	912	1230	0.030894309	0.029268293	9	15DA	T cells	31	7	7
ACGCCGATCGCGGATC-1_2_B9	-26.411113	-23.85612421	6A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4980	14882	0.068337589	0.003426959	9	6A	IN-PV	31	7	7
ACGGAGAAGAGGTTGC-1_2_B9	-28.51681229	1.422841555	9	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2291	3933	0.005847953	0.010170353	9	9	OPC	31	7	7
ACGGAGAAGGCAATTA-1_2_B9	16.89076835	-14.88170088	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4639	10949	0.017992511	0.012512558	9	L2-3	EN-L2-3-MS	31	7	7
ACGGAGAAGGCCATAG-1_2_B9	-15.84242897	8.951357214	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1229	1908	0.027777778	0.018867925	9	8	Astrocytes	31	7	7
ACGGAGACAGATGAGC-1_2_B9	-20.24422508	-4.903119524	13B	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3345	6656	0.024789663	0.010366587	9	13B	IN-SV2C	31	7	7
ACGGAGATCCTAGTGA-1_2_B9	-12.29128944	11.27086257	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1113	1623	0.1004313	0.021565003	9	8	Astrocytes	31	7	7
ACGGAGATCCTTCAAT-1_2_B9	-19.0356854	0.029464706	13A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4046	8693	0.018980789	0.019440929	9	13A	IN-VIP	31	7	7
ACGGAGATCTGGTGTA-1_2_B9	-9.10964901	-15.83198239	6B	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	797	1138	0.024604569	0.007908612	9	6B	IN-SST	31	7	7
ACGGCCAAGTCTTGCA-1_2_B9	-28.11505565	-4.479922907	9	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1261	1865	0.013941019	0.007506702	9	9	OPC	31	7	7
ACGGCCAGTCAGAATA-1_2_B9	34.30943505	-15.714134	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3335	6469	0.017622507	0.017004174	9	2	EN-L4	31	7	7
ACGGCCAGTTCGGCAC-1_2_B9	-8.767533805	-38.72021529	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1333	2017	0.065939514	0.028259792	9	16	EN-PYR	31	7	7
ACGGCCATCCCTCAGT-1_2_B9	33.37450783	-9.433344059	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	5438	14915	0.005363728	0.011330875	9	2	EN-L4	31	7	7
ACGGGCTAGGTGTGGT-1_2_B9	-5.333352875	-36.60969805	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	914	1317	0.074411541	0.022779043	9	16	EN-PYR	31	7	7
ACGGGCTCACTGTGTA-1_2_B9	34.62692714	-16.55714215	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4422	9954	0.017279486	0.013863773	9	2	EN-L4	31	7	7
ACGGGCTGTACGAAAT-1_2_B9	-29.10563422	-2.202350315	9	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1552	2586	0.017401392	0.005413766	9	9	OPC	31	7	7
ACGGGCTGTCTAAACC-1_2_B9	-9.787875362	18.25919386	11	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3654	7999	0.007375922	0.010626328	9	11	Glia-MIX	31	7	7
ACGGGCTGTTGTCTTT-1_2_B9	-17.06966662	17.62346205	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1432	2243	0.016049933	0.014266607	9	8	Astrocytes	31	7	7
ACGGGTCAGCTACCGC-1_2_B9	-10.87063263	14.43236179	11	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1659	2644	0.010590015	0.012481089	9	11	Glia-MIX	31	7	7
ACGGGTCTCCAGTATG-1_2_B9	31.62634255	9.394971712	14	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	750	1005	0.037810945	0.039800995	9	14	Microglia	31	7	7
ACGTCAAAGACTAGGC-1_2_B9	16.58033755	-13.09135903	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4571	10582	0.016537517	0.020601021	9	L2-3	EN-L2-3-MS	31	7	7
ACGTCAACAGACAAAT-1_2_B9	33.57105056	8.324920948	14	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	899	1241	0.012087027	0.006446414	9	14	Microglia	31	7	7
ACGTCAACAGGTGCCT-1_2_B9	-24.60889136	0.541121853	9	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1699	2640	0.0125	0.017424242	9	9	OPC	31	7	7
ACGTCAAGTAAGTAGT-1_2_B9	31.15580519	-18.57594757	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4666	10660	0.024953096	0.016791745	9	2	EN-L4	31	7	7
ACGTCAAGTCAGAAGC-1_2_B9	-13.79717638	-32.25523167	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2262	4161	0.042057198	0.016101899	9	16	EN-PYR	31	7	7
ACGTCAAGTGCAACGA-1_2_B9	16.4112425	-13.14022205	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3253	6165	0.028223844	0.013625304	9	L2-3	EN-L2-3-MS	31	7	7
ACGTCAAGTTGAGGTG-1_2_B9	28.78197568	-19.00959716	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	9602	53979	0.051149521	0.014653847	9	2	EN-L4	31	7	7
ACTATCTCAATCACAC-1_2_B9	22.79847938	-15.8426556	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4498	11005	0.047796456	0.026260791	9	2	EN-L4	31	7	7
ACTGATGCAAGAAGAG-1_2_B9	32.90755709	-17.50548695	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3002	5371	0.013405325	0.016011916	9	2	EN-L4	31	7	7
ACTGATGCATCGGACC-1_2_B9	16.78613615	-12.98598258	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4185	9096	0.014291996	0.024956025	9	L2-3	EN-L2-3-MS	31	7	7
ACTGATGGTCATCGGC-1_2_B9	-24.82757866	-19.59236486	6A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2858	5615	0.040605521	0.013535174	9	6A	IN-PV	31	7	7
ACTGATGGTTAAAGTG-1_2_B9	7.05086727	-0.6291425	12	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1017	1439	0.029881862	0.017373176	9	12	EN-MIX	31	7	7
ACTGATGTCAACGGGA-1_2_B9	-5.361648811	-34.9370651	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	889	1287	0.127428127	0.017871018	9	16	EN-PYR	31	7	7
ACTGATGTCCACGCAG-1_2_B9	-3.59766917	-34.2499974	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	884	1210	0.07768595	0.025619835	9	16	EN-PYR	31	7	7
ACTGCTCGTCTCTCGT-1_2_B9	-4.006719201	-35.46662515	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	931	1389	0.124550036	0.03599712	9	16	EN-PYR	31	7	7
ACTGCTCGTTGAACTC-1_2_B9	-21.05269135	-21.21779855	6A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1793	3223	0.108594477	0.007136209	9	6A	IN-PV	31	7	7
ACTGCTCTCACAAACC-1_2_B9	7.270632922	2.13846601	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	815	1077	0.107706592	0.013927577	9	16	EN-PYR	31	7	7
ACTGCTCTCCAGAAGG-1_2_B9	14.6173576	-21.89931399	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4849	13337	0.010272175	0.00479868	9	L2-3	EN-L2-3-MS	31	7	7
ACTTACTAGTGGTCCC-1_2_B9	15.19387982	-13.00580883	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4418	10372	0.021885847	0.018511377	9	L2-3	EN-L2-3-MS	31	7	7
ACTTACTTCACGAAGG-1_2_B9	26.95042273	7.380303701	15A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1099	1596	0.035714286	0.02443609	9	15A	Endo cells	31	7	7
ACTTGTTCAATAAGCA-1_2_B9	33.297208	-15.4151941	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2795	4963	0.026395325	0.013298408	9	2	EN-L4	31	7	7
ACTTGTTCAGTATAAG-1_2_B9	-19.31045611	5.766838089	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	762	1073	0.010251631	0.010251631	9	8	Astrocytes	31	7	7
ACTTGTTCATTCACTT-1_2_B9	26.44453813	5.360657093	15BA	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1101	1546	0.020698577	0.020051746	9	15BA	Stromal cells	31	7	7
ACTTGTTGTACTTCTT-1_2_B9	25.61561366	-8.449436763	3	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4039	9288	0.013673557	0.007751938	9	3	EN-L5-6	31	7	7
ACTTGTTGTTTGGCGC-1_2_B9	22.10576256	-16.1734446	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	5277	14562	0.015039143	0.024996566	9	L2-3	EN-L2-3-MS	31	7	7
ACTTGTTTCTGCTTGC-1_2_B9	31.3176482	-17.72393788	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	6650	23476	0.018529562	0.023087408	9	2	EN-L4	31	7	7
ACTTTCAGTCTTCTCG-1_2_B9	23.96961373	7.900602281	15A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2935	5465	0.022689844	0.026532479	9	15A	Endo cells	31	7	7
ACTTTCAGTTCGCGAC-1_2_B9	33.74314038	11.84809459	14	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	988	1353	0.021433851	0.016999261	9	14	Microglia	31	7	7
AGAATAGAGGCAGGTT-1_2_B9	-13.49076489	7.163480281	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	969	1385	0.068592058	0.006498195	9	8	Astrocytes	31	7	7
AGAATAGCATCGGTTA-1_2_B9	18.87340449	-25.66598872	3	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3983	9547	0.002199644	0.00974128	9	3	EN-L5-6	31	7	7
AGAATAGGTATTAGCC-1_2_B9	5.730176566	5.638078379	7	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2346	4019	0.010450361	0.008957452	9	7	Phagocytes	31	7	7
AGACGTTCATTGCGGC-1_2_B9	11.38672742	-15.09663798	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3139	6352	0.014483627	0.009918136	9	L2-3	EN-L2-3-MS	31	7	7
AGACGTTTCCACTCCA-1_2_B9	30.51561699	-18.46465162	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	7535	28764	0.025552774	0.016513698	9	2	EN-L4	31	7	7
AGAGCGAAGGGCTCTC-1_2_B9	19.53040697	-17.33682962	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	6462	23554	0.059989811	0.002929439	9	L2-3	EN-L2-3-MS	31	7	7
AGAGCGAGTAGAAGGA-1_2_B9	-5.223147539	-34.45670433	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	754	1116	0.136200717	0.023297491	9	16	EN-PYR	31	7	7
AGAGCGAGTATATCCG-1_2_B9	14.90388708	-21.60413925	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4675	12569	0.008274326	0.006205744	9	L2-3	EN-L2-3-MS	31	7	7
AGAGCGAGTCTCAACA-1_2_B9	28.20610844	6.549331651	15BA	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	771	1066	0.020637899	0.032833021	9	15BA	Stromal cells	31	7	7
AGAGCGATCCGCAGTG-1_2_B9	10.00431793	-18.30042113	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3860	8333	0.001920077	0.01224049	9	L2-3	EN-L2-3-MS	31	7	7
AGAGCGATCTGTTTGT-1_2_B9	-15.90914733	8.937819281	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1188	1802	0.011653718	0.004994451	9	8	Astrocytes	31	7	7
AGAGCTTAGCTGAAAT-1_2_B9	34.02220336	-15.98156539	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3543	7480	0.009090909	0.015641711	9	2	EN-L4	31	7	7
AGAGCTTCAAGACACG-1_2_B9	-3.815648339	-34.79549981	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	841	1137	0.074758135	0.021108179	9	16	EN-PYR	31	7	7
AGAGCTTCATGCATGT-1_2_B9	34.73262239	-6.357033426	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3429	8253	0.002423361	0.009087605	9	2	EN-L4	31	7	7
AGAGCTTGTTTGACTG-1_2_B9	29.7933483	-6.58689024	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4720	13245	0.001057003	0.005436014	9	2	EN-L4	31	7	7
AGAGTGGCACCTCGGA-1_2_B9	33.9858828	-16.62441311	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3908	8415	0.024242424	0.018062983	9	2	EN-L4	31	7	7
AGAGTGGGTACCAGTT-1_2_B9	-30.66048781	-21.57027553	6A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	5396	15283	0.054766734	0.015703723	9	6A	IN-PV	31	7	7
AGAGTGGTCGAGGTAG-1_2_B9	-27.62082058	-21.17949476	6A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3850	9220	0.079718004	0.005639913	9	6A	IN-PV	31	7	7
AGATCTGCAAGCCGCT-1_2_B9	-9.132437378	15.80344385	11	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2010	3425	0.007007299	0.006131387	9	11	Glia-MIX	31	7	7
AGATCTGCACATGGGA-1_2_B9	24.91151181	-17.19726091	3	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	5726	20382	0.034932784	0.005642233	9	3	EN-L5-6	31	7	7
AGATCTGTCATGTGGT-1_2_B9	25.76591979	9.108317911	15A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1758	2906	0.037164487	0.041293875	9	15A	Endo cells	31	7	7
AGATTGCGTACGCACC-1_2_B9	-15.80152062	10.04561959	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1338	2253	0.011540169	0.006213937	9	8	Astrocytes	31	7	7
AGATTGCGTAGAGTGC-1_2_B9	10.30606321	-12.11891221	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2703	4963	0.016522265	0.006447713	9	L2-3	EN-L2-3-MS	31	7	7
AGATTGCTCCACGCAG-1_2_B9	-12.69082434	-0.018685623	13A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2618	5278	0.019325502	0.01061008	9	13A	IN-VIP	31	7	7
AGATTGCTCCTCCTAG-1_2_B9	-13.75245432	-36.49490069	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2095	3907	0.111082672	0.006910673	9	16	EN-PYR	31	7	7
AGCAGCCAGCTGAAAT-1_2_B9	-31.42346052	0.281765298	9	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1629	2755	0.009800363	0.005807623	9	9	OPC	31	7	7
AGCAGCCAGTAGATGT-1_2_B9	-27.79032257	-3.644026832	9	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1420	2151	0.008833101	0.006973501	9	9	OPC	31	7	7
AGCAGCCCAGAGTGTG-1_2_B9	-16.00425933	11.43448367	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1280	1983	0.01412002	0.014624307	9	8	Astrocytes	31	7	7
AGCAGCCTCCGAACGC-1_2_B9	24.93385179	-15.31084649	3	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4275	9804	0.012239902	0.019379845	9	3	EN-L5-6	31	7	7
AGCATACAGTAGTGCG-1_2_B9	-16.45039186	0.246632923	13A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3329	6243	0.016658658	0.025148166	9	13A	IN-VIP	31	7	7
AGCATACTCCTTGCCA-1_2_B9	14.03883548	-14.87698433	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4665	12481	0.027321529	0.007691691	9	L2-3	EN-L2-3-MS	31	7	7
AGCATACTCGGAGGTA-1_2_B9	24.59525417	7.134796276	15A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2252	3751	0.018128499	0.01626233	9	15A	Endo cells	31	7	7
AGCATACTCTCGGACG-1_2_B9	-17.07623237	17.55403574	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1472	2420	0.010743802	0.011983471	9	8	Astrocytes	31	7	7
AGCCTAAGTAGAAAGG-1_2_B9	-3.521652587	-36.0948813	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	747	1064	0.102443609	0.026315789	9	16	EN-PYR	31	7	7
AGCGGTCAGCAGACTG-1_2_B9	-15.37616486	-4.398731867	13A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2848	5543	0.043839076	0.003608154	9	13A	IN-VIP	31	7	7
AGCGGTCCATGTTCCC-1_2_B9	34.3982212	-16.35109447	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4222	9264	0.015328152	0.010902418	9	2	EN-L4	31	7	7
AGCGGTCGTGCCTGGT-1_2_B9	24.27242068	8.222036253	15A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4045	8812	0.029164775	0.023263731	9	15A	Endo cells	31	7	7
AGCGGTCTCACCAGGC-1_2_B9	-5.390231439	-35.07931439	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	876	1222	0.123567921	0.014729951	9	16	EN-PYR	31	7	7
AGCGTATCAAAGGCGT-1_2_B9	-17.82674032	-1.811277905	13A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2766	4855	0.017301751	0.021421215	9	13A	IN-VIP	31	7	7
AGCGTATGTGGCCCTA-1_2_B9	-11.33697067	17.37855096	11	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2002	3325	0.003609023	0.01112782	9	11	Glia-MIX	31	7	7
AGCGTATTCCCATTAT-1_2_B9	7.328202738	1.902312599	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	856	1132	0.09540636	0.020318021	9	16	EN-PYR	31	7	7
AGCGTCGAGCCTTGAT-1_2_B9	24.56144311	-13.5133766	3	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3427	7452	0.02482555	0.009661836	9	3	EN-L5-6	31	7	7
AGCGTCGAGCGCCTCA-1_2_B9	-14.18733688	-5.472245207	13A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2362	4333	0.011077775	0.005538888	9	13A	IN-VIP	31	7	7
AGCGTCGAGCGTAATA-1_2_B9	34.58840477	-16.76802774	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3461	7088	0.023137698	0.020457111	9	2	EN-L4	31	7	7
AGCGTCGCACGCATCG-1_2_B9	-11.70964545	-38.238466	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1546	2506	0.09377494	0.019952115	9	16	EN-PYR	31	7	7
AGCGTCGCATAACCTG-1_2_B9	-32.20791351	-11.34931855	9	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	874	1300	0.010769231	0.020769231	9	9	OPC	31	7	7
AGCTCCTGTAGGAGTC-1_2_B9	-16.15965986	11.57557014	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1147	1752	0.007990868	0.009703196	9	8	Astrocytes	31	7	7
AGCTCCTGTCACAAGG-1_2_B9	-15.64590994	9.157132444	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1435	2437	0.016823964	0.00738613	9	8	Astrocytes	31	7	7
AGCTCTCAGAGGGATA-1_2_B9	16.70481117	-13.19428661	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	5731	15323	0.019186843	0.021275207	9	L2-3	EN-L2-3-MS	31	7	7
AGCTCTCCAAACAACA-1_2_B9	12.30178738	-17.01000702	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4329	11025	0.009795918	0.009070295	9	L2-3	EN-L2-3-MS	31	7	7
AGCTCTCCAGTTCCCT-1_2_B9	-18.60749096	7.653428224	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	745	1009	0.021803766	0.004955401	9	8	Astrocytes	31	7	7
AGCTCTCGTGAGCGAT-1_2_B9	15.47785563	-12.8520763	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3871	7802	0.027557037	0.014611638	9	L2-3	EN-L2-3-MS	31	7	7
AGCTCTCTCCAAAGTC-1_2_B9	9.421848306	-3.986218405	12	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2201	3808	0.024422269	0.012342437	9	12	EN-MIX	31	7	7
AGCTCTCTCCTGCTTG-1_2_B9	-34.57243236	-0.647169359	9	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1583	2926	0.006493506	0.005809979	9	9	OPC	31	7	7
AGCTTGAAGCCACGTC-1_2_B9	-4.002749583	-35.25905858	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	857	1221	0.08026208	0.03030303	9	16	EN-PYR	31	7	7
AGCTTGAGTCAGGACA-1_2_B9	-19.82323108	17.72340165	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1316	2245	0.008908686	0.004454343	9	8	Astrocytes	31	7	7
AGCTTGATCTCTTATG-1_2_B9	-13.91189103	-38.08199256	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1941	3663	0.057876058	0.023478023	9	16	EN-PYR	31	7	7
AGCTTGATCTGCAAGT-1_2_B9	-29.53430102	-3.259660683	9	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1400	2225	0.017078652	0.006292135	9	9	OPC	31	7	7
AGGCCACCAAGACGTG-1_2_B9	-16.50233377	17.20423709	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1924	3536	0.003959276	0.011029412	9	8	Astrocytes	31	7	7
AGGCCACCAAGTTCTG-1_2_B9	-22.63705024	12.67721106	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1015	1526	0.010484928	0.007208388	9	8	Astrocytes	31	7	7
AGGCCACGTCCGCTGA-1_2_B9	33.54165331	-16.50536427	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4247	9559	0.015378178	0.017888901	9	2	EN-L4	31	7	7
AGGCCACGTCGCATAT-1_2_B9	17.38012931	-13.38430678	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	6440	20369	0.020226815	0.016495655	9	L2-3	EN-L2-3-MS	31	7	7
AGGCCACTCTGTCTAT-1_2_B9	9.816057105	-16.95201673	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3538	7581	0.006727345	0.013190872	9	L2-3	EN-L2-3-MS	31	7	7
AGGCCGTAGACTACAA-1_2_B9	-16.41658203	25.36590285	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1839	3287	0.007909948	0.006693033	9	8	Astrocytes	31	7	7
AGGCCGTAGTTTGCGT-1_2_B9	-19.45450968	-2.203238479	13A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	5061	12701	0.024486261	0.008424534	9	13A	IN-VIP	31	7	7
AGGCCGTCAATGACCT-1_2_B9	-20.18394868	-5.527017729	13B	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3804	8392	0.011916111	0.0107245	9	13B	IN-SV2C	31	7	7
AGGCCGTGTACAGCAG-1_2_B9	-10.94346709	-38.53704711	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1310	2046	0.054740958	0.021994135	9	16	EN-PYR	31	7	7
AGGCCGTTCCACGCAG-1_2_B9	-7.896067156	-38.55451571	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1249	1781	0.0825379	0.020774846	9	16	EN-PYR	31	7	7
AGGGAGTCACAACGCC-1_2_B9	-9.355800678	15.62082095	11	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2159	3491	0.010598682	0.011171584	9	11	Glia-MIX	31	7	7
AGGGAGTGTCTTGCGG-1_2_B9	33.24157188	-16.61846043	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4457	10212	0.009890325	0.016647082	9	2	EN-L4	31	7	7
AGGGAGTGTGCAACGA-1_2_B9	-27.41397997	-3.461133984	9	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1283	1934	0.010341262	0.019648397	9	9	OPC	31	7	7
AGGGAGTTCCTTGACC-1_2_B9	34.24995222	-14.01327498	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3139	6547	0.02581335	0.01160837	9	2	EN-L4	31	7	7
AGGGAGTTCGCCAGCA-1_2_B9	-16.4927319	-3.507176371	13A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2575	4757	0.021021652	0.008618877	9	13A	IN-VIP	31	7	7
AGGGATGCAACACCTA-1_2_B9	-17.72795753	16.99706319	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1374	2270	0.019823789	0.00660793	9	8	Astrocytes	31	7	7
AGGGATGCATCATCCC-1_2_B9	17.15446683	-14.14806306	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	6601	21314	0.025241625	0.012761565	9	L2-3	EN-L2-3-MS	31	7	7
AGGGATGGTAGAGTGC-1_2_B9	-23.12481666	8.13226572	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	936	1401	0.011420414	0.01213419	9	8	Astrocytes	31	7	7
AGGGTGACAGCGTCCA-1_2_B9	23.30792356	-16.15971861	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	6521	21773	0.021816011	0.015018601	9	2	EN-L4	31	7	7
AGGTCATCATGACATC-1_2_B9	21.09982868	-22.67651804	3	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4072	9688	0.003303055	0.015792733	9	3	EN-L5-6	31	7	7
AGGTCATTCAACTCTT-1_2_B9	-2.928343083	-34.09563143	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	777	1031	0.031037827	0.01842871	9	16	EN-PYR	31	7	7
AGGTCATTCAGTTCGA-1_2_B9	-28.47584805	-5.995320531	9	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1143	1700	0.009411765	0.007058824	9	9	OPC	31	7	7
AGGTCATTCAGTTTGG-1_2_B9	32.2103712	-18.96082599	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	6034	18294	0.032141686	0.021318465	9	2	EN-L4	31	7	7
AGGTCATTCCCGACTT-1_2_B9	2.99562121	-25.77854403	10	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4862	14310	0.004262753	0.003983229	9	L2-3	EN-L2-3-Cntl	31	7	7
AGGTCATTCGATAGAA-1_2_B9	-5.289509427	-28.305182	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	763	1052	0.105513308	0.019011407	9	16	EN-PYR	31	7	7
AGGTCATTCTCTAGGA-1_2_B9	21.9137792	-16.58386491	3	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	5780	16509	0.014476952	0.015748985	9	3	EN-L5-6	31	7	7
AGGTCCGAGCCACTAT-1_2_B9	17.04177198	-14.77613412	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	6404	19812	0.025943872	0.010094892	9	L2-3	EN-L2-3-MS	31	7	7
AGGTCCGAGTGACTCT-1_2_B9	-24.45749747	-24.02030159	6A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3511	7608	0.018796004	0.007360673	9	6A	IN-PV	31	7	7
AGGTCCGCATCTATGG-1_2_B9	32.75656072	12.82633018	14	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1039	1371	0.016776076	0.037199125	9	14	Microglia	31	7	7
AGGTCCGGTGCCTTGG-1_2_B9	-17.91858713	-4.579066111	13A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3166	6625	0.027924528	0.006792453	9	13A	IN-VIP	31	7	7
AGGTCCGTCCACGTGG-1_2_B9	9.742711282	-14.00247682	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2930	5831	0.012690791	0.014234265	9	L2-3	EN-L2-3-MS	31	7	7
AGGTCCGTCCCTCTTT-1_2_B9	-15.01835123	-37.56941247	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2432	4761	0.060281453	0.018483512	9	16	EN-PYR	31	7	7
AGGTCCGTCTCTAGGA-1_2_B9	-12.29660478	-2.447754594	13A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2175	3708	0.008629989	0.012675297	9	13A	IN-VIP	31	7	7
AGTCTTTCAAACCCAT-1_2_B9	33.54756268	-11.91182959	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2936	5716	0.005773268	0.009447166	9	2	EN-L4	31	7	7
AGTCTTTGTACGCTGC-1_2_B9	22.06526098	-17.52892529	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	5918	18945	0.034151491	0.006439694	9	2	EN-L4	31	7	7
AGTGAGGAGCGAGAAA-1_2_B9	35.15639508	11.43036761	14	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	878	1131	0.020335986	0.00530504	9	14	Microglia	31	7	7
AGTGAGGAGGAGTTGC-1_2_B9	-23.56191428	8.067465522	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	884	1245	0.010441767	0.012048193	9	8	Astrocytes	31	7	7
AGTGAGGGTCATATGC-1_2_B9	-26.8153098	-11.50602945	9	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1089	1467	0.011588275	0.017723245	9	9	OPC	31	7	7
AGTGGGAAGGGTCGAT-1_2_B9	33.11581306	-18.90547865	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2510	3954	0.030601922	0.030601922	9	2	EN-L4	31	7	7
AGTGGGACAGTAACGG-1_2_B9	10.63194641	-11.99067396	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2339	3833	0.013305505	0.017218889	9	L2-3	EN-L2-3-MS	31	7	7
AGTGTCAAGAGTTGGC-1_2_B9	11.58111768	-11.33466385	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2616	4384	0.023494526	0.015282847	9	L2-3	EN-L2-3-MS	31	7	7
AGTGTCATCCTTGGTC-1_2_B9	-3.657616087	9.435848634	5	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	912	1223	0.01635323	0.040065413	9	oligos	OL-MS-1	31	7	7
AGTTGGTCAGGCTCAC-1_2_B9	23.29861813	-16.10164038	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	6221	20461	0.03313621	0.013782318	9	2	EN-L4	31	7	7
AGTTGGTGTCACTGGC-1_2_B9	17.11630289	-15.07681153	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4963	13347	0.021877575	0.014909718	9	L2-3	EN-L2-3-MS	31	7	7
AGTTGGTGTTCGGCAC-1_2_B9	16.46411585	-15.22305095	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	6172	18343	0.00877719	0.027421905	9	L2-3	EN-L2-3-MS	31	7	7
AGTTGGTTCCGTCAAA-1_2_B9	30.37340326	-10.97079198	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3820	8638	0.013544802	0.005325307	9	2	EN-L4	31	7	7
ATAACGCAGAGCTATA-1_2_B9	-24.1859418	0.661926825	9	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2128	3538	0.010740531	0.013284341	9	9	OPC	31	7	7
ATAACGCAGCGCCTCA-1_2_B9	-15.35790324	13.0297061	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1558	2539	0.010240252	0.011027964	9	8	Astrocytes	31	7	7
ATAACGCAGTGGAGTC-1_2_B9	33.65721858	14.31867116	14	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	852	1201	0.013322231	0.039966694	9	14	Microglia	31	7	7
ATAACGCTCCTTGACC-1_2_B9	-29.27225204	-3.082478888	9	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1334	2067	0.014029995	0.005321722	9	9	OPC	31	7	7
ATAAGAGAGGAGCGAG-1_2_B9	-18.13494343	23.58439108	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1231	1998	0.009009009	0.008508509	9	8	Astrocytes	31	7	7
ATAAGAGAGTAGGTGC-1_2_B9	-12.34590092	-13.96162085	6B	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1376	2142	0.011204482	0.019607843	9	6B	IN-SST	31	7	7
ATAAGAGCATCGGACC-1_2_B9	15.90830657	-28.65271002	3	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	5160	16338	0.004712939	0.003488799	9	3	EN-L5-6	31	7	7
ATAAGAGGTAGTAGTA-1_2_B9	-17.34308923	7.259922175	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1129	1822	0.010428101	0.007135016	9	8	Astrocytes	31	7	7
ATAGACCGTGCAGTAG-1_2_B9	24.25892176	-19.10310321	3	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4153	8853	0.006212583	0.011521518	9	3	EN-L5-6	31	7	7
ATAGACCTCAAGCCTA-1_2_B9	8.723246108	2.812250733	12	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1003	1583	0.075173721	0.008843967	9	12	EN-MIX	31	7	7
ATAGACCTCTGTCCGT-1_2_B9	9.831923284	-3.907069804	12	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1841	2987	0.024439237	0.024104453	9	12	EN-MIX	31	7	7
ATCACGAAGGCTAGAC-1_2_B9	-23.83331146	16.15835912	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1345	2222	0.005850585	0.00630063	9	8	Astrocytes	31	7	7
ATCACGATCAGCACAT-1_2_B9	-8.458220225	-16.83667775	6B	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	719	1051	0.082778306	0.003805899	9	6B	IN-SST	31	7	7
ATCACGATCTTGTTTG-1_2_B9	13.26481319	-19.41230375	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4782	12956	0.004708243	0.014356283	9	L2-3	EN-L2-3-MS	31	7	7
ATCATCTCAAGCTGTT-1_2_B9	4.805555644	5.108734287	7	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1830	2883	0.007977801	0.007977801	9	7	Phagocytes	31	7	7
ATCATCTCACGGTAGA-1_2_B9	18.19851613	-23.15015332	3	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2506	4538	0.004407228	0.026223006	9	3	EN-L5-6	31	7	7
ATCATCTCATGGTCTA-1_2_B9	8.265924948	-12.28624252	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2162	3647	0.025500411	0.010145325	9	L2-3	EN-L2-3-MS	31	7	7
ATCATCTTCCTATGTT-1_2_B9	24.92844637	-15.33331597	3	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4219	9652	0.019581434	0.017820141	9	3	EN-L5-6	31	7	7
ATCATGGAGATGAGAG-1_2_B9	-31.48650823	-5.056521927	9	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1208	1842	0.005428882	0.008686211	9	9	OPC	31	7	7
ATCATGGAGTCGATAA-1_2_B9	-12.32228501	-13.24227543	6A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1790	3073	0.044907257	0.0152945	9	6A	IN-PV	31	7	7
ATCATGGGTAACGACG-1_2_B9	22.42930867	-17.03319018	3	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3797	8998	0.012002667	0.027006001	9	3	EN-L5-6	31	7	7
ATCATGGTCTCGGACG-1_2_B9	9.002009427	-4.198855575	12	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2037	3659	0.042907898	0.014484832	9	12	EN-MIX	31	7	7
ATCCACCAGCCAGTTT-1_2_B9	16.58943281	-9.801812972	12	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1822	3112	0.031169666	0.005141388	9	12	EN-MIX	31	7	7
ATCCACCCATGCCTAA-1_2_B9	30.90137351	-18.81731577	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	6971	22147	0.024608299	0.016661399	9	2	EN-L4	31	7	7
ATCCACCCATGTTGAC-1_2_B9	-16.77161201	17.12344498	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1928	3609	0.005818786	0.004156276	9	8	Astrocytes	31	7	7
ATCCACCGTTGCTCCT-1_2_B9	35.23331799	-15.96422701	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	5233	13615	0.01285347	0.018141755	9	2	EN-L4	31	7	7
ATCCACCTCAAACGGG-1_2_B9	29.52784401	15.38044374	14	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1549	2701	0.015549796	0.123287671	9	14	Microglia	31	7	7
ATCCACCTCTACTATC-1_2_B9	34.15529428	-14.08871817	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4918	13178	0.012293216	0.01198968	9	2	EN-L4	31	7	7
ATCCGAAAGACCTTTG-1_2_B9	-18.86272043	24.02804154	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1660	2867	0.004534356	0.010115103	9	8	Astrocytes	31	7	7
ATCCGAAAGTGTCTCA-1_2_B9	20.60704306	-21.27469178	3	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4163	10311	0.014741538	0.014159635	9	3	EN-L5-6	31	7	7
ATCCGAAGTCCTCTTG-1_2_B9	-3.407860249	-34.30718448	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	682	1031	0.191076625	0.027158099	9	16	EN-PYR	31	7	7
ATCCGAAGTCTAGTCA-1_2_B9	-19.27475384	-1.70303401	13A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3276	6287	0.016064896	0.019087005	9	13A	IN-VIP	31	7	7
ATCGAGTGTCGCTTTC-1_2_B9	24.93246838	-16.45757709	3	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3794	8671	0.027678468	0.007726906	9	3	EN-L5-6	31	7	7
ATCGAGTTCTAACTCT-1_2_B9	36.04088613	13.4237846	14	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1055	1510	0.01986755	0.010596026	9	14	Microglia	31	7	7
ATCTACTAGGCCCTCA-1_2_B9	21.97414578	-20.86399013	3	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4405	12331	0.018733274	0.007055389	9	3	EN-L5-6	31	7	7
ATCTACTAGGGTCTCC-1_2_B9	-13.78473793	-38.22337915	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1988	3584	0.075892857	0.026785714	9	16	EN-PYR	31	7	7
ATCTACTGTGCTGTAT-1_2_B9	-24.09661866	0.903506151	9	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2304	3952	0.006578947	0.009868421	9	9	OPC	31	7	7
ATCTGCCGTGACCAAG-1_2_B9	-4.39047317	-36.33434233	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	932	1353	0.101995565	0.026607539	9	16	EN-PYR	31	7	7
ATCTGCCTCACAAACC-1_2_B9	-28.20614198	-21.6966319	6A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4999	14345	0.086232137	0.006134542	9	6A	IN-PV	31	7	7
ATCTGCCTCCCTCAGT-1_2_B9	-3.691773457	-34.10682251	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	779	1145	0.173799127	0.016593886	9	16	EN-PYR	31	7	7
ATCTGCCTCCTAGAAC-1_2_B9	-18.33205181	23.79140441	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1550	2593	0.012340918	0.005784805	9	8	Astrocytes	31	7	7
ATGAGGGAGAGTTGGC-1_2_B9	33.52334699	4.798783817	14	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1197	1686	0.0628707	0.017200474	9	14	Microglia	31	7	7
ATGAGGGAGCCACCTG-1_2_B9	27.76801123	7.509559884	15A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	883	1194	0.036850921	0.031825796	9	15A	Endo cells	31	7	7
ATGAGGGAGGGTGTTG-1_2_B9	-20.45420711	-4.986158261	13B	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3489	6974	0.018927445	0.01620304	9	13B	IN-SV2C	31	7	7
ATGAGGGCATGCAACT-1_2_B9	-4.105039975	21.19931781	1	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	791	1051	0.019029496	0.010466223	9	oligos	OL-Cntl	31	7	7
ATGAGGGGTAAATGTG-1_2_B9	-4.844857165	-34.33757804	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1092	1638	0.147741148	0.015262515	9	16	EN-PYR	31	7	7
ATGAGGGTCACCCGAG-1_2_B9	-28.05292546	-3.860171092	9	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1263	1832	0.01419214	0.004912664	9	9	OPC	31	7	7
ATGAGGGTCTTGTTTG-1_2_B9	-31.69816694	-7.832412973	9	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	990	1384	0.007947977	0.010115607	9	9	OPC	31	7	7
ATGCGATGTAAGGGAA-1_2_B9	12.53632583	-12.21246513	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2943	5279	0.027277894	0.028603902	9	L2-3	EN-L2-3-MS	31	7	7
ATGGGAGTCTGTACGA-1_2_B9	-11.33271242	27.95511002	15A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2184	3440	0.046802326	0.020930233	9	15A	Endo cells	31	7	7
ATGTGTGAGCTGCCCA-1_2_B9	31.51989568	-19.04555295	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4758	11389	0.014663272	0.026165598	9	2	EN-L4	31	7	7
ATGTGTGAGGACACCA-1_2_B9	-19.10228837	9.725549673	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	785	1122	0.021390374	0.006238859	9	8	Astrocytes	31	7	7
ATGTGTGCACATCCGG-1_2_B9	-17.35014447	17.8844366	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1826	3322	0.010535822	0.011438892	9	8	Astrocytes	31	7	7
ATGTGTGGTGGTTTCA-1_2_B9	-20.32523621	-4.849579665	13B	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3544	7404	0.022690438	0.016207455	9	13B	IN-SV2C	31	7	7
ATGTGTGTCCAAACAC-1_2_B9	25.00546261	-15.72803162	3	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3647	7572	0.024828315	0.023375594	9	3	EN-L5-6	31	7	7
ATTACTCGTAGTACCT-1_2_B9	-15.64401813	18.25568941	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1325	2301	0.005215124	0.012603216	9	8	Astrocytes	31	7	7
ATTACTCTCTCCAACC-1_2_B9	-21.03831964	18.78368884	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1298	2290	0.005676856	0.004803493	9	8	Astrocytes	31	7	7
ATTATCCCATCCGGGT-1_2_B9	-18.99867066	23.79779184	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1551	2637	0.006825939	0.007963595	9	8	Astrocytes	31	7	7
ATTATCCGTCGGGTCT-1_2_B9	-13.0920373	16.57288558	11	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1439	2426	0.004946414	0.01071723	9	11	Glia-MIX	31	7	7
ATTATCCTCCAAGCCG-1_2_B9	-17.50032248	18.37036076	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1430	2413	0.009531703	0.007459594	9	8	Astrocytes	31	7	7
ATTATCCTCGAGAACG-1_2_B9	-16.78548107	-15.14988356	6B	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1588	2653	0.013569544	0.009423294	9	6B	IN-SST	31	7	7
ATTCTACCATGCAATC-1_2_B9	-10.41957028	14.41545073	11	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1588	2442	0.016380016	0.014742015	9	11	Glia-MIX	31	7	7
ATTCTACCATGGTCTA-1_2_B9	37.25377982	13.40564934	14	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1017	1398	0.008583691	0.005722461	9	14	Microglia	31	7	7
ATTCTACTCGGAAATA-1_2_B9	-28.88985966	-7.522647152	9	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	904	1270	0.004724409	0.007086614	9	9	OPC	31	7	7
ATTGGACAGTCGCCGT-1_2_B9	-11.90644562	-8.235768498	13B	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1769	2757	0.027928908	0.003627131	9	13B	IN-SV2C	31	7	7
ATTGGACCACCCATGG-1_2_B9	25.38448931	-15.45888432	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	5424	13989	0.032525556	0.024876689	9	2	EN-L4	31	7	7
ATTGGACGTCATGCCG-1_2_B9	31.3166819	-17.30542958	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	5974	20181	0.023239681	0.008721074	9	2	EN-L4	31	7	7
ATTGGACTCCTTTCTC-1_2_B9	-17.86456244	16.4701805	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1290	1945	0.019023136	0.007197943	9	8	Astrocytes	31	7	7
ATTGGACTCGCCTGAG-1_2_B9	32.97706434	-8.322630061	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3405	7038	0.008383063	0.005825519	9	2	EN-L4	31	7	7
ATTGGTGAGCAATCTC-1_2_B9	-7.34942438	-37.56334921	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1055	1536	0.065755208	0.021484375	9	16	EN-PYR	31	7	7
ATTGGTGTCGTGGTCG-1_2_B9	11.21853679	-25.0070652	10	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4723	13014	0.001229445	0.009912402	9	L2-3	EN-L2-3-Cntl	31	7	7
ATTGGTGTCTGGCGAC-1_2_B9	-4.78408854	-34.01351211	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	919	1374	0.133187773	0.012372635	9	16	EN-PYR	31	7	7
ATTTCTGGTACTCAAC-1_2_B9	-9.397982699	-5.203809396	13A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1571	2561	0.010542757	0.010933229	9	13A	IN-VIP	31	7	7
ATTTCTGTCAGCTCTC-1_2_B9	30.79651936	-17.90915103	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	6089	21588	0.021030202	0.013989253	9	2	EN-L4	31	7	7
ATTTCTGTCGAATCCA-1_2_B9	32.65955521	-8.253728498	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2964	5857	0.004780604	0.009219737	9	2	EN-L4	31	7	7
CAACCAAAGTAGGCCA-1_2_B9	12.22632442	-16.93538304	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4357	10507	0.007042924	0.012658228	9	L2-3	EN-L2-3-MS	31	7	7
CAACCAACACGGCCAT-1_2_B9	7.107209698	-0.723219841	12	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	952	1428	0.021708683	0.012605042	9	12	EN-MIX	31	7	7
CAACCAACAGGGAGAG-1_2_B9	-24.47976755	-24.13034787	6A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4078	10508	0.049676437	0.003901789	9	6A	IN-PV	31	7	7
CAACCAAGTAAAGGAG-1_2_B9	-4.109802302	-36.36284325	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	953	1368	0.084064327	0.033625731	9	16	EN-PYR	31	7	7
CAACCAAGTACAGACG-1_2_B9	-12.90013161	16.27368925	11	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1383	2067	0.011127238	0.006289308	9	11	Glia-MIX	31	7	7
CAACCAATCCTCGCAT-1_2_B9	-5.698630074	-33.92338885	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	897	1225	0.04	0.01877551	9	16	EN-PYR	31	7	7
CAACCTCCAGCTTCGG-1_2_B9	1.988034699	5.263015234	7	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	794	1026	0.041910331	0.009746589	9	7	Phagocytes	31	7	7
CAACCTCGTACCGTAT-1_2_B9	24.99019456	-14.63079648	3	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	5520	15772	0.016611717	0.011919858	9	3	EN-L5-6	31	7	7
CAACCTCGTAGAGTGC-1_2_B9	-18.75884998	0.160570188	13A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3840	8159	0.011888712	0.012256404	9	13A	IN-VIP	31	7	7
CAACTAGGTAAAGGAG-1_2_B9	32.69575931	-8.538690303	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3279	6720	0.006994048	0.011011905	9	2	EN-L4	31	7	7
CAACTAGGTGCAACTT-1_2_B9	12.24467282	-23.69665328	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	6881	25619	0.003747219	0.011983294	9	L2-3	EN-L2-3-MS	31	7	7
CAACTAGTCGATAGAA-1_2_B9	-15.3888634	12.53694622	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1650	2882	0.006592644	0.009021513	9	8	Astrocytes	31	7	7
CAAGAAACAAGCTGGA-1_2_B9	-7.113734226	-37.65542366	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1055	1656	0.117149758	0.014492754	9	16	EN-PYR	31	7	7
CAAGAAACAAGGTGTG-1_2_B9	15.11348241	-19.93423537	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3829	8202	0.003657644	0.014752499	9	L2-3	EN-L2-3-MS	31	7	7
CAAGAAACAGACTCGC-1_2_B9	25.49869327	6.077609565	15A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1205	1677	0.038163387	0.016696482	9	15A	Endo cells	31	7	7
CAAGATCTCTGTACGA-1_2_B9	27.29772151	7.544906945	15A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1024	1425	0.035087719	0.025263158	9	15A	Endo cells	31	7	7
CAAGGCCAGCGATAGC-1_2_B9	-15.50603112	-6.624959292	13B	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2643	5037	0.01826484	0.005161803	9	13B	IN-SV2C	31	7	7
CAAGGCCTCCTGCAGG-1_2_B9	-8.237860062	-38.63328591	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1381	2357	0.154433602	0.024183284	9	16	EN-PYR	31	7	7
CAAGTTGGTGCACTTA-1_2_B9	11.94157421	-13.01823102	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3212	5943	0.016321723	0.011610298	9	L2-3	EN-L2-3-MS	31	7	7
CAAGTTGTCTTACCGC-1_2_B9	14.10109079	-21.96606806	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	5570	16747	0.005612946	0.005911507	9	L2-3	EN-L2-3-MS	31	7	7
CACAAACAGGCGACAT-1_2_B9	-18.21392744	16.78083969	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1319	1984	0.018649194	0.007056452	9	8	Astrocytes	31	7	7
CACAAACGTAGGCATG-1_2_B9	10.77076794	-1.250160464	12	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1624	2602	0.012298232	0.011529593	9	12	EN-MIX	31	7	7
CACAAACTCCCATTTA-1_2_B9	25.89579539	5.260679186	15BA	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1201	1851	0.021069692	0.016207455	9	15BA	Stromal cells	31	7	7
CACACAACAGGACGTA-1_2_B9	-14.85316187	7.144558864	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	972	1393	0.049533381	0.010768126	9	8	Astrocytes	31	7	7
CACACAAGTTCCAACA-1_2_B9	25.02844203	6.608525425	15A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1447	2076	0.042870906	0.01734104	9	15A	Endo cells	31	7	7
CACACCTAGAACAATC-1_2_B9	11.96716846	-3.335780341	12	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1531	2743	0.062705067	0.004010208	9	12	EN-MIX	31	7	7
CACACCTAGCTAGGCA-1_2_B9	-28.46247977	1.249952435	9	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2457	4498	0.00867052	0.024455313	9	9	OPC	31	7	7
CACACCTCACATGGGA-1_2_B9	-26.69877616	-1.608003524	9	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1740	2754	0.02432825	0.029411765	9	9	OPC	31	7	7
CACACCTGTTGATTGC-1_2_B9	-26.87556648	-1.743973409	9	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1443	2195	0.011389522	0.029157175	9	9	OPC	31	7	7
CACACCTTCATGTCCC-1_2_B9	35.91248766	-10.65321499	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4112	9744	0.00636289	0.012212644	9	2	EN-L4	31	7	7
CACACCTTCGATGAGG-1_2_B9	-18.86872691	24.13758781	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1776	3165	0.010742496	0.003791469	9	8	Astrocytes	31	7	7
CACACTCAGGTCATCT-1_2_B9	4.905046349	4.661167549	7	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2113	3528	0.007369615	0.012755102	9	7	Phagocytes	31	7	7
CACACTCGTGTGGCTC-1_2_B9	9.781090034	-10.7877629	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2813	5758	0.023098298	0.019451198	9	L2-3	EN-L2-3-MS	31	7	7
CACAGGCAGACACGAC-1_2_B9	-2.863641529	-35.01734878	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1062	1521	0.08086785	0.024326101	9	16	EN-PYR	31	7	7
CACAGGCAGCTCCTTC-1_2_B9	-24.73846553	-18.242749	6B	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3311	7548	0.017223105	0.018018018	9	6B	IN-SST	31	7	7
CACAGGCCAAGAGTCG-1_2_B9	-17.31414823	17.61097633	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1823	3219	0.00341721	0.007455732	9	8	Astrocytes	31	7	7
CACAGGCCAGCTGCAC-1_2_B9	24.66302333	4.567692414	15DA	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1931	3018	0.015241882	0.011597084	9	15DA	T cells	31	7	7
CACAGGCTCCTTGCCA-1_2_B9	-29.62513007	-2.600382976	9	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1473	2438	0.013125513	0.00369155	9	9	OPC	31	7	7
CACAGGCTCTTTAGGG-1_2_B9	-11.81796634	18.0079906	11	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2108	3783	0.00555115	0.008987576	9	11	Glia-MIX	31	7	7
CACAGTAAGCTAGTTC-1_2_B9	-2.813208971	-34.19121279	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	787	1106	0.138336347	0.03164557	9	16	EN-PYR	31	7	7
CACATAGGTCGCCATG-1_2_B9	-17.35811543	17.87040443	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1919	3696	0.017045455	0.00974026	9	8	Astrocytes	31	7	7
CACATAGGTTCAGACT-1_2_B9	21.51154427	-22.31161983	3	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3294	7510	0.006924101	0.015579228	9	3	EN-L5-6	31	7	7
CACATAGTCACTTACT-1_2_B9	-5.005246913	-30.87034761	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	896	1200	0.059166667	0.0225	9	16	EN-PYR	31	7	7
CACATAGTCTTTAGTC-1_2_B9	-17.30669216	17.94524759	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1724	3250	0.011076923	0.004307692	9	8	Astrocytes	31	7	7
CACATTTAGCAGCCTC-1_2_B9	-17.69290545	18.04238511	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1632	2771	0.008300253	0.005774089	9	8	Astrocytes	31	7	7
CACATTTCAAGTTCTG-1_2_B9	-7.819506629	-38.62243744	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1195	1820	0.109340659	0.024175824	9	16	EN-PYR	31	7	7
CACATTTCACCTGGTG-1_2_B9	-27.06551096	-22.80612961	6A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4729	12874	0.034332764	0.008155973	9	6A	IN-PV	31	7	7
CACATTTGTTCCACTC-1_2_B9	25.67426299	7.290179783	15A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1536	2374	0.02021904	0.01853412	9	15A	Endo cells	31	7	7
CACATTTTCCGTTGCT-1_2_B9	-3.035795029	-34.19176565	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	749	1013	0.07798618	0.019743337	9	16	EN-PYR	31	7	7
CACCACTCAGGAACGT-1_2_B9	-13.833211	-36.15725885	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2362	4930	0.159432049	0.009533469	9	16	EN-PYR	31	7	7
CACCACTCATACCATG-1_2_B9	34.43625874	13.38275653	14	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1284	1908	0.014675052	0.027777778	9	14	Microglia	31	7	7
CACCACTGTCTACCTC-1_2_B9	9.011231075	-3.436202159	12	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1861	3116	0.037548139	0.009627728	9	12	EN-MIX	31	7	7
CACCACTGTGTCCTCT-1_2_B9	19.21651089	-22.39696902	3	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4228	10013	0.015080395	0.01198442	9	3	EN-L5-6	31	7	7
CACCACTGTTACGACT-1_2_B9	-11.4899728	-27.35335738	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	980	1356	0.101032448	0.028023599	9	16	EN-PYR	31	7	7
CACCAGGAGATGAGAG-1_2_B9	-23.15245707	6.33542135	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	992	1420	0.015492958	0.014788732	9	8	Astrocytes	31	7	7
CACCAGGTCATTTGGG-1_2_B9	-26.34132696	-23.90144496	6A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4552	12770	0.037744714	0.004306969	9	6A	IN-PV	31	7	7
CACCTTGGTACAGACG-1_2_B9	-3.898565807	-34.48355241	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	875	1149	0.065274151	0.018276762	9	16	EN-PYR	31	7	7
CACTCCAAGAAACGCC-1_2_B9	10.50616624	-14.64810242	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2993	5808	0.016012397	0.011535813	9	L2-3	EN-L2-3-MS	31	7	7
CACTCCAAGTTTGCGT-1_2_B9	34.67477528	-16.87441643	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4486	10139	0.025249038	0.018049117	9	2	EN-L4	31	7	7
CACTCCACAACGATGG-1_2_B9	13.60301848	-12.87102254	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3931	8389	0.019787817	0.011920372	9	L2-3	EN-L2-3-MS	31	7	7
CACTCCACAAGCGATG-1_2_B9	31.22688258	-18.24195519	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	6119	18331	0.013365337	0.01341989	9	2	EN-L4	31	7	7
CACTCCACAGTTCCCT-1_2_B9	9.142892272	-18.33566768	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4043	9872	0.00445705	0.015093193	9	L2-3	EN-L2-3-MS	31	7	7
CACTCCATCAAGAAGT-1_2_B9	-7.141415116	-36.4733561	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	958	1365	0.023443223	0.014652015	9	16	EN-PYR	31	7	7
CAGAATCAGGGCTTCC-1_2_B9	-25.04186817	-18.63155397	6B	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2605	5141	0.014588601	0.014005057	9	6B	IN-SST	31	7	7
CAGAATCAGTCGAGTG-1_2_B9	-18.18526023	-14.53458115	6B	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2229	3971	0.025938051	0.014102241	9	6B	IN-SST	31	7	7
CAGAATCCACACTGCG-1_2_B9	-22.26112982	-14.66348993	6B	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2760	5193	0.020989794	0.005777008	9	6B	IN-SST	31	7	7
CAGAATCCATCCTAGA-1_2_B9	7.439717312	-12.87080144	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2081	3613	0.01632992	0.008026571	9	L2-3	EN-L2-3-MS	31	7	7
CAGAATCCATGTCGAT-1_2_B9	-24.34867594	-16.12228503	6A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3324	6647	0.012336392	0.009327516	9	6A	IN-PV	31	7	7
CAGAATCTCCCATTAT-1_2_B9	-15.25972666	8.96605947	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1892	3503	0.026548673	0.027405081	9	8	Astrocytes	31	7	7
CAGAATCTCTAGAGTC-1_2_B9	-25.86305763	-11.08295564	9	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1020	1397	0.009305655	0.020042949	9	9	OPC	31	7	7
CAGAGAGAGATGTTAG-1_2_B9	12.85552426	-12.48448988	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3570	6976	0.010034404	0.027522936	9	L2-3	EN-L2-3-MS	31	7	7
CAGAGAGGTCTCCATC-1_2_B9	-17.94342091	-2.5222612	13A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3218	6478	0.017752393	0.011114542	9	13A	IN-VIP	31	7	7
CAGATCACACATTTCT-1_2_B9	24.25024711	-19.95334057	3	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4846	12895	0.007754944	0.007522295	9	3	EN-L5-6	31	7	7
CAGATCACACGAAATA-1_2_B9	-25.34954624	-17.95712268	6B	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2398	4461	0.015467384	0.006052455	9	6B	IN-SST	31	7	7
CAGATCAGTCTGGAGA-1_2_B9	12.75018263	-12.14498817	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2886	5109	0.026423958	0.022900763	9	L2-3	EN-L2-3-MS	31	7	7
CAGATCAGTTCCCGAG-1_2_B9	-19.08138192	7.524520296	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	909	1317	0.01063022	0.008352316	9	8	Astrocytes	31	7	7
CAGATCATCCTTTACA-1_2_B9	-24.47240276	-22.37404573	6A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2999	6572	0.030888618	0.00456482	9	6A	IN-PV	31	7	7
CAGCAGCCAAACTGTC-1_2_B9	-15.65983877	16.37206	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2041	3661	0.015842666	0.011472275	9	8	Astrocytes	31	7	7
CAGCAGCCACACCGCA-1_2_B9	-10.83617283	14.22380999	11	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1644	2489	0.023704299	0.010445962	9	11	Glia-MIX	31	7	7
CAGCAGCCACATTCGA-1_2_B9	-17.16163783	-3.420971152	13A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2795	5435	0.010855566	0.018399264	9	13A	IN-VIP	31	7	7
CAGCAGCCATTTGCTT-1_2_B9	24.6854465	-13.40505837	3	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4344	10079	0.009227106	0.011905943	9	3	EN-L5-6	31	7	7
CAGCAGCGTGACTACT-1_2_B9	-24.81432546	-18.83646994	6B	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3025	6405	0.013583138	0.021389539	9	6B	IN-SST	31	7	7
CAGCATAAGAGGGCTT-1_2_B9	-4.460693841	-33.2420643	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	786	1033	0.052274927	0.011616651	9	16	EN-PYR	31	7	7
CAGCATAGTTAAAGAC-1_2_B9	29.96804234	8.555910371	15DA	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	694	1059	0.186024551	0.020774315	9	15DA	T cells	31	7	7
CAGCATATCTATCCTA-1_2_B9	-5.001710077	-30.69071103	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	838	1153	0.033824805	0.020815265	9	16	EN-PYR	31	7	7
CAGCCGACACTGAAGG-1_2_B9	34.81352686	-6.417370397	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2751	5482	0.005107625	0.009668004	9	2	EN-L4	31	7	7
CAGCCGATCAACCAAC-1_2_B9	22.00697918	-16.77298986	3	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	5354	15071	0.024085993	0.015725566	9	3	EN-L5-6	31	7	7
CAGCCGATCTTACCGC-1_2_B9	-24.90035931	-24.33439668	6A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	5029	14354	0.032325484	0.004528354	9	6A	IN-PV	31	7	7
CAGCGACCATCTGGTA-1_2_B9	24.18683588	-16.26912734	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	5371	16156	0.025687051	0.015474127	9	2	EN-L4	31	7	7
CAGCGACGTACATCCA-1_2_B9	24.05944904	-16.17372418	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4150	9641	0.027797946	0.022404315	9	2	EN-L4	31	7	7
CAGCGACGTTGAGTTC-1_2_B9	-18.58772158	-0.805849733	13A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3565	7259	0.014878082	0.024521284	9	13A	IN-VIP	31	7	7
CAGCGACTCTCAACTT-1_2_B9	33.20901579	-16.61069219	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4449	11062	0.007412764	0.015819924	9	2	EN-L4	31	7	7
CAGCTAACATACTACG-1_2_B9	-6.626180815	-38.30344993	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1086	1532	0.071148825	0.015665796	9	16	EN-PYR	31	7	7
CAGCTAACATCACGTA-1_2_B9	11.67793789	-13.52271515	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3148	6364	0.017913262	0.014142049	9	L2-3	EN-L2-3-MS	31	7	7
CAGCTAACATTTGCCC-1_2_B9	7.455772734	1.804740591	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	902	1197	0.06182122	0.01754386	9	16	EN-PYR	31	7	7
CAGCTGGAGGGCACTA-1_2_B9	37.18723564	9.064498161	14	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	775	1025	0.013658537	0.009756098	9	14	Microglia	31	7	7
CAGCTGGCATTCGACA-1_2_B9	-20.65286767	-5.746670345	13B	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	5616	15336	0.014214919	0.012258738	9	13B	IN-SV2C	31	7	7
CAGCTGGGTTCGGGCT-1_2_B9	31.14675269	13.26640325	14	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1130	1616	0.03960396	0.070544554	9	14	Microglia	31	7	7
CAGGTGCAGTCCAGGA-1_2_B9	31.37460041	-17.33269877	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	5994	17897	0.024920378	0.011901436	9	2	EN-L4	31	7	7
CAGGTGCCAAGTTGTC-1_2_B9	7.181879192	1.364463092	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	923	1286	0.026438569	0.038102644	9	16	EN-PYR	31	7	7
CAGGTGCCACCGATAT-1_2_B9	-9.236146931	-8.196533203	13A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1622	2541	0.033057851	0.007870917	9	13A	IN-VIP	31	7	7
CAGGTGCTCCAAGTAC-1_2_B9	-11.67363351	13.28416596	11	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1159	1594	0.018820577	0.014429109	9	11	Glia-MIX	31	7	7
CAGTAACGTAGCACGA-1_2_B9	-11.14576574	28.53014616	17	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1255	1841	0.081477458	0.017925041	9	oligos	OL-MS-2	31	7	7
CAGTAACGTCATATGC-1_2_B9	25.35980304	-15.27242547	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	5604	15752	0.032186389	0.016124937	9	2	EN-L4	31	7	7
CAGTAACGTTCGAATC-1_2_B9	19.29879658	-23.11077233	3	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4424	11876	0.003452341	0.030313237	9	3	EN-L5-6	31	7	7
CAGTAACTCAGGCGAA-1_2_B9	-30.04708347	-21.9473956	6A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	6266	19725	0.053434728	0.009936629	9	6A	IN-PV	31	7	7
CAGTAACTCGGTCTAA-1_2_B9	-4.396014596	-36.19139197	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1019	1423	0.080112439	0.034434294	9	16	EN-PYR	31	7	7
CAGTCCTAGACAGACC-1_2_B9	29.94107577	8.92935707	15DA	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	813	1061	0.072573044	0.036757776	9	15DA	T cells	31	7	7
CAGTCCTCACGGATAG-1_2_B9	16.94407995	-13.31824982	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	6209	19481	0.017504235	0.023561419	9	L2-3	EN-L2-3-MS	31	7	7
CAGTCCTTCTTACCGC-1_2_B9	-1.631090148	1.042542684	11	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3351	6927	0.005774506	0.008373033	9	11	Glia-MIX	31	7	7
CATATGGCAGGAATGC-1_2_B9	-17.2147953	18.10403226	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1615	2724	0.008443465	0.012481645	9	8	Astrocytes	31	7	7
CATATGGGTACATGTC-1_2_B9	-23.36477053	11.35258598	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1162	1834	0.019629226	0.011995638	9	8	Astrocytes	31	7	7
CATATGGTCATTCACT-1_2_B9	-7.698009181	-38.48040249	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1105	1683	0.103980986	0.018419489	9	16	EN-PYR	31	7	7
CATATGGTCGGCTACG-1_2_B9	27.96217816	6.814450336	15BA	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1060	1563	0.03646833	0.022392834	9	15BA	Stromal cells	31	7	7
CATATGGTCTCCCTGA-1_2_B9	-15.93720634	8.901530775	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1302	2181	0.012379642	0.008253095	9	8	Astrocytes	31	7	7
CATATTCAGCGTTCCG-1_2_B9	12.77056393	-15.70043474	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3855	8927	0.016130839	0.005040887	9	L2-3	EN-L2-3-MS	31	7	7
CATATTCCAATAACGA-1_2_B9	31.79477517	-18.49143634	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	6616	22316	0.026886539	0.016714465	9	2	EN-L4	31	7	7
CATATTCCACATTAGC-1_2_B9	-5.482127167	-29.23484863	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	963	1268	0.049684543	0.010252366	9	16	EN-PYR	31	7	7
CATCAGACAGGTTTCA-1_2_B9	-9.006514619	-27.61085385	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1008	1492	0.077747989	0.016085791	9	16	EN-PYR	31	7	7
CATCAGACATATGGTC-1_2_B9	-13.34354946	16.40606537	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1398	2083	0.031204993	0.013442151	9	8	Astrocytes	31	7	7
CATCAGAGTCTCTCGT-1_2_B9	34.03169765	-16.12962172	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3934	8702	0.022868306	0.014249598	9	2	EN-L4	31	7	7
CATCAGATCCAAATGC-1_2_B9	-7.362117168	-37.38399385	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1040	1528	0.078534031	0.016361257	9	16	EN-PYR	31	7	7
CATCCACAGCACAGGT-1_2_B9	-28.00789021	-4.61929945	9	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1147	1624	0.012315271	0.026477833	9	9	OPC	31	7	7
CATCCACTCCTCGCAT-1_2_B9	-12.51307927	0.290405237	13A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3390	7442	0.011421661	0.005912389	9	13A	IN-VIP	31	7	7
CATCCACTCTCACATT-1_2_B9	18.95475091	-13.97720294	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	6842	23362	0.030904888	0.015794881	9	L2-3	EN-L2-3-MS	31	7	7
CATCGAAAGGCCCTTG-1_2_B9	25.35433571	8.67899847	15A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1817	2863	0.055885435	0.032134125	9	15A	Endo cells	31	7	7
CATCGGGAGATCCTGT-1_2_B9	34.34864773	10.9412612	14	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	842	1122	0.01426025	0.020499109	9	14	Microglia	31	7	7
CATCGGGAGGCATTGG-1_2_B9	-19.49708691	-5.016823656	13B	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2695	4655	0.026638024	0.011385607	9	13B	IN-SV2C	31	7	7
CATCGGGAGTGGACGT-1_2_B9	32.01571101	14.06088375	14	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1059	1421	0.016889514	0.052779733	9	14	Microglia	31	7	7
CATCGGGCAAGCGCTC-1_2_B9	-27.82225664	-22.05224356	6A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4720	12189	0.052752482	0.006809418	9	6A	IN-PV	31	7	7
CATCGGGCAGACAAAT-1_2_B9	-28.56793728	-4.472726991	9	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1228	1815	0.009366391	0.01046832	9	9	OPC	31	7	7
CATCGGGTCTCGTATT-1_2_B9	-14.13585856	-6.146891192	13B	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2140	3952	0.026568826	0.006072874	9	13B	IN-SV2C	31	7	7
CATGACACAGACGTAG-1_2_B9	31.26589622	-19.02267965	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4914	11730	0.025404945	0.016965047	9	2	EN-L4	31	7	7
CATGACACATGCATGT-1_2_B9	-10.94026579	28.57025306	17	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	968	1326	0.036953243	0.018099548	9	oligos	OL-MS-2	31	7	7
CATGACAGTCGATTGT-1_2_B9	33.11602714	12.75012486	14	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1169	1660	0.015060241	0.03313253	9	14	Microglia	31	7	7
CATGCCTCACAGACAG-1_2_B9	17.24876255	-29.18046375	3	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3952	10614	0.003580177	0.004710759	9	3	EN-L5-6	31	7	7
CATGCCTGTTCCCTTG-1_2_B9	-9.998066392	-33.02981983	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1148	1721	0.079023823	0.010459035	9	16	EN-PYR	31	7	7
CATGCCTTCACTCCTG-1_2_B9	-9.292109839	-15.52041604	6B	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	806	1062	0.017890772	0.015065913	9	6B	IN-SST	31	7	7
CATGGCGCAGCTGCAC-1_2_B9	9.26735778	0.758888629	12	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	845	1289	0.039565555	0.018619085	9	12	EN-MIX	31	7	7
CATTATCAGAATGTGT-1_2_B9	34.52378077	-16.3887801	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3473	6988	0.015168861	0.019605037	9	2	EN-L4	31	7	7
CATTATCAGTGGGCTA-1_2_B9	12.68984567	-12.49835196	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3312	6477	0.020071021	0.017755134	9	L2-3	EN-L2-3-MS	31	7	7
CATTATCCATCAGTAC-1_2_B9	-11.7299048	18.06508371	11	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2262	4175	0.01005988	0.006946108	9	11	Glia-MIX	31	7	7
CATTATCCATCCGGGT-1_2_B9	26.04737886	7.264374629	15A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1266	1816	0.022577093	0.017070485	9	15A	Endo cells	31	7	7
CATTATCGTACAGACG-1_2_B9	-16.24819887	17.67245017	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1513	2400	0.01375	0.00875	9	8	Astrocytes	31	7	7
CATTCGCAGACTAGGC-1_2_B9	-7.798927921	-5.277562742	13A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1476	2413	0.035640282	0.003729797	9	13A	IN-VIP	31	7	7
CATTCGCAGGGCATGT-1_2_B9	34.66136201	-16.70495663	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3404	6692	0.01658697	0.015540944	9	2	EN-L4	31	7	7
CATTCGCGTTCAGCGC-1_2_B9	-14.52460315	21.93841313	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1549	2510	0.012350598	0.006374502	9	8	Astrocytes	31	7	7
CATTCGCGTTCAGTAC-1_2_B9	-29.34180642	-2.011077463	9	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1704	2892	0.006224066	0.004495159	9	9	OPC	31	7	7
CATTCGCTCCTTGCCA-1_2_B9	-12.0450004	-37.87145097	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1599	2773	0.110349802	0.018752254	9	16	EN-PYR	31	7	7
CCAATCCCATGTTCCC-1_2_B9	33.4719135	-18.79017234	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4776	10637	0.021058569	0.025007051	9	2	EN-L4	31	7	7
CCAATCCGTACCCAAT-1_2_B9	16.46530783	-13.80986699	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	6931	23450	0.01424307	0.014584222	9	L2-3	EN-L2-3-MS	31	7	7
CCAATCCTCGAGCCCA-1_2_B9	-18.66514552	23.83467682	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1597	2640	0.014015152	0.007954545	9	8	Astrocytes	31	7	7
CCACCTAGTCTCTCGT-1_2_B9	-18.66418456	23.66753834	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1442	2425	0.014845361	0.007835052	9	8	Astrocytes	31	7	7
CCACCTATCAGCACAT-1_2_B9	-11.42472019	28.45242552	17	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1549	2454	0.089242054	0.020782396	9	oligos	OL-MS-2	31	7	7
CCACCTATCTCTTGAT-1_2_B9	-19.15085271	-7.398714819	13B	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3717	8671	0.01476185	0.005766348	9	13B	IN-SV2C	31	7	7
CCACGGAAGCCACTAT-1_2_B9	33.71204915	7.689341364	14	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	776	1082	0.032347505	0.00831793	9	14	Microglia	31	7	7
CCACGGACAAGGACTG-1_2_B9	13.93298526	-13.04648796	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3800	7999	0.023377922	0.01687711	9	L2-3	EN-L2-3-MS	31	7	7
CCACGGACACCGAAAG-1_2_B9	13.07248874	-15.50810795	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4210	9621	0.008730901	0.016630288	9	L2-3	EN-L2-3-MS	31	7	7
CCACGGAGTTCTGTTT-1_2_B9	-16.0410368	16.35127211	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1734	3103	0.007734451	0.009668063	9	8	Astrocytes	31	7	7
CCACGGATCGTAGGTT-1_2_B9	35.43936905	7.790768207	14	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	865	1175	0.028085106	0.012765957	9	14	Microglia	31	7	7
CCACTACAGATAGTCA-1_2_B9	31.58061095	-18.17748844	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	6999	24231	0.025752136	0.012091948	9	2	EN-L4	31	7	7
CCACTACAGGGTTCCC-1_2_B9	-8.994576597	-27.31674015	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1117	1584	0.099116162	0.013888889	9	16	EN-PYR	31	7	7
CCACTACAGTCCCACG-1_2_B9	-17.1465786	17.59045924	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1960	3461	0.014157758	0.005778677	9	8	Astrocytes	31	7	7
CCACTACCAGCTGGCT-1_2_B9	-20.4997054	-5.341699927	13B	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4493	10942	0.017090111	0.016176202	9	13B	IN-SV2C	31	7	7
CCACTACTCGCTAGCG-1_2_B9	-6.166439081	-37.58259969	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	832	1128	0.046099291	0.014184397	9	16	EN-PYR	31	7	7
CCAGCGACAGGACCCT-1_2_B9	-17.47371709	6.086628795	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	752	1017	0.024582104	0.006882989	9	8	Astrocytes	31	7	7
CCAGCGAGTACGCTGC-1_2_B9	34.28243292	-14.15432826	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3072	5937	0.011453596	0.012969513	9	2	EN-L4	31	7	7
CCAGCGAGTTCAGTAC-1_2_B9	32.59053382	12.45152596	14	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1030	1380	0.023188406	0.034057971	9	14	Microglia	31	7	7
CCATGTCCAGACGTAG-1_2_B9	35.22626641	7.846718721	14	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	980	1344	0.017113095	0.014880952	9	14	Microglia	31	7	7
CCATGTCGTTTCGCTC-1_2_B9	24.83410759	-15.1618509	3	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4032	9370	0.018356457	0.01963714	9	3	EN-L5-6	31	7	7
CCATTCGCATGTTCCC-1_2_B9	-27.33682086	-22.10267184	6A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4555	12525	0.064830339	0.005748503	9	6A	IN-PV	31	7	7
CCATTCGGTACATGTC-1_2_B9	17.27192612	-13.31461518	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	5994	17862	0.022785802	0.016571493	9	L2-3	EN-L2-3-MS	31	7	7
CCATTCGGTCCTCTTG-1_2_B9	-13.32723537	-36.6607187	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1964	3829	0.150430922	0.01305824	9	16	EN-PYR	31	7	7
CCCAATCAGAAGGCCT-1_2_B9	-13.15138351	-37.45903142	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1826	3259	0.077631175	0.018717398	9	16	EN-PYR	31	7	7
CCCAATCAGACGACGT-1_2_B9	16.17326372	-14.06601621	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	5570	14283	0.02184415	0.010922075	9	L2-3	EN-L2-3-MS	31	7	7
CCCAATCCAGACTCGC-1_2_B9	34.44637083	-14.30147779	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3622	7586	0.008832059	0.018586871	9	2	EN-L4	31	7	7
CCCATACAGAGTGAGA-1_2_B9	-16.92927299	17.37898623	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1543	2565	0.012475634	0.01208577	9	8	Astrocytes	31	7	7
CCCATACCACAACGTT-1_2_B9	7.266170536	2.099652775	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	769	1016	0.053149606	0.012795276	9	16	EN-PYR	31	7	7
CCCATACGTTAAGTAG-1_2_B9	-26.71474055	-2.071458994	9	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1423	2108	0.014231499	0.037950664	9	9	OPC	31	7	7
CCCATACTCCTTCAAT-1_2_B9	-15.58893776	9.104229937	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1466	2330	0.02360515	0.007725322	9	8	Astrocytes	31	7	7
CCCATACTCGACGGAA-1_2_B9	-21.23572701	-25.80604504	6A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2913	5881	0.006121408	0.00374086	9	6A	IN-PV	31	7	7
CCCTCCTAGAAGGCCT-1_2_B9	12.33810229	-16.85793981	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4779	12774	0.010490058	0.009785502	9	L2-3	EN-L2-3-MS	31	7	7
CCCTCCTCATAGTAAG-1_2_B9	-7.799461905	-38.4891149	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1166	1944	0.143004115	0.014917695	9	16	EN-PYR	31	7	7
CCGGGATAGCCCGAAA-1_2_B9	7.46004154	1.596205869	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	894	1305	0.032950192	0.026819923	9	16	EN-PYR	31	7	7
CCGGGATAGTTGTCGT-1_2_B9	-24.47896167	-12.43902924	9	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	720	1081	0.011100833	0.003700278	9	9	OPC	31	7	7
CCGGGATCAAGTTCTG-1_2_B9	-7.214617507	-37.44083279	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1013	1579	0.121595947	0.025965801	9	16	EN-PYR	31	7	7
CCGGGATGTACAGTGG-1_2_B9	34.42553204	-16.46258834	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	5409	14178	0.014176894	0.015305403	9	2	EN-L4	31	7	7
CCGGGATGTGCACGAA-1_2_B9	-11.16409008	-15.34037129	6B	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1163	2074	0.163934426	0.006750241	9	6B	IN-SST	31	7	7
CCGGGATTCCGCAGTG-1_2_B9	34.20497489	-17.83130901	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3446	6868	0.018491555	0.022714036	9	2	EN-L4	31	7	7
CCGGTAGCATAAAGGT-1_2_B9	32.85747382	-15.62286187	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2974	5300	0.028867925	0.012075472	9	2	EN-L4	31	7	7
CCGGTAGCATCTCGCT-1_2_B9	27.58002172	5.493127147	15BA	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	975	1357	0.024318349	0.016212233	9	15BA	Stromal cells	31	7	7
CCGGTAGGTACTCAAC-1_2_B9	-31.37827325	2.561105943	9	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2031	3726	0.006977992	0.004562534	9	9	OPC	31	7	7
CCGGTAGGTGACAAAT-1_2_B9	-10.75103458	-4.685540396	13A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1721	2651	0.025273482	0.014334214	9	13A	IN-VIP	31	7	7
CCGGTAGGTTAAGATG-1_2_B9	34.35155947	-16.19423047	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3882	8098	0.017041245	0.009878982	9	2	EN-L4	31	7	7
CCGGTAGTCGGATGTT-1_2_B9	23.66575315	7.424918944	15A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1686	2563	0.061646508	0.032774093	9	15A	Endo cells	31	7	7
CCGTACTAGAAGGTTT-1_2_B9	-16.13921671	-0.108220552	13A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3390	7062	0.008212971	0.015576324	9	13A	IN-VIP	31	7	7
CCGTACTCAACACCTA-1_2_B9	26.44596027	8.732433934	15A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1692	2840	0.033802817	0.047535211	9	15A	Endo cells	31	7	7
CCGTACTCACAACGCC-1_2_B9	-18.25491632	-9.682248387	13B	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3951	8913	0.004712218	0.007629306	9	13B	IN-SV2C	31	7	7
CCGTACTCACAGGAGT-1_2_B9	-12.84007446	-1.436602221	13A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2499	4735	0.00844773	0.006758184	9	13A	IN-VIP	31	7	7
CCGTACTCAGACAAAT-1_2_B9	34.65160386	-16.56211402	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4654	11026	0.014239071	0.013876292	9	2	EN-L4	31	7	7
CCGTACTGTGCTGTAT-1_2_B9	3.940452957	4.204871193	7	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1597	2409	0.0373599	0.02864259	9	7	Phagocytes	31	7	7
CCGTGGAAGGGAAACA-1_2_B9	-28.95887174	-22.4554997	6A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4762	11610	0.035314384	0.012144703	9	6A	IN-PV	31	7	7
CCGTGGACACGAAGCA-1_2_B9	27.82727266	5.414151444	15BA	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	873	1134	0.060846561	0.020282187	9	15BA	Stromal cells	31	7	7
CCGTGGATCTATCGCC-1_2_B9	-3.52809716	18.51656531	1	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	804	1070	0.017757009	0.009345794	9	oligos	OL-Cntl	31	7	7
CCGTTCACAGCCTGTG-1_2_B9	14.73142565	-14.50510438	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	5368	15079	0.01399297	0.013528749	9	L2-3	EN-L2-3-MS	31	7	7
CCGTTCAGTAAGTAGT-1_2_B9	-26.72862701	-11.30348555	9	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1259	1911	0.016221873	0.017791732	9	9	OPC	31	7	7
CCGTTCATCAGGTAAA-1_2_B9	32.70482587	8.561144053	14	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	853	1103	0.026291931	0.024478694	9	14	Microglia	31	7	7
CCTAAAGGTCTCCCTA-1_2_B9	34.24397349	7.985975396	14	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	916	1177	0.0144435	0.011894647	9	14	Microglia	31	7	7
CCTAAAGGTCTCTTAT-1_2_B9	-19.55719297	-2.366207362	13A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3630	7833	0.022086046	0.013277161	9	13A	IN-VIP	31	7	7
CCTACACCAAGTAGTA-1_2_B9	-16.1784322	-8.539405997	13B	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2615	5260	0.01121673	0.006273764	9	13B	IN-SV2C	31	7	7
CCTACACCAGAAGCAC-1_2_B9	-2.934911467	-34.24437356	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	860	1145	0.098689956	0.021834061	9	16	EN-PYR	31	7	7
CCTACACGTAGTGAAT-1_2_B9	-3.119187466	-34.13347721	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	760	1000	0.082	0.021	9	16	EN-PYR	31	7	7
CCTACACGTTGCCTCT-1_2_B9	-19.52002898	-5.338473127	13A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3666	8320	0.019711538	0.009975962	9	13A	IN-VIP	31	7	7
CCTACACTCCTGCTTG-1_2_B9	35.13476359	13.10778035	14	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1103	1551	0.012250161	0.01934236	9	14	Microglia	31	7	7
CCTACCACAGCTGCAC-1_2_B9	-17.48122449	17.00841135	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1436	2342	0.012809564	0.00853971	9	8	Astrocytes	31	7	7
CCTACCAGTTATCCGA-1_2_B9	-15.81722476	0.804105447	13A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2922	5481	0.009122423	0.018609743	9	13A	IN-VIP	31	7	7
CCTAGCTAGATGTAAC-1_2_B9	-18.12900353	-14.20092529	6B	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2021	3400	0.022058824	0.015588235	9	6B	IN-SST	31	7	7
CCTAGCTAGGTGCTTT-1_2_B9	12.1472204	-12.55378513	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3277	6543	0.018340211	0.016964695	9	L2-3	EN-L2-3-MS	31	7	7
CCTAGCTAGTTCGATC-1_2_B9	-10.36789168	17.71339856	11	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2195	3992	0.009519038	0.009018036	9	11	Glia-MIX	31	7	7
CCTAGCTGTCCGCTGA-1_2_B9	-14.63221158	0.622189479	13A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3134	6738	0.010834075	0.009201543	9	13A	IN-VIP	31	7	7
CCTAGCTGTGATAAAC-1_2_B9	-24.8761972	-18.83614593	6B	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2939	6036	0.010603048	0.015076209	9	6B	IN-SST	31	7	7
CCTAGCTTCACATACG-1_2_B9	-30.69763813	1.057625449	9	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1872	3485	0.01205165	0.007460545	9	9	OPC	31	7	7
CCTAGCTTCCTTGACC-1_2_B9	-30.24572597	-2.111698322	9	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1524	2676	0.013452915	0.009342302	9	9	OPC	31	7	7
CCTATTAAGGATGTAT-1_2_B9	16.64135636	-13.27084072	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4866	12402	0.018626028	0.016207063	9	L2-3	EN-L2-3-MS	31	7	7
CCTATTAGTAATTGGA-1_2_B9	18.68643201	-15.34400478	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	5968	18913	0.021308095	0.007402316	9	L2-3	EN-L2-3-MS	31	7	7
CCTATTATCACAAACC-1_2_B9	-6.229678564	-10.46779531	13B	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	868	1232	0.036525974	0.00487013	9	13B	IN-SV2C	31	7	7
CCTATTATCCTTGCCA-1_2_B9	-2.775210158	2.585956241	11	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1927	3260	0.008588957	0.008282209	9	11	Glia-MIX	31	7	7
CCTATTATCGTACGGC-1_2_B9	-27.94957988	-7.869952454	9	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1005	1437	0.025748086	0.00487126	9	9	OPC	31	7	7
CCTCAGTCACGAGGTA-1_2_B9	31.29144689	-19.0134306	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	5752	16176	0.013847676	0.023244313	9	2	EN-L4	31	7	7
CCTCAGTCACTGTGTA-1_2_B9	16.85001389	-13.37826564	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	5019	12972	0.024437249	0.012411348	9	L2-3	EN-L2-3-MS	31	7	7
CCTCAGTTCTACCAGA-1_2_B9	-22.66847776	7.465681821	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1240	2120	0.018867925	0.014150943	9	8	Astrocytes	31	7	7
CCTCTGACAACACCCG-1_2_B9	15.24843179	-15.85879335	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	5836	17395	0.009772923	0.018568554	9	L2-3	EN-L2-3-MS	31	7	7
CCTCTGAGTCCGTGAC-1_2_B9	-17.86592607	24.46876092	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1800	3166	0.012634239	0.012318383	9	8	Astrocytes	31	7	7
CCTCTGATCGTCACGG-1_2_B9	13.21741867	-15.78070656	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4423	10410	0.021517771	0.007300672	9	L2-3	EN-L2-3-MS	31	7	7
CCTTACGAGGAGCGAG-1_2_B9	21.9611001	-16.28132791	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4386	10215	0.030445423	0.024180127	9	2	EN-L4	31	7	7
CCTTACGAGTTAAGTG-1_2_B9	-11.48980069	-6.456118015	13A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2124	3619	0.036474164	0.00967118	9	13A	IN-VIP	31	7	7
CCTTACGGTTAGATGA-1_2_B9	34.50533698	-16.60758806	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4131	8904	0.013140162	0.014937107	9	2	EN-L4	31	7	7
CCTTACGGTTTAGCTG-1_2_B9	-13.11836293	-37.27440484	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1785	3231	0.085731972	0.013618075	9	16	EN-PYR	31	7	7
CCTTACGTCCGCAGTG-1_2_B9	-27.92675764	0.356139469	9	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1652	2744	0.013119534	0.053571429	9	9	OPC	31	7	7
CCTTCCCCACCATGTA-1_2_B9	-12.30120337	31.48589884	17	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	927	1206	0.069651741	0.014096186	9	oligos	OL-MS-2	31	7	7
CCTTCCCGTCGGCATC-1_2_B9	-12.69348972	-38.14708808	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1937	3751	0.11623567	0.028792322	9	16	EN-PYR	31	7	7
CCTTCCCGTGCCTGTG-1_2_B9	-8.005678032	7.20574309	5	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1142	1572	0.057251908	0.019720102	9	oligos	OL-MS-1	31	7	7
CCTTCCCGTGTTAAGA-1_2_B9	28.97691019	-13.60981449	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	5601	15974	0.00976587	0.013709778	9	2	EN-L4	31	7	7
CCTTCCCTCATGCAAC-1_2_B9	11.69637548	-15.75903349	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3969	9097	0.013520941	0.014949984	9	L2-3	EN-L2-3-MS	31	7	7
CCTTCGACAGTCGTGC-1_2_B9	-2.466268267	24.23279906	1	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	780	1039	0.005774783	0.014436959	9	oligos	OL-Cntl	31	7	7
CCTTCGAGTCGAACAG-1_2_B9	36.45000436	13.20918902	14	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	963	1335	0.013483146	0.012734082	9	14	Microglia	31	7	7
CCTTTCTGTCCGACGT-1_2_B9	-17.25239738	6.725972838	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	881	1285	0.045914397	0.010116732	9	8	Astrocytes	31	7	7
CCTTTCTGTGAGGGAG-1_2_B9	33.94661349	-18.73785684	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3856	7759	0.021781157	0.02538987	9	2	EN-L4	31	7	7
CCTTTCTGTGGGTCAA-1_2_B9	-27.17117977	-6.81081833	9	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1025	1526	0.015727392	0.008519004	9	9	OPC	31	7	7
CCTTTCTGTTACCGAT-1_2_B9	-0.252076214	7.39399442	1	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1859	3284	0.013398295	0.015834348	9	oligos	OL-Cntl	31	7	7
CCTTTCTTCATGTCCC-1_2_B9	34.07305433	-13.29237265	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2964	6299	0.016510557	0.013176695	9	2	EN-L4	31	7	7
CGAACATAGGCTACGA-1_2_B9	13.66496933	-13.62156196	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4543	10190	0.015210991	0.014622179	9	L2-3	EN-L2-3-MS	31	7	7
CGAACATAGGTCGGAT-1_2_B9	-16.31369412	24.63440444	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1847	3370	0.010979228	0.019287834	9	8	Astrocytes	31	7	7
CGAACATCAAAGGCGT-1_2_B9	-26.95874231	-22.75190614	6A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4423	11211	0.040317545	0.005619481	9	6A	IN-PV	31	7	7
CGAATGTAGTCTCGGC-1_2_B9	-18.11372283	-2.072297988	13A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3044	5588	0.015032212	0.015748031	9	13A	IN-VIP	31	7	7
CGAATGTCAGGTGGAT-1_2_B9	30.74512613	-19.2137548	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	5511	15198	0.028819582	0.030727727	9	2	EN-L4	31	7	7
CGAATGTGTCTCACCT-1_2_B9	-17.40665598	-5.897975144	13B	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2005	3388	0.011511216	0.017119244	9	13B	IN-SV2C	31	7	7
CGAATGTTCCTAGGGC-1_2_B9	-17.3381695	18.04315288	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1686	2837	0.013041946	0.005992245	9	8	Astrocytes	31	7	7
CGACCTTAGGAGTACC-1_2_B9	-11.44759971	28.57736572	17	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1858	2879	0.027787426	0.014588399	9	oligos	OL-MS-2	31	7	7
CGACCTTCAGCTTAAC-1_2_B9	-15.12295619	20.08349115	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1493	2436	0.029146141	0.010673235	9	8	Astrocytes	31	7	7
CGACCTTCATCTACGA-1_2_B9	-20.64409537	6.479656994	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1137	1785	0.014565826	0.00952381	9	8	Astrocytes	31	7	7
CGACCTTTCGACCAGC-1_2_B9	13.48143733	-13.68967573	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4183	9226	0.012789941	0.017559072	9	L2-3	EN-L2-3-MS	31	7	7
CGACTTCAGGAATTAC-1_2_B9	11.78699236	-15.66925021	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3634	7936	0.008820565	0.009828629	9	L2-3	EN-L2-3-MS	31	7	7
CGACTTCCAGGGAGAG-1_2_B9	-29.77252768	-2.70584169	9	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1303	2099	0.006669843	0.004287756	9	9	OPC	31	7	7
CGACTTCCAGGGTACA-1_2_B9	10.50863872	-14.19196044	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2924	5646	0.008501594	0.013637974	9	L2-3	EN-L2-3-MS	31	7	7
CGACTTCCATAGACTC-1_2_B9	-17.35270161	17.57355601	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1529	2508	0.012360447	0.005980861	9	8	Astrocytes	31	7	7
CGACTTCGTAAGGGAA-1_2_B9	-17.02617121	5.763908951	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	718	1014	0.033530572	0.004930966	9	8	Astrocytes	31	7	7
CGACTTCGTCGCGTGT-1_2_B9	9.410586691	-13.17397004	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2453	4559	0.017109015	0.010309278	9	L2-3	EN-L2-3-MS	31	7	7
CGACTTCGTTAAGGGC-1_2_B9	-23.71643738	7.398366803	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	897	1198	0.011686144	0.00918197	9	8	Astrocytes	31	7	7
CGACTTCTCAAGAAGT-1_2_B9	36.40362667	13.74478491	14	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1157	1610	0.013664596	0.011180124	9	14	Microglia	31	7	7
CGAGAAGAGCGATCCC-1_2_B9	9.580373783	-13.40922411	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2491	4512	0.021054965	0.008865248	9	L2-3	EN-L2-3-MS	31	7	7
CGAGAAGCATGGAATA-1_2_B9	31.29654853	-18.737142	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	5225	12961	0.014967981	0.018439935	9	2	EN-L4	31	7	7
CGAGAAGGTCCCGACA-1_2_B9	-26.8684312	-18.30478782	6B	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2751	5222	0.030256607	0.017809268	9	6B	IN-SST	31	7	7
CGAGAAGGTCCTAGCG-1_2_B9	-26.73059956	-11.6079112	9	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1087	1625	0.011076923	0.034461538	9	9	OPC	31	7	7
CGAGAAGGTTGGTTTG-1_2_B9	-11.50845748	18.18702767	11	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2175	3785	0.016116248	0.007661823	9	11	Glia-MIX	31	7	7
CGAGAAGTCGGTGTTA-1_2_B9	-17.75933357	-4.536289396	13A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2709	5214	0.023973916	0.010164941	9	13A	IN-VIP	31	7	7
CGAGCACCAACAACCT-1_2_B9	-27.76567359	-22.92985531	6A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	6246	19916	0.035348464	0.006577626	9	6A	IN-PV	31	7	7
CGAGCACCAGCAGTTT-1_2_B9	-17.2934991	28.78148101	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2775	5803	0.008099259	0.009133207	9	8	Astrocytes	31	7	7
CGAGCACCAGGTCGTC-1_2_B9	9.853311906	-3.941280204	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2352	4331	0.028399908	0.015469868	9	2	EN-L4	31	7	7
CGAGCACTCTCGGACG-1_2_B9	-24.64175924	0.272529906	9	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2036	3422	0.052308591	0.010520164	9	9	OPC	31	7	7
CGAGCCAAGAAAGTGG-1_2_B9	-10.84871365	14.57615376	11	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2373	4268	0.007029053	0.009372071	9	11	Glia-MIX	31	7	7
CGAGCCAAGTATCTCG-1_2_B9	3.747168605	4.074710767	7	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1216	1707	0.027533685	0.029291154	9	7	Phagocytes	31	7	7
CGAGCCAGTCGCGGTT-1_2_B9	-11.38818708	28.50046358	17	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1587	2300	0.05173913	0.015652174	9	oligos	OL-MS-2	31	7	7
CGAGCCATCACGACTA-1_2_B9	34.51991691	-16.85505285	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4802	11531	0.017431272	0.0182985	9	2	EN-L4	31	7	7
CGATCGGTCCAAACAC-1_2_B9	-28.64293046	-4.956215537	9	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1052	1560	0.012179487	0.007692308	9	9	OPC	31	7	7
CGATGGCCACAGGCCT-1_2_B9	33.00836192	9.003950852	14	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1017	1367	0.040965618	0.031455743	9	14	Microglia	31	7	7
CGATGGCGTAGAAGGA-1_2_B9	-17.29607741	17.96592079	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1702	2827	0.009550761	0.007782101	9	8	Astrocytes	31	7	7
CGATGTAAGATAGTCA-1_2_B9	26.4996041	9.859098731	15A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1901	3065	0.04274062	0.046329527	9	15A	Endo cells	31	7	7
CGATGTAAGATGCCTT-1_2_B9	21.87927248	-16.5541663	3	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4609	10754	0.014599219	0.012274503	9	3	EN-L5-6	31	7	7
CGATGTAAGCTTATCG-1_2_B9	9.575819992	-11.56086617	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2169	3628	0.030871003	0.013781698	9	L2-3	EN-L2-3-MS	31	7	7
CGATGTATCACCACCT-1_2_B9	24.26190725	-19.29449819	3	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	5108	13057	0.01432182	0.011488091	9	3	EN-L5-6	31	7	7
CGATTGAAGAACAACT-1_2_B9	3.821393528	4.647405907	7	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1459	2001	0.014492754	0.019490255	9	7	Phagocytes	31	7	7
CGATTGAAGGACGAAA-1_2_B9	-9.448604963	-15.90670545	6B	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	943	1495	0.095652174	0.004013378	9	6B	IN-SST	31	7	7
CGATTGACACCCATGG-1_2_B9	-11.17038798	-27.26437585	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	746	1177	0.217502124	0.006796941	9	16	EN-PYR	31	7	7
CGATTGATCATATCGG-1_2_B9	28.40719233	7.086531725	15A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	842	1093	0.051235133	0.032021958	9	15A	Endo cells	31	7	7
CGATTGATCTGCAAGT-1_2_B9	37.38900167	9.149512532	14	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	799	1039	0.024061598	0.008662175	9	14	Microglia	31	7	7
CGCCAAGAGCTACCTA-1_2_B9	14.38596351	-14.79947401	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4774	12445	0.012053033	0.011329851	9	L2-3	EN-L2-3-MS	31	7	7
CGCCAAGAGCTGAACG-1_2_B9	-7.907315072	-38.6881185	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1383	2171	0.105020728	0.013818517	9	16	EN-PYR	31	7	7
CGCCAAGAGCTGCGAA-1_2_B9	13.02444736	-12.55229633	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3605	7117	0.017704089	0.021638331	9	L2-3	EN-L2-3-MS	31	7	7
CGCCAAGAGGACACCA-1_2_B9	-3.179964185	-34.82067744	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	825	1110	0.108108108	0.030630631	9	16	EN-PYR	31	7	7
CGCCAAGGTTACCGAT-1_2_B9	30.70221665	-18.70423927	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	7413	26840	0.016766021	0.017921013	9	2	EN-L4	31	7	7
CGCCAAGTCCGGCACA-1_2_B9	-8.029446453	-38.49113581	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1179	1702	0.066392479	0.015276146	9	16	EN-PYR	31	7	7
CGCCAAGTCTGACCTC-1_2_B9	24.8974004	4.655661742	15BA	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1605	2401	0.008746356	0.005830904	9	15BA	Stromal cells	31	7	7
CGCGGTAAGAGTACCG-1_2_B9	-3.688651377	-35.13033079	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	829	1168	0.109589041	0.023972603	9	16	EN-PYR	31	7	7
CGCGGTAAGGAGTAGA-1_2_B9	34.93252605	-11.14693579	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3431	6742	0.005784634	0.014239098	9	2	EN-L4	31	7	7
CGCGGTATCAGAGACG-1_2_B9	26.02658375	7.637243628	15A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1473	2237	0.031738936	0.026821636	9	15A	Endo cells	31	7	7
CGCGGTATCCACGACG-1_2_B9	-23.60321411	11.1511865	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1116	1689	0.025458851	0.007104796	9	8	Astrocytes	31	7	7
CGCGTTTAGAGATGAG-1_2_B9	36.41573176	13.66399486	14	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1189	1710	0.018128655	0.012865497	9	14	Microglia	31	7	7
CGCGTTTCACGTGAGA-1_2_B9	-28.66330482	-2.886242383	9	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1332	2038	0.00686948	0.012266928	9	9	OPC	31	7	7
CGCGTTTGTCCCTTGT-1_2_B9	-16.82472631	6.870500005	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1012	1445	0.025605536	0.011764706	9	8	Astrocytes	31	7	7
CGCGTTTTCCCATTAT-1_2_B9	8.333047797	-3.134291089	12	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2629	4630	0.086393089	0.008639309	9	12	EN-MIX	31	7	7
CGCGTTTTCCCTTGTG-1_2_B9	8.351492233	-3.026589109	12	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2026	3160	0.09556962	0.013291139	9	12	EN-MIX	31	7	7
CGCGTTTTCTCCCTGA-1_2_B9	22.90283973	-17.22134009	3	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3976	9605	0.020093701	0.016970328	9	3	EN-L5-6	31	7	7
CGCTATCAGCACGCCT-1_2_B9	23.52506872	-20.9257275	3	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	6073	19437	0.011421516	0.005299172	9	3	EN-L5-6	31	7	7
CGCTATCCAAGCCGTC-1_2_B9	-19.42880759	-0.671577199	13A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4311	9413	0.020822267	0.016041645	9	13A	IN-VIP	31	7	7
CGCTTCACATTCACTT-1_2_B9	-29.85618593	-2.884805327	9	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1461	2465	0.012981744	0.004462475	9	9	OPC	31	7	7
CGCTTCAGTATAGTAG-1_2_B9	31.46120917	-17.26324627	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	5771	16945	0.032398938	0.009501328	9	2	EN-L4	31	7	7
CGCTTCAGTGCCTGGT-1_2_B9	-23.99356163	12.6726512	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1153	1798	0.006117909	0.007786429	9	8	Astrocytes	31	7	7
CGGACACCATCGGTTA-1_2_B9	-19.28078558	9.800605949	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	843	1166	0.036020583	0.006003431	9	8	Astrocytes	31	7	7
CGGACGTAGATATACG-1_2_B9	27.90119119	-11.5505922	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3734	8150	0.007730061	0.006625767	9	2	EN-L4	31	7	7
CGGACGTAGTGACATA-1_2_B9	-4.832489522	-36.97905712	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	913	1242	0.030595813	0.031400966	9	16	EN-PYR	31	7	7
CGGACGTCAGTGAGTG-1_2_B9	31.29161459	-17.65884404	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	5773	16688	0.027325024	0.013542665	9	2	EN-L4	31	7	7
CGGACGTCATGTCCTC-1_2_B9	24.73100151	-13.77422955	3	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4371	10366	0.014180976	0.00868223	9	3	EN-L5-6	31	7	7
CGGACGTTCGCATGGC-1_2_B9	24.96627568	-13.06445079	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4590	11208	0.018112063	0.005264097	9	2	EN-L4	31	7	7
CGGACGTTCGCCCTTA-1_2_B9	-10.72417996	-15.2080506	6B	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1081	1630	0.067484663	0.004294479	9	6B	IN-SST	31	7	7
CGGACTGAGAGGTTAT-1_2_B9	-6.931255581	-37.5892777	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1024	1478	0.065629229	0.026387009	9	16	EN-PYR	31	7	7
CGGACTGGTAGCGATG-1_2_B9	-14.56586326	-37.91659317	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2365	4656	0.065936426	0.02233677	9	16	EN-PYR	31	7	7
CGGACTGTCCAAGCCG-1_2_B9	-22.87422635	-4.421340242	9	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2465	4481	0.013389868	0.005355947	9	9	OPC	31	7	7
CGGACTGTCGCTGATA-1_2_B9	-16.51777836	17.77420659	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1480	2310	0.016017316	0.014718615	9	8	Astrocytes	31	7	7
CGGAGCTCAGTTCCCT-1_2_B9	-10.50061762	-15.28344215	6B	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	971	1482	0.031039136	0.008097166	9	6B	IN-SST	31	7	7
CGGAGCTCATCGGGTC-1_2_B9	-10.58536657	-37.74412173	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1267	1924	0.07016632	0.019230769	9	16	EN-PYR	31	7	7
CGGAGCTGTAAACGCG-1_2_B9	-1.479635601	-1.094163204	11	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3485	7710	0.006744488	0.006485084	9	11	Glia-MIX	31	7	7
CGGAGCTGTACAGCAG-1_2_B9	-25.34640089	-22.27197813	6A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3276	6927	0.024974737	0.007795583	9	6A	IN-PV	31	7	7
CGGAGTCTCCTTTCGG-1_2_B9	-14.46911763	-8.703642858	13B	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2021	3516	0.012798635	0.004550626	9	13B	IN-SV2C	31	7	7
CGGAGTCTCGCGTAGC-1_2_B9	29.83254088	-13.43194653	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4952	13451	0.006244889	0.01538919	9	2	EN-L4	31	7	7
CGGCTAGAGATAGTCA-1_2_B9	32.9344037	-15.50574584	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2825	5017	0.026509866	0.013753239	9	2	EN-L4	31	7	7
CGGCTAGAGCTGATAA-1_2_B9	-24.54783937	-18.14492352	6B	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2962	5939	0.012291632	0.020205422	9	6B	IN-SST	31	7	7
CGGCTAGCATGATCCA-1_2_B9	-10.54072656	28.25461955	17	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	928	1261	0.058683584	0.022997621	9	oligos	OL-MS-2	31	7	7
CGGCTAGGTGGCCCTA-1_2_B9	15.34505003	-13.92093212	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	5477	14187	0.022273913	0.009163319	9	L2-3	EN-L2-3-MS	31	7	7
CGGGTCAAGGGTGTTG-1_2_B9	-22.84249028	-8.319986894	9	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1711	2693	0.047159302	0.00965466	9	9	OPC	31	7	7
CGGGTCACATCCGTGG-1_2_B9	12.57804266	-16.30504004	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4592	10804	0.008978156	0.016845613	9	L2-3	EN-L2-3-MS	31	7	7
CGGGTCAGTAAATACG-1_2_B9	-24.24357621	15.81489968	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1233	1985	0.00906801	0.011083123	9	8	Astrocytes	31	7	7
CGGGTCAGTTATCACG-1_2_B9	-13.22924097	-15.25135675	6A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1475	2683	0.016399553	0.008572493	9	6A	IN-PV	31	7	7
CGGTTAACAGGAATCG-1_2_B9	14.2871196	-14.63700144	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3967	8972	0.031319661	0.007579135	9	L2-3	EN-L2-3-MS	31	7	7
CGGTTAATCCACGTGG-1_2_B9	-1.295149337	-0.833501806	11	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2469	4398	0.01682583	0.010914052	9	11	Glia-MIX	31	7	7
CGTAGCGCATGCTGGC-1_2_B9	-24.01295569	6.356925661	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	840	1180	0.024576271	0.006779661	9	8	Astrocytes	31	7	7
CGTAGCGGTACTTGAC-1_2_B9	28.35277166	-14.25091297	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	6122	19392	0.025268152	0.011551155	9	2	EN-L4	31	7	7
CGTAGCGGTCCATCCT-1_2_B9	35.18661301	12.58865718	14	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1030	1344	0.007440476	0.007440476	9	14	Microglia	31	7	7
CGTAGGCCAGCTCCGA-1_2_B9	-10.06134037	-5.307638465	13A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1823	2994	0.019372077	0.01002004	9	13A	IN-VIP	31	7	7
CGTAGGCGTCATCGGC-1_2_B9	14.6831566	-14.53444909	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	5430	14576	0.012074643	0.012554885	9	L2-3	EN-L2-3-MS	31	7	7
CGTCACTAGAAGGACA-1_2_B9	12.43477793	-12.47525073	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3286	6462	0.01268957	0.02367688	9	L2-3	EN-L2-3-MS	31	7	7
CGTCACTCAACACGCC-1_2_B9	-11.19759061	-38.19519885	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1324	2149	0.069334574	0.020474639	9	16	EN-PYR	31	7	7
CGTCAGGAGCATGGCA-1_2_B9	-33.3733868	-5.052046798	9	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1215	1886	0.013255567	0.002651113	9	9	OPC	31	7	7
CGTCAGGAGCGAAGGG-1_2_B9	-16.95844648	17.01479154	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1503	2628	0.00304414	0.012937595	9	8	Astrocytes	31	7	7
CGTCAGGAGTTTGCGT-1_2_B9	-12.47419831	17.38271437	11	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1725	2952	0.007791328	0.011178862	9	11	Glia-MIX	31	7	7
CGTCAGGGTACTCAAC-1_2_B9	-28.01883231	-1.815575132	9	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1577	2458	0.006916192	0.008136697	9	9	OPC	31	7	7
CGTCAGGTCTGGAGCC-1_2_B9	-18.53860423	24.24952068	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1757	3183	0.018535972	0.007854226	9	8	Astrocytes	31	7	7
CGTCCATAGAAGATTC-1_2_B9	-15.84711418	9.108082735	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1418	2418	0.005789909	0.010752688	9	8	Astrocytes	31	7	7
CGTCCATAGAGGTACC-1_2_B9	-4.384538927	-35.78659894	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	911	1299	0.10469592	0.029253272	9	16	EN-PYR	31	7	7
CGTCCATGTAAATACG-1_2_B9	33.93880681	8.043928034	14	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1439	1980	0.022222222	0.007070707	9	14	Microglia	31	7	7
CGTCTACAGGGAACGG-1_2_B9	31.42549087	12.32572677	14	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	892	1152	0.024305556	0.046875	9	14	Microglia	31	7	7
CGTCTACCAGACGCTC-1_2_B9	25.03020752	-15.65056123	3	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4787	11450	0.014497817	0.018864629	9	3	EN-L5-6	31	7	7
CGTCTACTCATCGCTC-1_2_B9	-17.5321282	-16.43841775	6B	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1966	3685	0.023880597	0.00624152	9	6B	IN-SST	31	7	7
CGTGAGCAGCCACCTG-1_2_B9	-5.376906018	-28.22166616	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	955	1240	0.058870968	0.009677419	9	16	EN-PYR	31	7	7
CGTGAGCCAGATGAGC-1_2_B9	33.76668743	14.08494313	14	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1114	1504	0.005319149	0.025265957	9	14	Microglia	31	7	7
CGTGAGCGTAGAAGGA-1_2_B9	-19.04433544	-6.402624673	13B	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3052	5919	0.009798953	0.004561581	9	13B	IN-SV2C	31	7	7
CGTGAGCTCATCGATG-1_2_B9	30.999531	-18.62158603	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	7299	26483	0.01570819	0.016727712	9	2	EN-L4	31	7	7
CGTGTCTCAAGTACCT-1_2_B9	11.39064677	-11.2402819	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2275	3745	0.033110814	0.012283044	9	L2-3	EN-L2-3-MS	31	7	7
CGTTAGAGTAGGCATG-1_2_B9	-10.88930185	14.65283024	11	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2113	3701	0.00783572	0.010267495	9	11	Glia-MIX	31	7	7
CGTTAGAGTGTGAAAT-1_2_B9	33.91829015	-16.04865347	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3432	7020	0.020940171	0.010683761	9	2	EN-L4	31	7	7
CGTTCTGAGCCGCCTA-1_2_B9	26.1187913	5.40262271	15A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1007	1423	0.014757554	0.01054111	9	15A	Endo cells	31	7	7
CGTTCTGAGGCGCTCT-1_2_B9	22.10917564	-17.50922058	3	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	6610	22651	0.021456006	0.009624299	9	3	EN-L5-6	31	7	7
CGTTCTGCAAGCGCTC-1_2_B9	-13.13717136	6.897757407	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1046	1477	0.079214624	0.010155721	9	16	EN-PYR	31	7	7
CGTTGGGAGATAGTCA-1_2_B9	34.33550559	-17.13641181	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4202	9219	0.014860614	0.019850309	9	2	EN-L4	31	7	7
CGTTGGGAGCTTATCG-1_2_B9	16.33586471	-13.07548302	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4340	9592	0.021267723	0.01970392	9	L2-3	EN-L2-3-MS	31	7	7
CGTTGGGTCACAAACC-1_2_B9	19.74923429	-18.0191831	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3919	8391	0.019663926	0.014301037	9	L2-3	EN-L2-3-MS	31	7	7
CGTTGGGTCATAACCG-1_2_B9	34.19217033	7.821653327	14	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	975	1301	0.01537279	0.009223674	9	14	Microglia	31	7	7
CGTTGGGTCTCGAGTA-1_2_B9	-17.39017139	17.93664606	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1567	2675	0.013831776	0.007102804	9	8	Astrocytes	31	7	7
CTAACTTAGATCCCGC-1_2_B9	34.22396799	-13.79011756	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3615	7720	0.004792746	0.011010363	9	2	EN-L4	31	7	7
CTAACTTTCCCTGACT-1_2_B9	-17.3459596	17.73991905	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1662	2951	0.011521518	0.0074551	9	8	Astrocytes	31	7	7
CTAACTTTCCTAGAAC-1_2_B9	-10.72012436	-6.031138438	13A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1901	3127	0.016309562	0.012791813	9	13A	IN-VIP	31	7	7
CTAACTTTCTTCGAGA-1_2_B9	16.40137494	-13.51107803	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	5184	14556	0.022739764	0.012709536	9	L2-3	EN-L2-3-MS	31	7	7
CTAAGACAGAACTCGG-1_2_B9	27.90161595	7.210278032	15A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	873	1166	0.037735849	0.040308748	9	15A	Endo cells	31	7	7
CTAATGGCAAGAAAGG-1_2_B9	32.1298665	-10.68101995	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2597	4719	0.011866921	0.009324009	9	2	EN-L4	31	7	7
CTACACCTCGCGTAGC-1_2_B9	-15.68551831	9.152043944	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1398	2088	0.01532567	0.014846743	9	8	Astrocytes	31	7	7
CTACATTAGCGTGTCC-1_2_B9	23.20053412	-16.00286948	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4762	12560	0.012659236	0.017117834	9	L2-3	EN-L2-3-MS	31	7	7
CTACATTCACATCTTT-1_2_B9	-23.4577445	-19.34432004	6B	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2481	5003	0.010793524	0.016789926	9	6B	IN-SST	31	7	7
CTACATTCAGCTGTGC-1_2_B9	-11.51559686	-38.05392721	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1451	2465	0.098174442	0.021095335	9	16	EN-PYR	31	7	7
CTACATTCATGGGAAC-1_2_B9	24.98899232	-15.49746541	3	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3546	7339	0.015124676	0.017168552	9	3	EN-L5-6	31	7	7
CTACATTGTCCAAGTT-1_2_B9	9.975409134	-18.21681999	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4081	10048	0.005175159	0.009355096	9	L2-3	EN-L2-3-MS	31	7	7
CTACCCAAGGGAAACA-1_2_B9	-8.237301947	-2.963220395	13A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2038	4057	0.030810944	0.002711363	9	13A	IN-VIP	31	7	7
CTACCCAGTATTCGTG-1_2_B9	13.88119189	-19.45254297	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3315	6831	0.002488655	0.012589665	9	L2-3	EN-L2-3-MS	31	7	7
CTACGTCCAAGAGTCG-1_2_B9	-21.70547842	-25.41312463	6A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2455	4875	0.023179487	0.005538462	9	6A	IN-PV	31	7	7
CTACGTCGTACCATCA-1_2_B9	35.49623341	12.88643441	14	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	974	1283	0.003897116	0.017147311	9	14	Microglia	31	7	7
CTACGTCGTTGTCTTT-1_2_B9	10.45496309	-13.12668205	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3019	5882	0.020231214	0.007990479	9	L2-3	EN-L2-3-MS	31	7	7
CTACGTCTCAAACAAG-1_2_B9	-28.37502629	-4.469439692	9	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1355	2075	0.011084337	0.004819277	9	9	OPC	31	7	7
CTACGTCTCATCACCC-1_2_B9	9.90664218	-16.9586414	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3490	7767	0.012488734	0.009012489	9	L2-3	EN-L2-3-MS	31	7	7
CTAGAGTCAATTGCTG-1_2_B9	-16.80730843	11.56823013	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1072	1640	0.012804878	0.006097561	9	8	Astrocytes	31	7	7
CTAGAGTGTGTCGCTG-1_2_B9	25.23673626	9.917167356	15A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3060	6084	0.021367521	0.032380013	9	15A	Endo cells	31	7	7
CTAGAGTTCCAAACAC-1_2_B9	13.84099432	-23.84965104	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4851	14166	0.003388395	0.009318086	9	L2-3	EN-L2-3-MS	31	7	7
CTAGCCTAGTCTCCTC-1_2_B9	35.58261116	-10.20181177	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3711	9368	0.005444065	0.016332195	9	2	EN-L4	31	7	7
CTAGCCTAGTTAAGTG-1_2_B9	35.09448658	12.31853885	14	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	907	1186	0.016020236	0.020236088	9	14	Microglia	31	7	7
CTAGCCTCAATGCCAT-1_2_B9	-14.03121438	-38.12150129	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2321	4436	0.073715059	0.031785392	9	16	EN-PYR	31	7	7
CTAGCCTTCCTAGAAC-1_2_B9	33.58957558	12.58048907	14	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	980	1322	0.009077156	0.02269289	9	14	Microglia	31	7	7
CTAGCCTTCCTATTCA-1_2_B9	12.28097926	-23.51698945	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	6614	26254	0.00335187	0.006360935	9	L2-3	EN-L2-3-MS	31	7	7
CTAGTGATCAGAGACG-1_2_B9	-20.83060169	-23.43392022	6A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2033	3536	0.006504525	0.009049774	9	6A	IN-PV	31	7	7
CTCACACAGTACCGGA-1_2_B9	28.08151118	6.635312907	15DA	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	774	1050	0.020952381	0.02952381	9	15DA	T cells	31	7	7
CTCACACGTCGACTGC-1_2_B9	31.38249145	9.25878283	14	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1043	1568	0.021683673	0.012117347	9	14	Microglia	31	7	7
CTCACACTCACTCCTG-1_2_B9	-18.22791276	17.44484968	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1523	2479	0.0209762	0.005647438	9	8	Astrocytes	31	7	7
CTCACACTCCCAAGTA-1_2_B9	-10.42927185	-7.190007328	13A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2277	4188	0.020773639	0.011461318	9	13A	IN-VIP	31	7	7
CTCACACTCTACCAGA-1_2_B9	24.87613279	8.231218875	15A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2048	3514	0.052077405	0.03756403	9	15A	Endo cells	31	7	7
CTCAGAAAGGCTCAGA-1_2_B9	-3.77958006	-35.55745641	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	796	1037	0.038572806	0.029893925	9	16	EN-PYR	31	7	7
CTCAGAAAGTGCTGCC-1_2_B9	-5.318368421	-36.77834033	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	947	1318	0.090288316	0.023520486	9	16	EN-PYR	31	7	7
CTCAGAAAGTTTAGGA-1_2_B9	-16.27053421	8.815635711	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1102	1644	0.013990268	0.010340633	9	8	Astrocytes	31	7	7
CTCAGAACAGGCTGAA-1_2_B9	12.311708	-12.5508864	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3235	6042	0.016716319	0.018702416	9	L2-3	EN-L2-3-MS	31	7	7
CTCAGAATCAGCAACT-1_2_B9	24.77982902	-14.14870774	3	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4252	10037	0.027896782	0.00807014	9	3	EN-L5-6	31	7	7
CTCATTAAGGATATAC-1_2_B9	12.01632086	-17.04459216	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4248	10242	0.01074009	0.008006249	9	L2-3	EN-L2-3-MS	31	7	7
CTCATTACAAGAGGCT-1_2_B9	-16.94446642	-22.05502828	6A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1615	2603	0.023050327	0.006530926	9	6A	IN-PV	31	7	7
CTCCTAGTCACAATGC-1_2_B9	-3.838361135	-35.20701876	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	895	1294	0.125193199	0.027047913	9	16	EN-PYR	31	7	7
CTCGAAAAGGATGCGT-1_2_B9	10.66859775	-12.17536746	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2571	4439	0.016445145	0.010813246	9	L2-3	EN-L2-3-MS	31	7	7
CTCGAAAAGGCGTACA-1_2_B9	-9.797972278	22.62592807	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1692	2618	0.014132926	0.007257448	9	8	Astrocytes	31	7	7
CTCGAAACACTGTTAG-1_2_B9	27.70056464	7.576886137	15A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1012	1552	0.030927835	0.038659794	9	15A	Endo cells	31	7	7
CTCGAAAGTATCTGCA-1_2_B9	-8.413841653	-38.41804806	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1270	1891	0.083553675	0.023796933	9	16	EN-PYR	31	7	7
CTCGAGGCAATGGAGC-1_2_B9	-15.71159065	8.950969558	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1359	2009	0.016426083	0.025385764	9	8	Astrocytes	31	7	7
CTCGAGGCACGCTTTC-1_2_B9	-17.49022845	-0.253326392	13A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2620	4731	0.013950539	0.024941873	9	13A	IN-VIP	31	7	7
CTCGAGGCATAGGATA-1_2_B9	-17.25962199	-0.936441953	13A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2882	5378	0.017106731	0.021197471	9	13A	IN-VIP	31	7	7
CTCGAGGTCCAGTATG-1_2_B9	7.739877793	1.354989754	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	783	1093	0.057639524	0.013723696	9	16	EN-PYR	31	7	7
CTCGGAGAGCCAGTTT-1_2_B9	-10.33255665	27.49166763	5	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	809	1019	0.014720314	0.040235525	9	oligos	OL-MS-1	31	7	7
CTCGGAGGTTATCGGT-1_2_B9	33.85886256	-14.27442542	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2936	5425	0.012903226	0.017142857	9	2	EN-L4	31	7	7
CTCGGAGTCAAACAAG-1_2_B9	-11.28851154	17.21786872	11	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2042	3461	0.008668015	0.006356544	9	11	Glia-MIX	31	7	7
CTCGGGACATGTAAGA-1_2_B9	-11.76567182	-37.85402076	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1533	2509	0.074133121	0.01315265	9	16	EN-PYR	31	7	7
CTCGGGATCATTATCC-1_2_B9	33.72978684	8.581512835	14	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	903	1210	0.01322314	0.016528926	9	14	Microglia	31	7	7
CTCGTACCAACTGGCC-1_2_B9	19.19712826	-22.353719	3	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4320	10317	0.002713967	0.011243579	9	3	EN-L5-6	31	7	7
CTCGTACCACGACGAA-1_2_B9	-3.330157634	-35.09655534	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	774	1088	0.102941176	0.025735294	9	16	EN-PYR	31	7	7
CTCGTACTCGCCGTGA-1_2_B9	-3.76523445	-36.11105484	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	971	1459	0.122001371	0.034955449	9	16	EN-PYR	31	7	7
CTCGTCACAAGCTGAG-1_2_B9	-20.47046258	-5.165190978	13B	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4157	9337	0.017243226	0.010495877	9	13B	IN-SV2C	31	7	7
CTCGTCACAGCCTGTG-1_2_B9	11.2536675	-14.28583501	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3389	6664	0.010204082	0.014255702	9	L2-3	EN-L2-3-MS	31	7	7
CTCGTCACAGCTCCGA-1_2_B9	-7.563237956	-38.53268011	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1153	1732	0.08891455	0.023094688	9	16	EN-PYR	31	7	7
CTCGTCACAGCTGTAT-1_2_B9	39.26997162	14.79906466	14	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1225	1738	0.010356732	0.006904488	9	14	Microglia	31	7	7
CTCGTCATCATCACCC-1_2_B9	34.08959654	7.711295761	14	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1187	1580	0.015822785	0.005696203	9	14	Microglia	31	7	7
CTCTAATCAACACGCC-1_2_B9	-19.07120939	9.783849919	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	810	1149	0.026109661	0.006962576	9	8	Astrocytes	31	7	7
CTCTAATCACCTATCC-1_2_B9	25.69846189	5.548508129	15A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1161	1728	0.017361111	0.006365741	9	15A	Endo cells	31	7	7
CTCTAATGTTGGAGGT-1_2_B9	-27.76532684	-21.26736828	6A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3592	8128	0.046136811	0.005905512	9	6A	IN-PV	31	7	7
CTCTAATTCACCCTCA-1_2_B9	-7.818577796	-38.43098492	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1201	1994	0.149448345	0.020561685	9	16	EN-PYR	31	7	7
CTCTACGAGCACGCCT-1_2_B9	13.50286432	11.86635273	1	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1405	2092	0.018164436	0.014818356	9	oligos	OL-Cntl	31	7	7
CTCTACGAGCGATGAC-1_2_B9	-17.5357131	17.06983196	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1402	2258	0.005757307	0.003542958	9	8	Astrocytes	31	7	7
CTCTACGCAGGGCATA-1_2_B9	-20.45408687	-5.664972934	13B	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4672	11554	0.018608274	0.009260862	9	13B	IN-SV2C	31	7	7
CTCTACGCATCGATTG-1_2_B9	-4.90824717	-32.01646147	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1023	1466	0.123465211	0.012278308	9	16	EN-PYR	31	7	7
CTCTACGGTGAGTATA-1_2_B9	32.97317322	-15.69487257	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3641	7794	0.015011547	0.012188863	9	2	EN-L4	31	7	7
CTCTACGGTTCCCTTG-1_2_B9	34.59526267	-15.0323151	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4687	12031	0.010223589	0.012966503	9	2	EN-L4	31	7	7
CTCTACGTCAGGTTCA-1_2_B9	16.91160565	-27.36846873	3	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4024	10700	0.008224299	0.004859813	9	3	EN-L5-6	31	7	7
CTCTGGTCAATGTAAG-1_2_B9	32.95161699	-9.722494101	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4388	10322	0.009688045	0.011044371	9	2	EN-L4	31	7	7
CTCTGGTGTGTAATGA-1_2_B9	-24.88587484	-23.2073245	6A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3405	7766	0.052407932	0.003090394	9	6A	IN-PV	31	7	7
CTGAAACAGAACTGTA-1_2_B9	6.511408192	1.255626141	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	732	1018	0.163064833	0.023575639	9	16	EN-PYR	31	7	7
CTGAAACAGCTGATAA-1_2_B9	-23.50055618	-25.02911481	6A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3292	7279	0.006182168	0.005907405	9	6A	IN-PV	31	7	7
CTGAAACTCCACGACG-1_2_B9	-5.444154297	-36.78377753	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	946	1252	0.032747604	0.018370607	9	16	EN-PYR	31	7	7
CTGAAGTAGTACGTTC-1_2_B9	15.24553755	-12.81599308	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4150	8880	0.025788288	0.018468468	9	L2-3	EN-L2-3-MS	31	7	7
CTGAAGTCAAAGAATC-1_2_B9	-27.95511485	-4.469218576	9	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1235	1807	0.011621472	0.009961262	9	9	OPC	31	7	7
CTGAAGTGTAGCCTAT-1_2_B9	32.67234186	-5.452318438	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3946	10663	0.001875645	0.008627966	9	2	EN-L4	31	7	7
CTGATAGAGAAGAAGC-1_2_B9	-24.91250072	0.849231804	9	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2351	4089	0.023722181	0.03252629	9	9	OPC	31	7	7
CTGATAGAGCATGGCA-1_2_B9	33.96392765	-18.268807	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3571	7151	0.015522305	0.022794015	9	2	EN-L4	31	7	7
CTGATAGGTTGCGTTA-1_2_B9	31.90310601	-18.92078978	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4714	10910	0.018148488	0.020439963	9	2	EN-L4	31	7	7
CTGATAGTCACCACCT-1_2_B9	-7.704892072	-38.34472879	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1044	1432	0.043994413	0.015363128	9	16	EN-PYR	31	7	7
CTGATCCAGAAAGTGG-1_2_B9	29.51795895	14.83666279	14	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1149	1833	0.004909984	0.168030551	9	14	Microglia	31	7	7
CTGATCCAGAAGGTGA-1_2_B9	32.54207039	11.88297245	14	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	948	1252	0.019968051	0.040734824	9	14	Microglia	31	7	7
CTGATCCCAATAAGCA-1_2_B9	-30.89877698	-1.303514082	9	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1528	2622	0.009916095	0.008009153	9	9	OPC	31	7	7
CTGATCCGTAGCGTAG-1_2_B9	25.40445264	9.787695112	15A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2404	4105	0.033373934	0.042387333	9	15A	Endo cells	31	7	7
CTGATCCGTTCTCATT-1_2_B9	27.98878176	9.339833124	15DA	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	770	1017	0.053097345	0.101278269	9	15DA	T cells	31	7	7
CTGATCCTCTGCAGTA-1_2_B9	-18.01453384	-14.12467658	6B	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1829	2920	0.026027397	0.011643836	9	6B	IN-SST	31	7	7
CTGCCTAAGCGATCCC-1_2_B9	18.80268738	-14.11033015	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	6291	19160	0.02651357	0.012317328	9	L2-3	EN-L2-3-MS	31	7	7
CTGCCTACACAAGACG-1_2_B9	-24.76956326	-19.53389762	6A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2764	5315	0.014299153	0.010912512	9	6A	IN-PV	31	7	7
CTGCCTAGTAAGTAGT-1_2_B9	-23.90008632	-25.77833496	6A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4437	11821	0.008713307	0.004906522	9	6A	IN-PV	31	7	7
CTGCCTATCCGTAGTA-1_2_B9	-19.41811176	20.32748394	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1775	3188	0.010037641	0.00250941	9	8	Astrocytes	31	7	7
CTGCGGACACAGAGGT-1_2_B9	-29.71745184	-2.453920676	9	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1456	2422	0.01734104	0.005367465	9	9	OPC	31	7	7
CTGCGGACATTAGGCT-1_2_B9	-6.346075846	-36.9711645	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	837	1142	0.025394046	0.025394046	9	16	EN-PYR	31	7	7
CTGCGGAGTTCGTGAT-1_2_B9	31.42734168	-18.90591023	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4599	11114	0.025643333	0.023303941	9	2	EN-L4	31	7	7
CTGCGGATCAGAGACG-1_2_B9	-18.51425765	23.66053013	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1824	3199	0.007189747	0.006251954	9	8	Astrocytes	31	7	7
CTGCTGTAGTGAATTG-1_2_B9	31.35677588	-18.42821078	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	5697	15433	0.0205404	0.016652627	9	2	EN-L4	31	7	7
CTGCTGTCAAGAGTCG-1_2_B9	33.38914827	-9.264609942	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	6007	17826	0.003478066	0.008863458	9	2	EN-L4	31	7	7
CTGCTGTCATGACGGA-1_2_B9	-2.907497056	-35.08980224	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	751	1018	0.094302554	0.037328094	9	16	EN-PYR	31	7	7
CTGCTGTGTCACCTAA-1_2_B9	-25.06036975	-18.87870854	6B	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2352	4237	0.018173236	0.022893557	9	6B	IN-SST	31	7	7
CTGCTGTGTCTACCTC-1_2_B9	12.31966006	-12.48949694	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2912	5283	0.014575052	0.019875071	9	L2-3	EN-L2-3-MS	31	7	7
CTGCTGTGTGCTTCTC-1_2_B9	36.02954833	14.35243528	14	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1421	2154	0.012534819	0.020891365	9	14	Microglia	31	7	7
CTGCTGTTCTCATTCA-1_2_B9	34.66049615	-16.43611659	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4159	9102	0.016479895	0.019556142	9	2	EN-L4	31	7	7
CTGGTCTAGATCGGGT-1_2_B9	35.18633214	12.22464366	14	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	945	1291	0.014717273	0.017815647	9	14	Microglia	31	7	7
CTGGTCTAGCGATGAC-1_2_B9	33.69723141	10.85307212	14	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	829	1127	0.023957409	0.026619343	9	14	Microglia	31	7	7
CTGGTCTCAGCTGTGC-1_2_B9	12.6291252	-16.20456988	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4226	10273	0.012849216	0.009344885	9	L2-3	EN-L2-3-MS	31	7	7
CTGGTCTTCGCCATAA-1_2_B9	8.042870432	-11.51671083	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2033	3448	0.015951276	0.017111369	9	L2-3	EN-L2-3-MS	31	7	7
CTGTGCTAGAAAGTGG-1_2_B9	-16.97620934	-14.86402793	6B	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1893	3338	0.03594967	0.006890354	9	6B	IN-SST	31	7	7
CTGTGCTAGACCACGA-1_2_B9	34.08954891	-18.24763285	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3718	7444	0.017598066	0.023911875	9	2	EN-L4	31	7	7
CTGTGCTCATACTCTT-1_2_B9	-15.80082482	11.98509096	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1272	1978	0.00859454	0.008088979	9	8	Astrocytes	31	7	7
CTGTGCTCATTCTCAT-1_2_B9	6.965094726	-10.03558933	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1696	2881	0.032974662	0.008330441	9	L2-3	EN-L2-3-MS	31	7	7
CTGTGCTGTCTAGTCA-1_2_B9	-26.75293614	-1.760074299	9	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1502	2232	0.012096774	0.029569892	9	9	OPC	31	7	7
CTGTTTATCAACGGCC-1_2_B9	6.708342758	-9.833560587	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1469	2165	0.029099307	0.006004619	9	L2-3	EN-L2-3-MS	31	7	7
CTGTTTATCTATCCCG-1_2_B9	-16.52380462	-14.72419375	6B	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1615	2722	0.058780309	0.008082292	9	6B	IN-SST	31	7	7
CTTAACTAGATCTGCT-1_2_B9	-16.83428773	-10.01540902	13B	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3025	6798	0.006619594	0.003824654	9	13B	IN-SV2C	31	7	7
CTTAACTAGCTGAAAT-1_2_B9	24.60084561	-17.0648973	3	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	6602	24720	0.02920712	0.009627832	9	3	EN-L5-6	31	7	7
CTTAACTAGGACATTA-1_2_B9	7.524600322	-12.89400553	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1961	3348	0.007467145	0.008363202	9	L2-3	EN-L2-3-MS	31	7	7
CTTAACTGTCGCCATG-1_2_B9	-14.54501189	-15.1844564	6B	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1397	2326	0.025365434	0.016337059	9	6B	IN-SST	31	7	7
CTTAACTGTGCCTGGT-1_2_B9	-8.026498812	-38.80367013	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1288	1944	0.076131687	0.038065844	9	16	EN-PYR	31	7	7
CTTACCGAGAATGTTG-1_2_B9	26.66955522	3.924586413	15BA	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	678	1069	0.014967259	0.010289991	9	15BA	Stromal cells	31	7	7
CTTACCGCACGACTCG-1_2_B9	-26.04047896	-23.77664833	6A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4086	10177	0.059546035	0.003832171	9	6A	IN-PV	31	7	7
CTTACCGCATTCTCAT-1_2_B9	12.16351318	-17.18930013	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4192	10985	0.012016386	0.007828858	9	L2-3	EN-L2-3-MS	31	7	7
CTTACCGTCATTGCCC-1_2_B9	34.25557253	-13.73202927	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4309	11088	0.005681818	0.011904762	9	2	EN-L4	31	7	7
CTTACCGTCGGACAAG-1_2_B9	17.09404991	-26.18756669	3	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4900	14525	0.00454389	0.01080895	9	3	EN-L5-6	31	7	7
CTTACCGTCGTGGTCG-1_2_B9	30.85824714	-18.24692717	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	5785	17512	0.025753769	0.013876199	9	2	EN-L4	31	7	7
CTTAGGAAGCCAACAG-1_2_B9	-15.65618382	9.321932934	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1665	2975	0.006722689	0.01512605	9	8	Astrocytes	31	7	7
CTTAGGAGTATAATGG-1_2_B9	32.05877644	-14.81732385	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2984	5708	0.025928521	0.007358094	9	2	EN-L4	31	7	7
CTTAGGAGTCGCATAT-1_2_B9	-17.99247657	5.715671432	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	776	1089	0.031221304	0.011019284	9	8	Astrocytes	31	7	7
CTTAGGATCTGGCGAC-1_2_B9	-28.14593842	0.661746954	9	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1775	2848	0.004564607	0.025983146	9	9	OPC	31	7	7
CTTCTCTAGGGAACGG-1_2_B9	10.60805906	-14.30662155	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2951	5889	0.011037528	0.007131941	9	L2-3	EN-L2-3-MS	31	7	7
CTTCTCTCACACTGCG-1_2_B9	-4.612121101	35.85472358	17	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	894	1155	0.032900433	0.006060606	9	oligos	OL-MS-2	31	7	7
CTTCTCTGTCATACTG-1_2_B9	29.07519237	7.072731175	15DA	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	788	1007	0.055610725	0.027805362	9	15DA	T cells	31	7	7
CTTCTCTTCAACCAAC-1_2_B9	-32.15976066	-8.454175171	9	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1008	1585	0.012618297	0.008832808	9	9	OPC	31	7	7
CTTGGCTAGTTCGCAT-1_2_B9	-15.05105931	-37.61824817	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3371	7907	0.11091438	0.016441128	9	16	EN-PYR	31	7	7
CTTGGCTCATACGCTA-1_2_B9	-11.62235173	18.24544677	11	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2431	4844	0.008876961	0.007638315	9	11	Glia-MIX	31	7	7
CTTGGCTTCACGCGGT-1_2_B9	-22.91799607	8.60083695	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	849	1154	0.018197574	0.008665511	9	8	Astrocytes	31	7	7
CTTGGCTTCCATTCTA-1_2_B9	-15.59636641	-5.572540683	13A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3202	6698	0.010749477	0.004628247	9	13A	IN-VIP	31	7	7
CTTGGCTTCTAACGGT-1_2_B9	30.51519732	-17.43716916	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	5293	14839	0.037131882	0.006941169	9	2	EN-L4	31	7	7
CTTTGCGAGAAGGCCT-1_2_B9	-18.22259017	-14.25135345	6B	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2221	3940	0.006345178	0.018020305	9	6B	IN-SST	31	7	7
CTTTGCGAGAGACGAA-1_2_B9	-23.51519111	11.43680493	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1148	1769	0.012436405	0.006783493	9	8	Astrocytes	31	7	7
CTTTGCGCAAGCTGTT-1_2_B9	35.64366785	11.98092205	14	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1017	1383	0.02241504	0.019522777	9	14	Microglia	31	7	7
CTTTGCGCACAAGCCC-1_2_B9	-2.998857959	-34.43814528	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	832	1126	0.061278863	0.030195382	9	16	EN-PYR	31	7	7
GAAACTCCACGTCTCT-1_2_B9	-21.26430629	-21.23504303	6A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2215	4402	0.038845979	0.005679237	9	6A	IN-PV	31	7	7
GAAATGAAGGATCGCA-1_2_B9	-17.65970216	16.83733645	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1330	2222	0.0270027	0.008550855	9	8	Astrocytes	31	7	7
GAAATGAAGGTCGGAT-1_2_B9	33.30903505	-16.30061363	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4069	8630	0.007184241	0.017033604	9	2	EN-L4	31	7	7
GAAATGAGTCCGAGTC-1_2_B9	13.06822313	-12.63748801	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3835	7958	0.015456145	0.01319427	9	L2-3	EN-L2-3-MS	31	7	7
GAAATGAGTTACAGAA-1_2_B9	17.21346925	-13.23287258	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4503	10546	0.027498578	0.014033757	9	L2-3	EN-L2-3-MS	31	7	7
GAAATGATCGTGTAGT-1_2_B9	33.35307494	-15.87618302	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3322	6796	0.030311948	0.010741613	9	2	EN-L4	31	7	7
GAACATCAGCGATATA-1_2_B9	-15.72713721	8.672870239	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1364	2106	0.020892688	0.015669516	9	8	Astrocytes	31	7	7
GAACATCAGGTGATTA-1_2_B9	-27.06055234	-22.58452363	6A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4040	9745	0.049769112	0.00625962	9	6A	IN-PV	31	7	7
GAACATCTCAGAGGTG-1_2_B9	34.06503428	-18.39820729	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3810	7820	0.021099744	0.023529412	9	2	EN-L4	31	7	7
GAACATCTCCTACAGA-1_2_B9	-16.5157697	17.55473629	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1646	2915	0.011663808	0.017152659	9	8	Astrocytes	31	7	7
GAACATCTCTACCTGC-1_2_B9	32.00325328	9.682270093	14	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	962	1267	0.022099448	0.030781373	9	14	Microglia	31	7	7
GAACCTACAGGATTGG-1_2_B9	-17.23185753	17.42365043	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1534	2426	0.016075845	0.006595218	9	8	Astrocytes	31	7	7
GAACCTACATACTCTT-1_2_B9	-17.22068713	17.38762783	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1938	3315	0.023227753	0.007541478	9	8	Astrocytes	31	7	7
GAACCTATCACAACGT-1_2_B9	-17.4589539	18.12810123	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1646	2715	0.011418048	0.004051565	9	8	Astrocytes	31	7	7
GAACCTATCAGGCAAG-1_2_B9	-12.77316524	16.51439228	11	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1578	2501	0.023990404	0.010795682	9	11	Glia-MIX	31	7	7
GAACCTATCGCGTAGC-1_2_B9	12.96170075	-12.8472534	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3926	8358	0.012802106	0.017348648	9	L2-3	EN-L2-3-MS	31	7	7
GAACGGACACATGACT-1_2_B9	-2.834011934	-34.77369936	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	912	1314	0.114155251	0.02283105	9	16	EN-PYR	31	7	7
GAACGGAGTTAAGAAC-1_2_B9	-21.09685759	-27.56737123	6A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3317	7952	0.008802817	0.002137827	9	6A	IN-PV	31	7	7
GAACGGATCGATCCCT-1_2_B9	34.61857864	-16.81640714	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4780	11770	0.019201359	0.015717927	9	2	EN-L4	31	7	7
GAAGCAGCAAGGCTCC-1_2_B9	-18.46729007	-4.349437163	13B	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2250	3912	0.039366053	0.017382413	9	13B	IN-SV2C	31	7	7
GAAGCAGGTGAAGGCT-1_2_B9	-22.13753738	4.766083432	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	857	1266	0.018167457	0.01342812	9	8	Astrocytes	31	7	7
GAAGCAGGTTCAGTAC-1_2_B9	9.513027511	-29.39472341	10	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	5062	15859	0.002396116	0.004603065	9	L2-3	EN-L2-3-Cntl	31	7	7
GAAGCAGTCCGTACAA-1_2_B9	13.59676455	-14.89166668	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3590	7748	0.008776458	0.009163655	9	L2-3	EN-L2-3-MS	31	7	7
GAATAAGGTCAAACTC-1_2_B9	-3.161547886	-35.04364978	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	804	1126	0.097690941	0.030195382	9	16	EN-PYR	31	7	7
GAATGAAAGTCACGCC-1_2_B9	-23.76802393	-26.06915253	6A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4721	13303	0.018867925	0.004660603	9	6A	IN-PV	31	7	7
GAATGAACAGACGCTC-1_2_B9	9.849039305	-11.59910621	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2346	3964	0.029767911	0.019677094	9	L2-3	EN-L2-3-MS	31	7	7
GAATGAACATCGATGT-1_2_B9	-22.54683361	8.980352013	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	868	1221	0.018018018	0.005733006	9	8	Astrocytes	31	7	7
GAATGAAGTAGCGTAG-1_2_B9	35.09605226	9.338398939	14	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	939	1236	0.025080906	0.017799353	9	14	Microglia	31	7	7
GAATGAATCGAACGGA-1_2_B9	7.371605863	-14.4400494	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2622	4774	0.012987013	0.005446167	9	L2-3	EN-L2-3-MS	31	7	7
GACACGCAGGTGATTA-1_2_B9	-25.93469683	-11.28315891	9	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	862	1203	0.024106401	0.011637573	9	9	OPC	31	7	7
GACACGCCACCAGCAC-1_2_B9	-10.49740812	28.38652433	17	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	914	1165	0.029184549	0.00944206	9	oligos	OL-MS-2	31	7	7
GACACGCGTCCGAGTC-1_2_B9	23.09292317	-16.12876098	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	5050	13966	0.027208936	0.016468567	9	L2-3	EN-L2-3-MS	31	7	7
GACAGAGAGGCTAGGT-1_2_B9	-22.88848318	8.361390088	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	907	1299	0.008468052	0.01308699	9	8	Astrocytes	31	7	7
GACAGAGCATACTACG-1_2_B9	-24.65362827	-21.74939561	6A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3156	6659	0.034539721	0.00555639	9	6A	IN-PV	31	7	7
GACAGAGGTAGGCTGA-1_2_B9	-17.45102598	18.07233931	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1630	2821	0.007089685	0.010634527	9	8	Astrocytes	31	7	7
GACAGAGTCCTTTCGG-1_2_B9	31.83515029	-18.03889272	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	6349	18863	0.019456078	0.015533054	9	2	EN-L4	31	7	7
GACCAATCACTGTTAG-1_2_B9	-16.29972967	10.32371001	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1256	2129	0.022076092	0.01268201	9	8	Astrocytes	31	7	7
GACCAATCAGTGAGTG-1_2_B9	-15.84450214	8.951205296	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1167	1814	0.015435502	0.012679162	9	8	Astrocytes	31	7	7
GACCAATCATGGTCTA-1_2_B9	-26.718186	-11.51026501	9	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1183	1724	0.015661253	0.028422274	9	9	OPC	31	7	7
GACCTGGAGAGGGATA-1_2_B9	14.11283547	-13.5827323	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	5151	12654	0.014935989	0.016121385	9	L2-3	EN-L2-3-MS	31	7	7
GACCTGGAGCTGCGAA-1_2_B9	19.20186526	-14.09905798	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	5838	16542	0.024785395	0.017772942	9	2	EN-L4	31	7	7
GACCTGGAGTTCGCAT-1_2_B9	-3.06016034	-34.70324662	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	881	1196	0.076086957	0.026755853	9	16	EN-PYR	31	7	7
GACCTGGCAAGTTAAG-1_2_B9	35.38549898	13.02786042	14	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1076	1447	0.017277125	0.013130615	9	14	Microglia	31	7	7
GACGCGTAGCTTCGCG-1_2_B9	10.05859803	-14.61696848	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2995	5866	0.014490283	0.016195022	9	L2-3	EN-L2-3-MS	31	7	7
GACGCGTAGGTGCTTT-1_2_B9	4.676212685	19.85538186	1	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	876	1164	0.012027491	0.012027491	9	oligos	OL-Cntl	31	7	7
GACGCGTAGTGGTAAT-1_2_B9	-29.50201684	-21.42699378	6A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3905	9101	0.072519503	0.009889023	9	6A	IN-PV	31	7	7
GACGCGTCATGGTCTA-1_2_B9	-11.74617908	-37.4940318	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1502	2603	0.12024587	0.018440261	9	16	EN-PYR	31	7	7
GACGCGTGTCGTCTTC-1_2_B9	15.88268723	-12.91541508	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4339	10073	0.018266653	0.021344187	9	L2-3	EN-L2-3-MS	31	7	7
GACGCGTTCACTCCTG-1_2_B9	-7.939946894	-38.39712493	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1245	2124	0.186440678	0.015065913	9	16	EN-PYR	31	7	7
GACGCGTTCATTGCGA-1_2_B9	-30.37958416	-2.835978447	9	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1306	2075	0.005783133	0.004337349	9	9	OPC	31	7	7
GACGGCTAGTACTTGC-1_2_B9	31.97815022	-18.79444879	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	7107	25690	0.035266641	0.017866874	9	2	EN-L4	31	7	7
GACGGCTTCCGTAGGC-1_2_B9	24.38711663	-21.34800989	3	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3407	7993	0.009633429	0.00700613	9	3	EN-L5-6	31	7	7
GACGTGCCACATGACT-1_2_B9	-27.9558183	-1.813292859	9	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1524	2479	0.009681323	0.021782977	9	9	OPC	31	7	7
GACGTGCCATTTGCTT-1_2_B9	23.24870282	-16.06940076	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	5062	13731	0.037506372	0.016167795	9	2	EN-L4	31	7	7
GACGTGCGTGAGCGAT-1_2_B9	7.363113877	1.38261221	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	970	1276	0.042319749	0.03369906	9	16	EN-PYR	31	7	7
GACGTGCTCCCTCAGT-1_2_B9	-18.86561185	24.08393711	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1712	3224	0.006513648	0.008995037	9	8	Astrocytes	31	7	7
GACGTTAGTATCACCA-1_2_B9	9.089739809	-4.095670675	12	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2275	4140	0.048067633	0.016425121	9	12	EN-MIX	31	7	7
GACGTTAGTTCTCATT-1_2_B9	9.044500837	-11.32848337	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2002	3327	0.036369101	0.010820559	9	L2-3	EN-L2-3-MS	31	7	7
GACGTTATCACCTTAT-1_2_B9	34.16747695	13.07316136	14	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1258	1818	0.01870187	0.02310231	9	14	Microglia	31	7	7
GACTAACCAATCGGTT-1_2_B9	18.27588696	-23.39632908	3	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3526	7422	0.003637833	0.028698464	9	3	EN-L5-6	31	7	7
GACTAACTCTGTACGA-1_2_B9	16.94209857	-17.6305422	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3691	7852	0.024961793	0.009806419	9	L2-3	EN-L2-3-MS	31	7	7
GACTACACAATAGCAA-1_2_B9	6.466410934	-7.871831872	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1892	2868	0.042538354	0.006624826	9	L2-3	EN-L2-3-MS	31	7	7
GACTACACACTTACGA-1_2_B9	-15.59994132	9.243566494	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1638	2716	0.016568483	0.018777614	9	8	Astrocytes	31	7	7
GACTACATCACCTTAT-1_2_B9	-15.70436356	9.033907593	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1467	2465	0.017849899	0.011359026	9	8	Astrocytes	31	7	7
GACTGCGAGTGGGATC-1_2_B9	-29.78521266	-2.569305411	9	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1380	2301	0.01303781	0.00478053	9	9	OPC	31	7	7
GACTGCGAGTGTGAAT-1_2_B9	-17.47363809	17.36579932	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1411	2455	0.007739308	0.002443992	9	8	Astrocytes	31	7	7
GACTGCGCAAGTAGTA-1_2_B9	-8.960221135	-15.97693273	6B	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	825	1207	0.070422535	0.003314002	9	6B	IN-SST	31	7	7
GACTGCGCAGGGATTG-1_2_B9	-11.23007563	-27.40373538	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1070	1660	0.159638554	0.009638554	9	16	EN-PYR	31	7	7
GACTGCGCATGGGAAC-1_2_B9	6.522129306	2.099214749	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1322	1876	0.097014925	0.009061834	9	16	EN-PYR	31	7	7
GACTGCGTCACCCGAG-1_2_B9	-3.644010313	-33.41523771	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	664	1029	0.213799806	0.015549077	9	16	EN-PYR	31	7	7
GACTGCGTCTATCCTA-1_2_B9	-20.54506614	-5.252281964	13B	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4742	11891	0.025733748	0.011521319	9	13B	IN-SV2C	31	7	7
GAGCAGAGTAATAGCA-1_2_B9	7.919492967	3.365712463	12	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1370	1985	0.080100756	0.013602015	9	12	EN-MIX	31	7	7
GAGCAGAGTACATGTC-1_2_B9	27.04751211	4.587691851	15BA	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	739	1066	0.016885553	0.021575985	9	15BA	Stromal cells	31	7	7
GAGCAGAGTTAGGGTG-1_2_B9	-16.43284345	-2.198482866	13A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2732	5091	0.018267531	0.009428403	9	13A	IN-VIP	31	7	7
GAGGTGACAATGAAAC-1_2_B9	-14.68243307	-4.392581184	13A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3147	6139	0.00765597	0.005538361	9	13A	IN-VIP	31	7	7
GAGGTGACATTAGCCA-1_2_B9	-3.094504328	-34.11764239	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	800	1095	0.126027397	0.020091324	9	16	EN-PYR	31	7	7
GAGGTGAGTAAATGAC-1_2_B9	-3.699090556	-35.062095	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	755	1034	0.059961315	0.023210832	9	16	EN-PYR	31	7	7
GAGGTGAGTACGACCC-1_2_B9	25.02832406	-16.05602026	3	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3039	5621	0.030243729	0.013520726	9	3	EN-L5-6	31	7	7
GAGGTGAGTCTAGTGT-1_2_B9	-21.97456237	9.578452782	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1102	1728	0.026041667	0.006365741	9	8	Astrocytes	31	7	7
GAGTCCGCATAGACTC-1_2_B9	5.972284171	2.215131108	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	818	1050	0.078095238	0.02	9	16	EN-PYR	31	7	7
GAGTCCGGTACCGTAT-1_2_B9	-5.025283196	-34.89662025	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	964	1368	0.076754386	0.015350877	9	16	EN-PYR	31	7	7
GAGTCCGTCCACTCCA-1_2_B9	-10.96352319	-37.10013465	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1521	2455	0.10305499	0.020366599	9	16	EN-PYR	31	7	7
GAGTCCGTCCTGTACC-1_2_B9	11.78323756	-0.429671141	12	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	978	1625	0.038769231	0.016	9	12	EN-MIX	31	7	7
GATCAGTAGGTCATCT-1_2_B9	-17.76672589	18.60342815	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1546	2713	0.010320678	0.00589753	9	8	Astrocytes	31	7	7
GATCAGTCACTGTCGG-1_2_B9	34.15319432	-17.44661392	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4110	9429	0.01283275	0.022695938	9	2	EN-L4	31	7	7
GATCAGTCAGCATGAG-1_2_B9	37.45162214	10.18417881	14	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	871	1197	0.01754386	0.010860485	9	14	Microglia	31	7	7
GATCAGTTCTCTAGGA-1_2_B9	-10.76404464	-8.567647144	13B	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1430	2368	0.044341216	0.001689189	9	13B	IN-SV2C	31	7	7
GATCAGTTCTGGAGCC-1_2_B9	26.6159473	5.351704609	15BA	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	995	1424	0.014044944	0.019662921	9	15BA	Stromal cells	31	7	7
GATCGATAGTGTCCAT-1_2_B9	18.84228741	-13.86425036	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	6920	23673	0.021923711	0.01715034	9	L2-3	EN-L2-3-MS	31	7	7
GATCGATCACCGTTGG-1_2_B9	13.5126191	-18.51317473	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4556	11744	0.008685286	0.010558583	9	L2-3	EN-L2-3-MS	31	7	7
GATCGATGTCCATGAT-1_2_B9	25.7485588	3.833731883	15BA	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	882	1181	0.019475021	0.00592718	9	15BA	Stromal cells	31	7	7
GATCGATTCACTTACT-1_2_B9	12.33229582	-17.46226553	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3972	10307	0.010284273	0.00805278	9	L2-3	EN-L2-3-MS	31	7	7
GATCGCGAGTCATGCT-1_2_B9	-19.03622316	-3.04651911	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3362	6586	0.019283328	0.011084118	9	L2-3	EN-L2-3-MS	31	7	7
GATCGCGCATCAGTAC-1_2_B9	-16.17241127	0.044183675	13A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3019	5869	0.010223207	0.010223207	9	13A	IN-VIP	31	7	7
GATCGCGGTAGCGATG-1_2_B9	-4.854601392	-36.24639491	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	799	1122	0.053475936	0.02228164	9	16	EN-PYR	31	7	7
GATCGCGGTATAGTAG-1_2_B9	-30.01836918	-3.161857319	9	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1189	1848	0.00974026	0.004329004	9	9	OPC	31	7	7
GATCGCGTCAGTTCGA-1_2_B9	-28.70268697	-4.577353844	9	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1085	1727	0.006369427	0.004053272	9	9	OPC	31	7	7
GATCGCGTCGGCCGAT-1_2_B9	12.90035418	-13.93782383	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3346	6966	0.020671835	0.012632788	9	L2-3	EN-L2-3-MS	31	7	7
GATCGCGTCTTTAGGG-1_2_B9	-17.06056427	16.35287215	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1511	2747	0.004004368	0.005460502	9	8	Astrocytes	31	7	7
GATCGTACAAGGCTCC-1_2_B9	-15.67703555	12.6744874	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1364	2172	0.006906077	0.005524862	9	8	Astrocytes	31	7	7
GATCGTACAAGTTCTG-1_2_B9	-15.8021616	8.969822855	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1226	1974	0.014184397	0.019250253	9	8	Astrocytes	31	7	7
GATCTAGCAATAAGCA-1_2_B9	-26.96926483	-11.05162332	9	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1051	1536	0.029947917	0.012369792	9	9	OPC	31	7	7
GATCTAGTCATGTGGT-1_2_B9	33.80973206	-18.56576488	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4374	9759	0.01700994	0.018751921	9	2	EN-L4	31	7	7
GATGAAACATACTACG-1_2_B9	-22.4713457	-19.8806843	6A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2131	3674	0.020958084	0.009798585	9	6A	IN-PV	31	7	7
GATGAAAGTCTGGTCG-1_2_B9	27.28510388	-13.54303809	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3788	8828	0.039420027	0.005097417	9	L2-3	EN-L2-3-MS	31	7	7
GATGAAAGTGTGAATA-1_2_B9	-11.70840084	-38.58155441	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1403	2105	0.029928741	0.031353919	9	16	EN-PYR	31	7	7
GATGAGGCAGCTGTGC-1_2_B9	31.89686465	9.637229319	14	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	838	1035	0.028985507	0.033816425	9	14	Microglia	31	7	7
GATGCTAAGACAAAGG-1_2_B9	16.73657734	-13.30991395	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4323	9816	0.020374898	0.017828036	9	L2-3	EN-L2-3-MS	31	7	7
GATGCTACAATGGTCT-1_2_B9	29.76673267	9.549896191	15DB	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1020	1569	0.023581899	0.075844487	9	15DB	B cells	31	7	7
GATGCTAGTACGCTGC-1_2_B9	-9.100083647	-27.99959119	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1167	1687	0.088915234	0.01659751	9	16	EN-PYR	31	7	7
GATGCTAGTCAGAAGC-1_2_B9	12.49152102	-19.01966868	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4452	11313	0.006806329	0.007425086	9	L2-3	EN-L2-3-MS	31	7	7
GATTCAGCACCAGTTA-1_2_B9	-11.13642863	28.80327525	17	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1304	1837	0.060424605	0.008709853	9	oligos	OL-MS-2	31	7	7
GATTCAGGTACAAGTA-1_2_B9	-15.78311458	9.061527612	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1364	2216	0.018953069	0.017148014	9	8	Astrocytes	31	7	7
GATTCAGTCCATGAGT-1_2_B9	13.85670971	-16.57449802	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4949	12485	0.008490188	0.009291149	9	L2-3	EN-L2-3-MS	31	7	7
GCAAACTAGCCTCGTG-1_2_B9	-17.66142778	-14.82430882	6B	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1706	2992	0.010695187	0.01671123	9	6B	IN-SST	31	7	7
GCAAACTCAATGGAGC-1_2_B9	-29.98264281	-3.354336291	9	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1175	1821	0.014827018	0.002745744	9	9	OPC	31	7	7
GCAAACTGTCATTAGC-1_2_B9	-15.53852906	9.544179299	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1565	2478	0.027441485	0.01614205	9	8	Astrocytes	31	7	7
GCAAACTTCAAGAAGT-1_2_B9	-12.05442788	-37.98299452	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1526	2399	0.064610254	0.020425177	9	16	EN-PYR	31	7	7
GCAAACTTCGTTGCCT-1_2_B9	27.56391594	6.949721869	15BA	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1082	1662	0.051744886	0.027677497	9	15BA	Stromal cells	31	7	7
GCAATCAAGAGAGCTC-1_2_B9	-27.8808595	-20.85096967	6A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3746	8567	0.044472978	0.007937434	9	6A	IN-PV	31	7	7
GCAATCAAGAGGACGG-1_2_B9	4.760505226	5.173740569	7	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2035	3142	0.020369192	0.018141311	9	7	Phagocytes	31	7	7
GCAATCAAGTGCTGCC-1_2_B9	17.69450488	-13.51787152	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	5817	18639	0.025001341	0.010622887	9	L2-3	EN-L2-3-MS	31	7	7
GCAATCACAGACGCCT-1_2_B9	13.47667645	-19.28465349	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	5249	14016	0.004209475	0.017337329	9	L2-3	EN-L2-3-MS	31	7	7
GCAATCATCCTTGCCA-1_2_B9	-22.42274734	-23.32980592	6A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2551	5155	0.075072745	0.002133851	9	6A	IN-PV	31	7	7
GCACATACATGCCCGA-1_2_B9	13.92357754	-18.28829174	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	5934	18711	0.010582011	0.013895569	9	L2-3	EN-L2-3-MS	31	7	7
GCACATAGTGGCCCTA-1_2_B9	34.04684637	9.051327071	14	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	964	1304	0.023006135	0.020705521	9	14	Microglia	31	7	7
GCACATATCTCCGGTT-1_2_B9	31.61418634	-18.27214232	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	7048	25395	0.0333924	0.015514865	9	2	EN-L4	31	7	7
GCACTCTAGCGATTCT-1_2_B9	-18.05110658	-14.59137493	6B	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2226	4020	0.025621891	0.012935323	9	6B	IN-SST	31	7	7
GCACTCTTCAAAGTAG-1_2_B9	-19.74500385	-0.996771937	13A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4119	8863	0.023355523	0.02200158	9	13A	IN-VIP	31	7	7
GCAGCCAAGATAGCAT-1_2_B9	-13.22146186	6.814023858	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1187	1906	0.166841553	0.0204617	9	16	EN-PYR	31	7	7
GCAGCCAAGTCGTACT-1_2_B9	-3.2431641	-34.97923354	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	852	1237	0.139046079	0.024252223	9	16	EN-PYR	31	7	7
GCAGCCACAAGGACAC-1_2_B9	6.97741565	1.901574113	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	748	1000	0.1	0.02	9	16	EN-PYR	31	7	7
GCAGCCACAAGTCATC-1_2_B9	-27.98142647	-20.91330715	6A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3577	7848	0.067405708	0.005861366	9	6A	IN-PV	31	7	7
GCAGCCACAGGTCGTC-1_2_B9	35.06841105	10.36475406	14	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	772	1025	0.013658537	0.024390244	9	14	Microglia	31	7	7
GCAGTTAAGTGATCGG-1_2_B9	34.0502739	10.47088046	14	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	796	1064	0.022556391	0.02443609	9	14	Microglia	31	7	7
GCAGTTACATACTCTT-1_2_B9	29.84387635	9.402239251	15DA	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1015	1345	0.046096654	0.037174721	9	15DA	T cells	31	7	7
GCAGTTACATATACGC-1_2_B9	-15.20392849	0.637870097	13A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3442	6920	0.012572254	0.011127168	9	13A	IN-VIP	31	7	7
GCATACAAGCACAGGT-1_2_B9	5.940401188	5.957103305	7	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2453	4135	0.009915357	0.024909311	9	7	Phagocytes	31	7	7
GCATACAAGCTGCAAG-1_2_B9	31.92691831	-17.67200264	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4730	11008	0.015715843	0.018441134	9	2	EN-L4	31	7	7
GCATACAAGTGAACGC-1_2_B9	21.39573747	-22.21950915	3	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3732	8817	0.004309856	0.008619712	9	3	EN-L5-6	31	7	7
GCATACACAAGAAGAG-1_2_B9	34.04083291	7.781366632	14	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1129	1507	0.02720637	0.01061712	9	14	Microglia	31	7	7
GCATACATCAACGCTA-1_2_B9	13.88785745	-18.24829991	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4969	12960	0.005478395	0.012114198	9	L2-3	EN-L2-3-MS	31	7	7
GCATACATCCTCATTA-1_2_B9	25.83439416	5.387894426	15BA	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1177	1690	0.034911243	0.017751479	9	15BA	Stromal cells	31	7	7
GCATGATAGAACTGTA-1_2_B9	36.20374245	13.49004608	14	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1110	1537	0.01366298	0.01691607	9	14	Microglia	31	7	7
GCATGATAGTTGTAGA-1_2_B9	-17.66362356	23.86536328	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1554	2623	0.017155928	0.009912314	9	8	Astrocytes	31	7	7
GCATGATGTAGCGTAG-1_2_B9	18.2815336	-23.27175137	3	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3916	8610	0.004065041	0.027293844	9	3	EN-L5-6	31	7	7
GCATGATGTGGCGAAT-1_2_B9	10.81363017	-14.25355729	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3085	5843	0.005990074	0.014889612	9	L2-3	EN-L2-3-MS	31	7	7
GCATGATGTTGGTAAA-1_2_B9	10.44963045	-14.11376308	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2733	5014	0.010769844	0.009772637	9	L2-3	EN-L2-3-MS	31	7	7
GCATGCGAGATAGTCA-1_2_B9	34.3261525	8.297909228	14	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	804	1069	0.006548176	0.006548176	9	14	Microglia	31	7	7
GCATGCGTCATTGCCC-1_2_B9	-28.97692772	-3.421034085	9	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1357	2127	0.003761166	0.00658204	9	9	OPC	31	7	7
GCATGCGTCGGAAACG-1_2_B9	19.39867816	-22.26736272	3	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	5153	14121	0.012888606	0.010197578	9	3	EN-L5-6	31	7	7
GCATGTAGTTTGCATG-1_2_B9	31.89334347	-12.79355629	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4490	10464	0.0069763	0.007549694	9	2	EN-L4	31	7	7
GCATGTATCTTAGAGC-1_2_B9	-17.89017291	-3.002071664	13A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2576	4489	0.02405881	0.018489641	9	13A	IN-VIP	31	7	7
GCCAAATAGCAGGCTA-1_2_B9	31.66769133	-17.78830857	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	5843	16007	0.014930968	0.018117074	9	2	EN-L4	31	7	7
GCCAAATAGTTCGATC-1_2_B9	-29.33595878	-2.262568695	9	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1556	2596	0.012711864	0.006933744	9	9	OPC	31	7	7
GCCAAATCATCTCCCA-1_2_B9	33.57114778	8.450716333	14	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1118	1517	0.030982202	0.018457482	9	14	Microglia	31	7	7
GCCAAATGTACATGTC-1_2_B9	-6.24799358	-37.78313004	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1060	1571	0.066199873	0.019096117	9	16	EN-PYR	31	7	7
GCCAAATTCCCATTAT-1_2_B9	6.849082392	2.160893045	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	877	1149	0.083550914	0.007832898	9	16	EN-PYR	31	7	7
GCCAAATTCTGGTTCC-1_2_B9	22.79539303	16.39094047	1	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1200	1857	0.010231556	0.007000539	9	oligos	OL-Cntl	31	7	7
GCCTCTAAGACTACAA-1_2_B9	-21.71833268	-26.35136341	6A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3728	8651	0.020344469	0.003467807	9	6A	IN-PV	31	7	7
GCCTCTACAACACCTA-1_2_B9	-10.79846544	14.31342455	11	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1648	2503	0.015181782	0.011186576	9	11	Glia-MIX	31	7	7
GCCTCTAGTCGCGGTT-1_2_B9	-12.32709626	17.73403786	11	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1796	3041	0.010851694	0.007234462	9	11	Glia-MIX	31	7	7
GCCTCTAGTGCACCAC-1_2_B9	-12.50640683	-38.32821678	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1914	3457	0.097194099	0.033265837	9	16	EN-PYR	31	7	7
GCCTCTATCAGCAACT-1_2_B9	-28.53144413	-4.557600594	9	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1221	1890	0.012698413	0.008465608	9	9	OPC	31	7	7
GCGACCACACACGCTG-1_2_B9	27.75932803	-12.06584313	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4163	10417	0.020255352	0.006335797	9	2	EN-L4	31	7	7
GCGACCAGTCGGCACT-1_2_B9	12.52767513	-22.15339885	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4714	12308	0.013324667	0.009343516	9	L2-3	EN-L2-3-MS	31	7	7
GCGAGAAGTGGTCCGT-1_2_B9	-10.49150524	27.5527824	5	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	843	1292	0.188080495	0.042569659	9	oligos	OL-MS-1	31	7	7
GCGAGAATCTTTACGT-1_2_B9	-17.2899466	17.94394734	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1597	2607	0.012658228	0.00575374	9	8	Astrocytes	31	7	7
GCGCAACGTAATCGTC-1_2_B9	24.93070423	8.501225111	15A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2119	3494	0.025472238	0.025472238	9	15A	Endo cells	31	7	7
GCGCAACGTGTTTGTG-1_2_B9	10.56586131	-13.47527473	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3037	5984	0.007352941	0.026069519	9	L2-3	EN-L2-3-MS	31	7	7
GCGCAGTAGACTAGGC-1_2_B9	31.3051812	-19.16245644	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	5435	13960	0.025	0.026146132	9	2	EN-L4	31	7	7
GCGCAGTAGCTACCTA-1_2_B9	-12.58530895	-37.98520852	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1675	3079	0.086716466	0.023059435	9	16	EN-PYR	31	7	7
GCGCAGTGTCGCTTCT-1_2_B9	-11.6100189	-37.89144661	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1649	2872	0.140320334	0.021587744	9	16	EN-PYR	31	7	7
GCGCAGTGTTGAACTC-1_2_B9	30.75458495	-18.90192435	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	6655	22794	0.037641485	0.014828464	9	2	EN-L4	31	7	7
GCGCCAAAGTGACTCT-1_2_B9	-16.24561673	11.86603478	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1094	1648	0.015776699	0.018203883	9	8	Astrocytes	31	7	7
GCGCCAACAGCTTCGG-1_2_B9	25.24039884	-15.80398507	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	5055	12108	0.037991411	0.027006938	9	2	EN-L4	31	7	7
GCGCCAACAGGATCGA-1_2_B9	-11.18149513	-1.695587122	13A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2075	3693	0.007040347	0.007581912	9	13A	IN-VIP	31	7	7
GCGCCAAGTAAACGCG-1_2_B9	24.78241537	-13.94077803	3	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3883	8098	0.008767597	0.017164732	9	3	EN-L5-6	31	7	7
GCGCCAATCTGATTCT-1_2_B9	34.01312576	-17.21797783	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	6117	18309	0.014582992	0.015893823	9	2	EN-L4	31	7	7
GCGCGATAGACGCTTT-1_2_B9	-26.48624618	-10.71176421	9	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1268	1864	0.027360515	0.027896996	9	9	OPC	31	7	7
GCGCGATAGGCCGAAT-1_2_B9	31.71474617	-18.52082188	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4074	8977	0.025843823	0.018603097	9	2	EN-L4	31	7	7
GCGCGATTCAAGCCTA-1_2_B9	19.1400622	-14.05852095	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	6528	20497	0.032248622	0.015026589	9	2	EN-L4	31	7	7
GCGGGTTAGACTAGAT-1_2_B9	-27.99209008	-4.673607474	9	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1177	1704	0.009389671	0.004694836	9	9	OPC	31	7	7
GCGGGTTGTTATGCGT-1_2_B9	27.67217637	5.890448934	15A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	792	1037	0.024108004	0.021215043	9	15A	Endo cells	31	7	7
GCGGGTTGTTGAGGTG-1_2_B9	-28.506348	-2.094738036	9	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1434	2283	0.004380201	0.025843189	9	9	OPC	31	7	7
GCTCCTAAGAGTAATC-1_2_B9	27.24822131	7.897923897	15A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1051	1467	0.021131561	0.059986367	9	15A	Endo cells	31	7	7
GCTCCTACAATGGAGC-1_2_B9	-16.80171495	-2.342648332	13A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3409	7224	0.011627907	0.009136213	9	13A	IN-VIP	31	7	7
GCTCCTACAATGGTCT-1_2_B9	25.9310441	6.636258892	15BA	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1302	1902	0.027339642	0.026288118	9	15BA	Stromal cells	31	7	7
GCTCCTATCGCTTGTC-1_2_B9	-29.45203613	-0.506283895	9	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1634	3040	0.017434211	0.005592105	9	9	OPC	31	7	7
GCTCCTATCTGAGGGA-1_2_B9	-25.09483324	-18.51598855	6B	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2616	4809	0.009773342	0.008941568	9	6B	IN-SST	31	7	7
GCTCTGTCATGGTCTA-1_2_B9	-16.46036654	-1.685415035	13A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2460	4529	0.014572753	0.020975933	9	13A	IN-VIP	31	7	7
GCTCTGTGTGCCTGTG-1_2_B9	-14.14125072	-32.12517113	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2716	5363	0.055006526	0.018832743	9	16	EN-PYR	31	7	7
GCTCTGTTCGCGATCG-1_2_B9	36.85477067	13.44119255	14	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1003	1387	0.011535689	0.020187455	9	14	Microglia	31	7	7
GCTCTGTTCTATCGCC-1_2_B9	-12.71890607	-37.99166663	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1762	3321	0.125564589	0.027100271	9	16	EN-PYR	31	7	7
GCTGCAGGTCTGATTG-1_2_B9	-24.05550906	6.315321861	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	820	1285	0.010116732	0.010894942	9	8	Astrocytes	31	7	7
GCTGCGACACCTGGTG-1_2_B9	-10.90998151	16.92919472	11	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2025	3218	0.010565569	0.009011809	9	11	Glia-MIX	31	7	7
GCTGCGACATCGATGT-1_2_B9	31.75197285	-17.95085992	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	5312	13315	0.023282013	0.010214044	9	2	EN-L4	31	7	7
GCTGCGAGTTCAACCA-1_2_B9	-18.66989994	6.009753598	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	846	1129	0.020372011	0.024800709	9	8	Astrocytes	31	7	7
GCTGCGATCACTGGGC-1_2_B9	-7.541688016	-38.36797011	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1030	1489	0.049697784	0.018804567	9	16	EN-PYR	31	7	7
GCTGCTTCAAGGGTCA-1_2_B9	-5.159816161	-33.8469417	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	884	1302	0.139784946	0.015360983	9	16	EN-PYR	31	7	7
GCTGCTTCACACGCTG-1_2_B9	-27.883248	-3.812370492	9	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1414	2083	0.019683149	0.010081613	9	9	OPC	31	7	7
GCTGCTTCATCACGAT-1_2_B9	-18.5160719	17.87438998	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1648	2817	0.013489528	0.005679801	9	8	Astrocytes	31	7	7
GCTGGGTAGTCATGCT-1_2_B9	12.0595013	-13.2866172	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3194	6208	0.015947165	0.015625	9	L2-3	EN-L2-3-MS	31	7	7
GCTGGGTGTATAATGG-1_2_B9	18.95139242	-15.48539369	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	6598	20356	0.020387109	0.008154844	9	L2-3	EN-L2-3-MS	31	7	7
GCTGGGTTCAGTCAGT-1_2_B9	-15.92500258	0.522700185	13A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3393	6980	0.011461318	0.016618911	9	13A	IN-VIP	31	7	7
GCTGGGTTCCTCAACC-1_2_B9	-6.435230318	-2.881077027	13A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1421	2265	0.014128035	0.00397351	9	13A	IN-VIP	31	7	7
GCTTGAAAGGACAGAA-1_2_B9	33.4826768	12.60825253	14	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	986	1327	0.017332329	0.027128862	9	14	Microglia	31	7	7
GCTTGAAAGTCCCACG-1_2_B9	27.0903829	8.688640795	15A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1297	1919	0.034914018	0.05054716	9	15A	Endo cells	31	7	7
GCTTGAACAGGAATCG-1_2_B9	-8.376856696	-38.50249544	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1362	2141	0.111630079	0.019617001	9	16	EN-PYR	31	7	7
GCTTGAACATCTATGG-1_2_B9	-5.154576792	-33.6751434	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	882	1210	0.058677686	0.019008264	9	16	EN-PYR	31	7	7
GCTTGAAGTGGTTTCA-1_2_B9	-23.69067908	6.203798215	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	743	1001	0.021978022	0.011988012	9	8	Astrocytes	31	7	7
GGAAAGCGTCGCTTCT-1_2_B9	31.49403718	14.91687698	14	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	800	1096	0.012773723	0.064781022	9	14	Microglia	31	7	7
GGAACTTAGGATGGTC-1_2_B9	-26.85717889	-20.78263428	6A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2848	5823	0.033144427	0.010990898	9	6A	IN-PV	31	7	7
GGAACTTCAGCTCGAC-1_2_B9	25.97387134	9.370070713	15A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1909	3265	0.029709035	0.034303216	9	15A	Endo cells	31	7	7
GGAACTTGTAGGGTAC-1_2_B9	-14.84091422	-16.55870763	6B	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1583	2700	0.015185185	0.003703704	9	6B	IN-SST	31	7	7
GGAACTTGTCCGAGTC-1_2_B9	-17.75279399	23.41604317	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1519	2500	0.012	0.0108	9	8	Astrocytes	31	7	7
GGAATAAAGATACACA-1_2_B9	-23.40634652	-18.17215465	6A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2830	5492	0.024399126	0.006190823	9	6A	IN-PV	31	7	7
GGAATAAAGCGTTGCC-1_2_B9	12.88591711	-12.43024648	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3287	6736	0.017963183	0.021971496	9	L2-3	EN-L2-3-MS	31	7	7
GGAATAACAAGCCGCT-1_2_B9	28.78816588	6.93514442	15BA	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1164	1587	0.042848141	0.018273472	9	15BA	Stromal cells	31	7	7
GGAATAACATAAAGGT-1_2_B9	-17.2631549	17.83114687	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1563	2634	0.028853455	0.009870919	9	8	Astrocytes	31	7	7
GGAATAAGTACCGTTA-1_2_B9	16.71250513	-14.74130215	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4555	10599	0.011416171	0.01405793	9	L2-3	EN-L2-3-MS	31	7	7
GGACAAGAGATTACCC-1_2_B9	24.8986859	6.274495611	15BA	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1721	2631	0.011402509	0.019384265	9	15BA	Stromal cells	31	7	7
GGACAAGCAAGGTTCT-1_2_B9	-4.127466896	-35.44516183	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	784	1091	0.110907424	0.030247479	9	16	EN-PYR	31	7	7
GGACAAGCACTTAAGC-1_2_B9	-17.91420872	-2.196363596	13A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2857	5035	0.032174777	0.011320755	9	13A	IN-VIP	31	7	7
GGACAAGTCTTAGAGC-1_2_B9	15.26800403	-15.82752678	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4721	11998	0.00750125	0.024170695	9	L2-3	EN-L2-3-MS	31	7	7
GGACAGACACTGAAGG-1_2_B9	31.06564243	-18.94111897	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	5075	12323	0.028970218	0.016392112	9	2	EN-L4	31	7	7
GGACATTCACAGATTC-1_2_B9	19.12692578	-22.33093441	3	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4575	11720	0.006996587	0.006143345	9	3	EN-L5-6	31	7	7
GGACATTCATGGTTGT-1_2_B9	-4.580074246	-35.98631402	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	908	1264	0.075158228	0.022943038	9	16	EN-PYR	31	7	7
GGACATTGTACATCCA-1_2_B9	-12.4597186	-37.8373885	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1691	2717	0.034228929	0.015090173	9	16	EN-PYR	31	7	7
GGACGTCAGTGCAAGC-1_2_B9	30.20288614	-18.99119297	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	5906	16734	0.022588741	0.014581092	9	2	EN-L4	31	7	7
GGACGTCGTACAGTGG-1_2_B9	-3.960004974	-35.66184452	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	773	1013	0.038499506	0.025666338	9	16	EN-PYR	31	7	7
GGACGTCGTTGAACTC-1_2_B9	35.64871267	-11.47727253	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4262	9781	0.007361211	0.017482875	9	2	EN-L4	31	7	7
GGAGCAAAGATGGCGT-1_2_B9	16.49753162	-13.33154682	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4902	11713	0.017245795	0.016477418	9	L2-3	EN-L2-3-MS	31	7	7
GGAGCAAAGCTGTTCA-1_2_B9	27.31609874	9.333400829	15A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1255	1889	0.035468502	0.067231339	9	15A	Endo cells	31	7	7
GGAGCAAGTACGACCC-1_2_B9	-5.662969146	-37.12263428	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	968	1466	0.126193724	0.031377899	9	16	EN-PYR	31	7	7
GGAGCAATCACGAAGG-1_2_B9	-17.19380413	17.87976536	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1511	2467	0.008107013	0.011755168	9	8	Astrocytes	31	7	7
GGAGCAATCGTCACGG-1_2_B9	-32.03816976	-6.503832273	9	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1183	1742	0.008610792	0.005166475	9	9	OPC	31	7	7
GGATGTTAGTTGAGTA-1_2_B9	27.09711355	5.435656426	15A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	830	1076	0.014869888	0.027881041	9	15A	Endo cells	31	7	7
GGATGTTCATCGATGT-1_2_B9	34.73004292	-16.01577166	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3947	9046	0.010170241	0.01613973	9	2	EN-L4	31	7	7
GGATGTTGTCCGTCAG-1_2_B9	26.59321594	8.029468289	15BA	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1728	2822	0.080793763	0.033309709	9	15BA	Stromal cells	31	7	7
GGATGTTGTTCCATGA-1_2_B9	-17.3837557	-5.83588127	13B	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2125	3688	0.025759219	0.013286334	9	13B	IN-SV2C	31	7	7
GGATTACAGGCTCAGA-1_2_B9	-28.3274486	-4.276189875	9	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1241	1906	0.008394544	0.004721931	9	9	OPC	31	7	7
GGATTACCACGAGAGT-1_2_B9	23.94901741	-16.36729807	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	5093	13699	0.026936273	0.019855464	9	2	EN-L4	31	7	7
GGATTACTCAAACCGT-1_2_B9	-15.72630103	8.686426436	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1257	1894	0.018479409	0.023231257	9	8	Astrocytes	31	7	7
GGCAATTAGAGGTTGC-1_2_B9	-8.632729329	-38.7599029	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1228	1949	0.103642894	0.0282196	9	16	EN-PYR	31	7	7
GGCAATTAGGCGATAC-1_2_B9	-18.94107064	24.16399785	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1809	3392	0.015035377	0.004127358	9	8	Astrocytes	31	7	7
GGCAATTGTAAAGGAG-1_2_B9	-3.91472263	-35.02190869	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	805	1084	0.044280443	0.014760148	9	16	EN-PYR	31	7	7
GGCAATTGTTAAGGGC-1_2_B9	31.57517589	13.57812409	14	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1096	1587	0.015122873	0.059231254	9	14	Microglia	31	7	7
GGCCGATCACTGTTAG-1_2_B9	33.90531571	-16.55016636	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4383	10234	0.009087356	0.01924956	9	2	EN-L4	31	7	7
GGCCGATCATAGACTC-1_2_B9	29.50650866	15.60973366	14	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1963	3300	0.007878788	0.073939394	9	14	Microglia	31	7	7
GGCCGATTCCGCATAA-1_2_B9	32.74052503	8.254406007	14	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	776	1003	0.033898305	0.013958126	9	14	Microglia	31	7	7
GGCGACTCATCTATGG-1_2_B9	25.06584123	-15.61621606	3	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4508	11021	0.017874966	0.018873061	9	3	EN-L5-6	31	7	7
GGCGACTTCAACACTG-1_2_B9	-27.35404428	-1.255386677	9	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1422	2205	0.013605442	0.019501134	9	9	OPC	31	7	7
GGCGACTTCTCCAGGG-1_2_B9	27.35362706	4.325364536	15DA	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	835	1212	0.075082508	0.017326733	9	15DA	T cells	31	7	7
GGCGACTTCTCGCTTG-1_2_B9	17.07981696	-26.00279397	3	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	5439	16594	0.003615765	0.008497047	9	3	EN-L5-6	31	7	7
GGCGTGTAGTTGAGTA-1_2_B9	13.72669605	-0.767197855	12	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	828	1321	0.011355034	0.00681302	9	12	EN-MIX	31	7	7
GGCGTGTAGTTTAGGA-1_2_B9	-25.08251728	11.08799271	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	982	1657	0.004224502	0.004828002	9	8	Astrocytes	31	7	7
GGCGTGTCACGTTGGC-1_2_B9	-14.50268927	-32.20922387	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4377	10452	0.088595484	0.032816686	9	16	EN-PYR	31	7	7
GGCGTGTCATCGGTTA-1_2_B9	-35.32310274	-4.862411028	9	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1218	2009	0.005475361	0.00298656	9	9	OPC	31	7	7
GGCGTGTGTACAGACG-1_2_B9	10.84854104	-26.01024952	10	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4590	12657	0.002054199	0.003634353	9	L2-3	EN-L2-3-Cntl	31	7	7
GGCGTGTTCGCATGGC-1_2_B9	-26.80529091	-11.28419408	9	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	942	1304	0.010736196	0.016104294	9	9	OPC	31	7	7
GGCTCGAGTCTTTCAT-1_2_B9	-6.83153127	-27.86705829	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	861	1174	0.037478705	0.021294719	9	16	EN-PYR	31	7	7
GGCTCGATCAAGATCC-1_2_B9	12.79762926	-14.1107928	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4064	9154	0.014310684	0.014419926	9	L2-3	EN-L2-3-MS	31	7	7
GGCTCGATCGCACTCT-1_2_B9	34.76343281	-16.62737352	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4439	10896	0.01404185	0.018722467	9	2	EN-L4	31	7	7
GGCTCGATCGCCTGTT-1_2_B9	-10.09967645	-37.85107559	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1332	2029	0.069492361	0.011335633	9	16	EN-PYR	31	7	7
GGCTCGATCTGGCGTG-1_2_B9	-17.63877532	17.26473683	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1319	2128	0.010338346	0.007988722	9	8	Astrocytes	31	7	7
GGCTGGTAGACAATAC-1_2_B9	-6.752337393	-38.35937273	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1177	1741	0.083859851	0.026995979	9	16	EN-PYR	31	7	7
GGCTGGTTCAATCACG-1_2_B9	23.19591832	-16.28290739	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	6027	20038	0.031490169	0.011378381	9	2	EN-L4	31	7	7
GGGAATGAGGTGCAAC-1_2_B9	18.20087825	-23.20027394	3	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4259	10133	0.002664561	0.039672358	9	3	EN-L5-6	31	7	7
GGGAATGGTTCTGTTT-1_2_B9	-30.60243156	-1.813455167	9	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1450	2535	0.008284024	0.003550296	9	9	OPC	31	7	7
GGGACCTAGAAACCTA-1_2_B9	-4.739988663	-34.40013351	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	747	1083	0.087719298	0.013850416	9	16	EN-PYR	31	7	7
GGGACCTTCCTGCTTG-1_2_B9	-16.25837235	0.43870187	13A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3109	6388	0.009392611	0.020820288	9	13A	IN-VIP	31	7	7
GGGACCTTCGTCCGTT-1_2_B9	-28.01063695	-2.895125056	9	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1485	2309	0.012126462	0.012992638	9	9	OPC	31	7	7
GGGAGATAGAAACGCC-1_2_B9	-17.48707028	-5.938463087	13B	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2195	3715	0.008344549	0.008344549	9	13B	IN-SV2C	31	7	7
GGGAGATCACATCTTT-1_2_B9	11.34126819	-14.28533224	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3440	7100	0.019014085	0.012957746	9	L2-3	EN-L2-3-MS	31	7	7
GGGAGATCATCAGTAC-1_2_B9	-32.93862247	5.31804397	9	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2658	5255	0.004947669	0.011417697	9	9	OPC	31	7	7
GGGAGATGTATTCGTG-1_2_B9	-10.06943433	-37.56174592	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1282	2103	0.112696148	0.013314313	9	16	EN-PYR	31	7	7
GGGATGACAGCATACT-1_2_B9	18.82840348	-14.66428896	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	5548	16692	0.031272466	0.0107237	9	L2-3	EN-L2-3-MS	31	7	7
GGGATGAGTGAGGGTT-1_2_B9	-18.55269877	5.398965775	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	721	1032	0.041666667	0.011627907	9	8	Astrocytes	31	7	7
GGGATGAGTTTGCATG-1_2_B9	-22.34378212	7.241919858	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1294	1903	0.036258539	0.008933263	9	8	Astrocytes	31	7	7
GGGATGATCGCCTGTT-1_2_B9	-12.75854193	17.44000837	11	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1778	2776	0.015129683	0.01332853	9	11	Glia-MIX	31	7	7
GGGCACTAGTCGTACT-1_2_B9	-7.669858395	-38.68578142	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1089	1473	0.067209776	0.016972166	9	16	EN-PYR	31	7	7
GGGCACTCAATACGCT-1_2_B9	-7.949152304	-38.63444047	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1245	1822	0.062568606	0.018111965	9	16	EN-PYR	31	7	7
GGGCACTCACCACCAG-1_2_B9	12.80180823	-12.43771535	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3361	6586	0.018372305	0.018675979	9	L2-3	EN-L2-3-MS	31	7	7
GGGCACTCATCTACGA-1_2_B9	28.71319156	-18.74385315	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	9116	44754	0.030589445	0.011306252	9	2	EN-L4	31	7	7
GGGCATCCAGGGATTG-1_2_B9	-15.26257145	9.187202663	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1834	3316	0.012364294	0.007539204	9	8	Astrocytes	31	7	7
GGGCATCTCAACCATG-1_2_B9	-29.485236	-2.025662885	9	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1641	2700	0.006666667	0.007407407	9	9	OPC	31	7	7
GGGTCTGCACGACTCG-1_2_B9	27.31524359	5.582813571	15A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	902	1195	0.013389121	0.005020921	9	15A	Endo cells	31	7	7
GGGTCTGCACTCAGGC-1_2_B9	-15.94934347	8.938250498	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1133	1719	0.011052938	0.011052938	9	8	Astrocytes	31	7	7
GGGTCTGCAGTTAACC-1_2_B9	19.54064583	-10.11133002	3	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1738	2922	0.014715948	0.002053388	9	3	EN-L5-6	31	7	7
GGGTCTGGTGTGGTTT-1_2_B9	-4.640455215	-34.04006453	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	874	1253	0.105347167	0.012769354	9	16	EN-PYR	31	7	7
GGGTCTGTCGATCCCT-1_2_B9	-3.725446956	-34.94912694	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	947	1427	0.142957253	0.02452698	9	16	EN-PYR	31	7	7
GGGTCTGTCTACTTAC-1_2_B9	34.31537257	9.297804549	14	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	854	1190	0.009243697	0.024369748	9	14	Microglia	31	7	7
GGGTTGCTCTTGCAAG-1_2_B9	28.03026667	7.195827372	15A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	780	1100	0.026363636	0.033636364	9	15A	Endo cells	31	7	7
GGTATTGAGCCCAGCT-1_2_B9	9.22701459	-4.096352322	12	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1952	3116	0.031450578	0.017971759	9	12	EN-MIX	31	7	7
GGTATTGCAAGAAAGG-1_2_B9	-11.6446551	-38.84695263	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1641	2886	0.094248094	0.033957034	9	16	EN-PYR	31	7	7
GGTATTGCAGTTTACG-1_2_B9	-14.49770431	-2.706011282	13A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2830	5502	0.00781534	0.009632861	9	13A	IN-VIP	31	7	7
GGTATTGCATTTGCCC-1_2_B9	-30.32880955	-2.84339007	9	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1357	2201	0.006360745	0.001817356	9	9	OPC	31	7	7
GGTATTGGTAATAGCA-1_2_B9	-15.78549549	8.764388074	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1151	1777	0.014068655	0.018007878	9	8	Astrocytes	31	7	7
GGTGAAGGTCATATCG-1_2_B9	-10.84456226	15.1692168	11	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1588	2453	0.020790868	0.004484305	9	11	Glia-MIX	31	7	7
GGTGAAGGTTTGGCGC-1_2_B9	-20.01420572	-5.787124392	13A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4654	12089	0.042021673	0.005955828	9	13A	IN-VIP	31	7	7
GGTGAAGTCATGGTCA-1_2_B9	24.71110872	-19.55608178	3	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	5189	14859	0.020055185	0.004509052	9	3	EN-L5-6	31	7	7
GGTGCGTTCAGGCCCA-1_2_B9	7.967449038	-12.50143973	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2119	3567	0.023829549	0.015138772	9	L2-3	EN-L2-3-MS	31	7	7
GGTGCGTTCCCTCTTT-1_2_B9	-10.0406983	23.0957367	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2242	3875	0.005419355	0.009290323	9	8	Astrocytes	31	7	7
GGTGCGTTCTAGAGTC-1_2_B9	4.007069761	4.59676367	7	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1512	2124	0.010828625	0.018361582	9	7	Phagocytes	31	7	7
GGTGTTAAGACTAGGC-1_2_B9	-18.72166571	24.14967695	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1814	3216	0.007462687	0.00528607	9	8	Astrocytes	31	7	7
GGTGTTAAGTATCTCG-1_2_B9	34.58582931	-17.09505571	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4456	10330	0.013649564	0.019845111	9	2	EN-L4	31	7	7
GGTGTTAGTAGCGCTC-1_2_B9	-15.86712757	-3.200741959	13A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2394	4345	0.018642117	0.005293441	9	13A	IN-VIP	31	7	7
GGTGTTATCAGTGTTG-1_2_B9	-19.36399175	-21.43386537	6A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2908	6424	0.019769614	0.004669988	9	6A	IN-PV	31	7	7
GTAACGTCAAACCCAT-1_2_B9	-8.610230703	-5.335424858	13A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1497	2478	0.040758676	0.005649718	9	13A	IN-VIP	31	7	7
GTAACGTCATTCTTAC-1_2_B9	27.3115035	-12.45043462	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	5293	16022	0.017788041	0.010235926	9	2	EN-L4	31	7	7
GTAACTGAGCGGCTTC-1_2_B9	36.65719029	12.95843437	14	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	961	1441	0.016655101	0.011797363	9	14	Microglia	31	7	7
GTAACTGAGGGTCTCC-1_2_B9	29.80386127	-18.08065613	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	7591	31103	0.040414108	0.010352699	9	2	EN-L4	31	7	7
GTAACTGGTAGCGATG-1_2_B9	30.44028447	-17.16896898	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4555	10729	0.036629695	0.006897195	9	2	EN-L4	31	7	7
GTAACTGGTTGCCTCT-1_2_B9	25.05988711	5.22276201	15A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1435	2311	0.026828213	0.008221549	9	15A	Endo cells	31	7	7
GTAACTGTCTACTATC-1_2_B9	12.57609055	-15.65960835	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3867	8684	0.010939659	0.009557807	9	L2-3	EN-L2-3-MS	31	7	7
GTACGTACAGTAAGAT-1_2_B9	-30.19784995	-21.85641395	6A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	6571	22598	0.058013984	0.007744048	9	6A	IN-PV	31	7	7
GTACGTACATCATCCC-1_2_B9	24.87858339	7.921650584	15A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2019	3429	0.025663459	0.018664334	9	15A	Endo cells	31	7	7
GTACGTATCCAGTAGT-1_2_B9	10.15975134	-17.28513528	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3629	7884	0.008498224	0.009893455	9	L2-3	EN-L2-3-MS	31	7	7
GTACGTATCGTTACGA-1_2_B9	6.45813648	-7.745565603	12	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1553	2222	0.054455446	0.0090009	9	12	EN-MIX	31	7	7
GTACTCCAGACGCAAC-1_2_B9	25.17829649	-15.07235469	3	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	5811	15536	0.027355819	0.015190525	9	3	EN-L5-6	31	7	7
GTACTCCCAAGTACCT-1_2_B9	16.00378216	-13.06860541	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4775	11327	0.024366558	0.018539772	9	L2-3	EN-L2-3-MS	31	7	7
GTACTCCCAGATGAGC-1_2_B9	18.85333691	-22.46938022	3	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	5193	13936	0.006242824	0.017436854	9	3	EN-L5-6	31	7	7
GTACTCCCATGGGACA-1_2_B9	-17.93411072	23.69300287	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1585	2702	0.016284234	0.007401925	9	8	Astrocytes	31	7	7
GTACTCCTCGTTACAG-1_2_B9	26.43373185	9.429033665	15A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1707	2717	0.034596982	0.05520795	9	15A	Endo cells	31	7	7
GTACTCCTCTTTACAC-1_2_B9	36.32089935	13.84795269	14	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1216	1790	0.015642458	0.017318436	9	14	Microglia	31	7	7
GTACTTTTCCTGTAGA-1_2_B9	-9.430545159	15.96592409	11	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2061	3533	0.004811775	0.011604868	9	11	Glia-MIX	31	7	7
GTAGGCCAGCAGCGTA-1_2_B9	-10.72781475	14.40180363	11	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1922	3228	0.008983891	0.013320942	9	11	Glia-MIX	31	7	7
GTAGGCCAGGCTAGAC-1_2_B9	-17.80813169	6.211003143	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	731	1100	0.014545455	0.02	9	8	Astrocytes	31	7	7
GTAGGCCAGTAGCCGA-1_2_B9	13.20275561	-15.33831945	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4364	10795	0.012320519	0.009356183	9	L2-3	EN-L2-3-MS	31	7	7
GTAGGCCGTACAGTTC-1_2_B9	-4.991315089	-30.64069382	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	690	1001	0.143856144	0.014985015	9	16	EN-PYR	31	7	7
GTAGGCCGTCAACTGT-1_2_B9	-24.6376729	15.61859591	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1145	1934	0.007755946	0.008273009	9	8	Astrocytes	31	7	7
GTAGGCCTCAGTTCGA-1_2_B9	-13.09756898	-37.68251165	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1843	3384	0.059101655	0.015070922	9	16	EN-PYR	31	7	7
GTAGTCAAGAATGTTG-1_2_B9	-13.42172001	-37.4899082	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1956	3640	0.102472527	0.017032967	9	16	EN-PYR	31	7	7
GTAGTCAAGAGATGAG-1_2_B9	25.4079078	-16.10930682	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	5208	14299	0.032449822	0.01748374	9	2	EN-L4	31	7	7
GTAGTCACAACGATCT-1_2_B9	-13.7725046	3.569158796	13A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3650	7504	0.004930704	0.011993603	9	13A	IN-VIP	31	7	7
GTAGTCAGTACTTAGC-1_2_B9	14.55704806	-13.14317699	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	5099	13143	0.017347638	0.025641026	9	L2-3	EN-L2-3-MS	31	7	7
GTAGTCAGTCAACATC-1_2_B9	35.00075604	12.62378012	14	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1027	1442	0.012482663	0.024965326	9	14	Microglia	31	7	7
GTAGTCAGTGACGGTA-1_2_B9	16.0929022	-16.8115226	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4715	11665	0.01508787	0.011058723	9	L2-3	EN-L2-3-MS	31	7	7
GTAGTCATCAGCTCTC-1_2_B9	-17.48153427	18.0447635	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1553	2688	0.029389881	0.008556548	9	8	Astrocytes	31	7	7
GTAGTCATCGGCATCG-1_2_B9	11.30126396	-13.05397519	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2901	5312	0.015248494	0.016566265	9	L2-3	EN-L2-3-MS	31	7	7
GTATCTTAGAGTCTGG-1_2_B9	-13.05842639	16.05734377	11	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1209	1742	0.01836969	0.012629162	9	11	Glia-MIX	31	7	7
GTATCTTAGCCTTGAT-1_2_B9	17.97196895	-22.51636477	3	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4691	12007	0.014324977	0.017406513	9	3	EN-L5-6	31	7	7
GTATCTTAGTGTCCAT-1_2_B9	-29.25899776	-10.3989131	9	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	932	1347	0.008166295	0.031180401	9	9	OPC	31	7	7
GTATCTTCAGGACGTA-1_2_B9	10.94462474	-15.5218133	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3488	7437	0.004975124	0.013849671	9	L2-3	EN-L2-3-MS	31	7	7
GTATTCTAGGCATGTG-1_2_B9	-17.14064196	16.52585824	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1331	2264	0.011925795	0.005300353	9	8	Astrocytes	31	7	7
GTATTCTCAATGCCAT-1_2_B9	-4.44115078	-34.34018347	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	785	1170	0.139316239	0.013675214	9	16	EN-PYR	31	7	7
GTATTCTCATGAGCGA-1_2_B9	-24.61385372	-19.4771325	6A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2751	5306	0.027139088	0.010177158	9	6A	IN-PV	31	7	7
GTCAAGTTCTCGGACG-1_2_B9	33.10992231	-13.45997617	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2944	5672	0.012341326	0.008991537	9	2	EN-L4	31	7	7
GTCACAAAGAGTACAT-1_2_B9	22.37083868	-22.02362398	3	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4790	12681	0.00930526	0.008201246	9	3	EN-L5-6	31	7	7
GTCACAACATGTCGAT-1_2_B9	-18.80183432	24.09894496	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1855	3720	0.004301075	0.005107527	9	8	Astrocytes	31	7	7
GTCACAATCATTGCGA-1_2_B9	13.38418166	-19.38075426	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	5980	19099	0.004345777	0.011937798	9	L2-3	EN-L2-3-MS	31	7	7
GTCACAATCCTAGTGA-1_2_B9	-20.46240116	-4.901991553	13B	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3821	8206	0.02437241	0.009748964	9	13B	IN-SV2C	31	7	7
GTCACGGCACCAGGTC-1_2_B9	-2.845035044	-34.09740091	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	819	1203	0.181213633	0.029093932	9	16	EN-PYR	31	7	7
GTCACGGGTAATCGTC-1_2_B9	27.4992556	-11.89534701	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4357	10770	0.00538533	0.008913649	9	2	EN-L4	31	7	7
GTCATTTAGCCTATGT-1_2_B9	14.80215823	-12.66917826	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3850	8240	0.021723301	0.016262136	9	L2-3	EN-L2-3-MS	31	7	7
GTCATTTCACAGGAGT-1_2_B9	-11.88450729	-2.708306834	13A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1985	3338	0.02576393	0.006890354	9	13A	IN-VIP	31	7	7
GTCATTTCATGCTGGC-1_2_B9	-21.15144784	23.75238653	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1452	2498	0.020016013	0.007606085	9	8	Astrocytes	31	7	7
GTCATTTTCCACGAAT-1_2_B9	6.847401113	-13.22118287	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2151	3772	0.013255567	0.007423118	9	L2-3	EN-L2-3-MS	31	7	7
GTCCTCAAGAGCTATA-1_2_B9	34.81667992	12.70296746	14	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1036	1348	0.021513353	0.012611276	9	14	Microglia	31	7	7
GTCCTCACAAACCTAC-1_2_B9	26.16899166	7.773184963	15A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1527	2494	0.032477947	0.020048115	9	15A	Endo cells	31	7	7
GTCCTCACAGGGTTAG-1_2_B9	-5.235708596	-31.14704606	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	838	1320	0.177272727	0.009848485	9	16	EN-PYR	31	7	7
GTCGGGTTCACTTACT-1_2_B9	-19.70957883	-7.155016356	13B	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3757	7967	0.011673152	0.012300741	9	13B	IN-SV2C	31	7	7
GTCGGGTTCCACGCAG-1_2_B9	24.8731956	-16.80609334	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	6697	22547	0.033441256	0.009579988	9	2	EN-L4	31	7	7
GTCGTAAAGTTTAGGA-1_2_B9	33.83651367	-18.91533074	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4896	11416	0.019183602	0.026979678	9	2	EN-L4	31	7	7
GTCGTAATCAGTCAGT-1_2_B9	26.9063075	7.368381134	15A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1139	1670	0.015568862	0.020359281	9	15A	Endo cells	31	7	7
GTCGTAATCCGCTGTT-1_2_B9	-7.451301026	-37.33849545	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1125	1677	0.10614192	0.017889088	9	16	EN-PYR	31	7	7
GTCGTAATCGAATCCA-1_2_B9	-9.643435333	15.74250472	11	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1971	3118	0.010262989	0.012508018	9	11	Glia-MIX	31	7	7
GTCGTAATCTCCGGTT-1_2_B9	30.59213119	-18.99117091	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	6158	18105	0.027064347	0.014636841	9	2	EN-L4	31	7	7
GTCTCGTAGAAGGTGA-1_2_B9	-16.06418306	13.10078467	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1285	2162	0.004162812	0.019426457	9	8	Astrocytes	31	7	7
GTCTCGTGTCTCCATC-1_2_B9	24.19253457	-21.36219422	3	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3962	10144	0.003746057	0.006999211	9	3	EN-L5-6	31	7	7
GTCTTCGAGAACTGTA-1_2_B9	-24.93631519	-18.46742461	6B	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2782	5760	0.026736111	0.005555556	9	6B	IN-SST	31	7	7
GTCTTCGAGTAGGCCA-1_2_B9	-28.05065751	-4.309705443	9	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1290	1926	0.007268951	0.00623053	9	9	OPC	31	7	7
GTCTTCGCAGCTGTAT-1_2_B9	21.3001588	-13.80871794	3	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2734	5480	0.009124088	0.037591241	9	3	EN-L5-6	31	7	7
GTCTTCGGTTGCGCAC-1_2_B9	-24.1664009	-15.96666285	6B	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3587	7838	0.046823169	0.008165348	9	6B	IN-SST	31	7	7
GTGAAGGAGGTAGCCA-1_2_B9	-17.21292371	5.969756954	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	772	1073	0.024231128	0.009319664	9	8	Astrocytes	31	7	7
GTGAAGGCAAGCGCTC-1_2_B9	21.88529782	-16.36613786	3	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4514	10604	0.019898152	0.027536779	9	3	EN-L5-6	31	7	7
GTGAAGGCAATAGAGT-1_2_B9	30.52287791	-18.53407226	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	7948	32727	0.024200202	0.015277905	9	2	EN-L4	31	7	7
GTGAAGGCACGGTTTA-1_2_B9	-10.81863518	-37.3680886	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1491	2552	0.134404389	0.009404389	9	16	EN-PYR	31	7	7
GTGAAGGTCGAATGGG-1_2_B9	16.29794736	-13.2047617	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4149	9242	0.029430859	0.008006925	9	L2-3	EN-L2-3-MS	31	7	7
GTGCAGCGTACGAAAT-1_2_B9	-22.70994187	-24.66763419	6A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2941	6139	0.008633328	0.003583646	9	6A	IN-PV	31	7	7
GTGCAGCTCTCCAGGG-1_2_B9	34.01862161	-12.43931753	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4006	8996	0.007670076	0.010893731	9	2	EN-L4	31	7	7
GTGCATACAACTGCTA-1_2_B9	25.16347364	-16.00580636	3	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3945	9941	0.032994669	0.010662911	9	3	EN-L5-6	31	7	7
GTGCATACACAGGTTT-1_2_B9	-14.86878728	-14.98810245	6B	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1411	2167	0.018920166	0.021688971	9	6B	IN-SST	31	7	7
GTGCGGTAGTCCGTAT-1_2_B9	14.22388168	-13.18484543	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4020	8589	0.017697054	0.018279194	9	L2-3	EN-L2-3-MS	31	7	7
GTGCGGTCATGGAATA-1_2_B9	-6.246538589	-35.64309075	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	894	1199	0.058381985	0.016680567	9	16	EN-PYR	31	7	7
GTGCGGTGTGGTAACG-1_2_B9	-15.71813478	9.043082275	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1446	2309	0.00822867	0.016890429	9	8	Astrocytes	31	7	7
GTGCTTCCAGTAGAGC-1_2_B9	35.07787341	-15.42886235	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3908	8128	0.014640748	0.02140748	9	2	EN-L4	31	7	7
GTGCTTCGTCCCTACT-1_2_B9	-21.98478273	25.94940124	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1671	3078	0.003573749	0.005523067	9	8	Astrocytes	31	7	7
GTGGGTCAGACAATAC-1_2_B9	33.85282439	-18.76643942	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4649	10471	0.021201413	0.027027027	9	2	EN-L4	31	7	7
GTGGGTCAGTGGAGTC-1_2_B9	-24.58562434	11.36346077	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	966	1528	0.014397906	0.005890052	9	8	Astrocytes	31	7	7
GTGGGTCGTACTCAAC-1_2_B9	-12.71443593	-4.014531558	13A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2395	4364	0.01512374	0.011915674	9	13A	IN-VIP	31	7	7
GTGGGTCTCGTGACAT-1_2_B9	33.65614894	-15.48741465	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4371	10762	0.024530756	0.011243263	9	2	EN-L4	31	7	7
GTGTGCGAGAACAATC-1_2_B9	-31.09378886	-0.744873891	9	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1506	2464	0.005275974	0.006899351	9	9	OPC	31	7	7
GTGTGCGAGATGCGAC-1_2_B9	-18.95406464	23.65113003	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1389	2277	0.006148441	0.004830918	9	8	Astrocytes	31	7	7
GTGTGCGCAACACGCC-1_2_B9	-4.117819975	-33.89400767	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	829	1170	0.115384615	0.024786325	9	16	EN-PYR	31	7	7
GTGTGCGCAGGGTACA-1_2_B9	-22.50998428	6.59806315	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1012	1451	0.020675396	0.015161957	9	8	Astrocytes	31	7	7
GTGTGCGGTACATGTC-1_2_B9	28.05243994	7.093623429	15BA	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1060	1624	0.04864532	0.022783251	9	15BA	Stromal cells	31	7	7
GTGTTAGTCCGAATGT-1_2_B9	-16.32977248	16.7331267	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1632	2736	0.004751462	0.010233918	9	8	Astrocytes	31	7	7
GTGTTAGTCGGGAGTA-1_2_B9	17.30976109	-13.27920685	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4914	12555	0.011150936	0.014336918	9	L2-3	EN-L2-3-MS	31	7	7
GTTAAGCAGCCAGGAT-1_2_B9	9.991457504	-2.422647707	12	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1631	2436	0.028735632	0.005747126	9	12	EN-MIX	31	7	7
GTTACAGGTGTGCCTG-1_2_B9	-10.38404887	27.81404036	5	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	778	1005	0.04079602	0.04079602	9	oligos	OL-MS-1	31	7	7
GTTACAGTCCAGGGCT-1_2_B9	30.09935701	-10.00736904	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3637	7256	0.007028666	0.011025358	9	2	EN-L4	31	7	7
GTTACAGTCCTGCCAT-1_2_B9	-18.63518207	-17.46021548	6B	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2234	4348	0.012649494	0.001379945	9	6B	IN-SST	31	7	7
GTTCATTAGGGCACTA-1_2_B9	-7.079088044	-37.46728596	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1101	1704	0.140258216	0.018192488	9	16	EN-PYR	31	7	7
GTTCATTAGTGTACGG-1_2_B9	-16.98084594	17.62459915	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1668	2867	0.017091036	0.00941751	9	8	Astrocytes	31	7	7
GTTCATTCAAACCCAT-1_2_B9	13.34839908	-15.0946191	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3784	8646	0.014226232	0.007286607	9	L2-3	EN-L2-3-MS	31	7	7
GTTCATTCAAGTAATG-1_2_B9	-12.22987522	16.22326548	11	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1387	2136	0.013576779	0.007958801	9	11	Glia-MIX	31	7	7
GTTCATTGTAAGTTCC-1_2_B9	-15.8632996	8.845432243	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1081	1695	0.01120944	0.01179941	9	8	Astrocytes	31	7	7
GTTCATTTCAGCACAT-1_2_B9	34.48350444	-16.01660263	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3727	8013	0.013602895	0.019218769	9	2	EN-L4	31	7	7
GTTCATTTCCAGAAGG-1_2_B9	-18.80303655	23.73921546	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1547	2637	0.014789534	0.010238908	9	8	Astrocytes	31	7	7
GTTCGGGCACGAAACG-1_2_B9	-3.235302552	-33.84465951	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	782	1107	0.145438121	0.014453478	9	16	EN-PYR	31	7	7
GTTCGGGCACGGCCAT-1_2_B9	10.33715232	-18.94677344	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4365	11366	0.003871195	0.005278902	9	L2-3	EN-L2-3-MS	31	7	7
GTTCGGGCATACCATG-1_2_B9	-3.72122663	-34.47068387	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	899	1293	0.115235886	0.01933488	9	16	EN-PYR	31	7	7
GTTCTCGAGAGGTTGC-1_2_B9	12.46750643	-12.31248218	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3051	5908	0.017433988	0.021496276	9	L2-3	EN-L2-3-MS	31	7	7
GTTCTCGCACAGGTTT-1_2_B9	20.63399294	-21.86209016	3	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3584	8170	0.014198286	0.02374541	9	3	EN-L5-6	31	7	7
GTTCTCGGTCATATGC-1_2_B9	-7.861528432	-38.74769448	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1399	2119	0.121283624	0.029731005	9	16	EN-PYR	31	7	7
GTTCTCGTCAGAGACG-1_2_B9	-13.07231083	16.65416782	11	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1495	2290	0.020087336	0.015283843	9	11	Glia-MIX	31	7	7
GTTTCTAAGTAGGTGC-1_2_B9	13.70867784	-15.38483736	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4358	10738	0.013875955	0.006146396	9	L2-3	EN-L2-3-MS	31	7	7
GTTTCTAGTAATTGGA-1_2_B9	31.78001534	15.01810404	14	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	807	1039	0.020211742	0.068334937	9	14	Microglia	31	7	7
GTTTCTAGTTCATGGT-1_2_B9	27.84295508	6.094103736	15A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	764	1021	0.042115573	0.028403526	9	15A	Endo cells	31	7	7
TAAACCGAGCTCAACT-1_2_B9	-5.30093014	-31.7349434	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1078	1612	0.097394541	0.024813896	9	16	EN-PYR	31	7	7
TAAACCGTCTACTCAT-1_2_B9	30.40836606	-0.012182614	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3549	9415	0.001911843	0.003505045	9	2	EN-L4	31	7	7
TAAGAGACACCCATGG-1_2_B9	24.05956118	-16.32908402	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	5089	13919	0.032760974	0.019685322	9	2	EN-L4	31	7	7
TAAGAGACACTCTGTC-1_2_B9	-3.243696335	-35.714169	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	729	1038	0.102119461	0.028901734	9	16	EN-PYR	31	7	7
TAAGAGAGTACCGGCT-1_2_B9	-6.514883592	-35.66865399	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	806	1072	0.081156716	0.016791045	9	16	EN-PYR	31	7	7
TAAGAGAGTATTCGTG-1_2_B9	34.72652691	-11.8823261	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2713	5340	0.005617978	0.023033708	9	2	EN-L4	31	7	7
TAAGAGAGTGCCTGGT-1_2_B9	-29.83838098	-2.640190364	9	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1323	2147	0.007918025	0.005123428	9	9	OPC	31	7	7
TAAGAGAGTTACAGAA-1_2_B9	32.93163893	-18.83175055	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4072	9304	0.022141015	0.025150473	9	2	EN-L4	31	7	7
TAAGCGTCAGAAGCAC-1_2_B9	-16.86488586	-14.74984047	6B	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1814	3114	0.076750161	0.00834939	9	6B	IN-SST	31	7	7
TAAGCGTCAGGGTTAG-1_2_B9	13.59542098	-14.83302	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3844	8578	0.018186057	0.011074843	9	L2-3	EN-L2-3-MS	31	7	7
TAAGCGTGTGTAATGA-1_2_B9	-19.5923891	4.930650549	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	798	1174	0.019591141	0.009369676	9	8	Astrocytes	31	7	7
TAAGCGTTCACGACTA-1_2_B9	-25.45837532	-0.673153292	9	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1665	2508	0.011562998	0.026315789	9	9	OPC	31	7	7
TAAGCGTTCTTCAACT-1_2_B9	-10.63152882	-37.68772163	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1442	2324	0.104991394	0.013339071	9	16	EN-PYR	31	7	7
TAAGTGCCATCGTCGG-1_2_B9	7.356219248	-0.318211133	12	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	891	1435	0.012543554	0.020209059	9	12	EN-MIX	31	7	7
TAAGTGCTCAGCATGT-1_2_B9	23.26568969	-16.0518035	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	5716	15710	0.018650541	0.016868237	9	2	EN-L4	31	7	7
TACACGACACGACGAA-1_2_B9	-15.41613104	-5.643685389	13B	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3255	7041	0.012214174	0.008095441	9	13B	IN-SV2C	31	7	7
TACACGATCACTTACT-1_2_B9	34.20692393	7.678320686	14	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	948	1276	0.027429467	0.010188088	9	14	Microglia	31	7	7
TACAGTGCACTAGTAC-1_2_B9	-10.62007242	28.44625766	17	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	997	1440	0.097222222	0.025694444	9	oligos	OL-MS-2	31	7	7
TACCTATGTTGAGGTG-1_2_B9	23.14095093	-16.18387926	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	5780	17772	0.017949584	0.017893315	9	L2-3	EN-L2-3-MS	31	7	7
TACCTATTCTCCAACC-1_2_B9	-16.78313465	7.003645189	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	846	1188	0.015151515	0.014309764	9	8	Astrocytes	31	7	7
TACCTTAAGCGATATA-1_2_B9	9.829113872	-12.44725029	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2480	4430	0.010158014	0.020541761	9	L2-3	EN-L2-3-MS	31	7	7
TACCTTATCCTACAGA-1_2_B9	28.30023239	-18.72249796	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	7784	34126	0.046592041	0.010842173	9	2	EN-L4	31	7	7
TACCTTATCTATCCCG-1_2_B9	32.20232769	-12.80548832	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4574	11463	0.01648783	0.010381227	9	2	EN-L4	31	7	7
TACCTTATCTGATACG-1_2_B9	11.25249577	-15.52273171	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3380	7276	0.011407367	0.010307861	9	L2-3	EN-L2-3-MS	31	7	7
TACGGATCAAATTGCC-1_2_B9	30.50782372	-19.1191984	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	7790	30005	0.03106149	0.02236294	9	2	EN-L4	31	7	7
TACGGATGTAGGGACT-1_2_B9	21.89636629	-15.52330384	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4953	11516	0.045588746	0.025790205	9	2	EN-L4	31	7	7
TACGGGCAGCTAAACA-1_2_B9	33.73753911	12.4249684	14	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1070	1481	0.025658339	0.030384875	9	14	Microglia	31	7	7
TACGGGCCACGAAAGC-1_2_B9	23.58305513	-15.96399704	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	6333	19250	0.024051948	0.023636364	9	2	EN-L4	31	7	7
TACGGGCCAGACAAAT-1_2_B9	34.8207169	-16.25482234	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4211	9378	0.015888249	0.019193858	9	2	EN-L4	31	7	7
TACGGGCGTCGGGTCT-1_2_B9	18.26207642	-13.67253466	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	5132	12679	0.015774115	0.024134395	9	L2-3	EN-L2-3-MS	31	7	7
TACGGTAAGAATGTGT-1_2_B9	-19.52817633	-1.590706803	13A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3362	6547	0.016648847	0.023063999	9	13A	IN-VIP	31	7	7
TACGGTAAGGTGATAT-1_2_B9	16.66373991	-13.0423211	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4920	12376	0.016241112	0.019957983	9	L2-3	EN-L2-3-MS	31	7	7
TACGGTACAATAAGCA-1_2_B9	-17.20348837	17.72922	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1558	2551	0.009016072	0.005488044	9	8	Astrocytes	31	7	7
TACGGTACATTGTGCA-1_2_B9	-3.198278922	-34.86611844	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	784	1098	0.112021858	0.020947177	9	16	EN-PYR	31	7	7
TACTCATTCCAAGTAC-1_2_B9	-14.65797684	-3.224908257	13A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2781	5418	0.028054633	0.006090808	9	13A	IN-VIP	31	7	7
TACTCGCAGACACGAC-1_2_B9	36.17295359	-10.71004211	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4479	10007	0.005396223	0.032777056	9	2	EN-L4	31	7	7
TACTCGCAGTACATGA-1_2_B9	-16.46805623	7.324992554	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1143	1610	0.030434783	0.011801242	9	8	Astrocytes	31	7	7
TACTCGCCAACTGGCC-1_2_B9	7.008819149	-14.87073492	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2625	4809	0.009981285	0.011021002	9	L2-3	EN-L2-3-MS	31	7	7
TACTCGCCACGGATAG-1_2_B9	7.256563662	1.888249129	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	965	1393	0.130653266	0.004307251	9	16	EN-PYR	31	7	7
TACTCGCGTACCTACA-1_2_B9	30.50892565	-8.033527333	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4559	11344	0.007757405	0.005553597	9	2	EN-L4	31	7	7
TACTCGCTCATTGCCC-1_2_B9	-24.34485176	8.980225045	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	885	1238	0.020193861	0.006462036	9	8	Astrocytes	31	7	7
TACTCGCTCCATTCTA-1_2_B9	4.7699782	5.163707627	7	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1889	3063	0.019915116	0.017303297	9	7	Phagocytes	31	7	7
TACTCGCTCTTTCCTC-1_2_B9	28.84397195	-13.74891876	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	5406	15675	0.00969697	0.013141946	9	2	EN-L4	31	7	7
TACTTACAGCGATGAC-1_2_B9	14.03798843	-16.87816042	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	5451	15344	0.011861314	0.016553702	9	L2-3	EN-L2-3-MS	31	7	7
TACTTACAGTATCTCG-1_2_B9	-18.915299	24.27999483	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1608	2832	0.004237288	0.009180791	9	8	Astrocytes	31	7	7
TACTTACCAAAGTCAA-1_2_B9	-20.54224616	-5.19911472	13B	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4042	9269	0.017261841	0.01294638	9	13B	IN-SV2C	31	7	7
TACTTGTCACGGTGTC-1_2_B9	13.67986024	-23.89348658	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	5113	15005	0.003732089	0.009930023	9	L2-3	EN-L2-3-MS	31	7	7
TACTTGTGTACCGTAT-1_2_B9	-22.85247919	-4.499539758	9	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2328	4545	0.015181518	0.00550055	9	9	OPC	31	7	7
TACTTGTTCAGCTTAG-1_2_B9	-12.26841529	-1.011180201	13A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2540	5313	0.02333898	0.005081875	9	13A	IN-VIP	31	7	7
TACTTGTTCCAAAGTC-1_2_B9	38.20850527	14.07846243	14	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1104	1524	0.015091864	0.009186352	9	14	Microglia	31	7	7
TAGACCACAGTTAACC-1_2_B9	27.56574525	5.179216324	15BA	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	927	1304	0.062116564	0.019171779	9	15BA	Stromal cells	31	7	7
TAGACCAGTGATAAGT-1_2_B9	13.20827295	-19.07169902	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	5389	15566	0.001477579	0.012655788	9	L2-3	EN-L2-3-MS	31	7	7
TAGACCATCGTCACGG-1_2_B9	13.45216152	-15.93549393	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4780	13156	0.014898145	0.006536941	9	L2-3	EN-L2-3-MS	31	7	7
TAGACCATCTGAGTGT-1_2_B9	20.79952382	-19.20700798	3	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4795	13169	0.01875617	0.008884501	9	3	EN-L5-6	31	7	7
TAGACCATCTGTCTAT-1_2_B9	-0.672070223	-1.343974668	13A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1697	2513	0.033426184	0.02626343	9	13A	IN-VIP	31	7	7
TAGAGCTCAATGTTGC-1_2_B9	24.69449721	-14.9813677	3	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3166	6101	0.021963613	0.025077856	9	3	EN-L5-6	31	7	7
TAGAGCTTCGTGACAT-1_2_B9	-27.89535738	-20.89861821	6A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3584	8697	0.060595608	0.005519145	9	6A	IN-PV	31	7	7
TAGCCGGAGATGAGAG-1_2_B9	-11.97606354	-14.13810021	6B	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1117	1577	0.005072923	0.014584654	9	6B	IN-SST	31	7	7
TAGCCGGAGTCTCCTC-1_2_B9	10.03530168	-14.73077349	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2909	5765	0.011621856	0.013183001	9	L2-3	EN-L2-3-MS	31	7	7
TAGCCGGCATCGGTTA-1_2_B9	-10.79789953	14.27373182	11	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1723	2883	0.020464794	0.017343045	9	11	Glia-MIX	31	7	7
TAGCCGGTCTAACTTC-1_2_B9	33.25639685	7.950713067	14	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	832	1124	0.03202847	0.013345196	9	14	Microglia	31	7	7
TAGGCATGTCAAAGCG-1_2_B9	-11.62155786	28.36723679	17	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1751	2709	0.052417866	0.017718715	9	oligos	OL-MS-2	31	7	7
TAGGCATGTGACGCCT-1_2_B9	-30.43454959	-2.884887322	9	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1362	2284	0.007005254	0.004816112	9	9	OPC	31	7	7
TAGTGGTAGCATGGCA-1_2_B9	27.56742347	6.103844936	15A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	921	1304	0.021472393	0.015337423	9	15A	Endo cells	31	7	7
TAGTGGTCAACCGCCA-1_2_B9	-3.6625801	-35.07990685	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	723	1005	0.065671642	0.013930348	9	16	EN-PYR	31	7	7
TAGTGGTCAATGCCAT-1_2_B9	27.08741712	-13.58353777	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4901	14426	0.057049771	0.005337585	9	L2-3	EN-L2-3-MS	31	7	7
TAGTGGTTCATGCTCC-1_2_B9	-3.008906963	-34.28547687	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	696	1040	0.201923077	0.028846154	9	16	EN-PYR	31	7	7
TAGTTGGCAAATACAG-1_2_B9	32.49238587	-8.28399958	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2898	5970	0.009882747	0.01038526	9	2	EN-L4	31	7	7
TAGTTGGGTCTAGCCG-1_2_B9	36.42672433	10.60934535	14	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	776	1089	0.008264463	0.019283747	9	14	Microglia	31	7	7
TAGTTGGTCCTAGTGA-1_2_B9	-22.41865536	7.727838469	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1133	1692	0.013593381	0.008865248	9	8	Astrocytes	31	7	7
TAGTTGGTCCTCGCAT-1_2_B9	-4.212003398	-33.31488766	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	731	1004	0.107569721	0.023904382	9	16	EN-PYR	31	7	7
TAGTTGGTCGGCTACG-1_2_B9	34.54092494	-16.53515933	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3807	8024	0.022058824	0.017696909	9	2	EN-L4	31	7	7
TATCAGGAGTTGCAGG-1_2_B9	-30.50076572	-7.277231782	9	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1036	1473	0.00610998	0.016293279	9	9	OPC	31	7	7
TATCAGGCAAACCTAC-1_2_B9	34.08924557	7.611077739	14	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	910	1289	0.034134988	0.010085337	9	14	Microglia	31	7	7
TATCAGGCACCATCCT-1_2_B9	26.95391949	-16.88697894	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4942	13415	0.028997391	0.006112561	9	2	EN-L4	31	7	7
TATCAGGGTAGCTGCC-1_2_B9	-3.961026613	-35.53145992	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	830	1168	0.085616438	0.022260274	9	16	EN-PYR	31	7	7
TATCAGGGTGATGTCT-1_2_B9	10.86020818	-14.78215447	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3296	6566	0.006853488	0.012183978	9	L2-3	EN-L2-3-MS	31	7	7
TATCAGGGTGCGAAAC-1_2_B9	-22.8445789	-8.295892697	9	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1447	2156	0.014842301	0.012059369	9	9	OPC	31	7	7
TATCTCAAGACGACGT-1_2_B9	27.92700408	-18.09047116	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	5415	15021	0.04420478	0.009919446	9	2	EN-L4	31	7	7
TATCTCACAACACCCG-1_2_B9	-16.8071494	17.82208527	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1771	2948	0.026797829	0.011533243	9	8	Astrocytes	31	7	7
TATCTCACATACGCTA-1_2_B9	10.532891	-14.77783159	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3030	6049	0.014547859	0.012729377	9	L2-3	EN-L2-3-MS	31	7	7
TATCTCACATTGGGCC-1_2_B9	-16.38029152	12.07435949	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1153	1781	0.019090399	0.010106682	9	8	Astrocytes	31	7	7
TATCTCAGTCTAGTGT-1_2_B9	-17.99580221	19.09685867	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1327	2318	0.006902502	0.008196721	9	8	Astrocytes	31	7	7
TATCTCATCGGTCCGA-1_2_B9	10.00079448	-13.22439487	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2591	4714	0.011879508	0.014637251	9	L2-3	EN-L2-3-MS	31	7	7
TATGCCCAGATGCCAG-1_2_B9	33.82178227	8.231978727	14	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1699	2594	0.079028527	0.017347726	9	14	Microglia	31	7	7
TATGCCCGTCCAGTAT-1_2_B9	11.65204607	-12.74173887	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3040	5853	0.021185717	0.01469332	9	L2-3	EN-L2-3-MS	31	7	7
TATGCCCGTCCGAAGA-1_2_B9	-11.28042263	-27.38541436	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	997	1451	0.124052378	0.015161957	9	16	EN-PYR	31	7	7
TATGCCCGTTCCAACA-1_2_B9	-5.778973357	2.702186935	11	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3154	6197	0.005486526	0.006616105	9	11	Glia-MIX	31	7	7
TATGCCCTCTATCGCC-1_2_B9	-24.38372812	-18.20444274	6B	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3242	8010	0.006491885	0.005992509	9	6B	IN-SST	31	7	7
TATTACCAGAAGGGTA-1_2_B9	-29.71829945	-2.626992783	9	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1362	2307	0.019939315	0.006068487	9	9	OPC	31	7	7
TATTACCAGGGCTTGA-1_2_B9	30.06122544	-13.19694635	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3791	8197	0.019031353	0.010979627	9	2	EN-L4	31	7	7
TATTACCAGTGTCCCG-1_2_B9	23.88926777	7.718656961	15A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2189	3635	0.033287483	0.024209078	9	15A	Endo cells	31	7	7
TATTACCCAGACAAAT-1_2_B9	34.87569872	12.00402373	14	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	916	1313	0.01980198	0.010662605	9	14	Microglia	31	7	7
TATTACCCATCTACGA-1_2_B9	-29.58550756	-3.585534931	9	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1271	2037	0.024545901	0.005891016	9	9	OPC	31	7	7
TCAACGAAGTATGACA-1_2_B9	33.93740626	-13.98080195	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3954	8998	0.017003779	0.016781507	9	2	EN-L4	31	7	7
TCAACGAAGTTGAGTA-1_2_B9	11.21394939	-14.73548467	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3286	6228	0.003853565	0.014611432	9	L2-3	EN-L2-3-MS	31	7	7
TCAACGACAGACGTAG-1_2_B9	-7.602713074	-38.4984263	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1138	1771	0.126482213	0.030491248	9	16	EN-PYR	31	7	7
TCAATCTCAAAGAATC-1_2_B9	-26.6730575	-22.40642896	6A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3552	8149	0.037673334	0.008221868	9	6A	IN-PV	31	7	7
TCAATCTGTAGGACAC-1_2_B9	25.82233393	5.313733017	15A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1185	1739	0.051178838	0.010925819	9	15A	Endo cells	31	7	7
TCAATCTGTGTGAATA-1_2_B9	34.09815237	-14.11036478	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3309	6685	0.016305161	0.010770381	9	2	EN-L4	31	7	7
TCACAAGAGCTGCCCA-1_2_B9	-15.73689671	7.905781275	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1128	1634	0.034883721	0.010403917	9	8	Astrocytes	31	7	7
TCACAAGAGTCATGCT-1_2_B9	-24.40083649	-19.76022618	6A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2574	5159	0.039930219	0.005427408	9	6A	IN-PV	31	7	7
TCACAAGCATCCTTGC-1_2_B9	12.22167123	-23.92814081	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	5623	17661	0.002378121	0.006171791	9	L2-3	EN-L2-3-MS	31	7	7
TCACAAGGTATATGAG-1_2_B9	-18.54923664	-1.566974521	13A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3039	5516	0.022298767	0.019035533	9	13A	IN-VIP	31	7	7
TCACAAGGTTCAACCA-1_2_B9	14.72050301	-14.50701937	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	5092	13666	0.01463486	0.012732328	9	L2-3	EN-L2-3-MS	31	7	7
TCACGAAAGAATTCCC-1_2_B9	-17.35026192	18.1214275	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1880	3406	0.00616559	0.009395185	9	8	Astrocytes	31	7	7
TCACGAACATAGACTC-1_2_B9	-29.30710883	-2.055703469	9	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1683	2858	0.014345696	0.006298111	9	9	OPC	31	7	7
TCACGAATCAGGCGAA-1_2_B9	-4.460688551	-35.19913937	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	894	1268	0.081230284	0.018138801	9	16	EN-PYR	31	7	7
TCAGATGAGGATTCGG-1_2_B9	-17.59729571	-7.055620195	13B	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2474	4462	0.024428507	0.005378754	9	13B	IN-SV2C	31	7	7
TCAGATGAGTCTCAAC-1_2_B9	31.47623604	-19.11454057	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4689	10892	0.025339699	0.02368711	9	2	EN-L4	31	7	7
TCAGATGGTCTCGTTC-1_2_B9	15.45398233	-13.20088293	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4196	9899	0.025457117	0.010102031	9	L2-3	EN-L2-3-MS	31	7	7
TCAGATGGTGAGGCTA-1_2_B9	24.6951341	-16.93140024	3	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	5031	13304	0.034425737	0.011199639	9	3	EN-L5-6	31	7	7
TCAGATGTCGGCGCAT-1_2_B9	-0.107517236	27.77736021	1	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	848	1188	0.035353535	0.006734007	9	oligos	OL-Cntl	31	7	7
TCAGCAACACAGACTT-1_2_B9	-24.1351555	-19.23823124	6A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4087	10257	0.027493419	0.009456956	9	6A	IN-PV	31	7	7
TCAGCAACATTTGCCC-1_2_B9	19.20416545	-14.0824213	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	6124	19480	0.025308008	0.014887064	9	2	EN-L4	31	7	7
TCAGCAAGTAATCACC-1_2_B9	34.71289094	13.02305796	14	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1174	1651	0.021199273	0.023016354	9	14	Microglia	31	7	7
TCAGCAAGTCTCTCTG-1_2_B9	14.76428942	-14.53733122	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4918	13684	0.022361882	0.007819351	9	L2-3	EN-L2-3-MS	31	7	7
TCAGCAAGTGTGGCTC-1_2_B9	-4.232930928	-30.7359618	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	690	1092	0.186813187	0.015567766	9	16	EN-PYR	31	7	7
TCAGCTCAGCTCCTCT-1_2_B9	34.75245369	-12.41291223	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3680	8391	0.004647837	0.016803718	9	2	EN-L4	31	7	7
TCAGCTCAGTCAAGGC-1_2_B9	33.68923649	-16.44693852	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	5204	14877	0.011158164	0.019493177	9	2	EN-L4	31	7	7
TCAGCTCGTTCGTTGA-1_2_B9	-18.10066485	23.6570433	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1376	2241	0.015618028	0.008478358	9	8	Astrocytes	31	7	7
TCAGGATAGACAGACC-1_2_B9	-16.22830825	10.36592524	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1218	1936	0.022210744	0.006714876	9	8	Astrocytes	31	7	7
TCAGGATCAATCTACG-1_2_B9	24.8080102	8.207790137	15A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2319	4207	0.024245305	0.017352032	9	15A	Endo cells	31	7	7
TCAGGATGTTGACGTT-1_2_B9	7.356696869	-10.96991577	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1776	2844	0.020745429	0.01371308	9	L2-3	EN-L2-3-MS	31	7	7
TCAGGATTCAAACCGT-1_2_B9	34.16203895	-15.80874587	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3260	6323	0.015657125	0.020243555	9	2	EN-L4	31	7	7
TCAGGATTCCGCAAGC-1_2_B9	23.23423136	-15.944512	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	6013	18050	0.027922438	0.023213296	9	2	EN-L4	31	7	7
TCAGGTACATGCTAGT-1_2_B9	30.99362148	-18.19903269	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	5289	14641	0.022061335	0.018851171	9	2	EN-L4	31	7	7
TCATTACAGTGCCAGA-1_2_B9	-27.36686381	-12.58385879	9	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	839	1171	0.015371477	0.011101623	9	9	OPC	31	7	7
TCATTACAGTTAACGA-1_2_B9	-13.04054583	7.29949059	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1746	2662	0.058602554	0.015026296	9	8	Astrocytes	31	7	7
TCATTACGTACAGCAG-1_2_B9	-17.07042535	17.68721055	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1476	2431	0.004524887	0.012340601	9	8	Astrocytes	31	7	7
TCATTACTCTGCGGCA-1_2_B9	30.59096704	-19.07864344	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	5919	16172	0.025970814	0.019787287	9	2	EN-L4	31	7	7
TCATTACTCTTACCGC-1_2_B9	19.12773995	-15.6854038	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	6652	23213	0.027570758	0.006935769	9	L2-3	EN-L2-3-MS	31	7	7
TCATTTGGTGGTTTCA-1_2_B9	34.51376189	-6.438276603	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4006	10554	0.018571158	0.003695281	9	2	EN-L4	31	7	7
TCATTTGTCGGAGCAA-1_2_B9	18.62527125	-13.67311466	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	6172	18399	0.035980216	0.014239904	9	L2-3	EN-L2-3-MS	31	7	7
TCCACACAGTTGCAGG-1_2_B9	-29.20769536	-3.186327737	9	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1396	2198	0.011373976	0.009099181	9	9	OPC	31	7	7
TCCACACTCCTTGCCA-1_2_B9	30.02867752	-7.854468728	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	5777	19604	0.00316262	0.00515201	9	2	EN-L4	31	7	7
TCCACACTCGAACTGT-1_2_B9	-28.31794011	-4.347217986	9	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1204	1771	0.014680971	0.007905138	9	9	OPC	31	7	7
TCCCGATAGAGTCTGG-1_2_B9	29.33373733	6.36211991	15A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1032	1431	0.059399022	0.05870021	9	15A	Endo cells	31	7	7
TCCCGATAGCTAGTCT-1_2_B9	-11.59655273	-27.38438942	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	926	1384	0.096820809	0.01300578	9	16	EN-PYR	31	7	7
TCCCGATAGTACGACG-1_2_B9	-23.45095976	-9.592890555	9	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1180	1615	0.030959752	0.005572755	9	9	OPC	31	7	7
TCCCGATGTAGATTAG-1_2_B9	11.42015468	-15.68745824	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3692	7809	0.00973236	0.011525163	9	L2-3	EN-L2-3-MS	31	7	7
TCCCGATTCCGCATCT-1_2_B9	34.69368295	-16.41445085	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4151	9313	0.017502416	0.0180393	9	2	EN-L4	31	7	7
TCGAGGCCAGGCTCAC-1_2_B9	31.47381905	-18.7078386	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4987	12220	0.022831424	0.01898527	9	2	EN-L4	31	7	7
TCGAGGCCATGACATC-1_2_B9	-19.59413281	17.22100172	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1458	2415	0.00952381	0.002070393	9	8	Astrocytes	31	7	7
TCGAGGCGTAGGCATG-1_2_B9	-23.99066287	10.76883128	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1035	1646	0.014580802	0.006682868	9	8	Astrocytes	31	7	7
TCGAGGCTCAAACAAG-1_2_B9	-17.56201389	16.93104556	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1399	2245	0.030734967	0.011135857	9	8	Astrocytes	31	7	7
TCGAGGCTCCCTTGCA-1_2_B9	-16.62349919	6.334347451	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	801	1099	0.038216561	0.01455869	9	8	Astrocytes	31	7	7
TCGCGAGAGGCTAGCA-1_2_B9	27.64992815	8.820796095	15A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	881	1196	0.0409699	0.063545151	9	15A	Endo cells	31	7	7
TCGCGAGAGGTGCAAC-1_2_B9	-7.54080448	-38.3214278	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1123	1705	0.068621701	0.013489736	9	16	EN-PYR	31	7	7
TCGCGAGCACATTAGC-1_2_B9	37.4913185	-9.656301557	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2686	5268	0.012338648	0.003606682	9	2	EN-L4	31	7	7
TCGCGAGCATTGCGGC-1_2_B9	-11.87894431	-5.604837754	13A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1662	2506	0.014764565	0.049481245	9	13A	IN-VIP	31	7	7
TCGCGTTCAACTTGAC-1_2_B9	-4.426746699	-34.69971084	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	752	1093	0.104300091	0.010064044	9	16	EN-PYR	31	7	7
TCGCGTTCATGCATGT-1_2_B9	12.48766135	-13.18493625	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3438	7164	0.020379676	0.015354551	9	L2-3	EN-L2-3-MS	31	7	7
TCGCGTTGTTTCGCTC-1_2_B9	11.8490268	-13.57566972	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3216	6317	0.022162419	0.01535539	9	L2-3	EN-L2-3-MS	31	7	7
TCGGGACAGCCACCTG-1_2_B9	-27.65042983	-21.62644024	6A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3523	7649	0.037913453	0.008890051	9	6A	IN-PV	31	7	7
TCGGGACGTCCCGACA-1_2_B9	14.62136769	-15.7602154	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	6008	17154	0.011542497	0.013699429	9	L2-3	EN-L2-3-MS	31	7	7
TCGGGACGTTCCAACA-1_2_B9	-18.77135181	7.772806928	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	899	1260	0.015873016	0.007142857	9	8	Astrocytes	31	7	7
TCGGGACTCGTCTGAA-1_2_B9	-27.21720317	-0.683609514	9	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1513	2495	0.003607214	0.016432866	9	9	OPC	31	7	7
TCGGGACTCTAACTGG-1_2_B9	-15.80373291	9.11169274	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1282	1858	0.01022605	0.013455328	9	8	Astrocytes	31	7	7
TCGGTAACAAGTCTGT-1_2_B9	28.00018439	7.442828345	15BA	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1450	1948	0.019507187	0.023100616	9	15BA	Stromal cells	31	7	7
TCGGTAACAGGGTATG-1_2_B9	-18.5507336	19.53952266	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1745	2850	0.012280702	0.007368421	9	8	Astrocytes	31	7	7
TCGTACCAGTGGTAGC-1_2_B9	-13.24383637	16.58582448	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1537	2550	0.010588235	0.010588235	9	8	Astrocytes	31	7	7
TCGTACCCATGAACCT-1_2_B9	-16.8363918	-14.7270205	6B	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1628	2537	0.056365786	0.007094994	9	6B	IN-SST	31	7	7
TCGTACCGTACAGCAG-1_2_B9	-9.189969442	-38.46565387	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1405	2346	0.141517477	0.02344416	9	16	EN-PYR	31	7	7
TCGTACCTCTCTGAGA-1_2_B9	25.72354002	8.637500494	15A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1731	2636	0.032245827	0.032245827	9	15A	Endo cells	31	7	7
TCGTAGAAGACCTTTG-1_2_B9	36.6749918	14.45504299	14	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1054	1431	0.007686932	0.018867925	9	14	Microglia	31	7	7
TCGTAGAAGTGTTAGA-1_2_B9	-5.723954442	-34.22337555	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	996	1499	0.121414276	0.012008005	9	16	EN-PYR	31	7	7
TCGTAGACAACTGCTA-1_2_B9	20.42807467	-17.39059053	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	6543	22624	0.017680339	0.013437058	9	L2-3	EN-L2-3-MS	31	7	7
TCGTAGACATTAGCCA-1_2_B9	-15.57557092	12.56362956	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1365	2272	0.020246479	0.004841549	9	8	Astrocytes	31	7	7
TCGTAGAGTCGGCACT-1_2_B9	27.47449821	-18.95427759	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3061	6336	0.0625	0.011994949	9	2	EN-L4	31	7	7
TCTATTGGTGAGGCTA-1_2_B9	7.714316958	1.275406916	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	824	1094	0.042047532	0.02833638	9	16	EN-PYR	31	7	7
TCTCATAAGAAACCGC-1_2_B9	34.55795949	-14.42780044	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4032	9215	0.006836679	0.017471514	9	2	EN-L4	31	7	7
TCTCATAGTACCCAAT-1_2_B9	23.79973983	7.717870105	15A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2610	4763	0.017635944	0.034222129	9	15A	Endo cells	31	7	7
TCTCATATCTCGCATC-1_2_B9	34.7998105	12.39871035	14	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1058	1533	0.030658839	0.01826484	9	14	Microglia	31	7	7
TCTCTAAGTTCTCATT-1_2_B9	-15.19504379	-34.68710582	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2361	4641	0.127343245	0.013790131	9	16	EN-PYR	31	7	7
TCTGAGAAGCACACAG-1_2_B9	-18.47164742	23.79591637	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1598	2753	0.011260443	0.009444243	9	8	Astrocytes	31	7	7
TCTGAGAAGTCGCCGT-1_2_B9	24.73488654	-13.80985114	3	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4138	9070	0.018632856	0.012899669	9	3	EN-L5-6	31	7	7
TCTGAGACATATGGTC-1_2_B9	10.08566887	-4.000132026	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1948	3162	0.012966477	0.028779254	9	2	EN-L4	31	7	7
TCTGAGAGTCATCCCT-1_2_B9	-25.11144562	-18.04895274	6B	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2589	5693	0.01914632	0.007904444	9	6B	IN-SST	31	7	7
TCTGAGAGTGACTACT-1_2_B9	21.93101444	-14.66696084	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3186	6046	0.049288786	0.018524644	9	2	EN-L4	31	7	7
TCTGAGAGTGCATCTA-1_2_B9	-27.10235377	-22.57765715	6A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4214	10337	0.03656767	0.008803328	9	6A	IN-PV	31	7	7
TCTGAGAGTGTAATGA-1_2_B9	31.52311655	-17.67110376	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	5736	16159	0.022402376	0.013738474	9	2	EN-L4	31	7	7
TCTGAGATCATATCGG-1_2_B9	-17.45713772	17.26553933	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1358	2382	0.008396306	0.007556675	9	8	Astrocytes	31	7	7
TCTGAGATCGCGTTTC-1_2_B9	29.52858318	14.59325735	14	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1275	1975	0.036962025	0.077468354	9	14	Microglia	31	7	7
TCTGGAACACATGTGT-1_2_B9	10.15295933	-28.00273299	10	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	6736	25935	0.001465201	0.004549836	9	L2-3	EN-L2-3-Cntl	31	7	7
TCTGGAACAGATCTGT-1_2_B9	-28.20874216	-4.710015848	9	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1198	1748	0.007437071	0.018306636	9	9	OPC	31	7	7
TCTGGAAGTCTCCCTA-1_2_B9	-16.06439483	-0.004115487	13A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3522	7208	0.018590455	0.00818535	9	13A	IN-VIP	31	7	7
TCTGGAAGTCTCTCTG-1_2_B9	-33.75640561	5.091979864	9	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2562	5584	0.008954155	0.004118911	9	9	OPC	31	7	7
TCTGGAAGTGGGTATG-1_2_B9	-15.878612	8.840242814	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1116	1681	0.021415824	0.012492564	9	8	Astrocytes	31	7	7
TCTGGAATCCCTAACC-1_2_B9	-26.14069207	-17.66548151	6A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4433	10900	0.022844037	0.014495413	9	6A	IN-PV	31	7	7
TCTTTCCAGACCACGA-1_2_B9	8.549201581	-19.83413064	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4094	9213	0.014436123	0.013025073	9	L2-3	EN-L2-3-MS	31	7	7
TCTTTCCGTCATGCAT-1_2_B9	12.07731633	-15.9964292	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3811	10152	0.040484634	0.00462963	9	L2-3	EN-L2-3-MS	31	7	7
TCTTTCCTCAACACGT-1_2_B9	36.260106	14.29783878	14	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1133	1595	0.010658307	0.017554859	9	14	Microglia	31	7	7
TCTTTCCTCACCCTCA-1_2_B9	8.141444994	3.294348238	17	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	837	1044	0.019157088	0.017241379	9	oligos	OL-MS-2	31	7	7
TCTTTCCTCCAAGTAC-1_2_B9	-21.03036892	-27.51140102	6A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2869	6065	0.007749382	0.00362737	9	6A	IN-PV	31	7	7
TCTTTCCTCTCCAACC-1_2_B9	-13.21068379	16.63144076	11	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1407	2219	0.006759802	0.009463722	9	11	Glia-MIX	31	7	7
TGAAAGACACATTTCT-1_2_B9	-8.564834224	-38.31231765	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1285	1962	0.126911315	0.023955148	9	16	EN-PYR	31	7	7
TGAAAGACACTTCTGC-1_2_B9	-16.80058277	-15.07181114	6B	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1739	3020	0.044370861	0.005298013	9	6B	IN-SST	31	7	7
TGAAAGATCATTCACT-1_2_B9	33.95490215	-18.69725332	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4269	9558	0.012764177	0.026469973	9	2	EN-L4	31	7	7
TGACAACTCGCTTAGA-1_2_B9	-7.822200263	-10.91680253	6B	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	787	1130	0.053097345	0.023893805	9	6B	IN-SST	31	7	7
TGACGGCGTCTCTCGT-1_2_B9	17.21031656	-13.27053793	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	5378	14233	0.024731258	0.011873814	9	L2-3	EN-L2-3-MS	31	7	7
TGACTAGAGTCCTCCT-1_2_B9	10.05548029	-24.43176469	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4794	14766	0.001625356	0.00860084	9	L2-3	EN-L2-3-MS	31	7	7
TGACTAGAGTTAACGA-1_2_B9	15.11828798	-14.40182032	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	5149	13734	0.02220766	0.010339304	9	L2-3	EN-L2-3-MS	31	7	7
TGACTAGCATCATCCC-1_2_B9	21.94283996	-20.6667622	3	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	5311	17282	0.018516375	0.008679551	9	3	EN-L5-6	31	7	7
TGACTAGGTTCGCGAC-1_2_B9	24.97866058	-15.57028005	3	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3724	7770	0.017631918	0.015315315	9	3	EN-L5-6	31	7	7
TGACTAGTCAGTGCAT-1_2_B9	-18.55850073	-6.254314879	13B	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2871	5289	0.017772736	0.012478729	9	13B	IN-SV2C	31	7	7
TGACTTTAGTGGTAAT-1_2_B9	-13.27560509	-37.83233978	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1781	3026	0.04494382	0.018836748	9	16	EN-PYR	31	7	7
TGACTTTGTACCAGTT-1_2_B9	32.73519742	8.561074235	14	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	859	1092	0.0503663	0.013736264	9	14	Microglia	31	7	7
TGACTTTGTGACTCAT-1_2_B9	-3.867801007	-35.30385214	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	905	1262	0.121236133	0.020602219	9	16	EN-PYR	31	7	7
TGACTTTTCAACACAC-1_2_B9	-13.95039334	-16.24771117	6B	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1351	2238	0.03976765	0.004468275	9	6B	IN-SST	31	7	7
TGAGAGGAGTGCGTGA-1_2_B9	7.47833239	1.445977322	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	886	1278	0.098591549	0.019561815	9	16	EN-PYR	31	7	7
TGAGAGGTCCATGAGT-1_2_B9	-16.58143516	-3.9626845	13A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2838	5146	0.016712009	0.011076564	9	13A	IN-VIP	31	7	7
TGAGAGGTCGTACGGC-1_2_B9	33.63993387	7.672091581	14	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	830	1086	0.035911602	0.008287293	9	14	Microglia	31	7	7
TGAGCATAGGTCATCT-1_2_B9	5.553720259	-2.163069584	12	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	829	1100	0.02	0.004545455	9	12	EN-MIX	31	7	7
TGAGCATGTGTGCCTG-1_2_B9	11.74644873	-13.18013402	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3054	5936	0.008591644	0.010950135	9	L2-3	EN-L2-3-MS	31	7	7
TGAGCATGTTCCCGAG-1_2_B9	-25.62582893	8.750776826	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	876	1285	0.010894942	0.007003891	9	8	Astrocytes	31	7	7
TGAGCATTCAAACCGT-1_2_B9	-29.27768229	-3.87336034	9	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1320	2006	0.017447657	0.015453639	9	9	OPC	31	7	7
TGAGCATTCAGTCAGT-1_2_B9	-11.42901659	16.95080163	11	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1733	2929	0.009218163	0.008193923	9	11	Glia-MIX	31	7	7
TGAGCATTCCCTGACT-1_2_B9	24.71468432	7.334014447	15A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2140	3481	0.053432922	0.012352772	9	15A	Endo cells	31	7	7
TGAGCATTCGAATGGG-1_2_B9	15.20600187	-13.01064493	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4214	9803	0.031112925	0.014587371	9	L2-3	EN-L2-3-MS	31	7	7
TGAGCCGCAGGGCATA-1_2_B9	37.46683422	-9.747646772	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3014	6020	0.005980066	0.009468439	9	2	EN-L4	31	7	7
TGAGCCGCAGTAGAGC-1_2_B9	-2.662746622	-35.18328817	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	751	1055	0.134597156	0.052132701	9	16	EN-PYR	31	7	7
TGAGGGAAGAATGTGT-1_2_B9	20.82372645	-2.811786135	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1769	2952	0.041666667	0.005758808	9	2	EN-L4	31	7	7
TGAGGGAAGTGACTCT-1_2_B9	31.44084917	-19.26326481	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4729	11438	0.017573002	0.032260885	9	2	EN-L4	31	7	7
TGAGGGACAGTACACT-1_2_B9	-14.61474526	-5.043385287	13A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2394	4365	0.021764032	0.007789233	9	13A	IN-VIP	31	7	7
TGAGGGATCCAGAAGG-1_2_B9	-14.39480977	-14.84058109	6B	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1278	2064	0.014534884	0.014050388	9	6B	IN-SST	31	7	7
TGAGGGATCTCAACTT-1_2_B9	-17.84664681	5.455850032	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	735	1001	0.022977023	0.013986014	9	8	Astrocytes	31	7	7
TGATTTCCACTACAGT-1_2_B9	-26.74521406	-22.86929169	6A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3640	8041	0.005845044	0.012311902	9	6A	IN-PV	31	7	7
TGATTTCGTCTCACCT-1_2_B9	13.35244128	11.3810302	1	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1368	2063	0.011633543	0.011633543	9	oligos	OL-Cntl	31	7	7
TGATTTCGTGTCAATC-1_2_B9	17.10871312	-13.20597866	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4465	10264	0.01627046	0.02045986	9	L2-3	EN-L2-3-MS	31	7	7
TGATTTCGTTCCTCCA-1_2_B9	-19.42333315	-7.357054199	13B	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3813	8836	0.008488004	0.007808963	9	13B	IN-SV2C	31	7	7
TGATTTCTCTCTAAGG-1_2_B9	18.72417634	-13.64433487	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	5563	18039	0.02494595	0.016630634	9	L2-3	EN-L2-3-MS	31	7	7
TGCACCTAGTGTACTC-1_2_B9	25.54798154	-16.18748266	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	8034	32847	0.049715347	0.015496088	9	2	EN-L4	31	7	7
TGCACCTCAATCCAAC-1_2_B9	-12.24077496	11.58400112	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	892	1175	0.040851064	0.009361702	9	8	Astrocytes	31	7	7
TGCACCTGTAGCTGCC-1_2_B9	17.31417269	-15.08631355	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	7027	24768	0.016392119	0.009286176	9	L2-3	EN-L2-3-MS	31	7	7
TGCACCTGTCTTCTCG-1_2_B9	-24.3461071	-25.02705189	6A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4191	10150	0.010049261	0.005517241	9	6A	IN-PV	31	7	7
TGCCAAACAAGCTGTT-1_2_B9	-29.44620427	-4.429696737	9	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1236	1773	0.010152284	0.002820079	9	9	OPC	31	7	7
TGCCAAACAATCTACG-1_2_B9	-3.516295684	-35.40436242	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1020	1538	0.124837451	0.031859558	9	16	EN-PYR	31	7	7
TGCCAAAGTAAGGGCT-1_2_B9	-15.6109792	9.582606376	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1867	3283	0.00548279	0.011879379	9	8	Astrocytes	31	7	7
TGCCAAAGTACGAAAT-1_2_B9	35.90076963	13.53103235	14	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1198	1721	0.012783266	0.016269611	9	14	Microglia	31	7	7
TGCCAAATCCATGAAC-1_2_B9	25.32222636	7.850292856	15A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1932	3036	0.059288538	0.027338603	9	15A	Endo cells	31	7	7
TGCCAAATCGCCGTGA-1_2_B9	33.75649088	-16.65510828	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4016	8987	0.016802047	0.015911873	9	2	EN-L4	31	7	7
TGCCCATAGCGCCTCA-1_2_B9	-7.790010229	-38.74390666	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1089	1525	0.066229508	0.011147541	9	16	EN-PYR	31	7	7
TGCCCATCACCAGTTA-1_2_B9	13.17431924	-12.75144043	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3954	8297	0.016270941	0.018560926	9	L2-3	EN-L2-3-MS	31	7	7
TGCCCATCATGCAACT-1_2_B9	18.13604966	-24.40961563	3	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	5112	14310	0.003843466	0.022781272	9	3	EN-L5-6	31	7	7
TGCCCATCATTGGTAC-1_2_B9	8.851543622	-14.64997009	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2633	5033	0.014106894	0.008344924	9	L2-3	EN-L2-3-MS	31	7	7
TGCCCATGTCTAGGTT-1_2_B9	-18.14368113	-1.572544589	13A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2974	5281	0.020829388	0.01969324	9	13A	IN-VIP	31	7	7
TGCCCATTCAATCACG-1_2_B9	-17.05192166	17.21861934	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1446	2312	0.011678201	0.009515571	9	8	Astrocytes	31	7	7
TGCCCTAAGACTGTAA-1_2_B9	28.60158732	-13.70065685	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	6059	18797	0.029100388	0.008458797	9	2	EN-L4	31	7	7
TGCGCAGAGAGTACCG-1_2_B9	10.38825834	-14.53631211	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3199	6480	0.017283951	0.016203704	9	L2-3	EN-L2-3-MS	31	7	7
TGCGCAGAGTACGCCC-1_2_B9	-18.3858663	-9.706273816	13B	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3474	7086	0.003669207	0.009878634	9	13B	IN-SV2C	31	7	7
TGCGCAGCAGACTCGC-1_2_B9	18.9074307	-13.73011598	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	6768	22883	0.033736835	0.022374689	9	2	EN-L4	31	7	7
TGCGCAGGTGAGGGTT-1_2_B9	21.57066014	-3.029107917	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2103	3617	0.026541333	0.006635333	9	2	EN-L4	31	7	7
TGCGCAGTCCCAGGTG-1_2_B9	27.63037506	-12.29646293	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3895	8804	0.012153567	0.007269423	9	2	EN-L4	31	7	7
TGCGGGTAGAGACTAT-1_2_B9	-17.21618793	17.7450726	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1811	3222	0.012414649	0.006828057	9	8	Astrocytes	31	7	7
TGCGGGTAGAGTCGGT-1_2_B9	-6.493316386	-37.20614944	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1034	1586	0.114754098	0.021437579	9	16	EN-PYR	31	7	7
TGCGGGTAGTCATGCT-1_2_B9	-19.13585343	0.106261447	13A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4074	8339	0.026022305	0.018107687	9	13A	IN-VIP	31	7	7
TGCGGGTCACGACGAA-1_2_B9	-19.2053957	-5.385883049	13A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3257	6396	0.011726079	0.014227642	9	13A	IN-VIP	31	7	7
TGCGGGTGTAGCCTCG-1_2_B9	11.61439941	-15.77746237	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3709	7843	0.007267627	0.007522632	9	L2-3	EN-L2-3-MS	31	7	7
TGCGGGTTCCCATTAT-1_2_B9	-10.42979284	-13.61343461	6B	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1409	2323	0.12699096	0.007318123	9	6B	IN-SST	31	7	7
TGCGTGGCACTGTGTA-1_2_B9	10.08529175	-0.875705893	12	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1245	1844	0.036876356	0.009761388	9	12	EN-MIX	31	7	7
TGCGTGGGTTCGCGAC-1_2_B9	14.08109681	-22.88006899	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	5459	15894	0.00931169	0.005410847	9	L2-3	EN-L2-3-MS	31	7	7
TGCGTGGTCGAGAGCA-1_2_B9	-3.867716909	-35.5273539	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	831	1128	0.045212766	0.020390071	9	16	EN-PYR	31	7	7
TGCTACCAGGCTACGA-1_2_B9	-16.72764203	6.22993389	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1007	1479	0.020960108	0.018931711	9	8	Astrocytes	31	7	7
TGCTACCCACATCTTT-1_2_B9	34.74089432	-16.44065338	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4627	10897	0.016334771	0.017986602	9	2	EN-L4	31	7	7
TGCTGCTAGCCGCCTA-1_2_B9	-4.845410477	-33.80814775	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	874	1195	0.085355649	0.020920502	9	16	EN-PYR	31	7	7
TGCTGCTAGCGATAGC-1_2_B9	-5.524166483	-37.21723413	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1076	1639	0.128737035	0.025015253	9	16	EN-PYR	31	7	7
TGCTGCTCATTGCGGC-1_2_B9	-17.35287867	-16.08159074	6B	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1925	3369	0.016028495	0.010092015	9	6B	IN-SST	31	7	7
TGCTGCTGTAAACCTC-1_2_B9	17.10176719	-14.38465672	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	6571	20835	0.02025438	0.010991121	9	L2-3	EN-L2-3-MS	31	7	7
TGCTGCTGTATAAACG-1_2_B9	-18.06973259	8.575507569	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	937	1372	0.020408163	0.008017493	9	8	Astrocytes	31	7	7
TGCTGCTGTCGGATCC-1_2_B9	9.652968957	-11.5119792	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2391	4139	0.031891761	0.012080213	9	L2-3	EN-L2-3-MS	31	7	7
TGGACGCAGAAACCGC-1_2_B9	13.48653464	-14.78066164	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4564	10976	0.017219388	0.014030612	9	L2-3	EN-L2-3-MS	31	7	7
TGGCCAGAGAAGAAGC-1_2_B9	-7.872146327	-38.55086596	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1151	1629	0.063842848	0.016574586	9	16	EN-PYR	31	7	7
TGGCCAGAGACCTAGG-1_2_B9	-11.62939439	-27.37097791	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1030	1566	0.131545338	0.010855683	9	16	EN-PYR	31	7	7
TGGCCAGCATAAAGGT-1_2_B9	-16.09935189	-0.102730708	13A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3482	6793	0.021787134	0.010599146	9	13A	IN-VIP	31	7	7
TGGCCAGGTAGGAGTC-1_2_B9	-31.27949258	2.670822171	9	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2230	3948	0.005825735	0.007092199	9	9	OPC	31	7	7
TGGCCAGTCCTGCCAT-1_2_B9	-27.105719	-20.2402156	6A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2627	5200	0.119615385	0.004423077	9	6A	IN-PV	31	7	7
TGGCGCAAGGACACCA-1_2_B9	9.58530337	-4.086983357	12	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2141	3539	0.031364792	0.025996044	9	12	EN-MIX	31	7	7
TGGCGCACATGGGAAC-1_2_B9	16.69325354	7.100683788	1	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1877	3116	0.019255456	0.011232349	9	oligos	OL-Cntl	31	7	7
TGGCGCAGTGTCCTCT-1_2_B9	-17.81448463	17.95782543	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1675	2845	0.007029877	0.007381371	9	8	Astrocytes	31	7	7
TGGCGCAGTTCAGCGC-1_2_B9	-11.16488446	28.7190324	17	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1171	1640	0.045121951	0.009146341	9	oligos	OL-MS-2	31	7	7
TGGCGCAGTTTGGCGC-1_2_B9	24.15289132	7.798798358	15A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2022	3134	0.02744097	0.030312699	9	15A	Endo cells	31	7	7
TGGCGCATCAGATAAG-1_2_B9	21.98315992	-15.79363545	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3932	7607	0.020507427	0.022479295	9	2	EN-L4	31	7	7
TGGCGCATCATTTGGG-1_2_B9	-16.90305547	6.360589303	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1003	1507	0.01791639	0.00928998	9	8	Astrocytes	31	7	7
TGGCTGGAGATGCCTT-1_2_B9	-29.5567088	-2.481298363	9	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1479	2360	0.011016949	0.005084746	9	9	OPC	31	7	7
TGGCTGGAGGAGTCTG-1_2_B9	-2.706058064	-34.41897391	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	843	1161	0.080964686	0.015503876	9	16	EN-PYR	31	7	7
TGGCTGGAGTGTACTC-1_2_B9	9.346452169	-2.319994703	12	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1418	2184	0.095238095	0.010989011	9	12	EN-MIX	31	7	7
TGGCTGGCAGAAGCAC-1_2_B9	34.59543909	-17.32371544	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4257	8710	0.016188289	0.018599311	9	2	EN-L4	31	7	7
TGGCTGGGTAGGCATG-1_2_B9	-15.89462781	9.053379923	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1193	1909	0.008381351	0.012572027	9	8	Astrocytes	31	7	7
TGGCTGGTCACAATGC-1_2_B9	4.715273793	5.271875676	7	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1749	2634	0.009491268	0.011009871	9	7	Phagocytes	31	7	7
TGGCTGGTCTTCATGT-1_2_B9	17.09686258	6.846894427	1	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2098	3563	0.012349144	0.009261858	9	oligos	OL-Cntl	31	7	7
TGGGAAGAGCACACAG-1_2_B9	33.33062369	-17.97111519	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3135	5745	0.024543081	0.016884247	9	2	EN-L4	31	7	7
TGGGAAGAGCTCTCGG-1_2_B9	-14.09466285	-14.78912058	6B	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1507	2393	0.047221061	0.006686168	9	6B	IN-SST	31	7	7
TGGGAAGGTGTCGCTG-1_2_B9	-19.90469415	-1.253082832	13A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4507	9921	0.02580385	0.020159258	9	13A	IN-VIP	31	7	7
TGGGAAGTCAGCGACC-1_2_B9	34.57695295	-16.20533993	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3589	7077	0.011586831	0.012434647	9	2	EN-L4	31	7	7
TGGGCGTAGCGATAGC-1_2_B9	36.9949238	14.54488807	14	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1164	1663	0.003006615	0.017438364	9	14	Microglia	31	7	7
TGGGCGTAGCTAGGCA-1_2_B9	34.19089969	-16.39318641	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3612	7336	0.014858233	0.013767721	9	2	EN-L4	31	7	7
TGGGCGTAGTGGTAAT-1_2_B9	6.415204738	-1.514615267	12	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	937	1354	0.007385524	0.022156573	9	12	EN-MIX	31	7	7
TGGGCGTGTGGTACAG-1_2_B9	35.02125496	8.155758542	14	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	870	1202	0.014143095	0.008319468	9	14	Microglia	31	7	7
TGGGCGTTCTCTAGGA-1_2_B9	25.57565063	4.808199365	15A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1031	1757	0.018212863	0.007968127	9	15A	Endo cells	31	7	7
TGGTTAGGTACCAGTT-1_2_B9	32.14526845	-17.35250728	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	5276	13220	0.016414523	0.01172466	9	2	EN-L4	31	7	7
TGGTTAGTCCAAACTG-1_2_B9	7.814088625	-12.64418183	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2156	3716	0.012378902	0.012378902	9	L2-3	EN-L2-3-MS	31	7	7
TGGTTAGTCCAATGGT-1_2_B9	14.27878328	-13.20899008	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4457	10175	0.012383292	0.018673219	9	L2-3	EN-L2-3-MS	31	7	7
TGGTTCCAGTCGTTTG-1_2_B9	-26.92552855	-3.876615015	9	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1581	2405	0.014553015	0.016216216	9	9	OPC	31	7	7
TGGTTCCCAGCATACT-1_2_B9	12.97848941	-12.71636492	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3849	8391	0.015373615	0.021928256	9	L2-3	EN-L2-3-MS	31	7	7
TGGTTCCGTCGGATCC-1_2_B9	24.24801372	-17.4097119	3	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3360	7069	0.035365681	0.014995049	9	3	EN-L5-6	31	7	7
TGGTTCCGTGAGTATA-1_2_B9	-5.384269626	-35.12549154	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	924	1393	0.117731515	0.026561378	9	16	EN-PYR	31	7	7
TGGTTCCGTTAAGGGC-1_2_B9	32.20950564	9.302956832	14	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	743	1016	0.104330709	0.036417323	9	14	Microglia	31	7	7
TGTATTCAGATCCTGT-1_2_B9	-3.606590343	-35.56686472	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	826	1092	0.076007326	0.035714286	9	16	EN-PYR	31	7	7
TGTATTCAGGACACCA-1_2_B9	-15.80790402	8.471941476	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1054	1495	0.014046823	0.021404682	9	8	Astrocytes	31	7	7
TGTATTCAGTTGCAGG-1_2_B9	25.69044999	10.02982691	15A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2307	4045	0.049690977	0.044252163	9	15A	Endo cells	31	7	7
TGTATTCCAATCTGCA-1_2_B9	15.10252685	-14.40232092	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	5969	16430	0.009981741	0.011138162	9	L2-3	EN-L2-3-MS	31	7	7
TGTATTCGTATTACCG-1_2_B9	-18.46212104	-15.52813233	6B	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2000	3474	0.065342545	0.005181347	9	6B	IN-SST	31	7	7
TGTCCCAAGGGCATGT-1_2_B9	-33.88294037	-6.742790037	9	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1067	1634	0.010403917	0.004895961	9	9	OPC	31	7	7
TGTCCCACAGTTCCCT-1_2_B9	-19.21013014	-3.821736867	13B	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2581	4518	0.020362992	0.034971226	9	13B	IN-SV2C	31	7	7
TGTCCCAGTGACTCAT-1_2_B9	-26.57862942	-18.76551651	6B	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2090	3594	0.032554257	0.027824151	9	6B	IN-SST	31	7	7
TGTGGTACAGGTCCAC-1_2_B9	-3.833130639	-34.32124242	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	762	1032	0.129844961	0.009689922	9	16	EN-PYR	31	7	7
TGTGGTAGTCCATCCT-1_2_B9	-4.231376587	-34.63189106	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	724	1233	0.239253852	0.02351987	9	16	EN-PYR	31	7	7
TGTGTTTCACACCGCA-1_2_B9	-17.59249887	-15.33938122	6B	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1972	3452	0.029837775	0.007531866	9	6B	IN-SST	31	7	7
TGTGTTTCACAGAGGT-1_2_B9	18.50420902	-13.59349129	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	5496	14359	0.035239223	0.015391044	9	L2-3	EN-L2-3-MS	31	7	7
TGTGTTTCACATTAGC-1_2_B9	32.07178562	-17.46146454	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4820	11736	0.005538514	0.016615542	9	2	EN-L4	31	7	7
TGTGTTTCACGGCCAT-1_2_B9	14.38393177	-15.62868418	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	6562	21373	0.016375801	0.014504281	9	L2-3	EN-L2-3-MS	31	7	7
TGTGTTTCAGTTCATG-1_2_B9	37.18456136	13.63413091	14	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1071	1542	0.007133593	0.014915694	9	14	Microglia	31	7	7
TGTGTTTTCCTATGTT-1_2_B9	6.696325671	2.105869088	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1202	1707	0.095489162	0.014645577	9	16	EN-PYR	31	7	7
TGTTCCGAGCGTGAAC-1_2_B9	11.09505422	-25.84129517	10	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	6396	21533	0.003111503	0.007337575	9	L2-3	EN-L2-3-Cntl	31	7	7
TGTTCCGCATAAAGGT-1_2_B9	-23.12239092	12.24983719	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1189	1859	0.011296396	0.006455083	9	8	Astrocytes	31	7	7
TGTTCCGGTTTGTTGG-1_2_B9	-12.32413627	-37.69368073	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1651	2921	0.068127354	0.011297501	9	16	EN-PYR	31	7	7
TGTTCCGTCGCATGGC-1_2_B9	-20.23848301	-20.91395159	6B	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1573	2601	0.050365244	0.011918493	9	6B	IN-SST	31	7	7
TTAACTCAGCAGACTG-1_2_B9	-19.3002724	-7.385553305	13B	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3940	9151	0.016173096	0.008305103	9	13B	IN-SV2C	31	7	7
TTAACTCCATACGCCG-1_2_B9	27.06434267	-12.51417729	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	5109	14226	0.019752566	0.01082525	9	L2-3	EN-L2-3-MS	31	7	7
TTAACTCGTCGCGAAA-1_2_B9	11.0937286	-12.44680117	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2844	5462	0.013365068	0.019040644	9	L2-3	EN-L2-3-MS	31	7	7
TTAACTCTCCGTACAA-1_2_B9	-34.50728827	-4.666515138	9	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1294	2172	0.010128913	0.001841621	9	9	OPC	31	7	7
TTAACTCTCGAATGCT-1_2_B9	33.22483173	-12.01634548	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3009	6023	0.010127843	0.006807239	9	2	EN-L4	31	7	7
TTAACTCTCGAATGGG-1_2_B9	9.90888362	-17.80709893	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3237	6701	0.002686166	0.006864647	9	L2-3	EN-L2-3-MS	31	7	7
TTAACTCTCTAGAGTC-1_2_B9	7.836052153	-14.39230444	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2338	4232	0.005434783	0.013468809	9	L2-3	EN-L2-3-MS	31	7	7
TTAACTCTCTCGATGA-1_2_B9	-15.91851553	-21.27063413	6A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1565	2582	0.04415182	0.003872967	9	6A	IN-PV	31	7	7
TTAGGACCACATCCAA-1_2_B9	-16.50873388	-24.5060026	6A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1762	3209	0.025864755	0.003739483	9	6A	IN-PV	31	7	7
TTAGGACGTTCGAATC-1_2_B9	15.79076501	-10.9043232	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2327	4546	0.02441707	0.008358997	9	L2-3	EN-L2-3-MS	31	7	7
TTAGGACTCGAGAACG-1_2_B9	4.62750483	5.197190185	7	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1764	2662	0.00864012	0.012772352	9	7	Phagocytes	31	7	7
TTAGGCACAACGCACC-1_2_B9	34.42221757	-16.92627983	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	5254	14237	0.016506286	0.016576526	9	2	EN-L4	31	7	7
TTATGCTAGACCGGAT-1_2_B9	12.5075817	-21.09427045	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4289	10490	0.011439466	0.004099142	9	L2-3	EN-L2-3-MS	31	7	7
TTATGCTAGACTGTAA-1_2_B9	11.26511315	-12.30662859	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2598	4778	0.028882378	0.012766848	9	L2-3	EN-L2-3-MS	31	7	7
TTATGCTAGTGTACTC-1_2_B9	-10.37200513	-36.52104557	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1223	1867	0.084092126	0.013390466	9	16	EN-PYR	31	7	7
TTATGCTGTAGTAGTA-1_2_B9	27.65613091	8.356315444	15BA	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1588	2389	0.024696526	0.03557974	9	15BA	Stromal cells	31	7	7
TTATGCTGTTCAGGCC-1_2_B9	23.49539877	-23.77379295	3	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3927	10800	0.066481481	0.00212963	9	3	EN-L5-6	31	7	7
TTATGCTTCCCTAACC-1_2_B9	36.69720352	13.55960984	14	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1085	1546	0.01228978	0.014877102	9	14	Microglia	31	7	7
TTATGCTTCGGACAAG-1_2_B9	-33.35313571	-5.46188606	9	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1134	1834	0.0087241	0.003816794	9	9	OPC	31	7	7
TTATGCTTCTCGTTTA-1_2_B9	25.02830674	6.805032137	15A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1595	2589	0.015063731	0.018153727	9	15A	Endo cells	31	7	7
TTCCCAGAGCTCCTTC-1_2_B9	13.94725824	-23.77092903	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	5469	17528	0.005362848	0.004392971	9	L2-3	EN-L2-3-MS	31	7	7
TTCCCAGAGGCATGTG-1_2_B9	31.47601052	-17.64868102	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	6144	18512	0.023606309	0.012802506	9	2	EN-L4	31	7	7
TTCCCAGAGGTGTTAA-1_2_B9	-28.8684626	-4.911788584	9	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1170	1853	0.010253643	0.029681597	9	9	OPC	31	7	7
TTCCCAGGTTAGAACA-1_2_B9	39.14700075	16.1401534	14	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1529	2369	0.010975095	0.007598143	9	14	Microglia	31	7	7
TTCGAAGCACTCGACG-1_2_B9	34.7138955	11.67671096	14	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	908	1238	0.023424879	0.01453958	9	14	Microglia	31	7	7
TTCGAAGCATGATCCA-1_2_B9	-10.84319794	14.28825473	11	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1506	2252	0.019094139	0.012433393	9	11	Glia-MIX	31	7	7
TTCGAAGTCTCCGGTT-1_2_B9	-10.93604884	-37.28483833	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1352	2256	0.117021277	0.016843972	9	16	EN-PYR	31	7	7
TTCGGTCAGGGTTCCC-1_2_B9	20.34622022	-22.81232305	3	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3996	8847	0.002938849	0.015598508	9	3	EN-L5-6	31	7	7
TTCGGTCCAAGAGGCT-1_2_B9	-15.75206217	18.21363305	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1452	2441	0.024170422	0.010241704	9	8	Astrocytes	31	7	7
TTCGGTCTCATGTCCC-1_2_B9	-22.90252654	7.880016515	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1076	1648	0.015169903	0.008495146	9	8	Astrocytes	31	7	7
TTCGGTCTCCTAGTGA-1_2_B9	14.49413548	-12.85415721	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3918	8590	0.016298021	0.020721769	9	L2-3	EN-L2-3-MS	31	7	7
TTCTACAAGTTCGCGC-1_2_B9	11.13137707	-15.9283446	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3690	8198	0.007074896	0.014515736	9	L2-3	EN-L2-3-MS	31	7	7
TTCTACACAAGGTGTG-1_2_B9	2.260098737	6.203388381	7	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1177	1643	0.028606208	0.006086427	9	7	Phagocytes	31	7	7
TTCTACAGTGTAACGG-1_2_B9	-23.52500209	7.469371863	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1016	1430	0.037762238	0.00979021	9	8	Astrocytes	31	7	7
TTCTCAAGTCAGAGGT-1_2_B9	-17.0395139	5.666908725	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	728	1110	0.167567568	0.009009009	9	8	Astrocytes	31	7	7
TTCTCCTCACGCTTTC-1_2_B9	-2.956877158	-34.80952985	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	732	1054	0.151802657	0.034155598	9	16	EN-PYR	31	7	7
TTCTCCTCAGGATTGG-1_2_B9	36.43848337	11.54362401	14	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	806	1172	0.005119454	0.017918089	9	14	Microglia	31	7	7
TTCTCCTGTTGCTCCT-1_2_B9	34.64798602	-16.27704281	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4236	10034	0.005880008	0.01554714	9	2	EN-L4	31	7	7
TTCTCCTTCAGTACGT-1_2_B9	14.77707768	-1.057511296	12	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	850	1297	0.025443331	0.0077101	9	12	EN-MIX	31	7	7
TTCTTAGAGCACAGGT-1_2_B9	-17.72024233	5.818291219	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	777	1040	0.014423077	0.0125	9	8	Astrocytes	31	7	7
TTCTTAGTCACATAGC-1_2_B9	-5.193804041	-33.7120436	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	875	1316	0.137537994	0.01443769	9	16	EN-PYR	31	7	7
TTCTTAGTCACCTTAT-1_2_B9	27.31741636	-12.08576474	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	6118	20983	0.008911976	0.010675309	9	L2-3	EN-L2-3-MS	31	7	7
TTGAACGAGGATCGCA-1_2_B9	13.17320578	-14.48588326	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3996	8410	0.020689655	0.010820452	9	L2-3	EN-L2-3-MS	31	7	7
TTGAACGCAGATAATG-1_2_B9	9.154205069	-10.77239792	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1980	3673	0.016335421	0.016607678	9	L2-3	EN-L2-3-MS	31	7	7
TTGAACGCAGCCAATT-1_2_B9	34.66030619	-15.95231848	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4278	9679	0.008575266	0.016840583	9	2	EN-L4	31	7	7
TTGAACGGTAAGGATT-1_2_B9	27.28767733	8.912628859	15BA	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1228	1891	0.038075093	0.048122686	9	15BA	Stromal cells	31	7	7
TTGAACGTCTGCTGCT-1_2_B9	9.888794971	-14.73281279	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2970	5863	0.010233669	0.009380863	9	L2-3	EN-L2-3-MS	31	7	7
TTGACTTAGTGCCATT-1_2_B9	-22.57151835	-20.24083308	6A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2587	5047	0.028333664	0.0031702	9	6A	IN-PV	31	7	7
TTGACTTTCAGTACGT-1_2_B9	-5.859105504	-35.60276683	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	969	1570	0.158598726	0.015286624	9	16	EN-PYR	31	7	7
TTGACTTTCTGTCCGT-1_2_B9	24.83459785	-13.91368562	3	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	5338	15251	0.013310603	0.011277949	9	3	EN-L5-6	31	7	7
TTGCCGTCAAGCCCAC-1_2_B9	33.32657276	13.34169072	14	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1535	2427	0.022661722	0.021425628	9	14	Microglia	31	7	7
TTGCCGTCACCAGATT-1_2_B9	7.86427552	-13.41786237	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2472	4543	0.018049747	0.00770416	9	L2-3	EN-L2-3-MS	31	7	7
TTGCCGTTCGCTAGCG-1_2_B9	37.05852829	9.177434389	14	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	784	1003	0.015952144	0.010967099	9	14	Microglia	31	7	7
TTGCCGTTCTGGAGCC-1_2_B9	34.31020298	-14.06403314	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3309	6459	0.005573618	0.01192135	9	2	EN-L4	31	7	7
TTGCGTCCAGGGCATA-1_2_B9	-11.63496477	28.40581774	17	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1884	2951	0.066757032	0.012876991	9	oligos	OL-MS-2	31	7	7
TTGGAACCATTGTGCA-1_2_B9	14.79712473	-19.88449082	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4438	10552	0.002179682	0.015163002	9	L2-3	EN-L2-3-MS	31	7	7
TTGGAACTCTCTTATG-1_2_B9	24.64828632	-13.00070396	3	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4856	12161	0.011347751	0.007647397	9	3	EN-L5-6	31	7	7
TTGGCAAAGCAGATCG-1_2_B9	16.61623939	-13.24935493	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4102	8973	0.013150563	0.013039117	9	L2-3	EN-L2-3-MS	31	7	7
TTGGCAAAGGCTAGGT-1_2_B9	-31.96638783	-8.024155963	9	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1102	1787	0.008953553	0.007834359	9	9	OPC	31	7	7
TTGGCAACATTAGGCT-1_2_B9	23.30037275	-16.06334173	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	7466	28503	0.027225204	0.01873487	9	2	EN-L4	31	7	7
TTGTAGGAGAAACCGC-1_2_B9	32.63492196	14.68135069	14	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	966	1283	0.016367888	0.058456742	9	14	Microglia	31	7	7
TTGTAGGAGTAGCCGA-1_2_B9	-15.32438735	-34.93674495	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3561	7766	0.058975019	0.021503992	9	16	EN-PYR	31	7	7
TTGTAGGCAGGAACGT-1_2_B9	-29.66597196	-11.16587853	9	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	934	1301	0.008455035	0.009992314	9	9	OPC	31	7	7
TTGTAGGCATGAACCT-1_2_B9	-28.98745644	-22.59617303	6A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4871	12500	0.0432	0.00888	9	6A	IN-PV	31	7	7
TTTACTGTCAAGCCTA-1_2_B9	12.07407098	18.57954367	1	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1002	1524	0.008530184	0.00656168	9	oligos	OL-Cntl	31	7	7
TTTATGCAGATTACCC-1_2_B9	11.30405507	-16.47220995	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3896	9522	0.009241756	0.011552195	9	L2-3	EN-L2-3-MS	31	7	7
TTTATGCAGGAGTAGA-1_2_B9	-34.92660397	-3.792590496	9	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1293	2077	0.006740491	0.004814636	9	9	OPC	31	7	7
TTTATGCAGGCCCGTT-1_2_B9	-14.82434894	-0.231849434	13A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2942	6044	0.013567174	0.011416281	9	13A	IN-VIP	31	7	7
TTTATGCAGGTAGCCA-1_2_B9	-3.72315582	-33.66999659	16	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	766	1024	0.069335938	0.01953125	9	16	EN-PYR	31	7	7
TTTATGCGTAGCGTAG-1_2_B9	34.21984636	-17.30643945	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	4838	12539	0.014753968	0.017306005	9	2	EN-L4	31	7	7
TTTATGCTCCGGGTGT-1_2_B9	20.87295665	-21.5838999	3	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3631	9045	0.005970149	0.01116639	9	3	EN-L5-6	31	7	7
TTTCCTCCACGCTTTC-1_2_B9	-29.00932792	-0.078371443	9	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1531	2645	0.007561437	0.017391304	9	9	OPC	31	7	7
TTTCCTCCATCCGTGG-1_2_B9	-15.18539132	12.98024319	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1697	2952	0.008130081	0.005420054	9	8	Astrocytes	31	7	7
TTTCCTCCATGCCACG-1_2_B9	-15.54714938	8.918377273	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1592	2610	0.009578544	0.013409962	9	8	Astrocytes	31	7	7
TTTGCGCGTAAATGTG-1_2_B9	-15.23541339	-2.043408873	13A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2331	4347	0.021394065	0.009431792	9	13A	IN-VIP	31	7	7
TTTGCGCTCCATTCTA-1_2_B9	9.465178685	-15.06600206	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	2827	5546	0.014244501	0.009556437	9	L2-3	EN-L2-3-MS	31	7	7
TTTGCGCTCGTATCAG-1_2_B9	33.78216557	-14.15207625	2	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	3333	6810	0.017033774	0.00969163	9	2	EN-L4	31	7	7
TTTGGTTAGAGCTGCA-1_2_B9	26.17856278	9.938443687	15A	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1853	3125	0.0208	0.05664	9	15A	Endo cells	31	7	7
TTTGGTTCAGCTCGAC-1_2_B9	13.5007507	-18.53071257	4	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	5442	15990	0.007879925	0.014696685	9	L2-3	EN-L2-3-MS	31	7	7
TTTGTCAAGGACAGAA-1_2_B9	-11.4251393	17.4285012	11	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1923	3300	0.01	0.008484848	9	11	Glia-MIX	31	7	7
TTTGTCATCGCCATAA-1_2_B9	-15.71329346	9.336428271	8	2_B9	MS	Chronic inactive	53	male	parietal	CAP3	SEQ2	7	13	1477	2471	0.006879806	0.013759611	9	8	Astrocytes	31	7	7
AAACCTGAGAGGGCTT-1_371G_A3D3	13.61034003	-2.99117011	12	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1579	3322	0.025586996	0.002709211	3	12	EN-MIX	30	9	9
AAACCTGAGAGTACCG-1_371G_A3D3	-15.32546104	1.672600786	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4081	9168	0.004363002	0.011125654	3	13A	IN-VIP	30	9	9
AAACCTGAGATCTGCT-1_371G_A3D3	25.3751794	-9.795865686	3	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4069	9661	0.004036849	0.005589483	3	3	EN-L5-6	30	9	9
AAACCTGCAATGGTCT-1_371G_A3D3	-13.62426285	17.48768647	11	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1245	2020	0.002475248	0.007920792	3	11	Glia-MIX	30	9	9
AAACCTGCACGACTCG-1_371G_A3D3	-2.425357167	15.78544488	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	777	1108	0.002707581	0.008122744	3	oligos	OL-Cntl	30	9	9
AAACCTGCATTATCTC-1_371G_A3D3	12.48954654	-22.7882581	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5989	20734	0.006848654	0.008102633	3	L2-3	EN-L2-3-MS	30	9	9
AAACCTGGTGGACGAT-1_371G_A3D3	-15.15814259	0.510592448	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2963	5895	0.010347752	0.010347752	3	13A	IN-VIP	30	9	9
AAACCTGTCTCAAACG-1_371G_A3D3	21.82311438	-26.37686121	3	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3970	10517	0.003518114	0.006560806	3	3	EN-L5-6	30	9	9
AAACCTGTCTGTACGA-1_371G_A3D3	-18.69579348	-17.63550712	6B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2368	4615	0.009967497	0.004767064	3	6B	IN-SST	30	9	9
AAACGGGAGACTTTCG-1_371G_A3D3	2.839512577	14.56095722	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	978	1413	0.002830856	0.009200283	3	oligos	OL-Cntl	30	9	9
AAACGGGAGGACACCA-1_371G_A3D3	-29.36366307	0.417406043	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1856	3130	0.002236422	0.011501597	3	9	OPC	30	9	9
AAACGGGCAAAGGAAG-1_371G_A3D3	4.905327658	-19.02719444	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3664	7492	0.001334757	0.007741591	3	L2-3	EN-L2-3-MS	30	9	9
AAACGGGCAGTCAGCC-1_371G_A3D3	-25.28031264	13.44377889	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	969	1469	0.00136147	0.005445882	3	8	Astrocytes	30	9	9
AAACGGGCATCTACGA-1_371G_A3D3	-0.322833761	14.47431565	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	806	1147	0.009590235	0.02092415	3	oligos	OL-Cntl	30	9	9
AAACGGGCATTGGTAC-1_371G_A3D3	-0.07312119	15.85392147	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	860	1250	0.0088	0.0064	3	oligos	OL-Cntl	30	9	9
AAACGGGGTAGCCTCG-1_371G_A3D3	10.67675007	8.117366223	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1365	2199	0.004547522	0.017280582	3	oligos	OL-Cntl	30	9	9
AAACGGGGTAGGCATG-1_371G_A3D3	3.627987757	13.4552062	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1050	1687	0.004742146	0.014226437	3	oligos	OL-Cntl	30	9	9
AAACGGGGTCTTCTCG-1_371G_A3D3	-31.33404761	10.93840239	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	748	1087	0.009199632	0.006439742	3	8	Astrocytes	30	9	9
AAACGGGGTTCAGACT-1_371G_A3D3	10.21195674	-27.9561095	10	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	7180	33900	0.000737463	0.00359882	3	L2-3	EN-L2-3-Cntl	30	9	9
AAACGGGTCCTGCAGG-1_371G_A3D3	5.340164205	-19.53429973	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4182	10591	0.009347559	0.00443773	3	L2-3	EN-L2-3-MS	30	9	9
AAACGGGTCGCCCTTA-1_371G_A3D3	-2.482220682	-0.906535571	11	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2602	5120	0.021875	0.006835938	3	11	Glia-MIX	30	9	9
AAAGATGAGAGCTGGT-1_371G_A3D3	-0.838444582	16.99344169	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	754	1173	0.00341006	0.011082694	3	oligos	OL-Cntl	30	9	9
AAAGATGAGCTAGTGG-1_371G_A3D3	-9.235630566	-17.81201573	6B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	793	1151	0.00086881	0.006081668	3	6B	IN-SST	30	9	9
AAAGATGAGCTGCGAA-1_371G_A3D3	-12.95794142	-17.83796696	6B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1274	2166	0.00877193	0.003693444	3	6B	IN-SST	30	9	9
AAAGATGAGCTTATCG-1_371G_A3D3	-19.43266423	27.15744905	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1899	3504	0.002853881	0.005422374	3	8	Astrocytes	30	9	9
AAAGATGCAAACTGTC-1_371G_A3D3	-24.99662011	0.01765493	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2079	3602	0.002776235	0.005830094	3	9	OPC	30	9	9
AAAGATGCAATGGTCT-1_371G_A3D3	-20.8439628	27.08334422	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1750	3253	0.003381494	0.006455579	3	8	Astrocytes	30	9	9
AAAGATGCAGGGATTG-1_371G_A3D3	8.546949154	17.24368693	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	806	1219	0.001640689	0.013125513	3	oligos	OL-Cntl	30	9	9
AAAGATGCAGGGTACA-1_371G_A3D3	9.270069895	9.820008981	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1268	2141	0.004670715	0.015413358	3	oligos	OL-Cntl	30	9	9
AAAGATGGTCAAGCGA-1_371G_A3D3	5.684780484	32.18071671	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	832	1189	0.006728343	0.004205214	3	oligos	OL-Cntl	30	9	9
AAAGATGTCACTCTTA-1_371G_A3D3	-13.65656755	-0.346073849	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2458	4673	0.005777873	0.010699765	3	13A	IN-VIP	30	9	9
AAAGCAAAGCACAGGT-1_371G_A3D3	6.570345234	9.856752515	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1137	1868	0.004817987	0.012847966	3	oligos	OL-Cntl	30	9	9
AAAGCAAAGCCAACAG-1_371G_A3D3	-19.61566223	29.72146844	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2481	5222	0.00076599	0.001723478	3	8	Astrocytes	30	9	9
AAAGCAAAGGGATCTG-1_371G_A3D3	0.095375965	19.10073404	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	774	1125	0.006222222	0.010666667	3	oligos	OL-Cntl	30	9	9
AAAGCAAAGGGTCGAT-1_371G_A3D3	-28.4115626	0.068084863	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1837	2973	0.001681803	0.015136226	3	9	OPC	30	9	9
AAAGCAACAGATGGCA-1_371G_A3D3	3.12918315	14.34243904	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1087	1644	0.001216545	0.010340633	3	oligos	OL-Cntl	30	9	9
AAAGCAATCAGAGCTT-1_371G_A3D3	-6.682706199	0.151902777	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1807	3219	0.000310655	0.004659832	3	13A	IN-VIP	30	9	9
AAAGCAATCTTCGAGA-1_371G_A3D3	26.5238442	-2.832442394	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3724	10192	0.000981162	0.003532182	3	2	EN-L4	30	9	9
AAAGTAGAGGAGTAGA-1_371G_A3D3	-4.36150187	-4.655958101	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1243	2001	0.037481259	0.003998001	3	13A	IN-VIP	30	9	9
AAAGTAGAGTAGATGT-1_371G_A3D3	10.91956255	22.79695677	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	809	1240	0.003225806	0.003225806	3	oligos	OL-Cntl	30	9	9
AAAGTAGCACCAGATT-1_371G_A3D3	-22.76859069	-17.15415258	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4025	9005	0.006662965	0.007218212	3	6A	IN-PV	30	9	9
AAAGTAGGTCCGCTGA-1_371G_A3D3	9.736193306	8.025703813	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1499	2597	0.001155179	0.01270697	3	oligos	OL-Cntl	30	9	9
AAAGTAGGTCTTGTCC-1_371G_A3D3	-14.35298147	0.423364803	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3008	6333	0.011842729	0.009474183	3	13A	IN-VIP	30	9	9
AAAGTAGTCCTGCTTG-1_371G_A3D3	33.47986729	-2.351266252	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2603	5160	0.012403101	0.005813953	3	2	EN-L4	30	9	9
AAAGTAGTCGCCAAAT-1_371G_A3D3	-34.08631213	-0.165645805	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1614	2732	0.001464129	0.00658858	3	9	OPC	30	9	9
AAAGTAGTCTACTTAC-1_371G_A3D3	-23.89022402	17.63279304	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1305	2152	0.005576208	0.002788104	3	8	Astrocytes	30	9	9
AAATGCCAGACTGGGT-1_371G_A3D3	-34.45076891	-0.642213728	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1440	2411	0.005806719	0.006636251	3	9	OPC	30	9	9
AAATGCCAGCCACCTG-1_371G_A3D3	-30.50017235	1.51437456	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1912	3543	0.000282247	0.008467401	3	9	OPC	30	9	9
AAATGCCAGCTGCCCA-1_371G_A3D3	-0.480783106	15.51603473	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	690	1085	0.001843318	0.019354839	3	oligos	OL-Cntl	30	9	9
AAATGCCAGGATCGCA-1_371G_A3D3	-28.90998495	12.62245842	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	828	1344	0.007440476	0.004464286	3	8	Astrocytes	30	9	9
AAATGCCCAGCATACT-1_371G_A3D3	15.70264901	6.058850037	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2064	3882	0.001545595	0.010303967	3	oligos	OL-Cntl	30	9	9
AAATGCCGTAAGTAGT-1_371G_A3D3	5.609383939	-17.59199767	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3143	6463	0.008664707	0.01098561	3	L2-3	EN-L2-3-MS	30	9	9
AAATGCCGTATGAAAC-1_371G_A3D3	-25.10054614	13.514851	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1118	1689	0.003552398	0.005920663	3	8	Astrocytes	30	9	9
AAATGCCTCGAATGCT-1_371G_A3D3	14.95890357	-29.16487391	3	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5837	21344	0.005575337	0.004122939	3	3	EN-L5-6	30	9	9
AACACGTAGATAGTCA-1_371G_A3D3	-2.821575602	15.3419455	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	738	1050	0.000952381	0.016190476	3	oligos	OL-Cntl	30	9	9
AACACGTCAAGTACCT-1_371G_A3D3	23.9849503	-10.26097153	3	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5178	14734	0.005633229	0.005361748	3	3	EN-L5-6	30	9	9
AACACGTCAATTCCTT-1_371G_A3D3	-19.09611684	25.45020771	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1774	3027	0.0016518	0.008259002	3	8	Astrocytes	30	9	9
AACACGTCACACGCTG-1_371G_A3D3	-23.64074719	-17.26655457	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5343	13429	0.00208504	0.011542185	3	6A	IN-PV	30	9	9
AACACGTCAGACGCCT-1_371G_A3D3	8.508982789	6.743784961	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1410	2409	0.00456621	0.00705687	3	oligos	OL-Cntl	30	9	9
AACACGTGTATAGTAG-1_371G_A3D3	2.925616893	14.62454639	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1092	1821	0.003294893	0.012081274	3	oligos	OL-Cntl	30	9	9
AACACGTGTTAAGAAC-1_371G_A3D3	-25.08369579	22.1831441	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1172	1873	0.000533903	0.006406834	3	8	Astrocytes	30	9	9
AACACGTTCATGTGGT-1_371G_A3D3	-0.564312224	13.86420671	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	856	1275	0.005490196	0.016470588	3	oligos	OL-Cntl	30	9	9
AACACGTTCGCTTAGA-1_371G_A3D3	1.243890904	14.43908005	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	828	1175	0.003404255	0.019574468	3	oligos	OL-Cntl	30	9	9
AACACGTTCTAAGCCA-1_371G_A3D3	-2.640646193	16.70330117	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	789	1218	0.003284072	0.009031199	3	oligos	OL-Cntl	30	9	9
AACCATGAGCCGATTT-1_371G_A3D3	3.335962515	-17.13487797	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3104	7590	0.005533597	0.007114625	3	L2-3	EN-L2-3-MS	30	9	9
AACCATGAGCGATATA-1_371G_A3D3	1.725761825	12.26801223	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	990	1457	0.005490734	0.01509952	3	oligos	OL-Cntl	30	9	9
AACCATGCACTTAACG-1_371G_A3D3	-34.43353145	-0.627972176	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1611	2676	0.007100149	0.002242152	3	9	OPC	30	9	9
AACCATGCAGGCGATA-1_371G_A3D3	10.47578368	2.025823227	12	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	636	1015	0.000985222	0.00591133	3	12	EN-MIX	30	9	9
AACCATGCAGGTGCCT-1_371G_A3D3	1.318494523	15.67162375	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	853	1385	0.003610108	0.005776173	3	oligos	OL-Cntl	30	9	9
AACCATGGTTATGCGT-1_371G_A3D3	-13.53030926	-9.768029978	13B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2101	4154	0.012518055	0.008184882	3	13B	IN-SV2C	30	9	9
AACCATGTCCATGAGT-1_371G_A3D3	-0.306749701	14.34154187	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	864	1288	0.000776398	0.02173913	3	oligos	OL-Cntl	30	9	9
AACCATGTCGCGATCG-1_371G_A3D3	1.672515381	20.29681725	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	722	1070	0.001869159	0.010280374	3	oligos	OL-Cntl	30	9	9
AACCGCGGTAGTAGTA-1_371G_A3D3	29.80334547	-11.99631917	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3953	9193	0.037310997	0.006744262	3	2	EN-L4	30	9	9
AACCGCGGTGCTAGCC-1_371G_A3D3	5.29608708	18.35942321	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	944	1450	0.004827586	0.012413793	3	oligos	OL-Cntl	30	9	9
AACCGCGGTTAAAGAC-1_371G_A3D3	22.10614594	-1.11739884	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1979	3770	0.028381963	0.005570292	3	2	EN-L4	30	9	9
AACCGCGGTTCGTTGA-1_371G_A3D3	35.90205485	-10.01678013	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5877	15116	0.006946282	0.008534004	3	2	EN-L4	30	9	9
AACCGCGGTTGTCTTT-1_371G_A3D3	11.67373035	18.15060153	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	994	1567	0.005743459	0.005105297	3	oligos	OL-Cntl	30	9	9
AACCGCGTCGGCGGTT-1_371G_A3D3	8.784512177	17.30199634	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	904	1376	0.005087209	0.009447674	3	oligos	OL-Cntl	30	9	9
AACGTTGAGAAACCAT-1_371G_A3D3	34.82443476	-8.900488521	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	6065	17425	0.001836442	0.007116212	3	2	EN-L4	30	9	9
AACGTTGAGGACAGAA-1_371G_A3D3	-25.35334681	11.03016553	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	991	1378	0.005805515	0.006531205	3	8	Astrocytes	30	9	9
AACGTTGCACAGTCGC-1_371G_A3D3	-2.576513366	16.31841373	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	718	1060	0.004716981	0.018867925	3	oligos	OL-Cntl	30	9	9
AACGTTGCACGGACAA-1_371G_A3D3	2.702662833	8.888564539	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1451	2264	0.002208481	0.030035336	3	oligos	OL-Cntl	30	9	9
AACTCAGAGGGTGTGT-1_371G_A3D3	-26.68265266	1.59359465	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2484	4653	0.003008812	0.0782291	3	9	OPC	30	9	9
AACTCAGAGTCCCACG-1_371G_A3D3	-7.97466387	-37.57670721	16	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1026	1416	0.049435028	0.021186441	3	16	EN-PYR	30	9	9
AACTCAGCAATCCAAC-1_371G_A3D3	-23.98697219	-0.147328887	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1998	3595	0.003616134	0.006675939	3	9	OPC	30	9	9
AACTCAGCACCTCGGA-1_371G_A3D3	1.711024051	17.1479151	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	909	1528	0.003926702	0.006544503	3	oligos	OL-Cntl	30	9	9
AACTCAGCATCGGACC-1_371G_A3D3	1.027530719	19.89634653	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	798	1218	0.000821018	0.012315271	3	oligos	OL-Cntl	30	9	9
AACTCAGCATGTCGAT-1_371G_A3D3	-36.36706776	-6.249730768	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1135	1790	0.000558659	0.003351955	3	9	OPC	30	9	9
AACTCAGTCGTCACGG-1_371G_A3D3	-24.05748908	-19.42458462	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3316	7276	0.009483233	0.00893348	3	6A	IN-PV	30	9	9
AACTCCCAGCATGGCA-1_371G_A3D3	9.898511816	12.16075867	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1179	1980	0.00959596	0.008080808	3	oligos	OL-Cntl	30	9	9
AACTCCCAGCTACCTA-1_371G_A3D3	16.03340221	9.285882454	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1647	3175	0.000314961	0.005669291	3	oligos	OL-Cntl	30	9	9
AACTCCCAGGGAACGG-1_371G_A3D3	27.07841741	6.147279238	15BA	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	988	1411	0.010630758	0.021970234	3	15BA	Stromal cells	30	9	9
AACTCCCAGTACTTGC-1_371G_A3D3	19.22114395	-25.39049515	3	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3438	7455	0.004426559	0.009926224	3	3	EN-L5-6	30	9	9
AACTCCCGTTAAAGTG-1_371G_A3D3	-8.322675422	-15.07819519	6B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	828	1378	0.002902758	0.009433962	3	6B	IN-SST	30	9	9
AACTCCCGTTACCAGT-1_371G_A3D3	9.59145111	7.835296104	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1654	3007	0.010641836	0.013967409	3	oligos	OL-Cntl	30	9	9
AACTCCCTCACTTACT-1_371G_A3D3	-31.09443087	12.13030432	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	852	1423	0.014757554	0.003513703	3	8	Astrocytes	30	9	9
AACTCCCTCCCTAATT-1_371G_A3D3	-12.53900002	0.968323793	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3026	6640	0.004518072	0.007228916	3	13A	IN-VIP	30	9	9
AACTCTTCAAGCTGTT-1_371G_A3D3	10.89889502	-27.167091	10	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	7499	31313	0.0046626	0.004407115	3	L2-3	EN-L2-3-Cntl	30	9	9
AACTCTTCAGAGCCAA-1_371G_A3D3	28.40119091	-4.40547448	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4935	14666	0.000477294	0.005863903	3	2	EN-L4	30	9	9
AACTCTTGTGCACGAA-1_371G_A3D3	-15.95614262	2.37064441	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4173	9353	0.013685449	0.009943334	3	13A	IN-VIP	30	9	9
AACTCTTTCCTTGCCA-1_371G_A3D3	9.257642281	12.86102833	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1049	1762	0.000567537	0.010215664	3	oligos	OL-Cntl	30	9	9
AACTCTTTCTCGCTTG-1_371G_A3D3	13.34256302	7.002725323	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1778	3129	0.003195909	0.006711409	3	oligos	OL-Cntl	30	9	9
AACTGGTAGAGTAAGG-1_371G_A3D3	-15.64213353	1.322585838	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3611	7740	0.017183463	0.009431525	3	13A	IN-VIP	30	9	9
AACTGGTAGGAATTAC-1_371G_A3D3	9.396466569	11.5089951	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1145	1900	0.001052632	0.008421053	3	oligos	OL-Cntl	30	9	9
AACTGGTCAAAGTCAA-1_371G_A3D3	9.432611006	21.64334068	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	761	1238	0.002423263	0.005654281	3	oligos	OL-Cntl	30	9	9
AACTGGTCATCGATGT-1_371G_A3D3	-9.688215165	-0.72366394	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2420	4963	0.001007455	0.005238767	3	13A	IN-VIP	30	9	9
AACTGGTTCAGTCAGT-1_371G_A3D3	5.753488312	-19.90101953	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5039	14472	0.009259259	0.007462687	3	L2-3	EN-L2-3-MS	30	9	9
AACTGGTTCTTCGAGA-1_371G_A3D3	16.34497712	9.692134368	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1593	2820	0.00035461	0.004255319	3	oligos	OL-Cntl	30	9	9
AACTTTCAGTGAACGC-1_371G_A3D3	4.320510644	-17.04539214	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3253	7525	0.001727575	0.003986711	3	L2-3	EN-L2-3-MS	30	9	9
AACTTTCCAATGGACG-1_371G_A3D3	-6.242448015	-2.705256934	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1655	2839	0.004579077	0.007044734	3	13A	IN-VIP	30	9	9
AACTTTCCACCTCGGA-1_371G_A3D3	-14.30457002	-20.53536225	6B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1385	2247	0.007120605	0.012461059	3	6B	IN-SST	30	9	9
AACTTTCCACTTCGAA-1_371G_A3D3	-1.333958147	18.90289776	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	721	1158	0.002590674	0.008635579	3	oligos	OL-Cntl	30	9	9
AACTTTCCAGCTTAAC-1_371G_A3D3	18.67315562	-6.610020126	3	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2010	4255	0.000705053	0.003760282	3	3	EN-L5-6	30	9	9
AACTTTCCAGGTCGTC-1_371G_A3D3	-19.48669764	-27.59873423	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3450	9203	0.01955884	0.002173204	3	6A	IN-PV	30	9	9
AACTTTCGTCAGAAGC-1_371G_A3D3	35.86023576	-7.285640796	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3614	8243	0.002547616	0.004973917	3	2	EN-L4	30	9	9
AACTTTCGTTACGGAG-1_371G_A3D3	33.06459705	-6.659414098	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3658	8514	0.004815598	0.009161381	3	2	EN-L4	30	9	9
AACTTTCTCAACACTG-1_371G_A3D3	-2.925049676	16.39842387	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	676	1022	0	0.010763209	3	oligos	OL-Cntl	30	9	9
AACTTTCTCGTTGACA-1_371G_A3D3	5.681563182	15.09335753	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	904	1425	0.003508772	0.014035088	3	oligos	OL-Cntl	30	9	9
AAGACCTAGATGAGAG-1_371G_A3D3	2.761998872	12.88856517	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1007	1528	0	0.014397906	3	oligos	OL-Cntl	30	9	9
AAGACCTAGCTGCAAG-1_371G_A3D3	-25.66978994	14.82191113	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1196	2036	0.000491159	0.004911591	3	8	Astrocytes	30	9	9
AAGACCTAGCTTCGCG-1_371G_A3D3	-1.594103192	18.35776542	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	681	1021	0.000979432	0.002938296	3	oligos	OL-Cntl	30	9	9
AAGACCTAGGGATCTG-1_371G_A3D3	8.557649682	16.97139742	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	901	1409	0.003548616	0.005677786	3	oligos	OL-Cntl	30	9	9
AAGACCTAGGTCATCT-1_371G_A3D3	29.1972383	-2.998787905	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4727	13566	0.00818222	0.007150229	3	2	EN-L4	30	9	9
AAGACCTCATTGGTAC-1_371G_A3D3	11.58093808	6.857708944	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1663	2750	0.002181818	0.014909091	3	oligos	OL-Cntl	30	9	9
AAGACCTGTAGGCTGA-1_371G_A3D3	15.17379191	9.167377605	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1647	2868	0.004532775	0.006624826	3	oligos	OL-Cntl	30	9	9
AAGACCTGTGTCAATC-1_371G_A3D3	12.68007954	7.015387755	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1761	3222	0.002793296	0.011173184	3	oligos	OL-Cntl	30	9	9
AAGACCTGTTGCGTTA-1_371G_A3D3	-32.88786365	5.232538949	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2823	5313	0.003764352	0.007340486	3	9	OPC	30	9	9
AAGACCTTCCAGAGGA-1_371G_A3D3	-30.51928497	-9.035939091	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1167	1781	0.005053341	0.010668164	3	9	OPC	30	9	9
AAGACCTTCGGTTCGG-1_371G_A3D3	4.844280387	-17.86003265	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3284	7452	0.006038647	0.004696726	3	L2-3	EN-L2-3-MS	30	9	9
AAGACCTTCTTGTACT-1_371G_A3D3	13.60254856	13.76542716	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1108	1781	0.001122965	0.006737788	3	oligos	OL-Cntl	30	9	9
AAGCCGCAGAAGAAGC-1_371G_A3D3	5.886197745	-19.19350479	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3844	8546	0.003042359	0.006201732	3	L2-3	EN-L2-3-MS	30	9	9
AAGCCGCAGTCCCACG-1_371G_A3D3	2.707259646	13.37179244	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	949	1374	0.000727802	0.014556041	3	oligos	OL-Cntl	30	9	9
AAGCCGCCATGGTAGG-1_371G_A3D3	-2.336389276	14.64133525	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	766	1176	0.00170068	0.019557823	3	oligos	OL-Cntl	30	9	9
AAGCCGCGTTTGGCGC-1_371G_A3D3	35.94861729	-12.10308736	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5053	12925	0.012147002	0.013307544	3	2	EN-L4	30	9	9
AAGCCGCTCTCTTATG-1_371G_A3D3	-16.38294079	1.519466779	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3953	8299	0.007832269	0.01289312	3	13A	IN-VIP	30	9	9
AAGGAGCAGGAGTACC-1_371G_A3D3	0.077262036	14.24459125	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	912	1390	0	0.015827338	3	oligos	OL-Cntl	30	9	9
AAGGAGCCAAAGTGCG-1_371G_A3D3	34.84533867	-6.824488129	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3389	6270	0.007177033	0.007496013	3	2	EN-L4	30	9	9
AAGGAGCCAAGGTTTC-1_371G_A3D3	-23.1194715	18.79278547	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1483	2684	0.000745156	0.002980626	3	8	Astrocytes	30	9	9
AAGGAGCCAGAGTGTG-1_371G_A3D3	10.21485429	-27.40929557	10	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	6885	23112	0.000259605	0.004370024	3	L2-3	EN-L2-3-Cntl	30	9	9
AAGGAGCGTATAGTAG-1_371G_A3D3	-28.06252619	4.140329565	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2652	4901	0.0020404	0.00877372	3	9	OPC	30	9	9
AAGGAGCGTCCGAAGA-1_371G_A3D3	-29.34383691	0.21655592	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1677	2677	0.001867762	0.00896526	3	9	OPC	30	9	9
AAGGAGCGTCTGGTCG-1_371G_A3D3	-1.110448068	-19.9538874	10	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3334	8329	0.003361748	0.003721935	3	L2-3	EN-L2-3-Cntl	30	9	9
AAGGAGCTCATTGCGA-1_371G_A3D3	13.52302888	-30.94703706	3	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5203	18109	0.000773096	0.0028715	3	3	EN-L5-6	30	9	9
AAGGCAGAGACGACGT-1_371G_A3D3	7.345402996	-18.41619628	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4388	9871	0.00547057	0.009320231	3	L2-3	EN-L2-3-MS	30	9	9
AAGGCAGAGCCTCGTG-1_371G_A3D3	-0.532902592	21.23055845	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	784	1107	0.004516712	0.013550136	3	oligos	OL-Cntl	30	9	9
AAGGCAGAGGACATTA-1_371G_A3D3	5.967587996	9.691346731	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1177	1813	0.004412576	0.013237728	3	oligos	OL-Cntl	30	9	9
AAGGCAGCAAAGCAAT-1_371G_A3D3	10.16856511	11.91907736	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1247	2059	0.013598834	0.005342399	3	oligos	OL-Cntl	30	9	9
AAGGCAGCAATGGAGC-1_371G_A3D3	-14.99181569	-20.77833768	6B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1468	2385	0.008805031	0.01048218	3	6B	IN-SST	30	9	9
AAGGCAGCATCCCACT-1_371G_A3D3	-0.457186851	21.13299003	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	721	1002	0.000998004	0.007984032	3	oligos	OL-Cntl	30	9	9
AAGGCAGGTATAAACG-1_371G_A3D3	8.661732235	-17.71187958	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5328	13234	0.007027354	0.008160798	3	L2-3	EN-L2-3-MS	30	9	9
AAGGCAGGTCCAGTGC-1_371G_A3D3	-18.46255532	-9.876784684	13B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3508	7747	0.010842907	0.010713825	3	13B	IN-SV2C	30	9	9
AAGGCAGTCTTCGGTC-1_371G_A3D3	10.3460789	6.990032809	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1511	2479	0.004840662	0.011294877	3	oligos	OL-Cntl	30	9	9
AAGGTTCAGCCTATGT-1_371G_A3D3	-23.50293387	-19.30468208	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3490	7771	0.004761292	0.008235748	3	6A	IN-PV	30	9	9
AAGGTTCAGGATTCGG-1_371G_A3D3	18.5225018	24.64038508	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	871	1337	0.002243829	0.002243829	3	oligos	OL-Cntl	30	9	9
AAGGTTCCAAGGACAC-1_371G_A3D3	6.713509284	9.945824472	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1088	1788	0.002796421	0.013422819	3	oligos	OL-Cntl	30	9	9
AAGGTTCGTAGGCTGA-1_371G_A3D3	-30.64455841	10.28561929	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	911	1421	0.004222379	0.007037298	3	8	Astrocytes	30	9	9
AAGGTTCGTAGTAGTA-1_371G_A3D3	2.600511755	12.81510354	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1014	1594	0.007528231	0.012547051	3	oligos	OL-Cntl	30	9	9
AAGGTTCGTGGCTCCA-1_371G_A3D3	10.48579548	18.26950827	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	911	1458	0	0.005486968	3	oligos	OL-Cntl	30	9	9
AAGTCTGAGACACGAC-1_371G_A3D3	-22.79962177	-24.50178295	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3212	7346	0.012659951	0.005581269	3	6A	IN-PV	30	9	9
AAGTCTGAGGACATTA-1_371G_A3D3	11.89827089	8.297178268	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1486	2529	0.007117438	0.010676157	3	oligos	OL-Cntl	30	9	9
AAGTCTGCATCGATTG-1_371G_A3D3	1.268635319	-21.96241395	10	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4361	12114	0.004210005	0.003467063	3	L2-3	EN-L2-3-Cntl	30	9	9
AAGTCTGTCAACACGT-1_371G_A3D3	9.311400347	17.10399849	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1119	1734	0.00461361	0.006343714	3	oligos	OL-Cntl	30	9	9
AAGTCTGTCGGGAGTA-1_371G_A3D3	-30.09931405	-0.53449462	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1684	2762	0.006517017	0.011223751	3	9	OPC	30	9	9
AATCCAGCAACTGCTA-1_371G_A3D3	-28.18996298	0.128660245	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2007	3271	0.00397432	0.011922959	3	9	OPC	30	9	9
AATCCAGCACACCGCA-1_371G_A3D3	8.806467367	16.09827791	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	971	1575	0.008253968	0.008888889	3	oligos	OL-Cntl	30	9	9
AATCCAGCACGGACAA-1_371G_A3D3	5.594676051	-18.03067869	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3461	7725	0.002718447	0.011132686	3	L2-3	EN-L2-3-MS	30	9	9
AATCCAGGTAAAGGAG-1_371G_A3D3	-30.26371642	0.267139683	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1826	3061	0.000326691	0.006207122	3	9	OPC	30	9	9
AATCCAGGTCGCATAT-1_371G_A3D3	9.916962809	8.490736241	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1507	2748	0.00363901	0.008733624	3	oligos	OL-Cntl	30	9	9
AATCCAGGTTCGAATC-1_371G_A3D3	-35.62600402	-3.61462294	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1383	2476	0.006058158	0.002019386	3	9	OPC	30	9	9
AATCCAGTCACGCGGT-1_371G_A3D3	4.96848181	15.73341656	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	938	1414	0.006364922	0.010608204	3	oligos	OL-Cntl	30	9	9
AATCGGTAGACCCACC-1_371G_A3D3	8.43515677	15.84178048	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1008	1529	0.001962067	0.009810334	3	oligos	OL-Cntl	30	9	9
AATCGGTCACTGAAGG-1_371G_A3D3	28.58079543	-4.383194598	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4586	13217	0.000983582	0.005977151	3	2	EN-L4	30	9	9
AATCGGTCATTAACCG-1_371G_A3D3	-3.460462477	15.27794814	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	729	1070	0.010280374	0.025233645	3	oligos	OL-Cntl	30	9	9
AATCGGTGTACGCTGC-1_371G_A3D3	-25.17830469	13.68722489	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1049	1682	0.001783591	0.004161712	3	8	Astrocytes	30	9	9
AATCGGTGTCAGCTAT-1_371G_A3D3	-1.006407754	13.808337	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	812	1124	0.00088968	0.015124555	3	oligos	OL-Cntl	30	9	9
AATCGGTGTCTAGGTT-1_371G_A3D3	-19.39045804	-17.28545109	6B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2659	5578	0.004481893	0.006633202	3	6B	IN-SST	30	9	9
AATCGGTGTGGTCCGT-1_371G_A3D3	-13.05118759	0.509462716	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3174	6479	0.00030869	0.007099861	3	13A	IN-VIP	30	9	9
AATCGGTGTTATCCGA-1_371G_A3D3	35.98489399	-7.894291147	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4389	10776	0.003247958	0.006681514	3	2	EN-L4	30	9	9
AATCGGTTCAACGGCC-1_371G_A3D3	-10.77646728	0.40262831	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2395	4875	0.003692308	0.00574359	3	13A	IN-VIP	30	9	9
AATCGGTTCGACCAGC-1_371G_A3D3	9.16082459	9.649037668	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1269	2359	0.002967359	0.009325986	3	oligos	OL-Cntl	30	9	9
ACACCAAAGCTAACTC-1_371G_A3D3	-14.72738556	1.335298331	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3959	9408	0.008290816	0.007334184	3	13A	IN-VIP	30	9	9
ACACCAAAGCTAGTGG-1_371G_A3D3	-35.4258085	-3.801504664	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1502	2662	0.001126972	0.003756574	3	9	OPC	30	9	9
ACACCAACACATCTTT-1_371G_A3D3	4.853124025	10.97702363	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1179	1966	0.004069176	0.014750763	3	oligos	OL-Cntl	30	9	9
ACACCAACAGATAATG-1_371G_A3D3	8.631106006	15.74358822	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	999	1695	0	0.006489676	3	oligos	OL-Cntl	30	9	9
ACACCAACATAAGACA-1_371G_A3D3	9.520847293	8.764276791	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1337	2324	0.000430293	0.012048193	3	oligos	OL-Cntl	30	9	9
ACACCAACATTGGTAC-1_371G_A3D3	-22.03817956	24.81776135	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1579	2678	0.002240478	0.004107543	3	8	Astrocytes	30	9	9
ACACCAAGTAAACACA-1_371G_A3D3	35.98605217	-7.945078047	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4306	11154	0.003048234	0.009324009	3	2	EN-L4	30	9	9
ACACCAAGTCAGTGGA-1_371G_A3D3	8.668865821	6.743364024	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1682	2810	0.008896797	0.010320285	3	oligos	OL-Cntl	30	9	9
ACACCAAGTGGTAACG-1_371G_A3D3	-34.7670321	2.067049486	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1951	3683	0.001086071	0.004615802	3	9	OPC	30	9	9
ACACCAATCACGCATA-1_371G_A3D3	-8.307210214	7.456712637	5	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	762	1084	0.002767528	0.081180812	3	oligos	OL-MS-1	30	9	9
ACACCAATCAGTACGT-1_371G_A3D3	14.49633113	8.693145678	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1568	2633	0.004177744	0.010254463	3	oligos	OL-Cntl	30	9	9
ACACCAATCGTCTGAA-1_371G_A3D3	0.462131697	18.08185997	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	780	1180	0.000847458	0.005084746	3	oligos	OL-Cntl	30	9	9
ACACCAATCTGTCCGT-1_371G_A3D3	-34.26444844	-5.451649665	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1257	2158	0	0.001390176	3	9	OPC	30	9	9
ACACCCTAGTTAAGTG-1_371G_A3D3	-24.00256817	-25.43246999	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5985	17432	0.006654429	0.008834328	3	6A	IN-PV	30	9	9
ACACCCTCAAAGGTGC-1_371G_A3D3	-19.68375884	26.10418969	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1785	3163	0.000316156	0.0085362	3	8	Astrocytes	30	9	9
ACACCCTCAAAGTGCG-1_371G_A3D3	-29.10695907	0.921763464	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2109	3514	0.003984064	0.020204895	3	9	OPC	30	9	9
ACACCCTCACAGGCCT-1_371G_A3D3	-0.005588837	17.49514889	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	792	1197	0.004177109	0.005012531	3	oligos	OL-Cntl	30	9	9
ACACCCTCAGGGTTAG-1_371G_A3D3	-20.1565983	25.75080656	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1581	2476	0.001615509	0.005250404	3	8	Astrocytes	30	9	9
ACACCCTCATGGTCAT-1_371G_A3D3	-35.00173311	-0.180920956	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1719	3115	0.000963082	0.0035313	3	9	OPC	30	9	9
ACACCCTGTAGGGTAC-1_371G_A3D3	-33.55629749	-5.817973614	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1211	1917	0.005738132	0.008868023	3	9	OPC	30	9	9
ACACCCTGTATCGCAT-1_371G_A3D3	-31.40041635	11.74364212	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	790	1195	0.006694561	0.005857741	3	8	Astrocytes	30	9	9
ACACCCTGTCAATACC-1_371G_A3D3	4.768459786	-20.34820063	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3963	9660	0.004037267	0.003830228	3	L2-3	EN-L2-3-MS	30	9	9
ACACCCTTCGGCATCG-1_371G_A3D3	-3.512386002	17.99072544	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	910	1337	0.004487659	0.011219147	3	oligos	OL-Cntl	30	9	9
ACACCCTTCTCTGAGA-1_371G_A3D3	35.29575102	15.74342021	14	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1296	1978	0.006066734	0.023761375	3	14	Microglia	30	9	9
ACACCCTTCTTAACCT-1_371G_A3D3	9.221872983	16.52166506	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	927	1506	0.001992032	0.008632138	3	oligos	OL-Cntl	30	9	9
ACACCGGAGAACAACT-1_371G_A3D3	-27.93830416	-23.60146922	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5573	13342	0.010268326	0.01693899	3	6A	IN-PV	30	9	9
ACACCGGAGAGTCGGT-1_371G_A3D3	-27.01605348	-22.34200738	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3737	8205	0.015965874	0.014137721	3	6A	IN-PV	30	9	9
ACACCGGAGCTCTCGG-1_371G_A3D3	-11.4446284	-18.45014867	6B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	994	1461	0.03559206	0.006160164	3	6B	IN-SST	30	9	9
ACACCGGAGGGCTTCC-1_371G_A3D3	-14.3300341	0.801895587	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3156	6436	0.005282784	0.0077688	3	13A	IN-VIP	30	9	9
ACACCGGAGGGTATCG-1_371G_A3D3	9.152060267	8.115812097	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1615	2804	0	0.012125535	3	oligos	OL-Cntl	30	9	9
ACACCGGCACTGTGTA-1_371G_A3D3	-23.93632519	-25.20475854	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4561	11032	0.012327774	0.009427121	3	6A	IN-PV	30	9	9
ACACCGGCATGATCCA-1_371G_A3D3	-24.97556242	22.33855082	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1224	1924	0.002598753	0.005717256	3	8	Astrocytes	30	9	9
ACACCGGGTAAGAGAG-1_371G_A3D3	-27.81853816	4.306882635	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1885	2983	0.005363728	0.011062689	3	9	OPC	30	9	9
ACACCGGGTAGAGCTG-1_371G_A3D3	34.12358958	-8.904799649	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	6052	16938	0.010213721	0.007025623	3	2	EN-L4	30	9	9
ACACCGGGTAGTAGTA-1_371G_A3D3	-0.98471816	17.20092595	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	836	1169	0.005988024	0.011120616	3	oligos	OL-Cntl	30	9	9
ACACCGGTCAAGGTAA-1_371G_A3D3	12.50471381	11.51014434	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1301	2018	0.004459861	0.008424182	3	oligos	OL-Cntl	30	9	9
ACACCGGTCCACGCAG-1_371G_A3D3	-12.83409134	0.429742831	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2948	6290	0.011605723	0.005564388	3	13A	IN-VIP	30	9	9
ACACTGAGTCCTAGCG-1_371G_A3D3	9.930203217	-24.71584459	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5890	18120	0.004359823	0.004470199	3	L2-3	EN-L2-3-MS	30	9	9
ACAGCCGAGGCATTGG-1_371G_A3D3	-0.466529365	13.10404758	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1009	1527	0.005239031	0.020301244	3	oligos	OL-Cntl	30	9	9
ACAGCCGAGGGCTTCC-1_371G_A3D3	24.25810767	-11.10521437	3	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4967	13398	0.003806538	0.006493506	3	3	EN-L5-6	30	9	9
ACAGCCGAGTTAAGTG-1_371G_A3D3	-28.16002897	0.336420464	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1846	2878	0.002779708	0.007644197	3	9	OPC	30	9	9
ACAGCCGCAGGCTGAA-1_371G_A3D3	0.772739774	14.6055783	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	841	1273	0.003142184	0.014139827	3	oligos	OL-Cntl	30	9	9
ACAGCCGGTAGAGGAA-1_371G_A3D3	6.075105347	-19.0890754	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4223	9775	0.001841432	0.012890026	3	L2-3	EN-L2-3-MS	30	9	9
ACAGCCGGTTTACTCT-1_371G_A3D3	13.73173347	7.826985624	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1703	3020	0.007284768	0.014900662	3	oligos	OL-Cntl	30	9	9
ACAGCTAAGATGTGTA-1_371G_A3D3	-2.115668679	14.79360446	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	715	1018	0.002946955	0.017681729	3	oligos	OL-Cntl	30	9	9
ACAGCTAAGCTCTCGG-1_371G_A3D3	-2.084394301	14.82386066	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	716	1073	0.001863933	0.013979497	3	oligos	OL-Cntl	30	9	9
ACAGCTACACGAAACG-1_371G_A3D3	1.545444007	18.71736727	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	882	1353	0.001478197	0.011825573	3	oligos	OL-Cntl	30	9	9
ACAGCTACAGTGACAG-1_371G_A3D3	5.140035322	-19.95382009	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4235	10886	0.000459306	0.00744075	3	L2-3	EN-L2-3-MS	30	9	9
ACAGCTACATGTAGTC-1_371G_A3D3	-25.30129765	10.99326539	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	872	1244	0.002411576	0.006430868	3	8	Astrocytes	30	9	9
ACAGCTAGTCGAAAGC-1_371G_A3D3	7.347088015	-19.06743159	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5451	14147	0.003251573	0.005866968	3	L2-3	EN-L2-3-MS	30	9	9
ACAGCTAGTGACAAAT-1_371G_A3D3	35.86996799	-10.88603045	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4284	9899	0.009495909	0.008990807	3	2	EN-L4	30	9	9
ACAGCTAGTTATCGGT-1_371G_A3D3	-8.846538379	16.77489815	11	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4512	11241	0.001245441	0.006583044	3	11	Glia-MIX	30	9	9
ACAGCTATCATTCACT-1_371G_A3D3	1.146800622	14.87133427	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	887	1384	0.001445087	0.011560694	3	oligos	OL-Cntl	30	9	9
ACAGCTATCCAAGTAC-1_371G_A3D3	-30.83175548	-1.351909084	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1566	2563	0.003121342	0.007413188	3	9	OPC	30	9	9
ACATACGAGCCGATTT-1_371G_A3D3	-24.02811709	13.26521367	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1268	1919	0.001563314	0.005211047	3	8	Astrocytes	30	9	9
ACATACGCAAACAACA-1_371G_A3D3	-15.40556323	-25.83927665	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1817	3392	0.002063679	0.004127358	3	6A	IN-PV	30	9	9
ACATACGCAGCGTTCG-1_371G_A3D3	-15.28423639	-20.54255103	6B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1517	2631	0.020524515	0.00418092	3	6B	IN-SST	30	9	9
ACATACGCATGAAGTA-1_371G_A3D3	29.97708272	0.746213023	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3169	7200	0.000694444	0.005833333	3	2	EN-L4	30	9	9
ACATACGGTCATTAGC-1_371G_A3D3	15.50582103	6.447667341	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1976	3841	0.003124186	0.006248373	3	oligos	OL-Cntl	30	9	9
ACATACGGTCCTCCAT-1_371G_A3D3	2.713410317	16.77427688	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	878	1475	0	0.011525424	3	oligos	OL-Cntl	30	9	9
ACATACGGTGAGCGAT-1_371G_A3D3	-33.8326175	-2.541145748	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1525	2524	0.006339144	0.006735341	3	9	OPC	30	9	9
ACATACGGTGGGTCAA-1_371G_A3D3	-2.165526649	19.20085479	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	762	1071	0.000933707	0.011204482	3	oligos	OL-Cntl	30	9	9
ACATACGTCTTATCTG-1_371G_A3D3	-30.54688054	11.48405329	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	824	1226	0.001631321	0.002446982	3	8	Astrocytes	30	9	9
ACATCAGAGAAGGCCT-1_371G_A3D3	-31.27155238	11.37216295	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	710	1029	0.001943635	0.004859086	3	8	Astrocytes	30	9	9
ACATCAGAGCCGATTT-1_371G_A3D3	-18.16782615	-10.17545021	13B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3771	8617	0.00359754	0.007311129	3	13B	IN-SV2C	30	9	9
ACATCAGAGGAGTTTA-1_371G_A3D3	-24.11879985	-25.01778679	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3936	8779	0.010365645	0.011732544	3	6A	IN-PV	30	9	9
ACATCAGCACAAGACG-1_371G_A3D3	8.082343637	11.79603812	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1169	1904	0.00052521	0.009978992	3	oligos	OL-Cntl	30	9	9
ACATCAGCACGCGAAA-1_371G_A3D3	-13.27916104	-1.583577855	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2782	5151	0.02640264	0.007571345	3	13A	IN-VIP	30	9	9
ACATCAGCACGCTTTC-1_371G_A3D3	16.55762684	5.818697391	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2432	5178	0.003862495	0.011201236	3	oligos	OL-Cntl	30	9	9
ACATCAGGTACCTACA-1_371G_A3D3	-21.13253625	25.96115823	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1595	2791	0.002508062	0.006091007	3	8	Astrocytes	30	9	9
ACATCAGGTTCCCGAG-1_371G_A3D3	9.380003638	9.543480546	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1376	2289	0.003058104	0.014416776	3	oligos	OL-Cntl	30	9	9
ACATGGTAGCTAAACA-1_371G_A3D3	14.18883591	8.810018444	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1550	2703	0.001109878	0.00517943	3	oligos	OL-Cntl	30	9	9
ACATGGTGTACGCTGC-1_371G_A3D3	10.39949143	8.26441952	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1585	2668	0.002248876	0.012743628	3	oligos	OL-Cntl	30	9	9
ACATGGTTCCAAACTG-1_371G_A3D3	-2.70966646	16.85180016	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	746	1112	0.003597122	0.008093525	3	oligos	OL-Cntl	30	9	9
ACATGGTTCGGAGCAA-1_371G_A3D3	-12.32131975	14.67065665	11	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1046	1534	0.001303781	0.009126467	3	11	Glia-MIX	30	9	9
ACCAGTAAGTACACCT-1_371G_A3D3	-19.17663569	26.9563615	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1950	3676	0.003264418	0.004352557	3	8	Astrocytes	30	9	9
ACCAGTAAGTGTTGAA-1_371G_A3D3	-22.18279751	22.81147081	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1671	3040	0.001315789	0.002960526	3	8	Astrocytes	30	9	9
ACCAGTACAATAGAGT-1_371G_A3D3	-1.270270603	16.07791679	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	748	1064	0.001879699	0.018796992	3	oligos	OL-Cntl	30	9	9
ACCAGTACATGATCCA-1_371G_A3D3	-19.32175986	27.82505124	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2127	3816	0.000524109	0.002358491	3	8	Astrocytes	30	9	9
ACCCACTAGAATCTCC-1_371G_A3D3	1.083011361	-10.49328016	12	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1817	3255	0.026420891	0.005837174	3	12	EN-MIX	30	9	9
ACCCACTAGGACATTA-1_371G_A3D3	-2.528948114	16.93693227	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	791	1197	0.002506266	0.011695906	3	oligos	OL-Cntl	30	9	9
ACCCACTAGGGCTTCC-1_371G_A3D3	-0.759953292	16.50603344	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	767	1258	0.000794913	0.015898251	3	oligos	OL-Cntl	30	9	9
ACCCACTAGTGTACGG-1_371G_A3D3	-34.19162037	4.258324811	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2380	4377	0.002513137	0.003883939	3	9	OPC	30	9	9
ACCCACTGTACCATCA-1_371G_A3D3	9.799936629	7.813777456	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1595	2547	0.003533569	0.013741657	3	oligos	OL-Cntl	30	9	9
ACCGTAAAGGATGTAT-1_371G_A3D3	7.842715041	9.629581357	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1230	1825	0.010410959	0.012054795	3	oligos	OL-Cntl	30	9	9
ACCGTAACACTTCTGC-1_371G_A3D3	-30.21397396	1.414088333	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1957	3656	0.001641138	0.004376368	3	9	OPC	30	9	9
ACCGTAACATGAGCGA-1_371G_A3D3	-22.8619085	22.73263561	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1617	2813	0.002132954	0.004976893	3	8	Astrocytes	30	9	9
ACCGTAATCGTAGGAG-1_371G_A3D3	-18.55138077	-20.69666849	6B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2326	4504	0.010879218	0.004662522	3	6B	IN-SST	30	9	9
ACCGTAATCTGGCGAC-1_371G_A3D3	-20.34516758	25.6594879	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1795	2982	0.010731053	0.002682763	3	8	Astrocytes	30	9	9
ACCTTTAAGGATGGAA-1_371G_A3D3	28.51673212	9.952746364	15DB	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	962	1313	0.040365575	0.083777609	3	15DB	B cells	30	9	9
ACCTTTAAGGCGTACA-1_371G_A3D3	-13.36302765	-21.23706378	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1238	2152	0.020446097	0.00232342	3	6A	IN-PV	30	9	9
ACCTTTAAGTACGACG-1_371G_A3D3	-24.71701075	13.29366482	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1174	1873	0.00373732	0.00373732	3	8	Astrocytes	30	9	9
ACCTTTAAGTCGTTTG-1_371G_A3D3	-9.854619709	-0.160572653	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2369	4728	0.010786802	0.004230118	3	13A	IN-VIP	30	9	9
ACCTTTACAGGATCGA-1_371G_A3D3	31.1562273	15.22929938	14	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	792	1078	0.009276438	0.079777365	3	14	Microglia	30	9	9
ACCTTTAGTTGATTCG-1_371G_A3D3	1.517979345	13.78392861	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	860	1278	0.01486698	0.010954617	3	oligos	OL-Cntl	30	9	9
ACCTTTATCTTGGGTA-1_371G_A3D3	2.607298358	-21.52264964	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4851	14262	0.003996634	0.003575936	3	L2-3	EN-L2-3-MS	30	9	9
ACGAGCCAGATCCTGT-1_371G_A3D3	-0.287533803	16.23286035	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	667	1045	0.007655502	0.024880383	3	oligos	OL-Cntl	30	9	9
ACGAGCCAGCTAACAA-1_371G_A3D3	6.179581848	-19.20906946	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4683	11557	0.004153327	0.009950679	3	L2-3	EN-L2-3-MS	30	9	9
ACGAGCCAGGCATTGG-1_371G_A3D3	0.063930368	18.75360082	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	780	1144	0.003496503	0.011363636	3	oligos	OL-Cntl	30	9	9
ACGAGCCAGTCCGGTC-1_371G_A3D3	-32.87847862	5.321795906	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3102	5953	0.003359651	0.008735092	3	9	OPC	30	9	9
ACGAGCCAGTTCCACA-1_371G_A3D3	-0.810458542	13.61873585	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	992	1460	0.000684932	0.019863014	3	oligos	OL-Cntl	30	9	9
ACGAGGAAGATGAGAG-1_371G_A3D3	4.727004777	22.68399042	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	769	1089	0.006427916	0.001836547	3	oligos	OL-Cntl	30	9	9
ACGAGGAAGGCAATTA-1_371G_A3D3	-3.009892964	14.32476302	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	751	1086	0.004604052	0.018416206	3	oligos	OL-Cntl	30	9	9
ACGAGGACATCCCATC-1_371G_A3D3	-10.54723964	12.51841048	11	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	884	1288	0.01863354	0.00621118	3	11	Glia-MIX	30	9	9
ACGAGGAGTAGCCTCG-1_371G_A3D3	11.51435158	18.7970971	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1040	1578	0.002534854	0.005703422	3	oligos	OL-Cntl	30	9	9
ACGAGGAGTTGAGTTC-1_371G_A3D3	1.972203808	16.53054135	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	900	1385	0.011552347	0.01299639	3	oligos	OL-Cntl	30	9	9
ACGATACAGGGCTCTC-1_371G_A3D3	-30.85677152	1.454061226	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1938	3314	0.0006035	0.004828002	3	9	OPC	30	9	9
ACGATACAGTACCGGA-1_371G_A3D3	-9.091875307	-9.444901243	13B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1171	1718	0.068102445	0.007566938	3	13B	IN-SV2C	30	9	9
ACGATACCACTATCTT-1_371G_A3D3	-11.59906695	19.12851089	11	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2466	4609	0.002603602	0.007159905	3	11	Glia-MIX	30	9	9
ACGATACCAGGCGATA-1_371G_A3D3	-1.392259358	17.25976031	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	774	1165	0.006008584	0.018025751	3	oligos	OL-Cntl	30	9	9
ACGATACCATTATCTC-1_371G_A3D3	-27.45564546	4.377784688	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3989	9018	0.001996008	0.005988024	3	9	OPC	30	9	9
ACGATACGTTGCTCCT-1_371G_A3D3	-4.473530759	12.61064391	5	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	797	1084	0.005535055	0.016605166	3	oligos	OL-MS-1	30	9	9
ACGATACTCCACGTGG-1_371G_A3D3	-27.28429735	-0.033102626	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2054	3564	0.000561167	0.017957351	3	9	OPC	30	9	9
ACGATACTCGGCCGAT-1_371G_A3D3	-14.82194951	-9.967234706	13B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2835	5888	0.008491848	0.00611413	3	13B	IN-SV2C	30	9	9
ACGATACTCGTTTAGG-1_371G_A3D3	35.22259583	-9.837441933	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4606	11096	0.006128335	0.013248017	3	2	EN-L4	30	9	9
ACGATACTCTTCATGT-1_371G_A3D3	7.065256935	11.49704567	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1004	1575	0	0.011428571	3	oligos	OL-Cntl	30	9	9
ACGATGTAGTACACCT-1_371G_A3D3	-15.9137185	-14.32757196	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1850	3210	0.014953271	0.013395639	3	13A	IN-VIP	30	9	9
ACGATGTCATTAACCG-1_371G_A3D3	35.98498587	-10.2109196	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5321	13816	0.008902721	0.011001737	3	2	EN-L4	30	9	9
ACGATGTGTACGAAAT-1_371G_A3D3	28.76606232	-3.564531477	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3388	7745	0.002969658	0.005164622	3	2	EN-L4	30	9	9
ACGATGTTCTACCAGA-1_371G_A3D3	-29.13765918	10.57356821	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	909	1333	0.010502626	0.0060015	3	8	Astrocytes	30	9	9
ACGCAGCAGATGTAAC-1_371G_A3D3	-9.288396477	27.12406246	5	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1131	1606	0.016811955	0.01743462	3	oligos	OL-MS-1	30	9	9
ACGCAGCAGTGAATTG-1_371G_A3D3	-1.125305252	17.18935134	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	793	1169	0.001710864	0.013686912	3	oligos	OL-Cntl	30	9	9
ACGCAGCCAAGACACG-1_371G_A3D3	0.569354695	12.20246251	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	998	1459	0.000685401	0.018505826	3	oligos	OL-Cntl	30	9	9
ACGCAGCCACAAGTAA-1_371G_A3D3	-19.58291631	30.37561316	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2695	5328	0.00243994	0.006006006	3	8	Astrocytes	30	9	9
ACGCAGCCAGGCTCAC-1_371G_A3D3	-3.133472918	-35.29433205	16	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	941	1486	0.170928668	0.018169583	3	16	EN-PYR	30	9	9
ACGCAGCGTCTAGCCG-1_371G_A3D3	-28.85576987	0.579432732	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2183	4004	0.007992008	0.016233766	3	9	OPC	30	9	9
ACGCAGCGTGCAGTAG-1_371G_A3D3	2.296070071	13.12004764	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	892	1332	0.006756757	0.012012012	3	oligos	OL-Cntl	30	9	9
ACGCAGCGTGTCAATC-1_371G_A3D3	13.94044621	10.46284226	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1338	2187	0.001371742	0.006401463	3	oligos	OL-Cntl	30	9	9
ACGCAGCGTTAGTGGG-1_371G_A3D3	-2.828666195	13.90016157	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	728	1011	0.008902077	0.025717112	3	oligos	OL-Cntl	30	9	9
ACGCAGCTCACCTCGT-1_371G_A3D3	27.6954522	-3.681858461	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3778	9772	0.003786328	0.003581662	3	2	EN-L4	30	9	9
ACGCCAGAGCGATGAC-1_371G_A3D3	1.89755018	12.63737979	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1045	1608	0.002487562	0.019900498	3	oligos	OL-Cntl	30	9	9
ACGCCAGCAAGACACG-1_371G_A3D3	35.55122006	-8.689822675	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	6846	22836	0.008232615	0.007488177	3	2	EN-L4	30	9	9
ACGCCAGGTCGCTTCT-1_371G_A3D3	-14.23203115	1.119958714	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3369	7250	0.004413793	0.008	3	13A	IN-VIP	30	9	9
ACGCCAGTCGCAGGCT-1_371G_A3D3	-20.57318878	-6.594820968	13B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4960	11976	0.010270541	0.011606546	3	13B	IN-SV2C	30	9	9
ACGCCAGTCTGATTCT-1_371G_A3D3	-3.382842894	13.74251868	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	793	1133	0.004413063	0.030891439	3	oligos	OL-Cntl	30	9	9
ACGCCGACACTGCCAG-1_371G_A3D3	6.209922032	-19.85877569	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4356	10923	0.009246544	0.005492996	3	L2-3	EN-L2-3-MS	30	9	9
ACGCCGACAGTAACGG-1_371G_A3D3	-26.21039591	-22.69432435	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5321	13384	0.006948595	0.016885834	3	6A	IN-PV	30	9	9
ACGCCGAGTAAGTGTA-1_371G_A3D3	-2.999284676	15.1796387	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	757	1037	0.005785921	0.020250723	3	oligos	OL-Cntl	30	9	9
ACGCCGAGTCATATGC-1_371G_A3D3	-23.56764906	21.30166224	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1242	2003	0.000499251	0.001497753	3	8	Astrocytes	30	9	9
ACGCCGAGTTAAGATG-1_371G_A3D3	18.44522704	-24.32797297	3	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5714	15835	0.002968109	0.015029997	3	3	EN-L5-6	30	9	9
ACGCCGATCACCGTAA-1_371G_A3D3	-23.44207061	-25.14277562	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3639	8360	0.003947368	0.006100478	3	6A	IN-PV	30	9	9
ACGCCGATCCTCCTAG-1_371G_A3D3	-22.93542678	-19.15409652	6B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2864	5895	0.004410517	0.014588634	3	6B	IN-SST	30	9	9
ACGGAGAAGGCGACAT-1_371G_A3D3	8.111644177	-21.86799043	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	6805	20346	0.00501327	0.007667355	3	L2-3	EN-L2-3-MS	30	9	9
ACGGAGAAGGTGACCA-1_371G_A3D3	-19.63040356	-22.60001797	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2100	3647	0.021387442	0.003838772	3	6A	IN-PV	30	9	9
ACGGAGACATACGCTA-1_371G_A3D3	0.21085668	15.23939766	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	885	1315	0.000760456	0.015209125	3	oligos	OL-Cntl	30	9	9
ACGGAGACATTTGCTT-1_371G_A3D3	1.238714224	15.32717799	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	910	1411	0.004252303	0.009922041	3	oligos	OL-Cntl	30	9	9
ACGGAGAGTCTCACCT-1_371G_A3D3	-4.42043907	-18.51382693	10	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3493	8879	0.001013628	0.005856515	3	L2-3	EN-L2-3-Cntl	30	9	9
ACGGAGAGTGACGCCT-1_371G_A3D3	10.94922216	11.86343345	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1186	2009	0.004479841	0.005475361	3	oligos	OL-Cntl	30	9	9
ACGGAGATCAAAGTAG-1_371G_A3D3	-22.20524681	-25.25370632	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3009	6380	0.012695925	0.003448276	3	6A	IN-PV	30	9	9
ACGGAGATCCACGACG-1_371G_A3D3	21.80861426	-23.38501812	3	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5446	16943	0.019713156	0.00619725	3	3	EN-L5-6	30	9	9
ACGGAGATCCCTCTTT-1_371G_A3D3	8.771954589	15.45703176	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1060	1848	0.001623377	0.008116883	3	oligos	OL-Cntl	30	9	9
ACGGCCAAGAAACCGC-1_371G_A3D3	35.76995426	-11.15955985	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5354	13759	0.009012283	0.018387964	3	2	EN-L4	30	9	9
ACGGCCAAGATACACA-1_371G_A3D3	-23.15666318	-19.38218389	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3841	8894	0.005284461	0.007533168	3	6A	IN-PV	30	9	9
ACGGCCAAGCTGAACG-1_371G_A3D3	3.985129431	15.81631031	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	917	1360	0.001470588	0.011029412	3	oligos	OL-Cntl	30	9	9
ACGGCCATCAAGCCTA-1_371G_A3D3	5.633461775	-20.95414798	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5744	18121	0.002317753	0.005463275	3	L2-3	EN-L2-3-MS	30	9	9
ACGGCCATCACGCGGT-1_371G_A3D3	18.48588869	-24.18132699	3	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4988	13087	0.006800642	0.017345457	3	3	EN-L5-6	30	9	9
ACGGCCATCTGGAGCC-1_371G_A3D3	3.578280997	20.24151947	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	943	1327	0.00075358	0.006028636	3	oligos	OL-Cntl	30	9	9
ACGGGCTAGTGAACAT-1_371G_A3D3	11.01245438	-25.59840989	10	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	7547	28326	0.006919438	0.003671539	3	L2-3	EN-L2-3-Cntl	30	9	9
ACGGGCTCATCACGAT-1_371G_A3D3	-30.12925028	1.505300536	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2103	3609	0.00166251	0.005264616	3	9	OPC	30	9	9
ACGGGCTGTCAGAATA-1_371G_A3D3	37.51446072	-10.14723086	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	6639	18423	0.004830918	0.011018835	3	2	EN-L4	30	9	9
ACGGGCTGTCTCCACT-1_371G_A3D3	32.62865716	-6.902842647	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3951	9607	0.010721349	0.005516811	3	2	EN-L4	30	9	9
ACGGGCTTCATTATCC-1_371G_A3D3	0.079286996	17.4362825	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	796	1271	0.001573564	0.012588513	3	oligos	OL-Cntl	30	9	9
ACGGGCTTCCGAATGT-1_371G_A3D3	3.288852368	-23.92984664	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3680	8154	0.002943341	0.01214128	3	L2-3	EN-L2-3-MS	30	9	9
ACGGGCTTCTGGTGTA-1_371G_A3D3	-10.06240866	-1.718378474	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2306	4468	0.001566697	0.006266786	3	13A	IN-VIP	30	9	9
ACGGGCTTCTTAGAGC-1_371G_A3D3	-1.996496985	14.15790072	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	788	1106	0.001808318	0.015370705	3	oligos	OL-Cntl	30	9	9
ACGGGCTTCTTCATGT-1_371G_A3D3	5.619891814	-19.25054437	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3532	7862	0.005342152	0.005214958	3	L2-3	EN-L2-3-MS	30	9	9
ACGGGTCAGATCTGAA-1_371G_A3D3	3.138081191	-14.55977337	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2304	4197	0.013342864	0.005003574	3	L2-3	EN-L2-3-MS	30	9	9
ACGGGTCAGGTGACCA-1_371G_A3D3	29.888874	9.57429757	15DB	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1012	1437	0.008350731	0.060542797	3	15DB	B cells	30	9	9
ACGGGTCAGTCCAGGA-1_371G_A3D3	18.83260539	11.69450866	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1355	2323	0	0.00602669	3	oligos	OL-Cntl	30	9	9
ACGGGTCAGTGACATA-1_371G_A3D3	15.61800297	6.441250729	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1892	3507	0.0071286	0.00855432	3	oligos	OL-Cntl	30	9	9
ACGGGTCCAAGACGTG-1_371G_A3D3	7.430563294	-19.19972785	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5570	15410	0.003828683	0.008825438	3	L2-3	EN-L2-3-MS	30	9	9
ACGGGTCCAAGGACTG-1_371G_A3D3	18.99996385	-7.216216254	3	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2234	4478	0.006922733	0.002903082	3	3	EN-L5-6	30	9	9
ACGGGTCCACACCGCA-1_371G_A3D3	29.63385101	9.594236223	15DB	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1380	3631	0.01019003	0.043238777	3	15DB	B cells	30	9	9
ACGGGTCCAGACGTAG-1_371G_A3D3	-26.10450092	-22.51933388	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3686	7943	0.00717613	0.020521214	3	6A	IN-PV	30	9	9
ACGGGTCCATGCTGGC-1_371G_A3D3	12.0351533	9.240479102	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1506	2573	0.001554606	0.010104936	3	oligos	OL-Cntl	30	9	9
ACGGGTCTCTCGCTTG-1_371G_A3D3	-15.93478931	15.72783476	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2496	5488	0.000364431	0.008017493	3	8	Astrocytes	30	9	9
ACGTCAAAGCGGCTTC-1_371G_A3D3	35.41118118	-7.052466669	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3806	8592	0.013500931	0.005121043	3	2	EN-L4	30	9	9
ACGTCAAAGGAATGGA-1_371G_A3D3	8.352504298	13.76539344	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	978	1489	0.000671592	0.015446608	3	oligos	OL-Cntl	30	9	9
ACGTCAAGTATCACCA-1_371G_A3D3	35.15309212	-9.698292977	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4659	11120	0.004946043	0.012320144	3	2	EN-L4	30	9	9
ACGTCAAGTGTAACGG-1_371G_A3D3	-2.612646291	-0.914690025	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3203	6080	0.006907895	0.006414474	3	13A	IN-VIP	30	9	9
ACTATCTAGAGGGCTT-1_371G_A3D3	-11.73753004	28.28812919	16	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1576	2521	0.010710036	0.014676716	3	16	EN-PYR	30	9	9
ACTATCTCACCACGTG-1_371G_A3D3	8.056938584	16.24431083	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	860	1369	0.011687363	0.002191381	3	oligos	OL-Cntl	30	9	9
ACTATCTTCGCTTAGA-1_371G_A3D3	-21.95866991	-24.90735269	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2772	6011	0.022791549	0.004824488	3	6A	IN-PV	30	9	9
ACTGAACAGAGTACCG-1_371G_A3D3	-2.971557024	14.62230576	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	770	1113	0.007187781	0.014375562	3	oligos	OL-Cntl	30	9	9
ACTGAACAGCAGCCTC-1_371G_A3D3	-0.361539692	13.63941982	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	822	1173	0.000852515	0.014492754	3	oligos	OL-Cntl	30	9	9
ACTGAACAGTGCGATG-1_371G_A3D3	35.49220381	7.866600132	14	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	957	1348	0.013353116	0.013353116	3	14	Microglia	30	9	9
ACTGAACAGTGTTAGA-1_371G_A3D3	-0.596590481	13.25469904	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	988	1527	0.007858546	0.008513425	3	oligos	OL-Cntl	30	9	9
ACTGAACCAAAGCAAT-1_371G_A3D3	-18.44466753	-9.950596794	13B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4164	9821	0.004174728	0.008756746	3	13B	IN-SV2C	30	9	9
ACTGAACCAATGAAAC-1_371G_A3D3	19.94000351	-28.79776943	3	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3701	9333	0.00096432	0.006107361	3	3	EN-L5-6	30	9	9
ACTGAACCATTCCTGC-1_371G_A3D3	13.33761257	10.97853926	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1324	2072	0.002413127	0.00965251	3	oligos	OL-Cntl	30	9	9
ACTGAACTCAGATAAG-1_371G_A3D3	13.71855791	6.889863041	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1847	3235	0.001545595	0.012055641	3	oligos	OL-Cntl	30	9	9
ACTGAACTCCCGGATG-1_371G_A3D3	1.456798303	15.08697365	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	861	1376	0.015261628	0.013081395	3	oligos	OL-Cntl	30	9	9
ACTGAACTCTCTAAGG-1_371G_A3D3	37.88313603	14.75363931	14	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1341	2079	0.002886003	0.011063011	3	14	Microglia	30	9	9
ACTGAGTAGATATGCA-1_371G_A3D3	4.340769806	-22.08086152	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4808	14125	0.008778761	0.004318584	3	L2-3	EN-L2-3-MS	30	9	9
ACTGAGTAGGGTTTCT-1_371G_A3D3	-19.17996831	25.80298619	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1805	3116	0.006097561	0.005455712	3	8	Astrocytes	30	9	9
ACTGAGTCAAGACACG-1_371G_A3D3	-18.99628743	-27.11898553	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2935	6903	0.006229176	0.003042156	3	6A	IN-PV	30	9	9
ACTGAGTCACGAAACG-1_371G_A3D3	35.97893156	-10.67497215	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4138	8894	0.006071509	0.011693276	3	2	EN-L4	30	9	9
ACTGAGTCACGGACAA-1_371G_A3D3	-29.97940425	0.569368454	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2028	3402	0.001763668	0.005291005	3	9	OPC	30	9	9
ACTGAGTTCCGGCACA-1_371G_A3D3	14.89458201	11.7247675	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1420	2412	0.002487562	0.005389718	3	oligos	OL-Cntl	30	9	9
ACTGAGTTCTCGGACG-1_371G_A3D3	8.536520968	10.18210489	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1157	2022	0.004945598	0.010880317	3	oligos	OL-Cntl	30	9	9
ACTGATGAGCTGTTCA-1_371G_A3D3	-22.09231258	-25.76569532	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2975	6818	0.001026694	0.008360223	3	6A	IN-PV	30	9	9
ACTGATGAGGACCACA-1_371G_A3D3	-29.90370459	10.41556613	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	696	1009	0.007928642	0.008919722	3	8	Astrocytes	30	9	9
ACTGATGCATGGAATA-1_371G_A3D3	-23.22205105	22.89021591	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1512	2870	0.00174216	0.002090592	3	8	Astrocytes	30	9	9
ACTGATGGTAAGCACG-1_371G_A3D3	3.088444469	14.63993971	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	956	1403	0.003563792	0.013542409	3	oligos	OL-Cntl	30	9	9
ACTGATGGTACCGTAT-1_371G_A3D3	2.748110475	11.6871345	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1046	1602	0.001872659	0.017478152	3	oligos	OL-Cntl	30	9	9
ACTGATGGTTCCACTC-1_371G_A3D3	-1.288690861	13.71845538	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	870	1217	0.004108463	0.027937551	3	oligos	OL-Cntl	30	9	9
ACTGATGGTTCTCATT-1_371G_A3D3	-1.77161492	17.41092272	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	715	1026	0.000974659	0.009746589	3	oligos	OL-Cntl	30	9	9
ACTGATGTCCTCAATT-1_371G_A3D3	-21.3594652	-20.16832521	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2351	4649	0.010324801	0.008604001	3	6A	IN-PV	30	9	9
ACTGATGTCGCTTAGA-1_371G_A3D3	4.774111449	-19.60205819	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3693	8636	0.00185271	0.003589625	3	L2-3	EN-L2-3-MS	30	9	9
ACTGATGTCTTCAACT-1_371G_A3D3	-19.88275032	26.28642587	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1663	2783	0.000359324	0.004311894	3	8	Astrocytes	30	9	9
ACTGCTCAGGGTTTCT-1_371G_A3D3	-16.24324002	-19.09868036	6B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1820	3596	0.001668521	0.002502781	3	6B	IN-SST	30	9	9
ACTGCTCCACAAGACG-1_371G_A3D3	-14.54200118	-9.811376581	13B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2554	4885	0.006345957	0.003889458	3	13B	IN-SV2C	30	9	9
ACTGCTCCATCAGTCA-1_371G_A3D3	-14.81109475	1.101560651	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3551	7607	0.009464966	0.008413304	3	13A	IN-VIP	30	9	9
ACTGCTCGTATAAACG-1_371G_A3D3	0.200458498	19.20750816	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	797	1149	0.00435161	0.005221932	3	oligos	OL-Cntl	30	9	9
ACTGCTCTCCGTTGTC-1_371G_A3D3	3.590722028	-17.84383358	10	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2865	6055	0.001321222	0.006606111	3	L2-3	EN-L2-3-Cntl	30	9	9
ACTGCTCTCGGAAATA-1_371G_A3D3	8.782790607	-6.337899164	10	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1613	2898	0.015873016	0.001380262	3	L2-3	EN-L2-3-Cntl	30	9	9
ACTGTCCAGGACAGAA-1_371G_A3D3	-8.379715196	7.642059601	5	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	757	1057	0.002838221	0.029328288	3	oligos	OL-MS-1	30	9	9
ACTGTCCAGGTCATCT-1_371G_A3D3	-29.45019898	10.30861765	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	766	1090	0.008256881	0.004587156	3	8	Astrocytes	30	9	9
ACTGTCCAGTAATCCC-1_371G_A3D3	-28.87753885	21.3682082	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1112	1782	0.000561167	0.002805836	3	8	Astrocytes	30	9	9
ACTGTCCCATGGTCAT-1_371G_A3D3	15.5960592	9.905799141	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1534	2687	0.00334946	0.005954596	3	oligos	OL-Cntl	30	9	9
ACTGTCCGTACTTGAC-1_371G_A3D3	10.69820174	-27.78557562	10	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	7499	30038	0.001065317	0.005026966	3	L2-3	EN-L2-3-Cntl	30	9	9
ACTGTCCGTCCGACGT-1_371G_A3D3	9.622323566	7.830520339	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1723	3020	0.000993377	0.009271523	3	oligos	OL-Cntl	30	9	9
ACTGTCCGTCTAGTGT-1_371G_A3D3	-32.53648447	-3.652822658	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1396	2392	0.001672241	0.010033445	3	9	OPC	30	9	9
ACTGTCCTCCTATGTT-1_371G_A3D3	-0.617166508	20.0821722	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	682	1005	0.002985075	0.015920398	3	oligos	OL-Cntl	30	9	9
ACTGTCCTCGGAGGTA-1_371G_A3D3	-23.37505971	-26.11479994	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4997	13105	0.000839374	0.00869897	3	6A	IN-PV	30	9	9
ACTTACTAGCGTAATA-1_371G_A3D3	-18.74594679	-24.22787432	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2407	4866	0.009864365	0.005548705	3	6A	IN-PV	30	9	9
ACTTACTAGCTCAACT-1_371G_A3D3	8.523272394	15.81434484	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1009	1748	0.001144165	0.005720824	3	oligos	OL-Cntl	30	9	9
ACTTACTCATACCATG-1_371G_A3D3	2.639740941	13.36318912	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	891	1306	0.000765697	0.014548239	3	oligos	OL-Cntl	30	9	9
ACTTACTGTTGTGGCC-1_371G_A3D3	8.584046299	21.38458783	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	881	1255	0.000796813	0.00876494	3	oligos	OL-Cntl	30	9	9
ACTTACTTCTGTTTGT-1_371G_A3D3	-10.77552054	-0.948973869	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2276	4148	0.009643202	0.005303761	3	13A	IN-VIP	30	9	9
ACTTGTTCAAGTTGTC-1_371G_A3D3	4.212182306	-22.09925605	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5144	16711	0.001555861	0.004727425	3	L2-3	EN-L2-3-MS	30	9	9
ACTTGTTCAGTCGATT-1_371G_A3D3	-33.39841973	-2.910821678	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1423	2454	0.00203749	0.009779951	3	9	OPC	30	9	9
ACTTGTTGTCATATCG-1_371G_A3D3	-32.61639916	-8.578764949	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1024	1522	0.004599212	0.007227332	3	9	OPC	30	9	9
ACTTGTTTCGTAGGTT-1_371G_A3D3	-0.532989032	17.71071964	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	783	1135	0.007048458	0.008810573	3	oligos	OL-Cntl	30	9	9
ACTTGTTTCGTATCAG-1_371G_A3D3	5.813742305	-18.3237522	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3422	7601	0.002894356	0.014208657	3	L2-3	EN-L2-3-MS	30	9	9
ACTTGTTTCTGGTTCC-1_371G_A3D3	-1.177509561	17.93905721	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	837	1323	0.004535147	0.009070295	3	oligos	OL-Cntl	30	9	9
ACTTTCAAGATGGGTC-1_371G_A3D3	0.48574233	21.26532469	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	719	1067	0.001874414	0.00656045	3	oligos	OL-Cntl	30	9	9
ACTTTCACAATGTAAG-1_371G_A3D3	19.56482557	-6.878230471	3	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2323	5338	0.001124016	0.003559386	3	3	EN-L5-6	30	9	9
ACTTTCACATGGTAGG-1_371G_A3D3	14.02797936	20.62146234	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	908	1316	0.003039514	0.004559271	3	oligos	OL-Cntl	30	9	9
ACTTTCAGTGAGGGAG-1_371G_A3D3	-9.051773148	-1.472550188	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2204	4253	0.008464613	0.005172819	3	13A	IN-VIP	30	9	9
ACTTTCAGTTACCGAT-1_371G_A3D3	3.734581102	5.095316168	7	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1333	2059	0.003885381	0.012627489	3	7	Phagocytes	30	9	9
ACTTTCAGTTCACCTC-1_371G_A3D3	-9.091526522	-0.5523172	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2337	5084	0.000983478	0.006490952	3	13A	IN-VIP	30	9	9
ACTTTCATCCAAGCCG-1_371G_A3D3	-18.95401033	26.15018205	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1989	3799	0	0.00368518	3	8	Astrocytes	30	9	9
ACTTTCATCCAATGGT-1_371G_A3D3	-33.97557084	-0.243063519	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1645	2918	0.001028101	0.007539411	3	9	OPC	30	9	9
ACTTTCATCTGTCTAT-1_371G_A3D3	31.31087894	-7.134136816	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3878	9945	0.006535948	0.005530417	3	2	EN-L4	30	9	9
AGAATAGGTGGACGAT-1_371G_A3D3	-22.68773656	25.78517354	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1616	2759	0	0.003624502	3	8	Astrocytes	30	9	9
AGAATAGTCAGCATGT-1_371G_A3D3	35.77126028	-10.93066577	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4737	11274	0.006031577	0.009136065	3	2	EN-L4	30	9	9
AGAATAGTCTTAGCCC-1_371G_A3D3	22.86187604	-27.94176942	3	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4030	10473	0.000763869	0.003246443	3	3	EN-L5-6	30	9	9
AGACGTTAGGAATGGA-1_371G_A3D3	9.71591756	13.98640536	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1175	1838	0.007616975	0.011425462	3	oligos	OL-Cntl	30	9	9
AGACGTTAGGCAGGTT-1_371G_A3D3	13.86222362	9.030975866	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1573	2968	0.003706199	0.006401617	3	oligos	OL-Cntl	30	9	9
AGACGTTAGGTGCACA-1_371G_A3D3	1.466901738	17.34486375	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	755	1158	0.000863558	0.020725389	3	oligos	OL-Cntl	30	9	9
AGACGTTAGTATTGGA-1_371G_A3D3	33.01409201	-6.690219358	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3317	6777	0.003984064	0.006492548	3	2	EN-L4	30	9	9
AGACGTTCAGGAATCG-1_371G_A3D3	-29.71321667	-0.058672632	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1716	2738	0.005113221	0.007669832	3	9	OPC	30	9	9
AGACGTTCATGCAATC-1_371G_A3D3	36.05019064	-8.115047034	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4670	11779	0.001273453	0.010187622	3	2	EN-L4	30	9	9
AGACGTTGTACGCACC-1_371G_A3D3	-1.94818821	13.51310287	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	841	1231	0.004061738	0.020308692	3	oligos	OL-Cntl	30	9	9
AGACGTTGTCAGCTAT-1_371G_A3D3	-26.93137219	-1.162649684	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1790	3036	0.004940711	0.008893281	3	9	OPC	30	9	9
AGACGTTGTCATGCAT-1_371G_A3D3	1.831133263	14.49436207	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	863	1266	0.003159558	0.018167457	3	oligos	OL-Cntl	30	9	9
AGACGTTGTGACGCCT-1_371G_A3D3	-7.579504935	9.865513227	5	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	749	1054	0.001897533	0.027514231	3	oligos	OL-MS-1	30	9	9
AGACGTTGTGGGTCAA-1_371G_A3D3	-19.07267782	26.01608483	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1804	3143	0	0.007317849	3	8	Astrocytes	30	9	9
AGACGTTTCCTGCTTG-1_371G_A3D3	10.084968	6.999127695	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1508	2413	0.001243266	0.018648985	3	oligos	OL-Cntl	30	9	9
AGACGTTTCGTGGTCG-1_371G_A3D3	-33.94912281	-0.969038238	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1650	2779	0.001799208	0.006117308	3	9	OPC	30	9	9
AGAGCGACACAAGTAA-1_371G_A3D3	37.39882247	-9.864980392	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5489	13888	0.008856567	0.006840438	3	2	EN-L4	30	9	9
AGAGCGACACGTTGGC-1_371G_A3D3	-2.682247244	13.51482668	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	783	1070	0.002803738	0.027102804	3	oligos	OL-Cntl	30	9	9
AGAGCGACATCGGTTA-1_371G_A3D3	4.710819651	-17.30244918	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2835	5639	0.004256074	0.012768221	3	L2-3	EN-L2-3-MS	30	9	9
AGAGCGAGTCTAGGTT-1_371G_A3D3	-25.28629788	12.39818244	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1006	1500	0.004666667	0.006	3	8	Astrocytes	30	9	9
AGAGCGATCAGCGACC-1_371G_A3D3	10.14277155	-24.34296021	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	6699	24454	0.010836673	0.004171097	3	L2-3	EN-L2-3-MS	30	9	9
AGAGCGATCCCAAGAT-1_371G_A3D3	1.21123282	17.74157485	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	818	1220	0.008196721	0.004098361	3	oligos	OL-Cntl	30	9	9
AGAGCTTAGATGCGAC-1_371G_A3D3	-15.2423777	-22.80621338	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1494	2478	0.008878128	0.002824859	3	6A	IN-PV	30	9	9
AGAGCTTAGCGTGAGT-1_371G_A3D3	-35.64109026	-10.12103401	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	965	1501	0.000666223	0.00266489	3	9	OPC	30	9	9
AGAGCTTCAGATGAGC-1_371G_A3D3	-9.217697818	-3.301363189	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1674	3000	0.023666667	0.006333333	3	13A	IN-VIP	30	9	9
AGAGCTTTCACTGGGC-1_371G_A3D3	-25.72779976	11.91388332	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	984	1741	0.00459506	0.008615738	3	8	Astrocytes	30	9	9
AGAGTGGAGGACGAAA-1_371G_A3D3	-19.49289644	-20.23841938	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1648	2538	0.00394011	0.013790386	3	6A	IN-PV	30	9	9
AGAGTGGCACAACGTT-1_371G_A3D3	-18.0968906	0.957412141	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4456	10273	0.012459846	0.017326974	3	13A	IN-VIP	30	9	9
AGAGTGGGTGCTTCTC-1_371G_A3D3	14.14607722	9.286932181	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1556	2767	0.001807011	0.005782436	3	oligos	OL-Cntl	30	9	9
AGAGTGGGTGTCAATC-1_371G_A3D3	-23.01507631	22.82961085	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1414	2361	0.000847099	0.004235493	3	8	Astrocytes	30	9	9
AGAGTGGTCCTTTACA-1_371G_A3D3	-23.55180012	-18.79100802	6B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3096	6432	0.010727612	0.021299751	3	6B	IN-SST	30	9	9
AGAGTGGTCTCTTGAT-1_371G_A3D3	0.340910303	18.52314086	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	668	1007	0.003972195	0.002979146	3	oligos	OL-Cntl	30	9	9
AGATCTGAGCCACCTG-1_371G_A3D3	7.062094979	26.37199594	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	873	1281	0.006245121	0.005464481	3	oligos	OL-Cntl	30	9	9
AGATCTGAGTTCGATC-1_371G_A3D3	7.0794983	-18.105224	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3637	7958	0.006785625	0.010304097	3	L2-3	EN-L2-3-MS	30	9	9
AGATCTGCAAGTCATC-1_371G_A3D3	7.58619743	-18.28048273	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5341	14892	0.005640612	0.011214075	3	L2-3	EN-L2-3-MS	30	9	9
AGATCTGGTAATCACC-1_371G_A3D3	0.777219276	17.62119135	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	731	1140	0	0.012280702	3	oligos	OL-Cntl	30	9	9
AGATCTGGTATCTGCA-1_371G_A3D3	-30.28661448	11.59353954	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	880	1289	0.006982157	0.006982157	3	8	Astrocytes	30	9	9
AGATCTGGTTCCCTTG-1_371G_A3D3	-20.84008962	26.31975582	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1770	3286	0.003956178	0.001825928	3	8	Astrocytes	30	9	9
AGATCTGTCACATAGC-1_371G_A3D3	-21.26681865	26.28784679	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1709	3182	0.003771213	0.002514142	3	8	Astrocytes	30	9	9
AGATCTGTCCCTAATT-1_371G_A3D3	35.82388055	-8.416894283	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5041	13696	0.007228388	0.006206192	3	2	EN-L4	30	9	9
AGATCTGTCGTTACAG-1_371G_A3D3	8.066204437	15.0002693	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	962	1469	0.002042206	0.008168822	3	oligos	OL-Cntl	30	9	9
AGATCTGTCTTCAACT-1_371G_A3D3	10.77608836	22.99604485	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	803	1297	0	0.00154202	3	oligos	OL-Cntl	30	9	9
AGATTGCAGCTCCCAG-1_371G_A3D3	9.897881762	8.032240861	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1636	3060	0.001633987	0.007189542	3	oligos	OL-Cntl	30	9	9
AGATTGCCAAGGTTCT-1_371G_A3D3	5.553862837	-17.68320183	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3229	6855	0.005251641	0.007148067	3	L2-3	EN-L2-3-MS	30	9	9
AGATTGCCACCCATGG-1_371G_A3D3	-21.21893485	26.08493394	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1660	2911	0.002404672	0.002748196	3	8	Astrocytes	30	9	9
AGATTGCGTAAGGATT-1_371G_A3D3	-2.567261622	13.91885324	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	777	1102	0.001814882	0.022686025	3	oligos	OL-Cntl	30	9	9
AGATTGCGTTAAAGAC-1_371G_A3D3	11.04696434	9.399064002	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1278	2037	0.001963672	0.011291114	3	oligos	OL-Cntl	30	9	9
AGATTGCTCTGTGCAA-1_371G_A3D3	4.355089582	14.32844971	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1051	1609	0.001243008	0.008701057	3	oligos	OL-Cntl	30	9	9
AGCAGCCAGGAGCGAG-1_371G_A3D3	16.38544914	-6.666467784	3	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1774	2923	0.013342456	0.003079028	3	3	EN-L5-6	30	9	9
AGCAGCCCAGCTGTGC-1_371G_A3D3	-30.44246947	1.618131806	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2151	3899	0.00128238	0.005642472	3	9	OPC	30	9	9
AGCAGCCCAGGTGCCT-1_371G_A3D3	5.348521894	14.5524301	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1047	1557	0.003853565	0.015414258	3	oligos	OL-Cntl	30	9	9
AGCAGCCGTCATGCAT-1_371G_A3D3	-22.38278826	19.12971771	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1413	2426	0.004122012	0.004534213	3	8	Astrocytes	30	9	9
AGCAGCCTCGCGATCG-1_371G_A3D3	9.639429987	7.889231846	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1632	2709	0.00073828	0.014396456	3	oligos	OL-Cntl	30	9	9
AGCATACAGGAATGGA-1_371G_A3D3	2.818103718	14.98646267	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1102	1692	0.004728132	0.010638298	3	oligos	OL-Cntl	30	9	9
AGCATACAGGCTCTTA-1_371G_A3D3	-30.7644498	1.640274678	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1931	3332	0.005102041	0.006002401	3	9	OPC	30	9	9
AGCATACAGTCACGCC-1_371G_A3D3	-28.99319021	1.044622802	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2176	4065	0.005412054	0.011070111	3	9	OPC	30	9	9
AGCATACAGTGTACGG-1_371G_A3D3	6.302587736	-19.70666831	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4960	12997	0.00369316	0.009925367	3	L2-3	EN-L2-3-MS	30	9	9
AGCATACCATCCTAGA-1_371G_A3D3	-12.46535223	-10.30072189	13B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1708	2976	0.016129032	0.005040323	3	13B	IN-SV2C	30	9	9
AGCATACGTGCACTTA-1_371G_A3D3	-2.447074457	16.01360201	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	783	1212	0.004125413	0.01650165	3	oligos	OL-Cntl	30	9	9
AGCATACTCACCAGGC-1_371G_A3D3	-8.729163889	-19.71433847	6B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	778	1327	0.016578749	0.006028636	3	6B	IN-SST	30	9	9
AGCATACTCATACGGT-1_371G_A3D3	-2.92624557	14.78763299	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	723	1076	0.001858736	0.016728625	3	oligos	OL-Cntl	30	9	9
AGCATACTCATTTGGG-1_371G_A3D3	-35.33994444	-0.193612891	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1606	3376	0.001184834	0.003258294	3	9	OPC	30	9	9
AGCATACTCCACTCCA-1_371G_A3D3	3.233576114	-24.06703002	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4718	12285	0.001383801	0.010744811	3	L2-3	EN-L2-3-MS	30	9	9
AGCATACTCGCCATAA-1_371G_A3D3	8.633151456	9.968302951	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1136	1862	0.002685285	0.008055854	3	oligos	OL-Cntl	30	9	9
AGCATACTCTCTAAGG-1_371G_A3D3	22.2514301	-6.791065697	3	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1861	2930	0.032081911	0.004095563	3	3	EN-L5-6	30	9	9
AGCCTAAAGGCATGTG-1_371G_A3D3	-24.97386753	12.58304622	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1060	1704	0.004107981	0.002347418	3	8	Astrocytes	30	9	9
AGCCTAAAGGTACTCT-1_371G_A3D3	-0.837842402	23.19019595	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	702	1020	0.001960784	0.009803922	3	oligos	OL-Cntl	30	9	9
AGCCTAAAGTCCCACG-1_371G_A3D3	-9.873108811	14.62029662	11	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1622	2782	0.003235083	0.006110712	3	11	Glia-MIX	30	9	9
AGCCTAAGTGTGACCC-1_371G_A3D3	2.511773858	12.96871581	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	984	1479	0.010141988	0.019607843	3	oligos	OL-Cntl	30	9	9
AGCCTAATCCCACTTG-1_371G_A3D3	35.1562873	-9.723828496	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5148	13151	0.005474869	0.013459053	3	2	EN-L4	30	9	9
AGCCTAATCCGCGTTT-1_371G_A3D3	10.75846585	-24.83371107	10	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	6290	21940	0.004603464	0.006563355	3	L2-3	EN-L2-3-Cntl	30	9	9
AGCCTAATCCTAGAAC-1_371G_A3D3	-20.39354175	-7.069871704	13B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4969	12148	0.003539677	0.013500165	3	13B	IN-SV2C	30	9	9
AGCCTAATCTCACATT-1_371G_A3D3	6.706452395	-30.97537525	10	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	6255	23326	0.003729744	0.003686873	3	L2-3	EN-L2-3-Cntl	30	9	9
AGCGGTCAGCAGGTCA-1_371G_A3D3	-24.10178825	-19.16383404	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4069	8549	0.015557375	0.008071119	3	6A	IN-PV	30	9	9
AGCGGTCAGCTGCGAA-1_371G_A3D3	-22.5051476	-25.15792235	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3149	7351	0.006393688	0.007345939	3	6A	IN-PV	30	9	9
AGCGGTCAGGCAGTCA-1_371G_A3D3	-23.87609009	-25.01725153	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3689	7749	0.008775326	0.009936766	3	6A	IN-PV	30	9	9
AGCGGTCCAATTGCTG-1_371G_A3D3	23.64364983	7.473693481	15BA	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1725	2931	0.063800751	0.039918117	3	15BA	Stromal cells	30	9	9
AGCGGTCCAGCCTTTC-1_371G_A3D3	2.307279325	5.88749026	7	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	871	1252	0.019169329	0.008785942	3	7	Phagocytes	30	9	9
AGCGGTCCATGCCTAA-1_371G_A3D3	3.291912067	9.356289062	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1131	1807	0.003320421	0.024903154	3	oligos	OL-Cntl	30	9	9
AGCGGTCGTAAGAGGA-1_371G_A3D3	1.5155054	14.57347641	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	902	1451	0.008959338	0.014472777	3	oligos	OL-Cntl	30	9	9
AGCGGTCGTAGTGAAT-1_371G_A3D3	20.78669462	10.3015314	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1638	2794	0.00071582	0.006084467	3	oligos	OL-Cntl	30	9	9
AGCGGTCGTCGTCTTC-1_371G_A3D3	1.861405816	19.85516048	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	843	1241	0.002417405	0.011281225	3	oligos	OL-Cntl	30	9	9
AGCGGTCGTTGTGGCC-1_371G_A3D3	-27.46260409	4.375563942	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4916	11792	0.002544098	0.005851425	3	9	OPC	30	9	9
AGCGTATAGATAGCAT-1_371G_A3D3	2.658094336	12.84861282	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1023	1549	0.001936733	0.0174306	3	oligos	OL-Cntl	30	9	9
AGCGTATTCAGTGCAT-1_371G_A3D3	-23.58601462	22.35462294	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1311	2020	0.00049505	0.006930693	3	8	Astrocytes	30	9	9
AGCGTATTCCGGGTGT-1_371G_A3D3	-15.14807848	-8.384429397	13B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2808	5905	0.020829805	0.005249788	3	13B	IN-SV2C	30	9	9
AGCGTCGAGCACGCCT-1_371G_A3D3	-23.11993527	-24.0516111	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3146	6938	0.013980974	0.005477083	3	6A	IN-PV	30	9	9
AGCGTCGCACCCATGG-1_371G_A3D3	-2.814635406	13.9700685	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	725	1010	0.004950495	0.023762376	3	oligos	OL-Cntl	30	9	9
AGCGTCGTCACTCCTG-1_371G_A3D3	-33.84383936	-2.861551963	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1453	2475	0.001212121	0.007676768	3	9	OPC	30	9	9
AGCTCCTAGAATAGGG-1_371G_A3D3	-30.78015434	0.545877579	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1698	2945	0.001358234	0.003735144	3	9	OPC	30	9	9
AGCTCCTCAACACGCC-1_371G_A3D3	3.064329584	18.14390968	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	940	1455	0.000687285	0.002749141	3	oligos	OL-Cntl	30	9	9
AGCTCCTCAAGCCTAT-1_371G_A3D3	29.41929077	0.429361155	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3306	7635	0.003012443	0.004846103	3	2	EN-L4	30	9	9
AGCTCCTCAGGACCCT-1_371G_A3D3	4.163691635	12.17077738	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1142	1826	0.002738226	0.015334064	3	oligos	OL-Cntl	30	9	9
AGCTCCTGTCCAACTA-1_371G_A3D3	35.21584097	-8.126276448	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	6373	18968	0.001054407	0.0085407	3	2	EN-L4	30	9	9
AGCTCCTGTGTTGAGG-1_371G_A3D3	-3.132831536	12.84003987	5	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	871	1263	0	0.0253365	3	oligos	OL-MS-1	30	9	9
AGCTCCTGTTCGCTAA-1_371G_A3D3	-29.11309834	19.59636008	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1148	1849	0.004867496	0.002163332	3	8	Astrocytes	30	9	9
AGCTCCTTCACGACTA-1_371G_A3D3	6.254786048	-19.58688766	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4620	11535	0.002080624	0.007628955	3	L2-3	EN-L2-3-MS	30	9	9
AGCTCCTTCCGTTGTC-1_371G_A3D3	-19.63117303	25.62566136	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1763	3050	0.001311475	0.005245902	3	8	Astrocytes	30	9	9
AGCTCCTTCGCGATCG-1_371G_A3D3	9.27671398	-22.92077708	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	6176	19498	0.005385168	0.007026362	3	L2-3	EN-L2-3-MS	30	9	9
AGCTCCTTCGCGTAGC-1_371G_A3D3	36.00322852	-8.789913108	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4746	11516	0.001910386	0.011896492	3	2	EN-L4	30	9	9
AGCTCCTTCTTGTTTG-1_371G_A3D3	-20.32368633	26.14371192	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1767	3131	0	0.002555094	3	8	Astrocytes	30	9	9
AGCTCTCAGCACACAG-1_371G_A3D3	4.825495256	-21.03186705	10	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4992	13852	0.000938493	0.006280681	3	L2-3	EN-L2-3-Cntl	30	9	9
AGCTCTCCAAGAGGCT-1_371G_A3D3	0.907345841	14.75122653	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	869	1316	0.001519757	0.006838906	3	oligos	OL-Cntl	30	9	9
AGCTCTCCAAGGTGTG-1_371G_A3D3	-24.25730202	-24.90741863	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4697	11340	0.006261023	0.009082892	3	6A	IN-PV	30	9	9
AGCTCTCCATCTGGTA-1_371G_A3D3	7.955809084	12.01742937	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1083	1796	0.000556793	0.0155902	3	oligos	OL-Cntl	30	9	9
AGCTCTCGTACGACCC-1_371G_A3D3	2.400130827	12.69115393	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1021	1659	0.003616637	0.021097046	3	oligos	OL-Cntl	30	9	9
AGCTCTCGTAGCGTCC-1_371G_A3D3	-33.54724024	-3.129189445	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1401	2452	0.002854812	0.007748777	3	9	OPC	30	9	9
AGCTCTCGTCTAAAGA-1_371G_A3D3	11.66727528	7.085249282	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1632	2866	0.001046755	0.015352408	3	oligos	OL-Cntl	30	9	9
AGCTCTCTCATGCATG-1_371G_A3D3	-33.01772406	5.168618581	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3129	6886	0.001307	0.00798722	3	9	OPC	30	9	9
AGCTCTCTCCACTGGG-1_371G_A3D3	13.08826657	7.167276047	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1783	3216	0.004975124	0.009328358	3	oligos	OL-Cntl	30	9	9
AGCTCTCTCGAGAGCA-1_371G_A3D3	4.236587457	10.77953084	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1277	2048	0.005371094	0.020507813	3	oligos	OL-Cntl	30	9	9
AGCTCTCTCTGCGTAA-1_371G_A3D3	9.590500568	7.882731782	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1751	3159	0.002532447	0.006964229	3	oligos	OL-Cntl	30	9	9
AGCTTGAAGGGCACTA-1_371G_A3D3	7.404732668	11.55471291	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	998	1635	0.010397554	0.020795107	3	oligos	OL-Cntl	30	9	9
AGCTTGACACCAGGCT-1_371G_A3D3	-2.096801316	-12.55984825	10	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1980	3639	0.017587249	0.004396812	3	L2-3	EN-L2-3-Cntl	30	9	9
AGCTTGACAGGTCTCG-1_371G_A3D3	-19.10155439	28.2999177	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2276	4271	0.000468274	0.006321705	3	8	Astrocytes	30	9	9
AGCTTGATCAAACGGG-1_371G_A3D3	-20.57897077	-6.229631816	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	6650	19621	0.004637888	0.010397024	3	13A	IN-VIP	30	9	9
AGCTTGATCCAACCAA-1_371G_A3D3	-33.08266866	5.245996365	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3333	7426	0.001211958	0.006329114	3	9	OPC	30	9	9
AGCTTGATCTGAGTGT-1_371G_A3D3	2.267765996	13.40017649	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	974	1595	0.002507837	0.014420063	3	oligos	OL-Cntl	30	9	9
AGGCCACAGCGGCTTC-1_371G_A3D3	-16.15693403	1.547890676	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3897	8260	0.002905569	0.016707022	3	13A	IN-VIP	30	9	9
AGGCCACAGCGTGAAC-1_371G_A3D3	-29.03757785	-0.839819838	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1874	3053	0.005240747	0.010153947	3	9	OPC	30	9	9
AGGCCACCAATCACAC-1_371G_A3D3	35.85755829	-7.520580975	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4149	10203	0.006958738	0.007056748	3	2	EN-L4	30	9	9
AGGCCACCACGCTTTC-1_371G_A3D3	-24.28335909	6.428948146	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	808	1072	0.004664179	0.009328358	3	8	Astrocytes	30	9	9
AGGCCACCATCACCCT-1_371G_A3D3	-25.08743363	22.44150047	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1253	1998	0.001001001	0.007507508	3	8	Astrocytes	30	9	9
AGGCCACTCATAACCG-1_371G_A3D3	-0.849068742	14.45107607	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	760	1044	0.003831418	0.013409962	3	oligos	OL-Cntl	30	9	9
AGGCCGTAGCTTCGCG-1_371G_A3D3	0.440129727	12.92752229	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1047	1579	0.003799873	0.015832806	3	oligos	OL-Cntl	30	9	9
AGGCCGTGTGTTTGGT-1_371G_A3D3	0.226448737	19.5353962	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	795	1169	0.00427716	0.000855432	3	oligos	OL-Cntl	30	9	9
AGGCCGTTCCAAATGC-1_371G_A3D3	-29.98427906	-0.563909734	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1876	3091	0.006470398	0.006470398	3	9	OPC	30	9	9
AGGGAGTAGAGTACAT-1_371G_A3D3	6.687705145	-27.13099259	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5250	13131	0.006625543	0.01317493	3	L2-3	EN-L2-3-MS	30	9	9
AGGGAGTAGATGCCTT-1_371G_A3D3	-22.07220101	23.59260296	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1487	2269	0.002203614	0.006170119	3	8	Astrocytes	30	9	9
AGGGAGTCAATGTAAG-1_371G_A3D3	35.87694084	-9.671185272	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3997	9052	0.011268228	0.010384445	3	2	EN-L4	30	9	9
AGGGAGTCAGCCTTTC-1_371G_A3D3	-0.882490454	15.48240804	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	774	1153	0.002601908	0.013876843	3	oligos	OL-Cntl	30	9	9
AGGGAGTCAGCTGTTA-1_371G_A3D3	-3.193174954	-36.69025481	16	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1025	1335	0.025468165	0.038951311	3	16	EN-PYR	30	9	9
AGGGAGTGTAGCAAAT-1_371G_A3D3	3.743675827	12.01181959	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1004	1428	0.00280112	0.008403361	3	oligos	OL-Cntl	30	9	9
AGGGAGTGTCAAGCGA-1_371G_A3D3	13.72064425	11.53163567	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1290	2060	0.000970874	0.006796117	3	oligos	OL-Cntl	30	9	9
AGGGAGTGTCTAGGTT-1_371G_A3D3	-29.806783	-0.973196127	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1590	2662	0.002629602	0.007137491	3	9	OPC	30	9	9
AGGGAGTGTGCTGTAT-1_371G_A3D3	-12.17406929	1.778614909	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3223	6990	0.001573677	0.005007153	3	13A	IN-VIP	30	9	9
AGGGATGAGCCTATGT-1_371G_A3D3	-2.944794317	14.3105839	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	723	1029	0.006802721	0.019436346	3	oligos	OL-Cntl	30	9	9
AGGGATGAGTGCAAGC-1_371G_A3D3	-23.96069303	1.086372107	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2909	5581	0.001254256	0.013259273	3	9	OPC	30	9	9
AGGGATGCAACTGCTA-1_371G_A3D3	3.490893788	-16.2353193	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3665	9472	0.004539696	0.007495777	3	L2-3	EN-L2-3-MS	30	9	9
AGGGATGGTCGCATCG-1_371G_A3D3	14.79893774	10.48457758	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1583	2647	0.000755572	0.006800151	3	oligos	OL-Cntl	30	9	9
AGGGATGTCAATCTCT-1_371G_A3D3	-24.36773752	0.165631002	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2270	4271	0.001873098	0.008194802	3	9	OPC	30	9	9
AGGGATGTCATAGCAC-1_371G_A3D3	-22.09600636	-17.54205409	6B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3617	8232	0.020165209	0.003522838	3	6B	IN-SST	30	9	9
AGGGATGTCCTTTACA-1_371G_A3D3	-10.81376507	-7.84100663	13B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1861	3357	0.012511171	0.008042895	3	13B	IN-SV2C	30	9	9
AGGGATGTCGGGAGTA-1_371G_A3D3	11.53885105	9.002135291	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1323	2102	0.002378687	0.011893435	3	oligos	OL-Cntl	30	9	9
AGGGTGAAGAGGGCTT-1_371G_A3D3	-23.71603079	17.39625055	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1421	2320	0.004741379	0.009051724	3	8	Astrocytes	30	9	9
AGGGTGAAGAGTCGGT-1_371G_A3D3	-15.32021199	-22.82578707	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1575	2725	0.034862385	0.00293578	3	6A	IN-PV	30	9	9
AGGGTGACAATGAATG-1_371G_A3D3	28.82785976	7.160688094	15DA	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	906	1290	0.03875969	0.079844961	3	15DA	T cells	30	9	9
AGGGTGACAATGTTGC-1_371G_A3D3	0.520858588	13.23872942	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1003	1476	0.004065041	0.015582656	3	oligos	OL-Cntl	30	9	9
AGGGTGAGTAAACGCG-1_371G_A3D3	14.96135489	6.317904152	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2354	4407	0.010664851	0.012707057	3	oligos	OL-Cntl	30	9	9
AGGGTGAGTAGCGCAA-1_371G_A3D3	11.4530079	6.543267972	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1705	2720	0.002573529	0.01875	3	oligos	OL-Cntl	30	9	9
AGGGTGATCAGCATGT-1_371G_A3D3	28.85440804	-4.314125245	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3811	9209	0.004777935	0.005972418	3	2	EN-L4	30	9	9
AGGGTGATCCAAATGC-1_371G_A3D3	-0.408446689	20.62340769	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	702	1107	0.000903342	0.003613369	3	oligos	OL-Cntl	30	9	9
AGGTCATCACTGTTAG-1_371G_A3D3	10.1692265	-27.56727947	10	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	7273	29552	0.000236871	0.006327829	3	L2-3	EN-L2-3-Cntl	30	9	9
AGGTCATGTCATTAGC-1_371G_A3D3	7.438852269	-10.52640011	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2318	4610	0.006507592	0.018438178	3	L2-3	EN-L2-3-MS	30	9	9
AGGTCATGTTCAACCA-1_371G_A3D3	7.89487917	11.92337498	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1188	1937	0.009808983	0.01135777	3	oligos	OL-Cntl	30	9	9
AGGTCATTCTGACCTC-1_371G_A3D3	4.57260896	11.3630783	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1112	1763	0.000567215	0.014747589	3	oligos	OL-Cntl	30	9	9
AGGTCATTCTGAGTGT-1_371G_A3D3	5.234532675	-19.73581789	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3966	9434	0.001907992	0.00752597	3	L2-3	EN-L2-3-MS	30	9	9
AGGTCCGCACATTTCT-1_371G_A3D3	-9.901790437	1.99269867	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3166	7839	0.010460518	0.004082153	3	13A	IN-VIP	30	9	9
AGGTCCGCACCATGTA-1_371G_A3D3	-1.049275589	16.0522731	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	724	1021	0.007835455	0.011753183	3	oligos	OL-Cntl	30	9	9
AGGTCCGCATTCGACA-1_371G_A3D3	-13.46689491	0.652198278	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3053	6668	0.012897421	0.00779844	3	13A	IN-VIP	30	9	9
AGGTCCGGTCACTTCC-1_371G_A3D3	-18.46141223	-27.39385635	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2770	6930	0.002164502	0.001731602	3	6A	IN-PV	30	9	9
AGGTCCGGTGTAAGTA-1_371G_A3D3	-17.4056828	1.379994536	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4164	8923	0.003922448	0.014793231	3	13A	IN-VIP	30	9	9
AGGTCCGTCCGCAAGC-1_371G_A3D3	-7.181682898	-1.90576301	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1892	3426	0.002043199	0.004670169	3	13A	IN-VIP	30	9	9
AGGTCCGTCCTATTCA-1_371G_A3D3	0.077242641	16.69373761	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	770	1226	0.001631321	0.01223491	3	oligos	OL-Cntl	30	9	9
AGGTCCGTCTCGATGA-1_371G_A3D3	26.78628856	4.277156572	15BA	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	812	1148	0.006097561	0.025261324	3	15BA	Stromal cells	30	9	9
AGGTCCGTCTCTGAGA-1_371G_A3D3	7.467515541	10.6620013	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1278	2196	0.001821494	0.015027322	3	oligos	OL-Cntl	30	9	9
AGTAGTCAGAAAGTGG-1_371G_A3D3	5.418583572	11.69067674	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1138	1772	0.006207675	0.017494357	3	oligos	OL-Cntl	30	9	9
AGTAGTCAGACACGAC-1_371G_A3D3	-25.13375735	0.838271398	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3271	7539	0.005571031	0.013397002	3	9	OPC	30	9	9
AGTAGTCAGAGTTGGC-1_371G_A3D3	-14.70722982	-25.09472773	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1681	3283	0.024063357	0.001827597	3	6A	IN-PV	30	9	9
AGTAGTCAGCTGATAA-1_371G_A3D3	-16.3219904	15.94270359	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1990	4096	0.000244141	0.004150391	3	8	Astrocytes	30	9	9
AGTAGTCAGTCGATAA-1_371G_A3D3	-0.030966259	17.48828868	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	792	1152	0.001736111	0.009548611	3	oligos	OL-Cntl	30	9	9
AGTAGTCGTAAGTTCC-1_371G_A3D3	37.43485786	-9.544751539	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3997	9634	0.013286278	0.006643139	3	2	EN-L4	30	9	9
AGTAGTCTCGGTTCGG-1_371G_A3D3	6.387233929	-16.68174513	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3270	6950	0.009064748	0.006043165	3	L2-3	EN-L2-3-MS	30	9	9
AGTCTTTAGGTCATCT-1_371G_A3D3	1.613845778	17.89775354	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	738	1130	0.000884956	0.00619469	3	oligos	OL-Cntl	30	9	9
AGTCTTTAGTTGCAGG-1_371G_A3D3	6.307454739	-18.56107214	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3934	9465	0.003697834	0.007712625	3	L2-3	EN-L2-3-MS	30	9	9
AGTCTTTGTGTTCGAT-1_371G_A3D3	-5.095133419	-10.08109362	13B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1071	1654	0.04050786	0.005441354	3	13B	IN-SV2C	30	9	9
AGTCTTTGTTGTTTGG-1_371G_A3D3	6.253223199	34.38145893	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	949	1589	0.003146633	0.00377596	3	oligos	OL-Cntl	30	9	9
AGTCTTTTCAGGTTCA-1_371G_A3D3	-1.341794297	-0.895234574	11	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2448	4457	0.009647745	0.007404083	3	11	Glia-MIX	30	9	9
AGTCTTTTCGAGCCCA-1_371G_A3D3	-14.99040572	1.413883719	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3345	6909	0.002171081	0.011868577	3	13A	IN-VIP	30	9	9
AGTGAGGAGAACAATC-1_371G_A3D3	7.019004736	10.45733233	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1312	2141	0.001868286	0.014946287	3	oligos	OL-Cntl	30	9	9
AGTGAGGAGATCTGAA-1_371G_A3D3	5.181471121	21.24009376	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	792	1182	0.005076142	0.005076142	3	oligos	OL-Cntl	30	9	9
AGTGAGGCACGGATAG-1_371G_A3D3	10.75373973	9.774930017	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1261	2079	0.003848004	0.007696008	3	oligos	OL-Cntl	30	9	9
AGTGGGAAGCGGCTTC-1_371G_A3D3	13.45221202	7.435734541	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1889	3434	0.001456028	0.00990099	3	oligos	OL-Cntl	30	9	9
AGTGGGAGTAATAGCA-1_371G_A3D3	36.00101771	-11.09921895	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5616	14098	0.007235069	0.011916584	3	2	EN-L4	30	9	9
AGTGGGAGTCTGCGGT-1_371G_A3D3	0.903181029	12.86158434	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1003	1458	0.006858711	0.019890261	3	oligos	OL-Cntl	30	9	9
AGTGGGAGTGAAATCA-1_371G_A3D3	3.711691795	14.45065764	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	928	1386	0	0.014430014	3	oligos	OL-Cntl	30	9	9
AGTGGGAGTGCCTTGG-1_371G_A3D3	3.165042382	11.17195557	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1059	1566	0.007662835	0.03192848	3	oligos	OL-Cntl	30	9	9
AGTGGGAGTTTAAGCC-1_371G_A3D3	5.604161054	-18.50185284	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3237	6910	0.002315485	0.011722142	3	L2-3	EN-L2-3-MS	30	9	9
AGTGGGATCAAAGTAG-1_371G_A3D3	8.224950756	-19.92080676	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5027	12303	0.00495814	0.009103471	3	L2-3	EN-L2-3-MS	30	9	9
AGTGTCAGTACCGTAT-1_371G_A3D3	-29.416081	0.989807808	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2210	4035	0.003965304	0.007434944	3	9	OPC	30	9	9
AGTGTCAGTCTGATCA-1_371G_A3D3	10.71713545	-26.91824274	10	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	7661	29311	0.005936338	0.004264611	3	L2-3	EN-L2-3-Cntl	30	9	9
AGTGTCATCCTTGCCA-1_371G_A3D3	-0.715874857	14.69476355	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	791	1134	0.001763668	0.012345679	3	oligos	OL-Cntl	30	9	9
AGTTGGTAGATCCGAG-1_371G_A3D3	-3.902962156	13.78776338	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	793	1105	0.006334842	0.010859729	3	oligos	OL-Cntl	30	9	9
AGTTGGTAGTACGATA-1_371G_A3D3	29.4142581	0.875623079	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2548	5187	0.003084635	0.004434162	3	2	EN-L4	30	9	9
AGTTGGTCACCGTTGG-1_371G_A3D3	-13.17981971	-18.70190221	6B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1221	2028	0.005424063	0.00443787	3	6B	IN-SST	30	9	9
AGTTGGTCACGACGAA-1_371G_A3D3	2.263614016	12.98549333	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	915	1395	0.000716846	0.02078853	3	oligos	OL-Cntl	30	9	9
AGTTGGTCATCACGTA-1_371G_A3D3	8.514048299	17.71360252	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	846	1305	0.006130268	0.009195402	3	oligos	OL-Cntl	30	9	9
AGTTGGTGTCCGAATT-1_371G_A3D3	-31.20666052	-1.625748203	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1474	2696	0.00037092	0.005192878	3	9	OPC	30	9	9
AGTTGGTTCAAGGTAA-1_371G_A3D3	-28.421971	0.05522085	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1730	2675	0.006728972	0.010841121	3	9	OPC	30	9	9
AGTTGGTTCATCGCTC-1_371G_A3D3	1.380779886	14.09745757	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	878	1306	0.000765697	0.016079632	3	oligos	OL-Cntl	30	9	9
AGTTGGTTCTACGAGT-1_371G_A3D3	-20.68869985	28.02927129	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1935	3489	0.000859845	0.003152766	3	8	Astrocytes	30	9	9
ATAACGCAGAAGGTTT-1_371G_A3D3	-13.90047868	-9.194832598	13B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2269	4497	0.023348899	0.006893485	3	13B	IN-SV2C	30	9	9
ATAACGCAGCAGCGTA-1_371G_A3D3	2.216803511	12.93776624	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	957	1437	0.005567154	0.015309673	3	oligos	OL-Cntl	30	9	9
ATAAGAGGTTGATTCG-1_371G_A3D3	-13.26981224	-15.42687368	6B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1298	1952	0.008709016	0.009221311	3	6B	IN-SST	30	9	9
ATAGACCAGAAGATTC-1_371G_A3D3	-24.71810015	22.73991107	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1334	2239	0.001786512	0.004912908	3	8	Astrocytes	30	9	9
ATAGACCAGACAGAGA-1_371G_A3D3	-25.31342406	11.7228548	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	899	1270	0.001574803	0.007086614	3	8	Astrocytes	30	9	9
ATAGACCCAAGAAGAG-1_371G_A3D3	5.143117821	-19.61687629	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3763	8628	0.00336115	0.005099675	3	L2-3	EN-L2-3-MS	30	9	9
ATAGACCCAGATGGGT-1_371G_A3D3	35.86552942	-11.19895275	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4896	12558	0.005972289	0.008600096	3	2	EN-L4	30	9	9
ATAGACCCATAGACTC-1_371G_A3D3	-9.028505573	-1.752071673	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2170	4319	0.00046307	0.007177587	3	13A	IN-VIP	30	9	9
ATAGACCCATTCCTCG-1_371G_A3D3	-3.822052583	14.34226505	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	757	1054	0.009487666	0.023719165	3	oligos	OL-Cntl	30	9	9
ATAGACCGTCGACTAT-1_371G_A3D3	14.77433187	9.454919313	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1563	2715	0.002578269	0.008839779	3	oligos	OL-Cntl	30	9	9
ATAGACCGTCTAGAGG-1_371G_A3D3	-28.79583889	0.882200182	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2023	3400	0.005882353	0.01	3	9	OPC	30	9	9
ATCACGAAGTACGATA-1_371G_A3D3	4.32649989	-20.39981471	10	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3919	9563	0.00355537	0.005751333	3	L2-3	EN-L2-3-Cntl	30	9	9
ATCACGACAGCTGTTA-1_371G_A3D3	23.44616594	7.385396576	15DA	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2621	4803	0.000416406	0.027482823	3	15DA	T cells	30	9	9
ATCACGACAGTAACGG-1_371G_A3D3	-24.23856502	-19.12306012	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4323	9563	0.008783854	0.009620412	3	6A	IN-PV	30	9	9
ATCACGACAGTGGAGT-1_371G_A3D3	-21.02017979	8.808059045	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	871	1291	0.000774593	0.00232378	3	8	Astrocytes	30	9	9
ATCACGATCCAAGTAC-1_371G_A3D3	10.211026	22.58723318	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	840	1282	0.003900156	0.007020281	3	oligos	OL-Cntl	30	9	9
ATCACGATCGTTGACA-1_371G_A3D3	35.56149008	-10.69118077	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4675	11851	0.006750485	0.008016201	3	2	EN-L4	30	9	9
ATCATCTAGAGCCCAA-1_371G_A3D3	-26.13724018	-0.935258214	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1871	3227	0.005268051	0.010536102	3	9	OPC	30	9	9
ATCATCTAGGATGTAT-1_371G_A3D3	2.493087082	20.50682103	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	912	1402	0.000713267	0.006419401	3	oligos	OL-Cntl	30	9	9
ATCATCTGTATTAGCC-1_371G_A3D3	8.527267697	10.04864971	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1193	2050	0.00195122	0.011707317	3	oligos	OL-Cntl	30	9	9
ATCATCTGTTGTGGAG-1_371G_A3D3	-11.51240818	28.41558583	17	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2236	3842	0.008068714	0.016657991	3	oligos	OL-MS-2	30	9	9
ATCATCTTCCCAAGTA-1_371G_A3D3	-35.97175477	-4.076381073	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1260	2126	0.000470367	0.005644403	3	9	OPC	30	9	9
ATCATCTTCCGTAGGC-1_371G_A3D3	8.89075354	16.65393386	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	945	1511	0.003309067	0.009265387	3	oligos	OL-Cntl	30	9	9
ATCATCTTCTGGAGCC-1_371G_A3D3	28.8086613	-4.043714291	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4328	11822	0.001776349	0.006851633	3	2	EN-L4	30	9	9
ATCATGGGTGCACGAA-1_371G_A3D3	-17.40602502	1.448255065	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4503	10237	0.008107844	0.016020318	3	13A	IN-VIP	30	9	9
ATCATGGTCACAACGT-1_371G_A3D3	35.52527718	-7.197148794	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3879	9427	0.008168028	0.004667445	3	2	EN-L4	30	9	9
ATCATGGTCTCGCATC-1_371G_A3D3	35.79995077	-11.4346687	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5671	15732	0.00336893	0.012712942	3	2	EN-L4	30	9	9
ATCCACCAGTCGAGTG-1_371G_A3D3	11.91431099	6.596128783	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2026	3604	0.003884573	0.011653718	3	oligos	OL-Cntl	30	9	9
ATCCACCCAAAGTGCG-1_371G_A3D3	-19.17062554	29.16123779	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2175	4054	0.00123335	0.004933399	3	8	Astrocytes	30	9	9
ATCCACCCATGCTAGT-1_371G_A3D3	-4.651599946	6.226154697	5	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1172	1706	0.002930832	0.052754982	3	oligos	OL-MS-1	30	9	9
ATCCACCGTTACCGAT-1_371G_A3D3	-15.5217579	1.575814973	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4225	9857	0.009333469	0.009029116	3	13A	IN-VIP	30	9	9
ATCCGAAAGATAGCAT-1_371G_A3D3	1.746911749	20.04891639	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	853	1265	0.002371542	0.007114625	3	oligos	OL-Cntl	30	9	9
ATCCGAAGTAAGGATT-1_371G_A3D3	5.997508989	-19.51539431	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4203	10517	0.007891984	0.005419797	3	L2-3	EN-L2-3-MS	30	9	9
ATCCGAAGTATCAGTC-1_371G_A3D3	6.925191705	-17.30981284	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3762	8063	0.009301749	0.006821282	3	L2-3	EN-L2-3-MS	30	9	9
ATCCGAAGTTACGGAG-1_371G_A3D3	7.41800487	11.31580552	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1155	1859	0.000537924	0.017751479	3	oligos	OL-Cntl	30	9	9
ATCCGAATCCGGCACA-1_371G_A3D3	-25.08018127	13.29166987	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1042	1675	0.00358209	0.00358209	3	8	Astrocytes	30	9	9
ATCCGAATCTAACTGG-1_371G_A3D3	-34.05552729	-0.351556029	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1617	2883	0.002774887	0.009365245	3	9	OPC	30	9	9
ATCGAGTAGTATCTCG-1_371G_A3D3	28.97836846	-13.89685777	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	8645	36626	0.00335827	0.012668596	3	2	EN-L4	30	9	9
ATCGAGTAGTCTTGCA-1_371G_A3D3	-19.16373519	-23.35861501	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2256	4191	0.0255309	0.005726557	3	6A	IN-PV	30	9	9
ATCGAGTGTCAAACTC-1_371G_A3D3	2.140803454	14.48053916	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	948	1439	0.003474635	0.01181376	3	oligos	OL-Cntl	30	9	9
ATCGAGTGTCGTGGCT-1_371G_A3D3	-13.13525667	0.137707764	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2436	4721	0.025630163	0.009955518	3	13A	IN-VIP	30	9	9
ATCGAGTGTTGTTTGG-1_371G_A3D3	-19.23348271	27.74888439	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2155	4030	0.000744417	0.007940447	3	8	Astrocytes	30	9	9
ATCGAGTTCATAACCG-1_371G_A3D3	0.887841075	17.69286473	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	786	1199	0.006672227	0.01000834	3	oligos	OL-Cntl	30	9	9
ATCGAGTTCATTCACT-1_371G_A3D3	9.298098743	9.077146529	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1422	2333	0.004286327	0.015002143	3	oligos	OL-Cntl	30	9	9
ATCGAGTTCCTCCTAG-1_371G_A3D3	-18.10254701	26.00004357	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1869	3145	0.0063593	0.00317965	3	8	Astrocytes	30	9	9
ATCTACTAGAAACGAG-1_371G_A3D3	-22.47857465	-25.10315602	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2899	6527	0.006434809	0.008273326	3	6A	IN-PV	30	9	9
ATCTACTAGTGTCCAT-1_371G_A3D3	-5.302794174	-3.305415387	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1452	2472	0.012135922	0.008090615	3	13A	IN-VIP	30	9	9
ATCTACTCAGACGCTC-1_371G_A3D3	-33.80251961	-2.646431943	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1499	2555	0.001565558	0.003913894	3	9	OPC	30	9	9
ATCTACTCATCACCCT-1_371G_A3D3	-25.90459341	18.34186512	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1281	2309	0.002598528	0.001732352	3	8	Astrocytes	30	9	9
ATCTACTCATCACGTA-1_371G_A3D3	13.16561623	10.39138219	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1375	2493	0.000802246	0.006016847	3	oligos	OL-Cntl	30	9	9
ATCTACTGTATGAAAC-1_371G_A3D3	-5.240547653	-2.990640292	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1508	2615	0.016061185	0.005353728	3	13A	IN-VIP	30	9	9
ATCTACTGTCAATGTC-1_371G_A3D3	-30.01273529	10.57004853	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	803	1115	0.009865471	0.002690583	3	8	Astrocytes	30	9	9
ATCTACTTCAACGAAA-1_371G_A3D3	4.175110266	15.82859755	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1026	1489	0.007387508	0.006044325	3	oligos	OL-Cntl	30	9	9
ATCTACTTCTACCAGA-1_371G_A3D3	-29.85102786	2.098822891	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2491	4660	0.003218884	0.006652361	3	9	OPC	30	9	9
ATCTGCCAGAAGGCCT-1_371G_A3D3	-9.423166419	-16.37021275	6B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	867	1260	0.08015873	0.007142857	3	6B	IN-SST	30	9	9
ATCTGCCAGGATGTAT-1_371G_A3D3	3.423854123	-17.44444332	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3224	7345	0.011300204	0.003403676	3	L2-3	EN-L2-3-MS	30	9	9
ATCTGCCAGTTCGATC-1_371G_A3D3	-0.577728737	21.46430547	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	692	1006	0.011928429	0.003976143	3	oligos	OL-Cntl	30	9	9
ATCTGCCGTCGACTAT-1_371G_A3D3	11.06539157	7.153291195	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1700	2999	0.001667222	0.012337446	3	oligos	OL-Cntl	30	9	9
ATCTGCCTCCATTCTA-1_371G_A3D3	13.53743018	14.70482141	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1068	1751	0.001142204	0.00513992	3	oligos	OL-Cntl	30	9	9
ATGAGGGAGCTACCGC-1_371G_A3D3	32.84229399	-1.42962148	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2434	4830	0.009109731	0.003519669	3	2	EN-L4	30	9	9
ATGAGGGCAAACGCGA-1_371G_A3D3	20.33819117	0.434692921	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1690	2613	0.001913509	0.007654038	3	2	EN-L4	30	9	9
ATGAGGGGTCCGCTGA-1_371G_A3D3	2.989919813	15.05634853	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	874	1361	0.005143277	0.012490816	3	oligos	OL-Cntl	30	9	9
ATGAGGGTCACATACG-1_371G_A3D3	-24.69231911	21.60743736	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1401	2639	0.002273588	0.005683971	3	8	Astrocytes	30	9	9
ATGCGATAGACTGGGT-1_371G_A3D3	12.16855701	6.185744787	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1969	3645	0.004389575	0.017283951	3	oligos	OL-Cntl	30	9	9
ATGCGATAGAGTCGGT-1_371G_A3D3	3.907597298	22.3347401	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	814	1239	0.002421308	0.00645682	3	oligos	OL-Cntl	30	9	9
ATGCGATCACAGGCCT-1_371G_A3D3	2.050620237	19.92293102	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	848	1293	0.00154679	0.005413766	3	oligos	OL-Cntl	30	9	9
ATGCGATCACTTCGAA-1_371G_A3D3	0.847697136	13.4259219	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	991	1570	0.005095541	0.019745223	3	oligos	OL-Cntl	30	9	9
ATGCGATGTAAGAGAG-1_371G_A3D3	-30.45141592	9.559882812	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	734	1003	0.001994018	0.019940179	3	8	Astrocytes	30	9	9
ATGCGATGTGCGCTTG-1_371G_A3D3	28.27146258	-3.608228659	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3395	7782	0.000514007	0.005140067	3	2	EN-L4	30	9	9
ATGCGATTCAGGTAAA-1_371G_A3D3	-28.48305038	0.801833054	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1870	3160	0.004113924	0.019620253	3	9	OPC	30	9	9
ATGGGAGAGTGGAGAA-1_371G_A3D3	9.303512122	-23.41374243	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5037	13641	0.001979327	0.004325196	3	L2-3	EN-L2-3-MS	30	9	9
ATGGGAGCAGTCTTCC-1_371G_A3D3	10.6538857	20.83814094	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	924	1452	0.000688705	0.005509642	3	oligos	OL-Cntl	30	9	9
ATGGGAGGTACCGCTG-1_371G_A3D3	-30.07662396	0.934236659	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1847	3159	0.006331117	0.006647673	3	9	OPC	30	9	9
ATGGGAGTCCTTGGTC-1_371G_A3D3	-12.44997323	1.003088671	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3411	7531	0.008232638	0.003717966	3	13A	IN-VIP	30	9	9
ATGTGTGAGAGGGCTT-1_371G_A3D3	35.59818694	-12.8106081	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4645	11154	0.006455083	0.015241169	3	2	EN-L4	30	9	9
ATGTGTGCAGCTTCGG-1_371G_A3D3	1.185049539	13.51159097	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	966	1494	0.004685408	0.013386881	3	oligos	OL-Cntl	30	9	9
ATGTGTGGTCTGCGGT-1_371G_A3D3	-25.9157096	12.36931937	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	903	1328	0.005271084	0.005271084	3	8	Astrocytes	30	9	9
ATGTGTGGTGTCTGAT-1_371G_A3D3	-16.63296143	-24.76916644	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1990	4005	0.011735331	0.004993758	3	6A	IN-PV	30	9	9
ATGTGTGTCCGTACAA-1_371G_A3D3	-22.54826904	-25.86687443	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3643	9057	0.001545766	0.006072651	3	6A	IN-PV	30	9	9
ATTACTCAGAAACGAG-1_371G_A3D3	4.770754133	-18.05607904	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3305	7476	0.006554307	0.006153023	3	L2-3	EN-L2-3-MS	30	9	9
ATTACTCCATGTCCTC-1_371G_A3D3	-0.375384787	0.922743085	11	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2032	3462	0.002888504	0.004332756	3	11	Glia-MIX	30	9	9
ATTACTCGTCCGACGT-1_371G_A3D3	-14.54494544	-25.08406661	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1651	3177	0.002518099	0.003147624	3	6A	IN-PV	30	9	9
ATTACTCTCGACAGCC-1_371G_A3D3	1.50354826	17.56010513	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	801	1322	0.002269289	0.006051437	3	oligos	OL-Cntl	30	9	9
ATTATCCAGCGCCTCA-1_371G_A3D3	-28.54296362	20.80681993	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1117	1764	0.005102041	0.003968254	3	8	Astrocytes	30	9	9
ATTATCCCAATAGCAA-1_371G_A3D3	-4.057895555	-17.6620648	10	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3088	7397	0.014600514	0.004055698	3	L2-3	EN-L2-3-Cntl	30	9	9
ATTATCCGTACCGGCT-1_371G_A3D3	8.8937882	-19.70248051	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	6479	22384	0.005941744	0.006388492	3	L2-3	EN-L2-3-MS	30	9	9
ATTATCCGTCTTCGTC-1_371G_A3D3	0.397591308	18.14343154	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	696	1065	0.000938967	0.005633803	3	oligos	OL-Cntl	30	9	9
ATTATCCTCAACACGT-1_371G_A3D3	1.755421252	17.28167206	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	766	1152	0.002604167	0.006076389	3	oligos	OL-Cntl	30	9	9
ATTATCCTCACTTACT-1_371G_A3D3	14.15705206	16.56730946	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1178	1917	0.004694836	0.006781429	3	oligos	OL-Cntl	30	9	9
ATTATCCTCTGCAGTA-1_371G_A3D3	-28.81261471	-1.514277211	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1505	2465	0.002434077	0.007302231	3	9	OPC	30	9	9
ATTCTACAGCCCAACC-1_371G_A3D3	-19.17205123	-26.70036224	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2807	6243	0.002242512	0.004164664	3	6A	IN-PV	30	9	9
ATTCTACAGGATGGAA-1_371G_A3D3	-10.82786042	-3.695067002	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2242	3761	0.016219091	0.009306036	3	13A	IN-VIP	30	9	9
ATTCTACAGTCCCACG-1_371G_A3D3	16.44536151	6.553333565	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1928	3798	0.001843075	0.00895208	3	oligos	OL-Cntl	30	9	9
ATTCTACCACCAGGCT-1_371G_A3D3	-4.803863854	20.7236558	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	688	1048	0.001908397	0.006679389	3	oligos	OL-Cntl	30	9	9
ATTCTACGTTAAGATG-1_371G_A3D3	10.41461114	22.36158893	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	760	1147	0	0.005231037	3	oligos	OL-Cntl	30	9	9
ATTGGACCAAAGGTGC-1_371G_A3D3	10.73620228	14.47993454	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1098	1896	0.003691983	0.010021097	3	oligos	OL-Cntl	30	9	9
ATTGGACCAACACCCG-1_371G_A3D3	-31.41680066	2.352003017	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2202	3913	0.004344493	0.004600051	3	9	OPC	30	9	9
ATTGGACCATGCCACG-1_371G_A3D3	-20.22665201	7.302385735	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	767	1046	0.007648184	0.007648184	3	8	Astrocytes	30	9	9
ATTGGACGTAACGTTC-1_371G_A3D3	-24.65927387	6.127489685	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	656	1090	0.002752294	0.006422018	3	8	Astrocytes	30	9	9
ATTGGACTCTAGCACA-1_371G_A3D3	-28.55875073	1.436086261	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2385	4327	0.005315461	0.007626531	3	9	OPC	30	9	9
ATTGGTGAGAATCTCC-1_371G_A3D3	5.563731473	-26.73836017	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	6904	23212	0.004738928	0.008013097	3	L2-3	EN-L2-3-MS	30	9	9
ATTGGTGAGACTTTCG-1_371G_A3D3	8.955521201	-21.34148011	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4915	13550	0.009151292	0.004206642	3	L2-3	EN-L2-3-MS	30	9	9
ATTGGTGAGTGTCTCA-1_371G_A3D3	13.47633351	6.85617126	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1881	3308	0.005139057	0.010580411	3	oligos	OL-Cntl	30	9	9
ATTGGTGCAAAGTCAA-1_371G_A3D3	-3.095215387	12.84630506	5	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	912	1350	0	0.028148148	3	oligos	OL-MS-1	30	9	9
ATTGGTGCACGTCTCT-1_371G_A3D3	-24.26788401	16.23626291	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1292	2265	0.001324503	0.006181015	3	8	Astrocytes	30	9	9
ATTGGTGCAGGCTCAC-1_371G_A3D3	7.784565728	9.75066246	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1140	1835	0.000544959	0.009264305	3	oligos	OL-Cntl	30	9	9
ATTGGTGCATCCGTGG-1_371G_A3D3	-19.32752535	-17.46149954	6B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2985	6658	0.003454491	0.0031541	3	6B	IN-SST	30	9	9
ATTGGTGGTCCGAATT-1_371G_A3D3	-27.47904346	4.430578071	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2530	5422	0.000368868	0.002766507	3	8	Astrocytes	30	9	9
ATTGGTGTCCGCTGTT-1_371G_A3D3	-21.56700735	26.05702971	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1760	3300	0	0.007575758	3	8	Astrocytes	30	9	9
ATTTCTGAGCGATGAC-1_371G_A3D3	-13.50816374	-24.25341926	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1227	2236	0.001788909	0.00313059	3	6A	IN-PV	30	9	9
ATTTCTGGTCCGAACC-1_371G_A3D3	32.91806103	-8.281151359	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3903	9396	0.006811409	0.006066411	3	2	EN-L4	30	9	9
ATTTCTGGTGAGGGAG-1_371G_A3D3	-8.372024272	-2.508809478	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2353	4798	0.006669446	0.003959983	3	13A	IN-VIP	30	9	9
ATTTCTGTCGTGGACC-1_371G_A3D3	-32.76287232	-7.080287834	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1099	1736	0.010368664	0.006912442	3	9	OPC	30	9	9
CAACCAAAGTTAGGTA-1_371G_A3D3	-33.64146388	-2.698040006	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1534	2483	0.007652034	0.004430125	3	9	OPC	30	9	9
CAACCAAGTATATCCG-1_371G_A3D3	7.726390725	-18.43488093	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5712	16157	0.007241443	0.014049638	3	L2-3	EN-L2-3-MS	30	9	9
CAACCAAGTCAAAGAT-1_371G_A3D3	-30.46009526	1.823776796	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1958	3367	0.000297	0.009207009	3	9	OPC	30	9	9
CAACCAAGTGATGTCT-1_371G_A3D3	10.52936065	6.937675489	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1829	3279	0.003964623	0.01494358	3	oligos	OL-Cntl	30	9	9
CAACCAAGTTCGTGAT-1_371G_A3D3	-18.65267937	0.574592187	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5129	11720	0.015187713	0.014249147	3	13A	IN-VIP	30	9	9
CAACCTCAGCCATCGC-1_371G_A3D3	-0.011553881	14.95821192	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	877	1303	0.006907137	0.013814275	3	oligos	OL-Cntl	30	9	9
CAACCTCAGCGATTCT-1_371G_A3D3	34.41759191	-8.500196414	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4881	12859	0.006221324	0.009020919	3	2	EN-L4	30	9	9
CAACCTCAGGGAGTAA-1_371G_A3D3	-0.454661954	20.27857551	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	661	1007	0.000993049	0.003972195	3	oligos	OL-Cntl	30	9	9
CAACCTCCAATAGCAA-1_371G_A3D3	6.394100256	-21.34759289	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5952	19376	0.004696532	0.004799752	3	L2-3	EN-L2-3-MS	30	9	9
CAACCTCGTATAGGTA-1_371G_A3D3	19.11437662	21.61417012	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1085	1930	0.001036269	0.002590674	3	oligos	OL-Cntl	30	9	9
CAACCTCGTCGAACAG-1_371G_A3D3	7.859503199	-19.41900778	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4782	12261	0.00701411	0.005464481	3	L2-3	EN-L2-3-MS	30	9	9
CAACCTCGTTACAGAA-1_371G_A3D3	22.57312349	-1.991241708	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2336	4701	0.007445224	0.004892576	3	2	EN-L4	30	9	9
CAACCTCGTTACTGAC-1_371G_A3D3	-25.15139732	0.856448287	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3181	7752	0.006707946	0.00877193	3	9	OPC	30	9	9
CAACCTCTCCTAGAAC-1_371G_A3D3	-8.736486962	-18.32398059	6B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	703	1080	0.007407407	0.003703704	3	6B	IN-SST	30	9	9
CAACTAGAGAAAGTGG-1_371G_A3D3	-12.10402558	-22.16411858	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1206	1921	0.03539823	0.004164498	3	6A	IN-PV	30	9	9
CAACTAGCACAGCCCA-1_371G_A3D3	7.015658564	-20.62587749	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5162	13915	0.005174272	0.007473949	3	L2-3	EN-L2-3-MS	30	9	9
CAACTAGTCGGACAAG-1_371G_A3D3	-22.58444726	-4.507563493	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3365	6686	0.003739156	0.005533952	3	13A	IN-VIP	30	9	9
CAAGAAAAGGATGCGT-1_371G_A3D3	0.066880532	14.86657698	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	811	1181	0.015241321	0.013547841	3	oligos	OL-Cntl	30	9	9
CAAGAAAAGTTAGGTA-1_371G_A3D3	0.793551848	14.54108928	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	886	1312	0.006097561	0.012957317	3	oligos	OL-Cntl	30	9	9
CAAGAAACACATCCAA-1_371G_A3D3	-30.40111414	10.38690981	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	805	1228	0.019543974	0.004071661	3	8	Astrocytes	30	9	9
CAAGAAACACATGGGA-1_371G_A3D3	-12.84877351	0.293867799	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3216	6677	0.012131197	0.004343268	3	13A	IN-VIP	30	9	9
CAAGAAAGTTACCAGT-1_371G_A3D3	6.926198963	10.03809378	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1030	1639	0.006101281	0.015863331	3	oligos	OL-Cntl	30	9	9
CAAGAAATCATGTAGC-1_371G_A3D3	-29.87087038	0.56824302	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1893	3192	0.000626566	0.012531328	3	9	OPC	30	9	9
CAAGATCAGAGTACAT-1_371G_A3D3	-24.25968645	16.44869104	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1340	2082	0.005763689	0.004322767	3	8	Astrocytes	30	9	9
CAAGATCAGCTAACAA-1_371G_A3D3	-17.95218433	29.98905636	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3192	6324	0.000316256	0.010120177	3	8	Astrocytes	30	9	9
CAAGATCAGCTACCGC-1_371G_A3D3	8.075249705	8.76073673	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1366	2221	0.008554705	0.021161639	3	oligos	OL-Cntl	30	9	9
CAAGATCAGGCCCTCA-1_371G_A3D3	-13.44845767	0.380634952	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2928	6226	0.014616126	0.007548988	3	13A	IN-VIP	30	9	9
CAAGATCCATAGACTC-1_371G_A3D3	12.22335703	-1.325323785	12	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1529	2903	0.013778849	0.005167069	3	12	EN-MIX	30	9	9
CAAGATCGTTCAGACT-1_371G_A3D3	7.055847523	12.1369457	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1161	1755	0.001139601	0.009116809	3	oligos	OL-Cntl	30	9	9
CAAGATCTCACCCGAG-1_371G_A3D3	-22.86744305	-19.45319467	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3056	6824	0.010550996	0.006594373	3	6A	IN-PV	30	9	9
CAAGATCTCCTTGACC-1_371G_A3D3	3.323590943	12.62883402	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1092	1714	0.002333722	0.015752625	3	oligos	OL-Cntl	30	9	9
CAAGATCTCTGATACG-1_371G_A3D3	-20.04510907	26.00192755	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1786	3359	0.003572492	0.006847276	3	8	Astrocytes	30	9	9
CAAGGCCAGCAGCCTC-1_371G_A3D3	30.52903539	9.238042201	15DA	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1066	1731	0.001155402	0.010398614	3	15DA	T cells	30	9	9
CAAGGCCAGCGGATCA-1_371G_A3D3	-30.22106226	1.41719299	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2064	3550	0.00056338	0.005352113	3	9	OPC	30	9	9
CAAGGCCCACCCTATC-1_371G_A3D3	15.01209807	7.177393436	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1673	3078	0.000974659	0.01137102	3	oligos	OL-Cntl	30	9	9
CAAGGCCCATGAACCT-1_371G_A3D3	-0.070497629	23.02702101	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	678	1002	0.008982036	0.001996008	3	oligos	OL-Cntl	30	9	9
CAAGGCCGTCCGTCAG-1_371G_A3D3	-3.173268108	12.84958086	5	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	909	1287	0.002331002	0.025641026	3	oligos	OL-MS-1	30	9	9
CAAGGCCGTGACTCAT-1_371G_A3D3	-33.90329958	-0.87502238	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1508	2529	0.007908264	0.005931198	3	9	OPC	30	9	9
CAAGGCCGTGGTCCGT-1_371G_A3D3	-14.16417391	0.27766346	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2971	5769	0.005373548	0.008667013	3	13A	IN-VIP	30	9	9
CAAGGCCGTTACGACT-1_371G_A3D3	35.57988258	-8.248643502	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5156	13588	0.004857227	0.006844274	3	2	EN-L4	30	9	9
CAAGGCCTCATGTCCC-1_371G_A3D3	-3.248106665	12.89882553	5	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	891	1308	0.002293578	0.028287462	3	oligos	OL-MS-1	30	9	9
CAAGGCCTCCGGCACA-1_371G_A3D3	-35.78782593	-3.58805507	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1227	2003	0.005991013	0.005491762	3	9	OPC	30	9	9
CAAGTTGAGAAAGTGG-1_371G_A3D3	-2.791808159	13.7316541	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	733	1018	0.003929273	0.030451866	3	oligos	OL-Cntl	30	9	9
CAAGTTGAGTACGATA-1_371G_A3D3	-15.31256008	1.61463093	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4544	9789	0.00858106	0.008172438	3	13A	IN-VIP	30	9	9
CAAGTTGAGTTCCACA-1_371G_A3D3	-23.60177028	-25.82900373	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3666	7656	0.001698015	0.004963427	3	6A	IN-PV	30	9	9
CAAGTTGCACGGCGTT-1_371G_A3D3	-11.90657087	1.613593396	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3440	7734	0.008145849	0.00491337	3	13A	IN-VIP	30	9	9
CAAGTTGCATCTATGG-1_371G_A3D3	-22.35585273	23.62908096	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1533	2506	0.004788508	0.002394254	3	8	Astrocytes	30	9	9
CAAGTTGCATGGTTGT-1_371G_A3D3	13.50721728	-30.81855431	3	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5244	18567	0.000161577	0.003554694	3	3	EN-L5-6	30	9	9
CAAGTTGGTACTTGAC-1_371G_A3D3	27.684305	-2.276601892	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3843	9750	0.002358974	0.005435897	3	2	EN-L4	30	9	9
CAAGTTGGTCTCATCC-1_371G_A3D3	13.25163471	9.213732897	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1423	2484	0.003220612	0.009661836	3	oligos	OL-Cntl	30	9	9
CAAGTTGTCCAACCAA-1_371G_A3D3	7.7520032	-18.41233548	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4692	10980	0.007468124	0.00856102	3	L2-3	EN-L2-3-MS	30	9	9
CAAGTTGTCCTTAATC-1_371G_A3D3	-34.74305305	-0.823960304	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1487	2641	0.006058311	0.004543733	3	9	OPC	30	9	9
CACAAACCACCATCCT-1_371G_A3D3	-36.86408635	0.925079087	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1580	2800	0.001428571	0.003214286	3	9	OPC	30	9	9
CACAAACCAGCTGCTG-1_371G_A3D3	4.087992673	15.35337869	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	931	1506	0.001328021	0.01062417	3	oligos	OL-Cntl	30	9	9
CACAAACCAGTGAGTG-1_371G_A3D3	-13.65003551	1.977175975	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4623	10959	0.000912492	0.009307419	3	13A	IN-VIP	30	9	9
CACAAACCATCCAACA-1_371G_A3D3	-0.682030443	16.1644751	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	832	1169	0.002566296	0.01283148	3	oligos	OL-Cntl	30	9	9
CACAAACGTAGGACAC-1_371G_A3D3	10.74142017	14.57584944	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1090	1718	0.004656577	0.006984866	3	oligos	OL-Cntl	30	9	9
CACAAACGTCGTGGCT-1_371G_A3D3	4.791282394	-19.38504855	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4011	10346	0.006379277	0.005316064	3	L2-3	EN-L2-3-MS	30	9	9
CACAAACGTTGAACTC-1_371G_A3D3	-9.549013247	12.33972796	5	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1096	1504	0.005984043	0.017287234	3	oligos	OL-MS-1	30	9	9
CACAAACGTTGCTCCT-1_371G_A3D3	-21.29669072	8.606946682	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	870	1212	0	0.004950495	3	8	Astrocytes	30	9	9
CACAAACTCGAATGCT-1_371G_A3D3	17.79609666	7.260944313	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2259	4377	0.001142335	0.005711675	3	oligos	OL-Cntl	30	9	9
CACAAACTCTCTGAGA-1_371G_A3D3	-33.07177061	2.889323531	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1983	3686	0	0.00678242	3	9	OPC	30	9	9
CACAAACTCTTGCATT-1_371G_A3D3	-33.99066726	-3.220476953	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1454	2451	0.004895961	0.006935945	3	9	OPC	30	9	9
CACACAACAACACCTA-1_371G_A3D3	-19.14171788	27.78514426	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2178	4058	0.002957122	0.00542139	3	8	Astrocytes	30	9	9
CACACAACAGTGGAGT-1_371G_A3D3	38.95951857	12.92689531	14	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1128	1699	0.000588582	0.005885815	3	14	Microglia	30	9	9
CACACAAGTATTAGCC-1_371G_A3D3	-31.46845603	2.71673663	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2490	5052	0.002573238	0.006136184	3	9	OPC	30	9	9
CACACAATCAGTTTGG-1_371G_A3D3	-30.07524438	1.43693709	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1875	3222	0.000931099	0.005586592	3	9	OPC	30	9	9
CACACAATCATCATTC-1_371G_A3D3	-8.489532856	8.771084817	5	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	947	1315	0.034980989	0.025855513	3	oligos	OL-MS-1	30	9	9
CACACAATCCTATGTT-1_371G_A3D3	9.783835966	6.766856974	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1407	2445	0.00204499	0.010633947	3	oligos	OL-Cntl	30	9	9
CACACAATCCTCCTAG-1_371G_A3D3	-33.87389285	-0.284313986	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1863	3268	0.003977968	0.004895961	3	9	OPC	30	9	9
CACACCTAGAGATGAG-1_371G_A3D3	-0.869028123	13.68766999	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	881	1185	0.002531646	0.020253165	3	oligos	OL-Cntl	30	9	9
CACACCTAGCAGGCTA-1_371G_A3D3	7.946989012	9.89228247	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1260	2103	0	0.015691869	3	oligos	OL-Cntl	30	9	9
CACACCTCATATGGTC-1_371G_A3D3	-8.401512222	7.875691419	5	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	840	1219	0.002461034	0.014766202	3	oligos	OL-MS-1	30	9	9
CACACCTCATGACATC-1_371G_A3D3	-23.43023867	-19.3440176	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3617	7941	0.003777862	0.008437225	3	6A	IN-PV	30	9	9
CACACCTTCCAATGGT-1_371G_A3D3	-1.836893329	16.80509342	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	872	1316	0.001519757	0.012158055	3	oligos	OL-Cntl	30	9	9
CACACCTTCCGCTGTT-1_371G_A3D3	8.517924412	15.8407198	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	908	1464	0.004781421	0.008196721	3	oligos	OL-Cntl	30	9	9
CACACTCAGCCGCCTA-1_371G_A3D3	2.973219044	16.76232925	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	835	1236	0.002427184	0.008899676	3	oligos	OL-Cntl	30	9	9
CACACTCCAAACTGCT-1_371G_A3D3	-19.34425477	27.61026401	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2162	4607	0.001302366	0.003690037	3	8	Astrocytes	30	9	9
CACACTCGTGCGCTTG-1_371G_A3D3	-24.32397195	-18.50771345	6B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3649	7312	0.004649891	0.01928337	3	6B	IN-SST	30	9	9
CACACTCGTTCACGGC-1_371G_A3D3	19.64581626	-7.450180447	3	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2619	6321	0.003638665	0.001582028	3	3	EN-L5-6	30	9	9
CACACTCTCAAGGTAA-1_371G_A3D3	8.508590411	15.65682515	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	978	1484	0.000673854	0.011455526	3	oligos	OL-Cntl	30	9	9
CACACTCTCCAAACTG-1_371G_A3D3	1.476955062	14.99197672	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	952	1683	0	0.023767083	3	oligos	OL-Cntl	30	9	9
CACACTCTCGGCATCG-1_371G_A3D3	-13.72273374	0.605312944	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3284	7006	0.008135884	0.008564088	3	13A	IN-VIP	30	9	9
CACAGGCAGACTCGGA-1_371G_A3D3	15.02244746	-29.06881986	3	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5222	16727	0.004065284	0.005619657	3	3	EN-L5-6	30	9	9
CACAGGCAGCGATAGC-1_371G_A3D3	35.2636446	-8.37887267	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5649	14757	0.006979738	0.006302094	3	2	EN-L4	30	9	9
CACAGGCCAGTGGAGT-1_371G_A3D3	-5.027204567	10.62983611	5	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	790	1091	0.00091659	0.015582035	3	oligos	OL-MS-1	30	9	9
CACAGGCCATTTCACT-1_371G_A3D3	1.324567928	18.03514962	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	720	1110	0.002702703	0.006306306	3	oligos	OL-Cntl	30	9	9
CACAGGCTCGAACTGT-1_371G_A3D3	35.53743464	-7.458877699	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5305	15973	0.006824016	0.006636199	3	2	EN-L4	30	9	9
CACAGTAAGCGAGAAA-1_371G_A3D3	13.25643687	8.998098256	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1581	2684	0.000372578	0.010059613	3	oligos	OL-Cntl	30	9	9
CACAGTACACCGCTAG-1_371G_A3D3	1.481633205	14.79798516	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	835	1314	0.008371385	0.01065449	3	oligos	OL-Cntl	30	9	9
CACAGTACATGTCTCC-1_371G_A3D3	-1.998330481	15.05089647	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	770	1146	0	0.019197208	3	oligos	OL-Cntl	30	9	9
CACAGTAGTGATGATA-1_371G_A3D3	-16.43442116	12.99526739	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1377	2321	0.001723395	0.002585093	3	8	Astrocytes	30	9	9
CACATAGAGATATGGT-1_371G_A3D3	4.685400913	-20.03671879	10	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3725	8897	0.002247949	0.004608295	3	L2-3	EN-L2-3-Cntl	30	9	9
CACATAGAGCCAGTTT-1_371G_A3D3	-25.28834019	13.71162897	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1069	1595	0.002507837	0.005642633	3	8	Astrocytes	30	9	9
CACATAGAGTACACCT-1_371G_A3D3	14.65389581	8.597434005	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1737	3137	0.001912655	0.005737966	3	oligos	OL-Cntl	30	9	9
CACATAGCATGGTCTA-1_371G_A3D3	7.028501851	10.49103315	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1376	2247	0.007120605	0.021361816	3	oligos	OL-Cntl	30	9	9
CACATAGGTCATGCAT-1_371G_A3D3	6.739589083	-19.6385909	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4737	12044	0.004732647	0.006559283	3	L2-3	EN-L2-3-MS	30	9	9
CACATAGTCAAGATCC-1_371G_A3D3	-18.99689692	26.2296055	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1884	3132	0.002234994	0.011813538	3	8	Astrocytes	30	9	9
CACATAGTCCGCGCAA-1_371G_A3D3	-15.86685669	1.800240858	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3942	8623	0.008813638	0.013452395	3	13A	IN-VIP	30	9	9
CACATTTAGAGACTTA-1_371G_A3D3	-34.31785229	-13.32921115	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	630	1013	0	0.0029615	3	9	OPC	30	9	9
CACATTTAGTTAGCGG-1_371G_A3D3	7.024153848	-18.90469029	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5179	13842	0.007441121	0.010330877	3	L2-3	EN-L2-3-MS	30	9	9
CACATTTCAAAGCAAT-1_371G_A3D3	-15.15277662	-15.15540019	6B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1634	2540	0.021653543	0.011023622	3	6B	IN-SST	30	9	9
CACATTTCAAGTACCT-1_371G_A3D3	35.97652827	-8.559221797	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5466	14568	0.000892367	0.008374519	3	2	EN-L4	30	9	9
CACATTTCACCATCCT-1_371G_A3D3	-14.85988027	1.908039335	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4777	11200	0.003125	0.010803571	3	13A	IN-VIP	30	9	9
CACATTTGTAGCCTCG-1_371G_A3D3	2.693253094	14.23836894	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	929	1453	0.004129387	0.013076394	3	oligos	OL-Cntl	30	9	9
CACATTTTCATGCATG-1_371G_A3D3	-33.72081567	2.661424796	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2221	4256	0.008223684	0.004229323	3	9	OPC	30	9	9
CACATTTTCGACAGCC-1_371G_A3D3	-13.46997649	-0.220992662	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2704	5799	0.006897741	0.00879462	3	13A	IN-VIP	30	9	9
CACATTTTCGTTGCCT-1_371G_A3D3	-14.29711522	1.878167336	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4425	10922	0.002838308	0.010254532	3	13A	IN-VIP	30	9	9
CACATTTTCTAACGGT-1_371G_A3D3	-11.62658007	17.44213248	11	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1929	3254	0.003073141	0.010141364	3	11	Glia-MIX	30	9	9
CACATTTTCTGCCCTA-1_371G_A3D3	-6.957630539	-0.135470945	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2121	4484	0.018287244	0.003568243	3	13A	IN-VIP	30	9	9
CACATTTTCTTTAGTC-1_371G_A3D3	10.64101521	24.10905224	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	690	1087	0	0.003679853	3	oligos	OL-Cntl	30	9	9
CACCACTAGAAGATTC-1_371G_A3D3	-9.788114907	-7.707249681	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1663	3055	0.016366612	0.00589198	3	13A	IN-VIP	30	9	9
CACCACTGTGCTGTAT-1_371G_A3D3	0.16448529	15.44457691	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	960	1365	0.004395604	0.015384615	3	oligos	OL-Cntl	30	9	9
CACCACTTCGCCGTGA-1_371G_A3D3	14.98721481	2.816824909	12	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	933	1406	0.093172119	0.004267425	3	12	EN-MIX	30	9	9
CACCAGGAGAATGTGT-1_371G_A3D3	8.094256036	-18.05157767	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5402	13998	0.004143449	0.01228747	3	L2-3	EN-L2-3-MS	30	9	9
CACCAGGCAAAGGTGC-1_371G_A3D3	-3.055140278	15.38338188	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	694	1043	0.006711409	0.0105465	3	oligos	OL-Cntl	30	9	9
CACCAGGCATCGGAAG-1_371G_A3D3	5.878641709	16.3227485	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	933	1319	0.007581501	0.013646702	3	oligos	OL-Cntl	30	9	9
CACCAGGCATGCATGT-1_371G_A3D3	3.512364535	16.30354624	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	974	1580	0.001898734	0.003797468	3	oligos	OL-Cntl	30	9	9
CACCAGGGTTAAAGTG-1_371G_A3D3	-22.48830686	-17.07138735	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5182	14756	0.008945514	0.004404988	3	6A	IN-PV	30	9	9
CACCAGGTCTATCCTA-1_371G_A3D3	4.977501433	10.64650455	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1294	2077	0.002407318	0.0105922	3	oligos	OL-Cntl	30	9	9
CACCTTGAGCATCATC-1_371G_A3D3	8.871897871	20.98796527	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	818	1249	0.006405124	0.008006405	3	oligos	OL-Cntl	30	9	9
CACCTTGAGCGTGTCC-1_371G_A3D3	-17.71268189	-10.35947434	13B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3689	8869	0.002931559	0.004510091	3	13B	IN-SV2C	30	9	9
CACCTTGAGTACACCT-1_371G_A3D3	-25.63059027	14.7149237	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1060	1625	0.011692308	0.004923077	3	8	Astrocytes	30	9	9
CACCTTGAGTACGATA-1_371G_A3D3	-4.404409376	23.37056353	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	648	1021	0	0.002938296	3	oligos	OL-Cntl	30	9	9
CACCTTGCATGCATGT-1_371G_A3D3	19.84797336	21.73343945	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1021	1726	0.001158749	0.00405562	3	oligos	OL-Cntl	30	9	9
CACCTTGGTGCAGACA-1_371G_A3D3	3.505309709	12.42148897	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1073	1629	0.005524862	0.012277471	3	oligos	OL-Cntl	30	9	9
CACCTTGGTTCGCGAC-1_371G_A3D3	6.313933261	-20.36046704	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5016	13372	0.003140891	0.006880048	3	L2-3	EN-L2-3-MS	30	9	9
CACCTTGTCAATAAGG-1_371G_A3D3	17.71415283	7.159012302	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2159	4207	0.002139292	0.005942477	3	oligos	OL-Cntl	30	9	9
CACCTTGTCAGTACGT-1_371G_A3D3	-16.50619684	1.568424757	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3895	8163	0.006247703	0.015803014	3	13A	IN-VIP	30	9	9
CACCTTGTCGATCCCT-1_371G_A3D3	-19.45924543	27.64833338	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2162	4080	0.001470588	0.003431373	3	8	Astrocytes	30	9	9
CACCTTGTCTAACTGG-1_371G_A3D3	-3.779128609	-13.67872205	10	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2471	4992	0.006810897	0.005408654	3	L2-3	EN-L2-3-Cntl	30	9	9
CACTCCAGTCGAACAG-1_371G_A3D3	-19.4565868	-23.11692824	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2439	4836	0.022746071	0.004755997	3	6A	IN-PV	30	9	9
CACTCCATCACATAGC-1_371G_A3D3	-20.97296693	-27.72433878	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3915	9712	0.002780066	0.004633443	3	6A	IN-PV	30	9	9
CACTCCATCACTATTC-1_371G_A3D3	3.660283601	15.93999436	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1006	1564	0.002557545	0.00511509	3	oligos	OL-Cntl	30	9	9
CACTCCATCCAGTAGT-1_371G_A3D3	-23.84068193	-19.13540801	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4891	13639	0.02177579	0.006672043	3	6A	IN-PV	30	9	9
CACTCCATCTACTCAT-1_371G_A3D3	12.90782803	13.1473275	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1173	2054	0.000486855	0.006815969	3	oligos	OL-Cntl	30	9	9
CACTCCATCTTGTCAT-1_371G_A3D3	-19.16317375	29.92618551	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2714	5944	0.007234186	0.004542396	3	8	Astrocytes	30	9	9
CAGAATCAGAACAACT-1_371G_A3D3	17.58815926	-10.79996135	3	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2517	5296	0.006231118	0.012651057	3	3	EN-L5-6	30	9	9
CAGAATCAGATCGGGT-1_371G_A3D3	3.092266728	14.42085187	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1003	1467	0.00408998	0.015678255	3	oligos	OL-Cntl	30	9	9
CAGAATCAGGAGTACC-1_371G_A3D3	9.463659518	14.71379267	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1098	1787	0.003357583	0.010632345	3	oligos	OL-Cntl	30	9	9
CAGAATCAGGTAGCCA-1_371G_A3D3	-1.579765877	17.65644268	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	745	1084	0.002767528	0.01199262	3	oligos	OL-Cntl	30	9	9
CAGAATCAGTCATCCA-1_371G_A3D3	-0.983452102	14.52264157	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	866	1240	0.008870968	0.015322581	3	oligos	OL-Cntl	30	9	9
CAGAATCCAACCGCCA-1_371G_A3D3	-19.12259415	-26.50967686	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2900	6940	0.00129683	0.00518732	3	6A	IN-PV	30	9	9
CAGAATCCAGGATCGA-1_371G_A3D3	4.216752809	-19.83630474	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3530	8001	0.005249344	0.003249594	3	L2-3	EN-L2-3-MS	30	9	9
CAGAATCGTAGAAAGG-1_371G_A3D3	34.93106272	-9.607756787	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3994	8673	0.005880318	0.010838234	3	2	EN-L4	30	9	9
CAGAATCGTAGCGCTC-1_371G_A3D3	35.89358827	-8.073530763	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4251	10033	0.008472042	0.007874016	3	2	EN-L4	30	9	9
CAGAATCGTCCCGACA-1_371G_A3D3	2.994317986	15.22641092	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1153	1778	0.027559055	0.016310461	3	oligos	OL-Cntl	30	9	9
CAGAATCGTGGACGAT-1_371G_A3D3	0.855715205	17.82093322	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	700	1099	0.002729754	0.008189263	3	oligos	OL-Cntl	30	9	9
CAGAATCTCATCGATG-1_371G_A3D3	-16.03578771	-22.47957109	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1755	3206	0.046787274	0.008733624	3	6A	IN-PV	30	9	9
CAGAATCTCATCGCTC-1_371G_A3D3	3.912551074	30.7788218	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	822	1253	0.001596169	0.004788508	3	oligos	OL-Cntl	30	9	9
CAGAATCTCCATTCTA-1_371G_A3D3	6.3407087	-18.9160191	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4143	9765	0.00327701	0.012903226	3	L2-3	EN-L2-3-MS	30	9	9
CAGAGAGAGCTAGTTC-1_371G_A3D3	-22.59430202	-17.13250247	6B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3168	6698	0.014481935	0.007315617	3	6B	IN-SST	30	9	9
CAGAGAGCACAGGAGT-1_371G_A3D3	-18.15026274	28.49024893	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2460	4852	0.001236603	0.005358615	3	8	Astrocytes	30	9	9
CAGAGAGCAGCCAATT-1_371G_A3D3	-13.08028319	-17.47006314	6B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1227	1941	0.041731066	0.005667182	3	6B	IN-SST	30	9	9
CAGAGAGCAGGTCGTC-1_371G_A3D3	-17.95950812	1.259155238	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4623	9905	0.005855628	0.025542655	3	13A	IN-VIP	30	9	9
CAGAGAGGTGTATGGG-1_371G_A3D3	12.22061857	6.031710372	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2156	4149	0.005061461	0.009881899	3	oligos	OL-Cntl	30	9	9
CAGAGAGTCTGGCGTG-1_371G_A3D3	-1.993730297	13.76530592	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	811	1133	0.006178288	0.030008826	3	oligos	OL-Cntl	30	9	9
CAGATCAAGATCACGG-1_371G_A3D3	27.79191481	6.844975858	15BA	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	900	1274	0.010204082	0.033751962	3	15BA	Stromal cells	30	9	9
CAGATCACAATAGCAA-1_371G_A3D3	11.05825803	26.60171877	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	770	1099	0.001819836	0.009099181	3	oligos	OL-Cntl	30	9	9
CAGATCACATGATCCA-1_371G_A3D3	10.64057144	14.71112485	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1149	1966	0.00508647	0.00508647	3	oligos	OL-Cntl	30	9	9
CAGATCAGTCTTCGTC-1_371G_A3D3	-34.04307946	4.295292916	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2417	4760	0.000840336	0.005252101	3	9	OPC	30	9	9
CAGATCAGTGGCTCCA-1_371G_A3D3	4.984846629	15.40376265	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	952	1389	0	0.016558675	3	oligos	OL-Cntl	30	9	9
CAGATCATCAGCACAT-1_371G_A3D3	-2.778929883	17.04147801	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	721	1025	0.00195122	0.009756098	3	oligos	OL-Cntl	30	9	9
CAGATCATCGGAGCAA-1_371G_A3D3	-28.35187718	-0.01763105	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1862	3358	0.011614056	0.016081001	3	9	OPC	30	9	9
CAGATCATCGTAGGAG-1_371G_A3D3	-12.33411609	0.379197706	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2955	6109	0.01571452	0.004092323	3	13A	IN-VIP	30	9	9
CAGCAGCAGGAGTTGC-1_371G_A3D3	-5.115067686	-2.433311448	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1512	2647	0.006044579	0.003400076	3	13A	IN-VIP	30	9	9
CAGCAGCAGGCAATTA-1_371G_A3D3	-26.11873471	-22.51898837	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4574	10391	0.00769897	0.015686652	3	6A	IN-PV	30	9	9
CAGCAGCAGTTGAGAT-1_371G_A3D3	10.17792901	-27.47596427	10	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	7817	32675	0.00082632	0.004407039	3	L2-3	EN-L2-3-Cntl	30	9	9
CAGCAGCCAAGCTGGA-1_371G_A3D3	0.369875249	12.87580474	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1055	1615	0.001857585	0.029721362	3	oligos	OL-Cntl	30	9	9
CAGCAGCGTAAACGCG-1_371G_A3D3	-24.72637679	-17.81984332	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5602	16359	0.007518797	0.015832264	3	6A	IN-PV	30	9	9
CAGCAGCGTCCTCCAT-1_371G_A3D3	-6.437861914	-1.992071204	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1774	3192	0.00877193	0.002506266	3	13A	IN-VIP	30	9	9
CAGCAGCGTGCTCTTC-1_371G_A3D3	-24.20960457	23.48521468	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1420	2567	0.001558239	0.006622517	3	8	Astrocytes	30	9	9
CAGCAGCGTTGAACTC-1_371G_A3D3	16.65470297	5.827556693	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2448	4968	0.005837359	0.008252818	3	oligos	OL-Cntl	30	9	9
CAGCAGCTCATGCATG-1_371G_A3D3	12.2443203	9.784687928	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1385	2359	0	0.00805426	3	oligos	OL-Cntl	30	9	9
CAGCAGCTCATGTCCC-1_371G_A3D3	3.283748456	14.47197231	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1054	1609	0.001864512	0.008701057	3	oligos	OL-Cntl	30	9	9
CAGCAGCTCCAATGGT-1_371G_A3D3	6.594597453	31.59628444	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	807	1213	0.001648805	0.002473207	3	oligos	OL-Cntl	30	9	9
CAGCAGCTCTCAAGTG-1_371G_A3D3	35.8200859	-11.41973092	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	6049	17240	0.010324826	0.014559165	3	2	EN-L4	30	9	9
CAGCATAAGCTCAACT-1_371G_A3D3	0.710545324	17.34679595	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	844	1386	0.000721501	0.005772006	3	oligos	OL-Cntl	30	9	9
CAGCATACAAGTACCT-1_371G_A3D3	-33.05204441	5.330256135	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3455	7414	0.001753439	0.004316159	3	9	OPC	30	9	9
CAGCATACACACCGCA-1_371G_A3D3	6.143150202	-19.25627008	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4732	12323	0.002921367	0.011847764	3	L2-3	EN-L2-3-MS	30	9	9
CAGCATACAGCTTAAC-1_371G_A3D3	-15.34050074	1.821325206	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4339	10088	0.004361618	0.016554322	3	13A	IN-VIP	30	9	9
CAGCATAGTTTAGCTG-1_371G_A3D3	-30.29193119	9.973259687	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	778	1080	0.00462963	0.006481481	3	8	Astrocytes	30	9	9
CAGCATATCATGCATG-1_371G_A3D3	-0.642273005	13.14307956	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	953	1401	0.007137759	0.014275517	3	oligos	OL-Cntl	30	9	9
CAGCATATCTGCGGCA-1_371G_A3D3	26.78060378	6.553048402	15BA	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1085	1518	0.005928854	0.019104084	3	15BA	Stromal cells	30	9	9
CAGCCGAAGATCGATA-1_371G_A3D3	9.709140067	14.17480756	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1150	1940	0.003608247	0.008762887	3	oligos	OL-Cntl	30	9	9
CAGCCGAAGCGGCTTC-1_371G_A3D3	7.922201373	9.958784045	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1269	2178	0.004132231	0.011478421	3	oligos	OL-Cntl	30	9	9
CAGCCGAAGGTAAACT-1_371G_A3D3	11.39220133	7.903527511	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1591	2923	0.002736914	0.011631885	3	oligos	OL-Cntl	30	9	9
CAGCCGACACAGAGGT-1_371G_A3D3	4.076609561	16.10649914	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	968	1442	0.006241331	0.0110957	3	oligos	OL-Cntl	30	9	9
CAGCCGACAGGGATTG-1_371G_A3D3	4.479587915	14.87059014	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	918	1474	0	0.018317503	3	oligos	OL-Cntl	30	9	9
CAGCCGAGTAGCGTAG-1_371G_A3D3	35.96337579	-10.54641404	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5580	14555	0.003160426	0.01147372	3	2	EN-L4	30	9	9
CAGCCGATCCATGAGT-1_371G_A3D3	33.94838386	-12.73238283	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5708	16767	0.02481064	0.008588298	3	2	EN-L4	30	9	9
CAGCCGATCGAACGGA-1_371G_A3D3	9.219843092	-24.12912389	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5570	17474	0.006523978	0.005150509	3	L2-3	EN-L2-3-MS	30	9	9
CAGCCGATCTCCAACC-1_371G_A3D3	20.28209307	6.996843526	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2408	4564	0.000657318	0.007887818	3	oligos	OL-Cntl	30	9	9
CAGCGACAGAAGGTTT-1_371G_A3D3	1.516458367	14.34819542	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	936	1441	0.006245663	0.009715475	3	oligos	OL-Cntl	30	9	9
CAGCGACAGGACATTA-1_371G_A3D3	15.25351212	-28.48239504	3	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5845	20157	0.005953267	0.007888079	3	3	EN-L5-6	30	9	9
CAGCGACAGGTGTTAA-1_371G_A3D3	-3.181701479	-26.14653226	10	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3859	10411	0.002017097	0.003073672	3	L2-3	EN-L2-3-Cntl	30	9	9
CAGCGACCACTGAAGG-1_371G_A3D3	-25.04672503	21.83127245	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1153	1791	0.006700168	0.004466778	3	8	Astrocytes	30	9	9
CAGCGACCATACGCTA-1_371G_A3D3	-13.51233384	1.56550802	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4032	9140	0.004595186	0.010065646	3	13A	IN-VIP	30	9	9
CAGCGACGTATTCGTG-1_371G_A3D3	8.549043059	32.08546811	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	817	1334	0.000749625	0.007496252	3	oligos	OL-Cntl	30	9	9
CAGCGACTCATCTGCC-1_371G_A3D3	-18.1785701	-23.01626099	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2136	3717	0.003497444	0.006994888	3	6A	IN-PV	30	9	9
CAGCTAAAGGTCATCT-1_371G_A3D3	-1.591654914	20.66191173	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	723	1035	0.009661836	0.009661836	3	oligos	OL-Cntl	30	9	9
CAGCTAACAACTGCGC-1_371G_A3D3	0.525444588	14.11609787	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	970	1470	0.006802721	0.016326531	3	oligos	OL-Cntl	30	9	9
CAGCTAACAAGCCGTC-1_371G_A3D3	-18.41824312	28.59624643	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2543	5116	0.006059421	0.005863956	3	8	Astrocytes	30	9	9
CAGCTAACAATGTAAG-1_371G_A3D3	6.971789711	9.921303724	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1129	1821	0.003844042	0.012630423	3	oligos	OL-Cntl	30	9	9
CAGCTAAGTAGCAAAT-1_371G_A3D3	9.858899256	15.48188493	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1173	1883	0.009559214	0.004779607	3	oligos	OL-Cntl	30	9	9
CAGCTAAGTTCCCGAG-1_371G_A3D3	19.9522735	1.257861847	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1518	2658	0.010158014	0.002633559	3	2	EN-L4	30	9	9
CAGCTAATCGCCAGCA-1_371G_A3D3	-19.51812226	24.7349435	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1699	2938	0.003063308	0.006807352	3	8	Astrocytes	30	9	9
CAGCTAATCTCTGAGA-1_371G_A3D3	8.759057897	21.04450256	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	867	1413	0.004953999	0.007784855	3	oligos	OL-Cntl	30	9	9
CAGCTAATCTGACCTC-1_371G_A3D3	-18.90366458	-23.11180822	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2200	4419	0.021498076	0.004752206	3	6A	IN-PV	30	9	9
CAGCTAATCTGCGGCA-1_371G_A3D3	-1.883499207	17.23586574	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	700	1040	0.000961538	0.017307692	3	oligos	OL-Cntl	30	9	9
CAGCTGGTCATGTAGC-1_371G_A3D3	15.96527568	6.256753645	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1977	3745	0.00293725	0.007743658	3	oligos	OL-Cntl	30	9	9
CAGCTGGTCTCTTGAT-1_371G_A3D3	7.759222712	9.336068617	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1211	1946	0.003597122	0.014902364	3	oligos	OL-Cntl	30	9	9
CAGGTGCAGTCCGTAT-1_371G_A3D3	11.68505703	-23.82786654	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4942	14042	0.001922803	0.008617006	3	L2-3	EN-L2-3-MS	30	9	9
CAGGTGCAGTGTGAAT-1_371G_A3D3	-2.967011067	17.89350865	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	701	1034	0.000967118	0.005802708	3	oligos	OL-Cntl	30	9	9
CAGGTGCCAAAGTGCG-1_371G_A3D3	6.696776743	-27.06896665	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5996	16570	0.007966204	0.004888352	3	L2-3	EN-L2-3-MS	30	9	9
CAGTAACAGGTGATAT-1_371G_A3D3	-2.787250573	16.5448127	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	684	1004	0.006972112	0.008964143	3	oligos	OL-Cntl	30	9	9
CAGTAACCAAAGAATC-1_371G_A3D3	16.21043423	6.123561265	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2161	4142	0.003621439	0.012795751	3	oligos	OL-Cntl	30	9	9
CAGTAACCATGTAGTC-1_371G_A3D3	-2.098781699	17.43381049	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	701	1061	0.001885014	0.017907634	3	oligos	OL-Cntl	30	9	9
CAGTAACGTCAGAAGC-1_371G_A3D3	-30.62485185	9.973187939	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	863	1257	0.003977725	0.008750994	3	8	Astrocytes	30	9	9
CAGTAACGTGTGTGCC-1_371G_A3D3	-0.491542156	22.01626233	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	739	1140	0.000877193	0.007894737	3	oligos	OL-Cntl	30	9	9
CAGTAACTCACAGGCC-1_371G_A3D3	-0.527356493	13.4241896	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	947	1401	0.005710207	0.014989293	3	oligos	OL-Cntl	30	9	9
CAGTCCTAGATGAGAG-1_371G_A3D3	-0.095099273	12.57644994	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	919	1300	0	0.021538462	3	oligos	OL-Cntl	30	9	9
CAGTCCTAGCAGACTG-1_371G_A3D3	-36.70912906	0.666608101	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1782	3128	0.000959079	0.003516624	3	9	OPC	30	9	9
CAGTCCTAGCTAGTGG-1_371G_A3D3	8.652054543	17.5789843	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	864	1377	0.005083515	0.004357298	3	oligos	OL-Cntl	30	9	9
CAGTCCTAGGGTATCG-1_371G_A3D3	-29.12716566	0.862068253	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2023	3565	0.003366059	0.008976157	3	9	OPC	30	9	9
CAGTCCTCACATGTGT-1_371G_A3D3	-22.96846421	-19.49913189	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3063	6850	0.007153285	0.007445255	3	6A	IN-PV	30	9	9
CAGTCCTCACCAGTTA-1_371G_A3D3	-33.85008931	3.073016653	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2296	4571	0.000437541	0.005031722	3	9	OPC	30	9	9
CAGTCCTCACCCTATC-1_371G_A3D3	-30.54295579	1.768905901	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2005	3723	0.00456621	0.006446414	3	9	OPC	30	9	9
CAGTCCTGTCACACGC-1_371G_A3D3	7.453015274	-20.48342951	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4293	11609	0.01292101	0.005082264	3	L2-3	EN-L2-3-MS	30	9	9
CAGTCCTGTCCAGTGC-1_371G_A3D3	-2.8603335	14.97286242	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	761	1065	0.001877934	0.020657277	3	oligos	OL-Cntl	30	9	9
CAGTCCTTCACATGCA-1_371G_A3D3	4.978138077	-20.20812155	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4367	11501	0.001738979	0.007216764	3	L2-3	EN-L2-3-MS	30	9	9
CAGTCCTTCAGAAATG-1_371G_A3D3	-25.30885956	11.31148936	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	941	1291	0.00232378	0.00232378	3	8	Astrocytes	30	9	9
CATATGGAGACAGACC-1_371G_A3D3	17.19055515	-26.56940865	3	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	6194	21794	0.004404882	0.00679086	3	3	EN-L5-6	30	9	9
CATATGGAGGTACTCT-1_371G_A3D3	-23.13866152	-19.52250417	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2875	6189	0.001777347	0.011633543	3	6A	IN-PV	30	9	9
CATATGGAGTACGACG-1_371G_A3D3	-0.433404059	13.58278206	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	878	1307	0.000765111	0.01606733	3	oligos	OL-Cntl	30	9	9
CATATGGCACGCATCG-1_371G_A3D3	-15.80477468	-9.218670964	13B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2643	5579	0.015773436	0.003943359	3	13B	IN-SV2C	30	9	9
CATATGGCACGTGAGA-1_371G_A3D3	-2.079643437	14.5207027	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	762	1108	0.000902527	0.018050542	3	oligos	OL-Cntl	30	9	9
CATATGGGTGTGCGTC-1_371G_A3D3	-15.10038112	1.840925177	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3917	8505	0.001410935	0.013521458	3	13A	IN-VIP	30	9	9
CATATGGGTTAAGTAG-1_371G_A3D3	-4.338483764	6.22205806	5	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1539	2513	0.001193792	0.037007561	3	oligos	OL-MS-1	30	9	9
CATATGGGTTACGACT-1_371G_A3D3	1.15362111	15.60045074	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	836	1266	0.002369668	0.008688784	3	oligos	OL-Cntl	30	9	9
CATATGGTCCCTTGTG-1_371G_A3D3	-1.635906538	17.25518411	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	703	1013	0.000987167	0.006910168	3	oligos	OL-Cntl	30	9	9
CATATGGTCTGATACG-1_371G_A3D3	-0.946610682	16.12149873	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	793	1132	0.002650177	0.016784452	3	oligos	OL-Cntl	30	9	9
CATATTCCACTGCCAG-1_371G_A3D3	11.64288831	9.301273803	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1352	2243	0.001783326	0.014266607	3	oligos	OL-Cntl	30	9	9
CATATTCGTATGGTTC-1_371G_A3D3	-16.82647768	1.116306436	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3541	7402	0.009051608	0.014995947	3	13A	IN-VIP	30	9	9
CATATTCGTTCGCTAA-1_371G_A3D3	4.835923678	-17.4711562	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3097	6084	0.003451677	0.007725181	3	L2-3	EN-L2-3-MS	30	9	9
CATATTCTCATCGATG-1_371G_A3D3	-33.34735248	-0.444981994	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1662	2705	0	0.006284658	3	9	OPC	30	9	9
CATCAAGAGATCCCAT-1_371G_A3D3	-29.77692912	0.314661293	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1865	3106	0.002897618	0.004829363	3	9	OPC	30	9	9
CATCAAGAGTGCGTGA-1_371G_A3D3	2.881609502	9.265470947	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1014	1536	0.001302083	0.016276042	3	oligos	OL-Cntl	30	9	9
CATCAAGCATATGCTG-1_371G_A3D3	-17.64729484	1.579216043	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5302	12597	0.004604271	0.020163531	3	13A	IN-VIP	30	9	9
CATCAAGTCACCGTAA-1_371G_A3D3	-26.44540005	10.79333249	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	892	1351	0.000740192	0.003700962	3	8	Astrocytes	30	9	9
CATCAGAAGCGTTTAC-1_371G_A3D3	35.16857562	10.88099539	14	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	782	1074	0.002793296	0.019553073	3	14	Microglia	30	9	9
CATCAGAAGCTGCCCA-1_371G_A3D3	-1.322022408	17.07761927	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	771	1117	0.003581021	0.015219338	3	oligos	OL-Cntl	30	9	9
CATCAGACAGTGGGAT-1_371G_A3D3	-4.377405554	7.410832667	5	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1008	1530	0.005228758	0.019607843	3	oligos	OL-MS-1	30	9	9
CATCAGAGTCGCATAT-1_371G_A3D3	-22.84221722	-26.42593116	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4626	13264	0.000980097	0.00701146	3	6A	IN-PV	30	9	9
CATCAGAGTGTATGGG-1_371G_A3D3	7.788590126	-20.44999441	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4980	13099	0.00404611	0.006489045	3	L2-3	EN-L2-3-MS	30	9	9
CATCAGAGTTAGAACA-1_371G_A3D3	1.380006788	15.40827038	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	836	1185	0.000843882	0.016033755	3	oligos	OL-Cntl	30	9	9
CATCAGATCAACACAC-1_371G_A3D3	-8.541541248	-2.80561334	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2151	4238	0.025247758	0.005427088	3	13A	IN-VIP	30	9	9
CATCAGATCAGATAAG-1_371G_A3D3	14.8488042	-29.17141024	3	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4968	15820	0.003792668	0.005752212	3	3	EN-L5-6	30	9	9
CATCAGATCCTGTACC-1_371G_A3D3	-0.859269194	18.33483192	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	739	1126	0.001776199	0.008880995	3	oligos	OL-Cntl	30	9	9
CATCAGATCCTTGACC-1_371G_A3D3	7.225152721	-18.57451878	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4507	10776	0.004454343	0.010671863	3	L2-3	EN-L2-3-MS	30	9	9
CATCCACAGATAGCAT-1_371G_A3D3	8.733961052	15.63809575	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1026	1688	0.000592417	0.008293839	3	oligos	OL-Cntl	30	9	9
CATCCACGTACATCCA-1_371G_A3D3	-14.93275847	1.578074849	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4024	8854	0.007228371	0.008244861	3	13A	IN-VIP	30	9	9
CATCCACGTCAATGTC-1_371G_A3D3	-2.091206805	16.76968063	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	824	1202	0	0.006655574	3	oligos	OL-Cntl	30	9	9
CATCCACGTTGTCGCG-1_371G_A3D3	12.39120833	-24.04216064	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	7469	28129	0.005225923	0.008354367	3	L2-3	EN-L2-3-MS	30	9	9
CATCCACTCAGGCGAA-1_371G_A3D3	-25.37308875	11.0483041	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	919	1271	0.016522423	0.011014949	3	8	Astrocytes	30	9	9
CATCCACTCCAGTAGT-1_371G_A3D3	-8.358717198	-17.14693468	6B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	696	1077	0.067780873	0.005571031	3	6B	IN-SST	30	9	9
CATCCACTCCGTACAA-1_371G_A3D3	-12.97092457	-16.89176363	6B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1252	1986	0.025679758	0.004531722	3	6B	IN-SST	30	9	9
CATCGAAAGTGCGATG-1_371G_A3D3	7.153323991	13.10597042	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1252	1932	0.005693582	0.007763975	3	oligos	OL-Cntl	30	9	9
CATCGAACACCGAATT-1_371G_A3D3	-9.111226083	-0.895124414	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2126	3994	0.009263896	0.004006009	3	13A	IN-VIP	30	9	9
CATCGAACACGAGGTA-1_371G_A3D3	16.15325704	-27.8109479	3	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4259	10930	0.024611162	0.00558097	3	3	EN-L5-6	30	9	9
CATCGAATCCTATTCA-1_371G_A3D3	-26.04118386	-22.40956201	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3355	6413	0.005925464	0.023701856	3	6A	IN-PV	30	9	9
CATCGGGCACTCGACG-1_371G_A3D3	8.508167172	15.98070945	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1065	1605	0.006853583	0.008099688	3	oligos	OL-Cntl	30	9	9
CATCGGGGTGCCTGCA-1_371G_A3D3	-27.17920117	13.48511239	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	832	1244	0.002411576	0.004019293	3	8	Astrocytes	30	9	9
CATCGGGTCTTTACAC-1_371G_A3D3	2.495085882	12.91848019	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	942	1468	0.004087193	0.014986376	3	oligos	OL-Cntl	30	9	9
CATGACAAGTGTTGAA-1_371G_A3D3	3.497409778	13.77483849	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1033	1517	0.001318392	0.019116678	3	oligos	OL-Cntl	30	9	9
CATGACACACCACGTG-1_371G_A3D3	-8.278075808	7.241250335	5	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	990	1501	0.00532978	0.052631579	3	oligos	OL-MS-1	30	9	9
CATGACACACGTCAGC-1_371G_A3D3	-32.96649591	5.307945231	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3401	7046	0.002128867	0.004683508	3	9	OPC	30	9	9
CATGACACATCCTAGA-1_371G_A3D3	-15.1615319	1.729690886	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3922	8171	0.007587811	0.010402643	3	13A	IN-VIP	30	9	9
CATGACAGTGAAATCA-1_371G_A3D3	3.999146473	13.73969203	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1108	1722	0.00174216	0.016260163	3	oligos	OL-Cntl	30	9	9
CATGACAGTTCGCGAC-1_371G_A3D3	-34.22769421	-0.653467855	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1481	2502	0.000799361	0.004796163	3	9	OPC	30	9	9
CATGACATCATAAAGG-1_371G_A3D3	6.152716968	-19.43748279	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4899	12214	0.001801212	0.009251678	3	L2-3	EN-L2-3-MS	30	9	9
CATGACATCGAACGGA-1_371G_A3D3	36.00327491	-12.37100183	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5690	14420	0.003744799	0.013661581	3	2	EN-L4	30	9	9
CATGACATCTTGTATC-1_371G_A3D3	5.512505346	14.62326771	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1002	1572	0.002544529	0.010814249	3	oligos	OL-Cntl	30	9	9
CATGCCTAGACCTAGG-1_371G_A3D3	-18.84438768	-23.79548419	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3063	6850	0.01080292	0.002043796	3	6A	IN-PV	30	9	9
CATGCCTAGCCACGCT-1_371G_A3D3	8.096283553	15.47024013	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	940	1526	0.005897772	0.005242464	3	oligos	OL-Cntl	30	9	9
CATGCCTAGTGTACCT-1_371G_A3D3	19.72348887	-7.667344859	3	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2471	5058	0.002372479	0.004151839	3	3	EN-L5-6	30	9	9
CATGCCTCACCGGAAA-1_371G_A3D3	-15.00557601	1.541247182	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3801	8635	0.004516503	0.013202085	3	13A	IN-VIP	30	9	9
CATGCCTCACTAGTAC-1_371G_A3D3	-14.76420172	-21.64008659	6B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1456	2574	0.033411033	0.005050505	3	6B	IN-SST	30	9	9
CATGCCTCATGTTGAC-1_371G_A3D3	15.55950323	5.679379773	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2726	5229	0.008605852	0.01166571	3	oligos	OL-Cntl	30	9	9
CATGCCTGTAGAGGAA-1_371G_A3D3	35.83391913	-7.564033085	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4240	10268	0.003408648	0.007206856	3	2	EN-L4	30	9	9
CATGCCTGTATAATGG-1_371G_A3D3	20.2950033	21.37830054	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	980	1634	0.000611995	0.000611995	3	oligos	OL-Cntl	30	9	9
CATGCCTGTCATGCAT-1_371G_A3D3	-29.38706235	0.686151632	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2039	3505	0.000570613	0.010841655	3	9	OPC	30	9	9
CATGCCTTCAAACAAG-1_371G_A3D3	5.238087674	11.55699375	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1181	1833	0.009274414	0.009819967	3	oligos	OL-Cntl	30	9	9
CATGCCTTCTAACGGT-1_371G_A3D3	-15.52951178	0.555975402	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4033	9162	0.015607946	0.009386597	3	13A	IN-VIP	30	9	9
CATGGCGAGGGCTTGA-1_371G_A3D3	-20.15685837	-20.24476459	6B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2136	3743	0.006411969	0.014694096	3	6B	IN-SST	30	9	9
CATGGCGCAATAGCGG-1_371G_A3D3	33.70426715	-6.870083501	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4799	12201	0.00827801	0.005737235	3	2	EN-L4	30	9	9
CATGGCGCAGCTATTG-1_371G_A3D3	32.59780458	-12.67887558	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4164	9546	0.016027656	0.009323277	3	2	EN-L4	30	9	9
CATGGCGCATCAGTAC-1_371G_A3D3	-17.26874806	1.485579001	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4343	9653	0.004972547	0.016575158	3	13A	IN-VIP	30	9	9
CATGGCGCATCGGTTA-1_371G_A3D3	3.937408849	13.83558229	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1007	1586	0.008827238	0.016393443	3	oligos	OL-Cntl	30	9	9
CATGGCGGTGCAGTAG-1_371G_A3D3	35.91671918	-12.3983463	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4939	10973	0.00719949	0.018135423	3	2	EN-L4	30	9	9
CATGGCGTCACTGGGC-1_371G_A3D3	-3.412697901	15.32311119	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	865	1290	0.003100775	0.011627907	3	oligos	OL-Cntl	30	9	9
CATGGCGTCCAACCAA-1_371G_A3D3	8.413195095	15.86925109	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	974	1560	0.005769231	0.008333333	3	oligos	OL-Cntl	30	9	9
CATTATCAGAGTGACC-1_371G_A3D3	-4.675824572	6.241821696	5	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1309	2125	0.000470588	0.024	3	oligos	OL-MS-1	30	9	9
CATTATCAGGATGGTC-1_371G_A3D3	9.064461098	9.837582674	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1145	1869	0.000535045	0.009095773	3	oligos	OL-Cntl	30	9	9
CATTATCAGGTGACCA-1_371G_A3D3	-11.3421898	-9.00246956	13B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1638	2718	0.041942605	0.004415011	3	13B	IN-SV2C	30	9	9
CATTATCCAATGAATG-1_371G_A3D3	-24.41145189	15.76105909	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1206	1744	0.001146789	0.004587156	3	8	Astrocytes	30	9	9
CATTATCCAGCCTGTG-1_371G_A3D3	-8.945856451	-15.56615623	6B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	824	1118	0.023255814	0.011627907	3	6B	IN-SST	30	9	9
CATTATCGTATATGAG-1_371G_A3D3	-18.43314607	-10.06656569	13B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4188	9952	0.006330386	0.014067524	3	13B	IN-SV2C	30	9	9
CATTATCGTCTGGAGA-1_371G_A3D3	-31.36970212	10.8810894	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	736	1113	0.004492363	0.004492363	3	8	Astrocytes	30	9	9
CATTATCGTTAAGGGC-1_371G_A3D3	-30.55790525	9.926835443	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	902	1288	0.005434783	0.00621118	3	8	Astrocytes	30	9	9
CATTATCTCCTCCTAG-1_371G_A3D3	12.07818725	8.444788857	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1417	2420	0.002479339	0.011983471	3	oligos	OL-Cntl	30	9	9
CATTCGCAGTGTTGAA-1_371G_A3D3	-28.37676639	-22.34764956	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5027	13481	0.038795342	0.009346488	3	6A	IN-PV	30	9	9
CATTCGCCAGTATGCT-1_371G_A3D3	-16.59229717	1.701004303	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4206	9329	0.013291886	0.015006968	3	13A	IN-VIP	30	9	9
CATTCGCGTCCCTTGT-1_371G_A3D3	-1.115644582	18.29499976	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	661	1004	0.002988048	0.017928287	3	oligos	OL-Cntl	30	9	9
CATTCGCTCGGTCTAA-1_371G_A3D3	7.963293116	9.647419752	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1245	2198	0.00500455	0.009099181	3	oligos	OL-Cntl	30	9	9
CCAATCCAGGCCCTTG-1_371G_A3D3	9.535022055	9.467937925	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1338	2461	0.006501422	0.0146282	3	oligos	OL-Cntl	30	9	9
CCAATCCCAAACCCAT-1_371G_A3D3	-2.679050462	13.0889599	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	902	1247	0.004009623	0.036086608	3	oligos	OL-Cntl	30	9	9
CCAATCCCAGGACGTA-1_371G_A3D3	-0.637405432	-0.80482147	11	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1656	2596	0.011171032	0.025038521	3	11	Glia-MIX	30	9	9
CCAATCCGTACAGCAG-1_371G_A3D3	8.874679904	12.33174948	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1211	2060	0.000485437	0.012135922	3	oligos	OL-Cntl	30	9	9
CCAATCCGTTCGAATC-1_371G_A3D3	-3.435155474	19.86168956	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	717	1069	0.005612722	0.008419083	3	oligos	OL-Cntl	30	9	9
CCAATCCTCGTTTGCC-1_371G_A3D3	-14.47768116	-21.3076177	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1653	3222	0.027001862	0.003414029	3	6A	IN-PV	30	9	9
CCAATCCTCTCAAGTG-1_371G_A3D3	-14.97064066	1.510208841	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3435	7572	0.010036978	0.012810354	3	13A	IN-VIP	30	9	9
CCAATCCTCTGCCAGG-1_371G_A3D3	3.820752782	10.53089154	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1196	1880	0.004255319	0.021276596	3	oligos	OL-Cntl	30	9	9
CCACCTAAGGCTCATT-1_371G_A3D3	6.611651351	15.94827906	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	933	1530	0.00130719	0.009803922	3	oligos	OL-Cntl	30	9	9
CCACCTACACATAACC-1_371G_A3D3	7.005513913	-18.87605644	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5300	14227	0.003303578	0.011105644	3	L2-3	EN-L2-3-MS	30	9	9
CCACCTACACCGCTAG-1_371G_A3D3	-23.81095988	-23.37287493	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2888	5602	0.009639414	0.047661549	3	6A	IN-PV	30	9	9
CCACCTACAGGTCTCG-1_371G_A3D3	-5.127001741	-3.188912819	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1540	2813	0.006754355	0.004976893	3	13A	IN-VIP	30	9	9
CCACCTACAGTGGGAT-1_371G_A3D3	-13.85812551	-9.097758449	13B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2401	4269	0.010072617	0.008901382	3	13B	IN-SV2C	30	9	9
CCACCTAGTCCGAGTC-1_371G_A3D3	-10.66563772	14.70091042	11	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1343	2135	0.003747073	0.003747073	3	11	Glia-MIX	30	9	9
CCACCTAGTGCATCTA-1_371G_A3D3	4.742419374	-20.64243904	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4499	12442	0.000964475	0.005786851	3	L2-3	EN-L2-3-MS	30	9	9
CCACCTAGTTCATGGT-1_371G_A3D3	-4.757052202	-3.733092387	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1278	2200	0.019545455	0.005454545	3	13A	IN-VIP	30	9	9
CCACCTATCCTGCTTG-1_371G_A3D3	3.533265226	15.48609946	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	951	1422	0	0.008438819	3	oligos	OL-Cntl	30	9	9
CCACGGAAGTATTGGA-1_371G_A3D3	-31.56786149	-3.713373451	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1280	1926	0.001038422	0.036863967	3	9	OPC	30	9	9
CCACGGACACCATGTA-1_371G_A3D3	-30.48105124	-1.285881896	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1635	2863	0.00174642	0.007684247	3	9	OPC	30	9	9
CCACGGACAGCTGTGC-1_371G_A3D3	-21.52093452	26.06580729	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1823	3155	0.001901743	0.002852615	3	8	Astrocytes	30	9	9
CCACGGAGTTGCTCCT-1_371G_A3D3	17.20892521	-4.958227594	3	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1547	2721	0.018375597	0.005512679	3	3	EN-L5-6	30	9	9
CCACGGATCATGTAGC-1_371G_A3D3	-14.65430859	-18.25423675	6B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1359	2233	0.017465293	0.006717421	3	6B	IN-SST	30	9	9
CCACGGATCCCTAACC-1_371G_A3D3	9.715962344	12.46831845	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1089	1884	0.004246285	0.010615711	3	oligos	OL-Cntl	30	9	9
CCACGGATCTCTGAGA-1_371G_A3D3	-18.66457525	-9.987542459	13B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4625	10557	0.000189448	0.016860851	3	13B	IN-SV2C	30	9	9
CCACGGATCTGCGTAA-1_371G_A3D3	20.04534237	-29.22314504	3	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5274	16428	0.002678354	0.005904553	3	3	EN-L5-6	30	9	9
CCACTACAGCAAATCA-1_371G_A3D3	-2.470342386	14.09459732	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	824	1143	0.000874891	0.022747157	3	oligos	OL-Cntl	30	9	9
CCACTACAGCCTATGT-1_371G_A3D3	-13.5926424	1.546686739	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4430	10527	0.003514772	0.00645958	3	13A	IN-VIP	30	9	9
CCACTACCACATCTTT-1_371G_A3D3	16.28974607	6.194579116	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2190	4263	0.003753225	0.008679334	3	oligos	OL-Cntl	30	9	9
CCACTACCATCTCCCA-1_371G_A3D3	-0.438777296	13.11507795	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1012	1458	0.001371742	0.014403292	3	oligos	OL-Cntl	30	9	9
CCACTACGTCTGCGGT-1_371G_A3D3	-14.09357364	1.765542632	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3896	8336	0.004678503	0.005878119	3	13A	IN-VIP	30	9	9
CCACTACGTTCCATGA-1_371G_A3D3	35.94569158	-7.81462947	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4730	12119	0.004703358	0.006766235	3	2	EN-L4	30	9	9
CCAGCGACAGTACACT-1_371G_A3D3	5.290396065	21.69534234	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	751	1080	0.003703704	0.00462963	3	oligos	OL-Cntl	30	9	9
CCAGCGACAGTGACAG-1_371G_A3D3	-2.159891952	17.03244644	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	699	1006	0.001988072	0.019880716	3	oligos	OL-Cntl	30	9	9
CCAGCGATCCCATTAT-1_371G_A3D3	-8.755385983	-18.18831654	6B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	852	1327	0.036925396	0.006028636	3	6B	IN-SST	30	9	9
CCAGCGATCTCTGCTG-1_371G_A3D3	-2.345387134	16.21931883	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	796	1157	0.005185825	0.017286085	3	oligos	OL-Cntl	30	9	9
CCATGTCCAAGCCATT-1_371G_A3D3	9.439531211	8.361849893	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1490	2502	0.001199041	0.019584333	3	oligos	OL-Cntl	30	9	9
CCATGTCCATCCCATC-1_371G_A3D3	-2.556993894	14.60955935	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	782	1112	0.002697842	0.03057554	3	oligos	OL-Cntl	30	9	9
CCATGTCGTATAGGTA-1_371G_A3D3	-8.974904335	-37.45326056	16	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1070	1461	0.015742642	0.016427105	3	16	EN-PYR	30	9	9
CCATGTCGTCCGAAGA-1_371G_A3D3	4.178426455	15.95805756	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1052	1578	0.003802281	0.004435995	3	oligos	OL-Cntl	30	9	9
CCATGTCGTGGGTCAA-1_371G_A3D3	-0.251366325	17.29718695	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	834	1275	0.000784314	0.008627451	3	oligos	OL-Cntl	30	9	9
CCATTCGAGACAGACC-1_371G_A3D3	6.677631249	9.723641717	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1140	1962	0.009683996	0.019877676	3	oligos	OL-Cntl	30	9	9
CCATTCGAGATGCCAG-1_371G_A3D3	17.95948781	-24.8740879	3	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	6542	22579	0.019265689	0.007263386	3	3	EN-L5-6	30	9	9
CCATTCGAGGCCGAAT-1_371G_A3D3	-23.934785	11.86678717	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1176	1639	0.003050641	0.007931666	3	8	Astrocytes	30	9	9
CCATTCGCAGCGATCC-1_371G_A3D3	5.095646989	10.69260463	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1164	1785	0.001680672	0.017927171	3	oligos	OL-Cntl	30	9	9
CCATTCGCATTTGCCC-1_371G_A3D3	-9.422027466	27.55702731	17	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1057	1479	0.045977011	0.01352265	3	oligos	OL-MS-2	30	9	9
CCATTCGGTATTCTCT-1_371G_A3D3	33.13100984	-6.84654511	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4329	11099	0.01054149	0.004775205	3	2	EN-L4	30	9	9
CCATTCGTCAGGCGAA-1_371G_A3D3	-5.56286905	-37.86982855	16	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1049	1399	0.012866333	0.030021444	3	16	EN-PYR	30	9	9
CCATTCGTCCACGTTC-1_371G_A3D3	-10.88887044	-0.928408594	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2541	4864	0.006167763	0.004523026	3	13A	IN-VIP	30	9	9
CCCAATCAGTTAAGTG-1_371G_A3D3	4.540580571	22.72442585	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	871	1258	0.00317965	0.009538951	3	oligos	OL-Cntl	30	9	9
CCCAATCCACCCTATC-1_371G_A3D3	-4.776357529	-3.003491093	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1477	2540	0.009448819	0.001968504	3	13A	IN-VIP	30	9	9
CCCAATCCAGGTCGTC-1_371G_A3D3	37.29928977	-9.882763977	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	6543	19438	0.007768289	0.008900093	3	2	EN-L4	30	9	9
CCCAATCCATCCGTGG-1_371G_A3D3	9.222320693	12.93975053	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1065	1785	0.003921569	0.006722689	3	oligos	OL-Cntl	30	9	9
CCCAATCGTACCATCA-1_371G_A3D3	6.748531678	9.818779474	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1171	1863	0.002147075	0.014492754	3	oligos	OL-Cntl	30	9	9
CCCAATCGTCCTCCAT-1_371G_A3D3	2.495277303	15.63550191	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	975	1610	0.008074534	0.008074534	3	oligos	OL-Cntl	30	9	9
CCCAATCGTCTAGCGC-1_371G_A3D3	-2.08418935	17.57419717	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	796	1123	0.001780944	0.011576135	3	oligos	OL-Cntl	30	9	9
CCCAATCGTGATAAGT-1_371G_A3D3	15.87236469	-22.19121781	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	8747	37103	0.0047166	0.009136727	3	L2-3	EN-L2-3-MS	30	9	9
CCCAATCTCACTCTTA-1_371G_A3D3	-19.34234719	26.72918922	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1798	3322	0.001204094	0.007224564	3	8	Astrocytes	30	9	9
CCCAGTTAGACCTTTG-1_371G_A3D3	-7.234287877	9.896281434	5	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	757	1032	0.003875969	0.029069767	3	oligos	OL-MS-1	30	9	9
CCCAGTTAGCTAGGCA-1_371G_A3D3	-35.17013706	1.420032388	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1791	3420	0.000292398	0.003508772	3	9	OPC	30	9	9
CCCAGTTCAAGCCGCT-1_371G_A3D3	1.366092168	17.53187839	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	761	1210	0.000826446	0.00661157	3	oligos	OL-Cntl	30	9	9
CCCAGTTGTAATTGGA-1_371G_A3D3	1.878280601	14.74803459	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	911	1353	0.002217295	0.012564671	3	oligos	OL-Cntl	30	9	9
CCCAGTTGTGTTGGGA-1_371G_A3D3	15.16001108	6.898083374	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1736	3189	0.00156789	0.013797429	3	oligos	OL-Cntl	30	9	9
CCCAGTTTCGGAAACG-1_371G_A3D3	32.83863216	10.73245198	14	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	862	1396	0.011461318	0.021489971	3	14	Microglia	30	9	9
CCCAGTTTCTCCAACC-1_371G_A3D3	-12.23065722	-10.39221058	13B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1529	2593	0.013883533	0.003470883	3	13B	IN-SV2C	30	9	9
CCCATACAGAGTCTGG-1_371G_A3D3	-11.32809149	17.6713422	11	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2489	4633	0.001726743	0.009281243	3	11	Glia-MIX	30	9	9
CCCATACAGCAGGTCA-1_371G_A3D3	-1.327067735	19.83358406	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	770	1062	0.014124294	0.011299435	3	oligos	OL-Cntl	30	9	9
CCCATACAGTGGTCCC-1_371G_A3D3	6.780242206	-21.10969931	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	7726	27756	0.00061248	0.012717971	3	L2-3	EN-L2-3-MS	30	9	9
CCCATACCATGTTCCC-1_371G_A3D3	3.393074014	11.82816873	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1079	1770	0.003954802	0.016949153	3	oligos	OL-Cntl	30	9	9
CCCATACTCGTGACAT-1_371G_A3D3	2.85121135	14.9081069	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1050	1588	0.00440806	0.008186398	3	oligos	OL-Cntl	30	9	9
CCCATACTCTCAAGTG-1_371G_A3D3	0.464166487	14.1723897	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	893	1296	0.00308642	0.010802469	3	oligos	OL-Cntl	30	9	9
CCCTCCTAGACCTTTG-1_371G_A3D3	33.15674795	-7.071654602	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4583	12091	0.003390952	0.005706724	3	2	EN-L4	30	9	9
CCCTCCTAGATCGATA-1_371G_A3D3	3.825352141	16.76821945	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	972	1535	0.002605863	0.01237785	3	oligos	OL-Cntl	30	9	9
CCCTCCTAGCCGATTT-1_371G_A3D3	6.811768507	-19.08186555	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4998	12862	0.005520137	0.010884777	3	L2-3	EN-L2-3-MS	30	9	9
CCCTCCTAGCGATGAC-1_371G_A3D3	-29.3906674	13.19307674	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	892	1329	0.007524454	0.0082769	3	8	Astrocytes	30	9	9
CCCTCCTAGGTAAACT-1_371G_A3D3	2.375440678	20.30006014	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	915	1366	0.001464129	0.011713031	3	oligos	OL-Cntl	30	9	9
CCCTCCTAGTGAATTG-1_371G_A3D3	-7.906693832	1.629400709	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2217	4932	0.006893755	0.007096513	3	13A	IN-VIP	30	9	9
CCCTCCTCAGGTCTCG-1_371G_A3D3	10.33563822	7.957461413	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1486	2459	0.001220008	0.009353396	3	oligos	OL-Cntl	30	9	9
CCCTCCTGTAATTGGA-1_371G_A3D3	35.97159344	-8.181655711	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5000	13760	0.00377907	0.008502907	3	2	EN-L4	30	9	9
CCCTCCTGTACCGAGA-1_371G_A3D3	-13.34842744	4.36961814	6B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3475	7006	0.011133314	0.008849558	3	6B	IN-SST	30	9	9
CCCTCCTGTTGTCGCG-1_371G_A3D3	33.91238951	-7.714143989	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5620	15628	0.002751472	0.007614538	3	2	EN-L4	30	9	9
CCCTCCTTCCAAATGC-1_371G_A3D3	-10.8440297	15.73095212	11	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1647	2795	0.002146691	0.008586762	3	11	Glia-MIX	30	9	9
CCGGGATAGCCCAACC-1_371G_A3D3	6.808306642	9.524409833	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1187	2017	0.00594943	0.00594943	3	oligos	OL-Cntl	30	9	9
CCGGGATAGCTCAACT-1_371G_A3D3	-3.217895238	12.97995239	5	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	809	1130	0.008849558	0.024778761	3	oligos	OL-MS-1	30	9	9
CCGGGATCAAGGACAC-1_371G_A3D3	-23.92199542	-25.11079798	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4172	10131	0.010166815	0.008784918	3	6A	IN-PV	30	9	9
CCGGGATCATGCGCAC-1_371G_A3D3	-19.45339349	20.04362111	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1708	2762	0.001810282	0.002534395	3	8	Astrocytes	30	9	9
CCGGGATGTCTAGTGT-1_371G_A3D3	-23.59842054	-19.22356499	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3522	7308	0.004789272	0.00971538	3	6A	IN-PV	30	9	9
CCGGTAGAGACATAAC-1_371G_A3D3	33.38878183	-7.155457772	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4689	12678	0.003549456	0.009544092	3	2	EN-L4	30	9	9
CCGGTAGAGAGCAATT-1_371G_A3D3	2.520842046	15.45417667	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1024	1597	0.008140263	0.011897307	3	oligos	OL-Cntl	30	9	9
CCGGTAGAGCTGAAAT-1_371G_A3D3	-28.97570795	0.145776809	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1722	2867	0.003836763	0.014300663	3	9	OPC	30	9	9
CCGGTAGAGGAGTTTA-1_371G_A3D3	15.40540538	7.895234182	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1751	3256	0.002457002	0.00522113	3	oligos	OL-Cntl	30	9	9
CCGGTAGCAATGAAAC-1_371G_A3D3	-20.57096277	26.3863017	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1794	2997	0.002335669	0.004337671	3	8	Astrocytes	30	9	9
CCGGTAGCAATGTAAG-1_371G_A3D3	-17.12992209	1.714285998	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4466	9817	0.005500662	0.013446063	3	13A	IN-VIP	30	9	9
CCGGTAGCAGCTGCAC-1_371G_A3D3	10.7264574	-27.29607458	10	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	8680	37854	0.004332435	0.003909759	3	L2-3	EN-L2-3-Cntl	30	9	9
CCGGTAGCAGGTCTCG-1_371G_A3D3	-13.86147812	-10.12817265	13B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2150	4125	0.002666667	0.006787879	3	13B	IN-SV2C	30	9	9
CCGGTAGCATAACCTG-1_371G_A3D3	-16.05560211	1.478663378	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3903	8343	0.003475968	0.012105957	3	13A	IN-VIP	30	9	9
CCGGTAGCATCGGACC-1_371G_A3D3	-19.68270681	-24.43509872	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2794	5698	0.014917515	0.003685504	3	6A	IN-PV	30	9	9
CCGGTAGCATCGGTTA-1_371G_A3D3	3.198330195	-24.18519766	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5462	15670	0.004275686	0.004594767	3	L2-3	EN-L2-3-MS	30	9	9
CCGGTAGCATGCTGGC-1_371G_A3D3	-33.5295519	-2.878131206	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1469	2349	0.002554278	0.006385696	3	9	OPC	30	9	9
CCGGTAGGTGAAAGAG-1_371G_A3D3	-14.02254785	-9.295826578	13B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2099	3847	0.012477255	0.007538342	3	13B	IN-SV2C	30	9	9
CCGGTAGGTTGTTTGG-1_371G_A3D3	27.26801913	7.171878967	15BA	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1209	1882	0.009564293	0.033475027	3	15BA	Stromal cells	30	9	9
CCGGTAGTCAGTCAGT-1_371G_A3D3	0.843708263	12.98024482	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1077	1592	0.001884422	0.015075377	3	oligos	OL-Cntl	30	9	9
CCGTACTAGCAGATCG-1_371G_A3D3	2.672306354	15.20423766	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	839	1243	0.004827031	0.013676589	3	oligos	OL-Cntl	30	9	9
CCGTACTAGCCTATGT-1_371G_A3D3	-8.568224037	-18.09467723	6B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	753	1134	0.007936508	0.00617284	3	6B	IN-SST	30	9	9
CCGTACTCAAGCCGTC-1_371G_A3D3	-34.1423881	-0.889317466	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1808	3138	0	0.003824092	3	9	OPC	30	9	9
CCGTACTGTAGCGTGA-1_371G_A3D3	-35.3311035	-3.266968842	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1336	2272	0.004401408	0.007922535	3	9	OPC	30	9	9
CCGTACTGTCAGTGGA-1_371G_A3D3	-1.951171911	18.81084857	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	731	1047	0.005730659	0.012416428	3	oligos	OL-Cntl	30	9	9
CCGTACTGTTACAGAA-1_371G_A3D3	-20.35201524	-6.982779778	13B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4732	11900	0.011092437	0.009159664	3	13B	IN-SV2C	30	9	9
CCGTACTTCACATGCA-1_371G_A3D3	8.559187462	15.80380582	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1008	1599	0.003126954	0.00750469	3	oligos	OL-Cntl	30	9	9
CCGTACTTCCCTGACT-1_371G_A3D3	15.45317076	9.250263736	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1602	2859	0.007345226	0.00664568	3	oligos	OL-Cntl	30	9	9
CCGTGGAAGTACGCCC-1_371G_A3D3	-1.964734915	14.04641309	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	812	1152	0.000868056	0.019097222	3	oligos	OL-Cntl	30	9	9
CCGTGGAGTGTAATGA-1_371G_A3D3	14.22233188	1.633941469	12	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1052	1896	0.029008439	0.004746835	3	12	EN-MIX	30	9	9
CCGTGGATCGCCAGCA-1_371G_A3D3	-0.764313062	15.9895193	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	747	1102	0.001814882	0.007259528	3	oligos	OL-Cntl	30	9	9
CCGTGGATCTCGCATC-1_371G_A3D3	19.86332284	-29.31624322	3	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	6193	22832	0.000875964	0.004905396	3	3	EN-L5-6	30	9	9
CCGTTCAAGCGATTCT-1_371G_A3D3	0.737536272	14.47055493	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	966	1528	0.001308901	0.021596859	3	oligos	OL-Cntl	30	9	9
CCGTTCAAGTCGTACT-1_371G_A3D3	8.939871856	15.14384214	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1106	1767	0.001131862	0.008488964	3	oligos	OL-Cntl	30	9	9
CCGTTCAAGTGTTTGC-1_371G_A3D3	-28.87928342	-0.297719177	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1597	2515	0.002385686	0.016699801	3	9	OPC	30	9	9
CCGTTCACACGGTAAG-1_371G_A3D3	-24.13427025	16.75175346	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1318	2182	0.008707608	0.004124656	3	8	Astrocytes	30	9	9
CCGTTCACATACTACG-1_371G_A3D3	10.56655678	16.68760778	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1058	1716	0.009324009	0.004662005	3	oligos	OL-Cntl	30	9	9
CCGTTCACATCCGGGT-1_371G_A3D3	-3.475878004	-7.585407548	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	718	1026	0.009746589	0.004873294	3	13A	IN-VIP	30	9	9
CCGTTCAGTAAGGATT-1_371G_A3D3	6.581281627	-21.14706515	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	6543	21534	0.002925606	0.009334076	3	L2-3	EN-L2-3-MS	30	9	9
CCGTTCATCCCTAATT-1_371G_A3D3	-23.6470287	-25.83185283	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4742	12556	0.002070723	0.00573431	3	6A	IN-PV	30	9	9
CCGTTCATCCGCGCAA-1_371G_A3D3	2.717748537	14.08577638	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1074	1585	0.005678233	0.016403785	3	oligos	OL-Cntl	30	9	9
CCGTTCATCTGCTTGC-1_371G_A3D3	-18.55734201	27.38813529	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2223	4067	0.001475289	0.002704696	3	8	Astrocytes	30	9	9
CCTAAAGAGGAGTACC-1_371G_A3D3	2.258771336	16.39075426	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	905	1401	0	0.006423983	3	oligos	OL-Cntl	30	9	9
CCTAAAGAGGCACATG-1_371G_A3D3	35.86204883	-11.40895148	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5181	12635	0.001582905	0.01527503	3	2	EN-L4	30	9	9
CCTAAAGCAAGTCTAC-1_371G_A3D3	-2.820670301	14.64233686	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	836	1234	0.004051864	0.021069692	3	oligos	OL-Cntl	30	9	9
CCTAAAGCAATGCCAT-1_371G_A3D3	-19.80254768	29.50750459	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2223	4224	0.00094697	0.005918561	3	8	Astrocytes	30	9	9
CCTAAAGCACTACAGT-1_371G_A3D3	-15.8430474	1.163467928	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3538	7624	0.012460651	0.010755509	3	13A	IN-VIP	30	9	9
CCTAAAGCAGATGGGT-1_371G_A3D3	18.46356648	-28.81121121	3	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	6854	23764	0.000799529	0.00551254	3	3	EN-L5-6	30	9	9
CCTAAAGGTGATAAAC-1_371G_A3D3	5.600032856	-19.39311418	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3807	8598	0.002209816	0.006396836	3	L2-3	EN-L2-3-MS	30	9	9
CCTACACAGAAACGCC-1_371G_A3D3	0.848619866	13.54534556	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	975	1608	0.008706468	0.008084577	3	oligos	OL-Cntl	30	9	9
CCTACACAGAGGGATA-1_371G_A3D3	-1.828636555	17.12541231	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	746	1098	0.000910747	0.015482696	3	oligos	OL-Cntl	30	9	9
CCTACACAGCTAAGAT-1_371G_A3D3	9.191442346	10.5047237	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1234	2102	0.001427212	0.006660324	3	oligos	OL-Cntl	30	9	9
CCTACACAGCTAGTCT-1_371G_A3D3	-23.47084623	-20.66724177	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3236	6760	0.016272189	0.006360947	3	6A	IN-PV	30	9	9
CCTACACAGGTAAACT-1_371G_A3D3	-14.88202154	-9.56763625	13B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2993	5976	0.003514056	0.004016064	3	13B	IN-SV2C	30	9	9
CCTACACCAGACGCCT-1_371G_A3D3	0.152841885	19.39284236	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	752	1073	0.001863933	0.009319664	3	oligos	OL-Cntl	30	9	9
CCTACACGTCTTCAAG-1_371G_A3D3	1.974797756	20.41845899	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	818	1228	0.002442997	0.00732899	3	oligos	OL-Cntl	30	9	9
CCTACACGTGCTGTAT-1_371G_A3D3	3.739512045	19.42895253	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	834	1277	0	0.006264683	3	oligos	OL-Cntl	30	9	9
CCTACACGTTCGCGAC-1_371G_A3D3	-18.85463018	-17.82176444	6B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2625	5794	0.020883673	0.003279254	3	6B	IN-SST	30	9	9
CCTACACTCGCGTAGC-1_371G_A3D3	-16.16756758	1.133705659	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3556	6927	0.002021077	0.014436264	3	13A	IN-VIP	30	9	9
CCTACCAAGGAGTAGA-1_371G_A3D3	-2.103120579	14.03150219	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	792	1130	0.001769912	0.019469027	3	oligos	OL-Cntl	30	9	9
CCTACCAAGTCACGCC-1_371G_A3D3	1.745191918	16.91055482	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	851	1362	0.001468429	0.015418502	3	oligos	OL-Cntl	30	9	9
CCTACCACACCCATTC-1_371G_A3D3	-35.10030201	-0.599797469	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1417	2488	0.003617363	0.00562701	3	9	OPC	30	9	9
CCTACCATCAGTGTTG-1_371G_A3D3	-29.36272733	0.121011655	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1908	3138	0.000637349	0.009560229	3	9	OPC	30	9	9
CCTAGCTAGCGACGTA-1_371G_A3D3	-17.76426865	-23.64572092	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2247	4546	0.012538495	0.003959525	3	6A	IN-PV	30	9	9
CCTAGCTCACTTAACG-1_371G_A3D3	2.961098361	11.28559545	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	979	1556	0.000642674	0.016066838	3	oligos	OL-Cntl	30	9	9
CCTAGCTCATAACCTG-1_371G_A3D3	1.932386173	20.23211399	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	876	1345	0.011895911	0.008178439	3	oligos	OL-Cntl	30	9	9
CCTAGCTGTAAGAGAG-1_371G_A3D3	-1.061297787	15.86551104	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	783	1097	0.004557885	0.010027347	3	oligos	OL-Cntl	30	9	9
CCTAGCTGTCGCTTCT-1_371G_A3D3	-13.82338022	-15.42665149	6B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1561	2836	0.012341326	0.008815233	3	6B	IN-SST	30	9	9
CCTAGCTGTGCACTTA-1_371G_A3D3	36.97670307	8.710850353	14	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	830	1173	0.00170503	0.007672634	3	14	Microglia	30	9	9
CCTAGCTTCTTGACGA-1_371G_A3D3	-19.29065239	27.90289571	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2218	4177	0.000957625	0.003351688	3	8	Astrocytes	30	9	9
CCTATTAAGCCACGCT-1_371G_A3D3	-9.051028297	27.03611076	5	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1069	1515	0.020462046	0.007920792	3	oligos	OL-MS-1	30	9	9
CCTATTAAGGATTCGG-1_371G_A3D3	-26.01872895	10.86116874	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	885	1304	0.002300613	0.011503067	3	8	Astrocytes	30	9	9
CCTATTAAGGGTGTGT-1_371G_A3D3	-12.41520607	-3.982534891	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2648	5566	0.006827165	0.005749192	3	13A	IN-VIP	30	9	9
CCTATTAAGGTAGCCA-1_371G_A3D3	-3.663695634	16.34184393	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	680	1011	0.001978239	0.009891197	3	oligos	OL-Cntl	30	9	9
CCTATTACACAGACTT-1_371G_A3D3	-15.46975096	-18.97665702	6B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1664	3066	0.01826484	0.001304631	3	6B	IN-SST	30	9	9
CCTATTACAGATCCAT-1_371G_A3D3	-30.44972375	0.684109691	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1792	3031	0.001649621	0.004289014	3	9	OPC	30	9	9
CCTATTACAGCTTAAC-1_371G_A3D3	2.707466683	15.13696942	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1023	1515	0.002640264	0.007920792	3	oligos	OL-Cntl	30	9	9
CCTATTAGTCTTCAAG-1_371G_A3D3	6.623919308	9.550991656	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1211	2089	0.004786979	0.011010053	3	oligos	OL-Cntl	30	9	9
CCTATTATCTATCGCC-1_371G_A3D3	-37.3249224	-9.606033839	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	983	1765	0.002266289	0.001699717	3	9	OPC	30	9	9
CCTATTATCTTCAACT-1_371G_A3D3	12.89929042	9.952975531	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1246	2077	0.005777564	0.007703418	3	oligos	OL-Cntl	30	9	9
CCTCAGTAGCGATTCT-1_371G_A3D3	2.242140008	14.87303819	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1026	1573	0.006993007	0.011443102	3	oligos	OL-Cntl	30	9	9
CCTCAGTGTCCCTACT-1_371G_A3D3	35.03809079	-8.987771475	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	6382	18991	0.010057396	0.007793165	3	2	EN-L4	30	9	9
CCTCAGTGTCGCGTGT-1_371G_A3D3	-0.242737097	16.37011583	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	727	1099	0	0.010009099	3	oligos	OL-Cntl	30	9	9
CCTCAGTGTGACAAAT-1_371G_A3D3	35.78108837	10.41702469	14	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	737	1016	0.003937008	0.010826772	3	14	Microglia	30	9	9
CCTCAGTGTTGCTCCT-1_371G_A3D3	-3.717301627	-23.30916324	10	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5191	15732	0.000444953	0.003559624	3	L2-3	EN-L2-3-Cntl	30	9	9
CCTCAGTGTTTAGGAA-1_371G_A3D3	33.4212394	-2.441270925	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2933	6076	0.006912442	0.004114549	3	2	EN-L4	30	9	9
CCTCAGTTCGGTTCGG-1_371G_A3D3	5.630141724	21.3591234	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	877	1288	0.000776398	0.007763975	3	oligos	OL-Cntl	30	9	9
CCTCAGTTCTGCGGCA-1_371G_A3D3	3.557526581	9.860843768	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1114	1672	0.002392344	0.023325359	3	oligos	OL-Cntl	30	9	9
CCTCTGAAGACAAGCC-1_371G_A3D3	6.968074485	-19.05413239	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5474	14451	0.001729984	0.010103107	3	L2-3	EN-L2-3-MS	30	9	9
CCTCTGACAAATTGCC-1_371G_A3D3	-33.92511402	1.819786461	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1802	3174	0.003780718	0.004725898	3	9	OPC	30	9	9
CCTCTGACAAGTCTGT-1_371G_A3D3	-25.13149145	0.950865343	11	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3616	8613	0.005456868	0.007430628	3	11	Glia-MIX	30	9	9
CCTCTGACACGACGAA-1_371G_A3D3	-16.9728639	-21.49163885	6B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1741	3066	0.02446184	0.010437052	3	6B	IN-SST	30	9	9
CCTCTGACACGCTTTC-1_371G_A3D3	5.823068944	-19.55337911	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4529	11124	0.000269687	0.008719885	3	L2-3	EN-L2-3-MS	30	9	9
CCTCTGATCGAATGGG-1_371G_A3D3	-18.39035239	-15.58639375	6B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2136	3511	0.018228425	0.007405298	3	6B	IN-SST	30	9	9
CCTCTGATCTTGAGAC-1_371G_A3D3	-20.58240521	-20.20333337	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2194	4062	0.021418021	0.009354998	3	6A	IN-PV	30	9	9
CCTTACGAGCGCCTCA-1_371G_A3D3	-23.31882922	-26.17747847	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5708	17127	0.001109359	0.007531967	3	6A	IN-PV	30	9	9
CCTTACGAGGCTAGCA-1_371G_A3D3	35.94848327	-8.56684651	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5341	14024	0.001853965	0.006274957	3	2	EN-L4	30	9	9
CCTTACGAGTAGGTGC-1_371G_A3D3	-29.81080542	0.194286348	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1778	2990	0.001337793	0.011705686	3	9	OPC	30	9	9
CCTTACGCAGTGACAG-1_371G_A3D3	1.91410958	15.95056618	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	884	1407	0.004264392	0.008528785	3	oligos	OL-Cntl	30	9	9
CCTTACGGTAGAAAGG-1_371G_A3D3	-2.686082894	17.38128197	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	793	1159	0	0.007765315	3	oligos	OL-Cntl	30	9	9
CCTTACGGTAGAGCTG-1_371G_A3D3	-23.74025872	-25.68052166	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3880	8573	0.008281815	0.008748396	3	6A	IN-PV	30	9	9
CCTTACGGTCTAGCCG-1_371G_A3D3	-29.00587756	21.58927251	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1164	1754	0.009122007	0.005131129	3	8	Astrocytes	30	9	9
CCTTACGGTTTGTGTG-1_371G_A3D3	-8.680890989	-2.363026387	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1996	3624	0.02593819	0.004139073	3	13A	IN-VIP	30	9	9
CCTTACGTCAGCGATT-1_371G_A3D3	9.429044392	8.453672464	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1424	2428	0.001235585	0.01029654	3	oligos	OL-Cntl	30	9	9
CCTTACGTCCGCAAGC-1_371G_A3D3	0.59359121	17.98527186	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	813	1292	0.000773994	0.012383901	3	oligos	OL-Cntl	30	9	9
CCTTCCCAGCTTATCG-1_371G_A3D3	-16.6400787	2.067102421	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5287	13282	0.003689203	0.01106761	3	13A	IN-VIP	30	9	9
CCTTCCCCAAGCGTAG-1_371G_A3D3	-2.770253296	13.24064619	5	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	801	1052	0.002851711	0.022813688	3	oligos	OL-MS-1	30	9	9
CCTTCCCCAATCACAC-1_371G_A3D3	-3.908652463	17.53565422	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	773	1130	0.013274336	0.009734513	3	oligos	OL-Cntl	30	9	9
CCTTCCCCAGGATCGA-1_371G_A3D3	20.23285926	10.74794329	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1585	2787	0.002511661	0.006099749	3	oligos	OL-Cntl	30	9	9
CCTTCCCTCACTCCTG-1_371G_A3D3	8.970369256	10.84651632	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1227	2076	0.000481696	0.01300578	3	oligos	OL-Cntl	30	9	9
CCTTCCCTCCGCAGTG-1_371G_A3D3	7.846147274	9.965068676	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1160	1993	0.000501756	0.007526342	3	oligos	OL-Cntl	30	9	9
CCTTCCCTCTACTCAT-1_371G_A3D3	37.3718494	-9.780482248	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5137	14022	0.007416916	0.006275852	3	2	EN-L4	30	9	9
CCTTCCCTCTCAACTT-1_371G_A3D3	33.74186687	15.78845066	14	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1130	1717	0.007571345	0.036691904	3	14	Microglia	30	9	9
CCTTCGAAGGAACTGC-1_371G_A3D3	10.96369053	9.347031029	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1299	2192	0.00729927	0.009580292	3	oligos	OL-Cntl	30	9	9
CCTTCGACACATAACC-1_371G_A3D3	-16.38208631	2.235482903	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	6117	17924	0.005523321	0.008926579	3	13A	IN-VIP	30	9	9
CCTTCGACACCCATGG-1_371G_A3D3	-9.386246299	-16.06636327	6B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	848	1286	0.034992224	0.00622084	3	6B	IN-SST	30	9	9
CCTTCGATCCTCCTAG-1_371G_A3D3	-6.524182911	-0.234063384	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1824	3488	0.006020642	0.002866972	3	13A	IN-VIP	30	9	9
CCTTTCTAGTTAGGTA-1_371G_A3D3	4.7008119	-19.71119535	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3692	9102	0.001538123	0.004834102	3	L2-3	EN-L2-3-MS	30	9	9
CCTTTCTCAAAGCGGT-1_371G_A3D3	-14.604615	0.797499403	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3026	6177	0.006637526	0.008580217	3	13A	IN-VIP	30	9	9
CCTTTCTCATACTCTT-1_371G_A3D3	-26.71113594	10.99100308	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	713	1018	0.009823183	0.001964637	3	8	Astrocytes	30	9	9
CCTTTCTCATAGACTC-1_371G_A3D3	-15.65442495	0.960279163	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3413	7140	0.015546218	0.009663866	3	13A	IN-VIP	30	9	9
CCTTTCTCATCCGGGT-1_371G_A3D3	7.487908956	13.30026578	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1047	1732	0.002309469	0.011547344	3	oligos	OL-Cntl	30	9	9
CCTTTCTGTTAAGGGC-1_371G_A3D3	-34.00831033	3.233381996	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2343	4615	0.000216685	0.004983749	3	9	OPC	30	9	9
CCTTTCTGTTCAGACT-1_371G_A3D3	-0.498090181	19.32509028	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	795	1187	0	0.0042123	3	oligos	OL-Cntl	30	9	9
CCTTTCTTCAACGCTA-1_371G_A3D3	-30.75904283	1.631146783	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2031	4351	0.001608826	0.004596644	3	9	OPC	30	9	9
CCTTTCTTCTCGAGTA-1_371G_A3D3	8.369040725	17.8872857	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	818	1322	0.00075643	0.006051437	3	oligos	OL-Cntl	30	9	9
CGAACATAGTTACCCA-1_371G_A3D3	-1.566499638	13.40733828	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	925	1335	0.001498127	0.010486891	3	oligos	OL-Cntl	30	9	9
CGAACATCAGTCAGAG-1_371G_A3D3	-13.72000927	-10.94874284	13B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2114	4001	0.00099975	0.002749313	3	13B	IN-SV2C	30	9	9
CGAACATGTAAGGATT-1_371G_A3D3	-23.0237175	22.37343906	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1540	2683	0.008572493	0.003727171	3	8	Astrocytes	30	9	9
CGAACATGTCAGAATA-1_371G_A3D3	7.594159406	15.98715323	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1032	1562	0.005121639	0.005761844	3	oligos	OL-Cntl	30	9	9
CGAACATGTCAGTGGA-1_371G_A3D3	-3.81437117	-16.80795075	10	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2760	6055	0.011230388	0.00297275	3	L2-3	EN-L2-3-Cntl	30	9	9
CGAACATGTCGAACAG-1_371G_A3D3	38.74606969	14.45963522	14	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1212	1889	0.000529381	0.00847009	3	14	Microglia	30	9	9
CGAACATGTGGGTATG-1_371G_A3D3	-34.1569095	1.844770297	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1891	3417	0.001463272	0.00468247	3	9	OPC	30	9	9
CGAACATTCAACGGCC-1_371G_A3D3	6.98470828	-21.06363103	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5913	16745	0.005971932	0.006210809	3	L2-3	EN-L2-3-MS	30	9	9
CGAACATTCGCCGTGA-1_371G_A3D3	1.525105071	17.55241127	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	826	1269	0.002364066	0.005516154	3	oligos	OL-Cntl	30	9	9
CGAATGTAGAATGTTG-1_371G_A3D3	-16.49250966	2.147551657	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5787	15797	0.005254162	0.014876242	3	13A	IN-VIP	30	9	9
CGAATGTAGTGTGGCA-1_371G_A3D3	32.96317096	-3.166471293	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2860	5536	0.009212428	0.00867052	3	2	EN-L4	30	9	9
CGAATGTCAAAGCAAT-1_371G_A3D3	-13.11499553	0.402861011	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3263	6644	0.008880193	0.006773028	3	13A	IN-VIP	30	9	9
CGAATGTCACGAAACG-1_371G_A3D3	22.23464092	-0.727876743	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1802	3233	0.008351376	0.005567584	3	2	EN-L4	30	9	9
CGAATGTCAGGAACGT-1_371G_A3D3	-10.16381839	-5.87345381	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2002	3172	0.019230769	0.007566204	3	13A	IN-VIP	30	9	9
CGAATGTGTAGAGGAA-1_371G_A3D3	-19.12510391	29.08103135	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2289	4003	0.000499625	0.006245316	3	8	Astrocytes	30	9	9
CGAATGTGTGCAGTAG-1_371G_A3D3	36.00647534	-12.31764722	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4861	11085	0.009652684	0.01714028	3	2	EN-L4	30	9	9
CGACCTTAGACTTTCG-1_371G_A3D3	3.384935395	9.454351241	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1137	1674	0.000597372	0.015531661	3	oligos	OL-Cntl	30	9	9
CGACCTTAGCACACAG-1_371G_A3D3	13.16555624	-33.74813855	3	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4697	14647	0.000341367	0.002389568	3	3	EN-L5-6	30	9	9
CGACCTTAGCTATGCT-1_371G_A3D3	-1.271654905	16.92778743	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	762	1235	0.00242915	0.007287449	3	oligos	OL-Cntl	30	9	9
CGACCTTAGCTGGAAC-1_371G_A3D3	-0.592255135	17.04083634	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	815	1180	0.003389831	0.023728814	3	oligos	OL-Cntl	30	9	9
CGACCTTCAACGATGG-1_371G_A3D3	-27.21929776	-0.068483584	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2361	4522	0.002211411	0.028084918	3	9	OPC	30	9	9
CGACCTTCATTAGGCT-1_371G_A3D3	-1.240087478	15.81672767	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	862	1254	0.002392344	0.012759171	3	oligos	OL-Cntl	30	9	9
CGACCTTGTGAGGGAG-1_371G_A3D3	-14.75445414	-20.39202003	6B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1601	2911	0.027481965	0.005839918	3	6B	IN-SST	30	9	9
CGACCTTTCATTTGGG-1_371G_A3D3	35.84570296	-8.046288992	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5414	14752	0.002914859	0.007592191	3	2	EN-L4	30	9	9
CGACCTTTCGCAAACT-1_371G_A3D3	-28.00747991	4.226926894	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2102	3913	0.002044467	0.006900077	3	9	OPC	30	9	9
CGACTTCCAAGCCATT-1_371G_A3D3	15.15903173	5.479082763	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2513	5939	0.002188921	0.006061627	3	oligos	OL-Cntl	30	9	9
CGACTTCCAGTCGATT-1_371G_A3D3	-33.79541032	-0.299057945	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1645	2747	0.003276301	0.01565344	3	9	OPC	30	9	9
CGACTTCTCCGAACGC-1_371G_A3D3	-1.464022412	18.39250958	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	695	1042	0.000959693	0.007677543	3	oligos	OL-Cntl	30	9	9
CGAGAAGAGAAACGAG-1_371G_A3D3	0.399993078	12.93717814	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	970	1421	0.00140746	0.020408163	3	oligos	OL-Cntl	30	9	9
CGAGAAGAGGTGGGTT-1_371G_A3D3	35.00688309	-12.71312572	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3698	7368	0.009229099	0.012757872	3	2	EN-L4	30	9	9
CGAGAAGCAAGTCTAC-1_371G_A3D3	8.285287515	8.639893666	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1410	2186	0.001829826	0.016925892	3	oligos	OL-Cntl	30	9	9
CGAGAAGCACTAGTAC-1_371G_A3D3	-18.12844743	1.234643348	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5934	15290	0.010333551	0.010856769	3	13A	IN-VIP	30	9	9
CGAGAAGCAGTCCTTC-1_371G_A3D3	-30.78747541	-12.05792397	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	860	1386	0.001443001	0.006493506	3	9	OPC	30	9	9
CGAGAAGGTATCACCA-1_371G_A3D3	-1.49690417	13.54819256	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	880	1281	0.00078064	0.012490242	3	oligos	OL-Cntl	30	9	9
CGAGAAGGTCGTCTTC-1_371G_A3D3	-0.516554533	17.69146471	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	817	1186	0.004215852	0.016020236	3	oligos	OL-Cntl	30	9	9
CGAGAAGGTTGAGTTC-1_371G_A3D3	-12.04189471	-16.35565418	6B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1070	1657	0.015691008	0.004828002	3	6B	IN-SST	30	9	9
CGAGAAGTCCCAAGAT-1_371G_A3D3	2.060389842	14.48302672	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	974	1532	0.007832898	0.016318538	3	oligos	OL-Cntl	30	9	9
CGAGAAGTCGCATGGC-1_371G_A3D3	34.67743741	10.83829047	14	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	933	1384	0.002890173	0.01734104	3	14	Microglia	30	9	9
CGAGAAGTCGCCGTGA-1_371G_A3D3	-17.51697555	1.47113818	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3889	8465	0.009214412	0.018665092	3	13A	IN-VIP	30	9	9
CGAGAAGTCGTTTATC-1_371G_A3D3	7.532630568	14.43657885	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1073	1518	0.004611331	0.007905138	3	oligos	OL-Cntl	30	9	9
CGAGCACAGCACACAG-1_371G_A3D3	-4.183685661	11.56098546	5	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	821	1098	0.004553734	0.028233151	3	oligos	OL-MS-1	30	9	9
CGAGCACCATGCTGGC-1_371G_A3D3	-14.25815467	1.559551023	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4225	10099	0.005149025	0.00663432	3	13A	IN-VIP	30	9	9
CGAGCACCATTCACTT-1_371G_A3D3	4.028822187	9.418972967	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1297	2046	0.002443793	0.017595308	3	oligos	OL-Cntl	30	9	9
CGAGCACGTAGTAGTA-1_371G_A3D3	-13.07415612	0.497592646	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3511	7455	0.002682763	0.006438632	3	13A	IN-VIP	30	9	9
CGAGCACGTCAACTGT-1_371G_A3D3	-15.16737462	1.750219251	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4258	9492	0.001158871	0.01179941	3	13A	IN-VIP	30	9	9
CGAGCACGTTCGTCTC-1_371G_A3D3	-19.63867731	9.012734447	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1160	1978	0.002527806	0.009100101	3	8	Astrocytes	30	9	9
CGAGCACTCACTGGGC-1_371G_A3D3	1.93818269	20.29018482	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	847	1207	0.001657001	0.02071251	3	oligos	OL-Cntl	30	9	9
CGAGCACTCATGTCCC-1_371G_A3D3	-10.61298339	18.72412744	11	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3054	6049	0.001157216	0.004959497	3	11	Glia-MIX	30	9	9
CGAGCACTCCAAATGC-1_371G_A3D3	-3.395648143	13.90779566	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	765	1125	0.008	0.018666667	3	oligos	OL-Cntl	30	9	9
CGAGCACTCCACGAAT-1_371G_A3D3	5.527697015	-19.52151674	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3756	8600	0.004418605	0.009534884	3	L2-3	EN-L2-3-MS	30	9	9
CGAGCACTCCCGACTT-1_371G_A3D3	4.712852025	-20.36647994	10	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3970	9710	0.002883625	0.004016478	3	L2-3	EN-L2-3-Cntl	30	9	9
CGAGCCAAGCACCGCT-1_371G_A3D3	7.802579205	14.27234618	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1022	1659	0.01084991	0.010247137	3	oligos	OL-Cntl	30	9	9
CGAGCCAAGGACCACA-1_371G_A3D3	-29.22093702	10.50525846	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	875	1193	0.002514669	0.005029338	3	8	Astrocytes	30	9	9
CGAGCCACAGAAGCAC-1_371G_A3D3	-3.202705808	14.49522831	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	699	1003	0.002991027	0.019940179	3	oligos	OL-Cntl	30	9	9
CGAGCCAGTTCGGGCT-1_371G_A3D3	-19.16657026	30.28903874	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2997	6165	0.000973236	0.005839416	3	8	Astrocytes	30	9	9
CGAGCCAGTTGCTCCT-1_371G_A3D3	2.022539014	17.25758657	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	858	1285	0.00233463	0.006225681	3	oligos	OL-Cntl	30	9	9
CGAGCCATCCAAATGC-1_371G_A3D3	-24.97636883	12.57725869	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1042	1600	0.003125	0.005	3	8	Astrocytes	30	9	9
CGAGCCATCTCAAACG-1_371G_A3D3	-3.089305406	13.242728	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	808	1162	0.002581756	0.01979346	3	oligos	OL-Cntl	30	9	9
CGATCGGCACACAGAG-1_371G_A3D3	35.95180535	-10.51911082	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4511	9720	0.003292181	0.013065844	3	2	EN-L4	30	9	9
CGATCGGCAGTCAGAG-1_371G_A3D3	-22.52420402	-26.77939449	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4158	10386	9.63E-05	0.006162141	3	6A	IN-PV	30	9	9
CGATCGGGTATGGTTC-1_371G_A3D3	6.126885974	11.18586744	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1178	1827	0.002736727	0.017515052	3	oligos	OL-Cntl	30	9	9
CGATCGGGTGCCTGCA-1_371G_A3D3	-25.08801458	6.756967722	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	818	1099	0.008189263	0.008189263	3	8	Astrocytes	30	9	9
CGATCGGTCAAGGCTT-1_371G_A3D3	-17.75241667	1.180224037	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4328	9096	0.010114336	0.019459103	3	13A	IN-VIP	30	9	9
CGATCGGTCAGGTAAA-1_371G_A3D3	-22.31292412	-24.37240849	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2617	5244	0.006674294	0.006102212	3	6A	IN-PV	30	9	9
CGATCGGTCATAAAGG-1_371G_A3D3	-2.230224006	14.88340783	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	745	1005	0.00199005	0.004975124	3	oligos	OL-Cntl	30	9	9
CGATGGCAGACAAAGG-1_371G_A3D3	-14.0518312	0.920305447	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3086	5726	0.006811037	0.012224939	3	13A	IN-VIP	30	9	9
CGATGGCAGCTGATAA-1_371G_A3D3	11.93356481	7.844918901	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1553	2695	0.000742115	0.012615955	3	oligos	OL-Cntl	30	9	9
CGATGGCAGGCTAGAC-1_371G_A3D3	-15.78636772	2.233965887	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4254	9623	0.003637119	0.011950535	3	13A	IN-VIP	30	9	9
CGATGGCCAGCTGGCT-1_371G_A3D3	3.234720964	-24.08214953	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5624	15867	0.002773051	0.011596395	3	L2-3	EN-L2-3-MS	30	9	9
CGATGGCCAGTCTTCC-1_371G_A3D3	-0.736429229	15.71725421	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	818	1271	0.002360346	0.014162077	3	oligos	OL-Cntl	30	9	9
CGATGGCCATGTAAGA-1_371G_A3D3	32.28841636	-8.496098149	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3312	7157	0.024591309	0.008662848	3	2	EN-L4	30	9	9
CGATGGCGTAAAGTCA-1_371G_A3D3	-29.3186938	0.657952556	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2017	3558	0.00084317	0.018830804	3	9	OPC	30	9	9
CGATGGCGTACTTAGC-1_371G_A3D3	11.88367076	9.543283876	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1474	2459	0.002846686	0.012200081	3	oligos	OL-Cntl	30	9	9
CGATGGCGTAGCTAAA-1_371G_A3D3	15.30008005	-29.14637384	3	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5761	19188	0.004117157	0.004169272	3	3	EN-L5-6	30	9	9
CGATGGCTCACCCTCA-1_371G_A3D3	10.26260242	16.42398023	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1072	1816	0.004405286	0.003854626	3	oligos	OL-Cntl	30	9	9
CGATGGCTCCCTCTTT-1_371G_A3D3	-1.491958228	18.18218854	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	729	1108	0	0.001805054	3	oligos	OL-Cntl	30	9	9
CGATGGCTCCGGCACA-1_371G_A3D3	-8.735098905	-18.07525803	6B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	748	1067	0.002811621	0.001874414	3	6B	IN-SST	30	9	9
CGATGGCTCGGTCCGA-1_371G_A3D3	2.768909493	14.67489645	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1004	1652	0.001210654	0.010290557	3	oligos	OL-Cntl	30	9	9
CGATGTAAGAGTACCG-1_371G_A3D3	-17.57714621	1.403188898	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4439	9329	0.00407332	0.01511416	3	13A	IN-VIP	30	9	9
CGATGTAAGCCCAATT-1_371G_A3D3	-2.974492678	12.9906083	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	888	1258	0.000794913	0.024642289	3	oligos	OL-Cntl	30	9	9
CGATGTAAGTTTAGGA-1_371G_A3D3	-1.294276015	-0.879027926	11	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2527	4581	0.00960489	0.014407335	3	11	Glia-MIX	30	9	9
CGATGTACAGCCACCA-1_371G_A3D3	6.088926136	14.44783278	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1098	1762	0.002837684	0.006810443	3	oligos	OL-Cntl	30	9	9
CGATGTAGTAGCGTGA-1_371G_A3D3	-1.932253524	15.75102791	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	729	1015	0.001970443	0.01773399	3	oligos	OL-Cntl	30	9	9
CGATGTATCCTTAATC-1_371G_A3D3	-2.780435404	17.48539024	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	778	1111	0.00540054	0.00540054	3	oligos	OL-Cntl	30	9	9
CGATTGACAGCCTATA-1_371G_A3D3	-29.41827344	0.344695275	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1790	2846	0.000702741	0.008432888	3	9	OPC	30	9	9
CGATTGACAGCTTAAC-1_371G_A3D3	-12.113594	17.69874392	11	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1839	2926	0.002734108	0.006493506	3	11	Glia-MIX	30	9	9
CGATTGACAGTCGATT-1_371G_A3D3	2.518917974	14.9818551	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	940	1466	0.004774898	0.010914052	3	oligos	OL-Cntl	30	9	9
CGATTGACATTCACTT-1_371G_A3D3	5.313457051	15.51390418	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	849	1316	0.000759878	0.011398176	3	oligos	OL-Cntl	30	9	9
CGATTGAGTACCCAAT-1_371G_A3D3	-33.1602802	5.057582699	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2860	5873	0	0.006470288	3	9	OPC	30	9	9
CGATTGAGTATGAAAC-1_371G_A3D3	8.548668694	15.81289262	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	959	1582	0.000632111	0.008217446	3	oligos	OL-Cntl	30	9	9
CGATTGAGTCATATGC-1_371G_A3D3	7.131161391	9.44497042	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1233	2001	0.002498751	0.010494753	3	oligos	OL-Cntl	30	9	9
CGATTGATCCAAATGC-1_371G_A3D3	-34.22305434	-3.026742352	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1530	2674	0.001495886	0.003739716	3	9	OPC	30	9	9
CGATTGATCCAGAGGA-1_371G_A3D3	-0.396353186	16.32796997	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	843	1216	0.004111842	0.010690789	3	oligos	OL-Cntl	30	9	9
CGCCAAGAGAGCTTCT-1_371G_A3D3	0.712636058	13.03806822	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1021	1520	0.006578947	0.007894737	3	oligos	OL-Cntl	30	9	9
CGCCAAGAGGATTCGG-1_371G_A3D3	12.70591932	8.271875773	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1604	2664	0.002252252	0.010885886	3	oligos	OL-Cntl	30	9	9
CGCCAAGGTGTCTGAT-1_371G_A3D3	8.426478086	-30.89814399	10	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5358	16625	0.003428571	0.002947368	3	L2-3	EN-L2-3-Cntl	30	9	9
CGCCAAGGTGTGAATA-1_371G_A3D3	6.870452749	-20.75871675	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4804	12914	0.007356357	0.006427133	3	L2-3	EN-L2-3-MS	30	9	9
CGCCAAGTCAGTTGAC-1_371G_A3D3	15.98496747	5.956112775	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2419	4797	0.0022931	0.010631645	3	oligos	OL-Cntl	30	9	9
CGCCAAGTCATCGGAT-1_371G_A3D3	-28.4927269	0.034313502	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1830	2879	0.0048628	0.011809656	3	9	OPC	30	9	9
CGCGGTAAGATCTGCT-1_371G_A3D3	3.146490213	11.2571732	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1057	1629	0.003069368	0.025168815	3	oligos	OL-Cntl	30	9	9
CGCGGTAAGCTCCTTC-1_371G_A3D3	-36.15429663	-3.073672752	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1419	2524	0.00118859	0.003565769	3	9	OPC	30	9	9
CGCGGTAAGGAGTCTG-1_371G_A3D3	-18.66756205	0.449063267	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4572	9978	0.007115654	0.013329325	3	13A	IN-VIP	30	9	9
CGCGGTACAGTCCTTC-1_371G_A3D3	-13.96302477	1.228393554	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3543	7534	0.007963897	0.007698434	3	13A	IN-VIP	30	9	9
CGCGGTACATGGTCTA-1_371G_A3D3	-30.75168637	2.34110372	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2258	4077	0.005641403	0.0090753	3	9	OPC	30	9	9
CGCGGTAGTACTTGAC-1_371G_A3D3	-20.45573983	23.67359163	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1505	2310	0.003463203	0.005194805	3	8	Astrocytes	30	9	9
CGCGGTAGTCAGAGGT-1_371G_A3D3	-19.39738414	26.14541834	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1836	3367	0.000594001	0.003861004	3	8	Astrocytes	30	9	9
CGCGGTAGTGGACGAT-1_371G_A3D3	-1.47432199	15.39898635	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	835	1266	0.004739336	0.018167457	3	oligos	OL-Cntl	30	9	9
CGCGGTAGTGTTTGGT-1_371G_A3D3	10.16194632	-2.821057137	12	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2346	4661	0.015232783	0.01652006	3	12	EN-MIX	30	9	9
CGCGTTTAGTGGAGTC-1_371G_A3D3	-29.41088009	-0.24195038	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1911	3075	0.001626016	0.011707317	3	9	OPC	30	9	9
CGCGTTTCAAGGGTCA-1_371G_A3D3	13.93393512	15.32381353	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1103	1707	0.001171646	0.009958992	3	oligos	OL-Cntl	30	9	9
CGCGTTTCAATGAAAC-1_371G_A3D3	6.443429597	9.462624544	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1181	1834	0.002726281	0.010905125	3	oligos	OL-Cntl	30	9	9
CGCGTTTCACTGTGTA-1_371G_A3D3	-2.925793239	14.695674	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	797	1160	0.000862069	0.014655172	3	oligos	OL-Cntl	30	9	9
CGCGTTTCATAGACTC-1_371G_A3D3	2.140213585	16.98860595	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	833	1291	0.00232378	0.006196747	3	oligos	OL-Cntl	30	9	9
CGCGTTTCATTCGACA-1_371G_A3D3	-27.87931206	0.402233029	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2244	3739	0.000802354	0.021128644	3	9	OPC	30	9	9
CGCGTTTTCCACGAAT-1_371G_A3D3	1.115796628	13.43903276	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	915	1448	0.005524862	0.01519337	3	oligos	OL-Cntl	30	9	9
CGCGTTTTCGCCATAA-1_371G_A3D3	-19.54863055	27.22989971	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2091	4052	0.000493583	0.004935834	3	8	Astrocytes	30	9	9
CGCTATCAGAGCTGGT-1_371G_A3D3	7.502446205	9.370006833	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1216	2096	0	0.015744275	3	oligos	OL-Cntl	30	9	9
CGCTATCAGTCGATAA-1_371G_A3D3	11.95464656	18.34737672	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1088	1699	0.001765745	0.010594467	3	oligos	OL-Cntl	30	9	9
CGCTATCCACACAGAG-1_371G_A3D3	35.50500392	-7.746147985	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4804	11734	0.004090677	0.005454236	3	2	EN-L4	30	9	9
CGCTATCCATGGTAGG-1_371G_A3D3	1.767246463	17.35529932	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	810	1243	0.003218021	0.009654063	3	oligos	OL-Cntl	30	9	9
CGCTATCGTCGATTGT-1_371G_A3D3	-17.05147357	1.421807889	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4199	8941	0.010065988	0.01297394	3	13A	IN-VIP	30	9	9
CGCTATCTCCAGAAGG-1_371G_A3D3	-7.469527068	9.764855103	5	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	874	1244	0.007234727	0.017684887	3	oligos	OL-MS-1	30	9	9
CGCTATCTCTGTCCGT-1_371G_A3D3	-0.882706068	16.03411109	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	753	1069	0.004677268	0.020579981	3	oligos	OL-Cntl	30	9	9
CGCTGGACAAGTAATG-1_371G_A3D3	-1.177444271	8.422213649	5	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1407	2123	0.009420631	0.014601978	3	oligos	OL-MS-1	30	9	9
CGCTGGACAATAACGA-1_371G_A3D3	15.98735874	5.829400641	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2560	5219	0.006706266	0.006897873	3	oligos	OL-Cntl	30	9	9
CGCTGGAGTAATCACC-1_371G_A3D3	33.41163203	14.77119207	14	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	865	1179	0.009329941	0.039864292	3	14	Microglia	30	9	9
CGCTGGAGTTCCACGG-1_371G_A3D3	-22.14179568	-17.64853036	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3615	8144	0.003683694	0.00577112	3	6A	IN-PV	30	9	9
CGCTGGATCGCCTGAG-1_371G_A3D3	-15.7176524	15.92672743	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2284	4536	0.005070547	0.00617284	3	8	Astrocytes	30	9	9
CGCTGGATCTCTTATG-1_371G_A3D3	-9.872954858	18.3505966	11	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3896	9977	0.001503458	0.006214293	3	11	Glia-MIX	30	9	9
CGCTGGATCTGTCCGT-1_371G_A3D3	11.31284963	-26.83967191	10	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	9270	42938	0.006427873	0.005286692	3	L2-3	EN-L2-3-Cntl	30	9	9
CGCTGGATCTTGACGA-1_371G_A3D3	-2.700975378	15.01861239	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	832	1244	0.000803859	0.018488746	3	oligos	OL-Cntl	30	9	9
CGCTTCAAGATAGTCA-1_371G_A3D3	-18.45127856	28.31695445	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2185	3849	0.000519615	0.004416732	3	8	Astrocytes	30	9	9
CGCTTCACACAGGTTT-1_371G_A3D3	-23.87221715	1.091066695	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3369	7433	0.000941746	0.008610252	3	9	OPC	30	9	9
CGCTTCACACGGCCAT-1_371G_A3D3	5.631420869	-27.28480624	10	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	6130	20160	0.001041667	0.004910714	3	L2-3	EN-L2-3-Cntl	30	9	9
CGCTTCACAGTGAGTG-1_371G_A3D3	4.821150571	-21.40195659	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5742	17874	0.00139868	0.00537093	3	L2-3	EN-L2-3-MS	30	9	9
CGCTTCACATGCCACG-1_371G_A3D3	7.742505124	14.55512828	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1013	1627	0.000614628	0.011063307	3	oligos	OL-Cntl	30	9	9
CGCTTCATCGTGTAGT-1_371G_A3D3	-11.38416587	-10.09019913	13B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1392	2302	0.007819288	0.002172024	3	13B	IN-SV2C	30	9	9
CGGACACAGACAAAGG-1_371G_A3D3	-1.127983054	16.92904893	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	754	1079	0.005560704	0.012974977	3	oligos	OL-Cntl	30	9	9
CGGACACAGCCAGTAG-1_371G_A3D3	-24.54509168	21.66011699	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1234	1986	0.000503525	0.007049345	3	8	Astrocytes	30	9	9
CGGACACAGTGGGCTA-1_371G_A3D3	-15.42436834	1.826232355	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4458	10390	0.005967276	0.009720885	3	13A	IN-VIP	30	9	9
CGGACACCAAGCCCAC-1_371G_A3D3	-5.236685867	-3.105781161	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1481	2518	0.00675139	0.005162828	3	13A	IN-VIP	30	9	9
CGGACACCAGACAAAT-1_371G_A3D3	0.022320553	21.43785775	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	722	1053	0.002849003	0.004748338	3	oligos	OL-Cntl	30	9	9
CGGACACGTCCGAGTC-1_371G_A3D3	2.875440765	15.0816712	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1014	1586	0.001261034	0.010718789	3	oligos	OL-Cntl	30	9	9
CGGACACGTGTGTGCC-1_371G_A3D3	-15.95149589	1.897375603	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4360	9119	0.01239171	0.010637131	3	13A	IN-VIP	30	9	9
CGGACACTCACCACCT-1_371G_A3D3	-29.22553752	1.689990332	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2298	4558	0.000438789	0.008995173	3	9	OPC	30	9	9
CGGACACTCAGTACGT-1_371G_A3D3	-32.72661842	-7.519294002	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1201	1918	0.001042753	0.003128259	3	9	OPC	30	9	9
CGGACACTCCCTCAGT-1_371G_A3D3	-0.330069452	17.87125108	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	721	1067	0.005623243	0.015932521	3	oligos	OL-Cntl	30	9	9
CGGACACTCCGAGCCA-1_371G_A3D3	4.47111484	14.66712672	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1113	1709	0.001170275	0.009947338	3	oligos	OL-Cntl	30	9	9
CGGACACTCCGCATAA-1_371G_A3D3	-30.80662689	-0.817170797	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1605	2719	0.000735565	0.004045605	3	9	OPC	30	9	9
CGGACACTCCGCTGTT-1_371G_A3D3	-19.64711621	27.04415556	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1862	3406	0.001467998	0.003229595	3	8	Astrocytes	30	9	9
CGGACGTAGAACAATC-1_371G_A3D3	-17.98714316	-24.72018041	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2111	4031	0.001488464	0.005209625	3	6A	IN-PV	30	9	9
CGGACGTAGGCTACGA-1_371G_A3D3	-3.768051987	6.26311447	5	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1689	2577	0.007760962	0.014745828	3	oligos	OL-MS-1	30	9	9
CGGACGTAGTAGGCCA-1_371G_A3D3	-14.04549875	-0.746547966	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2341	3937	0.005842012	0.016256033	3	13A	IN-VIP	30	9	9
CGGACGTAGTTCGATC-1_371G_A3D3	-18.85686756	29.58372839	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2756	5198	0.002116199	0.004809542	3	8	Astrocytes	30	9	9
CGGACGTCACAACGCC-1_371G_A3D3	-0.873475642	15.4954506	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	839	1270	0.002362205	0.012598425	3	oligos	OL-Cntl	30	9	9
CGGACGTCAGCTGGCT-1_371G_A3D3	13.99332558	-32.57221296	3	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4005	11622	0.001720874	0.002409224	3	3	EN-L5-6	30	9	9
CGGACGTCAGTTCATG-1_371G_A3D3	-12.4595884	0.800775822	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3188	6699	0.007762353	0.004926108	3	13A	IN-VIP	30	9	9
CGGACGTCATCGTCGG-1_371G_A3D3	-1.575381317	18.14834174	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	698	1079	0.002780352	0.003707136	3	oligos	OL-Cntl	30	9	9
CGGACGTTCGTTTAGG-1_371G_A3D3	7.778050469	11.33916926	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1071	1683	0.002376708	0.013666072	3	oligos	OL-Cntl	30	9	9
CGGACTGAGCACAGGT-1_371G_A3D3	-9.110121934	-9.441979584	13B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1310	1974	0.006585613	0.005065856	3	13B	IN-SV2C	30	9	9
CGGACTGCACACCGCA-1_371G_A3D3	4.04608211	10.66512035	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1206	1724	0.003480278	0.017401392	3	oligos	OL-Cntl	30	9	9
CGGACTGCACCAGTTA-1_371G_A3D3	-3.531280255	14.97623715	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	690	1009	0.003964321	0.021803766	3	oligos	OL-Cntl	30	9	9
CGGACTGGTCTGCGGT-1_371G_A3D3	-19.22395159	27.86638871	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2303	4458	0.000448632	0.004934948	3	8	Astrocytes	30	9	9
CGGACTGTCTAACGGT-1_371G_A3D3	-15.1197958	-18.89714038	6B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1435	2522	0.002775575	0.003568596	3	6B	IN-SST	30	9	9
CGGAGCTAGCAGCCTC-1_371G_A3D3	35.83817305	-9.898256322	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4988	11731	0.008183446	0.008353934	3	2	EN-L4	30	9	9
CGGAGCTAGCGCCTTG-1_371G_A3D3	2.830109509	13.60943837	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	977	1513	0.00462657	0.011896894	3	oligos	OL-Cntl	30	9	9
CGGAGCTAGTTTCCTT-1_371G_A3D3	2.889341131	14.82225162	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1088	1768	0.003959276	0.012443439	3	oligos	OL-Cntl	30	9	9
CGGAGCTCAAATACAG-1_371G_A3D3	0.243599464	18.68112482	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	763	1107	0.000903342	0.007226739	3	oligos	OL-Cntl	30	9	9
CGGAGCTCACGGCCAT-1_371G_A3D3	-14.86733711	-6.106757794	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3455	7905	0.011638204	0.009487666	3	13A	IN-VIP	30	9	9
CGGAGCTGTAAAGTCA-1_371G_A3D3	-3.351635504	-7.264329532	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	815	1225	0.024489796	0.004897959	3	13A	IN-VIP	30	9	9
CGGAGCTTCAGTCAGT-1_371G_A3D3	19.95311369	-29.45658622	3	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	6626	23599	0.001016992	0.004491716	3	3	EN-L5-6	30	9	9
CGGAGCTTCAGTTCGA-1_371G_A3D3	-2.724553293	-0.902452081	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3237	6571	0.01308781	0.008826663	3	13A	IN-VIP	30	9	9
CGGAGCTTCATCGCTC-1_371G_A3D3	9.438130535	14.79628425	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1170	1968	0.004573171	0.010162602	3	oligos	OL-Cntl	30	9	9
CGGAGCTTCTCCAGGG-1_371G_A3D3	-21.24056527	26.05903933	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1691	2834	0.002822865	0.00564573	3	8	Astrocytes	30	9	9
CGGAGTCCAAGGACTG-1_371G_A3D3	-15.50593335	1.880719364	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3496	6928	0.009526559	0.01198037	3	13A	IN-VIP	30	9	9
CGGAGTCCAATGACCT-1_371G_A3D3	11.48935261	13.22530201	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1467	2399	0.003334723	0.009170488	3	oligos	OL-Cntl	30	9	9
CGGAGTCCAGCTCGAC-1_371G_A3D3	14.8064259	10.34413672	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1523	2786	0.005384063	0.009332376	3	oligos	OL-Cntl	30	9	9
CGGAGTCCAGGTGCCT-1_371G_A3D3	-24.03786522	-25.08184413	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4730	11554	0.004587156	0.00752986	3	6A	IN-PV	30	9	9
CGGAGTCGTTCTGAAC-1_371G_A3D3	-16.51662175	1.314871772	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3448	6841	0.005116211	0.015348633	3	13A	IN-VIP	30	9	9
CGGAGTCTCCAGAGGA-1_371G_A3D3	-34.19667309	-2.075028502	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1483	2495	0.000400802	0.00240481	3	9	OPC	30	9	9
CGGAGTCTCCAGGGCT-1_371G_A3D3	8.759974282	13.68230218	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1080	1707	0.001757469	0.012302285	3	oligos	OL-Cntl	30	9	9
CGGCTAGAGCAACGGT-1_371G_A3D3	21.94994883	-1.878629032	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2449	4752	0.011153199	0.007786195	3	2	EN-L4	30	9	9
CGGCTAGCATCGGAAG-1_371G_A3D3	-17.29170462	1.537260175	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4144	8750	0.011657143	0.015885714	3	13A	IN-VIP	30	9	9
CGGCTAGGTAGGGTAC-1_371G_A3D3	16.12317386	-4.892398237	12	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1497	2915	0.002058319	0.002401372	3	12	EN-MIX	30	9	9
CGGCTAGGTGATGTCT-1_371G_A3D3	-30.33786808	0.12920662	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1837	3286	0.003043214	0.012477176	3	9	OPC	30	9	9
CGGCTAGTCAGAGCTT-1_371G_A3D3	26.99225496	4.810042517	15BA	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	904	1389	0.004319654	0.010079194	3	15BA	Stromal cells	30	9	9
CGGCTAGTCCCTAACC-1_371G_A3D3	-2.593321242	-12.43094049	10	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2119	3916	0.003575077	0.008937692	3	L2-3	EN-L2-3-Cntl	30	9	9
CGGCTAGTCCTTTCGG-1_371G_A3D3	24.22318872	-10.86693766	3	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5425	15226	0.00091948	0.009260476	3	3	EN-L5-6	30	9	9
CGGGTCACAGTTCATG-1_371G_A3D3	3.211775857	-24.12024676	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4352	10357	0.0047311	0.005986289	3	L2-3	EN-L2-3-MS	30	9	9
CGGGTCAGTTGCGTTA-1_371G_A3D3	-18.1321645	1.105825452	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4617	9793	0.006024712	0.022056571	3	13A	IN-VIP	30	9	9
CGGGTCATCACGCATA-1_371G_A3D3	-23.99138816	1.000398107	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2965	5765	0.002254987	0.014397225	3	9	OPC	30	9	9
CGGGTCATCTCGCTTG-1_371G_A3D3	-15.84719597	13.47712448	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1577	2745	0.003642987	0.006921676	3	8	Astrocytes	30	9	9
CGGGTCATCTGCTGTC-1_371G_A3D3	1.942277299	16.8175966	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	833	1270	0.003149606	0.008661417	3	oligos	OL-Cntl	30	9	9
CGGTTAAAGCTCCCAG-1_371G_A3D3	4.870311196	12.09863178	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1075	1550	0.002580645	0.013548387	3	oligos	OL-Cntl	30	9	9
CGGTTAAAGGCCGAAT-1_371G_A3D3	-1.965503487	17.5828819	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	705	1012	0.000988142	0.01284585	3	oligos	OL-Cntl	30	9	9
CGGTTAAAGGCTAGGT-1_371G_A3D3	35.76806901	-8.047118228	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4094	9086	0.007594101	0.007484041	3	2	EN-L4	30	9	9
CGGTTAACAACACGCC-1_371G_A3D3	0.355475118	18.10614724	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	764	1133	0.0070609	0.006178288	3	oligos	OL-Cntl	30	9	9
CGGTTAACACAGGCCT-1_371G_A3D3	-32.94245663	5.340964934	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3723	7883	0.001649118	0.009641	3	9	OPC	30	9	9
CGGTTAACAGCTCCGA-1_371G_A3D3	3.268819588	21.22708574	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	883	1331	0.00150263	0.006761833	3	oligos	OL-Cntl	30	9	9
CGGTTAAGTGGCGAAT-1_371G_A3D3	-19.98249853	26.66886222	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1824	3205	0.000312012	0.006864275	3	8	Astrocytes	30	9	9
CGGTTAAGTTACGCGC-1_371G_A3D3	-25.62134254	11.44756641	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	987	1353	0.001478197	0.001478197	3	8	Astrocytes	30	9	9
CGGTTAATCCTCGCAT-1_371G_A3D3	-0.114210468	17.65768452	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	744	1150	0.000869565	0.013043478	3	oligos	OL-Cntl	30	9	9
CGGTTAATCCTTTCGG-1_371G_A3D3	9.482210205	8.257283407	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1461	2445	0.004907975	0.013496933	3	oligos	OL-Cntl	30	9	9
CGTAGCGAGGATGGAA-1_371G_A3D3	-13.1389775	-17.28720555	6B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1211	1824	0.008223684	0.010416667	3	6B	IN-SST	30	9	9
CGTAGCGCACTTAAGC-1_371G_A3D3	-23.10823226	-26.14292609	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3760	9255	0.023122636	0.004430038	3	6A	IN-PV	30	9	9
CGTAGCGCATGAACCT-1_371G_A3D3	26.80709091	-0.157686512	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3306	8446	0.009235141	0.000947194	3	2	EN-L4	30	9	9
CGTAGCGGTGTTTGGT-1_371G_A3D3	-2.632657728	16.03627368	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	773	1116	0	0.018817204	3	oligos	OL-Cntl	30	9	9
CGTAGCGTCAAACGGG-1_371G_A3D3	6.347440195	-19.9575663	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5433	15105	0.004237008	0.006289308	3	L2-3	EN-L2-3-MS	30	9	9
CGTAGCGTCTCGGACG-1_371G_A3D3	-30.34086496	1.388827366	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1782	3105	0.001610306	0.010305958	3	9	OPC	30	9	9
CGTAGGCAGATGTTAG-1_371G_A3D3	-4.93982713	-37.233428	16	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	928	1281	0.051522248	0.017174083	3	16	EN-PYR	30	9	9
CGTAGGCCAAGGCTCC-1_371G_A3D3	-0.16051954	16.35736105	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	839	1213	0.000824402	0.01071723	3	oligos	OL-Cntl	30	9	9
CGTAGGCCAAGTCATC-1_371G_A3D3	-3.284179348	-17.69444736	10	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3161	7279	0.002885012	0.002472867	3	L2-3	EN-L2-3-Cntl	30	9	9
CGTAGGCCAGATGGGT-1_371G_A3D3	-0.230610378	13.79686183	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	877	1293	0.002320186	0.016241299	3	oligos	OL-Cntl	30	9	9
CGTAGGCCAGGTCCAC-1_371G_A3D3	9.514547867	8.438145343	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1380	2264	0.002650177	0.011042403	3	oligos	OL-Cntl	30	9	9
CGTAGGCCAGTGACAG-1_371G_A3D3	-19.09516046	29.09452325	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2367	4317	0.000694927	0.004401205	3	8	Astrocytes	30	9	9
CGTAGGCCATTACGAC-1_371G_A3D3	-5.660172615	-35.99214674	16	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	808	1046	0.037284895	0.019120459	3	16	EN-PYR	30	9	9
CGTAGGCGTAATAGCA-1_371G_A3D3	-24.32359324	18.15408755	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1336	2113	0.00615239	0.009938476	3	8	Astrocytes	30	9	9
CGTAGGCGTAGCGTAG-1_371G_A3D3	2.829576701	13.33990238	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	919	1290	0.005426357	0.01627907	3	oligos	OL-Cntl	30	9	9
CGTAGGCGTCACCTAA-1_371G_A3D3	10.26146693	17.57486362	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	976	1484	0.000673854	0.008086253	3	oligos	OL-Cntl	30	9	9
CGTAGGCGTGAACCTT-1_371G_A3D3	-30.3302454	1.509425078	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2105	3794	0.001054296	0.006589352	3	9	OPC	30	9	9
CGTAGGCGTTAGAACA-1_371G_A3D3	-7.566290824	8.962178632	5	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	792	1115	0.005381166	0.038565022	3	oligos	OL-MS-1	30	9	9
CGTAGGCTCATAAAGG-1_371G_A3D3	-0.924874851	15.88447306	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	802	1138	0.003514938	0.016695958	3	oligos	OL-Cntl	30	9	9
CGTAGGCTCCACGTTC-1_371G_A3D3	3.834639385	14.06479352	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	981	1456	0.002747253	0.016483516	3	oligos	OL-Cntl	30	9	9
CGTAGGCTCGTGACAT-1_371G_A3D3	5.958259334	-19.82068596	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3805	9043	0.006745549	0.006524384	3	L2-3	EN-L2-3-MS	30	9	9
CGTAGGCTCTATCCCG-1_371G_A3D3	29.99127806	15.95226476	14	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1611	2755	0.002177858	0.117241379	3	14	Microglia	30	9	9
CGTCACTCAAGAAAGG-1_371G_A3D3	17.3298673	-32.23740435	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	6015	20093	0.000149306	0.004379635	3	2	EN-L4	30	9	9
CGTCACTCAATGGATA-1_371G_A3D3	-1.29944989	15.76425213	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	785	1109	0.003606853	0.017132552	3	oligos	OL-Cntl	30	9	9
CGTCACTGTAGCGATG-1_371G_A3D3	8.823786478	9.562968368	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1264	2035	0.001474201	0.007371007	3	oligos	OL-Cntl	30	9	9
CGTCACTTCGGAAACG-1_371G_A3D3	-8.666172229	-17.756738	6B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	707	1035	0.021256039	0.001932367	3	6B	IN-SST	30	9	9
CGTCACTTCTCCTATA-1_371G_A3D3	12.14487016	8.150208267	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1612	2858	0.00489853	0.015745276	3	oligos	OL-Cntl	30	9	9
CGTCAGGAGTCATGCT-1_371G_A3D3	12.91155444	6.985070935	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1772	3018	0.003976143	0.014247846	3	oligos	OL-Cntl	30	9	9
CGTCAGGCACCATGTA-1_371G_A3D3	23.4657213	-0.483572163	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2112	3911	0.003579647	0.003579647	3	2	EN-L4	30	9	9
CGTCAGGCACGTGAGA-1_371G_A3D3	7.879517377	9.844224649	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1117	1740	0.002298851	0.01091954	3	oligos	OL-Cntl	30	9	9
CGTCAGGCAGCTTCGG-1_371G_A3D3	-22.49829385	-25.4814096	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3485	7478	0.001069805	0.004947847	3	6A	IN-PV	30	9	9
CGTCAGGGTGCTCTTC-1_371G_A3D3	14.74817874	20.09189969	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1054	1616	0.007425743	0.006188119	3	oligos	OL-Cntl	30	9	9
CGTCAGGGTTTGCATG-1_371G_A3D3	35.92517606	-10.82738232	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4613	10770	0.006778087	0.011606314	3	2	EN-L4	30	9	9
CGTCAGGTCACAGTAC-1_371G_A3D3	4.757908607	-21.45153744	10	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5359	17000	0.001529412	0.005235294	3	L2-3	EN-L2-3-Cntl	30	9	9
CGTCAGGTCAGGTTCA-1_371G_A3D3	-18.88260966	25.75074354	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1936	3534	0.003961517	0.004244482	3	8	Astrocytes	30	9	9
CGTCAGGTCTGATTCT-1_371G_A3D3	-2.46031153	17.47995603	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	719	1059	0.002832861	0.012275732	3	oligos	OL-Cntl	30	9	9
CGTCCATAGAGACGAA-1_371G_A3D3	3.567557696	10.07367885	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1133	1682	0.002972652	0.015457788	3	oligos	OL-Cntl	30	9	9
CGTCCATCAACGATCT-1_371G_A3D3	1.196064139	14.96311326	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	877	1299	0.003849115	0.016936105	3	oligos	OL-Cntl	30	9	9
CGTCCATCAATGGATA-1_371G_A3D3	-0.446503988	16.11314399	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	781	1136	0	0.007922535	3	oligos	OL-Cntl	30	9	9
CGTCCATCATGAACCT-1_371G_A3D3	-19.91188181	30.5255241	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2752	5721	0.001048768	0.003146303	3	8	Astrocytes	30	9	9
CGTCCATCATGACATC-1_371G_A3D3	-29.06524825	0.556613706	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2036	3369	0.002374592	0.009201543	3	9	OPC	30	9	9
CGTCCATCATTTGCCC-1_371G_A3D3	-7.180084497	-13.54526474	14	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1748	2675	0.020934579	0.007102804	3	14	Microglia	30	9	9
CGTCCATGTCTGCGGT-1_371G_A3D3	-19.49142406	28.22111572	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2078	3751	0.003732338	0.007731272	3	8	Astrocytes	30	9	9
CGTCCATTCGGGAGTA-1_371G_A3D3	32.64133373	-9.098294843	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3868	8972	0.01148016	0.009473919	3	2	EN-L4	30	9	9
CGTCCATTCTGTCCGT-1_371G_A3D3	-22.06133217	10.07404796	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1037	1749	0.001143511	0.001715266	3	8	Astrocytes	30	9	9
CGTCTACCAACACCCG-1_371G_A3D3	3.609959291	10.63777184	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1154	1742	0.002296211	0.020665901	3	oligos	OL-Cntl	30	9	9
CGTCTACCAAGCCGCT-1_371G_A3D3	-19.9534099	30.04802133	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2363	4616	0.002816291	0.004116118	3	8	Astrocytes	30	9	9
CGTCTACCAAGCGATG-1_371G_A3D3	2.557349104	13.36274472	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	968	1511	0.001323627	0.012574454	3	oligos	OL-Cntl	30	9	9
CGTCTACCAAGCTGAG-1_371G_A3D3	-14.59793033	0.048699279	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3031	6156	0.015432099	0.007472385	3	13A	IN-VIP	30	9	9
CGTCTACCAGCTCGAC-1_371G_A3D3	-23.20938421	-19.29477882	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3577	7523	0.007045062	0.006114582	3	6A	IN-PV	30	9	9
CGTCTACGTGTCAATC-1_371G_A3D3	8.832790908	12.62428983	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1146	1861	0.002149382	0.011284256	3	oligos	OL-Cntl	30	9	9
CGTCTACTCAAAGACA-1_371G_A3D3	7.500533519	-18.41941896	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4548	10936	0.005486467	0.01316752	3	L2-3	EN-L2-3-MS	30	9	9
CGTCTACTCAATACCG-1_371G_A3D3	-20.06363632	-16.97097694	6B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3851	9435	0.000741918	0.008055114	3	6B	IN-SST	30	9	9
CGTGAGCAGCACAGGT-1_371G_A3D3	36.02825481	-9.139483517	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4772	11811	0.004995343	0.009821353	3	2	EN-L4	30	9	9
CGTGAGCAGCGTTTAC-1_371G_A3D3	6.084787056	-19.94882331	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4247	10067	0.007450084	0.005761399	3	L2-3	EN-L2-3-MS	30	9	9
CGTGAGCAGGATGTAT-1_371G_A3D3	-12.86721708	-2.124053393	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2575	4693	0.022160665	0.008523333	3	13A	IN-VIP	30	9	9
CGTGAGCCAATACGCT-1_371G_A3D3	6.881813037	-19.16938791	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5495	14398	0.00611196	0.006528685	3	L2-3	EN-L2-3-MS	30	9	9
CGTGAGCCATTCACTT-1_371G_A3D3	15.28983568	6.043663522	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2190	4303	0.00232396	0.01394376	3	oligos	OL-Cntl	30	9	9
CGTGAGCTCAACCAAC-1_371G_A3D3	11.0943513	6.213642946	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1817	3075	0.004227642	0.024715447	3	oligos	OL-Cntl	30	9	9
CGTGAGCTCGCGTAGC-1_371G_A3D3	7.815891901	9.541004583	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1215	1977	0.001011634	0.013151239	3	oligos	OL-Cntl	30	9	9
CGTGAGCTCTATCCTA-1_371G_A3D3	12.95583702	13.86228763	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1287	2025	0.000493827	0.008888889	3	oligos	OL-Cntl	30	9	9
CGTGTAAAGCATGGCA-1_371G_A3D3	9.886384085	-3.90007961	12	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2285	3770	0.00265252	0.017506631	3	12	EN-MIX	30	9	9
CGTGTAAAGGAGTTTA-1_371G_A3D3	-5.622632081	-3.374248342	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1514	2530	0.012648221	0.005928854	3	13A	IN-VIP	30	9	9
CGTGTAAAGTACCGGA-1_371G_A3D3	-31.22395918	13.03081455	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	960	1598	0	0.005006258	3	8	Astrocytes	30	9	9
CGTGTAACAACCGCCA-1_371G_A3D3	-14.20694068	-9.1422364	13B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2799	5676	0.00017618	0.009689922	3	13B	IN-SV2C	30	9	9
CGTGTAAGTAAGTGGC-1_371G_A3D3	-12.84494729	-17.35196602	6B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1376	2008	0.004482072	0.009960159	3	6B	IN-SST	30	9	9
CGTGTAAGTCAGAAGC-1_371G_A3D3	-30.51174702	-1.398221838	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1568	2484	0.000402576	0.004025765	3	9	OPC	30	9	9
CGTGTAATCAGCATGT-1_371G_A3D3	-11.11377766	-19.18843103	6B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	991	1536	0.004557292	0.001953125	3	6B	IN-SST	30	9	9
CGTGTCTAGACAAGCC-1_371G_A3D3	-24.26434042	13.07682788	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1274	2038	0.005397448	0.008832188	3	8	Astrocytes	30	9	9
CGTGTCTAGCGTAGTG-1_371G_A3D3	-3.139337725	14.36085931	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	736	1045	0.010526316	0.018181818	3	oligos	OL-Cntl	30	9	9
CGTGTCTAGTACGATA-1_371G_A3D3	8.431275784	11.13485469	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1174	1791	0.001675042	0.01451703	3	oligos	OL-Cntl	30	9	9
CGTGTCTAGTCAAGCG-1_371G_A3D3	35.93392264	9.998780546	14	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	734	1105	0.00361991	0.006334842	3	14	Microglia	30	9	9
CGTGTCTGTTCCATGA-1_371G_A3D3	-0.69847095	14.1982211	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	832	1240	0	0.023387097	3	oligos	OL-Cntl	30	9	9
CGTGTCTTCAGAAATG-1_371G_A3D3	11.6004531	7.002283456	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1636	2755	0.000725953	0.013067151	3	oligos	OL-Cntl	30	9	9
CGTGTCTTCAGCACAT-1_371G_A3D3	13.61127222	9.806050364	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1376	2294	0.00043592	0.010462075	3	oligos	OL-Cntl	30	9	9
CGTTAGACAATGGTCT-1_371G_A3D3	4.69034625	-19.59692702	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3768	8860	0.009480813	0.004288939	3	L2-3	EN-L2-3-MS	30	9	9
CGTTAGATCTAACGGT-1_371G_A3D3	-4.155186382	5.815180876	5	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2970	6118	0.000326904	0.023373652	3	oligos	OL-MS-1	30	9	9
CGTTAGATCTTAACCT-1_371G_A3D3	3.443871447	15.03134416	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1002	1585	0.00126183	0.013249211	3	oligos	OL-Cntl	30	9	9
CGTTCTGAGTAGGCCA-1_371G_A3D3	-34.4855132	-0.403297067	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1514	2467	0.003648156	0.007701662	3	9	OPC	30	9	9
CGTTCTGCAGACAGGT-1_371G_A3D3	22.44734788	-0.842969447	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2000	3869	0.012147842	0.003360041	3	2	EN-L4	30	9	9
CGTTCTGCATCCAACA-1_371G_A3D3	8.851369294	15.28142909	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1097	1684	0.002375297	0.01128266	3	oligos	OL-Cntl	30	9	9
CGTTGGGAGCACCGCT-1_371G_A3D3	-17.8764483	-10.33336373	13B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3149	6281	0.000796052	0.008119726	3	13B	IN-SV2C	30	9	9
CGTTGGGAGGACTGGT-1_371G_A3D3	-21.23768232	9.24685316	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	986	1396	0.002148997	0.005730659	3	8	Astrocytes	30	9	9
CGTTGGGAGTGAAGTT-1_371G_A3D3	-20.28607937	-18.85309958	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5586	18389	0.007069444	0.003425961	3	6A	IN-PV	30	9	9
CGTTGGGCACATCTTT-1_371G_A3D3	10.9460478	8.647184314	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1372	2401	0.004997918	0.010828821	3	oligos	OL-Cntl	30	9	9
CGTTGGGCAGCTTCGG-1_371G_A3D3	10.71190739	9.479165718	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1358	2177	0.000918695	0.01423978	3	oligos	OL-Cntl	30	9	9
CGTTGGGGTGCTAGCC-1_371G_A3D3	-23.91676051	16.92481818	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1320	2391	0.00250941	0.00418235	3	8	Astrocytes	30	9	9
CTAACTTAGACCTTTG-1_371G_A3D3	-34.77111491	-7.31146338	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1063	1641	0.001828154	0.001218769	3	9	OPC	30	9	9
CTAACTTGTAAGTTCC-1_371G_A3D3	-28.10115946	9.110423632	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	755	1094	0.006398537	0.005484461	3	8	Astrocytes	30	9	9
CTAACTTGTGTCAATC-1_371G_A3D3	-0.960173132	15.49620822	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	818	1196	0.005016722	0.012541806	3	oligos	OL-Cntl	30	9	9
CTAACTTTCACTTCAT-1_371G_A3D3	36.94194384	9.299102415	14	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	673	1015	0.001970443	0.007881773	3	14	Microglia	30	9	9
CTAACTTTCTGATACG-1_371G_A3D3	-9.743107636	-38.78393089	16	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1198	1682	0.030321046	0.019619501	3	16	EN-PYR	30	9	9
CTAAGACAGAAACCGC-1_371G_A3D3	-9.37521894	-18.35366701	6B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	853	1240	0.018548387	0.00483871	3	6B	IN-SST	30	9	9
CTAAGACCACCCATTC-1_371G_A3D3	35.88186499	-7.648526637	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4080	9879	0.01153963	0.007490637	3	2	EN-L4	30	9	9
CTAAGACCAGACACTT-1_371G_A3D3	-22.87835157	-25.31763544	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3531	7975	0.002131661	0.00677116	3	6A	IN-PV	30	9	9
CTAAGACCAGCTGGCT-1_371G_A3D3	-0.678923113	15.77161579	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	716	1078	0	0.008348794	3	oligos	OL-Cntl	30	9	9
CTAAGACGTGCGCTTG-1_371G_A3D3	12.29282928	6.046598307	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2049	3773	0.002650411	0.015372383	3	oligos	OL-Cntl	30	9	9
CTAAGACGTTACCGAT-1_371G_A3D3	30.92933027	15.58615771	14	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	970	1496	0.002005348	0.107620321	3	14	Microglia	30	9	9
CTAAGACTCGTAGATC-1_371G_A3D3	-14.55029579	-23.804172	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1497	2560	0.022265625	0.0078125	3	6A	IN-PV	30	9	9
CTAATGGCAATTCCTT-1_371G_A3D3	-21.0448362	25.80515715	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1646	2853	0.001402033	0.002453558	3	8	Astrocytes	30	9	9
CTAATGGCACGGTGTC-1_371G_A3D3	-2.813857227	17.54061382	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	737	1084	0.009225092	0.010147601	3	oligos	OL-Cntl	30	9	9
CTAATGGGTCCATCCT-1_371G_A3D3	-33.6836612	-2.806334095	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1453	2419	0.008267879	0.006614303	3	9	OPC	30	9	9
CTAATGGGTTGACGTT-1_371G_A3D3	34.99650796	-6.62355942	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3481	7267	0.005229118	0.006192376	3	2	EN-L4	30	9	9
CTAATGGTCAGTTGAC-1_371G_A3D3	-2.844392103	15.58743951	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	756	1127	0.003549246	0.014196983	3	oligos	OL-Cntl	30	9	9
CTAATGGTCTCGTATT-1_371G_A3D3	12.11836975	8.857245144	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1480	2665	0.001125704	0.007879925	3	oligos	OL-Cntl	30	9	9
CTACACCAGCTACCTA-1_371G_A3D3	29.39561875	-1.920856085	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4349	11190	0.004915103	0.003932082	3	2	EN-L4	30	9	9
CTACACCAGTAGTGCG-1_371G_A3D3	7.695643612	9.488631067	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1301	2235	0.001342282	0.014765101	3	oligos	OL-Cntl	30	9	9
CTACACCCAACTGGCC-1_371G_A3D3	-14.99449354	1.595670042	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4015	8826	0.006911398	0.012916383	3	13A	IN-VIP	30	9	9
CTACACCCACATTTCT-1_371G_A3D3	-37.02182711	2.303086056	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1748	3238	0.002470661	0.003397159	3	9	OPC	30	9	9
CTACACCCATCGGACC-1_371G_A3D3	32.64914311	-3.474451858	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3200	6848	0.004526869	0.007301402	3	2	EN-L4	30	9	9
CTACACCGTAGAGTGC-1_371G_A3D3	-7.427983978	-13.63195506	6B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1167	1652	0.045399516	0.017554479	3	6B	IN-SST	30	9	9
CTACACCTCTCAAGTG-1_371G_A3D3	-2.982263628	14.31094644	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	824	1206	0.000829187	0.014096186	3	oligos	OL-Cntl	30	9	9
CTACATTAGAGAGCTC-1_371G_A3D3	4.816653199	-19.04080514	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3797	9037	0.00088525	0.005090185	3	L2-3	EN-L2-3-MS	30	9	9
CTACATTAGGCCCGTT-1_371G_A3D3	-34.92272454	0.460424722	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1661	3066	0.000978474	0.004892368	3	9	OPC	30	9	9
CTACATTCAAGGTTCT-1_371G_A3D3	-26.36133613	-23.01489187	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	6003	16531	0.002903636	0.011251588	3	6A	IN-PV	30	9	9
CTACATTCACATCCAA-1_371G_A3D3	-23.07461545	-26.35738259	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4134	11626	0.001978324	0.005418889	3	6A	IN-PV	30	9	9
CTACATTCATCGATGT-1_371G_A3D3	15.81607265	14.33470821	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1174	1883	0.000531067	0.007434944	3	oligos	OL-Cntl	30	9	9
CTACATTGTATCTGCA-1_371G_A3D3	15.40989718	7.195026551	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1757	3427	0.003209804	0.006127809	3	oligos	OL-Cntl	30	9	9
CTACATTGTCCCTTGT-1_371G_A3D3	3.048159404	14.51559133	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1034	1728	0.001157407	0.012152778	3	oligos	OL-Cntl	30	9	9
CTACATTTCGAGCCCA-1_371G_A3D3	-23.71104829	-19.37528345	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3597	8166	0.005388195	0.008082292	3	6A	IN-PV	30	9	9
CTACATTTCGCACTCT-1_371G_A3D3	-19.45848322	26.53936703	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1799	3514	0.003130336	0.00284576	3	8	Astrocytes	30	9	9
CTACCCAAGAACTCGG-1_371G_A3D3	8.119265145	-21.35823069	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	6753	21779	0.004775242	0.007208779	3	L2-3	EN-L2-3-MS	30	9	9
CTACCCAAGCTGGAAC-1_371G_A3D3	9.89382442	7.715203155	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1441	2181	0.005043558	0.016047685	3	oligos	OL-Cntl	30	9	9
CTACCCACAAAGCAAT-1_371G_A3D3	-22.29498592	-24.97307428	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2934	6343	0.011035787	0.005044931	3	6A	IN-PV	30	9	9
CTACCCAGTAAATGTG-1_371G_A3D3	35.73563029	-7.936567236	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4921	12057	0.003483454	0.006386332	3	2	EN-L4	30	9	9
CTACCCAGTGAACCTT-1_371G_A3D3	-19.63034462	28.11679818	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2046	3855	0.00077821	0.004928664	3	8	Astrocytes	30	9	9
CTACCCAGTGCTCTTC-1_371G_A3D3	-13.20120051	1.336888145	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3595	7684	0.001952108	0.008589276	3	13A	IN-VIP	30	9	9
CTACCCAGTTCGCTAA-1_371G_A3D3	-16.95636453	-24.94555235	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1987	3711	0.001347346	0.002964161	3	6A	IN-PV	30	9	9
CTACCCAGTTGAGTTC-1_371G_A3D3	1.304614762	18.33648187	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	777	1223	0.006541292	0.012264922	3	oligos	OL-Cntl	30	9	9
CTACCCATCGGCGCAT-1_371G_A3D3	-9.152126459	-17.38849022	6B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	800	1149	0.006962576	0.006092254	3	6B	IN-SST	30	9	9
CTACCCATCGTGGTCG-1_371G_A3D3	0.9829692	12.99072165	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	956	1475	0.01559322	0.019661017	3	oligos	OL-Cntl	30	9	9
CTACCCATCTTGAGAC-1_371G_A3D3	8.829614085	13.75778341	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1097	1766	0.00396376	0.006228766	3	oligos	OL-Cntl	30	9	9
CTACGTCAGAGACGAA-1_371G_A3D3	-19.17568988	-26.7432341	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2685	6022	0.004317502	0.004151445	3	6A	IN-PV	30	9	9
CTACGTCAGCTCCTCT-1_371G_A3D3	8.330275699	9.858050418	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1234	2194	0.006836828	0.008204193	3	oligos	OL-Cntl	30	9	9
CTACGTCGTCAACTGT-1_371G_A3D3	14.1742545	-29.6400102	3	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5019	16146	0.010590858	0.003406416	3	3	EN-L5-6	30	9	9
CTACGTCGTTACGACT-1_371G_A3D3	-30.15663198	-1.480722132	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1610	2624	0.001143293	0.005716463	3	9	OPC	30	9	9
CTACGTCTCTCAACTT-1_371G_A3D3	9.397732776	9.987756482	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1294	2264	0.000883392	0.00795053	3	oligos	OL-Cntl	30	9	9
CTAGAGTAGAGTAAGG-1_371G_A3D3	-33.67799688	1.867253305	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1748	3049	0.000983929	0.006887504	3	9	OPC	30	9	9
CTAGAGTAGGATGTAT-1_371G_A3D3	11.39936498	14.82026795	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1097	1767	0.003961517	0.008488964	3	oligos	OL-Cntl	30	9	9
CTAGAGTCAGACAAAT-1_371G_A3D3	1.634455148	13.66863549	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1016	1682	0.008917955	0.013674197	3	oligos	OL-Cntl	30	9	9
CTAGAGTGTTAGAACA-1_371G_A3D3	15.78760365	8.662590188	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1871	3482	0.003446295	0.008615738	3	oligos	OL-Cntl	30	9	9
CTAGAGTTCCTTGACC-1_371G_A3D3	-3.194394251	-17.45381053	10	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2865	6364	0.001885607	0.003614079	3	L2-3	EN-L2-3-Cntl	30	9	9
CTAGCCTAGACACGAC-1_371G_A3D3	-2.688099092	14.04105436	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	849	1241	0.004029009	0.015310234	3	oligos	OL-Cntl	30	9	9
CTAGCCTAGACGCACA-1_371G_A3D3	-16.16487986	2.112634303	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4471	10513	0.013221725	0.012365643	3	13A	IN-VIP	30	9	9
CTAGCCTAGCACGCCT-1_371G_A3D3	6.024387317	25.89992558	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	901	1302	0.007680492	0.004608295	3	oligos	OL-Cntl	30	9	9
CTAGCCTCACGAGGTA-1_371G_A3D3	-16.38416357	2.384497113	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	6346	17788	0.009500787	0.009107263	3	13A	IN-VIP	30	9	9
CTAGCCTCATCAGTCA-1_371G_A3D3	-30.4976484	1.941404345	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2234	4145	0.000965018	0.007237636	3	9	OPC	30	9	9
CTAGCCTGTATTACCG-1_371G_A3D3	13.7275823	-32.20738715	3	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3892	10949	0.011690565	0.002739976	3	3	EN-L5-6	30	9	9
CTAGCCTGTCGGGTCT-1_371G_A3D3	-32.90135818	-3.708024568	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1342	2257	0.004873726	0.003987594	3	9	OPC	30	9	9
CTAGCCTGTGGTTTCA-1_371G_A3D3	-14.4528463	-5.04516399	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3285	7179	0.010307842	0.005153921	3	13A	IN-VIP	30	9	9
CTAGCCTTCCGCGCAA-1_371G_A3D3	-20.02346402	-20.81642283	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1858	3140	0.008917197	0.012738854	3	6A	IN-PV	30	9	9
CTAGCCTTCCTAAGTG-1_371G_A3D3	10.11691449	19.67096473	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	984	1590	0.000628931	0.003773585	3	oligos	OL-Cntl	30	9	9
CTAGCCTTCCTTGACC-1_371G_A3D3	-21.42756218	25.78251134	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1587	2770	0.006137184	0.003249097	3	8	Astrocytes	30	9	9
CTAGTGACAAGTAGTA-1_371G_A3D3	-0.057437268	17.82960415	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	733	1113	0.002695418	0.011680144	3	oligos	OL-Cntl	30	9	9
CTAGTGACAGGACGTA-1_371G_A3D3	-30.8629005	11.20348957	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	734	1093	0.000914913	0.000914913	3	8	Astrocytes	30	9	9
CTAGTGACAGGTTTCA-1_371G_A3D3	-15.66715627	1.808163151	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3870	8420	0.009382423	0.013895487	3	13A	IN-VIP	30	9	9
CTAGTGAGTGTGTGCC-1_371G_A3D3	-4.528916058	17.32492068	5	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	910	1321	0.003028009	0.012112036	3	oligos	OL-MS-1	30	9	9
CTAGTGAGTTTGACAC-1_371G_A3D3	4.08263263	15.28255963	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1013	1592	0.004396985	0.005025126	3	oligos	OL-Cntl	30	9	9
CTAGTGATCGTACCGG-1_371G_A3D3	-28.1663036	0.299743072	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1874	2883	0.001040583	0.011099549	3	9	OPC	30	9	9
CTCACACCAAATTGCC-1_371G_A3D3	9.936438423	-24.02162465	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	7051	26320	0.002697568	0.004293313	3	L2-3	EN-L2-3-MS	30	9	9
CTCACACGTAAACACA-1_371G_A3D3	14.46067176	10.23271017	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1395	2344	0.000853242	0.00725256	3	oligos	OL-Cntl	30	9	9
CTCACACTCAGGCGAA-1_371G_A3D3	-0.22437811	14.55000658	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	865	1275	0.001568627	0.014117647	3	oligos	OL-Cntl	30	9	9
CTCACACTCATCGCTC-1_371G_A3D3	6.933246028	-18.59295186	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5313	13736	0.002693652	0.012085032	3	L2-3	EN-L2-3-MS	30	9	9
CTCACACTCCTTAATC-1_371G_A3D3	28.24237975	-1.691736671	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4300	11891	0.001093264	0.005045833	3	2	EN-L4	30	9	9
CTCAGAAAGGATGCGT-1_371G_A3D3	-30.03096887	-1.127878918	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1619	2534	0.000394633	0.01183899	3	9	OPC	30	9	9
CTCAGAAAGTGAATTG-1_371G_A3D3	8.25842182	8.872991065	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1281	2056	0.004377432	0.016050584	3	oligos	OL-Cntl	30	9	9
CTCAGAACAATCGGTT-1_371G_A3D3	20.44262453	0.38931943	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1515	2343	0.019632949	0.006402049	3	2	EN-L4	30	9	9
CTCAGAATCAAGATCC-1_371G_A3D3	-9.704952967	-1.237650243	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2377	4629	0.011449557	0.006696911	3	13A	IN-VIP	30	9	9
CTCAGAATCAGTGTTG-1_371G_A3D3	-0.765201606	15.19169686	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	779	1129	0.001771479	0.013286094	3	oligos	OL-Cntl	30	9	9
CTCATTAAGGCCCGTT-1_371G_A3D3	35.40808575	-6.968174212	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3652	8627	0.01170743	0.006607164	3	2	EN-L4	30	9	9
CTCATTAAGGCTCATT-1_371G_A3D3	12.81026849	10.20741084	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1262	2204	0	0.004990926	3	oligos	OL-Cntl	30	9	9
CTCATTACACATCTTT-1_371G_A3D3	5.460677896	-19.76182986	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4168	10205	0.003919647	0.006859383	3	L2-3	EN-L2-3-MS	30	9	9
CTCATTAGTCAGAAGC-1_371G_A3D3	0.188076733	19.25635846	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	808	1149	0.001740644	0.01305483	3	oligos	OL-Cntl	30	9	9
CTCCTAGAGAGCTTCT-1_371G_A3D3	-2.388598065	13.43640229	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	859	1266	0.003159558	0.030015798	3	oligos	OL-Cntl	30	9	9
CTCCTAGAGCGTGTCC-1_371G_A3D3	-22.7575241	-7.862578347	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2091	3482	0.012923607	0.009764503	3	9	OPC	30	9	9
CTCCTAGCACATCTTT-1_371G_A3D3	0.687916651	8.652861194	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1329	2052	0.0082846	0.016569201	3	oligos	OL-Cntl	30	9	9
CTCCTAGCACGTAAGG-1_371G_A3D3	10.13587292	-22.25193332	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	7346	25240	0.004675119	0.005784469	3	L2-3	EN-L2-3-MS	30	9	9
CTCCTAGCACGTTGGC-1_371G_A3D3	-0.918362411	13.93719003	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	944	1499	0.000667111	0.016677785	3	oligos	OL-Cntl	30	9	9
CTCCTAGGTTCCGGCA-1_371G_A3D3	15.02107499	6.721929086	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1810	3195	0.00312989	0.012206573	3	oligos	OL-Cntl	30	9	9
CTCGAAAAGAACTCGG-1_371G_A3D3	-9.931883011	12.29945595	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	917	1347	0.011878248	0.013363029	3	oligos	OL-Cntl	30	9	9
CTCGAAAAGGCGTACA-1_371G_A3D3	0.050735752	13.01107258	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	905	1227	0.005704971	0.008149959	3	oligos	OL-Cntl	30	9	9
CTCGAAACAAGGCTCC-1_371G_A3D3	8.33166011	15.94996944	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	893	1367	0.002926116	0.010972933	3	oligos	OL-Cntl	30	9	9
CTCGAAACAATCAGAA-1_371G_A3D3	-24.20725666	-18.37409402	6B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4420	10848	0.0070059	0.015578909	3	6B	IN-SST	30	9	9
CTCGAAACACTTAAGC-1_371G_A3D3	-25.44565049	10.90634071	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	964	1487	0.000672495	0.00537996	3	8	Astrocytes	30	9	9
CTCGAAACATGCAACT-1_371G_A3D3	9.05778758	9.886945022	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1204	2030	0.000985222	0.017241379	3	oligos	OL-Cntl	30	9	9
CTCGAAAGTAGCGCTC-1_371G_A3D3	-0.621896118	21.46020866	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	786	1083	0.003693444	0.010156971	3	oligos	OL-Cntl	30	9	9
CTCGAAATCAGCAACT-1_371G_A3D3	-1.005117806	19.22298183	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	739	1021	0.001958864	0.010773751	3	oligos	OL-Cntl	30	9	9
CTCGAGGAGATATGGT-1_371G_A3D3	-29.2534996	-0.408348695	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1654	2491	0.002007226	0.008028904	3	9	OPC	30	9	9
CTCGAGGAGTACGATA-1_371G_A3D3	36.07167008	-9.334865806	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4663	10998	0.00290962	0.012002182	3	2	EN-L4	30	9	9
CTCGAGGGTCTCTCTG-1_371G_A3D3	7.862274794	9.590111088	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1288	2260	0.004867257	0.011061947	3	oligos	OL-Cntl	30	9	9
CTCGAGGGTTGTGGCC-1_371G_A3D3	6.967146917	-18.35196322	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4334	9562	0.004183225	0.01652374	3	L2-3	EN-L2-3-MS	30	9	9
CTCGAGGTCTGCCAGG-1_371G_A3D3	-16.64614926	-22.0895624	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1737	3078	0.02891488	0.00877193	3	6A	IN-PV	30	9	9
CTCGAGGTCTTGAGGT-1_371G_A3D3	4.424865007	9.334349568	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1349	2155	0.002784223	0.019489559	3	oligos	OL-Cntl	30	9	9
CTCGGAGAGAGTCGGT-1_371G_A3D3	3.608033791	10.37529858	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1131	1735	0.006916427	0.025936599	3	oligos	OL-Cntl	30	9	9
CTCGGAGAGTAGCCGA-1_371G_A3D3	-16.42045809	16.10886515	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1739	3252	0.000922509	0.003690037	3	8	Astrocytes	30	9	9
CTCGGAGGTGCAACGA-1_371G_A3D3	-0.319235596	14.91625213	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	806	1196	0.00083612	0.017558528	3	oligos	OL-Cntl	30	9	9
CTCGGAGGTTGGACCC-1_371G_A3D3	-0.339268955	15.85132026	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	807	1163	0.000859845	0.020636285	3	oligos	OL-Cntl	30	9	9
CTCGGAGTCGTTTATC-1_371G_A3D3	-23.47898692	-24.67396351	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3730	9187	0.010340699	0.004462828	3	6A	IN-PV	30	9	9
CTCGGGAAGCCACCTG-1_371G_A3D3	12.65119666	-23.9395602	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5830	17476	0.001373312	0.007782101	3	L2-3	EN-L2-3-MS	30	9	9
CTCGGGAAGGCTCATT-1_371G_A3D3	-32.16168704	-9.15671847	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1050	1500	0.002	0.004666667	3	9	OPC	30	9	9
CTCGGGAAGTGCCATT-1_371G_A3D3	35.16315158	10.60654313	14	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	721	1015	0.001970443	0.019704433	3	14	Microglia	30	9	9
CTCGGGACATTTCAGG-1_371G_A3D3	7.757110847	-19.00141479	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4720	11062	0.006870367	0.005243175	3	L2-3	EN-L2-3-MS	30	9	9
CTCGGGAGTAGCAAAT-1_371G_A3D3	15.24821333	6.551243881	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1667	2995	0.00033389	0.008681135	3	oligos	OL-Cntl	30	9	9
CTCGGGAGTGGAAAGA-1_371G_A3D3	-30.44011107	9.953194988	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	848	1150	0	0.006086957	3	8	Astrocytes	30	9	9
CTCGGGAGTTAAGATG-1_371G_A3D3	-8.011561667	-10.28528155	6B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	956	1444	0.148891967	0.024930748	3	6B	IN-SST	30	9	9
CTCGGGATCCGGCACA-1_371G_A3D3	-3.682529245	-5.981743424	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1003	1462	0.001367989	0.006155951	3	13A	IN-VIP	30	9	9
CTCGTACAGAAGGCCT-1_371G_A3D3	-8.694523115	-33.51599451	16	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1020	1387	0.030281182	0.01369863	3	16	EN-PYR	30	9	9
CTCGTACAGATATACG-1_371G_A3D3	6.680582347	12.17735968	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1151	1779	0.002810568	0.006183249	3	oligos	OL-Cntl	30	9	9
CTCGTACAGTTCCACA-1_371G_A3D3	-2.644562067	13.02252754	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	949	1333	0.000750188	0.028507127	3	oligos	OL-Cntl	30	9	9
CTCGTACCAGCGTAAG-1_371G_A3D3	6.221087395	9.73913838	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1444	2207	0.001359311	0.012233802	3	oligos	OL-Cntl	30	9	9
CTCGTACCATCGGAAG-1_371G_A3D3	2.913824069	14.86469673	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1004	1527	0.003929273	0.008513425	3	oligos	OL-Cntl	30	9	9
CTCGTACCATTATCTC-1_371G_A3D3	-15.85296331	0.392523674	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2907	5376	0.009300595	0.013392857	3	13A	IN-VIP	30	9	9
CTCGTACTCACCACCT-1_371G_A3D3	-4.682796451	6.175947246	5	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1226	1769	0.002826456	0.026003392	3	oligos	OL-MS-1	30	9	9
CTCGTACTCCTCAATT-1_371G_A3D3	16.35585233	5.993136362	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2300	4751	0.00210482	0.01157651	3	oligos	OL-Cntl	30	9	9
CTCGTACTCTGTCTCG-1_371G_A3D3	-29.53015463	0.848555142	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2006	3337	0.000599341	0.011087803	3	9	OPC	30	9	9
CTCGTCAAGCGATGAC-1_371G_A3D3	-25.33390168	22.55031721	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1333	2290	0.008296943	0.006550218	3	8	Astrocytes	30	9	9
CTCGTCAAGTGGTCCC-1_371G_A3D3	-2.08518973	14.77070445	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	744	1081	0.001850139	0.013876041	3	oligos	OL-Cntl	30	9	9
CTCGTCACAGGATTGG-1_371G_A3D3	35.92771836	-12.50187393	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5366	13807	0.01122619	0.011588325	3	2	EN-L4	30	9	9
CTCGTCACATTGGGCC-1_371G_A3D3	29.07997915	-2.672179977	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4605	12969	0.008558871	0.004780631	3	2	EN-L4	30	9	9
CTCGTCAGTTATTCTC-1_371G_A3D3	-2.686062482	16.83675216	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	776	1113	0.001796945	0.018867925	3	oligos	OL-Cntl	30	9	9
CTCGTCATCAACCATG-1_371G_A3D3	18.47398086	-24.10587328	3	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5261	13623	0.005358585	0.016369375	3	3	EN-L5-6	30	9	9
CTCGTCATCGTAGGAG-1_371G_A3D3	7.868842187	-18.21557321	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5474	13818	0.006440874	0.01042119	3	L2-3	EN-L2-3-MS	30	9	9
CTCTAATAGCTGCGAA-1_371G_A3D3	-3.633533678	16.68838153	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	740	1029	0.000971817	0.014577259	3	oligos	OL-Cntl	30	9	9
CTCTAATAGTCCCACG-1_371G_A3D3	-0.344406208	17.69223286	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	774	1138	0.000878735	0.010544815	3	oligos	OL-Cntl	30	9	9
CTCTAATGTATTAGCC-1_371G_A3D3	-0.619029886	15.91151847	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	803	1125	0.001777778	0.011555556	3	oligos	OL-Cntl	30	9	9
CTCTAATTCAACACGT-1_371G_A3D3	34.65415418	-8.887762466	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5365	14446	0.009275924	0.007476118	3	2	EN-L4	30	9	9
CTCTAATTCTCAAGTG-1_371G_A3D3	20.80478411	13.60397295	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1348	2232	0	0.004032258	3	oligos	OL-Cntl	30	9	9
CTCTAATTCTTGTTTG-1_371G_A3D3	-13.31350517	-19.01651982	6B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1274	2246	0.025823687	0.00222618	3	6B	IN-SST	30	9	9
CTCTACGAGACGCTTT-1_371G_A3D3	-10.95665252	18.88393748	11	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2757	5523	0.00362122	0.004526525	3	11	Glia-MIX	30	9	9
CTCTACGAGGCGATAC-1_371G_A3D3	-19.26635383	29.33063378	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2558	5270	0	0.004933586	3	8	Astrocytes	30	9	9
CTCTACGCATGCTGGC-1_371G_A3D3	-29.98897156	1.001288549	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1992	3619	0.003592153	0.008289583	3	9	OPC	30	9	9
CTCTACGGTTTGACAC-1_371G_A3D3	-20.46444652	26.08184651	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1784	3332	0.00030012	0.006602641	3	8	Astrocytes	30	9	9
CTCTACGTCGCGATCG-1_371G_A3D3	3.625116234	13.19770806	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	983	1540	0	0.015584416	3	oligos	OL-Cntl	30	9	9
CTCTACGTCGGACAAG-1_371G_A3D3	11.05840768	7.197140213	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1490	2474	0.004042037	0.016168149	3	oligos	OL-Cntl	30	9	9
CTCTACGTCGTCTGAA-1_371G_A3D3	8.973144252	12.24811612	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1118	1755	0.002849003	0.012535613	3	oligos	OL-Cntl	30	9	9
CTCTACGTCGTTTAGG-1_371G_A3D3	-5.081977319	-9.855422652	13B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	860	1289	0.063615206	0.003103181	3	13B	IN-SV2C	30	9	9
CTCTGGTAGTACCGGA-1_371G_A3D3	-18.36466797	29.183955	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2678	5187	0.009832273	0.00597648	3	8	Astrocytes	30	9	9
CTCTGGTCACGACGAA-1_371G_A3D3	15.10996026	6.878691252	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1927	3520	0.002272727	0.011931818	3	oligos	OL-Cntl	30	9	9
CTCTGGTCAGTGGGAT-1_371G_A3D3	-3.394893959	-17.37532959	10	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2878	5893	0.0023757	0.005090786	3	L2-3	EN-L2-3-Cntl	30	9	9
CTCTGGTCATGAAGTA-1_371G_A3D3	-0.070622698	18.40701926	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	782	1145	0.011353712	0.004366812	3	oligos	OL-Cntl	30	9	9
CTCTGGTCATGCGCAC-1_371G_A3D3	-18.74705189	10.1290152	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	797	1019	0.031403337	0.004906771	3	8	Astrocytes	30	9	9
CTCTGGTGTCGATTGT-1_371G_A3D3	4.289390751	-16.95973183	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2472	4314	0.004867872	0.006258693	3	L2-3	EN-L2-3-MS	30	9	9
CTCTGGTGTCGCGAAA-1_371G_A3D3	-16.86108394	1.290649074	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4018	8191	0.007813454	0.012818948	3	13A	IN-VIP	30	9	9
CTCTGGTTCTTGTACT-1_371G_A3D3	1.562051811	14.78312349	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	913	1387	0	0.009372747	3	oligos	OL-Cntl	30	9	9
CTGAAACAGCAGGTCA-1_371G_A3D3	4.873946362	-20.85409998	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5460	15861	0.001891432	0.005106866	3	L2-3	EN-L2-3-MS	30	9	9
CTGAAACAGCCGGTAA-1_371G_A3D3	12.37824591	9.117620594	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1369	2278	0	0.010974539	3	oligos	OL-Cntl	30	9	9
CTGAAACCAATAACGA-1_371G_A3D3	0.970908301	8.629595943	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1404	2192	0.001368613	0.011861314	3	oligos	OL-Cntl	30	9	9
CTGAAACCACCGGAAA-1_371G_A3D3	7.994808462	-17.7723478	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4661	11364	0.002463921	0.017335445	3	L2-3	EN-L2-3-MS	30	9	9
CTGAAACGTAGGACAC-1_371G_A3D3	-3.109802665	12.65757397	5	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	808	1148	0.004355401	0.033972125	3	oligos	OL-MS-1	30	9	9
CTGAAACGTGGTGTAG-1_371G_A3D3	-9.5875383	2.829515271	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2771	5591	0.00321946	0.005008049	3	13A	IN-VIP	30	9	9
CTGAAACGTTGCTCCT-1_371G_A3D3	-22.42061704	22.78458501	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1672	3053	0.001310187	0.002620373	3	8	Astrocytes	30	9	9
CTGAAACTCACGACTA-1_371G_A3D3	11.45871921	7.978336069	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1457	2504	0.005191693	0.016373802	3	oligos	OL-Cntl	30	9	9
CTGAAACTCACTTATC-1_371G_A3D3	2.140137806	20.36200393	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	825	1260	0.001587302	0.012698413	3	oligos	OL-Cntl	30	9	9
CTGAAACTCCAAATGC-1_371G_A3D3	18.34278281	-28.96107498	3	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	7247	29850	0.000536013	0.004053601	3	3	EN-L5-6	30	9	9
CTGAAACTCTCTTGAT-1_371G_A3D3	-0.03649647	19.44266455	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	825	1278	0.000782473	0.004694836	3	oligos	OL-Cntl	30	9	9
CTGAAACTCTGACCTC-1_371G_A3D3	29.6374563	6.337964362	15DA	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	915	1381	0.002896452	0.028964518	3	15DA	T cells	30	9	9
CTGAAGTAGGAACTGC-1_371G_A3D3	-2.178162745	13.83618036	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	794	1093	0.001829826	0.031107045	3	oligos	OL-Cntl	30	9	9
CTGAAGTAGTATGACA-1_371G_A3D3	-22.71206635	-26.56311443	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3610	8723	0.001146395	0.004814857	3	6A	IN-PV	30	9	9
CTGAAGTAGTGTACCT-1_371G_A3D3	13.86236224	8.164789918	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1487	2392	0.002508361	0.005852843	3	oligos	OL-Cntl	30	9	9
CTGAAGTCAAACGTGG-1_371G_A3D3	-2.166816782	17.27946109	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	689	1006	0.002982107	0.00695825	3	oligos	OL-Cntl	30	9	9
CTGAAGTCATCGATGT-1_371G_A3D3	-25.12668881	0.040179504	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2109	3654	0.000547345	0.004926108	3	9	OPC	30	9	9
CTGAAGTGTATATCCG-1_371G_A3D3	-32.90071987	-1.982945913	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1536	2563	0.001170503	0.002341007	3	9	OPC	30	9	9
CTGAAGTGTTAGGGTG-1_371G_A3D3	-10.81556963	-18.51052686	6B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1075	1754	0.025085519	0.003420753	3	6B	IN-SST	30	9	9
CTGAAGTGTTGTTTGG-1_371G_A3D3	5.696800141	-19.12744231	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3828	8818	0.000567022	0.014629168	3	L2-3	EN-L2-3-MS	30	9	9
CTGAAGTTCAGCTCGG-1_371G_A3D3	5.258019104	-19.37140735	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4579	12794	0.003439112	0.005393153	3	L2-3	EN-L2-3-MS	30	9	9
CTGAAGTTCCTCAATT-1_371G_A3D3	-5.675909251	-5.512663401	13B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1275	2099	0.020485946	0.001429252	3	13B	IN-SV2C	30	9	9
CTGATAGAGCTGATAA-1_371G_A3D3	-1.214936012	14.19016289	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	814	1175	0.001702128	0.018723404	3	oligos	OL-Cntl	30	9	9
CTGATAGAGGACCACA-1_371G_A3D3	-14.93313933	0.895293231	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3123	5862	0.008188332	0.009894234	3	13A	IN-VIP	30	9	9
CTGATAGGTCTTTCAT-1_371G_A3D3	7.910169187	11.94136031	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1090	1640	0.001829268	0.01402439	3	oligos	OL-Cntl	30	9	9
CTGATAGGTTCCCTTG-1_371G_A3D3	-15.39117403	-19.02853787	6B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1629	3044	0.013797635	0.002628121	3	6B	IN-SST	30	9	9
CTGATAGGTTGAACTC-1_371G_A3D3	-33.43009421	1.559546059	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1849	3242	0.00400987	0.005552128	3	9	OPC	30	9	9
CTGATAGTCTTTACGT-1_371G_A3D3	3.426888568	-2.606714657	12	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	971	1696	0.001179245	0.004716981	3	12	EN-MIX	30	9	9
CTGATCCAGGGTGTTG-1_371G_A3D3	6.605527079	10.06605606	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1261	1920	0.0015625	0.0171875	3	oligos	OL-Cntl	30	9	9
CTGATCCGTACTCGCG-1_371G_A3D3	6.081103323	-19.17338266	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3762	8500	0.005176471	0.006823529	3	L2-3	EN-L2-3-MS	30	9	9
CTGATCCGTCTAGTGT-1_371G_A3D3	-30.85747659	-1.318135551	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1505	2540	0.000787402	0.006299213	3	9	OPC	30	9	9
CTGATCCGTTCGTGAT-1_371G_A3D3	5.741047473	-19.40242229	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4434	10975	0.003006834	0.008200456	3	L2-3	EN-L2-3-MS	30	9	9
CTGATCCTCAGTTGAC-1_371G_A3D3	-5.47195412	-21.52585589	10	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3463	9214	0.000434122	0.002821793	3	L2-3	EN-L2-3-Cntl	30	9	9
CTGCCTACAACGCACC-1_371G_A3D3	36.02261477	-12.05360896	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5949	16141	0.005142184	0.010408277	3	2	EN-L4	30	9	9
CTGCCTACAACTGCTA-1_371G_A3D3	3.565432142	14.26907971	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	979	1498	0.001335113	0.017356475	3	oligos	OL-Cntl	30	9	9
CTGCCTACACATCTTT-1_371G_A3D3	8.329836121	9.357371374	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1332	2233	0.002686968	0.011643529	3	oligos	OL-Cntl	30	9	9
CTGCCTACAGCTTAAC-1_371G_A3D3	-1.06056597	13.03654601	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	943	1378	0.003628447	0.034107402	3	oligos	OL-Cntl	30	9	9
CTGCCTACAGTATGCT-1_371G_A3D3	-23.9087825	1.191904717	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3145	6149	0.003415189	0.008619288	3	9	OPC	30	9	9
CTGCCTACATCAGTCA-1_371G_A3D3	2.512222092	15.30550994	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	959	1504	0.001329787	0.008643617	3	oligos	OL-Cntl	30	9	9
CTGCCTACATGTCTCC-1_371G_A3D3	16.68807719	-5.261960852	3	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1366	2346	0.034526854	0.002131287	3	3	EN-L5-6	30	9	9
CTGCCTAGTAGAAGGA-1_371G_A3D3	-16.90048566	1.451734088	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3834	7969	0.005646882	0.01242314	3	13A	IN-VIP	30	9	9
CTGCCTAGTCATATGC-1_371G_A3D3	18.28114617	17.55093524	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1130	1891	0.003172924	0.008989952	3	oligos	OL-Cntl	30	9	9
CTGCCTAGTCTCCCTA-1_371G_A3D3	-12.96656893	0.508599647	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2849	5740	0.01010453	0.008885017	3	13A	IN-VIP	30	9	9
CTGCCTATCCTCTAGC-1_371G_A3D3	-9.893339722	0.399818476	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2913	5843	0.005305494	0.003080609	3	13A	IN-VIP	30	9	9
CTGCGGAAGCACCGCT-1_371G_A3D3	-36.10665807	-1.897260069	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1495	2709	0.00110742	0.005537099	3	9	OPC	30	9	9
CTGCGGACAGCTGCAC-1_371G_A3D3	10.81043125	-27.60499374	10	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	7051	22836	0.001795411	0.005867928	3	L2-3	EN-L2-3-Cntl	30	9	9
CTGCGGAGTAGATTAG-1_371G_A3D3	-28.79528075	1.408747773	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2600	4671	0.000856348	0.008135303	3	9	OPC	30	9	9
CTGCGGATCGGAGGTA-1_371G_A3D3	9.611968901	-30.13546102	10	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4700	12656	0.006321113	0.004266751	3	L2-3	EN-L2-3-Cntl	30	9	9
CTGCTGTAGAACTGTA-1_371G_A3D3	-18.91689922	28.90637741	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2445	4803	0.005413283	0.004372267	3	8	Astrocytes	30	9	9
CTGCTGTAGCGTCTAT-1_371G_A3D3	8.9302567	9.953571241	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1247	2145	0.007459207	0.005128205	3	oligos	OL-Cntl	30	9	9
CTGCTGTCAGTATCTG-1_371G_A3D3	9.216992499	10.07789122	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1198	1939	0.006704487	0.007735946	3	oligos	OL-Cntl	30	9	9
CTGCTGTGTCGCTTTC-1_371G_A3D3	-20.50744597	-6.636011714	13B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5494	14540	0.009422283	0.012998624	3	13B	IN-SV2C	30	9	9
CTGCTGTGTTAAGAAC-1_371G_A3D3	-17.90078951	-17.18627235	6B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2347	4799	0.015419879	0.004584288	3	6B	IN-SST	30	9	9
CTGCTGTGTTGGTAAA-1_371G_A3D3	29.62638587	14.94412987	14	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1105	1863	0.002683843	0.176060118	3	14	Microglia	30	9	9
CTGCTGTTCAGAAATG-1_371G_A3D3	32.88265817	-16.76075058	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5365	13795	0.013555636	0.016237767	3	2	EN-L4	30	9	9
CTGGTCTAGAACAACT-1_371G_A3D3	-30.74187442	-0.890322216	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1644	2839	0.001408947	0.007396971	3	9	OPC	30	9	9
CTGGTCTAGAGTGAGA-1_371G_A3D3	5.398544035	-20.18148083	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4875	13477	0.000667804	0.006826445	3	L2-3	EN-L2-3-MS	30	9	9
CTGGTCTCAAGGTTCT-1_371G_A3D3	10.17362755	-27.50812893	10	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	8039	35178	0.001279209	0.004718858	3	L2-3	EN-L2-3-Cntl	30	9	9
CTGGTCTCACGGCTAC-1_371G_A3D3	0.503794919	18.97044356	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	765	1164	0.004295533	0.013745704	3	oligos	OL-Cntl	30	9	9
CTGGTCTCATTACCTT-1_371G_A3D3	-6.668673625	0.401848784	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2048	4410	0.02585034	0.003401361	3	13A	IN-VIP	30	9	9
CTGGTCTTCGTACGGC-1_371G_A3D3	9.244377147	11.4561846	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1110	1843	0.00759631	0.012479653	3	oligos	OL-Cntl	30	9	9
CTGGTCTTCGTCGTTC-1_371G_A3D3	8.85480052	8.604134741	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1453	2597	0.003080477	0.010396611	3	oligos	OL-Cntl	30	9	9
CTGGTCTTCTTCCTTC-1_371G_A3D3	28.65381739	-4.572758629	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5727	21603	0.01032264	0.006202842	3	2	EN-L4	30	9	9
CTGTGCTCAGCTATTG-1_371G_A3D3	36.0196748	-10.45268309	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5215	13077	0.00565879	0.010705819	3	2	EN-L4	30	9	9
CTGTGCTGTTGATTCG-1_371G_A3D3	-12.04026555	12.8340268	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1077	1613	0.003099814	0.00433974	3	8	Astrocytes	30	9	9
CTGTGCTTCGACCAGC-1_371G_A3D3	14.42821882	-20.70651325	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	7096	23469	0.010993225	0.006348801	3	L2-3	EN-L2-3-MS	30	9	9
CTGTGCTTCGTCTGCT-1_371G_A3D3	-1.522816792	16.99230019	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	745	1051	0.009514748	0.014272122	3	oligos	OL-Cntl	30	9	9
CTGTGCTTCTACTTAC-1_371G_A3D3	10.92035903	7.357844727	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1437	2244	0.001782531	0.018716578	3	oligos	OL-Cntl	30	9	9
CTGTGCTTCTCCTATA-1_371G_A3D3	6.687766132	-21.04600354	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	6808	22802	0.004166301	0.004297869	3	L2-3	EN-L2-3-MS	30	9	9
CTGTTTAAGAAACGCC-1_371G_A3D3	1.825766607	19.95104576	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	807	1221	0.001638002	0.00982801	3	oligos	OL-Cntl	30	9	9
CTGTTTAAGGTGCTTT-1_371G_A3D3	-12.37958227	16.45274101	11	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1520	2396	0.002086811	0.008764608	3	11	Glia-MIX	30	9	9
CTGTTTACACGCTTTC-1_371G_A3D3	36.02116886	-8.542514902	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5042	13048	0.001226242	0.008507051	3	2	EN-L4	30	9	9
CTGTTTACAGACAAGC-1_371G_A3D3	3.043515779	14.7860005	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1085	1753	0.001711352	0.014261266	3	oligos	OL-Cntl	30	9	9
CTGTTTACAGTTTACG-1_371G_A3D3	-11.57215568	-18.46385001	6B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	969	1417	0.00564573	0.004940014	3	6B	IN-SST	30	9	9
CTGTTTAGTGCAACGA-1_371G_A3D3	-0.539829392	15.18326656	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	794	1162	0.000860585	0.013769363	3	oligos	OL-Cntl	30	9	9
CTGTTTATCATGCAAC-1_371G_A3D3	-22.84172804	-19.45148296	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3057	6442	0.007451102	0.006519714	3	6A	IN-PV	30	9	9
CTGTTTATCCGTTGTC-1_371G_A3D3	3.05120444	14.24883011	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	929	1372	0.002915452	0.016034985	3	oligos	OL-Cntl	30	9	9
CTGTTTATCCTTCAAT-1_371G_A3D3	-3.702421112	-17.95634216	10	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2907	6640	0.002108434	0.007981928	3	L2-3	EN-L2-3-Cntl	30	9	9
CTTAACTAGCCAGAAC-1_371G_A3D3	-30.0705559	-0.573854453	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1696	2831	0	0.007064641	3	9	OPC	30	9	9
CTTAACTAGGTAAACT-1_371G_A3D3	14.52509752	10.20478005	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1439	2491	0.000401445	0.006423123	3	oligos	OL-Cntl	30	9	9
CTTAACTCACCGCTAG-1_371G_A3D3	-35.45042288	1.180414751	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1698	3116	0.000320924	0.005134788	3	9	OPC	30	9	9
CTTAACTCATGTAAGA-1_371G_A3D3	-18.8697722	24.62191279	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1561	2631	0.001140251	0.003800836	3	8	Astrocytes	30	9	9
CTTAACTTCCAGTATG-1_371G_A3D3	-16.76780996	14.46411249	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1517	2903	0.003100241	0.000688942	3	8	Astrocytes	30	9	9
CTTAACTTCGACAGCC-1_371G_A3D3	9.669410959	-23.37010005	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5988	18749	0.001973439	0.005973652	3	L2-3	EN-L2-3-MS	30	9	9
CTTACCGAGAAACGAG-1_371G_A3D3	10.2870443	19.38129783	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1024	1670	0.007784431	0.004790419	3	oligos	OL-Cntl	30	9	9
CTTACCGCAATGACCT-1_371G_A3D3	35.94537837	-11.0591235	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5252	13340	0.005097451	0.010269865	3	2	EN-L4	30	9	9
CTTACCGCAGTGAGTG-1_371G_A3D3	-16.03798217	1.804340689	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4053	8849	0.003616228	0.012204769	3	13A	IN-VIP	30	9	9
CTTACCGGTCAGAATA-1_371G_A3D3	-19.62082524	27.99345611	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2277	4642	0.001077122	0.003662215	3	8	Astrocytes	30	9	9
CTTAGGACATTCCTCG-1_371G_A3D3	-33.88821631	-0.437542081	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1595	2724	0.004038179	0.010646109	3	9	OPC	30	9	9
CTTCTCTAGAGTAAGG-1_371G_A3D3	-32.76201794	-3.497810412	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1345	2186	0.000457457	0.0105215	3	9	OPC	30	9	9
CTTCTCTAGCGATATA-1_371G_A3D3	-29.94186341	0.225008632	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1779	3099	0.001290739	0.007744434	3	9	OPC	30	9	9
CTTCTCTTCCGCGGTA-1_371G_A3D3	2.005976118	12.57377762	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1041	1664	0.006610577	0.013822115	3	oligos	OL-Cntl	30	9	9
CTTCTCTTCGGTTAAC-1_371G_A3D3	-14.32987981	-21.40687664	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1463	2760	0.010869565	0.002173913	3	6A	IN-PV	30	9	9
CTTCTCTTCTTGTATC-1_371G_A3D3	5.076259707	-19.49048418	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4073	10707	0.002054731	0.004856636	3	L2-3	EN-L2-3-MS	30	9	9
CTTGGCTAGACAATAC-1_371G_A3D3	5.236869484	-20.17193386	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4708	12045	0.002739726	0.007804068	3	L2-3	EN-L2-3-MS	30	9	9
CTTGGCTCAATAGCAA-1_371G_A3D3	-2.934984927	16.23416422	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	736	1058	0.004725898	0.019848771	3	oligos	OL-Cntl	30	9	9
CTTGGCTGTCTCTCGT-1_371G_A3D3	-1.338726293	15.07316482	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	790	1179	0.000848176	0.016963528	3	oligos	OL-Cntl	30	9	9
CTTGGCTGTTACTGAC-1_371G_A3D3	11.38122193	13.0328364	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1283	2353	0.006374841	0.002549936	3	oligos	OL-Cntl	30	9	9
CTTGGCTTCCGTCATC-1_371G_A3D3	-17.3710258	1.432561085	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4173	8908	0.008756174	0.016726538	3	13A	IN-VIP	30	9	9
CTTTGCGCAAGTCTGT-1_371G_A3D3	14.37454017	10.92472238	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1332	2110	0.007582938	0.005687204	3	oligos	OL-Cntl	30	9	9
CTTTGCGCAATGAAAC-1_371G_A3D3	-34.16622378	2.118942272	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1924	3889	0.002828491	0.005656981	3	9	OPC	30	9	9
CTTTGCGCACAGACTT-1_371G_A3D3	-33.88281364	3.005345669	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2088	4247	0.00023546	0.004473746	3	9	OPC	30	9	9
CTTTGCGCACATTCGA-1_371G_A3D3	-30.87660772	2.17916504	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2095	3922	0.002039776	0.005609383	3	9	OPC	30	9	9
CTTTGCGCAGTAAGAT-1_371G_A3D3	-24.36562994	-23.93277832	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3612	8165	0.042620943	0.007348438	3	6A	IN-PV	30	9	9
GAAACTCAGTGTTTGC-1_371G_A3D3	36.02350265	-11.95111229	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5204	13541	0.009822022	0.014253009	3	2	EN-L4	30	9	9
GAAACTCCAAGACGTG-1_371G_A3D3	-15.80190995	1.156388038	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3209	6290	0.004292528	0.011605723	3	13A	IN-VIP	30	9	9
GAAACTCCACGCCAGT-1_371G_A3D3	36.04507745	-12.15484454	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5720	15594	0.011607028	0.012440682	3	2	EN-L4	30	9	9
GAAACTCCAGTATAAG-1_371G_A3D3	25.4340752	-9.744795555	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	6313	18642	0.007778135	0.005632443	3	2	EN-L4	30	9	9
GAAACTCGTCATCCCT-1_371G_A3D3	8.838810139	10.30659538	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1166	1957	0.003065917	0.009708738	3	oligos	OL-Cntl	30	9	9
GAAACTCGTGGGTATG-1_371G_A3D3	11.43972724	8.307627377	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1388	2312	0.001730104	0.015138408	3	oligos	OL-Cntl	30	9	9
GAAACTCGTTGTGGAG-1_371G_A3D3	-14.9866331	-9.615005572	13B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2354	4705	0.012539851	0.004463337	3	13B	IN-SV2C	30	9	9
GAAACTCTCAACGGGA-1_371G_A3D3	-15.09959015	-18.72590103	6B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1622	2731	0.00292933	0.00292933	3	6B	IN-SST	30	9	9
GAAACTCTCCAGAAGG-1_371G_A3D3	-24.87392449	0.151325846	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2488	4722	0.002117747	0.007835663	3	9	OPC	30	9	9
GAAACTCTCCTAGTGA-1_371G_A3D3	-28.94562771	0.087255238	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1759	2767	0.000722804	0.008673654	3	9	OPC	30	9	9
GAAACTCTCTGTCAAG-1_371G_A3D3	-15.05852767	-18.42806666	6B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1511	2612	0.004594181	0.006891271	3	6B	IN-SST	30	9	9
GAAATGAAGCTAACTC-1_371G_A3D3	-24.06937905	21.56554587	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1255	2100	0.001428571	0.003333333	3	8	Astrocytes	30	9	9
GAAATGACACGGTAGA-1_371G_A3D3	-3.788882698	14.37235684	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	737	1046	0.004780115	0.021988528	3	oligos	OL-Cntl	30	9	9
GAAATGACACTGAAGG-1_371G_A3D3	-28.69937878	1.283594648	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2186	3741	0.014167335	0.016573109	3	9	OPC	30	9	9
GAAATGACAGTAAGCG-1_371G_A3D3	-25.20031525	0.819604698	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2884	6075	0.000329218	0.015967078	3	9	OPC	30	9	9
GAAATGACATTGAGCT-1_371G_A3D3	-22.92526509	24.47850126	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1621	2918	0.001028101	0.002056203	3	8	Astrocytes	30	9	9
GAAATGAGTCTCGTTC-1_371G_A3D3	-15.30617593	1.40363425	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3598	7519	0.005851842	0.012102673	3	13A	IN-VIP	30	9	9
GAAATGAGTTATCCGA-1_371G_A3D3	-16.51792978	-18.95692606	6B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1902	3801	0.002367798	0.003157064	3	6B	IN-SST	30	9	9
GAAATGATCAGCTCGG-1_371G_A3D3	10.82291228	12.58302869	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1184	1893	0.004226096	0.011621764	3	oligos	OL-Cntl	30	9	9
GAACATCAGCTATGCT-1_371G_A3D3	8.004002853	10.1122264	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1060	1699	0.001177163	0.00765156	3	oligos	OL-Cntl	30	9	9
GAACATCAGGACAGAA-1_371G_A3D3	-16.38669566	15.74994443	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1978	3619	0.002210555	0.004144791	3	8	Astrocytes	30	9	9
GAACATCCACCATGTA-1_371G_A3D3	13.11660534	-33.90066649	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5450	19391	0.002165953	0.004383477	3	2	EN-L4	30	9	9
GAACATCCATCCGCGA-1_371G_A3D3	11.48439769	7.307542422	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1674	2885	0.003812825	0.011438475	3	oligos	OL-Cntl	30	9	9
GAACATCGTCCCTTGT-1_371G_A3D3	-23.81276724	1.182031703	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3864	8834	0.001811184	0.009395517	3	9	OPC	30	9	9
GAACATCTCAGCGACC-1_371G_A3D3	15.51083704	9.961780763	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1441	2474	0.002425222	0.007679871	3	oligos	OL-Cntl	30	9	9
GAACATCTCCAAGTAC-1_371G_A3D3	-8.548336693	-17.20995609	6B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	743	1104	0.067028986	0.000905797	3	6B	IN-SST	30	9	9
GAACCTAAGCTAGTCT-1_371G_A3D3	-0.281379725	18.07163675	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	825	1272	0.003144654	0.006289308	3	oligos	OL-Cntl	30	9	9
GAACCTAAGGCGATAC-1_371G_A3D3	-16.82038198	1.516521098	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3887	7906	0.000885403	0.015937263	3	13A	IN-VIP	30	9	9
GAACCTAAGTTCCACA-1_371G_A3D3	-23.43423744	-25.72999782	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4603	12369	0.000646778	0.005093379	3	6A	IN-PV	30	9	9
GAACCTACAATGGACG-1_371G_A3D3	11.99758252	6.029470676	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2093	3756	0.004526092	0.016240682	3	oligos	OL-Cntl	30	9	9
GAACCTAGTCCGTGAC-1_371G_A3D3	-0.448011186	15.76155586	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	809	1143	0	0.012248469	3	oligos	OL-Cntl	30	9	9
GAACCTAGTCTGATCA-1_371G_A3D3	-30.31275051	1.437138597	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1995	3403	0.002938584	0.00528945	3	9	OPC	30	9	9
GAACCTAGTCTGCAAT-1_371G_A3D3	16.52679341	9.445380388	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1514	2712	0.001474926	0.008112094	3	oligos	OL-Cntl	30	9	9
GAACCTAGTGTTAAGA-1_371G_A3D3	-30.75153917	9.89983304	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	901	1339	0.006721434	0.008215086	3	8	Astrocytes	30	9	9
GAACCTATCAAACGGG-1_371G_A3D3	10.06149438	13.86173615	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1114	1830	0.002185792	0.006557377	3	oligos	OL-Cntl	30	9	9
GAACCTATCAAGGTAA-1_371G_A3D3	-2.454397403	16.43949053	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	791	1177	0	0.013593883	3	oligos	OL-Cntl	30	9	9
GAACCTATCGCAGGCT-1_371G_A3D3	-13.0553871	-17.56673274	6B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1121	1757	0.030734206	0.007398976	3	6B	IN-SST	30	9	9
GAACCTATCTTTAGTC-1_371G_A3D3	-18.65914987	0.659137725	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5595	14366	0.005359877	0.01677572	3	13A	IN-VIP	30	9	9
GAACGGAAGTAGTGCG-1_371G_A3D3	-16.60658536	0.37292989	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4528	9461	0.012155163	0.009301342	3	13A	IN-VIP	30	9	9
GAACGGAAGTTAGCGG-1_371G_A3D3	-19.16278263	28.86414581	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2289	4188	0.002148997	0.003820439	3	8	Astrocytes	30	9	9
GAACGGAGTGGTCTCG-1_371G_A3D3	-14.27283541	1.219581061	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3584	7547	0.002517557	0.008347688	3	13A	IN-VIP	30	9	9
GAACGGATCAGCGACC-1_371G_A3D3	6.143451116	6.02925882	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2429	4520	0.002433628	0.031637168	3	oligos	OL-Cntl	30	9	9
GAACGGATCATCTGCC-1_371G_A3D3	11.01127454	-26.88622384	10	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	7397	30371	0.007046195	0.00589378	3	L2-3	EN-L2-3-Cntl	30	9	9
GAACGGATCCGCATAA-1_371G_A3D3	-20.42835652	-6.852031417	13B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5128	13164	0.001671225	0.009495594	3	13B	IN-SV2C	30	9	9
GAACGGATCTGCTTGC-1_371G_A3D3	22.38856779	-6.669896355	3	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2139	4010	0.003990025	0.002743142	3	3	EN-L5-6	30	9	9
GAACGGATCTTAACCT-1_371G_A3D3	-11.99223256	-10.18445055	13B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1628	2736	0.043859649	0.002923977	3	13B	IN-SV2C	30	9	9
GAACGGATCTTGCCGT-1_371G_A3D3	-8.541940949	-14.85073671	6B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	955	1293	0.046403712	0.011600928	3	6B	IN-SST	30	9	9
GAAGCAGAGGATTCGG-1_371G_A3D3	-17.18995508	1.530077476	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4367	9365	0.012920448	0.013454351	3	13A	IN-VIP	30	9	9
GAAGCAGAGTATTGGA-1_371G_A3D3	-18.98120842	28.26473701	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2285	4245	0.004004711	0.004711425	3	8	Astrocytes	30	9	9
GAAGCAGAGTTGTCGT-1_371G_A3D3	-23.1189504	-18.64053877	6B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2712	5073	0.013798541	0.013404297	3	6B	IN-SST	30	9	9
GAAGCAGCACAACGTT-1_371G_A3D3	7.970717725	-17.92620544	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4322	10492	0.005051468	0.012962257	3	L2-3	EN-L2-3-MS	30	9	9
GAAGCAGCATTGAGCT-1_371G_A3D3	8.58962178	15.80639591	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	980	1527	0.007203667	0.003274394	3	oligos	OL-Cntl	30	9	9
GAAGCAGTCCAAACTG-1_371G_A3D3	-25.44114995	11.62536062	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1010	1404	0.007122507	0.006410256	3	8	Astrocytes	30	9	9
GAAGCAGTCGACGGAA-1_371G_A3D3	-6.341673367	10.35230621	5	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	770	1083	0.012927054	0.020313943	3	oligos	OL-MS-1	30	9	9
GAAGCAGTCGATCCCT-1_371G_A3D3	18.40930431	23.88092559	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	957	1478	0.00135318	0.00338295	3	oligos	OL-Cntl	30	9	9
GAAGCAGTCTTAGAGC-1_371G_A3D3	-18.303253	-10.01443978	13B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3586	7992	0.006006006	0.007507508	3	13B	IN-SV2C	30	9	9
GAATAAGAGGTGCTAG-1_371G_A3D3	4.928470695	-17.77652006	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3447	7592	0.002239199	0.006849315	3	L2-3	EN-L2-3-MS	30	9	9
GAATAAGCAACTTGAC-1_371G_A3D3	16.05427853	6.508632842	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2096	4101	0.00658376	0.006827603	3	oligos	OL-Cntl	30	9	9
GAATAAGTCAATCTCT-1_371G_A3D3	-21.78889521	-27.26487914	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3599	8694	0.00126524	0.005060962	3	6A	IN-PV	30	9	9
GAATGAAAGACAATAC-1_371G_A3D3	-9.203401291	17.32193729	11	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3139	6157	0.004222836	0.011206757	3	11	Glia-MIX	30	9	9
GAATGAAAGTACACCT-1_371G_A3D3	16.76358495	5.87261094	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2440	5366	0.000186359	0.005777115	3	oligos	OL-Cntl	30	9	9
GAATGAAGTCTTCTCG-1_371G_A3D3	-34.72494954	0.733622009	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1733	3339	0.001197963	0.004192872	3	9	OPC	30	9	9
GAATGAATCGTCCGTT-1_371G_A3D3	7.999387489	-10.37882935	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2638	5881	0.005101173	0.006291447	3	L2-3	EN-L2-3-MS	30	9	9
GACACGCAGATCCTGT-1_371G_A3D3	20.80620781	-26.9384098	3	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5270	17458	0.006759079	0.00526979	3	3	EN-L5-6	30	9	9
GACACGCAGCACCGCT-1_371G_A3D3	-1.010109964	19.65032042	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	837	1198	0.016694491	0.005843072	3	oligos	OL-Cntl	30	9	9
GACACGCCAAGAGTCG-1_371G_A3D3	22.62570584	0.9249928	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1814	3134	0.026483727	0.004467135	3	2	EN-L4	30	9	9
GACACGCCAGGTCCAC-1_371G_A3D3	36.0136314	-11.00856358	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	6231	17572	0.004211245	0.011780105	3	2	EN-L4	30	9	9
GACACGCGTCTCCCTA-1_371G_A3D3	-20.52175489	-6.408248817	13B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5330	14506	0.00916862	0.009030746	3	13B	IN-SV2C	30	9	9
GACACGCGTGCAGACA-1_371G_A3D3	-33.16578554	5.324636114	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3624	7839	0.003061615	0.003061615	3	9	OPC	30	9	9
GACACGCGTGCATCTA-1_371G_A3D3	3.70246226	9.231213717	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1386	2365	0.005073996	0.022410148	3	oligos	OL-Cntl	30	9	9
GACACGCTCGTCACGG-1_371G_A3D3	-28.49690218	20.50417956	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1090	1768	0.004524887	0.003959276	3	8	Astrocytes	30	9	9
GACAGAGAGTGCCAGA-1_371G_A3D3	12.89420487	-2.089400625	12	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1437	2547	0.015312132	0.007067138	3	12	EN-MIX	30	9	9
GACAGAGCATGAGCGA-1_371G_A3D3	-2.542984543	14.27938863	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	762	1085	0.003686636	0.023963134	3	oligos	OL-Cntl	30	9	9
GACAGAGCATGTAAGA-1_371G_A3D3	31.66475255	-12.62107583	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3604	7899	0.036333713	0.011140651	3	2	EN-L4	30	9	9
GACAGAGGTAGTACCT-1_371G_A3D3	6.842825694	-18.69576337	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4226	9755	0.003895438	0.012198872	3	L2-3	EN-L2-3-MS	30	9	9
GACAGAGTCAATACCG-1_371G_A3D3	5.168724262	12.29054342	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1012	1556	0.000642674	0.020565553	3	oligos	OL-Cntl	30	9	9
GACAGAGTCATGCTCC-1_371G_A3D3	-30.80794412	2.342595952	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2312	4114	0.002916869	0.003646087	3	9	OPC	30	9	9
GACCAATCACAAGCCC-1_371G_A3D3	4.867216521	-20.95943648	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	6309	20184	0.000891795	0.005697582	3	L2-3	EN-L2-3-MS	30	9	9
GACCAATCAGGTGGAT-1_371G_A3D3	9.24713967	-0.714524279	12	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1280	2030	0.012807882	0.01182266	3	12	EN-MIX	30	9	9
GACCAATGTAAGTTCC-1_371G_A3D3	1.785858994	-31.29023947	10	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5751	22908	0.002313602	0.002095338	3	L2-3	EN-L2-3-Cntl	30	9	9
GACCAATTCGGATGTT-1_371G_A3D3	-19.35678253	26.59709179	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1876	3204	0.00062422	0.004681648	3	8	Astrocytes	30	9	9
GACCTGGAGGCATTGG-1_371G_A3D3	10.72575182	-27.48217185	10	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	7230	28513	0.001473012	0.006137551	3	L2-3	EN-L2-3-Cntl	30	9	9
GACCTGGAGTACATGA-1_371G_A3D3	0.35465697	16.96271303	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	890	1275	0	0.004705882	3	oligos	OL-Cntl	30	9	9
GACCTGGCAAGTTCTG-1_371G_A3D3	5.811245955	-18.93870504	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4144	9579	0.00104395	0.006368097	3	L2-3	EN-L2-3-MS	30	9	9
GACCTGGCACCAGATT-1_371G_A3D3	12.80669724	-25.69009102	3	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	8399	33267	0.004508973	0.012084047	3	3	EN-L5-6	30	9	9
GACCTGGCATTGGCGC-1_371G_A3D3	4.136668145	15.74626844	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	902	1439	0.002779708	0.009728978	3	oligos	OL-Cntl	30	9	9
GACCTGGGTCCATCCT-1_371G_A3D3	-3.353092732	15.24324154	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	709	1024	0.005859375	0.010742188	3	oligos	OL-Cntl	30	9	9
GACCTGGGTGTTTGGT-1_371G_A3D3	-19.09169124	30.04261362	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2860	5826	0.000514933	0.00394782	3	8	Astrocytes	30	9	9
GACGCGTAGCCATCGC-1_371G_A3D3	34.93952263	-9.307206295	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5584	14782	0.004938439	0.012582871	3	2	EN-L4	30	9	9
GACGCGTAGCTTCGCG-1_371G_A3D3	-22.6714638	-8.392895071	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2487	4108	0.029211295	0.016796495	3	9	OPC	30	9	9
GACGCGTCACAGGCCT-1_371G_A3D3	1.030142979	20.7564363	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	701	1069	0.000935454	0.005612722	3	oligos	OL-Cntl	30	9	9
GACGCGTGTCAGAAGC-1_371G_A3D3	35.51606971	15.40737296	14	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1340	2136	0.000468165	0.01170412	3	14	Microglia	30	9	9
GACGCGTGTTATTCTC-1_371G_A3D3	0.0781212	19.60249514	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	719	1096	0.003649635	0.005474453	3	oligos	OL-Cntl	30	9	9
GACGCGTTCATGTGGT-1_371G_A3D3	-29.93372591	0.358727024	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1797	3031	0.002309469	0.005278786	3	9	OPC	30	9	9
GACGCGTTCCGGGTGT-1_371G_A3D3	16.06124818	6.18098767	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2063	3905	0.003841229	0.009475032	3	oligos	OL-Cntl	30	9	9
GACGCGTTCGAACTGT-1_371G_A3D3	-0.255028511	16.117717	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	853	1285	0.00077821	0.012451362	3	oligos	OL-Cntl	30	9	9
GACGGCTCAGCCAGAA-1_371G_A3D3	-26.67025969	11.01623583	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	821	1222	0	0.004091653	3	8	Astrocytes	30	9	9
GACGGCTCAGTGAGTG-1_371G_A3D3	9.769301744	-24.19790907	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5714	16377	0.003785797	0.004213226	3	L2-3	EN-L2-3-MS	30	9	9
GACGGCTCATGATCCA-1_371G_A3D3	28.45809781	-3.668292761	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3430	8432	0.001067362	0.00509962	3	2	EN-L4	30	9	9
GACGGCTGTCCCGACA-1_371G_A3D3	8.648372261	16.05855972	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	917	1486	0.003364738	0.010094213	3	oligos	OL-Cntl	30	9	9
GACGGCTGTCGGCATC-1_371G_A3D3	30.65563681	-2.879757541	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3000	6828	0.014499121	0.003075571	3	2	EN-L4	30	9	9
GACGGCTGTTGTCGCG-1_371G_A3D3	10.95326706	-27.82486357	10	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	6574	20670	0.002999516	0.006676343	3	L2-3	EN-L2-3-Cntl	30	9	9
GACGGCTTCCTGTAGA-1_371G_A3D3	3.844481941	9.703116528	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1136	1680	0.001785714	0.016666667	3	oligos	OL-Cntl	30	9	9
GACGGCTTCGTATCAG-1_371G_A3D3	24.29257918	-11.10626901	3	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5079	12463	0.0006419	0.007943513	3	3	EN-L5-6	30	9	9
GACGTGCAGAGCTTCT-1_371G_A3D3	6.199395795	-19.41734176	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4463	10642	0.005825973	0.007141515	3	L2-3	EN-L2-3-MS	30	9	9
GACGTGCGTGGCTCCA-1_371G_A3D3	-25.65399906	12.19874662	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	951	1373	0.005826657	0.005098325	3	8	Astrocytes	30	9	9
GACGTTAAGATGGGTC-1_371G_A3D3	-15.61399927	1.098695942	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3674	7531	0.006904794	0.010755544	3	13A	IN-VIP	30	9	9
GACGTTAAGCTCCTCT-1_371G_A3D3	-28.93885007	0.723316515	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2042	3528	0.001133787	0.008503401	3	9	OPC	30	9	9
GACGTTAGTCAATACC-1_371G_A3D3	-19.03024325	29.99236869	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2576	4944	0.000809061	0.004449838	3	8	Astrocytes	30	9	9
GACGTTAGTCAGAGGT-1_371G_A3D3	0.92639612	13.40976146	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1077	1604	0.001870324	0.016832918	3	oligos	OL-Cntl	30	9	9
GACGTTATCAGGATCT-1_371G_A3D3	-30.6456537	1.343224049	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2191	3919	0.004337841	0.006634345	3	9	OPC	30	9	9
GACTAACAGGCTAGCA-1_371G_A3D3	12.28096488	6.726975457	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1855	3294	0.006071645	0.010928962	3	oligos	OL-Cntl	30	9	9
GACTAACAGGCTATCT-1_371G_A3D3	-21.24239656	7.607393415	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	898	1267	0.003157064	0.006314128	3	8	Astrocytes	30	9	9
GACTAACAGTGGAGAA-1_371G_A3D3	4.241182434	10.67991979	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1193	1876	0.004797441	0.014925373	3	oligos	OL-Cntl	30	9	9
GACTAACCACACTGCG-1_371G_A3D3	36.13245386	-7.800896709	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4904	12748	0.000392218	0.007452149	3	2	EN-L4	30	9	9
GACTAACGTCCCTTGT-1_371G_A3D3	24.04965423	7.96797603	15DA	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	6290	14172	7.06E-05	0.029212532	3	15DA	T cells	30	9	9
GACTAACGTTGCCTCT-1_371G_A3D3	-22.89005463	-26.46154861	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4580	12626	0.004039284	0.006019325	3	6A	IN-PV	30	9	9
GACTAACTCTTGAGGT-1_371G_A3D3	-0.323257835	16.51139027	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	791	1150	0.000869565	0.006086957	3	oligos	OL-Cntl	30	9	9
GACTACAAGACTAGGC-1_371G_A3D3	-31.30771875	-4.618123385	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1278	2109	0.001422475	0.007112376	3	9	OPC	30	9	9
GACTACACAAGACACG-1_371G_A3D3	-2.628076942	14.61309279	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	762	1057	0.002838221	0.014191107	3	oligos	OL-Cntl	30	9	9
GACTACACAATCACAC-1_371G_A3D3	-2.884296023	-0.890376262	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3587	8535	0.003749268	0.005975395	3	13A	IN-VIP	30	9	9
GACTACACATCACAAC-1_371G_A3D3	-18.57341154	29.52075239	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2751	5750	0.000695652	0.005217391	3	8	Astrocytes	30	9	9
GACTACAGTAAACACA-1_371G_A3D3	-13.51924686	1.951114059	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4985	13358	0.004117383	0.007635874	3	13A	IN-VIP	30	9	9
GACTACAGTTAGATGA-1_371G_A3D3	22.0096496	-25.99837019	3	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4128	10428	0.011891063	0.00575374	3	3	EN-L5-6	30	9	9
GACTACATCGACAGCC-1_371G_A3D3	-29.88719176	1.497050339	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2120	3730	0.005093834	0.008310992	3	9	OPC	30	9	9
GACTACATCGGTCCGA-1_371G_A3D3	24.30945132	-11.1777834	3	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5781	16866	0.004328234	0.010020159	3	3	EN-L5-6	30	9	9
GACTGCGCAAAGCGGT-1_371G_A3D3	6.647325351	21.50112782	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	948	1373	0.01019665	0.005098325	3	oligos	OL-Cntl	30	9	9
GACTGCGCAGTAAGCG-1_371G_A3D3	-18.11555507	-10.20683929	13B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4298	10853	0.002856353	0.008200498	3	13B	IN-SV2C	30	9	9
GACTGCGCAGTGAGTG-1_371G_A3D3	10.19248009	-24.13336227	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	7408	26796	0.004030452	0.005560531	3	L2-3	EN-L2-3-MS	30	9	9
GACTGCGGTACAAGTA-1_371G_A3D3	12.69386042	8.44877999	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1568	2725	0.001100917	0.008073394	3	oligos	OL-Cntl	30	9	9
GACTGCGGTGGTCCGT-1_371G_A3D3	1.799693777	16.06019011	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	919	1463	0.003417635	0.004784689	3	oligos	OL-Cntl	30	9	9
GACTGCGTCAGCACAT-1_371G_A3D3	-21.56359981	-26.49928237	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2964	6875	0.009890909	0.004363636	3	6A	IN-PV	30	9	9
GACTGCGTCGCTTAGA-1_371G_A3D3	-30.07246325	0.2541961	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1845	2949	0.001017294	0.01525941	3	9	OPC	30	9	9
GAGCAGAAGAGGTACC-1_371G_A3D3	-1.239775176	17.91389116	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	839	1195	0.012552301	0.008368201	3	oligos	OL-Cntl	30	9	9
GAGCAGAAGGCTAGAC-1_371G_A3D3	-12.66865045	-0.805410081	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2755	5290	0.01020794	0.008128544	3	13A	IN-VIP	30	9	9
GAGCAGAAGGGCTTGA-1_371G_A3D3	11.97983496	8.769275437	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1430	2504	0.002396166	0.01158147	3	oligos	OL-Cntl	30	9	9
GAGCAGACACACCGAC-1_371G_A3D3	-1.990081306	16.54419735	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	739	1030	0.011650485	0.013592233	3	oligos	OL-Cntl	30	9	9
GAGCAGACAGACGCAA-1_371G_A3D3	12.6092313	9.633526627	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1381	2212	0.001356239	0.014466546	3	oligos	OL-Cntl	30	9	9
GAGCAGAGTAAGGGCT-1_371G_A3D3	-0.743341077	16.86927246	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	787	1229	0	0.013018714	3	oligos	OL-Cntl	30	9	9
GAGCAGAGTGATGCCC-1_371G_A3D3	-16.36059119	1.3745351	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3916	8421	0.006175039	0.017100107	3	13A	IN-VIP	30	9	9
GAGCAGATCACTCCTG-1_371G_A3D3	-23.56369188	-25.42642718	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4064	10465	0.008982322	0.011466794	3	6A	IN-PV	30	9	9
GAGCAGATCAGTCCCT-1_371G_A3D3	29.35529708	-0.068321796	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3591	8973	0.001671682	0.0036777	3	2	EN-L4	30	9	9
GAGCAGATCGTAGGAG-1_371G_A3D3	-29.61391879	-0.590996881	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1541	2468	0.000810373	0.012965964	3	9	OPC	30	9	9
GAGCAGATCTGCTTGC-1_371G_A3D3	-38.57771223	-0.323540769	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1540	2810	0.001423488	0.002846975	3	9	OPC	30	9	9
GAGCAGATCTTGACGA-1_371G_A3D3	-2.837070491	16.18197406	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	728	1004	0.001992032	0.012948207	3	oligos	OL-Cntl	30	9	9
GAGGTGAAGATGGCGT-1_371G_A3D3	6.694283502	-18.35152666	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3830	8137	0.003195281	0.016099299	3	L2-3	EN-L2-3-MS	30	9	9
GAGGTGAAGATGTGTA-1_371G_A3D3	-32.54277707	-8.512493678	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	978	1532	0.007180157	0.00848564	3	9	OPC	30	9	9
GAGGTGAAGCGTTGCC-1_371G_A3D3	-2.365526157	14.98327691	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	746	1060	0.009433962	0.01509434	3	oligos	OL-Cntl	30	9	9
GAGGTGAAGCTACCGC-1_371G_A3D3	-3.353123239	-6.306376803	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	994	1596	0.006265664	0.005639098	3	13A	IN-VIP	30	9	9
GAGGTGAAGGAATCGC-1_371G_A3D3	33.782098	-7.734784529	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	7063	20775	0.003080626	0.007797834	3	2	EN-L4	30	9	9
GAGGTGAAGGCCGAAT-1_371G_A3D3	-2.864182299	15.73967191	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	766	1125	0	0.018666667	3	oligos	OL-Cntl	30	9	9
GAGGTGAAGTAACCCT-1_371G_A3D3	9.579250687	8.417847167	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1418	2320	0.004310345	0.017241379	3	oligos	OL-Cntl	30	9	9
GAGGTGAAGTGGAGTC-1_371G_A3D3	9.361850508	9.839810847	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1293	1910	0.001570681	0.008900524	3	oligos	OL-Cntl	30	9	9
GAGGTGAGTAGGAGTC-1_371G_A3D3	35.94148245	-8.731456979	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5406	14100	0.002340426	0.007375887	3	2	EN-L4	30	9	9
GAGGTGAGTCTCCACT-1_371G_A3D3	-18.24149841	-10.06802716	13B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3733	8559	0.009113214	0.00654282	3	13B	IN-SV2C	30	9	9
GAGGTGAGTTCCGTCT-1_371G_A3D3	-13.88632032	-21.18772121	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1263	2134	0.016869728	0.005623243	3	6A	IN-PV	30	9	9
GAGGTGATCGAACGGA-1_371G_A3D3	-28.02884116	0.18906686	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1897	2906	0.001720578	0.014108741	3	9	OPC	30	9	9
GAGTCCGAGTGAATTG-1_371G_A3D3	8.249155368	16.23891173	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	974	1523	0.001313198	0.005252791	3	oligos	OL-Cntl	30	9	9
GAGTCCGCATTCTTAC-1_371G_A3D3	38.36727164	13.49798507	14	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1090	1618	0.009270705	0.008034611	3	14	Microglia	30	9	9
GAGTCCGGTCCAAGTT-1_371G_A3D3	13.26919945	-24.24133858	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	7675	27192	0.011032657	0.005773757	3	L2-3	EN-L2-3-MS	30	9	9
GAGTCCGTCCTGCAGG-1_371G_A3D3	3.767878964	-2.572378709	12	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	819	1117	0.047448523	0.006266786	3	12	EN-MIX	30	9	9
GATCAGTAGAGTCTGG-1_371G_A3D3	1.567387707	17.33636948	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	862	1353	0.001478197	0.008130081	3	oligos	OL-Cntl	30	9	9
GATCAGTCACATGACT-1_371G_A3D3	-29.03380691	1.709850204	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2436	4700	0.000425532	0.01212766	3	9	OPC	30	9	9
GATCAGTCAGTTTACG-1_371G_A3D3	7.632111412	9.907126476	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1231	2085	0.004796163	0.012470024	3	oligos	OL-Cntl	30	9	9
GATCAGTGTCAGGACA-1_371G_A3D3	0.572624959	13.52466575	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1055	1637	0.003054368	0.01038485	3	oligos	OL-Cntl	30	9	9
GATCAGTGTCGCTTTC-1_371G_A3D3	-18.49191546	-20.36274033	6B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2337	4684	0.006191289	0.004269855	3	6B	IN-SST	30	9	9
GATCAGTTCAGAAATG-1_371G_A3D3	12.32084266	8.330061698	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1624	2882	0.002428869	0.013185288	3	oligos	OL-Cntl	30	9	9
GATCAGTTCCAAAGTC-1_371G_A3D3	-1.423409009	-1.037547896	11	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2387	4896	0.012663399	0.006740196	3	11	Glia-MIX	30	9	9
GATCGATAGACCCACC-1_371G_A3D3	28.58383396	0.603640465	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2735	5942	0.000673174	0.003029283	3	2	EN-L4	30	9	9
GATCGATGTATCACCA-1_371G_A3D3	1.6905451	20.30430644	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	869	1301	0.002305919	0.011529593	3	oligos	OL-Cntl	30	9	9
GATCGATGTGCGGTAA-1_371G_A3D3	9.108729678	12.88600492	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1043	1711	0.002922268	0.012273524	3	oligos	OL-Cntl	30	9	9
GATCGATTCACGATGT-1_371G_A3D3	0.329376531	13.36951676	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1024	1556	0.003213368	0.013496144	3	oligos	OL-Cntl	30	9	9
GATCGATTCCACTCCA-1_371G_A3D3	3.294797578	-24.05548044	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5287	15067	0.005442357	0.005707838	3	L2-3	EN-L2-3-MS	30	9	9
GATCGATTCGTGGGAA-1_371G_A3D3	1.45482386	13.82731868	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	943	1403	0.000712758	0.009978617	3	oligos	OL-Cntl	30	9	9
GATCGCGCAAGCGATG-1_371G_A3D3	14.1702579	8.498157239	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1647	3021	0.002979146	0.014564714	3	oligos	OL-Cntl	30	9	9
GATCGCGCAGGCGATA-1_371G_A3D3	-28.77328049	0.882201274	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2165	3714	0.005115778	0.012924071	3	9	OPC	30	9	9
GATCGCGCATGGGAAC-1_371G_A3D3	-7.589634618	11.02685494	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	720	1090	0.001834862	0.022018349	3	oligos	OL-Cntl	30	9	9
GATCGCGCATGTCTCC-1_371G_A3D3	-0.294901894	13.70658006	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	976	1537	0.005204945	0.018217306	3	oligos	OL-Cntl	30	9	9
GATCGCGGTTAAGACA-1_371G_A3D3	10.71723004	-27.78022881	10	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	9566	47450	0.00227608	0.005374078	3	L2-3	EN-L2-3-Cntl	30	9	9
GATCGTAAGCCGTCGT-1_371G_A3D3	6.669955122	-20.71525083	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4962	12851	0.004279823	0.007003346	3	L2-3	EN-L2-3-MS	30	9	9
GATCGTAGTCCGAATT-1_371G_A3D3	-5.068631475	29.45698131	11	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1309	2121	0.017916077	0.00990099	3	11	Glia-MIX	30	9	9
GATCTAGAGCCCAACC-1_371G_A3D3	6.651215088	-27.24969515	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4821	13562	0.002654476	0.00420292	3	L2-3	EN-L2-3-MS	30	9	9
GATCTAGAGTCCATAC-1_371G_A3D3	-0.006849239	19.67545802	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	673	1010	0.001980198	0.017821782	3	oligos	OL-Cntl	30	9	9
GATCTAGCAGCGATCC-1_371G_A3D3	8.493562969	15.71697284	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1010	1527	0.005239031	0.013097577	3	oligos	OL-Cntl	30	9	9
GATCTAGGTCGGATCC-1_371G_A3D3	-29.64136123	-5.653476911	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1373	2173	0.003681546	0.013805798	3	9	OPC	30	9	9
GATCTAGGTTAAGACA-1_371G_A3D3	10.63342258	22.75220536	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	792	1156	0	0.002595156	3	oligos	OL-Cntl	30	9	9
GATCTAGTCAAGCCTA-1_371G_A3D3	2.537552233	13.08696684	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	908	1334	0.002248876	0.017241379	3	oligos	OL-Cntl	30	9	9
GATCTAGTCGACAGCC-1_371G_A3D3	3.186334068	-24.14965356	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5072	13581	0.005743318	0.010603048	3	L2-3	EN-L2-3-MS	30	9	9
GATGAAAAGCCGTCGT-1_371G_A3D3	-32.49939598	-13.33730376	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	721	1068	0.014044944	0.009363296	3	9	OPC	30	9	9
GATGAAATCCAAACTG-1_371G_A3D3	-3.322032578	13.82651202	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	852	1186	0.00084317	0.013490725	3	oligos	OL-Cntl	30	9	9
GATGAAATCGTTTGCC-1_371G_A3D3	-1.001625777	14.78484763	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	769	1103	0.00543971	0.019945603	3	oligos	OL-Cntl	30	9	9
GATGAGGAGAAGGTGA-1_371G_A3D3	9.708623228	6.722972656	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1297	2009	0.00149328	0.010452962	3	oligos	OL-Cntl	30	9	9
GATGAGGAGACTACAA-1_371G_A3D3	-27.45439355	4.464931004	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2323	4124	0.001939864	0.004364694	3	8	Astrocytes	30	9	9
GATGAGGGTATTACCG-1_371G_A3D3	-32.88315797	5.289886227	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2826	5306	0.001319261	0.006219374	3	9	OPC	30	9	9
GATGAGGGTGCGATAG-1_371G_A3D3	19.12102858	14.50593147	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1129	1858	0.000538213	0.005382131	3	oligos	OL-Cntl	30	9	9
GATGAGGGTTCCATGA-1_371G_A3D3	-23.90759724	-19.18917792	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3599	7610	0.01826544	0.011432326	3	6A	IN-PV	30	9	9
GATGAGGTCCGCATCT-1_371G_A3D3	-2.631353753	17.17063719	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	777	1114	0.001795332	0.02064632	3	oligos	OL-Cntl	30	9	9
GATGAGGTCCGGGTGT-1_371G_A3D3	6.62636645	9.778120123	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1075	1717	0.002912056	0.009318579	3	oligos	OL-Cntl	30	9	9
GATGAGGTCTAGCACA-1_371G_A3D3	-11.70939554	-18.92345912	6B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1006	1630	0.004907975	0.004907975	3	6B	IN-SST	30	9	9
GATGCTAAGCCAGAAC-1_371G_A3D3	-16.91176317	-10.51192195	13B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3488	8597	0.011166686	0.003722229	3	13B	IN-SV2C	30	9	9
GATGCTACAGATGAGC-1_371G_A3D3	-27.82646141	9.777763647	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	746	1041	0.003842459	0.004803074	3	8	Astrocytes	30	9	9
GATGCTACATACTCTT-1_371G_A3D3	-14.57164176	1.342915387	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4003	9420	0.008492569	0.009766454	3	13A	IN-VIP	30	9	9
GATGCTACATATACGC-1_371G_A3D3	-15.31965779	1.636873703	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4525	10813	0.008970683	0.009803015	3	13A	IN-VIP	30	9	9
GATGCTAGTCCTGCTT-1_371G_A3D3	3.071573993	15.43877303	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	891	1330	0.00075188	0.016541353	3	oligos	OL-Cntl	30	9	9
GATTCAGAGGAGCGAG-1_371G_A3D3	-2.286367142	16.85561751	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	749	1118	0.003577818	0.010733453	3	oligos	OL-Cntl	30	9	9
GATTCAGCAAACAACA-1_371G_A3D3	10.32087198	-26.8869301	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	6480	19920	0.004317269	0.004166667	3	L2-3	EN-L2-3-MS	30	9	9
GATTCAGCATCGTCGG-1_371G_A3D3	-9.115332501	-17.33358607	6B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	764	1095	0.026484018	0.006392694	3	6B	IN-SST	30	9	9
GATTCAGGTGACCAAG-1_371G_A3D3	8.983469985	15.97299515	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1089	1837	0.008709853	0.005443658	3	oligos	OL-Cntl	30	9	9
GATTCAGGTGGTCTCG-1_371G_A3D3	9.559525652	12.79289834	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1134	1823	0.001645639	0.009325288	3	oligos	OL-Cntl	30	9	9
GATTCAGTCAACACTG-1_371G_A3D3	-23.13857485	23.51261956	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1469	2490	0.001606426	0.006024096	3	8	Astrocytes	30	9	9
GATTCAGTCACGCATA-1_371G_A3D3	33.75562985	-7.291981156	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5060	13595	0.001103347	0.008532549	3	2	EN-L4	30	9	9
GATTCAGTCACTTCAT-1_371G_A3D3	4.631727292	-19.68145621	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3449	7958	0.00427243	0.005026389	3	L2-3	EN-L2-3-MS	30	9	9
GATTCAGTCCGTAGGC-1_371G_A3D3	-0.900474635	14.85488115	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	820	1161	0.010335917	0.010335917	3	oligos	OL-Cntl	30	9	9
GCAAACTAGATCTGCT-1_371G_A3D3	-25.14956141	13.57674887	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1142	1762	0.000567537	0.012485812	3	8	Astrocytes	30	9	9
GCAAACTAGCTAGTGG-1_371G_A3D3	-22.4569721	-17.11586402	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5676	16893	0.002012668	0.008465045	3	6A	IN-PV	30	9	9
GCAAACTCATAGAAAC-1_371G_A3D3	30.25473931	0.428867223	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3392	6769	0.003397843	0.005022899	3	2	EN-L4	30	9	9
GCAAACTGTCGCTTTC-1_371G_A3D3	27.74621289	-1.701522513	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3751	9446	0.00666949	0.003281812	3	2	EN-L4	30	9	9
GCAAACTGTGTGGTTT-1_371G_A3D3	-23.10663422	-19.26908938	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3305	6768	0.01891253	0.007387707	3	6A	IN-PV	30	9	9
GCAAACTTCTCCGGTT-1_371G_A3D3	-3.59123506	-16.96604833	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2600	5582	0.011823719	0.003224651	3	L2-3	EN-L2-3-MS	30	9	9
GCAAACTTCTGTACGA-1_371G_A3D3	35.88550576	-11.16799525	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4805	11332	0.013413343	0.010589481	3	2	EN-L4	30	9	9
GCAATCAAGAGAGCTC-1_371G_A3D3	10.71172372	-26.54875191	10	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	7322	25817	0.00511291	0.003950885	3	L2-3	EN-L2-3-Cntl	30	9	9
GCAATCAAGATGAGAG-1_371G_A3D3	-21.95479767	9.432682113	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1017	1459	0.004797807	0.002741604	3	8	Astrocytes	30	9	9
GCAATCAAGCTGTCTA-1_371G_A3D3	-0.022950589	18.01342535	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	718	1096	0.006386861	0.003649635	3	oligos	OL-Cntl	30	9	9
GCAATCAAGGAGTAGA-1_371G_A3D3	7.466967506	-18.10662237	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3707	7608	0.010120925	0.015772871	3	L2-3	EN-L2-3-MS	30	9	9
GCAATCAAGTAGCGGT-1_371G_A3D3	-24.78776757	23.56337013	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1391	2188	0	0.005484461	3	8	Astrocytes	30	9	9
GCAATCAAGTCGATAA-1_371G_A3D3	-21.11016642	-25.39368552	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3476	8228	0.006684492	0.00352455	3	6A	IN-PV	30	9	9
GCAATCAAGTTAGGTA-1_371G_A3D3	33.65451231	-7.465280611	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5230	13866	0.002596279	0.00814943	3	2	EN-L4	30	9	9
GCAATCACACATGACT-1_371G_A3D3	12.34707246	10.32257481	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1237	1924	0.003638254	0.014553015	3	oligos	OL-Cntl	30	9	9
GCAATCACACCACCAG-1_371G_A3D3	-23.16454201	22.74256317	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1561	2962	0.002700878	0.002363268	3	8	Astrocytes	30	9	9
GCAATCACATATGGTC-1_371G_A3D3	-29.36056021	10.44516065	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	809	1220	0.000819672	0.005737705	3	8	Astrocytes	30	9	9
GCAATCAGTCTTGCGG-1_371G_A3D3	-18.32270244	-9.911776332	13B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4696	11791	0.003307607	0.00941396	3	13B	IN-SV2C	30	9	9
GCAATCATCAGGTAAA-1_371G_A3D3	8.716587639	20.92087147	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	857	1359	0.007358352	0.004415011	3	oligos	OL-Cntl	30	9	9
GCAATCATCCAAGTAC-1_371G_A3D3	12.84606272	-24.26942427	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	7989	31377	0.002294674	0.00729834	3	L2-3	EN-L2-3-MS	30	9	9
GCACATAAGACACTAA-1_371G_A3D3	-15.85794182	13.60415603	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1652	2918	0.003427005	0.003427005	3	8	Astrocytes	30	9	9
GCACATACAAATCCGT-1_371G_A3D3	-4.824038885	6.289995255	5	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1016	1442	0.000693481	0.034674064	3	oligos	OL-MS-1	30	9	9
GCACATACAACGATCT-1_371G_A3D3	35.92625189	-10.00633228	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	6024	16938	0.00667139	0.011335459	3	2	EN-L4	30	9	9
GCACATACACTTGGAT-1_371G_A3D3	4.717485521	-21.2779723	10	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5209	15453	0.002264932	0.002847344	3	L2-3	EN-L2-3-Cntl	30	9	9
GCACATACATGCTGGC-1_371G_A3D3	6.279999504	-20.83152503	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5556	16083	0.004414599	0.004912019	3	L2-3	EN-L2-3-MS	30	9	9
GCACATATCAAGATCC-1_371G_A3D3	-23.37540237	-18.65863614	6B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2971	6029	0.015591309	0.015093714	3	6B	IN-SST	30	9	9
GCACATATCCGGGTGT-1_371G_A3D3	9.4457936	20.41133073	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	863	1357	0	0.005158438	3	oligos	OL-Cntl	30	9	9
GCACATATCTCCGGTT-1_371G_A3D3	12.11420242	20.15289617	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	927	1463	0.008202324	0.004101162	3	oligos	OL-Cntl	30	9	9
GCACATATCTCGCATC-1_371G_A3D3	2.591985516	13.41728975	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	963	1520	0.003947368	0.028289474	3	oligos	OL-Cntl	30	9	9
GCACATATCTGCTTGC-1_371G_A3D3	8.274514393	13.99668395	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1051	1616	0.001856436	0.01299505	3	oligos	OL-Cntl	30	9	9
GCACATATCTTCCTTC-1_371G_A3D3	-19.32118437	-17.58488574	6B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3260	7909	0.001011506	0.00644835	3	6B	IN-SST	30	9	9
GCACTCTAGAGGTAGA-1_371G_A3D3	8.911982048	11.63156627	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1279	2044	0	0.009295499	3	oligos	OL-Cntl	30	9	9
GCACTCTAGTCCGGTC-1_371G_A3D3	-2.797268105	13.34435577	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	822	1166	0.006003431	0.024013722	3	oligos	OL-Cntl	30	9	9
GCACTCTCAATAGAGT-1_371G_A3D3	-1.413017209	-1.043569566	11	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1649	2780	0.008992806	0.012589928	3	11	Glia-MIX	30	9	9
GCACTCTGTCGCGTGT-1_371G_A3D3	-31.93967301	-5.646686544	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1171	1797	0.001669449	0.007234279	3	9	OPC	30	9	9
GCACTCTGTGGAAAGA-1_371G_A3D3	2.171931582	15.76921207	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	945	1553	0.00257566	0.00772698	3	oligos	OL-Cntl	30	9	9
GCACTCTTCAGGTTCA-1_371G_A3D3	2.793188231	21.98234633	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	718	1064	0.004699248	0.009398496	3	oligos	OL-Cntl	30	9	9
GCACTCTTCTTTCCTC-1_371G_A3D3	16.47908631	5.651140904	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2740	5763	0.003123373	0.012840534	3	oligos	OL-Cntl	30	9	9
GCAGCCAAGAGTGAGA-1_371G_A3D3	2.247518979	12.70426512	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	971	1441	0.006245663	0.013879251	3	oligos	OL-Cntl	30	9	9
GCAGCCAAGGCGACAT-1_371G_A3D3	15.37353251	-1.943883166	12	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	850	1364	0.00659824	0.005865103	3	12	EN-MIX	30	9	9
GCAGCCAAGTCACGCC-1_371G_A3D3	-2.494153382	15.42532262	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	770	1148	0	0.013066202	3	oligos	OL-Cntl	30	9	9
GCAGCCACAAGTCATC-1_371G_A3D3	-19.5621142	26.02073851	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1978	3793	0.001581861	0.009754811	3	8	Astrocytes	30	9	9
GCAGCCACACAGACAG-1_371G_A3D3	-24.19494044	0.966433806	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2930	5792	0.003625691	0.01433011	3	9	OPC	30	9	9
GCAGCCACATAAGACA-1_371G_A3D3	0.784273321	-10.43921068	12	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1738	2957	0.009130876	0.00574907	3	12	EN-MIX	30	9	9
GCAGCCATCGCACTCT-1_371G_A3D3	-33.21691851	-0.616616747	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1764	2846	0.003513703	0.005621926	3	9	OPC	30	9	9
GCAGTTAAGCGATCCC-1_371G_A3D3	15.35901649	5.936620611	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2587	5044	0.001189532	0.015067407	3	oligos	OL-Cntl	30	9	9
GCAGTTACAAGTACCT-1_371G_A3D3	-34.58850665	1.633075758	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1884	3577	0.000559128	0.005311714	3	9	OPC	30	9	9
GCAGTTACAAGTCATC-1_371G_A3D3	-29.07181319	13.02524886	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	826	1213	0.000824402	0.004946414	3	8	Astrocytes	30	9	9
GCAGTTAGTTCAGGCC-1_371G_A3D3	4.624572393	13.65323124	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1176	1745	0	0.011461318	3	oligos	OL-Cntl	30	9	9
GCAGTTATCAATCACG-1_371G_A3D3	-1.368760104	18.70619898	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	713	1013	0.000987167	0.006910168	3	oligos	OL-Cntl	30	9	9
GCAGTTATCCTCAATT-1_371G_A3D3	-9.700834576	-0.191741475	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2338	4636	0.012726488	0.006039689	3	13A	IN-VIP	30	9	9
GCATACAAGTTATCGC-1_371G_A3D3	9.216508987	9.652837098	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1349	2241	0.001338688	0.009370817	3	oligos	OL-Cntl	30	9	9
GCATACACACCCTATC-1_371G_A3D3	12.60352785	9.331671944	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1430	2305	0.003036876	0.007809111	3	oligos	OL-Cntl	30	9	9
GCATACACAGCATGAG-1_371G_A3D3	-25.37128396	13.52891557	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1070	1584	0.005681818	0.006944444	3	8	Astrocytes	30	9	9
GCATACACATCAGTAC-1_371G_A3D3	8.421591603	9.568018314	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1303	2110	0.000947867	0.009004739	3	oligos	OL-Cntl	30	9	9
GCATACACATGGGAAC-1_371G_A3D3	29.97428045	9.672746406	15DB	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1236	1858	0.002691066	0.035522067	3	15DB	B cells	30	9	9
GCATACACATTCTTAC-1_371G_A3D3	-28.64296803	10.47466493	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	763	1102	0.016333938	0.001814882	3	8	Astrocytes	30	9	9
GCATACAGTAGCGCTC-1_371G_A3D3	25.44468374	-26.54944157	3	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4009	10732	0.004379426	0.004938502	3	3	EN-L5-6	30	9	9
GCATACAGTTCTGAAC-1_371G_A3D3	4.807770869	-19.77851009	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3758	8998	0.003667482	0.004556568	3	L2-3	EN-L2-3-MS	30	9	9
GCATACATCAGCTTAG-1_371G_A3D3	5.656092423	-19.82843261	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4817	12485	0.001682018	0.007288746	3	L2-3	EN-L2-3-MS	30	9	9
GCATACATCCAATGGT-1_371G_A3D3	9.784341398	7.892810873	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1657	3082	0.002920182	0.00908501	3	oligos	OL-Cntl	30	9	9
GCATACATCGTTACAG-1_371G_A3D3	-2.59591145	-0.893726272	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3680	7881	0.007867022	0.008247684	3	13A	IN-VIP	30	9	9
GCATGATCAAGCCCAC-1_371G_A3D3	-29.1320435	21.12126766	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1089	1667	0.00659868	0.00419916	3	8	Astrocytes	30	9	9
GCATGATCACCAGGCT-1_371G_A3D3	11.16706267	7.644496996	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1576	2729	0.003297911	0.01355808	3	oligos	OL-Cntl	30	9	9
GCATGATCATTATCTC-1_371G_A3D3	7.763848755	-20.77671521	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	7019	22702	0.005021584	0.009778874	3	L2-3	EN-L2-3-MS	30	9	9
GCATGATGTTCGGCAC-1_371G_A3D3	-2.899711152	16.21948811	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	746	1042	0.011516315	0.022072937	3	oligos	OL-Cntl	30	9	9
GCATGATTCAAGCCTA-1_371G_A3D3	2.489493967	12.6257295	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1034	1567	0.004467135	0.018506701	3	oligos	OL-Cntl	30	9	9
GCATGATTCGATAGAA-1_371G_A3D3	-12.31980485	1.267244228	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3228	6928	0.003897229	0.006784065	3	13A	IN-VIP	30	9	9
GCATGCGAGATAGCAT-1_371G_A3D3	-32.84407041	5.321946234	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3189	6336	0.002840909	0.010890152	3	9	OPC	30	9	9
GCATGCGAGGAATCGC-1_371G_A3D3	7.776531008	11.48455791	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1093	1802	0.002774695	0.018312986	3	oligos	OL-Cntl	30	9	9
GCATGCGAGTTCGCGC-1_371G_A3D3	-19.40089748	-17.09104055	6B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2963	6147	0.000325362	0.005368472	3	6B	IN-SST	30	9	9
GCATGCGGTCTGATCA-1_371G_A3D3	3.001940308	14.97628527	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1117	1719	0.002908668	0.010471204	3	oligos	OL-Cntl	30	9	9
GCATGCGTCGCCATAA-1_371G_A3D3	-19.76086742	26.16128909	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1785	3185	0.001569859	0.006593407	3	8	Astrocytes	30	9	9
GCATGTACAAACTGCT-1_371G_A3D3	0.581642514	13.36823593	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	922	1405	0.004982206	0.014946619	3	oligos	OL-Cntl	30	9	9
GCATGTACACTTGGAT-1_371G_A3D3	17.53943161	-0.110595758	12	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1096	1712	0.018691589	0.002336449	3	12	EN-MIX	30	9	9
GCATGTACATTCACTT-1_371G_A3D3	-25.28064125	22.21626663	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1168	1921	0.000520562	0.00468506	3	8	Astrocytes	30	9	9
GCATGTAGTGCACCAC-1_371G_A3D3	-13.91578841	0.653280758	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3092	5941	0.000673287	0.009257701	3	13A	IN-VIP	30	9	9
GCATGTATCATTATCC-1_371G_A3D3	35.94732226	-9.647388948	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5968	16788	0.00571837	0.01096021	3	2	EN-L4	30	9	9
GCCAAATAGAGAACAG-1_371G_A3D3	12.55520882	7.692786449	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1577	2534	0.000789266	0.008681926	3	oligos	OL-Cntl	30	9	9
GCCAAATAGCGTTGCC-1_371G_A3D3	-30.25221749	1.364160772	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1943	3390	0.001474926	0.009439528	3	9	OPC	30	9	9
GCCAAATCACAAGCCC-1_371G_A3D3	35.9116855	-9.626674001	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5082	12999	0.005154243	0.00992384	3	2	EN-L4	30	9	9
GCCAAATCACGGATAG-1_371G_A3D3	11.24396677	9.19337851	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1368	2300	0.002173913	0.013478261	3	oligos	OL-Cntl	30	9	9
GCCAAATGTAAATACG-1_371G_A3D3	-23.96444842	16.74823419	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1333	2089	0.003350886	0.007180469	3	8	Astrocytes	30	9	9
GCCAAATGTGTAACGG-1_371G_A3D3	6.592646712	16.90831865	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1023	1565	0.000638978	0.006389776	3	oligos	OL-Cntl	30	9	9
GCCTCTAAGAAGCCCA-1_371G_A3D3	-17.14973576	1.371458439	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4173	9157	0.004368243	0.016053293	3	13A	IN-VIP	30	9	9
GCCTCTAAGAGCTGCA-1_371G_A3D3	13.41519148	9.083986858	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1633	2791	0.003224651	0.012182014	3	oligos	OL-Cntl	30	9	9
GCCTCTAAGGACTGGT-1_371G_A3D3	36.11996352	-8.019104916	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4279	9845	0.001218893	0.009547994	3	2	EN-L4	30	9	9
GCCTCTAGTCCTAGCG-1_371G_A3D3	5.126206938	-19.4644863	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4032	10298	0.001942125	0.010196155	3	L2-3	EN-L2-3-MS	30	9	9
GCCTCTAGTTTGGCGC-1_371G_A3D3	5.008422866	32.16820424	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	750	1073	0.002795899	0.009319664	3	oligos	OL-Cntl	30	9	9
GCCTCTATCTACTCAT-1_371G_A3D3	-30.87839008	9.970656271	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	800	1147	0.009590235	0.007846556	3	8	Astrocytes	30	9	9
GCGACCAAGTCGTTTG-1_371G_A3D3	6.413299693	10.5786014	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1108	1738	0.001150748	0.010932106	3	oligos	OL-Cntl	30	9	9
GCGACCACAACGATCT-1_371G_A3D3	-18.24327658	-9.768547381	13B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3082	6061	0.013034153	0.008579442	3	13B	IN-SV2C	30	9	9
GCGACCACAGCCAGAA-1_371G_A3D3	2.668884947	13.10802645	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	971	1439	0.004864489	0.009034051	3	oligos	OL-Cntl	30	9	9
GCGACCACAGTAAGCG-1_371G_A3D3	-1.531817663	19.80765876	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	792	1119	0.002680965	0.004468275	3	oligos	OL-Cntl	30	9	9
GCGACCAGTAACGTTC-1_371G_A3D3	4.714451511	-21.21276486	10	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5174	15014	0.001598508	0.004262688	3	L2-3	EN-L2-3-Cntl	30	9	9
GCGACCAGTATGGTTC-1_371G_A3D3	8.099617061	11.96779059	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1045	1599	0.001876173	0.009380863	3	oligos	OL-Cntl	30	9	9
GCGACCAGTCGGATCC-1_371G_A3D3	-25.21992399	22.13460235	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1269	2008	0.001992032	0.006474104	3	8	Astrocytes	30	9	9
GCGACCAGTGACTCAT-1_371G_A3D3	-10.89224499	15.58695084	11	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1816	2997	0.00333667	0.003670337	3	11	Glia-MIX	30	9	9
GCGACCATCTGTTGAG-1_371G_A3D3	26.39722894	4.985199952	15BA	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1068	1567	0.004467135	0.007657945	3	15BA	Stromal cells	30	9	9
GCGAGAACAGACACTT-1_371G_A3D3	1.635353529	15.24307048	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	822	1235	0.003238866	0.011336032	3	oligos	OL-Cntl	30	9	9
GCGAGAACATATACCG-1_371G_A3D3	30.19927847	16.11236527	14	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1780	3279	0.002134797	0.08905154	3	14	Microglia	30	9	9
GCGAGAACATTACCTT-1_371G_A3D3	6.208609273	9.409320083	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1258	2018	0.005946482	0.013379584	3	oligos	OL-Cntl	30	9	9
GCGAGAAGTATCTGCA-1_371G_A3D3	-21.24217565	25.19251973	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2027	3842	0.001561687	0.002863092	3	8	Astrocytes	30	9	9
GCGAGAAGTTACCAGT-1_371G_A3D3	-18.22322372	-10.03179629	13B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3905	9404	0.002233092	0.012228839	3	13B	IN-SV2C	30	9	9
GCGCAACAGTCCAGGA-1_371G_A3D3	-1.335727935	19.20344168	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	760	1118	0.002683363	0.008944544	3	oligos	OL-Cntl	30	9	9
GCGCAACCACACTGCG-1_371G_A3D3	-0.98749313	13.05359529	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	984	1474	0.002713704	0.016960651	3	oligos	OL-Cntl	30	9	9
GCGCAACCACGGTTTA-1_371G_A3D3	-33.93764473	-0.382111025	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1615	2708	0.005539143	0.008862629	3	9	OPC	30	9	9
GCGCAACTCGGCATCG-1_371G_A3D3	9.408321741	8.390356906	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1438	2671	0.004867091	0.007113441	3	oligos	OL-Cntl	30	9	9
GCGCAGTAGATCCTGT-1_371G_A3D3	6.86812614	-18.89722119	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5009	12723	0.004637271	0.014854987	3	L2-3	EN-L2-3-MS	30	9	9
GCGCAGTAGATGGGTC-1_371G_A3D3	-21.80988839	9.681969318	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	924	1341	0.002237136	0.003728561	3	8	Astrocytes	30	9	9
GCGCAGTCAACTGCGC-1_371G_A3D3	26.82862261	7.252947303	15A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1035	1492	0.001340483	0.022788204	3	15A	Endo cells	30	9	9
GCGCAGTCACCTCGGA-1_371G_A3D3	35.2267332	13.9858525	14	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1035	1433	0.001395673	0.017445918	3	14	Microglia	30	9	9
GCGCAGTGTAACGACG-1_371G_A3D3	-30.66064757	-1.264907363	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1576	2682	0.007084265	0.00857569	3	9	OPC	30	9	9
GCGCAGTGTACCGTTA-1_371G_A3D3	-23.35036831	22.78899572	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1414	2407	0.000415455	0.007062734	3	8	Astrocytes	30	9	9
GCGCAGTTCCTTGACC-1_371G_A3D3	-19.13133955	28.31289677	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2539	4959	0.002016536	0.002419843	3	8	Astrocytes	30	9	9
GCGCAGTTCTAACTTC-1_371G_A3D3	-21.46216973	25.7947989	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1672	2868	0.001046025	0.006624826	3	8	Astrocytes	30	9	9
GCGCCAACAAGTTCTG-1_371G_A3D3	16.85819065	-0.564449845	12	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	858	1292	0.005417957	0.003869969	3	12	EN-MIX	30	9	9
GCGCCAACATCATCCC-1_371G_A3D3	-0.012211806	13.43750232	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1057	1634	0.00244798	0.012239902	3	oligos	OL-Cntl	30	9	9
GCGCCAAGTTGGTGGA-1_371G_A3D3	-12.88183801	0.430792325	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3729	8248	0.00800194	0.004728419	3	13A	IN-VIP	30	9	9
GCGCCAATCATTATCC-1_371G_A3D3	9.253766125	12.44096887	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1134	2048	0.004882813	0.0078125	3	oligos	OL-Cntl	30	9	9
GCGCGATCAGTTCCCT-1_371G_A3D3	17.42712655	-5.912208737	3	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1775	3237	0.013901761	0.00463392	3	3	EN-L5-6	30	9	9
GCGCGATCATAGACTC-1_371G_A3D3	-35.39411069	-4.144816344	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1249	2096	0.002862595	0.005725191	3	9	OPC	30	9	9
GCGCGATCATGCGCAC-1_371G_A3D3	-2.561948695	-0.923780084	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2403	4404	0.009082652	0.009082652	3	13A	IN-VIP	30	9	9
GCGCGATTCACATAGC-1_371G_A3D3	4.687963125	9.871519455	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1417	2147	0.001397299	0.01956218	3	oligos	OL-Cntl	30	9	9
GCGGGTTAGAGCTGCA-1_371G_A3D3	-13.82618949	-15.91356047	6B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1377	2331	0.02016302	0.012012012	3	6B	IN-SST	30	9	9
GCGGGTTAGGATTCGG-1_371G_A3D3	8.624753937	15.85798908	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1025	1624	0.001847291	0.007389163	3	oligos	OL-Cntl	30	9	9
GCGGGTTAGGGCATGT-1_371G_A3D3	7.692511786	-20.19908243	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	6184	18065	0.006310545	0.006808746	3	L2-3	EN-L2-3-MS	30	9	9
GCGGGTTCAAAGAATC-1_371G_A3D3	-22.89170988	-19.22182969	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2678	4901	0.016323199	0.0081616	3	6A	IN-PV	30	9	9
GCGGGTTCAGCCTTGG-1_371G_A3D3	0.259523808	13.65324769	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	902	1532	0.005221932	0.01305483	3	oligos	OL-Cntl	30	9	9
GCGGGTTGTCATATGC-1_371G_A3D3	8.686240635	13.39589631	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1035	1602	0.004369538	0.009987516	3	oligos	OL-Cntl	30	9	9
GCGGGTTGTGTGGTTT-1_371G_A3D3	-14.4043832	1.840614037	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4141	9177	0.004794595	0.012313392	3	13A	IN-VIP	30	9	9
GCGGGTTTCCGAATGT-1_371G_A3D3	-16.63014274	-18.94586289	6B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2187	4828	0.0008285	0.002071251	3	6B	IN-SST	30	9	9
GCGGGTTTCGGTTAAC-1_371G_A3D3	-18.57640962	-17.69354617	6B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2382	5062	0.012643224	0.002963256	3	6B	IN-SST	30	9	9
GCGGGTTTCTGCGACG-1_371G_A3D3	4.875079892	13.04881424	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1061	1608	0.000621891	0.006840796	3	oligos	OL-Cntl	30	9	9
GCTCCTAAGTAGTGCG-1_371G_A3D3	-34.16467855	-0.15912123	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1520	2512	0.001194268	0.005175159	3	9	OPC	30	9	9
GCTCCTACAATAAGCA-1_371G_A3D3	-17.58278313	28.48113217	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2241	4546	0.002859657	0.004179498	3	8	Astrocytes	30	9	9
GCTCCTACATACTCTT-1_371G_A3D3	22.31222821	-26.80464342	3	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4320	12102	0.004627334	0.006445216	3	3	EN-L5-6	30	9	9
GCTCCTAGTATATGGA-1_371G_A3D3	-2.555557247	-0.943617388	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2219	4003	0.003247564	0.008993255	3	13A	IN-VIP	30	9	9
GCTCTGTAGAGGGCTT-1_371G_A3D3	-30.66864587	1.472813672	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2026	3641	0.004669047	0.008514144	3	9	OPC	30	9	9
GCTCTGTAGGCCCTCA-1_371G_A3D3	-18.57865174	-9.739740294	13B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3994	8567	0.013773783	0.009571612	3	13B	IN-SV2C	30	9	9
GCTCTGTGTAGGCTGA-1_371G_A3D3	-2.088813258	17.4286845	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	746	1053	0.004748338	0.014245014	3	oligos	OL-Cntl	30	9	9
GCTCTGTTCTGTGCAA-1_371G_A3D3	15.57398632	6.634411886	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1870	3436	0.002037253	0.007857974	3	oligos	OL-Cntl	30	9	9
GCTGCAGAGCTAGTCT-1_371G_A3D3	-0.563977457	15.61168113	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	804	1219	0.004101723	0.013125513	3	oligos	OL-Cntl	30	9	9
GCTGCAGAGTAGCGGT-1_371G_A3D3	17.7867606	-5.827698532	3	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1574	2928	0.010587432	0.00102459	3	3	EN-L5-6	30	9	9
GCTGCAGCACAGCGTC-1_371G_A3D3	-2.201994387	14.55081377	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	810	1156	0.007785467	0.015570934	3	oligos	OL-Cntl	30	9	9
GCTGCAGGTACCGAGA-1_371G_A3D3	-29.08143473	10.75134766	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	921	1322	0.004538578	0.001512859	3	8	Astrocytes	30	9	9
GCTGCAGGTCGAACAG-1_371G_A3D3	1.307902083	17.34652871	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	811	1228	0	0.00732899	3	oligos	OL-Cntl	30	9	9
GCTGCAGGTGCGAAAC-1_371G_A3D3	0.497639258	14.33421745	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	864	1234	0.000810373	0.017828201	3	oligos	OL-Cntl	30	9	9
GCTGCGAAGACATAAC-1_371G_A3D3	-24.67903459	-1.218443145	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1607	2681	0.007459903	0.010816859	3	9	OPC	30	9	9
GCTGCGATCACCCGAG-1_371G_A3D3	-33.26654301	-8.405078311	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1052	1586	0.010718789	0.006935687	3	9	OPC	30	9	9
GCTGCGATCACTTATC-1_371G_A3D3	-15.76214584	2.346793554	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4065	9139	0.005361637	0.010504432	3	13A	IN-VIP	30	9	9
GCTGCGATCCCTCAGT-1_371G_A3D3	9.959236159	18.11506068	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	956	1425	0.000701754	0.008421053	3	oligos	OL-Cntl	30	9	9
GCTGCGATCGACAGCC-1_371G_A3D3	19.91113373	-28.98233389	3	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4838	16479	0.000910249	0.005218763	3	3	EN-L5-6	30	9	9
GCTGCGATCTACTCAT-1_371G_A3D3	35.99122636	-9.809162265	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4923	12004	0.011912696	0.008413862	3	2	EN-L4	30	9	9
GCTGCTTAGAATCTCC-1_371G_A3D3	3.859606888	15.76003056	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	968	1465	0.000682594	0.008191126	3	oligos	OL-Cntl	30	9	9
GCTGCTTAGATGTCGG-1_371G_A3D3	36.0141627	-12.19232904	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5664	14651	0.00750802	0.013514436	3	2	EN-L4	30	9	9
GCTGCTTAGGGTGTGT-1_371G_A3D3	-19.30511898	20.14233345	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1568	2441	0.000409668	0.003277345	3	8	Astrocytes	30	9	9
GCTGCTTCACCAGCAC-1_371G_A3D3	-14.97203141	1.545956809	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4072	8722	0.008140335	0.005961935	3	13A	IN-VIP	30	9	9
GCTGCTTCATACAGCT-1_371G_A3D3	2.996371804	14.51757787	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	997	1471	0.001359619	0.011556764	3	oligos	OL-Cntl	30	9	9
GCTGCTTGTGAAGGCT-1_371G_A3D3	3.720944817	10.50132484	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1201	1853	0.000539665	0.015650297	3	oligos	OL-Cntl	30	9	9
GCTGGGTAGGAGTTTA-1_371G_A3D3	-2.142644533	13.03591857	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	921	1373	0.006554989	0.032774945	3	oligos	OL-Cntl	30	9	9
GCTGGGTCAAACTGTC-1_371G_A3D3	-29.3796514	1.220962524	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2192	3916	0.002298264	0.013534219	3	9	OPC	30	9	9
GCTGGGTCATAGGATA-1_371G_A3D3	-1.664048449	13.74658708	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	872	1216	0.000822368	0.013157895	3	oligos	OL-Cntl	30	9	9
GCTGGGTCATTAGCCA-1_371G_A3D3	9.374620853	-23.17044504	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	7955	29464	0.00485338	0.007161282	3	L2-3	EN-L2-3-MS	30	9	9
GCTGGGTGTCGACTGC-1_371G_A3D3	-1.492071334	17.99306042	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	815	1201	0.003330558	0.007493755	3	oligos	OL-Cntl	30	9	9
GCTGGGTTCACTCTTA-1_371G_A3D3	-10.10125645	-17.6916806	6B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1006	1623	0.067775724	0.004313001	3	6B	IN-SST	30	9	9
GCTGGGTTCACTTCAT-1_371G_A3D3	16.13484162	6.296304397	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1868	3366	0.000594177	0.008912656	3	oligos	OL-Cntl	30	9	9
GCTGGGTTCTGAAAGA-1_371G_A3D3	36.01311016	-11.31352535	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5105	12063	0.00530548	0.014507171	3	2	EN-L4	30	9	9
GCTTCCAAGCAGACTG-1_371G_A3D3	11.47882242	8.430843958	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1508	2732	0.00329429	0.011346999	3	oligos	OL-Cntl	30	9	9
GCTTCCAGTCGACTGC-1_371G_A3D3	15.33205352	1.706042776	12	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	995	1447	0.013130615	0.006219765	3	12	EN-MIX	30	9	9
GCTTCCAGTCGCATCG-1_371G_A3D3	7.178355612	9.5816382	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1190	1923	0.004680187	0.013520541	3	oligos	OL-Cntl	30	9	9
GCTTCCAGTCTCTCTG-1_371G_A3D3	33.2782933	-7.033232756	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4040	9535	0.003670687	0.009124279	3	2	EN-L4	30	9	9
GCTTCCATCACTGGGC-1_371G_A3D3	-31.62962449	1.656104044	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2051	3505	0.004279601	0.009985735	3	9	OPC	30	9	9
GCTTCCATCCAATGGT-1_371G_A3D3	5.80063458	-19.41603325	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4215	9945	0.004022122	0.005932629	3	L2-3	EN-L2-3-MS	30	9	9
GCTTCCATCCGCATCT-1_371G_A3D3	-28.80081886	0.888453856	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2257	4195	0.001668653	0.007628129	3	9	OPC	30	9	9
GCTTCCATCGACCAGC-1_371G_A3D3	-4.575242517	6.21393541	5	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1492	2412	0.006633499	0.025704809	3	oligos	OL-MS-1	30	9	9
GCTTCCATCGGCCGAT-1_371G_A3D3	-20.95934882	-28.03264883	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4222	11578	0.001122819	0.004836759	3	6A	IN-PV	30	9	9
GCTTGAAAGATCGGGT-1_371G_A3D3	13.68278028	15.17329808	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1175	1897	0	0.007380074	3	oligos	OL-Cntl	30	9	9
GCTTGAAAGCTTATCG-1_371G_A3D3	-19.91578011	30.38653414	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2432	4604	0.000651607	0.002389227	3	8	Astrocytes	30	9	9
GCTTGAAAGTACGTAA-1_371G_A3D3	2.26107032	17.81746789	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	892	1426	0.000701262	0.011220196	3	oligos	OL-Cntl	30	9	9
GCTTGAACACAGATTC-1_371G_A3D3	-17.85167989	29.09580432	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2569	4617	0.00259909	0.005847953	3	8	Astrocytes	30	9	9
GCTTGAACATGTAGTC-1_371G_A3D3	8.17231974	-17.68417514	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4196	9690	0.005779154	0.016821465	3	L2-3	EN-L2-3-MS	30	9	9
GCTTGAACATGTCTCC-1_371G_A3D3	18.08542108	-6.818630217	3	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2140	4219	0.000948092	0.004029391	3	3	EN-L5-6	30	9	9
GCTTGAACATTCTCAT-1_371G_A3D3	1.775234236	17.26649079	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	863	1420	0.000704225	0.007042254	3	oligos	OL-Cntl	30	9	9
GCTTGAATCGACAGCC-1_371G_A3D3	-23.0002683	-26.30800364	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4505	12168	0.003369494	0.00591716	3	6A	IN-PV	30	9	9
GGAAAGCCAATACGCT-1_371G_A3D3	8.19569483	-17.39915252	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4429	10239	0.008008595	0.014356871	3	L2-3	EN-L2-3-MS	30	9	9
GGAAAGCCATAAGACA-1_371G_A3D3	-14.91490068	1.486212999	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3449	6778	0.007819416	0.014311006	3	13A	IN-VIP	30	9	9
GGAAAGCGTCCAAGTT-1_371G_A3D3	-3.197490029	13.58555626	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	746	1084	0.001845018	0.018450185	3	oligos	OL-Cntl	30	9	9
GGAAAGCTCACCACCT-1_371G_A3D3	4.992682004	-19.30866569	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4005	10411	0.002209202	0.007396023	3	L2-3	EN-L2-3-MS	30	9	9
GGAACTTAGTTCGCGC-1_371G_A3D3	-17.66224784	-9.479696983	13B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3484	8111	0.010109728	0.007890519	3	13B	IN-SV2C	30	9	9
GGAACTTCAATCGGTT-1_371G_A3D3	1.650428842	23.87282248	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	714	1029	0.004859086	0.006802721	3	oligos	OL-Cntl	30	9	9
GGAACTTCACCGCTAG-1_371G_A3D3	5.894372659	-21.2481704	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5686	17069	0.004218173	0.005389888	3	L2-3	EN-L2-3-MS	30	9	9
GGAACTTGTCTGATCA-1_371G_A3D3	8.31829337	15.91113567	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	891	1421	0.002111189	0.013370866	3	oligos	OL-Cntl	30	9	9
GGAACTTTCAAGGCTT-1_371G_A3D3	5.041920527	-19.54194207	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3799	9082	0.001101079	0.004404316	3	L2-3	EN-L2-3-MS	30	9	9
GGAACTTTCACAGGCC-1_371G_A3D3	-19.08057301	28.96111593	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2300	4518	0.000664011	0.006861443	3	8	Astrocytes	30	9	9
GGAACTTTCTGCTGTC-1_371G_A3D3	5.967281093	-18.65305752	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3533	7410	0.002159244	0.009581646	3	L2-3	EN-L2-3-MS	30	9	9
GGAATAACACATTTCT-1_371G_A3D3	-17.6197474	17.87214388	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1581	2686	0.001489203	0.002978407	3	8	Astrocytes	30	9	9
GGAATAACAGAGTGTG-1_371G_A3D3	-18.84537266	26.58372671	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2069	3835	0.003650587	0.004693611	3	8	Astrocytes	30	9	9
GGAATAAGTCGGGTCT-1_371G_A3D3	29.70698427	0.899036514	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2700	4932	0.00162206	0.00486618	3	2	EN-L4	30	9	9
GGAATAAGTCTCAACA-1_371G_A3D3	35.67749151	-7.524660325	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4445	11232	0.004273504	0.006766382	3	2	EN-L4	30	9	9
GGAATAAGTTATGCGT-1_371G_A3D3	-22.99830903	22.84184588	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1696	3005	0.000332779	0.001331115	3	8	Astrocytes	30	9	9
GGAATAATCGCCTGAG-1_371G_A3D3	8.380464083	9.849939783	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1270	2125	0.005176471	0.008470588	3	oligos	OL-Cntl	30	9	9
GGAATAATCGGAGGTA-1_371G_A3D3	-10.00489919	-15.95985037	6B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1057	1500	0.01	0.006666667	3	6B	IN-SST	30	9	9
GGACAAGCAACTGCGC-1_371G_A3D3	12.43721125	19.35050115	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	928	1413	0.000707714	0.004246285	3	oligos	OL-Cntl	30	9	9
GGACAAGCAAGAGTCG-1_371G_A3D3	-26.24756413	-22.85558559	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5236	12755	0.006899255	0.014112113	3	6A	IN-PV	30	9	9
GGACAAGCACCACGTG-1_371G_A3D3	-3.376504952	-4.819819551	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1146	1855	0.005929919	0.004312668	3	13A	IN-VIP	30	9	9
GGACAAGCACGTCTCT-1_371G_A3D3	-19.29911295	28.67083246	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2186	4348	0.000229991	0.011729531	3	8	Astrocytes	30	9	9
GGACAAGCAGCTGTTA-1_371G_A3D3	0.374217334	13.9846568	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	962	1396	0.001432665	0.013610315	3	oligos	OL-Cntl	30	9	9
GGACAAGTCAATAAGG-1_371G_A3D3	7.606946209	9.911372892	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1197	2001	0.0009995	0.011994003	3	oligos	OL-Cntl	30	9	9
GGACAAGTCTCGAGTA-1_371G_A3D3	-29.6030407	-3.46556782	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1444	2421	0.001239157	0.008261049	3	9	OPC	30	9	9
GGACAAGTCTGAGTGT-1_371G_A3D3	8.687308308	14.98539356	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1029	1684	0	0.01128266	3	oligos	OL-Cntl	30	9	9
GGACAGAAGGCGATAC-1_371G_A3D3	-9.506385946	-16.23565172	6B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	973	1469	0.023144997	0.006807352	3	6B	IN-SST	30	9	9
GGACAGAAGGCTACGA-1_371G_A3D3	-11.82875753	-19.13603693	6B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1034	1756	0.002277904	0.006833713	3	6B	IN-SST	30	9	9
GGACAGACAATGGAGC-1_371G_A3D3	-2.835001216	15.02196922	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	744	1014	0.003944773	0.016765286	3	oligos	OL-Cntl	30	9	9
GGACAGACACCGGAAA-1_371G_A3D3	-16.00058391	15.57477347	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2221	4359	0.00022941	0.005047029	3	8	Astrocytes	30	9	9
GGACAGACATACGCTA-1_371G_A3D3	-16.64226348	-24.55838448	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1981	3852	0.015316719	0.003894081	3	6A	IN-PV	30	9	9
GGACATTAGAGGTTGC-1_371G_A3D3	-14.50317498	1.792225785	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4406	10226	0.00068453	0.008605515	3	13A	IN-VIP	30	9	9
GGACATTAGGTGACCA-1_371G_A3D3	10.61857843	7.26273502	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1545	2451	0.004079967	0.015095879	3	oligos	OL-Cntl	30	9	9
GGACATTGTATGAATG-1_371G_A3D3	-28.55929733	0.11053671	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1781	2922	0.002395619	0.01026694	3	9	OPC	30	9	9
GGACATTGTTGTACAC-1_371G_A3D3	-9.421474131	-20.15749004	6B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	958	1440	0.06875	0.007638889	3	6B	IN-SST	30	9	9
GGACATTTCTTCGAGA-1_371G_A3D3	-8.722730839	-1.928876399	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2019	3815	0.008125819	0.006815203	3	13A	IN-VIP	30	9	9
GGACGTCAGCAGATCG-1_371G_A3D3	-29.72650123	0.895750314	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1988	3560	0.001404494	0.008146067	3	9	OPC	30	9	9
GGACGTCCAGTTTACG-1_371G_A3D3	12.75103914	9.471132108	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1384	2460	0.00203252	0.010162602	3	oligos	OL-Cntl	30	9	9
GGACGTCCATACGCCG-1_371G_A3D3	-28.15174959	0.754823856	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2226	3715	0.003499327	0.015881561	3	9	OPC	30	9	9
GGACGTCGTCGCTTCT-1_371G_A3D3	-17.75578462	29.94831387	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2875	5373	0.000558347	0.016005956	3	8	Astrocytes	30	9	9
GGACGTCGTGTGAATA-1_371G_A3D3	-23.79345625	-19.02206357	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3126	6155	0.013484972	0.013647441	3	6A	IN-PV	30	9	9
GGACGTCTCCTCAACC-1_371G_A3D3	-19.9285495	26.28788965	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1947	3736	0.002141328	0.005353319	3	8	Astrocytes	30	9	9
GGAGCAAAGAGAGCTC-1_371G_A3D3	-19.158199	26.89426098	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1941	3500	0.004	0.006571429	3	8	Astrocytes	30	9	9
GGAGCAAAGCGTAATA-1_371G_A3D3	-35.76673216	1.392998023	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1701	3098	0.000645578	0.004196256	3	9	OPC	30	9	9
GGAGCAAAGGATCGCA-1_371G_A3D3	30.20849914	16.13473082	14	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1585	2585	0.002321083	0.086653772	3	14	Microglia	30	9	9
GGAGCAACACCAGTTA-1_371G_A3D3	35.94257682	-11.8901291	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4909	11748	0.012002043	0.014896153	3	2	EN-L4	30	9	9
GGAGCAAGTAAGAGAG-1_371G_A3D3	35.87308606	-11.32995334	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5602	14767	0.014424054	0.011105844	3	2	EN-L4	30	9	9
GGAGCAAGTCGAATCT-1_371G_A3D3	8.405429655	13.14801732	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1083	1698	0.004122497	0.00942285	3	oligos	OL-Cntl	30	9	9
GGAGCAATCTTGTACT-1_371G_A3D3	-28.87211863	0.758113433	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1933	3231	0.000928505	0.014856082	3	9	OPC	30	9	9
GGAGCAATCTTTACAC-1_371G_A3D3	-10.67795984	28.36428829	17	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1026	1385	0.00866426	0.01732852	3	oligos	OL-MS-2	30	9	9
GGATGTTAGCTGTTCA-1_371G_A3D3	11.44868858	10.0485334	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1215	2058	0	0.014577259	3	oligos	OL-Cntl	30	9	9
GGATGTTAGGGCTTGA-1_371G_A3D3	-20.53416892	25.80753373	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1719	2860	0.004195804	0.005594406	3	8	Astrocytes	30	9	9
GGATGTTCACGCGAAA-1_371G_A3D3	1.179901928	19.36828494	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	766	1175	0.005957447	0.006808511	3	oligos	OL-Cntl	30	9	9
GGATGTTCAGCCTATA-1_371G_A3D3	-1.89283149	14.32084739	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	802	1095	0.000913242	0.012785388	3	oligos	OL-Cntl	30	9	9
GGATGTTCAGGGATTG-1_371G_A3D3	2.620978895	13.07143084	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	988	1506	0.002656042	0.012616202	3	oligos	OL-Cntl	30	9	9
GGATGTTCAGGTGGAT-1_371G_A3D3	1.32244125	14.29082452	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	844	1302	0.000768049	0.012288786	3	oligos	OL-Cntl	30	9	9
GGATGTTCATATGGTC-1_371G_A3D3	4.477971107	14.01432877	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1106	1738	0.00575374	0.010356732	3	oligos	OL-Cntl	30	9	9
GGATGTTTCAGCCTAA-1_371G_A3D3	13.68091666	7.50157162	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1838	3205	0.0024961	0.011856474	3	oligos	OL-Cntl	30	9	9
GGATGTTTCAGGCCCA-1_371G_A3D3	10.93414312	14.39096266	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1086	1801	0.001665741	0.004441977	3	oligos	OL-Cntl	30	9	9
GGATGTTTCGTTACGA-1_371G_A3D3	2.229839273	15.3810078	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	943	1453	0.0110117	0.010323469	3	oligos	OL-Cntl	30	9	9
GGATGTTTCTAACGGT-1_371G_A3D3	-36.27260306	-4.716265173	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1239	2154	0.001392758	0.001392758	3	9	OPC	30	9	9
GGATTACAGACAATAC-1_371G_A3D3	8.954280783	10.95662435	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1217	1906	0.003147954	0.012591815	3	oligos	OL-Cntl	30	9	9
GGATTACAGCCACTAT-1_371G_A3D3	-0.014070045	12.9975391	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	989	1585	0.001892744	0.020820189	3	oligos	OL-Cntl	30	9	9
GGATTACGTAACGACG-1_371G_A3D3	-23.32139503	-26.13721792	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4893	13610	0.001322557	0.006392359	3	6A	IN-PV	30	9	9
GGATTACGTCATGCAT-1_371G_A3D3	4.647906786	9.309888721	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1586	2855	0.001401051	0.01821366	3	oligos	OL-Cntl	30	9	9
GGATTACGTGCGATAG-1_371G_A3D3	3.530382141	19.25469701	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	898	1287	0.001554002	0.018648019	3	oligos	OL-Cntl	30	9	9
GGATTACTCATGTCTT-1_371G_A3D3	-19.44188653	25.32367258	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1814	3225	0.000930233	0.006821705	3	8	Astrocytes	30	9	9
GGATTACTCCAGTAGT-1_371G_A3D3	-17.43402536	5.693194209	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	938	1285	0.006225681	0.028793774	3	8	Astrocytes	30	9	9
GGATTACTCCGTCATC-1_371G_A3D3	-2.785982958	16.76965125	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	745	1079	0.000926784	0.017608897	3	oligos	OL-Cntl	30	9	9
GGATTACTCGGACAAG-1_371G_A3D3	-11.42502313	-38.65687545	16	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1536	2317	0.029779888	0.020716444	3	16	EN-PYR	30	9	9
GGCAATTAGTGGGATC-1_371G_A3D3	-8.866205179	-4.791538368	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1646	2727	0.013934727	0.00770077	3	13A	IN-VIP	30	9	9
GGCAATTCATCCCATC-1_371G_A3D3	-4.338702207	24.09180626	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	687	1022	0.002935421	0.004892368	3	oligos	OL-Cntl	30	9	9
GGCAATTCATTGGGCC-1_371G_A3D3	-2.446519689	16.49471957	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	854	1276	0.003918495	0.018025078	3	oligos	OL-Cntl	30	9	9
GGCAATTTCACGAAGG-1_371G_A3D3	-30.53208527	1.126579521	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1920	3340	0.000299401	0.00508982	3	9	OPC	30	9	9
GGCAATTTCGTTGACA-1_371G_A3D3	1.014797275	15.84678001	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	831	1218	0.00410509	0.013136289	3	oligos	OL-Cntl	30	9	9
GGCCGATAGTCGATAA-1_371G_A3D3	-8.603357401	-2.621983403	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2194	3830	0.012010444	0.003655352	3	13A	IN-VIP	30	9	9
GGCCGATAGTGAACAT-1_371G_A3D3	16.09051897	6.147466234	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2282	4435	0.000676437	0.012626832	3	oligos	OL-Cntl	30	9	9
GGCCGATCACCGAATT-1_371G_A3D3	-14.61639338	-0.228943556	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3848	9161	0.016046283	0.01015173	3	13A	IN-VIP	30	9	9
GGCCGATCACTGTTAG-1_371G_A3D3	-32.9840678	4.344933133	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2566	4930	0.001622718	0.006693712	3	9	OPC	30	9	9
GGCCGATCAGTACACT-1_371G_A3D3	4.205186681	3.949606733	14	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2636	4954	0.002825999	0.045215987	3	14	Microglia	30	9	9
GGCCGATGTCGAACAG-1_371G_A3D3	11.8378202	6.228416416	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1967	3485	0.006599713	0.028120516	3	oligos	OL-Cntl	30	9	9
GGCCGATGTCTAGCCG-1_371G_A3D3	-18.15376201	-24.95370637	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2312	5003	0.004797122	0.004797122	3	6A	IN-PV	30	9	9
GGCCGATGTGATGTCT-1_371G_A3D3	4.627856481	14.56328584	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1005	1521	0.003287311	0.015779093	3	oligos	OL-Cntl	30	9	9
GGCCGATTCGGTTCGG-1_371G_A3D3	-25.24276412	13.48606109	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1074	1609	0.003729024	0.011187073	3	8	Astrocytes	30	9	9
GGCCGATTCTGTTGAG-1_371G_A3D3	-15.24830834	1.012662674	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3555	7496	0.009338314	0.009471718	3	13A	IN-VIP	30	9	9
GGCGACTAGAGTGACC-1_371G_A3D3	1.382964425	13.2300087	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	930	1379	0.005076142	0.016678753	3	oligos	OL-Cntl	30	9	9
GGCGACTAGCCTATGT-1_371G_A3D3	15.24320423	8.703660796	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1662	2948	0.002035278	0.005088195	3	oligos	OL-Cntl	30	9	9
GGCGACTAGCGTTCCG-1_371G_A3D3	-19.45174159	26.09999612	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1796	3013	0.002323266	0.005974112	3	8	Astrocytes	30	9	9
GGCGACTAGGACACCA-1_371G_A3D3	3.931164609	-19.10026479	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3851	9121	0.01173117	0.006578226	3	L2-3	EN-L2-3-MS	30	9	9
GGCGACTCAAGCCCAC-1_371G_A3D3	33.15105514	-7.218525761	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4106	9567	0.00909376	0.00700324	3	2	EN-L4	30	9	9
GGCGACTTCATAACCG-1_371G_A3D3	0.43010312	17.06386891	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	849	1361	0.003673769	0.006612785	3	oligos	OL-Cntl	30	9	9
GGCGACTTCATCACCC-1_371G_A3D3	8.242351824	11.65897334	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1112	1716	0.000582751	0.008741259	3	oligos	OL-Cntl	30	9	9
GGCGACTTCCCAAGTA-1_371G_A3D3	-22.74572198	-25.74685874	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3642	7954	0.005028916	0.007166206	3	6A	IN-PV	30	9	9
GGCGTGTAGACGCTTT-1_371G_A3D3	-22.72506003	-26.17465797	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3897	10001	0.00169983	0.00689931	3	6A	IN-PV	30	9	9
GGCGTGTCAATCGAAA-1_371G_A3D3	-23.84833505	-0.382232749	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1695	2819	0.001418943	0.003902093	3	9	OPC	30	9	9
GGCGTGTTCTTTAGGG-1_371G_A3D3	4.448497401	10.21023785	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1250	1931	0.004660798	0.015535992	3	oligos	OL-Cntl	30	9	9
GGCTCGACAATAAGCA-1_371G_A3D3	12.61404183	2.010887658	12	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	750	1036	0.092664093	0.004826255	3	12	EN-MIX	30	9	9
GGCTCGACATGCCTAA-1_371G_A3D3	-26.07339083	-22.33479641	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3354	6775	0.010627306	0.015645756	3	6A	IN-PV	30	9	9
GGCTCGATCGGATGTT-1_371G_A3D3	-17.65155874	0.340831188	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3064	5510	0.007985481	0.017967332	3	13A	IN-VIP	30	9	9
GGCTCGATCGTCTGCT-1_371G_A3D3	-15.42690798	0.453713854	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3568	7558	0.016141836	0.00992326	3	13A	IN-VIP	30	9	9
GGCTGGTCACAGTCGC-1_371G_A3D3	7.107286501	-20.19412171	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	6213	17796	0.004776354	0.009103169	3	L2-3	EN-L2-3-MS	30	9	9
GGCTGGTCACATCTTT-1_371G_A3D3	3.235484897	9.257322368	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1305	2001	0.0009995	0.019490255	3	oligos	OL-Cntl	30	9	9
GGCTGGTCACGAAACG-1_371G_A3D3	0.015382486	16.49402082	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	743	1056	0	0.010416667	3	oligos	OL-Cntl	30	9	9
GGCTGGTCATACGCTA-1_371G_A3D3	-24.69569781	18.56185296	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1341	2234	0	0.006266786	3	8	Astrocytes	30	9	9
GGCTGGTGTAAGAGGA-1_371G_A3D3	-0.965446244	15.55307539	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	875	1219	0.002461034	0.012305168	3	oligos	OL-Cntl	30	9	9
GGCTGGTGTACCATCA-1_371G_A3D3	36.02345685	-8.304366853	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4234	9282	0.002477914	0.007433743	3	2	EN-L4	30	9	9
GGCTGGTGTATCAGTC-1_371G_A3D3	5.231286197	-21.89212712	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	6069	19996	0.00370074	0.00380076	3	L2-3	EN-L2-3-MS	30	9	9
GGCTGGTGTCCTAGCG-1_371G_A3D3	35.99951278	-9.927432946	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4852	11737	0.008690466	0.009798074	3	2	EN-L4	30	9	9
GGCTGGTGTGGCAAAC-1_371G_A3D3	11.2151093	9.192782553	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1342	2295	0	0.011328976	3	oligos	OL-Cntl	30	9	9
GGCTGGTGTTGGTGGA-1_371G_A3D3	32.71861959	-1.865789166	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2570	4862	0.016248457	0.005964624	3	2	EN-L4	30	9	9
GGCTGGTGTTGTGGCC-1_371G_A3D3	13.36208956	7.026011844	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1585	2668	0.001124438	0.009370315	3	oligos	OL-Cntl	30	9	9
GGCTGGTTCGGATGTT-1_371G_A3D3	8.824756162	9.725554188	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1320	2211	0.00226142	0.007688829	3	oligos	OL-Cntl	30	9	9
GGCTGGTTCGGTCTAA-1_371G_A3D3	-19.16782228	24.40654991	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1865	3364	0.001189061	0.006242568	3	8	Astrocytes	30	9	9
GGCTGGTTCGTCACGG-1_371G_A3D3	-29.17342875	0.767184198	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1912	3325	0.005112782	0.010526316	3	9	OPC	30	9	9
GGCTGGTTCTTGGGTA-1_371G_A3D3	20.09509333	-20.27749969	3	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	7273	26892	0.01524617	0.006395954	3	3	EN-L5-6	30	9	9
GGGAATGAGCCCAACC-1_371G_A3D3	-5.220391407	-2.302378536	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1575	2774	0.00036049	0.005046864	3	13A	IN-VIP	30	9	9
GGGAATGAGCTAGCCC-1_371G_A3D3	4.622579205	10.44292292	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1248	1905	0.001049869	0.02152231	3	oligos	OL-Cntl	30	9	9
GGGAATGCAATGGTCT-1_371G_A3D3	2.117267885	17.63843767	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	855	1328	0.000753012	0.009789157	3	oligos	OL-Cntl	30	9	9
GGGAATGGTCCGAACC-1_371G_A3D3	4.985566929	-20.154896	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5122	13630	0.000733676	0.005355833	3	L2-3	EN-L2-3-MS	30	9	9
GGGAATGGTGTGGCTC-1_371G_A3D3	-19.6245289	19.74543687	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1740	2823	0.001062699	0.004959263	3	8	Astrocytes	30	9	9
GGGAATGGTTCACCTC-1_371G_A3D3	-3.312710044	16.59158994	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	857	1259	0.003971406	0.01350278	3	oligos	OL-Cntl	30	9	9
GGGACCTAGACATAAC-1_371G_A3D3	6.848027949	-21.03035871	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	6660	21700	0.004884793	0.006958525	3	L2-3	EN-L2-3-MS	30	9	9
GGGACCTAGAGTGAGA-1_371G_A3D3	6.684834176	11.24357423	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1104	1725	0.002898551	0.013333333	3	oligos	OL-Cntl	30	9	9
GGGACCTCAAGTAGTA-1_371G_A3D3	36.04487687	-12.51295705	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	6088	16686	0.004614647	0.013843941	3	2	EN-L4	30	9	9
GGGACCTCACAACTGT-1_371G_A3D3	0.32506374	21.08353741	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	742	1062	0.003766478	0.015065913	3	oligos	OL-Cntl	30	9	9
GGGACCTCATACAGCT-1_371G_A3D3	-20.56735683	-6.570449075	13B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4563	10808	0.009900074	0.015081421	3	13B	IN-SV2C	30	9	9
GGGACCTCATCGACGC-1_371G_A3D3	-2.761840047	13.15369059	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	858	1206	0.001658375	0.018242123	3	oligos	OL-Cntl	30	9	9
GGGACCTCATTCCTGC-1_371G_A3D3	-1.223597988	17.68618324	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	732	1072	0.000932836	0.009328358	3	oligos	OL-Cntl	30	9	9
GGGACCTGTACTCTCC-1_371G_A3D3	2.757427252	14.50517831	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	992	1390	0.002158273	0.01294964	3	oligos	OL-Cntl	30	9	9
GGGACCTGTAGCTCCG-1_371G_A3D3	-10.68758561	18.83132068	11	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3431	6763	0.000591453	0.009315393	3	11	Glia-MIX	30	9	9
GGGACCTGTCATATGC-1_371G_A3D3	-0.080960456	17.95796345	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	758	1182	0.004230118	0.00676819	3	oligos	OL-Cntl	30	9	9
GGGACCTGTGAGCGAT-1_371G_A3D3	-2.754215711	25.78629468	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	761	1039	0.001924928	0.007699711	3	oligos	OL-Cntl	30	9	9
GGGACCTGTGTGGCTC-1_371G_A3D3	6.937385063	21.69380456	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	941	1356	0.005899705	0.005899705	3	oligos	OL-Cntl	30	9	9
GGGAGATAGATAGCAT-1_371G_A3D3	35.45256762	-8.713185729	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	6082	17459	0.002863852	0.007274185	3	2	EN-L4	30	9	9
GGGAGATCAGGACCCT-1_371G_A3D3	-0.427611195	19.16243763	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	869	1337	0.000747943	0.008975318	3	oligos	OL-Cntl	30	9	9
GGGAGATGTCTGATCA-1_371G_A3D3	11.41095154	13.22350323	11	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1074	1564	0.003196931	0.003196931	3	11	Glia-MIX	30	9	9
GGGAGATGTGAAAGAG-1_371G_A3D3	-16.03058549	-23.7958122	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1912	3230	0.007430341	0.00371517	3	6A	IN-PV	30	9	9
GGGAGATTCATGCAAC-1_371G_A3D3	-1.222313544	16.23527906	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	778	1140	0.001754386	0.018421053	3	oligos	OL-Cntl	30	9	9
GGGAGATTCCTGCTTG-1_371G_A3D3	6.970064119	9.405502728	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1286	2187	0.006401463	0.007773205	3	oligos	OL-Cntl	30	9	9
GGGAGATTCTACTCAT-1_371G_A3D3	-19.66498553	26.46610074	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1745	3039	0.002303389	0.006581112	3	8	Astrocytes	30	9	9
GGGAGATTCTGAAAGA-1_371G_A3D3	-32.10173237	-4.010688791	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1273	1930	0.010880829	0.00880829	3	9	OPC	30	9	9
GGGATGAAGACTGGGT-1_371G_A3D3	-15.32780733	-25.63079139	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1837	3443	0.000871333	0.002323555	3	6A	IN-PV	30	9	9
GGGATGAAGGTCATCT-1_371G_A3D3	10.52205137	17.38678541	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1047	1640	0.004878049	0.007317073	3	oligos	OL-Cntl	30	9	9
GGGATGAAGTGCAAGC-1_371G_A3D3	-1.794902219	13.52867824	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	856	1301	0.013066872	0.024596464	3	oligos	OL-Cntl	30	9	9
GGGATGAAGTGGGTTG-1_371G_A3D3	7.491286525	-10.40317674	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2124	4067	0.003688222	0.007868208	3	L2-3	EN-L2-3-MS	30	9	9
GGGATGAAGTTGAGTA-1_371G_A3D3	8.434392278	17.5046392	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	897	1416	0.008474576	0.007768362	3	oligos	OL-Cntl	30	9	9
GGGATGACAAGGACTG-1_371G_A3D3	-25.87949573	-22.6582648	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4103	8685	0.013126079	0.011974669	3	6A	IN-PV	30	9	9
GGGATGAGTAGCTAAA-1_371G_A3D3	2.085428717	17.09421027	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	874	1295	0.000772201	0.018532819	3	oligos	OL-Cntl	30	9	9
GGGATGAGTTAAGATG-1_371G_A3D3	8.920459392	9.953582311	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1216	1979	0.007579586	0.009600808	3	oligos	OL-Cntl	30	9	9
GGGATGAGTTGCTCCT-1_371G_A3D3	-12.81290518	0.576722555	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3035	6348	0.005828607	0.007718967	3	13A	IN-VIP	30	9	9
GGGATGATCAGCATGT-1_371G_A3D3	15.15444444	6.064673835	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2137	4105	0.004384896	0.009744214	3	oligos	OL-Cntl	30	9	9
GGGATGATCCAGAAGG-1_371G_A3D3	14.20582699	-17.55420596	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	6695	20437	0.003082644	0.010128688	3	L2-3	EN-L2-3-MS	30	9	9
GGGATGATCCGAACGC-1_371G_A3D3	2.01937616	15.81293622	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	876	1369	0.005113221	0.013148283	3	oligos	OL-Cntl	30	9	9
GGGATGATCTCGGACG-1_371G_A3D3	-17.87568057	28.60192319	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2453	4427	0.000225887	0.008809578	3	8	Astrocytes	30	9	9
GGGATGATCTGATTCT-1_371G_A3D3	-30.53523183	1.135294422	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1856	3192	0.001566416	0.007205514	3	9	OPC	30	9	9
GGGATGATCTTGGGTA-1_371G_A3D3	-17.7024518	1.095875571	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3987	8226	0.014344761	0.017262339	3	13A	IN-VIP	30	9	9
GGGCACTAGAGGTTGC-1_371G_A3D3	3.942511309	14.4991133	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1039	1670	0.001796407	0.008383234	3	oligos	OL-Cntl	30	9	9
GGGCACTAGGGTATCG-1_371G_A3D3	-12.04051769	-10.8519193	13B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1371	2311	0.009519688	0.005192557	3	13B	IN-SV2C	30	9	9
GGGCACTCATTCCTGC-1_371G_A3D3	-10.98587464	2.623749981	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3344	7854	0.000381971	0.007257448	3	13A	IN-VIP	30	9	9
GGGCACTCATTGGTAC-1_371G_A3D3	0.908915353	19.02198046	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	840	1306	0.000765697	0.008422665	3	oligos	OL-Cntl	30	9	9
GGGCACTGTAAGTGGC-1_371G_A3D3	35.78787848	-8.67453022	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5680	14599	0.00506884	0.007740256	3	2	EN-L4	30	9	9
GGGCACTGTCCTAGCG-1_371G_A3D3	-15.15418878	1.598093534	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3758	7673	0.005995048	0.01042617	3	13A	IN-VIP	30	9	9
GGGCACTGTCTCATCC-1_371G_A3D3	8.156372417	9.544510557	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1338	2295	0.002614379	0.009150327	3	oligos	OL-Cntl	30	9	9
GGGCACTTCCCATTTA-1_371G_A3D3	5.778445362	-19.64798511	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5192	14053	0.001352024	0.004838824	3	L2-3	EN-L2-3-MS	30	9	9
GGGCACTTCCGCGCAA-1_371G_A3D3	-14.79618286	1.548971423	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3655	8007	0.001248907	0.009741476	3	13A	IN-VIP	30	9	9
GGGCATCAGAACAACT-1_371G_A3D3	33.19130554	-7.076133501	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4206	9979	0.005711995	0.008317467	3	2	EN-L4	30	9	9
GGGCATCAGACTTTCG-1_371G_A3D3	9.36884251	-22.72076931	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	6157	19629	0.006113404	0.005807733	3	L2-3	EN-L2-3-MS	30	9	9
GGGCATCCAAGGTTCT-1_371G_A3D3	-13.20922577	-9.015783371	13B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2251	3994	0.015022534	0.005007511	3	13B	IN-SV2C	30	9	9
GGGCATCCAATCACAC-1_371G_A3D3	-1.146730486	-18.55645127	10	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2699	6075	0.002798354	0.003292181	3	L2-3	EN-L2-3-Cntl	30	9	9
GGGCATCCAGACGCAA-1_371G_A3D3	-28.78366935	0.97636881	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2290	4212	0.004273504	0.010683761	3	9	OPC	30	9	9
GGGCATCGTCAAACTC-1_371G_A3D3	-24.318543	0.794740196	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2194	4255	0.001410106	0.007755582	3	9	OPC	30	9	9
GGGCATCGTCAGTGGA-1_371G_A3D3	10.44171258	13.44883499	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1165	1844	0	0.009219089	3	oligos	OL-Cntl	30	9	9
GGGCATCGTCGAGTTT-1_371G_A3D3	-23.9306978	19.3044197	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1519	2539	0.002363135	0.003150847	3	8	Astrocytes	30	9	9
GGGCATCGTTGAACTC-1_371G_A3D3	-24.02106393	21.47484714	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1290	1941	0.004121587	0.006697579	3	8	Astrocytes	30	9	9
GGGCATCTCACAGGCC-1_371G_A3D3	-1.440011167	16.3876585	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	777	1148	0.003484321	0.014808362	3	oligos	OL-Cntl	30	9	9
GGGTCTGAGGAACTGC-1_371G_A3D3	-19.49013272	29.33370969	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2107	4002	0.000249875	0.001999	3	8	Astrocytes	30	9	9
GGGTCTGAGTAGATGT-1_371G_A3D3	-13.51305017	-10.50440444	13B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1969	3696	0.002705628	0.004599567	3	13B	IN-SV2C	30	9	9
GGGTCTGCAGCATGAG-1_371G_A3D3	-8.42017741	-17.99633176	6B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	690	1041	0.014409222	0.008645533	3	6B	IN-SST	30	9	9
GGGTCTGGTTGTACAC-1_371G_A3D3	-13.02871159	-15.4258793	6B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1366	1967	0.03202847	0.015251652	3	6B	IN-SST	30	9	9
GGGTCTGTCCTATGTT-1_371G_A3D3	-15.02403823	-22.52128503	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1572	2657	0.054572826	0.005645465	3	6A	IN-PV	30	9	9
GGGTCTGTCGATAGAA-1_371G_A3D3	8.624971585	-31.76782985	10	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4181	11933	0.005782284	0.00276544	3	L2-3	EN-L2-3-Cntl	30	9	9
GGGTCTGTCGGAATCT-1_371G_A3D3	9.523991334	12.06508102	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1028	1615	0.00619195	0.012383901	3	oligos	OL-Cntl	30	9	9
GGGTCTGTCTAACCGA-1_371G_A3D3	6.827681142	9.368043082	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1222	1838	0.002720348	0.013601741	3	oligos	OL-Cntl	30	9	9
GGGTCTGTCTCACATT-1_371G_A3D3	4.691774601	14.45055179	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	956	1494	0.002677376	0.008701473	3	oligos	OL-Cntl	30	9	9
GGGTCTGTCTTTACGT-1_371G_A3D3	30.20619095	16.12221134	14	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1486	2644	0.001134644	0.117624811	3	14	Microglia	30	9	9
GGGTTGCAGAAGGTGA-1_371G_A3D3	33.07766347	-6.801640332	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3939	9435	0.004239534	0.008267091	3	2	EN-L4	30	9	9
GGGTTGCAGCCGTCGT-1_371G_A3D3	-2.035086686	13.86627684	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	847	1207	0.004142502	0.028169014	3	oligos	OL-Cntl	30	9	9
GGGTTGCAGCTGCGAA-1_371G_A3D3	-9.235722853	0.702790397	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2473	5251	0.004380118	0.004951438	3	13A	IN-VIP	30	9	9
GGGTTGCAGGTGTGGT-1_371G_A3D3	-30.71916376	-0.289699211	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1714	2561	0.001952362	0.00624756	3	9	OPC	30	9	9
GGGTTGCAGTGGGTTG-1_371G_A3D3	-16.54008975	15.13447333	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1730	3149	0.003810734	0.004128295	3	8	Astrocytes	30	9	9
GGGTTGCCAAACAACA-1_371G_A3D3	24.10825436	-6.475032113	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3836	8684	0.003915246	0.005066789	3	2	EN-L4	30	9	9
GGGTTGCCACCCATGG-1_371G_A3D3	0.79085496	13.02468618	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	966	1497	0.008016032	0.021376086	3	oligos	OL-Cntl	30	9	9
GGGTTGCCATACTACG-1_371G_A3D3	5.061440048	10.21392353	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1272	2005	0.010972569	0.0159601	3	oligos	OL-Cntl	30	9	9
GGGTTGCGTGACTCAT-1_371G_A3D3	-3.766781964	14.08019855	5	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	807	1210	0.001652893	0.015702479	3	oligos	OL-MS-1	30	9	9
GGGTTGCTCGCCGTGA-1_371G_A3D3	-17.97509071	1.291719607	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5621	14075	0.007033748	0.011367673	3	13A	IN-VIP	30	9	9
GGGTTGCTCTTACCGC-1_371G_A3D3	-1.503822342	18.26401003	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	752	1131	0.004420866	0.011494253	3	oligos	OL-Cntl	30	9	9
GGTATTGAGCCCTAAT-1_371G_A3D3	10.09864892	-22.69414437	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	6363	19769	0.003591482	0.00607011	3	L2-3	EN-L2-3-MS	30	9	9
GGTATTGCACATCCGG-1_371G_A3D3	-23.92995343	-25.05991599	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3301	6841	0.00116942	0.011255664	3	6A	IN-PV	30	9	9
GGTATTGCAGGGTTAG-1_371G_A3D3	2.87340539	16.12820303	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	841	1239	0.004842615	0.012106538	3	oligos	OL-Cntl	30	9	9
GGTATTGCAGTTTACG-1_371G_A3D3	35.92439435	-9.335608298	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4354	10344	0.005897138	0.012664346	3	2	EN-L4	30	9	9
GGTATTGCATAGTAAG-1_371G_A3D3	7.377119996	-18.8579757	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5142	13512	0.006660746	0.009547069	3	L2-3	EN-L2-3-MS	30	9	9
GGTATTGCATGGTCTA-1_371G_A3D3	3.11277394	10.76988096	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1205	1921	0.006246746	0.020301926	3	oligos	OL-Cntl	30	9	9
GGTATTGGTCGGGTCT-1_371G_A3D3	-14.52887446	-0.029902847	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2964	5819	0.022168758	0.007733288	3	13A	IN-VIP	30	9	9
GGTATTGGTGCGGTAA-1_371G_A3D3	35.86321807	-10.96879985	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5117	13141	0.008066357	0.010805875	3	2	EN-L4	30	9	9
GGTATTGTCCGCGGTA-1_371G_A3D3	1.735295229	18.79508321	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	765	1108	0.002707581	0.005415162	3	oligos	OL-Cntl	30	9	9
GGTGAAGAGACTTTCG-1_371G_A3D3	35.71388144	-9.012348478	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5034	12570	0.003420843	0.011058075	3	2	EN-L4	30	9	9
GGTGAAGAGAGACTAT-1_371G_A3D3	-3.077612795	15.93994855	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	714	1051	0.000951475	0.006660324	3	oligos	OL-Cntl	30	9	9
GGTGAAGAGGATGGTC-1_371G_A3D3	-20.61300361	27.3253651	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1858	3152	0.005076142	0.006662437	3	8	Astrocytes	30	9	9
GGTGAAGCAAGCCTAT-1_371G_A3D3	7.677131723	9.245593744	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1293	1992	0.001004016	0.019076305	3	oligos	OL-Cntl	30	9	9
GGTGAAGCATGAAGTA-1_371G_A3D3	15.79368436	-28.99547842	3	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	6673	23346	0.000942346	0.006082412	3	3	EN-L5-6	30	9	9
GGTGAAGGTATAGTAG-1_371G_A3D3	-10.26883708	-5.940495773	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1953	3085	0.017828201	0.006482982	3	13A	IN-VIP	30	9	9
GGTGAAGGTGTGAATA-1_371G_A3D3	-19.01102688	29.48194577	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2769	5686	0.001055223	0.004220893	3	8	Astrocytes	30	9	9
GGTGAAGTCACTCCTG-1_371G_A3D3	36.0014297	-10.54009372	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5703	15719	0.004834913	0.009542592	3	2	EN-L4	30	9	9
GGTGAAGTCACTTATC-1_371G_A3D3	-0.059805653	15.36634876	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	840	1144	0.000874126	0.013986014	3	oligos	OL-Cntl	30	9	9
GGTGAAGTCATATCGG-1_371G_A3D3	-4.123688037	11.69842363	5	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	753	1042	0.001919386	0.014395393	3	oligos	OL-MS-1	30	9	9
GGTGCGTAGAGACTTA-1_371G_A3D3	-2.677865581	14.6040076	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	807	1197	0.004177109	0.01754386	3	oligos	OL-Cntl	30	9	9
GGTGCGTCAATCTACG-1_371G_A3D3	10.25789543	12.12923163	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1210	2061	0.000970403	0.012615235	3	oligos	OL-Cntl	30	9	9
GGTGCGTGTACGCACC-1_371G_A3D3	-9.098459162	-4.751536374	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1815	3207	0.047396321	0.006548176	3	13A	IN-VIP	30	9	9
GGTGCGTTCTTTACGT-1_371G_A3D3	-9.644519731	-18.38991105	6B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	855	1354	0.004431315	0.005169867	3	6B	IN-SST	30	9	9
GGTGTTAAGATGCGAC-1_371G_A3D3	-6.687496212	11.14966617	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	748	1050	0.003809524	0.013333333	3	oligos	OL-Cntl	30	9	9
GGTGTTAAGCGTGAAC-1_371G_A3D3	-23.66233891	-0.15116435	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1677	2885	0.001386482	0.006932409	3	9	OPC	30	9	9
GGTGTTAAGGACATTA-1_371G_A3D3	-30.33855213	1.737474401	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2212	3798	0.003422854	0.007898894	3	9	OPC	30	9	9
GGTGTTAAGGAGCGAG-1_371G_A3D3	-30.43856374	0.430247504	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1909	3237	0.000308928	0.012048193	3	9	OPC	30	9	9
GGTGTTAAGGGAAACA-1_371G_A3D3	-27.18792499	-0.182210756	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1836	3120	0.00224359	0.016666667	3	9	OPC	30	9	9
GGTGTTAGTTATGCGT-1_371G_A3D3	35.99143635	-9.352969559	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5015	11769	0.004503356	0.011640751	3	2	EN-L4	30	9	9
GGTGTTATCCACGACG-1_371G_A3D3	35.90125053	-7.711685217	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4544	12579	0.004849352	0.009460211	3	2	EN-L4	30	9	9
GTAACGTGTATCAGTC-1_371G_A3D3	22.37027659	16.03597693	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1305	2130	0.002816901	0.007981221	3	oligos	OL-Cntl	30	9	9
GTAACGTTCATTATCC-1_371G_A3D3	8.138528737	29.94526484	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	725	1128	0.002659574	0.004432624	3	oligos	OL-Cntl	30	9	9
GTAACGTTCTGTCCGT-1_371G_A3D3	-2.493015736	16.49447735	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	703	1111	0.00360036	0.00990099	3	oligos	OL-Cntl	30	9	9
GTAACTGTCACATGCA-1_371G_A3D3	6.200230856	-19.84151185	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4196	10172	0.003932363	0.005800236	3	L2-3	EN-L2-3-MS	30	9	9
GTACGTAAGAAGGTGA-1_371G_A3D3	1.799236886	14.98814848	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	921	1441	0.00277585	0.012491325	3	oligos	OL-Cntl	30	9	9
GTACGTAAGCACCGCT-1_371G_A3D3	9.580299022	10.47628728	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1302	2163	0.003698567	0.008321775	3	oligos	OL-Cntl	30	9	9
GTACGTAAGCGTGAAC-1_371G_A3D3	-23.80546511	-19.32564873	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2944	6054	0.007102742	0.009084903	3	6A	IN-PV	30	9	9
GTACGTACACAAGACG-1_371G_A3D3	37.38584123	-9.763696317	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4382	10161	0.003641374	0.009841551	3	2	EN-L4	30	9	9
GTACGTACACCCAGTG-1_371G_A3D3	-33.96802888	1.592927807	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1770	3238	0.002779494	0.008647313	3	9	OPC	30	9	9
GTACGTACAGCGTTCG-1_371G_A3D3	2.808955401	15.71436534	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	968	1482	0.016869096	0.002024291	3	oligos	OL-Cntl	30	9	9
GTACGTACAGGTCTCG-1_371G_A3D3	11.69847484	6.619645036	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1921	3549	0.001127078	0.01718794	3	oligos	OL-Cntl	30	9	9
GTACGTACAGGTGGAT-1_371G_A3D3	-18.9546991	28.18935114	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2317	4563	0.000657462	0.003944773	3	8	Astrocytes	30	9	9
GTACGTACATAACCTG-1_371G_A3D3	-3.997548494	6.953759579	5	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1244	2018	0.003964321	0.023290387	3	oligos	OL-MS-1	30	9	9
GTACGTACATGGATGG-1_371G_A3D3	4.336957046	9.384613789	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1195	1836	0.003812636	0.025599129	3	oligos	OL-Cntl	30	9	9
GTACGTAGTACTTGAC-1_371G_A3D3	11.62410267	9.646055394	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1337	2222	0.002250225	0.010351035	3	oligos	OL-Cntl	30	9	9
GTACGTAGTCCTCCAT-1_371G_A3D3	-10.62548859	-18.44673387	6B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1019	1604	0.014962594	0.006234414	3	6B	IN-SST	30	9	9
GTACGTAGTGTATGGG-1_371G_A3D3	-1.784940738	18.13850184	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	728	1059	0.002832861	0.007554297	3	oligos	OL-Cntl	30	9	9
GTACGTATCCCTAATT-1_371G_A3D3	8.015234933	6.999283369	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1123	1748	0.000572082	0.010869565	3	oligos	OL-Cntl	30	9	9
GTACGTATCGGTCCGA-1_371G_A3D3	7.310562586	9.364007702	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1344	2145	0.001864802	0.018181818	3	oligos	OL-Cntl	30	9	9
GTACGTATCTAACTCT-1_371G_A3D3	6.504231414	-31.7002909	10	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5908	20482	0.00029294	0.004003515	3	L2-3	EN-L2-3-Cntl	30	9	9
GTACGTATCTTCGGTC-1_371G_A3D3	-15.66587506	2.370488766	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4272	10236	0.01084408	0.011234857	3	13A	IN-VIP	30	9	9
GTACTCCAGCTGCCCA-1_371G_A3D3	-9.975096095	-5.758481755	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1803	2891	0.015565548	0.012452439	3	13A	IN-VIP	30	9	9
GTACTCCAGGTGCTAG-1_371G_A3D3	-19.1125275	26.1683784	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1918	3409	0.000586682	0.003520094	3	8	Astrocytes	30	9	9
GTACTCCAGTACGCGA-1_371G_A3D3	-12.39202147	16.31872503	11	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1496	2366	0.000845309	0.004649197	3	11	Glia-MIX	30	9	9
GTACTCCCAGCTCCGA-1_371G_A3D3	1.060150207	-9.442978147	12	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1582	2434	0.003697617	0.003697617	3	12	EN-MIX	30	9	9
GTACTCCGTAAATACG-1_371G_A3D3	-0.550678592	13.72971202	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	818	1175	0.000851064	0.023829787	3	oligos	OL-Cntl	30	9	9
GTACTCCGTAAGGATT-1_371G_A3D3	4.822658997	-21.2113921	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	6307	19935	0.001003261	0.003862553	3	L2-3	EN-L2-3-MS	30	9	9
GTACTCCTCAGTCCCT-1_371G_A3D3	9.542821965	8.105512162	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1562	2642	0.004163512	0.012112036	3	oligos	OL-Cntl	30	9	9
GTACTTTAGATGTAAC-1_371G_A3D3	-1.186986617	11.9076202	5	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	974	1426	0.002805049	0.02173913	3	oligos	OL-MS-1	30	9	9
GTACTTTAGATGTCGG-1_371G_A3D3	33.79304684	-6.48114797	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3480	7483	0.004810905	0.006815448	3	2	EN-L4	30	9	9
GTACTTTCAAGCCCAC-1_371G_A3D3	6.798413152	-18.96401338	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4616	11900	0.005462185	0.006722689	3	L2-3	EN-L2-3-MS	30	9	9
GTACTTTGTCGTCTTC-1_371G_A3D3	-24.29006541	-25.29589213	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4045	9356	0.002885849	0.012077811	3	6A	IN-PV	30	9	9
GTACTTTTCTGTCCGT-1_371G_A3D3	-21.34926841	25.87134338	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1662	2925	0.003076923	0.002735043	3	8	Astrocytes	30	9	9
GTAGGCCAGGCCATAG-1_371G_A3D3	8.38361777	12.9548773	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1092	1770	0.00960452	0.011299435	3	oligos	OL-Cntl	30	9	9
GTAGGCCAGTGCCATT-1_371G_A3D3	-22.29266712	19.12853125	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1575	2773	0.001803101	0.003606203	3	8	Astrocytes	30	9	9
GTAGGCCCACTTGGAT-1_371G_A3D3	-32.91640035	5.051808228	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2962	5855	0.001366354	0.004782237	3	9	OPC	30	9	9
GTAGGCCGTGCGATAG-1_371G_A3D3	6.501253273	10.10549631	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1082	1780	0.005617978	0.01741573	3	oligos	OL-Cntl	30	9	9
GTAGGCCTCTGGTATG-1_371G_A3D3	-34.57242314	-1.533639617	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1452	2435	0.000821355	0.009445585	3	9	OPC	30	9	9
GTAGGCCTCTTATCTG-1_371G_A3D3	11.24412643	19.26918916	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	967	1537	0	0.009759271	3	oligos	OL-Cntl	30	9	9
GTAGTCAAGACATAAC-1_371G_A3D3	-0.103747234	13.67359467	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	906	1295	0.004633205	0.017760618	3	oligos	OL-Cntl	30	9	9
GTAGTCAAGTGCCAGA-1_371G_A3D3	35.88703052	-10.96230263	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4787	11524	0.011541132	0.008764318	3	2	EN-L4	30	9	9
GTAGTCAGTCGCGAAA-1_371G_A3D3	-1.297082333	15.74878642	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	740	1028	0.006809339	0.015564202	3	oligos	OL-Cntl	30	9	9
GTAGTCAGTCTCTCGT-1_371G_A3D3	-19.99953405	25.89475295	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1722	2816	0.000710227	0.005681818	3	8	Astrocytes	30	9	9
GTAGTCAGTCTGATTG-1_371G_A3D3	7.160156558	11.20624998	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1182	1931	0.004660798	0.020714656	3	oligos	OL-Cntl	30	9	9
GTAGTCAGTGCTTCTC-1_371G_A3D3	15.65070742	12.37512493	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1288	2186	0.002744739	0.010064044	3	oligos	OL-Cntl	30	9	9
GTAGTCATCAACGGGA-1_371G_A3D3	14.0698535	8.994659266	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1670	2733	0.002561288	0.011342847	3	oligos	OL-Cntl	30	9	9
GTAGTCATCACCATAG-1_371G_A3D3	7.629656908	9.492567895	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1268	1976	0.000506073	0.011639676	3	oligos	OL-Cntl	30	9	9
GTATCTTAGTACGCCC-1_371G_A3D3	-12.93213511	-0.054106079	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2448	4815	0.013499481	0.009968847	3	13A	IN-VIP	30	9	9
GTATCTTCATATGAGA-1_371G_A3D3	10.77480902	-27.9061429	10	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5529	18308	0.000546209	0.006390649	3	L2-3	EN-L2-3-Cntl	30	9	9
GTATCTTGTCCCTTGT-1_371G_A3D3	2.256017881	16.33621405	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	925	1477	0.006093433	0.006770481	3	oligos	OL-Cntl	30	9	9
GTATCTTGTCGCATAT-1_371G_A3D3	35.87433032	-7.611951539	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4557	12065	0.003066722	0.006050559	3	2	EN-L4	30	9	9
GTATCTTGTTCAACCA-1_371G_A3D3	-33.03800741	-13.01928097	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	785	1225	0.009795918	0.001632653	3	9	OPC	30	9	9
GTATCTTTCGGCCGAT-1_371G_A3D3	11.98366504	-19.09077715	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5791	16892	0.01089273	0.010182335	3	L2-3	EN-L2-3-MS	30	9	9
GTATCTTTCTCACATT-1_371G_A3D3	8.483973379	17.02756281	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	875	1406	0.002133713	0.009246088	3	oligos	OL-Cntl	30	9	9
GTATCTTTCTGCAGTA-1_371G_A3D3	-19.95886785	26.03928835	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1788	3443	0.001742666	0.001742666	3	8	Astrocytes	30	9	9
GTATTCTGTAATCGTC-1_371G_A3D3	-34.01052974	-7.772328042	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	988	1513	0.002643754	0.002643754	3	9	OPC	30	9	9
GTATTCTTCCAACCAA-1_371G_A3D3	-0.331643701	14.57846572	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	851	1338	0.003736921	0.013452915	3	oligos	OL-Cntl	30	9	9
GTCAAGTCAACGATCT-1_371G_A3D3	-2.830710451	15.23815675	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	715	1041	0.00192123	0.007684918	3	oligos	OL-Cntl	30	9	9
GTCAAGTCAAGTAGTA-1_371G_A3D3	-30.25097293	2.247759894	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2332	4200	0.001428571	0.01047619	3	9	OPC	30	9	9
GTCAAGTCAAGTCATC-1_371G_A3D3	6.432897834	-18.85987843	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3849	9011	0.00810121	0.006769504	3	L2-3	EN-L2-3-MS	30	9	9
GTCAAGTCAGCTCGAC-1_371G_A3D3	18.89906907	-14.84763264	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	8666	35291	0.020373466	0.012326089	3	L2-3	EN-L2-3-MS	30	9	9
GTCAAGTCATTTGCTT-1_371G_A3D3	-27.25775685	-0.815425361	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2034	3932	0.002288911	0.01017294	3	9	OPC	30	9	9
GTCAAGTGTCCGAAGA-1_371G_A3D3	-22.86649894	-4.626992124	13B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1804	2717	0.009569378	0.008465219	3	13B	IN-SV2C	30	9	9
GTCAAGTGTCCGCTGA-1_371G_A3D3	12.53050262	7.336480012	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1847	3347	0.000896325	0.011652226	3	oligos	OL-Cntl	30	9	9
GTCAAGTGTCGCGGTT-1_371G_A3D3	7.794226567	-17.9219153	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3972	8975	0.005013928	0.013927577	3	L2-3	EN-L2-3-MS	30	9	9
GTCAAGTGTTACAGAA-1_371G_A3D3	-18.61604988	-21.51619969	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2173	4098	0.01659346	0.005612494	3	6A	IN-PV	30	9	9
GTCACAAAGGCTACGA-1_371G_A3D3	9.612579082	15.24521448	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	976	1552	0.004510309	0.007731959	3	oligos	OL-Cntl	30	9	9
GTCACAAAGTAGGCCA-1_371G_A3D3	-30.28523915	-1.555029419	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1558	2531	0.004741209	0.007111814	3	9	OPC	30	9	9
GTCACAAAGTTAACGA-1_371G_A3D3	35.83869631	-11.41749592	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5968	17224	0.011031119	0.017127264	3	2	EN-L4	30	9	9
GTCACAACAATGGATA-1_371G_A3D3	-10.45456435	15.55415492	11	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1752	2839	0.003874604	0.007396971	3	11	Glia-MIX	30	9	9
GTCACAACATTACCTT-1_371G_A3D3	-18.99435991	29.56710295	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2440	4767	0.003985735	0.005034613	3	8	Astrocytes	30	9	9
GTCACAAGTATATGAG-1_371G_A3D3	1.285587662	15.15739067	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	855	1302	0.003840246	0.015360983	3	oligos	OL-Cntl	30	9	9
GTCACAATCAGCGATT-1_371G_A3D3	-14.64201939	1.153929055	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3366	7215	0.012335412	0.008870409	3	13A	IN-VIP	30	9	9
GTCACAATCCATGAGT-1_371G_A3D3	6.195105302	-19.46447936	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4463	10179	0.003438452	0.005599764	3	L2-3	EN-L2-3-MS	30	9	9
GTCACAATCGCCATAA-1_371G_A3D3	6.145293815	34.48047314	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	862	1317	0.001518603	0.006074412	3	oligos	OL-Cntl	30	9	9
GTCACGGAGATGCCTT-1_371G_A3D3	18.65855731	-24.06884713	3	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	6489	19523	0.006914921	0.014239615	3	3	EN-L5-6	30	9	9
GTCACGGAGCTAGGCA-1_371G_A3D3	24.99391704	-12.16795368	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	9708	42547	0.006721978	0.008484735	3	2	EN-L4	30	9	9
GTCACGGAGGCGACAT-1_371G_A3D3	-19.69258165	25.56083789	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1764	3079	0.000649562	0.005521273	3	8	Astrocytes	30	9	9
GTCACGGGTACCCAAT-1_371G_A3D3	-18.96735918	27.87878568	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2130	4136	0.000241779	0.006769826	3	8	Astrocytes	30	9	9
GTCACGGGTGTATGGG-1_371G_A3D3	-29.52251475	-2.860136127	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1490	2251	0.003109729	0.007552199	3	9	OPC	30	9	9
GTCATTTAGAAGGACA-1_371G_A3D3	9.376485221	14.22712784	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1186	2098	0.004766444	0.008102955	3	oligos	OL-Cntl	30	9	9
GTCATTTAGTACATGA-1_371G_A3D3	-34.91596177	-2.428174192	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1532	2563	0.00702302	0.004682013	3	9	OPC	30	9	9
GTCATTTCACCTGGTG-1_371G_A3D3	10.92401037	8.760879507	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1572	2705	0.001109057	0.008133087	3	oligos	OL-Cntl	30	9	9
GTCATTTGTCGGCTCA-1_371G_A3D3	0.907432143	18.04992973	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	820	1327	0.003767898	0.005275057	3	oligos	OL-Cntl	30	9	9
GTCCTCAAGAAGCCCA-1_371G_A3D3	1.436455261	16.76503203	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	884	1306	0.009954058	0.011485452	3	oligos	OL-Cntl	30	9	9
GTCCTCAAGCCACGTC-1_371G_A3D3	33.18391523	-6.954604848	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3933	9527	0.003778734	0.009131941	3	2	EN-L4	30	9	9
GTCCTCAAGGCCCTCA-1_371G_A3D3	-20.39776358	26.07174006	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1567	2520	0.005555556	0.004761905	3	8	Astrocytes	30	9	9
GTCCTCAAGTGTCCCG-1_371G_A3D3	0.279767758	15.24291399	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	879	1306	0.00229709	0.013782542	3	oligos	OL-Cntl	30	9	9
GTCCTCACAACTTGAC-1_371G_A3D3	6.075920326	33.92858162	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	909	1376	0.012354651	0.007994186	3	oligos	OL-Cntl	30	9	9
GTCCTCACACATCCGG-1_371G_A3D3	-18.85739888	26.87188755	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2051	3546	0.003102087	0.003948111	3	8	Astrocytes	30	9	9
GTCCTCACACCAACCG-1_371G_A3D3	1.700872071	14.08613652	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	901	1302	0.002304147	0.011520737	3	oligos	OL-Cntl	30	9	9
GTCCTCACATCCGGGT-1_371G_A3D3	-2.221269617	19.03245349	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	763	1147	0.001743679	0.006974717	3	oligos	OL-Cntl	30	9	9
GTCCTCAGTCGCATCG-1_371G_A3D3	36.02028788	-11.95605558	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	6137	16027	0.006988207	0.012104574	3	2	EN-L4	30	9	9
GTCCTCAGTCTTGATG-1_371G_A3D3	-2.538783646	-0.922930572	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2489	4479	0.009153829	0.008930565	3	13A	IN-VIP	30	9	9
GTCCTCATCACTTCAT-1_371G_A3D3	35.98863917	-9.379099834	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	6071	17447	0.002407291	0.00951453	3	2	EN-L4	30	9	9
GTCCTCATCCTTGCCA-1_371G_A3D3	-1.771896428	17.92284953	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	812	1273	0.025923016	0.009426551	3	oligos	OL-Cntl	30	9	9
GTCCTCATCGTCCAGG-1_371G_A3D3	34.98496243	-7.455483378	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4787	12885	0.014590609	0.004734187	3	2	EN-L4	30	9	9
GTCGGGTAGAGAGCTC-1_371G_A3D3	-30.5166172	-0.078246187	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1663	2780	0.002517986	0.010431655	3	9	OPC	30	9	9
GTCGGGTAGTACGCCC-1_371G_A3D3	32.93458602	-3.099788414	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2862	5871	0.004258218	0.007494464	3	2	EN-L4	30	9	9
GTCGGGTCATGAAGTA-1_371G_A3D3	9.102214126	9.825472868	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1205	1909	0.004190676	0.011000524	3	oligos	OL-Cntl	30	9	9
GTCGGGTGTTTACTCT-1_371G_A3D3	-2.437258933	15.9709961	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	858	1261	0.001586043	0.013481364	3	oligos	OL-Cntl	30	9	9
GTCGGGTTCACCCTCA-1_371G_A3D3	-8.222066007	-2.90775595	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1835	3299	0.0506214	0.005153077	3	13A	IN-VIP	30	9	9
GTCGGGTTCCGCAAGC-1_371G_A3D3	-7.431694857	11.89095171	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	733	1020	0.005882353	0.012745098	3	oligos	OL-Cntl	30	9	9
GTCGTAAAGCGATTCT-1_371G_A3D3	-24.00427667	-19.39896882	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2932	5636	0.003371185	0.012242725	3	6A	IN-PV	30	9	9
GTCGTAACACTCAGGC-1_371G_A3D3	-4.453001627	13.94032752	5	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	797	1104	0.001811594	0.011775362	3	oligos	OL-MS-1	30	9	9
GTCGTAACAGGCTGAA-1_371G_A3D3	3.688462758	9.311892089	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1267	1880	0.003191489	0.023404255	3	oligos	OL-Cntl	30	9	9
GTCGTAAGTCGCGAAA-1_371G_A3D3	7.133614616	15.95728775	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1044	1534	0.00065189	0.011082138	3	oligos	OL-Cntl	30	9	9
GTCGTAATCCGTTGCT-1_371G_A3D3	-30.27285761	9.952177168	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	744	1051	0.002854424	0.003805899	3	8	Astrocytes	30	9	9
GTCGTAATCGGTTAAC-1_371G_A3D3	-16.28773833	15.75172708	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2195	4274	0.003509593	0.003977539	3	8	Astrocytes	30	9	9
GTCTCGTCATCTGGTA-1_371G_A3D3	-1.609348919	13.70422642	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	805	1191	0.004198153	0.020990764	3	oligos	OL-Cntl	30	9	9
GTCTCGTGTCTAGTCA-1_371G_A3D3	-2.881686078	15.39786463	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	770	1115	0.004484305	0.023318386	3	oligos	OL-Cntl	30	9	9
GTCTCGTGTTAAAGAC-1_371G_A3D3	0.853861466	17.37010993	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	829	1223	0.004088307	0.008176615	3	oligos	OL-Cntl	30	9	9
GTCTCGTTCATCGATG-1_371G_A3D3	-4.159188153	-4.299267677	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1179	1970	0.015736041	0.006091371	3	13A	IN-VIP	30	9	9
GTCTCGTTCCGCGGTA-1_371G_A3D3	5.130507919	-19.56564737	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3784	8924	0.003361721	0.009188705	3	L2-3	EN-L2-3-MS	30	9	9
GTCTCGTTCTAACGGT-1_371G_A3D3	30.69283901	-1.352169757	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3247	7417	0.004718889	0.00323581	3	2	EN-L4	30	9	9
GTCTCGTTCTTTAGTC-1_371G_A3D3	-9.026175503	27.09421176	5	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1278	1908	0.019392034	0.015199161	3	oligos	OL-MS-1	30	9	9
GTCTTCGCAATGAAAC-1_371G_A3D3	2.339465877	15.72506794	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1033	1741	0.001723148	0.008041356	3	oligos	OL-Cntl	30	9	9
GTCTTCGCACAGGCCT-1_371G_A3D3	3.276351419	11.14780536	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1121	1747	0.00171723	0.021751574	3	oligos	OL-Cntl	30	9	9
GTCTTCGCAGCATACT-1_371G_A3D3	-1.50474447	13.47908665	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	931	1396	0.004297994	0.013610315	3	oligos	OL-Cntl	30	9	9
GTCTTCGTCAGATAAG-1_371G_A3D3	7.849290761	15.4437802	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1043	1665	0.001801802	0.009009009	3	oligos	OL-Cntl	30	9	9
GTCTTCGTCCGCAGTG-1_371G_A3D3	2.498321121	15.08394998	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	909	1393	0.00143575	0.011486001	3	oligos	OL-Cntl	30	9	9
GTGAAGGAGGAATCGC-1_371G_A3D3	-19.05675286	28.93101381	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2306	4386	0.001367989	0.005243958	3	8	Astrocytes	30	9	9
GTGAAGGGTCCCGACA-1_371G_A3D3	-29.23088472	0.166758064	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1702	2853	0.002453558	0.008762706	3	9	OPC	30	9	9
GTGAAGGTCACAACGT-1_371G_A3D3	-23.13461802	7.306751389	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1022	1509	0.044400265	0.005964215	3	8	Astrocytes	30	9	9
GTGCAGCAGGGAAACA-1_371G_A3D3	-14.2249209	1.127194346	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3319	7003	0.013422819	0.007282593	3	13A	IN-VIP	30	9	9
GTGCAGCAGGGTATCG-1_371G_A3D3	-30.58302569	-1.625293001	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1609	2540	0.00511811	0.006299213	3	9	OPC	30	9	9
GTGCAGCCAAGGACAC-1_371G_A3D3	10.98472995	7.059760516	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1699	2840	0.012323944	0.01584507	3	oligos	OL-Cntl	30	9	9
GTGCAGCCAAGTACCT-1_371G_A3D3	-32.5485166	-8.015061814	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1160	1768	0.002262443	0.003393665	3	9	OPC	30	9	9
GTGCAGCTCCATGCTC-1_371G_A3D3	1.904433328	12.92864236	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	984	1578	0.000633714	0.018377693	3	oligos	OL-Cntl	30	9	9
GTGCAGCTCGCATGAT-1_371G_A3D3	11.29609949	-26.89889794	10	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	9244	41257	0.003199457	0.004362896	3	L2-3	EN-L2-3-Cntl	30	9	9
GTGCATAAGCCAGTAG-1_371G_A3D3	-19.79309504	27.49516131	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2019	3509	0.001424907	0.004844685	3	8	Astrocytes	30	9	9
GTGCATAAGGCTCATT-1_371G_A3D3	10.83757384	7.679777817	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1522	2625	0.001142857	0.017142857	3	oligos	OL-Cntl	30	9	9
GTGCATAAGTTTGCGT-1_371G_A3D3	-2.589616937	15.42531727	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	789	1206	0.001658375	0.012437811	3	oligos	OL-Cntl	30	9	9
GTGCATACAAGTTCTG-1_371G_A3D3	-18.33506292	-17.62207336	6B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2178	4152	0.004094412	0.007225434	3	6B	IN-SST	30	9	9
GTGCATAGTTTGCATG-1_371G_A3D3	-30.51219214	-10.53845555	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	981	1571	0.000636537	0.008274984	3	9	OPC	30	9	9
GTGCATATCAAGCCTA-1_371G_A3D3	-19.93420348	-17.83898594	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3600	8941	0.002348731	0.002460575	3	6A	IN-PV	30	9	9
GTGCATATCTTGGGTA-1_371G_A3D3	0.810559253	14.1194854	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	943	1499	0	0.01400934	3	oligos	OL-Cntl	30	9	9
GTGCGGTCAGACTCGC-1_371G_A3D3	-14.8570226	-10.02854297	13B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3130	7230	0.000829876	0.006639004	3	13B	IN-SV2C	30	9	9
GTGCGGTGTGTGAATA-1_371G_A3D3	-0.961637106	16.53248831	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	784	1083	0.002770083	0.00923361	3	oligos	OL-Cntl	30	9	9
GTGCGGTGTGTTCGAT-1_371G_A3D3	35.90959425	-8.742058389	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5261	13759	0.004288102	0.0096664	3	2	EN-L4	30	9	9
GTGCGGTTCACAGTAC-1_371G_A3D3	7.351987097	29.92612417	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	678	1013	0.0029615	0.0029615	3	oligos	OL-Cntl	30	9	9
GTGCGGTTCATACGGT-1_371G_A3D3	-17.0451473	-26.34427905	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2297	4950	0.001818182	0.003636364	3	6A	IN-PV	30	9	9
GTGCGGTTCATGTCCC-1_371G_A3D3	6.997063172	10.42018085	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1377	2302	0.00086881	0.017810599	3	oligos	OL-Cntl	30	9	9
GTGCGGTTCCCACTTG-1_371G_A3D3	-24.06655888	-24.96913231	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4179	9832	0.019934906	0.007628153	3	6A	IN-PV	30	9	9
GTGCTTCAGCGATATA-1_371G_A3D3	1.87201879	12.66629333	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	943	1446	0.003457815	0.017289073	3	oligos	OL-Cntl	30	9	9
GTGCTTCCAGACGCAA-1_371G_A3D3	-20.12748732	27.84341294	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2035	3471	0.001728608	0.003457217	3	8	Astrocytes	30	9	9
GTGCTTCCAGATCCAT-1_371G_A3D3	29.12179485	-0.132058054	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3418	8049	0.004472605	0.004099888	3	2	EN-L4	30	9	9
GTGCTTCCATATGCTG-1_371G_A3D3	0.310816064	-0.66664419	6B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	932	1377	0.031227306	0.005083515	3	6B	IN-SST	30	9	9
GTGCTTCGTAGCGTGA-1_371G_A3D3	-0.413750898	13.53686727	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	895	1293	0.003093581	0.016241299	3	oligos	OL-Cntl	30	9	9
GTGGGTCAGCTAAACA-1_371G_A3D3	29.14346746	1.086973656	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2638	5190	0.000770713	0.004431599	3	2	EN-L4	30	9	9
GTGGGTCCACCAGCAC-1_371G_A3D3	3.204229839	15.04435819	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1088	1804	0.004988914	0.011640798	3	oligos	OL-Cntl	30	9	9
GTGGGTCCATCACGAT-1_371G_A3D3	-1.303835042	13.46419075	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	924	1338	0.004484305	0.019431988	3	oligos	OL-Cntl	30	9	9
GTGGGTCGTGCTCTTC-1_371G_A3D3	9.60354871	-30.09372764	10	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4705	13610	0.006906686	0.003379868	3	L2-3	EN-L2-3-Cntl	30	9	9
GTGGGTCTCATGCATG-1_371G_A3D3	4.358652832	16.48733368	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	881	1348	0.00148368	0.008902077	3	oligos	OL-Cntl	30	9	9
GTGGGTCTCCTCATTA-1_371G_A3D3	-1.337653302	-0.887087447	11	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2580	4926	0.028217621	0.005075112	3	11	Glia-MIX	30	9	9
GTGGGTCTCGAATCCA-1_371G_A3D3	28.12913832	-3.611516562	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3832	9997	0.00080024	0.005701711	3	2	EN-L4	30	9	9
GTGGGTCTCGTTACGA-1_371G_A3D3	-14.12565044	-9.85314177	13B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2388	4910	0.003665988	0.005295316	3	13B	IN-SV2C	30	9	9
GTGGGTCTCTCAAGTG-1_371G_A3D3	2.52167318	18.2472733	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	839	1381	0.002896452	0.001448226	3	oligos	OL-Cntl	30	9	9
GTGGGTCTCTTCGGTC-1_371G_A3D3	0.518338953	13.59880926	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	949	1468	0	0.01226158	3	oligos	OL-Cntl	30	9	9
GTGTGCGAGGGAACGG-1_371G_A3D3	-2.756933385	14.39905804	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	799	1148	0.005226481	0.020905923	3	oligos	OL-Cntl	30	9	9
GTGTGCGAGTACTTGC-1_371G_A3D3	10.51529599	-27.77097241	10	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	7829	29347	0.000613351	0.004089004	3	L2-3	EN-L2-3-Cntl	30	9	9
GTGTGCGAGTGGACGT-1_371G_A3D3	10.15896574	-27.44897371	10	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	6761	24087	0.000581226	0.005604683	3	L2-3	EN-L2-3-Cntl	30	9	9
GTGTGCGCAGTAGAGC-1_371G_A3D3	-31.06163453	10.28458924	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	937	1416	0.000706215	0.006355932	3	8	Astrocytes	30	9	9
GTGTGCGCATCGGACC-1_371G_A3D3	14.76248161	1.739711392	12	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	845	1152	0.001736111	0.002604167	3	12	EN-MIX	30	9	9
GTGTGCGGTACCTACA-1_371G_A3D3	-2.266047282	-0.678958414	11	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4219	10391	0.008468867	0.007121547	3	11	Glia-MIX	30	9	9
GTGTGCGTCGATCCCT-1_371G_A3D3	-4.683876834	-4.036596088	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1249	2036	0.017681729	0.006385069	3	13A	IN-VIP	30	9	9
GTGTGCGTCGCCCTTA-1_371G_A3D3	35.18304236	-9.140028401	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	6993	21936	0.007977753	0.010257112	3	2	EN-L4	30	9	9
GTGTGCGTCGTAGATC-1_371G_A3D3	-20.06199507	26.77179995	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1872	3210	0.000934579	0.003426791	3	8	Astrocytes	30	9	9
GTGTGCGTCTAAGCCA-1_371G_A3D3	-1.667449156	17.21757512	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	678	1004	0.001992032	0.022908367	3	oligos	OL-Cntl	30	9	9
GTGTTAGAGACCTTTG-1_371G_A3D3	2.586972855	12.92239798	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	910	1350	0.000740741	0.015555556	3	oligos	OL-Cntl	30	9	9
GTGTTAGAGAGTAAGG-1_371G_A3D3	24.28673993	-11.12910152	3	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4678	11331	0.004059659	0.007236784	3	3	EN-L5-6	30	9	9
GTGTTAGAGGCTAGGT-1_371G_A3D3	-4.803665571	10.22333302	5	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	771	1047	0.00286533	0.035339064	3	oligos	OL-MS-1	30	9	9
GTGTTAGGTAGCACGA-1_371G_A3D3	-22.96255873	-25.52986815	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3546	8014	0.00461692	0.008110806	3	6A	IN-PV	30	9	9
GTGTTAGTCAGTTTGG-1_371G_A3D3	28.7404072	-3.909523625	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3505	8183	0.000855432	0.007943297	3	2	EN-L4	30	9	9
GTGTTAGTCCCGACTT-1_371G_A3D3	9.083836562	12.63908419	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1001	1560	0.001282051	0.017948718	3	oligos	OL-Cntl	30	9	9
GTTAAGCAGCTGAAAT-1_371G_A3D3	-17.32792328	-16.93711502	6B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1951	3527	0.013042246	0.007088177	3	6B	IN-SST	30	9	9
GTTAAGCAGTAGATGT-1_371G_A3D3	8.876548543	-25.00796832	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5573	17039	0.006162333	0.005223311	3	L2-3	EN-L2-3-MS	30	9	9
GTTAAGCTCAGAGGTG-1_371G_A3D3	15.13052891	-28.90095228	3	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5828	18918	0.00544455	0.00544455	3	3	EN-L5-6	30	9	9
GTTAAGCTCCATTCTA-1_371G_A3D3	1.343980895	16.16985697	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	746	1177	0.000849618	0.003398471	3	oligos	OL-Cntl	30	9	9
GTTACAGAGATATGGT-1_371G_A3D3	32.98105593	-6.971977885	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4527	12011	0.008242444	0.005328449	3	2	EN-L4	30	9	9
GTTACAGAGGCGATAC-1_371G_A3D3	-29.90650436	0.24805606	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1941	3242	0.002467613	0.006785935	3	9	OPC	30	9	9
GTTACAGCAAGCCTAT-1_371G_A3D3	-31.540369	-12.64793905	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	768	1120	0.003571429	0.003571429	3	9	OPC	30	9	9
GTTACAGCATCCTAGA-1_371G_A3D3	36.02562206	-10.40770752	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4848	11478	0.003484928	0.01036766	3	2	EN-L4	30	9	9
GTTACAGGTAGGCTGA-1_371G_A3D3	-31.03182405	-3.740185088	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1412	2252	0.003108348	0.004440497	3	9	OPC	30	9	9
GTTACAGGTGTGCCTG-1_371G_A3D3	8.434899197	15.73627229	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1013	1665	0.003003003	0.005405405	3	oligos	OL-Cntl	30	9	9
GTTACAGGTTTGTTGG-1_371G_A3D3	-21.45370433	-26.25350297	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2746	6009	0.009485771	0.003994009	3	6A	IN-PV	30	9	9
GTTACAGTCGAACTGT-1_371G_A3D3	-0.910093286	17.20548437	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	795	1210	0.001652893	0.009917355	3	oligos	OL-Cntl	30	9	9
GTTACAGTCTTGTCAT-1_371G_A3D3	-13.73953225	1.389529923	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3328	6799	0.001176644	0.007942344	3	13A	IN-VIP	30	9	9
GTTCATTAGAGACTAT-1_371G_A3D3	-32.58662847	-12.93442271	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	726	1021	0.008814887	0.005876592	3	9	OPC	30	9	9
GTTCATTAGAGGTACC-1_371G_A3D3	-28.55140652	12.76858605	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	912	1368	0.004385965	0.001461988	3	8	Astrocytes	30	9	9
GTTCATTAGCTCCTTC-1_371G_A3D3	36.06918682	-9.15382057	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5098	13179	0.003945671	0.011761135	3	2	EN-L4	30	9	9
GTTCATTCACACTGCG-1_371G_A3D3	12.08046227	-24.05256616	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	7015	24778	0.001049318	0.006659133	3	L2-3	EN-L2-3-MS	30	9	9
GTTCATTGTAGGAGTC-1_371G_A3D3	3.412824757	14.68401822	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1027	1637	0.003054368	0.011606597	3	oligos	OL-Cntl	30	9	9
GTTCATTGTGCTAGCC-1_371G_A3D3	-19.00894939	29.7146905	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2671	5692	0.001229796	0.005973296	3	8	Astrocytes	30	9	9
GTTCATTTCCCATTTA-1_371G_A3D3	2.659351541	16.83077841	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	931	1490	0.010067114	0.013422819	3	oligos	OL-Cntl	30	9	9
GTTCATTTCCCTTGTG-1_371G_A3D3	7.344647683	-20.8597023	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	6090	20143	0.004418408	0.00610634	3	L2-3	EN-L2-3-MS	30	9	9
GTTCGGGCAATAGCAA-1_371G_A3D3	-29.48357919	10.59733992	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	820	1133	0.001765225	0.0070609	3	8	Astrocytes	30	9	9
GTTCGGGCACATCTTT-1_371G_A3D3	2.503177785	13.34599717	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	914	1396	0	0.014326648	3	oligos	OL-Cntl	30	9	9
GTTCGGGCACGGCTAC-1_371G_A3D3	-17.29767669	-10.32296063	13B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3828	9617	0.006654882	0.004055319	3	13B	IN-SV2C	30	9	9
GTTCGGGGTCCCTTGT-1_371G_A3D3	2.759952891	14.93942792	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1022	1632	0.005514706	0.008578431	3	oligos	OL-Cntl	30	9	9
GTTCGGGTCATTCACT-1_371G_A3D3	-31.45281063	-1.46739348	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1439	2329	0.000429369	0.005152426	3	9	OPC	30	9	9
GTTCGGGTCGCTTGTC-1_371G_A3D3	37.2484552	-9.64061129	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5708	16163	0.009156716	0.008971107	3	2	EN-L4	30	9	9
GTTCGGGTCTATCCCG-1_371G_A3D3	-18.58127736	0.617863484	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5080	12286	0.010418362	0.016441478	3	13A	IN-VIP	30	9	9
GTTCTCGAGACTAAGT-1_371G_A3D3	19.49430383	12.32031615	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1338	2290	0.003056769	0.004366812	3	oligos	OL-Cntl	30	9	9
GTTCTCGAGGGTCTCC-1_371G_A3D3	-24.63528322	21.55412721	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1195	1859	0.005379236	0.004303389	3	8	Astrocytes	30	9	9
GTTCTCGAGTGACATA-1_371G_A3D3	-30.66279835	-1.592353985	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1501	2678	0.001120239	0.004480956	3	9	OPC	30	9	9
GTTCTCGAGTGACTCT-1_371G_A3D3	-18.2982552	-24.41907271	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2359	4667	0.002142704	0.003642597	3	6A	IN-PV	30	9	9
GTTCTCGCACCAACCG-1_371G_A3D3	35.7605354	-8.422263417	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5022	13092	0.004659334	0.006416132	3	2	EN-L4	30	9	9
GTTCTCGGTACCGTAT-1_371G_A3D3	9.827275223	-23.52796816	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5974	20307	0.002560693	0.003939528	3	L2-3	EN-L2-3-MS	30	9	9
GTTCTCGGTTACGTCA-1_371G_A3D3	3.87551121	14.19758106	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1061	1722	0.006387921	0.010452962	3	oligos	OL-Cntl	30	9	9
GTTCTCGTCGGTTAAC-1_371G_A3D3	2.865688317	14.98803702	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	996	1526	0.001310616	0.012450852	3	oligos	OL-Cntl	30	9	9
GTTTCTAAGAGCTTCT-1_371G_A3D3	11.36373544	8.315860377	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1457	2377	0.001262095	0.010096761	3	oligos	OL-Cntl	30	9	9
GTTTCTAAGCCCAGCT-1_371G_A3D3	-0.362373002	13.18279343	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1012	1603	0.001247661	0.017467249	3	oligos	OL-Cntl	30	9	9
GTTTCTAAGGTGCTTT-1_371G_A3D3	-17.05725347	-25.10868829	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2389	5410	0.006654344	0.002957486	3	6A	IN-PV	30	9	9
GTTTCTATCATCGATG-1_371G_A3D3	-0.591946704	15.84025976	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	699	1026	0.000974659	0.016569201	3	oligos	OL-Cntl	30	9	9
TAAACCGCACAGACTT-1_371G_A3D3	-33.88476483	-0.95521368	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1607	2830	0	0.003886926	3	9	OPC	30	9	9
TAAACCGGTACAAGTA-1_371G_A3D3	15.98321564	13.88552162	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1253	2005	0.000997506	0.004488778	3	oligos	OL-Cntl	30	9	9
TAAACCGGTCGACTAT-1_371G_A3D3	14.86157544	1.495565573	12	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1311	2575	0.001941748	0.003495146	3	12	EN-MIX	30	9	9
TAAACCGGTCGCATCG-1_371G_A3D3	35.52977552	-7.163876658	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3651	8462	0.016308201	0.006145119	3	2	EN-L4	30	9	9
TAAACCGGTCTAACGT-1_371G_A3D3	10.20835856	12.07950967	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1267	2165	0.003233256	0.008775982	3	oligos	OL-Cntl	30	9	9
TAAACCGGTGAGTGAC-1_371G_A3D3	-9.933842968	12.27702284	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1025	1479	0.006085193	0.018255578	3	oligos	OL-Cntl	30	9	9
TAAACCGTCCACGACG-1_371G_A3D3	-22.47473855	-16.96755993	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4711	13413	0.014910907	0.006188027	3	6A	IN-PV	30	9	9
TAAACCGTCCTTAATC-1_371G_A3D3	15.39742443	10.36310571	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1291	2182	0.001833181	0.004124656	3	oligos	OL-Cntl	30	9	9
TAAACCGTCGGGAGTA-1_371G_A3D3	33.47729631	-5.498356174	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3506	7676	0.018629495	0.003126628	3	2	EN-L4	30	9	9
TAAGAGAAGTCATGCT-1_371G_A3D3	1.733730938	15.23940489	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	803	1221	0.001638002	0.00982801	3	oligos	OL-Cntl	30	9	9
TAAGAGACAATAGCAA-1_371G_A3D3	-13.19043743	1.543848741	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3543	7749	0.001935734	0.006452445	3	13A	IN-VIP	30	9	9
TAAGAGACAGGTCCAC-1_371G_A3D3	0.162290782	17.06444258	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	783	1183	0.006762468	0.012679628	3	oligos	OL-Cntl	30	9	9
TAAGCGTAGGACCACA-1_371G_A3D3	-18.30064013	25.3046279	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1746	2850	0.008421053	0.005964912	3	8	Astrocytes	30	9	9
TAAGCGTAGGGCACTA-1_371G_A3D3	-21.62978852	25.41674746	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1640	2919	0.001370332	0.007879411	3	8	Astrocytes	30	9	9
TAAGCGTCACCCTATC-1_371G_A3D3	30.76511584	-7.459523922	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5065	14490	0.014699793	0.004968944	3	2	EN-L4	30	9	9
TAAGCGTCACGGTGTC-1_371G_A3D3	-1.275156982	16.55987807	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	735	1001	0.002997003	0.006993007	3	oligos	OL-Cntl	30	9	9
TAAGCGTCAGTTCCCT-1_371G_A3D3	-13.55433861	-10.44425768	13B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1981	4022	0.00099453	0.002486325	3	13B	IN-SV2C	30	9	9
TAAGTGCAGGTGCTTT-1_371G_A3D3	0.907909234	13.85460867	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	863	1300	0.004615385	0.019230769	3	oligos	OL-Cntl	30	9	9
TAAGTGCCAAACTGTC-1_371G_A3D3	17.00300619	6.63949874	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2064	4016	0.003984064	0.006474104	3	oligos	OL-Cntl	30	9	9
TAAGTGCCAAGACGTG-1_371G_A3D3	-19.95415091	-22.52491957	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2313	4552	0.025043937	0.00659051	3	6A	IN-PV	30	9	9
TAAGTGCGTCTAGTCA-1_371G_A3D3	8.280891657	10.17460107	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1166	1893	0.00264131	0.011093502	3	oligos	OL-Cntl	30	9	9
TAAGTGCGTCTGCGGT-1_371G_A3D3	37.55469829	-10.12470902	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5635	15461	0.005562383	0.009766509	3	2	EN-L4	30	9	9
TAAGTGCGTGAGGGAG-1_371G_A3D3	-8.587825495	-5.132440958	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1593	2617	0.037065342	0.006113871	3	13A	IN-VIP	30	9	9
TAAGTGCTCAGAAATG-1_371G_A3D3	-0.743761727	13.28597436	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	936	1375	0.005818182	0.016727273	3	oligos	OL-Cntl	30	9	9
TAAGTGCTCCACTCCA-1_371G_A3D3	6.45312161	-20.13372327	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5613	17115	0.003914695	0.007595676	3	L2-3	EN-L2-3-MS	30	9	9
TAAGTGCTCCTCAACC-1_371G_A3D3	3.043041261	7.052958005	7	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1086	1668	0.006594724	0.009592326	3	7	Phagocytes	30	9	9
TAAGTGCTCGCAAGCC-1_371G_A3D3	8.62048355	-19.1970263	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5632	16171	0.008842991	0.008348278	3	L2-3	EN-L2-3-MS	30	9	9
TAAGTGCTCGGAATCT-1_371G_A3D3	21.51263579	-22.73982492	3	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	6358	20177	0.007235962	0.009714031	3	3	EN-L5-6	30	9	9
TAAGTGCTCGTGGTCG-1_371G_A3D3	8.699470553	15.75806097	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	950	1467	0.002726653	0.006816633	3	oligos	OL-Cntl	30	9	9
TACACGAAGCGTTCCG-1_371G_A3D3	-28.06848855	0.465684198	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2324	4454	0.006735519	0.010103278	3	9	OPC	30	9	9
TACACGACAGATAATG-1_371G_A3D3	-0.655257546	-26.72213158	10	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	6828	26687	0.002585529	0.002997714	3	L2-3	EN-L2-3-Cntl	30	9	9
TACACGAGTCCAAGTT-1_371G_A3D3	-19.43826759	20.21249427	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2140	4072	0.001964637	0.00589391	3	8	Astrocytes	30	9	9
TACACGATCCGCAAGC-1_371G_A3D3	12.15314054	9.881289859	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1294	2017	0.001487357	0.013882003	3	oligos	OL-Cntl	30	9	9
TACACGATCGTGTAGT-1_371G_A3D3	-4.597837988	-3.933638475	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1276	1935	0.002067183	0.00620155	3	13A	IN-VIP	30	9	9
TACAGTGAGCTACCGC-1_371G_A3D3	23.91712292	0.335017756	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1956	3965	0.008322825	0.003278689	3	2	EN-L4	30	9	9
TACAGTGCAAAGAATC-1_371G_A3D3	-17.94336506	-15.05272301	6B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2086	3557	0.014056789	0.013494518	3	6B	IN-SST	30	9	9
TACAGTGCACGACTCG-1_371G_A3D3	12.26558255	11.0191079	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1261	1956	0.001022495	0.008691207	3	oligos	OL-Cntl	30	9	9
TACAGTGCAGGTCTCG-1_371G_A3D3	-33.34257862	-3.07963642	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1431	2496	0.003205128	0.008413462	3	9	OPC	30	9	9
TACAGTGGTCGAGATG-1_371G_A3D3	35.43959346	-6.869389921	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3243	6002	0.003332223	0.011662779	3	2	EN-L4	30	9	9
TACAGTGGTCTCTTTA-1_371G_A3D3	-0.937526241	15.66512927	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	791	1218	0	0.015599343	3	oligos	OL-Cntl	30	9	9
TACAGTGTCGGTTAAC-1_371G_A3D3	9.52723953	8.160849058	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1526	2717	0.004416636	0.012881855	3	oligos	OL-Cntl	30	9	9
TACAGTGTCGTACGGC-1_371G_A3D3	9.243780497	9.509020753	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1356	2237	0.003576218	0.014304873	3	oligos	OL-Cntl	30	9	9
TACCTATAGCGATAGC-1_371G_A3D3	15.31087022	5.576766937	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2378	5132	0.000974279	0.007014809	3	oligos	OL-Cntl	30	9	9
TACCTATAGCGTGAAC-1_371G_A3D3	12.10480199	6.678656544	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1739	3198	0.001563477	0.011257036	3	oligos	OL-Cntl	30	9	9
TACCTATAGTGGTCCC-1_371G_A3D3	5.013743589	12.45017824	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1082	1736	0.004608295	0.017857143	3	oligos	OL-Cntl	30	9	9
TACCTATCAACACCCG-1_371G_A3D3	0.637419443	17.86840914	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	731	1117	0.016114593	0.009847807	3	oligos	OL-Cntl	30	9	9
TACCTATCAGGCTGAA-1_371G_A3D3	-6.492621202	12.23031817	5	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	769	1086	0.006445672	0.013812155	3	oligos	OL-MS-1	30	9	9
TACCTATGTGAAAGAG-1_371G_A3D3	4.30729595	14.71044264	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	950	1413	0.002123142	0.011323425	3	oligos	OL-Cntl	30	9	9
TACCTATGTGCGAAAC-1_371G_A3D3	10.21729985	-29.98168937	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4455	11269	0.005590558	0.009761292	3	2	EN-L4	30	9	9
TACCTATTCAACGAAA-1_371G_A3D3	8.610026757	14.08792229	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	933	1412	0.003541076	0.008498584	3	oligos	OL-Cntl	30	9	9
TACCTATTCTCCCTGA-1_371G_A3D3	5.090342681	-19.89171335	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4273	11099	0.000630687	0.006487071	3	L2-3	EN-L2-3-MS	30	9	9
TACCTATTCTTACCTA-1_371G_A3D3	9.794991854	-29.83004816	10	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5900	20459	0.002101765	0.005620998	3	L2-3	EN-L2-3-Cntl	30	9	9
TACCTTAAGAAACGCC-1_371G_A3D3	34.93617817	-7.056972736	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3340	6640	0.013403614	0.012048193	3	2	EN-L4	30	9	9
TACCTTAAGCGTTCCG-1_371G_A3D3	-18.54259685	26.95678101	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2155	4190	0.000954654	0.005966587	3	8	Astrocytes	30	9	9
TACCTTAAGGCGACAT-1_371G_A3D3	-25.15318384	11.26301969	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1089	1824	0.005482456	0.006578947	3	8	Astrocytes	30	9	9
TACCTTACATAGTAAG-1_371G_A3D3	35.27617704	-6.58828213	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3316	6857	0.008896019	0.0064168	3	2	EN-L4	30	9	9
TACCTTACATCGGGTC-1_371G_A3D3	18.85904448	11.20835039	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1490	2663	0.000375516	0.004506196	3	oligos	OL-Cntl	30	9	9
TACCTTACATTCTTAC-1_371G_A3D3	3.722185927	21.52165934	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	868	1364	0.001466276	0.004398827	3	oligos	OL-Cntl	30	9	9
TACCTTAGTAAAGTCA-1_371G_A3D3	2.952098813	14.73075457	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	875	1293	0.00154679	0.009280742	3	oligos	OL-Cntl	30	9	9
TACCTTAGTACGACCC-1_371G_A3D3	16.13575141	5.8023376	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2370	4855	0.004325438	0.011122554	3	oligos	OL-Cntl	30	9	9
TACCTTAGTACTTCTT-1_371G_A3D3	-10.80236183	-17.8815068	6B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	904	1344	0.037946429	0.005208333	3	6B	IN-SST	30	9	9
TACCTTATCAACACAC-1_371G_A3D3	12.06647322	26.88796924	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	850	1344	0	0.004464286	3	oligos	OL-Cntl	30	9	9
TACCTTATCAACACGT-1_371G_A3D3	22.74795423	-26.58368495	3	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4507	13837	0.00281853	0.00440847	3	3	EN-L5-6	30	9	9
TACCTTATCAGCGATT-1_371G_A3D3	-4.919675144	-10.01182302	13B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	849	1242	0.012882448	0.000805153	3	13B	IN-SV2C	30	9	9
TACCTTATCTGCCCTA-1_371G_A3D3	8.353194698	15.9867635	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	959	1585	0.003154574	0.005678233	3	oligos	OL-Cntl	30	9	9
TACCTTATCTTCTGGC-1_371G_A3D3	-25.01765407	7.010496822	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	759	1110	0.004504505	0.001801802	3	8	Astrocytes	30	9	9
TACGGATAGCAGATCG-1_371G_A3D3	-10.66395009	12.38561651	11	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	769	1033	0.010648596	0.020329138	3	11	Glia-MIX	30	9	9
TACGGATCAGCTATTG-1_371G_A3D3	-4.455338688	-18.31940674	10	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3255	7672	0.000651721	0.002346194	3	L2-3	EN-L2-3-Cntl	30	9	9
TACGGATGTGAGTGAC-1_371G_A3D3	1.890677878	18.38746741	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	873	1298	0.003081664	0.006933744	3	oligos	OL-Cntl	30	9	9
TACGGGCAGACGCTTT-1_371G_A3D3	21.7256187	10.83703159	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1784	3194	0.009079524	0.004696306	3	oligos	OL-Cntl	30	9	9
TACGGGCAGCTTTGGT-1_371G_A3D3	35.13596457	-11.45242413	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3829	7915	0.004674668	0.015034744	3	2	EN-L4	30	9	9
TACGGGCCATCGGTTA-1_371G_A3D3	-16.75121066	12.2244629	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1191	1977	0.000505817	0.006069803	3	8	Astrocytes	30	9	9
TACGGGCGTCATGCCG-1_371G_A3D3	-18.73552558	28.66145189	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2141	3899	0.003077712	0.006924853	3	8	Astrocytes	30	9	9
TACGGGCTCAACACCA-1_371G_A3D3	4.560531619	-25.58615923	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4734	12792	0.005081301	0.006253909	3	L2-3	EN-L2-3-MS	30	9	9
TACGGGCTCAGCAACT-1_371G_A3D3	-10.22242772	-3.425091859	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1854	2969	0.009767599	0.017177501	3	13A	IN-VIP	30	9	9
TACGGTACAAGTAATG-1_371G_A3D3	-28.77315827	1.500060856	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2705	4844	0.003509496	0.009083402	3	9	OPC	30	9	9
TACGGTACACACCGCA-1_371G_A3D3	9.361890473	-22.78744467	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	7090	24049	0.004158177	0.005738284	3	L2-3	EN-L2-3-MS	30	9	9
TACGGTACAGGTGCCT-1_371G_A3D3	-28.7565424	0.491790016	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2116	3565	0.005049088	0.006732118	3	9	OPC	30	9	9
TACGGTAGTATAAACG-1_371G_A3D3	-30.31219139	1.52213446	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1802	3134	0.000319081	0.005424378	3	9	OPC	30	9	9
TACGGTAGTGGTCCGT-1_371G_A3D3	22.3809687	-26.13373616	3	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3261	7774	0.009390275	0.003987651	3	3	EN-L5-6	30	9	9
TACGGTATCAACACTG-1_371G_A3D3	9.367392107	8.362238981	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1408	2358	0.008057676	0.007633588	3	oligos	OL-Cntl	30	9	9
TACTCATAGAGTACCG-1_371G_A3D3	6.52777836	-19.36076886	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4347	10795	0.009541454	0.008429829	3	L2-3	EN-L2-3-MS	30	9	9
TACTCATCAATGGAAT-1_371G_A3D3	1.723089669	14.96599993	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	888	1304	0.006134969	0.011503067	3	oligos	OL-Cntl	30	9	9
TACTCATCATCTCGCT-1_371G_A3D3	1.528602325	18.34472107	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	808	1172	0.003412969	0.015358362	3	oligos	OL-Cntl	30	9	9
TACTCATTCCTCCTAG-1_371G_A3D3	4.407360088	-19.89958328	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3429	8197	0.000609979	0.003415884	3	L2-3	EN-L2-3-MS	30	9	9
TACTCATTCGCCTGAG-1_371G_A3D3	4.945219076	-17.54884306	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3167	6779	0.007523234	0.007523234	3	L2-3	EN-L2-3-MS	30	9	9
TACTCGCGTACCGAGA-1_371G_A3D3	-18.62634989	24.90262681	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2148	3903	0.002305919	0.006149116	3	8	Astrocytes	30	9	9
TACTCGCTCCGAGCCA-1_371G_A3D3	12.49205077	9.066785977	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1579	2698	0.006300964	0.010007413	3	oligos	OL-Cntl	30	9	9
TACTTACAGGGCTCTC-1_371G_A3D3	-16.67235254	1.673235514	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3979	8493	0.007771106	0.013187331	3	13A	IN-VIP	30	9	9
TACTTACCAAATTGCC-1_371G_A3D3	10.10956654	22.55977838	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	790	1209	0.00165426	0.004962779	3	oligos	OL-Cntl	30	9	9
TACTTACCAAGTAGTA-1_371G_A3D3	1.508414918	14.00596427	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	877	1332	0.000750751	0.016516517	3	oligos	OL-Cntl	30	9	9
TACTTACCAGCCAGAA-1_371G_A3D3	8.76943566	-21.35700143	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	6363	20807	0.010765608	0.004661893	3	L2-3	EN-L2-3-MS	30	9	9
TACTTACTCACCCTCA-1_371G_A3D3	-19.91770055	25.93773554	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1631	2902	0.00034459	0.004479669	3	8	Astrocytes	30	9	9
TACTTACTCGCCATAA-1_371G_A3D3	-2.82479662	15.76493757	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	783	1120	0.002678571	0.014285714	3	oligos	OL-Cntl	30	9	9
TACTTACTCTATGTGG-1_371G_A3D3	8.380719101	-21.17606	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5768	18438	0.004935459	0.005748997	3	L2-3	EN-L2-3-MS	30	9	9
TACTTACTCTGCTGTC-1_371G_A3D3	35.90515829	-9.033289156	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4922	13202	0.004999243	0.009241024	3	2	EN-L4	30	9	9
TACTTGTAGATTACCC-1_371G_A3D3	15.41636517	-28.53623045	3	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5608	20003	0.007148928	0.0039994	3	3	EN-L5-6	30	9	9
TACTTGTAGGCGTACA-1_371G_A3D3	-19.43341094	-17.67424986	6B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2926	6335	0.002683504	0.005524862	3	6B	IN-SST	30	9	9
TACTTGTAGGGTTCCC-1_371G_A3D3	7.827324067	8.88414606	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1373	2199	0.003638017	0.014097317	3	oligos	OL-Cntl	30	9	9
TACTTGTAGGTGATTA-1_371G_A3D3	5.956208088	14.55494114	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1038	1642	0.00182704	0.012180268	3	oligos	OL-Cntl	30	9	9
TACTTGTAGTGAACGC-1_371G_A3D3	-17.25008345	1.192748389	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4136	8687	0.010935881	0.011741683	3	13A	IN-VIP	30	9	9
TACTTGTCAATAGCAA-1_371G_A3D3	-16.57172587	13.44452469	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1408	2495	0.000400802	0.002805611	3	8	Astrocytes	30	9	9
TACTTGTGTTCGTTGA-1_371G_A3D3	-1.286474369	26.08252966	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	760	1088	0.003676471	0.006433824	3	oligos	OL-Cntl	30	9	9
TACTTGTTCAGTACGT-1_371G_A3D3	-24.16371009	22.16078001	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1371	2474	0.000404204	0.00323363	3	8	Astrocytes	30	9	9
TAGACCAAGACGCACA-1_371G_A3D3	28.31040216	-4.946301722	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5173	15035	0.001064184	0.005320918	3	2	EN-L4	30	9	9
TAGACCAAGCTAACAA-1_371G_A3D3	18.62119535	-7.693831764	3	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2114	4398	0.025238745	0.002955889	3	3	EN-L5-6	30	9	9
TAGACCACAGATAATG-1_371G_A3D3	-13.33444598	0.739923411	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3244	6917	0.002746856	0.008095995	3	13A	IN-VIP	30	9	9
TAGACCACAGGTCCAC-1_371G_A3D3	12.50946215	10.62027292	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1365	2323	0.001721911	0.007748601	3	oligos	OL-Cntl	30	9	9
TAGACCACATGCCCGA-1_371G_A3D3	-15.1443179	1.592852842	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3689	7748	0.006969541	0.01135777	3	13A	IN-VIP	30	9	9
TAGACCAGTCGTGGCT-1_371G_A3D3	-30.32687925	0.462033503	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1826	3150	0.004444444	0.012698413	3	9	OPC	30	9	9
TAGACCAGTTTGTGTG-1_371G_A3D3	-33.22894527	4.845105588	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2738	5466	0.003110135	0.004024881	3	9	OPC	30	9	9
TAGACCATCCACGACG-1_371G_A3D3	-14.96316644	-18.17485343	6B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1574	2720	0.031985294	0.006985294	3	6B	IN-SST	30	9	9
TAGACCATCTAACTCT-1_371G_A3D3	13.33228772	10.00290109	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1349	2273	0.002639683	0.009678839	3	oligos	OL-Cntl	30	9	9
TAGACCATCTCAAACG-1_371G_A3D3	-21.41443338	-26.1829961	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2612	5840	0.003767123	0.004965753	3	6A	IN-PV	30	9	9
TAGAGCTAGCTGCGAA-1_371G_A3D3	-20.13648967	25.76183266	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1702	2783	0.00323392	0.006108516	3	8	Astrocytes	30	9	9
TAGAGCTCAAGCGAGT-1_371G_A3D3	-17.22668546	1.461884121	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4191	9063	0.013682004	0.013240649	3	13A	IN-VIP	30	9	9
TAGAGCTCAATAGCAA-1_371G_A3D3	-2.474334919	14.33810848	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	719	1003	0.001994018	0.016949153	3	oligos	OL-Cntl	30	9	9
TAGAGCTCAGCATACT-1_371G_A3D3	11.37866146	-8.28942437	10	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2491	5189	0.006745038	0.003468876	3	L2-3	EN-L2-3-Cntl	30	9	9
TAGAGCTCATCGGTTA-1_371G_A3D3	-2.579029386	15.6209371	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	731	1010	0.012871287	0.01980198	3	oligos	OL-Cntl	30	9	9
TAGAGCTCATGTTCCC-1_371G_A3D3	3.261486641	-23.99869791	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3822	8545	0.00327677	0.007840843	3	L2-3	EN-L2-3-MS	30	9	9
TAGAGCTGTAAGTAGT-1_371G_A3D3	-19.32766419	28.13471986	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2017	4126	0.000727096	0.00484731	3	8	Astrocytes	30	9	9
TAGAGCTGTACGAAAT-1_371G_A3D3	-24.18646803	16.37386324	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1368	2351	0.006805615	0.005104211	3	8	Astrocytes	30	9	9
TAGAGCTTCCGCAGTG-1_371G_A3D3	-5.054049144	-2.934565774	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1462	2504	0.004792332	0.007188498	3	13A	IN-VIP	30	9	9
TAGCCGGAGAGATGAG-1_371G_A3D3	12.93582777	11.75831013	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1379	2234	0.00179051	0.010743062	3	oligos	OL-Cntl	30	9	9
TAGCCGGAGAGGGATA-1_371G_A3D3	-18.15728354	0.769525636	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3671	6983	0.005584992	0.0203351	3	13A	IN-VIP	30	9	9
TAGCCGGAGCAATCTC-1_371G_A3D3	-1.601460225	15.38462813	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	790	1190	0.003361345	0.008403361	3	oligos	OL-Cntl	30	9	9
TAGCCGGAGCCAGGAT-1_371G_A3D3	3.004636018	17.67937248	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	822	1255	0.003187251	0.016733068	3	oligos	OL-Cntl	30	9	9
TAGCCGGAGGGTTCCC-1_371G_A3D3	-2.884838921	16.62781794	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	829	1158	0.005181347	0.010362694	3	oligos	OL-Cntl	30	9	9
TAGCCGGGTCGAATCT-1_371G_A3D3	8.259126017	17.41177462	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	829	1346	0.001485884	0.008172363	3	oligos	OL-Cntl	30	9	9
TAGCCGGTCACAGGCC-1_371G_A3D3	-17.14038303	1.569662876	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4353	9132	0.005694262	0.011936049	3	13A	IN-VIP	30	9	9
TAGGCATAGGCTACGA-1_371G_A3D3	-1.421023861	16.91139788	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	777	1091	0.00091659	0.015582035	3	oligos	OL-Cntl	30	9	9
TAGGCATCAAGGACAC-1_371G_A3D3	-18.14626535	28.37468244	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2517	4771	0.00607839	0.004611193	3	8	Astrocytes	30	9	9
TAGGCATCACATAACC-1_371G_A3D3	15.58431093	5.667182726	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2705	5690	0.014586995	0.014059754	3	oligos	OL-Cntl	30	9	9
TAGGCATCAGGGTATG-1_371G_A3D3	8.069368035	10.48424816	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1266	1923	0.002600104	0.011960478	3	oligos	OL-Cntl	30	9	9
TAGGCATGTCCCTACT-1_371G_A3D3	14.19905384	11.6268521	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1407	2402	0.002497918	0.007910075	3	oligos	OL-Cntl	30	9	9
TAGGCATGTGATAAGT-1_371G_A3D3	-24.68516702	14.07671588	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1224	1864	0.001072961	0.003755365	3	8	Astrocytes	30	9	9
TAGGCATGTTTGCATG-1_371G_A3D3	-2.128531095	18.01661339	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	839	1162	0.002581756	0.006884682	3	oligos	OL-Cntl	30	9	9
TAGGCATTCAGCACAT-1_371G_A3D3	0.145644348	19.16700085	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	705	1099	0.001819836	0.009099181	3	oligos	OL-Cntl	30	9	9
TAGGCATTCAGTGCAT-1_371G_A3D3	8.642706276	17.31697443	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	878	1345	0.000743494	0.0133829	3	oligos	OL-Cntl	30	9	9
TAGGCATTCTTTAGTC-1_371G_A3D3	22.78876825	0.001776033	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1937	3604	0.009711432	0.004162042	3	2	EN-L4	30	9	9
TAGTGGTAGCGCTTAT-1_371G_A3D3	6.966377056	-2.771622232	12	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1309	2440	0.012295082	0.008196721	3	12	EN-MIX	30	9	9
TAGTGGTAGGTTCCTA-1_371G_A3D3	2.709268705	12.12859271	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	985	1467	0.002726653	0.019086571	3	oligos	OL-Cntl	30	9	9
TAGTGGTCACCATCCT-1_371G_A3D3	15.10539325	-29.18176947	3	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	6612	26244	0.000266728	0.005753696	3	3	EN-L5-6	30	9	9
TAGTGGTCAGCCACCA-1_371G_A3D3	3.642723293	10.30347845	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1121	1685	0.001780415	0.012462908	3	oligos	OL-Cntl	30	9	9
TAGTGGTCATGTCGAT-1_371G_A3D3	6.479611113	-18.47311035	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3879	8529	0.004455388	0.013131668	3	L2-3	EN-L2-3-MS	30	9	9
TAGTGGTGTCCATCCT-1_371G_A3D3	-24.51514726	12.35718244	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1268	2091	0.00095648	0.005738881	3	8	Astrocytes	30	9	9
TAGTGGTTCGATGAGG-1_371G_A3D3	1.350178644	-10.32160417	12	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1944	3193	0.002192296	0.003758221	3	12	EN-MIX	30	9	9
TAGTGGTTCGGTCTAA-1_371G_A3D3	10.1345295	10.96623968	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1211	1982	0.000504541	0.008072654	3	oligos	OL-Cntl	30	9	9
TAGTGGTTCTCGGACG-1_371G_A3D3	0.215422316	17.64300184	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	751	1130	0.007079646	0.007079646	3	oligos	OL-Cntl	30	9	9
TAGTTGGAGTCACGCC-1_371G_A3D3	4.783328146	-17.40674565	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2816	5685	0.00351803	0.012137203	3	L2-3	EN-L2-3-MS	30	9	9
TAGTTGGGTAAATGAC-1_371G_A3D3	-3.122807634	14.9990515	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	725	1034	0.002901354	0.01450677	3	oligos	OL-Cntl	30	9	9
TAGTTGGGTGTCTGAT-1_371G_A3D3	-17.59184061	0.629934087	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3469	6944	0.010368664	0.016849078	3	13A	IN-VIP	30	9	9
TAGTTGGTCTGTACGA-1_371G_A3D3	2.344526861	15.44668653	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	970	1492	0.00536193	0.007372654	3	oligos	OL-Cntl	30	9	9
TATCAGGAGACTAGGC-1_371G_A3D3	-11.62340818	13.01261939	11	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	893	1147	0.006102877	0.013949433	3	11	Glia-MIX	30	9	9
TATCAGGCAAGTCTGT-1_371G_A3D3	8.860772877	9.968295954	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1209	2231	0.000896459	0.009412819	3	oligos	OL-Cntl	30	9	9
TATCAGGGTCCGAACC-1_371G_A3D3	-21.17713792	19.31381868	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1363	2137	0.002339729	0.005147403	3	8	Astrocytes	30	9	9
TATCAGGTCATGCAAC-1_371G_A3D3	5.059921987	-17.82827881	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3674	8619	0.001160227	0.008005569	3	L2-3	EN-L2-3-MS	30	9	9
TATCAGGTCCAAACAC-1_371G_A3D3	10.64560492	18.22795293	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1044	1694	0	0.006493506	3	oligos	OL-Cntl	30	9	9
TATCTCATCGCCTGAG-1_371G_A3D3	-18.50012489	-9.786772388	13B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3589	7721	0.005698744	0.011008937	3	13B	IN-SV2C	30	9	9
TATCTCATCTTTACAC-1_371G_A3D3	-0.006080649	20.12662362	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	670	1021	0.003917728	0.003917728	3	oligos	OL-Cntl	30	9	9
TATGCCCAGCGCTTAT-1_371G_A3D3	9.188083022	10.05582081	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1249	2248	0.002669039	0.007562278	3	oligos	OL-Cntl	30	9	9
TATGCCCAGGACATTA-1_371G_A3D3	0.004705226	18.60589722	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	783	1140	0	0.007894737	3	oligos	OL-Cntl	30	9	9
TATGCCCAGGATTCGG-1_371G_A3D3	-2.802291916	15.33632474	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	729	1080	0.000925926	0.016666667	3	oligos	OL-Cntl	30	9	9
TATGCCCAGGCTAGCA-1_371G_A3D3	0.773023179	14.1382735	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	915	1358	0.01988218	0.013254786	3	oligos	OL-Cntl	30	9	9
TATGCCCGTAGCGATG-1_371G_A3D3	19.63888037	-23.2247611	3	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4244	10467	0.016719213	0.006496608	3	3	EN-L5-6	30	9	9
TATGCCCGTATTCGTG-1_371G_A3D3	-30.55574603	1.627520397	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1890	3514	0.004553216	0.007968127	3	9	OPC	30	9	9
TATGCCCGTCTAGTCA-1_371G_A3D3	4.585106868	-18.13940426	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3155	6682	0.002394493	0.00568692	3	L2-3	EN-L2-3-MS	30	9	9
TATGCCCGTCTGATTG-1_371G_A3D3	-21.66959822	-25.02648213	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2541	5195	0.001154957	0.012897016	3	6A	IN-PV	30	9	9
TATGCCCTCACTCCTG-1_371G_A3D3	-13.87676713	17.8764227	11	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1952	3061	0.004246978	0.005880431	3	11	Glia-MIX	30	9	9
TATGCCCTCGGCTTGG-1_371G_A3D3	-2.782172558	15.64399709	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	818	1220	0.004098361	0.013114754	3	oligos	OL-Cntl	30	9	9
TATGCCCTCTAAGCCA-1_371G_A3D3	-2.538384657	15.14078122	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	683	1039	0.011549567	0.008662175	3	oligos	OL-Cntl	30	9	9
TATGCCCTCTGCGGCA-1_371G_A3D3	-3.009486186	14.21339558	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	816	1128	0.005319149	0.020390071	3	oligos	OL-Cntl	30	9	9
TATGCCCTCTTGCAAG-1_371G_A3D3	10.38129905	17.63994367	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	986	1547	0.000646412	0.012281836	3	oligos	OL-Cntl	30	9	9
TATTACCAGGAGTTGC-1_371G_A3D3	-8.466145352	-17.05466556	6B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	742	1098	0.015482696	0.007285974	3	6B	IN-SST	30	9	9
TATTACCAGTGGCACA-1_371G_A3D3	14.54340294	11.29017967	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1257	2081	0.001441615	0.005766458	3	oligos	OL-Cntl	30	9	9
TATTACCCAACGCACC-1_371G_A3D3	14.31966218	8.621279889	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1654	3019	0.001324942	0.007949652	3	oligos	OL-Cntl	30	9	9
TATTACCCAGGTGCCT-1_371G_A3D3	-25.35112434	12.44017154	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1089	1802	0	0.004439512	3	8	Astrocytes	30	9	9
TATTACCGTACGCACC-1_371G_A3D3	-30.85471125	1.526975113	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1934	3449	0.001449696	0.004059148	3	9	OPC	30	9	9
TATTACCGTCGCATAT-1_371G_A3D3	-3.478617452	-36.51170734	16	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	876	1095	0.03196347	0.02283105	3	16	EN-PYR	30	9	9
TCAACGAAGCTTATCG-1_371G_A3D3	-10.93625529	15.05409082	11	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1455	2226	0.004043127	0.008086253	3	11	Glia-MIX	30	9	9
TCAACGAGTAGCGATG-1_371G_A3D3	15.6233096	6.057611901	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1987	3752	0.004797441	0.010927505	3	oligos	OL-Cntl	30	9	9
TCAACGAGTATTACCG-1_371G_A3D3	-24.469907	12.12377756	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1110	1783	0.002804262	0.007291082	3	8	Astrocytes	30	9	9
TCAACGAGTGACCAAG-1_371G_A3D3	-12.07914624	-16.16957256	6B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1088	1570	0.01910828	0.010191083	3	6B	IN-SST	30	9	9
TCAACGAGTGTTGAGG-1_371G_A3D3	-26.86292578	13.69063405	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1008	1591	0.007542426	0.002514142	3	8	Astrocytes	30	9	9
TCAACGATCTGGGCCA-1_371G_A3D3	3.961488832	12.38109518	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1060	1698	0.004711425	0.012956419	3	oligos	OL-Cntl	30	9	9
TCAATCTCACGTCAGC-1_371G_A3D3	37.60818384	10.47015578	14	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	809	1141	0.001752848	0.01051709	3	14	Microglia	30	9	9
TCAATCTCAGCTCGAC-1_371G_A3D3	10.3667561	9.657134731	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1304	2185	0.004118993	0.006864989	3	oligos	OL-Cntl	30	9	9
TCAATCTCAGGCGATA-1_371G_A3D3	14.26058777	-20.26346697	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4771	12440	0.011173633	0.010771704	3	L2-3	EN-L2-3-MS	30	9	9
TCAATCTGTGCTGTAT-1_371G_A3D3	14.57352093	1.667313545	12	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	926	1544	0.00388601	0.012305699	3	12	EN-MIX	30	9	9
TCAATCTGTTACGCGC-1_371G_A3D3	-4.233582386	5.906062826	5	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2178	3739	0.000802354	0.024338058	3	oligos	OL-MS-1	30	9	9
TCAATCTTCACGCGGT-1_371G_A3D3	-32.92760963	5.119383411	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2805	5574	0.001973448	0.00574094	3	9	OPC	30	9	9
TCACAAGAGCGCCTTG-1_371G_A3D3	-14.97900667	1.50123604	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3455	7068	0.00565931	0.012450481	3	13A	IN-VIP	30	9	9
TCACAAGAGGGTGTGT-1_371G_A3D3	-16.61683249	-21.91213583	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1644	2918	0.026730637	0.004112406	3	6A	IN-PV	30	9	9
TCACAAGCACATCCGG-1_371G_A3D3	10.13188468	-27.65235221	10	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	8246	36343	0.001898577	0.00426492	3	L2-3	EN-L2-3-Cntl	30	9	9
TCACAAGCACGCGAAA-1_371G_A3D3	36.00919145	-10.48110458	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5214	13577	0.003314429	0.010458864	3	2	EN-L4	30	9	9
TCACAAGCACTGTGTA-1_371G_A3D3	-24.71149861	12.56486345	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1113	1616	0.010519802	0.006806931	3	8	Astrocytes	30	9	9
TCACAAGCAGTCGATT-1_371G_A3D3	3.515968944	13.68473995	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1010	1527	0	0.011787819	3	oligos	OL-Cntl	30	9	9
TCACAAGCAGTGGGAT-1_371G_A3D3	7.393347409	9.44831149	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1219	1760	0.001136364	0.016477273	3	oligos	OL-Cntl	30	9	9
TCACGAAAGATCGATA-1_371G_A3D3	-34.31731189	1.314496536	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1765	3250	0.000307692	0.004307692	3	9	OPC	30	9	9
TCACGAAAGTACGACG-1_371G_A3D3	-19.27520814	27.41942107	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2049	3672	0.001361656	0.007352941	3	8	Astrocytes	30	9	9
TCACGAACACCAGATT-1_371G_A3D3	-14.53136992	-10.10447642	13B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2653	5343	0.000748643	0.005427662	3	13B	IN-SV2C	30	9	9
TCACGAATCAGGCAAG-1_371G_A3D3	17.20168791	0.091141983	12	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1105	2034	0.001474926	0.005899705	3	12	EN-MIX	30	9	9
TCACGAATCTTCATGT-1_371G_A3D3	10.25483511	7.810138949	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1460	2354	0.000424809	0.014018692	3	oligos	OL-Cntl	30	9	9
TCAGATGAGATGTCGG-1_371G_A3D3	2.294002463	15.38427184	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	920	1393	0.002153625	0.012921752	3	oligos	OL-Cntl	30	9	9
TCAGATGAGGTAAACT-1_371G_A3D3	-5.64386858	-2.83562873	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1602	2888	0.01800554	0.004847645	3	13A	IN-VIP	30	9	9
TCAGATGCAACACCTA-1_371G_A3D3	-29.17354501	1.675168461	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2444	4394	0.001365498	0.006372326	3	9	OPC	30	9	9
TCAGATGCAGCTGTGC-1_371G_A3D3	25.78531868	-26.73071171	3	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5348	17091	0.000994676	0.002691475	3	3	EN-L5-6	30	9	9
TCAGATGCAGGGTACA-1_371G_A3D3	11.30743918	-24.0813176	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	6284	21280	0.006531955	0.004981203	3	L2-3	EN-L2-3-MS	30	9	9
TCAGATGGTAGCGCTC-1_371G_A3D3	-15.75544585	21.96179538	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1308	1927	0.00363259	0.008303062	3	8	Astrocytes	30	9	9
TCAGATGGTGTGACGA-1_371G_A3D3	-19.38887085	27.69599793	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2132	4043	0.00445214	0.003957457	3	8	Astrocytes	30	9	9
TCAGATGTCACCATAG-1_371G_A3D3	-33.3181798	-3.00439803	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1526	2537	0	0.008671659	3	9	OPC	30	9	9
TCAGATGTCATACGGT-1_371G_A3D3	-25.31279215	-2.145862322	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1428	2266	0.015004413	0.008826125	3	9	OPC	30	9	9
TCAGATGTCGGAAATA-1_371G_A3D3	1.796024733	17.29631242	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	839	1271	0.004720692	0.011801731	3	oligos	OL-Cntl	30	9	9
TCAGCAAAGGATGGAA-1_371G_A3D3	0.654507136	13.32653949	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	974	1406	0.000711238	0.022759602	3	oligos	OL-Cntl	30	9	9
TCAGCAAAGTCCATAC-1_371G_A3D3	8.687168515	-13.84648142	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3254	6003	0.015492254	0.017491254	3	L2-3	EN-L2-3-MS	30	9	9
TCAGCAACAAAGCAAT-1_371G_A3D3	2.947109372	13.05244167	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	940	1507	0.00199071	0.01128069	3	oligos	OL-Cntl	30	9	9
TCAGCAACAATAGCGG-1_371G_A3D3	35.98082633	-11.70010809	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5554	13978	0.011160395	0.010373444	3	2	EN-L4	30	9	9
TCAGCAACACCAACCG-1_371G_A3D3	-29.94652454	1.349452948	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2283	4104	0.003898635	0.002923977	3	9	OPC	30	9	9
TCAGCAACACTTCTGC-1_371G_A3D3	10.18067424	-27.67297786	10	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	8041	39973	0.000650439	0.005253546	3	L2-3	EN-L2-3-Cntl	30	9	9
TCAGCAAGTTGGTGGA-1_371G_A3D3	-9.912276841	-5.00618581	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1959	3209	0.019009037	0.009037083	3	13A	IN-VIP	30	9	9
TCAGCAATCGTACGGC-1_371G_A3D3	2.063762312	13.8602954	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	877	1338	0.000747384	0.014200299	3	oligos	OL-Cntl	30	9	9
TCAGCTCAGTTTAGGA-1_371G_A3D3	12.89104803	7.241851174	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1696	2994	0.005344021	0.010688043	3	oligos	OL-Cntl	30	9	9
TCAGCTCCAACGCACC-1_371G_A3D3	-22.26885387	24.87075534	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1517	2366	0.000845309	0.003381234	3	8	Astrocytes	30	9	9
TCAGCTCCACGGCCAT-1_371G_A3D3	-19.28426451	26.13016238	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2117	4969	0.001207486	0.006842423	3	8	Astrocytes	30	9	9
TCAGCTCGTCATCCCT-1_371G_A3D3	6.998237709	-18.97715303	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5207	13751	0.002036216	0.008726638	3	L2-3	EN-L2-3-MS	30	9	9
TCAGCTCGTGTAAGTA-1_371G_A3D3	32.75730174	-3.153028241	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3042	6286	0.001431753	0.005249761	3	2	EN-L4	30	9	9
TCAGCTCTCATCGATG-1_371G_A3D3	-29.49618629	10.81988243	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	838	1331	0.00150263	0.00150263	3	8	Astrocytes	30	9	9
TCAGCTCTCCACTCCA-1_371G_A3D3	11.35944366	6.579938573	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1786	3018	0.001325381	0.015904573	3	oligos	OL-Cntl	30	9	9
TCAGCTCTCCCTAATT-1_371G_A3D3	-10.90734011	6.854474834	11	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3136	6587	0.01017155	0.00834978	3	11	Glia-MIX	30	9	9
TCAGGATAGAATAGGG-1_371G_A3D3	-2.804199228	14.74978337	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	747	1008	0.00297619	0.012896825	3	oligos	OL-Cntl	30	9	9
TCAGGATAGTTTAGGA-1_371G_A3D3	-22.55771573	23.50296694	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1533	2403	0.002496879	0.004161465	3	8	Astrocytes	30	9	9
TCAGGATCAAATCCGT-1_371G_A3D3	5.087212839	-18.84320763	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3442	8265	0.00399274	0.011373261	3	L2-3	EN-L2-3-MS	30	9	9
TCAGGATGTCTCCATC-1_371G_A3D3	6.106439961	-19.86684777	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4815	12847	0.002101658	0.007861758	3	L2-3	EN-L2-3-MS	30	9	9
TCAGGATTCGGTGTTA-1_371G_A3D3	12.44143226	-24.1673211	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	6020	18663	0.004447302	0.009805498	3	L2-3	EN-L2-3-MS	30	9	9
TCAGGTAAGGAGCGTT-1_371G_A3D3	-13.49110488	-0.542851862	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2847	5443	0.007716333	0.008634944	3	13A	IN-VIP	30	9	9
TCATTACCAAGTAGTA-1_371G_A3D3	-20.59375831	28.09753349	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2097	4608	0.000868056	0.006076389	3	8	Astrocytes	30	9	9
TCATTACGTGCCTGGT-1_371G_A3D3	21.96256967	-26.13976921	3	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4390	12567	0.007400334	0.006286305	3	3	EN-L5-6	30	9	9
TCATTACTCGGATGTT-1_371G_A3D3	-2.208746774	14.27790342	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	709	1066	0.004690432	0.018761726	3	oligos	OL-Cntl	30	9	9
TCATTACTCTACTATC-1_371G_A3D3	-35.08554661	-12.72536758	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	813	1244	0.000803859	0.002411576	3	9	OPC	30	9	9
TCATTTGAGGCGATAC-1_371G_A3D3	-1.553329801	17.52917037	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	683	1037	0.00289296	0.017357763	3	oligos	OL-Cntl	30	9	9
TCATTTGCAAGTACCT-1_371G_A3D3	-14.7112344	0.536649821	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3382	7743	0.009815317	0.007232339	3	13A	IN-VIP	30	9	9
TCATTTGGTTTAGCTG-1_371G_A3D3	-34.19900614	-3.347068122	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1343	2192	0.000456204	0.004562044	3	9	OPC	30	9	9
TCCACACAGAGCCCAA-1_371G_A3D3	-12.54687429	-15.77124288	6B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1144	1576	0.019670051	0.018401015	3	6B	IN-SST	30	9	9
TCCACACAGAGCTTCT-1_371G_A3D3	-23.59045326	-18.8645973	6B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3047	6151	0.010729963	0.018533572	3	6B	IN-SST	30	9	9
TCCACACCAAGCCTAT-1_371G_A3D3	10.18835341	-27.84405587	10	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	8805	45629	0.002607991	0.004185934	3	L2-3	EN-L2-3-Cntl	30	9	9
TCCACACGTAGGAGTC-1_371G_A3D3	-6.19340948	-36.24085287	16	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	949	1411	0.117647059	0.015591779	3	16	EN-PYR	30	9	9
TCCACACGTTCAGCGC-1_371G_A3D3	-19.12274386	27.2119795	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2272	4551	0.001538123	0.002197319	3	8	Astrocytes	30	9	9
TCCACACTCAATCACG-1_371G_A3D3	9.979380958	19.505198	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	927	1483	0.00606878	0.012137559	3	oligos	OL-Cntl	30	9	9
TCCACACTCACTCCTG-1_371G_A3D3	-16.24990513	1.710783058	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4262	9598	0.006355491	0.013231923	3	13A	IN-VIP	30	9	9
TCCACACTCCAAACAC-1_371G_A3D3	35.93186494	-7.765950113	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4150	9831	0.001830943	0.007730648	3	2	EN-L4	30	9	9
TCCACACTCCAAATGC-1_371G_A3D3	0.640891022	15.92625021	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	842	1277	0.000783085	0.018010963	3	oligos	OL-Cntl	30	9	9
TCCACACTCTACGAGT-1_371G_A3D3	1.85627527	29.96394225	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	805	1186	0.001686341	0.005059022	3	oligos	OL-Cntl	30	9	9
TCCCGATAGACTGGGT-1_371G_A3D3	-9.476280777	-16.73439911	6B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	855	1214	0.016474465	0.009060956	3	6B	IN-SST	30	9	9
TCCCGATAGCTGTCTA-1_371G_A3D3	4.385726041	9.87508043	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1233	2045	0.004400978	0.012224939	3	oligos	OL-Cntl	30	9	9
TCCCGATCACATAACC-1_371G_A3D3	-28.66233919	1.845970587	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3105	7178	0.003900808	0.010309278	3	9	OPC	30	9	9
TCCCGATCATGGTTGT-1_371G_A3D3	-18.90006192	-24.35272784	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2521	5231	0.012808258	0.002102848	3	6A	IN-PV	30	9	9
TCCCGATCATGTTCCC-1_371G_A3D3	-2.896511117	17.53056997	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	732	1075	0.001860465	0.005581395	3	oligos	OL-Cntl	30	9	9
TCCCGATGTAGCAAAT-1_371G_A3D3	-13.38142773	3.502559586	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2846	5508	0.02124183	0.00617284	3	13A	IN-VIP	30	9	9
TCCCGATGTGTCCTCT-1_371G_A3D3	-10.62587825	17.51346	11	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2755	5327	0.004129904	0.008259809	3	11	Glia-MIX	30	9	9
TCCCGATTCACGACTA-1_371G_A3D3	7.160990097	12.18978947	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1279	2180	0.002293578	0.012385321	3	oligos	OL-Cntl	30	9	9
TCCCGATTCCGTTGTC-1_371G_A3D3	-25.81035133	-22.91140635	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5190	12399	0.008629728	0.012662311	3	6A	IN-PV	30	9	9
TCCCGATTCTCGGACG-1_371G_A3D3	-17.88269932	-26.33530695	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2442	5042	0.001586672	0.004165014	3	6A	IN-PV	30	9	9
TCGAGGCAGCTCTCGG-1_371G_A3D3	-14.28611623	0.953344156	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3347	7074	0.012298558	0.009188578	3	13A	IN-VIP	30	9	9
TCGAGGCGTACCTACA-1_371G_A3D3	4.941050392	14.86997617	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	991	1519	0.000658328	0.011849901	3	oligos	OL-Cntl	30	9	9
TCGAGGCGTAGAGGAA-1_371G_A3D3	-2.538903148	14.76133286	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	890	1229	0.002441009	0.014646054	3	oligos	OL-Cntl	30	9	9
TCGAGGCGTCTCTTAT-1_371G_A3D3	-12.54500144	-10.97879455	13B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1563	3033	0.000659413	0.006264425	3	13B	IN-SV2C	30	9	9
TCGAGGCTCAAACCGT-1_371G_A3D3	-31.05633562	10.15105967	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	868	1185	0.001687764	0.012658228	3	8	Astrocytes	30	9	9
TCGCGAGAGAGGTAGA-1_371G_A3D3	-29.71995401	-11.48084962	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	919	1325	0.006037736	0.005283019	3	9	OPC	30	9	9
TCGCGAGAGTACGTTC-1_371G_A3D3	35.21477536	-9.817831802	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4566	11607	0.010769363	0.012923236	3	2	EN-L4	30	9	9
TCGCGAGCAACAACCT-1_371G_A3D3	-2.86029105	14.26537208	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	779	1088	0.001838235	0.017463235	3	oligos	OL-Cntl	30	9	9
TCGCGAGCAGAGTGTG-1_371G_A3D3	8.342192539	11.57442866	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1105	1787	0.001119194	0.011751539	3	oligos	OL-Cntl	30	9	9
TCGCGAGGTTCGAATC-1_371G_A3D3	9.680401428	11.83277702	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1187	1886	0.001590668	0.011664899	3	oligos	OL-Cntl	30	9	9
TCGCGTTCAAAGGCGT-1_371G_A3D3	-13.35984312	0.607730419	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2934	5869	0.00579315	0.006304311	3	13A	IN-VIP	30	9	9
TCGCGTTCAGAGCCAA-1_371G_A3D3	22.94711863	-25.46625564	3	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4336	11482	0.011234976	0.004964292	3	3	EN-L5-6	30	9	9
TCGCGTTGTTCGCGAC-1_371G_A3D3	-0.468540782	-0.574833427	11	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1377	2090	0.015311005	0.009569378	3	11	Glia-MIX	30	9	9
TCGGGACAGAAGGCCT-1_371G_A3D3	-6.66538338	11.05202037	5	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	775	1036	0.016409266	0.013513514	3	oligos	OL-MS-1	30	9	9
TCGGGACAGCCGTCGT-1_371G_A3D3	-32.82921266	5.282286591	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3152	6007	0.002164142	0.004994173	3	9	OPC	30	9	9
TCGGGACAGTGAAGTT-1_371G_A3D3	2.390058103	12.84204322	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	873	1370	0.002919708	0.019708029	3	oligos	OL-Cntl	30	9	9
TCGGGACGTATCTGCA-1_371G_A3D3	-13.81680232	1.441802003	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3789	8463	0.001181614	0.008034976	3	13A	IN-VIP	30	9	9
TCGGGACGTCTAAAGA-1_371G_A3D3	-1.098423557	18.18418153	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	834	1268	0.000788644	0.006309148	3	oligos	OL-Cntl	30	9	9
TCGGGACGTGTGTGCC-1_371G_A3D3	12.64584192	10.93885604	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1365	2141	0	0.010742644	3	oligos	OL-Cntl	30	9	9
TCGGGACTCAGCGATT-1_371G_A3D3	-20.57909774	-6.292860823	13B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	6511	19407	0.015612923	0.010666254	3	13B	IN-SV2C	30	9	9
TCGGGACTCATAACCG-1_371G_A3D3	-29.41182904	0.114316583	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1947	3366	0.007130125	0.005347594	3	9	OPC	30	9	9
TCGGTAAGTATGAAAC-1_371G_A3D3	10.53200636	12.30785754	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1218	2040	0.00245098	0.007352941	3	oligos	OL-Cntl	30	9	9
TCGGTAATCCAAAGTC-1_371G_A3D3	22.67955257	-0.59365974	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2155	3979	0.006534305	0.007288263	3	2	EN-L4	30	9	9
TCGGTAATCCTGTACC-1_371G_A3D3	-13.36991012	0.464780115	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3097	6387	0.010490058	0.008924378	3	13A	IN-VIP	30	9	9
TCGGTAATCTCTGCTG-1_371G_A3D3	23.29359359	-28.9067897	3	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3909	10774	0.000371264	0.006682755	3	3	EN-L5-6	30	9	9
TCGGTAATCTGCGTAA-1_371G_A3D3	-3.181457857	16.10756253	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	727	1020	0.002941176	0.008823529	3	oligos	OL-Cntl	30	9	9
TCGTACCAGACCACGA-1_371G_A3D3	0.184004705	12.48096892	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	942	1404	0	0.019230769	3	oligos	OL-Cntl	30	9	9
TCGTACCCAACAACCT-1_371G_A3D3	-0.44169171	13.51759073	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	847	1248	0.002403846	0.022435897	3	oligos	OL-Cntl	30	9	9
TCGTACCCACATGACT-1_371G_A3D3	26.90942879	-0.87901358	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3683	9197	0.004131782	0.002827009	3	2	EN-L4	30	9	9
TCGTACCCACGTGAGA-1_371G_A3D3	-17.36738449	1.479927582	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4300	9228	0.004659731	0.019614218	3	13A	IN-VIP	30	9	9
TCGTACCCAGCTCGAC-1_371G_A3D3	-1.199394979	15.51514024	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	766	1104	0.000905797	0.014492754	3	oligos	OL-Cntl	30	9	9
TCGTACCGTAGAGGAA-1_371G_A3D3	2.930725716	14.89029219	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	973	1445	0.001384083	0.010380623	3	oligos	OL-Cntl	30	9	9
TCGTACCGTCTCATCC-1_371G_A3D3	10.68755753	7.39422065	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1533	2620	0.007633588	0.012977099	3	oligos	OL-Cntl	30	9	9
TCGTACCGTGGAAAGA-1_371G_A3D3	-10.76059443	-1.676110277	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2154	3782	0.004759387	0.013749339	3	13A	IN-VIP	30	9	9
TCGTACCGTGTTCTTT-1_371G_A3D3	7.147426716	-21.01971131	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	6344	20378	0.005692413	0.006084994	3	L2-3	EN-L2-3-MS	30	9	9
TCGTACCGTTCGTTGA-1_371G_A3D3	-23.77193964	-19.40633268	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2791	5456	0.008247801	0.007881232	3	6A	IN-PV	30	9	9
TCGTAGAAGATAGCAT-1_371G_A3D3	11.95123138	6.162855696	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2011	3738	0.004815409	0.017388978	3	oligos	OL-Cntl	30	9	9
TCGTAGAAGCTGTTCA-1_371G_A3D3	35.97447787	-8.707764728	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	6360	19415	0.006077775	0.012773629	3	2	EN-L4	30	9	9
TCGTAGACAGCCAGAA-1_371G_A3D3	35.36430285	-6.982962397	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3697	8025	0.00211838	0.005856698	3	2	EN-L4	30	9	9
TCGTAGACAGGACGTA-1_371G_A3D3	-9.930556359	-4.287866323	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1884	3280	0.014329268	0.0125	3	13A	IN-VIP	30	9	9
TCGTAGATCACAATGC-1_371G_A3D3	-23.53162428	21.44610445	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1259	2091	0.00047824	0.003347681	3	8	Astrocytes	30	9	9
TCGTAGATCCAGATCA-1_371G_A3D3	-14.12175466	-9.948493545	13B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2213	4185	0.013142174	0.003345281	3	13B	IN-SV2C	30	9	9
TCTATTGAGGATCGCA-1_371G_A3D3	-17.95852018	7.956579875	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1160	1776	0.001126126	0.018581081	3	8	Astrocytes	30	9	9
TCTATTGCATACAGCT-1_371G_A3D3	-10.11373953	-17.63490864	6B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	873	1285	0.028793774	0.005447471	3	6B	IN-SST	30	9	9
TCTATTGTCGTAGGTT-1_371G_A3D3	10.77811907	8.088707276	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1410	2374	0.00210615	0.01221567	3	oligos	OL-Cntl	30	9	9
TCTCATAAGCCAGAAC-1_371G_A3D3	35.98672156	-10.5294385	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5179	13906	0.00409895	0.009995685	3	2	EN-L4	30	9	9
TCTCATAAGGTGCTTT-1_371G_A3D3	-8.363453104	-18.49005355	6B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	721	1138	0.000878735	0.003514938	3	6B	IN-SST	30	9	9
TCTCATACATAGACTC-1_371G_A3D3	-25.29865298	15.12818666	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1094	1820	0.004945055	0.002747253	3	8	Astrocytes	30	9	9
TCTCATAGTCCGAGTC-1_371G_A3D3	-14.14744534	-24.02979969	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1671	3584	0.134207589	0.002232143	3	6A	IN-PV	30	9	9
TCTCATAGTTTAAGCC-1_371G_A3D3	-13.22081709	0.105865137	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2606	5106	0.00195848	0.007050529	3	13A	IN-VIP	30	9	9
TCTCATATCCTAGTGA-1_371G_A3D3	27.53929157	-1.970143889	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4062	10646	0.00187864	0.0023483	3	2	EN-L4	30	9	9
TCTCTAAAGCGGCTTC-1_371G_A3D3	8.251411232	13.58371963	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1086	1835	0.003269755	0.011444142	3	oligos	OL-Cntl	30	9	9
TCTCTAAAGGGTTCCC-1_371G_A3D3	12.2116868	9.895822804	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1362	2475	0.002424242	0.009292929	3	oligos	OL-Cntl	30	9	9
TCTCTAAAGTTGAGTA-1_371G_A3D3	-24.01735808	-1.193609618	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1439	2267	0.001764446	0.004852228	3	9	OPC	30	9	9
TCTCTAACACGCTTTC-1_371G_A3D3	-19.3285748	24.33417911	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1629	2978	0.005372733	0.005036938	3	8	Astrocytes	30	9	9
TCTCTAACAGCTTCGG-1_371G_A3D3	-34.36232964	-1.45744765	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1461	2612	0.001531394	0.003062787	3	9	OPC	30	9	9
TCTCTAAGTCTAGTCA-1_371G_A3D3	13.37085076	9.196521124	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1457	2388	0.001256281	0.010887772	3	oligos	OL-Cntl	30	9	9
TCTGAGAAGGTTACCT-1_371G_A3D3	3.180863919	9.263087774	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1322	2138	0.001403181	0.014967259	3	oligos	OL-Cntl	30	9	9
TCTGAGACAAAGCAAT-1_371G_A3D3	-22.02324403	10.10301523	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1007	1613	0.001859888	0.003719777	3	8	Astrocytes	30	9	9
TCTGAGAGTAAGTAGT-1_371G_A3D3	6.910909612	11.50244402	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1024	1591	0.007542426	0.008170962	3	oligos	OL-Cntl	30	9	9
TCTGAGAGTCAACTGT-1_371G_A3D3	-15.34789467	1.616315476	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3754	7666	0.007826768	0.012653274	3	13A	IN-VIP	30	9	9
TCTGAGAGTCCGAAGA-1_371G_A3D3	-19.94144511	26.2001614	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1887	3378	0.002368265	0.003552398	3	8	Astrocytes	30	9	9
TCTGAGATCACGCATA-1_371G_A3D3	-9.190364251	-17.19089551	6B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	783	1099	0.017288444	0.006369427	3	6B	IN-SST	30	9	9
TCTGAGATCGCCTGTT-1_371G_A3D3	35.91983727	-8.904671861	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5193	14229	0.004076182	0.008222644	3	2	EN-L4	30	9	9
TCTGGAAAGAGACTTA-1_371G_A3D3	-0.220488247	15.51428293	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	875	1168	0	0.017123288	3	oligos	OL-Cntl	30	9	9
TCTGGAAAGAGGGATA-1_371G_A3D3	-14.07827341	-1.188025967	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2464	4398	0.017280582	0.011368804	3	13A	IN-VIP	30	9	9
TCTGGAAAGTCTCAAC-1_371G_A3D3	10.85760221	18.34417839	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	981	1516	0.011873351	0.01121372	3	oligos	OL-Cntl	30	9	9
TCTGGAACACATCTTT-1_371G_A3D3	-24.09309734	-25.02913413	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4292	10749	0.006698298	0.009210159	3	6A	IN-PV	30	9	9
TCTGGAAGTCATATCG-1_371G_A3D3	2.432367546	16.76525442	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	894	1346	0.000742942	0.008915305	3	oligos	OL-Cntl	30	9	9
TCTGGAAGTGACGGTA-1_371G_A3D3	-24.56433489	22.2934238	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1314	2149	0.001395998	0.00511866	3	8	Astrocytes	30	9	9
TCTGGAATCATGCATG-1_371G_A3D3	-0.497767257	18.74141052	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	691	1052	0.002851711	0.006653992	3	oligos	OL-Cntl	30	9	9
TCTGGAATCCGGCACA-1_371G_A3D3	-4.453329834	6.187736736	5	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1560	2732	0.000366032	0.033674963	3	oligos	OL-MS-1	30	9	9
TCTTCGGCAATCCAAC-1_371G_A3D3	-9.159602941	17.39649719	11	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3314	6829	0.003367989	0.005857373	3	11	Glia-MIX	30	9	9
TCTTCGGCACTACAGT-1_371G_A3D3	-0.67500491	17.02522606	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	722	1110	0.002702703	0.009009009	3	oligos	OL-Cntl	30	9	9
TCTTCGGGTCATGCCG-1_371G_A3D3	-22.97384416	-19.39969117	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3049	6781	0.003981714	0.007373544	3	6A	IN-PV	30	9	9
TCTTCGGTCTGAGTGT-1_371G_A3D3	2.448042864	12.67618795	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	838	1208	0.004966887	0.00910596	3	oligos	OL-Cntl	30	9	9
TCTTTCCCAGCCTATA-1_371G_A3D3	-29.97696647	-10.27358899	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1069	1681	0.005353956	0.010113028	3	9	OPC	30	9	9
TCTTTCCTCCTAGTGA-1_371G_A3D3	35.91228832	-8.131135947	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4790	12940	0.005100464	0.008114374	3	2	EN-L4	30	9	9
TGAAAGAAGGATTCGG-1_371G_A3D3	34.86422862	-5.497303616	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2923	5878	0.006294658	0.010377679	3	2	EN-L4	30	9	9
TGAAAGACACATTTCT-1_371G_A3D3	10.1534107	21.64449884	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	833	1281	0	0.00312256	3	oligos	OL-Cntl	30	9	9
TGAAAGACATGGAATA-1_371G_A3D3	3.716632811	16.77963377	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	967	1455	0.007560137	0.009621993	3	oligos	OL-Cntl	30	9	9
TGAAAGAGTAACGTTC-1_371G_A3D3	-11.79210613	17.40966717	11	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1841	2924	0.006497948	0.00752394	3	11	Glia-MIX	30	9	9
TGAAAGAGTAGAGCTG-1_371G_A3D3	-25.41198499	-2.047322962	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1427	2127	0.009402915	0.010813352	3	9	OPC	30	9	9
TGAAAGAGTATCACCA-1_371G_A3D3	-9.774415793	0.558222138	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2630	5422	0.002582073	0.003135374	3	13A	IN-VIP	30	9	9
TGAAAGAGTCGACTAT-1_371G_A3D3	10.79028564	-27.61619161	10	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	7048	23922	0.002299139	0.005601538	3	L2-3	EN-L2-3-Cntl	30	9	9
TGAAAGAGTTTACTCT-1_371G_A3D3	8.723402561	15.44665471	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1048	1778	0.002249719	0.012373453	3	oligos	OL-Cntl	30	9	9
TGAAAGATCAGTGTTG-1_371G_A3D3	21.86662641	-26.08890881	3	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4342	11863	0.005647813	0.005563517	3	3	EN-L5-6	30	9	9
TGAAAGATCTGGGCCA-1_371G_A3D3	-19.78383109	-20.12904689	6B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1936	3332	0.005402161	0.018007203	3	6B	IN-SST	30	9	9
TGACAACAGAGCTATA-1_371G_A3D3	-1.631746938	19.33140595	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	933	1426	0.003506311	0.008415147	3	oligos	OL-Cntl	30	9	9
TGACAACCAATCCGAT-1_371G_A3D3	0.062369663	18.58251839	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	765	1111	0.00090009	0.00720072	3	oligos	OL-Cntl	30	9	9
TGACAACCAGACAAAT-1_371G_A3D3	-24.96816359	0.015315621	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2025	3434	0.004950495	0.010483401	3	9	OPC	30	9	9
TGACAACCATCAGTAC-1_371G_A3D3	-4.569316586	15.59182523	5	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	762	1089	0.006427916	0.022038567	3	oligos	OL-MS-1	30	9	9
TGACAACCATTGTGCA-1_371G_A3D3	24.22007195	-10.9171333	3	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5238	14974	0.000667824	0.007947108	3	3	EN-L5-6	30	9	9
TGACAACGTCTTCTCG-1_371G_A3D3	-1.408822503	15.68898645	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	829	1201	0.005828476	0.017485429	3	oligos	OL-Cntl	30	9	9
TGACAACTCACAAACC-1_371G_A3D3	2.745253959	15.08996873	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	956	1485	0.002020202	0.010774411	3	oligos	OL-Cntl	30	9	9
TGACAACTCGTTTGCC-1_371G_A3D3	-16.9647743	1.536367797	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4484	10294	0.008451525	0.01321158	3	13A	IN-VIP	30	9	9
TGACGGCAGCCACGTC-1_371G_A3D3	13.88308365	-31.53094813	3	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3783	10312	0.008630721	0.002909232	3	3	EN-L5-6	30	9	9
TGACGGCCACATAACC-1_371G_A3D3	-16.08277534	2.42866039	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4777	11403	0.009646584	0.01368061	3	13A	IN-VIP	30	9	9
TGACGGCCAGGTCTCG-1_371G_A3D3	13.21351401	9.943432648	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1402	2375	0.003368421	0.005894737	3	oligos	OL-Cntl	30	9	9
TGACGGCCAGTATCTG-1_371G_A3D3	29.52683839	14.22341823	14	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1661	3500	0.186285714	0.082571429	3	14	Microglia	30	9	9
TGACGGCGTCATGCAT-1_371G_A3D3	-0.057080755	14.92792316	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	808	1160	0.001724138	0.013793103	3	oligos	OL-Cntl	30	9	9
TGACGGCGTTATGTGC-1_371G_A3D3	-2.838884039	17.5865261	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	810	1144	0.000874126	0.012237762	3	oligos	OL-Cntl	30	9	9
TGACGGCTCACCTTAT-1_371G_A3D3	7.837570471	9.591277339	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1279	2006	0.002991027	0.014955135	3	oligos	OL-Cntl	30	9	9
TGACGGCTCGCTGATA-1_371G_A3D3	-18.20841468	24.47331885	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1657	2825	0.003539823	0.004955752	3	8	Astrocytes	30	9	9
TGACGGCTCGTAGGTT-1_371G_A3D3	-5.69386339	-9.834384282	13B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	808	1109	0.037871957	0.004508566	3	13B	IN-SV2C	30	9	9
TGACTAGAGACTAAGT-1_371G_A3D3	-17.27681763	-5.852677773	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4012	9240	0.006709957	0.005952381	3	13A	IN-VIP	30	9	9
TGACTAGCAATTGCTG-1_371G_A3D3	-11.05979249	19.05740261	11	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3091	6410	0.005460218	0.008268331	3	11	Glia-MIX	30	9	9
TGACTAGTCAGCTGGC-1_371G_A3D3	1.18441546	13.83332456	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	867	1322	0.001512859	0.009077156	3	oligos	OL-Cntl	30	9	9
TGACTAGTCTACCAGA-1_371G_A3D3	13.88985577	-30.99923065	3	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3527	8990	0.003893215	0.003559511	3	3	EN-L5-6	30	9	9
TGACTTTAGCAATCTC-1_371G_A3D3	-11.56188384	-27.35641854	16	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	851	1088	0.033088235	0.012867647	3	16	EN-PYR	30	9	9
TGACTTTAGCGTTGCC-1_371G_A3D3	7.199571304	-20.80240258	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5437	15162	0.003033901	0.007452843	3	L2-3	EN-L2-3-MS	30	9	9
TGACTTTAGGTGCTTT-1_371G_A3D3	35.94588603	-8.584693845	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5263	14568	0.003844042	0.008649094	3	2	EN-L4	30	9	9
TGACTTTCAAGCTGAG-1_371G_A3D3	-12.47032381	-17.32516734	6B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1198	1823	0.027427318	0.010422381	3	6B	IN-SST	30	9	9
TGACTTTCATCGATTG-1_371G_A3D3	-23.22376598	-26.21659738	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4175	10235	0.001172447	0.006643869	3	6A	IN-PV	30	9	9
TGACTTTGTAGCTCCG-1_371G_A3D3	0.671772855	13.12772902	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	987	1639	0.001830384	0.017083588	3	oligos	OL-Cntl	30	9	9
TGACTTTTCCAAAGTC-1_371G_A3D3	-29.72171946	0.790510518	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1840	3169	0.000315557	0.009466709	3	9	OPC	30	9	9
TGACTTTTCGCTTGTC-1_371G_A3D3	3.018567836	14.91480289	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	927	1371	0.003646973	0.008752735	3	oligos	OL-Cntl	30	9	9
TGACTTTTCTTCCTTC-1_371G_A3D3	10.29279719	19.60926379	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	901	1472	0.002038043	0.008831522	3	oligos	OL-Cntl	30	9	9
TGAGAGGAGGGATCTG-1_371G_A3D3	-1.084534206	18.34507114	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	710	1023	0.001955034	0.007820137	3	oligos	OL-Cntl	30	9	9
TGAGAGGAGTATCTCG-1_371G_A3D3	26.82999208	6.907392625	15BA	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1137	1696	0.011792453	0.020636792	3	15BA	Stromal cells	30	9	9
TGAGAGGAGTCGTACT-1_371G_A3D3	-23.30847418	1.801036882	11	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4115	10618	0.005274063	0.007911094	3	11	Glia-MIX	30	9	9
TGAGAGGCAATGTAAG-1_371G_A3D3	9.53788524	8.033319493	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1598	2730	0.004029304	0.01978022	3	oligos	OL-Cntl	30	9	9
TGAGAGGCACGGTGTC-1_371G_A3D3	-1.354975564	21.93778119	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	707	1016	0	0.008858268	3	oligos	OL-Cntl	30	9	9
TGAGAGGGTCAATGTC-1_371G_A3D3	-18.97135619	-3.563243392	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4670	11226	0.007571709	0.008818813	3	13A	IN-VIP	30	9	9
TGAGAGGGTCGTCTTC-1_371G_A3D3	15.61995013	13.89044186	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1279	2069	0.001933301	0.006283229	3	oligos	OL-Cntl	30	9	9
TGAGAGGGTCTAAAGA-1_371G_A3D3	1.011784136	14.97268692	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	799	1234	0.004862237	0.016207455	3	oligos	OL-Cntl	30	9	9
TGAGAGGGTGGGTATG-1_371G_A3D3	2.854897061	15.01680386	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1021	1652	0.010895884	0.004842615	3	oligos	OL-Cntl	30	9	9
TGAGAGGTCCACGAAT-1_371G_A3D3	-28.65591999	-5.251607227	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1176	1976	0	0.004048583	3	9	OPC	30	9	9
TGAGAGGTCGGGAGTA-1_371G_A3D3	24.52074544	1.194862633	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2223	4323	0.009484155	0.003007171	3	2	EN-L4	30	9	9
TGAGAGGTCTGACCTC-1_371G_A3D3	8.909795334	17.58287574	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	926	1548	0.00129199	0.005167959	3	oligos	OL-Cntl	30	9	9
TGAGCATCAAGTAATG-1_371G_A3D3	-30.0258622	0.860041721	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1987	3694	0.001353546	0.007850568	3	9	OPC	30	9	9
TGAGCATCACCAGGTC-1_371G_A3D3	7.510888993	11.61490288	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	985	1489	0.009402283	0.010745467	3	oligos	OL-Cntl	30	9	9
TGAGCATCACTGAAGG-1_371G_A3D3	7.97630296	-17.76817392	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4383	10306	0.006889191	0.011255579	3	L2-3	EN-L2-3-MS	30	9	9
TGAGCATGTTCAACCA-1_371G_A3D3	1.655161481	15.67037504	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	841	1347	0.002227171	0.014105419	3	oligos	OL-Cntl	30	9	9
TGAGCATTCACTTACT-1_371G_A3D3	-19.13158306	-17.9513439	6B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2553	5261	0.008743585	0.009693975	3	6B	IN-SST	30	9	9
TGAGCATTCCACGTTC-1_371G_A3D3	-22.49339271	-4.532578948	13B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2641	5579	0.00250941	0.003226385	3	13B	IN-SV2C	30	9	9
TGAGCCGAGCGCCTTG-1_371G_A3D3	-3.245315283	24.84351061	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	889	1187	0.00758214	0.0042123	3	oligos	OL-Cntl	30	9	9
TGAGCCGCACGCGAAA-1_371G_A3D3	-33.74769706	-12.63292393	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	688	1000	0.002	0.004	3	9	OPC	30	9	9
TGAGCCGCATTACCTT-1_371G_A3D3	2.794267617	16.23030181	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	969	1530	0.003921569	0.006535948	3	oligos	OL-Cntl	30	9	9
TGAGCCGGTCTCTCTG-1_371G_A3D3	8.733375494	15.12167518	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1082	1717	0.004076878	0.011648224	3	oligos	OL-Cntl	30	9	9
TGAGCCGGTGGTTTCA-1_371G_A3D3	3.990906305	15.96833211	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1124	1758	0.001137656	0.005688282	3	oligos	OL-Cntl	30	9	9
TGAGCCGTCGCGCCAA-1_371G_A3D3	4.769896023	-20.3147089	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4049	10455	0.002008608	0.005834529	3	L2-3	EN-L2-3-MS	30	9	9
TGAGGGAAGCGTCTAT-1_371G_A3D3	6.254015855	-19.26666022	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4222	10076	0.002381898	0.012008734	3	L2-3	EN-L2-3-MS	30	9	9
TGAGGGACAAGTTCTG-1_371G_A3D3	-9.568811169	-1.658334073	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2019	3607	0.0085944	0.006930968	3	13A	IN-VIP	30	9	9
TGAGGGAGTCGCTTTC-1_371G_A3D3	6.756972302	-20.74499267	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	6466	21253	0.005458053	0.005693314	3	L2-3	EN-L2-3-MS	30	9	9
TGAGGGAGTTGGACCC-1_371G_A3D3	-23.80738575	-24.83648787	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3719	8311	0.011911924	0.009024185	3	6A	IN-PV	30	9	9
TGAGGGATCACCGGGT-1_371G_A3D3	34.33335723	-6.785781516	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3849	8945	0.007378424	0.005589715	3	2	EN-L4	30	9	9
TGAGGGATCTGACCTC-1_371G_A3D3	-23.77590327	-18.7621687	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4424	10592	0.008024924	0.009535498	3	6A	IN-PV	30	9	9
TGATTTCAGGAGTTGC-1_371G_A3D3	35.33311248	-11.63114648	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4440	10588	0.008689082	0.012655837	3	2	EN-L4	30	9	9
TGATTTCAGGGCATGT-1_371G_A3D3	-9.751823025	-2.557102149	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2280	4406	0.004539265	0.005447118	3	13A	IN-VIP	30	9	9
TGATTTCCACGTAAGG-1_371G_A3D3	-29.8540608	0.358533575	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1804	3215	0.002488336	0.008398134	3	9	OPC	30	9	9
TGATTTCCAGGGCATA-1_371G_A3D3	-19.8636203	28.51200615	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2045	3759	0.000798085	0.004522479	3	8	Astrocytes	30	9	9
TGATTTCTCTGACCTC-1_371G_A3D3	-16.32716784	15.57135552	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2031	3973	0	0.002768689	3	8	Astrocytes	30	9	9
TGCACCTCACGCATCG-1_371G_A3D3	-0.156142878	15.25710129	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	911	1355	0.000738007	0.01402214	3	oligos	OL-Cntl	30	9	9
TGCACCTCAGCCTATA-1_371G_A3D3	7.702000405	9.819328024	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1161	1873	0.005339028	0.012279765	3	oligos	OL-Cntl	30	9	9
TGCACCTGTTCGCTAA-1_371G_A3D3	-10.90752532	-9.713363212	13B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1283	2069	0.056065732	0.003383277	3	13B	IN-SV2C	30	9	9
TGCACCTTCCTCTAGC-1_371G_A3D3	23.48368373	-9.131353922	3	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4284	13964	0.000501289	0.002721283	3	3	EN-L5-6	30	9	9
TGCACCTTCGAATGCT-1_371G_A3D3	-34.35426145	2.826377068	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2075	3930	0.003562341	0.00610687	3	9	OPC	30	9	9
TGCACCTTCTGCTGTC-1_371G_A3D3	9.739291576	-30.16921316	10	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5815	16786	0.004170142	0.00345526	3	L2-3	EN-L2-3-Cntl	30	9	9
TGCCAAAAGAGTACAT-1_371G_A3D3	35.29586346	-8.867169903	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5946	15999	0.002437652	0.008250516	3	2	EN-L4	30	9	9
TGCCAAAAGTACGATA-1_371G_A3D3	14.33907379	9.094478476	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1572	2747	0.006916636	0.00728067	3	oligos	OL-Cntl	30	9	9
TGCCAAACAGTATCTG-1_371G_A3D3	-14.1128931	0.753773522	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3159	6636	0.011151296	0.00994575	3	13A	IN-VIP	30	9	9
TGCCAAAGTGATAAGT-1_371G_A3D3	2.254360433	12.29924713	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1007	1456	0.005494505	0.021978022	3	oligos	OL-Cntl	30	9	9
TGCCAAATCCTTGGTC-1_371G_A3D3	33.42901806	-7.263794485	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5246	13739	0.003784846	0.008588689	3	2	EN-L4	30	9	9
TGCCCATAGCTCCTCT-1_371G_A3D3	8.915958154	13.93663449	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1117	1924	0.007276507	0.012474012	3	oligos	OL-Cntl	30	9	9
TGCCCATCACTAAGTC-1_371G_A3D3	-15.80342765	-17.77802684	6B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1641	2962	0.016880486	0.004388926	3	6B	IN-SST	30	9	9
TGCCCATCACTCGACG-1_371G_A3D3	-3.202165266	12.88298497	5	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	946	1359	0.003679176	0.028697572	3	oligos	OL-MS-1	30	9	9
TGCCCATCATTGGTAC-1_371G_A3D3	7.09127186	11.97822568	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1099	1717	0.003494467	0.013395457	3	oligos	OL-Cntl	30	9	9
TGCCCATTCAAGAAGT-1_371G_A3D3	-19.25872517	28.77072572	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2338	5310	0.000376648	0.009981168	3	8	Astrocytes	30	9	9
TGCCCATTCACAATGC-1_371G_A3D3	-2.298190824	16.44178835	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	740	1029	0.002915452	0.015549077	3	oligos	OL-Cntl	30	9	9
TGCCCATTCTCTAGGA-1_371G_A3D3	-30.60572426	1.067304759	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1753	2965	0.003035413	0.003372681	3	9	OPC	30	9	9
TGCCCTAGTACCGTTA-1_371G_A3D3	3.150866672	-24.2058138	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3810	8401	0.007499107	0.005356505	3	L2-3	EN-L2-3-MS	30	9	9
TGCCCTAGTGCCTGTG-1_371G_A3D3	33.12547342	-6.937532693	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4185	9578	0.003236584	0.009396534	3	2	EN-L4	30	9	9
TGCCCTATCTTAGCCC-1_371G_A3D3	13.14572903	-24.29125454	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	8884	36664	0.005454942	0.0071187	3	L2-3	EN-L2-3-MS	30	9	9
TGCGCAGCAGCCTATA-1_371G_A3D3	-7.518135829	9.186169146	5	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	880	1328	0.003012048	0.02936747	3	oligos	OL-MS-1	30	9	9
TGCGCAGGTATATCCG-1_371G_A3D3	-9.497771055	-0.314698675	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2557	5600	0.009464286	0.004464286	3	13A	IN-VIP	30	9	9
TGCGCAGGTTGGGACA-1_371G_A3D3	-24.53586605	15.54303594	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1095	1775	0.005070423	0.005633803	3	8	Astrocytes	30	9	9
TGCGGGTCAAGGCTCC-1_371G_A3D3	4.920239244	-20.90024808	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5427	15619	0.001088418	0.007042704	3	L2-3	EN-L2-3-MS	30	9	9
TGCGGGTGTGTAATGA-1_371G_A3D3	-13.80805863	-10.70413294	13B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2051	4022	0.005718548	0.004226753	3	13B	IN-SV2C	30	9	9
TGCGGGTTCAGAAATG-1_371G_A3D3	-26.05991109	14.50047667	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1114	1804	0.004988914	0.002217295	3	8	Astrocytes	30	9	9
TGCGGGTTCCTAGAAC-1_371G_A3D3	5.720220208	-19.40375082	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4080	9641	0.006430868	0.005497355	3	L2-3	EN-L2-3-MS	30	9	9
TGCGGGTTCTACCTGC-1_371G_A3D3	-32.30949674	2.662241031	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2018	3674	0.001360915	0.003810561	3	9	OPC	30	9	9
TGCGTGGAGATCGATA-1_371G_A3D3	-1.272824812	16.08570322	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	762	1071	0.00280112	0.01774043	3	oligos	OL-Cntl	30	9	9
TGCGTGGAGCGGCTTC-1_371G_A3D3	8.649753022	13.2822563	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1084	1774	0.002254791	0.006764374	3	oligos	OL-Cntl	30	9	9
TGCGTGGAGTTATCGC-1_371G_A3D3	-23.05372314	-25.3930225	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3483	7961	0.011305112	0.008290416	3	6A	IN-PV	30	9	9
TGCGTGGCATACAGCT-1_371G_A3D3	-0.172647418	14.73832697	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	824	1226	0.001631321	0.02365416	3	oligos	OL-Cntl	30	9	9
TGCGTGGGTACTTCTT-1_371G_A3D3	-33.78389259	-4.360854339	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1375	2282	0.006573181	0.004382121	3	9	OPC	30	9	9
TGCGTGGGTGACTACT-1_371G_A3D3	-2.641942511	13.84736656	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	855	1215	0.000823045	0.020576132	3	oligos	OL-Cntl	30	9	9
TGCGTGGTCTGGGCCA-1_371G_A3D3	-8.853729251	-15.40508654	6B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	731	1009	0.030723489	0.015857284	3	6B	IN-SST	30	9	9
TGCTACCCACCAGTTA-1_371G_A3D3	1.184584881	22.80994863	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	751	1086	0.00092081	0.005524862	3	oligos	OL-Cntl	30	9	9
TGCTACCTCAAACGGG-1_371G_A3D3	36.05302683	-10.23900578	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5581	14789	0.002299006	0.011359794	3	2	EN-L4	30	9	9
TGCTACCTCGGATGTT-1_371G_A3D3	-24.00847684	0.95059178	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2603	4704	0.003401361	0.009778912	3	9	OPC	30	9	9
TGCTACCTCTCGCATC-1_371G_A3D3	13.5459597	9.181653966	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1536	2656	0.008659639	0.007906627	3	oligos	OL-Cntl	30	9	9
TGCTGCTAGAAGGCCT-1_371G_A3D3	5.455974229	-18.1963502	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3394	7627	0.004326734	0.013635768	3	L2-3	EN-L2-3-MS	30	9	9
TGCTGCTAGGCTCATT-1_371G_A3D3	15.20682477	6.288164361	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1848	3453	0.001158413	0.010425717	3	oligos	OL-Cntl	30	9	9
TGCTGCTAGTCAAGGC-1_371G_A3D3	6.414980456	9.207019969	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1386	2210	0.005429864	0.015384615	3	oligos	OL-Cntl	30	9	9
TGCTGCTGTCCGTGAC-1_371G_A3D3	-28.09380972	0.5641836	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2136	3687	0.003525902	0.028749661	3	9	OPC	30	9	9
TGCTGCTGTTACTGAC-1_371G_A3D3	-11.04014117	-18.45058287	6B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1017	1537	0.004554327	0.007156799	3	6B	IN-SST	30	9	9
TGCTGCTGTTCGGGCT-1_371G_A3D3	3.840433226	16.64231057	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	960	1449	0.002070393	0.008971705	3	oligos	OL-Cntl	30	9	9
TGCTGCTTCCCGGATG-1_371G_A3D3	-19.41371402	26.65889439	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1849	3457	0.001446341	0.006363899	3	8	Astrocytes	30	9	9
TGCTGCTTCGTTGACA-1_371G_A3D3	-1.869010538	16.45577419	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	703	1032	0.003875969	0.01744186	3	oligos	OL-Cntl	30	9	9
TGCTGCTTCTGATACG-1_371G_A3D3	-16.56175274	13.23418684	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1268	1822	0.004390779	0.007683864	3	8	Astrocytes	30	9	9
TGGACGCAGCGCCTCA-1_371G_A3D3	-3.330329722	16.11517494	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	765	1088	0.000919118	0.013786765	3	oligos	OL-Cntl	30	9	9
TGGACGCAGGCAATTA-1_371G_A3D3	18.84116122	-7.205125518	3	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2182	4326	0.017337032	0.00554785	3	3	EN-L5-6	30	9	9
TGGACGCCAATCCGAT-1_371G_A3D3	10.65873839	-27.8494987	10	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	8091	35524	0.00036595	0.004701047	3	L2-3	EN-L2-3-Cntl	30	9	9
TGGACGCCATAGAAAC-1_371G_A3D3	5.802654107	-9.694946474	12	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1653	2333	0.007715388	0.009429919	3	12	EN-MIX	30	9	9
TGGACGCGTACATGTC-1_371G_A3D3	2.196322374	15.39243386	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	846	1349	0.003706449	0.013343217	3	oligos	OL-Cntl	30	9	9
TGGACGCGTCTCATCC-1_371G_A3D3	-25.33905105	6.847862132	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	817	1158	0.000863558	0.003454231	3	8	Astrocytes	30	9	9
TGGACGCGTGTTAAGA-1_371G_A3D3	13.56649524	-29.40667373	3	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2979	6801	0.017644464	0.003970004	3	3	EN-L5-6	30	9	9
TGGACGCTCATGGTCA-1_371G_A3D3	31.760935	16.14047029	14	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1174	1885	0.004774536	0.061007958	3	14	Microglia	30	9	9
TGGACGCTCCGCTGTT-1_371G_A3D3	1.204271573	13.77326707	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	829	1193	0.004191115	0.019279128	3	oligos	OL-Cntl	30	9	9
TGGACGCTCGGAGCAA-1_371G_A3D3	11.93269214	-1.349406839	12	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1297	2160	0.008796296	0.008796296	3	12	EN-MIX	30	9	9
TGGACGCTCTAACTGG-1_371G_A3D3	-30.60583419	1.847738351	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1905	3489	0.001433075	0.007451992	3	9	OPC	30	9	9
TGGCCAGCAAGGTGTG-1_371G_A3D3	-24.50288847	15.75495254	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1352	2009	0.00099552	0.008461921	3	8	Astrocytes	30	9	9
TGGCCAGCAGAGCCAA-1_371G_A3D3	6.602672185	-21.03508419	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	6324	19593	0.003113357	0.005308018	3	L2-3	EN-L2-3-MS	30	9	9
TGGCCAGCATTCTTAC-1_371G_A3D3	36.00622652	-10.21755461	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4809	11774	0.004246645	0.014438594	3	2	EN-L4	30	9	9
TGGCCAGGTGTAACGG-1_371G_A3D3	1.855562711	17.71617002	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	838	1261	0.003965107	0.008723236	3	oligos	OL-Cntl	30	9	9
TGGCCAGGTGTGCCTG-1_371G_A3D3	4.308692972	18.15964336	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	974	1521	0.005259698	0.01183432	3	oligos	OL-Cntl	30	9	9
TGGCCAGTCATGCATG-1_371G_A3D3	11.80246167	13.30241444	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1697	3532	0.001698754	0.00198188	3	oligos	OL-Cntl	30	9	9
TGGCCAGTCTCCTATA-1_371G_A3D3	17.67204759	6.956688376	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2227	4300	0.002093023	0.007209302	3	oligos	OL-Cntl	30	9	9
TGGCGCAGTATTACCG-1_371G_A3D3	-32.7977377	5.380148289	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3655	7621	0.00472379	0.009316363	3	9	OPC	30	9	9
TGGCGCATCAAGGTAA-1_371G_A3D3	2.362186553	16.12614671	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	884	1345	0.003717472	0.010408922	3	oligos	OL-Cntl	30	9	9
TGGCGCATCACAATGC-1_371G_A3D3	-17.63299276	1.33557444	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4137	8846	0.007121863	0.016730726	3	13A	IN-VIP	30	9	9
TGGCTGGAGCGGATCA-1_371G_A3D3	8.777419478	12.33895682	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1117	1751	0.000571102	0.011422045	3	oligos	OL-Cntl	30	9	9
TGGCTGGCATAGAAAC-1_371G_A3D3	13.11054387	6.974470344	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1839	3120	0.002884615	0.013782051	3	oligos	OL-Cntl	30	9	9
TGGCTGGGTTCTGTTT-1_371G_A3D3	8.288742616	12.25459423	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1053	1603	0.002495321	0.014971928	3	oligos	OL-Cntl	30	9	9
TGGCTGGTCGCTTGTC-1_371G_A3D3	-15.79374692	1.129577747	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3639	8046	0.006338553	0.010564256	3	13A	IN-VIP	30	9	9
TGGCTGGTCGGAGCAA-1_371G_A3D3	-0.386399354	14.06286808	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	920	1359	0.00147167	0.02133922	3	oligos	OL-Cntl	30	9	9
TGGGAAGAGTATCTCG-1_371G_A3D3	35.51012979	-7.176945719	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3914	8823	0.004986966	0.005893687	3	2	EN-L4	30	9	9
TGGGAAGCACCACCAG-1_371G_A3D3	13.67096701	-30.73083515	3	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4527	14569	0.005147917	0.002745556	3	3	EN-L5-6	30	9	9
TGGGAAGCACGAGGTA-1_371G_A3D3	-8.601201078	-1.656718858	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1954	3881	0.000515331	0.004895645	3	13A	IN-VIP	30	9	9
TGGGAAGGTTATCACG-1_371G_A3D3	-31.22616711	10.29945778	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	933	1376	0.015261628	0.005087209	3	8	Astrocytes	30	9	9
TGGGAAGTCAAGGTAA-1_371G_A3D3	-30.23615894	0.972550499	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2021	3244	0.002466091	0.003390875	3	9	OPC	30	9	9
TGGGAAGTCATGCTCC-1_371G_A3D3	7.906890168	19.14591247	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1126	1748	0.000572082	0.01201373	3	oligos	OL-Cntl	30	9	9
TGGGAAGTCGGCATCG-1_371G_A3D3	-25.77948454	13.39113548	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	947	1446	0.006224066	0.003457815	3	8	Astrocytes	30	9	9
TGGGCGTAGATGTGTA-1_371G_A3D3	1.047329153	15.82921308	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	785	1113	0.001796945	0.009883199	3	oligos	OL-Cntl	30	9	9
TGGGCGTGTTCCGGCA-1_371G_A3D3	7.853538841	9.375741567	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1289	1953	0.002048131	0.015360983	3	oligos	OL-Cntl	30	9	9
TGGGCGTGTTGATTGC-1_371G_A3D3	-0.851709915	17.74954215	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	861	1299	0.000769823	0.010007698	3	oligos	OL-Cntl	30	9	9
TGGGCGTTCATCACCC-1_371G_A3D3	2.799784083	15.91374395	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1052	1726	0.00811124	0.007531866	3	oligos	OL-Cntl	30	9	9
TGGGCGTTCGATGAGG-1_371G_A3D3	-19.39618056	-21.157066	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2190	4194	0.018121125	0.006199332	3	6A	IN-PV	30	9	9
TGGGCGTTCGTCCGTT-1_371G_A3D3	5.142598778	14.87644985	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1004	1618	0.002472188	0.009888752	3	oligos	OL-Cntl	30	9	9
TGGGCGTTCTCAACTT-1_371G_A3D3	2.688619017	13.31176013	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	967	1480	0.001351351	0.016216216	3	oligos	OL-Cntl	30	9	9
TGGTTAGAGACACTAA-1_371G_A3D3	-13.19465792	-9.835267206	13B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1850	3327	0.012623986	0.002404569	3	13B	IN-SV2C	30	9	9
TGGTTAGCAGGCAGTA-1_371G_A3D3	-1.0787899	15.86389626	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	795	1072	0.000932836	0.013059701	3	oligos	OL-Cntl	30	9	9
TGGTTAGGTCTAGTCA-1_371G_A3D3	-20.2416702	30.2078882	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2289	4285	0.000466744	0.003033839	3	8	Astrocytes	30	9	9
TGGTTAGGTGCCTTGG-1_371G_A3D3	7.020348827	-20.72580144	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4964	13316	0.004130369	0.007659958	3	L2-3	EN-L2-3-MS	30	9	9
TGGTTCCAGTACGTAA-1_371G_A3D3	-30.96565396	1.886966531	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2072	3668	0.001363141	0.010359869	3	9	OPC	30	9	9
TGGTTCCCAGCTATTG-1_371G_A3D3	-17.48364776	1.447813928	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5100	12272	0.011245111	0.01458605	3	13A	IN-VIP	30	9	9
TGGTTCCCAGTGGGAT-1_371G_A3D3	-19.14025945	27.01026726	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2024	3715	0.004845222	0.00538358	3	8	Astrocytes	30	9	9
TGGTTCCGTGGCCCTA-1_371G_A3D3	-28.58465279	0.417147256	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2046	3526	0.00113443	0.013329552	3	9	OPC	30	9	9
TGGTTCCTCATCATTC-1_371G_A3D3	4.400323224	21.75455864	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	891	1384	0.00433526	0.009393064	3	oligos	OL-Cntl	30	9	9
TGGTTCCTCGCTTAGA-1_371G_A3D3	-18.37796769	-9.93660014	13B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3898	9104	0.011643234	0.008018453	3	13B	IN-SV2C	30	9	9
TGGTTCCTCGTCGTTC-1_371G_A3D3	3.266641044	-24.00641616	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4502	10965	0.004103967	0.011673507	3	L2-3	EN-L2-3-MS	30	9	9
TGGTTCCTCTACTATC-1_371G_A3D3	-34.24188731	-0.180786174	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1737	3168	0.000631313	0.004734848	3	9	OPC	30	9	9
TGTATTCAGATCTGCT-1_371G_A3D3	-14.49957363	0.456320288	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3076	6059	0.002310612	0.009242449	3	13A	IN-VIP	30	9	9
TGTATTCAGGCGACAT-1_371G_A3D3	-1.152569051	13.26832796	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	819	1144	0.003496503	0.024475524	3	oligos	OL-Cntl	30	9	9
TGTATTCCAGCCTTGG-1_371G_A3D3	-19.19858933	24.55218272	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1589	2826	0	0.005661713	3	8	Astrocytes	30	9	9
TGTATTCGTCAGTGGA-1_371G_A3D3	-15.07037312	-25.63254342	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1639	3228	0.000619579	0.000309789	3	6A	IN-PV	30	9	9
TGTATTCTCTTGTTTG-1_371G_A3D3	-0.411475536	13.99664525	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	810	1183	0.00591716	0.016060862	3	oligos	OL-Cntl	30	9	9
TGTCCCACAAGAGTCG-1_371G_A3D3	3.536331721	23.82364245	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	793	1127	0	0.007098492	3	oligos	OL-Cntl	30	9	9
TGTCCCATCTGGCGTG-1_371G_A3D3	-3.752091738	15.80921169	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	817	1236	0.003236246	0.011326861	3	oligos	OL-Cntl	30	9	9
TGTGGTACAAACGCGA-1_371G_A3D3	-3.232815073	13.35931491	5	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	762	1035	0	0.029951691	3	oligos	OL-MS-1	30	9	9
TGTGGTACAACTGGCC-1_371G_A3D3	-35.70641256	-10.1635802	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	873	1349	0.002965159	0.005930319	3	9	OPC	30	9	9
TGTGGTACATCTACGA-1_371G_A3D3	-13.00625499	17.97147905	11	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1646	2687	0.001860811	0.01153703	3	11	Glia-MIX	30	9	9
TGTGGTAGTAGGAGTC-1_371G_A3D3	3.987532789	11.29243187	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1122	1656	0.003623188	0.013285024	3	oligos	OL-Cntl	30	9	9
TGTGGTATCAACACGT-1_371G_A3D3	-10.18669702	-3.857760692	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1756	2711	0.03799336	0.015492438	3	13A	IN-VIP	30	9	9
TGTGGTATCTCGCTTG-1_371G_A3D3	19.50698342	-26.53967317	3	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3403	8424	0.007834758	0.005698006	3	3	EN-L5-6	30	9	9
TGTGGTATCTCTGAGA-1_371G_A3D3	-22.79773773	-19.15116154	6B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2304	4142	0.006277161	0.014968614	3	6B	IN-SST	30	9	9
TGTGTTTAGATGCCTT-1_371G_A3D3	-4.786431113	-10.06445167	13B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	730	1109	0.000901713	0.001803427	3	13B	IN-SV2C	30	9	9
TGTGTTTAGCCCAGCT-1_371G_A3D3	-34.05693092	-0.534267503	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1675	3131	0.00095816	0.007665283	3	9	OPC	30	9	9
TGTGTTTCACGTCTCT-1_371G_A3D3	-32.75858889	-8.253273856	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1121	1765	0.006798867	0.006798867	3	9	OPC	30	9	9
TGTGTTTCATGATCCA-1_371G_A3D3	-9.360367954	-20.21732502	6B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	871	1379	0.069615664	0.004350979	3	6B	IN-SST	30	9	9
TGTGTTTGTGCGAAAC-1_371G_A3D3	-6.982718645	9.873740362	5	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	862	1153	0.003469211	0.026019081	3	oligos	OL-MS-1	30	9	9
TGTGTTTGTTATGCGT-1_371G_A3D3	-15.34351355	1.627243721	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4507	10353	0.009176084	0.011590843	3	13A	IN-VIP	30	9	9
TGTGTTTTCAGCGATT-1_371G_A3D3	4.946548177	14.97903278	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	951	1451	0.011026878	0.009648518	3	oligos	OL-Cntl	30	9	9
TGTGTTTTCCTGCTTG-1_371G_A3D3	35.35646385	-6.833245495	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3405	6908	0.008251303	0.011725536	3	2	EN-L4	30	9	9
TGTGTTTTCTGATACG-1_371G_A3D3	-22.83207286	-19.48442154	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2712	6002	0.000166611	0.006164612	3	6A	IN-PV	30	9	9
TGTTCCGAGAGACTAT-1_371G_A3D3	8.748335773	12.2669671	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1123	1791	0.001116695	0.01228364	3	oligos	OL-Cntl	30	9	9
TGTTCCGAGGAGCGTT-1_371G_A3D3	0.082932062	13.15811702	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1009	1561	0.00256246	0.02049968	3	oligos	OL-Cntl	30	9	9
TGTTCCGAGGCCCTCA-1_371G_A3D3	-0.734195032	-26.99211673	10	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5181	16035	0.001371999	0.003866542	3	L2-3	EN-L2-3-Cntl	30	9	9
TGTTCCGAGTCTCAAC-1_371G_A3D3	-20.37030329	-27.70787322	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3583	8815	0.008394782	0.005558707	3	6A	IN-PV	30	9	9
TGTTCCGCATGATCCA-1_371G_A3D3	-18.97214491	27.74478833	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2232	4057	0.003943801	0.005915701	3	8	Astrocytes	30	9	9
TGTTCCGGTCCGAATT-1_371G_A3D3	4.652383926	27.38531012	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	876	1321	0.001514005	0.009084027	3	oligos	OL-Cntl	30	9	9
TTAACTCAGACTAAGT-1_371G_A3D3	-25.11179606	13.56064245	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1131	2098	0.001906578	0.002383222	3	8	Astrocytes	30	9	9
TTAACTCCACGGTGTC-1_371G_A3D3	-29.99649023	0.228349654	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1754	3030	0.002640264	0.009240924	3	9	OPC	30	9	9
TTAACTCGTAAACGCG-1_371G_A3D3	-1.540518507	18.41199165	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	761	1131	0.012378426	0.003536693	3	oligos	OL-Cntl	30	9	9
TTAACTCGTAAGGGAA-1_371G_A3D3	34.38736864	-4.789201538	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2300	4262	0.013843266	0.012435476	3	2	EN-L4	30	9	9
TTAACTCGTAGCTAAA-1_371G_A3D3	3.828534726	12.00882598	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1094	1704	0.004694836	0.009976526	3	oligos	OL-Cntl	30	9	9
TTAACTCGTATGCTTG-1_371G_A3D3	-24.40879621	21.84260983	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1164	1988	0.001006036	0.005030181	3	8	Astrocytes	30	9	9
TTAACTCGTGCACTTA-1_371G_A3D3	-5.90891266	-37.93206783	16	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1270	2123	0.1238813	0.019312294	3	16	EN-PYR	30	9	9
TTAACTCTCAATAAGG-1_371G_A3D3	-9.68806581	-3.041150726	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2089	3736	0.009368308	0.004817987	3	13A	IN-VIP	30	9	9
TTAACTCTCTCGGACG-1_371G_A3D3	-30.72618824	-3.710685616	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1482	2269	0.004407228	0.006610842	3	9	OPC	30	9	9
TTAGGACCACTGTTAG-1_371G_A3D3	13.73481464	-32.89176976	3	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4104	13258	0.001433097	0.002790768	3	3	EN-L5-6	30	9	9
TTAGGACCAGACGCCT-1_371G_A3D3	33.38634039	-7.346836627	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	6330	21232	0.002637528	0.006217031	3	2	EN-L4	30	9	9
TTAGGACGTGGGTATG-1_371G_A3D3	-17.10648053	1.068619757	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3685	7278	0.011679033	0.013053037	3	13A	IN-VIP	30	9	9
TTAGGCAAGCCCAATT-1_371G_A3D3	8.329421996	-20.66737257	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5565	16100	0.007639752	0.005714286	3	L2-3	EN-L2-3-MS	30	9	9
TTAGGCAAGGGATACC-1_371G_A3D3	24.35399992	-11.76572813	3	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4996	12399	0.007419953	0.007016695	3	3	EN-L5-6	30	9	9
TTAGGCAAGTACTTGC-1_371G_A3D3	-12.67967222	0.851175493	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3492	8095	0.007906115	0.00728845	3	13A	IN-VIP	30	9	9
TTAGGCAAGTGCGATG-1_371G_A3D3	-23.22936183	-19.30501025	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2882	6247	0.00608292	0.011045302	3	6A	IN-PV	30	9	9
TTAGGCACATATGGTC-1_371G_A3D3	-22.81187651	-19.5241019	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2865	6348	0.018431002	0.004883428	3	6A	IN-PV	30	9	9
TTAGGCAGTAAACGCG-1_371G_A3D3	0.251569786	12.62431016	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1065	1597	0.014402004	0.018785222	3	oligos	OL-Cntl	30	9	9
TTAGTTCAGACCTAGG-1_371G_A3D3	5.179963181	-19.70176866	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4419	11798	0.004322767	0.006950331	3	L2-3	EN-L2-3-MS	30	9	9
TTAGTTCAGTGTTTGC-1_371G_A3D3	-23.46032675	-25.54962028	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4384	12403	0.003789406	0.007095058	3	6A	IN-PV	30	9	9
TTAGTTCCATCACCCT-1_371G_A3D3	-34.33463724	1.549983926	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1796	3328	0.001502404	0.006310096	3	9	OPC	30	9	9
TTAGTTCGTACAGTTC-1_371G_A3D3	-23.73898397	0.02628448	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1666	2820	0.00248227	0.009929078	3	9	OPC	30	9	9
TTAGTTCTCAGCACAT-1_371G_A3D3	7.891968567	13.23458768	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1051	1651	0.004239855	0.007874016	3	oligos	OL-Cntl	30	9	9
TTAGTTCTCCAGGGCT-1_371G_A3D3	2.081196813	15.76516295	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	966	1591	0.008799497	0.011313639	3	oligos	OL-Cntl	30	9	9
TTAGTTCTCCGCGGTA-1_371G_A3D3	-33.4318443	-3.173203749	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1335	2210	0	0.005429864	3	9	OPC	30	9	9
TTATGCTAGACTTGAA-1_371G_A3D3	9.422854248	-20.09016178	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4970	15821	0.003539599	0.006067884	3	L2-3	EN-L2-3-MS	30	9	9
TTATGCTCACGAAGCA-1_371G_A3D3	-5.717050794	-3.847713155	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1629	2750	0.002545455	0.003636364	3	13A	IN-VIP	30	9	9
TTATGCTCATTTCAGG-1_371G_A3D3	1.280075853	17.73036792	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	803	1253	0.005586592	0.008778931	3	oligos	OL-Cntl	30	9	9
TTATGCTGTACTTGAC-1_371G_A3D3	8.457217941	15.76916727	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	951	1546	0.001293661	0.007761966	3	oligos	OL-Cntl	30	9	9
TTATGCTGTAGCGTGA-1_371G_A3D3	-13.69116762	1.380315997	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3580	7918	0.001010356	0.008714322	3	13A	IN-VIP	30	9	9
TTATGCTGTGAGCGAT-1_371G_A3D3	1.883665234	17.11787956	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	795	1233	0.00162206	0.0081103	3	oligos	OL-Cntl	30	9	9
TTATGCTGTGGTCCGT-1_371G_A3D3	24.3838278	-11.6295023	3	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5541	16281	0.006940606	0.008783244	3	3	EN-L5-6	30	9	9
TTATGCTTCTATCGCC-1_371G_A3D3	-14.36179465	-5.793660014	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3604	8590	0.014086147	0.002793946	3	13A	IN-VIP	30	9	9
TTATGCTTCTCCTATA-1_371G_A3D3	-2.31046153	17.86239181	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	705	1044	0	0.013409962	3	oligos	OL-Cntl	30	9	9
TTCCCAGAGTGCTGCC-1_371G_A3D3	14.82001015	6.970296328	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1573	2874	0.003827418	0.009394572	3	oligos	OL-Cntl	30	9	9
TTCCCAGCATTGCGGC-1_371G_A3D3	4.948948157	23.08620058	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	885	1345	0.002973978	0.011152416	3	oligos	OL-Cntl	30	9	9
TTCCCAGGTCTTCTCG-1_371G_A3D3	-33.27017372	3.283269765	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2397	4880	0.002254098	0.003688525	3	9	OPC	30	9	9
TTCCCAGGTGTAATGA-1_371G_A3D3	-11.47213373	-17.93667304	6B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	989	1532	0.017624021	0.001958225	3	6B	IN-SST	30	9	9
TTCGAAGAGCCAGTTT-1_371G_A3D3	2.816424788	11.27893754	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1142	1663	0.003006615	0.016235719	3	oligos	OL-Cntl	30	9	9
TTCGAAGAGTCTCCTC-1_371G_A3D3	-22.71005708	-19.16048369	6B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2588	5053	0.004947556	0.011082525	3	6B	IN-SST	30	9	9
TTCGAAGCAATACGCT-1_371G_A3D3	-6.093404799	-6.211058484	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1378	2156	0.013914657	0.00974026	3	13A	IN-VIP	30	9	9
TTCGAAGTCGCCTGTT-1_371G_A3D3	7.933603497	15.98713	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	931	1452	0.008264463	0.007575758	3	oligos	OL-Cntl	30	9	9
TTCGAAGTCGTACGGC-1_371G_A3D3	8.874740693	11.2249194	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1213	1901	0.003682272	0.013677012	3	oligos	OL-Cntl	30	9	9
TTCGGTCAGCTGAAAT-1_371G_A3D3	-29.6338338	20.22020433	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1076	1666	0.005402161	0.004801921	3	8	Astrocytes	30	9	9
TTCGGTCAGGCCATAG-1_371G_A3D3	-3.121161023	13.67611756	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	736	1031	0.002909796	0.021338506	3	oligos	OL-Cntl	30	9	9
TTCGGTCCAAGCGCTC-1_371G_A3D3	-18.42766621	26.43963499	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2041	3671	0.000544811	0.004630891	3	8	Astrocytes	30	9	9
TTCGGTCCATCAGTAC-1_371G_A3D3	-19.05562885	28.80888694	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2421	4624	0.002595156	0.004757785	3	8	Astrocytes	30	9	9
TTCGGTCGTCGTTGTA-1_371G_A3D3	-17.74901576	1.287699973	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4624	11066	0.014729803	0.019067414	3	13A	IN-VIP	30	9	9
TTCGGTCTCTGGGCCA-1_371G_A3D3	15.31722086	6.126365923	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2097	3972	0.002014099	0.008308157	3	oligos	OL-Cntl	30	9	9
TTCTACAAGCATGGCA-1_371G_A3D3	5.403312887	-19.21401686	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3506	8120	0.00320197	0.008251232	3	L2-3	EN-L2-3-MS	30	9	9
TTCTACACAAAGGTGC-1_371G_A3D3	-12.99468068	14.79643236	11	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1015	1592	0.002512563	0.005025126	3	11	Glia-MIX	30	9	9
TTCTACATCGGACAAG-1_371G_A3D3	28.15564836	6.42111001	15BA	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	757	1148	0.004355401	0.024390244	3	15BA	Stromal cells	30	9	9
TTCTCAAGTTCTGTTT-1_371G_A3D3	31.00917527	-1.404992448	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3472	8911	0.007294355	0.003478846	3	2	EN-L4	30	9	9
TTCTCAATCGCCTGTT-1_371G_A3D3	-15.39694713	1.927086585	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3798	9161	0.012116581	0.009605938	3	13A	IN-VIP	30	9	9
TTCTCAATCTAGCACA-1_371G_A3D3	-29.24694931	-0.04093785	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1691	2872	0.000696379	0.010445682	3	9	OPC	30	9	9
TTCTCCTGTGCCTGCA-1_371G_A3D3	-23.83189497	1.28789769	11	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3339	6905	0.003765387	0.009847936	3	11	Glia-MIX	30	9	9
TTCTCCTTCCGCGGTA-1_371G_A3D3	15.36041648	6.362918502	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1814	3413	0.001171989	0.008496924	3	oligos	OL-Cntl	30	9	9
TTCTCCTTCCTCCTAG-1_371G_A3D3	8.846184201	25.13648759	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	647	1039	0.003849856	0.007699711	3	oligos	OL-Cntl	30	9	9
TTCTCCTTCTGCAAGT-1_371G_A3D3	-21.22741317	25.93310339	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1670	3039	0.001645278	0.004935834	3	8	Astrocytes	30	9	9
TTCTTAGAGTGAAGAG-1_371G_A3D3	-24.32345587	22.13550928	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1274	2008	0.001494024	0.002988048	3	8	Astrocytes	30	9	9
TTCTTAGCAAACAACA-1_371G_A3D3	-16.59827047	1.278824416	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3392	7125	0.014877193	0.010807018	3	13A	IN-VIP	30	9	9
TTCTTAGCACCAGGCT-1_371G_A3D3	15.22751469	5.537381203	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2646	6144	0.004231771	0.009765625	3	oligos	OL-Cntl	30	9	9
TTCTTAGGTAAAGGAG-1_371G_A3D3	-24.4286463	-25.26362368	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4399	10860	0.005616943	0.011970534	3	6A	IN-PV	30	9	9
TTCTTAGGTTCCCGAG-1_371G_A3D3	-20.42222483	26.03907179	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1776	3279	0.000914913	0.003659652	3	8	Astrocytes	30	9	9
TTGAACGAGATCGGGT-1_371G_A3D3	2.644049644	13.12216215	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	927	1284	0.000778816	0.010124611	3	oligos	OL-Cntl	30	9	9
TTGAACGAGGATGGTC-1_371G_A3D3	13.51047291	-24.23442007	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	6955	22203	0.005674909	0.011575012	3	L2-3	EN-L2-3-MS	30	9	9
TTGAACGCAAGGACTG-1_371G_A3D3	35.83021888	-12.10143739	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4511	10365	0.006753497	0.012252774	3	2	EN-L4	30	9	9
TTGAACGCAATAGCGG-1_371G_A3D3	-10.88380579	-8.457110106	13B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1699	2817	0.017749379	0.005324814	3	13B	IN-SV2C	30	9	9
TTGAACGTCAACGCTA-1_371G_A3D3	15.26452908	-29.35524062	3	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5494	19592	0.007707227	0.003521846	3	3	EN-L5-6	30	9	9
TTGAACGTCAGCTGGC-1_371G_A3D3	8.295754668	13.38068383	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1002	1674	0	0.010752688	3	oligos	OL-Cntl	30	9	9
TTGACTTAGCTGAAAT-1_371G_A3D3	-5.496167865	-2.761211764	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1548	2843	0.013014421	0.001406964	3	13A	IN-VIP	30	9	9
TTGACTTAGGTGCACA-1_371G_A3D3	-28.07716679	-12.90009355	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	793	1260	0.005555556	0.004761905	3	9	OPC	30	9	9
TTGACTTCACATTCGA-1_371G_A3D3	15.25170838	8.244168672	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1620	2974	0.000336247	0.007733692	3	oligos	OL-Cntl	30	9	9
TTGACTTGTGTGCCTG-1_371G_A3D3	12.16229142	9.720319816	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1258	2068	0.002417795	0.010154739	3	oligos	OL-Cntl	30	9	9
TTGACTTGTGTTGGGA-1_371G_A3D3	5.940029293	-18.24745804	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4255	10713	0.007747596	0.008120975	3	L2-3	EN-L2-3-MS	30	9	9
TTGACTTTCGTAGGTT-1_371G_A3D3	8.590451183	17.47908329	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	833	1335	0.000749064	0.008988764	3	oligos	OL-Cntl	30	9	9
TTGCCGTAGGCTAGCA-1_371G_A3D3	8.001440551	-21.35597386	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5478	15121	0.00767145	0.005290655	3	L2-3	EN-L2-3-MS	30	9	9
TTGCCGTAGTACGTTC-1_371G_A3D3	8.555152652	15.89413477	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	956	1657	0	0.006638503	3	oligos	OL-Cntl	30	9	9
TTGCCGTCACGAGAGT-1_371G_A3D3	9.748407308	8.406988798	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1369	2265	0.00397351	0.009271523	3	oligos	OL-Cntl	30	9	9
TTGCCGTGTATTAGCC-1_371G_A3D3	1.637736185	13.56685504	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	819	1212	0.002475248	0.008250825	3	oligos	OL-Cntl	30	9	9
TTGCCGTTCAGTTGAC-1_371G_A3D3	1.861990061	16.88106287	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	837	1418	0.001410437	0.007757405	3	oligos	OL-Cntl	30	9	9
TTGCCGTTCATTCACT-1_371G_A3D3	-28.55302913	1.44060671	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2573	4580	0.011353712	0.008733624	3	9	OPC	30	9	9
TTGCGTCAGTTTCCTT-1_371G_A3D3	-1.625110293	15.78853943	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	889	1283	0.022603274	0.012470772	3	oligos	OL-Cntl	30	9	9
TTGCGTCCACATCCGG-1_371G_A3D3	2.737626405	11.32203627	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	985	1504	0.006648936	0.017952128	3	oligos	OL-Cntl	30	9	9
TTGCGTCCAGTGGGAT-1_371G_A3D3	13.90688795	7.925011159	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1554	2520	0.000396825	0.007539683	3	oligos	OL-Cntl	30	9	9
TTGCGTCCATTATCTC-1_371G_A3D3	-14.15359255	-24.92735741	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1522	2815	0.011722913	0.002486679	3	6A	IN-PV	30	9	9
TTGCGTCGTACTTAGC-1_371G_A3D3	6.720789432	-20.69043408	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4500	12245	0.002368314	0.008574929	3	L2-3	EN-L2-3-MS	30	9	9
TTGGAACAGCACGCCT-1_371G_A3D3	-32.99066757	5.352008335	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2915	6055	0.000990917	0.007266722	3	9	OPC	30	9	9
TTGGAACAGTAGCGGT-1_371G_A3D3	13.70816565	18.89584147	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1066	1648	0.001820388	0.009101942	3	oligos	OL-Cntl	30	9	9
TTGGAACCAAGCGATG-1_371G_A3D3	5.185363562	12.39273415	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1076	1545	0.000647249	0.012944984	3	oligos	OL-Cntl	30	9	9
TTGGAACCAAGTCATC-1_371G_A3D3	22.86678306	16.35398123	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1239	1874	0.001600854	0.006403415	3	oligos	OL-Cntl	30	9	9
TTGGAACCACCGAAAG-1_371G_A3D3	8.469072366	17.59918396	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	832	1237	0.009700889	0.010509297	3	oligos	OL-Cntl	30	9	9
TTGGAACCACTCAGGC-1_371G_A3D3	-1.043940952	17.52326974	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	884	1384	0.001445087	0.013728324	3	oligos	OL-Cntl	30	9	9
TTGGAACGTTAGAACA-1_371G_A3D3	4.148295829	9.777282439	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1453	2640	0.004545455	0.013636364	3	oligos	OL-Cntl	30	9	9
TTGGAACTCACCTTAT-1_371G_A3D3	-23.09172829	-26.24357912	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4010	9854	0.011365943	0.003145931	3	6A	IN-PV	30	9	9
TTGGAACTCCACTCCA-1_371G_A3D3	-26.2568612	-22.86688064	6A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5122	13756	0.006978773	0.012649026	3	6A	IN-PV	30	9	9
TTGGCAACAGCGTAAG-1_371G_A3D3	-9.292258397	-15.61298082	6B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	892	1323	0.03250189	0.009826153	3	6B	IN-SST	30	9	9
TTGTAGGAGAAGGGTA-1_371G_A3D3	31.01218613	15.49404059	14	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1010	1564	0.003836317	0.097186701	3	14	Microglia	30	9	9
TTGTAGGAGGAGTTTA-1_371G_A3D3	-27.04810451	-11.0792338	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	982	1429	0.00209937	0.012596221	3	9	OPC	30	9	9
TTGTAGGAGTATCTCG-1_371G_A3D3	35.96242282	-10.69697314	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4476	10504	0.005331302	0.009996192	3	2	EN-L4	30	9	9
TTGTAGGCAAAGAATC-1_371G_A3D3	-0.399966649	14.5938977	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	822	1204	0.002491694	0.015780731	3	oligos	OL-Cntl	30	9	9
TTGTAGGCAAGCGTAG-1_371G_A3D3	18.5650541	-24.40059523	3	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5091	13362	0.012049094	0.00913037	3	3	EN-L5-6	30	9	9
TTGTAGGCAATGAAAC-1_371G_A3D3	32.34050442	-8.328985031	2	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3079	6492	0.020024646	0.006777572	3	2	EN-L4	30	9	9
TTGTAGGCACGAAACG-1_371G_A3D3	-15.24187779	-18.25475899	6B	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1486	2650	0.013584906	0.002641509	3	6B	IN-SST	30	9	9
TTGTAGGCAGGGAGAG-1_371G_A3D3	-1.958032908	13.94145129	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	748	1069	0	0.018709074	3	oligos	OL-Cntl	30	9	9
TTGTAGGGTCGACTAT-1_371G_A3D3	8.659655332	6.766875544	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1556	2726	0.002201027	0.011371974	3	oligos	OL-Cntl	30	9	9
TTTACTGAGCCGATTT-1_371G_A3D3	6.931717028	11.02273269	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1131	1757	0.003984064	0.010244735	3	oligos	OL-Cntl	30	9	9
TTTACTGAGTACGTTC-1_371G_A3D3	-26.36549648	11.13807841	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	912	1520	0.000657895	0.001315789	3	8	Astrocytes	30	9	9
TTTACTGGTCGCGGTT-1_371G_A3D3	-1.993538057	25.8440133	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	689	1030	0	0.005825243	3	oligos	OL-Cntl	30	9	9
TTTACTGTCAATACCG-1_371G_A3D3	-34.19711871	-2.648317844	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1509	2421	0.00165221	0.00330442	3	9	OPC	30	9	9
TTTACTGTCTGGCGAC-1_371G_A3D3	35.83132046	10.74459903	14	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	792	1134	0.007054674	0.008818342	3	14	Microglia	30	9	9
TTTATGCCAAGGCTCC-1_371G_A3D3	1.445189939	17.51479527	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	761	1158	0	0.013816926	3	oligos	OL-Cntl	30	9	9
TTTATGCCAGGCTCAC-1_371G_A3D3	9.134559007	20.87631699	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	939	1539	0.001949318	0.001949318	3	oligos	OL-Cntl	30	9	9
TTTATGCCAGTAAGAT-1_371G_A3D3	16.5318936	22.20609229	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1082	1719	0.000581734	0.002326934	3	oligos	OL-Cntl	30	9	9
TTTATGCGTAATCGTC-1_371G_A3D3	23.21935061	-27.96558947	3	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4786	14637	0.006558721	0.003757601	3	3	EN-L5-6	30	9	9
TTTATGCGTTGCGCAC-1_371G_A3D3	-1.164380112	0.924818581	11	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2676	5108	0.001957713	0.013508222	3	11	Glia-MIX	30	9	9
TTTATGCTCACCAGGC-1_371G_A3D3	5.542872073	15.31669573	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	809	1277	0.000783085	0.014095536	3	oligos	OL-Cntl	30	9	9
TTTATGCTCTTGCATT-1_371G_A3D3	3.078402843	-15.29308812	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2480	5198	0.005386687	0.003270489	3	L2-3	EN-L2-3-MS	30	9	9
TTTCCTCAGCCGTCGT-1_371G_A3D3	3.878623619	3.893685993	14	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1363	2337	0.000855798	0.125374412	3	14	Microglia	30	9	9
TTTCCTCGTCGCTTTC-1_371G_A3D3	-30.4227321	-2.803822333	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1404	2414	0.00041425	0.007870754	3	9	OPC	30	9	9
TTTCCTCTCAGGTAAA-1_371G_A3D3	-4.159348554	21.91307924	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	788	1096	0.002737226	0.009124088	3	oligos	OL-Cntl	30	9	9
TTTCCTCTCGGACAAG-1_371G_A3D3	-0.412042992	-25.50378568	10	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	4796	14834	0.002292032	0.003842524	3	L2-3	EN-L2-3-Cntl	30	9	9
TTTGCGCAGCGTAGTG-1_371G_A3D3	-25.50961093	11.26332824	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1059	1653	0.003024803	0.007864489	3	8	Astrocytes	30	9	9
TTTGCGCAGTCACGCC-1_371G_A3D3	10.07512337	-32.46207269	10	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	5906	23729	0.001011421	0.002907834	3	L2-3	EN-L2-3-Cntl	30	9	9
TTTGCGCCAATCTGCA-1_371G_A3D3	-25.9513472	12.2994601	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	866	1244	0.004019293	0.002411576	3	8	Astrocytes	30	9	9
TTTGCGCCACCTCGTT-1_371G_A3D3	5.640182798	-21.98651088	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	8058	36698	0.005150144	0.003760423	3	L2-3	EN-L2-3-MS	30	9	9
TTTGCGCGTAGAGGAA-1_371G_A3D3	-1.048795521	14.94116474	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	792	1146	0.001745201	0.015706806	3	oligos	OL-Cntl	30	9	9
TTTGCGCGTCCTCTTG-1_371G_A3D3	-12.26838088	1.927262159	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	3488	7608	0.000657203	0.012355415	3	13A	IN-VIP	30	9	9
TTTGCGCTCGGTCTAA-1_371G_A3D3	15.743161	-16.6241783	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	7595	26790	0.008585293	0.009294513	3	L2-3	EN-L2-3-MS	30	9	9
TTTGCGCTCTTACCTA-1_371G_A3D3	-6.447102086	0.008738558	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1941	3775	0.010596026	0.005298013	3	13A	IN-VIP	30	9	9
TTTGGTTTCACAATGC-1_371G_A3D3	12.9691733	-31.441393	3	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2740	6651	0.009772966	0.003307773	3	3	EN-L5-6	30	9	9
TTTGGTTTCACATGCA-1_371G_A3D3	1.294613511	15.52847087	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	795	1232	0.002435065	0.007305195	3	oligos	OL-Cntl	30	9	9
TTTGGTTTCTTAGCCC-1_371G_A3D3	-5.200790372	-1.274799484	13A	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1533	2755	0.000725953	0.003266788	3	13A	IN-VIP	30	9	9
TTTGTCAAGCTGGAAC-1_371G_A3D3	-36.08463741	-4.614706634	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1344	2424	0.001237624	0.004537954	3	9	OPC	30	9	9
TTTGTCACACCAACCG-1_371G_A3D3	-33.12591478	1.504396652	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1976	3467	0.009229882	0.009229882	3	9	OPC	30	9	9
TTTGTCACACTGAAGG-1_371G_A3D3	-0.448316676	14.70093339	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	840	1260	0.000793651	0.018253968	3	oligos	OL-Cntl	30	9	9
TTTGTCACAGTCTTCC-1_371G_A3D3	8.562221733	15.60933136	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1150	2100	0.003333333	0.006666667	3	oligos	OL-Cntl	30	9	9
TTTGTCAGTAGGGACT-1_371G_A3D3	-24.40799793	15.79297599	8	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1196	1802	0.001109878	0.006104329	3	8	Astrocytes	30	9	9
TTTGTCATCAACGCTA-1_371G_A3D3	-30.31986412	-0.510247956	9	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1729	3034	0.002636783	0.006921556	3	9	OPC	30	9	9
TTTGTCATCAGAGACG-1_371G_A3D3	8.189713652	10.88108654	1	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	1160	1979	0.002021223	0.01414856	3	oligos	OL-Cntl	30	9	9
TTTGTCATCTATCCCG-1_371G_A3D3	3.527065064	-16.92758914	4	371G_A3D3	MS	Acute/Chronic active	40	male	prefrontal	CAP5	SEQ3	7.9	27	2790	5980	0.005685619	0.004849498	3	L2-3	EN-L2-3-MS	30	9	9
AAACCTGAGCACCGCT-1_3_C4	18.85874065	16.93401986	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1066	1753	0.005134056	0.002281803	6	oligos	OL-Cntl	51	20	20
AAACCTGAGTCATGCT-1_3_C4	-31.2434406	11.09619728	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	724	1010	0.018811881	0.002970297	6	8	Astrocytes	51	20	20
AAACCTGTCCCTTGTG-1_3_C4	18.54479054	-6.34294185	3	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1712	3187	0.003765297	0.005961719	6	3	EN-L5-6	51	20	20
AAACCTGTCGCGTAGC-1_3_C4	-21.7492296	9.819466781	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	861	1295	0.000772201	0.004633205	6	8	Astrocytes	51	20	20
AAACCTGTCGGCATCG-1_3_C4	-34.91277151	-3.875327476	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1249	2046	0.00684262	0.00684262	6	9	OPC	51	20	20
AAACGGGAGAATAGGG-1_3_C4	-31.51869224	12.59843069	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	839	1249	0.005604484	0.004803843	6	8	Astrocytes	51	20	20
AAACGGGAGACTGTAA-1_3_C4	-15.47179159	-21.16362438	6A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1648	2886	0.031531532	0.002079002	6	6A	IN-PV	51	20	20
AAACGGGAGATGTAAC-1_3_C4	-24.22385027	-16.03872025	6A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	3794	9185	0.011322809	0.0044638	6	6A	IN-PV	51	20	20
AAACGGGCAAACCTAC-1_3_C4	-25.23556156	25.81392607	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1590	3019	0.003312355	0.003974826	6	8	Astrocytes	51	20	20
AAAGATGGTCTAAACC-1_3_C4	-33.49322673	-13.13623346	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	678	1004	0.001992032	0.002988048	6	9	OPC	51	20	20
AAAGATGTCCGTACAA-1_3_C4	-9.4451385	-5.430325871	13A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1613	2847	0.026343519	0.008429926	6	13A	IN-VIP	51	20	20
AAAGATGTCCTCAATT-1_3_C4	-31.28117364	11.42198131	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	733	1067	0.002811621	0.004686036	6	8	Astrocytes	51	20	20
AAAGATGTCGATCCCT-1_3_C4	-25.7265027	22.24714657	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1208	2165	0.006928406	0.006004619	6	8	Astrocytes	51	20	20
AAAGATGTCGGATGTT-1_3_C4	-29.33400298	20.4198486	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	969	1520	0.009210526	0.003947368	6	8	Astrocytes	51	20	20
AAAGCAAAGCTGCAAG-1_3_C4	-25.33702188	22.61637145	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1375	2422	0.000825764	0.004954583	6	8	Astrocytes	51	20	20
AAAGCAACACGTCAGC-1_3_C4	10.07775885	20.74924808	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	947	1512	0.003306878	0.005952381	6	oligos	OL-Cntl	51	20	20
AAAGCAACAGGAACGT-1_3_C4	-2.638285923	-0.90793995	13A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	3158	6412	0.012944479	0.009981285	6	13A	IN-VIP	51	20	20
AAAGCAACATGGATGG-1_3_C4	-28.00501713	10.94173316	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	732	1082	0.00831793	0.006469501	6	8	Astrocytes	51	20	20
AAAGCAAGTGAGGGAG-1_3_C4	21.60122466	9.325651081	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1870	3433	0.003786775	0.00699097	6	oligos	OL-Cntl	51	20	20
AAAGCAAGTGCGGTAA-1_3_C4	22.54815228	13.01924066	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1412	2452	0.002039152	0.005709625	6	oligos	OL-Cntl	51	20	20
AAAGCAAGTTGGACCC-1_3_C4	18.28256924	8.402431873	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1908	4113	0.009968393	0.002917578	6	oligos	OL-Cntl	51	20	20
AAAGCAATCCTGCCAT-1_3_C4	-23.02505497	23.9773737	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1517	2728	0.004765396	0.004032258	6	8	Astrocytes	51	20	20
AAAGCAATCGCAGGCT-1_3_C4	-28.23301465	16.64590832	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1080	1857	0.011308562	0.006462036	6	8	Astrocytes	51	20	20
AAAGCAATCTTAGAGC-1_3_C4	-23.08817127	-4.722301385	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1598	2848	0.030196629	0.003511236	6	9	OPC	51	20	20
AAAGTAGAGTACGTTC-1_3_C4	-28.95461952	10.58151897	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	762	1201	0.006661116	0.006661116	6	8	Astrocytes	51	20	20
AAAGTAGGTACGCTGC-1_3_C4	-8.536292849	-2.782127209	13A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2016	4073	0.016695311	0.00343727	6	13A	IN-VIP	51	20	20
AAAGTAGGTTTGGCGC-1_3_C4	-8.489134655	-5.389709258	13A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1525	2578	0.022110163	0.005430566	6	13A	IN-VIP	51	20	20
AAAGTAGTCCACGTGG-1_3_C4	17.4464335	14.27524865	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1229	2147	0.002328831	0.006986493	6	oligos	OL-Cntl	51	20	20
AAAGTAGTCGAGAACG-1_3_C4	-26.4920785	11.66923272	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	906	1392	0.011494253	0.001436782	6	8	Astrocytes	51	20	20
AAATGCCAGCCACGCT-1_3_C4	19.3421533	11.49012172	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1390	2519	0.001190949	0.005160778	6	oligos	OL-Cntl	51	20	20
AAATGCCAGCGATTCT-1_3_C4	-1.958328476	15.14010431	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	686	1017	0.010816126	0.026548673	6	oligos	OL-Cntl	51	20	20
AAATGCCAGTTACCCA-1_3_C4	-24.72365917	27.0146761	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1764	3603	0.002497918	0.003053011	6	8	Astrocytes	51	20	20
AAATGCCGTCGACTAT-1_3_C4	4.572703203	25.3375727	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	778	1159	0.002588438	0.010353753	6	oligos	OL-Cntl	51	20	20
AAATGCCGTTATTCTC-1_3_C4	9.990007689	12.94774412	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1172	1891	0.009518773	0.008989952	6	oligos	OL-Cntl	51	20	20
AAATGCCGTTGGGACA-1_3_C4	12.16374103	16.56619639	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1046	1838	0.002720348	0.002720348	6	oligos	OL-Cntl	51	20	20
AAATGCCTCGGTGTCG-1_3_C4	8.406017746	-19.95620119	4	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	4435	11887	0.012366451	0.012955329	6	L2-3	EN-L2-3-MS	51	20	20
AAATGCCTCTTTACAC-1_3_C4	-31.70919504	12.02133151	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	763	1137	0.008795075	0.001759015	6	8	Astrocytes	51	20	20
AACACGTAGCAGACTG-1_3_C4	-15.24648645	-6.889259558	13A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	4752	13854	0.007434676	0.002959434	6	13A	IN-VIP	51	20	20
AACACGTAGCGCTTAT-1_3_C4	-23.6233846	-0.336736386	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1639	3006	0.002661344	0.001996008	6	9	OPC	51	20	20
AACACGTAGGCTACGA-1_3_C4	-27.59195727	22.64014944	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1222	2190	0.011415525	0.008219178	6	8	Astrocytes	51	20	20
AACACGTAGTTCGCAT-1_3_C4	16.06679369	25.75554454	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	884	1339	0	0.004480956	6	oligos	OL-Cntl	51	20	20
AACACGTGTAAGTAGT-1_3_C4	4.892205639	24.75471659	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	790	1166	0.000857633	0.011149228	6	oligos	OL-Cntl	51	20	20
AACACGTGTCATGCAT-1_3_C4	-9.657853734	14.11095101	11	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1500	2538	0.005910165	0.00394011	6	11	Glia-MIX	51	20	20
AACACGTGTGAAATCA-1_3_C4	-24.65790065	22.73886455	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1315	2217	0.01398286	0.00496166	6	8	Astrocytes	51	20	20
AACCATGAGGAGCGAG-1_3_C4	-23.79007428	21.97428335	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1330	2358	0.005513147	0.005513147	6	8	Astrocytes	51	20	20
AACCATGCACTGCCAG-1_3_C4	19.86387752	13.94139332	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1328	2258	0.001771479	0.006200177	6	oligos	OL-Cntl	51	20	20
AACCATGCATGTCTCC-1_3_C4	14.56443208	24.20262382	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	821	1291	0.001549187	0.00464756	6	oligos	OL-Cntl	51	20	20
AACCATGGTAAACACA-1_3_C4	24.97890836	-8.243626219	3	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	3268	6868	0.009755387	0.003494467	6	3	EN-L5-6	51	20	20
AACCATGTCACGCATA-1_3_C4	20.15866607	-27.37938419	3	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	3651	9095	0.001429357	0.002308961	6	3	EN-L5-6	51	20	20
AACCGCGCAACTGGCC-1_3_C4	2.661070277	22.97249671	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	958	1532	0.003916449	0.003263708	6	oligos	OL-Cntl	51	20	20
AACCGCGCAATCCAAC-1_3_C4	-24.18355812	18.68040424	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1372	2214	0.009033424	0.005871725	6	8	Astrocytes	51	20	20
AACCGCGCATCATCCC-1_3_C4	-11.40488706	2.402827159	13A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	3419	8084	0.00655616	0.007545769	6	13A	IN-VIP	51	20	20
AACCGCGCATCGACGC-1_3_C4	-22.915902	26.22881103	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1738	3041	0.004932588	0.002959553	6	8	Astrocytes	51	20	20
AACCGCGCATCGGTTA-1_3_C4	-38.80251423	-7.331325963	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1155	2074	0.00144648	0.00048216	6	9	OPC	51	20	20
AACGTTGAGCCCAACC-1_3_C4	-11.0579874	15.95984732	11	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1574	2518	0.005162828	0.002779984	6	11	Glia-MIX	51	20	20
AACGTTGAGGATATAC-1_3_C4	2.817597	-19.3880151	4	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	3508	8911	0.010660981	0.004713276	6	L2-3	EN-L2-3-MS	51	20	20
AACGTTGCAAGGGTCA-1_3_C4	20.65077068	-29.06931094	3	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	4634	14132	0.004457968	0.003113501	6	3	EN-L5-6	51	20	20
AACGTTGCAGATCGGA-1_3_C4	-24.02154643	22.59966467	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1412	2432	0.002878289	0.003289474	6	8	Astrocytes	51	20	20
AACGTTGGTTAAAGAC-1_3_C4	-16.18162626	14.65086116	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1817	3474	0.000863558	0.004605642	6	8	Astrocytes	51	20	20
AACGTTGTCAGTCAGT-1_3_C4	13.79094454	19.55964542	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	945	1453	0.00550585	0.013764625	6	oligos	OL-Cntl	51	20	20
AACTCAGAGCGCCTCA-1_3_C4	-36.07455039	-0.932331121	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1401	2362	0.00084674	0.00296359	6	9	OPC	51	20	20
AACTCAGGTACCGTAT-1_3_C4	-31.14417687	11.06802187	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	763	1129	0.007085917	0.004428698	6	8	Astrocytes	51	20	20
AACTCCCAGCTCCTTC-1_3_C4	-9.589530435	17.81551229	11	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2535	5425	0.005714286	0.003686636	6	11	Glia-MIX	51	20	20
AACTCCCGTATATGAG-1_3_C4	-14.74633109	-25.28952874	6A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1654	3229	0.032827501	0.002787241	6	6A	IN-PV	51	20	20
AACTCCCTCAGGATCT-1_3_C4	12.32489235	23.57137694	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	759	1163	0.000859845	0.004299226	6	oligos	OL-Cntl	51	20	20
AACTCTTGTCATTAGC-1_3_C4	12.92681576	29.52571996	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	773	1184	0.011824324	0.008445946	6	oligos	OL-Cntl	51	20	20
AACTCTTGTCTAACGT-1_3_C4	-12.60269125	0.616146322	13A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2751	5852	0.00786056	0.00786056	6	13A	IN-VIP	51	20	20
AACTCTTTCACGCGGT-1_3_C4	25.5536197	7.145820693	15A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1439	2240	0.015178571	0.016071429	6	15A	Endo cells	51	20	20
AACTGGTCACCAACCG-1_3_C4	16.36656832	17.02237351	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1001	1616	0.007425743	0.006806931	6	oligos	OL-Cntl	51	20	20
AACTGGTCAGAGCCAA-1_3_C4	-1.928831358	19.50468526	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	872	1191	0.004198153	0.005877414	6	oligos	OL-Cntl	51	20	20
AACTGGTCATACAGCT-1_3_C4	-26.061522	22.57762856	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1208	2084	0.012476008	0.005758157	6	8	Astrocytes	51	20	20
AACTGGTGTGATGCCC-1_3_C4	0.266962331	18.10969846	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	733	1128	0.003546099	0.008865248	6	oligos	OL-Cntl	51	20	20
AACTGGTTCATCGATG-1_3_C4	-11.6267573	-22.54264986	6A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1063	1892	0.069767442	0.002114165	6	6A	IN-PV	51	20	20
AACTGGTTCTGATTCT-1_3_C4	2.419597679	25.0938072	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	683	1031	0.008729389	0.005819593	6	oligos	OL-Cntl	51	20	20
AACTTTCCACAGCCCA-1_3_C4	17.83741525	20.3944515	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	866	1491	0.002682763	0.000670691	6	oligos	OL-Cntl	51	20	20
AAGACCTCAAAGCGGT-1_3_C4	0.835944393	26.68061481	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	743	1038	0.003853565	0.004816956	6	oligos	OL-Cntl	51	20	20
AAGACCTCAATCCAAC-1_3_C4	-28.4625034	23.38211777	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1145	1991	0.005524862	0.001506781	6	8	Astrocytes	51	20	20
AAGACCTGTCTCTTAT-1_3_C4	-11.03036715	-21.17140013	6A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	966	1674	0.086021505	0.002986858	6	6A	IN-PV	51	20	20
AAGACCTGTGCAACGA-1_3_C4	-28.74736441	10.7336383	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	807	1126	0.006216696	0.007104796	6	8	Astrocytes	51	20	20
AAGACCTGTGGCAAAC-1_3_C4	-33.57410196	-10.29838981	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	943	1451	0.006891799	0.004824259	6	9	OPC	51	20	20
AAGACCTGTTACCGAT-1_3_C4	-36.29838299	-1.051326521	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1379	2408	0.003322259	0.004983389	6	9	OPC	51	20	20
AAGACCTGTTGCTCCT-1_3_C4	17.45352522	17.48645124	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1090	1814	0.004410143	0.007166483	6	oligos	OL-Cntl	51	20	20
AAGACCTTCCGTTGCT-1_3_C4	9.032380934	30.75428119	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	774	1389	0.002159827	0.005759539	6	oligos	OL-Cntl	51	20	20
AAGACCTTCCTTTCTC-1_3_C4	12.48586205	25.43960686	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	711	1148	0.009581882	0.004355401	6	oligos	OL-Cntl	51	20	20
AAGCCGCAGGTGATAT-1_3_C4	10.97508899	25.11133256	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	821	1220	0.001639344	0.005737705	6	oligos	OL-Cntl	51	20	20
AAGCCGCAGGTGCTTT-1_3_C4	16.30661021	17.47359269	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1100	1992	0.008534137	0.010040161	6	oligos	OL-Cntl	51	20	20
AAGCCGCCACGCATCG-1_3_C4	-26.00260902	20.54638886	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1585	2846	0.008784259	0.005270555	6	8	Astrocytes	51	20	20
AAGCCGCGTGTGAATA-1_3_C4	17.84024326	-7.220185469	3	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1821	3450	0.011884058	0.002318841	6	3	EN-L5-6	51	20	20
AAGGAGCAGTCACGCC-1_3_C4	18.34340206	20.12036246	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	943	1517	0	0.005273566	6	oligos	OL-Cntl	51	20	20
AAGGAGCAGTTGAGTA-1_3_C4	11.39492943	23.14222356	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	852	1318	0.004552352	0.007587253	6	oligos	OL-Cntl	51	20	20
AAGGAGCGTACGCTGC-1_3_C4	16.45597339	15.77650976	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1099	1828	0.011487965	0.004923414	6	oligos	OL-Cntl	51	20	20
AAGGAGCGTGACCAAG-1_3_C4	27.22958465	4.902977563	15BA	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	902	1315	0.019011407	0.011406844	6	15BA	Stromal cells	51	20	20
AAGGAGCTCACTGGGC-1_3_C4	16.49661182	9.643237574	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1537	2621	0.00610454	0.007630675	6	oligos	OL-Cntl	51	20	20
AAGGAGCTCTCTGTCG-1_3_C4	-13.22118724	4.661914925	6B	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1701	2957	0.018599932	0.003381806	6	6B	IN-SST	51	20	20
AAGGCAGAGAAGATTC-1_3_C4	-17.57934033	13.90550997	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1403	2385	0.001677149	0.005450734	6	8	Astrocytes	51	20	20
AAGGCAGAGCCCAGCT-1_3_C4	-22.65599662	23.94261419	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1509	2805	0.002495544	0.004278075	6	8	Astrocytes	51	20	20
AAGGCAGAGCTAACTC-1_3_C4	21.91262467	-22.92925575	3	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	4353	11372	0.008441787	0.005451987	6	3	EN-L5-6	51	20	20
AAGGCAGAGGAGTTGC-1_3_C4	31.98133419	15.27817831	14	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1013	1677	0.004770423	0.075730471	6	14	Microglia	51	20	20
AAGGCAGAGGTACTCT-1_3_C4	3.347636513	27.67724357	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	732	1195	0.00167364	0.00334728	6	oligos	OL-Cntl	51	20	20
AAGGCAGAGTTGTCGT-1_3_C4	-9.272119637	13.91111878	11	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1577	2467	0.004458857	0.006080259	6	11	Glia-MIX	51	20	20
AAGGTTCAGTTATCGC-1_3_C4	-24.10335225	26.19559149	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1524	2689	0.005950167	0.004462626	6	8	Astrocytes	51	20	20
AAGGTTCCAACACCTA-1_3_C4	13.16161759	24.00966548	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	864	1428	0.00210084	0.004901961	6	oligos	OL-Cntl	51	20	20
AAGGTTCCAATAGCGG-1_3_C4	-37.30966306	-5.411386195	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1208	2034	0.001966568	0.001474926	6	9	OPC	51	20	20
AAGGTTCGTGTGACGA-1_3_C4	-31.00833546	11.94107579	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	789	1140	0.009649123	0.001754386	6	8	Astrocytes	51	20	20
AAGGTTCTCCCTTGCA-1_3_C4	-12.39937873	0.768896603	13A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	3257	7570	0.009643329	0.004623514	6	13A	IN-VIP	51	20	20
AAGGTTCTCGTATCAG-1_3_C4	-27.97665308	23.35792634	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1184	2102	0.005233111	0.003805899	6	8	Astrocytes	51	20	20
AAGTCTGCACGTCAGC-1_3_C4	-34.92627699	-7.182694046	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1059	1650	0	0.004242424	6	9	OPC	51	20	20
AAGTCTGCAGTACACT-1_3_C4	-24.05913892	22.9937446	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1309	2427	0.003296251	0.003296251	6	8	Astrocytes	51	20	20
AAGTCTGGTGCTTCTC-1_3_C4	-17.89537467	-25.07791819	6A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2547	5932	0.001011463	0.001685772	6	6A	IN-PV	51	20	20
AATCCAGCACTGCCAG-1_3_C4	-28.58309392	12.5359864	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	825	1207	0.023198012	0.006628003	6	8	Astrocytes	51	20	20
AATCCAGGTGAGGGAG-1_3_C4	12.95628011	22.14257062	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	850	1263	0.001583531	0.005542359	6	oligos	OL-Cntl	51	20	20
AATCCAGTCCATGAGT-1_3_C4	-4.420579239	20.99409281	5	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	726	1033	0.019361084	0.021297193	6	oligos	OL-MS-1	51	20	20
AATCGGTAGTAAGTAC-1_3_C4	5.136728834	-3.725042609	12	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1066	1628	0.021498771	0.006142506	6	12	EN-MIX	51	20	20
ACACCAACAATAACGA-1_3_C4	0.192579981	23.28199444	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	703	1067	0.004686036	0.004686036	6	oligos	OL-Cntl	51	20	20
ACACCAACATGGTCAT-1_3_C4	-12.53469958	-19.33074763	6B	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1094	1985	0.027707809	0.004534005	6	6B	IN-SST	51	20	20
ACACCAACATTCCTGC-1_3_C4	16.39337607	17.59024601	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1083	1881	0.005847953	0.004784689	6	oligos	OL-Cntl	51	20	20
ACACCAATCCAATGGT-1_3_C4	39.37096202	14.44729688	14	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1165	1792	0.000558036	0.006696429	6	14	Microglia	51	20	20
ACACCCTAGCAAATCA-1_3_C4	33.32498805	-5.541539637	2	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	3078	6388	0.006105197	0.005948654	6	2	EN-L4	51	20	20
ACACCCTAGGTCATCT-1_3_C4	-24.74835453	26.14601929	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1784	3583	0.006977393	0.005302819	6	8	Astrocytes	51	20	20
ACACCCTCAGCATGAG-1_3_C4	-26.32714819	24.25711718	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1406	2661	0.002254791	0.002254791	6	8	Astrocytes	51	20	20
ACACCCTCATTTCAGG-1_3_C4	11.42317617	19.40094673	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	873	1368	0.000730994	0.009502924	6	oligos	OL-Cntl	51	20	20
ACACCCTGTCGGCATC-1_3_C4	14.96580017	23.4240403	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	849	1265	0.006324111	0.005533597	6	oligos	OL-Cntl	51	20	20
ACACCCTTCCAGTATG-1_3_C4	13.20387728	-29.82087393	3	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	3009	7176	0.003205128	0.003483835	6	3	EN-L5-6	51	20	20
ACACCGGAGAGTAATC-1_3_C4	-21.15567548	24.99102416	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1833	3278	0.004881025	0.00823673	6	8	Astrocytes	51	20	20
ACACCGGAGGAGTACC-1_3_C4	-14.57258304	-22.88519504	6A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1464	2428	0.011532125	0.003294893	6	6A	IN-PV	51	20	20
ACACCGGAGTGTTTGC-1_3_C4	-22.40923501	23.74452077	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1485	2473	0.004852406	0.004448039	6	8	Astrocytes	51	20	20
ACACCGGGTCTTCAAG-1_3_C4	24.5485573	-29.65072728	3	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	3095	8197	0.000975967	0.002195925	6	3	EN-L5-6	51	20	20
ACACCGGGTGGCGAAT-1_3_C4	4.667778673	21.79065924	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	909	1533	0.002609263	0.010437052	6	oligos	OL-Cntl	51	20	20
ACACCGGTCCAAGCCG-1_3_C4	-17.77386781	-26.54750507	6A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2545	6080	0.034868421	0.002960526	6	6A	IN-PV	51	20	20
ACACTGAAGCCAGGAT-1_3_C4	-4.519667055	22.64133317	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	672	1026	0.005847953	0.010721248	6	oligos	OL-Cntl	51	20	20
ACACTGAAGGGCTCTC-1_3_C4	-27.07224978	13.42404099	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	966	1695	0.002949853	0.001179941	6	8	Astrocytes	51	20	20
ACACTGAGTAATCGTC-1_3_C4	0.626143913	23.32306865	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	702	1100	0.001818182	0.005454545	6	oligos	OL-Cntl	51	20	20
ACACTGAGTAGGGTAC-1_3_C4	-25.93254248	22.77824826	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1255	2210	0.004977376	0.003167421	6	8	Astrocytes	51	20	20
ACACTGATCGACCAGC-1_3_C4	-23.77238749	27.57303161	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1825	3633	0.003027801	0.004954583	6	8	Astrocytes	51	20	20
ACACTGATCTGTCAAG-1_3_C4	18.6841419	-7.94940384	3	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2401	4901	0.00999796	0.00346868	6	3	EN-L5-6	51	20	20
ACAGCCGAGACAAGCC-1_3_C4	18.08208484	15.13914292	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1243	2099	0.006193425	0.005717008	6	oligos	OL-Cntl	51	20	20
ACAGCCGAGATATGCA-1_3_C4	-28.08446993	11.3771432	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	760	1139	0.003511853	0.001755926	6	8	Astrocytes	51	20	20
ACAGCCGCAGGTGGAT-1_3_C4	4.565922475	27.31345357	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	844	1323	0.002267574	0.001511716	6	oligos	OL-Cntl	51	20	20
ACAGCCGCATGCCCGA-1_3_C4	17.33430534	12.36159314	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1411	2591	0.007333076	0.005789271	6	oligos	OL-Cntl	51	20	20
ACAGCCGGTTAAGTAG-1_3_C4	-0.127454914	2.238888935	11	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	937	1290	0.003100775	0.00620155	6	11	Glia-MIX	51	20	20
ACAGCTACATAAGACA-1_3_C4	7.840320312	13.91445368	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1069	1836	0.005991285	0.008169935	6	oligos	OL-Cntl	51	20	20
ACAGCTAGTGCACTTA-1_3_C4	17.20286664	12.24592159	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1293	2268	0.008377425	0.005291005	6	oligos	OL-Cntl	51	20	20
ACAGCTATCCATGCTC-1_3_C4	1.995890978	23.77487494	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	762	1178	0.013582343	0.005942275	6	oligos	OL-Cntl	51	20	20
ACATACGAGCTACCGC-1_3_C4	-0.95240519	20.93786089	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	719	1118	0.000894454	0.009838998	6	oligos	OL-Cntl	51	20	20
ACATACGCATCACGAT-1_3_C4	-24.91738918	26.29912786	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1615	3222	0.005586592	0.003724395	6	8	Astrocytes	51	20	20
ACATCAGCAAGAGGCT-1_3_C4	-11.2670781	17.19864101	11	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1976	3665	0.001091405	0.005729877	6	11	Glia-MIX	51	20	20
ACATCAGCACAAGACG-1_3_C4	14.87594122	18.70957236	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1058	1634	0.004283966	0.004283966	6	oligos	OL-Cntl	51	20	20
ACATCAGCATTGGCGC-1_3_C4	-14.07433432	-24.47693638	6A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1452	2771	0.01948755	0.002526164	6	6A	IN-PV	51	20	20
ACATCAGGTGACAAAT-1_3_C4	-20.74797024	8.117314174	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	723	1045	0.003827751	0.003827751	6	8	Astrocytes	51	20	20
ACATCAGTCATCTGCC-1_3_C4	7.04454467	22.58457158	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	968	1513	0.006609385	0.003965631	6	oligos	OL-Cntl	51	20	20
ACATGGTCAGACTCGC-1_3_C4	-21.23484477	9.807516031	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	959	1576	0.001269036	0.003807107	6	8	Astrocytes	51	20	20
ACATGGTCAGCAGTTT-1_3_C4	-11.78373647	17.72581526	11	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1927	3535	0.00990099	0.005940594	6	11	Glia-MIX	51	20	20
ACATGGTCATGCTGGC-1_3_C4	6.059846432	28.99159717	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	726	1118	0.002683363	0.005366726	6	oligos	OL-Cntl	51	20	20
ACATGGTGTTAAGTAG-1_3_C4	-10.83445027	9.643632903	11	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	3562	8071	0.004956015	0.007062322	6	11	Glia-MIX	51	20	20
ACCAGTAAGACAAGCC-1_3_C4	15.58051274	22.23422987	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	943	1578	0.000633714	0.003802281	6	oligos	OL-Cntl	51	20	20
ACCAGTACACCGGAAA-1_3_C4	11.28490061	20.49921649	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	947	1499	0.002668446	0.010006671	6	oligos	OL-Cntl	51	20	20
ACCAGTAGTCACTTCC-1_3_C4	-27.15752285	12.49002182	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	913	1371	0.00948213	0.008752735	6	8	Astrocytes	51	20	20
ACCAGTATCAACACAC-1_3_C4	3.902882198	30.25738402	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	681	1007	0.003972195	0.004965243	6	oligos	OL-Cntl	51	20	20
ACCAGTATCAGCTGGC-1_3_C4	11.90615856	22.63139857	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	862	1356	0.002949853	0.008112094	6	oligos	OL-Cntl	51	20	20
ACCCACTAGCGATAGC-1_3_C4	-17.64522608	-26.55063761	6A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2567	5674	0.006697215	0.001762425	6	6A	IN-PV	51	20	20
ACCCACTAGCTAGGCA-1_3_C4	14.85997688	22.12281178	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	964	1547	0.00258565	0.010989011	6	oligos	OL-Cntl	51	20	20
ACCCACTCAGGTCGTC-1_3_C4	16.07765232	8.292255458	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1772	3160	0.00664557	0.004746835	6	oligos	OL-Cntl	51	20	20
ACCCACTTCGTTTGCC-1_3_C4	-3.206747106	33.23753012	17	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	990	1586	0.01702396	0.005674653	6	oligos	OL-MS-2	51	20	20
ACCGTAAAGCCATCGC-1_3_C4	5.480321791	29.56757086	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	756	1132	0.007067138	0.000883392	6	oligos	OL-Cntl	51	20	20
ACCGTAAAGGACATTA-1_3_C4	39.38643909	14.6604608	14	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1272	1941	0.001545595	0.011334364	6	14	Microglia	51	20	20
ACCGTAACAGTCAGAG-1_3_C4	4.857390545	22.17784598	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	855	1300	0.007692308	0.008461538	6	oligos	OL-Cntl	51	20	20
ACCGTAAGTCAAACTC-1_3_C4	20.55806156	15.67601465	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1206	2048	0.001464844	0.004394531	6	oligos	OL-Cntl	51	20	20
ACCGTAAGTGCTTCTC-1_3_C4	-16.24468523	14.46466318	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1672	3018	0.003644798	0.003644798	6	8	Astrocytes	51	20	20
ACCGTAATCCTAGAAC-1_3_C4	11.99066272	24.68485458	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	761	1186	0.001686341	0.009274874	6	oligos	OL-Cntl	51	20	20
ACCGTAATCTGCTGCT-1_3_C4	5.816768722	21.12223932	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	876	1363	0.011738811	0.01027146	6	oligos	OL-Cntl	51	20	20
ACCTTTAAGAATTCCC-1_3_C4	25.70223912	3.723434803	15BA	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	985	1814	0.005512679	0.003307607	6	15BA	Stromal cells	51	20	20
ACCTTTAAGAGTACAT-1_3_C4	15.71328319	19.42324257	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	902	1500	0	0.006	6	oligos	OL-Cntl	51	20	20
ACCTTTACAGCAGTTT-1_3_C4	10.10583036	29.84402995	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	709	1131	0.00530504	0.003536693	6	oligos	OL-Cntl	51	20	20
ACGAGCCAGCCACCTG-1_3_C4	15.70229488	-1.85142649	12	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	824	1148	0.006097561	0.00087108	6	12	EN-MIX	51	20	20
ACGAGCCAGTAGATGT-1_3_C4	15.51009497	-6.476459674	10	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1694	3170	0.010725552	0.004100946	6	L2-3	EN-L2-3-Cntl	51	20	20
ACGAGCCCAATCCGAT-1_3_C4	-31.33429786	12.6643878	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	928	1397	0.020758769	0.007158196	6	8	Astrocytes	51	20	20
ACGAGCCCACGCTTTC-1_3_C4	-8.900493307	-18.43878807	6B	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	762	1189	0.052144659	0.003364172	6	6B	IN-SST	51	20	20
ACGAGCCCAGTACACT-1_3_C4	17.13776258	5.841458872	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2676	5811	0.005678885	0.016176218	6	oligos	OL-Cntl	51	20	20
ACGAGCCCATGGTTGT-1_3_C4	15.37264058	19.30028442	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1039	1703	0.014679977	0.005871991	6	oligos	OL-Cntl	51	20	20
ACGAGGAAGCCGGTAA-1_3_C4	-28.52979854	10.50461073	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	774	1053	0.004748338	0.004748338	6	8	Astrocytes	51	20	20
ACGAGGACAATGAAAC-1_3_C4	11.42229871	16.55078956	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1083	1814	0.011576626	0.014332966	6	oligos	OL-Cntl	51	20	20
ACGAGGACAGCATACT-1_3_C4	-12.01377858	-1.089554517	13A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2564	4882	0.021917247	0.005325686	6	13A	IN-VIP	51	20	20
ACGAGGAGTGTCTGAT-1_3_C4	22.47148193	15.46478393	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1411	2301	0.007822686	0.006518905	6	oligos	OL-Cntl	51	20	20
ACGATACAGATCCCAT-1_3_C4	-31.51042137	12.5448575	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	819	1213	0.001648805	0.006595218	6	8	Astrocytes	51	20	20
ACGATACAGGGTGTTG-1_3_C4	-30.72706978	12.26751247	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	769	1152	0.0078125	0.000868056	6	8	Astrocytes	51	20	20
ACGATACCATACTCTT-1_3_C4	5.360020631	30.00693241	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	671	1074	0.000931099	0.004655493	6	oligos	OL-Cntl	51	20	20
ACGATACGTAATTGGA-1_3_C4	18.82234569	9.520569942	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1420	2413	0.007459594	0.003315375	6	oligos	OL-Cntl	51	20	20
ACGATACTCCACGCAG-1_3_C4	-24.5452619	26.65635515	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1740	3427	0.005252407	0.003209804	6	8	Astrocytes	51	20	20
ACGATGTAGAAGGACA-1_3_C4	-23.67453083	-0.944827905	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1551	2428	0.004942339	0.002059308	6	9	OPC	51	20	20
ACGATGTCACGTCAGC-1_3_C4	-32.91731102	-13.08233969	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	759	1106	0.004520796	0.000904159	6	9	OPC	51	20	20
ACGATGTGTAGCAAAT-1_3_C4	-27.41280635	11.33899644	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	769	1183	0.00591716	0.003381234	6	8	Astrocytes	51	20	20
ACGATGTGTCTTGTCC-1_3_C4	-28.29058758	23.19386279	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1209	1908	0.004716981	0.002620545	6	8	Astrocytes	51	20	20
ACGATGTTCAAGCCTA-1_3_C4	23.4191489	-10.49617602	3	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	3753	9547	0.011626689	0.002828114	6	3	EN-L5-6	51	20	20
ACGATGTTCGACGGAA-1_3_C4	16.50690954	-29.37885724	3	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	4568	13290	0.009029345	0.003160271	6	3	EN-L5-6	51	20	20
ACGCAGCAGAGTCGGT-1_3_C4	-24.95156561	-1.670853341	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1661	3097	0.003551824	0.002260252	6	9	OPC	51	20	20
ACGCAGCCATGCCTAA-1_3_C4	-35.0581277	4.888482453	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2515	5179	0.003089399	0.003282487	6	9	OPC	51	20	20
ACGCAGCGTATAAACG-1_3_C4	-4.511126777	21.37795945	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	734	1050	0.018095238	0.016190476	6	oligos	OL-Cntl	51	20	20
ACGCAGCTCCGTCAAA-1_3_C4	22.7223651	-26.49239159	3	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	4471	12047	0.004150411	0.009379929	6	3	EN-L5-6	51	20	20
ACGCCAGAGATGCGAC-1_3_C4	18.50368759	12.5503524	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1485	2584	0.007352941	0.004643963	6	oligos	OL-Cntl	51	20	20
ACGCCAGTCAAAGACA-1_3_C4	16.53172338	-0.662129842	12	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	695	1039	0.000962464	0	6	12	EN-MIX	51	20	20
ACGCCGACAGATAATG-1_3_C4	-27.77392964	13.63206085	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	860	1359	0.005150846	0.004415011	6	8	Astrocytes	51	20	20
ACGCCGACAGGGATTG-1_3_C4	17.48346513	17.82358203	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1191	1930	0.003108808	0.004145078	6	oligos	OL-Cntl	51	20	20
ACGCCGAGTGCACTTA-1_3_C4	17.01664159	12.03660044	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1384	2519	0.006351727	0.004366812	6	oligos	OL-Cntl	51	20	20
ACGCCGAGTTCGCGAC-1_3_C4	37.16780005	10.33266843	14	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	782	1090	0.003669725	0.017431193	6	14	Microglia	51	20	20
ACGCCGATCTTCAACT-1_3_C4	4.37590348	27.49162854	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	763	1105	0.00361991	0.010859729	6	oligos	OL-Cntl	51	20	20
ACGGAGAAGTTAACGA-1_3_C4	9.34566782	-13.90237028	4	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2805	5076	0.012214342	0.022261623	6	L2-3	EN-L2-3-MS	51	20	20
ACGGAGATCGAGCCCA-1_3_C4	10.74569821	24.12331724	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	816	1280	0.00390625	0.003125	6	oligos	OL-Cntl	51	20	20
ACGGAGATCGGTGTCG-1_3_C4	18.61186758	7.503718005	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2234	4703	0.004677865	0.006378907	6	oligos	OL-Cntl	51	20	20
ACGGCCAAGGTTCCTA-1_3_C4	-9.323603579	13.63671514	11	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1182	1923	0.001040042	0.002600104	6	11	Glia-MIX	51	20	20
ACGGCCACAATGAATG-1_3_C4	4.767271621	24.01491278	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	898	1445	0.00899654	0.007612457	6	oligos	OL-Cntl	51	20	20
ACGGCCACAGGATTGG-1_3_C4	-22.43082665	19.4308804	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1741	3426	0.002335085	0.003794513	6	8	Astrocytes	51	20	20
ACGGCCACATGGTCTA-1_3_C4	3.828796048	23.86822667	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	919	1434	0.00348675	0.009065551	6	oligos	OL-Cntl	51	20	20
ACGGCCAGTTAAGGGC-1_3_C4	8.183245565	9.56488194	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1282	2185	0.011899314	0.01006865	6	oligos	OL-Cntl	51	20	20
ACGGCCATCGTCTGAA-1_3_C4	-27.87854778	0.835233006	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	3254	7008	0.006421233	0.00913242	6	9	OPC	51	20	20
ACGGCCATCTGACCTC-1_3_C4	6.704731691	-21.95023122	4	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	4242	12271	0.011164534	0.005948985	6	L2-3	EN-L2-3-MS	51	20	20
ACGGGCTAGACGACGT-1_3_C4	10.93908814	15.24659919	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1130	1883	0.013276686	0.012214551	6	oligos	OL-Cntl	51	20	20
ACGGGCTAGATGTGTA-1_3_C4	7.246752785	19.71515276	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1024	1539	0.006497726	0.009746589	6	oligos	OL-Cntl	51	20	20
ACGGGCTAGGAGCGAG-1_3_C4	-30.31623757	-2.704170507	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1491	2403	0.003745318	0.005409904	6	9	OPC	51	20	20
ACGGGCTGTAAGAGAG-1_3_C4	4.818702557	24.69540972	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	855	1304	0.003067485	0.008435583	6	oligos	OL-Cntl	51	20	20
ACGGGCTGTAATTGGA-1_3_C4	2.16919817	22.09455999	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	853	1325	0.009811321	0.006792453	6	oligos	OL-Cntl	51	20	20
ACGGGCTGTCACCCAG-1_3_C4	17.46726782	8.622341982	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1770	3228	0.002788104	0.006505576	6	oligos	OL-Cntl	51	20	20
ACGGGCTTCCACTGGG-1_3_C4	-0.90976339	-0.33920468	11	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1805	3176	0.014798489	0.005667506	6	11	Glia-MIX	51	20	20
ACGGGTCAGGGCTTGA-1_3_C4	4.276709117	20.93229788	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	830	1224	0.008169935	0.007352941	6	oligos	OL-Cntl	51	20	20
ACGGGTCCAGCCTGTG-1_3_C4	-27.32407785	12.49304149	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	991	1676	0	0.005966587	6	8	Astrocytes	51	20	20
ACGTCAAAGTGTGGCA-1_3_C4	-33.87331071	-3.596829421	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1392	2298	0.009573542	0.010008703	6	9	OPC	51	20	20
ACGTCAACATTATCTC-1_3_C4	-33.77415203	-12.25550536	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	825	1399	0.000714796	0.005003574	6	9	OPC	51	20	20
ACGTCAAGTACCGAGA-1_3_C4	20.09288802	15.32737478	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1236	2098	0.002859867	0.005243089	6	oligos	OL-Cntl	51	20	20
ACGTCAAGTCCGAGTC-1_3_C4	-14.29801099	-24.15907624	6A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1463	2823	0.035777542	0.003542331	6	6A	IN-PV	51	20	20
ACGTCAATCAACCATG-1_3_C4	-8.634299966	-17.90628414	6B	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	751	1218	0.086206897	0.003284072	6	6B	IN-SST	51	20	20
ACGTCAATCAGTCAGT-1_3_C4	8.206859703	28.57576531	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	852	1384	0.007225434	0.003612717	6	oligos	OL-Cntl	51	20	20
ACGTCAATCATTATCC-1_3_C4	-30.78982328	10.79160126	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	821	1313	0.005331302	0.006854532	6	8	Astrocytes	51	20	20
ACGTCAATCCGAACGC-1_3_C4	-29.00042914	21.10741156	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1068	1821	0.002745744	0.005491488	6	8	Astrocytes	51	20	20
ACTATCTGTCTCTTAT-1_3_C4	-24.66883878	-2.276108987	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1384	3065	0.003262643	0.002936378	6	9	OPC	51	20	20
ACTATCTGTTTGGCGC-1_3_C4	-17.10673914	-4.3185714	13A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	3329	7840	0.018239796	0.00880102	6	13A	IN-VIP	51	20	20
ACTATCTTCTGCTGTC-1_3_C4	-9.072976137	-19.28161366	6B	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	797	1354	0.041358936	0.002215657	6	6B	IN-SST	51	20	20
ACTGAACAGCTACCGC-1_3_C4	17.7720906	13.02944471	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1407	2545	0.011394892	0.007858546	6	oligos	OL-Cntl	51	20	20
ACTGAACAGGCCCTTG-1_3_C4	11.05305649	22.78319375	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	821	1330	0.007518797	0.006015038	6	oligos	OL-Cntl	51	20	20
ACTGAGTAGGAGTAGA-1_3_C4	-11.73065493	-0.932284488	13A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2761	5440	0.009926471	0.005330882	6	13A	IN-VIP	51	20	20
ACTGAGTAGGCTAGCA-1_3_C4	17.25122388	8.699832777	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1626	2987	0.006695681	0.012052226	6	oligos	OL-Cntl	51	20	20
ACTGAGTCACTCGACG-1_3_C4	39.00824878	13.6908442	14	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1048	1492	0.001340483	0.008713137	6	14	Microglia	51	20	20
ACTGAGTGTCCGAAGA-1_3_C4	-0.597054302	24.21575755	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	725	1092	0.001831502	0.01007326	6	oligos	OL-Cntl	51	20	20
ACTGATGAGACGCTTT-1_3_C4	17.11618179	19.06390495	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	971	1705	0.011143695	0.002932551	6	oligos	OL-Cntl	51	20	20
ACTGATGCACGTGAGA-1_3_C4	-24.24620724	2.234222428	11	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	4484	11196	0.003036799	0.005448374	6	11	Glia-MIX	51	20	20
ACTGATGCAGCGTCCA-1_3_C4	-36.7705828	-0.86249867	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1635	2833	0.008824568	0.002823862	6	9	OPC	51	20	20
ACTGATGGTCCGACGT-1_3_C4	12.88223381	25.42778675	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	809	1221	0.008190008	0.003276003	6	oligos	OL-Cntl	51	20	20
ACTGATGGTGAGTATA-1_3_C4	-12.36553749	17.87611774	11	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1690	2847	0.005268704	0.008078679	6	11	Glia-MIX	51	20	20
ACTGATGTCCACGTGG-1_3_C4	4.187562359	20.2057986	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	805	1292	0.001547988	0.013157895	6	oligos	OL-Cntl	51	20	20
ACTGATGTCGCCGTGA-1_3_C4	20.48982558	10.54968494	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1584	2582	0.005034857	0.005422153	6	oligos	OL-Cntl	51	20	20
ACTGCTCAGGAGCGTT-1_3_C4	18.0857686	13.54805071	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1261	2290	0.002183406	0.005240175	6	oligos	OL-Cntl	51	20	20
ACTGCTCAGGTGCAAC-1_3_C4	-9.090094358	-18.9193808	6B	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	774	1215	0.071604938	0.000823045	6	6B	IN-SST	51	20	20
ACTGCTCCAACACCTA-1_3_C4	-37.46199162	1.210105233	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1600	2816	0.002485795	0.004261364	6	9	OPC	51	20	20
ACTGCTCCAATGGTCT-1_3_C4	-9.622593033	13.73193426	11	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1214	1938	0.011867905	0.003095975	6	11	Glia-MIX	51	20	20
ACTGCTCCACATCCAA-1_3_C4	16.90561902	18.2952799	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1081	1666	0.006602641	0.005402161	6	oligos	OL-Cntl	51	20	20
ACTGCTCTCCTATGTT-1_3_C4	-17.86125152	-8.076092736	13B	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	3099	6638	0.018830973	0.00542332	6	13B	IN-SV2C	51	20	20
ACTGTCCAGCGATATA-1_3_C4	7.271528682	-21.07533149	4	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	6115	18983	0.006848233	0.0106411	6	L2-3	EN-L2-3-MS	51	20	20
ACTGTCCAGTACGTTC-1_3_C4	1.048990974	21.50320669	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	789	1125	0.009777778	0.012444444	6	oligos	OL-Cntl	51	20	20
ACTGTCCAGTCCCACG-1_3_C4	17.77351181	12.05002845	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1431	2544	0.007861635	0.004323899	6	oligos	OL-Cntl	51	20	20
ACTGTCCGTCGCATAT-1_3_C4	1.769280984	24.52847326	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	717	1146	0.006108202	0.003490401	6	oligos	OL-Cntl	51	20	20
ACTGTCCGTGCCTGGT-1_3_C4	8.905030202	27.51837889	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	968	1653	0.003024803	0.004234725	6	oligos	OL-Cntl	51	20	20
ACTGTCCGTGGTGTAG-1_3_C4	18.26122221	15.2036383	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1188	2064	0.000968992	0.00872093	6	oligos	OL-Cntl	51	20	20
ACTGTCCGTTACAGAA-1_3_C4	-33.9260499	-11.48526749	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	901	1371	0.005105762	0.003646973	6	9	OPC	51	20	20
ACTTACTAGACATAAC-1_3_C4	-15.13764369	-7.491507256	13A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	3541	10115	0.021453287	0.002471577	6	13A	IN-VIP	51	20	20
ACTTACTAGAGTACAT-1_3_C4	11.31566349	23.83436606	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	801	1280	0.00546875	0.00625	6	oligos	OL-Cntl	51	20	20
ACTTACTCAAGGTGTG-1_3_C4	-14.62035815	-2.396471221	13A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2167	3874	0.016262261	0.011099639	6	13A	IN-VIP	51	20	20
ACTTACTCACATGGGA-1_3_C4	22.48298311	12.44719556	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1380	2535	0.001577909	0.003944773	6	oligos	OL-Cntl	51	20	20
ACTTACTCACCATCCT-1_3_C4	-9.674954286	-0.079628388	13A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2409	5153	0.003493111	0.006598098	6	13A	IN-VIP	51	20	20
ACTTACTGTCAATACC-1_3_C4	5.31198397	-14.13084126	4	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2693	6075	0.030288066	0.005925926	6	L2-3	EN-L2-3-MS	51	20	20
ACTTACTGTTATCCGA-1_3_C4	14.76041975	18.83281844	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	921	1540	0.001298701	0.004545455	6	oligos	OL-Cntl	51	20	20
ACTTACTGTTGTCGCG-1_3_C4	9.904703319	-20.71302654	4	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	5715	18902	0.007512433	0.006665961	6	L2-3	EN-L2-3-MS	51	20	20
ACTTACTTCCCTTGCA-1_3_C4	15.8010391	27.51279968	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	753	1138	0.000878735	0.003514938	6	oligos	OL-Cntl	51	20	20
ACTTGTTCAAGCCGTC-1_3_C4	11.80383132	24.39682567	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	754	1165	0.002575107	0.007725322	6	oligos	OL-Cntl	51	20	20
ACTTGTTCACACGCTG-1_3_C4	23.50734485	-26.37169254	3	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	3311	9018	0.004546463	0.003215791	6	3	EN-L5-6	51	20	20
ACTTGTTGTGGCTCCA-1_3_C4	21.58019035	12.79350131	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1433	2425	0.001649485	0.002474227	6	oligos	OL-Cntl	51	20	20
ACTTGTTTCCACGCAG-1_3_C4	8.441154387	27.93998411	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	845	1478	0.00405954	0.00405954	6	oligos	OL-Cntl	51	20	20
ACTTTCAAGCGATATA-1_3_C4	-13.72515467	-23.95164266	6A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1470	2831	0.032850583	0.002119392	6	6A	IN-PV	51	20	20
ACTTTCAAGTTAACGA-1_3_C4	-31.81526124	12.53996889	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	862	1508	0.00331565	0.00198939	6	8	Astrocytes	51	20	20
ACTTTCAGTAGGAGTC-1_3_C4	6.436839513	20.29800341	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	900	1362	0.013950073	0.00660793	6	oligos	OL-Cntl	51	20	20
ACTTTCAGTTATGTGC-1_3_C4	15.43122987	21.8239341	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	993	1695	0	0.007079646	6	oligos	OL-Cntl	51	20	20
AGAATAGCATGTCCTC-1_3_C4	3.046234296	25.60362301	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	726	1066	0.010318949	0.005628518	6	oligos	OL-Cntl	51	20	20
AGAATAGGTCGTTGTA-1_3_C4	18.29702798	9.477059264	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1470	2776	0.001801153	0.005403458	6	oligos	OL-Cntl	51	20	20
AGAATAGTCCAAACTG-1_3_C4	-37.73181038	-5.22271053	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1185	2097	0.005245589	0.003338102	6	9	OPC	51	20	20
AGACGTTAGCGTGTCC-1_3_C4	-19.58158539	24.86572715	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1786	3334	0.00569886	0.0074985	6	8	Astrocytes	51	20	20
AGACGTTGTCAATGTC-1_3_C4	-24.32824337	1.682388915	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	3633	8378	0.004058248	0.004177608	6	9	OPC	51	20	20
AGACGTTGTGCAGACA-1_3_C4	-38.347866	-1.551202194	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1338	2319	0.001293661	0.002156102	6	9	OPC	51	20	20
AGACGTTGTTACGGAG-1_3_C4	-14.1756985	-5.077825868	13A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2827	5772	0.017325017	0.007623008	6	13A	IN-VIP	51	20	20
AGAGCGACAATCCAAC-1_3_C4	-34.66299791	-1.791359043	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1539	2621	0.007630675	0.007249142	6	9	OPC	51	20	20
AGAGCGACAGAAGCAC-1_3_C4	-15.79770072	0.774335339	13A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	3750	8072	0.01845887	0.008424182	6	13A	IN-VIP	51	20	20
AGAGCGAGTTATGTGC-1_3_C4	-10.61468097	-2.832426832	13A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2048	3939	0.012185834	0.003808073	6	13A	IN-VIP	51	20	20
AGAGCTTGTACTCAAC-1_3_C4	1.130967049	24.86048832	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	674	1000	0.004	0.006	6	oligos	OL-Cntl	51	20	20
AGAGTGGCAAGTTAAG-1_3_C4	21.20675507	10.50665873	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1528	2699	0.000370508	0.008151167	6	oligos	OL-Cntl	51	20	20
AGAGTGGTCAAACCGT-1_3_C4	20.08974231	13.61747173	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1348	2263	0.003977022	0.006628369	6	oligos	OL-Cntl	51	20	20
AGAGTGGTCTCGCTTG-1_3_C4	-28.34849613	22.03015872	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1186	2011	0.004475385	0.00497265	6	8	Astrocytes	51	20	20
AGATCTGCAAGTCTGT-1_3_C4	-11.56347661	-2.134555643	13A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2312	4479	0.015405224	0.008037508	6	13A	IN-VIP	51	20	20
AGATCTGCAATGGTCT-1_3_C4	-17.43996911	-17.46709956	6B	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1987	4133	0.02855069	0.001209775	6	6B	IN-SST	51	20	20
AGATCTGCACTGTTAG-1_3_C4	-10.32257755	-1.624672192	13A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2148	4087	0.011744556	0.005382921	6	13A	IN-VIP	51	20	20
AGATCTGGTCAGCTAT-1_3_C4	9.098942625	31.078464	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	654	1047	0.00095511	0.00095511	6	oligos	OL-Cntl	51	20	20
AGATCTGTCTCTAGGA-1_3_C4	-29.83355072	13.29258002	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	810	1329	0.003762227	0.003762227	6	8	Astrocytes	51	20	20
AGATTGCAGACCTTTG-1_3_C4	25.49642158	3.750022941	15BA	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1106	1989	0	0.000502765	6	15BA	Stromal cells	51	20	20
AGATTGCAGGGTCGAT-1_3_C4	-13.48388342	7.395613646	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	919	1414	0.113861386	0.007072136	6	8	Astrocytes	51	20	20
AGATTGCCACGGACAA-1_3_C4	-15.22676672	-17.34038398	6B	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1628	3024	0.035714286	0.002645503	6	6B	IN-SST	51	20	20
AGATTGCCAGCGTTCG-1_3_C4	-28.35334099	22.29712592	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1227	2016	0.030753968	0.004464286	6	8	Astrocytes	51	20	20
AGATTGCGTCTCCACT-1_3_C4	-37.4557176	-1.59476313	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1369	2316	0.0082038	0.007340242	6	9	OPC	51	20	20
AGATTGCTCTGCTGCT-1_3_C4	-28.73622021	12.50614522	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	859	1317	0.001518603	0.003796507	6	8	Astrocytes	51	20	20
AGCAGCCAGCCTTGAT-1_3_C4	-25.7478077	15.89414387	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1121	1864	0.003218884	0.004828326	6	8	Astrocytes	51	20	20
AGCAGCCAGCGATAGC-1_3_C4	-24.22110783	18.82107963	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1485	2716	0.00257732	0.005891016	6	8	Astrocytes	51	20	20
AGCAGCCGTTGTGGAG-1_3_C4	-1.381285541	19.80631415	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	794	1216	0.016447368	0.006578947	6	oligos	OL-Cntl	51	20	20
AGCAGCCTCCTAGTGA-1_3_C4	-24.3128728	22.24795785	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1264	2012	0.005964215	0.005964215	6	8	Astrocytes	51	20	20
AGCATACAGATACACA-1_3_C4	-8.930287995	-17.77534534	6B	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	750	1097	0.038286235	0.003646308	6	6B	IN-SST	51	20	20
AGCATACAGGGCTCTC-1_3_C4	5.098848714	31.23593337	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	838	1348	0.00148368	0.003709199	6	oligos	OL-Cntl	51	20	20
AGCATACCATCCTTGC-1_3_C4	16.14191433	18.62197417	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1070	1809	0.001105583	0.005527916	6	oligos	OL-Cntl	51	20	20
AGCCTAAAGCATGGCA-1_3_C4	7.454700402	20.94647907	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	993	1637	0.001832621	0.004886988	6	oligos	OL-Cntl	51	20	20
AGCCTAAAGCGTCAAG-1_3_C4	-10.67118665	0.164748576	13A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2319	4543	0.018930222	0.00396214	6	13A	IN-VIP	51	20	20
AGCCTAACAATCTGCA-1_3_C4	-18.77122547	-28.17412922	6A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2967	7458	0.010324484	0.002145347	6	6A	IN-PV	51	20	20
AGCCTAACACGAAGCA-1_3_C4	22.82004607	11.07824518	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1712	3052	0.000982962	0.005897772	6	oligos	OL-Cntl	51	20	20
AGCCTAACATCAGTCA-1_3_C4	-4.968430847	-8.937440269	13A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	777	1273	0.091123331	0.001571092	6	13A	IN-VIP	51	20	20
AGCCTAACATCGGGTC-1_3_C4	-19.33889004	8.533645386	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1100	1624	0.015394089	0.007389163	6	8	Astrocytes	51	20	20
AGCCTAAGTAAACCTC-1_3_C4	-7.350638134	-1.95370633	13A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2053	3990	0.014536341	0.002506266	6	13A	IN-VIP	51	20	20
AGCCTAAGTTGTTTGG-1_3_C4	-25.03395751	19.50547456	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1476	2716	0.002945508	0.002209131	6	8	Astrocytes	51	20	20
AGCCTAATCCATGAGT-1_3_C4	4.75164571	30.55187984	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	718	1091	0.002749771	0.005499542	6	oligos	OL-Cntl	51	20	20
AGCGGTCAGCCCAATT-1_3_C4	-27.34800946	20.69813139	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1304	2102	0.008087536	0.001427212	6	8	Astrocytes	51	20	20
AGCGGTCCAGTCGATT-1_3_C4	-0.563191502	27.59491341	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	737	1124	0.003558719	0.004448399	6	oligos	OL-Cntl	51	20	20
AGCGGTCGTGTCGCTG-1_3_C4	13.82871615	-27.50529108	3	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2825	6245	0.010888711	0.004003203	6	3	EN-L5-6	51	20	20
AGCGGTCTCAGCGACC-1_3_C4	-8.988175822	-0.626671878	13A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2163	4291	0.008389653	0.002563505	6	13A	IN-VIP	51	20	20
AGCGGTCTCCTTTCTC-1_3_C4	15.54355835	-1.054851079	12	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	665	1057	0	0.002838221	6	12	EN-MIX	51	20	20
AGCGGTCTCTACCAGA-1_3_C4	-25.14891636	25.91837131	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1698	3211	0.006228589	0.001868577	6	8	Astrocytes	51	20	20
AGCGTATAGTCTCCTC-1_3_C4	-22.14224395	24.18437241	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1584	2859	0.001049318	0.009443861	6	8	Astrocytes	51	20	20
AGCGTATGTGGTTTCA-1_3_C4	14.89423622	22.41285522	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	984	1570	0.014649682	0.008917197	6	oligos	OL-Cntl	51	20	20
AGCGTATTCCTTGCCA-1_3_C4	3.312642325	-18.22082989	4	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	3573	9051	0.005192796	0.006297647	6	L2-3	EN-L2-3-MS	51	20	20
AGCGTCGCAAGTTGTC-1_3_C4	-12.62826625	-3.976421289	13A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2267	4117	0.020888997	0.006801069	6	13A	IN-VIP	51	20	20
AGCGTCGGTAACGACG-1_3_C4	-19.44061346	8.120506048	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	971	1460	0.002054795	0.002739726	6	8	Astrocytes	51	20	20
AGCGTCGGTACCGTTA-1_3_C4	-24.89431667	26.01381617	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1607	3133	0.006383658	0.003191829	6	8	Astrocytes	51	20	20
AGCGTCGGTGACCAAG-1_3_C4	-16.78297	-26.34917889	6A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2301	5023	0.003981684	0.0037826	6	6A	IN-PV	51	20	20
AGCGTCGTCGTCCGTT-1_3_C4	5.262213275	25.42414295	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	854	1245	0.007228916	0.007228916	6	oligos	OL-Cntl	51	20	20
AGCGTCGTCTCTTATG-1_3_C4	-15.06377886	0.69854697	13A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2896	6056	0.008256275	0.018659181	6	13A	IN-VIP	51	20	20
AGCTCCTGTGCCTGTG-1_3_C4	11.85343354	29.30683857	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	797	1236	0.018608414	0.001618123	6	oligos	OL-Cntl	51	20	20
AGCTCTCAGACAGAGA-1_3_C4	-21.38279978	-27.85039005	6A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	4659	13770	0.007770516	0.002469136	6	6A	IN-PV	51	20	20
AGCTCTCAGACTAAGT-1_3_C4	21.05332345	14.55084603	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1265	2172	0.000460405	0.008287293	6	oligos	OL-Cntl	51	20	20
AGCTCTCCACATGACT-1_3_C4	-29.07085367	20.9559581	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1058	1681	0.004164188	0.006543724	6	8	Astrocytes	51	20	20
AGCTCTCCACTACAGT-1_3_C4	-16.46546908	14.65587489	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1624	3278	0.00152532	0.000915192	6	8	Astrocytes	51	20	20
AGCTCTCCAGAGTGTG-1_3_C4	-35.95963582	-5.198804171	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1278	2219	0.005407841	0.006759802	6	9	OPC	51	20	20
AGCTCTCTCATGTCTT-1_3_C4	21.15468003	10.32678149	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1741	3309	0.002417649	0.003928679	6	oligos	OL-Cntl	51	20	20
AGCTTGAAGGGCTTCC-1_3_C4	11.95775194	24.20448978	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	892	1450	0.00137931	0.008275862	6	oligos	OL-Cntl	51	20	20
AGCTTGACAGATCTGT-1_3_C4	21.79133054	-8.802500802	3	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2006	3832	0.020615866	0.003131524	6	3	EN-L5-6	51	20	20
AGGCCACAGCAGCCTC-1_3_C4	-28.03101952	21.75379963	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1382	2445	0.005316973	0.002453988	6	8	Astrocytes	51	20	20
AGGCCACAGGATTCGG-1_3_C4	0.638575531	23.27527797	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	753	1179	0.005937235	0.01187447	6	oligos	OL-Cntl	51	20	20
AGGCCGTCAATACGCT-1_3_C4	9.619903916	22.75380139	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	928	1432	0.000698324	0.01047486	6	oligos	OL-Cntl	51	20	20
AGGCCGTCAGTGACAG-1_3_C4	-23.23931387	25.56290337	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1779	3455	0.002315485	0.00723589	6	8	Astrocytes	51	20	20
AGGCCGTGTAGGAGTC-1_3_C4	-33.36836419	-12.25941833	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	875	1406	0	0.003556188	6	9	OPC	51	20	20
AGGCCGTGTCGCATCG-1_3_C4	-11.85404836	-19.22257476	6B	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	958	1674	0.006571087	0.001194743	6	6B	IN-SST	51	20	20
AGGCCGTTCTATCGCC-1_3_C4	-24.61484238	24.2223658	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1380	2403	0.002080732	0.007906783	6	8	Astrocytes	51	20	20
AGGGAGTAGATCCCAT-1_3_C4	16.1032867	17.44052511	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1093	1830	0.004371585	0.009289617	6	oligos	OL-Cntl	51	20	20
AGGGAGTAGATCTGCT-1_3_C4	3.082657923	26.63746469	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	745	1153	0.000867303	0.006938422	6	oligos	OL-Cntl	51	20	20
AGGGAGTAGCGTCTAT-1_3_C4	6.821832233	25.70287202	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	907	1380	0	0.003623188	6	oligos	OL-Cntl	51	20	20
AGGGAGTGTAAACCTC-1_3_C4	-22.60861769	23.9480924	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1599	2789	0.001792757	0.008605235	6	8	Astrocytes	51	20	20
AGGGAGTGTAGCTCCG-1_3_C4	14.64915245	27.18434806	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	836	1370	0.002189781	0.010218978	6	oligos	OL-Cntl	51	20	20
AGGGAGTGTTGATTGC-1_3_C4	16.74513474	27.45730896	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	804	1223	0.002452984	0.006541292	6	oligos	OL-Cntl	51	20	20
AGGGAGTTCACGGTTA-1_3_C4	-9.921313866	-6.39638182	13A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1762	3210	0.037694704	0.003426791	6	13A	IN-VIP	51	20	20
AGGGATGAGACCGGAT-1_3_C4	-9.919300522	14.00738043	11	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1273	1946	0.002055498	0.004110997	6	11	Glia-MIX	51	20	20
AGGGATGAGATCCCAT-1_3_C4	-20.21456728	30.66326138	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2692	5670	0.005114638	0.004761905	6	8	Astrocytes	51	20	20
AGGGATGAGTACGATA-1_3_C4	1.811999893	24.17816695	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	749	1112	0.010791367	0.004496403	6	oligos	OL-Cntl	51	20	20
AGGGATGTCCCGACTT-1_3_C4	11.92749621	14.71623526	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1062	1768	0.013574661	0.007352941	6	oligos	OL-Cntl	51	20	20
AGGGATGTCTTTAGGG-1_3_C4	11.63622741	20.26760628	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	926	1491	0.008718981	0.005365526	6	oligos	OL-Cntl	51	20	20
AGGGTGACATATGCTG-1_3_C4	-23.58323739	14.68159056	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1148	1757	0.010813887	0.005122368	6	8	Astrocytes	51	20	20
AGGGTGATCAAGATCC-1_3_C4	0.820976575	23.55348685	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	739	1113	0.011680144	0.016172507	6	oligos	OL-Cntl	51	20	20
AGGGTGATCCGCGTTT-1_3_C4	-7.320140843	-2.752851854	13A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1561	3004	0.020306258	0.002330226	6	13A	IN-VIP	51	20	20
AGGGTGATCCTATTCA-1_3_C4	-24.34995011	19.15008753	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1525	2686	0.002978407	0.002978407	6	8	Astrocytes	51	20	20
AGGTCATCAAGGACTG-1_3_C4	-37.56040621	-0.602072833	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1442	2604	0.003840246	0.006528418	6	9	OPC	51	20	20
AGGTCATCAGATGGCA-1_3_C4	12.72695189	20.67341351	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	990	1651	0.010902483	0.006662629	6	oligos	OL-Cntl	51	20	20
AGGTCATGTCCTCTTG-1_3_C4	-37.35548421	-0.46356455	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1614	3031	0.002309469	0.006268558	6	9	OPC	51	20	20
AGGTCATGTCTTCAAG-1_3_C4	6.937555282	-14.37190377	4	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2914	6283	0.016075123	0.011777813	6	L2-3	EN-L2-3-MS	51	20	20
AGGTCATGTGAGGCTA-1_3_C4	6.056933827	30.6051178	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	715	1140	0.007894737	0.004385965	6	oligos	OL-Cntl	51	20	20
AGGTCATTCACTTACT-1_3_C4	1.461924998	32.78497077	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	814	1218	0.005747126	0.003284072	6	oligos	OL-Cntl	51	20	20
AGGTCCGAGTACCGGA-1_3_C4	1.778675758	22.67946317	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	833	1246	0.000802568	0.004012841	6	oligos	OL-Cntl	51	20	20
AGGTCCGGTCAACATC-1_3_C4	-22.5585272	24.49868774	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1703	3170	0.00851735	0.008832808	6	8	Astrocytes	51	20	20
AGGTCCGTCTGTCAAG-1_3_C4	21.13748403	14.46059572	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1292	2054	0.008763389	0.003894839	6	oligos	OL-Cntl	51	20	20
AGTAGTCAGTCCGGTC-1_3_C4	-22.73616331	-1.364040211	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	927	1395	0.002867384	0.008602151	6	9	OPC	51	20	20
AGTAGTCCACGGTAAG-1_3_C4	-31.4501498	11.14893523	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	684	1001	0.004995005	0.001998002	6	8	Astrocytes	51	20	20
AGTAGTCGTCAATGTC-1_3_C4	-14.42213407	-21.56100865	6A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1473	2835	0.034567901	0.000705467	6	6A	IN-PV	51	20	20
AGTAGTCGTTGAGGTG-1_3_C4	4.610312763	22.15762581	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	822	1333	0.004501125	0.010502626	6	oligos	OL-Cntl	51	20	20
AGTCTTTAGGAGTTGC-1_3_C4	-35.80342829	-7.161690945	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	989	1572	0.005089059	0.003816794	6	9	OPC	51	20	20
AGTCTTTCACAAGTAA-1_3_C4	11.05229034	23.07737371	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	775	1155	0.00952381	0.008658009	6	oligos	OL-Cntl	51	20	20
AGTCTTTCACGAAACG-1_3_C4	2.659576342	23.05517457	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	751	1078	0.008348794	0.003710575	6	oligos	OL-Cntl	51	20	20
AGTGAGGAGATGTCGG-1_3_C4	19.23361105	-0.080977744	12	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1229	2064	0.089147287	0.002906977	6	12	EN-MIX	51	20	20
AGTGAGGAGTAGCGGT-1_3_C4	13.33140255	-1.097923287	12	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1110	2065	0.027118644	0.000968523	6	12	EN-MIX	51	20	20
AGTGAGGCAGTCGATT-1_3_C4	-31.33662767	12.13082867	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	813	1247	0.002405774	0.002405774	6	8	Astrocytes	51	20	20
AGTGAGGGTGTGGCTC-1_3_C4	-0.050761919	23.65208083	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	761	1110	0.007207207	0.004504505	6	oligos	OL-Cntl	51	20	20
AGTGAGGGTTTACTCT-1_3_C4	21.68584451	11.45881546	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1518	2704	0.00147929	0.004807692	6	oligos	OL-Cntl	51	20	20
AGTGAGGTCAAGGTAA-1_3_C4	16.93978023	26.26825244	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	916	1399	0.002144389	0.002859185	6	oligos	OL-Cntl	51	20	20
AGTGGGAAGCCAGGAT-1_3_C4	5.380504023	17.69028286	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	905	1363	0.013206163	0.016140866	6	oligos	OL-Cntl	51	20	20
AGTGGGAAGCGTGAAC-1_3_C4	13.61684858	17.18718833	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1075	1582	0.00505689	0.005689001	6	oligos	OL-Cntl	51	20	20
AGTGGGACAACACGCC-1_3_C4	4.1155891	27.72596132	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	778	1193	0.012573345	0.010058676	6	oligos	OL-Cntl	51	20	20
AGTGGGACACCTATCC-1_3_C4	-26.14034604	11.7842026	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	946	1486	0.010094213	0.006056528	6	8	Astrocytes	51	20	20
AGTGGGAGTAAGTGTA-1_3_C4	13.70029274	-27.58223826	3	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2462	4921	0.009754115	0.003657793	6	3	EN-L5-6	51	20	20
AGTGGGAGTGTGACCC-1_3_C4	17.25905217	14.11522327	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1233	1978	0.008088979	0.006572295	6	oligos	OL-Cntl	51	20	20
AGTGGGAGTTAAGATG-1_3_C4	-0.665870309	21.31626758	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	739	1136	0.003521127	0.007922535	6	oligos	OL-Cntl	51	20	20
AGTGGGAGTTCTCATT-1_3_C4	-23.28976031	17.77784249	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1253	2185	0.002745995	0.002745995	6	8	Astrocytes	51	20	20
AGTGGGAGTTTGTTTC-1_3_C4	-29.4675691	20.52015887	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	992	1469	0.008168822	0.004765146	6	8	Astrocytes	51	20	20
AGTGGGATCCCTCAGT-1_3_C4	15.75353486	27.34044392	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	846	1313	0.001523229	0.004569688	6	oligos	OL-Cntl	51	20	20
AGTGGGATCTGTTGAG-1_3_C4	19.88602178	16.72562946	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1140	1834	0.002726281	0.00436205	6	oligos	OL-Cntl	51	20	20
AGTGTCAAGTAATCCC-1_3_C4	13.69993069	13.88216666	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1177	2131	0.000469263	0.008916002	6	oligos	OL-Cntl	51	20	20
AGTGTCAGTACAGACG-1_3_C4	-33.03791233	-7.095962635	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1213	1916	0.005219207	0.004175365	6	9	OPC	51	20	20
AGTGTCAGTCTTGCGG-1_3_C4	-1.326791113	20.00405093	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	822	1235	0.000809717	0.011336032	6	oligos	OL-Cntl	51	20	20
AGTTGGTAGTCACGCC-1_3_C4	-25.33556206	23.52700087	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1391	2541	0.007083825	0.003935458	6	8	Astrocytes	51	20	20
AGTTGGTCAATGGACG-1_3_C4	-35.58487732	-7.872359979	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1035	1666	0.004801921	0.0030012	6	9	OPC	51	20	20
AGTTGGTGTACCATCA-1_3_C4	-27.50259021	4.364673207	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	3235	7346	0.001905799	0.007623196	6	9	OPC	51	20	20
AGTTGGTGTCGAGATG-1_3_C4	-15.19618242	-4.272240942	13A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	3575	7742	0.020020666	0.006070783	6	13A	IN-VIP	51	20	20
ATAACGCAGAATGTGT-1_3_C4	15.1246732	21.9348857	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	856	1365	0.001465201	0.005128205	6	oligos	OL-Cntl	51	20	20
ATAACGCAGTCAAGGC-1_3_C4	16.94044691	23.07472411	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	848	1416	0.000706215	0.004943503	6	oligos	OL-Cntl	51	20	20
ATAACGCGTGTGACCC-1_3_C4	-9.429308056	17.64369711	11	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2678	5254	0.008945565	0.005138942	6	11	Glia-MIX	51	20	20
ATAACGCGTTGGACCC-1_3_C4	22.77450426	-23.18747283	3	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	3423	8249	0.012001455	0.008485877	6	3	EN-L5-6	51	20	20
ATAAGAGAGTGGAGTC-1_3_C4	-31.31031154	11.18430542	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	698	1109	0.00270514	0.003606853	6	8	Astrocytes	51	20	20
ATAAGAGTCGGAGCAA-1_3_C4	-31.32453469	11.437328	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	758	1229	0.002441009	0.003254679	6	8	Astrocytes	51	20	20
ATAGACCAGCAGGTCA-1_3_C4	-25.83801198	22.18683027	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1121	1737	0.015544041	0.005757052	6	8	Astrocytes	51	20	20
ATAGACCTCTCGAGTA-1_3_C4	15.53046837	18.94593214	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	982	1606	0.01120797	0.003113325	6	oligos	OL-Cntl	51	20	20
ATCACGAAGCAAATCA-1_3_C4	32.12331971	-9.294181745	2	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	3815	9585	0.013771518	0.004277517	6	2	EN-L4	51	20	20
ATCACGACACAAGTAA-1_3_C4	-35.05023891	5.030695216	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2672	5817	0.006876397	0.003266288	6	9	OPC	51	20	20
ATCACGACACGCATCG-1_3_C4	-19.13682454	7.820910063	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1035	1705	0.005865103	0.003519062	6	8	Astrocytes	51	20	20
ATCACGATCATGTGGT-1_3_C4	-33.04654878	-8.779078211	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	971	1436	0.002785515	0.004874652	6	9	OPC	51	20	20
ATCATCTAGATGCCTT-1_3_C4	18.1587681	-5.903620679	3	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1569	3253	0.016292653	0.001537043	6	3	EN-L5-6	51	20	20
ATCATCTAGCCAGAAC-1_3_C4	5.058135848	28.22864209	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	755	1219	0.001640689	0.008203445	6	oligos	OL-Cntl	51	20	20
ATCATCTGTAAGTGTA-1_3_C4	-23.43450233	0.689687576	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1972	3525	0.002836879	0.003404255	6	9	OPC	51	20	20
ATCATGGAGAAGGGTA-1_3_C4	15.52131002	15.30595981	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1197	1904	0.006302521	0.006827731	6	oligos	OL-Cntl	51	20	20
ATCATGGAGTTGAGTA-1_3_C4	11.07040791	22.052297	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	877	1314	0.00608828	0.003805175	6	oligos	OL-Cntl	51	20	20
ATCATGGCAAGCCATT-1_3_C4	-23.17375837	1.29830366	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2756	6257	0.00319642	0.00479463	6	9	OPC	51	20	20
ATCATGGGTCGACTAT-1_3_C4	4.686320267	24.93843594	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	784	1174	0	0.005962521	6	oligos	OL-Cntl	51	20	20
ATCATGGTCCGCATAA-1_3_C4	-34.40732521	-11.61517627	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	776	1127	0.005323869	0.002661934	6	9	OPC	51	20	20
ATCCACCGTCTCCACT-1_3_C4	-15.12709553	1.48735321	13A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	4004	10080	0.007440476	0.0125	6	13A	IN-VIP	51	20	20
ATCCACCTCACCTCGT-1_3_C4	10.75036702	-33.88875787	3	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	4900	17359	0.002131459	0.001958638	6	3	EN-L5-6	51	20	20
ATCCGAACATGGATGG-1_3_C4	-13.00573348	16.06318119	11	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1231	1821	0.007688083	0.006040637	6	11	Glia-MIX	51	20	20
ATCGAGTAGCGTCTAT-1_3_C4	22.23400173	-10.47586821	3	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2214	4069	0.040304743	0.004177931	6	3	EN-L5-6	51	20	20
ATCGAGTGTGAGTGAC-1_3_C4	-37.84930492	-7.747563848	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1081	1817	0.000550358	0.000550358	6	9	OPC	51	20	20
ATCTACTAGAACTGTA-1_3_C4	10.31553446	29.78037444	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	725	1107	0.021680217	0.001806685	6	oligos	OL-Cntl	51	20	20
ATCTACTAGTCAAGCG-1_3_C4	-27.39891668	16.93043246	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1278	2204	0.003176044	0.003176044	6	8	Astrocytes	51	20	20
ATCTACTCAAGCCGTC-1_3_C4	14.8335379	21.87264315	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	972	1591	0.000628536	0.008170962	6	oligos	OL-Cntl	51	20	20
ATCTACTCATGGGAAC-1_3_C4	-28.24416376	22.42642724	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1158	1815	0.004958678	0.005509642	6	8	Astrocytes	51	20	20
ATCTACTGTCCCTACT-1_3_C4	-16.75099511	-8.735006341	13B	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2757	6371	0.034531471	0.002982263	6	13B	IN-SV2C	51	20	20
ATCTACTTCCACGCAG-1_3_C4	2.76319709	28.86977894	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	683	1055	0.001895735	0.004739336	6	oligos	OL-Cntl	51	20	20
ATCTACTTCCGCAGTG-1_3_C4	-5.952459577	-3.913520629	13A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1383	2398	0.01292744	0.005838198	6	13A	IN-VIP	51	20	20
ATCTACTTCTTGGGTA-1_3_C4	18.23360937	-5.913093476	3	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1545	3111	0.00032144	0.00096432	6	3	EN-L5-6	51	20	20
ATCTGCCAGCAATATG-1_3_C4	17.15035809	15.63966066	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1133	1953	0.008704557	0.004096262	6	oligos	OL-Cntl	51	20	20
ATCTGCCAGCCGCCTA-1_3_C4	31.50580792	-9.882765835	2	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	4127	10062	0.014708805	0.004770423	6	2	EN-L4	51	20	20
ATCTGCCAGCTGCCCA-1_3_C4	17.58566701	14.27056049	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1271	2212	0.003616637	0.011301989	6	oligos	OL-Cntl	51	20	20
ATCTGCCGTCTCCATC-1_3_C4	23.79073944	-10.91509998	3	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	4030	10427	0.008247818	0.004411624	6	3	EN-L5-6	51	20	20
ATCTGCCTCACAACGT-1_3_C4	16.19496082	10.12640686	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1466	2680	0.001119403	0.006716418	6	oligos	OL-Cntl	51	20	20
ATCTGCCTCCTATGTT-1_3_C4	-23.3474447	22.78188178	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1537	2957	0.006763612	0.002705445	6	8	Astrocytes	51	20	20
ATCTGCCTCTATCGCC-1_3_C4	16.28122859	15.77247425	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1193	2248	0.00088968	0.004003559	6	oligos	OL-Cntl	51	20	20
ATCTGCCTCTCGATGA-1_3_C4	-36.16594472	-1.977024954	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1380	2323	0.003443823	0.0038743	6	9	OPC	51	20	20
ATCTGCCTCTTAGAGC-1_3_C4	39.20820217	12.38380515	14	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	959	1491	0.006036217	0.008718981	6	14	Microglia	51	20	20
ATGAGGGAGCCAGTTT-1_3_C4	15.47923863	-26.20770637	3	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	3660	9387	0.005006924	0.004154682	6	3	EN-L5-6	51	20	20
ATGAGGGAGGGTGTTG-1_3_C4	5.727723895	32.12242342	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	655	1030	0.000970874	0.008737864	6	oligos	OL-Cntl	51	20	20
ATGAGGGCAGTTTACG-1_3_C4	-21.24892842	27.56911491	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1828	3298	0.006064281	0.004851425	6	8	Astrocytes	51	20	20
ATGAGGGCATGTTGAC-1_3_C4	3.743982195	27.57187457	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	714	1036	0.007722008	0.006756757	6	oligos	OL-Cntl	51	20	20
ATGAGGGTCAGAAATG-1_3_C4	16.69724948	16.85968873	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1135	1788	0.002796421	0.005592841	6	oligos	OL-Cntl	51	20	20
ATGCGATCAGGTGCCT-1_3_C4	18.37218111	22.25511671	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	907	1441	0.0055517	0.000693963	6	oligos	OL-Cntl	51	20	20
ATGCGATGTCAGATAA-1_3_C4	2.029092779	-26.1695365	4	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	3635	9071	0.005181347	0.002866277	6	L2-3	EN-L2-3-MS	51	20	20
ATGCGATTCAACGGGA-1_3_C4	-33.60207366	-10.63112349	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	980	1575	0.003174603	0.005714286	6	9	OPC	51	20	20
ATGCGATTCGCCTGAG-1_3_C4	-21.00567553	8.975566974	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1026	1572	0.009541985	0.003816794	6	8	Astrocytes	51	20	20
ATGGGAGAGGAGCGTT-1_3_C4	-32.97577073	-5.475295595	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1187	1940	0.007731959	0.003092784	6	9	OPC	51	20	20
ATGGGAGAGGCGTACA-1_3_C4	-0.995168472	27.15917659	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	701	1071	0.013071895	0.00280112	6	oligos	OL-Cntl	51	20	20
ATGGGAGCATTGGCGC-1_3_C4	15.65979371	9.616733707	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1461	2515	0.007157058	0.014314115	6	oligos	OL-Cntl	51	20	20
ATGGGAGTCCCTGACT-1_3_C4	-28.60861469	10.72042429	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	902	1372	0.005830904	0.010932945	6	8	Astrocytes	51	20	20
ATGGGAGTCTCGGACG-1_3_C4	-14.22470096	-0.342417252	13A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2471	4604	0.010860122	0.013466551	6	13A	IN-VIP	51	20	20
ATGTGTGAGCAGACTG-1_3_C4	-35.94434666	-9.680899564	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	876	1304	0.001533742	0.002300613	6	9	OPC	51	20	20
ATGTGTGGTCCGCTGA-1_3_C4	10.4168	-20.20382563	4	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	3342	8073	0.01585532	0.004583178	6	L2-3	EN-L2-3-MS	51	20	20
ATGTGTGGTCGACTAT-1_3_C4	15.90667931	18.10493532	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1015	1776	0.000563063	0.005630631	6	oligos	OL-Cntl	51	20	20
ATGTGTGGTCTCCACT-1_3_C4	-0.185132978	21.41458746	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	707	1051	0.014272122	0.002854424	6	oligos	OL-Cntl	51	20	20
ATGTGTGGTGATGTGG-1_3_C4	2.15237282	26.88152298	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	670	1007	0.000993049	0.003972195	6	oligos	OL-Cntl	51	20	20
ATTACTCAGACGCACA-1_3_C4	-8.799622578	14.71793726	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2097	3959	0.006819904	0.003536247	6	oligos	OL-Cntl	51	20	20
ATTACTCCACTTCTGC-1_3_C4	-35.61746493	-6.561928013	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1089	1783	0.003365115	0.003365115	6	9	OPC	51	20	20
ATTACTCGTCCGTCAG-1_3_C4	-28.84703746	21.7022119	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1044	1758	0.003981797	0.003981797	6	8	Astrocytes	51	20	20
ATTATCCCAAGGACTG-1_3_C4	-14.16012938	-8.227478457	13B	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2847	6980	0.001719198	0.002148997	6	13B	IN-SV2C	51	20	20
ATTATCCCAATGCCAT-1_3_C4	-29.83354384	10.69823181	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	702	1069	0.006548176	0.006548176	6	8	Astrocytes	51	20	20
ATTATCCTCTTTCCTC-1_3_C4	-34.45077339	-12.69750615	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	777	1252	0	0.003194888	6	9	OPC	51	20	20
ATTCTACTCTTACCTA-1_3_C4	14.42076326	-7.965587747	10	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2069	4785	0.006478579	0.003134796	6	L2-3	EN-L2-3-Cntl	51	20	20
ATTGGACAGGTAGCCA-1_3_C4	37.06032294	11.31367026	14	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	836	1141	0.006134969	0.01665206	6	14	Microglia	51	20	20
ATTGGACCAACAACCT-1_3_C4	-22.4616794	28.12696693	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1804	3510	0.011680912	0.005698006	6	8	Astrocytes	51	20	20
ATTGGACGTCTAGGTT-1_3_C4	3.228360627	25.72741947	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	737	1144	0.009615385	0.009615385	6	oligos	OL-Cntl	51	20	20
ATTGGTGAGAACTCGG-1_3_C4	18.23127986	15.87036168	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1077	1719	0.006399069	0.002908668	6	oligos	OL-Cntl	51	20	20
ATTGGTGAGAATGTTG-1_3_C4	4.61841258	-28.71057813	10	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	4674	15059	0.006706953	0.003121057	6	L2-3	EN-L2-3-Cntl	51	20	20
ATTGGTGAGCGGCTTC-1_3_C4	-35.68283617	-4.366502993	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1311	2187	0.001828989	0.002743484	6	9	OPC	51	20	20
ATTGGTGCAACACGCC-1_3_C4	0.998340758	23.1793975	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	693	1117	0.00179051	0.010743062	6	oligos	OL-Cntl	51	20	20
ATTGGTGCACTCGACG-1_3_C4	3.63878108	-20.15339576	4	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	4512	13240	0.003851964	0.010800604	6	L2-3	EN-L2-3-MS	51	20	20
ATTGGTGCATACGCTA-1_3_C4	-22.40561874	19.63445164	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1588	3113	0.000321234	0.004176036	6	8	Astrocytes	51	20	20
ATTGGTGGTGACTCAT-1_3_C4	9.822184171	21.28980218	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	802	1269	0.00394011	0.007092199	6	oligos	OL-Cntl	51	20	20
ATTGGTGTCACAAACC-1_3_C4	2.792473207	-11.56788835	12	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1928	4020	0.011691542	0.003731343	6	12	EN-MIX	51	20	20
ATTGGTGTCCACGTGG-1_3_C4	-25.32684666	24.19403255	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1365	2196	0.010473588	0.00273224	6	8	Astrocytes	51	20	20
ATTTCTGAGAATAGGG-1_3_C4	-13.47485145	14.32327515	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	813	1192	0.011744966	0.005033557	6	8	Astrocytes	51	20	20
ATTTCTGCATCGATTG-1_3_C4	-2.753161965	0.83116243	11	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2154	4041	0.01979708	0.001979708	6	11	Glia-MIX	51	20	20
CAACCAACATGTAGTC-1_3_C4	-27.70945371	22.57625387	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1226	2045	0.005378973	0.006356968	6	8	Astrocytes	51	20	20
CAACCAAGTGGTGTAG-1_3_C4	15.90509565	18.83945373	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1051	1806	0.002214839	0.009966777	6	oligos	OL-Cntl	51	20	20
CAACCAATCATAACCG-1_3_C4	20.36741321	8.942925744	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1668	3211	0.000311429	0.003114295	6	oligos	OL-Cntl	51	20	20
CAACCTCAGAGTAATC-1_3_C4	21.06468425	11.70789599	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1511	2671	0.004867091	0.004867091	6	oligos	OL-Cntl	51	20	20
CAACCTCAGTGAATTG-1_3_C4	-4.066462305	25.49396606	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	719	1052	0.004752852	0.010456274	6	oligos	OL-Cntl	51	20	20
CAACCTCAGTGCCATT-1_3_C4	9.603799396	21.50983998	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	857	1428	0.00280112	0.008403361	6	oligos	OL-Cntl	51	20	20
CAACCTCCAGCATGAG-1_3_C4	-36.74514613	-7.177786208	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1232	2113	0.001893043	0	6	9	OPC	51	20	20
CAACCTCCAGCTGCTG-1_3_C4	-31.54205014	12.44554909	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	875	1324	0.012839879	0.003021148	6	8	Astrocytes	51	20	20
CAACCTCTCTCCAACC-1_3_C4	22.17896316	17.69406377	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1190	1969	0.000507872	0.00507872	6	oligos	OL-Cntl	51	20	20
CAACTAGAGATGGGTC-1_3_C4	18.55733881	21.21220371	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1029	1612	0.006823821	0.003722084	6	oligos	OL-Cntl	51	20	20
CAACTAGAGGGATCTG-1_3_C4	12.77931684	15.827101	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1193	2013	0.014406359	0.00993542	6	oligos	OL-Cntl	51	20	20
CAACTAGGTATGGTTC-1_3_C4	17.51765001	12.34460626	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1338	2367	0.016899028	0.002534854	6	oligos	OL-Cntl	51	20	20
CAACTAGGTGCACGAA-1_3_C4	14.47355229	12.87447579	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1301	2333	0.009429919	0.010715817	6	oligos	OL-Cntl	51	20	20
CAACTAGTCGCGCCAA-1_3_C4	-36.73360255	1.573022983	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1696	3077	0	0.002924927	6	9	OPC	51	20	20
CAACTAGTCTGTACGA-1_3_C4	39.34771725	12.52029529	14	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	970	1379	0.001450326	0.013052937	6	14	Microglia	51	20	20
CAAGAAAAGGCAGGTT-1_3_C4	-12.02219384	-5.841604818	13A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1994	3516	0.02559727	0.007679181	6	13A	IN-VIP	51	20	20
CAAGAAACACGTAAGG-1_3_C4	-31.4868224	12.23006718	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	805	1200	0.009166667	0.005	6	8	Astrocytes	51	20	20
CAAGAAACACTATCTT-1_3_C4	21.18055337	11.57670974	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1596	2845	0.001757469	0.008435852	6	oligos	OL-Cntl	51	20	20
CAAGAAATCTGTCTCG-1_3_C4	15.76353087	22.05492067	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	998	1696	0.001768868	0.005306604	6	oligos	OL-Cntl	51	20	20
CAAGATCCAAGGTTTC-1_3_C4	15.1981955	20.20463375	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1048	1664	0.001201923	0.011418269	6	oligos	OL-Cntl	51	20	20
CAAGATCGTGTGTGCC-1_3_C4	3.104127008	25.65158244	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	754	1087	0.001839926	0.009199632	6	oligos	OL-Cntl	51	20	20
CAAGATCTCAGGCCCA-1_3_C4	-23.60928046	23.44504533	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1475	2357	0.009758167	0.005515486	6	8	Astrocytes	51	20	20
CAAGGCCCACACCGAC-1_3_C4	14.63365811	21.16415734	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	935	1563	0.003198976	0.004478567	6	oligos	OL-Cntl	51	20	20
CAAGGCCGTCAGAAGC-1_3_C4	5.355353095	-14.24088502	4	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2466	4981	0.011845011	0.006022887	6	L2-3	EN-L2-3-MS	51	20	20
CAAGGCCGTCATTAGC-1_3_C4	16.33310567	13.24741755	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1344	2218	0.003155996	0.006311993	6	oligos	OL-Cntl	51	20	20
CAAGGCCGTTGGAGGT-1_3_C4	1.975523816	23.7459155	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	747	1149	0.00870322	0.007832898	6	oligos	OL-Cntl	51	20	20
CAAGTTGCATGCCTTC-1_3_C4	-27.29494501	16.07052532	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1091	1762	0.002837684	0.006810443	6	8	Astrocytes	51	20	20
CAAGTTGTCCCTCAGT-1_3_C4	-7.325110356	-6.267232774	13A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1220	1915	0.023498695	0.006266319	6	13A	IN-VIP	51	20	20
CAAGTTGTCTGAGTGT-1_3_C4	5.833005428	21.0134739	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	827	1218	0.003284072	0.013957307	6	oligos	OL-Cntl	51	20	20
CACAAACAGATATGGT-1_3_C4	-23.07305865	25.27095523	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1602	2879	0.003473428	0.005210142	6	8	Astrocytes	51	20	20
CACAAACCAAGACGTG-1_3_C4	-35.15541189	-2.567622488	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1720	3716	0.004843918	0.003229279	6	9	OPC	51	20	20
CACAAACCACCCTATC-1_3_C4	9.243170167	28.17409618	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	786	1344	0.000744048	0.008184524	6	oligos	OL-Cntl	51	20	20
CACAAACGTGCAACTT-1_3_C4	9.001386067	-25.83932418	4	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	6197	21677	0.004843844	0.005305162	6	L2-3	EN-L2-3-MS	51	20	20
CACAAACTCAGGCCCA-1_3_C4	1.598286039	-19.86230331	10	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	3909	12024	0.001330672	0.00499002	6	L2-3	EN-L2-3-Cntl	51	20	20
CACACAATCAGCTCTC-1_3_C4	7.036818973	25.4529302	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1011	1661	0.003612282	0.006622517	6	oligos	OL-Cntl	51	20	20
CACACAATCGCCTGAG-1_3_C4	-29.07589488	21.73040214	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1183	1852	0.005939525	0.007019438	6	8	Astrocytes	51	20	20
CACACCTAGCGTCAAG-1_3_C4	25.47321415	3.787510686	15BA	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1184	1996	0.00250501	0.003507014	6	15BA	Stromal cells	51	20	20
CACACCTCAGGCTCAC-1_3_C4	13.94753831	19.49538756	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1054	1691	0.007687759	0.006505027	6	oligos	OL-Cntl	51	20	20
CACACCTGTGTCAATC-1_3_C4	16.89861155	-0.740540139	12	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	832	1258	0.008744038	0.001589825	6	12	EN-MIX	51	20	20
CACACCTGTGTTTGTG-1_3_C4	-27.31207077	15.84006799	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1034	1607	0.00746733	0.00248911	6	8	Astrocytes	51	20	20
CACACCTGTTCGGGCT-1_3_C4	15.77342222	29.01976186	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	857	1313	0.003808073	0.006092917	6	oligos	OL-Cntl	51	20	20
CACACTCAGCTCCTCT-1_3_C4	-31.46931313	12.38197649	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	859	1326	0.018853695	0.005279035	6	8	Astrocytes	51	20	20
CACACTCCAATGAATG-1_3_C4	21.36550324	15.79480733	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1187	1951	0.001025115	0.002050231	6	oligos	OL-Cntl	51	20	20
CACACTCCAGCCAATT-1_3_C4	6.504257771	21.22232713	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	969	1620	0.001234568	0.004320988	6	oligos	OL-Cntl	51	20	20
CACACTCCATTTCACT-1_3_C4	-1.822295034	18.84557353	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	817	1218	0.022988506	0.018883415	6	oligos	OL-Cntl	51	20	20
CACACTCGTACCGAGA-1_3_C4	8.065980543	19.36002921	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1104	1689	0.00473653	0.010065127	6	oligos	OL-Cntl	51	20	20
CACACTCGTTCGTCTC-1_3_C4	-20.15203499	8.906402623	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	970	1433	0.003489184	0.00209351	6	8	Astrocytes	51	20	20
CACAGGCCATGCAACT-1_3_C4	21.24747421	11.20867857	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1695	3032	0.000989446	0.002968338	6	oligos	OL-Cntl	51	20	20
CACAGGCCATTACCTT-1_3_C4	16.29493243	-29.30324773	3	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	6003	21936	0.002461707	0.004148432	6	3	EN-L5-6	51	20	20
CACAGGCGTCTAGCCG-1_3_C4	13.15547771	22.68466721	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	889	1385	0.007942238	0.005776173	6	oligos	OL-Cntl	51	20	20
CACAGGCTCCCTTGCA-1_3_C4	-22.73322998	27.50886033	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2018	3861	0.009065009	0.004403004	6	8	Astrocytes	51	20	20
CACAGGCTCCTCTAGC-1_3_C4	6.996252871	25.61537681	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	959	1500	0.005333333	0.004	6	oligos	OL-Cntl	51	20	20
CACAGTAAGCTAAACA-1_3_C4	-31.68394221	11.92069357	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	844	1256	0.007165605	0.001592357	6	8	Astrocytes	51	20	20
CACAGTACACCTCGGA-1_3_C4	-11.94416597	17.36677123	11	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1621	2657	0.009785472	0.009032744	6	11	Glia-MIX	51	20	20
CACAGTACACGTCAGC-1_3_C4	-20.72299025	30.8344894	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2841	6028	0.001161248	0.005640345	6	8	Astrocytes	51	20	20
CACATAGAGGAATTAC-1_3_C4	-8.271143474	-17.75416567	6B	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	687	1038	0.021194605	0.001926782	6	6B	IN-SST	51	20	20
CACATAGAGTACTTGC-1_3_C4	-37.35139088	0.300207491	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1668	3131	0.001916321	0.004152028	6	9	OPC	51	20	20
CACATAGAGTTGAGTA-1_3_C4	-10.78264676	-3.418360794	13A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2159	3889	0.025713551	0.005399846	6	13A	IN-VIP	51	20	20
CACATAGCATTAACCG-1_3_C4	15.32434064	25.6937039	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	828	1288	0	0.007763975	6	oligos	OL-Cntl	51	20	20
CACATAGGTAACGACG-1_3_C4	1.570637735	24.22960302	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	812	1239	0.005649718	0.00645682	6	oligos	OL-Cntl	51	20	20
CACATAGGTCCAAGTT-1_3_C4	17.26524975	18.16710807	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1040	1904	0.00052521	0.00210084	6	oligos	OL-Cntl	51	20	20
CACATAGGTCGCATCG-1_3_C4	-33.65165361	4.257667221	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2384	4789	0.001044059	0.005429108	6	9	OPC	51	20	20
CACATAGGTTCAACCA-1_3_C4	4.465829115	16.48532832	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	939	1468	0.009536785	0.013623978	6	oligos	OL-Cntl	51	20	20
CACATAGTCAATAAGG-1_3_C4	-28.22598193	9.333647959	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	822	1291	0.003872967	0.008520527	6	8	Astrocytes	51	20	20
CACATAGTCCGCGGTA-1_3_C4	-9.770205958	18.09024466	11	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2823	6037	0.003809839	0.007619679	6	11	Glia-MIX	51	20	20
CACATTTAGAAGGTTT-1_3_C4	-26.55619501	25.04472485	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1413	2584	0.002708978	0.003869969	6	8	Astrocytes	51	20	20
CACATTTAGACACGAC-1_3_C4	-23.48688773	26.97810908	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1864	3624	0.004690949	0.003863135	6	8	Astrocytes	51	20	20
CACATTTAGCAGGCTA-1_3_C4	10.56302418	21.19633959	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	960	1538	0.007802341	0.004551365	6	oligos	OL-Cntl	51	20	20
CACATTTAGCTAGGCA-1_3_C4	3.288667599	26.24670606	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	724	1181	0.00084674	0.009314141	6	oligos	OL-Cntl	51	20	20
CACATTTCATTCGACA-1_3_C4	-21.01088865	8.529369411	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	840	1339	0.001493652	0.004480956	6	8	Astrocytes	51	20	20
CACATTTGTCCATCCT-1_3_C4	-10.30580962	-18.93461729	6B	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	974	1705	0.025806452	0.001759531	6	6B	IN-SST	51	20	20
CACATTTGTCCGCTGA-1_3_C4	-27.94757917	11.57565288	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	834	1236	0.004854369	0.003236246	6	8	Astrocytes	51	20	20
CACATTTTCATCTGTT-1_3_C4	-8.92551816	15.93375291	11	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2455	5159	0.00290754	0.006008916	6	11	Glia-MIX	51	20	20
CACATTTTCATGCAAC-1_3_C4	11.46956782	22.1933931	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	919	1600	0.003125	0.005625	6	oligos	OL-Cntl	51	20	20
CACCACTAGAATTGTG-1_3_C4	5.469279074	25.71885594	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	858	1379	0	0.002900653	6	oligos	OL-Cntl	51	20	20
CACCACTAGATCCTGT-1_3_C4	22.95786985	18.57840652	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1116	1788	0.000559284	0.005033557	6	oligos	OL-Cntl	51	20	20
CACCACTAGCCAGAAC-1_3_C4	0.480630014	-16.00081856	10	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2918	7825	0.020702875	0.002428115	6	L2-3	EN-L2-3-Cntl	51	20	20
CACCACTAGTGTACCT-1_3_C4	21.82750032	9.687253314	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1771	3050	0.00557377	0.007213115	6	oligos	OL-Cntl	51	20	20
CACCACTCAGATGGCA-1_3_C4	-20.96649573	9.964060786	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1132	1816	0.001101322	0.005506608	6	8	Astrocytes	51	20	20
CACCACTGTCAAAGAT-1_3_C4	3.617964202	17.51245532	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	943	1497	0.001336005	0.006680027	6	oligos	OL-Cntl	51	20	20
CACCACTGTTCAACCA-1_3_C4	-12.02049198	-19.09017876	6B	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1020	1632	0.03370098	0.005514706	6	6B	IN-SST	51	20	20
CACCACTTCCAAACAC-1_3_C4	39.57030355	15.26278878	14	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1323	2039	0.002452182	0.005885238	6	14	Microglia	51	20	20
CACCAGGAGTTTGCGT-1_3_C4	-25.36085945	16.90984596	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1143	1818	0.00440044	0.00660066	6	8	Astrocytes	51	20	20
CACCAGGCACCCATTC-1_3_C4	12.3227633	32.55413482	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	685	1066	0	0.000938086	6	oligos	OL-Cntl	51	20	20
CACCAGGGTCAACATC-1_3_C4	-16.9252213	-21.77964033	6A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1998	4238	0.023124115	0.002123643	6	6A	IN-PV	51	20	20
CACCAGGTCAGGCCCA-1_3_C4	17.55082922	7.111831488	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2132	4071	0.006632277	0.006386637	6	oligos	OL-Cntl	51	20	20
CACCAGGTCAGTGCAT-1_3_C4	-13.54299103	-5.247725941	13A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2610	5456	0.024560117	0.003665689	6	13A	IN-VIP	51	20	20
CACCAGGTCCACGACG-1_3_C4	21.33789421	10.69209504	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1600	2823	0.004250797	0.00460503	6	oligos	OL-Cntl	51	20	20
CACCAGGTCGACAGCC-1_3_C4	38.0319587	11.90438005	14	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	940	1340	0.017164179	0.019402985	6	14	Microglia	51	20	20
CACCTTGAGGCAGGTT-1_3_C4	-36.57823202	-0.052351831	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1666	2895	0.00552677	0.003108808	6	9	OPC	51	20	20
CACCTTGGTCAGAGGT-1_3_C4	-25.83432775	12.37709068	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1109	1879	0.009579564	0.005854178	6	8	Astrocytes	51	20	20
CACCTTGTCACAACGT-1_3_C4	-0.300767408	25.69508281	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	728	1139	0.002633889	0.007901668	6	oligos	OL-Cntl	51	20	20
CACTCCAAGTACACCT-1_3_C4	-15.52318535	-18.92880972	6B	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1582	3083	0.01070386	0.002270516	6	6B	IN-SST	51	20	20
CACTCCACAAGAAGAG-1_3_C4	15.57508644	-8.087471052	3	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2387	4787	0.007102569	0.003342386	6	3	EN-L5-6	51	20	20
CACTCCACATGCGCAC-1_3_C4	39.59040547	14.91002867	14	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1259	1956	0.00204499	0.009202454	6	14	Microglia	51	20	20
CACTCCAGTCACTGGC-1_3_C4	-12.64716773	17.62912587	11	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1610	2688	0.01264881	0.004464286	6	11	Glia-MIX	51	20	20
CACTCCAGTCCGTCAG-1_3_C4	10.2547571	29.551898	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	703	1125	0.002666667	0.004444444	6	oligos	OL-Cntl	51	20	20
CACTCCAGTCGGCTCA-1_3_C4	-14.88801513	-6.780234517	13A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	4329	12285	0.015059015	0.002930403	6	13A	IN-VIP	51	20	20
CACTCCATCAGAGGTG-1_3_C4	-36.34994016	-1.59344409	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1577	2803	0.008919015	0.002854085	6	9	OPC	51	20	20
CACTCCATCAGCTGGC-1_3_C4	-21.83488373	9.934695857	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	987	1482	0.004048583	0.004723347	6	8	Astrocytes	51	20	20
CACTCCATCAGGATCT-1_3_C4	14.86631607	22.29859956	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	903	1358	0.010309278	0.003681885	6	oligos	OL-Cntl	51	20	20
CACTCCATCTCGATGA-1_3_C4	5.787683403	26.22477061	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	893	1480	0.00472973	0.007432432	6	oligos	OL-Cntl	51	20	20
CACTCCATCTTGCCGT-1_3_C4	15.90281978	17.18400904	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1112	1856	0.014547414	0.00862069	6	oligos	OL-Cntl	51	20	20
CAGAATCCATCGGGTC-1_3_C4	6.755423421	20.57860004	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1020	1608	0.007462687	0.009950249	6	oligos	OL-Cntl	51	20	20
CAGAATCGTCCATGAT-1_3_C4	-11.97993574	-18.64806367	6B	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1058	1768	0.033936652	0.006221719	6	6B	IN-SST	51	20	20
CAGAATCTCACGCGGT-1_3_C4	-35.39616874	-4.828657008	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1260	2084	0.003838772	0.003358925	6	9	OPC	51	20	20
CAGAGAGAGCGAAGGG-1_3_C4	4.428129847	-11.5408373	4	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1983	3510	0.013960114	0.005413105	6	L2-3	EN-L2-3-MS	51	20	20
CAGAGAGAGGGTGTGT-1_3_C4	5.731278435	-13.62481217	4	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2603	5016	0.011164274	0.005582137	6	L2-3	EN-L2-3-MS	51	20	20
CAGAGAGCAGGAATCG-1_3_C4	-24.70649673	17.53736287	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1293	2049	0.007808687	0.005368472	6	8	Astrocytes	51	20	20
CAGAGAGGTGCTTCTC-1_3_C4	-1.455482745	24.61820395	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	672	1024	0.006835938	0.008789063	6	oligos	OL-Cntl	51	20	20
CAGAGAGGTTCCACGG-1_3_C4	-26.38580749	13.03839905	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1056	1760	0.0125	0.005113636	6	8	Astrocytes	51	20	20
CAGATCACATGGAATA-1_3_C4	12.26257278	27.60721505	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	785	1195	0.00083682	0.005857741	6	oligos	OL-Cntl	51	20	20
CAGATCAGTGCCTGCA-1_3_C4	-18.92920916	-18.87013993	6B	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2599	5407	0.009062327	0.016830035	6	6B	IN-SST	51	20	20
CAGCAGCAGCCGTCGT-1_3_C4	-1.972555449	23.87352675	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	809	1166	0.006861063	0.010291595	6	oligos	OL-Cntl	51	20	20
CAGCAGCCAGGGTTAG-1_3_C4	11.75798678	26.39163903	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	727	1149	0.007832898	0.00435161	6	oligos	OL-Cntl	51	20	20
CAGCAGCTCCAGTAGT-1_3_C4	-20.77708823	8.453933404	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	799	1157	0.006914434	0.001728608	6	8	Astrocytes	51	20	20
CAGCAGCTCCGTAGTA-1_3_C4	-2.222636969	23.33545465	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	766	1132	0.004416961	0.015017668	6	oligos	OL-Cntl	51	20	20
CAGCATACAAGTAATG-1_3_C4	10.2986153	25.53519268	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	848	1359	0.005886681	0.002943341	6	oligos	OL-Cntl	51	20	20
CAGCATACATGCCTTC-1_3_C4	-6.563494456	-2.419024636	13A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1760	3256	0.002149877	0.003378378	6	13A	IN-VIP	51	20	20
CAGCATAGTATTACCG-1_3_C4	-26.45769429	13.84890987	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	989	1605	0.004984424	0.005607477	6	8	Astrocytes	51	20	20
CAGCATAGTCTCTTAT-1_3_C4	16.50301776	21.58373591	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	920	1560	0.001923077	0.001923077	6	oligos	OL-Cntl	51	20	20
CAGCATAGTTAAGGGC-1_3_C4	-16.75842623	14.54829876	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1625	3052	0.000982962	0.002948886	6	8	Astrocytes	51	20	20
CAGCATAGTTGGACCC-1_3_C4	-13.17422381	-1.139476937	13A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	3014	6629	0.019459949	0.01040881	6	13A	IN-VIP	51	20	20
CAGCATATCAGATAAG-1_3_C4	28.00645841	0.807594393	2	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	3710	9893	0.004548671	0.002628121	6	2	EN-L4	51	20	20
CAGCATATCCTCAACC-1_3_C4	-26.859795	19.08853442	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1231	1977	0.007081437	0.005058169	6	8	Astrocytes	51	20	20
CAGCATATCTCGTATT-1_3_C4	-9.281691332	17.77493533	11	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	3577	8393	0.006791374	0.004765876	6	11	Glia-MIX	51	20	20
CAGCATATCTTGCAAG-1_3_C4	-27.48005028	18.03485547	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1142	2096	0	0.001908397	6	8	Astrocytes	51	20	20
CAGCCGAAGATGTGGC-1_3_C4	-35.38964978	1.225373793	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1822	3243	0.004008634	0.003391921	6	9	OPC	51	20	20
CAGCCGACACAGAGGT-1_3_C4	4.658988552	22.33085305	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	910	1438	0.004172462	0.004867872	6	oligos	OL-Cntl	51	20	20
CAGCCGACATGCCTTC-1_3_C4	-26.99660813	13.12179694	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1029	1518	0.016469038	0.004611331	6	8	Astrocytes	51	20	20
CAGCCGAGTGCTAGCC-1_3_C4	6.475186123	21.43575369	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	955	1475	0.001355932	0.007457627	6	oligos	OL-Cntl	51	20	20
CAGCGACAGGTGTTAA-1_3_C4	8.699879968	8.243373228	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1726	3318	0.01084991	0.007836046	6	oligos	OL-Cntl	51	20	20
CAGCGACAGTATTGGA-1_3_C4	12.65350025	15.48677906	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1150	1749	0.008576329	0.006289308	6	oligos	OL-Cntl	51	20	20
CAGCGACGTCACAAGG-1_3_C4	6.231573427	20.75765982	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	975	1527	0.003929273	0.007203667	6	oligos	OL-Cntl	51	20	20
CAGCGACTCGCAAGCC-1_3_C4	12.2618966	14.3049501	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1244	2200	0.005	0.005909091	6	oligos	OL-Cntl	51	20	20
CAGCGACTCTCGCATC-1_3_C4	-26.15658922	15.10308303	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1036	1536	0.012369792	0.005859375	6	8	Astrocytes	51	20	20
CAGCTAAAGCGTGAAC-1_3_C4	22.74948539	13.17936423	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1376	2392	0.00041806	0.001254181	6	oligos	OL-Cntl	51	20	20
CAGCTAAGTATGCTTG-1_3_C4	6.098886609	22.72361475	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	925	1416	0.000706215	0.006355932	6	oligos	OL-Cntl	51	20	20
CAGCTAATCAGGCAAG-1_3_C4	-13.78660925	-24.29264284	6A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1420	2661	0.038707253	0.00263059	6	6A	IN-PV	51	20	20
CAGCTAATCGGATGTT-1_3_C4	-25.02207749	20.14985037	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1724	3235	0.000618238	0.00309119	6	8	Astrocytes	51	20	20
CAGCTGGAGCTAACTC-1_3_C4	22.12457613	16.16365343	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1346	2165	0.001385681	0.003233256	6	oligos	OL-Cntl	51	20	20
CAGCTGGAGGCTCAGA-1_3_C4	14.77677126	21.12548553	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	956	1485	0.004040404	0.006060606	6	oligos	OL-Cntl	51	20	20
CAGCTGGTCAGCACAT-1_3_C4	18.78943522	8.843166637	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1714	3525	0.00141844	0.003120567	6	oligos	OL-Cntl	51	20	20
CAGGTGCAGCGATCCC-1_3_C4	21.17638752	10.36449537	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1633	2810	0.003558719	0.007117438	6	oligos	OL-Cntl	51	20	20
CAGGTGCAGGCCCTCA-1_3_C4	-22.2819748	10.0592014	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	845	1320	0.003787879	0.006818182	6	8	Astrocytes	51	20	20
CAGGTGCGTTCGCGAC-1_3_C4	-1.786730767	23.26615761	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	676	1015	0.014778325	0.003940887	6	oligos	OL-Cntl	51	20	20
CAGGTGCTCCAGATCA-1_3_C4	-8.344605408	-12.22577606	6B	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	727	1181	0.025402202	0.00762066	6	6B	IN-SST	51	20	20
CAGTAACCAAACAACA-1_3_C4	40.13522714	13.20135763	14	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1036	1590	0.003773585	0.003773585	6	14	Microglia	51	20	20
CAGTAACCAAGGTGTG-1_3_C4	12.22450936	-6.244248335	12	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1552	2979	0.079221215	0.002014099	6	12	EN-MIX	51	20	20
CAGTAACGTCAAACTC-1_3_C4	10.93181637	-20.65302326	4	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	3672	9638	0.018364806	0.003112679	6	L2-3	EN-L2-3-MS	51	20	20
CAGTAACGTTACTGAC-1_3_C4	-35.01786564	2.393154005	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1938	3814	0.003670687	0.00550603	6	9	OPC	51	20	20
CAGTCCTAGGGTGTGT-1_3_C4	21.83781498	11.80209435	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1526	2580	0.001937984	0.009302326	6	oligos	OL-Cntl	51	20	20
CAGTCCTCATGTTCCC-1_3_C4	13.37960716	18.83158287	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	974	1591	0.001885607	0.006913891	6	oligos	OL-Cntl	51	20	20
CAGTCCTGTCGGCATC-1_3_C4	21.07083123	16.27071109	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1125	1905	0.004199475	0.005249344	6	oligos	OL-Cntl	51	20	20
CAGTCCTTCAACCATG-1_3_C4	-29.1493619	21.05211844	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1058	1723	0.011607661	0.002321532	6	8	Astrocytes	51	20	20
CATATGGAGGACGAAA-1_3_C4	-24.89270547	22.54644438	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1381	2248	0.007562278	0.008007117	6	8	Astrocytes	51	20	20
CATATGGAGTGTTTGC-1_3_C4	-22.06152711	-16.7501609	6B	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2725	5727	0.013794308	0.006286014	6	6B	IN-SST	51	20	20
CATATGGCACAGGAGT-1_3_C4	-15.14817227	-24.00262294	6A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1761	3516	0.013651877	0.003981797	6	6A	IN-PV	51	20	20
CATATGGCACGGTTTA-1_3_C4	3.918505348	24.49197065	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	773	1209	0.00082713	0.009098428	6	oligos	OL-Cntl	51	20	20
CATATGGGTCTAAAGA-1_3_C4	-29.40154436	20.78660878	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	996	1555	0.011575563	0.005144695	6	8	Astrocytes	51	20	20
CATATGGGTCTTGTCC-1_3_C4	13.3810235	21.72412739	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	952	1564	0.007033248	0.004475703	6	oligos	OL-Cntl	51	20	20
CATATTCAGAGGTACC-1_3_C4	20.58596521	7.561046428	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2260	4643	0.003015292	0.008830498	6	oligos	OL-Cntl	51	20	20
CATATTCAGTGCGTGA-1_3_C4	5.59301956	23.62212568	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	855	1365	0	0.01025641	6	oligos	OL-Cntl	51	20	20
CATATTCCATCCTTGC-1_3_C4	16.53163103	17.01383624	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1041	1801	0.001665741	0.00388673	6	oligos	OL-Cntl	51	20	20
CATATTCCATTTCACT-1_3_C4	-37.50807854	-1.688597261	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1395	2644	0.002647504	0.002269289	6	9	OPC	51	20	20
CATCAAGAGAAGGTGA-1_3_C4	-24.37599734	22.37552948	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1401	2337	0.005990586	0.004706889	6	8	Astrocytes	51	20	20
CATCAAGTCGGTGTCG-1_3_C4	22.95639579	-10.96084071	3	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2769	5848	0.029069767	0.002564979	6	3	EN-L5-6	51	20	20
CATCAAGTCGTAGGAG-1_3_C4	8.377582145	28.68727947	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	857	1444	0.000692521	0.007617729	6	oligos	OL-Cntl	51	20	20
CATCAGAAGCTCAACT-1_3_C4	16.18093271	-28.49735031	3	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	5132	16674	0.004797889	0.005937388	6	3	EN-L5-6	51	20	20
CATCAGACAGCTATTG-1_3_C4	-8.900534828	-18.46883275	6B	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	700	1167	0.084832905	0.003427592	6	6B	IN-SST	51	20	20
CATCAGACATCTGGTA-1_3_C4	40.1083725	11.67421619	14	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	809	1179	0.003392706	0.006785411	6	14	Microglia	51	20	20
CATCAGAGTTCCACTC-1_3_C4	10.31916399	26.35897045	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	828	1378	0.002177068	0.009433962	6	oligos	OL-Cntl	51	20	20
CATCAGATCGTGACAT-1_3_C4	18.2681413	7.654641006	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1954	3839	0.004428237	0.006772597	6	oligos	OL-Cntl	51	20	20
CATCCACAGTGCAAGC-1_3_C4	-24.74090489	24.68119385	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1486	2567	0.005064277	0.006622517	6	8	Astrocytes	51	20	20
CATCCACGTGCGAAAC-1_3_C4	20.07073642	21.06406713	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	962	1502	0.003328895	0.002663116	6	oligos	OL-Cntl	51	20	20
CATCCACGTGTGGTTT-1_3_C4	-24.96736836	26.0902903	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1640	3219	0.004349177	0.002795899	6	8	Astrocytes	51	20	20
CATCCACTCAACCAAC-1_3_C4	12.63706599	30.5504847	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	640	1013	0.003948667	0.001974334	6	oligos	OL-Cntl	51	20	20
CATCGAAAGCGGATCA-1_3_C4	3.349035948	28.61179374	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	687	1001	0.007992008	0.002997003	6	oligos	OL-Cntl	51	20	20
CATCGAAAGTCTCCTC-1_3_C4	-17.58138451	13.90334039	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1345	2295	0.00087146	0.003050109	6	8	Astrocytes	51	20	20
CATCGAACACACAGAG-1_3_C4	-0.977426628	23.91708485	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	708	1020	0.005882353	0.008823529	6	oligos	OL-Cntl	51	20	20
CATCGAAGTACCAGTT-1_3_C4	20.6495133	10.70058023	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1582	2817	0.014554491	0.004969826	6	oligos	OL-Cntl	51	20	20
CATCGAAGTGATAAGT-1_3_C4	-20.5649646	8.23426409	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	807	1198	0.004173623	0.002504174	6	8	Astrocytes	51	20	20
CATCGAATCTTTCCTC-1_3_C4	39.41448111	13.96219193	14	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1043	1612	0.001861042	0.005583127	6	14	Microglia	51	20	20
CATCGGGCAATGGAAT-1_3_C4	0.891019354	24.7383301	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	652	1008	0.004960317	0.008928571	6	oligos	OL-Cntl	51	20	20
CATCGGGGTGGTCTCG-1_3_C4	-26.4789689	10.54102531	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1018	1635	0.009174312	0.004892966	6	8	Astrocytes	51	20	20
CATCGGGGTTCACCTC-1_3_C4	2.985415809	-21.9661032	4	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	5502	18103	0.003756283	0.006021101	6	L2-3	EN-L2-3-MS	51	20	20
CATCGGGGTTTCCACC-1_3_C4	7.58725203	22.6259547	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1049	1620	0.009259259	0.009259259	6	oligos	OL-Cntl	51	20	20
CATCGGGTCTAACTTC-1_3_C4	-22.07288264	8.986875497	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1112	1740	0.002873563	0.008045977	6	8	Astrocytes	51	20	20
CATGACAAGACTCGGA-1_3_C4	11.63290873	-21.04993343	4	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	4687	13153	0.010035733	0.004561697	6	L2-3	EN-L2-3-MS	51	20	20
CATGACAAGCAACGGT-1_3_C4	12.98879162	10.93511069	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1321	2379	0.004623792	0.008827238	6	oligos	OL-Cntl	51	20	20
CATGACAAGGATATAC-1_3_C4	18.63438805	7.920397371	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1889	3699	0.003514463	0.005136523	6	oligos	OL-Cntl	51	20	20
CATGACAAGTAAGTAC-1_3_C4	-4.385027226	29.89449591	11	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1100	1694	0.00472255	0.002361275	6	11	Glia-MIX	51	20	20
CATGACACAATCACAC-1_3_C4	-27.21407846	13.53230075	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	960	1542	0.002594034	0.004539559	6	8	Astrocytes	51	20	20
CATGACAGTCCGTCAG-1_3_C4	19.53084679	20.623197	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1040	1689	0.004144464	0.001776199	6	oligos	OL-Cntl	51	20	20
CATGACAGTTCAGACT-1_3_C4	39.0918627	15.65229537	14	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1433	2285	0.002625821	0.008752735	6	14	Microglia	51	20	20
CATGCCTAGTACGTAA-1_3_C4	25.31642967	-27.51582341	3	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	4312	12005	0.003998334	0.003248646	6	3	EN-L5-6	51	20	20
CATGCCTAGTTACGGG-1_3_C4	9.949815997	26.44026666	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	854	1342	0.001490313	0.010432191	6	oligos	OL-Cntl	51	20	20
CATGCCTCACGGACAA-1_3_C4	11.57290542	16.58370564	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1179	1909	0.005762179	0.006809848	6	oligos	OL-Cntl	51	20	20
CATGCCTGTCTAGTCA-1_3_C4	11.78390071	30.06959313	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	683	1005	0.002985075	0.002985075	6	oligos	OL-Cntl	51	20	20
CATGCCTTCAACCAAC-1_3_C4	21.64203743	17.42956786	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1210	2003	0.002496256	0.006490265	6	oligos	OL-Cntl	51	20	20
CATGCCTTCCTCAATT-1_3_C4	-21.24121859	9.784143743	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	929	1513	0.001321877	0.005287508	6	8	Astrocytes	51	20	20
CATGCCTTCGGTGTTA-1_3_C4	39.62193114	9.902219594	14	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	760	1078	0.000927644	0.004638219	6	14	Microglia	51	20	20
CATGGCGAGCCCAACC-1_3_C4	18.80262221	-6.707678749	3	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1805	3709	0.005931518	0.002696145	6	3	EN-L5-6	51	20	20
CATGGCGGTCTAAACC-1_3_C4	-17.5027899	-1.920983783	13A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	3708	8080	0.023267327	0.014851485	6	13A	IN-VIP	51	20	20
CATGGCGTCACATGCA-1_3_C4	-36.12600152	-2.23582978	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1503	2579	0.004265219	0.005816208	6	9	OPC	51	20	20
CATGGCGTCAGTCAGT-1_3_C4	12.9981983	31.11045576	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	945	1464	0.005464481	0.00136612	6	oligos	OL-Cntl	51	20	20
CATGGCGTCCCATTAT-1_3_C4	-32.94142622	-12.19140657	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	851	1306	0	0.011485452	6	9	OPC	51	20	20
CATGGCGTCCGAATGT-1_3_C4	-32.10608127	-12.54291921	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	809	1249	0.001601281	0.004003203	6	9	OPC	51	20	20
CATTATCAGGGCACTA-1_3_C4	3.68741437	26.23504267	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	722	1099	0.002729754	0.005459509	6	oligos	OL-Cntl	51	20	20
CATTATCCATTGCGGC-1_3_C4	36.43746501	11.6903558	14	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	844	1188	0.002525253	0.02020202	6	14	Microglia	51	20	20
CATTATCTCGGCCGAT-1_3_C4	18.02893837	8.934795669	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1624	2970	0.005050505	0.005723906	6	oligos	OL-Cntl	51	20	20
CATTCGCAGGGCTTGA-1_3_C4	-22.76109161	-4.499189108	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2940	6143	0.041022302	0.003906886	6	9	OPC	51	20	20
CATTCGCAGTCGTACT-1_3_C4	3.505021239	-15.34611974	4	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2554	5260	0.015589354	0.006463878	6	L2-3	EN-L2-3-MS	51	20	20
CATTCGCGTGAGGCTA-1_3_C4	13.61474503	-32.18535405	3	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	3741	10397	0.002596903	0.00240454	6	3	EN-L5-6	51	20	20
CATTCGCGTTACTGAC-1_3_C4	23.11432565	11.84122883	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1631	3043	0.001643115	0.005915215	6	oligos	OL-Cntl	51	20	20
CATTCGCTCCTCCTAG-1_3_C4	3.73273864	7.269510704	7	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1175	1902	0.003680336	0.005257624	6	7	Phagocytes	51	20	20
CCAATCCCAACTTGAC-1_3_C4	-36.99367898	-0.005721341	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1577	2881	0.003471017	0.006247831	6	9	OPC	51	20	20
CCAATCCCAGTATAAG-1_3_C4	-16.27716665	14.5840199	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1792	3383	0.001182383	0.006798699	6	8	Astrocytes	51	20	20
CCAATCCGTAGCGTAG-1_3_C4	-14.60725629	-21.23639859	6A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1870	3638	0.012094557	0.001649258	6	6A	IN-PV	51	20	20
CCAATCCGTCTGGTCG-1_3_C4	16.01813834	14.26765476	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1279	2095	0.001909308	0.007159905	6	oligos	OL-Cntl	51	20	20
CCAATCCGTTGGTTTG-1_3_C4	22.39657207	13.50745336	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1323	2189	0.003197807	0.004111466	6	oligos	OL-Cntl	51	20	20
CCAATCCTCGCGCCAA-1_3_C4	14.37420701	6.881473026	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1832	3563	0.013471793	0.012349144	6	oligos	OL-Cntl	51	20	20
CCACCTAAGGGCACTA-1_3_C4	15.32152092	23.24316885	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	880	1390	0.001438849	0.007913669	6	oligos	OL-Cntl	51	20	20
CCACCTAAGTGGGTTG-1_3_C4	-28.38983713	10.61728906	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	755	1065	0.004694836	0.002816901	6	8	Astrocytes	51	20	20
CCACCTACAGACAAAT-1_3_C4	-13.32448372	-19.16095201	6B	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1182	2085	0.033573141	0.004316547	6	6B	IN-SST	51	20	20
CCACCTACAGCTGTTA-1_3_C4	1.519571541	26.51996774	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	711	1083	0.010156971	0.006463527	6	oligos	OL-Cntl	51	20	20
CCACCTACATGAAGTA-1_3_C4	5.054327487	22.57750272	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	809	1312	0	0.010670732	6	oligos	OL-Cntl	51	20	20
CCACCTAGTCGAGATG-1_3_C4	22.57925623	10.8658696	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1856	3354	0.005664878	0.007155635	6	oligos	OL-Cntl	51	20	20
CCACCTAGTCTTCGTC-1_3_C4	17.18977669	-28.85538487	3	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	4647	14118	0.001629126	0.004249894	6	3	EN-L5-6	51	20	20
CCACGGAGTACGACCC-1_3_C4	21.02983567	8.005778594	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2116	4106	0.004383829	0.006332197	6	oligos	OL-Cntl	51	20	20
CCACGGATCGTCGTTC-1_3_C4	20.75757784	11.89259817	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1411	2526	0.001979414	0.004354711	6	oligos	OL-Cntl	51	20	20
CCACTACAGAAGGTTT-1_3_C4	13.7151329	20.23528425	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1031	1618	0.005562423	0.003708282	6	oligos	OL-Cntl	51	20	20
CCACTACAGGCCCTCA-1_3_C4	19.7156433	21.46880555	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	991	1613	0	0.001239926	6	oligos	OL-Cntl	51	20	20
CCACTACAGTGATCGG-1_3_C4	-26.20784242	11.25538679	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	918	1486	0.00269179	0.00538358	6	8	Astrocytes	51	20	20
CCACTACCACCAGGTC-1_3_C4	-6.423102806	-2.897341482	13A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1759	3347	0.013146101	0.002688975	6	13A	IN-VIP	51	20	20
CCACTACGTCGGCTCA-1_3_C4	20.91667083	14.34207434	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1376	2439	0.000410004	0.002460025	6	oligos	OL-Cntl	51	20	20
CCACTACTCATCATTC-1_3_C4	-26.44484013	-8.645941978	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1154	1849	0.009734992	0.002704164	6	9	OPC	51	20	20
CCAGCGAAGATACACA-1_3_C4	6.394238478	19.09708444	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1038	1577	0.0082435	0.009511731	6	oligos	OL-Cntl	51	20	20
CCAGCGAAGTACGATA-1_3_C4	5.286984576	23.5954889	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	895	1328	0.004518072	0.012048193	6	oligos	OL-Cntl	51	20	20
CCAGCGACACACAGAG-1_3_C4	-36.61844263	2.065108051	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1845	3517	0.001137333	0.003696332	6	9	OPC	51	20	20
CCAGCGACACCATCCT-1_3_C4	-4.026957253	22.80704314	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	709	1068	0.00093633	0.009363296	6	oligos	OL-Cntl	51	20	20
CCAGCGACATATACGC-1_3_C4	-24.09550041	29.73813319	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1871	3864	0.004658385	0.002329193	6	8	Astrocytes	51	20	20
CCAGCGAGTACAGACG-1_3_C4	16.09707081	-0.604002495	12	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	724	1059	0.010387158	0.001888574	6	12	EN-MIX	51	20	20
CCAGCGATCTATGTGG-1_3_C4	-24.05169058	18.84095633	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1383	2506	0.002394254	0.004788508	6	8	Astrocytes	51	20	20
CCAGCGATCTTGAGGT-1_3_C4	6.898211977	25.52292963	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	915	1402	0	0.009272468	6	oligos	OL-Cntl	51	20	20
CCATGTCCACCGAAAG-1_3_C4	15.42541719	21.13097185	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1038	1703	0.004110393	0.003523194	6	oligos	OL-Cntl	51	20	20
CCATGTCCAGGATCGA-1_3_C4	-0.480838851	25.25048718	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	703	1043	0.005752637	0.013422819	6	oligos	OL-Cntl	51	20	20
CCATGTCCATTCCTGC-1_3_C4	26.62209606	3.74250455	15DA	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	802	1039	0.015399423	0.008662175	6	15DA	T cells	51	20	20
CCATGTCGTAGCCTCG-1_3_C4	25.43512269	3.913103912	15BA	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1157	1806	0.00110742	0.006644518	6	15BA	Stromal cells	51	20	20
CCATGTCGTCTCTCTG-1_3_C4	10.80737708	16.25173496	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1116	1774	0.00789177	0.006200676	6	oligos	OL-Cntl	51	20	20
CCATGTCGTTCAACCA-1_3_C4	20.33769742	7.167807686	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2206	4505	0.001775805	0.002885683	6	oligos	OL-Cntl	51	20	20
CCATGTCTCGGAGGTA-1_3_C4	16.13579232	21.00339628	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	987	1496	0.007352941	0.002005348	6	oligos	OL-Cntl	51	20	20
CCATTCGAGATGTGGC-1_3_C4	7.128401831	25.30276187	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	966	1507	0.00796284	0.01061712	6	oligos	OL-Cntl	51	20	20
CCATTCGAGGTCGGAT-1_3_C4	24.94145695	-28.22381948	3	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	3668	9233	0.005198744	0.002815986	6	3	EN-L5-6	51	20	20
CCATTCGAGTGGAGTC-1_3_C4	-8.753565141	-18.20572138	6B	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	733	1163	0.045571797	0.00171969	6	6B	IN-SST	51	20	20
CCATTCGCAAACCTAC-1_3_C4	5.834019535	25.55089353	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	895	1370	0.005109489	0.010948905	6	oligos	OL-Cntl	51	20	20
CCATTCGCACGGTAAG-1_3_C4	34.2371285	14.80128358	14	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	906	1215	0.005761317	0.052674897	6	14	Microglia	51	20	20
CCATTCGCAGTCACTA-1_3_C4	-23.63361679	19.56512215	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1412	2481	0.005642886	0.003224506	6	8	Astrocytes	51	20	20
CCATTCGGTATAGGGC-1_3_C4	-28.07146284	13.0757752	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	816	1191	0.001679261	0.002518892	6	8	Astrocytes	51	20	20
CCCAATCAGAGGGCTT-1_3_C4	-31.82358972	-10.34133794	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1026	1466	0.002046385	0.008867667	6	9	OPC	51	20	20
CCCAATCGTAATCGTC-1_3_C4	12.80645546	16.46413042	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1095	1764	0.006235828	0.009070295	6	oligos	OL-Cntl	51	20	20
CCCAATCGTTGTTTGG-1_3_C4	10.57670027	26.2410156	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	873	1417	0.006351447	0.007057163	6	oligos	OL-Cntl	51	20	20
CCCAATCTCACGAAGG-1_3_C4	-0.938599742	4.627295678	11	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	974	1274	0.03610675	0.007849294	6	11	Glia-MIX	51	20	20
CCCAATCTCCAACCAA-1_3_C4	15.54183757	18.559312	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1083	1778	0.007874016	0.003374578	6	oligos	OL-Cntl	51	20	20
CCCAATCTCTTCTGGC-1_3_C4	17.40981095	17.85200845	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1074	1963	0.004075395	0.002037697	6	oligos	OL-Cntl	51	20	20
CCCAGTTAGTCCATAC-1_3_C4	-16.14954751	-2.317153769	13A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2920	6273	0.018173123	0.009405388	6	13A	IN-VIP	51	20	20
CCCAGTTCACGCCAGT-1_3_C4	-22.97216202	28.29008947	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1964	4013	0.00049838	0.006728134	6	8	Astrocytes	51	20	20
CCCAGTTCACGGTGTC-1_3_C4	14.05358079	17.41979296	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1071	1733	0.00288517	0.008655511	6	oligos	OL-Cntl	51	20	20
CCCAGTTCAGCCAATT-1_3_C4	21.26089299	14.30121549	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1234	2113	0	0.004259347	6	oligos	OL-Cntl	51	20	20
CCCAGTTGTGGCTCCA-1_3_C4	17.70048283	13.24006102	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1342	2346	0.008098892	0.006393862	6	oligos	OL-Cntl	51	20	20
CCCAGTTGTTATCACG-1_3_C4	3.437302663	4.69839278	7	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1415	2096	0.015744275	0.005725191	6	7	Phagocytes	51	20	20
CCCAGTTGTTGTTTGG-1_3_C4	-35.41175711	-12.11695343	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	801	1251	0.003197442	0.002398082	6	9	OPC	51	20	20
CCCAGTTTCACAATGC-1_3_C4	-18.78526893	-20.63576976	6B	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2604	5578	0.010577268	0.00250986	6	6B	IN-SST	51	20	20
CCCAGTTTCACCGTAA-1_3_C4	15.39262242	22.20592669	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	884	1449	0.003450656	0.008281573	6	oligos	OL-Cntl	51	20	20
CCCAGTTTCGATAGAA-1_3_C4	14.67195431	14.39607757	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1192	1795	0.010584958	0.006685237	6	oligos	OL-Cntl	51	20	20
CCCATACAGCCCAGCT-1_3_C4	7.687202612	-21.85530837	4	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	6955	25770	0.004152115	0.010089251	6	L2-3	EN-L2-3-MS	51	20	20
CCCATACAGTCCAGGA-1_3_C4	5.749651404	6.471708606	7	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1910	3299	0.006062443	0.006365565	6	7	Phagocytes	51	20	20
CCCATACCAAACAACA-1_3_C4	24.48231629	-27.42114905	3	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	3857	10406	0.012108399	0.002882952	6	3	EN-L5-6	51	20	20
CCCATACCAGCTGTGC-1_3_C4	-5.313566508	-4.190427005	13A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1385	2318	0.021138913	0.003451251	6	13A	IN-VIP	51	20	20
CCCATACTCGGTGTCG-1_3_C4	-32.06039967	-12.37264391	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	849	1165	0.000858369	0.006008584	6	9	OPC	51	20	20
CCCATACTCTGGCGAC-1_3_C4	17.59700742	5.836795205	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2975	6339	0.006783404	0.008045433	6	oligos	OL-Cntl	51	20	20
CCCATACTCTTCTGGC-1_3_C4	30.91694777	-11.04528535	2	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	3904	8490	0.020848057	0.006831567	6	2	EN-L4	51	20	20
CCCTCCTCATTACCTT-1_3_C4	16.21855394	-28.63801017	3	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	4876	16236	0.010655334	0.0036339	6	3	EN-L5-6	51	20	20
CCCTCCTGTTGAACTC-1_3_C4	13.95005418	21.83942204	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	858	1325	0.003018868	0.005283019	6	oligos	OL-Cntl	51	20	20
CCCTCCTTCAGATAAG-1_3_C4	17.12125311	13.24703047	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1345	2499	0.006402561	0.005202081	6	oligos	OL-Cntl	51	20	20
CCCTCCTTCAGTTTGG-1_3_C4	-36.80198798	2.654418508	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1994	3881	0.002834321	0.003091987	6	9	OPC	51	20	20
CCGGGATCACATCCGG-1_3_C4	32.39534909	-2.75260217	2	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2654	5430	0.01160221	0.003683241	6	2	EN-L4	51	20	20
CCGGGATGTCATCCCT-1_3_C4	13.7712113	19.32159363	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1067	1817	0.003302146	0.011007155	6	oligos	OL-Cntl	51	20	20
CCGGGATGTTGATTGC-1_3_C4	14.0130966	12.38260278	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1313	2258	0.005757307	0.007085917	6	oligos	OL-Cntl	51	20	20
CCGGTAGTCTGAGGGA-1_3_C4	-8.302076768	-17.64271299	6B	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	638	1022	0.069471624	0.003913894	6	6B	IN-SST	51	20	20
CCGTACTAGAAACCAT-1_3_C4	-35.14943266	-1.027133878	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1556	2927	0.001708234	0.006832935	6	9	OPC	51	20	20
CCGTACTCACGACGAA-1_3_C4	4.06571884	-17.04440475	4	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2889	5873	0.004256768	0.010556785	6	L2-3	EN-L2-3-MS	51	20	20
CCGTACTTCCTGTAGA-1_3_C4	12.32991095	17.03137306	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1141	1973	0.005068424	0.01064369	6	oligos	OL-Cntl	51	20	20
CCGTACTTCGCTAGCG-1_3_C4	-10.04438713	-3.198170615	13A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1984	3608	0.012472284	0.00886918	6	13A	IN-VIP	51	20	20
CCGTGGACACCATCCT-1_3_C4	-24.45944339	22.37612368	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1441	2507	0.000797766	0.005584364	6	8	Astrocytes	51	20	20
CCGTTCAAGATGTTAG-1_3_C4	-20.70879786	-23.08838889	6A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	3095	7099	0.020707142	0.004930272	6	6A	IN-PV	51	20	20
CCGTTCAAGCCGGTAA-1_3_C4	31.33454777	-6.874689058	2	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	3311	7942	0.031352304	0.002392344	6	2	EN-L4	51	20	20
CCGTTCACAGATTGCT-1_3_C4	-36.94588201	-4.151842155	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1340	2401	0.002498959	0.001665973	6	9	OPC	51	20	20
CCGTTCATCTCGTTTA-1_3_C4	23.09189212	-10.53197839	3	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2776	6098	0.002459823	0.00360774	6	3	EN-L5-6	51	20	20
CCTAAAGGTTGTCTTT-1_3_C4	-37.06217966	-8.985577772	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1005	1667	0.00479904	0.00359928	6	9	OPC	51	20	20
CCTACACAGACTAAGT-1_3_C4	-16.6890607	-17.23003071	6B	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2015	4157	0.017801299	0.00505172	6	6B	IN-SST	51	20	20
CCTACACAGAGGTTGC-1_3_C4	10.5492468	20.96348001	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	952	1653	0.004234725	0.007259528	6	oligos	OL-Cntl	51	20	20
CCTACACAGCCCAATT-1_3_C4	5.806993643	-2.705172429	12	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	776	1197	0.019214703	0.003341688	6	12	EN-MIX	51	20	20
CCTACACAGGAATCGC-1_3_C4	5.629923638	25.22556357	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	869	1272	0.000786164	0.007075472	6	oligos	OL-Cntl	51	20	20
CCTACACCAGTGGAGT-1_3_C4	12.73778153	0.562226679	12	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	733	1185	0.001687764	0.006751055	6	12	EN-MIX	51	20	20
CCTACACGTCGAACAG-1_3_C4	-19.52245316	25.01087985	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1897	3596	0.004727475	0.010567297	6	8	Astrocytes	51	20	20
CCTACCAGTCTTCGTC-1_3_C4	18.53580677	13.85636012	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1277	2286	0.000437445	0.003937008	6	oligos	OL-Cntl	51	20	20
CCTACCATCCAAATGC-1_3_C4	-21.67693823	19.87354509	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2102	4241	0.001650554	0.001650554	6	8	Astrocytes	51	20	20
CCTAGCTAGAATGTGT-1_3_C4	-20.20147489	-26.24497435	6A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2746	5855	0.023057216	0.002220325	6	6A	IN-PV	51	20	20
CCTAGCTAGTGTGGCA-1_3_C4	-21.00748954	23.52057705	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1461	2478	0.002824859	0.006053269	6	8	Astrocytes	51	20	20
CCTAGCTCATGTCCTC-1_3_C4	-35.42830232	-11.48759677	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	893	1451	0.007580979	0.004824259	6	9	OPC	51	20	20
CCTAGCTGTAGGAGTC-1_3_C4	-27.69828678	12.16047373	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	908	1335	0.02247191	0.006741573	6	8	Astrocytes	51	20	20
CCTAGCTGTAGGCATG-1_3_C4	1.207448115	18.7183074	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	813	1184	0.007601351	0.019425676	6	oligos	OL-Cntl	51	20	20
CCTAGCTGTGACTACT-1_3_C4	2.601987854	27.41439156	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	702	1021	0.000979432	0.001958864	6	oligos	OL-Cntl	51	20	20
CCTAGCTGTGCTCTTC-1_3_C4	15.29601646	-2.439257497	12	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	952	1498	0	0.002670227	6	12	EN-MIX	51	20	20
CCTAGCTTCGGTCCGA-1_3_C4	-16.71784018	12.80494335	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1395	2407	0.005816369	0.006231824	6	8	Astrocytes	51	20	20
CCTAGCTTCTGGTATG-1_3_C4	7.589601216	19.66110907	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1040	1645	0.007902736	0.007902736	6	oligos	OL-Cntl	51	20	20
CCTATTAAGATGTGTA-1_3_C4	15.57930145	22.05836367	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	951	1488	0.001344086	0.005376344	6	oligos	OL-Cntl	51	20	20
CCTATTAAGGCGTACA-1_3_C4	9.406737313	9.547089255	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1280	2177	0.006890216	0.019292605	6	oligos	OL-Cntl	51	20	20
CCTATTAAGTTCGCAT-1_3_C4	-8.918312258	13.74428667	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1510	2464	0.006493506	0.003246753	6	oligos	OL-Cntl	51	20	20
CCTATTACAAGGACTG-1_3_C4	-31.17281798	10.98950301	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	732	1162	0.006024096	0.004302926	6	8	Astrocytes	51	20	20
CCTATTAGTACAGTGG-1_3_C4	-12.67159882	15.64880475	11	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1279	1977	0.005563986	0.004552352	6	11	Glia-MIX	51	20	20
CCTATTAGTGCAGTAG-1_3_C4	-38.26905845	-2.031345318	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1295	2306	0.005637467	0.004336513	6	9	OPC	51	20	20
CCTATTATCACCCGAG-1_3_C4	10.13335571	29.73181169	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	682	1052	0	0.006653992	6	oligos	OL-Cntl	51	20	20
CCTATTATCTCCAGGG-1_3_C4	-7.697100835	-2.562455597	13A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1733	3189	0.020696143	0.000940734	6	13A	IN-VIP	51	20	20
CCTCAGTAGTTGCAGG-1_3_C4	16.86722207	18.66577671	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1066	1805	0.000554017	0.004432133	6	oligos	OL-Cntl	51	20	20
CCTCAGTCAGATTGCT-1_3_C4	9.869958346	14.27310323	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1133	1858	0.008073197	0.011840689	6	oligos	OL-Cntl	51	20	20
CCTCAGTCATACGCCG-1_3_C4	9.710612589	25.48594742	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	854	1464	0.005464481	0.005464481	6	oligos	OL-Cntl	51	20	20
CCTCAGTTCGAACTGT-1_3_C4	37.51594867	-10.12871189	2	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	5304	15262	0.016315031	0.008255799	6	2	EN-L4	51	20	20
CCTCAGTTCTGGCGAC-1_3_C4	12.20638914	20.13921277	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	928	1508	0.00729443	0.00862069	6	oligos	OL-Cntl	51	20	20
CCTCAGTTCTTATCTG-1_3_C4	9.903571492	26.67268085	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	836	1321	0.006056018	0.003785011	6	oligos	OL-Cntl	51	20	20
CCTCTGACATTGGTAC-1_3_C4	-36.18384622	2.501378481	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1851	3451	0.005795422	0.004056795	6	9	OPC	51	20	20
CCTCTGAGTGTGGCTC-1_3_C4	-30.3624528	11.35503003	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	811	1191	0.020990764	0.004198153	6	8	Astrocytes	51	20	20
CCTCTGAGTTAAGTAG-1_3_C4	19.66137878	13.62356983	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1383	2277	0.001317523	0.010540184	6	oligos	OL-Cntl	51	20	20
CCTCTGATCGCCAAAT-1_3_C4	13.85603298	-30.56299969	3	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	3485	9551	0.005339755	0.00198932	6	3	EN-L5-6	51	20	20
CCTCTGATCGTAGGTT-1_3_C4	-36.72582895	-10.33961928	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	982	1531	0.006531679	0.003919007	6	9	OPC	51	20	20
CCTTACGAGATCCGAG-1_3_C4	-27.8949856	17.07798173	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1001	1566	0.005108557	0.007024266	6	8	Astrocytes	51	20	20
CCTTACGAGTTGTCGT-1_3_C4	17.46402283	15.12154648	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1167	2034	0.008357915	0.006882989	6	oligos	OL-Cntl	51	20	20
CCTTACGCAGCTGCAC-1_3_C4	7.986714759	-18.03244044	4	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	4801	13401	0.005895082	0.017386762	6	L2-3	EN-L2-3-MS	51	20	20
CCTTACGGTACGCACC-1_3_C4	-23.93413742	18.68999967	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1365	2398	0.005838198	0.002919099	6	8	Astrocytes	51	20	20
CCTTACGGTCAGTGGA-1_3_C4	15.32733641	22.13706293	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	909	1407	0.001421464	0.004975124	6	oligos	OL-Cntl	51	20	20
CCTTACGGTTGTTTGG-1_3_C4	-35.31640803	-10.80901915	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	922	1600	0	0.005	6	9	OPC	51	20	20
CCTTACGGTTTGACAC-1_3_C4	-6.285797703	-0.204204285	13A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1816	3542	0.012987013	0.00310559	6	13A	IN-VIP	51	20	20
CCTTACGTCAGATAAG-1_3_C4	17.24051343	-4.858958638	3	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1333	2311	0.049329295	0.003028992	6	3	EN-L5-6	51	20	20
CCTTACGTCAGTACGT-1_3_C4	-13.9949502	-22.01486785	6A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1466	2789	0.023664396	0.001434206	6	6A	IN-PV	51	20	20
CCTTACGTCTCGATGA-1_3_C4	-0.240334274	25.32592497	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	751	1120	0.003571429	0.009821429	6	oligos	OL-Cntl	51	20	20
CCTTCCCCAAATCCGT-1_3_C4	4.35724555	5.17453908	7	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1575	2527	0.002374357	0.001582905	6	7	Phagocytes	51	20	20
CCTTCCCGTAAGGGCT-1_3_C4	-21.11010531	9.855197105	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	968	1529	0.001308044	0.003270111	6	8	Astrocytes	51	20	20
CCTTCCCTCGCGCCAA-1_3_C4	-5.035992955	-10.48527566	6B	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	777	1229	0.026037429	0.00081367	6	6B	IN-SST	51	20	20
CCTTCCCTCTCGAGTA-1_3_C4	17.07309636	-0.375694086	12	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	885	1388	0.001440922	0.000720461	6	12	EN-MIX	51	20	20
CCTTCGAAGAATTGTG-1_3_C4	11.05917233	23.10454042	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	757	1201	0.006661116	0.001665279	6	oligos	OL-Cntl	51	20	20
CCTTCGACATACTACG-1_3_C4	1.966383908	-17.9152994	4	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	3079	7513	0.007986157	0.003726873	6	L2-3	EN-L2-3-MS	51	20	20
CCTTCGAGTCGAGATG-1_3_C4	-31.64447758	12.13848553	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	761	1212	0.00330033	0.004125413	6	8	Astrocytes	51	20	20
CCTTCGAGTGTGGTTT-1_3_C4	2.188019491	-10.15930826	12	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1496	2781	0.035598706	0.001797914	6	12	EN-MIX	51	20	20
CCTTCGATCTACTTAC-1_3_C4	16.12753148	15.8895818	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1120	1918	0.008342023	0.00729927	6	oligos	OL-Cntl	51	20	20
CCTTCGATCTGAGTGT-1_3_C4	-14.74688267	-6.523657157	13A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2903	6255	0.016946443	0.002877698	6	13A	IN-VIP	51	20	20
CCTTTCTGTAAACGCG-1_3_C4	2.866661117	25.60325466	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	692	1014	0.009861933	0.007889546	6	oligos	OL-Cntl	51	20	20
CCTTTCTGTCGCTTCT-1_3_C4	-23.40338953	0.537535667	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2214	4822	0.004769805	0.004147657	6	9	OPC	51	20	20
CCTTTCTTCGTAGGAG-1_3_C4	2.279159928	5.509269477	7	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	890	1201	0.003330558	0.024146545	6	7	Phagocytes	51	20	20
CGAACATAGATAGGAG-1_3_C4	16.71623238	16.79146761	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1122	1701	0.002351558	0.0111699	6	oligos	OL-Cntl	51	20	20
CGAACATGTACATCCA-1_3_C4	-36.87119597	-4.630537797	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1261	2272	0.011003521	0.003080986	6	9	OPC	51	20	20
CGAACATGTTAAGATG-1_3_C4	3.558396596	-15.76356111	4	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2684	5431	0.018412815	0.00902228	6	L2-3	EN-L2-3-MS	51	20	20
CGAACATGTTATGCGT-1_3_C4	-35.14438078	4.73993269	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2578	5479	0.009308268	0.002737726	6	9	OPC	51	20	20
CGAACATGTTCCCGAG-1_3_C4	17.82378424	8.973290143	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1708	3397	0.002060642	0.004710038	6	oligos	OL-Cntl	51	20	20
CGAACATTCCCTCAGT-1_3_C4	13.58319013	19.34935837	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	958	1542	0.005188067	0.003242542	6	oligos	OL-Cntl	51	20	20
CGAATGTAGGTAAACT-1_3_C4	35.91987932	7.901049459	14	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	792	1146	0.0008726	0.003490401	6	14	Microglia	51	20	20
CGAATGTAGGTAGCTG-1_3_C4	11.69794469	21.86578995	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	936	1377	0.004357298	0.007988381	6	oligos	OL-Cntl	51	20	20
CGAATGTAGTCTCAAC-1_3_C4	10.9435641	24.06393988	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	823	1348	0.00074184	0.008160237	6	oligos	OL-Cntl	51	20	20
CGAATGTAGTTATCGC-1_3_C4	2.041435344	23.77867106	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	786	1204	0.014119601	0.010797342	6	oligos	OL-Cntl	51	20	20
CGAATGTCAAGTAATG-1_3_C4	16.07033116	15.98887213	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1266	2164	0.001848429	0.005083179	6	oligos	OL-Cntl	51	20	20
CGAATGTCATGTCGAT-1_3_C4	-24.34149768	17.96628956	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1299	2167	0.002307337	0.006460545	6	8	Astrocytes	51	20	20
CGAATGTGTGTGCCTG-1_3_C4	0.766911761	26.09338384	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	740	1195	0.005857741	0.00251046	6	oligos	OL-Cntl	51	20	20
CGAATGTTCGTAGGAG-1_3_C4	2.976330371	23.09665654	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	840	1263	0.005542359	0.015835313	6	oligos	OL-Cntl	51	20	20
CGAATGTTCTAGCACA-1_3_C4	-29.39595005	-0.695179008	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1857	3528	0.003117914	0.007369615	6	9	OPC	51	20	20
CGACCTTAGTCGCCGT-1_3_C4	-19.76841385	-26.64581363	6A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	3102	7390	0.013937754	0.00202977	6	6A	IN-PV	51	20	20
CGACCTTCACTTACGA-1_3_C4	-15.9397441	-26.07393614	6A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1873	3743	0.014961261	0.001870158	6	6A	IN-PV	51	20	20
CGACCTTCATCGGACC-1_3_C4	15.12399868	10.56388202	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1320	2240	0.003571429	0.014285714	6	oligos	OL-Cntl	51	20	20
CGACCTTGTAAGGGAA-1_3_C4	-13.62050047	-24.11642331	6A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1358	2537	0.05597162	0.001576665	6	6A	IN-PV	51	20	20
CGACCTTGTGAAATCA-1_3_C4	-24.99413414	17.44184934	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1308	2056	0.00729572	0.006322957	6	8	Astrocytes	51	20	20
CGACCTTGTGCGCTTG-1_3_C4	-0.123216379	25.04680032	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	756	1100	0.001818182	0.007272727	6	oligos	OL-Cntl	51	20	20
CGACCTTTCAGCCTAA-1_3_C4	16.58523824	16.32605378	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1171	2007	0.001494768	0.007972098	6	oligos	OL-Cntl	51	20	20
CGACTTCAGGTGTTAA-1_3_C4	15.52000081	-5.566163348	10	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1511	2868	0.003835425	0.002440725	6	L2-3	EN-L2-3-Cntl	51	20	20
CGACTTCCAAACGTGG-1_3_C4	17.26043035	17.97352374	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1153	1965	0.001017812	0.004071247	6	oligos	OL-Cntl	51	20	20
CGACTTCCAGATCCAT-1_3_C4	-14.82264882	-3.612969961	13A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	5065	14288	0.007208847	0.011758119	6	13A	IN-VIP	51	20	20
CGACTTCCATGGTCTA-1_3_C4	10.34191197	-19.98116388	4	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	4134	11531	0.01578354	0.004943197	6	L2-3	EN-L2-3-MS	51	20	20
CGACTTCGTAAGAGAG-1_3_C4	22.8239865	10.98238955	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1823	3286	0.001521607	0.005173463	6	oligos	OL-Cntl	51	20	20
CGACTTCGTAGCACGA-1_3_C4	2.058940734	27.24778966	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	766	1091	0.007332722	0.010082493	6	oligos	OL-Cntl	51	20	20
CGACTTCTCAATCACG-1_3_C4	2.647772446	20.57558695	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	864	1311	0.007627765	0.012967201	6	oligos	OL-Cntl	51	20	20
CGACTTCTCTGTCTAT-1_3_C4	11.39342736	28.65637742	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	757	1286	0.000777605	0.005443235	6	oligos	OL-Cntl	51	20	20
CGAGAAGAGACTAGAT-1_3_C4	-12.56774187	14.81130858	11	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1040	1542	0.002594034	0.004539559	6	11	Glia-MIX	51	20	20
CGAGAAGAGGATGGTC-1_3_C4	21.27797113	10.44721059	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1497	2502	0.004796163	0.003197442	6	oligos	OL-Cntl	51	20	20
CGAGAAGGTGACTACT-1_3_C4	11.74668988	13.75410533	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1249	2205	0.001814059	0.006802721	6	oligos	OL-Cntl	51	20	20
CGAGAAGGTTCCGTCT-1_3_C4	-23.40969529	23.88996788	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1438	2579	0.004265219	0.00271423	6	8	Astrocytes	51	20	20
CGAGCACAGAGGACGG-1_3_C4	-23.50158609	-0.064978907	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1934	3546	0.004512126	0.007050197	6	9	OPC	51	20	20
CGAGCACCACTGTTAG-1_3_C4	-20.25672403	27.91428736	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2134	4100	0.00804878	0.009268293	6	8	Astrocytes	51	20	20
CGAGCACCAGGGAGAG-1_3_C4	12.98218542	23.06191452	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	883	1407	0.006396588	0.004975124	6	oligos	OL-Cntl	51	20	20
CGAGCCAAGATCCGAG-1_3_C4	-31.42982919	12.26345942	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	888	1330	0.006015038	0.011278195	6	8	Astrocytes	51	20	20
CGAGCCACAATTGCTG-1_3_C4	18.11180098	21.93413491	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	955	1565	0.008306709	0.005111821	6	oligos	OL-Cntl	51	20	20
CGAGCCACACAGGAGT-1_3_C4	-27.21512227	12.52960509	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	931	1377	0.027596224	0.001452433	6	8	Astrocytes	51	20	20
CGAGCCAGTCGCCATG-1_3_C4	-24.19135372	15.72221656	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1297	2185	0.004576659	0.006864989	6	8	Astrocytes	51	20	20
CGAGCCAGTTCCACAA-1_3_C4	7.304255432	20.65349055	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1006	1673	0.001793186	0.008965929	6	oligos	OL-Cntl	51	20	20
CGAGCCATCACGAAGG-1_3_C4	-25.9900818	19.09038274	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1392	2361	0.001270648	0.003388395	6	8	Astrocytes	51	20	20
CGAGCCATCCGAATGT-1_3_C4	19.13501631	19.28037142	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1089	1808	0.002765487	0.004424779	6	oligos	OL-Cntl	51	20	20
CGAGCCATCGTCGTTC-1_3_C4	-32.90082244	-11.3915929	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	930	1504	0.004654255	0.003324468	6	9	OPC	51	20	20
CGATCGGAGCGATGAC-1_3_C4	-22.22737237	10.19489459	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	955	1449	0.004140787	0.002070393	6	8	Astrocytes	51	20	20
CGATCGGAGTGTACGG-1_3_C4	-0.347422258	28.40965675	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	800	1091	0.001833181	0.010082493	6	oligos	OL-Cntl	51	20	20
CGATCGGCATCGATTG-1_3_C4	-11.38655676	-18.10533701	6B	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	951	1560	0.028205128	0.004487179	6	6B	IN-SST	51	20	20
CGATCGGGTAGCCTCG-1_3_C4	-10.95678974	-18.12015998	6B	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1101	1766	0.062853907	0.007361268	6	6B	IN-SST	51	20	20
CGATCGGGTCCGCTGA-1_3_C4	-26.57738394	13.7771765	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	944	1538	0	0.007152146	6	8	Astrocytes	51	20	20
CGATCGGGTCTCCCTA-1_3_C4	3.923104381	25.43522283	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	751	1117	0.00179051	0.011638317	6	oligos	OL-Cntl	51	20	20
CGATCGGGTTGAGGTG-1_3_C4	-5.354278156	-10.57414709	6B	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	700	1052	0.051330798	0.009505703	6	6B	IN-SST	51	20	20
CGATCGGTCACCGGGT-1_3_C4	4.432012807	31.17075073	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	802	1210	0.003305785	0.004132231	6	oligos	OL-Cntl	51	20	20
CGATGGCAGGCCATAG-1_3_C4	-16.59399094	-24.69701659	6A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1980	3873	0.019881229	0.003872967	6	6A	IN-PV	51	20	20
CGATGGCAGGTGCAAC-1_3_C4	-16.24847461	-9.136618376	13B	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2807	5960	0.011912752	0.003691275	6	13B	IN-SV2C	51	20	20
CGATGGCCAACGCACC-1_3_C4	-23.52705424	24.12255914	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1589	2818	0.004613201	0.004258339	6	8	Astrocytes	51	20	20
CGATGGCCAATGACCT-1_3_C4	12.46389068	31.1147458	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	710	1061	0.000942507	0.003770028	6	oligos	OL-Cntl	51	20	20
CGATGGCCACAACGTT-1_3_C4	38.30707954	11.41287355	14	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	946	1383	0.002892263	0.01373825	6	14	Microglia	51	20	20
CGATGGCGTGTAATGA-1_3_C4	17.78930878	8.336567957	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1821	3397	0.016190757	0.011186341	6	oligos	OL-Cntl	51	20	20
CGATGGCTCACAGTAC-1_3_C4	-18.7534967	-27.39052483	6A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2874	6765	0.008130081	0.001773836	6	6A	IN-PV	51	20	20
CGATGTAAGAAGGCCT-1_3_C4	-31.90962645	11.90302514	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	766	1204	0.023255814	0.005813953	6	8	Astrocytes	51	20	20
CGATGTAAGGGAAACA-1_3_C4	24.65162353	-24.01015693	3	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	3321	7827	0.015203782	0.00268302	6	3	EN-L5-6	51	20	20
CGATGTACAAATACAG-1_3_C4	13.78391555	20.63547705	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	987	1435	0.005574913	0.007665505	6	oligos	OL-Cntl	51	20	20
CGATGTATCACTATTC-1_3_C4	-28.63029741	10.71843369	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	791	1248	0	0.006410256	6	8	Astrocytes	51	20	20
CGATGTATCCTGCCAT-1_3_C4	12.15571856	-18.31000222	4	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	7046	24174	0.010010755	0.010962191	6	L2-3	EN-L2-3-MS	51	20	20
CGATTGAAGAGCAATT-1_3_C4	0.672622027	26.97053742	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	741	1087	0.00275989	0.007359706	6	oligos	OL-Cntl	51	20	20
CGATTGACAAGTTGTC-1_3_C4	-29.8306051	9.500084218	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	848	1227	0.00407498	0.014669927	6	8	Astrocytes	51	20	20
CGATTGAGTGGCGAAT-1_3_C4	-16.30908173	15.71222706	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2005	3752	0.002398721	0.013059701	6	8	Astrocytes	51	20	20
CGATTGATCACATGCA-1_3_C4	12.99687474	22.73729986	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	893	1380	0.003623188	0.007971014	6	oligos	OL-Cntl	51	20	20
CGATTGATCCAGTATG-1_3_C4	-18.13813673	-8.506004036	13B	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	3734	8657	0.007277348	0.007623888	6	13B	IN-SV2C	51	20	20
CGATTGATCCTATTCA-1_3_C4	17.91301278	12.91112834	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1413	2582	0.003872967	0.008520527	6	oligos	OL-Cntl	51	20	20
CGCCAAGAGAAACGCC-1_3_C4	-24.03605435	22.254994	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1512	2678	0.016056759	0.006348021	6	8	Astrocytes	51	20	20
CGCCAAGAGCTGATAA-1_3_C4	16.2954249	13.51033891	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1323	2150	0.006511628	0.009302326	6	oligos	OL-Cntl	51	20	20
CGCCAAGCAATGGATA-1_3_C4	-0.114642528	27.4567192	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	710	1055	0.002843602	0.000947867	6	oligos	OL-Cntl	51	20	20
CGCCAAGGTACTTCTT-1_3_C4	14.12385709	12.36936019	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1314	2197	0.009103323	0.010923987	6	oligos	OL-Cntl	51	20	20
CGCCAAGTCACATACG-1_3_C4	4.926926378	-5.373548905	12	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	902	1369	0.00146092	0.002191381	6	12	EN-MIX	51	20	20
CGCGGTAAGTAACCCT-1_3_C4	-19.18605758	19.7334229	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1557	2666	0.003750938	0.011252813	6	8	Astrocytes	51	20	20
CGCGGTACAAATCCGT-1_3_C4	23.18043181	18.64283684	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1151	2014	0.008937438	0.006454816	6	oligos	OL-Cntl	51	20	20
CGCGGTACAAGGACTG-1_3_C4	-6.135519122	-33.87136368	16	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	748	1193	0.096395641	0.003352892	6	16	EN-PYR	51	20	20
CGCGGTACACCAACCG-1_3_C4	-1.395796361	21.58693704	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	700	1078	0.010204082	0.013914657	6	oligos	OL-Cntl	51	20	20
CGCGGTAGTAGGGACT-1_3_C4	-10.18320853	-1.15698208	13A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2155	4031	0.012651947	0.004961548	6	13A	IN-VIP	51	20	20
CGCGGTAGTGAGGGTT-1_3_C4	3.587217113	23.96356822	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	913	1339	0.00373413	0.005227782	6	oligos	OL-Cntl	51	20	20
CGCGGTAGTGCTGTAT-1_3_C4	-2.197225726	24.40564636	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	778	1141	0.006134969	0.009640666	6	oligos	OL-Cntl	51	20	20
CGCGGTATCCGTTGTC-1_3_C4	-28.41226757	13.11159435	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	794	1171	0.005123826	0.003415884	6	8	Astrocytes	51	20	20
CGCGGTATCTGCGGCA-1_3_C4	-8.503066815	-2.861224378	13B	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2250	4628	0.028089888	0.004321521	6	13B	IN-SV2C	51	20	20
CGCGGTATCTTCGGTC-1_3_C4	5.366702105	33.06064171	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	718	1134	0.004409171	0.001763668	6	oligos	OL-Cntl	51	20	20
CGCGTTTAGACAGAGA-1_3_C4	-22.89561059	24.11124128	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1636	2914	0.003088538	0.005147563	6	8	Astrocytes	51	20	20
CGCGTTTCAAGCCCAC-1_3_C4	-13.49253615	-24.15666812	6A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1251	2301	0.049109083	0.00478053	6	6A	IN-PV	51	20	20
CGCGTTTCAGGCTCAC-1_3_C4	20.64486373	-29.41377333	3	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	5724	19128	0.002195734	0.003607277	6	3	EN-L5-6	51	20	20
CGCGTTTTCGACCAGC-1_3_C4	-32.1911949	-2.656793964	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1379	2281	0.006137659	0.003945638	6	9	OPC	51	20	20
CGCGTTTTCGTTTGCC-1_3_C4	21.21982933	16.11271802	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1294	2163	0.000462321	0.006010171	6	oligos	OL-Cntl	51	20	20
CGCGTTTTCTTAACCT-1_3_C4	-16.11208089	14.7790973	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1734	3061	0.003920287	0.006207122	6	8	Astrocytes	51	20	20
CGCTATCAGACAGGCT-1_3_C4	11.99344547	13.53796493	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1311	2288	0.003059441	0.003933566	6	oligos	OL-Cntl	51	20	20
CGCTATCAGGCTAGGT-1_3_C4	-29.36247582	10.41508387	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	781	1107	0.002710027	0.001806685	6	8	Astrocytes	51	20	20
CGCTATCCACGAAACG-1_3_C4	1.2532753	24.56221158	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	659	1018	0.002946955	0.009823183	6	oligos	OL-Cntl	51	20	20
CGCTATCTCATGTCTT-1_3_C4	6.057754035	28.7553474	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	754	1258	0	0.0063593	6	oligos	OL-Cntl	51	20	20
CGCTATCTCCCAGGTG-1_3_C4	11.8065038	30.67179642	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	683	1110	0.004504505	0.001801802	6	oligos	OL-Cntl	51	20	20
CGCTATCTCTCCAACC-1_3_C4	-26.85298545	17.0168368	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1200	2177	0.009646302	0.004593477	6	8	Astrocytes	51	20	20
CGCTGGACAAACTGCT-1_3_C4	12.9047213	25.4084563	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	797	1305	0.006130268	0.006130268	6	oligos	OL-Cntl	51	20	20
CGCTGGACACAGGTTT-1_3_C4	16.49452275	-0.644368566	12	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	734	1046	0.019120459	0.004780115	6	12	EN-MIX	51	20	20
CGCTGGATCCGGCACA-1_3_C4	25.74367372	3.597786251	15BA	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	819	1253	0.004788508	0.007980846	6	15BA	Stromal cells	51	20	20
CGCTGGATCGTGGGAA-1_3_C4	16.4652506	-9.643921971	3	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2364	4814	0.009555463	0.005608641	6	3	EN-L5-6	51	20	20
CGCTGGATCTCGATGA-1_3_C4	-17.80003148	-7.521582564	13B	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	3343	7004	0.018132496	0.008138207	6	13B	IN-SV2C	51	20	20
CGCTTCAAGCTGGAAC-1_3_C4	-31.14020289	12.80266827	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	932	1384	0.01734104	0.005057803	6	8	Astrocytes	51	20	20
CGCTTCAAGGATCGCA-1_3_C4	5.418315826	30.04403079	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	758	1221	0.000819001	0.005733006	6	oligos	OL-Cntl	51	20	20
CGCTTCACACTGCCAG-1_3_C4	12.07786423	13.42039302	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1449	2428	0.003294893	0.007413509	6	oligos	OL-Cntl	51	20	20
CGCTTCAGTCCAACTA-1_3_C4	22.46209577	15.59145157	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1585	2666	0.005251313	0.008252063	6	oligos	OL-Cntl	51	20	20
CGCTTCATCTCAACTT-1_3_C4	-34.17877806	-6.334394424	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1354	2484	0.005233494	0.004428341	6	9	OPC	51	20	20
CGGACACAGAATGTTG-1_3_C4	25.74698612	3.592302915	15BA	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	796	1193	0.002514669	0.001676446	6	15BA	Stromal cells	51	20	20
CGGACACCATAGAAAC-1_3_C4	-25.14232121	20.03831448	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1829	3385	0.002658789	0.001181684	6	8	Astrocytes	51	20	20
CGGACACGTAAACCTC-1_3_C4	11.82825652	14.00245039	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1299	2462	0.008529651	0.005686434	6	oligos	OL-Cntl	51	20	20
CGGACACGTAGGGACT-1_3_C4	13.17408215	-22.22117746	4	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	5495	16154	0.006685651	0.004023771	6	L2-3	EN-L2-3-MS	51	20	20
CGGACACGTCTAAAGA-1_3_C4	5.689407617	30.98035665	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	818	1274	0.003139717	0.003924647	6	oligos	OL-Cntl	51	20	20
CGGACACTCACCATAG-1_3_C4	14.10394756	22.18928731	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	967	1560	0.001923077	0.003205128	6	oligos	OL-Cntl	51	20	20
CGGACACTCGCAGGCT-1_3_C4	20.51336926	23.17000032	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1216	2103	0.002377556	0.005706134	6	oligos	OL-Cntl	51	20	20
CGGACGTAGAATGTTG-1_3_C4	21.12550208	17.03681437	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1195	1900	0.002105263	0.003157895	6	oligos	OL-Cntl	51	20	20
CGGACGTCATATGAGA-1_3_C4	-22.91101598	24.10057661	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1566	2732	0.001464129	0.004392387	6	8	Astrocytes	51	20	20
CGGACGTGTATTCTCT-1_3_C4	39.52348983	12.31132868	14	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	966	1408	0.001420455	0.005681818	6	14	Microglia	51	20	20
CGGACGTGTCTAGGTT-1_3_C4	37.37106149	-10.08492864	2	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	4172	9089	0.014082957	0.007921664	6	2	EN-L4	51	20	20
CGGACGTGTGATGATA-1_3_C4	17.89400516	21.05390259	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1033	1669	0.008987418	0.004194128	6	oligos	OL-Cntl	51	20	20
CGGACGTGTGTGTGCC-1_3_C4	0.726414463	24.23197266	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	655	1082	0	0.007393715	6	oligos	OL-Cntl	51	20	20
CGGACTGAGCCGCCTA-1_3_C4	-31.89948056	-0.849980434	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1618	2721	0.00183756	0.004777655	6	9	OPC	51	20	20
CGGACTGCAAAGTGCG-1_3_C4	16.45460508	24.31771904	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	859	1333	0.002250563	0.005251313	6	oligos	OL-Cntl	51	20	20
CGGACTGCAAGAGGCT-1_3_C4	-27.68833844	22.08106309	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1326	2192	0.006843066	0.001368613	6	8	Astrocytes	51	20	20
CGGACTGCAAGTCTGT-1_3_C4	-20.74969468	17.35335171	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1564	2525	0.007524752	0.005148515	6	8	Astrocytes	51	20	20
CGGACTGCAGGGCATA-1_3_C4	20.85516854	10.88626623	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1636	3098	0.000322789	0.004519045	6	oligos	OL-Cntl	51	20	20
CGGAGCTAGGGATACC-1_3_C4	-11.25910954	8.785886178	11	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	5003	12486	0.003924395	0.006407176	6	11	Glia-MIX	51	20	20
CGGAGCTAGTGAAGTT-1_3_C4	-24.31358379	14.39093709	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1331	2250	0.000444444	0.007555556	6	8	Astrocytes	51	20	20
CGGAGCTCAGTACACT-1_3_C4	5.800662662	16.31887757	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1063	1663	0.003006615	0.010222489	6	oligos	OL-Cntl	51	20	20
CGGAGCTTCTCAAGTG-1_3_C4	-35.9707531	-1.772052899	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1559	2680	0.008955224	0.003358209	6	9	OPC	51	20	20
CGGAGTCGTCGCCATG-1_3_C4	34.03773028	14.99223027	14	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1133	1678	0	0.040524434	6	14	Microglia	51	20	20
CGGAGTCTCAACACAC-1_3_C4	17.94878882	17.29093096	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1092	1816	0.00715859	0.00715859	6	oligos	OL-Cntl	51	20	20
CGGAGTCTCAACGAAA-1_3_C4	16.3975808	15.88447109	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1221	2136	0.008895131	0.008426966	6	oligos	OL-Cntl	51	20	20
CGGAGTCTCGAATCCA-1_3_C4	-26.47588516	24.98752906	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1502	2751	0.002544529	0.003635042	6	8	Astrocytes	51	20	20
CGGAGTCTCTCTGCTG-1_3_C4	-1.114064376	23.5210587	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	719	1036	0.001930502	0.012548263	6	oligos	OL-Cntl	51	20	20
CGGCTAGCAACTGCTA-1_3_C4	-22.32633654	29.51176249	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2155	4068	0.015486726	0.004424779	6	8	Astrocytes	51	20	20
CGGCTAGCATGCATGT-1_3_C4	3.543763707	-20.63443512	4	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	4146	10875	0.011034483	0.006436782	6	L2-3	EN-L2-3-MS	51	20	20
CGGCTAGGTCGACTGC-1_3_C4	20.80219219	8.295358473	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1941	3625	0.001931034	0.004137931	6	oligos	OL-Cntl	51	20	20
CGGCTAGTCCTAAGTG-1_3_C4	17.11912235	15.70929812	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1279	2263	0.007954043	0.004860804	6	oligos	OL-Cntl	51	20	20
CGGGTCAAGCTGCCCA-1_3_C4	23.06283147	-10.43996189	3	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2998	6544	0.016198044	0.003973105	6	3	EN-L5-6	51	20	20
CGGGTCACAGTAGAGC-1_3_C4	-23.95425024	12.15983691	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1327	2208	0.010416667	0.006793478	6	8	Astrocytes	51	20	20
CGGGTCAGTAGCTTGT-1_3_C4	11.31962195	-22.31193712	4	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	6102	19005	0.005787951	0.003420153	6	L2-3	EN-L2-3-MS	51	20	20
CGGGTCATCGTCACGG-1_3_C4	14.8641172	11.31627645	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1484	2479	0.00524405	0.010891489	6	oligos	OL-Cntl	51	20	20
CGGGTCATCTAACCGA-1_3_C4	-28.85480001	10.06429035	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	741	1113	0.002695418	0.012578616	6	8	Astrocytes	51	20	20
CGGGTCATCTAACGGT-1_3_C4	-1.51644828	23.99809345	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	721	1091	0.006416132	0.009165903	6	oligos	OL-Cntl	51	20	20
CGGTTAAAGCTAGGCA-1_3_C4	3.396512911	28.66674676	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	719	1151	0.00086881	0.003475239	6	oligos	OL-Cntl	51	20	20
CGGTTAACATCCTTGC-1_3_C4	12.94794686	26.39189451	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	710	1182	0.000846024	0.007614213	6	oligos	OL-Cntl	51	20	20
CGGTTAAGTTCCACAA-1_3_C4	18.41984547	8.850594572	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1650	3113	0.009637006	0.005782204	6	oligos	OL-Cntl	51	20	20
CGTAGCGAGCTGCCCA-1_3_C4	-29.87995475	-7.333238681	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1236	2098	0.003336511	0.000476644	6	9	OPC	51	20	20
CGTAGCGAGTACGTTC-1_3_C4	18.28952806	12.76531722	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1336	2496	0.003205128	0.005208333	6	oligos	OL-Cntl	51	20	20
CGTAGCGAGTGAACGC-1_3_C4	-26.47752871	22.80913156	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1367	2354	0.011469839	0.005522515	6	8	Astrocytes	51	20	20
CGTAGCGCAACACCTA-1_3_C4	16.38969207	14.41073154	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1323	2196	0.00273224	0.004553734	6	oligos	OL-Cntl	51	20	20
CGTAGCGCAATGGAGC-1_3_C4	16.32759812	13.90037203	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1366	2301	0.002172968	0.003476749	6	oligos	OL-Cntl	51	20	20
CGTAGCGGTGTGCGTC-1_3_C4	-25.09478248	15.37095891	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1062	1657	0.007845504	0.009052505	6	8	Astrocytes	51	20	20
CGTAGCGGTTGGTGGA-1_3_C4	-31.33293602	11.60830114	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	777	1125	0.006222222	0.003555556	6	8	Astrocytes	51	20	20
CGTAGCGTCAGGTTCA-1_3_C4	1.300412037	20.41973776	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	826	1268	0.003943218	0.011041009	6	oligos	OL-Cntl	51	20	20
CGTAGGCAGCAGATCG-1_3_C4	-4.87599835	-9.895312306	13A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	869	1282	0.017940718	0.003900156	6	13A	IN-VIP	51	20	20
CGTAGGCAGGCTATCT-1_3_C4	10.24166307	20.20546922	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	948	1505	0	0.007973422	6	oligos	OL-Cntl	51	20	20
CGTAGGCCATCAGTAC-1_3_C4	20.24594655	7.177084133	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2160	4605	0.00412595	0.006080347	6	oligos	OL-Cntl	51	20	20
CGTAGGCTCAAACAAG-1_3_C4	-12.9709116	14.63938846	11	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	959	1404	0.002136752	0.002849003	6	11	Glia-MIX	51	20	20
CGTAGGCTCCCTTGTG-1_3_C4	1.822270784	29.05459703	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	788	1152	0	0.004340278	6	oligos	OL-Cntl	51	20	20
CGTAGGCTCTCTGTCG-1_3_C4	0.338694032	25.26639424	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	668	1023	0	0.002932551	6	oligos	OL-Cntl	51	20	20
CGTCACTAGTGAAGAG-1_3_C4	-29.4393216	19.98819473	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	968	1547	0.013574661	0.003232062	6	8	Astrocytes	51	20	20
CGTCACTGTTCGTCTC-1_3_C4	38.11781084	13.12417775	14	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1142	1569	0.013384321	0.008922881	6	14	Microglia	51	20	20
CGTCACTTCCGCGTTT-1_3_C4	-22.60594341	25.0972918	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1642	2791	0.006091007	0.006807596	6	8	Astrocytes	51	20	20
CGTCAGGCAAAGGCGT-1_3_C4	-35.10715224	-4.161861576	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1381	2218	0.002254283	0.004508566	6	9	OPC	51	20	20
CGTCAGGCACATCCAA-1_3_C4	0.190809834	25.39426487	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	796	1101	0.00181653	0.006357856	6	oligos	OL-Cntl	51	20	20
CGTCAGGCACTGTCGG-1_3_C4	4.003865893	17.98329508	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1071	1735	0.004610951	0.01037464	6	oligos	OL-Cntl	51	20	20
CGTCAGGGTCTAGTCA-1_3_C4	23.16481029	18.72394458	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1159	1965	0.003562341	0.003053435	6	oligos	OL-Cntl	51	20	20
CGTCAGGGTGGGTATG-1_3_C4	4.002445983	30.4970707	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	721	1099	0.000909918	0.005459509	6	oligos	OL-Cntl	51	20	20
CGTCAGGGTGTTTGTG-1_3_C4	-12.00102286	15.72739153	11	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1408	2151	0.009762901	0.0041841	6	11	Glia-MIX	51	20	20
CGTCCATAGATCTGAA-1_3_C4	2.076115576	23.82523328	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	731	1051	0.002854424	0.010466223	6	oligos	OL-Cntl	51	20	20
CGTCCATCATCCGCGA-1_3_C4	11.36106468	19.93354848	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	943	1508	0.027851459	0.01061008	6	oligos	OL-Cntl	51	20	20
CGTCCATGTAACGACG-1_3_C4	21.63199392	17.59448151	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1135	1754	0.001140251	0.005701254	6	oligos	OL-Cntl	51	20	20
CGTCCATTCACAGGCC-1_3_C4	-37.36082241	0.276892895	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1568	2849	0.003510004	0.003159003	6	9	OPC	51	20	20
CGTCTACAGGATGCGT-1_3_C4	2.573886483	19.60385486	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	930	1386	0.009379509	0.015151515	6	oligos	OL-Cntl	51	20	20
CGTCTACAGTTATCGC-1_3_C4	37.60696765	10.54089703	14	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	917	1347	0.005196733	0.011135857	6	14	Microglia	51	20	20
CGTCTACCAGCCTTGG-1_3_C4	-0.884593699	-0.600730912	11	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1779	3069	0.005213425	0.007820137	6	11	Glia-MIX	51	20	20
CGTCTACCATGTTGAC-1_3_C4	-10.89582517	-20.85523575	6B	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	974	1614	0.111524164	0.005576208	6	6B	IN-SST	51	20	20
CGTCTACTCTTTCCTC-1_3_C4	11.81512873	23.63819186	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	776	1238	0.008077544	0.009693053	6	oligos	OL-Cntl	51	20	20
CGTGAGCCACTCTGTC-1_3_C4	22.4075974	-9.675853801	3	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2489	5273	0.008154751	0.003034326	6	3	EN-L5-6	51	20	20
CGTGAGCGTACAGCAG-1_3_C4	-11.67106013	13.7332035	11	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	893	1355	0.019926199	0.004428044	6	11	Glia-MIX	51	20	20
CGTGAGCTCAGCAACT-1_3_C4	-15.38786968	15.38085234	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2566	5487	0.000728996	0.004556224	6	8	Astrocytes	51	20	20
CGTGTAACAAGTCTGT-1_3_C4	5.162705892	-9.572196128	12	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1491	2331	0.023166023	0.00986701	6	12	EN-MIX	51	20	20
CGTGTAACATGGGACA-1_3_C4	-34.2654582	-9.848704873	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	919	1323	0.001511716	0.001511716	6	9	OPC	51	20	20
CGTGTAAGTCCTCCAT-1_3_C4	7.45838506	-21.78512001	4	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	5107	14143	0.009050414	0.010181715	6	L2-3	EN-L2-3-MS	51	20	20
CGTGTAAGTGTGCCTG-1_3_C4	23.16858237	-25.7498871	3	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2901	6257	0.01118747	0.003835704	6	3	EN-L5-6	51	20	20
CGTGTAATCATGCATG-1_3_C4	38.21868096	14.3384674	14	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1229	1810	0.001104972	0.007734807	6	14	Microglia	51	20	20
CGTGTAATCCTACAGA-1_3_C4	3.554258434	19.75036019	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	926	1441	0.015961138	0.0111034	6	oligos	OL-Cntl	51	20	20
CGTGTCTGTGTAAGTA-1_3_C4	14.39000927	18.00685955	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1031	1600	0.00375	0.01125	6	oligos	OL-Cntl	51	20	20
CGTGTCTTCCGTACAA-1_3_C4	-36.79353578	-2.974096046	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1342	2152	0.00464684	0.00232342	6	9	OPC	51	20	20
CGTTAGATCGTGTAGT-1_3_C4	5.68676649	20.88724249	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	849	1274	0.002354788	0.003139717	6	oligos	OL-Cntl	51	20	20
CGTTAGATCTTAGAGC-1_3_C4	25.21360783	4.057646799	15DA	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1383	2512	0.002388535	0.003184713	6	15DA	T cells	51	20	20
CGTTCTGAGATCACGG-1_3_C4	-23.79851586	1.060333615	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	3259	7269	0.009767506	0.005640391	6	9	OPC	51	20	20
CGTTCTGAGTTGTAGA-1_3_C4	6.151713009	19.15111448	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	923	1481	0.010803511	0.013504389	6	oligos	OL-Cntl	51	20	20
CGTTCTGGTCTCTTTA-1_3_C4	11.63039204	29.96842019	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	698	1062	0.011299435	0.003766478	6	oligos	OL-Cntl	51	20	20
CGTTCTGGTTTACTCT-1_3_C4	4.669965969	28.47950071	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	818	1263	0.003958828	0.007125891	6	oligos	OL-Cntl	51	20	20
CGTTCTGTCCAAGTAC-1_3_C4	15.72582769	10.10791756	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1443	2487	0.011660635	0.008443908	6	oligos	OL-Cntl	51	20	20
CGTTCTGTCCCAAGTA-1_3_C4	-15.65295182	-19.31868898	6B	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1733	3365	0.004160475	0.003566122	6	6B	IN-SST	51	20	20
CGTTGGGGTCCATGAT-1_3_C4	20.38406365	11.42328282	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1538	2694	0.001855976	0.004454343	6	oligos	OL-Cntl	51	20	20
CGTTGGGGTTGAACTC-1_3_C4	13.44970061	11.59348602	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1489	2609	0.005749329	0.014181679	6	oligos	OL-Cntl	51	20	20
CGTTGGGTCAGCTTAG-1_3_C4	3.257079351	18.50273471	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	985	1502	0.005992011	0.015312916	6	oligos	OL-Cntl	51	20	20
CGTTGGGTCTGTTGAG-1_3_C4	14.67528336	16.14094248	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1194	1963	0.003056546	0.014263882	6	oligos	OL-Cntl	51	20	20
CTAACTTAGATGTGTA-1_3_C4	6.617493412	20.33922261	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	896	1393	0.005025126	0.010768126	6	oligos	OL-Cntl	51	20	20
CTAACTTCAAAGGAAG-1_3_C4	19.64267008	15.04909008	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1343	2224	0.007643885	0.005395683	6	oligos	OL-Cntl	51	20	20
CTAACTTCATTAGCCA-1_3_C4	-3.746971824	-18.47461005	4	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	3442	9139	0.005361637	0.008206587	6	L2-3	EN-L2-3-MS	51	20	20
CTAACTTTCATTCACT-1_3_C4	-29.30707338	10.37698684	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	727	1161	0.007751938	0.003445306	6	8	Astrocytes	51	20	20
CTAACTTTCCACGACG-1_3_C4	-8.554686899	-2.811058003	13A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1700	3187	0.034515218	0.005961719	6	13A	IN-VIP	51	20	20
CTAACTTTCGTATCAG-1_3_C4	-36.18977837	-3.551964347	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1360	2407	0.003323639	0.002908184	6	9	OPC	51	20	20
CTAAGACAGTCTTGCA-1_3_C4	17.15420817	17.03967463	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1016	1656	0.003623188	0.007246377	6	oligos	OL-Cntl	51	20	20
CTAAGACCACTCAGGC-1_3_C4	21.05288979	10.3544593	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1635	2994	0.002004008	0.00501002	6	oligos	OL-Cntl	51	20	20
CTAAGACCAGCCTTTC-1_3_C4	-14.43965688	0.580483702	13A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	3561	8292	0.013989387	0.007718283	6	13A	IN-VIP	51	20	20
CTAAGACGTGAAAGAG-1_3_C4	-37.46654919	-4.82888085	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1291	2167	0.005999077	0.002768805	6	9	OPC	51	20	20
CTAAGACGTGAGGGTT-1_3_C4	5.576118737	-11.0207268	4	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1909	3222	0.032898821	0.003724395	6	L2-3	EN-L2-3-MS	51	20	20
CTAAGACTCTAACCGA-1_3_C4	-27.75803287	4.351257615	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1975	3860	0.010621762	0.002849741	6	9	OPC	51	20	20
CTAATGGAGAAGGTGA-1_3_C4	2.917602044	25.34454237	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	698	1046	0.007648184	0.008604207	6	oligos	OL-Cntl	51	20	20
CTAATGGAGTCCGGTC-1_3_C4	13.18510348	28.84116076	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	823	1257	0.000795545	0.00636436	6	oligos	OL-Cntl	51	20	20
CTAATGGCACGACTCG-1_3_C4	-8.275424293	-18.11578106	6B	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	666	1219	0.169811321	0.003281378	6	6B	IN-SST	51	20	20
CTAATGGCAGCGTCCA-1_3_C4	11.70793265	23.05800223	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	804	1310	0.003816794	0.002290076	6	oligos	OL-Cntl	51	20	20
CTAATGGGTTACCAGT-1_3_C4	-9.629478006	22.23551448	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	849	1207	0.005799503	0.006628003	6	8	Astrocytes	51	20	20
CTAATGGGTTCACGGC-1_3_C4	11.90279064	-22.28355801	4	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	4571	13456	0.008174792	0.003641498	6	L2-3	EN-L2-3-MS	51	20	20
CTACACCCACCGTTGG-1_3_C4	-11.80517797	-19.12613535	6B	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1035	1844	0.000542299	0.003253796	6	6B	IN-SST	51	20	20
CTACACCCAGCTTCGG-1_3_C4	25.59994017	3.867019398	15BA	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	976	1464	0.00136612	0.008879781	6	15BA	Stromal cells	51	20	20
CTACACCGTCTCATCC-1_3_C4	-4.211754656	22.69445818	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	735	1074	0.001862197	0.01396648	6	oligos	OL-Cntl	51	20	20
CTACACCGTTCGTGAT-1_3_C4	-0.63540958	-0.410649436	11	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1308	2232	0.009408602	0.004480287	6	11	Glia-MIX	51	20	20
CTACACCTCAACACAC-1_3_C4	-25.54567261	22.59733745	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1347	2236	0.007155635	0.005813953	6	8	Astrocytes	51	20	20
CTACACCTCGTGGGAA-1_3_C4	21.18356481	17.84636352	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1143	1781	0.008422235	0.006737788	6	oligos	OL-Cntl	51	20	20
CTACATTTCACCTCGT-1_3_C4	-28.36523552	21.57712216	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1118	1994	0.003510532	0.008525577	6	8	Astrocytes	51	20	20
CTACATTTCCGCATAA-1_3_C4	38.06263939	9.862961594	14	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	808	1194	0	0.010050251	6	14	Microglia	51	20	20
CTACATTTCGCCATAA-1_3_C4	-34.08349474	-3.200008477	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1429	2712	0.001474926	0.005530973	6	9	OPC	51	20	20
CTACATTTCTGCAGTA-1_3_C4	-35.33302599	-4.883477264	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1198	2033	0.004426955	0.003443187	6	9	OPC	51	20	20
CTACCCAAGCAATCTC-1_3_C4	3.321616528	7.186271343	7	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	991	1566	0.019795658	0.005108557	6	7	Phagocytes	51	20	20
CTACCCAAGGCTAGGT-1_3_C4	-21.84714605	25.71004387	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1711	3325	0.004210526	0.008120301	6	8	Astrocytes	51	20	20
CTACCCAAGTCCCACG-1_3_C4	-22.38699807	29.96721571	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2118	4081	0.006861063	0.003430532	6	8	Astrocytes	51	20	20
CTACCCAGTATAGTAG-1_3_C4	18.71626475	14.02360154	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1192	2001	0.005997001	0.003998001	6	oligos	OL-Cntl	51	20	20
CTACCCATCCCTAATT-1_3_C4	12.25678166	27.49531512	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	767	1138	0.002636204	0.001757469	6	oligos	OL-Cntl	51	20	20
CTACCCATCGCTGATA-1_3_C4	3.162940301	-24.16413579	4	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	5249	13987	0.008150425	0.013155073	6	L2-3	EN-L2-3-MS	51	20	20
CTACGTCCAACTTGAC-1_3_C4	17.83543596	18.09267552	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1108	1865	0.004289544	0.004825737	6	oligos	OL-Cntl	51	20	20
CTACGTCCATGCAATC-1_3_C4	3.603379076	29.12544676	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	804	1234	0.0089141	0.004051864	6	oligos	OL-Cntl	51	20	20
CTACGTCCATGGAATA-1_3_C4	-19.02062083	-20.88109669	6A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2813	6666	0.037053705	0.00150015	6	6A	IN-PV	51	20	20
CTACGTCTCCGTTGCT-1_3_C4	-17.59737134	-17.36525541	6B	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2151	4467	0.025520484	0.002910231	6	6B	IN-SST	51	20	20
CTAGAGTAGAACAACT-1_3_C4	16.88943535	18.40924002	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	992	1639	0.003660769	0.004270897	6	oligos	OL-Cntl	51	20	20
CTAGAGTCACATTCGA-1_3_C4	18.65383588	7.35286801	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1901	3803	0.001051801	0.007099658	6	oligos	OL-Cntl	51	20	20
CTAGAGTCAGGGCATA-1_3_C4	33.32753124	-11.21096078	2	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2308	3710	0.018328841	0.009433962	6	2	EN-L4	51	20	20
CTAGCCTAGATATACG-1_3_C4	-20.26603273	9.189502586	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1151	1800	0.003333333	0.009444444	6	8	Astrocytes	51	20	20
CTAGCCTAGGCTATCT-1_3_C4	3.546553671	26.31015986	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	795	1291	0.00697134	0.005422153	6	oligos	OL-Cntl	51	20	20
CTAGCCTAGTGCAAGC-1_3_C4	15.81354795	27.34344206	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	820	1259	0.001588562	0.007148531	6	oligos	OL-Cntl	51	20	20
CTAGCCTAGTGGGTTG-1_3_C4	-20.00948529	8.526815616	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	940	1458	0.003429355	0.007544582	6	8	Astrocytes	51	20	20
CTAGCCTAGTTGAGAT-1_3_C4	3.73159	23.63422683	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	830	1272	0.004716981	0.007075472	6	oligos	OL-Cntl	51	20	20
CTAGCCTCATGGTAGG-1_3_C4	16.21926627	11.48489203	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1430	2449	0.004491629	0.004899959	6	oligos	OL-Cntl	51	20	20
CTAGCCTGTGCTGTAT-1_3_C4	-32.73965001	-4.497705199	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1445	2436	0.002052545	0.01272578	6	9	OPC	51	20	20
CTAGCCTTCATTGCGA-1_3_C4	16.52624473	29.26562143	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	819	1167	0.011139674	0.00428449	6	oligos	OL-Cntl	51	20	20
CTAGCCTTCCGCGCAA-1_3_C4	10.4483077	16.33325581	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1151	2037	0.003927344	0.00736377	6	oligos	OL-Cntl	51	20	20
CTAGTGACAGGACCCT-1_3_C4	2.436583356	-19.96359555	4	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	3478	8507	0.010461972	0.002233455	6	L2-3	EN-L2-3-MS	51	20	20
CTAGTGAGTCGAAAGC-1_3_C4	-19.57843538	-20.71381352	6A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2265	4783	0.030106628	0.004181476	6	6A	IN-PV	51	20	20
CTAGTGATCAAAGACA-1_3_C4	-22.67212233	-1.550535168	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1172	2074	0.005785921	0.009643202	6	9	OPC	51	20	20
CTCACACAGACTTTCG-1_3_C4	-8.980566752	-17.92471514	6B	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	837	1342	0.057377049	0.002235469	6	6B	IN-SST	51	20	20
CTCACACCATCGTCGG-1_3_C4	1.131672994	15.9324564	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	860	1354	0.004431315	0.016986706	6	oligos	OL-Cntl	51	20	20
CTCACACTCTATGTGG-1_3_C4	11.71958283	22.96689329	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	864	1361	0.005878031	0.003673769	6	oligos	OL-Cntl	51	20	20
CTCACACTCTTGTATC-1_3_C4	10.46496176	23.79967442	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	847	1363	0.000733676	0.002201027	6	oligos	OL-Cntl	51	20	20
CTCAGAAAGAAGGTGA-1_3_C4	-3.1600356	20.37219594	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	738	1104	0.007246377	0.008152174	6	oligos	OL-Cntl	51	20	20
CTCAGAAAGTGTACTC-1_3_C4	-36.17162771	2.00359268	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1721	3235	0.001236476	0.004945904	6	9	OPC	51	20	20
CTCAGAACATAAAGGT-1_3_C4	9.949462933	20.15611138	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	943	1543	0.001944264	0.01036941	6	oligos	OL-Cntl	51	20	20
CTCAGAAGTGTATGGG-1_3_C4	23.22869968	-23.98582422	3	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	3110	7423	0.018860299	0.00754412	6	3	EN-L5-6	51	20	20
CTCAGAAGTTACCGAT-1_3_C4	16.052257	9.607106119	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1667	2997	0.014347681	0.010677344	6	oligos	OL-Cntl	51	20	20
CTCAGAATCAACGAAA-1_3_C4	4.5016278	24.60595371	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	779	1133	0.001765225	0.012356575	6	oligos	OL-Cntl	51	20	20
CTCAGAATCGGCGCAT-1_3_C4	8.481443525	6.635371715	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1624	2714	0.003684598	0.012159175	6	oligos	OL-Cntl	51	20	20
CTCATTAAGATAGGAG-1_3_C4	-12.12930888	17.90610703	11	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1908	3391	0.002654084	0.007667355	6	11	Glia-MIX	51	20	20
CTCATTAAGATGGGTC-1_3_C4	-28.03518644	12.62271662	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	897	1442	0.016643551	0.002773925	6	8	Astrocytes	51	20	20
CTCATTAAGTTTAGGA-1_3_C4	20.48992092	8.609848029	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1873	3692	0.001895991	0.005687974	6	oligos	OL-Cntl	51	20	20
CTCATTAGTCGTGGCT-1_3_C4	-9.36461592	13.6311959	11	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1257	2171	0.005527407	0.004606172	6	11	Glia-MIX	51	20	20
CTCATTATCGCCAAAT-1_3_C4	-35.88713789	-8.408941205	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1052	1740	0.008045977	0.005172414	6	9	OPC	51	20	20
CTCCTAGAGGAATCGC-1_3_C4	-37.69556803	0.43317974	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1646	2960	0.002702703	0.002027027	6	9	OPC	51	20	20
CTCCTAGCAAGCGAGT-1_3_C4	12.67878014	28.49017593	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	719	1126	0.002664298	0.002664298	6	oligos	OL-Cntl	51	20	20
CTCCTAGTCAGGTTCA-1_3_C4	-28.1212819	4.235368355	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1903	3501	0.007140817	0.009140246	6	9	OPC	51	20	20
CTCCTAGTCCAGGGCT-1_3_C4	2.907773735	26.70812332	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	664	1044	0.003831418	0.001915709	6	oligos	OL-Cntl	51	20	20
CTCGAAAAGTCCTCCT-1_3_C4	-28.45538554	22.91685999	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1203	2056	0.005350195	0.003404669	6	8	Astrocytes	51	20	20
CTCGAAACATTCACTT-1_3_C4	-35.3564488	5.184685993	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2842	6857	0.002041709	0.002333382	6	9	OPC	51	20	20
CTCGAAAGTCGAGATG-1_3_C4	-24.4494792	16.54367873	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1372	2312	0.005190311	0.005190311	6	8	Astrocytes	51	20	20
CTCGAAATCAGAAATG-1_3_C4	-34.5006389	-12.98521045	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	752	1098	0.00273224	0.005464481	6	9	OPC	51	20	20
CTCGAAATCAGTACGT-1_3_C4	-16.62466534	14.62646774	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1669	2938	0.001701838	0.005105514	6	8	Astrocytes	51	20	20
CTCGAGGAGACAAGCC-1_3_C4	4.016675367	7.141665279	7	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1210	1897	0.003690037	0.006852926	6	7	Phagocytes	51	20	20
CTCGAGGAGGATGGTC-1_3_C4	-9.400665219	0.584389082	13A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2608	5288	0.004538578	0.004916793	6	13A	IN-VIP	51	20	20
CTCGAGGCAAGTTAAG-1_3_C4	-1.339792684	21.08962094	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	750	1142	0.008756567	0.011383538	6	oligos	OL-Cntl	51	20	20
CTCGAGGCATCGTCGG-1_3_C4	-28.22947713	11.24423736	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	850	1266	0.006319115	0.002369668	6	8	Astrocytes	51	20	20
CTCGAGGTCCGTACAA-1_3_C4	5.607769154	31.69199386	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	798	1227	0.00407498	0.004889976	6	oligos	OL-Cntl	51	20	20
CTCGAGGTCTCCTATA-1_3_C4	-23.44458741	2.197429856	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	3185	6370	0.006907378	0.002982732	6	9	OPC	51	20	20
CTCGGAGAGATCCCGC-1_3_C4	-23.37587125	25.02852278	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1525	2622	0.008009153	0.003432494	6	8	Astrocytes	51	20	20
CTCGGAGCAGTTTACG-1_3_C4	10.84505505	29.75666047	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	725	1160	0.006034483	0.010344828	6	oligos	OL-Cntl	51	20	20
CTCGGAGCATCAGTAC-1_3_C4	-24.76620773	17.15175086	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1218	1953	0.006144393	0.007680492	6	8	Astrocytes	51	20	20
CTCGGAGGTCATGCCG-1_3_C4	38.51757826	10.15187929	14	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	829	1089	0.002754821	0.015610652	6	14	Microglia	51	20	20
CTCGGAGGTCCGACGT-1_3_C4	5.89364359	34.07116192	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	845	1267	0.003157064	0.016574586	6	oligos	OL-Cntl	51	20	20
CTCGGGAGTTCCCGAG-1_3_C4	6.765439722	-16.32218868	4	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	3255	6633	0.010402533	0.013870044	6	L2-3	EN-L2-3-MS	51	20	20
CTCGGGATCTTGCATT-1_3_C4	-36.14370217	-3.073110763	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1292	2236	0.004472272	0.004025045	6	9	OPC	51	20	20
CTCGGGATCTTTAGTC-1_3_C4	4.867908764	23.69679422	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	913	1420	0.005633803	0.009859155	6	oligos	OL-Cntl	51	20	20
CTCGTACAGGGCATGT-1_3_C4	6.01044554	21.21471261	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	892	1354	0	0.014771049	6	oligos	OL-Cntl	51	20	20
CTCGTACGTAAGAGGA-1_3_C4	2.009938551	26.47798279	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	730	1073	0.005591799	0.001863933	6	oligos	OL-Cntl	51	20	20
CTCGTACGTGATGTGG-1_3_C4	12.58982552	29.48749714	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	704	1039	0.010587103	0.003849856	6	oligos	OL-Cntl	51	20	20
CTCGTACTCATGTCTT-1_3_C4	-0.611657449	23.56894461	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	708	1122	0.003565062	0.006238859	6	oligos	OL-Cntl	51	20	20
CTCGTACTCGAACTGT-1_3_C4	-1.213655925	25.47575313	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	690	1021	0.006856024	0.007835455	6	oligos	OL-Cntl	51	20	20
CTCGTCAAGAACTGTA-1_3_C4	13.24992311	14.29081005	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1282	2197	0.000910332	0.009558489	6	oligos	OL-Cntl	51	20	20
CTCGTCACAAGTAGTA-1_3_C4	-7.118960283	-34.32047696	16	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	746	1057	0.01986755	0.011352886	6	16	EN-PYR	51	20	20
CTCGTCACATTGTGCA-1_3_C4	19.02416227	-7.462278824	3	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2342	4957	0.001008675	0.001815614	6	3	EN-L5-6	51	20	20
CTCGTCATCAACACAC-1_3_C4	-23.42673089	0.685650266	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2675	6268	0.001754946	0.004626675	6	9	OPC	51	20	20
CTCGTCATCAGTACGT-1_3_C4	-6.123529479	-33.17248498	16	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	780	1105	0.05520362	0.009954751	6	16	EN-PYR	51	20	20
CTCGTCATCAGTTCGA-1_3_C4	31.30633702	-3.297394377	2	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	3213	7666	0.009131229	0.002478476	6	2	EN-L4	51	20	20
CTCGTCATCGCACTCT-1_3_C4	39.67200637	14.07895446	14	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1052	1603	0.001247661	0.001871491	6	14	Microglia	51	20	20
CTCTAATAGCTATGCT-1_3_C4	11.85935938	22.74308546	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	844	1356	0.005899705	0.005162242	6	oligos	OL-Cntl	51	20	20
CTCTAATCAAAGGAAG-1_3_C4	-27.82246509	8.681892298	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	738	1097	0.003646308	0.001823154	6	8	Astrocytes	51	20	20
CTCTAATTCACGCGGT-1_3_C4	12.00605064	31.20884239	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	819	1316	0.000759878	0.003039514	6	oligos	OL-Cntl	51	20	20
CTCTACGAGGTGTGGT-1_3_C4	-24.1679411	16.33430583	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1221	1895	0.002110818	0.006332454	6	8	Astrocytes	51	20	20
CTCTACGCATCTACGA-1_3_C4	1.637014989	18.76436876	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	721	1199	0.00500417	0.009174312	6	oligos	OL-Cntl	51	20	20
CTCTGGTCAGATTGCT-1_3_C4	9.285267506	-26.02242345	4	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	5862	18474	0.004817581	0.006928656	6	L2-3	EN-L2-3-MS	51	20	20
CTCTGGTGTCTGGAGA-1_3_C4	20.89629329	16.97577891	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1187	1936	0.000516529	0.002066116	6	oligos	OL-Cntl	51	20	20
CTCTGGTTCCTTGGTC-1_3_C4	4.323280679	-13.65260146	4	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2374	5092	0.022584446	0.006087981	6	L2-3	EN-L2-3-MS	51	20	20
CTCTGGTTCTACTATC-1_3_C4	-37.90772506	-1.02822578	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1390	2541	0.003541913	0.002754821	6	9	OPC	51	20	20
CTGAAACAGTAGGTGC-1_3_C4	6.339910765	24.62497853	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	912	1434	0.018131102	0.006973501	6	oligos	OL-Cntl	51	20	20
CTGAAACCAATGGAAT-1_3_C4	-21.91743766	25.53469998	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1664	3192	0	0.011591479	6	8	Astrocytes	51	20	20
CTGAAACCACTCGACG-1_3_C4	-28.34599384	22.40687138	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1167	1847	0.028695181	0.001624256	6	8	Astrocytes	51	20	20
CTGAAACGTATATGAG-1_3_C4	-24.29133638	26.13805345	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1304	2181	0.006877579	0.004126547	6	8	Astrocytes	51	20	20
CTGAAACGTTACGTCA-1_3_C4	-16.58843795	14.57132434	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1657	2886	0.003811504	0.007623008	6	8	Astrocytes	51	20	20
CTGAAACTCGCTTGTC-1_3_C4	-15.08390108	-15.91346509	6B	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1603	2905	0.026850258	0.003786575	6	6B	IN-SST	51	20	20
CTGAAGTGTCCGAAGA-1_3_C4	-0.245575734	26.30657798	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	769	1062	0.005649718	0.010357815	6	oligos	OL-Cntl	51	20	20
CTGATAGAGAAGGCCT-1_3_C4	-34.47922354	3.781436322	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2228	4381	0.004108651	0.003423876	6	9	OPC	51	20	20
CTGATAGAGCAGACTG-1_3_C4	17.57175068	8.642998899	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1743	3167	0.012630249	0.008841175	6	oligos	OL-Cntl	51	20	20
CTGATAGAGTGTGGCA-1_3_C4	-28.54450224	10.52717712	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	836	1150	0.026956522	0.003478261	6	8	Astrocytes	51	20	20
CTGATAGCAGACAGGT-1_3_C4	15.26610074	-6.355970379	10	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1591	2838	0.005637773	0.002818887	6	L2-3	EN-L2-3-Cntl	51	20	20
CTGATAGCATACTACG-1_3_C4	-11.80635386	19.46294811	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2213	4279	0.009347978	0.007945782	6	8	Astrocytes	51	20	20
CTGATAGGTTTAGGAA-1_3_C4	1.394088266	23.99488208	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	732	1123	0.007123776	0.009795191	6	oligos	OL-Cntl	51	20	20
CTGATCCCACATCCGG-1_3_C4	-10.0559607	18.34520471	11	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2213	3962	0.003785967	0.006057547	6	11	Glia-MIX	51	20	20
CTGATCCGTGATGTGG-1_3_C4	-27.85275458	9.190788965	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	800	1205	0.002489627	0.004979253	6	8	Astrocytes	51	20	20
CTGATCCTCAAGGCTT-1_3_C4	3.400315226	23.07440771	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	780	1224	0.008169935	0.008169935	6	oligos	OL-Cntl	51	20	20
CTGATCCTCGGCTTGG-1_3_C4	5.55881294	26.0016888	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	824	1323	0.006802721	0.007558579	6	oligos	OL-Cntl	51	20	20
CTGCCTAAGTGTCTCA-1_3_C4	-1.948610295	25.32493689	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	690	1067	0.024367385	0.005623243	6	oligos	OL-Cntl	51	20	20
CTGCCTAGTTTACTCT-1_3_C4	-27.87182387	22.10506188	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1218	2177	0.001378043	0.003215434	6	8	Astrocytes	51	20	20
CTGCCTAGTTTGTTGG-1_3_C4	9.50520241	16.81272337	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	993	1664	0.001802885	0.009014423	6	oligos	OL-Cntl	51	20	20
CTGCCTATCCATGAAC-1_3_C4	-28.16404292	11.48073426	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	813	1189	0.004205214	0.003364172	6	8	Astrocytes	51	20	20
CTGCCTATCGATAGAA-1_3_C4	5.242323388	-5.258661855	12	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	856	1358	0.000736377	0.000736377	6	12	EN-MIX	51	20	20
CTGCCTATCGATGAGG-1_3_C4	3.99776315	27.5132254	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	725	1012	0.006916996	0.010869565	6	oligos	OL-Cntl	51	20	20
CTGCCTATCGGATGTT-1_3_C4	20.85022088	14.19662236	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1407	2370	0.001687764	0.005485232	6	oligos	OL-Cntl	51	20	20
CTGCGGAAGAGCTGGT-1_3_C4	31.41624593	-13.37413107	2	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	3286	6829	0.034412066	0.007468151	6	2	EN-L4	51	20	20
CTGCGGAAGCAATATG-1_3_C4	-10.22185479	-19.6918914	6B	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1056	1711	0.025131502	0.002337814	6	6B	IN-SST	51	20	20
CTGCGGACAACACCCG-1_3_C4	31.63178251	-9.642768205	2	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2977	5877	0.030457717	0.003232942	6	2	EN-L4	51	20	20
CTGCGGACACCAGTTA-1_3_C4	-1.471763432	23.18915359	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	735	1081	0.007400555	0.009250694	6	oligos	OL-Cntl	51	20	20
CTGCGGACACCATCCT-1_3_C4	13.46566003	-29.97897664	3	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	3776	9892	0.001920744	0.003234937	6	3	EN-L5-6	51	20	20
CTGCGGAGTCGCTTCT-1_3_C4	-12.50602345	0.299273616	13A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	3688	8584	0.009203169	0.006407269	6	13A	IN-VIP	51	20	20
CTGCGGAGTGTCGCTG-1_3_C4	21.56914411	9.265155217	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1756	2984	0.001340483	0.009048257	6	oligos	OL-Cntl	51	20	20
CTGCGGATCACTTATC-1_3_C4	18.59086466	9.038664169	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1671	3155	0.001267829	0.003169572	6	oligos	OL-Cntl	51	20	20
CTGCGGATCCTTGGTC-1_3_C4	-29.20321022	19.60261296	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1105	1794	0.002229654	0.001114827	6	8	Astrocytes	51	20	20
CTGCTGTAGGACAGCT-1_3_C4	-1.770814795	23.65052258	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	680	1033	0.003872217	0.016456922	6	oligos	OL-Cntl	51	20	20
CTGCTGTAGGCTATCT-1_3_C4	-34.73681306	-7.654982952	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1034	1644	0.003649635	0.006082725	6	9	OPC	51	20	20
CTGCTGTCAAAGCGGT-1_3_C4	-33.56719758	4.984568869	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2731	5702	0.005261312	0.003682918	6	9	OPC	51	20	20
CTGCTGTCACTTAACG-1_3_C4	16.78691496	24.10038191	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	905	1307	0.002295333	0.003060444	6	oligos	OL-Cntl	51	20	20
CTGCTGTGTACTCTCC-1_3_C4	3.402601126	-19.52975965	4	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	4029	9897	0.001515611	0.007173891	6	L2-3	EN-L2-3-MS	51	20	20
CTGCTGTGTCCCTTGT-1_3_C4	-24.45390367	18.72849728	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1315	2082	0.010566763	0.001440922	6	8	Astrocytes	51	20	20
CTGGTCTAGTGTGGCA-1_3_C4	-28.40848661	20.98271675	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1171	1784	0.004484305	0.003923767	6	8	Astrocytes	51	20	20
CTGGTCTGTAGCCTCG-1_3_C4	-17.65647732	14.07306832	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1254	2088	0.001436782	0.00335249	6	8	Astrocytes	51	20	20
CTGGTCTTCGTTTAGG-1_3_C4	-23.21570203	24.76360571	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1603	3142	0.002546149	0.003182686	6	8	Astrocytes	51	20	20
CTGTGCTAGATCGGGT-1_3_C4	-11.58304519	18.08780645	11	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1926	3579	0.006146968	0.006426376	6	11	Glia-MIX	51	20	20
CTGTGCTAGGGCTTCC-1_3_C4	0.518220292	27.55083384	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	844	1325	0.00754717	0.006792453	6	oligos	OL-Cntl	51	20	20
CTGTGCTAGTGAAGTT-1_3_C4	12.93258133	15.40122777	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1135	1792	0.006696429	0.012276786	6	oligos	OL-Cntl	51	20	20
CTGTGCTCAAGGGTCA-1_3_C4	-11.60103225	-19.36086398	6B	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	901	1458	0.059670782	0.006858711	6	6B	IN-SST	51	20	20
CTGTGCTCAATGAATG-1_3_C4	-30.50419053	11.03889927	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	765	1150	0.012173913	0.006956522	6	8	Astrocytes	51	20	20
CTGTGCTCAGCTGGCT-1_3_C4	13.98364217	15.88593793	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1116	1771	0.007905138	0.005646527	6	oligos	OL-Cntl	51	20	20
CTGTGCTGTAAACGCG-1_3_C4	18.89693694	-7.601982771	3	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2305	4745	0.029504742	0.002107482	6	3	EN-L5-6	51	20	20
CTGTGCTGTCCATGAT-1_3_C4	-28.2076407	9.526346134	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	758	1075	0.010232558	0.002790698	6	8	Astrocytes	51	20	20
CTGTGCTGTCTACCTC-1_3_C4	-0.652954802	27.50434181	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	733	1012	0.001976285	0.005928854	6	oligos	OL-Cntl	51	20	20
CTGTGCTGTTTGGCGC-1_3_C4	15.87023259	22.2214317	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	924	1472	0.008831522	0.004076087	6	oligos	OL-Cntl	51	20	20
CTGTGCTTCTAAGCCA-1_3_C4	-27.73644843	21.30598178	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1177	1862	0.001074114	0.004296455	6	8	Astrocytes	51	20	20
CTGTGCTTCTATGTGG-1_3_C4	18.39145777	15.4959486	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1198	2066	0.005808325	0.004356244	6	oligos	OL-Cntl	51	20	20
CTGTTTAGTATAAACG-1_3_C4	-27.17651477	14.93621013	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1020	1672	0.001196172	0.003588517	6	8	Astrocytes	51	20	20
CTGTTTAGTGCAACTT-1_3_C4	3.176223556	25.50940102	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	810	1222	0.001636661	0.003273322	6	oligos	OL-Cntl	51	20	20
CTGTTTATCGTACCGG-1_3_C4	19.40702086	17.30780649	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1090	1775	0.006760563	0.007323944	6	oligos	OL-Cntl	51	20	20
CTTAACTCATCGGTTA-1_3_C4	-29.95783427	20.04698726	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	951	1492	0.004021448	0.001340483	6	8	Astrocytes	51	20	20
CTTAACTCATGGTTGT-1_3_C4	17.16356166	12.40541503	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1218	2241	0.008924587	0.003569835	6	oligos	OL-Cntl	51	20	20
CTTAACTGTAAGGATT-1_3_C4	21.2867967	8.770624131	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2036	3901	0.004870546	0.007690336	6	oligos	OL-Cntl	51	20	20
CTTAACTTCATCACCC-1_3_C4	23.26587574	-9.152316863	3	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	3324	9115	0.008886451	0.002742732	6	3	EN-L5-6	51	20	20
CTTACCGGTAAGTGGC-1_3_C4	-7.042916548	-1.174281097	13A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1824	3484	0.008036739	0.002583238	6	13A	IN-VIP	51	20	20
CTTACCGGTGTCAATC-1_3_C4	-38.09037378	-8.129615238	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1039	1819	0.001099505	0.002748763	6	9	OPC	51	20	20
CTTACCGGTTTGTTTC-1_3_C4	-25.19938112	22.26698767	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1226	2108	0.016603416	0.00711575	6	8	Astrocytes	51	20	20
CTTACCGTCTTCCTTC-1_3_C4	11.44041581	21.10827046	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	943	1481	0.015530047	0.004051317	6	oligos	OL-Cntl	51	20	20
CTTAGGAAGAAACCGC-1_3_C4	22.55822455	18.54117215	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1075	1767	0	0.003395586	6	oligos	OL-Cntl	51	20	20
CTTAGGAAGTTGAGAT-1_3_C4	14.81974066	27.76986876	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	686	1003	0.001994018	0.006979063	6	oligos	OL-Cntl	51	20	20
CTTAGGACATCCGTGG-1_3_C4	5.278861085	21.57135366	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	812	1360	0.004411765	0.011029412	6	oligos	OL-Cntl	51	20	20
CTTAGGAGTGCGCTTG-1_3_C4	25.60518954	-25.01093381	3	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	4697	14270	0.005886475	0.003924317	6	3	EN-L5-6	51	20	20
CTTAGGATCCCAAGTA-1_3_C4	19.29269745	18.80359864	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1078	1892	0.003699789	0.004756871	6	oligos	OL-Cntl	51	20	20
CTTAGGATCGCCCTTA-1_3_C4	-22.44896889	24.19640998	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1610	2832	0.018714689	0.004943503	6	8	Astrocytes	51	20	20
CTTAGGATCTCCTATA-1_3_C4	-14.55002795	0.453686227	13A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	3045	6477	0.009263548	0.010498688	6	13A	IN-VIP	51	20	20
CTTAGGATCTGCAGTA-1_3_C4	-10.97817534	-15.92471592	6B	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	997	1554	0.055341055	0.008365508	6	6B	IN-SST	51	20	20
CTTCTCTAGGCAGGTT-1_3_C4	12.69435763	17.56467278	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1074	1808	0.003318584	0.006084071	6	oligos	OL-Cntl	51	20	20
CTTCTCTCAAGCCGTC-1_3_C4	16.27877358	16.86996153	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1136	1815	0.003856749	0.002754821	6	oligos	OL-Cntl	51	20	20
CTTCTCTCACTTCTGC-1_3_C4	0.644896225	19.95102806	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	732	1110	0	0.005405405	6	oligos	OL-Cntl	51	20	20
CTTCTCTGTCTGATTG-1_3_C4	29.99028057	8.985960874	15DB	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	820	1475	0.019661017	0.02779661	6	15DB	B cells	51	20	20
CTTCTCTGTTATGTGC-1_3_C4	20.23260542	-26.77595729	3	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	4358	12613	0.000792833	0.002537065	6	3	EN-L5-6	51	20	20
CTTGGCTCAGTACACT-1_3_C4	-28.55487393	16.50036337	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	958	1553	0.007083065	0.00386349	6	8	Astrocytes	51	20	20
CTTGGCTCAGTATCTG-1_3_C4	-28.45278588	13.5437314	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	865	1420	0.00915493	0.002112676	6	8	Astrocytes	51	20	20
CTTGGCTCATTACGAC-1_3_C4	7.721450465	22.6513585	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1141	1755	0.001139601	0.009116809	6	oligos	OL-Cntl	51	20	20
CTTGGCTGTAGCGTCC-1_3_C4	15.71363348	17.17817215	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1136	1776	0.005067568	0.003941441	6	oligos	OL-Cntl	51	20	20
CTTTGCGAGTCGAGTG-1_3_C4	14.55643251	8.447920226	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1585	2891	0.00311311	0.012106538	6	oligos	OL-Cntl	51	20	20
CTTTGCGCAAGCTGTT-1_3_C4	6.723780812	-20.39144524	4	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	4440	12523	0.005589715	0.014133993	6	L2-3	EN-L2-3-MS	51	20	20
CTTTGCGCAATTCCTT-1_3_C4	11.15279513	20.848337	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	946	1605	0.001246106	0.005607477	6	oligos	OL-Cntl	51	20	20
GAAACTCAGTGGGTTG-1_3_C4	-11.77665685	-2.587958399	13A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2350	4396	0.006824386	0.00955414	6	13A	IN-VIP	51	20	20
GAAACTCGTAGAAGGA-1_3_C4	11.75660948	22.30688651	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	916	1419	0.014094433	0.00845666	6	oligos	OL-Cntl	51	20	20
GAAACTCTCAGCTCGG-1_3_C4	17.77152928	12.67201988	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1290	2090	0.002870813	0.00861244	6	oligos	OL-Cntl	51	20	20
GAAACTCTCCGTAGTA-1_3_C4	11.87099658	21.53069129	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	837	1311	0.001525553	0.004576659	6	oligos	OL-Cntl	51	20	20
GAAACTCTCGCGATCG-1_3_C4	-10.03636498	16.06346341	11	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1869	3386	0.00472534	0.002658004	6	11	Glia-MIX	51	20	20
GAAATGAAGAGACTTA-1_3_C4	5.563639034	21.01049007	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	789	1177	0.009345794	0.010195412	6	oligos	OL-Cntl	51	20	20
GAAATGAAGATCCCAT-1_3_C4	18.03683857	23.26055585	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	809	1288	0.002329193	0.001552795	6	oligos	OL-Cntl	51	20	20
GAAATGAAGTACGTTC-1_3_C4	-5.072966438	29.25856445	11	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1259	2139	0.022440393	0.006545115	6	11	Glia-MIX	51	20	20
GAAATGACAATGGAAT-1_3_C4	16.94841873	11.90132796	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1287	2229	0.002243158	0.007626738	6	oligos	OL-Cntl	51	20	20
GAAATGACACTCTGTC-1_3_C4	-28.26273629	22.9976485	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1161	1998	0.003503504	0.002502503	6	8	Astrocytes	51	20	20
GAAATGAGTACCATCA-1_3_C4	19.54572702	-7.477852773	3	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1863	3498	0.000285878	0.002572899	6	3	EN-L5-6	51	20	20
GAAATGAGTTCAGGCC-1_3_C4	15.1149972	21.4360175	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	856	1419	0.009866103	0.006342495	6	oligos	OL-Cntl	51	20	20
GAACATCAGCTCCTTC-1_3_C4	-12.03946994	-19.33424921	6B	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1050	1870	0.026203209	0.004278075	6	6B	IN-SST	51	20	20
GAACATCCACCATCCT-1_3_C4	39.4187408	10.1989622	14	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	802	1168	0.003424658	0.004280822	6	14	Microglia	51	20	20
GAACATCGTAGTACCT-1_3_C4	21.31565734	19.12399321	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	963	1544	0.00388601	0.010362694	6	oligos	OL-Cntl	51	20	20
GAACATCGTCAGTGGA-1_3_C4	17.18200174	7.185507965	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2174	4151	0.014213443	0.00746808	6	oligos	OL-Cntl	51	20	20
GAACATCTCTACCTGC-1_3_C4	-23.37973522	0.873177839	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2393	5290	0.001134216	0.004725898	6	9	OPC	51	20	20
GAACCTAAGAGCCCAA-1_3_C4	2.773814637	-11.6000303	12	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1860	3360	0.02797619	0.00327381	6	12	EN-MIX	51	20	20
GAACCTACACACTGCG-1_3_C4	8.408024642	28.31749954	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	933	1515	0.01320132	0.004620462	6	oligos	OL-Cntl	51	20	20
GAACCTAGTACTCAAC-1_3_C4	13.47642485	-31.06841286	3	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	3645	10229	0.000391045	0.002150748	6	3	EN-L5-6	51	20	20
GAACGGAAGAATCTCC-1_3_C4	-22.64329072	-20.10825443	6A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	3250	7378	0.016400108	0.007454595	6	6A	IN-PV	51	20	20
GAACGGAAGCTAAACA-1_3_C4	1.315941554	24.70315156	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	636	1026	0.001949318	0.003898635	6	oligos	OL-Cntl	51	20	20
GAACGGACACGAAAGC-1_3_C4	-25.00917352	19.60752164	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1489	2527	0.006331619	0.004748714	6	8	Astrocytes	51	20	20
GAACGGACATGACATC-1_3_C4	2.301623566	20.71150961	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	827	1151	0.004344049	0.016507385	6	oligos	OL-Cntl	51	20	20
GAACGGAGTCCGTCAG-1_3_C4	18.67606	18.7544103	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1062	1865	0.003753351	0.005898123	6	oligos	OL-Cntl	51	20	20
GAACGGAGTTTAGCTG-1_3_C4	16.68177266	24.37639743	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	881	1404	0.002849003	0.000712251	6	oligos	OL-Cntl	51	20	20
GAAGCAGAGCGTGAAC-1_3_C4	14.01523228	28.62311073	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	759	1170	0.008547009	0.002564103	6	oligos	OL-Cntl	51	20	20
GAAGCAGAGCGTTTAC-1_3_C4	-32.53785869	-11.28697422	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	907	1271	0.000786782	0.003147128	6	9	OPC	51	20	20
GAAGCAGAGCTGCGAA-1_3_C4	-22.40835692	24.31327421	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1610	2847	0	0.005619951	6	8	Astrocytes	51	20	20
GAAGCAGCACTTCTGC-1_3_C4	12.2986374	31.29373699	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	713	1123	0.003561888	0.003561888	6	oligos	OL-Cntl	51	20	20
GAAGCAGCATACCATG-1_3_C4	4.312502124	23.88730725	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	891	1309	0.00381971	0.005347594	6	oligos	OL-Cntl	51	20	20
GAAGCAGGTCGTCTTC-1_3_C4	18.71659679	22.18823816	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	955	1605	0.004984424	0.004984424	6	oligos	OL-Cntl	51	20	20
GAAGCAGTCTCTGTCG-1_3_C4	9.735055712	21.22438521	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	859	1324	0.009818731	0.009063444	6	oligos	OL-Cntl	51	20	20
GAAGCAGTCTTCCTTC-1_3_C4	-24.26956042	22.46214185	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1407	2380	0.008403361	0.002521008	6	8	Astrocytes	51	20	20
GAATAAGAGATCCCAT-1_3_C4	12.02935188	20.73316175	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	921	1550	0.001935484	0.010322581	6	oligos	OL-Cntl	51	20	20
GAATAAGAGATGGGTC-1_3_C4	-31.31459802	11.21097993	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	687	1113	0.002695418	0.001796945	6	8	Astrocytes	51	20	20
GAATAAGAGGCATGGT-1_3_C4	-17.01063686	12.87656247	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1353	2454	0.001629992	0.002852486	6	8	Astrocytes	51	20	20
GAATAAGCAGCAGTTT-1_3_C4	15.24393575	19.85809993	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1051	1703	0.003523194	0.003523194	6	oligos	OL-Cntl	51	20	20
GAATAAGGTCACTGGC-1_3_C4	-27.23533033	23.95733587	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1275	2269	0.005288673	0.003085059	6	8	Astrocytes	51	20	20
GAATGAACACCCAGTG-1_3_C4	-24.99115553	24.34315813	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1443	2748	0.006550218	0.008005822	6	8	Astrocytes	51	20	20
GAATGAACACGACGAA-1_3_C4	-24.78443618	17.11968728	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1288	2273	0.001759789	0.005719314	6	8	Astrocytes	51	20	20
GAATGAACACGTCAGC-1_3_C4	1.70331471	23.99383287	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	716	1119	0.004468275	0.00893655	6	oligos	OL-Cntl	51	20	20
GAATGAACAGACGCCT-1_3_C4	32.5361774	15.35031693	14	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1092	1717	0.001164822	0.048922539	6	14	Microglia	51	20	20
GAATGAACAGCCTATA-1_3_C4	3.410682195	25.54653641	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	783	1162	0.00172117	0.011187608	6	oligos	OL-Cntl	51	20	20
GAATGAAGTAATCGTC-1_3_C4	10.84199689	-21.02270413	4	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	3965	10997	0.009911794	0.002455215	6	L2-3	EN-L2-3-MS	51	20	20
GAATGAAGTCTCCACT-1_3_C4	5.100416711	21.34640462	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	865	1384	0.005057803	0.005057803	6	oligos	OL-Cntl	51	20	20
GAATGAATCAGAGGTG-1_3_C4	1.983544265	-17.82886627	4	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	3127	7326	0.011193011	0.002866503	6	L2-3	EN-L2-3-MS	51	20	20
GAATGAATCCAAAGTC-1_3_C4	2.08368105	-17.62734129	4	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	3296	9014	0.013090748	0.002218771	6	L2-3	EN-L2-3-MS	51	20	20
GACACGCAGGTAAACT-1_3_C4	-34.29829996	-10.1637295	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1041	1651	0.005451242	0.001211387	6	9	OPC	51	20	20
GACACGCAGTGTGGCA-1_3_C4	22.08708537	12.26201052	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1465	2563	0.002341007	0.007413188	6	oligos	OL-Cntl	51	20	20
GACACGCCAAGGTTTC-1_3_C4	18.10324012	17.3265745	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1212	2114	0.003311258	0.005676443	6	oligos	OL-Cntl	51	20	20
GACACGCGTAGCTTGT-1_3_C4	-2.520558053	-0.926174853	11	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2971	6033	0.016243991	0.005967181	6	11	Glia-MIX	51	20	20
GACACGCGTTTGACTG-1_3_C4	10.2850029	17.24377212	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1031	1645	0.009118541	0.012765957	6	oligos	OL-Cntl	51	20	20
GACACGCTCTAACTGG-1_3_C4	-38.90908042	-1.338087236	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1407	2677	0.001120657	0.000747105	6	9	OPC	51	20	20
GACAGAGCATGCCACG-1_3_C4	17.43607373	20.37900073	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	976	1598	0.001877347	0.003754693	6	oligos	OL-Cntl	51	20	20
GACAGAGGTGACGCCT-1_3_C4	-11.92627932	13.9149156	11	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	999	1417	0.01905434	0.006351447	6	11	Glia-MIX	51	20	20
GACAGAGGTGTGGTTT-1_3_C4	-22.63350973	27.33770573	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2012	3915	0.010983397	0.004342273	6	8	Astrocytes	51	20	20
GACAGAGTCATCGCTC-1_3_C4	21.76398166	12.40117855	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1432	2521	0.00396668	0.001586672	6	oligos	OL-Cntl	51	20	20
GACAGAGTCGGTCTAA-1_3_C4	18.45470643	16.22439832	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1170	1889	0.001588142	0.005293806	6	oligos	OL-Cntl	51	20	20
GACAGAGTCTTGTCAT-1_3_C4	3.255579618	26.41693748	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	730	1168	0.002568493	0.004280822	6	oligos	OL-Cntl	51	20	20
GACCAATAGGTCATCT-1_3_C4	6.137322171	21.62688142	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	887	1497	0.004008016	0.008016032	6	oligos	OL-Cntl	51	20	20
GACCAATGTAAGAGAG-1_3_C4	11.66946612	16.52948825	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1074	1660	0.001807229	0.009638554	6	oligos	OL-Cntl	51	20	20
GACCAATTCGCAGGCT-1_3_C4	4.505384531	-15.45244638	4	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	3107	7111	0.013218957	0.004781325	6	L2-3	EN-L2-3-MS	51	20	20
GACCTGGCAACGATGG-1_3_C4	-23.87684162	-0.187215912	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2037	3766	0.00424854	0.003717472	6	9	OPC	51	20	20
GACCTGGGTCTAAAGA-1_3_C4	-34.79018595	4.814832122	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2461	4944	0.002022654	0.0052589	6	9	OPC	51	20	20
GACCTGGTCTGGCGTG-1_3_C4	16.47575201	20.84243909	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	985	1567	0.005743459	0.004467135	6	oligos	OL-Cntl	51	20	20
GACGCGTAGTGAACAT-1_3_C4	2.074107924	20.4055172	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	826	1243	0.004022526	0.019308126	6	oligos	OL-Cntl	51	20	20
GACGCGTCAACAACCT-1_3_C4	-0.624838547	19.18667204	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	791	1173	0.002557545	0.016197783	6	oligos	OL-Cntl	51	20	20
GACGCGTCAACTGCGC-1_3_C4	20.91838268	14.90441348	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1164	2047	0.00048852	0.006350757	6	oligos	OL-Cntl	51	20	20
GACGCGTCAGCTCGAC-1_3_C4	16.96552861	21.50683668	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	953	1534	0.001303781	0.003911343	6	oligos	OL-Cntl	51	20	20
GACGCGTCATAACCTG-1_3_C4	-22.59248543	-4.518895274	13A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2566	5121	0.008201523	0.008006249	6	13A	IN-VIP	51	20	20
GACGCGTTCACGCATA-1_3_C4	-25.72948529	19.30363657	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1378	2288	0.006555944	0.003496503	6	8	Astrocytes	51	20	20
GACGGCTAGGGCACTA-1_3_C4	-18.75399358	-24.31239906	6A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2328	4766	0.0096517	0.003986572	6	6A	IN-PV	51	20	20
GACGGCTGTCCAAGTT-1_3_C4	-28.46890746	12.28822576	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	759	1156	0.000865052	0.00432526	6	8	Astrocytes	51	20	20
GACGGCTGTGAGGCTA-1_3_C4	-12.05409121	13.79193874	11	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	786	1065	0.010328638	0.00657277	6	11	Glia-MIX	51	20	20
GACGGCTTCACCTTAT-1_3_C4	22.30761864	17.70035887	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1124	1764	0.002267574	0.005668934	6	oligos	OL-Cntl	51	20	20
GACGGCTTCGGCATCG-1_3_C4	-1.592781398	21.97919599	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	708	1017	0.01179941	0.007866273	6	oligos	OL-Cntl	51	20	20
GACGGCTTCGTGTAGT-1_3_C4	-29.97148051	9.705245742	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	739	1119	0.00714924	0.002680965	6	8	Astrocytes	51	20	20
GACGTGCAGCTACCGC-1_3_C4	12.16724406	17.53713047	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1138	1815	0.009366391	0.007162534	6	oligos	OL-Cntl	51	20	20
GACGTGCCATCTCCCA-1_3_C4	2.539029114	24.38475497	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	887	1244	0.002411576	0.003215434	6	oligos	OL-Cntl	51	20	20
GACGTGCGTTGCTCCT-1_3_C4	-27.65533767	17.16441307	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1085	1826	0.001642935	0.004381161	6	8	Astrocytes	51	20	20
GACGTTAAGTTAGGTA-1_3_C4	-0.943771978	25.49853233	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	727	1107	0	0.007226739	6	oligos	OL-Cntl	51	20	20
GACGTTAGTAATAGCA-1_3_C4	-24.15005932	19.21065645	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1460	2390	0.00209205	0.0041841	6	8	Astrocytes	51	20	20
GACGTTAGTGCGCTTG-1_3_C4	-29.54536678	19.92296855	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	992	1627	0.004917025	0.002458513	6	8	Astrocytes	51	20	20
GACGTTATCTTAGAGC-1_3_C4	5.905385082	-13.34812541	4	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2379	4677	0.008338679	0.008124866	6	L2-3	EN-L2-3-MS	51	20	20
GACTAACCACACATGT-1_3_C4	11.97067647	13.48538295	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1265	2178	0.005509642	0.01010101	6	oligos	OL-Cntl	51	20	20
GACTAACGTACCGTAT-1_3_C4	24.25807901	-29.41048598	3	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	3346	9106	0.011421041	0.002415989	6	3	EN-L5-6	51	20	20
GACTAACGTCTGCCAG-1_3_C4	16.42243349	16.07772964	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1090	1837	0.003810561	0.008165487	6	oligos	OL-Cntl	51	20	20
GACTAACTCACTCTTA-1_3_C4	23.69272179	13.08185611	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1387	2514	0.001193317	0.00159109	6	oligos	OL-Cntl	51	20	20
GACTAACTCGCAGGCT-1_3_C4	3.12544105	23.53240377	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	815	1158	0.006044905	0.005181347	6	oligos	OL-Cntl	51	20	20
GACTACAAGGGATCTG-1_3_C4	-23.832721	25.3163757	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1624	3046	0.014445174	0.004267892	6	8	Astrocytes	51	20	20
GACTACACAAGCCCAC-1_3_C4	32.01446514	-10.29140971	2	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	5110	13665	0.011489206	0.008927918	6	2	EN-L4	51	20	20
GACTACACACCAGGCT-1_3_C4	-21.67687346	25.86013337	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1736	3366	0.000891266	0.01010101	6	8	Astrocytes	51	20	20
GACTACACAGTTCCCT-1_3_C4	15.8514586	17.82998289	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1109	1945	0.000514139	0.005141388	6	oligos	OL-Cntl	51	20	20
GACTACACATCAGTAC-1_3_C4	10.71754846	31.62756324	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	935	1542	0.018158236	0.005188067	6	oligos	OL-Cntl	51	20	20
GACTACAGTTGTCGCG-1_3_C4	18.74112479	18.39767301	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1081	1707	0.003514938	0.002929115	6	oligos	OL-Cntl	51	20	20
GACTGCGCACTTACGA-1_3_C4	-27.04782545	12.0262068	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	860	1230	0.010569106	0.002439024	6	8	Astrocytes	51	20	20
GACTGCGTCTTGCAAG-1_3_C4	-0.035689335	24.58182109	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	771	1144	0.002622378	0.01048951	6	oligos	OL-Cntl	51	20	20
GAGCAGAAGGCGATAC-1_3_C4	-8.969550299	-2.518345966	13A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2257	4478	0.013622153	0.003796338	6	13A	IN-VIP	51	20	20
GAGCAGACACATTTCT-1_3_C4	2.292176177	25.38676846	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	663	1056	0.011363636	0.005681818	6	oligos	OL-Cntl	51	20	20
GAGCAGACACGCCAGT-1_3_C4	39.87545062	14.30330968	14	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1229	1892	0.001057082	0.004756871	6	14	Microglia	51	20	20
GAGCAGACAGCCTTTC-1_3_C4	12.45286196	20.87989007	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	933	1529	0.005232178	0.006540222	6	oligos	OL-Cntl	51	20	20
GAGCAGACAGCTCGAC-1_3_C4	17.91187317	-28.93087574	3	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	4635	12788	0.01110416	0.003518924	6	3	EN-L5-6	51	20	20
GAGCAGAGTAATCACC-1_3_C4	-29.97868768	13.32289586	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	894	1345	0.005204461	0.004460967	6	8	Astrocytes	51	20	20
GAGGTGAAGCAATATG-1_3_C4	21.89133679	16.13050925	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1274	2019	0.000495295	0.010896483	6	oligos	OL-Cntl	51	20	20
GAGGTGAAGTCTTGCA-1_3_C4	-1.109013	24.80098965	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	688	1014	0.00295858	0.00887574	6	oligos	OL-Cntl	51	20	20
GAGGTGACACGCCAGT-1_3_C4	19.18123235	-17.57338017	4	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	8534	37597	0.038806288	0.004973801	6	L2-3	EN-L2-3-MS	51	20	20
GAGGTGAGTGTCCTCT-1_3_C4	-32.15304985	-8.881808958	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1004	1603	0	0.01996257	6	9	OPC	51	20	20
GAGGTGATCCTTGACC-1_3_C4	5.928466091	6.52629088	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1876	3267	0.003979186	0.006734007	6	oligos	OL-Cntl	51	20	20
GAGGTGATCGCAAGCC-1_3_C4	8.478178018	-21.83088458	4	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	5236	14962	0.010894265	0.009958562	6	L2-3	EN-L2-3-MS	51	20	20
GAGTCCGAGGGAGTAA-1_3_C4	14.79443972	21.89945909	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1004	1519	0.005266623	0.007241606	6	oligos	OL-Cntl	51	20	20
GAGTCCGCAGACGCTC-1_3_C4	-29.89267805	13.43824647	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	860	1322	0.008320726	0.003025719	6	8	Astrocytes	51	20	20
GAGTCCGGTCCGAGTC-1_3_C4	-14.83857935	-4.163463086	13A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	4379	10731	0.013605442	0.006336781	6	13A	IN-VIP	51	20	20
GAGTCCGTCAACGAAA-1_3_C4	18.66909669	-6.638251502	3	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1745	3494	0.012593017	0.002575844	6	3	EN-L5-6	51	20	20
GAGTCCGTCCCGACTT-1_3_C4	14.03844499	20.04461195	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	911	1448	0.002071823	0.003453039	6	oligos	OL-Cntl	51	20	20
GATCAGTAGAACAATC-1_3_C4	25.11850004	4.329079083	15BA	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1553	2718	0.002207506	0.005518764	6	15BA	Stromal cells	51	20	20
GATCAGTCAACTTGAC-1_3_C4	-28.9628729	10.18403957	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	690	1060	0.003773585	0.005660377	6	8	Astrocytes	51	20	20
GATCAGTGTCTCTCTG-1_3_C4	13.04416706	26.50952628	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	788	1302	0.009984639	0.001536098	6	oligos	OL-Cntl	51	20	20
GATCAGTTCCAGTAGT-1_3_C4	17.71264851	15.19291285	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1124	1856	0.003232759	0.009159483	6	oligos	OL-Cntl	51	20	20
GATCAGTTCCCACTTG-1_3_C4	32.7611227	9.059805701	14	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	752	1338	0.000747384	0.016442451	6	14	Microglia	51	20	20
GATCAGTTCCCAGGTG-1_3_C4	2.630669504	-26.95821618	10	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	3640	9463	0.001162422	0.005495086	6	L2-3	EN-L2-3-Cntl	51	20	20
GATCGATAGTGTTTGC-1_3_C4	-37.10948423	-3.262111684	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1229	2190	0.005479452	0.003196347	6	9	OPC	51	20	20
GATCGATCATGACATC-1_3_C4	-38.3214393	-7.932745507	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1137	2090	0.003827751	0.001913876	6	9	OPC	51	20	20
GATCGATGTAATCGTC-1_3_C4	18.29194951	18.99894024	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1060	1785	0.003361345	0.005042017	6	oligos	OL-Cntl	51	20	20
GATCGATGTCCCTTGT-1_3_C4	-38.08125447	-0.343493287	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1601	3099	0	0.005162956	6	9	OPC	51	20	20
GATCGATGTCGCATAT-1_3_C4	14.83431705	26.71984561	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	841	1430	0.003496503	0.000699301	6	oligos	OL-Cntl	51	20	20
GATCGATGTTCGCGAC-1_3_C4	-34.14316604	-7.787979481	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1139	1677	0.008944544	0.004770423	6	9	OPC	51	20	20
GATCGATGTTGTGGAG-1_3_C4	33.12244625	-5.221790373	2	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2991	6121	0.015847084	0.003757556	6	2	EN-L4	51	20	20
GATCGATTCATCATTC-1_3_C4	3.330273083	-24.04981323	4	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	4944	14662	0.005456282	0.01452735	6	L2-3	EN-L2-3-MS	51	20	20
GATCGCGAGGGATCTG-1_3_C4	-16.82208797	13.28323837	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1335	2141	0.001868286	0.005137786	6	8	Astrocytes	51	20	20
GATCGCGAGTGAACAT-1_3_C4	38.08496242	11.75871681	14	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1027	1709	0.000585138	0.01170275	6	14	Microglia	51	20	20
GATCGCGCACACCGAC-1_3_C4	12.01032566	13.38887847	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1463	2912	0.000343407	0.004464286	6	oligos	OL-Cntl	51	20	20
GATCGCGCATCTACGA-1_3_C4	-3.1989553	-5.979893842	13A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	918	1500	0.012	0.002666667	6	13A	IN-VIP	51	20	20
GATCGCGGTTACGACT-1_3_C4	20.84283364	19.50382265	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1082	1803	0.00942873	0.000554631	6	oligos	OL-Cntl	51	20	20
GATCGCGTCATTATCC-1_3_C4	20.28300055	15.01361885	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1320	2203	0.002723559	0.004539265	6	oligos	OL-Cntl	51	20	20
GATCGTAAGAAGATTC-1_3_C4	-35.62004908	4.795260452	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2436	5189	0.004817884	0.0025053	6	9	OPC	51	20	20
GATCGTAAGATGCCAG-1_3_C4	12.78143367	23.62524787	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	856	1270	0.009448819	0.004724409	6	oligos	OL-Cntl	51	20	20
GATCGTAAGGTGACCA-1_3_C4	10.18614616	-20.65038458	4	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	5808	18313	0.009829083	0.010375143	6	L2-3	EN-L2-3-MS	51	20	20
GATCGTAAGTCCTCCT-1_3_C4	20.90652829	8.121862606	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1979	3873	0.002065582	0.008262329	6	oligos	OL-Cntl	51	20	20
GATCGTACAGACAAAT-1_3_C4	3.239910165	17.9616754	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	989	1647	0.004250152	0.011536126	6	oligos	OL-Cntl	51	20	20
GATCGTAGTAGGAGTC-1_3_C4	-28.45136381	21.98877401	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1252	2074	0.018322083	0.004339441	6	8	Astrocytes	51	20	20
GATCGTAGTTAAGTAG-1_3_C4	-12.41275893	-0.965244532	13A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2506	4743	0.015391103	0.008433481	6	13A	IN-VIP	51	20	20
GATCGTATCAAGGTAA-1_3_C4	18.02830049	16.89494308	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1178	1961	0.002039776	0.00917899	6	oligos	OL-Cntl	51	20	20
GATCGTATCATCATTC-1_3_C4	-39.52886254	0.081421688	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1571	3067	0.002934464	0.003912618	6	9	OPC	51	20	20
GATCTAGAGGTAGCTG-1_3_C4	-16.53923486	14.74631828	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1747	3156	0.00095057	0.006653992	6	8	Astrocytes	51	20	20
GATCTAGCAGGTGGAT-1_3_C4	16.74766716	14.1115802	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1281	2060	0.006796117	0.007281553	6	oligos	OL-Cntl	51	20	20
GATCTAGGTCTAGTGT-1_3_C4	-1.344572739	22.95582618	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	773	1187	0	0.01095198	6	oligos	OL-Cntl	51	20	20
GATCTAGGTCTCATCC-1_3_C4	-37.34402141	-0.658753835	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1514	2899	0.003794412	0.002414626	6	9	OPC	51	20	20
GATCTAGTCAGGTAAA-1_3_C4	3.61358206	26.70701538	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	709	1090	0.002752294	0.005504587	6	oligos	OL-Cntl	51	20	20
GATGAAAGTTCGCGAC-1_3_C4	-1.534578315	20.22574866	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	665	1026	0.005847953	0.00877193	6	oligos	OL-Cntl	51	20	20
GATGAAATCGAGCCCA-1_3_C4	15.20043142	-8.101094255	3	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2354	5059	0.002767345	0.00395335	6	3	EN-L5-6	51	20	20
GATGAGGAGCCAGTTT-1_3_C4	3.506201676	22.24129658	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	813	1212	0.004950495	0.00660066	6	oligos	OL-Cntl	51	20	20
GATGAGGAGGGCTTCC-1_3_C4	-0.105623471	20.26874639	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	694	1084	0.002767528	0.006457565	6	oligos	OL-Cntl	51	20	20
GATGAGGCATCACCCT-1_3_C4	2.376024358	26.54124597	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	642	1021	0	0.003917728	6	oligos	OL-Cntl	51	20	20
GATGAGGGTCAATACC-1_3_C4	0.286273541	18.65813008	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	717	1134	0.007936508	0.013227513	6	oligos	OL-Cntl	51	20	20
GATGCTAAGAATTGTG-1_3_C4	16.98164538	11.80765451	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1440	2828	0.002475248	0.007072136	6	oligos	OL-Cntl	51	20	20
GATGCTAAGTGCAAGC-1_3_C4	-31.80972244	-9.18159059	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	998	1510	0.005298013	0.016556291	6	9	OPC	51	20	20
GATGCTAGTAAAGTCA-1_3_C4	10.3316392	19.97594097	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	938	1509	0.004638834	0.006626905	6	oligos	OL-Cntl	51	20	20
GATGCTAGTTTAGCTG-1_3_C4	-24.34999936	22.66284573	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1314	2234	0.004923903	0.003133393	6	8	Astrocytes	51	20	20
GATGCTATCAGTCAGT-1_3_C4	-23.74835339	-25.38134146	6A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	4973	14576	0.017288694	0.010976948	6	6A	IN-PV	51	20	20
GATGCTATCCCTCTTT-1_3_C4	5.569874415	30.25362868	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	696	1053	0.000949668	0.002849003	6	oligos	OL-Cntl	51	20	20
GATGCTATCTTACCGC-1_3_C4	-27.79069664	13.18400586	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	956	1681	0.000594884	0.002379536	6	8	Astrocytes	51	20	20
GATTCAGAGGTGCAAC-1_3_C4	1.039073411	24.78667127	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	667	1040	0.014423077	0.002884615	6	oligos	OL-Cntl	51	20	20
GATTCAGCAAAGGCGT-1_3_C4	8.046098149	35.03041964	17	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1056	1538	0.004551365	0.005851756	6	oligos	OL-MS-2	51	20	20
GATTCAGGTAATCGTC-1_3_C4	-25.00302058	25.2636391	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1432	2593	0.008484381	0.006556113	6	8	Astrocytes	51	20	20
GATTCAGGTCTCATCC-1_3_C4	-39.21451217	-1.220641204	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1402	2662	0.003005259	0.002253944	6	9	OPC	51	20	20
GCAAACTAGCGCCTTG-1_3_C4	-28.6081276	20.39373472	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1231	2009	0.007964161	0.005475361	6	8	Astrocytes	51	20	20
GCAAACTCAAGTCATC-1_3_C4	7.172707588	-21.79721604	4	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	5168	15767	0.007610833	0.007293715	6	L2-3	EN-L2-3-MS	51	20	20
GCAAACTCAAGTCTGT-1_3_C4	3.789816194	27.11344077	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	699	1089	0.018365473	0.003673095	6	oligos	OL-Cntl	51	20	20
GCAAACTCACCGATAT-1_3_C4	-31.89290734	0.403949465	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1718	2998	0.002001334	0.002668446	6	9	OPC	51	20	20
GCAAACTCAGAGTGTG-1_3_C4	-2.068329886	22.59172279	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	822	1272	0.009433962	0.009433962	6	oligos	OL-Cntl	51	20	20
GCAAACTGTCGCGTGT-1_3_C4	-33.16190147	-10.10406525	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1031	1691	0.00295683	0.008870491	6	9	OPC	51	20	20
GCAAACTGTTGAACTC-1_3_C4	-28.90669162	10.85265569	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	781	1170	0.013675214	0.004273504	6	8	Astrocytes	51	20	20
GCAAACTTCCGCAAGC-1_3_C4	1.406808882	18.14655466	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	769	1212	0.004950495	0.014026403	6	oligos	OL-Cntl	51	20	20
GCAAACTTCTATGTGG-1_3_C4	-10.87159287	-35.67082428	16	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1268	1924	0.051455301	0.009355509	6	16	EN-PYR	51	20	20
GCAATCAAGGCAGTCA-1_3_C4	14.50790084	16.48321392	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1087	1703	0.003523194	0.002935995	6	oligos	OL-Cntl	51	20	20
GCAATCAAGTCAAGCG-1_3_C4	-36.20281432	-4.974043216	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1193	1974	0.001519757	0.001519757	6	9	OPC	51	20	20
GCAATCACAATCGAAA-1_3_C4	22.20871476	17.08531055	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1198	1924	0.001559252	0.009355509	6	oligos	OL-Cntl	51	20	20
GCAATCACACTCGACG-1_3_C4	-9.128140221	17.04191423	11	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2890	6291	0.002702273	0.004450803	6	11	Glia-MIX	51	20	20
GCAATCATCCGCGTTT-1_3_C4	12.18146682	19.97426853	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1069	1854	0.012405609	0.003236246	6	oligos	OL-Cntl	51	20	20
GCAATCATCCTATTCA-1_3_C4	2.293712211	27.44577302	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	778	1220	0.005737705	0.004918033	6	oligos	OL-Cntl	51	20	20
GCAATCATCTAAGCCA-1_3_C4	-34.64966317	-13.19712136	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	667	1052	0.00095057	0.002851711	6	9	OPC	51	20	20
GCACATAAGCAGATCG-1_3_C4	5.922640447	18.35495123	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1012	1565	0.005750799	0.017891374	6	oligos	OL-Cntl	51	20	20
GCACATAAGGAGTAGA-1_3_C4	-0.280985948	22.89863167	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	860	1298	0.019260401	0.01540832	6	oligos	OL-Cntl	51	20	20
GCACATAGTATATCCG-1_3_C4	-21.71484227	10.3849136	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1074	1688	0.004146919	0.002369668	6	8	Astrocytes	51	20	20
GCACATAGTCACCCAG-1_3_C4	2.536820074	23.11022251	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	820	1253	0.007980846	0.004788508	6	oligos	OL-Cntl	51	20	20
GCACATAGTCTCACCT-1_3_C4	0.462189946	25.44584299	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	751	1225	0.003265306	0.007346939	6	oligos	OL-Cntl	51	20	20
GCACATAGTCTTGCGG-1_3_C4	19.67204336	14.92255995	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1148	1946	0.009763618	0	6	oligos	OL-Cntl	51	20	20
GCACTCTAGATCCCAT-1_3_C4	12.07180296	9.439329767	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1527	2599	0.007310504	0.010003848	6	oligos	OL-Cntl	51	20	20
GCACTCTAGGCAGGTT-1_3_C4	-11.9502726	17.63091717	11	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1765	3014	0.008294625	0.00265428	6	11	Glia-MIX	51	20	20
GCACTCTCACCGAAAG-1_3_C4	38.15222098	9.319007806	14	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	775	1104	0.004528986	0.008152174	6	14	Microglia	51	20	20
GCACTCTCATTTGCCC-1_3_C4	-35.42733109	0.590674994	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1637	3337	0.005094396	0.009889122	6	9	OPC	51	20	20
GCACTCTTCAGTTGAC-1_3_C4	19.26869274	14.50235499	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1340	2379	0.002101723	0.001261034	6	oligos	OL-Cntl	51	20	20
GCAGCCAAGTTATCGC-1_3_C4	22.24844006	-9.555117615	3	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2204	4297	0.010239702	0.003723528	6	3	EN-L5-6	51	20	20
GCAGCCACAGGACGTA-1_3_C4	-15.06924641	-3.526594078	13A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	4681	11898	0.007144058	0.009917633	6	13A	IN-VIP	51	20	20
GCAGCCACATAGTAAG-1_3_C4	-26.84467874	9.971393609	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	908	1380	0.000724638	0.008695652	6	8	Astrocytes	51	20	20
GCAGCCATCACAGTAC-1_3_C4	15.41293751	10.31425947	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1505	2720	0.012867647	0.008088235	6	oligos	OL-Cntl	51	20	20
GCAGCCATCCTTTCGG-1_3_C4	4.009167943	25.34591354	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	731	1136	0.002640845	0.006161972	6	oligos	OL-Cntl	51	20	20
GCAGTTAAGATGTAAC-1_3_C4	15.61933982	19.77813767	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1098	1764	0.001133787	0.002834467	6	oligos	OL-Cntl	51	20	20
GCAGTTAGTCCTAGCG-1_3_C4	9.800890849	25.73120097	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	914	1387	0.004325883	0.002883922	6	oligos	OL-Cntl	51	20	20
GCAGTTAGTGGTAACG-1_3_C4	-15.00635144	-6.103165404	13A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	4598	12332	0.004865391	0.007865715	6	13A	IN-VIP	51	20	20
GCAGTTAGTGTTCGAT-1_3_C4	-28.50963538	22.25449988	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1096	1747	0.002862049	0.003434459	6	8	Astrocytes	51	20	20
GCATACATCAGGTTCA-1_3_C4	-17.16793517	-4.600886662	13A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	3888	9323	0.017054596	0.008366406	6	13A	IN-VIP	51	20	20
GCATGATAGTCAAGCG-1_3_C4	9.261017232	20.41077858	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	913	1454	0.001375516	0.007565337	6	oligos	OL-Cntl	51	20	20
GCATGATGTGCAGTAG-1_3_C4	14.53695306	13.09247303	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1395	2247	0.012016021	0.009790832	6	oligos	OL-Cntl	51	20	20
GCATGATTCGCGGATC-1_3_C4	-19.85550923	-24.05115	6A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2955	6684	0.016906044	0.004338719	6	6A	IN-PV	51	20	20
GCATGATTCTTACCTA-1_3_C4	-25.6576728	22.48583422	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1360	2275	0.003516484	0.006153846	6	8	Astrocytes	51	20	20
GCATGCGCAACGATGG-1_3_C4	7.181671717	29.16414963	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	898	1433	0.009071877	0.00418702	6	oligos	OL-Cntl	51	20	20
GCATGCGCACTTCGAA-1_3_C4	-28.60927973	10.26118075	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	831	1247	0.008821171	0.006415397	6	8	Astrocytes	51	20	20
GCATGCGGTGTAATGA-1_3_C4	-3.743252436	20.06077274	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	740	1100	0.012727273	0.013636364	6	oligos	OL-Cntl	51	20	20
GCATGTAAGCACAGGT-1_3_C4	-8.934354302	14.93564648	11	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2060	3771	0.00636436	0.00636436	6	11	Glia-MIX	51	20	20
GCATGTACAGCCTTTC-1_3_C4	0.76749923	25.05468537	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	633	1003	0.013958126	0.004985045	6	oligos	OL-Cntl	51	20	20
GCATGTACATTTCAGG-1_3_C4	-39.12531695	0.097280315	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1543	2869	0.004531196	0.004182642	6	9	OPC	51	20	20
GCATGTAGTAAGGATT-1_3_C4	-10.25646016	-35.87044168	16	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1180	2070	0.057971014	0.004347826	6	16	EN-PYR	51	20	20
GCATGTATCCGTCATC-1_3_C4	-16.42369804	-9.916656498	13B	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2816	6242	0.006408202	0.002723486	6	13B	IN-SV2C	51	20	20
GCATGTATCCTATGTT-1_3_C4	20.16688188	9.002481994	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1692	3358	0	0.004764741	6	oligos	OL-Cntl	51	20	20
GCCAAATAGAGCTATA-1_3_C4	-1.846332346	18.39584467	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	725	1094	0.001828154	0.013711152	6	oligos	OL-Cntl	51	20	20
GCCAAATAGTACGTAA-1_3_C4	12.13606793	-21.71878908	4	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	4919	13643	0.006670087	0.004837646	6	L2-3	EN-L2-3-MS	51	20	20
GCCAAATAGTATCTCG-1_3_C4	17.48674374	12.15828587	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1385	2486	0.002815768	0.004022526	6	oligos	OL-Cntl	51	20	20
GCCAAATCACATGTGT-1_3_C4	25.36834416	-27.38454075	3	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	4780	14662	0.006752148	0.003410176	6	3	EN-L5-6	51	20	20
GCCAAATCAGACAGGT-1_3_C4	16.23967522	6.141237084	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2237	4350	0.011494253	0.012873563	6	oligos	OL-Cntl	51	20	20
GCCAAATGTGATGTGG-1_3_C4	-35.57459094	0.481620979	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1785	3111	0.005785921	0.005464481	6	9	OPC	51	20	20
GCCAAATTCAGAAATG-1_3_C4	7.103139372	25.50886323	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	987	1602	0	0.004369538	6	oligos	OL-Cntl	51	20	20
GCCTCTAAGGAGTACC-1_3_C4	10.93109951	32.04678481	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	925	1538	0.00130039	0.004551365	6	oligos	OL-Cntl	51	20	20
GCCTCTACACGGCCAT-1_3_C4	-24.99211098	15.5418749	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1104	1760	0.005113636	0.002840909	6	8	Astrocytes	51	20	20
GCCTCTACATCCCATC-1_3_C4	-20.06361418	-29.0237342	6A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	4728	15899	0.000943456	0.00232719	6	6A	IN-PV	51	20	20
GCCTCTATCCACGCAG-1_3_C4	18.03207664	8.625517503	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1766	3373	0.005040024	0.00296472	6	oligos	OL-Cntl	51	20	20
GCCTCTATCTGTCAAG-1_3_C4	-24.46934035	17.85061889	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1271	2090	0.015311005	0.004784689	6	8	Astrocytes	51	20	20
GCGACCAAGCGTGAGT-1_3_C4	20.94744396	7.242989021	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2713	5241	0.001526426	0.004006869	6	oligos	OL-Cntl	51	20	20
GCGACCACAGCTTAAC-1_3_C4	2.448368132	21.25328565	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	969	1486	0.014131898	0.006056528	6	oligos	OL-Cntl	51	20	20
GCGACCAGTAGGCTGA-1_3_C4	-19.08030738	19.79568623	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1647	2735	0.006581353	0.007678245	6	8	Astrocytes	51	20	20
GCGACCATCAAGATCC-1_3_C4	-36.26809668	-0.302751404	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1601	2799	0.005001786	0.00035727	6	9	OPC	51	20	20
GCGACCATCTTATCTG-1_3_C4	-37.75581249	-1.259975303	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1330	2381	0.000839983	0.006299874	6	9	OPC	51	20	20
GCGAGAAAGACAGACC-1_3_C4	20.81410904	23.89942533	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1073	1664	0.000600962	0.003605769	6	oligos	OL-Cntl	51	20	20
GCGAGAAAGCGGCTTC-1_3_C4	16.45935696	17.49229283	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1012	1621	0.000616903	0.004318322	6	oligos	OL-Cntl	51	20	20
GCGAGAAAGGGTCGAT-1_3_C4	-26.6258692	1.819625928	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1926	3382	0.006505027	0.003548196	6	9	OPC	51	20	20
GCGAGAACACAGATTC-1_3_C4	20.99539312	10.41692642	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1675	2972	0.005047106	0.009084791	6	oligos	OL-Cntl	51	20	20
GCGAGAACAGATCCAT-1_3_C4	8.301625744	19.61511532	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1134	1746	0.001145475	0.006872852	6	oligos	OL-Cntl	51	20	20
GCGAGAACATGCCACG-1_3_C4	-36.37269887	-7.817681403	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1138	1933	0.001551992	0.003621314	6	9	OPC	51	20	20
GCGAGAAGTTCCTCCA-1_3_C4	-10.4811417	16.62049904	11	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1873	3095	0.005815832	0.007754443	6	11	Glia-MIX	51	20	20
GCGCAACCAAGCGATG-1_3_C4	19.96959936	11.42260922	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1538	2733	0.004390779	0.006586169	6	oligos	OL-Cntl	51	20	20
GCGCAACCATTACGAC-1_3_C4	38.15112781	9.4440555	14	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	804	1087	0.006439742	0.012879485	6	14	Microglia	51	20	20
GCGCAGTAGCATGGCA-1_3_C4	2.458447663	27.10467788	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	718	1000	0.001	0.009	6	oligos	OL-Cntl	51	20	20
GCGCAGTAGGCCCGTT-1_3_C4	17.30215518	13.19169997	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1409	2562	0.00234192	0.008196721	6	oligos	OL-Cntl	51	20	20
GCGCAGTCACGCTTTC-1_3_C4	18.6836443	7.872332448	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2045	4354	0.00597152	0.003215434	6	oligos	OL-Cntl	51	20	20
GCGCAGTGTGAAAGAG-1_3_C4	13.52294903	-20.5805502	4	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	6179	17770	0.008835115	0.00669668	6	L2-3	EN-L2-3-MS	51	20	20
GCGCAGTGTTCCATGA-1_3_C4	-17.84163486	-21.28463199	6A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2021	3771	0.018032352	0.002916998	6	6A	IN-PV	51	20	20
GCGCAGTGTTCTGTTT-1_3_C4	-24.3093967	18.58677331	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1392	2429	0.001235076	0.004940305	6	8	Astrocytes	51	20	20
GCGCAGTTCAGCTCGG-1_3_C4	5.043020304	17.88652355	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1040	1558	0.009627728	0.011553273	6	oligos	OL-Cntl	51	20	20
GCGCAGTTCCTTCAAT-1_3_C4	12.21304464	20.6377405	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1020	1663	0.005411906	0.010222489	6	oligos	OL-Cntl	51	20	20
GCGCAGTTCTATGTGG-1_3_C4	-1.846065015	23.56788463	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	727	1115	0.014349776	0.004484305	6	oligos	OL-Cntl	51	20	20
GCGCCAAAGCATCATC-1_3_C4	-26.91612139	12.85838805	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	977	1519	0.004608295	0.005266623	6	8	Astrocytes	51	20	20
GCGCCAAGTAAACGCG-1_3_C4	24.50573946	-24.49849324	3	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	3572	8524	0.005748475	0.005161896	6	3	EN-L5-6	51	20	20
GCGCCAAGTCTAAAGA-1_3_C4	-7.674788685	-2.746684143	13A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1809	3324	0.018050542	0.005415162	6	13A	IN-VIP	51	20	20
GCGCCAATCCAACCAA-1_3_C4	30.1224203	9.443559519	15DA	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	848	1142	0.00525394	0.056917688	6	15DA	T cells	51	20	20
GCGCCAATCCTGCTTG-1_3_C4	4.641421216	30.75275897	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	726	1115	0.003587444	0.004484305	6	oligos	OL-Cntl	51	20	20
GCGCCAATCGGCTTGG-1_3_C4	9.50346509	-21.01868253	4	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	6396	19813	0.007469843	0.009640135	6	L2-3	EN-L2-3-MS	51	20	20
GCGCGATGTCTTCAAG-1_3_C4	-22.26906032	29.58643248	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2285	4707	0.002549395	0.006798385	6	8	Astrocytes	51	20	20
GCGCGATTCCAACCAA-1_3_C4	-37.77938955	-4.817562435	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1398	2439	0.000820008	0.000820008	6	9	OPC	51	20	20
GCGCGATTCGTCGTTC-1_3_C4	-28.33972014	12.06749431	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	788	1165	0.003433476	0.003433476	6	8	Astrocytes	51	20	20
GCGCGATTCTACTATC-1_3_C4	-18.7869127	-1.72766434	13A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	5188	13351	0.026964272	0.008988091	6	13A	IN-VIP	51	20	20
GCGGGTTAGAAACCGC-1_3_C4	3.141794667	-20.84821059	4	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	4946	14593	0.005893236	0.004728294	6	L2-3	EN-L2-3-MS	51	20	20
GCGGGTTAGCCGATTT-1_3_C4	-24.046316	15.87151113	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1264	2107	0.009966777	0.007119127	6	8	Astrocytes	51	20	20
GCGGGTTAGCCTATGT-1_3_C4	4.78860721	31.0390565	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	784	1150	0	0.003478261	6	oligos	OL-Cntl	51	20	20
GCGGGTTAGTGTTAGA-1_3_C4	-0.500777335	3.157163269	11	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	894	1211	0.012386457	0.002477291	6	11	Glia-MIX	51	20	20
GCGGGTTCACAGTCGC-1_3_C4	22.15229613	14.6531031	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1363	2314	0.001296456	0.003889369	6	oligos	OL-Cntl	51	20	20
GCGGGTTCACCGTTGG-1_3_C4	15.43795305	23.92854564	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	912	1462	0.000683995	0.006155951	6	oligos	OL-Cntl	51	20	20
GCGGGTTCATGCAACT-1_3_C4	12.00886528	24.15972228	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	896	1438	0.00069541	0.006954103	6	oligos	OL-Cntl	51	20	20
GCTCCTAAGAAAGTGG-1_3_C4	-28.65317284	10.13134567	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	859	1210	0.019834711	0.00661157	6	8	Astrocytes	51	20	20
GCTCCTAAGGAATCGC-1_3_C4	10.90089667	25.56132241	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	896	1376	0.011627907	0.007994186	6	oligos	OL-Cntl	51	20	20
GCTCCTAAGGTGTTAA-1_3_C4	39.61071635	14.13243528	14	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1064	1536	0.000651042	0.010416667	6	14	Microglia	51	20	20
GCTCCTAAGTGGGATC-1_3_C4	20.98199242	8.014012788	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2048	3686	0.001356484	0.009766685	6	oligos	OL-Cntl	51	20	20
GCTCCTACATGGATGG-1_3_C4	24.3946931	-24.69541634	3	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2366	4795	0.024608968	0.004171011	6	3	EN-L5-6	51	20	20
GCTCCTATCCTCCTAG-1_3_C4	-28.61792482	21.84452104	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1121	1955	0.003580563	0.00511509	6	8	Astrocytes	51	20	20
GCTCTGTAGCTTCGCG-1_3_C4	-3.811608907	36.74251527	5	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	972	1438	0.021557719	0.013908206	6	oligos	OL-MS-1	51	20	20
GCTCTGTAGGCTCATT-1_3_C4	-23.51848952	29.80655381	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2075	3949	0.004811345	0.002025829	6	8	Astrocytes	51	20	20
GCTCTGTCATCCAACA-1_3_C4	-14.11720786	0.529974982	13A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	3147	6852	0.012113252	0.015907764	6	13A	IN-VIP	51	20	20
GCTCTGTCATGCCCGA-1_3_C4	-32.60204706	-10.96898799	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	954	1391	0.002156722	0.002875629	6	9	OPC	51	20	20
GCTCTGTGTCCATCCT-1_3_C4	6.732482057	21.13935082	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1030	1592	0.00879397	0.003140704	6	oligos	OL-Cntl	51	20	20
GCTCTGTTCTCAAGTG-1_3_C4	-16.86231536	12.47231685	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1189	1803	0.003327787	0.003882418	6	8	Astrocytes	51	20	20
GCTGCAGAGACGCTTT-1_3_C4	18.94604516	8.083058903	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1777	3247	0.003387743	0.008623345	6	oligos	OL-Cntl	51	20	20
GCTGCAGAGCCCAATT-1_3_C4	-21.32497442	27.23380274	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2136	4237	0.009912674	0.007080481	6	8	Astrocytes	51	20	20
GCTGCAGAGGCGCTCT-1_3_C4	-33.68030347	1.406736939	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1960	3583	0.009489255	0.008372872	6	9	OPC	51	20	20
GCTGCAGAGTGCGATG-1_3_C4	-25.48788862	16.45001963	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1158	1740	0.011494253	0.004022989	6	8	Astrocytes	51	20	20
GCTGCAGAGTGTTAGA-1_3_C4	13.27607515	18.99934264	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1037	1690	0.007100592	0.005325444	6	oligos	OL-Cntl	51	20	20
GCTGCAGCAAACCTAC-1_3_C4	-2.482335988	-0.873559169	11	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	3562	8217	0.013143483	0.008275526	6	11	Glia-MIX	51	20	20
GCTGCAGCAAGTCATC-1_3_C4	31.72959469	11.47600794	14	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	732	1009	0.042616452	0.077304262	6	14	Microglia	51	20	20
GCTGCAGCACTTAAGC-1_3_C4	22.37437472	-25.82250409	3	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	4390	11044	0.008239768	0.009326331	6	3	EN-L5-6	51	20	20
GCTGCAGCATAAAGGT-1_3_C4	21.41140273	10.02749108	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1594	2789	0.002151309	0.009322338	6	oligos	OL-Cntl	51	20	20
GCTGCAGGTAAAGTCA-1_3_C4	2.562639865	24.64876586	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	746	1123	0.000890472	0.005342832	6	oligos	OL-Cntl	51	20	20
GCTGCAGGTGTTTGGT-1_3_C4	11.94787639	21.18523573	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	924	1530	0.010457516	0.007189542	6	oligos	OL-Cntl	51	20	20
GCTGCGAAGAAACCAT-1_3_C4	-11.61938868	-1.579749936	13A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2269	4061	0.007141098	0.005417385	6	13A	IN-VIP	51	20	20
GCTGCGAAGCTATGCT-1_3_C4	20.17743016	15.90465922	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1119	1751	0.003426613	0.003426613	6	oligos	OL-Cntl	51	20	20
GCTGCGACAGGTGGAT-1_3_C4	-30.4460978	10.62948303	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	735	1053	0.004748338	0.010446344	6	8	Astrocytes	51	20	20
GCTGCGAGTATTAGCC-1_3_C4	-21.33535598	23.53780925	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1441	2476	0.012116317	0.00726979	6	8	Astrocytes	51	20	20
GCTGCGAGTGAGTGAC-1_3_C4	3.967077812	30.23323601	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	702	1037	0.00096432	0.00289296	6	oligos	OL-Cntl	51	20	20
GCTGCGATCCTCAACC-1_3_C4	19.83025878	9.040166996	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1782	3340	0.003892216	0.00508982	6	oligos	OL-Cntl	51	20	20
GCTGCGATCCTGTAGA-1_3_C4	-32.00869429	-0.410191425	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1623	2750	0.003636364	0.009454545	6	9	OPC	51	20	20
GCTGCTTAGCCAACAG-1_3_C4	13.79819994	18.61083167	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1036	1762	0.008513053	0.006810443	6	oligos	OL-Cntl	51	20	20
GCTGCTTCATGGGAAC-1_3_C4	11.9549388	16.86935411	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1176	1945	0.002570694	0.004113111	6	oligos	OL-Cntl	51	20	20
GCTGCTTGTCCAGTAT-1_3_C4	16.81543403	23.69388985	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	915	1483	0.002022927	0.002697235	6	oligos	OL-Cntl	51	20	20
GCTGCTTGTTACGGAG-1_3_C4	4.183633634	5.500586098	7	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1425	2188	0.004113346	0.009140768	6	7	Phagocytes	51	20	20
GCTGCTTGTTTAGCTG-1_3_C4	-11.55552498	15.81305536	11	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1391	2287	0.007870573	0.004809794	6	11	Glia-MIX	51	20	20
GCTGCTTTCGGAATCT-1_3_C4	13.25730937	-31.80793717	3	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	3439	8731	0.001718016	0.002290688	6	3	EN-L5-6	51	20	20
GCTGGGTAGACGACGT-1_3_C4	-1.519139902	25.36880183	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	694	1009	0.006937562	0.011892963	6	oligos	OL-Cntl	51	20	20
GCTGGGTAGAGTCTGG-1_3_C4	9.911161089	10.48155311	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1432	2388	0.00879397	0.010469012	6	oligos	OL-Cntl	51	20	20
GCTGGGTAGCCTCGTG-1_3_C4	-17.51648922	13.15868328	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1137	1830	0.001092896	0.00273224	6	8	Astrocytes	51	20	20
GCTGGGTCATTCTCAT-1_3_C4	-35.37937561	-7.478286906	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1172	2023	0	0.002471577	6	9	OPC	51	20	20
GCTGGGTGTGCACGAA-1_3_C4	-23.49971438	0.765758698	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2712	6266	0.005266518	0.00335142	6	9	OPC	51	20	20
GCTTCCAAGGCATGTG-1_3_C4	15.43022703	10.27713019	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1544	2869	0.009759498	0.005576856	6	oligos	OL-Cntl	51	20	20
GCTTCCAAGGGAAACA-1_3_C4	-30.07504014	-1.747902367	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1536	2455	0.005702648	0.004887984	6	9	OPC	51	20	20
GCTTCCAGTCTAACGT-1_3_C4	2.723691955	23.34206311	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	777	1147	0.003487358	0.003487358	6	oligos	OL-Cntl	51	20	20
GCTTCCATCATATCGG-1_3_C4	-15.91945901	-16.56933905	6B	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1788	3451	0.031295277	0.005795422	6	6B	IN-SST	51	20	20
GCTTGAAAGACCTTTG-1_3_C4	7.605154395	22.80193815	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1094	1562	0.002560819	0.013444302	6	oligos	OL-Cntl	51	20	20
GCTTGAATCACGCGGT-1_3_C4	3.526032033	-15.48717761	4	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2842	6215	0.01383749	0.00611424	6	L2-3	EN-L2-3-MS	51	20	20
GCTTGAATCCAGTAGT-1_3_C4	-28.55219048	10.88583625	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	765	1130	0.007964602	0.001769912	6	8	Astrocytes	51	20	20
GGAAAGCAGATCGGGT-1_3_C4	11.50116887	23.66806518	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	773	1172	0.016211604	0.005119454	6	oligos	OL-Cntl	51	20	20
GGAAAGCCACAACTGT-1_3_C4	10.81732692	1.522027892	12	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	731	1324	0.006797583	0.003021148	6	12	EN-MIX	51	20	20
GGAAAGCGTAACGACG-1_3_C4	-35.69471857	-1.335477194	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1456	2563	0.002731174	0.003121342	6	9	OPC	51	20	20
GGAAAGCGTCCAACTA-1_3_C4	-26.79936778	14.02480915	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1013	1708	0.0029274	0.005269321	6	8	Astrocytes	51	20	20
GGAAAGCGTTGAACTC-1_3_C4	-29.38208937	20.05014206	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1115	1769	0.023742227	0.002826456	6	8	Astrocytes	51	20	20
GGAAAGCTCAAACGGG-1_3_C4	-28.11114116	21.93718319	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1153	1829	0.003827228	0.004373975	6	8	Astrocytes	51	20	20
GGAAAGCTCTGAAAGA-1_3_C4	-34.13875759	-6.193440445	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1233	2094	0.002387775	0.004297994	6	9	OPC	51	20	20
GGAACTTAGTGGTAAT-1_3_C4	-6.233481346	-1.866683016	13A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1674	2993	0.008686936	0.004343468	6	13A	IN-VIP	51	20	20
GGAACTTCATGTAGTC-1_3_C4	-28.75586241	20.93587996	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1082	1695	0.001179941	0.005309735	6	8	Astrocytes	51	20	20
GGAACTTTCTTGTATC-1_3_C4	3.878854891	20.49757525	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	836	1317	0.01594533	0.01063022	6	oligos	OL-Cntl	51	20	20
GGAATAAGTCGCGGTT-1_3_C4	4.782996552	22.42902214	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	863	1323	0.001511716	0.006046863	6	oligos	OL-Cntl	51	20	20
GGAATAAGTCTTGTCC-1_3_C4	-28.72275983	20.74882942	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1162	2010	0.008955224	0.005472637	6	8	Astrocytes	51	20	20
GGACAAGCAATGGTCT-1_3_C4	-28.31472953	9.994640692	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	719	1040	0.005769231	0.006730769	6	8	Astrocytes	51	20	20
GGACAAGGTCATACTG-1_3_C4	12.49391214	26.28539566	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	795	1257	0.020684169	0.003977725	6	oligos	OL-Cntl	51	20	20
GGACAAGGTGTTTGGT-1_3_C4	-11.30968553	-3.131423634	13A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2222	4291	0.02680028	0.005360056	6	13A	IN-VIP	51	20	20
GGACAAGTCAGCCTAA-1_3_C4	5.837664628	26.54831523	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	817	1208	0.011589404	0.006622517	6	oligos	OL-Cntl	51	20	20
GGACAGAAGGTGCTAG-1_3_C4	19.01826613	-25.51386133	3	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	4692	12295	0.004066694	0.005774705	6	3	EN-L5-6	51	20	20
GGACAGAGTTACCGAT-1_3_C4	-9.141519022	13.89407312	11	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1463	2488	0.006028939	0.007234727	6	11	Glia-MIX	51	20	20
GGACATTCAAACCTAC-1_3_C4	8.819243975	14.00589091	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1078	1753	0.00855676	0.007415859	6	oligos	OL-Cntl	51	20	20
GGACATTCACGAAACG-1_3_C4	-38.19976238	-1.054916549	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1530	2773	0.003606203	0.001803101	6	9	OPC	51	20	20
GGACATTGTGACGCCT-1_3_C4	-31.39220302	-12.64567904	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	776	1089	0.002754821	0.005509642	6	9	OPC	51	20	20
GGACATTTCATGTGGT-1_3_C4	19.33361877	10.66806445	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1534	2732	0.000366032	0.007686676	6	oligos	OL-Cntl	51	20	20
GGACGTCAGTATCGAA-1_3_C4	5.280837446	30.26560184	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	798	1173	0.005967604	0.009377664	6	oligos	OL-Cntl	51	20	20
GGACGTCAGTGGAGAA-1_3_C4	-30.22720645	12.66885492	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	803	1249	0.012810248	0.007205765	6	8	Astrocytes	51	20	20
GGACGTCGTTGAGTTC-1_3_C4	16.63155898	-9.86594422	3	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2615	4912	0.025651466	0.003053746	6	3	EN-L5-6	51	20	20
GGACGTCTCAGGCCCA-1_3_C4	16.28913514	16.95952157	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1083	1836	0.000544662	0.00708061	6	oligos	OL-Cntl	51	20	20
GGACGTCTCCCGGATG-1_3_C4	-24.58116574	15.73141798	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1198	2022	0.003461919	0.004945598	6	8	Astrocytes	51	20	20
GGACGTCTCGACGGAA-1_3_C4	16.94825169	14.77104142	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1314	2242	0.010258698	0.004014273	6	oligos	OL-Cntl	51	20	20
GGAGCAACAATGGAAT-1_3_C4	21.31331615	16.36858102	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1357	2215	0.011738149	0.009480813	6	oligos	OL-Cntl	51	20	20
GGAGCAAGTCCTAGCG-1_3_C4	-6.643642642	-5.880950277	13A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1238	1951	0.027678114	0.004100461	6	13A	IN-VIP	51	20	20
GGAGCAAGTTAGGGTG-1_3_C4	16.53452928	10.07501749	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1524	2652	0.008295626	0.006410256	6	oligos	OL-Cntl	51	20	20
GGAGCAAGTTCCAACA-1_3_C4	7.321862481	20.3429836	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1040	1633	0.007960808	0.009185548	6	oligos	OL-Cntl	51	20	20
GGAGCAATCCTCATTA-1_3_C4	-36.62113224	-10.04532809	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	895	1517	0.003295979	0.003295979	6	9	OPC	51	20	20
GGAGCAATCGCGGATC-1_3_C4	23.5550871	-25.29281704	3	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2732	5351	0.00971781	0.004298262	6	3	EN-L5-6	51	20	20
GGAGCAATCTGGTATG-1_3_C4	-9.295089673	17.0705249	11	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2423	4514	0.003322995	0.003766061	6	11	Glia-MIX	51	20	20
GGATGTTGTATGAATG-1_3_C4	-27.44985006	18.23134028	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1228	1995	0.005513784	0.005012531	6	8	Astrocytes	51	20	20
GGATGTTTCCTCGCAT-1_3_C4	-22.80841468	24.80268481	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1664	3052	0.003604194	0.00819135	6	8	Astrocytes	51	20	20
GGATTACCAAATACAG-1_3_C4	25.7910026	3.597514205	15BA	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	785	1166	0.001715266	0.004288165	6	15BA	Stromal cells	51	20	20
GGATTACCACTCTGTC-1_3_C4	-9.771888883	-18.4720448	6B	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	803	1216	0.002467105	0.003289474	6	6B	IN-SST	51	20	20
GGATTACCAGACTCGC-1_3_C4	22.58764901	14.7427252	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1242	2130	0.000938967	0.001877934	6	oligos	OL-Cntl	51	20	20
GGATTACGTCGGCACT-1_3_C4	0.14882844	19.40927365	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	765	1078	0.001855288	0.010204082	6	oligos	OL-Cntl	51	20	20
GGATTACGTCTCTTAT-1_3_C4	-36.25000344	-11.63245651	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	766	1281	0.00078064	0.00234192	6	9	OPC	51	20	20
GGCAATTCACGAAGCA-1_3_C4	-33.47790224	-11.81627762	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	789	1158	0.006044905	0.002590674	6	9	OPC	51	20	20
GGCAATTCATTCGACA-1_3_C4	-25.08651865	27.40140901	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1827	3339	0.002096436	0.002994909	6	8	Astrocytes	51	20	20
GGCAATTTCAAGGCTT-1_3_C4	34.6736616	6.566956512	14	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	878	1224	0.014705882	0.005718954	6	14	Microglia	51	20	20
GGCAATTTCCTTCAAT-1_3_C4	17.101323	12.42149874	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1370	2516	0.00317965	0.007551669	6	oligos	OL-Cntl	51	20	20
GGCAATTTCGACCAGC-1_3_C4	8.699220761	30.30267364	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	795	1213	0.000824402	0.007419621	6	oligos	OL-Cntl	51	20	20
GGCAATTTCGGTTCGG-1_3_C4	-26.19773025	12.00211737	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	979	1480	0.008783784	0.00472973	6	8	Astrocytes	51	20	20
GGCCGATCAAACTGCT-1_3_C4	4.793041019	4.946766557	7	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1933	3269	0.000917712	0.01009483	6	7	Phagocytes	51	20	20
GGCCGATCATATGAGA-1_3_C4	4.78468593	25.87284039	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	874	1345	0.0133829	0.009665428	6	oligos	OL-Cntl	51	20	20
GGCCGATGTAGCCTCG-1_3_C4	8.835115773	-8.901145568	10	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2361	5665	0.001235658	0.001941748	6	L2-3	EN-L2-3-Cntl	51	20	20
GGCCGATGTCTCTCGT-1_3_C4	2.503125139	30.0625435	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	736	1070	0.005607477	0.006542056	6	oligos	OL-Cntl	51	20	20
GGCCGATGTGTAAGTA-1_3_C4	-0.718218227	24.21050611	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	794	1206	0.00331675	0.008291874	6	oligos	OL-Cntl	51	20	20
GGCGACTAGACCTTTG-1_3_C4	18.14268484	6.048728236	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2728	6062	0.007423293	0.006268558	6	oligos	OL-Cntl	51	20	20
GGCGACTAGTGAAGAG-1_3_C4	24.47445392	-25.62735933	3	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2893	5758	0.006773185	0.001910386	6	3	EN-L5-6	51	20	20
GGCGACTCACCGAAAG-1_3_C4	37.42367372	14.90730414	14	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1297	1865	0.003217158	0.025737265	6	14	Microglia	51	20	20
GGCGACTCAGCCTATA-1_3_C4	21.95886949	11.75919117	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1441	2384	0.000838926	0.008389262	6	oligos	OL-Cntl	51	20	20
GGCGACTGTCGAGATG-1_3_C4	5.009750587	23.3175387	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1003	1595	0.007523511	0.010031348	6	oligos	OL-Cntl	51	20	20
GGCGACTTCCCACTTG-1_3_C4	18.57452311	16.91330531	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1187	1871	0.002137894	0.003741315	6	oligos	OL-Cntl	51	20	20
GGCGTGTGTAGTACCT-1_3_C4	-31.51776416	11.672814	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	764	1168	0.003424658	0.004280822	6	8	Astrocytes	51	20	20
GGCTCGAAGTGGACGT-1_3_C4	20.44678148	16.20509443	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1278	2130	0.003286385	0.005164319	6	oligos	OL-Cntl	51	20	20
GGCTCGACACGGTTTA-1_3_C4	-28.29747619	13.09681639	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	915	1361	0.011021308	0.004408523	6	8	Astrocytes	51	20	20
GGCTCGACATAACCTG-1_3_C4	-4.467769705	21.11050275	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	740	1104	0.070652174	0.011775362	6	oligos	OL-Cntl	51	20	20
GGCTGGTAGCGTGTCC-1_3_C4	17.25242376	-4.831996841	3	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1513	2890	0.097231834	0.003114187	6	3	EN-L5-6	51	20	20
GGCTGGTAGGAGTTTA-1_3_C4	-23.14038488	25.66026951	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1759	3163	0.002213089	0.0056908	6	8	Astrocytes	51	20	20
GGCTGGTCATGCCACG-1_3_C4	3.038630913	26.59781993	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	744	1164	0.011168385	0.001718213	6	oligos	OL-Cntl	51	20	20
GGCTGGTGTACGAAAT-1_3_C4	15.80746678	12.67036387	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1240	2163	0.002773925	0.009708738	6	oligos	OL-Cntl	51	20	20
GGCTGGTTCTGCTGCT-1_3_C4	10.95035522	14.72753599	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1092	1903	0.016815554	0.011560694	6	oligos	OL-Cntl	51	20	20
GGCTGGTTCTGGTGTA-1_3_C4	23.23026826	-24.91644464	3	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	4325	12222	0.014072983	0.004745541	6	3	EN-L5-6	51	20	20
GGGAATGAGCCCAACC-1_3_C4	-12.14715983	-0.561241332	13A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2836	5408	0.013868343	0.00591716	6	13A	IN-VIP	51	20	20
GGGAATGAGGCAATTA-1_3_C4	38.83769833	13.70060608	14	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1094	1589	0.004405286	0.013215859	6	14	Microglia	51	20	20
GGGAATGCAAGACGTG-1_3_C4	-29.21772752	12.03405571	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	817	1315	0.009125475	0.003802281	6	8	Astrocytes	51	20	20
GGGAATGCACATTTCT-1_3_C4	13.24783921	15.83194865	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1099	1789	0.003353829	0.011738401	6	oligos	OL-Cntl	51	20	20
GGGAATGCAGATGGCA-1_3_C4	6.775090579	20.89230748	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	901	1344	0.001488095	0.007440476	6	oligos	OL-Cntl	51	20	20
GGGAATGGTGCCTGTG-1_3_C4	15.67291187	18.20829882	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1121	1851	0.006482982	0.008103728	6	oligos	OL-Cntl	51	20	20
GGGAATGGTTTGCATG-1_3_C4	2.55732846	27.16034532	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	699	1009	0.002973241	0.005946482	6	oligos	OL-Cntl	51	20	20
GGGAATGTCAGAGGTG-1_3_C4	-12.96281874	3.105492164	13A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	3020	6121	0.012416272	0.007188368	6	13A	IN-VIP	51	20	20
GGGAATGTCTAGAGTC-1_3_C4	5.2169948	30.26290833	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	722	1105	0.00361991	0.008144796	6	oligos	OL-Cntl	51	20	20
GGGAATGTCTGGTTCC-1_3_C4	12.48830912	24.29280413	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	833	1259	0.004765687	0.007942812	6	oligos	OL-Cntl	51	20	20
GGGACCTAGGGAGTAA-1_3_C4	-4.089845384	16.87100318	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	751	1017	0.007866273	0.010816126	6	oligos	OL-Cntl	51	20	20
GGGACCTAGTGCCAGA-1_3_C4	-36.23943647	3.507497836	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2105	4046	0.003954523	0.002965892	6	9	OPC	51	20	20
GGGACCTCAAGACACG-1_3_C4	-24.18591315	17.89109219	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1288	2269	0.009695901	0.005729396	6	8	Astrocytes	51	20	20
GGGACCTCATCTGGTA-1_3_C4	-30.08348891	13.66135042	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	965	1576	0.008248731	0.003172589	6	8	Astrocytes	51	20	20
GGGACCTCATGCATGT-1_3_C4	11.84380996	22.48536655	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	901	1463	0.002734108	0.004784689	6	oligos	OL-Cntl	51	20	20
GGGACCTGTCACACGC-1_3_C4	-0.674595256	20.57099983	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	842	1246	0.021669342	0.012038523	6	oligos	OL-Cntl	51	20	20
GGGACCTGTCGATTGT-1_3_C4	5.740360669	25.20798245	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	887	1482	0.005398111	0.007422402	6	oligos	OL-Cntl	51	20	20
GGGACCTGTGCTTCTC-1_3_C4	19.59982842	16.45381976	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1246	2198	0.001364877	0.006369427	6	oligos	OL-Cntl	51	20	20
GGGACCTTCCCGACTT-1_3_C4	9.163973507	30.71649282	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	852	1386	0.004329004	0.005050505	6	oligos	OL-Cntl	51	20	20
GGGACCTTCCGTAGTA-1_3_C4	-4.761701349	-4.619042701	13A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1137	1840	0.011413043	0.009782609	6	13A	IN-VIP	51	20	20
GGGAGATCACGCTTTC-1_3_C4	-30.46780884	-12.67477692	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	797	1250	0.0024	0.0048	6	9	OPC	51	20	20
GGGAGATCATCGGAAG-1_3_C4	19.37902007	16.81820219	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1136	1816	0.008259912	0.002753304	6	oligos	OL-Cntl	51	20	20
GGGAGATTCCTATGTT-1_3_C4	17.99060748	9.639759566	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1495	2669	0.001498689	0.006744099	6	oligos	OL-Cntl	51	20	20
GGGATGAAGATAGGAG-1_3_C4	-21.51680987	9.98827138	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1102	1699	0.004708652	0.003531489	6	8	Astrocytes	51	20	20
GGGATGAAGCTACCGC-1_3_C4	15.85361966	19.77792095	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1055	1668	0.001798561	0.008992806	6	oligos	OL-Cntl	51	20	20
GGGATGAAGGGCACTA-1_3_C4	-20.93458386	9.702907453	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1055	1708	0.00058548	0.00117096	6	8	Astrocytes	51	20	20
GGGATGAAGTACGATA-1_3_C4	25.73012707	3.609509078	15BA	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	854	1278	0.003912363	0.009389671	6	15BA	Stromal cells	51	20	20
GGGATGACAAACCTAC-1_3_C4	3.936497417	-18.7930931	4	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	3580	8620	0.005568445	0.008236659	6	L2-3	EN-L2-3-MS	51	20	20
GGGATGACATTTGCCC-1_3_C4	5.053724206	24.43835615	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	888	1373	0.003641661	0.007283321	6	oligos	OL-Cntl	51	20	20
GGGATGAGTCCTAGCG-1_3_C4	-35.35334359	-1.569562681	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1398	2232	0.001344086	0.003584229	6	9	OPC	51	20	20
GGGCACTAGGGATCTG-1_3_C4	13.07318371	31.02999425	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	803	1172	0.003412969	0.005119454	6	oligos	OL-Cntl	51	20	20
GGGCACTCATCGGGTC-1_3_C4	16.30929428	14.05829123	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1301	2096	0.002385496	0.010496183	6	oligos	OL-Cntl	51	20	20
GGGCACTTCCACGTTC-1_3_C4	9.007196319	24.35871898	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	784	1236	0.004854369	0.006472492	6	oligos	OL-Cntl	51	20	20
GGGCACTTCGGTGTTA-1_3_C4	15.88394458	17.38163933	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1123	1928	0.008298755	0.005705394	6	oligos	OL-Cntl	51	20	20
GGGCACTTCTATCCCG-1_3_C4	-1.681587857	21.65195391	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	666	1025	0.00097561	0.020487805	6	oligos	OL-Cntl	51	20	20
GGGCATCAGCTGCCCA-1_3_C4	19.75468933	8.849508594	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1691	3201	0.002499219	0.00531084	6	oligos	OL-Cntl	51	20	20
GGGCATCAGGATATAC-1_3_C4	-30.23085692	10.22053661	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	787	1145	0.009606987	0.002620087	6	8	Astrocytes	51	20	20
GGGCATCCATTCCTGC-1_3_C4	1.198251564	19.61265886	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	822	1304	0.003834356	0.011503067	6	oligos	OL-Cntl	51	20	20
GGGCATCGTCAACTGT-1_3_C4	23.99738642	-12.30066633	3	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	3895	8700	0.010114943	0.005862069	6	3	EN-L5-6	51	20	20
GGGCATCGTGCTGTAT-1_3_C4	16.96302938	6.821063222	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2071	3903	0.008198821	0.0097361	6	oligos	OL-Cntl	51	20	20
GGGCATCTCTGCGGCA-1_3_C4	-20.12229248	8.062753025	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	737	1058	0	0.003780718	6	8	Astrocytes	51	20	20
GGGTCTGCACTGTGTA-1_3_C4	17.90319717	19.71361542	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1117	1916	0.013048017	0.006784969	6	oligos	OL-Cntl	51	20	20
GGGTTGCCACAAGCCC-1_3_C4	11.13868679	-21.84322141	4	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	4591	13308	0.008716561	0.003080854	6	L2-3	EN-L2-3-MS	51	20	20
GGGTTGCCATGGTAGG-1_3_C4	-23.99230459	27.39871986	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1854	3790	0.002902375	0.006860158	6	8	Astrocytes	51	20	20
GGGTTGCGTCCGAACC-1_3_C4	7.213094061	25.20966349	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1042	1661	0.005418423	0.009632751	6	oligos	OL-Cntl	51	20	20
GGGTTGCTCCACGTGG-1_3_C4	16.13950516	24.36949677	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	829	1240	0	0.005645161	6	oligos	OL-Cntl	51	20	20
GGTATTGAGAATTCCC-1_3_C4	-0.78135368	21.27510283	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	713	1149	0.000870322	0.006962576	6	oligos	OL-Cntl	51	20	20
GGTATTGAGTAGCCGA-1_3_C4	-36.0848333	-3.241727316	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1390	2494	0.001202887	0.007217322	6	9	OPC	51	20	20
GGTATTGCAAGCCCAC-1_3_C4	15.30388271	18.71983635	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1049	1660	0.004819277	0.009638554	6	oligos	OL-Cntl	51	20	20
GGTATTGCAGAGCCAA-1_3_C4	-23.31513272	22.83250057	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1502	2970	0.004040404	0.003367003	6	8	Astrocytes	51	20	20
GGTATTGGTGCAGGTA-1_3_C4	8.318857952	28.41300278	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	879	1413	0.004246285	0.004246285	6	oligos	OL-Cntl	51	20	20
GGTATTGTCGCTTAGA-1_3_C4	-24.45038594	22.27116222	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1190	1993	0.003512293	0.006021074	6	8	Astrocytes	51	20	20
GGTATTGTCTATCCTA-1_3_C4	-24.5717094	22.17512289	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1197	1935	0.014470284	0.002067183	6	8	Astrocytes	51	20	20
GGTGAAGCATTAGCCA-1_3_C4	20.69101097	8.52310588	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1865	3753	0.002930989	0.002664535	6	oligos	OL-Cntl	51	20	20
GGTGAAGGTACTTCTT-1_3_C4	-4.118905877	-5.009790765	13A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1158	1959	0.033180194	0.000510465	6	13A	IN-VIP	51	20	20
GGTGAAGGTAGCACGA-1_3_C4	-26.42740271	12.14433689	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	917	1363	0.006603081	0.007336757	6	8	Astrocytes	51	20	20
GGTGAAGGTCCTAGCG-1_3_C4	-27.82400829	9.969527441	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	767	1063	0.011288805	0.00752587	6	8	Astrocytes	51	20	20
GGTGAAGGTCTTCAAG-1_3_C4	-0.866693488	24.31276767	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	777	1081	0.004625347	0.006475486	6	oligos	OL-Cntl	51	20	20
GGTGAAGTCGGCCGAT-1_3_C4	-13.64938845	-24.23576176	6A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1471	2808	0.072293447	0.002849003	6	6A	IN-PV	51	20	20
GGTGCGTCAATCACAC-1_3_C4	20.05429746	6.839855517	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2485	5077	0.002166634	0.005712035	6	oligos	OL-Cntl	51	20	20
GGTGTTAAGGTGCTTT-1_3_C4	8.304377457	25.11593778	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	847	1374	0.015283843	0.005822416	6	oligos	OL-Cntl	51	20	20
GGTGTTACAATGGAAT-1_3_C4	-5.524735666	-8.646155085	13A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	811	1119	0.015192136	0.013404826	6	13A	IN-VIP	51	20	20
GGTGTTACATTGGGCC-1_3_C4	4.638241691	27.19238979	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	798	1190	0.005042017	0.004201681	6	oligos	OL-Cntl	51	20	20
GGTGTTAGTCACCTAA-1_3_C4	2.25003885	23.84294982	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	772	1143	0.003499563	0.01312336	6	oligos	OL-Cntl	51	20	20
GGTGTTATCAGGCCCA-1_3_C4	3.3732718	-20.62484044	4	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	4781	14208	0.001337275	0.005841779	6	L2-3	EN-L2-3-MS	51	20	20
GGTGTTATCATCTGTT-1_3_C4	-11.69033094	-2.223955009	13A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2206	4047	0.015814183	0.008154188	6	13A	IN-VIP	51	20	20
GGTGTTATCCGCAGTG-1_3_C4	2.67206553	23.78235296	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	792	1172	0.010238908	0.007679181	6	oligos	OL-Cntl	51	20	20
GGTGTTATCTAGCACA-1_3_C4	17.43509783	8.31853568	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1801	3298	0.007580352	0.009399636	6	oligos	OL-Cntl	51	20	20
GTAACGTAGAGACGAA-1_3_C4	-27.65982002	22.5394045	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1203	2188	0.003199269	0.004113346	6	8	Astrocytes	51	20	20
GTAACGTCACCCTATC-1_3_C4	-22.85734734	24.73727951	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1714	3289	0.002128306	0.005776832	6	8	Astrocytes	51	20	20
GTAACGTGTAGAGGAA-1_3_C4	-7.200767963	-13.4886323	13A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1721	2919	0.024665982	0.006509078	6	13A	IN-VIP	51	20	20
GTAACTGAGGGTCTCC-1_3_C4	20.42907507	-22.90367261	3	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	4469	12351	0.013925998	0.007853615	6	3	EN-L5-6	51	20	20
GTAACTGCAGGACGTA-1_3_C4	16.03833278	21.8095075	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	965	1491	0.002682763	0.004694836	6	oligos	OL-Cntl	51	20	20
GTAACTGGTAATAGCA-1_3_C4	-36.01427177	-3.195224632	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1359	2249	0.005780347	0.004001779	6	9	OPC	51	20	20
GTAACTGGTCTTCAAG-1_3_C4	-35.8435048	-0.441189238	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1406	2422	0.002890173	0.005367465	6	9	OPC	51	20	20
GTAACTGGTGACGCCT-1_3_C4	13.88066267	-32.99952507	3	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	4218	14055	0.000711491	0.002561366	6	3	EN-L5-6	51	20	20
GTAACTGTCTATGTGG-1_3_C4	2.744906931	-12.3483811	4	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1943	3856	0.016856846	0.004149378	6	L2-3	EN-L2-3-MS	51	20	20
GTACGTAAGCTGATAA-1_3_C4	5.702267217	25.68615589	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	866	1239	0	0.002421308	6	oligos	OL-Cntl	51	20	20
GTACGTATCTTAACCT-1_3_C4	-36.0571325	4.320310174	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2008	3925	0.000509554	0.002038217	6	9	OPC	51	20	20
GTACTCCCACCAGCAC-1_3_C4	-35.79600038	-3.734911594	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1387	2441	0.002867677	0.005735354	6	9	OPC	51	20	20
GTACTCCCAGTGACAG-1_3_C4	7.282753095	-15.3604144	4	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	3321	7172	0.006971556	0.00864473	6	L2-3	EN-L2-3-MS	51	20	20
GTACTCCCATACGCCG-1_3_C4	-33.72806163	-10.85186174	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1009	1583	0.000631712	0.010107391	6	9	OPC	51	20	20
GTACTCCTCGGCGGTT-1_3_C4	-28.03550584	13.48964831	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	963	1574	0.013977128	0.002541296	6	8	Astrocytes	51	20	20
GTACTCCTCTTTCCTC-1_3_C4	11.3579972	30.44054854	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	742	1096	0.013686131	0.002737226	6	oligos	OL-Cntl	51	20	20
GTACTTTAGTAGGTGC-1_3_C4	-25.33592232	22.99004074	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1355	2308	0.002599653	0.007365685	6	8	Astrocytes	51	20	20
GTACTTTCAGTATGCT-1_3_C4	40.07796417	11.75903152	14	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	775	1101	0	0.004541326	6	14	Microglia	51	20	20
GTAGGCCCAGCTGTAT-1_3_C4	-22.59739299	25.7361483	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1934	3646	0.007405376	0.00521119	6	8	Astrocytes	51	20	20
GTAGGCCCAGGAACGT-1_3_C4	-36.27330073	0.660557781	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1626	2666	0.006376594	0.005626407	6	9	OPC	51	20	20
GTAGGCCGTTACTGAC-1_3_C4	30.2835807	-10.52790205	2	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	3786	9077	0.022694723	0.004627079	6	2	EN-L4	51	20	20
GTAGGCCTCGCATGAT-1_3_C4	-19.27952371	25.69305242	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1743	3133	0.00446856	0.011171401	6	8	Astrocytes	51	20	20
GTAGTCACAGTGGAGT-1_3_C4	-1.321552256	23.91471258	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	722	1130	0.001769912	0.010619469	6	oligos	OL-Cntl	51	20	20
GTAGTCATCATATCGG-1_3_C4	39.572442	11.39893751	14	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	912	1334	0.000749625	0.007496252	6	14	Microglia	51	20	20
GTATCTTAGGGTGTGT-1_3_C4	15.89310348	25.63641093	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	755	1156	0.001730104	0.002595156	6	oligos	OL-Cntl	51	20	20
GTATCTTCATGGTCAT-1_3_C4	-37.4670686	-9.380181311	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1103	1872	0.003205128	0.00534188	6	9	OPC	51	20	20
GTATTCTCAGTTTACG-1_3_C4	-1.631628797	1.255500845	11	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2106	3904	0.005635246	0.003329918	6	11	Glia-MIX	51	20	20
GTCAAGTAGACAGACC-1_3_C4	7.421841864	25.03611689	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1004	1439	0.001389854	0.009034051	6	oligos	OL-Cntl	51	20	20
GTCAAGTAGTGAATTG-1_3_C4	18.76959554	7.431012038	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2021	3968	0.002268145	0.005796371	6	oligos	OL-Cntl	51	20	20
GTCAAGTAGTTTGCGT-1_3_C4	9.947854791	23.47968687	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	849	1344	0.017113095	0.006696429	6	oligos	OL-Cntl	51	20	20
GTCAAGTCAGACGCCT-1_3_C4	25.36807995	-26.73666369	3	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	4346	12494	0.001360653	0.002481191	6	3	EN-L5-6	51	20	20
GTCAAGTCAGCCAATT-1_3_C4	14.81886361	16.14410548	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1124	1758	0.007394767	0.010807736	6	oligos	OL-Cntl	51	20	20
GTCAAGTGTTAGTGGG-1_3_C4	22.70796821	10.69692762	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1574	2715	0.002946593	0.003683241	6	oligos	OL-Cntl	51	20	20
GTCAAGTTCGTTGACA-1_3_C4	16.88817698	10.37730008	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1612	2934	0.005794138	0.006816633	6	oligos	OL-Cntl	51	20	20
GTCACAAAGCAATATG-1_3_C4	22.5060586	16.25701072	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1348	2215	0.004514673	0.003160271	6	oligos	OL-Cntl	51	20	20
GTCACAAAGGCAAAGA-1_3_C4	-30.08293	20.62241872	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	962	1451	0.011026878	0.009648518	6	8	Astrocytes	51	20	20
GTCACAACAATGACCT-1_3_C4	20.97148204	16.68704128	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1253	2104	0.00095057	0.006178707	6	oligos	OL-Cntl	51	20	20
GTCACAACATTTGCTT-1_3_C4	16.90791395	17.4249429	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1134	1966	0.002543235	0.007121058	6	oligos	OL-Cntl	51	20	20
GTCACAATCGGAGGTA-1_3_C4	7.933436863	27.58170197	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	829	1296	0.00462963	0.009259259	6	oligos	OL-Cntl	51	20	20
GTCACAATCTATGTGG-1_3_C4	1.894922289	23.67161699	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	697	1103	0.000906618	0.008159565	6	oligos	OL-Cntl	51	20	20
GTCACGGAGAGGGATA-1_3_C4	-28.17157637	10.4934492	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	869	1225	0.004897959	0.004897959	6	8	Astrocytes	51	20	20
GTCACGGAGCTACCGC-1_3_C4	3.278991636	-20.93214526	4	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	3993	10599	0.010095292	0.003019153	6	L2-3	EN-L2-3-MS	51	20	20
GTCACGGCAGCTGTAT-1_3_C4	-29.51873889	19.74154575	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1018	1505	0.010631229	0.005980066	6	8	Astrocytes	51	20	20
GTCACGGGTCAAAGCG-1_3_C4	-2.00404382	23.35208361	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	670	1013	0.023692004	0.005923001	6	oligos	OL-Cntl	51	20	20
GTCACGGTCCACGAAT-1_3_C4	15.37768462	18.06887776	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1102	1779	0.005621135	0.004496908	6	oligos	OL-Cntl	51	20	20
GTCACGGTCGCATGAT-1_3_C4	-16.72079672	-1.054663875	13A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2904	5418	0.015873016	0.019195275	6	13A	IN-VIP	51	20	20
GTCACGGTCGGTTAAC-1_3_C4	-8.860034666	15.37803826	11	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2465	4777	0.001256018	0.005861419	6	11	Glia-MIX	51	20	20
GTCATTTCATGACATC-1_3_C4	-27.4366303	22.92852628	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1336	2342	0.005123826	0.003415884	6	8	Astrocytes	51	20	20
GTCATTTGTCAGATAA-1_3_C4	-25.92668315	22.3126195	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1206	1883	0.007966012	0.002655337	6	8	Astrocytes	51	20	20
GTCATTTGTTATGTGC-1_3_C4	-38.64829975	-2.321794755	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1319	2491	0.008430349	0.004014452	6	9	OPC	51	20	20
GTCCTCAAGCGATAGC-1_3_C4	-28.51129751	10.479691	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	812	1173	0.007672634	0.004262575	6	8	Astrocytes	51	20	20
GTCCTCACACTCAGGC-1_3_C4	-37.5764587	-1.037177538	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1572	2793	0.001074114	0.004654493	6	9	OPC	51	20	20
GTCCTCACATGCGCAC-1_3_C4	16.95803074	18.80647661	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1081	1903	0.003152916	0.004203889	6	oligos	OL-Cntl	51	20	20
GTCCTCATCAGGTAAA-1_3_C4	-22.16577195	24.56615338	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1581	2674	0.008227375	0.003365744	6	8	Astrocytes	51	20	20
GTCCTCATCTCAAGTG-1_3_C4	0.912579036	22.92188397	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	861	1254	0.007177033	0.010366826	6	oligos	OL-Cntl	51	20	20
GTCGGGTAGCGGCTTC-1_3_C4	15.54988855	27.75367479	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	806	1210	0.004132231	0.004958678	6	oligos	OL-Cntl	51	20	20
GTCGGGTAGCTGAACG-1_3_C4	14.53981323	2.201002563	12	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	824	1092	0.014652015	0.001831502	6	12	EN-MIX	51	20	20
GTCGGGTCACACCGAC-1_3_C4	15.09656129	16.25191844	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1104	1798	0.007230256	0.011123471	6	oligos	OL-Cntl	51	20	20
GTCGTAAGTAAATGTG-1_3_C4	21.87977985	17.79718345	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1163	1837	0.004354927	0.009254219	6	oligos	OL-Cntl	51	20	20
GTCGTAAGTGCCTGCA-1_3_C4	8.301553429	28.04350048	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	885	1397	0.004294918	0.009305655	6	oligos	OL-Cntl	51	20	20
GTCGTAATCGCCTGAG-1_3_C4	13.5039239	-30.72366063	3	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	3455	8872	0.001690712	0.003381425	6	3	EN-L5-6	51	20	20
GTCTCGTAGACTCGGA-1_3_C4	19.41931949	17.04809601	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1090	1757	0.009675583	0.006260672	6	oligos	OL-Cntl	51	20	20
GTCTCGTAGAGTACCG-1_3_C4	9.513492589	-23.42485614	4	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	4852	14130	0.005095541	0.013163482	6	L2-3	EN-L2-3-MS	51	20	20
GTCTCGTCAAGGCTCC-1_3_C4	17.23465083	15.15005908	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1251	2304	0.001302083	0.003472222	6	oligos	OL-Cntl	51	20	20
GTCTCGTCACATGGGA-1_3_C4	13.71067	26.93522213	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	845	1350	0.005185185	0.005185185	6	oligos	OL-Cntl	51	20	20
GTCTCGTTCTTGTACT-1_3_C4	13.48808686	20.35488698	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	945	1419	0.007751938	0.003523608	6	oligos	OL-Cntl	51	20	20
GTCTTCGAGTGTGAAT-1_3_C4	4.013782705	-14.43776981	4	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2506	5195	0.030606352	0.004427334	6	L2-3	EN-L2-3-MS	51	20	20
GTCTTCGCAAGCCGCT-1_3_C4	4.600692324	22.49641881	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	810	1329	0.005267118	0.004514673	6	oligos	OL-Cntl	51	20	20
GTCTTCGCATTGGCGC-1_3_C4	10.91872492	20.58123694	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	926	1490	0.000671141	0.008053691	6	oligos	OL-Cntl	51	20	20
GTCTTCGGTCAACATC-1_3_C4	-4.075223629	-7.956220838	13A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	720	1062	0.043314501	0.002824859	6	13A	IN-VIP	51	20	20
GTGAAGGCAAGCTGAG-1_3_C4	0.572806227	18.58888901	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	726	1048	0.001908397	0.008587786	6	oligos	OL-Cntl	51	20	20
GTGAAGGCACCGGAAA-1_3_C4	-11.91541108	-2.712026925	13A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2636	5119	0.016995507	0.010158234	6	13A	IN-VIP	51	20	20
GTGAAGGGTATATGAG-1_3_C4	-16.68127463	-15.85465738	6B	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1821	3444	0.024680604	0.006097561	6	6B	IN-SST	51	20	20
GTGAAGGTCACCAGGC-1_3_C4	-23.41147319	0.640804748	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2041	3851	0.00181771	0.007530512	6	9	OPC	51	20	20
GTGAAGGTCCTGCTTG-1_3_C4	-22.30375473	22.51241263	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1529	2563	0.008973859	0.005462349	6	8	Astrocytes	51	20	20
GTGCAGCAGGAGTTTA-1_3_C4	21.64934231	17.13511074	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1203	1974	0.002026342	0.005572442	6	oligos	OL-Cntl	51	20	20
GTGCAGCAGTGGGTTG-1_3_C4	25.35416012	3.971499649	15BA	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1318	2285	0.002188184	0.007002188	6	15BA	Stromal cells	51	20	20
GTGCAGCGTGATAAGT-1_3_C4	-7.380671248	-6.202500607	13A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1365	2225	0.054382022	0.005842697	6	13A	IN-VIP	51	20	20
GTGCAGCGTTGGTGGA-1_3_C4	4.168627722	-18.16577634	4	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	3805	8920	0.005829596	0.005381166	6	L2-3	EN-L2-3-MS	51	20	20
GTGCAGCTCCTTGGTC-1_3_C4	21.22701812	14.74535616	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1326	2310	0.001731602	0.006060606	6	oligos	OL-Cntl	51	20	20
GTGCATAAGAAACGAG-1_3_C4	11.38863807	23.41452989	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	852	1313	0.012185834	0.001523229	6	oligos	OL-Cntl	51	20	20
GTGCATAAGATGTAAC-1_3_C4	0.262509186	0.003728305	11	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	723	1022	0.044031311	0.004892368	6	11	Glia-MIX	51	20	20
GTGCATAAGGCTATCT-1_3_C4	21.33769307	10.3802373	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1636	2947	0.000678656	0.005768578	6	oligos	OL-Cntl	51	20	20
GTGCATAAGGTAAACT-1_3_C4	3.271218192	19.6053069	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	824	1303	0.003837299	0.006907137	6	oligos	OL-Cntl	51	20	20
GTGCATACACTGCCAG-1_3_C4	-20.49585875	30.59771756	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2572	5095	0.003140334	0.005299313	6	8	Astrocytes	51	20	20
GTGCATACAGTGGGAT-1_3_C4	-27.46586714	10.23591008	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	727	1070	0.002803738	0.002803738	6	8	Astrocytes	51	20	20
GTGCATACATCTACGA-1_3_C4	-10.11866826	-4.556324338	13A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1819	3189	0.017560364	0.009720916	6	13A	IN-VIP	51	20	20
GTGCATAGTAAACGCG-1_3_C4	-16.29087098	15.06313486	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1838	3347	0.000298775	0.003286525	6	8	Astrocytes	51	20	20
GTGCATATCTGACCTC-1_3_C4	-21.86461268	-18.57940391	6B	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2411	4619	0.018185754	0.010608357	6	6B	IN-SST	51	20	20
GTGCGGTAGCATCATC-1_3_C4	-7.270436715	-1.230178763	13A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1827	3290	0.011550152	0.004255319	6	13A	IN-VIP	51	20	20
GTGCGGTCATCCGGGT-1_3_C4	20.05277591	12.94941787	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1377	2407	0.003739094	0.005816369	6	oligos	OL-Cntl	51	20	20
GTGCGGTGTCCGTGAC-1_3_C4	-12.30851568	-0.792148242	13A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2684	5252	0.005140899	0.009329779	6	13A	IN-VIP	51	20	20
GTGCGGTGTCTAACGT-1_3_C4	1.819133677	30.27938307	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	777	1208	0.001655629	0.005794702	6	oligos	OL-Cntl	51	20	20
GTGCGGTGTTCTGTTT-1_3_C4	15.2047648	19.40746917	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1048	1634	0.006119951	0.004283966	6	oligos	OL-Cntl	51	20	20
GTGCGGTTCATGTCTT-1_3_C4	-11.44136807	15.04732199	11	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1285	2012	0.003976143	0.006461233	6	11	Glia-MIX	51	20	20
GTGCGGTTCATTGCGA-1_3_C4	8.001211541	19.18853753	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1263	2050	0.002926829	0.012682927	6	oligos	OL-Cntl	51	20	20
GTGCGGTTCGCCCTTA-1_3_C4	1.448270674	24.34519195	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	670	1025	0.004878049	0.008780488	6	oligos	OL-Cntl	51	20	20
GTGCGGTTCTCTGCTG-1_3_C4	38.42395449	8.727188046	14	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	731	1003	0.011964108	0.001994018	6	14	Microglia	51	20	20
GTGCTTCAGCAGCGTA-1_3_C4	11.54744178	0.964235144	12	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	791	1099	0.029117379	0.002729754	6	12	EN-MIX	51	20	20
GTGCTTCCATACTCTT-1_3_C4	18.19238256	19.90529586	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1055	1813	0.01103144	0.00275786	6	oligos	OL-Cntl	51	20	20
GTGCTTCGTAATTGGA-1_3_C4	-28.30315657	10.96036434	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	818	1205	0.005809129	0.000829876	6	8	Astrocytes	51	20	20
GTGCTTCGTAGCAAAT-1_3_C4	-30.85592146	10.77103968	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	789	1123	0.007123776	0.003561888	6	8	Astrocytes	51	20	20
GTGCTTCTCGGAAATA-1_3_C4	37.62544979	14.09405184	14	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1129	1652	0.001210654	0.018765133	6	14	Microglia	51	20	20
GTGCTTCTCGGTTAAC-1_3_C4	2.634027395	25.93415295	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	740	1126	0.002664298	0.007992895	6	oligos	OL-Cntl	51	20	20
GTGGGTCAGATCCCGC-1_3_C4	-3.31167228	24.51642641	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	753	1132	0.003533569	0.007067138	6	oligos	OL-Cntl	51	20	20
GTGGGTCTCGGTGTTA-1_3_C4	-23.62951156	19.27701176	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1547	2986	0.001339585	0.006697924	6	8	Astrocytes	51	20	20
GTGTTAGCACATGACT-1_3_C4	-22.34770457	23.86386828	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1513	2788	0.005380201	0.009684362	6	8	Astrocytes	51	20	20
GTGTTAGCAGTATAAG-1_3_C4	39.82466179	12.03602949	14	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	965	1346	0.001485884	0.008915305	6	14	Microglia	51	20	20
GTGTTAGCATGAACCT-1_3_C4	6.624979225	-16.47808671	4	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	3297	7323	0.006691247	0.013245937	6	L2-3	EN-L2-3-MS	51	20	20
GTGTTAGGTAAACGCG-1_3_C4	-8.148819134	-6.606643363	13A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1331	2113	0.029342168	0.005679129	6	13A	IN-VIP	51	20	20
GTGTTAGGTATAGGGC-1_3_C4	1.276945927	21.47206635	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	772	1151	0.002606429	0.009556907	6	oligos	OL-Cntl	51	20	20
GTGTTAGGTTATCGGT-1_3_C4	-16.99248036	-26.16507435	6A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2226	4968	0.017512077	0.002214171	6	6A	IN-PV	51	20	20
GTGTTAGTCAGCCTAA-1_3_C4	3.986841882	5.305973309	7	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1305	2027	0.005920079	0.006413419	6	7	Phagocytes	51	20	20
GTTAAGCCACATCTTT-1_3_C4	14.67886782	28.03502143	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	760	1130	0	0.002654867	6	oligos	OL-Cntl	51	20	20
GTTAAGCTCCGAATGT-1_3_C4	13.99622903	26.56886009	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	721	1063	0.005644403	0.004703669	6	oligos	OL-Cntl	51	20	20
GTTACAGAGTCCTCCT-1_3_C4	-28.28027854	10.11312951	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	731	1048	0.009541985	0.000954198	6	8	Astrocytes	51	20	20
GTTACAGGTTGTCTTT-1_3_C4	8.920940422	31.21121338	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	623	1000	0.003	0.001	6	oligos	OL-Cntl	51	20	20
GTTACAGTCAGGTAAA-1_3_C4	-2.725829873	18.88912609	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	650	1035	0.033816425	0.010628019	6	oligos	OL-Cntl	51	20	20
GTTACAGTCCAGATCA-1_3_C4	5.873609386	-14.44903983	4	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2866	6642	0.025143029	0.005269497	6	L2-3	EN-L2-3-MS	51	20	20
GTTCATTCAATCCAAC-1_3_C4	35.88693807	13.74005557	14	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1258	2070	0.004830918	0.014009662	6	14	Microglia	51	20	20
GTTCATTGTCCGAATT-1_3_C4	3.691650157	26.42453273	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	776	1173	0.000852515	0.00511509	6	oligos	OL-Cntl	51	20	20
GTTCATTTCACGCATA-1_3_C4	11.94419594	24.70090435	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	816	1343	0.003723008	0.005956813	6	oligos	OL-Cntl	51	20	20
GTTCGGGAGATGTAAC-1_3_C4	-18.03720964	23.51088155	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1351	2352	0.005102041	0.007653061	6	8	Astrocytes	51	20	20
GTTCGGGAGATGTCGG-1_3_C4	19.42978618	20.95881583	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	966	1604	0.009975062	0.002493766	6	oligos	OL-Cntl	51	20	20
GTTCGGGGTCCAGTTA-1_3_C4	39.86581762	12.01868026	14	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	871	1318	0.003034901	0.01138088	6	14	Microglia	51	20	20
GTTCTCGAGCAGACTG-1_3_C4	-16.14333836	11.95780395	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1517	2563	0.001170503	0.008583691	6	8	Astrocytes	51	20	20
GTTCTCGAGTACGTAA-1_3_C4	-29.97221543	20.77011731	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1016	1837	0.008165487	0.005988024	6	8	Astrocytes	51	20	20
GTTCTCGCAGGAATGC-1_3_C4	-4.689394067	-34.82790608	16	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	695	1029	0.042759961	0.013605442	6	16	EN-PYR	51	20	20
GTTCTCGTCGTTACGA-1_3_C4	22.16763381	-6.835611901	3	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1636	2726	0.014673514	0.003301541	6	3	EN-L5-6	51	20	20
GTTCTCGTCTAGCACA-1_3_C4	4.061212493	-13.99529431	4	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2384	4871	0.021556149	0.00431123	6	L2-3	EN-L2-3-MS	51	20	20
GTTTCTAAGAGGACGG-1_3_C4	19.72417757	13.7393132	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1347	2334	0.001713796	0.002570694	6	oligos	OL-Cntl	51	20	20
TAAACCGGTGCCTTGG-1_3_C4	-29.48889433	20.58779759	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	955	1562	0.007682458	0.004481434	6	8	Astrocytes	51	20	20
TAAACCGTCGGCTACG-1_3_C4	-31.45990215	11.30271381	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	681	1043	0.003835091	0.004793864	6	8	Astrocytes	51	20	20
TAAACCGTCTCTGTCG-1_3_C4	16.72831502	13.26190535	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1186	2152	0.011152416	0.007434944	6	oligos	OL-Cntl	51	20	20
TAAGAGAAGCGCCTTG-1_3_C4	14.82352136	21.2509953	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	933	1423	0.002810963	0.002810963	6	oligos	OL-Cntl	51	20	20
TAAGAGACACAGTCGC-1_3_C4	15.9151057	15.90301892	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1166	1923	0.016640666	0.003120125	6	oligos	OL-Cntl	51	20	20
TAAGAGACATCGTCGG-1_3_C4	11.78582233	21.09656774	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	939	1538	0.00260078	0.006501951	6	oligos	OL-Cntl	51	20	20
TAAGAGAGTCGCGTGT-1_3_C4	3.405174107	-18.24872993	4	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	3430	8455	0.00626848	0.008633944	6	L2-3	EN-L2-3-MS	51	20	20
TAAGAGAGTTACTGAC-1_3_C4	-35.84693265	-6.871000271	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1016	1678	0.005959476	0.003575685	6	9	OPC	51	20	20
TAAGCGTAGGGATGGG-1_3_C4	-0.358670196	18.78104007	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	655	1022	0.000978474	0.009784736	6	oligos	OL-Cntl	51	20	20
TAAGCGTAGTGGACGT-1_3_C4	-28.29397094	12.33987877	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	739	1177	0.002548853	0.002548853	6	8	Astrocytes	51	20	20
TAAGCGTAGTTCGATC-1_3_C4	4.63101884	24.5049513	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	805	1180	0.001694915	0.010169492	6	oligos	OL-Cntl	51	20	20
TAAGCGTCATGCAACT-1_3_C4	-32.17508159	-11.33451478	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	828	1222	0.003273322	0.004909984	6	9	OPC	51	20	20
TAAGCGTGTAAGCACG-1_3_C4	-1.790344195	1.431750851	11	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2020	3728	0.00804721	0.005901288	6	11	Glia-MIX	51	20	20
TAAGCGTTCAACCATG-1_3_C4	-34.84908314	-3.524915054	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1396	2334	0.000856898	0.001713796	6	9	OPC	51	20	20
TAAGCGTTCGAGGTAG-1_3_C4	-4.43742882	-8.171158607	13A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	779	1114	0.034111311	0.00448833	6	13A	IN-VIP	51	20	20
TAAGCGTTCTTCAACT-1_3_C4	13.06674171	-31.19425903	3	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2538	6270	0.002392344	0.003349282	6	3	EN-L5-6	51	20	20
TAAGTGCAGCACCGTC-1_3_C4	6.054613736	-14.40173991	4	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2683	5847	0.025654182	0.004104669	6	L2-3	EN-L2-3-MS	51	20	20
TAAGTGCAGCAGCGTA-1_3_C4	4.956981034	22.21237984	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	834	1324	0.00755287	0.004531722	6	oligos	OL-Cntl	51	20	20
TAAGTGCAGGCAGTCA-1_3_C4	-24.69838587	17.68516879	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1366	2297	0.007400958	0.006530257	6	8	Astrocytes	51	20	20
TAAGTGCAGTGTACTC-1_3_C4	9.684493993	24.57408656	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	774	1155	0.005194805	0.006060606	6	oligos	OL-Cntl	51	20	20
TAAGTGCGTAGGGTAC-1_3_C4	-25.70248776	12.07795631	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	888	1333	0.0060015	0.007501875	6	8	Astrocytes	51	20	20
TAAGTGCTCAGCTCGG-1_3_C4	13.34871018	8.915519139	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1482	2798	0.002501787	0.011436741	6	oligos	OL-Cntl	51	20	20
TAAGTGCTCCTTTCTC-1_3_C4	13.8306818	29.29602591	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	736	1110	0.000900901	0.001801802	6	oligos	OL-Cntl	51	20	20
TACACGAAGGCGATAC-1_3_C4	-7.351352398	-7.184276987	13A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1178	1621	0.020357804	0.008019741	6	13A	IN-VIP	51	20	20
TACACGAGTGATGTGG-1_3_C4	-24.78290531	22.14868731	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1272	2150	0.006511628	0.005581395	6	8	Astrocytes	51	20	20
TACACGAGTTTAGCTG-1_3_C4	-33.92664043	-3.698214763	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1379	2343	0.008962868	0.005975245	6	9	OPC	51	20	20
TACACGATCAACACGT-1_3_C4	-18.7284329	-17.55135277	6B	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2617	5663	0.015716052	0.002825358	6	6B	IN-SST	51	20	20
TACACGATCCAGATCA-1_3_C4	6.718436761	25.68800894	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	929	1377	0.001452433	0.005809731	6	oligos	OL-Cntl	51	20	20
TACACGATCTTACCGC-1_3_C4	33.27164869	-10.33271412	2	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	4105	10677	0.009834223	0.007211764	6	2	EN-L4	51	20	20
TACAGTGAGGGTTCCC-1_3_C4	15.23724249	2.996991871	12	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1004	1728	0.025462963	0.001157407	6	12	EN-MIX	51	20	20
TACAGTGCAAGGACTG-1_3_C4	13.73624807	19.32590899	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1030	1775	0.001690141	0.006760563	6	oligos	OL-Cntl	51	20	20
TACAGTGCATACGCCG-1_3_C4	-36.4759568	-5.27421763	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1162	2012	0.000497018	0.003479125	6	9	OPC	51	20	20
TACAGTGCATCACCCT-1_3_C4	15.15418502	17.5868519	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1057	1727	0.00984366	0.007527504	6	oligos	OL-Cntl	51	20	20
TACAGTGGTCTACCTC-1_3_C4	-20.89260028	17.93475655	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1813	3274	0.012828345	0.007635919	6	8	Astrocytes	51	20	20
TACAGTGTCTTCTGGC-1_3_C4	-24.28747516	-16.02558982	6A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2853	6054	0.008589362	0.005285761	6	6A	IN-PV	51	20	20
TACCTATAGCACACAG-1_3_C4	-24.16650314	18.32106723	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1243	2082	0.000960615	0.002881844	6	8	Astrocytes	51	20	20
TACCTATAGTGAACAT-1_3_C4	37.43772244	9.979598078	14	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	735	1034	0.00483559	0.008704062	6	14	Microglia	51	20	20
TACCTATCACCGATAT-1_3_C4	-26.25887428	14.46882181	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1022	1577	0.003804692	0.001902346	6	8	Astrocytes	51	20	20
TACCTATCATCACGTA-1_3_C4	-15.68046099	-5.232307635	13A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	5098	17061	0.007385265	0.006681906	6	13A	IN-VIP	51	20	20
TACCTATTCACAGGCC-1_3_C4	-0.813212452	19.54664794	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	661	1055	0	0.006635071	6	oligos	OL-Cntl	51	20	20
TACCTATTCCAACCAA-1_3_C4	-22.10793735	-20.15242166	6A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2655	6007	0.032129183	0.008323622	6	6A	IN-PV	51	20	20
TACCTTAAGCTGCGAA-1_3_C4	-22.69520754	-0.239332048	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1659	3486	0.003155479	0.007171543	6	9	OPC	51	20	20
TACCTTAAGGAATCGC-1_3_C4	-14.52281224	-0.272638204	13A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2501	4686	0.013657704	0.021766965	6	13A	IN-VIP	51	20	20
TACCTTACACACATGT-1_3_C4	-15.11296484	-10.2602871	13B	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2278	4794	0.010638298	0.002085941	6	13B	IN-SV2C	51	20	20
TACCTTAGTCCATCCT-1_3_C4	-9.888291326	22.93413709	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1834	3206	0.004054897	0.008421709	6	8	Astrocytes	51	20	20
TACCTTAGTCCGTGAC-1_3_C4	37.32881089	10.61344565	14	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	783	1092	0.02014652	0.007326007	6	14	Microglia	51	20	20
TACCTTATCGAGGTAG-1_3_C4	22.6314825	11.83873787	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1557	2811	0.001778726	0.002490217	6	oligos	OL-Cntl	51	20	20
TACCTTATCTCCAGGG-1_3_C4	8.754140758	20.90001996	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	879	1491	0.005365526	0.009389671	6	oligos	OL-Cntl	51	20	20
TACGGATAGGCTCAGA-1_3_C4	-7.605977245	-5.4950034	13A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1515	2632	0.035334347	0.005699088	6	13A	IN-VIP	51	20	20
TACGGATCACCAGATT-1_3_C4	-26.32119628	14.04215556	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	958	1430	0.007692308	0.00979021	6	8	Astrocytes	51	20	20
TACGGATGTAAGTTCC-1_3_C4	-8.949547474	13.59998176	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1519	2304	0.0078125	0.008246528	6	oligos	OL-Cntl	51	20	20
TACGGATGTCTGATTG-1_3_C4	-22.92168022	1.274925338	11	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2560	5358	0.004292647	0.003359462	6	11	Glia-MIX	51	20	20
TACGGATTCTCAAACG-1_3_C4	17.27089542	10.46786373	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1604	2847	0.013347383	0.005971198	6	oligos	OL-Cntl	51	20	20
TACGGATTCTCGCTTG-1_3_C4	-20.56715817	9.849728571	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1071	1824	0.001096491	0.006578947	6	8	Astrocytes	51	20	20
TACGGGCAGGATGGTC-1_3_C4	15.55793057	15.91471356	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1196	1971	0.00304414	0.007102993	6	oligos	OL-Cntl	51	20	20
TACGGGCAGGCTCAGA-1_3_C4	19.43014961	10.37541386	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1462	2645	0.004536862	0.006049149	6	oligos	OL-Cntl	51	20	20
TACGGGCAGTAGGTGC-1_3_C4	-11.2561506	-3.1394663	13A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2198	4030	0.033995037	0.007444169	6	13A	IN-VIP	51	20	20
TACGGGCAGTGTTGAA-1_3_C4	-12.72870154	0.234919999	13A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	3347	7118	0.007164934	0.007024445	6	13A	IN-VIP	51	20	20
TACGGGCGTACCAGTT-1_3_C4	34.21789128	15.7098204	14	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1089	1701	0.001175779	0.059376837	6	14	Microglia	51	20	20
TACGGGCTCCCTGACT-1_3_C4	-29.22981835	20.79222813	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1091	1711	0.005844535	0.005844535	6	8	Astrocytes	51	20	20
TACGGTACAGCGTAAG-1_3_C4	18.23400471	8.341847037	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1789	3494	0.000858615	0.005437894	6	oligos	OL-Cntl	51	20	20
TACGGTACATTTGCTT-1_3_C4	21.84076007	-9.466439244	3	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1889	3567	0.023268853	0.003364172	6	3	EN-L5-6	51	20	20
TACGGTAGTCGAACAG-1_3_C4	-25.64780748	22.83745812	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1306	2121	0.011315417	0.00330033	6	8	Astrocytes	51	20	20
TACGGTAGTGATAAAC-1_3_C4	27.16013351	4.936043326	15BA	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	832	1320	0.016666667	0.018939394	6	15BA	Stromal cells	51	20	20
TACGGTATCTTGTCAT-1_3_C4	13.91476137	29.42734998	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	724	1160	0	0.001724138	6	oligos	OL-Cntl	51	20	20
TACTCATAGTACGATA-1_3_C4	-23.3179418	-1.115967871	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1243	1961	0.005099439	0.008669046	6	9	OPC	51	20	20
TACTCATCAAGTCTAC-1_3_C4	-35.69117611	3.43209338	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1971	3689	0.00352399	0.004066143	6	9	OPC	51	20	20
TACTCATCACGAGAGT-1_3_C4	-34.92189342	2.45869572	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1855	3300	0.000909091	0.003030303	6	9	OPC	51	20	20
TACTCATCACTACAGT-1_3_C4	-9.818640533	-0.04499029	13A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2542	5818	0.008937779	0.001203163	6	13A	IN-VIP	51	20	20
TACTCATTCCCAAGTA-1_3_C4	19.89531357	11.8028056	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1424	2611	0.003446955	0.00536193	6	oligos	OL-Cntl	51	20	20
TACTCATTCGCTAGCG-1_3_C4	-11.12600466	18.42118798	11	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2149	4484	0.003122212	0.00646744	6	11	Glia-MIX	51	20	20
TACTCGCAGATGTCGG-1_3_C4	7.158754181	30.93058006	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	877	1460	0.000684932	0.008219178	6	oligos	OL-Cntl	51	20	20
TACTCGCCAAACAACA-1_3_C4	-27.11639063	13.83462638	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	970	1553	0.003219575	0.005795235	6	8	Astrocytes	51	20	20
TACTCGCCAGCTCCGA-1_3_C4	20.55125586	7.304454754	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2039	3916	0.002808989	0.006128703	6	oligos	OL-Cntl	51	20	20
TACTCGCGTTAAGATG-1_3_C4	8.460832886	28.51695324	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	770	1163	0.000859845	0.004299226	6	oligos	OL-Cntl	51	20	20
TACTCGCTCAAGCCTA-1_3_C4	-37.01224945	0.624515759	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1602	2867	0.00313917	0.003487967	6	9	OPC	51	20	20
TACTTACCAGACGCCT-1_3_C4	16.38337309	19.5115561	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1020	1696	0.002948113	0.004127358	6	oligos	OL-Cntl	51	20	20
TACTTACGTATCACCA-1_3_C4	-4.803702252	-8.335035518	13A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	851	1213	0.014839242	0.003297609	6	13A	IN-VIP	51	20	20
TACTTACTCGCTTAGA-1_3_C4	15.13010334	25.7737888	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	873	1337	0.002243829	0.003739716	6	oligos	OL-Cntl	51	20	20
TACTTACTCTGGCGAC-1_3_C4	-35.12139753	5.159631467	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	3015	7326	0.003958504	0.003685504	6	9	OPC	51	20	20
TACTTGTAGCACCGTC-1_3_C4	8.640879833	27.21310916	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	759	1183	0.003381234	0.003381234	6	oligos	OL-Cntl	51	20	20
TACTTGTAGCGTGAGT-1_3_C4	-25.66340646	22.53756528	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1288	2229	0.003589053	0.007626738	6	8	Astrocytes	51	20	20
TACTTGTAGTACCGGA-1_3_C4	18.66767593	-10.98290281	3	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2988	6806	0.017778431	0.007346459	6	3	EN-L5-6	51	20	20
TACTTGTCAGATCGGA-1_3_C4	-37.09796008	2.595275827	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1812	3501	0.002285061	0.001142531	6	9	OPC	51	20	20
TACTTGTTCCAGTAGT-1_3_C4	11.1078485	21.22931617	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	946	1583	0.010739103	0.008212255	6	oligos	OL-Cntl	51	20	20
TACTTGTTCGGATGTT-1_3_C4	-17.08977221	-1.769714763	13A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2753	5310	0.021468927	0.015442561	6	13A	IN-VIP	51	20	20
TAGACCAAGCTTTGGT-1_3_C4	19.54219705	16.70561964	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1213	2077	0.000481464	0.004333173	6	oligos	OL-Cntl	51	20	20
TAGACCAAGGTGTTAA-1_3_C4	-8.549537318	-18.22927841	6B	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	722	1227	0.078239609	0.001629992	6	6B	IN-SST	51	20	20
TAGACCAGTAGAGTGC-1_3_C4	-29.43674883	19.98093693	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1098	1696	0.020636792	0.003537736	6	8	Astrocytes	51	20	20
TAGACCATCTACCAGA-1_3_C4	16.51827199	18.97572691	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1047	1782	0.004489338	0.005611672	6	oligos	OL-Cntl	51	20	20
TAGAGCTAGACGCAAC-1_3_C4	17.13261583	13.02011639	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1266	2288	0.005244755	0.003933566	6	oligos	OL-Cntl	51	20	20
TAGAGCTCACTTACGA-1_3_C4	15.57556556	19.82325138	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1002	1626	0.001230012	0.003690037	6	oligos	OL-Cntl	51	20	20
TAGAGCTGTAGCGTGA-1_3_C4	-32.19000108	-12.48011963	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	817	1186	0.001686341	0.004215852	6	9	OPC	51	20	20
TAGAGCTGTCTCTTAT-1_3_C4	10.63024252	14.89845351	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1105	1796	0.021158129	0.009465479	6	oligos	OL-Cntl	51	20	20
TAGAGCTGTGCGGTAA-1_3_C4	-13.72178591	-10.33242113	13B	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1924	3447	0.004931825	0.001450537	6	13B	IN-SV2C	51	20	20
TAGAGCTGTGTTCTTT-1_3_C4	23.05074118	-27.64784419	3	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	3467	8569	0.003150893	0.003150893	6	3	EN-L5-6	51	20	20
TAGAGCTTCGCATGGC-1_3_C4	18.39414907	-6.022257494	3	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1548	2901	0.001378835	0.001723544	6	3	EN-L5-6	51	20	20
TAGCCGGAGGGTGTGT-1_3_C4	-22.00466338	9.967939364	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	837	1209	0.004962779	0.003308519	6	8	Astrocytes	51	20	20
TAGCCGGCACCACCAG-1_3_C4	5.881836609	-26.85622745	4	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	6800	23813	0.008188804	0.003947424	6	L2-3	EN-L2-3-MS	51	20	20
TAGCCGGGTGTCCTCT-1_3_C4	-34.64009639	-3.697988765	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1397	2385	0.007966457	0.00293501	6	9	OPC	51	20	20
TAGCCGGTCCCAAGTA-1_3_C4	15.218175	17.79115375	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1115	1791	0.003908431	0.009491904	6	oligos	OL-Cntl	51	20	20
TAGGCATTCGTTACGA-1_3_C4	10.38474794	-18.87966755	4	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	4997	14436	0.008035467	0.011637573	6	L2-3	EN-L2-3-MS	51	20	20
TAGTGGTAGCCGGTAA-1_3_C4	11.31078249	30.11757371	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	729	1103	0.003626473	0.002719855	6	oligos	OL-Cntl	51	20	20
TAGTGGTCAGCGTAAG-1_3_C4	-10.63897129	-4.677898722	13A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1886	3048	0.016076115	0.01476378	6	13A	IN-VIP	51	20	20
TAGTGGTTCTGCAAGT-1_3_C4	-24.37200368	18.11421404	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1418	2666	0.003375844	0.006751688	6	8	Astrocytes	51	20	20
TAGTTGGCACGAAATA-1_3_C4	1.469229191	-12.23193392	12	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1959	3824	0.025627615	0.003399582	6	12	EN-MIX	51	20	20
TAGTTGGCACTGAAGG-1_3_C4	2.759865185	26.27592675	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	675	1097	0.000911577	0.005469462	6	oligos	OL-Cntl	51	20	20
TAGTTGGGTCGAAAGC-1_3_C4	6.719138107	24.82102386	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	949	1387	0.003604903	0.007930786	6	oligos	OL-Cntl	51	20	20
TAGTTGGGTTGCGCAC-1_3_C4	18.54417961	-7.981571663	3	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1971	4407	0.072157931	0.000680735	6	3	EN-L5-6	51	20	20
TATCAGGCAAATTGCC-1_3_C4	11.19723452	24.65585242	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	798	1308	0.013761468	0.003058104	6	oligos	OL-Cntl	51	20	20
TATCAGGCACAACGCC-1_3_C4	21.76139652	14.49186375	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1227	2011	0.00099453	0.00397812	6	oligos	OL-Cntl	51	20	20
TATCAGGCAGACGCTC-1_3_C4	-31.56632425	12.59807094	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	874	1304	0.007668712	0.003067485	6	8	Astrocytes	51	20	20
TATCAGGCAGGCTGAA-1_3_C4	3.759463647	24.7395123	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	784	1124	0.002669039	0.005338078	6	oligos	OL-Cntl	51	20	20
TATCAGGCATCCTAGA-1_3_C4	-14.76801833	-24.05803765	6A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1533	2849	0.024921025	0.002457002	6	6A	IN-PV	51	20	20
TATCTCAAGGGAAACA-1_3_C4	2.54488223	26.14729682	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	712	1042	0.008637236	0.004798464	6	oligos	OL-Cntl	51	20	20
TATCTCACATCGACGC-1_3_C4	-31.37422875	11.9241099	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	796	1257	0.023866348	0.007159905	6	8	Astrocytes	51	20	20
TATGCCCAGCATGGCA-1_3_C4	-8.81997468	15.21674169	11	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2442	4849	0.003505878	0.006393071	6	11	Glia-MIX	51	20	20
TATGCCCCAAAGTGCG-1_3_C4	10.7096147	23.80029149	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	865	1355	0.011808118	0.009594096	6	oligos	OL-Cntl	51	20	20
TATGCCCCAATGCCAT-1_3_C4	17.32545623	26.40051152	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	878	1363	0.001467351	0.002934703	6	oligos	OL-Cntl	51	20	20
TATGCCCGTACATCCA-1_3_C4	6.836462828	30.30784019	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	885	1402	0.009985735	0.007845934	6	oligos	OL-Cntl	51	20	20
TATGCCCTCAGCTTAG-1_3_C4	6.255523288	26.58983909	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	856	1310	0.003816794	0.002290076	6	oligos	OL-Cntl	51	20	20
TATGCCCTCATTGCCC-1_3_C4	-32.68827887	-13.00467584	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	718	1052	0.001901141	0.002851711	6	9	OPC	51	20	20
TATTACCAGACCCACC-1_3_C4	-18.18464984	-21.77358446	6A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2246	4990	0.024849699	0.00260521	6	6A	IN-PV	51	20	20
TATTACCAGTTACCCA-1_3_C4	17.39246595	22.78692842	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	945	1545	0.001941748	0.001294498	6	oligos	OL-Cntl	51	20	20
TATTACCGTCATCGGC-1_3_C4	21.13829491	16.96389611	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1148	1901	0.008416623	0.005260389	6	oligos	OL-Cntl	51	20	20
TATTACCGTTCCGGCA-1_3_C4	34.53869108	-3.444989085	2	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	3140	7562	0.030415234	0.002512563	6	2	EN-L4	51	20	20
TCAACGACAATGGTCT-1_3_C4	15.05575613	19.6255157	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1023	1685	0.002967359	0.008308605	6	oligos	OL-Cntl	51	20	20
TCAACGACACCGCTAG-1_3_C4	-31.26544633	12.13666454	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	813	1143	0.007874016	0.002624672	6	8	Astrocytes	51	20	20
TCAACGACATTGTGCA-1_3_C4	40.00711824	12.89963198	14	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1004	1535	0.000651466	0.004560261	6	14	Microglia	51	20	20
TCAACGACATTTCACT-1_3_C4	-22.95604047	25.01647685	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1850	4085	0.004161567	0.004651163	6	8	Astrocytes	51	20	20
TCAACGAGTACAGACG-1_3_C4	-17.20295695	-5.744448363	13A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	3128	7015	0.010548824	0.011689237	6	13A	IN-VIP	51	20	20
TCAACGAGTAGCAAAT-1_3_C4	-21.82595742	10.40345446	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1305	2637	0.00303375	0.004171407	6	8	Astrocytes	51	20	20
TCAACGAGTCCGAACC-1_3_C4	-4.670664962	-3.742616423	13A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1374	2647	0.03853419	0.005666793	6	13A	IN-VIP	51	20	20
TCAATCTAGCTGATAA-1_3_C4	20.96471191	7.968694516	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1978	3908	0.002047083	0.006653019	6	oligos	OL-Cntl	51	20	20
TCAATCTCATGCCACG-1_3_C4	-26.33039618	19.07417501	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1359	2318	0.001294219	0.007765315	6	8	Astrocytes	51	20	20
TCAATCTGTCTAGCCG-1_3_C4	-34.64270795	-8.239245378	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	964	1503	0.00332668	0.003992016	6	9	OPC	51	20	20
TCAATCTGTGATGTGG-1_3_C4	-22.49508376	24.67268465	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1705	3187	0.004706621	0.003451522	6	8	Astrocytes	51	20	20
TCAATCTGTGCCTGGT-1_3_C4	-31.65475195	12.05589756	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	837	1373	0.002913328	0.005826657	6	8	Astrocytes	51	20	20
TCAATCTGTGTTTGGT-1_3_C4	9.34649786	28.01445155	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	798	1298	0.000770416	0.006163328	6	oligos	OL-Cntl	51	20	20
TCAATCTGTTAGGGTG-1_3_C4	-29.59452698	20.05768335	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1102	1836	0.006535948	0.003267974	6	8	Astrocytes	51	20	20
TCAATCTGTTCGCTAA-1_3_C4	-11.2003771	16.16206305	11	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1472	2574	0.0003885	0.005439005	6	11	Glia-MIX	51	20	20
TCAATCTTCCTTGACC-1_3_C4	-11.64706651	-22.19737049	6A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1153	2484	0.009259259	0.001207729	6	6A	IN-PV	51	20	20
TCACAAGAGAAGGTGA-1_3_C4	-10.30876576	-14.828445	6B	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	961	1418	0.043018336	0.00493653	6	6B	IN-SST	51	20	20
TCACAAGAGGTGCTTT-1_3_C4	20.7781868	10.85255774	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1515	2763	0.005066956	0.009410062	6	oligos	OL-Cntl	51	20	20
TCACAAGCAATCCAAC-1_3_C4	10.92650036	14.92823744	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1188	1935	0.009819121	0.010852713	6	oligos	OL-Cntl	51	20	20
TCACAAGCATGTAAGA-1_3_C4	21.10066812	10.26406618	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1833	3478	0.006037953	0.006325474	6	oligos	OL-Cntl	51	20	20
TCACAAGTCAGAGGTG-1_3_C4	17.0462944	24.02058886	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	838	1280	0.00390625	0.00390625	6	oligos	OL-Cntl	51	20	20
TCACAAGTCAGCCTAA-1_3_C4	0.971417927	26.42006621	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	705	1071	0.000933707	0.004668534	6	oligos	OL-Cntl	51	20	20
TCACAAGTCCTTTCGG-1_3_C4	9.442863794	24.53788378	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	719	1091	0.005499542	0.005499542	6	oligos	OL-Cntl	51	20	20
TCACGAACAAGTACCT-1_3_C4	-37.65295202	-0.322928173	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1652	2892	0.004840941	0.002074689	6	9	OPC	51	20	20
TCACGAACAATCAGAA-1_3_C4	4.214998678	18.70035994	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	952	1496	0.00868984	0.006684492	6	oligos	OL-Cntl	51	20	20
TCACGAACATGGATGG-1_3_C4	-14.56038823	-21.37677705	6A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1656	3304	0.017857143	0.001210654	6	6A	IN-PV	51	20	20
TCAGATGAGATTACCC-1_3_C4	-30.05134276	20.83374407	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	978	1507	0.01061712	0.00597213	6	8	Astrocytes	51	20	20
TCAGATGCAATTCCTT-1_3_C4	-36.40163758	-7.54764633	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1063	1815	0.008815427	0.002754821	6	9	OPC	51	20	20
TCAGATGCAGCGTCCA-1_3_C4	-27.59373602	15.88360899	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	986	1591	0.003771213	0.001885607	6	8	Astrocytes	51	20	20
TCAGATGCAGGTGGAT-1_3_C4	15.50840311	-5.218462007	10	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1415	2612	0.000382848	0.003445636	6	L2-3	EN-L2-3-Cntl	51	20	20
TCAGATGCATAAGACA-1_3_C4	4.583082734	25.37200466	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	790	1233	0.00973236	0.00892133	6	oligos	OL-Cntl	51	20	20
TCAGATGTCATGCATG-1_3_C4	19.09657061	15.69757505	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1220	2175	0.002298851	0.003218391	6	oligos	OL-Cntl	51	20	20
TCAGATGTCTTCCTTC-1_3_C4	-38.45404921	-1.161151585	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1387	2681	0.001491981	0.001864976	6	9	OPC	51	20	20
TCAGCAAAGATGTAAC-1_3_C4	-17.34956534	14.27782993	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1528	2657	0.003387279	0.005645465	6	8	Astrocytes	51	20	20
TCAGCAACAGTAACGG-1_3_C4	-10.08138509	22.7327362	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1666	2686	0.005584512	0.003723008	6	8	Astrocytes	51	20	20
TCAGCAAGTTCTGAAC-1_3_C4	9.221717151	-20.61771484	4	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	6203	18878	0.004237737	0.013401843	6	L2-3	EN-L2-3-MS	51	20	20
TCAGCAATCCGCGTTT-1_3_C4	10.43905384	21.69379963	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	897	1468	0.006811989	0.00613079	6	oligos	OL-Cntl	51	20	20
TCAGCAATCGCAGGCT-1_3_C4	-23.26879896	22.60865719	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1488	2788	0.00071736	0.004662841	6	8	Astrocytes	51	20	20
TCAGCAATCTATGTGG-1_3_C4	16.28343579	18.39863781	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1018	1780	0.00505618	0.002808989	6	oligos	OL-Cntl	51	20	20
TCAGCTCAGATATGGT-1_3_C4	-37.14035996	-0.032887178	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1492	2800	0.005357143	0.002142857	6	9	OPC	51	20	20
TCAGCTCAGATGCGAC-1_3_C4	13.39712531	25.67128137	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	730	1134	0.008818342	0.004409171	6	oligos	OL-Cntl	51	20	20
TCAGCTCCAAGCGTAG-1_3_C4	-7.340571367	-6.928491853	13A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1205	1774	0.029312289	0.014092446	6	13A	IN-VIP	51	20	20
TCAGCTCCATGGTCAT-1_3_C4	18.74675742	14.37445098	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1246	2207	0.000453104	0.00362483	6	oligos	OL-Cntl	51	20	20
TCAGCTCGTACTTCTT-1_3_C4	-22.5605644	19.57557784	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1462	2493	0.005615724	0.002005616	6	8	Astrocytes	51	20	20
TCAGCTCGTCTGATTG-1_3_C4	-31.83585818	12.05866742	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	758	1123	0.010685663	0.003561888	6	8	Astrocytes	51	20	20
TCAGCTCGTGAGGGTT-1_3_C4	-24.80284204	17.45811532	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1248	1974	0.004559271	0.004052685	6	8	Astrocytes	51	20	20
TCAGCTCTCAGATAAG-1_3_C4	-14.18681642	-4.685019845	13A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	3153	7210	0.006102635	0.006380028	6	13A	IN-VIP	51	20	20
TCAGGATAGGCAGGTT-1_3_C4	-7.826298413	-5.305698194	13A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1515	2590	0.023166023	0.004247104	6	13A	IN-VIP	51	20	20
TCAGGATCATCACCCT-1_3_C4	-29.3556112	20.4247755	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1033	1632	0.022058824	0.003676471	6	8	Astrocytes	51	20	20
TCAGGATGTAAATGAC-1_3_C4	-24.82714227	-2.45112609	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1096	1952	0.03125	0.004098361	6	9	OPC	51	20	20
TCAGGATGTCTGCCAG-1_3_C4	-10.50286341	16.0230343	11	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1769	2969	0.006736275	0.004378579	6	11	Glia-MIX	51	20	20
TCAGGTAAGAATTCCC-1_3_C4	-21.6977918	-18.59433393	6B	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2749	6198	0.010648596	0.008712488	6	6B	IN-SST	51	20	20
TCAGGTAAGCACCGCT-1_3_C4	-19.74911596	19.76219466	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1883	3441	0.003777972	0.005812264	6	8	Astrocytes	51	20	20
TCAGGTAAGCTCTCGG-1_3_C4	-36.23430886	-2.954389587	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1390	2344	0.001706485	0.005119454	6	9	OPC	51	20	20
TCAGGTACACGAAAGC-1_3_C4	4.646719338	22.12665808	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	812	1261	0.002379064	0.004758128	6	oligos	OL-Cntl	51	20	20
TCAGGTACACGACTCG-1_3_C4	18.96544527	18.15314728	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1066	1699	0.002942908	0.001177163	6	oligos	OL-Cntl	51	20	20
TCAGGTACACGTGAGA-1_3_C4	9.731144183	24.03728883	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	746	1130	0.001769912	0.003539823	6	oligos	OL-Cntl	51	20	20
TCAGGTACAGCTCGCA-1_3_C4	-7.710997711	-6.232477237	13A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1377	2261	0.028748341	0.00398054	6	13A	IN-VIP	51	20	20
TCAGGTACAGCTGTAT-1_3_C4	3.328083011	26.83944837	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	748	1156	0.000865052	0.00432526	6	oligos	OL-Cntl	51	20	20
TCAGGTAGTGCGGTAA-1_3_C4	-23.64581781	-1.394217239	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1189	1791	0.005583473	0.000558347	6	9	OPC	51	20	20
TCATTACAGTCGAGTG-1_3_C4	-5.271965503	-2.680040426	13A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1494	2805	0.00285205	0.002139037	6	13A	IN-VIP	51	20	20
TCATTACCACCGGAAA-1_3_C4	10.27903487	18.87552136	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1031	1747	0.010303377	0.013737836	6	oligos	OL-Cntl	51	20	20
TCATTACCAGTCAGCC-1_3_C4	13.06105574	19.06363025	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1068	1828	0.00273523	0.008205689	6	oligos	OL-Cntl	51	20	20
TCATTACGTACAAGTA-1_3_C4	15.32410707	20.76216599	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1004	1638	0.006715507	0.007936508	6	oligos	OL-Cntl	51	20	20
TCATTACGTCCTAGCG-1_3_C4	32.65870246	9.358195314	14	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	631	1233	0	0.00729927	6	14	Microglia	51	20	20
TCATTACGTCTTGCGG-1_3_C4	-33.65126335	-9.772758035	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	952	1424	0.002808989	0.00491573	6	9	OPC	51	20	20
TCATTACTCGCTGATA-1_3_C4	-28.77105554	9.984634365	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	714	1021	0.002938296	0.005876592	6	8	Astrocytes	51	20	20
TCATTTGAGTCACGCC-1_3_C4	-5.537517258	-2.864609182	13A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1579	3109	0.024123512	0.005146349	6	13A	IN-VIP	51	20	20
TCATTTGCAAACCCAT-1_3_C4	13.15715351	28.98775434	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	811	1205	0.004979253	0.003319502	6	oligos	OL-Cntl	51	20	20
TCATTTGCAGCTTAAC-1_3_C4	-10.09098213	14.66160927	11	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1323	2310	0.005194805	0.004329004	6	11	Glia-MIX	51	20	20
TCATTTGCATCAGTCA-1_3_C4	39.9175543	11.46184538	14	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	879	1318	0.003034901	0.003793627	6	14	Microglia	51	20	20
TCATTTGGTGAGGGAG-1_3_C4	-35.25189965	-6.928919994	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1019	1531	0.003919007	0.005878511	6	9	OPC	51	20	20
TCATTTGTCTTGACGA-1_3_C4	-36.27438664	-5.519257526	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1127	1956	0.002556237	0.00408998	6	9	OPC	51	20	20
TCCACACAGCTATGCT-1_3_C4	22.48326143	12.71998794	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1440	2591	0.001543805	0.005017368	6	oligos	OL-Cntl	51	20	20
TCCACACGTAAACCTC-1_3_C4	17.0607079	14.65734891	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1248	2157	0.002781641	0.005563282	6	oligos	OL-Cntl	51	20	20
TCCACACGTTACCGAT-1_3_C4	-28.18860164	11.71638729	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	831	1232	0.007305195	0.008116883	6	8	Astrocytes	51	20	20
TCCACACGTTCAGCGC-1_3_C4	-4.447095697	30.09948203	11	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1228	2087	0.013895544	0.006708194	6	11	Glia-MIX	51	20	20
TCCCGATAGAGCAATT-1_3_C4	23.10301744	-25.87844567	3	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	3688	9168	0.014725131	0.003926702	6	3	EN-L5-6	51	20	20
TCCCGATCACTACAGT-1_3_C4	-9.098054487	18.99781119	11	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	4184	10066	0.003377707	0.00735148	6	11	Glia-MIX	51	20	20
TCCCGATGTCGGCACT-1_3_C4	-8.268796403	-17.37716851	6B	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	703	1105	0.085067873	0.001809955	6	6B	IN-SST	51	20	20
TCCCGATGTTTGCATG-1_3_C4	9.456580421	16.54670994	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1161	1967	0.004575496	0.006100661	6	oligos	OL-Cntl	51	20	20
TCCCGATTCAGTACGT-1_3_C4	21.87065389	-8.573703413	2	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1952	3857	0.007259528	0.005444646	6	2	EN-L4	51	20	20
TCGAGGCAGACGCAAC-1_3_C4	-25.5086677	22.28063083	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1393	2295	0.007407407	0.006535948	6	8	Astrocytes	51	20	20
TCGAGGCAGTACTTGC-1_3_C4	10.74355629	17.19704899	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1078	1767	0.001131862	0.01188455	6	oligos	OL-Cntl	51	20	20
TCGAGGCAGTGCCAGA-1_3_C4	-31.10910587	2.370889704	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2208	4035	0.012143742	0.007187113	6	9	OPC	51	20	20
TCGAGGCTCCACTCCA-1_3_C4	14.5500893	15.55981373	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1341	2417	0.003309888	0.002896152	6	oligos	OL-Cntl	51	20	20
TCGCGAGCATATGAGA-1_3_C4	-36.41550252	-4.706627978	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1358	2273	0.001319842	0.002199736	6	9	OPC	51	20	20
TCGCGAGGTCGGGTCT-1_3_C4	4.179821782	22.29116532	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	803	1293	0.002320186	0.007733952	6	oligos	OL-Cntl	51	20	20
TCGCGAGGTTCAGACT-1_3_C4	-15.26831907	-5.861167098	13A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	4388	11674	0.009422649	0.008480384	6	13A	IN-VIP	51	20	20
TCGCGAGTCACAGTAC-1_3_C4	5.225140469	17.49205247	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	969	1458	0.00617284	0.018518519	6	oligos	OL-Cntl	51	20	20
TCGCGAGTCGTGGGAA-1_3_C4	21.65808188	10.13880731	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1767	3180	0.001886792	0.006603774	6	oligos	OL-Cntl	51	20	20
TCGCGAGTCTCTGAGA-1_3_C4	17.26830917	14.57487159	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1148	1973	0.006082108	0.004561581	6	oligos	OL-Cntl	51	20	20
TCGCGTTCAGGCTGAA-1_3_C4	-31.50639075	11.92762842	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	798	1153	0.011274935	0.006071119	6	8	Astrocytes	51	20	20
TCGCGTTTCCTTGCCA-1_3_C4	6.466585903	-16.69478186	4	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	3462	8141	0.008352782	0.015231544	6	L2-3	EN-L2-3-MS	51	20	20
TCGGGACAGTGGACGT-1_3_C4	-14.99729055	-9.316271376	13A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2606	5967	0.036534272	0.001173119	6	13A	IN-VIP	51	20	20
TCGGGACCACTGCCAG-1_3_C4	16.72416092	16.39128688	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1255	2014	0.009930487	0.006951341	6	oligos	OL-Cntl	51	20	20
TCGGGACGTAGGAGTC-1_3_C4	13.11762786	8.05896964	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1646	3042	0.004273504	0.015121631	6	oligos	OL-Cntl	51	20	20
TCGGGACTCGCAGGCT-1_3_C4	21.2144769	12.10197495	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1477	2576	0.000776398	0.008152174	6	oligos	OL-Cntl	51	20	20
TCGGTAACAACACCTA-1_3_C4	-15.18589532	0.778326667	13A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	3493	7498	0.012936783	0.011469725	6	13A	IN-VIP	51	20	20
TCGGTAACAGATGGCA-1_3_C4	-23.67369471	-1.119291403	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1333	2259	0.00708278	0.004426737	6	9	OPC	51	20	20
TCGGTAACAGTTCCCT-1_3_C4	-36.234984	-2.159445727	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1403	2415	0.000414079	0.006625259	6	9	OPC	51	20	20
TCGGTAAGTCAGTGGA-1_3_C4	29.89241263	9.400753276	15DB	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	800	1438	0.009735744	0.039638387	6	15DB	B cells	51	20	20
TCGGTAAGTCATATCG-1_3_C4	-36.76499084	-3.239099911	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1320	2258	0.004871568	0.004428698	6	9	OPC	51	20	20
TCGTACCAGAGACTTA-1_3_C4	-29.5203119	20.53443059	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1076	1598	0.01126408	0.007509387	6	8	Astrocytes	51	20	20
TCGTACCAGTGTTAGA-1_3_C4	-29.28209904	20.85242751	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1098	1690	0.010059172	0.00295858	6	8	Astrocytes	51	20	20
TCGTACCCAGACGCCT-1_3_C4	-35.3137032	-1.401407036	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1592	2710	0.003690037	0.002214022	6	9	OPC	51	20	20
TCGTACCGTAATCGTC-1_3_C4	-1.185667646	21.93185737	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	788	1194	0.00921273	0.013400335	6	oligos	OL-Cntl	51	20	20
TCGTACCGTGAGGGTT-1_3_C4	-36.37275647	-4.033359992	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1279	2212	0.000904159	0.009041591	6	9	OPC	51	20	20
TCGTACCGTTGCGTTA-1_3_C4	-27.30682609	16.69445076	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	970	1578	0.005069708	0.003168568	6	8	Astrocytes	51	20	20
TCGTAGAAGTACGCGA-1_3_C4	-28.95332679	10.13190211	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	692	1032	0.034883721	0.006782946	6	8	Astrocytes	51	20	20
TCGTAGACACTTAAGC-1_3_C4	1.957702684	18.32191437	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	834	1215	0.010699588	0.017283951	6	oligos	OL-Cntl	51	20	20
TCGTAGACAGTCGTGC-1_3_C4	19.16616233	-7.277810138	3	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2320	4712	0.007852292	0.001910017	6	3	EN-L5-6	51	20	20
TCGTAGAGTTACCAGT-1_3_C4	22.88320368	-26.25038266	3	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	3262	7613	0.00893209	0.002627085	6	3	EN-L5-6	51	20	20
TCGTAGATCATCGATG-1_3_C4	2.847224272	26.21310966	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	710	1097	0.002734731	0.000911577	6	oligos	OL-Cntl	51	20	20
TCGTAGATCTGCCCTA-1_3_C4	-14.57610448	-3.991670064	13A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	3667	8432	0.012333966	0.007708729	6	13A	IN-VIP	51	20	20
TCGTAGATCTTGTCAT-1_3_C4	16.98855963	21.08289856	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	931	1454	0.004126547	0.004126547	6	oligos	OL-Cntl	51	20	20
TCTATTGCAAACCCAT-1_3_C4	15.94924935	21.79709029	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1008	1669	0.000599161	0.004793289	6	oligos	OL-Cntl	51	20	20
TCTATTGCACTAGTAC-1_3_C4	8.86962067	30.53103714	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	817	1490	0.002013423	0.003355705	6	oligos	OL-Cntl	51	20	20
TCTATTGCATCACGAT-1_3_C4	-37.58018629	-5.453641431	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1173	2083	0.003840614	0.00144023	6	9	OPC	51	20	20
TCTATTGGTTGGTGGA-1_3_C4	-1.513266568	21.12927481	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	676	1034	0.008704062	0.003868472	6	oligos	OL-Cntl	51	20	20
TCTATTGTCGAACTGT-1_3_C4	4.140858035	-13.66179801	4	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2312	5093	0.006086786	0.003730611	6	L2-3	EN-L2-3-MS	51	20	20
TCTCATAAGATGGCGT-1_3_C4	14.38315763	19.61290012	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	968	1502	0.003328895	0.007989348	6	oligos	OL-Cntl	51	20	20
TCTCATACATTCCTGC-1_3_C4	-9.859803408	-1.828991443	13A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2122	4526	0.018338489	0.005523641	6	13A	IN-VIP	51	20	20
TCTCATAGTAAGTAGT-1_3_C4	15.76546535	15.14631059	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1160	1904	0.00210084	0.007352941	6	oligos	OL-Cntl	51	20	20
TCTCATAGTTAGAACA-1_3_C4	-31.51309758	12.54963687	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	925	1488	0.002016129	0.006048387	6	8	Astrocytes	51	20	20
TCTCTAACAAAGTGCG-1_3_C4	10.81269464	29.11297144	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	838	1335	0.015730337	0.003745318	6	oligos	OL-Cntl	51	20	20
TCTCTAACATAGTAAG-1_3_C4	17.95057959	-5.6654551	3	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1389	2506	0.002793296	0.001596169	6	3	EN-L5-6	51	20	20
TCTGAGAGTACGCACC-1_3_C4	-16.79485813	-18.20702519	6B	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1950	3820	0.027748691	0.003141361	6	6B	IN-SST	51	20	20
TCTGAGAGTGCAGACA-1_3_C4	31.71859523	-12.26612915	2	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	3995	9259	0.018684523	0.0071282	6	2	EN-L4	51	20	20
TCTGAGATCAACACAC-1_3_C4	-24.70473364	25.83866121	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1583	2978	0.005708529	0.003693754	6	8	Astrocytes	51	20	20
TCTGAGATCTCAAACG-1_3_C4	-24.64171857	22.40818154	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1351	2466	0.006893755	0.004460665	6	8	Astrocytes	51	20	20
TCTGGAAAGATCTGCT-1_3_C4	10.51427281	20.61629362	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	833	1400	0.002857143	0.007142857	6	oligos	OL-Cntl	51	20	20
TCTGGAAAGTGAAGAG-1_3_C4	29.82873891	9.46124958	15DB	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	923	1822	0.003841932	0.05104281	6	15DB	B cells	51	20	20
TCTGGAACATGCATGT-1_3_C4	-21.45685508	27.7526652	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1842	3687	0.001084893	0.006238134	6	8	Astrocytes	51	20	20
TCTGGAACATGTTCCC-1_3_C4	30.68732713	9.123965897	14	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	818	1169	0.01283148	0.017964072	6	14	Microglia	51	20	20
TCTGGAATCACAGTAC-1_3_C4	0.948376695	17.71359909	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	797	1362	0.002936858	0.005873715	6	oligos	OL-Cntl	51	20	20
TCTTCGGGTCAAAGCG-1_3_C4	-0.15749393	-10.88363665	12	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1839	3646	0.020844761	0.001371366	6	12	EN-MIX	51	20	20
TCTTCGGTCAATCTCT-1_3_C4	10.47394614	23.33932064	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	770	1264	0.003955696	0.003164557	6	oligos	OL-Cntl	51	20	20
TCTTCGGTCGAACTGT-1_3_C4	-0.203776691	25.5250278	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	712	1035	0.000966184	0.014492754	6	oligos	OL-Cntl	51	20	20
TCTTTCCCACCACGTG-1_3_C4	16.1014983	18.89371624	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	930	1566	0.003831418	0.007024266	6	oligos	OL-Cntl	51	20	20
TCTTTCCCAGATGGGT-1_3_C4	-31.35433848	11.08702807	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	661	1033	0.001936108	0.008712488	6	8	Astrocytes	51	20	20
TCTTTCCGTGTTCTTT-1_3_C4	23.71250621	-12.17464379	3	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	3035	6919	0.016476369	0.003902298	6	3	EN-L5-6	51	20	20
TCTTTCCTCATACGGT-1_3_C4	10.427795	29.21706697	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	733	1214	0.005766063	0.004118616	6	oligos	OL-Cntl	51	20	20
TGAAAGAAGCCTATGT-1_3_C4	5.94149054	28.71395696	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	726	1153	0.002601908	0.005203816	6	oligos	OL-Cntl	51	20	20
TGAAAGAAGGCTCAGA-1_3_C4	-24.01938756	29.24148752	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1807	3341	0.006884166	0.00568692	6	8	Astrocytes	51	20	20
TGAAAGAGTTTACTCT-1_3_C4	3.103679263	-24.28410211	4	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	3621	8974	0.008357477	0.007688879	6	L2-3	EN-L2-3-MS	51	20	20
TGAAAGAGTTTGCATG-1_3_C4	13.9236382	-3.057610541	12	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1238	2285	0.010065646	0.002188184	6	12	EN-MIX	51	20	20
TGACAACAGTGCCATT-1_3_C4	19.7999549	-7.021607211	3	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2642	6426	0.004046063	0.002489885	6	3	EN-L5-6	51	20	20
TGACAACCAATGGTCT-1_3_C4	17.27771981	5.70858841	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	3229	7714	0.004926108	0.008815141	6	oligos	OL-Cntl	51	20	20
TGACAACCACAGCGTC-1_3_C4	11.30067839	21.96280266	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	971	1536	0.013020833	0.006510417	6	oligos	OL-Cntl	51	20	20
TGACAACGTAGCTTGT-1_3_C4	18.81400144	8.079512086	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1852	3449	0.004059148	0.00637866	6	oligos	OL-Cntl	51	20	20
TGACAACGTGTTTGTG-1_3_C4	-12.89173647	-1.384260852	13A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2514	4843	0.011563081	0.014866818	6	13A	IN-VIP	51	20	20
TGACAACTCATCGGAT-1_3_C4	11.1469365	20.61992697	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	918	1476	0.00203252	0.004742547	6	oligos	OL-Cntl	51	20	20
TGACAACTCTAGAGTC-1_3_C4	3.481050073	21.49059316	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	817	1336	0.015718563	0.013473054	6	oligos	OL-Cntl	51	20	20
TGACGGCAGCCTCGTG-1_3_C4	14.81201572	22.28631942	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	971	1463	0.000683527	0.008202324	6	oligos	OL-Cntl	51	20	20
TGACGGCAGTGGGCTA-1_3_C4	23.29428252	12.15614719	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1625	2781	0.000359583	0.004314995	6	oligos	OL-Cntl	51	20	20
TGACGGCCAGCTGTGC-1_3_C4	2.477635923	20.25709585	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	896	1368	0.004385965	0.009502924	6	oligos	OL-Cntl	51	20	20
TGACGGCCATATGCTG-1_3_C4	-21.04244766	8.729871219	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	829	1332	0.001501502	0.007507508	6	8	Astrocytes	51	20	20
TGACGGCGTCTGATTG-1_3_C4	22.89347049	-26.05379029	3	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	3042	7018	0.004559704	0.005557139	6	3	EN-L5-6	51	20	20
TGACGGCGTTCAGTAC-1_3_C4	3.438651129	26.61012265	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	770	1202	0.004159734	0.013311148	6	oligos	OL-Cntl	51	20	20
TGACTAGCAGCTGTTA-1_3_C4	0.057456365	25.62117604	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	657	1019	0.00686948	0.001962709	6	oligos	OL-Cntl	51	20	20
TGACTAGCATGTAAGA-1_3_C4	7.575741073	18.91883179	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1156	1841	0.005431831	0.011406844	6	oligos	OL-Cntl	51	20	20
TGACTAGTCACCACCT-1_3_C4	13.12629228	24.65950663	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	876	1411	0.002834869	0.001417434	6	oligos	OL-Cntl	51	20	20
TGACTAGTCCGCGCAA-1_3_C4	38.25010072	9.603975387	14	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	734	1021	0.003917728	0.002938296	6	14	Microglia	51	20	20
TGACTTTAGCTAGGCA-1_3_C4	17.46168895	14.61467764	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1225	2086	0.004793864	0.004793864	6	oligos	OL-Cntl	51	20	20
TGACTTTCACATAACC-1_3_C4	-27.09743933	22.64962777	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1341	2363	0.003385527	0.004655099	6	8	Astrocytes	51	20	20
TGACTTTCACCCATTC-1_3_C4	8.60476513	27.69441063	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	885	1394	0.010760402	0.008608321	6	oligos	OL-Cntl	51	20	20
TGACTTTGTGGAAAGA-1_3_C4	-12.17686466	-1.183869613	13A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2887	6022	0.016605779	0.008967121	6	13A	IN-VIP	51	20	20
TGAGAGGAGAAGATTC-1_3_C4	-18.53047132	19.12879265	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1530	2666	0.001500375	0.009752438	6	8	Astrocytes	51	20	20
TGAGAGGCACGTGAGA-1_3_C4	-24.37907133	18.89088096	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1538	2648	0.007930514	0.004154079	6	8	Astrocytes	51	20	20
TGAGAGGCATGAAGTA-1_3_C4	23.38415857	-10.26533349	3	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2986	6406	0.001092726	0.004058695	6	3	EN-L5-6	51	20	20
TGAGAGGGTACAGCAG-1_3_C4	40.09543162	11.90464819	14	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	921	1325	0.001509434	0.005283019	6	14	Microglia	51	20	20
TGAGAGGGTAGCGATG-1_3_C4	-13.47279451	-17.54847263	6B	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1317	1980	0.016161616	0.006060606	6	6B	IN-SST	51	20	20
TGAGAGGGTCATTAGC-1_3_C4	21.99674824	14.33429377	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1249	2095	0.001909308	0.003341289	6	oligos	OL-Cntl	51	20	20
TGAGCATGTTCCACTC-1_3_C4	-2.45448992	24.21358033	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	787	1259	0.000794281	0.010325655	6	oligos	OL-Cntl	51	20	20
TGAGCATTCAGTCCCT-1_3_C4	15.47497724	9.810225254	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1489	2572	0.00155521	0.00466563	6	oligos	OL-Cntl	51	20	20
TGAGCCGAGCAGGTCA-1_3_C4	3.409703352	22.6840242	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	824	1246	0.004012841	0.011235955	6	oligos	OL-Cntl	51	20	20
TGAGCCGGTATGAAAC-1_3_C4	0.445373107	28.49512833	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	687	1016	0.00984252	0.000984252	6	oligos	OL-Cntl	51	20	20
TGAGCCGGTGCCTTGG-1_3_C4	-7.908093752	-6.193186121	13A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1394	2308	0.024263432	0.003466205	6	13A	IN-VIP	51	20	20
TGAGCCGGTGGTCTCG-1_3_C4	-15.68370475	-10.93860467	13B	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2975	6659	0.006307253	0.00390449	6	13B	IN-SV2C	51	20	20
TGAGCCGTCTGGAGCC-1_3_C4	-23.72475199	-0.496968321	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1658	2864	0.002094972	0.003840782	6	9	OPC	51	20	20
TGAGGGACACAAGTAA-1_3_C4	16.0066978	18.65840151	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1078	1841	0.001086366	0.007604563	6	oligos	OL-Cntl	51	20	20
TGAGGGAGTCCAGTTA-1_3_C4	-16.54687664	13.50902791	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1496	2531	0.004346108	0.006321612	6	8	Astrocytes	51	20	20
TGAGGGATCCACTCCA-1_3_C4	-33.02218707	-9.228618077	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	960	1580	0.003797468	0.007594937	6	9	OPC	51	20	20
TGAGGGATCCCATTTA-1_3_C4	-22.23393239	24.14660952	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1645	2930	0.014334471	0.005119454	6	8	Astrocytes	51	20	20
TGAGGGATCCTAAGTG-1_3_C4	-12.04703267	-2.120754149	13A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2342	4250	0.023294118	0.004941176	6	13A	IN-VIP	51	20	20
TGAGGGATCGTACGGC-1_3_C4	20.63854786	17.72209963	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1090	1745	0.001146132	0.005730659	6	oligos	OL-Cntl	51	20	20
TGAGGGATCTGCTGCT-1_3_C4	-28.426325	21.75215497	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1068	1892	0.007928118	0.005813953	6	8	Astrocytes	51	20	20
TGATTTCAGCGCTCCA-1_3_C4	15.26570502	6.922508564	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1785	3441	0.004359198	0.011043301	6	oligos	OL-Cntl	51	20	20
TGATTTCCAATCCAAC-1_3_C4	-13.48055712	-0.603099136	13A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	3177	7075	0.013144876	0.009187279	6	13A	IN-VIP	51	20	20
TGATTTCGTCCTCCAT-1_3_C4	17.4673606	14.75013459	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1090	1785	0.000560224	0.007843137	6	oligos	OL-Cntl	51	20	20
TGATTTCTCCTAGTGA-1_3_C4	-28.58672115	21.5892829	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1103	2032	0.006889764	0.000492126	6	8	Astrocytes	51	20	20
TGATTTCTCTCCGGTT-1_3_C4	23.18150567	-24.78297671	3	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	3547	9512	0.011143818	0.004520606	6	3	EN-L5-6	51	20	20
TGATTTCTCTGCTGCT-1_3_C4	11.77705488	20.07790722	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	942	1498	0.008010681	0.00400534	6	oligos	OL-Cntl	51	20	20
TGCACCTAGAACTGTA-1_3_C4	-28.94756427	20.60380963	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1082	1690	0.008284024	0.004733728	6	8	Astrocytes	51	20	20
TGCACCTAGGACTGGT-1_3_C4	-22.03493357	26.33589668	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1836	3434	0.003785673	0.009027373	6	8	Astrocytes	51	20	20
TGCACCTAGGCCGAAT-1_3_C4	7.331290681	20.30443958	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	881	1373	0.004369993	0.02403496	6	oligos	OL-Cntl	51	20	20
TGCACCTAGGTTACCT-1_3_C4	15.28949717	17.00415475	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1030	1682	0.005350773	0.008917955	6	oligos	OL-Cntl	51	20	20
TGCACCTCAATCTGCA-1_3_C4	-0.908293462	25.44383958	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	683	1064	0.006578947	0.006578947	6	oligos	OL-Cntl	51	20	20
TGCACCTCAGACAGGT-1_3_C4	5.546859418	24.12811894	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	894	1419	0.00422833	0.011275546	6	oligos	OL-Cntl	51	20	20
TGCACCTGTAAACGCG-1_3_C4	-37.01667904	0.181913464	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1619	2786	0.001794688	0.003589375	6	9	OPC	51	20	20
TGCACCTGTCACACGC-1_3_C4	7.959642528	-18.50620434	4	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	4448	11089	0.007935792	0.015691226	6	L2-3	EN-L2-3-MS	51	20	20
TGCACCTGTGTGTGCC-1_3_C4	-22.47193558	-17.58424189	6B	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2827	5827	0.0161318	0.007207826	6	6B	IN-SST	51	20	20
TGCACCTGTTATTCTC-1_3_C4	21.86054354	14.3051007	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1316	2244	0.001782531	0.003565062	6	oligos	OL-Cntl	51	20	20
TGCACCTTCAAACGGG-1_3_C4	-36.90273436	-6.503180391	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1225	2048	0.002929688	0.001464844	6	9	OPC	51	20	20
TGCCCATAGCACGCCT-1_3_C4	20.84817371	12.17887327	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1509	2762	0.001086169	0.00615496	6	oligos	OL-Cntl	51	20	20
TGCCCATAGCAGCCTC-1_3_C4	16.9302142	17.63388492	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1077	1942	0.001029866	0.005149331	6	oligos	OL-Cntl	51	20	20
TGCCCATAGTGAACGC-1_3_C4	-6.892922793	-0.547370063	13A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1818	3627	0.003859939	0.003308519	6	13A	IN-VIP	51	20	20
TGCCCATAGTGCGTGA-1_3_C4	18.78353263	16.22325936	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1184	1890	0.002116402	0.003174603	6	oligos	OL-Cntl	51	20	20
TGCCCATAGTTAGCGG-1_3_C4	-24.16737587	22.02956854	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1352	2289	0.01747488	0.004805592	6	8	Astrocytes	51	20	20
TGCCCATCAACACCTA-1_3_C4	38.25206998	11.15080606	14	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	914	1390	0	0.015107914	6	14	Microglia	51	20	20
TGCCCATGTGGTAACG-1_3_C4	14.64347058	28.82409053	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	775	1183	0.006762468	0.004226543	6	oligos	OL-Cntl	51	20	20
TGCCCATGTTGGAGGT-1_3_C4	8.797982906	23.0174904	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	980	1565	0.003194888	0.005111821	6	oligos	OL-Cntl	51	20	20
TGCCCATTCGTTACAG-1_3_C4	-28.566966	21.16081634	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1133	1813	0.00551572	0.00551572	6	8	Astrocytes	51	20	20
TGCCCATTCTTGTTTG-1_3_C4	19.87364668	13.19814675	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1393	2403	0.003745318	0.003745318	6	oligos	OL-Cntl	51	20	20
TGCCCTAAGGAGTTGC-1_3_C4	23.3623072	-25.21739537	3	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	3233	7693	0.01455869	0.002859743	6	3	EN-L5-6	51	20	20
TGCCCTATCAGTGCAT-1_3_C4	13.53087694	11.82020268	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1300	2349	0	0.01660281	6	oligos	OL-Cntl	51	20	20
TGCCCTATCCGTACAA-1_3_C4	31.13975826	-3.49861985	2	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	3331	7740	0.007751938	0.002583979	6	2	EN-L4	51	20	20
TGCCCTATCGGCGCTA-1_3_C4	-24.37045902	27.97975997	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1543	3004	0.000665779	0.002996005	6	8	Astrocytes	51	20	20
TGCGCAGAGACACGAC-1_3_C4	-26.62973044	9.886878459	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	833	1276	0.002351097	0.002351097	6	8	Astrocytes	51	20	20
TGCGCAGAGAGCAATT-1_3_C4	17.27533058	21.93031207	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1007	1625	0.002461538	0.007384615	6	oligos	OL-Cntl	51	20	20
TGCGCAGAGAGGTACC-1_3_C4	17.89380943	12.94519816	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1405	2472	0.004449838	0.006067961	6	oligos	OL-Cntl	51	20	20
TGCGGGTAGAGACTAT-1_3_C4	21.08885026	11.43152779	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1539	2638	0.006444276	0.002653525	6	oligos	OL-Cntl	51	20	20
TGCGGGTAGCCGCCTA-1_3_C4	4.755344842	26.04613886	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	814	1244	0.013665595	0.004019293	6	oligos	OL-Cntl	51	20	20
TGCGGGTAGCGTGAGT-1_3_C4	14.42282945	6.90284015	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1853	3400	0.008529412	0.010294118	6	oligos	OL-Cntl	51	20	20
TGCGGGTGTAGAGCTG-1_3_C4	-24.32197119	21.83451397	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1322	2303	0.009552757	0.008250109	6	8	Astrocytes	51	20	20
TGCGGGTGTCAATACC-1_3_C4	17.86457737	7.941422474	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1980	3798	0.001053186	0.006582412	6	oligos	OL-Cntl	51	20	20
TGCGGGTGTCACTTCC-1_3_C4	-8.837347312	-18.08643442	6B	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	827	1318	0.053869499	0.002276176	6	6B	IN-SST	51	20	20
TGCGGGTGTCGAATCT-1_3_C4	13.7689704	24.8735905	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	922	1413	0.004953999	0.009200283	6	oligos	OL-Cntl	51	20	20
TGCGGGTGTTCGAATC-1_3_C4	4.430506751	22.19422337	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	894	1447	0.002073255	0.007601935	6	oligos	OL-Cntl	51	20	20
TGCGGGTTCATACGGT-1_3_C4	21.90129935	10.12832475	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1650	2780	0.001438849	0.009352518	6	oligos	OL-Cntl	51	20	20
TGCGTGGAGCCCAGCT-1_3_C4	-24.16421214	18.37144204	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1368	2311	0.006057984	0.009086975	6	8	Astrocytes	51	20	20
TGCGTGGAGGGTTCCC-1_3_C4	-8.337501016	-17.68643366	6B	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	741	1154	0.058925477	0.004332756	6	6B	IN-SST	51	20	20
TGCGTGGAGTGCCATT-1_3_C4	-23.04268381	22.9135825	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1669	3156	0.003485425	0.006653992	6	8	Astrocytes	51	20	20
TGCGTGGCACTGTGTA-1_3_C4	33.53773029	-10.55382777	2	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	3159	6059	0.010727843	0.012213237	6	2	EN-L4	51	20	20
TGCGTGGCATCTCGCT-1_3_C4	-19.79484871	19.53252081	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1794	3316	0.005729795	0.006936068	6	8	Astrocytes	51	20	20
TGCGTGGGTACTCTCC-1_3_C4	-1.414976525	29.05250771	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	780	1210	0.000826446	0.004958678	6	oligos	OL-Cntl	51	20	20
TGCGTGGGTCACTGGC-1_3_C4	21.19187751	14.33342185	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1259	2123	0.000942063	0.007536505	6	oligos	OL-Cntl	51	20	20
TGCGTGGGTCTAACGT-1_3_C4	-0.578190844	23.09859129	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	688	1036	0.000965251	0.004826255	6	oligos	OL-Cntl	51	20	20
TGCGTGGTCAACACAC-1_3_C4	8.643744383	-24.41890203	4	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	5372	15875	0.007433071	0.005228346	6	L2-3	EN-L2-3-MS	51	20	20
TGCGTGGTCTGTCTAT-1_3_C4	12.99009527	31.14490893	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	766	1139	0.003511853	0.001755926	6	oligos	OL-Cntl	51	20	20
TGCTACCCAGTATGCT-1_3_C4	-23.63598389	0.06908636	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2053	3925	0.001273885	0.005605096	6	9	OPC	51	20	20
TGCTACCCATAGTAAG-1_3_C4	16.3735294	21.5558404	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	983	1642	0.007308161	0.00182704	6	oligos	OL-Cntl	51	20	20
TGCTACCGTATGGTTC-1_3_C4	14.59650029	-30.87230576	3	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	4019	11739	0.005792657	0.003918562	6	3	EN-L5-6	51	20	20
TGCTGCTCAAGACACG-1_3_C4	13.71653664	17.22327166	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1165	1931	0.008803729	0.007767996	6	oligos	OL-Cntl	51	20	20
TGCTGCTCAGTATGCT-1_3_C4	-35.60808625	-4.090357571	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1418	2547	0	0.003533569	6	9	OPC	51	20	20
TGCTGCTGTAACGCGA-1_3_C4	6.779116494	25.54864024	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	992	1522	0.001971091	0.009198423	6	oligos	OL-Cntl	51	20	20
TGCTGCTTCGACGGAA-1_3_C4	-15.39529298	15.14525752	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2677	5608	0.00053495	0.007667618	6	8	Astrocytes	51	20	20
TGCTGCTTCGCAAACT-1_3_C4	14.75890482	28.98603164	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	667	1025	0.006829268	0.00195122	6	oligos	OL-Cntl	51	20	20
TGCTGCTTCGTGGACC-1_3_C4	-36.0212943	-1.336701429	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1653	2882	0.005204719	0.003122831	6	9	OPC	51	20	20
TGGACGCAGGCTAGAC-1_3_C4	20.76913407	18.3228164	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1118	1814	0.003858875	0.005512679	6	oligos	OL-Cntl	51	20	20
TGGACGCAGGGATACC-1_3_C4	-37.26881265	2.689423599	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1934	3432	0.000874126	0.002622378	6	9	OPC	51	20	20
TGGACGCGTCATTAGC-1_3_C4	15.81462524	-7.619949962	3	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	3731	10372	0.002795989	0.003278056	6	3	EN-L5-6	51	20	20
TGGACGCGTTATCCGA-1_3_C4	-8.54666725	-18.19557501	6B	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	680	1022	0.022504892	0.000978474	6	6B	IN-SST	51	20	20
TGGCCAGAGCCGTCGT-1_3_C4	5.168076651	19.83147012	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1014	1519	0.004608295	0.00921659	6	oligos	OL-Cntl	51	20	20
TGGCCAGAGCTCCTCT-1_3_C4	5.832230683	24.37948946	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	931	1540	0.005194805	0.003896104	6	oligos	OL-Cntl	51	20	20
TGGCCAGAGTCTCAAC-1_3_C4	12.33765635	28.11620981	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	763	1156	0	0.00432526	6	oligos	OL-Cntl	51	20	20
TGGCCAGCAGACACTT-1_3_C4	24.07482724	-9.717058387	3	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	3179	6741	0.015279632	0.004153686	6	3	EN-L5-6	51	20	20
TGGCCAGCATCCTAGA-1_3_C4	-36.24038009	2.701730785	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1944	3547	0.004228926	0.003101212	6	9	OPC	51	20	20
TGGCCAGCATGTAAGA-1_3_C4	16.53811429	-0.399946588	12	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	727	1112	0.002697842	0.000899281	6	12	EN-MIX	51	20	20
TGGCCAGGTGACCAAG-1_3_C4	2.111622491	27.29911592	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	750	1116	0.000896057	0.004480287	6	oligos	OL-Cntl	51	20	20
TGGCCAGTCCAAACAC-1_3_C4	-17.8196626	13.86843854	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1223	1973	0.001520527	0.002027369	6	8	Astrocytes	51	20	20
TGGCCAGTCGAACGGA-1_3_C4	-12.68458659	-2.070813269	13A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2654	5487	0.016037908	0.007836705	6	13A	IN-VIP	51	20	20
TGGCCAGTCGTAGGAG-1_3_C4	-11.93874029	19.57596727	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2290	4519	0.003540606	0.003540606	6	8	Astrocytes	51	20	20
TGGCCAGTCTCTGCTG-1_3_C4	-17.22637497	13.1836597	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1371	2423	0.002476269	0.002476269	6	8	Astrocytes	51	20	20
TGGCGCACACAAGTAA-1_3_C4	-28.3978446	21.15534342	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1043	1629	0.006752609	0.004297115	6	8	Astrocytes	51	20	20
TGGCGCACATGCCCGA-1_3_C4	23.01346594	-10.72709454	3	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2875	6146	0.021314676	0.005043931	6	3	EN-L5-6	51	20	20
TGGCGCAGTCTTCGTC-1_3_C4	-7.933915553	-2.345776851	13A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1995	3757	0.011711472	0.004258717	6	13A	IN-VIP	51	20	20
TGGCGCAGTGCTCTTC-1_3_C4	17.31331243	18.74941549	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1062	1726	0.00405562	0.005793743	6	oligos	OL-Cntl	51	20	20
TGGCGCATCAAGGCTT-1_3_C4	-20.43445085	-5.670791305	13B	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	5149	13870	0.010958904	0.010310022	6	13B	IN-SV2C	51	20	20
TGGCGCATCGATCCCT-1_3_C4	19.18385004	8.539257161	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1905	4132	0.000484027	0.00411423	6	oligos	OL-Cntl	51	20	20
TGGCGCATCTCAAGTG-1_3_C4	-13.62155682	-24.1165642	6A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1477	2717	0.037541406	0.001472212	6	6A	IN-PV	51	20	20
TGGCGCATCTTCCTTC-1_3_C4	-28.27984116	16.36922643	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1120	1928	0.002074689	0.004149378	6	8	Astrocytes	51	20	20
TGGCTGGAGTGTCTCA-1_3_C4	14.61771561	20.63502819	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	984	1612	0.001240695	0.006203474	6	oligos	OL-Cntl	51	20	20
TGGCTGGGTACGACCC-1_3_C4	1.140389488	24.33424284	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	800	1196	0.014214047	0.010033445	6	oligos	OL-Cntl	51	20	20
TGGCTGGGTCCGAGTC-1_3_C4	-21.93385498	27.08626329	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1862	3583	0.004186436	0.006140106	6	8	Astrocytes	51	20	20
TGGCTGGGTCGAATCT-1_3_C4	-10.35205645	16.064531	11	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2115	3911	0.001789824	0.004602403	6	11	Glia-MIX	51	20	20
TGGCTGGTCGCAAACT-1_3_C4	14.98834948	20.88993956	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	934	1430	0.006993007	0.00979021	6	oligos	OL-Cntl	51	20	20
TGGGAAGAGAAACCGC-1_3_C4	6.500853876	25.16516498	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	925	1377	0.000726216	0.005809731	6	oligos	OL-Cntl	51	20	20
TGGGAAGCAATGTAAG-1_3_C4	-11.14086982	-19.72549058	6B	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	993	1670	0.055688623	0.003592814	6	6B	IN-SST	51	20	20
TGGGAAGCATCGGAAG-1_3_C4	15.55103876	12.14743131	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1542	2833	0.001764914	0.008118602	6	oligos	OL-Cntl	51	20	20
TGGGAAGGTAGAGTGC-1_3_C4	15.95810594	8.340325704	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1729	2993	0.001670565	0.014700969	6	oligos	OL-Cntl	51	20	20
TGGGAAGGTGATGTGG-1_3_C4	-16.58445968	-15.67782817	6B	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2032	3730	0.048257373	0.003217158	6	6B	IN-SST	51	20	20
TGGGCGTCAAAGCAAT-1_3_C4	-37.37153279	-2.4068003	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1432	2504	0	0.001996805	6	9	OPC	51	20	20
TGGGCGTCATCAGTCA-1_3_C4	12.86769803	17.8484758	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1106	1727	0.004053272	0.006369427	6	oligos	OL-Cntl	51	20	20
TGGGCGTGTGAGGCTA-1_3_C4	-29.4442697	21.06461436	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1107	1764	0.004535147	0.001133787	6	8	Astrocytes	51	20	20
TGGGCGTTCAAGATCC-1_3_C4	-18.38556951	-21.34672102	6A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2364	5072	0.030165615	0.003351735	6	6A	IN-PV	51	20	20
TGGGCGTTCGCGTAGC-1_3_C4	4.949743734	22.10313402	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	933	1476	0.014227642	0.008130081	6	oligos	OL-Cntl	51	20	20
TGGTTAGAGATCCGAG-1_3_C4	-11.03923204	16.34075368	11	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2002	3493	0.002862869	0.006870885	6	11	Glia-MIX	51	20	20
TGGTTAGAGCCCAATT-1_3_C4	19.67852165	19.49863158	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1066	1814	0.000551268	0.001653804	6	oligos	OL-Cntl	51	20	20
TGGTTAGGTATGCTTG-1_3_C4	14.50349835	20.11779717	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	902	1519	0.003291639	0.007899934	6	oligos	OL-Cntl	51	20	20
TGGTTAGGTTCCTCCA-1_3_C4	17.09658275	10.03248948	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1528	3013	0.00066379	0.005310322	6	oligos	OL-Cntl	51	20	20
TGGTTAGTCCACTGGG-1_3_C4	16.48156522	20.53354329	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	896	1467	0.00408998	0.002726653	6	oligos	OL-Cntl	51	20	20
TGGTTCCCACATCCAA-1_3_C4	-37.13805415	2.661188204	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1840	3343	0.007777445	0.004486988	6	9	OPC	51	20	20
TGGTTCCGTCTCCCTA-1_3_C4	16.10097178	6.648816365	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2052	4389	0.007746639	0.011619959	6	oligos	OL-Cntl	51	20	20
TGGTTCCGTTGTGGCC-1_3_C4	-25.81294101	10.82791174	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	783	1121	0.005352364	0.004460303	6	8	Astrocytes	51	20	20
TGGTTCCTCAGCTTAG-1_3_C4	16.22141246	9.572061402	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1565	2788	0.008249641	0.008608321	6	oligos	OL-Cntl	51	20	20
TGTATTCAGTTGCAGG-1_3_C4	-0.918212188	23.07566001	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	697	1012	0.011857708	0.009881423	6	oligos	OL-Cntl	51	20	20
TGTATTCGTAAGAGAG-1_3_C4	13.43053455	21.36929064	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	881	1349	0.00222387	0.003706449	6	oligos	OL-Cntl	51	20	20
TGTCCCACAAACGCGA-1_3_C4	-23.27585797	22.0218119	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1493	2478	0.005246166	0.007263923	6	8	Astrocytes	51	20	20
TGTCCCACAGTATCTG-1_3_C4	-9.305502417	13.8504633	11	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1448	2362	0.00127011	0.0042337	6	11	Glia-MIX	51	20	20
TGTCCCACATATACCG-1_3_C4	24.09107638	-6.56286652	2	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	3744	7958	0.029153054	0.004146771	6	2	EN-L4	51	20	20
TGTCCCAGTCTGGTCG-1_3_C4	6.371970363	-21.98304492	4	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	4022	10647	0.0154034	0.005165774	6	L2-3	EN-L2-3-MS	51	20	20
TGTGGTAAGACTACAA-1_3_C4	18.52855118	-7.172841071	3	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2085	4037	0.012137726	0.001733961	6	3	EN-L5-6	51	20	20
TGTGGTAAGTGGGTTG-1_3_C4	-27.82502928	13.00426721	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	816	1219	0.002461034	0.002461034	6	8	Astrocytes	51	20	20
TGTGGTACACTGTGTA-1_3_C4	-13.09056825	14.55629282	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	755	1121	0.004460303	0.002676182	6	8	Astrocytes	51	20	20
TGTGGTAGTAGCGCTC-1_3_C4	-20.1713301	19.95046884	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1721	3259	0.003068426	0.005216324	6	8	Astrocytes	51	20	20
TGTGGTATCACATACG-1_3_C4	-10.35133558	-1.235553504	13A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2118	3945	0.015462611	0.005323194	6	13A	IN-VIP	51	20	20
TGTGTTTAGTCATCCA-1_3_C4	-17.66427593	-24.6746024	6A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2395	5381	0.016353838	0.001300873	6	6A	IN-PV	51	20	20
TGTGTTTCAACGATGG-1_3_C4	-3.861503392	22.29172053	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	756	1096	0.002737226	0.016423358	6	oligos	OL-Cntl	51	20	20
TGTGTTTCAAGCCTAT-1_3_C4	-9.378077124	14.26006173	11	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1478	2418	0.002894955	0.004135649	6	11	Glia-MIX	51	20	20
TGTGTTTGTAGAAAGG-1_3_C4	5.275517193	25.26622296	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	889	1298	0.00385208	0.005392912	6	oligos	OL-Cntl	51	20	20
TGTGTTTTCCGCAAGC-1_3_C4	-28.94315853	10.89106911	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	783	1258	0.015898251	0.0063593	6	8	Astrocytes	51	20	20
TGTTCCGCAATGGAGC-1_3_C4	-35.88518937	-0.663070258	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1627	2854	0.005956552	0.006657323	6	9	OPC	51	20	20
TGTTCCGCACAGACTT-1_3_C4	8.415265323	9.810949755	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1214	1902	0.005783386	0.01997897	6	oligos	OL-Cntl	51	20	20
TGTTCCGCACGCGAAA-1_3_C4	9.862841648	19.26462385	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	915	1510	0.001986755	0.011258278	6	oligos	OL-Cntl	51	20	20
TGTTCCGCAGACAAAT-1_3_C4	-22.56980704	23.87975105	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1504	2582	0.006196747	0.00697134	6	8	Astrocytes	51	20	20
TGTTCCGCATAGTAAG-1_3_C4	-36.31681694	-3.992876104	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1339	2319	0.000862441	0.003449763	6	9	OPC	51	20	20
TGTTCCGGTATATCCG-1_3_C4	-35.97753341	-6.17176116	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1251	2165	0.000923788	0.002309469	6	9	OPC	51	20	20
TGTTCCGTCTATCCCG-1_3_C4	10.7540132	20.79753289	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1036	1652	0.020581114	0.006658596	6	oligos	OL-Cntl	51	20	20
TTAACTCCAGGTGGAT-1_3_C4	-35.34498545	-9.231882853	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	955	1614	0.001239157	0.002478315	6	9	OPC	51	20	20
TTAACTCGTGAAAGAG-1_3_C4	2.723037286	-11.11290002	12	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1706	3253	0.013833385	0.004918537	6	12	EN-MIX	51	20	20
TTAACTCTCAGGCGAA-1_3_C4	1.142504713	24.75196031	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	647	1018	0.016699411	0.00589391	6	oligos	OL-Cntl	51	20	20
TTAGGACCACCCATTC-1_3_C4	10.5819219	21.38757454	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	931	1497	0.013360053	0.006012024	6	oligos	OL-Cntl	51	20	20
TTAGGACCATGCCTAA-1_3_C4	-16.64192278	12.92024123	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1340	2247	0.003560303	0.007120605	6	8	Astrocytes	51	20	20
TTAGGACGTCGACTAT-1_3_C4	12.70163207	32.2134143	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	666	1058	0.006616257	0.005671078	6	oligos	OL-Cntl	51	20	20
TTAGGCAAGCTGAAAT-1_3_C4	5.479031195	29.93588825	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	734	1078	0.000927644	0.00742115	6	oligos	OL-Cntl	51	20	20
TTAGGCACAACGCACC-1_3_C4	22.76724424	-9.709920586	3	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2831	6399	0.022347242	0.001875293	6	3	EN-L5-6	51	20	20
TTAGGCACAATCGGTT-1_3_C4	15.57569139	25.16732654	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	875	1354	0.003692762	0.00295421	6	oligos	OL-Cntl	51	20	20
TTAGGCACACGGTTTA-1_3_C4	-36.14706732	1.907610956	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1792	3564	0.003367003	0.003647587	6	9	OPC	51	20	20
TTAGGCACAGTAAGAT-1_3_C4	-5.265082038	-8.675096696	13A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1008	1592	0.028266332	0.003768844	6	13A	IN-VIP	51	20	20
TTAGGCAGTATCAGTC-1_3_C4	6.862269469	-14.59005661	4	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2775	5813	0.012386031	0.006365044	6	L2-3	EN-L2-3-MS	51	20	20
TTAGGCATCACAGTAC-1_3_C4	17.15972066	13.57703809	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1199	2204	0.004083485	0.006352087	6	oligos	OL-Cntl	51	20	20
TTAGTTCAGTACGCCC-1_3_C4	-28.56794663	21.0417862	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1084	1925	0.001038961	0.004155844	6	8	Astrocytes	51	20	20
TTATGCTCAAATACAG-1_3_C4	12.43178808	25.35818115	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	736	1181	0.00169348	0.00254022	6	oligos	OL-Cntl	51	20	20
TTATGCTCAAGCCATT-1_3_C4	-11.34787065	15.77561874	11	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1390	2390	0.0041841	0.008786611	6	11	Glia-MIX	51	20	20
TTATGCTGTTGGAGGT-1_3_C4	22.67075431	-9.08729744	3	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2677	6040	0.001655629	0.004635762	6	3	EN-L5-6	51	20	20
TTCCCAGAGAATCTCC-1_3_C4	10.87194078	30.52608758	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	672	1012	0.004940711	0.001976285	6	oligos	OL-Cntl	51	20	20
TTCCCAGAGACCTAGG-1_3_C4	10.42967377	21.21839177	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	860	1405	0.012099644	0.012099644	6	oligos	OL-Cntl	51	20	20
TTCCCAGAGGACAGAA-1_3_C4	-21.24315656	9.578859766	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1125	1726	0.003476246	0.008690614	6	8	Astrocytes	51	20	20
TTCCCAGCAGACTCGC-1_3_C4	-8.171245649	-2.86462687	13A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1838	3290	0.017325228	0.004559271	6	13A	IN-VIP	51	20	20
TTCGAAGAGCCACGTC-1_3_C4	-13.36987885	-19.41241953	6B	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1339	2498	0.04643715	0.001200961	6	6B	IN-SST	51	20	20
TTCGAAGCAAGAGTCG-1_3_C4	-14.55594652	-5.130464434	13A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	3206	6968	0.014494834	0.005453502	6	13A	IN-VIP	51	20	20
TTCGAAGCACACGCTG-1_3_C4	6.950450813	21.61383594	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	877	1349	0.00148258	0.006671609	6	oligos	OL-Cntl	51	20	20
TTCGAAGCATGGGACA-1_3_C4	-16.15449199	14.73252483	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2024	3897	0.001539646	0.003592507	6	8	Astrocytes	51	20	20
TTCGAAGGTGACTACT-1_3_C4	15.85460818	19.8822307	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1007	1646	0.001215067	0.006075334	6	oligos	OL-Cntl	51	20	20
TTCGAAGGTTCTGAAC-1_3_C4	-31.63772491	12.5699765	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	823	1238	0.006462036	0.003231018	6	8	Astrocytes	51	20	20
TTCGAAGTCATCACCC-1_3_C4	-32.51321234	-11.2072287	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	974	1669	0.005991612	0.001797484	6	9	OPC	51	20	20
TTCGGTCAGGCACATG-1_3_C4	10.08739448	29.02753072	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	792	1210	0.000826446	0.003305785	6	oligos	OL-Cntl	51	20	20
TTCGGTCGTATGGTTC-1_3_C4	-17.14688861	-5.607229324	13A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	3048	7157	0.010898421	0.007265614	6	13A	IN-VIP	51	20	20
TTCGGTCGTCGCTTCT-1_3_C4	-16.4471728	15.24107667	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2071	4378	0	0.007537688	6	8	Astrocytes	51	20	20
TTCGGTCGTTTGACTG-1_3_C4	-29.99746439	20.81178481	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	967	1694	0.00472255	0.006493506	6	8	Astrocytes	51	20	20
TTCTACAAGAGTACAT-1_3_C4	19.93370383	22.90296136	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	985	1758	0.001706485	0.002844141	6	oligos	OL-Cntl	51	20	20
TTCTACACAGGCGATA-1_3_C4	-23.14280585	23.79883721	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1604	3091	0.007117438	0.006470398	6	8	Astrocytes	51	20	20
TTCTACACATTGTGCA-1_3_C4	18.36223631	16.91657869	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1025	1685	0.005341246	0.003560831	6	oligos	OL-Cntl	51	20	20
TTCTACATCGCGTAGC-1_3_C4	-14.64647737	0.129622463	13A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	3159	6952	0.008774453	0.010644419	6	13A	IN-VIP	51	20	20
TTCTCAAAGAGTGACC-1_3_C4	-17.03071548	-2.421365267	13A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2744	5195	0.019249278	0.007699711	6	13A	IN-VIP	51	20	20
TTCTCAAAGTACACCT-1_3_C4	2.336601476	-11.33290053	12	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1767	3676	0.010609358	0.002992383	6	12	EN-MIX	51	20	20
TTCTCAACACGAAATA-1_3_C4	-27.65615284	12.36142593	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	933	1405	0.004270463	0.004982206	6	8	Astrocytes	51	20	20
TTCTCAACAGCAGTTT-1_3_C4	2.741319797	-7.47796808	12	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1299	2193	0.034199726	0.003191974	6	12	EN-MIX	51	20	20
TTCTCAACATGGGAAC-1_3_C4	-24.06675942	23.57682218	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1426	2695	0.003710575	0.005565863	6	8	Astrocytes	51	20	20
TTCTCAAGTAAAGTCA-1_3_C4	-28.89245288	10.23426437	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	727	1106	0.009041591	0.004520796	6	8	Astrocytes	51	20	20
TTCTCCTGTAGCCTAT-1_3_C4	21.95847395	11.33602704	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1636	3252	0.001845018	0.002152522	6	oligos	OL-Cntl	51	20	20
TTCTCCTGTGTGGTTT-1_3_C4	-4.524107011	-7.962773165	13A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	847	1186	0.015177066	0.004215852	6	13A	IN-VIP	51	20	20
TTCTCCTTCGCCATAA-1_3_C4	-37.39529911	-9.405320726	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	900	1509	0.005964215	0.001988072	6	9	OPC	51	20	20
TTCTCCTTCGGAGGTA-1_3_C4	-11.98125972	-1.250447056	13A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2257	4248	0.012947269	0.006355932	6	13A	IN-VIP	51	20	20
TTCTTAGCACCGAATT-1_3_C4	-8.872537127	14.42200153	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1755	3196	0.008760951	0.003754693	6	oligos	OL-Cntl	51	20	20
TTCTTAGTCGCCCTTA-1_3_C4	39.0385609	14.565005	14	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1010	1602	0.00062422	0.007490637	6	14	Microglia	51	20	20
TTGAACGCAGTCAGCC-1_3_C4	21.48407458	9.06761123	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1962	3540	0.005367232	0.007344633	6	oligos	OL-Cntl	51	20	20
TTGACTTAGTTCGATC-1_3_C4	15.44365998	21.63091297	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	912	1429	0.00209937	0.00489853	6	oligos	OL-Cntl	51	20	20
TTGACTTCACAAGTAA-1_3_C4	-16.72882711	-8.663313039	13B	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2742	6091	0.025611558	0.004761123	6	13B	IN-SV2C	51	20	20
TTGACTTCAGCATGAG-1_3_C4	-6.567176906	-2.242589508	13A	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1791	3544	0.017776524	0.003668172	6	13A	IN-VIP	51	20	20
TTGACTTCATGCAACT-1_3_C4	-24.8581155	-1.548134189	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1784	4297	0.000465441	0.006748895	6	9	OPC	51	20	20
TTGCCGTTCCAAACAC-1_3_C4	15.522948	13.38753357	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1388	2318	0.005176877	0.009059534	6	oligos	OL-Cntl	51	20	20
TTGCGTCAGACAATAC-1_3_C4	8.944935989	20.56170011	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	964	1446	0.005532503	0.011065007	6	oligos	OL-Cntl	51	20	20
TTGCGTCCAGGGAGAG-1_3_C4	4.042235708	18.35259081	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	937	1459	0.018505826	0.011651816	6	oligos	OL-Cntl	51	20	20
TTGCGTCGTATATGAG-1_3_C4	-1.665776555	21.92618328	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	702	1056	0.035984848	0.006628788	6	oligos	OL-Cntl	51	20	20
TTGCGTCGTTACTGAC-1_3_C4	-24.27775757	17.7555418	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1225	2130	0.004225352	0.001877934	6	8	Astrocytes	51	20	20
TTGCGTCTCACGGTTA-1_3_C4	-22.33201133	25.6733455	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1662	2913	0.004806042	0.006179197	6	8	Astrocytes	51	20	20
TTGGAACCAGACGCAA-1_3_C4	21.60324926	11.29182874	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1525	2743	0.00255195	0.004739336	6	oligos	OL-Cntl	51	20	20
TTGGAACGTCAGGACA-1_3_C4	-33.70335637	-3.948235422	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1239	1869	0.003745318	0.014981273	6	9	OPC	51	20	20
TTGGAACTCCTCAACC-1_3_C4	12.49987541	20.91638835	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	965	1594	0.005018821	0.006900878	6	oligos	OL-Cntl	51	20	20
TTGGAACTCGCCAGCA-1_3_C4	12.28129091	24.2058135	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	770	1172	0.003412969	0.002559727	6	oligos	OL-Cntl	51	20	20
TTGGCAAAGGCTACGA-1_3_C4	-24.40094462	18.07399213	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1337	2184	0.006410256	0.007326007	6	8	Astrocytes	51	20	20
TTGGCAACAATTGCTG-1_3_C4	-20.94680185	9.918682469	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1065	1751	0.001142204	0.005711022	6	8	Astrocytes	51	20	20
TTGGCAAGTCGAGATG-1_3_C4	-30.92639063	11.28926269	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	726	1057	0.005676443	0.004730369	6	8	Astrocytes	51	20	20
TTGGCAAGTTCCAACA-1_3_C4	16.91126489	14.54174056	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1229	2091	0.0023912	0.007651841	6	oligos	OL-Cntl	51	20	20
TTGTAGGAGAGATGAG-1_3_C4	-11.12186585	-15.49393606	6B	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1079	1627	0.035648433	0.00676091	6	6B	IN-SST	51	20	20
TTGTAGGAGCCGCCTA-1_3_C4	4.127879441	22.82380221	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	749	1209	0.004135649	0.011579818	6	oligos	OL-Cntl	51	20	20
TTGTAGGTCACCTTAT-1_3_C4	26.95193053	4.639635692	15BA	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	768	1135	0.004405286	0.014977974	6	15BA	Stromal cells	51	20	20
TTTACTGCACAGGAGT-1_3_C4	-10.05191423	13.7047651	11	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1040	1624	0.017241379	0.004310345	6	11	Glia-MIX	51	20	20
TTTACTGCACGGTGTC-1_3_C4	-37.46195916	-5.714370951	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1186	2125	0.008470588	0.002352941	6	9	OPC	51	20	20
TTTATGCAGAATGTGT-1_3_C4	14.30846855	25.81678054	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	826	1307	0.009181331	0.003825555	6	oligos	OL-Cntl	51	20	20
TTTATGCAGCGATGAC-1_3_C4	39.39446951	9.926916185	14	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	761	1072	0.015858209	0.009328358	6	14	Microglia	51	20	20
TTTATGCTCTGTTGAG-1_3_C4	-2.817194279	-14.52320162	10	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2509	5934	0.003707449	0.004044489	6	L2-3	EN-L2-3-Cntl	51	20	20
TTTCCTCGTAATAGCA-1_3_C4	-9.918324367	22.50397559	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1173	1892	0.010570825	0.002114165	6	8	Astrocytes	51	20	20
TTTCCTCGTGTAACGG-1_3_C4	-34.5760391	-12.95477308	9	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	643	1022	0.001956947	0	6	9	OPC	51	20	20
TTTCCTCGTGTTTGGT-1_3_C4	14.51016787	-7.563803246	10	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1858	3987	0.004514673	0.002257336	6	L2-3	EN-L2-3-Cntl	51	20	20
TTTCCTCTCTGGCGAC-1_3_C4	12.07511732	25.24932112	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	696	1095	0.00456621	0.003652968	6	oligos	OL-Cntl	51	20	20
TTTGCGCAGTCTCCTC-1_3_C4	39.31650894	15.91433033	14	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1337	2129	0.000939408	0.006575857	6	14	Microglia	51	20	20
TTTGCGCCATGCATGT-1_3_C4	-16.1417624	14.93145986	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	2044	3542	0.003952569	0.007058159	6	8	Astrocytes	51	20	20
TTTGCGCGTAGCAAAT-1_3_C4	20.55527715	10.39849068	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1476	2543	0.002359418	0.003932363	6	oligos	OL-Cntl	51	20	20
TTTGCGCGTAGCGTGA-1_3_C4	9.89228863	23.34999514	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	812	1271	0.003147128	0.005507474	6	oligos	OL-Cntl	51	20	20
TTTGCGCGTCAAAGCG-1_3_C4	-28.19887687	12.05143644	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	853	1273	0.004713276	0.000785546	6	8	Astrocytes	51	20	20
TTTGCGCGTCTCTCTG-1_3_C4	11.1864144	16.18044489	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1061	1917	0.014084507	0.002608242	6	oligos	OL-Cntl	51	20	20
TTTGCGCTCCCAGGTG-1_3_C4	10.81947061	26.66595247	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	829	1336	0.000748503	0.002245509	6	oligos	OL-Cntl	51	20	20
TTTGCGCTCTGCGGCA-1_3_C4	1.253621602	24.33585123	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	726	1109	0.007213706	0.008115419	6	oligos	OL-Cntl	51	20	20
TTTGCGCTCTGCTGCT-1_3_C4	4.511027047	-15.86028966	4	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	3436	8583	0.004427356	0.007922638	6	L2-3	EN-L2-3-MS	51	20	20
TTTGGTTCACGGACAA-1_3_C4	6.913256519	33.21622016	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	808	1256	0.01433121	0.001592357	6	oligos	OL-Cntl	51	20	20
TTTGGTTCATCCGCGA-1_3_C4	-10.79856142	13.3916232	11	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	881	1295	0.011583012	0.001544402	6	11	Glia-MIX	51	20	20
TTTGGTTGTACTTGAC-1_3_C4	11.24357132	23.1783371	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	774	1214	0.001647446	0.004942339	6	oligos	OL-Cntl	51	20	20
TTTGTCAAGACAAAGG-1_3_C4	32.89828577	-4.565227206	2	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	3113	7099	0.008170165	0.004085082	6	2	EN-L4	51	20	20
TTTGTCACAAGACGTG-1_3_C4	20.12181938	17.7136555	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1139	1782	0.004489338	0.004489338	6	oligos	OL-Cntl	51	20	20
TTTGTCAGTATAGGGC-1_3_C4	-20.3947951	8.13207686	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	771	1185	0.005063291	0.005063291	6	8	Astrocytes	51	20	20
TTTGTCAGTGGCGAAT-1_3_C4	20.97581985	14.60012348	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1184	2119	0.000943841	0.008966494	6	oligos	OL-Cntl	51	20	20
TTTGTCAGTTAAGTAG-1_3_C4	-25.45358532	12.88424761	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	996	1655	0.001812689	0.009063444	6	8	Astrocytes	51	20	20
TTTGTCATCCATTCTA-1_3_C4	-25.11834286	25.81067583	8	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1404	2938	0.000680735	0.005445882	6	8	Astrocytes	51	20	20
TTTGTCATCCTCAATT-1_3_C4	11.767968	31.70851242	1	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	779	1281	0.00078064	0.005464481	6	oligos	OL-Cntl	51	20	20
TTTGTCATCGTGGGAA-1_3_C4	-24.2016768	-12.54152572	11	3_C4	MS	Acute/Chronic active	50	female	motor-premotor	CAP1	SEQ1	8.9	22	1048	1848	0.018398268	0.004329004	6	11	Glia-MIX	51	20	20
AAACCTGTCCATTCTA-1_4_A5	12.81551826	-32.69697305	3	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2787	6422	0.006072874	0.000934288	0	3	EN-L5-6	NA	NA	NA
AAACGGGAGACAAAGG-1_4_A5	-6.57264673	-10.77669308	6B	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	984	1467	0.00408998	0.003408316	0	6B	IN-SST	NA	NA	NA
AAACGGGTCGCCTGTT-1_4_A5	6.430089464	-5.894098962	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1190	1924	0.01039501	0.003118503	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AAAGATGAGATGAGAG-1_4_A5	22.69348235	0.205856253	2	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1856	3031	0.004289014	0.002639393	0	2	EN-L4	NA	NA	NA
AAAGCAAGTACTCGCG-1_4_A5	-13.84748977	-24.36044197	6A	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1373	2336	0.005993151	0.002996575	0	6A	IN-PV	NA	NA	NA
AAAGCAAGTTACAGAA-1_4_A5	24.12283497	0.005704041	2	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2264	4360	0.008944954	0.00206422	0	2	EN-L4	NA	NA	NA
AAAGCAATCGTTGACA-1_4_A5	-11.5033455	-21.99261245	6A	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	951	1433	0.016050244	0.002791347	0	6A	IN-PV	NA	NA	NA
AACACGTGTCAGAGGT-1_4_A5	20.6026604	1.725659976	2	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1529	2766	0.009399855	0.000361533	0	2	EN-L4	NA	NA	NA
AACACGTGTGCCTGGT-1_4_A5	0.617271008	-11.39831631	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1692	2958	0.005747126	0.004056795	0	12	EN-MIX	NA	NA	NA
AACACGTTCAAACCAC-1_4_A5	3.927053874	-29.83157555	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	3404	8606	0.004415524	0.002207762	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AACCATGAGGCAATTA-1_4_A5	3.120306506	-7.574253515	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1332	2031	0.010339734	0.002461841	0	12	EN-MIX	NA	NA	NA
AACCATGCAATCCAAC-1_4_A5	4.121932793	-2.487799546	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	805	1207	0.011599006	0.003314002	0	12	EN-MIX	NA	NA	NA
AACCATGGTATAAACG-1_4_A5	-7.98614072	-2.135755938	13A	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1949	3338	0.007789095	0.005991612	0	13A	IN-VIP	NA	NA	NA
AACCATGGTCATATGC-1_4_A5	14.6050914	29.12603998	1	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	719	1047	0.003820439	0.00286533	0	oligos	OL-Cntl	NA	NA	NA
AACCGCGCACACGCTG-1_4_A5	1.411305619	-7.1678478	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1251	1906	0.007869885	0.00524659	0	12	EN-MIX	NA	NA	NA
AACGTTGAGCCATCGC-1_4_A5	-34.62892778	-11.34433807	9	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	840	1221	0	0.002457002	0	9	OPC	NA	NA	NA
AACGTTGGTAGCCTAT-1_4_A5	3.65171939	-28.73847431	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	3125	7377	0.004744476	0.001626678	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AACGTTGGTATAAACG-1_4_A5	3.712007526	-3.725309032	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	936	1583	0.000631712	0.005053696	0	12	EN-MIX	NA	NA	NA
AACGTTGGTCGAAAGC-1_4_A5	-29.58501692	13.87753751	8	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	810	1276	0.013322884	0.000783699	0	8	Astrocytes	NA	NA	NA
AACGTTGTCATGCATG-1_4_A5	-7.659982439	0.460215368	13A	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2170	4215	0.0113879	0.005219454	0	13A	IN-VIP	NA	NA	NA
AACTCAGAGAGTGAGA-1_4_A5	-10.23850264	-17.59320852	6B	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	983	1504	0.011303191	0.003989362	0	6B	IN-SST	NA	NA	NA
AACTCAGGTGGCGAAT-1_4_A5	10.86771693	-0.628951632	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1264	2111	0.024159166	0.007579346	0	12	EN-MIX	NA	NA	NA
AACTCAGGTTAGTGGG-1_4_A5	13.1217826	-31.80482058	3	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2889	6457	0.003871767	0.003871767	0	3	EN-L5-6	NA	NA	NA
AACTCCCTCTCCAGGG-1_4_A5	0.15379841	-10.15673246	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1631	2819	0.001418943	0.003547357	0	12	EN-MIX	NA	NA	NA
AACTCTTAGCGTTCCG-1_4_A5	1.486569883	-6.186735315	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1190	1764	0.007369615	0.00170068	0	12	EN-MIX	NA	NA	NA
AACTCTTAGCTGTTCA-1_4_A5	20.70225265	-28.423769	3	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	3293	8155	0.012507664	0.003923973	0	3	EN-L5-6	NA	NA	NA
AACTGGTCACGCGAAA-1_4_A5	-0.687196847	4.086608938	11	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	974	1467	0.002726653	0.005453306	0	11	Glia-MIX	NA	NA	NA
AACTGGTCATGCTAGT-1_4_A5	-2.539477151	2.471296566	11	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1879	3165	0.004107425	0.006635071	0	11	Glia-MIX	NA	NA	NA
AACTGGTGTACCAGTT-1_4_A5	-29.0271823	13.80879773	8	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	777	1111	0.00360036	0.00270027	0	8	Astrocytes	NA	NA	NA
AACTGGTGTTCCACTC-1_4_A5	10.35383991	28.62692134	1	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	821	1194	0.003350084	0.004187605	0	oligos	OL-Cntl	NA	NA	NA
AACTGGTTCAGAGCTT-1_4_A5	-0.532270264	28.11125439	1	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	800	1057	0.000946074	0.004730369	0	oligos	OL-Cntl	NA	NA	NA
AACTGGTTCGATAGAA-1_4_A5	-0.449537064	-13.18212335	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1968	3535	0.003677511	0.002263083	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AACTTTCGTATCACCA-1_4_A5	1.085810427	0.402688695	11	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1036	1758	0.003412969	0.00625711	0	11	Glia-MIX	NA	NA	NA
AACTTTCTCGTACGGC-1_4_A5	-34.18147379	-11.58545434	9	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	823	1206	0.000829187	0.00331675	0	9	OPC	NA	NA	NA
AAGACCTAGCTGATAA-1_4_A5	1.842136631	-6.441104682	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1093	1801	0.008328706	0.004441977	0	12	EN-MIX	NA	NA	NA
AAGACCTTCGGTGTCG-1_4_A5	6.474526752	-5.82173788	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1179	1955	0.000511509	0.001023018	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AAGCCGCAGCACACAG-1_4_A5	15.83312295	25.94838705	1	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	910	1293	0.000773395	0.005413766	0	oligos	OL-Cntl	NA	NA	NA
AAGCCGCGTAGTAGTA-1_4_A5	2.928979203	28.99942515	1	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	737	1068	0.004681648	0.003745318	0	oligos	OL-Cntl	NA	NA	NA
AAGCCGCTCAGTGCAT-1_4_A5	-37.90157106	0.118736593	9	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1564	2705	0.000739372	0.004436229	0	9	OPC	NA	NA	NA
AAGCCGCTCCATGAAC-1_4_A5	-9.040960309	13.92315225	11	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1715	2810	0.002135231	0.003914591	0	11	Glia-MIX	NA	NA	NA
AAGCCGCTCTTTACAC-1_4_A5	25.20169534	-5.212443286	2	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	4113	11136	0.001706178	0.001975575	0	2	EN-L4	NA	NA	NA
AAGGAGCGTGACCAAG-1_4_A5	15.18707794	1.815398695	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	837	1164	0.004295533	0.004295533	0	12	EN-MIX	NA	NA	NA
AAGGAGCGTGTAATGA-1_4_A5	2.711238408	-5.943529411	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1161	1768	0.003393665	0.007352941	0	12	EN-MIX	NA	NA	NA
AAGGAGCTCACATACG-1_4_A5	23.16239156	1.141694463	2	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2067	3909	0.005372218	0.002558199	0	2	EN-L4	NA	NA	NA
AAGGAGCTCCGATATG-1_4_A5	-14.01365438	-24.40497819	6A	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1421	2478	0.024213075	0.002017756	0	6A	IN-PV	NA	NA	NA
AAGGCAGAGCCGATTT-1_4_A5	4.349878015	-4.340818595	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1150	2043	0.001957905	0.003426334	0	12	EN-MIX	NA	NA	NA
AAGGTTCAGCTAACTC-1_4_A5	31.75205574	-4.072622434	2	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	3234	6690	0.008071749	0.003736921	0	2	EN-L4	NA	NA	NA
AAGTCTGAGACCACGA-1_4_A5	-4.467936328	-9.604946541	13A	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	740	1051	0.02188392	0.003805899	0	13A	IN-VIP	NA	NA	NA
AAGTCTGAGACTAGGC-1_4_A5	-5.973340851	-4.11173707	13A	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1367	2161	0.015270708	0.000925497	0	13A	IN-VIP	NA	NA	NA
AAGTCTGTCATCGATG-1_4_A5	-13.60664116	-10.62989528	13B	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1733	3095	0.010662359	0.002584814	0	13B	IN-SV2C	NA	NA	NA
ACACCAACACCATGTA-1_4_A5	8.418133601	-7.078019736	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1564	2727	0.008434177	0.001833517	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACACCAACAGGGTTAG-1_4_A5	16.95202227	1.65643749	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	852	1219	0.005742412	0.004922067	0	12	EN-MIX	NA	NA	NA
ACACCAATCTGCGTAA-1_4_A5	-11.62091909	-21.99375875	6A	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1073	2000	0.011	0.002	0	6A	IN-PV	NA	NA	NA
ACACCCTAGTACGTTC-1_4_A5	25.33290446	-1.85559227	2	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2813	5834	0.019026397	0.002399726	0	2	EN-L4	NA	NA	NA
ACACCCTCAGCCTTTC-1_4_A5	-3.996664475	-7.207568528	13A	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	974	1556	0.048843188	0.003213368	0	13A	IN-VIP	NA	NA	NA
ACACCCTTCAGTGTTG-1_4_A5	-28.42827846	22.26782307	8	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1106	1791	0.008933557	0.003908431	0	8	Astrocytes	NA	NA	NA
ACACCGGGTGATGCCC-1_4_A5	10.59402738	-7.531190527	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2110	4097	0.003417134	0.000732243	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACACCGGTCAACACGT-1_4_A5	-17.71546591	-24.91289971	6A	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2251	4474	0.008270004	0.004023245	0	6A	IN-PV	NA	NA	NA
ACACTGAAGAGTCTGG-1_4_A5	-8.531318627	-17.49903602	6B	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	791	1121	0.009812667	0.002676182	0	6B	IN-SST	NA	NA	NA
ACACTGAGTGACAAAT-1_4_A5	17.41601432	1.711738243	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1047	1601	0.020612117	0.001873829	0	12	EN-MIX	NA	NA	NA
ACACTGATCCGAAGAG-1_4_A5	4.870784124	-29.02491344	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	3361	7210	0.007212205	0.004022191	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACAGCCGCAGCCTATA-1_4_A5	-0.085609968	-12.078083	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1918	3419	0.001169933	0.001462416	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACAGCCGCAGGAATGC-1_4_A5	8.938557367	-7.530505825	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1949	3380	0.003254438	0.002366864	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACAGCCGCATGCAACT-1_4_A5	2.727554475	-6.253479884	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1124	1741	0.003446295	0.005169443	0	12	EN-MIX	NA	NA	NA
ACAGCCGGTAAGAGAG-1_4_A5	3.082909531	-3.677345698	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	895	1225	0.00244898	0.004897959	0	12	EN-MIX	NA	NA	NA
ACAGCCGGTACGACCC-1_4_A5	8.772390205	-8.651944364	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2169	4405	0	0.002497162	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACAGCTAGTCGGCTCA-1_4_A5	0.666559012	-10.99546306	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1795	3045	0.00952381	0.003940887	0	12	EN-MIX	NA	NA	NA
ACAGCTAGTTCAGGCC-1_4_A5	21.6744798	1.39887613	2	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1450	2589	0	0.001158749	0	2	EN-L4	NA	NA	NA
ACAGCTATCCTCATTA-1_4_A5	14.84594275	27.98018993	1	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	723	1059	0.004721435	0.003777148	0	oligos	OL-Cntl	NA	NA	NA
ACAGCTATCGATGAGG-1_4_A5	9.803102781	-7.607272972	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1911	3540	0.003107345	0.001412429	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACATCAGGTGGCCCTA-1_4_A5	12.34710767	0.400332681	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1008	1540	0.005844156	0.009090909	0	12	EN-MIX	NA	NA	NA
ACATGGTAGAAACGAG-1_4_A5	-16.39721046	-25.95533795	6A	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1953	3658	0.005740842	0.003007108	0	6A	IN-PV	NA	NA	NA
ACATGGTCAAGTTCTG-1_4_A5	-8.617937821	-18.05679719	6B	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	774	1164	0.025773196	0.005154639	0	6B	IN-SST	NA	NA	NA
ACATGGTGTTCAGTAC-1_4_A5	12.52884929	0.425124863	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	818	1321	0.000757002	0.011355034	0	12	EN-MIX	NA	NA	NA
ACCAGTAAGCGATCCC-1_4_A5	-36.50246155	-7.133036451	9	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1138	1826	0.000547645	0.000547645	0	9	OPC	NA	NA	NA
ACCAGTACACAGAGGT-1_4_A5	-18.30434981	-17.23087717	6B	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2412	5098	0.020596312	0.004315418	0	6B	IN-SST	NA	NA	NA
ACCAGTAGTTGCGCAC-1_4_A5	-1.059109595	3.478442655	11	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1199	1867	0.002678093	0.007498661	0	11	Glia-MIX	NA	NA	NA
ACCAGTATCAAACCGT-1_4_A5	-12.65681219	-10.77769666	13B	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1592	2802	0.004639543	0.002141328	0	13B	IN-SV2C	NA	NA	NA
ACCAGTATCTGATTCT-1_4_A5	-3.831169179	-8.35134978	13A	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	928	1436	0.014623955	0.000696379	0	13A	IN-VIP	NA	NA	NA
ACCCACTAGGTTACCT-1_4_A5	22.50065514	-6.270374272	2	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1825	2911	0.005839918	0.002748196	0	2	EN-L4	NA	NA	NA
ACCCACTGTTCGGGCT-1_4_A5	-1.392373079	3.136927552	11	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1320	2044	0.007338552	0.004892368	0	11	Glia-MIX	NA	NA	NA
ACCGTAAAGCTATGCT-1_4_A5	18.85184758	1.340506114	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1188	1856	0.005387931	0.004849138	0	12	EN-MIX	NA	NA	NA
ACCGTAACAGTATGCT-1_4_A5	-16.51302174	-25.9052172	6A	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1910	3490	0.003438395	0.004297994	0	6A	IN-PV	NA	NA	NA
ACGAGCCAGCCACCTG-1_4_A5	15.92345045	-33.21151724	3	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	5432	16159	0.006436042	0.002042206	0	3	EN-L5-6	NA	NA	NA
ACGAGCCTCCCAGGTG-1_4_A5	9.020371032	28.16414152	1	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	937	1412	0.008498584	0.002124646	0	oligos	OL-Cntl	NA	NA	NA
ACGAGGAAGCTAACAA-1_4_A5	0.514452846	-10.14579484	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1656	2761	0.00760594	0.005795002	0	12	EN-MIX	NA	NA	NA
ACGAGGAAGCTTATCG-1_4_A5	3.957717583	-3.318198336	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	847	1155	0.012987013	0.004329004	0	12	EN-MIX	NA	NA	NA
ACGAGGACATGAACCT-1_4_A5	-4.365543993	-3.388334172	13A	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1357	2164	0.006007394	0.005083179	0	13A	IN-VIP	NA	NA	NA
ACGAGGAGTTCAGACT-1_4_A5	-1.300724938	3.171388639	11	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1346	2098	0.003813155	0.003336511	0	11	Glia-MIX	NA	NA	NA
ACGATACCACCTTGTC-1_4_A5	-10.02727477	12.6239019	11	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	972	1476	0.002710027	0.006097561	0	11	Glia-MIX	NA	NA	NA
ACGATACGTCTAGGTT-1_4_A5	12.10333302	0.894931128	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	832	1207	0.017398509	0.017398509	0	12	EN-MIX	NA	NA	NA
ACGATACTCGGAGCAA-1_4_A5	-6.291862361	-4.349372448	13A	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1565	2602	0.008455035	0.003074558	0	13A	IN-VIP	NA	NA	NA
ACGATGTAGGTGCACA-1_4_A5	31.66098432	-3.204697736	2	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2999	5996	0.004169446	0.002168112	0	2	EN-L4	NA	NA	NA
ACGATGTGTTTAAGCC-1_4_A5	-36.35860608	-7.977206886	9	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	952	1383	0.002169197	0.004338395	0	9	OPC	NA	NA	NA
ACGCAGCTCTGGAGCC-1_4_A5	13.51383499	-32.33768294	3	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	3421	7992	0.002127127	0.002377377	0	3	EN-L5-6	NA	NA	NA
ACGCCAGAGCACAGGT-1_4_A5	22.62007067	-0.289469018	2	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1976	3586	0.027607362	0.00250976	0	2	EN-L4	NA	NA	NA
ACGCCAGAGCTCAACT-1_4_A5	2.434578866	-8.181535241	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1293	1995	0.000501253	0.005513784	0	12	EN-MIX	NA	NA	NA
ACGCCAGAGCTGCGAA-1_4_A5	-3.909697237	-5.091946351	13A	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1164	1918	0.015119917	0.001564129	0	13A	IN-VIP	NA	NA	NA
ACGCCAGAGGCCCTTG-1_4_A5	-5.616875236	-10.42490981	6B	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	802	1175	0.012765957	0.002553191	0	6B	IN-SST	NA	NA	NA
ACGCCAGGTTACGACT-1_4_A5	15.78985472	28.95198267	1	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	839	1164	0.00257732	0.001718213	0	oligos	OL-Cntl	NA	NA	NA
ACGCCAGGTTCACCTC-1_4_A5	11.23330073	22.7218972	1	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	888	1449	0.002760524	0.006901311	0	oligos	OL-Cntl	NA	NA	NA
ACGGAGAAGATCACGG-1_4_A5	2.020199055	-25.75283576	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	3712	8936	0.002797672	0.002126231	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACGGAGACAATTGCTG-1_4_A5	-1.070627541	3.346640883	11	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1206	1788	0.004474273	0.007829978	0	11	Glia-MIX	NA	NA	NA
ACGGAGAGTTGAGTTC-1_4_A5	8.294771309	-7.532005257	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1725	3197	0.001876759	0.001563966	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACGGAGAGTTTAGGAA-1_4_A5	1.453002758	-26.61608658	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	3274	7345	0.004765146	0.003267529	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACGGAGATCGCCTGAG-1_4_A5	-9.072841097	-20.09541829	6B	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	841	1590	0	0.000628931	0	6B	IN-SST	NA	NA	NA
ACGGCCAAGTCAAGGC-1_4_A5	25.46465934	-2.521652932	2	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	3054	6669	0.009596641	0.001349528	0	2	EN-L4	NA	NA	NA
ACGGCCATCCAGAGGA-1_4_A5	22.78256801	0.254795172	2	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2001	3445	0.008417997	0.001741655	0	2	EN-L4	NA	NA	NA
ACGGCCATCCCATTTA-1_4_A5	13.03486652	25.88892477	1	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	892	1358	0.001472754	0.005154639	0	oligos	OL-Cntl	NA	NA	NA
ACGGGCTAGAGTCGGT-1_4_A5	19.65009569	-7.049125909	3	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2400	4804	0.000832639	0.002914238	0	3	EN-L5-6	NA	NA	NA
ACGGGCTAGGGATCTG-1_4_A5	-0.275033364	-12.46204099	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1933	3485	0.001147776	0.001147776	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACGGGCTCACTCGACG-1_4_A5	-4.633122083	-8.162855243	13A	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	769	1023	0.005865103	0.002932551	0	13A	IN-VIP	NA	NA	NA
ACGGGCTGTTATGCGT-1_4_A5	23.09290913	0.329578696	2	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2116	3840	0.005729167	0.00078125	0	2	EN-L4	NA	NA	NA
ACGGGTCAGGTCATCT-1_4_A5	3.024436928	-5.738456082	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1029	1719	0.004653869	0.004072135	0	12	EN-MIX	NA	NA	NA
ACGGGTCAGTCATGCT-1_4_A5	17.32082201	0.578077938	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	957	1446	0.017980636	0.004840941	0	12	EN-MIX	NA	NA	NA
ACGTCAAAGAAGGCCT-1_4_A5	19.26516072	-7.008496686	3	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1973	3720	0.000806452	0.002150538	0	3	EN-L5-6	NA	NA	NA
ACGTCAACACAGCGTC-1_4_A5	13.58446139	0.588127881	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	674	1031	0.007759457	0.012609117	0	12	EN-MIX	NA	NA	NA
ACGTCAACAGCCTGTG-1_4_A5	-27.21945359	9.569247	8	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	818	1181	0.00084674	0.00508044	0	8	Astrocytes	NA	NA	NA
ACTATCTAGACTCGGA-1_4_A5	15.49383961	-5.925742865	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1377	2266	0.001323919	0.003089144	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACTATCTCAGACTCGC-1_4_A5	9.842954753	-8.733516667	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2385	4889	0.000613622	0.001636326	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACTGAACAGAAACCAT-1_4_A5	3.345670394	-28.70877503	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	3362	8929	0.00291186	0.001903909	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACTGAACAGTGACTCT-1_4_A5	2.363541077	-6.98896067	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1259	1962	0.011722732	0.002038736	0	12	EN-MIX	NA	NA	NA
ACTGAACAGTTAGGTA-1_4_A5	21.61461269	-8.457584617	3	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1780	3165	0.005687204	0.003475513	0	3	EN-L5-6	NA	NA	NA
ACTGAACCAGATAATG-1_4_A5	-3.018914122	2.407587021	11	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2190	3824	0.005230126	0.006014644	0	11	Glia-MIX	NA	NA	NA
ACTGAACCAGGGTACA-1_4_A5	-1.05799975	3.513524064	11	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1142	1897	0.002108593	0.002635741	0	11	Glia-MIX	NA	NA	NA
ACTGAACGTCGCATAT-1_4_A5	0.345538956	-11.75866295	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1834	3295	0.008497724	0.003945372	0	12	EN-MIX	NA	NA	NA
ACTGAACGTCTGGAGA-1_4_A5	12.16715705	-0.740093392	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1106	2012	0.005467197	0.00944334	0	12	EN-MIX	NA	NA	NA
ACTGAGTAGACTAAGT-1_4_A5	22.91744757	-0.321241235	2	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1840	3323	0.016250376	0.003310262	0	2	EN-L4	NA	NA	NA
ACTGAGTGTTACGTCA-1_4_A5	19.37966201	1.533472632	2	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1235	1890	0.004232804	0.002645503	0	2	EN-L4	NA	NA	NA
ACTGATGAGCCCAATT-1_4_A5	15.30198661	-7.981799499	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1854	3324	0.007220217	0.001504212	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACTGATGAGTCCCACG-1_4_A5	7.272135077	-0.4771889	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	854	1203	0.028262677	0.014131338	0	12	EN-MIX	NA	NA	NA
ACTGATGTCGCACTCT-1_4_A5	-36.03884446	-7.943451128	9	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1028	1698	0	0.002355713	0	9	OPC	NA	NA	NA
ACTGATGTCTTCGAGA-1_4_A5	-4.754993766	-3.849854926	13A	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1330	2160	0.010185185	0.002314815	0	13A	IN-VIP	NA	NA	NA
ACTGCTCAGGATGCGT-1_4_A5	-5.089903717	-10.40190105	13B	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	887	1265	0.008695652	0.001581028	0	13B	IN-SV2C	NA	NA	NA
ACTGCTCAGGCTAGCA-1_4_A5	0.945214824	-10.20623706	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1509	2463	0.005684125	0.002436054	0	12	EN-MIX	NA	NA	NA
ACTGCTCCATGCTAGT-1_4_A5	19.36952369	1.278726845	2	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1451	2336	0.014982877	0.002996575	0	2	EN-L4	NA	NA	NA
ACTGTCCAGAGCCCAA-1_4_A5	-28.26736334	9.232149286	8	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	751	1247	0.001603849	0.004811548	0	8	Astrocytes	NA	NA	NA
ACTGTCCAGTAGATGT-1_4_A5	-14.10106407	-21.45779081	6A	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1343	2241	0.012494422	0.00713967	0	6A	IN-PV	NA	NA	NA
ACTGTCCAGTGCGTGA-1_4_A5	-9.31555689	13.54071826	11	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1240	1876	0.00533049	0.004264392	0	11	Glia-MIX	NA	NA	NA
ACTGTCCGTAAGAGAG-1_4_A5	6.596490232	-2.302913291	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1193	1718	0.014551804	0.009895227	0	12	EN-MIX	NA	NA	NA
ACTGTCCGTGAGTGAC-1_4_A5	3.242640226	-29.59486077	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	4061	10517	0.005134544	0.001806599	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACTTACTAGAAGGTTT-1_4_A5	24.17910917	-26.89798678	3	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2877	6356	0.015103839	0.001730648	0	3	EN-L5-6	NA	NA	NA
ACTTACTAGGCTAGAC-1_4_A5	-4.1468491	-8.298020181	13A	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	721	1084	0.03597786	0	0	13A	IN-VIP	NA	NA	NA
ACTTACTCAATGAATG-1_4_A5	16.43531162	1.883318906	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	810	1131	0.008841733	0.00265252	0	12	EN-MIX	NA	NA	NA
ACTTACTCAGACGTAG-1_4_A5	8.29224806	-7.199239431	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1590	2737	0.008037998	0.001826818	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACTTTCACACACTGCG-1_4_A5	17.87744506	-5.356046995	3	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1139	1900	0.001578947	0.001052632	0	3	EN-L5-6	NA	NA	NA
AGAATAGAGGACACCA-1_4_A5	10.74375798	-8.648554376	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2459	5190	0.017726397	0.002119461	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AGAATAGCATCGGGTC-1_4_A5	8.807981157	27.39747726	1	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	805	1197	0.004177109	0.006683375	0	oligos	OL-Cntl	NA	NA	NA
AGAATAGTCACTGGGC-1_4_A5	0.850264126	-10.47901983	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1598	2811	0.002490217	0.004980434	0	12	EN-MIX	NA	NA	NA
AGAATAGTCTCTTGAT-1_4_A5	16.70613438	-6.42186362	3	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1601	3043	0.000657246	0.000985869	0	3	EN-L5-6	NA	NA	NA
AGAGCGAAGCTAGCCC-1_4_A5	23.17203618	-9.244956109	3	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	3144	7014	0.002708868	0.002708868	0	3	EN-L5-6	NA	NA	NA
AGAGCGACATATGAGA-1_4_A5	-4.047043129	-4.964818031	13A	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1106	1707	0.005272408	0.004100762	0	13A	IN-VIP	NA	NA	NA
AGAGCTTAGATCCGAG-1_4_A5	-15.01541539	-9.398168186	13A	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2728	6277	0.02692369	0.003186235	0	13A	IN-VIP	NA	NA	NA
AGAGCTTAGCTATGCT-1_4_A5	-4.06519495	-8.993930555	13A	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	856	1257	0.017501989	0.00159109	0	13A	IN-VIP	NA	NA	NA
AGAGTGGCATACTCTT-1_4_A5	24.63711013	-1.461716576	2	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2480	5288	0.028933434	0.001891074	0	2	EN-L4	NA	NA	NA
AGAGTGGCATCGTCGG-1_4_A5	3.837008608	-3.850812641	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	882	1205	0.011618257	0.001659751	0	12	EN-MIX	NA	NA	NA
AGAGTGGGTTGATTCG-1_4_A5	-35.23440166	-12.31349309	9	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	831	1272	0.001572327	0.003930818	0	9	OPC	NA	NA	NA
AGATCTGAGTCCTCCT-1_4_A5	17.90646416	1.048682502	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1058	1595	0.011912226	0.002507837	0	12	EN-MIX	NA	NA	NA
AGATTGCCAGACGCAA-1_4_A5	9.857860041	-8.224720345	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2050	3921	0.007141035	0.001530222	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AGATTGCTCCTTTCGG-1_4_A5	3.665951604	-28.26057049	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	3117	6882	0.007410636	0.001888986	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AGCAGCCAGTAAGTAC-1_4_A5	0.514495973	-11.63044549	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1907	3277	0.005797986	0.003967043	0	12	EN-MIX	NA	NA	NA
AGCAGCCAGTGACATA-1_4_A5	7.294284537	-33.26921007	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	3454	8318	0.006491945	0.002765088	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AGCAGCCCAAACTGCT-1_4_A5	21.18463937	-1.314500583	2	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1955	4006	0.008736895	0.004742886	0	2	EN-L4	NA	NA	NA
AGCAGCCTCGGCTTGG-1_4_A5	22.70678549	-0.356876576	2	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2067	3705	0.0048583	0.003238866	0	2	EN-L4	NA	NA	NA
AGCATACCAATGCCAT-1_4_A5	5.701585819	-9.616689163	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1713	3262	0.004598406	0.010116493	0	12	EN-MIX	NA	NA	NA
AGCATACTCCCAAGAT-1_4_A5	-0.099080332	-11.51297513	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1817	3353	0.002385923	0.001789442	0	12	EN-MIX	NA	NA	NA
AGCATACTCTCTAGGA-1_4_A5	9.17035206	-8.389181688	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2300	4365	0.009163803	0.004352806	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AGCCTAAAGGGTCTCC-1_4_A5	-32.18214141	-12.34392867	9	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	868	1231	0.001624695	0.003249391	0	9	OPC	NA	NA	NA
AGCCTAAGTAGCTCCG-1_4_A5	-34.99192571	-9.97756314	9	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	982	1516	0.003957784	0.002638522	0	9	OPC	NA	NA	NA
AGCGGTCAGGGTTTCT-1_4_A5	2.000212513	29.63587736	1	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	788	1072	0.007462687	0.003731343	0	oligos	OL-Cntl	NA	NA	NA
AGCGGTCGTAATCGTC-1_4_A5	13.53117384	1.987047459	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	729	1042	0.002879079	0.003838772	0	12	EN-MIX	NA	NA	NA
AGCGGTCTCATTGCCC-1_4_A5	-4.272277311	-8.704465711	13A	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	971	1449	0.017253278	0.000690131	0	13A	IN-VIP	NA	NA	NA
AGCGTCGCAGACGTAG-1_4_A5	10.65226329	1.299718234	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	870	1395	0.017204301	0.012903226	0	12	EN-MIX	NA	NA	NA
AGCGTCGGTGTTTGGT-1_4_A5	3.18820572	-5.268371466	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	998	1477	0.001354096	0.002708192	0	12	EN-MIX	NA	NA	NA
AGCTCCTAGTGCGTGA-1_4_A5	25.18021495	-2.167652988	2	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	3181	7651	0.004966671	0.002744739	0	2	EN-L4	NA	NA	NA
AGCTCCTCAGAAGCAC-1_4_A5	9.725731094	-8.069143534	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2014	3755	0.003728362	0.00159787	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AGCTCCTTCATTGCGA-1_4_A5	-18.41971813	-27.97318793	6A	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2796	7081	0.008897048	0.001977122	0	6A	IN-PV	NA	NA	NA
AGCTCTCAGTCCGTAT-1_4_A5	-10.6119664	-21.0487384	6B	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	892	1284	0.014018692	0.001557632	0	6B	IN-SST	NA	NA	NA
AGCTCTCCAAATACAG-1_4_A5	3.705184029	-28.32863828	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2689	5687	0.007385265	0.002461755	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AGCTCTCGTAGCACGA-1_4_A5	22.5537501	-6.29627428	2	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1956	3256	0.006142506	0.002764128	0	2	EN-L4	NA	NA	NA
AGCTTGAGTACTTAGC-1_4_A5	10.63013818	-7.362492539	2	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2003	3813	0.008392342	0.001311303	0	2	EN-L4	NA	NA	NA
AGCTTGATCACGGTTA-1_4_A5	9.887833251	-8.486491688	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2277	4504	0.004662522	0.001110124	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AGGCCACAGAATTCCC-1_4_A5	-0.485184188	4.67800226	11	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	775	1100	0.005454545	0.001818182	0	11	Glia-MIX	NA	NA	NA
AGGCCGTAGTGCAAGC-1_4_A5	-11.90866008	-22.45002644	6A	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1159	1831	0.036592026	0.001638449	0	6A	IN-PV	NA	NA	NA
AGGGAGTCACCTCGGA-1_4_A5	14.75091187	28.74769124	1	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	695	1008	0	0.003968254	0	oligos	OL-Cntl	NA	NA	NA
AGGGAGTCATTCTCAT-1_4_A5	-0.566089633	4.391141791	11	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	903	1341	0.004474273	0.002982849	0	11	Glia-MIX	NA	NA	NA
AGGGAGTTCTCTTGAT-1_4_A5	8.381398417	-7.040302824	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1652	2833	0.00388281	0.001764914	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AGGGATGCATGAGCGA-1_4_A5	23.16046828	0.001503122	2	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2252	4130	0.017433414	0.002421308	0	2	EN-L4	NA	NA	NA
AGGGATGGTGAGGCTA-1_4_A5	1.821736202	-7.280180516	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1278	1903	0.001576458	0.002101944	0	12	EN-MIX	NA	NA	NA
AGGGTGATCAAAGACA-1_4_A5	10.05436198	-8.242301244	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2279	4526	0.00508175	0.002872293	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AGGTCATGTTTCCACC-1_4_A5	-37.44694144	-7.710880327	9	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	924	1554	0.001930502	0.001930502	0	9	OPC	NA	NA	NA
AGGTCCGCATGTTCCC-1_4_A5	12.9175997	-32.05866526	3	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2724	6070	0.000658979	0.002635914	0	3	EN-L5-6	NA	NA	NA
AGGTCCGTCTTGCAAG-1_4_A5	18.51381281	-6.38378192	3	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1614	2837	0.006697215	0.002467395	0	3	EN-L5-6	NA	NA	NA
AGTAGTCGTTAAAGTG-1_4_A5	4.843323414	-5.680204403	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1065	1613	0	0.001859888	0	12	EN-MIX	NA	NA	NA
AGTCTTTCACAACTGT-1_4_A5	19.89543375	1.20390771	2	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1385	2232	0.005824373	0.002240143	0	2	EN-L4	NA	NA	NA
AGTGAGGCAATCACAC-1_4_A5	-28.07551117	13.82162767	8	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	930	1525	0.015081967	0.001967213	0	8	Astrocytes	NA	NA	NA
AGTGAGGTCTATCGCC-1_4_A5	13.44506422	28.86995264	1	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	797	1196	0.005016722	0.001672241	0	oligos	OL-Cntl	NA	NA	NA
AGTGGGAAGAAGGACA-1_4_A5	1.654276105	-12.44011133	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1950	3348	0.010752688	0.002986858	0	12	EN-MIX	NA	NA	NA
AGTGGGACACAACGCC-1_4_A5	-0.591244906	-14.53715666	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2147	4062	0.003938946	0.002461841	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AGTGGGATCTGCAGTA-1_4_A5	-36.59873872	-7.375430085	9	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1168	1846	0.004333694	0.003791983	0	9	OPC	NA	NA	NA
AGTGGGATCTTGTACT-1_4_A5	21.27944022	-0.340074204	2	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1531	2450	0.015918367	0.004081633	0	2	EN-L4	NA	NA	NA
AGTGTCAAGATGTGGC-1_4_A5	10.37399293	30.59781142	1	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	853	1259	0.001588562	0.003177125	0	oligos	OL-Cntl	NA	NA	NA
AGTGTCAGTCCAACTA-1_4_A5	1.914926742	-7.335581003	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1225	1949	0.005130836	0.006157004	0	12	EN-MIX	NA	NA	NA
AGTGTCAGTTGTCTTT-1_4_A5	-11.85262502	-10.95699178	13B	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1605	2749	0.019279738	0.001818843	0	13B	IN-SV2C	NA	NA	NA
AGTTGGTAGAGCCTAG-1_4_A5	18.46907549	1.538424982	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1111	1804	0.011086475	0.003880266	0	12	EN-MIX	NA	NA	NA
AGTTGGTCACGTCTCT-1_4_A5	8.294621683	-32.47152797	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	3300	7607	0.003417905	0.003549362	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AGTTGGTCATTGTGCA-1_4_A5	21.62630287	-8.373999896	3	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1595	2793	0.001074114	0.001432152	0	3	EN-L5-6	NA	NA	NA
ATAACGCTCTTTACAC-1_4_A5	6.013740411	-28.48559861	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2566	5120	0.005273438	0.002539063	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ATAAGAGGTAGCGTGA-1_4_A5	8.718762097	-8.610956805	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2101	3943	0.003296982	0.002282526	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ATAGACCAGTGCGATG-1_4_A5	22.47634097	0.120266695	2	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1802	3073	0.013342011	0.001952489	0	2	EN-L4	NA	NA	NA
ATAGACCCATGCCACG-1_4_A5	12.89018815	-32.52155927	3	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2570	5705	0.001402279	0.002453988	0	3	EN-L5-6	NA	NA	NA
ATAGACCGTCATCCCT-1_4_A5	-3.902493656	-6.741508377	13A	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	981	1452	0.004820937	0.004132231	0	13A	IN-VIP	NA	NA	NA
ATAGACCTCGTATCAG-1_4_A5	16.74416742	-0.516282271	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	750	1054	0.000948767	0.001897533	0	12	EN-MIX	NA	NA	NA
ATCACGACAGTGAGTG-1_4_A5	-35.51235418	-11.9899412	9	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	825	1278	0.00312989	0.000782473	0	9	OPC	NA	NA	NA
ATCACGATCACCATAG-1_4_A5	-5.900572481	-29.88508865	16	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	682	1080	0.160185185	0.001851852	0	16	EN-PYR	NA	NA	NA
ATCATCTCATAGGATA-1_4_A5	19.47569578	1.567083982	2	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1308	2065	0.004842615	0.003874092	0	2	EN-L4	NA	NA	NA
ATCATCTGTCGCGGTT-1_4_A5	17.89229424	-0.02799755	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1119	1802	0.01054384	0.001664817	0	12	EN-MIX	NA	NA	NA
ATCATGGGTCATCGGC-1_4_A5	6.928936517	-6.151625555	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1280	2069	0	0.001449976	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ATCATGGTCTTCCTTC-1_4_A5	24.52400634	0.353959111	2	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2083	3787	0.007393715	0.003168735	0	2	EN-L4	NA	NA	NA
ATCCACCAGAAACCTA-1_4_A5	-4.346880831	-7.595118884	13A	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	979	1561	0.012171685	0.003203075	0	13A	IN-VIP	NA	NA	NA
ATCCACCAGACACGAC-1_4_A5	2.510420256	29.61357523	1	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	730	1075	0.000930233	0.008372093	0	oligos	OL-Cntl	NA	NA	NA
ATCCACCGTATTCGTG-1_4_A5	13.33513401	-1.241644898	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1148	2147	0.001397299	0.005589194	0	12	EN-MIX	NA	NA	NA
ATCCACCTCTGGGCCA-1_4_A5	-28.20378724	13.53777233	8	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	926	1404	0.002849003	0.000712251	0	8	Astrocytes	NA	NA	NA
ATCCGAAAGTACTTGC-1_4_A5	1.281690158	-10.19473771	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1604	2782	0.006470165	0.001078361	0	12	EN-MIX	NA	NA	NA
ATCCGAAAGTGAAGAG-1_4_A5	14.09531032	0.788770946	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	777	1219	0	0.002461034	0	12	EN-MIX	NA	NA	NA
ATCCGAAGTCTAGAGG-1_4_A5	22.91312606	1.061292646	2	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1793	3277	0.0021361	0.004577357	0	2	EN-L4	NA	NA	NA
ATCGAGTCAACTGCTA-1_4_A5	9.927027449	-8.510194888	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2402	4941	0.001011941	0.00222627	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ATCTACTTCCAGTAGT-1_4_A5	14.36163628	-8.382666599	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2430	5145	0.013605442	0.002137998	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ATCTGCCCACCCATTC-1_4_A5	25.44643274	-2.508117917	2	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2778	6462	0.00355927	0.001702259	0	2	EN-L4	NA	NA	NA
ATCTGCCGTTTGGGCC-1_4_A5	-1.56904808	-18.91377598	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	3127	6966	0.00129199	0.003014643	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ATGAGGGTCCTTGCCA-1_4_A5	4.368725005	-6.967551352	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1181	1770	0.006214689	0.005084746	0	12	EN-MIX	NA	NA	NA
ATGCGATAGTGTACTC-1_4_A5	19.77237289	-6.953678058	3	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2106	4165	0.000720288	0.001680672	0	3	EN-L5-6	NA	NA	NA
ATGGGAGAGCGACGTA-1_4_A5	-0.532744701	4.76225204	11	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	769	1127	0.000887311	0.003549246	0	11	Glia-MIX	NA	NA	NA
ATGGGAGGTCCATGAT-1_4_A5	17.55309888	1.651248379	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1041	1551	0.003868472	0.003868472	0	12	EN-MIX	NA	NA	NA
ATGGGAGTCAGCGACC-1_4_A5	23.15200665	0.090934267	2	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2047	3961	0.017419843	0.002272153	0	2	EN-L4	NA	NA	NA
ATGGGAGTCCGAAGAG-1_4_A5	9.813052733	-6.973514561	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1700	2903	0.000688942	0.002066827	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ATGGGAGTCGTACCGG-1_4_A5	18.24282248	-5.957500879	3	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1428	2589	0.003862495	0.002317497	0	3	EN-L5-6	NA	NA	NA
ATTACTCGTTGATTCG-1_4_A5	-11.61794696	-10.9935853	13B	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1441	2413	0.007874016	0.002900953	0	13B	IN-SV2C	NA	NA	NA
ATTATCCCATCACCCT-1_4_A5	-3.389247791	-7.514488986	13A	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	769	1076	0.005576208	0.001858736	0	13A	IN-VIP	NA	NA	NA
ATTATCCCATTGCGGC-1_4_A5	2.127279661	-6.410045336	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1176	1896	0.011075949	0.002109705	0	12	EN-MIX	NA	NA	NA
ATTGGACCACATCTTT-1_4_A5	-21.13614725	-16.65459638	6A	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	3662	8735	0.004121351	0.003892387	0	6A	IN-PV	NA	NA	NA
ATTGGACTCGAGAACG-1_4_A5	2.980757477	-3.547782632	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	789	1038	0.016377649	0.006743738	0	12	EN-MIX	NA	NA	NA
ATTGGACTCTACCAGA-1_4_A5	-12.59451561	-18.23062768	6B	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1121	1674	0.009557945	0.002389486	0	6B	IN-SST	NA	NA	NA
CAACCAAGTAGCGCTC-1_4_A5	10.71025767	31.81516378	1	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	812	1175	0	0.002553191	0	oligos	OL-Cntl	NA	NA	NA
CAACCAAGTTACCAGT-1_4_A5	25.1716778	-0.645830782	2	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2681	5874	0.006298945	0.002553626	0	2	EN-L4	NA	NA	NA
CAACCTCCAGGGCATA-1_4_A5	1.758847881	-6.53194283	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1143	1777	0.005064716	0.00450197	0	12	EN-MIX	NA	NA	NA
CAACCTCTCAGCCTAA-1_4_A5	-12.30987951	-21.18999214	6B	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1042	1753	0.005134056	0.005704507	0	6B	IN-SST	NA	NA	NA
CAACCTCTCCCGACTT-1_4_A5	-18.98041171	6.604643526	8	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	636	1099	0.000909918	0.004549591	0	8	Astrocytes	NA	NA	NA
CAACTAGCAAACGCGA-1_4_A5	2.543941203	-6.615600107	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1312	2304	0.003038194	0.00390625	0	12	EN-MIX	NA	NA	NA
CAACTAGTCCATGCTC-1_4_A5	-0.748121846	3.260655731	11	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1030	1563	0.002559181	0.003198976	0	11	Glia-MIX	NA	NA	NA
CAACTAGTCGAATCCA-1_4_A5	11.85992154	31.61675335	1	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	823	1233	0.00729927	0.00081103	0	oligos	OL-Cntl	NA	NA	NA
CAAGAAAAGGTAGCTG-1_4_A5	-27.55248658	9.437119378	8	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	769	1073	0.000931966	0.002795899	0	8	Astrocytes	NA	NA	NA
CAAGAAAGTATGCTTG-1_4_A5	3.657423934	-2.544720114	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	857	1357	0.003684598	0.005158438	0	12	EN-MIX	NA	NA	NA
CAAGATCGTAGGAGTC-1_4_A5	-0.560694999	4.806872833	11	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	781	1169	0.000855432	0.001710864	0	11	Glia-MIX	NA	NA	NA
CAAGATCGTCTCGTTC-1_4_A5	9.570436451	-8.005614107	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1886	3409	0.005866823	0.003813435	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CAAGGCCCAGCGTCCA-1_4_A5	-9.060010856	-19.96197693	6B	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	747	1086	0.077348066	0.003683241	0	6B	IN-SST	NA	NA	NA
CAAGGCCCATGTTCCC-1_4_A5	25.85939174	-5.179685709	2	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	4676	13307	0.00616217	0.002029007	0	2	EN-L4	NA	NA	NA
CAAGGCCGTTCCACGG-1_4_A5	21.29203131	-29.25321721	3	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	4223	10756	0.001208628	0.004183711	0	3	EN-L5-6	NA	NA	NA
CAAGGCCTCTTGTCAT-1_4_A5	4.195837499	-3.437902196	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	851	1182	0	0.004230118	0	12	EN-MIX	NA	NA	NA
CAAGTTGAGATATGCA-1_4_A5	22.89093289	-10.02465432	3	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2714	5421	0.010883601	0.001844678	0	3	EN-L5-6	NA	NA	NA
CAAGTTGCACATCTTT-1_4_A5	-31.639	-11.89595904	9	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	829	1175	0.002553191	0.004255319	0	9	OPC	NA	NA	NA
CAAGTTGCACCTCGTT-1_4_A5	9.497025355	-8.967647446	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2486	5290	0.001890359	0.001512287	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CAAGTTGCAGACGTAG-1_4_A5	3.156147498	-4.952020064	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	918	1292	0.003869969	0.005417957	0	12	EN-MIX	NA	NA	NA
CAAGTTGGTAGCGTAG-1_4_A5	3.133216775	-25.92710635	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2838	5906	0.008127328	0.00253979	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CAAGTTGTCAAACCGT-1_4_A5	3.916791607	30.23505743	1	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	697	1001	0.010989011	0.003996004	0	oligos	OL-Cntl	NA	NA	NA
CAAGTTGTCTAACTCT-1_4_A5	-14.04578076	-24.37437619	6A	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1538	2694	0.020044543	0.002598367	0	6A	IN-PV	NA	NA	NA
CACAAACAGAGTACAT-1_4_A5	-4.45452379	-8.064884444	13A	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	818	1203	0.017456359	0.004987531	0	13A	IN-VIP	NA	NA	NA
CACAAACAGCTATGCT-1_4_A5	-0.422594936	-11.4574776	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1699	3050	0.001311475	0.002295082	0	12	EN-MIX	NA	NA	NA
CACAAACCAAGCGAGT-1_4_A5	18.217183	14.55482263	1	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1268	2151	0.005578801	0.0009298	0	oligos	OL-Cntl	NA	NA	NA
CACAAACCATCCCATC-1_4_A5	-35.35057153	-9.174995265	9	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1047	1614	0.000619579	0.004337051	0	9	OPC	NA	NA	NA
CACAAACCATGGAATA-1_4_A5	-0.866047441	3.817307173	11	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1034	1579	0.000633312	0.003799873	0	11	Glia-MIX	NA	NA	NA
CACAAACGTGCGCTTG-1_4_A5	24.5552943	-28.94378238	3	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2798	6154	0.003574911	0.002437439	0	3	EN-L5-6	NA	NA	NA
CACAAACGTGTGAAAT-1_4_A5	0.703878277	-11.02350363	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1546	2543	0.009044436	0.003145891	0	12	EN-MIX	NA	NA	NA
CACAAACTCTACTATC-1_4_A5	24.68482756	-28.60074798	3	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2792	6292	0.000476796	0.00158932	0	3	EN-L5-6	NA	NA	NA
CACACAAAGACTTTCG-1_4_A5	-0.487298476	4.633002677	11	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	796	1140	0.005263158	0.004385965	0	11	Glia-MIX	NA	NA	NA
CACACCTAGGATCGCA-1_4_A5	-29.13500081	13.74365782	8	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	757	1108	0.007220217	0.001805054	0	8	Astrocytes	NA	NA	NA
CACACCTGTCGCGGTT-1_4_A5	-26.41094794	26.28231655	8	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1391	2472	0.002427184	0.002831715	0	8	Astrocytes	NA	NA	NA
CACACCTGTGTCAATC-1_4_A5	4.150096186	-32.82269679	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	5484	17806	0.002471077	0.002414916	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CACACCTTCATCACCC-1_4_A5	-20.43236056	-24.67381027	6A	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2497	5013	0.015759027	0.004189108	0	6A	IN-PV	NA	NA	NA
CACACCTTCCACGTTC-1_4_A5	0.573164022	-11.23334098	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1707	2876	0.005563282	0.003129346	0	12	EN-MIX	NA	NA	NA
CACACTCGTGAGGCTA-1_4_A5	14.06400271	1.722228612	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	889	1381	0.00724113	0.005792904	0	12	EN-MIX	NA	NA	NA
CACACTCTCCGCGTTT-1_4_A5	11.30996943	-8.571417261	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2629	5557	0.008097895	0.002339392	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CACAGGCAGAAACCAT-1_4_A5	-0.859382327	-13.96054891	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2113	3964	0.004540868	0.002018163	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CACAGGCGTATTCGTG-1_4_A5	-36.06856268	-8.336390458	9	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1021	1598	0.003754693	0.001877347	0	9	OPC	NA	NA	NA
CACAGGCTCCTCATTA-1_4_A5	10.1022698	-8.85697143	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2724	6108	0.001637197	0.002128356	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CACATAGAGCTAAACA-1_4_A5	8.661221433	-30.55840468	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	3728	9090	0.011991199	0.00220022	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CACATAGAGGCCCGTT-1_4_A5	3.242392384	-5.797695726	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1057	1524	0.015748031	0.003937008	0	12	EN-MIX	NA	NA	NA
CACATAGCATCGGGTC-1_4_A5	-5.154920246	-10.42938392	6B	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	850	1193	0.011735122	0.004191115	0	6B	IN-SST	NA	NA	NA
CACATTTAGGTAAACT-1_4_A5	16.93665529	1.786860911	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	929	1316	0.017477204	0.001519757	0	12	EN-MIX	NA	NA	NA
CACATTTGTTAGATGA-1_4_A5	-12.11397732	-19.23467758	6B	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	983	1599	0.011257036	0.002501563	0	6B	IN-SST	NA	NA	NA
CACCACTGTAGGACAC-1_4_A5	8.735615808	27.72121597	1	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	838	1275	0.010196078	0.008627451	0	oligos	OL-Cntl	NA	NA	NA
CACCACTGTCCGTTAA-1_4_A5	27.76950283	-4.11266519	2	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	3291	7234	0.003732375	0.00317943	0	2	EN-L4	NA	NA	NA
CACCACTTCACCCTCA-1_4_A5	6.198811778	29.16070945	1	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	642	1001	0.001998002	0.002997003	0	oligos	OL-Cntl	NA	NA	NA
CACCACTTCGAGAGCA-1_4_A5	-9.178953271	-20.1122674	6B	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	758	1098	0.0428051	0.003642987	0	6B	IN-SST	NA	NA	NA
CACCACTTCTGATACG-1_4_A5	19.46076355	1.557208173	2	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1384	2304	0.003472222	0.002170139	0	2	EN-L4	NA	NA	NA
CACCAGGAGCGATTCT-1_4_A5	-3.468409053	2.470386599	11	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2416	4627	0.003241841	0.002593473	0	11	Glia-MIX	NA	NA	NA
CACCAGGCAGTATCTG-1_4_A5	-8.041395454	-1.085232816	13A	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1979	3794	0.002108593	0.003953611	0	13A	IN-VIP	NA	NA	NA
CACCTTGAGCCTCGTG-1_4_A5	3.14049027	-6.343927195	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1167	1721	0.013364323	0.004067403	0	12	EN-MIX	NA	NA	NA
CACCTTGAGTTACCCA-1_4_A5	-1.502577302	-17.56764106	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2600	5480	0.01040146	0.002189781	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CACCTTGGTACTCTCC-1_4_A5	14.18514445	29.28033372	1	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	837	1254	0.002392344	0.000797448	0	oligos	OL-Cntl	NA	NA	NA
CACCTTGGTTCGTCTC-1_4_A5	31.4622446	-2.50429014	2	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	3259	7317	0.002733361	0.003006697	0	2	EN-L4	NA	NA	NA
CACTCCAGTCAACTGT-1_4_A5	14.33281542	-5.013453662	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2054	4459	0.002691186	0.007625028	0	12	EN-MIX	NA	NA	NA
CAGAATCCATACGCTA-1_4_A5	2.025665539	-8.042551224	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1334	2101	0.010471204	0.004283674	0	12	EN-MIX	NA	NA	NA
CAGAATCTCATTATCC-1_4_A5	-9.038384467	-19.68675973	6B	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	698	1064	0.021616541	0	0	6B	IN-SST	NA	NA	NA
CAGAGAGGTTCCATGA-1_4_A5	-0.29680878	-17.76769471	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2541	5055	0.003363007	0.002769535	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CAGATCAGTAGTGAAT-1_4_A5	22.78615316	0.064220666	2	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1984	3409	0.002933412	0.003226753	0	2	EN-L4	NA	NA	NA
CAGATCAGTTCGTTGA-1_4_A5	18.56436774	-7.061484591	3	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1807	3069	0.001629195	0.002606712	0	3	EN-L5-6	NA	NA	NA
CAGATCATCTACTTAC-1_4_A5	8.444575293	-27.76201202	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	4669	12804	0.004842237	0.003592627	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CAGCAGCCAATAACGA-1_4_A5	24.81330813	-2.606939972	2	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2432	5148	0.003108003	0.001942502	0	2	EN-L4	NA	NA	NA
CAGCAGCCACCTCGGA-1_4_A5	-1.366618729	-15.7476809	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2192	3971	0.002518257	0.002014606	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CAGCAGCTCACGGTTA-1_4_A5	4.580379407	31.62286169	1	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	742	1073	0.008387698	0.003727866	0	oligos	OL-Cntl	NA	NA	NA
CAGCAGCTCACTCTTA-1_4_A5	-25.2534335	6.365409461	8	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	634	1083	0.002770083	0.004616805	0	8	Astrocytes	NA	NA	NA
CAGCAGCTCGTACCGG-1_4_A5	-0.205834463	-16.12283074	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2401	4718	0.005298855	0.002967359	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CAGCATAGTATCACCA-1_4_A5	-0.556034455	4.519757742	11	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	853	1275	0.002352941	0.00627451	0	11	Glia-MIX	NA	NA	NA
CAGCATATCATGTCCC-1_4_A5	-3.720193033	-6.274421349	13A	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1018	1589	0.008181246	0.002517306	0	13A	IN-VIP	NA	NA	NA
CAGCATATCGCAAACT-1_4_A5	-20.26714593	-16.67725309	6B	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	3237	7622	0.012988717	0.003542377	0	6B	IN-SST	NA	NA	NA
CAGCCGACATTATCTC-1_4_A5	24.53388853	-25.20053681	3	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2551	5710	0.014185639	0.002101576	0	3	EN-L5-6	NA	NA	NA
CAGCCGAGTATATGGA-1_4_A5	8.235490325	-7.083455082	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1604	2669	0.008242788	0.002997377	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CAGCCGATCGGCGCTA-1_4_A5	-1.342375976	-15.85815674	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2589	5470	0.000548446	0.002193784	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CAGCGACCAAGCCATT-1_4_A5	-12.88145105	-18.16948084	6B	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1288	2483	0.004027386	0.003221909	0	6B	IN-SST	NA	NA	NA
CAGCTAAAGAGCCCAA-1_4_A5	-14.26467137	-24.6826061	6A	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1535	2553	0.014101058	0.002741872	0	6A	IN-PV	NA	NA	NA
CAGCTAAAGGGTTCCC-1_4_A5	-3.326920509	-6.158060864	13A	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	976	1556	0.041131105	0	0	13A	IN-VIP	NA	NA	NA
CAGCTAACACATTTCT-1_4_A5	2.810149075	29.84700386	1	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	746	1100	0.007272727	0.004545455	0	oligos	OL-Cntl	NA	NA	NA
CAGCTAAGTACATGTC-1_4_A5	-5.860990312	-5.205793022	13A	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1219	1995	0.009022556	0.002506266	0	13A	IN-VIP	NA	NA	NA
CAGCTAAGTCACCTAA-1_4_A5	6.742722364	-2.886870084	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1083	1854	0.012405609	0.004854369	0	12	EN-MIX	NA	NA	NA
CAGCTAAGTCTCTCGT-1_4_A5	15.89590989	-0.185924178	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	728	1095	0.00456621	0.001826484	0	12	EN-MIX	NA	NA	NA
CAGCTGGAGGCTATCT-1_4_A5	-4.790438595	-8.436323119	13A	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	770	1246	0.005617978	0.007223114	0	13A	IN-VIP	NA	NA	NA
CAGGTGCCACACGCTG-1_4_A5	-5.044315195	-2.622971935	13A	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1614	2847	0.003161222	0.003863716	0	13A	IN-VIP	NA	NA	NA
CAGTAACCAGCAGTTT-1_4_A5	10.6258096	1.936276929	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	884	1322	0.013615734	0.015128593	0	12	EN-MIX	NA	NA	NA
CAGTAACGTAGTACCT-1_4_A5	-35.20863271	-10.06316405	9	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	914	1388	0.002881844	0.001440922	0	9	OPC	NA	NA	NA
CAGTAACGTTGCCTCT-1_4_A5	-31.19997508	12.18311472	8	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	816	1207	0.006628003	0.001657001	0	8	Astrocytes	NA	NA	NA
CAGTAACTCAACACCA-1_4_A5	2.790665425	-24.97429841	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	4566	11523	0.00147531	0.002777055	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CAGTCCTAGCGAGAAA-1_4_A5	20.75894323	-28.07843259	3	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2747	5834	0.000685636	0.002056908	0	3	EN-L5-6	NA	NA	NA
CAGTCCTCAAGCGAGT-1_4_A5	10.64584953	1.597236675	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	734	1124	0.012455516	0.008896797	0	12	EN-MIX	NA	NA	NA
CAGTCCTTCTTGACGA-1_4_A5	8.387122386	-7.119993149	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1632	2773	0.009015507	0.002884962	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CATATGGAGAGATGAG-1_4_A5	8.592892648	-8.430829935	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2140	4128	0.002664729	0.001937984	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CATATGGAGGATGTAT-1_4_A5	9.788145629	-8.717094962	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2246	4588	0.001961639	0.00087184	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CATATGGCATGCGCAC-1_4_A5	10.02358204	-8.565276712	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2265	4422	0.000904568	0.002487562	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CATATGGGTATCACCA-1_4_A5	-15.23113791	-18.97452803	6B	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1480	2530	0.009090909	0.000790514	0	6B	IN-SST	NA	NA	NA
CATATGGTCAGTTTGG-1_4_A5	-5.164104224	-10.27253013	13B	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	887	1347	0.017074981	0.001484781	0	13B	IN-SV2C	NA	NA	NA
CATATTCAGCAGGTCA-1_4_A5	-0.51774921	4.257878366	11	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	885	1323	0.003779289	0.006802721	0	11	Glia-MIX	NA	NA	NA
CATATTCAGGACAGAA-1_4_A5	8.217301242	-7.175760373	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1653	2742	0.002917578	0.004376368	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CATCAAGAGCTATGCT-1_4_A5	21.54587986	-3.298776568	2	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2198	3839	0.026829904	0.002604845	0	2	EN-L4	NA	NA	NA
CATCAGAAGATCGGGT-1_4_A5	-18.83344443	6.975235399	8	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	823	1286	0.002332815	0.00777605	0	8	Astrocytes	NA	NA	NA
CATCAGAAGGGCTTGA-1_4_A5	-18.03860993	-17.77716456	6B	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2134	4150	0.003373494	0.002891566	0	6B	IN-SST	NA	NA	NA
CATCAGACATAGTAAG-1_4_A5	30.31128272	-3.13690002	2	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	3172	6795	0.007211185	0.002207506	0	2	EN-L4	NA	NA	NA
CATCAGATCTCCAACC-1_4_A5	15.82072448	26.15321211	1	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	772	1126	0.000888099	0.002664298	0	oligos	OL-Cntl	NA	NA	NA
CATCCACAGGAGTACC-1_4_A5	-34.61689844	-11.28510899	9	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	810	1282	0	0.004680187	0	9	OPC	NA	NA	NA
CATCCACAGTGGGTTG-1_4_A5	15.5291904	-2.385633183	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1019	1593	0.026993095	0.001883239	0	12	EN-MIX	NA	NA	NA
CATCCACCACACCGCA-1_4_A5	24.13405209	-0.002832203	2	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2104	4093	0.000488639	0.002198876	0	2	EN-L4	NA	NA	NA
CATCCACCATGCATGT-1_4_A5	2.454127925	-25.22100566	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2936	6382	0.005797556	0.00235036	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CATCGAAAGACATAAC-1_4_A5	13.45403343	-32.47098126	3	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	3547	9027	0.001218567	0.001883239	0	3	EN-L5-6	NA	NA	NA
CATCGAAAGGCAAAGA-1_4_A5	3.57647308	-3.49629529	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	956	1334	0.008245877	0.002248876	0	12	EN-MIX	NA	NA	NA
CATCGAAGTGTGGTTT-1_4_A5	2.791783955	-6.032701943	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1206	1789	0.001117943	0.001117943	0	12	EN-MIX	NA	NA	NA
CATCGAATCCAAAGTC-1_4_A5	20.87335283	-28.56902313	3	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	3631	9011	0.003107313	0.003662191	0	3	EN-L5-6	NA	NA	NA
CATCGGGAGAAGAAGC-1_4_A5	-0.540350244	4.831871028	11	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	749	1006	0.000994036	0.002982107	0	11	Glia-MIX	NA	NA	NA
CATCGGGCATCGATTG-1_4_A5	-8.293901631	-18.10759289	6B	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	719	1015	0.004926108	0.001970443	0	6B	IN-SST	NA	NA	NA
CATGACACACACCGAC-1_4_A5	2.335655319	29.69222148	1	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	789	1115	0.001793722	0.000896861	0	oligos	OL-Cntl	NA	NA	NA
CATGACACACATTAGC-1_4_A5	13.91643183	-1.263623185	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1170	2160	0.005555556	0.006018519	0	12	EN-MIX	NA	NA	NA
CATGACAGTTAAGATG-1_4_A5	-10.00914997	-17.46068486	6B	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	970	1533	0.008480104	0.001956947	0	6B	IN-SST	NA	NA	NA
CATGCCTAGAACAATC-1_4_A5	13.49949125	-31.70756355	3	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	3591	9290	0.000538213	0.002691066	0	3	EN-L5-6	NA	NA	NA
CATGGCGAGTAGCGGT-1_4_A5	10.82445768	-0.136412996	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1156	1816	0.023127753	0.006057269	0	12	EN-MIX	NA	NA	NA
CATGGCGCAGATGGGT-1_4_A5	2.819138295	-6.628193264	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1209	1788	0.000559284	0.003355705	0	12	EN-MIX	NA	NA	NA
CATTATCAGACTAGGC-1_4_A5	-1.423766827	-0.744009862	11	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2060	3841	0.001041395	0.001822442	0	11	Glia-MIX	NA	NA	NA
CATTATCAGAGTACAT-1_4_A5	13.07385964	-31.23704675	3	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	3007	7067	0.003113061	0.002405547	0	3	EN-L5-6	NA	NA	NA
CATTATCGTCCGTGAC-1_4_A5	5.994204021	-5.553738721	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1110	1701	0.008818342	0.001175779	0	12	EN-MIX	NA	NA	NA
CATTCGCAGGACATTA-1_4_A5	11.52513862	1.792673492	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	617	1042	0.000959693	0.007677543	0	12	EN-MIX	NA	NA	NA
CATTCGCTCTGAGTGT-1_4_A5	3.819699734	-28.35894025	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	3098	6403	0.004997657	0.003592066	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CATTCGCTCTTGACGA-1_4_A5	0.445305811	-11.14104407	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1632	2867	0.001395187	0.00209278	0	12	EN-MIX	NA	NA	NA
CCAATCCAGGGTTTCT-1_4_A5	23.76188306	0.353376351	2	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1904	3563	0.000841987	0.003087286	0	2	EN-L4	NA	NA	NA
CCAATCCCACCATGTA-1_4_A5	12.91362178	-1.56789324	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1290	2371	0	0.011809363	0	12	EN-MIX	NA	NA	NA
CCAATCCCACCCAGTG-1_4_A5	-4.291345216	-8.680755428	13A	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	903	1337	0.015706806	0.002991773	0	13A	IN-VIP	NA	NA	NA
CCAATCCCAGATAATG-1_4_A5	-3.646677087	2.365085256	11	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2611	5304	0.001131222	0.003205128	0	11	Glia-MIX	NA	NA	NA
CCAATCCGTCTGCCAG-1_4_A5	-9.940933784	11.83747756	11	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	840	1390	0.005035971	0.007194245	0	11	Glia-MIX	NA	NA	NA
CCAATCCTCCCATTAT-1_4_A5	21.1489452	-0.189035123	2	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1719	3218	0.002486016	0.004039776	0	2	EN-L4	NA	NA	NA
CCACCTAAGAAAGTGG-1_4_A5	-4.100476902	3.024909984	11	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2943	5543	0.007577124	0.006855493	0	11	Glia-MIX	NA	NA	NA
CCACCTAAGAGACTTA-1_4_A5	14.60572719	1.161407877	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1001	1625	0.011692308	0.003076923	0	12	EN-MIX	NA	NA	NA
CCACCTAAGATACACA-1_4_A5	20.99918827	0.765362701	2	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1630	2737	0.000365364	0.004018999	0	2	EN-L4	NA	NA	NA
CCACCTATCCTATTCA-1_4_A5	1.316447931	-9.832217894	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1426	2356	0.00466893	0.001697793	0	12	EN-MIX	NA	NA	NA
CCACGGACAATCGGTT-1_4_A5	-28.06727759	17.24643428	8	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	977	1635	0.005504587	0.001834862	0	8	Astrocytes	NA	NA	NA
CCACGGATCACGCGGT-1_4_A5	23.98140266	-29.92569587	3	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	4235	12820	0.000468019	0.002652106	0	3	EN-L5-6	NA	NA	NA
CCACGGATCAGGTAAA-1_4_A5	3.562686248	-28.85868183	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	3230	7324	0.004505735	0.001501912	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CCACGGATCGGTGTTA-1_4_A5	12.15028863	0.510719843	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	936	1412	0.01203966	0.019830028	0	12	EN-MIX	NA	NA	NA
CCACTACCAACAACCT-1_4_A5	-0.756200561	-13.85217968	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2073	3973	0.003020388	0.004027183	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CCACTACGTCTAAACC-1_4_A5	-9.358450684	13.71685425	11	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1361	2291	0.004364906	0.004801397	0	11	Glia-MIX	NA	NA	NA
CCAGCGATCAGTGCAT-1_4_A5	17.05907655	23.15643115	1	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	930	1492	0.004691689	0.006032172	0	oligos	OL-Cntl	NA	NA	NA
CCATGTCAGCACGCCT-1_4_A5	11.35629521	-8.609220078	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2605	5350	0.008411215	0.00317757	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CCATGTCAGTGGTCCC-1_4_A5	25.05120717	-0.35605669	2	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2538	5067	0.003552398	0.001776199	0	2	EN-L4	NA	NA	NA
CCATGTCGTCAACTGT-1_4_A5	16.4867911	-6.858017843	3	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2026	3935	0.005082592	0.001778907	0	3	EN-L5-6	NA	NA	NA
CCATGTCGTGCGATAG-1_4_A5	-1.033865888	3.445305312	11	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1200	1869	0.002675227	0.003745318	0	11	Glia-MIX	NA	NA	NA
CCATTCGGTATTAGCC-1_4_A5	-3.614831033	-6.665725582	13A	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	972	1478	0.01962111	0.00270636	0	13A	IN-VIP	NA	NA	NA
CCATTCGGTCAAACTC-1_4_A5	22.65523637	-0.045366193	2	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2135	4181	0.001674241	0.003587658	0	2	EN-L4	NA	NA	NA
CCATTCGGTGTATGGG-1_4_A5	-2.79049311	2.375799221	11	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1883	3069	0.004561746	0.006190942	0	11	Glia-MIX	NA	NA	NA
CCCAATCCACGAGGTA-1_4_A5	-11.76034212	14.12432713	11	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1118	1627	0.002458513	0.000614628	0	11	Glia-MIX	NA	NA	NA
CCCAATCGTGTTCTTT-1_4_A5	-0.047134234	29.47519351	1	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	817	1119	0.00178731	0.008042895	0	oligos	OL-Cntl	NA	NA	NA
CCCAATCTCCAAGTAC-1_4_A5	2.506145633	30.27377034	1	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	776	1103	0	0.00543971	0	oligos	OL-Cntl	NA	NA	NA
CCCAGTTGTCAAGCGA-1_4_A5	21.86606183	0.905662515	2	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1803	3075	0.003577236	0.002276423	0	2	EN-L4	NA	NA	NA
CCCAGTTGTTTCGCTC-1_4_A5	25.11672539	-29.37370233	3	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	3461	8523	0.001055966	0.002581251	0	3	EN-L5-6	NA	NA	NA
CCCATACAGACTAGAT-1_4_A5	-0.979907566	3.606191529	11	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1154	1741	0.003446295	0.005743825	0	11	Glia-MIX	NA	NA	NA
CCCATACAGCAACGGT-1_4_A5	-1.293823098	3.168006848	11	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1337	2120	0.001886792	0.002830189	0	11	Glia-MIX	NA	NA	NA
CCCATACAGTCCCACG-1_4_A5	0.871716507	30.59842641	1	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	905	1322	0.00075643	0.006807867	0	oligos	OL-Cntl	NA	NA	NA
CCCATACCAGATTGCT-1_4_A5	22.43099405	-8.810323549	3	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2339	4446	0.000899685	0.001574449	0	3	EN-L5-6	NA	NA	NA
CCCATACGTTTCGCTC-1_4_A5	17.01158713	29.9657376	1	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	864	1241	0.002417405	0.005640612	0	oligos	OL-Cntl	NA	NA	NA
CCCTCCTGTTGCTCCT-1_4_A5	12.17695472	29.88637551	1	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	766	1141	0.002629273	0.002629273	0	oligos	OL-Cntl	NA	NA	NA
CCGGGATCAAGTCTGT-1_4_A5	14.97170909	27.83226605	1	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	765	1139	0.001755926	0.000877963	0	oligos	OL-Cntl	NA	NA	NA
CCGGGATCATATGCTG-1_4_A5	-14.83379956	-10.77236869	13B	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2250	4374	0.003200732	0.003657979	0	13B	IN-SV2C	NA	NA	NA
CCGGGATGTGTGGCTC-1_4_A5	19.15379786	1.025499073	2	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1331	2052	0.011695906	0.007797271	0	2	EN-L4	NA	NA	NA
CCGGTAGCATGCCACG-1_4_A5	25.01422313	-3.806392395	2	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	3406	8251	0.001575567	0.002181554	0	2	EN-L4	NA	NA	NA
CCGGTAGGTGAGTGAC-1_4_A5	-12.00137218	13.66401854	11	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	812	1275	0.011764706	0.000784314	0	11	Glia-MIX	NA	NA	NA
CCGGTAGTCAAGCCTA-1_4_A5	-8.88700809	14.36498288	1	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1739	3187	0.003765297	0.004079071	0	oligos	OL-Cntl	NA	NA	NA
CCGGTAGTCAGGCGAA-1_4_A5	-0.559843354	4.798948403	11	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	810	1118	0.009838998	0.008050089	0	11	Glia-MIX	NA	NA	NA
CCGGTAGTCTGGCGAC-1_4_A5	-0.671441509	-0.458235834	11	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1266	1931	0.019678923	0.002071466	0	11	Glia-MIX	NA	NA	NA
CCGTACTAGAATTCCC-1_4_A5	7.436732474	-32.59373955	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	4160	11589	0.004918457	0.002502373	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CCGTACTGTTTGACAC-1_4_A5	11.80416336	3.27611995	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1551	2656	0.004894578	0.003012048	0	12	EN-MIX	NA	NA	NA
CCGTGGAAGTTAGGTA-1_4_A5	-4.098283842	-6.515140451	13A	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1111	1625	0.004923077	0.004923077	0	13A	IN-VIP	NA	NA	NA
CCGTGGACAGGCTCAC-1_4_A5	12.15705862	0.462403337	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	918	1345	0.012639405	0.024535316	0	12	EN-MIX	NA	NA	NA
CCGTGGATCTGCCAGG-1_4_A5	-19.25278706	-26.16061441	6A	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2409	4956	0.004640839	0.003026634	0	6A	IN-PV	NA	NA	NA
CCGTTCAAGACAGGCT-1_4_A5	-9.122845133	-5.273737759	13A	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1658	2879	0.012504342	0.005557485	0	13A	IN-VIP	NA	NA	NA
CCGTTCAAGACCCACC-1_4_A5	1.967847011	-6.423058738	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1234	1989	0.005530417	0.001508296	0	12	EN-MIX	NA	NA	NA
CCGTTCACAATACGCT-1_4_A5	-0.61106468	4.18374781	11	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	875	1390	0.001438849	0.002877698	0	11	Glia-MIX	NA	NA	NA
CCGTTCATCGGAGGTA-1_4_A5	9.238693912	-7.249858015	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1810	3283	0.004264392	0.001827597	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CCGTTCATCTACTCAT-1_4_A5	-0.525130658	4.235063396	11	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	915	1396	0.00286533	0.001432665	0	11	Glia-MIX	NA	NA	NA
CCTAAAGCACTGCCAG-1_4_A5	-36.41261315	-7.976600081	9	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1101	1778	0.001124859	0.003374578	0	9	OPC	NA	NA	NA
CCTACACTCGCCCTTA-1_4_A5	1.201241882	-10.4287735	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1739	3110	0.00096463	0.003858521	0	12	EN-MIX	NA	NA	NA
CCTACCAAGGCCATAG-1_4_A5	3.795598651	-29.72132871	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	3419	8721	0.002751978	0.001490655	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CCTACCACAATGACCT-1_4_A5	4.370751812	-32.61452917	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	4904	15809	0.001328357	0.002656715	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CCTACCACATTCACTT-1_4_A5	-0.835107634	3.346862433	11	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1153	1919	0.000521105	0.002605524	0	11	Glia-MIX	NA	NA	NA
CCTACCATCTAGCACA-1_4_A5	-34.8289771	-12.45295327	9	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	731	1097	0.002734731	0.001823154	0	9	OPC	NA	NA	NA
CCTAGCTCACAAGTAA-1_4_A5	22.74244066	-6.812745754	3	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2841	5880	0.006972789	0.00255102	0	3	EN-L5-6	NA	NA	NA
CCTAGCTGTGCTCTTC-1_4_A5	10.68153965	-34.19949334	3	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	6518	24293	0.000164656	0.001646565	0	3	EN-L5-6	NA	NA	NA
CCTAGCTGTTCCCTTG-1_4_A5	-4.702722302	-9.172274289	13A	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	713	1117	0.009847807	0.000895255	0	13A	IN-VIP	NA	NA	NA
CCTATTAGTGGTTTCA-1_4_A5	-0.342487486	-15.02769842	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2292	4542	0.002862175	0.001981506	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CCTATTATCATGCAAC-1_4_A5	18.40638358	1.666567633	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1056	1577	0.001902346	0	0	12	EN-MIX	NA	NA	NA
CCTCAGTGTCACCTAA-1_4_A5	23.10257745	0.438138821	2	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1951	3398	0.006474397	0.002060035	0	2	EN-L4	NA	NA	NA
CCTCAGTTCCGCAAGC-1_4_A5	8.292370099	-7.274797534	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1679	2910	0.006185567	0.001718213	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CCTCTGACACACCGCA-1_4_A5	-0.559874522	4.323164767	11	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	833	1231	0.001624695	0.003249391	0	11	Glia-MIX	NA	NA	NA
CCTCTGACAGTCAGAG-1_4_A5	-13.33721693	-19.09623662	6B	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1192	1951	0.019989749	0.003587904	0	6B	IN-SST	NA	NA	NA
CCTCTGACATGAGCGA-1_4_A5	9.346586995	-3.868215713	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2200	3926	0.044574631	0.007641365	0	12	EN-MIX	NA	NA	NA
CCTCTGATCCAGGGCT-1_4_A5	13.73734719	-31.16733136	3	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2775	5918	0.007772896	0.002703616	0	3	EN-L5-6	NA	NA	NA
CCTTACGAGAGCTGCA-1_4_A5	13.14488479	27.76445619	1	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	816	1164	0.014604811	0.001718213	0	oligos	OL-Cntl	NA	NA	NA
CCTTACGAGCGATCCC-1_4_A5	5.990503533	-5.641409182	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1121	1763	0.00453772	0.000567215	0	12	EN-MIX	NA	NA	NA
CCTTACGTCGGAAACG-1_4_A5	2.434482016	-7.953320258	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1336	2054	0.004868549	0.00292113	0	12	EN-MIX	NA	NA	NA
CCTTACGTCGTAGATC-1_4_A5	1.996776769	-8.362038545	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1437	2346	0.003836317	0.00170503	0	12	EN-MIX	NA	NA	NA
CCTTCCCCACAGAGGT-1_4_A5	26.02184804	-2.633509588	2	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	3422	8077	0.001733317	0.00222855	0	2	EN-L4	NA	NA	NA
CCTTCCCCAGGAATCG-1_4_A5	13.60788316	-30.53473086	3	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2887	6312	0.001742712	0.002376426	0	3	EN-L5-6	NA	NA	NA
CCTTCCCCATGCATGT-1_4_A5	29.93810631	-1.819622371	2	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	3763	8554	0.00935235	0.002688801	0	2	EN-L4	NA	NA	NA
CCTTCCCGTGATGATA-1_4_A5	24.91318849	-3.860783546	2	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	3492	8426	0.001542844	0.002610966	0	2	EN-L4	NA	NA	NA
CCTTCGACAGATCCAT-1_4_A5	2.045474541	-7.868370821	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1281	2039	0.004413928	0.003923492	0	12	EN-MIX	NA	NA	NA
CCTTCGAGTTGTACAC-1_4_A5	0.635797056	-11.31644398	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1880	3279	0.003354681	0.003354681	0	12	EN-MIX	NA	NA	NA
CCTTCGATCCGATATG-1_4_A5	11.08136566	-8.740220553	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2624	5518	0.004168177	0.001268576	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CCTTCGATCGTTTGCC-1_4_A5	1.085050411	-10.46880138	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1630	2880	0.003819444	0.002083333	0	12	EN-MIX	NA	NA	NA
CCTTTCTAGAGTCTGG-1_4_A5	20.76435237	-28.88604599	3	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	3570	8619	0.003712728	0.005569092	0	3	EN-L5-6	NA	NA	NA
CCTTTCTCAGGTGGAT-1_4_A5	-2.924409961	2.34632259	11	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2123	3908	0.002047083	0.005117707	0	11	Glia-MIX	NA	NA	NA
CCTTTCTGTCCCGACA-1_4_A5	-11.60263931	-19.11873565	6B	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1000	1619	0	0.003705991	0	6B	IN-SST	NA	NA	NA
CCTTTCTGTGCAACGA-1_4_A5	-33.43242821	-12.26666454	9	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	783	1073	0.005591799	0.001863933	0	9	OPC	NA	NA	NA
CGAACATGTGCCTTGG-1_4_A5	-9.602158519	-17.68794619	6B	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	885	1323	0.007558579	0.003023432	0	6B	IN-SST	NA	NA	NA
CGAACATTCCCAGGTG-1_4_A5	-16.24125959	-25.77613958	6A	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2022	3822	0.001831502	0.001831502	0	6A	IN-PV	NA	NA	NA
CGAACATTCTTCCTTC-1_4_A5	13.24923632	-2.976277737	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1243	2117	0.003778932	0.007085498	0	12	EN-MIX	NA	NA	NA
CGAATGTTCTACCAGA-1_4_A5	24.06821491	0.012429687	2	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2083	3871	0.003874968	0.001291656	0	2	EN-L4	NA	NA	NA
CGACCTTGTGTTGAGG-1_4_A5	-3.074352814	2.400329123	11	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2258	3946	0.006588951	0.003801318	0	11	Glia-MIX	NA	NA	NA
CGACTTCAGAACTCGG-1_4_A5	3.115739048	-25.99302113	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2692	5505	0.003269755	0.002543143	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGACTTCAGCGATAGC-1_4_A5	4.378654218	-4.320266777	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1073	1885	0.000530504	0.00795756	0	12	EN-MIX	NA	NA	NA
CGACTTCAGGGATGGG-1_4_A5	-38.31898261	-4.247166616	9	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1282	2106	0.007122507	0.00379867	0	9	OPC	NA	NA	NA
CGACTTCCAACGCACC-1_4_A5	-32.30107922	-12.23308245	9	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	879	1280	0.00234375	0.00390625	0	9	OPC	NA	NA	NA
CGACTTCCAAGGACTG-1_4_A5	4.68441642	-2.002583655	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	743	1037	0.010607522	0.008678881	0	12	EN-MIX	NA	NA	NA
CGACTTCCACATCCGG-1_4_A5	0.200418144	0.016081762	11	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	745	1073	0.003727866	0.002795899	0	11	Glia-MIX	NA	NA	NA
CGAGAAGCAACAACCT-1_4_A5	18.02343819	-5.518457396	3	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1340	2340	0.00982906	0.002564103	0	3	EN-L5-6	NA	NA	NA
CGAGAAGGTGCCTGCA-1_4_A5	18.74006126	1.417073869	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1221	1800	0.005555556	0.001666667	0	12	EN-MIX	NA	NA	NA
CGAGCACAGGACAGAA-1_4_A5	-0.90057248	3.770161095	11	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1159	1773	0.001692047	0.003384095	0	11	Glia-MIX	NA	NA	NA
CGAGCACGTAAACACA-1_4_A5	4.470497043	32.72430883	1	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	703	1015	0.00591133	0.003940887	0	oligos	OL-Cntl	NA	NA	NA
CGAGCACGTAGCTCCG-1_4_A5	21.70900869	-28.9943405	3	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	3989	10012	0.008290052	0.003895326	0	3	EN-L5-6	NA	NA	NA
CGAGCACTCAAACCGT-1_4_A5	1.902194805	30.81114166	1	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	778	1048	0.011450382	0.004770992	0	oligos	OL-Cntl	NA	NA	NA
CGAGCACTCAACGCTA-1_4_A5	21.52925474	-8.311539911	3	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1653	2755	0.00508167	0.001814882	0	3	EN-L5-6	NA	NA	NA
CGAGCACTCTTGTATC-1_4_A5	3.622566526	-28.87085268	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	3535	8043	0.007832898	0.001989307	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGAGCCAAGTGAAGAG-1_4_A5	4.013310863	-3.199694023	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	870	1227	0.005704971	0.001629992	0	12	EN-MIX	NA	NA	NA
CGAGCCAGTAGGGTAC-1_4_A5	-15.24148626	-24.09472134	6A	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1700	2982	0.025821596	0.002012072	0	6A	IN-PV	NA	NA	NA
CGAGCCAGTGAAATCA-1_4_A5	-4.95809247	-10.46239688	13B	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	702	1042	0.00671785	0.001919386	0	13B	IN-SV2C	NA	NA	NA
CGAGCCATCCCATTAT-1_4_A5	-0.32795366	-13.60564568	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1975	3701	0.004052959	0.003512564	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGAGCCATCTGTCCGT-1_4_A5	1.039264787	33.66545209	1	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	832	1214	0.001647446	0.004118616	0	oligos	OL-Cntl	NA	NA	NA
CGATCGGGTAGGCTGA-1_4_A5	21.04521557	-27.82165981	3	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	3466	8295	0.0039783	0.005424955	0	3	EN-L5-6	NA	NA	NA
CGATTGAAGGCGATAC-1_4_A5	22.01378467	1.003609037	2	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1745	3208	0.002805486	0.002182045	0	2	EN-L4	NA	NA	NA
CGATTGACAGTCGTGC-1_4_A5	-3.760110037	2.919449874	11	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2911	5364	0.006338553	0.006338553	0	11	Glia-MIX	NA	NA	NA
CGATTGAGTGCCTGGT-1_4_A5	-35.24862033	-9.445855587	9	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	949	1439	0.002779708	0.003474635	0	9	OPC	NA	NA	NA
CGCCAAGCACGCATCG-1_4_A5	19.05019073	-7.38362626	3	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2143	3903	0.008455035	0.003330771	0	3	EN-L5-6	NA	NA	NA
CGCCAAGGTTCTGTTT-1_4_A5	-17.78923879	-25.08062924	6A	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2682	5919	0.004054739	0.000844737	0	6A	IN-PV	NA	NA	NA
CGCCAAGTCAGCATGT-1_4_A5	14.52560054	1.712346912	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	882	1258	0.003974563	0.00317965	0	12	EN-MIX	NA	NA	NA
CGCGGTATCAACACAC-1_4_A5	-11.97386064	13.70700867	11	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	794	1137	0.001759015	0.005277045	0	11	Glia-MIX	NA	NA	NA
CGCGGTATCACCGTAA-1_4_A5	1.216985059	-9.855541799	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1456	2350	0.003829787	0.001276596	0	12	EN-MIX	NA	NA	NA
CGCGTTTAGCTGAACG-1_4_A5	-4.950794444	-4.208872561	13A	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1304	2267	0.011910013	0.003087781	0	13A	IN-VIP	NA	NA	NA
CGCGTTTCAGGTGGAT-1_4_A5	25.01876829	-28.0393843	3	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	3433	7747	0.005937782	0.002452562	0	3	EN-L5-6	NA	NA	NA
CGCGTTTGTTCTGTTT-1_4_A5	1.92909783	-27.91115589	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	3764	9246	0.005840363	0.002487562	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGCTATCAGGATGCGT-1_4_A5	-0.523060419	4.634210978	11	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	815	1211	0	0.004954583	0	11	Glia-MIX	NA	NA	NA
CGCTATCCAATGGAAT-1_4_A5	25.69625562	-5.049440488	2	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	4221	11049	0.002262648	0.002534166	0	2	EN-L4	NA	NA	NA
CGCTATCCAGTACACT-1_4_A5	3.993133485	32.4062483	1	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	739	1002	0.002994012	0.000998004	0	oligos	OL-Cntl	NA	NA	NA
CGCTATCGTGTAATGA-1_4_A5	1.657583722	24.42909812	1	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	792	1085	0.001843318	0.003686636	0	oligos	OL-Cntl	NA	NA	NA
CGCTGGAAGCGCCTTG-1_4_A5	-17.57860431	-21.18751766	6A	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1925	3196	0.00563204	0.005319149	0	6A	IN-PV	NA	NA	NA
CGCTGGACACAGGTTT-1_4_A5	6.196534546	-32.08992951	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	4853	14550	0.012920962	0.001993127	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGCTGGACAGACAGGT-1_4_A5	-10.42116966	12.572945	11	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	798	1046	0.002868069	0.000956023	0	11	Glia-MIX	NA	NA	NA
CGCTGGAGTAGCGATG-1_4_A5	-1.878508074	2.738060701	11	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1528	2327	0.006446068	0.005586592	0	11	Glia-MIX	NA	NA	NA
CGCTTCAAGATGTAAC-1_4_A5	-3.394154056	-6.131472988	13A	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1042	1679	0.010720667	0.003573556	0	13A	IN-VIP	NA	NA	NA
CGCTTCAAGTGTACTC-1_4_A5	3.225861984	-26.0997962	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2559	5129	0.006239033	0.001754728	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGCTTCACAATCACAC-1_4_A5	-1.992430414	-15.12700651	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2240	4720	0.006991525	0.002118644	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGCTTCACACCTTGTC-1_4_A5	-11.9713947	-10.89290821	13B	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1407	2604	0.000768049	0.003072197	0	13B	IN-SV2C	NA	NA	NA
CGGACACTCACTCCTG-1_4_A5	-3.632332829	2.539031455	11	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2486	4543	0.000880475	0.00572309	0	11	Glia-MIX	NA	NA	NA
CGGACACTCGGCGGTT-1_4_A5	-1.175784589	3.383934496	11	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1303	2003	0.003494758	0.004992511	0	11	Glia-MIX	NA	NA	NA
CGGACACTCGTGACAT-1_4_A5	-19.55619231	-26.17621425	6A	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2418	4881	0.01761934	0.003073141	0	6A	IN-PV	NA	NA	NA
CGGACACTCGTTGCCT-1_4_A5	-0.304384475	-11.5455614	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1788	3394	0.005008839	0.002062463	0	12	EN-MIX	NA	NA	NA
CGGACGTAGATCTGAA-1_4_A5	21.31332929	-8.121747636	3	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1481	2518	0.004368546	0.002382844	0	3	EN-L5-6	NA	NA	NA
CGGACGTCACGGATAG-1_4_A5	2.110292415	31.00618181	1	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	800	1097	0.00911577	0.004557885	0	oligos	OL-Cntl	NA	NA	NA
CGGACGTCATTACCTT-1_4_A5	-20.36724224	-26.7427058	6A	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2875	6259	0.014379294	0.003035629	0	6A	IN-PV	NA	NA	NA
CGGACTGAGGTTACCT-1_4_A5	-3.841903087	-4.761104297	13A	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1111	1711	0.004675628	0.000584454	0	13A	IN-VIP	NA	NA	NA
CGGACTGCAGCTGTGC-1_4_A5	21.79425728	0.360574094	2	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1773	3199	0.009377931	0	0	2	EN-L4	NA	NA	NA
CGGAGTCAGTCAATAG-1_4_A5	0.002026632	-15.37237903	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2473	4590	0.004139434	0.002178649	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGGAGTCGTTAAAGTG-1_4_A5	-36.86863813	-8.174855222	9	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1040	1679	0.000595593	0.002977963	0	9	OPC	NA	NA	NA
CGGAGTCGTTACGGAG-1_4_A5	4.943496032	-31.14233948	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	3405	8181	0.001833517	0.002077986	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGGAGTCTCAACACGT-1_4_A5	0.243619675	-13.10623574	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1889	3298	0.006064281	0.004851425	0	12	EN-MIX	NA	NA	NA
CGGAGTCTCTCAACTT-1_4_A5	1.088522492	-10.38709938	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1579	2503	0.002397123	0.003595685	0	12	EN-MIX	NA	NA	NA
CGGCTAGGTATAATGG-1_4_A5	-3.053963615	2.339653078	11	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2081	3607	0.004158581	0.007762684	0	11	Glia-MIX	NA	NA	NA
CGGCTAGGTTGTTTGG-1_4_A5	-15.5393162	-25.15056806	6A	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1740	3190	0.008777429	0.002194357	0	6A	IN-PV	NA	NA	NA
CGGGTCAGTCTGCGGT-1_4_A5	2.996870902	-6.098065891	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1160	1721	0.006391633	0.001743173	0	12	EN-MIX	NA	NA	NA
CGGTTAAAGCTAGTCT-1_4_A5	24.55074838	-25.05700157	3	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2972	6478	0.002469898	0.002315529	0	3	EN-L5-6	NA	NA	NA
CGGTTAAAGGGAGTAA-1_4_A5	16.95690285	1.409372689	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	912	1383	0.003615329	0.001446132	0	12	EN-MIX	NA	NA	NA
CGGTTAAGTGCATCTA-1_4_A5	-0.629082665	4.329089599	11	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	984	1440	0.005555556	0.005555556	0	11	Glia-MIX	NA	NA	NA
CGGTTAAGTGTGTGCC-1_4_A5	21.17164065	-0.218746057	2	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1694	2620	0.007251908	0.004961832	0	2	EN-L4	NA	NA	NA
CGGTTAAGTTAGAACA-1_4_A5	15.7469753	-6.149920628	3	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1490	2509	0.006377043	0.001594261	0	3	EN-L5-6	NA	NA	NA
CGTAGCGCAAGGTGTG-1_4_A5	-26.3607653	16.52806114	8	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1131	1813	0.003861004	0.001103144	0	8	Astrocytes	NA	NA	NA
CGTAGCGCACATCCGG-1_4_A5	-18.40717773	6.362644717	8	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	627	1015	0.001970443	0.002955665	0	8	Astrocytes	NA	NA	NA
CGTAGCGTCCCTTGTG-1_4_A5	8.690885127	-7.749100634	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1917	3500	0.008285714	0	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGTAGGCAGGACTGGT-1_4_A5	-4.003115985	-8.650633569	13A	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	931	1389	0.010799136	0	0	13A	IN-VIP	NA	NA	NA
CGTAGGCGTTATGCGT-1_4_A5	-31.56916108	12.01587151	8	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	795	1134	0.000881834	0.000881834	0	8	Astrocytes	NA	NA	NA
CGTAGGCTCCTCATTA-1_4_A5	4.34247013	-3.852514672	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1169	2124	0.005178908	0.005649718	0	12	EN-MIX	NA	NA	NA
CGTCACTCAAGAAAGG-1_4_A5	20.67252508	-28.3630454	3	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	3526	8255	0.0037553	0.003634161	0	3	EN-L5-6	NA	NA	NA
CGTCACTCAGTAACGG-1_4_A5	-28.68438039	11.48636231	8	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	675	1110	0.010810811	0.003603604	0	8	Astrocytes	NA	NA	NA
CGTCACTGTCTAGTCA-1_4_A5	4.1808263	-10.23909921	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1839	3197	0.003440726	0.008445418	0	12	EN-MIX	NA	NA	NA
CGTCACTGTCTCGTTC-1_4_A5	-4.117620319	-7.591600769	13A	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1061	1669	0.011983223	0.002995806	0	13A	IN-VIP	NA	NA	NA
CGTCACTTCAGGTAAA-1_4_A5	13.09960518	-31.97420772	3	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2677	5758	0.0024314	0.001563043	0	3	EN-L5-6	NA	NA	NA
CGTCAGGAGTAGATGT-1_4_A5	3.574424549	29.2313232	1	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	819	1161	0.006029285	0.006029285	0	oligos	OL-Cntl	NA	NA	NA
CGTCAGGCATCATCCC-1_4_A5	-0.482761207	-14.63870741	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2277	4438	0.002929247	0.005633168	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGTCAGGTCTACTTAC-1_4_A5	11.28093756	-8.701334074	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2841	6176	0.004047927	0.001943005	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGTCTACAGATTACCC-1_4_A5	4.005423255	-2.409479949	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	884	1389	0.005039597	0.008639309	0	12	EN-MIX	NA	NA	NA
CGTCTACCAATGGAGC-1_4_A5	1.791553703	-10.52081851	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1673	2754	0.004357298	0.002178649	0	12	EN-MIX	NA	NA	NA
CGTCTACCACCGAATT-1_4_A5	22.61846042	0.862736328	2	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1941	3450	0.006376812	0.002898551	0	2	EN-L4	NA	NA	NA
CGTCTACTCCGCGGTA-1_4_A5	17.09002845	-4.350285323	3	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1522	2591	0.001543805	0.005017368	0	3	EN-L5-6	NA	NA	NA
CGTGAGCGTGCAACGA-1_4_A5	21.60892365	1.053841547	2	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1575	2701	0.011477231	0.001851166	0	2	EN-L4	NA	NA	NA
CGTGAGCTCTGCTGTC-1_4_A5	-0.227182201	-12.36398859	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1964	3551	0.002816108	0.002816108	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGTGTAAGTTATCACG-1_4_A5	-8.134952105	-2.043340244	13A	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1958	3794	0.020558777	0.002635741	0	13A	IN-VIP	NA	NA	NA
CGTGTCTAGTATTGGA-1_4_A5	-3.367706696	2.553075221	11	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2562	4624	0.006487889	0.006920415	0	11	Glia-MIX	NA	NA	NA
CGTTAGACATAACCTG-1_4_A5	14.15940747	-1.14159432	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	929	1584	0.000631313	0.005681818	0	12	EN-MIX	NA	NA	NA
CGTTCTGAGAATAGGG-1_4_A5	24.69787348	-28.02717752	3	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2618	5611	0.002851542	0.003742648	0	3	EN-L5-6	NA	NA	NA
CGTTCTGGTCTTGTCC-1_4_A5	0.466055017	-11.39093502	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1700	2981	0.007044616	0.002683663	0	12	EN-MIX	NA	NA	NA
CGTTCTGGTTCGTGAT-1_4_A5	-35.73644108	-8.971229239	9	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	960	1460	0.000684932	0.003424658	0	9	OPC	NA	NA	NA
CGTTGGGAGAGTAAGG-1_4_A5	-0.542205538	4.745699518	11	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	783	1188	0.004208754	0.005050505	0	11	Glia-MIX	NA	NA	NA
CGTTGGGCACCTATCC-1_4_A5	-11.61210688	-22.16263779	6A	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1015	1657	0.006638503	0.004828002	0	6A	IN-PV	NA	NA	NA
CTAAGACAGGTGATAT-1_4_A5	-22.87177264	-1.487034219	9	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	927	1303	0.001534919	0.001534919	0	9	OPC	NA	NA	NA
CTAAGACCATCACGAT-1_4_A5	6.81973578	-6.089799988	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1271	2115	0.007092199	0.001891253	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTAAGACGTAAGTAGT-1_4_A5	17.44847903	-0.086215823	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	961	1399	0.014295926	0	0	12	EN-MIX	NA	NA	NA
CTAATGGTCTCACATT-1_4_A5	-0.364971488	-16.8152179	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2306	4417	0.008376726	0.00226398	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTACACCAGGAATCGC-1_4_A5	8.137124739	31.97000685	1	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	799	1206	0.002487562	0.004975124	0	oligos	OL-Cntl	NA	NA	NA
CTACACCAGTTGAGTA-1_4_A5	0.125012422	-11.57354035	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1783	3057	0.000981354	0.003271181	0	12	EN-MIX	NA	NA	NA
CTACACCTCCACTCCA-1_4_A5	10.16679208	30.49690212	1	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	811	1219	0.004101723	0.005742412	0	oligos	OL-Cntl	NA	NA	NA
CTACCCAAGGCAAAGA-1_4_A5	24.91464664	-1.373207656	2	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2487	5273	0.000379291	0.002086099	0	2	EN-L4	NA	NA	NA
CTACCCAGTGACGCCT-1_4_A5	-36.90770315	-6.709323132	9	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1195	1963	0.001018849	0.00356597	0	9	OPC	NA	NA	NA
CTACCCAGTGCAACGA-1_4_A5	22.91383308	-9.163372709	3	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2987	6569	0.007459278	0.001978992	0	3	EN-L5-6	NA	NA	NA
CTACGTCCAATAGAGT-1_4_A5	18.74538534	1.611140825	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1192	1909	0	0.004190676	0	12	EN-MIX	NA	NA	NA
CTACGTCGTAATAGCA-1_4_A5	-7.821970354	-2.382780468	13A	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1962	3452	0.00608343	0.003186559	0	13A	IN-VIP	NA	NA	NA
CTACGTCTCTAACTGG-1_4_A5	-0.910025358	3.703950331	11	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1054	1608	0.001865672	0.002487562	0	11	Glia-MIX	NA	NA	NA
CTAGCCTAGGCTCATT-1_4_A5	0.862277517	0.196808672	11	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	853	1229	0.005695688	0.004068348	0	11	Glia-MIX	NA	NA	NA
CTAGCCTCAAACGCGA-1_4_A5	-12.78466079	14.51935848	11	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	741	1043	0.002876318	0.000958773	0	11	Glia-MIX	NA	NA	NA
CTAGCCTCACTCGACG-1_4_A5	-12.97352972	14.72079537	11	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	872	1181	0.00084674	0.0042337	0	11	Glia-MIX	NA	NA	NA
CTAGCCTCACTTAAGC-1_4_A5	12.69774289	32.05889319	1	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	739	1052	0.001901141	0.005703422	0	oligos	OL-Cntl	NA	NA	NA
CTAGCCTGTTATGTGC-1_4_A5	-24.23591474	-1.722602424	9	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1467	2786	0.001794688	0.003948313	0	9	OPC	NA	NA	NA
CTAGCCTTCCTATTCA-1_4_A5	12.35890008	31.63459217	1	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	703	1020	0.000980392	0.003921569	0	oligos	OL-Cntl	NA	NA	NA
CTAGTGAAGCACAGGT-1_4_A5	2.980244966	-6.027225303	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1156	1769	0.005652911	0.003957038	0	12	EN-MIX	NA	NA	NA
CTAGTGAAGCTATGCT-1_4_A5	19.02509745	1.622619175	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1194	1991	0.039176293	0.002511301	0	12	EN-MIX	NA	NA	NA
CTCACACAGGCTCATT-1_4_A5	-1.616907429	-17.47492197	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2617	5643	0.001772107	0.002126528	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTCACACGTCTGGAGA-1_4_A5	5.062457919	-1.931475649	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	790	1181	0.012701101	0.00254022	0	12	EN-MIX	NA	NA	NA
CTCACACGTGCCTGCA-1_4_A5	-36.0315119	-7.666577869	9	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1069	1737	0	0.002878526	0	9	OPC	NA	NA	NA
CTCACACGTTGTGGCC-1_4_A5	-0.514011725	4.744322903	11	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	709	1007	0.004965243	0.005958292	0	11	Glia-MIX	NA	NA	NA
CTCACACTCCGTACAA-1_4_A5	-34.99597023	-10.29621637	9	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	902	1321	0	0.000757002	0	9	OPC	NA	NA	NA
CTCACACTCTGCGTAA-1_4_A5	2.251175946	30.42761864	1	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	778	1091	0.00091659	0.006416132	0	oligos	OL-Cntl	NA	NA	NA
CTCAGAAGTAGCCTCG-1_4_A5	-0.290765301	4.823550922	11	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	795	1077	0.005571031	0.005571031	0	11	Glia-MIX	NA	NA	NA
CTCAGAATCACATACG-1_4_A5	15.07110412	30.42996109	1	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	771	1156	0	0.002595156	0	oligos	OL-Cntl	NA	NA	NA
CTCATTAGTAAGCACG-1_4_A5	-35.34881975	-9.810873402	9	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	968	1502	0.003994674	0.002663116	0	9	OPC	NA	NA	NA
CTCATTATCTATCCTA-1_4_A5	1.136218209	-10.68839876	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1634	2723	0.00734484	0.00367242	0	12	EN-MIX	NA	NA	NA
CTCCTAGCACAGACTT-1_4_A5	3.488996282	30.57349026	1	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	717	1000	0.005	0.007	0	oligos	OL-Cntl	NA	NA	NA
CTCCTAGGTAAGGATT-1_4_A5	-5.319629138	-3.759964379	13A	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1551	2485	0.001207243	0.005231388	0	13A	IN-VIP	NA	NA	NA
CTCGAAAAGACAATAC-1_4_A5	8.601883366	-7.637050988	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1909	3508	0.002565564	0.001710376	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTCGAAAAGATCTGCT-1_4_A5	-8.085056013	-0.034080839	13A	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2332	4389	0.004556847	0.005012531	0	13A	IN-VIP	NA	NA	NA
CTCGAAAAGTCGATAA-1_4_A5	7.985666494	-29.50485818	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	5305	15459	0.007180283	0.002522802	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTCGAAACAGCTGTGC-1_4_A5	10.98083962	23.20783837	1	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	745	1162	0.004302926	0.003442341	0	oligos	OL-Cntl	NA	NA	NA
CTCGAAAGTTAGTGGG-1_4_A5	3.519417764	-5.494937494	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1107	1633	0.006736069	0.004286589	0	12	EN-MIX	NA	NA	NA
CTCGAAAGTTTGTTTC-1_4_A5	-4.704380794	-3.396046499	13A	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1450	2455	0.021181263	0.001221996	0	13A	IN-VIP	NA	NA	NA
CTCGAGGAGTCGTTTG-1_4_A5	14.52976243	-8.19940805	3	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2035	3988	0.003510532	0.002006018	0	3	EN-L5-6	NA	NA	NA
CTCGAGGTCGGCGCTA-1_4_A5	9.361158235	-7.847092089	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1980	3640	0	0.002197802	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTCGGAGAGCGATGAC-1_4_A5	9.673517979	-6.774322897	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1660	3106	0.004829363	0.001931745	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTCGGAGAGTTGTAGA-1_4_A5	-12.83476777	-23.133249	6A	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1213	1843	0.018990776	0.001627781	0	6A	IN-PV	NA	NA	NA
CTCGGAGTCACAAACC-1_4_A5	15.55046618	-5.065006551	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1230	1986	0.002517623	0.005035247	0	12	EN-MIX	NA	NA	NA
CTCGGAGTCCTTTACA-1_4_A5	21.40817789	1.282512699	2	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1389	2302	0.009991312	0.002172024	0	2	EN-L4	NA	NA	NA
CTCGGAGTCTGGTGTA-1_4_A5	30.49123121	-4.611142998	2	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	3442	7244	0.0146328	0.003589177	0	2	EN-L4	NA	NA	NA
CTCGGGAAGAGTACCG-1_4_A5	-4.064752483	-6.316704557	13A	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1181	1788	0.003914989	0.002796421	0	13A	IN-VIP	NA	NA	NA
CTCGGGACAATCCGAT-1_4_A5	-0.965201676	-0.659078991	11	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1352	2064	0.009205426	0.001453488	0	11	Glia-MIX	NA	NA	NA
CTCGGGATCTGCGGCA-1_4_A5	15.01657331	-1.098688731	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	816	1226	0.017944535	0.003262643	0	12	EN-MIX	NA	NA	NA
CTCGTACAGTGCAAGC-1_4_A5	17.04414437	1.735606318	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	906	1274	0.002354788	0.001569859	0	12	EN-MIX	NA	NA	NA
CTCGTCAAGACGCACA-1_4_A5	14.25283975	29.84171349	1	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	885	1332	0.000750751	0.003003003	0	oligos	OL-Cntl	NA	NA	NA
CTCGTCAAGCTAAACA-1_4_A5	2.786068039	-24.83463914	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	4336	10743	0.004374942	0.002327097	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTCGTCAGTCTCTTTA-1_4_A5	-33.62644364	-11.97892647	9	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	818	1183	0.000845309	0.000845309	0	9	OPC	NA	NA	NA
CTCTACGAGAGGGATA-1_4_A5	11.87259171	24.71349133	1	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	892	1347	0.013363029	0.005939124	0	oligos	OL-Cntl	NA	NA	NA
CTCTACGCAATGAAAC-1_4_A5	10.28689829	1.201827415	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	836	1307	0.014537108	0.013006886	0	12	EN-MIX	NA	NA	NA
CTCTACGGTCTGGTCG-1_4_A5	-33.75986198	-11.23735045	9	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	897	1339	0	0.002240478	0	9	OPC	NA	NA	NA
CTCTACGGTTCGGGCT-1_4_A5	21.3957029	-2.114292156	2	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2051	3524	0.004540295	0.003121453	0	2	EN-L4	NA	NA	NA
CTCTACGTCCGCTGTT-1_4_A5	6.871298776	-3.088519852	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1171	1919	0.008337676	0.003647733	0	12	EN-MIX	NA	NA	NA
CTCTACGTCGAACTGT-1_4_A5	14.0581979	29.82649225	1	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	850	1177	0.004248088	0.001699235	0	oligos	OL-Cntl	NA	NA	NA
CTCTGGTAGTCGTACT-1_4_A5	12.29892283	28.41079478	1	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	839	1217	0.006573541	0.004108463	0	oligos	OL-Cntl	NA	NA	NA
CTCTGGTCAAGCTGTT-1_4_A5	10.45672734	1.32173772	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	817	1207	0.010770505	0.008285004	0	12	EN-MIX	NA	NA	NA
CTCTGGTTCTTCAACT-1_4_A5	12.5393208	28.18323828	1	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	736	1023	0.008797654	0	0	oligos	OL-Cntl	NA	NA	NA
CTGAAACAGCGCCTCA-1_4_A5	-16.53344064	-10.63703331	13B	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	3021	6372	0.005335844	0.003138732	0	13B	IN-SV2C	NA	NA	NA
CTGAAACCACGTAAGG-1_4_A5	21.49021386	0.023737552	2	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1687	2785	0.007540395	0.002872531	0	2	EN-L4	NA	NA	NA
CTGAAACTCTGCCAGG-1_4_A5	21.62047199	0.253011986	2	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1645	2687	0.00818757	0.001860811	0	2	EN-L4	NA	NA	NA
CTGAAGTCATAGACTC-1_4_A5	8.64990584	-8.387322175	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2029	3900	0.004615385	0.002307692	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTGAAGTGTGCTTCTC-1_4_A5	15.91595527	1.825159724	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	896	1302	0.006912442	0.002304147	0	12	EN-MIX	NA	NA	NA
CTGATAGAGGTGATTA-1_4_A5	24.6124925	-28.1277312	3	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2887	6015	0.007315046	0.002493766	0	3	EN-L5-6	NA	NA	NA
CTGATAGTCATCACCC-1_4_A5	17.09293071	15.5781355	1	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1268	2074	0.0024108	0.004339441	0	oligos	OL-Cntl	NA	NA	NA
CTGATCCCACCATCCT-1_4_A5	-0.982265051	-0.590400672	11	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1839	3306	0.011191773	0.003024803	0	11	Glia-MIX	NA	NA	NA
CTGATCCCAGTAAGAT-1_4_A5	-1.939868033	2.502414701	11	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1510	2369	0.002110595	0.00422119	0	11	Glia-MIX	NA	NA	NA
CTGATCCCATGCATGT-1_4_A5	-33.48411659	-12.16758004	9	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	751	1039	0.000962464	0.001924928	0	9	OPC	NA	NA	NA
CTGATCCGTATCGCAT-1_4_A5	-0.914379616	3.383649973	11	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1140	1762	0.005107832	0.003972758	0	11	Glia-MIX	NA	NA	NA
CTGATCCGTCTGATCA-1_4_A5	-0.553863666	4.533662142	11	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	995	1450	0.004827586	0.002758621	0	11	Glia-MIX	NA	NA	NA
CTGATCCTCACTCCTG-1_4_A5	10.5602249	29.62313284	1	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	723	1046	0.001912046	0	0	oligos	OL-Cntl	NA	NA	NA
CTGATCCTCCGCGGTA-1_4_A5	-11.100595	12.93888954	11	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	928	1393	0.000717875	0.004307251	0	11	Glia-MIX	NA	NA	NA
CTGCCTAGTGTCCTCT-1_4_A5	10.54002619	31.63448257	1	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	830	1295	0.001544402	0.002316602	0	oligos	OL-Cntl	NA	NA	NA
CTGCCTATCCATGCTC-1_4_A5	1.262252204	-26.75537925	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	3889	9420	0.006050955	0.002866242	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTGCGGAAGTTCCACA-1_4_A5	6.410192587	-8.392781972	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2027	3605	0.006380028	0.00221914	0	12	EN-MIX	NA	NA	NA
CTGCGGACACAACGTT-1_4_A5	10.71784778	0.821682648	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	980	1573	0.00317864	0.011443102	0	12	EN-MIX	NA	NA	NA
CTGCGGACATGGTAGG-1_4_A5	6.556852316	-5.664619996	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1290	2186	0.032936871	0.004117109	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTGCGGACATTTGCCC-1_4_A5	17.62286803	1.641245883	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1041	1633	0.009797918	0.002449479	0	12	EN-MIX	NA	NA	NA
CTGCGGAGTAATCACC-1_4_A5	14.93266304	2.821789108	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	890	1263	0.004750594	0.006334125	0	12	EN-MIX	NA	NA	NA
CTGCGGAGTAGGCATG-1_4_A5	11.28627738	-8.736086479	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2720	5694	0.000878117	0.002809975	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTGCTGTAGGGTGTTG-1_4_A5	-0.083811253	-12.37814358	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2018	3567	0.006447996	0.002242781	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTGCTGTCAGGGCATA-1_4_A5	6.699111852	-30.06169173	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	3604	8341	0.004795588	0.004435919	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTGGTCTAGCTCCTCT-1_4_A5	29.93678309	-1.930433427	2	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	3676	8697	0.006898931	0.003564448	0	2	EN-L4	NA	NA	NA
CTGGTCTCAGCTCGAC-1_4_A5	13.32235667	-4.072241858	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1672	3420	0.003216374	0.006725146	0	12	EN-MIX	NA	NA	NA
CTGTGCTGTATCAGTC-1_4_A5	-21.32306345	-28.35973663	6A	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	4167	9832	0.013628967	0.004170057	0	6A	IN-PV	NA	NA	NA
CTGTGCTTCTGTCTCG-1_4_A5	32.03211083	-1.728162531	2	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2527	4796	0.01292744	0.002710592	0	2	EN-L4	NA	NA	NA
CTGTTTAAGTATGACA-1_4_A5	-10.68387104	-18.22417397	6B	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1010	1577	0.019657578	0.002536462	0	6B	IN-SST	NA	NA	NA
CTTACCGCACCCATTC-1_4_A5	-7.481140219	-2.567040722	13A	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1797	3046	0.006237689	0.001969796	0	13A	IN-VIP	NA	NA	NA
CTTACCGGTTGGGACA-1_4_A5	-4.039476087	-8.516118181	13A	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	856	1240	0.006451613	0.001612903	0	13A	IN-VIP	NA	NA	NA
CTTAGGAAGGCATGGT-1_4_A5	-4.226176669	-8.849770028	13A	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	987	1621	0.018507094	0.000616903	0	13A	IN-VIP	NA	NA	NA
CTTCTCTAGCAGCCTC-1_4_A5	13.11702841	-32.13441907	3	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2759	6954	0	0.003451251	0	3	EN-L5-6	NA	NA	NA
CTTCTCTGTACTCTCC-1_4_A5	-32.94869784	-12.76526313	9	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	728	1008	0.000992063	0.004960317	0	9	OPC	NA	NA	NA
CTTGGCTGTTCAGACT-1_4_A5	-4.679323931	-4.095427889	13A	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1255	2155	0.016241299	0.001392111	0	13A	IN-VIP	NA	NA	NA
CTTGGCTTCAAAGTAG-1_4_A5	18.51422133	1.440007637	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1279	2147	0.004191896	0.002794597	0	12	EN-MIX	NA	NA	NA
CTTGGCTTCTTGGGTA-1_4_A5	12.22591068	-0.281681762	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	904	1467	0.001363327	0.010224949	0	12	EN-MIX	NA	NA	NA
CTTTGCGAGATATGCA-1_4_A5	3.428164424	-28.15581912	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2682	5764	0.005204719	0.002081888	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTTTGCGAGGCATGTG-1_4_A5	-3.967856345	-7.946129659	13A	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	664	1015	0.010837438	0.001970443	0	13A	IN-VIP	NA	NA	NA
GAAACTCGTTGTTTGG-1_4_A5	25.36250456	-2.46693741	2	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2828	6444	0.004810677	0.00248293	0	2	EN-L4	NA	NA	NA
GAAATGAGTACTTGAC-1_4_A5	11.73910938	29.32206295	1	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	763	1146	0.004363002	0.006108202	0	oligos	OL-Cntl	NA	NA	NA
GAACATCCATTAGGCT-1_4_A5	-0.821312569	3.321013397	11	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1118	1779	0.001686341	0.003934795	0	11	Glia-MIX	NA	NA	NA
GAACCTAAGGAATCGC-1_4_A5	4.091950913	-2.43797083	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	840	1353	0.003695492	0.005912786	0	12	EN-MIX	NA	NA	NA
GAACCTAAGGCTCAGA-1_4_A5	-6.469375201	-3.114863861	13A	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1570	2737	0.022287176	0.002922908	0	13A	IN-VIP	NA	NA	NA
GAACCTAGTGAGGCTA-1_4_A5	3.455716175	-6.307888555	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1220	1815	0.007713499	0.006060606	0	12	EN-MIX	NA	NA	NA
GAACCTATCGTCGTTC-1_4_A5	13.29314206	31.45076902	1	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	734	1120	0	0.002678571	0	oligos	OL-Cntl	NA	NA	NA
GAACGGACACAGACTT-1_4_A5	-13.93085044	-16.39200414	6B	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1352	2362	0.010584251	0.00550381	0	6B	IN-SST	NA	NA	NA
GAACGGAGTCAAAGAT-1_4_A5	26.51428574	-4.438416645	2	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	3808	9128	0.00361525	0.002300613	0	2	EN-L4	NA	NA	NA
GAACGGATCAACACCA-1_4_A5	22.70414507	0.153088367	2	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2005	3511	0.006835659	0.002278553	0	2	EN-L4	NA	NA	NA
GAACGGATCTCTGAGA-1_4_A5	17.31227881	22.03649161	1	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	987	1449	0.002760524	0.003450656	0	oligos	OL-Cntl	NA	NA	NA
GAAGCAGCATCACAAC-1_4_A5	2.482493322	-5.87935087	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1027	1534	0.001955671	0.004563233	0	12	EN-MIX	NA	NA	NA
GAAGCAGTCTTAACCT-1_4_A5	5.818418157	30.77705097	1	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	729	1081	0.004625347	0.005550416	0	oligos	OL-Cntl	NA	NA	NA
GAATAAGCAGGGTATG-1_4_A5	22.81668886	0.807258128	2	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1874	3369	0.010982487	0.001187296	0	2	EN-L4	NA	NA	NA
GAATGAATCTATCCCG-1_4_A5	-2.400592008	-1.658017474	13B	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1724	3023	0.009262322	0.003307972	0	13B	IN-SV2C	NA	NA	NA
GACACGCAGAGACTTA-1_4_A5	2.635774593	-7.648347644	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1441	2431	0.004524887	0.006581654	0	12	EN-MIX	NA	NA	NA
GACACGCAGCCCAGCT-1_4_A5	2.76498352	29.55790996	1	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	698	1014	0.003944773	0.003944773	0	oligos	OL-Cntl	NA	NA	NA
GACAGAGAGAAGCCCA-1_4_A5	3.708893589	-28.48052751	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	3036	6546	0.002138711	0.002597006	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GACAGAGAGCTAACTC-1_4_A5	1.09553159	-10.30881193	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1398	2266	0.009708738	0.003089144	0	12	EN-MIX	NA	NA	NA
GACAGAGCAAAGGTGC-1_4_A5	9.157944229	-8.674551035	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2200	4145	0.002412545	0.0026538	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GACAGAGCATTTGCCC-1_4_A5	21.19595655	-28.8179927	3	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	3565	9015	0.000110926	0.002551303	0	3	EN-L5-6	NA	NA	NA
GACAGAGGTTGTGGAG-1_4_A5	15.05454907	-30.88798664	3	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	3652	9013	0.001664263	0.00266282	0	3	EN-L5-6	NA	NA	NA
GACCAATCAAATACAG-1_4_A5	3.162901435	-7.77875233	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1454	2434	0.012736237	0.00451931	0	12	EN-MIX	NA	NA	NA
GACCAATCACTACAGT-1_4_A5	3.531350993	-2.564511327	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	810	1327	0.003767898	0.007535795	0	12	EN-MIX	NA	NA	NA
GACCAATTCGCCCTTA-1_4_A5	13.08883303	-32.07016344	3	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2841	6719	0.005209108	0.002381307	0	3	EN-L5-6	NA	NA	NA
GACCTGGAGCGGATCA-1_4_A5	0.257112131	-0.345717809	6B	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	950	1513	0.007270324	0.005287508	0	6B	IN-SST	NA	NA	NA
GACCTGGTCTAACTTC-1_4_A5	-0.497171962	4.39560605	11	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	794	1189	0.000841043	0.006728343	0	11	Glia-MIX	NA	NA	NA
GACCTGGTCTGGAGCC-1_4_A5	11.40562994	-8.565714426	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2719	5612	0.016928011	0.001603706	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GACGCGTCATTTGCCC-1_4_A5	-1.011883114	3.640181954	11	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1120	1669	0.003594967	0.003594967	0	11	Glia-MIX	NA	NA	NA
GACGCGTTCATAGCAC-1_4_A5	-1.011733586	3.588168938	11	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1111	1666	0.006002401	0.003601441	0	11	Glia-MIX	NA	NA	NA
GACGGCTAGCCAGTAG-1_4_A5	2.92735897	-5.989382892	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1195	1739	0.007475561	0.003450259	0	12	EN-MIX	NA	NA	NA
GACGGCTCATGATCCA-1_4_A5	14.64168462	-33.066889	3	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	4332	11890	0.002859546	0.002859546	0	3	EN-L5-6	NA	NA	NA
GACGGCTGTAAGTGTA-1_4_A5	22.90888617	0.111370898	2	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2322	4021	0.007709525	0.002984332	0	2	EN-L4	NA	NA	NA
GACGGCTGTGAGTATA-1_4_A5	13.93521864	-1.267009982	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1011	1808	0.002765487	0.004977876	0	12	EN-MIX	NA	NA	NA
GACGTGCTCTGAGGGA-1_4_A5	21.68274539	1.10177674	2	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1559	2572	0.008164852	0.000777605	0	2	EN-L4	NA	NA	NA
GACGTTATCACCTCGT-1_4_A5	1.892627711	-6.770015022	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1214	2000	0.011	0.003	0	12	EN-MIX	NA	NA	NA
GACGTTATCATTATCC-1_4_A5	25.29345673	-1.754910437	2	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2842	5731	0.010294887	0.001744896	0	2	EN-L4	NA	NA	NA
GACGTTATCGCCTGAG-1_4_A5	21.0171316	-1.063004347	2	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1758	2927	0.021865391	0.002391527	0	2	EN-L4	NA	NA	NA
GACTAACTCCGCATCT-1_4_A5	-14.83406658	-10.63298701	13B	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2326	4447	0.00337306	0.00314819	0	13B	IN-SV2C	NA	NA	NA
GACTACATCTTGTATC-1_4_A5	10.00427882	-8.849939807	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2484	5538	0.003250271	0.002527988	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GACTGCGAGAAGGTTT-1_4_A5	20.92768429	-0.073564641	2	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1557	2451	0.013055896	0.002855977	0	2	EN-L4	NA	NA	NA
GAGCAGAAGCTAACAA-1_4_A5	-18.35225315	-17.61196408	6A	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2424	4958	0.005445744	0.002218637	0	6A	IN-PV	NA	NA	NA
GAGCAGACAAGTTCTG-1_4_A5	13.14085686	-32.00638322	3	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	3155	7551	0.002781089	0.002251357	0	3	EN-L5-6	NA	NA	NA
GAGCAGAGTACGACCC-1_4_A5	-0.112327114	-0.034231461	11	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	958	1411	0.003543586	0.003543586	0	11	Glia-MIX	NA	NA	NA
GAGGTGAAGATCTGCT-1_4_A5	-0.520907352	4.737046133	11	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	759	1108	0.003610108	0.007220217	0	11	Glia-MIX	NA	NA	NA
GAGGTGACACGCCAGT-1_4_A5	11.56317498	1.316542625	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	726	1085	0.043317972	0	0	12	EN-MIX	NA	NA	NA
GAGGTGAGTATGAATG-1_4_A5	8.699468623	-6.307665784	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1523	2528	0.008702532	0.001977848	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GAGGTGAGTTCAGCGC-1_4_A5	4.597951255	-7.40314083	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1481	2286	0.009623797	0.002624672	0	12	EN-MIX	NA	NA	NA
GAGGTGATCGCAAACT-1_4_A5	7.038439174	-7.026002326	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1452	2473	0.006874242	0.002426203	0	12	EN-MIX	NA	NA	NA
GAGTCCGCAAGGTTTC-1_4_A5	18.17485676	23.36612615	1	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	870	1372	0.008746356	0.002915452	0	oligos	OL-Cntl	NA	NA	NA
GAGTCCGTCTGTTTGT-1_4_A5	12.16887231	32.97706815	1	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	726	1015	0.00591133	0	0	oligos	OL-Cntl	NA	NA	NA
GATCAGTCACTTGGAT-1_4_A5	22.19278256	1.160685005	2	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1584	2697	0.003707824	0.004078606	0	2	EN-L4	NA	NA	NA
GATCAGTGTAATCGTC-1_4_A5	8.476881126	-6.94898378	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1582	2803	0.009275776	0.001427042	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GATCAGTGTACATCCA-1_4_A5	-1.98034033	-19.43388279	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2635	5716	0.006298111	0.00279916	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GATCAGTTCGGTCTAA-1_4_A5	19.57800643	1.564799676	2	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1304	2168	0.003228782	0.004151292	0	2	EN-L4	NA	NA	NA
GATCGATCAATGAAAC-1_4_A5	24.95812548	-0.229446387	2	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2321	4475	0.005810056	0.003798883	0	2	EN-L4	NA	NA	NA
GATCGATGTTCGGCAC-1_4_A5	13.16302147	28.78965842	1	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	776	1177	0.003398471	0.003398471	0	oligos	OL-Cntl	NA	NA	NA
GATCGATTCAAGCCTA-1_4_A5	7.763667167	-32.29224532	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	3987	11090	0.004959423	0.002434626	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GATCGATTCTGCGGCA-1_4_A5	7.467276331	26.53299849	1	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	849	1195	0.007531381	0.010041841	0	oligos	OL-Cntl	NA	NA	NA
GATCGCGCAGCTGGCT-1_4_A5	10.54416357	1.0221379	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	985	1632	0.007965686	0.011642157	0	12	EN-MIX	NA	NA	NA
GATCGCGGTCCGAGTC-1_4_A5	-3.665696762	-6.110192673	13A	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1040	1514	0.005284016	0.001981506	0	13A	IN-VIP	NA	NA	NA
GATCGCGGTCGAATCT-1_4_A5	-1.672705006	-17.56796196	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2815	6099	0.000491884	0.001967536	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GATCGCGGTCGCCATG-1_4_A5	22.56544137	0.135487069	2	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1902	3349	0.019408779	0.001194386	0	2	EN-L4	NA	NA	NA
GATCGTAAGTCTCCTC-1_4_A5	-1.382969794	-19.02223438	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2819	5735	0.00331299	0.001569311	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GATCGTACACATGTGT-1_4_A5	-37.30802882	-7.454733946	9	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1088	1783	0.001121705	0.00224341	0	9	OPC	NA	NA	NA
GATCGTAGTACCGTAT-1_4_A5	-6.149898547	-3.159330907	13A	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1613	2741	0.006202116	0.002188982	0	13A	IN-VIP	NA	NA	NA
GATCGTATCAATACCG-1_4_A5	0.559291465	-10.15150376	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1443	2455	0.003665988	0.002851324	0	12	EN-MIX	NA	NA	NA
GATCGTATCCATGCTC-1_4_A5	11.08004476	-8.638904846	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2376	4713	0.004031403	0.00233397	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GATCGTATCCCAACGG-1_4_A5	12.53453775	1.180947797	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	872	1365	0.005128205	0.005860806	0	12	EN-MIX	NA	NA	NA
GATCTAGAGAAGAAGC-1_4_A5	6.567247275	-33.06251982	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	3549	9074	0.000771435	0.001212255	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GATCTAGCATGACATC-1_4_A5	22.99052942	1.020766104	2	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1793	3091	0.004529279	0.002911679	0	2	EN-L4	NA	NA	NA
GATCTAGTCACCACCT-1_4_A5	17.78613203	-5.401515277	3	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1286	2348	0	0.003833049	0	3	EN-L5-6	NA	NA	NA
GATGAGGAGAGTAAGG-1_4_A5	-32.64766851	-12.61897491	9	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	818	1194	0.006700168	0.000837521	0	9	OPC	NA	NA	NA
GATGCTAAGTTTAGGA-1_4_A5	3.092188955	-5.304565093	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	975	1437	0.003479471	0.003479471	0	12	EN-MIX	NA	NA	NA
GATGCTAGTCTGCAAT-1_4_A5	12.26963103	0.559890696	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	785	1106	0.011754069	0.018083183	0	12	EN-MIX	NA	NA	NA
GATGCTATCCACTCCA-1_4_A5	1.543388481	-26.16665472	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	3397	7746	0.004131164	0.001936483	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GATTCAGAGGGAAACA-1_4_A5	-18.89222069	-28.36227754	6A	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2870	6449	0.00279113	0.00279113	0	6A	IN-PV	NA	NA	NA
GATTCAGCAAAGGCGT-1_4_A5	9.640690183	-8.555949847	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2409	4709	0.004034827	0.003610108	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GATTCAGCATATACGC-1_4_A5	-15.87681903	-10.8934255	13B	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2659	5438	0.00643619	0.002942258	0	13B	IN-SV2C	NA	NA	NA
GATTCAGGTATAGGGC-1_4_A5	20.28763784	1.599968214	2	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1327	2135	0.01030445	0.001873536	0	2	EN-L4	NA	NA	NA
GATTCAGGTGCGGTAA-1_4_A5	9.004962336	-8.660912049	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2252	4412	0.005893019	0.00294651	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GATTCAGTCCACTCCA-1_4_A5	14.26796647	-32.91762635	3	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	3734	10160	0.006397638	0.00226378	0	3	EN-L5-6	NA	NA	NA
GCAAACTGTACCCAAT-1_4_A5	15.52695031	1.819721382	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1145	1791	0.008375209	0.003350084	0	12	EN-MIX	NA	NA	NA
GCAAACTGTGTGTGCC-1_4_A5	-0.956797864	3.72012701	11	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1085	1728	0.001157407	0.004050926	0	11	Glia-MIX	NA	NA	NA
GCAATCAAGGACACCA-1_4_A5	14.07183222	-31.13076054	3	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2912	6521	0.007820886	0.003067014	0	3	EN-L5-6	NA	NA	NA
GCAATCACACCATCCT-1_4_A5	-7.073156314	-28.29791195	16	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	840	1244	0.118971061	0.004823151	0	16	EN-PYR	NA	NA	NA
GCAATCAGTAGCGATG-1_4_A5	-17.91737213	-27.05300638	6A	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2576	5398	0.000370508	0.002964061	0	6A	IN-PV	NA	NA	NA
GCAATCAGTATCACCA-1_4_A5	-34.692138	-12.42465272	9	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	748	1114	0.002692998	0.000897666	0	9	OPC	NA	NA	NA
GCACATAGTGGCGAAT-1_4_A5	0.051130882	31.22602395	1	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	882	1275	0.013333333	0.004705882	0	oligos	OL-Cntl	NA	NA	NA
GCACATATCTACCTGC-1_4_A5	15.59655585	-2.345071136	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1015	1492	0.003351206	0.000670241	0	12	EN-MIX	NA	NA	NA
GCACATATCTATCGCC-1_4_A5	2.396967246	30.43721642	1	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	728	1097	0.010938924	0.002734731	0	oligos	OL-Cntl	NA	NA	NA
GCACATATCTGCCCTA-1_4_A5	-0.583080901	3.964965819	11	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	941	1390	0.002158273	0.004316547	0	11	Glia-MIX	NA	NA	NA
GCACTCTAGCGATGAC-1_4_A5	-9.886149877	-17.90891949	6B	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	865	1312	0.00304878	0.00304878	0	6B	IN-SST	NA	NA	NA
GCACTCTTCTACCTGC-1_4_A5	5.613195909	-9.665640568	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1673	3036	0.008234519	0.007575758	0	12	EN-MIX	NA	NA	NA
GCAGCCAAGGCACATG-1_4_A5	-0.478491653	35.22787907	17	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	814	1119	0.010723861	0.004468275	0	oligos	OL-MS-2	NA	NA	NA
GCAGCCACACATGGGA-1_4_A5	10.21941564	-8.068028938	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2223	4347	0.001610306	0.001610306	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCAGCCACATCCGGGT-1_4_A5	-12.73776902	-10.77827407	13B	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1685	2831	0.014482515	0.002472625	0	13B	IN-SV2C	NA	NA	NA
GCAGCCAGTCCTCTTG-1_4_A5	22.94478397	0.328138853	2	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2001	3397	0.00117751	0.004121283	0	2	EN-L4	NA	NA	NA
GCAGTTAAGTCCCACG-1_4_A5	-0.880440484	-17.2125814	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2568	5517	0.016494472	0.002356353	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCAGTTACAAGTCATC-1_4_A5	-3.68936469	-6.955755998	13A	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	924	1361	0.010286554	0.001469508	0	13A	IN-VIP	NA	NA	NA
GCAGTTACAGCAGTTT-1_4_A5	-37.96095252	0.376702498	9	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1630	2801	0.001428061	0.003927169	0	9	OPC	NA	NA	NA
GCATACAAGATATGCA-1_4_A5	22.38240756	-0.245931354	2	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1843	3371	0.008899436	0.001483239	0	2	EN-L4	NA	NA	NA
GCATGCGAGCGTCAAG-1_4_A5	-13.67578945	-18.01366329	6B	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1357	2226	0.015274034	0.00359389	0	6B	IN-SST	NA	NA	NA
GCATGCGGTAAATGTG-1_4_A5	17.41817073	-5.535152427	3	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1624	3088	0.000323834	0.002266839	0	3	EN-L5-6	NA	NA	NA
GCATGTAAGACCCACC-1_4_A5	-14.99784244	-23.86137094	6A	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1569	2620	0.029770992	0.003435115	0	6A	IN-PV	NA	NA	NA
GCATGTATCCTAGGGC-1_4_A5	14.87089658	-0.704407291	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	711	1020	0.009803922	0.003921569	0	12	EN-MIX	NA	NA	NA
GCCAAATCACCGGAAA-1_4_A5	-9.76497334	-19.86438962	6B	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	845	1218	0.041871921	0.003284072	0	6B	IN-SST	NA	NA	NA
GCCAAATTCATCGGAT-1_4_A5	2.776242474	-6.760297211	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1305	2264	0.000883392	0.010600707	0	12	EN-MIX	NA	NA	NA
GCCTCTACAATGTAAG-1_4_A5	-1.107636788	3.394533811	11	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1236	1987	0.002516356	0.004529441	0	11	Glia-MIX	NA	NA	NA
GCCTCTATCAACTCTT-1_4_A5	30.52298179	-3.081032939	2	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2941	6199	0.003871592	0.004516858	0	2	EN-L4	NA	NA	NA
GCCTCTATCTCGAGTA-1_4_A5	1.56082532	-9.262580417	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1481	2437	0.005334428	0.002462043	0	12	EN-MIX	NA	NA	NA
GCGACCAAGTCAAGCG-1_4_A5	-20.61095201	-26.68965337	6A	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	3199	6810	0.013362702	0.004111601	0	6A	IN-PV	NA	NA	NA
GCGACCACACGGCTAC-1_4_A5	-0.493291071	-13.20883053	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1938	3610	0.004432133	0.003047091	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCGACCACATCGTCGG-1_4_A5	1.630440449	1.121007658	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1523	2529	0.015816528	0.004744958	0	12	EN-MIX	NA	NA	NA
GCGAGAAAGTACGCGA-1_4_A5	3.414456798	29.21872347	1	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	829	1244	0.002411576	0.004823151	0	oligos	OL-Cntl	NA	NA	NA
GCGAGAACAGACGCCT-1_4_A5	-14.07500678	-24.53144192	6A	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1457	2505	0.01996008	0.001996008	0	6A	IN-PV	NA	NA	NA
GCGAGAATCCGTCAAA-1_4_A5	3.7931145	29.8887289	1	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	720	1035	0.003864734	0.004830918	0	oligos	OL-Cntl	NA	NA	NA
GCGCAACCACGGTGTC-1_4_A5	-0.718191495	4.185263493	11	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	958	1418	0.002115656	0.004231312	0	11	Glia-MIX	NA	NA	NA
GCGCAACTCCAGTATG-1_4_A5	2.026492103	6.204226981	7	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	814	1049	0.004766444	0.005719733	0	7	Phagocytes	NA	NA	NA
GCGCAGTAGCCACTAT-1_4_A5	23.24776851	1.237196674	2	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1850	3284	0.001218027	0.003045067	0	2	EN-L4	NA	NA	NA
GCGCAGTAGCGTCTAT-1_4_A5	25.1380083	-1.533357369	2	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2431	4732	0.003803888	0.00295858	0	2	EN-L4	NA	NA	NA
GCGCAGTAGTGGAGTC-1_4_A5	2.300125329	30.26720872	1	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	809	1160	0.005172414	0.006034483	0	oligos	OL-Cntl	NA	NA	NA
GCGCAGTCAAGGTGTG-1_4_A5	3.692050481	-3.172261146	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	959	1553	0.004507405	0.004507405	0	12	EN-MIX	NA	NA	NA
GCGCAGTGTAAGGGAA-1_4_A5	-0.616204156	-15.65669457	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2551	5029	0.002585007	0.00357924	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCGCAGTTCACGGTTA-1_4_A5	12.27244026	31.91355924	1	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	662	1012	0.001976285	0.001976285	0	oligos	OL-Cntl	NA	NA	NA
GCGCAGTTCAGTACGT-1_4_A5	-28.36703273	13.84911549	8	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	812	1213	0.007419621	0.003297609	0	8	Astrocytes	NA	NA	NA
GCGCAGTTCCCATTAT-1_4_A5	5.578602969	33.57115721	1	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	744	1129	0.001771479	0.004428698	0	oligos	OL-Cntl	NA	NA	NA
GCGCAGTTCTCATTCA-1_4_A5	-14.32500608	-10.39177218	13B	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2169	4280	0.006074766	0.003037383	0	13B	IN-SV2C	NA	NA	NA
GCGCCAAAGAATGTGT-1_4_A5	-13.83217691	-17.93393109	6B	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1290	2112	0.016098485	0.00094697	0	6B	IN-SST	NA	NA	NA
GCGCCAACATGCCTAA-1_4_A5	25.6385371	0.175168761	2	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2574	5296	0.009629909	0.002454683	0	2	EN-L4	NA	NA	NA
GCGCCAATCATTGCGA-1_4_A5	22.59389162	0.084252202	2	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1934	3276	0.010683761	0.001526252	0	2	EN-L4	NA	NA	NA
GCGCCAATCTGAGTGT-1_4_A5	10.4227013	-8.082692976	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2106	3926	0.004075395	0.002037697	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCGCGATTCCTCATTA-1_4_A5	-16.44955012	-25.1805186	6A	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1955	3657	0.006836205	0.004101723	0	6A	IN-PV	NA	NA	NA
GCGGGTTAGCTACCGC-1_4_A5	4.011193237	30.44293535	1	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	762	1097	0.00911577	0.001823154	0	oligos	OL-Cntl	NA	NA	NA
GCGGGTTCACCGAATT-1_4_A5	7.737702168	31.46308926	1	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	813	1182	0.003384095	0.005076142	0	oligos	OL-Cntl	NA	NA	NA
GCGGGTTGTTGAACTC-1_4_A5	3.941037862	-28.76366053	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	3257	7392	0.005681818	0.002029221	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCGGGTTTCAAGATCC-1_4_A5	4.623175929	-3.881265975	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1032	1656	0.006642512	0.007850242	0	12	EN-MIX	NA	NA	NA
GCTCCTACAAAGTGCG-1_4_A5	0.130109096	-11.79876442	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2049	3677	0.001903726	0.001359804	0	12	EN-MIX	NA	NA	NA
GCTCCTACATGTTGAC-1_4_A5	-3.316627099	-7.490736358	13A	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	773	1145	0.011353712	0.001746725	0	13A	IN-VIP	NA	NA	NA
GCTCCTAGTGAGGCTA-1_4_A5	13.12004612	25.44468135	1	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	918	1354	0.002215657	0.003692762	0	oligos	OL-Cntl	NA	NA	NA
GCTCTGTCACCATGTA-1_4_A5	-0.689669567	-14.04459844	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2218	4088	0.006849315	0.000489237	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCTCTGTTCACATAGC-1_4_A5	-14.18637534	-24.3967663	6A	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1641	3023	0.005623553	0.002315581	0	6A	IN-PV	NA	NA	NA
GCTCTGTTCACGCGGT-1_4_A5	3.090895519	-5.070023834	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	963	1503	0.005322688	0.005322688	0	12	EN-MIX	NA	NA	NA
GCTCTGTTCCACTCCA-1_4_A5	-3.836847104	-7.673927988	13A	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	875	1320	0.010606061	0.003787879	0	13A	IN-VIP	NA	NA	NA
GCTCTGTTCTGTTTGT-1_4_A5	-1.586468303	-15.96753784	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2558	5194	0.008278783	0.003273007	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCTGCAGAGCGTGAGT-1_4_A5	-0.535551419	4.760284427	11	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	753	1058	0.001890359	0.001890359	0	11	Glia-MIX	NA	NA	NA
GCTGCAGCAAACTGCT-1_4_A5	10.15698884	31.50668644	1	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	774	1142	0.003502627	0.004378284	0	oligos	OL-Cntl	NA	NA	NA
GCTGCAGCAAGGCTCC-1_4_A5	-16.14400762	-18.87901968	6B	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1724	3354	0.003577818	0.001490757	0	6B	IN-SST	NA	NA	NA
GCTGCAGGTACCGTAT-1_4_A5	14.62119195	1.521271632	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1253	2324	0.00172117	0.008605852	0	12	EN-MIX	NA	NA	NA
GCTGCAGGTCTTGCGG-1_4_A5	14.20907401	-2.046520862	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1094	2025	0.000493827	0.005432099	0	12	EN-MIX	NA	NA	NA
GCTGCGACAAGCGATG-1_4_A5	-6.645990424	-0.768823693	13A	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1844	3456	0.008101852	0.002893519	0	13A	IN-VIP	NA	NA	NA
GCTGCGACACGAAACG-1_4_A5	4.685052278	33.57843427	1	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	749	1100	0.002727273	0.005454545	0	oligos	OL-Cntl	NA	NA	NA
GCTGCGACATTTCACT-1_4_A5	0.552603247	-10.76501521	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1706	2984	0.004691689	0.007707775	0	12	EN-MIX	NA	NA	NA
GCTGCGAGTACGAAAT-1_4_A5	0.154778696	0.149446294	11	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	850	1204	0.029069767	0.005813953	0	11	Glia-MIX	NA	NA	NA
GCTGCGAGTTCCATGA-1_4_A5	16.70704351	1.812600788	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	788	1140	0	0.001754386	0	12	EN-MIX	NA	NA	NA
GCTGCGATCTAAGCCA-1_4_A5	-0.038140688	-12.67538301	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2108	3642	0.001647446	0.006040637	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCTGCTTCAAAGCAAT-1_4_A5	2.683138526	29.76002476	1	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	761	1046	0.010516252	0.002868069	0	oligos	OL-Cntl	NA	NA	NA
GCTGCTTCAAGAAGAG-1_4_A5	-9.090057851	-17.53706158	6B	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	775	1042	0.02303263	0.001919386	0	6B	IN-SST	NA	NA	NA
GCTGCTTCACTGCCAG-1_4_A5	11.29996036	-0.312467489	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1272	2132	0.017354597	0.004690432	0	12	EN-MIX	NA	NA	NA
GCTGCTTCAGATCTGT-1_4_A5	15.11020205	2.922416667	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1012	1495	0.008695652	0	0	12	EN-MIX	NA	NA	NA
GCTGCTTGTTACGGAG-1_4_A5	0.360332799	-0.65754799	13B	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	878	1387	0.003604903	0.003604903	0	13B	IN-SV2C	NA	NA	NA
GCTGGGTTCCAACCAA-1_4_A5	-18.53465952	6.213785155	8	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	656	1040	0.001923077	0.003846154	0	8	Astrocytes	NA	NA	NA
GCTTCCACACGAAATA-1_4_A5	-0.460831254	4.700767066	11	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	763	1081	0.001850139	0.002775208	0	11	Glia-MIX	NA	NA	NA
GCTTGAAAGAACAATC-1_4_A5	21.22133443	0.494724325	2	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1320	2155	0.013921114	0.002320186	0	2	EN-L4	NA	NA	NA
GCTTGAATCACGGTTA-1_4_A5	14.28871378	-4.789574022	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1547	2876	0.006954103	0.006606398	0	12	EN-MIX	NA	NA	NA
GCTTGAATCACTATTC-1_4_A5	11.13427927	32.16254093	1	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	873	1316	0.003039514	0.005319149	0	oligos	OL-Cntl	NA	NA	NA
GGAAAGCTCCGTCATC-1_4_A5	22.48357798	-8.882057916	3	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2334	4778	0.000418585	0.001674341	0	3	EN-L5-6	NA	NA	NA
GGAAAGCTCCGTTGCT-1_4_A5	-12.28133016	-10.09391496	13B	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1583	2582	0.008520527	0.003872967	0	13B	IN-SV2C	NA	NA	NA
GGAAAGCTCTATCGCC-1_4_A5	-37.22265405	-0.029826387	9	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1483	2553	0.007442225	0.003525264	0	9	OPC	NA	NA	NA
GGAATAAAGAAGGTGA-1_4_A5	-13.98205708	-24.29198333	6A	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1422	2446	0.021668029	0.002452984	0	6A	IN-PV	NA	NA	NA
GGAATAACACCATCCT-1_4_A5	0.247923688	-1.054258502	13A	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	952	1384	0.007225434	0.00867052	0	13A	IN-VIP	NA	NA	NA
GGAATAAGTGTGGTTT-1_4_A5	19.36900703	1.582053988	2	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1444	2413	0.021549938	0.000414422	0	2	EN-L4	NA	NA	NA
GGAATAATCTAGAGTC-1_4_A5	-33.7984808	-12.78933861	9	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	682	1008	0	0.00297619	0	9	OPC	NA	NA	NA
GGACAAGAGGTCGGAT-1_4_A5	19.11035562	-7.475712844	3	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2086	3691	0.010024384	0.002980222	0	3	EN-L5-6	NA	NA	NA
GGACAAGCATATACCG-1_4_A5	18.15086482	-6.092814767	3	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1663	3016	0.004310345	0.004310345	0	3	EN-L5-6	NA	NA	NA
GGACAAGGTAGCTAAA-1_4_A5	20.47499377	-27.57425469	3	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	3373	7137	0.002522068	0.003082528	0	3	EN-L5-6	NA	NA	NA
GGACAAGTCTACTCAT-1_4_A5	1.14089685	0.930066871	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1075	1535	0.003908795	0.001954397	0	12	EN-MIX	NA	NA	NA
GGACAGAAGCTTATCG-1_4_A5	25.86491024	-1.940264927	2	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2875	6179	0.007930086	0.001618385	0	2	EN-L4	NA	NA	NA
GGACAGACATGCCTTC-1_4_A5	8.372417983	-6.928559244	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1600	2811	0.001067236	0.001067236	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GGACAGAGTTTGTTTC-1_4_A5	-0.558792136	4.735050569	11	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	887	1215	0.002469136	0.003292181	0	11	Glia-MIX	NA	NA	NA
GGACAGATCACATAGC-1_4_A5	20.93729275	-27.68589157	3	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2765	6148	0.002277163	0.003415745	0	3	EN-L5-6	NA	NA	NA
GGACAGATCAGAAATG-1_4_A5	16.10685427	-1.319619653	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	908	1281	0.00312256	0.00234192	0	12	EN-MIX	NA	NA	NA
GGACATTCAAATACAG-1_4_A5	-16.53718229	-26.13958047	6A	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2059	3920	0.002295918	0.001785714	0	6A	IN-PV	NA	NA	NA
GGACATTCATTGCGGC-1_4_A5	-23.49897297	-2.277554716	9	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1066	1792	0.003348214	0.002790179	0	9	OPC	NA	NA	NA
GGACATTGTGAGTGAC-1_4_A5	6.072105689	-31.19668276	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	3376	8015	0.009232689	0.002744853	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GGACATTGTTCTGTTT-1_4_A5	16.6239886	-6.692796879	3	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1804	3407	0.000587027	0.003228647	0	3	EN-L5-6	NA	NA	NA
GGACGTCAGGGAAACA-1_4_A5	-9.627359893	13.70107623	11	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1261	1954	0.004094166	0.004605937	0	11	Glia-MIX	NA	NA	NA
GGACGTCGTAAGCACG-1_4_A5	3.959209461	31.18434255	1	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	756	1070	0.004672897	0.003738318	0	oligos	OL-Cntl	NA	NA	NA
GGACGTCGTAGCAAAT-1_4_A5	-0.365141858	-16.26900466	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2544	4996	0.003002402	0.002201761	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GGAGCAAAGAGCTTCT-1_4_A5	-4.20011952	-8.046341554	13A	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	762	1273	0.011783189	0.000785546	0	13A	IN-VIP	NA	NA	NA
GGAGCAACATGATCCA-1_4_A5	37.68391404	9.165650196	14	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	873	1188	0.03030303	0.011784512	0	14	Microglia	NA	NA	NA
GGAGCAAGTAGCTGCC-1_4_A5	-9.404583134	13.75694121	11	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1442	2345	0.001705757	0.003411514	0	11	Glia-MIX	NA	NA	NA
GGATGTTCAGCTCGCA-1_4_A5	3.475684892	-28.61534586	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	3101	6751	0.001629388	0.002962524	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GGATTACAGTACGATA-1_4_A5	0.594835495	-11.13885081	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1653	2784	0.007183908	0.000718391	0	12	EN-MIX	NA	NA	NA
GGATTACCACTACAGT-1_4_A5	-14.76457462	-17.67380684	6B	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1547	2583	0.018195896	0.003871467	0	6B	IN-SST	NA	NA	NA
GGATTACCATATGGTC-1_4_A5	-1.801540905	-16.3600249	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2331	4944	0.003843042	0.002022654	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GGCAATTAGATCCTGT-1_4_A5	-26.73538289	20.09014415	8	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1299	2275	0.007032967	0.005274725	0	8	Astrocytes	NA	NA	NA
GGCAATTAGCGTGTCC-1_4_A5	-4.054452706	-8.821602556	13A	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	847	1223	0.035159444	0.003270646	0	13A	IN-VIP	NA	NA	NA
GGCAATTGTTCTGAAC-1_4_A5	-3.930178871	-6.725383924	13A	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	996	1465	0.004095563	0.002047782	0	13A	IN-VIP	NA	NA	NA
GGCAATTGTTGAGTTC-1_4_A5	18.29150868	-0.15334538	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1369	2257	0.011962782	0.001772264	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GGCAATTGTTGTCGCG-1_4_A5	10.56586472	-0.452734907	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1063	1635	0.005504587	0.003669725	0	12	EN-MIX	NA	NA	NA
GGCAATTTCACGCGGT-1_4_A5	-12.88368232	-21.26966124	6A	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1096	1809	0.001658375	0.003869541	0	6A	IN-PV	NA	NA	NA
GGCCGATGTAAATGTG-1_4_A5	-1.672419333	28.37883638	1	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	692	1011	0.014836795	0.004945598	0	oligos	OL-Cntl	NA	NA	NA
GGCCGATGTCACCCAG-1_4_A5	2.158608015	6.050405381	7	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	748	1002	0.007984032	0.00499002	0	7	Phagocytes	NA	NA	NA
GGCCGATTCGGCTACG-1_4_A5	-11.91123875	12.84465585	11	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	844	1285	0.00077821	0.007782101	0	11	Glia-MIX	NA	NA	NA
GGCGACTGTCCGAACC-1_4_A5	31.96993234	-2.052532735	2	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2622	5025	0.00318408	0.00318408	0	2	EN-L4	NA	NA	NA
GGCGACTTCTCAAACG-1_4_A5	4.365065743	-11.73033753	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2058	4214	0.008542952	0.004983389	0	12	EN-MIX	NA	NA	NA
GGCGTGTAGAGGGATA-1_4_A5	21.28035217	0.046803959	2	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1767	3160	0.013924051	0.001265823	0	2	EN-L4	NA	NA	NA
GGCGTGTGTAGAGGAA-1_4_A5	-6.309071139	-10.50370394	6B	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1064	1596	0.018796992	0.005012531	0	6B	IN-SST	NA	NA	NA
GGCGTGTGTGTGACCC-1_4_A5	-1.490723387	-17.24621758	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2587	5396	0.006856931	0.00222387	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GGGAATGGTCATATCG-1_4_A5	23.54201111	-0.606601508	2	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2094	3778	0.011646374	0.002646903	0	2	EN-L4	NA	NA	NA
GGGAATGGTCCTGCTT-1_4_A5	10.40974387	30.17944511	1	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	682	1004	0.010956175	0.000996016	0	oligos	OL-Cntl	NA	NA	NA
GGGAATGTCCGCATAA-1_4_A5	10.2315186	-0.870224705	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1222	1977	0.016186141	0.009104704	0	12	EN-MIX	NA	NA	NA
GGGACCTAGACCGGAT-1_4_A5	16.31751972	1.712579479	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	861	1247	0.019246191	0.002405774	0	12	EN-MIX	NA	NA	NA
GGGACCTCATCGGGTC-1_4_A5	16.35841968	-3.987963912	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1415	2363	0.015234871	0.007194245	0	12	EN-MIX	NA	NA	NA
GGGACCTGTCTCTTAT-1_4_A5	21.92242471	0.061863326	2	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1803	3124	0.01056338	0.00128041	0	2	EN-L4	NA	NA	NA
GGGACCTGTCTTCAAG-1_4_A5	10.2372629	1.542674059	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	709	1023	0.018572825	0.00684262	0	12	EN-MIX	NA	NA	NA
GGGACCTTCAGCAACT-1_4_A5	8.758581997	-8.75949433	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2359	4890	0.004703476	0.002249489	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GGGACCTTCTGTGCAA-1_4_A5	5.953879888	-9.336419425	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1518	2717	0.005888848	0.00736106	0	12	EN-MIX	NA	NA	NA
GGGAGATCACTTCTGC-1_4_A5	-4.896709522	-9.355203512	13A	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	909	1477	0.02098849	0.000677048	0	13A	IN-VIP	NA	NA	NA
GGGAGATGTCATGCAT-1_4_A5	12.0685117	-0.741338793	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1069	1849	0.00378583	0.013520822	0	12	EN-MIX	NA	NA	NA
GGGATGACATCGACGC-1_4_A5	-10.91929737	-0.20037433	13A	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2340	4246	0.010833726	0.003061705	0	13A	IN-VIP	NA	NA	NA
GGGATGACATGCGCAC-1_4_A5	-1.930741738	2.694350408	11	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1563	2568	0.003504673	0.005451713	0	11	Glia-MIX	NA	NA	NA
GGGATGAGTCGGATCC-1_4_A5	-27.52182418	9.503015639	8	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	761	1032	0.003875969	0.002906977	0	8	Astrocytes	NA	NA	NA
GGGCACTAGCTGCCCA-1_4_A5	-3.425747799	-7.449840953	13A	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	745	1071	0.014005602	0.001867414	0	13A	IN-VIP	NA	NA	NA
GGGCACTCAAGTAATG-1_4_A5	-6.830871485	-9.092645045	13A	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1008	1640	0.020731707	0.008536585	0	13A	IN-VIP	NA	NA	NA
GGGCACTCACGGTTTA-1_4_A5	2.478625044	-5.927646996	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1176	1808	0.002765487	0.002212389	0	12	EN-MIX	NA	NA	NA
GGGCACTCATTCGACA-1_4_A5	0.47848253	-11.38975636	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1749	3057	0.006215244	0.003598299	0	12	EN-MIX	NA	NA	NA
GGGCACTGTGGCCCTA-1_4_A5	-36.33689966	-4.256559526	9	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1272	2018	0.00099108	0.00099108	0	9	OPC	NA	NA	NA
GGGCACTGTTCTGTTT-1_4_A5	-3.317570856	-6.032880647	13A	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	882	1397	0.007874016	0.002863278	0	13A	IN-VIP	NA	NA	NA
GGGCATCAGTACGCGA-1_4_A5	0.96683794	-11.2328695	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1814	3015	0.004975124	0.006301824	0	12	EN-MIX	NA	NA	NA
GGGCATCCACAGGCCT-1_4_A5	-18.98515624	-27.24329436	6A	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2700	5675	0.005991189	0.003171806	0	6A	IN-PV	NA	NA	NA
GGGCATCCACATGGGA-1_4_A5	-13.565132	-23.91037028	6A	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1380	2345	0.028144989	0.003837953	0	6A	IN-PV	NA	NA	NA
GGGCATCCATACAGCT-1_4_A5	10.58575298	0.98051788	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	989	1548	0.012273902	0.014211886	0	12	EN-MIX	NA	NA	NA
GGGCATCGTGGCAAAC-1_4_A5	2.912633031	-7.731646515	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1283	1976	0.004554656	0.004554656	0	12	EN-MIX	NA	NA	NA
GGGCATCTCTGCTGTC-1_4_A5	14.93816085	-33.18618497	3	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	4615	12964	0.004782475	0.003548288	0	3	EN-L5-6	NA	NA	NA
GGGTCTGAGCCAACAG-1_4_A5	-6.782732218	-9.620510962	13A	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	648	1004	0.00498008	0.007968127	0	13A	IN-VIP	NA	NA	NA
GGGTCTGAGCCCAATT-1_4_A5	13.9401332	-4.375000288	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1732	3084	0.017509728	0.010376135	0	12	EN-MIX	NA	NA	NA
GGGTCTGAGGACATTA-1_4_A5	-2.160051433	5.967433028	11	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1102	1547	0.000646412	0.003232062	0	11	Glia-MIX	NA	NA	NA
GGGTTGCAGAACAATC-1_4_A5	20.38430484	1.52784288	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1427	2381	0.008819824	0.00251995	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GGGTTGCCAACCGCCA-1_4_A5	-17.99073534	-17.63914851	6B	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2087	4110	0.001946472	0.003163017	0	6B	IN-SST	NA	NA	NA
GGGTTGCGTTAAGATG-1_4_A5	-8.199855197	-1.442734248	13A	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1912	3373	0.006225912	0.001185888	0	13A	IN-VIP	NA	NA	NA
GGGTTGCTCACATAGC-1_4_A5	0.427291956	-13.61716644	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2168	3797	0.002897024	0.001580195	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GGGTTGCTCCGTACAA-1_4_A5	-33.95663389	-10.33884026	9	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	977	1434	0.00069735	0.0013947	0	9	OPC	NA	NA	NA
GGGTTGCTCCTTGACC-1_4_A5	-3.432209167	-6.564114368	13A	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	956	1488	0.012096774	0.004032258	0	13A	IN-VIP	NA	NA	NA
GGTATTGAGTGCGATG-1_4_A5	-29.91892793	13.27322858	8	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	825	1363	0.003668379	0.001467351	0	8	Astrocytes	NA	NA	NA
GGTATTGGTCTAGCCG-1_4_A5	3.895027078	-4.124116406	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	905	1286	0.005443235	0.005443235	0	12	EN-MIX	NA	NA	NA
GGTATTGGTTTGGGCC-1_4_A5	-1.499431311	-17.25561244	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2381	4675	0.001925134	0.004064171	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GGTGAAGGTCACCCAG-1_4_A5	-35.45443726	-11.27822151	9	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	913	1450	0.000689655	0.002068966	0	9	OPC	NA	NA	NA
GGTGAAGGTCTGATCA-1_4_A5	17.41661358	-5.208246191	3	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1266	2147	0.001863065	0.000931532	0	3	EN-L5-6	NA	NA	NA
GGTGAAGGTTGAACTC-1_4_A5	21.59728549	-8.430110092	3	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1763	3376	0.007405213	0.001777251	0	3	EN-L5-6	NA	NA	NA
GGTGAAGTCAGCTCGG-1_4_A5	-4.686110322	-4.06144333	13A	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1335	2136	0.005617978	0.005617978	0	13A	IN-VIP	NA	NA	NA
GGTGAAGTCTCATTCA-1_4_A5	0.652465061	-11.07374144	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1679	2811	0.009605123	0.001422981	0	12	EN-MIX	NA	NA	NA
GGTGCGTAGAGTTGGC-1_4_A5	25.04477392	-28.45611245	3	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	3314	7535	0.00066357	0.002786994	0	3	EN-L5-6	NA	NA	NA
GGTGCGTTCAGCGACC-1_4_A5	-9.257943681	0.07302731	13A	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2438	5065	0.016189536	0.003356367	0	13A	IN-VIP	NA	NA	NA
GGTGCGTTCTAACCGA-1_4_A5	-13.92043654	-24.47284672	6A	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1388	2371	0.010544074	0.00421763	0	6A	IN-PV	NA	NA	NA
GGTGTTAGTCGCGGTT-1_4_A5	2.581057677	-6.273114643	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1172	1781	0.00729927	0.002245929	0	12	EN-MIX	NA	NA	NA
GGTGTTATCCGAGCCA-1_4_A5	23.07909272	-9.1481796	3	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	3119	6572	0.001825928	0.002586732	0	3	EN-L5-6	NA	NA	NA
GTAACGTCATGGTCAT-1_4_A5	22.34780996	0.39385328	2	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1845	3213	0.007469655	0.001867414	0	2	EN-L4	NA	NA	NA
GTAACGTGTGTTCGAT-1_4_A5	-1.850060924	2.79525018	11	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1525	2262	0.003094607	0.00530504	0	11	Glia-MIX	NA	NA	NA
GTAACTGTCGCAAGCC-1_4_A5	11.76363481	-0.653140379	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1089	1778	0.013498313	0.006749156	0	12	EN-MIX	NA	NA	NA
GTACGTAAGATCCCAT-1_4_A5	-35.41956534	-8.852999364	9	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1125	1688	0.002962085	0.001777251	0	9	OPC	NA	NA	NA
GTACGTAAGCCCTAAT-1_4_A5	13.35320912	-32.1129326	3	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	3254	7562	0.000661201	0.002512563	0	3	EN-L5-6	NA	NA	NA
GTACGTATCGCAAGCC-1_4_A5	10.44417954	-7.554152876	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1878	3648	0.000274123	0.002192982	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GTACGTATCTATCGCC-1_4_A5	22.61857172	-26.0409724	3	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	3286	7986	0.020410719	0.002504383	0	3	EN-L5-6	NA	NA	NA
GTACTCCCAACTGCGC-1_4_A5	1.409843618	-7.598577127	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1367	2202	0.004541326	0.004087193	0	12	EN-MIX	NA	NA	NA
GTACTCCGTCATGCAT-1_4_A5	-32.4554043	-12.94802442	9	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	710	1000	0.002	0.001	0	9	OPC	NA	NA	NA
GTACTCCTCACATAGC-1_4_A5	-6.447150312	-10.46904351	13B	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1156	1997	0.00901352	0.00450676	0	13B	IN-SV2C	NA	NA	NA
GTAGTCAAGAAACGAG-1_4_A5	5.642380775	30.25456473	1	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	726	1033	0.000968054	0.008712488	0	oligos	OL-Cntl	NA	NA	NA
GTAGTCACATCAGTAC-1_4_A5	7.050239009	-6.357944736	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1300	2119	0.004247286	0.004247286	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GTAGTCATCGTGGACC-1_4_A5	-20.47585717	-16.5466814	6A	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2954	5747	0.01409431	0.0045241	0	6A	IN-PV	NA	NA	NA
GTATCTTAGATCCTGT-1_4_A5	21.19442459	-8.007696527	3	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1361	2335	0.001284797	0.003426124	0	3	EN-L5-6	NA	NA	NA
GTATCTTAGCTGCCCA-1_4_A5	3.779256514	-5.340025628	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1010	1526	0.007863696	0.005242464	0	12	EN-MIX	NA	NA	NA
GTATCTTCACAACTGT-1_4_A5	8.417274897	-7.397904242	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1807	3367	0.023463023	0.001188001	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GTATCTTGTACGACCC-1_4_A5	12.40144119	0.939925936	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	781	1201	0.01498751	0.005828476	0	12	EN-MIX	NA	NA	NA
GTATCTTGTAGCGCAA-1_4_A5	-0.370909195	-13.01183201	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1908	3389	0.001475361	0.003245795	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GTATTCTCATATACCG-1_4_A5	13.88420053	-32.43896561	3	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	3437	8735	0.001259302	0.002747567	0	3	EN-L5-6	NA	NA	NA
GTATTCTGTAGAAGGA-1_4_A5	-11.05117643	14.49995055	11	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1165	1790	0.002234637	0.004469274	0	11	Glia-MIX	NA	NA	NA
GTCAAGTAGCAGATCG-1_4_A5	16.17422781	1.701191904	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	769	1073	0.016775396	0.003727866	0	12	EN-MIX	NA	NA	NA
GTCAAGTAGTGGAGAA-1_4_A5	16.22168665	-7.187602201	3	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2276	4641	0.01077354	0.007326007	0	3	EN-L5-6	NA	NA	NA
GTCAAGTCATAGACTC-1_4_A5	13.39490142	-28.2142929	3	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2060	3976	0.00528169	0.003772636	0	3	EN-L5-6	NA	NA	NA
GTCACAACAGCTTAAC-1_4_A5	5.499031484	33.70934358	1	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	708	1038	0.005780347	0.000963391	0	oligos	OL-Cntl	NA	NA	NA
GTCACAATCCGCATCT-1_4_A5	-23.10283746	-1.988924746	9	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	798	1149	0.00435161	0.001740644	0	9	OPC	NA	NA	NA
GTCACAATCCTTCAAT-1_4_A5	-9.592615278	-18.777851	6B	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	863	1248	0.028044872	0.002403846	0	6B	IN-SST	NA	NA	NA
GTCACGGAGAGTACCG-1_4_A5	-15.29917218	-17.37045347	6B	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1673	2776	0.012247839	0.003602305	0	6B	IN-SST	NA	NA	NA
GTCACGGTCAACGGGA-1_4_A5	-21.61969982	-26.01235593	6A	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2486	4640	0.021767241	0.002586207	0	6A	IN-PV	NA	NA	NA
GTCATTTCACAGGAGT-1_4_A5	1.532984405	28.71321608	1	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	752	1030	0.002912621	0.001941748	0	oligos	OL-Cntl	NA	NA	NA
GTCCTCACACTAGTAC-1_4_A5	18.58871529	11.66203647	1	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1508	2589	0.004248745	0.006566242	0	oligos	OL-Cntl	NA	NA	NA
GTCCTCACATGATCCA-1_4_A5	-13.37876944	-18.4336151	6B	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1238	2273	0.024197096	0.004839419	0	6B	IN-SST	NA	NA	NA
GTCCTCATCACATGCA-1_4_A5	15.05038388	-33.41468201	3	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	4705	14659	0.004707006	0.003410874	0	3	EN-L5-6	NA	NA	NA
GTCGGGTTCGGTCCGA-1_4_A5	17.03009813	-6.641910347	3	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1704	3091	0.006470398	0.005176318	0	3	EN-L5-6	NA	NA	NA
GTCGTAAAGGGTATCG-1_4_A5	-27.55444488	10.3227741	8	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	678	1021	0.005876592	0.001958864	0	8	Astrocytes	NA	NA	NA
GTCGTAAGTGTGGTTT-1_4_A5	15.02271906	-1.046389145	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	807	1123	0.008014248	0.005342832	0	12	EN-MIX	NA	NA	NA
GTCTCGTAGCTACCGC-1_4_A5	-34.82406393	-10.71025402	9	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	880	1327	0.012057272	0.00075358	0	9	OPC	NA	NA	NA
GTCTCGTTCCAACCAA-1_4_A5	-23.70001614	18.81712383	8	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1318	2220	0.001801802	0.001351351	0	8	Astrocytes	NA	NA	NA
GTCTTCGGTACTCAAC-1_4_A5	5.900880523	34.65197432	11	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	763	1064	0.00093985	0.006578947	0	11	Glia-MIX	NA	NA	NA
GTCTTCGTCACTCTTA-1_4_A5	-33.85401835	-12.64433593	9	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	722	1078	0.002782931	0.001855288	0	9	OPC	NA	NA	NA
GTGAAGGCAAGTACCT-1_4_A5	4.553604367	-3.950885301	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	995	1519	0.004608295	0.008558262	0	12	EN-MIX	NA	NA	NA
GTGAAGGTCAGCGACC-1_4_A5	21.37084501	-8.143181844	3	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1459	2444	0.01309329	0.002045827	0	3	EN-L5-6	NA	NA	NA
GTGAAGGTCCCGGATG-1_4_A5	-14.27594545	-18.59901541	6B	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1289	2110	0.010900474	0.002843602	0	6B	IN-SST	NA	NA	NA
GTGCATAAGACGCACA-1_4_A5	0.829034726	-23.17969589	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	4333	11340	0.006613757	0.001940035	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GTGCATACAACGATGG-1_4_A5	1.109730899	30.48262318	1	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	830	1139	0.001755926	0.007023705	0	oligos	OL-Cntl	NA	NA	NA
GTGCATACAGATAATG-1_4_A5	0.641257398	31.23902738	1	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	767	1036	0.001930502	0.001930502	0	oligos	OL-Cntl	NA	NA	NA
GTGCGGTAGACTGTAA-1_4_A5	0.789118822	-16.54082272	4	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2637	5324	0.009579264	0.003005259	0	L2-3	EN-L2-3-MS	NA	NA	NA
GTGCTTCAGTTTGCGT-1_4_A5	2.84504133	-5.479641577	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1021	1507	0.00265428	0.00066357	0	12	EN-MIX	NA	NA	NA
GTGCTTCCACATAACC-1_4_A5	-2.994050283	2.31294543	11	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2261	4334	0.00184587	0.004614675	0	11	Glia-MIX	NA	NA	NA
GTGCTTCGTCCGTGAC-1_4_A5	14.75117392	-8.106908835	3	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2224	4355	0.006659013	0.002525832	0	3	EN-L5-6	NA	NA	NA
GTGGGTCCAGACGCTC-1_4_A5	10.77548804	32.23910105	1	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	840	1256	0.010350318	0.003980892	0	oligos	OL-Cntl	NA	NA	NA
GTGGGTCGTAAGTGGC-1_4_A5	22.66488261	0.791498497	2	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1825	3056	0.004253927	0.004581152	0	2	EN-L4	NA	NA	NA
GTGGGTCGTAATCACC-1_4_A5	20.9830897	-27.79476659	3	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	3101	7207	0.008741501	0.00208131	0	3	EN-L5-6	NA	NA	NA
GTGGGTCTCGCCAAAT-1_4_A5	20.20112628	15.76318759	1	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1188	1833	0.003273322	0.002182215	0	oligos	OL-Cntl	NA	NA	NA
GTGTGCGCAATGTAAG-1_4_A5	17.78032663	27.68970194	1	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	931	1366	0.004392387	0.005856515	0	oligos	OL-Cntl	NA	NA	NA
GTGTTAGCAACCGCCA-1_4_A5	0.118849638	-17.3370136	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2446	4580	0.005240175	0.005240175	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GTGTTAGTCACAGGCC-1_4_A5	11.03028533	1.603350883	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	852	1334	0.011244378	0.007496252	0	12	EN-MIX	NA	NA	NA
GTGTTAGTCACAGTAC-1_4_A5	24.13782715	0.139045619	2	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2137	4167	0.000239981	0.002159827	0	2	EN-L4	NA	NA	NA
GTTAAGCAGAGCTATA-1_4_A5	-36.91269459	-7.228708473	9	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1066	1701	0.001763668	0.005291005	0	9	OPC	NA	NA	NA
GTTAAGCGTAGCTCCG-1_4_A5	-15.97109675	-24.31844961	6A	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1854	3207	0.016838167	0.002494543	0	6A	IN-PV	NA	NA	NA
GTTACAGGTCTGATTG-1_4_A5	-8.979489094	-14.60892433	6B	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	821	1142	0.010507881	0.003502627	0	6B	IN-SST	NA	NA	NA
GTTACAGTCGGATGGA-1_4_A5	8.574028244	-7.273547654	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1762	3106	0.000643915	0.003541533	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GTTCATTAGCAATATG-1_4_A5	2.00139008	-7.269069127	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1213	1966	0.01017294	0.003051882	0	12	EN-MIX	NA	NA	NA
GTTCATTCACCCAGTG-1_4_A5	15.31099269	1.603662641	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	766	1054	0.020872865	0.001897533	0	12	EN-MIX	NA	NA	NA
GTTCATTGTCTTTCAT-1_4_A5	14.39315989	-1.222847044	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	929	1445	0.002768166	0.003460208	0	12	EN-MIX	NA	NA	NA
GTTCGGGCACTGTTAG-1_4_A5	-0.555913944	4.280142643	11	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	959	1483	0.002697235	0.003371544	0	11	Glia-MIX	NA	NA	NA
GTTCGGGGTCTTCAAG-1_4_A5	22.410086	-8.83644126	3	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2316	4453	0	0.001122839	0	3	EN-L5-6	NA	NA	NA
GTTCTCGAGTGAACGC-1_4_A5	2.730734139	-5.683609985	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1078	1727	0.005211349	0.003474233	0	12	EN-MIX	NA	NA	NA
GTTTCTATCGCGGATC-1_4_A5	-15.34331412	-10.72817665	13B	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2305	4170	0.002877698	0.003357314	0	13B	IN-SV2C	NA	NA	NA
TAAACCGAGATGCGAC-1_4_A5	3.296869122	-2.92661129	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	778	1101	0.007266122	0.002724796	0	12	EN-MIX	NA	NA	NA
TAAACCGGTTCTGTTT-1_4_A5	7.875968127	-7.149413751	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1525	2764	0.007959479	0.001808973	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TAAGCGTGTCACCTAA-1_4_A5	3.59177727	-28.29463123	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2622	5283	0.000946432	0.003407155	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TAAGCGTGTCGAAAGC-1_4_A5	-9.399065968	-20.36485872	6B	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	738	1021	0	0.001958864	0	6B	IN-SST	NA	NA	NA
TAAGTGCGTTACGGAG-1_4_A5	23.30732526	0.093471822	2	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1933	3606	0.008042152	0.001941209	0	2	EN-L4	NA	NA	NA
TAAGTGCTCCAATGGT-1_4_A5	21.0393059	-27.640003	3	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2523	5611	0.004455534	0.002495099	0	3	EN-L5-6	NA	NA	NA
TACACGAAGACCTTTG-1_4_A5	18.73311163	1.635783079	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1155	1795	0.003342618	0.002228412	0	12	EN-MIX	NA	NA	NA
TACACGAAGTCTCAAC-1_4_A5	-5.632098463	-4.572063715	13A	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1266	2098	0.004766444	0.001906578	0	13A	IN-VIP	NA	NA	NA
TACACGACAACTGGCC-1_4_A5	25.65005316	-4.895298215	2	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	4869	15483	0.004391914	0.001033391	0	2	EN-L4	NA	NA	NA
TACACGACAGCCTATA-1_4_A5	10.65575204	30.66974782	1	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	841	1257	0	0.005568815	0	oligos	OL-Cntl	NA	NA	NA
TACACGATCTATCGCC-1_4_A5	13.80931219	-2.753323044	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1157	1962	0.00509684	0.006116208	0	12	EN-MIX	NA	NA	NA
TACACGATCTGTCTCG-1_4_A5	-13.85231053	-18.57583536	6B	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1317	2227	0.007633588	0.004490346	0	6B	IN-SST	NA	NA	NA
TACAGTGGTCTACCTC-1_4_A5	9.200116674	-7.866137665	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2212	4575	0.005245902	0.002622951	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TACCTATCAGCGATCC-1_4_A5	-8.938833809	13.73400849	1	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1367	2322	0.003445306	0.005598622	0	oligos	OL-Cntl	NA	NA	NA
TACCTATGTTTGACAC-1_4_A5	-18.19752155	-17.8018328	6B	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2134	4116	0.006802721	0.004130224	0	6B	IN-SST	NA	NA	NA
TACCTTACAGCGTCCA-1_4_A5	3.006557327	-3.371779746	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	873	1235	0.012145749	0.004048583	0	12	EN-MIX	NA	NA	NA
TACCTTAGTCCGAAGA-1_4_A5	13.93935866	-31.26094678	3	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2919	6529	0.01087456	0.001837954	0	3	EN-L5-6	NA	NA	NA
TACCTTATCACCGGGT-1_4_A5	-15.4022202	-22.43455621	6A	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1457	2412	0.00331675	0.002902156	0	6A	IN-PV	NA	NA	NA
TACGGATGTTCATGGT-1_4_A5	1.312713697	-7.821779823	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1282	2121	0.003771806	0.003771806	0	12	EN-MIX	NA	NA	NA
TACGGTAGTGCCTGGT-1_4_A5	-1.002699339	3.505535669	11	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1144	1800	0.002222222	0.003888889	0	11	Glia-MIX	NA	NA	NA
TACGGTAGTTACAGAA-1_4_A5	3.40012007	-27.53223165	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2788	5958	0.00973481	0.002014099	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TACTCATAGCTGAACG-1_4_A5	-33.38825002	-11.55622457	9	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	919	1377	0.000726216	0.002178649	0	9	OPC	NA	NA	NA
TACTCATGTAGCTCCG-1_4_A5	21.3269902	1.457027118	2	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1589	2614	0.000382555	0.001147666	0	2	EN-L4	NA	NA	NA
TACTCGCAGGGTTCCC-1_4_A5	23.17104834	0.4509398	2	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1991	3618	0.003869541	0.002211166	0	2	EN-L4	NA	NA	NA
TACTCGCCAAGCTGTT-1_4_A5	-0.485094341	4.71234106	11	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	721	1052	0.003802281	0.002851711	0	11	Glia-MIX	NA	NA	NA
TACTCGCCAATAACGA-1_4_A5	-27.43152781	10.39812326	8	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	763	1149	0.000870322	0.001740644	0	8	Astrocytes	NA	NA	NA
TACTTACCATAGTAAG-1_4_A5	-14.92569999	-9.301704812	13A	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2161	4287	0.015628645	0.002332634	0	13A	IN-VIP	NA	NA	NA
TACTTACCATTAACCG-1_4_A5	-0.535342359	-12.46634153	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1723	3065	0.00228385	0.001957586	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TACTTACGTAGCTCCG-1_4_A5	15.62595943	-5.047474475	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1222	2100	0.01	0.003333333	0	12	EN-MIX	NA	NA	NA
TACTTACGTCGCTTCT-1_4_A5	18.39774584	1.637990304	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1021	1503	0.003992016	0.001996008	0	12	EN-MIX	NA	NA	NA
TACTTACTCCCTAACC-1_4_A5	5.839291161	34.33863499	1	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	758	1109	0.00541028	0.006311993	0	oligos	OL-Cntl	NA	NA	NA
TACTTGTAGAAAGTGG-1_4_A5	16.76458051	-6.743493033	3	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1802	3209	0.008102213	0.002492988	0	3	EN-L5-6	NA	NA	NA
TACTTGTAGCGATGAC-1_4_A5	6.294103991	-5.701825638	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1178	1899	0.006845708	0.001053186	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TACTTGTGTTCAGGCC-1_4_A5	18.75593765	-6.380652348	3	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1683	3215	0.000622084	0.00155521	0	3	EN-L5-6	NA	NA	NA
TAGACCATCATGTCCC-1_4_A5	2.949062912	-27.84180972	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	3019	7165	0.001674808	0.002512212	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TAGACCATCTCCAACC-1_4_A5	5.003490525	34.13761798	1	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	696	1026	0.001949318	0	0	oligos	OL-Cntl	NA	NA	NA
TAGAGCTTCACAAACC-1_4_A5	-33.17597378	-12.99242999	9	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	762	1064	0.004699248	0.002819549	0	9	OPC	NA	NA	NA
TAGAGCTTCAGTCCCT-1_4_A5	10.71300016	-7.351785867	2	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2004	3767	0.006105654	0.001592779	0	2	EN-L4	NA	NA	NA
TAGCCGGAGATCGGGT-1_4_A5	4.41139637	-30.24773751	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	3236	7447	0.00295421	0.001745669	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TAGCCGGGTATGGTTC-1_4_A5	5.648777296	-5.6189372	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1196	1906	0.006820567	0.002098636	0	12	EN-MIX	NA	NA	NA
TAGCCGGTCTAGCACA-1_4_A5	-4.601287651	-9.633284737	13A	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	789	1139	0.01404741	0.001755926	0	13A	IN-VIP	NA	NA	NA
TAGCCGGTCTGAGGGA-1_4_A5	10.04202238	-8.284028601	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2180	4207	0.000713097	0.003803185	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TAGGCATGTAGAGGAA-1_4_A5	-32.55345449	-13.3765823	9	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	745	1060	0.001886792	0.004716981	0	9	OPC	NA	NA	NA
TAGGCATTCGCCTGTT-1_4_A5	-28.36270214	13.22261096	8	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	789	1235	0.00242915	0.003238866	0	8	Astrocytes	NA	NA	NA
TAGTGGTGTAAACGCG-1_4_A5	26.75918208	-0.206533819	2	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2806	6190	0.007754443	0.002261712	0	2	EN-L4	NA	NA	NA
TAGTGGTGTCGGCATC-1_4_A5	-4.153467283	-8.55906278	13A	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	774	1169	0.02994012	0.005132592	0	13A	IN-VIP	NA	NA	NA
TAGTGGTGTGTTCGAT-1_4_A5	9.056409668	-8.5953197	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2228	4302	0.006973501	0.0013947	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TAGTGGTTCGAGAACG-1_4_A5	-9.900982178	11.82025329	1	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	713	1004	0.00498008	0.003984064	0	oligos	OL-Cntl	NA	NA	NA
TATCAGGCACTAAGTC-1_4_A5	-8.449366069	-18.3325304	6B	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	789	1156	0.006920415	0.003460208	0	6B	IN-SST	NA	NA	NA
TATCAGGCATCACCCT-1_4_A5	22.73751744	0.977360116	2	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1828	3220	0.002795031	0.001863354	0	2	EN-L4	NA	NA	NA
TATCAGGCATGGATGG-1_4_A5	22.26443338	-1.380093588	2	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2154	3796	0.016069547	0.006059009	0	2	EN-L4	NA	NA	NA
TATCAGGCATTAGCCA-1_4_A5	30.74163999	-3.385758395	2	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	3540	7934	0.009579027	0.002520797	0	2	EN-L4	NA	NA	NA
TATCAGGTCCCACTTG-1_4_A5	1.152686183	0.945021703	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	931	1265	0.015019763	0.002371542	0	12	EN-MIX	NA	NA	NA
TATCTCATCGCATGGC-1_4_A5	-0.839118399	-12.80429827	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1914	3391	0.004128576	0.003243881	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TATCTCATCTAACTCT-1_4_A5	0.467289541	0.966298995	11	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1351	2080	0.004807692	0.001923077	0	11	Glia-MIX	NA	NA	NA
TATGCCCAGGCACATG-1_4_A5	4.006735368	-3.604417005	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1042	1668	0.006594724	0.006594724	0	12	EN-MIX	NA	NA	NA
TATGCCCCAAGAGTCG-1_4_A5	21.66603953	1.162905813	2	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1556	2584	0.001547988	0.001547988	0	2	EN-L4	NA	NA	NA
TATGCCCGTCGAGTTT-1_4_A5	-11.07642512	-20.11075652	6A	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	923	1486	0.01345895	0.002018843	0	6A	IN-PV	NA	NA	NA
TATGCCCGTCTTGCGG-1_4_A5	-8.710143261	-17.72368381	6B	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	826	1186	0.003372681	0	0	6B	IN-SST	NA	NA	NA
TCAACGAAGCGCCTCA-1_4_A5	-33.93663624	-10.36074087	9	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	973	1516	0.003298153	0.003957784	0	9	OPC	NA	NA	NA
TCAACGACAACACGCC-1_4_A5	18.01870455	1.44360086	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1059	1580	0.025949367	0.001898734	0	12	EN-MIX	NA	NA	NA
TCAACGATCTGGTGTA-1_4_A5	13.87835312	-32.04894587	3	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	3429	8455	0.002483737	0.002010645	0	3	EN-L5-6	NA	NA	NA
TCAACGATCTTGAGAC-1_4_A5	11.60211392	-8.413916204	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2063	3547	0.005920496	0.001409642	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TCAATCTCATCACAAC-1_4_A5	0.780575729	-10.5620664	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1649	2817	0.004969826	0.005679801	0	12	EN-MIX	NA	NA	NA
TCAATCTGTAACGCGA-1_4_A5	16.3155468	1.671170082	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	890	1260	0.01031746	0.003174603	0	12	EN-MIX	NA	NA	NA
TCACAAGAGGGATACC-1_4_A5	2.262171292	-10.6254174	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1693	2849	0.009126009	0.002808003	0	12	EN-MIX	NA	NA	NA
TCACAAGAGTACGCGA-1_4_A5	3.447766847	-6.857295396	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1233	1858	0.012378902	0.002152853	0	12	EN-MIX	NA	NA	NA
TCACAAGAGTGTACGG-1_4_A5	-11.98161048	-10.31067061	13A	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1701	2820	0.017375887	0.00177305	0	13A	IN-VIP	NA	NA	NA
TCACAAGCAGACACTT-1_4_A5	-0.636330966	-14.75804231	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2276	4373	0.00114338	0.005259547	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TCACAAGCATCTACGA-1_4_A5	22.29043462	-8.749627652	3	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2180	4297	0.001629044	0.002327205	0	3	EN-L5-6	NA	NA	NA
TCACAAGTCGTAGGTT-1_4_A5	3.639986763	-5.130979268	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	928	1267	0.00789266	0.002367798	0	12	EN-MIX	NA	NA	NA
TCAGATGTCCACGAAT-1_4_A5	11.17221825	-9.047031124	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2926	6515	0.002609363	0.002609363	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TCAGATGTCTCATTCA-1_4_A5	24.67216544	-27.33474037	3	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2681	6302	0.008886068	0.002538877	0	3	EN-L5-6	NA	NA	NA
TCAGCAACATGTCCTC-1_4_A5	30.39747367	-3.1563564	2	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	3468	7715	0.0022035	0.004018146	0	2	EN-L4	NA	NA	NA
TCAGCAAGTACGCACC-1_4_A5	3.674705026	26.28514609	1	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	828	1194	0.014237856	0.006700168	0	oligos	OL-Cntl	NA	NA	NA
TCAGCAAGTTACCGAT-1_4_A5	10.2824835	28.16397585	1	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	868	1327	0.003767898	0.005275057	0	oligos	OL-Cntl	NA	NA	NA
TCAGCAATCTTATCTG-1_4_A5	14.02030695	-1.530945919	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1068	2096	0.000477099	0.006679389	0	12	EN-MIX	NA	NA	NA
TCAGCTCCACATTTCT-1_4_A5	-10.38030865	-20.68274789	6B	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	885	1312	0.003810976	0.002286585	0	6B	IN-SST	NA	NA	NA
TCAGCTCGTCAAGCGA-1_4_A5	18.5301987	1.575894079	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1121	1690	0.002366864	0.00295858	0	12	EN-MIX	NA	NA	NA
TCAGCTCTCCCAAGTA-1_4_A5	-8.741317353	-13.70821011	6B	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	766	1159	0.022433132	0.011216566	0	6B	IN-SST	NA	NA	NA
TCAGCTCTCCTACAGA-1_4_A5	-1.472595842	3.120215472	11	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1468	2537	0.004729996	0.004729996	0	11	Glia-MIX	NA	NA	NA
TCAGGATTCAAGCCTA-1_4_A5	3.341950683	-12.34287081	4	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2100	3598	0.006948305	0.00639244	0	L2-3	EN-L2-3-MS	NA	NA	NA
TCAGGTACACCAGGTC-1_4_A5	-11.84263467	13.15626709	11	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	843	1230	0.004878049	0.006504065	0	11	Glia-MIX	NA	NA	NA
TCATTACAGAAACCTA-1_4_A5	-0.490152041	4.695201513	11	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	715	1123	0.002671416	0.00445236	0	11	Glia-MIX	NA	NA	NA
TCATTACCATGACGGA-1_4_A5	-16.78035538	-9.228477771	13B	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2971	6020	0.01345515	0.004983389	0	13B	IN-SV2C	NA	NA	NA
TCATTTGGTGGCTCCA-1_4_A5	-12.33842807	-22.74183282	6A	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1151	1829	0.036632039	0.003827228	0	6A	IN-PV	NA	NA	NA
TCATTTGTCATGCTCC-1_4_A5	-0.784049984	3.479617531	11	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1001	1586	0.001261034	0.002522068	0	11	Glia-MIX	NA	NA	NA
TCATTTGTCCAACCAA-1_4_A5	12.1617948	31.42169615	1	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	682	1023	0.003910068	0	0	oligos	OL-Cntl	NA	NA	NA
TCCACACAGACAATAC-1_4_A5	11.9603653	29.9621219	1	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	771	1267	0	0.002367798	0	oligos	OL-Cntl	NA	NA	NA
TCCACACAGCTAGTCT-1_4_A5	-2.754824549	2.28932089	11	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2048	3968	0.002268145	0.004284274	0	11	Glia-MIX	NA	NA	NA
TCCACACCATGGTCTA-1_4_A5	-12.71773701	14.55240088	11	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	930	1395	0.005734767	0.001433692	0	11	Glia-MIX	NA	NA	NA
TCCACACGTCTGATCA-1_4_A5	-3.29044079	-6.007612618	13A	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	965	1564	0.00511509	0.001918159	0	13A	IN-VIP	NA	NA	NA
TCCACACTCACTGGGC-1_4_A5	-4.811326474	3.101961879	11	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	3332	7756	0.003094379	0.004125838	0	11	Glia-MIX	NA	NA	NA
TCCCGATCAACACCTA-1_4_A5	11.76843769	32.51271155	1	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	816	1241	0.002417405	0.004029009	0	oligos	OL-Cntl	NA	NA	NA
TCCCGATGTCAATACC-1_4_A5	-20.5397219	-27.86595966	6A	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	3572	9148	0.010603411	0.002514211	0	6A	IN-PV	NA	NA	NA
TCGAGGCAGCAACGGT-1_4_A5	22.84625443	-9.066536356	3	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2588	5074	0.001970832	0.001773749	0	3	EN-L5-6	NA	NA	NA
TCGAGGCCATCTATGG-1_4_A5	-9.072406629	13.64278612	11	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1362	2198	0.001364877	0.006824386	0	11	Glia-MIX	NA	NA	NA
TCGAGGCCATTGGCGC-1_4_A5	-32.51474048	-12.22981479	9	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	806	1128	0.000886525	0.00177305	0	9	OPC	NA	NA	NA
TCGAGGCGTAGCCTCG-1_4_A5	-3.685410593	-7.901979343	13A	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	775	1085	0.005529954	0.000921659	0	13A	IN-VIP	NA	NA	NA
TCGAGGCTCGCAGGCT-1_4_A5	19.18583494	-7.282000473	3	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2301	4856	0.005766063	0.003500824	0	3	EN-L5-6	NA	NA	NA
TCGCGAGAGGAATTAC-1_4_A5	6.334946741	25.94602076	1	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	814	1135	0.003524229	0.008810573	0	oligos	OL-Cntl	NA	NA	NA
TCGCGAGGTCTAGTCA-1_4_A5	-1.997512908	2.714707644	11	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1602	2755	0.005444646	0.006533575	0	11	Glia-MIX	NA	NA	NA
TCGCGTTAGCCGTCGT-1_4_A5	0.65941452	-10.79938497	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1646	2755	0.001451906	0.001814882	0	12	EN-MIX	NA	NA	NA
TCGCGTTTCACATAGC-1_4_A5	4.509197713	-1.805493281	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	875	1299	0.003079292	0.010007698	0	12	EN-MIX	NA	NA	NA
TCGGGACAGGAGCGTT-1_4_A5	22.14945355	-0.035349533	2	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1862	3203	0.016546987	0.002809866	0	2	EN-L4	NA	NA	NA
TCGGGACAGTCCAGGA-1_4_A5	16.49222989	-6.800012759	3	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1930	3615	0.004979253	0.001936376	0	3	EN-L5-6	NA	NA	NA
TCGGGACCAGCTCGAC-1_4_A5	4.150143073	-4.050428879	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1061	1676	0.003579952	0.001193317	0	12	EN-MIX	NA	NA	NA
TCGGGACTCCTCGCAT-1_4_A5	20.7695211	-27.88583823	3	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	3550	8629	0.006142079	0.003013095	0	3	EN-L5-6	NA	NA	NA
TCGGGACTCTTAGCCC-1_4_A5	2.437970985	-6.880662191	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1217	2182	0.00091659	0.005499542	0	12	EN-MIX	NA	NA	NA
TCGGTAAAGTTTCCTT-1_4_A5	15.03255775	29.84299143	1	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	781	1124	0.003558719	0.002669039	0	oligos	OL-Cntl	NA	NA	NA
TCGGTAACACATTTCT-1_4_A5	-0.805721727	3.761544698	11	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1014	1646	0.0018226	0.006075334	0	11	Glia-MIX	NA	NA	NA
TCGGTAAGTAGGCATG-1_4_A5	4.125140859	-2.651874162	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	735	1020	0.015686275	0.006862745	0	12	EN-MIX	NA	NA	NA
TCGTACCAGCAACGGT-1_4_A5	-37.65031217	-0.182392682	9	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1435	2307	0.008235804	0.00390117	0	9	OPC	NA	NA	NA
TCGTACCGTTCCCGAG-1_4_A5	2.202922088	-16.92128551	4	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2660	5511	0.007076756	0.007621121	0	L2-3	EN-L2-3-MS	NA	NA	NA
TCGTACCTCCCAAGTA-1_4_A5	21.55589903	-8.316616528	3	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1760	2897	0.000690369	0.001380739	0	3	EN-L5-6	NA	NA	NA
TCTATTGAGTATGACA-1_4_A5	6.49819254	-5.944801669	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1241	2016	0.006448413	0.001488095	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TCTCATAAGCTAACTC-1_4_A5	-12.08620425	14.79550407	11	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1066	1637	0.003054368	0.003054368	0	11	Glia-MIX	NA	NA	NA
TCTCATACACCTATCC-1_4_A5	-16.91441676	-11.09183313	13B	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	3895	10526	0.009215276	0.003040091	0	13B	IN-SV2C	NA	NA	NA
TCTCTAAGTCAAAGAT-1_4_A5	-6.715999768	-1.561301437	13A	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1690	2997	0.016349683	0.003670337	0	13A	IN-VIP	NA	NA	NA
TCTGGAAGTAAACGCG-1_4_A5	8.248838585	-7.243684327	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1624	2800	0.005	0.003214286	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TCTGGAATCAACGAAA-1_4_A5	-8.675156572	-18.0052202	6B	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	772	1162	0.018932874	0.00172117	0	6B	IN-SST	NA	NA	NA
TCTGGAATCTGATTCT-1_4_A5	25.31208313	-0.13400144	2	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2426	4845	0.006811146	0.001444788	0	2	EN-L4	NA	NA	NA
TCTTCGGGTACCGTAT-1_4_A5	25.40269337	-2.475191635	2	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2928	6920	0.005491329	0.001589595	0	2	EN-L4	NA	NA	NA
TCTTCGGTCCAACCAA-1_4_A5	2.682531582	-5.563541755	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1066	1596	0.006265664	0.003132832	0	12	EN-MIX	NA	NA	NA
TCTTTCCAGCGGATCA-1_4_A5	-3.331402014	-5.567694854	13A	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	915	1337	0.005983545	0	0	13A	IN-VIP	NA	NA	NA
TGACAACAGTGCGTGA-1_4_A5	25.38208716	-2.456241211	2	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2890	6401	0.00140603	0.002812061	0	2	EN-L4	NA	NA	NA
TGACAACCACGAAGCA-1_4_A5	23.8833314	0.197037776	2	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2074	3885	0.004890605	0.001544402	0	2	EN-L4	NA	NA	NA
TGACAACCATGCTGGC-1_4_A5	3.721763474	31.00181092	1	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	731	1053	0.004748338	0.004748338	0	oligos	OL-Cntl	NA	NA	NA
TGACAACGTCTAACGT-1_4_A5	21.90576488	-8.544945151	3	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2040	3791	0.005803218	0.002110261	0	3	EN-L5-6	NA	NA	NA
TGACAACGTGCGCTTG-1_4_A5	-5.362281284	-4.157840063	13A	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1357	2168	0.00599631	0.004151292	0	13A	IN-VIP	NA	NA	NA
TGACGGCAGATGTGGC-1_4_A5	18.47455509	-5.722445373	3	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1548	2701	0.011106997	0.002221399	0	3	EN-L5-6	NA	NA	NA
TGACGGCTCGTACCGG-1_4_A5	13.05049072	-9.330299883	3	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2235	4556	0.001097454	0.001975417	0	3	EN-L5-6	NA	NA	NA
TGACGGCTCGTCTGAA-1_4_A5	-2.969382396	2.331890043	11	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2203	3980	0.002512563	0.005276382	0	11	Glia-MIX	NA	NA	NA
TGACTAGCACATAACC-1_4_A5	14.39877217	-32.38070332	3	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	4338	12411	0.005881879	0.001772621	0	3	EN-L5-6	NA	NA	NA
TGACTAGTCGTTTAGG-1_4_A5	-9.939859084	11.86961041	11	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	806	1124	0.001779359	0.008007117	0	11	Glia-MIX	NA	NA	NA
TGACTTTCAATGAATG-1_4_A5	-0.092909456	-16.30544188	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2232	3993	0.007763586	0.004758327	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TGAGAGGAGCGATTCT-1_4_A5	23.01257714	-0.755736776	2	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2032	3759	0.020218143	0.003990423	0	2	EN-L4	NA	NA	NA
TGAGAGGCATGGGACA-1_4_A5	-0.898711749	4.07005407	11	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	940	1385	0.002166065	0.003610108	0	11	Glia-MIX	NA	NA	NA
TGAGAGGGTAGAAGGA-1_4_A5	-4.059957741	-7.165975435	13A	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	976	1424	0.004213483	0.002808989	0	13A	IN-VIP	NA	NA	NA
TGAGGGACAAGTTAAG-1_4_A5	23.23012623	-9.324792526	3	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	3383	7370	0.00936228	0.004613297	0	3	EN-L5-6	NA	NA	NA
TGAGGGAGTGCTCTTC-1_4_A5	-0.523596333	4.785637908	11	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	748	1086	0.001841621	0.00092081	0	11	Glia-MIX	NA	NA	NA
TGAGGGATCCTATTCA-1_4_A5	1.657760076	-10.34132615	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1609	2587	0.006571318	0.001159644	0	12	EN-MIX	NA	NA	NA
TGATTTCTCCCAAGAT-1_4_A5	16.2797724	27.41254498	1	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	846	1187	0.00673968	0.0042123	0	oligos	OL-Cntl	NA	NA	NA
TGCACCTCATATGCTG-1_4_A5	24.37386448	-0.256550335	2	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2149	4146	0.00265316	0.001447178	0	2	EN-L4	NA	NA	NA
TGCACCTGTCTAGTCA-1_4_A5	-11.70964661	-10.97482622	6B	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1183	1865	0.025737265	0	0	6B	IN-SST	NA	NA	NA
TGCACCTTCAACACAC-1_4_A5	7.932749297	-32.44828544	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	3365	8086	0.019663616	0.000742023	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TGCACCTTCCGCGCAA-1_4_A5	4.011223497	-8.953387395	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1714	3412	0.003810082	0.004396249	0	12	EN-MIX	NA	NA	NA
TGCCAAAAGGTTACCT-1_4_A5	16.34115861	1.668119045	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	860	1174	0	0.000851789	0	12	EN-MIX	NA	NA	NA
TGCCAAAGTTATCACG-1_4_A5	25.79042675	-2.538362709	2	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	3200	7107	0.006331786	0.002673421	0	2	EN-L4	NA	NA	NA
TGCCCATGTCAGAAGC-1_4_A5	-10.20989237	15.04779769	11	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1635	2811	0.001067236	0.004980434	0	11	Glia-MIX	NA	NA	NA
TGCCCATTCCCAAGAT-1_4_A5	-4.49880493	3.388343481	11	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	3205	6520	0.004141104	0.00797546	0	11	Glia-MIX	NA	NA	NA
TGCCCATTCTGAAAGA-1_4_A5	-34.9559255	-11.61234305	9	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	808	1233	0.00162206	0.00567721	0	9	OPC	NA	NA	NA
TGCCCTATCAACACTG-1_4_A5	24.19867466	-6.35926812	2	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	3545	8163	0.003430111	0.002327576	0	2	EN-L4	NA	NA	NA
TGCCCTATCTACGAGT-1_4_A5	5.310676441	-2.568946161	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	938	1451	0.013094418	0.007580979	0	12	EN-MIX	NA	NA	NA
TGCGCAGGTACGCACC-1_4_A5	21.08266022	1.519983229	2	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1310	2125	0.000470588	0.000941176	0	2	EN-L4	NA	NA	NA
TGCGCAGGTATATGAG-1_4_A5	4.692980978	-31.07789595	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	4246	11755	0.003147597	0.002467035	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TGCGCAGTCACCTTAT-1_4_A5	-15.77316548	-10.20844179	13B	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2640	5336	0.007683658	0.004122939	0	13B	IN-SV2C	NA	NA	NA
TGCGCAGTCAGCTCGG-1_4_A5	-32.6225031	-12.48805151	9	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	790	1130	0.003539823	0.003539823	0	9	OPC	NA	NA	NA
TGCGCAGTCCAGAGGA-1_4_A5	-10.95635918	12.85381879	11	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	935	1407	0.001421464	0.002132196	0	11	Glia-MIX	NA	NA	NA
TGCGGGTAGAGCTTCT-1_4_A5	-0.516685621	4.737677574	11	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	794	1120	0.000892857	0.004464286	0	11	Glia-MIX	NA	NA	NA
TGCGGGTTCAGTCAGT-1_4_A5	13.25413237	-32.63022172	3	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	3376	8285	0.004103802	0.002293301	0	3	EN-L5-6	NA	NA	NA
TGCGTGGAGCTTCGCG-1_4_A5	-0.521350178	4.741141526	11	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	703	1026	0.003898635	0.005847953	0	11	Glia-MIX	NA	NA	NA
TGCGTGGAGGGTCTCC-1_4_A5	23.41773302	-25.85283393	3	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2649	5572	0.001076813	0.003589375	0	3	EN-L5-6	NA	NA	NA
TGCGTGGCACAGACTT-1_4_A5	-18.5948841	6.587157873	8	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	780	1201	0	0.006661116	0	8	Astrocytes	NA	NA	NA
TGCGTGGGTCATATGC-1_4_A5	17.14897158	-4.851075413	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1234	2085	0.005275779	0.004796163	0	12	EN-MIX	NA	NA	NA
TGCGTGGGTCATGCCG-1_4_A5	-2.348098016	2.452854728	11	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1621	2818	0.003548616	0.006032647	0	11	Glia-MIX	NA	NA	NA
TGCGTGGGTCCGACGT-1_4_A5	-27.18728169	14.29549314	8	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1017	1545	0.003236246	0.001294498	0	8	Astrocytes	NA	NA	NA
TGCGTGGTCGCATGGC-1_4_A5	-4.153634513	-8.728856367	13A	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	843	1212	0.010726073	0.002475248	0	13A	IN-VIP	NA	NA	NA
TGCTACCAGTGGAGAA-1_4_A5	-0.950539778	3.582536789	11	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1103	1694	0.003541913	0.004132231	0	11	Glia-MIX	NA	NA	NA
TGCTACCCATCTCCCA-1_4_A5	24.05638376	-0.017143125	2	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1980	3648	0.002192982	0.001370614	0	2	EN-L4	NA	NA	NA
TGCTACCGTCGGATCC-1_4_A5	-16.59800302	-25.41191468	6A	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2077	3915	0.008429119	0.001532567	0	6A	IN-PV	NA	NA	NA
TGCTGCTCAGACGCAA-1_4_A5	-9.514457313	-15.84775572	6B	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1065	1876	0.014392324	0.003731343	0	6B	IN-SST	NA	NA	NA
TGCTGCTGTAGCACGA-1_4_A5	1.151719948	-8.052156488	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1423	2434	0.015201315	0.003697617	0	12	EN-MIX	NA	NA	NA
TGCTGCTGTCTTGCGG-1_4_A5	18.34944443	-6.221771157	3	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1742	3116	0.000962773	0.001604621	0	3	EN-L5-6	NA	NA	NA
TGCTGCTTCACAAACC-1_4_A5	25.22884194	-2.797540499	2	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2838	6366	0.000314169	0.000785423	0	2	EN-L4	NA	NA	NA
TGCTGCTTCGCGATCG-1_4_A5	-5.175492621	-5.034749467	13A	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1129	1729	0.022556391	0.00578369	0	13A	IN-VIP	NA	NA	NA
TGGACGCCACGCCAGT-1_4_A5	-1.770731885	-19.04302538	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	3057	6447	0.004963549	0.002171553	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TGGACGCTCTCTGCTG-1_4_A5	-21.53763517	-26.42584885	6A	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2500	4830	0.01863354	0.002898551	0	6A	IN-PV	NA	NA	NA
TGGACGCTCTTGCCGT-1_4_A5	-27.8977527	8.491581634	8	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	648	1021	0.002938296	0.001958864	0	8	Astrocytes	NA	NA	NA
TGGCCAGAGCCACGTC-1_4_A5	9.046532295	-8.803914245	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2462	4941	0.007893139	0.002631046	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TGGCCAGCAAGTTAAG-1_4_A5	18.69624486	1.413513974	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1256	1938	0.00877193	0.002063983	0	12	EN-MIX	NA	NA	NA
TGGCCAGCAATGAAAC-1_4_A5	-10.86876175	7.657871574	1	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2935	6045	0.003804797	0.004797353	0	oligos	OL-Cntl	NA	NA	NA
TGGCCAGGTCAAGCGA-1_4_A5	-7.855960388	-1.616726076	13A	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1830	3154	0.0082435	0.002219404	0	13A	IN-VIP	NA	NA	NA
TGGCCAGGTCAGAAGC-1_4_A5	-11.67319993	13.66565825	11	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	886	1393	0.002153625	0.007178751	0	11	Glia-MIX	NA	NA	NA
TGGCCAGGTGTAACGG-1_4_A5	32.16756101	-2.875652582	2	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2662	5038	0.014291385	0.002580389	0	2	EN-L4	NA	NA	NA
TGGCGCAAGTCGAGTG-1_4_A5	-11.60651124	-22.29770812	6A	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1021	1685	0.011869436	0.001780415	0	6A	IN-PV	NA	NA	NA
TGGCGCACACCAGGTC-1_4_A5	-8.192438832	-15.71934697	6B	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	696	1240	0.003225806	0.006451613	0	6B	IN-SST	NA	NA	NA
TGGCGCACACGTCAGC-1_4_A5	-24.80998934	6.228561031	8	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	753	1285	0.00233463	0.007003891	0	8	Astrocytes	NA	NA	NA
TGGCTGGAGCAGACTG-1_4_A5	-9.065804159	-20.0776678	6B	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	680	1077	0.020427112	0.002785515	0	6B	IN-SST	NA	NA	NA
TGGCTGGGTAAGGATT-1_4_A5	23.07147494	0.078465895	2	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2060	3959	0.016418287	0.003031068	0	2	EN-L4	NA	NA	NA
TGGCTGGTCTTGCATT-1_4_A5	-17.40760585	-17.42533541	6B	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2068	4026	0.009687034	0.001738698	0	6B	IN-SST	NA	NA	NA
TGGGAAGAGCCACGTC-1_4_A5	-9.818878191	-17.71028339	6B	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	930	1382	0.010853835	0.000723589	0	6B	IN-SST	NA	NA	NA
TGGGAAGGTACCGAGA-1_4_A5	17.32231174	-4.984771867	3	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1239	1870	0.003743316	0.002673797	0	3	EN-L5-6	NA	NA	NA
TGGGAAGTCTGCTGCT-1_4_A5	-0.796936049	-0.417840055	11	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1401	2199	0.008185539	0.005002274	0	11	Glia-MIX	NA	NA	NA
TGGGCGTAGCGTGAAC-1_4_A5	-4.617624348	-9.254002387	13A	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	806	1179	0.015267176	0.005937235	0	13A	IN-VIP	NA	NA	NA
TGGGCGTCATCGATTG-1_4_A5	14.28882555	0.108405996	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	664	1092	0	0.007326007	0	12	EN-MIX	NA	NA	NA
TGGGCGTGTCGATTGT-1_4_A5	-9.743885008	13.2342871	11	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1283	2054	0	0.004868549	0	11	Glia-MIX	NA	NA	NA
TGGGCGTGTCTCTCTG-1_4_A5	1.203271244	-11.22197792	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1703	2878	0.005559416	0.002084781	0	12	EN-MIX	NA	NA	NA
TGGGCGTGTGCACCAC-1_4_A5	-34.14019327	-12.47688162	9	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	741	1198	0.002504174	0.001669449	0	9	OPC	NA	NA	NA
TGGGCGTTCAAAGTAG-1_4_A5	4.394011787	26.63836833	1	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	807	1137	0.002638522	0.006156552	0	oligos	OL-Cntl	NA	NA	NA
TGGGCGTTCAGGATCT-1_4_A5	-5.843532003	-4.067778257	13A	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1408	2390	0.005857741	0.0041841	0	13A	IN-VIP	NA	NA	NA
TGGGCGTTCTCCCTGA-1_4_A5	23.84375391	-8.626586424	2	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	3514	8272	0.011484526	0.001571567	0	2	EN-L4	NA	NA	NA
TGGTTAGTCTGTGCAA-1_4_A5	-3.350360984	-6.043136383	13A	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	994	1542	0.01232166	0.001945525	0	13A	IN-VIP	NA	NA	NA
TGGTTCCAGGTGATTA-1_4_A5	-0.124840241	-15.64396889	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2406	4708	0.00531011	0.002548853	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TGGTTCCCATCCGGGT-1_4_A5	-9.386124027	-20.56800757	6B	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	712	1208	0.014900662	0.005794702	0	6B	IN-SST	NA	NA	NA
TGGTTCCCATCTCCCA-1_4_A5	3.923033744	31.54694533	1	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	755	1021	0.007835455	0.002938296	0	oligos	OL-Cntl	NA	NA	NA
TGTATTCCAGAGCCAA-1_4_A5	-22.80885295	-1.629035118	9	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	908	1245	0.002409639	0.000803213	0	9	OPC	NA	NA	NA
TGTATTCCATCGGAAG-1_4_A5	3.004099695	-26.83209421	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2827	5631	0.003551767	0.004794885	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TGTCCCAAGTTATCGC-1_4_A5	5.831215315	-31.13289161	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	3729	8819	0.002494614	0.002608005	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TGTCCCAGTTCGTTGA-1_4_A5	21.03850765	-29.0731091	3	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	3820	9280	0.000862069	0.002909483	0	3	EN-L5-6	NA	NA	NA
TGTCCCATCGCGTAGC-1_4_A5	-7.227245185	-2.722748018	13A	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1665	2673	0.00748223	0.004489338	0	13A	IN-VIP	NA	NA	NA
TGTCCCATCTGCAAGT-1_4_A5	-3.64268506	-5.131419591	13A	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1128	1771	0.004517222	0.004517222	0	13A	IN-VIP	NA	NA	NA
TGTGGTAAGGGTTCCC-1_4_A5	12.80618342	-1.058764699	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	965	1561	0.007046765	0.00512492	0	12	EN-MIX	NA	NA	NA
TGTGGTAGTAAGTAGT-1_4_A5	-26.36797071	9.62531121	8	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	770	1148	0	0.004355401	0	8	Astrocytes	NA	NA	NA
TGTGTTTCATGCCCGA-1_4_A5	-0.524870157	4.66148577	11	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	790	1206	0.00331675	0.004145937	0	11	Glia-MIX	NA	NA	NA
TGTGTTTGTTACCAGT-1_4_A5	24.80831751	-24.40350946	3	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	3310	7172	0.00250976	0.005577245	0	3	EN-L5-6	NA	NA	NA
TGTTCCGAGAGTTGGC-1_4_A5	16.52363441	1.707338169	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	808	1169	0.007698888	0.003421728	0	12	EN-MIX	NA	NA	NA
TGTTCCGAGCCACGTC-1_4_A5	18.25882239	-5.420563725	3	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1339	2223	0.000899685	0.002249213	0	3	EN-L5-6	NA	NA	NA
TGTTCCGCATGAACCT-1_4_A5	-9.02128947	-18.62900364	6B	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	791	1078	0.031539889	0.004638219	0	6B	IN-SST	NA	NA	NA
TGTTCCGGTCATGCCG-1_4_A5	-19.00648762	7.025593729	8	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	813	1200	0.004166667	0.005	0	8	Astrocytes	NA	NA	NA
TTAACTCAGCCGATTT-1_4_A5	18.49615331	-6.332185097	3	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1670	2848	0.009129213	0.002457865	0	3	EN-L5-6	NA	NA	NA
TTAACTCAGCTACCTA-1_4_A5	8.251565934	-6.991177458	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1505	2658	0.01241535	0.001881114	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TTAACTCCACAAGACG-1_4_A5	17.82010733	1.350247478	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	919	1341	0	0.002982849	0	12	EN-MIX	NA	NA	NA
TTAACTCTCAGCTCTC-1_4_A5	-28.50468437	22.1657865	8	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1027	1609	0.003729024	0.003729024	0	8	Astrocytes	NA	NA	NA
TTAGGACAGAAGATTC-1_4_A5	8.489735553	-7.879174818	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1836	3517	0.001137333	0.001137333	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TTAGGACGTTATGCGT-1_4_A5	16.01375947	-5.261178706	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1262	2166	0.001846722	0.002308403	0	12	EN-MIX	NA	NA	NA
TTAGGACGTTTGTTGG-1_4_A5	-0.146667383	-11.4656415	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1544	2599	0.001539053	0.00346287	0	12	EN-MIX	NA	NA	NA
TTAGGCACACATAACC-1_4_A5	-16.48669322	-26.1245907	6A	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2006	4040	0.006435644	0.002475248	0	6A	IN-PV	NA	NA	NA
TTAGGCACACCATCCT-1_4_A5	-13.03262505	-18.2799226	6B	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1221	2009	0.022896964	0.00298656	0	6B	IN-SST	NA	NA	NA
TTAGGCACAGACGCCT-1_4_A5	19.72460074	1.62182056	2	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1513	2591	0.004245465	0.000771903	0	2	EN-L4	NA	NA	NA
TTAGGCAGTCGCGAAA-1_4_A5	-28.05906687	9.690245358	8	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	766	1128	0.00177305	0.002659574	0	8	Astrocytes	NA	NA	NA
TTAGTTCGTAGCGTCC-1_4_A5	21.58319121	0.991082213	2	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1513	2616	0.021788991	0.000764526	0	2	EN-L4	NA	NA	NA
TTATGCTTCGTCTGAA-1_4_A5	19.61849376	0.082223343	2	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1371	2132	0.007973734	0.002814259	0	2	EN-L4	NA	NA	NA
TTATGCTTCTGCCCTA-1_4_A5	-4.652121369	-5.00526881	13A	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1132	1729	0.01735107	0.001735107	0	13A	IN-VIP	NA	NA	NA
TTCCCAGGTTCTGGTA-1_4_A5	3.486246341	-5.025202542	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1052	1542	0.002594034	0.004539559	0	12	EN-MIX	NA	NA	NA
TTCGGTCAGGTGACCA-1_4_A5	1.263077438	-9.599473677	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1495	2377	0.00252419	0.00504838	0	12	EN-MIX	NA	NA	NA
TTCGGTCCAAGTCATC-1_4_A5	-15.35011856	-23.82079981	6A	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1666	2871	0.016370603	0.003483107	0	6A	IN-PV	NA	NA	NA
TTCGGTCGTACCATCA-1_4_A5	5.607145818	-1.700981335	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	714	1038	0.012524085	0.00867052	0	12	EN-MIX	NA	NA	NA
TTCGGTCGTCAGAATA-1_4_A5	11.2762617	-8.461020085	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2588	5487	0.003098232	0.001275743	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TTCGGTCGTTGCTCCT-1_4_A5	17.6291783	1.627445686	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	938	1301	0.003074558	0	0	12	EN-MIX	NA	NA	NA
TTCTACAAGGAGTTTA-1_4_A5	-32.8845841	-12.23749443	9	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	817	1165	0.005150215	0.001716738	0	9	OPC	NA	NA	NA
TTCTACACAATCCGAT-1_4_A5	-3.806580538	-4.080679424	13A	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1210	2008	0.030876494	0.001494024	0	13A	IN-VIP	NA	NA	NA
TTCTACACATTTGCTT-1_4_A5	5.288726525	-7.566725839	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1404	2191	0.005020539	0.002738476	0	12	EN-MIX	NA	NA	NA
TTCTACATCTCTGTCG-1_4_A5	-3.791813962	-6.006817378	13A	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1052	1572	0.019083969	0.000636132	0	13A	IN-VIP	NA	NA	NA
TTCTCAAGTATGCTTG-1_4_A5	-11.49172687	-22.26735067	6A	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1008	1588	0.012594458	0.003778338	0	6A	IN-PV	NA	NA	NA
TTCTCCTAGATAGGAG-1_4_A5	17.59908953	-5.394842051	3	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1251	1922	0.002601457	0.005202914	0	3	EN-L5-6	NA	NA	NA
TTCTTAGAGGCTAGCA-1_4_A5	2.932576122	-5.781560281	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1018	1562	0.014084507	0.000640205	0	12	EN-MIX	NA	NA	NA
TTCTTAGGTACTCTCC-1_4_A5	17.43688454	1.574152437	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	907	1295	0.006949807	0.003088803	0	12	EN-MIX	NA	NA	NA
TTGAACGGTAAGTGGC-1_4_A5	-15.20730645	-24.93509787	6A	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1625	2873	0.008701706	0.001392273	0	6A	IN-PV	NA	NA	NA
TTGAACGGTGTCCTCT-1_4_A5	6.85407065	-5.899431343	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1235	2057	0.00097229	0.003889159	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TTGAACGTCCAGTAGT-1_4_A5	-32.59907605	-12.7751794	9	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	813	1176	0.00170068	0.00085034	0	9	OPC	NA	NA	NA
TTGACTTCACCAGTTA-1_4_A5	8.183560181	-7.026458113	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1552	2878	0.001737318	0.001389854	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TTGACTTCATTGTGCA-1_4_A5	3.997814066	-3.4661346	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	857	1184	0.006756757	0.006756757	0	12	EN-MIX	NA	NA	NA
TTGCCGTAGTAGCCGA-1_4_A5	25.26472553	-1.960899423	2	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2781	5701	0.008594983	0.001929486	0	2	EN-L4	NA	NA	NA
TTGCCGTCAAGTTAAG-1_4_A5	6.510747704	-5.813219939	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1281	2125	0.005647059	0.001882353	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TTGCCGTGTACCGTTA-1_4_A5	25.25649888	-1.911421053	2	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2636	5394	0.006117909	0.001112347	0	2	EN-L4	NA	NA	NA
TTGCGTCCATATGGTC-1_4_A5	-26.63800144	9.784500606	8	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	854	1209	0.00082713	0.004135649	0	8	Astrocytes	NA	NA	NA
TTGGAACCAAACGTGG-1_4_A5	3.603479388	-5.305274647	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1067	1536	0.0078125	0.002604167	0	12	EN-MIX	NA	NA	NA
TTGGAACCAACCGCCA-1_4_A5	16.43570566	17.45112855	1	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1039	1751	0.00513992	0.004568818	0	oligos	OL-Cntl	NA	NA	NA
TTGGCAACACCTATCC-1_4_A5	14.10877189	-1.382832077	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	904	1471	0.002039429	0.009517335	0	12	EN-MIX	NA	NA	NA
TTGTAGGGTACTTCTT-1_4_A5	1.332906571	-8.081193063	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1338	2159	0.001389532	0.004631774	0	12	EN-MIX	NA	NA	NA
TTTACTGGTACCGCTG-1_4_A5	18.56220285	1.483203011	12	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1121	1757	0.013090495	0.001707456	0	12	EN-MIX	NA	NA	NA
TTTATGCCAATAGCAA-1_4_A5	7.547412679	-8.279275336	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2006	3632	0.007984581	0.004129956	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TTTATGCGTTGAGGTG-1_4_A5	9.958381218	-8.553168278	10	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	2056	4156	0.002887392	0.000721848	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TTTCCTCCAGTCTTCC-1_4_A5	19.47727273	1.701813328	2	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1275	2096	0.010019084	0.001908397	0	2	EN-L4	NA	NA	NA
TTTGGTTCAACCGCCA-1_4_A5	11.03700434	31.49501254	1	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	844	1262	0.003961965	0.002377179	0	oligos	OL-Cntl	NA	NA	NA
TTTGGTTCATCACAAC-1_4_A5	21.80344775	1.346124071	2	4_A5	Control	Control	61	female	prefrontal	CAP1	SEQ1	7.3	15	1669	3015	0.0013267	0.00199005	0	2	EN-L4	NA	NA	NA
AAACCTGAGAAACCTA-1_4_D9	-9.162342546	-8.217923948	13A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1376	1878	0.003194888	0.014376997	12	13A	IN-VIP	23	6	6
AAACCTGGTAAACGCG-1_4_D9	-22.23350556	-22.28770537	6A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	2287	4064	0.01230315	0.006151575	12	6A	IN-PV	23	6	6
AAAGATGCAGACAAAT-1_4_D9	-7.911495029	-10.49085664	6B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	848	1080	0.010185185	0.011111111	12	6B	IN-SST	23	6	6
AAAGATGCATATACGC-1_4_D9	-20.87572352	-25.99269379	6A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	3477	8531	0.001758293	0.004688782	12	6A	IN-PV	23	6	6
AAAGATGTCACAATGC-1_4_D9	-9.610767327	-13.17877799	6B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	994	1349	0.003706449	0.004447739	12	6B	IN-SST	23	6	6
AAAGCAAAGGCACATG-1_4_D9	-22.1893622	-22.32419089	6A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	2136	3582	0.005862647	0.008096036	12	6A	IN-PV	23	6	6
AAAGTAGCAAACCCAT-1_4_D9	-11.99924367	-9.111355243	13B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1799	3006	0.004657352	0.008982036	12	13B	IN-SV2C	23	6	6
AAAGTAGCACGCGAAA-1_4_D9	-12.20497784	11.73432755	8	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	862	1060	0.011320755	0.005660377	12	8	Astrocytes	23	6	6
AACACGTGTATAATGG-1_4_D9	-10.96295371	-7.087163809	13A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	2131	3528	0.007086168	0.006802721	12	13A	IN-VIP	23	6	6
AACACGTTCCAGAAGG-1_4_D9	-21.83224018	-22.52396757	6B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	2412	4206	0.007845934	0.007132668	12	6B	IN-SST	23	6	6
AACCATGGTCAATACC-1_4_D9	-21.08424194	-23.4099684	6A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	2542	5450	0.011376147	0.004036697	12	6A	IN-PV	23	6	6
AACGTTGCACAGTCGC-1_4_D9	-24.47504057	-12.1119509	9	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	778	1003	0.010967099	0.005982054	12	9	OPC	23	6	6
AACGTTGCACCAGTTA-1_4_D9	10.08640279	0.610114465	12	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	976	1277	0.007047768	0.004698512	12	12	EN-MIX	23	6	6
AACTCAGAGGGCACTA-1_4_D9	-23.809203	-22.28039904	6A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	3197	6333	0.006474025	0.006474025	12	6A	IN-PV	23	6	6
AACTGGTAGGAGTTTA-1_4_D9	-14.8397227	-13.69885544	6B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1572	2527	0.007518797	0.009101702	12	6B	IN-SST	23	6	6
AACTTTCCACTTAAGC-1_4_D9	-15.2928227	-14.26036267	6B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1551	2491	0.003211562	0.00923324	12	6B	IN-SST	23	6	6
AACTTTCTCACTATTC-1_4_D9	-21.59791551	-22.11542989	6A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1914	3235	0.008037094	0.008346213	12	6A	IN-PV	23	6	6
AAGGCAGCAGGCAGTA-1_4_D9	-7.101280083	-37.49491569	16	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1039	1425	0.016842105	0.011929825	12	16	EN-PYR	23	6	6
AAGGCAGTCACAGGCC-1_4_D9	-10.60295884	-13.47979145	6B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1269	1888	0.007415254	0.011652542	12	6B	IN-SST	23	6	6
AAGGCAGTCTTTCCTC-1_4_D9	-11.82632952	0.173060083	13A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	2348	4303	0.003718336	0.005577504	12	13A	IN-VIP	23	6	6
AAGTCTGGTATTAGCC-1_4_D9	-11.01183226	-8.968529658	13B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1477	2248	0.013345196	0.005782918	12	13B	IN-SV2C	23	6	6
AATCCAGAGACTTGAA-1_4_D9	-13.30331505	-14.33153769	6A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1287	1876	0.005863539	0.006929638	12	6A	IN-PV	23	6	6
AATCCAGGTAGGCATG-1_4_D9	-8.956563425	35.77587026	17	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	823	1038	0.002890173	0.00867052	12	oligos	OL-MS-2	23	6	6
ACACCAACACCGCTAG-1_4_D9	33.24519772	6.674940042	14	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	849	1064	0.009398496	0.010338346	12	14	Microglia	23	6	6
ACACCGGGTCGTTGTA-1_4_D9	12.13919494	-2.276790851	12	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1260	1809	0.002763958	0.007739082	12	12	EN-MIX	23	6	6
ACACCGGGTTTAAGCC-1_4_D9	-8.927449489	35.12006881	17	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	951	1216	0.011513158	0.006578947	12	oligos	OL-MS-2	23	6	6
ACACTGAGTTACCAGT-1_4_D9	-14.63665869	-14.30378317	6B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1517	2339	0.004275331	0.005985464	12	6B	IN-SST	23	6	6
ACACTGATCGAGCCCA-1_4_D9	27.43842803	4.377667997	15BA	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	803	1023	0.007820137	0.013685239	12	15BA	Stromal cells	23	6	6
ACAGCCGCATCCTAGA-1_4_D9	-12.30181566	31.63676388	17	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	823	1005	0.014925373	0.005970149	12	oligos	OL-MS-2	23	6	6
ACAGCTAAGACAGACC-1_4_D9	-10.79230354	-32.49837414	16	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1200	1742	0.021239954	0.010332951	12	16	EN-PYR	23	6	6
ACATACGTCCGCATCT-1_4_D9	-8.327386074	-9.898661058	6B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	928	1235	0.008906883	0.0048583	12	6B	IN-SST	23	6	6
ACATGGTTCACGCATA-1_4_D9	-10.73621359	-7.419318012	13A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1719	2543	0.006685018	0.007864727	12	13A	IN-VIP	23	6	6
ACCAGTAAGTTTGCGT-1_4_D9	-10.98734514	-13.30320659	6B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1202	1639	0.016473459	0.006101281	12	6B	IN-SST	23	6	6
ACCAGTACAGCTGCAC-1_4_D9	-16.89421644	-8.066377667	13B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	2610	5029	0.005170014	0.004573474	12	13B	IN-SV2C	23	6	6
ACCAGTATCTGAGTGT-1_4_D9	-9.64212374	-13.69784888	6B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1006	1323	0.003023432	0.0143613	12	6B	IN-SST	23	6	6
ACCCACTGTCTAACGT-1_4_D9	-14.59578428	6.940058404	8	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	864	1038	0.01734104	0.00867052	12	8	Astrocytes	23	6	6
ACCGTAAAGGGTGTGT-1_4_D9	32.83948948	10.55262366	14	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1032	1367	0.008046818	0.021214338	12	14	Microglia	23	6	6
ACCGTAACATGGAATA-1_4_D9	-13.0753956	6.850104578	16	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1014	1332	0.028528529	0.00975976	12	16	EN-PYR	23	6	6
ACCGTAATCGTTACAG-1_4_D9	33.12662247	6.441073802	14	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	993	1210	0.017355372	0.008264463	12	14	Microglia	23	6	6
ACGAGCCAGTCAAGCG-1_4_D9	-7.771558383	-7.490743671	13A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1280	1817	0.002201431	0.008805724	12	13A	IN-VIP	23	6	6
ACGAGCCAGTTAACGA-1_4_D9	-14.93514774	6.923624688	8	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	888	1173	0.009377664	0.011082694	12	8	Astrocytes	23	6	6
ACGAGCCAGTTCGCGC-1_4_D9	-8.459582036	-9.744453063	13A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1089	1490	0.002684564	0.009395973	12	13A	IN-VIP	23	6	6
ACGAGGACAGGATTGG-1_4_D9	19.98513862	-11.07126769	3	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	2739	5198	0.004232397	0.008272412	12	3	EN-L5-6	23	6	6
ACGATACCAGTAACGG-1_4_D9	-16.44859605	6.05756828	8	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	870	1247	0.004811548	0.01042502	12	8	Astrocytes	23	6	6
ACGATGTCATGTTGAC-1_4_D9	-7.941512268	-10.75349422	6B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	949	1252	0.045527157	0.026357827	12	6B	IN-SST	23	6	6
ACGCAGCAGATCGGGT-1_4_D9	-7.993215497	-10.82192609	6B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	861	1045	0.006698565	0.009569378	12	6B	IN-SST	23	6	6
ACGCCAGCAAGTTAAG-1_4_D9	-15.01238342	6.783481961	8	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	860	1050	0.005714286	0.008571429	12	8	Astrocytes	23	6	6
ACGCCAGGTTACCGAT-1_4_D9	-12.05097412	-2.552414933	13A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	2421	3926	0.004839531	0.007131941	12	13A	IN-VIP	23	6	6
ACGCCAGTCCGCATAA-1_4_D9	-24.25815775	-12.14474388	17	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1087	1426	0.012622721	0.001402525	12	oligos	OL-MS-2	23	6	6
ACGCCGACATGGGAAC-1_4_D9	8.307635778	3.301574486	12	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1680	2368	0.016891892	0.012246622	12	12	EN-MIX	23	6	6
ACGGAGAGTGAGTATA-1_4_D9	-16.38136994	-21.17472125	6B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1472	2452	0.003262643	0.006933116	12	6B	IN-SST	23	6	6
ACGGCCACAATGAAAC-1_4_D9	-14.76720106	6.811912649	15DA	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	826	1039	0.020211742	0.007699711	12	15DA	T cells	23	6	6
ACGGGTCAGCAATCTC-1_4_D9	-8.835954312	-8.420718344	13A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1276	1888	0.004237288	0.010063559	12	13A	IN-VIP	23	6	6
ACGGGTCTCCAGATCA-1_4_D9	-9.122513842	-20.20500515	6B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	858	1227	0.002444988	0.00407498	12	6B	IN-SST	23	6	6
ACGTCAAGTCCAGTTA-1_4_D9	-20.77684804	-22.04070957	6A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	2039	3445	0.002612482	0.007256894	12	6A	IN-PV	23	6	6
ACGTCAATCCGTTGTC-1_4_D9	-8.125151052	-11.45657278	6B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	887	1108	0.040613718	0.009927798	12	6B	IN-SST	23	6	6
ACTGATGAGCAATCTC-1_4_D9	-24.84587428	-11.92378527	9	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	926	1215	0.005761317	0.006584362	12	9	OPC	23	6	6
ACTGATGTCGCTAGCG-1_4_D9	-20.79965044	-26.07589254	6A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	2971	6489	0.000770535	0.006318385	12	6A	IN-PV	23	6	6
ACTGCTCCAAGTCATC-1_4_D9	-7.621472104	-38.3612991	16	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1108	1499	0.011340894	0.018679119	12	16	EN-PYR	23	6	6
ACTGCTCCACGGATAG-1_4_D9	-8.849935232	-9.059225021	13A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1436	1929	0.005184033	0.003628823	12	13A	IN-VIP	23	6	6
ACTGCTCGTACTTAGC-1_4_D9	19.9692668	-11.03190425	3	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	2544	4612	0.005854293	0.007588899	12	3	EN-L5-6	23	6	6
ACTGCTCGTCACAAGG-1_4_D9	-12.13736074	31.98056025	17	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	828	1000	0.009	0.011	12	oligos	OL-MS-2	23	6	6
ACTGTCCTCCACTCCA-1_4_D9	-15.52650728	-14.11419605	6B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1909	3138	0.004780115	0.010197578	12	6B	IN-SST	23	6	6
ACTTACTCACCCATGG-1_4_D9	-14.96196041	6.769553836	8	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	754	1009	0.014866204	0.003964321	12	8	Astrocytes	23	6	6
AGAGCGAAGATGTCGG-1_4_D9	-21.33449005	-23.37150158	6A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	2865	5688	0.001230661	0.005274262	12	6A	IN-PV	23	6	6
AGAGTGGAGGTGTGGT-1_4_D9	6.721493453	1.139478794	16	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1069	1464	0.006147541	0.017759563	12	16	EN-PYR	23	6	6
AGAGTGGGTACGCTGC-1_4_D9	4.785784049	0.900053133	16	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1065	1398	0.033619456	0.010729614	12	16	EN-PYR	23	6	6
AGCAGCCCATTACGAC-1_4_D9	27.66653453	4.919182345	15A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	861	1094	0.010968921	0.021937843	12	15A	Endo cells	23	6	6
AGCAGCCGTACACCGC-1_4_D9	-14.80087718	6.884323018	8	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	869	1052	0.009505703	0.005703422	12	8	Astrocytes	23	6	6
AGCAGCCTCCCAAGTA-1_4_D9	-8.937754803	-27.68027278	16	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1133	1574	0.053367217	0.015247776	12	16	EN-PYR	23	6	6
AGCATACCAAATCCGT-1_4_D9	-12.29213736	11.47577901	8	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	848	1033	0.014520813	0.006776379	12	8	Astrocytes	23	6	6
AGCATACCATCCTAGA-1_4_D9	-14.88599864	6.967898968	8	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	902	1114	0.017953321	0.008078995	12	8	Astrocytes	23	6	6
AGCATACGTAACGCGA-1_4_D9	-21.64173527	-22.67509337	6A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	2613	4895	0.003268641	0.006537283	12	6A	IN-PV	23	6	6
AGCATACTCGGAAATA-1_4_D9	32.87551771	5.678643051	14	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	855	1037	0.011571842	0.005785921	12	14	Microglia	23	6	6
AGCCTAACAAACTGTC-1_4_D9	-5.471670678	-28.10601134	16	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1024	1341	0.031319911	0.011931394	12	16	EN-PYR	23	6	6
AGCGTCGAGGCGCTCT-1_4_D9	-8.370990074	-9.470200615	13A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1115	1450	0.003448276	0.031034483	12	13A	IN-VIP	23	6	6
AGCGTCGCACCGAATT-1_4_D9	-15.24559782	-14.14517734	6B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1590	2558	0.005473026	0.005863956	12	6B	IN-SST	23	6	6
AGCGTCGGTTGGAGGT-1_4_D9	-8.574527077	-10.42222572	6B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1029	1326	0.00678733	0.013574661	12	6B	IN-SST	23	6	6
AGCTCCTCAAAGTCAA-1_4_D9	-21.045682	-23.55128301	6A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	2616	5565	0.002515723	0.005211141	12	6A	IN-PV	23	6	6
AGCTCCTGTTCAACCA-1_4_D9	-20.51120514	-21.71408968	6A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1926	3365	0.002971768	0.010401189	12	6A	IN-PV	23	6	6
AGCTCTCCAGACGTAG-1_4_D9	29.01799461	6.073815242	15A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1137	1482	0.013495277	0.039136302	12	15A	Endo cells	23	6	6
AGCTTGAGTGACCAAG-1_4_D9	-10.43206237	-12.93572704	6B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1321	1925	0.010909091	0.01038961	12	6B	IN-SST	23	6	6
AGCTTGATCAGAGACG-1_4_D9	-4.958593102	-30.41266078	16	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	835	1043	0.007670182	0.016299137	12	16	EN-PYR	23	6	6
AGGCCACCAGTACACT-1_4_D9	5.79785193	1.6393581	16	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1179	1577	0.010779962	0.007609385	12	16	EN-PYR	23	6	6
AGGGATGAGCTCCCAG-1_4_D9	-11.9950776	12.50598068	11	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1045	1407	0.001421464	0.010660981	12	11	Glia-MIX	23	6	6
AGGGATGAGTGACTCT-1_4_D9	-8.483332107	-9.738937375	13A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1156	1599	0.004377736	0.011882427	12	13A	IN-VIP	23	6	6
AGGGTGACACCGAAAG-1_4_D9	25.4433246	7.218346889	15A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1570	2215	0.008126411	0.027990971	12	15A	Endo cells	23	6	6
AGGGTGACATCACAAC-1_4_D9	-7.472654878	-31.47727319	16	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	977	1307	0.00841622	0.009946442	12	16	EN-PYR	23	6	6
AGGGTGAGTCTACCTC-1_4_D9	-10.64941839	-13.37116282	6B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1286	1851	0.004862237	0.013506213	12	6B	IN-SST	23	6	6
AGGTCATAGTGTTAGA-1_4_D9	-5.624917748	-30.90020901	16	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	990	1301	0.020753267	0.01537279	12	16	EN-PYR	23	6	6
AGGTCATGTAGCAAAT-1_4_D9	-16.53580458	-21.3388055	6A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1634	2580	0.003488372	0.003875969	12	6A	IN-PV	23	6	6
AGGTCATTCTTCTGGC-1_4_D9	-22.90884552	-15.73751542	6A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	4205	10337	0.005610912	0.006191351	12	6A	IN-PV	23	6	6
AGGTCCGCATCATCCC-1_4_D9	-22.53038558	-22.7376959	6A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	2938	6371	0.009417674	0.00643541	12	6A	IN-PV	23	6	6
AGTAGTCAGTTCCACA-1_4_D9	-14.03629563	-14.06038421	6B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1325	1841	0.010320478	0.003802281	12	6B	IN-SST	23	6	6
AGTAGTCGTCAAACTC-1_4_D9	-8.913798754	-8.745761531	13A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1367	1954	0.01381781	0.01432958	12	13A	IN-VIP	23	6	6
AGTGAGGCAAGAGTCG-1_4_D9	-14.09940592	-36.11683971	16	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	2390	4722	0.074968234	0.00995341	12	16	EN-PYR	23	6	6
AGTGGGAGTAGCAAAT-1_4_D9	-14.79300601	6.866789316	8	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	822	1007	0.02979146	0.006951341	12	8	Astrocytes	23	6	6
AGTGTCAGTTCGCTAA-1_4_D9	-8.305241806	-10.02200247	6B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1091	1389	0.010079194	0.016558675	12	6B	IN-SST	23	6	6
AGTTGGTTCAGTTAGC-1_4_D9	-9.75272907	-13.22915866	6B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1013	1310	0.01221374	0.017557252	12	6B	IN-SST	23	6	6
AGTTGGTTCCAACCAA-1_4_D9	-14.52986621	-14.30469928	6B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1369	2190	0.00456621	0.011415525	12	6B	IN-SST	23	6	6
AGTTGGTTCCGCTGTT-1_4_D9	27.03722585	4.157362411	15BA	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	947	1243	0.005631537	0.011263073	12	15BA	Stromal cells	23	6	6
ATAGACCCAAGTCTAC-1_4_D9	-16.42017677	6.090898312	8	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	807	1024	0.00390625	0.005859375	12	8	Astrocytes	23	6	6
ATCACGAAGTAGATGT-1_4_D9	-12.17302023	-13.19435561	6B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1730	2585	0.007350097	0.015087041	12	6B	IN-SST	23	6	6
ATCACGACACAACGCC-1_4_D9	-12.24028064	11.57025165	15DA	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	855	1087	0.006439742	0.011039558	12	15DA	T cells	23	6	6
ATCATCTTCCCTTGTG-1_4_D9	-24.89960828	-11.82014205	9	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	872	1099	0.004549591	0.006369427	12	9	OPC	23	6	6
ATCATGGTCGAGAACG-1_4_D9	-10.18561616	-7.778458279	13A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1622	2322	0.003875969	0.012919897	12	13A	IN-VIP	23	6	6
ATCTACTCACTGTGTA-1_4_D9	27.07670339	3.74724447	15BA	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	818	1009	0.016848365	0.009910803	12	15BA	Stromal cells	23	6	6
ATCTACTTCGTTGCCT-1_4_D9	-8.290610074	-32.04263098	16	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	942	1271	0.02281668	0.007081039	12	16	EN-PYR	23	6	6
ATGAGGGGTGTGAAAT-1_4_D9	-15.5243682	-14.04184305	6B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1847	3083	0.002919235	0.007460266	12	6B	IN-SST	23	6	6
ATTACTCGTCGAATCT-1_4_D9	-7.512030213	-9.335820244	13A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1024	1398	0.003576538	0.004291845	12	13A	IN-VIP	23	6	6
ATTATCCCACACAGAG-1_4_D9	-9.422200497	-13.78913779	6B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1054	1417	0.056457304	0.016231475	12	6B	IN-SST	23	6	6
ATTATCCGTTGCGTTA-1_4_D9	-9.926824821	-13.57025596	6B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	975	1306	0.003062787	0.004594181	12	6B	IN-SST	23	6	6
ATTATCCTCACGACTA-1_4_D9	-11.24028029	-13.11503536	6B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1500	2305	0.010412148	0.00824295	12	6B	IN-SST	23	6	6
ATTGGACAGCCCAACC-1_4_D9	-11.37529556	-9.097923643	13B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1409	2279	0.001755156	0.009214568	12	13B	IN-SV2C	23	6	6
ATTGGACCACCTCGTT-1_4_D9	-8.945247795	35.59030749	17	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	995	1295	0.010810811	0.010810811	12	oligos	OL-MS-2	23	6	6
ATTGGTGCAAGTAGTA-1_4_D9	-9.810115848	-13.62059783	6B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	890	1229	0.00081367	0.007323027	12	6B	IN-SST	23	6	6
ATTGGTGGTCTCATCC-1_4_D9	-19.78327992	-15.38861492	6B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	2499	4784	0.002508361	0.006688963	12	6B	IN-SST	23	6	6
CAACCAAAGGGATACC-1_4_D9	-15.15891895	-5.286739979	13A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	2613	4422	0.004070556	0.008141113	12	13A	IN-VIP	23	6	6
CAACCTCTCAACGCTA-1_4_D9	-21.01974379	-23.42943933	6A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	2432	5031	0.005167959	0.003776585	12	6A	IN-PV	23	6	6
CAACTAGGTCTAGCGC-1_4_D9	-11.70404283	-13.24942869	6B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1410	1971	0.028411974	0.008625063	12	6B	IN-SST	23	6	6
CAACTAGGTTACGACT-1_4_D9	-23.58680343	-22.21886709	6A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	2809	5091	0.011981929	0.008642703	12	6A	IN-PV	23	6	6
CAACTAGGTTCGCGAC-1_4_D9	-10.12790814	-7.326553132	13A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1638	2355	0.007643312	0.007218684	12	13A	IN-VIP	23	6	6
CAAGATCAGAGCTGCA-1_4_D9	-8.152128046	-10.46625849	6B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	851	1057	0.011352886	0.006622517	12	6B	IN-SST	23	6	6
CAAGGCCAGTGGAGAA-1_4_D9	-16.53270699	-21.36587718	6A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1620	2697	0.003707824	0.006674082	12	6A	IN-PV	23	6	6
CAAGGCCGTCAGAATA-1_4_D9	-10.45916853	-13.46117321	6B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1213	1779	0.001686341	0.005621135	12	6B	IN-SST	23	6	6
CACAAACAGTTGCAGG-1_4_D9	-10.71212885	-7.162226173	13A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1927	2884	0.003814147	0.008668516	12	13A	IN-VIP	23	6	6
CACAAACGTCTAAAGA-1_4_D9	-16.13681434	-13.93072348	6B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	2327	4384	0.004790146	0.007071168	12	6B	IN-SST	23	6	6
CACAAACTCACTTCAT-1_4_D9	-16.30915282	6.134018002	8	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	810	1081	0.007400555	0.011100833	12	8	Astrocytes	23	6	6
CACAAACTCCATGCTC-1_4_D9	-8.957208637	35.12525862	17	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1039	1355	0.01402214	0.008118081	12	oligos	OL-MS-2	23	6	6
CACACAACAGATGGGT-1_4_D9	-15.27466138	-14.15623593	6B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1709	2902	0.005513439	0.006547209	12	6B	IN-SST	23	6	6
CACACAACATGGGAAC-1_4_D9	7.613347474	2.340657189	16	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	873	1077	0.026926648	0.011142061	12	16	EN-PYR	23	6	6
CACACAATCAGAGACG-1_4_D9	33.24298016	6.429664062	14	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	826	1047	0.008595989	0.008595989	12	14	Microglia	23	6	6
CACACCTAGACGCACA-1_4_D9	-10.16405649	-7.507442193	13A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1805	2944	0.003736413	0.005774457	12	13A	IN-VIP	23	6	6
CACACCTAGGTACTCT-1_4_D9	5.188293975	0.361138463	16	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	864	1049	0.01620591	0.010486177	12	16	EN-PYR	23	6	6
CACACCTGTTTGCATG-1_4_D9	-12.20597544	11.74939569	8	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	977	1276	0.00862069	0.004702194	12	8	Astrocytes	23	6	6
CACACCTTCAACGAAA-1_4_D9	-8.855553829	35.70778872	17	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	917	1138	0.012302285	0.004393673	12	oligos	OL-MS-2	23	6	6
CACACCTTCTGCTGCT-1_4_D9	-15.10331347	7.062208581	8	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	967	1207	0.009942005	0.006628003	12	8	Astrocytes	23	6	6
CACACTCCACCATCCT-1_4_D9	-16.15978791	6.633711719	8	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	827	1037	0.004821601	0.005785921	12	8	Astrocytes	23	6	6
CACAGGCTCTGCGGCA-1_4_D9	7.547692748	2.225209195	16	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	843	1058	0.02362949	0.012287335	12	16	EN-PYR	23	6	6
CACATAGAGGAGTCTG-1_4_D9	-5.401687917	-32.15743584	16	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	799	1025	0.011707317	0.010731707	12	16	EN-PYR	23	6	6
CACATAGTCCATGAAC-1_4_D9	7.56013565	2.267398382	16	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	900	1139	0.023705004	0.007023705	12	16	EN-PYR	23	6	6
CACATTTGTAGCGCAA-1_4_D9	-9.276287409	-8.202576928	13A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1372	1966	0.009155646	0.009664293	12	13A	IN-VIP	23	6	6
CACCACTAGCGATAGC-1_4_D9	-6.186407324	-30.62387813	16	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	896	1159	0.03106126	0.017256255	12	16	EN-PYR	23	6	6
CACCACTGTAAATACG-1_4_D9	7.331263013	2.312073998	16	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	867	1090	0.023853211	0.009174312	12	16	EN-PYR	23	6	6
CACCACTTCAAACCAC-1_4_D9	7.564854284	2.427115831	16	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	840	1033	0.024201355	0.010648596	12	16	EN-PYR	23	6	6
CACCACTTCGGAGGTA-1_4_D9	31.55179324	9.307353884	14	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	945	1303	0.009976976	0.061396777	12	14	Microglia	23	6	6
CACCTTGAGTACGCCC-1_4_D9	-16.6150548	6.607754964	8	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	879	1150	0.009565217	0.006956522	12	8	Astrocytes	23	6	6
CACCTTGCATTTGCCC-1_4_D9	-24.46351628	-12.00125353	9	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	787	1001	0.004995005	0.00999001	12	9	OPC	23	6	6
CACCTTGGTTTGTTGG-1_4_D9	-11.58099446	-33.46382772	16	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1377	2029	0.023656974	0.011335633	12	16	EN-PYR	23	6	6
CAGAATCCATCCCACT-1_4_D9	-22.41622506	-15.15635363	6B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	4406	10005	0.006096952	0.007996002	12	6B	IN-SST	23	6	6
CAGAGAGGTCCTCCAT-1_4_D9	-11.18788525	33.22351276	17	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1034	1343	0.006701415	0.006701415	12	oligos	OL-MS-2	23	6	6
CAGATCAGTACAGTGG-1_4_D9	-15.03378983	-14.11418354	6B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1676	2686	0.017125838	0.006701415	12	6B	IN-SST	23	6	6
CAGATCATCTGGCGTG-1_4_D9	-8.441376013	-9.704326767	13A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1127	1474	0.005427408	0.014925373	12	13A	IN-VIP	23	6	6
CAGCAGCAGTACGTAA-1_4_D9	-21.89329605	-22.10107627	6A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1928	3180	0.009119497	0.00754717	12	6A	IN-PV	23	6	6
CAGCAGCTCACCGTAA-1_4_D9	-11.77693107	-13.15026604	6B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1528	2348	0.005962521	0.013202726	12	6B	IN-SST	23	6	6
CAGCATACAGCTGCAC-1_4_D9	33.11238746	7.377442235	14	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	803	1008	0.018849206	0.011904762	12	14	Microglia	23	6	6
CAGCATACATGTTCCC-1_4_D9	-9.009388428	35.68794268	17	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	788	1017	0.008849558	0.003933137	12	oligos	OL-MS-2	23	6	6
CAGCATATCCTGCAGG-1_4_D9	-20.21704291	-15.21724372	6B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	2799	5548	0.003785148	0.00666907	12	6B	IN-SST	23	6	6
CAGCGACTCAGGCCCA-1_4_D9	-12.6423345	-13.44943992	6B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1439	2078	0.008180943	0.009143407	12	6B	IN-SST	23	6	6
CAGCTAAAGCCTCGTG-1_4_D9	-7.464169777	-7.925921032	13A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1204	1640	0.001219512	0.006707317	12	13A	IN-VIP	23	6	6
CAGGTGCAGCTTCGCG-1_4_D9	-8.624753262	-9.601591759	13A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1196	1674	0.001792115	0.002986858	12	13A	IN-VIP	23	6	6
CAGTAACAGATACACA-1_4_D9	-15.00385592	-14.1826274	6B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1667	2638	0.004927976	0.011751327	12	6B	IN-SST	23	6	6
CAGTAACCAGGGCATA-1_4_D9	-12.11956027	-8.811209591	13B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	2064	3522	0.003123225	0.00653038	12	13B	IN-SV2C	23	6	6
CAGTAACTCATCTGTT-1_4_D9	-21.33054369	-23.18902135	6A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	2255	4140	0.004589372	0.00410628	12	6A	IN-PV	23	6	6
CAGTAACTCCATGAAC-1_4_D9	7.43537634	2.239413095	16	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	823	1003	0.027916251	0.00997009	12	16	EN-PYR	23	6	6
CAGTCCTCATACTACG-1_4_D9	-8.190304827	-11.63341342	6B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1021	1308	0.023700306	0.009938838	12	6B	IN-SST	23	6	6
CATATGGTCCACTCCA-1_4_D9	-10.04444839	-7.049618462	13A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1883	2923	0.009579199	0.006842285	12	13A	IN-VIP	23	6	6
CATATTCAGATCCCAT-1_4_D9	8.569798745	2.887274199	12	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	896	1125	0.019555556	0.008888889	12	12	EN-MIX	23	6	6
CATATTCAGCTTCGCG-1_4_D9	1.862510878	5.48617798	7	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	961	1153	0.006071119	0.012142238	12	7	Phagocytes	23	6	6
CATCAAGAGATACACA-1_4_D9	-15.43578408	-14.2449748	6B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1661	2615	0.001912046	0.005736138	12	6B	IN-SST	23	6	6
CATCAAGCACAGGCCT-1_4_D9	-20.8818694	-23.49392867	6A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	2404	4739	0.005275375	0.00548639	12	6A	IN-PV	23	6	6
CATCAAGTCACCACCT-1_4_D9	8.091115916	2.22524835	12	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	767	1006	0.019880716	0.009940358	12	12	EN-MIX	23	6	6
CATCAGAAGTTTGCGT-1_4_D9	-16.63301209	6.035593075	8	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	737	1071	0.004668534	0.004668534	12	8	Astrocytes	23	6	6
CATCAGACAAAGTCAA-1_4_D9	29.54288657	9.425163911	15DA	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	835	1100	0.023636364	0.072727273	12	15DA	T cells	23	6	6
CATCGAAGTAGAGGAA-1_4_D9	-14.37579845	-5.560574771	13A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	2374	4301	0.005812602	0.006510114	12	13A	IN-VIP	23	6	6
CATCGGGCACCAGATT-1_4_D9	-15.328859	-14.20211781	6B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1765	2773	0.006851785	0.01298233	12	6B	IN-SST	23	6	6
CATGACACAACCGCCA-1_4_D9	-8.985632801	35.50893569	17	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1006	1284	0.010124611	0.010124611	12	oligos	OL-MS-2	23	6	6
CATGACAGTACCGTAT-1_4_D9	24.9858108	6.800402097	15A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1562	2234	0.006714414	0.014324082	12	15A	Endo cells	23	6	6
CATGACAGTCTAAACC-1_4_D9	32.92365343	6.478357651	14	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	802	1041	0.013448607	0.018251681	12	14	Microglia	23	6	6
CATGACAGTTTGTTTC-1_4_D9	-16.13427923	7.808720818	8	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1090	1539	0.008447044	0.005847953	12	8	Astrocytes	23	6	6
CATGACATCTAGAGTC-1_4_D9	-16.18984702	6.519749628	8	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	827	1011	0.003956479	0.004945598	12	8	Astrocytes	23	6	6
CATGACATCTTGAGGT-1_4_D9	-10.61270768	-13.2708163	6B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1299	1898	0.003688093	0.009483667	12	6B	IN-SST	23	6	6
CATGCCTCACATGGGA-1_4_D9	7.59979118	2.306288794	16	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	890	1127	0.035492458	0.00621118	12	16	EN-PYR	23	6	6
CATGGCGCATGGTCTA-1_4_D9	-7.597397412	-38.27639204	16	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1195	1708	0.021077283	0.019906323	12	16	EN-PYR	23	6	6
CATGGCGTCCTGCCAT-1_4_D9	-11.65135206	-8.821474529	13B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1631	2618	0.004201681	0.011077158	12	13B	IN-SV2C	23	6	6
CATTCGCCAGGACCCT-1_4_D9	-14.87987386	7.423766031	8	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1061	1388	0.009365994	0.007204611	12	8	Astrocytes	23	6	6
CATTCGCCATCCCATC-1_4_D9	1.751831593	6.078152018	7	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1020	1263	0.015043547	0.006334125	12	7	Phagocytes	23	6	6
CCAATCCTCCCTGACT-1_4_D9	-23.22499664	-22.61957214	6A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	3692	8781	0.008996697	0.006035759	12	6A	IN-PV	23	6	6
CCACGGAGTCACAAGG-1_4_D9	-8.13028438	-10.77758111	6B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1085	1355	0.017712177	0.019926199	12	6B	IN-SST	23	6	6
CCACGGATCACTCCTG-1_4_D9	29.32100742	5.568860884	15DA	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	946	1204	0.025747508	0.026578073	12	15DA	T cells	23	6	6
CCACTACGTATATGGA-1_4_D9	-8.951201712	35.620258	17	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	822	1036	0.014478764	0.00965251	12	oligos	OL-MS-2	23	6	6
CCACTACGTCAGCTAT-1_4_D9	7.735154098	2.656526825	16	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	831	1021	0.022526934	0.007835455	12	16	EN-PYR	23	6	6
CCACTACTCATCACCC-1_4_D9	7.576036342	2.185362669	16	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	821	1032	0.016472868	0.006782946	12	16	EN-PYR	23	6	6
CCAGCGATCCTTGACC-1_4_D9	-9.810475009	-13.24154541	6B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1057	1465	0.00887372	0.011604096	12	6B	IN-SST	23	6	6
CCCAATCCATCTCGCT-1_4_D9	-25.49497887	-10.92736131	9	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	950	1327	0.006782216	0.006028636	12	9	OPC	23	6	6
CCCAATCTCTGTTGAG-1_4_D9	-21.4762971	-23.24696546	6A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	2886	6265	0.006863528	0.005426975	12	6A	IN-PV	23	6	6
CCCAGTTAGTGAACAT-1_4_D9	-9.724070584	-7.529915115	13A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1544	2315	0.005615551	0.007343413	12	13A	IN-VIP	23	6	6
CCCAGTTCAAAGGAAG-1_4_D9	-5.466487465	-28.21863703	16	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	966	1255	0.00876494	0.007968127	12	16	EN-PYR	23	6	6
CCCAGTTTCCCAGGTG-1_4_D9	-5.468642654	-30.16155008	16	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	893	1163	0.012897678	0.014617369	12	16	EN-PYR	23	6	6
CCCATACAGTATGACA-1_4_D9	-12.37938901	31.81153693	17	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1312	1715	0.01516035	0.010495627	12	oligos	OL-MS-2	23	6	6
CCCATACAGTTACCCA-1_4_D9	-15.35533276	-14.15970782	6B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1624	2520	0.003968254	0.008730159	12	6B	IN-SST	23	6	6
CCCATACCACATGGGA-1_4_D9	7.687062554	2.184545162	16	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	833	1039	0.028873917	0.010587103	12	16	EN-PYR	23	6	6
CCCATACCAGAGTGTG-1_4_D9	-10.77954155	-6.958708326	13A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1981	3156	0.005703422	0.014575412	12	13A	IN-VIP	23	6	6
CCGTGGAGTCTAGTGT-1_4_D9	-9.573368092	-13.60489901	6B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	897	1213	0.004122012	0.009068425	12	6B	IN-SST	23	6	6
CCGTTCAAGTCATCCA-1_4_D9	-16.83687241	-21.45514049	6A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1759	2876	0.001390821	0.01147427	12	6A	IN-PV	23	6	6
CCTAAAGAGATGTGGC-1_4_D9	-5.666730965	-32.44879355	16	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	804	1054	0.016129032	0.0056926	12	16	EN-PYR	23	6	6
CCTAAAGTCTGTTGAG-1_4_D9	-16.26137274	-21.23954103	6B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1300	2030	0.010344828	0.011330049	12	6B	IN-SST	23	6	6
CCTACCAAGACCCACC-1_4_D9	19.85759096	-25.69406664	3	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	3171	7100	0.002957746	0.013239437	12	3	EN-L5-6	23	6	6
CCTACCACAAGGGTCA-1_4_D9	-9.837092643	35.23250412	17	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	840	1033	0.004840271	0.009680542	12	oligos	OL-MS-2	23	6	6
CCTACCATCATTGCCC-1_4_D9	-16.65918407	-21.98465872	6A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1748	3288	0.003041363	0.008211679	12	6A	IN-PV	23	6	6
CCTACCATCTAACTGG-1_4_D9	-21.21245437	-22.76609821	6A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	2305	3971	0.003777386	0.005791992	12	6A	IN-PV	23	6	6
CCTCTGAAGCGTCAAG-1_4_D9	-10.21062253	-13.38857884	6B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1121	1554	0.003861004	0.019305019	12	6B	IN-SST	23	6	6
CCTCTGACATCCAACA-1_4_D9	24.88913156	6.682505503	15A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1626	2239	0.010719071	0.015185351	12	15A	Endo cells	23	6	6
CCTTACGAGGACTGGT-1_4_D9	-8.96397964	-8.681231234	13A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1431	1966	0.003051882	0.01525941	12	13A	IN-VIP	23	6	6
CCTTACGCACGTTGGC-1_4_D9	-6.29197632	-30.9195837	16	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	874	1156	0.030276817	0.009515571	12	16	EN-PYR	23	6	6
CCTTCCCGTGCGAAAC-1_4_D9	-6.514098005	-28.7133955	16	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	928	1172	0.018771331	0.005119454	12	16	EN-PYR	23	6	6
CCTTCGAAGCTGGAAC-1_4_D9	-11.04568664	-8.722169921	13B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1752	2570	0.013229572	0.015953307	12	13B	IN-SV2C	23	6	6
CCTTCGAAGTGAAGAG-1_4_D9	-10.44679006	-13.87344086	6B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1121	1654	0.007255139	0.008464329	12	6B	IN-SST	23	6	6
CCTTCGACAGATCGGA-1_4_D9	-21.03341552	-21.9657205	6A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1848	2941	0.006800408	0.009860592	12	6A	IN-PV	23	6	6
CCTTCGACAGCTGCTG-1_4_D9	-15.82197964	7.392088068	8	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1068	1373	0.007283321	0.008739985	12	8	Astrocytes	23	6	6
CCTTTCTAGACGCTTT-1_4_D9	-9.784731664	-7.776845481	13A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1581	2411	0.005391954	0.010369141	12	13A	IN-VIP	23	6	6
CCTTTCTCATGGGAAC-1_4_D9	-12.18797906	31.85720165	17	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1005	1279	0.017982799	0.007818608	12	oligos	OL-MS-2	23	6	6
CCTTTCTGTGCCTGTG-1_4_D9	-25.01501344	-11.50737659	9	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	950	1240	0.008870968	0.00483871	12	9	OPC	23	6	6
CGAACATAGCTGAACG-1_4_D9	-15.19152737	-14.19864785	6B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1645	2530	0.006324111	0.004743083	12	6B	IN-SST	23	6	6
CGAATGTAGTGTACCT-1_4_D9	-24.46176355	-12.06242757	9	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	797	1015	0.008866995	0.006896552	12	9	OPC	23	6	6
CGAATGTGTACGCACC-1_4_D9	-15.9809764	6.294089971	8	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	820	1078	0.008348794	0.00742115	12	8	Astrocytes	23	6	6
CGAATGTGTGTAAGTA-1_4_D9	-2.886243777	29.96837586	17	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	860	1086	0.005524862	0.011049724	12	oligos	OL-MS-2	23	6	6
CGACCTTTCAGCTCTC-1_4_D9	-15.55377259	-14.31248308	6B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1780	2916	0.00617284	0.010631001	12	6B	IN-SST	23	6	6
CGACTTCCAATCTGCA-1_4_D9	-9.444104891	-8.210531654	13A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1360	2023	0.003954523	0.015323777	12	13A	IN-VIP	23	6	6
CGAGAAGCATATGGTC-1_4_D9	-11.90972125	-8.766708933	13B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1911	3700	0.004054054	0.010810811	12	13B	IN-SV2C	23	6	6
CGAGAAGGTGGTCCGT-1_4_D9	-8.430535901	-10.21461261	6B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	987	1341	0.040268456	0.009694258	12	6B	IN-SST	23	6	6
CGAGAAGTCCGCAGTG-1_4_D9	-11.73261377	-8.689852622	13B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1954	3141	0.014008278	0.006049029	12	13B	IN-SV2C	23	6	6
CGAGAAGTCTGCTGTC-1_4_D9	-24.63359043	-12.03560944	9	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1006	1325	0.009056604	0.006037736	12	9	OPC	23	6	6
CGAGCACTCCAACCAA-1_4_D9	-16.01423609	-5.326119111	13A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	4576	10881	0.004778973	0.010844591	12	13A	IN-VIP	23	6	6
CGAGCACTCCCTTGCA-1_4_D9	-11.98819008	32.6422422	17	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1380	1861	0.009672219	0.006985492	12	oligos	OL-MS-2	23	6	6
CGATTGACACGACTCG-1_4_D9	-21.04179591	-23.39922458	6A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	2450	4791	0.003965769	0.005426842	12	6A	IN-PV	23	6	6
CGCGGTAAGACACTAA-1_4_D9	-11.52879848	-8.832143781	13B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1663	2575	0.003495146	0.010485437	12	13B	IN-SV2C	23	6	6
CGCGTTTCAGGTGGAT-1_4_D9	-22.19068479	-22.20429614	6A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	2190	3984	0.009287149	0.0062751	12	6A	IN-PV	23	6	6
CGCGTTTTCCCAAGAT-1_4_D9	7.415146829	2.041191683	16	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	966	1238	0.027463651	0.012116317	12	16	EN-PYR	23	6	6
CGCTTCAGTCTACCTC-1_4_D9	-15.64658368	-14.33087987	6B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1865	3160	0.004746835	0.005696203	12	6B	IN-SST	23	6	6
CGGACGTAGAATGTTG-1_4_D9	-9.344300175	-13.14575555	6B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	855	1094	0.014625229	0.011882998	12	6B	IN-SST	23	6	6
CGGACGTCATGGGAAC-1_4_D9	7.126548213	2.307108648	16	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	917	1120	0.019642857	0.009821429	12	16	EN-PYR	23	6	6
CGGACGTTCCTCATTA-1_4_D9	32.66891927	5.232495157	14	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	862	1066	0.016885553	0.004690432	12	14	Microglia	23	6	6
CGGACTGTCAGTCCCT-1_4_D9	-11.97563802	-34.44567616	16	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1394	2198	0.027297543	0.015468608	12	16	EN-PYR	23	6	6
CGGAGCTGTACAGTGG-1_4_D9	-9.83718432	35.18772379	17	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	921	1150	0.013913043	0.016521739	12	oligos	OL-MS-2	23	6	6
CGGAGCTTCTCGTATT-1_4_D9	-12.01140937	-8.840207179	13B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1840	3314	0.004526252	0.010259505	12	13B	IN-SV2C	23	6	6
CGGAGTCGTGCCTGCA-1_4_D9	-16.64898754	-21.39678931	6A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1584	2539	0.009058685	0.007877117	12	6A	IN-PV	23	6	6
CGGAGTCGTTACGCGC-1_4_D9	-9.747169301	-13.45737351	6B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1006	1374	0.001455604	0.011644833	12	6B	IN-SST	23	6	6
CGGCTAGGTCTACCTC-1_4_D9	-11.977511	-9.053398853	13B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1864	3449	0.003479269	0.007248478	12	13B	IN-SV2C	23	6	6
CGGGTCACATTCCTGC-1_4_D9	-10.48288884	-13.3653355	6B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1249	1774	0.002818489	0.015219842	12	6B	IN-SST	23	6	6
CGGTTAAGTCCCTTGT-1_4_D9	-11.98930141	12.05554824	11	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1540	2061	0.007763222	0.001940805	12	11	Glia-MIX	23	6	6
CGTAGCGAGCCATCGC-1_4_D9	-2.730127509	29.93417387	17	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	822	1044	0.00862069	0.002873563	12	oligos	OL-MS-2	23	6	6
CGTAGGCCACGTCTCT-1_4_D9	-10.70401724	-13.66926936	6B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1204	1745	0.002292264	0.005730659	12	6B	IN-SST	23	6	6
CGTCACTGTATTACCG-1_4_D9	-13.47948441	-14.27370312	6B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1228	1728	0.008101852	0.005208333	12	6B	IN-SST	23	6	6
CGTCAGGTCACTTCAT-1_4_D9	3.903734212	0.749964643	16	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1046	1361	0.011756062	0.006612785	12	16	EN-PYR	23	6	6
CGTCTACAGGACCACA-1_4_D9	-21.02146608	-23.38548565	6A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	2347	4819	0.004772774	0.003942727	12	6A	IN-PV	23	6	6
CGTCTACCATTCCTGC-1_4_D9	-11.23206391	-8.741484363	6B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1652	2509	0.01155839	0.013949781	12	6B	IN-SST	23	6	6
CGTGAGCCAAACGCGA-1_4_D9	-11.00282023	-14.03253875	6B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1329	2023	0.006920415	0.002965892	12	6B	IN-SST	23	6	6
CGTGAGCCAAGCTGGA-1_4_D9	-11.88018987	-8.869761027	6B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1696	2906	0.006538197	0.010323469	12	6B	IN-SST	23	6	6
CGTGAGCCATTAGGCT-1_4_D9	-10.87951748	-32.53442653	16	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1198	1708	0.025175644	0.011709602	12	16	EN-PYR	23	6	6
CGTGTAAGTAGAGTGC-1_4_D9	-21.35055889	-23.07249195	6A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	2252	4106	0.002922552	0.004870921	12	6A	IN-PV	23	6	6
CGTTAGATCCTTAATC-1_4_D9	-8.053579933	-10.94641687	6B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	815	1047	0.006685769	0.013371538	12	6B	IN-SST	23	6	6
CGTTCTGCATCAGTCA-1_4_D9	-9.113612595	-8.611235489	13A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1358	1928	0.006224066	0.012966805	12	13A	IN-VIP	23	6	6
CGTTGGGAGATGTGGC-1_4_D9	-9.184287878	-9.959917409	6B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1156	1502	0.008655126	0.016644474	12	6B	IN-SST	23	6	6
CGTTGGGGTGCCTTGG-1_4_D9	25.1207072	7.127112354	15A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1809	2621	0.00610454	0.017550553	12	15A	Endo cells	23	6	6
CTAACTTAGCTACCTA-1_4_D9	-10.4399719	-7.276726364	13A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1763	2732	0.004758419	0.005490483	12	13A	IN-VIP	23	6	6
CTAACTTAGGGAGTAA-1_4_D9	-9.639252074	-13.1610529	6B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	978	1271	0.012588513	0.004720692	12	6B	IN-SST	23	6	6
CTAATGGCAAAGGTGC-1_4_D9	-15.27408822	-14.12802798	6B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1662	2798	0.00393138	0.00964975	12	6B	IN-SST	23	6	6
CTACGTCAGACTCGGA-1_4_D9	-8.424058392	-9.719428695	13A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1050	1406	0.008534851	0.007823613	12	13A	IN-VIP	23	6	6
CTACGTCCAAGGACAC-1_4_D9	-13.00226373	6.937258658	16	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1187	1617	0.00742115	0.011131725	12	16	EN-PYR	23	6	6
CTACGTCGTAAGGGAA-1_4_D9	-14.54750652	-14.23395404	6B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1370	1967	0.001525165	0.010167768	12	6B	IN-SST	23	6	6
CTAGCCTAGCCGGTAA-1_4_D9	32.69320702	7.646526664	14	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	753	1012	0.007905138	0.018774704	12	14	Microglia	23	6	6
CTAGCCTCACAGACAG-1_4_D9	-12.25269155	31.80341678	17	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1020	1288	0.013975155	0.010093168	12	oligos	OL-MS-2	23	6	6
CTAGCCTCACAGCCCA-1_4_D9	-23.66560251	-9.041970399	9	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1594	2304	0.009114583	0.009114583	12	9	OPC	23	6	6
CTCACACAGTCATGCT-1_4_D9	-11.15564638	-6.774591226	13A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	2057	3293	0.005162466	0.017916793	12	13A	IN-VIP	23	6	6
CTCACACGTCGTCTTC-1_4_D9	-24.01975486	-22.12061679	6A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	3349	7159	0.014806537	0.013828747	12	6A	IN-PV	23	6	6
CTCCTAGAGCTATGCT-1_4_D9	-6.438233385	-33.42767032	16	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	904	1199	0.028356964	0.013344454	12	16	EN-PYR	23	6	6
CTCCTAGCACACATGT-1_4_D9	-12.30709792	31.8071656	17	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	912	1098	0.018214936	0.010928962	12	oligos	OL-MS-2	23	6	6
CTCCTAGTCCTTGCCA-1_4_D9	-23.52205119	-22.29614163	6A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	3037	6782	0.040106163	0.005455618	12	6A	IN-PV	23	6	6
CTCGGGACAGCCAGAA-1_4_D9	-16.5552245	5.986968062	8	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	744	1008	0.006944444	0.009920635	12	8	Astrocytes	23	6	6
CTCGGGACATCTCCCA-1_4_D9	-9.564680742	35.3857791	17	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	986	1255	0.01752988	0.015139442	12	oligos	OL-MS-2	23	6	6
CTCGGGAGTACCGCTG-1_4_D9	-8.077644844	-11.13375812	6B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	897	1091	0.005499542	0.012832264	12	6B	IN-SST	23	6	6
CTCGGGAGTCGAAAGC-1_4_D9	-16.3013631	6.024882626	8	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	760	1019	0.008832188	0.011776251	12	8	Astrocytes	23	6	6
CTCGTACAGTTACGGG-1_4_D9	-20.5876438	-23.22575714	6A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	2069	3967	0.003024956	0.010335266	12	6A	IN-PV	23	6	6
CTCGTACGTTGTCGCG-1_4_D9	-11.77724561	-8.880737599	13B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1728	2759	0.006524103	0.007973904	12	13B	IN-SV2C	23	6	6
CTCGTCACATTAACCG-1_4_D9	-15.74576001	-14.1469091	6B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	2090	3574	0.003637381	0.008114158	12	6B	IN-SST	23	6	6
CTCGTCAGTGCCTTGG-1_4_D9	-12.87904276	-13.35224454	6B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1762	2923	0.0071844	0.009921314	12	6B	IN-SST	23	6	6
CTCGTCATCGTAGGTT-1_4_D9	27.49279554	6.270656444	15A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1054	1346	0.008172363	0.020059435	12	15A	Endo cells	23	6	6
CTCTACGAGCGCTCCA-1_4_D9	8.979105967	2.186276814	12	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	782	1063	0.005644403	0.005644403	12	12	EN-MIX	23	6	6
CTCTACGAGGAGTTTA-1_4_D9	18.66538841	-8.811395695	3	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	2262	4091	0.003422146	0.008310926	12	3	EN-L5-6	23	6	6
CTGAAGTTCAAACCGT-1_4_D9	-9.633699545	-13.87533369	6B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	930	1278	0.00312989	0.007042254	12	6B	IN-SST	23	6	6
CTGATAGAGTCGAGTG-1_4_D9	-1.717997251	3.085748798	11	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1351	1857	0.004308024	0.011308562	12	11	Glia-MIX	23	6	6
CTGATAGCAAACTGCT-1_4_D9	32.92909989	7.332102574	14	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	935	1177	0.008496177	0.016992353	12	14	Microglia	23	6	6
CTGATAGTCACATAGC-1_4_D9	-22.93902503	-22.51702451	6A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	2819	5891	0.013410287	0.005432015	12	6A	IN-PV	23	6	6
CTGCGGAAGTCAAGCG-1_4_D9	-21.94257328	-22.56079488	6A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	2341	4553	0.006589062	0.007467604	12	6A	IN-PV	23	6	6
CTGCGGAGTCAATACC-1_4_D9	-13.27340362	-16.59961011	6B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1252	2006	0.001994018	0.00448654	12	6B	IN-SST	23	6	6
CTGCTGTTCTCGCATC-1_4_D9	-8.129053223	-11.28671386	6B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	857	1027	0.009737098	0.016553067	12	6B	IN-SST	23	6	6
CTGGTCTGTCTTCAAG-1_4_D9	-22.63290384	-22.6786571	6A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	2831	6009	0.006823099	0.006157431	12	6A	IN-PV	23	6	6
CTGTGCTCATTACGAC-1_4_D9	-10.56678181	-2.301562579	13A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	2116	3396	0.00147232	0.015312132	12	13A	IN-VIP	23	6	6
CTTAACTAGAATGTGT-1_4_D9	-21.38403142	-23.27849404	6A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	2390	4846	0.004746182	0.006397028	12	6A	IN-PV	23	6	6
CTTACCGTCTGGTGTA-1_4_D9	-9.863256236	-7.437457828	13A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1645	2430	0.004115226	0.008641975	12	13A	IN-VIP	23	6	6
CTTCTCTCAAGCCTAT-1_4_D9	-8.084051759	-10.90150054	6B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	901	1086	0.007366483	0.011049724	12	6B	IN-SST	23	6	6
CTTCTCTCAAGCTGGA-1_4_D9	27.92126998	5.942291604	15A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	798	1100	0.006363636	0.016363636	12	15A	Endo cells	23	6	6
CTTTGCGCAAGAAGAG-1_4_D9	26.03930757	7.464284022	15A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1500	2209	0.006337709	0.024898144	12	15A	Endo cells	23	6	6
CTTTGCGCATGTAGTC-1_4_D9	24.67846283	7.366533795	15A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	2282	3362	0.007138608	0.013682332	12	15A	Endo cells	23	6	6
CTTTGCGTCACATGCA-1_4_D9	-10.41052329	-13.40698851	6B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1204	1668	0.005995204	0.013189448	12	6B	IN-SST	23	6	6
CTTTGCGTCCGCGGTA-1_4_D9	-2.957055508	29.96274162	17	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	825	1081	0.004625347	0.011100833	12	oligos	OL-MS-2	23	6	6
GAAACTCCACATCCGG-1_4_D9	-9.438115059	-13.51497144	6B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	838	1069	0.014031805	0.010289991	12	6B	IN-SST	23	6	6
GAAATGACACGAAGCA-1_4_D9	-16.83590537	6.7039356	8	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	901	1183	0.004226543	0.008453085	12	8	Astrocytes	23	6	6
GAACATCGTAGCTAAA-1_4_D9	-16.0483074	-13.97772235	6B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	2005	3026	0.008261732	0.007270324	12	6B	IN-SST	23	6	6
GAACCTAAGGTGTGGT-1_4_D9	-7.634355094	34.97934027	17	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	880	1149	0.014795474	0.007832898	12	oligos	OL-MS-2	23	6	6
GAACCTAAGTGGAGAA-1_4_D9	-10.3632726	-13.61533999	6B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1183	1832	0.003275109	0.00709607	12	6B	IN-SST	23	6	6
GAACCTACACCAGCAC-1_4_D9	-11.22938488	-6.764901309	13A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	2118	3559	0.004776623	0.008710312	12	13A	IN-VIP	23	6	6
GAACCTATCTGCCCTA-1_4_D9	-5.454996827	-30.17027451	16	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	807	1050	0.021904762	0.016190476	12	16	EN-PYR	23	6	6
GAAGCAGCATCGGACC-1_4_D9	-14.42608769	-17.07238562	6A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1423	2301	0.001303781	0.002607562	12	6A	IN-PV	23	6	6
GAATAAGTCAACGGGA-1_4_D9	-10.60082963	-7.181870258	13A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1924	2869	0.006622517	0.009062391	12	13A	IN-VIP	23	6	6
GAATGAACACATGTGT-1_4_D9	33.18442289	6.947296442	14	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	920	1222	0.004091653	0.008183306	12	14	Microglia	23	6	6
GAATGAACAGGTCCAC-1_4_D9	-10.46016784	-13.40029251	6B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1234	1731	0.003466205	0.008087811	12	6B	IN-SST	23	6	6
GACACGCAGCGAGAAA-1_4_D9	25.57892913	7.6310977	15A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1656	2400	0.004166667	0.059583333	12	15A	Endo cells	23	6	6
GACACGCGTGACAAAT-1_4_D9	-16.74191731	-6.996414229	13A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	2942	5623	0.021696603	0.004446025	12	13A	IN-VIP	23	6	6
GACAGAGCATGGGAAC-1_4_D9	6.557874895	2.166608113	16	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1284	1725	0.033043478	0.006376812	12	16	EN-PYR	23	6	6
GACCAATCATTTCACT-1_4_D9	-11.6553113	-7.86961309	13B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	2181	3766	0.007966012	0.00929368	12	13B	IN-SV2C	23	6	6
GACCTGGGTTCGGGCT-1_4_D9	-10.8212146	-13.68854736	6B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1281	1815	0.003305785	0.008264463	12	6B	IN-SST	23	6	6
GACGGCTTCCTCAATT-1_4_D9	-10.2859475	-7.403043564	13A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1720	2537	0.004729996	0.014978321	12	13A	IN-VIP	23	6	6
GACGTGCGTACTTGAC-1_4_D9	-8.21963863	-31.63592519	16	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	952	1257	0.023866348	0.011137629	12	16	EN-PYR	23	6	6
GACGTTAGTTAAGATG-1_4_D9	-11.89364414	-9.024924214	13B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1875	3232	0.004022277	0.004022277	12	13B	IN-SV2C	23	6	6
GACGTTATCAGGCCCA-1_4_D9	-14.74321342	-5.392307375	13A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	2461	4301	0.008835155	0.007207626	12	13A	IN-VIP	23	6	6
GACGTTATCCCTGACT-1_4_D9	-10.73438791	-32.60310988	16	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1118	1565	0.026198083	0.01341853	12	16	EN-PYR	23	6	6
GACTACAAGAGTAATC-1_4_D9	-15.23221881	7.23646133	8	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	968	1237	0.008892482	0.007275667	12	8	Astrocytes	23	6	6
GACTACAAGATATGGT-1_4_D9	4.263534488	1.229768767	16	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	957	1303	0.008442057	0.004604758	12	16	EN-PYR	23	6	6
GACTACACAATACGCT-1_4_D9	7.66833598	2.264676543	16	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	820	1025	0.034146341	0.012682927	12	16	EN-PYR	23	6	6
GACTACATCTGCGACG-1_4_D9	-15.04029704	-17.67546795	6B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1736	3052	0.000982962	0.00655308	12	6B	IN-SST	23	6	6
GACTGCGGTCTACCTC-1_4_D9	24.85455694	6.827661559	15A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1984	2887	0.006234846	0.012816072	12	15A	Endo cells	23	6	6
GAGCAGACATTCCTCG-1_4_D9	-15.36691535	-14.18004046	6B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1773	2800	0.004285714	0.013571429	12	6B	IN-SST	23	6	6
GAGCAGATCTAACTCT-1_4_D9	-12.09565149	31.82778332	17	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	877	1121	0.017841213	0.008920607	12	oligos	OL-MS-2	23	6	6
GAGGTGACACATTAGC-1_4_D9	-28.26225805	-12.68356068	9	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	872	1152	0.006076389	0.006076389	12	9	OPC	23	6	6
GATCAGTGTCATCGGC-1_4_D9	1.576390475	6.143761367	17	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	963	1213	0.004122012	0.007419621	12	oligos	OL-MS-2	23	6	6
GATCGATTCTTGTATC-1_4_D9	-8.148178079	-32.5145248	16	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	965	1359	0.024282561	0.016188374	12	16	EN-PYR	23	6	6
GATCGCGTCCTTTACA-1_4_D9	-24.51972699	-12.30219472	9	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	903	1331	0.00150263	0.003005259	12	9	OPC	23	6	6
GATCGTACACCAGGTC-1_4_D9	-5.443023632	-28.00411142	16	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	842	1059	0.01605288	0.014164306	12	16	EN-PYR	23	6	6
GATCGTAGTTACTGAC-1_4_D9	-15.37116984	-14.04105537	6B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1767	2759	0.005436752	0.005074302	12	6B	IN-SST	23	6	6
GATGAGGCAATAGCAA-1_4_D9	-17.45882608	7.076292533	8	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	937	1271	0.002360346	0.004720692	12	8	Astrocytes	23	6	6
GATGAGGCACAGCCCA-1_4_D9	33.83085866	6.761893568	14	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1208	1613	0.006199628	0.011779293	12	14	Microglia	23	6	6
GATGAGGGTTCAGTAC-1_4_D9	-22.17323683	-22.46269396	6A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	2587	5300	0.031132075	0.006603774	12	6A	IN-PV	23	6	6
GATGAGGTCTGAGTGT-1_4_D9	-10.55749826	-13.47657514	6B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1216	1772	0.001128668	0.006207675	12	6B	IN-SST	23	6	6
GATGCTAGTCCAACTA-1_4_D9	-12.01438472	-8.84005726	13B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1980	3443	0.002323555	0.011327331	12	13B	IN-SV2C	23	6	6
GATGCTATCTTGCCGT-1_4_D9	-15.74334952	-14.34196889	6B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1922	3430	0.006997085	0.006997085	12	6B	IN-SST	23	6	6
GATTCAGTCGGCTACG-1_4_D9	-9.788971988	-13.54753553	6B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1221	1660	0.004819277	0.006626506	12	6B	IN-SST	23	6	6
GATTCAGTCTAACCGA-1_4_D9	5.833901955	0.674067184	16	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1124	1545	0.005825243	0.010355987	12	16	EN-PYR	23	6	6
GCACATAAGATTACCC-1_4_D9	-16.41233688	-7.059631369	13A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	2418	4324	0.032377428	0.006012951	12	13A	IN-VIP	23	6	6
GCACATACAAGCCCAC-1_4_D9	-8.377676949	-9.909819754	13A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1043	1306	0.007656968	0.013016845	12	13A	IN-VIP	23	6	6
GCACATAGTAATTGGA-1_4_D9	-4.95991647	-30.43979113	16	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	821	1069	0.021515435	0.016838167	12	16	EN-PYR	23	6	6
GCACATAGTGCAGGTA-1_4_D9	-16.4485079	-21.1962394	6A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1569	2428	0.004118616	0.005766063	12	6A	IN-PV	23	6	6
GCACATATCTTAGAGC-1_4_D9	-13.66262186	-14.15092095	6B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1217	1741	0.005169443	0.014933946	12	6B	IN-SST	23	6	6
GCACTCTAGCTAGTTC-1_4_D9	-9.972872089	-7.296036339	13A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1690	2539	0.003544703	0.005120126	12	13A	IN-VIP	23	6	6
GCACTCTTCAGTTGAC-1_4_D9	7.336651627	2.326873078	16	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	930	1163	0.017196905	0.012897678	12	16	EN-PYR	23	6	6
GCAGTTATCTCTGTCG-1_4_D9	9.156704126	1.650051346	12	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	692	1019	0.00686948	0.004906771	12	12	EN-MIX	23	6	6
GCATACAAGGGTTTCT-1_4_D9	-6.355977586	-29.39223184	16	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	924	1229	0.009764036	0.015459723	12	16	EN-PYR	23	6	6
GCATACACATGGATGG-1_4_D9	-9.669209415	-13.47961431	6B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1028	1335	0.007490637	0.005243446	12	6B	IN-SST	23	6	6
GCATACAGTCGTGGCT-1_4_D9	-20.86516939	-15.29141091	6B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	2846	5196	0.021555042	0.005773672	12	6B	IN-SST	23	6	6
GCATACATCCCTAACC-1_4_D9	33.06613438	6.262571589	14	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	851	1035	0.012560386	0.011594203	12	14	Microglia	23	6	6
GCATACATCTTGACGA-1_4_D9	-8.708433048	-9.235231409	13A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1232	1654	0.008464329	0.009673519	12	13A	IN-VIP	23	6	6
GCATGATAGAGGGATA-1_4_D9	-20.8573211	-22.02589049	6A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1964	3101	0.005159626	0.008706869	12	6A	IN-PV	23	6	6
GCATGATAGGCCCGTT-1_4_D9	33.21314563	7.566029944	14	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	840	1034	0.012572534	0.015473888	12	14	Microglia	23	6	6
GCATGATGTCCGAGTC-1_4_D9	-10.15478098	-13.44556684	6B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1067	1428	0.003501401	0.00280112	12	6B	IN-SST	23	6	6
GCATGCGGTGGCTCCA-1_4_D9	-24.39911047	-12.05486432	9	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	835	1017	0.009832842	0.007866273	12	9	OPC	23	6	6
GCATGCGTCACTCTTA-1_4_D9	19.91601623	-10.93247327	3	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	2236	3646	0.002468459	0.007953922	12	3	EN-L5-6	23	6	6
GCATGTAAGTCCAGGA-1_4_D9	-23.50157206	-11.30636377	16	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	841	1057	0.008514664	0.011352886	12	16	EN-PYR	23	6	6
GCCAAATCAGACTCGC-1_4_D9	-22.21852031	-22.34149775	6A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	2493	4495	0.009121246	0.008231368	12	6A	IN-PV	23	6	6
GCCAAATGTCTCACCT-1_4_D9	7.95003727	2.607186965	16	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	948	1241	0.016921837	0.012892828	12	16	EN-PYR	23	6	6
GCCTCTACATCATCCC-1_4_D9	32.49406734	4.963324512	14	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	950	1206	0.014096186	0.006633499	12	14	Microglia	23	6	6
GCGACCAAGACAGACC-1_4_D9	-14.02179523	-5.618086076	13A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	2312	3715	0.004037685	0.003768506	12	13A	IN-VIP	23	6	6
GCGACCACACCGGAAA-1_4_D9	-8.648268969	-9.495373202	13A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1226	1672	0.00777512	0.010167464	12	13A	IN-VIP	23	6	6
GCGACCAGTAGGAGTC-1_4_D9	28.06301001	5.43748719	15DA	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	857	1124	0.005338078	0.025800712	12	15DA	T cells	23	6	6
GCGACCAGTGCATCTA-1_4_D9	-20.97176457	-17.52810854	6A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	2982	5893	0.002206007	0.007636179	12	6A	IN-PV	23	6	6
GCGAGAACAGCCTGTG-1_4_D9	-11.3691666	-8.165615782	13B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1659	2518	0.002382844	0.011914218	12	13B	IN-SV2C	23	6	6
GCGAGAACATGGTAGG-1_4_D9	-10.66340256	-7.228670389	13A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	2039	3205	0.00374415	0.009984399	12	13A	IN-VIP	23	6	6
GCGAGAAGTCATCCCT-1_4_D9	-16.65810287	6.178831833	8	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	874	1164	0.006872852	0.007731959	12	8	Astrocytes	23	6	6
GCGAGAATCCGGGTGT-1_4_D9	-13.37721798	6.802149805	16	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	883	1060	0.008490566	0.003773585	12	16	EN-PYR	23	6	6
GCGAGAATCGGCTTGG-1_4_D9	-13.40194026	-14.26709585	6B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1188	1683	0.011883541	0.01010101	12	6B	IN-SST	23	6	6
GCGCAACTCGAACTGT-1_4_D9	7.43485614	2.362943154	16	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	909	1143	0.020122485	0.006124234	12	16	EN-PYR	23	6	6
GCGCAACTCTGGCGTG-1_4_D9	-16.40357169	6.41375375	8	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	764	1028	0.006809339	0.010700389	12	8	Astrocytes	23	6	6
GCGCAGTTCATGTCCC-1_4_D9	-15.35490587	-4.784683152	13A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	3074	5993	0.004171533	0.006674454	12	13A	IN-VIP	23	6	6
GCGCAGTTCTATCCTA-1_4_D9	-21.0476762	-23.35578435	6A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	2555	4815	0.003530633	0.004361371	12	6A	IN-PV	23	6	6
GCGCCAAGTTACGTCA-1_4_D9	-20.98967978	-23.36819939	6A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	2429	4580	0.001746725	0.006768559	12	6A	IN-PV	23	6	6
GCGCCAATCTCAAACG-1_4_D9	-15.20047482	-14.20249078	6B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1522	2344	0.005119454	0.006825939	12	6B	IN-SST	23	6	6
GCGCGATCATTGGTAC-1_4_D9	-8.969424428	-8.651051814	13A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1348	1881	0.008506114	0.013822435	12	13A	IN-VIP	23	6	6
GCGGGTTGTATCAGTC-1_4_D9	-21.00666704	-15.69853403	6B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	2827	5088	0.003930818	0.006092767	12	6B	IN-SST	23	6	6
GCTCCTAAGAGCTATA-1_4_D9	-11.60252479	-33.17805776	16	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1442	2257	0.034116083	0.010633584	12	16	EN-PYR	23	6	6
GCTCTGTAGTCCCACG-1_4_D9	-8.921289633	-14.3898895	6B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	833	1089	0.003673095	0.005509642	12	6B	IN-SST	23	6	6
GCTGCAGTCCCTGACT-1_4_D9	-1.908112055	32.09957828	17	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1166	1631	0.014714899	0.009196812	12	oligos	OL-MS-2	23	6	6
GCTGCGAAGCACCGTC-1_4_D9	-15.5575832	-14.25365531	6B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1894	3397	0.004121283	0.005887548	12	6B	IN-SST	23	6	6
GCTGCTTCAGTATCTG-1_4_D9	5.647464501	1.649417454	16	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	796	1007	0.019860973	0.012909633	12	16	EN-PYR	23	6	6
GCTGCTTCATGGGACA-1_4_D9	7.513794276	2.333991751	16	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	859	1050	0.017142857	0.00952381	12	16	EN-PYR	23	6	6
GCTGCTTGTTCCCTTG-1_4_D9	-14.66737246	6.854241757	8	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	839	1015	0.015763547	0.003940887	12	8	Astrocytes	23	6	6
GCTGGGTTCAGTTAGC-1_4_D9	-9.630540345	35.28570266	17	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	843	1093	0.010064044	0.013723696	12	oligos	OL-MS-2	23	6	6
GCTTCCAAGTGTCCCG-1_4_D9	-5.233486705	-31.72973772	16	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1058	1444	0.029085873	0.010387812	12	16	EN-PYR	23	6	6
GCTTGAACAGGATCGA-1_4_D9	-17.08058798	-7.058774374	13A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	3235	6957	0.015811413	0.005605865	12	13A	IN-VIP	23	6	6
GGAAAGCGTCTGATTG-1_4_D9	10.93592559	-1.51328677	12	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1191	1660	0.002409639	0.010843373	12	12	EN-MIX	23	6	6
GGAAAGCGTGGTAACG-1_4_D9	-6.537665777	-33.01785258	16	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	867	1122	0.01426025	0.010695187	12	16	EN-PYR	23	6	6
GGAACTTAGAACTGTA-1_4_D9	-13.39294008	-14.29975985	6B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1149	1637	0.002443494	0.006719609	12	6B	IN-SST	23	6	6
GGAACTTCAAAGAATC-1_4_D9	-8.66037627	-9.146941402	13A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1198	1573	0.006993007	0.017164654	12	13A	IN-VIP	23	6	6
GGAATAAAGTTCGCAT-1_4_D9	-11.25025087	-13.00764635	6B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1551	2211	0.027589326	0.007236545	12	6B	IN-SST	23	6	6
GGAATAATCAAGCCTA-1_4_D9	-10.20639319	-13.12355813	6B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1154	1540	0.007142857	0.013636364	12	6B	IN-SST	23	6	6
GGAATAATCACGAAGG-1_4_D9	-10.66244949	-13.27607649	6B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1428	2103	0.003328578	0.007608179	12	6B	IN-SST	23	6	6
GGACAGACAAATTGCC-1_4_D9	-10.24792446	-13.45605495	6B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1145	1545	0.006472492	0.015533981	12	6B	IN-SST	23	6	6
GGACATTAGATGCCTT-1_4_D9	6.861832146	1.472674278	16	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	774	1000	0.015	0.005	12	16	EN-PYR	23	6	6
GGACGTCAGCTACCGC-1_4_D9	-1.669271934	36.56601784	17	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	862	1195	0.005020921	0.005020921	12	oligos	OL-MS-2	23	6	6
GGACGTCAGTAAGTAC-1_4_D9	-8.116741112	-10.60565682	6B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	977	1262	0.00792393	0.008716323	12	6B	IN-SST	23	6	6
GGACGTCTCATGCATG-1_4_D9	-15.40500655	6.900750611	8	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	901	1165	0.004291845	0.006008584	12	8	Astrocytes	23	6	6
GGAGCAACATTCCTGC-1_4_D9	-16.69391302	6.789833719	8	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	915	1144	0.009615385	0.01048951	12	8	Astrocytes	23	6	6
GGATTACCAACAACCT-1_4_D9	-10.68123091	-13.25915411	6B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1334	1940	0.006185567	0.009278351	12	6B	IN-SST	23	6	6
GGATTACTCAGTGTTG-1_4_D9	-22.10047861	-22.51167043	6A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	2430	4449	0.020454035	0.010114633	12	6A	IN-PV	23	6	6
GGCAATTGTGGACGAT-1_4_D9	-16.5998662	-7.84336049	13B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	2471	4716	0.00466497	0.003816794	12	13B	IN-SV2C	23	6	6
GGCAATTTCCTTCAAT-1_4_D9	6.564594151	2.111020685	16	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	940	1168	0.017979452	0.017979452	12	16	EN-PYR	23	6	6
GGCCGATCAAACTGCT-1_4_D9	-3.021484075	30.03570237	17	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1041	1409	0.005677786	0.004258339	12	oligos	OL-MS-2	23	6	6
GGCGACTAGCGTTTAC-1_4_D9	26.41631152	6.698240096	15A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1100	1433	0.003489184	0.019539428	12	15A	Endo cells	23	6	6
GGCGACTCAAACGTGG-1_4_D9	-8.675883516	-9.224412128	13A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1219	1733	0.006924409	0.005193306	12	13A	IN-VIP	23	6	6
GGCGTGTGTTCAGGCC-1_4_D9	27.96330624	5.665070252	15DA	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	858	1082	0.02310536	0.028650647	12	15DA	T cells	23	6	6
GGCTGGTGTCTTGATG-1_4_D9	-16.59216458	7.787823731	8	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1146	1589	0.010069226	0.005034613	12	8	Astrocytes	23	6	6
GGCTGGTGTGTTTGTG-1_4_D9	-10.74136792	-7.13059918	13A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	2028	3348	0.003584229	0.006869773	12	13A	IN-VIP	23	6	6
GGGAATGAGCCGATTT-1_4_D9	20.61646564	-11.93916329	12	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	2076	3276	0.007936508	0.006715507	12	12	EN-MIX	23	6	6
GGGACCTGTAGCGATG-1_4_D9	-12.83583098	-15.15632853	6B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1248	1870	0.004278075	0.003208556	12	6B	IN-SST	23	6	6
GGGACCTGTCGCGTGT-1_4_D9	-22.1925011	-22.21022657	6A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	2266	4025	0.009937888	0.01242236	12	6A	IN-PV	23	6	6
GGGAGATTCCGGGTGT-1_4_D9	-20.99106091	-23.41640654	6A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	2376	4339	0.000691404	0.004378889	12	6A	IN-PV	23	6	6
GGGAGATTCTAAGCCA-1_4_D9	-24.40324533	-11.86275361	9	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	770	1007	0.004965243	0.006951341	12	9	OPC	23	6	6
GGGATGACACATTAGC-1_4_D9	-20.40050982	-23.39772978	6A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	2198	4528	0.001987633	0.006404594	12	6A	IN-PV	23	6	6
GGGCATCGTCGTGGCT-1_4_D9	-9.538730612	-9.424902062	13A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1298	1939	0.001547189	0.005673027	12	13A	IN-VIP	23	6	6
GGGTTGCCAGTGACAG-1_4_D9	-9.113945677	-9.088586023	13A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1365	1892	0.009513742	0.00845666	12	13A	IN-VIP	23	6	6
GGGTTGCTCAACTCTT-1_4_D9	-10.71347677	-7.137491293	13A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1887	2938	0.008849558	0.010891763	12	13A	IN-VIP	23	6	6
GGGTTGCTCCACGTGG-1_4_D9	-12.0350858	12.28506287	11	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	888	1106	0.005424955	0.009041591	12	11	Glia-MIX	23	6	6
GGTATTGAGAGTACCG-1_4_D9	-8.229691817	-10.18104966	6B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	895	1155	0.005194805	0.011255411	12	6B	IN-SST	23	6	6
GGTGAAGGTTAGTGGG-1_4_D9	-8.034258072	-35.91480133	16	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1104	1614	0.037174721	0.00929368	12	16	EN-PYR	23	6	6
GGTGCGTAGTTGAGTA-1_4_D9	-14.84897913	-14.17061463	6B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1361	1906	0.013116474	0.008394544	12	6B	IN-SST	23	6	6
GGTGTTACAAGGTTTC-1_4_D9	-11.753022	-34.36696338	16	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1388	2098	0.04528122	0.009056244	12	16	EN-PYR	23	6	6
GTAACGTAGATGTCGG-1_4_D9	-11.17471991	-8.764326049	13B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1435	2184	0.009615385	0.010989011	12	13B	IN-SV2C	23	6	6
GTAACGTGTCTAGCGC-1_4_D9	-7.688535911	31.69238584	17	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1408	1947	0.011813046	0.008217771	12	oligos	OL-MS-2	23	6	6
GTAACGTGTGGTACAG-1_4_D9	-11.20852345	-13.34738169	6B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1304	1897	0.015287296	0.009488666	12	6B	IN-SST	23	6	6
GTAACGTTCAGCACAT-1_4_D9	-20.1831497	-15.1552071	6B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	2353	4315	0.006025492	0.009501738	12	6B	IN-SST	23	6	6
GTAACTGGTGAGTATA-1_4_D9	-23.55585463	-22.05496408	6A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	2599	4711	0.018679686	0.00997665	12	6A	IN-PV	23	6	6
GTACGTACAGACGCAA-1_4_D9	-16.29589388	-8.958572297	13B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	2595	6140	0.003908795	0.003094463	12	13B	IN-SV2C	23	6	6
GTACTTTCAGATAATG-1_4_D9	28.14012914	5.763331231	15A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	877	1131	0.00530504	0.01061008	12	15A	Endo cells	23	6	6
GTACTTTCAGCTTAAC-1_4_D9	-10.3841972	-13.06146073	6B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1600	2336	0.00385274	0.018835616	12	6B	IN-SST	23	6	6
GTACTTTTCAACACCA-1_4_D9	-14.41826108	6.819937972	16	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	807	1017	0.012782694	0.006882989	12	16	EN-PYR	23	6	6
GTAGGCCGTGACGGTA-1_4_D9	-8.419776357	-9.893635656	13A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1040	1324	0.008308157	0.009818731	12	13A	IN-VIP	23	6	6
GTAGTCATCTCCTATA-1_4_D9	-9.614451147	-7.407946433	13A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1429	2156	0.006493506	0.004174397	12	13A	IN-VIP	23	6	6
GTATCTTAGCGTGAAC-1_4_D9	-8.642039546	35.69321694	17	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	836	1048	0.006679389	0.013358779	12	oligos	OL-MS-2	23	6	6
GTATTCTTCAGTCAGT-1_4_D9	-9.184849689	-8.532015139	13A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1369	1932	0.005175983	0.004658385	12	13A	IN-VIP	23	6	6
GTCAAGTGTGAGTATA-1_4_D9	-16.97420379	6.70532153	8	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	798	1032	0.004844961	0.007751938	12	8	Astrocytes	23	6	6
GTCACAATCTACGAGT-1_4_D9	10.16796339	0.616932436	12	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	877	1148	0.015679443	0.008710801	12	12	EN-MIX	23	6	6
GTCACGGCACAGGTTT-1_4_D9	19.77133114	-10.67426894	3	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	2062	3887	0.035502959	0.003859017	12	3	EN-L5-6	23	6	6
GTCATTTTCCAGAAGG-1_4_D9	-9.626913916	-6.313748603	13A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1696	2496	0.00400641	0.009615385	12	13A	IN-VIP	23	6	6
GTCCTCACAGACGTAG-1_4_D9	-9.28508665	-13.01790845	6B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	831	1051	0.011417697	0.008563273	12	6B	IN-SST	23	6	6
GTCCTCAGTAAGAGGA-1_4_D9	-5.278954407	-30.29446991	16	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	963	1284	0.029595016	0.01635514	12	16	EN-PYR	23	6	6
GTCGTAACATCTACGA-1_4_D9	-12.13063718	-13.36000744	6B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1384	1923	0.012480499	0.009880395	12	6B	IN-SST	23	6	6
GTCTCGTAGATGTGGC-1_4_D9	-20.94890206	-23.40620221	6A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	2331	4322	0.000925497	0.004858862	12	6A	IN-PV	23	6	6
GTCTCGTCATCGACGC-1_4_D9	-22.13687449	-22.43201239	6A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	2460	4460	0.010762332	0.006950673	12	6A	IN-PV	23	6	6
GTCTCGTGTCGCGGTT-1_4_D9	-8.354004261	-9.718471714	13A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1163	1556	0.001285347	0.011568123	12	13A	IN-VIP	23	6	6
GTCTTCGTCTCAAACG-1_4_D9	-8.952332423	-14.22165537	6B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	736	1006	0.013916501	0.008946322	12	6B	IN-SST	23	6	6
GTGAAGGCATATACCG-1_4_D9	-10.66400887	-7.009795181	13A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	2044	3342	0.008976661	0.005086774	12	13A	IN-VIP	23	6	6
GTGCAGCCATCACGTA-1_4_D9	-11.23219001	-13.09128917	6B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1429	2103	0.002377556	0.014740846	12	6B	IN-SST	23	6	6
GTGCATAAGCCCAGCT-1_4_D9	-24.46633489	-12.18011924	9	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	815	1007	0.007944389	0.008937438	12	9	OPC	23	6	6
GTGCATACAGATCCAT-1_4_D9	-6.487086955	-30.56983503	16	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	837	1115	0.02690583	0.019730942	12	16	EN-PYR	23	6	6
GTGCGGTGTCTTCGTC-1_4_D9	-20.76246861	-26.17748462	6A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	2958	6473	0.003089757	0.006797466	12	6A	IN-PV	23	6	6
GTGGGTCAGGATCGCA-1_4_D9	-9.319940554	-13.68276342	6B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	892	1126	0.024866785	0.007104796	12	6B	IN-SST	23	6	6
GTGGGTCCAGGCGATA-1_4_D9	-17.25635508	7.067010856	8	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	783	1011	0.052423343	0.010880317	12	8	Astrocytes	23	6	6
GTGGGTCGTGGCTCCA-1_4_D9	31.122101	4.492377032	15DA	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1219	1492	0.008042895	0.042895442	12	15DA	T cells	23	6	6
GTGTTAGTCTGTCTCG-1_4_D9	-18.44260126	-21.46558054	6A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	2080	3611	0.003323179	0.003877042	12	6A	IN-PV	23	6	6
GTTAAGCTCAAACAAG-1_4_D9	24.93636042	7.049097601	15A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1778	2480	0.008064516	0.020967742	12	15A	Endo cells	23	6	6
GTTACAGAGCCACTAT-1_4_D9	-20.79316357	-23.52356827	6A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	2213	4184	0.002629063	0.00501912	12	6A	IN-PV	23	6	6
GTTACAGAGCGATATA-1_4_D9	-23.68044412	-22.40573819	6A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	3143	6989	0.007440263	0.004578624	12	6A	IN-PV	23	6	6
GTTACAGAGCTAACAA-1_4_D9	-23.49591171	-22.6355849	6A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	3645	7855	0.00649268	0.007511139	12	6A	IN-PV	23	6	6
GTTACAGCACATAACC-1_4_D9	6.232647403	2.1060829	16	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1286	1726	0.036500579	0.015063731	12	16	EN-PYR	23	6	6
GTTCATTTCCTAGTGA-1_4_D9	-7.597106498	-38.04706285	16	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1096	1524	0.033464567	0.020997375	12	16	EN-PYR	23	6	6
GTTCTCGAGGCTACGA-1_4_D9	-10.19063886	-7.387676472	13A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1744	2470	0.008906883	0.01902834	12	13A	IN-VIP	23	6	6
GTTCTCGGTTGTCTTT-1_4_D9	-6.04022169	-29.88898587	16	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	855	1099	0.006369427	0.008189263	12	16	EN-PYR	23	6	6
TAAACCGGTTACGACT-1_4_D9	-10.68503197	-7.336789711	13A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1900	2817	0.005324814	0.011004615	12	13A	IN-VIP	23	6	6
TAAGAGAAGTAGCCGA-1_4_D9	-9.461782941	-13.78945435	6B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	921	1291	0.00464756	0.00697134	12	6B	IN-SST	23	6	6
TAAGAGATCATACGGT-1_4_D9	-18.31017359	-6.039423357	13B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	2467	4521	0.01747401	0.00818403	12	13B	IN-SV2C	23	6	6
TAAGCGTCAGGTCGTC-1_4_D9	-15.58386762	-14.18985332	6B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1858	3015	0.0026534	0.008623549	12	6B	IN-SST	23	6	6
TAAGCGTGTCCGCTGA-1_4_D9	-9.143655026	-8.993417743	13A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1327	1920	0.00625	0.008333333	12	13A	IN-VIP	23	6	6
TACCTTACATATACCG-1_4_D9	-12.3076587	11.48680098	8	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	950	1248	0.020032051	0.004807692	12	8	Astrocytes	23	6	6
TACCTTAGTTGGTTTG-1_4_D9	-8.990220475	35.28895289	17	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	847	1048	0.011450382	0.009541985	12	oligos	OL-MS-2	23	6	6
TACGGATTCAGTTGAC-1_4_D9	-10.93899946	-8.988454284	13A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1496	2199	0.005457026	0.006821282	12	13A	IN-VIP	23	6	6
TACGGGCAGACTTGAA-1_4_D9	26.00986869	7.073133936	15A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1445	2059	0.005828072	0.018941234	12	15A	Endo cells	23	6	6
TACGGGCAGCACACAG-1_4_D9	-10.62353336	-7.084340903	13A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1959	3029	0.006602839	0.013205678	12	13A	IN-VIP	23	6	6
TACGGGCCATTCCTCG-1_4_D9	32.82030343	4.972446382	14	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	988	1241	0.014504432	0.010475423	12	14	Microglia	23	6	6
TACGGTACAAGCGAGT-1_4_D9	-14.88623134	-14.43666883	6B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1392	2235	0.007158837	0.003131991	12	6B	IN-SST	23	6	6
TACTCGCGTCTAAAGA-1_4_D9	-7.175610411	-33.53159588	16	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	851	1086	0.018416206	0.009208103	12	16	EN-PYR	23	6	6
TACTCGCTCCAGAGGA-1_4_D9	-8.4307271	-9.975516056	6B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1113	1458	0.005486968	0.01303155	12	6B	IN-SST	23	6	6
TACTTACGTCTTGCGG-1_4_D9	-24.44902698	-12.23023145	9	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	835	1052	0.003802281	0.005703422	12	9	OPC	23	6	6
TACTTGTGTTATCCGA-1_4_D9	-0.581576201	30.92323314	17	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	827	1046	0.008604207	0.008604207	12	oligos	OL-MS-2	23	6	6
TAGACCATCACCATAG-1_4_D9	10.35396511	0.599051329	12	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	962	1303	0.023023791	0.002302379	12	12	EN-MIX	23	6	6
TAGAGCTCAATAGCAA-1_4_D9	-5.644773396	-33.91272228	16	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	990	1338	0.029895366	0.012705531	12	16	EN-PYR	23	6	6
TAGGCATAGTAGCGGT-1_4_D9	-8.838956666	-8.998485423	13A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1185	1561	0.003203075	0.01409353	12	13A	IN-VIP	23	6	6
TAGTGGTAGTGTGGCA-1_4_D9	-13.93131244	-21.85561908	6B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1195	1785	0.001120448	0.002240896	12	6B	IN-SST	23	6	6
TAGTTGGTCAGAGACG-1_4_D9	26.46408677	3.693076577	15BA	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	827	1037	0.006750241	0.003857281	12	15BA	Stromal cells	23	6	6
TAGTTGGTCTTGAGGT-1_4_D9	-11.08937331	29.46763829	17	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1009	1269	0.020488574	0.008668243	12	oligos	OL-MS-2	23	6	6
TATCAGGGTGTTGAGG-1_4_D9	33.96554049	8.067943475	14	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1621	2246	0.015138023	0.010685663	12	14	Microglia	23	6	6
TATGCCCTCTCCCTGA-1_4_D9	-11.32953639	-13.23766351	6B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1461	2171	0.024412713	0.010133579	12	6B	IN-SST	23	6	6
TCAACGATCAATCTCT-1_4_D9	24.25882686	8.188037178	15A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	4826	10614	0.006029772	0.018466177	12	15A	Endo cells	23	6	6
TCAATCTAGATCCCAT-1_4_D9	33.59388297	7.201325165	14	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1063	1387	0.008651766	0.011535689	12	14	Microglia	23	6	6
TCAATCTGTTACCGAT-1_4_D9	33.19604697	7.536841415	14	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	889	1101	0.009082652	0.006357856	12	14	Microglia	23	6	6
TCACGAATCAACACCA-1_4_D9	32.98766685	5.639639895	14	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1122	1389	0.018718503	0.008639309	12	14	Microglia	23	6	6
TCACGAATCCAAGTAC-1_4_D9	-8.930651879	-9.270769459	6B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1257	1788	0.003914989	0.011744966	12	6B	IN-SST	23	6	6
TCAGATGCAAACTGTC-1_4_D9	-12.03625516	12.09007655	11	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1161	1479	0.001352265	0.012170385	12	11	Glia-MIX	23	6	6
TCAGCAATCGCTAGCG-1_4_D9	-16.01873953	-14.20853802	6B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	2225	3721	0.00107498	0.005374899	12	6B	IN-SST	23	6	6
TCAGCTCCACGCGAAA-1_4_D9	-16.30970721	6.128183687	8	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	733	1002	0.013972056	0.018962076	12	8	Astrocytes	23	6	6
TCAGGATCAAGAGTCG-1_4_D9	-23.56192919	-22.00939813	6A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	2652	4546	0.008798944	0.004179498	12	6A	IN-PV	23	6	6
TCATTACCACGGCCAT-1_4_D9	-11.85752551	30.262132	17	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	911	1161	0.010335917	0.008613264	12	oligos	OL-MS-2	23	6	6
TCCACACGTTGGTGGA-1_4_D9	-27.03901127	-17.94018308	13A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	3348	6403	0.009839138	0.01655474	12	13A	IN-VIP	23	6	6
TCCCGATGTACAGACG-1_4_D9	-23.76953193	-22.42276927	6A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	3322	6617	0.023122261	0.00770742	12	6A	IN-PV	23	6	6
TCGCGAGAGTCCGTAT-1_4_D9	-24.24573561	-22.7310206	6A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	4582	12546	0.051251395	0.004304161	12	6A	IN-PV	23	6	6
TCGCGAGCATACTCTT-1_4_D9	-9.543017792	-13.15996019	6B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	896	1240	0.008064516	0.009677419	12	6B	IN-SST	23	6	6
TCGCGTTCACATCTTT-1_4_D9	-9.447289373	-13.49720432	6B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	936	1223	0.007358953	0.004905969	12	6B	IN-SST	23	6	6
TCGTACCCAGTATGCT-1_4_D9	-10.6730462	-7.21817573	13A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1905	2980	0.003020134	0.006040268	12	13A	IN-VIP	23	6	6
TCGTACCCATCGTCGG-1_4_D9	-9.385249196	-13.9952954	6B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	881	1208	0.004966887	0.00910596	12	6B	IN-SST	23	6	6
TCGTACCGTTACGACT-1_4_D9	-10.37169338	-7.32215256	13A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1922	2799	0.005716327	0.017506252	12	13A	IN-VIP	23	6	6
TCGTAGACACACAGAG-1_4_D9	-8.777903933	-9.171260932	13A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1323	1755	0.004558405	0.013675214	12	13A	IN-VIP	23	6	6
TCTATTGTCCGTCATC-1_4_D9	-9.225192486	-13.78636981	6B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	837	1182	0.004230118	0.020304569	12	6B	IN-SST	23	6	6
TCTGGAATCCTTTACA-1_4_D9	-14.77526365	-5.448984126	13A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	2600	4740	0.008649789	0.004852321	12	13A	IN-VIP	23	6	6
TCTTCGGTCTGCTTGC-1_4_D9	-11.84959485	-12.75020976	6B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1991	3344	0.008971292	0.007476077	12	6B	IN-SST	23	6	6
TCTTTCCCATCGACGC-1_4_D9	-9.623550541	-10.85876882	6B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1101	1426	0.013323983	0.00911641	12	6B	IN-SST	23	6	6
TCTTTCCGTAATAGCA-1_4_D9	-11.66480388	-8.733277696	13B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1692	2545	0.007072692	0.007858546	12	13B	IN-SV2C	23	6	6
TGACAACTCTACTATC-1_4_D9	7.5428262	2.521964688	16	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	789	1035	0.035748792	0.005797101	12	16	EN-PYR	23	6	6
TGACGGCCAAAGGAAG-1_4_D9	-13.77971082	6.721370159	8	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	839	1004	0.013944223	0.005976096	12	8	Astrocytes	23	6	6
TGACTAGAGGTACTCT-1_4_D9	7.893651389	3.073577224	16	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	911	1129	0.011514615	0.005314438	12	16	EN-PYR	23	6	6
TGAGCATCACTTCTGC-1_4_D9	-9.739722734	-13.72570711	6B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	959	1378	0.003628447	0.013062409	12	6B	IN-SST	23	6	6
TGAGCATGTACATCCA-1_4_D9	-7.939749157	-26.80085492	16	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	817	1023	0.022482893	0.009775171	12	16	EN-PYR	23	6	6
TGAGCATTCGGAGCAA-1_4_D9	-15.109671	-14.28851465	6B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1601	2482	0.002417405	0.011684126	12	6B	IN-SST	23	6	6
TGAGCCGTCCTCAACC-1_4_D9	8.487971962	1.603140687	12	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	818	1033	0.007744434	0.008712488	12	12	EN-MIX	23	6	6
TGAGGGAGTACTTAGC-1_4_D9	-10.82833435	-7.18892569	13A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1908	2828	0.007779349	0.012022631	12	13A	IN-VIP	23	6	6
TGAGGGATCTACCTGC-1_4_D9	-16.71386959	-7.65730544	13B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	2319	4284	0.006069094	0.008636788	12	13B	IN-SV2C	23	6	6
TGATTTCGTAGCTGCC-1_4_D9	-9.447292051	-9.446999794	13A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1187	1726	0.004634994	0.007531866	12	13A	IN-VIP	23	6	6
TGCACCTAGTGGTAGC-1_4_D9	-2.892851249	29.96421701	17	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	834	1055	0.004739336	0.004739336	12	oligos	OL-MS-2	23	6	6
TGCACCTCATTGAGCT-1_4_D9	-16.9230552	6.732670525	8	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	906	1171	0.011955594	0.010247652	12	8	Astrocytes	23	6	6
TGCCCATAGATTACCC-1_4_D9	-14.83647548	-13.96726452	6B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1631	2746	0.003641661	0.011289148	12	6B	IN-SST	23	6	6
TGCCCTATCACCATAG-1_4_D9	-16.65228035	-21.34671919	6A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1624	2630	0.007604563	0.00418251	12	6A	IN-PV	23	6	6
TGCGCAGAGATTACCC-1_4_D9	-16.49284519	6.120104598	8	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	755	1077	0.005571031	0.007428041	12	8	Astrocytes	23	6	6
TGCTACCCAAGTAATG-1_4_D9	1.010732374	1.308980878	11	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	2124	3173	0.008194138	0.010085093	12	11	Glia-MIX	23	6	6
TGCTACCTCAGGTAAA-1_4_D9	-11.86675738	-9.017649038	13B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1654	2678	0.004107543	0.002987304	12	13B	IN-SV2C	23	6	6
TGGACGCAGGGTGTGT-1_4_D9	-5.341903005	-33.91981031	16	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	829	1125	0.024888889	0.012444444	12	16	EN-PYR	23	6	6
TGGACGCCAGAGTGTG-1_4_D9	-1.768293541	36.67134481	17	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	870	1249	0.004003203	0.008006405	12	oligos	OL-MS-2	23	6	6
TGGCGCACATAAAGGT-1_4_D9	6.385690008	2.106350905	16	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	825	1012	0.014822134	0.013833992	12	16	EN-PYR	23	6	6
TGGCTGGAGGAGTAGA-1_4_D9	-16.48668464	-21.23108131	6A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1527	2465	0.005273834	0.006896552	12	6A	IN-PV	23	6	6
TGGCTGGGTCAAACTC-1_4_D9	1.615504343	6.048103853	7	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	840	1013	0.004935834	0.008884501	12	7	Phagocytes	23	6	6
TGGGAAGAGTACATGA-1_4_D9	6.470644374	2.099274235	12	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1503	2074	0.026518804	0.009643202	12	12	EN-MIX	23	6	6
TGGGCGTAGCTGATAA-1_4_D9	-10.64261943	-7.142043103	13A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1892	2934	0.008861622	0.009543286	12	13A	IN-VIP	23	6	6
TGGGCGTCACAACTGT-1_4_D9	-25.24315699	-11.39643794	9	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	809	1020	0.006862745	0.006862745	12	9	OPC	23	6	6
TGGTTAGAGCGCCTTG-1_4_D9	-12.67213153	-14.83589624	6B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1243	1889	0.001058761	0.004764426	12	6B	IN-SST	23	6	6
TGGTTAGCAAATACAG-1_4_D9	-12.39613469	-8.813955135	6B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	2150	4142	0.010622887	0.004587156	12	6B	IN-SST	23	6	6
TGGTTAGTCAGTCCCT-1_4_D9	-10.90506322	-2.795149232	13A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	2039	3472	0.005184332	0.010368664	12	13A	IN-VIP	23	6	6
TGGTTCCTCGGTTCGG-1_4_D9	-24.51208438	-12.11464854	9	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	886	1170	0.008547009	0.011965812	12	9	OPC	23	6	6
TGTATTCTCAAAGACA-1_4_D9	-2.943937982	29.94868277	17	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	794	1019	0.012757605	0.005888126	12	oligos	OL-MS-2	23	6	6
TGTCCCACATTTGCTT-1_4_D9	-11.50855855	-8.642334894	13B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1819	2967	0.002022245	0.013481631	12	13B	IN-SV2C	23	6	6
TGTGGTACACTTCGAA-1_4_D9	-14.84470009	6.904643422	8	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	838	1002	0.011976048	0.00499002	12	8	Astrocytes	23	6	6
TGTGGTAGTCTGATTG-1_4_D9	-9.169233365	-15.53213938	6B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	820	1088	0.005514706	0.001838235	12	6B	IN-SST	23	6	6
TGTGTTTAGAAGGGTA-1_4_D9	-26.89933581	-10.21508595	9	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1119	1552	0.005798969	0.007087629	12	9	OPC	23	6	6
TGTTCCGGTAAGTGTA-1_4_D9	-17.39417487	6.715079185	8	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	815	1131	0.000884173	0.00530504	12	8	Astrocytes	23	6	6
TTAGGACAGAAACCGC-1_4_D9	25.79525956	3.520677317	15DA	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	940	1187	0.01010952	0.01516428	12	15DA	T cells	23	6	6
TTAGGACCACCGAATT-1_4_D9	-7.509099284	35.76816543	17	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	811	1093	0.014638609	0.005489478	12	oligos	OL-MS-2	23	6	6
TTAGGCACATATGGTC-1_4_D9	33.02436532	6.04806815	14	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	828	1007	0.009930487	0.012909633	12	14	Microglia	23	6	6
TTAGGCAGTTGAGTTC-1_4_D9	-8.671259737	-9.484522055	13A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1116	1429	0.012596221	0.011196641	12	13A	IN-VIP	23	6	6
TTAGGCAGTTGGTGGA-1_4_D9	-11.57421613	-13.28803119	6B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1351	1898	0.012118019	0.006849315	12	6B	IN-SST	23	6	6
TTAGTTCAGCGCTCCA-1_4_D9	-12.07356576	11.84107996	11	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	815	1024	0.005859375	0.004882813	12	11	Glia-MIX	23	6	6
TTATGCTGTCATATGC-1_4_D9	-2.13823291	29.97539274	17	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	859	1084	0.005535055	0.014760148	12	oligos	OL-MS-2	23	6	6
TTCCCAGCAGATTGCT-1_4_D9	25.35111719	4.473930795	15A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1012	1406	0.00284495	0.0056899	12	15A	Endo cells	23	6	6
TTCCCAGTCCTCCTAG-1_4_D9	-12.19222376	31.97514344	17	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1132	1441	0.013879251	0.004857738	12	oligos	OL-MS-2	23	6	6
TTCGAAGAGTGTTGAA-1_4_D9	-10.23029226	-37.20698285	16	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1189	1661	0.011438892	0.016857315	12	16	EN-PYR	23	6	6
TTCGAAGGTCAAGCGA-1_4_D9	-5.295208686	-34.94131898	16	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	793	1057	0.029328288	0.012298959	12	16	EN-PYR	23	6	6
TTCGGTCTCCAGATCA-1_4_D9	32.76853919	5.091241534	14	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1065	1408	0.005681818	0.010653409	12	14	Microglia	23	6	6
TTCTCAACAAATTGCC-1_4_D9	-11.52540985	-12.58329978	6B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1658	2279	0.005265467	0.007020623	12	6B	IN-SST	23	6	6
TTCTCAAGTTAAAGAC-1_4_D9	-9.526370196	-13.64675324	6B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	881	1185	0.001687764	0.0092827	12	6B	IN-SST	23	6	6
TTCTCCTTCAAGAAGT-1_4_D9	-9.496329562	-7.460846814	13A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1540	2276	0.003954306	0.012741652	12	13A	IN-VIP	23	6	6
TTCTTAGAGGCAAAGA-1_4_D9	-9.548255358	-7.174101047	13A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1540	2150	0.003255814	0.013953488	12	13A	IN-VIP	23	6	6
TTCTTAGGTGAGGCTA-1_4_D9	32.83161934	7.981201512	14	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1054	1283	0.015588465	0.02416212	12	14	Microglia	23	6	6
TTGAACGCAATGAAAC-1_4_D9	-11.12042299	33.17941722	17	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1014	1237	0.012126112	0.011317704	12	oligos	OL-MS-2	23	6	6
TTGACTTCAAGCGTAG-1_4_D9	25.66008112	7.720880441	15A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1788	2713	0.0084777	0.019166974	12	15A	Endo cells	23	6	6
TTGCGTCCACATCCGG-1_4_D9	-6.168784876	-30.96982968	16	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	785	1022	0.016634051	0.016634051	12	16	EN-PYR	23	6	6
TTGGAACAGCTGCCCA-1_4_D9	-9.904305862	-9.749990593	13B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1248	1752	0.006849315	0.003995434	12	13B	IN-SV2C	23	6	6
TTGGAACTCCCTTGCA-1_4_D9	33.32721917	6.515930522	14	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	977	1242	0.013687601	0.012077295	12	14	Microglia	23	6	6
TTGGCAACAGCCACCA-1_4_D9	-16.71445976	-21.36925589	6A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1823	3184	0.005653266	0.002826633	12	6A	IN-PV	23	6	6
TTTACTGCAGCCTTTC-1_4_D9	-10.57403553	-13.40116408	6B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1215	1958	0	0.01072523	12	6B	IN-SST	23	6	6
TTTATGCAGTTGAGTA-1_4_D9	-9.408867724	-11.3073718	6B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1066	1495	0.01270903	0.012040134	12	6B	IN-SST	23	6	6
TTTCCTCGTACTTAGC-1_4_D9	-22.34209755	-15.72379898	6A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	3006	5906	0.007788689	0.004740941	12	6A	IN-PV	23	6	6
TTTGCGCTCGTAGGTT-1_4_D9	26.82373215	4.514066106	15A	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	788	1017	0.000983284	0.01179941	12	15A	Endo cells	23	6	6
TTTGGTTCATCCGTGG-1_4_D9	-8.603911813	-10.1044469	6B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1029	1420	0.008450704	0.011971831	12	6B	IN-SST	23	6	6
TTTGGTTGTCCGAATT-1_4_D9	-12.26864785	-8.815092648	13B	4_D9	MS	Chronic inactive	48	female	parietal	CAP3	SEQ2	9.1	21	1978	3564	0.003647587	0.005050505	12	13B	IN-SV2C	23	6	6
AAACCTGAGTGAATTG-1_5_B5	32.95047131	-10.40829751	2	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	3190	7247	0.007865324	0.008279288	4	2	EN-L4	26	17	17
AAACCTGCAACAACCT-1_5_B5	14.74336953	-0.72934925	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	715	1124	0.00088968	0.003558719	4	12	EN-MIX	26	17	17
AAACCTGGTCATCCCT-1_5_B5	21.61825718	16.70581196	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1401	2520	0.000396825	0.00515873	4	oligos	OL-Cntl	26	17	17
AAACCTGTCATTATCC-1_5_B5	15.48498701	-4.22375183	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1524	2463	0.015428339	0.006902152	4	12	EN-MIX	26	17	17
AAACCTGTCCATTCTA-1_5_B5	24.15226406	14.79056757	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1399	2357	0.001272804	0.003818413	4	oligos	OL-Cntl	26	17	17
AAACGGGAGGCAAAGA-1_5_B5	18.62735119	9.782037906	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1620	2897	0.009665171	0.004487401	4	oligos	OL-Cntl	26	17	17
AAACGGGGTATGAATG-1_5_B5	8.83957469	15.37666896	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1133	2056	0.005350195	0.008754864	4	oligos	OL-Cntl	26	17	17
AAACGGGGTTAAAGTG-1_5_B5	14.89240924	17.67151366	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1022	1571	0.008911521	0.005092298	4	oligos	OL-Cntl	26	17	17
AAAGATGCATGCTAGT-1_5_B5	-5.002398455	3.2729085	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	3535	7863	0.002670736	0.004959939	4	11	Glia-MIX	26	17	17
AAAGATGGTCCTCCAT-1_5_B5	33.73452349	-11.36574308	2	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	3108	7216	0.008314856	0.010947894	4	2	EN-L4	26	17	17
AAAGCAAGTAGCGATG-1_5_B5	-4.678870577	3.325606858	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	3481	7083	0.002541296	0.007341522	4	11	Glia-MIX	26	17	17
AAAGCAAGTCAATACC-1_5_B5	-0.744814944	25.47878103	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	728	1038	0.006743738	0.00867052	4	oligos	OL-Cntl	26	17	17
AAAGCAAGTGGAAAGA-1_5_B5	0.249881147	25.29638279	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	716	1109	0.001803427	0.007213706	4	oligos	OL-Cntl	26	17	17
AAAGCAATCCAATGGT-1_5_B5	0.099777576	28.52639178	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	841	1190	0.004201681	0.003361345	4	oligos	OL-Cntl	26	17	17
AAAGTAGAGATACACA-1_5_B5	3.251311464	25.87405626	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	774	1266	0.004739336	0.003159558	4	oligos	OL-Cntl	26	17	17
AAAGTAGCACAACGCC-1_5_B5	18.76750275	9.38714516	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1579	2990	0.006688963	0.005685619	4	oligos	OL-Cntl	26	17	17
AAAGTAGCACAACTGT-1_5_B5	-24.59674217	17.00858295	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1179	2162	0.007400555	0.005087882	4	8	Astrocytes	26	17	17
AAAGTAGCATCTCCCA-1_5_B5	-15.76344998	-2.133197884	13A	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2765	5870	0.013798978	0.011584327	4	13A	IN-VIP	26	17	17
AAATGCCCAAGCCGCT-1_5_B5	-20.45149223	28.01095914	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2212	4689	0.002345916	0.005971422	4	8	Astrocytes	26	17	17
AAATGCCGTAGAAAGG-1_5_B5	37.18583315	9.662125127	14	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	800	1065	0.001877934	0.008450704	4	14	Microglia	26	17	17
AAATGCCGTAGAGCTG-1_5_B5	-12.18627961	17.83090772	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2023	3772	0.001060445	0.011134677	4	11	Glia-MIX	26	17	17
AAATGCCTCGAGAGCA-1_5_B5	21.51840909	9.969723957	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1536	2605	0.000383877	0.005758157	4	oligos	OL-Cntl	26	17	17
AAATGCCTCTGATACG-1_5_B5	17.25645663	14.73368407	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1182	1960	0.001530612	0.005102041	4	oligos	OL-Cntl	26	17	17
AACACGTCACGCTTTC-1_5_B5	22.05450266	-1.737767745	2	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1984	3484	0.002009185	0.011768083	4	2	EN-L4	26	17	17
AACACGTCAGATGGCA-1_5_B5	-2.486930594	2.464356526	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1771	2705	0.001848429	0.005914972	4	11	Glia-MIX	26	17	17
AACACGTGTCAATACC-1_5_B5	18.66904509	12.33845372	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1464	2644	0.001512859	0.004538578	4	oligos	OL-Cntl	26	17	17
AACACGTGTGCACCAC-1_5_B5	19.93796562	11.2202421	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1592	2802	0.01034975	0.004996431	4	oligos	OL-Cntl	26	17	17
AACACGTTCAAACCAC-1_5_B5	16.81489529	-0.774798673	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	696	1006	0.013916501	0.001988072	4	12	EN-MIX	26	17	17
AACACGTTCCTTGGTC-1_5_B5	-10.0403681	12.38743485	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	878	1212	0.000825083	0.00660066	4	11	Glia-MIX	26	17	17
AACACGTTCTTGCATT-1_5_B5	-33.22638077	2.219203372	9	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1864	3572	0.004759239	0.009238522	4	9	OPC	26	17	17
AACCATGAGGGAGTAA-1_5_B5	-1.293518538	3.292570004	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1201	1717	0.004076878	0.005824112	4	11	Glia-MIX	26	17	17
AACCATGCAATCCAAC-1_5_B5	10.3419773	-17.62881492	4	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	3827	9664	0.006622517	0.009830298	4	L2-3	EN-L2-3-MS	26	17	17
AACCATGCACTGTGTA-1_5_B5	15.43089591	10.36285017	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1512	2640	0.004166667	0.007954545	4	oligos	OL-Cntl	26	17	17
AACCATGCATGTAGTC-1_5_B5	10.73153642	16.9660733	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	973	1691	0.007687759	0.014784151	4	oligos	OL-Cntl	26	17	17
AACCATGGTCAGAATA-1_5_B5	8.30103958	28.30504557	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	799	1221	0.000819001	0.008190008	4	oligos	OL-Cntl	26	17	17
AACCATGGTTAAGAAC-1_5_B5	-10.09818985	18.19106466	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2475	5121	0.003905487	0.005662956	4	11	Glia-MIX	26	17	17
AACCATGTCGCATGAT-1_5_B5	13.11746542	-9.575822529	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2819	4923	0.005484461	0.014828357	4	11	Glia-MIX	26	17	17
AACCGCGCAAATCCGT-1_5_B5	15.37241506	11.41806055	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1523	2635	0.001897533	0.008728653	4	oligos	OL-Cntl	26	17	17
AACCGCGTCCCTTGTG-1_5_B5	12.11064058	24.11711074	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	885	1369	0.00146092	0.012417823	4	oligos	OL-Cntl	26	17	17
AACCGCGTCTACTATC-1_5_B5	-31.24239114	1.788460295	9	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1935	3427	0.0002918	0.011380216	4	9	OPC	26	17	17
AACGTTGAGCCCAGCT-1_5_B5	-8.084234226	9.269557553	5	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	748	1132	0.000883392	0.019434629	4	oligos	OL-MS-1	26	17	17
AACGTTGCAAGTCTGT-1_5_B5	-18.05766705	6.587995471	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	787	1177	0.001699235	0.004248088	4	8	Astrocytes	26	17	17
AACGTTGCATCCCATC-1_5_B5	-10.87222674	-0.821617464	13A	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2497	5267	0.008353902	0.005885703	4	13A	IN-VIP	26	17	17
AACGTTGGTATAAACG-1_5_B5	10.46920985	-26.67133078	10	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	5378	16839	0.000415702	0.007898331	4	L2-3	EN-L2-3-Cntl	26	17	17
AACTCAGGTACAGTGG-1_5_B5	4.191491363	25.43764433	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	814	1195	0.005857741	0.007531381	4	oligos	OL-Cntl	26	17	17
AACTCAGGTGGCGAAT-1_5_B5	27.37346671	-12.52317271	4	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	6011	19889	0.023379758	0.010508321	4	L2-3	EN-L2-3-MS	26	17	17
AACTCCCAGAGCAATT-1_5_B5	0.203007848	25.33130775	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	724	1119	0.00357462	0.011617516	4	oligos	OL-Cntl	26	17	17
AACTCCCAGTACCGGA-1_5_B5	2.200149881	20.8373888	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	886	1370	0.005839416	0.01459854	4	oligos	OL-Cntl	26	17	17
AACTCCCCAAACTGCT-1_5_B5	-9.077900829	-20.24078108	6B	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	825	1128	0.006205674	0.002659574	4	6B	IN-SST	26	17	17
AACTCCCCACCAGATT-1_5_B5	-30.23770106	-11.32968545	9	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	853	1206	0.004145937	0.019900498	4	9	OPC	26	17	17
AACTCCCCACGAAATA-1_5_B5	17.69810401	14.68671097	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1275	2263	0.000441891	0.006628369	4	oligos	OL-Cntl	26	17	17
AACTCCCGTAGGCATG-1_5_B5	18.6776078	8.377809709	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2022	4438	0.005182515	0.004281208	4	oligos	OL-Cntl	26	17	17
AACTCCCGTATATGGA-1_5_B5	-8.034162693	-10.87190677	6B	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	772	1004	0.027888446	0.011952191	4	6B	IN-SST	26	17	17
AACTCCCGTCCCTACT-1_5_B5	14.81760953	-1.777242547	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1024	1607	0.000622278	0.008711886	4	12	EN-MIX	26	17	17
AACTCCCGTTAGTGGG-1_5_B5	-10.55424947	9.673113131	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	3847	8764	0.003080785	0.00433592	4	11	Glia-MIX	26	17	17
AACTCTTCACAACGCC-1_5_B5	2.108611778	26.32063624	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	766	1122	0.009803922	0.006238859	4	oligos	OL-Cntl	26	17	17
AACTCTTGTGTGGCTC-1_5_B5	11.13571493	20.52500052	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	960	1563	0.001919386	0.003198976	4	oligos	OL-Cntl	26	17	17
AACTCTTTCACAGTAC-1_5_B5	-5.849442348	3.726786122	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	5136	15371	0.002016785	0.003968512	4	11	Glia-MIX	26	17	17
AACTCTTTCTTTACAC-1_5_B5	-0.188851437	21.85909063	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	705	1136	0.001760563	0.011443662	4	oligos	OL-Cntl	26	17	17
AACTGGTCACCAGTTA-1_5_B5	8.080667714	0.783306208	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	994	1349	0.009636768	0.077835434	4	12	EN-MIX	26	17	17
AACTGGTCACGCGAAA-1_5_B5	-5.928477856	3.889892218	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	4955	12540	0.00199362	0.005582137	4	11	Glia-MIX	26	17	17
AACTGGTCACTAAGTC-1_5_B5	15.12839556	23.15330893	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	959	1466	0.002046385	0.004774898	4	oligos	OL-Cntl	26	17	17
AACTGGTCATGCTAGT-1_5_B5	-6.429102865	4.502422956	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	8682	33737	0.004090464	0.010107597	4	11	Glia-MIX	26	17	17
AACTGGTGTCTCACCT-1_5_B5	-33.33535292	-11.28186288	9	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	884	1309	0.000763942	0.003055768	4	9	OPC	26	17	17
AACTTTCCAGCATGAG-1_5_B5	14.50803955	17.78234021	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	959	1450	0	0.009655172	4	oligos	OL-Cntl	26	17	17
AACTTTCGTAGCGTCC-1_5_B5	14.59319893	19.71898404	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1006	1676	0.000596659	0.004176611	4	oligos	OL-Cntl	26	17	17
AACTTTCGTATCACCA-1_5_B5	-6.125713976	3.116068063	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	7995	34805	0.003476512	0.008102284	4	11	Glia-MIX	26	17	17
AACTTTCGTATTACCG-1_5_B5	16.56280477	19.2727544	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1102	1946	0.002055498	0.008735868	4	oligos	OL-Cntl	26	17	17
AACTTTCTCGTCCAGG-1_5_B5	-9.06848229	14.30768607	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1776	3096	0.003552972	0.006136951	4	11	Glia-MIX	26	17	17
AAGACCTCAGCTGTAT-1_5_B5	-8.900411431	16.30966971	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	3868	9271	0.001725812	0.007550426	4	11	Glia-MIX	26	17	17
AAGACCTCATTATCTC-1_5_B5	-28.14312531	9.559394831	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	748	1115	0.002690583	0.004484305	4	8	Astrocytes	26	17	17
AAGCCGCAGTTACGGG-1_5_B5	-11.02207372	7.140362033	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2865	5435	0.00625575	0.010119595	4	oligos	OL-Cntl	26	17	17
AAGCCGCTCAGCTCTC-1_5_B5	33.08742323	10.64455311	14	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	768	1088	0.009191176	0.021139706	4	14	Microglia	26	17	17
AAGCCGCTCCATGAAC-1_5_B5	-10.77940256	9.468996012	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	6280	19180	0.001876955	0.006673618	4	11	Glia-MIX	26	17	17
AAGCCGCTCTTTACAC-1_5_B5	16.25156271	-0.939815084	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	874	1266	0.000789889	0.001579779	4	12	EN-MIX	26	17	17
AAGGAGCTCTAACTGG-1_5_B5	5.767000048	13.32702848	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1114	1709	0.00702165	0.019309538	4	oligos	OL-Cntl	26	17	17
AAGGCAGAGACTAAGT-1_5_B5	-1.209127282	25.71239649	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	734	1025	0.003902439	0.011707317	4	oligos	OL-Cntl	26	17	17
AAGGCAGAGATACACA-1_5_B5	-34.22150861	-0.025396036	9	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1734	3156	0.003802281	0.008555133	4	9	OPC	26	17	17
AAGGCAGAGATGGCGT-1_5_B5	5.408218474	18.83944031	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1035	1757	0.004553216	0.012521343	4	oligos	OL-Cntl	26	17	17
AAGGCAGAGCCACGCT-1_5_B5	-35.64698653	-10.59138546	9	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	921	1404	0.007834758	0.006410256	4	9	OPC	26	17	17
AAGGCAGAGCCGATTT-1_5_B5	11.23073469	-18.07836263	4	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	5489	17083	0.002868349	0.009366036	4	L2-3	EN-L2-3-MS	26	17	17
AAGGCAGCAGATCCAT-1_5_B5	18.04038919	22.15861922	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	960	1487	0.00268998	0.003362475	4	oligos	OL-Cntl	26	17	17
AAGGCAGCATGGTCAT-1_5_B5	-13.72350357	-24.47605794	6A	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1392	2695	0	0.002597403	4	6A	IN-PV	26	17	17
AAGGCAGTCAGGATCT-1_5_B5	-15.54108381	15.45199827	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2351	4312	0.000463822	0.00974026	4	8	Astrocytes	26	17	17
AAGGTTCAGGATTCGG-1_5_B5	15.54086643	12.81550031	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1401	2492	0.000802568	0.005617978	4	oligos	OL-Cntl	26	17	17
AAGGTTCAGTTGCAGG-1_5_B5	-1.166550866	22.27691735	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	706	1014	0.007889546	0.006903353	4	oligos	OL-Cntl	26	17	17
AAGGTTCCAATCCAAC-1_5_B5	-34.95323186	-7.722758742	9	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1131	1888	0.001588983	0.002118644	4	9	OPC	26	17	17
AAGGTTCCACCCTATC-1_5_B5	-15.85396976	12.02482734	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1511	2536	0.003154574	0.00670347	4	8	Astrocytes	26	17	17
AAGGTTCGTACCCAAT-1_5_B5	13.72686752	19.73699697	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1051	1845	0.001084011	0.007588076	4	oligos	OL-Cntl	26	17	17
AAGGTTCGTGGTCTCG-1_5_B5	13.25883782	22.62142416	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	878	1302	0.002304147	0.006144393	4	oligos	OL-Cntl	26	17	17
AAGGTTCTCGTCACGG-1_5_B5	-2.298252218	2.492534162	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1664	2610	0.001915709	0.006896552	4	11	Glia-MIX	26	17	17
AAGTCTGGTACCCAAT-1_5_B5	-15.19729181	-18.65676641	6B	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1527	3103	0.038349984	0.00257815	4	6B	IN-SST	26	17	17
AAGTCTGTCCCAAGTA-1_5_B5	22.92759796	18.64489572	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1093	1782	0	0.004489338	4	oligos	OL-Cntl	26	17	17
AATCCAGAGCCAGAAC-1_5_B5	-2.791515091	2.34820378	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1933	3165	0.002843602	0.007898894	4	11	Glia-MIX	26	17	17
AATCGGTAGCGCTTAT-1_5_B5	-20.09177562	-27.16734132	6A	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	3403	8958	0.017749498	0.002790802	4	6A	IN-PV	26	17	17
AATCGGTAGTACATGA-1_5_B5	-36.71148216	1.132493307	9	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1506	2882	0.001734906	0.002428869	4	9	OPC	26	17	17
AATCGGTCAGGGATTG-1_5_B5	4.885369502	25.54347138	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	763	1138	0.003514938	0.007029877	4	oligos	OL-Cntl	26	17	17
AATCGGTGTCATGCCG-1_5_B5	21.35205017	16.27177207	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1402	2341	0.011106365	0.005553182	4	oligos	OL-Cntl	26	17	17
AATCGGTGTGGCAAAC-1_5_B5	-15.86543979	11.92767836	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1675	3535	0.001697313	0.008203678	4	8	Astrocytes	26	17	17
AATCGGTGTTCCACAA-1_5_B5	20.19288941	-22.61042736	3	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	3451	7686	0.002081707	0.010668748	4	3	EN-L5-6	26	17	17
AATCGGTTCACGATGT-1_5_B5	-3.029461035	2.352946062	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2041	3336	0.004796163	0.006594724	4	11	Glia-MIX	26	17	17
AATCGGTTCGCCAAAT-1_5_B5	4.634427076	24.86978531	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	833	1292	0.002321981	0.01006192	4	oligos	OL-Cntl	26	17	17
ACACCAAGTTACGTCA-1_5_B5	13.92929967	-0.695943534	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	804	1166	0.004288165	0.005145798	4	12	EN-MIX	26	17	17
ACACCAATCCAAATGC-1_5_B5	13.49122187	-2.872282558	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1415	2376	0.001683502	0.008838384	4	12	EN-MIX	26	17	17
ACACCAATCTGCGTAA-1_5_B5	-21.34737824	-27.90773725	6A	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	5081	16828	0.007546946	0.005526503	4	6A	IN-PV	26	17	17
ACACCCTAGCGATCCC-1_5_B5	-11.96069415	-14.90244885	6B	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1256	1898	0.025816649	0.015806112	4	6B	IN-SST	26	17	17
ACACCCTAGCTAAACA-1_5_B5	-4.195060509	26.18297652	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	878	1324	0.006042296	0.004531722	4	11	Glia-MIX	26	17	17
ACACCCTCACGCATCG-1_5_B5	19.5225548	19.65190417	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1019	1622	0.001849568	0.006781751	4	oligos	OL-Cntl	26	17	17
ACACCCTCATATGAGA-1_5_B5	20.5396835	11.16674756	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1452	2649	0.014722537	0.006795017	4	oligos	OL-Cntl	26	17	17
ACACCCTCATGCAATC-1_5_B5	13.91885677	7.903176246	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1875	3417	0.002926544	0.013754756	4	oligos	OL-Cntl	26	17	17
ACACCCTGTTCCACTC-1_5_B5	36.80249883	14.99477257	14	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1325	1942	0.013903193	0.01853759	4	14	Microglia	26	17	17
ACACCGGAGACGCAAC-1_5_B5	-18.21769519	5.972702399	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	781	1025	0.00195122	0.013658537	4	8	Astrocytes	26	17	17
ACACCGGAGCACAGGT-1_5_B5	13.60598728	16.0563754	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1159	1805	0.009418283	0.010526316	4	oligos	OL-Cntl	26	17	17
ACACCGGTCTGGCGTG-1_5_B5	9.019384597	1.885709985	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	837	1026	0.014619883	0.046783626	4	12	EN-MIX	26	17	17
ACACTGAAGTACCGGA-1_5_B5	38.96495564	15.24737272	14	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1268	1903	0.000525486	0.011560694	4	14	Microglia	26	17	17
ACACTGACAACTTGAC-1_5_B5	21.2172839	11.0996823	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1542	2812	0.001422475	0.002133713	4	oligos	OL-Cntl	26	17	17
ACACTGACAGTTAACC-1_5_B5	13.75289157	16.4037287	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1094	1802	0.003884573	0.01054384	4	oligos	OL-Cntl	26	17	17
ACACTGATCACTTATC-1_5_B5	13.99922944	-0.831094252	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	982	1570	0.001910828	0.010191083	4	12	EN-MIX	26	17	17
ACAGCCGAGAGACTTA-1_5_B5	-16.65870784	12.44254737	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1219	1859	0.001075847	0.005379236	4	8	Astrocytes	26	17	17
ACAGCCGAGCCCTAAT-1_5_B5	5.840978128	-14.8116681	4	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2365	4477	0.004690641	0.011838285	4	L2-3	EN-L2-3-MS	26	17	17
ACAGCCGAGGACCACA-1_5_B5	3.033983549	-13.06552706	4	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2188	4387	0.002051516	0.007978117	4	L2-3	EN-L2-3-MS	26	17	17
ACAGCCGAGTAAGTAC-1_5_B5	-3.020075298	2.341057475	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2112	3506	0.001996577	0.006274957	4	11	Glia-MIX	26	17	17
ACAGCCGCACAGACTT-1_5_B5	13.50640987	-2.357613026	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1140	1809	0.001105583	0.007186291	4	12	EN-MIX	26	17	17
ACAGCCGCACTTCTGC-1_5_B5	1.208471508	23.44545613	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	793	1210	0.000826446	0.009090909	4	oligos	OL-Cntl	26	17	17
ACAGCCGCATCTCCCA-1_5_B5	21.96816135	10.39449252	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1629	2889	0.003461405	0.005192108	4	oligos	OL-Cntl	26	17	17
ACAGCCGCATGCAACT-1_5_B5	7.674800499	-20.25250017	4	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	4130	10605	0.00348892	0.006694955	4	L2-3	EN-L2-3-MS	26	17	17
ACAGCCGGTATATCCG-1_5_B5	-2.260680571	25.00250522	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	793	1119	0.00178731	0.008042895	4	oligos	OL-Cntl	26	17	17
ACAGCCGGTCCCTTGT-1_5_B5	0.280626615	26.37572547	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	740	1057	0.008514664	0.011352886	4	oligos	OL-Cntl	26	17	17
ACAGCCGGTTCATGGT-1_5_B5	-10.24310102	-18.49822919	6B	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	938	1560	0.030128205	0.002564103	4	6B	IN-SST	26	17	17
ACAGCCGGTTGGTGGA-1_5_B5	-21.35303415	9.935537709	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1139	1754	0.000570125	0.00627138	4	8	Astrocytes	26	17	17
ACAGCTAAGTTGTCGT-1_5_B5	-19.98375321	20.50620323	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1756	3518	0.009664582	0.007390563	4	8	Astrocytes	26	17	17
ACAGCTAGTCAACATC-1_5_B5	3.148528992	25.67476109	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	757	1127	0.005323869	0.005323869	4	oligos	OL-Cntl	26	17	17
ACAGCTAGTTATGCGT-1_5_B5	-19.64772314	-25.19527487	6A	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	3052	7050	0.002836879	0.002978723	4	6A	IN-PV	26	17	17
ACAGCTATCGAGCCCA-1_5_B5	-1.410805917	27.7808546	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	757	1094	0.000914077	0.010054845	4	oligos	OL-Cntl	26	17	17
ACATACGAGCCACCTG-1_5_B5	6.542003031	-3.370652233	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1257	1823	0.00603401	0.015907844	4	12	EN-MIX	26	17	17
ACATACGCATGTCTCC-1_5_B5	20.55828073	18.57637843	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1222	2078	0.007218479	0.005293551	4	oligos	OL-Cntl	26	17	17
ACATCAGAGGAGCGTT-1_5_B5	14.02139556	19.51427643	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1061	1677	0.008944544	0.007751938	4	oligos	OL-Cntl	26	17	17
ACATCAGCAAACCCAT-1_5_B5	-9.528756935	13.60683396	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1162	1719	0	0.006399069	4	11	Glia-MIX	26	17	17
ACATCAGCAGTAAGCG-1_5_B5	16.17361548	14.32288352	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1420	2504	0.005990415	0.004792332	4	oligos	OL-Cntl	26	17	17
ACATCAGGTCGCCATG-1_5_B5	25.44264329	4.463536844	15BA	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1429	2684	0.007824143	0.004843517	4	15BA	Stromal cells	26	17	17
ACATCAGGTGGCCCTA-1_5_B5	18.22952136	-23.26555832	3	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	5048	14665	0.005727924	0.035185817	4	3	EN-L5-6	26	17	17
ACATCAGTCGACCAGC-1_5_B5	2.451839	26.28201124	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	716	1123	0.016918967	0.011576135	4	oligos	OL-Cntl	26	17	17
ACATGGTAGACTCGGA-1_5_B5	36.93867577	14.08646378	14	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1152	1591	0.021370207	0.011313639	4	14	Microglia	26	17	17
ACATGGTAGTCCGGTC-1_5_B5	7.382761612	-14.68322766	4	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2732	5505	0.007811081	0.010535876	4	L2-3	EN-L2-3-MS	26	17	17
ACATGGTCAAGGGTCA-1_5_B5	16.46060638	17.52619471	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1102	1956	0.001022495	0.003067485	4	oligos	OL-Cntl	26	17	17
ACATGGTCAGGTGGAT-1_5_B5	-0.96722532	3.653858514	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1075	1541	0.003244646	0.005840363	4	11	Glia-MIX	26	17	17
ACATGGTGTTCAGTAC-1_5_B5	18.33316337	-23.48671851	3	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	4833	14405	0.001110725	0.021867407	4	3	EN-L5-6	26	17	17
ACCAGTAAGAATCTCC-1_5_B5	20.56332387	11.51332165	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1514	2858	0.005948216	0.00209937	4	oligos	OL-Cntl	26	17	17
ACCAGTAAGACACGAC-1_5_B5	-3.691415879	16.56016514	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	747	1092	0.002747253	0.012820513	4	oligos	OL-Cntl	26	17	17
ACCAGTAAGATGCCAG-1_5_B5	4.244473637	25.04516857	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	843	1324	0.003021148	0.003776435	4	oligos	OL-Cntl	26	17	17
ACCAGTAAGCGCTTAT-1_5_B5	-32.78754076	3.627476665	9	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2505	5818	0.000515641	0.003781368	4	9	OPC	26	17	17
ACCAGTAAGTTGCAGG-1_5_B5	-10.00040653	-15.95711127	6B	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	923	1263	0.023752969	0.01266825	4	6B	IN-SST	26	17	17
ACCAGTAGTAGCTGCC-1_5_B5	-2.8344295	2.564877987	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2030	3229	0.003716321	0.01269743	4	11	Glia-MIX	26	17	17
ACCAGTAGTTCAGACT-1_5_B5	16.73315269	24.24061515	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	887	1364	0.001466276	0.004398827	4	oligos	OL-Cntl	26	17	17
ACCAGTAGTTGCGCAC-1_5_B5	-6.103224858	4.180013479	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	5533	14840	0.00222372	0.006536388	4	11	Glia-MIX	26	17	17
ACCCACTAGGGCTCTC-1_5_B5	12.47924885	18.97196977	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1067	1748	0.000572082	0.005148741	4	oligos	OL-Cntl	26	17	17
ACCCACTCAAGTAATG-1_5_B5	12.73430756	0.587711857	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	757	1056	0.001893939	0.008522727	4	12	EN-MIX	26	17	17
ACCCACTGTTCGGGCT-1_5_B5	-6.14451823	4.263347743	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	5586	13928	0.004020678	0.007538771	4	11	Glia-MIX	26	17	17
ACCCACTTCCTGCCAT-1_5_B5	-2.79777024	2.237733552	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1887	3074	0.002277163	0.004229018	4	11	Glia-MIX	26	17	17
ACCGTAACAGTTTACG-1_5_B5	25.35929846	4.646852691	15BA	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1708	2779	0.003238575	0.009715725	4	15BA	Stromal cells	26	17	17
ACCGTAATCAACACAC-1_5_B5	3.909348101	7.41164535	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1181	1859	0.002689618	0.003227542	4	oligos	OL-Cntl	26	17	17
ACCGTAATCCGCATCT-1_5_B5	4.693034376	22.55014941	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	777	1217	0.002465078	0.006573541	4	oligos	OL-Cntl	26	17	17
ACCTTTACACCACCAG-1_5_B5	-4.106602651	2.424248912	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2346	4248	0.002589454	0.002824859	4	11	Glia-MIX	26	17	17
ACCTTTACATTGGCGC-1_5_B5	6.238366201	-1.69785114	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	896	1214	0.006589786	0.020593081	4	12	EN-MIX	26	17	17
ACCTTTAGTCATATCG-1_5_B5	15.78268072	8.4537852	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1696	3261	0.00275989	0.009199632	4	oligos	OL-Cntl	26	17	17
ACCTTTATCCACGACG-1_5_B5	13.69189906	19.71633235	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1023	1661	0.002408188	0.012040939	4	oligos	OL-Cntl	26	17	17
ACGAGCCAGCCACCTG-1_5_B5	14.71708921	-7.541455477	10	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1616	2793	0.008234873	0.001074114	4	L2-3	EN-L2-3-Cntl	26	17	17
ACGAGCCAGCGCTCCA-1_5_B5	21.22699156	25.24058309	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1219	1998	0.00950951	0.008508509	4	oligos	OL-Cntl	26	17	17
ACGAGCCAGGCTCAGA-1_5_B5	-35.15611953	4.195854655	9	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2139	4190	0.005727924	0.00477327	4	9	OPC	26	17	17
ACGAGCCGTCCTAGCG-1_5_B5	-3.546596619	24.91943297	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	816	1237	0	0.006467259	4	oligos	OL-Cntl	26	17	17
ACGAGCCTCAATCACG-1_5_B5	12.01619313	0.44742701	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	921	1275	0.003921569	0.037647059	4	12	EN-MIX	26	17	17
ACGAGCCTCCACGTTC-1_5_B5	-15.3273153	15.92427222	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2601	5067	0.000592066	0.009867772	4	8	Astrocytes	26	17	17
ACGAGCCTCCTATTCA-1_5_B5	-21.219217	19.11696307	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1554	2937	0.001702417	0.007490637	4	8	Astrocytes	26	17	17
ACGAGCCTCTAACTCT-1_5_B5	-9.11894672	15.61446231	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2330	3886	0.000772002	0.006948019	4	11	Glia-MIX	26	17	17
ACGAGGAAGCTCCTCT-1_5_B5	5.935064737	-9.523934398	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1457	2315	0.00950324	0.015550756	4	12	EN-MIX	26	17	17
ACGAGGAAGTTGAGTA-1_5_B5	-16.35056443	17.20174038	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2074	3839	0.000781454	0.013545194	4	8	Astrocytes	26	17	17
ACGAGGACAGCCAGAA-1_5_B5	15.25651765	12.89621977	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1462	2521	0.00595002	0.011106704	4	oligos	OL-Cntl	26	17	17
ACGAGGAGTTCAGACT-1_5_B5	-6.316330344	4.391874529	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	7150	23657	0.003254851	0.009257302	4	11	Glia-MIX	26	17	17
ACGAGGAGTTGCCTCT-1_5_B5	39.18188783	15.27973523	14	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1232	1973	0	0.011150532	4	14	Microglia	26	17	17
ACGAGGATCCGCGTTT-1_5_B5	-12.42212024	32.085198	17	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	895	1137	0.013192612	0.022867194	4	oligos	OL-MS-2	26	17	17
ACGATACAGGGTGTGT-1_5_B5	5.327727423	22.15160028	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	867	1330	0.001503759	0.015037594	4	oligos	OL-Cntl	26	17	17
ACGATACCACCTTGTC-1_5_B5	-10.65908106	9.587040536	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	4607	11657	0.002573561	0.006004976	4	11	Glia-MIX	26	17	17
ACGATACGTCTAGGTT-1_5_B5	18.28533838	-22.94866074	3	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	4577	11655	0.013899614	0.047704848	4	3	EN-L5-6	26	17	17
ACGATACTCACTCCTG-1_5_B5	0.085296149	0.287883473	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	879	1263	0.008709422	0.011084719	4	11	Glia-MIX	26	17	17
ACGATACTCTATGTGG-1_5_B5	-17.01659999	-24.92093847	6A	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2167	4672	0.021618151	0.002996575	4	6A	IN-PV	26	17	17
ACGATACTCTCCAGGG-1_5_B5	-8.472869745	-18.63753865	6B	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	717	1002	0.000998004	0.008982036	4	6B	IN-SST	26	17	17
ACGATGTCAAGTTGTC-1_5_B5	8.76377658	10.05073393	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1247	2100	0.004285714	0.010952381	4	oligos	OL-Cntl	26	17	17
ACGATGTCACAGGCCT-1_5_B5	15.58030445	12.15027278	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1453	2635	0.006072106	0.006072106	4	oligos	OL-Cntl	26	17	17
ACGATGTTCAAACCGT-1_5_B5	13.54489973	13.76732086	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1059	1665	0.001801802	0.015015015	4	oligos	OL-Cntl	26	17	17
ACGATGTTCCCTCAGT-1_5_B5	4.514292396	24.76546335	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	833	1180	0.004237288	0.007627119	4	oligos	OL-Cntl	26	17	17
ACGCAGCAGCGAAGGG-1_5_B5	3.804224022	24.41868874	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	805	1141	0.004382121	0.008764242	4	oligos	OL-Cntl	26	17	17
ACGCAGCGTCTCAACA-1_5_B5	-0.114702627	25.58271025	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	718	1059	0	0.013220019	4	oligos	OL-Cntl	26	17	17
ACGCAGCTCAGGCAAG-1_5_B5	-1.182943812	22.68731692	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	786	1174	0.017035775	0.010221465	4	oligos	OL-Cntl	26	17	17
ACGCAGCTCATACGGT-1_5_B5	7.964000387	28.57518022	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	948	1464	0.008879781	0.008879781	4	oligos	OL-Cntl	26	17	17
ACGCAGCTCTGGAGCC-1_5_B5	15.64275013	-1.324459398	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	850	1250	0.0024	0.0016	4	12	EN-MIX	26	17	17
ACGCCAGAGGCCCTTG-1_5_B5	-17.82005287	-8.529703008	13B	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	3678	8855	0.010050819	0.005081875	4	13B	IN-SV2C	26	17	17
ACGCCAGGTAGGCATG-1_5_B5	18.48661519	17.71821269	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1219	2115	0.003782506	0.008510638	4	oligos	OL-Cntl	26	17	17
ACGCCAGGTTCACCTC-1_5_B5	17.5870562	5.732362281	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	3763	9508	0.003155238	0.008834666	4	oligos	OL-Cntl	26	17	17
ACGCCGAAGATACACA-1_5_B5	-16.34518778	12.42161267	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1473	2640	0.001136364	0.009090909	4	8	Astrocytes	26	17	17
ACGCCGAAGTTAACGA-1_5_B5	21.0903039	14.19303383	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1284	2146	0	0.003261883	4	oligos	OL-Cntl	26	17	17
ACGCCGACAGACGCCT-1_5_B5	1.961948795	22.16479022	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	850	1326	0.000754148	0.016591252	4	oligos	OL-Cntl	26	17	17
ACGCCGACAGATCGGA-1_5_B5	4.304146048	25.59689839	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	778	1186	0.003372681	0.010118044	4	oligos	OL-Cntl	26	17	17
ACGCCGATCAACGCTA-1_5_B5	9.714333444	-2.791351008	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1512	2139	0.013557737	0.014025245	4	12	EN-MIX	26	17	17
ACGGAGAAGAGACTAT-1_5_B5	2.18224122	20.13211575	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	854	1248	0.007211538	0.010416667	4	oligos	OL-Cntl	26	17	17
ACGGAGAAGATCACGG-1_5_B5	3.926623941	-5.255590136	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	860	1254	0.005582137	0.002392344	4	12	EN-MIX	26	17	17
ACGGAGAAGGCAGTCA-1_5_B5	3.8598863	26.72777404	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	718	1068	0.003745318	0.004681648	4	oligos	OL-Cntl	26	17	17
ACGGAGACAATTGCTG-1_5_B5	-6.137213268	4.290224518	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	5329	12730	0.003063629	0.01162608	4	11	Glia-MIX	26	17	17
ACGGAGATCGCCTGAG-1_5_B5	-20.16832187	-26.02868297	6A	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	4071	11729	0.000341035	0.002643022	4	6A	IN-PV	26	17	17
ACGGCCAAGTCAAGGC-1_5_B5	16.4838001	1.553189302	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	723	1013	0.016781836	0.000987167	4	12	EN-MIX	26	17	17
ACGGCCAAGTTCGATC-1_5_B5	13.00767834	11.86911379	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1364	2307	0.00520156	0.014304291	4	oligos	OL-Cntl	26	17	17
ACGGCCACATGCCACG-1_5_B5	-19.53376545	-16.92295053	6B	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2822	6080	0.0125	0.008059211	4	6B	IN-SST	26	17	17
ACGGCCAGTCCTCCAT-1_5_B5	39.21494428	16.12105195	14	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1772	2856	0.00280112	0.006652661	4	14	Microglia	26	17	17
ACGGCCAGTTAGGGTG-1_5_B5	4.543410017	12.85284618	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1125	1680	0.000595238	0.019047619	4	oligos	OL-Cntl	26	17	17
ACGGGCTCAAGTCATC-1_5_B5	-27.48118083	8.659764327	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	841	1305	0.005363985	0.006130268	4	8	Astrocytes	26	17	17
ACGGGCTGTACCGCTG-1_5_B5	7.374717209	19.92945183	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1040	1600	0	0.011875	4	oligos	OL-Cntl	26	17	17
ACGGGCTGTGAGGGTT-1_5_B5	-28.53307294	-1.832528707	9	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1639	3016	0.00862069	0.00729443	4	9	OPC	26	17	17
ACGGGCTTCGTTACAG-1_5_B5	-28.3217905	-0.107435379	9	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1365	2236	0.000447227	0.038014311	4	9	OPC	26	17	17
ACGGGTCAGGAGTTGC-1_5_B5	-28.25199848	0.889839523	9	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2107	3894	0.002568053	0.010529019	4	9	OPC	26	17	17
ACGGGTCAGGTCATCT-1_5_B5	2.256812331	-20.8688038	4	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	3895	10723	0.003170754	0.004103329	4	L2-3	EN-L2-3-MS	26	17	17
ACGGGTCGTCTGCGGT-1_5_B5	-15.3190779	-20.10546062	6B	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1633	3126	0.014395393	0.002879079	4	6B	IN-SST	26	17	17
ACGGGTCGTGACCAAG-1_5_B5	15.29126088	12.19925013	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1416	2312	0.001730104	0.007352941	4	oligos	OL-Cntl	26	17	17
ACGGGTCGTTCGTGAT-1_5_B5	-9.052245666	16.82898321	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	3106	6351	0.002204377	0.004723666	4	11	Glia-MIX	26	17	17
ACGGGTCTCTATCCCG-1_5_B5	8.482928018	6.635707918	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1648	2603	0.004994237	0.009988475	4	oligos	OL-Cntl	26	17	17
ACGTCAAAGGGTGTTG-1_5_B5	17.34073512	5.467282053	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	3489	7919	0.007324157	0.008460664	4	oligos	OL-Cntl	26	17	17
ACGTCAACACAGCGTC-1_5_B5	20.95476545	-24.31671673	3	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	3523	8489	0.00942396	0.022617505	4	3	EN-L5-6	26	17	17
ACGTCAACAGTAAGAT-1_5_B5	6.410884412	-8.199211984	4	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2167	3743	0.004007481	0.020304569	4	L2-3	EN-L2-3-MS	26	17	17
ACGTCAATCTGTCAAG-1_5_B5	-15.43367087	15.26548404	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2630	4874	0.001846533	0.006360279	4	8	Astrocytes	26	17	17
ACTATCTCACATTAGC-1_5_B5	5.913610191	-15.09499523	4	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2896	7065	0.00651097	0.006794055	4	L2-3	EN-L2-3-MS	26	17	17
ACTATCTGTAGGCTGA-1_5_B5	5.468810183	-18.08520101	4	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	3681	9396	0.003512133	0.011600681	4	L2-3	EN-L2-3-MS	26	17	17
ACTATCTTCATGCTCC-1_5_B5	11.77798402	2.692188501	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	799	1344	0.008184524	0.00297619	4	12	EN-MIX	26	17	17
ACTATCTTCTTCCTTC-1_5_B5	0.646029536	-1.640765838	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	687	1170	0	0.005982906	4	8	Astrocytes	26	17	17
ACTGAACCAAACCTAC-1_5_B5	-30.97599164	-1.320445366	9	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1576	2679	0.006345651	0.008958567	4	9	OPC	26	17	17
ACTGAACCAATGCCAT-1_5_B5	17.62368048	7.22203769	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1992	3744	0.007745726	0.00667735	4	oligos	OL-Cntl	26	17	17
ACTGAACCACTATCTT-1_5_B5	-5.197401224	13.28954808	5	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	805	1174	0.011073254	0.035775128	4	oligos	OL-MS-1	26	17	17
ACTGAACCAGATAATG-1_5_B5	-6.467442991	4.536136684	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	8637	32597	0.003988097	0.010092953	4	11	Glia-MIX	26	17	17
ACTGAACCAGGGTACA-1_5_B5	-6.009640097	4.061854669	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	5360	14331	0.001884028	0.006559207	4	11	Glia-MIX	26	17	17
ACTGAACGTCTGGAGA-1_5_B5	18.43103207	-22.65790169	3	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	5667	17593	0.004433582	0.016824874	4	3	EN-L5-6	26	17	17
ACTGAACGTGTGAATA-1_5_B5	33.52607631	-14.57956787	2	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	3417	7667	0.0103039	0.020868658	4	2	EN-L4	26	17	17
ACTGAACTCCCAAGTA-1_5_B5	-15.65383266	15.68515749	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2059	3677	0.00326353	0.006799021	4	8	Astrocytes	26	17	17
ACTGAGTAGAGTAAGG-1_5_B5	-16.28667776	22.88342649	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1614	3165	0.005371248	0.00600316	4	8	Astrocytes	26	17	17
ACTGAGTAGGCTAGCA-1_5_B5	-2.85203305	2.365597914	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1999	3212	0.003113325	0.007160648	4	11	Glia-MIX	26	17	17
ACTGAGTGTGATAAAC-1_5_B5	13.60154627	20.94968374	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	971	1484	0	0.007412399	4	oligos	OL-Cntl	26	17	17
ACTGATGAGACTGGGT-1_5_B5	10.33716403	7.231397237	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1441	2463	0.00365408	0.019894438	4	oligos	OL-Cntl	26	17	17
ACTGATGAGTCCCACG-1_5_B5	16.56914494	-13.18586448	4	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	4829	11627	0.024425905	0.018147415	4	L2-3	EN-L2-3-MS	26	17	17
ACTGATGCACCAGGTC-1_5_B5	-20.78406151	24.71869432	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2020	4021	0.001243472	0.003481721	4	8	Astrocytes	26	17	17
ACTGATGGTTCTCATT-1_5_B5	-15.45663762	7.707366175	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	776	1061	0.001885014	0.006597549	4	8	Astrocytes	26	17	17
ACTGATGTCAGAAATG-1_5_B5	-1.275123246	0.844910238	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	3687	8473	0.00542901	0.008497581	4	11	Glia-MIX	26	17	17
ACTGCTCAGAAGGTGA-1_5_B5	-36.76418721	1.034220274	9	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1536	2715	0.004788214	0.001841621	4	9	OPC	26	17	17
ACTGCTCAGACAAGCC-1_5_B5	-15.4213617	14.96277968	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1860	3302	0.000302847	0.005451242	4	8	Astrocytes	26	17	17
ACTGCTCAGCCGGTAA-1_5_B5	15.56359075	15.17374073	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1332	2225	0.008089888	0.009438202	4	oligos	OL-Cntl	26	17	17
ACTGCTCCACCAGGCT-1_5_B5	-27.86119944	0.126380305	9	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1761	2949	0.001356392	0.038318074	4	9	OPC	26	17	17
ACTGTCCAGAGCCCAA-1_5_B5	-18.93658857	30.25014688	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	3328	7657	0.000783597	0.00718297	4	8	Astrocytes	26	17	17
ACTGTCCAGCTTCGCG-1_5_B5	12.63801098	12.93313574	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1232	2103	0.001426534	0.010936757	4	oligos	OL-Cntl	26	17	17
ACTGTCCAGTAGATGT-1_5_B5	-23.58358656	-25.96843042	6A	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	5472	16695	0.010182689	0.00820605	4	6A	IN-PV	26	17	17
ACTGTCCAGTGCGTGA-1_5_B5	-10.60683321	9.58865142	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	5004	12669	0.00363091	0.005841029	4	11	Glia-MIX	26	17	17
ACTGTCCCATATACCG-1_5_B5	-35.65827341	0.080768369	9	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1675	3031	0.002969317	0.004289014	4	9	OPC	26	17	17
ACTGTCCCATCCTAGA-1_5_B5	14.40731352	19.77341783	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1035	1749	0.003430532	0.008576329	4	oligos	OL-Cntl	26	17	17
ACTGTCCCATGCTGGC-1_5_B5	17.91856397	8.106335937	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1972	4095	0.002197802	0.008547009	4	oligos	OL-Cntl	26	17	17
ACTGTCCGTAACGACG-1_5_B5	1.34982331	25.40819422	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	851	1197	0.004177109	0.005847953	4	oligos	OL-Cntl	26	17	17
ACTGTCCGTAAGAGAG-1_5_B5	11.65093927	-14.49302391	4	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	4749	11103	0.011258218	0.01990453	4	L2-3	EN-L2-3-MS	26	17	17
ACTGTCCGTGAGTGAC-1_5_B5	5.308342966	-5.397048285	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	953	1451	0.008270159	0.00137836	4	12	EN-MIX	26	17	17
ACTGTCCTCAACCATG-1_5_B5	22.33316667	15.8867134	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1340	2191	0.004107713	0.013235965	4	oligos	OL-Cntl	26	17	17
ACTGTCCTCGTCGTTC-1_5_B5	-8.175120918	8.177677885	5	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	700	1049	0.001906578	0.028598665	4	oligos	OL-MS-1	26	17	17
ACTTACTCATCGGGTC-1_5_B5	4.876882881	23.99904128	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	910	1460	0.004794521	0.003424658	4	oligos	OL-Cntl	26	17	17
ACTTACTGTCTAGAGG-1_5_B5	-15.91127712	13.99930248	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1690	2823	0.001062699	0.007438895	4	8	Astrocytes	26	17	17
ACTTACTGTCTCTTTA-1_5_B5	3.452869701	-6.105400978	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1050	1752	0.006278539	0.002283105	4	12	EN-MIX	26	17	17
ACTTGTTAGGAATCGC-1_5_B5	11.37106944	23.58501341	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	782	1233	0.00081103	0.00324412	4	oligos	OL-Cntl	26	17	17
ACTTGTTCATGCCTTC-1_5_B5	-9.984959758	12.33910781	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	840	1250	0.004	0.0064	4	oligos	OL-Cntl	26	17	17
ACTTGTTGTTCTCATT-1_5_B5	-4.727327246	-9.245736941	13A	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	953	1604	0.001870324	0.004987531	4	13A	IN-VIP	26	17	17
ACTTGTTTCAGATAAG-1_5_B5	15.72025959	27.76347607	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	826	1308	0	0.009938838	4	oligos	OL-Cntl	26	17	17
ACTTGTTTCCCAACGG-1_5_B5	-3.459265367	22.05590468	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	809	1193	0.010896899	0.016764459	4	oligos	OL-Cntl	26	17	17
ACTTTCAAGACGCAAC-1_5_B5	-4.470484542	35.71083531	17	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	814	1088	0.007352941	0.013786765	4	oligos	OL-MS-2	26	17	17
ACTTTCACACCATCCT-1_5_B5	12.39209169	0.298844082	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1013	1652	0.001815981	0.023002421	4	12	EN-MIX	26	17	17
ACTTTCAGTAAGAGGA-1_5_B5	32.32157952	-12.23457738	2	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	4311	10978	0.009837858	0.012752778	4	2	EN-L4	26	17	17
ACTTTCAGTCGACTAT-1_5_B5	15.46859465	24.06682509	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	894	1435	0.004878049	0.004181185	4	oligos	OL-Cntl	26	17	17
ACTTTCAGTCGCATCG-1_5_B5	22.95308341	-3.609439756	2	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2073	3882	0.00618238	0.003348789	4	2	EN-L4	26	17	17
ACTTTCATCCGCAAGC-1_5_B5	10.43189889	16.38579418	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1095	1903	0.001576458	0.007882291	4	oligos	OL-Cntl	26	17	17
ACTTTCATCCGTAGGC-1_5_B5	11.7693788	2.766078135	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	953	1461	0.00752909	0.008213552	4	12	EN-MIX	26	17	17
ACTTTCATCCTCTAGC-1_5_B5	11.80476746	3.251876261	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	711	1086	0.001841621	0.005524862	4	12	EN-MIX	26	17	17
ACTTTCATCCTGCCAT-1_5_B5	10.89741141	3.361082329	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	772	1149	0.000870322	0.00435161	4	12	EN-MIX	26	17	17
ACTTTCATCGGATGGA-1_5_B5	-30.26428968	9.479005908	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	722	1166	0.006003431	0.010291595	4	8	Astrocytes	26	17	17
ACTTTCATCTGGAGCC-1_5_B5	-0.851232713	3.478475999	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1051	1581	0.001897533	0.006325111	4	11	Glia-MIX	26	17	17
AGAATAGAGTACGCGA-1_5_B5	16.99242366	19.62166014	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1048	1737	0.004605642	0.002302821	4	oligos	OL-Cntl	26	17	17
AGAATAGGTTGATTCG-1_5_B5	-3.225334926	2.454638578	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2342	4051	0.006418168	0.007405579	4	11	Glia-MIX	26	17	17
AGAATAGTCAGGTAAA-1_5_B5	2.8453403	26.68553854	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	732	1168	0.001712329	0.003424658	4	oligos	OL-Cntl	26	17	17
AGAATAGTCCGTACAA-1_5_B5	16.9376149	12.39728645	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1353	2429	0.002470152	0.006998765	4	oligos	OL-Cntl	26	17	17
AGAATAGTCGTTGCCT-1_5_B5	-5.080160031	3.413522631	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	3870	8976	0.002562389	0.006350267	4	11	Glia-MIX	26	17	17
AGACGTTTCTGGGCCA-1_5_B5	2.048149194	18.23761008	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	823	1411	0.008504607	0.008504607	4	oligos	OL-Cntl	26	17	17
AGAGCTTCACATTTCT-1_5_B5	13.03560921	26.35042988	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	682	1097	0	0.007292616	4	oligos	OL-Cntl	26	17	17
AGAGCTTGTTACAGAA-1_5_B5	35.63159949	10.93881722	14	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	814	1077	0.006499536	0.018570102	4	14	Microglia	26	17	17
AGAGCTTTCCTGTACC-1_5_B5	0.628912966	27.16382341	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	723	1028	0.013618677	0.008754864	4	oligos	OL-Cntl	26	17	17
AGAGTGGAGTGCAAGC-1_5_B5	-2.537613575	2.458676821	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1705	2734	0.001828822	0.008778347	4	11	Glia-MIX	26	17	17
AGATCTGCACAACGTT-1_5_B5	17.10690859	12.57408191	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1243	2361	0.005506141	0.003388395	4	oligos	OL-Cntl	26	17	17
AGATCTGGTGCGAAAC-1_5_B5	9.501017039	-1.392116119	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1302	1761	0.035775128	0.019875071	4	12	EN-MIX	26	17	17
AGATCTGTCCTCTAGC-1_5_B5	-22.57774473	-20.37961066	6A	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2792	6290	0.013513514	0.013672496	4	6A	IN-PV	26	17	17
AGATCTGTCTCTGCTG-1_5_B5	-12.24373637	16.40289287	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1495	2637	0.001896094	0.003412969	4	11	Glia-MIX	26	17	17
AGATTGCAGAGCTGCA-1_5_B5	-4.496886543	21.21972244	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	850	1365	0.00952381	0.010989011	4	oligos	OL-Cntl	26	17	17
AGATTGCAGCCGCCTA-1_5_B5	37.48025826	9.807855937	14	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	844	1166	0.009433962	0.008576329	4	14	Microglia	26	17	17
AGATTGCCAAACTGCT-1_5_B5	12.53618984	25.4597544	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	717	1104	0.003623188	0.009963768	4	oligos	OL-Cntl	26	17	17
AGATTGCCACCGATAT-1_5_B5	16.14534555	22.25540813	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	936	1520	0.007894737	0.004605263	4	oligos	OL-Cntl	26	17	17
AGATTGCCAGGAATGC-1_5_B5	1.077394459	25.15525674	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	680	1044	0.00862069	0.005747126	4	oligos	OL-Cntl	26	17	17
AGATTGCGTTACGACT-1_5_B5	18.46666422	7.202129998	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2076	4060	0.010591133	0.003940887	4	oligos	OL-Cntl	26	17	17
AGATTGCTCCAAATGC-1_5_B5	23.91086798	-22.25231937	3	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	4343	12575	0.012485089	0.011371769	4	3	EN-L5-6	26	17	17
AGATTGCTCTACGAGT-1_5_B5	7.926112927	-14.89879982	4	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2904	6380	0.004702194	0.011442006	4	L2-3	EN-L2-3-MS	26	17	17
AGCAGCCAGTATGACA-1_5_B5	-12.14260213	-0.275202351	13A	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2664	5046	0.008521601	0.00673801	4	13A	IN-VIP	26	17	17
AGCAGCCAGTGACATA-1_5_B5	17.30632381	-0.258859614	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	888	1322	0.010590015	0.002269289	4	12	EN-MIX	26	17	17
AGCAGCCCAAACTGCT-1_5_B5	34.47753084	-8.639380555	2	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	6108	20102	0.006964481	0.009352303	4	2	EN-L4	26	17	17
AGCAGCCGTAACGCGA-1_5_B5	14.55218905	9.304257366	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1604	2890	0.002076125	0.006228374	4	oligos	OL-Cntl	26	17	17
AGCAGCCTCCTCTAGC-1_5_B5	21.51691822	-5.035899308	2	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2096	3486	0.005737235	0.01319564	4	2	EN-L4	26	17	17
AGCATACAGCTTATCG-1_5_B5	-13.11458777	-17.80238927	6B	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1202	2053	0.01412567	0.00243546	4	6B	IN-SST	26	17	17
AGCATACCAAACGCGA-1_5_B5	10.59293722	19.9868447	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1019	1722	0.003484321	0.009291521	4	oligos	OL-Cntl	26	17	17
AGCATACCAATGCCAT-1_5_B5	13.96245974	-20.09677937	4	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	6281	20780	0.004860443	0.021222329	4	L2-3	EN-L2-3-MS	26	17	17
AGCATACGTATAGGGC-1_5_B5	3.776103656	24.866123	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	815	1232	0.003246753	0.008116883	4	oligos	OL-Cntl	26	17	17
AGCATACGTCGAACAG-1_5_B5	-24.47160329	16.41981637	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1212	2046	0.004398827	0.009775171	4	8	Astrocytes	26	17	17
AGCATACTCGTAGGTT-1_5_B5	4.975740306	30.30109357	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	759	1136	0.003521127	0.003521127	4	oligos	OL-Cntl	26	17	17
AGCCTAAAGCAGCGTA-1_5_B5	14.35487729	12.36176752	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1431	2464	0.004058442	0.008116883	4	oligos	OL-Cntl	26	17	17
AGCCTAACACATTTCT-1_5_B5	13.42702318	19.64254967	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1088	1907	0.003670687	0.003670687	4	oligos	OL-Cntl	26	17	17
AGCCTAACACCTATCC-1_5_B5	7.397661352	20.04431939	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	988	1530	0.005228758	0.010457516	4	oligos	OL-Cntl	26	17	17
AGCCTAAGTTCTCATT-1_5_B5	1.861042244	15.6919257	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	873	1435	0.004878049	0.022996516	4	oligos	OL-Cntl	26	17	17
AGCCTAATCTTTACAC-1_5_B5	21.24763495	9.742265362	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1773	3263	0.005822862	0.008887527	4	oligos	OL-Cntl	26	17	17
AGCGGTCGTAATCGTC-1_5_B5	33.34053471	-5.871974706	2	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	3084	6525	0.001226054	0.009348659	4	2	EN-L4	26	17	17
AGCGGTCGTCTGATTG-1_5_B5	5.58676576	5.743815733	7	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2647	4782	0.003973233	0.012756169	4	7	Phagocytes	26	17	17
AGCGGTCGTGGGTCAA-1_5_B5	16.26028176	15.16463308	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1245	1981	0.003533569	0.009591116	4	oligos	OL-Cntl	26	17	17
AGCGGTCTCCGAAGAG-1_5_B5	-9.446450209	15.52895929	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2048	3042	0.002301118	0.012491782	4	11	Glia-MIX	26	17	17
AGCGTATCACAAGACG-1_5_B5	13.93268586	16.96943063	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1109	1752	0.005707763	0.011986301	4	oligos	OL-Cntl	26	17	17
AGCGTATCAGCATGAG-1_5_B5	21.63169495	9.500440541	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1796	3132	0.00862069	0.00798212	4	oligos	OL-Cntl	26	17	17
AGCGTATCAGGTGCCT-1_5_B5	-31.37354677	-12.21264923	9	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	894	1270	0.003149606	0.006299213	4	9	OPC	26	17	17
AGCGTATTCTAAGCCA-1_5_B5	0.648175155	26.38178767	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	914	1315	0.005323194	0.005323194	4	oligos	OL-Cntl	26	17	17
AGCGTCGAGGCAAAGA-1_5_B5	15.56994614	16.04622271	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1137	1782	0.002805836	0.002805836	4	oligos	OL-Cntl	26	17	17
AGCGTCGCACTCAGGC-1_5_B5	-4.633838151	3.600607102	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	3300	6200	0.004677419	0.012580645	4	11	Glia-MIX	26	17	17
AGCGTCGCAGACGTAG-1_5_B5	35.10992927	-14.38142886	2	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	4094	9323	0.00997533	0.02928242	4	2	EN-L4	26	17	17
AGCGTCGGTGCTCTTC-1_5_B5	-1.261198266	25.07030377	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	689	1025	0.009756098	0.009756098	4	oligos	OL-Cntl	26	17	17
AGCGTCGTCAAGAAGT-1_5_B5	-18.99409555	7.595897957	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1071	1817	0.002751789	0.009906439	4	8	Astrocytes	26	17	17
AGCTCCTAGAGCTTCT-1_5_B5	8.091029654	2.191292846	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	786	1092	0.012820513	0.015567766	4	12	EN-MIX	26	17	17
AGCTCCTAGTGCGTGA-1_5_B5	16.47121655	1.452304513	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	754	1145	0.004366812	0.005240175	4	12	EN-MIX	26	17	17
AGCTCCTAGTTAGCGG-1_5_B5	-9.427552683	17.21915452	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2712	5021	0.002389962	0.010157339	4	11	Glia-MIX	26	17	17
AGCTCCTGTCAATACC-1_5_B5	17.59146491	13.17770988	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1234	2076	0.003371869	0.006743738	4	oligos	OL-Cntl	26	17	17
AGCTCCTTCAACCATG-1_5_B5	12.37151174	12.02989985	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1209	1945	0.003598972	0.011825193	4	oligos	OL-Cntl	26	17	17
AGCTCCTTCCCAGGTG-1_5_B5	0.203927189	-16.05296547	10	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2643	6123	0.003103054	0.005879471	4	L2-3	EN-L2-3-Cntl	26	17	17
AGCTCTCCAAAGCAAT-1_5_B5	9.814963442	-3.88194444	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2168	3502	0.032552827	0.024271845	4	12	EN-MIX	26	17	17
AGCTCTCCATTGTGCA-1_5_B5	-9.522562698	12.98649036	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1016	1460	0.002739726	0.007534247	4	oligos	OL-Cntl	26	17	17
AGCTCTCGTCAAAGAT-1_5_B5	4.990443537	23.16214654	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	869	1262	0.011885895	0.014263074	4	oligos	OL-Cntl	26	17	17
AGCTCTCGTCTTTCAT-1_5_B5	0.871943918	1.043666328	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	761	1215	0	0.009053498	4	11	Glia-MIX	26	17	17
AGCTCTCTCTAACTCT-1_5_B5	14.26146175	16.17231954	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1163	1977	0.001517451	0.00809307	4	oligos	OL-Cntl	26	17	17
AGCTTGAAGACGCTTT-1_5_B5	15.08574394	9.201394162	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1666	3165	0.000947867	0.009478673	4	oligos	OL-Cntl	26	17	17
AGCTTGAAGGCCCTTG-1_5_B5	-0.46239658	1.285802289	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1311	1988	0.003018109	0.014084507	4	11	Glia-MIX	26	17	17
AGCTTGATCAGCTGGC-1_5_B5	-36.50270188	-0.935247573	9	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1618	2953	0.008127328	0.004740941	4	9	OPC	26	17	17
AGCTTGATCGGCATCG-1_5_B5	-18.42982293	19.18973342	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1846	3719	0.001344447	0.011024469	4	8	Astrocytes	26	17	17
AGGCCACAGAATTCCC-1_5_B5	-4.80364844	3.029500557	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	3148	6303	0.003173092	0.005394257	4	11	Glia-MIX	26	17	17
AGGCCACAGGTGCAAC-1_5_B5	14.16118395	-0.494835331	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	763	1101	0.005449591	0.004541326	4	12	EN-MIX	26	17	17
AGGCCACCAGATCGGA-1_5_B5	3.489228623	12.9652373	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	985	1538	0.006501951	0.028608583	4	oligos	OL-Cntl	26	17	17
AGGCCACCAGGATTGG-1_5_B5	9.631224273	-14.19318751	4	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	3016	6145	0.005532954	0.019853539	4	L2-3	EN-L2-3-MS	26	17	17
AGGCCACCATTTGCTT-1_5_B5	13.77247619	-3.069810266	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1312	2300	0.002608696	0.005652174	4	12	EN-MIX	26	17	17
AGGCCGTCAAACCCAT-1_5_B5	5.457935456	17.61374013	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	993	1494	0.004016064	0.011378849	4	oligos	OL-Cntl	26	17	17
AGGCCGTCATCCCACT-1_5_B5	14.07231048	7.90405356	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1609	2673	0.007856341	0.01271979	4	oligos	OL-Cntl	26	17	17
AGGCCGTGTAAGCACG-1_5_B5	11.71973427	18.11447841	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1070	1870	0.001069519	0.007486631	4	oligos	OL-Cntl	26	17	17
AGGCCGTGTACCAGTT-1_5_B5	-29.86969514	-2.667449477	9	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1565	2413	0.004973063	0.006216328	4	9	OPC	26	17	17
AGGCCGTTCTGGTATG-1_5_B5	15.24723673	16.55024216	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1139	1932	0.002070393	0.004658385	4	oligos	OL-Cntl	26	17	17
AGGGAGTAGCGTAGTG-1_5_B5	-4.291853793	18.63174502	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	852	1237	0	0.022635408	4	oligos	OL-Cntl	26	17	17
AGGGAGTAGTCATGCT-1_5_B5	11.41185288	24.91952788	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	809	1225	0.009795918	0.005714286	4	oligos	OL-Cntl	26	17	17
AGGGAGTCAGTTCCCT-1_5_B5	6.386539438	-8.286279376	4	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2513	4771	0.002724796	0.017187173	4	L2-3	EN-L2-3-MS	26	17	17
AGGGAGTCATGCCACG-1_5_B5	-0.64529517	4.958307965	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	840	1084	0.006457565	0.010147601	4	11	Glia-MIX	26	17	17
AGGGAGTCATTCTCAT-1_5_B5	-6.033376436	4.20218045	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	5113	13251	0.004226096	0.008150328	4	11	Glia-MIX	26	17	17
AGGGAGTGTAAGAGGA-1_5_B5	6.537062977	17.20988946	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1151	1972	0.000507099	0.016227181	4	oligos	OL-Cntl	26	17	17
AGGGAGTTCATTGCGA-1_5_B5	-2.236008485	2.54469108	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1609	2513	0.003183446	0.006366892	4	11	Glia-MIX	26	17	17
AGGGAGTTCTTGCAAG-1_5_B5	16.56348907	10.60583784	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1380	2258	0.003985828	0.011071745	4	oligos	OL-Cntl	26	17	17
AGGGATGGTGGTCTCG-1_5_B5	15.65076711	13.16328516	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1368	2419	0.005374122	0.009094667	4	oligos	OL-Cntl	26	17	17
AGGGATGTCAACACCA-1_5_B5	0.677200897	23.5029295	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	727	1080	0.001851852	0.005555556	4	oligos	OL-Cntl	26	17	17
AGGGATGTCATGTAGC-1_5_B5	11.73950242	21.53306926	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	961	1573	0	0.01207883	4	oligos	OL-Cntl	26	17	17
AGGGATGTCTTCGAGA-1_5_B5	10.74910808	21.87970467	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	850	1375	0.000727273	0.008727273	4	oligos	OL-Cntl	26	17	17
AGGGTGAAGATCCCGC-1_5_B5	8.820804786	0.676961218	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	944	1265	0.022134387	0.031620553	4	12	EN-MIX	26	17	17
AGGGTGAGTCATATCG-1_5_B5	-0.533617647	-15.9517424	10	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2226	4497	0.01445408	0.004002668	4	L2-3	EN-L2-3-Cntl	26	17	17
AGGGTGATCACGACTA-1_5_B5	10.97230644	19.08225093	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	927	1457	0.008922443	0.00754976	4	oligos	OL-Cntl	26	17	17
AGGTCATAGTCCCACG-1_5_B5	15.291912	14.87787345	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1209	2130	0.000938967	0.007511737	4	oligos	OL-Cntl	26	17	17
AGGTCATCACGGTTTA-1_5_B5	13.59246648	6.949147534	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1729	3291	0.006381039	0.01519295	4	oligos	OL-Cntl	26	17	17
AGGTCATCAGCTCCGA-1_5_B5	-19.61466205	8.809711076	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1013	1395	0.001433692	0.007168459	4	8	Astrocytes	26	17	17
AGGTCATTCGGAAACG-1_5_B5	-0.986538862	3.800556937	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1095	1519	0.002633311	0.006583278	4	11	Glia-MIX	26	17	17
AGGTCCGAGTAGGTGC-1_5_B5	-1.070273063	3.360732549	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1116	1618	0.000618047	0.010506799	4	11	Glia-MIX	26	17	17
AGGTCCGAGTATCTCG-1_5_B5	5.638871694	10.71858043	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1236	1945	0.002056555	0.02159383	4	oligos	OL-Cntl	26	17	17
AGGTCCGCAGGTGGAT-1_5_B5	16.75200762	17.89168758	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1067	1898	0.00052687	0.005795574	4	oligos	OL-Cntl	26	17	17
AGGTCCGGTAAGCACG-1_5_B5	4.967219762	13.76988185	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1027	1672	0.002990431	0.011961722	4	oligos	OL-Cntl	26	17	17
AGGTCCGTCTAACTGG-1_5_B5	14.15308268	11.73879006	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1659	2959	0.007096992	0.007772896	4	oligos	OL-Cntl	26	17	17
AGTAGTCGTCGCCATG-1_5_B5	3.682455162	29.06522158	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	738	1074	0	0.005586592	4	oligos	OL-Cntl	26	17	17
AGTAGTCTCCACGACG-1_5_B5	18.95912733	-24.25584807	3	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2858	5867	0.006476905	0.023521391	4	3	EN-L5-6	26	17	17
AGTCTTTAGTCGCCGT-1_5_B5	35.82812765	13.35978532	14	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1040	1579	0.010132996	0.013932869	4	14	Microglia	26	17	17
AGTCTTTCAGCCACCA-1_5_B5	17.233175	17.53921798	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1072	1797	0.000556483	0.006121313	4	oligos	OL-Cntl	26	17	17
AGTCTTTCATGCAATC-1_5_B5	-15.13791156	12.46715584	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1917	3576	0.001957494	0.009787472	4	8	Astrocytes	26	17	17
AGTCTTTGTCGAGTTT-1_5_B5	-6.086709842	3.120644854	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	5131	14606	0.005340271	0.004313296	4	11	Glia-MIX	26	17	17
AGTCTTTGTGAGGCTA-1_5_B5	17.04872368	15.1355212	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1180	1958	0.006128703	0.01072523	4	oligos	OL-Cntl	26	17	17
AGTCTTTGTTAGTGGG-1_5_B5	-3.893708489	2.809735441	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2558	4529	0.005519982	0.005519982	4	11	Glia-MIX	26	17	17
AGTCTTTTCACCTCGT-1_5_B5	11.46284036	23.43121836	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	728	1137	0.002638522	0.000879507	4	oligos	OL-Cntl	26	17	17
AGTGAGGAGGGATACC-1_5_B5	16.2472463	20.30886498	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	953	1509	0.004638834	0.004638834	4	oligos	OL-Cntl	26	17	17
AGTGAGGAGTTTAGGA-1_5_B5	12.89265687	18.83257422	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1090	1797	0.003338898	0.002782415	4	oligos	OL-Cntl	26	17	17
AGTGAGGCAATGGAGC-1_5_B5	-3.210892288	2.447057343	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2198	3515	0.006543385	0.010241821	4	11	Glia-MIX	26	17	17
AGTGAGGCATTGGCGC-1_5_B5	3.421610144	5.107619995	7	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1152	1563	0.003838772	0.01215611	4	7	Phagocytes	26	17	17
AGTGAGGGTGTAAGTA-1_5_B5	4.521757674	25.29558563	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	793	1078	0.002782931	0.004638219	4	oligos	OL-Cntl	26	17	17
AGTGGGAAGAGTACCG-1_5_B5	8.863827739	20.59447815	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	947	1613	0.001239926	0.007439554	4	oligos	OL-Cntl	26	17	17
AGTGGGACAGACAAAT-1_5_B5	4.486918292	24.33680508	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	868	1271	0.003147128	0.011801731	4	oligos	OL-Cntl	26	17	17
AGTGGGACATAACCTG-1_5_B5	-21.94256494	29.82315313	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2431	4963	0.002417892	0.006246222	4	8	Astrocytes	26	17	17
AGTGGGACATTGGCGC-1_5_B5	-5.702351153	18.64594114	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	821	1135	0.004405286	0.017621145	4	oligos	OL-Cntl	26	17	17
AGTGGGAGTCTTCAAG-1_5_B5	22.18978016	15.69478531	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1449	2536	0.001182965	0.007886435	4	oligos	OL-Cntl	26	17	17
AGTGGGAGTGCCTGCA-1_5_B5	17.15424356	9.496997432	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1526	2704	0.01035503	0.012204142	4	oligos	OL-Cntl	26	17	17
AGTGTCAAGATCTGCT-1_5_B5	-2.902284974	2.370176887	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1935	3197	0.002815139	0.008758211	4	11	Glia-MIX	26	17	17
AGTGTCACATCGGAAG-1_5_B5	-19.04397585	7.117054972	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	899	1266	0.002369668	0.007898894	4	8	Astrocytes	26	17	17
AGTTGGTAGCCCAACC-1_5_B5	-23.63689476	0.916969507	9	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2263	4315	0.001158749	0.011355736	4	9	OPC	26	17	17
AGTTGGTAGCCTATGT-1_5_B5	7.477764156	1.619737512	16	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	857	1054	0.0056926	0.046489564	4	16	EN-PYR	26	17	17
AGTTGGTAGGTAAACT-1_5_B5	11.94851402	13.79168532	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1232	2203	0.004539265	0.005447118	4	oligos	OL-Cntl	26	17	17
AGTTGGTGTCCCTTGT-1_5_B5	9.80889552	-19.29425058	4	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	4065	10741	0.00307234	0.005958477	4	L2-3	EN-L2-3-MS	26	17	17
ATAACGCGTAATCGTC-1_5_B5	-25.46770534	-0.991726743	9	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2188	5071	0.002760797	0.010254388	4	9	OPC	26	17	17
ATAACGCTCATAGCAC-1_5_B5	15.62537611	-0.022013534	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	741	1137	0.000879507	0.002638522	4	12	EN-MIX	26	17	17
ATAACGCTCTGCGACG-1_5_B5	38.22921905	10.47530857	14	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	915	1331	0.000751315	0.006010518	4	14	Microglia	26	17	17
ATAAGAGCACCAGTTA-1_5_B5	38.21473481	10.44442066	14	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	854	1206	0.005804312	0.005804312	4	14	Microglia	26	17	17
ATAAGAGCAGCTGTTA-1_5_B5	-9.873510743	14.04465703	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1617	2721	0.004410143	0.006615215	4	11	Glia-MIX	26	17	17
ATAAGAGCATCGGGTC-1_5_B5	18.01440631	-9.80485601	3	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2450	5297	0.006229941	0.008684161	4	3	EN-L5-6	26	17	17
ATAGACCAGACACGAC-1_5_B5	4.610456593	-2.218097325	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	769	1046	0.004780115	0.002868069	4	12	EN-MIX	26	17	17
ATAGACCAGCTGGAAC-1_5_B5	-3.779444314	22.5641775	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	722	1023	0.011730205	0.009775171	4	oligos	OL-Cntl	26	17	17
ATAGACCCAAGTCATC-1_5_B5	39.44688705	14.22287689	14	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1153	1857	0.005923533	0.002692515	4	14	Microglia	26	17	17
ATAGACCGTAGCGATG-1_5_B5	4.854520034	-8.762038184	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1235	1919	0.005732152	0.005732152	4	12	EN-MIX	26	17	17
ATCACGACACTGAAGG-1_5_B5	39.00666387	10.08664961	14	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	820	1094	0.011882998	0.003656307	4	14	Microglia	26	17	17
ATCACGACACTTGGAT-1_5_B5	18.11372902	17.49439335	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1154	1956	0.001533742	0.008691207	4	oligos	OL-Cntl	26	17	17
ATCACGACAGCTATTG-1_5_B5	37.0914696	10.0366625	14	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	843	1169	0	0.011976048	4	14	Microglia	26	17	17
ATCACGACATTTGCTT-1_5_B5	13.13938435	-4.663246146	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2031	3302	0.006056935	0.007571169	4	12	EN-MIX	26	17	17
ATCATCTCATCGTCGG-1_5_B5	-9.513350162	13.75505205	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1411	2047	0.002931119	0.008793356	4	11	Glia-MIX	26	17	17
ATCATCTGTCATATGC-1_5_B5	-3.067433644	2.25084639	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2032	3617	0.003594139	0.005529444	4	11	Glia-MIX	26	17	17
ATCATCTGTGAGTATA-1_5_B5	10.27731642	22.8701159	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	902	1465	0.002730375	0.005460751	4	oligos	OL-Cntl	26	17	17
ATCATGGGTACCGTAT-1_5_B5	-9.929639266	11.85311038	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	786	1143	0.000874891	0.012248469	4	11	Glia-MIX	26	17	17
ATCATGGGTTAAAGAC-1_5_B5	3.332067248	28.89181338	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	692	1042	0.000959693	0.008637236	4	oligos	OL-Cntl	26	17	17
ATCATGGTCAGGCCCA-1_5_B5	13.4575836	-2.410972585	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1167	2061	0.001455604	0.009218826	4	12	EN-MIX	26	17	17
ATCCACCAGGAGTACC-1_5_B5	-19.20802498	-17.87550535	6B	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2819	6522	0.000153327	0.004139834	4	6B	IN-SST	26	17	17
ATCCACCAGGCCATAG-1_5_B5	13.95137199	-3.114794839	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1378	2263	0.001767565	0.007512152	4	12	EN-MIX	26	17	17
ATCCACCGTATTCGTG-1_5_B5	17.8433391	-24.11126846	3	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	5383	17631	0.002268731	0.013555669	4	3	EN-L5-6	26	17	17
ATCCACCGTGCGATAG-1_5_B5	17.93640243	14.35759638	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1318	2366	0.010566357	0.00591716	4	oligos	OL-Cntl	26	17	17
ATCCACCTCCCTAACC-1_5_B5	5.037060153	32.71963326	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	774	1122	0.001782531	0.009803922	4	oligos	OL-Cntl	26	17	17
ATCCGAAAGATCCTGT-1_5_B5	-4.974812836	3.42643597	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	3541	7410	0.00242915	0.004723347	4	11	Glia-MIX	26	17	17
ATCCGAAAGCTGAACG-1_5_B5	4.778316732	17.34712278	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	951	1508	0	0.00862069	4	oligos	OL-Cntl	26	17	17
ATCCGAATCCGCATAA-1_5_B5	4.925573735	22.90308305	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	871	1507	0.00199071	0.0066357	4	oligos	OL-Cntl	26	17	17
ATCCGAATCGGCCGAT-1_5_B5	19.9123916	14.07784348	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1398	2523	0.008719778	0.008323424	4	oligos	OL-Cntl	26	17	17
ATCGAGTCAAGAAGAG-1_5_B5	0.386751245	27.00683157	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	758	1041	0.002881844	0.000960615	4	oligos	OL-Cntl	26	17	17
ATCGAGTCAAGCCTAT-1_5_B5	24.50120209	-24.30117749	3	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	3014	6863	0.012822381	0.004225557	4	3	EN-L5-6	26	17	17
ATCTACTCAATGGACG-1_5_B5	15.49685105	-26.42045217	3	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	3271	8648	0.005781684	0.009597595	4	3	EN-L5-6	26	17	17
ATCTACTCACTTCTGC-1_5_B5	15.94014977	-4.219767925	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1457	2376	0.006313131	0.013047138	4	12	EN-MIX	26	17	17
ATCTACTGTGCCTTGG-1_5_B5	1.229207952	22.58864848	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	734	1115	0	0.00896861	4	oligos	OL-Cntl	26	17	17
ATCTACTGTTACGCGC-1_5_B5	30.61129697	0.088400899	2	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	4956	16897	0.004024383	0.004438658	4	2	EN-L4	26	17	17
ATCTGCCAGGTGATAT-1_5_B5	-4.900188522	3.453542605	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	3580	7361	0.002037767	0.008694471	4	11	Glia-MIX	26	17	17
ATCTGCCAGTCTCCTC-1_5_B5	0.19362267	-0.192222182	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	886	1310	0.003816794	0.006870229	4	11	Glia-MIX	26	17	17
ATGCGATAGCCCAGCT-1_5_B5	-19.43377801	5.327453221	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	903	1635	0.012844037	0.015902141	4	8	Astrocytes	26	17	17
ATGCGATAGCGATAGC-1_5_B5	7.389051633	19.84901913	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1003	1541	0.004542505	0.00908501	4	oligos	OL-Cntl	26	17	17
ATGCGATAGGGTCTCC-1_5_B5	-18.50048899	24.4022753	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1628	2785	0.000718133	0.004667864	4	8	Astrocytes	26	17	17
ATGCGATGTCGAATCT-1_5_B5	13.68422588	-0.018717813	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	795	1211	0.001651528	0.007431874	4	12	EN-MIX	26	17	17
ATGCGATTCTTGACGA-1_5_B5	5.828275388	18.03634541	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	958	1503	0.007318696	0.010645376	4	oligos	OL-Cntl	26	17	17
ATGGGAGAGCGACGTA-1_5_B5	-5.488709685	3.97359207	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	4615	10800	0.002037037	0.007037037	4	11	Glia-MIX	26	17	17
ATGGGAGAGGTACTCT-1_5_B5	4.725157813	13.28761814	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1046	1718	0.009313155	0.019790454	4	oligos	OL-Cntl	26	17	17
ATGGGAGGTCTTGATG-1_5_B5	2.175496595	20.84312264	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	807	1151	0.005212858	0.008688097	4	oligos	OL-Cntl	26	17	17
ATGGGAGTCCTAGGGC-1_5_B5	18.45347617	17.57367	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1119	1758	0.002275313	0.005688282	4	oligos	OL-Cntl	26	17	17
ATGTGTGAGACAGAGA-1_5_B5	-18.04748471	-6.344890061	13B	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2549	4941	0.003845375	0.010524185	4	13B	IN-SV2C	26	17	17
ATGTGTGGTCATATGC-1_5_B5	13.58040176	17.21738187	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1073	1742	0.002870264	0.009184845	4	oligos	OL-Cntl	26	17	17
ATGTGTGGTTCCCGAG-1_5_B5	3.125063645	26.74333983	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	735	1097	0.002734731	0.005469462	4	oligos	OL-Cntl	26	17	17
ATGTGTGTCCTTTCTC-1_5_B5	-33.87981968	-3.059426647	9	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1626	2735	0.002925046	0.006215722	4	9	OPC	26	17	17
ATTACTCAGAGCTGCA-1_5_B5	-18.04839842	-25.34296385	6A	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2554	6610	0.002571861	0.004387292	4	6A	IN-PV	26	17	17
ATTACTCCACGCATCG-1_5_B5	12.13464298	25.09455772	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	745	1144	0.001748252	0.002622378	4	oligos	OL-Cntl	26	17	17
ATTACTCGTAGGACAC-1_5_B5	15.72707554	15.94670119	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1158	1949	0.004104669	0.006157004	4	oligos	OL-Cntl	26	17	17
ATTACTCGTCCTCCAT-1_5_B5	17.3445164	14.36383971	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1193	2128	0.001409774	0.007988722	4	oligos	OL-Cntl	26	17	17
ATTATCCAGGCTAGCA-1_5_B5	11.54038557	2.012968302	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	805	1099	0.002729754	0.007279345	4	12	EN-MIX	26	17	17
ATTATCCGTAGGGTAC-1_5_B5	5.022807288	-16.15689974	4	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	3074	7619	0.004593779	0.004068775	4	L2-3	EN-L2-3-MS	26	17	17
ATTATCCGTCCTAGCG-1_5_B5	18.2334124	7.377515619	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1954	4003	0.002498126	0.005246065	4	oligos	OL-Cntl	26	17	17
ATTATCCGTGCCTGTG-1_5_B5	-31.27952883	-1.760414267	9	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1511	2684	0.001490313	0.004470939	4	9	OPC	26	17	17
ATTCTACCACGCATCG-1_5_B5	-11.78705953	13.40590377	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	747	1042	0.013435701	0.004798464	4	11	Glia-MIX	26	17	17
ATTCTACCAGCCTTTC-1_5_B5	5.298226641	5.22927338	7	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2570	4935	0.010739615	0.007700101	4	7	Phagocytes	26	17	17
ATTCTACGTAGCTAAA-1_5_B5	-9.814433854	-3.134421822	13A	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2241	5065	0.0017769	0.006910168	4	13A	IN-VIP	26	17	17
ATTGGACCACGCATCG-1_5_B5	16.1183339	15.83711976	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1223	2101	0.002379819	0.006663494	4	oligos	OL-Cntl	26	17	17
ATTGGACGTGTAAGTA-1_5_B5	-4.189924842	2.988042204	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2870	5419	0.002214431	0.007381436	4	11	Glia-MIX	26	17	17
ATTGGACTCAACTCTT-1_5_B5	-9.183919398	15.76318971	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2198	3855	0.002075227	0.008300908	4	11	Glia-MIX	26	17	17
ATTGGACTCTAACTCT-1_5_B5	6.179408564	-2.888744223	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1094	1603	0.009357455	0.015595758	4	12	EN-MIX	26	17	17
ATTGGTGGTTACGCGC-1_5_B5	4.866606838	24.67935495	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	834	1314	0.00913242	0.003805175	4	oligos	OL-Cntl	26	17	17
ATTTCTGAGCCGCCTA-1_5_B5	-17.02982715	12.57324683	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1240	2215	0.000451467	0.000902935	4	8	Astrocytes	26	17	17
ATTTCTGCAAATACAG-1_5_B5	-3.503797022	27.28286355	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	701	1045	0.001913876	0.001913876	4	oligos	OL-Cntl	26	17	17
ATTTCTGCACACCGAC-1_5_B5	10.74253522	19.94183933	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	884	1485	0.004040404	0.007407407	4	oligos	OL-Cntl	26	17	17
CAACCAACACCGATAT-1_5_B5	14.16406719	0.644001417	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	697	1031	0.000969932	0.019398642	4	12	EN-MIX	26	17	17
CAACCAAGTAGCGCAA-1_5_B5	-18.39546126	-23.67243275	6A	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2184	4639	0.015951714	0.002371201	4	6A	IN-PV	26	17	17
CAACCAAGTTCGTGAT-1_5_B5	-24.62752671	16.03325348	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1127	1959	0.001531394	0.009698826	4	8	Astrocytes	26	17	17
CAACCAATCGTTGACA-1_5_B5	-7.313157373	9.999352029	5	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	739	1037	0.00192864	0.038572806	4	oligos	OL-MS-1	26	17	17
CAACCTCAGACATAAC-1_5_B5	13.09357464	-2.674388964	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1292	2105	0.001900238	0.016627078	4	12	EN-MIX	26	17	17
CAACCTCCAACACCTA-1_5_B5	16.77231447	-5.278867882	3	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1541	2765	0.000723327	0.021338156	4	3	EN-L5-6	26	17	17
CAACCTCCAACTGCTA-1_5_B5	10.22768617	16.82107923	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1026	1733	0	0.00577034	4	oligos	OL-Cntl	26	17	17
CAACCTCTCAGCCTAA-1_5_B5	-23.07897977	-26.16009747	6A	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	4318	12469	0.006736707	0.0072179	4	6A	IN-PV	26	17	17
CAACCTCTCCCGACTT-1_5_B5	-17.19664543	28.68986405	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	3203	7536	0.000928875	0.006369427	4	8	Astrocytes	26	17	17
CAACCTCTCGTGGGAA-1_5_B5	7.672891745	-11.90676499	4	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2146	3694	0.012452626	0.019491067	4	L2-3	EN-L2-3-MS	26	17	17
CAACTAGAGCTCCCAG-1_5_B5	-3.413515512	2.497829274	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2512	4220	0.003554502	0.005687204	4	11	Glia-MIX	26	17	17
CAACTAGAGTAAGTAC-1_5_B5	-21.7878858	25.69420856	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1800	3691	0.004334869	0.005147656	4	8	Astrocytes	26	17	17
CAACTAGCAAACGCGA-1_5_B5	8.216647381	-20.36193258	4	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	5191	15812	0.002213509	0.00917025	4	L2-3	EN-L2-3-MS	26	17	17
CAACTAGCAAGGCTCC-1_5_B5	13.39821689	0.497836568	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	860	1314	0.000761035	0.005327245	4	12	EN-MIX	26	17	17
CAACTAGCAATCAGAA-1_5_B5	-35.13053638	-4.397353133	9	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1262	1923	0.002080083	0.003120125	4	9	OPC	26	17	17
CAACTAGGTAAATGTG-1_5_B5	-33.67202469	-3.962819719	9	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1479	2496	0.007211538	0.003605769	4	9	OPC	26	17	17
CAACTAGTCCATGCTC-1_5_B5	-5.876665662	3.776425459	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	4822	12577	0.002067266	0.005088654	4	11	Glia-MIX	26	17	17
CAAGAAAAGAGTAAGG-1_5_B5	11.56617518	-11.52950643	4	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2907	5534	0.015359595	0.016263101	4	L2-3	EN-L2-3-MS	26	17	17
CAAGAAAAGATGGGTC-1_5_B5	-23.75774291	-23.47403562	6A	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	3466	7199	0.010557022	0.005695235	4	6A	IN-PV	26	17	17
CAAGAAAAGGCTCAGA-1_5_B5	-29.70269555	-10.4369431	9	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	928	1293	0.002320186	0.017014695	4	9	OPC	26	17	17
CAAGAAAAGGTGCACA-1_5_B5	-15.96199132	13.16933587	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1650	2960	0.001689189	0.009797297	4	8	Astrocytes	26	17	17
CAAGAAACAGCTGGCT-1_5_B5	-18.17865022	7.657865866	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1342	2728	0.001099707	0.005865103	4	8	Astrocytes	26	17	17
CAAGAAACATGCAACT-1_5_B5	16.30077122	-0.838222327	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	816	1236	0.00566343	0.001618123	4	12	EN-MIX	26	17	17
CAAGAAAGTATGCTTG-1_5_B5	8.587493506	-20.28818763	4	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	5270	16875	0.004444444	0.011851852	4	L2-3	EN-L2-3-MS	26	17	17
CAAGAAAGTGCTAGCC-1_5_B5	18.31918872	7.32421642	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2021	3960	0.001515152	0.006060606	4	oligos	OL-Cntl	26	17	17
CAAGATCAGGGAACGG-1_5_B5	-4.40277576	3.260739885	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	3075	5827	0.002402609	0.009267204	4	11	Glia-MIX	26	17	17
CAAGATCCAGTTAACC-1_5_B5	-31.70742264	-0.751415306	9	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1801	3380	0.002366864	0.003846154	4	9	OPC	26	17	17
CAAGATCGTAGGAGTC-1_5_B5	-5.673435567	4.10667083	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	4692	11215	0.003209987	0.008024967	4	11	Glia-MIX	26	17	17
CAAGATCTCTTCTGGC-1_5_B5	4.219455001	-10.33344772	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1726	3093	0.004849661	0.008729389	4	12	EN-MIX	26	17	17
CAAGGCCAGCGATTCT-1_5_B5	-27.81840983	0.417331712	9	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1982	3432	0.001456876	0.038461538	4	9	OPC	26	17	17
CAAGGCCAGGCATGGT-1_5_B5	-7.502125913	8.116148692	5	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	940	1320	0.006060606	0.023484848	4	oligos	OL-MS-1	26	17	17
CAAGGCCCATGGTCAT-1_5_B5	-32.00648401	-10.29853082	9	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	934	1449	0.003450656	0.005521049	4	9	OPC	26	17	17
CAAGGCCCATGTTCCC-1_5_B5	20.63406316	1.85861306	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1208	1933	0.010346611	0.003103983	4	12	EN-MIX	26	17	17
CAAGGCCGTTCCACGG-1_5_B5	17.027002	-5.047702511	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1178	1810	0.001657459	0.003314917	4	12	EN-MIX	26	17	17
CAAGGCCTCTACGAGT-1_5_B5	-32.84852711	-10.86506595	9	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	950	1454	0	0.006189821	4	9	OPC	26	17	17
CAAGTTGTCCCAACGG-1_5_B5	40.78519367	14.63122673	14	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1324	2065	0.002421308	0.013559322	4	14	Microglia	26	17	17
CACAAACAGCGCCTCA-1_5_B5	12.0110956	0.777805593	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	824	1141	0.007887818	0.021034181	4	12	EN-MIX	26	17	17
CACAAACCAACTTGAC-1_5_B5	14.34630771	-4.4208131	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1541	2499	0.003601441	0.014805922	4	12	EN-MIX	26	17	17
CACAAACCAAGCGAGT-1_5_B5	18.60624852	5.947417818	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	4550	12259	0.0026919	0.005546945	4	oligos	OL-Cntl	26	17	17
CACAAACCAGACAAGC-1_5_B5	-17.57928999	-7.160608537	13B	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2789	5653	0.011498319	0.010436936	4	13B	IN-SV2C	26	17	17
CACAAACCAGGCTGAA-1_5_B5	14.22973329	16.1536914	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1196	1951	0.003587904	0.009226038	4	oligos	OL-Cntl	26	17	17
CACAAACCATGGAATA-1_5_B5	-5.70863518	3.917477981	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	4461	10510	0.00190295	0.007897241	4	11	Glia-MIX	26	17	17
CACAAACGTACGAAAT-1_5_B5	10.61813242	22.76241816	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	862	1328	0.011295181	0.009036145	4	oligos	OL-Cntl	26	17	17
CACAAACGTTCCACGG-1_5_B5	4.986797752	-1.936378333	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	755	1069	0.001870907	0.011225444	4	12	EN-MIX	26	17	17
CACAAACTCCCTTGCA-1_5_B5	-8.709700062	-8.63832753	13A	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1189	1787	0.019026301	0.011191942	4	13A	IN-VIP	26	17	17
CACAAACTCTGAGTGT-1_5_B5	-15.20668208	15.48941639	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2977	5917	0.001183032	0.008957242	4	8	Astrocytes	26	17	17
CACACAAAGACTTTCG-1_5_B5	-5.30693059	3.387983492	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	3766	8142	0.002824859	0.008474576	4	11	Glia-MIX	26	17	17
CACACAAAGTACGCCC-1_5_B5	14.03456094	-3.80302423	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1487	2593	0.001156961	0.018511377	4	12	EN-MIX	26	17	17
CACACAATCAGTTTGG-1_5_B5	15.77318754	14.57102554	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1219	2212	0.004520796	0.007233273	4	oligos	OL-Cntl	26	17	17
CACACAATCTGGAGCC-1_5_B5	15.21393464	23.51662443	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	873	1336	0.001497006	0.003742515	4	oligos	OL-Cntl	26	17	17
CACACAATCTTTACGT-1_5_B5	-12.38886544	12.900946	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	898	1202	0.000831947	0.004159734	4	8	Astrocytes	26	17	17
CACACCTCAAATCCGT-1_5_B5	11.9264959	-0.441947828	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1205	1783	0.003365115	0.010095345	4	12	EN-MIX	26	17	17
CACACCTCACACCGAC-1_5_B5	-10.04590194	12.22220674	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	863	1136	0.001760563	0.009683099	4	11	Glia-MIX	26	17	17
CACACCTCAGACGCTC-1_5_B5	16.3836971	9.090757143	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1793	3346	0.001195457	0.009862522	4	oligos	OL-Cntl	26	17	17
CACACCTGTGTCAATC-1_5_B5	8.652284997	-6.783807286	10	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1572	2859	0.003847499	0.003847499	4	L2-3	EN-L2-3-Cntl	26	17	17
CACACCTTCGCCTGTT-1_5_B5	20.35722654	14.75657836	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1292	2476	0.001615509	0.00726979	4	oligos	OL-Cntl	26	17	17
CACACCTTCTGTACGA-1_5_B5	3.272362499	13.17213536	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	961	1529	0.003924133	0.017004578	4	oligos	OL-Cntl	26	17	17
CACACCTTCTGTTGAG-1_5_B5	17.88019915	-23.32770779	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2016	3490	0.005157593	0.054441261	4	12	EN-MIX	26	17	17
CACACTCAGATCTGCT-1_5_B5	3.316567239	27.3945421	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	712	1029	0.002915452	0.001943635	4	oligos	OL-Cntl	26	17	17
CACACTCAGCGCTTAT-1_5_B5	-8.37861205	-18.26205409	6B	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	697	1054	0.000948767	0.001897533	4	6B	IN-SST	26	17	17
CACACTCGTGAGGCTA-1_5_B5	33.2930338	-8.764830517	2	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	3874	9222	0.010409889	0.013120798	4	2	EN-L4	26	17	17
CACACTCTCAGTCAGT-1_5_B5	1.107678857	0.94678547	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	862	1319	0.003790751	0.009855951	4	12	EN-MIX	26	17	17
CACACTCTCTCGCTTG-1_5_B5	-18.5544458	-17.64325135	6B	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2315	4949	0.013942211	0.005253587	4	6B	IN-SST	26	17	17
CACACTCTCTGGAGCC-1_5_B5	-17.74833271	28.39505046	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2328	4880	0.000204918	0.014139344	4	8	Astrocytes	26	17	17
CACAGGCCACAGGCCT-1_5_B5	11.2284388	21.24712362	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	970	1579	0.00569981	0.006333122	4	oligos	OL-Cntl	26	17	17
CACAGGCGTAAGGGAA-1_5_B5	-20.27648846	25.47105285	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2066	3848	0.002338877	0.007796258	4	8	Astrocytes	26	17	17
CACAGGCGTCTAACGT-1_5_B5	-31.77289405	-9.623722963	9	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	915	1345	0.002973978	0.011152416	4	9	OPC	26	17	17
CACAGGCGTGTCTGAT-1_5_B5	1.756285137	17.67841129	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	847	1331	0.006761833	0.019534185	4	oligos	OL-Cntl	26	17	17
CACAGGCTCATCGATG-1_5_B5	12.5105313	0.459950058	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	855	1269	0.001576044	0.018124507	4	12	EN-MIX	26	17	17
CACAGGCTCCTCATTA-1_5_B5	20.86860819	-1.300424599	2	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1701	2731	0.006224826	0.008055657	4	2	EN-L4	26	17	17
CACAGTAAGAAGGGTA-1_5_B5	2.478214127	22.83243328	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	820	1270	0.003149606	0.008661417	4	oligos	OL-Cntl	26	17	17
CACAGTAAGAGGTAGA-1_5_B5	-0.721506207	22.69749304	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	799	1144	0.006118881	0.01048951	4	oligos	OL-Cntl	26	17	17
CACAGTAAGATGAGAG-1_5_B5	-21.70127846	26.8462343	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1981	3967	0.002520797	0.010335266	4	8	Astrocytes	26	17	17
CACATAGAGCTAAACA-1_5_B5	17.06202091	-0.243024237	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	858	1241	0.016116035	0.000805802	4	12	EN-MIX	26	17	17
CACATAGCAAGGTGTG-1_5_B5	16.12924463	8.355752836	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1954	3582	0.005304299	0.007537688	4	oligos	OL-Cntl	26	17	17
CACATAGCAGGCTCAC-1_5_B5	1.41541529	25.2245587	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	795	1121	0.004460303	0.008028546	4	oligos	OL-Cntl	26	17	17
CACATAGCAGTATCTG-1_5_B5	11.96341409	26.46809293	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	773	1184	0.001689189	0.002533784	4	oligos	OL-Cntl	26	17	17
CACATAGGTGTAAGTA-1_5_B5	-15.87533884	12.5721079	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1578	2756	0.000362845	0.017416546	4	8	Astrocytes	26	17	17
CACATTTAGATATACG-1_5_B5	13.56374917	0.289456224	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	783	1174	0.002555366	0.005110733	4	12	EN-MIX	26	17	17
CACATTTAGCTGCCCA-1_5_B5	13.24182101	16.57764744	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1216	2119	0.002831524	0.014629542	4	oligos	OL-Cntl	26	17	17
CACATTTAGTCCCACG-1_5_B5	4.441951208	24.79426738	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	826	1318	0.002276176	0.012139605	4	oligos	OL-Cntl	26	17	17
CACATTTCACAACGTT-1_5_B5	12.9871572	0.768973957	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	797	1160	0.010344828	0.012068966	4	12	EN-MIX	26	17	17
CACATTTGTGGTGTAG-1_5_B5	1.09623734	1.072028256	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1551	2219	0.009013069	0.009013069	4	12	EN-MIX	26	17	17
CACATTTTCAGTACGT-1_5_B5	18.80581964	13.46228197	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1422	2497	0.002803364	0.004405286	4	oligos	OL-Cntl	26	17	17
CACCACTAGAGCTATA-1_5_B5	18.52699177	16.51480664	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1218	2032	0.002952756	0.002952756	4	oligos	OL-Cntl	26	17	17
CACCACTAGGATATAC-1_5_B5	17.66225444	9.895884658	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1562	2772	0.001082251	0.005772006	4	oligos	OL-Cntl	26	17	17
CACCACTGTCACTGGC-1_5_B5	10.41362528	-1.549928269	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1551	2222	0.0090009	0.01980198	4	12	EN-MIX	26	17	17
CACCACTGTCCGTTAA-1_5_B5	16.98940335	1.746328301	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	813	1169	0.003421728	0.002566296	4	12	EN-MIX	26	17	17
CACCACTTCATACGGT-1_5_B5	12.95081108	1.95097528	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	726	1055	0.000947867	0.012322275	4	12	EN-MIX	26	17	17
CACCACTTCCAAGTAC-1_5_B5	-2.022821014	1.731584956	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1845	3132	0.002554278	0.011813538	4	11	Glia-MIX	26	17	17
CACCAGGAGCGATTCT-1_5_B5	-6.367034803	4.39957513	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	7908	27283	0.002455742	0.008210241	4	11	Glia-MIX	26	17	17
CACCAGGCAAGACACG-1_5_B5	-30.54218247	-12.50649651	9	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	837	1187	0.00758214	0.01095198	4	9	OPC	26	17	17
CACCAGGCACACAGAG-1_5_B5	1.254435238	21.86131914	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	923	1472	0.008152174	0.013586957	4	oligos	OL-Cntl	26	17	17
CACCAGGCAGCTGTTA-1_5_B5	17.96405299	14.10218555	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1244	1979	0	0.011622031	4	oligos	OL-Cntl	26	17	17
CACCAGGCATCATCCC-1_5_B5	15.487739	-5.117250586	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1274	2287	0.00218627	0.001749016	4	12	EN-MIX	26	17	17
CACCAGGGTCATATGC-1_5_B5	-0.575313748	4.524344998	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	854	1131	0.000884173	0.007073386	4	11	Glia-MIX	26	17	17
CACCAGGTCACGGTTA-1_5_B5	11.86814126	3.180532003	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1218	1753	0.003422704	0.007415859	4	12	EN-MIX	26	17	17
CACCAGGTCAGCTCTC-1_5_B5	12.82697072	1.768326549	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	934	1368	0.003654971	0.013888889	4	12	EN-MIX	26	17	17
CACCAGGTCATCGCTC-1_5_B5	15.77976968	11.98961073	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1398	2375	0.001263158	0.007157895	4	oligos	OL-Cntl	26	17	17
CACCAGGTCTACCAGA-1_5_B5	0.896912311	1.041347769	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1014	1442	0.004854369	0.014563107	4	11	Glia-MIX	26	17	17
CACCTTGAGATGTTAG-1_5_B5	18.07622806	-10.55101097	3	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2741	5610	0.007843137	0.017825312	4	3	EN-L5-6	26	17	17
CACCTTGAGTCCTCCT-1_5_B5	12.93789992	2.441233743	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	816	1160	0.004310345	0.015517241	4	12	EN-MIX	26	17	17
CACCTTGCAAAGAATC-1_5_B5	21.31704444	14.41424538	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1312	2264	0.003975265	0.004858657	4	oligos	OL-Cntl	26	17	17
CACCTTGTCACCTCGT-1_5_B5	14.60755325	23.18119363	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	907	1473	0.008825526	0.00407332	4	oligos	OL-Cntl	26	17	17
CACTCCAAGCTGAAAT-1_5_B5	16.25507868	23.84434989	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	909	1460	0	0.005479452	4	oligos	OL-Cntl	26	17	17
CACTCCAGTCAACTGT-1_5_B5	17.84737335	-24.34227016	3	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	7049	27245	0.003083135	0.014387961	4	3	EN-L5-6	26	17	17
CACTCCATCATGTCCC-1_5_B5	12.71176853	14.1852654	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1194	2072	0.000482625	0.008204633	4	oligos	OL-Cntl	26	17	17
CAGAATCAGGGAAACA-1_5_B5	34.23737718	-12.35564138	2	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2559	4666	0.015002143	0.020574368	4	2	EN-L4	26	17	17
CAGAATCAGTATCGAA-1_5_B5	13.90558993	14.77747538	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1269	2276	0.004393673	0.01142355	4	oligos	OL-Cntl	26	17	17
CAGAATCCATCACCCT-1_5_B5	11.53142235	-0.134926728	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1222	1846	0.004333694	0.011375948	4	12	EN-MIX	26	17	17
CAGAATCGTCTGCCAG-1_5_B5	12.88723922	17.60877324	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1096	1839	0.000543774	0.008700381	4	oligos	OL-Cntl	26	17	17
CAGAATCGTTCACCTC-1_5_B5	-9.069105207	-20.09355141	6B	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	805	1178	0.006791171	0.004244482	4	6B	IN-SST	26	17	17
CAGAATCGTTGCCTCT-1_5_B5	-30.76704766	0.769603584	9	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1728	3134	0.002871729	0.00606254	4	9	OPC	26	17	17
CAGAATCTCCCTTGTG-1_5_B5	18.40748835	18.80389447	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1091	1810	0.004972376	0.004972376	4	oligos	OL-Cntl	26	17	17
CAGAATCTCTGACCTC-1_5_B5	-2.893140301	19.79852323	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	671	1046	0.007648184	0.015296367	4	oligos	OL-Cntl	26	17	17
CAGAATCTCTTCAACT-1_5_B5	11.86565724	3.190627492	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	917	1527	0.004584152	0.001964637	4	12	EN-MIX	26	17	17
CAGAGAGAGAGACTAT-1_5_B5	6.704903854	25.88588471	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	935	1416	0.000706215	0.006355932	4	oligos	OL-Cntl	26	17	17
CAGAGAGAGATCTGCT-1_5_B5	-3.594498992	2.486399739	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2369	4160	0.002884615	0.006009615	4	11	Glia-MIX	26	17	17
CAGAGAGCACTTGGAT-1_5_B5	19.35265873	17.23433712	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1216	2177	0.000459348	0.004593477	4	oligos	OL-Cntl	26	17	17
CAGAGAGCATCACAAC-1_5_B5	14.7009535	21.36438952	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1041	1662	0.000601685	0.009025271	4	oligos	OL-Cntl	26	17	17
CAGAGAGGTAATTGGA-1_5_B5	13.55066654	15.6023556	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1178	1993	0.00652283	0.011540391	4	oligos	OL-Cntl	26	17	17
CAGAGAGGTCTGGAGA-1_5_B5	14.32167482	14.65412199	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1283	2201	0.008178101	0.007723762	4	oligos	OL-Cntl	26	17	17
CAGAGAGTCAACGGGA-1_5_B5	-4.648136854	3.372591882	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	3434	6676	0.003744757	0.007789095	4	11	Glia-MIX	26	17	17
CAGATCAAGCGCTCCA-1_5_B5	20.89046801	14.63164402	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1237	2119	0.002359604	0.00660689	4	oligos	OL-Cntl	26	17	17
CAGATCAAGTACGTTC-1_5_B5	-9.590073784	17.87224314	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2509	4874	0.001846533	0.005539598	4	11	Glia-MIX	26	17	17
CAGATCAGTGTAATGA-1_5_B5	-36.70109786	0.440224884	9	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1709	3205	0.000936037	0.0049922	4	9	OPC	26	17	17
CAGATCAGTTTACTCT-1_5_B5	-15.03885775	-18.48347383	6B	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1557	3023	0.007939133	0.001984783	4	6B	IN-SST	26	17	17
CAGATCATCGGAAACG-1_5_B5	9.916264374	9.090857192	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1418	2712	0.005530973	0.009218289	4	oligos	OL-Cntl	26	17	17
CAGATCATCTACTTAC-1_5_B5	22.35561319	-6.304445261	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1767	2897	0.00517777	0.00517777	4	11	Glia-MIX	26	17	17
CAGCAGCAGTACACCT-1_5_B5	17.29434294	15.63516068	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1247	2113	0.010411737	0.002839565	4	oligos	OL-Cntl	26	17	17
CAGCAGCCAGCCTGTG-1_5_B5	13.10014643	0.621575186	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	697	1019	0.000981354	0.010794897	4	12	EN-MIX	26	17	17
CAGCAGCCATCTGGTA-1_5_B5	3.164108067	-3.038690536	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	831	1203	0.013300083	0.007481297	4	12	EN-MIX	26	17	17
CAGCAGCCATTGGGCC-1_5_B5	39.74231533	15.17782741	14	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1409	2223	0	0.004048583	4	14	Microglia	26	17	17
CAGCAGCGTGTCAATC-1_5_B5	39.65883084	15.17785793	14	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1389	2123	0.011304757	0.0089496	4	14	Microglia	26	17	17
CAGCAGCTCACGGTTA-1_5_B5	19.15399237	6.261261245	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2759	6165	0.005839416	0.00405515	4	oligos	OL-Cntl	26	17	17
CAGCAGCTCACTCTTA-1_5_B5	-18.98044227	30.01509664	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2752	6174	0.000971817	0.010204082	4	8	Astrocytes	26	17	17
CAGCAGCTCGGCATCG-1_5_B5	-11.49795531	18.21855629	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2666	5202	0.002883506	0.008458285	4	11	Glia-MIX	26	17	17
CAGCATAAGAACAACT-1_5_B5	6.33704315	-3.533673663	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1550	2620	0.003816794	0.01221374	4	12	EN-MIX	26	17	17
CAGCATAAGTTAACGA-1_5_B5	7.864650983	-12.96181229	4	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2452	4661	0.011585497	0.012872774	4	L2-3	EN-L2-3-MS	26	17	17
CAGCATACAAGCGTAG-1_5_B5	12.10211059	0.547022054	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	986	1356	0.007374631	0.019174041	4	12	EN-MIX	26	17	17
CAGCATAGTATCACCA-1_5_B5	-5.401041838	3.46515227	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	4069	8958	0.002009377	0.008037508	4	11	Glia-MIX	26	17	17
CAGCATAGTCAACATC-1_5_B5	14.27591289	-4.886694562	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1882	3190	0.005642633	0.010658307	4	12	EN-MIX	26	17	17
CAGCATATCGCAAACT-1_5_B5	-8.884528772	-17.76348072	6B	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	757	1196	0.016722408	0.002508361	4	6B	IN-SST	26	17	17
CAGCCGAAGCGTAATA-1_5_B5	-0.827908918	25.42517683	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	729	1027	0.00097371	0.010710808	4	oligos	OL-Cntl	26	17	17
CAGCCGACATTATCTC-1_5_B5	13.05148568	2.255375857	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	861	1161	0.007751938	0.002583979	4	12	EN-MIX	26	17	17
CAGCCGAGTCACCCAG-1_5_B5	-15.41198629	15.12970584	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2046	3514	0.001138304	0.008252703	4	8	Astrocytes	26	17	17
CAGCCGAGTCTCTTAT-1_5_B5	11.96239404	-0.016828972	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1022	1470	0.006122449	0.034013605	4	12	EN-MIX	26	17	17
CAGCCGAGTGCACGAA-1_5_B5	16.9233933	13.31446998	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1370	2323	0.005165734	0.006457167	4	oligos	OL-Cntl	26	17	17
CAGCCGATCGCTGATA-1_5_B5	-9.108515826	16.11762443	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2803	5544	0.001623377	0.005952381	4	11	Glia-MIX	26	17	17
CAGCCGATCTGGTGTA-1_5_B5	5.365623736	-5.424486809	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1049	1645	0.009118541	0.005471125	4	12	EN-MIX	26	17	17
CAGCGACAGTTGCAGG-1_5_B5	-18.89900376	24.55742294	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2088	3886	0.000514668	0.012866701	4	8	Astrocytes	26	17	17
CAGCGACCAAGCCATT-1_5_B5	-20.21276076	-17.81504077	6A	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	4554	13261	0.003695046	0.003393409	4	6A	IN-PV	26	17	17
CAGCGACCAGGCTCAC-1_5_B5	18.11567759	18.59701446	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1186	1969	0.002031488	0.006094464	4	oligos	OL-Cntl	26	17	17
CAGCGACGTAAGCACG-1_5_B5	-0.550372744	4.768007645	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	796	1041	0.002881844	0.00192123	4	11	Glia-MIX	26	17	17
CAGCGACGTGGTAACG-1_5_B5	21.35938358	15.04769243	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1259	2017	0.001487357	0.003470501	4	oligos	OL-Cntl	26	17	17
CAGCGACGTTAAGATG-1_5_B5	-9.32164	-7.948247028	13A	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1765	2914	0.021619767	0.024708305	4	13A	IN-VIP	26	17	17
CAGCGACGTTCAGTAC-1_5_B5	10.39041671	0.653786843	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	948	1271	0.028324154	0.007867821	4	12	EN-MIX	26	17	17
CAGCTAAAGCTAGTGG-1_5_B5	12.03789321	16.38575994	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1138	1726	0.00405562	0.007531866	4	oligos	OL-Cntl	26	17	17
CAGCTAAAGGAGTACC-1_5_B5	-2.323504972	23.42670154	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	770	1097	0.013673655	0.00911577	4	oligos	OL-Cntl	26	17	17
CAGCTAAAGTAATCCC-1_5_B5	-11.25633457	16.81309691	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2279	4274	0.000701919	0.007721104	4	11	Glia-MIX	26	17	17
CAGCTAACATACTCTT-1_5_B5	-5.113969644	-1.18014366	13A	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1496	2761	0.001810938	0.003259689	4	13A	IN-VIP	26	17	17
CAGCTAAGTCACCTAA-1_5_B5	15.04159077	-19.73457105	4	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	4674	12548	0.010121135	0.011715014	4	L2-3	EN-L2-3-MS	26	17	17
CAGCTAAGTTCCACGG-1_5_B5	2.799435528	26.61038472	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	671	1051	0.00190295	0.00190295	4	oligos	OL-Cntl	26	17	17
CAGCTAATCACCTCGT-1_5_B5	-4.68844045	2.744470598	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	3122	6373	0.001255296	0.004864271	4	11	Glia-MIX	26	17	17
CAGCTAATCTGATTCT-1_5_B5	-32.75773988	-7.435630654	9	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1221	1883	0.001593202	0.007966012	4	9	OPC	26	17	17
CAGCTAATCTGCAGTA-1_5_B5	14.78231474	21.31468427	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	968	1397	0.005726557	0.001431639	4	oligos	OL-Cntl	26	17	17
CAGCTGGAGAGTTGGC-1_5_B5	-2.802678948	2.46355686	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2023	2936	0.00647139	0.009877384	4	11	Glia-MIX	26	17	17
CAGCTGGAGGCTATCT-1_5_B5	-14.81716206	0.500733851	13A	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	3288	7402	0.007295326	0.011888679	4	13A	IN-VIP	26	17	17
CAGCTGGCAATGACCT-1_5_B5	15.28036574	24.02599417	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	841	1333	0.001500375	0.004501125	4	oligos	OL-Cntl	26	17	17
CAGCTGGTCACAATGC-1_5_B5	16.47773884	11.12357192	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1334	2360	0.006355932	0.008050847	4	oligos	OL-Cntl	26	17	17
CAGCTGGTCCAGAAGG-1_5_B5	-16.94147091	18.13582062	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1916	3461	0.007223346	0.011846287	4	8	Astrocytes	26	17	17
CAGGTGCAGTCCCACG-1_5_B5	19.64676647	16.26672946	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1204	1932	0.000517598	0.004658385	4	oligos	OL-Cntl	26	17	17
CAGTAACAGATCTGCT-1_5_B5	15.62572136	15.66006081	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1196	2027	0.006906759	0.006413419	4	oligos	OL-Cntl	26	17	17
CAGTAACCAGCAGTTT-1_5_B5	37.55539664	-10.34744	2	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	4674	11336	0.009615385	0.019318984	4	2	EN-L4	26	17	17
CAGTAACGTAGCGTAG-1_5_B5	4.377296453	23.69003867	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	817	1154	0.019064125	0.008665511	4	oligos	OL-Cntl	26	17	17
CAGTAACGTCCCTACT-1_5_B5	6.654073927	-16.53942422	4	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	3303	7602	0.006840305	0.014075243	4	L2-3	EN-L2-3-MS	26	17	17
CAGTAACGTTCTCATT-1_5_B5	17.06842791	15.24088964	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1162	1960	0.003571429	0.005102041	4	oligos	OL-Cntl	26	17	17
CAGTAACTCAACACCA-1_5_B5	2.066971922	-6.122483813	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1097	1692	0.003546099	0.004137116	4	12	EN-MIX	26	17	17
CAGTAACTCACCAGGC-1_5_B5	14.62656573	12.88172998	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1392	2730	0.002564103	0.008058608	4	oligos	OL-Cntl	26	17	17
CAGTAACTCTTGTTTG-1_5_B5	-34.7750177	-7.746651122	9	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1091	1756	0.003986333	0.006264237	4	9	OPC	26	17	17
CAGTCCTAGCTCCTCT-1_5_B5	10.70808723	1.173106133	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	792	1195	0.00083682	0.011715481	4	12	EN-MIX	26	17	17
CAGTCCTAGTTGAGAT-1_5_B5	-2.378633594	2.516410128	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1693	2602	0.003843198	0.010760953	4	11	Glia-MIX	26	17	17
CAGTCCTCAAGCGAGT-1_5_B5	34.24596584	-14.03269866	2	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	3561	7688	0.009365245	0.01326743	4	2	EN-L4	26	17	17
CAGTCCTCAGGCTCAC-1_5_B5	13.8814128	0.348120884	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	783	1078	0.002782931	0.011131725	4	12	EN-MIX	26	17	17
CAGTCCTGTCGGCTCA-1_5_B5	-33.15305732	-12.72781295	9	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	805	1226	0	0.004893964	4	9	OPC	26	17	17
CAGTCCTTCTATCCCG-1_5_B5	-4.878986778	2.956581258	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	3301	6741	0.002076843	0.007268951	4	11	Glia-MIX	26	17	17
CATATGGCATGCGCAC-1_5_B5	7.91110065	35.16464513	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1163	1750	0.002857143	0.005142857	4	oligos	OL-Cntl	26	17	17
CATATGGGTAGAGTGC-1_5_B5	6.846608501	13.01411607	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1108	1843	0.022788931	0.009224091	4	oligos	OL-Cntl	26	17	17
CATATTCAGCAGGTCA-1_5_B5	-6.076060806	3.921394073	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	5708	16951	0.001887794	0.005840363	4	11	Glia-MIX	26	17	17
CATATTCAGGGTTCCC-1_5_B5	18.00923899	19.50081823	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1111	1853	0.001618996	0.003237992	4	oligos	OL-Cntl	26	17	17
CATATTCCAAGGCTCC-1_5_B5	9.751767189	14.85772947	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1063	1888	0.004237288	0.006885593	4	oligos	OL-Cntl	26	17	17
CATATTCCACATCCGG-1_5_B5	5.170464107	4.978339888	7	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2509	4971	0.0006035	0.006638503	4	7	Phagocytes	26	17	17
CATATTCGTATCTGCA-1_5_B5	39.33306331	15.96254726	14	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1452	2251	0.001776988	0.008440693	4	14	Microglia	26	17	17
CATATTCTCGTGACAT-1_5_B5	-5.438789809	3.528313693	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	4077	10214	0.001860192	0.003916193	4	11	Glia-MIX	26	17	17
CATCAAGAGATGCCAG-1_5_B5	38.74626729	15.97582177	14	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1423	2174	0.006439742	0.018399264	4	14	Microglia	26	17	17
CATCAAGAGCTGTTCA-1_5_B5	10.13212453	22.74478071	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	840	1346	0.001485884	0.009658247	4	oligos	OL-Cntl	26	17	17
CATCAAGCACGGATAG-1_5_B5	-3.158344452	23.55542346	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	821	1119	0.00714924	0.00714924	4	oligos	OL-Cntl	26	17	17
CATCAAGGTAACGCGA-1_5_B5	-1.848834036	2.736652774	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1579	2368	0.005067568	0.008445946	4	11	Glia-MIX	26	17	17
CATCAAGTCTGCCAGG-1_5_B5	-24.54002064	25.51730373	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1433	2559	0.005080109	0.005080109	4	8	Astrocytes	26	17	17
CATCAAGTCTTCGGTC-1_5_B5	19.87261952	10.93576266	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1507	2814	0.004619758	0.002842928	4	oligos	OL-Cntl	26	17	17
CATCAGAAGATCGGGT-1_5_B5	-10.52263615	18.6136309	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	4969	12877	0.001320183	0.007222179	4	11	Glia-MIX	26	17	17
CATCAGAAGCCCAGCT-1_5_B5	-28.45369448	0.128224689	9	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1797	3017	0.004640371	0.021544581	4	9	OPC	26	17	17
CATCAGAAGTCTCGGC-1_5_B5	-1.653653939	21.81726716	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	703	1032	0.003875969	0.019379845	4	oligos	OL-Cntl	26	17	17
CATCAGACATGAGCGA-1_5_B5	6.555023839	19.96143652	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	959	1558	0.015404365	0.014120668	4	oligos	OL-Cntl	26	17	17
CATCAGAGTAATTGGA-1_5_B5	-8.908977911	-9.603649712	13B	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1084	1472	0.014945652	0.013586957	4	13B	IN-SV2C	26	17	17
CATCCACAGGAGTCTG-1_5_B5	35.95132959	8.096239781	14	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	762	1017	0.009832842	0.001966568	4	14	Microglia	26	17	17
CATCCACGTACCATCA-1_5_B5	-35.50966822	3.553352252	9	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2109	4398	0.002728513	0.002273761	4	9	OPC	26	17	17
CATCCACGTCGCATCG-1_5_B5	-10.41738295	18.29255249	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2524	4773	0.002723654	0.007123402	4	11	Glia-MIX	26	17	17
CATCCACGTTATCACG-1_5_B5	-9.378400694	13.52418431	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1118	1606	0.00124533	0.006849315	4	11	Glia-MIX	26	17	17
CATCCACTCTTGACGA-1_5_B5	-0.024159007	20.38205437	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	701	1030	0.000970874	0.011650485	4	oligos	OL-Cntl	26	17	17
CATCGAAAGACATAAC-1_5_B5	15.74661077	-1.51261129	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	789	1162	0.002581756	0.003442341	4	12	EN-MIX	26	17	17
CATCGAAAGCAATCTC-1_5_B5	-1.684187675	22.81518398	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	815	1243	0.004827031	0.012067578	4	oligos	OL-Cntl	26	17	17
CATCGAACATGTAGTC-1_5_B5	-15.29592706	15.48869341	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2255	4302	0.00162715	0.006741051	4	8	Astrocytes	26	17	17
CATCGAAGTCAACTGT-1_5_B5	5.479284017	24.52194956	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	893	1451	0.00137836	0.003445899	4	oligos	OL-Cntl	26	17	17
CATCGAATCACCTTAT-1_5_B5	13.98678521	11.34453692	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1451	2687	0.009304057	0.010420543	4	oligos	OL-Cntl	26	17	17
CATCGAATCCAAAGTC-1_5_B5	14.48795321	-1.057136074	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	868	1259	0.004765687	0.002382844	4	12	EN-MIX	26	17	17
CATCGGGAGAAGAAGC-1_5_B5	-4.641023851	3.674938081	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	3712	6947	0.003022888	0.01065208	4	11	Glia-MIX	26	17	17
CATCGGGAGATGTGTA-1_5_B5	37.73670924	15.10557004	14	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1376	1965	0.009669211	0.016284987	4	14	Microglia	26	17	17
CATCGGGAGTGGAGTC-1_5_B5	-4.629082441	3.480828671	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	3648	7434	0.003362927	0.008340059	4	11	Glia-MIX	26	17	17
CATCGGGAGTGTCCAT-1_5_B5	-22.73987723	-8.05442066	9	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2128	3413	0.024611778	0.008203926	4	9	OPC	26	17	17
CATCGGGGTCGCCATG-1_5_B5	-19.36863111	8.556522352	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1195	1766	0.00396376	0.007361268	4	8	Astrocytes	26	17	17
CATGACAAGAAACGAG-1_5_B5	-16.53090733	12.7121598	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1488	2413	0.000414422	0.003729797	4	8	Astrocytes	26	17	17
CATGACAAGAAGGTGA-1_5_B5	-0.701013754	27.59785567	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	751	1006	0	0.00695825	4	oligos	OL-Cntl	26	17	17
CATGACAAGCGATTCT-1_5_B5	13.88657985	-3.020705606	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1220	1946	0.007194245	0.011305242	4	12	EN-MIX	26	17	17
CATGACACACATTAGC-1_5_B5	21.4656485	-24.6822401	3	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	5082	14703	0.004148813	0.013466639	4	3	EN-L5-6	26	17	17
CATGACACACCCATGG-1_5_B5	20.8241528	10.41671677	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1503	2524	0.00118859	0.010301109	4	oligos	OL-Cntl	26	17	17
CATGACAGTTTGTGTG-1_5_B5	17.75861493	-10.86858588	3	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	3026	6124	0.007184847	0.014043109	4	3	EN-L5-6	26	17	17
CATGACATCAATCTCT-1_5_B5	16.95912912	13.13611282	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1339	2568	0.002336449	0.006619938	4	oligos	OL-Cntl	26	17	17
CATGCCTAGAACAATC-1_5_B5	15.74073376	-1.853552387	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	978	1594	0	0.00250941	4	12	EN-MIX	26	17	17
CATGCCTCACCAGGTC-1_5_B5	-1.347751304	20.19538671	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	790	1212	0.001650165	0.01650165	4	oligos	OL-Cntl	26	17	17
CATGCCTCATCCGCGA-1_5_B5	2.2100088	20.61335218	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	887	1380	0.003623188	0.007246377	4	oligos	OL-Cntl	26	17	17
CATGCCTGTAGTAGTA-1_5_B5	9.865979336	-1.476360566	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1440	2135	0.020140515	0.051522248	4	12	EN-MIX	26	17	17
CATGCCTTCATGTCCC-1_5_B5	-3.528928947	23.92524328	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	745	1111	0.00720072	0.01530153	4	oligos	OL-Cntl	26	17	17
CATGCCTTCTTAACCT-1_5_B5	20.45146022	6.874758946	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	3030	7114	0.004357605	0.008293506	4	oligos	OL-Cntl	26	17	17
CATGGCGAGTAGCGGT-1_5_B5	34.65954077	-14.54864278	2	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	4662	11029	0.016229939	0.01686463	4	2	EN-L4	26	17	17
CATGGCGCAGCTGCAC-1_5_B5	14.02765332	-0.990664365	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	867	1330	0.002255639	0.003007519	4	12	EN-MIX	26	17	17
CATGGCGCAGTTCATG-1_5_B5	4.123951524	23.0962776	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	865	1268	0.003154574	0.007097792	4	oligos	OL-Cntl	26	17	17
CATGGCGCATCCGCGA-1_5_B5	6.61574305	-2.013967959	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1068	1447	0.007601935	0.02073255	4	12	EN-MIX	26	17	17
CATGGCGGTCAACTGT-1_5_B5	5.108036285	18.78955597	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1010	1468	0.006811989	0.008174387	4	oligos	OL-Cntl	26	17	17
CATTATCAGGATATAC-1_5_B5	15.93035213	18.9166402	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	997	1629	0.007366483	0.004297115	4	oligos	OL-Cntl	26	17	17
CATTATCCAACCGCCA-1_5_B5	3.549341243	-17.24735949	4	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	3162	7945	0.001510384	0.00566394	4	L2-3	EN-L2-3-MS	26	17	17
CATTATCCAATGTTGC-1_5_B5	-8.717869491	14.6954219	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2225	4134	0.002660861	0.006047412	4	oligos	OL-Cntl	26	17	17
CATTATCCACATTTCT-1_5_B5	12.49193545	1.626038422	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	801	1219	0.002461034	0.009844135	4	12	EN-MIX	26	17	17
CATTATCCATCCCATC-1_5_B5	17.22061113	18.27402111	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1161	1950	0.002564103	0.006153846	4	oligos	OL-Cntl	26	17	17
CATTATCCATCCTAGA-1_5_B5	3.53383154	-2.833334993	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	794	1136	0.007922535	0.006161972	4	12	EN-MIX	26	17	17
CATTATCGTCCCGACA-1_5_B5	5.940557049	18.00141719	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	919	1494	0.009370817	0.016064257	4	oligos	OL-Cntl	26	17	17
CATTATCTCACTCCTG-1_5_B5	18.62703238	7.606969288	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1960	4301	0.003255057	0.003487561	4	oligos	OL-Cntl	26	17	17
CATTATCTCGGCTACG-1_5_B5	4.137669413	25.22461003	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	831	1367	0.001463058	0.008778347	4	oligos	OL-Cntl	26	17	17
CATTCGCAGGACATTA-1_5_B5	21.57151346	-2.85831582	2	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	3369	8290	0.002050663	0.009770808	4	2	EN-L4	26	17	17
CATTCGCCATACAGCT-1_5_B5	13.87056462	10.18754429	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1437	2679	0.005599104	0.010451661	4	oligos	OL-Cntl	26	17	17
CATTCGCGTCTAAACC-1_5_B5	14.00395576	16.95538009	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1120	1723	0.000580383	0.006964597	4	oligos	OL-Cntl	26	17	17
CCAATCCAGGCTATCT-1_5_B5	9.988267301	-2.630479155	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1909	3102	0.026112186	0.014829142	4	12	EN-MIX	26	17	17
CCAATCCAGTACGCCC-1_5_B5	13.84771963	16.04617849	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1235	2108	0.008064516	0.007590133	4	oligos	OL-Cntl	26	17	17
CCAATCCCACCATGTA-1_5_B5	18.33715325	-23.83397667	3	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	5203	15125	0.000727273	0.029157025	4	3	EN-L5-6	26	17	17
CCAATCCCACCGATAT-1_5_B5	14.81764619	9.986993169	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1508	2771	0.006134969	0.011187297	4	oligos	OL-Cntl	26	17	17
CCAATCCCAGATAATG-1_5_B5	-6.388427779	4.422352019	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	8924	36346	0.002283608	0.008088923	4	11	Glia-MIX	26	17	17
CCAATCCGTCATACTG-1_5_B5	12.23857141	1.442773785	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	844	1140	0.012280702	0.012280702	4	12	EN-MIX	26	17	17
CCAATCCGTCTGCCAG-1_5_B5	-8.897255833	16.00453513	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	3670	8699	0.003793539	0.007931946	4	11	Glia-MIX	26	17	17
CCAATCCGTGCCTGGT-1_5_B5	13.62350473	-2.518614425	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1253	2057	0.000486145	0.009236753	4	12	EN-MIX	26	17	17
CCAATCCTCGTCGTTC-1_5_B5	33.92528503	14.6533234	14	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	905	1242	0.008856683	0.030595813	4	14	Microglia	26	17	17
CCAATCCTCTCGTTTA-1_5_B5	39.21342865	15.93370554	14	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1409	2405	0.005821206	0.010810811	4	14	Microglia	26	17	17
CCACCTAAGAAAGTGG-1_5_B5	-6.473951233	4.532156942	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	9717	40514	0.004911882	0.011206003	4	11	Glia-MIX	26	17	17
CCACCTAAGGCTAGGT-1_5_B5	-3.789203739	27.31245688	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	800	1112	0.003597122	0.004496403	4	oligos	OL-Cntl	26	17	17
CCACCTAAGTCGTACT-1_5_B5	-2.458599282	21.17803824	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	663	1008	0.00297619	0.011904762	4	oligos	OL-Cntl	26	17	17
CCACCTAAGTGTACTC-1_5_B5	-3.519286852	2.492053627	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2498	4499	0.002222716	0.00822405	4	11	Glia-MIX	26	17	17
CCACCTACAGCCAGAA-1_5_B5	-23.35348724	-2.191786109	9	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	942	1270	0.002362205	0.007874016	4	9	OPC	26	17	17
CCACCTACATCCGTGG-1_5_B5	15.50236607	1.26503592	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	784	1118	0.003577818	0.008944544	4	12	EN-MIX	26	17	17
CCACCTACATTACCTT-1_5_B5	10.8746332	19.5965987	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	938	1562	0.002560819	0.006402049	4	oligos	OL-Cntl	26	17	17
CCACCTAGTGTGTGCC-1_5_B5	13.69418111	-4.614619707	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2286	3806	0.005780347	0.023121387	4	12	EN-MIX	26	17	17
CCACCTAGTTCCACTC-1_5_B5	-2.796655767	2.238380483	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1771	2956	0.00135318	0.00744249	4	11	Glia-MIX	26	17	17
CCACGGAAGACTAGAT-1_5_B5	35.25647025	15.49071511	14	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1395	2044	0.002935421	0.025440313	4	14	Microglia	26	17	17
CCACGGACACAACGTT-1_5_B5	14.98597854	23.94859515	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	963	1559	0.000641437	0.003848621	4	oligos	OL-Cntl	26	17	17
CCACGGATCACGCGGT-1_5_B5	15.98620384	-5.306404089	3	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1227	2221	0	0.000900495	4	3	EN-L5-6	26	17	17
CCACGGATCAGGTAAA-1_5_B5	16.4792089	-0.891899707	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	793	1072	0.006529851	0.002798507	4	12	EN-MIX	26	17	17
CCACGGATCGGTGTTA-1_5_B5	18.25614856	-23.10843379	3	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	4388	10651	0.00891935	0.04778894	4	3	EN-L5-6	26	17	17
CCACTACGTACGCACC-1_5_B5	-12.20040459	12.58353497	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1080	1535	0.001302932	0.009771987	4	11	Glia-MIX	26	17	17
CCACTACGTCTAAACC-1_5_B5	-10.68464551	9.567557065	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	5252	14432	0.002217295	0.005681818	4	11	Glia-MIX	26	17	17
CCACTACGTTCGTTGA-1_5_B5	-29.63270069	0.461925851	9	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1760	3081	0.00259656	0.010061668	4	9	OPC	26	17	17
CCACTACTCGCAAACT-1_5_B5	12.44423805	12.31111069	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1337	2184	0.000457875	0.008699634	4	oligos	OL-Cntl	26	17	17
CCACTACTCGGCGCAT-1_5_B5	-21.08003094	-24.08165086	6A	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2417	4784	0.013795987	0.005016722	4	6A	IN-PV	26	17	17
CCACTACTCTGCCAGG-1_5_B5	35.3105582	7.812468617	14	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1013	1400	0.005714286	0.017142857	4	14	Microglia	26	17	17
CCAGCGAAGCAATCTC-1_5_B5	16.89926271	18.88793009	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1067	1751	0.001142204	0.007995431	4	oligos	OL-Cntl	26	17	17
CCAGCGAAGCCTCGTG-1_5_B5	2.833212661	26.01309406	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	782	1215	0.002469136	0.007407407	4	oligos	OL-Cntl	26	17	17
CCAGCGACAAGGACTG-1_5_B5	20.94930969	18.35674341	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1148	1935	0.001550388	0.001550388	4	oligos	OL-Cntl	26	17	17
CCAGCGATCGCGATCG-1_5_B5	-4.358969744	2.99315997	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	3045	5936	0.002190027	0.00421159	4	11	Glia-MIX	26	17	17
CCAGCGATCTTGGGTA-1_5_B5	0.542485215	28.28609551	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	831	1210	0.002479339	0.007438017	4	oligos	OL-Cntl	26	17	17
CCATGTCAGAATCTCC-1_5_B5	-6.109379933	8.217032159	5	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1073	1543	0.001944264	0.025923526	4	oligos	OL-MS-1	26	17	17
CCATGTCCACCACGTG-1_5_B5	2.209262027	20.90980129	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	900	1430	0.002097902	0.014685315	4	oligos	OL-Cntl	26	17	17
CCATGTCGTGCGATAG-1_5_B5	-5.932151612	4.151974453	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	5087	12265	0.002690583	0.007908683	4	11	Glia-MIX	26	17	17
CCATTCGAGGCTAGAC-1_5_B5	11.83670629	19.91808326	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1012	1651	0.000605694	0.007268322	4	oligos	OL-Cntl	26	17	17
CCATTCGCACATTTCT-1_5_B5	0.626753828	1.459742347	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	860	1202	0.003327787	0.022462562	4	11	Glia-MIX	26	17	17
CCATTCGCACCACCAG-1_5_B5	4.385465375	-2.951300545	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	897	1289	0	0.017843289	4	12	EN-MIX	26	17	17
CCATTCGGTGTATGGG-1_5_B5	-6.475073924	4.564002637	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	8029	27128	0.004755234	0.009621056	4	11	Glia-MIX	26	17	17
CCATTCGTCACGACTA-1_5_B5	18.99842592	6.248574104	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2331	4926	0.001218027	0.006496143	4	oligos	OL-Cntl	26	17	17
CCATTCGTCGTACGGC-1_5_B5	1.254367763	19.84536674	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	904	1395	0.007885305	0.010752688	4	oligos	OL-Cntl	26	17	17
CCCAATCAGACGCTTT-1_5_B5	5.421458478	24.22543308	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	945	1462	0.000683995	0.002735978	4	oligos	OL-Cntl	26	17	17
CCCAATCCACGTTGGC-1_5_B5	20.06106652	11.17626345	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1595	3118	0.004169339	0.002565747	4	oligos	OL-Cntl	26	17	17
CCCAATCCATCTGGTA-1_5_B5	17.61560247	13.34902537	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1244	2185	0.003203661	0.006407323	4	oligos	OL-Cntl	26	17	17
CCCAATCGTATGAAAC-1_5_B5	17.36954956	14.44055934	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1232	2135	0.001873536	0.007962529	4	oligos	OL-Cntl	26	17	17
CCCAATCTCAGAGACG-1_5_B5	9.653872709	0.936458971	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	857	1109	0.022542831	0.035166817	4	12	EN-MIX	26	17	17
CCCAATCTCCTCATTA-1_5_B5	11.32590378	1.828597727	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	674	1026	0	0.009746589	4	12	EN-MIX	26	17	17
CCCAATCTCTGTCTCG-1_5_B5	5.673706044	-9.872041441	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1605	2596	0.006548536	0.01348228	4	12	EN-MIX	26	17	17
CCCAGTTGTTTCGCTC-1_5_B5	15.33966576	-2.302152398	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1066	1557	0.001926782	0.005780347	4	12	EN-MIX	26	17	17
CCCATACAGAAACCTA-1_5_B5	4.777302055	-5.128867997	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	818	1184	0.004222973	0.002533784	4	12	EN-MIX	26	17	17
CCCATACAGACTAGAT-1_5_B5	-5.992453378	4.207486273	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	4714	10583	0.002267788	0.00973259	4	11	Glia-MIX	26	17	17
CCCATACAGCAACGGT-1_5_B5	-5.951345989	4.009432929	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	5158	12781	0.001564823	0.006494015	4	11	Glia-MIX	26	17	17
CCCATACAGCTAGTTC-1_5_B5	-31.67362902	-12.99813906	9	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	736	1039	0.003849856	0.014436959	4	9	OPC	26	17	17
CCCATACGTGCACCAC-1_5_B5	-25.28333335	11.0803545	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1019	1693	0.000590667	0.008269344	4	8	Astrocytes	26	17	17
CCCATACTCAATCTCT-1_5_B5	-0.954268963	3.554640788	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1093	1581	0.001265022	0.006325111	4	11	Glia-MIX	26	17	17
CCCATACTCTCATTCA-1_5_B5	-15.33535033	15.50176219	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2674	5141	0.000778059	0.006029955	4	8	Astrocytes	26	17	17
CCCATACTCTCCAACC-1_5_B5	12.49318415	15.3320737	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1251	2010	0.006467662	0.011940299	4	oligos	OL-Cntl	26	17	17
CCCTCCTAGCAGATCG-1_5_B5	4.817397842	13.12792305	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1176	1902	0.011566772	0.01787592	4	oligos	OL-Cntl	26	17	17
CCCTCCTAGGCGTACA-1_5_B5	15.81971375	14.82063097	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1248	2036	0.001473477	0.007858546	4	oligos	OL-Cntl	26	17	17
CCCTCCTCAATCACAC-1_5_B5	14.47596471	1.606831648	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1082	1745	0.00286533	0.012034384	4	12	EN-MIX	26	17	17
CCCTCCTCACGGTTTA-1_5_B5	-5.509656966	9.235658346	5	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	999	1508	0.00464191	0.026525199	4	oligos	OL-MS-1	26	17	17
CCCTCCTCATGCATGT-1_5_B5	14.78393393	1.212441372	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	816	1181	0.00169348	0.009314141	4	12	EN-MIX	26	17	17
CCCTCCTGTGGTGTAG-1_5_B5	33.89013734	-11.81302546	2	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2266	4067	0.012539956	0.019670519	4	2	EN-L4	26	17	17
CCCTCCTTCCGCAAGC-1_5_B5	12.16098756	2.946322832	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1063	1592	0.004396985	0.007537688	4	12	EN-MIX	26	17	17
CCCTCCTTCGGTGTCG-1_5_B5	17.58740425	12.51418944	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1441	2679	0.005599104	0.004479283	4	oligos	OL-Cntl	26	17	17
CCGGGATAGGCTAGCA-1_5_B5	10.96863128	24.63089553	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	849	1313	0.010662605	0.005331302	4	oligos	OL-Cntl	26	17	17
CCGGGATCACAGACAG-1_5_B5	2.150764852	20.91537663	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	931	1350	0.004444444	0.011111111	4	oligos	OL-Cntl	26	17	17
CCGGGATGTCTCCCTA-1_5_B5	5.079882579	23.47650979	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	884	1304	0.003067485	0.013803681	4	oligos	OL-Cntl	26	17	17
CCGGTAGCACTAGTAC-1_5_B5	-2.334876964	13.89650665	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	876	1340	0.001492537	0.02761194	4	oligos	OL-Cntl	26	17	17
CCGGTAGCATGCCACG-1_5_B5	16.43008113	-0.161026046	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	752	1058	0.002835539	0.00094518	4	12	EN-MIX	26	17	17
CCGGTAGGTCTGATTG-1_5_B5	-29.18405207	-0.035991776	9	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1532	2727	0.00220022	0.030436377	4	9	OPC	26	17	17
CCGGTAGGTGAGTGAC-1_5_B5	-20.07816093	20.25987951	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2244	4549	0.004176742	0.005715542	4	8	Astrocytes	26	17	17
CCGGTAGGTTTAAGCC-1_5_B5	17.88263225	18.10028681	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1134	1856	0.001616379	0.00862069	4	oligos	OL-Cntl	26	17	17
CCGGTAGTCAAGCCTA-1_5_B5	-10.60820394	9.593186416	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	6129	20660	0.003823814	0.005372701	4	11	Glia-MIX	26	17	17
CCGGTAGTCAGGCGAA-1_5_B5	-4.786039837	3.773572138	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	3894	7527	0.003321376	0.01155839	4	11	Glia-MIX	26	17	17
CCGTACTAGAATTCCC-1_5_B5	17.65843989	0.071908767	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	995	1581	0.005060089	0.001265022	4	12	EN-MIX	26	17	17
CCGTACTAGTGTCCAT-1_5_B5	37.45627328	9.138922571	14	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	726	1010	0.004950495	0.012871287	4	14	Microglia	26	17	17
CCGTACTGTGCACTTA-1_5_B5	-8.844007002	0.664011757	13A	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2372	5206	0.006146754	0.004610065	4	13A	IN-VIP	26	17	17
CCGTACTGTTGGTTTG-1_5_B5	16.30385882	10.67718945	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1581	2758	0.006526468	0.010514866	4	oligos	OL-Cntl	26	17	17
CCGTACTGTTTGACAC-1_5_B5	6.572216838	-27.08471962	4	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	6177	19324	0.003208445	0.0088491	4	L2-3	EN-L2-3-MS	26	17	17
CCGTACTTCATAGCAC-1_5_B5	-2.480128433	2.324834467	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1665	2660	0.00075188	0.005263158	4	11	Glia-MIX	26	17	17
CCGTACTTCCACGTGG-1_5_B5	-3.064840795	2.333696666	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2116	3418	0.003218256	0.009069631	4	11	Glia-MIX	26	17	17
CCGTACTTCGTTACAG-1_5_B5	10.91413028	11.63070175	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1352	2360	0.004661017	0.006779661	4	oligos	OL-Cntl	26	17	17
CCGTACTTCTCAAACG-1_5_B5	-13.9847364	-19.31667093	6B	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1345	2540	0.042913386	0.007086614	4	6B	IN-SST	26	17	17
CCGTGGACAGGCTCAC-1_5_B5	18.23643435	-23.33682822	3	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	4053	9168	0.011561955	0.043411867	4	3	EN-L5-6	26	17	17
CCGTGGACATTGTGCA-1_5_B5	-15.53747793	15.30803324	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2312	4360	0.001834862	0.004816514	4	8	Astrocytes	26	17	17
CCGTGGAGTGACGCCT-1_5_B5	4.546932125	-1.885032971	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	945	1322	0.00075643	0.015885023	4	12	EN-MIX	26	17	17
CCGTGGATCAACGCTA-1_5_B5	-33.44278344	-4.242089348	9	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1471	2492	0	0.005617978	4	9	OPC	26	17	17
CCGTTCAAGACAGGCT-1_5_B5	-16.70478727	2.266341566	13A	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	6483	20329	0.014216144	0.013232328	4	13A	IN-VIP	26	17	17
CCGTTCAAGTCGATAA-1_5_B5	-4.433767602	21.20059729	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	748	1102	0	0.01814882	4	oligos	OL-Cntl	26	17	17
CCGTTCAAGTGTTAGA-1_5_B5	17.9331133	9.001369904	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1714	3159	0.010129788	0.007280785	4	oligos	OL-Cntl	26	17	17
CCGTTCACAATACGCT-1_5_B5	-5.631994304	3.574495992	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	4165	10043	0.002190581	0.006770885	4	11	Glia-MIX	26	17	17
CCGTTCACATGTTGAC-1_5_B5	-34.06577929	-3.514347593	9	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1654	3261	0.002453235	0.008586323	4	9	OPC	26	17	17
CCGTTCATCAAACCGT-1_5_B5	-0.551971377	4.767190628	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	943	1297	0.00616808	0.01233616	4	11	Glia-MIX	26	17	17
CCGTTCATCAGGATCT-1_5_B5	12.12788009	1.373447469	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	673	1017	0.002949853	0.012782694	4	12	EN-MIX	26	17	17
CCGTTCATCTACTCAT-1_5_B5	-5.677212977	3.555343957	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	4468	12034	0.001495762	0.004237992	4	11	Glia-MIX	26	17	17
CCTAAAGAGTTTAGGA-1_5_B5	-36.29439383	-2.332278115	9	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1357	2343	0.007255655	0.003414426	4	9	OPC	26	17	17
CCTAAAGCACGACTCG-1_5_B5	-3.58313685	2.475070689	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2460	4342	0.00161216	0.005757715	4	11	Glia-MIX	26	17	17
CCTAAAGCACGGTTTA-1_5_B5	13.22204496	16.0378132	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1092	1790	0.002234637	0.010055866	4	oligos	OL-Cntl	26	17	17
CCTAAAGGTCTTTCAT-1_5_B5	5.833476622	20.08493127	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	930	1524	0.005905512	0.007874016	4	oligos	OL-Cntl	26	17	17
CCTAAAGGTTAAGACA-1_5_B5	-1.383403455	3.169653709	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1426	2205	0.001814059	0.005442177	4	11	Glia-MIX	26	17	17
CCTACACAGCTGCCCA-1_5_B5	-32.63938196	3.259887616	9	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2315	4585	0.000654308	0.003707743	4	9	OPC	26	17	17
CCTACACCAGTATCTG-1_5_B5	14.27599891	8.85052277	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1660	3032	0.01121372	0.013852243	4	oligos	OL-Cntl	26	17	17
CCTACACCATTCGACA-1_5_B5	13.96346786	-0.716652424	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	944	1613	0.001859888	0.00433974	4	12	EN-MIX	26	17	17
CCTACACGTTCGTGAT-1_5_B5	-12.99259493	-10.29901949	13B	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1903	3449	0.002609452	0.003479269	4	13B	IN-SV2C	26	17	17
CCTACACTCTTGAGGT-1_5_B5	5.747495576	20.23028345	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	861	1426	0.004908836	0.00631136	4	oligos	OL-Cntl	26	17	17
CCTACCAAGGAATTAC-1_5_B5	5.83291577	-2.119628075	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	913	1304	0.009202454	0.016871166	4	12	EN-MIX	26	17	17
CCTACCAAGGCCATAG-1_5_B5	17.03000432	-0.742813708	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	783	1143	0.003499563	0.002624672	4	12	EN-MIX	26	17	17
CCTACCAAGTAGCCGA-1_5_B5	10.89797099	20.25474346	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	943	1445	0.003460208	0.009688581	4	oligos	OL-Cntl	26	17	17
CCTACCACAATCCAAC-1_5_B5	12.09514821	-5.827412065	3	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1419	2471	0.003237556	0.002428167	4	3	EN-L5-6	26	17	17
CCTACCACAATGACCT-1_5_B5	7.152443736	-5.820459671	10	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1337	2374	0.00126369	0.00210615	4	L2-3	EN-L2-3-Cntl	26	17	17
CCTACCACATTCACTT-1_5_B5	-5.950124984	3.816844666	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	5383	15934	0.00169449	0.005083469	4	11	Glia-MIX	26	17	17
CCTACCAGTCCGTTAA-1_5_B5	4.55830007	-1.652924179	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	742	1060	0.000943396	0.009433962	4	12	EN-MIX	26	17	17
CCTACCATCACTATTC-1_5_B5	6.589019706	20.80643721	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	945	1613	0.008679479	0.003719777	4	oligos	OL-Cntl	26	17	17
CCTACCATCGGCTACG-1_5_B5	-1.891666626	22.50313931	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	751	1140	0.001754386	0.007017544	4	oligos	OL-Cntl	26	17	17
CCTACCATCTAGCACA-1_5_B5	-35.10980157	5.219378123	9	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	3257	8436	0.002015173	0.002370792	4	9	OPC	26	17	17
CCTACCATCTGTTTGT-1_5_B5	-9.495979604	-16.51478876	6B	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	880	1300	0.004615385	0.009230769	4	6B	IN-SST	26	17	17
CCTAGCTAGCTCAACT-1_5_B5	12.44001929	2.509838624	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	915	1458	0.002057613	0.018518519	4	12	EN-MIX	26	17	17
CCTAGCTGTGCTCTTC-1_5_B5	16.62154149	-6.739852926	3	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1907	3774	0	0.000794913	4	3	EN-L5-6	26	17	17
CCTAGCTGTGTTGGGA-1_5_B5	7.720884761	20.54059677	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1016	1670	0.004790419	0.009580838	4	oligos	OL-Cntl	26	17	17
CCTAGCTGTTAAAGTG-1_5_B5	-0.313305403	28.38912632	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	827	1200	0	0.0025	4	oligos	OL-Cntl	26	17	17
CCTAGCTGTTCCCTTG-1_5_B5	-14.61958358	-6.804527221	13B	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	3579	9242	0.008439732	0.002921446	4	13B	IN-SV2C	26	17	17
CCTAGCTTCATAGCAC-1_5_B5	14.73827441	20.88294461	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1027	1673	0.001195457	0.007770472	4	oligos	OL-Cntl	26	17	17
CCTATTAAGTGTCCCG-1_5_B5	32.66060251	-8.713806037	2	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	3358	7760	0.005412371	0.01443299	4	2	EN-L4	26	17	17
CCTATTACAAAGCGGT-1_5_B5	3.134157431	25.52765175	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	772	1186	0.010961214	0.007588533	4	oligos	OL-Cntl	26	17	17
CCTATTAGTGCTGTAT-1_5_B5	0.351938391	-0.737388294	6B	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1054	1649	0.002425713	0.003638569	4	6B	IN-SST	26	17	17
CCTATTATCCAAACAC-1_5_B5	12.9975432	23.13637719	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	851	1352	0.002218935	0.006656805	4	oligos	OL-Cntl	26	17	17
CCTATTATCTGCCCTA-1_5_B5	10.83157962	20.26189145	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	974	1673	0.005977286	0.008368201	4	oligos	OL-Cntl	26	17	17
CCTCAGTAGGATGGTC-1_5_B5	18.07673351	8.689836652	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1747	3053	0.001310187	0.00589584	4	oligos	OL-Cntl	26	17	17
CCTCAGTTCATTGCCC-1_5_B5	39.51306789	14.63709119	14	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1153	1692	0.009456265	0.007092199	4	14	Microglia	26	17	17
CCTCAGTTCGCCTGTT-1_5_B5	16.40097915	16.57202033	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1140	2008	0.000498008	0.00498008	4	oligos	OL-Cntl	26	17	17
CCTCTGACAAGGGTCA-1_5_B5	-24.09225198	7.559903562	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1089	1945	0.010282776	0.009254499	4	8	Astrocytes	26	17	17
CCTCTGACACACCGCA-1_5_B5	-5.599815001	3.573623055	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	4025	9091	0.002529975	0.006709933	4	11	Glia-MIX	26	17	17
CCTCTGACATATGAGA-1_5_B5	6.895749187	-3.215687912	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1308	1896	0.008966245	0.00685654	4	12	EN-MIX	26	17	17
CCTCTGACATGAGCGA-1_5_B5	28.38153505	-18.98311977	2	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	8139	32882	0.037923484	0.014628064	4	2	EN-L4	26	17	17
CCTTACGAGTCATGCT-1_5_B5	5.822529558	-2.053873792	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	911	1218	0.008210181	0.009031199	4	12	EN-MIX	26	17	17
CCTTACGAGTCTCGGC-1_5_B5	20.71208224	19.75366492	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1075	1728	0.000578704	0.002893519	4	oligos	OL-Cntl	26	17	17
CCTTACGCAAAGGCGT-1_5_B5	7.278233456	18.31376348	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1085	1699	0.012948793	0.004120071	4	oligos	OL-Cntl	26	17	17
CCTTACGCACATCCAA-1_5_B5	5.165338098	4.815074163	7	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2771	5327	0.003003567	0.010700206	4	7	Phagocytes	26	17	17
CCTTACGCAGTAAGCG-1_5_B5	11.36272823	22.74441588	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	870	1405	0.001423488	0.006405694	4	oligos	OL-Cntl	26	17	17
CCTTACGGTGAAGGCT-1_5_B5	-19.00306395	8.243113731	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1025	1527	0.000654879	0.003929273	4	8	Astrocytes	26	17	17
CCTTACGTCCAGGGCT-1_5_B5	15.76745146	8.53962011	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1715	3250	0.003692308	0.009538462	4	oligos	OL-Cntl	26	17	17
CCTTACGTCCATGCTC-1_5_B5	10.90831039	14.90882977	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1130	2001	0.004497751	0.010994503	4	oligos	OL-Cntl	26	17	17
CCTTACGTCGTGGGAA-1_5_B5	14.64797328	20.98448802	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1025	1590	0.001886792	0.006289308	4	oligos	OL-Cntl	26	17	17
CCTTCCCAGCCGCCTA-1_5_B5	15.90439233	14.03734353	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1391	2532	0.000789889	0.008293839	4	oligos	OL-Cntl	26	17	17
CCTTCCCCACAGAGGT-1_5_B5	16.62921322	1.736227679	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	720	1061	0.003770028	0.000942507	4	12	EN-MIX	26	17	17
CCTTCCCCATGCATGT-1_5_B5	16.32795322	1.574855557	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	808	1120	0.010714286	0.002678571	4	12	EN-MIX	26	17	17
CCTTCCCGTATCAGTC-1_5_B5	12.6525291	30.2177456	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	858	1324	0.003776435	0.003021148	4	oligos	OL-Cntl	26	17	17
CCTTCCCGTGAGGGAG-1_5_B5	5.724428871	24.15307275	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	899	1408	0.006392045	0.005681818	4	oligos	OL-Cntl	26	17	17
CCTTCCCGTGTTCGAT-1_5_B5	-13.8045703	24.45166918	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2217	4441	0.00450349	0.014861518	4	8	Astrocytes	26	17	17
CCTTCCCGTTCACGGC-1_5_B5	14.4627134	20.81459788	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	955	1522	0.00065703	0.006570302	4	oligos	OL-Cntl	26	17	17
CCTTCCCGTTTCGCTC-1_5_B5	17.6031696	14.74273525	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1249	2475	0	0.002424242	4	oligos	OL-Cntl	26	17	17
CCTTCCCTCCTGCTTG-1_5_B5	11.14830688	22.63317105	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	875	1440	0.004861111	0.003472222	4	oligos	OL-Cntl	26	17	17
CCTTCGAAGATGCCTT-1_5_B5	-18.65316372	-20.44043686	6B	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2569	5663	0.007769733	0.007239979	4	6B	IN-SST	26	17	17
CCTTCGACAAGAGTCG-1_5_B5	-3.655555856	2.90298004	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2721	4584	0.006544503	0.013089005	4	11	Glia-MIX	26	17	17
CCTTCGATCCCATTAT-1_5_B5	-0.656903227	3.722348484	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	966	1435	0.001393728	0.004181185	4	11	Glia-MIX	26	17	17
CCTTCGATCCCTTGCA-1_5_B5	13.82213598	0.308169143	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	693	1076	0.001858736	0.001858736	4	12	EN-MIX	26	17	17
CCTTTCTAGAGTAATC-1_5_B5	10.95870272	14.10982694	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1087	1850	0.004864865	0.014054054	4	oligos	OL-Cntl	26	17	17
CCTTTCTCAGCCTTGG-1_5_B5	-15.43996009	15.39027083	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2320	4272	0.000468165	0.010299625	4	8	Astrocytes	26	17	17
CCTTTCTCAGGTGGAT-1_5_B5	-6.403718564	4.453078609	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	9636	46487	0.003183686	0.007485964	4	11	Glia-MIX	26	17	17
CCTTTCTCAGTAAGCG-1_5_B5	14.12372609	11.67892314	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1395	2442	0.006961507	0.011875512	4	oligos	OL-Cntl	26	17	17
CCTTTCTCATCCTTGC-1_5_B5	0.51308964	1.74734007	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	829	1203	0.00166251	0.004987531	4	11	Glia-MIX	26	17	17
CCTTTCTGTATGAATG-1_5_B5	4.527380164	21.70269483	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	880	1395	0.012903226	0.007168459	4	oligos	OL-Cntl	26	17	17
CCTTTCTGTCATGCAT-1_5_B5	14.1340598	-1.290252917	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	985	1608	0.002487562	0.006840796	4	12	EN-MIX	26	17	17
CCTTTCTGTCCATGAT-1_5_B5	11.93491119	3.136821139	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1005	1489	0.002014775	0.01208865	4	12	EN-MIX	26	17	17
CCTTTCTGTGGGTCAA-1_5_B5	39.50170574	14.5013924	14	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1135	1751	0.001713307	0.005711022	4	14	Microglia	26	17	17
CCTTTCTTCATTCACT-1_5_B5	13.78897138	-0.593351278	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	977	1685	0.001780415	0.011275964	4	12	EN-MIX	26	17	17
CCTTTCTTCCTCAACC-1_5_B5	-1.300952421	25.37458804	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	629	1002	0.000998004	0.006986028	4	oligos	OL-Cntl	26	17	17
CGAACATCAGGATCGA-1_5_B5	-3.664776265	22.0587858	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	818	1256	0.003980892	0.013535032	4	oligos	OL-Cntl	26	17	17
CGAACATGTCATCCCT-1_5_B5	17.60378428	8.776204848	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1584	2946	0.002715547	0.006449423	4	oligos	OL-Cntl	26	17	17
CGAACATTCGCGGATC-1_5_B5	15.81555298	6.250574743	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2410	4455	0.007182941	0.011896745	4	oligos	OL-Cntl	26	17	17
CGAACATTCGCGTTTC-1_5_B5	24.21081946	27.50991195	17	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1455	2333	0.005143592	0.007715388	4	oligos	OL-MS-2	26	17	17
CGAACATTCGGTCCGA-1_5_B5	-0.495257647	4.732075446	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	782	1042	0.002879079	0.009596929	4	11	Glia-MIX	26	17	17
CGAACATTCTTCCTTC-1_5_B5	15.08326807	-21.25172461	4	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	5890	19604	0.00341767	0.00999796	4	L2-3	EN-L2-3-MS	26	17	17
CGAACATTCTTGTATC-1_5_B5	-5.110712473	3.324691108	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	3524	7366	0.003529731	0.006652186	4	11	Glia-MIX	26	17	17
CGAATGTCAGACAAGC-1_5_B5	39.61126375	14.64679681	14	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1287	1901	0.003156234	0.012624934	4	14	Microglia	26	17	17
CGAATGTCAGCTGTTA-1_5_B5	15.19683204	16.58456212	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1194	2003	0.000499251	0.009985022	4	oligos	OL-Cntl	26	17	17
CGAATGTCATAGTAAG-1_5_B5	20.32705913	-2.337810098	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1619	2426	0.009892828	0.020197857	4	12	EN-MIX	26	17	17
CGAATGTGTGATAAAC-1_5_B5	14.33522127	17.42089205	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1065	1665	0.003603604	0.008408408	4	oligos	OL-Cntl	26	17	17
CGAATGTTCATGTAGC-1_5_B5	6.271422585	17.42225494	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1082	1742	0.003444317	0.011481056	4	oligos	OL-Cntl	26	17	17
CGACCTTAGGCGACAT-1_5_B5	-23.06163742	25.45264211	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1904	3722	0.000806018	0.005910801	4	8	Astrocytes	26	17	17
CGACCTTAGTCCATAC-1_5_B5	7.274787695	-1.413570362	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1028	1501	0.01332445	0.005996003	4	12	EN-MIX	26	17	17
CGACCTTAGTTTAGGA-1_5_B5	-15.96230568	13.76341333	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1729	3059	0.001634521	0.009153318	4	8	Astrocytes	26	17	17
CGACCTTGTCTCCCTA-1_5_B5	14.10919571	8.155521516	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1838	3525	0.002836879	0.009929078	4	oligos	OL-Cntl	26	17	17
CGACCTTGTGTTGAGG-1_5_B5	-6.485222275	4.568681543	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	8371	29088	0.005809956	0.011138614	4	11	Glia-MIX	26	17	17
CGACCTTGTTGTACAC-1_5_B5	1.665234836	22.12639178	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	883	1289	0.003103181	0.006982157	4	oligos	OL-Cntl	26	17	17
CGACCTTTCACATAGC-1_5_B5	-12.32647883	-21.62331131	6A	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1098	1635	0.016513761	0.005504587	4	6A	IN-PV	26	17	17
CGACTTCAGCGATAGC-1_5_B5	11.84229075	-18.46782795	4	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	4446	12308	0.001381215	0.013162171	4	L2-3	EN-L2-3-MS	26	17	17
CGACTTCCAAGGACTG-1_5_B5	8.164252772	-15.50158802	4	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	3355	7181	0.006823562	0.014761175	4	L2-3	EN-L2-3-MS	26	17	17
CGACTTCGTCATACTG-1_5_B5	7.23818751	-0.16110068	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	809	1041	0.020172911	0.018251681	4	12	EN-MIX	26	17	17
CGACTTCGTGCGAAAC-1_5_B5	6.58310114	-1.101439147	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	834	1045	0.00861244	0.044976077	4	12	EN-MIX	26	17	17
CGACTTCTCCGCATCT-1_5_B5	15.16342396	15.24317638	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1236	2170	0.004147465	0.009677419	4	oligos	OL-Cntl	26	17	17
CGACTTCTCTTCAACT-1_5_B5	-15.81110281	15.06608288	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1954	3667	0.004090537	0.007362967	4	8	Astrocytes	26	17	17
CGAGAAGCAAGACACG-1_5_B5	8.758936	8.301353097	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1620	2720	0.001838235	0.011397059	4	oligos	OL-Cntl	26	17	17
CGAGAAGTCCCTAACC-1_5_B5	5.703857123	-2.366949334	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	935	1238	0.004038772	0.017770598	4	12	EN-MIX	26	17	17
CGAGAAGTCCGCGTTT-1_5_B5	37.63687947	13.21256155	14	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1086	1590	0.001257862	0.011949686	4	14	Microglia	26	17	17
CGAGAAGTCGGATGGA-1_5_B5	11.95477891	-1.253461254	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1269	1628	0.005528256	0.007371007	4	12	EN-MIX	26	17	17
CGAGCACAGCCATCGC-1_5_B5	-20.87168138	23.94988772	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1750	3436	0.009895227	0.006111758	4	8	Astrocytes	26	17	17
CGAGCACAGCGATATA-1_5_B5	17.09849509	6.288022517	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2366	4626	0.005836576	0.009727626	4	oligos	OL-Cntl	26	17	17
CGAGCACAGGACAGAA-1_5_B5	-5.711498626	4.068397633	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	4699	10508	0.003140464	0.008279406	4	11	Glia-MIX	26	17	17
CGAGCACAGGTGATTA-1_5_B5	20.56068078	7.237104192	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2309	4676	0.001924722	0.00534645	4	oligos	OL-Cntl	26	17	17
CGAGCACAGTGGACGT-1_5_B5	-33.66493424	0.867817976	9	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1921	3439	0.004652515	0.00785112	4	9	OPC	26	17	17
CGAGCACCAACTGCGC-1_5_B5	-3.017131902	24.30910514	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	794	1043	0.004793864	0.009587728	4	oligos	OL-Cntl	26	17	17
CGAGCACGTAAACCTC-1_5_B5	20.08874976	8.701089029	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1933	3587	0.001115138	0.007805966	4	oligos	OL-Cntl	26	17	17
CGAGCACGTAGCTCCG-1_5_B5	17.29047812	-4.947803762	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1243	2004	0.01497006	0.00249501	4	12	EN-MIX	26	17	17
CGAGCACGTGGTCTCG-1_5_B5	1.746733518	21.0611985	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	873	1339	0.001493652	0.016430172	4	oligos	OL-Cntl	26	17	17
CGAGCACGTTGGTAAA-1_5_B5	-27.57121583	-0.114754109	9	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1888	3183	0.005655042	0.027646874	4	9	OPC	26	17	17
CGAGCACTCTGGGCCA-1_5_B5	12.63016809	15.2558112	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1191	1894	0.004223865	0.012671595	4	oligos	OL-Cntl	26	17	17
CGAGCACTCTTGTATC-1_5_B5	17.12802337	-0.645179177	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	889	1277	0.013312451	0.001566171	4	12	EN-MIX	26	17	17
CGAGCCACACATCTTT-1_5_B5	-1.120397447	0.881369514	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2559	4818	0.001867995	0.013075965	4	11	Glia-MIX	26	17	17
CGAGCCACATGAAGTA-1_5_B5	-1.432637192	3.046163259	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1287	1835	0.00599455	0.010354223	4	11	Glia-MIX	26	17	17
CGAGCCAGTGAAATCA-1_5_B5	-16.38643555	-9.957842326	13B	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2836	6124	0.004082299	0.002775963	4	13B	IN-SV2C	26	17	17
CGAGCCATCACTTACT-1_5_B5	5.601168623	17.98168409	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1012	1562	0.002560819	0.011523688	4	oligos	OL-Cntl	26	17	17
CGATCGGAGACCGGAT-1_5_B5	21.42309849	10.57665465	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1686	3109	0.007397877	0.00611129	4	oligos	OL-Cntl	26	17	17
CGATCGGCACCCAGTG-1_5_B5	-25.32502485	11.05578513	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1109	1902	0.004731861	0.014721346	4	8	Astrocytes	26	17	17
CGATCGGGTAGGCTGA-1_5_B5	14.75636223	-1.041962903	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	835	1250	0.008	0.0064	4	12	EN-MIX	26	17	17
CGATCGGGTATATGAG-1_5_B5	14.41977946	17.24222764	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1099	1781	0.003930376	0.006176305	4	oligos	OL-Cntl	26	17	17
CGATCGGGTCTTCAAG-1_5_B5	-1.705382586	2.867742917	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1348	1930	0.003108808	0.016580311	4	11	Glia-MIX	26	17	17
CGATCGGTCGGAGGTA-1_5_B5	4.7259649	4.631630981	7	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1899	2975	0.003697479	0.008403361	4	7	Phagocytes	26	17	17
CGATGGCAGAGAACAG-1_5_B5	11.55948008	0.046217316	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1084	1489	0.00402955	0.013431833	4	12	EN-MIX	26	17	17
CGATGGCAGGAATTAC-1_5_B5	4.506704347	18.90027571	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1064	1775	0.004507042	0.004507042	4	oligos	OL-Cntl	26	17	17
CGATGGCCAGACAAAT-1_5_B5	15.45495607	12.52709609	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1400	2606	0.010360706	0.009209517	4	oligos	OL-Cntl	26	17	17
CGATGGCCATTGTGCA-1_5_B5	17.18113361	14.5552245	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1332	2333	0.00642949	0.000857265	4	oligos	OL-Cntl	26	17	17
CGATGGCGTTGTGGCC-1_5_B5	8.083628288	0.971990702	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	814	1013	0.008884501	0.055281343	4	12	EN-MIX	26	17	17
CGATGGCGTTTCCACC-1_5_B5	17.57280878	11.99385781	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1473	2559	0.014458773	0.005470887	4	oligos	OL-Cntl	26	17	17
CGATGGCTCTCGATGA-1_5_B5	9.72610226	-14.81637231	4	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	3159	6628	0.005280628	0.012673506	4	L2-3	EN-L2-3-MS	26	17	17
CGATGTAAGTTGAGTA-1_5_B5	-3.700147277	2.638068284	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2513	4260	0.00399061	0.007746479	4	11	Glia-MIX	26	17	17
CGATGTAGTACATGTC-1_5_B5	-11.52594205	33.41943192	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	927	1181	0.00677392	0.008467401	4	11	Glia-MIX	26	17	17
CGATGTAGTGGTTTCA-1_5_B5	21.5088611	14.13305272	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1387	2270	0	0.00969163	4	oligos	OL-Cntl	26	17	17
CGATGTAGTTCCACTC-1_5_B5	-4.755950321	3.628061051	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	3670	7367	0.002036107	0.010994978	4	11	Glia-MIX	26	17	17
CGATTGACAGTCGTGC-1_5_B5	-6.492077929	4.567251116	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	10178	42609	0.006266282	0.014175409	4	11	Glia-MIX	26	17	17
CGATTGAGTCCGAAGA-1_5_B5	6.403242398	19.93218349	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1049	1766	0.005662514	0.01189128	4	oligos	OL-Cntl	26	17	17
CGCCAAGGTCTAGGTT-1_5_B5	21.21539572	10.23740029	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1802	3335	0.006596702	0.004497751	4	oligos	OL-Cntl	26	17	17
CGCCAAGTCAGCATGT-1_5_B5	27.9653414	-9.823351253	2	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	3276	6894	0.005221932	0.006237308	4	2	EN-L4	26	17	17
CGCCAAGTCGAACGGA-1_5_B5	-0.670001974	16.11085636	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	845	1290	0.003100775	0.020155039	4	oligos	OL-Cntl	26	17	17
CGCGGTAGTAGCGATG-1_5_B5	16.07307883	12.43793785	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1467	2422	0.000412882	0.008257638	4	oligos	OL-Cntl	26	17	17
CGCGGTAGTCAACATC-1_5_B5	-18.30013224	6.641248092	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	787	1099	0.002729754	0.009099181	4	8	Astrocytes	26	17	17
CGCGGTAGTGGTAACG-1_5_B5	19.86538013	8.691036091	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2001	4082	0.000489956	0.003919647	4	oligos	OL-Cntl	26	17	17
CGCGGTATCAACACAC-1_5_B5	-9.597531489	18.01605788	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2759	5598	0.001429082	0.005180422	4	11	Glia-MIX	26	17	17
CGCGTTTAGACAGGCT-1_5_B5	5.934496997	-1.730892124	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	906	1168	0.008561644	0.017979452	4	12	EN-MIX	26	17	17
CGCGTTTCAGGTGGAT-1_5_B5	15.34006406	-2.055761897	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	876	1267	0.009471192	0.00394633	4	12	EN-MIX	26	17	17
CGCGTTTCATATGGTC-1_5_B5	15.76466096	10.99012635	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1506	2788	0.0017934	0.011836442	4	oligos	OL-Cntl	26	17	17
CGCGTTTCATCGGGTC-1_5_B5	22.99295911	12.57206726	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1486	2668	0.004497751	0.004122939	4	oligos	OL-Cntl	26	17	17
CGCGTTTGTCGTCTTC-1_5_B5	11.52809682	-0.991318511	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1149	1546	0.006468305	0.027813713	4	12	EN-MIX	26	17	17
CGCGTTTGTGGTCTCG-1_5_B5	15.97567265	15.06509706	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1377	2439	0.011890119	0.010250103	4	oligos	OL-Cntl	26	17	17
CGCGTTTGTTCTGTTT-1_5_B5	4.640672535	-5.452597279	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	957	1507	0.00796284	0.00199071	4	12	EN-MIX	26	17	17
CGCGTTTTCAACACGT-1_5_B5	-18.80783627	-18.26692609	6A	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2525	5586	0.008413892	0.002506266	4	6A	IN-PV	26	17	17
CGCTATCAGGATGCGT-1_5_B5	-4.882540283	3.359154675	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	3722	7622	0.000787195	0.006691157	4	11	Glia-MIX	26	17	17
CGCTATCCAATGGAAT-1_5_B5	20.71133137	1.787768678	2	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1205	1998	0.002002002	0	4	2	EN-L4	26	17	17
CGCTATCCATGCTGGC-1_5_B5	11.19559685	14.23564616	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1195	2159	0.002315887	0.008337193	4	oligos	OL-Cntl	26	17	17
CGCTATCGTCTTCAAG-1_5_B5	16.5288361	9.023663686	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1737	3138	0.004780115	0.008285532	4	oligos	OL-Cntl	26	17	17
CGCTGGACACAGGTTT-1_5_B5	9.277165633	-6.256221888	10	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1440	2574	0.019425019	0.000777001	4	L2-3	EN-L2-3-Cntl	26	17	17
CGCTGGAGTAGCGATG-1_5_B5	-6.360465258	4.46559947	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	5820	14051	0.004341328	0.012668137	4	11	Glia-MIX	26	17	17
CGCTGGAGTTCGGGCT-1_5_B5	9.919200913	-2.116531943	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1542	2148	0.02839851	0.039106145	4	12	EN-MIX	26	17	17
CGCTGGATCAAGATCC-1_5_B5	3.210093827	26.51930026	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	796	1176	0.008503401	0.004251701	4	oligos	OL-Cntl	26	17	17
CGCTGGATCGTGTAGT-1_5_B5	15.2788217	19.97610823	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1004	1654	0.004232164	0.004836759	4	oligos	OL-Cntl	26	17	17
CGCTTCAAGAGCCCAA-1_5_B5	-3.67829602	1.831637231	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2325	4113	0.004376368	0.002188184	4	11	Glia-MIX	26	17	17
CGCTTCAAGGCTAGGT-1_5_B5	33.87805542	-11.64373631	2	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2533	4857	0.010500309	0.014823965	4	2	EN-L4	26	17	17
CGCTTCAAGTGAACGC-1_5_B5	11.80851235	13.36793736	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1448	2600	0.000384615	0.005384615	4	oligos	OL-Cntl	26	17	17
CGCTTCACACCTTGTC-1_5_B5	-17.3498251	-10.77705507	13B	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	4880	15160	0.001385224	0.004023747	4	13B	IN-SV2C	26	17	17
CGCTTCAGTTAGATGA-1_5_B5	5.535558082	-13.48698849	4	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2256	4436	0.00270514	0.009242561	4	L2-3	EN-L2-3-MS	26	17	17
CGGACACCATCCCACT-1_5_B5	13.98458243	21.37388522	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1013	1564	0.008951407	0.006393862	4	oligos	OL-Cntl	26	17	17
CGGACACGTAGCGTCC-1_5_B5	-28.03085074	0.459783007	9	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1941	3365	0.001783061	0.03922734	4	9	OPC	26	17	17
CGGACACTCACTCCTG-1_5_B5	-6.392375415	4.414026064	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	8047	27888	0.002223178	0.009287149	4	11	Glia-MIX	26	17	17
CGGACACTCGGCGGTT-1_5_B5	-6.109738454	4.326077477	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	5408	12718	0.00306652	0.008649159	4	11	Glia-MIX	26	17	17
CGGACGTCAATGGAGC-1_5_B5	-3.357715789	2.469819971	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2389	3964	0.001765893	0.007820383	4	11	Glia-MIX	26	17	17
CGGACGTCATATGAGA-1_5_B5	-20.26489238	25.60268273	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2199	4537	0.005730659	0.007273529	4	8	Astrocytes	26	17	17
CGGACGTCATGGGACA-1_5_B5	12.10549242	-1.179980094	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1228	1643	0.001825928	0.013998783	4	12	EN-MIX	26	17	17
CGGACGTGTAACGTTC-1_5_B5	-30.01709663	-0.197517004	9	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1752	3047	0.000984575	0.010502133	4	9	OPC	26	17	17
CGGACGTGTTTCGCTC-1_5_B5	16.96427595	-0.611568306	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	832	1243	0.011263073	0.000804505	4	12	EN-MIX	26	17	17
CGGACGTTCAAGGTAA-1_5_B5	2.96258866	18.53505821	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1012	1600	0.003125	0.008125	4	oligos	OL-Cntl	26	17	17
CGGACGTTCTGAGTGT-1_5_B5	6.840037681	18.37059996	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	998	1481	0.002700878	0.007427414	4	oligos	OL-Cntl	26	17	17
CGGACGTTCTGTCAAG-1_5_B5	-17.70790212	28.57597826	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2760	5656	0.001944837	0.00937058	4	8	Astrocytes	26	17	17
CGGACTGAGGATATAC-1_5_B5	-8.947212672	-17.9009994	6B	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	775	1184	0.033783784	0.005912162	4	6B	IN-SST	26	17	17
CGGACTGAGGCCCGTT-1_5_B5	-18.98325926	6.976720882	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	765	1041	0.002881844	0.010566763	4	8	Astrocytes	26	17	17
CGGACTGGTGGTGTAG-1_5_B5	-6.938244631	8.575270383	5	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	920	1300	0.006923077	0.015384615	4	oligos	OL-MS-1	26	17	17
CGGACTGGTTCGCGAC-1_5_B5	-2.407872183	25.88741155	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	718	1092	0.007326007	0.006410256	4	oligos	OL-Cntl	26	17	17
CGGACTGGTTCGTTGA-1_5_B5	2.395230055	27.19379595	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	723	1068	0.00093633	0.010299625	4	oligos	OL-Cntl	26	17	17
CGGACTGTCCAAATGC-1_5_B5	-17.9881974	6.685320421	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	906	1410	0.00141844	0.005673759	4	8	Astrocytes	26	17	17
CGGACTGTCCACGAAT-1_5_B5	-18.51141568	25.63017394	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2410	4763	0.000419903	0.009657779	4	8	Astrocytes	26	17	17
CGGAGCTGTGGGTCAA-1_5_B5	15.31138567	20.36503474	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1067	1806	0.00055371	0.009413068	4	oligos	OL-Cntl	26	17	17
CGGAGCTGTTGTACAC-1_5_B5	13.6366032	16.33281491	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1242	2043	0.00391581	0.00783162	4	oligos	OL-Cntl	26	17	17
CGGAGTCAGGGCACTA-1_5_B5	-10.991945	7.152806183	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2732	4881	0.007580414	0.017004712	4	oligos	OL-Cntl	26	17	17
CGGAGTCCACTTAACG-1_5_B5	0.448507976	1.430937506	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	988	1295	0.005405405	0.016988417	4	11	Glia-MIX	26	17	17
CGGAGTCGTTACGGAG-1_5_B5	16.95174814	-0.642377622	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	822	1194	0.003350084	0	4	12	EN-MIX	26	17	17
CGGAGTCTCAACACAC-1_5_B5	12.0528786	-1.375068782	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1263	1698	0.004711425	0.024734982	4	12	EN-MIX	26	17	17
CGGAGTCTCCCTGACT-1_5_B5	8.204231194	27.46522358	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	888	1358	0.005891016	0.008836524	4	oligos	OL-Cntl	26	17	17
CGGCTAGGTACTTAGC-1_5_B5	18.90436559	14.5428127	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1227	2218	0.00405771	0.008115419	4	oligos	OL-Cntl	26	17	17
CGGCTAGGTATAATGG-1_5_B5	-6.441305191	4.510615708	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	7434	23174	0.003969966	0.01264348	4	11	Glia-MIX	26	17	17
CGGCTAGGTCGTGGCT-1_5_B5	-2.719488673	2.343541691	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1951	3139	0.004460019	0.007008601	4	11	Glia-MIX	26	17	17
CGGGTCAAGGAATGGA-1_5_B5	20.34577304	17.03523643	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1254	2009	0.00149328	0.004977601	4	oligos	OL-Cntl	26	17	17
CGGGTCACAAGCCATT-1_5_B5	11.40773356	0.404544616	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	956	1224	0.014705882	0.027777778	4	12	EN-MIX	26	17	17
CGGGTCACACCGAATT-1_5_B5	39.05604656	16.00925177	14	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1545	2400	0.00875	0.012916667	4	14	Microglia	26	17	17
CGGGTCACATAGTAAG-1_5_B5	-18.80003489	19.69814146	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1729	3446	0.001741149	0.008995937	4	8	Astrocytes	26	17	17
CGGGTCATCATGTGGT-1_5_B5	-1.900233964	24.81639024	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	699	1019	0.001962709	0.011776251	4	oligos	OL-Cntl	26	17	17
CGGTTAAAGGAATCGC-1_5_B5	-20.02525389	7.620833077	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	756	1090	0.000917431	0.004587156	4	8	Astrocytes	26	17	17
CGGTTAAAGGCAGGTT-1_5_B5	31.65218818	-10.39030106	2	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2791	5882	0.024991499	0.005100306	4	2	EN-L4	26	17	17
CGGTTAACATTGTGCA-1_5_B5	-8.75916694	14.75942667	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2227	4004	0.008491508	0.006993007	4	oligos	OL-Cntl	26	17	17
CGGTTAAGTCAAAGAT-1_5_B5	6.59244061	21.58968091	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	975	1567	0.007657945	0.008934269	4	oligos	OL-Cntl	26	17	17
CGGTTAAGTGCATCTA-1_5_B5	-5.769099568	4.120333079	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	4696	10351	0.003091489	0.008018549	4	11	Glia-MIX	26	17	17
CGGTTAAGTTCCACGG-1_5_B5	-18.55791546	19.2584169	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1933	3775	0.002649007	0.008211921	4	8	Astrocytes	26	17	17
CGGTTAATCTCTAGGA-1_5_B5	-3.662252734	2.561602175	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2435	4326	0.002773925	0.008552936	4	11	Glia-MIX	26	17	17
CGTAGCGAGCGTGTCC-1_5_B5	-9.927230118	11.75961163	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	875	1151	0.003475239	0.007819288	4	11	Glia-MIX	26	17	17
CGTAGCGCACATCCGG-1_5_B5	-15.24544766	15.0686606	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2410	4899	0.002041233	0.006123699	4	8	Astrocytes	26	17	17
CGTAGCGCACCCAGTG-1_5_B5	-32.09366697	-11.88708772	9	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	951	1349	0.003706449	0.00148258	4	9	OPC	26	17	17
CGTAGCGCAGATGGCA-1_5_B5	14.71852704	20.26825607	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1081	1752	0.01369863	0.00913242	4	oligos	OL-Cntl	26	17	17
CGTAGCGGTACTTAGC-1_5_B5	14.83342222	6.887435399	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2282	4249	0.004236291	0.009884679	4	oligos	OL-Cntl	26	17	17
CGTAGCGTCCCACTTG-1_5_B5	13.76163821	19.77643101	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1010	1485	0.003367003	0.006060606	4	oligos	OL-Cntl	26	17	17
CGTAGGCAGCGCCTTG-1_5_B5	5.299984924	20.59042409	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1006	1570	0.00955414	0.005732484	4	oligos	OL-Cntl	26	17	17
CGTAGGCAGCTCCTTC-1_5_B5	9.484982048	15.11540013	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	928	1512	0.007275132	0.013227513	4	oligos	OL-Cntl	26	17	17
CGTAGGCCAGGGCATA-1_5_B5	12.60016338	14.93166242	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1231	2068	0.011121857	0.013056093	4	oligos	OL-Cntl	26	17	17
CGTAGGCTCCTCATTA-1_5_B5	8.196534072	-17.61191784	4	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	5067	14688	0.003472222	0.012731481	4	L2-3	EN-L2-3-MS	26	17	17
CGTAGGCTCTTAGCCC-1_5_B5	24.11240377	-13.24068149	3	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2937	5574	0.013993541	0.017940438	4	3	EN-L5-6	26	17	17
CGTCACTAGTTGCAGG-1_5_B5	-8.964795203	-7.608821788	13A	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1353	1910	0.02565445	0.031937173	4	13A	IN-VIP	26	17	17
CGTCACTCAAGAAAGG-1_5_B5	15.26947027	-1.294324384	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	876	1335	0.0082397	0.001498127	4	12	EN-MIX	26	17	17
CGTCACTGTCTAGTCA-1_5_B5	8.38780338	-19.11681467	4	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	6285	19372	0.004181293	0.013473054	4	L2-3	EN-L2-3-MS	26	17	17
CGTCACTTCAGCTCGG-1_5_B5	18.51251002	18.10721867	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1188	1940	0.001546392	0.003608247	4	oligos	OL-Cntl	26	17	17
CGTCACTTCATAACCG-1_5_B5	13.78897811	-1.261188826	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	963	1525	0.001967213	0.011147541	4	12	EN-MIX	26	17	17
CGTCAGGCAGGATTGG-1_5_B5	-8.66611652	-15.39206248	6B	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	710	1001	0.040959041	0.008991009	4	6B	IN-SST	26	17	17
CGTCAGGGTTTGGCGC-1_5_B5	-4.543317011	20.83713134	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	755	1115	0.009865471	0.017040359	4	oligos	OL-Cntl	26	17	17
CGTCAGGTCTACTTAC-1_5_B5	16.65947423	-0.249796638	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	716	1011	0.007912957	0.00098912	4	12	EN-MIX	26	17	17
CGTCCATTCGATCCCT-1_5_B5	-2.27816677	25.73080353	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	684	1079	0.002780352	0.008341057	4	oligos	OL-Cntl	26	17	17
CGTCTACAGATTACCC-1_5_B5	8.471516784	-16.98738164	4	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	4057	9740	0.00698152	0.022587269	4	L2-3	EN-L2-3-MS	26	17	17
CGTCTACAGCGATAGC-1_5_B5	-21.9377291	24.60646234	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1864	3692	0	0.00595883	4	8	Astrocytes	26	17	17
CGTCTACAGTTAGGTA-1_5_B5	-9.935484487	16.73970923	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2361	4635	0.002157497	0.009061489	4	11	Glia-MIX	26	17	17
CGTCTACCAAGCCGCT-1_5_B5	7.281731971	18.74802426	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1280	1989	0.002011061	0.008044243	4	oligos	OL-Cntl	26	17	17
CGTCTACCACATAACC-1_5_B5	17.17335924	21.43537245	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1038	1558	0.001283697	0.005134788	4	oligos	OL-Cntl	26	17	17
CGTCTACCACTCTGTC-1_5_B5	13.4111627	0.435977894	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	762	1045	0.006698565	0.01722488	4	12	EN-MIX	26	17	17
CGTCTACTCCGCGGTA-1_5_B5	24.30901754	-22.30005714	3	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	5769	16274	0.002457908	0.007680964	4	3	EN-L5-6	26	17	17
CGTCTACTCGATCCCT-1_5_B5	-15.12217566	15.01898784	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2445	4564	0.000876424	0.01665206	4	8	Astrocytes	26	17	17
CGTGAGCCACTGCCAG-1_5_B5	-36.4661185	2.59637527	9	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2023	3925	0.002292994	0.002292994	4	9	OPC	26	17	17
CGTGAGCCAGACGCCT-1_5_B5	-31.68581938	-10.01597888	9	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	924	1298	0.002311248	0.005392912	4	9	OPC	26	17	17
CGTGAGCTCATCGGAT-1_5_B5	21.14593569	14.0281611	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1442	2587	0.002319289	0.010436799	4	oligos	OL-Cntl	26	17	17
CGTGTAAGTAGGCTGA-1_5_B5	20.74251984	-2.360680701	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1739	2750	0.008363636	0.012727273	4	12	EN-MIX	26	17	17
CGTGTAAGTCTAGTGT-1_5_B5	11.27628159	18.49035476	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1085	1945	0.001028278	0.006169666	4	oligos	OL-Cntl	26	17	17
CGTGTCTAGCGTGAGT-1_5_B5	4.836087556	22.38776523	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	898	1372	0.000728863	0.00728863	4	oligos	OL-Cntl	26	17	17
CGTGTCTAGTATTGGA-1_5_B5	-6.478400415	4.551323121	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	9109	34359	0.005297011	0.012340289	4	11	Glia-MIX	26	17	17
CGTGTCTCACGCTTTC-1_5_B5	12.32362043	29.75768624	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	824	1311	0.000762777	0.00228833	4	oligos	OL-Cntl	26	17	17
CGTTAGACACTGTGTA-1_5_B5	-4.686043503	3.473568984	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	3597	6840	0.004532164	0.006871345	4	11	Glia-MIX	26	17	17
CGTTAGACATAACCTG-1_5_B5	18.54388789	-26.44653814	3	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	4443	12257	0.001468549	0.012401077	4	3	EN-L5-6	26	17	17
CGTTAGAGTAAGGATT-1_5_B5	-3.602286933	2.467676789	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2488	4370	0.001372998	0.006864989	4	11	Glia-MIX	26	17	17
CGTTAGAGTACCCAAT-1_5_B5	25.71261009	3.469290543	15DA	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	812	1032	0.007751938	0.009689922	4	15DA	T cells	26	17	17
CGTTAGAGTCATCCCT-1_5_B5	11.60311704	22.55896069	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	906	1451	0	0.003445899	4	oligos	OL-Cntl	26	17	17
CGTTCTGAGTCCATAC-1_5_B5	6.62348793	-27.10658123	4	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	3539	7576	0.003563886	0.009767687	4	L2-3	EN-L2-3-MS	26	17	17
CGTTGGGAGAGTAAGG-1_5_B5	-5.064214477	3.674279925	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	4018	8391	0.002145156	0.006197116	4	11	Glia-MIX	26	17	17
CGTTGGGAGTGGAGTC-1_5_B5	-9.217178797	-14.66345879	6B	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	857	1221	0.009009009	0.008190008	4	6B	IN-SST	26	17	17
CGTTGGGCATGCTGGC-1_5_B5	18.47058647	18.86164956	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1154	2025	0.002962963	0.005925926	4	oligos	OL-Cntl	26	17	17
CGTTGGGGTCTGCCAG-1_5_B5	-15.43517031	15.36982228	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2443	4800	0.000208333	0.003333333	4	8	Astrocytes	26	17	17
CGTTGGGTCATGCAAC-1_5_B5	-19.94943471	24.7407639	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2067	3843	0.006765548	0.005464481	4	8	Astrocytes	26	17	17
CTAACTTAGAACTGTA-1_5_B5	18.62349324	6.158245295	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2642	5895	0.003731976	0.0057676	4	oligos	OL-Cntl	26	17	17
CTAACTTAGCAGGTCA-1_5_B5	0.484087825	-16.27322132	10	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2471	5754	0.000173792	0.003823427	4	L2-3	EN-L2-3-Cntl	26	17	17
CTAACTTCAGCTGTTA-1_5_B5	3.364158737	-2.58381387	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	817	1259	0.001588562	0.004765687	4	12	EN-MIX	26	17	17
CTAACTTCATAGAAAC-1_5_B5	22.56581971	-26.16036212	3	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2790	6879	0.007413868	0.007559238	4	3	EN-L5-6	26	17	17
CTAACTTGTCGAAAGC-1_5_B5	3.691077722	20.33436526	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	959	1646	0.006682868	0.006682868	4	oligos	OL-Cntl	26	17	17
CTAACTTGTTTAGCTG-1_5_B5	36.93937021	12.94051324	14	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1160	2182	0	0.008707608	4	14	Microglia	26	17	17
CTAACTTTCGCACTCT-1_5_B5	11.47440705	3.386492724	6B	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	739	1094	0.001828154	0.003656307	4	6B	IN-SST	26	17	17
CTAACTTTCTATCCCG-1_5_B5	0.804027627	0.879594678	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	759	1104	0	0.005434783	4	11	Glia-MIX	26	17	17
CTAAGACCAAACTGTC-1_5_B5	12.02479351	-1.385155068	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1344	2106	0.002374169	0.030389364	4	12	EN-MIX	26	17	17
CTAAGACCAAGTCATC-1_5_B5	-26.77887014	-2.829166973	9	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1216	1905	0.001049869	0.026771654	4	9	OPC	26	17	17
CTAAGACCACTTAACG-1_5_B5	10.15668309	-0.166740089	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1063	1470	0.019047619	0.023129252	4	12	EN-MIX	26	17	17
CTAAGACCAGCCTTTC-1_5_B5	14.04093454	0.337973316	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	695	1109	0	0.006311993	4	12	EN-MIX	26	17	17
CTAAGACCATGCCTTC-1_5_B5	8.077256876	3.450137161	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1127	1733	0.002308136	0.015579919	4	12	EN-MIX	26	17	17
CTAAGACGTACCGTTA-1_5_B5	20.42133985	10.73003984	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1630	2894	0.002073255	0.010366275	4	oligos	OL-Cntl	26	17	17
CTAATGGCAACGATGG-1_5_B5	-2.908438355	2.318140384	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1958	3211	0.001868577	0.006540019	4	11	Glia-MIX	26	17	17
CTAATGGGTAAGTGGC-1_5_B5	4.363082109	17.17717643	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	972	1548	0.003875969	0.023901809	4	oligos	OL-Cntl	26	17	17
CTAATGGGTACTCTCC-1_5_B5	13.19181241	27.58253364	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	843	1249	0.013610889	0.001601281	4	oligos	OL-Cntl	26	17	17
CTAATGGGTAGGAGTC-1_5_B5	5.042493592	25.65092737	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	779	1165	0.001716738	0.007725322	4	oligos	OL-Cntl	26	17	17
CTACACCAGCAGGCTA-1_5_B5	-0.117845526	3.721870837	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	827	1094	0.006398537	0.005484461	4	11	Glia-MIX	26	17	17
CTACACCTCTCAAGTG-1_5_B5	2.284002436	-16.9953032	4	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2939	7321	0.003005054	0.005327141	4	L2-3	EN-L2-3-MS	26	17	17
CTACACCTCTCATTCA-1_5_B5	20.77485597	14.43826914	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1222	2127	0.000470146	0.003761166	4	oligos	OL-Cntl	26	17	17
CTACATTAGACAAGCC-1_5_B5	10.3168141	19.7535667	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	886	1396	0.001432665	0.003581662	4	oligos	OL-Cntl	26	17	17
CTACATTGTCGACTGC-1_5_B5	22.25533893	14.10636739	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1474	2531	0.003951008	0.002765705	4	oligos	OL-Cntl	26	17	17
CTACATTGTGATAAGT-1_5_B5	-23.67058693	5.980875241	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	916	1487	0.00672495	0.014122394	4	8	Astrocytes	26	17	17
CTACATTTCCCTGACT-1_5_B5	1.341209655	1.036510331	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1389	2188	0.001371115	0.007312614	4	12	EN-MIX	26	17	17
CTACATTTCCTCAACC-1_5_B5	11.28239415	23.0884264	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	833	1416	0	0.002824859	4	oligos	OL-Cntl	26	17	17
CTACATTTCCTTTACA-1_5_B5	0.854250508	0.792241933	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1049	1663	0.001803969	0.005411906	4	11	Glia-MIX	26	17	17
CTACATTTCTCCAACC-1_5_B5	-18.52490667	6.441477959	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	736	1232	0.001623377	0.004058442	4	8	Astrocytes	26	17	17
CTACCCAAGAACAATC-1_5_B5	14.23226425	-4.250750965	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1687	3004	0.003328895	0.010652463	4	12	EN-MIX	26	17	17
CTACCCAAGGTGCTAG-1_5_B5	39.47483814	15.26254179	14	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1288	2002	0.003996004	0.012487512	4	14	Microglia	26	17	17
CTACCCACACGTTGGC-1_5_B5	13.48076756	-2.57912333	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1258	2008	0.003984064	0.011454183	4	12	EN-MIX	26	17	17
CTACCCACATCGGACC-1_5_B5	15.19171871	14.7877931	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1280	2232	0.001344086	0.00672043	4	oligos	OL-Cntl	26	17	17
CTACCCACATCTATGG-1_5_B5	-18.76484678	29.87371023	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2761	5983	0.003509945	0.009025572	4	8	Astrocytes	26	17	17
CTACCCAGTACTCGCG-1_5_B5	5.954462602	17.32027592	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	915	1425	0.005614035	0.010526316	4	oligos	OL-Cntl	26	17	17
CTACCCAGTGCAACGA-1_5_B5	14.37743742	2.53719094	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	728	1014	0.01183432	0.003944773	4	12	EN-MIX	26	17	17
CTACGTCAGGAGTACC-1_5_B5	-0.060591702	28.80196267	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	836	1171	0.002561913	0.004269855	4	oligos	OL-Cntl	26	17	17
CTACGTCCATGCCTAA-1_5_B5	-14.78206937	-20.68394048	6A	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1516	2370	0.010548523	0.007172996	4	6A	IN-PV	26	17	17
CTACGTCTCTAACTGG-1_5_B5	-6.170191476	4.242418493	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	5483	14651	0.002047642	0.008054058	4	11	Glia-MIX	26	17	17
CTAGAGTCACACCGAC-1_5_B5	4.397489996	21.45409476	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	890	1439	0.000694927	0.010423905	4	oligos	OL-Cntl	26	17	17
CTAGAGTCACCAGCAC-1_5_B5	-13.00733892	-1.338484562	13A	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2586	5289	0.004915863	0.010398941	4	13A	IN-VIP	26	17	17
CTAGAGTCATGGAATA-1_5_B5	3.904689856	12.27677014	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1138	1905	0.007349081	0.01312336	4	oligos	OL-Cntl	26	17	17
CTAGAGTGTTTCGCTC-1_5_B5	20.69260433	-24.52147459	3	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	3194	7401	0.003513039	0.023915687	4	3	EN-L5-6	26	17	17
CTAGCCTAGTTAGGTA-1_5_B5	-15.63521904	14.24503057	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1847	3134	0	0.007977026	4	8	Astrocytes	26	17	17
CTAGCCTCAGTACACT-1_5_B5	1.187262391	0.952966249	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	993	1441	0.009715475	0.003469813	4	12	EN-MIX	26	17	17
CTAGCCTCAGTCACTA-1_5_B5	12.79918937	0.903170719	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	775	1066	0.002814259	0.022514071	4	12	EN-MIX	26	17	17
CTAGTGAAGTGTCTCA-1_5_B5	-11.95303818	-19.79552431	6B	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1104	1923	0.023920957	0.004680187	4	6B	IN-SST	26	17	17
CTAGTGACACCATGTA-1_5_B5	14.22468412	24.08600419	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	916	1453	0	0.003441156	4	oligos	OL-Cntl	26	17	17
CTAGTGACAGTCTTCC-1_5_B5	20.57309428	19.02688031	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1064	1798	0.001112347	0.003893215	4	oligos	OL-Cntl	26	17	17
CTAGTGAGTCCTCCAT-1_5_B5	9.416189652	8.080767982	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1488	2637	0.00303375	0.013651877	4	oligos	OL-Cntl	26	17	17
CTAGTGAGTTCCACAA-1_5_B5	14.84100731	16.90199283	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1106	1932	0	0.007246377	4	oligos	OL-Cntl	26	17	17
CTAGTGATCGCTTAGA-1_5_B5	3.361775569	27.08370356	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	715	1036	0	0.007722008	4	oligos	OL-Cntl	26	17	17
CTAGTGATCGTAGGAG-1_5_B5	4.819151371	5.248964931	7	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1989	3225	0.013953488	0.010852713	4	7	Phagocytes	26	17	17
CTCACACAGCGTTTAC-1_5_B5	4.536806451	-6.732419562	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1228	1857	0.00538503	0.007539041	4	12	EN-MIX	26	17	17
CTCACACAGGAATGGA-1_5_B5	-4.044108587	2.821464133	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2938	5408	0.004622781	0.007211538	4	11	Glia-MIX	26	17	17
CTCACACCAACTTGAC-1_5_B5	-24.34002189	15.76197756	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1244	2207	0.001359311	0.009062075	4	8	Astrocytes	26	17	17
CTCACACCAATGGAGC-1_5_B5	-20.49333379	25.64030841	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2124	4744	0.000421585	0.00737774	4	8	Astrocytes	26	17	17
CTCACACCACCAACCG-1_5_B5	11.66912557	-5.31409148	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1090	1733	0.000577034	0.008655511	4	12	EN-MIX	26	17	17
CTCACACCATCTATGG-1_5_B5	15.20089237	9.495854175	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1566	2897	0.001380739	0.011391094	4	oligos	OL-Cntl	26	17	17
CTCACACGTCTCGTTC-1_5_B5	13.61163995	0.452638402	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	735	1134	0.001763668	0.00617284	4	12	EN-MIX	26	17	17
CTCACACGTCTGGAGA-1_5_B5	10.57552769	-14.55257631	4	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	3957	9336	0.009640103	0.01520994	4	L2-3	EN-L2-3-MS	26	17	17
CTCACACGTTGTGGCC-1_5_B5	-5.085426707	3.524167812	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	3815	8125	0.002461538	0.007138462	4	11	Glia-MIX	26	17	17
CTCACACGTTTACTCT-1_5_B5	-3.872206563	27.31566174	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	928	1392	0.001436782	0.007902299	4	oligos	OL-Cntl	26	17	17
CTCACACTCCCTCTTT-1_5_B5	1.269286494	0.974678947	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1187	1938	0.001547988	0.004643963	4	12	EN-MIX	26	17	17
CTCACACTCTGCCAGG-1_5_B5	3.321891636	-2.418932598	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	725	1122	0	0.004456328	4	12	EN-MIX	26	17	17
CTCAGAACAGCCTTGG-1_5_B5	18.10053102	16.39194427	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1324	2336	0.002568493	0.007705479	4	oligos	OL-Cntl	26	17	17
CTCAGAAGTAGCCTCG-1_5_B5	-2.066863807	-0.460411556	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	3863	8448	0.004024621	0.015506629	4	11	Glia-MIX	26	17	17
CTCAGAAGTGGCAAAC-1_5_B5	6.724049667	-14.19783647	4	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2425	4576	0.001092657	0.012237762	4	L2-3	EN-L2-3-MS	26	17	17
CTCATTAAGTGGAGAA-1_5_B5	19.40621695	-25.06882699	3	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	4223	11381	0.009138037	0.007644319	4	3	EN-L5-6	26	17	17
CTCATTACAGCCAGAA-1_5_B5	6.737899077	-2.405088712	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1368	1917	0.006259781	0.018257694	4	12	EN-MIX	26	17	17
CTCATTACATTGTGCA-1_5_B5	6.235351108	18.07483937	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	946	1455	0.006872852	0.01580756	4	oligos	OL-Cntl	26	17	17
CTCATTAGTTTGACAC-1_5_B5	4.505131086	-2.85491238	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	839	1342	0.002235469	0.002980626	4	12	EN-MIX	26	17	17
CTCATTATCCCTGACT-1_5_B5	10.01312503	15.78030019	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1022	1738	0.008055236	0.01438435	4	oligos	OL-Cntl	26	17	17
CTCATTATCTAACCGA-1_5_B5	-5.353287083	3.421127732	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	3661	8334	0.002519798	0.005519558	4	11	Glia-MIX	26	17	17
CTCCTAGAGTATTGGA-1_5_B5	15.75876014	11.7297802	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1400	2385	0.004192872	0.010062893	4	oligos	OL-Cntl	26	17	17
CTCCTAGCACATGTGT-1_5_B5	-31.38966237	-1.302792625	9	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1561	2677	0.00149421	0.006723945	4	9	OPC	26	17	17
CTCCTAGGTCATATGC-1_5_B5	12.40302663	2.658827917	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1106	1779	0.001686341	0.010118044	4	12	EN-MIX	26	17	17
CTCCTAGGTCCAACTA-1_5_B5	-4.261088753	2.496596681	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2503	4804	0.001248959	0.003746878	4	11	Glia-MIX	26	17	17
CTCCTAGGTCGCGGTT-1_5_B5	-2.837625873	25.24050501	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	714	1041	0.000960615	0.009606148	4	oligos	OL-Cntl	26	17	17
CTCCTAGGTGCAGGTA-1_5_B5	3.475382892	-2.47542051	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	717	1039	0.002887392	0.011549567	4	12	EN-MIX	26	17	17
CTCCTAGTCATCGCTC-1_5_B5	5.695508102	23.9480734	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	922	1361	0.003673769	0.010286554	4	oligos	OL-Cntl	26	17	17
CTCCTAGTCGTGGGAA-1_5_B5	12.62295328	13.31300124	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1154	1943	0.00514668	0.008749357	4	oligos	OL-Cntl	26	17	17
CTCGAAAAGAGCTATA-1_5_B5	17.72119418	-10.7106324	3	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2556	4728	0.002115059	0.034052453	4	3	EN-L5-6	26	17	17
CTCGAAAAGTCGATAA-1_5_B5	8.516889412	-6.345643272	10	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1341	2157	0.009272137	0.001854427	4	L2-3	EN-L2-3-Cntl	26	17	17
CTCGAAACAAGGACAC-1_5_B5	10.30629439	23.17130537	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	882	1353	0.003695492	0.009608278	4	oligos	OL-Cntl	26	17	17
CTCGAAACAGCTGTGC-1_5_B5	18.59796098	6.078889726	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	3034	7206	0.002081599	0.00596725	4	oligos	OL-Cntl	26	17	17
CTCGAAAGTTCAACCA-1_5_B5	-1.554519201	22.06938515	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	720	1047	0.00191022	0.007640879	4	oligos	OL-Cntl	26	17	17
CTCGAGGCATGCATGT-1_5_B5	21.07097515	9.744751431	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1839	3361	0	0.007438262	4	oligos	OL-Cntl	26	17	17
CTCGAGGTCACCTTAT-1_5_B5	13.26839694	0.404593134	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	786	1168	0.002568493	0.015410959	4	12	EN-MIX	26	17	17
CTCGGAGCAATCACAC-1_5_B5	7.427956213	19.769249	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1074	1675	0.008955224	0.007164179	4	oligos	OL-Cntl	26	17	17
CTCGGAGGTACGACCC-1_5_B5	4.603006199	-5.272600747	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	905	1354	0.005908419	0.000738552	4	12	EN-MIX	26	17	17
CTCGGAGGTCCATGAT-1_5_B5	15.97599524	23.90587725	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1007	1586	0.000630517	0.002522068	4	oligos	OL-Cntl	26	17	17
CTCGGAGTCCGATATG-1_5_B5	8.862292195	0.757513471	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	986	1315	0.009125475	0.0121673	4	12	EN-MIX	26	17	17
CTCGGAGTCTACTATC-1_5_B5	11.9911143	24.55112304	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	800	1278	0.00312989	0.006259781	4	oligos	OL-Cntl	26	17	17
CTCGGAGTCTGGTGTA-1_5_B5	16.45535062	1.883336928	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	806	1113	0.02425876	0.00359389	4	12	EN-MIX	26	17	17
CTCGGGAAGCAGCCTC-1_5_B5	-3.075085475	2.414236975	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2093	3219	0.005902454	0.010872942	4	11	Glia-MIX	26	17	17
CTCGGGATCAGTACGT-1_5_B5	38.70878704	13.974847	14	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1064	1518	0.003293808	0.017786561	4	14	Microglia	26	17	17
CTCGTACAGAAACGCC-1_5_B5	37.34665332	15.06936023	14	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1332	1984	0.002016129	0.015120968	4	14	Microglia	26	17	17
CTCGTACCACGTCTCT-1_5_B5	-36.0739812	-4.088170801	9	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1347	2329	0.003864319	0.008158008	4	9	OPC	26	17	17
CTCGTACGTAGCTGCC-1_5_B5	14.23611477	16.5831014	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1236	2343	0.000853606	0.012377294	4	oligos	OL-Cntl	26	17	17
CTCGTACGTTGGGACA-1_5_B5	12.2885717	22.32908717	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	904	1403	0.010691376	0.009265859	4	oligos	OL-Cntl	26	17	17
CTCGTACTCACTTCAT-1_5_B5	13.21667818	15.80072911	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1197	1965	0.002544529	0.010178117	4	oligos	OL-Cntl	26	17	17
CTCGTACTCTGCAGTA-1_5_B5	5.53282141	23.75464338	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	937	1377	0.016702977	0.006535948	4	oligos	OL-Cntl	26	17	17
CTCGTCAAGCTAAACA-1_5_B5	1.605455133	-6.991066568	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1262	1939	0.004641568	0.001547189	4	12	EN-MIX	26	17	17
CTCGTCACACGTGAGA-1_5_B5	14.86880712	28.0594035	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	788	1142	0.00262697	0.007880911	4	oligos	OL-Cntl	26	17	17
CTCGTCAGTTACGCGC-1_5_B5	-17.66720099	13.89204756	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1530	2523	0.000396354	0.00554895	4	8	Astrocytes	26	17	17
CTCGTCATCCACGAAT-1_5_B5	16.01265514	19.29627031	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1018	1577	0.006975269	0.006975269	4	oligos	OL-Cntl	26	17	17
CTCTAATCATGTCGAT-1_5_B5	-1.071926595	25.66322824	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	699	1011	0.007912957	0.008902077	4	oligos	OL-Cntl	26	17	17
CTCTAATCATTGGTAC-1_5_B5	-37.636488	-1.915533265	9	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1401	2697	0.002966259	0.001483129	4	9	OPC	26	17	17
CTCTAATCATTTCAGG-1_5_B5	3.797199743	-2.607257745	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	795	1135	0.011453744	0.000881057	4	12	EN-MIX	26	17	17
CTCTAATTCATGCTCC-1_5_B5	18.85329425	9.687220774	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1483	2828	0.000353607	0.004596888	4	oligos	OL-Cntl	26	17	17
CTCTACGCAAACGTGG-1_5_B5	39.05830814	14.91183283	14	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1239	1884	0.00477707	0.00955414	4	14	Microglia	26	17	17
CTCTACGCAATCCGAT-1_5_B5	-14.8355113	-20.69656804	6A	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1690	2904	0.008608815	0.004820937	4	6A	IN-PV	26	17	17
CTCTACGCAATGAAAC-1_5_B5	35.14045836	-14.21266421	2	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	4209	10085	0.011601388	0.023301934	4	2	EN-L4	26	17	17
CTCTACGCATTCACTT-1_5_B5	-15.07857666	-25.04039759	6A	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2137	5110	0.000978474	0.0037182	4	6A	IN-PV	26	17	17
CTCTACGTCAGTACGT-1_5_B5	-8.170772537	-15.60664448	6B	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	868	1251	0.014388489	0.009592326	4	6B	IN-SST	26	17	17
CTCTACGTCCGCTGTT-1_5_B5	14.97337607	-20.82027371	4	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	5359	15122	0.008133845	0.008464489	4	L2-3	EN-L2-3-MS	26	17	17
CTCTGGTCAAGCTGTT-1_5_B5	34.36805479	-14.13492768	2	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	4172	9907	0.009589179	0.012314525	4	2	EN-L4	26	17	17
CTCTGGTTCCAAATGC-1_5_B5	14.9189676	21.11370722	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1048	1691	0	0.003548196	4	oligos	OL-Cntl	26	17	17
CTCTGGTTCTGAAAGA-1_5_B5	-0.587230361	27.83840503	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	774	1153	0.001734605	0.00954033	4	oligos	OL-Cntl	26	17	17
CTGAAACAGCCACCTG-1_5_B5	17.77143847	8.056606373	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1847	3512	0.006833713	0.005694761	4	oligos	OL-Cntl	26	17	17
CTGAAACCAAGCCATT-1_5_B5	15.42379597	22.86502435	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1072	1735	0.002881844	0.006340058	4	oligos	OL-Cntl	26	17	17
CTGAAACCATGGTAGG-1_5_B5	-15.76187731	14.30888629	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1643	2689	0.000371885	0.013015991	4	8	Astrocytes	26	17	17
CTGAAACGTAAACCTC-1_5_B5	16.9889699	18.77488594	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1051	1758	0.001137656	0.00625711	4	oligos	OL-Cntl	26	17	17
CTGAAACTCATCATTC-1_5_B5	12.86317626	2.267475213	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	669	1003	0	0.010967099	4	12	EN-MIX	26	17	17
CTGAAACTCCCAGGTG-1_5_B5	15.14922524	15.50109167	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1276	2112	0.007102273	0.011363636	4	oligos	OL-Cntl	26	17	17
CTGAAACTCTGTGCAA-1_5_B5	17.3900823	13.02017655	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1435	2597	0.001540239	0.010396611	4	oligos	OL-Cntl	26	17	17
CTGAAGTAGCTTATCG-1_5_B5	2.225459491	24.92002793	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	733	1164	0.031786942	0.005154639	4	oligos	OL-Cntl	26	17	17
CTGAAGTAGTTATCGC-1_5_B5	37.07947066	12.23027066	14	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1061	1535	0.002605863	0.015635179	4	14	Microglia	26	17	17
CTGAAGTCACCCTATC-1_5_B5	20.7063664	11.04895343	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1474	2583	0.003484321	0.004645761	4	oligos	OL-Cntl	26	17	17
CTGAAGTCAGCTCGAC-1_5_B5	3.158603401	18.08533999	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	918	1442	0.001386963	0.0110957	4	oligos	OL-Cntl	26	17	17
CTGAAGTCATCTATGG-1_5_B5	-3.079570481	2.274689639	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1999	3439	0.00261704	0.006397208	4	11	Glia-MIX	26	17	17
CTGAAGTGTCATGCAT-1_5_B5	-2.632256469	2.643740333	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1840	2656	0.004141566	0.016942771	4	11	Glia-MIX	26	17	17
CTGATAGGTAGGCTGA-1_5_B5	-9.955578452	17.99979909	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2759	5045	0.002775025	0.006739346	4	11	Glia-MIX	26	17	17
CTGATAGGTTGCCTCT-1_5_B5	-8.197005396	-15.22738239	6B	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	771	1531	0.020248204	0.002612671	4	6B	IN-SST	26	17	17
CTGATCCCAGTAAGAT-1_5_B5	-6.02602314	4.218924333	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	6454	18750	0.002293333	0.009173333	4	11	Glia-MIX	26	17	17
CTGATCCCAGTACACT-1_5_B5	14.3663122	15.68260808	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1200	2001	0.008495752	0.006996502	4	oligos	OL-Cntl	26	17	17
CTGATCCGTATCGCAT-1_5_B5	-5.980403004	3.953080326	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	5115	13049	0.001685953	0.006284006	4	11	Glia-MIX	26	17	17
CTGATCCGTCTGATCA-1_5_B5	-6.017240611	4.190920056	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	4909	11391	0.002984813	0.008954438	4	11	Glia-MIX	26	17	17
CTGATCCGTTCCGTCT-1_5_B5	11.71826298	1.926646167	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	790	1127	0	0.016858917	4	12	EN-MIX	26	17	17
CTGATCCTCCGCGGTA-1_5_B5	-10.23399833	18.07215308	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	3268	6777	0.000885347	0.008263243	4	11	Glia-MIX	26	17	17
CTGCCTAAGATCCCGC-1_5_B5	13.7028919	11.37876216	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1453	2368	0.003800676	0.01097973	4	oligos	OL-Cntl	26	17	17
CTGCCTAAGCAATATG-1_5_B5	-36.55495769	1.695571811	9	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1934	4042	0.002968827	0.004453241	4	9	OPC	26	17	17
CTGCCTACAAGAAAGG-1_5_B5	1.984465707	19.94909476	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	914	1450	0.011034483	0.01862069	4	oligos	OL-Cntl	26	17	17
CTGCCTATCACCTCGT-1_5_B5	11.94607665	2.841952218	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1259	1917	0.00312989	0.011476265	4	12	EN-MIX	26	17	17
CTGCCTATCCATGCTC-1_5_B5	3.333600544	-5.61186693	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1018	1609	0.008701057	0.001864512	4	12	EN-MIX	26	17	17
CTGCCTATCGTGGTCG-1_5_B5	20.86659439	10.93555487	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1583	2970	0.003030303	0.008417508	4	oligos	OL-Cntl	26	17	17
CTGCCTATCTTACCTA-1_5_B5	-30.77769652	-12.14631366	9	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	897	1247	0.011226945	0.006415397	4	9	OPC	26	17	17
CTGCGGAAGTACGTAA-1_5_B5	13.34289433	22.4883976	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	882	1291	0.00464756	0.005422153	4	oligos	OL-Cntl	26	17	17
CTGCGGAAGTTACCCA-1_5_B5	10.08994672	19.49565987	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	995	1593	0.002510986	0.010671689	4	oligos	OL-Cntl	26	17	17
CTGCGGACACAACGTT-1_5_B5	34.86241687	-12.79531011	2	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	4056	9440	0.004661017	0.016419492	4	2	EN-L4	26	17	17
CTGCGGAGTGTAATGA-1_5_B5	15.069063	19.16245388	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1105	1857	0.001615509	0.008077544	4	oligos	OL-Cntl	26	17	17
CTGCGGATCATGTCCC-1_5_B5	12.79783776	18.15156658	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1094	1768	0.003959276	0.005090498	4	oligos	OL-Cntl	26	17	17
CTGCGGATCTTGTACT-1_5_B5	-0.512778227	4.593672366	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	778	1006	0.003976143	0.007952286	4	11	Glia-MIX	26	17	17
CTGCTGTCAGGGCATA-1_5_B5	17.13157424	-0.550697784	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	838	1214	0.009884679	0.004942339	4	12	EN-MIX	26	17	17
CTGCTGTGTCTAGTGT-1_5_B5	3.809037472	27.2839913	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	826	1297	0.00693909	0.00616808	4	oligos	OL-Cntl	26	17	17
CTGGTCTAGCTCCTCT-1_5_B5	17.63279142	1.286134531	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	937	1393	0.008614501	0.003589375	4	12	EN-MIX	26	17	17
CTGGTCTCACCACGTG-1_5_B5	-15.29400038	15.20990087	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2920	6560	0.000457317	0.011890244	4	8	Astrocytes	26	17	17
CTGGTCTCAGCTCGAC-1_5_B5	18.3362428	-22.12770741	3	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	6821	24095	0.006308363	0.013903299	4	3	EN-L5-6	26	17	17
CTGGTCTTCACAGTAC-1_5_B5	-13.31603323	4.566382465	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	3672	8354	0.004548719	0.011491501	4	8	Astrocytes	26	17	17
CTGTGCTGTATCAGTC-1_5_B5	-13.10210922	-23.72139428	6A	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1177	1769	0.015828151	0.001695873	4	6A	IN-PV	26	17	17
CTGTGCTGTGTTTGTG-1_5_B5	-4.483890962	2.769888056	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2809	5172	0.002706883	0.007347254	4	11	Glia-MIX	26	17	17
CTGTTTAGTCTCAACA-1_5_B5	17.30695155	15.12881022	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1146	2081	0.000961076	0.00528592	4	oligos	OL-Cntl	26	17	17
CTGTTTAGTGTATGGG-1_5_B5	20.61661552	-1.793362523	2	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1666	2902	0.018952447	0.008959338	4	2	EN-L4	26	17	17
CTTAACTGTTACTGAC-1_5_B5	20.79485401	15.46239107	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1092	1924	0.001039501	0.001559252	4	oligos	OL-Cntl	26	17	17
CTTAACTGTTGTCGCG-1_5_B5	-18.4319796	24.622919	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2044	3885	0.003603604	0.007464607	4	8	Astrocytes	26	17	17
CTTACCGCACAGGCCT-1_5_B5	-4.892277446	2.974658335	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	3063	6334	0.001894537	0.005367856	4	11	Glia-MIX	26	17	17
CTTACCGCAGGGTTAG-1_5_B5	11.42781938	1.803324859	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	977	1332	0.005255255	0.015765766	4	12	EN-MIX	26	17	17
CTTACCGGTAATCGTC-1_5_B5	-34.79548475	-0.170460909	9	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1518	2720	0.002573529	0.010294118	4	9	OPC	26	17	17
CTTACCGGTATGAATG-1_5_B5	-32.14042277	1.440249916	9	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2121	4430	0.011738149	0.005191874	4	9	OPC	26	17	17
CTTACCGGTCTAAACC-1_5_B5	-36.76286667	1.594108608	9	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1689	3277	0.001220629	0.000915471	4	9	OPC	26	17	17
CTTACCGTCCCTAACC-1_5_B5	13.72809182	16.71463168	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1182	1998	0.008008008	0.005005005	4	oligos	OL-Cntl	26	17	17
CTTAGGATCCCTAACC-1_5_B5	11.22160769	-1.550045866	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1360	2054	0.00097371	0.019474197	4	12	EN-MIX	26	17	17
CTTAGGATCCGCATCT-1_5_B5	3.853514586	-3.616968642	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	938	1447	0.00138217	0.00691085	4	12	EN-MIX	26	17	17
CTTAGGATCTTCGAGA-1_5_B5	8.591532517	-15.17192362	4	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	3194	7036	0.016913019	0.005827175	4	L2-3	EN-L2-3-MS	26	17	17
CTTCTCTAGGCGATAC-1_5_B5	-31.87055252	-9.055394378	9	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1061	1629	0.014119091	0.012277471	4	9	OPC	26	17	17
CTTCTCTCAAGTCATC-1_5_B5	14.95301216	22.22669368	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	888	1488	0.001344086	0.004032258	4	oligos	OL-Cntl	26	17	17
CTTCTCTCACAACGCC-1_5_B5	11.30418078	-0.779884751	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1505	2745	0.006557377	0.009107468	4	12	EN-MIX	26	17	17
CTTCTCTCATGAGCGA-1_5_B5	-15.73086587	10.72220054	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1339	2375	0.000842105	0.009263158	4	8	Astrocytes	26	17	17
CTTCTCTCATGTTCCC-1_5_B5	-16.33253293	-19.9665462	6B	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1889	3798	0.018957346	0.003686151	4	6B	IN-SST	26	17	17
CTTCTCTGTCCCTACT-1_5_B5	-3.116939251	-9.074246296	6B	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	769	1297	0.00539707	0.00385505	4	6B	IN-SST	26	17	17
CTTCTCTTCCAAGTAC-1_5_B5	12.71110119	26.05036982	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	702	1123	0.007123776	0.00890472	4	oligos	OL-Cntl	26	17	17
CTTCTCTTCCCTAACC-1_5_B5	12.04529765	3.001610264	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	967	1483	0.002022927	0.005394471	4	12	EN-MIX	26	17	17
CTTCTCTTCCCTCTTT-1_5_B5	15.66442204	19.91901139	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1005	1823	0.011519473	0.004388371	4	oligos	OL-Cntl	26	17	17
CTTCTCTTCCGCAAGC-1_5_B5	13.11707205	13.26998471	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1329	2312	0.00216263	0.008217993	4	oligos	OL-Cntl	26	17	17
CTTCTCTTCTGTCTAT-1_5_B5	1.045445097	0.955022603	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	726	1076	0.003717472	0.006505576	4	12	EN-MIX	26	17	17
CTTCTCTTCTTAGAGC-1_5_B5	15.43076888	-7.777086782	10	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2213	4801	0.002707769	0.009581337	4	L2-3	EN-L2-3-Cntl	26	17	17
CTTGGCTGTACTTCTT-1_5_B5	-9.554293959	22.12867253	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	736	1000	0.004	0.013	4	8	Astrocytes	26	17	17
CTTGGCTGTTGGAGGT-1_5_B5	13.37472661	-2.576389134	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1287	1936	0.00981405	0.008264463	4	12	EN-MIX	26	17	17
CTTGGCTTCAACACAC-1_5_B5	35.63458316	7.782847931	14	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	751	1058	0	0.001890359	4	14	Microglia	26	17	17
CTTGGCTTCATTGCGA-1_5_B5	-16.69013464	-17.84297571	6B	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1921	4075	0.001717791	0.002699387	4	6B	IN-SST	26	17	17
CTTGGCTTCGAATCCA-1_5_B5	14.2288927	25.99490155	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	819	1344	0.004464286	0.001488095	4	oligos	OL-Cntl	26	17	17
CTTGGCTTCTTGGGTA-1_5_B5	19.89192135	-23.11663502	3	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	5252	16199	0.001851966	0.01006235	4	3	EN-L5-6	26	17	17
CTTTGCGAGAAACGCC-1_5_B5	-8.356307617	-12.09799883	6B	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	818	1046	0.028680688	0.024856597	4	6B	IN-SST	26	17	17
CTTTGCGAGGCATGTG-1_5_B5	-12.51064458	0.816760874	13A	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	3733	9280	0.007866379	0.004849138	4	13A	IN-VIP	26	17	17
CTTTGCGCAATGAATG-1_5_B5	-15.39947202	11.97618449	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1619	2842	0.001055595	0.008092892	4	8	Astrocytes	26	17	17
CTTTGCGCACGCGAAA-1_5_B5	17.65133531	15.29295594	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1159	2112	0.004261364	0.003314394	4	oligos	OL-Cntl	26	17	17
GAAACTCAGCGTTGCC-1_5_B5	4.988137075	5.333410205	7	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2035	3501	0.001713796	0.00428449	4	7	Phagocytes	26	17	17
GAAACTCAGCTCCCAG-1_5_B5	-0.452244656	29.03385	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	979	1481	0.002025658	0.006076975	4	oligos	OL-Cntl	26	17	17
GAAACTCAGTTAAGTG-1_5_B5	-33.34570668	-1.790462193	9	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1662	3137	0.002550207	0.003187759	4	9	OPC	26	17	17
GAAACTCCAATAGCAA-1_5_B5	10.83065492	20.76678137	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	947	1565	0.001277955	0.005111821	4	oligos	OL-Cntl	26	17	17
GAAATGACATCCTTGC-1_5_B5	-27.5955785	4.333299648	9	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2595	5640	0.003368794	0.005496454	4	9	OPC	26	17	17
GAACATCAGACTACAA-1_5_B5	-15.14591719	-25.47065099	6A	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1756	3747	0	0.00053376	4	6A	IN-PV	26	17	17
GAACATCCATGTCTCC-1_5_B5	6.656940452	-1.149498181	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	758	1008	0.006944444	0.021825397	4	12	EN-MIX	26	17	17
GAACATCCATTAGGCT-1_5_B5	-5.987647936	3.867715176	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	5636	16304	0.00251472	0.006562807	4	11	Glia-MIX	26	17	17
GAACATCCATTCGACA-1_5_B5	18.33089496	12.57468773	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1343	2372	0.006745363	0.003372681	4	oligos	OL-Cntl	26	17	17
GAACATCGTACTTAGC-1_5_B5	14.68633578	7.419146727	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1890	3514	0.001992032	0.012521343	4	oligos	OL-Cntl	26	17	17
GAACATCTCGTTACAG-1_5_B5	13.79204392	11.74625036	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1309	2157	0.002318034	0.01483542	4	oligos	OL-Cntl	26	17	17
GAACATCTCTCGCTTG-1_5_B5	10.33817035	0.855797202	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1085	1654	0.015719468	0.019347037	4	12	EN-MIX	26	17	17
GAACATCTCTGTTTGT-1_5_B5	1.807053101	21.42476191	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	801	1135	0.006167401	0.012334802	4	oligos	OL-Cntl	26	17	17
GAACCTAAGGAATCGC-1_5_B5	14.58418099	-19.73517106	4	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	4570	12302	0.006828158	0.009348073	4	L2-3	EN-L2-3-MS	26	17	17
GAACCTACAATCCAAC-1_5_B5	13.88251684	-3.704881845	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1346	2270	0.004845815	0.011013216	4	12	EN-MIX	26	17	17
GAACCTACACGGCGTT-1_5_B5	8.371982708	12.09451146	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1161	1930	0.006735751	0.014507772	4	oligos	OL-Cntl	26	17	17
GAACCTACAGGACGTA-1_5_B5	12.4100629	12.46113269	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1305	2235	0.0098434	0.008501119	4	oligos	OL-Cntl	26	17	17
GAACCTACATAACCTG-1_5_B5	12.46873384	18.06588816	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1111	1897	0.000527148	0.004217185	4	oligos	OL-Cntl	26	17	17
GAACCTAGTACCGTTA-1_5_B5	1.143715512	25.967231	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	758	1137	0.002638522	0.00351803	4	oligos	OL-Cntl	26	17	17
GAACCTATCAGCAACT-1_5_B5	0.268876131	25.16089392	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	739	1071	0.014005602	0.008403361	4	oligos	OL-Cntl	26	17	17
GAACCTATCTGGCGTG-1_5_B5	9.950082084	7.858976319	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1617	3040	0.013157895	0.023026316	4	oligos	OL-Cntl	26	17	17
GAACGGACAAGTCTGT-1_5_B5	-4.128443749	2.942027951	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	3016	5611	0.002316878	0.00659419	4	11	Glia-MIX	26	17	17
GAACGGACACAGACTT-1_5_B5	-22.43026393	-16.97817024	6A	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	4985	15018	0.008389932	0.008523106	4	6A	IN-PV	26	17	17
GAACGGACATTATCTC-1_5_B5	16.74042679	10.38700619	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1532	2704	0.009245562	0.007026627	4	oligos	OL-Cntl	26	17	17
GAACGGAGTAGGAGTC-1_5_B5	-4.670238571	3.451471899	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	3538	7083	0.003247212	0.007059156	4	11	Glia-MIX	26	17	17
GAACGGAGTCAAAGAT-1_5_B5	17.58615763	1.673002945	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	926	1305	0.004597701	0.002298851	4	12	EN-MIX	26	17	17
GAACGGATCCTTGGTC-1_5_B5	23.13867915	18.62899308	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1183	1854	0	0.00377562	4	oligos	OL-Cntl	26	17	17
GAACGGATCGTTTATC-1_5_B5	14.69736101	17.66703675	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1008	1639	0.001830384	0.009151922	4	oligos	OL-Cntl	26	17	17
GAAGCAGCAGAAGCAC-1_5_B5	5.015130933	19.12359632	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1090	1749	0.010291595	0.006861063	4	oligos	OL-Cntl	26	17	17
GAAGCAGGTGCGAAAC-1_5_B5	-2.624276524	2.411797967	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1972	3066	0.003261579	0.010110894	4	11	Glia-MIX	26	17	17
GAAGCAGGTTGTTTGG-1_5_B5	16.16264954	14.28517984	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1213	2099	0.009528347	0.009528347	4	oligos	OL-Cntl	26	17	17
GAAGCAGTCTTCGAGA-1_5_B5	13.62823271	16.36180868	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1205	2008	0.003984064	0.006972112	4	oligos	OL-Cntl	26	17	17
GAATAAGGTCTCTCGT-1_5_B5	-7.880415958	8.022030633	5	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	751	1120	0.007142857	0.020535714	4	oligos	OL-MS-1	26	17	17
GAATAAGGTTACCAGT-1_5_B5	-7.092591317	8.754252357	5	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	707	1056	0.002840909	0.024621212	4	oligos	OL-MS-1	26	17	17
GAATGAAAGCCCAACC-1_5_B5	9.812203184	-3.819209295	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1894	2896	0.027969613	0.026933702	4	12	EN-MIX	26	17	17
GAATGAACAATGCCAT-1_5_B5	1.608451482	25.36837797	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	705	1057	0.004730369	0.008514664	4	oligos	OL-Cntl	26	17	17
GAATGAACACAACGTT-1_5_B5	21.60867703	14.72884629	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1333	2296	0.00087108	0.005226481	4	oligos	OL-Cntl	26	17	17
GAATGAAGTAGCCTAT-1_5_B5	4.774587383	23.2568164	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	895	1394	0.003586801	0.008608321	4	oligos	OL-Cntl	26	17	17
GAATGAAGTCTCATCC-1_5_B5	20.94087702	7.925456823	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2076	4177	0.002394063	0.006224563	4	oligos	OL-Cntl	26	17	17
GAATGAATCACAGGCC-1_5_B5	11.98836071	1.027623699	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	751	1015	0.006896552	0.007881773	4	12	EN-MIX	26	17	17
GAATGAATCGCCAAAT-1_5_B5	12.31954691	0.438878707	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	923	1362	0.002936858	0.030837004	4	12	EN-MIX	26	17	17
GAATGAATCTCGCTTG-1_5_B5	2.181249538	21.6992733	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	915	1435	0.002787456	0.006271777	4	oligos	OL-Cntl	26	17	17
GACACGCAGAGACTTA-1_5_B5	9.206695245	-18.72890616	4	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	5098	14339	0.002650115	0.009414882	4	L2-3	EN-L2-3-MS	26	17	17
GACACGCAGCTCTCGG-1_5_B5	-16.09085982	12.35425552	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1310	2008	0.004482072	0.011952191	4	8	Astrocytes	26	17	17
GACACGCAGGCTCAGA-1_5_B5	6.436061972	-3.07176833	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1422	2196	0.009107468	0.015938069	4	12	EN-MIX	26	17	17
GACACGCCACATTAGC-1_5_B5	13.90848351	26.42135188	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	804	1303	0.003837299	0.003837299	4	oligos	OL-Cntl	26	17	17
GACACGCTCACTCCTG-1_5_B5	16.74484182	-5.256034545	3	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1559	2767	0	0.01770871	4	3	EN-L5-6	26	17	17
GACAGAGAGAAGCCCA-1_5_B5	16.88455376	-0.697151115	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	714	1015	0.002955665	0	4	12	EN-MIX	26	17	17
GACAGAGCATTTGCCC-1_5_B5	15.32373902	-1.541877242	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	981	1538	0	0.003250975	4	12	EN-MIX	26	17	17
GACAGAGGTTGTGGAG-1_5_B5	15.23781591	-2.182476509	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	935	1388	0.001440922	0.005763689	4	12	EN-MIX	26	17	17
GACAGAGTCAGCGACC-1_5_B5	-30.43970727	-12.43703181	9	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	868	1202	0.003327787	0.009151414	4	9	OPC	26	17	17
GACAGAGTCCGAACGC-1_5_B5	-3.251073722	9.681691094	5	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	967	1513	0.007931262	0.033707865	4	oligos	OL-MS-1	26	17	17
GACAGAGTCCGGGTGT-1_5_B5	5.899611261	26.35524571	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	891	1270	0.005511811	0.01023622	4	oligos	OL-Cntl	26	17	17
GACAGAGTCTGAGGGA-1_5_B5	-15.26873079	15.23668002	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2354	4300	0.00255814	0.010232558	4	8	Astrocytes	26	17	17
GACCAATAGGCTCAGA-1_5_B5	-19.48478934	24.49439783	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1982	3946	0.001267106	0.012164217	4	8	Astrocytes	26	17	17
GACCAATCACGGTTTA-1_5_B5	-9.037465007	13.72722373	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1427	2209	0.003621548	0.005432322	4	oligos	OL-Cntl	26	17	17
GACCAATCACTACAGT-1_5_B5	5.668382384	-19.57186118	4	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	3651	8627	0.002318303	0.009620957	4	L2-3	EN-L2-3-MS	26	17	17
GACCTGGAGACCTAGG-1_5_B5	-15.18430991	-9.430620322	13B	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2293	4528	0.004416961	0.005079505	4	13B	IN-SV2C	26	17	17
GACCTGGAGCGGATCA-1_5_B5	-1.50763096	-1.11261668	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	3674	8773	0.005585319	0.007523082	4	11	Glia-MIX	26	17	17
GACCTGGCAAAGGCGT-1_5_B5	13.0182393	19.74635336	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1123	1748	0.003432494	0.00228833	4	oligos	OL-Cntl	26	17	17
GACCTGGGTAAGTGTA-1_5_B5	36.73016656	14.22885701	14	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1370	2080	0.012980769	0.018269231	4	14	Microglia	26	17	17
GACCTGGGTAGCTAAA-1_5_B5	14.1133314	7.736006235	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1771	3189	0.01661963	0.012543117	4	oligos	OL-Cntl	26	17	17
GACCTGGTCTAACTTC-1_5_B5	-5.466051426	3.451593101	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	3708	8211	0.001461454	0.006576544	4	11	Glia-MIX	26	17	17
GACCTGGTCTTCCTTC-1_5_B5	18.99365486	21.18229816	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1018	1949	0.002565418	0.002565418	4	oligos	OL-Cntl	26	17	17
GACGCGTCAGCCTGTG-1_5_B5	-27.98460871	0.642916213	9	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2000	3761	0	0.011167243	4	9	OPC	26	17	17
GACGCGTCATTTGCCC-1_5_B5	-5.956495764	4.244954468	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	4773	11075	0.002257336	0.007494357	4	11	Glia-MIX	26	17	17
GACGCGTGTTACAGAA-1_5_B5	8.465808327	18.98851552	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1222	1900	0.002631579	0.012631579	4	oligos	OL-Cntl	26	17	17
GACGCGTTCACCGTAA-1_5_B5	0.52756433	1.87642414	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	792	1057	0.002838221	0.008514664	4	11	Glia-MIX	26	17	17
GACGCGTTCATAGCAC-1_5_B5	-5.696169904	3.938762489	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	4581	10419	0.002399463	0.007582302	4	11	Glia-MIX	26	17	17
GACGGCTAGTCTCGGC-1_5_B5	5.155800642	13.84264218	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1100	1600	0.0025	0.013125	4	oligos	OL-Cntl	26	17	17
GACGGCTCAGTAAGAT-1_5_B5	-0.538227591	4.799498703	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	812	1075	0.002790698	0.012093023	4	11	Glia-MIX	26	17	17
GACGGCTCATGATCCA-1_5_B5	15.52214311	-5.302759701	10	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1230	2118	0.007554297	0.001416431	4	L2-3	EN-L2-3-Cntl	26	17	17
GACGGCTGTGAGTATA-1_5_B5	18.94479342	-26.50116786	3	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	3889	9606	0.001561524	0.011555278	4	3	EN-L5-6	26	17	17
GACGGCTGTTCACGGC-1_5_B5	-15.11404003	17.05236563	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2132	4323	0.002544529	0.009946796	4	8	Astrocytes	26	17	17
GACGTGCAGATAGGAG-1_5_B5	6.667997331	18.9723944	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	999	1545	0.003883495	0.020064725	4	oligos	OL-Cntl	26	17	17
GACGTGCCAATTGCTG-1_5_B5	-2.356486583	24.22653369	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	839	1126	0.008880995	0.007992895	4	oligos	OL-Cntl	26	17	17
GACGTGCCAGGAATCG-1_5_B5	-0.707292959	21.15732748	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	763	1116	0.001792115	0.009856631	4	oligos	OL-Cntl	26	17	17
GACGTGCCATTACGAC-1_5_B5	-11.66707666	-21.58105671	6B	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1025	1650	0.043030303	0.003030303	4	6B	IN-SST	26	17	17
GACGTGCGTGATAAGT-1_5_B5	-0.581816087	4.803045659	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	831	1057	0.003784295	0.018921476	4	11	Glia-MIX	26	17	17
GACGTGCTCGGCATCG-1_5_B5	6.812591039	-2.276763571	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1267	2044	0.01369863	0.016144814	4	12	EN-MIX	26	17	17
GACGTGCTCGTAGGAG-1_5_B5	37.07104907	9.097564129	14	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	813	1027	0.00097371	0.010710808	4	14	Microglia	26	17	17
GACGTGCTCTAACCGA-1_5_B5	-1.520227096	19.67143301	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	814	1251	0.005595524	0.019984013	4	oligos	OL-Cntl	26	17	17
GACGTTAAGACTAGAT-1_5_B5	21.08449217	14.75396688	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1249	2108	0.00426945	0.00426945	4	oligos	OL-Cntl	26	17	17
GACGTTACAATAGAGT-1_5_B5	0.854050997	25.63118196	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	745	1069	0.002806361	0.005612722	4	oligos	OL-Cntl	26	17	17
GACGTTACAGCTCCGA-1_5_B5	15.84217101	17.92928986	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1074	1781	0.001122965	0.008983717	4	oligos	OL-Cntl	26	17	17
GACGTTAGTATGGTTC-1_5_B5	19.07330586	15.04301668	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1124	1801	0.004997224	0.005552471	4	oligos	OL-Cntl	26	17	17
GACGTTAGTCAATACC-1_5_B5	6.017975383	18.15874865	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	909	1411	0.004961021	0.01275691	4	oligos	OL-Cntl	26	17	17
GACGTTAGTGTGAATA-1_5_B5	-1.622126406	2.908523706	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1394	2018	0.001982161	0.010406343	4	11	Glia-MIX	26	17	17
GACGTTAGTGTGGTTT-1_5_B5	14.95048282	18.19706336	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1093	1793	0.005577245	0.010039041	4	oligos	OL-Cntl	26	17	17
GACTAACGTGACGGTA-1_5_B5	6.012282573	16.82410442	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1075	1707	0.000585823	0.009958992	4	oligos	OL-Cntl	26	17	17
GACTAACTCAACGAAA-1_5_B5	14.03648794	-4.083054433	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1531	2432	0.002878289	0.020148026	4	12	EN-MIX	26	17	17
GACTAACTCTTATCTG-1_5_B5	-4.72198331	2.92801457	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2877	5715	0.00279965	0.007174103	4	11	Glia-MIX	26	17	17
GACTAACTCTTTAGGG-1_5_B5	-20.3783655	23.85100611	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1778	3460	0.006069364	0.010404624	4	8	Astrocytes	26	17	17
GACTACAGTCCGTTAA-1_5_B5	-13.0871947	-0.247907985	13A	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2797	5550	0.014774775	0.007927928	4	13A	IN-VIP	26	17	17
GACTACATCGGTTCGG-1_5_B5	39.91609681	14.2398397	14	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1244	1813	0.001654716	0.006067292	4	14	Microglia	26	17	17
GACTGCGAGTTAGCGG-1_5_B5	-3.720493957	2.679653273	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2761	4729	0.003171918	0.009515754	4	11	Glia-MIX	26	17	17
GACTGCGCATGAGCGA-1_5_B5	2.639596775	-3.211140646	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	721	1044	0.001915709	0.001915709	4	12	EN-MIX	26	17	17
GACTGCGGTTACGCGC-1_5_B5	8.127373842	3.3748285	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1119	1467	0.00408998	0.024539877	4	12	EN-MIX	26	17	17
GACTGCGTCGACGGAA-1_5_B5	1.382215446	21.89575608	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	836	1208	0.003311258	0.014900662	4	oligos	OL-Cntl	26	17	17
GAGCAGAAGATGCCAG-1_5_B5	-8.363307557	-12.26814554	6B	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	840	1101	0.025431426	0.02270663	4	6B	IN-SST	26	17	17
GAGCAGACAAGTTCTG-1_5_B5	15.86028009	-1.150107245	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	722	1074	0.003724395	0.000931099	4	12	EN-MIX	26	17	17
GAGCAGAGTAATCGTC-1_5_B5	-24.34449825	6.163038904	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	835	1399	0.003573981	0.011436741	4	8	Astrocytes	26	17	17
GAGCAGAGTAGTACCT-1_5_B5	10.26414239	0.333272321	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1060	1391	0.028037383	0.017253774	4	12	EN-MIX	26	17	17
GAGCAGATCCAAGCCG-1_5_B5	13.63734891	0.662505016	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	739	1039	0.008662175	0.00481232	4	12	EN-MIX	26	17	17
GAGGTGAAGATCTGCT-1_5_B5	-5.408282111	3.696572279	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	4080	8975	0.002339833	0.008245125	4	11	Glia-MIX	26	17	17
GAGGTGAAGGATGCGT-1_5_B5	12.96407526	15.58759152	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1246	2037	0.000490918	0.013745704	4	oligos	OL-Cntl	26	17	17
GAGGTGACAGCTCGCA-1_5_B5	39.50483292	14.32235097	14	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1210	1804	0.002217295	0.013858093	4	14	Microglia	26	17	17
GAGGTGAGTTAGAACA-1_5_B5	2.636447274	29.94484538	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	748	1062	0.001883239	0.006591337	4	oligos	OL-Cntl	26	17	17
GAGGTGATCGATGAGG-1_5_B5	-27.13404262	-11.88150212	9	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1131	1616	0.004950495	0.040222772	4	9	OPC	26	17	17
GAGGTGATCGCTTGTC-1_5_B5	8.622519576	0.351146865	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1146	1545	0.009708738	0.042718447	4	12	EN-MIX	26	17	17
GAGGTGATCTTCAACT-1_5_B5	-2.514281849	14.86087999	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	698	1059	0.005665722	0.023607177	4	oligos	OL-Cntl	26	17	17
GAGTCCGAGAACAACT-1_5_B5	4.427985492	-14.20712078	4	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2411	4715	0.006574761	0.005514316	4	L2-3	EN-L2-3-MS	26	17	17
GAGTCCGAGTGAATTG-1_5_B5	-2.750094556	23.96951381	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	809	1140	0.004385965	0.016666667	4	oligos	OL-Cntl	26	17	17
GATCAGTAGCTACCTA-1_5_B5	-36.7250893	-5.103709883	9	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1294	2192	0.001368613	0.003193431	4	9	OPC	26	17	17
GATCAGTGTCGCATAT-1_5_B5	17.96277278	7.555526818	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1881	3667	0.001363512	0.009271884	4	oligos	OL-Cntl	26	17	17
GATCGATAGGACTGGT-1_5_B5	-18.92790631	24.91581275	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2106	4176	0.000957854	0.010057471	4	8	Astrocytes	26	17	17
GATCGATGTCGAAAGC-1_5_B5	-4.739405924	3.155078807	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	3075	5723	0.003145204	0.008736677	4	11	Glia-MIX	26	17	17
GATCGATGTTCATGGT-1_5_B5	-11.1887721	16.70834707	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2162	3921	0.001020148	0.005865851	4	11	Glia-MIX	26	17	17
GATCGATTCAAGCCTA-1_5_B5	17.64442839	-0.049303956	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	963	1464	0.004781421	0.00273224	4	12	EN-MIX	26	17	17
GATCGATTCAGTACGT-1_5_B5	-32.44134755	-3.606900846	9	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1282	2071	0.000965717	0.021728634	4	9	OPC	26	17	17
GATCGATTCCGTACAA-1_5_B5	-3.718399116	2.565620929	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2480	4277	0.002104279	0.00748188	4	11	Glia-MIX	26	17	17
GATCGATTCGCATGGC-1_5_B5	18.0690918	7.471005911	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1991	3960	0.001515152	0.012121212	4	oligos	OL-Cntl	26	17	17
GATCGATTCGGATGGA-1_5_B5	17.42837344	6.7195038	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2194	4379	0.001141813	0.01210322	4	oligos	OL-Cntl	26	17	17
GATCGCGAGCGTGAAC-1_5_B5	14.03165718	16.73768838	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1101	1798	0.003893215	0.010011123	4	oligos	OL-Cntl	26	17	17
GATCGCGCAGCTGGCT-1_5_B5	35.11083384	-14.04773963	2	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	4362	10700	0.008691589	0.019252336	4	2	EN-L4	26	17	17
GATCGCGGTCCTCTTG-1_5_B5	10.91289598	0.903851561	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	910	1270	0.018897638	0.015748031	4	12	EN-MIX	26	17	17
GATCGCGGTGGTCCGT-1_5_B5	-1.1801571	3.324397064	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1179	1648	0.003640777	0.007281553	4	11	Glia-MIX	26	17	17
GATCGCGGTTAAGGGC-1_5_B5	7.886211287	19.80622897	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1081	1635	0.006116208	0.009785933	4	oligos	OL-Cntl	26	17	17
GATCGCGGTTAGGGTG-1_5_B5	1.372788336	1.026201227	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1297	1830	0.009836066	0.006557377	4	12	EN-MIX	26	17	17
GATCGCGTCAATCTCT-1_5_B5	4.587446629	13.06778501	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1101	1709	0.00234055	0.01638385	4	oligos	OL-Cntl	26	17	17
GATCGTAAGAGCCCAA-1_5_B5	7.944300995	1.316565781	16	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	898	1125	0.011555556	0.049777778	4	16	EN-PYR	26	17	17
GATCGTAAGCAACGGT-1_5_B5	10.60596216	15.34328244	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1165	1892	0.001585624	0.007928118	4	oligos	OL-Cntl	26	17	17
GATCGTAAGTCTCCTC-1_5_B5	1.160306981	0.985768563	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	791	1028	0.003891051	0.004863813	4	12	EN-MIX	26	17	17
GATCGTACACGGCTAC-1_5_B5	-28.2647187	0.124580202	9	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1805	3191	0.004073958	0.016922595	4	9	OPC	26	17	17
GATCGTACATACAGCT-1_5_B5	38.42818795	16.02378291	14	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1478	2396	0.010434057	0.019198664	4	14	Microglia	26	17	17
GATCGTAGTTCCACTC-1_5_B5	-5.298303059	3.52274403	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	3927	8674	0.002190454	0.005764353	4	11	Glia-MIX	26	17	17
GATCGTATCCCAACGG-1_5_B5	24.03096016	-22.3871705	3	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	4315	10831	0.003600776	0.010433016	4	3	EN-L5-6	26	17	17
GATCGTATCGTGGGAA-1_5_B5	9.426726804	14.50322624	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1104	1732	0.001732102	0.01039261	4	oligos	OL-Cntl	26	17	17
GATCGTATCTATCGCC-1_5_B5	-0.520927339	4.526944266	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	777	1078	0.001855288	0.005565863	4	11	Glia-MIX	26	17	17
GATCTAGAGAAGAAGC-1_5_B5	16.969935	-0.046729835	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	710	1003	0	0	4	12	EN-MIX	26	17	17
GATCTAGCACATTTCT-1_5_B5	13.50587165	27.86676454	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	745	1227	0.006519967	0.001629992	4	oligos	OL-Cntl	26	17	17
GATCTAGCACGGCTAC-1_5_B5	-3.64310033	2.603239597	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2572	4657	0.003865149	0.00837449	4	11	Glia-MIX	26	17	17
GATCTAGTCACCACCT-1_5_B5	25.71417542	-28.710501	3	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	5521	20734	4.82E-05	0.003761937	4	3	EN-L5-6	26	17	17
GATGAAAAGATGCCTT-1_5_B5	16.00961331	17.70562974	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1076	1720	0.002906977	0.003488372	4	oligos	OL-Cntl	26	17	17
GATGAAAAGGTTACCT-1_5_B5	-31.17866448	-10.28183707	9	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	947	1381	0	0.017378711	4	9	OPC	26	17	17
GATGAAACAACGATCT-1_5_B5	-3.050796507	2.296616289	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2002	3345	0.002092676	0.00568012	4	11	Glia-MIX	26	17	17
GATGAAACACCACCAG-1_5_B5	10.19150419	0.615228103	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1018	1358	0.020618557	0.01988218	4	12	EN-MIX	26	17	17
GATGAAAGTAGATTAG-1_5_B5	-4.529373286	3.563499799	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	3242	6138	0.00325839	0.009449332	4	11	Glia-MIX	26	17	17
GATGAAATCGCACTCT-1_5_B5	-3.001220783	2.252402128	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2076	3509	0.005129667	0.007409518	4	11	Glia-MIX	26	17	17
GATGAGGAGTGAACGC-1_5_B5	18.5386532	15.8499032	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1252	2169	0.001844168	0.007376671	4	oligos	OL-Cntl	26	17	17
GATGAGGCAGACACTT-1_5_B5	-17.2825891	18.31055419	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2001	4341	0.002533978	0.007832297	4	8	Astrocytes	26	17	17
GATGAGGCATGCTGGC-1_5_B5	16.52530113	9.29536853	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1603	2690	0.001858736	0.011152416	4	oligos	OL-Cntl	26	17	17
GATGAGGCATTGCGGC-1_5_B5	21.56519008	10.98762186	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1675	2970	0.004040404	0.006060606	4	oligos	OL-Cntl	26	17	17
GATGAGGGTTAGGGTG-1_5_B5	1.887746389	22.20753477	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	918	1444	0.013157895	0.008310249	4	oligos	OL-Cntl	26	17	17
GATGAGGTCCAATGGT-1_5_B5	30.10180629	16.0251743	14	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1285	2129	0.003757633	0.137153593	4	14	Microglia	26	17	17
GATGCTAAGATCCCGC-1_5_B5	-3.291123591	2.537460231	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2367	3922	0.004844467	0.011218766	4	11	Glia-MIX	26	17	17
GATGCTAAGTAGGCCA-1_5_B5	37.8056448	13.14584069	14	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1084	1474	0.006784261	0.016282225	4	14	Microglia	26	17	17
GATGCTAAGTAGGTGC-1_5_B5	39.5577176	14.49457663	14	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1271	1844	0.002169197	0.00867679	4	14	Microglia	26	17	17
GATGCTAGTACCTACA-1_5_B5	11.92168549	3.072835379	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1304	1858	0.001614639	0.010764263	4	12	EN-MIX	26	17	17
GATGCTAGTCTGCAAT-1_5_B5	18.27161481	-23.26361501	3	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	4023	9839	0.009655453	0.030185995	4	3	EN-L5-6	26	17	17
GATGCTATCCACTCCA-1_5_B5	2.661429071	-3.467494948	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	761	1103	0.00543971	0	4	12	EN-MIX	26	17	17
GATGCTATCCTGTACC-1_5_B5	14.59876664	-5.532840018	3	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1818	3103	0.001933613	0.010634869	4	3	EN-L5-6	26	17	17
GATTCAGCAAGTTGTC-1_5_B5	-19.63086822	24.51149668	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1614	3110	0.000643087	0.010932476	4	8	Astrocytes	26	17	17
GATTCAGCACCAACCG-1_5_B5	-15.44657088	15.04899078	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2225	4545	0.000220022	0.003960396	4	8	Astrocytes	26	17	17
GATTCAGGTACAGTTC-1_5_B5	-7.242117483	9.52568051	5	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	810	1158	0.018134715	0.023316062	4	oligos	OL-MS-1	26	17	17
GATTCAGTCCACTCCA-1_5_B5	15.69206009	-1.36722375	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	786	1170	0.005982906	0.001709402	4	12	EN-MIX	26	17	17
GATTCAGTCTATCCTA-1_5_B5	5.895063763	16.37879469	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1059	1646	0.006682868	0.010935601	4	oligos	OL-Cntl	26	17	17
GCAAACTCACGGTAGA-1_5_B5	10.91822479	-2.093260552	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1578	2387	0.007959782	0.031839129	4	12	EN-MIX	26	17	17
GCAAACTGTACCGGCT-1_5_B5	-33.89304004	-4.410202	9	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1350	2117	0.001889466	0.005196032	4	9	OPC	26	17	17
GCAAACTGTGGTAACG-1_5_B5	-2.319650494	2.48374658	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1588	2426	0.00370981	0.006183017	4	11	Glia-MIX	26	17	17
GCAAACTGTGTGTGCC-1_5_B5	-5.697534642	3.801709614	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	4660	11097	0.001171488	0.00648824	4	11	Glia-MIX	26	17	17
GCAAACTGTGTTTGTG-1_5_B5	7.198735183	27.18279542	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	866	1254	0.00877193	0.003189793	4	oligos	OL-Cntl	26	17	17
GCAATCACAAGCCGTC-1_5_B5	-33.55658276	-9.388126434	9	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1049	1556	0.002570694	0.003856041	4	9	OPC	26	17	17
GCAATCACAGCGATCC-1_5_B5	6.662416183	-1.51010177	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	856	1138	0.005272408	0.014938489	4	12	EN-MIX	26	17	17
GCAATCACAGCTGCAC-1_5_B5	15.60455485	15.33065797	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1280	2062	0.012124151	0.007274491	4	oligos	OL-Cntl	26	17	17
GCAATCACATCCGTGG-1_5_B5	15.38266684	23.67660027	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	973	1670	0.001796407	0.005988024	4	oligos	OL-Cntl	26	17	17
GCAATCAGTATCACCA-1_5_B5	-35.01522089	5.076514029	9	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2989	7116	0.002107926	0.002670039	4	9	OPC	26	17	17
GCACATAAGAAACCGC-1_5_B5	-15.71651775	12.05484177	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1480	2202	0.000908265	0.011807448	4	8	Astrocytes	26	17	17
GCACATAAGGCAGTCA-1_5_B5	19.99802099	15.16448018	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1255	2193	0.001823985	0.004103967	4	oligos	OL-Cntl	26	17	17
GCACATAAGGCTAGGT-1_5_B5	-9.351098935	12.86972947	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1100	1539	0.001299545	0.012995452	4	oligos	OL-Cntl	26	17	17
GCACATACAAGTTAAG-1_5_B5	8.817872395	0.535819316	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	965	1254	0.011961722	0.035087719	4	12	EN-MIX	26	17	17
GCACATACACATTAGC-1_5_B5	16.2170604	12.00528453	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1460	2527	0.001582905	0.008310249	4	oligos	OL-Cntl	26	17	17
GCACATACACGAAATA-1_5_B5	16.38966518	21.6516059	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	933	1488	0.003360215	0.007392473	4	oligos	OL-Cntl	26	17	17
GCACATAGTAGCTGCC-1_5_B5	-19.99925175	24.99100936	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1817	3108	0.003539254	0.011261261	4	8	Astrocytes	26	17	17
GCACATATCTGCCCTA-1_5_B5	-5.242040451	3.443738833	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	3515	7229	0.002074976	0.005394937	4	11	Glia-MIX	26	17	17
GCACTCTAGCTAGTCT-1_5_B5	-15.27610419	15.0916802	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2602	5182	0.000192976	0.009262833	4	8	Astrocytes	26	17	17
GCACTCTAGGCAATTA-1_5_B5	30.14675564	16.10359333	14	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1683	2968	0.004380054	0.081873315	4	14	Microglia	26	17	17
GCACTCTCAGACTCGC-1_5_B5	-20.96116896	25.57026044	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1776	3411	0.002931692	0.012899443	4	8	Astrocytes	26	17	17
GCACTCTCATCCGCGA-1_5_B5	-7.906387445	-9.807351345	13A	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1153	1681	0.009518144	0.013682332	4	13A	IN-VIP	26	17	17
GCACTCTTCTACCTGC-1_5_B5	8.839565856	-17.62943059	4	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	5906	18014	0.005773287	0.017097813	4	L2-3	EN-L2-3-MS	26	17	17
GCAGCCAAGCTACCTA-1_5_B5	14.78804922	-4.446484544	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1588	2693	0.004455997	0.008540661	4	12	EN-MIX	26	17	17
GCAGCCATCCCATTAT-1_5_B5	14.79748048	22.45064287	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1008	1582	0.002528445	0.005689001	4	oligos	OL-Cntl	26	17	17
GCAGCCATCCGTCAAA-1_5_B5	-4.528585165	21.52142534	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	734	1083	0.010156971	0.01754386	4	oligos	OL-Cntl	26	17	17
GCAGTTAAGTAAGTAC-1_5_B5	18.23045741	17.89717585	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1107	1915	0.003655352	0.005744125	4	oligos	OL-Cntl	26	17	17
GCATACACAAGTCTGT-1_5_B5	13.98511112	20.09453384	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1039	1621	0.005552128	0.009253547	4	oligos	OL-Cntl	26	17	17
GCATACATCGGCCGAT-1_5_B5	16.5170907	20.65856464	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	991	1623	0.01047443	0.004313001	4	oligos	OL-Cntl	26	17	17
GCATGATAGCGCTCCA-1_5_B5	6.540096635	26.97661585	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	788	1164	0.005154639	0.006013746	4	oligos	OL-Cntl	26	17	17
GCATGATAGTGCGTGA-1_5_B5	-0.103992412	22.30883523	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	845	1300	0.001538462	0.01	4	oligos	OL-Cntl	26	17	17
GCATGATCACATCCAA-1_5_B5	8.456404919	0.23307592	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1404	2094	0.008118434	0.074976122	4	12	EN-MIX	26	17	17
GCATGATCACCGATAT-1_5_B5	11.90217447	0.278185758	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	943	1291	0.003098373	0.017815647	4	12	EN-MIX	26	17	17
GCATGATTCTGGTATG-1_5_B5	16.4962136	15.33426234	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1279	2172	0.004143646	0.004604052	4	oligos	OL-Cntl	26	17	17
GCATGCGGTAAATGTG-1_5_B5	22.45570841	-27.20840849	3	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	5759	18085	0.000774122	0.007132983	4	3	EN-L5-6	26	17	17
GCATGCGGTGAGGCTA-1_5_B5	-1.285015051	22.7900679	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	829	1265	0.012648221	0.013438735	4	oligos	OL-Cntl	26	17	17
GCATGCGGTTGCCTCT-1_5_B5	1.933200804	21.95184442	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	895	1389	0.001439885	0.012958963	4	oligos	OL-Cntl	26	17	17
GCATGCGTCACCAGGC-1_5_B5	-27.88535647	-12.8979586	9	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	805	1008	0.003968254	0.01984127	4	9	OPC	26	17	17
GCATGTACAATGGAAT-1_5_B5	-4.602846038	3.47987873	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	3417	6494	0.003695719	0.008007391	4	11	Glia-MIX	26	17	17
GCCAAATAGCTCTCGG-1_5_B5	5.32569473	29.75829172	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	706	1091	0.005499542	0.003666361	4	oligos	OL-Cntl	26	17	17
GCCAAATAGGATATAC-1_5_B5	-16.9959242	12.86725387	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1249	1971	0.004058853	0.00608828	4	8	Astrocytes	26	17	17
GCCAAATAGGCCCTTG-1_5_B5	11.7765386	1.923563948	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	720	1005	0.013930348	0.017910448	4	12	EN-MIX	26	17	17
GCCAAATCATCATCCC-1_5_B5	11.89935469	3.167231895	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1016	1507	0.00265428	0.00597213	4	12	EN-MIX	26	17	17
GCCAAATGTCATATCG-1_5_B5	15.3257144	16.32461011	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1185	1882	0.006376196	0.010095643	4	oligos	OL-Cntl	26	17	17
GCCAAATTCAGTCAGT-1_5_B5	36.8997641	9.414416663	14	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	817	1071	0.010270775	0.010270775	4	14	Microglia	26	17	17
GCCAAATTCATCGGAT-1_5_B5	8.878281082	-20.66837496	4	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	4989	14656	0.00191048	0.011462882	4	L2-3	EN-L2-3-MS	26	17	17
GCCTCTACAATGTAAG-1_5_B5	-6.090493349	4.124503152	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	5495	14753	0.00216905	0.006981631	4	11	Glia-MIX	26	17	17
GCCTCTACATGCTGGC-1_5_B5	16.03721969	1.488590198	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	763	1063	0	0.005644403	4	12	EN-MIX	26	17	17
GCCTCTATCATCTGCC-1_5_B5	-10.99837066	18.32354388	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	3416	6863	0.00131138	0.013259508	4	11	Glia-MIX	26	17	17
GCCTCTATCTCACATT-1_5_B5	15.63301731	0.080736574	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	690	1095	0.000913242	0.006392694	4	12	EN-MIX	26	17	17
GCGACCAAGGTTCCTA-1_5_B5	16.39915164	9.746588662	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1626	3199	0.002813379	0.009377931	4	oligos	OL-Cntl	26	17	17
GCGACCAAGTCAAGCG-1_5_B5	-9.599651514	-19.8274481	6A	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	807	1146	0.017452007	0.003490401	4	6A	IN-PV	26	17	17
GCGACCAAGTCCCACG-1_5_B5	8.370830411	0.599215988	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	999	1339	0.005974608	0.061986557	4	12	EN-MIX	26	17	17
GCGACCACACACAGAG-1_5_B5	15.34742078	15.57291468	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1325	2297	0.004788855	0.010883761	4	oligos	OL-Cntl	26	17	17
GCGACCACATCGTCGG-1_5_B5	37.56791014	-10.20409578	2	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	5556	15370	0.013793103	0.0129473	4	2	EN-L4	26	17	17
GCGACCAGTAAGTGTA-1_5_B5	14.10382325	8.454965921	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1789	3538	0.005370266	0.010457886	4	oligos	OL-Cntl	26	17	17
GCGAGAAAGTCCATAC-1_5_B5	12.21716736	11.67894269	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1354	2317	0.000863185	0.018558481	4	oligos	OL-Cntl	26	17	17
GCGAGAAAGTGACATA-1_5_B5	-4.197309045	2.940820828	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	3069	5640	0.003723404	0.004432624	4	11	Glia-MIX	26	17	17
GCGAGAAAGTTTCCTT-1_5_B5	16.18732257	20.70127587	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	972	1563	0.002559181	0.011516315	4	oligos	OL-Cntl	26	17	17
GCGAGAACAGGTGGAT-1_5_B5	35.95542515	8.142351408	14	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1026	1663	0	0.008418521	4	14	Microglia	26	17	17
GCGAGAACAGGTTTCA-1_5_B5	6.384032272	-5.995356713	10	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1223	1981	0.013124685	0.003533569	4	L2-3	EN-L2-3-Cntl	26	17	17
GCGAGAACATCACAAC-1_5_B5	-1.372274784	3.144353729	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1323	1943	0.001029336	0.011322697	4	11	Glia-MIX	26	17	17
GCGAGAAGTCTCTCGT-1_5_B5	-14.90140627	11.38315861	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1866	2909	0.00446889	0.010656583	4	8	Astrocytes	26	17	17
GCGAGAATCAGCTCTC-1_5_B5	13.9781462	16.25694535	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1115	1930	0	0.010362694	4	oligos	OL-Cntl	26	17	17
GCGCAACAGAGCAATT-1_5_B5	11.64696689	-1.104013047	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1313	1970	0.002030457	0.016243655	4	12	EN-MIX	26	17	17
GCGCAACAGTATCTCG-1_5_B5	-3.351441464	11.42955023	5	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	950	1357	0.011053795	0.020633751	4	oligos	OL-MS-1	26	17	17
GCGCAACCACGGTGTC-1_5_B5	-4.878410593	3.405137421	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	3680	7158	0.002095557	0.007404303	4	11	Glia-MIX	26	17	17
GCGCAACGTCTCCATC-1_5_B5	-20.53988941	25.47942016	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1988	4101	0.003901487	0.009266033	4	8	Astrocytes	26	17	17
GCGCAACTCCGTAGGC-1_5_B5	6.801382744	-1.533341241	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1201	1563	0.014075496	0.028150992	4	12	EN-MIX	26	17	17
GCGCAACTCTGGCGTG-1_5_B5	18.11015324	15.21082986	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1249	2205	0.001814059	0.003628118	4	oligos	OL-Cntl	26	17	17
GCGCAGTCAAGGTGTG-1_5_B5	8.845703017	-16.47501339	4	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	3685	8699	0.003908495	0.015978848	4	L2-3	EN-L2-3-MS	26	17	17
GCGCAGTCACCCATGG-1_5_B5	0.659320135	28.83113049	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	811	1082	0.012014787	0.003696858	4	oligos	OL-Cntl	26	17	17
GCGCAGTGTGCATCTA-1_5_B5	-0.709947375	4.566609214	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	936	1257	0.000795545	0.00318218	4	11	Glia-MIX	26	17	17
GCGCAGTGTTCGAATC-1_5_B5	-13.28307012	23.96340702	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2013	3930	0.00178117	0.015267176	4	8	Astrocytes	26	17	17
GCGCAGTTCACGGTTA-1_5_B5	18.54813728	6.250318193	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2394	4990	0.00260521	0.006012024	4	oligos	OL-Cntl	26	17	17
GCGCAGTTCCAGAGGA-1_5_B5	-18.04731239	-21.75941743	6A	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2276	4487	0.012034767	0.002897259	4	6A	IN-PV	26	17	17
GCGCCAACATTCCTCG-1_5_B5	1.564990612	1.103040791	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1446	2056	0.00729572	0.014105058	4	12	EN-MIX	26	17	17
GCGCCAATCCTTTCTC-1_5_B5	-31.68615348	-3.823763929	9	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1274	2059	0.001942691	0.026711996	4	9	OPC	26	17	17
GCGCGATAGAGGACGG-1_5_B5	16.94011381	-0.73930703	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	796	1192	0.01090604	0.002516779	4	12	EN-MIX	26	17	17
GCGCGATAGCTCCTTC-1_5_B5	-12.35454395	13.17869511	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1055	1494	0.00334672	0.013386881	4	11	Glia-MIX	26	17	17
GCGCGATCACTTACGA-1_5_B5	-30.40557968	-12.43518155	9	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	878	1170	0.006837607	0.015384615	4	9	OPC	26	17	17
GCGCGATGTTTGCATG-1_5_B5	-15.46655735	11.88478511	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1527	2509	0.000398565	0.011159825	4	8	Astrocytes	26	17	17
GCGCGATTCGCTTGTC-1_5_B5	-35.21571265	-3.875172911	9	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1371	2557	0.000782167	0.004301916	4	9	OPC	26	17	17
GCGCGATTCGGCGGTT-1_5_B5	17.65615647	16.664241	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1202	2117	0.001889466	0.005668399	4	oligos	OL-Cntl	26	17	17
GCGGGTTGTTGAACTC-1_5_B5	16.57408682	-0.711265951	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	794	1134	0.009700176	0.000881834	4	12	EN-MIX	26	17	17
GCGGGTTTCAAGATCC-1_5_B5	9.583844528	-17.46721126	4	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	4315	11008	0.004905523	0.011900436	4	L2-3	EN-L2-3-MS	26	17	17
GCGGGTTTCTACTTAC-1_5_B5	10.30469783	-2.133108083	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1788	2696	0.027077151	0.025222552	4	12	EN-MIX	26	17	17
GCTCCTAAGAATTGTG-1_5_B5	11.90345945	21.20520089	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	944	1491	0.002682763	0.006706908	4	oligos	OL-Cntl	26	17	17
GCTCCTAAGTGAACAT-1_5_B5	11.87018547	2.949890924	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1234	1849	0.00378583	0.016224986	4	12	EN-MIX	26	17	17
GCTCCTACATCCCATC-1_5_B5	19.53054739	16.57239565	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1147	1841	0.001086366	0.004345464	4	oligos	OL-Cntl	26	17	17
GCTCCTAGTCTCATCC-1_5_B5	-3.74412186	27.3503857	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	798	1167	0.002570694	0.009425878	4	oligos	OL-Cntl	26	17	17
GCTCCTAGTTAAGGGC-1_5_B5	5.278972658	24.43167899	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	844	1259	0.007148531	0.008737093	4	oligos	OL-Cntl	26	17	17
GCTCCTATCCTTCAAT-1_5_B5	12.69637436	2.250613581	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	772	1164	0.003436426	0.012027491	4	12	EN-MIX	26	17	17
GCTCTGTCAATCCGAT-1_5_B5	-32.18198155	-1.238535542	9	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1477	2462	0.001624695	0.006904955	4	9	OPC	26	17	17
GCTCTGTCACGCGAAA-1_5_B5	-2.372412289	24.77403052	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	783	1014	0.006903353	0.013806706	4	oligos	OL-Cntl	26	17	17
GCTGCAGAGCAGATCG-1_5_B5	22.43592277	16.06916244	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1351	2068	0.00483559	0.005802708	4	oligos	OL-Cntl	26	17	17
GCTGCAGAGCCGTCGT-1_5_B5	-1.507581982	2.987899913	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1263	1776	0.002815315	0.011824324	4	11	Glia-MIX	26	17	17
GCTGCAGAGCGTGAGT-1_5_B5	-4.681448037	3.481144915	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	3384	6382	0.001253526	0.009558132	4	11	Glia-MIX	26	17	17
GCTGCAGGTACCGTAT-1_5_B5	36.16454828	-8.562552177	2	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	4561	12352	0.002428756	0.015544041	4	2	EN-L4	26	17	17
GCTGCAGGTCGGATCC-1_5_B5	8.193907347	0.810249165	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	877	1115	0.004484305	0.041255605	4	12	EN-MIX	26	17	17
GCTGCAGGTCTTGCGG-1_5_B5	15.80197629	-26.37678333	3	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	4423	12508	0.001039335	0.00959386	4	3	EN-L5-6	26	17	17
GCTGCAGGTGCACGAA-1_5_B5	-31.42887469	2.329035882	9	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2113	4065	0.003690037	0.006642066	4	9	OPC	26	17	17
GCTGCAGTCAGTTGAC-1_5_B5	16.84543725	12.33340409	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1393	2481	0.004030633	0.006852076	4	oligos	OL-Cntl	26	17	17
GCTGCGACACAGTCGC-1_5_B5	17.60934769	7.864384282	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1967	3819	0.004189578	0.005498822	4	oligos	OL-Cntl	26	17	17
GCTGCGACACGAGAGT-1_5_B5	-3.743993585	24.81602245	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	738	1105	0.000904977	0.010859729	4	oligos	OL-Cntl	26	17	17
GCTGCGACATCGTCGG-1_5_B5	33.99203095	15.00904473	14	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1170	1579	0.005066498	0.033565548	4	14	Microglia	26	17	17
GCTGCGAGTATAATGG-1_5_B5	-35.56922252	4.488353552	9	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2288	4716	0.00466497	0.004240882	4	9	OPC	26	17	17
GCTGCGATCAGCGACC-1_5_B5	17.89856728	7.889405762	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2004	4037	0.001486252	0.006440426	4	oligos	OL-Cntl	26	17	17
GCTGCGATCTGCGGCA-1_5_B5	40.35631001	14.5067724	14	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1290	1859	0.002151694	0.010758472	4	14	Microglia	26	17	17
GCTGCTTCAATGTTGC-1_5_B5	13.42445101	-2.542898642	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1323	2233	0.002686968	0.013434841	4	12	EN-MIX	26	17	17
GCTGCTTCACTGCCAG-1_5_B5	34.78342362	-14.65042709	2	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	5296	14087	0.017604884	0.011641939	4	2	EN-L4	26	17	17
GCTGCTTCATATACGC-1_5_B5	8.630765723	0.09343565	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1442	2149	0.005583993	0.062819916	4	12	EN-MIX	26	17	17
GCTGCTTGTTACGGAG-1_5_B5	-1.96512388	-1.110298328	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	3609	8474	0.003422233	0.009440642	4	11	Glia-MIX	26	17	17
GCTGGGTAGATCGGGT-1_5_B5	10.20565212	-0.364045793	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1186	1623	0.015403574	0.024645718	4	12	EN-MIX	26	17	17
GCTGGGTCATCCAACA-1_5_B5	39.26981923	16.12489576	14	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1672	2663	0.003379647	0.007510327	4	14	Microglia	26	17	17
GCTGGGTGTCCGACGT-1_5_B5	8.133500438	3.209784886	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	826	1005	0.004975124	0.026865672	4	12	EN-MIX	26	17	17
GCTGGGTTCCAACCAA-1_5_B5	-15.22997972	15.25256844	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2906	5606	0.002318944	0.008740635	4	8	Astrocytes	26	17	17
GCTGGGTTCGGAGCAA-1_5_B5	5.715303592	13.50025657	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1198	1934	0.003619442	0.013960703	4	oligos	OL-Cntl	26	17	17
GCTGGGTTCTGCAAGT-1_5_B5	14.04210812	7.563370784	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1778	3118	0.017318794	0.013470173	4	oligos	OL-Cntl	26	17	17
GCTTCCAAGGCTCTTA-1_5_B5	13.60877115	16.47986023	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1174	2073	0.004341534	0.008200675	4	oligos	OL-Cntl	26	17	17
GCTTCCACAATACGCT-1_5_B5	12.29304883	2.69536497	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1019	1610	0.003726708	0.007453416	4	12	EN-MIX	26	17	17
GCTTCCACACGAAATA-1_5_B5	-5.154858925	3.443620543	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	3735	7770	0.002831403	0.007593308	4	11	Glia-MIX	26	17	17
GCTTGAAAGCTACCTA-1_5_B5	18.49274818	15.25106275	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1244	2080	0.023557692	0.003846154	4	oligos	OL-Cntl	26	17	17
GCTTGAAAGGCGTACA-1_5_B5	1.150948837	19.63139016	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	847	1289	0.006206362	0.008533747	4	oligos	OL-Cntl	26	17	17
GCTTGAAAGGTGGGTT-1_5_B5	-15.69708294	15.34269051	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2338	5032	0.000794913	0.008147854	4	8	Astrocytes	26	17	17
GCTTGAAAGTGTGGCA-1_5_B5	37.33077668	11.10549277	14	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	967	1313	0.033511043	0.00990099	4	14	Microglia	26	17	17
GCTTGAATCACGGTTA-1_5_B5	17.18645197	-26.82707532	3	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	5729	18507	0.00448479	0.008321176	4	3	EN-L5-6	26	17	17
GCTTGAATCCGTAGTA-1_5_B5	6.786078721	-2.361208087	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1202	1606	0.00871731	0.02739726	4	12	EN-MIX	26	17	17
GGAAAGCAGCGCCTTG-1_5_B5	-3.784662105	22.40836824	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	808	1168	0.005136986	0.012842466	4	oligos	OL-Cntl	26	17	17
GGAAAGCCAAACGTGG-1_5_B5	33.8175341	14.29609731	14	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	995	1529	0.012426422	0.023544801	4	14	Microglia	26	17	17
GGAAAGCGTCGGCACT-1_5_B5	37.45336058	13.75370073	14	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1043	1450	0.00137931	0.009655172	4	14	Microglia	26	17	17
GGAAAGCGTCTGCCAG-1_5_B5	-4.662751931	3.388437561	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	3310	6369	0.002198147	0.009420631	4	11	Glia-MIX	26	17	17
GGAACTTCAGCTTAAC-1_5_B5	37.59840092	11.44586864	14	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	938	1316	0.005319149	0.009878419	4	14	Microglia	26	17	17
GGAACTTTCCGCGCAA-1_5_B5	20.12430194	14.89401621	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1316	2400	0.000416667	0.005833333	4	oligos	OL-Cntl	26	17	17
GGAACTTTCTAACTCT-1_5_B5	19.94443482	-3.981119123	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1966	3345	0.014349776	0.011659193	4	12	EN-MIX	26	17	17
GGAACTTTCTAACTTC-1_5_B5	12.99481149	2.30665864	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	894	1373	0.004369993	0.009468318	4	12	EN-MIX	26	17	17
GGAATAAAGCCACGTC-1_5_B5	18.80125003	6.663443894	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2281	4606	0.003256622	0.008250109	4	oligos	OL-Cntl	26	17	17
GGAATAACACAGATTC-1_5_B5	12.22887757	16.35507424	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1143	1928	0.004149378	0.00466805	4	oligos	OL-Cntl	26	17	17
GGAATAACACCATCCT-1_5_B5	-16.31959848	0.185745034	13A	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	4708	11448	0.007250175	0.015985325	4	13A	IN-VIP	26	17	17
GGAATAATCTTGCATT-1_5_B5	8.333408277	12.32082961	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1243	2433	0.006576243	0.011508426	4	oligos	OL-Cntl	26	17	17
GGACAAGAGGGTTCCC-1_5_B5	-4.479797071	3.424326986	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	3106	5652	0.002476999	0.01079264	4	11	Glia-MIX	26	17	17
GGACAAGAGTCGAGTG-1_5_B5	-4.126860537	21.86765997	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	692	1010	0	0.021782178	4	oligos	OL-Cntl	26	17	17
GGACAAGCAATAGCGG-1_5_B5	2.418983022	22.3188866	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	919	1409	0.00212917	0.010645848	4	oligos	OL-Cntl	26	17	17
GGACAAGGTAGCTAAA-1_5_B5	16.6038685	0.472808953	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	921	1257	0.00477327	0.00159109	4	12	EN-MIX	26	17	17
GGACAAGTCATCGGAT-1_5_B5	4.804620417	12.85857162	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1157	1860	0.002688172	0.020967742	4	oligos	OL-Cntl	26	17	17
GGACAAGTCCTATGTT-1_5_B5	39.27620191	12.37709416	14	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1096	1588	0.001259446	0.011335013	4	14	Microglia	26	17	17
GGACAGAAGAGTACAT-1_5_B5	-10.97809198	6.880580195	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2990	5588	0.003758053	0.010558339	4	11	Glia-MIX	26	17	17
GGACAGACACCAGCAC-1_5_B5	2.37722252	26.66710995	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	732	1026	0	0.005847953	4	oligos	OL-Cntl	26	17	17
GGACAGAGTTTGTTTC-1_5_B5	-5.151775351	3.896523594	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	4426	9182	0.003158353	0.010019604	4	11	Glia-MIX	26	17	17
GGACAGATCACATAGC-1_5_B5	13.57378074	0.582610817	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	682	1010	0.003960396	0.004950495	4	12	EN-MIX	26	17	17
GGACAGATCCAGTAGT-1_5_B5	4.123840816	27.66080904	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	900	1382	0	0.00723589	4	oligos	OL-Cntl	26	17	17
GGACAGATCCATGAAC-1_5_B5	18.04208842	13.25158067	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1335	2388	0.002093802	0.006700168	4	oligos	OL-Cntl	26	17	17
GGACAGATCCGCATCT-1_5_B5	16.00504439	14.65520804	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1239	1968	0.00254065	0.012195122	4	oligos	OL-Cntl	26	17	17
GGACATTAGAAAGTGG-1_5_B5	-33.72281685	-3.93726547	9	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1348	2309	0.003031615	0.01039411	4	9	OPC	26	17	17
GGACATTAGATTACCC-1_5_B5	1.426256775	0.535979906	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1264	1861	0.001074691	0.010209565	4	12	EN-MIX	26	17	17
GGACATTAGCCAGTTT-1_5_B5	-7.641391556	-10.59051467	6B	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	773	1054	0.018026565	0.011385199	4	6B	IN-SST	26	17	17
GGACATTAGGTAGCCA-1_5_B5	10.56455894	-1.18972453	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1286	1794	0.004459309	0.038461538	4	12	EN-MIX	26	17	17
GGACATTGTGAGTGAC-1_5_B5	16.60985808	-0.610099436	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	727	1035	0.01352657	0.002898551	4	12	EN-MIX	26	17	17
GGACGTCAGAAGAAGC-1_5_B5	7.159189259	2.101207608	16	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	785	1034	0.03868472	0.032882012	4	16	EN-PYR	26	17	17
GGACGTCAGAGTCGGT-1_5_B5	-17.11880178	18.21384107	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1578	2805	0.003208556	0.009269162	4	8	Astrocytes	26	17	17
GGACGTCAGGGAAACA-1_5_B5	-10.64704314	9.698717251	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	4641	11379	0.003339485	0.006415326	4	11	Glia-MIX	26	17	17
GGACGTCCAGCCTGTG-1_5_B5	18.85745703	11.78785591	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1442	2704	0.00591716	0.003698225	4	oligos	OL-Cntl	26	17	17
GGACGTCTCCTAGTGA-1_5_B5	-4.768951197	3.171615459	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	3078	5929	0.00337325	0.00742115	4	11	Glia-MIX	26	17	17
GGACGTCTCTCCAACC-1_5_B5	12.08610125	15.78700425	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1167	2008	0.000498008	0.009960159	4	oligos	OL-Cntl	26	17	17
GGAGCAAAGAGCTTCT-1_5_B5	-12.33966374	0.138629686	13A	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	3578	8585	0.008969132	0.005241701	4	13A	IN-VIP	26	17	17
GGAGCAAAGAGTCTGG-1_5_B5	5.321423872	11.59299598	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1112	1853	0.005936319	0.026443605	4	oligos	OL-Cntl	26	17	17
GGAGCAAGTAGCTGCC-1_5_B5	-10.73767562	9.527942108	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	5413	14354	0.001811342	0.007663369	4	11	Glia-MIX	26	17	17
GGAGCAATCCCTGACT-1_5_B5	11.51275217	10.21083066	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1371	2358	0.002120441	0.013570823	4	oligos	OL-Cntl	26	17	17
GGATGTTGTAGCGTAG-1_5_B5	-8.960438196	-18.15657441	6B	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	836	1271	0.033044847	0.002360346	4	6B	IN-SST	26	17	17
GGATGTTTCGAACGGA-1_5_B5	20.85552484	19.11166437	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1029	1560	0.016666667	0.005769231	4	oligos	OL-Cntl	26	17	17
GGATTACCAGGAATCG-1_5_B5	5.395367371	22.31928861	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	938	1407	0.002842928	0.007107321	4	oligos	OL-Cntl	26	17	17
GGATTACCAGTCACTA-1_5_B5	-7.663175862	0.945780019	13A	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2161	4291	0.003728735	0.004660918	4	13A	IN-VIP	26	17	17
GGATTACGTCCGCTGA-1_5_B5	-15.42524299	11.35184658	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1588	2616	0.000382263	0.009174312	4	8	Astrocytes	26	17	17
GGATTACGTCGTCTTC-1_5_B5	1.363329086	21.97755961	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	888	1308	0.00382263	0.012996942	4	oligos	OL-Cntl	26	17	17
GGATTACTCGGCGGTT-1_5_B5	18.84809274	6.211137493	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2770	6269	0.003349817	0.004944967	4	oligos	OL-Cntl	26	17	17
GGCAATTAGAATTCCC-1_5_B5	12.59257236	-1.555952977	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1357	2133	0.001875293	0.026722925	4	12	EN-MIX	26	17	17
GGCAATTAGGAATCGC-1_5_B5	10.30153395	23.43093119	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	825	1180	0.003389831	0.003389831	4	oligos	OL-Cntl	26	17	17
GGCAATTAGGGTTCCC-1_5_B5	-12.53404777	-21.52192503	6A	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1191	2071	0.001931434	0.004828585	4	6A	IN-PV	26	17	17
GGCAATTAGTACATGA-1_5_B5	15.26382249	1.691355285	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	947	1376	0.002180233	0.016715116	4	12	EN-MIX	26	17	17
GGCAATTCAAGCGAGT-1_5_B5	13.19182789	15.93897992	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1123	1728	0.008680556	0.01099537	4	oligos	OL-Cntl	26	17	17
GGCAATTCACCACGTG-1_5_B5	14.75073714	1.238088739	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	868	1195	0.00251046	0.008368201	4	12	EN-MIX	26	17	17
GGCAATTCACCTATCC-1_5_B5	-0.380740224	4.827472616	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	781	1077	0.006499536	0.004642526	4	11	Glia-MIX	26	17	17
GGCAATTGTCTAGTGT-1_5_B5	17.45313267	16.80405261	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1191	1977	0.005058169	0.007587253	4	oligos	OL-Cntl	26	17	17
GGCAATTGTGACGGTA-1_5_B5	15.62386259	21.75503744	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1049	1758	0.014220705	0.002844141	4	oligos	OL-Cntl	26	17	17
GGCAATTGTTGTCGCG-1_5_B5	34.63333342	-14.98199299	2	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	4504	10579	0.00397013	0.016164099	4	2	EN-L4	26	17	17
GGCAATTTCACGCGGT-1_5_B5	-23.20356989	-26.20515489	6A	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	4532	12253	0.001713866	0.008324492	4	6A	IN-PV	26	17	17
GGCCGATAGAAACGAG-1_5_B5	-11.79405461	-19.07860866	6B	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1217	2136	0.026685393	0.004213483	4	6B	IN-SST	26	17	17
GGCCGATAGAGTACCG-1_5_B5	-27.57077476	4.381978911	9	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1834	3115	0.004815409	0.009630819	4	9	OPC	26	17	17
GGCCGATAGCAGGTCA-1_5_B5	25.64098477	5.145382597	15A	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1180	1799	0.002223457	0.007782101	4	15A	Endo cells	26	17	17
GGCCGATGTATTAGCC-1_5_B5	19.16806786	12.3135792	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1525	2679	0.000373274	0.008212019	4	oligos	OL-Cntl	26	17	17
GGCCGATGTCCTGCTT-1_5_B5	39.09577067	10.72070908	14	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	894	1246	0.004815409	0.003210273	4	14	Microglia	26	17	17
GGCCGATGTGGCGAAT-1_5_B5	6.501365766	19.05589162	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	991	1503	0.001996008	0.017964072	4	oligos	OL-Cntl	26	17	17
GGCCGATTCCTCATTA-1_5_B5	13.59364003	0.522649685	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	785	1157	0.001728608	0.005185825	4	12	EN-MIX	26	17	17
GGCCGATTCCTGCCAT-1_5_B5	-12.19158012	12.58876599	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	974	1376	0.005813953	0.009447674	4	11	Glia-MIX	26	17	17
GGCCGATTCGGCTACG-1_5_B5	-10.34324823	17.57184293	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	3465	7075	0.000706714	0.011166078	4	11	Glia-MIX	26	17	17
GGCGACTAGCAATCTC-1_5_B5	22.62046467	12.58332435	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1413	2447	0.001634655	0.002860646	4	oligos	OL-Cntl	26	17	17
GGCGACTCAGCGTAAG-1_5_B5	5.677459303	18.65492862	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	966	1505	0.001328904	0.015946844	4	oligos	OL-Cntl	26	17	17
GGCGACTGTTCGGCAC-1_5_B5	18.55545586	20.36168326	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1036	1839	0.001087548	0.002718869	4	oligos	OL-Cntl	26	17	17
GGCGACTTCCGAAGAG-1_5_B5	15.63939624	-0.982477083	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	687	1010	0	0.002970297	4	12	EN-MIX	26	17	17
GGCGACTTCTCAAACG-1_5_B5	12.66592419	-19.02775928	4	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	6580	22686	0.006876488	0.010491052	4	L2-3	EN-L2-3-MS	26	17	17
GGCGACTTCTGTCTAT-1_5_B5	10.2793191	0.943980976	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	914	1295	0.007722008	0.026254826	4	12	EN-MIX	26	17	17
GGCGTGTCACCAACCG-1_5_B5	10.80704654	16.75673626	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1060	1774	0.000563698	0.011837655	4	oligos	OL-Cntl	26	17	17
GGCGTGTCACTAAGTC-1_5_B5	-30.30127429	-12.83996615	9	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	748	1062	0.00094162	0.016949153	4	9	OPC	26	17	17
GGCGTGTCATTGCGGC-1_5_B5	2.502222828	25.62163142	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	804	1201	0.016652789	0.010824313	4	oligos	OL-Cntl	26	17	17
GGCGTGTGTCTGGTCG-1_5_B5	-13.4635422	24.06621456	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1994	3643	0.003842987	0.014822948	4	8	Astrocytes	26	17	17
GGCTCGAAGAATGTTG-1_5_B5	-3.948119201	3.301959605	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	3152	5721	0.004894249	0.011886034	4	11	Glia-MIX	26	17	17
GGCTCGAAGCGAGAAA-1_5_B5	-2.163756158	24.42930211	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	827	1145	0.002620087	0.010480349	4	oligos	OL-Cntl	26	17	17
GGCTCGAAGTGAATTG-1_5_B5	11.56292575	26.27096881	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	950	1477	0.002031144	0.00338524	4	oligos	OL-Cntl	26	17	17
GGCTCGAAGTTTGCGT-1_5_B5	7.527242993	-16.20839121	4	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	3124	6350	0.00488189	0.017637795	4	L2-3	EN-L2-3-MS	26	17	17
GGCTCGAGTAAGTTCC-1_5_B5	15.29939538	13.47250719	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1360	2143	0.00419972	0.006066262	4	oligos	OL-Cntl	26	17	17
GGCTCGAGTCGGATCC-1_5_B5	-36.7522005	2.347185907	9	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1889	3632	0.004129956	0.004405286	4	9	OPC	26	17	17
GGCTCGATCAACTCTT-1_5_B5	14.26893248	0.854977004	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	754	1069	0.000935454	0.019644528	4	12	EN-MIX	26	17	17
GGCTGGTAGGCTCAGA-1_5_B5	-0.880497947	25.55962078	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	690	1020	0.000980392	0.008823529	4	oligos	OL-Cntl	26	17	17
GGCTGGTAGTGTACCT-1_5_B5	-1.623269339	2.925694499	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1329	1878	0.00372737	0.011182109	4	11	Glia-MIX	26	17	17
GGCTGGTCACAGACTT-1_5_B5	12.59709238	18.733334	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1094	1872	0.003739316	0.006410256	4	oligos	OL-Cntl	26	17	17
GGCTGGTCAGTGGAGT-1_5_B5	5.22451431	18.47300428	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1015	1511	0.00595632	0.014559894	4	oligos	OL-Cntl	26	17	17
GGCTGGTCAGTTCCCT-1_5_B5	4.576604907	25.07963826	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	817	1199	0.001668057	0.00500417	4	oligos	OL-Cntl	26	17	17
GGCTGGTGTAAACACA-1_5_B5	8.298009357	3.156791882	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1000	1312	0.007621951	0.035060976	4	12	EN-MIX	26	17	17
GGGAATGAGACTAGAT-1_5_B5	15.68195308	15.04334283	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1197	1892	0.004756871	0.015327696	4	oligos	OL-Cntl	26	17	17
GGGAATGCACCAGGCT-1_5_B5	-37.48015547	-9.006894773	9	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	888	1429	0.00139958	0.00139958	4	9	OPC	26	17	17
GGGAATGCAGGGATTG-1_5_B5	-3.373006812	2.514036285	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2293	3678	0.001903208	0.013050571	4	11	Glia-MIX	26	17	17
GGGAATGTCCGCATAA-1_5_B5	32.99528039	-16.6194084	2	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	5137	13699	0.017811519	0.022556391	4	2	EN-L4	26	17	17
GGGAATGTCTCTGTCG-1_5_B5	-3.324667857	2.430072063	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2299	3700	0.003783784	0.009189189	4	11	Glia-MIX	26	17	17
GGGACCTCATCGGGTC-1_5_B5	24.06259867	-20.50713547	3	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	5498	16216	0.011840158	0.012210163	4	3	EN-L5-6	26	17	17
GGGACCTGTACGCTGC-1_5_B5	13.34713537	11.78249156	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1334	2080	0.004807692	0.012980769	4	oligos	OL-Cntl	26	17	17
GGGACCTGTCTTCAAG-1_5_B5	34.22614954	-14.35103237	2	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	3402	7184	0.013919822	0.018234967	4	2	EN-L4	26	17	17
GGGACCTTCACAATGC-1_5_B5	17.28522075	12.2996647	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1374	2342	0	0.005550811	4	oligos	OL-Cntl	26	17	17
GGGACCTTCTGTGCAA-1_5_B5	13.91831011	-13.45504629	4	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	5930	18166	0.006440603	0.019046571	4	L2-3	EN-L2-3-MS	26	17	17
GGGAGATAGGCACATG-1_5_B5	17.52473376	14.61595455	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1259	2193	0.005471956	0.006839945	4	oligos	OL-Cntl	26	17	17
GGGAGATAGGGTGTTG-1_5_B5	14.00109836	11.5036247	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1461	2298	0.002175805	0.013489991	4	oligos	OL-Cntl	26	17	17
GGGAGATCATCTCCCA-1_5_B5	12.63565342	16.91468714	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1048	1850	0.011351351	0.007567568	4	oligos	OL-Cntl	26	17	17
GGGAGATGTCATGCAT-1_5_B5	17.86618988	-22.72551603	3	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	4843	12755	0.006350451	0.018424147	4	3	EN-L5-6	26	17	17
GGGAGATGTCGAAAGC-1_5_B5	-15.43936316	15.06817831	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2167	3734	0.001071237	0.010712373	4	8	Astrocytes	26	17	17
GGGATGAAGAAGGCCT-1_5_B5	16.67024507	9.942889413	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1607	3038	0.000987492	0.005266623	4	oligos	OL-Cntl	26	17	17
GGGATGAAGAGTGACC-1_5_B5	-15.21003469	15.53526577	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	3025	6594	0.001213224	0.011222323	4	8	Astrocytes	26	17	17
GGGATGACATGCGCAC-1_5_B5	-6.21470167	4.285572233	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	5977	15787	0.003167163	0.00855134	4	11	Glia-MIX	26	17	17
GGGCACTCAAGTAATG-1_5_B5	-16.87897337	0.901177495	13A	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	3959	8586	0.013626834	0.018867925	4	13A	IN-VIP	26	17	17
GGGCACTCATTCCTCG-1_5_B5	12.43504004	2.653149087	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1070	1666	0.0030012	0.009003601	4	12	EN-MIX	26	17	17
GGGCACTGTCCAGTTA-1_5_B5	-18.89759059	19.72813936	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1649	3081	0.003894839	0.007140539	4	8	Astrocytes	26	17	17
GGGCACTGTTCTGTTT-1_5_B5	-10.65476546	2.458404322	13A	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	3277	8590	0.006868452	0.004540163	4	13A	IN-VIP	26	17	17
GGGCACTTCGCCTGTT-1_5_B5	4.390445123	-4.230806772	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1167	1731	0.002888504	0.019064125	4	12	EN-MIX	26	17	17
GGGCACTTCTCCAACC-1_5_B5	-18.6375874	25.46329068	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2140	4477	0	0.012061648	4	8	Astrocytes	26	17	17
GGGCATCCAAGCCGCT-1_5_B5	15.90076566	24.02603477	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	905	1420	0.009859155	0.005633803	4	oligos	OL-Cntl	26	17	17
GGGCATCCACACATGT-1_5_B5	-24.46012652	0.205730587	9	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1853	3001	0.004998334	0.021326225	4	9	OPC	26	17	17
GGGCATCCATACAGCT-1_5_B5	24.35092104	-13.44634459	3	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	4101	9120	0.010964912	0.023574561	4	3	EN-L5-6	26	17	17
GGGCATCCATCATCCC-1_5_B5	1.186054786	0.958482985	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1313	2097	0.00286123	0.009060563	4	12	EN-MIX	26	17	17
GGGCATCTCCGCTGTT-1_5_B5	12.3873304	2.718435965	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1253	1972	0.001521298	0.009127789	4	12	EN-MIX	26	17	17
GGGCATCTCCTTTACA-1_5_B5	4.484954653	-1.836237477	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	876	1158	0.000863558	0.006908463	4	12	EN-MIX	26	17	17
GGGCATCTCTGCTGTC-1_5_B5	15.47901157	-5.199931341	10	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1299	2242	0.006244425	0.003568243	4	L2-3	EN-L2-3-Cntl	26	17	17
GGGTCTGAGCCAACAG-1_5_B5	-13.71398582	-0.772470069	13A	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	3134	6583	0.007443415	0.010785356	4	13A	IN-VIP	26	17	17
GGGTCTGAGCCACGTC-1_5_B5	10.26332001	18.97111831	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1048	1800	0.005	0.003888889	4	oligos	OL-Cntl	26	17	17
GGGTCTGAGCCCAATT-1_5_B5	21.80217095	-16.56887288	3	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	6381	21921	0.014141691	0.025044478	4	3	EN-L5-6	26	17	17
GGGTCTGAGTGAAGTT-1_5_B5	17.15671424	8.172726909	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1867	3475	0.006618705	0.007769784	4	oligos	OL-Cntl	26	17	17
GGGTCTGGTCCGCTGA-1_5_B5	-7.374269116	-6.484212845	13A	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1435	2234	0.015219338	0.005371531	4	13A	IN-VIP	26	17	17
GGGTCTGGTTTGGCGC-1_5_B5	11.20787076	29.37985873	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	833	1468	0.000681199	0.002724796	4	oligos	OL-Cntl	26	17	17
GGGTCTGTCACCAGGC-1_5_B5	13.92812085	20.70859593	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	956	1527	0.009168304	0.001309758	4	oligos	OL-Cntl	26	17	17
GGGTCTGTCGCCAAAT-1_5_B5	-0.957955901	24.73716393	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	784	1114	0.006283662	0.008078995	4	oligos	OL-Cntl	26	17	17
GGGTCTGTCGTATCAG-1_5_B5	11.75120992	-0.033579502	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	819	1108	0.009025271	0.013537906	4	12	EN-MIX	26	17	17
GGGTTGCAGGCCATAG-1_5_B5	-7.962179157	-10.89001155	6B	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	862	1089	0.018365473	0.024793388	4	6B	IN-SST	26	17	17
GGGTTGCCAGCATGAG-1_5_B5	-1.001780992	25.72698978	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	729	1079	0.000926784	0.005560704	4	oligos	OL-Cntl	26	17	17
GGGTTGCGTATAATGG-1_5_B5	21.58331137	15.84992526	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1369	2288	0.000874126	0.007867133	4	oligos	OL-Cntl	26	17	17
GGGTTGCGTATCACCA-1_5_B5	15.4445398	-0.960299042	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	673	1073	0.002795899	0.001863933	4	12	EN-MIX	26	17	17
GGGTTGCTCCGTCATC-1_5_B5	14.20460483	-4.156657744	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1562	2590	0.002702703	0.013513514	4	12	EN-MIX	26	17	17
GGTATTGCAAGGCTCC-1_5_B5	16.03574167	10.81169451	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1452	2688	0.002604167	0.005580357	4	oligos	OL-Cntl	26	17	17
GGTATTGCACCAGATT-1_5_B5	4.120456221	22.1757665	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	863	1254	0.010366826	0.003189793	4	oligos	OL-Cntl	26	17	17
GGTATTGGTAGCGCAA-1_5_B5	-3.829353929	22.00747194	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	741	1000	0.005	0.016	4	oligos	OL-Cntl	26	17	17
GGTATTGGTGCGGTAA-1_5_B5	15.24639803	18.12676125	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1050	1641	0.000609385	0.009750152	4	oligos	OL-Cntl	26	17	17
GGTATTGTCGCAAGCC-1_5_B5	6.060171085	16.1857427	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1025	1586	0.002522068	0.013240858	4	oligos	OL-Cntl	26	17	17
GGTGAAGGTACCGTTA-1_5_B5	13.7263555	20.38861359	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	964	1471	0.004078858	0.007477906	4	oligos	OL-Cntl	26	17	17
GGTGAAGGTCTGATCA-1_5_B5	22.54704608	-26.2228824	3	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	4747	13696	0.001606308	0.005841121	4	3	EN-L5-6	26	17	17
GGTGAAGGTGCTGTAT-1_5_B5	11.62797484	1.028086639	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	785	1078	0.012987013	0.018552876	4	12	EN-MIX	26	17	17
GGTGAAGGTGTGACGA-1_5_B5	4.491561922	27.83998576	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	853	1288	0.00621118	0.00931677	4	oligos	OL-Cntl	26	17	17
GGTGCGTAGAGTTGGC-1_5_B5	15.34177134	-2.154025052	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	849	1220	0.000819672	0.001639344	4	12	EN-MIX	26	17	17
GGTGCGTAGCCGTCGT-1_5_B5	-19.50013535	24.39836224	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2079	4313	0.000927429	0.010201716	4	8	Astrocytes	26	17	17
GGTGCGTCATTGTGCA-1_5_B5	-30.6889704	-2.692125906	9	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1359	2076	0.004816956	0.009152216	4	9	OPC	26	17	17
GGTGCGTTCAGCGACC-1_5_B5	-3.657226607	-7.598086148	13A	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	712	1053	0.017094017	0.00379867	4	13A	IN-VIP	26	17	17
GGTGCGTTCTACTTAC-1_5_B5	14.18636332	11.17571113	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1550	2739	0.005111355	0.010952903	4	oligos	OL-Cntl	26	17	17
GGTGTTACAAGCCTAT-1_5_B5	7.873506777	19.79729798	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1094	1858	0.002152853	0.004843918	4	oligos	OL-Cntl	26	17	17
GGTGTTATCCGAGCCA-1_5_B5	15.02633198	2.788097922	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	789	1042	0.002879079	0.001919386	4	12	EN-MIX	26	17	17
GGTGTTATCTCGTTTA-1_5_B5	-13.04489194	-17.91765711	6B	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1173	2033	0.005902607	0.006886375	4	6B	IN-SST	26	17	17
GTAACGTGTGTTCGAT-1_5_B5	-6.465251584	4.540701087	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	8142	27184	0.004671866	0.010925544	4	11	Glia-MIX	26	17	17
GTAACGTTCGTTTAGG-1_5_B5	21.43422251	16.61208578	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1280	2301	0.000434594	0.005649718	4	oligos	OL-Cntl	26	17	17
GTAACTGAGACACGAC-1_5_B5	-9.626087107	-18.44336895	6B	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	921	1546	0.009055627	0.005174644	4	6B	IN-SST	26	17	17
GTAACTGAGAGCTATA-1_5_B5	15.80947088	22.87897358	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	924	1399	0.002144389	0.001429593	4	oligos	OL-Cntl	26	17	17
GTAACTGTCGACAGCC-1_5_B5	-3.797215982	2.590767284	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2577	4651	0.002795098	0.006235218	4	11	Glia-MIX	26	17	17
GTAACTGTCGCAAGCC-1_5_B5	18.68069829	-22.55197622	3	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	5707	18024	0.013925877	0.014591656	4	3	EN-L5-6	26	17	17
GTAACTGTCTTGTATC-1_5_B5	-19.00826924	6.877247279	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	853	1600	0.00125	0.0025	4	8	Astrocytes	26	17	17
GTACGTAGTCGGCACT-1_5_B5	-35.06716201	-0.26250562	9	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1819	3191	0.000626763	0.005327484	4	9	OPC	26	17	17
GTACGTAGTGATGCCC-1_5_B5	35.81864747	15.63472342	14	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1240	1894	0.014255544	0.024815206	4	14	Microglia	26	17	17
GTACGTAGTGCTCTTC-1_5_B5	-12.2291393	13.11847989	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	994	1356	0.005162242	0.01179941	4	11	Glia-MIX	26	17	17
GTACGTAGTTTGTTGG-1_5_B5	-16.33600824	-24.34280572	6A	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1967	4135	0.007738815	0.00362757	4	6A	IN-PV	26	17	17
GTACGTATCTTGCAAG-1_5_B5	11.59841992	14.16145992	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1110	1827	0.00711549	0.004926108	4	oligos	OL-Cntl	26	17	17
GTACTCCAGCTATGCT-1_5_B5	15.66503514	29.77878356	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	831	1229	0.010577705	0.002441009	4	oligos	OL-Cntl	26	17	17
GTACTCCCAATGACCT-1_5_B5	36.51410927	8.159239846	14	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	832	1158	0.000863558	0.008635579	4	14	Microglia	26	17	17
GTACTCCCATCGGTTA-1_5_B5	-23.98238468	16.13858986	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1548	2852	0.000701262	0.002103787	4	8	Astrocytes	26	17	17
GTACTCCTCACATAGC-1_5_B5	-17.44899024	-9.914603428	13B	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	4338	12110	0.006936416	0.005202312	4	13B	IN-SV2C	26	17	17
GTACTCCTCAGGCAAG-1_5_B5	-3.816077369	22.53695786	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	817	1338	0.002242152	0.011210762	4	oligos	OL-Cntl	26	17	17
GTACTCCTCAGTCCCT-1_5_B5	19.91852485	17.10405107	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1183	1897	0.000527148	0.00843437	4	oligos	OL-Cntl	26	17	17
GTACTCCTCTACTCAT-1_5_B5	5.932206757	34.17635074	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	701	1083	0.006463527	0.012003693	4	oligos	OL-Cntl	26	17	17
GTACTTTAGTCTCCTC-1_5_B5	2.89913886	-13.11293987	4	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2163	4601	0.004998913	0.005650945	4	L2-3	EN-L2-3-MS	26	17	17
GTACTTTGTGCTCTTC-1_5_B5	11.82405593	16.32085994	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1176	1988	0.005030181	0.011569416	4	oligos	OL-Cntl	26	17	17
GTAGGCCAGCTCCTTC-1_5_B5	17.63870661	18.0505907	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1141	1862	0.004296455	0.006444683	4	oligos	OL-Cntl	26	17	17
GTAGGCCAGTTGTAGA-1_5_B5	39.27887763	14.95862393	14	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1295	1877	0	0.004794885	4	14	Microglia	26	17	17
GTAGGCCTCCAGTATG-1_5_B5	20.77591925	14.45689073	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1386	2438	0.01435603	0.004511895	4	oligos	OL-Cntl	26	17	17
GTAGTCAAGACTTGAA-1_5_B5	19.90668035	12.82344495	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1385	2447	0.0044953	0.009807928	4	oligos	OL-Cntl	26	17	17
GTAGTCAAGATAGTCA-1_5_B5	-10.05896491	12.1755861	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	857	1147	0.003487358	0.006974717	4	oligos	OL-Cntl	26	17	17
GTAGTCAAGGTGACCA-1_5_B5	-26.70468564	-2.672181516	9	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1401	2372	0.00084317	0.037099494	4	9	OPC	26	17	17
GTAGTCAGTTCGAATC-1_5_B5	15.26729325	14.80777235	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1159	1872	0.001602564	0.013354701	4	oligos	OL-Cntl	26	17	17
GTATCTTCATGTAAGA-1_5_B5	-9.572583184	-5.449410366	13A	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1719	3135	0.011164274	0.008931419	4	13A	IN-VIP	26	17	17
GTATCTTGTACGACCC-1_5_B5	14.12251235	-23.3883867	4	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	5354	16968	0.008191891	0.009075908	4	L2-3	EN-L2-3-MS	26	17	17
GTATCTTTCTACTATC-1_5_B5	40.11185136	11.20713833	14	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	808	1220	0.002459016	0.001639344	4	14	Microglia	26	17	17
GTATTCTAGCCGATTT-1_5_B5	13.77048669	16.05983411	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1184	2134	0.000468604	0.007966261	4	oligos	OL-Cntl	26	17	17
GTATTCTCACTATCTT-1_5_B5	16.57812254	20.71124007	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1003	1615	0.00495356	0.00371517	4	oligos	OL-Cntl	26	17	17
GTATTCTGTGTCTGAT-1_5_B5	-34.12649234	-3.454666711	9	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1322	2233	0.004030452	0.010300045	4	9	OPC	26	17	17
GTATTCTTCAGCCTAA-1_5_B5	-22.50610825	-24.52829675	6A	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	3271	8525	0.007859238	0.006217009	4	6A	IN-PV	26	17	17
GTATTCTTCTGGTATG-1_5_B5	10.02401442	22.8781066	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	877	1345	0.005947955	0.000743494	4	oligos	OL-Cntl	26	17	17
GTCAAGTCAATGGAGC-1_5_B5	13.98163325	17.35795331	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1077	1758	0.006825939	0.011945392	4	oligos	OL-Cntl	26	17	17
GTCAAGTTCTGGTTCC-1_5_B5	-20.46109829	-27.46101901	6A	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	3397	8426	0.006052694	0.003560408	4	6A	IN-PV	26	17	17
GTCACAAAGTGCCAGA-1_5_B5	-4.131997445	18.60087362	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	908	1259	0.008737093	0.021445592	4	oligos	OL-Cntl	26	17	17
GTCACAACAACAACCT-1_5_B5	-9.7170677	17.78747006	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2644	5037	0.000992654	0.009529482	4	11	Glia-MIX	26	17	17
GTCACAACATGCAACT-1_5_B5	7.880458441	9.369334021	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1362	2407	0.005816369	0.012463648	4	oligos	OL-Cntl	26	17	17
GTCACAAGTTCCACGG-1_5_B5	-10.26747327	-16.18902491	6B	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1050	1470	0.028571429	0.012244898	4	6B	IN-SST	26	17	17
GTCACAATCTGATTCT-1_5_B5	-10.08548663	14.21608089	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1270	1922	0.003121748	0.008844953	4	11	Glia-MIX	26	17	17
GTCACAATCTGTGCAA-1_5_B5	-34.06330011	-3.297946743	9	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1649	3062	0.00163292	0.004898759	4	9	OPC	26	17	17
GTCACGGAGTTGTAGA-1_5_B5	-19.1669607	7.272583207	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1007	1686	0.003558719	0.004744958	4	8	Astrocytes	26	17	17
GTCACGGCACTCGACG-1_5_B5	-1.095638167	3.765272164	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1140	1639	0.002440513	0.009151922	4	11	Glia-MIX	26	17	17
GTCACGGGTTGGTTTG-1_5_B5	7.085771329	-0.962495053	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	985	1297	0.025443331	0.017733231	4	12	EN-MIX	26	17	17
GTCACGGTCATGTCTT-1_5_B5	37.44116648	11.2195628	14	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	979	1342	0.001490313	0.016393443	4	14	Microglia	26	17	17
GTCACGGTCTGCGTAA-1_5_B5	-1.634946394	20.44940018	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	710	1026	0.004873294	0.00877193	4	oligos	OL-Cntl	26	17	17
GTCATTTCAAGTTGTC-1_5_B5	37.57426003	-10.06467792	2	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	3302	6937	0.006631109	0.012541444	4	2	EN-L4	26	17	17
GTCATTTCACGAAACG-1_5_B5	-16.48347374	12.275279	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1308	2021	0	0.006432459	4	8	Astrocytes	26	17	17
GTCCTCAAGTCAATAG-1_5_B5	-4.275924977	3.189630822	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2964	5398	0.004631345	0.009447944	4	11	Glia-MIX	26	17	17
GTCCTCACAGCTGCTG-1_5_B5	-20.83663	8.554098258	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	886	1327	0.00075358	0.004521477	4	8	Astrocytes	26	17	17
GTCCTCACATCATCCC-1_5_B5	-35.44656356	-12.04357724	9	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	805	1231	0.004061738	0.005686434	4	9	OPC	26	17	17
GTCCTCAGTAGCTCCG-1_5_B5	6.807210859	20.46877137	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1044	1658	0.003618818	0.007840772	4	oligos	OL-Cntl	26	17	17
GTCCTCAGTATATCCG-1_5_B5	12.41833798	1.454666879	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	717	1034	0.005802708	0.010638298	4	12	EN-MIX	26	17	17
GTCCTCATCACATGCA-1_5_B5	15.39512799	-5.849743817	10	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1318	2373	0.00505689	0.002528445	4	L2-3	EN-L2-3-Cntl	26	17	17
GTCCTCATCCAAAGTC-1_5_B5	13.16459137	-4.585289176	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1799	2726	0.005502568	0.012839325	4	12	EN-MIX	26	17	17
GTCGGGTAGATAGGAG-1_5_B5	-33.053675	-10.97004172	9	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	811	1160	0.004310345	0.003448276	4	9	OPC	26	17	17
GTCGGGTAGTCTCAAC-1_5_B5	-1.272871665	23.55834618	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	733	1088	0.000919118	0.011948529	4	oligos	OL-Cntl	26	17	17
GTCGGGTGTGAGTGAC-1_5_B5	-21.78911892	27.00193707	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2046	4109	0.002920419	0.006327574	4	8	Astrocytes	26	17	17
GTCGGGTGTTAGAACA-1_5_B5	4.861656226	19.82137305	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	958	1448	0.009668508	0.010359116	4	oligos	OL-Cntl	26	17	17
GTCGGGTGTTGTGGCC-1_5_B5	-0.994154707	26.40783975	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	749	1050	0.001904762	0.011428571	4	oligos	OL-Cntl	26	17	17
GTCGGGTTCCACGTTC-1_5_B5	5.840493102	-9.727553811	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1404	2108	0.003795066	0.012333966	4	12	EN-MIX	26	17	17
GTCGTAAAGAGCTTCT-1_5_B5	14.47532403	21.41305004	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	950	1511	0.003309067	0.006618134	4	oligos	OL-Cntl	26	17	17
GTCGTAAAGATCTGCT-1_5_B5	11.11466626	23.06259119	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	885	1437	0	0.008350731	4	oligos	OL-Cntl	26	17	17
GTCGTAAAGGTGTTAA-1_5_B5	2.120761863	24.33550823	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	748	1122	0	0.003565062	4	oligos	OL-Cntl	26	17	17
GTCGTAAAGGTTACCT-1_5_B5	5.159889626	13.42067015	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1179	1851	0.01458671	0.01458671	4	oligos	OL-Cntl	26	17	17
GTCGTAACAGCGTAAG-1_5_B5	5.212307161	18.65674332	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	966	1491	0.015425889	0.012743125	4	oligos	OL-Cntl	26	17	17
GTCGTAATCCCTCAGT-1_5_B5	1.829516692	17.81384362	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	829	1329	0.005267118	0.009781791	4	oligos	OL-Cntl	26	17	17
GTCTCGTCAATCCAAC-1_5_B5	9.938159505	-2.492958651	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1666	2494	0.036086608	0.020048115	4	12	EN-MIX	26	17	17
GTCTCGTCAGCTGTGC-1_5_B5	-7.737280476	9.602197965	5	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	797	1161	0.007751938	0.017226529	4	oligos	OL-MS-1	26	17	17
GTCTCGTGTGCCTGGT-1_5_B5	13.26697821	12.33667297	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1381	2146	0.007455732	0.006989748	4	oligos	OL-Cntl	26	17	17
GTCTCGTTCAACTCTT-1_5_B5	21.51712066	-5.077769826	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1897	3103	0.007412182	0.023203352	4	12	EN-MIX	26	17	17
GTCTTCGCAATCCAAC-1_5_B5	13.39939943	0.665436023	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	743	1089	0.004591368	0.008264463	4	12	EN-MIX	26	17	17
GTCTTCGCAATGGAAT-1_5_B5	6.120886725	16.49133222	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	993	1607	0.003733665	0.024268824	4	oligos	OL-Cntl	26	17	17
GTCTTCGCACCTGGTG-1_5_B5	-3.085582738	2.302462493	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2162	3681	0.001901657	0.00869329	4	11	Glia-MIX	26	17	17
GTCTTCGCACGCCAGT-1_5_B5	39.53754197	15.53964716	14	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1407	2243	0.000445831	0.005795809	4	14	Microglia	26	17	17
GTCTTCGCATTTCACT-1_5_B5	15.3805353	20.57995947	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1067	1784	0.002242152	0.006165919	4	oligos	OL-Cntl	26	17	17
GTCTTCGGTACTCAAC-1_5_B5	-10.97393526	6.862848782	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	3847	8972	0.003232278	0.011591618	4	11	Glia-MIX	26	17	17
GTCTTCGGTTCCAACA-1_5_B5	-2.604544519	2.324450114	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1704	2837	0.00140994	0.005992245	4	11	Glia-MIX	26	17	17
GTGAAGGAGAATCTCC-1_5_B5	-10.55213722	-0.419684518	13A	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2407	4653	0.007951859	0.008166774	4	13A	IN-VIP	26	17	17
GTGAAGGAGGCGACAT-1_5_B5	6.71930812	19.43059596	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1088	1771	0.004517222	0.019198193	4	oligos	OL-Cntl	26	17	17
GTGAAGGCAAGTACCT-1_5_B5	11.70537753	-18.08766076	4	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	4345	11154	0.003496503	0.013986014	4	L2-3	EN-L2-3-MS	26	17	17
GTGAAGGCATAGACTC-1_5_B5	-32.55694596	2.499384077	9	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1886	3565	0.002524544	0.003927069	4	9	OPC	26	17	17
GTGAAGGGTCGAGATG-1_5_B5	4.761628295	22.1315737	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	954	1474	0.000678426	0.011533243	4	oligos	OL-Cntl	26	17	17
GTGAAGGGTTTGACAC-1_5_B5	-10.31763833	-17.18834035	6B	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	920	1440	0.00625	0.004166667	4	6B	IN-SST	26	17	17
GTGCAGCCAATCGAAA-1_5_B5	6.858703074	18.91356149	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1128	1787	0.00391718	0.011191942	4	oligos	OL-Cntl	26	17	17
GTGCAGCCAGGGTTAG-1_5_B5	-2.000718027	2.710126575	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1655	2391	0.00334588	0.010037641	4	11	Glia-MIX	26	17	17
GTGCAGCGTACACCGC-1_5_B5	0.437709776	28.00655456	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	971	1422	0.007032349	0.006329114	4	oligos	OL-Cntl	26	17	17
GTGCAGCGTAGGGACT-1_5_B5	-4.207204638	13.44595623	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	953	1340	0.003731343	0.020895522	4	oligos	OL-Cntl	26	17	17
GTGCAGCGTCCGAAGA-1_5_B5	19.04082166	15.28576635	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1237	2112	0.005208333	0.003787879	4	oligos	OL-Cntl	26	17	17
GTGCAGCTCATGCTCC-1_5_B5	10.96731098	-1.292257412	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1339	1876	0.015991471	0.026119403	4	12	EN-MIX	26	17	17
GTGCATAAGACGCACA-1_5_B5	1.549508392	-7.248127978	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1226	1920	0.009375	0.0015625	4	12	EN-MIX	26	17	17
GTGCATACACCCTATC-1_5_B5	2.495822489	27.06260966	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	737	1023	0.001955034	0.008797654	4	oligos	OL-Cntl	26	17	17
GTGCATACATCCTAGA-1_5_B5	14.07452235	-4.140907954	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1500	2179	0.005966039	0.015603488	4	12	EN-MIX	26	17	17
GTGCATATCAGCACAT-1_5_B5	-1.390631248	3.090323065	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1201	1696	0.001179245	0.007665094	4	11	Glia-MIX	26	17	17
GTGCGGTAGTGTACGG-1_5_B5	3.660648674	20.15201536	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	928	1440	0.001388889	0.002083333	4	oligos	OL-Cntl	26	17	17
GTGCGGTTCGCCAGCA-1_5_B5	12.48621329	0.435689873	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	910	1255	0.001593625	0.021513944	4	12	EN-MIX	26	17	17
GTGCTTCAGGTACTCT-1_5_B5	18.20441549	12.81750153	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1304	2185	0.003203661	0.006407323	4	oligos	OL-Cntl	26	17	17
GTGCTTCCAACTTGAC-1_5_B5	20.08022224	11.35551713	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1412	2594	0.008866615	0.00385505	4	oligos	OL-Cntl	26	17	17
GTGCTTCCACATAACC-1_5_B5	-6.324104462	4.419390643	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	7592	26639	0.001952025	0.009009347	4	11	Glia-MIX	26	17	17
GTGCTTCGTCATATCG-1_5_B5	-1.610493833	19.50825753	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	735	1088	0.000919118	0.018382353	4	oligos	OL-Cntl	26	17	17
GTGCTTCGTCTAGGTT-1_5_B5	39.71573341	15.38775188	14	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1461	2270	0.002202643	0.002202643	4	14	Microglia	26	17	17
GTGCTTCTCTGATTCT-1_5_B5	9.217548255	10.31687082	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1290	2408	0.004152824	0.007475083	4	oligos	OL-Cntl	26	17	17
GTGGGTCAGCTACCTA-1_5_B5	8.88422526	2.512230209	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	929	1236	0.011326861	0.066343042	4	12	EN-MIX	26	17	17
GTGGGTCAGGGCTTCC-1_5_B5	3.591967982	16.50057169	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	988	1629	0.003683241	0.012277471	4	oligos	OL-Cntl	26	17	17
GTGGGTCAGTGTCCAT-1_5_B5	6.174465181	-3.323884614	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1259	1728	0.002893519	0.017361111	4	12	EN-MIX	26	17	17
GTGGGTCGTAATCACC-1_5_B5	14.97702553	-0.492971186	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	852	1380	0.010144928	0.002898551	4	12	EN-MIX	26	17	17
GTGGGTCGTGGTGTAG-1_5_B5	0.151299867	19.57605739	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	805	1263	0.017418844	0.013460016	4	oligos	OL-Cntl	26	17	17
GTGGGTCTCGTTTATC-1_5_B5	14.83601097	17.04213621	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1091	1950	0.004102564	0.006153846	4	oligos	OL-Cntl	26	17	17
GTGTGCGAGAAGGCCT-1_5_B5	-1.724279401	2.851748244	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1439	2040	0.004901961	0.007352941	4	11	Glia-MIX	26	17	17
GTGTGCGCATAGACTC-1_5_B5	-0.332935648	12.72060886	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	863	1251	0.003996803	0.025579536	4	oligos	OL-Cntl	26	17	17
GTGTGCGGTGTGCGTC-1_5_B5	-9.924476658	17.55650859	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2389	4488	0.002896613	0.007130125	4	11	Glia-MIX	26	17	17
GTGTGCGTCACGACTA-1_5_B5	16.67915122	15.42938002	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1219	2285	0.005689278	0.007439825	4	oligos	OL-Cntl	26	17	17
GTGTTAGAGCGAAGGG-1_5_B5	37.93570916	10.60167712	14	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	897	1227	0.000814996	0.012224939	4	14	Microglia	26	17	17
GTGTTAGAGGAGCGTT-1_5_B5	7.032842977	14.80915234	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1105	1743	0.008032129	0.017211704	4	oligos	OL-Cntl	26	17	17
GTGTTAGCAGGCTGAA-1_5_B5	11.99867562	-12.56190913	4	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	3625	8078	0.018321367	0.023149294	4	L2-3	EN-L2-3-MS	26	17	17
GTGTTAGGTTCCACGG-1_5_B5	-15.23893145	14.9905945	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2329	4982	0.000200723	0.007426736	4	8	Astrocytes	26	17	17
GTGTTAGTCACAGGCC-1_5_B5	31.90481788	-12.67370642	2	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	4150	10500	0.010857143	0.016571429	4	2	EN-L4	26	17	17
GTGTTAGTCCCTTGCA-1_5_B5	15.08817177	20.64449985	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1046	1724	0.004060325	0.005800464	4	oligos	OL-Cntl	26	17	17
GTGTTAGTCGGCTACG-1_5_B5	-3.613926006	2.594971511	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2575	4397	0.002501706	0.007732545	4	11	Glia-MIX	26	17	17
GTGTTAGTCTAACTCT-1_5_B5	-9.13467038	16.13896206	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2256	4390	0.001822323	0.003872437	4	11	Glia-MIX	26	17	17
GTTAAGCAGACCACGA-1_5_B5	6.840484867	-14.68546376	4	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2714	5418	0.007013658	0.008490218	4	L2-3	EN-L2-3-MS	26	17	17
GTTAAGCAGCTGATAA-1_5_B5	14.10649694	17.12020071	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1073	1836	0.009259259	0.003267974	4	oligos	OL-Cntl	26	17	17
GTTAAGCAGGGCTCTC-1_5_B5	12.04053572	21.34639407	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	975	1523	0.006565988	0.01116218	4	oligos	OL-Cntl	26	17	17
GTTAAGCCAGGTGGAT-1_5_B5	-31.29994798	-3.565127668	9	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1381	2122	0.002827521	0.01460886	4	9	OPC	26	17	17
GTTAAGCTCCTCAACC-1_5_B5	1.656207856	23.77952451	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	699	1106	0.002712477	0.008137432	4	oligos	OL-Cntl	26	17	17
GTTACAGGTCCCTACT-1_5_B5	20.33000038	7.540369735	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2060	4151	0.005299928	0.007949892	4	oligos	OL-Cntl	26	17	17
GTTACAGGTGTTCTTT-1_5_B5	13.92932119	-2.828517271	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1113	1760	0.001704545	0.005681818	4	12	EN-MIX	26	17	17
GTTACAGGTTAGAACA-1_5_B5	4.6576841	20.19373221	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	902	1509	0.007952286	0.011928429	4	oligos	OL-Cntl	26	17	17
GTTCATTAGGTTCCTA-1_5_B5	-1.081381821	25.77079858	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	691	1024	0.029296875	0.0078125	4	oligos	OL-Cntl	26	17	17
GTTCATTCAGACACTT-1_5_B5	18.51094486	18.29527688	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1085	1854	0.000539374	0.002696872	4	oligos	OL-Cntl	26	17	17
GTTCATTCATGCTAGT-1_5_B5	0.744427314	23.68426778	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	727	1165	0.003433476	0.004291845	4	oligos	OL-Cntl	26	17	17
GTTCATTGTGCTCTTC-1_5_B5	12.02278087	17.02984241	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1023	1654	0.003022975	0.007255139	4	oligos	OL-Cntl	26	17	17
GTTCATTTCAGGATCT-1_5_B5	5.694934945	-2.519417822	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	880	1209	0.003308519	0.00248139	4	12	EN-MIX	26	17	17
GTTCGGGCACTGTTAG-1_5_B5	-6.08517094	4.241718302	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	5086	12487	0.003283415	0.008568912	4	11	Glia-MIX	26	17	17
GTTCGGGCAGCGTCCA-1_5_B5	-3.290196532	2.59383431	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2481	4063	0.003937977	0.008368201	4	11	Glia-MIX	26	17	17
GTTCGGGTCGCCTGTT-1_5_B5	5.58572824	19.80078875	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	931	1408	0.017045455	0.013494318	4	oligos	OL-Cntl	26	17	17
GTTCGGGTCTGCTGCT-1_5_B5	32.76782813	16.74442335	14	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1238	1816	0.001101322	0.060022026	4	14	Microglia	26	17	17
GTTCTCGAGCGCCTCA-1_5_B5	-34.96860776	-7.700196293	9	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1155	1858	0	0.002152853	4	9	OPC	26	17	17
GTTCTCGCACATGGGA-1_5_B5	-29.29798785	-0.487651561	9	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1614	2587	0.005411674	0.011209896	4	9	OPC	26	17	17
GTTCTCGCACTGTTAG-1_5_B5	19.66305495	25.81247553	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1022	1614	0.004337051	0.005576208	4	oligos	OL-Cntl	26	17	17
GTTCTCGGTTCAGGCC-1_5_B5	-8.130305279	7.971832317	5	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	715	1124	0.005338078	0.023131673	4	oligos	OL-MS-1	26	17	17
GTTTCTAAGCCGCCTA-1_5_B5	-32.73588289	-8.478517156	9	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	999	1513	0.003304693	0.009914078	4	9	OPC	26	17	17
GTTTCTACAGGACCCT-1_5_B5	3.329495551	26.86722504	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	749	1215	0.004115226	0.003292181	4	oligos	OL-Cntl	26	17	17
GTTTCTAGTCGACTAT-1_5_B5	-25.42170159	12.24725912	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	957	1509	0.000662691	0.007289596	4	8	Astrocytes	26	17	17
TAAACCGAGAATGTGT-1_5_B5	-9.049042267	-15.22456682	6B	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	784	1125	0.015111111	0.002666667	4	6B	IN-SST	26	17	17
TAAACCGCAATCGAAA-1_5_B5	34.40329042	-16.10473912	2	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	4922	13232	0.022823458	0.013452237	4	2	EN-L4	26	17	17
TAAACCGCATCCTTGC-1_5_B5	-34.20266991	-3.061126463	9	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1520	2816	0.002130682	0.007457386	4	9	OPC	26	17	17
TAAACCGCATGCAACT-1_5_B5	-29.23167385	-10.33538044	9	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	987	1456	0.003434066	0.035027473	4	9	OPC	26	17	17
TAAACCGGTAGGCATG-1_5_B5	-28.36049207	0.061430289	9	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1549	2414	0.002899751	0.01905551	4	9	OPC	26	17	17
TAAACCGTCCCACTTG-1_5_B5	13.4503923	-2.90400643	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1472	2364	0.001692047	0.021573604	4	12	EN-MIX	26	17	17
TAAACCGTCCTTTCGG-1_5_B5	-23.36631514	1.281805653	9	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	3296	7826	0.00153335	0.005366726	4	9	OPC	26	17	17
TAAGAGAAGCTCCTTC-1_5_B5	11.39501331	20.29575876	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	918	1516	0.000659631	0.007915567	4	oligos	OL-Cntl	26	17	17
TAAGAGAGTAATCGTC-1_5_B5	5.170645831	13.92254847	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1033	1730	0.001734104	0.00867052	4	oligos	OL-Cntl	26	17	17
TAAGAGATCCAAACTG-1_5_B5	4.281515284	19.00574495	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	945	1550	0.000645161	0.012258065	4	oligos	OL-Cntl	26	17	17
TAAGAGATCGTTTGCC-1_5_B5	-10.66935731	15.67767147	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1574	2625	0.004571429	0.003047619	4	11	Glia-MIX	26	17	17
TAAGTGCAGCCCAATT-1_5_B5	10.58756169	1.238723598	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	931	1246	0.012841091	0.012038523	4	12	EN-MIX	26	17	17
TAAGTGCAGGACAGAA-1_5_B5	-4.35547097	3.186379876	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	3304	6576	0.002281022	0.007907543	4	11	Glia-MIX	26	17	17
TAAGTGCAGGCATTGG-1_5_B5	-1.523686619	25.36511514	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	785	1108	0.004512635	0.00631769	4	oligos	OL-Cntl	26	17	17
TAAGTGCAGGTGGGTT-1_5_B5	5.903596458	16.54309786	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1028	1744	0.000573394	0.006880734	4	oligos	OL-Cntl	26	17	17
TAAGTGCCATTAGGCT-1_5_B5	16.95623276	10.71445748	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1586	2953	0.000338639	0.008804605	4	oligos	OL-Cntl	26	17	17
TACACGAAGTGTTGAA-1_5_B5	11.92478011	13.59860839	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1390	2674	0.003739716	0.004861631	4	oligos	OL-Cntl	26	17	17
TACACGACAACTGGCC-1_5_B5	20.87549482	1.770025985	2	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1222	2072	0.00965251	0.000965251	4	2	EN-L4	26	17	17
TACACGACAGTCACTA-1_5_B5	-15.97526172	14.25364802	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1614	2685	0.004096834	0.005214153	4	8	Astrocytes	26	17	17
TACACGATCGGCTACG-1_5_B5	16.14399476	20.55938704	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1001	1633	0.00061237	0.006123699	4	oligos	OL-Cntl	26	17	17
TACACGATCTATCGCC-1_5_B5	11.63776196	-25.15561418	3	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	5943	22227	0.005938723	0.01237234	4	3	EN-L5-6	26	17	17
TACAGTGCAGACTCGC-1_5_B5	11.75180246	-3.182015096	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1597	2387	0.005446167	0.012987013	4	12	EN-MIX	26	17	17
TACAGTGTCGTAGGTT-1_5_B5	-1.349093461	13.56483339	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	964	1596	0.004385965	0.021303258	4	oligos	OL-Cntl	26	17	17
TACCTATCAATTGCTG-1_5_B5	1.009529607	22.04360097	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	880	1317	0.006833713	0.009111617	4	oligos	OL-Cntl	26	17	17
TACCTATCAGCGATCC-1_5_B5	-10.60934595	9.548812457	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	6113	20692	0.002658032	0.00608931	4	11	Glia-MIX	26	17	17
TACCTATCATCAGTAC-1_5_B5	16.85696147	12.40520309	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1352	2499	0.0020008	0.009203681	4	oligos	OL-Cntl	26	17	17
TACCTATGTTATGTGC-1_5_B5	10.94112658	19.19951461	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	958	1525	0.001311475	0.00852459	4	oligos	OL-Cntl	26	17	17
TACCTATTCTGTCTCG-1_5_B5	-6.561956611	12.02661203	5	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	731	1068	0	0.017790262	4	oligos	OL-MS-1	26	17	17
TACCTTACATTATCTC-1_5_B5	15.90870031	19.76808195	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	920	1518	0.003952569	0.0085639	4	oligos	OL-Cntl	26	17	17
TACCTTAGTAGAAAGG-1_5_B5	5.426626272	5.899050617	7	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2130	3753	0.005062617	0.004796163	4	7	Phagocytes	26	17	17
TACCTTATCGTACGGC-1_5_B5	9.648074134	22.5341572	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	827	1404	0.002136752	0.010683761	4	oligos	OL-Cntl	26	17	17
TACCTTATCTGCGTAA-1_5_B5	14.79697354	21.4769476	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	947	1588	0	0.00440806	4	oligos	OL-Cntl	26	17	17
TACGGATAGGTGATAT-1_5_B5	-4.313030904	-34.88635553	16	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	787	1005	0.013930348	0.017910448	4	16	EN-PYR	26	17	17
TACGGATAGTGACATA-1_5_B5	-4.290703122	3.022591265	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2925	5484	0.003282276	0.007111597	4	11	Glia-MIX	26	17	17
TACGGATCACTCTGTC-1_5_B5	20.00086557	-22.63383383	3	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	3410	7942	0.011332158	0.012969025	4	3	EN-L5-6	26	17	17
TACGGATCATCAGTCA-1_5_B5	11.33954513	2.230639968	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	826	1067	0.007497657	0.018744142	4	12	EN-MIX	26	17	17
TACGGATGTATGAAAC-1_5_B5	-15.42522488	-23.19550402	6A	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1628	3107	0.018667525	0.003862247	4	6A	IN-PV	26	17	17
TACGGATTCGCAAACT-1_5_B5	14.49754467	29.97437134	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	765	1143	0.000874891	0.000874891	4	oligos	OL-Cntl	26	17	17
TACGGATTCGCAAGCC-1_5_B5	-0.575029927	4.568517658	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	940	1295	0.003088803	0.006949807	4	11	Glia-MIX	26	17	17
TACGGGCCAGCTCCGA-1_5_B5	13.38254648	28.14703441	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	820	1224	0.003267974	0.001633987	4	oligos	OL-Cntl	26	17	17
TACGGGCCATTCCTCG-1_5_B5	39.78160824	14.00778784	14	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1143	1701	0.002351558	0.0111699	4	14	Microglia	26	17	17
TACGGGCTCAGCGATT-1_5_B5	15.04254776	-0.735725806	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	739	1048	0.002862595	0.003816794	4	12	EN-MIX	26	17	17
TACGGGCTCTACCTGC-1_5_B5	-11.79870571	13.49343616	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1018	1461	0.010951403	0.00752909	4	11	Glia-MIX	26	17	17
TACGGTACACGAAAGC-1_5_B5	-15.83948423	-16.97176075	6B	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1825	3546	0.011562324	0.007050197	4	6B	IN-SST	26	17	17
TACGGTAGTCTCTTAT-1_5_B5	19.97802412	13.42832133	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1536	2711	0.002213205	0.008852822	4	oligos	OL-Cntl	26	17	17
TACGGTAGTGCCTGGT-1_5_B5	-5.916794016	4.135923871	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	5176	13261	0.0024885	0.007390091	4	11	Glia-MIX	26	17	17
TACGGTATCTACTTAC-1_5_B5	39.6495398	10.92499127	14	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	828	1151	0	0.004344049	4	14	Microglia	26	17	17
TACTCATAGAAACCGC-1_5_B5	-5.507608533	-8.187506296	13A	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	790	1114	0.000897666	0.010771993	4	13A	IN-VIP	26	17	17
TACTCATAGAGTAATC-1_5_B5	15.91365378	14.72362743	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1231	2219	0.000450653	0.008111762	4	oligos	OL-Cntl	26	17	17
TACTCATTCATGCTCC-1_5_B5	18.41044389	17.58965231	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1094	1834	0.002181025	0.009269357	4	oligos	OL-Cntl	26	17	17
TACTCGCAGCCCAATT-1_5_B5	13.04727681	2.248871387	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	708	1003	0.000997009	0.006979063	4	12	EN-MIX	26	17	17
TACTCGCAGTACGCGA-1_5_B5	14.56407409	15.42274884	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1304	2109	0.001422475	0.009957326	4	oligos	OL-Cntl	26	17	17
TACTCGCCAAGCTGTT-1_5_B5	-4.955348144	3.197640923	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	3344	6651	0.0022553	0.00541272	4	11	Glia-MIX	26	17	17
TACTCGCCACCAGTTA-1_5_B5	13.85165176	0.544223628	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	674	1082	0	0.006469501	4	12	EN-MIX	26	17	17
TACTCGCTCCAGAAGG-1_5_B5	9.36258867	25.88306649	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1003	1527	0.009168304	0.006548788	4	oligos	OL-Cntl	26	17	17
TACTCGCTCCGCTGTT-1_5_B5	-5.70212622	-9.965776626	13A	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	703	1068	0.00093633	0.003745318	4	13A	IN-VIP	26	17	17
TACTCGCTCCTCAATT-1_5_B5	-4.781894709	2.852387346	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	3096	6634	0.00105517	0.00542659	4	11	Glia-MIX	26	17	17
TACTTACAGTCCGGTC-1_5_B5	19.38584958	8.69215297	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1770	3681	0.001358327	0.004889976	4	oligos	OL-Cntl	26	17	17
TACTTACCAATAGAGT-1_5_B5	13.15225708	1.519002845	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	879	1203	0.009975062	0.009975062	4	12	EN-MIX	26	17	17
TACTTACTCCCTAACC-1_5_B5	-11.04881627	7.184549556	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	4445	13027	0.004145237	0.008290474	4	11	Glia-MIX	26	17	17
TACTTACTCGCAAGCC-1_5_B5	0.478754348	1.770334091	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	915	1337	0	0.007479432	4	11	Glia-MIX	26	17	17
TACTTGTCATCGATGT-1_5_B5	5.077994556	-16.2092837	4	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	3169	7862	0.002543882	0.002925464	4	L2-3	EN-L2-3-MS	26	17	17
TACTTGTCATTGTGCA-1_5_B5	10.2114133	-18.30053503	4	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	4694	14374	0.006400445	0.008070127	4	L2-3	EN-L2-3-MS	26	17	17
TACTTGTGTCTCTTTA-1_5_B5	11.54597902	-0.475500286	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1308	2172	0.001381215	0.010128913	4	12	EN-MIX	26	17	17
TAGACCACAGCATACT-1_5_B5	-9.948493131	17.67410015	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2673	5192	0.002311248	0.006355932	4	11	Glia-MIX	26	17	17
TAGACCAGTTTAGGAA-1_5_B5	39.55874089	13.86423161	14	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1044	1563	0.005758157	0.004478567	4	14	Microglia	26	17	17
TAGACCATCGAATCCA-1_5_B5	15.94003484	10.28054812	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1434	2727	0.00660066	0.007334067	4	oligos	OL-Cntl	26	17	17
TAGAGCTCACAGATTC-1_5_B5	8.249141321	-12.94585548	4	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2533	4914	0.014855515	0.016483516	4	L2-3	EN-L2-3-MS	26	17	17
TAGAGCTGTACTTCTT-1_5_B5	-4.244871554	21.11169913	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	759	1102	0.00907441	0.013611615	4	oligos	OL-Cntl	26	17	17
TAGAGCTGTCGGATCC-1_5_B5	8.734982187	22.99026697	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	941	1528	0.009162304	0.004581152	4	oligos	OL-Cntl	26	17	17
TAGAGCTGTCTACCTC-1_5_B5	11.33490064	20.60880944	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	995	1595	0.004388715	0.010031348	4	oligos	OL-Cntl	26	17	17
TAGAGCTTCACCTTAT-1_5_B5	-5.341415688	3.818673741	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	4048	8957	0.003237691	0.007480183	4	11	Glia-MIX	26	17	17
TAGCCGGAGAAGGTGA-1_5_B5	-15.24829387	15.08269292	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2348	4095	0.001709402	0.008791209	4	8	Astrocytes	26	17	17
TAGCCGGAGATCGGGT-1_5_B5	16.75134984	-0.448042086	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	727	1017	0.005899705	0.002949853	4	12	EN-MIX	26	17	17
TAGCCGGCAAGCCGCT-1_5_B5	39.30462219	15.99185448	14	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1550	2315	0.000863931	0.011231102	4	14	Microglia	26	17	17
TAGCCGGCAGCTGGCT-1_5_B5	21.08909081	9.529107531	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1909	3606	0.004437049	0.005823627	4	oligos	OL-Cntl	26	17	17
TAGCCGGGTACTTGAC-1_5_B5	-9.321326905	13.16286705	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1119	1638	0.001221001	0.006715507	4	oligos	OL-Cntl	26	17	17
TAGCCGGGTCTTCGTC-1_5_B5	13.73270394	-0.127328766	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	759	1127	0.005323869	0.005323869	4	12	EN-MIX	26	17	17
TAGGCATGTATAAACG-1_5_B5	6.362781934	-14.99846131	4	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2670	5531	0.007955162	0.010847948	4	L2-3	EN-L2-3-MS	26	17	17
TAGGCATGTGTGCGTC-1_5_B5	-11.39642078	-21.12417044	6B	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	976	1592	0.027638191	0.003140704	4	6B	IN-SST	26	17	17
TAGGCATGTTTAGGAA-1_5_B5	6.099013092	24.74624046	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	885	1365	0.006593407	0.004395604	4	oligos	OL-Cntl	26	17	17
TAGTGGTAGCTAGGCA-1_5_B5	-15.61130119	15.28527644	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1955	3398	0.002060035	0.01177163	4	8	Astrocytes	26	17	17
TAGTGGTCACTGAAGG-1_5_B5	9.37412278	-15.9876639	4	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	3607	8671	0.009110829	0.011648022	4	L2-3	EN-L2-3-MS	26	17	17
TAGTGGTTCGAGAACG-1_5_B5	-10.77885006	9.494988161	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	4969	13263	0.00429767	0.007238181	4	11	Glia-MIX	26	17	17
TAGTGGTTCTGCTGTC-1_5_B5	-5.463623998	3.588576641	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	4136	10137	0.002762158	0.004340535	4	11	Glia-MIX	26	17	17
TAGTTGGAGGCTCTTA-1_5_B5	1.211389149	24.92112193	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	682	1147	0.001743679	0.002615519	4	oligos	OL-Cntl	26	17	17
TATCAGGCAGCAGTTT-1_5_B5	-12.21068513	12.61584495	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1118	1515	0.00330033	0.008580858	4	11	Glia-MIX	26	17	17
TATCAGGGTAGCTAAA-1_5_B5	-10.16423028	16.57333598	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1952	3503	0.001998287	0.011704253	4	11	Glia-MIX	26	17	17
TATCTCAGTCGACTAT-1_5_B5	10.39206739	16.59252942	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1007	1732	0.001732102	0.008660508	4	oligos	OL-Cntl	26	17	17
TATCTCAGTCTCCACT-1_5_B5	17.94551182	19.14656498	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1003	1729	0.010410642	0.002891845	4	oligos	OL-Cntl	26	17	17
TATCTCAGTGAGTGAC-1_5_B5	11.45116931	1.903974533	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	791	1087	0.00275989	0.011959522	4	12	EN-MIX	26	17	17
TATCTCATCTGCGGCA-1_5_B5	-2.565249958	2.384368517	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1762	2769	0.005417118	0.008306248	4	11	Glia-MIX	26	17	17
TATGCCCAGCACCGCT-1_5_B5	39.29923768	16.28606225	14	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2139	3530	0.001983003	0.011331445	4	14	Microglia	26	17	17
TATGCCCAGGCACATG-1_5_B5	7.925826937	-18.16339095	4	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	4450	11401	0.003069906	0.017893167	4	L2-3	EN-L2-3-MS	26	17	17
TATGCCCCAATCCGAT-1_5_B5	3.763356543	23.6012424	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	833	1318	0.003034901	0.009104704	4	oligos	OL-Cntl	26	17	17
TATGCCCGTCCGAACC-1_5_B5	-27.42681928	-11.91591074	9	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1046	1745	0.000573066	0.030372493	4	9	OPC	26	17	17
TATGCCCGTTATCCGA-1_5_B5	-19.00283142	19.79585544	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1846	3726	0.003757381	0.008856683	4	8	Astrocytes	26	17	17
TATGCCCGTTGCTCCT-1_5_B5	14.80862895	-0.403303883	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	804	1218	0	0.003284072	4	12	EN-MIX	26	17	17
TATTACCAGATATACG-1_5_B5	-4.997715734	3.152203168	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	3333	7377	0.002168903	0.003931137	4	11	Glia-MIX	26	17	17
TATTACCCAGTGGGAT-1_5_B5	17.37851749	5.836145567	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2812	6540	0.004281346	0.006574924	4	oligos	OL-Cntl	26	17	17
TATTACCGTCATCCCT-1_5_B5	12.16216611	24.29070102	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	828	1411	0.007087172	0.004252303	4	oligos	OL-Cntl	26	17	17
TATTACCGTTGTCTTT-1_5_B5	-0.879402928	5.040158446	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	774	1144	0.002622378	0.002622378	4	11	Glia-MIX	26	17	17
TATTACCTCTTGTACT-1_5_B5	-1.919649724	2.692378039	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1455	2280	0.002192982	0.004385965	4	11	Glia-MIX	26	17	17
TCAACGAAGTCGTACT-1_5_B5	15.85400233	15.73768454	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1161	2013	0.008941878	0.003974168	4	oligos	OL-Cntl	26	17	17
TCAACGACAATTGCTG-1_5_B5	13.55748086	15.73616756	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1312	2272	0.004401408	0.011443662	4	oligos	OL-Cntl	26	17	17
TCAACGACATGTCTCC-1_5_B5	2.865159095	27.68237208	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	710	1092	0.003663004	0.004578755	4	oligos	OL-Cntl	26	17	17
TCAACGAGTACATGTC-1_5_B5	6.70698819	18.42363827	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1163	1885	0.009018568	0.006896552	4	oligos	OL-Cntl	26	17	17
TCAACGAGTCGGCACT-1_5_B5	17.13149543	10.14391916	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1500	2668	0.004122939	0.004497751	4	oligos	OL-Cntl	26	17	17
TCAACGAGTCTGCAAT-1_5_B5	-9.964532251	11.92079258	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	743	1051	0.000951475	0.002854424	4	oligos	OL-Cntl	26	17	17
TCAACGAGTGATAAAC-1_5_B5	5.174620505	24.32887151	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	875	1279	0.007818608	0.005473026	4	oligos	OL-Cntl	26	17	17
TCAACGATCTCCTATA-1_5_B5	-3.169331003	2.28444783	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2067	3633	0.002202037	0.007431874	4	11	Glia-MIX	26	17	17
TCAATCTCACAGACAG-1_5_B5	-14.43417758	21.51141698	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1506	2697	0.000741565	0.013718947	4	8	Astrocytes	26	17	17
TCAATCTCATGCATGT-1_5_B5	14.68706427	16.94873077	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1109	1972	0.009634888	0.010141988	4	oligos	OL-Cntl	26	17	17
TCAATCTGTAACGCGA-1_5_B5	-17.40383652	6.385588428	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	750	1049	0.000953289	0.014299333	4	8	Astrocytes	26	17	17
TCAATCTTCCTTTCTC-1_5_B5	5.553042301	32.4334075	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	748	1309	0.004583652	0.003055768	4	oligos	OL-Cntl	26	17	17
TCAATCTTCTGCAAGT-1_5_B5	-18.79707084	24.0877751	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1852	3353	0.004175365	0.005666567	4	8	Astrocytes	26	17	17
TCACAAGAGTGTTGAA-1_5_B5	12.1834057	0.900438102	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	861	1096	0.016423358	0.020072993	4	12	EN-MIX	26	17	17
TCACAAGCACCGAAAG-1_5_B5	12.96589007	0.58965035	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	741	1125	0.003555556	0.013333333	4	12	EN-MIX	26	17	17
TCACAAGCAGATCGGA-1_5_B5	2.839979114	23.25624065	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	802	1229	0.004882018	0.007323027	4	oligos	OL-Cntl	26	17	17
TCACAAGGTGATAAGT-1_5_B5	12.44792283	-0.620791965	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	977	1401	0.014989293	0.009279086	4	12	EN-MIX	26	17	17
TCACAAGTCAGCAACT-1_5_B5	-19.15905476	27.88667218	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2374	5013	0.002593258	0.011170956	4	8	Astrocytes	26	17	17
TCACAAGTCGCGTAGC-1_5_B5	-4.533162593	21.48872444	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	700	1001	0.003996004	0.022977023	4	oligos	OL-Cntl	26	17	17
TCACGAAAGCGACGTA-1_5_B5	16.77939865	7.394548784	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2165	4011	0.003490401	0.01022189	4	oligos	OL-Cntl	26	17	17
TCACGAAGTTCATGGT-1_5_B5	-20.01780027	23.77254917	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1797	3747	0.002935682	0.009340806	4	8	Astrocytes	26	17	17
TCACGAAGTTTGACAC-1_5_B5	-11.98095817	32.57400687	17	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1081	1492	0.008042895	0.021447721	4	oligos	OL-MS-2	26	17	17
TCACGAATCAGGCAAG-1_5_B5	-10.72353287	-20.01951439	6B	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	924	1402	0.024964337	0.002853067	4	6B	IN-SST	26	17	17
TCACGAATCGCATGGC-1_5_B5	-4.199687851	3.128587358	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	3153	5868	0.004260395	0.007498296	4	11	Glia-MIX	26	17	17
TCAGATGCAAACCTAC-1_5_B5	16.05938057	-0.968207718	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	734	1161	0.002583979	0	4	12	EN-MIX	26	17	17
TCAGATGCACAAGTAA-1_5_B5	15.87050592	13.03350524	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1249	2081	0.001441615	0.008649688	4	oligos	OL-Cntl	26	17	17
TCAGATGCACAGGAGT-1_5_B5	0.934735017	18.35815043	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	838	1395	0.011469534	0.013620072	4	oligos	OL-Cntl	26	17	17
TCAGATGGTCGAGATG-1_5_B5	6.231538876	18.38532526	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1002	1629	0.01043585	0.012891344	4	oligos	OL-Cntl	26	17	17
TCAGATGGTCTGATCA-1_5_B5	10.96131122	21.6780886	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	925	1596	0.002506266	0.006892231	4	oligos	OL-Cntl	26	17	17
TCAGATGGTGAAGGCT-1_5_B5	22.37667144	15.94521881	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1459	2542	0.003147128	0.007867821	4	oligos	OL-Cntl	26	17	17
TCAGATGTCTCTGTCG-1_5_B5	-18.98850703	23.62291992	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1525	2773	0.00036062	0.005048684	4	8	Astrocytes	26	17	17
TCAGCAACAGACACTT-1_5_B5	-18.03020271	28.24503056	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2331	4740	0.000421941	0.012869198	4	8	Astrocytes	26	17	17
TCAGCAACATGTCCTC-1_5_B5	16.61310806	1.735942581	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	771	1089	0.001836547	0.000918274	4	12	EN-MIX	26	17	17
TCAGCAATCAGCGATT-1_5_B5	-20.44047506	23.78151947	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1905	3902	0.003331625	0.008969759	4	8	Astrocytes	26	17	17
TCAGCAATCATGTAGC-1_5_B5	13.09759756	16.78485994	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1195	2157	0.00880853	0.003708855	4	oligos	OL-Cntl	26	17	17
TCAGCAATCCACGACG-1_5_B5	13.51837475	0.373400437	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	801	1239	0.002421308	0.008071025	4	12	EN-MIX	26	17	17
TCAGCAATCCCACTTG-1_5_B5	4.844179036	23.94997063	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	846	1255	0.001593625	0.006374502	4	oligos	OL-Cntl	26	17	17
TCAGCAATCTGTGCAA-1_5_B5	3.575188282	23.82248333	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	796	1144	0.002622378	0.01486014	4	oligos	OL-Cntl	26	17	17
TCAGCAATCTTATCTG-1_5_B5	17.81498179	-26.51452929	3	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	5925	23109	0.000605825	0.010904842	4	3	EN-L5-6	26	17	17
TCAGCTCAGCGTCTAT-1_5_B5	1.362151826	20.83142815	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	774	1097	0.006381039	0.004557885	4	oligos	OL-Cntl	26	17	17
TCAGCTCAGTGTACCT-1_5_B5	-6.924088534	9.661296937	5	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	833	1160	0.01637931	0.034482759	4	oligos	OL-MS-1	26	17	17
TCAGCTCCAGATCCAT-1_5_B5	-7.96221503	7.903061814	5	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	862	1243	0.000804505	0.041834272	4	oligos	OL-MS-1	26	17	17
TCAGCTCCATTCTCAT-1_5_B5	20.6004079	11.85960533	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1482	2740	0.002554745	0.00620438	4	oligos	OL-Cntl	26	17	17
TCAGCTCTCCCAAGTA-1_5_B5	-24.79870378	-18.88146458	6B	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	3716	9129	0.020155548	0.024318107	4	6B	IN-SST	26	17	17
TCAGCTCTCCTACAGA-1_5_B5	-6.258909524	4.371222141	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	6727	21833	0.00329776	0.007740576	4	11	Glia-MIX	26	17	17
TCAGCTCTCGCATGGC-1_5_B5	14.59885489	-3.50358889	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1339	2349	0.002979991	0.00553427	4	12	EN-MIX	26	17	17
TCAGGATCAAGAAAGG-1_5_B5	21.07559685	14.37232966	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1248	1915	0.004699739	0.007832898	4	oligos	OL-Cntl	26	17	17
TCAGGATGTCAAAGCG-1_5_B5	14.72738859	17.08762612	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1137	1923	0.002600104	0.00624025	4	oligos	OL-Cntl	26	17	17
TCAGGATGTCGCATCG-1_5_B5	-4.622402954	3.426147651	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	3358	6660	0.002252252	0.00975976	4	11	Glia-MIX	26	17	17
TCAGGATTCGCATGAT-1_5_B5	11.04727696	22.86458396	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	809	1339	0.002240478	0.006721434	4	oligos	OL-Cntl	26	17	17
TCAGGATTCGCGTTTC-1_5_B5	21.03227379	16.02347502	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1313	2147	0.001863065	0.008849558	4	oligos	OL-Cntl	26	17	17
TCAGGTACACCAGGTC-1_5_B5	-9.119011808	17.37450584	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	4348	10167	0.002262221	0.00688502	4	11	Glia-MIX	26	17	17
TCAGGTAGTTTGGCGC-1_5_B5	14.90599508	19.48203767	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1027	1681	0.009518144	0.001784652	4	oligos	OL-Cntl	26	17	17
TCAGGTATCTACCAGA-1_5_B5	0.449041027	25.59064434	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	720	1093	0.003659652	0.009149131	4	oligos	OL-Cntl	26	17	17
TCAGGTATCTCGTATT-1_5_B5	-15.26069215	15.49996487	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2566	5385	0.000185701	0.005013928	4	8	Astrocytes	26	17	17
TCATTACAGAAACCTA-1_5_B5	-5.834827413	3.752722751	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	5505	17662	0.002151512	0.004755973	4	11	Glia-MIX	26	17	17
TCATTACAGGCATTGG-1_5_B5	22.88396892	18.08557485	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1110	1806	0.00055371	0.003875969	4	oligos	OL-Cntl	26	17	17
TCATTACCAAACTGCT-1_5_B5	12.90442804	2.404517331	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	896	1361	0.001469508	0.008817046	4	12	EN-MIX	26	17	17
TCATTACGTGTTGGGA-1_5_B5	16.75926596	5.92080086	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2591	5817	0.006016847	0.008595496	4	oligos	OL-Cntl	26	17	17
TCATTACTCCCTTGCA-1_5_B5	17.42363663	-5.158695456	3	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1660	2910	0.004123711	0.010652921	4	3	EN-L5-6	26	17	17
TCATTACTCTCTTATG-1_5_B5	4.434062142	26.3333972	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	795	1291	0.00464756	0.006196747	4	oligos	OL-Cntl	26	17	17
TCATTTGAGGCTCTTA-1_5_B5	19.36529571	-26.39236873	3	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	4252	14351	0.002438854	0.006619748	4	3	EN-L5-6	26	17	17
TCATTTGCAATAGAGT-1_5_B5	12.81940861	23.63587309	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	879	1469	0.016337645	0.004084411	4	oligos	OL-Cntl	26	17	17
TCATTTGCACCCAGTG-1_5_B5	7.268150137	35.3590066	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	993	1521	0.040762656	0.002629849	4	11	Glia-MIX	26	17	17
TCATTTGGTCTAACGT-1_5_B5	17.36372962	12.36640053	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1308	2283	0.008322383	0.006132282	4	oligos	OL-Cntl	26	17	17
TCATTTGGTGAGTATA-1_5_B5	8.526894424	12.90853581	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1296	2332	0.003430532	0.010720412	4	oligos	OL-Cntl	26	17	17
TCATTTGGTTGAGGTG-1_5_B5	-6.097316386	2.942532659	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	5332	15539	0.004376086	0.00444044	4	11	Glia-MIX	26	17	17
TCATTTGTCATGCTCC-1_5_B5	-6.072831346	3.955504132	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	7206	30998	0.001580747	0.004161559	4	11	Glia-MIX	26	17	17
TCCACACAGCGCCTTG-1_5_B5	14.72291555	-0.303479543	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	674	1018	0.009823183	0.001964637	4	12	EN-MIX	26	17	17
TCCACACAGCTAGTCT-1_5_B5	-6.173171704	4.167673188	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	7373	26168	0.002178233	0.006114338	4	11	Glia-MIX	26	17	17
TCCACACCACCAGCAC-1_5_B5	0.210889118	0.05099496	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	754	1065	0.002816901	0.009389671	4	11	Glia-MIX	26	17	17
TCCACACCACCAGGTC-1_5_B5	15.79539281	-2.607157679	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1061	1796	0	0.00389755	4	12	EN-MIX	26	17	17
TCCACACGTAAATGTG-1_5_B5	5.508392964	17.42076155	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1051	1668	0.010791367	0.01558753	4	oligos	OL-Cntl	26	17	17
TCCACACGTTCTGAAC-1_5_B5	18.74689075	9.508012608	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1566	2927	0.006491288	0.005466348	4	oligos	OL-Cntl	26	17	17
TCCACACTCACTGGGC-1_5_B5	-6.368093325	4.407005676	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	10156	53573	0.002519926	0.007018461	4	11	Glia-MIX	26	17	17
TCCCGATAGGTTACCT-1_5_B5	16.35282522	11.14014341	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1557	2825	0.003185841	0.010973451	4	oligos	OL-Cntl	26	17	17
TCCCGATCACAGGCCT-1_5_B5	-9.36118826	-16.20890065	6B	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	905	1316	0.005319149	0.010638298	4	6B	IN-SST	26	17	17
TCCCGATCACGTAAGG-1_5_B5	10.63180781	-1.350809692	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1330	1814	0.007717751	0.030319735	4	12	EN-MIX	26	17	17
TCCCGATCACTCTGTC-1_5_B5	18.92855446	7.322209219	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2190	4309	0.003016941	0.005569738	4	oligos	OL-Cntl	26	17	17
TCCCGATGTCAATACC-1_5_B5	-11.33988308	-22.06173796	6A	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	887	1457	0.021276596	0.002745367	4	6A	IN-PV	26	17	17
TCCCGATGTGTTCGAT-1_5_B5	7.497498315	22.81764644	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1109	1773	0.001128032	0.007896221	4	oligos	OL-Cntl	26	17	17
TCCCGATTCACTTACT-1_5_B5	17.62624362	9.469299497	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1600	3132	0.002873563	0.008301405	4	oligos	OL-Cntl	26	17	17
TCCCGATTCTTATCTG-1_5_B5	15.95990205	16.0056923	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1138	1980	0.004040404	0.006060606	4	oligos	OL-Cntl	26	17	17
TCGAGGCCATCTATGG-1_5_B5	-10.78769564	9.442535553	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	5741	16257	0.002091407	0.009903426	4	11	Glia-MIX	26	17	17
TCGAGGCCATTGAGCT-1_5_B5	18.58161474	8.992001404	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1661	3038	0.003620803	0.002962475	4	oligos	OL-Cntl	26	17	17
TCGAGGCGTAAGAGGA-1_5_B5	13.57465314	12.43383134	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1443	2375	0.005052632	0.011789474	4	oligos	OL-Cntl	26	17	17
TCGAGGCGTGCTTCTC-1_5_B5	-18.35728792	5.925533291	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	785	1080	0	0.009259259	4	8	Astrocytes	26	17	17
TCGCGAGAGACCGGAT-1_5_B5	-15.24808799	15.2744635	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2770	5406	0.001479837	0.009248983	4	8	Astrocytes	26	17	17
TCGCGAGGTACTCGCG-1_5_B5	15.81303467	13.00437657	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1449	2506	0.003192338	0.004788508	4	oligos	OL-Cntl	26	17	17
TCGCGAGGTCGTCTTC-1_5_B5	14.04761629	16.05197645	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1213	1988	0.006539235	0.00804829	4	oligos	OL-Cntl	26	17	17
TCGCGAGGTCTAGTCA-1_5_B5	-6.151228661	4.263188921	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	6214	17875	0.002797203	0.007776224	4	11	Glia-MIX	26	17	17
TCGCGAGTCTGTTTGT-1_5_B5	-4.139598489	2.64285493	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2692	4848	0.002268977	0.005363036	4	11	Glia-MIX	26	17	17
TCGCGTTCATCCAACA-1_5_B5	19.26433294	16.08096379	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1316	2392	0.006688963	0.005852843	4	oligos	OL-Cntl	26	17	17
TCGCGTTGTCTAGGTT-1_5_B5	8.755565864	2.875164867	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	820	1057	0.005676443	0.020813623	4	12	EN-MIX	26	17	17
TCGCGTTGTTAGATGA-1_5_B5	-3.815020679	2.652016242	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2659	4703	0.002338933	0.006378907	4	11	Glia-MIX	26	17	17
TCGCGTTTCACATAGC-1_5_B5	8.208965537	-18.76958114	4	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	4223	10353	0.002897711	0.015357867	4	L2-3	EN-L2-3-MS	26	17	17
TCGCGTTTCAGCGATT-1_5_B5	5.983228524	33.16866537	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	767	1181	0.010160881	0.00592718	4	oligos	OL-Cntl	26	17	17
TCGGGACAGATCCGAG-1_5_B5	5.783806089	6.158035452	7	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2312	4129	0.000726568	0.00799225	4	7	Phagocytes	26	17	17
TCGGGACAGCGCTTAT-1_5_B5	10.9044581	22.94645911	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	900	1405	0	0.009964413	4	oligos	OL-Cntl	26	17	17
TCGGGACCAGCTCGAC-1_5_B5	9.540724274	-18.44856537	4	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	4264	10712	0.004480956	0.007374907	4	L2-3	EN-L2-3-MS	26	17	17
TCGGGACTCCTCGCAT-1_5_B5	14.32646663	-1.105427651	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	928	1406	0.008534851	0.00284495	4	12	EN-MIX	26	17	17
TCGGGACTCTTAGCCC-1_5_B5	8.580591674	-20.37301573	4	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	5247	16831	0.001188284	0.014615887	4	L2-3	EN-L2-3-MS	26	17	17
TCGGTAACAAACCTAC-1_5_B5	18.81431451	6.317772967	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2631	5781	0.000864902	0.008649023	4	oligos	OL-Cntl	26	17	17
TCGGTAACACATTTCT-1_5_B5	-5.857197728	3.888653403	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	5006	13509	0.001332445	0.007402472	4	11	Glia-MIX	26	17	17
TCGGTAAGTCTCTTAT-1_5_B5	-7.025754698	-9.929378781	13A	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	748	1006	0.015904573	0.004970179	4	13A	IN-VIP	26	17	17
TCGGTAAGTTGGACCC-1_5_B5	18.08254656	14.68759853	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1213	1992	0.00502008	0.003012048	4	oligos	OL-Cntl	26	17	17
TCGGTAATCATCACCC-1_5_B5	16.14880537	15.64637347	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1208	1928	0.000518672	0.007261411	4	oligos	OL-Cntl	26	17	17
TCGTACCCATGGGACA-1_5_B5	-9.372534337	13.14464521	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1205	1665	0.01021021	0.009009009	4	oligos	OL-Cntl	26	17	17
TCGTACCGTTCCATGA-1_5_B5	15.13816876	22.10515578	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	900	1392	0	0.006465517	4	oligos	OL-Cntl	26	17	17
TCGTACCTCACCTCGT-1_5_B5	10.11372625	-0.426144551	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1233	1805	0.013850416	0.028254848	4	12	EN-MIX	26	17	17
TCGTAGAAGAATCTCC-1_5_B5	13.96593977	19.81779605	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1021	1861	0.002686728	0.007522837	4	oligos	OL-Cntl	26	17	17
TCGTAGAAGCCTTGAT-1_5_B5	-0.951459943	3.59010383	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1106	1606	0.00373599	0.008094645	4	11	Glia-MIX	26	17	17
TCGTAGAGTGAAGGCT-1_5_B5	15.81168838	15.00732352	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1238	2014	0.007447865	0.006454816	4	oligos	OL-Cntl	26	17	17
TCGTAGAGTTCTGTTT-1_5_B5	1.556685617	25.9451314	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	729	1125	0.012444444	0.007111111	4	oligos	OL-Cntl	26	17	17
TCGTAGATCTGTACGA-1_5_B5	15.76854889	17.77327063	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1141	2010	0.005472637	0.008955224	4	oligos	OL-Cntl	26	17	17
TCTATTGAGCAGGTCA-1_5_B5	9.463816692	1.410981851	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	807	1079	0.006487488	0.012048193	4	12	EN-MIX	26	17	17
TCTATTGCACAGGCCT-1_5_B5	-1.177051475	23.55756936	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	735	1168	0.004280822	0.005136986	4	oligos	OL-Cntl	26	17	17
TCTATTGCATCTATGG-1_5_B5	1.955397662	16.90117376	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	972	1718	0.004656577	0.008731083	4	oligos	OL-Cntl	26	17	17
TCTATTGGTCCTAGCG-1_5_B5	5.267453197	20.22641822	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	822	1352	0.00147929	0.006656805	4	oligos	OL-Cntl	26	17	17
TCTATTGGTTACCGAT-1_5_B5	15.26143688	21.96926368	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	835	1378	0.000725689	0.006531205	4	oligos	OL-Cntl	26	17	17
TCTATTGTCCAAACTG-1_5_B5	-4.282163363	2.515106255	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2654	5709	0.002101944	0.004028727	4	11	Glia-MIX	26	17	17
TCTATTGTCCATGCTC-1_5_B5	13.0912404	0.536285049	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	877	1364	0.005131965	0.008797654	4	12	EN-MIX	26	17	17
TCTATTGTCCGATATG-1_5_B5	9.972437473	-0.565929677	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1107	1710	0.007017544	0.011111111	4	12	EN-MIX	26	17	17
TCTCATAAGTAAGTAC-1_5_B5	38.99915211	10.84440089	14	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	809	1148	0.00087108	0.00261324	4	14	Microglia	26	17	17
TCTCTAAGTTGCGCAC-1_5_B5	11.07404178	-14.71732932	4	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	3378	6931	0.005915452	0.01918915	4	L2-3	EN-L2-3-MS	26	17	17
TCTGAGATCAGTACGT-1_5_B5	35.91813006	8.102959469	14	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	829	1161	0.004306632	0.002583979	4	14	Microglia	26	17	17
TCTGGAAAGATGAGAG-1_5_B5	11.59034048	24.43252826	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	812	1261	0.000793021	0.004758128	4	oligos	OL-Cntl	26	17	17
TCTGGAACAGACAAGC-1_5_B5	12.49514754	12.08308477	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1238	2110	0	0.015165877	4	oligos	OL-Cntl	26	17	17
TCTGGAAGTCATATCG-1_5_B5	-10.45087133	17.36194212	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2803	5361	0.003544115	0.005969036	4	11	Glia-MIX	26	17	17
TCTGGAAGTCGCGGTT-1_5_B5	5.867925502	17.66916557	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1066	1730	0.010404624	0.011560694	4	oligos	OL-Cntl	26	17	17
TCTGGAAGTCTGATCA-1_5_B5	-2.697347376	2.437282924	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1911	2993	0.004343468	0.008686936	4	11	Glia-MIX	26	17	17
TCTGGAATCCTGCTTG-1_5_B5	11.44435549	12.6504435	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1161	1874	0.002134472	0.017609392	4	oligos	OL-Cntl	26	17	17
TCTGGAATCTGAGGGA-1_5_B5	10.71691045	22.35059396	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	810	1332	0	0.004504505	4	oligos	OL-Cntl	26	17	17
TCTTCGGAGATCACGG-1_5_B5	-0.917519532	3.794826728	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1102	1636	0.001222494	0.005501222	4	11	Glia-MIX	26	17	17
TCTTCGGCACCTCGGA-1_5_B5	34.25298322	-13.46718836	2	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	3036	6339	0.019245938	0.014828837	4	2	EN-L4	26	17	17
TCTTCGGGTACCATCA-1_5_B5	-17.61951547	12.50243409	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1099	1804	0.001108647	0.010532151	4	8	Astrocytes	26	17	17
TCTTCGGGTCCGTGAC-1_5_B5	17.10443293	5.50074265	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	3533	8528	0.005745779	0.013015947	4	oligos	OL-Cntl	26	17	17
TCTTCGGGTGCCTGCA-1_5_B5	2.381650313	25.32264953	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	665	1018	0.000982318	0.00589391	4	oligos	OL-Cntl	26	17	17
TCTTCGGTCATTTGGG-1_5_B5	39.67555989	12.63881766	14	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	943	1371	0	0.006564551	4	14	Microglia	26	17	17
TCTTCGGTCCTAGGGC-1_5_B5	14.58343948	30.50200841	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	910	1448	0.006906077	0.003453039	4	oligos	OL-Cntl	26	17	17
TCTTCGGTCTCCCTGA-1_5_B5	5.972559016	-13.28350366	4	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2449	5173	0.007732457	0.00811908	4	L2-3	EN-L2-3-MS	26	17	17
TCTTTCCGTCATGCAT-1_5_B5	-9.982260542	11.93475261	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	830	1200	0.000833333	0.009166667	4	11	Glia-MIX	26	17	17
TGAAAGACAGCGAACA-1_5_B5	6.228510164	26.96111184	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	883	1295	0.005405405	0.004633205	4	oligos	OL-Cntl	26	17	17
TGAAAGAGTCTGATTG-1_5_B5	2.340620204	23.01724316	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	854	1292	0.007739938	0.005417957	4	oligos	OL-Cntl	26	17	17
TGAAAGAGTTCTCATT-1_5_B5	39.51535113	14.93549923	14	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1206	1827	0.010399562	0.006020799	4	14	Microglia	26	17	17
TGAAAGATCCTACAGA-1_5_B5	13.54378804	-2.903344848	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1281	2006	0.003489531	0.011465603	4	12	EN-MIX	26	17	17
TGACAACCAATGAAAC-1_5_B5	11.95297274	16.6383732	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1193	2139	0.000467508	0.007012623	4	oligos	OL-Cntl	26	17	17
TGACAACGTGACCAAG-1_5_B5	12.6631884	0.489019998	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	909	1267	0.008681926	0.011049724	4	12	EN-MIX	26	17	17
TGACAACTCATTTGGG-1_5_B5	15.81713229	19.36671949	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1055	1767	0.000565931	0.007923033	4	oligos	OL-Cntl	26	17	17
TGACGGCAGAAACCTA-1_5_B5	-27.70635767	0.387703412	9	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2359	4489	0.002004901	0.026509245	4	9	OPC	26	17	17
TGACGGCAGATCCCGC-1_5_B5	15.41619173	18.65174822	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1160	1973	0.001520527	0.006082108	4	oligos	OL-Cntl	26	17	17
TGACGGCAGCTACCGC-1_5_B5	39.78368977	14.67894751	14	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1219	1772	0.003386005	0.011851016	4	14	Microglia	26	17	17
TGACGGCAGGGAACGG-1_5_B5	-37.11933951	0.492684768	9	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1834	3260	0.003067485	0.005214724	4	9	OPC	26	17	17
TGACGGCCACCATCCT-1_5_B5	11.18639078	-0.098095004	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1144	1637	0.005497862	0.026267563	4	12	EN-MIX	26	17	17
TGACGGCCAGACAGGT-1_5_B5	11.66110908	2.701518288	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	887	1112	0.008992806	0.021582734	4	12	EN-MIX	26	17	17
TGACGGCTCGTACCGG-1_5_B5	6.705486178	-27.23274938	3	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	7473	27488	0.00076397	0.004292782	4	3	EN-L5-6	26	17	17
TGACGGCTCGTCTGAA-1_5_B5	-6.393140363	4.481538206	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	7562	24135	0.00310752	0.01081417	4	11	Glia-MIX	26	17	17
TGACGGCTCTCACATT-1_5_B5	36.5482466	15.67181235	14	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1472	2257	0.007532122	0.019494905	4	14	Microglia	26	17	17
TGACGGCTCTGGGCCA-1_5_B5	-15.22241436	15.80513038	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2603	4898	0.003062474	0.006329114	4	8	Astrocytes	26	17	17
TGACGGCTCTTGCAAG-1_5_B5	-13.84364389	24.4733131	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2079	4013	0.004734613	0.01968602	4	8	Astrocytes	26	17	17
TGACTAGAGCCAGAAC-1_5_B5	4.866389156	23.86086466	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	834	1191	0.004198153	0.010075567	4	oligos	OL-Cntl	26	17	17
TGACTAGCACATAACC-1_5_B5	15.40318016	-4.830237195	10	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1190	2087	0.011978917	0.00143747	4	L2-3	EN-L2-3-Cntl	26	17	17
TGACTAGGTATATGAG-1_5_B5	-3.552347353	2.555843734	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2504	4366	0.002977554	0.009619789	4	11	Glia-MIX	26	17	17
TGACTAGTCCGCAAGC-1_5_B5	16.69097302	11.75901588	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1498	2645	0.006049149	0.007183365	4	oligos	OL-Cntl	26	17	17
TGACTAGTCCTGCCAT-1_5_B5	-10.49945147	9.634386218	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	3190	6947	0.002159205	0.004894199	4	11	Glia-MIX	26	17	17
TGACTAGTCGTTTAGG-1_5_B5	-10.77244684	9.49614356	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	4411	9953	0.002913694	0.009243444	4	11	Glia-MIX	26	17	17
TGACTTTAGCAATATG-1_5_B5	1.53468841	21.00108512	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	780	1292	0.001547988	0.013157895	4	oligos	OL-Cntl	26	17	17
TGACTTTGTTATGTGC-1_5_B5	-3.097881777	21.53858685	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	898	1489	0.013431833	0.010745467	4	oligos	OL-Cntl	26	17	17
TGACTTTTCACAATGC-1_5_B5	0.936727463	19.5781398	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	802	1268	0	0.012618297	4	oligos	OL-Cntl	26	17	17
TGAGAGGAGTCTTGCA-1_5_B5	-30.81705453	0.955010768	9	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1900	3268	0.009791922	0.004895961	4	9	OPC	26	17	17
TGAGAGGCATGGGACA-1_5_B5	-5.632387171	3.963211569	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	4401	9778	0.00245449	0.009408877	4	11	Glia-MIX	26	17	17
TGAGAGGGTCTCTTAT-1_5_B5	39.54100285	14.71730413	14	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1283	1965	0.004580153	0.007124682	4	14	Microglia	26	17	17
TGAGAGGTCGCATGGC-1_5_B5	16.39738906	6.174338891	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2236	4590	0.003921569	0.008496732	4	oligos	OL-Cntl	26	17	17
TGAGAGGTCTTACCGC-1_5_B5	5.02582617	23.07323691	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	926	1415	0.001413428	0.014134276	4	oligos	OL-Cntl	26	17	17
TGAGCATCAGGCTGAA-1_5_B5	-2.125211445	22.44698799	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	760	1053	0.005698006	0.012345679	4	oligos	OL-Cntl	26	17	17
TGAGCATCAGTGAGTG-1_5_B5	-11.69577074	18.83101054	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2498	4815	0.003322949	0.00768432	4	11	Glia-MIX	26	17	17
TGAGCCGCAGGACCCT-1_5_B5	10.78911368	22.22388266	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	954	1592	0.004396985	0.011306533	4	oligos	OL-Cntl	26	17	17
TGAGCCGCATACGCCG-1_5_B5	39.65967241	15.35675206	14	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1405	2210	0.000904977	0.006334842	4	14	Microglia	26	17	17
TGAGCCGTCACATACG-1_5_B5	22.45354315	15.89425634	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1330	2118	0.000472144	0.013220019	4	oligos	OL-Cntl	26	17	17
TGAGGGAAGGTCATCT-1_5_B5	8.468728599	-14.88172936	4	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	3034	6446	0.006515669	0.015358362	4	L2-3	EN-L2-3-MS	26	17	17
TGAGGGAAGTTCGATC-1_5_B5	4.701843506	23.39229743	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	852	1241	0.001611604	0.012087027	4	oligos	OL-Cntl	26	17	17
TGAGGGACAAGTTAAG-1_5_B5	14.81782623	2.738700137	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	764	1046	0.012428298	0.006692161	4	12	EN-MIX	26	17	17
TGAGGGAGTGAGGGTT-1_5_B5	1.970266635	22.34602903	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	771	1132	0.00795053	0.006183746	4	oligos	OL-Cntl	26	17	17
TGAGGGAGTGCTCTTC-1_5_B5	-5.141121704	3.474170833	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	3921	8271	0.002538992	0.007375166	4	11	Glia-MIX	26	17	17
TGAGGGAGTTATGTGC-1_5_B5	-29.37515134	-10.34676874	9	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	972	1372	0	0.031341108	4	9	OPC	26	17	17
TGAGGGAGTTTGGCGC-1_5_B5	-16.13090221	12.63533051	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1323	2083	0.000960154	0.010081613	4	8	Astrocytes	26	17	17
TGAGGGATCTCCAACC-1_5_B5	15.29079311	-4.494958497	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1812	2888	0.019390582	0.015927978	4	12	EN-MIX	26	17	17
TGATTTCCAACGCACC-1_5_B5	13.64257994	16.27789227	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1138	1897	0.003162889	0.010015814	4	oligos	OL-Cntl	26	17	17
TGATTTCGTCCCTACT-1_5_B5	17.80790663	13.11049617	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1305	2407	0.001246365	0.004985459	4	oligos	OL-Cntl	26	17	17
TGATTTCTCCTCATTA-1_5_B5	17.19618243	12.65076782	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1280	2199	0.016371078	0.006821282	4	oligos	OL-Cntl	26	17	17
TGCACCTAGGCCGAAT-1_5_B5	2.787425016	-8.056377335	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1508	2543	0.016909162	0.007078254	4	12	EN-MIX	26	17	17
TGCACCTAGTACGCGA-1_5_B5	15.73405738	14.20358196	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1408	2348	0.008517888	0.009369676	4	oligos	OL-Cntl	26	17	17
TGCACCTAGTTATCGC-1_5_B5	3.707623265	25.10804168	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	822	1173	0.002557545	0.005967604	4	oligos	OL-Cntl	26	17	17
TGCACCTTCAACACAC-1_5_B5	17.21243869	0.054784234	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	799	1191	0.039462636	0.000839631	4	12	EN-MIX	26	17	17
TGCACCTTCCGCGCAA-1_5_B5	11.76150627	-18.77175345	4	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	5586	17067	0.004687408	0.009784965	4	L2-3	EN-L2-3-MS	26	17	17
TGCCAAAGTTATCACG-1_5_B5	17.07363076	1.698473015	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	795	1152	0.009548611	0.003472222	4	12	EN-MIX	26	17	17
TGCCAAATCCTAGTGA-1_5_B5	11.64572794	19.22542848	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1106	1900	0.003157895	0.01	4	oligos	OL-Cntl	26	17	17
TGCCAAATCGGCTTGG-1_5_B5	22.47591881	16.01444731	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1411	2334	0.006855184	0.00856898	4	oligos	OL-Cntl	26	17	17
TGCCCATAGAATGTGT-1_5_B5	6.193387349	16.14636139	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1061	1636	0.012836186	0.016503667	4	oligos	OL-Cntl	26	17	17
TGCCCATAGCTGCAAG-1_5_B5	11.44299457	11.19919272	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1606	2739	0.002920774	0.01350858	4	oligos	OL-Cntl	26	17	17
TGCCCATAGGGTTCCC-1_5_B5	13.87545387	0.032330449	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	840	1301	0.001537279	0.005380477	4	12	EN-MIX	26	17	17
TGCCCATCAGGAACGT-1_5_B5	6.420798317	13.42108225	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1446	2320	0.00387931	0.010344828	4	oligos	OL-Cntl	26	17	17
TGCCCATCAGTTCCCT-1_5_B5	15.71077969	1.815970866	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	977	1436	0	0.004178273	4	12	EN-MIX	26	17	17
TGCCCATGTCAGAAGC-1_5_B5	-8.926115262	16.90604259	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	4984	12120	0.001237624	0.007425743	4	11	Glia-MIX	26	17	17
TGCCCATTCCCAAGAT-1_5_B5	-6.462858544	4.526487691	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	8897	31764	0.003337111	0.012655837	4	11	Glia-MIX	26	17	17
TGCCCATTCTGAAAGA-1_5_B5	-34.97113858	5.062034332	9	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	3011	6572	0.003195374	0.003347535	4	9	OPC	26	17	17
TGCCCTAAGTTATCGC-1_5_B5	12.26269841	14.73456721	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1325	2173	0.005062126	0.012425219	4	oligos	OL-Cntl	26	17	17
TGCCCTACAAACCTAC-1_5_B5	12.5309475	15.04100776	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1304	2425	0.002886598	0.005360825	4	oligos	OL-Cntl	26	17	17
TGCCCTACATACGCCG-1_5_B5	-15.63893884	13.76958165	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1628	2513	0.001591723	0.0155193	4	8	Astrocytes	26	17	17
TGCCCTAGTAGCGATG-1_5_B5	13.08061315	16.67277662	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1197	1890	0.001058201	0.006349206	4	oligos	OL-Cntl	26	17	17
TGCCCTAGTTATCACG-1_5_B5	17.32027975	13.86789694	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1292	2213	0.001807501	0.010845007	4	oligos	OL-Cntl	26	17	17
TGCCCTAGTTATTCTC-1_5_B5	-20.58482456	24.86406075	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1993	4160	0.004567308	0.006009615	4	8	Astrocytes	26	17	17
TGCCCTATCAACACTG-1_5_B5	16.89817055	1.793285667	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	889	1297	0.00616808	0.00308404	4	12	EN-MIX	26	17	17
TGCCCTATCGAATGCT-1_5_B5	6.268965167	33.96572501	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1010	1644	0.001824818	0.006690998	4	oligos	OL-Cntl	26	17	17
TGCCCTATCTACGAGT-1_5_B5	10.3300578	-13.90881336	4	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	3544	7790	0.008087291	0.024133504	4	L2-3	EN-L2-3-MS	26	17	17
TGCGCAGAGTACGTAA-1_5_B5	15.69002752	21.27656634	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	980	1505	0.001993355	0.005980066	4	oligos	OL-Cntl	26	17	17
TGCGCAGGTATATGAG-1_5_B5	7.129942889	-5.889102354	10	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1345	2276	0.007469244	0.003514938	4	L2-3	EN-L2-3-Cntl	26	17	17
TGCGCAGGTTACGCGC-1_5_B5	6.142192638	26.45312828	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	901	1347	0.002969562	0.005939124	4	oligos	OL-Cntl	26	17	17
TGCGCAGTCAGCTCTC-1_5_B5	17.6376391	9.393930314	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1653	3071	0.003907522	0.00716379	4	oligos	OL-Cntl	26	17	17
TGCGCAGTCCAGAGGA-1_5_B5	-8.988214576	16.55858273	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	3241	6442	0.003259857	0.006674946	4	11	Glia-MIX	26	17	17
TGCGGGTAGAGCTTCT-1_5_B5	-4.270819466	3.093615625	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	3208	5935	0.00168492	0.011457456	4	11	Glia-MIX	26	17	17
TGCGGGTCAAAGGCGT-1_5_B5	13.69255881	18.33897473	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1210	2118	0.003305005	0.009915014	4	oligos	OL-Cntl	26	17	17
TGCGGGTGTCTAGTGT-1_5_B5	21.81505081	14.21695657	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1443	2444	0.000409165	0.005319149	4	oligos	OL-Cntl	26	17	17
TGCGGGTTCAGTCAGT-1_5_B5	15.7655786	-1.729615283	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	849	1245	0.004819277	0.001606426	4	12	EN-MIX	26	17	17
TGCGGGTTCTACTTAC-1_5_B5	-2.637429346	18.09519407	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	803	1296	0.00462963	0.008487654	4	oligos	OL-Cntl	26	17	17
TGCGTGGAGAGACTAT-1_5_B5	2.28532067	21.04220525	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	905	1345	0.010408922	0.005947955	4	oligos	OL-Cntl	26	17	17
TGCGTGGAGCTTCGCG-1_5_B5	-4.258809969	2.948437905	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	3057	5616	0.004273504	0.006766382	4	11	Glia-MIX	26	17	17
TGCGTGGAGGGTCTCC-1_5_B5	14.06271775	0.008831155	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	718	1006	0.002982107	0.004970179	4	12	EN-MIX	26	17	17
TGCGTGGCACAGACTT-1_5_B5	-15.210642	15.20079774	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2992	5641	0	0.008686403	4	8	Astrocytes	26	17	17
TGCGTGGCATGGAATA-1_5_B5	10.75251922	-1.485449353	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1818	2602	0.008839354	0.03189854	4	12	EN-MIX	26	17	17
TGCGTGGGTATGAAAC-1_5_B5	-1.254666307	27.93036367	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	728	1057	0	0.003784295	4	oligos	OL-Cntl	26	17	17
TGCGTGGGTCATATGC-1_5_B5	22.65103839	-26.16949791	3	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	4326	10973	0.004465506	0.006379295	4	3	EN-L5-6	26	17	17
TGCGTGGGTCATGCCG-1_5_B5	-6.080039955	4.182797991	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	5621	14289	0.002379453	0.00895794	4	11	Glia-MIX	26	17	17
TGCTACCAGCAACGGT-1_5_B5	14.04401118	20.94005265	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1013	1615	0.010526316	0.00619195	4	oligos	OL-Cntl	26	17	17
TGCTACCAGCGCCTCA-1_5_B5	20.76497628	18.51208754	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1088	1797	0.002782415	0.008347245	4	oligos	OL-Cntl	26	17	17
TGCTACCAGGCCCGTT-1_5_B5	-3.074965561	2.296369797	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2144	3471	0.002592913	0.005762028	4	11	Glia-MIX	26	17	17
TGCTACCAGTGGAGAA-1_5_B5	-4.971137803	3.688946859	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	4109	8317	0.003366599	0.007093904	4	11	Glia-MIX	26	17	17
TGCTACCCACAACTGT-1_5_B5	-0.193828505	3.154513224	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1016	1395	0.003584229	0.008602151	4	11	Glia-MIX	26	17	17
TGCTACCCACGGTGTC-1_5_B5	-36.50651869	-0.112361907	9	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1715	2873	0.002784546	0.004176819	4	9	OPC	26	17	17
TGCTACCTCCTCCTAG-1_5_B5	11.47997647	1.875265595	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	700	1041	0.002881844	0.008645533	4	12	EN-MIX	26	17	17
TGCTGCTCACTATCTT-1_5_B5	-30.74316336	-13.29927127	9	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	874	1316	0.003799392	0.009118541	4	9	OPC	26	17	17
TGCTGCTCAGACGCAA-1_5_B5	-23.8872446	-19.34955482	6A	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	3611	8695	0.014951121	0.012995975	4	6A	IN-PV	26	17	17
TGCTGCTGTAAGCACG-1_5_B5	6.687339084	25.60014368	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	949	1469	0	0.004084411	4	oligos	OL-Cntl	26	17	17
TGCTGCTGTCCCTACT-1_5_B5	35.68119339	7.808761536	14	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	761	1019	0.02060844	0.008832188	4	14	Microglia	26	17	17
TGCTGCTGTTTCCACC-1_5_B5	13.46198844	0.612720441	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	712	1091	0.00091659	0.004582951	4	12	EN-MIX	26	17	17
TGCTGCTTCATCGGAT-1_5_B5	32.78313987	8.266832661	14	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	763	1005	0.011940299	0.009950249	4	14	Microglia	26	17	17
TGCTGCTTCCGTCATC-1_5_B5	4.955196053	4.866278155	7	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2408	4249	0.001647446	0.012708873	4	7	Phagocytes	26	17	17
TGGACGCCACGCCAGT-1_5_B5	2.683207483	-3.239724835	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	743	1026	0.010721248	0.002923977	4	12	EN-MIX	26	17	17
TGGACGCCATGGGACA-1_5_B5	13.30893514	0.54341221	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	867	1214	0	0.015650741	4	12	EN-MIX	26	17	17
TGGACGCGTTACAGAA-1_5_B5	3.398475501	-5.202566325	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	952	1433	0.010467551	0.005582694	4	12	EN-MIX	26	17	17
TGGACGCTCTTGCCGT-1_5_B5	-19.00465651	30.18030909	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	3065	6563	0.001523693	0.008380314	4	8	Astrocytes	26	17	17
TGGCCAGAGTTGAGTA-1_5_B5	16.01740682	15.50712723	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1250	2111	0.005210801	0.007105637	4	oligos	OL-Cntl	26	17	17
TGGCCAGCAATGAAAC-1_5_B5	-10.73297368	9.24005672	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	8362	31571	0.002977416	0.010199233	4	11	Glia-MIX	26	17	17
TGGCCAGGTCAGAAGC-1_5_B5	-9.014552157	16.83249814	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	3314	7150	0.001538462	0.006153846	4	11	Glia-MIX	26	17	17
TGGCCAGTCAGGCCCA-1_5_B5	-18.09955431	8.480775486	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	772	1043	0.003835091	0.011505273	4	8	Astrocytes	26	17	17
TGGCGCAAGAAACGCC-1_5_B5	3.841485558	16.42868183	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1022	1704	0.005868545	0.024061033	4	oligos	OL-Cntl	26	17	17
TGGCGCACAATGAATG-1_5_B5	38.97824869	16.02121466	14	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1496	2317	0.006042296	0.018990073	4	14	Microglia	26	17	17
TGGCGCACACCAGGTC-1_5_B5	-20.22031875	-20.34191777	6A	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2505	5482	0.004560379	0.009668004	4	6A	IN-PV	26	17	17
TGGCGCACACGTCAGC-1_5_B5	-17.28223753	28.80778543	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	3059	6231	0.001444391	0.014122934	4	8	Astrocytes	26	17	17
TGGCGCAGTCCGCTGA-1_5_B5	39.50049032	15.78128418	14	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1430	2169	0.00230521	0.006454587	4	14	Microglia	26	17	17
TGGCGCAGTCTTGCGG-1_5_B5	7.407039548	19.98911527	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1064	1737	0.006332758	0.006908463	4	oligos	OL-Cntl	26	17	17
TGGCGCAGTTCGGGCT-1_5_B5	-1.111170492	24.66707771	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	803	1170	0.001709402	0.012820513	4	oligos	OL-Cntl	26	17	17
TGGCTGGAGCAGACTG-1_5_B5	-20.38771567	-25.23554829	6A	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2688	5775	0.016103896	0.005021645	4	6A	IN-PV	26	17	17
TGGCTGGGTTACCAGT-1_5_B5	3.974202578	21.89875194	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	891	1386	0.002164502	0.015151515	4	oligos	OL-Cntl	26	17	17
TGGCTGGTCAGCTCTC-1_5_B5	12.65477986	11.59597063	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1267	2076	0.011078998	0.015414258	4	oligos	OL-Cntl	26	17	17
TGGCTGGTCTGGAGCC-1_5_B5	14.11225562	-4.344773756	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1653	2584	0.007352941	0.009287926	4	12	EN-MIX	26	17	17
TGGGAAGAGAACAATC-1_5_B5	9.399795089	14.56700306	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1085	1757	0.002276608	0.009675583	4	oligos	OL-Cntl	26	17	17
TGGGAAGCAAGTAGTA-1_5_B5	-3.183066396	23.83488359	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	807	1240	0.009677419	0.007258065	4	oligos	OL-Cntl	26	17	17
TGGGAAGTCCCTTGTG-1_5_B5	14.98943621	15.46408634	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1423	2330	0.006866953	0.009871245	4	oligos	OL-Cntl	26	17	17
TGGGAAGTCTTACCTA-1_5_B5	-3.867149144	2.636495542	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2684	5044	0.00297383	0.007335448	4	11	Glia-MIX	26	17	17
TGGGCGTCATCGATTG-1_5_B5	21.06744689	-27.60478616	3	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	3120	7091	0.000705119	0.006487096	4	3	EN-L5-6	26	17	17
TGGGCGTGTCCAGTTA-1_5_B5	-28.18265014	0.216446812	9	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1801	3072	0.003255208	0.034179688	4	9	OPC	26	17	17
TGGGCGTGTCGATTGT-1_5_B5	-10.86457793	9.48023391	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	4714	11101	0.000540492	0.010179263	4	11	Glia-MIX	26	17	17
TGGGCGTTCACCTTAT-1_5_B5	8.036492182	-10.36040504	4	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2518	4866	0.003288122	0.022811344	4	L2-3	EN-L2-3-MS	26	17	17
TGGGCGTTCTCCCTGA-1_5_B5	16.81885636	1.586967229	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	761	1115	0.024215247	0.000896861	4	12	EN-MIX	26	17	17
TGGTTAGAGACAAAGG-1_5_B5	33.97128247	-11.94716878	2	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2193	3812	0.007607555	0.01521511	4	2	EN-L4	26	17	17
TGGTTAGAGCCACGTC-1_5_B5	7.774210342	-11.3739165	4	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2110	3657	0.017500684	0.016953787	4	L2-3	EN-L2-3-MS	26	17	17
TGGTTAGCAGTAACGG-1_5_B5	8.988715085	19.65756488	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	935	1386	0.007215007	0.013708514	4	oligos	OL-Cntl	26	17	17
TGGTTAGTCCGTTGTC-1_5_B5	5.421690279	-16.23942949	4	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	3168	7307	0.006021623	0.004242507	4	L2-3	EN-L2-3-MS	26	17	17
TGGTTAGTCTTACCGC-1_5_B5	-17.12104223	14.27096149	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1592	2740	0.001094891	0.004744526	4	8	Astrocytes	26	17	17
TGGTTCCAGACAGAGA-1_5_B5	-0.498066143	27.38528031	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	826	1262	0.003169572	0.008716323	4	oligos	OL-Cntl	26	17	17
TGGTTCCCAGCCACCA-1_5_B5	11.16748334	1.276820025	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	896	1263	0.011084719	0.015043547	4	12	EN-MIX	26	17	17
TGGTTCCCAGCTGCAC-1_5_B5	18.0325151	18.18944231	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1113	1893	0.004226096	0.004754358	4	oligos	OL-Cntl	26	17	17
TGGTTCCCATCCGGGT-1_5_B5	-19.44959598	-26.13456196	6A	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	3005	7536	0.014596603	0.002521231	4	6A	IN-PV	26	17	17
TGGTTCCTCAGCTGGC-1_5_B5	11.41056365	-1.00641396	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1206	1844	0.00867679	0.01626898	4	12	EN-MIX	26	17	17
TGTATTCAGGTGCAAC-1_5_B5	14.60736836	17.49792883	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1083	1800	0.007777778	0.006666667	4	oligos	OL-Cntl	26	17	17
TGTATTCCATGAACCT-1_5_B5	-1.381830023	3.142102373	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1348	2046	0.003910068	0.005865103	4	11	Glia-MIX	26	17	17
TGTATTCCATTAGGCT-1_5_B5	13.13789303	18.19707406	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1016	1664	0.002403846	0.009014423	4	oligos	OL-Cntl	26	17	17
TGTATTCGTAAGTAGT-1_5_B5	16.50080845	-9.852537432	3	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2979	7076	0.003957038	0.008762012	4	3	EN-L5-6	26	17	17
TGTCCCAAGGCATGGT-1_5_B5	7.038025228	-10.80300644	4	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1882	3022	0.006618134	0.018530774	4	L2-3	EN-L2-3-MS	26	17	17
TGTCCCAAGTTATCGC-1_5_B5	16.52756822	-0.841066016	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	948	1338	0.003736921	0.002989537	4	12	EN-MIX	26	17	17
TGTCCCACACGAAGCA-1_5_B5	-3.08216911	2.400150655	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2109	3290	0.002735562	0.011854103	4	11	Glia-MIX	26	17	17
TGTCCCACAGCCAGAA-1_5_B5	-22.71123946	0.632267684	9	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1931	3386	0.003248671	0.007974011	4	9	OPC	26	17	17
TGTCCCACATTCCTGC-1_5_B5	-4.554915345	2.992777199	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2952	5079	0.002756448	0.006497342	4	11	Glia-MIX	26	17	17
TGTCCCAGTCGTTGTA-1_5_B5	6.409833673	-1.086039108	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	849	1052	0.012357414	0.018060837	4	12	EN-MIX	26	17	17
TGTCCCAGTTCGTTGA-1_5_B5	15.76008056	-1.886929992	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1003	1512	0.000661376	0.005952381	4	12	EN-MIX	26	17	17
TGTGGTAAGGGTTCCC-1_5_B5	21.18156605	-22.82763825	3	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	4333	11528	0.005291464	0.013445524	4	3	EN-L5-6	26	17	17
TGTGGTAAGTCTCAAC-1_5_B5	7.104018138	18.25388929	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1088	1750	0.022857143	0.008571429	4	oligos	OL-Cntl	26	17	17
TGTGGTACATCCTTGC-1_5_B5	-9.562255539	-16.86728557	6B	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	931	1485	0.021548822	0.008080808	4	6B	IN-SST	26	17	17
TGTGGTACATGTCTCC-1_5_B5	37.06774563	14.72534806	14	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1313	1897	0.006325778	0.010015814	4	14	Microglia	26	17	17
TGTGGTAGTCAAAGCG-1_5_B5	-23.4789877	1.068559361	9	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2849	5842	0.002567614	0.011468675	4	9	OPC	26	17	17
TGTGGTAGTGTCGCTG-1_5_B5	-4.085335809	2.886842057	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2969	5426	0.002948765	0.006081828	4	11	Glia-MIX	26	17	17
TGTGTTTAGAAACGCC-1_5_B5	14.24855817	15.59742303	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1128	1814	0.002205072	0.01047409	4	oligos	OL-Cntl	26	17	17
TGTGTTTCAGGCGATA-1_5_B5	10.23662201	-2.552347412	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1562	2361	0.020330368	0.021177467	4	12	EN-MIX	26	17	17
TGTGTTTCATGCCCGA-1_5_B5	-5.651727693	3.895078463	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	4339	10144	0.002957413	0.006407729	4	11	Glia-MIX	26	17	17
TGTGTTTTCGTAGATC-1_5_B5	6.224292384	-1.476383745	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	786	1014	0.003944773	0.025641026	4	12	EN-MIX	26	17	17
TGTGTTTTCTTAGAGC-1_5_B5	-29.56137705	20.34227665	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1139	2085	0.005275779	0.008153477	4	8	Astrocytes	26	17	17
TGTTCCGGTCATGCCG-1_5_B5	-10.37777319	18.61685034	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	4198	9169	0.002399389	0.012651325	4	11	Glia-MIX	26	17	17
TGTTCCGTCCTTAATC-1_5_B5	0.839988597	20.50802474	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	776	1271	0.007081039	0.008654603	4	oligos	OL-Cntl	26	17	17
TGTTCCGTCTTTAGGG-1_5_B5	-3.298785835	2.351313381	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2210	3833	0.002608923	0.006783199	4	11	Glia-MIX	26	17	17
TTAACTCAGACCTAGG-1_5_B5	-16.27551716	-4.041338577	13A	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2816	6050	0.008429752	0.010578512	4	13A	IN-VIP	26	17	17
TTAACTCCAAGAGGCT-1_5_B5	2.22212733	26.30748377	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	676	1009	0.001982161	0.012884044	4	oligos	OL-Cntl	26	17	17
TTAACTCGTGTGCCTG-1_5_B5	10.57092148	23.16031619	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	843	1466	0.000682128	0.010231924	4	oligos	OL-Cntl	26	17	17
TTAACTCTCGTTTGCC-1_5_B5	-21.30066867	9.820683068	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	987	1723	0	0.003482298	4	8	Astrocytes	26	17	17
TTAGGACAGAGTCTGG-1_5_B5	17.9314653	-8.047636341	3	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2021	3742	0.000267237	0.004543025	4	3	EN-L5-6	26	17	17
TTAGGACCAATCCAAC-1_5_B5	-21.73309106	26.38411406	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1891	3643	0.003293988	0.003019489	4	8	Astrocytes	26	17	17
TTAGGACCACTGCCAG-1_5_B5	9.853229551	-0.840260599	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1218	1695	0.010029499	0.026548673	4	12	EN-MIX	26	17	17
TTAGGACGTTGTGGAG-1_5_B5	1.175183647	18.2046341	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	712	1145	0.015720524	0.007860262	4	oligos	OL-Cntl	26	17	17
TTAGGACTCTGTCTCG-1_5_B5	13.36183868	20.74834551	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1020	1742	0.003444317	0.007462687	4	oligos	OL-Cntl	26	17	17
TTAGGCAAGACTCGGA-1_5_B5	14.7607886	12.83948045	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1398	2354	0.006796941	0.008496177	4	oligos	OL-Cntl	26	17	17
TTAGGCACACAACTGT-1_5_B5	39.91611024	11.60050102	14	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	958	1454	0.000687758	0.00343879	4	14	Microglia	26	17	17
TTAGGCACACACGCTG-1_5_B5	18.73379997	17.85070999	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1096	1813	0.00551572	0.007722008	4	oligos	OL-Cntl	26	17	17
TTAGGCAGTCTCAACA-1_5_B5	18.69042438	8.807995062	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1627	3062	0.006531679	0.004572175	4	oligos	OL-Cntl	26	17	17
TTAGGCATCGCAAGCC-1_5_B5	3.094220681	22.85901561	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	895	1483	0.002697235	0.007417397	4	oligos	OL-Cntl	26	17	17
TTAGTTCCATCTCCCA-1_5_B5	14.11987477	26.74187116	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	738	1160	0.007758621	0.005172414	4	oligos	OL-Cntl	26	17	17
TTATGCTAGATCCTGT-1_5_B5	-10.70789224	9.197993727	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	6586	25627	0.002770515	0.004604519	4	11	Glia-MIX	26	17	17
TTATGCTAGCGCCTCA-1_5_B5	16.96291705	13.59492435	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1291	2255	0.001330377	0.00443459	4	oligos	OL-Cntl	26	17	17
TTATGCTCATTCACTT-1_5_B5	1.840093997	22.7458454	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	717	1078	0.005565863	0.010204082	4	oligos	OL-Cntl	26	17	17
TTATGCTGTCTCCACT-1_5_B5	-25.12312874	-8.417582909	9	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1049	1680	0.005952381	0.004166667	4	9	OPC	26	17	17
TTATGCTTCTTAACCT-1_5_B5	12.39067436	27.34767026	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	834	1418	0.002820874	0.007052186	4	oligos	OL-Cntl	26	17	17
TTCCCAGAGACGACGT-1_5_B5	15.8239783	18.6386165	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1067	1824	0.000548246	0.007127193	4	oligos	OL-Cntl	26	17	17
TTCCCAGAGCGTGAAC-1_5_B5	-18.13679439	29.64782614	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	3158	6946	0.002015549	0.010941549	4	8	Astrocytes	26	17	17
TTCCCAGCAGCTGTGC-1_5_B5	1.520219504	22.67106874	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	798	1265	0.002371542	0.012648221	4	oligos	OL-Cntl	26	17	17
TTCCCAGGTACAGTTC-1_5_B5	34.4775264	-13.3125002	2	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	4177	10302	0.00922151	0.013686663	4	2	EN-L4	26	17	17
TTCCCAGGTACGACCC-1_5_B5	-2.932242405	2.197209662	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2077	3312	0.004227053	0.008152174	4	11	Glia-MIX	26	17	17
TTCCCAGGTGATAAAC-1_5_B5	-0.838238062	3.358833384	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1112	1657	0.001810501	0.007845504	4	11	Glia-MIX	26	17	17
TTCCCAGTCACATGCA-1_5_B5	-19.72030794	24.37075414	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1759	3499	0.002572163	0.012289225	4	8	Astrocytes	26	17	17
TTCGAAGAGACTAAGT-1_5_B5	38.14696804	11.23625894	14	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	981	1341	0.000745712	0.011185682	4	14	Microglia	26	17	17
TTCGAAGAGTTTAGGA-1_5_B5	14.44134751	18.34766763	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1041	1673	0.001195457	0.008368201	4	oligos	OL-Cntl	26	17	17
TTCGAAGCATATGAGA-1_5_B5	5.559419473	19.10301619	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1023	1509	0.005301524	0.011928429	4	oligos	OL-Cntl	26	17	17
TTCGAAGTCGGATGTT-1_5_B5	-1.75421118	2.843455226	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1412	2093	0.003822265	0.006688963	4	11	Glia-MIX	26	17	17
TTCGGTCAGAGATGAG-1_5_B5	0.573534106	29.00464094	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	703	1011	0	0.003956479	4	oligos	OL-Cntl	26	17	17
TTCGGTCCAATGACCT-1_5_B5	-9.341563637	13.83521696	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1550	2304	0.002170139	0.0078125	4	11	Glia-MIX	26	17	17
TTCGGTCGTACCATCA-1_5_B5	10.56679498	-13.8633232	4	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	3651	8361	0.008731013	0.021887334	4	L2-3	EN-L2-3-MS	26	17	17
TTCGGTCGTGGTTTCA-1_5_B5	11.88131503	18.93942243	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1020	1735	0.004610951	0.011527378	4	oligos	OL-Cntl	26	17	17
TTCGGTCGTGTAAGTA-1_5_B5	-27.06178573	-2.815722843	9	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1379	2044	0.001956947	0.034735812	4	9	OPC	26	17	17
TTCTACACAAGTACCT-1_5_B5	12.88944117	26.42187522	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	704	1113	0.006289308	0.002695418	4	oligos	OL-Cntl	26	17	17
TTCTACAGTCGGATCC-1_5_B5	-16.03554674	-16.87898512	6B	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1746	3297	0.021534729	0.003336366	4	6B	IN-SST	26	17	17
TTCTACAGTGCACTTA-1_5_B5	-9.512858033	13.58082986	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1098	1617	0.001855288	0.002473717	4	11	Glia-MIX	26	17	17
TTCTACAGTTATCGGT-1_5_B5	17.43711231	12.54450002	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1284	2231	0.000896459	0.005826983	4	oligos	OL-Cntl	26	17	17
TTCTACAGTTCAGGCC-1_5_B5	21.8105346	-25.84122922	3	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	4389	14075	0.004404973	0.010586146	4	3	EN-L5-6	26	17	17
TTCTCAACATCACAAC-1_5_B5	13.32545949	20.59844959	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1009	1776	0.010135135	0.005630631	4	oligos	OL-Cntl	26	17	17
TTCTCAATCTTATCTG-1_5_B5	-2.961932284	23.95528994	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	746	1232	0.00974026	0.008116883	4	oligos	OL-Cntl	26	17	17
TTCTCCTTCACTGGGC-1_5_B5	-28.29212616	-4.454559477	9	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1314	2325	0.000430108	0.004731183	4	9	OPC	26	17	17
TTCTTAGCATGTCCTC-1_5_B5	39.01711225	15.88093952	14	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1262	1939	0.005673027	0.005157298	4	14	Microglia	26	17	17
TTCTTAGGTCAATACC-1_5_B5	-4.403398766	29.77290808	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1401	2193	0.00501596	0.007295942	4	11	Glia-MIX	26	17	17
TTCTTAGTCTTCTGGC-1_5_B5	2.940818842	-3.551410504	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	879	1338	0.002989537	0.005231689	4	12	EN-MIX	26	17	17
TTGAACGAGCTCCCAG-1_5_B5	-1.474937648	20.00689133	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	789	1206	0.001658375	0.023217247	4	oligos	OL-Cntl	26	17	17
TTGAACGCAACGATGG-1_5_B5	-3.428226015	2.707027938	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2610	4321	0.005322842	0.010645684	4	11	Glia-MIX	26	17	17
TTGAACGCAAGGTTCT-1_5_B5	5.234633496	30.7443001	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	828	1252	0.00798722	0.004792332	4	oligos	OL-Cntl	26	17	17
TTGAACGCATTTGCCC-1_5_B5	19.68284349	13.55312938	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1319	2268	0	0.005291005	4	oligos	OL-Cntl	26	17	17
TTGAACGTCGCCGTGA-1_5_B5	10.97588842	21.71581452	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	909	1551	0.001934236	0.013539652	4	oligos	OL-Cntl	26	17	17
TTGAACGTCGCTGATA-1_5_B5	-1.473820887	25.47711002	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	676	1007	0.002979146	0.009930487	4	oligos	OL-Cntl	26	17	17
TTGACTTGTGTCAATC-1_5_B5	5.83316699	20.81026183	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	936	1633	0.007348438	0.006736069	4	oligos	OL-Cntl	26	17	17
TTGACTTTCTAACCGA-1_5_B5	-33.8044065	0.223614098	9	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1519	2683	0.010436079	0.01155423	4	9	OPC	26	17	17
TTGCCGTAGGCATGTG-1_5_B5	36.10369396	15.07121687	14	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1376	1933	0.016037248	0.025866529	4	14	Microglia	26	17	17
TTGCCGTGTAGGCATG-1_5_B5	-1.017151133	3.536165119	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1081	1627	0.002458513	0.006146281	4	11	Glia-MIX	26	17	17
TTGCGTCAGCATGGCA-1_5_B5	13.68405656	12.32575392	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1241	2096	0.008110687	0.010019084	4	oligos	OL-Cntl	26	17	17
TTGCGTCAGCTAGTCT-1_5_B5	17.02787755	15.80956201	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1214	2216	0.004061372	0.00631769	4	oligos	OL-Cntl	26	17	17
TTGCGTCTCAATACCG-1_5_B5	-3.230756673	17.36028911	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	859	1382	0.003617945	0.02170767	4	oligos	OL-Cntl	26	17	17
TTGCGTCTCCTGCCAT-1_5_B5	-9.701228057	-17.13566678	6B	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	925	1496	0.088235294	0.007352941	4	6B	IN-SST	26	17	17
TTGGAACCAACCGCCA-1_5_B5	17.96947899	5.771599344	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	4225	12313	0.004791684	0.007715423	4	oligos	OL-Cntl	26	17	17
TTGGAACCAAGAAGAG-1_5_B5	-0.412317648	26.73891423	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	775	1044	0.002873563	0.012452107	4	oligos	OL-Cntl	26	17	17
TTGGAACGTAATAGCA-1_5_B5	14.51490433	7.049288922	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1966	3483	0.006316394	0.013207005	4	oligos	OL-Cntl	26	17	17
TTGGAACGTAGGACAC-1_5_B5	39.65089638	15.10120061	14	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1241	1921	0.001041124	0.007287871	4	14	Microglia	26	17	17
TTGGAACGTTAAGACA-1_5_B5	4.81373836	13.08598533	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1066	1599	0.015009381	0.011257036	4	oligos	OL-Cntl	26	17	17
TTGGCAAAGATGTAAC-1_5_B5	12.02350798	13.40477165	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1391	2529	0.007512851	0.01107157	4	oligos	OL-Cntl	26	17	17
TTGGCAACACCTATCC-1_5_B5	18.39177223	-26.56100145	3	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	4110	11396	0.002632503	0.014654265	4	3	EN-L5-6	26	17	17
TTGGCAATCTGCCCTA-1_5_B5	21.48977741	-2.253581918	2	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2286	4723	0.0120686	0.009951302	4	2	EN-L4	26	17	17
TTGTAGGTCCAGAAGG-1_5_B5	16.46394557	15.31089868	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1133	1889	0.006352567	0.00847009	4	oligos	OL-Cntl	26	17	17
TTGTAGGTCTACGAGT-1_5_B5	37.49795776	13.93380473	14	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1086	1535	0.009120521	0.018892508	4	14	Microglia	26	17	17
TTTACTGAGGCAGTCA-1_5_B5	-0.518903808	4.67569225	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	814	1155	0.002597403	0.006060606	4	11	Glia-MIX	26	17	17
TTTACTGAGTGGACGT-1_5_B5	-3.0902591	2.308822724	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2192	3920	0.003571429	0.007142857	4	11	Glia-MIX	26	17	17
TTTACTGCACGGCGTT-1_5_B5	-19.06916311	7.342790572	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	913	1348	0.00148368	0.005934718	4	8	Astrocytes	26	17	17
TTTACTGCAGGTCGTC-1_5_B5	11.54969973	24.37704861	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	772	1190	0.005042017	0.002521008	4	oligos	OL-Cntl	26	17	17
TTTACTGGTTCCGTCT-1_5_B5	19.2727509	-24.58473855	3	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2909	6649	0.010227102	0.016243044	4	3	EN-L5-6	26	17	17
TTTATGCAGACGCACA-1_5_B5	39.32603249	13.71214501	14	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1034	1543	0.001296176	0.007777058	4	14	Microglia	26	17	17
TTTATGCAGAGTGACC-1_5_B5	-18.80977085	-24.62007163	6A	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2647	5789	0.003973052	0.00362757	4	6A	IN-PV	26	17	17
TTTATGCAGCCTTGAT-1_5_B5	-5.85534617	3.718186546	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	5012	15208	0.002104156	0.004537086	4	11	Glia-MIX	26	17	17
TTTATGCCATCACAAC-1_5_B5	6.096124993	-1.572877253	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	810	1122	0.016042781	0.01426025	4	12	EN-MIX	26	17	17
TTTATGCCATGTCGAT-1_5_B5	7.687876633	-12.24510476	4	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	2090	3770	0.012732095	0.016710875	4	L2-3	EN-L2-3-MS	26	17	17
TTTATGCGTAACGACG-1_5_B5	6.372865435	-1.7421673	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	819	1038	0.003853565	0.009633911	4	12	EN-MIX	26	17	17
TTTATGCGTTAAGTAG-1_5_B5	-7.080133624	-9.241529667	13A	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	921	1293	0.028615623	0.013147718	4	13A	IN-VIP	26	17	17
TTTATGCGTTCAGGCC-1_5_B5	16.29384745	20.5453561	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1036	1830	0.00273224	0.003278689	4	oligos	OL-Cntl	26	17	17
TTTATGCTCCCATTAT-1_5_B5	18.87097085	7.956170379	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1915	3947	0.001520142	0.004560426	4	oligos	OL-Cntl	26	17	17
TTTATGCTCTGACCTC-1_5_B5	11.64519932	24.46726853	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	872	1461	0.006844627	0.004791239	4	oligos	OL-Cntl	26	17	17
TTTCCTCCACAAGCCC-1_5_B5	-1.608624774	2.872598517	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1420	2284	0.002189142	0.003940455	4	11	Glia-MIX	26	17	17
TTTCCTCGTCCGTGAC-1_5_B5	-19.45139602	8.626632285	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1073	1772	0.001693002	0.007900677	4	8	Astrocytes	26	17	17
TTTCCTCGTTAAGAAC-1_5_B5	12.28544902	-1.371644158	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1067	1666	0.003601441	0.004801921	4	12	EN-MIX	26	17	17
TTTCCTCTCTTGCCGT-1_5_B5	-16.08614716	13.6655198	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1550	2852	0.000701262	0.003506311	4	8	Astrocytes	26	17	17
TTTGCGCAGCGCTTAT-1_5_B5	0.090541901	25.35570299	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	708	1028	0.007782101	0.004863813	4	oligos	OL-Cntl	26	17	17
TTTGCGCCATAGGATA-1_5_B5	8.947406654	0.341492253	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1153	1560	0.021794872	0.034615385	4	12	EN-MIX	26	17	17
TTTGCGCCATTCGACA-1_5_B5	10.41603627	22.49568948	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	863	1386	0.000721501	0.01010101	4	oligos	OL-Cntl	26	17	17
TTTGCGCGTTAAGATG-1_5_B5	-1.88283	16.30443623	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	716	1032	0.00872093	0.016472868	4	oligos	OL-Cntl	26	17	17
TTTGCGCTCTCCGGTT-1_5_B5	-28.04499179	-0.225383385	9	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1612	3087	0.000323939	0.014577259	4	9	OPC	26	17	17
TTTGGTTGTCACTTCC-1_5_B5	-23.64334408	-1.867292853	9	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	984	1456	0.001373626	0.004120879	4	9	OPC	26	17	17
TTTGGTTTCAAGGCTT-1_5_B5	4.67626974	22.24939756	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	888	1392	0.002155172	0.011494253	4	oligos	OL-Cntl	26	17	17
TTTGGTTTCACTCTTA-1_5_B5	-9.08533238	16.52854954	11	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	3042	6765	0.002365115	0.003695492	4	11	Glia-MIX	26	17	17
TTTGGTTTCCTTTCGG-1_5_B5	13.5276739	0.561921511	12	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	725	1162	0.004302926	0.010327022	4	12	EN-MIX	26	17	17
TTTGGTTTCTGCTTGC-1_5_B5	-25.45981697	11.15723317	8	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1048	2060	0.002912621	0.003398058	4	8	Astrocytes	26	17	17
TTTGTCAGTACCTACA-1_5_B5	14.61686493	20.24195559	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1014	1651	0.010902483	0.008479709	4	oligos	OL-Cntl	26	17	17
TTTGTCAGTCGCATCG-1_5_B5	17.88741623	9.155116201	1	5_B5	MS	Acute/Chronic active	51	female	temporal	CAP1	SEQ1	9	10	1639	3261	0.003373198	0.005213125	4	oligos	OL-Cntl	26	17	17
AAACCTGCAGGCTGAA-1_6_C5	11.28586142	30.56358987	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	715	1096	0.003649635	0.000912409	0	oligos	OL-Cntl	NA	NA	NA
AAACCTGTCGTACGGC-1_6_C5	-36.41244199	-9.590114933	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	909	1505	0.007973422	0.001993355	0	9	OPC	NA	NA	NA
AAACGGGAGGAACTGC-1_6_C5	11.79807251	27.5176332	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	838	1249	0.001601281	0.004003203	0	oligos	OL-Cntl	NA	NA	NA
AAACGGGAGTGAAGTT-1_6_C5	-15.03954135	-19.16635051	6B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1423	2412	0.001243781	0.001658375	0	6B	IN-SST	NA	NA	NA
AAACGGGCAGTTCATG-1_6_C5	-37.58823359	-8.474101923	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	948	1611	0.000620732	0.001241465	0	9	OPC	NA	NA	NA
AAACGGGCATGGATGG-1_6_C5	22.39379328	-6.574148827	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1951	3805	0.004204993	0.002102497	0	3	EN-L5-6	NA	NA	NA
AAACGGGGTCTGCAAT-1_6_C5	20.78530974	18.50956196	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1091	1727	0.006369427	0.001158078	0	oligos	OL-Cntl	NA	NA	NA
AAACGGGTCAATCACG-1_6_C5	21.53263702	0.739441063	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1506	2675	0.014205607	0.000747664	0	2	EN-L4	NA	NA	NA
AAAGATGAGACAGACC-1_6_C5	-11.90944586	-10.82921734	13B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1295	2202	0.000908265	0.001362398	0	13B	IN-SV2C	NA	NA	NA
AAAGATGAGGACATTA-1_6_C5	13.65249191	-32.41328722	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3041	7795	0.005388069	0.002694035	0	3	EN-L5-6	NA	NA	NA
AAAGATGTCACTTATC-1_6_C5	-15.32351538	-24.86733726	6A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1635	3048	0.030511811	0.00328084	0	6A	IN-PV	NA	NA	NA
AAAGCAAAGACTACAA-1_6_C5	0.403880423	-26.01311771	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	4276	13170	0.00516325	0.002505695	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AAAGCAAAGACTAGAT-1_6_C5	13.37762316	-28.71632295	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2769	6335	0.015943173	0.005051302	0	3	EN-L5-6	NA	NA	NA
AAAGCAAAGAGATGAG-1_6_C5	23.39335504	1.07610052	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1991	3703	0.008911693	0.001080205	0	2	EN-L4	NA	NA	NA
AAAGCAACACTTGGAT-1_6_C5	-30.06056443	11.44395795	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	732	1033	0.001936108	0.008712488	0	8	Astrocytes	NA	NA	NA
AAAGCAACATCATCCC-1_6_C5	-39.37618962	-0.423895715	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1455	2635	0.004174573	0.001518027	0	9	OPC	NA	NA	NA
AAAGCAACATGACGGA-1_6_C5	-31.43256807	12.2362137	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	787	1221	0	0.004095004	0	8	Astrocytes	NA	NA	NA
AAAGCAACATGCAACT-1_6_C5	-26.65773599	10.44161259	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	862	1180	0.004237288	0.000847458	0	8	Astrocytes	NA	NA	NA
AAAGCAACATTTCACT-1_6_C5	-14.38983474	-19.73355169	6B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1286	2241	0.011155734	0.004016064	0	6B	IN-SST	NA	NA	NA
AAAGCAAGTCTGATTG-1_6_C5	-28.18197906	17.01928681	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	945	1533	0.000652316	0.003913894	0	8	Astrocytes	NA	NA	NA
AAAGCAATCAGTGCAT-1_6_C5	23.52900643	12.67751998	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1367	2357	0.002545609	0.003394145	0	oligos	OL-Cntl	NA	NA	NA
AAAGCAATCCTTCAAT-1_6_C5	-36.20147489	-11.60235963	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	803	1343	0	0	0	9	OPC	NA	NA	NA
AAAGTAGAGTACGCCC-1_6_C5	-36.39130012	-10.57910334	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1012	1568	0.011479592	0.00255102	0	9	OPC	NA	NA	NA
AAAGTAGAGTAGTGCG-1_6_C5	1.672082508	-10.17516754	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1601	2672	0.005613772	0.007110778	0	12	EN-MIX	NA	NA	NA
AAAGTAGCAAGTCTGT-1_6_C5	-27.12190954	22.48938462	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1263	2156	0.003710575	0.006957328	0	8	Astrocytes	NA	NA	NA
AAAGTAGTCCTTTCTC-1_6_C5	19.85059282	-6.888972262	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2151	5003	0.002798321	0.002398561	0	3	EN-L5-6	NA	NA	NA
AAAGTAGTCTACGAGT-1_6_C5	10.74435007	-9.283568666	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3141	8556	0.000233754	0.001051893	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AAATGCCAGACACTAA-1_6_C5	17.26761021	22.23027339	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	877	1358	0	0.002209131	0	oligos	OL-Cntl	NA	NA	NA
AAATGCCAGTCACGCC-1_6_C5	-15.02848652	-10.37552519	13B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2283	4916	0.010170871	0.001627339	0	13B	IN-SV2C	NA	NA	NA
AAATGCCGTCTGCAAT-1_6_C5	-36.254719	4.571371398	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2061	4265	0.004454865	0.001641266	0	9	OPC	NA	NA	NA
AAATGCCGTGACCAAG-1_6_C5	-18.91925516	-27.61674628	6A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2734	6292	0.008264463	0.002860776	0	6A	IN-PV	NA	NA	NA
AAATGCCGTGTAATGA-1_6_C5	-38.04388788	-8.164030408	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1134	1921	0.001561687	0.005726184	0	9	OPC	NA	NA	NA
AAATGCCGTTCATGGT-1_6_C5	-38.96152006	-0.07160217	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1466	2839	0.00105671	0.004579077	0	9	OPC	NA	NA	NA
AAATGCCTCGAATGCT-1_6_C5	14.69269228	29.56243856	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	737	1082	0	0.000924214	0	oligos	OL-Cntl	NA	NA	NA
AACACGTAGCCATCGC-1_6_C5	-36.11125606	-11.00346226	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	829	1456	0.004120879	0.00206044	0	9	OPC	NA	NA	NA
AACACGTCAGATGGGT-1_6_C5	18.19692461	15.45840214	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1187	1919	0.002605524	0.004168838	0	oligos	OL-Cntl	NA	NA	NA
AACACGTTCTAACCGA-1_6_C5	17.19920301	23.3906218	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	855	1313	0.001523229	0.003046458	0	oligos	OL-Cntl	NA	NA	NA
AACACGTTCTAACTGG-1_6_C5	-7.737984195	0.202943438	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2060	4045	0.01013597	0.000741656	0	13A	IN-VIP	NA	NA	NA
AACCATGAGCTACCTA-1_6_C5	14.78471346	27.54985033	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	814	1184	0.004222973	0.005912162	0	oligos	OL-Cntl	NA	NA	NA
AACCATGAGGCAAAGA-1_6_C5	-35.32707664	-6.725800914	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1129	1752	0.006849315	0.002283105	0	9	OPC	NA	NA	NA
AACCATGAGGGCTTGA-1_6_C5	23.73795734	18.17860069	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1178	1785	0.010644258	0.003361345	0	oligos	OL-Cntl	NA	NA	NA
AACCATGAGTGGTAAT-1_6_C5	-37.63476144	-8.85042679	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1012	1709	0.004095963	0.002925688	0	9	OPC	NA	NA	NA
AACCATGCAGATGAGC-1_6_C5	-10.54388417	9.751525277	11	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3189	6953	0.002301165	0.003020279	0	11	Glia-MIX	NA	NA	NA
AACCATGCAGCTGCAC-1_6_C5	19.11673261	9.020394285	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1663	3355	0.00119225	0.005663189	0	oligos	OL-Cntl	NA	NA	NA
AACCATGGTTCTCATT-1_6_C5	-23.55280706	-1.833798457	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	964	1409	0.002838893	0.004258339	0	9	OPC	NA	NA	NA
AACCATGTCATGCTCC-1_6_C5	-1.703730135	-15.9744998	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2125	4691	0.003837135	0.00255809	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AACCATGTCGCGTTTC-1_6_C5	-27.00543596	17.62736139	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1138	1816	0.000550661	0.002202643	0	8	Astrocytes	NA	NA	NA
AACCGCGTCGTCCGTT-1_6_C5	21.27177375	-1.090715971	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1592	2618	0.01566081	0.00381971	0	2	EN-L4	NA	NA	NA
AACGTTGAGCTGCGAA-1_6_C5	-26.92888012	26.32114456	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1374	2453	0.004076641	0.003668977	0	8	Astrocytes	NA	NA	NA
AACGTTGCACAACGCC-1_6_C5	16.28897617	14.67604424	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1182	1865	0.000536193	0.010723861	0	oligos	OL-Cntl	NA	NA	NA
AACGTTGCACATTTCT-1_6_C5	-10.39878564	18.23022897	11	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2041	3741	0.000534616	0.001069233	0	11	Glia-MIX	NA	NA	NA
AACGTTGGTAATCACC-1_6_C5	-7.754071865	-1.903613329	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1790	3216	0.004353234	0.003109453	0	13A	IN-VIP	NA	NA	NA
AACGTTGGTACAAGTA-1_6_C5	-3.577370433	-7.798306245	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	740	1067	0.014058107	0.000937207	0	13A	IN-VIP	NA	NA	NA
AACGTTGGTCGGCATC-1_6_C5	12.54396248	31.1005707	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	681	1028	0	0.004863813	0	oligos	OL-Cntl	NA	NA	NA
AACGTTGTCCGCTGTT-1_6_C5	25.14838979	-29.53468351	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3492	9898	0.001616488	0.004243281	0	3	EN-L5-6	NA	NA	NA
AACGTTGTCCTCTAGC-1_6_C5	-11.49712201	-22.11092392	6B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	998	1589	0.032095658	0.002517306	0	6B	IN-SST	NA	NA	NA
AACGTTGTCGTACCGG-1_6_C5	-27.7528746	24.61291099	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1141	1890	0.002645503	0.001587302	0	8	Astrocytes	NA	NA	NA
AACTCAGCAATAGCAA-1_6_C5	25.99794838	-4.068734981	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3945	11437	0.002623065	0.002710501	0	2	EN-L4	NA	NA	NA
AACTCAGCACCTCGGA-1_6_C5	-0.341665299	-11.77522318	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1796	3494	0.002003434	0.004006869	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AACTCAGGTCTGCGGT-1_6_C5	3.349232469	-6.812047823	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1166	1868	0.0251606	0.00267666	0	12	EN-MIX	NA	NA	NA
AACTCAGTCAACGAAA-1_6_C5	7.262162478	-30.76704641	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	6002	24169	0.006413174	0.001655013	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AACTCCCCAAACGTGG-1_6_C5	-6.347633022	-0.235079653	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1868	3746	0.010945008	0.00560598	0	13A	IN-VIP	NA	NA	NA
AACTCCCCACATGGGA-1_6_C5	23.74431719	0.55714195	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1908	3640	0.000824176	0.001648352	0	2	EN-L4	NA	NA	NA
AACTCCCCAGTTCATG-1_6_C5	0.944972004	-28.60828655	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	4435	13262	0.002488312	0.003996381	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AACTCCCGTGTCTGAT-1_6_C5	6.759014873	30.52491435	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	781	1147	0.002615519	0.007846556	0	oligos	OL-Cntl	NA	NA	NA
AACTCCCTCAAAGTAG-1_6_C5	0.91666647	-11.87195806	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1957	3536	0.008484163	0.004242081	0	12	EN-MIX	NA	NA	NA
AACTCCCTCGCATGGC-1_6_C5	-25.08133372	27.57450369	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1518	2757	0.000362713	0.003989844	0	8	Astrocytes	NA	NA	NA
AACTCCCTCTGGTATG-1_6_C5	-1.421520891	-18.09000928	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2859	6795	0.005298013	0.003679176	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AACTCCCTCTGTCTCG-1_6_C5	29.6559795	-3.336184285	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	4091	11944	0.011972539	0.002595445	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AACTCTTAGTAACCCT-1_6_C5	16.25042591	1.470950966	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	733	1051	0.035204567	0.003805899	0	12	EN-MIX	NA	NA	NA
AACTCTTCAAGTACCT-1_6_C5	14.46296453	30.56188846	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	740	1104	0.001811594	0.001811594	0	oligos	OL-Cntl	NA	NA	NA
AACTCTTGTCATACTG-1_6_C5	2.34014588	-7.78473265	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1357	2207	0.006796556	0.009515179	0	12	EN-MIX	NA	NA	NA
AACTCTTGTTATCCGA-1_6_C5	-5.265000818	-3.956163446	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1346	2141	0.015413358	0.002335357	0	13A	IN-VIP	NA	NA	NA
AACTCTTTCATCTGCC-1_6_C5	1.459516296	-27.98933609	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3487	9276	0.006468305	0.000539025	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AACTGGTAGAATTGTG-1_6_C5	-27.73979403	16.56016748	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1039	1559	0.005131495	0.003848621	0	8	Astrocytes	NA	NA	NA
AACTGGTAGCCCAGCT-1_6_C5	-28.27314772	17.23916337	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1037	1783	0.001682557	0.002804262	0	8	Astrocytes	NA	NA	NA
AACTGGTCAATTCCTT-1_6_C5	-29.79094805	14.21434313	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	828	1304	0.003067485	0.002300613	0	8	Astrocytes	NA	NA	NA
AACTGGTCAGTTAACC-1_6_C5	24.86010611	-1.18813366	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2333	5210	0.010940499	0.00134357	0	2	EN-L4	NA	NA	NA
AACTGGTCATCCTAGA-1_6_C5	1.153988367	-26.56254973	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3568	8959	0.005804219	0.003236968	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AACTGGTCATGCTAGT-1_6_C5	-0.516120283	4.717042547	11	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	866	1222	0.002454992	0.004909984	0	11	Glia-MIX	NA	NA	NA
AACTGGTGTAGCGATG-1_6_C5	3.703047546	-8.063845241	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1275	1915	0.009399478	0.004699739	0	12	EN-MIX	NA	NA	NA
AACTGGTTCACGATGT-1_6_C5	-37.09578321	-8.277768452	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1019	1651	0.006662629	0.000605694	0	9	OPC	NA	NA	NA
AACTGGTTCTCTGCTG-1_6_C5	-11.03838754	-20.33752615	6A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	858	1286	0.000777605	0.000777605	0	6A	IN-PV	NA	NA	NA
AACTTTCAGCCCTAAT-1_6_C5	-6.050808904	2.711344969	11	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3962	10291	0.00340103	0.002429307	0	11	Glia-MIX	NA	NA	NA
AACTTTCAGGCTCATT-1_6_C5	19.9358806	-6.868580789	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2203	5350	0.004485981	0.000934579	0	3	EN-L5-6	NA	NA	NA
AACTTTCCAAACTGTC-1_6_C5	12.23646864	28.09342571	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	647	1009	0.001982161	0.002973241	0	oligos	OL-Cntl	NA	NA	NA
AACTTTCCAGCGTTCG-1_6_C5	23.55002954	13.06265392	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1327	2224	0.001348921	0.002248201	0	oligos	OL-Cntl	NA	NA	NA
AACTTTCTCCTTGGTC-1_6_C5	15.16334996	23.21699045	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	744	1093	0.001829826	0.000914913	0	oligos	OL-Cntl	NA	NA	NA
AACTTTCTCGTGACAT-1_6_C5	-9.709265253	16.35386369	11	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1770	3043	0.001971738	0.003286231	0	11	Glia-MIX	NA	NA	NA
AAGACCTAGGCCCTCA-1_6_C5	0.055720831	-17.69537355	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2861	6893	0.005657914	0.003046569	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AAGACCTGTGCGAAAC-1_6_C5	-15.63456498	-25.83591138	6A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1727	3248	0.013238916	0.0033867	0	6A	IN-PV	NA	NA	NA
AAGACCTTCAGTCAGT-1_6_C5	19.85407715	-6.863856776	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2066	4654	0.001289214	0.003008165	0	3	EN-L5-6	NA	NA	NA
AAGACCTTCGGATGTT-1_6_C5	-4.885821327	-1.89024378	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1510	2655	0.023728814	0.002259887	0	13A	IN-VIP	NA	NA	NA
AAGCCGCAGAGTAAGG-1_6_C5	-34.43059538	-10.69919362	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	918	1438	0.002781641	0.002086231	0	9	OPC	NA	NA	NA
AAGCCGCAGTAAGTAC-1_6_C5	4.091844856	-31.4836224	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	4541	13732	0.001165162	0.002257501	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AAGCCGCAGTCAATAG-1_6_C5	17.45219641	20.58049657	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	985	1586	0.000630517	0.00630517	0	oligos	OL-Cntl	NA	NA	NA
AAGCCGCAGTCGCCGT-1_6_C5	-28.24740181	15.23422045	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1023	1645	0.001823708	0.001823708	0	8	Astrocytes	NA	NA	NA
AAGCCGCCATTCCTCG-1_6_C5	-11.88867099	14.27308899	11	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	885	1282	0.001560062	0.004680187	0	11	Glia-MIX	NA	NA	NA
AAGCCGCTCCATGAAC-1_6_C5	-9.998933925	12.04765955	11	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	809	1117	0.002685765	0.000895255	0	11	Glia-MIX	NA	NA	NA
AAGCCGCTCGTGACAT-1_6_C5	1.598976799	-28.69522064	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	4168	10905	0.008253095	0.002475928	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AAGGAGCAGAAACGCC-1_6_C5	14.33531962	26.4325116	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	756	1114	0.002692998	0.001795332	0	oligos	OL-Cntl	NA	NA	NA
AAGGAGCAGATATACG-1_6_C5	-9.576811816	-2.147291544	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2007	3547	0.007330138	0.006484353	0	13A	IN-VIP	NA	NA	NA
AAGGAGCCAGGAATCG-1_6_C5	16.92248285	20.71116251	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	933	1428	0.00070028	0.00280112	0	oligos	OL-Cntl	NA	NA	NA
AAGGAGCCATGATCCA-1_6_C5	-23.35769873	-0.205499265	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1671	2985	0.001005025	0.002345059	0	9	OPC	NA	NA	NA
AAGGAGCGTGCGCTTG-1_6_C5	11.48409807	-8.715166108	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2797	6310	0.006339144	0.002535658	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AAGGAGCGTTCTGAAC-1_6_C5	33.42939895	-4.711830849	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2844	5895	0.025954198	0.004410517	0	2	EN-L4	NA	NA	NA
AAGGAGCGTTGAGGTG-1_6_C5	13.99299987	-32.0488435	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3777	10458	0.000286862	0.002294894	0	3	EN-L5-6	NA	NA	NA
AAGGAGCTCTCCAGGG-1_6_C5	-0.341639861	-12.82376014	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2163	4591	0.008277064	0.002178175	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AAGGAGCTCTTACCGC-1_6_C5	15.03449406	30.15853009	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	711	1006	0.001988072	0.004970179	0	oligos	OL-Cntl	NA	NA	NA
AAGGCAGAGAGACTAT-1_6_C5	32.00235679	-9.101594485	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3572	8171	0.017133766	0.007954963	0	2	EN-L4	NA	NA	NA
AAGGCAGAGCTAACTC-1_6_C5	-15.79820495	-25.86549598	6A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2143	4765	0.004407135	0.002728227	0	6A	IN-PV	NA	NA	NA
AAGGCAGCAGACGCTC-1_6_C5	-28.21086273	14.75765632	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	883	1304	0.002300613	0.007668712	0	8	Astrocytes	NA	NA	NA
AAGGCAGGTAAGGGCT-1_6_C5	1.153624698	-28.23901519	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3972	10437	0.004215771	0.006323656	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AAGGCAGGTGCTTCTC-1_6_C5	1.314183678	-10.89232374	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1718	2984	0.010723861	0.003351206	0	12	EN-MIX	NA	NA	NA
AAGGTTCAGAAACCGC-1_6_C5	26.25410092	0.692243017	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2487	5111	0.006065349	0.002543534	0	2	EN-L4	NA	NA	NA
AAGGTTCCAAGGACTG-1_6_C5	-27.69534925	9.884050988	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	760	1129	0.015057573	0.004428698	0	8	Astrocytes	NA	NA	NA
AAGGTTCCACCAGGTC-1_6_C5	-12.03139029	-10.73219422	13B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1456	2538	0.00748621	0.003546099	0	13B	IN-SV2C	NA	NA	NA
AAGGTTCGTCGTTGTA-1_6_C5	3.039932745	-28.3410826	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3171	7479	0.002005616	0.00294157	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AAGTCTGAGAGGTTAT-1_6_C5	-5.892981431	-3.271597585	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1476	2360	0.011016949	0.005932203	0	13A	IN-VIP	NA	NA	NA
AAGTCTGCACATGACT-1_6_C5	4.990366791	-31.30477463	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3648	9853	0.004465645	0.001319395	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AAGTCTGCATGCCCGA-1_6_C5	1.481973943	-27.62277183	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3159	7812	0.002432156	0.001664107	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AAGTCTGGTCATCCCT-1_6_C5	24.98791118	-1.535161357	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2519	5320	0.016917293	0.004511278	0	2	EN-L4	NA	NA	NA
AAGTCTGGTCTCTCTG-1_6_C5	-0.748498059	-11.1993496	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1758	3770	0.007427056	0.00265252	0	12	EN-MIX	NA	NA	NA
AAGTCTGGTTACCAGT-1_6_C5	-0.841734117	-16.64844572	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2320	4625	0.004972973	0.003675676	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AAGTCTGTCCAATGGT-1_6_C5	20.22535857	17.50943029	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1280	2075	0.028433735	0.002891566	0	oligos	OL-Cntl	NA	NA	NA
AATCCAGTCGAATGCT-1_6_C5	18.88594028	21.10343107	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	953	1520	0	0.003947368	0	oligos	OL-Cntl	NA	NA	NA
AATCCAGTCTCGTTTA-1_6_C5	-28.02258639	23.92450439	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1203	2070	0.002415459	0.002415459	0	8	Astrocytes	NA	NA	NA
AATCCAGTCTGTTTGT-1_6_C5	0.42001089	-8.723927407	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1464	2669	0.014612214	0.002622705	0	12	EN-MIX	NA	NA	NA
AATCGGTCACTACAGT-1_6_C5	-1.591950261	-18.28511983	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2825	6240	0.008333333	0.001923077	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AATCGGTGTGGCCCTA-1_6_C5	3.378723273	-6.148537729	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1109	1720	0.009302326	0.005813953	0	12	EN-MIX	NA	NA	NA
ACACCAAAGTGATCGG-1_6_C5	31.12079166	-2.405481315	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2674	5935	0.005391744	0.003538332	0	2	EN-L4	NA	NA	NA
ACACCAAAGTGGTCCC-1_6_C5	0.780752524	-27.34830251	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3821	10549	0.001706323	0.002749076	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACACCAAAGTTAGCGG-1_6_C5	15.96788877	25.58307333	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	799	1237	0	0.006467259	0	oligos	OL-Cntl	NA	NA	NA
ACACCAAGTGCCTGGT-1_6_C5	17.14921953	24.19293016	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	899	1357	0.002210759	0.004421518	0	oligos	OL-Cntl	NA	NA	NA
ACACCAAGTGGCGAAT-1_6_C5	11.64051598	27.61875328	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	781	1135	0.000881057	0.003524229	0	oligos	OL-Cntl	NA	NA	NA
ACACCAAGTGGCTCCA-1_6_C5	3.468436867	-28.8386347	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3349	8222	0.000972999	0.001702749	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACACCAATCACATAGC-1_6_C5	-38.29610438	0.63836205	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1474	2647	0.001511145	0.001511145	0	9	OPC	NA	NA	NA
ACACCAATCGAGCCCA-1_6_C5	-15.5391661	-19.5589099	6A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1589	2787	0.006817366	0.001076426	0	6A	IN-PV	NA	NA	NA
ACACCCTAGTTGCAGG-1_6_C5	-11.60882321	-22.45203123	6A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1046	1747	0.025186033	0.003434459	0	6A	IN-PV	NA	NA	NA
ACACCCTCAAGACACG-1_6_C5	16.51483107	-32.57682357	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	4971	16483	0.010131651	0.002305406	0	3	EN-L5-6	NA	NA	NA
ACACCCTCACAGACTT-1_6_C5	1.075662981	-17.54645682	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2756	6108	0.007531107	0.00573019	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACACCCTCAGCTGGCT-1_6_C5	-19.50561029	-28.95413896	6A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3311	9123	0.001534583	0.003288392	0	6A	IN-PV	NA	NA	NA
ACACCCTGTCCGTGAC-1_6_C5	15.68658302	-0.836221137	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	727	1054	0.000948767	0.0028463	0	12	EN-MIX	NA	NA	NA
ACACCCTTCATGTGGT-1_6_C5	28.59943114	-1.633883064	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3562	8868	0.005751015	0.00541272	0	2	EN-L4	NA	NA	NA
ACACCGGAGCTCCTTC-1_6_C5	13.09223439	-0.871326426	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1059	2122	0.003770028	0.000471254	0	12	EN-MIX	NA	NA	NA
ACACCGGAGCTGCCCA-1_6_C5	18.95236469	14.65008305	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1101	1878	0.001064963	0.001597444	0	oligos	OL-Cntl	NA	NA	NA
ACACCGGCACCATCCT-1_6_C5	1.27717452	-22.01954086	4	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	4671	13832	0.004337767	0.00838635	0	L2-3	EN-L2-3-MS	NA	NA	NA
ACACCGGCATGCCCGA-1_6_C5	1.337331353	-9.715114193	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1546	2527	0.00514444	0.003561535	0	12	EN-MIX	NA	NA	NA
ACACCGGCATTGGGCC-1_6_C5	-0.758816329	-25.32222744	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	4424	13084	0.003057169	0.002140018	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACACCGGGTAATTGGA-1_6_C5	0.085918672	-15.20632477	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2536	5261	0.012355066	0.003611481	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACACCGGGTGTCTGAT-1_6_C5	4.252457421	31.55027278	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	701	1029	0.004859086	0.004859086	0	oligos	OL-Cntl	NA	NA	NA
ACACTGACACAGAGGT-1_6_C5	15.52214574	-3.264321472	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1052	1706	0.001172333	0.001758499	0	12	EN-MIX	NA	NA	NA
ACACTGACATACTCTT-1_6_C5	4.356113917	-32.46646792	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	4742	16114	0.000806752	0.002172024	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACACTGAGTAGCTCCG-1_6_C5	12.93851078	21.82951356	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	872	1344	0.002232143	0.002232143	0	oligos	OL-Cntl	NA	NA	NA
ACACTGAGTCGAATCT-1_6_C5	20.27251877	20.7452975	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	992	1480	0.002027027	0.002702703	0	oligos	OL-Cntl	NA	NA	NA
ACACTGAGTTACGCGC-1_6_C5	23.00047635	12.38480024	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1358	2324	0.002581756	0.001290878	0	oligos	OL-Cntl	NA	NA	NA
ACACTGATCACAGGCC-1_6_C5	10.52971711	-8.594692387	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2425	5744	0.001218663	0.002089136	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACAGCCGAGCTGCAAG-1_6_C5	0.312761908	-26.55668156	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3647	9555	0.001988488	0.003767661	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACAGCCGAGTAGGTGC-1_6_C5	0.975491787	-21.48583353	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3895	10277	0.009925075	0.006032889	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACAGCCGAGTTGAGAT-1_6_C5	0.809578477	-16.67738718	4	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2701	5981	0.017555593	0.00518308	0	L2-3	EN-L2-3-MS	NA	NA	NA
ACAGCCGCACCGAATT-1_6_C5	-1.477693471	-22.57071721	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3890	11101	0.002972705	0.002972705	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACAGCCGCACGAAGCA-1_6_C5	1.424524151	-16.83739729	4	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2720	5791	0.009152133	0.004835089	0	L2-3	EN-L2-3-MS	NA	NA	NA
ACAGCTACAAGCCATT-1_6_C5	-15.70964676	-19.19478179	6B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1767	3614	0.004150526	0.002767017	0	6B	IN-SST	NA	NA	NA
ACAGCTACACGCATCG-1_6_C5	-27.89789563	23.04059035	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1211	2083	0.000960154	0.004320691	0	8	Astrocytes	NA	NA	NA
ACAGCTACAGTCAGAG-1_6_C5	0.457349405	-27.27688193	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	4242	11471	0.002528114	0.002702467	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACAGCTACATTAGGCT-1_6_C5	2.751450504	-5.340414249	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	893	1338	0.001494768	0.002989537	0	12	EN-MIX	NA	NA	NA
ACAGCTAGTCGCATAT-1_6_C5	7.887067535	-32.34685435	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3499	8966	0.006022753	0.002119117	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACAGCTATCAAGAAGT-1_6_C5	2.355642854	-28.79877872	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3591	8751	0.002628271	0.003999543	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACAGCTATCAGCGACC-1_6_C5	12.18803189	31.95949289	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	736	1066	0.002814259	0	0	oligos	OL-Cntl	NA	NA	NA
ACAGCTATCCACGAAT-1_6_C5	-8.483400695	-17.8907328	6B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	721	1051	0.015223597	0.000951475	0	6B	IN-SST	NA	NA	NA
ACATACGAGTCAAGGC-1_6_C5	-2.412290635	-22.58253869	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3535	9121	0.002521653	0.003508387	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACATACGAGTTATCGC-1_6_C5	-14.79884669	-19.11406482	6B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1448	2680	0.00858209	0.003358209	0	6B	IN-SST	NA	NA	NA
ACATACGCATGTCTCC-1_6_C5	1.549186114	-16.69408098	4	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2575	5243	0.010108716	0.004577532	0	L2-3	EN-L2-3-MS	NA	NA	NA
ACATCAGAGACTAGGC-1_6_C5	1.803062169	-17.46791439	4	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2710	5704	0.01542777	0.00157784	0	L2-3	EN-L2-3-MS	NA	NA	NA
ACATCAGCAACTTGAC-1_6_C5	-16.52499694	-17.80825985	6B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1883	3672	0.01171024	0.001089325	0	6B	IN-SST	NA	NA	NA
ACATCAGCACGAGAGT-1_6_C5	3.948584242	-13.67296795	4	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2200	4195	0.014779499	0.004529201	0	L2-3	EN-L2-3-MS	NA	NA	NA
ACATCAGCAGTAAGCG-1_6_C5	-4.281994059	-8.628585729	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	888	1287	0.022533023	0.004662005	0	13A	IN-VIP	NA	NA	NA
ACATCAGTCCCATTAT-1_6_C5	-26.24293386	20.4246207	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1366	2349	0.000851426	0.002128565	0	8	Astrocytes	NA	NA	NA
ACATCAGTCTCAACTT-1_6_C5	1.923397333	-26.09286115	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2986	6990	0.012875536	0.003433476	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACATGGTCAGACAAAT-1_6_C5	0.803842735	-29.48302058	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3866	10199	0.000980488	0.003921953	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACATGGTGTAAGGATT-1_6_C5	-12.14233275	14.81183052	11	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1059	1568	0.00127551	0.004464286	0	11	Glia-MIX	NA	NA	NA
ACATGGTGTAATCACC-1_6_C5	-13.74596311	-24.50455749	6A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1143	1846	0.000541712	0.001625135	0	6A	IN-PV	NA	NA	NA
ACATGGTGTACTTCTT-1_6_C5	-2.498600084	-26.15754539	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3389	8741	0.002974488	0.001716051	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACCAGTAAGACAGACC-1_6_C5	6.239999305	26.44430014	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	825	1184	0.001689189	0.01097973	0	oligos	OL-Cntl	NA	NA	NA
ACCAGTAAGACTAAGT-1_6_C5	14.54940221	1.611256879	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	882	1255	0.011952191	0.003984064	0	12	EN-MIX	NA	NA	NA
ACCAGTAGTTGGAGGT-1_6_C5	-16.15624669	-22.08354667	6A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1489	2332	0.012435678	0.005574614	0	6A	IN-PV	NA	NA	NA
ACCAGTATCAACACCA-1_6_C5	-2.577272587	-0.934620083	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2968	6550	0.008854962	0.003358779	0	13A	IN-VIP	NA	NA	NA
ACCAGTATCATCGATG-1_6_C5	18.5566857	24.88470803	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	881	1435	0.002090592	0.002787456	0	oligos	OL-Cntl	NA	NA	NA
ACCCACTAGTCATCCA-1_6_C5	-39.06994367	-0.300577651	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1412	2472	0.000404531	0.001618123	0	9	OPC	NA	NA	NA
ACCCACTCAGGTTTCA-1_6_C5	-13.05033549	19.36344535	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1709	3124	0.002560819	0.000960307	0	8	Astrocytes	NA	NA	NA
ACCCACTCAGTATAAG-1_6_C5	0.537361747	-23.13501269	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3795	9830	0.005798576	0.002339776	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACCCACTCATAGACTC-1_6_C5	-22.4451953	31.57815475	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2667	6036	0.002153744	0.004473161	0	8	Astrocytes	NA	NA	NA
ACCCACTGTAGCGCTC-1_6_C5	13.87049095	31.13858649	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	916	1407	0.002842928	0.001421464	0	oligos	OL-Cntl	NA	NA	NA
ACCCACTGTTCGGCAC-1_6_C5	16.07600949	25.98251114	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	874	1336	0.000748503	0.001497006	0	oligos	OL-Cntl	NA	NA	NA
ACCCACTGTTGACGTT-1_6_C5	23.01101116	12.27852709	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1449	2460	0.000406504	0.004471545	0	oligos	OL-Cntl	NA	NA	NA
ACCCACTTCACCCTCA-1_6_C5	15.73693072	1.65150423	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	926	1368	0.001461988	0.002923977	0	12	EN-MIX	NA	NA	NA
ACCCACTTCCAAAGTC-1_6_C5	-26.68586458	26.68602354	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1416	2536	0.006309148	0.003548896	0	8	Astrocytes	NA	NA	NA
ACCCACTTCCCTAATT-1_6_C5	-7.047410345	-0.248393745	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1950	3992	0.01252505	0.002004008	0	13A	IN-VIP	NA	NA	NA
ACCGTAACAGATTGCT-1_6_C5	25.66201265	-5.261455409	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3960	11276	0.005587088	0.002394466	0	2	EN-L4	NA	NA	NA
ACCGTAACAGCCAATT-1_6_C5	-11.97398106	-19.14076806	6B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1038	1677	0.033392964	0.002385212	0	6B	IN-SST	NA	NA	NA
ACCGTAAGTAGAGGAA-1_6_C5	-16.3256728	-18.8846866	6B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1907	4007	0.007986024	0.001746943	0	6B	IN-SST	NA	NA	NA
ACCGTAAGTGGTACAG-1_6_C5	-5.727310109	-10.21009183	13B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1017	1459	0.008910212	0.003427005	0	13B	IN-SV2C	NA	NA	NA
ACCTTTACACTGCCAG-1_6_C5	19.74619114	-6.906253388	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2200	4765	0.011542497	0.001888772	0	3	EN-L5-6	NA	NA	NA
ACCTTTATCACGGTTA-1_6_C5	24.10696533	1.332188917	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2026	4402	0.00408905	0.001363017	0	2	EN-L4	NA	NA	NA
ACGAGCCAGAAGGACA-1_6_C5	-37.44554102	-5.578850701	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1213	2003	0.001997004	0.002496256	0	9	OPC	NA	NA	NA
ACGAGCCAGGACCACA-1_6_C5	15.50749765	-30.31860016	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	4183	11572	0.010110612	0.002246803	0	3	EN-L5-6	NA	NA	NA
ACGAGCCAGTGCGATG-1_6_C5	10.9380495	29.38262898	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	743	1142	0.009632224	0.00262697	0	oligos	OL-Cntl	NA	NA	NA
ACGAGCCCACCATCCT-1_6_C5	-18.92098961	-24.88331585	6A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3036	7518	0.008379888	0.003591381	0	6A	IN-PV	NA	NA	NA
ACGAGCCCATTTCACT-1_6_C5	5.784160263	33.51895173	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	722	1060	0.000943396	0.000943396	0	oligos	OL-Cntl	NA	NA	NA
ACGAGCCGTCGGCACT-1_6_C5	30.49855533	-3.613119223	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3082	6719	0.003423128	0.006102099	0	2	EN-L4	NA	NA	NA
ACGAGCCGTGCCTGCA-1_6_C5	-3.469337787	-8.865087345	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	860	1225	0.017142857	0.000816327	0	13A	IN-VIP	NA	NA	NA
ACGAGCCTCGGATGTT-1_6_C5	14.02157473	28.87671308	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	696	1015	0	0.002955665	0	oligos	OL-Cntl	NA	NA	NA
ACGAGCCTCGGTTCGG-1_6_C5	-38.13066659	-4.868754399	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1207	2061	0.000485201	0.002911208	0	9	OPC	NA	NA	NA
ACGAGGAAGGAATTAC-1_6_C5	5.880721043	34.01371633	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	717	1030	0.001941748	0.002912621	0	oligos	OL-Cntl	NA	NA	NA
ACGAGGAAGGAGTCTG-1_6_C5	-10.28852148	-18.38021649	6B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	963	1483	0.025623736	0.002022927	0	6B	IN-SST	NA	NA	NA
ACGAGGACAAGCGATG-1_6_C5	-35.52000316	-9.427603674	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	929	1354	0.003692762	0.003692762	0	9	OPC	NA	NA	NA
ACGAGGAGTAATCACC-1_6_C5	12.09767221	32.7393409	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	711	1022	0.001956947	0.000978474	0	oligos	OL-Cntl	NA	NA	NA
ACGAGGATCACGCATA-1_6_C5	20.67650702	-28.50674834	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3609	10452	0.004209721	0.003061615	0	3	EN-L5-6	NA	NA	NA
ACGAGGATCAGATAAG-1_6_C5	32.31135135	-7.294508356	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3326	6796	0.013831666	0.005002943	0	2	EN-L4	NA	NA	NA
ACGAGGATCCACGTTC-1_6_C5	20.47250483	21.32391476	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1101	1812	0.001103753	0.003311258	0	oligos	OL-Cntl	NA	NA	NA
ACGAGGATCGTCTGCT-1_6_C5	25.04038774	-29.36397337	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3667	10617	0.002919846	0.003861731	0	3	EN-L5-6	NA	NA	NA
ACGATACAGACGACGT-1_6_C5	-28.69951914	14.28134814	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	870	1313	0	0	0	8	Astrocytes	NA	NA	NA
ACGATACAGATGTGGC-1_6_C5	0.478692032	-18.5899999	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2851	5944	0.00538358	0.004037685	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACGATACCAAGAAAGG-1_6_C5	-25.83520671	17.95989589	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1181	1871	0.003741315	0.005344735	0	8	Astrocytes	NA	NA	NA
ACGATACCAAGTTCTG-1_6_C5	-35.72198757	-7.972987077	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1043	1618	0.000618047	0.000618047	0	9	OPC	NA	NA	NA
ACGATACCACTTAAGC-1_6_C5	4.61354252	-31.2576528	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3462	9253	0.000324219	0.001945315	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACGATACGTGCTCTTC-1_6_C5	-1.118772049	-19.76859483	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3002	6671	0.001499026	0.0058462	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACGATACTCAACGGCC-1_6_C5	-30.32556815	20.80637021	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1012	1659	0.003013864	0.001808318	0	8	Astrocytes	NA	NA	NA
ACGATACTCAGCTTAG-1_6_C5	-26.54889619	18.55282539	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1176	1967	0.000508388	0.002033554	0	8	Astrocytes	NA	NA	NA
ACGATACTCCCTAACC-1_6_C5	-28.2003169	14.65029142	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	941	1467	0.00204499	0.002726653	0	8	Astrocytes	NA	NA	NA
ACGATGTAGTCACGCC-1_6_C5	2.903275892	5.137391286	7	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	981	1358	0.001472754	0.002209131	0	7	Phagocytes	NA	NA	NA
ACGATGTCACGGACAA-1_6_C5	15.19323433	29.06084978	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	815	1250	0.0032	0.0056	0	oligos	OL-Cntl	NA	NA	NA
ACGATGTGTGCAGACA-1_6_C5	27.30370752	0.2095702	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3648	9875	0.009822785	0.002531646	0	2	EN-L4	NA	NA	NA
ACGATGTGTTTCGCTC-1_6_C5	-27.55320547	13.77334608	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	877	1271	0.001573564	0.000786782	0	8	Astrocytes	NA	NA	NA
ACGCAGCCACATTTCT-1_6_C5	-26.45292998	17.93003102	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1221	2006	0.000997009	0.000498504	0	8	Astrocytes	NA	NA	NA
ACGCAGCGTTGTACAC-1_6_C5	19.62124143	-6.994294106	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2194	4503	0.001332445	0.001776593	0	3	EN-L5-6	NA	NA	NA
ACGCAGCTCTTGACGA-1_6_C5	-7.701318617	0.693040078	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2243	4489	0.015370907	0.004009802	0	13A	IN-VIP	NA	NA	NA
ACGCCAGAGCTAGCCC-1_6_C5	23.45710149	0.552595182	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2027	3711	0.00323363	0.002694691	0	2	EN-L4	NA	NA	NA
ACGCCAGAGTACTTGC-1_6_C5	-28.29340187	13.59841143	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	781	1198	0.001669449	0.000834725	0	8	Astrocytes	NA	NA	NA
ACGCCAGAGTGACATA-1_6_C5	-20.20796449	-29.15887077	6A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	4475	12657	0.00371336	0.002765268	0	6A	IN-PV	NA	NA	NA
ACGCCAGCAAGTAGTA-1_6_C5	14.19580902	30.45372751	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	813	1158	0.004317789	0.004317789	0	oligos	OL-Cntl	NA	NA	NA
ACGCCAGGTCATCGGC-1_6_C5	20.33395251	23.57241717	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	974	1558	0.003851091	0.001925546	0	oligos	OL-Cntl	NA	NA	NA
ACGCCAGGTGTTCTTT-1_6_C5	26.47110478	-2.171124964	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3112	7418	0.001078458	0.002830952	0	2	EN-L4	NA	NA	NA
ACGCCAGTCACCCTCA-1_6_C5	-35.50675311	-3.642323573	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1366	2313	0.003458712	0.007349762	0	9	OPC	NA	NA	NA
ACGCCGAAGCCACGCT-1_6_C5	15.45445985	28.93085705	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	847	1296	0.00154321	0.003858025	0	oligos	OL-Cntl	NA	NA	NA
ACGCCGACAGCTGGCT-1_6_C5	20.19113782	19.89388251	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	981	1587	0.00063012	0.003780718	0	oligos	OL-Cntl	NA	NA	NA
ACGCCGACATCACCCT-1_6_C5	-27.98199193	17.42633408	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	970	1579	0.001899937	0.002533249	0	8	Astrocytes	NA	NA	NA
ACGCCGAGTACGAAAT-1_6_C5	26.1773392	-5.46574768	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	4537	13429	0.003946683	0.002755231	0	2	EN-L4	NA	NA	NA
ACGCCGAGTTCCCTTG-1_6_C5	18.47035795	24.875406	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	947	1386	0.003607504	0.001443001	0	oligos	OL-Cntl	NA	NA	NA
ACGCCGATCACAAACC-1_6_C5	19.91201055	21.86788712	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1038	1722	0.004065041	0.004065041	0	oligos	OL-Cntl	NA	NA	NA
ACGCCGATCCTTTCGG-1_6_C5	17.15217975	23.32793569	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	898	1391	0.000718907	0.003594536	0	oligos	OL-Cntl	NA	NA	NA
ACGCCGATCGCTTGTC-1_6_C5	5.468412571	30.38507234	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	779	1168	0.002568493	0.006849315	0	oligos	OL-Cntl	NA	NA	NA
ACGCCGATCGGCGCTA-1_6_C5	-1.886027771	-19.16278226	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2845	6750	0.006222222	0.002814815	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACGCCGATCTATCCTA-1_6_C5	14.79562258	-33.0268646	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	4206	12753	0.00133302	0.003136517	0	3	EN-L5-6	NA	NA	NA
ACGGAGAAGAGGACGG-1_6_C5	-23.70561731	30.25213129	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1879	3364	0.001189061	0.002378121	0	8	Astrocytes	NA	NA	NA
ACGGAGAAGGGTGTTG-1_6_C5	-36.07761777	-5.466245129	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1123	1725	0.009275362	0.002898551	0	9	OPC	NA	NA	NA
ACGGAGAAGTACACCT-1_6_C5	11.99377383	32.96389561	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	772	1096	0.00729927	0.002737226	0	oligos	OL-Cntl	NA	NA	NA
ACGGAGAGTTCAGTAC-1_6_C5	3.292120392	-13.2008737	4	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2012	3662	0.011196068	0.00791917	0	L2-3	EN-L2-3-MS	NA	NA	NA
ACGGAGATCATCACCC-1_6_C5	12.18597465	27.4331313	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	856	1337	0.004487659	0.003739716	0	oligos	OL-Cntl	NA	NA	NA
ACGGCCAAGGGCTCTC-1_6_C5	18.50130225	15.48859954	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1085	1776	0.005630631	0.002815315	0	oligos	OL-Cntl	NA	NA	NA
ACGGCCAAGTGCCAGA-1_6_C5	-39.32221315	-3.158550683	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1235	2211	0.003618272	0.002713704	0	9	OPC	NA	NA	NA
ACGGCCACACTTAAGC-1_6_C5	-13.80025055	-17.99402591	6B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1403	2323	0.023245803	0.004304778	0	6B	IN-SST	NA	NA	NA
ACGGCCAGTTCCATGA-1_6_C5	3.067857586	-30.11599742	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	4210	12327	0.003001541	0.00324491	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACGGGCTAGACAGAGA-1_6_C5	27.8444986	1.00784338	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2908	6595	0.012585292	0.003639121	0	2	EN-L4	NA	NA	NA
ACGGGCTAGATCCCGC-1_6_C5	19.08052892	8.840772942	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1655	2961	0.00540358	0.006416751	0	oligos	OL-Cntl	NA	NA	NA
ACGGGCTAGGAATCGC-1_6_C5	2.851381407	30.35153455	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	683	1016	0.001968504	0.00492126	0	oligos	OL-Cntl	NA	NA	NA
ACGGGCTCAACAACCT-1_6_C5	-16.63401014	-10.7545108	13B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3286	8215	0.010468655	0.002556299	0	13B	IN-SV2C	NA	NA	NA
ACGGGCTGTGGCCCTA-1_6_C5	3.772940456	-32.59203182	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	5073	16438	0.00431926	0.002798394	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACGGGCTTCACCGTAA-1_6_C5	-13.88855525	-17.93859314	6B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1366	2405	0.012058212	0.006237006	0	6B	IN-SST	NA	NA	NA
ACGGGCTTCATAGCAC-1_6_C5	-37.76359585	-4.891769305	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1190	2115	0.000945626	0.002836879	0	9	OPC	NA	NA	NA
ACGGGCTTCTTTACGT-1_6_C5	10.06733113	28.86876165	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	766	1160	0	0.006034483	0	oligos	OL-Cntl	NA	NA	NA
ACGGGTCAGAGTGACC-1_6_C5	11.11015763	26.94021253	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	762	1184	0.000844595	0.003378378	0	oligos	OL-Cntl	NA	NA	NA
ACGGGTCAGAGTGAGA-1_6_C5	25.16819875	-0.931110035	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2683	5604	0.006959315	0.003033547	0	2	EN-L4	NA	NA	NA
ACGGGTCAGGCTACGA-1_6_C5	20.21562925	11.7772823	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1371	2481	0.002821443	0.006449012	0	oligos	OL-Cntl	NA	NA	NA
ACGGGTCAGTGAACGC-1_6_C5	10.34865577	28.96870314	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	731	1088	0	0.000919118	0	oligos	OL-Cntl	NA	NA	NA
ACGGGTCCACTCGACG-1_6_C5	11.07906491	24.25530678	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	835	1284	0.001557632	0.007788162	0	oligos	OL-Cntl	NA	NA	NA
ACGGGTCCAGCGAACA-1_6_C5	-23.96336635	17.24925173	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1375	2172	0.006445672	0.002762431	0	8	Astrocytes	NA	NA	NA
ACGGGTCGTCTCCATC-1_6_C5	11.20214175	-22.47155115	4	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	4123	10425	0.008920863	0.008345324	0	L2-3	EN-L2-3-MS	NA	NA	NA
ACGGGTCGTCTGGTCG-1_6_C5	17.40921462	24.35078128	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	883	1256	0.00477707	0	0	oligos	OL-Cntl	NA	NA	NA
ACGTCAAAGCCCTAAT-1_6_C5	-16.49935207	-26.27962698	6A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2027	4079	0.009316009	0.001716107	0	6A	IN-PV	NA	NA	NA
ACGTCAAAGTGCAAGC-1_6_C5	-18.50478169	-27.63774509	6A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2404	5126	0.000780336	0.002145923	0	6A	IN-PV	NA	NA	NA
ACGTCAACAGGAATCG-1_6_C5	27.68906531	0.255158291	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	4159	11261	0.00603854	0.005860936	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACGTCAACAGGACCCT-1_6_C5	-28.83753726	22.60046034	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1074	1806	0.002214839	0.002214839	0	8	Astrocytes	NA	NA	NA
ACGTCAACAGGTCCAC-1_6_C5	-26.7736792	25.68772342	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1380	2405	0.000831601	0.002494802	0	8	Astrocytes	NA	NA	NA
ACGTCAACATGTCGAT-1_6_C5	15.62846459	-8.423514452	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1934	3641	0.003845098	0.007690195	0	12	EN-MIX	NA	NA	NA
ACGTCAAGTACATCCA-1_6_C5	-29.28185064	20.51929484	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1063	1759	0.012507106	0.004548039	0	8	Astrocytes	NA	NA	NA
ACGTCAAGTGCACGAA-1_6_C5	-26.66419192	15.59503926	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1179	1929	0.001036807	0.00155521	0	8	Astrocytes	NA	NA	NA
ACGTCAAGTTGCCTCT-1_6_C5	-28.62007003	15.47502402	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	988	1556	0.007069409	0.005141388	0	8	Astrocytes	NA	NA	NA
ACGTCAATCGCCATAA-1_6_C5	-37.1985168	-8.848762309	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	956	1547	0.001292825	0.00258565	0	9	OPC	NA	NA	NA
ACTATCTCATGATCCA-1_6_C5	-3.522888632	-5.128521758	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1112	1829	0.01038819	0.003280481	0	13A	IN-VIP	NA	NA	NA
ACTATCTGTTCATGGT-1_6_C5	-9.740954114	-18.46808259	6B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	844	1331	0.011269722	0.000751315	0	6B	IN-SST	NA	NA	NA
ACTATCTTCAGCTCTC-1_6_C5	22.99358371	1.171933018	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1826	3513	0.010247652	0.003700541	0	2	EN-L4	NA	NA	NA
ACTATCTTCCACGTGG-1_6_C5	12.27941211	27.64747959	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	721	1065	0.000938967	0.003755869	0	oligos	OL-Cntl	NA	NA	NA
ACTGAACAGGCGACAT-1_6_C5	24.43889772	-29.57625264	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2882	7411	0.001889084	0.004587775	0	3	EN-L5-6	NA	NA	NA
ACTGAACCACCATGTA-1_6_C5	4.54158052	-31.80197339	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	4179	12007	0.003914383	0.001998834	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACTGAACCAGATAATG-1_6_C5	-1.054128936	4.074393895	11	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1068	1524	0.00328084	0.00656168	0	11	Glia-MIX	NA	NA	NA
ACTGAACCAGGTGGAT-1_6_C5	13.08111467	25.19119613	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	872	1333	0.000750188	0	0	oligos	OL-Cntl	NA	NA	NA
ACTGAACGTACATGTC-1_6_C5	10.43401668	30.35820815	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	761	1137	0.001759015	0.001759015	0	oligos	OL-Cntl	NA	NA	NA
ACTGAACGTTGTTTGG-1_6_C5	25.64787576	-4.583026057	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	4183	12214	0.001228099	0.002046832	0	2	EN-L4	NA	NA	NA
ACTGAACTCAGCCTAA-1_6_C5	9.448282108	-9.110768646	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2647	6420	0.010747664	0.001557632	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACTGAGTAGAAGGCCT-1_6_C5	16.03225512	-6.76739647	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1763	3003	0.003663004	0.002664003	0	3	EN-L5-6	NA	NA	NA
ACTGAGTAGCTGCGAA-1_6_C5	21.02337495	19.09901905	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1000	1616	0.000618812	0.004950495	0	oligos	OL-Cntl	NA	NA	NA
ACTGAGTCAGGTCGTC-1_6_C5	-19.36422337	-28.17954847	6A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2840	6179	0.001294708	0.002265739	0	6A	IN-PV	NA	NA	NA
ACTGAGTGTAGAGGAA-1_6_C5	-38.18386994	-5.019388229	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1277	2081	0.004805382	0.003844306	0	9	OPC	NA	NA	NA
ACTGAGTTCACAGGCC-1_6_C5	-25.71274936	25.34887578	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1377	2534	0.016969219	0.00394633	0	8	Astrocytes	NA	NA	NA
ACTGATGAGACGCACA-1_6_C5	-23.15187062	-0.49192398	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1424	2365	0.002959831	0.002536998	0	9	OPC	NA	NA	NA
ACTGATGAGCGATATA-1_6_C5	-0.372125674	-12.38823021	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1935	3885	0.012355212	0.001544402	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACTGATGCATACCATG-1_6_C5	-20.43029766	-27.45975163	6A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3144	7134	0.018082422	0.003504345	0	6A	IN-PV	NA	NA	NA
ACTGATGGTCGACTAT-1_6_C5	8.468690631	-8.561516493	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2055	4016	0.006972112	0.003237052	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACTGATGGTTAAGACA-1_6_C5	1.258030018	-28.68331707	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	4599	13807	0.004490476	0.001883103	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACTGCTCAGCTAGTCT-1_6_C5	23.43923532	18.40314767	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1253	1957	0.000510986	0.003576903	0	oligos	OL-Cntl	NA	NA	NA
ACTGCTCCAATGGAAT-1_6_C5	-27.91755752	25.1932845	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1260	2174	0.003219871	0.004139834	0	8	Astrocytes	NA	NA	NA
ACTGCTCCACATGACT-1_6_C5	13.0071751	29.22086036	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	826	1312	0.00304878	0.000762195	0	oligos	OL-Cntl	NA	NA	NA
ACTGCTCGTCGACTGC-1_6_C5	-23.66846653	-0.131326341	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1927	3687	0.004339571	0.002983455	0	9	OPC	NA	NA	NA
ACTGCTCTCCAAAGTC-1_6_C5	0.863781728	-27.5575032	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	4135	12073	0.00298186	0.00306469	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACTGCTCTCTTGAGAC-1_6_C5	-28.04970539	16.19989394	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	937	1557	0.008991651	0.002569043	0	8	Astrocytes	NA	NA	NA
ACTGTCCAGCCTATGT-1_6_C5	-38.27342226	2.465075507	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1745	3223	0.003412969	0.003412969	0	9	OPC	NA	NA	NA
ACTGTCCAGGAACTGC-1_6_C5	2.12772053	-8.040534318	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1478	2433	0.016440608	0.004521167	0	12	EN-MIX	NA	NA	NA
ACTGTCCAGGAGTACC-1_6_C5	-34.78216161	-9.760219101	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	835	1426	0.001402525	0.002103787	0	9	OPC	NA	NA	NA
ACTGTCCCATCGGGTC-1_6_C5	0.437312028	-7.367479352	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1313	2178	0.006427916	0.006427916	0	12	EN-MIX	NA	NA	NA
ACTGTCCCATGCCTAA-1_6_C5	14.78036542	-0.583197624	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	724	1028	0.002918288	0.003891051	0	12	EN-MIX	NA	NA	NA
ACTGTCCTCAACGGCC-1_6_C5	-25.59818442	19.34088354	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1350	2332	0.003859348	0.003430532	0	8	Astrocytes	NA	NA	NA
ACTTACTAGTGTACGG-1_6_C5	-4.729729767	-8.086177378	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	835	1172	0.019624573	0.004266212	0	13A	IN-VIP	NA	NA	NA
ACTTACTGTCGAGATG-1_6_C5	16.73422194	25.0627046	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	889	1364	0.007331378	0.002199413	0	oligos	OL-Cntl	NA	NA	NA
ACTTACTTCGCTTGTC-1_6_C5	16.85927077	25.07447505	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	836	1295	0.000772201	0.000772201	0	oligos	OL-Cntl	NA	NA	NA
ACTTGTTAGACAGGCT-1_6_C5	10.79808584	25.41045237	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	801	1203	0.006650042	0.004156276	0	oligos	OL-Cntl	NA	NA	NA
ACTTGTTCAATAGCAA-1_6_C5	9.662791193	-8.988543715	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2545	6356	0.011170548	0.002045312	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACTTGTTGTCGTGGCT-1_6_C5	-8.328368795	-1.513203188	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2205	4695	0.022364217	0.003407881	0	13A	IN-VIP	NA	NA	NA
ACTTGTTGTGGTGTAG-1_6_C5	4.069878631	-31.18208029	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	4391	12835	0.005687573	0.002649007	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACTTGTTGTTGATTCG-1_6_C5	-14.24012202	-23.58121764	6A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1373	2387	0.000418936	0.004189359	0	6A	IN-PV	NA	NA	NA
ACTTTCAAGCTGCCCA-1_6_C5	-36.63034409	-7.392291445	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1143	1936	0.005165289	0.002582645	0	9	OPC	NA	NA	NA
ACTTTCACACTTAAGC-1_6_C5	-11.9470296	17.20425585	11	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1394	2217	0.00270636	0.00315742	0	11	Glia-MIX	NA	NA	NA
ACTTTCAGTGTTAAGA-1_6_C5	8.507055694	-8.371243195	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2109	4373	0.008918363	0.000686028	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACTTTCAGTTCGAATC-1_6_C5	-27.26741187	17.91628694	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1017	1584	0.005681818	0.006313131	0	8	Astrocytes	NA	NA	NA
ACTTTCATCTGTGCAA-1_6_C5	-11.66472061	-19.25411519	6B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	869	1435	0.005574913	0.002090592	0	6B	IN-SST	NA	NA	NA
AGACGTTCAAAGTCAA-1_6_C5	12.78816876	30.97863733	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	714	1054	0	0.0028463	0	oligos	OL-Cntl	NA	NA	NA
AGACGTTCATTCGACA-1_6_C5	-24.78859545	26.7204283	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1491	2687	0.004093785	0.00334946	0	8	Astrocytes	NA	NA	NA
AGACGTTGTAAGGGAA-1_6_C5	21.91497237	0.029571717	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1648	2627	0.012181195	0.002283974	0	2	EN-L4	NA	NA	NA
AGACGTTGTGTTCTTT-1_6_C5	1.748666913	-5.819986704	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1065	1617	0.008039579	0.013605442	0	12	EN-MIX	NA	NA	NA
AGACGTTTCGATCCCT-1_6_C5	13.0419626	-9.374597874	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2032	4046	0.007414731	0.005190311	0	3	EN-L5-6	NA	NA	NA
AGACGTTTCGCTTGTC-1_6_C5	-3.221580333	-7.320125339	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	790	1272	0.016509434	0.001572327	0	13A	IN-VIP	NA	NA	NA
AGAGCGACAACACGCC-1_6_C5	2.946118344	-27.89610081	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3537	9476	0.006964964	0.002532714	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AGAGCTTAGAAGAAGC-1_6_C5	14.60875683	-32.92265234	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	4045	10772	0.001763832	0.002506498	0	3	EN-L5-6	NA	NA	NA
AGAGCTTAGAATTCCC-1_6_C5	8.221616188	-7.088620813	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1549	2977	0.008733624	0.000335909	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AGAGCTTAGAGTTGGC-1_6_C5	17.15913352	28.84527951	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	843	1263	0	0.004750594	0	oligos	OL-Cntl	NA	NA	NA
AGAGCTTAGTACGATA-1_6_C5	2.351982929	-29.38324184	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3905	10633	0.007617794	0.00178689	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AGAGCTTAGTAGCGGT-1_6_C5	-14.74713112	-21.86096592	6A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1576	2905	0.023063683	0.00172117	0	6A	IN-PV	NA	NA	NA
AGAGCTTTCGTCACGG-1_6_C5	-24.75718821	24.92292246	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1442	2454	0.027302363	0.002852486	0	8	Astrocytes	NA	NA	NA
AGAGTGGAGCTGATAA-1_6_C5	-4.89937007	-7.632262986	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1006	1510	0.041059603	0.005960265	0	13A	IN-VIP	NA	NA	NA
AGAGTGGCAAAGAATC-1_6_C5	23.63685835	0.518585604	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2069	3938	0.009141696	0.002285424	0	2	EN-L4	NA	NA	NA
AGAGTGGCACCCTATC-1_6_C5	-7.504725042	-2.389163421	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1923	4087	0.02373379	0.002202104	0	13A	IN-VIP	NA	NA	NA
AGAGTGGGTAGCACGA-1_6_C5	-16.80412792	-26.23411344	6A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2182	4835	0.012409514	0.003929679	0	6A	IN-PV	NA	NA	NA
AGAGTGGGTGTGGTTT-1_6_C5	4.151508759	30.17804943	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	702	1102	0.000907441	0.008166969	0	oligos	OL-Cntl	NA	NA	NA
AGAGTGGTCTAACTCT-1_6_C5	-28.42139874	24.70721249	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1115	1830	0.001639344	0.003825137	0	8	Astrocytes	NA	NA	NA
AGATCTGCACATGACT-1_6_C5	-5.412315936	36.29042311	17	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	702	1010	0.021782178	0.001980198	0	oligos	OL-MS-2	NA	NA	NA
AGATCTGCAGTTCCCT-1_6_C5	23.79321261	0.205786417	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2122	4361	0.013987618	0.001375831	0	2	EN-L4	NA	NA	NA
AGATCTGGTCACCCAG-1_6_C5	-25.59555359	25.64293097	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1471	2765	0.008679928	0.003254973	0	8	Astrocytes	NA	NA	NA
AGATCTGTCATACGGT-1_6_C5	-28.42180876	23.12327234	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1022	1718	0.003492433	0.001746217	0	8	Astrocytes	NA	NA	NA
AGATCTGTCCGAACGC-1_6_C5	-11.41341828	-22.29510952	6A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	885	1504	0.005319149	0.003324468	0	6A	IN-PV	NA	NA	NA
AGATCTGTCGAATCCA-1_6_C5	10.07131505	29.56114579	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	679	1020	0.001960784	0.003921569	0	oligos	OL-Cntl	NA	NA	NA
AGATCTGTCTTACCTA-1_6_C5	-37.89934321	-7.431449732	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	957	1675	0.005970149	0.00119403	0	9	OPC	NA	NA	NA
AGATTGCAGCAGCGTA-1_6_C5	-34.8862417	-12.20098038	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	765	1225	0.004897959	0.001632653	0	9	OPC	NA	NA	NA
AGATTGCAGCCAGTTT-1_6_C5	-26.59199264	17.71100506	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1140	1861	0	0.003761419	0	8	Astrocytes	NA	NA	NA
AGATTGCCATCCGTGG-1_6_C5	-11.87792636	-19.12330259	6B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	960	1620	0.016049383	0.001234568	0	6B	IN-SST	NA	NA	NA
AGATTGCGTATTCGTG-1_6_C5	-27.74334971	17.85472401	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1054	1714	0.000583431	0.004084014	0	8	Astrocytes	NA	NA	NA
AGATTGCGTCCGACGT-1_6_C5	12.73422521	29.2622689	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	758	1124	0.001779359	0.002669039	0	oligos	OL-Cntl	NA	NA	NA
AGATTGCTCACCTCGT-1_6_C5	1.562028787	-21.28648365	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3712	10283	0.007390839	0.005834873	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AGATTGCTCTGGTTCC-1_6_C5	13.72084294	-32.94815585	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3735	11045	0.000633771	0.002535084	0	3	EN-L5-6	NA	NA	NA
AGCAGCCAGACTAGGC-1_6_C5	19.69642949	23.77187651	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1004	1594	0.00250941	0.005018821	0	oligos	OL-Cntl	NA	NA	NA
AGCAGCCAGCCTTGAT-1_6_C5	-26.65027132	25.56330955	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1333	2193	0.000911993	0.004559964	0	8	Astrocytes	NA	NA	NA
AGCAGCCCAAACTGCT-1_6_C5	15.44616919	1.780311877	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1027	1784	0.007286996	0.006165919	0	12	EN-MIX	NA	NA	NA
AGCAGCCCATGCCTAA-1_6_C5	20.56116028	23.79549272	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1126	1701	0.001763668	0.005878895	0	oligos	OL-Cntl	NA	NA	NA
AGCAGCCGTACCTACA-1_6_C5	-0.821947897	-0.506813278	11	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1432	2249	0.006224989	0.003557137	0	11	Glia-MIX	NA	NA	NA
AGCAGCCGTCATGCAT-1_6_C5	-16.93529875	-10.60106565	13B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3823	9474	0.007916403	0.003061009	0	13B	IN-SV2C	NA	NA	NA
AGCAGCCGTCTTGATG-1_6_C5	6.124323086	29.9551543	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	766	1101	0.003633061	0.005449591	0	oligos	OL-Cntl	NA	NA	NA
AGCAGCCGTTGACGTT-1_6_C5	20.28007026	24.00491274	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	995	1593	0.003138732	0.002510986	0	oligos	OL-Cntl	NA	NA	NA
AGCAGCCGTTTGGGCC-1_6_C5	13.67166744	27.95195328	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	765	1132	0.009717314	0.002650177	0	oligos	OL-Cntl	NA	NA	NA
AGCAGCCTCGGTTCGG-1_6_C5	5.270802901	-30.00963653	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3886	10461	0.004588471	0.00363254	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AGCAGCCTCTTTAGTC-1_6_C5	13.22191438	23.73580866	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	925	1427	0.004905396	0.007007708	0	oligos	OL-Cntl	NA	NA	NA
AGCATACAGATGAGAG-1_6_C5	-16.67411566	-25.37715582	6A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2095	4148	0.008437801	0.003857281	0	6A	IN-PV	NA	NA	NA
AGCATACCAATGCCAT-1_6_C5	4.849400172	-1.789495684	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	830	1326	0.003016591	0.009049774	0	12	EN-MIX	NA	NA	NA
AGCATACCAGGATCGA-1_6_C5	17.17559261	-4.86523724	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1524	2865	0.018150087	0.002443281	0	3	EN-L5-6	NA	NA	NA
AGCATACGTATGAAAC-1_6_C5	-26.92300501	14.89467376	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1047	1681	0.001784652	0.002379536	0	8	Astrocytes	NA	NA	NA
AGCATACGTCCGAACC-1_6_C5	-26.11917705	18.43867948	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1298	2101	0.000475964	0.001427891	0	8	Astrocytes	NA	NA	NA
AGCATACTCAAAGTAG-1_6_C5	3.408746683	-16.97000455	4	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3020	6365	0.010997643	0.008169678	0	L2-3	EN-L2-3-MS	NA	NA	NA
AGCATACTCAGTCCCT-1_6_C5	-12.49772202	-19.04001757	6B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1110	1926	0.022326064	0.002596054	0	6B	IN-SST	NA	NA	NA
AGCATACTCCTGTAGA-1_6_C5	-28.66621635	14.10152312	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	868	1324	0.002265861	0.003021148	0	8	Astrocytes	NA	NA	NA
AGCCTAACACCAGTTA-1_6_C5	1.745186581	-28.33164748	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3899	10041	0.009859576	0.003684892	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AGCCTAACACGGTGTC-1_6_C5	8.40161482	27.91081552	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	841	1254	0.003189793	0.005582137	0	oligos	OL-Cntl	NA	NA	NA
AGCCTAAGTTGGAGGT-1_6_C5	-16.45633958	-18.83197452	6B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1889	3802	0.003682272	0.001841136	0	6B	IN-SST	NA	NA	NA
AGCCTAATCCTTTACA-1_6_C5	-37.94217515	-0.190911032	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1454	2648	0.00755287	0.003021148	0	9	OPC	NA	NA	NA
AGCCTAATCTAGCACA-1_6_C5	-8.823569468	-31.04898103	16	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1070	1606	0.120174346	0.00871731	0	16	EN-PYR	NA	NA	NA
AGCGGTCAGCGCTCCA-1_6_C5	23.29577456	11.61684994	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1717	2932	0.000682128	0.004774898	0	oligos	OL-Cntl	NA	NA	NA
AGCGGTCAGTACATGA-1_6_C5	15.64867813	-0.706575351	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	737	1022	0.004892368	0.001956947	0	12	EN-MIX	NA	NA	NA
AGCGGTCCAGACGCCT-1_6_C5	-9.236322263	0.292681892	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2264	4362	0.008023842	0.007106832	0	13A	IN-VIP	NA	NA	NA
AGCGGTCCATGCATGT-1_6_C5	-14.49380501	-7.314792018	13B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3847	10240	0.009375	0.002929688	0	13B	IN-SV2C	NA	NA	NA
AGCGGTCGTAATAGCA-1_6_C5	-7.953970968	-0.498451	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2125	3933	0.003559624	0.003559624	0	13A	IN-VIP	NA	NA	NA
AGCGGTCTCTATCGCC-1_6_C5	-36.58068468	-5.318799774	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1237	2096	0.009541985	0.004293893	0	9	OPC	NA	NA	NA
AGCGTATCACAAGACG-1_6_C5	13.84942635	29.45543481	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	738	1095	0.001826484	0.001826484	0	oligos	OL-Cntl	NA	NA	NA
AGCGTATCACATAACC-1_6_C5	-1.376306289	-16.42047687	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2388	4857	0.005353099	0.003088326	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AGCGTATCAGCGAACA-1_6_C5	3.10917857	27.51340662	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	742	1069	0.001870907	0.002806361	0	oligos	OL-Cntl	NA	NA	NA
AGCGTATCAGTCGTGC-1_6_C5	-16.62353348	-26.11126582	6A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2096	4133	0.013307525	0.00290346	0	6A	IN-PV	NA	NA	NA
AGCGTATGTGCAGTAG-1_6_C5	4.882972937	31.20932342	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	746	1082	0.004621072	0.007393715	0	oligos	OL-Cntl	NA	NA	NA
AGCGTCGAGTCTCAAC-1_6_C5	6.314074983	-8.343338058	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1691	2771	0.009382894	0.002526164	0	12	EN-MIX	NA	NA	NA
AGCGTCGCAGATCTGT-1_6_C5	-5.025818626	-2.677413939	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1533	2815	0.011367673	0.003552398	0	13A	IN-VIP	NA	NA	NA
AGCGTCGGTACCGTTA-1_6_C5	-21.20495342	-28.32238303	6A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	4055	10918	0.010533065	0.003663675	0	6A	IN-PV	NA	NA	NA
AGCGTCGGTCGCGTGT-1_6_C5	-36.53396751	-9.808104424	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	858	1444	0	0.000692521	0	9	OPC	NA	NA	NA
AGCTCCTAGCGATCCC-1_6_C5	-19.44308573	-18.13011565	6A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3015	6966	0.011627907	0.004450187	0	6A	IN-PV	NA	NA	NA
AGCTCCTAGCTAGTTC-1_6_C5	9.775763012	25.33996407	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	955	1548	0.001937984	0.005167959	0	oligos	OL-Cntl	NA	NA	NA
AGCTCCTAGGTAGCCA-1_6_C5	-6.826942915	-2.054674779	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1628	2993	0.020380889	0.002672903	0	13A	IN-VIP	NA	NA	NA
AGCTCCTAGTTAAGTG-1_6_C5	-37.20385414	-0.211497502	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1526	2602	0.004996157	0.001537279	0	9	OPC	NA	NA	NA
AGCTCCTCAATCACAC-1_6_C5	20.44529631	20.46089129	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1046	1821	0.002196595	0.003844042	0	oligos	OL-Cntl	NA	NA	NA
AGCTCCTCACGGTTTA-1_6_C5	-4.565589851	-3.613460593	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1352	2307	0.004334634	0.001733853	0	13A	IN-VIP	NA	NA	NA
AGCTCCTCAGCATGAG-1_6_C5	-37.27868621	-8.935180319	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1041	1639	0.007931666	0.003660769	0	9	OPC	NA	NA	NA
AGCTCCTGTAAACACA-1_6_C5	-27.03732063	18.51574439	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1182	1927	0.002594707	0.002594707	0	8	Astrocytes	NA	NA	NA
AGCTCCTGTTCGCTAA-1_6_C5	-7.456794369	-1.414598046	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1817	3223	0.018926466	0.004033509	0	13A	IN-VIP	NA	NA	NA
AGCTCCTTCCGGGTGT-1_6_C5	-4.252627171	-8.647571783	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	959	1531	0.029392554	0.003265839	0	13A	IN-VIP	NA	NA	NA
AGCTCTCAGGTAGCTG-1_6_C5	10.40171619	29.47209707	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	742	1124	0.00088968	0.002669039	0	oligos	OL-Cntl	NA	NA	NA
AGCTCTCCAGCCACCA-1_6_C5	-37.07088222	-7.428713582	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1042	1739	0.002875216	0.001725129	0	9	OPC	NA	NA	NA
AGCTCTCGTCTGGTCG-1_6_C5	-35.14036129	-12.2552983	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	828	1279	0.006254887	0.000781861	0	9	OPC	NA	NA	NA
AGCTCTCGTGGACGAT-1_6_C5	-3.72209004	-7.420961608	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	795	1190	0.008403361	0.001680672	0	13A	IN-VIP	NA	NA	NA
AGCTCTCGTTCGGGCT-1_6_C5	3.704303828	-28.37384255	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2872	6695	0.002389843	0.001792382	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AGCTCTCTCCACTCCA-1_6_C5	-2.865073812	-26.1442815	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3874	10974	0.001366867	0.002369236	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AGCTCTCTCGATGAGG-1_6_C5	31.37231891	-8.936154943	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3642	8263	0.020210577	0.0050829	0	2	EN-L4	NA	NA	NA
AGCTTGACAGCGTCCA-1_6_C5	3.087051783	-32.26553075	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	5712	20749	0.001253072	0.001494048	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AGCTTGAGTAAAGGAG-1_6_C5	11.38327584	28.76533087	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	697	1021	0.001958864	0.003917728	0	oligos	OL-Cntl	NA	NA	NA
AGCTTGAGTCGTCTTC-1_6_C5	3.323800952	-8.578328397	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1479	2428	0.008237232	0.005766063	0	12	EN-MIX	NA	NA	NA
AGCTTGAGTGAGGCTA-1_6_C5	20.04281502	11.51691744	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1439	2499	0.0020008	0.006402561	0	oligos	OL-Cntl	NA	NA	NA
AGCTTGATCCCTGACT-1_6_C5	13.71752398	30.29700375	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	785	1213	0	0.005770816	0	oligos	OL-Cntl	NA	NA	NA
AGGCCACGTGTGAAAT-1_6_C5	2.751836581	28.06175142	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	719	1053	0	0.002849003	0	oligos	OL-Cntl	NA	NA	NA
AGGCCACTCGTCTGCT-1_6_C5	3.008898478	33.8045592	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	816	1160	0.010344828	0.004310345	0	oligos	OL-Cntl	NA	NA	NA
AGGCCGTAGTGAAGTT-1_6_C5	13.74356246	29.8956026	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	815	1210	0.002479339	0.003305785	0	oligos	OL-Cntl	NA	NA	NA
AGGCCGTCACCAGCAC-1_6_C5	3.677933068	-6.946750431	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1259	1926	0.023883697	0.00623053	0	12	EN-MIX	NA	NA	NA
AGGCCGTCAGACTCGC-1_6_C5	-1.216921003	35.29912334	17	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	781	1112	0.009892086	0.002697842	0	oligos	OL-MS-2	NA	NA	NA
AGGCCGTTCCGAAGAG-1_6_C5	19.50720248	22.09149993	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1038	1627	0.001843884	0.003073141	0	oligos	OL-Cntl	NA	NA	NA
AGGCCGTTCCGTTGCT-1_6_C5	-12.12325726	-19.115963	6B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1095	1815	0.025895317	0.003856749	0	6B	IN-SST	NA	NA	NA
AGGCCGTTCGCTTGTC-1_6_C5	-17.38018309	-11.39345718	13B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3150	7245	0.004968944	0.002346446	0	13B	IN-SV2C	NA	NA	NA
AGGCCGTTCTGATACG-1_6_C5	13.77304226	30.91403275	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	784	1222	0.000818331	0.002454992	0	oligos	OL-Cntl	NA	NA	NA
AGGCCGTTCTTCTGGC-1_6_C5	-27.08663655	24.72246195	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1263	2096	0.002385496	0.004770992	0	8	Astrocytes	NA	NA	NA
AGGCCGTTCTTGCATT-1_6_C5	27.46631552	0.349109253	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3884	10930	0.006953339	0.003110704	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AGGGAGTAGGATGGAA-1_6_C5	-6.171972921	-3.245496217	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1473	2394	0.023391813	0.003341688	0	13A	IN-VIP	NA	NA	NA
AGGGAGTAGGGATGGG-1_6_C5	5.967036112	27.77936346	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	733	1006	0.004970179	0.007952286	0	oligos	OL-Cntl	NA	NA	NA
AGGGAGTCATACGCCG-1_6_C5	2.140352711	-13.45640524	4	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2108	3824	0.008629707	0.004445607	0	L2-3	EN-L2-3-MS	NA	NA	NA
AGGGAGTTCGCATGGC-1_6_C5	-16.26858806	-19.54930709	6B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1698	3051	0.008849558	0.002622091	0	6B	IN-SST	NA	NA	NA
AGGGATGAGCAATCTC-1_6_C5	-27.14310906	14.275364	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1073	1689	0.003552398	0.005328597	0	8	Astrocytes	NA	NA	NA
AGGGATGAGGTGTGGT-1_6_C5	3.169893677	-12.76894626	4	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2086	3816	0.022012579	0.005503145	0	L2-3	EN-L2-3-MS	NA	NA	NA
AGGGATGAGTATCGAA-1_6_C5	20.65698903	1.697060943	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1564	3038	0.02600395	0.002633311	0	2	EN-L4	NA	NA	NA
AGGGATGCAGCCTTTC-1_6_C5	13.56649431	-32.77031018	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3287	8687	0.000345344	0.003683665	0	3	EN-L5-6	NA	NA	NA
AGGGATGGTTGGTAAA-1_6_C5	16.35448437	-29.1156796	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	4928	15231	0.004792857	0.005121135	0	3	EN-L5-6	NA	NA	NA
AGGGTGAAGATGTTAG-1_6_C5	14.54417214	-32.84795212	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3941	10859	0.00193388	0.003131043	0	3	EN-L5-6	NA	NA	NA
AGGGTGAAGCTCAACT-1_6_C5	16.71768108	23.80741461	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	924	1385	0.002888087	0.009386282	0	oligos	OL-Cntl	NA	NA	NA
AGGGTGAAGGATGGAA-1_6_C5	13.57928293	20.07208184	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	985	1495	0.005351171	0.004013378	0	oligos	OL-Cntl	NA	NA	NA
AGGGTGACAAACTGCT-1_6_C5	-15.59336248	-19.18209018	6B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1638	3175	0.011338583	0.003779528	0	6B	IN-SST	NA	NA	NA
AGGGTGACAACACCCG-1_6_C5	5.238261411	33.49116649	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	738	1020	0.000980392	0.004901961	0	oligos	OL-Cntl	NA	NA	NA
AGGGTGACATCGTCGG-1_6_C5	9.645861327	-7.929474586	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2285	4485	0.004236343	0.002229654	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AGGGTGAGTCGTCTTC-1_6_C5	12.40285961	19.00501149	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	990	1526	0.017693316	0.007208388	0	oligos	OL-Cntl	NA	NA	NA
AGGGTGATCTTGGGTA-1_6_C5	-23.10806223	27.64601755	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1627	2709	0.00147656	0.007382798	0	8	Astrocytes	NA	NA	NA
AGGTCATAGATGTAAC-1_6_C5	-2.117931051	-12.64508503	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2038	3865	0.010349288	0.006209573	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AGGTCATAGTTCCACA-1_6_C5	-37.12757409	-9.26783722	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	961	1666	0.00060024	0.00120048	0	9	OPC	NA	NA	NA
AGGTCATAGTTTAGGA-1_6_C5	18.09505903	-0.181432595	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1155	2007	0.001993024	0.002989537	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AGGTCATGTTCTCATT-1_6_C5	15.82362488	-2.627962072	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1062	1949	0.002052335	0.00564392	0	12	EN-MIX	NA	NA	NA
AGGTCATTCAGCTCTC-1_6_C5	3.867505146	-31.63675806	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	4687	15527	0.000193212	0.001867714	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AGGTCATTCTAACTTC-1_6_C5	-1.543782405	-24.96059276	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3890	10770	0.002692665	0.002506964	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AGGTCCGAGCTCAACT-1_6_C5	-20.01462445	-26.31715738	6A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2659	5656	0.014674682	0.003005658	0	6A	IN-PV	NA	NA	NA
AGGTCCGAGTGGAGAA-1_6_C5	5.351778929	29.94332122	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	698	1009	0.005946482	0.003964321	0	oligos	OL-Cntl	NA	NA	NA
AGGTCCGGTACTTAGC-1_6_C5	2.508540317	29.43937293	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	721	1008	0.000992063	0.00297619	0	oligos	OL-Cntl	NA	NA	NA
AGGTCCGGTTGAGTTC-1_6_C5	21.83126035	-29.07236946	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3583	9482	0.002531112	0.005273149	0	3	EN-L5-6	NA	NA	NA
AGGTCCGTCAAACCGT-1_6_C5	-4.74368921	-1.67766444	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1406	2518	0.002779984	0.004765687	0	13A	IN-VIP	NA	NA	NA
AGGTCCGTCTTGGGTA-1_6_C5	-13.01432046	-19.40663937	6B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1267	2175	0.011954023	0.002758621	0	6B	IN-SST	NA	NA	NA
AGTAGTCAGATGTGTA-1_6_C5	-5.800502959	-2.440293784	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1726	3388	0.014757969	0.002066116	0	13A	IN-VIP	NA	NA	NA
AGTAGTCAGCGAGAAA-1_6_C5	-13.67396041	-18.13965609	6B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1263	2066	0.014520813	0.002420136	0	6B	IN-SST	NA	NA	NA
AGTCTTTAGGTGACCA-1_6_C5	-0.96205938	-19.41384875	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2682	5781	0.004324511	0.004497492	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AGTCTTTGTCGCGGTT-1_6_C5	24.1169082	-29.41168639	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2819	6631	0.00377017	0.003016136	0	3	EN-L5-6	NA	NA	NA
AGTCTTTGTGCCTGGT-1_6_C5	15.8798716	25.10471393	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	827	1246	0.003210273	0.007223114	0	oligos	OL-Cntl	NA	NA	NA
AGTCTTTGTGGCAAAC-1_6_C5	25.3186015	-5.30494916	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	5084	17323	0.000923628	0.001904982	0	2	EN-L4	NA	NA	NA
AGTCTTTTCCGCATAA-1_6_C5	13.16686142	28.48545156	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	783	1235	0.00242915	0.004048583	0	oligos	OL-Cntl	NA	NA	NA
AGTGAGGAGATCTGAA-1_6_C5	5.660496345	30.74411592	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	700	1006	0.002982107	0.001988072	0	oligos	OL-Cntl	NA	NA	NA
AGTGAGGAGTACGTAA-1_6_C5	-28.81896898	13.43055611	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	769	1085	0.000921659	0.006451613	0	8	Astrocytes	NA	NA	NA
AGTGAGGCAAAGGAAG-1_6_C5	-19.95479627	-27.56997707	6A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2857	6273	0.00286944	0.00143472	0	6A	IN-PV	NA	NA	NA
AGTGAGGCACGCGAAA-1_6_C5	-7.221281697	-4.159608692	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1557	2416	0.027317881	0.004966887	0	13A	IN-VIP	NA	NA	NA
AGTGAGGCACTAAGTC-1_6_C5	-10.73057319	-20.96506062	6A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	838	1279	0.010946052	0.001563722	0	6A	IN-PV	NA	NA	NA
AGTGAGGCAGAAGCAC-1_6_C5	6.769098951	31.4761874	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	755	1101	0.007266122	0.008174387	0	oligos	OL-Cntl	NA	NA	NA
AGTGAGGCATAGGATA-1_6_C5	2.665913133	-12.33488277	4	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2008	3586	0.015616286	0.006413832	0	L2-3	EN-L2-3-MS	NA	NA	NA
AGTGAGGTCATATCGG-1_6_C5	-3.556194979	-7.078639501	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	831	1168	0.011130137	0.002568493	0	13A	IN-VIP	NA	NA	NA
AGTGAGGTCCCTAATT-1_6_C5	-27.06368926	25.17971441	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1420	2560	0.00078125	0.003125	0	8	Astrocytes	NA	NA	NA
AGTGGGACAGCATGAG-1_6_C5	16.4998937	18.12347591	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1053	1590	0.005660377	0.003144654	0	oligos	OL-Cntl	NA	NA	NA
AGTGGGACATTGGCGC-1_6_C5	10.03753713	-9.024071047	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2546	5516	0.001631617	0.001450326	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AGTGGGAGTTCAGCGC-1_6_C5	-23.76016483	-2.180135174	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1019	1486	0.012786003	0.006056528	0	9	OPC	NA	NA	NA
AGTGTCAAGGTGTGGT-1_6_C5	4.297822381	-3.451024245	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	947	1324	0.032477341	0.006042296	0	12	EN-MIX	NA	NA	NA
AGTGTCAAGTCTCAAC-1_6_C5	-16.36981698	-9.652183381	13B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2762	6001	0.018496917	0.004665889	0	13B	IN-SV2C	NA	NA	NA
AGTGTCAGTCAGTGGA-1_6_C5	-11.21560601	-21.84464404	6B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	884	1324	0.028700906	0.002265861	0	6B	IN-SST	NA	NA	NA
AGTGTCATCGTGACAT-1_6_C5	-1.599216605	-16.3319175	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2573	5443	0.0049605	0.002204667	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AGTTGGTAGAAAGTGG-1_6_C5	-19.04465404	-27.04120029	6A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2402	4686	0.012804097	0.004268032	0	6A	IN-PV	NA	NA	NA
AGTTGGTAGCGATGAC-1_6_C5	14.8525237	29.3791735	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	790	1144	0.005244755	0.004370629	0	oligos	OL-Cntl	NA	NA	NA
AGTTGGTGTCACAAGG-1_6_C5	31.44659696	-8.322824122	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3295	7342	0.036638518	0.005448107	0	2	EN-L4	NA	NA	NA
AGTTGGTTCAACACAC-1_6_C5	10.70018508	30.00636777	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	716	1045	0.006698565	0.005741627	0	oligos	OL-Cntl	NA	NA	NA
AGTTGGTTCCATGCTC-1_6_C5	1.426383429	-29.55309731	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	4155	12445	0.00586581	0.00249096	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ATAACGCAGACTTTCG-1_6_C5	-14.28313876	-18.91615669	6B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1396	2497	0.005206247	0.006007209	0	6B	IN-SST	NA	NA	NA
ATAACGCAGTGTACTC-1_6_C5	19.35833475	19.34573799	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1001	1533	0.001304631	0.000652316	0	oligos	OL-Cntl	NA	NA	NA
ATAACGCGTGTCGCTG-1_6_C5	-37.33475976	2.901951041	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1792	3412	0.00087925	0.001758499	0	9	OPC	NA	NA	NA
ATAACGCTCTCCAACC-1_6_C5	-38.40974529	-5.43151623	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1146	2034	0.001474926	0.003441495	0	9	OPC	NA	NA	NA
ATAAGAGAGCGATCCC-1_6_C5	14.63369765	-7.988248906	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1928	3896	0.004106776	0.002566735	0	3	EN-L5-6	NA	NA	NA
ATAAGAGAGCTATGCT-1_6_C5	-29.85245832	13.41936921	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	756	1137	0.001759015	0.002638522	0	8	Astrocytes	NA	NA	NA
ATAAGAGCATGATCCA-1_6_C5	5.998680446	-5.66614365	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1122	1851	0.021069692	0.001080497	0	12	EN-MIX	NA	NA	NA
ATAGACCCATTTGCCC-1_6_C5	12.745998	30.63887908	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	724	1097	0.000911577	0	0	oligos	OL-Cntl	NA	NA	NA
ATAGACCGTCATATCG-1_6_C5	-3.863582268	-7.175488544	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	933	1361	0.023512123	0.007347539	0	13A	IN-VIP	NA	NA	NA
ATAGACCGTCCAGTAT-1_6_C5	11.11098307	-8.927505943	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2696	6044	0.001323627	0.00148908	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ATAGACCGTGGAAAGA-1_6_C5	10.42208333	29.37886692	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	747	1097	0.001823154	0.00911577	0	oligos	OL-Cntl	NA	NA	NA
ATAGACCGTTCCAACA-1_6_C5	-1.978981966	-19.29479287	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2614	6070	0.004777595	0.003459638	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ATAGACCTCAAACCGT-1_6_C5	19.25711156	24.78160367	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	973	1520	0.001315789	0.002631579	0	oligos	OL-Cntl	NA	NA	NA
ATAGACCTCGGCATCG-1_6_C5	-26.93298061	17.04778288	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1087	1755	0.001709402	0.001139601	0	8	Astrocytes	NA	NA	NA
ATCACGAAGCCCAACC-1_6_C5	-27.48189583	25.01045747	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1276	2088	0.005268199	0.00335249	0	8	Astrocytes	NA	NA	NA
ATCACGAGTGCGGTAA-1_6_C5	-25.63111739	17.75049916	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1111	1745	0	0.005157593	0	8	Astrocytes	NA	NA	NA
ATCACGAGTTCCCTTG-1_6_C5	4.338438412	-30.371395	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3369	9190	0.001523395	0.002067465	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ATCACGATCCGCGGTA-1_6_C5	-37.58499149	-5.504847761	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1179	1987	0.001509814	0.001006543	0	9	OPC	NA	NA	NA
ATCACGATCTACTATC-1_6_C5	25.55190732	-5.038150308	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	4358	13497	0.000740905	0.001629992	0	2	EN-L4	NA	NA	NA
ATCATCTGTCAGGACA-1_6_C5	2.128633113	-13.82701994	4	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2222	4198	0.010957599	0.006908051	0	L2-3	EN-L2-3-MS	NA	NA	NA
ATCATGGAGAGCCTAG-1_6_C5	-28.40320854	13.26996695	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	835	1183	0.00591716	0.002535926	0	8	Astrocytes	NA	NA	NA
ATCATGGCACGAGAGT-1_6_C5	13.13964774	25.30158992	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	767	1104	0.005434783	0.009963768	0	oligos	OL-Cntl	NA	NA	NA
ATCATGGGTCTGCCAG-1_6_C5	15.11179677	25.07924467	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	844	1255	0.004780876	0.004780876	0	oligos	OL-Cntl	NA	NA	NA
ATCATGGTCATGCTCC-1_6_C5	13.74501591	-32.99758199	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3719	11188	0.0024133	0.00178763	0	3	EN-L5-6	NA	NA	NA
ATCATGGTCCAGTATG-1_6_C5	17.7504398	22.72474471	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	962	1429	0.00209937	0.00209937	0	oligos	OL-Cntl	NA	NA	NA
ATCATGGTCCTTGACC-1_6_C5	-3.288336987	-7.37009446	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	747	1101	0.011807448	0.003633061	0	13A	IN-VIP	NA	NA	NA
ATCATGGTCCTTTCGG-1_6_C5	24.43039792	-29.61804386	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2738	7093	0	0.004229522	0	3	EN-L5-6	NA	NA	NA
ATCATGGTCGGCGCTA-1_6_C5	-15.429239	-10.81161485	13B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2467	5081	0.003936233	0.002558551	0	13B	IN-SV2C	NA	NA	NA
ATCCACCCAACTGGCC-1_6_C5	1.219334643	-9.735890524	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1538	2780	0.013669065	0.002158273	0	12	EN-MIX	NA	NA	NA
ATCCACCCAAGCGAGT-1_6_C5	20.97602255	1.626380319	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1306	2141	0.000467071	0.002802429	0	2	EN-L4	NA	NA	NA
ATCCACCGTCGGATCC-1_6_C5	18.98179582	14.36961126	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1122	1864	0.001072961	0.001072961	0	oligos	OL-Cntl	NA	NA	NA
ATCCACCGTGACAAAT-1_6_C5	-0.408143408	-16.29576886	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2835	6474	0.001853568	0.00308928	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ATCCACCTCCAAACTG-1_6_C5	-27.6526673	-7.049841723	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	860	1309	0.014514897	0.004583652	0	9	OPC	NA	NA	NA
ATCCGAAAGCCAGTTT-1_6_C5	-28.10070472	23.41016184	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1210	2018	0.001982161	0.002477701	0	8	Astrocytes	NA	NA	NA
ATCCGAAAGCGATGAC-1_6_C5	-30.69636923	-13.50096816	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	774	1067	0.001874414	0.000937207	0	9	OPC	NA	NA	NA
ATCCGAAAGGAGTTTA-1_6_C5	-17.67955463	-24.86669904	6A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2148	4291	0	0.002097413	0	6A	IN-PV	NA	NA	NA
ATCCGAAAGGCGACAT-1_6_C5	-29.66565598	20.87798605	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	984	1540	0.000649351	0.007792208	0	8	Astrocytes	NA	NA	NA
ATCCGAAGTCAGATAA-1_6_C5	12.74209348	27.97518372	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	716	1049	0	0.002859867	0	oligos	OL-Cntl	NA	NA	NA
ATCCGAAGTCTAGGTT-1_6_C5	-28.88741479	16.81237796	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	894	1316	0.002279635	0.001519757	0	8	Astrocytes	NA	NA	NA
ATCCGAATCACATGCA-1_6_C5	9.021209665	31.94367654	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	706	1016	0.001968504	0.001968504	0	oligos	OL-Cntl	NA	NA	NA
ATCGAGTAGTTAACGA-1_6_C5	-6.422299571	-2.059749666	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1782	3216	0.007151741	0.004353234	0	13A	IN-VIP	NA	NA	NA
ATCGAGTGTTCCCGAG-1_6_C5	5.454463753	29.80002526	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	731	1081	0.001850139	0.000925069	0	oligos	OL-Cntl	NA	NA	NA
ATCGAGTGTTCGGGCT-1_6_C5	22.84763993	1.437375416	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1665	3127	0.001918772	0.001598977	0	2	EN-L4	NA	NA	NA
ATCGAGTTCCTTTCGG-1_6_C5	-1.784420394	-17.65429566	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2550	5640	0.001241135	0.002659574	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ATCTACTAGCGTAGTG-1_6_C5	30.97580036	-7.291373345	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3583	8338	0.013072679	0.005277045	0	2	EN-L4	NA	NA	NA
ATCTACTAGTATCTCG-1_6_C5	-11.45180761	-22.0535327	6A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	959	1573	0.001907184	0.001907184	0	6A	IN-PV	NA	NA	NA
ATCTACTCACCGAAAG-1_6_C5	-1.475075305	-19.91352355	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2984	6768	0.003989362	0.005023641	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ATCTACTCAGTCTTCC-1_6_C5	4.168025958	-27.6562492	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3545	10335	0.012772134	0.001741655	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ATCTACTGTAGGCTGA-1_6_C5	25.13655412	-29.55847848	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3431	9727	0.005962784	0.000822453	0	3	EN-L5-6	NA	NA	NA
ATCTACTGTTCCACGG-1_6_C5	-29.06040885	21.97546441	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1007	1683	0.005347594	0.003565062	0	8	Astrocytes	NA	NA	NA
ATCTGCCAGAAACCGC-1_6_C5	21.30735388	14.87868707	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1101	1777	0.003939223	0.003939223	0	oligos	OL-Cntl	NA	NA	NA
ATCTGCCAGATGTCGG-1_6_C5	9.757618477	-26.33019879	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	5325	15747	0.007048962	0.004254779	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ATCTGCCAGCATCATC-1_6_C5	11.71912643	32.31670652	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	850	1303	0.005372218	0.004604758	0	oligos	OL-Cntl	NA	NA	NA
ATCTGCCAGGTGCAAC-1_6_C5	4.346788001	30.24728524	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	718	1076	0.003717472	0.006505576	0	oligos	OL-Cntl	NA	NA	NA
ATCTGCCCATCGATTG-1_6_C5	13.14445305	29.70091133	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	869	1300	0.001538462	0.002307692	0	oligos	OL-Cntl	NA	NA	NA
ATCTGCCGTCTCAACA-1_6_C5	11.62603347	27.75699105	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	716	1049	0.002859867	0.006673022	0	oligos	OL-Cntl	NA	NA	NA
ATCTGCCGTTAAGGGC-1_6_C5	-0.224369042	-17.36105102	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2439	4759	0.001891154	0.003782307	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ATGAGGGAGAAACCGC-1_6_C5	2.618770627	-3.40367013	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	794	1197	0.006683375	0	0	12	EN-MIX	NA	NA	NA
ATGAGGGAGCAATCTC-1_6_C5	-19.31688505	-28.92383783	6A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3088	7632	0.001572327	0.002096436	0	6A	IN-PV	NA	NA	NA
ATGAGGGCAAAGCGGT-1_6_C5	-3.239633367	-5.819198136	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1041	1781	0.013475576	0.002807412	0	13A	IN-VIP	NA	NA	NA
ATGAGGGCACGAGGTA-1_6_C5	25.43455595	-0.465637597	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2522	5115	0.000782014	0.002932551	0	2	EN-L4	NA	NA	NA
ATGAGGGCAGCTCGCA-1_6_C5	-37.17693452	-8.44670924	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	983	1540	0.001298701	0.003896104	0	9	OPC	NA	NA	NA
ATGAGGGGTGACTACT-1_6_C5	10.6245738	29.77599361	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	686	1022	0.007827789	0.001956947	0	oligos	OL-Cntl	NA	NA	NA
ATGAGGGGTGTTGGGA-1_6_C5	-29.18416298	13.00403387	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	750	1155	0.002597403	0.004329004	0	8	Astrocytes	NA	NA	NA
ATGCGATAGTTACCCA-1_6_C5	11.15150971	31.79893047	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	764	1096	0.002737226	0.004562044	0	oligos	OL-Cntl	NA	NA	NA
ATGCGATGTAGAGTGC-1_6_C5	-34.39122605	-8.803940807	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	996	1574	0.00317662	0.00317662	0	9	OPC	NA	NA	NA
ATGCGATGTGAAGGCT-1_6_C5	-27.55825314	24.86311368	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1267	2093	0.001433349	0.004777831	0	8	Astrocytes	NA	NA	NA
ATGCGATTCAATACCG-1_6_C5	-36.48861187	-7.395308829	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	993	1543	0.005832793	0.002592353	0	9	OPC	NA	NA	NA
ATGCGATTCCTAGTGA-1_6_C5	-10.1974495	14.7742257	11	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1376	2217	0.00180424	0.00586378	0	11	Glia-MIX	NA	NA	NA
ATGGGAGAGACACGAC-1_6_C5	15.39518644	28.79869701	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	751	1101	0.000908265	0.002724796	0	oligos	OL-Cntl	NA	NA	NA
ATGGGAGAGTAGGCCA-1_6_C5	2.672482918	-10.77281758	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1669	2763	0.026782483	0.004343105	0	12	EN-MIX	NA	NA	NA
ATGGGAGAGTATTGGA-1_6_C5	-24.90194995	27.20340523	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1394	2312	0.000432526	0.004757785	0	8	Astrocytes	NA	NA	NA
ATGGGAGCAAGCGCTC-1_6_C5	-37.33335923	-5.97799905	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1168	1943	0.000514668	0.003602676	0	9	OPC	NA	NA	NA
ATGGGAGGTATAGGTA-1_6_C5	1.521873817	-26.1963777	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3099	6986	0.002433438	0.002719725	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ATGTGTGGTACGCTGC-1_6_C5	4.0348019	-3.694109302	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	815	1138	0.009666081	0.003514938	0	12	EN-MIX	NA	NA	NA
ATTACTCAGATGTTAG-1_6_C5	-31.9326839	12.88439317	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	780	1197	0.005847953	0.001670844	0	8	Astrocytes	NA	NA	NA
ATTACTCAGCTCAACT-1_6_C5	14.51929679	-7.97657049	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1947	3881	0.003864983	0.002061324	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ATTACTCCAAATACAG-1_6_C5	-13.7115266	-24.3387277	6A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1305	2511	0.000796495	0.001592991	0	6A	IN-PV	NA	NA	NA
ATTACTCTCCTCTAGC-1_6_C5	14.38864795	-8.284213031	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1967	4464	0	0.002688172	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ATTATCCGTACCTACA-1_6_C5	4.543034515	-32.75393151	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3890	11500	0.002173913	0.001652174	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ATTATCCTCTGCAAGT-1_6_C5	3.865739453	-9.489329643	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1465	2354	0.013593883	0.009770603	0	12	EN-MIX	NA	NA	NA
ATTCTACAGAGCTGGT-1_6_C5	0.13868141	-21.14673847	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3281	8212	0.007184608	0.003531417	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ATTCTACAGTGGACGT-1_6_C5	-0.376750636	-17.5263726	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2608	6107	0.009497298	0.001801212	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ATTCTACGTAATCACC-1_6_C5	16.35535217	-7.770807415	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1956	3649	0.013976432	0.006303097	0	3	EN-L5-6	NA	NA	NA
ATTGGACAGAAAGTGG-1_6_C5	-4.630217659	-3.267577898	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1384	2303	0.006513244	0.001302649	0	13A	IN-VIP	NA	NA	NA
ATTGGACAGCAGGCTA-1_6_C5	21.28775546	-1.119821906	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1874	3348	0.001792115	0.005973716	0	2	EN-L4	NA	NA	NA
ATTGGTGCAAGTTCTG-1_6_C5	0.163836391	-20.52672287	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2910	6697	0.002687771	0.006868747	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ATTGGTGGTCGTGGCT-1_6_C5	22.18222292	11.59662148	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1503	2562	0.00234192	0.003512881	0	oligos	OL-Cntl	NA	NA	NA
ATTGGTGTCCTCGCAT-1_6_C5	-27.69228174	25.16442216	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1255	2170	0	0.002764977	0	8	Astrocytes	NA	NA	NA
ATTGGTGTCGGCGCAT-1_6_C5	1.879478737	-29.81606698	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	4704	15419	0.002853622	0.002075362	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ATTTCTGAGTATCTCG-1_6_C5	18.04980418	-5.567842	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1202	2069	0.002899952	0.003383277	0	3	EN-L5-6	NA	NA	NA
ATTTCTGCAAAGAATC-1_6_C5	-39.36047424	-1.832434447	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1135	1910	0.005235602	0.00104712	0	9	OPC	NA	NA	NA
CAACCAAAGCTAGGCA-1_6_C5	16.67765821	25.0045324	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	827	1298	0	0.001540832	0	oligos	OL-Cntl	NA	NA	NA
CAACCAACACATCCAA-1_6_C5	-26.6535384	25.13545272	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1299	2225	0.000449438	0.003146067	0	8	Astrocytes	NA	NA	NA
CAACCAACATCCTAGA-1_6_C5	-3.247022256	-24.65021086	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3537	9936	0.001207729	0.002113527	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CAACCAAGTGAAAGAG-1_6_C5	23.10295266	-0.203168756	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2258	4188	0.00286533	0.003820439	0	2	EN-L4	NA	NA	NA
CAACCAAGTGAGTGAC-1_6_C5	-13.83300785	-24.29918269	6A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1340	2386	0.028918692	0.002095557	0	6A	IN-PV	NA	NA	NA
CAACCAATCATAACCG-1_6_C5	17.7653492	24.85496827	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	973	1452	0.002754821	0.002754821	0	oligos	OL-Cntl	NA	NA	NA
CAACCAATCATGGTCA-1_6_C5	1.072810527	-10.56133039	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1637	2963	0.00641242	0.003374958	0	12	EN-MIX	NA	NA	NA
CAACCAATCCCTAATT-1_6_C5	12.65846935	31.06686765	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	768	1165	0.000858369	0.001716738	0	oligos	OL-Cntl	NA	NA	NA
CAACCTCAGTCCGTAT-1_6_C5	25.06274927	-29.49061435	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	4116	13694	0.00109537	0.004235432	0	3	EN-L5-6	NA	NA	NA
CAACCTCAGTCTCGGC-1_6_C5	-4.775591113	-6.491644392	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1022	1506	0.017928287	0.01062417	0	13A	IN-VIP	NA	NA	NA
CAACCTCCACGTCAGC-1_6_C5	-38.15488273	2.465293728	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1711	3429	0.000874891	0.002916302	0	9	OPC	NA	NA	NA
CAACCTCGTCTCCACT-1_6_C5	-9.331954297	-19.27740808	6B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	789	1281	0.057767369	0.00156128	0	6B	IN-SST	NA	NA	NA
CAACCTCTCTAACCGA-1_6_C5	-29.21737305	15.71293829	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	874	1501	0	0.00266489	0	8	Astrocytes	NA	NA	NA
CAACCTCTCTTCATGT-1_6_C5	16.93322178	26.36988151	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	808	1214	0.006589786	0.004118616	0	oligos	OL-Cntl	NA	NA	NA
CAACTAGAGCGTCAAG-1_6_C5	1.007539169	-19.71372436	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3337	7819	0.00818519	0.002302085	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CAACTAGGTCAAAGAT-1_6_C5	16.8342902	23.57057805	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	900	1324	0.004531722	0.003776435	0	oligos	OL-Cntl	NA	NA	NA
CAACTAGGTCGAATCT-1_6_C5	12.17290275	28.36704975	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	723	1065	0.001877934	0	0	oligos	OL-Cntl	NA	NA	NA
CAACTAGTCAACACAC-1_6_C5	14.99452941	28.76993488	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	735	1037	0.00192864	0.004821601	0	oligos	OL-Cntl	NA	NA	NA
CAACTAGTCAGCACAT-1_6_C5	14.44484432	-33.15485998	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	4728	16948	0.001888128	0.002773189	0	3	EN-L5-6	NA	NA	NA
CAACTAGTCGTTTAGG-1_6_C5	10.00879449	30.07566127	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	678	1046	0.005736138	0.000956023	0	oligos	OL-Cntl	NA	NA	NA
CAAGAAACACTGTCGG-1_6_C5	-19.79111228	-27.78945589	6A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2889	6439	0.009939432	0.002795465	0	6A	IN-PV	NA	NA	NA
CAAGAAACATGCAACT-1_6_C5	3.108102984	-32.34102336	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	6818	33548	0.001550018	0.001907714	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CAAGAAAGTCCCTACT-1_6_C5	8.862931321	-30.70186734	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3745	9134	0.01346617	0.003393913	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CAAGAAAGTCTGATTG-1_6_C5	2.920648558	-27.74445398	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3364	8100	0.005555556	0.002592593	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CAAGAAATCGTTACAG-1_6_C5	-31.89959441	11.99854449	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	725	1122	0	0.001782531	0	8	Astrocytes	NA	NA	NA
CAAGAAATCTAACTGG-1_6_C5	-27.11893695	25.29977313	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1320	2240	0	0.003571429	0	8	Astrocytes	NA	NA	NA
CAAGATCAGCGTGAGT-1_6_C5	-12.00478679	17.04307495	11	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1355	2121	0.00660066	0.001885903	0	11	Glia-MIX	NA	NA	NA
CAAGATCCACTCTGTC-1_6_C5	23.09545267	-9.213387207	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3001	7038	0.001989201	0.003125888	0	3	EN-L5-6	NA	NA	NA
CAAGATCCAGGCAGTA-1_6_C5	-28.39609061	11.80024866	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	892	1272	0.017295597	0.004716981	0	8	Astrocytes	NA	NA	NA
CAAGATCCATATGGTC-1_6_C5	19.96313453	-7.000661179	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2541	6118	0.001307617	0.001634521	0	3	EN-L5-6	NA	NA	NA
CAAGATCGTCGAGTTT-1_6_C5	14.85643464	28.13424184	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	777	1130	0.000884956	0.004424779	0	oligos	OL-Cntl	NA	NA	NA
CAAGATCGTGAAATCA-1_6_C5	13.33702208	25.86757261	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	827	1269	0.000788022	0.004728132	0	oligos	OL-Cntl	NA	NA	NA
CAAGGCCAGAGGACGG-1_6_C5	10.56132053	30.98482158	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	779	1211	0.000825764	0.001651528	0	oligos	OL-Cntl	NA	NA	NA
CAAGGCCAGTCATGCT-1_6_C5	19.10621811	15.84346475	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1154	1873	0.002135611	0.005339028	0	oligos	OL-Cntl	NA	NA	NA
CAAGGCCCAGCGTTCG-1_6_C5	-20.49874215	9.396930681	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	830	1220	0.001639344	0.008196721	0	8	Astrocytes	NA	NA	NA
CAAGGCCCATATGCTG-1_6_C5	-36.69621953	-1.486587726	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1360	2238	0.00178731	0.00178731	0	9	OPC	NA	NA	NA
CAAGGCCCATCGATGT-1_6_C5	24.57321539	-0.041598058	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2554	5950	0.006218487	0.002184874	0	2	EN-L4	NA	NA	NA
CAAGGCCCATCGTCGG-1_6_C5	19.39058969	24.16183026	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1075	1665	0.001201201	0.004204204	0	oligos	OL-Cntl	NA	NA	NA
CAAGGCCGTTCAGCGC-1_6_C5	13.3561837	26.11145492	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	820	1240	0.003225806	0.002419355	0	oligos	OL-Cntl	NA	NA	NA
CAAGGCCTCTTGACGA-1_6_C5	-26.05578726	17.18221426	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1200	2036	0.007367387	0.008840864	0	8	Astrocytes	NA	NA	NA
CAAGTTGAGGCATTGG-1_6_C5	0.89710231	-28.08728097	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3996	11289	0.005049163	0.003277527	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CAAGTTGAGGGCATGT-1_6_C5	16.01912912	-32.69182444	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	4765	15030	0.007052562	0.002994012	0	3	EN-L5-6	NA	NA	NA
CAAGTTGCATAGAAAC-1_6_C5	-27.62807079	14.16521619	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	858	1225	0.004081633	0.003265306	0	8	Astrocytes	NA	NA	NA
CAAGTTGCATGTCTCC-1_6_C5	13.24797619	29.46314779	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	817	1237	0.002425222	0.00323363	0	oligos	OL-Cntl	NA	NA	NA
CAAGTTGGTACTTGAC-1_6_C5	-27.97776849	11.21246995	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	683	1039	0.001924928	0.00481232	0	8	Astrocytes	NA	NA	NA
CAAGTTGTCCTTCAAT-1_6_C5	3.117158082	-4.822325577	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	886	1361	0.002939015	0.003673769	0	12	EN-MIX	NA	NA	NA
CAAGTTGTCGCGTAGC-1_6_C5	15.84717208	-7.52612561	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2278	4966	0.003624648	0.004228756	0	3	EN-L5-6	NA	NA	NA
CACAAACAGCCTATGT-1_6_C5	19.90694637	19.97606066	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1076	1738	0.003452244	0.00287687	0	oligos	OL-Cntl	NA	NA	NA
CACAAACAGGACAGCT-1_6_C5	1.010185583	-25.86986551	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3315	7795	0.001282874	0.00436177	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CACAAACAGTGTTAGA-1_6_C5	-17.81289845	-16.89530272	6B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2086	3805	0.025492773	0.002890933	0	6B	IN-SST	NA	NA	NA
CACAAACCATGGTCAT-1_6_C5	-27.33681455	9.390799285	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	724	1051	0.009514748	0.00190295	0	8	Astrocytes	NA	NA	NA
CACAAACCATTACCTT-1_6_C5	8.463526337	-28.56580854	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	5313	16476	0.005644574	0.003034717	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CACAAACGTCACCCAG-1_6_C5	25.02585203	-29.74175529	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3260	9135	0.000875753	0.001751505	0	3	EN-L5-6	NA	NA	NA
CACAAACGTCTTCAAG-1_6_C5	-27.19670832	24.9206096	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1330	2185	0.001830664	0.003661327	0	8	Astrocytes	NA	NA	NA
CACAAACGTTACCGAT-1_6_C5	-17.39586199	-23.67768821	6A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2004	4331	0.003001616	0.003001616	0	6A	IN-PV	NA	NA	NA
CACAAACTCACCTTAT-1_6_C5	-14.71174631	-7.381791577	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3158	8284	0.010019314	0.00156929	0	13A	IN-VIP	NA	NA	NA
CACAAACTCATTGCGA-1_6_C5	23.31284893	-6.85502886	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	4143	11196	0.001429082	0.002947481	0	3	EN-L5-6	NA	NA	NA
CACAAACTCCCATTTA-1_6_C5	-1.333693263	-22.5714277	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	4137	11238	0.007296672	0.002491547	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CACAAACTCGTAGGAG-1_6_C5	11.83292825	13.90273031	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1148	1816	0.005506608	0.005506608	0	oligos	OL-Cntl	NA	NA	NA
CACAAACTCTTAGAGC-1_6_C5	27.06211499	-2.589518927	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3239	7966	0.003766006	0.001631936	0	2	EN-L4	NA	NA	NA
CACACAAAGAACTGTA-1_6_C5	10.31540789	29.8534407	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	757	1143	0.009623797	0.011373578	0	oligos	OL-Cntl	NA	NA	NA
CACACAAAGACCACGA-1_6_C5	16.65063915	15.923084	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1133	1853	0.003777658	0.004317323	0	oligos	OL-Cntl	NA	NA	NA
CACACAACAATTGCTG-1_6_C5	19.87026379	21.18227184	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1055	1711	0.001168907	0.002922268	0	oligos	OL-Cntl	NA	NA	NA
CACACAACATCGACGC-1_6_C5	19.17707429	9.320150207	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1488	2674	0.000747943	0.003365744	0	oligos	OL-Cntl	NA	NA	NA
CACACAAGTCGCATCG-1_6_C5	25.65281415	-3.409613586	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3403	8825	0.004532578	0.001926346	0	2	EN-L4	NA	NA	NA
CACACAAGTCTCATCC-1_6_C5	5.104371303	-5.464314161	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1004	1603	0.001871491	0.004366812	0	12	EN-MIX	NA	NA	NA
CACACAAGTTACAGAA-1_6_C5	11.07452252	31.05821798	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	725	1086	0	0.001841621	0	oligos	OL-Cntl	NA	NA	NA
CACACAAGTTCCTCCA-1_6_C5	19.66742863	20.80905445	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1035	1797	0.000556483	0.007790762	0	oligos	OL-Cntl	NA	NA	NA
CACACAATCAATCTCT-1_6_C5	-23.11097302	30.4361756	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2042	3940	0.005076142	0.005329949	0	8	Astrocytes	NA	NA	NA
CACACAATCTGCGGCA-1_6_C5	12.94950401	25.71132875	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	813	1215	0.003292181	0.003292181	0	oligos	OL-Cntl	NA	NA	NA
CACACAATCTTGACGA-1_6_C5	21.72650999	19.33636025	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1013	1536	0.001302083	0.005208333	0	oligos	OL-Cntl	NA	NA	NA
CACACCTAGAATCTCC-1_6_C5	-15.65115994	-11.25945383	13B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2721	6076	0.005760369	0.002468729	0	13B	IN-SV2C	NA	NA	NA
CACACCTAGCTAACTC-1_6_C5	26.7974627	0.208194647	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2885	7631	0.009042065	0.001441489	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CACACCTCAATCCAAC-1_6_C5	22.56569701	-8.913612864	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2407	5410	0.002772643	0.000924214	0	3	EN-L5-6	NA	NA	NA
CACACCTGTCTCCATC-1_6_C5	7.031604739	-6.034223303	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1380	2435	0.002464066	0.002464066	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CACACTCAGCAAATCA-1_6_C5	0.108155605	-22.33235585	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	4262	12131	0.005687907	0.006264941	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CACACTCAGTGGGCTA-1_6_C5	1.212266364	-11.27601211	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1731	3007	0.008646492	0.00498836	0	12	EN-MIX	NA	NA	NA
CACACTCCAATCCGAT-1_6_C5	12.2393664	28.97995594	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	722	1111	0	0.00090009	0	oligos	OL-Cntl	NA	NA	NA
CACACTCGTCTCCATC-1_6_C5	12.69311107	29.45556417	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	791	1283	0	0.003897116	0	oligos	OL-Cntl	NA	NA	NA
CACACTCGTTCGCTAA-1_6_C5	13.79119308	30.33748791	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	905	1366	0.002928258	0.00658858	0	oligos	OL-Cntl	NA	NA	NA
CACACTCTCCTACAGA-1_6_C5	12.09567043	31.01757815	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	725	1074	0.000931099	0.001862197	0	oligos	OL-Cntl	NA	NA	NA
CACAGGCCAGACGCAA-1_6_C5	18.28517726	15.81953386	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1105	1814	0.003858875	0.00275634	0	oligos	OL-Cntl	NA	NA	NA
CACAGGCTCAAACCAC-1_6_C5	-20.10021024	-28.16193477	6A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3182	7759	0.003608712	0.002062121	0	6A	IN-PV	NA	NA	NA
CACAGTACACAACTGT-1_6_C5	22.17011961	1.557860854	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1501	2760	0.015217391	0.001811594	0	2	EN-L4	NA	NA	NA
CACAGTACATGGAATA-1_6_C5	12.90095305	31.80177665	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	814	1196	0.001672241	0.003344482	0	oligos	OL-Cntl	NA	NA	NA
CACAGTAGTCGGCATC-1_6_C5	-13.10011806	19.36818186	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1543	2659	0.005265137	0.001504325	0	8	Astrocytes	NA	NA	NA
CACAGTAGTTCTCATT-1_6_C5	-29.23222661	14.81742051	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	911	1487	0.000672495	0.002017485	0	8	Astrocytes	NA	NA	NA
CACAGTATCAACCAAC-1_6_C5	-14.26914776	-6.645511788	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2735	5793	0.022095633	0.006904885	0	13A	IN-VIP	NA	NA	NA
CACAGTATCGGAGGTA-1_6_C5	-37.92083468	-0.183852933	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1430	2481	0.000403063	0.004030633	0	9	OPC	NA	NA	NA
CACAGTATCTACTATC-1_6_C5	18.04420544	24.77085686	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	905	1428	0.00070028	0.00210084	0	oligos	OL-Cntl	NA	NA	NA
CACAGTATCTGCTTGC-1_6_C5	22.44956886	13.6236855	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1349	2191	0.000912825	0.00182565	0	oligos	OL-Cntl	NA	NA	NA
CACAGTATCTTCGAGA-1_6_C5	-36.28596181	-4.321560618	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1284	2158	0.000463392	0.00463392	0	9	OPC	NA	NA	NA
CACATAGAGAATAGGG-1_6_C5	-28.33296299	22.30186612	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1166	1891	0.003172924	0.005817028	0	8	Astrocytes	NA	NA	NA
CACATAGAGCTGCAAG-1_6_C5	14.57901472	29.69120984	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	812	1181	0.00508044	0.00508044	0	oligos	OL-Cntl	NA	NA	NA
CACATAGCACTTGGAT-1_6_C5	22.33676773	0.147836509	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1772	3301	0.017267495	0.000908816	0	2	EN-L4	NA	NA	NA
CACATAGCATACTACG-1_6_C5	19.01716532	14.09180944	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1231	2058	0	0.002915452	0	oligos	OL-Cntl	NA	NA	NA
CACATAGCATTCCTCG-1_6_C5	-9.068881183	33.24326967	17	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	951	1463	0.075871497	0.002734108	0	oligos	OL-MS-2	NA	NA	NA
CACATAGGTTATCACG-1_6_C5	-39.4269281	-2.797130069	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1312	2442	0.002047502	0.001228501	0	9	OPC	NA	NA	NA
CACATAGTCTAAGCCA-1_6_C5	26.94888396	-4.014023619	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3492	8968	0.007694023	0.002230152	0	2	EN-L4	NA	NA	NA
CACATTTAGGTACTCT-1_6_C5	-2.997936806	-6.768131128	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	831	1339	0.008961912	0.002987304	0	13A	IN-VIP	NA	NA	NA
CACATTTAGGTGACCA-1_6_C5	-34.81313461	-11.35106629	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	871	1345	0.002973978	0.003717472	0	9	OPC	NA	NA	NA
CACATTTAGTGAACAT-1_6_C5	-12.19397237	-18.56792712	6B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1033	1706	0.023446659	0.005275498	0	6B	IN-SST	NA	NA	NA
CACATTTCAGGGTACA-1_6_C5	-30.43519901	20.30971844	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	901	1388	0.007925072	0.003602305	0	8	Astrocytes	NA	NA	NA
CACATTTGTAAGAGAG-1_6_C5	-34.01061209	-10.93376025	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	873	1323	0	0.003023432	0	9	OPC	NA	NA	NA
CACATTTTCAGGATCT-1_6_C5	15.19468141	26.28716112	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	805	1283	0.003117693	0.00233827	0	oligos	OL-Cntl	NA	NA	NA
CACCACTAGATCCGAG-1_6_C5	20.75314049	-27.98653554	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3256	8235	0.001700061	0.00376442	0	3	EN-L5-6	NA	NA	NA
CACCACTAGTAGATGT-1_6_C5	19.71206738	8.404140827	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1904	3831	0.000783085	0.004176455	0	oligos	OL-Cntl	NA	NA	NA
CACCACTCAACGCACC-1_6_C5	20.66763856	23.22864953	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1134	1831	0.001638449	0.002184599	0	oligos	OL-Cntl	NA	NA	NA
CACCACTCAATCCGAT-1_6_C5	11.80329704	31.42711269	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	813	1196	0.00083612	0.002508361	0	oligos	OL-Cntl	NA	NA	NA
CACCACTGTATGCTTG-1_6_C5	19.27955827	12.78470831	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1316	2254	0.006654836	0.004436557	0	oligos	OL-Cntl	NA	NA	NA
CACCACTTCACGCATA-1_6_C5	-14.16993861	-24.69670199	6A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1376	2543	0.01179709	0.0043256	0	6A	IN-PV	NA	NA	NA
CACCACTTCTCATTCA-1_6_C5	4.568768985	31.78742312	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	736	1066	0.00750469	0.002814259	0	oligos	OL-Cntl	NA	NA	NA
CACCAGGAGACACTAA-1_6_C5	-26.73641502	18.62726114	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1202	1928	0	0.005705394	0	8	Astrocytes	NA	NA	NA
CACCAGGAGCGATTCT-1_6_C5	-1.365654297	3.071657563	11	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1249	1945	0.004113111	0.004627249	0	11	Glia-MIX	NA	NA	NA
CACCAGGAGTGGAGAA-1_6_C5	19.16286984	14.48238335	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1131	1850	0.001081081	0.003243243	0	oligos	OL-Cntl	NA	NA	NA
CACCAGGAGTGTTTGC-1_6_C5	-28.58575144	11.39537236	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	720	1019	0.003925417	0.004906771	0	8	Astrocytes	NA	NA	NA
CACCAGGCACAGATTC-1_6_C5	-3.659676435	-15.45904245	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2310	4600	0.006956522	0.005434783	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CACCAGGGTACTTCTT-1_6_C5	1.769381869	-29.37887464	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	4272	12527	0.00526862	0.002394827	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CACCAGGGTTTAGCTG-1_6_C5	-4.965406089	-2.505177796	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1409	2517	0.001589193	0.004370282	0	13A	IN-VIP	NA	NA	NA
CACCTTGAGACTTGAA-1_6_C5	23.61496225	12.71389614	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1464	2326	0.006018917	0.002149613	0	oligos	OL-Cntl	NA	NA	NA
CACCTTGCACTTCTGC-1_6_C5	17.00228411	22.03024422	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	992	1506	0.003320053	0.003984064	0	oligos	OL-Cntl	NA	NA	NA
CACCTTGGTAAATGAC-1_6_C5	-20.65137412	-28.70440538	6A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	4150	11335	0.006352007	0.001852669	0	6A	IN-PV	NA	NA	NA
CACCTTGGTCATGCAT-1_6_C5	19.81701744	21.71596205	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	895	1404	0.000712251	0.002136752	0	oligos	OL-Cntl	NA	NA	NA
CACCTTGGTGGCAAAC-1_6_C5	-11.83522699	13.86992759	11	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	778	1114	0	0	0	11	Glia-MIX	NA	NA	NA
CACCTTGGTTACCAGT-1_6_C5	1.674677231	-22.99055422	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	4357	12221	0.017429016	0.004664103	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CACCTTGTCACTATTC-1_6_C5	10.3671916	30.39876392	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	688	1030	0.003883495	0.004854369	0	oligos	OL-Cntl	NA	NA	NA
CACCTTGTCAGTTTGG-1_6_C5	-28.76601117	12.79204824	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	767	1083	0	0.003693444	0	8	Astrocytes	NA	NA	NA
CACCTTGTCTAACTGG-1_6_C5	-25.57417252	20.66652304	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1492	2641	0.000378644	0.002271867	0	8	Astrocytes	NA	NA	NA
CACTCCAAGCGTGAGT-1_6_C5	6.544738062	35.15623094	11	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	822	1173	0.00511509	0.00511509	0	11	Glia-MIX	NA	NA	NA
CACTCCAAGTCCTCCT-1_6_C5	13.26408115	29.91695687	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	798	1234	0.001620746	0.004051864	0	oligos	OL-Cntl	NA	NA	NA
CACTCCACACCATCCT-1_6_C5	18.98934583	22.14607152	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	947	1576	0.000634518	0.003172589	0	oligos	OL-Cntl	NA	NA	NA
CACTCCACACGGCTAC-1_6_C5	39.08758443	9.152780736	14	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	772	1018	0.002946955	0.006876228	0	14	Microglia	NA	NA	NA
CACTCCACATAGAAAC-1_6_C5	-19.80140296	-28.28222482	6A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3224	7287	0.001646768	0.003842459	0	6A	IN-PV	NA	NA	NA
CACTCCAGTCAACTGT-1_6_C5	13.9279642	-0.767941269	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	958	1838	0.003808487	0.006528836	0	12	EN-MIX	NA	NA	NA
CACTCCAGTTCCCGAG-1_6_C5	19.48311949	12.2543875	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1314	2155	0.000928074	0.004640371	0	oligos	OL-Cntl	NA	NA	NA
CACTCCATCCTTGACC-1_6_C5	-28.20416949	17.32433224	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1018	1678	0.001787843	0.003575685	0	8	Astrocytes	NA	NA	NA
CACTCCATCGCCCTTA-1_6_C5	-4.338284664	-17.1501545	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2810	6485	0.005242868	0.007093292	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CACTCCATCGTGACAT-1_6_C5	0.270561485	-15.16794192	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2113	4067	0.00491763	0.003688222	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CAGAATCAGCGTAGTG-1_6_C5	1.383461198	-10.29169839	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1658	2769	0.001083424	0.006500542	0	12	EN-MIX	NA	NA	NA
CAGAATCAGGCTACGA-1_6_C5	18.96699351	22.22306562	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1002	1595	0.005642633	0.003761755	0	oligos	OL-Cntl	NA	NA	NA
CAGAATCAGTAGCGGT-1_6_C5	-26.92076181	25.17955864	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1251	2021	0.000494805	0.003463632	0	8	Astrocytes	NA	NA	NA
CAGAATCCACACCGAC-1_6_C5	-24.15422848	29.48647222	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1678	3080	0.001623377	0.003571429	0	8	Astrocytes	NA	NA	NA
CAGAATCCACCGGAAA-1_6_C5	-32.181264	-1.20510403	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1514	2660	0.010150376	0.001879699	0	9	OPC	NA	NA	NA
CAGAATCCACGTAAGG-1_6_C5	12.22871944	31.05351384	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	746	1085	0.003686636	0.004608295	0	oligos	OL-Cntl	NA	NA	NA
CAGAATCGTATATCCG-1_6_C5	11.39867075	29.47586811	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	735	1071	0.003734827	0.00280112	0	oligos	OL-Cntl	NA	NA	NA
CAGAATCGTTGGACCC-1_6_C5	-5.296473789	-2.576753252	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1571	2965	0.024957841	0.004721754	0	13A	IN-VIP	NA	NA	NA
CAGAATCTCAGGTTCA-1_6_C5	8.285946378	30.12830968	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	660	1003	0.001994018	0.002991027	0	oligos	OL-Cntl	NA	NA	NA
CAGAATCTCATGCAAC-1_6_C5	12.36412855	26.73448588	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	807	1260	0.001587302	0.003968254	0	oligos	OL-Cntl	NA	NA	NA
CAGAATCTCGCGGATC-1_6_C5	-6.272270574	-2.627329872	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1647	3012	0.02622842	0.004316069	0	13A	IN-VIP	NA	NA	NA
CAGAATCTCTGCGTAA-1_6_C5	-11.73033514	-0.463257491	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2586	5046	0.021403092	0.005747126	0	13A	IN-VIP	NA	NA	NA
CAGAATCTCTTCATGT-1_6_C5	18.13565936	21.91740054	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	758	1256	0.001592357	0.002388535	0	oligos	OL-Cntl	NA	NA	NA
CAGAGAGCAATAACGA-1_6_C5	17.413077	22.83437368	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	923	1411	0.002834869	0.003543586	0	oligos	OL-Cntl	NA	NA	NA
CAGAGAGTCTCGCTTG-1_6_C5	-3.392053555	-6.745764998	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	933	1499	0.021347565	0.004002668	0	13A	IN-VIP	NA	NA	NA
CAGATCAAGAGCTGCA-1_6_C5	25.41590249	-28.48901892	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3964	10150	0.003940887	0.000985222	0	3	EN-L5-6	NA	NA	NA
CAGATCAAGTCTTGCA-1_6_C5	38.63621454	9.080094089	14	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	878	1121	0.002676182	0.010704728	0	14	Microglia	NA	NA	NA
CAGATCACAAACCTAC-1_6_C5	20.94271435	19.92211978	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	992	1651	0.000605694	0.000605694	0	oligos	OL-Cntl	NA	NA	NA
CAGATCATCAAACCGT-1_6_C5	25.63557311	-2.016924897	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3107	7178	0.016299805	0.002925606	0	2	EN-L4	NA	NA	NA
CAGATCATCCTTTCTC-1_6_C5	-24.25087029	19.06962506	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1243	2061	0.000485201	0.003881611	0	8	Astrocytes	NA	NA	NA
CAGCAGCAGATACACA-1_6_C5	1.231984699	-9.413060085	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1435	2461	0.008126778	0.006095083	0	12	EN-MIX	NA	NA	NA
CAGCAGCAGCTGAAAT-1_6_C5	-13.55936706	-19.3158378	6B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1257	2253	0.005770084	0.003550821	0	6B	IN-SST	NA	NA	NA
CAGCAGCCAGTCGATT-1_6_C5	-1.67859387	-18.0763022	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3326	8509	0.005053473	0.00223293	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CAGCAGCGTGTTGGGA-1_6_C5	-13.57889435	-24.11351735	6A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1310	2302	0.022154648	0.002172024	0	6A	IN-PV	NA	NA	NA
CAGCAGCTCAGGCCCA-1_6_C5	-36.13225234	4.764299214	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2277	4798	0.001250521	0.001250521	0	9	OPC	NA	NA	NA
CAGCAGCTCCTGTACC-1_6_C5	15.73428279	23.51288225	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	878	1307	0	0.001530222	0	oligos	OL-Cntl	NA	NA	NA
CAGCAGCTCGAACGGA-1_6_C5	-10.5806521	1.348458278	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2191	4237	0.014160963	0.002596177	0	13A	IN-VIP	NA	NA	NA
CAGCAGCTCGACGGAA-1_6_C5	-29.42724979	14.1705782	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	900	1406	0.009246088	0.000711238	0	8	Astrocytes	NA	NA	NA
CAGCAGCTCTCCTATA-1_6_C5	14.62421919	2.656528258	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	729	1057	0.001892148	0.002838221	0	12	EN-MIX	NA	NA	NA
CAGCAGCTCTGCAGTA-1_6_C5	-37.74616345	-2.581177735	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1244	2106	0.001899335	0.004273504	0	9	OPC	NA	NA	NA
CAGCATACAAGTACCT-1_6_C5	-28.34270273	23.54931447	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1212	2129	0.000469704	0.002818225	0	8	Astrocytes	NA	NA	NA
CAGCATACACAGACTT-1_6_C5	-8.504091251	-31.50823494	16	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1009	1543	0.110174984	0.006480881	0	16	EN-PYR	NA	NA	NA
CAGCATACACATAACC-1_6_C5	3.819266966	-6.887087694	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1130	1666	0.009003601	0.005402161	0	12	EN-MIX	NA	NA	NA
CAGCATAGTTATGCGT-1_6_C5	30.18816777	-0.238490679	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3281	8088	0.016320475	0.002596439	0	2	EN-L4	NA	NA	NA
CAGCATATCTTTCCTC-1_6_C5	15.71946135	26.07926191	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	823	1281	0.00156128	0.00156128	0	oligos	OL-Cntl	NA	NA	NA
CAGCCGAAGAAGGTTT-1_6_C5	-26.83999065	9.721627901	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	739	1064	0.001879699	0.002819549	0	8	Astrocytes	NA	NA	NA
CAGCCGAAGTGACTCT-1_6_C5	-21.16358487	-28.02755578	6A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	4032	11021	0.013065965	0.00417385	0	6A	IN-PV	NA	NA	NA
CAGCCGAAGTGCGTGA-1_6_C5	13.02920411	31.33583007	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	674	1042	0.003838772	0.001919386	0	oligos	OL-Cntl	NA	NA	NA
CAGCCGACAAGCTGGA-1_6_C5	3.296748133	-13.72070867	4	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2073	3846	0.018200728	0.008060322	0	L2-3	EN-L2-3-MS	NA	NA	NA
CAGCCGACATCGGTTA-1_6_C5	17.20373187	-4.876964133	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1336	2333	0.012430347	0.002143163	0	3	EN-L5-6	NA	NA	NA
CAGCCGAGTACGACCC-1_6_C5	-20.73055383	-26.45867364	6A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3245	7958	0.01759236	0.00452375	0	6A	IN-PV	NA	NA	NA
CAGCCGAGTATAAACG-1_6_C5	-4.977893526	-4.135668881	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1379	2236	0.009391771	0.004919499	0	13A	IN-VIP	NA	NA	NA
CAGCCGATCGTAGATC-1_6_C5	-24.33362102	28.0277108	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1546	2633	0.009115078	0.001898975	0	8	Astrocytes	NA	NA	NA
CAGCCGATCTGGTGTA-1_6_C5	2.92736217	-32.41204805	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	7429	32070	0.008949174	0.003055815	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CAGCGACCAAGCCATT-1_6_C5	-8.138030871	-17.50802157	6B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	631	1005	0.0039801	0.000995025	0	6B	IN-SST	NA	NA	NA
CAGCGACCACGTTGGC-1_6_C5	-0.142209337	35.87885965	17	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	753	1086	0.009208103	0.002762431	0	oligos	OL-MS-2	NA	NA	NA
CAGCGACCATGAACCT-1_6_C5	-10.49919804	17.94968253	11	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2247	4234	0.003070383	0.003542749	0	11	Glia-MIX	NA	NA	NA
CAGCGACGTACGCACC-1_6_C5	-15.6257411	-25.38982775	6A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1804	3357	0.007447125	0.00297885	0	6A	IN-PV	NA	NA	NA
CAGCGACGTCTCGTTC-1_6_C5	-36.08764421	-11.66709098	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	828	1343	0	0.002233805	0	9	OPC	NA	NA	NA
CAGCGACGTCTGCGGT-1_6_C5	11.92886482	27.09953536	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	806	1283	0.00233827	0.00233827	0	oligos	OL-Cntl	NA	NA	NA
CAGCGACGTGCGCTTG-1_6_C5	13.10444688	27.87007913	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	800	1142	0.001751313	0.008756567	0	oligos	OL-Cntl	NA	NA	NA
CAGCGACGTGTGACGA-1_6_C5	4.132788306	25.98497006	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	754	1072	0.007462687	0.005597015	0	oligos	OL-Cntl	NA	NA	NA
CAGCGACTCTCTTGAT-1_6_C5	-38.07915797	-5.700188623	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1161	2031	0.003446578	0.001477105	0	9	OPC	NA	NA	NA
CAGCTAAAGCACACAG-1_6_C5	13.09078406	29.71273905	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	799	1204	0.000830565	0.002491694	0	oligos	OL-Cntl	NA	NA	NA
CAGCTAAAGCTGAAAT-1_6_C5	17.48183222	22.07878234	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	862	1388	0.000720461	0.003602305	0	oligos	OL-Cntl	NA	NA	NA
CAGCTAAAGGACAGCT-1_6_C5	19.86496167	-6.972859473	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2311	4919	0.006505387	0.004472454	0	3	EN-L5-6	NA	NA	NA
CAGCTAAAGGGCTCTC-1_6_C5	23.04878676	-9.115861612	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3134	7391	0.00446489	0.001488297	0	3	EN-L5-6	NA	NA	NA
CAGCTAACAAGTCATC-1_6_C5	5.381884816	29.80480792	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	699	1000	0.009	0.007	0	oligos	OL-Cntl	NA	NA	NA
CAGCTAACAGTAAGCG-1_6_C5	16.84392458	24.17245037	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	887	1401	0.000713776	0.000713776	0	oligos	OL-Cntl	NA	NA	NA
CAGCTAACATGCCTAA-1_6_C5	-16.17712582	-10.99080487	13B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2866	6901	0.004781916	0.003477757	0	13B	IN-SV2C	NA	NA	NA
CAGCTAAGTCTCTTTA-1_6_C5	-28.13951443	4.272205614	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1606	2871	0.002786486	0.003831418	0	9	OPC	NA	NA	NA
CAGCTAATCGTGACAT-1_6_C5	3.822006567	-3.265015545	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	818	1139	0.015803336	0.006145742	0	12	EN-MIX	NA	NA	NA
CAGCTGGAGATGCCTT-1_6_C5	-26.81987361	16.60730531	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1190	2041	0.00244978	0.003429691	0	8	Astrocytes	NA	NA	NA
CAGCTGGAGCGTTGCC-1_6_C5	-27.5349492	13.23045949	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	887	1336	0.000748503	0.002994012	0	8	Astrocytes	NA	NA	NA
CAGCTGGGTGCTAGCC-1_6_C5	-38.09625012	-0.875849521	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1377	2427	0.000824063	0.002472188	0	9	OPC	NA	NA	NA
CAGCTGGGTTTGACTG-1_6_C5	12.30197997	29.59133446	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	875	1318	0.005311077	0.003034901	0	oligos	OL-Cntl	NA	NA	NA
CAGCTGGTCGAACTGT-1_6_C5	-25.59888204	19.91044436	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1355	2267	0.001323335	0.001764446	0	8	Astrocytes	NA	NA	NA
CAGCTGGTCTATCCTA-1_6_C5	12.90120016	29.80131312	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	745	1116	0.003584229	0.001792115	0	oligos	OL-Cntl	NA	NA	NA
CAGCTGGTCTCTAAGG-1_6_C5	-33.062153	-13.3680734	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	656	1000	0.001	0.004	0	9	OPC	NA	NA	NA
CAGGTGCAGACGCAAC-1_6_C5	20.40911951	20.42367764	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1106	1765	0.001133144	0.003399433	0	oligos	OL-Cntl	NA	NA	NA
CAGGTGCCAAAGCAAT-1_6_C5	10.13566079	31.55420865	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	750	1110	0.004504505	0.001801802	0	oligos	OL-Cntl	NA	NA	NA
CAGGTGCCACAACGCC-1_6_C5	-0.882718718	-20.05302636	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2998	6575	0.000760456	0.008060837	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CAGGTGCCACCAACCG-1_6_C5	21.55452633	24.599775	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1095	1730	0.002312139	0.005202312	0	oligos	OL-Cntl	NA	NA	NA
CAGGTGCTCCCTTGCA-1_6_C5	-27.99983337	22.2263104	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1215	2028	0.000493097	0.00147929	0	8	Astrocytes	NA	NA	NA
CAGGTGCTCTCGATGA-1_6_C5	14.94171941	15.94700809	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1136	1688	0.005331754	0.005924171	0	oligos	OL-Cntl	NA	NA	NA
CAGGTGCTCTGCGACG-1_6_C5	-36.42052568	-7.456721259	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1109	1725	0.002318841	0.003478261	0	9	OPC	NA	NA	NA
CAGTAACAGGACCACA-1_6_C5	-13.27364832	4.517330806	6B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3387	8222	0.002189248	0.001945999	0	6B	IN-SST	NA	NA	NA
CAGTAACCACGGTAGA-1_6_C5	-24.75939194	27.83014927	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1561	2670	0.00411985	0.005617978	0	8	Astrocytes	NA	NA	NA
CAGTAACCATGGATGG-1_6_C5	-7.555661249	0.969152362	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2149	4210	0.015914489	0.002612827	0	13A	IN-VIP	NA	NA	NA
CAGTAACTCCGCAAGC-1_6_C5	-26.55843461	10.09172913	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	806	1200	0.001666667	0.004166667	0	8	Astrocytes	NA	NA	NA
CAGTCCTAGATAGGAG-1_6_C5	4.188859911	28.16909612	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	766	1071	0.001867414	0.003734827	0	oligos	OL-Cntl	NA	NA	NA
CAGTCCTAGGCGTACA-1_6_C5	5.876405358	-31.67662195	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	4575	14241	0.004494066	0.002527912	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CAGTCCTAGTTCGCAT-1_6_C5	4.483394001	-30.68834373	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3257	8931	0.000223939	0.001343635	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CAGTCCTCAGATCCAT-1_6_C5	15.65777083	-4.156213822	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1083	1788	0.005033557	0.001118568	0	12	EN-MIX	NA	NA	NA
CAGTCCTCATAGTAAG-1_6_C5	20.84436231	18.71860987	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1059	1653	0.003024803	0.005444646	0	oligos	OL-Cntl	NA	NA	NA
CAGTCCTGTCTCTCGT-1_6_C5	23.10390592	13.66908833	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1272	2097	0.006676204	0.00286123	0	oligos	OL-Cntl	NA	NA	NA
CAGTCCTGTGACGGTA-1_6_C5	14.86332062	-7.60812549	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1852	3250	0.022153846	0.002153846	0	3	EN-L5-6	NA	NA	NA
CAGTCCTGTTTGACTG-1_6_C5	24.51515272	-29.37778203	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2982	7645	0.009679529	0.002223676	0	3	EN-L5-6	NA	NA	NA
CAGTCCTTCACTGGGC-1_6_C5	-13.35930954	-19.06531086	6B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1238	2058	0.00728863	0.005344995	0	6B	IN-SST	NA	NA	NA
CAGTCCTTCCATTCTA-1_6_C5	0.131361053	-23.84140666	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	4427	13246	0.006643515	0.004831647	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CAGTCCTTCGTACCGG-1_6_C5	-12.24833313	16.31880546	11	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1267	2030	0.003448276	0.002955665	0	11	Glia-MIX	NA	NA	NA
CATATGGGTAATCACC-1_6_C5	24.82744727	-29.55743956	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3211	8368	0.001075526	0.003226577	0	3	EN-L5-6	NA	NA	NA
CATATGGTCGCGTTTC-1_6_C5	14.95484223	29.05365357	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	821	1204	0.015780731	0.008305648	0	oligos	OL-Cntl	NA	NA	NA
CATATTCAGAGGTTGC-1_6_C5	13.74238875	29.15156841	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	798	1188	0	0.004208754	0	oligos	OL-Cntl	NA	NA	NA
CATATTCAGATGTGGC-1_6_C5	-38.27594222	-8.253835701	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	996	1719	0.001163467	0.001163467	0	9	OPC	NA	NA	NA
CATATTCAGGAACTGC-1_6_C5	-39.0533088	-2.983101356	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1163	1976	0.004048583	0	0	9	OPC	NA	NA	NA
CATATTCAGGCAATTA-1_6_C5	-35.40993908	-12.25569454	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	797	1303	0.00076746	0.007674597	0	9	OPC	NA	NA	NA
CATATTCGTTCCACTC-1_6_C5	-36.87727777	-9.425039513	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	853	1431	0.000698812	0.00349406	0	9	OPC	NA	NA	NA
CATATTCGTTGTTTGG-1_6_C5	-2.074201865	-15.81906209	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2350	5366	0.000372717	0.001863586	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CATATTCTCCATGAAC-1_6_C5	11.96703474	13.36099595	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1648	3131	0.005748962	0.002555094	0	oligos	OL-Cntl	NA	NA	NA
CATATTCTCGCCCTTA-1_6_C5	22.76348365	12.97917162	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1300	2222	0	0.003150315	0	oligos	OL-Cntl	NA	NA	NA
CATCAAGAGAGTAAGG-1_6_C5	-27.61432367	18.03746874	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1115	1830	0.002185792	0.006557377	0	8	Astrocytes	NA	NA	NA
CATCAAGAGCAATCTC-1_6_C5	-23.19166795	-4.72937441	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1653	2959	0.006083136	0.002365664	0	9	OPC	NA	NA	NA
CATCAAGAGCTCCTTC-1_6_C5	-12.67173099	-2.543239805	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2606	5073	0.025034496	0.014587029	0	13A	IN-VIP	NA	NA	NA
CATCAAGAGGCCATAG-1_6_C5	-8.576075146	-18.20152573	6B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	787	1143	0.016622922	0.006999125	0	6B	IN-SST	NA	NA	NA
CATCAGATCCTCAATT-1_6_C5	17.4974898	25.21719363	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	846	1279	0.000781861	0.002345582	0	oligos	OL-Cntl	NA	NA	NA
CATCAGATCTTGCCGT-1_6_C5	3.653793617	-32.08931457	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	4961	17629	0.002552612	0.002722786	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CATCCACAGTGATCGG-1_6_C5	-12.9380704	-23.56838414	6A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1170	1859	0.023130715	0.002689618	0	6A	IN-PV	NA	NA	NA
CATCCACCACTATCTT-1_6_C5	-16.10486464	-25.84546889	6A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2054	4546	0.003739551	0.001979762	0	6A	IN-PV	NA	NA	NA
CATCCACCATGAAGTA-1_6_C5	7.461036788	-32.243963	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	4669	14199	0.004648215	0.001549405	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CATCCACGTCAGAGGT-1_6_C5	11.18319233	29.59202188	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	769	1106	0.011754069	0.006329114	0	oligos	OL-Cntl	NA	NA	NA
CATCCACGTGTGGCTC-1_6_C5	-16.95906539	-10.93627519	13B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3568	8759	0.010160977	0.003881722	0	13B	IN-SV2C	NA	NA	NA
CATCCACGTTGACGTT-1_6_C5	-26.65622161	17.73824841	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1212	1998	0.001001001	0.003003003	0	8	Astrocytes	NA	NA	NA
CATCCACTCATGCATG-1_6_C5	-1.111841458	-15.65412375	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2282	4806	0.003329172	0.004161465	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CATCCACTCTAGCACA-1_6_C5	-11.06990105	-0.502807127	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2821	5721	0.010138088	0.006117812	0	13A	IN-VIP	NA	NA	NA
CATCCACTCTCCCTGA-1_6_C5	-4.971715499	-2.425007023	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1507	2824	0.004957507	0.002124646	0	13A	IN-VIP	NA	NA	NA
CATCCACTCTGCTGCT-1_6_C5	-27.95348152	17.45259764	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1003	1656	0.001811594	0.003019324	0	8	Astrocytes	NA	NA	NA
CATCGAAAGCCGATTT-1_6_C5	31.40051873	-8.695710547	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3928	9029	0.010964669	0.005980729	0	2	EN-L4	NA	NA	NA
CATCGAAAGGCAGTCA-1_6_C5	22.87420132	12.12902565	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1483	2431	0.000411353	0.002879473	0	oligos	OL-Cntl	NA	NA	NA
CATCGGGAGACAAAGG-1_6_C5	11.48473944	31.27438307	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	859	1268	0.004731861	0.005520505	0	oligos	OL-Cntl	NA	NA	NA
CATCGGGTCATCGATG-1_6_C5	0.992947373	-27.81195361	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	4291	13908	0.00402646	0.002157032	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CATGACAAGTTGAGAT-1_6_C5	-11.39106579	-22.3765209	6A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	988	1632	0.021446078	0.00122549	0	6A	IN-PV	NA	NA	NA
CATGACACACATGGGA-1_6_C5	23.29126684	-9.22221196	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3338	8130	0.003075031	0.002460025	0	3	EN-L5-6	NA	NA	NA
CATGACACATTAGCCA-1_6_C5	-29.22571595	12.67572869	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	733	1070	0.000934579	0.001869159	0	8	Astrocytes	NA	NA	NA
CATGACAGTTAAGGGC-1_6_C5	-18.19093524	-26.40588174	6A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2502	5488	0.027879009	0.003644315	0	6A	IN-PV	NA	NA	NA
CATGCCTAGACATAAC-1_6_C5	-5.22192419	-4.323238478	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1226	1995	0.014035088	0.003007519	0	13A	IN-VIP	NA	NA	NA
CATGCCTCATATGAGA-1_6_C5	-27.1364957	15.20770991	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1032	1629	0.006138735	0.004297115	0	8	Astrocytes	NA	NA	NA
CATGCCTCATCGGTTA-1_6_C5	4.670096152	-15.48272337	4	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2805	5946	0.019677094	0.008409014	0	L2-3	EN-L2-3-MS	NA	NA	NA
CATGCCTCATGCCTAA-1_6_C5	28.39353504	-0.838129043	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3092	6958	0.00531762	0.002012072	0	2	EN-L4	NA	NA	NA
CATGCCTGTGATGATA-1_6_C5	14.36335554	-8.327810036	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2310	5054	0.001582905	0.001978631	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CATGGCGAGTGGTCCC-1_6_C5	21.1382328	7.45026179	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2055	3965	0.00075662	0.004791929	0	oligos	OL-Cntl	NA	NA	NA
CATGGCGCAAGGTGTG-1_6_C5	-16.01611443	-17.03247882	6B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1691	2995	0.020367279	0.006343907	0	6B	IN-SST	NA	NA	NA
CATGGCGCAGGGCATA-1_6_C5	2.971030523	-24.67768227	4	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	4371	11279	0.008777374	0.003989715	0	L2-3	EN-L2-3-MS	NA	NA	NA
CATGGCGCATGCTAGT-1_6_C5	-2.062788289	-19.36867852	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2670	6343	0.005675548	0.003153082	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CATGGCGGTACAGCAG-1_6_C5	21.42215089	19.24340773	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1195	2058	0.000485909	0.001943635	0	oligos	OL-Cntl	NA	NA	NA
CATGGCGGTGCCTGTG-1_6_C5	-24.63874517	-5.779148021	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1435	2357	0.01357658	0.000424268	0	9	OPC	NA	NA	NA
CATGGCGGTGGTAACG-1_6_C5	-25.77289027	19.7328367	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1429	2277	0.002195872	0.002635046	0	8	Astrocytes	NA	NA	NA
CATTATCAGAACAATC-1_6_C5	16.4114355	29.24726156	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	738	1091	0.00091659	0.004582951	0	oligos	OL-Cntl	NA	NA	NA
CATTATCAGAGTGACC-1_6_C5	-15.71077433	-19.30438607	6B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1641	3152	0.008248731	0.002538071	0	6B	IN-SST	NA	NA	NA
CATTATCAGTAGTGCG-1_6_C5	-19.1614182	-28.82996814	6A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2910	6971	0.000717257	0.002438675	0	6A	IN-PV	NA	NA	NA
CATTATCCAGTCCTTC-1_6_C5	-39.24137043	-1.45605447	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1310	2436	0.006978654	0.002052545	0	9	OPC	NA	NA	NA
CATTATCGTAATCACC-1_6_C5	10.90336832	30.84584834	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	693	1003	0.001994018	0.006979063	0	oligos	OL-Cntl	NA	NA	NA
CATTATCGTAGCTCCG-1_6_C5	13.19352901	28.75737288	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	833	1297	0	0.00231303	0	oligos	OL-Cntl	NA	NA	NA
CATTATCTCCACGACG-1_6_C5	-26.87793484	25.12622601	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1278	2182	0.002291476	0.003208066	0	8	Astrocytes	NA	NA	NA
CATTCGCAGATGCCTT-1_6_C5	13.81226479	29.42162219	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	867	1360	0.011764706	0.002205882	0	oligos	OL-Cntl	NA	NA	NA
CATTCGCAGCGCTTAT-1_6_C5	-39.29165633	-2.140696092	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1217	2098	0.0042898	0.002859867	0	9	OPC	NA	NA	NA
CATTCGCGTCCGTGAC-1_6_C5	-4.547828367	-9.009648122	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	948	1448	0.070441989	0.002071823	0	13A	IN-VIP	NA	NA	NA
CATTCGCGTTCAGTAC-1_6_C5	0.509766959	-29.14511325	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	4485	14045	0.001779993	0.001851193	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CCAATCCAGAATAGGG-1_6_C5	21.87861089	0.448260277	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1761	2802	0.006067095	0.00178444	0	2	EN-L4	NA	NA	NA
CCAATCCAGCAGCGTA-1_6_C5	-36.29188433	-8.247507969	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	954	1475	0.002711864	0	0	9	OPC	NA	NA	NA
CCAATCCCAGATAATG-1_6_C5	-1.085157158	3.455595995	11	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1283	2122	0.002356268	0.003770028	0	11	Glia-MIX	NA	NA	NA
CCAATCCGTAAACGCG-1_6_C5	24.03382328	0.595953738	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2022	4265	0.004454865	0.002344666	0	2	EN-L4	NA	NA	NA
CCAATCCGTCTCCCTA-1_6_C5	-39.84942	-0.29192911	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1566	3222	0.00496586	0.004655493	0	9	OPC	NA	NA	NA
CCAATCCTCTAACGGT-1_6_C5	3.674101603	-28.11474763	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2642	5915	0.010819949	0.001859679	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CCAATCCTCTTTACAC-1_6_C5	23.10097062	-9.054356405	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3111	7937	0.000377977	0.002141867	0	3	EN-L5-6	NA	NA	NA
CCACCTAAGAAAGTGG-1_6_C5	-2.87014185	2.253207709	11	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1911	3156	0.004119138	0.004752852	0	11	Glia-MIX	NA	NA	NA
CCACCTAAGAGCTTCT-1_6_C5	3.235330924	-11.60193871	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1889	3278	0.02776083	0.008846858	0	12	EN-MIX	NA	NA	NA
CCACCTAAGGGAAACA-1_6_C5	10.68876488	-34.02487296	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	4945	15662	0.010918146	0.00268165	0	3	EN-L5-6	NA	NA	NA
CCACCTAAGGTTCCTA-1_6_C5	-15.50319359	-11.18292749	13B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2643	6163	0.003894207	0.002920656	0	13B	IN-SV2C	NA	NA	NA
CCACCTACAAGCCATT-1_6_C5	16.70676981	24.02453797	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	925	1397	0.001431639	0.003579098	0	oligos	OL-Cntl	NA	NA	NA
CCACCTACACATAACC-1_6_C5	19.80378384	20.45289951	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	993	1617	0.001855288	0.001855288	0	oligos	OL-Cntl	NA	NA	NA
CCACCTAGTAGCGCAA-1_6_C5	4.16988201	-30.83454957	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3768	11017	0.001906145	0.001633839	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CCACCTATCTTAACCT-1_6_C5	21.92956583	1.065960613	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1620	3094	0.004524887	0.003555268	0	2	EN-L4	NA	NA	NA
CCACGGACAATGGAGC-1_6_C5	-4.885507086	-9.342940679	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	914	1436	0.04735376	0.002785515	0	13A	IN-VIP	NA	NA	NA
CCACGGAGTAAGAGAG-1_6_C5	-0.867174996	-18.30393055	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2690	5553	0.010985053	0.001620746	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CCACGGAGTCAGAATA-1_6_C5	-6.286800658	-2.033065782	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1666	2844	0.025668073	0.00140647	0	13A	IN-VIP	NA	NA	NA
CCACGGATCTATGTGG-1_6_C5	28.62328458	-5.71474489	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	4292	10753	0.007346787	0.004184879	0	2	EN-L4	NA	NA	NA
CCACTACAGAAGATTC-1_6_C5	-28.10730833	10.90501633	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	829	1208	0.000827815	0.004139073	0	8	Astrocytes	NA	NA	NA
CCACTACAGACAGGCT-1_6_C5	-24.72661355	28.96796166	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1823	3495	0.001144492	0.002288984	0	8	Astrocytes	NA	NA	NA
CCACTACAGACCCACC-1_6_C5	-32.85884706	-12.91725349	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	755	1113	0.00359389	0.006289308	0	9	OPC	NA	NA	NA
CCACTACAGAGCTGCA-1_6_C5	-27.83565734	8.856356293	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	773	1129	0.003542958	0.006200177	0	8	Astrocytes	NA	NA	NA
CCACTACAGCATCATC-1_6_C5	19.16783974	10.46696911	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1390	2469	0.000810045	0.001620089	0	oligos	OL-Cntl	NA	NA	NA
CCACTACCACTAGTAC-1_6_C5	21.14229438	20.47533262	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1198	2101	0.004759638	0.001427891	0	oligos	OL-Cntl	NA	NA	NA
CCACTACCAGCGTAAG-1_6_C5	-24.77362049	28.01105568	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1597	2774	0.002523432	0.002523432	0	8	Astrocytes	NA	NA	NA
CCACTACGTCATCGGC-1_6_C5	-2.187052493	31.21189916	17	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	906	1290	0.003875969	0.002325581	0	oligos	OL-MS-2	NA	NA	NA
CCACTACGTCTAAACC-1_6_C5	-10.08833537	11.90464038	11	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	731	1053	0.00379867	0.007597341	0	11	Glia-MIX	NA	NA	NA
CCACTACTCATACGGT-1_6_C5	-16.6476519	-9.916683264	13B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3051	6905	0.015785663	0.003186097	0	13B	IN-SV2C	NA	NA	NA
CCAGCGAAGCAATATG-1_6_C5	5.360317821	30.24185744	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	807	1179	0.002544529	0.006785411	0	oligos	OL-Cntl	NA	NA	NA
CCAGCGAAGCGCCTTG-1_6_C5	19.20186876	15.16067239	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1108	1710	0.012280702	0.002923977	0	oligos	OL-Cntl	NA	NA	NA
CCAGCGAAGGCTATCT-1_6_C5	10.63139442	27.15117775	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	858	1301	0.007686395	0.006917756	0	oligos	OL-Cntl	NA	NA	NA
CCAGCGACAAATACAG-1_6_C5	-25.17148859	27.57081743	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1578	2690	0.003717472	0.001486989	0	8	Astrocytes	NA	NA	NA
CCAGCGAGTACAGCAG-1_6_C5	8.458019839	32.79174791	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	822	1244	0.006430868	0.001607717	0	oligos	OL-Cntl	NA	NA	NA
CCAGCGAGTCCGTCAG-1_6_C5	20.93555586	-28.92743935	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3911	10560	0.004356061	0.006723485	0	3	EN-L5-6	NA	NA	NA
CCAGCGAGTGCAACGA-1_6_C5	3.199282688	30.21886956	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	743	1028	0.001945525	0.000972763	0	oligos	OL-Cntl	NA	NA	NA
CCATGTCCAATGACCT-1_6_C5	-9.144439531	0.850433174	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2537	5261	0.015396312	0.003801559	0	13A	IN-VIP	NA	NA	NA
CCATGTCCACAAGCCC-1_6_C5	18.59408878	22.17324209	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	973	1492	0.001340483	0.006032172	0	oligos	OL-Cntl	NA	NA	NA
CCATGTCCATCGGGTC-1_6_C5	4.659366779	-30.7546746	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3862	10615	0.002072539	0.00178992	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CCATGTCGTCTGGAGA-1_6_C5	14.09097962	28.91488845	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	728	1050	0	0.005714286	0	oligos	OL-Cntl	NA	NA	NA
CCATGTCTCAGGCGAA-1_6_C5	-10.9514507	16.36345179	11	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1554	2587	0.001932741	0.001932741	0	11	Glia-MIX	NA	NA	NA
CCATGTCTCCAGAAGG-1_6_C5	-35.29158994	-9.193911779	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	955	1411	0.001417434	0.002126152	0	9	OPC	NA	NA	NA
CCATGTCTCTTACCGC-1_6_C5	20.8168243	19.70516317	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1044	1631	0	0.003065604	0	oligos	OL-Cntl	NA	NA	NA
CCATTCGAGAAACCAT-1_6_C5	18.19202148	22.14288749	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	871	1406	0.0056899	0.000711238	0	oligos	OL-Cntl	NA	NA	NA
CCATTCGAGCAATCTC-1_6_C5	16.9679033	16.48467126	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1046	1768	0.000565611	0.003393665	0	oligos	OL-Cntl	NA	NA	NA
CCATTCGAGGGTGTGT-1_6_C5	-11.38367582	15.98086609	11	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1356	2140	0.005607477	0.003738318	0	11	Glia-MIX	NA	NA	NA
CCATTCGCAAGGTTCT-1_6_C5	-17.6750577	14.1875385	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1273	1968	0.00050813	0.00152439	0	8	Astrocytes	NA	NA	NA
CCATTCGCACGTGAGA-1_6_C5	13.80887925	-31.35365385	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2932	6955	0.000718907	0.003306973	0	3	EN-L5-6	NA	NA	NA
CCATTCGCACTTCTGC-1_6_C5	-28.37725627	16.10889867	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	958	1567	0.002552648	0.005105297	0	8	Astrocytes	NA	NA	NA
CCATTCGGTCCAGTAT-1_6_C5	15.94427171	-7.446844658	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2380	4797	0.003960809	0.002710027	0	3	EN-L5-6	NA	NA	NA
CCATTCGGTGTATGGG-1_6_C5	-9.917023434	11.77631097	11	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	888	1233	0.0081103	0.00729927	0	11	Glia-MIX	NA	NA	NA
CCATTCGTCCACTCCA-1_6_C5	27.69534598	-0.985399441	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	4133	12935	0.004020101	0.002319289	0	2	EN-L4	NA	NA	NA
CCATTCGTCCAGATCA-1_6_C5	11.48949677	30.35247987	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	714	1044	0.001915709	0.001915709	0	oligos	OL-Cntl	NA	NA	NA
CCATTCGTCCCTAATT-1_6_C5	-12.94691517	14.58654975	11	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	797	1177	0.002548853	0.000849618	0	11	Glia-MIX	NA	NA	NA
CCATTCGTCTAACCGA-1_6_C5	-27.93709172	25.01768323	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1202	2101	0	0.002379819	0	8	Astrocytes	NA	NA	NA
CCATTCGTCTAACTTC-1_6_C5	-3.284276271	-20.86356495	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3075	7522	0.003722414	0.002127094	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CCCAATCAGCAGCGTA-1_6_C5	-0.214852009	-11.64604826	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1844	3624	0.023178808	0.002207506	0	12	EN-MIX	NA	NA	NA
CCCAATCAGGGTTCCC-1_6_C5	1.302633805	-11.82134753	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2006	3739	0.010965499	0.008558438	0	12	EN-MIX	NA	NA	NA
CCCAATCCATGCTGGC-1_6_C5	2.457742025	-25.53240872	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3710	10540	0.006166983	0.00113852	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CCCAATCGTAGCCTAT-1_6_C5	16.31721196	18.21135044	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1011	1578	0.000633714	0.007604563	0	oligos	OL-Cntl	NA	NA	NA
CCCAATCGTCTAGGTT-1_6_C5	13.66357163	29.54809215	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	844	1273	0.00785546	0.003142184	0	oligos	OL-Cntl	NA	NA	NA
CCCAATCGTGCCTGGT-1_6_C5	-36.04746639	-7.265229889	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1164	1897	0.009488666	0.004217185	0	9	OPC	NA	NA	NA
CCCAATCTCAACCATG-1_6_C5	-38.73567032	-0.905831168	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1495	2881	0.003818119	0.001388407	0	9	OPC	NA	NA	NA
CCCAATCTCAGCAACT-1_6_C5	1.078765712	-28.19204588	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3939	10668	0.002530934	0.002530934	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CCCAATCTCCCGACTT-1_6_C5	15.41159143	30.91267802	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	868	1400	0.007857143	0.002857143	0	oligos	OL-Cntl	NA	NA	NA
CCCAATCTCGATAGAA-1_6_C5	-8.615094926	-18.03459958	6B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	764	1201	0.076602831	0.004163197	0	6B	IN-SST	NA	NA	NA
CCCAGTTAGTATCGAA-1_6_C5	15.62730504	21.98382468	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	928	1432	0	0.004888268	0	oligos	OL-Cntl	NA	NA	NA
CCCAGTTCATTAACCG-1_6_C5	40.19676481	11.42399201	14	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	856	1206	0.009121061	0.001658375	0	14	Microglia	NA	NA	NA
CCCAGTTGTATATGGA-1_6_C5	25.4090042	-29.41430376	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	4002	12902	0.000465044	0.002790265	0	3	EN-L5-6	NA	NA	NA
CCCAGTTGTTCCACTC-1_6_C5	-27.1415409	18.50414041	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1170	1979	0.002526529	0.002021223	0	8	Astrocytes	NA	NA	NA
CCCAGTTTCCAGTAGT-1_6_C5	20.48217874	22.35227515	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1053	1723	0.001160766	0.003482298	0	oligos	OL-Cntl	NA	NA	NA
CCCAGTTTCGCTTGTC-1_6_C5	1.910266347	-6.149633849	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1103	1771	0.001693958	0.003952569	0	12	EN-MIX	NA	NA	NA
CCCAGTTTCTGCGACG-1_6_C5	21.51395518	18.93648573	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1005	1537	0.001951854	0.000650618	0	oligos	OL-Cntl	NA	NA	NA
CCCATACAGAAACCTA-1_6_C5	1.066587401	-30.38387865	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	6159	23188	0.001983785	0.003105054	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CCCATACAGCCCAACC-1_6_C5	18.43796245	11.87780542	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1272	2240	0.009375	0.005357143	0	oligos	OL-Cntl	NA	NA	NA
CCCATACAGTCTCAAC-1_6_C5	-39.16537833	0.052984127	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1438	2903	0.003789184	0.001722356	0	9	OPC	NA	NA	NA
CCCATACAGTCTTGCA-1_6_C5	1.249645017	-9.423496618	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1493	2399	0.011254689	0.003334723	0	12	EN-MIX	NA	NA	NA
CCCATACCACGTCTCT-1_6_C5	19.87341236	14.82049296	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1199	1998	0.000500501	0.002502503	0	oligos	OL-Cntl	NA	NA	NA
CCCATACCAGTATGCT-1_6_C5	-38.66546006	0.299178177	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1506	2765	0.001446655	0.002531646	0	9	OPC	NA	NA	NA
CCCATACTCAGTCCCT-1_6_C5	-23.38063075	-4.920297702	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1187	1811	0.009387079	0.002760906	0	9	OPC	NA	NA	NA
CCCTCCTAGCCAGGAT-1_6_C5	-38.8778346	-0.476855893	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1410	2542	0.001180173	0.002360346	0	9	OPC	NA	NA	NA
CCCTCCTAGCGGATCA-1_6_C5	14.23930288	-2.714453191	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1135	2111	0.001421127	0.003315964	0	12	EN-MIX	NA	NA	NA
CCCTCCTAGTCCATAC-1_6_C5	3.575921429	-5.53693152	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	996	1498	0.004672897	0.003337784	0	12	EN-MIX	NA	NA	NA
CCCTCCTAGTTAACGA-1_6_C5	12.43445361	29.9325648	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	764	1187	0.00168492	0.00084246	0	oligos	OL-Cntl	NA	NA	NA
CCCTCCTCAACACCCG-1_6_C5	11.36323869	28.45817122	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	890	1400	0.000714286	0.002857143	0	oligos	OL-Cntl	NA	NA	NA
CCCTCCTCACTGAAGG-1_6_C5	-22.80218153	31.09946764	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2144	4201	0.00166627	0.005236848	0	8	Astrocytes	NA	NA	NA
CCCTCCTGTGTGACGA-1_6_C5	18.82101011	24.38108062	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	908	1400	0.002142857	0.005714286	0	oligos	OL-Cntl	NA	NA	NA
CCCTCCTGTTTACTCT-1_6_C5	0.178056605	-11.26057304	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1773	3358	0.003871352	0.002977963	0	12	EN-MIX	NA	NA	NA
CCGGGATCACACCGCA-1_6_C5	25.7797504	3.737389122	15BA	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	905	1250	0.0104	0.0048	0	15BA	Stromal cells	NA	NA	NA
CCGGGATCAGCTGTTA-1_6_C5	-27.41203608	15.03584853	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	985	1499	0.001334223	0.005336891	0	8	Astrocytes	NA	NA	NA
CCGGGATGTCTAGGTT-1_6_C5	-11.66323544	-19.15887619	6B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	970	1464	0.006830601	0.003415301	0	6B	IN-SST	NA	NA	NA
CCGGGATTCGCAAACT-1_6_C5	17.97634952	23.27697343	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	880	1321	0.000757002	0.006056018	0	oligos	OL-Cntl	NA	NA	NA
CCGGTAGAGATGTGGC-1_6_C5	-1.00704914	22.11928001	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	762	1095	0.01369863	0.003652968	0	oligos	OL-Cntl	NA	NA	NA
CCGGTAGCAAGTTGTC-1_6_C5	24.78278039	-0.179645534	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2332	4778	0.002302219	0.002511511	0	2	EN-L4	NA	NA	NA
CCGGTAGCACAACTGT-1_6_C5	17.75955873	16.75072512	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1034	1608	0.000621891	0.003731343	0	oligos	OL-Cntl	NA	NA	NA
CCGGTAGGTCATACTG-1_6_C5	-1.869618191	-18.27620943	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2869	6402	0.005154639	0.002030615	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CCGGTAGGTCGGCATC-1_6_C5	13.21517948	18.56122411	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1007	1569	0.003186743	0.006373486	0	oligos	OL-Cntl	NA	NA	NA
CCGGTAGTCAAGCCTA-1_6_C5	-9.839790335	12.50456717	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	834	1256	0.003184713	0.003184713	0	oligos	OL-Cntl	NA	NA	NA
CCGGTAGTCCAAGTAC-1_6_C5	2.17608315	-10.68587335	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1666	2877	0.012860619	0.003475843	0	12	EN-MIX	NA	NA	NA
CCGGTAGTCCTCTAGC-1_6_C5	30.70793131	-7.381711559	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	4551	12211	0.007206617	0.004422242	0	2	EN-L4	NA	NA	NA
CCGGTAGTCTGTACGA-1_6_C5	-26.03442496	18.84185621	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1261	1957	0.003065917	0.001532959	0	8	Astrocytes	NA	NA	NA
CCGTACTAGAGCTATA-1_6_C5	-27.40925591	15.34480272	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	983	1535	0.001302932	0.007166124	0	8	Astrocytes	NA	NA	NA
CCGTACTGTGAGTATA-1_6_C5	2.895895923	-27.21519317	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3114	7212	0.001525236	0.005684969	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CCGTACTGTTTGACAC-1_6_C5	11.81975609	3.21376638	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	825	1218	0.00410509	0.001642036	0	12	EN-MIX	NA	NA	NA
CCGTACTTCCGGCACA-1_6_C5	9.42571804	-7.332897758	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1892	3452	0.002317497	0.001448436	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CCGTGGAAGGTGGGTT-1_6_C5	38.95052389	9.209835329	14	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	791	1106	0.005424955	0.007233273	0	14	Microglia	NA	NA	NA
CCGTGGAAGTATTGGA-1_6_C5	-37.32865295	-5.860343252	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1087	1753	0.002852253	0.000570451	0	9	OPC	NA	NA	NA
CCGTGGACAAGTACCT-1_6_C5	-37.79267161	-8.385609146	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	995	1606	0.000622665	0.00373599	0	9	OPC	NA	NA	NA
CCGTGGAGTACATGTC-1_6_C5	2.569649628	-8.189854308	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1405	2193	0.013679891	0.004559964	0	12	EN-MIX	NA	NA	NA
CCGTGGAGTCAACATC-1_6_C5	12.70684321	31.17230802	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	765	1154	0.000866551	0.002599653	0	oligos	OL-Cntl	NA	NA	NA
CCGTGGATCTGATTCT-1_6_C5	2.068971946	-5.643643406	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	962	1493	0.003348962	0.004688547	0	12	EN-MIX	NA	NA	NA
CCGTGGATCTTCGGTC-1_6_C5	16.35694593	22.68691584	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	972	1485	0.004040404	0.003367003	0	oligos	OL-Cntl	NA	NA	NA
CCGTTCAAGACAGGCT-1_6_C5	-5.428684685	-8.477226115	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	795	1174	0.012776831	0.005110733	0	13A	IN-VIP	NA	NA	NA
CCGTTCAAGCCACCTG-1_6_C5	-37.56004485	-5.092652077	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1272	2132	0.003752345	0.001876173	0	9	OPC	NA	NA	NA
CCGTTCAAGGTGCTTT-1_6_C5	-37.41547039	-5.673639086	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1164	2065	0.002421308	0.001452785	0	9	OPC	NA	NA	NA
CCGTTCACAAGACGTG-1_6_C5	-7.949556936	1.041821234	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2184	4459	0.009643418	0.003588248	0	13A	IN-VIP	NA	NA	NA
CCGTTCACACCTTGTC-1_6_C5	-2.602063877	-19.5741747	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3144	8685	0.000230282	0.002878526	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CCGTTCAGTAAGGATT-1_6_C5	-37.43838185	-5.965546052	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1174	1896	0.000527426	0.004219409	0	9	OPC	NA	NA	NA
CCGTTCAGTAATCGTC-1_6_C5	-20.95860763	9.355363608	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	934	1347	0.00074239	0.002969562	0	8	Astrocytes	NA	NA	NA
CCGTTCAGTCCTAGCG-1_6_C5	17.31330442	25.62508538	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	879	1294	0.000772798	0.00618238	0	oligos	OL-Cntl	NA	NA	NA
CCGTTCAGTCGAAAGC-1_6_C5	-26.54641492	9.841330885	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	797	1095	0.000913242	0.002739726	0	8	Astrocytes	NA	NA	NA
CCGTTCAGTGTCTGAT-1_6_C5	-6.156869457	-2.82265027	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1612	2802	0.009992862	0.004639543	0	13A	IN-VIP	NA	NA	NA
CCGTTCATCTGGTTCC-1_6_C5	17.23059689	23.05377948	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	848	1348	0.00148368	0.005192878	0	oligos	OL-Cntl	NA	NA	NA
CCGTTCATCTTGCCGT-1_6_C5	7.237104381	-33.25352832	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	4626	15275	0.002553191	0.001963993	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CCTAAAGAGAAACCAT-1_6_C5	11.7161925	21.46822283	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	891	1302	0.006144393	0.009984639	0	oligos	OL-Cntl	NA	NA	NA
CCTAAAGAGAGTGACC-1_6_C5	23.49107598	12.91433669	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1302	2134	0.000468604	0.000937207	0	oligos	OL-Cntl	NA	NA	NA
CCTAAAGAGCTGTTCA-1_6_C5	19.51227846	1.539274356	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1211	1960	0.000510204	0.004081633	0	2	EN-L4	NA	NA	NA
CCTAAAGGTACCGGCT-1_6_C5	-37.50326722	-9.398931643	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1033	1688	0.005331754	0.000592417	0	9	OPC	NA	NA	NA
CCTAAAGGTTTGTTTC-1_6_C5	10.60988231	26.53588185	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	765	1162	0.004302926	0.008605852	0	oligos	OL-Cntl	NA	NA	NA
CCTAAAGTCACCACCT-1_6_C5	22.10603486	12.10131883	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1412	2363	0.001692763	0.004231909	0	oligos	OL-Cntl	NA	NA	NA
CCTAAAGTCGGTCCGA-1_6_C5	14.27153161	26.4770035	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	741	1083	0.001846722	0.001846722	0	oligos	OL-Cntl	NA	NA	NA
CCTACACGTGTCCTCT-1_6_C5	-28.17193993	23.86629407	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1203	2085	0.000959233	0.00383693	0	8	Astrocytes	NA	NA	NA
CCTACACTCGCATGGC-1_6_C5	12.86330049	29.20016108	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	791	1258	0.001589825	0	0	oligos	OL-Cntl	NA	NA	NA
CCTACCAAGTTCGATC-1_6_C5	13.86293911	2.356492284	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	871	1546	0.007115136	0.001940492	0	12	EN-MIX	NA	NA	NA
CCTACCACAATCCAAC-1_6_C5	-36.06750592	4.76265489	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2264	5061	0.001383126	0.002766252	0	9	OPC	NA	NA	NA
CCTACCACACAGGCCT-1_6_C5	-0.306309885	-12.37546222	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2027	3844	0.015348595	0.00182102	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CCTACCAGTAAAGTCA-1_6_C5	10.26369756	29.6884385	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	758	1145	0.001746725	0.000873362	0	oligos	OL-Cntl	NA	NA	NA
CCTACCAGTTCATGGT-1_6_C5	-34.99353448	-12.01636082	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	721	1047	0.003820439	0.007640879	0	9	OPC	NA	NA	NA
CCTACCATCGAACTGT-1_6_C5	20.56026761	20.1362445	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	994	1614	0.000619579	0.003717472	0	oligos	OL-Cntl	NA	NA	NA
CCTACCATCTAACCGA-1_6_C5	11.7863307	31.77356473	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	756	1148	0.003484321	0.004355401	0	oligos	OL-Cntl	NA	NA	NA
CCTAGCTAGATGCGAC-1_6_C5	-2.082092211	-18.00625569	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2652	6309	0.010461246	0.00253606	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CCTAGCTAGGGATACC-1_6_C5	-39.01627244	0.332869774	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1567	3261	0.000613309	0.000306654	0	9	OPC	NA	NA	NA
CCTAGCTCAAATACAG-1_6_C5	2.953763567	-24.65743996	4	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	5133	15781	0.005893163	0.006336734	0	L2-3	EN-L2-3-MS	NA	NA	NA
CCTAGCTCAGATGGGT-1_6_C5	-15.69469668	-25.85721515	6A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1874	4058	0.011335633	0.003449975	0	6A	IN-PV	NA	NA	NA
CCTAGCTCAGCATGAG-1_6_C5	3.925801289	31.72308653	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	753	1119	0.00357462	0.00178731	0	oligos	OL-Cntl	NA	NA	NA
CCTAGCTGTAAACCTC-1_6_C5	20.89724075	-29.00338545	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	4334	12888	0.004888268	0.003414029	0	3	EN-L5-6	NA	NA	NA
CCTAGCTGTTATCGGT-1_6_C5	1.941952516	-31.31040551	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	5290	17495	0.000971706	0.0028008	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CCTATTAAGCAACGGT-1_6_C5	13.05384882	1.190735395	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	636	1148	0.00261324	0.00087108	0	12	EN-MIX	NA	NA	NA
CCTATTAAGCCCTAAT-1_6_C5	-0.539819601	-13.62232901	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2010	4103	0.00828662	0.003899586	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CCTATTACAGACAAAT-1_6_C5	17.04112398	17.64263641	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1065	1671	0.013764213	0.004189108	0	oligos	OL-Cntl	NA	NA	NA
CCTATTACAGGAATCG-1_6_C5	18.44064078	1.618620345	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1031	1523	0.008535785	0.001969796	0	12	EN-MIX	NA	NA	NA
CCTATTAGTCTAGCGC-1_6_C5	2.585660209	-19.68620634	4	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3143	6988	0.013022324	0.007727533	0	L2-3	EN-L2-3-MS	NA	NA	NA
CCTATTAGTTGCCTCT-1_6_C5	-1.386914638	-1.166162199	11	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2181	4324	0.007400555	0.003006475	0	11	Glia-MIX	NA	NA	NA
CCTATTATCAACGGGA-1_6_C5	10.25840085	30.01670924	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	679	1001	0.002997003	0.001998002	0	oligos	OL-Cntl	NA	NA	NA
CCTATTATCTTTCCTC-1_6_C5	-2.38330221	-0.9171455	11	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2284	4621	0.003678857	0.002164034	0	11	Glia-MIX	NA	NA	NA
CCTCAGTCAATAACGA-1_6_C5	-6.464007727	-0.187007526	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1945	3750	0.0088	0.0016	0	13A	IN-VIP	NA	NA	NA
CCTCAGTCACGGCCAT-1_6_C5	-8.718756483	1.323242624	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2387	4740	0.006751055	0.00443038	0	13A	IN-VIP	NA	NA	NA
CCTCAGTTCTGGCGTG-1_6_C5	23.62703778	17.94555528	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1239	2069	0.002416626	0.004833253	0	oligos	OL-Cntl	NA	NA	NA
CCTCTGAAGCGATGAC-1_6_C5	15.21358807	28.57473127	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	744	1107	0.000903342	0.005420054	0	oligos	OL-Cntl	NA	NA	NA
CCTCTGACAAAGTCAA-1_6_C5	18.04537768	1.647975087	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1033	1568	0.003826531	0	0	12	EN-MIX	NA	NA	NA
CCTCTGACATGAGCGA-1_6_C5	8.488418601	-0.221223192	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1064	1604	0.043017456	0.006857855	0	12	EN-MIX	NA	NA	NA
CCTCTGACATGGAATA-1_6_C5	-14.5146273	-7.024760153	13B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3134	7436	0.007665412	0.004975793	0	13B	IN-SV2C	NA	NA	NA
CCTCTGAGTCAACATC-1_6_C5	20.21749307	23.93463733	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1062	1719	0.005235602	0.002908668	0	oligos	OL-Cntl	NA	NA	NA
CCTCTGATCACATGCA-1_6_C5	18.69395476	8.908690337	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1600	3049	0.005575599	0.002623811	0	oligos	OL-Cntl	NA	NA	NA
CCTCTGATCCGAATGT-1_6_C5	-15.93536062	-25.78746091	6A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1822	3528	0.004535147	0.000566893	0	6A	IN-PV	NA	NA	NA
CCTTACGGTGAACCTT-1_6_C5	7.007955476	-33.08851276	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	4449	14309	0.004053393	0.002376127	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CCTTACGTCCGTTGTC-1_6_C5	-26.52697829	27.28587291	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1505	2712	0.00479351	0.001843658	0	8	Astrocytes	NA	NA	NA
CCTTACGTCCTGCAGG-1_6_C5	5.562896624	30.02985284	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	683	1020	0.003921569	0.007843137	0	oligos	OL-Cntl	NA	NA	NA
CCTTACGTCGATCCCT-1_6_C5	1.739439924	-23.20180133	4	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	4783	14810	0.008845375	0.003848751	0	L2-3	EN-L2-3-MS	NA	NA	NA
CCTTACGTCGGAATCT-1_6_C5	-27.11501485	18.19050162	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1143	1794	0.011148272	0.001672241	0	8	Astrocytes	NA	NA	NA
CCTTACGTCTCGTATT-1_6_C5	-17.7864174	-23.47504177	6A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2190	4591	0.01459377	0.002831627	0	6A	IN-PV	NA	NA	NA
CCTTCCCAGACAATAC-1_6_C5	11.04648933	-8.95434599	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2842	7014	0.000855432	0.001710864	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CCTTCCCAGAGACGAA-1_6_C5	-3.440536654	-7.458344549	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	828	1284	0.00623053	0.003894081	0	13A	IN-VIP	NA	NA	NA
CCTTCCCAGGCTCATT-1_6_C5	-26.88469843	25.62412301	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1273	2234	0.00179051	0.004028648	0	8	Astrocytes	NA	NA	NA
CCTTCCCCATCACAAC-1_6_C5	18.97979567	14.78023264	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1152	1898	0.00052687	0.004741834	0	oligos	OL-Cntl	NA	NA	NA
CCTTCCCTCATGTGGT-1_6_C5	-12.36141667	-19.21463227	6B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1123	1874	0.010672359	0.00266809	0	6B	IN-SST	NA	NA	NA
CCTTCCCTCCACGACG-1_6_C5	20.63490247	21.02459647	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	965	1644	0.001824818	0.00486618	0	oligos	OL-Cntl	NA	NA	NA
CCTTCCCTCGTTGACA-1_6_C5	-28.20501138	13.74042144	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	835	1339	0	0.002987304	0	8	Astrocytes	NA	NA	NA
CCTTCCCTCTTAGCCC-1_6_C5	13.15694001	29.61859574	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	813	1311	0.001525553	0.00228833	0	oligos	OL-Cntl	NA	NA	NA
CCTTCGAAGAAGGCCT-1_6_C5	2.839783937	-24.79688472	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3892	10009	0.004695774	0.003896493	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CCTTCGAAGACCTTTG-1_6_C5	-0.134644824	-20.26553477	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3074	7342	0.009534187	0.004630891	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CCTTCGACACATGTGT-1_6_C5	19.89488153	22.3800132	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1008	1742	0.00401837	0.002296211	0	oligos	OL-Cntl	NA	NA	NA
CCTTCGATCCGGGTGT-1_6_C5	-0.8866886	-0.5630164	11	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1608	2725	0.021651376	0.005504587	0	11	Glia-MIX	NA	NA	NA
CCTTTCTAGGGAAACA-1_6_C5	13.967793	-31.4003352	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3238	7942	0.009695291	0.002518257	0	3	EN-L5-6	NA	NA	NA
CCTTTCTCAGGTGGAT-1_6_C5	-0.766883794	4.103685312	11	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1013	1485	0.006060606	0.005387205	0	11	Glia-MIX	NA	NA	NA
CCTTTCTCATCACAAC-1_6_C5	11.33184151	30.02099755	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	673	1037	0.00192864	0.003857281	0	oligos	OL-Cntl	NA	NA	NA
CCTTTCTGTCCTGCTT-1_6_C5	-29.18577149	13.53759635	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	778	1237	0.000808407	0.002425222	0	8	Astrocytes	NA	NA	NA
CCTTTCTGTCGCTTTC-1_6_C5	18.21239391	18.86410737	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1057	1868	0.004282655	0.00267666	0	oligos	OL-Cntl	NA	NA	NA
CCTTTCTGTCGGCATC-1_6_C5	15.35782257	30.05945212	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	785	1124	0	0.00088968	0	oligos	OL-Cntl	NA	NA	NA
CCTTTCTTCAGCACAT-1_6_C5	11.17626563	26.35433792	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	896	1384	0	0.005057803	0	oligos	OL-Cntl	NA	NA	NA
CGAACATAGCTATGCT-1_6_C5	25.12483166	-29.53453618	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3624	10493	0.001238921	0.002191937	0	3	EN-L5-6	NA	NA	NA
CGAACATAGGGCTTGA-1_6_C5	-19.23862589	-28.39883352	6A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3004	7405	0.008102633	0.00243079	0	6A	IN-PV	NA	NA	NA
CGAACATCAAGCCTAT-1_6_C5	5.962916309	28.71077874	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	705	1102	0.003629764	0.002722323	0	oligos	OL-Cntl	NA	NA	NA
CGAACATGTGGCTCCA-1_6_C5	26.78053763	-2.311411646	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3680	9652	0.006527145	0.001968504	0	2	EN-L4	NA	NA	NA
CGAACATTCAGCACAT-1_6_C5	12.63428216	31.34070887	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	730	1024	0	0.001953125	0	oligos	OL-Cntl	NA	NA	NA
CGAACATTCTCCAACC-1_6_C5	-14.91703148	-19.03087124	6B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1451	2491	0.001605781	0.003613007	0	6B	IN-SST	NA	NA	NA
CGAATGTAGCCTTGAT-1_6_C5	2.449422415	-19.65681376	4	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3479	8142	0.012281995	0.006140997	0	L2-3	EN-L2-3-MS	NA	NA	NA
CGAATGTAGCTAAGAT-1_6_C5	17.69608913	23.79813683	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	876	1326	0	0.003770739	0	oligos	OL-Cntl	NA	NA	NA
CGAATGTAGTATCTCG-1_6_C5	-34.9405186	-11.3336815	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	823	1195	0.00251046	0.00251046	0	9	OPC	NA	NA	NA
CGAATGTCACACAGAG-1_6_C5	-30.477679	20.54362656	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	890	1358	0.002945508	0.004418262	0	8	Astrocytes	NA	NA	NA
CGAATGTGTAGGCTGA-1_6_C5	-25.31588211	17.80418993	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1152	1793	0.002230898	0.006692694	0	8	Astrocytes	NA	NA	NA
CGAATGTGTATAATGG-1_6_C5	9.57342721	25.60757525	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	926	1447	0.00138217	0.006219765	0	oligos	OL-Cntl	NA	NA	NA
CGAATGTGTCGGGTCT-1_6_C5	1.308403626	-19.78735492	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3215	6987	0.00729927	0.004723057	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGAATGTTCAAGGCTT-1_6_C5	-26.87390935	9.966310154	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	768	1072	0.000932836	0.008395522	0	8	Astrocytes	NA	NA	NA
CGACCTTAGAGGTACC-1_6_C5	-15.03666132	-11.01012806	13B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2431	5310	0.001129944	0.002259887	0	13B	IN-SV2C	NA	NA	NA
CGACCTTAGCAGCGTA-1_6_C5	23.73292591	18.21464228	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1246	1992	0.001506024	0.00251004	0	oligos	OL-Cntl	NA	NA	NA
CGACCTTAGCGTGAAC-1_6_C5	25.42108145	-1.812372099	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2649	5548	0.004686373	0.003965393	0	2	EN-L4	NA	NA	NA
CGACCTTAGTAGGTGC-1_6_C5	-26.09494388	26.62994222	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1508	2747	0.001456134	0.002912268	0	8	Astrocytes	NA	NA	NA
CGACCTTCATATGCTG-1_6_C5	12.99299739	29.94318386	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	693	1019	0.002944063	0.000981354	0	oligos	OL-Cntl	NA	NA	NA
CGACCTTGTACCGCTG-1_6_C5	-35.80106967	4.904872098	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2220	4412	0.002039891	0.003399819	0	9	OPC	NA	NA	NA
CGACCTTGTATATGGA-1_6_C5	8.774720813	28.31478257	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	877	1334	0.005247376	0.004497751	0	oligos	OL-Cntl	NA	NA	NA
CGACCTTGTATCAGTC-1_6_C5	-1.320702556	-1.133976421	11	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2041	3879	0.01778809	0.002062387	0	11	Glia-MIX	NA	NA	NA
CGACCTTGTGTTGAGG-1_6_C5	-1.447806524	4.320069881	11	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1133	1644	0.006690998	0.00486618	0	11	Glia-MIX	NA	NA	NA
CGACCTTTCGGCGCAT-1_6_C5	4.600199913	25.86637208	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	797	1185	0.004219409	0.003375527	0	oligos	OL-Cntl	NA	NA	NA
CGACTTCCACAGACAG-1_6_C5	17.02869569	24.57780818	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	823	1252	0.000798722	0.00399361	0	oligos	OL-Cntl	NA	NA	NA
CGACTTCCATACGCCG-1_6_C5	12.47620723	27.35189028	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	841	1316	0.000759878	0.002279635	0	oligos	OL-Cntl	NA	NA	NA
CGACTTCCATTAGGCT-1_6_C5	3.626021739	-15.71527808	4	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2712	5338	0.012176845	0.00861746	0	L2-3	EN-L2-3-MS	NA	NA	NA
CGACTTCGTCTGATTG-1_6_C5	0.228422524	-16.54871359	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2451	4592	0.006968641	0.003484321	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGACTTCGTGACTACT-1_6_C5	0.29756009	-20.58183475	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3018	6488	0.003853268	0.005240444	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGACTTCTCAAACCAC-1_6_C5	27.13739827	-0.007421145	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	4214	13367	0.003590933	0.002543577	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGACTTCTCCTCAATT-1_6_C5	-7.169938592	0.567213312	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1991	4170	0.010791367	0.001918465	0	13A	IN-VIP	NA	NA	NA
CGACTTCTCCTCGCAT-1_6_C5	30.37267863	9.52525914	14	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1153	1565	0.002555911	0.028753994	0	14	Microglia	NA	NA	NA
CGACTTCTCGCGGATC-1_6_C5	-25.41910485	27.34019072	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1444	2414	0.009113505	0.002899751	0	8	Astrocytes	NA	NA	NA
CGACTTCTCTTGCATT-1_6_C5	-7.84679686	0.881388002	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2122	4496	0.004670819	0.002001779	0	13A	IN-VIP	NA	NA	NA
CGACTTCTCTTGCCGT-1_6_C5	13.9456461	29.4814945	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	764	1130	0	0.007964602	0	oligos	OL-Cntl	NA	NA	NA
CGAGAAGAGAGAACAG-1_6_C5	31.7669017	-3.173987616	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3363	7229	0.009406557	0.003319961	0	2	EN-L4	NA	NA	NA
CGAGAAGAGAGCTGCA-1_6_C5	20.7309973	20.56315984	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1017	1538	0.001950585	0.005851756	0	oligos	OL-Cntl	NA	NA	NA
CGAGAAGAGTAGATGT-1_6_C5	-20.6488017	8.767782365	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	887	1261	0	0.007137193	0	8	Astrocytes	NA	NA	NA
CGAGAAGAGTGTTAGA-1_6_C5	3.11549791	-24.23384344	4	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2780	5438	0.011769033	0.006252299	0	L2-3	EN-L2-3-MS	NA	NA	NA
CGAGAAGCATAGGATA-1_6_C5	0.167771259	36.15259272	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	798	1157	0.026793431	0.006914434	0	oligos	OL-Cntl	NA	NA	NA
CGAGAAGGTGCAACGA-1_6_C5	-30.46416646	20.2652383	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	892	1303	0.001534919	0.003837299	0	8	Astrocytes	NA	NA	NA
CGAGCACAGCTTCGCG-1_6_C5	-36.96880915	-10.44896294	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	962	1528	0.001963351	0.005235602	0	9	OPC	NA	NA	NA
CGAGCACCACGCATCG-1_6_C5	8.528728301	-8.455791414	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2148	4555	0.008342481	0.001756312	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGAGCACCAGGTGGAT-1_6_C5	7.778929829	-29.90411795	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	5221	16740	0.005316607	0.003524492	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGAGCACGTACCGCTG-1_6_C5	21.23824309	-7.985274738	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1340	2364	0.011844332	0.000423012	0	12	EN-MIX	NA	NA	NA
CGAGCACGTGACGCCT-1_6_C5	10.57981797	-7.58706139	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2823	7404	0.005672609	0.001350621	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGAGCACGTGTCAATC-1_6_C5	12.95756622	25.17978162	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	784	1174	0.000851789	0.005110733	0	oligos	OL-Cntl	NA	NA	NA
CGAGCACTCAATCACG-1_6_C5	17.86699107	-5.343368671	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1287	2191	0.001369238	0.002282063	0	3	EN-L5-6	NA	NA	NA
CGAGCACTCCCTAACC-1_6_C5	-25.22077254	20.35813023	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1560	2708	0.002215657	0.00295421	0	8	Astrocytes	NA	NA	NA
CGAGCCAAGACCGGAT-1_6_C5	-38.08443303	-4.39799822	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1275	2200	0.001363636	0.002727273	0	9	OPC	NA	NA	NA
CGAGCCAAGGACTGGT-1_6_C5	-36.99273986	3.85484488	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1954	3981	0.011303693	0.003516704	0	9	OPC	NA	NA	NA
CGAGCCACAAGAGTCG-1_6_C5	24.48830863	-28.62285118	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3218	7917	0.00265252	0.004420866	0	3	EN-L5-6	NA	NA	NA
CGAGCCACAGACGCAA-1_6_C5	-14.38192507	-25.04729777	6A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1443	2631	0.015203345	0.00418092	0	6A	IN-PV	NA	NA	NA
CGAGCCAGTTCCCTTG-1_6_C5	20.81773869	22.87554017	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1091	1707	0.002929115	0.005858231	0	oligos	OL-Cntl	NA	NA	NA
CGAGCCAGTTTAGCTG-1_6_C5	-1.128118679	-21.54087552	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3324	8190	0.006715507	0.001831502	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGATCGGGTCTCATCC-1_6_C5	15.82152808	29.06428598	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	817	1232	0.001623377	0.00487013	0	oligos	OL-Cntl	NA	NA	NA
CGATCGGGTGGTGTAG-1_6_C5	-6.751997805	-2.623517778	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1716	3103	0.016435707	0.001933613	0	13A	IN-VIP	NA	NA	NA
CGATCGGTCGAGAACG-1_6_C5	-25.41065956	-6.453962186	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1237	1880	0.021276596	0.00106383	0	9	OPC	NA	NA	NA
CGATGGCAGAATGTTG-1_6_C5	18.4246182	-7.017275955	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1795	3179	0.007549544	0.007549544	0	3	EN-L5-6	NA	NA	NA
CGATGGCAGCGTCTAT-1_6_C5	-36.26320022	-9.1528412	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	950	1461	0.002737851	0.001368925	0	9	OPC	NA	NA	NA
CGATGGCAGTACGATA-1_6_C5	30.68519308	-4.302115823	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3599	7894	0.001900177	0.004307069	0	2	EN-L4	NA	NA	NA
CGATGGCCATCTATGG-1_6_C5	17.92060833	22.29462742	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	919	1411	0.002834869	0.003543586	0	oligos	OL-Cntl	NA	NA	NA
CGATGGCGTCAAAGCG-1_6_C5	1.628555907	-19.39323184	4	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3066	6700	0.008955224	0.003880597	0	L2-3	EN-L2-3-MS	NA	NA	NA
CGATGGCGTCAGCTAT-1_6_C5	23.77359368	0.090008253	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2052	3938	0.000253936	0.003047232	0	2	EN-L4	NA	NA	NA
CGATGGCGTTATCCGA-1_6_C5	5.583821676	27.46595496	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	733	1084	0.003690037	0.007380074	0	oligos	OL-Cntl	NA	NA	NA
CGATGGCGTTCAGACT-1_6_C5	-34.01292679	-12.69251955	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	695	1049	0.000953289	0.001906578	0	9	OPC	NA	NA	NA
CGATGGCTCACTCTTA-1_6_C5	-0.670930811	0.838419506	11	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1567	2614	0.007268554	0.004973221	0	11	Glia-MIX	NA	NA	NA
CGATGGCTCCCGACTT-1_6_C5	1.772239504	-8.002796144	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1316	2119	0.004247286	0.006134969	0	12	EN-MIX	NA	NA	NA
CGATGGCTCCCTCAGT-1_6_C5	21.50299021	11.85436503	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1398	2277	0.00307422	0.004830918	0	oligos	OL-Cntl	NA	NA	NA
CGATGTAAGGCAATTA-1_6_C5	26.01281506	-5.316004333	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	4702	14293	0.002658644	0.002728608	0	2	EN-L4	NA	NA	NA
CGATGTAGTAAGAGAG-1_6_C5	6.275704594	-29.55725597	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3750	9903	0.001110775	0.002221549	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGATGTAGTGTAACGG-1_6_C5	4.571274554	33.44511429	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	736	1062	0.001883239	0.003766478	0	oligos	OL-Cntl	NA	NA	NA
CGATGTATCGTACCGG-1_6_C5	19.71360806	8.541928909	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1656	2925	0.001025641	0.005470085	0	oligos	OL-Cntl	NA	NA	NA
CGATTGACACAAGACG-1_6_C5	-24.81145139	28.7828216	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1683	3036	0.005270092	0.000988142	0	8	Astrocytes	NA	NA	NA
CGATTGACACCTCGGA-1_6_C5	1.181616343	-28.4093334	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3972	11431	0.001399703	0.001662147	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGATTGACAGACGCAA-1_6_C5	-11.78972084	-9.280702517	13B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1683	2547	0.020808795	0.005496663	0	13B	IN-SV2C	NA	NA	NA
CGATTGACAGTCGTGC-1_6_C5	-1.782781624	2.823160465	11	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1481	2167	0.007844947	0.006922012	0	11	Glia-MIX	NA	NA	NA
CGATTGAGTCGAGTTT-1_6_C5	29.7216158	-11.0238234	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3939	8866	0.035303406	0.006316264	0	2	EN-L4	NA	NA	NA
CGATTGAGTGGGTATG-1_6_C5	19.29275814	-6.960392091	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1924	3713	0.001885268	0.00269324	0	3	EN-L5-6	NA	NA	NA
CGATTGATCGGTCCGA-1_6_C5	15.389932	-8.009461976	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2284	4523	0.006853858	0.00508512	0	3	EN-L5-6	NA	NA	NA
CGATTGATCTAACCGA-1_6_C5	16.4509109	24.51826609	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	915	1437	0.003479471	0.005567154	0	oligos	OL-Cntl	NA	NA	NA
CGCCAAGAGCTCAACT-1_6_C5	5.832962807	27.27206019	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	869	1256	0.002388535	0.005573248	0	oligos	OL-Cntl	NA	NA	NA
CGCCAAGCATCTATGG-1_6_C5	17.02044946	29.05248142	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	844	1227	0.002444988	0.008149959	0	oligos	OL-Cntl	NA	NA	NA
CGCCAAGGTAAACACA-1_6_C5	-10.99549338	31.9907523	17	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	898	1228	0.026872964	0.009771987	0	oligos	OL-MS-2	NA	NA	NA
CGCCAAGGTGCCTTGG-1_6_C5	16.33303822	18.00937883	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	999	1723	0.008705746	0.003482298	0	oligos	OL-Cntl	NA	NA	NA
CGCCAAGTCGAGAGCA-1_6_C5	-37.76312329	-5.561951611	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1257	2098	0.003813155	0.005243089	0	9	OPC	NA	NA	NA
CGCGGTACATGCCTTC-1_6_C5	1.818812001	-16.72184618	4	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2563	5220	0.007854406	0.005938697	0	L2-3	EN-L2-3-MS	NA	NA	NA
CGCGGTAGTCATATCG-1_6_C5	22.22806446	11.6890188	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1635	2996	0.002670227	0.005006676	0	oligos	OL-Cntl	NA	NA	NA
CGCGGTAGTGACTCAT-1_6_C5	11.02657612	33.02624834	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	861	1328	0.001506024	0.003012048	0	oligos	OL-Cntl	NA	NA	NA
CGCGGTAGTTGGTTTG-1_6_C5	-28.13440576	17.36570367	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1064	1685	0.000593472	0.001780415	0	8	Astrocytes	NA	NA	NA
CGCGGTATCCAGAAGG-1_6_C5	4.644231821	30.52630068	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	680	1015	0.000985222	0.004926108	0	oligos	OL-Cntl	NA	NA	NA
CGCGTTTAGTCGAGTG-1_6_C5	1.166545826	-7.683920488	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1320	2207	0.002718623	0.002265519	0	12	EN-MIX	NA	NA	NA
CGCGTTTCAATGGAGC-1_6_C5	16.2136874	-29.41564875	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	4679	13568	0.012824292	0.004643278	0	3	EN-L5-6	NA	NA	NA
CGCGTTTCACATGGGA-1_6_C5	-12.68330726	-18.55526134	6B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1204	2020	0.021287129	0.002970297	0	6B	IN-SST	NA	NA	NA
CGCGTTTCACCTTGTC-1_6_C5	1.843115793	-16.71858868	4	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2549	5175	0.015652174	0.006570048	0	L2-3	EN-L2-3-MS	NA	NA	NA
CGCGTTTGTCTGATCA-1_6_C5	-15.74298602	-11.62519312	13B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2747	5796	0.007936508	0.004485852	0	13B	IN-SV2C	NA	NA	NA
CGCGTTTTCAAAGTAG-1_6_C5	4.5794331	-31.25830366	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	4157	11208	0.002052106	0.00178444	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGCGTTTTCAACGGCC-1_6_C5	11.11899351	-20.88563359	4	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3517	8439	0.015760161	0.005687878	0	L2-3	EN-L2-3-MS	NA	NA	NA
CGCGTTTTCCTGTACC-1_6_C5	-1.733419891	-12.7029535	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2075	4022	0.010193933	0.005718548	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGCTATCAGCTAACAA-1_6_C5	0.725795161	-29.43266084	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	4610	14065	0.003412727	0.002132954	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGCTATCAGTGCGATG-1_6_C5	5.358806923	26.93375425	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	787	1148	0.00174216	0.006968641	0	oligos	OL-Cntl	NA	NA	NA
CGCTATCAGTGTCTCA-1_6_C5	4.271783479	-32.93013946	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	5215	17613	0.003236246	0.001589735	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGCTATCAGTTACCCA-1_6_C5	-23.80047773	30.25577247	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1865	3603	0.000555093	0.001942825	0	8	Astrocytes	NA	NA	NA
CGCTATCCACCCATTC-1_6_C5	22.8474414	19.03204486	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1038	1632	0.000612745	0.003676471	0	oligos	OL-Cntl	NA	NA	NA
CGCTATCCAGACACTT-1_6_C5	-8.430135256	0.805746268	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2469	5094	0.010600707	0.00333726	0	13A	IN-VIP	NA	NA	NA
CGCTATCCATTCTCAT-1_6_C5	-24.35837756	27.76892784	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1624	2859	0.001748863	0.002098636	0	8	Astrocytes	NA	NA	NA
CGCTATCTCGAGCCCA-1_6_C5	-4.522232533	-3.516272969	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1281	2159	0.000463177	0.000926355	0	13A	IN-VIP	NA	NA	NA
CGCTGGAAGACGACGT-1_6_C5	1.790787366	-29.75556436	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	4785	13378	0.00179399	0.002616236	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGCTGGAAGATCCTGT-1_6_C5	20.32954002	15.15760037	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1183	1869	0.002675227	0.002675227	0	oligos	OL-Cntl	NA	NA	NA
CGCTGGAAGCAGACTG-1_6_C5	22.5131639	20.73759998	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1067	1609	0.002486016	0.004350528	0	oligos	OL-Cntl	NA	NA	NA
CGCTGGAGTAGCGATG-1_6_C5	-0.534506571	4.754487667	11	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	780	1063	0.006585136	0.010348071	0	11	Glia-MIX	NA	NA	NA
CGCTGGAGTAGCGTAG-1_6_C5	17.98787806	25.02341949	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	856	1276	0.002351097	0.003134796	0	oligos	OL-Cntl	NA	NA	NA
CGCTGGAGTAGGAGTC-1_6_C5	0.683962038	-11.75202272	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1781	3218	0.013051585	0.003418272	0	12	EN-MIX	NA	NA	NA
CGCTGGAGTGCACTTA-1_6_C5	21.4276712	15.05075353	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1298	2093	0.000955566	0.002388915	0	oligos	OL-Cntl	NA	NA	NA
CGCTGGAGTTTAAGCC-1_6_C5	15.8680049	24.5624345	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	821	1257	0.002386635	0.002386635	0	oligos	OL-Cntl	NA	NA	NA
CGCTGGATCATAAAGG-1_6_C5	27.90056731	-4.619711159	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3572	8485	0.003299941	0.002592811	0	2	EN-L4	NA	NA	NA
CGCTTCAAGACCCACC-1_6_C5	-24.06647715	28.55848067	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1742	3100	0.001935484	0.002580645	0	8	Astrocytes	NA	NA	NA
CGCTTCAAGAGTAAGG-1_6_C5	-37.4639819	-5.911669671	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1204	2049	0.003416301	0.003904344	0	9	OPC	NA	NA	NA
CGCTTCAAGATGGGTC-1_6_C5	0.70516687	32.74125232	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	831	1144	0.001748252	0.002622378	0	oligos	OL-Cntl	NA	NA	NA
CGCTTCAAGGGATCTG-1_6_C5	16.0662948	-32.72056912	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	5004	15705	0.005539637	0.002419612	0	3	EN-L5-6	NA	NA	NA
CGCTTCAAGTGCCATT-1_6_C5	-38.18041544	-4.764886882	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1259	2180	0.000917431	0.000917431	0	9	OPC	NA	NA	NA
CGCTTCAAGTTCGATC-1_6_C5	-9.277249898	-17.66796936	6B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	831	1340	0.010447761	0.003731343	0	6B	IN-SST	NA	NA	NA
CGCTTCACAATGACCT-1_6_C5	-9.803015711	0.438279147	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2558	5159	0.006978097	0.004652064	0	13A	IN-VIP	NA	NA	NA
CGCTTCACACCAACCG-1_6_C5	25.16729225	-29.59922242	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3905	12015	0.002913025	0.002663337	0	3	EN-L5-6	NA	NA	NA
CGCTTCACACCTTGTC-1_6_C5	-4.877167898	-10.42181868	13B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	706	1056	0	0.001893939	0	13B	IN-SV2C	NA	NA	NA
CGCTTCACATACAGCT-1_6_C5	-27.68554143	25.03191156	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1281	2282	0.001314636	0.000876424	0	8	Astrocytes	NA	NA	NA
CGCTTCACATGCCTTC-1_6_C5	19.59969237	21.75685809	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1018	1761	0	0.003407155	0	oligos	OL-Cntl	NA	NA	NA
CGCTTCAGTGATAAGT-1_6_C5	-8.968572559	16.6686528	11	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2699	5296	0.003398792	0.00320997	0	11	Glia-MIX	NA	NA	NA
CGCTTCAGTTACTGAC-1_6_C5	-14.58341911	-19.132629	6B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1331	2248	0.00044484	0.008451957	0	6B	IN-SST	NA	NA	NA
CGGACACAGAAGGCCT-1_6_C5	-26.26192902	18.65238501	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1172	1917	0	0.00312989	0	8	Astrocytes	NA	NA	NA
CGGACACAGTGAACGC-1_6_C5	17.78894613	22.50855885	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	991	1530	0.003921569	0.005228758	0	oligos	OL-Cntl	NA	NA	NA
CGGACACCATAAGACA-1_6_C5	23.30558985	12.57430541	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1278	2125	0.001411765	0.001411765	0	oligos	OL-Cntl	NA	NA	NA
CGGACACGTAAACCTC-1_6_C5	16.60059156	24.33782648	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	818	1209	0.00082713	0.00165426	0	oligos	OL-Cntl	NA	NA	NA
CGGACACGTCGTGGCT-1_6_C5	31.29522276	-7.557157349	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3989	9045	0.023438364	0.006412383	0	2	EN-L4	NA	NA	NA
CGGACACTCACTCCTG-1_6_C5	-0.954485728	3.482725672	11	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1173	1784	0.002242152	0.001681614	0	11	Glia-MIX	NA	NA	NA
CGGACACTCAGAAATG-1_6_C5	-14.1647539	-6.66144701	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2628	5305	0.008482564	0.005089538	0	13A	IN-VIP	NA	NA	NA
CGGACACTCGGTCCGA-1_6_C5	11.46582408	31.14099245	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	687	1008	0.005952381	0.00297619	0	oligos	OL-Cntl	NA	NA	NA
CGGACGTAGTATCGAA-1_6_C5	-0.55728381	-16.07185206	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2346	4894	0.004086637	0.0044953	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGGACGTCAACACCCG-1_6_C5	-11.04017642	1.200276719	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2747	5987	0.009520628	0.003674628	0	13A	IN-VIP	NA	NA	NA
CGGACGTCAACTGCGC-1_6_C5	-21.15480943	-28.16070688	6A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3724	9396	0.007875692	0.003192848	0	6A	IN-PV	NA	NA	NA
CGGACGTCACATAACC-1_6_C5	-22.64322675	31.34642103	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2288	4695	0.004685836	0.004472843	0	8	Astrocytes	NA	NA	NA
CGGACGTCACATGACT-1_6_C5	-28.04636614	13.16151925	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	845	1259	0.004765687	0.003177125	0	8	Astrocytes	NA	NA	NA
CGGACGTCAGATGGGT-1_6_C5	20.68869089	-28.39167434	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3076	7580	0.001451187	0.004353562	0	3	EN-L5-6	NA	NA	NA
CGGACGTGTACCGTTA-1_6_C5	-13.67111381	-19.05924196	6B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1269	2074	0.013982642	0.008678881	0	6B	IN-SST	NA	NA	NA
CGGACGTGTCCAACTA-1_6_C5	14.73617372	-30.59955072	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2923	6188	0.005656109	0.003070459	0	3	EN-L5-6	NA	NA	NA
CGGACGTGTTTCGCTC-1_6_C5	3.586337946	-32.6972435	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	6240	23857	0.006119797	0.001970072	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGGACGTTCGGGAGTA-1_6_C5	4.486643926	33.35054362	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	778	1080	0.00462963	0.009259259	0	oligos	OL-Cntl	NA	NA	NA
CGGACGTTCTCCAACC-1_6_C5	10.92063938	25.17700485	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	859	1258	0.001589825	0.003974563	0	oligos	OL-Cntl	NA	NA	NA
CGGACTGAGACAGGCT-1_6_C5	-17.64494199	-26.74318223	6A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2405	5193	0.006547275	0.003081071	0	6A	IN-PV	NA	NA	NA
CGGACTGAGTATCGAA-1_6_C5	-1.382330111	-12.88753672	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2014	3844	0.009105099	0.004162331	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGGACTGCAATCGGTT-1_6_C5	12.33525577	26.35943772	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	790	1212	0.004950495	0.004950495	0	oligos	OL-Cntl	NA	NA	NA
CGGACTGCACGAAAGC-1_6_C5	27.75763118	0.760851559	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3307	8379	0.005609261	0.00238692	0	2	EN-L4	NA	NA	NA
CGGACTGCAGCTCCGA-1_6_C5	0.532092802	-18.22389225	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2685	6024	0.003984064	0.00315405	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGGACTGGTCTGCGGT-1_6_C5	14.57768446	30.68883233	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	821	1222	0.000818331	0.004091653	0	oligos	OL-Cntl	NA	NA	NA
CGGACTGGTGTTAAGA-1_6_C5	-36.75525563	-6.792656338	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1161	1857	0.001077006	0.007539041	0	9	OPC	NA	NA	NA
CGGACTGTCCGCGCAA-1_6_C5	-15.55321472	-22.62884054	6A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1551	2681	0.004848937	0.00074599	0	6A	IN-PV	NA	NA	NA
CGGAGCTAGCTGATAA-1_6_C5	16.9811442	21.38677859	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1010	1540	0.003896104	0.005194805	0	oligos	OL-Cntl	NA	NA	NA
CGGAGCTCACCAGATT-1_6_C5	0.903404251	-10.7313518	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1780	3184	0.00879397	0.002826633	0	12	EN-MIX	NA	NA	NA
CGGAGCTCACTTGGAT-1_6_C5	25.3357174	-1.009692748	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2607	5725	0.008384279	0.003144105	0	2	EN-L4	NA	NA	NA
CGGAGCTCAGTCGTGC-1_6_C5	2.896123344	27.52493953	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	813	1196	0.005016722	0.005852843	0	oligos	OL-Cntl	NA	NA	NA
CGGAGCTGTCTGGTCG-1_6_C5	15.04750501	26.55646513	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	759	1103	0.000906618	0.004533092	0	oligos	OL-Cntl	NA	NA	NA
CGGAGCTTCCCTCAGT-1_6_C5	17.10512372	24.11299886	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	850	1369	0	0.00146092	0	oligos	OL-Cntl	NA	NA	NA
CGGAGTCAGAGAACAG-1_6_C5	-11.15268562	-0.42890696	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2401	4455	0.009876543	0.007407407	0	13A	IN-VIP	NA	NA	NA
CGGAGTCAGCCACGCT-1_6_C5	-20.02376739	-26.8264717	6A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2689	5997	0.006003002	0.005169251	0	6A	IN-PV	NA	NA	NA
CGGAGTCAGGCCATAG-1_6_C5	14.24088431	29.03141245	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	786	1173	0.000852515	0.00511509	0	oligos	OL-Cntl	NA	NA	NA
CGGAGTCAGTCCTCCT-1_6_C5	-9.582590237	-13.27955248	6B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1179	2121	0.035832155	0.007543612	0	6B	IN-SST	NA	NA	NA
CGGAGTCCACATGTGT-1_6_C5	13.24796836	24.50424332	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	969	1598	0.003128911	0.000625782	0	oligos	OL-Cntl	NA	NA	NA
CGGAGTCCAGCTGCAC-1_6_C5	0.425833699	-20.55587955	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3105	7088	0.005361174	0.004373589	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGGAGTCGTAAACGCG-1_6_C5	-9.365997514	-5.492682427	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1786	2862	0.021313767	0.008036338	0	13A	IN-VIP	NA	NA	NA
CGGAGTCGTCTTGTCC-1_6_C5	-28.67850936	13.56119668	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	861	1278	0.006259781	0.00312989	0	8	Astrocytes	NA	NA	NA
CGGCTAGAGACGCAAC-1_6_C5	3.656370355	-28.44813841	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2760	6343	0.002207157	0.000945925	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGGCTAGAGTGTGAAT-1_6_C5	-26.95972967	8.677076607	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	797	1130	0.000884956	0.007079646	0	8	Astrocytes	NA	NA	NA
CGGCTAGCAATGAATG-1_6_C5	24.9154624	-4.603973237	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	4445	14008	0.003997716	0.00256996	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGGCTAGCAGTGGGAT-1_6_C5	2.763719511	-24.97727344	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	4637	12632	0.004195693	0.003008233	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGGCTAGGTAAACGCG-1_6_C5	1.378915457	-19.71592188	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3112	7098	0.006058045	0.004649197	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGGCTAGGTATAATGG-1_6_C5	-0.914652875	3.847623002	11	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1010	1477	0.005416385	0.006770481	0	11	Glia-MIX	NA	NA	NA
CGGCTAGTCACGCGGT-1_6_C5	-25.09436988	28.05416056	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1524	2636	0.000758725	0.003414264	0	8	Astrocytes	NA	NA	NA
CGGGTCAAGATCTGCT-1_6_C5	31.76933829	-2.306374411	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3056	6413	0.009823795	0.004833931	0	2	EN-L4	NA	NA	NA
CGGGTCACAACGATGG-1_6_C5	3.646794345	-28.93325409	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3398	8213	0.003774504	0.00267868	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGGGTCACAGGGTACA-1_6_C5	1.55242285	24.04386956	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	750	1079	0.007414272	0.006487488	0	oligos	OL-Cntl	NA	NA	NA
CGGGTCACAGTAAGAT-1_6_C5	6.964728825	29.21796318	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	692	1033	0.005808325	0.006776379	0	oligos	OL-Cntl	NA	NA	NA
CGGGTCAGTCTAGGTT-1_6_C5	23.16859027	19.36123685	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1043	1556	0.000642674	0.001928021	0	oligos	OL-Cntl	NA	NA	NA
CGGGTCAGTGAACCTT-1_6_C5	-4.250323678	-4.752085516	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1182	1896	0.022679325	0.001582278	0	13A	IN-VIP	NA	NA	NA
CGGGTCATCCAAGCCG-1_6_C5	5.14359828	31.25502192	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	710	1000	0.004	0.005	0	oligos	OL-Cntl	NA	NA	NA
CGGGTCATCTGACCTC-1_6_C5	-15.68217269	-6.798516494	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	4597	13019	0.017282433	0.001613027	0	13A	IN-VIP	NA	NA	NA
CGGTTAAAGCAGATCG-1_6_C5	-8.143604311	-1.017433049	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2056	3760	0.003723404	0.006382979	0	13A	IN-VIP	NA	NA	NA
CGGTTAAAGCGTGTCC-1_6_C5	-0.577429212	29.28549833	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	852	1166	0.001715266	0.005145798	0	oligos	OL-Cntl	NA	NA	NA
CGGTTAAAGCTCCCAG-1_6_C5	13.84062291	26.53504835	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	755	1056	0.005681818	0.002840909	0	oligos	OL-Cntl	NA	NA	NA
CGGTTAAAGCTTTGGT-1_6_C5	1.390528742	-7.821983184	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1379	2299	0.013919095	0.004349717	0	12	EN-MIX	NA	NA	NA
CGGTTAATCTGGTTCC-1_6_C5	2.128828033	-30.34299895	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	4264	12560	0.001273885	0.00294586	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGTAGCGAGCGATGAC-1_6_C5	14.25994796	28.63093655	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	801	1206	0.002487562	0.002487562	0	oligos	OL-Cntl	NA	NA	NA
CGTAGCGAGTTTCCTT-1_6_C5	0.402355696	-15.97644158	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2392	4808	0.001039933	0.002703827	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGTAGCGCACATAACC-1_6_C5	-38.05171702	-0.318692847	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1515	2865	0.005235602	0.002792321	0	9	OPC	NA	NA	NA
CGTAGCGCATGTCTCC-1_6_C5	16.82915058	16.62714073	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1173	1825	0.006575342	0.003287671	0	oligos	OL-Cntl	NA	NA	NA
CGTAGCGGTACAGTTC-1_6_C5	1.76447237	31.15691812	17	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	702	1019	0.011776251	0.004906771	0	oligos	OL-MS-2	NA	NA	NA
CGTAGCGGTTCGGGCT-1_6_C5	25.03345809	-28.42383246	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3261	8000	0.004625	0.002625	0	3	EN-L5-6	NA	NA	NA
CGTAGGCAGATCACGG-1_6_C5	5.77663755	26.49638972	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	851	1248	0.003205128	0.008814103	0	oligos	OL-Cntl	NA	NA	NA
CGTAGGCGTAAACCTC-1_6_C5	-3.774814947	-4.755371674	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1182	2042	0.000489716	0.001958864	0	13A	IN-VIP	NA	NA	NA
CGTAGGCGTAGCTGCC-1_6_C5	22.94238781	-0.096699358	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1942	3620	0.005801105	0.003314917	0	2	EN-L4	NA	NA	NA
CGTAGGCTCGCATGAT-1_6_C5	1.180614465	-8.068883819	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1351	2096	0.005248092	0.001908397	0	12	EN-MIX	NA	NA	NA
CGTAGGCTCGTATCAG-1_6_C5	2.318606374	-19.48610952	4	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3263	7162	0.008377548	0.0086568	0	L2-3	EN-L2-3-MS	NA	NA	NA
CGTAGGCTCTGTACGA-1_6_C5	18.33414621	12.45343182	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1316	2168	0.002767528	0.005535055	0	oligos	OL-Cntl	NA	NA	NA
CGTAGGCTCTTGCAAG-1_6_C5	28.54025696	-1.670783861	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3515	8375	0.000835821	0.002626866	0	2	EN-L4	NA	NA	NA
CGTCACTCAATCCAAC-1_6_C5	37.99561131	10.65462319	14	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	947	1293	0.008507347	0.012374323	0	14	Microglia	NA	NA	NA
CGTCACTCATGCAATC-1_6_C5	12.51906535	28.64898746	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	716	1088	0.009191176	0.002757353	0	oligos	OL-Cntl	NA	NA	NA
CGTCACTCATTATCTC-1_6_C5	-9.230541493	1.061659558	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2625	5460	0.001648352	0.006593407	0	13A	IN-VIP	NA	NA	NA
CGTCACTCATTGGCGC-1_6_C5	-13.55213739	-19.28110473	6B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1223	2245	0.003563474	0.002227171	0	6B	IN-SST	NA	NA	NA
CGTCACTGTCTAGTCA-1_6_C5	4.489955597	-1.873478041	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	883	1326	0.00678733	0.003016591	0	12	EN-MIX	NA	NA	NA
CGTCACTGTTATGCGT-1_6_C5	2.323674136	-27.96979618	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3582	8867	0.003044998	0.002706665	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGTCACTGTTCCTCCA-1_6_C5	11.55196163	29.35340274	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	780	1201	0.003330558	0.000832639	0	oligos	OL-Cntl	NA	NA	NA
CGTCACTTCCATGCTC-1_6_C5	-8.028365498	0.670482706	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2123	4107	0.015826637	0.002678354	0	13A	IN-VIP	NA	NA	NA
CGTCACTTCGCTTAGA-1_6_C5	-22.8995517	-1.020542878	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1252	1860	0.003763441	0.008064516	0	9	OPC	NA	NA	NA
CGTCAGGCAAGCCGCT-1_6_C5	25.44763354	-29.13213061	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	4635	14247	0.001895136	0.007369973	0	3	EN-L5-6	NA	NA	NA
CGTCAGGCACGTTGGC-1_6_C5	-11.22853214	29.70112547	17	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1247	1849	0.072471606	0.002163332	0	oligos	OL-MS-2	NA	NA	NA
CGTCAGGCAGTATAAG-1_6_C5	-3.237296414	-5.918171618	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	897	1357	0.018422992	0.001473839	0	13A	IN-VIP	NA	NA	NA
CGTCAGGCATAGAAAC-1_6_C5	-15.06354965	-21.5775154	6A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1584	2673	0.023943135	0.004115226	0	6A	IN-PV	NA	NA	NA
CGTCAGGCATGGAATA-1_6_C5	-8.107185526	-1.085662722	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2241	4089	0.006603081	0.006603081	0	13A	IN-VIP	NA	NA	NA
CGTCAGGGTACGACCC-1_6_C5	1.683247233	-16.8863173	4	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2573	5122	0.00468567	0.002538071	0	L2-3	EN-L2-3-MS	NA	NA	NA
CGTCAGGGTGAGTGAC-1_6_C5	5.080144093	-16.06988177	4	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3022	6234	0.016843118	0.004170677	0	L2-3	EN-L2-3-MS	NA	NA	NA
CGTCAGGTCCTGTACC-1_6_C5	25.79783092	-5.022183078	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	4542	13155	0.001520334	0.003040669	0	2	EN-L4	NA	NA	NA
CGTCAGGTCTGCCAGG-1_6_C5	-38.31569321	-2.425904281	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1278	2253	0.000443853	0.001331558	0	9	OPC	NA	NA	NA
CGTCCATCAAGTCTGT-1_6_C5	-13.38089983	14.39107065	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	762	1034	0.005802708	0.00483559	0	8	Astrocytes	NA	NA	NA
CGTCCATCAGTGGGAT-1_6_C5	-37.18330578	-8.773378404	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	971	1599	0.002501563	0.001876173	0	9	OPC	NA	NA	NA
CGTCCATGTACTCGCG-1_6_C5	1.333718223	-22.15491571	4	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	4119	10105	0.003364671	0.009005443	0	L2-3	EN-L2-3-MS	NA	NA	NA
CGTCCATGTCCGCTGA-1_6_C5	3.646098125	-16.40447556	4	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2778	5448	0.01376652	0.009911894	0	L2-3	EN-L2-3-MS	NA	NA	NA
CGTCCATGTCTGCGGT-1_6_C5	5.543539392	-29.44723174	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	4122	11141	0.009065613	0.002692756	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGTCCATGTCTTCAAG-1_6_C5	8.137135256	29.81063038	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	725	1009	0	0.003964321	0	oligos	OL-Cntl	NA	NA	NA
CGTCCATGTGGCCCTA-1_6_C5	-18.27013635	-21.59553918	6A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2280	4546	0.011438627	0.002859657	0	6A	IN-PV	NA	NA	NA
CGTCCATGTGTATGGG-1_6_C5	3.391377765	-6.983435304	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1128	1626	0.00799508	0.006765068	0	12	EN-MIX	NA	NA	NA
CGTCCATGTGTGGCTC-1_6_C5	14.44157034	19.74959784	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1029	1523	0.003282994	0.005252791	0	oligos	OL-Cntl	NA	NA	NA
CGTCCATTCACCTTAT-1_6_C5	10.17912472	-34.22998498	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	5307	18661	0.005841059	0.002893736	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGTCCATTCAGTGCAT-1_6_C5	-26.12824743	26.18093957	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1505	2806	0.006771205	0.003207413	0	8	Astrocytes	NA	NA	NA
CGTCCATTCGCGTAGC-1_6_C5	-11.48383138	-0.222084834	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2454	4852	0.029472383	0.002267106	0	13A	IN-VIP	NA	NA	NA
CGTCCATTCTCAACTT-1_6_C5	-27.98944131	16.18374248	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	983	1610	0.000621118	0.000621118	0	8	Astrocytes	NA	NA	NA
CGTCCATTCTTGTTTG-1_6_C5	25.87771041	-5.243176551	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	4945	17109	0.004383658	0.002221053	0	2	EN-L4	NA	NA	NA
CGTCTACCACGAGAGT-1_6_C5	-33.49081341	-11.33309648	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	845	1445	0.000692042	0.002768166	0	9	OPC	NA	NA	NA
CGTCTACCACTTACGA-1_6_C5	2.869044662	-14.63203275	4	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2124	3721	0.013974738	0.007256114	0	L2-3	EN-L2-3-MS	NA	NA	NA
CGTCTACCAGTATAAG-1_6_C5	27.67583562	-5.939532849	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	5790	19128	0.00334588	0.002875366	0	2	EN-L4	NA	NA	NA
CGTCTACTCAGGTAAA-1_6_C5	15.53935727	28.75094132	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	816	1229	0.00081367	0.008950366	0	oligos	OL-Cntl	NA	NA	NA
CGTCTACTCCGCGGTA-1_6_C5	12.61613415	1.098457548	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	744	1067	0.004686036	0.001874414	0	12	EN-MIX	NA	NA	NA
CGTGAGCAGCTACCTA-1_6_C5	18.56772862	11.76224725	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1356	2323	0.0038743	0.004304778	0	oligos	OL-Cntl	NA	NA	NA
CGTGAGCGTTACAGAA-1_6_C5	22.29400691	19.68391493	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1111	1723	0.002321532	0.002321532	0	oligos	OL-Cntl	NA	NA	NA
CGTGTAAAGAAGATTC-1_6_C5	1.484070785	-17.27529718	4	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2781	5726	0.018337408	0.002794272	0	L2-3	EN-L2-3-MS	NA	NA	NA
CGTGTAACATTGGTAC-1_6_C5	0.100212286	-17.33631762	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2757	6370	0.00455259	0.003453689	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGTGTAAGTCCAGTAT-1_6_C5	22.81382888	17.92092214	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1147	1844	0.000542299	0.003253796	0	oligos	OL-Cntl	NA	NA	NA
CGTGTAAGTCGGCTCA-1_6_C5	5.590743528	30.21594631	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	773	1105	0.00361991	0.007239819	0	oligos	OL-Cntl	NA	NA	NA
CGTGTAAGTTCGTCTC-1_6_C5	-17.89379549	-26.12771306	6A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2327	4858	0.006792919	0.005763689	0	6A	IN-PV	NA	NA	NA
CGTGTAATCACTGGGC-1_6_C5	14.44074483	-8.239083055	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2028	4298	0.002791996	0.001861331	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGTGTAATCCAAACAC-1_6_C5	-0.453187773	-12.293868	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1866	3615	0.017427386	0.001659751	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGTGTAATCTAACTCT-1_6_C5	-10.36328733	-20.13354129	6A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	955	1518	0.029644269	0.003952569	0	6A	IN-PV	NA	NA	NA
CGTGTCTAGATCCGAG-1_6_C5	-27.36880387	17.1663523	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1098	1775	0.001126761	0.002816901	0	8	Astrocytes	NA	NA	NA
CGTGTCTAGATCTGAA-1_6_C5	-7.823836104	-2.532397575	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1824	3231	0.027855153	0.003404519	0	13A	IN-VIP	NA	NA	NA
CGTGTCTAGGGTTTCT-1_6_C5	4.932227251	30.54391591	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	692	1064	0.003759398	0.007518797	0	oligos	OL-Cntl	NA	NA	NA
CGTGTCTAGTATTGGA-1_6_C5	-1.078403655	3.65244773	11	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1221	1825	0.005479452	0.003287671	0	11	Glia-MIX	NA	NA	NA
CGTGTCTCAATAAGCA-1_6_C5	14.90093069	28.53596763	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	712	1040	0.003846154	0.006730769	0	oligos	OL-Cntl	NA	NA	NA
CGTGTCTCAGACGTAG-1_6_C5	2.964153777	-24.58975844	4	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	4384	11502	0.007650843	0.008346375	0	L2-3	EN-L2-3-MS	NA	NA	NA
CGTGTCTCATGTAAGA-1_6_C5	-13.48257903	-21.55856434	6A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1234	2060	0.02961165	0.000485437	0	6A	IN-PV	NA	NA	NA
CGTTAGAAGCTGTTCA-1_6_C5	6.309582824	-32.40864479	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	4001	11648	0.003262363	0.002232143	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGTTAGAAGGATATAC-1_6_C5	-9.125061958	16.2136023	11	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1961	3482	0.009190121	0.002871913	0	11	Glia-MIX	NA	NA	NA
CGTTAGAAGTACTTGC-1_6_C5	9.826901625	31.76528107	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	722	1037	0.004821601	0.003857281	0	oligos	OL-Cntl	NA	NA	NA
CGTTAGAAGTTTAGGA-1_6_C5	18.27211405	24.71807604	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	935	1393	0.004307251	0.0028715	0	oligos	OL-Cntl	NA	NA	NA
CGTTAGACATTCCTGC-1_6_C5	10.91654021	-8.508441996	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2285	4584	0.003490401	0.002835951	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGTTAGAGTCAAAGCG-1_6_C5	16.91422033	21.89360544	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	947	1421	0.002111189	0.005629838	0	oligos	OL-Cntl	NA	NA	NA
CGTTAGAGTGATAAGT-1_6_C5	20.76753282	14.90940329	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1258	2038	0.005397448	0.007850834	0	oligos	OL-Cntl	NA	NA	NA
CGTTAGATCGGACAAG-1_6_C5	-24.53061988	27.13653427	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1546	2703	0.001109878	0.003329634	0	8	Astrocytes	NA	NA	NA
CGTTCTGGTCGGCATC-1_6_C5	-27.14660124	17.78556363	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1107	1788	0	0.001118568	0	8	Astrocytes	NA	NA	NA
CGTTCTGTCGAGCCCA-1_6_C5	2.102986162	-14.04907628	4	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2222	4117	0.01141608	0.006072383	0	L2-3	EN-L2-3-MS	NA	NA	NA
CGTTCTGTCTGGAGCC-1_6_C5	15.88205212	22.79024016	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	944	1361	0.001469508	0.006612785	0	oligos	OL-Cntl	NA	NA	NA
CGTTCTGTCTTGGGTA-1_6_C5	-20.03492257	-26.09698297	6A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3019	6937	0.01239729	0.003315554	0	6A	IN-PV	NA	NA	NA
CGTTGGGAGAATGTTG-1_6_C5	25.17276691	-3.114335907	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3053	7578	0.001319609	0.001583531	0	2	EN-L4	NA	NA	NA
CGTTGGGCATCACAAC-1_6_C5	18.67422793	1.635987329	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1159	1810	0.001104972	0.002209945	0	12	EN-MIX	NA	NA	NA
CGTTGGGCATTACCTT-1_6_C5	-18.5857088	-28.44247047	6A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2879	6603	0.002271695	0.001968802	0	6A	IN-PV	NA	NA	NA
CGTTGGGTCACATGCA-1_6_C5	26.42002962	-4.571814419	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3864	9932	0.000302054	0.004228756	0	2	EN-L4	NA	NA	NA
CGTTGGGTCACTCCTG-1_6_C5	-27.72784528	17.41150505	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1045	1645	0.003039514	0.001823708	0	8	Astrocytes	NA	NA	NA
CGTTGGGTCTACCTGC-1_6_C5	3.835244618	28.51375756	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	735	1037	0.006750241	0.00096432	0	oligos	OL-Cntl	NA	NA	NA
CTAACTTAGCTAACAA-1_6_C5	25.38388588	-2.615973222	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2860	7265	0.000137646	0.003441156	0	2	EN-L4	NA	NA	NA
CTAACTTAGGACACCA-1_6_C5	12.76641234	-32.99427297	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3140	8541	0.003629552	0.001639152	0	3	EN-L5-6	NA	NA	NA
CTAACTTAGTGTACCT-1_6_C5	19.44724081	18.82316234	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1015	1623	0.003696858	0.004929144	0	oligos	OL-Cntl	NA	NA	NA
CTAACTTTCAAAGTAG-1_6_C5	3.008484335	-27.90254347	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2946	7698	0.005066251	0.002727981	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTAACTTTCTCGCATC-1_6_C5	17.21765834	14.1911375	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1176	1910	0.013089005	0.003664921	0	oligos	OL-Cntl	NA	NA	NA
CTAAGACAGCGATAGC-1_6_C5	-5.179162142	-8.502706044	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	803	1058	0.02173913	0.002835539	0	13A	IN-VIP	NA	NA	NA
CTAAGACGTTCCACAA-1_6_C5	19.9722531	13.16205708	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1223	1900	0.001052632	0.004210526	0	oligos	OL-Cntl	NA	NA	NA
CTAAGACGTTTGTGTG-1_6_C5	-0.051206713	-15.46224492	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2310	4680	0.009401709	0.003846154	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTAATGGAGCGATATA-1_6_C5	1.057541845	-12.28440806	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1911	3581	0.010890813	0.005864284	0	12	EN-MIX	NA	NA	NA
CTAATGGAGGTACTCT-1_6_C5	13.52328064	25.61567903	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	755	1136	0.000880282	0.007042254	0	oligos	OL-Cntl	NA	NA	NA
CTAATGGAGTCGAGTG-1_6_C5	-12.61916173	15.9326577	11	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1157	1745	0.002292264	0.004584527	0	11	Glia-MIX	NA	NA	NA
CTAATGGGTAACGCGA-1_6_C5	-6.666711249	-0.816205032	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1743	3119	0.003526771	0.00288554	0	13A	IN-VIP	NA	NA	NA
CTAATGGGTATGAATG-1_6_C5	10.16944396	-7.996367735	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2033	4170	0.002158273	0.001918465	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTAATGGGTGACAAAT-1_6_C5	25.1015906	-4.303571891	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3985	12248	0.002775963	0.001714566	0	2	EN-L4	NA	NA	NA
CTAATGGTCTGTCTCG-1_6_C5	-36.58202653	-4.479851889	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1313	2222	0.004050405	0.00630063	0	9	OPC	NA	NA	NA
CTACACCAGAAACCGC-1_6_C5	-27.65524849	18.8324009	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1403	2614	0.003060444	0.003442999	0	8	Astrocytes	NA	NA	NA
CTACACCAGCATCATC-1_6_C5	10.71067217	27.41892522	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	847	1395	0	0.003584229	0	oligos	OL-Cntl	NA	NA	NA
CTACACCCACCAGGCT-1_6_C5	-27.68694334	24.86771422	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1338	2454	0.000407498	0.00203749	0	8	Astrocytes	NA	NA	NA
CTACACCGTCGCTTTC-1_6_C5	13.55602597	-32.76784899	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3608	10796	0.000833642	0.002130419	0	3	EN-L5-6	NA	NA	NA
CTACACCGTGTGCGTC-1_6_C5	-0.839730828	-13.80334742	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2142	4283	0.003035256	0.003268737	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTACACCTCACTCTTA-1_6_C5	11.54731303	30.06313149	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	647	1014	0.003944773	0.000986193	0	oligos	OL-Cntl	NA	NA	NA
CTACACCTCGTAGATC-1_6_C5	16.4003016	21.59707491	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	970	1550	0.001935484	0.003225806	0	oligos	OL-Cntl	NA	NA	NA
CTACACCTCTGTTTGT-1_6_C5	14.88457124	27.74397966	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	743	1123	0.001780944	0.005342832	0	oligos	OL-Cntl	NA	NA	NA
CTACATTAGATTACCC-1_6_C5	16.23809272	23.23945542	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	814	1220	0.000819672	0.004918033	0	oligos	OL-Cntl	NA	NA	NA
CTACATTAGGAGTCTG-1_6_C5	-12.26133227	-19.41771239	6B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1129	1831	0.016384489	0.005461496	0	6B	IN-SST	NA	NA	NA
CTACATTCAAGCCATT-1_6_C5	-24.82891136	28.41545988	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1568	3073	0.003579564	0.002928734	0	8	Astrocytes	NA	NA	NA
CTACATTCAGCGAACA-1_6_C5	13.82657	-32.50904271	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3491	8815	0.001474759	0.003743619	0	3	EN-L5-6	NA	NA	NA
CTACCCAAGAACTGTA-1_6_C5	-26.55058919	17.87826502	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1172	1953	0.001024066	0.006656426	0	8	Astrocytes	NA	NA	NA
CTACCCAAGCGTTTAC-1_6_C5	18.85769523	23.72297777	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1010	1523	0.005252791	0.006565988	0	oligos	OL-Cntl	NA	NA	NA
CTACCCAAGTCTTGCA-1_6_C5	-12.07142504	-20.81608701	6A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1082	1818	0.00440044	0.00330033	0	6A	IN-PV	NA	NA	NA
CTACCCAGTAAATACG-1_6_C5	5.565301666	29.88148284	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	766	1084	0.007380074	0.006457565	0	oligos	OL-Cntl	NA	NA	NA
CTACCCAGTAAGGGAA-1_6_C5	-26.94800813	14.33726161	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	978	1496	0.000668449	0.002673797	0	8	Astrocytes	NA	NA	NA
CTACCCAGTAATCACC-1_6_C5	13.84230117	-32.59193607	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3598	9904	0.001110662	0.003836834	0	3	EN-L5-6	NA	NA	NA
CTACCCAGTACGAAAT-1_6_C5	12.04078743	22.5529285	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	907	1373	0.003641661	0.003641661	0	oligos	OL-Cntl	NA	NA	NA
CTACCCAGTACTTCTT-1_6_C5	1.185201433	-28.04716291	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3996	11000	0.009545455	0.002181818	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTACCCAGTGACTACT-1_6_C5	-19.70403728	-28.73800224	6A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3416	8995	0.003779878	0.002668149	0	6A	IN-PV	NA	NA	NA
CTACCCAGTGCAGTAG-1_6_C5	2.44380264	29.87693315	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	732	1099	0.022747953	0.004549591	0	oligos	OL-Cntl	NA	NA	NA
CTACCCAGTGTGTGCC-1_6_C5	-28.80369205	13.60860614	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	835	1226	0.013050571	0.000815661	0	8	Astrocytes	NA	NA	NA
CTACCCAGTTTGCATG-1_6_C5	-0.25011212	-11.48204991	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1733	3370	0.005341246	0.004154303	0	12	EN-MIX	NA	NA	NA
CTACCCATCATCGATG-1_6_C5	2.712422255	-31.95284446	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	5334	18453	0.00249282	0.002221861	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTACCCATCCTAGTGA-1_6_C5	-38.60795972	-3.144654318	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1302	2288	0.000437063	0.002622378	0	9	OPC	NA	NA	NA
CTACCCATCGAACGGA-1_6_C5	-26.4917596	17.81551088	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1164	1876	0.000533049	0.000533049	0	8	Astrocytes	NA	NA	NA
CTACCCATCGCCAGCA-1_6_C5	-17.05798565	-23.96543045	6A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1928	4017	0.00373413	0.002240478	0	6A	IN-PV	NA	NA	NA
CTACCCATCTCAACTT-1_6_C5	5.46292815	30.31074494	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	688	1058	0.006616257	0.002835539	0	oligos	OL-Cntl	NA	NA	NA
CTACCCATCTGGTATG-1_6_C5	10.61710034	31.496654	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	726	1057	0.002838221	0.004730369	0	oligos	OL-Cntl	NA	NA	NA
CTACGTCAGATGGGTC-1_6_C5	-18.720842	-28.23377315	6A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2712	6273	0.00047824	0.00191296	0	6A	IN-PV	NA	NA	NA
CTACGTCAGGGAGTAA-1_6_C5	2.974362068	-19.4489324	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2954	5825	0.010643777	0.002403433	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTACGTCCAAGGTTTC-1_6_C5	-15.21946141	-19.30994655	6B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1523	2794	0.010379384	0.001073729	0	6B	IN-SST	NA	NA	NA
CTACGTCCACCCATGG-1_6_C5	19.51149119	21.98987484	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	909	1324	0.006042296	0.006042296	0	oligos	OL-Cntl	NA	NA	NA
CTACGTCCAGCTCCGA-1_6_C5	-0.359197398	-21.4269929	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3797	9402	0.004892576	0.005105297	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTACGTCCAGCTCGAC-1_6_C5	-14.83546471	-18.44652119	6B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1489	2450	0.032244898	0.005714286	0	6B	IN-SST	NA	NA	NA
CTACGTCCATCCGCGA-1_6_C5	-0.248700073	-15.18701729	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2499	5187	0.009832273	0.005012531	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTACGTCGTCTTCTCG-1_6_C5	-37.0978515	-6.076952822	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1143	1973	0.001013685	0.003547897	0	9	OPC	NA	NA	NA
CTACGTCTCCAACCAA-1_6_C5	-14.98369129	-10.18586139	13B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2079	4283	0.016343684	0.002101331	0	13B	IN-SV2C	NA	NA	NA
CTAGAGTAGACAATAC-1_6_C5	-35.30451833	-11.03199674	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	898	1361	0.000734754	0.002204262	0	9	OPC	NA	NA	NA
CTAGAGTGTCGCTTTC-1_6_C5	6.007194099	29.11225224	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	717	1051	0.006660324	0.005708849	0	oligos	OL-Cntl	NA	NA	NA
CTAGAGTTCGTTTATC-1_6_C5	1.671243965	-27.8568446	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3146	8416	0.000475285	0.002257605	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTAGAGTTCTCGATGA-1_6_C5	3.002267644	-4.764926185	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	886	1381	0.009413469	0.003620565	0	12	EN-MIX	NA	NA	NA
CTAGCCTAGTTGAGTA-1_6_C5	17.42449653	23.57862335	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	894	1333	0.001500375	0.001500375	0	oligos	OL-Cntl	NA	NA	NA
CTAGCCTCACCAGGTC-1_6_C5	14.4640295	30.41654489	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	757	1112	0.002697842	0.002697842	0	oligos	OL-Cntl	NA	NA	NA
CTAGCCTCACGAAACG-1_6_C5	-21.1450394	9.544296261	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	930	1352	0.003698225	0.00147929	0	8	Astrocytes	NA	NA	NA
CTAGCCTTCACAGGCC-1_6_C5	-22.69492772	31.45589491	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2164	4421	0.001357159	0.002488125	0	8	Astrocytes	NA	NA	NA
CTAGTGAAGAGACTAT-1_6_C5	-4.507047456	-2.385745648	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1325	2271	0.008806693	0.002642008	0	13A	IN-VIP	NA	NA	NA
CTAGTGAAGTGTGGCA-1_6_C5	16.77724361	28.08172756	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	732	1043	0.002876318	0.001917546	0	oligos	OL-Cntl	NA	NA	NA
CTAGTGACAGTTCATG-1_6_C5	11.10007794	28.53455576	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	723	1077	0.000928505	0.002785515	0	oligos	OL-Cntl	NA	NA	NA
CTAGTGAGTCAGTGGA-1_6_C5	16.87557143	23.82408709	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	923	1396	0.004297994	0.00286533	0	oligos	OL-Cntl	NA	NA	NA
CTAGTGAGTCTTGATG-1_6_C5	19.67957008	-6.920482391	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2197	5214	0.022056003	0.004411201	0	3	EN-L5-6	NA	NA	NA
CTAGTGAGTGTAACGG-1_6_C5	23.15361155	19.93786	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	991	1479	0.001352265	0.003380663	0	oligos	OL-Cntl	NA	NA	NA
CTAGTGATCAACACGT-1_6_C5	10.66533031	-9.000197998	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2932	7453	0.006037837	0.001744264	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTCACACAGTGAAGTT-1_6_C5	-0.698291047	-16.8665073	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2535	5433	0.012332045	0.00496963	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTCACACCAAGCTGTT-1_6_C5	-23.72751518	29.94356619	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1806	3356	0.000297974	0.003575685	0	8	Astrocytes	NA	NA	NA
CTCACACCATCGTCGG-1_6_C5	25.82872052	-3.722904086	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3964	11746	0.001021624	0.002894602	0	2	EN-L4	NA	NA	NA
CTCACACTCAACACAC-1_6_C5	22.84781569	13.68103957	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1185	2068	0.000483559	0.001934236	0	oligos	OL-Cntl	NA	NA	NA
CTCACACTCGACCAGC-1_6_C5	3.12505294	-31.71007839	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	5278	19117	0.001464665	0.001360046	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTCACACTCGTTGACA-1_6_C5	12.7899041	31.2405995	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	726	1069	0.000935454	0.003741815	0	oligos	OL-Cntl	NA	NA	NA
CTCAGAAAGCGATCCC-1_6_C5	0.172415593	32.38075301	17	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	822	1143	0.006124234	0.005249344	0	oligos	OL-MS-2	NA	NA	NA
CTCAGAACACCCATTC-1_6_C5	-18.11006595	-22.39059087	6A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2134	4227	0.010172699	0.003075467	0	6A	IN-PV	NA	NA	NA
CTCAGAAGTACGACCC-1_6_C5	19.52384813	0.194196422	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1354	2165	0.011547344	0.001847575	0	2	EN-L4	NA	NA	NA
CTCAGAAGTATCGCAT-1_6_C5	13.37536696	19.56649044	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	941	1443	0.001386001	0.003465003	0	oligos	OL-Cntl	NA	NA	NA
CTCAGAAGTCGTCTTC-1_6_C5	21.5968877	1.574504059	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1520	2860	0	0.002447552	0	2	EN-L4	NA	NA	NA
CTCAGAAGTTTGTTGG-1_6_C5	-29.12071184	12.83457473	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	780	1163	0.000859845	0.000859845	0	8	Astrocytes	NA	NA	NA
CTCAGAATCACAGTAC-1_6_C5	9.620152721	30.10467138	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	745	1173	0.00170503	0.00341006	0	oligos	OL-Cntl	NA	NA	NA
CTCAGAATCTACTCAT-1_6_C5	-15.25920525	-11.71037574	13B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2372	5015	0.015752742	0.002791625	0	13B	IN-SV2C	NA	NA	NA
CTCATTAAGCAACGGT-1_6_C5	17.42461972	24.34124224	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	924	1443	0.004851005	0.004851005	0	oligos	OL-Cntl	NA	NA	NA
CTCATTAAGCAGGTCA-1_6_C5	-27.98360928	16.03341654	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1089	1682	0.003567182	0.001189061	0	8	Astrocytes	NA	NA	NA
CTCATTAAGGTGTGGT-1_6_C5	14.28879978	-32.92348813	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	4094	12442	0.00739431	0.001687832	0	3	EN-L5-6	NA	NA	NA
CTCATTACAGCTGCAC-1_6_C5	-5.536482071	-1.976644654	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1460	2448	0.015931373	0.002042484	0	13A	IN-VIP	NA	NA	NA
CTCATTACAGTCAGAG-1_6_C5	23.46200161	0.336446235	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1833	3505	0.002853067	0.001997147	0	2	EN-L4	NA	NA	NA
CTCATTAGTACACCGC-1_6_C5	11.87402345	26.61844707	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	816	1241	0.006446414	0.006446414	0	oligos	OL-Cntl	NA	NA	NA
CTCATTAGTCGCGAAA-1_6_C5	-20.07595113	-27.93235021	6A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3437	8803	0.032829717	0.003294331	0	6A	IN-PV	NA	NA	NA
CTCATTAGTGTGGTTT-1_6_C5	29.68353666	-3.556448102	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	4839	15178	0.024970352	0.003623666	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTCATTATCAGTTTGG-1_6_C5	4.169267142	-32.84057947	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	5403	20452	0.004302758	0.002298064	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTCCTAGAGGAGTTTA-1_6_C5	13.56642241	27.85414751	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	796	1215	0	0.001646091	0	oligos	OL-Cntl	NA	NA	NA
CTCCTAGAGGCAGGTT-1_6_C5	4.287070279	-30.97986187	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3989	10622	0.002636038	0.002165317	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTCCTAGAGTTTCCTT-1_6_C5	-24.95425791	25.87774291	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1518	2814	0	0.011016347	0	8	Astrocytes	NA	NA	NA
CTCCTAGCAATGCCAT-1_6_C5	11.27937984	28.61777798	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	703	1064	0.001879699	0.002819549	0	oligos	OL-Cntl	NA	NA	NA
CTCCTAGCAATGGAGC-1_6_C5	12.07470699	30.12964067	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	715	1079	0.003707136	0.001853568	0	oligos	OL-Cntl	NA	NA	NA
CTCCTAGCACCGTTGG-1_6_C5	-37.63832808	-5.359849449	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1156	1952	0.001536885	0.002561475	0	9	OPC	NA	NA	NA
CTCCTAGCATCGGGTC-1_6_C5	22.83935735	14.18944914	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1166	1902	0.005257624	0.002628812	0	oligos	OL-Cntl	NA	NA	NA
CTCCTAGCATGCGCAC-1_6_C5	20.91573237	-28.8260889	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3608	9693	0.003198184	0.00371402	0	3	EN-L5-6	NA	NA	NA
CTCCTAGTCACAATGC-1_6_C5	-8.951908112	-18.5964952	6B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	733	1191	0.01511335	0	0	6B	IN-SST	NA	NA	NA
CTCCTAGTCTGACCTC-1_6_C5	18.05699468	21.85323566	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	842	1460	0.003424658	0.002739726	0	oligos	OL-Cntl	NA	NA	NA
CTCGAAACAAGCGAGT-1_6_C5	-9.096852616	14.15143516	11	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1574	2660	0.003007519	0.003383459	0	11	Glia-MIX	NA	NA	NA
CTCGAAACACAGAGGT-1_6_C5	-14.49588229	-6.88094043	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2704	5554	0.015664386	0.002520706	0	13A	IN-VIP	NA	NA	NA
CTCGAAACAGGTGCCT-1_6_C5	5.023138484	-31.8846207	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	4693	16111	0.00204829	0.001737943	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTCGAAACATGGAATA-1_6_C5	13.11227176	29.75428291	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	739	1009	0.001982161	0	0	oligos	OL-Cntl	NA	NA	NA
CTCGAAACATTTCAGG-1_6_C5	14.36851367	-8.337535073	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2402	5707	0.004380585	0.003154021	0	3	EN-L5-6	NA	NA	NA
CTCGAAAGTCAATACC-1_6_C5	15.64825069	-0.996215015	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	739	1075	0.00372093	0.004651163	0	12	EN-MIX	NA	NA	NA
CTCGAAATCCGTTGTC-1_6_C5	12.55707699	20.57445222	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	934	1379	0.001450326	0.005801305	0	oligos	OL-Cntl	NA	NA	NA
CTCGAGGCAAGCCATT-1_6_C5	0.580167368	-26.22651373	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3887	9893	0.002425958	0.00192055	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTCGAGGCATCATCCC-1_6_C5	17.48581393	22.21517661	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	964	1546	0.004527814	0.002587322	0	oligos	OL-Cntl	NA	NA	NA
CTCGAGGCATGCAATC-1_6_C5	-20.05927856	-29.30470817	6A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	4544	14446	0.000138447	0.002076699	0	6A	IN-PV	NA	NA	NA
CTCGAGGGTTCCTCCA-1_6_C5	23.0374411	12.35717848	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1442	2449	0.003674969	0.003674969	0	oligos	OL-Cntl	NA	NA	NA
CTCGAGGTCAAAGACA-1_6_C5	0.836313226	-27.54814698	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	4014	10831	0.006370603	0.001846552	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTCGGAGGTACGACCC-1_6_C5	1.802889122	-31.73270946	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	7010	27664	0.002205032	0.00372325	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTCGGAGGTATAGTAG-1_6_C5	-37.54948844	-6.106548071	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1105	1738	0.000575374	0.002301496	0	9	OPC	NA	NA	NA
CTCGGAGGTCATGCAT-1_6_C5	20.70061596	-27.90326451	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2896	6254	0.008314679	0.00271826	0	3	EN-L5-6	NA	NA	NA
CTCGGAGTCGTACGGC-1_6_C5	-26.57375964	10.04916159	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	806	1206	0.001658375	0.000829187	0	8	Astrocytes	NA	NA	NA
CTCGGGAAGGTAAACT-1_6_C5	9.678605433	27.77640908	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	835	1321	0.004542014	0.003028009	0	oligos	OL-Cntl	NA	NA	NA
CTCGGGACATCCGGGT-1_6_C5	15.70753739	-1.448053695	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	894	1328	0.003012048	0.001506024	0	12	EN-MIX	NA	NA	NA
CTCGGGAGTATTCGTG-1_6_C5	-15.90508659	-10.21676869	13B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2546	5263	0.005700171	0.00399012	0	13B	IN-SV2C	NA	NA	NA
CTCGGGATCATCACCC-1_6_C5	20.05217124	-0.968755403	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1306	2065	0.00968523	0.002905569	0	12	EN-MIX	NA	NA	NA
CTCGTACAGACAGACC-1_6_C5	-18.82482126	-21.25079655	6A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2998	6918	0.027609136	0.002891009	0	6A	IN-PV	NA	NA	NA
CTCGTACAGAGGGCTT-1_6_C5	13.19252815	-1.232724031	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1120	1850	0.003243243	0.012972973	0	12	EN-MIX	NA	NA	NA
CTCGTACAGCATGGCA-1_6_C5	8.847346517	33.44050598	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	916	1377	0.01016703	0.004357298	0	oligos	OL-Cntl	NA	NA	NA
CTCGTACAGCTGGAAC-1_6_C5	-1.298205934	-22.21984481	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3964	11056	0.005155572	0.003346599	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTCGTACCAAGCCATT-1_6_C5	-8.57828806	1.185220244	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2230	4510	0.009756098	0.002882483	0	13A	IN-VIP	NA	NA	NA
CTCGTACCAGCTATTG-1_6_C5	-7.082440144	-0.537735026	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1814	3364	0.017241379	0.001783591	0	13A	IN-VIP	NA	NA	NA
CTCGTACGTAGAAGGA-1_6_C5	-12.32028694	-22.31622139	6A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1126	1779	0.017987634	0.002248454	0	6A	IN-PV	NA	NA	NA
CTCGTACGTCTGCGGT-1_6_C5	-28.1436544	12.53602394	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	829	1184	0.000844595	0.005067568	0	8	Astrocytes	NA	NA	NA
CTCGTACTCCAAATGC-1_6_C5	-24.17053179	28.27531375	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1745	3325	0.001804511	0.002406015	0	8	Astrocytes	NA	NA	NA
CTCGTCAAGTGTACTC-1_6_C5	-26.81640917	17.00942813	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1135	1887	0.002649709	0.00317965	0	8	Astrocytes	NA	NA	NA
CTCGTCACAGGATTGG-1_6_C5	20.3667481	-28.34678435	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3060	7090	0.007052186	0.005359661	0	3	EN-L5-6	NA	NA	NA
CTCGTCAGTAAATACG-1_6_C5	17.31452433	1.678988601	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	974	1488	0.006048387	0.002016129	0	12	EN-MIX	NA	NA	NA
CTCGTCAGTTGGTAAA-1_6_C5	8.494716692	-7.785236081	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1894	3868	0.013702172	0.001292658	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTCGTCATCTGGCGTG-1_6_C5	16.40156193	24.01059919	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	923	1396	0.002148997	0.005730659	0	oligos	OL-Cntl	NA	NA	NA
CTCTAATAGCCCAACC-1_6_C5	23.11634478	19.47695385	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	913	1390	0.001438849	0.002877698	0	oligos	OL-Cntl	NA	NA	NA
CTCTAATAGGTGCTTT-1_6_C5	14.49896767	30.34557537	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	766	1144	0.002622378	0.002622378	0	oligos	OL-Cntl	NA	NA	NA
CTCTAATAGTGAAGTT-1_6_C5	21.2914998	1.57438279	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1433	2539	0.007877117	0.001969279	0	2	EN-L4	NA	NA	NA
CTCTAATCAAATCCGT-1_6_C5	-37.04787118	-8.473769887	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	964	1596	0.001253133	0.001879699	0	9	OPC	NA	NA	NA
CTCTAATCAAGCCCAC-1_6_C5	-27.27117358	8.777238356	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	663	1008	0.001984127	0	0	8	Astrocytes	NA	NA	NA
CTCTAATCAGCCTGTG-1_6_C5	-38.44754107	-6.582392201	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1065	1860	0.003225806	0.004301075	0	9	OPC	NA	NA	NA
CTCTAATGTCGCATAT-1_6_C5	18.70916193	20.61801429	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1047	1780	0.003370787	0.004494382	0	oligos	OL-Cntl	NA	NA	NA
CTCTAATTCAACGAAA-1_6_C5	6.564274685	-33.13896585	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3856	11448	0.003581412	0.001222921	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTCTAATTCACTCTTA-1_6_C5	-14.15138116	-10.61243696	13B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2127	4538	0.005288673	0.001983253	0	13B	IN-SV2C	NA	NA	NA
CTCTAATTCCTGCAGG-1_6_C5	23.31503454	12.56623797	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1308	2189	0.000913659	0.001827318	0	oligos	OL-Cntl	NA	NA	NA
CTCTAATTCGTAGGTT-1_6_C5	4.223731246	-30.03497465	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3172	8539	0.001639536	0.00421595	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTCTACGAGCCAGTTT-1_6_C5	8.377505835	28.41147111	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	891	1439	0.006254343	0.004169562	0	oligos	OL-Cntl	NA	NA	NA
CTCTACGCAGCATGAG-1_6_C5	25.20293861	-29.63064299	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3612	10060	0.000994036	0.00387674	0	3	EN-L5-6	NA	NA	NA
CTCTACGCATAGGATA-1_6_C5	-18.46504707	-23.55811025	6A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2295	4648	0.01742685	0.003657487	0	6A	IN-PV	NA	NA	NA
CTCTACGCATCCGCGA-1_6_C5	-1.958328585	-15.75900698	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2319	5206	0.005186323	0.001728774	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTCTACGCATGGAATA-1_6_C5	2.83381516	-6.747701852	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1227	1886	0.004241782	0.003711559	0	12	EN-MIX	NA	NA	NA
CTCTACGGTAGCGCTC-1_6_C5	22.64725448	20.84084087	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1038	1580	0.001898734	0.003797468	0	oligos	OL-Cntl	NA	NA	NA
CTCTACGGTCAAGCGA-1_6_C5	16.65189682	20.18928126	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	919	1348	0.002967359	0.007418398	0	oligos	OL-Cntl	NA	NA	NA
CTCTACGGTTATCCGA-1_6_C5	-29.42404031	15.97723846	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	851	1365	0.001465201	0.002930403	0	8	Astrocytes	NA	NA	NA
CTCTACGGTTATTCTC-1_6_C5	7.887274943	34.04188455	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	839	1243	0.004827031	0.004827031	0	oligos	OL-Cntl	NA	NA	NA
CTCTACGTCACGCGGT-1_6_C5	11.50911688	26.25935475	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	886	1283	0.013250195	0.006235386	0	oligos	OL-Cntl	NA	NA	NA
CTCTACGTCGTAGGAG-1_6_C5	1.39123875	-10.41466792	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1711	2753	0.005811842	0.005085361	0	12	EN-MIX	NA	NA	NA
CTCTACGTCTCCAGGG-1_6_C5	-3.657618322	-4.447500406	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1163	1937	0.007743934	0.002581311	0	13A	IN-VIP	NA	NA	NA
CTCTACGTCTCGAGTA-1_6_C5	-24.44657377	29.3647383	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1791	3320	0.001506024	0.003313253	0	8	Astrocytes	NA	NA	NA
CTCTGGTAGCACCGTC-1_6_C5	-15.16786846	-19.44367036	6B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1609	3098	0.016462234	0.0058102	0	6B	IN-SST	NA	NA	NA
CTCTGGTCAAGAAAGG-1_6_C5	21.34396795	0.570488485	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1382	2201	0.005906406	0.002726034	0	2	EN-L4	NA	NA	NA
CTCTGGTCAATCGGTT-1_6_C5	-3.170971981	-6.460346885	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	905	1397	0.013600573	0.005726557	0	13A	IN-VIP	NA	NA	NA
CTCTGGTCACTTACGA-1_6_C5	1.897306154	-10.86592113	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1738	3088	0.013601036	0.005829016	0	12	EN-MIX	NA	NA	NA
CTCTGGTCATGAAGTA-1_6_C5	-23.36756238	13.95622	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	979	1418	0.013399154	0	0	8	Astrocytes	NA	NA	NA
CTCTGGTGTCGATTGT-1_6_C5	4.963890606	29.7181713	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	679	1030	0.002912621	0.00776699	0	oligos	OL-Cntl	NA	NA	NA
CTCTGGTGTCTTTCAT-1_6_C5	-9.846396655	22.83038752	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1482	2287	0.009619589	0.006121557	0	8	Astrocytes	NA	NA	NA
CTCTGGTGTGAACCTT-1_6_C5	22.84475162	-9.00324484	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2655	5864	0.000511596	0.001875853	0	3	EN-L5-6	NA	NA	NA
CTCTGGTTCTTTACGT-1_6_C5	2.32128012	-31.47170264	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	5784	25461	0.000785515	0.002435097	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTGAAACAGAAGGTGA-1_6_C5	-20.40694905	-24.46142298	6A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2699	5281	0.017231585	0.002651013	0	6A	IN-PV	NA	NA	NA
CTGAAACAGCTAACTC-1_6_C5	24.19210824	-6.354547004	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3726	9467	0.002218232	0.004013943	0	2	EN-L4	NA	NA	NA
CTGAAACAGGGATCTG-1_6_C5	14.86866539	27.22952842	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	755	1147	0.004359198	0.003487358	0	oligos	OL-Cntl	NA	NA	NA
CTGAAACGTAAGGGCT-1_6_C5	14.90721596	29.140211	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	817	1162	0.005163511	0.005163511	0	oligos	OL-Cntl	NA	NA	NA
CTGAAACGTTCGTGAT-1_6_C5	-22.8231215	16.34308087	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1205	1807	0.002767017	0.004427227	0	8	Astrocytes	NA	NA	NA
CTGAAACTCCAGGGCT-1_6_C5	13.16917481	-33.5915528	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	4045	11905	0.000839983	0.002267955	0	2	EN-L4	NA	NA	NA
CTGAAACTCCCATTAT-1_6_C5	11.9292639	28.96216584	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	829	1242	0	0.003220612	0	oligos	OL-Cntl	NA	NA	NA
CTGAAGTAGAAACCGC-1_6_C5	-19.95737772	-27.6609393	6A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3156	8068	0.01189886	0.002974715	0	6A	IN-PV	NA	NA	NA
CTGAAGTCAGAAGCAC-1_6_C5	17.20504633	23.2390721	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	903	1361	0.001469508	0.002939015	0	oligos	OL-Cntl	NA	NA	NA
CTGAAGTGTGTCTGAT-1_6_C5	14.11696005	-3.368978425	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1155	1829	0.01038819	0.00874795	0	12	EN-MIX	NA	NA	NA
CTGAAGTTCAGGATCT-1_6_C5	-0.331472843	-17.40645929	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2526	5477	0.008763922	0.002008399	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTGAAGTTCCTCCTAG-1_6_C5	1.564365829	-23.08839697	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	4628	14815	0.00958488	0.002227472	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTGATAGAGATGTTAG-1_6_C5	-16.65183659	-10.66486505	13B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2823	5815	0.007738607	0.003267412	0	13B	IN-SV2C	NA	NA	NA
CTGATAGAGCTAGTTC-1_6_C5	-26.23214653	19.58265555	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1400	2386	0.001676446	0.004191115	0	8	Astrocytes	NA	NA	NA
CTGATAGAGTGTGGCA-1_6_C5	17.28113954	25.41184827	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	948	1408	0.012784091	0.004971591	0	oligos	OL-Cntl	NA	NA	NA
CTGATAGGTCATCGGC-1_6_C5	27.33096056	0.386782232	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3779	10375	0.003951807	0.00260241	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTGATAGTCAGCGACC-1_6_C5	-1.753838854	-18.08630693	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3002	7255	0.007305307	0.002481048	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTGATCCAGGAGTCTG-1_6_C5	19.17558743	-7.315228942	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2141	4428	0.008581752	0.00203252	0	3	EN-L5-6	NA	NA	NA
CTGATCCGTCTAGTGT-1_6_C5	23.96409277	0.145320671	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1952	3720	0.005376344	0.001344086	0	2	EN-L4	NA	NA	NA
CTGATCCTCAGTGCAT-1_6_C5	-37.20591413	-5.255681923	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1185	1938	0.002063983	0.003095975	0	9	OPC	NA	NA	NA
CTGCCTACAGATGAGC-1_6_C5	22.68084862	1.273657647	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1706	3117	0.012191209	0.002887392	0	2	EN-L4	NA	NA	NA
CTGCCTACAGTTTACG-1_6_C5	-1.386052992	-1.349683315	6B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1694	2877	0.015988877	0.004518596	0	6B	IN-SST	NA	NA	NA
CTGCCTACATAGACTC-1_6_C5	8.995182935	29.79419027	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	784	1211	0.012386457	0.003303055	0	oligos	OL-Cntl	NA	NA	NA
CTGCCTACATCACGTA-1_6_C5	-26.77078275	16.38906531	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1056	1634	0.00122399	0.003671971	0	8	Astrocytes	NA	NA	NA
CTGCCTACATGATCCA-1_6_C5	26.04831148	-27.1768587	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	4325	12224	0.003026832	0.003108639	0	3	EN-L5-6	NA	NA	NA
CTGCCTACATTCCTCG-1_6_C5	-24.99542643	28.51282527	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1591	2924	0.001025992	0.001367989	0	8	Astrocytes	NA	NA	NA
CTGCCTAGTAACGACG-1_6_C5	-0.055668196	-15.46337579	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2172	4209	0.005939653	0.004038964	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTGCCTAGTAATCGTC-1_6_C5	18.47140534	13.25595129	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1267	2153	0.003251277	0.001393405	0	oligos	OL-Cntl	NA	NA	NA
CTGCCTAGTACTCAAC-1_6_C5	-13.67046411	-10.5493063	13B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1875	3597	0.006394217	0.002780095	0	13B	IN-SV2C	NA	NA	NA
CTGCCTAGTGGCTCCA-1_6_C5	27.38634571	-2.787474879	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3251	7682	0.003775059	0.002863838	0	2	EN-L4	NA	NA	NA
CTGCCTATCGAACGGA-1_6_C5	18.70576254	1.593784786	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1166	1934	0.007238883	0.003619442	0	12	EN-MIX	NA	NA	NA
CTGCCTATCGGTTAAC-1_6_C5	-1.550625916	-16.02163712	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2107	4473	0.004247708	0.002906327	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTGCCTATCTACTATC-1_6_C5	-15.91184043	-25.83001451	6A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1878	3823	0.014386607	0.002615747	0	6A	IN-PV	NA	NA	NA
CTGCGGAAGCCACCTG-1_6_C5	19.19490966	24.90513863	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	936	1442	0.002773925	0.000693481	0	oligos	OL-Cntl	NA	NA	NA
CTGCGGAAGGTGCACA-1_6_C5	-28.96025887	21.52406609	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1093	1748	0.000572082	0.003432494	0	8	Astrocytes	NA	NA	NA
CTGCGGACAGCGTCCA-1_6_C5	1.498055176	-26.77447348	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3695	8873	0.007325595	0.003042939	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTGCGGACAGTCTTCC-1_6_C5	15.67837693	22.1440908	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	892	1303	0	0.003837299	0	oligos	OL-Cntl	NA	NA	NA
CTGCGGACATGTCCTC-1_6_C5	-10.04186466	18.22577364	11	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2330	4668	0.001285347	0.004712939	0	11	Glia-MIX	NA	NA	NA
CTGCGGAGTATAATGG-1_6_C5	18.81776996	13.644147	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1266	2033	0.003443187	0.003443187	0	oligos	OL-Cntl	NA	NA	NA
CTGCGGAGTCTCGTTC-1_6_C5	-4.191403461	-5.028842471	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1068	1700	0.011176471	0.004705882	0	13A	IN-VIP	NA	NA	NA
CTGCGGAGTCTGGAGA-1_6_C5	2.980512266	34.03527289	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	761	1089	0.01010101	0.005509642	0	oligos	OL-Cntl	NA	NA	NA
CTGCGGATCACTGGGC-1_6_C5	23.10793232	12.30966342	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1475	2420	0.001239669	0.002892562	0	oligos	OL-Cntl	NA	NA	NA
CTGCGGATCTTGTTTG-1_6_C5	4.228175659	-30.14024741	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3517	9349	0.002674083	0.002032303	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTGCTGTAGATGTTAG-1_6_C5	13.84076487	26.60192864	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	794	1237	0.001616815	0	0	oligos	OL-Cntl	NA	NA	NA
CTGCTGTAGCAGGTCA-1_6_C5	-19.14252514	-28.64979308	6A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3010	7440	0.009677419	0.003494624	0	6A	IN-PV	NA	NA	NA
CTGCTGTAGTCTCGGC-1_6_C5	-4.468696517	-3.565536018	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1381	2396	0.020868114	0.004590985	0	13A	IN-VIP	NA	NA	NA
CTGCTGTGTACTTGAC-1_6_C5	-32.20214399	-1.296886402	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1385	2259	0.001770695	0.001770695	0	9	OPC	NA	NA	NA
CTGCTGTGTCGAGTTT-1_6_C5	2.401189196	29.80260472	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	734	1079	0.003707136	0.008341057	0	oligos	OL-Cntl	NA	NA	NA
CTGCTGTGTGATGCCC-1_6_C5	-27.41899054	8.892205309	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	738	1029	0.019436346	0.003887269	0	8	Astrocytes	NA	NA	NA
CTGCTGTTCCACGCAG-1_6_C5	3.508147776	-9.652819037	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1538	2445	0.02208589	0.007361963	0	12	EN-MIX	NA	NA	NA
CTGGTCTAGCAATATG-1_6_C5	12.32342142	28.69970052	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	779	1231	0	0.007311129	0	oligos	OL-Cntl	NA	NA	NA
CTGGTCTAGGTGCAAC-1_6_C5	0.638145246	-16.62930587	4	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2428	4914	0.007733008	0.004070004	0	L2-3	EN-L2-3-MS	NA	NA	NA
CTGGTCTAGTGTCCCG-1_6_C5	-25.54823777	18.33145848	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1240	1877	0.003729355	0.002663825	0	8	Astrocytes	NA	NA	NA
CTGGTCTCAGCTCGAC-1_6_C5	13.35664344	-0.136424283	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	816	1401	0.007851535	0.004282655	0	12	EN-MIX	NA	NA	NA
CTGGTCTGTTCCGGCA-1_6_C5	5.951963087	29.31804541	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	695	1041	0.003842459	0.005763689	0	oligos	OL-Cntl	NA	NA	NA
CTGGTCTTCACTTATC-1_6_C5	-13.96306637	-11.09455196	13B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2006	4225	0.012781065	0.001656805	0	13B	IN-SV2C	NA	NA	NA
CTGGTCTTCTTAGAGC-1_6_C5	2.947465233	-7.76818336	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1341	2057	0.021390374	0.004861449	0	12	EN-MIX	NA	NA	NA
CTGTGCTAGATCCGAG-1_6_C5	22.7612936	19.63007766	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1059	1668	0.001199041	0.001199041	0	oligos	OL-Cntl	NA	NA	NA
CTGTGCTAGGATCGCA-1_6_C5	22.95405347	19.28150354	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1096	1672	0.004784689	0.002392344	0	oligos	OL-Cntl	NA	NA	NA
CTGTGCTCAAAGTGCG-1_6_C5	-25.62964312	18.94891059	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1344	2197	0.00819299	0.002730997	0	8	Astrocytes	NA	NA	NA
CTGTGCTCATTGGTAC-1_6_C5	23.14139585	18.77711837	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1168	1873	0.003203417	0.003203417	0	oligos	OL-Cntl	NA	NA	NA
CTGTGCTTCAATCACG-1_6_C5	-27.74281055	17.60207172	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1077	1726	0.001738123	0.003476246	0	8	Astrocytes	NA	NA	NA
CTGTGCTTCATCTGTT-1_6_C5	25.05096389	-29.5637497	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3689	11023	0.001179352	0.005533884	0	3	EN-L5-6	NA	NA	NA
CTGTGCTTCCCAAGTA-1_6_C5	0.709747932	-11.28684675	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1788	3241	0.005553841	0.003085467	0	12	EN-MIX	NA	NA	NA
CTGTTTAAGCTCCTTC-1_6_C5	-15.86090863	-18.83432478	6B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1761	3614	0.035694521	0.002767017	0	6B	IN-SST	NA	NA	NA
CTGTTTAAGGTTACCT-1_6_C5	-28.00485481	18.19709627	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1101	1779	0.001124227	0.002810568	0	8	Astrocytes	NA	NA	NA
CTGTTTACACTTAAGC-1_6_C5	8.758718801	32.24305906	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	707	1112	0.000899281	0.001798561	0	oligos	OL-Cntl	NA	NA	NA
CTGTTTACAGCCTGTG-1_6_C5	24.68980767	-29.00478847	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3769	10706	0.006818606	0.008966934	0	3	EN-L5-6	NA	NA	NA
CTGTTTACAGGCAGTA-1_6_C5	-19.50406097	-27.59600937	6A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2618	5532	0.006688359	0.00253073	0	6A	IN-PV	NA	NA	NA
CTGTTTAGTAATCACC-1_6_C5	-3.938120011	-8.215454759	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	711	1022	0.030332681	0	0	13A	IN-VIP	NA	NA	NA
CTGTTTAGTACGACCC-1_6_C5	-34.86552349	-11.91666905	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	786	1206	0.000829187	0.002487562	0	9	OPC	NA	NA	NA
CTGTTTATCAGGCCCA-1_6_C5	-27.56166916	16.87301424	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	992	1535	0.000651466	0.003257329	0	8	Astrocytes	NA	NA	NA
CTGTTTATCTAAGCCA-1_6_C5	-9.915385131	22.32353721	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	946	1390	0.009352518	0.004316547	0	8	Astrocytes	NA	NA	NA
CTGTTTATCTTCTGGC-1_6_C5	1.853967927	-5.644277935	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1111	1860	0.005913978	0.001612903	0	12	EN-MIX	NA	NA	NA
CTTAACTAGATGTTAG-1_6_C5	18.03053109	21.32206581	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	843	1287	0.002331002	0.001554002	0	oligos	OL-Cntl	NA	NA	NA
CTTAACTAGCAGGTCA-1_6_C5	-34.53445487	-11.67176997	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	850	1505	0.002657807	0.005315615	0	9	OPC	NA	NA	NA
CTTAACTAGCGGATCA-1_6_C5	-37.39201195	-7.943888229	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	997	1643	0.001217285	0.003043214	0	9	OPC	NA	NA	NA
CTTAACTAGGCTACGA-1_6_C5	20.1251825	12.34095019	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1231	2137	0.001871783	0.003743566	0	oligos	OL-Cntl	NA	NA	NA
CTTAACTCAAATACAG-1_6_C5	0.347414573	-18.98086316	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2865	6684	0.006134051	0.003889886	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTTAACTCAATGCCAT-1_6_C5	11.25984102	30.66175939	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	668	1003	0	0.000997009	0	oligos	OL-Cntl	NA	NA	NA
CTTAACTCACTTCGAA-1_6_C5	-5.630980827	-4.262594985	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1221	1937	0.024780589	0.003097574	0	13A	IN-VIP	NA	NA	NA
CTTAACTGTAGCGCAA-1_6_C5	24.35431962	-29.59731139	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2887	7279	0.010166232	0.002335486	0	3	EN-L5-6	NA	NA	NA
CTTACCGAGCCATCGC-1_6_C5	-23.51950755	0.14865402	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2080	4004	0.000999001	0.002747253	0	9	OPC	NA	NA	NA
CTTACCGAGTCCGTAT-1_6_C5	24.98807188	0.053420013	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2239	4629	0.004104558	0.003672499	0	2	EN-L4	NA	NA	NA
CTTACCGCAACGATGG-1_6_C5	16.88585459	23.22616431	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	830	1339	0	0.004480956	0	oligos	OL-Cntl	NA	NA	NA
CTTACCGGTGCACTTA-1_6_C5	25.14103456	-29.62921614	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	4233	14389	0.003335882	0.003266384	0	3	EN-L5-6	NA	NA	NA
CTTACCGGTGGTTTCA-1_6_C5	1.769622347	-7.045851678	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1152	1796	0.002227171	0.00389755	0	12	EN-MIX	NA	NA	NA
CTTAGGAAGCCAGAAC-1_6_C5	25.36260665	-5.152659743	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	4849	17342	0.000691962	0.002133549	0	2	EN-L4	NA	NA	NA
CTTAGGACAATGCCAT-1_6_C5	-39.23452283	-2.233589472	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1141	2029	0.001971414	0.001478561	0	9	OPC	NA	NA	NA
CTTAGGATCCTAGGGC-1_6_C5	-30.30640732	20.32830902	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	970	1526	0.009174312	0.001965924	0	8	Astrocytes	NA	NA	NA
CTTAGGATCTGTCTCG-1_6_C5	-29.52501066	12.78165646	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	667	1020	0.000980392	0.000980392	0	8	Astrocytes	NA	NA	NA
CTTCTCTAGAAGGTTT-1_6_C5	-28.16665981	23.61273957	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1209	1996	0.007014028	0.006012024	0	8	Astrocytes	NA	NA	NA
CTTCTCTCAGCGAACA-1_6_C5	19.54983064	22.83670171	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1076	1806	0.009413068	0.007751938	0	oligos	OL-Cntl	NA	NA	NA
CTTCTCTCAGTTAACC-1_6_C5	0.730617043	-8.128600546	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1451	2550	0.009019608	0.002745098	0	12	EN-MIX	NA	NA	NA
CTTCTCTGTCATTAGC-1_6_C5	17.89061861	20.3848461	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	913	1485	0.002693603	0.002020202	0	oligos	OL-Cntl	NA	NA	NA
CTTCTCTTCCGCGTTT-1_6_C5	-34.27676867	-12.57197593	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	728	1129	0.00088574	0.003542958	0	9	OPC	NA	NA	NA
CTTGGCTAGATCCCGC-1_6_C5	2.179771918	-31.41236504	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	5331	18898	0.002381204	0.002592867	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTTGGCTAGCTCAACT-1_6_C5	-39.56466922	-2.207506815	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1379	2729	0.000732869	0.002931477	0	9	OPC	NA	NA	NA
CTTGGCTCAGTTCATG-1_6_C5	0.183390034	-11.55771225	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1830	3523	0.007096225	0.00567698	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTTGGCTCATTTGCCC-1_6_C5	0.463791882	-29.01917341	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3784	10421	0.003166683	0.002494962	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTTGGCTGTAAAGTCA-1_6_C5	-37.57481495	-1.108596162	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1534	2731	0.003295496	0.002196997	0	9	OPC	NA	NA	NA
CTTGGCTGTGGTAACG-1_6_C5	-14.57543792	-23.21810651	6A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1584	2682	0.017524236	0.004101417	0	6A	IN-PV	NA	NA	NA
CTTGGCTTCCACGTGG-1_6_C5	18.81975064	14.62040511	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1181	2144	0.003264925	0.003731343	0	oligos	OL-Cntl	NA	NA	NA
CTTTGCGAGCTCAACT-1_6_C5	-28.60430415	14.83544648	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	853	1323	0.002267574	0.000755858	0	8	Astrocytes	NA	NA	NA
CTTTGCGAGTCTCCTC-1_6_C5	-28.22307373	22.95120224	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1128	1934	0.002585315	0.005687694	0	8	Astrocytes	NA	NA	NA
CTTTGCGAGTGCGATG-1_6_C5	-12.79908616	-10.98685799	13B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1525	2694	0.02264291	0.001484781	0	13B	IN-SV2C	NA	NA	NA
CTTTGCGCATAAAGGT-1_6_C5	15.95334398	25.38435192	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	858	1322	0	0.002269289	0	oligos	OL-Cntl	NA	NA	NA
CTTTGCGGTGTTAAGA-1_6_C5	25.11257904	-0.55828037	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2420	4937	0.002228074	0.002633178	0	2	EN-L4	NA	NA	NA
CTTTGCGGTGTTTGGT-1_6_C5	0.945498541	-20.47523946	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3153	7461	0.008175848	0.005227181	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTTTGCGTCTTAGCCC-1_6_C5	0.983328308	-10.58310921	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1761	3069	0.001629195	0.007820137	0	12	EN-MIX	NA	NA	NA
GAAACTCAGAAGGTTT-1_6_C5	-0.427099655	-15.30453777	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2292	4736	0.008023649	0.003800676	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GAAACTCCACTACAGT-1_6_C5	10.04433979	30.16573266	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	768	1221	0	0.004095004	0	oligos	OL-Cntl	NA	NA	NA
GAAACTCCAGTAACGG-1_6_C5	2.513391817	-3.410002751	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	806	1233	0.00648824	0.00648824	0	12	EN-MIX	NA	NA	NA
GAAACTCCATAGACTC-1_6_C5	11.62685169	27.26657805	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	858	1298	0.000770416	0.005392912	0	oligos	OL-Cntl	NA	NA	NA
GAAACTCGTCGCATAT-1_6_C5	18.8527256	22.82890015	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	936	1439	0	0.002084781	0	oligos	OL-Cntl	NA	NA	NA
GAAACTCTCTTCGGTC-1_6_C5	7.539210991	-7.125534947	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1532	2950	0.005084746	0.002372881	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GAAACTCTCTTTAGGG-1_6_C5	-7.309440908	-0.731255714	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1888	3576	0.009228188	0.003355705	0	13A	IN-VIP	NA	NA	NA
GAAATGAAGAGTACCG-1_6_C5	-1.412487317	-1.336779818	6A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2489	5170	0.008704062	0.003288201	0	6A	IN-PV	NA	NA	NA
GAAATGACAACTGCGC-1_6_C5	-37.50290934	-7.414056135	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1120	1854	0.001618123	0.001618123	0	9	OPC	NA	NA	NA
GAAATGACATCGGTTA-1_6_C5	8.425114656	-8.057868176	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2040	4079	0.007109586	0.001470949	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GAAATGACATCTCCCA-1_6_C5	21.52416899	12.47773314	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1360	2296	0.00304878	0.004355401	0	oligos	OL-Cntl	NA	NA	NA
GAAATGAGTAGGAGTC-1_6_C5	20.92098679	1.622829399	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1261	2127	0.004701457	0.001410437	0	2	EN-L4	NA	NA	NA
GAAATGAGTCACCCAG-1_6_C5	-0.462165368	-14.95220261	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2306	4890	0.006134969	0.002862986	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GAAATGAGTCGAATCT-1_6_C5	26.20740567	-29.92168837	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3272	8893	0.000449792	0.002473856	0	3	EN-L5-6	NA	NA	NA
GAAATGAGTCTGATCA-1_6_C5	19.88468152	-6.959842866	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2402	5778	0.009691935	0.002596054	0	3	EN-L5-6	NA	NA	NA
GAAATGAGTTTGGGCC-1_6_C5	-7.677395392	0.664243311	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1955	3599	0.027785496	0.003612114	0	13A	IN-VIP	NA	NA	NA
GAAATGATCTGACCTC-1_6_C5	14.32785913	-33.36172238	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	4312	13953	0.00344012	0.003081775	0	3	EN-L5-6	NA	NA	NA
GAACATCAGAATTCCC-1_6_C5	18.18362542	23.36840127	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	866	1356	0.000737463	0.002949853	0	oligos	OL-Cntl	NA	NA	NA
GAACATCAGTGAACGC-1_6_C5	-27.35396647	-6.800627379	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1031	1499	0.007338225	0.004002668	0	9	OPC	NA	NA	NA
GAACATCCACCACGTG-1_6_C5	-25.86855917	19.12900161	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1303	2225	0.001797753	0.002247191	0	8	Astrocytes	NA	NA	NA
GAACATCCACGGTTTA-1_6_C5	12.36217929	31.2156151	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	678	1072	0.000932836	0.003731343	0	oligos	OL-Cntl	NA	NA	NA
GAACATCTCAGCCTAA-1_6_C5	-5.574175412	-2.433965554	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1610	3006	0.004657352	0.001996008	0	13A	IN-VIP	NA	NA	NA
GAACCTAAGTATCTCG-1_6_C5	-9.337886957	-19.58806663	6B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	803	1261	0.057890563	0.00555115	0	6B	IN-SST	NA	NA	NA
GAACCTACAAACAACA-1_6_C5	-20.14339468	-28.44486848	6A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3490	9055	0.016565433	0.003754832	0	6A	IN-PV	NA	NA	NA
GAACCTATCATCTGTT-1_6_C5	-15.78521836	-11.14314502	13B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2841	6660	0.02042042	0.001951952	0	13B	IN-SV2C	NA	NA	NA
GAACGGACACCAGGTC-1_6_C5	15.49723638	25.87450642	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	829	1297	0.00077101	0.00077101	0	oligos	OL-Cntl	NA	NA	NA
GAACGGAGTGGACGAT-1_6_C5	25.37555413	-2.26720449	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2676	5869	0.009371273	0.001533481	0	2	EN-L4	NA	NA	NA
GAACGGAGTGTTTGTG-1_6_C5	13.11051049	-9.536707424	4	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3358	7082	0.021462864	0.003388873	0	L2-3	EN-L2-3-MS	NA	NA	NA
GAACGGATCCTGTACC-1_6_C5	22.06717679	20.23866281	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1011	1605	0.001246106	0.003738318	0	oligos	OL-Cntl	NA	NA	NA
GAAGCAGCATGTCTCC-1_6_C5	3.25057823	-32.49657524	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	5638	19429	0.001441145	0.002470534	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GAAGCAGGTGGTTTCA-1_6_C5	12.27403459	28.96128679	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	779	1190	0.001680672	0.004201681	0	oligos	OL-Cntl	NA	NA	NA
GAAGCAGTCGGAAATA-1_6_C5	4.99567462	30.40479199	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	694	1026	0	0.005847953	0	oligos	OL-Cntl	NA	NA	NA
GAATAAGAGCCGATTT-1_6_C5	1.292494903	-8.63151268	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1378	2256	0.003546099	0.005319149	0	12	EN-MIX	NA	NA	NA
GAATAAGAGGCTAGGT-1_6_C5	-7.213417496	-0.694219638	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1837	3496	0.014874142	0.00228833	0	13A	IN-VIP	NA	NA	NA
GAATAAGAGGGTCGAT-1_6_C5	-33.86653699	-13.35651766	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	713	1076	0.007434944	0.002788104	0	9	OPC	NA	NA	NA
GAATAAGCAAACAACA-1_6_C5	-33.88348961	-12.76606926	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	683	1006	0.000994036	0.004970179	0	9	OPC	NA	NA	NA
GAATAAGCACGAGGTA-1_6_C5	14.64160247	30.16920094	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	828	1193	0.004191115	0.003352892	0	oligos	OL-Cntl	NA	NA	NA
GAATAAGCACTCGACG-1_6_C5	-1.054961694	-23.89337754	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3497	9176	0.005666957	0.003814298	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GAATAAGGTGCTCTTC-1_6_C5	-0.253851336	-17.21074609	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2433	5004	0.010391687	0.002797762	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GAATAAGGTTCCGTCT-1_6_C5	2.421123783	-7.690548531	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1318	2119	0.009438414	0.007078811	0	12	EN-MIX	NA	NA	NA
GAATAAGTCACCCTCA-1_6_C5	13.72343629	31.05549168	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	783	1168	0.003424658	0.002568493	0	oligos	OL-Cntl	NA	NA	NA
GAATGAACAGTCAGCC-1_6_C5	-25.3264022	20.3951938	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1569	2808	0.001424501	0.001780627	0	8	Astrocytes	NA	NA	NA
GAATGAATCGCCGTGA-1_6_C5	-19.8687572	-27.36667065	6A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2934	6654	0.010219417	0.005259994	0	6A	IN-PV	NA	NA	NA
GAATGAATCGTGGTCG-1_6_C5	29.68008286	-3.313420035	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	4274	12519	0.015736081	0.002635993	0	2	EN-L4	NA	NA	NA
GACACGCAGACGACGT-1_6_C5	-28.06928476	17.92431851	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1092	1719	0.005235602	0.002326934	0	8	Astrocytes	NA	NA	NA
GACACGCCAGGAATGC-1_6_C5	-26.0933814	20.15100392	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1415	2455	0.00203666	0.004480652	0	8	Astrocytes	NA	NA	NA
GACACGCCATTCTTAC-1_6_C5	20.9880537	23.65973999	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1131	1760	0.002840909	0.005113636	0	oligos	OL-Cntl	NA	NA	NA
GACACGCGTGATGATA-1_6_C5	17.40503083	24.14582564	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	839	1307	0.004590666	0.003060444	0	oligos	OL-Cntl	NA	NA	NA
GACACGCGTGTGCCTG-1_6_C5	-26.33864939	9.731659215	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	799	1144	0.001748252	0.003496503	0	8	Astrocytes	NA	NA	NA
GACAGAGAGACAAGCC-1_6_C5	4.451216907	31.44680048	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	749	1106	0.003616637	0	0	oligos	OL-Cntl	NA	NA	NA
GACAGAGAGATCGGGT-1_6_C5	-32.87028575	-13.16335631	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	763	1114	0	0.008078995	0	9	OPC	NA	NA	NA
GACAGAGAGTAACCCT-1_6_C5	12.20060706	29.10411748	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	800	1225	0.010612245	0.004897959	0	oligos	OL-Cntl	NA	NA	NA
GACAGAGAGTGCAAGC-1_6_C5	24.23005166	-6.343988404	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3170	6284	0.002705283	0.001909612	0	2	EN-L4	NA	NA	NA
GACAGAGCATAGTAAG-1_6_C5	5.18371566	26.15269051	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	840	1238	0.002423263	0	0	oligos	OL-Cntl	NA	NA	NA
GACAGAGGTAAATACG-1_6_C5	-24.5966287	11.34325319	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	991	1513	0	0.003304693	0	8	Astrocytes	NA	NA	NA
GACAGAGGTGTGCCTG-1_6_C5	-0.07458772	30.18990442	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	780	1119	0.00357462	0.00178731	0	oligos	OL-Cntl	NA	NA	NA
GACAGAGGTTACCGAT-1_6_C5	18.94766411	21.85028427	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1011	1647	0.003035823	0.004250152	0	oligos	OL-Cntl	NA	NA	NA
GACAGAGGTTCCTCCA-1_6_C5	-7.052117658	-0.431115939	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2009	3796	0.008956797	0.002634352	0	13A	IN-VIP	NA	NA	NA
GACAGAGGTTGTCGCG-1_6_C5	9.054560393	32.19619322	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	745	1070	0.000934579	0.003738318	0	oligos	OL-Cntl	NA	NA	NA
GACCAATAGATCGATA-1_6_C5	0.716892126	24.44159054	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	770	1064	0.005639098	0.004699248	0	oligos	OL-Cntl	NA	NA	NA
GACCAATAGTCACGCC-1_6_C5	0.066505908	-14.3589155	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2114	4278	0.004675082	0.002337541	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GACCAATCACCACGTG-1_6_C5	-12.22874497	-33.19226942	16	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1641	3161	0.174944638	0.003796267	0	16	EN-PYR	NA	NA	NA
GACCAATCACCTGGTG-1_6_C5	2.135334702	-13.727279	4	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2121	4095	0.012210012	0.007814408	0	L2-3	EN-L2-3-MS	NA	NA	NA
GACCAATCAGCTCGAC-1_6_C5	23.01151342	-9.314345297	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2948	6491	0.003697427	0.003235249	0	3	EN-L5-6	NA	NA	NA
GACCAATCATGTAGTC-1_6_C5	17.55752894	18.98410166	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1052	1720	0.001744186	0.008139535	0	oligos	OL-Cntl	NA	NA	NA
GACCAATTCGGCGCAT-1_6_C5	1.149952011	-10.41632903	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1598	2753	0.013076644	0.006901562	0	12	EN-MIX	NA	NA	NA
GACCAATTCTCGATGA-1_6_C5	-6.962333661	-0.77883354	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1979	3853	0.00389307	0.002076304	0	13A	IN-VIP	NA	NA	NA
GACCTGGAGAATGTTG-1_6_C5	-37.50820759	-7.569613353	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1120	1940	0.000515464	0	0	9	OPC	NA	NA	NA
GACCTGGCAGCGTCCA-1_6_C5	4.823837377	5.866767804	7	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1634	2628	0.002663623	0.005707763	0	7	Phagocytes	NA	NA	NA
GACCTGGCATCGGACC-1_6_C5	31.80695159	-2.298650756	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2792	5760	0.008333333	0.003125	0	2	EN-L4	NA	NA	NA
GACCTGGCATGGTCAT-1_6_C5	-15.11933967	-25.48394376	6A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1613	3058	0.008502289	0.001635056	0	6A	IN-PV	NA	NA	NA
GACCTGGGTGTGGCTC-1_6_C5	-26.95106576	18.59723014	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1250	2060	0.000970874	0.005825243	0	8	Astrocytes	NA	NA	NA
GACCTGGTCAAACGGG-1_6_C5	-23.0447157	19.04354526	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1434	2413	0.001243266	0.005801906	0	8	Astrocytes	NA	NA	NA
GACCTGGTCGTGGACC-1_6_C5	-15.80098164	-9.838163524	13B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2481	5020	0.008964143	0.003585657	0	13B	IN-SV2C	NA	NA	NA
GACCTGGTCTCTGTCG-1_6_C5	10.57822624	31.14535116	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	719	1034	0	0.000967118	0	oligos	OL-Cntl	NA	NA	NA
GACCTGGTCTGGGCCA-1_6_C5	4.272153846	-27.81429175	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3719	10571	0.004162331	0.003500142	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GACCTGGTCTTATCTG-1_6_C5	18.38580064	18.69516007	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1121	1764	0.001133787	0.002834467	0	oligos	OL-Cntl	NA	NA	NA
GACGCGTCAAAGTGCG-1_6_C5	23.77357058	-8.610009025	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3729	9469	0.008343014	0.002745802	0	3	EN-L5-6	NA	NA	NA
GACGCGTCATGCCTTC-1_6_C5	-16.41848647	-10.27538258	13B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2913	6167	0.006323982	0.003405221	0	13B	IN-SV2C	NA	NA	NA
GACGCGTGTCCAGTAT-1_6_C5	0.170019769	25.13529671	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	722	1027	0.00194742	0.00292113	0	oligos	OL-Cntl	NA	NA	NA
GACGGCTAGAGCCTAG-1_6_C5	25.8468502	0.467088943	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2380	4918	0.001016673	0.001626678	0	2	EN-L4	NA	NA	NA
GACGGCTAGCTTTGGT-1_6_C5	-37.57214129	-2.962523203	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1307	2162	0.004625347	0.002775208	0	9	OPC	NA	NA	NA
GACGGCTAGTCTCCTC-1_6_C5	-30.44739638	20.57259785	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	900	1426	0.001402525	0.002103787	0	8	Astrocytes	NA	NA	NA
GACGGCTCAGGGTACA-1_6_C5	22.76048571	18.9750283	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1137	1721	0.001743173	0.00232423	0	oligos	OL-Cntl	NA	NA	NA
GACGGCTGTACCGTAT-1_6_C5	-16.32524186	-10.50643168	13B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2841	6005	0.004329725	0.004829309	0	13B	IN-SV2C	NA	NA	NA
GACGGCTGTGGCAAAC-1_6_C5	18.53414387	8.724323808	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1614	2792	0.00752149	0.006088825	0	oligos	OL-Cntl	NA	NA	NA
GACGGCTTCGCCATAA-1_6_C5	5.818723457	-32.27642255	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	4272	13554	0.001180463	0.001844474	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GACGGCTTCGGAAACG-1_6_C5	-7.948041581	-0.495895743	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2190	4037	0.007431261	0.004706465	0	13A	IN-VIP	NA	NA	NA
GACGTGCAGACAGGCT-1_6_C5	12.11902761	32.81300963	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	723	1010	0.001980198	0.003960396	0	oligos	OL-Cntl	NA	NA	NA
GACGTGCAGCCACGCT-1_6_C5	3.247405575	-17.30286706	4	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2946	5957	0.013261709	0.009232835	0	L2-3	EN-L2-3-MS	NA	NA	NA
GACGTGCCACCGATAT-1_6_C5	13.93855193	30.58472534	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	854	1273	0.005498822	0.005498822	0	oligos	OL-Cntl	NA	NA	NA
GACGTGCCAGTATCTG-1_6_C5	-27.81651773	22.29616561	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1166	1971	0.00456621	0.002029427	0	8	Astrocytes	NA	NA	NA
GACGTGCGTACCGCTG-1_6_C5	0.269813116	-16.55105153	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2507	5449	0.013580473	0.002202239	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GACGTGCGTCACTGGC-1_6_C5	-38.38189257	-0.438055061	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1332	2176	0.001838235	0.000459559	0	9	OPC	NA	NA	NA
GACGTTAAGAAGGCCT-1_6_C5	-14.183177	-24.7762732	6A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1465	2734	0.014630578	0.003657644	0	6A	IN-PV	NA	NA	NA
GACGTTAAGGTGCTTT-1_6_C5	18.1353584	18.93470797	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1042	1626	0.004920049	0.003690037	0	oligos	OL-Cntl	NA	NA	NA
GACTAACAGTGAAGTT-1_6_C5	-36.7089592	-2.860191362	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1405	2326	0.002149613	0.003439381	0	9	OPC	NA	NA	NA
GACTAACCAACTGGCC-1_6_C5	23.07335815	-9.088067243	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3018	7357	0.003669974	0.0021748	0	3	EN-L5-6	NA	NA	NA
GACTAACCACAGACAG-1_6_C5	0.798744412	-16.93791693	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2839	5972	0.003014066	0.006865372	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GACTAACGTAATTGGA-1_6_C5	4.291302769	-3.947698969	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1000	1467	0.018404908	0.003408316	0	12	EN-MIX	NA	NA	NA
GACTAACTCAACTCTT-1_6_C5	19.44451599	10.13138669	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1526	2820	0.00212766	0.002836879	0	oligos	OL-Cntl	NA	NA	NA
GACTACAAGAATAGGG-1_6_C5	-28.38918692	14.90679775	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	910	1351	0.000740192	0.006661732	0	8	Astrocytes	NA	NA	NA
GACTACACAAACCCAT-1_6_C5	16.26614467	0.441000613	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	699	1031	0.003879728	0.002909796	0	12	EN-MIX	NA	NA	NA
GACTACAGTTTACTCT-1_6_C5	0.91038528	-11.65773481	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1807	3406	0.010275984	0.00645919	0	12	EN-MIX	NA	NA	NA
GACTACATCCTCTAGC-1_6_C5	0.04185855	-20.20481499	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3029	6746	0.008004744	0.007263564	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GACTACATCTAACTTC-1_6_C5	0.212086334	-11.71249939	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1790	3352	0.005071599	0.004176611	0	12	EN-MIX	NA	NA	NA
GACTACATCTACTTAC-1_6_C5	-29.48396675	13.11284707	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	757	1152	0.000868056	0.002604167	0	8	Astrocytes	NA	NA	NA
GACTGCGAGACCTAGG-1_6_C5	5.628624059	32.33109487	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	739	1082	0.004621072	0.004621072	0	oligos	OL-Cntl	NA	NA	NA
GACTGCGAGGAACTGC-1_6_C5	-21.01155847	9.043422353	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	831	1150	0.003478261	0.00173913	0	8	Astrocytes	NA	NA	NA
GACTGCGCAAATTGCC-1_6_C5	-22.66940648	31.44192758	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2483	5276	0.004169826	0.002084913	0	8	Astrocytes	NA	NA	NA
GACTGCGCAAGAAGAG-1_6_C5	7.474204093	33.80734907	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	931	1476	0.00203252	0.002710027	0	oligos	OL-Cntl	NA	NA	NA
GACTGCGCATAGGATA-1_6_C5	-26.65867242	19.9152151	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1377	2446	0.002452984	0.002452984	0	8	Astrocytes	NA	NA	NA
GACTGCGCATGAGCGA-1_6_C5	1.005888513	-28.82912204	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	5651	18381	0.001577716	0.005549208	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GACTGCGGTAGCCTAT-1_6_C5	-27.60918494	25.53287346	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1273	2281	0.000438404	0.005699255	0	8	Astrocytes	NA	NA	NA
GACTGCGTCCGAGCCA-1_6_C5	15.13897843	2.931530044	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	823	1248	0.007211538	0.00400641	0	12	EN-MIX	NA	NA	NA
GACTGCGTCTCGCATC-1_6_C5	3.522978229	-3.634036941	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	844	1215	0.005761317	0.003292181	0	12	EN-MIX	NA	NA	NA
GAGCAGAAGATCTGCT-1_6_C5	-31.95884131	12.07081884	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	761	1199	0.009174312	0	0	8	Astrocytes	NA	NA	NA
GAGCAGAAGCCAGGAT-1_6_C5	2.988363825	-26.24623101	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	4865	14057	0.004410614	0.003130113	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GAGCAGAAGGCACATG-1_6_C5	12.21838884	28.48478456	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	763	1127	0.001774623	0.003549246	0	oligos	OL-Cntl	NA	NA	NA
GAGCAGACAATCCAAC-1_6_C5	2.231905626	-10.90092478	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1690	3007	0.012969737	0.005653475	0	12	EN-MIX	NA	NA	NA
GAGCAGACAGGAACGT-1_6_C5	4.450840295	31.50368175	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	704	1052	0.001901141	0.004752852	0	oligos	OL-Cntl	NA	NA	NA
GAGCAGACATTGCGGC-1_6_C5	-27.50581948	4.414762005	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2257	4355	0.00206659	0.001607348	0	9	OPC	NA	NA	NA
GAGCAGAGTCGCATCG-1_6_C5	31.88158323	-2.59232087	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2905	5933	0.00842744	0.002696781	0	2	EN-L4	NA	NA	NA
GAGCAGAGTGAAAGAG-1_6_C5	0.492871301	-15.96762647	4	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2327	4794	0.006257822	0.003754693	0	L2-3	EN-L2-3-MS	NA	NA	NA
GAGCAGATCATCTGCC-1_6_C5	19.02223887	9.64518093	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1491	2898	0.002760524	0.001725328	0	oligos	OL-Cntl	NA	NA	NA
GAGGTGAAGGAGTCTG-1_6_C5	2.285467177	-5.914000691	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1101	1642	0.001218027	0.002436054	0	12	EN-MIX	NA	NA	NA
GAGGTGAAGGATGGAA-1_6_C5	-35.20252617	-11.54494808	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	832	1268	0.003154574	0.005520505	0	9	OPC	NA	NA	NA
GAGGTGAAGGTCATCT-1_6_C5	-28.54401245	13.91163945	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	878	1333	0.009002251	0.003750938	0	8	Astrocytes	NA	NA	NA
GAGGTGACAATGGAGC-1_6_C5	2.997522732	-32.53666692	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	5275	17173	0.000582309	0.002620392	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GAGGTGACACCGCTAG-1_6_C5	11.58145144	26.15057967	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	814	1199	0	0.002502085	0	oligos	OL-Cntl	NA	NA	NA
GAGGTGAGTAAGCACG-1_6_C5	-35.47749398	-10.85744739	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	887	1377	0.002904866	0.005083515	0	9	OPC	NA	NA	NA
GAGTCCGCACCACGTG-1_6_C5	15.41851356	1.663103911	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1198	2151	0.006508601	0.0032543	0	12	EN-MIX	NA	NA	NA
GAGTCCGCAGCTGCAC-1_6_C5	19.49153229	15.40318015	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1107	1798	0.001112347	0.002224694	0	oligos	OL-Cntl	NA	NA	NA
GAGTCCGCATGTCGAT-1_6_C5	0.31824732	-11.65976282	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1934	3622	0.002208724	0.005521811	0	12	EN-MIX	NA	NA	NA
GAGTCCGGTAAGAGAG-1_6_C5	-14.26919961	-24.86886477	6A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1427	2519	0	0.002381898	0	6A	IN-PV	NA	NA	NA
GAGTCCGGTTCGAATC-1_6_C5	17.07585307	24.5376191	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	837	1305	0	0.000766284	0	oligos	OL-Cntl	NA	NA	NA
GAGTCCGTCGTTTAGG-1_6_C5	-16.14099931	-9.725792078	13B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2652	5483	0.004924312	0.00474193	0	13B	IN-SV2C	NA	NA	NA
GAGTCCGTCTTCATGT-1_6_C5	13.86326029	30.5424656	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	782	1100	0.001818182	0.002727273	0	oligos	OL-Cntl	NA	NA	NA
GAGTCCGTCTTGCAAG-1_6_C5	-1.113802541	-17.12292416	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2552	5459	0.012822861	0.003297307	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GATCAGTAGGCTCATT-1_6_C5	-9.65320564	3.054759816	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3081	7213	0.007625121	0.005129627	0	13A	IN-VIP	NA	NA	NA
GATCAGTAGTCCATAC-1_6_C5	13.16494017	28.87242067	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	772	1212	0	0.004950495	0	oligos	OL-Cntl	NA	NA	NA
GATCAGTCAAACTGTC-1_6_C5	-13.13130429	19.42624641	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1638	3110	0.00096463	0.003536977	0	8	Astrocytes	NA	NA	NA
GATCAGTCAAGTCTGT-1_6_C5	0.945544281	-27.67141341	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3699	10385	0.002599904	0.002599904	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GATCAGTCAGCGTCCA-1_6_C5	-27.92782869	23.88029386	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1188	2022	0.001978239	0.003956479	0	8	Astrocytes	NA	NA	NA
GATCAGTGTACGCTGC-1_6_C5	8.289682919	34.68250801	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	842	1203	0.002493766	0.005818786	0	oligos	OL-Cntl	NA	NA	NA
GATCAGTGTGAGGGTT-1_6_C5	9.076850416	31.02373947	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	745	1118	0.003577818	0.002683363	0	oligos	OL-Cntl	NA	NA	NA
GATCAGTGTGTTTGTG-1_6_C5	-17.99510434	-17.68807192	6B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2158	4125	0.005575758	0.003878788	0	6B	IN-SST	NA	NA	NA
GATCAGTTCAGCACAT-1_6_C5	-34.84435495	-10.8749784	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	804	1240	0.004032258	0.001612903	0	9	OPC	NA	NA	NA
GATCGATCACTACAGT-1_6_C5	20.13701501	19.94777293	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1048	1714	0.004667445	0.002917153	0	oligos	OL-Cntl	NA	NA	NA
GATCGATCATAGAAAC-1_6_C5	30.00620209	-2.543974251	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3221	7661	0.008745595	0.002741157	0	2	EN-L4	NA	NA	NA
GATCGATTCTGAAAGA-1_6_C5	1.069348928	-21.4682708	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3736	9364	0.007368646	0.002883383	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GATCGCGAGCCCAGCT-1_6_C5	-27.15031942	25.72119499	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1326	2470	0.001619433	0.002834008	0	8	Astrocytes	NA	NA	NA
GATCGCGAGCCTATGT-1_6_C5	-34.27413657	-12.71305828	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	700	1023	0.001955034	0.001955034	0	9	OPC	NA	NA	NA
GATCGCGGTACCTACA-1_6_C5	19.2952707	21.49557631	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	988	1619	0.002470661	0.003088326	0	oligos	OL-Cntl	NA	NA	NA
GATCGCGGTATCACCA-1_6_C5	-13.27449029	4.680756748	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2311	4525	0.011270718	0.001325967	0	8	Astrocytes	NA	NA	NA
GATCGCGTCCCTTGTG-1_6_C5	19.33089053	19.35987127	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1016	1708	0.00117096	0.004098361	0	oligos	OL-Cntl	NA	NA	NA
GATCGTACACCTTGTC-1_6_C5	12.001511	26.49730166	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	796	1191	0.005877414	0.003358522	0	oligos	OL-Cntl	NA	NA	NA
GATCGTATCAGTCCCT-1_6_C5	19.53823342	15.37621895	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1223	1982	0.002018163	0.00605449	0	oligos	OL-Cntl	NA	NA	NA
GATCTAGAGATATGGT-1_6_C5	-13.84671132	-11.34144984	13B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2214	5104	0.024098746	0.000979624	0	13B	IN-SV2C	NA	NA	NA
GATCTAGCACGTGAGA-1_6_C5	22.09982418	18.86549382	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1023	1552	0.004510309	0.004510309	0	oligos	OL-Cntl	NA	NA	NA
GATCTAGCATCCAACA-1_6_C5	-37.54314978	-6.909954629	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1142	1953	0.004096262	0.004096262	0	9	OPC	NA	NA	NA
GATCTAGGTCGTGGCT-1_6_C5	12.95360401	-7.374467889	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2479	5252	0.005902513	0.002284844	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GATCTAGTCACTATTC-1_6_C5	18.7677032	21.31482189	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	950	1540	0.001948052	0.001298701	0	oligos	OL-Cntl	NA	NA	NA
GATGAAAAGAAACCAT-1_6_C5	18.43990525	24.71020079	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	954	1410	0.002836879	0.002836879	0	oligos	OL-Cntl	NA	NA	NA
GATGAAAAGTCATCCA-1_6_C5	27.04611188	0.355293823	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2862	7343	0.002451314	0.001225657	0	2	EN-L4	NA	NA	NA
GATGAAACAAAGAATC-1_6_C5	-20.69891785	-23.78916777	6A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2246	4365	0.025887743	0.002749141	0	6A	IN-PV	NA	NA	NA
GATGAAACAGTCAGCC-1_6_C5	-15.7854724	-10.8567483	13B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2658	5763	0.022384175	0.002082249	0	13B	IN-SV2C	NA	NA	NA
GATGAAACATTTCAGG-1_6_C5	10.64558466	-8.031965322	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2302	5140	0.00155642	0.001945525	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GATGAAAGTAAAGTCA-1_6_C5	-25.3211481	20.15981629	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1436	2554	0.003132341	0.005090055	0	8	Astrocytes	NA	NA	NA
GATGAAAGTTACGTCA-1_6_C5	-17.60063237	-24.61760087	6A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2038	4225	0.003313609	0.001656805	0	6A	IN-PV	NA	NA	NA
GATGAAATCACCAGGC-1_6_C5	-23.1944927	14.35877469	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1005	1549	0.009683667	0.002582311	0	8	Astrocytes	NA	NA	NA
GATGAAATCGCTAGCG-1_6_C5	14.45860475	-33.43196554	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	4490	15015	0.000532801	0.002331002	0	3	EN-L5-6	NA	NA	NA
GATGAAATCTCTTATG-1_6_C5	-5.667805121	-5.803312397	13B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1161	2001	0.010994503	0.001999	0	13B	IN-SV2C	NA	NA	NA
GATGAGGAGATCACGG-1_6_C5	-27.65041637	17.49581385	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1043	1585	0.00126183	0.002523659	0	8	Astrocytes	NA	NA	NA
GATGAGGAGCAGCGTA-1_6_C5	5.038202465	27.45479587	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	804	1132	0.001766784	0.001766784	0	oligos	OL-Cntl	NA	NA	NA
GATGAGGAGCGTTCCG-1_6_C5	1.452375986	-27.71878449	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3505	8652	0.004276468	0.002889505	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GATGAGGCAGCCTATA-1_6_C5	-0.681007105	-14.08194218	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1975	3936	0.005843496	0.006097561	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GATGAGGGTCTAGTGT-1_6_C5	10.40425076	25.19363001	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	872	1239	0.00322841	0.011299435	0	oligos	OL-Cntl	NA	NA	NA
GATGAGGGTGACTACT-1_6_C5	11.32273958	26.07892351	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	873	1314	0.002283105	0.00761035	0	oligos	OL-Cntl	NA	NA	NA
GATGAGGGTTGCGCAC-1_6_C5	15.68657672	28.74424089	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	779	1157	0.000864304	0.002592913	0	oligos	OL-Cntl	NA	NA	NA
GATGCTAAGGCAGTCA-1_6_C5	10.89189829	-8.172668661	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2148	4364	0.004124656	0.002062328	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GATGCTAAGTAGGCCA-1_6_C5	21.54923412	-8.537292171	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1673	2633	0.005317129	0.005317129	0	3	EN-L5-6	NA	NA	NA
GATGCTAAGTGTTTGC-1_6_C5	18.57875024	-6.71418721	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1772	3842	0.004424779	0.00234253	0	3	EN-L5-6	NA	NA	NA
GATGCTACATATGCTG-1_6_C5	15.52991929	-1.654553892	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	941	1517	0.018457482	0	0	12	EN-MIX	NA	NA	NA
GATGCTAGTGAAGGCT-1_6_C5	5.744662354	33.42439899	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	722	1031	0	0.001939864	0	oligos	OL-Cntl	NA	NA	NA
GATGCTAGTTACGCGC-1_6_C5	9.925910414	30.90469226	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	729	1060	0.000943396	0.002830189	0	oligos	OL-Cntl	NA	NA	NA
GATGCTATCCGCGTTT-1_6_C5	-39.2455232	-2.647477778	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1141	2017	0.000495786	0.003966287	0	9	OPC	NA	NA	NA
GATGCTATCGCGTAGC-1_6_C5	-37.099994	-6.067911009	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1116	1781	0.000561482	0.003368894	0	9	OPC	NA	NA	NA
GATGCTATCTTGTCAT-1_6_C5	-24.9777978	26.15466948	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1523	2879	0.004515457	0.004515457	0	8	Astrocytes	NA	NA	NA
GATTCAGAGCCCGAAA-1_6_C5	-30.27807782	20.50479334	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	862	1348	0.007418398	0.002225519	0	8	Astrocytes	NA	NA	NA
GATTCAGGTCAATGTC-1_6_C5	12.29651925	28.41578495	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	745	1140	0.001754386	0.003508772	0	oligos	OL-Cntl	NA	NA	NA
GCAAACTAGCTCAACT-1_6_C5	-12.13999138	-0.535400584	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2936	6279	0.011944577	0.005892658	0	13A	IN-VIP	NA	NA	NA
GCAAACTCACTTAAGC-1_6_C5	11.09741682	31.30332941	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	756	1128	0	0.003546099	0	oligos	OL-Cntl	NA	NA	NA
GCAAACTCATATGAGA-1_6_C5	3.662005315	31.6824979	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	750	1115	0.000896861	0.004484305	0	oligos	OL-Cntl	NA	NA	NA
GCAAACTGTAAACGCG-1_6_C5	8.122932191	-31.97897286	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	4012	11058	0.005697233	0.003074697	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCAAACTGTACCCAAT-1_6_C5	23.31820658	15.06359476	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1237	2034	0.002949853	0.005408063	0	oligos	OL-Cntl	NA	NA	NA
GCAAACTGTCCTAGCG-1_6_C5	-11.49267199	-22.37919823	6A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	969	1690	0.007692308	0.001775148	0	6A	IN-PV	NA	NA	NA
GCAAACTGTCTGCAAT-1_6_C5	-4.147778287	-5.309499274	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1124	1986	0.006042296	0.004028197	0	13A	IN-VIP	NA	NA	NA
GCAAACTGTGAGGCTA-1_6_C5	-30.38483988	20.84564375	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	958	1516	0.000659631	0.002638522	0	8	Astrocytes	NA	NA	NA
GCAAACTGTGAGGGTT-1_6_C5	23.4413835	-9.841000939	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3158	6948	0.002590674	0.00388601	0	3	EN-L5-6	NA	NA	NA
GCAAACTGTTGCCTCT-1_6_C5	13.3841427	1.671418506	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	939	1626	0.003690037	0.004920049	0	12	EN-MIX	NA	NA	NA
GCAAACTGTTGTTTGG-1_6_C5	-10.54901493	9.696656588	11	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3569	8898	0.004158238	0.004607777	0	11	Glia-MIX	NA	NA	NA
GCAAACTTCAATCACG-1_6_C5	19.95284664	21.15375685	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	884	1389	0.001439885	0.001439885	0	oligos	OL-Cntl	NA	NA	NA
GCAATCAAGACTTTCG-1_6_C5	20.27161941	11.90926505	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1378	2321	0.004739336	0.005170185	0	oligos	OL-Cntl	NA	NA	NA
GCAATCAAGCGACGTA-1_6_C5	2.735523885	-7.448376427	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1390	2225	0.008539326	0.006741573	0	12	EN-MIX	NA	NA	NA
GCAATCAAGCTAACAA-1_6_C5	18.98599246	14.17545182	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1210	2040	0.002941176	0.000980392	0	oligos	OL-Cntl	NA	NA	NA
GCAATCACAATAAGCA-1_6_C5	13.31106874	31.19527787	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	770	1133	0.005295675	0.000882613	0	oligos	OL-Cntl	NA	NA	NA
GCAATCACATCATCCC-1_6_C5	-14.06653187	-18.49728094	6B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1312	2284	0.006567426	0.003502627	0	6B	IN-SST	NA	NA	NA
GCAATCACATGCCTAA-1_6_C5	-20.07500951	-25.83335942	6A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2581	5765	0.017692975	0.004509974	0	6A	IN-PV	NA	NA	NA
GCAATCAGTGAACCTT-1_6_C5	1.667937761	-17.60415303	4	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2883	6425	0.010894942	0.009649805	0	L2-3	EN-L2-3-MS	NA	NA	NA
GCAATCAGTTATTCTC-1_6_C5	-1.767691779	-18.23910652	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2781	6340	0.001104101	0.00362776	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCAATCAGTTCTGGTA-1_6_C5	1.433525068	-16.68433422	4	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2352	4651	0.010535369	0.005805203	0	L2-3	EN-L2-3-MS	NA	NA	NA
GCAATCATCCGTAGTA-1_6_C5	32.46918655	-3.615135745	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3028	6641	0.013251016	0.002559855	0	2	EN-L4	NA	NA	NA
GCAATCATCTGTGCAA-1_6_C5	11.30706042	27.84390695	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	821	1239	0.002421308	0.00322841	0	oligos	OL-Cntl	NA	NA	NA
GCACATAAGTAACCCT-1_6_C5	14.40306467	-32.7760156	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3972	11259	0.003108624	0.003019806	0	3	EN-L5-6	NA	NA	NA
GCACATAGTATAGGTA-1_6_C5	-26.15259874	26.49476337	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1539	2825	0.001415929	0.003185841	0	8	Astrocytes	NA	NA	NA
GCACATATCAGAGACG-1_6_C5	17.59688562	27.13915135	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	862	1236	0.004045307	0.001618123	0	oligos	OL-Cntl	NA	NA	NA
GCACATATCTGCCAGG-1_6_C5	-15.40655946	-10.76923261	13B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2408	5069	0.001775498	0.003550996	0	13B	IN-SV2C	NA	NA	NA
GCACTCTCACAGATTC-1_6_C5	6.251102644	26.13311327	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	861	1282	0.002340094	0.005460218	0	oligos	OL-Cntl	NA	NA	NA
GCACTCTGTCATTAGC-1_6_C5	-9.170867595	-20.14958112	6B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	791	1203	0.063175395	0.003325021	0	6B	IN-SST	NA	NA	NA
GCACTCTTCAGCTCGG-1_6_C5	22.34346491	-8.806967055	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2253	4764	0.001259446	0.002938707	0	3	EN-L5-6	NA	NA	NA
GCACTCTTCTACCTGC-1_6_C5	5.274281523	-1.767939274	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	788	1205	0.005809129	0.009128631	0	12	EN-MIX	NA	NA	NA
GCAGCCAAGATGTGTA-1_6_C5	13.84185915	28.23379649	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	819	1165	0.001716738	0.003433476	0	oligos	OL-Cntl	NA	NA	NA
GCAGCCAAGTTTAGGA-1_6_C5	-22.72053734	31.31695267	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2282	4767	0.011327879	0.001468429	0	8	Astrocytes	NA	NA	NA
GCAGCCACAAGCCTAT-1_6_C5	22.49908178	11.50545652	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1705	3141	0.00191022	0.00222859	0	oligos	OL-Cntl	NA	NA	NA
GCAGCCACAATGGAAT-1_6_C5	29.65912034	-3.437044747	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	4320	11531	0.009366057	0.003035296	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCAGCCACACTTGGAT-1_6_C5	20.25967927	-0.877362828	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1389	2225	0.015280899	0.00494382	0	2	EN-L4	NA	NA	NA
GCAGCCACATCTACGA-1_6_C5	13.72116929	-32.46190319	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3611	9736	0.003389482	0.002670501	0	3	EN-L5-6	NA	NA	NA
GCAGCCACATGCCTTC-1_6_C5	-10.74393668	-0.134905938	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2720	5632	0.010830966	0.002840909	0	13A	IN-VIP	NA	NA	NA
GCAGCCAGTAGCGATG-1_6_C5	1.015276972	-23.05047551	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	4794	14227	0.008012933	0.002600689	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCAGCCAGTCAGTGGA-1_6_C5	22.02630524	0.227213827	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1873	3738	0.006955591	0.002675227	0	2	EN-L4	NA	NA	NA
GCAGCCATCACCAGGC-1_6_C5	-28.05044994	18.3721273	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1161	2032	0.007874016	0.00246063	0	8	Astrocytes	NA	NA	NA
GCAGCCATCATAACCG-1_6_C5	20.50588263	12.40985109	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1375	2393	0.002089427	0.00459674	0	oligos	OL-Cntl	NA	NA	NA
GCAGCCATCGCCAAAT-1_6_C5	-20.22521453	-29.12499573	6A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	4279	12692	0.007012291	0.003387961	0	6A	IN-PV	NA	NA	NA
GCAGTTAAGGTGCTTT-1_6_C5	-0.062361277	-10.41241156	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1509	2676	0.007847534	0.001494768	0	12	EN-MIX	NA	NA	NA
GCAGTTAAGTGGGATC-1_6_C5	11.00716499	-29.28599495	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	5203	14838	0.009570023	0.004717617	0	3	EN-L5-6	NA	NA	NA
GCAGTTACAGGCAGTA-1_6_C5	2.014517062	-30.3307831	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	4717	13118	0.000457387	0.002210703	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCAGTTACAGGGATTG-1_6_C5	12.39598774	20.5890279	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	949	1546	0.000646831	0.004527814	0	oligos	OL-Cntl	NA	NA	NA
GCAGTTAGTCCCTTGT-1_6_C5	-17.42341396	-19.47232838	6B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2251	4674	0.006418485	0.002353445	0	6B	IN-SST	NA	NA	NA
GCAGTTATCGCGCCAA-1_6_C5	10.4995088	30.60382534	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	710	1106	0.005424955	0.007233273	0	oligos	OL-Cntl	NA	NA	NA
GCAGTTATCTTGCATT-1_6_C5	11.36818739	27.04567577	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	835	1315	0	0.003802281	0	oligos	OL-Cntl	NA	NA	NA
GCATACAAGAATTCCC-1_6_C5	10.34071212	31.20347074	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	887	1343	0.002978407	0.000744602	0	oligos	OL-Cntl	NA	NA	NA
GCATACAAGATAGTCA-1_6_C5	15.66059302	18.47323034	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1010	1532	0.001305483	0.006527415	0	oligos	OL-Cntl	NA	NA	NA
GCATACAAGCCCAATT-1_6_C5	9.665289971	30.19275538	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	776	1147	0.001743679	0.002615519	0	oligos	OL-Cntl	NA	NA	NA
GCATACACATACGCCG-1_6_C5	18.55226933	22.97933506	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	845	1340	0.002238806	0.002238806	0	oligos	OL-Cntl	NA	NA	NA
GCATACAGTCTACCTC-1_6_C5	20.06483691	20.91445953	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1039	1683	0.001188354	0.004753417	0	oligos	OL-Cntl	NA	NA	NA
GCATACAGTCTCTTTA-1_6_C5	-1.681275933	-17.76594302	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2716	6083	0.001808318	0.003452244	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCATACAGTGTGGCTC-1_6_C5	-16.45692591	-9.687845456	13B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2942	6251	0.011678131	0.006239002	0	13B	IN-SV2C	NA	NA	NA
GCATACATCAACGCTA-1_6_C5	-14.47925571	-17.47054512	6B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1442	2719	0.025009195	0.004413387	0	6B	IN-SST	NA	NA	NA
GCATGATAGCTACCGC-1_6_C5	14.62054835	29.51984074	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	791	1146	0.001745201	0.007853403	0	oligos	OL-Cntl	NA	NA	NA
GCATGATAGTGTACGG-1_6_C5	-7.546160018	-1.92204128	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1874	3291	0.007596475	0.003646308	0	13A	IN-VIP	NA	NA	NA
GCATGATCACATTTCT-1_6_C5	-38.29666883	-5.573030256	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1125	1896	0.001054852	0.001054852	0	9	OPC	NA	NA	NA
GCATGATCAGACAGGT-1_6_C5	23.12132318	-9.510230861	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2830	5507	0.004539677	0.005992373	0	3	EN-L5-6	NA	NA	NA
GCATGATCATCCAACA-1_6_C5	-16.91387079	-26.35653969	6A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2176	4766	0.007133865	0.002727654	0	6A	IN-PV	NA	NA	NA
GCATGATCATCGATGT-1_6_C5	19.4471152	10.53998638	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1403	2558	0.004300235	0.001172791	0	oligos	OL-Cntl	NA	NA	NA
GCATGATCATCTCGCT-1_6_C5	10.28121103	31.4550138	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	857	1300	0.002307692	0.005384615	0	oligos	OL-Cntl	NA	NA	NA
GCATGATGTCCAAGTT-1_6_C5	-1.906016045	-15.93415494	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2489	5490	0.003642987	0.003278689	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCATGATGTCTAGAGG-1_6_C5	5.718458666	21.83747322	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	783	1243	0.004022526	0.006436042	0	oligos	OL-Cntl	NA	NA	NA
GCATGATGTGATAAAC-1_6_C5	-27.96032972	16.29097406	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	980	1574	0.002541296	0.002541296	0	8	Astrocytes	NA	NA	NA
GCATGATGTGCACGAA-1_6_C5	10.87935892	31.94509883	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	789	1225	0	0.00244898	0	oligos	OL-Cntl	NA	NA	NA
GCATGATGTGCTCTTC-1_6_C5	-1.212800294	-21.45608005	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3411	8489	0.006478973	0.002238191	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCATGATTCTGCAAGT-1_6_C5	-36.83368542	-4.33888737	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1267	2070	0.001932367	0.005797101	0	9	OPC	NA	NA	NA
GCATGCGAGCATCATC-1_6_C5	9.409777697	-7.300817713	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2566	6372	0.002667922	0.003295669	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCATGCGAGCCAGTTT-1_6_C5	-0.677433822	-25.02973292	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3483	8382	0.002028156	0.001908852	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCATGCGAGGTGCAAC-1_6_C5	-37.68779263	-5.102159289	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1219	1994	0.001504514	0.003510532	0	9	OPC	NA	NA	NA
GCATGCGAGTGACATA-1_6_C5	6.081910215	30.35913269	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	724	1068	0.015917603	0.004681648	0	oligos	OL-Cntl	NA	NA	NA
GCATGCGCATGCCACG-1_6_C5	-26.40743764	26.38911611	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1399	2641	0.005301022	0.004543733	0	8	Astrocytes	NA	NA	NA
GCATGCGGTAAATGTG-1_6_C5	14.03299969	-0.086314298	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	811	1304	0.000766871	0.005368098	0	12	EN-MIX	NA	NA	NA
GCATGTAAGAGGTACC-1_6_C5	3.535826276	-32.31222415	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	4867	15059	0.00351949	0.002523408	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCATGTAGTAGCGTCC-1_6_C5	25.79195694	-5.204300241	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	5456	19889	0.001709488	0.001910604	0	2	EN-L4	NA	NA	NA
GCATGTAGTTGTGGAG-1_6_C5	3.275058236	-15.23870244	4	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2481	4811	0.015381418	0.007690709	0	L2-3	EN-L2-3-MS	NA	NA	NA
GCATGTATCCGTAGTA-1_6_C5	18.41164004	28.41597205	17	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	918	1354	0.004431315	0.00295421	0	oligos	OL-MS-2	NA	NA	NA
GCCAAATCAGGGAGAG-1_6_C5	1.454710097	-28.68764324	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	5231	15494	0.003549761	0.003743385	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCCAAATCAGTTAACC-1_6_C5	11.40887652	31.53861898	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	785	1114	0.001795332	0.002692998	0	oligos	OL-Cntl	NA	NA	NA
GCCAAATTCCACGTTC-1_6_C5	-26.44923347	18.44877817	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1208	2005	0.00798005	0.004987531	0	8	Astrocytes	NA	NA	NA
GCCAAATTCTGTCAAG-1_6_C5	1.043248738	-7.647735075	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1287	2336	0.007705479	0.004708904	0	12	EN-MIX	NA	NA	NA
GCCTCTAAGATGTGTA-1_6_C5	-20.19110267	-27.94749575	6A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3287	7817	0.008826916	0.003326084	0	6A	IN-PV	NA	NA	NA
GCCTCTAAGGCAAAGA-1_6_C5	5.175092824	29.64901513	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	724	1076	0.00464684	0.007434944	0	oligos	OL-Cntl	NA	NA	NA
GCCTCTACAGTCCTTC-1_6_C5	10.05490774	-8.598303536	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2205	5027	0.000994629	0.001392481	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCCTCTAGTACCATCA-1_6_C5	10.61343166	31.51262283	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	812	1251	0	0.001598721	0	oligos	OL-Cntl	NA	NA	NA
GCCTCTAGTTTGTTTC-1_6_C5	8.524357762	-8.359103988	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1952	4089	0.00342382	0.001956469	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCCTCTATCATGTCCC-1_6_C5	-25.55568782	20.42424949	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1433	2567	0.00077912	0.003506038	0	8	Astrocytes	NA	NA	NA
GCCTCTATCCACGCAG-1_6_C5	2.209643135	-10.73085893	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1731	3228	0.016728625	0.004027261	0	12	EN-MIX	NA	NA	NA
GCGACCACATCGTCGG-1_6_C5	10.73205083	2.226468439	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	741	1065	0.014084507	0.00657277	0	12	EN-MIX	NA	NA	NA
GCGACCATCTACTCAT-1_6_C5	-5.973333955	-4.419521145	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1558	3234	0.009276438	0.002782931	0	13A	IN-VIP	NA	NA	NA
GCGACCATCTCGTATT-1_6_C5	-9.519545929	-0.050974527	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2352	4563	0.009423625	0.004821389	0	13A	IN-VIP	NA	NA	NA
GCGAGAACAGGTTTCA-1_6_C5	2.091730845	-32.04943982	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	7746	36315	0.006361008	0.003662398	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCGAGAATCACAGTAC-1_6_C5	20.57532593	20.42889803	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1228	2016	0.005952381	0.003968254	0	oligos	OL-Cntl	NA	NA	NA
GCGCAACAGCCGCCTA-1_6_C5	-26.78996059	20.14020569	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1229	2056	0.000972763	0.000972763	0	8	Astrocytes	NA	NA	NA
GCGCAACAGCGCTCCA-1_6_C5	-37.3398926	-6.957143989	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1040	1640	0.001219512	0.001829268	0	9	OPC	NA	NA	NA
GCGCAACCACCTATCC-1_6_C5	-16.60747783	-11.12987015	13B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3573	8625	0.004985507	0.003710145	0	13B	IN-SV2C	NA	NA	NA
GCGCAACCATCGATGT-1_6_C5	-38.85294435	-3.82560425	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1315	2274	0.001319261	0.003078276	0	9	OPC	NA	NA	NA
GCGCAACGTCGCGAAA-1_6_C5	12.11301628	32.70648192	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	755	1109	0	0.003606853	0	oligos	OL-Cntl	NA	NA	NA
GCGCAACTCAAGAAGT-1_6_C5	2.343237154	-19.07717483	4	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2937	5787	0.005529635	0.004147227	0	L2-3	EN-L2-3-MS	NA	NA	NA
GCGCAACTCTTGACGA-1_6_C5	-4.684296783	-3.816496734	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1248	1989	0.029663147	0.003519356	0	13A	IN-VIP	NA	NA	NA
GCGCAGTAGGTGCAAC-1_6_C5	-27.47256316	25.76309804	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1446	2703	0.001849797	0.002959674	0	8	Astrocytes	NA	NA	NA
GCGCAGTAGTGAACGC-1_6_C5	-3.390582045	-24.69446628	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3325	8483	0.003300719	0.00377225	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCGCAGTGTCTCACCT-1_6_C5	2.226919474	-13.10988122	4	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2292	4554	0.014273166	0.008124726	0	L2-3	EN-L2-3-MS	NA	NA	NA
GCGCAGTGTTATGCGT-1_6_C5	9.81459396	-8.467690267	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2154	4407	0.00136147	0.002042206	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCGCCAAAGTACGACG-1_6_C5	13.9577579	20.38159966	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	940	1420	0.002816901	0.007042254	0	oligos	OL-Cntl	NA	NA	NA
GCGCCAAAGTTTGCGT-1_6_C5	6.563423402	31.91934877	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	775	1223	0.017170891	0.004088307	0	oligos	OL-Cntl	NA	NA	NA
GCGCCAACAACAACCT-1_6_C5	-20.28745401	-29.23122974	6A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	4755	15239	0.008071396	0.00118118	0	6A	IN-PV	NA	NA	NA
GCGCCAACAAGGACAC-1_6_C5	15.81370483	-6.118162383	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1610	2843	0.001406964	0.004924376	0	3	EN-L5-6	NA	NA	NA
GCGCCAACACGGCGTT-1_6_C5	22.86363027	13.25139393	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1382	2229	0.002243158	0.007178107	0	oligos	OL-Cntl	NA	NA	NA
GCGCCAACATCCCACT-1_6_C5	31.46665361	-4.881389872	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3952	9081	0.005836362	0.003413721	0	2	EN-L4	NA	NA	NA
GCGCCAATCAGCAACT-1_6_C5	10.7523446	28.118693	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	844	1374	0.001455604	0.002183406	0	oligos	OL-Cntl	NA	NA	NA
GCGCCAATCTGGAGCC-1_6_C5	17.35613582	23.17949104	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	966	1508	0.00132626	0.00132626	0	oligos	OL-Cntl	NA	NA	NA
GCGCGATAGAGGACGG-1_6_C5	2.708790085	-32.06389967	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	5549	18285	0.005359584	0.002734482	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCGCGATAGAGTACCG-1_6_C5	9.019358095	29.9072224	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	828	1214	0.000823723	0.00247117	0	oligos	OL-Cntl	NA	NA	NA
GCGCGATAGTACATGA-1_6_C5	18.23250262	13.03568174	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1356	2197	0.011379153	0.003641329	0	oligos	OL-Cntl	NA	NA	NA
GCGGGTTCAATAGAGT-1_6_C5	12.64978201	28.23903301	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	752	1085	0.003686636	0.004608295	0	oligos	OL-Cntl	NA	NA	NA
GCGGGTTGTATGAAAC-1_6_C5	25.40371534	-1.768923594	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2498	5029	0.003976934	0.001988467	0	2	EN-L4	NA	NA	NA
GCGGGTTTCTACGAGT-1_6_C5	-37.198205	-5.314730089	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1216	2172	0.003222836	0.005064457	0	9	OPC	NA	NA	NA
GCTCCTAAGAGCCTAG-1_6_C5	7.087285581	-5.992747532	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1534	2872	0.012883008	0.001392758	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCTCCTAAGTAGGCCA-1_6_C5	13.44116007	20.17176183	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1074	1681	0.006543724	0.004164188	0	oligos	OL-Cntl	NA	NA	NA
GCTCCTACACTTAAGC-1_6_C5	25.74333586	3.749975246	15BA	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	864	1255	0.007968127	0.003187251	0	15BA	Stromal cells	NA	NA	NA
GCTCCTAGTCAAAGAT-1_6_C5	18.91394285	8.269974433	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1768	3358	0.00565813	0.005062537	0	oligos	OL-Cntl	NA	NA	NA
GCTCCTATCCGCGTTT-1_6_C5	-25.10091019	17.54536895	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1135	1739	0.001150086	0.004600345	0	8	Astrocytes	NA	NA	NA
GCTCTGTCACCCTATC-1_6_C5	24.20463306	-0.060816371	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2252	4805	0.002497399	0.001456816	0	2	EN-L4	NA	NA	NA
GCTCTGTGTAAAGGAG-1_6_C5	23.25278223	-8.617610574	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2661	5383	0.006316181	0.00334386	0	3	EN-L5-6	NA	NA	NA
GCTCTGTTCAGTTTGG-1_6_C5	12.33506215	30.81673697	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	721	1082	0.004621072	0.000924214	0	oligos	OL-Cntl	NA	NA	NA
GCTCTGTTCATGTCTT-1_6_C5	-35.33708119	-11.92419455	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	798	1208	0.001655629	0.003311258	0	9	OPC	NA	NA	NA
GCTCTGTTCGCTGATA-1_6_C5	-12.98752751	-18.99951307	6B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1227	2062	0.012124151	0.004364694	0	6B	IN-SST	NA	NA	NA
GCTGCAGGTATTAGCC-1_6_C5	27.53353938	0.18865864	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	4167	11769	0.011555782	0.003228821	0	2	EN-L4	NA	NA	NA
GCTGCAGGTCGCCATG-1_6_C5	18.39951644	20.1102516	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	961	1480	0.00472973	0.006081081	0	oligos	OL-Cntl	NA	NA	NA
GCTGCAGTCCGAATGT-1_6_C5	25.21737708	-29.083653	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3806	11262	0.002752619	0.003995738	0	3	EN-L5-6	NA	NA	NA
GCTGCGAAGATATGCA-1_6_C5	-19.96043629	-18.71471724	6A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3482	8090	0.001359703	0.004573548	0	6A	IN-PV	NA	NA	NA
GCTGCGAAGCCGTCGT-1_6_C5	27.43418944	0.318226386	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	4158	11373	0.002989537	0.003077464	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCTGCGACACAGGAGT-1_6_C5	-21.78328591	9.931240637	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	927	1359	0.003679176	0.007358352	0	8	Astrocytes	NA	NA	NA
GCTGCGATCACCGTAA-1_6_C5	10.85842043	31.75177025	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	831	1280	0.0015625	0.003125	0	oligos	OL-Cntl	NA	NA	NA
GCTGCGATCGCAGGCT-1_6_C5	-14.70834338	-7.159840062	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3450	8549	0.018598667	0.003977073	0	13A	IN-VIP	NA	NA	NA
GCTGCGATCTACTATC-1_6_C5	8.900018241	28.05742507	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	872	1328	0.008283133	0.00376506	0	oligos	OL-Cntl	NA	NA	NA
GCTGCTTAGAACTGTA-1_6_C5	3.51560042	-28.23155028	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2814	6269	0.004306907	0.003030786	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCTGCTTCATACCATG-1_6_C5	-27.9266695	12.79378503	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	881	1329	0.003762227	0.006019564	0	8	Astrocytes	NA	NA	NA
GCTGCTTGTTACGACT-1_6_C5	13.95374803	29.72420592	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	796	1222	0.002454992	0.002454992	0	oligos	OL-Cntl	NA	NA	NA
GCTGCTTGTTCCCGAG-1_6_C5	23.9437476	-1.102263133	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2302	4496	0.001779359	0.004448399	0	2	EN-L4	NA	NA	NA
GCTGCTTTCGCATGGC-1_6_C5	12.26130226	32.03331844	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	684	1016	0.001968504	0.000984252	0	oligos	OL-Cntl	NA	NA	NA
GCTGGGTAGTCAATAG-1_6_C5	20.6284808	19.60706208	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1126	1754	0.005131129	0.002850627	0	oligos	OL-Cntl	NA	NA	NA
GCTGGGTCATACGCTA-1_6_C5	5.418657172	31.79929328	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	767	1098	0.003642987	0.004553734	0	oligos	OL-Cntl	NA	NA	NA
GCTGGGTGTCCGTTAA-1_6_C5	20.65282631	21.06162043	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1073	1747	0	0.005151689	0	oligos	OL-Cntl	NA	NA	NA
GCTGGGTGTGATGATA-1_6_C5	3.003399257	28.12801034	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	789	1091	0.008249313	0.004582951	0	oligos	OL-Cntl	NA	NA	NA
GCTGGGTGTTCATGGT-1_6_C5	-13.85076408	-10.46040453	13B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1951	3752	0.015458422	0.003464819	0	13B	IN-SV2C	NA	NA	NA
GCTGGGTGTTTAGGAA-1_6_C5	0.940706004	-28.21130181	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	4839	13922	0.004668869	0.002944979	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCTTCCACAGAGTGTG-1_6_C5	0.615697594	-14.0829827	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2163	3944	0.001774848	0.003549696	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCTTCCAGTCCCTTGT-1_6_C5	-38.92790326	0.346589511	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1572	2919	0.000685166	0.002055498	0	9	OPC	NA	NA	NA
GCTTCCAGTGCCTGGT-1_6_C5	27.57523816	0.121254312	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3798	11100	0.004054054	0.001981982	0	2	EN-L4	NA	NA	NA
GCTTCCATCACGAAGG-1_6_C5	23.32569386	-0.283549873	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2369	4769	0.013000629	0.002096876	0	2	EN-L4	NA	NA	NA
GCTTCCATCGGCGGTT-1_6_C5	-38.17769271	2.239693394	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1556	2764	0.001447178	0.002532562	0	9	OPC	NA	NA	NA
GCTTGAACAAAGTCAA-1_6_C5	22.99563566	19.3805342	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1166	1809	0.006080708	0.00331675	0	oligos	OL-Cntl	NA	NA	NA
GCTTGAACATGAAGTA-1_6_C5	23.02072477	0.149246533	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1939	3648	0.008497807	0.00191886	0	2	EN-L4	NA	NA	NA
GCTTGAAGTCGACTAT-1_6_C5	24.95018082	-1.523601873	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2442	5580	0.011111111	0.002150538	0	2	EN-L4	NA	NA	NA
GCTTGAAGTGGGTATG-1_6_C5	5.911279698	25.76379528	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	817	1184	0.007601351	0.004222973	0	oligos	OL-Cntl	NA	NA	NA
GCTTGAAGTGTATGGG-1_6_C5	16.85453225	0.777888839	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1149	1732	0.006351039	0.001732102	0	12	EN-MIX	NA	NA	NA
GCTTGAATCAAGCCTA-1_6_C5	16.55128206	24.55442334	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	856	1275	0.007843137	0.000784314	0	oligos	OL-Cntl	NA	NA	NA
GCTTGAATCACGGTTA-1_6_C5	13.65473644	-0.138061106	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	754	1178	0.005942275	0.005093379	0	12	EN-MIX	NA	NA	NA
GCTTGAATCATCTGTT-1_6_C5	6.428749829	-7.629993485	11	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2220	4211	0.01591071	0.005936832	0	11	Glia-MIX	NA	NA	NA
GGAAAGCAGCTCCTTC-1_6_C5	11.10870218	-8.778525044	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2823	7332	0.003818876	0.001636661	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GGAAAGCAGGGTCTCC-1_6_C5	-0.907615612	-20.28813715	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3013	6733	0.002227833	0.004901233	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GGAAAGCGTGAGGCTA-1_6_C5	2.192225116	-28.46585434	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3367	7967	0.001255178	0.003263462	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GGAAAGCTCAGCTCTC-1_6_C5	32.26829702	-4.388205328	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2950	6552	0.021672772	0.004273504	0	2	EN-L4	NA	NA	NA
GGAAAGCTCTTGAGAC-1_6_C5	2.741680886	-25.72679524	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	4038	11527	0.000694023	0.001995315	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GGAACTTAGAACTCGG-1_6_C5	23.35421837	12.39129858	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1428	2298	0.001740644	0.003916449	0	oligos	OL-Cntl	NA	NA	NA
GGAACTTAGCCCAATT-1_6_C5	-1.520106661	-15.30322761	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2156	4238	0.004719207	0.002595564	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GGAACTTAGCTACCGC-1_6_C5	-11.54345439	-22.05324652	6A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1009	1661	0.017459362	0.001204094	0	6A	IN-PV	NA	NA	NA
GGAACTTAGGCCGAAT-1_6_C5	17.83501932	22.37150053	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	953	1498	0.001335113	0.00200267	0	oligos	OL-Cntl	NA	NA	NA
GGAACTTAGTTAACGA-1_6_C5	22.47797873	-8.862596193	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2322	4929	0.000811524	0.002028809	0	3	EN-L5-6	NA	NA	NA
GGAACTTGTATAGTAG-1_6_C5	-35.19582871	-11.46120566	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	821	1240	0.001612903	0.003225806	0	9	OPC	NA	NA	NA
GGAACTTGTCTAAACC-1_6_C5	-12.15897908	-19.16850432	6B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1053	1634	0.006731946	0.003059976	0	6B	IN-SST	NA	NA	NA
GGAACTTGTTCCAACA-1_6_C5	-5.267848742	-4.30204616	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1236	2064	0.010174419	0.002422481	0	13A	IN-VIP	NA	NA	NA
GGAACTTTCAAACGGG-1_6_C5	19.57338905	-7.045422773	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2131	4354	0.003215434	0.003215434	0	3	EN-L5-6	NA	NA	NA
GGAATAAAGGTCATCT-1_6_C5	-38.25997306	-8.56387383	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	989	1624	0.000615764	0.001847291	0	9	OPC	NA	NA	NA
GGAATAACACAACGCC-1_6_C5	22.73857118	12.44846164	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1433	2517	0.001589193	0.003575685	0	oligos	OL-Cntl	NA	NA	NA
GGAATAAGTGCGATAG-1_6_C5	15.77899414	-7.152870506	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2006	3733	0.00241093	0.004018216	0	3	EN-L5-6	NA	NA	NA
GGAATAATCGGATGGA-1_6_C5	-28.54098247	16.52862733	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	939	1401	0.000713776	0.009279086	0	8	Astrocytes	NA	NA	NA
GGACAAGAGATCCCGC-1_6_C5	12.66262462	31.5528282	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	719	1028	0	0.004863813	0	oligos	OL-Cntl	NA	NA	NA
GGACAAGCATTTCAGG-1_6_C5	16.67273278	22.19570366	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	879	1311	0.00228833	0.006864989	0	oligos	OL-Cntl	NA	NA	NA
GGACAAGGTAACGACG-1_6_C5	-27.37964137	25.58196216	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1482	2633	0.008735283	0.004177744	0	8	Astrocytes	NA	NA	NA
GGACAAGGTCCTGCTT-1_6_C5	20.67423009	20.17212722	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1127	1870	0.000534759	0.003743316	0	oligos	OL-Cntl	NA	NA	NA
GGACAAGGTGCTCTTC-1_6_C5	20.09363518	11.31629184	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1401	2344	0.001279863	0.004692833	0	oligos	OL-Cntl	NA	NA	NA
GGACAAGGTTTGTGTG-1_6_C5	23.18849374	-26.34975536	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3396	7811	0.007041352	0.007297401	0	3	EN-L5-6	NA	NA	NA
GGACAGAAGGCTAGGT-1_6_C5	-6.004798847	-4.199086191	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1417	2281	0.008768084	0.003068829	0	13A	IN-VIP	NA	NA	NA
GGACAGAAGTCAAGGC-1_6_C5	-5.413117565	-10.13853542	13B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	929	1384	0.020953757	0.000722543	0	13B	IN-SV2C	NA	NA	NA
GGACAGACATCACCCT-1_6_C5	-11.55725904	-19.03543224	6B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	915	1418	0.007052186	0.005641749	0	6B	IN-SST	NA	NA	NA
GGACAGAGTCCATGAT-1_6_C5	-26.55891317	18.651437	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1275	2115	0.002836879	0.003782506	0	8	Astrocytes	NA	NA	NA
GGACAGATCACGACTA-1_6_C5	19.92321221	22.15530794	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1047	1765	0.003399433	0.00509915	0	oligos	OL-Cntl	NA	NA	NA
GGACAGATCCTCCTAG-1_6_C5	29.2918831	-1.738293249	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3317	8019	0.009976306	0.004364634	0	2	EN-L4	NA	NA	NA
GGACAGATCCTTGGTC-1_6_C5	11.57822276	29.63942119	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	772	1132	0.001766784	0.004416961	0	oligos	OL-Cntl	NA	NA	NA
GGACAGATCGAACTGT-1_6_C5	25.83099662	-4.988140162	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	4966	15948	0.005204414	0.00282167	0	2	EN-L4	NA	NA	NA
GGACATTAGAAGGCCT-1_6_C5	-25.00204306	27.23549682	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1523	2641	0.004165089	0.004165089	0	8	Astrocytes	NA	NA	NA
GGACATTCAGCCTATA-1_6_C5	10.80969397	31.24041111	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	814	1293	0	0.003093581	0	oligos	OL-Cntl	NA	NA	NA
GGACATTCATCTATGG-1_6_C5	0.954229489	-26.5036621	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3689	10326	0.004842146	0.003776874	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GGACATTGTAGCACGA-1_6_C5	23.54305659	0.022275813	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2013	3905	0.026120359	0.001024328	0	2	EN-L4	NA	NA	NA
GGACATTGTGCACTTA-1_6_C5	4.269841146	31.72430682	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	710	1035	0.000966184	0.003864734	0	oligos	OL-Cntl	NA	NA	NA
GGACATTTCAACGAAA-1_6_C5	-1.330053858	-16.07784851	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2282	4525	0.00198895	0.001546961	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GGACGTCAGAGTCGGT-1_6_C5	-4.128724817	26.2238464	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	743	1025	0.004878049	0.004878049	0	oligos	OL-Cntl	NA	NA	NA
GGACGTCAGTACGACG-1_6_C5	12.00534926	33.25730668	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	705	1019	0.001962709	0.001962709	0	oligos	OL-Cntl	NA	NA	NA
GGACGTCCAGTAAGAT-1_6_C5	24.71846592	-27.12560816	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3156	7824	0.007924335	0.002428425	0	3	EN-L5-6	NA	NA	NA
GGACGTCGTAAACACA-1_6_C5	15.10572752	2.729563386	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	724	1011	0.016815035	0.001978239	0	12	EN-MIX	NA	NA	NA
GGACGTCGTCGAAAGC-1_6_C5	17.13177412	22.32534902	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	940	1362	0.000734214	0.005139501	0	oligos	OL-Cntl	NA	NA	NA
GGACGTCGTTCCCGAG-1_6_C5	0.565073461	35.40109716	17	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	756	1051	0.002854424	0.003805899	0	oligos	OL-MS-2	NA	NA	NA
GGACGTCTCAGCAACT-1_6_C5	-1.734949843	-23.25011806	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3681	9960	0.006024096	0.003915663	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GGACGTCTCCCAGGTG-1_6_C5	-11.29908659	17.58069203	11	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1760	2956	0.00135318	0.00338295	0	11	Glia-MIX	NA	NA	NA
GGAGCAAAGAAGGTTT-1_6_C5	-36.27171478	-9.536463401	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	972	1611	0.006828057	0.001862197	0	9	OPC	NA	NA	NA
GGAGCAAAGATAGCAT-1_6_C5	3.36855356	-15.19410018	4	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2449	4722	0.018212622	0.004659043	0	L2-3	EN-L2-3-MS	NA	NA	NA
GGAGCAAAGGTGCTAG-1_6_C5	-28.95831464	14.08900884	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	909	1387	0.000720981	0.001441961	0	8	Astrocytes	NA	NA	NA
GGAGCAAAGTAGGCCA-1_6_C5	13.01655565	31.20679036	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	827	1180	0.005932203	0.003389831	0	oligos	OL-Cntl	NA	NA	NA
GGAGCAAAGTCTCCTC-1_6_C5	3.215711708	-14.880265	4	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2247	4247	0.012008477	0.004709206	0	L2-3	EN-L2-3-MS	NA	NA	NA
GGAGCAACAACTTGAC-1_6_C5	18.70948138	8.535807216	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1670	3058	0.001962067	0.004251145	0	oligos	OL-Cntl	NA	NA	NA
GGAGCAAGTCACAAGG-1_6_C5	-27.2813346	25.99587669	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1482	2665	0.001876173	0.003001876	0	8	Astrocytes	NA	NA	NA
GGAGCAAGTCCGAACC-1_6_C5	12.99592812	31.12025432	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	694	1029	0.000971817	0.002915452	0	oligos	OL-Cntl	NA	NA	NA
GGAGCAAGTGTTAAGA-1_6_C5	3.624580636	-28.77787221	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3213	7632	0.003275681	0.003144654	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GGAGCAAGTTATTCTC-1_6_C5	-13.33651331	-19.59228743	6B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1370	2457	0.015466015	0.002849003	0	6B	IN-SST	NA	NA	NA
GGAGCAATCACCCTCA-1_6_C5	12.65458793	27.91672228	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	836	1296	0.00154321	0.00617284	0	oligos	OL-Cntl	NA	NA	NA
GGAGCAATCCAAATGC-1_6_C5	4.187025354	-4.131425084	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1013	1411	0.008504607	0.007795889	0	12	EN-MIX	NA	NA	NA
GGAGCAATCGTTGACA-1_6_C5	11.04500147	26.8463488	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	809	1194	0.001675042	0.001675042	0	oligos	OL-Cntl	NA	NA	NA
GGAGCAATCTGCTGTC-1_6_C5	-17.73846845	-26.60390552	6A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2457	5410	0.008502773	0.003696858	0	6A	IN-PV	NA	NA	NA
GGATGTTCATCATCCC-1_6_C5	-28.13988094	23.48504246	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1132	1898	0.002634352	0.003161222	0	8	Astrocytes	NA	NA	NA
GGATGTTGTGTATGGG-1_6_C5	-16.08840552	-24.64990363	6A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2099	4267	0.019451605	0.002343567	0	6A	IN-PV	NA	NA	NA
GGATGTTGTTCGCGAC-1_6_C5	22.44700962	1.220652061	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1725	3340	0.010479042	0.001497006	0	2	EN-L4	NA	NA	NA
GGATGTTTCATCTGCC-1_6_C5	10.72115164	25.44391044	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	824	1319	0.00227445	0.00227445	0	oligos	OL-Cntl	NA	NA	NA
GGATTACAGCAATATG-1_6_C5	-20.17273606	-27.67410363	6A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2837	6342	0.00157679	0.002207506	0	6A	IN-PV	NA	NA	NA
GGATTACAGGCTATCT-1_6_C5	-28.40789993	24.62746605	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1227	2065	0.001452785	0.001937046	0	8	Astrocytes	NA	NA	NA
GGATTACAGGTGTTAA-1_6_C5	-29.83015534	13.46795032	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	813	1211	0.000825764	0.003303055	0	8	Astrocytes	NA	NA	NA
GGATTACAGTGCCAGA-1_6_C5	-16.7191002	-18.11567212	6B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2035	4042	0.009153884	0.002474023	0	6B	IN-SST	NA	NA	NA
GGCAATTAGAAAGTGG-1_6_C5	30.46202559	-3.163982937	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3163	7399	0.009190431	0.002567915	0	2	EN-L4	NA	NA	NA
GGCAATTCATGGTAGG-1_6_C5	-10.71014187	-1.660610427	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2300	4570	0.017286652	0.00940919	0	13A	IN-VIP	NA	NA	NA
GGCAATTTCAGCCTAA-1_6_C5	11.337133	20.92197716	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	937	1423	0.001405481	0.006324666	0	oligos	OL-Cntl	NA	NA	NA
GGCAATTTCCGCATCT-1_6_C5	20.60229707	19.82394184	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1044	1634	0	0.003671971	0	oligos	OL-Cntl	NA	NA	NA
GGCCGATAGATCGATA-1_6_C5	-27.5145972	15.70365518	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1011	1607	0.005600498	0.004355943	0	8	Astrocytes	NA	NA	NA
GGCCGATCACCGCTAG-1_6_C5	18.00104306	24.6674795	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	919	1362	0.004405286	0.001468429	0	oligos	OL-Cntl	NA	NA	NA
GGCCGATCAGGGAGAG-1_6_C5	7.12652945	21.26849332	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	947	1451	0.024810476	0.006202619	0	oligos	OL-Cntl	NA	NA	NA
GGCCGATCATGACGGA-1_6_C5	29.33088414	-1.771063104	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	4519	12908	0.005268051	0.004028509	0	2	EN-L4	NA	NA	NA
GGCCGATGTAAGGGAA-1_6_C5	17.34845423	-5.487583857	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1583	2761	0.004346251	0.003984064	0	3	EN-L5-6	NA	NA	NA
GGCCGATGTACTTGAC-1_6_C5	19.64057328	19.2592821	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1109	1734	0.007497116	0.001730104	0	oligos	OL-Cntl	NA	NA	NA
GGCCGATGTCAAAGAT-1_6_C5	-27.43812267	14.85401716	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	901	1335	0.000749064	0.002247191	0	8	Astrocytes	NA	NA	NA
GGCCGATTCCTACAGA-1_6_C5	1.194495243	-28.70952245	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	4040	10940	0.002833638	0.002010969	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GGCCGATTCTGGGCCA-1_6_C5	14.24762964	24.49906395	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	839	1263	0.005542359	0.001583531	0	oligos	OL-Cntl	NA	NA	NA
GGCCGATTCTGGTATG-1_6_C5	-2.214787206	-20.11684115	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3314	8055	0.000620732	0.002855369	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GGCGACTAGAGTACCG-1_6_C5	-8.329135243	-1.312597413	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2185	4099	0.016101488	0.006099049	0	13A	IN-VIP	NA	NA	NA
GGCGACTAGGCTACGA-1_6_C5	-36.08798838	4.440753088	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2156	4215	0.002846975	0.003558719	0	9	OPC	NA	NA	NA
GGCGACTCACAGCGTC-1_6_C5	23.01314615	15.1561505	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1384	2185	0.000915332	0.004576659	0	oligos	OL-Cntl	NA	NA	NA
GGCGACTCACCAGATT-1_6_C5	29.22908643	-2.165646726	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3986	10429	0.007862691	0.003835459	0	2	EN-L4	NA	NA	NA
GGCGACTCAGCGAACA-1_6_C5	16.08780589	28.88568603	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	816	1189	0.000841043	0.003364172	0	oligos	OL-Cntl	NA	NA	NA
GGCGACTCAGGGATTG-1_6_C5	3.382819162	-14.29799753	4	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2382	4464	0.006944444	0.011200717	0	L2-3	EN-L2-3-MS	NA	NA	NA
GGCGACTGTACCCAAT-1_6_C5	-9.489791709	-7.229652462	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1758	3033	0.012858556	0.004615892	0	13A	IN-VIP	NA	NA	NA
GGCGACTTCCGAAGAG-1_6_C5	25.33862405	-5.185672279	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	5414	19092	0.000314268	0.001571339	0	2	EN-L4	NA	NA	NA
GGCGACTTCTCAAACG-1_6_C5	4.42830333	-4.260251137	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1069	1811	0.007730536	0.005521811	0	12	EN-MIX	NA	NA	NA
GGCGTGTAGATCTGCT-1_6_C5	-11.04908076	-19.68572159	6B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	866	1311	0.028985507	0.003051106	0	6B	IN-SST	NA	NA	NA
GGCGTGTAGTAGCGGT-1_6_C5	-34.89223126	-12.02580358	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	774	1130	0	0.001769912	0	9	OPC	NA	NA	NA
GGCGTGTAGTGTACTC-1_6_C5	9.62938259	34.01840297	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	830	1209	0.003308519	0.003308519	0	oligos	OL-Cntl	NA	NA	NA
GGCGTGTCAGACAAGC-1_6_C5	24.88683772	0.350093315	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2321	4557	0.014483213	0.001974984	0	2	EN-L4	NA	NA	NA
GGCGTGTGTATCACCA-1_6_C5	-27.08336846	8.472144518	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	737	1039	0.001924928	0	0	8	Astrocytes	NA	NA	NA
GGCGTGTTCCATGCTC-1_6_C5	3.341762076	-7.080860057	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1276	1958	0.016343207	0.005617978	0	12	EN-MIX	NA	NA	NA
GGCGTGTTCTTAGCCC-1_6_C5	-26.73927288	16.98476588	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1122	1769	0.009044658	0.003957038	0	8	Astrocytes	NA	NA	NA
GGCGTGTTCTTTAGGG-1_6_C5	-31.25051147	-12.75394838	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	756	1134	0.010582011	0.002645503	0	9	OPC	NA	NA	NA
GGCTCGAAGAAACGCC-1_6_C5	20.75849331	-28.86019489	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3570	8593	0.003025719	0.006633306	0	3	EN-L5-6	NA	NA	NA
GGCTCGAAGATCCCAT-1_6_C5	-12.79512771	15.56791584	11	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1145	1774	0.006200676	0.005636979	0	11	Glia-MIX	NA	NA	NA
GGCTCGAAGATCGATA-1_6_C5	20.48229889	1.438332005	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1536	2463	0.002030045	0.002842063	0	2	EN-L4	NA	NA	NA
GGCTCGAGTCTGGAGA-1_6_C5	18.7217952	1.485277979	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1235	1926	0.005711319	0.003115265	0	12	EN-MIX	NA	NA	NA
GGCTCGAGTTTGGGCC-1_6_C5	-14.96995872	-11.55408569	13B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2111	4273	0.003276387	0.003510414	0	13B	IN-SV2C	NA	NA	NA
GGCTGGTAGAACTGTA-1_6_C5	-18.94916898	-24.37522917	6A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2912	6474	0.001853568	0.00308928	0	6A	IN-PV	NA	NA	NA
GGCTGGTAGAGCTGCA-1_6_C5	2.013361115	-21.98161578	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3827	9144	0.004374453	0.003608924	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GGCTGGTCAGTCGATT-1_6_C5	-37.24182014	-4.865635836	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1356	2296	0.004790941	0.00130662	0	9	OPC	NA	NA	NA
GGCTGGTCATGGTCTA-1_6_C5	-21.60090244	-28.36773179	6A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	5356	16490	0.02801698	0.003577926	0	6A	IN-PV	NA	NA	NA
GGCTGGTTCACATGCA-1_6_C5	-36.48723321	-10.53407486	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	966	1469	0.00136147	0.002042206	0	9	OPC	NA	NA	NA
GGCTGGTTCCGTACAA-1_6_C5	-27.79635063	16.12085568	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	969	1461	0.000684463	0.003422313	0	8	Astrocytes	NA	NA	NA
GGCTGGTTCGCCATAA-1_6_C5	-1.538605133	-18.00489962	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2791	6066	0.003132212	0.002802506	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GGCTGGTTCGCGGATC-1_6_C5	-36.16235035	4.651254682	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2194	4713	0.001273074	0.00233397	0	9	OPC	NA	NA	NA
GGGAATGAGAGCCTAG-1_6_C5	-36.0989408	-9.156463099	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	904	1419	0.001409443	0.004933051	0	9	OPC	NA	NA	NA
GGGAATGAGGCCGAAT-1_6_C5	2.880795607	-25.87664409	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	4706	14565	0.001098524	0.002197048	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GGGAATGAGTGGAGTC-1_6_C5	-36.09401891	-6.377094098	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1094	1781	0.002807412	0.003930376	0	9	OPC	NA	NA	NA
GGGAATGCAAGCCTAT-1_6_C5	3.244617824	-26.06432099	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2911	7040	0.002982955	0.000710227	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GGGAATGCACTTACGA-1_6_C5	-29.12584414	16.19537383	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	924	1478	0.00270636	0.00405954	0	8	Astrocytes	NA	NA	NA
GGGAATGCAGTATGCT-1_6_C5	-34.77344856	-10.81633572	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	897	1486	0.000672948	0.003364738	0	9	OPC	NA	NA	NA
GGGAATGGTTGATTGC-1_6_C5	-13.05882664	-17.90308923	6B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1119	1809	0.011055832	0.001105583	0	6B	IN-SST	NA	NA	NA
GGGAATGTCATGTGGT-1_6_C5	-5.835518202	-9.945079962	13B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1116	1814	0.001102536	0.001102536	0	13B	IN-SV2C	NA	NA	NA
GGGAATGTCCTTTCGG-1_6_C5	12.72892801	27.72796183	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	816	1217	0.002465078	0.004930156	0	oligos	OL-Cntl	NA	NA	NA
GGGACCTAGATAGCAT-1_6_C5	-35.837956	-11.2630767	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	879	1431	0.000698812	0.001397624	0	9	OPC	NA	NA	NA
GGGACCTAGCTAGGCA-1_6_C5	-39.33131706	-2.953892777	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1181	2089	0.000957396	0.006701771	0	9	OPC	NA	NA	NA
GGGACCTCAGTATGCT-1_6_C5	22.43846984	19.5653127	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1134	1790	0.001117318	0.005027933	0	oligos	OL-Cntl	NA	NA	NA
GGGACCTTCAAACGGG-1_6_C5	-16.57500805	-10.78777938	13B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3158	7467	0.009106736	0.004821213	0	13B	IN-SV2C	NA	NA	NA
GGGACCTTCTCTTATG-1_6_C5	17.42327034	15.84687388	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1070	1816	0.004405286	0.004955947	0	oligos	OL-Cntl	NA	NA	NA
GGGACCTTCTGTGCAA-1_6_C5	6.085857758	-1.505786081	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	770	1156	0.006055363	0.009515571	0	12	EN-MIX	NA	NA	NA
GGGAGATAGACAATAC-1_6_C5	-16.8650807	-10.29276618	13B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3178	7051	0.014182385	0.002269182	0	13B	IN-SV2C	NA	NA	NA
GGGAGATCAAGCTGGA-1_6_C5	-37.89042225	-7.677599157	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1005	1641	0.001218769	0.001218769	0	9	OPC	NA	NA	NA
GGGAGATGTGTGAATA-1_6_C5	1.354111652	-23.24035622	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	4210	10782	0.007605268	0.004173623	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GGGAGATGTTCTGAAC-1_6_C5	-11.60640867	16.30601795	11	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1472	2412	0.004145937	0.00331675	0	11	Glia-MIX	NA	NA	NA
GGGAGATTCTGGCGTG-1_6_C5	23.66323915	13.52336078	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1200	1918	0	0.001042753	0	oligos	OL-Cntl	NA	NA	NA
GGGATGAAGTGTGAAT-1_6_C5	-27.14272924	16.9246134	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1021	1665	0.001801802	0.001801802	0	8	Astrocytes	NA	NA	NA
GGGATGACATCAGTAC-1_6_C5	27.17819823	0.156239344	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3594	9892	0.004448039	0.001213101	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GGGATGAGTATAGTAG-1_6_C5	5.072357587	29.21102862	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	706	1018	0.002946955	0.002946955	0	oligos	OL-Cntl	NA	NA	NA
GGGCACTAGTACGTTC-1_6_C5	16.92281053	23.6428005	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	873	1306	0.003062787	0.001531394	0	oligos	OL-Cntl	NA	NA	NA
GGGCACTAGTGAACGC-1_6_C5	11.80467507	33.39369899	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	763	1105	0.00361991	0.008144796	0	oligos	OL-Cntl	NA	NA	NA
GGGCACTGTATAGTAG-1_6_C5	19.20046069	21.6726565	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1027	1595	0.001880878	0.005015674	0	oligos	OL-Cntl	NA	NA	NA
GGGCACTGTCGCGTGT-1_6_C5	0.518027405	-17.1640431	4	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2755	5524	0.003801593	0.005068791	0	L2-3	EN-L2-3-MS	NA	NA	NA
GGGCACTGTTCACCTC-1_6_C5	18.38563578	21.11790436	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	979	1602	0.004369538	0.003745318	0	oligos	OL-Cntl	NA	NA	NA
GGGCACTGTTGGACCC-1_6_C5	5.716132986	33.77077364	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	752	1118	0.001788909	0.001788909	0	oligos	OL-Cntl	NA	NA	NA
GGGCATCAGCCACGTC-1_6_C5	-3.275488545	-6.745641566	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	793	1109	0.00541028	0.004508566	0	13A	IN-VIP	NA	NA	NA
GGGCATCCAACGCACC-1_6_C5	2.866333088	-20.86158092	4	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3941	9455	0.009730301	0.004230566	0	L2-3	EN-L2-3-MS	NA	NA	NA
GGGCATCCACAACGTT-1_6_C5	-14.38123484	-21.32152893	6A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1538	3119	0.012504008	0.002564925	0	6A	IN-PV	NA	NA	NA
GGGCATCCACGAAACG-1_6_C5	11.52866385	30.58943787	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	741	1138	0.003514938	0.002636204	0	oligos	OL-Cntl	NA	NA	NA
GGGCATCGTCTCTTAT-1_6_C5	29.74706698	-0.592962793	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3040	6470	0.005564142	0.00324575	0	2	EN-L4	NA	NA	NA
GGGCATCGTTCAGCGC-1_6_C5	6.495087433	26.09983051	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	786	1098	0.000910747	0.003642987	0	oligos	OL-Cntl	NA	NA	NA
GGGCATCGTTGGAGGT-1_6_C5	-24.45546123	22.3184358	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1315	2209	0.005432322	0.004526935	0	8	Astrocytes	NA	NA	NA
GGGCATCTCAGCTGGC-1_6_C5	-7.869968339	-1.903553821	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1880	3371	0.014535746	0.005932958	0	13A	IN-VIP	NA	NA	NA
GGGCATCTCCAGGGCT-1_6_C5	15.47757371	-30.24818399	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	4643	13923	0.010414422	0.002944768	0	3	EN-L5-6	NA	NA	NA
GGGCATCTCCCTGACT-1_6_C5	23.12263762	12.64943158	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1322	2278	0.001316945	0.002633889	0	oligos	OL-Cntl	NA	NA	NA
GGGCATCTCTAACGGT-1_6_C5	19.83330208	-6.871288075	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2073	4773	0.000419024	0.002514142	0	3	EN-L5-6	NA	NA	NA
GGGTCTGAGCCCAATT-1_6_C5	11.60894999	0.106040978	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	833	1193	0.018440905	0.015926236	0	12	EN-MIX	NA	NA	NA
GGGTCTGAGTCCTCCT-1_6_C5	6.345223544	-8.406763328	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1874	3204	0.009051186	0.005930087	0	12	EN-MIX	NA	NA	NA
GGGTCTGCAAAGTCAA-1_6_C5	29.54781143	-0.574425645	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3843	10479	0.0036263	0.003053727	0	2	EN-L4	NA	NA	NA
GGGTCTGCAAGACGTG-1_6_C5	0.359578037	-19.13478398	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2822	6249	0.00656105	0.003680589	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GGGTCTGGTGGTACAG-1_6_C5	13.91804073	27.10481507	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	760	1112	0.004496403	0.003597122	0	oligos	OL-Cntl	NA	NA	NA
GGGTCTGGTGTGCCTG-1_6_C5	30.23020781	-2.601075252	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3868	9926	0.014910336	0.002115656	0	2	EN-L4	NA	NA	NA
GGGTCTGGTTCGGCAC-1_6_C5	30.5001355	-2.266201767	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2790	6119	0.002941657	0.003105083	0	2	EN-L4	NA	NA	NA
GGGTCTGTCCTACAGA-1_6_C5	28.31142824	-5.532159811	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	4024	10416	0.00124808	0.005184332	0	2	EN-L4	NA	NA	NA
GGGTCTGTCGTATCAG-1_6_C5	25.83192103	-3.155264705	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3177	8121	0.002832164	0.003201576	0	2	EN-L4	NA	NA	NA
GGGTTGCCAAGCTGGA-1_6_C5	-8.152458312	0.041227515	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2133	4279	0.010516476	0.003038093	0	13A	IN-VIP	NA	NA	NA
GGGTTGCCATGGTTGT-1_6_C5	16.96443477	29.00467786	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	853	1200	0.0025	0.0025	0	oligos	OL-Cntl	NA	NA	NA
GGGTTGCGTATCACCA-1_6_C5	15.14270373	-33.19804957	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	5513	19408	0.004946414	0.00340066	0	3	EN-L5-6	NA	NA	NA
GGGTTGCGTTGAACTC-1_6_C5	-0.346453691	-14.36621361	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2114	3989	0.003509652	0.003760341	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GGGTTGCTCAGAGCTT-1_6_C5	-28.26697403	9.587772202	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	721	1037	0.00289296	0.00192864	0	8	Astrocytes	NA	NA	NA
GGGTTGCTCCAAATGC-1_6_C5	16.16216585	22.54775441	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	889	1365	0.002197802	0.003663004	0	oligos	OL-Cntl	NA	NA	NA
GGTATTGAGCTTCGCG-1_6_C5	-27.97500817	18.00558659	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1150	1886	0.002120891	0.001060445	0	8	Astrocytes	NA	NA	NA
GGTATTGAGGACTGGT-1_6_C5	-20.07052742	-29.00697907	6A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3624	9712	0.001853377	0.002985997	0	6A	IN-PV	NA	NA	NA
GGTATTGCACCGGAAA-1_6_C5	20.75830078	-27.90883312	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2831	5907	0.000846453	0.003724395	0	3	EN-L5-6	NA	NA	NA
GGTATTGCAGGGAGAG-1_6_C5	-11.84842323	-9.318490755	13B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1614	2488	0.006430868	0.003617363	0	13B	IN-SV2C	NA	NA	NA
GGTATTGCATACTCTT-1_6_C5	-1.129032219	-18.1955936	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2764	6265	0.005586592	0.001755786	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GGTATTGCATATACGC-1_6_C5	-27.63725877	17.3900689	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1037	1714	0.001166861	0.005250875	0	8	Astrocytes	NA	NA	NA
GGTATTGTCGCTGATA-1_6_C5	-9.23134768	0.66455666	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2484	5139	0.007783615	0.003891808	0	13A	IN-VIP	NA	NA	NA
GGTATTGTCTATGTGG-1_6_C5	-11.8859448	-22.05354528	6A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1021	1667	0.0089982	0.00179964	0	6A	IN-PV	NA	NA	NA
GGTGAAGCACACGCTG-1_6_C5	20.75660953	-28.21925194	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3318	7115	0.00224877	0.003654252	0	3	EN-L5-6	NA	NA	NA
GGTGAAGCATATACCG-1_6_C5	-1.726375359	-15.89350962	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2282	4859	0.003292859	0.002469644	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GGTGAAGCATGTCGAT-1_6_C5	-25.57894334	20.31067	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1452	2421	0.000826105	0.004543577	0	8	Astrocytes	NA	NA	NA
GGTGAAGGTACCGGCT-1_6_C5	1.208551831	-28.25528651	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	4228	11067	0.007319057	0.004337219	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GGTGAAGGTCCGAATT-1_6_C5	9.500638273	-9.215072363	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2679	6198	0.001290739	0.001452081	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GGTGAAGGTCTCATCC-1_6_C5	12.01285486	32.557257	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	773	1141	0.002629273	0.000876424	0	oligos	OL-Cntl	NA	NA	NA
GGTGAAGTCACGGTTA-1_6_C5	32.31998635	-3.743580402	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3099	6684	0.012866547	0.005685218	0	2	EN-L4	NA	NA	NA
GGTGAAGTCAGTTAGC-1_6_C5	-37.17270018	-7.759854548	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1083	1756	0.001138952	0.002277904	0	9	OPC	NA	NA	NA
GGTGCGTAGCAATCTC-1_6_C5	23.07712345	12.2596672	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1495	2558	0.004691165	0.001954652	0	oligos	OL-Cntl	NA	NA	NA
GGTGCGTAGTCCCACG-1_6_C5	12.13231519	29.6922166	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	701	1028	0	0.001945525	0	oligos	OL-Cntl	NA	NA	NA
GGTGCGTCATGGTCAT-1_6_C5	7.517058208	-32.49254038	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	5231	17126	0.006014247	0.002394021	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GGTGCGTGTCTCATCC-1_6_C5	-35.98151574	-10.40642595	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	933	1444	0.002077562	0.002077562	0	9	OPC	NA	NA	NA
GGTGCGTTCGGATGTT-1_6_C5	14.8935238	1.673606671	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	978	1431	0.011180992	0.00349406	0	12	EN-MIX	NA	NA	NA
GGTGTTAAGACTTGAA-1_6_C5	17.99659026	22.85920156	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	937	1476	0.001355014	0.00203252	0	oligos	OL-Cntl	NA	NA	NA
GGTGTTAAGCCAGGAT-1_6_C5	14.93708156	28.00898644	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	707	1059	0	0.000944287	0	oligos	OL-Cntl	NA	NA	NA
GGTGTTACAAAGCAAT-1_6_C5	9.349098613	-7.645556991	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1998	3460	0.001156069	0.002023121	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GGTGTTACAAGGACAC-1_6_C5	-4.290405194	-4.572020848	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1192	1925	0.011948052	0.002077922	0	13A	IN-VIP	NA	NA	NA
GGTGTTACAGGGTATG-1_6_C5	12.22385742	32.09429018	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	689	1006	0	0.003976143	0	oligos	OL-Cntl	NA	NA	NA
GGTGTTAGTGGGTCAA-1_6_C5	25.01112617	-0.004667653	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2284	4461	0.003810805	0.00224165	0	2	EN-L4	NA	NA	NA
GGTGTTAGTGTTGAGG-1_6_C5	27.43393931	0.67150369	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3886	9581	0.005323035	0.002922451	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GGTGTTAGTTCGGCAC-1_6_C5	-36.66656811	-4.634088461	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1326	2239	0.008039303	0.003126396	0	9	OPC	NA	NA	NA
GTAACGTCAGCTGTTA-1_6_C5	4.848009026	-14.37269971	4	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2474	4729	0.021569042	0.002748996	0	L2-3	EN-L2-3-MS	NA	NA	NA
GTAACGTTCAAGGTAA-1_6_C5	-2.198177479	5.99285208	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1142	1688	0.002962085	0.002369668	0	oligos	OL-Cntl	NA	NA	NA
GTAACGTTCGGATGTT-1_6_C5	-14.0869481	-24.31154842	6A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1383	2404	0.023710483	0.00124792	0	6A	IN-PV	NA	NA	NA
GTAACTGGTGAGGGTT-1_6_C5	2.473838263	-9.216241691	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1487	2496	0.005608974	0.005208333	0	12	EN-MIX	NA	NA	NA
GTACGTACAGAAGCAC-1_6_C5	-26.60815607	25.9216694	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1363	2551	0.001568013	0.004704038	0	8	Astrocytes	NA	NA	NA
GTACGTAGTCTAGTCA-1_6_C5	-30.46742293	19.68757804	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	969	1571	0.001273074	0.001909612	0	8	Astrocytes	NA	NA	NA
GTACGTAGTGCGGTAA-1_6_C5	19.13557484	23.01584976	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	979	1494	0.000669344	0.004016064	0	oligos	OL-Cntl	NA	NA	NA
GTACGTAGTTCCACTC-1_6_C5	-19.09242428	-28.59633152	6A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3280	8646	0.000462642	0.00277585	0	6A	IN-PV	NA	NA	NA
GTACGTATCACCCTCA-1_6_C5	6.077572332	-32.5476501	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	4206	13525	0.007319778	0.001848429	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GTACGTATCTTAGAGC-1_6_C5	-37.04853305	-8.173377791	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1050	1755	0.000569801	0.002849003	0	9	OPC	NA	NA	NA
GTACTCCAGGATGCGT-1_6_C5	22.47170335	12.97372023	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1306	2163	0.004623209	0.002311604	0	oligos	OL-Cntl	NA	NA	NA
GTACTCCAGGTCATCT-1_6_C5	23.32155481	0.177236569	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2020	3866	0.015519917	0.003103983	0	2	EN-L4	NA	NA	NA
GTACTCCCACCATCCT-1_6_C5	16.47248062	-32.64755502	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	5403	19109	0.003663195	0.002668899	0	3	EN-L5-6	NA	NA	NA
GTACTCCCAGCTGCTG-1_6_C5	10.58224077	31.51943043	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	854	1285	0	0.006225681	0	oligos	OL-Cntl	NA	NA	NA
GTACTCCGTCTAGCGC-1_6_C5	2.471692592	-11.09902954	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1667	2958	0.01352265	0.006761325	0	12	EN-MIX	NA	NA	NA
GTACTCCGTTCCCGAG-1_6_C5	11.84835906	27.02611271	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	753	1108	0.000902527	0.001805054	0	oligos	OL-Cntl	NA	NA	NA
GTACTCCTCCTAAGTG-1_6_C5	-9.008261568	15.29382451	11	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1873	3423	0.002337131	0.003213555	0	11	Glia-MIX	NA	NA	NA
GTACTTTAGGGTGTGT-1_6_C5	-19.55699839	-24.16750353	6A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2963	7333	0.025773899	0.003818355	0	6A	IN-PV	NA	NA	NA
GTACTTTAGGTGGGTT-1_6_C5	-35.63300274	-10.82991998	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	890	1383	0.002169197	0.002169197	0	9	OPC	NA	NA	NA
GTACTTTCAATCGGTT-1_6_C5	3.12283509	-10.99368854	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1726	2883	0.015955602	0.005549775	0	12	EN-MIX	NA	NA	NA
GTACTTTGTATATGGA-1_6_C5	-34.79937373	-12.86727634	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	788	1165	0.004291845	0.003433476	0	9	OPC	NA	NA	NA
GTACTTTTCAGGCGAA-1_6_C5	-4.600051355	-4.082137581	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1194	1969	0.013712544	0.00507872	0	13A	IN-VIP	NA	NA	NA
GTAGGCCCACCCTATC-1_6_C5	15.23349295	-30.23748552	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3735	9991	0.007306576	0.003903513	0	3	EN-L5-6	NA	NA	NA
GTAGGCCCAGCTGCAC-1_6_C5	-11.93269076	-22.39113771	6B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1226	2052	0.037037037	0.004385965	0	6B	IN-SST	NA	NA	NA
GTAGGCCGTAGTGAAT-1_6_C5	2.586915891	-13.68013616	4	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2221	4105	0.018270402	0.004872107	0	L2-3	EN-L2-3-MS	NA	NA	NA
GTAGGCCGTGCAACTT-1_6_C5	16.70532716	22.49760318	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	882	1319	0	0.0015163	0	oligos	OL-Cntl	NA	NA	NA
GTAGGCCTCTAACGGT-1_6_C5	8.050560278	29.93990779	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	770	1125	0.005333333	0.004444444	0	oligos	OL-Cntl	NA	NA	NA
GTAGTCAAGAAGAAGC-1_6_C5	15.62165756	28.99698029	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	838	1209	0.008271299	0.003308519	0	oligos	OL-Cntl	NA	NA	NA
GTAGTCAAGAGGTTAT-1_6_C5	6.651663923	-8.356640509	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1875	3375	0.010962963	0.002666667	0	3	EN-L5-6	NA	NA	NA
GTAGTCAAGAGTACAT-1_6_C5	-1.693375439	-18.2261343	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2964	7025	0.006690391	0.003274021	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GTAGTCAAGGCATGTG-1_6_C5	2.537132949	-8.062536936	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1414	2281	0.020604998	0.012275318	0	12	EN-MIX	NA	NA	NA
GTAGTCAAGTCCATAC-1_6_C5	22.70753313	18.82169614	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1039	1640	0.002439024	0.004878049	0	oligos	OL-Cntl	NA	NA	NA
GTAGTCACACAAGCCC-1_6_C5	4.455951809	-2.798069524	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	782	1082	0.038817006	0.007393715	0	12	EN-MIX	NA	NA	NA
GTAGTCACATGCCTAA-1_6_C5	19.71648037	10.95248367	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1430	2483	0.003221909	0.005235602	0	oligos	OL-Cntl	NA	NA	NA
GTAGTCAGTAAGTGTA-1_6_C5	23.23240923	14.46804076	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1205	1915	0	0.001044386	0	oligos	OL-Cntl	NA	NA	NA
GTAGTCAGTTAGATGA-1_6_C5	3.170604329	-27.46109429	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3091	7124	0.006035935	0.001263335	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GTAGTCAGTTATGCGT-1_6_C5	-14.17054935	-22.33047537	6A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1318	2362	0.010584251	0.00254022	0	6A	IN-PV	NA	NA	NA
GTAGTCAGTTCCGTCT-1_6_C5	19.9690626	14.9891244	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1172	2026	0.00148075	0.001974334	0	oligos	OL-Cntl	NA	NA	NA
GTAGTCATCCGCATAA-1_6_C5	20.01300093	11.07183553	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1570	2776	0.002161383	0.003242075	0	oligos	OL-Cntl	NA	NA	NA
GTATCTTCAATCGAAA-1_6_C5	-6.956570627	-0.731106167	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1775	3291	0.017927682	0.00303859	0	13A	IN-VIP	NA	NA	NA
GTATCTTCATGACGGA-1_6_C5	27.84316798	-4.295464441	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3441	8265	0.001330913	0.002782819	0	2	EN-L4	NA	NA	NA
GTATCTTGTCATACTG-1_6_C5	13.93067926	29.28495988	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	776	1100	0.007272727	0.003636364	0	oligos	OL-Cntl	NA	NA	NA
GTATCTTGTCGACTGC-1_6_C5	-18.12143006	-19.97598975	6B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2026	3889	0.00745693	0.00231422	0	6B	IN-SST	NA	NA	NA
GTATTCTCAGTCAGCC-1_6_C5	8.288233205	32.77612674	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	811	1219	0.004922067	0.004922067	0	oligos	OL-Cntl	NA	NA	NA
GTATTCTGTCCAGTAT-1_6_C5	-35.17087414	-12.49890015	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	787	1279	0.000781861	0.003909304	0	9	OPC	NA	NA	NA
GTATTCTTCAAACAAG-1_6_C5	0.268728246	-10.43041846	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1515	2708	0.01366322	0.004800591	0	12	EN-MIX	NA	NA	NA
GTATTCTTCCAGATCA-1_6_C5	-16.7507333	-23.3078987	6A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1733	3505	0.010556348	0.001426534	0	6A	IN-PV	NA	NA	NA
GTCAAGTAGAAAGTGG-1_6_C5	-36.21320511	-10.62613976	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	990	1528	0.006544503	0.001963351	0	9	OPC	NA	NA	NA
GTCAAGTAGAATGTGT-1_6_C5	-36.8693967	-8.239891002	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1073	1819	0.004947774	0.001649258	0	9	OPC	NA	NA	NA
GTCAAGTAGGTAGCTG-1_6_C5	-20.3653787	-28.99869937	6A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	4341	12243	0.002777097	0.002858776	0	6A	IN-PV	NA	NA	NA
GTCAAGTCACTACAGT-1_6_C5	27.21645073	-1.763029935	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3088	7413	0.007824093	0.002293269	0	2	EN-L4	NA	NA	NA
GTCAAGTGTTACAGAA-1_6_C5	-28.16520639	22.66025299	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1174	1882	0.00053135	0.003719447	0	8	Astrocytes	NA	NA	NA
GTCAAGTTCTAGCACA-1_6_C5	23.48080248	12.74803642	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1331	2233	0.000895656	0.00447828	0	oligos	OL-Cntl	NA	NA	NA
GTCAAGTTCTCAAACG-1_6_C5	4.354963345	-30.06762102	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3398	8789	0.003072022	0.001820457	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GTCACAAAGTACGTAA-1_6_C5	28.24578133	-0.048459412	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2874	6471	0.001699892	0.004326997	0	2	EN-L4	NA	NA	NA
GTCACAACAAGAGTCG-1_6_C5	-35.739295	-8.122706414	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	969	1444	0.003462604	0.003462604	0	9	OPC	NA	NA	NA
GTCACAACAATCTACG-1_6_C5	-28.47282698	23.56554316	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1112	1920	0.000520833	0.003645833	0	8	Astrocytes	NA	NA	NA
GTCACAACATCGGTTA-1_6_C5	7.445209417	-32.49577879	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	4553	13789	0.002828341	0.002030604	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GTCACAACATGAGCGA-1_6_C5	17.46773322	1.658731047	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	911	1416	0.003531073	0.000706215	0	12	EN-MIX	NA	NA	NA
GTCACAACATTGTGCA-1_6_C5	20.19509117	21.22581517	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	926	1419	0.007047216	0.005637773	0	oligos	OL-Cntl	NA	NA	NA
GTCACAATCTAACGGT-1_6_C5	1.215926034	-26.75578998	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3517	8817	0.005897698	0.003062266	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GTCACAATCTTGAGGT-1_6_C5	17.86727962	15.200401	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1164	1954	0.006653019	0.004605937	0	oligos	OL-Cntl	NA	NA	NA
GTCACGGAGAGCTGCA-1_6_C5	-34.78394568	-10.4386136	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	948	1504	0.000664894	0.003989362	0	9	OPC	NA	NA	NA
GTCACGGAGATCGGGT-1_6_C5	3.152317413	34.12661703	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	754	1062	0.005649718	0.005649718	0	oligos	OL-Cntl	NA	NA	NA
GTCACGGGTACCGGCT-1_6_C5	9.64846658	27.33248837	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	913	1309	0.011459129	0.001527884	0	oligos	OL-Cntl	NA	NA	NA
GTCACGGGTTTGCATG-1_6_C5	20.08730068	1.489297526	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1490	2640	0.004545455	0.002651515	0	2	EN-L4	NA	NA	NA
GTCACGGTCATTGCCC-1_6_C5	24.47260427	-29.61158002	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2837	6991	0.003719067	0.003146903	0	3	EN-L5-6	NA	NA	NA
GTCATTTAGCCCGAAA-1_6_C5	9.888434112	27.19603641	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	847	1347	0.001484781	0.003711952	0	oligos	OL-Cntl	NA	NA	NA
GTCATTTAGGGCTTCC-1_6_C5	14.92999643	25.58868928	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	817	1327	0.00075358	0.003767898	0	oligos	OL-Cntl	NA	NA	NA
GTCATTTCAAATCCGT-1_6_C5	-10.46862815	16.02469352	11	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1653	2800	0.007142857	0.002857143	0	11	Glia-MIX	NA	NA	NA
GTCATTTCAACTGCGC-1_6_C5	-25.72772261	19.48980431	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1301	2246	0	0.004897596	0	8	Astrocytes	NA	NA	NA
GTCATTTCAGATCGGA-1_6_C5	33.40773029	-4.764513267	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2748	5584	0.01969914	0.003402579	0	2	EN-L4	NA	NA	NA
GTCCTCAAGGCATTGG-1_6_C5	2.047647416	-12.66368701	4	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1966	3623	0.011316588	0.006624344	0	L2-3	EN-L2-3-MS	NA	NA	NA
GTCCTCAAGTCTCAAC-1_6_C5	2.492065618	-8.47949806	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1548	2579	0.007367197	0.005428461	0	12	EN-MIX	NA	NA	NA
GTCCTCACACTTAAGC-1_6_C5	1.413893204	-19.09892117	4	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2950	6560	0.00320122	0.005792683	0	L2-3	EN-L2-3-MS	NA	NA	NA
GTCCTCACAGATGGCA-1_6_C5	-39.39880076	-1.052735924	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1303	2271	0	0.002201673	0	9	OPC	NA	NA	NA
GTCCTCACATCGGAAG-1_6_C5	-36.73312955	-4.902176318	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1340	2181	0.004126547	0.001834021	0	9	OPC	NA	NA	NA
GTCCTCAGTCTGATCA-1_6_C5	-38.36887844	-1.18608398	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1343	2371	0.000843526	0.002952341	0	9	OPC	NA	NA	NA
GTCCTCAGTGCACCAC-1_6_C5	-10.72058885	-0.978705761	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2319	4240	0.007783019	0.005188679	0	13A	IN-VIP	NA	NA	NA
GTCCTCAGTTCATGGT-1_6_C5	22.50316899	13.07700838	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1308	2146	0.00139795	0.003261883	0	oligos	OL-Cntl	NA	NA	NA
GTCCTCATCTGTCTCG-1_6_C5	19.45807567	20.430714	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	944	1524	0.00656168	0.002624672	0	oligos	OL-Cntl	NA	NA	NA
GTCCTCATCTTAACCT-1_6_C5	29.68652747	-5.497480767	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3980	10123	0.006914946	0.004939247	0	2	EN-L4	NA	NA	NA
GTCGGGTCAAAGCGGT-1_6_C5	-27.10998122	13.49972089	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	897	1348	0	0.002225519	0	8	Astrocytes	NA	NA	NA
GTCGGGTCATTAACCG-1_6_C5	-6.064108532	-2.910689537	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1593	2744	0.012026239	0.002915452	0	13A	IN-VIP	NA	NA	NA
GTCGGGTGTAAACACA-1_6_C5	-28.04137911	22.97181814	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1249	2100	0.001428571	0.005238095	0	8	Astrocytes	NA	NA	NA
GTCGGGTGTCTTGTCC-1_6_C5	14.84755459	-33.46129895	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	4585	14103	0.000212721	0.003261717	0	3	EN-L5-6	NA	NA	NA
GTCGGGTTCAACACAC-1_6_C5	-35.23236076	-12.17630859	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	810	1262	0.003961965	0.003961965	0	9	OPC	NA	NA	NA
GTCGGGTTCCTCAACC-1_6_C5	-25.04875368	27.47792281	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1582	2774	0.00036049	0.003604903	0	8	Astrocytes	NA	NA	NA
GTCGGGTTCGGCGCAT-1_6_C5	-35.08594821	-6.65033956	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1090	1560	0.005769231	0.001923077	0	9	OPC	NA	NA	NA
GTCGTAAAGACTAGAT-1_6_C5	20.64564911	19.74615618	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1030	1573	0	0.00317864	0	oligos	OL-Cntl	NA	NA	NA
GTCGTAACATTAGGCT-1_6_C5	-4.070337604	25.53471916	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	725	1038	0.035645472	0.004816956	0	oligos	OL-Cntl	NA	NA	NA
GTCGTAATCATTTGGG-1_6_C5	-5.069122199	-2.515061843	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1536	2761	0.00905469	0.003259689	0	13A	IN-VIP	NA	NA	NA
GTCGTAATCTAACGGT-1_6_C5	5.363742351	29.62641911	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	731	1125	0.000888889	0.002666667	0	oligos	OL-Cntl	NA	NA	NA
GTCTCGTAGCTAACAA-1_6_C5	-28.61124121	22.42542104	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1050	1690	0.001775148	0.004733728	0	8	Astrocytes	NA	NA	NA
GTCTCGTCAATGTAAG-1_6_C5	18.67557095	20.42830918	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1129	1896	0.00685654	0.002109705	0	oligos	OL-Cntl	NA	NA	NA
GTCTCGTCACATGACT-1_6_C5	12.71925688	28.48463668	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	678	1024	0.000976563	0.004882813	0	oligos	OL-Cntl	NA	NA	NA
GTCTCGTGTACGACCC-1_6_C5	-0.423805535	-14.84097208	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2309	4554	0.002635046	0.004611331	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GTCTCGTGTTCGTGAT-1_6_C5	24.27843413	-0.039086088	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2392	4923	0.007921999	0.001828154	0	2	EN-L4	NA	NA	NA
GTCTCGTTCGGTGTTA-1_6_C5	5.107864491	31.23734826	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	753	1169	0.005132592	0.002566296	0	oligos	OL-Cntl	NA	NA	NA
GTCTCGTTCTTCATGT-1_6_C5	25.4830023	-5.327292434	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	5102	19804	0.000201979	0.001918804	0	2	EN-L4	NA	NA	NA
GTCTTCGAGCCAGTTT-1_6_C5	-1.381685653	-1.182888115	11	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1686	2833	0.013766325	0.003176844	0	11	Glia-MIX	NA	NA	NA
GTCTTCGCAAGCCCAC-1_6_C5	0.448473532	-25.65478077	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	5274	17033	0.004814184	0.002348383	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GTCTTCGGTAAGTAGT-1_6_C5	-23.01978376	-0.568275524	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1356	2141	0	0.000934143	0	9	OPC	NA	NA	NA
GTCTTCGTCAGTTTGG-1_6_C5	-27.79691915	17.65924494	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1058	1708	0.00175644	0.00175644	0	8	Astrocytes	NA	NA	NA
GTCTTCGTCCTATGTT-1_6_C5	-25.59413602	20.21258172	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1350	2388	0	0.002512563	0	8	Astrocytes	NA	NA	NA
GTGAAGGAGAAACGCC-1_6_C5	-2.286725102	-19.60692242	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3011	7156	0.004471772	0.002515372	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GTGAAGGCACCCATTC-1_6_C5	12.37715455	28.7998046	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	796	1248	0	0.000801282	0	oligos	OL-Cntl	NA	NA	NA
GTGAAGGGTAGCGTGA-1_6_C5	-11.61864208	17.68581752	11	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1844	3175	0.005984252	0.004409449	0	11	Glia-MIX	NA	NA	NA
GTGAAGGTCTCTGTCG-1_6_C5	15.74788701	-7.744597386	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2094	4652	0.010318143	0.004729149	0	3	EN-L5-6	NA	NA	NA
GTGCAGCAGCCACTAT-1_6_C5	21.21775791	24.03166791	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1117	1697	0.002357101	0.006482027	0	oligos	OL-Cntl	NA	NA	NA
GTGCAGCGTACCGGCT-1_6_C5	-38.04499526	-0.970690902	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1373	2441	0	0.002048341	0	9	OPC	NA	NA	NA
GTGCAGCGTTGACGTT-1_6_C5	-0.504892549	-16.99717414	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2542	4962	0.003426038	0.002216848	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GTGCAGCTCAAACCAC-1_6_C5	-23.14796091	0.022805042	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1739	3059	0.003595946	0.004903563	0	9	OPC	NA	NA	NA
GTGCAGCTCACTCCTG-1_6_C5	22.59355046	19.45113522	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1184	1911	0.002093145	0.005232862	0	oligos	OL-Cntl	NA	NA	NA
GTGCAGCTCGGCTTGG-1_6_C5	18.59776879	8.977404377	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1605	2918	0.005825908	0.004455106	0	oligos	OL-Cntl	NA	NA	NA
GTGCATAAGCGACGTA-1_6_C5	17.57621196	22.65563539	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	928	1415	0.001413428	0.007773852	0	oligos	OL-Cntl	NA	NA	NA
GTGCATACATCGACGC-1_6_C5	-15.64766353	-17.72015624	6B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1766	3322	0.018362432	0.003010235	0	6B	IN-SST	NA	NA	NA
GTGCATAGTTCGCGAC-1_6_C5	-0.397552129	-14.60739014	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2200	4299	0.004419632	0.003023959	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GTGCATAGTTGTTTGG-1_6_C5	-37.86825675	-0.871862375	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1429	2628	0.002663623	0.00152207	0	9	OPC	NA	NA	NA
GTGCATATCCAAGTAC-1_6_C5	-27.7543134	22.53370937	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1278	2060	0.002427184	0.002427184	0	8	Astrocytes	NA	NA	NA
GTGCATATCGCCAAAT-1_6_C5	6.412825838	28.39372375	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	723	1049	0.001906578	0.003813155	0	oligos	OL-Cntl	NA	NA	NA
GTGCATATCGGCATCG-1_6_C5	19.3674598	10.08436106	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1538	2744	0.000364431	0.004008746	0	oligos	OL-Cntl	NA	NA	NA
GTGCGGTAGAAACGCC-1_6_C5	17.55835633	28.86825082	17	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	844	1254	0.009569378	0.001594896	0	oligos	OL-MS-2	NA	NA	NA
GTGCGGTGTCGCGGTT-1_6_C5	12.73957996	29.73926714	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	732	1085	0.010138249	0.007373272	0	oligos	OL-Cntl	NA	NA	NA
GTGCGGTGTCTAGTGT-1_6_C5	20.01289358	27.07676867	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	991	1505	0.002657807	0.001328904	0	oligos	OL-Cntl	NA	NA	NA
GTGCGGTGTGGCTCCA-1_6_C5	-15.42387721	-7.111644966	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	4115	11032	0.006979695	0.002084844	0	13A	IN-VIP	NA	NA	NA
GTGCGGTTCACCTTAT-1_6_C5	12.03032693	28.50869724	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	806	1223	0.003270646	0.001635323	0	oligos	OL-Cntl	NA	NA	NA
GTGCGGTTCCGTAGGC-1_6_C5	1.657091255	-17.00312537	4	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2885	6276	0.007966858	0.005098789	0	L2-3	EN-L2-3-MS	NA	NA	NA
GTGCTTCAGGAGTACC-1_6_C5	14.13325112	1.87187974	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	747	1016	0.015748031	0.00492126	0	12	EN-MIX	NA	NA	NA
GTGCTTCCACATAACC-1_6_C5	-0.995821219	3.820902168	11	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1095	1789	0.002794857	0.004471772	0	11	Glia-MIX	NA	NA	NA
GTGCTTCCACCCATGG-1_6_C5	21.29960539	22.98246678	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1137	1799	0.003335186	0.006670372	0	oligos	OL-Cntl	NA	NA	NA
GTGCTTCTCAGCTGGC-1_6_C5	13.35337288	-30.55486071	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2921	6832	0.006293911	0.003805621	0	3	EN-L5-6	NA	NA	NA
GTGCTTCTCCAAACAC-1_6_C5	14.5582999	23.984943	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	886	1394	0.00286944	0.004304161	0	oligos	OL-Cntl	NA	NA	NA
GTGCTTCTCGCAAACT-1_6_C5	-0.28467889	-25.75137298	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	5230	16456	0.003038405	0.002734565	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GTGGGTCCACCCAGTG-1_6_C5	-9.064143282	-19.97112268	6B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	720	1022	0.040117417	0.001956947	0	6B	IN-SST	NA	NA	NA
GTGGGTCCAGACGCTC-1_6_C5	13.22689741	31.97940574	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	810	1272	0.000786164	0.004716981	0	oligos	OL-Cntl	NA	NA	NA
GTGGGTCGTTAGATGA-1_6_C5	22.21243852	16.02501516	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1241	1915	0.003133159	0.005744125	0	oligos	OL-Cntl	NA	NA	NA
GTGGGTCTCAAGGTAA-1_6_C5	-16.34819762	-10.60322396	13B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2771	5786	0.009505703	0.002419634	0	13B	IN-SV2C	NA	NA	NA
GTGGGTCTCTGGCGAC-1_6_C5	3.412031797	30.94533168	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	725	1082	0	0.004621072	0	oligos	OL-Cntl	NA	NA	NA
GTGTGCGAGATCGATA-1_6_C5	6.033907504	-32.5998424	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	4624	15014	0.002197949	0.001665113	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GTGTGCGAGGCCATAG-1_6_C5	2.728809286	-12.28664863	4	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1876	3388	0.012987013	0.006198347	0	L2-3	EN-L2-3-MS	NA	NA	NA
GTGTGCGCAAAGCAAT-1_6_C5	-27.85266599	4.409543957	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1421	2211	0.005427408	0.002713704	0	9	OPC	NA	NA	NA
GTGTGCGCACAACGCC-1_6_C5	-13.53748994	-5.239625913	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2387	4907	0.017525983	0.004687182	0	13A	IN-VIP	NA	NA	NA
GTGTGCGTCATCATTC-1_6_C5	-8.532044308	-17.82550394	6B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	780	1164	0.018041237	0.003436426	0	6B	IN-SST	NA	NA	NA
GTGTTAGAGCCACGTC-1_6_C5	-16.4832546	-9.731538182	13B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2869	6040	0.006125828	0.004139073	0	13B	IN-SV2C	NA	NA	NA
GTGTTAGGTACTTCTT-1_6_C5	-15.70509322	-11.2265238	13B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2753	6011	0.00598902	0.003493595	0	13B	IN-SV2C	NA	NA	NA
GTGTTAGTCTGAAAGA-1_6_C5	-1.737047834	-17.83360047	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2688	5822	0.005668155	0.002404672	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GTGTTAGTCTGTCCGT-1_6_C5	30.87887784	-4.507151622	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3077	6377	0.006586169	0.00266583	0	2	EN-L4	NA	NA	NA
GTTAAGCAGCTCCCAG-1_6_C5	1.25650854	-16.55901024	4	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2393	4595	0.014798694	0.003482046	0	L2-3	EN-L2-3-MS	NA	NA	NA
GTTAAGCCACTTCGAA-1_6_C5	15.55806492	-7.921251937	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2131	4071	0.010316875	0.003193319	0	3	EN-L5-6	NA	NA	NA
GTTAAGCCAGATCGGA-1_6_C5	23.13504787	1.005058724	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1908	3642	0.012081274	0.001098298	0	2	EN-L4	NA	NA	NA
GTTAAGCCATGGTTGT-1_6_C5	-3.966738259	-5.802600621	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1006	1647	0.015786278	0.001821494	0	13A	IN-VIP	NA	NA	NA
GTTACAGAGATCCCAT-1_6_C5	-13.25779349	-18.35998591	6B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1191	1947	0.00770416	0.006676939	0	6B	IN-SST	NA	NA	NA
GTTACAGAGCAGCCTC-1_6_C5	-13.91612968	-34.78488514	16	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2317	4878	0.143501435	0.004510045	0	16	EN-PYR	NA	NA	NA
GTTACAGGTCAGGACA-1_6_C5	16.35524703	1.690386615	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	771	1117	0.008952551	0.004476276	0	12	EN-MIX	NA	NA	NA
GTTCATTAGATCCCAT-1_6_C5	-24.32636633	26.61371746	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1454	2392	0.006688963	0.002508361	0	8	Astrocytes	NA	NA	NA
GTTCATTAGATCGGGT-1_6_C5	18.52225874	-6.938815585	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2046	4314	0.003940658	0.003708855	0	3	EN-L5-6	NA	NA	NA
GTTCATTCAGGTGGAT-1_6_C5	2.831195669	-25.81709414	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3301	8075	0.003962848	0.001857585	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GTTCATTGTACCGGCT-1_6_C5	22.99105642	-0.314499025	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2045	3926	0.011462048	0.002037697	0	2	EN-L4	NA	NA	NA
GTTCATTTCAGAAATG-1_6_C5	1.040364704	0.97073706	11	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	945	1571	0.001909612	0.005728835	0	11	Glia-MIX	NA	NA	NA
GTTCATTTCTGACCTC-1_6_C5	-37.15579322	-8.817210487	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	991	1661	0.004214329	0.002408188	0	9	OPC	NA	NA	NA
GTTCGGGCAAGCCATT-1_6_C5	5.900038566	26.38205803	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	805	1159	0.003451251	0.000862813	0	oligos	OL-Cntl	NA	NA	NA
GTTCGGGCACGAGAGT-1_6_C5	23.19580273	1.347596476	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1917	3819	0	0.001047395	0	2	EN-L4	NA	NA	NA
GTTCGGGCAGGTTTCA-1_6_C5	16.14925678	22.91080528	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	957	1438	0.004867872	0.007649513	0	oligos	OL-Cntl	NA	NA	NA
GTTCGGGCATCGGGTC-1_6_C5	4.250907278	-3.336185753	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	896	1238	0.00726979	0.005654281	0	12	EN-MIX	NA	NA	NA
GTTCGGGGTTCAACCA-1_6_C5	1.233107442	-29.42076483	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	4464	14734	0.002239718	0.001153794	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GTTCGGGTCAAACGGG-1_6_C5	26.96378491	-4.000437416	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3800	9777	0.007977907	0.00235246	0	2	EN-L4	NA	NA	NA
GTTCGGGTCGTTACGA-1_6_C5	-27.6816248	17.90315189	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1058	1628	0.002457002	0.001228501	0	8	Astrocytes	NA	NA	NA
GTTCTCGCACTAGTAC-1_6_C5	16.70238107	24.4405575	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	882	1383	0.002169197	0.002892263	0	oligos	OL-Cntl	NA	NA	NA
GTTCTCGCACTGTTAG-1_6_C5	-21.64009706	-26.51813952	6A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2530	5170	0.00270793	0.002321083	0	6A	IN-PV	NA	NA	NA
GTTCTCGCAGCAGTTT-1_6_C5	-36.9186526	-9.153605928	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	879	1353	0	0.002217295	0	9	OPC	NA	NA	NA
GTTCTCGGTCATGCCG-1_6_C5	-38.05923531	-8.510355007	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1028	1704	0	0.001760563	0	9	OPC	NA	NA	NA
GTTCTCGTCCGGGTGT-1_6_C5	1.243106149	-18.2181754	4	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2632	5983	0.012201237	0.003175664	0	L2-3	EN-L2-3-MS	NA	NA	NA
GTTCTCGTCCTGCAGG-1_6_C5	9.794073523	-8.968664614	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2482	5673	0.008637405	0.001762736	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GTTTCTAAGACGCTTT-1_6_C5	-29.5728093	15.50086967	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	936	1528	0.00065445	0	0	8	Astrocytes	NA	NA	NA
GTTTCTAGTGACGCCT-1_6_C5	-0.375571028	-16.12116934	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2336	5022	0.010951812	0.002787734	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GTTTCTAGTGCGAAAC-1_6_C5	2.891997387	-7.79373781	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1306	2174	0.021159154	0.005519779	0	12	EN-MIX	NA	NA	NA
GTTTCTATCTAACTGG-1_6_C5	-15.36468845	-11.06914454	13B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2385	4889	0.00245449	0.001227245	0	13B	IN-SV2C	NA	NA	NA
GTTTCTATCTCCAACC-1_6_C5	-7.869713178	-16.5940226	6B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	611	1033	0.028073572	0.001936108	0	6B	IN-SST	NA	NA	NA
GTTTCTATCTCCTATA-1_6_C5	1.743451971	-5.713901825	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1048	1684	0.009501188	0.002969121	0	12	EN-MIX	NA	NA	NA
TAAACCGAGATGGGTC-1_6_C5	4.227888904	-3.231752349	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	918	1300	0.041538462	0.013076923	0	12	EN-MIX	NA	NA	NA
TAAACCGAGCACCGTC-1_6_C5	-27.4318928	15.38830822	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	989	1580	0.008227848	0.001898734	0	8	Astrocytes	NA	NA	NA
TAAACCGAGCCCAGCT-1_6_C5	-3.238844789	-5.535050638	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	960	1633	0.014696877	0.002449479	0	13A	IN-VIP	NA	NA	NA
TAAACCGCACATTTCT-1_6_C5	-37.60977515	-5.40556113	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1239	2145	0.003729604	0.001864802	0	9	OPC	NA	NA	NA
TAAACCGGTAAAGGAG-1_6_C5	14.49564955	28.86694787	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	712	1035	0	0.000966184	0	oligos	OL-Cntl	NA	NA	NA
TAAGAGACAGAGTGTG-1_6_C5	-35.21287384	-11.92409785	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	822	1253	0	0.000798085	0	9	OPC	NA	NA	NA
TAAGAGAGTAGAAAGG-1_6_C5	0.49403025	-11.7943099	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1752	3251	0.013534297	0.004306367	0	12	EN-MIX	NA	NA	NA
TAAGCGTAGATAGTCA-1_6_C5	1.602188977	-16.81103211	4	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2422	4931	0.01622389	0.004258771	0	L2-3	EN-L2-3-MS	NA	NA	NA
TAAGCGTAGCCCGAAA-1_6_C5	11.35976771	29.26412053	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	724	1091	0.007332722	0.002749771	0	oligos	OL-Cntl	NA	NA	NA
TAAGCGTTCTGGGCCA-1_6_C5	5.699797284	32.15485137	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	711	1025	0.00195122	0.004878049	0	oligos	OL-Cntl	NA	NA	NA
TAAGTGCAGCACCGCT-1_6_C5	6.79839	-30.18219485	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	4777	14154	0.006076021	0.001766285	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TAAGTGCCAGTATAAG-1_6_C5	6.777320661	-27.65019804	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	5437	17161	0.004253831	0.00209778	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TAAGTGCTCAGTGTTG-1_6_C5	-7.11014101	-1.484681616	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1749	3160	0.008227848	0.00221519	0	13A	IN-VIP	NA	NA	NA
TAAGTGCTCTACCAGA-1_6_C5	0.876290778	-29.47331509	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	4559	14396	0.001736593	0.003681578	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TACACGAAGGACTGGT-1_6_C5	-27.17703799	18.32101781	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1067	1801	0	0.004441977	0	8	Astrocytes	NA	NA	NA
TACACGAAGGATATAC-1_6_C5	9.156424631	33.54705365	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	873	1253	0.002394254	0.003990423	0	oligos	OL-Cntl	NA	NA	NA
TACACGAGTCCAACTA-1_6_C5	-33.6944605	-12.58045893	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	688	1074	0	0.003724395	0	9	OPC	NA	NA	NA
TACACGAGTGCCTTGG-1_6_C5	11.14372452	27.53223774	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	863	1293	0.003866976	0.003866976	0	oligos	OL-Cntl	NA	NA	NA
TACACGATCAGCTGGC-1_6_C5	1.570024312	-12.44677672	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2069	3910	0.015601023	0.006649616	0	12	EN-MIX	NA	NA	NA
TACAGTGAGCTAACAA-1_6_C5	14.81311514	28.07600325	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	769	1132	0.000883392	0.001766784	0	oligos	OL-Cntl	NA	NA	NA
TACAGTGCAATCCGAT-1_6_C5	-17.02188346	-23.65989288	6A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1893	3950	0.005822785	0.001772152	0	6A	IN-PV	NA	NA	NA
TACAGTGCAGCCTATA-1_6_C5	38.5939181	8.98688039	14	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	849	1117	0.005371531	0.00179051	0	14	Microglia	NA	NA	NA
TACAGTGCATGTCTCC-1_6_C5	7.083806586	27.27538004	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	821	1247	0.001603849	0.003207698	0	oligos	OL-Cntl	NA	NA	NA
TACAGTGTCCCAGGTG-1_6_C5	0.829742874	-16.94291432	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2673	5520	0.006521739	0.00307971	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TACAGTGTCGCTGATA-1_6_C5	3.257213476	-30.10182389	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3987	10939	0.003016729	0.001828321	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TACAGTGTCTGCGGCA-1_6_C5	-33.21968433	-13.2933137	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	758	1027	0.003894839	0.00292113	0	9	OPC	NA	NA	NA
TACAGTGTCTGGCGAC-1_6_C5	-27.63268503	17.46342283	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1101	1797	0.002225932	0.002782415	0	8	Astrocytes	NA	NA	NA
TACCTATAGCTCCTTC-1_6_C5	18.12849128	23.28677678	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	834	1284	0.003115265	0.004672897	0	oligos	OL-Cntl	NA	NA	NA
TACCTATCAGCCTTGG-1_6_C5	-28.3107788	23.16360901	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1076	1957	0.005109862	0.003065917	0	8	Astrocytes	NA	NA	NA
TACCTATCATTGAGCT-1_6_C5	25.02351003	-29.24004876	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3724	10109	0.000890296	0.003165496	0	3	EN-L5-6	NA	NA	NA
TACCTATGTTACTGAC-1_6_C5	2.178918987	-9.985675032	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1583	2672	0.016841317	0.004491018	0	12	EN-MIX	NA	NA	NA
TACCTATTCATATCGG-1_6_C5	1.076819653	-16.76794076	4	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2480	5092	0.009426551	0.002945797	0	L2-3	EN-L2-3-MS	NA	NA	NA
TACCTATTCCAGAAGG-1_6_C5	21.96645957	25.31456452	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1134	1837	0.034295046	0.004899292	0	oligos	OL-Cntl	NA	NA	NA
TACCTTAAGTACGTAA-1_6_C5	-36.04091526	-9.729067321	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	863	1361	0.002939015	0.001469508	0	9	OPC	NA	NA	NA
TACCTTAAGTCTTGCA-1_6_C5	18.76109544	-6.420442055	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1724	3401	0	0.002352249	0	3	EN-L5-6	NA	NA	NA
TACCTTACAATCAGAA-1_6_C5	18.65004459	21.2346008	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	954	1517	0.007910349	0.000659196	0	oligos	OL-Cntl	NA	NA	NA
TACCTTACACACCGAC-1_6_C5	-26.26555718	9.766051016	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	832	1196	0.001672241	0.002508361	0	8	Astrocytes	NA	NA	NA
TACCTTACACGAAAGC-1_6_C5	14.81792069	-33.23803376	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	4407	13626	0.002275062	0.003669455	0	3	EN-L5-6	NA	NA	NA
TACCTTACACGCGAAA-1_6_C5	20.76822507	-29.02265105	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3942	11542	0.001039681	0.003552244	0	3	EN-L5-6	NA	NA	NA
TACCTTACACTCTGTC-1_6_C5	27.2025752	-1.734877313	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3431	9096	0.008355321	0.002198769	0	2	EN-L4	NA	NA	NA
TACCTTACATAGGATA-1_6_C5	3.387888935	-29.65825729	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3264	8288	0.002895753	0.001930502	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TACCTTAGTCATCGGC-1_6_C5	-27.93553956	23.57556472	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1253	2125	0	0.003764706	0	8	Astrocytes	NA	NA	NA
TACCTTAGTGCCTTGG-1_6_C5	17.85507888	21.03509302	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	846	1447	0.000691085	0.003455425	0	oligos	OL-Cntl	NA	NA	NA
TACCTTAGTGTGAAAT-1_6_C5	16.12122282	24.95169188	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	849	1281	0.00312256	0.00156128	0	oligos	OL-Cntl	NA	NA	NA
TACCTTATCGAGAACG-1_6_C5	-28.25158095	22.51208725	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1145	1939	0.00051573	0.006188757	0	8	Astrocytes	NA	NA	NA
TACGGATAGCGGATCA-1_6_C5	1.493099247	-28.24542413	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3907	10942	0.001827819	0.00283312	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TACGGATGTTATCGGT-1_6_C5	23.23527817	1.119113758	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1829	3307	0.0081645	0.003628666	0	2	EN-L4	NA	NA	NA
TACGGATGTTCCAACA-1_6_C5	22.70983537	1.237841558	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1618	2765	0.009041591	0.001446655	0	2	EN-L4	NA	NA	NA
TACGGATTCATCTGCC-1_6_C5	18.78416889	21.95678936	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	959	1550	0	0.003225806	0	oligos	OL-Cntl	NA	NA	NA
TACGGATTCGTTACGA-1_6_C5	-37.67378457	-5.144350152	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1224	2097	0.003338102	0.003814974	0	9	OPC	NA	NA	NA
TACGGATTCTCGCATC-1_6_C5	-27.93828968	23.08599683	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1212	2084	0.000959693	0.003838772	0	8	Astrocytes	NA	NA	NA
TACGGGCCAAGCCCAC-1_6_C5	17.68493446	-5.423015659	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1479	2920	0.008219178	0.003082192	0	3	EN-L5-6	NA	NA	NA
TACGGGCCAAGTAATG-1_6_C5	-22.73847683	-1.176647519	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1094	1666	0.007202881	0.00240096	0	9	OPC	NA	NA	NA
TACGGGCCACAGAGGT-1_6_C5	-33.73349267	-12.85290841	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	690	1071	0.000933707	0.000933707	0	9	OPC	NA	NA	NA
TACGGGCCAGTCCTTC-1_6_C5	11.41156157	24.63448793	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	829	1369	0.007304602	0.00146092	0	oligos	OL-Cntl	NA	NA	NA
TACGGGCTCAGCGATT-1_6_C5	10.7159076	-34.15610294	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	5516	18905	0.002856387	0.001692674	0	3	EN-L5-6	NA	NA	NA
TACGGGCTCATCATTC-1_6_C5	14.32195747	28.96387149	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	738	1068	0.00093633	0.002808989	0	oligos	OL-Cntl	NA	NA	NA
TACGGGCTCGCTTGTC-1_6_C5	-20.97909154	-27.74741868	6A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3643	9341	0.014024194	0.002355208	0	6A	IN-PV	NA	NA	NA
TACGGGCTCTGCGACG-1_6_C5	2.633626063	-11.26214451	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1750	3125	0.01312	0.00608	0	12	EN-MIX	NA	NA	NA
TACGGGCTCTTGCCGT-1_6_C5	24.71004338	-29.42938593	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3212	8361	0.005023323	0.003946896	0	3	EN-L5-6	NA	NA	NA
TACGGTAAGTAGGCCA-1_6_C5	23.55573787	-26.75297511	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2709	5813	0.006365044	0.005332875	0	3	EN-L5-6	NA	NA	NA
TACGGTACATGAGCGA-1_6_C5	6.74744406	25.81508896	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	915	1294	0.006955178	0.004636785	0	oligos	OL-Cntl	NA	NA	NA
TACTCATAGAATGTGT-1_6_C5	-0.817307469	-16.6149242	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2195	4292	0.011416589	0.005591799	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TACTCATCATAGAAAC-1_6_C5	11.73602754	31.57882937	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	810	1228	0.000814332	0.001628664	0	oligos	OL-Cntl	NA	NA	NA
TACTCATGTGCTTCTC-1_6_C5	-23.95119564	-2.018149357	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1130	1980	0.003030303	0.001515152	0	9	OPC	NA	NA	NA
TACTCATGTTCGAATC-1_6_C5	16.82259996	24.32119902	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	846	1246	0.004012841	0.001605136	0	oligos	OL-Cntl	NA	NA	NA
TACTCATTCAATCTCT-1_6_C5	14.17558323	28.98461311	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	706	1027	0.007789679	0.00097371	0	oligos	OL-Cntl	NA	NA	NA
TACTCATTCACTTATC-1_6_C5	18.81316944	13.43905785	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1265	2336	0.001284247	0.004280822	0	oligos	OL-Cntl	NA	NA	NA
TACTCATTCCGCGGTA-1_6_C5	11.81507274	29.39087258	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	810	1300	0.000769231	0.006153846	0	oligos	OL-Cntl	NA	NA	NA
TACTCATTCCTAAGTG-1_6_C5	13.93494948	28.69314858	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	724	1112	0.005395683	0	0	oligos	OL-Cntl	NA	NA	NA
TACTCGCAGAGTAAGG-1_6_C5	-36.32375846	-8.396026254	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	961	1526	0.002621232	0.001965924	0	9	OPC	NA	NA	NA
TACTCGCAGGGTGTTG-1_6_C5	-35.41330334	5.192568556	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2777	6095	0.004265792	0.001640689	0	9	OPC	NA	NA	NA
TACTCGCAGTGTTGAA-1_6_C5	3.794664181	-4.520532656	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	916	1334	0.026236882	0.007496252	0	12	EN-MIX	NA	NA	NA
TACTCGCCAGGATCGA-1_6_C5	22.64659291	18.94433224	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1091	1590	0.005660377	0.003773585	0	oligos	OL-Cntl	NA	NA	NA
TACTCGCCATGCATGT-1_6_C5	11.68842833	21.70655207	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	888	1373	0.005098325	0.005826657	0	oligos	OL-Cntl	NA	NA	NA
TACTCGCGTAATTGGA-1_6_C5	5.237339069	-29.39762292	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3462	8580	0.005011655	0.001981352	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TACTCGCGTCGATTGT-1_6_C5	0.356799677	-12.43109187	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1920	3614	0.007470946	0.005257333	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TACTTACAGAAACCAT-1_6_C5	15.47998932	-1.093362023	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	801	1278	0.002347418	0.00312989	0	12	EN-MIX	NA	NA	NA
TACTTACAGACACTAA-1_6_C5	-24.43528455	29.11704764	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1818	3548	0.001972943	0.002818489	0	8	Astrocytes	NA	NA	NA
TACTTACAGAGTACAT-1_6_C5	15.61574702	28.20204256	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	731	1105	0	0.002714932	0	oligos	OL-Cntl	NA	NA	NA
TACTTACCACAGAGGT-1_6_C5	19.2866934	15.20466783	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1013	1592	0.000628141	0.001256281	0	oligos	OL-Cntl	NA	NA	NA
TACTTACGTCCGAGTC-1_6_C5	-17.97489367	-21.97873268	6A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2119	4602	0.019339418	0.001738375	0	6A	IN-PV	NA	NA	NA
TACTTACTCTAACGGT-1_6_C5	0.687350797	29.47776353	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	730	1024	0.000976563	0.005859375	0	oligos	OL-Cntl	NA	NA	NA
TACTTGTAGCTACCGC-1_6_C5	0.210732764	-9.719810194	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1491	2644	0.007564297	0.001891074	0	12	EN-MIX	NA	NA	NA
TACTTGTAGTGGGCTA-1_6_C5	-7.411191358	-2.813201488	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1832	3314	0.02021726	0.003017502	0	13A	IN-VIP	NA	NA	NA
TACTTGTCAGGGTATG-1_6_C5	18.72775239	-6.436814072	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1719	3503	0.001141878	0.000856409	0	3	EN-L5-6	NA	NA	NA
TACTTGTCATACTACG-1_6_C5	10.3334739	29.52261565	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	661	1042	0	0.00671785	0	oligos	OL-Cntl	NA	NA	NA
TACTTGTTCGTTACAG-1_6_C5	-13.64712721	-24.1661477	6A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1376	2610	0.005363985	0.001532567	0	6A	IN-PV	NA	NA	NA
TAGACCAAGCTGATAA-1_6_C5	-28.34634392	23.40800131	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1121	1822	0.00219539	0.002744237	0	8	Astrocytes	NA	NA	NA
TAGACCAAGGATCGCA-1_6_C5	-36.77367819	-7.264183342	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1056	1676	0.007159905	0.002386635	0	9	OPC	NA	NA	NA
TAGACCACAAAGTGCG-1_6_C5	0.463334133	-26.42678604	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3598	8812	0.003631412	0.003177485	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TAGACCACAATGGTCT-1_6_C5	12.32264872	27.32841552	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	740	1071	0	0.003734827	0	oligos	OL-Cntl	NA	NA	NA
TAGACCACAGTAGAGC-1_6_C5	28.41025252	-2.187799945	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3259	7560	0.003703704	0.002248677	0	2	EN-L4	NA	NA	NA
TAGACCACATACTCTT-1_6_C5	3.747581272	-27.90324552	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3518	10484	0.012685998	0.001812285	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TAGAGCTAGTACGCCC-1_6_C5	-28.91665716	14.32665358	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	850	1332	0.006006006	0.002252252	0	8	Astrocytes	NA	NA	NA
TAGAGCTAGTACTTGC-1_6_C5	23.96407031	0.370506692	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2079	3944	0.011156187	0.001267748	0	2	EN-L4	NA	NA	NA
TAGAGCTGTGCAACGA-1_6_C5	-9.792638175	15.83464197	11	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1748	2850	0.00245614	0.002105263	0	11	Glia-MIX	NA	NA	NA
TAGAGCTGTGCGAAAC-1_6_C5	-13.49905208	-17.51193707	6B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1330	2245	0.037861915	0.004899777	0	6B	IN-SST	NA	NA	NA
TAGAGCTTCGGAGGTA-1_6_C5	-26.98378179	22.90969987	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1141	1848	0.000541126	0.003246753	0	8	Astrocytes	NA	NA	NA
TAGAGCTTCTTATCTG-1_6_C5	27.19174745	0.202201379	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3342	8425	0.007715134	0.002492582	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TAGCCGGAGAGCAATT-1_6_C5	4.087577063	-32.59669694	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	4808	14468	0	0.002073542	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TAGCCGGAGATACACA-1_6_C5	16.25306422	1.696853103	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	830	1335	0.034456929	0.002247191	0	12	EN-MIX	NA	NA	NA
TAGCCGGAGCAGGCTA-1_6_C5	15.28283917	28.74695544	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	839	1280	0.00390625	0.00390625	0	oligos	OL-Cntl	NA	NA	NA
TAGCCGGAGCTAGCCC-1_6_C5	-25.71016888	26.78348335	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1572	2887	0.001731902	0.002424662	0	8	Astrocytes	NA	NA	NA
TAGCCGGCAACAACCT-1_6_C5	22.1960545	1.50561918	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1620	3066	0.007175473	0.000978474	0	2	EN-L4	NA	NA	NA
TAGCCGGTCGCCAGCA-1_6_C5	-37.38269168	-7.437907863	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1081	1738	0.003452244	0.002301496	0	9	OPC	NA	NA	NA
TAGGCATAGTAGGCCA-1_6_C5	3.543536026	-5.967160715	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1209	1726	0.015063731	0.004634994	0	12	EN-MIX	NA	NA	NA
TAGGCATGTCTGATTG-1_6_C5	-22.64127488	31.49671904	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2318	5070	0.002564103	0.002564103	0	8	Astrocytes	NA	NA	NA
TAGGCATTCTCGTTTA-1_6_C5	-27.67850099	16.89365132	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	998	1552	0.00128866	0.00064433	0	8	Astrocytes	NA	NA	NA
TAGTGGTAGAGGACGG-1_6_C5	13.34332539	26.72584971	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	762	1116	0.000896057	0.004480287	0	oligos	OL-Cntl	NA	NA	NA
TAGTGGTCACATGTGT-1_6_C5	24.5509625	-26.00083353	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2829	6579	0.010943912	0.003191974	0	3	EN-L5-6	NA	NA	NA
TAGTGGTTCAAGGCTT-1_6_C5	24.58648628	-29.53178078	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3011	7628	0.006423702	0.003277399	0	3	EN-L5-6	NA	NA	NA
TAGTGGTTCGTTGCCT-1_6_C5	13.31974221	-31.56800414	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2772	6739	0.007271108	0.002671019	0	3	EN-L5-6	NA	NA	NA
TAGTTGGAGGACGAAA-1_6_C5	13.46283975	30.315827	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	751	1083	0.001846722	0.001846722	0	oligos	OL-Cntl	NA	NA	NA
TAGTTGGCACATCCGG-1_6_C5	0.936982508	-27.53782946	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3454	9455	0.003595981	0.002749868	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TAGTTGGGTCCGAACC-1_6_C5	-18.92186372	-28.20258	6A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2667	6270	0.001754386	0.002392344	0	6A	IN-PV	NA	NA	NA
TAGTTGGGTTCGTGAT-1_6_C5	-12.2573974	-18.73700401	6B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1107	1755	0.026210826	0.005128205	0	6B	IN-SST	NA	NA	NA
TAGTTGGTCCAGGGCT-1_6_C5	10.6323463	-8.218296498	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2112	4135	0.004111245	0.002902056	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TAGTTGGTCCGTAGGC-1_6_C5	1.217833893	-10.6561863	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1715	3250	0.011384615	0.002769231	0	12	EN-MIX	NA	NA	NA
TATCAGGAGACAAAGG-1_6_C5	-0.191415254	-26.47133614	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3833	9885	0.011229135	0.003136065	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TATCAGGGTTTGGGCC-1_6_C5	-10.57603942	-18.87498382	6B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	917	1420	0.042957746	0.000704225	0	6B	IN-SST	NA	NA	NA
TATCAGGTCTTTACAC-1_6_C5	-1.842806631	-17.62189582	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2713	6684	0.000897666	0.001944943	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TATCTCAAGAGCTATA-1_6_C5	-35.44122343	-11.99939635	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	814	1191	0.006717045	0.003358522	0	9	OPC	NA	NA	NA
TATCTCAAGCCGTCGT-1_6_C5	10.10273361	-7.075846239	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1923	3847	0.007538342	0.000519886	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TATCTCAAGCTAAACA-1_6_C5	2.923848838	-6.877855459	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1265	2079	0.030784031	0.003367003	0	12	EN-MIX	NA	NA	NA
TATCTCAGTCAAACTC-1_6_C5	-2.131917368	-18.24428637	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2893	7402	0.006619832	0.002161578	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TATCTCATCGTTTGCC-1_6_C5	-14.93114155	-25.54540097	6A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1588	3138	0.014340344	0.00223072	0	6A	IN-PV	NA	NA	NA
TATGCCCAGCTTTGGT-1_6_C5	18.61206912	-6.479859106	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1743	3634	0.003577325	0.001651073	0	3	EN-L5-6	NA	NA	NA
TATGCCCCAGGAACGT-1_6_C5	0.782336186	-23.49642536	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3558	8753	0.006512053	0.004569862	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TATGCCCGTCCGACGT-1_6_C5	14.32185409	-0.202855038	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	691	1004	0.002988048	0.001992032	0	12	EN-MIX	NA	NA	NA
TATGCCCTCGACAGCC-1_6_C5	17.84249255	22.15001965	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	953	1512	0.001322751	0.003968254	0	oligos	OL-Cntl	NA	NA	NA
TATTACCCATGACATC-1_6_C5	26.04647443	0.407008785	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2534	5497	0.001455339	0.003274513	0	2	EN-L4	NA	NA	NA
TATTACCGTCTCAACA-1_6_C5	24.95023513	-1.601379084	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2570	6512	0.003992629	0.001535627	0	2	EN-L4	NA	NA	NA
TATTACCTCGCTGATA-1_6_C5	-10.17595719	-18.42358449	6B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	911	1471	0.048266485	0.002039429	0	6B	IN-SST	NA	NA	NA
TATTACCTCTGCGTAA-1_6_C5	23.81836667	0.204790831	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2133	4845	0.002270382	0.002683179	0	2	EN-L4	NA	NA	NA
TCAACGAAGGATGTAT-1_6_C5	-7.597978775	-2.970251281	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1870	3600	0.018333333	0.003333333	0	13A	IN-VIP	NA	NA	NA
TCAACGAAGGCACATG-1_6_C5	-25.53557842	26.18834191	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1442	2533	0.003553099	0.005527043	0	8	Astrocytes	NA	NA	NA
TCAACGAAGGCATTGG-1_6_C5	11.03739812	25.02336714	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	770	1156	0.000865052	0.003460208	0	oligos	OL-Cntl	NA	NA	NA
TCAACGACAAGTAATG-1_6_C5	9.175848194	-7.605268661	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1939	3634	0.009356081	0.002201431	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TCAACGAGTCCGAGTC-1_6_C5	-26.51690882	9.872169864	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	882	1330	0.00075188	0.003007519	0	8	Astrocytes	NA	NA	NA
TCAACGATCTATGTGG-1_6_C5	-12.33765765	14.67877903	11	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	928	1353	0.003695492	0.00443459	0	11	Glia-MIX	NA	NA	NA
TCAATCTAGCAAATCA-1_6_C5	0.811767944	-6.471242725	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1279	2181	0.010087116	0.002751032	0	12	EN-MIX	NA	NA	NA
TCAATCTCATGCAACT-1_6_C5	-25.83192349	18.9480647	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1308	2254	0.000443656	0.00310559	0	8	Astrocytes	NA	NA	NA
TCAATCTGTATAGGTA-1_6_C5	-33.37693539	-12.89975791	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	687	1031	0.000969932	0.002909796	0	9	OPC	NA	NA	NA
TCACAAGAGAGACGAA-1_6_C5	19.73470547	20.15777712	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1017	1547	0.007756949	0.005171299	0	oligos	OL-Cntl	NA	NA	NA
TCACAAGAGTAGCCGA-1_6_C5	1.031769137	-12.37837838	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2007	3781	0.007669929	0.006083047	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TCACAAGCAGGAATCG-1_6_C5	-29.00454261	13.55612941	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	837	1273	0.009426551	0.003142184	0	8	Astrocytes	NA	NA	NA
TCACAAGCATGCAACT-1_6_C5	22.60266146	12.0350788	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1470	2608	0.000766871	0.00345092	0	oligos	OL-Cntl	NA	NA	NA
TCACAAGCATTAACCG-1_6_C5	-7.9232481	1.411317561	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2313	4604	0.00716768	0.001086012	0	13A	IN-VIP	NA	NA	NA
TCACAAGGTCACCTAA-1_6_C5	-36.59878866	-7.606113925	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1031	1663	0.003006615	0.00420926	0	9	OPC	NA	NA	NA
TCACAAGTCAGGCCCA-1_6_C5	1.003331076	-30.02963463	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	4940	16476	0.003095412	0.002124302	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TCACAAGTCCATGAGT-1_6_C5	-27.33753377	17.23395692	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1039	1664	0.003605769	0.004807692	0	8	Astrocytes	NA	NA	NA
TCACAAGTCTACTCAT-1_6_C5	1.863622314	-20.29081168	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3352	7982	0.004384866	0.005888249	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TCACGAAAGCATCATC-1_6_C5	-2.565017935	-0.954682544	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2940	6088	0.006570302	0.006241787	0	13A	IN-VIP	NA	NA	NA
TCACGAAAGGCCATAG-1_6_C5	-29.2383755	13.48031725	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	798	1179	0.002544529	0.004240882	0	8	Astrocytes	NA	NA	NA
TCACGAAAGGCCCGTT-1_6_C5	-26.14201	25.8197013	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1360	2388	0.001675042	0.004606365	0	8	Astrocytes	NA	NA	NA
TCACGAAAGGGTATCG-1_6_C5	2.10856346	-19.22027935	4	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3189	7168	0.008091518	0.005022321	0	L2-3	EN-L2-3-MS	NA	NA	NA
TCACGAAAGTGGACGT-1_6_C5	2.568391356	-16.36043574	4	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2598	5219	0.011688063	0.009388772	0	L2-3	EN-L2-3-MS	NA	NA	NA
TCACGAACAAATACAG-1_6_C5	22.79677974	19.75423155	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1147	1855	0.000539084	0.001617251	0	oligos	OL-Cntl	NA	NA	NA
TCACGAAGTGACCAAG-1_6_C5	-26.45630577	17.95646387	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1169	1806	0.011074197	0.002214839	0	8	Astrocytes	NA	NA	NA
TCACGAAGTGCACGAA-1_6_C5	11.8226989	26.45281109	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	875	1295	0.004633205	0.007722008	0	oligos	OL-Cntl	NA	NA	NA
TCACGAATCCTTGCCA-1_6_C5	19.00751286	6.1887017	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2631	5924	0.002869683	0.003882512	0	oligos	OL-Cntl	NA	NA	NA
TCACGAATCTGCGTAA-1_6_C5	8.546183343	-8.221454095	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1948	3964	0.006559031	0.002522704	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TCAGATGCAAACCTAC-1_6_C5	10.65194673	-34.11537678	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	6199	25539	0.000978895	0.001331297	0	3	EN-L5-6	NA	NA	NA
TCAGATGCAAAGCGGT-1_6_C5	-15.26846477	-25.27257692	6A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1712	3189	0.012229539	0.00156789	0	6A	IN-PV	NA	NA	NA
TCAGATGCACACAGAG-1_6_C5	14.30111701	25.74685454	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	854	1347	0	0.002969562	0	oligos	OL-Cntl	NA	NA	NA
TCAGATGGTAAGTTCC-1_6_C5	11.61414215	29.99935363	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	673	1007	0.003972195	0.003972195	0	oligos	OL-Cntl	NA	NA	NA
TCAGATGTCTGTTTGT-1_6_C5	25.67632594	0.439376137	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2489	5553	0.007923645	0.002701243	0	2	EN-L4	NA	NA	NA
TCAGCAAAGTTATCGC-1_6_C5	3.457490286	-30.05975177	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3860	10714	0.000933358	0.002053388	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TCAGCAACATTACGAC-1_6_C5	16.93708078	-0.484780835	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	873	1343	0.00446761	0.006701415	0	12	EN-MIX	NA	NA	NA
TCAGCAATCCTAGGGC-1_6_C5	11.91621281	30.0726314	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	712	1080	0.000925926	0.005555556	0	oligos	OL-Cntl	NA	NA	NA
TCAGCAATCGGCATCG-1_6_C5	13.98992756	21.9931209	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	899	1381	0	0.003620565	0	oligos	OL-Cntl	NA	NA	NA
TCAGCAATCTTATCTG-1_6_C5	1.311712806	1.008027435	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	685	1087	0.000919963	0.003679853	0	12	EN-MIX	NA	NA	NA
TCAGCTCAGACATAAC-1_6_C5	17.78300224	22.3011878	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	878	1344	0.001488095	0.002232143	0	oligos	OL-Cntl	NA	NA	NA
TCAGCTCAGGCCCGTT-1_6_C5	12.97462112	30.0605015	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	764	1150	0.00173913	0.006086957	0	oligos	OL-Cntl	NA	NA	NA
TCAGCTCCAAACGTGG-1_6_C5	-15.78925675	-9.894507997	13B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2623	5748	0.016701461	0.00295755	0	13B	IN-SV2C	NA	NA	NA
TCAGCTCCACCATGTA-1_6_C5	-1.462766387	-16.36389157	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2168	4178	0.00454763	0.004308281	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TCAGCTCCAGCTGTAT-1_6_C5	1.547028669	-5.553150882	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1052	1667	0.00239952	0.00179964	0	12	EN-MIX	NA	NA	NA
TCAGCTCCAGCTGTTA-1_6_C5	-12.32376774	-10.89213203	13B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1430	2564	0.001170047	0.002340094	0	13B	IN-SV2C	NA	NA	NA
TCAGCTCTCATGTCCC-1_6_C5	25.91136007	0.431239657	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2869	7483	0.014833623	0.003741815	0	2	EN-L4	NA	NA	NA
TCAGGATGTCCGAATT-1_6_C5	2.993053721	-32.07965471	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	5261	20309	0.000393914	0.001920331	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TCAGGATGTTTGGGCC-1_6_C5	-27.12659164	18.30256217	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1133	1896	0.004219409	0.002109705	0	8	Astrocytes	NA	NA	NA
TCAGGATTCACCGGGT-1_6_C5	-8.884114555	-17.23060171	6B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	817	1260	0.017460317	0.003968254	0	6B	IN-SST	NA	NA	NA
TCAGGATTCATCACCC-1_6_C5	-3.279521308	-6.228269652	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	872	1362	0.033039648	0.002936858	0	13A	IN-VIP	NA	NA	NA
TCAGGTAAGAATGTGT-1_6_C5	-11.05206074	-0.762845058	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2673	5583	0.013970983	0.00483611	0	13A	IN-VIP	NA	NA	NA
TCAGGTAAGCCCGAAA-1_6_C5	29.06976388	-4.853634034	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	4031	10637	0.011187365	0.002350287	0	2	EN-L4	NA	NA	NA
TCAGGTACACTTCTGC-1_6_C5	-24.88319685	26.81884365	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1348	2326	0.000859845	0.003439381	0	8	Astrocytes	NA	NA	NA
TCAGGTACATCCGCGA-1_6_C5	-28.55458567	15.30145856	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	910	1418	0.004231312	0.002115656	0	8	Astrocytes	NA	NA	NA
TCAGGTAGTGATAAGT-1_6_C5	-26.83130457	10.31122407	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	780	1165	0.001716738	0	0	8	Astrocytes	NA	NA	NA
TCAGGTATCGACAGCC-1_6_C5	-3.470324901	-6.29954145	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	873	1370	0.002919708	0.000729927	0	13A	IN-VIP	NA	NA	NA
TCATTACAGACTTTCG-1_6_C5	-38.53518744	-1.883544188	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1265	2340	0.001709402	0.000854701	0	9	OPC	NA	NA	NA
TCATTACAGTCATCCA-1_6_C5	24.66711289	-0.235493629	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2165	4611	0.007807417	0.001734982	0	2	EN-L4	NA	NA	NA
TCATTACCACGGTAAG-1_6_C5	1.511891414	-28.02801487	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3594	9623	0.001662683	0.002078354	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TCATTACTCAGATAAG-1_6_C5	13.04236112	31.27078698	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	706	1037	0.00096432	0.00096432	0	oligos	OL-Cntl	NA	NA	NA
TCATTACTCGTTTAGG-1_6_C5	-0.400302175	-12.23877273	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1795	3382	0.001774098	0.002069781	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TCATTTGAGCAGCGTA-1_6_C5	-7.52586764	-2.244379361	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1734	3166	0.012634239	0.00473784	0	13A	IN-VIP	NA	NA	NA
TCATTTGGTCGACTGC-1_6_C5	2.859002718	-6.412082508	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1147	1782	0.007856341	0.008978676	0	12	EN-MIX	NA	NA	NA
TCATTTGGTCTTGATG-1_6_C5	-28.13448785	11.49485372	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	736	1114	0.005385996	0.003590664	0	8	Astrocytes	NA	NA	NA
TCATTTGGTTACGCGC-1_6_C5	-35.93647796	-10.91262437	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	788	1198	0.003338898	0.002504174	0	9	OPC	NA	NA	NA
TCCACACAGAAGGTTT-1_6_C5	-27.27831299	10.28356889	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	718	1038	0.001926782	0.002890173	0	8	Astrocytes	NA	NA	NA
TCCACACAGCGCCTTG-1_6_C5	20.91515331	-29.44613725	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	5485	20768	0.006500385	0.002214946	0	3	EN-L5-6	NA	NA	NA
TCCACACAGCTAGTCT-1_6_C5	-0.830761787	3.643723922	11	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1031	1621	0.001850709	0.002467613	0	11	Glia-MIX	NA	NA	NA
TCCACACCACCAGGTC-1_6_C5	14.83517598	-33.44212052	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	6705	30443	0.000361331	0.001773807	0	3	EN-L5-6	NA	NA	NA
TCCACACCATACTCTT-1_6_C5	14.11383525	-33.06428594	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	4551	15201	0.002236695	0.002368265	0	3	EN-L5-6	NA	NA	NA
TCCACACCATCGGAAG-1_6_C5	16.65370454	17.88819213	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	995	1519	0.005266623	0.011191573	0	oligos	OL-Cntl	NA	NA	NA
TCCACACGTACAGTGG-1_6_C5	12.75108792	29.68952582	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	798	1242	0	0.000805153	0	oligos	OL-Cntl	NA	NA	NA
TCCACACGTCAAAGAT-1_6_C5	10.33667458	-8.839039079	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2634	6132	0.000815395	0.001630789	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TCCACACGTCGGCATC-1_6_C5	17.07342464	23.4350391	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	874	1318	0.001517451	0.004552352	0	oligos	OL-Cntl	NA	NA	NA
TCCACACTCACTGGGC-1_6_C5	-2.630821219	2.34285709	11	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1750	3157	0.002534051	0.004751346	0	11	Glia-MIX	NA	NA	NA
TCCACACTCGCTTAGA-1_6_C5	4.070853124	-32.81528104	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	5043	16736	0.000179254	0.001792543	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TCCACACTCTTCGGTC-1_6_C5	-12.44059784	-19.15362756	6B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1312	2359	0.027554048	0.006782535	0	6B	IN-SST	NA	NA	NA
TCCCGATAGATTACCC-1_6_C5	-16.24154498	-18.94532316	6B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1858	4070	0.000737101	0.003194103	0	6B	IN-SST	NA	NA	NA
TCCCGATAGTATCGAA-1_6_C5	-24.58600454	29.29038816	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1710	3127	0.000319795	0.001598977	0	8	Astrocytes	NA	NA	NA
TCCCGATCAGATGGGT-1_6_C5	20.47504983	-28.54497883	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3394	8149	0.003681433	0.003926862	0	3	EN-L5-6	NA	NA	NA
TCCCGATCATGTTGAC-1_6_C5	12.62365766	27.98661406	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	671	1000	0.001	0.004	0	oligos	OL-Cntl	NA	NA	NA
TCCCGATGTACAGCAG-1_6_C5	-10.77705345	16.45730105	11	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1910	3421	0.001753873	0.002338498	0	11	Glia-MIX	NA	NA	NA
TCCCGATGTTTAGCTG-1_6_C5	3.990221019	26.10892273	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	713	1073	0.001863933	0.004659832	0	oligos	OL-Cntl	NA	NA	NA
TCCCGATTCTCAAACG-1_6_C5	15.50320927	-1.178474846	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	839	1332	0.003003003	0.003003003	0	12	EN-MIX	NA	NA	NA
TCGAGGCAGTTAGGTA-1_6_C5	-8.758997811	-18.36138365	6B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	746	1076	0.013011152	0.002788104	0	6B	IN-SST	NA	NA	NA
TCGAGGCCATACGCTA-1_6_C5	-11.08294897	2.207910037	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3212	7259	0.005097121	0.003995041	0	13A	IN-VIP	NA	NA	NA
TCGAGGCGTAACGTTC-1_6_C5	22.11910966	-6.961579677	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1604	2803	0.008205494	0.002854085	0	3	EN-L5-6	NA	NA	NA
TCGAGGCGTGATGTGG-1_6_C5	22.26898619	19.83167115	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1118	1722	0.005807201	0.004645761	0	oligos	OL-Cntl	NA	NA	NA
TCGAGGCGTGTCTGAT-1_6_C5	-27.04061463	23.53668385	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1349	2274	0.001759015	0.004397537	0	8	Astrocytes	NA	NA	NA
TCGCGAGAGGAATGGA-1_6_C5	-11.65874471	13.96647972	11	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1045	1522	0	0.005913272	0	11	Glia-MIX	NA	NA	NA
TCGCGAGCACCAGATT-1_6_C5	18.96800367	10.4159918	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1461	2549	0.001569243	0.003138486	0	oligos	OL-Cntl	NA	NA	NA
TCGCGAGCATCGATTG-1_6_C5	14.30560826	28.22691873	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	697	1013	0.001974334	0.000987167	0	oligos	OL-Cntl	NA	NA	NA
TCGCGAGGTCCGACGT-1_6_C5	0.165563524	-10.56175289	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1626	2908	0.002407153	0.003094911	0	12	EN-MIX	NA	NA	NA
TCGCGAGGTCTAGTCA-1_6_C5	-0.501512111	4.714099526	11	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	768	1139	0.005267779	0.006145742	0	11	Glia-MIX	NA	NA	NA
TCGCGAGTCAGTTCGA-1_6_C5	23.28506194	11.91117847	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1647	2776	0.003242075	0.004682997	0	oligos	OL-Cntl	NA	NA	NA
TCGCGAGTCCCTTGTG-1_6_C5	2.987771576	26.43155248	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	761	1172	0.000853242	0.004266212	0	oligos	OL-Cntl	NA	NA	NA
TCGCGAGTCGTCCGTT-1_6_C5	-37.40907483	-7.993366334	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1022	1689	0.003552398	0.002960332	0	9	OPC	NA	NA	NA
TCGCGAGTCTTCTGGC-1_6_C5	-1.065823002	-18.92478482	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2680	5700	0.002982456	0.004385965	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TCGCGTTAGTACGATA-1_6_C5	8.713507101	-6.311558582	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1497	2551	0.003136025	0.003136025	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TCGCGTTGTCCAGTAT-1_6_C5	14.63452877	29.56949252	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	729	1026	0	0.003898635	0	oligos	OL-Cntl	NA	NA	NA
TCGCGTTGTTTGCATG-1_6_C5	-36.05965826	-8.552415255	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1036	1668	0.002398082	0.001199041	0	9	OPC	NA	NA	NA
TCGCGTTTCTCCGGTT-1_6_C5	6.317729242	-8.435603176	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1886	3247	0.003079766	0.004003696	0	12	EN-MIX	NA	NA	NA
TCGGGACAGGACAGAA-1_6_C5	26.27284114	-5.620713819	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	5414	18171	0.005833471	0.003191899	0	2	EN-L4	NA	NA	NA
TCGGGACCAAGTTAAG-1_6_C5	2.553105409	-11.5640388	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1821	3191	0.019116264	0.003760577	0	12	EN-MIX	NA	NA	NA
TCGGGACCAGATAATG-1_6_C5	-17.6435833	-21.20771107	6A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1896	3498	0.014865638	0.005717553	0	6A	IN-PV	NA	NA	NA
TCGGGACCAGCTGTTA-1_6_C5	-25.41734953	20.15964106	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1528	2774	0.003604903	0.001441961	0	8	Astrocytes	NA	NA	NA
TCGGGACGTTCGTGAT-1_6_C5	-8.768555077	-16.51459863	6B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	772	1163	0.042132416	0.004299226	0	6B	IN-SST	NA	NA	NA
TCGGGACTCATGTAGC-1_6_C5	24.13787962	0.972150413	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2018	3899	0.011028469	0.001025904	0	2	EN-L4	NA	NA	NA
TCGGTAAAGAAGGTGA-1_6_C5	-14.82639787	-6.979609407	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2946	6308	0.014267597	0.002219404	0	13A	IN-VIP	NA	NA	NA
TCGGTAAAGTCCAGGA-1_6_C5	-34.41907009	-8.84227866	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	978	1434	0.005578801	0.00488145	0	9	OPC	NA	NA	NA
TCGGTAAAGTTGTAGA-1_6_C5	-9.665549314	-2.732111738	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2081	3681	0.013854931	0.006519967	0	13A	IN-VIP	NA	NA	NA
TCGGTAACAACCGCCA-1_6_C5	13.62337744	30.32559599	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	850	1250	0.0016	0.0072	0	oligos	OL-Cntl	NA	NA	NA
TCGGTAAGTACGACCC-1_6_C5	-0.263127795	-16.55478092	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2654	5415	0.004062789	0.001846722	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TCGGTAAGTTCCGGCA-1_6_C5	-9.400089577	1.380063258	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2832	5988	0.009352037	0.003507014	0	13A	IN-VIP	NA	NA	NA
TCGTACCGTAAGTGTA-1_6_C5	-3.757010001	-4.613625898	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1253	2104	0.02661597	0.003802281	0	13A	IN-VIP	NA	NA	NA
TCGTACCGTCGCATCG-1_6_C5	2.978884737	-25.41088789	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2886	6086	0.00213605	0.005093658	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TCGTACCGTGCACGAA-1_6_C5	13.24932321	29.55487787	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	773	1111	0.00090009	0.00180018	0	oligos	OL-Cntl	NA	NA	NA
TCGTACCGTTGGTAAA-1_6_C5	19.52731934	12.99165004	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1254	2077	0.001444391	0.0052961	0	oligos	OL-Cntl	NA	NA	NA
TCGTACCTCATGTGGT-1_6_C5	-25.58965751	19.68190912	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1408	2405	0.002910603	0.002494802	0	8	Astrocytes	NA	NA	NA
TCGTAGAGTAATCGTC-1_6_C5	9.075061192	-8.110826846	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2038	3971	0.002518257	0.003273735	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TCGTAGAGTCTTCGTC-1_6_C5	19.50939578	11.55380801	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1261	2144	0.000932836	0.004197761	0	oligos	OL-Cntl	NA	NA	NA
TCGTAGAGTTGAGTTC-1_6_C5	23.51141061	12.65659649	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1385	2346	0.003836317	0.002131287	0	oligos	OL-Cntl	NA	NA	NA
TCTATTGGTGTTTGTG-1_6_C5	-23.04633913	-0.551838976	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1272	1976	0.001518219	0.006072874	0	9	OPC	NA	NA	NA
TCTATTGTCTTGTCAT-1_6_C5	12.88510137	23.09560254	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	804	1227	0.00407498	0.00407498	0	oligos	OL-Cntl	NA	NA	NA
TCTCATAAGTGAAGTT-1_6_C5	15.30304711	29.62048926	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	772	1115	0.004484305	0.000896861	0	oligos	OL-Cntl	NA	NA	NA
TCTCATAAGTTCGCGC-1_6_C5	-24.74658879	26.71739043	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1440	2630	0.000760456	0.003041825	0	8	Astrocytes	NA	NA	NA
TCTCATACAAGTAATG-1_6_C5	-26.54938466	9.865828692	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	803	1153	0.001734605	0.004336513	0	8	Astrocytes	NA	NA	NA
TCTCATACACAAGTAA-1_6_C5	15.57541092	-5.200007825	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1310	2566	0.003507405	0.003897116	0	12	EN-MIX	NA	NA	NA
TCTCATACACGACTCG-1_6_C5	-0.275696417	-10.98082693	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1636	3057	0.012757605	0.003598299	0	12	EN-MIX	NA	NA	NA
TCTCATAGTAGCCTAT-1_6_C5	-17.67214903	-24.6008806	6A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2311	5461	0.001464933	0.003662333	0	6A	IN-PV	NA	NA	NA
TCTCATAGTCACTTCC-1_6_C5	25.63913949	-4.086197349	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3881	11641	0.00446697	0.002834808	0	2	EN-L4	NA	NA	NA
TCTCATATCCCTCTTT-1_6_C5	-0.201857312	-0.147216212	11	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	941	1447	0.024187975	0.00276434	0	11	Glia-MIX	NA	NA	NA
TCTCATATCTGTACGA-1_6_C5	0.152200194	0.756407131	11	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	931	1336	0.003742515	0.000748503	0	11	Glia-MIX	NA	NA	NA
TCTCTAAAGCCCGAAA-1_6_C5	-28.31808697	22.33370737	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1070	1761	0.003407155	0.001135718	0	8	Astrocytes	NA	NA	NA
TCTCTAAAGTCCGTAT-1_6_C5	-18.33038089	-27.90208098	6A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2439	5791	0.005698498	0.001726817	0	6A	IN-PV	NA	NA	NA
TCTCTAAAGTGCTGCC-1_6_C5	-28.29527826	21.98397112	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1048	1815	0.000550964	0.002203857	0	8	Astrocytes	NA	NA	NA
TCTCTAAAGTGGGCTA-1_6_C5	-38.36292823	-7.655596135	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1146	2071	0.001931434	0.002414293	0	9	OPC	NA	NA	NA
TCTCTAAGTCTTTCAT-1_6_C5	-3.967376369	-4.603899261	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1125	1899	0.009478673	0.002632965	0	13A	IN-VIP	NA	NA	NA
TCTCTAAGTTAGGGTG-1_6_C5	-35.97420598	-10.49470742	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	901	1389	0	0.002159827	0	9	OPC	NA	NA	NA
TCTGAGAAGAGACTAT-1_6_C5	-19.91612721	-26.72091937	6A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2907	6660	0.012612613	0.003753754	0	6A	IN-PV	NA	NA	NA
TCTGAGAAGATGGCGT-1_6_C5	31.53027699	-9.145285248	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3902	8877	0.011265067	0.003942773	0	2	EN-L4	NA	NA	NA
TCTGAGACACGTCTCT-1_6_C5	14.40168052	-31.97662823	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3694	10178	0.00697583	0.001965023	0	3	EN-L5-6	NA	NA	NA
TCTGAGACAGCTGTTA-1_6_C5	12.80827391	30.61443697	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	687	1064	0.00093985	0.006578947	0	oligos	OL-Cntl	NA	NA	NA
TCTGAGAGTACTCTCC-1_6_C5	19.6021015	20.59733024	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	946	1372	0.000728863	0.001457726	0	oligos	OL-Cntl	NA	NA	NA
TCTGAGATCAGTGCAT-1_6_C5	26.91140248	-0.809114463	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2948	6312	0.003010139	0.002217997	0	2	EN-L4	NA	NA	NA
TCTGAGATCTTGTATC-1_6_C5	3.775564718	-4.085973417	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1004	1494	0.03815261	0.005354752	0	12	EN-MIX	NA	NA	NA
TCTGGAACACCGGAAA-1_6_C5	-28.09260685	23.23221225	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1198	1997	0.000500751	0.00450676	0	8	Astrocytes	NA	NA	NA
TCTGGAACACTTGGAT-1_6_C5	22.68547143	13.87721721	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1174	1987	0.002013085	0.005535984	0	oligos	OL-Cntl	NA	NA	NA
TCTTCGGAGCGACGTA-1_6_C5	-26.99234005	10.97749851	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	784	1143	0.000874891	0.006124234	0	8	Astrocytes	NA	NA	NA
TCTTCGGAGCTCTCGG-1_6_C5	7.475942204	-7.24750237	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1560	2701	0.009626064	0.003332099	0	12	EN-MIX	NA	NA	NA
TCTTCGGAGGTGCACA-1_6_C5	-34.87991863	-12.14619622	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	841	1326	0.005279035	0	0	9	OPC	NA	NA	NA
TCTTTCCCAGTCTTCC-1_6_C5	-8.193325501	-1.011426051	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2014	3861	0.012432012	0.005180005	0	13A	IN-VIP	NA	NA	NA
TCTTTCCCATTGTGCA-1_6_C5	20.46950412	11.52559495	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1331	2547	0	0.002355713	0	oligos	OL-Cntl	NA	NA	NA
TCTTTCCTCCCATTTA-1_6_C5	15.10313242	30.27008601	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	793	1214	0.00247117	0.000823723	0	oligos	OL-Cntl	NA	NA	NA
TGAAAGAAGACGCAAC-1_6_C5	-29.49378716	21.11170122	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	961	1498	0.00400534	0.00400534	0	8	Astrocytes	NA	NA	NA
TGAAAGACACCATGTA-1_6_C5	1.940654145	-16.65902163	4	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2541	5252	0.007425743	0.008187357	0	L2-3	EN-L2-3-MS	NA	NA	NA
TGAAAGAGTACATGTC-1_6_C5	-11.82980299	-0.361027242	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2551	5067	0.023682652	0.003947109	0	13A	IN-VIP	NA	NA	NA
TGAAAGAGTTCGCGAC-1_6_C5	3.128335644	-21.19549275	4	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3862	9771	0.01924061	0.003377341	0	L2-3	EN-L2-3-MS	NA	NA	NA
TGAAAGATCCAGAAGG-1_6_C5	2.810174297	-7.961912034	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1391	2332	0.026586621	0.005145798	0	12	EN-MIX	NA	NA	NA
TGACAACAGAGATGAG-1_6_C5	-0.463408557	-25.55746322	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	5011	15431	0.002203357	0.002397771	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TGACAACAGCACCGTC-1_6_C5	-26.50320874	16.9326507	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1175	1873	0.004805125	0.00373732	0	8	Astrocytes	NA	NA	NA
TGACAACAGCCCAGCT-1_6_C5	-37.57895398	-0.391272934	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1600	2784	0	0.004310345	0	9	OPC	NA	NA	NA
TGACAACAGGAGCGTT-1_6_C5	3.727807016	28.20257774	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	750	1072	0	0.004664179	0	oligos	OL-Cntl	NA	NA	NA
TGACAACGTAATCGTC-1_6_C5	0.611426922	29.47288701	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	850	1318	0.006069803	0.001517451	0	oligos	OL-Cntl	NA	NA	NA
TGACAACGTCTCATCC-1_6_C5	-24.13519751	28.17714237	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1720	3101	0.001612383	0.005804579	0	8	Astrocytes	NA	NA	NA
TGACAACGTTGTCGCG-1_6_C5	13.9479579	-32.20637462	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3360	8437	0.001540832	0.00320019	0	3	EN-L5-6	NA	NA	NA
TGACAACTCGCGGATC-1_6_C5	-14.51897542	-7.312174976	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3431	8183	0.015153367	0.006232433	0	13A	IN-VIP	NA	NA	NA
TGACGGCAGCCTTGAT-1_6_C5	17.07716559	28.97611389	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	872	1251	0.001598721	0.001598721	0	oligos	OL-Cntl	NA	NA	NA
TGACGGCCACCCAGTG-1_6_C5	13.08404119	31.00526926	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	742	1045	0.000956938	0.001913876	0	oligos	OL-Cntl	NA	NA	NA
TGACGGCCACCGCTAG-1_6_C5	-0.307418194	-11.09749815	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1538	2803	0.001070282	0.002140564	0	12	EN-MIX	NA	NA	NA
TGACGGCGTATAATGG-1_6_C5	-34.22534353	-8.79289081	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1001	1618	0.001854141	0.004944376	0	9	OPC	NA	NA	NA
TGACGGCGTGATAAGT-1_6_C5	21.28997898	-2.204435801	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1955	3760	0.007712766	0.00212766	0	2	EN-L4	NA	NA	NA
TGACGGCTCACAACGT-1_6_C5	-0.319999003	-17.41017143	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2531	5116	0.003322909	0.001563722	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TGACGGCTCACCCGAG-1_6_C5	16.84829147	16.48156309	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1188	1832	0.005458515	0.010917031	0	oligos	OL-Cntl	NA	NA	NA
TGACGGCTCGTACCGG-1_6_C5	11.92266608	3.173579805	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1158	1914	0.001044932	0.002089864	0	12	EN-MIX	NA	NA	NA
TGACGGCTCGTCTGAA-1_6_C5	-0.98651208	3.85227528	11	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1104	1676	0.003579952	0.005966587	0	11	Glia-MIX	NA	NA	NA
TGACGGCTCTAACTGG-1_6_C5	-10.66165076	16.85806836	11	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1960	3402	0.002351558	0.003821282	0	11	Glia-MIX	NA	NA	NA
TGACGGCTCTTCGAGA-1_6_C5	-12.15297985	16.99529367	11	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1372	2169	0.000461042	0.00461042	0	11	Glia-MIX	NA	NA	NA
TGACTAGAGAGGACGG-1_6_C5	-0.640262363	-16.16148319	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2350	4655	0.014178303	0.002792696	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TGACTAGCACAGATTC-1_6_C5	-37.58491809	-4.709319347	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1207	2062	0.001939864	0.00242483	0	9	OPC	NA	NA	NA
TGACTAGCACGGTAGA-1_6_C5	10.68677463	30.49350594	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	682	1002	0.002994012	0.001996008	0	oligos	OL-Cntl	NA	NA	NA
TGACTAGGTGGCAAAC-1_6_C5	-5.995249898	-1.751340107	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1609	2799	0.01607717	0.003215434	0	13A	IN-VIP	NA	NA	NA
TGACTAGTCCAAGCCG-1_6_C5	8.78904506	-8.375296794	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2196	4418	0.001358081	0.003395201	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TGACTAGTCTGCTGCT-1_6_C5	5.814566807	30.18236044	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	739	1100	0.006363636	0.002727273	0	oligos	OL-Cntl	NA	NA	NA
TGACTTTCACTCAGGC-1_6_C5	11.79189309	30.81717908	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	812	1207	0	0.002485501	0	oligos	OL-Cntl	NA	NA	NA
TGACTTTCACTGCCAG-1_6_C5	25.55494409	1.042845957	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2292	4645	0.005812702	0.001506997	0	2	EN-L4	NA	NA	NA
TGACTTTCATGGAATA-1_6_C5	4.144376982	-29.79031615	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3467	9211	0.004776897	0.001737054	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TGACTTTGTAGGAGTC-1_6_C5	-9.048247824	-0.379345129	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2020	3592	0.0077951	0.004454343	0	13A	IN-VIP	NA	NA	NA
TGACTTTTCACCATAG-1_6_C5	-26.69281631	25.87019191	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1314	2212	0.001808318	0.002712477	0	8	Astrocytes	NA	NA	NA
TGACTTTTCCAAATGC-1_6_C5	-1.994470011	-17.98333837	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2688	6359	0.004088693	0.002673376	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TGACTTTTCGCTAGCG-1_6_C5	25.57596483	-2.566634144	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3051	7637	0.000523766	0.001440356	0	2	EN-L4	NA	NA	NA
TGACTTTTCTGCCCTA-1_6_C5	-3.112821189	-6.455253176	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	848	1291	0.007745933	0.00464756	0	13A	IN-VIP	NA	NA	NA
TGAGAGGAGCAATCTC-1_6_C5	11.26923284	24.96945849	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	832	1278	0.00312989	0.008607199	0	oligos	OL-Cntl	NA	NA	NA
TGAGAGGCATTATCTC-1_6_C5	1.336316148	-17.05452449	4	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2736	5748	0.01026444	0.005045233	0	L2-3	EN-L2-3-MS	NA	NA	NA
TGAGAGGGTTATCCGA-1_6_C5	25.139564	-3.195560999	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3193	7882	0.000126871	0.002029942	0	2	EN-L4	NA	NA	NA
TGAGAGGTCTCCCTGA-1_6_C5	23.32558022	11.62487824	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1801	3137	0.000956328	0.003506535	0	oligos	OL-Cntl	NA	NA	NA
TGAGCATAGCGGCTTC-1_6_C5	-4.872173318	-9.970615086	13B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	855	1326	0.012066365	0.003016591	0	13B	IN-SV2C	NA	NA	NA
TGAGCATCAGATAATG-1_6_C5	-36.80910693	-8.971450561	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	900	1396	0.002148997	0.00286533	0	9	OPC	NA	NA	NA
TGAGCATCAGCTGTGC-1_6_C5	13.29898202	29.82384957	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	843	1327	0.001507159	0.00075358	0	oligos	OL-Cntl	NA	NA	NA
TGAGCATGTTCAACCA-1_6_C5	-24.88635789	27.08703789	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1381	2403	0.002496879	0.001664586	0	8	Astrocytes	NA	NA	NA
TGAGCCGAGTAGCGGT-1_6_C5	7.478398681	-7.175212843	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1622	3078	0.007797271	0.002923977	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TGAGCCGCAACACCTA-1_6_C5	6.651931957	32.59549049	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	816	1231	0.003249391	0.005686434	0	oligos	OL-Cntl	NA	NA	NA
TGAGCCGCACGTTGGC-1_6_C5	12.18060094	32.71548246	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	736	1063	0.000940734	0.002822201	0	oligos	OL-Cntl	NA	NA	NA
TGAGCCGGTCACCCAG-1_6_C5	-9.848961145	-32.11004245	16	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1094	1655	0.099697885	0.005438066	0	16	EN-PYR	NA	NA	NA
TGAGGGACACGGCCAT-1_6_C5	-26.93697341	24.90228935	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1319	2135	0.00234192	0.00234192	0	8	Astrocytes	NA	NA	NA
TGAGGGACAGCGTCCA-1_6_C5	17.74823351	25.18695063	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	934	1307	0.003060444	0.003825555	0	oligos	OL-Cntl	NA	NA	NA
TGAGGGACAGCTGTGC-1_6_C5	-1.525680299	-17.51213421	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2515	5636	0.003548616	0.001774308	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TGAGGGAGTTACCGAT-1_6_C5	0.60710884	-23.73206262	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3678	9537	0.009017511	0.002306805	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TGAGGGATCAACGGGA-1_6_C5	22.64938323	0.891746049	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1680	3147	0.01938354	0.001906578	0	2	EN-L4	NA	NA	NA
TGAGGGATCATGTCTT-1_6_C5	3.065632737	29.14725949	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	735	1031	0.001939864	0.005819593	0	oligos	OL-Cntl	NA	NA	NA
TGAGGGATCCGAGCCA-1_6_C5	26.16534036	-3.820734166	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3771	10011	0.002097693	0.002597143	0	2	EN-L4	NA	NA	NA
TGAGGGATCGTTTAGG-1_6_C5	12.00619732	27.53541887	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	752	1142	0.001751313	0.003502627	0	oligos	OL-Cntl	NA	NA	NA
TGATTTCAGATAGCAT-1_6_C5	4.563126388	-2.276079102	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	731	1025	0.014634146	0.010731707	0	12	EN-MIX	NA	NA	NA
TGATTTCCAAACGTGG-1_6_C5	12.55515322	31.20747934	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	671	1009	0	0.003964321	0	oligos	OL-Cntl	NA	NA	NA
TGATTTCCATGCATGT-1_6_C5	14.79918773	27.29939158	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	678	1052	0.001901141	0.003802281	0	oligos	OL-Cntl	NA	NA	NA
TGATTTCTCTGCGGCA-1_6_C5	-1.406776184	-15.36989815	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1936	3728	0.001072961	0.002682403	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TGCACCTAGAACAATC-1_6_C5	6.476695488	-5.684857514	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1151	1973	0.009630005	0.001520527	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TGCACCTAGTATGACA-1_6_C5	-9.596789195	-0.750949858	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2265	4442	0.016884286	0.005628095	0	13A	IN-VIP	NA	NA	NA
TGCACCTCAAGTTGTC-1_6_C5	-1.197717285	-0.885640444	11	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2243	4218	0.007586534	0.003793267	0	11	Glia-MIX	NA	NA	NA
TGCACCTCACCTATCC-1_6_C5	8.845552573	33.70695893	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	841	1241	0.003223207	0.004029009	0	oligos	OL-Cntl	NA	NA	NA
TGCACCTTCCGCGCAA-1_6_C5	3.942829582	-2.410642588	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	871	1400	0.005714286	0.005	0	12	EN-MIX	NA	NA	NA
TGCACCTTCGTTACAG-1_6_C5	26.37196671	0.6217581	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2750	5969	0.003350645	0.002345451	0	2	EN-L4	NA	NA	NA
TGCCAAAAGAGGTTGC-1_6_C5	2.859299274	-7.815483688	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1339	2174	0.016559338	0.002299908	0	12	EN-MIX	NA	NA	NA
TGCCAAAAGATGCCTT-1_6_C5	7.093450205	35.39606068	11	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	927	1429	0.009097271	0.00349895	0	11	Glia-MIX	NA	NA	NA
TGCCAAAAGATTACCC-1_6_C5	14.54110138	26.01112098	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	759	1096	0	0.000912409	0	oligos	OL-Cntl	NA	NA	NA
TGCCAAAAGCATGGCA-1_6_C5	19.84812261	21.95406155	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	979	1520	0.002631579	0.001973684	0	oligos	OL-Cntl	NA	NA	NA
TGCCAAACAATCAGAA-1_6_C5	-20.11571966	-28.85911253	6A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3636	9403	0.008614272	0.002765075	0	6A	IN-PV	NA	NA	NA
TGCCAAACACATGTGT-1_6_C5	11.17528329	31.55584419	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	762	1288	0.005434783	0.002329193	0	oligos	OL-Cntl	NA	NA	NA
TGCCAAAGTGACTACT-1_6_C5	0.353340046	-0.5202693	6B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	809	1219	0.005742412	0.000820345	0	6B	IN-SST	NA	NA	NA
TGCCAAATCGCAGGCT-1_6_C5	0.750455895	-29.66951022	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	4277	12372	0.000161655	0.003233107	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TGCCCATAGGCAAAGA-1_6_C5	19.77047655	-6.965823963	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2465	5651	0.01008671	0.002123518	0	3	EN-L5-6	NA	NA	NA
TGCCCATAGTCGTACT-1_6_C5	2.72743871	-11.10502256	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1720	3018	0.015241882	0.003644798	0	12	EN-MIX	NA	NA	NA
TGCCCATAGTGGTAAT-1_6_C5	16.74097737	23.44995729	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	915	1403	0.002138275	0.003563792	0	oligos	OL-Cntl	NA	NA	NA
TGCCCATCATACCATG-1_6_C5	22.77042198	12.64553415	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1421	2307	0.000866927	0.003467707	0	oligos	OL-Cntl	NA	NA	NA
TGCCCATCATTACCTT-1_6_C5	16.50141097	-0.657570248	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	731	1082	0.004621072	0.003696858	0	12	EN-MIX	NA	NA	NA
TGCCCATGTCAGAAGC-1_6_C5	-10.9439041	12.73358656	11	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	765	1132	0.002650177	0.007067138	0	11	Glia-MIX	NA	NA	NA
TGCCCATGTGACAAAT-1_6_C5	3.437610078	31.96427157	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	836	1198	0.002504174	0.005843072	0	oligos	OL-Cntl	NA	NA	NA
TGCCCATTCACGCGGT-1_6_C5	1.052472867	-17.21657672	4	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2718	5519	0.012683457	0.004167422	0	L2-3	EN-L2-3-MS	NA	NA	NA
TGCCCATTCCCAAGAT-1_6_C5	-1.994814032	2.708546554	11	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1634	2638	0.004169826	0.008339651	0	11	Glia-MIX	NA	NA	NA
TGCCCATTCCTGCTTG-1_6_C5	-22.93976325	12.11493521	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	951	1552	0.00064433	0.005154639	0	8	Astrocytes	NA	NA	NA
TGCCCTAAGATAGGAG-1_6_C5	25.88340634	-5.222139589	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	4278	12129	0.000742023	0.003215434	0	2	EN-L4	NA	NA	NA
TGCCCTAAGCCACGCT-1_6_C5	19.97943261	-6.931791586	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2545	5874	0.000510725	0.002213143	0	3	EN-L5-6	NA	NA	NA
TGCCCTAAGGCCCTCA-1_6_C5	40.03169405	10.6071655	14	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	821	1199	0	0.003336113	0	14	Microglia	NA	NA	NA
TGCCCTAAGGGATCTG-1_6_C5	0.227353965	-15.83729095	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2457	4880	0.01045082	0.004713115	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TGCCCTAAGTGTACCT-1_6_C5	15.08074275	2.95864052	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	931	1367	0.001463058	0.005120702	0	12	EN-MIX	NA	NA	NA
TGCCCTACACACTGCG-1_6_C5	18.45246337	-6.929645634	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1782	3239	0.004631059	0.004322322	0	3	EN-L5-6	NA	NA	NA
TGCCCTACACGAAATA-1_6_C5	18.912992	14.22298565	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1198	1989	0.001508296	0.001508296	0	oligos	OL-Cntl	NA	NA	NA
TGCCCTACACGCCAGT-1_6_C5	-27.26898207	15.95148178	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1134	1766	0.005096263	0.00396376	0	8	Astrocytes	NA	NA	NA
TGCCCTACAGACTCGC-1_6_C5	22.25353249	-8.724568778	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2159	4259	0.002817563	0.002347969	0	3	EN-L5-6	NA	NA	NA
TGCCCTACAGATAATG-1_6_C5	-37.17173433	-9.208588095	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	970	1526	0.000655308	0.003931848	0	9	OPC	NA	NA	NA
TGCCCTAGTAAGGGAA-1_6_C5	-19.88370722	-28.776632	6A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3944	10646	0.004790532	0.002630096	0	6A	IN-PV	NA	NA	NA
TGCCCTAGTACGACCC-1_6_C5	-4.854352872	-7.388973104	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1062	1556	0.014138817	0.005141388	0	13A	IN-VIP	NA	NA	NA
TGCCCTAGTCGTGGCT-1_6_C5	-15.5802371	-26.01677875	6A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1709	3271	0.007337206	0.001834301	0	6A	IN-PV	NA	NA	NA
TGCCCTAGTCTCTTAT-1_6_C5	-16.8346334	-11.00516675	13B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3570	8849	0.006328399	0.002938185	0	13B	IN-SV2C	NA	NA	NA
TGCCCTATCAATCTCT-1_6_C5	-12.06155606	-19.30212475	6B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1034	1775	0.034366197	0.003943662	0	6B	IN-SST	NA	NA	NA
TGCCCTATCACTATTC-1_6_C5	11.6865692	14.01080803	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1054	1693	0.010041347	0.005316007	0	oligos	OL-Cntl	NA	NA	NA
TGCCCTATCAGCACAT-1_6_C5	15.68586261	-1.729957848	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1013	1642	0.004872107	0.003045067	0	12	EN-MIX	NA	NA	NA
TGCGCAGAGCGAAGGG-1_6_C5	2.661428426	-10.91282699	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1702	3070	0.006514658	0.005537459	0	12	EN-MIX	NA	NA	NA
TGCGCAGAGGCAGGTT-1_6_C5	3.149594149	-9.451311624	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1693	3181	0.001886199	0.004086765	0	12	EN-MIX	NA	NA	NA
TGCGCAGCACCATGTA-1_6_C5	18.61481549	-6.451948478	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1741	3108	0.001608752	0.004182754	0	3	EN-L5-6	NA	NA	NA
TGCGCAGCACGTCTCT-1_6_C5	17.78981129	28.25023056	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	867	1295	0.003088803	0.004633205	0	oligos	OL-Cntl	NA	NA	NA
TGCGCAGTCGTCACGG-1_6_C5	-11.63913027	17.87001973	11	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2001	3628	0.011025358	0.004134509	0	11	Glia-MIX	NA	NA	NA
TGCGCAGTCTCAAGTG-1_6_C5	2.91457833	-7.532571733	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1299	2067	0.01161103	0.004354136	0	12	EN-MIX	NA	NA	NA
TGCGGGTAGACTAGAT-1_6_C5	5.073660099	31.03670054	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	818	1143	0.000874891	0.006124234	0	oligos	OL-Cntl	NA	NA	NA
TGCGGGTAGAGCTGCA-1_6_C5	-14.68718123	-10.4605468	13B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2116	4165	0.011764706	0.002641056	0	13B	IN-SV2C	NA	NA	NA
TGCGGGTAGCGCCTCA-1_6_C5	12.90818439	28.88014371	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	838	1398	0.001430615	0.00286123	0	oligos	OL-Cntl	NA	NA	NA
TGCGGGTAGTTAGCGG-1_6_C5	0.473397145	-16.22311847	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2446	4990	0.002805611	0.004208417	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TGCGGGTAGTTTCCTT-1_6_C5	-18.15836862	-23.66805406	6A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2175	4349	0.023683605	0.00436882	0	6A	IN-PV	NA	NA	NA
TGCGGGTTCGCTTAGA-1_6_C5	-29.40525463	13.93977482	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	902	1423	0.001405481	0.002810963	0	8	Astrocytes	NA	NA	NA
TGCGGGTTCTGTGCAA-1_6_C5	29.74184857	-7.793309559	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	5536	18162	0.020151966	0.003028301	0	2	EN-L4	NA	NA	NA
TGCGTGGCAGGTCGTC-1_6_C5	2.815989642	-27.23880794	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3224	7530	0.005577689	0.003718459	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TGCGTGGCATCGGGTC-1_6_C5	-17.84296208	-22.2249459	6A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1882	3517	0.003411999	0.007108331	0	6A	IN-PV	NA	NA	NA
TGCGTGGGTATAGTAG-1_6_C5	6.585936536	29.6191493	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	810	1185	0.002531646	0.006751055	0	oligos	OL-Cntl	NA	NA	NA
TGCGTGGGTCATGCCG-1_6_C5	-0.518912492	4.614433595	11	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	800	1184	0.004222973	0.007601351	0	11	Glia-MIX	NA	NA	NA
TGCGTGGGTCTACCTC-1_6_C5	-36.00869531	-7.205735617	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1024	1660	0.001204819	0.001204819	0	9	OPC	NA	NA	NA
TGCGTGGTCAACGGCC-1_6_C5	-0.089223928	-14.35072891	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2214	4135	0.005804111	0.005078597	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TGCTACCAGGCAGTCA-1_6_C5	-23.67104397	30.39613731	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1961	3634	0.001375894	0.00247661	0	8	Astrocytes	NA	NA	NA
TGCTACCCATGGTCAT-1_6_C5	21.18475024	19.44977495	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1134	1898	0.00052687	0.001580611	0	oligos	OL-Cntl	NA	NA	NA
TGCTACCGTTGTACAC-1_6_C5	-14.8034899	-23.97129143	6A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1565	2791	0.01504837	0.002866356	0	6A	IN-PV	NA	NA	NA
TGCTACCTCGTCACGG-1_6_C5	30.09026851	9.503623717	15DA	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	909	1242	0.009661836	0.086151369	0	15DA	T cells	NA	NA	NA
TGCTGCTAGACAGACC-1_6_C5	0.934959431	-17.04259358	4	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2586	5391	0.00556483	0.004637359	0	L2-3	EN-L2-3-MS	NA	NA	NA
TGCTGCTAGATATACG-1_6_C5	-20.88529364	9.817061346	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1042	1472	0	0.004755435	0	8	Astrocytes	NA	NA	NA
TGCTGCTAGGATGGTC-1_6_C5	-26.43026055	25.81957628	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1456	2501	0.00119952	0.00119952	0	8	Astrocytes	NA	NA	NA
TGCTGCTAGTACTTGC-1_6_C5	-4.740010491	-4.038338784	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1371	2411	0.03442555	0.002073828	0	13A	IN-VIP	NA	NA	NA
TGCTGCTCACACATGT-1_6_C5	11.88211815	32.77633197	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	733	1110	0.000900901	0.002702703	0	oligos	OL-Cntl	NA	NA	NA
TGCTGCTCAGCTCCGA-1_6_C5	19.7438663	24.82930537	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1009	1479	0.000676133	0.00270453	0	oligos	OL-Cntl	NA	NA	NA
TGCTGCTCATCTCGCT-1_6_C5	-26.11431678	26.63794052	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1594	2907	0.003095975	0.002407981	0	8	Astrocytes	NA	NA	NA
TGCTGCTGTAAACCTC-1_6_C5	-38.54686622	0.199508016	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1543	2793	0.000716076	0.001432152	0	9	OPC	NA	NA	NA
TGCTGCTGTCACTGGC-1_6_C5	-33.94353102	-10.8495048	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	926	1479	0.003380663	0.00270453	0	9	OPC	NA	NA	NA
TGCTGCTGTCGACTAT-1_6_C5	-28.25767777	4.296696108	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1161	1863	0	0.002683843	0	9	OPC	NA	NA	NA
TGCTGCTGTTAGATGA-1_6_C5	2.7364609	29.55791108	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	669	1019	0.002944063	0.000981354	0	oligos	OL-Cntl	NA	NA	NA
TGCTGCTTCAATCACG-1_6_C5	19.02056469	21.93011778	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1041	1690	0.001775148	0.005325444	0	oligos	OL-Cntl	NA	NA	NA
TGCTGCTTCACTCCTG-1_6_C5	-36.58815564	-7.519297657	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1138	1921	0.001041124	0.002602811	0	9	OPC	NA	NA	NA
TGGACGCAGCTAACAA-1_6_C5	-35.48215895	-11.90312318	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	815	1185	0.003375527	0.000843882	0	9	OPC	NA	NA	NA
TGGACGCCACATGGGA-1_6_C5	-29.54944364	13.89897215	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	854	1292	0.001547988	0.000773994	0	8	Astrocytes	NA	NA	NA
TGGACGCCACATTCGA-1_6_C5	21.34768199	7.491794897	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1957	3585	0.0013947	0.00390516	0	oligos	OL-Cntl	NA	NA	NA
TGGACGCGTGTGGTTT-1_6_C5	-34.00181328	-12.19888166	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	812	1238	0.003231018	0.001615509	0	9	OPC	NA	NA	NA
TGGACGCGTTACAGAA-1_6_C5	0.300164161	-26.68103668	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	6649	24661	0.006487977	0.003608937	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TGGACGCTCCTATGTT-1_6_C5	4.699225504	-5.283559452	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	923	1403	0.000712758	0.002851033	0	12	EN-MIX	NA	NA	NA
TGGACGCTCTTGTTTG-1_6_C5	25.33115508	0.086777988	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2447	5051	0.003959612	0.001583845	0	2	EN-L4	NA	NA	NA
TGGCCAGAGTTAGGTA-1_6_C5	0.367473555	36.17755404	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	749	1082	0.000924214	0.002772643	0	oligos	OL-Cntl	NA	NA	NA
TGGCCAGCAATGAAAC-1_6_C5	11.98909264	13.3734734	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1612	2623	0.003431186	0.006099886	0	oligos	OL-Cntl	NA	NA	NA
TGGCCAGGTAACGCGA-1_6_C5	-16.12014121	-9.222103881	13B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2737	5832	0.021090535	0.003257888	0	13B	IN-SV2C	NA	NA	NA
TGGCCAGTCTGATACG-1_6_C5	20.81994799	-28.88898189	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	4082	10773	0.006033603	0.004084285	0	3	EN-L5-6	NA	NA	NA
TGGCGCAAGCGTAATA-1_6_C5	-21.12980856	-28.0539819	6A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3714	9645	0.010264386	0.003628823	0	6A	IN-PV	NA	NA	NA
TGGCGCACAAGAGGCT-1_6_C5	25.63662263	0.436782695	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2722	6129	0.006200033	0.000652635	0	2	EN-L4	NA	NA	NA
TGGCGCACATCGGTTA-1_6_C5	19.0618673	22.2227097	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	947	1521	0.000657462	0.003287311	0	oligos	OL-Cntl	NA	NA	NA
TGGCGCACATGAAGTA-1_6_C5	18.71816292	26.42838324	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	967	1443	0.000693001	0.004158004	0	oligos	OL-Cntl	NA	NA	NA
TGGCGCAGTACAGTTC-1_6_C5	-36.41822935	-7.844803155	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1035	1609	0.00621504	0.004350528	0	9	OPC	NA	NA	NA
TGGCTGGAGAATAGGG-1_6_C5	5.442508388	33.25554774	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	718	1031	0	0.006789525	0	oligos	OL-Cntl	NA	NA	NA
TGGCTGGAGCCGCCTA-1_6_C5	17.13581562	27.36281991	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	852	1235	0.001619433	0.003238866	0	oligos	OL-Cntl	NA	NA	NA
TGGCTGGAGCTAGGCA-1_6_C5	-3.176510218	-6.101216587	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	869	1381	0.006517017	0.000724113	0	13A	IN-VIP	NA	NA	NA
TGGCTGGAGGCTATCT-1_6_C5	-14.20197262	-7.895907319	13B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3304	8527	0.005746452	0.002110942	0	13B	IN-SV2C	NA	NA	NA
TGGCTGGAGTATCTCG-1_6_C5	-19.77201156	-27.30579295	6A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2753	6055	0.008918249	0.004128819	0	6A	IN-PV	NA	NA	NA
TGGCTGGCAAGCTGGA-1_6_C5	-8.575853785	-17.96103484	6B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	734	1087	0.011959522	0.004599816	0	6B	IN-SST	NA	NA	NA
TGGCTGGCAAGGACTG-1_6_C5	-8.241028171	-1.697707843	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2278	3915	0.022222222	0.004853129	0	13A	IN-VIP	NA	NA	NA
TGGCTGGCAATGGTCT-1_6_C5	-0.58227502	-23.20278128	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3416	8253	0.002423361	0.002181025	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TGGCTGGCACGAAAGC-1_6_C5	-10.8410125	1.430371162	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2585	5299	0.003396867	0.003208152	0	13A	IN-VIP	NA	NA	NA
TGGCTGGCACTTACGA-1_6_C5	10.37976295	-8.949169905	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2404	4989	0.003006615	0.002204851	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TGGCTGGTCAGGTTCA-1_6_C5	-9.767416342	2.52736562	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3273	8621	0.008699687	0.003595871	0	13A	IN-VIP	NA	NA	NA
TGGGAAGAGTCGATAA-1_6_C5	-27.62477916	25.33153843	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1271	2177	0.000459348	0.003215434	0	8	Astrocytes	NA	NA	NA
TGGGAAGCACACATGT-1_6_C5	0.205163198	-17.17131173	4	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2338	4419	0.009278117	0.003620729	0	L2-3	EN-L2-3-MS	NA	NA	NA
TGGGAAGCACCTATCC-1_6_C5	1.751456043	-29.64603749	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	4707	14610	0.0045859	0.002053388	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TGGGAAGCATCCGTGG-1_6_C5	7.23829646	-32.38150535	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	4492	12688	0.001261034	0.002364439	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TGGGAAGCATTGGTAC-1_6_C5	14.16240259	28.25457656	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	704	1065	0.003755869	0	0	oligos	OL-Cntl	NA	NA	NA
TGGGAAGGTCAGCTAT-1_6_C5	11.19089934	30.04011126	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	800	1191	0	0.000839631	0	oligos	OL-Cntl	NA	NA	NA
TGGGAAGGTGCACCAC-1_6_C5	25.01397276	0.026254241	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2316	4715	0.016330859	0.001908802	0	2	EN-L4	NA	NA	NA
TGGGAAGGTTCTGTTT-1_6_C5	-15.99705708	-25.72821988	6A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1856	3473	0.009501872	0.002303484	0	6A	IN-PV	NA	NA	NA
TGGGCGTAGGCTCATT-1_6_C5	2.543828279	-29.28443057	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3884	10410	0.006916427	0.00259366	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TGGGCGTCACATTTCT-1_6_C5	2.390749109	-21.07382489	4	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3389	8185	0.007819181	0.003176542	0	L2-3	EN-L2-3-MS	NA	NA	NA
TGGGCGTCAGTCAGCC-1_6_C5	1.146983795	-19.59776029	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3044	6544	0.006265281	0.002139364	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TGGGCGTCATGATCCA-1_6_C5	3.237449923	-20.26214815	4	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3491	7861	0.012084976	0.006360514	0	L2-3	EN-L2-3-MS	NA	NA	NA
TGGGCGTCATGTTGAC-1_6_C5	-37.34998043	-5.740683795	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1120	1868	0.003747323	0.00267666	0	9	OPC	NA	NA	NA
TGGGCGTTCATTGCCC-1_6_C5	7.132397711	-33.17822835	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	4736	15539	0.00199498	0.001608855	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TGGTTAGAGAAGGTTT-1_6_C5	22.41294068	-6.952170958	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2228	4124	0.003879728	0.002667313	0	3	EN-L5-6	NA	NA	NA
TGGTTAGAGCAGCGTA-1_6_C5	-27.70152339	17.19219419	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1099	1786	0.003919373	0.003359462	0	8	Astrocytes	NA	NA	NA
TGGTTAGAGTTTAGGA-1_6_C5	2.57738461	-7.382747471	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1347	2158	0.022706209	0.006024096	0	12	EN-MIX	NA	NA	NA
TGGTTAGCATCCGGGT-1_6_C5	-0.812882778	-0.532186944	11	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1515	2449	0.030216415	0.005716619	0	11	Glia-MIX	NA	NA	NA
TGGTTAGTCCTAGTGA-1_6_C5	19.97254378	-6.975199694	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2470	5789	0.00241838	0.00241838	0	3	EN-L5-6	NA	NA	NA
TGGTTAGTCGAGAGCA-1_6_C5	-37.47762668	-5.735455747	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1166	1931	0.001553599	0.003625065	0	9	OPC	NA	NA	NA
TGGTTCCAGGACAGAA-1_6_C5	16.05455905	23.55304086	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	862	1289	0.004654771	0.000775795	0	oligos	OL-Cntl	NA	NA	NA
TGGTTCCCAAGGACAC-1_6_C5	-15.28028589	-10.14884325	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2569	5555	0.00180018	0.002160216	0	13A	IN-VIP	NA	NA	NA
TGGTTCCCACTGTTAG-1_6_C5	-17.49176619	-24.50378933	6A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2213	4903	0.002855395	0.002243524	0	6A	IN-PV	NA	NA	NA
TGGTTCCCATACGCTA-1_6_C5	-11.77806996	-19.1504908	6B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	979	1552	0.017396907	0.003865979	0	6B	IN-SST	NA	NA	NA
TGGTTCCCATGTCCTC-1_6_C5	24.3880122	-28.99044289	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2570	5373	0.003163968	0.003722315	0	3	EN-L5-6	NA	NA	NA
TGGTTCCGTAGGCTGA-1_6_C5	12.93017374	27.78667868	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	743	1093	0.009149131	0.005489478	0	oligos	OL-Cntl	NA	NA	NA
TGGTTCCGTGATAAGT-1_6_C5	-28.57138654	22.89696799	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1147	1906	0.000524659	0.001573977	0	8	Astrocytes	NA	NA	NA
TGGTTCCTCCTCGCAT-1_6_C5	-28.38522111	23.27349157	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1139	1971	0.002029427	0.003551497	0	8	Astrocytes	NA	NA	NA
TGTATTCAGCGTCAAG-1_6_C5	6.796737955	-29.91831942	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3438	8333	0.010560422	0.002160086	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TGTATTCCAAATTGCC-1_6_C5	16.51940902	1.512533153	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	804	1193	0.005867561	0.004191115	0	12	EN-MIX	NA	NA	NA
TGTATTCCACCCATTC-1_6_C5	-28.47690483	21.98206624	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1077	1678	0.002979738	0.005959476	0	8	Astrocytes	NA	NA	NA
TGTATTCCAGTGGAGT-1_6_C5	22.52895795	19.14602607	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	890	1260	0.002380952	0.001587302	0	oligos	OL-Cntl	NA	NA	NA
TGTCCCAAGCTAAACA-1_6_C5	11.21880257	33.49700455	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	833	1169	0.005132592	0.00427716	0	oligos	OL-Cntl	NA	NA	NA
TGTCCCAAGCTGATAA-1_6_C5	-3.235368336	-7.058364055	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	887	1281	0.007806401	0.00078064	0	13A	IN-VIP	NA	NA	NA
TGTCCCAGTACCGTAT-1_6_C5	1.101219933	-27.65321061	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	4263	12055	0.002986313	0.003401078	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TGTCCCAGTGCAGTAG-1_6_C5	13.92065179	28.83399299	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	827	1162	0	0.006024096	0	oligos	OL-Cntl	NA	NA	NA
TGTCCCAGTTTGGGCC-1_6_C5	25.40779722	-4.238193734	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3981	10758	0.00046477	0.002230898	0	2	EN-L4	NA	NA	NA
TGTGGTAAGATCCCAT-1_6_C5	-11.92357506	16.32661683	11	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1280	2036	0.000982318	0.003438114	0	11	Glia-MIX	NA	NA	NA
TGTGGTAAGTTGCAGG-1_6_C5	11.89948816	29.93895719	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	803	1135	0.001762115	0.003524229	0	oligos	OL-Cntl	NA	NA	NA
TGTGGTACAAGGACTG-1_6_C5	-3.872283955	-5.217435855	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1062	1696	0.024174528	0.002948113	0	13A	IN-VIP	NA	NA	NA
TGTGGTACAATGGATA-1_6_C5	5.416713125	30.98594588	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	829	1198	0.000834725	0.00918197	0	oligos	OL-Cntl	NA	NA	NA
TGTGGTAGTACGCACC-1_6_C5	8.722989026	30.46286591	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	686	1049	0.001906578	0.006673022	0	oligos	OL-Cntl	NA	NA	NA
TGTGGTAGTGACTCAT-1_6_C5	-15.84154946	-9.658235689	13B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2462	5024	0.027070064	0.003781847	0	13B	IN-SV2C	NA	NA	NA
TGTGGTAGTGTTGAGG-1_6_C5	18.3496961	12.66919537	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1350	2171	0.007830493	0.006909258	0	oligos	OL-Cntl	NA	NA	NA
TGTGGTATCATATCGG-1_6_C5	-23.02603004	29.64913527	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1883	3562	0.010387423	0.003368894	0	8	Astrocytes	NA	NA	NA
TGTGGTATCTGTACGA-1_6_C5	-27.74580227	12.23226799	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	838	1176	0.00170068	0.003401361	0	8	Astrocytes	NA	NA	NA
TGTGTTTCACAACTGT-1_6_C5	-27.95903395	18.03020284	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1116	1828	0.003829322	0.002188184	0	8	Astrocytes	NA	NA	NA
TGTGTTTCAGAGTGTG-1_6_C5	22.14488376	0.96241568	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1645	2870	0.009407666	0.001045296	0	2	EN-L4	NA	NA	NA
TGTGTTTTCTGCAGTA-1_6_C5	4.127303737	-32.65186104	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	4909	18030	0.001164725	0.001552967	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TGTTCCGAGAATGTGT-1_6_C5	3.821148453	30.51318045	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	736	1041	0.008645533	0.005763689	0	oligos	OL-Cntl	NA	NA	NA
TGTTCCGAGAGCCCAA-1_6_C5	21.68987686	-8.68529242	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1921	3480	0.024137931	0.001724138	0	3	EN-L5-6	NA	NA	NA
TGTTCCGAGTACCGGA-1_6_C5	1.312960195	-26.78874651	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3573	8544	0.008075843	0.002691948	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TGTTCCGCAATCGGTT-1_6_C5	-24.88811387	20.05093901	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1477	2370	0.003375527	0.005063291	0	8	Astrocytes	NA	NA	NA
TGTTCCGCATATACGC-1_6_C5	12.34116913	28.94520546	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	794	1173	0.000852515	0	0	oligos	OL-Cntl	NA	NA	NA
TGTTCCGCATGACATC-1_6_C5	16.66017854	25.62782244	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	886	1415	0.002826855	0.00565371	0	oligos	OL-Cntl	NA	NA	NA
TGTTCCGGTAAGCACG-1_6_C5	17.89159857	-5.375033819	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1178	2043	0.020558003	0.000978953	0	3	EN-L5-6	NA	NA	NA
TGTTCCGGTCCCTTGT-1_6_C5	23.89770131	0.253092825	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2084	4214	0.002135738	0.003084955	0	2	EN-L4	NA	NA	NA
TGTTCCGTCAGTTTGG-1_6_C5	13.45152008	-28.28496987	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2473	5390	0.010760668	0.002040816	0	3	EN-L5-6	NA	NA	NA
TTAACTCCAGATGGCA-1_6_C5	6.574528439	-33.28002302	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3988	11830	0.00194421	0.001859679	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TTAACTCGTGATAAAC-1_6_C5	14.58119387	-8.211568751	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2144	4299	0.007210979	0.004652245	0	3	EN-L5-6	NA	NA	NA
TTAACTCGTTATCACG-1_6_C5	-30.15166436	13.91348319	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	737	1157	0	0.002592913	0	8	Astrocytes	NA	NA	NA
TTAACTCTCCCTAATT-1_6_C5	-2.258912583	-17.93372853	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2570	5649	0.007966012	0.003363427	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TTAGGACCAGTGGAGT-1_6_C5	19.14671247	8.357437889	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1741	3168	0.005050505	0.003787879	0	oligos	OL-Cntl	NA	NA	NA
TTAGGACGTCCAAGTT-1_6_C5	-16.61261427	-10.62725045	13B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2846	6341	0.004258003	0.002680965	0	13B	IN-SV2C	NA	NA	NA
TTAGGACGTCCGAATT-1_6_C5	21.73157368	10.99756358	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1727	3283	0.005178191	0.00548279	0	oligos	OL-Cntl	NA	NA	NA
TTAGGACGTTCAGGCC-1_6_C5	11.29059428	25.43733116	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	873	1317	0.00531511	0.002277904	0	oligos	OL-Cntl	NA	NA	NA
TTAGGACGTTGTACAC-1_6_C5	0.338826002	-12.65425678	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2094	4050	0.00617284	0.00345679	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TTAGGACTCACGAAGG-1_6_C5	11.87680934	23.45164063	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	833	1265	0.011067194	0.007114625	0	oligos	OL-Cntl	NA	NA	NA
TTAGGACTCCGGGTGT-1_6_C5	3.232417785	-29.3123168	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3751	10483	0.002480206	0.001812458	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TTAGGCACAATCACAC-1_6_C5	1.237429795	-10.32508328	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1572	2944	0.025815217	0.005434783	0	12	EN-MIX	NA	NA	NA
TTAGGCACATCGGACC-1_6_C5	22.87127668	0.228555517	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2062	3941	0.015732048	0.004059883	0	2	EN-L4	NA	NA	NA
TTAGGCAGTTTACTCT-1_6_C5	14.79617832	27.67782305	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	754	1145	0.001746725	0.00349345	0	oligos	OL-Cntl	NA	NA	NA
TTAGTTCAGGACCACA-1_6_C5	-8.280458192	-17.97855026	6B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	695	1062	0.032015066	0.00094162	0	6B	IN-SST	NA	NA	NA
TTAGTTCAGTGGGATC-1_6_C5	9.240788407	-8.561270996	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2470	5142	0.006028783	0.00369506	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TTAGTTCGTCTAGCGC-1_6_C5	-35.10946439	-10.66800189	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	964	1440	0.009027778	0.002777778	0	9	OPC	NA	NA	NA
TTAGTTCTCCTCAACC-1_6_C5	-37.49833498	-8.574793595	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	961	1564	0.001918159	0.001918159	0	9	OPC	NA	NA	NA
TTATGCTGTACCGCTG-1_6_C5	-35.86160006	4.914921309	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2366	5255	0.002283539	0.002093245	0	9	OPC	NA	NA	NA
TTATGCTGTCCTCCAT-1_6_C5	25.89515046	-3.039271304	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3365	9266	0.000215843	0.002482193	0	2	EN-L4	NA	NA	NA
TTATGCTTCAACACAC-1_6_C5	15.56833169	-6.363512468	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1560	3305	0.000302572	0.001512859	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TTATGCTTCGAATCCA-1_6_C5	3.871514667	-5.436514437	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1000	1478	0.00947226	0.00270636	0	12	EN-MIX	NA	NA	NA
TTATGCTTCGCCAAAT-1_6_C5	-14.78630165	-3.716987508	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3773	8839	0.020590565	0.004864804	0	13A	IN-VIP	NA	NA	NA
TTCCCAGAGGTCATCT-1_6_C5	4.140169765	-29.59046875	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3193	8281	0.001811375	0.000966067	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TTCCCAGAGTCGCCGT-1_6_C5	-36.59931587	-5.608829851	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1158	1818	0.00220022	0.000550055	0	9	OPC	NA	NA	NA
TTCCCAGCAAATTGCC-1_6_C5	-8.225664935	0.613623572	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2168	4440	0.00990991	0.002702703	0	13A	IN-VIP	NA	NA	NA
TTCCCAGCAACAACCT-1_6_C5	-25.10059172	27.5784417	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1690	3257	0.007982806	0.003377341	0	8	Astrocytes	NA	NA	NA
TTCCCAGCAAGCGCTC-1_6_C5	5.38989184	29.99554231	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	713	1043	0.003835091	0.001917546	0	oligos	OL-Cntl	NA	NA	NA
TTCCCAGCAGCCTATA-1_6_C5	-2.826987465	-26.6248217	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3673	10373	0.002506507	0.002602911	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TTCCCAGGTACGACCC-1_6_C5	1.060021511	-29.12317587	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	4787	15647	0.002684221	0.002556401	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TTCCCAGGTCATCGGC-1_6_C5	-8.525193661	-18.14140916	6B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	719	1073	0.032618826	0.006523765	0	6B	IN-SST	NA	NA	NA
TTCCCAGTCCGTTGTC-1_6_C5	-9.972954534	-18.40194021	6B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	879	1392	0.012931034	0.004310345	0	6B	IN-SST	NA	NA	NA
TTCCCAGTCGGACAAG-1_6_C5	3.529276455	-28.7826309	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3580	8942	0.002012972	0.001901141	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TTCCCAGTCGGTGTTA-1_6_C5	-25.41552952	20.64832731	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1530	2723	0.000367242	0.002203452	0	8	Astrocytes	NA	NA	NA
TTCCCAGTCTCTAAGG-1_6_C5	-17.84222494	-26.58912992	6A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2545	5545	0.003967538	0.003246168	0	6A	IN-PV	NA	NA	NA
TTCGAAGAGGATCGCA-1_6_C5	13.85604976	28.89163805	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	760	1108	0.003610108	0.002707581	0	oligos	OL-Cntl	NA	NA	NA
TTCGAAGAGGGCTCTC-1_6_C5	-10.24625044	-14.84595145	6B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1222	1781	0.020774846	0.013475576	0	6B	IN-SST	NA	NA	NA
TTCGAAGCACGAAGCA-1_6_C5	-0.154574426	-15.00715646	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2545	5310	0.000564972	0.008474576	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TTCGAAGCACTAAGTC-1_6_C5	2.135006128	-17.05040479	4	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2770	5663	0.009358997	0.006886809	0	L2-3	EN-L2-3-MS	NA	NA	NA
TTCGAAGTCACCACCT-1_6_C5	-20.20255257	-17.54661426	6A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	4233	12186	0.008944691	0.003938946	0	6A	IN-PV	NA	NA	NA
TTCGAAGTCACTTATC-1_6_C5	25.60619633	-2.677963256	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2928	7097	0.001409046	0.002818092	0	2	EN-L4	NA	NA	NA
TTCGAAGTCATGTCCC-1_6_C5	-28.43821505	21.95173581	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1055	1667	0.00359928	0.00179964	0	8	Astrocytes	NA	NA	NA
TTCGGTCAGAATCTCC-1_6_C5	20.06774226	15.32140621	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1191	2056	0.000486381	0.002431907	0	oligos	OL-Cntl	NA	NA	NA
TTCGGTCAGCGTAGTG-1_6_C5	1.003786108	-10.47493784	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1667	2733	0.006952067	0.002561288	0	12	EN-MIX	NA	NA	NA
TTCGGTCAGTGTTTGC-1_6_C5	6.528233365	-30.45418064	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3968	10728	0.004101417	0.003262491	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TTCGGTCCACGGCCAT-1_6_C5	18.30677709	22.13059235	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	932	1509	0.001988072	0.003313453	0	oligos	OL-Cntl	NA	NA	NA
TTCGGTCGTGCCTGGT-1_6_C5	1.040765903	-19.53134812	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3165	7728	0.007505176	0.003752588	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TTCGGTCGTGTAATGA-1_6_C5	-29.69457655	21.02219685	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	987	1652	0.009079903	0.001815981	0	8	Astrocytes	NA	NA	NA
TTCGGTCGTGTGCGTC-1_6_C5	15.03807672	-0.879841348	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	789	1090	0.000917431	0.006422018	0	12	EN-MIX	NA	NA	NA
TTCGGTCGTTGCTCCT-1_6_C5	15.33895793	28.73357552	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	822	1274	0.008634223	0.000784929	0	oligos	OL-Cntl	NA	NA	NA
TTCGGTCTCCTCAATT-1_6_C5	-24.77268676	28.60966259	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1565	3010	0.00166113	0.00166113	0	8	Astrocytes	NA	NA	NA
TTCTACAAGCAACGGT-1_6_C5	-0.188593534	-10.52301166	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1562	2912	0.012019231	0.004120879	0	12	EN-MIX	NA	NA	NA
TTCTACAAGCAGGCTA-1_6_C5	3.132445124	-32.12325246	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	4723	15241	0.001771537	0.002296437	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TTCTACAAGTACTTGC-1_6_C5	0.342891174	-8.784963747	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1422	2608	0.004217791	0.001533742	0	12	EN-MIX	NA	NA	NA
TTCTACACAAGGTGTG-1_6_C5	2.580697196	-16.63951088	4	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2765	5919	0.014360534	0.004223686	0	L2-3	EN-L2-3-MS	NA	NA	NA
TTCTACACATGCATGT-1_6_C5	20.61678776	11.84525489	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1244	2112	0.001893939	0.002840909	0	oligos	OL-Cntl	NA	NA	NA
TTCTACACATTCTTAC-1_6_C5	-27.05712709	19.25349631	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1152	1942	0.000514933	0.003604531	0	8	Astrocytes	NA	NA	NA
TTCTACAGTATAGTAG-1_6_C5	21.654397	-8.449654638	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1947	3928	0.00509165	0.002291242	0	3	EN-L5-6	NA	NA	NA
TTCTACAGTCGGGTCT-1_6_C5	1.250650743	-10.63806826	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1712	2982	0.006036217	0.003688799	0	12	EN-MIX	NA	NA	NA
TTCTACAGTGGTAACG-1_6_C5	-36.3397697	-7.84434534	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	933	1416	0	0.001412429	0	9	OPC	NA	NA	NA
TTCTACAGTTACTGAC-1_6_C5	-22.43059991	-4.544845142	13B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2617	5533	0.005964215	0.00144587	0	13B	IN-SV2C	NA	NA	NA
TTCTACATCTTAGAGC-1_6_C5	0.555835962	-24.67608586	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2995	7442	0.003762429	0.003090567	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TTCTACATCTTGCATT-1_6_C5	2.834997802	-7.087009891	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1182	1929	0.023846553	0.002592017	0	12	EN-MIX	NA	NA	NA
TTCTCAAAGCTAGGCA-1_6_C5	23.07220372	-9.119986366	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2896	6778	0.003393331	0.001622898	0	3	EN-L5-6	NA	NA	NA
TTCTCAACAGGGCATA-1_6_C5	-38.46078877	-5.799060216	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1087	1822	0.000548847	0.003293085	0	9	OPC	NA	NA	NA
TTCTCAAGTAAATGAC-1_6_C5	-27.81827221	16.3886475	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	897	1394	0.00143472	0.00215208	0	8	Astrocytes	NA	NA	NA
TTCTCAAGTCAGTGGA-1_6_C5	15.38223075	30.35871138	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	785	1149	0.001740644	0.003481288	0	oligos	OL-Cntl	NA	NA	NA
TTCTCAATCAGGCCCA-1_6_C5	-10.63181067	-19.97334223	6A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1113	1955	0.008695652	0.002046036	0	6A	IN-PV	NA	NA	NA
TTCTCAATCTCTAGGA-1_6_C5	5.596896721	-32.42380279	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	4106	13010	0.001460415	0.001152959	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TTCTCCTAGAATCTCC-1_6_C5	17.1770535	24.40223226	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	851	1241	0.004029009	0.003223207	0	oligos	OL-Cntl	NA	NA	NA
TTCTCCTCAGGGTTAG-1_6_C5	-28.15390372	4.282064957	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1551	2689	0.005950167	0.001487542	0	9	OPC	NA	NA	NA
TTCTCCTGTACAAGTA-1_6_C5	23.14306184	18.47191156	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1155	1841	0.003802281	0.005431831	0	oligos	OL-Cntl	NA	NA	NA
TTCTCCTGTTCGTTGA-1_6_C5	15.52394669	-6.45583512	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1622	3025	0.002975207	0.00231405	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TTCTCCTTCATAACCG-1_6_C5	-13.14108658	14.72739139	11	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	873	1351	0.002220577	0.003700962	0	11	Glia-MIX	NA	NA	NA
TTCTTAGAGATGCCAG-1_6_C5	-14.75380862	-24.02378981	6A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1486	2664	0.026276276	0.005255255	0	6A	IN-PV	NA	NA	NA
TTCTTAGCAAGCCCAC-1_6_C5	11.64662378	29.2227229	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	738	1081	0.000925069	0.001850139	0	oligos	OL-Cntl	NA	NA	NA
TTCTTAGCATATACGC-1_6_C5	16.66904505	24.0100093	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	863	1354	0	0.001477105	0	oligos	OL-Cntl	NA	NA	NA
TTCTTAGCATCATCCC-1_6_C5	23.23264795	12.31964838	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1536	2809	0.000355999	0.00249199	0	oligos	OL-Cntl	NA	NA	NA
TTCTTAGCATGTCTCC-1_6_C5	-30.47777829	20.10733331	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	914	1488	0.001344086	0	0	8	Astrocytes	NA	NA	NA
TTCTTAGGTCGGCTCA-1_6_C5	1.848122895	-8.144457204	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1317	2199	0.01273306	0.002728513	0	12	EN-MIX	NA	NA	NA
TTCTTAGGTGCAACTT-1_6_C5	15.76444296	-2.644985147	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1058	1790	0.038547486	0.000558659	0	12	EN-MIX	NA	NA	NA
TTCTTAGGTGCGATAG-1_6_C5	-2.27555033	-19.45089834	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3007	7558	0.005027785	0.002778513	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TTCTTAGTCTAGCACA-1_6_C5	19.54988867	-7.259218069	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1860	3721	0.011556033	0.00214996	0	3	EN-L5-6	NA	NA	NA
TTGAACGCAAATCCGT-1_6_C5	-37.85773843	-8.851214074	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1157	2021	0.001979218	0.000989609	0	9	OPC	NA	NA	NA
TTGAACGCACCTCGTT-1_6_C5	-3.513684908	-15.60258574	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2230	4561	0.004385003	0.003288752	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TTGAACGTCACCCTCA-1_6_C5	4.279720813	7.005551043	7	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1155	1756	0.005125285	0.00284738	0	7	Phagocytes	NA	NA	NA
TTGAACGTCCTATGTT-1_6_C5	-3.286409412	-6.042677897	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1008	1657	0.021122511	0.003621002	0	13A	IN-VIP	NA	NA	NA
TTGAACGTCTTTACAC-1_6_C5	7.284033286	35.32135502	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	843	1271	0.013375295	0.007081039	0	oligos	OL-Cntl	NA	NA	NA
TTGACTTAGACAGGCT-1_6_C5	-26.39806326	26.06742222	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1375	2364	0.010152284	0.001692047	0	8	Astrocytes	NA	NA	NA
TTGACTTCAAGTCTGT-1_6_C5	23.22235534	-9.158114015	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3031	7283	0.001510367	0.002471509	0	3	EN-L5-6	NA	NA	NA
TTGCCGTAGGTGCTAG-1_6_C5	12.22054691	-21.33850639	4	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	4979	14691	0.036416854	0.002995031	0	L2-3	EN-L2-3-MS	NA	NA	NA
TTGCCGTAGTCCCACG-1_6_C5	12.81557896	27.24107637	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	760	1148	0.00087108	0.00261324	0	oligos	OL-Cntl	NA	NA	NA
TTGCCGTAGTGGCACA-1_6_C5	21.05730801	12.61160694	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1738	3022	0.006618134	0.001654533	0	oligos	OL-Cntl	NA	NA	NA
TTGCCGTGTCTTCAAG-1_6_C5	0.723754275	-10.61711767	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1706	3075	0.007479675	0.004552846	0	12	EN-MIX	NA	NA	NA
TTGCCGTGTTATCCGA-1_6_C5	-3.238123505	-6.603983929	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	922	1489	0.011417058	0.003357958	0	13A	IN-VIP	NA	NA	NA
TTGCCGTGTTGAGGTG-1_6_C5	10.24217699	23.62490225	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	792	1141	0.002629273	0.006134969	0	oligos	OL-Cntl	NA	NA	NA
TTGCCGTGTTTGGGCC-1_6_C5	-26.95860227	24.91344807	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1302	2195	0.00546697	0.002277904	0	8	Astrocytes	NA	NA	NA
TTGCCGTTCAACCAAC-1_6_C5	25.96332581	-4.397155068	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3900	10839	0.00332134	0.002952302	0	2	EN-L4	NA	NA	NA
TTGCCGTTCCACGACG-1_6_C5	21.61116776	15.18900253	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1112	1714	0.001750292	0.004084014	0	oligos	OL-Cntl	NA	NA	NA
TTGCCGTTCGACAGCC-1_6_C5	-38.11099531	-4.303138412	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1280	2276	0.003514938	0.003075571	0	9	OPC	NA	NA	NA
TTGCGTCAGTACTTGC-1_6_C5	-27.1306267	25.14010894	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1308	2249	0.000444642	0.003112494	0	8	Astrocytes	NA	NA	NA
TTGCGTCTCTATCCTA-1_6_C5	4.618234931	28.44940036	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	767	1043	0.004793864	0.003835091	0	oligos	OL-Cntl	NA	NA	NA
TTGCGTCTCTGAGGGA-1_6_C5	-0.39035591	-14.5693724	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2316	4802	0.008954602	0.004789671	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TTGGAACAGTTGAGTA-1_6_C5	14.44959115	-30.65226644	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	3065	7448	0.009264232	0.004027927	0	3	EN-L5-6	NA	NA	NA
TTGGAACCAGGCTGAA-1_6_C5	-26.30138826	18.85979236	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1318	2112	0.004734848	0.002840909	0	8	Astrocytes	NA	NA	NA
TTGGAACCAGTGGGAT-1_6_C5	-4.379396516	-8.927694653	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	666	1010	0.05049505	0.001980198	0	13A	IN-VIP	NA	NA	NA
TTGGAACTCGTCCAGG-1_6_C5	7.628629411	-32.4322881	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	4582	14172	0.005151002	0.002469658	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TTGGAACTCTCTGCTG-1_6_C5	18.37315637	-5.946644381	3	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1423	2734	0.005486467	0.002560351	0	3	EN-L5-6	NA	NA	NA
TTGGCAAAGGAGTTTA-1_6_C5	-7.014343104	-0.492424038	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1923	3649	0.004932858	0.001918334	0	13A	IN-VIP	NA	NA	NA
TTGGCAACACGTGAGA-1_6_C5	-33.70424701	-11.19306486	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	975	1694	0.002951594	0.001770956	0	9	OPC	NA	NA	NA
TTGGCAACAGTGGGAT-1_6_C5	18.95514026	9.424524836	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1584	2886	0.004158004	0.002425502	0	oligos	OL-Cntl	NA	NA	NA
TTGGCAAGTCTAGAGG-1_6_C5	-27.36489	17.62110134	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1138	1916	0.001043841	0.001565762	0	8	Astrocytes	NA	NA	NA
TTGTAGGAGCCGATTT-1_6_C5	15.54014357	25.77127281	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	786	1199	0.001668057	0.000834028	0	oligos	OL-Cntl	NA	NA	NA
TTGTAGGAGGAGCGAG-1_6_C5	2.669512446	-14.17459982	4	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2330	4419	0.011088482	0.004978502	0	L2-3	EN-L2-3-MS	NA	NA	NA
TTGTAGGGTCGCGGTT-1_6_C5	-27.71678281	17.71758681	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1136	1938	0.007223942	0.004127967	0	8	Astrocytes	NA	NA	NA
TTTACTGAGCGATAGC-1_6_C5	-34.09389299	-12.71815048	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	695	1015	0.002955665	0.002955665	0	9	OPC	NA	NA	NA
TTTACTGCACGAGAGT-1_6_C5	-35.62952421	-11.93768097	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	821	1333	0	0.000750188	0	9	OPC	NA	NA	NA
TTTACTGCAGCGTCCA-1_6_C5	-7.649049443	-2.74105303	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1696	3235	0.038330757	0.006491499	0	13A	IN-VIP	NA	NA	NA
TTTACTGCAGCTGTTA-1_6_C5	21.74873969	1.190681106	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1407	2466	0.006893755	0.002027575	0	2	EN-L4	NA	NA	NA
TTTACTGGTAAGGATT-1_6_C5	-9.249098189	0.421343945	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2290	4284	0.018207283	0.003034547	0	13A	IN-VIP	NA	NA	NA
TTTACTGTCCAAATGC-1_6_C5	-14.3621402	-25.04754825	6A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1423	2747	0.002184201	0.001820167	0	6A	IN-PV	NA	NA	NA
TTTACTGTCGAACGGA-1_6_C5	2.049257828	-13.24620075	4	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2188	4198	0.010957599	0.006431634	0	L2-3	EN-L2-3-MS	NA	NA	NA
TTTATGCCATTACCTT-1_6_C5	16.52159422	24.2865811	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	814	1228	0.00732899	0.001628664	0	oligos	OL-Cntl	NA	NA	NA
TTTATGCGTAAACCTC-1_6_C5	-4.394448052	-3.646677874	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1246	2110	0.01563981	0.00521327	0	13A	IN-VIP	NA	NA	NA
TTTATGCGTCAGAATA-1_6_C5	-0.724345448	-11.97522423	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1821	3531	0.005664118	0.001699235	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TTTATGCGTGCCTTGG-1_6_C5	2.032409011	-7.438161266	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1248	1963	0.009679063	0.005094244	0	12	EN-MIX	NA	NA	NA
TTTCCTCCAAGCCTAT-1_6_C5	12.46201581	22.81125553	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	833	1334	0.002248876	0.003748126	0	oligos	OL-Cntl	NA	NA	NA
TTTCCTCGTACTTGAC-1_6_C5	1.222257007	-10.53889452	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1632	2907	0.009287926	0.00378397	0	12	EN-MIX	NA	NA	NA
TTTCCTCGTGGACGAT-1_6_C5	-1.557077139	-17.76880564	10	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2490	5629	0.000177651	0.001954166	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TTTCCTCGTGGTACAG-1_6_C5	-4.524010649	-3.301631059	13A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1272	2235	0.01655481	0.002237136	0	13A	IN-VIP	NA	NA	NA
TTTGCGCAGAAGGTGA-1_6_C5	-13.74046741	-11.19258838	13B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1995	3979	0.030158331	0.002513194	0	13B	IN-SV2C	NA	NA	NA
TTTGCGCAGCCCAATT-1_6_C5	13.68570874	29.75220383	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	764	1182	0.001692047	0.003384095	0	oligos	OL-Cntl	NA	NA	NA
TTTGCGCAGCGGATCA-1_6_C5	-38.85541635	-1.669481659	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1346	2268	0.004409171	0.00308642	0	9	OPC	NA	NA	NA
TTTGCGCAGTGCTGCC-1_6_C5	19.19816356	1.679785167	2	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1153	1925	0.002077922	0.002077922	0	2	EN-L4	NA	NA	NA
TTTGCGCCACGAGAGT-1_6_C5	0.849562603	-10.70960082	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1535	2734	0.005486467	0.002560351	0	12	EN-MIX	NA	NA	NA
TTTGCGCGTCGCGGTT-1_6_C5	9.349037162	28.19944246	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	826	1249	0	0.004003203	0	oligos	OL-Cntl	NA	NA	NA
TTTGGTTAGCTAGTTC-1_6_C5	-11.92331467	-10.72342713	13B	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1339	2312	0.000865052	0.002595156	0	13B	IN-SV2C	NA	NA	NA
TTTGGTTAGGGATCTG-1_6_C5	-29.56622963	12.50396938	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	680	1047	0.016236867	0	0	8	Astrocytes	NA	NA	NA
TTTGGTTGTAACGTTC-1_6_C5	-21.80184424	31.52955247	8	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	2508	5339	0.004495224	0.002622214	0	8	Astrocytes	NA	NA	NA
TTTGGTTTCGATCCCT-1_6_C5	1.157730207	-11.85816695	12	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1818	3488	0.01146789	0.005447248	0	12	EN-MIX	NA	NA	NA
TTTGTCAAGCTGAACG-1_6_C5	-35.91228371	-7.591448789	9	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1024	1646	0.003037667	0.003037667	0	9	OPC	NA	NA	NA
TTTGTCAAGGATCGCA-1_6_C5	23.3958758	12.75316046	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1316	2184	0.001831502	0.004120879	0	oligos	OL-Cntl	NA	NA	NA
TTTGTCACACAGAGGT-1_6_C5	23.38060344	12.51501151	1	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1339	2174	0.004139834	0.004599816	0	oligos	OL-Cntl	NA	NA	NA
TTTGTCAGTTTAGCTG-1_6_C5	-15.03581404	-25.38892577	6A	6_C5	Control	Control	64	male	motor-premotor	CAP1	SEQ1	7.5	18	1748	3652	0.018893757	0.001369113	0	6A	IN-PV	NA	NA	NA
AAACCTGAGACGCAAC-1_7_D5	-1.50083879	13.86902794	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	848	1357	0.011790715	0.028002948	5	oligos	OL-Cntl	40	16	16
AAACCTGCACAGGAGT-1_7_D5	24.17749098	-29.00548392	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4004	11520	0.013454861	0.003385417	5	3	EN-L5-6	40	16	16
AAACCTGGTCAAGCGA-1_7_D5	9.923489523	8.34718675	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1405	2388	0.009631491	0.015075377	5	oligos	OL-Cntl	40	16	16
AAACCTGGTCGCGTGT-1_7_D5	6.192622838	-3.278297644	12	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1327	2252	0.010213144	0.006660746	5	12	EN-MIX	40	16	16
AAACCTGGTTAGTGGG-1_7_D5	4.655895031	15.34131359	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	945	1407	0	0.011371713	5	oligos	OL-Cntl	40	16	16
AAACCTGTCGCGTAGC-1_7_D5	-34.59983903	4.684959011	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2270	4151	0.006022645	0.003613587	5	9	OPC	40	16	16
AAACCTGTCTACTATC-1_7_D5	-0.280834472	15.82826147	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	784	1195	0	0.019246862	5	oligos	OL-Cntl	40	16	16
AAACGGGAGACCCACC-1_7_D5	2.000405642	23.22727344	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	812	1220	0.001639344	0.007377049	5	oligos	OL-Cntl	40	16	16
AAACGGGCAGTGGAGT-1_7_D5	-17.76279918	0.671049591	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4112	9045	0.022443339	0.013709232	5	13A	IN-VIP	40	16	16
AAACGGGGTGTGTGCC-1_7_D5	-5.397270758	-35.25823914	16	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	780	1053	0.061728395	0.01994302	5	16	EN-PYR	40	16	16
AAACGGGTCACGCATA-1_7_D5	-20.86202463	23.77392213	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1572	2935	0.003747871	0.004429302	5	8	Astrocytes	40	16	16
AAACGGGTCTGTCCGT-1_7_D5	24.66648489	-29.052963	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4779	15518	0.002706534	0.002384328	5	3	EN-L5-6	40	16	16
AAAGATGAGTTAGGTA-1_7_D5	36.98197443	9.885961889	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	754	1033	0.002904163	0.008712488	5	14	Microglia	40	16	16
AAAGATGCATACTCTT-1_7_D5	-1.964738501	16.46838366	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	667	1000	0.006	0.02	5	oligos	OL-Cntl	40	16	16
AAAGATGCATTAACCG-1_7_D5	-20.22488452	29.87989119	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2489	5674	0.001233698	0.004406063	5	8	Astrocytes	40	16	16
AAAGCAAAGAGTCTGG-1_7_D5	-29.00264565	17.08162904	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	991	1687	0	0.007113219	5	8	Astrocytes	40	16	16
AAAGCAAAGCGATAGC-1_7_D5	-1.179182904	17.67742452	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	701	1021	0.016650343	0.010773751	5	oligos	OL-Cntl	40	16	16
AAAGCAAAGCTCCTCT-1_7_D5	11.71535689	-5.328364464	12	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1188	2047	0.004396678	0.005862237	5	12	EN-MIX	40	16	16
AAAGCAACATATGGTC-1_7_D5	-1.136960102	22.96722356	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	734	1125	0.017777778	0.012444444	5	oligos	OL-Cntl	40	16	16
AAAGCAACATGTAAGA-1_7_D5	-33.96384237	-3.973669004	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1270	2089	0.001914792	0.003350886	5	9	OPC	40	16	16
AAAGCAAGTTATGCGT-1_7_D5	-37.13974571	-9.930496988	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1045	1805	0.000554017	0.002216066	5	9	OPC	40	16	16
AAAGCAAGTTTGTTGG-1_7_D5	-26.30178389	13.72061327	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	972	1524	0.005905512	0.003937008	5	8	Astrocytes	40	16	16
AAAGCAATCCAAGTAC-1_7_D5	-16.14711078	1.139548753	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3921	8404	0.00618753	0.013445978	5	13A	IN-VIP	40	16	16
AAAGCAATCGTTACGA-1_7_D5	10.94729518	7.80141346	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1490	2443	0.006958657	0.011870651	5	oligos	OL-Cntl	40	16	16
AAAGCAATCTCTGAGA-1_7_D5	11.46916294	9.560112184	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1374	2327	0.011173184	0.008165019	5	oligos	OL-Cntl	40	16	16
AAAGCAATCTGCTGTC-1_7_D5	6.210246981	11.31889662	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1113	1787	0.015109121	0.011751539	5	oligos	OL-Cntl	40	16	16
AAAGTAGAGCTAAGAT-1_7_D5	18.38822949	-24.01385278	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4880	13678	0.000584881	0.024857435	5	3	EN-L5-6	40	16	16
AAAGTAGAGTTGTCGT-1_7_D5	2.179791326	23.48527336	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	771	1075	0.011162791	0.008372093	5	oligos	OL-Cntl	40	16	16
AAAGTAGCAAGACACG-1_7_D5	-1.657915719	17.72078244	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	773	1111	0.01170117	0.00720072	5	oligos	OL-Cntl	40	16	16
AAAGTAGCATTGAGCT-1_7_D5	39.00233935	10.07093271	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	947	1365	0.004395604	0.006593407	5	14	Microglia	40	16	16
AAAGTAGTCAACACCA-1_7_D5	1.887477592	20.02758599	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	870	1248	0.013621795	0.003205128	5	oligos	OL-Cntl	40	16	16
AAAGTAGTCCCGACTT-1_7_D5	-31.234879	-12.81942205	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	762	1299	0.002309469	0.010777521	5	9	OPC	40	16	16
AAAGTAGTCCTAAGTG-1_7_D5	14.36301875	8.622087413	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1715	2945	0.001697793	0.005772496	5	oligos	OL-Cntl	40	16	16
AAATGCCAGACAAGCC-1_7_D5	1.816442818	20.85985262	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	801	1195	0.00167364	0.0041841	5	oligos	OL-Cntl	40	16	16
AAATGCCAGTGACTCT-1_7_D5	8.891442409	-23.06667641	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	8071	34051	0.004610731	0.006431529	5	L2-3	EN-L2-3-MS	40	16	16
AAATGCCAGTTGTCGT-1_7_D5	13.53398191	14.6349684	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1284	2062	0.006304559	0.009214355	5	oligos	OL-Cntl	40	16	16
AAATGCCCAAAGCAAT-1_7_D5	13.56523016	8.416852102	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1675	3248	0.001539409	0.011391626	5	oligos	OL-Cntl	40	16	16
AAATGCCCAATCAGAA-1_7_D5	-13.97287139	1.737983769	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3989	9625	0.013194805	0.008831169	5	13A	IN-VIP	40	16	16
AAATGCCCAGCCACCA-1_7_D5	-33.78812562	-9.230069977	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	867	1237	0.010509297	0.00323363	5	9	OPC	40	16	16
AAATGCCTCAGTGCAT-1_7_D5	-33.92429725	2.791763721	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2109	3903	0.006149116	0.004611837	5	9	OPC	40	16	16
AAATGCCTCCGAAGAG-1_7_D5	36.69436041	12.42426547	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	978	1376	0	0.023982558	5	14	Microglia	40	16	16
AAATGCCTCGGTGTCG-1_7_D5	12.66394781	-6.761977239	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2250	4886	0.003069996	0.007777323	5	3	EN-L5-6	40	16	16
AACACGTCACCATCCT-1_7_D5	14.14352143	10.40146857	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1434	2536	0.005520505	0.008675079	5	oligos	OL-Cntl	40	16	16
AACACGTGTAGCGTCC-1_7_D5	16.02836349	-28.40029096	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	5286	17837	0.011268711	0.00414868	5	3	EN-L5-6	40	16	16
AACACGTGTTACCAGT-1_7_D5	9.740083191	-30.45543592	10	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	5425	16979	0.000883444	0.007420932	5	L2-3	EN-L2-3-Cntl	40	16	16
AACACGTTCTGCAAGT-1_7_D5	30.51847487	15.60914603	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	945	1345	0.00669145	0.137546468	5	14	Microglia	40	16	16
AACCATGAGGGTATCG-1_7_D5	-3.242437865	12.83372985	5	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	835	1214	0.000823723	0.042009885	5	oligos	OL-MS-1	40	16	16
AACCATGCATGTTCCC-1_7_D5	13.01665934	13.89787471	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1242	2139	0.006545115	0.002337541	5	oligos	OL-Cntl	40	16	16
AACCATGGTGTATGGG-1_7_D5	32.99016288	16.61635302	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1212	1744	0.008027523	0.044724771	5	14	Microglia	40	16	16
AACCGCGAGAAGATTC-1_7_D5	-32.28059357	2.442944999	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1900	3479	0.001437195	0.004024145	5	9	OPC	40	16	16
AACCGCGAGCCTATGT-1_7_D5	36.00287026	-9.979480277	2	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	6015	16661	0.008402857	0.011764	5	2	EN-L4	40	16	16
AACCGCGAGCTTTGGT-1_7_D5	9.625932299	10.15551115	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1251	1991	0.002511301	0.015067805	5	oligos	OL-Cntl	40	16	16
AACCGCGAGGGAAACA-1_7_D5	-4.170946438	-33.46142721	16	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	781	1058	0.098298677	0.009451796	5	16	EN-PYR	40	16	16
AACCGCGGTGCACCAC-1_7_D5	-34.86413784	3.057398043	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1932	3726	0.001610306	0.005904455	5	9	OPC	40	16	16
AACCGCGGTGTCTGAT-1_7_D5	38.58423092	12.62382977	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1039	1499	0	0.010006671	5	14	Microglia	40	16	16
AACCGCGTCATAGCAC-1_7_D5	-7.721601319	-37.05617546	16	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	937	1312	0.041920732	0.023628049	5	16	EN-PYR	40	16	16
AACCGCGTCGCCTGAG-1_7_D5	12.4666228	-6.455030565	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1747	3489	0.00057323	0.00171969	5	3	EN-L5-6	40	16	16
AACGTTGAGATGTTAG-1_7_D5	2.476369901	12.44824797	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1013	1574	0.012071156	0.018424396	5	oligos	OL-Cntl	40	16	16
AACGTTGCACCCATTC-1_7_D5	0.300370554	15.27552329	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	943	1471	0.010876954	0.018354861	5	oligos	OL-Cntl	40	16	16
AACGTTGCACGACGAA-1_7_D5	3.24625512	15.33926808	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1034	1655	0.002416918	0.009667674	5	oligos	OL-Cntl	40	16	16
AACGTTGCAGCGATCC-1_7_D5	15.43047827	-27.4806004	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3936	10298	0.016022529	0.003981356	5	3	EN-L5-6	40	16	16
AACGTTGGTAGAGGAA-1_7_D5	-22.89464248	28.75281126	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2063	4392	0.002959927	0.004098361	5	8	Astrocytes	40	16	16
AACGTTGGTCATTAGC-1_7_D5	10.04021529	11.09744237	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1326	2227	0.006735519	0.010327795	5	oligos	OL-Cntl	40	16	16
AACGTTGTCAGTACGT-1_7_D5	7.356035373	-20.88378827	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	6536	21959	0.00464502	0.009016804	5	L2-3	EN-L2-3-MS	40	16	16
AACGTTGTCCTGCCAT-1_7_D5	-11.94174826	18.88105813	11	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3362	6744	0.010379597	0.012158956	5	11	Glia-MIX	40	16	16
AACTCAGAGCACCGTC-1_7_D5	13.9638816	7.90021483	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1722	3053	0.005568293	0.01277432	5	oligos	OL-Cntl	40	16	16
AACTCAGAGCAGGCTA-1_7_D5	11.69529108	8.320150926	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1548	2604	0.007296467	0.015745008	5	oligos	OL-Cntl	40	16	16
AACTCAGCACCAGATT-1_7_D5	-27.68220948	10.85644597	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	754	1134	0.000881834	0.004409171	5	8	Astrocytes	40	16	16
AACTCAGCAGGTCCAC-1_7_D5	6.96139742	12.09837588	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1135	1690	0.007100592	0.015384615	5	oligos	OL-Cntl	40	16	16
AACTCAGGTCAGTGGA-1_7_D5	2.122814101	12.94469166	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	839	1253	0.016759777	0.022346369	5	oligos	OL-Cntl	40	16	16
AACTCAGGTGAAAGAG-1_7_D5	12.90233458	-7.095690529	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2513	4992	0.008613782	0.00400641	5	3	EN-L5-6	40	16	16
AACTCAGGTGATGTCT-1_7_D5	2.765767717	17.10226657	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	848	1268	0.011041009	0.019716088	5	oligos	OL-Cntl	40	16	16
AACTCAGTCAAGATCC-1_7_D5	8.726913601	11.50799363	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1112	1634	0.015911873	0.015299878	5	oligos	OL-Cntl	40	16	16
AACTCAGTCCCTAATT-1_7_D5	32.41890786	16.45140497	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1261	1843	0.002712968	0.061313077	5	14	Microglia	40	16	16
AACTCAGTCGGAGCAA-1_7_D5	-11.95160511	-18.44622503	6B	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1031	1566	0.030651341	0.005108557	5	6B	IN-SST	40	16	16
AACTCAGTCTTTAGTC-1_7_D5	14.71977412	9.845422393	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1416	2506	0.006384677	0.003990423	5	oligos	OL-Cntl	40	16	16
AACTCCCAGTCGTACT-1_7_D5	-23.41439659	-18.9517014	6B	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3306	6739	0.006380769	0.031458673	5	6B	IN-SST	40	16	16
AACTCCCCAGTATCTG-1_7_D5	-18.5602441	28.64902431	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2454	4797	0.003126954	0.00979779	5	8	Astrocytes	40	16	16
AACTCCCGTACCCAAT-1_7_D5	9.627762037	-23.70616987	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	7268	27832	0.004239724	0.007257833	5	L2-3	EN-L2-3-MS	40	16	16
AACTCCCGTAGTAGTA-1_7_D5	-17.61333235	1.417717576	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4715	11351	0.005726368	0.017443397	5	13A	IN-VIP	40	16	16
AACTCCCGTCTTGTCC-1_7_D5	-35.02052163	-0.464787104	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1526	2642	0.005677517	0.003785011	5	9	OPC	40	16	16
AACTCCCTCCTTAATC-1_7_D5	-3.778196612	24.64601358	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	693	1029	0.006802721	0.011661808	5	oligos	OL-Cntl	40	16	16
AACTCTTAGATCTGCT-1_7_D5	-32.80309767	-11.18127226	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	953	1493	0.002009377	0.002009377	5	9	OPC	40	16	16
AACTCTTCAATCCGAT-1_7_D5	37.46159626	12.89186571	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1007	1376	0.005087209	0.011627907	5	14	Microglia	40	16	16
AACTCTTCACATCTTT-1_7_D5	14.13122058	8.80338017	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1623	3058	0.002289078	0.008175278	5	oligos	OL-Cntl	40	16	16
AACTCTTCATTGGTAC-1_7_D5	-34.53829063	0.617723741	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1640	2839	0.002465657	0.005283551	5	9	OPC	40	16	16
AACTCTTGTGAACCTT-1_7_D5	-36.06616524	0.445259624	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1556	2896	0.002762431	0.004143646	5	9	OPC	40	16	16
AACTCTTGTTGAACTC-1_7_D5	10.02423982	12.10678325	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1254	2139	0.004675082	0.009817672	5	oligos	OL-Cntl	40	16	16
AACTCTTTCACTTCAT-1_7_D5	15.03460409	10.0829297	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1441	2463	0.003248071	0.005684125	5	oligos	OL-Cntl	40	16	16
AACTCTTTCCATTCTA-1_7_D5	38.09118783	14.424023	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1107	1576	0.003172589	0.014593909	5	14	Microglia	40	16	16
AACTGGTCAATGCCAT-1_7_D5	2.879294248	15.17850161	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1060	1682	0.007134364	0.009512485	5	oligos	OL-Cntl	40	16	16
AACTGGTGTCTCCACT-1_7_D5	8.491565618	11.5290536	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1124	1793	0.003346347	0.011712214	5	oligos	OL-Cntl	40	16	16
AACTGGTGTCTTCGTC-1_7_D5	12.4973847	8.942506051	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1470	2515	0.003578529	0.013518887	5	oligos	OL-Cntl	40	16	16
AACTGGTGTGCAGACA-1_7_D5	-5.590213937	-35.13438074	16	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	852	1120	0.079464286	0.01875	5	16	EN-PYR	40	16	16
AACTGGTGTGTGTGCC-1_7_D5	-36.84065789	-4.989550591	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1203	2016	0.006944444	0.00297619	5	9	OPC	40	16	16
AACTGGTGTTCCTCCA-1_7_D5	12.06112156	-5.824850999	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1522	2992	0.004010695	0.009692513	5	3	EN-L5-6	40	16	16
AACTGGTTCAGAGACG-1_7_D5	18.48134265	-24.16411692	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	5249	15283	0.000916051	0.024471635	5	3	EN-L5-6	40	16	16
AACTGGTTCCACTGGG-1_7_D5	10.4151759	10.28440953	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1325	2164	0.000924214	0.013401109	5	oligos	OL-Cntl	40	16	16
AACTGGTTCCTTCAAT-1_7_D5	-25.79763462	19.23747007	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1528	2629	0.004944846	0.009128946	5	8	Astrocytes	40	16	16
AACTTTCAGCAGCCTC-1_7_D5	-16.10409807	2.338819127	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4701	11696	0.011029412	0.013508892	5	13A	IN-VIP	40	16	16
AACTTTCCATCTCGCT-1_7_D5	11.72991449	8.188984237	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1554	2873	0.006961364	0.014966934	5	oligos	OL-Cntl	40	16	16
AACTTTCGTTAAGGGC-1_7_D5	12.54461729	21.18998861	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	982	1544	0.006476684	0.004533679	5	oligos	OL-Cntl	40	16	16
AACTTTCTCCGAAGAG-1_7_D5	6.676693837	-18.50763142	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3916	8728	0.003437214	0.018560953	5	L2-3	EN-L2-3-MS	40	16	16
AACTTTCTCGAGAACG-1_7_D5	32.83495601	16.72814598	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1164	1784	0.000560538	0.062219731	5	14	Microglia	40	16	16
AACTTTCTCTGCAAGT-1_7_D5	3.253546406	-24.07835843	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4632	12629	0.015044738	0.011402328	5	L2-3	EN-L2-3-MS	40	16	16
AAGACCTAGCATGGCA-1_7_D5	9.972211243	12.90380148	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1246	2045	0.016625917	0.006356968	5	oligos	OL-Cntl	40	16	16
AAGACCTAGGAATTAC-1_7_D5	-20.80849072	27.88924567	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1984	3814	0.004457263	0.006030414	5	8	Astrocytes	40	16	16
AAGACCTAGTACGATA-1_7_D5	3.366484512	13.21592232	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1129	1837	0.001633097	0.009254219	5	oligos	OL-Cntl	40	16	16
AAGACCTCACGGTAAG-1_7_D5	31.32147599	15.33253308	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	884	1256	0.007961783	0.084394904	5	14	Microglia	40	16	16
AAGACCTCATCAGTCA-1_7_D5	-34.60560089	-12.90266987	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	717	1076	0.000929368	0.003717472	5	9	OPC	40	16	16
AAGACCTCATTCCTCG-1_7_D5	-19.31404115	28.90727759	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2391	5125	0.00097561	0.010731707	5	8	Astrocytes	40	16	16
AAGACCTGTCGATTGT-1_7_D5	37.67591953	10.05006648	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	810	1043	0.001917546	0.007670182	5	14	Microglia	40	16	16
AAGACCTGTTGCTCCT-1_7_D5	7.811034766	-19.65384531	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4033	9527	0.006927679	0.008187257	5	L2-3	EN-L2-3-MS	40	16	16
AAGACCTGTTTGGCGC-1_7_D5	14.81967558	10.60809375	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1343	2383	0.000419639	0.007133865	5	oligos	OL-Cntl	40	16	16
AAGCCGCAGATCCCAT-1_7_D5	-34.1364055	0.331527048	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1704	2972	0.009421265	0.004710633	5	9	OPC	40	16	16
AAGCCGCAGTAGCGGT-1_7_D5	15.86699094	7.579320383	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1815	3344	0.001196172	0.010167464	5	oligos	OL-Cntl	40	16	16
AAGCCGCAGTCAAGGC-1_7_D5	37.18136996	15.66488748	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1415	2129	0.012212306	0.017379051	5	14	Microglia	40	16	16
AAGCCGCAGTCTTGCA-1_7_D5	0.824831002	18.66920905	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	911	1465	0	0.00887372	5	oligos	OL-Cntl	40	16	16
AAGCCGCCACCGGAAA-1_7_D5	9.168933384	22.09011043	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	753	1149	0.003481288	0.005221932	5	oligos	OL-Cntl	40	16	16
AAGCCGCCAGACAAAT-1_7_D5	-25.53004667	22.7270344	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1230	1974	0.005572442	0.00810537	5	8	Astrocytes	40	16	16
AAGCCGCCAGACAGGT-1_7_D5	26.92862669	-5.957627577	2	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	5758	19483	0.001180516	0.004876046	5	2	EN-L4	40	16	16
AAGCCGCCATAGTAAG-1_7_D5	36.79455224	11.66444063	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	894	1221	0.000819001	0.021294021	5	14	Microglia	40	16	16
AAGCCGCGTTGGACCC-1_7_D5	-0.391636982	1.301481183	11	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1352	2109	0.015647226	0.004741584	5	11	Glia-MIX	40	16	16
AAGCCGCTCCTGTACC-1_7_D5	-15.8294106	1.50103056	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4169	9456	0.009517766	0.015545685	5	13A	IN-VIP	40	16	16
AAGGAGCAGAACAACT-1_7_D5	-1.175082409	13.97615727	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	799	1175	0.002553191	0.025531915	5	oligos	OL-Cntl	40	16	16
AAGGAGCCACATTTCT-1_7_D5	-20.34746587	20.39757908	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2009	3888	0.001286008	0.003343621	5	8	Astrocytes	40	16	16
AAGGAGCCAGACGCAA-1_7_D5	11.56690178	-13.9611191	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4025	7953	0.02351314	0.018483591	5	L2-3	EN-L2-3-MS	40	16	16
AAGGAGCCAGGGTATG-1_7_D5	12.31937454	-6.224636503	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1707	3217	0.008703761	0.003419335	5	3	EN-L5-6	40	16	16
AAGGAGCGTGCAGGTA-1_7_D5	-19.3046595	26.36033293	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2160	4334	0.001153669	0.01176742	5	8	Astrocytes	40	16	16
AAGGAGCTCGGCTACG-1_7_D5	-31.83634992	0.32646794	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1683	2970	0.002020202	0.007070707	5	9	OPC	40	16	16
AAGGAGCTCTGGTTCC-1_7_D5	-31.53125964	-0.148918828	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1623	2747	0.003276301	0.005460502	5	9	OPC	40	16	16
AAGGCAGAGCTGAACG-1_7_D5	-19.7758569	26.01386658	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1966	3892	0.001798561	0.010791367	5	8	Astrocytes	40	16	16
AAGGCAGAGTCGCCGT-1_7_D5	35.43540459	10.82277225	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	805	1086	0.003683241	0.026703499	5	14	Microglia	40	16	16
AAGGCAGAGTGAATTG-1_7_D5	-32.38693437	-8.146105205	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1156	1630	0.003067485	0.007361963	5	9	OPC	40	16	16
AAGGCAGCATAACCTG-1_7_D5	12.1715797	12.85686469	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1142	1881	0.005847953	0.006911217	5	oligos	OL-Cntl	40	16	16
AAGGCAGGTGTTCGAT-1_7_D5	-32.52175576	-8.316803806	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1076	1528	0.001963351	0.005235602	5	9	OPC	40	16	16
AAGGCAGGTTAGGGTG-1_7_D5	4.673695665	12.29515151	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1127	1788	0.010626398	0.011744966	5	oligos	OL-Cntl	40	16	16
AAGGTTCAGCGCCTTG-1_7_D5	10.56694464	19.11466401	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	921	1432	0.005586592	0.009776536	5	oligos	OL-Cntl	40	16	16
AAGGTTCGTGTTCTTT-1_7_D5	-17.41909866	1.559811404	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3777	8215	0.008277541	0.027388923	5	13A	IN-VIP	40	16	16
AAGGTTCTCCCATTAT-1_7_D5	26.91688684	7.478584709	15A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1157	1771	0.005646527	0.038961039	5	15A	Endo cells	40	16	16
AAGGTTCTCGGAAACG-1_7_D5	0.14435709	12.74762703	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1019	1562	0.015364917	0.02240717	5	oligos	OL-Cntl	40	16	16
AAGGTTCTCTAACTTC-1_7_D5	9.085793247	13.33820924	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	991	1678	0.003575685	0.017878427	5	oligos	OL-Cntl	40	16	16
AAGGTTCTCTCATTCA-1_7_D5	0.554355628	19.42335022	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	745	1186	0.008431703	0.018549747	5	oligos	OL-Cntl	40	16	16
AAGTCTGAGACTGGGT-1_7_D5	1.066771317	17.90807564	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	758	1052	0.005703422	0.008555133	5	oligos	OL-Cntl	40	16	16
AAGTCTGCAAACCCAT-1_7_D5	-28.81393103	-1.554640744	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1666	2593	0.003470883	0.005399152	5	9	OPC	40	16	16
AAGTCTGCAAATCCGT-1_7_D5	24.91624399	-29.32238418	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4388	14215	0.006260992	0.002743581	5	3	EN-L5-6	40	16	16
AAGTCTGGTGCACCAC-1_7_D5	13.98012489	13.78310113	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1074	1772	0.010158014	0.003950339	5	oligos	OL-Cntl	40	16	16
AAGTCTGGTGGCCCTA-1_7_D5	3.730240783	14.45653174	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	911	1406	0.00284495	0.012802276	5	oligos	OL-Cntl	40	16	16
AAGTCTGGTTGGTTTG-1_7_D5	15.22827037	19.29175575	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1164	1920	0.0234375	0.002604167	5	oligos	OL-Cntl	40	16	16
AATCCAGCAGTAACGG-1_7_D5	34.68772871	-8.611567191	2	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	6546	21075	0.0057414	0.00801898	5	2	EN-L4	40	16	16
AATCCAGGTACCGCTG-1_7_D5	10.32999259	17.87917639	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	976	1575	0.000634921	0.012698413	5	oligos	OL-Cntl	40	16	16
AATCCAGGTGACTCAT-1_7_D5	-36.68335733	-1.954197314	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1389	2362	0.00719729	0.0042337	5	9	OPC	40	16	16
AATCCAGGTGCTAGCC-1_7_D5	14.54338772	13.40977058	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1374	2336	0.000856164	0.006421233	5	oligos	OL-Cntl	40	16	16
AATCCAGTCTCACATT-1_7_D5	10.11618079	21.98312162	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	832	1324	0.014350453	0.004531722	5	oligos	OL-Cntl	40	16	16
AATCGGTCACACAGAG-1_7_D5	31.23266317	15.02980904	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	803	1036	0.003861004	0.061776062	5	14	Microglia	40	16	16
AATCGGTCATCAGTCA-1_7_D5	-9.621211056	-19.59462754	6B	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	855	1375	0.031272727	0.001454545	5	6B	IN-SST	40	16	16
AATCGGTGTCAAAGCG-1_7_D5	4.387200573	10.83578036	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1244	1940	0.007216495	0.019587629	5	oligos	OL-Cntl	40	16	16
AATCGGTGTCCGACGT-1_7_D5	37.51467119	12.59290316	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1036	1479	0.007437458	0.014874915	5	14	Microglia	40	16	16
AATCGGTGTCCGAGTC-1_7_D5	-30.45010688	1.349583256	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1886	3242	0.003701419	0.00987045	5	9	OPC	40	16	16
AATCGGTGTGTATGGG-1_7_D5	8.693231184	12.02350088	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1071	1598	0.004380476	0.021276596	5	oligos	OL-Cntl	40	16	16
AATCGGTTCAAACGGG-1_7_D5	12.66964213	26.35194563	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	790	1242	0.008856683	0.002415459	5	oligos	OL-Cntl	40	16	16
AATCGGTTCAGCATGT-1_7_D5	-21.97271744	27.05583093	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1834	3442	0.003486345	0.007844277	5	8	Astrocytes	40	16	16
ACACCAAAGAGACGAA-1_7_D5	4.219569984	26.77446113	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	822	1290	0.007751938	0.005426357	5	oligos	OL-Cntl	40	16	16
ACACCAAAGATCCCAT-1_7_D5	6.617532159	10.55467232	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1247	1946	0.007708119	0.021582734	5	oligos	OL-Cntl	40	16	16
ACACCAAAGCGTGAGT-1_7_D5	10.56743318	9.881098893	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1393	2392	0.007107023	0.012541806	5	oligos	OL-Cntl	40	16	16
ACACCAAAGTTACGGG-1_7_D5	-4.855942467	19.64754122	5	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	839	1212	0.021452145	0.008250825	5	oligos	OL-MS-1	40	16	16
ACACCAACACTCTGTC-1_7_D5	-35.28231676	-4.297728269	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1309	2132	0.002814259	0.006097561	5	9	OPC	40	16	16
ACACCAAGTTATCCGA-1_7_D5	30.86867224	14.96596099	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	762	1013	0.004935834	0.103652517	5	14	Microglia	40	16	16
ACACCAAGTTTAGGAA-1_7_D5	14.10194496	9.079502804	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1586	2803	0.009989297	0.004994649	5	oligos	OL-Cntl	40	16	16
ACACCCTAGAGGTACC-1_7_D5	5.00595909	11.22701236	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1308	2071	0.008691453	0.018348624	5	oligos	OL-Cntl	40	16	16
ACACCCTAGGCCCGTT-1_7_D5	11.65247294	10.57377399	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1303	2306	0.007805724	0.015611448	5	oligos	OL-Cntl	40	16	16
ACACCCTAGTGAAGTT-1_7_D5	2.573417043	22.31928301	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	927	1406	0.000711238	0.0056899	5	oligos	OL-Cntl	40	16	16
ACACCCTCAAAGTCAA-1_7_D5	32.63493028	16.73254675	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1331	1999	0.006503252	0.071035518	5	14	Microglia	40	16	16
ACACCCTCATCTGGTA-1_7_D5	37.98722811	13.85352524	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1095	1604	0.001870324	0.016832918	5	14	Microglia	40	16	16
ACACCCTGTCGCTTTC-1_7_D5	16.83046196	7.7071254	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1899	3891	0.009509124	0.005654074	5	oligos	OL-Cntl	40	16	16
ACACCCTGTTAAGACA-1_7_D5	-0.029749658	20.79330461	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	727	1029	0.001943635	0.01068999	5	oligos	OL-Cntl	40	16	16
ACACCCTGTTGTGGCC-1_7_D5	37.58480348	9.940493756	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	820	1097	0.002734731	0.015496809	5	14	Microglia	40	16	16
ACACCCTGTTTCCACC-1_7_D5	-17.22097851	-23.18316743	6A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2065	4613	0.004769131	0.003034901	5	6A	IN-PV	40	16	16
ACACCCTTCACAAACC-1_7_D5	11.04900108	14.33372782	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1305	2350	0.002978723	0.01106383	5	oligos	OL-Cntl	40	16	16
ACACCGGAGACAGAGA-1_7_D5	9.25822059	13.22595329	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1094	1752	0.007420091	0.010273973	5	oligos	OL-Cntl	40	16	16
ACACCGGAGCTAACTC-1_7_D5	-36.09799446	-5.667736032	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1135	1729	0.000578369	0.002891845	5	9	OPC	40	16	16
ACACCGGCAAGGTGTG-1_7_D5	-24.00201079	0.896848033	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2224	3962	0.003028773	0.012619889	5	9	OPC	40	16	16
ACACCGGCAGGCAGTA-1_7_D5	-3.157071151	16.17993194	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	797	1170	0.011111111	0.015384615	5	oligos	OL-Cntl	40	16	16
ACACCGGGTAAGTTCC-1_7_D5	12.11329715	8.36596516	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1570	2685	0.00744879	0.014897579	5	oligos	OL-Cntl	40	16	16
ACACCGGGTACCGAGA-1_7_D5	-18.16286302	-10.11576318	13B	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3869	9004	0.005997335	0.006219458	5	13B	IN-SV2C	40	16	16
ACACCGGTCACAAACC-1_7_D5	4.065214348	14.79000936	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1084	1693	0.008860012	0.017129356	5	oligos	OL-Cntl	40	16	16
ACACCGGTCACAGTAC-1_7_D5	-33.45005241	3.788032977	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2442	4988	0.000801925	0.011627907	5	9	OPC	40	16	16
ACACCGGTCGGCGCTA-1_7_D5	-28.14421418	-13.05436751	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	736	1085	0.000921659	0.012903226	5	9	OPC	40	16	16
ACACCGGTCTGTCCGT-1_7_D5	-2.136504757	15.88651365	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	756	1034	0.002901354	0.023210832	5	oligos	OL-Cntl	40	16	16
ACACTGAAGGCCCGTT-1_7_D5	3.294421116	-11.24172127	12	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1869	3348	0.057048984	0.005376344	5	12	EN-MIX	40	16	16
ACACTGACAGCCTATA-1_7_D5	3.551935889	10.68865177	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1110	1705	0.004105572	0.026979472	5	oligos	OL-Cntl	40	16	16
ACACTGAGTGACTCAT-1_7_D5	11.85248828	-5.230307941	12	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1157	2134	0.043111528	0.005623243	5	12	EN-MIX	40	16	16
ACACTGATCTATCCTA-1_7_D5	9.874970876	13.6387956	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1169	2046	0.00684262	0.005376344	5	oligos	OL-Cntl	40	16	16
ACAGCCGAGGGCTCTC-1_7_D5	-8.43968277	-16.04194498	6B	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	772	1158	0.07253886	0.013816926	5	6B	IN-SST	40	16	16
ACAGCCGCAGGATTGG-1_7_D5	6.845541394	12.44657695	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1287	2202	0.009536785	0.009990917	5	oligos	OL-Cntl	40	16	16
ACAGCCGGTGGTGTAG-1_7_D5	-16.20447188	0.472996054	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4699	12090	0.033416046	0.010008271	5	13A	IN-VIP	40	16	16
ACAGCCGTCGCATGGC-1_7_D5	15.16679817	-29.03660525	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	6605	24503	0.003183284	0.007019549	5	3	EN-L5-6	40	16	16
ACAGCTAAGCCAGTAG-1_7_D5	39.14491339	12.63744315	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	976	1459	0.002741604	0.010966415	5	14	Microglia	40	16	16
ACAGCTAAGTGGACGT-1_7_D5	-20.46603064	-27.06302687	6A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3383	8542	0.013345821	0.004682744	5	6A	IN-PV	40	16	16
ACAGCTACAAGCGCTC-1_7_D5	-34.4212432	-2.418820053	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1452	2411	0.000829531	0.006221485	5	9	OPC	40	16	16
ACAGCTACAATGCCAT-1_7_D5	23.39839924	12.09186781	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1596	2877	0.005908933	0.003823427	5	oligos	OL-Cntl	40	16	16
ACAGCTACATGGATGG-1_7_D5	34.48480741	-8.410130834	2	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	6105	19314	0.002329916	0.012736875	5	2	EN-L4	40	16	16
ACAGCTATCAGGCGAA-1_7_D5	-33.85421678	2.737995316	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1990	3655	0.001915185	0.007660739	5	9	OPC	40	16	16
ACAGCTATCCGAAGAG-1_7_D5	16.63345829	-16.6849254	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	7478	25138	0.015753043	0.009388177	5	L2-3	EN-L2-3-MS	40	16	16
ACAGCTATCGCACTCT-1_7_D5	-31.40073241	2.370245972	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2017	3895	0.006418485	0.005905006	5	9	OPC	40	16	16
ACAGCTATCTCAAACG-1_7_D5	9.156974604	13.40079877	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1109	1833	0.003818876	0.010365521	5	oligos	OL-Cntl	40	16	16
ACAGCTATCTGAGGGA-1_7_D5	-0.121351454	15.62556705	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	870	1224	0.007352941	0.01879085	5	oligos	OL-Cntl	40	16	16
ACATACGAGGCGATAC-1_7_D5	3.636668644	21.44877343	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	854	1300	0.006153846	0.014615385	5	oligos	OL-Cntl	40	16	16
ACATACGCAGCCTTGG-1_7_D5	-15.86772171	-5.531467042	13B	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4304	10938	0.015907844	0.005576888	5	13B	IN-SV2C	40	16	16
ACATACGTCCGTCAAA-1_7_D5	4.569431252	14.51489252	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	928	1380	0.015217391	0.012318841	5	oligos	OL-Cntl	40	16	16
ACATACGTCTAAGCCA-1_7_D5	10.1326115	13.16473978	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1063	1633	0.003674219	0.008573178	5	oligos	OL-Cntl	40	16	16
ACATACGTCTATCCTA-1_7_D5	19.60708924	-24.8329152	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	8607	38520	0.004413292	0.006957425	5	3	EN-L5-6	40	16	16
ACATCAGAGAAACCTA-1_7_D5	38.99040972	10.42100464	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	865	1243	0.002413516	0.005631537	5	14	Microglia	40	16	16
ACATCAGCACCATGTA-1_7_D5	-9.827756419	-2.577199442	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1900	3463	0.022235056	0.005486572	5	13A	IN-VIP	40	16	16
ACATCAGCAGGGTACA-1_7_D5	31.39291288	15.33796122	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	997	1494	0.020749665	0.065595716	5	14	Microglia	40	16	16
ACATCAGTCGACAGCC-1_7_D5	1.787282538	23.86516321	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	644	1012	0.005928854	0.003952569	5	oligos	OL-Cntl	40	16	16
ACATGGTAGAATAGGG-1_7_D5	-25.61818118	25.5919899	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1524	2979	0.003021148	0.002685465	5	8	Astrocytes	40	16	16
ACATGGTAGATACACA-1_7_D5	-31.22139527	2.21034383	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2165	3970	0.004534005	0.004030227	5	9	OPC	40	16	16
ACATGGTCACACAGAG-1_7_D5	-4.470111679	19.17381952	5	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	742	1051	0.015223597	0.010466223	5	oligos	OL-MS-1	40	16	16
ACATGGTCAGTCACTA-1_7_D5	8.595680508	11.58709165	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1212	2014	0.000496524	0.016385303	5	oligos	OL-Cntl	40	16	16
ACATGGTGTAAGAGGA-1_7_D5	-16.98882583	1.429810773	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3723	7620	0.012073491	0.016272966	5	13A	IN-VIP	40	16	16
ACATGGTGTCTGGAGA-1_7_D5	8.10654742	-22.32414009	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	7202	25175	0.003217478	0.007110228	5	L2-3	EN-L2-3-MS	40	16	16
ACATGGTGTTAAAGTG-1_7_D5	-21.0129812	26.23230377	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1906	3650	0.002739726	0.006575342	5	8	Astrocytes	40	16	16
ACATGGTTCCGAACGC-1_7_D5	9.52187866	15.93615661	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	983	1582	0.012010114	0.00505689	5	oligos	OL-Cntl	40	16	16
ACATGGTTCTGGCGTG-1_7_D5	-36.24140561	0.570627987	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1621	2787	0.004664514	0.00287047	5	9	OPC	40	16	16
ACCAGTAAGACCACGA-1_7_D5	15.3990223	9.534815863	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1484	2570	0.00155642	0.009727626	5	oligos	OL-Cntl	40	16	16
ACCAGTAAGAGGTTGC-1_7_D5	3.441672745	16.46184992	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	945	1427	0.004204625	0.005606167	5	oligos	OL-Cntl	40	16	16
ACCAGTAAGCTAGTGG-1_7_D5	-34.55658117	2.444277051	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2048	3796	0.004214963	0.005532139	5	9	OPC	40	16	16
ACCAGTACACATCCAA-1_7_D5	-0.435737693	18.69996747	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	775	1174	0.005110733	0.004258944	5	oligos	OL-Cntl	40	16	16
ACCAGTACAGGCAGTA-1_7_D5	-0.533739864	14.55502054	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	902	1275	0.007843137	0.013333333	5	oligos	OL-Cntl	40	16	16
ACCAGTAGTCCCTTGT-1_7_D5	11.25947945	-18.87588656	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	9097	40754	0.010919174	0.005324631	5	L2-3	EN-L2-3-MS	40	16	16
ACCAGTAGTCTCCCTA-1_7_D5	38.83900734	10.7684864	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	894	1150	0.006086957	0.010434783	5	14	Microglia	40	16	16
ACCAGTATCATAAAGG-1_7_D5	-15.54450677	-18.91814598	6B	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1683	3229	0.019200991	0.003716321	5	6B	IN-SST	40	16	16
ACCAGTATCATGCAAC-1_7_D5	-24.13619401	23.7844445	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1477	2850	0.003508772	0.007719298	5	8	Astrocytes	40	16	16
ACCAGTATCCGCAAGC-1_7_D5	2.388006027	19.33196259	5	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	914	1467	0.048398091	0.010224949	5	oligos	OL-MS-1	40	16	16
ACCAGTATCGTACGGC-1_7_D5	9.642646399	15.4228334	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1073	1730	0.006936416	0.006936416	5	oligos	OL-Cntl	40	16	16
ACCAGTATCTGCTTGC-1_7_D5	5.145857086	11.4890802	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1160	2010	0.008457711	0.012437811	5	oligos	OL-Cntl	40	16	16
ACCCACTAGATATGGT-1_7_D5	38.20714147	12.3207605	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	944	1310	0.001526718	0.01221374	5	14	Microglia	40	16	16
ACCCACTCACTTCGAA-1_7_D5	-16.72921642	-5.285565728	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4865	11957	0.0088651	0.008530568	5	13A	IN-VIP	40	16	16
ACCCACTCATGCCCGA-1_7_D5	9.982625772	15.07847494	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1041	1774	0.001127396	0.008455468	5	oligos	OL-Cntl	40	16	16
ACCCACTGTGCTCTTC-1_7_D5	33.82725466	-8.385014042	2	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4145	9848	0.018176279	0.014825345	5	2	EN-L4	40	16	16
ACCCACTTCTAACCGA-1_7_D5	10.44567632	7.184788341	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1546	2506	0.00518755	0.021947326	5	oligos	OL-Cntl	40	16	16
ACCCACTTCTGATACG-1_7_D5	4.252235966	15.77271738	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	995	1564	0.004475703	0.00831202	5	oligos	OL-Cntl	40	16	16
ACCCACTTCTGCGACG-1_7_D5	5.339674928	-19.71402874	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4025	9272	0.004637619	0.007333909	5	L2-3	EN-L2-3-MS	40	16	16
ACCGTAAAGCTAGTTC-1_7_D5	2.341328321	14.89809005	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	924	1377	0.005809731	0.013071895	5	oligos	OL-Cntl	40	16	16
ACCGTAACATGAAGTA-1_7_D5	35.57072291	14.78135438	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1174	1656	0.005434783	0.016304348	5	14	Microglia	40	16	16
ACCGTAAGTACGCTGC-1_7_D5	-3.981975546	16.14362766	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	775	1056	0.004734848	0.022727273	5	oligos	OL-Cntl	40	16	16
ACCGTAATCCAGTAGT-1_7_D5	-17.24511149	19.41187422	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1377	2434	0.006573541	0.008627773	5	8	Astrocytes	40	16	16
ACCGTAATCGAGCCCA-1_7_D5	12.96946544	-7.245457281	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3317	9413	0.00403697	0.003718262	5	3	EN-L5-6	40	16	16
ACCGTAATCTAAGCCA-1_7_D5	10.02675255	12.58847193	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1235	2179	0.010096374	0.008719596	5	oligos	OL-Cntl	40	16	16
ACCTTTACAATCACAC-1_7_D5	22.38454483	-27.71574437	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	6214	22448	0.002271917	0.008998574	5	3	EN-L5-6	40	16	16
ACCTTTACAATGCCAT-1_7_D5	12.24650134	-6.12289499	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1575	3206	0.004990643	0.003119152	5	3	EN-L5-6	40	16	16
ACCTTTACATTGGTAC-1_7_D5	12.90985909	-7.146989336	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2854	7676	0.002866076	0.002475248	5	3	EN-L5-6	40	16	16
ACCTTTAGTAGTGAAT-1_7_D5	9.213432313	14.72849707	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1003	1653	0.004234725	0.018753781	5	oligos	OL-Cntl	40	16	16
ACCTTTAGTGGTTTCA-1_7_D5	12.23559095	11.99787028	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1302	2206	0.002719855	0.006799637	5	oligos	OL-Cntl	40	16	16
ACCTTTAGTGTAAGTA-1_7_D5	10.82491773	17.456021	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1083	1753	0.001711352	0.006274957	5	oligos	OL-Cntl	40	16	16
ACCTTTAGTTAGGGTG-1_7_D5	9.600912038	21.03870292	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	868	1314	0.017503805	0.00761035	5	oligos	OL-Cntl	40	16	16
ACCTTTATCATAGCAC-1_7_D5	13.73562111	13.68334419	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1131	1993	0.001003512	0.006021074	5	oligos	OL-Cntl	40	16	16
ACGAGCCAGCAATATG-1_7_D5	-0.201548475	-22.67418056	10	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4686	14661	0.005865903	0.003273992	5	L2-3	EN-L2-3-Cntl	40	16	16
ACGAGCCAGCCCAACC-1_7_D5	25.30014224	4.107501868	15BA	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1334	2262	0.004420866	0.007073386	5	15BA	Stromal cells	40	16	16
ACGAGCCCAATAACGA-1_7_D5	7.646411599	-18.22218999	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3751	8329	0.011285869	0.021851363	5	L2-3	EN-L2-3-MS	40	16	16
ACGAGCCGTTCAGTAC-1_7_D5	-34.47531749	2.569308063	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2079	4005	0.00474407	0.0082397	5	9	OPC	40	16	16
ACGAGCCTCACAAACC-1_7_D5	-15.48904684	2.083582364	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4044	9356	0.006306114	0.011864044	5	13A	IN-VIP	40	16	16
ACGAGCCTCGTCTGAA-1_7_D5	9.308919544	12.24469951	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1249	2167	0.00369174	0.008767882	5	oligos	OL-Cntl	40	16	16
ACGAGGAAGCGTTTAC-1_7_D5	-19.23645995	28.21760209	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2149	4483	0.005576623	0.010484051	5	8	Astrocytes	40	16	16
ACGAGGAAGTGTTGAA-1_7_D5	9.001344232	-21.69452446	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	5119	14051	0.005835884	0.007401608	5	L2-3	EN-L2-3-MS	40	16	16
ACGAGGACAACTTGAC-1_7_D5	10.68547728	23.32270888	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	796	1209	0.014888337	0.009925558	5	oligos	OL-Cntl	40	16	16
ACGAGGACACAGGTTT-1_7_D5	31.51106649	-1.289647534	2	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3424	8052	0.006706408	0.004470939	5	2	EN-L4	40	16	16
ACGAGGACACGAAAGC-1_7_D5	30.26503943	13.873845	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1135	1690	0.010650888	0.115384615	5	14	Microglia	40	16	16
ACGAGGAGTCCATCCT-1_7_D5	0.9587139	19.37218845	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	788	1097	0.007292616	0.003646308	5	oligos	OL-Cntl	40	16	16
ACGAGGAGTCTCTTAT-1_7_D5	3.340631057	13.02601436	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1070	1725	0.006956522	0.011014493	5	oligos	OL-Cntl	40	16	16
ACGAGGAGTGAGTATA-1_7_D5	7.073516559	13.40642534	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1259	1996	0.010521042	0.009519038	5	oligos	OL-Cntl	40	16	16
ACGAGGAGTTCCACAA-1_7_D5	14.28284793	11.4001626	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1130	1834	0.003816794	0.005452563	5	oligos	OL-Cntl	40	16	16
ACGAGGATCCAAAGTC-1_7_D5	15.31900314	11.2896407	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1339	2259	0.000442674	0.008853475	5	oligos	OL-Cntl	40	16	16
ACGATACAGACAGGCT-1_7_D5	34.72115632	-5.40171983	2	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2928	5744	0.011316156	0.00591922	5	2	EN-L4	40	16	16
ACGATACAGCTACCGC-1_7_D5	-32.41462451	3.124101936	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2253	4318	0.001157943	0.003705419	5	9	OPC	40	16	16
ACGATACAGGTCGGAT-1_7_D5	-15.52918265	-0.193309677	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2842	5395	0.013716404	0.016682113	5	13A	IN-VIP	40	16	16
ACGATACTCTCAAACG-1_7_D5	31.32613665	15.79034409	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1071	1583	0.005685407	0.08780796	5	14	Microglia	40	16	16
ACGATACTCTGGTGTA-1_7_D5	-24.87153483	-19.20931163	6A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3264	8087	0.040558922	0.007913936	5	6A	IN-PV	40	16	16
ACGATACTCTGTCCGT-1_7_D5	-34.57715996	-13.09350861	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	710	1071	0.016806723	0.001867414	5	9	OPC	40	16	16
ACGATACTCTTACCGC-1_7_D5	27.35246326	-5.965426321	2	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	5994	21709	0.00119766	0.004606384	5	2	EN-L4	40	16	16
ACGATGTAGAGTAAGG-1_7_D5	-29.59328043	0.117888276	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1738	2797	0.011440829	0.011083304	5	9	OPC	40	16	16
ACGATGTAGATCCCAT-1_7_D5	-34.62640824	1.140923812	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1768	3242	0.005552128	0.004935225	5	9	OPC	40	16	16
ACGATGTAGTCTCAAC-1_7_D5	-20.1316133	25.30722259	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1505	2412	0.002487562	0.009535655	5	8	Astrocytes	40	16	16
ACGATGTCAGCTCGCA-1_7_D5	12.49834484	7.363496256	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1827	3219	0.00963032	0.009009009	5	oligos	OL-Cntl	40	16	16
ACGATGTCATCGGACC-1_7_D5	11.57672348	28.77330108	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	779	1151	0.003475239	0.003475239	5	oligos	OL-Cntl	40	16	16
ACGATGTGTATAGGTA-1_7_D5	0.039633839	21.70274228	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	788	1141	0.008764242	0.003505697	5	oligos	OL-Cntl	40	16	16
ACGATGTGTATGGTTC-1_7_D5	-34.32305449	-1.194736163	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1370	2201	0.004543389	0.014084507	5	9	OPC	40	16	16
ACGATGTGTCTAAACC-1_7_D5	-2.521452172	14.7419632	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	764	1129	0.014171833	0.034543844	5	oligos	OL-Cntl	40	16	16
ACGATGTGTCTAGCCG-1_7_D5	3.261283583	10.94955471	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1123	1633	0.018983466	0.025107165	5	oligos	OL-Cntl	40	16	16
ACGATGTGTTAAAGTG-1_7_D5	12.07941924	16.32323313	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1139	1784	0.010650224	0.005605381	5	oligos	OL-Cntl	40	16	16
ACGATGTTCGACAGCC-1_7_D5	12.94721974	-7.213275278	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3237	8704	0.012063419	0.002527574	5	3	EN-L5-6	40	16	16
ACGCAGCAGAAGGTGA-1_7_D5	-13.81267685	0.540486912	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3268	6669	0.018443545	0.010346379	5	13A	IN-VIP	40	16	16
ACGCAGCAGGCCCGTT-1_7_D5	-16.06109	2.005412308	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	5133	12779	0.011346741	0.011346741	5	13A	IN-VIP	40	16	16
ACGCAGCCACAACGTT-1_7_D5	-0.313395105	12.81950659	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1093	1691	0.010053223	0.017740982	5	oligos	OL-Cntl	40	16	16
ACGCAGCGTGGGTATG-1_7_D5	-30.46799454	1.712749144	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1914	3210	0.001869159	0.012772586	5	9	OPC	40	16	16
ACGCAGCGTGGGTCAA-1_7_D5	-36.71183556	-6.871153307	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1196	1976	0.007591093	0.005060729	5	9	OPC	40	16	16
ACGCAGCTCACGATGT-1_7_D5	17.02770123	-26.30348749	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	6127	20757	0.006407477	0.006262947	5	3	EN-L5-6	40	16	16
ACGCAGCTCATCTGCC-1_7_D5	9.576257053	14.50394998	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1160	1941	0.005667182	0.006697579	5	oligos	OL-Cntl	40	16	16
ACGCAGCTCTGGGCCA-1_7_D5	-2.857294062	17.46164495	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	955	1379	0.002900653	0.0137781	5	oligos	OL-Cntl	40	16	16
ACGCAGCTCTTCCTTC-1_7_D5	-3.298119457	14.40278598	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	771	1101	0.012715713	0.02270663	5	oligos	OL-Cntl	40	16	16
ACGCCAGCATCCAACA-1_7_D5	-34.45459372	1.921392765	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1884	3661	0.004916689	0.005462988	5	9	OPC	40	16	16
ACGCCAGGTCCTCCAT-1_7_D5	-3.95500725	20.56651639	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	700	1067	0.000937207	0.004686036	5	oligos	OL-Cntl	40	16	16
ACGCCAGTCCTTGGTC-1_7_D5	1.799095903	28.41788687	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	697	1014	0.000986193	0.00295858	5	oligos	OL-Cntl	40	16	16
ACGCCGAAGCTGCAAG-1_7_D5	-20.08847299	28.44024773	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2312	4642	0.002800517	0.006678156	5	8	Astrocytes	40	16	16
ACGCCGAAGGAATGGA-1_7_D5	-18.36820664	29.41690239	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2287	4048	0.003705534	0.01506917	5	8	Astrocytes	40	16	16
ACGCCGACAATCTGCA-1_7_D5	-23.06255899	-26.25180409	6A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	5194	15272	0.002291776	0.008839707	5	6A	IN-PV	40	16	16
ACGCCGACACAGGAGT-1_7_D5	14.08304682	-17.42642022	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	9463	43225	0.015754772	0.007888953	5	L2-3	EN-L2-3-MS	40	16	16
ACGCCGACATGCCACG-1_7_D5	31.09557631	15.00853638	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	785	1044	0.012452107	0.090996169	5	14	Microglia	40	16	16
ACGCCGAGTCTAAAGA-1_7_D5	4.402472528	12.34361374	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1086	1744	0.012041284	0.009747706	5	oligos	OL-Cntl	40	16	16
ACGCCGATCATGTGGT-1_7_D5	-10.35703841	-5.551726359	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2114	4124	0.0128516	0.01042677	5	13A	IN-VIP	40	16	16
ACGCCGATCTGCTGCT-1_7_D5	-19.68858595	28.20293186	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2202	4879	0.0030744	0.009223201	5	8	Astrocytes	40	16	16
ACGGAGACAATAGCAA-1_7_D5	-21.38489666	26.79995562	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1904	3903	0.00486805	0.005380477	5	8	Astrocytes	40	16	16
ACGGAGACACAAGACG-1_7_D5	-5.494247729	18.39798386	5	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	740	1002	0.002994012	0.007984032	5	oligos	OL-MS-1	40	16	16
ACGGAGATCCTCGCAT-1_7_D5	-19.62428433	24.99481394	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1512	2615	0.002294455	0.007648184	5	8	Astrocytes	40	16	16
ACGGCCAAGAAACGAG-1_7_D5	35.84499169	11.13616641	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	851	1126	0.005328597	0.011545293	5	14	Microglia	40	16	16
ACGGCCAAGCGATAGC-1_7_D5	-35.41710725	-0.688602747	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1406	2374	0.0042123	0.00463353	5	9	OPC	40	16	16
ACGGCCAAGGCAGGTT-1_7_D5	-0.481629699	15.74957975	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	772	1119	0.00714924	0.016085791	5	oligos	OL-Cntl	40	16	16
ACGGCCAAGTGCGATG-1_7_D5	38.03207866	11.90221016	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1004	1399	0.005003574	0.008577555	5	14	Microglia	40	16	16
ACGGCCACAACTGCGC-1_7_D5	0.393626242	9.970077085	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1065	1609	0.011808577	0.014916097	5	oligos	OL-Cntl	40	16	16
ACGGCCACAATTGCTG-1_7_D5	19.18131082	12.66934321	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1451	2619	0.003436426	0.006491027	5	oligos	OL-Cntl	40	16	16
ACGGCCACACTTCTGC-1_7_D5	0.640363825	20.42434404	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	786	1174	0.003407155	0.007666099	5	oligos	OL-Cntl	40	16	16
ACGGCCAGTAAGTGGC-1_7_D5	32.42998681	16.73161008	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1518	2298	0.003046127	0.072236728	5	14	Microglia	40	16	16
ACGGCCAGTAGCTCCG-1_7_D5	11.57754372	18.67570536	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1094	1829	0.001093494	0.004920722	5	oligos	OL-Cntl	40	16	16
ACGGCCATCAGGCCCA-1_7_D5	4.896623082	-22.44530889	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	5509	18440	0.007700651	0.004229935	5	L2-3	EN-L2-3-MS	40	16	16
ACGGCCATCCAGAGGA-1_7_D5	13.50362021	9.274800075	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1643	2785	0.001436266	0.006822262	5	oligos	OL-Cntl	40	16	16
ACGGCCATCGCAGGCT-1_7_D5	17.2133801	13.10703984	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1302	2362	0.00508044	0.00254022	5	oligos	OL-Cntl	40	16	16
ACGGCCATCTGCCAGG-1_7_D5	-37.99226088	-7.656742423	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1033	2051	0.002437835	0.00487567	5	9	OPC	40	16	16
ACGGGCTAGATCCTGT-1_7_D5	-20.33525067	28.75324539	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2191	4294	0.003493246	0.007685142	5	8	Astrocytes	40	16	16
ACGGGCTAGCTGCCCA-1_7_D5	-29.66647135	-0.427319566	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1941	3420	0.007894737	0.006140351	5	9	OPC	40	16	16
ACGGGCTAGGAATCGC-1_7_D5	0.197444101	18.99414515	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	733	1008	0.012896825	0.012896825	5	oligos	OL-Cntl	40	16	16
ACGGGCTAGGTTCCTA-1_7_D5	35.77531084	-7.633137551	2	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4812	12355	0.009065156	0.007527317	5	2	EN-L4	40	16	16
ACGGGCTCACGTTGGC-1_7_D5	-13.05914016	-4.366352636	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2578	5269	0.028658189	0.007401784	5	13A	IN-VIP	40	16	16
ACGGGCTGTCTGCAAT-1_7_D5	5.880392749	-22.12462417	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	6646	22596	0.004071517	0.004691096	5	L2-3	EN-L2-3-MS	40	16	16
ACGGGCTTCGCCAGCA-1_7_D5	4.533546316	5.662846623	7	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1561	2292	0.009162304	0.014397906	5	7	Phagocytes	40	16	16
ACGGGTCAGAGTTGGC-1_7_D5	-0.741911713	14.10343267	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	905	1337	0.020942408	0.026925954	5	oligos	OL-Cntl	40	16	16
ACGGGTCAGGATCGCA-1_7_D5	8.372655119	-19.23387794	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	7320	24138	0.007747121	0.008492833	5	L2-3	EN-L2-3-MS	40	16	16
ACGGGTCAGTGTACTC-1_7_D5	-13.89407654	-4.594776618	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2779	5848	0.022229822	0.003248974	5	13A	IN-VIP	40	16	16
ACGGGTCCAGCTGTGC-1_7_D5	-33.4405115	2.599080584	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2113	4009	0.004988775	0.011973061	5	9	OPC	40	16	16
ACGGGTCGTTCGCGAC-1_7_D5	-3.561762238	17.44874341	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	767	1086	0.006445672	0.011049724	5	oligos	OL-Cntl	40	16	16
ACGGGTCGTTCGGCAC-1_7_D5	9.222334887	12.43756369	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1069	1790	0.01452514	0.011731844	5	oligos	OL-Cntl	40	16	16
ACGGGTCGTTGTGGCC-1_7_D5	16.40278184	5.967565914	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2401	4712	0.013157895	0.009974533	5	oligos	OL-Cntl	40	16	16
ACGGGTCGTTTAGGAA-1_7_D5	30.74053637	15.2468429	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	966	1308	0.001529052	0.099388379	5	14	Microglia	40	16	16
ACGGGTCTCATCGGAT-1_7_D5	12.3083212	16.33038902	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1126	1837	0.002721829	0.009254219	5	oligos	OL-Cntl	40	16	16
ACGGGTCTCGACAGCC-1_7_D5	5.606258666	14.57280275	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1071	1683	0.004159239	0.021984551	5	oligos	OL-Cntl	40	16	16
ACGTCAAAGTTGAGTA-1_7_D5	-1.462137903	18.34172601	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	738	1062	0.008474576	0.007532957	5	oligos	OL-Cntl	40	16	16
ACGTCAACAAGCCATT-1_7_D5	1.510581061	15.2501484	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	878	1306	0.008422665	0.013782542	5	oligos	OL-Cntl	40	16	16
ACGTCAACACAGAGGT-1_7_D5	-18.75079675	-20.31119464	6B	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2660	5760	0.009201389	0.003819444	5	6B	IN-SST	40	16	16
ACGTCAAGTAGATTAG-1_7_D5	27.76797562	-6.543301116	2	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4890	15806	0.046058459	0.00284702	5	2	EN-L4	40	16	16
ACGTCAAGTTACGCGC-1_7_D5	8.438978525	-17.46314932	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4941	12532	0.008937121	0.024018513	5	L2-3	EN-L2-3-MS	40	16	16
ACGTCAATCCAAAGTC-1_7_D5	12.31796882	11.58746441	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1301	2273	0.000439947	0.00791905	5	oligos	OL-Cntl	40	16	16
ACGTCAATCGGATGTT-1_7_D5	2.400301142	20.68259961	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	887	1362	0.002202643	0.005139501	5	oligos	OL-Cntl	40	16	16
ACTATCTAGTCACGCC-1_7_D5	10.70841662	21.60533385	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	905	1459	0.001370802	0.005483208	5	oligos	OL-Cntl	40	16	16
ACTATCTAGTGGTAGC-1_7_D5	5.073248303	9.565278964	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1537	2563	0.014436208	0.01755755	5	oligos	OL-Cntl	40	16	16
ACTATCTCAGCTGTTA-1_7_D5	-17.71623405	1.365068106	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	5168	13300	0.009849624	0.01518797	5	13A	IN-VIP	40	16	16
ACTATCTTCGCCTGTT-1_7_D5	13.00309992	14.31955791	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1157	1985	0.005037783	0.010579345	5	oligos	OL-Cntl	40	16	16
ACTGAACCAGAGCCAA-1_7_D5	22.24594356	-27.4918334	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	5933	17583	0.006483535	0.006426662	5	3	EN-L5-6	40	16	16
ACTGAACGTACAGACG-1_7_D5	-31.92094038	2.644370071	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2246	4072	0.009086444	0.00589391	5	9	OPC	40	16	16
ACTGAACGTGAAAGAG-1_7_D5	-12.73725665	-0.759576644	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3269	6994	0.030597655	0.005719188	5	13A	IN-VIP	40	16	16
ACTGAACTCACAGGCC-1_7_D5	12.57398367	-6.625046103	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1964	4262	0.001877053	0.004458001	5	3	EN-L5-6	40	16	16
ACTGAACTCCCGACTT-1_7_D5	16.7332086	5.799615171	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2836	6293	0.005879549	0.011441284	5	oligos	OL-Cntl	40	16	16
ACTGAGTAGTCCGGTC-1_7_D5	12.46032966	9.571324045	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1435	2424	0.002475248	0.008250825	5	oligos	OL-Cntl	40	16	16
ACTGAGTCACGGTAGA-1_7_D5	10.21182045	12.42807462	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1181	2009	0.004479841	0.009955202	5	oligos	OL-Cntl	40	16	16
ACTGAGTGTTCGTGAT-1_7_D5	-1.281132613	13.63834305	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	952	1406	0.007823613	0.022048364	5	oligos	OL-Cntl	40	16	16
ACTGAGTTCAACACGT-1_7_D5	4.065567493	-17.45509115	10	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2950	7082	0.000423609	0.01016662	5	L2-3	EN-L2-3-Cntl	40	16	16
ACTGAGTTCATGTCCC-1_7_D5	13.05526954	-24.26836585	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	7788	29545	0.006735488	0.008935522	5	L2-3	EN-L2-3-MS	40	16	16
ACTGAGTTCTAACTCT-1_7_D5	10.23870227	-27.17300036	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4839	12513	0.001838088	0.00743227	5	L2-3	EN-L2-3-MS	40	16	16
ACTGATGAGGAGTACC-1_7_D5	-25.6343478	21.68529241	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1190	2000	0.0035	0.0055	5	8	Astrocytes	40	16	16
ACTGATGAGTACTTGC-1_7_D5	-24.61732889	22.65807402	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1363	2235	0.000894855	0.0049217	5	8	Astrocytes	40	16	16
ACTGATGCAGTCCTTC-1_7_D5	32.60225295	16.76688201	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1434	2216	0.009025271	0.059115523	5	14	Microglia	40	16	16
ACTGATGGTCCAAGTT-1_7_D5	2.82987092	20.95936594	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	868	1277	0.006264683	0.007830854	5	oligos	OL-Cntl	40	16	16
ACTGATGGTCTCTTAT-1_7_D5	32.62294476	16.50266097	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1206	1848	0.001082251	0.058982684	5	14	Microglia	40	16	16
ACTGATGGTGCCTGCA-1_7_D5	12.34690555	9.792966976	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1469	2539	0.011027964	0.009846396	5	oligos	OL-Cntl	40	16	16
ACTGATGTCCTCGCAT-1_7_D5	38.30176965	13.30543506	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1040	1489	0.014103425	0.01208865	5	14	Microglia	40	16	16
ACTGCTCAGACCTAGG-1_7_D5	12.51370369	-30.70690417	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2784	6658	0.01201562	0.003454491	5	3	EN-L5-6	40	16	16
ACTGCTCAGCACGCCT-1_7_D5	25.65519365	-28.07426378	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	5140	17329	0.002019736	0.002596803	5	3	EN-L5-6	40	16	16
ACTGCTCAGCGTAATA-1_7_D5	-34.16058531	2.57813108	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2019	3778	0.006881948	0.005558497	5	9	OPC	40	16	16
ACTGCTCCATGACATC-1_7_D5	-2.963445189	15.4793763	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	763	1082	0.007393715	0.018484288	5	oligos	OL-Cntl	40	16	16
ACTGCTCGTATAGGGC-1_7_D5	-2.85127883	12.63800604	5	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	985	1487	0.032952253	0.024209818	5	oligos	OL-MS-1	40	16	16
ACTGCTCTCGCAGGCT-1_7_D5	-0.996754855	0.786809035	11	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2823	6552	0.123015873	0.007326007	5	11	Glia-MIX	40	16	16
ACTGCTCTCTGATACG-1_7_D5	-0.632328866	15.85669475	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	739	1083	0.010156971	0.016620499	5	oligos	OL-Cntl	40	16	16
ACTGTCCAGACAAGCC-1_7_D5	-9.680349942	22.33011958	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	997	1368	0.002923977	0.005847953	5	8	Astrocytes	40	16	16
ACTGTCCCACCTTGTC-1_7_D5	12.46100237	-6.446869331	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1956	4058	0.01084278	0.002957122	5	3	EN-L5-6	40	16	16
ACTGTCCGTGCATCTA-1_7_D5	-33.72811128	2.390076166	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1993	3641	0.003021148	0.007964845	5	9	OPC	40	16	16
ACTGTCCGTTCAGGCC-1_7_D5	22.94768144	-22.16590806	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	7836	31560	0.007889734	0.008016477	5	3	EN-L5-6	40	16	16
ACTGTCCGTTGCCTCT-1_7_D5	-31.67989456	1.065990109	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1901	3142	0.004774029	0.007638447	5	9	OPC	40	16	16
ACTGTCCTCACTCCTG-1_7_D5	6.889424455	-20.82215421	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3868	10800	0.007407407	0.006388889	5	L2-3	EN-L2-3-MS	40	16	16
ACTGTCCTCCAAGCCG-1_7_D5	-23.17461454	-18.62265743	6B	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3502	7603	0.012758122	0.011179797	5	6B	IN-SST	40	16	16
ACTGTCCTCGACCAGC-1_7_D5	30.86253901	15.57657251	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	979	1396	0.001432665	0.103868195	5	14	Microglia	40	16	16
ACTTACTAGCTACCGC-1_7_D5	38.01408997	15.38148391	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1251	1900	0.003684211	0.014736842	5	14	Microglia	40	16	16
ACTTACTCACCCAGTG-1_7_D5	-33.89489331	1.843768869	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1960	3400	0.004411765	0.008529412	5	9	OPC	40	16	16
ACTTACTCACCTCGTT-1_7_D5	37.63864072	14.2762875	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1110	1652	0.001210654	0.016343826	5	14	Microglia	40	16	16
ACTTACTCAGGGTACA-1_7_D5	-36.75315831	-1.078552533	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1400	2459	0.005286702	0.004473363	5	9	OPC	40	16	16
ACTTACTGTAGAGTGC-1_7_D5	-17.66022046	13.95979478	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1400	2559	0.004298554	0.005470887	5	8	Astrocytes	40	16	16
ACTTACTGTGGTCCGT-1_7_D5	-2.182735039	13.7322588	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	851	1267	0.009471192	0.023677979	5	oligos	OL-Cntl	40	16	16
ACTTACTTCGCCATAA-1_7_D5	-1.2137405	8.384808094	5	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1502	2383	0.036508603	0.013008812	5	oligos	OL-MS-1	40	16	16
ACTTGTTAGAAGGTGA-1_7_D5	5.63416104	-19.65232522	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4270	10339	0.003481962	0.01092949	5	L2-3	EN-L2-3-MS	40	16	16
ACTTGTTAGTACACCT-1_7_D5	-12.51718082	0.857562759	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3639	8739	0.011099668	0.006408056	5	13A	IN-VIP	40	16	16
ACTTGTTCAAACGTGG-1_7_D5	-2.624611446	15.20165256	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	733	1051	0.005708849	0.019980971	5	oligos	OL-Cntl	40	16	16
ACTTGTTCACAGAGGT-1_7_D5	16.73065649	6.144491183	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2284	5017	0.005780347	0.005581025	5	oligos	OL-Cntl	40	16	16
ACTTGTTCACATTCGA-1_7_D5	-35.79581306	1.59046879	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1812	3292	0.003037667	0.003948967	5	9	OPC	40	16	16
ACTTGTTCAGACGCTC-1_7_D5	2.075721801	14.6219207	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	914	1460	0.007534247	0.016438356	5	oligos	OL-Cntl	40	16	16
ACTTGTTCAGCCTATA-1_7_D5	-28.16477692	17.4469073	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1044	1726	0.000579374	0.005214368	5	8	Astrocytes	40	16	16
ACTTGTTGTTGTGGCC-1_7_D5	1.727097632	15.72896539	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	864	1337	0.002243829	0.01421092	5	oligos	OL-Cntl	40	16	16
ACTTGTTTCCTCGCAT-1_7_D5	11.91941136	6.535884825	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1854	3710	0.00296496	0.021293801	5	oligos	OL-Cntl	40	16	16
ACTTGTTTCGGATGGA-1_7_D5	-10.94756774	-1.196766953	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2419	4755	0.013880126	0.009884332	5	13A	IN-VIP	40	16	16
ACTTGTTTCGTCCGTT-1_7_D5	9.05821018	14.1005662	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1004	1568	0.001913265	0.008928571	5	oligos	OL-Cntl	40	16	16
ACTTGTTTCTGTGCAA-1_7_D5	17.18122654	-5.001846702	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1451	2203	0.006808897	0.007262823	5	3	EN-L5-6	40	16	16
ACTTTCAAGGGAAACA-1_7_D5	-9.355030251	13.75045186	11	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1444	2345	0.012793177	0.012366738	5	11	Glia-MIX	40	16	16
ACTTTCAAGGGTCTCC-1_7_D5	-13.81372382	1.787487166	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4082	10193	0.008339056	0.006671245	5	13A	IN-VIP	40	16	16
ACTTTCACAAGAGGCT-1_7_D5	-21.12186436	9.970933551	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1041	1827	0.002189381	0.002736727	5	8	Astrocytes	40	16	16
ACTTTCACATAAAGGT-1_7_D5	37.6996359	12.39041295	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1067	1485	0.006734007	0.012794613	5	14	Microglia	40	16	16
ACTTTCAGTGTAAGTA-1_7_D5	9.460572696	11.99806849	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1343	2207	0.013593113	0.009062075	5	oligos	OL-Cntl	40	16	16
ACTTTCAGTTAGATGA-1_7_D5	19.20175689	-27.14846342	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4219	11416	0.015416959	0.004379818	5	3	EN-L5-6	40	16	16
ACTTTCATCATCTGCC-1_7_D5	-19.74840709	27.58434921	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1935	4124	0.004607177	0.003394762	5	8	Astrocytes	40	16	16
ACTTTCATCGCCGTGA-1_7_D5	35.9702222	-7.723761366	2	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4497	11863	0.001433027	0.011295625	5	2	EN-L4	40	16	16
AGAATAGAGCGTCTAT-1_7_D5	-32.64531266	-8.968243467	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	933	1391	0.006470165	0.005032351	5	9	OPC	40	16	16
AGAATAGCATGACGGA-1_7_D5	-20.60542636	28.85248258	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2397	5463	0.000732198	0.005125389	5	8	Astrocytes	40	16	16
AGAATAGGTTCCACTC-1_7_D5	13.16128522	-7.403355531	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2323	4877	0.009226984	0.000820176	5	3	EN-L5-6	40	16	16
AGAATAGGTTGCCTCT-1_7_D5	40.61828553	14.39687799	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1064	1433	0.025122121	0.015352408	5	14	Microglia	40	16	16
AGAATAGTCCCTCTTT-1_7_D5	26.59778086	5.213683475	15BA	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1104	1769	0.012436405	0.027699265	5	15BA	Stromal cells	40	16	16
AGAATAGTCTGCTTGC-1_7_D5	12.0655613	-5.841630984	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1440	2617	0.003439052	0.003056935	5	3	EN-L5-6	40	16	16
AGAATAGTCTTACCTA-1_7_D5	-36.25304881	1.224020676	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1639	3218	0.003729024	0.004350528	5	9	OPC	40	16	16
AGACGTTAGAATTCCC-1_7_D5	16.05761852	9.34451633	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1598	2700	0.002222222	0.008888889	5	oligos	OL-Cntl	40	16	16
AGACGTTCACAACGCC-1_7_D5	4.986948977	15.94549772	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1003	1411	0.005669738	0.009213324	5	oligos	OL-Cntl	40	16	16
AGACGTTCAGTAAGCG-1_7_D5	-7.63568267	11.51762387	5	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	619	1018	0.002946955	0.012770138	5	oligos	OL-MS-1	40	16	16
AGACGTTCATACCATG-1_7_D5	14.94124952	20.99217665	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	915	1335	0.002247191	0.005992509	5	oligos	OL-Cntl	40	16	16
AGACGTTCATCACGTA-1_7_D5	39.95407218	12.128916	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	974	1396	0.011461318	0.005730659	5	14	Microglia	40	16	16
AGACGTTGTAGCGCTC-1_7_D5	-34.37856941	1.964292183	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1914	3538	0.004522329	0.003674392	5	9	OPC	40	16	16
AGAGCGAAGGCAGTCA-1_7_D5	12.91145734	14.09455852	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1160	1857	0.001077006	0.00915455	5	oligos	OL-Cntl	40	16	16
AGAGCGAAGTCCAGGA-1_7_D5	13.71746545	-10.0637164	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3031	5505	0.01071753	0.021798365	5	13A	IN-VIP	40	16	16
AGAGCGACAAAGAATC-1_7_D5	2.163132744	11.93074013	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	972	1526	0.005897772	0.024246396	5	oligos	OL-Cntl	40	16	16
AGAGCGACACTTACGA-1_7_D5	-35.25115511	1.776131976	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1755	3048	0.002296588	0.00492126	5	9	OPC	40	16	16
AGAGCGAGTGCTGTAT-1_7_D5	34.19035475	15.42940448	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	933	1309	0.011459129	0.055767762	5	14	Microglia	40	16	16
AGAGCTTAGCTTTGGT-1_7_D5	36.66575924	12.51173946	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1021	1433	0.001395673	0.015352408	5	14	Microglia	40	16	16
AGAGCTTCAGACGTAG-1_7_D5	33.01364737	15.06303477	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	995	1336	0.00748503	0.050149701	5	14	Microglia	40	16	16
AGAGCTTCATCATCCC-1_7_D5	15.24377325	10.2749928	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1464	2556	0.00312989	0.009780908	5	oligos	OL-Cntl	40	16	16
AGAGCTTTCATCTGCC-1_7_D5	7.299939708	32.02609294	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	712	1099	0.004549591	0.004549591	5	oligos	OL-Cntl	40	16	16
AGAGTGGCAGCTGTGC-1_7_D5	12.95965968	-7.219159791	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2973	7362	0.011681608	0.003803314	5	3	EN-L5-6	40	16	16
AGAGTGGTCCGAACGC-1_7_D5	-19.16628513	28.39265613	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2303	4876	0.004511895	0.007383101	5	8	Astrocytes	40	16	16
AGAGTGGTCTGGTGTA-1_7_D5	18.49782438	-23.13441365	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4951	13325	0.01163227	0.018161351	5	3	EN-L5-6	40	16	16
AGAGTGGTCTTAGAGC-1_7_D5	-34.36912009	3.153585588	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2169	4332	0.004155125	0.004385965	5	9	OPC	40	16	16
AGATCTGAGGAGTCTG-1_7_D5	-25.41057547	25.41388149	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1627	3513	0.002561913	0.006547111	5	8	Astrocytes	40	16	16
AGATCTGCAAACTGCT-1_7_D5	-35.0619312	-4.419002348	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1360	2090	0.005741627	0.005741627	5	9	OPC	40	16	16
AGATCTGCAAGCCGCT-1_7_D5	11.31786846	-4.878098413	12	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	784	1241	0.024979855	0.005640612	5	12	EN-MIX	40	16	16
AGATCTGCATGTCGAT-1_7_D5	9.535959608	15.60900677	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	940	1490	0.002013423	0.012080537	5	oligos	OL-Cntl	40	16	16
AGATCTGGTTCCCTTG-1_7_D5	9.363675503	10.81371754	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1166	1852	0.002699784	0.01511879	5	oligos	OL-Cntl	40	16	16
AGATCTGTCACTCTTA-1_7_D5	-33.11633701	3.267252487	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2275	4487	0.004457321	0.00735458	5	9	OPC	40	16	16
AGATCTGTCCTGTACC-1_7_D5	1.668308958	14.82181283	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	816	1292	0.003095975	0.010835913	5	oligos	OL-Cntl	40	16	16
AGATCTGTCGCATGAT-1_7_D5	21.56675652	9.136829226	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1907	3343	0.003290458	0.005384385	5	oligos	OL-Cntl	40	16	16
AGATTGCAGATAGTCA-1_7_D5	-32.3922061	2.974929854	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2192	4208	0.004752852	0.004515209	5	9	OPC	40	16	16
AGATTGCAGCACCGCT-1_7_D5	16.02522643	6.235187203	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2042	3864	0.001035197	0.007246377	5	oligos	OL-Cntl	40	16	16
AGATTGCCAGCGTTCG-1_7_D5	-26.47596467	12.69045064	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	949	1719	0.001745201	0.007562536	5	8	Astrocytes	40	16	16
AGCAGCCCAAAGTCAA-1_7_D5	-19.97989036	28.22897692	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2212	4010	0.004239401	0.005486284	5	8	Astrocytes	40	16	16
AGCAGCCGTCAGAAGC-1_7_D5	-17.62634698	1.422108304	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4973	11917	0.009566166	0.023328019	5	13A	IN-VIP	40	16	16
AGCAGCCGTTCCACGG-1_7_D5	7.244262701	-20.51979678	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4472	12256	0.005874674	0.005874674	5	L2-3	EN-L2-3-MS	40	16	16
AGCAGCCTCAGTACGT-1_7_D5	1.272514038	16.8515807	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	851	1269	0.010244287	0.005516154	5	oligos	OL-Cntl	40	16	16
AGCATACAGGATCGCA-1_7_D5	-17.51959646	1.494150283	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4568	10584	0.010298564	0.023148148	5	13A	IN-VIP	40	16	16
AGCATACCACTTCTGC-1_7_D5	-1.246970745	20.72831371	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	743	1016	0.00492126	0.007874016	5	oligos	OL-Cntl	40	16	16
AGCATACCAGGATCGA-1_7_D5	-36.49705691	1.283531157	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1638	2893	0.003802281	0.005184929	5	9	OPC	40	16	16
AGCATACCATGCTGGC-1_7_D5	8.032758286	10.22300514	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1080	1768	0.002828054	0.014705882	5	oligos	OL-Cntl	40	16	16
AGCATACGTAATCACC-1_7_D5	12.36406509	7.631618066	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1581	2678	0.008961912	0.011949216	5	oligos	OL-Cntl	40	16	16
AGCATACTCGGCTACG-1_7_D5	-17.33254502	-0.386850332	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3294	6580	0.01443769	0.020212766	5	13A	IN-VIP	40	16	16
AGCATACTCTTTCCTC-1_7_D5	5.439695745	20.58782459	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	979	1540	0.005194805	0.004545455	5	oligos	OL-Cntl	40	16	16
AGCCTAAAGCCAGTAG-1_7_D5	23.05910903	-28.45837456	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	5229	15925	0.000690738	0.004144427	5	3	EN-L5-6	40	16	16
AGCCTAAAGGATGCGT-1_7_D5	0.956373447	13.26318855	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	939	1281	0.019516003	0.021077283	5	oligos	OL-Cntl	40	16	16
AGCCTAACAGAGCCAA-1_7_D5	-18.82176305	-20.80119974	6B	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2462	5181	0.024705655	0.005597375	5	6B	IN-SST	40	16	16
AGCCTAACAGATCTGT-1_7_D5	0.905093643	-21.42434931	10	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3714	9856	0.002739448	0.003551136	5	L2-3	EN-L2-3-Cntl	40	16	16
AGCCTAACAGTCCTTC-1_7_D5	4.066581028	14.26710903	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1120	1814	0.003307607	0.008820287	5	oligos	OL-Cntl	40	16	16
AGCCTAATCCACGTGG-1_7_D5	-29.37075308	17.41639372	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	955	1598	0.001251564	0.002503129	5	8	Astrocytes	40	16	16
AGCGGTCAGTCTTGCA-1_7_D5	4.859348873	11.15927741	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1349	2177	0.016995866	0.012402389	5	oligos	OL-Cntl	40	16	16
AGCGGTCAGTTGAGAT-1_7_D5	11.8250828	7.199655752	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1670	2706	0.004065041	0.016999261	5	oligos	OL-Cntl	40	16	16
AGCGGTCCAGGGAGAG-1_7_D5	-18.18086679	28.70911065	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2559	5179	0.006178799	0.008882024	5	8	Astrocytes	40	16	16
AGCGGTCCAGGTCGTC-1_7_D5	12.97557974	-7.271331575	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3442	9024	0.041555851	0.003102837	5	3	EN-L5-6	40	16	16
AGCGGTCCATCCCACT-1_7_D5	-1.469112922	23.162936	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	740	1111	0.00540054	0.01170117	5	oligos	OL-Cntl	40	16	16
AGCGGTCGTCTCTCGT-1_7_D5	-16.12348183	22.20911429	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1181	1834	0.00436205	0.010359869	5	8	Astrocytes	40	16	16
AGCGGTCGTTCCATGA-1_7_D5	-15.1071946	-21.67336915	6A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1581	2801	0.041056765	0.005712246	5	6A	IN-PV	40	16	16
AGCGGTCTCCCACTTG-1_7_D5	11.53900807	-13.98076649	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4949	12344	0.010774465	0.019199611	5	L2-3	EN-L2-3-MS	40	16	16
AGCGGTCTCCGTTGCT-1_7_D5	3.967831837	10.79959194	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1181	1765	0.009065156	0.018130312	5	oligos	OL-Cntl	40	16	16
AGCGTATAGTAGGCCA-1_7_D5	-26.96201595	16.72726503	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1090	1762	0.001135074	0.006242906	5	8	Astrocytes	40	16	16
AGCGTATAGTTCGCGC-1_7_D5	11.89440357	8.673001401	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1546	2752	0.007994186	0.009084302	5	oligos	OL-Cntl	40	16	16
AGCGTATGTAGAAAGG-1_7_D5	12.82751556	14.59016145	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1280	2085	0.006235012	0.006714628	5	oligos	OL-Cntl	40	16	16
AGCGTATGTAGCGTAG-1_7_D5	2.675704819	15.82744364	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	968	1539	0.010396361	0.012995452	5	oligos	OL-Cntl	40	16	16
AGCGTATTCGGTGTCG-1_7_D5	10.47138702	7.387258693	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1502	2553	0.003525264	0.011359185	5	oligos	OL-Cntl	40	16	16
AGCGTATTCGTCTGCT-1_7_D5	12.65812157	-6.754640784	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2092	4722	0.001694197	0.004870817	5	3	EN-L5-6	40	16	16
AGCGTATTCTTGGGTA-1_7_D5	9.877529587	14.28656846	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1055	1710	0.00877193	0.011111111	5	oligos	OL-Cntl	40	16	16
AGCGTATTCTTTACAC-1_7_D5	-27.68997686	10.9088305	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	695	1043	0.000958773	0.005752637	5	8	Astrocytes	40	16	16
AGCGTCGAGAGCTTCT-1_7_D5	-34.49119196	4.906813861	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2803	6044	0.0049636	0.007279947	5	9	OPC	40	16	16
AGCGTCGAGCCACGCT-1_7_D5	-31.68429671	2.186519998	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2013	3587	0.007805966	0.005296905	5	9	OPC	40	16	16
AGCGTCGCAAGCCGTC-1_7_D5	-34.94214869	5.120186262	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2910	6489	0.00554785	0.003698567	5	9	OPC	40	16	16
AGCGTCGCACGGTTTA-1_7_D5	2.016400725	20.81993489	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	872	1383	0.018799711	0.013015184	5	oligos	OL-Cntl	40	16	16
AGCGTCGCACTAGTAC-1_7_D5	12.83381145	-7.025641756	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2489	5714	0.001925096	0.003325166	5	3	EN-L5-6	40	16	16
AGCGTCGCATTCCTCG-1_7_D5	-1.847806142	17.33967486	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	737	1050	0.014285714	0.01047619	5	oligos	OL-Cntl	40	16	16
AGCGTCGGTTTGCATG-1_7_D5	-16.08636076	-18.85695407	6B	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1828	3496	0.020022883	0.005148741	5	6B	IN-SST	40	16	16
AGCGTCGTCAACGCTA-1_7_D5	9.704142756	12.8728206	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1139	1927	0.002594707	0.009859886	5	oligos	OL-Cntl	40	16	16
AGCGTCGTCCTTGACC-1_7_D5	-5.116026789	-1.705411853	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1490	2731	0.000732332	0.001830831	5	13A	IN-VIP	40	16	16
AGCTCCTAGGTGCAAC-1_7_D5	10.49329381	-27.73573383	10	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	8768	38747	0.001806591	0.005677859	5	L2-3	EN-L2-3-Cntl	40	16	16
AGCTCCTAGGTTACCT-1_7_D5	15.2150716	14.80076423	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1283	2136	0.008895131	0.003277154	5	oligos	OL-Cntl	40	16	16
AGCTCCTCAAGACACG-1_7_D5	-0.510791391	16.20531864	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	751	1077	0.004642526	0.021355617	5	oligos	OL-Cntl	40	16	16
AGCTCCTCAAGTAGTA-1_7_D5	12.57996233	-6.637072188	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1953	3821	0.006281078	0.004187386	5	3	EN-L5-6	40	16	16
AGCTCCTCACAGTCGC-1_7_D5	-0.196618845	20.76382238	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	726	1146	0.011343805	0.010471204	5	oligos	OL-Cntl	40	16	16
AGCTCCTTCATGGTCA-1_7_D5	10.71923925	17.50055975	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1040	1610	0.002484472	0.008695652	5	oligos	OL-Cntl	40	16	16
AGCTCCTTCTCCGGTT-1_7_D5	-12.8749874	0.955624341	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3053	6248	0.014564661	0.007202305	5	13A	IN-VIP	40	16	16
AGCTCCTTCTGCAGTA-1_7_D5	14.03992642	-33.12152989	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4124	12670	0.005209155	0.003157064	5	3	EN-L5-6	40	16	16
AGCTCTCCACTATCTT-1_7_D5	-35.0643764	5.156817555	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2762	6145	0.002766477	0.004719284	5	9	OPC	40	16	16
AGCTCTCGTAAGCACG-1_7_D5	3.47383508	17.34666156	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	827	1286	0.000777605	0.006998445	5	oligos	OL-Cntl	40	16	16
AGCTCTCGTCCAGTAT-1_7_D5	30.56971237	15.59779218	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	986	1493	0.010716678	0.128600134	5	14	Microglia	40	16	16
AGCTCTCTCAGCTCGG-1_7_D5	-0.316769087	16.24003598	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	813	1199	0.003336113	0.00500417	5	oligos	OL-Cntl	40	16	16
AGCTCTCTCCGCATCT-1_7_D5	-11.34910507	-20.6572729	6B	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	943	1499	0.018012008	0.010006671	5	6B	IN-SST	40	16	16
AGCTTGACACTATCTT-1_7_D5	6.362892032	11.24178697	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1188	1818	0.008250825	0.013751375	5	oligos	OL-Cntl	40	16	16
AGCTTGACAGCCACCA-1_7_D5	21.26966271	-24.42143246	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	5503	16314	0.006497487	0.013178865	5	3	EN-L5-6	40	16	16
AGCTTGAGTAAGGGAA-1_7_D5	-34.49952943	-2.912277314	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1440	2182	0.001374885	0.005041247	5	9	OPC	40	16	16
AGCTTGAGTGTGACGA-1_7_D5	-34.72834993	-3.443297864	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1362	2157	0.006026889	0.005563282	5	9	OPC	40	16	16
AGCTTGATCCCATTTA-1_7_D5	11.87320574	-5.570060255	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1393	2433	0.008220304	0.003699137	5	3	EN-L5-6	40	16	16
AGCTTGATCCGTTGTC-1_7_D5	2.994527017	19.90642255	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	732	1055	0.000947867	0.01042654	5	oligos	OL-Cntl	40	16	16
AGGCCACCAAAGAATC-1_7_D5	-26.51273229	19.21485493	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1409	2447	0.009807928	0.003677973	5	8	Astrocytes	40	16	16
AGGCCACCAAGACACG-1_7_D5	-31.5489155	2.73460857	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2347	4537	0.005289839	0.007934759	5	9	OPC	40	16	16
AGGCCACCAATCCGAT-1_7_D5	4.982125046	10.72397076	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1381	2268	0.009259259	0.015432099	5	oligos	OL-Cntl	40	16	16
AGGCCACCACAGAGGT-1_7_D5	-16.86457606	-24.9482403	6A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2083	4353	0.043418332	0.002297266	5	6A	IN-PV	40	16	16
AGGCCACGTCCCTTGT-1_7_D5	3.395466533	-17.31013631	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2992	6468	0.010513296	0.00572047	5	L2-3	EN-L2-3-MS	40	16	16
AGGCCACGTCTAGAGG-1_7_D5	-1.073539119	13.58590677	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	842	1219	0.004922067	0.026251025	5	oligos	OL-Cntl	40	16	16
AGGCCACTCGTTACGA-1_7_D5	4.220318304	16.40392929	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1133	1837	0.003266195	0.007076756	5	oligos	OL-Cntl	40	16	16
AGGCCGTCACGCCAGT-1_7_D5	13.96623363	10.70247782	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1524	2599	0.003078107	0.006540977	5	oligos	OL-Cntl	40	16	16
AGGCCGTGTCTAGCGC-1_7_D5	32.95654621	14.92318833	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	727	1007	0.000993049	0.049652433	5	14	Microglia	40	16	16
AGGCCGTGTCTCAACA-1_7_D5	24.32064009	-11.76229887	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4352	9862	0.009227337	0.008416143	5	3	EN-L5-6	40	16	16
AGGCCGTGTGGTAACG-1_7_D5	11.08845515	8.505301397	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1509	2538	0.001970055	0.013396375	5	oligos	OL-Cntl	40	16	16
AGGCCGTTCACTCCTG-1_7_D5	7.050451059	10.34741157	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1348	2110	0.000473934	0.018957346	5	oligos	OL-Cntl	40	16	16
AGGCCGTTCCAAACTG-1_7_D5	4.277353602	-28.25669116	10	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3892	10671	0.006559835	0.003279918	5	L2-3	EN-L2-3-Cntl	40	16	16
AGGGAGTCACGCATCG-1_7_D5	17.17778132	-26.31184791	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	6311	21612	0.005968906	0.006431612	5	3	EN-L5-6	40	16	16
AGGGAGTCACTCAGGC-1_7_D5	7.845701377	11.66076496	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1132	1845	0.00596206	0.011382114	5	oligos	OL-Cntl	40	16	16
AGGGAGTGTTAAGTAG-1_7_D5	0.271305647	14.68174666	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	875	1308	0.009174312	0.01529052	5	oligos	OL-Cntl	40	16	16
AGGGAGTGTTCAGACT-1_7_D5	39.37468566	9.446445107	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	759	1004	0.019920319	0.007968127	5	14	Microglia	40	16	16
AGGGAGTTCTAACTTC-1_7_D5	1.28009416	17.90502263	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	783	1211	0.002477291	0.009083402	5	oligos	OL-Cntl	40	16	16
AGGGATGAGCATCATC-1_7_D5	21.49395348	-29.20600038	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4640	14482	0.002762049	0.002831101	5	3	EN-L5-6	40	16	16
AGGGATGCAAGGCTCC-1_7_D5	-3.661386426	18.52064941	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	857	1270	0.007086614	0.016535433	5	oligos	OL-Cntl	40	16	16
AGGGATGCAGATCCAT-1_7_D5	12.13919066	9.059427212	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1457	2632	0.003419453	0.013297872	5	oligos	OL-Cntl	40	16	16
AGGGATGCATCACAAC-1_7_D5	-23.3710718	-25.47107251	6A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4387	12357	0.023225702	0.007283321	5	6A	IN-PV	40	16	16
AGGGATGCATGCCTAA-1_7_D5	11.45420365	7.863239373	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1596	2900	0.006206897	0.015862069	5	oligos	OL-Cntl	40	16	16
AGGGATGCATTAGGCT-1_7_D5	15.58538603	6.564409394	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1957	3670	0.003814714	0.013623978	5	oligos	OL-Cntl	40	16	16
AGGGATGGTAGCGTCC-1_7_D5	40.75176602	14.67259353	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1279	1903	0.011035208	0.015239096	5	14	Microglia	40	16	16
AGGGATGGTTCGTGAT-1_7_D5	24.22798252	-10.88277685	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4898	12643	0.002135569	0.006802183	5	3	EN-L5-6	40	16	16
AGGGATGTCCCTAACC-1_7_D5	1.259225565	13.6020478	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	933	1610	0.004968944	0.028571429	5	oligos	OL-Cntl	40	16	16
AGGGTGACACTTGGAT-1_7_D5	12.94516856	-7.187456095	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2687	6005	0.006161532	0.003996669	5	3	EN-L5-6	40	16	16
AGGGTGAGTAATAGCA-1_7_D5	-28.37785024	9.500760976	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	732	1107	0.003613369	0.002710027	5	8	Astrocytes	40	16	16
AGGGTGAGTCGGGTCT-1_7_D5	5.593319939	5.486252092	7	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3122	5975	0.005020921	0.013556485	5	7	Phagocytes	40	16	16
AGGGTGAGTTCGGCAC-1_7_D5	-3.960788531	16.02184679	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	899	1234	0.012155592	0.013776337	5	oligos	OL-Cntl	40	16	16
AGGTCATCACGACTCG-1_7_D5	-31.70914267	0.319110675	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1817	3302	0.005754088	0.006359782	5	9	OPC	40	16	16
AGGTCATGTAATAGCA-1_7_D5	38.487489	16.09056971	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1498	2252	0.006216696	0.03374778	5	14	Microglia	40	16	16
AGGTCATGTAGCGCAA-1_7_D5	11.32765604	-4.923629037	12	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	853	1290	0.001550388	0.008527132	5	12	EN-MIX	40	16	16
AGGTCATGTCCAGTTA-1_7_D5	0.202430521	19.16633606	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	723	1081	0.003700278	0.012950971	5	oligos	OL-Cntl	40	16	16
AGGTCATTCGCTTAGA-1_7_D5	11.82679884	17.36083284	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1081	1772	0.005643341	0.005079007	5	oligos	OL-Cntl	40	16	16
AGGTCATTCGTTTGCC-1_7_D5	34.45206752	-8.29069462	2	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4815	13266	0.009422584	0.011759385	5	2	EN-L4	40	16	16
AGGTCCGAGGCTAGCA-1_7_D5	33.87465444	14.42585021	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1003	1387	0.002883922	0.031002163	5	14	Microglia	40	16	16
AGGTCCGGTCCTCCAT-1_7_D5	-23.0986098	24.29694207	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1662	2789	0.002151309	0.003585515	5	8	Astrocytes	40	16	16
AGGTCCGGTGTGACGA-1_7_D5	-31.48982087	2.527444179	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2088	3793	0.006854732	0.007645663	5	9	OPC	40	16	16
AGGTCCGTCGTACCGG-1_7_D5	11.68299028	17.83307807	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	950	1433	0.005582694	0.009769714	5	oligos	OL-Cntl	40	16	16
AGTAGTCAGAAAGTGG-1_7_D5	2.026206596	18.18678254	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	870	1431	0.009783368	0.006289308	5	oligos	OL-Cntl	40	16	16
AGTAGTCAGCCTCGTG-1_7_D5	33.80043461	-8.239020696	2	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4025	10266	0.007305669	0.014708747	5	2	EN-L4	40	16	16
AGTAGTCGTAGGGTAC-1_7_D5	33.15767185	15.85000466	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1140	1692	0.005319149	0.04964539	5	14	Microglia	40	16	16
AGTAGTCTCAACGGGA-1_7_D5	1.343971707	15.1766814	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	886	1346	0.004457652	0.014858841	5	oligos	OL-Cntl	40	16	16
AGTAGTCTCGGTTAAC-1_7_D5	0.016669496	8.457717426	5	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1237	1945	0.008226221	0.040616967	5	oligos	OL-MS-1	40	16	16
AGTCTTTAGATGTCGG-1_7_D5	-36.72243132	-3.722126445	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1254	2123	0.000942063	0.000942063	5	9	OPC	40	16	16
AGTCTTTCAATGCCAT-1_7_D5	6.534801335	11.20645764	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1141	1940	0.012886598	0.021134021	5	oligos	OL-Cntl	40	16	16
AGTCTTTCATACTCTT-1_7_D5	-38.17478119	-0.908006937	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1498	2690	0.004089219	0.002230483	5	9	OPC	40	16	16
AGTCTTTGTAAGAGGA-1_7_D5	34.51622044	-5.584832188	2	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3079	6100	0.010983607	0.00704918	5	2	EN-L4	40	16	16
AGTCTTTGTGATAAGT-1_7_D5	0.39065096	18.8471256	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	765	1149	0	0.003481288	5	oligos	OL-Cntl	40	16	16
AGTCTTTGTGTTGAGG-1_7_D5	6.427931063	-16.2384803	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3214	6253	0.006876699	0.005757237	5	L2-3	EN-L2-3-MS	40	16	16
AGTGAGGAGACTGGGT-1_7_D5	39.07682284	9.867251397	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	879	1207	0.005799503	0.004142502	5	14	Microglia	40	16	16
AGTGAGGAGCTGGAAC-1_7_D5	-18.85576296	28.2095	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2306	4892	0.003679477	0.010016353	5	8	Astrocytes	40	16	16
AGTGAGGCAATGAAAC-1_7_D5	2.542679444	11.50304352	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1074	1664	0.018028846	0.018028846	5	oligos	OL-Cntl	40	16	16
AGTGAGGCAGGAATGC-1_7_D5	6.508131572	-20.79334163	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4944	13898	0.010073392	0.008058713	5	L2-3	EN-L2-3-MS	40	16	16
AGTGAGGGTAAACCTC-1_7_D5	-35.52945922	-6.57287871	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1190	1761	0.002271437	0.002839296	5	9	OPC	40	16	16
AGTGAGGGTGATGTCT-1_7_D5	3.55024501	27.54553155	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	713	1002	0.011976048	0.001996008	5	oligos	OL-Cntl	40	16	16
AGTGAGGTCAGCGATT-1_7_D5	12.26121864	-6.167210279	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1676	3176	0.047544081	0.008816121	5	3	EN-L5-6	40	16	16
AGTGAGGTCAGGTAAA-1_7_D5	-1.858864439	17.84592897	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	738	1106	0.002712477	0.013562387	5	oligos	OL-Cntl	40	16	16
AGTGGGAAGGATCGCA-1_7_D5	-35.38822926	0.152709661	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1625	3015	0.004311774	0.005638474	5	9	OPC	40	16	16
AGTGGGAAGTCTTGCA-1_7_D5	32.96302749	14.87484936	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	775	1045	0.001913876	0.059330144	5	14	Microglia	40	16	16
AGTGGGACACAGCGTC-1_7_D5	3.078961994	13.4126367	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	993	1498	0.004672897	0.012016021	5	oligos	OL-Cntl	40	16	16
AGTGGGACATCAGTAC-1_7_D5	13.00689729	10.78206865	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1413	2252	0.000888099	0.011545293	5	oligos	OL-Cntl	40	16	16
AGTGGGAGTATGAATG-1_7_D5	14.79236343	16.05575563	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1209	1937	0.005162623	0.010841507	5	oligos	OL-Cntl	40	16	16
AGTGGGAGTGCTAGCC-1_7_D5	32.73535995	15.61969067	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1074	1445	0.002076125	0.04567474	5	14	Microglia	40	16	16
AGTGGGATCAGTCAGT-1_7_D5	-14.82560707	0.938811909	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2994	6085	0.002629417	0.020542317	5	13A	IN-VIP	40	16	16
AGTGGGATCCATGCTC-1_7_D5	-4.395636571	20.7103085	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	726	1001	0.008991009	0.012987013	5	oligos	OL-Cntl	40	16	16
AGTGGGATCTTTAGTC-1_7_D5	-26.51712915	13.59692343	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1019	1672	0.002990431	0.003588517	5	8	Astrocytes	40	16	16
AGTGTCAAGATTACCC-1_7_D5	30.60605397	15.35415115	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	848	1197	0.010860485	0.115288221	5	14	Microglia	40	16	16
AGTGTCAAGCCAACAG-1_7_D5	38.14251299	10.95685684	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	935	1303	0.003837299	0.013046815	5	14	Microglia	40	16	16
AGTGTCAAGCCATCGC-1_7_D5	2.539143194	11.71579221	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1102	1600	0.01	0.023125	5	oligos	OL-Cntl	40	16	16
AGTGTCAAGCTTTGGT-1_7_D5	19.80182547	-28.53542191	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3778	9980	0.002204409	0.006112224	5	3	EN-L5-6	40	16	16
AGTGTCACAACAACCT-1_7_D5	4.760186876	-5.439010068	12	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1213	2310	0.017748918	0.003463203	5	12	EN-MIX	40	16	16
AGTGTCAGTAGCACGA-1_7_D5	-30.68680248	1.010646927	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1822	3090	0.009708738	0.007119741	5	9	OPC	40	16	16
AGTGTCATCAAGAAGT-1_7_D5	-9.535898255	-16.5191041	6B	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	895	1375	0.084363636	0.002909091	5	6B	IN-SST	40	16	16
AGTTGGTAGTCATGCT-1_7_D5	-32.13535843	-7.817272875	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1157	1614	0.006195787	0.006815366	5	9	OPC	40	16	16
AGTTGGTAGTCCCACG-1_7_D5	8.36072729	14.33054613	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1016	1562	0.011523688	0.019846351	5	oligos	OL-Cntl	40	16	16
AGTTGGTCAAAGGTGC-1_7_D5	-2.073061393	15.01494925	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	801	1183	0.010989011	0.020287405	5	oligos	OL-Cntl	40	16	16
AGTTGGTCACCGCTAG-1_7_D5	-24.93771076	25.90277784	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1417	2627	0.000761325	0.003045299	5	8	Astrocytes	40	16	16
AGTTGGTGTAACGTTC-1_7_D5	34.3554702	14.77997773	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	873	1221	0.014742015	0.031941032	5	14	Microglia	40	16	16
AGTTGGTGTTCACGGC-1_7_D5	2.979398727	11.38156308	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	994	1454	0.008253095	0.028198074	5	oligos	OL-Cntl	40	16	16
AGTTGGTTCGAACTGT-1_7_D5	22.04616312	14.84406452	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1309	2090	0.002870813	0.007655502	5	oligos	OL-Cntl	40	16	16
ATAACGCAGCCCAATT-1_7_D5	30.91173126	-1.604384605	2	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3341	8652	0.011789182	0.003236246	5	2	EN-L4	40	16	16
ATAACGCCAAAGGCGT-1_7_D5	-17.52701971	-10.53464139	13B	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4032	10863	0.001380834	0.005707447	5	13B	IN-SV2C	40	16	16
ATAACGCGTACTCTCC-1_7_D5	13.7059848	10.3878494	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1339	2320	0.001293103	0.010344828	5	oligos	OL-Cntl	40	16	16
ATAACGCGTCAAGCGA-1_7_D5	-14.43768311	1.149947669	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3371	7188	0.00375626	0.011268781	5	13A	IN-VIP	40	16	16
ATAACGCTCCACGCAG-1_7_D5	22.41241417	-27.09522789	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	7163	26709	0.003407091	0.00599049	5	3	EN-L5-6	40	16	16
ATAACGCTCTAACTGG-1_7_D5	16.15717482	8.469007163	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1709	2997	0.001334668	0.008341675	5	oligos	OL-Cntl	40	16	16
ATAAGAGAGGACCACA-1_7_D5	11.90696076	-5.561891648	12	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1292	2167	0.033225658	0.003230272	5	12	EN-MIX	40	16	16
ATAAGAGCAATGGTCT-1_7_D5	-34.45972777	0.981734115	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1740	3276	0.002747253	0.007326007	5	9	OPC	40	16	16
ATAAGAGCATCGATTG-1_7_D5	8.50195857	11.93708021	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1131	1865	0.004825737	0.011796247	5	oligos	OL-Cntl	40	16	16
ATAAGAGGTATGGTTC-1_7_D5	-0.762664834	18.38472092	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	721	1058	0.002835539	0.008506616	5	oligos	OL-Cntl	40	16	16
ATAAGAGTCACTTACT-1_7_D5	-35.9271795	-3.348400065	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1253	2042	0	0.003917728	5	9	OPC	40	16	16
ATAAGAGTCCCACTTG-1_7_D5	6.963170593	-21.61189195	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	5065	15352	0.011920271	0.007100052	5	L2-3	EN-L2-3-MS	40	16	16
ATAGACCAGTCGCCGT-1_7_D5	-20.65594407	28.8769307	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2007	4020	0.003482587	0.008208955	5	8	Astrocytes	40	16	16
ATAGACCCAAAGCGGT-1_7_D5	11.17993026	18.72334049	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1042	1679	0.00238237	0.005360334	5	oligos	OL-Cntl	40	16	16
ATAGACCCATCGGAAG-1_7_D5	15.08885358	-27.5213114	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3090	7112	0.02348144	0.002952756	5	3	EN-L5-6	40	16	16
ATAGACCGTACTCAAC-1_7_D5	37.2742139	9.994274412	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	757	1009	0.00099108	0.011892963	5	14	Microglia	40	16	16
ATAGACCTCCGATATG-1_7_D5	7.069563636	-18.78684438	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4697	12754	0.004155559	0.018033558	5	L2-3	EN-L2-3-MS	40	16	16
ATAGACCTCGTCTGAA-1_7_D5	13.45990265	-7.64458843	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2282	4951	0.028883054	0.002625732	5	3	EN-L5-6	40	16	16
ATCACGAAGATGGGTC-1_7_D5	25.51497501	-27.42647665	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4437	11923	0.001174201	0.004025832	5	3	EN-L5-6	40	16	16
ATCACGAAGTGATCGG-1_7_D5	-2.575009186	14.81271761	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	726	1028	0.013618677	0.023346304	5	oligos	OL-Cntl	40	16	16
ATCACGACACATTAGC-1_7_D5	5.795477925	-18.73535122	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4588	13437	0.007293295	0.012577212	5	L2-3	EN-L2-3-MS	40	16	16
ATCACGACACTTCTGC-1_7_D5	4.868713714	14.15226482	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1025	1652	0.006658596	0.013317191	5	oligos	OL-Cntl	40	16	16
ATCACGATCCTGTAGA-1_7_D5	15.65788595	11.58325579	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1338	2288	0	0.005681818	5	oligos	OL-Cntl	40	16	16
ATCACGATCGGAAACG-1_7_D5	11.62069875	0.359404905	12	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1036	1892	0.007928118	0.003699789	5	12	EN-MIX	40	16	16
ATCATCTCAGTCTTCC-1_7_D5	9.507249914	13.49585127	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1141	2024	0.003458498	0.008399209	5	oligos	OL-Cntl	40	16	16
ATCATCTGTAAGTAGT-1_7_D5	10.30281131	22.3050167	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	924	1481	0.016205267	0.004726536	5	oligos	OL-Cntl	40	16	16
ATCATCTGTCACCTAA-1_7_D5	5.761148689	26.29218855	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	834	1190	0	0.008403361	5	oligos	OL-Cntl	40	16	16
ATCATCTGTCATATGC-1_7_D5	-20.08863867	30.40841997	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2639	5818	0.005843933	0.005156411	5	8	Astrocytes	40	16	16
ATCATCTGTCCAGTGC-1_7_D5	-19.28050084	28.98343587	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2596	5594	0.00303897	0.006435467	5	8	Astrocytes	40	16	16
ATCATCTTCGCTAGCG-1_7_D5	8.680805001	13.49028124	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1135	1854	0.008629989	0.008629989	5	oligos	OL-Cntl	40	16	16
ATCATCTTCGGGAGTA-1_7_D5	-25.00134287	25.14595585	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1667	3235	0.00309119	0.004327666	5	8	Astrocytes	40	16	16
ATCATGGAGGCGCTCT-1_7_D5	-18.76607641	29.06640309	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2744	6230	0.0105939	0.006741573	5	8	Astrocytes	40	16	16
ATCATGGAGTCAAGGC-1_7_D5	13.8503118	16.83625647	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1045	1507	0.00199071	0.00796284	5	oligos	OL-Cntl	40	16	16
ATCATGGAGTTCGCAT-1_7_D5	8.095267689	15.03826238	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1075	1722	0.004065041	0.010452962	5	oligos	OL-Cntl	40	16	16
ATCATGGCACATTTCT-1_7_D5	-36.18274596	-0.725093991	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1399	2384	0.001258389	0.003775168	5	9	OPC	40	16	16
ATCATGGCAGGTGGAT-1_7_D5	-26.1898314	-22.54732286	6A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4314	10220	0.022113503	0.016438356	5	6A	IN-PV	40	16	16
ATCATGGCATACGCCG-1_7_D5	14.01203068	7.745964997	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1981	3643	0.003568488	0.010430963	5	oligos	OL-Cntl	40	16	16
ATCATGGGTTCCCTTG-1_7_D5	9.696302963	12.74148137	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1191	1999	0.006003002	0.011005503	5	oligos	OL-Cntl	40	16	16
ATCATGGTCCTGTAGA-1_7_D5	-9.93313992	0.02937012	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2701	5993	0.012180878	0.00500584	5	13A	IN-VIP	40	16	16
ATCATGGTCGGTTCGG-1_7_D5	34.17503659	15.34174928	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	899	1213	0	0.045342127	5	14	Microglia	40	16	16
ATCATGGTCTTGCAAG-1_7_D5	-37.20630308	2.954692652	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1887	3608	0.000831486	0.002217295	5	9	OPC	40	16	16
ATCCACCAGAAGGTTT-1_7_D5	31.0199239	16.15132647	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1300	1937	0.00464636	0.081569437	5	14	Microglia	40	16	16
ATCCACCAGTGCCATT-1_7_D5	-25.12345901	8.452319249	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1182	2214	0.116982836	0.006323397	5	8	Astrocytes	40	16	16
ATCCACCCAAGCTGTT-1_7_D5	6.500958882	30.35639097	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	774	1140	0.007017544	0.001754386	5	oligos	OL-Cntl	40	16	16
ATCCACCCAGCCTATA-1_7_D5	38.19318632	14.64302813	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1211	1800	0.001666667	0.01	5	14	Microglia	40	16	16
ATCCACCCATTGTGCA-1_7_D5	13.43354823	0.937090221	12	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	821	1101	0.005449591	0.004541326	5	12	EN-MIX	40	16	16
ATCCACCGTCATTAGC-1_7_D5	10.55629897	18.38429712	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1051	1764	0.003401361	0.004535147	5	oligos	OL-Cntl	40	16	16
ATCCACCTCGCTGATA-1_7_D5	10.5898701	-18.59187118	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	5185	14119	0.014306962	0.007224308	5	L2-3	EN-L2-3-MS	40	16	16
ATCCACCTCGTCCGTT-1_7_D5	-26.83968847	12.59223256	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	915	1496	0.004010695	0.003342246	5	8	Astrocytes	40	16	16
ATCCACCTCTGCGGCA-1_7_D5	-16.7871629	-5.37340795	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3800	7569	0.01598626	0.011362135	5	13A	IN-VIP	40	16	16
ATCCGAAAGTGAAGAG-1_7_D5	8.993632658	26.72681118	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	915	1521	0.011176857	0.006574622	5	oligos	OL-Cntl	40	16	16
ATCCGAAAGTGTACGG-1_7_D5	-32.93246192	5.269452726	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2906	5705	0.005258545	0.009465381	5	9	OPC	40	16	16
ATCCGAACACACAGAG-1_7_D5	-29.57946198	21.75386424	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1081	1874	0.009605123	0.002134472	5	8	Astrocytes	40	16	16
ATCCGAACACAGACTT-1_7_D5	5.512468526	5.424166325	7	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2854	5383	0.00260078	0.040683634	5	7	Phagocytes	40	16	16
ATCCGAACACCACCAG-1_7_D5	37.10589734	11.02759572	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	860	1189	0.001682086	0.019343987	5	14	Microglia	40	16	16
ATCCGAACACGCATCG-1_7_D5	-3.141808972	17.57661037	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	852	1203	0.00166251	0.010806318	5	oligos	OL-Cntl	40	16	16
ATCCGAACAGATGGCA-1_7_D5	14.97328999	11.23651997	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1444	2551	0.001568013	0.005488044	5	oligos	OL-Cntl	40	16	16
ATCCGAATCGAGAACG-1_7_D5	7.273390531	-20.11364701	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	6415	19624	0.006624541	0.008255198	5	L2-3	EN-L2-3-MS	40	16	16
ATCCGAATCGGAAATA-1_7_D5	-17.48016161	1.663171995	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4881	10796	0.010652093	0.019636903	5	13A	IN-VIP	40	16	16
ATCGAGTCAACTGCTA-1_7_D5	-3.926255825	15.05727923	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	917	1343	0.015636634	0.019359643	5	oligos	OL-Cntl	40	16	16
ATCGAGTCAAGTACCT-1_7_D5	20.55330544	-29.59160014	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4187	12173	0.001478682	0.002957365	5	3	EN-L5-6	40	16	16
ATCGAGTCACTTACGA-1_7_D5	1.260361449	21.14899392	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	761	1099	0.002729754	0.007279345	5	oligos	OL-Cntl	40	16	16
ATCGAGTCAGCGTAAG-1_7_D5	4.513534964	15.85356407	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1160	1899	0.003686151	0.008425487	5	oligos	OL-Cntl	40	16	16
ATCGAGTGTACCATCA-1_7_D5	19.76904424	-29.49781579	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	7785	30919	0.000905592	0.003687053	5	3	EN-L5-6	40	16	16
ATCGAGTGTCAAGCGA-1_7_D5	14.30066812	10.65042184	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1365	2278	0.001755926	0.008779631	5	oligos	OL-Cntl	40	16	16
ATCGAGTGTGAGTGAC-1_7_D5	10.40426822	-1.856609635	12	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1537	2526	0.018606492	0.011084719	5	12	EN-MIX	40	16	16
ATCGAGTGTTGGACCC-1_7_D5	-1.186183053	16.35325517	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	769	1120	0.007142857	0.016964286	5	oligos	OL-Cntl	40	16	16
ATCTACTAGGGTGTTG-1_7_D5	38.60403256	14.83662871	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	989	1361	0.005143277	0.014695077	5	14	Microglia	40	16	16
ATCTACTAGTGTTGAA-1_7_D5	-28.344304	12.96998075	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	815	1233	0.00243309	0.00486618	5	8	Astrocytes	40	16	16
ATCTACTCACACCGCA-1_7_D5	9.461344366	28.17518578	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	931	1477	0.00338524	0.004739336	5	oligos	OL-Cntl	40	16	16
ATCTACTCACGACTCG-1_7_D5	30.93270117	15.28410591	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	863	1176	0.011054422	0.087585034	5	14	Microglia	40	16	16
ATCTACTCATGCTAGT-1_7_D5	-34.70106227	2.446351344	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1899	3499	0.000857388	0.003143755	5	9	OPC	40	16	16
ATCTACTCATTCCTGC-1_7_D5	17.74335127	8.296589455	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1816	3578	0.004471772	0.004751258	5	oligos	OL-Cntl	40	16	16
ATCTACTGTAGTACCT-1_7_D5	-35.24507409	2.903699169	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2006	4137	0.000483442	0.005801305	5	9	OPC	40	16	16
ATCTACTGTCCCTTGT-1_7_D5	7.938253404	-21.20981113	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	6545	23558	0.005348502	0.005306053	5	L2-3	EN-L2-3-MS	40	16	16
ATCTACTGTCGAAAGC-1_7_D5	1.26827151	14.83738881	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	891	1299	0	0.017705928	5	oligos	OL-Cntl	40	16	16
ATCTACTGTCTAGTGT-1_7_D5	-15.07349502	-6.398838091	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4973	14915	0.011330875	0.004961448	5	13A	IN-VIP	40	16	16
ATCTACTTCACCGGGT-1_7_D5	9.639585248	-24.20449398	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	8203	36384	0.004782322	0.004782322	5	L2-3	EN-L2-3-MS	40	16	16
ATCTACTTCCGTCAAA-1_7_D5	-31.31329359	-12.52335988	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	805	1339	0.002240478	0.002240478	5	9	OPC	40	16	16
ATCTACTTCTAACCGA-1_7_D5	4.946882093	10.57559818	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1183	1894	0.007391763	0.020063358	5	oligos	OL-Cntl	40	16	16
ATCTGCCAGAATGTGT-1_7_D5	0.216235285	16.49308971	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	849	1246	0.009630819	0.009630819	5	oligos	OL-Cntl	40	16	16
ATCTGCCAGGCGTACA-1_7_D5	-21.41397783	20.0940124	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2276	4892	0.000408831	0.002452984	5	8	Astrocytes	40	16	16
ATCTGCCAGTGGCACA-1_7_D5	-21.50342929	25.83850814	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1662	3212	0.000933998	0.00498132	5	8	Astrocytes	40	16	16
ATCTGCCAGTTAGCGG-1_7_D5	-20.93109309	10.15086703	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1205	2108	0.00142315	0.004743833	5	8	Astrocytes	40	16	16
ATCTGCCCAAACGCGA-1_7_D5	-36.90005007	2.161407337	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1689	3250	0.006153846	0.002769231	5	9	OPC	40	16	16
ATCTGCCGTGAAGGCT-1_7_D5	35.38051637	15.37436922	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1125	1517	0.000659196	0.02504944	5	14	Microglia	40	16	16
ATCTGCCTCACAACGT-1_7_D5	3.452861261	15.74820884	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	974	1475	0.016949153	0.012881356	5	oligos	OL-Cntl	40	16	16
ATCTGCCTCCAGATCA-1_7_D5	12.4496883	-6.447156258	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1912	3823	0.01621763	0.003662046	5	3	EN-L5-6	40	16	16
ATCTGCCTCGAATGCT-1_7_D5	-0.282231795	20.53883161	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	726	1102	0.003629764	0.009981851	5	oligos	OL-Cntl	40	16	16
ATGAGGGAGATCACGG-1_7_D5	1.862878935	12.06363553	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	826	1212	0.002475248	0.018976898	5	oligos	OL-Cntl	40	16	16
ATGAGGGAGCCAACAG-1_7_D5	9.566440481	13.1310746	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1135	1815	0.003305785	0.011570248	5	oligos	OL-Cntl	40	16	16
ATGAGGGAGTAGATGT-1_7_D5	-34.98547692	2.431497681	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1783	3021	0.001655081	0.007613373	5	9	OPC	40	16	16
ATGAGGGCAAGCCCAC-1_7_D5	-30.89653824	1.890332334	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2081	3803	0.005521956	0.007888509	5	9	OPC	40	16	16
ATGAGGGCACATCCGG-1_7_D5	-22.17922424	24.40713287	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1732	3065	0.005872757	0.004893964	5	8	Astrocytes	40	16	16
ATGAGGGGTCAGGACA-1_7_D5	-19.14089004	-3.989304578	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	5088	13566	0.022703818	0.010246204	5	13A	IN-VIP	40	16	16
ATGAGGGGTCATCGGC-1_7_D5	-33.65821824	-0.505194434	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1752	3041	0.007234462	0.011180533	5	9	OPC	40	16	16
ATGAGGGGTTACTGAC-1_7_D5	37.3201221	11.09954315	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	903	1251	0.000799361	0.023980815	5	14	Microglia	40	16	16
ATGAGGGTCCGTAGGC-1_7_D5	15.38875534	8.864666897	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1547	2911	0.004122295	0.010649261	5	oligos	OL-Cntl	40	16	16
ATGCGATCACGGTAAG-1_7_D5	19.67418613	10.92022923	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1566	2808	0.000712251	0.004273504	5	oligos	OL-Cntl	40	16	16
ATGCGATGTCACTGGC-1_7_D5	25.026454	-27.42621635	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	5092	15077	0.007693838	0.003979572	5	3	EN-L5-6	40	16	16
ATGCGATGTTCCAACA-1_7_D5	7.18695063	-20.97305025	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	5850	17869	0.004700879	0.012871453	5	L2-3	EN-L2-3-MS	40	16	16
ATGCGATTCCTTCAAT-1_7_D5	-37.02485273	2.387267227	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1792	3576	0.005872483	0.002796421	5	9	OPC	40	16	16
ATGCGATTCGCAAGCC-1_7_D5	37.93093401	13.89654614	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1147	1664	0.015024038	0.011418269	5	14	Microglia	40	16	16
ATGCGATTCTGATACG-1_7_D5	9.944540433	20.83883485	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	865	1289	0.010861133	0.010861133	5	oligos	OL-Cntl	40	16	16
ATGCGATTCTTGAGGT-1_7_D5	5.101631376	5.815681245	7	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1921	3115	0.003210273	0.01187801	5	7	Phagocytes	40	16	16
ATGGGAGCACAACTGT-1_7_D5	30.52057222	15.66213331	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1049	1539	0.005198181	0.119558155	5	14	Microglia	40	16	16
ATGGGAGCACGTTGGC-1_7_D5	12.8943529	-7.120588424	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2718	5943	0.007403668	0.006730607	5	3	EN-L5-6	40	16	16
ATGGGAGCAGCTTCGG-1_7_D5	8.850192013	-16.66395524	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3928	9680	0.013533058	0.011983471	5	L2-3	EN-L2-3-MS	40	16	16
ATGGGAGTCCCGGATG-1_7_D5	-31.14611615	-0.319139831	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1821	3214	0.016801493	0.005911637	5	9	OPC	40	16	16
ATGTGTGAGAACAACT-1_7_D5	-14.06637111	-19.94581302	6B	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1354	2288	0.008304196	0.011363636	5	6B	IN-SST	40	16	16
ATGTGTGAGTCTCAAC-1_7_D5	38.83977252	12.81118949	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	962	1339	0.00746826	0.012696042	5	14	Microglia	40	16	16
ATGTGTGCAGACGCCT-1_7_D5	6.292629054	19.74685476	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1018	1595	0.019435737	0.008777429	5	oligos	OL-Cntl	40	16	16
ATGTGTGCAGATGGGT-1_7_D5	8.297149139	-17.27064688	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3760	8109	0.008015785	0.022197558	5	L2-3	EN-L2-3-MS	40	16	16
ATGTGTGCAGGAATGC-1_7_D5	-0.57212392	16.71735617	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	902	1359	0.012509198	0.019131714	5	oligos	OL-Cntl	40	16	16
ATGTGTGCATCCCACT-1_7_D5	8.832931136	-20.77525806	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	6280	21123	0.006817213	0.004592151	5	L2-3	EN-L2-3-MS	40	16	16
ATGTGTGGTAGCGCAA-1_7_D5	37.606844	10.20634876	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	874	1200	0.001666667	0.0075	5	14	Microglia	40	16	16
ATGTGTGGTTAAAGAC-1_7_D5	-19.79181867	28.94485016	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2336	4947	0.002829998	0.004244997	5	8	Astrocytes	40	16	16
ATGTGTGTCGATCCCT-1_7_D5	2.708634567	25.70011392	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	674	1025	0.014634146	0.006829268	5	oligos	OL-Cntl	40	16	16
ATTACTCAGATAGTCA-1_7_D5	20.58465037	-33.17701034	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4885	15554	0.010608204	0.003857529	5	3	EN-L5-6	40	16	16
ATTACTCAGATGTTAG-1_7_D5	-14.10268017	-1.754366584	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2052	3560	0.006179775	0.017977528	5	13A	IN-VIP	40	16	16
ATTACTCAGTTGAGTA-1_7_D5	-10.39847557	12.60867915	11	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1032	1689	0.013617525	0.006512729	5	11	Glia-MIX	40	16	16
ATTACTCCAACTGCTA-1_7_D5	15.58688622	10.74154255	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1386	2354	0.010195412	0.005522515	5	oligos	OL-Cntl	40	16	16
ATTACTCCAAGTACCT-1_7_D5	-0.735986026	14.10670852	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	784	1108	0.009025271	0.013537906	5	oligos	OL-Cntl	40	16	16
ATTACTCGTCAGAATA-1_7_D5	-35.56725417	-4.705651194	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1403	2574	0.004273504	0.003108003	5	9	OPC	40	16	16
ATTACTCTCAACGCTA-1_7_D5	-28.08049442	13.75724822	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	888	1468	0.00613079	0.005449591	5	8	Astrocytes	40	16	16
ATTACTCTCTGAAAGA-1_7_D5	-0.546710953	1.087352415	11	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1539	2497	0.020424509	0.010812976	5	11	Glia-MIX	40	16	16
ATTATCCAGAGCTGGT-1_7_D5	-19.32929831	28.79495983	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2444	5224	0.002871363	0.006316998	5	8	Astrocytes	40	16	16
ATTATCCAGATCCCAT-1_7_D5	39.10585052	16.16654352	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1587	2649	0.003020008	0.013967535	5	14	Microglia	40	16	16
ATTATCCCAAACCTAC-1_7_D5	16.58689908	6.628665161	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2109	4245	0.001413428	0.006124853	5	oligos	OL-Cntl	40	16	16
ATTATCCCATAAAGGT-1_7_D5	35.17254284	15.82985199	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1158	1613	0.000619963	0.03533788	5	14	Microglia	40	16	16
ATTATCCGTCCCGACA-1_7_D5	9.635694693	15.76642321	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	957	1520	0.005263158	0.003289474	5	oligos	OL-Cntl	40	16	16
ATTATCCGTCGTGGCT-1_7_D5	1.379968382	20.58230505	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	822	1250	0.0136	0.0064	5	oligos	OL-Cntl	40	16	16
ATTATCCGTCTAGGTT-1_7_D5	-26.9574795	18.89019523	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1370	2376	0	0.002525253	5	8	Astrocytes	40	16	16
ATTATCCGTTACGGAG-1_7_D5	15.84407775	6.328763699	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2056	3969	0.021415974	0.007054674	5	oligos	OL-Cntl	40	16	16
ATTATCCGTTCGCGAC-1_7_D5	-33.48876401	2.253531897	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2007	3811	0.006035161	0.010758331	5	9	OPC	40	16	16
ATTATCCTCACAATGC-1_7_D5	-36.88225369	2.896741807	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1924	3953	0.002529724	0.003288642	5	9	OPC	40	16	16
ATTATCCTCGAACTGT-1_7_D5	-1.621327023	-21.89373096	10	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3547	9738	0.003902239	0.002772643	5	L2-3	EN-L2-3-Cntl	40	16	16
ATTCTACAGCGCCTCA-1_7_D5	1.770359941	18.64158219	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	819	1303	0.015349194	0.006907137	5	oligos	OL-Cntl	40	16	16
ATTCTACCACGGCTAC-1_7_D5	-8.561912926	7.597452369	15DA	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	761	1262	0.001584786	0.019809826	5	15DA	T cells	40	16	16
ATTCTACCATGCAATC-1_7_D5	13.38336871	13.44257967	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1189	2093	0.006688963	0.003822265	5	oligos	OL-Cntl	40	16	16
ATTCTACGTAAATGAC-1_7_D5	31.30667221	15.34759843	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	956	1322	0.012102874	0.072617247	5	14	Microglia	40	16	16
ATTCTACTCAACACCA-1_7_D5	9.596202649	12.93826085	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1092	1820	0.003296703	0.007692308	5	oligos	OL-Cntl	40	16	16
ATTCTACTCGCATGGC-1_7_D5	29.98849036	15.6245457	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1133	1777	0.008441193	0.167698368	5	14	Microglia	40	16	16
ATTGGACAGATCCTGT-1_7_D5	6.190910974	-17.84048769	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3376	8002	0.017245689	0.010122469	5	L2-3	EN-L2-3-MS	40	16	16
ATTGGACAGCCTATGT-1_7_D5	0.14720186	24.21743464	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	778	1101	0.004541326	0.009082652	5	oligos	OL-Cntl	40	16	16
ATTGGACAGTGACATA-1_7_D5	-19.68638843	27.2790263	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1947	3554	0.000562746	0.009566685	5	8	Astrocytes	40	16	16
ATTGGACGTCAGAATA-1_7_D5	12.87282736	13.55353853	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1240	2087	0.005270724	0.00574988	5	oligos	OL-Cntl	40	16	16
ATTGGACGTCAGAGGT-1_7_D5	-19.95029808	28.51561948	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2410	4803	0.004372267	0.00582969	5	8	Astrocytes	40	16	16
ATTGGACGTTGATTCG-1_7_D5	2.473907182	21.10539241	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	918	1408	0.013494318	0.004261364	5	oligos	OL-Cntl	40	16	16
ATTGGACTCCAAACTG-1_7_D5	7.848844179	9.430587649	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1315	2165	0.011547344	0.013394919	5	oligos	OL-Cntl	40	16	16
ATTGGTGAGTGGGCTA-1_7_D5	-23.75856325	19.09965249	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1354	2275	0.00043956	0.007032967	5	8	Astrocytes	40	16	16
ATTGGTGCACCTTGTC-1_7_D5	-25.12761893	25.44864099	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1584	3244	0.001541307	0.00431566	5	8	Astrocytes	40	16	16
ATTGGTGCACTTGGAT-1_7_D5	13.74236198	9.591963068	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1403	2494	0.007217322	0.006415397	5	oligos	OL-Cntl	40	16	16
ATTGGTGCAGTAGAGC-1_7_D5	11.80984379	-5.373754027	12	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1275	2089	0.014839636	0.004786979	5	12	EN-MIX	40	16	16
ATTGGTGGTGCACTTA-1_7_D5	-2.241616634	23.59022252	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	743	1000	0.023	0.005	5	oligos	OL-Cntl	40	16	16
ATTGGTGGTTGTGGAG-1_7_D5	15.49111972	-7.94229262	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2291	4714	0.011243106	0.002757743	5	3	EN-L5-6	40	16	16
ATTGGTGGTTTCGCTC-1_7_D5	9.124384996	10.50646183	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1159	1944	0.002572016	0.005658436	5	oligos	OL-Cntl	40	16	16
ATTTCTGCAAGTCTGT-1_7_D5	-25.53407282	22.19585546	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1290	2070	0.001449275	0.004830918	5	8	Astrocytes	40	16	16
ATTTCTGCAGGTCCAC-1_7_D5	-12.10229268	1.049317647	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3152	7612	0.009721492	0.003809774	5	13A	IN-VIP	40	16	16
ATTTCTGCAGTTCCCT-1_7_D5	-22.76286994	-1.073729845	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1160	1781	0.001684447	0.003368894	5	9	OPC	40	16	16
ATTTCTGCATTACCTT-1_7_D5	9.691452251	21.5939239	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	798	1318	0.003793627	0.005311077	5	oligos	OL-Cntl	40	16	16
ATTTCTGGTGCTGTAT-1_7_D5	10.07848658	14.13668296	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1075	1764	0.002834467	0.007369615	5	oligos	OL-Cntl	40	16	16
ATTTCTGGTGGGTATG-1_7_D5	15.14530471	9.457120052	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1574	2767	0.001445609	0.009035056	5	oligos	OL-Cntl	40	16	16
CAACCAAAGGACTGGT-1_7_D5	-9.803399339	-2.735325916	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2314	4268	0.00398313	0.008434864	5	13A	IN-VIP	40	16	16
CAACCAACACTGAAGG-1_7_D5	0.018504086	18.71901867	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	779	1126	0.007992895	0.011545293	5	oligos	OL-Cntl	40	16	16
CAACCAACATGCTGGC-1_7_D5	1.447837457	18.21415073	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	712	1045	0.002870813	0.010526316	5	oligos	OL-Cntl	40	16	16
CAACCAAGTATGAAAC-1_7_D5	-6.773411597	-0.88197836	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1797	3390	0.009144543	0.002064897	5	13A	IN-VIP	40	16	16
CAACCAAGTTTGGCGC-1_7_D5	-19.58112092	29.60224991	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2522	5116	0.006059421	0.006254887	5	8	Astrocytes	40	16	16
CAACCAAGTTTGTTTC-1_7_D5	24.14333836	-29.09300261	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4635	15465	0.006595538	0.002263175	5	3	EN-L5-6	40	16	16
CAACCAATCACAAACC-1_7_D5	2.037402077	15.78459669	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	887	1322	0.017397882	0.019667171	5	oligos	OL-Cntl	40	16	16
CAACCAATCATAGCAC-1_7_D5	-37.59430867	-9.829403319	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	968	2028	0.00443787	0.00147929	5	9	OPC	40	16	16
CAACCAATCATCTGTT-1_7_D5	-35.11797124	5.181012551	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2931	6895	0.000145033	0.002175489	5	9	OPC	40	16	16
CAACCAATCGAGAACG-1_7_D5	-14.88025816	-18.17403497	6B	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1574	2820	0.054964539	0.003546099	5	6B	IN-SST	40	16	16
CAACCTCAGAACTCGG-1_7_D5	-16.59239603	1.649991505	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4195	9671	0.007755144	0.016027298	5	13A	IN-VIP	40	16	16
CAACCTCAGATGTGTA-1_7_D5	-9.896448811	22.91848543	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1700	2804	0.004636234	0.009272468	5	8	Astrocytes	40	16	16
CAACCTCCACCGAATT-1_7_D5	11.32526857	8.937291238	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1599	2930	0.004095563	0.006825939	5	oligos	OL-Cntl	40	16	16
CAACCTCGTGCAGGTA-1_7_D5	11.86485492	-5.538716059	12	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1405	2618	0.027883881	0.00381971	5	12	EN-MIX	40	16	16
CAACCTCTCAGAGGTG-1_7_D5	4.978312916	5.631046384	7	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2125	3639	0.010992031	0.009892828	5	7	Phagocytes	40	16	16
CAACCTCTCATGTCCC-1_7_D5	22.09978802	-28.01101803	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	6655	25846	0.002514896	0.005261936	5	3	EN-L5-6	40	16	16
CAACCTCTCGCTGATA-1_7_D5	-36.1308312	-6.968046145	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1110	1826	0.002190581	0.001642935	5	9	OPC	40	16	16
CAACCTCTCTCACATT-1_7_D5	30.46088847	16.15929397	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1224	1995	0.004511278	0.120300752	5	14	Microglia	40	16	16
CAACTAGCACAGATTC-1_7_D5	39.04636345	15.42167729	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1351	2060	0.000485437	0.010194175	5	14	Microglia	40	16	16
CAACTAGGTATAATGG-1_7_D5	-19.14628973	28.70087684	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2538	5841	0.015579524	0.010443417	5	8	Astrocytes	40	16	16
CAACTAGGTCTGCCAG-1_7_D5	5.84988302	31.11962072	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	735	1042	0.008637236	0.003838772	5	oligos	OL-Cntl	40	16	16
CAACTAGGTGTGCCTG-1_7_D5	-32.39408191	3.052564119	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2177	4280	0.004439252	0.009579439	5	9	OPC	40	16	16
CAACTAGTCCTTTACA-1_7_D5	36.75548465	9.56979335	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	794	1113	0	0.025157233	5	14	Microglia	40	16	16
CAAGAAAAGGCTAGCA-1_7_D5	15.93790262	6.963582646	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2117	4039	0.005199307	0.011141372	5	oligos	OL-Cntl	40	16	16
CAAGAAACACCGCTAG-1_7_D5	13.02071241	12.9672379	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1344	2279	0.003071523	0.009653357	5	oligos	OL-Cntl	40	16	16
CAAGAAAGTACAGTTC-1_7_D5	-0.92592566	-28.12693391	10	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	6750	30627	0.000261207	0.002710027	5	L2-3	EN-L2-3-Cntl	40	16	16
CAAGAAAGTGTGACGA-1_7_D5	-35.18399939	-0.02699835	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1743	3185	0.002511774	0.005965463	5	9	OPC	40	16	16
CAAGAAAGTTCTCATT-1_7_D5	-30.66625356	1.773490972	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1881	3427	0.003793405	0.009629413	5	9	OPC	40	16	16
CAAGAAATCGGATGGA-1_7_D5	-1.768485732	17.17077027	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	724	1013	0.007897335	0.008884501	5	oligos	OL-Cntl	40	16	16
CAAGAAATCGGTTCGG-1_7_D5	-32.68493375	-11.3867104	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	979	1417	0.001411433	0.004940014	5	9	OPC	40	16	16
CAAGAAATCTCAAACG-1_7_D5	12.09799967	-5.887229321	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1474	2628	0.005707763	0.001902588	5	3	EN-L5-6	40	16	16
CAAGATCAGACTGGGT-1_7_D5	-14.4301573	1.173463856	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3325	7358	0.008969829	0.017124219	5	13A	IN-VIP	40	16	16
CAAGATCAGGAGTTTA-1_7_D5	36.18120833	10.8160491	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	791	1017	0	0.020648968	5	14	Microglia	40	16	16
CAAGATCCAAGCCGCT-1_7_D5	-36.12371699	-4.237301052	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1241	1965	0.003053435	0.004580153	5	9	OPC	40	16	16
CAAGATCCACCGGAAA-1_7_D5	-12.885578	-19.26612423	6B	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1217	2177	0.041341295	0.00413413	5	6B	IN-SST	40	16	16
CAAGATCGTCGGCACT-1_7_D5	29.42589835	0.605730908	2	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2869	6259	0.013740214	0.004473558	5	2	EN-L4	40	16	16
CAAGGCCAGTAGGCCA-1_7_D5	-24.03259489	29.97304644	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1973	3973	0.002768689	0.00478228	5	8	Astrocytes	40	16	16
CAAGGCCCAGATCTGT-1_7_D5	-24.4081665	19.66430272	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1550	2882	0.001734906	0.002428869	5	8	Astrocytes	40	16	16
CAAGGCCCATAAAGGT-1_7_D5	-26.45994694	12.67555263	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	990	1514	0.001321004	0.001981506	5	8	Astrocytes	40	16	16
CAAGGCCCATCGGACC-1_7_D5	20.74506806	14.4769227	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1223	2119	0.007550731	0.004247286	5	oligos	OL-Cntl	40	16	16
CAAGGCCGTACCTACA-1_7_D5	6.406407818	-18.9878564	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3829	9316	0.005796479	0.012022327	5	L2-3	EN-L2-3-MS	40	16	16
CAAGGCCGTCCAAGTT-1_7_D5	-0.195928279	15.2401853	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	885	1293	0.005413766	0.009280742	5	oligos	OL-Cntl	40	16	16
CAAGGCCGTTAGGGTG-1_7_D5	-24.49031214	16.3268031	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1213	2141	0.005137786	0.007006072	5	8	Astrocytes	40	16	16
CAAGGCCTCATTGCGA-1_7_D5	4.266440326	-15.33419318	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2780	6025	0.014439834	0.005145228	5	L2-3	EN-L2-3-MS	40	16	16
CAAGGCCTCCGTAGTA-1_7_D5	1.920719562	23.69255313	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	726	1103	0.003626473	0.013599275	5	oligos	OL-Cntl	40	16	16
CAAGGCCTCCTTGACC-1_7_D5	2.675420429	11.48039256	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1041	1647	0.021857923	0.017000607	5	oligos	OL-Cntl	40	16	16
CAAGTTGAGATATACG-1_7_D5	-20.72788731	30.3884735	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2582	5758	0.002605071	0.0024314	5	8	Astrocytes	40	16	16
CAAGTTGCAGTGGGAT-1_7_D5	5.90541134	-18.24037269	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3574	8238	0.008861374	0.014445254	5	L2-3	EN-L2-3-MS	40	16	16
CAAGTTGCATAACCTG-1_7_D5	1.98857477	13.11217477	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1034	1671	0.007181329	0.017953321	5	oligos	OL-Cntl	40	16	16
CAAGTTGCATGACATC-1_7_D5	3.397213278	17.16318217	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	826	1212	0.00330033	0.005775578	5	oligos	OL-Cntl	40	16	16
CAAGTTGGTCATCCCT-1_7_D5	5.109173418	-22.70841621	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	5378	16951	0.007551177	0.003362633	5	L2-3	EN-L2-3-MS	40	16	16
CAAGTTGGTCTTTCAT-1_7_D5	2.933817649	6.169810532	7	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	965	1333	0.006751688	0.019504876	5	7	Phagocytes	40	16	16
CAAGTTGGTGCTTCTC-1_7_D5	2.423211168	18.70716987	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1018	1595	0.003761755	0.009404389	5	oligos	OL-Cntl	40	16	16
CAAGTTGGTGGCGAAT-1_7_D5	-16.04881538	2.2729326	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4405	10406	0.010282529	0.011916202	5	13A	IN-VIP	40	16	16
CAAGTTGGTTACTGAC-1_7_D5	-15.49709811	-17.01522895	6B	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1671	3089	0.028488184	0.004208482	5	6B	IN-SST	40	16	16
CAAGTTGTCGGTTCGG-1_7_D5	-22.54778388	18.95136899	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1632	3423	0.001460707	0.004966404	5	8	Astrocytes	40	16	16
CACAAACAGTTGTCGT-1_7_D5	-35.24703758	-4.725375342	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1253	1971	0.001014713	0.00456621	5	9	OPC	40	16	16
CACAAACGTAGCTAAA-1_7_D5	38.45436395	10.50922058	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	895	1268	0.008675079	0.018138801	5	14	Microglia	40	16	16
CACAAACGTAGCTCCG-1_7_D5	34.33992659	14.83065302	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	849	1193	0.00838223	0.039396479	5	14	Microglia	40	16	16
CACAAACGTCGACTAT-1_7_D5	38.11966755	15.4966749	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1417	2089	0.003350886	0.01388224	5	14	Microglia	40	16	16
CACAAACGTTTGACAC-1_7_D5	17.24998636	5.69886636	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3249	7588	0.006984713	0.007775435	5	oligos	OL-Cntl	40	16	16
CACAAACGTTTGTTGG-1_7_D5	11.36361177	-4.928520213	12	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	850	1333	0.030757689	0.005251313	5	12	EN-MIX	40	16	16
CACAAACTCCGTAGGC-1_7_D5	-28.43390776	20.5679747	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1122	1786	0.011198208	0.008398656	5	8	Astrocytes	40	16	16
CACAAACTCGGCGCAT-1_7_D5	-17.54533477	0.811420709	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3352	5975	0.009874477	0.024435146	5	13A	IN-VIP	40	16	16
CACACAAAGACACTAA-1_7_D5	38.1864748	12.02122882	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1038	1422	0.003516174	0.007735584	5	14	Microglia	40	16	16
CACACAAAGTCAATAG-1_7_D5	1.329591312	13.01540033	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	934	1367	0.007315289	0.01975128	5	oligos	OL-Cntl	40	16	16
CACACAAAGTCATCCA-1_7_D5	-32.39174779	3.429561499	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2338	4553	0.004392708	0.017570832	5	9	OPC	40	16	16
CACACAACACAGCGTC-1_7_D5	-37.48758595	2.905263019	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1857	3534	0.000848896	0.002829655	5	9	OPC	40	16	16
CACACAACAGGACCCT-1_7_D5	-19.13265534	29.83731583	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2859	6228	0.002408478	0.009312781	5	8	Astrocytes	40	16	16
CACACAACAGTGGGAT-1_7_D5	8.982130747	14.63916104	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1099	1794	0.005016722	0.003901895	5	oligos	OL-Cntl	40	16	16
CACACAATCAACACGT-1_7_D5	-3.988897752	18.59458963	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	832	1226	0.006525285	0.013866232	5	oligos	OL-Cntl	40	16	16
CACACAATCGTCACGG-1_7_D5	35.18926279	15.72089191	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1160	1669	0.000599161	0.032354703	5	14	Microglia	40	16	16
CACACAATCTTATCTG-1_7_D5	-14.76122305	-6.614541319	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3419	8189	0.01917206	0.002198071	5	13A	IN-VIP	40	16	16
CACACCTAGACTGGGT-1_7_D5	-19.55583662	29.75938183	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2734	6179	0.001780223	0.008091924	5	8	Astrocytes	40	16	16
CACACCTAGCTAGTGG-1_7_D5	-20.16794856	-18.69216243	6A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	5584	18306	0.00071015	0.00316836	5	6A	IN-PV	40	16	16
CACACCTAGTATTGGA-1_7_D5	14.56314732	12.83756352	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1376	2242	0.002230152	0.009366637	5	oligos	OL-Cntl	40	16	16
CACACCTCAGGAATCG-1_7_D5	32.75965661	15.06684125	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	839	1128	0.000886525	0.053191489	5	14	Microglia	40	16	16
CACACCTCATTTGCTT-1_7_D5	-0.863691297	13.99373399	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1075	1717	0.001747234	0.013395457	5	oligos	OL-Cntl	40	16	16
CACACCTGTACAAGTA-1_7_D5	-19.31883619	28.82566735	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2495	5498	0.003455802	0.007639142	5	8	Astrocytes	40	16	16
CACACCTGTCTCCACT-1_7_D5	20.60473438	-26.92775577	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4541	13687	0.015635274	0.004018412	5	3	EN-L5-6	40	16	16
CACACCTGTTAAGATG-1_7_D5	-4.204459034	21.88700468	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	764	1117	0.00179051	0.011638317	5	oligos	OL-Cntl	40	16	16
CACACCTGTTCAGGCC-1_7_D5	-34.82087496	3.827286536	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2328	4794	0.004171882	0.003963287	5	9	OPC	40	16	16
CACACCTGTTGGTGGA-1_7_D5	-39.07322747	0.363040265	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1559	2973	0.004036327	0.001681803	5	9	OPC	40	16	16
CACACCTTCACGGTTA-1_7_D5	-21.93262941	27.47979859	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1626	2986	0.000669792	0.006028131	5	8	Astrocytes	40	16	16
CACACCTTCATCACCC-1_7_D5	10.87467973	10.03863834	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1342	2243	0.003566652	0.009362461	5	oligos	OL-Cntl	40	16	16
CACACCTTCATGTCTT-1_7_D5	-25.0126218	16.99040743	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1215	2296	0.00043554	0.005662021	5	8	Astrocytes	40	16	16
CACACCTTCCTAGAAC-1_7_D5	18.24478199	16.29383584	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1216	2146	0.00139795	0.003727866	5	oligos	OL-Cntl	40	16	16
CACACCTTCGAATGGG-1_7_D5	12.50535728	7.165765323	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1835	3214	0.004667082	0.016490355	5	oligos	OL-Cntl	40	16	16
CACACTCCAAGTCTGT-1_7_D5	3.293523656	-22.14138085	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4673	14396	0.003889969	0.008335649	5	L2-3	EN-L2-3-MS	40	16	16
CACACTCCACGAAACG-1_7_D5	-33.09102927	5.254708614	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3084	6645	0.003611738	0.006019564	5	9	OPC	40	16	16
CACACTCGTCCAGTTA-1_7_D5	-19.62347738	27.98010901	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2204	4260	0.003755869	0.003755869	5	8	Astrocytes	40	16	16
CACACTCGTTACGCGC-1_7_D5	11.59440609	-5.162379989	12	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1051	1805	0.024930748	0.010526316	5	12	EN-MIX	40	16	16
CACACTCTCGGCTTGG-1_7_D5	-28.23736835	11.94402634	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	828	1292	0.008513932	0.003095975	5	8	Astrocytes	40	16	16
CACACTCTCGTTTAGG-1_7_D5	-17.06105612	-25.90293749	6A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2322	5475	0.050228311	0.005844749	5	6A	IN-PV	40	16	16
CACAGGCAGTAGCCGA-1_7_D5	6.851555886	11.1745329	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1141	1797	0.001112966	0.021702838	5	oligos	OL-Cntl	40	16	16
CACAGGCCACGGTGTC-1_7_D5	-34.45840421	-2.679280534	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1473	2476	0.002423263	0.004442649	5	9	OPC	40	16	16
CACAGGCGTCTGCGGT-1_7_D5	8.66386056	17.0573534	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	902	1377	0.011619463	0.006535948	5	oligos	OL-Cntl	40	16	16
CACAGGCGTTGCGTTA-1_7_D5	19.9976248	-29.5779995	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	8878	37573	0.001330743	0.003220398	5	3	EN-L5-6	40	16	16
CACAGGCTCCCTTGCA-1_7_D5	37.25266892	10.16358941	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	808	1113	0.016172507	0.015274034	5	14	Microglia	40	16	16
CACAGGCTCGCCTGAG-1_7_D5	1.016960718	15.69920803	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	841	1165	0.005150215	0.012875536	5	oligos	OL-Cntl	40	16	16
CACAGGCTCTAACTTC-1_7_D5	-23.42119249	0.850603919	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2655	5824	0.002575549	0.004464286	5	9	OPC	40	16	16
CACAGTAAGCTGAACG-1_7_D5	-24.55497683	12.0889622	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1134	1822	0.001646542	0.009330406	5	8	Astrocytes	40	16	16
CACAGTAAGCTTTGGT-1_7_D5	6.758177524	-18.99830259	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4127	9580	0.002192067	0.012734864	5	L2-3	EN-L2-3-MS	40	16	16
CACAGTACAACTGCGC-1_7_D5	-11.81222441	0.794868821	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3337	7567	0.020747985	0.003568125	5	13A	IN-VIP	40	16	16
CACAGTACACGGTGTC-1_7_D5	29.17999968	7.267203489	15DA	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	885	2448	0.528594771	0.04370915	5	15DA	T cells	40	16	16
CACAGTACATGGTCTA-1_7_D5	3.573625292	22.40897042	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	832	1295	0.001544402	0.007722008	5	oligos	OL-Cntl	40	16	16
CACAGTAGTAGCTAAA-1_7_D5	-31.99164252	3.234369594	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2402	4596	0.006527415	0.010226284	5	9	OPC	40	16	16
CACAGTATCACCACCT-1_7_D5	-34.46087823	-11.58576372	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	814	1195	0.009205021	0.00167364	5	9	OPC	40	16	16
CACAGTATCCAAAGTC-1_7_D5	-2.385922376	-12.57559895	10	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2144	4045	0.005438813	0.007663782	5	L2-3	EN-L2-3-Cntl	40	16	16
CACAGTATCCCGACTT-1_7_D5	-30.88053228	10.74482878	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	684	1128	0.037234043	0.007092199	5	8	Astrocytes	40	16	16
CACAGTATCCCTCAGT-1_7_D5	34.56050259	15.0656836	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1021	1374	0.008005822	0.034934498	5	14	Microglia	40	16	16
CACAGTATCCCTGACT-1_7_D5	-24.95758515	25.32831825	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1585	3158	0.000633312	0.006966434	5	8	Astrocytes	40	16	16
CACAGTATCTTTAGGG-1_7_D5	-33.66459385	-3.114119128	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1435	2424	0.001237624	0.005775578	5	9	OPC	40	16	16
CACATAGAGCTGAACG-1_7_D5	1.924558766	14.19972899	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	951	1346	0.00371471	0.011887073	5	oligos	OL-Cntl	40	16	16
CACATAGAGTTGAGTA-1_7_D5	-30.81033138	2.237825652	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2073	3641	0.006591596	0.007415545	5	9	OPC	40	16	16
CACATAGCAACGATGG-1_7_D5	14.88665431	11.0351599	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1393	2432	0.001644737	0.006167763	5	oligos	OL-Cntl	40	16	16
CACATAGTCCGGCACA-1_7_D5	-19.28099028	30.3410777	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3202	7552	0.000794492	0.007150424	5	8	Astrocytes	40	16	16
CACATAGTCGGTTCGG-1_7_D5	10.5377493	12.32674751	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1269	2058	0.004859086	0.011661808	5	oligos	OL-Cntl	40	16	16
CACATAGTCGTACCGG-1_7_D5	5.293565486	-17.65300786	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2863	6049	0.012398744	0.017523558	5	L2-3	EN-L2-3-MS	40	16	16
CACATTTAGAGGGCTT-1_7_D5	7.533465685	16.78593288	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	953	1548	0.003875969	0.003875969	5	oligos	OL-Cntl	40	16	16
CACATTTAGATAGCAT-1_7_D5	21.85460593	-1.953349766	2	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2411	4955	0.008072654	0.009081736	5	2	EN-L4	40	16	16
CACATTTTCCTCCTAG-1_7_D5	-24.10520356	19.22490033	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1650	3194	0.001565435	0.00313087	5	8	Astrocytes	40	16	16
CACATTTTCTGAGTGT-1_7_D5	-21.46831122	25.97989077	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1690	3166	0.00473784	0.00473784	5	8	Astrocytes	40	16	16
CACCACTCAAACCTAC-1_7_D5	2.960525956	15.05389158	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	927	1432	0.002793296	0.016061453	5	oligos	OL-Cntl	40	16	16
CACCACTCACATGGGA-1_7_D5	1.479809447	13.66400336	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1011	1453	0.003441156	0.014452856	5	oligos	OL-Cntl	40	16	16
CACCACTCACCGGAAA-1_7_D5	-29.91565959	18.68944328	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1047	1809	0.006633499	0.004975124	5	8	Astrocytes	40	16	16
CACCACTCAGGTCCAC-1_7_D5	-31.45202757	2.608631788	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2334	4451	0.001797349	0.003594698	5	9	OPC	40	16	16
CACCACTCATATACCG-1_7_D5	-2.840679968	16.86879113	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	782	1174	0.010221465	0.011925043	5	oligos	OL-Cntl	40	16	16
CACCACTGTAATTGGA-1_7_D5	37.18403414	12.12648658	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1009	1369	0.008035062	0.014609204	5	14	Microglia	40	16	16
CACCACTGTGTTGAGG-1_7_D5	36.63454794	9.484525556	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	839	1188	0.048821549	0.02020202	5	14	Microglia	40	16	16
CACCACTGTTAAGGGC-1_7_D5	3.398859134	17.75990355	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1062	1704	0.01584507	0.008802817	5	oligos	OL-Cntl	40	16	16
CACCACTTCACATACG-1_7_D5	-19.20732532	28.73312032	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2443	5528	0.002532562	0.009044863	5	8	Astrocytes	40	16	16
CACCACTTCTCGATGA-1_7_D5	9.487418864	13.42770267	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1187	1954	0.002047083	0.009211873	5	oligos	OL-Cntl	40	16	16
CACCACTTCTGAGTGT-1_7_D5	10.27143235	10.616677	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1380	2253	0.007101642	0.011540169	5	oligos	OL-Cntl	40	16	16
CACCAGGAGACTTTCG-1_7_D5	39.16106715	12.77431036	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1049	1517	0.006591958	0.007910349	5	14	Microglia	40	16	16
CACCAGGCACATTAGC-1_7_D5	33.43211017	-6.437394753	2	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3751	8631	0.001737921	0.010311667	5	2	EN-L4	40	16	16
CACCAGGCAGACAAGC-1_7_D5	6.549659189	21.7206319	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	909	1384	0.009393064	0.003612717	5	oligos	OL-Cntl	40	16	16
CACCAGGGTCACTTCC-1_7_D5	3.638468098	16.36386783	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	967	1540	0.005844156	0.01038961	5	oligos	OL-Cntl	40	16	16
CACCAGGTCAAACCGT-1_7_D5	-36.31547404	0.577035471	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1414	2626	0.006092917	0.00418888	5	9	OPC	40	16	16
CACCAGGTCAGAGGTG-1_7_D5	-7.227830493	10.66234883	5	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	709	1024	0	0.014648438	5	oligos	OL-MS-1	40	16	16
CACCAGGTCGTACCGG-1_7_D5	2.354995111	15.22924494	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	965	1508	0.00464191	0.017241379	5	oligos	OL-Cntl	40	16	16
CACCAGGTCGTGGACC-1_7_D5	-6.935468624	10.1303297	5	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	747	1053	0.025641026	0.029439696	5	oligos	OL-MS-1	40	16	16
CACCTTGAGCTAACAA-1_7_D5	15.55910835	11.15487075	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1535	2697	0.000741565	0.005932518	5	oligos	OL-Cntl	40	16	16
CACCTTGAGGGATACC-1_7_D5	-28.50558255	11.12014921	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	751	1072	0.004664179	0.003731343	5	8	Astrocytes	40	16	16
CACCTTGCAGTCGTGC-1_7_D5	-0.281469518	16.71440047	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	796	1123	0.011576135	0.017809439	5	oligos	OL-Cntl	40	16	16
CACCTTGCATGACGGA-1_7_D5	4.022615588	4.898448612	7	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1372	1884	0.005307856	0.007961783	5	7	Phagocytes	40	16	16
CACCTTGTCAGCAACT-1_7_D5	-27.6740066	8.470826929	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	707	1328	0.005271084	0.003012048	5	8	Astrocytes	40	16	16
CACCTTGTCCCGGATG-1_7_D5	7.795583647	16.89103257	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	993	1554	0.001930502	0.010939511	5	oligos	OL-Cntl	40	16	16
CACCTTGTCGTAGGAG-1_7_D5	37.23641462	14.12818773	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1055	1446	0.005532503	0.01659751	5	14	Microglia	40	16	16
CACCTTGTCGTTTAGG-1_7_D5	32.19047387	15.64737549	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1035	1422	0.002109705	0.076652602	5	14	Microglia	40	16	16
CACCTTGTCTGCTGCT-1_7_D5	-15.99746994	0.686923892	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3980	9687	0.012800661	0.009290802	5	13A	IN-VIP	40	16	16
CACTCCAAGGATATAC-1_7_D5	-28.54202294	22.88075126	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1089	1771	0.00621118	0.004517222	5	8	Astrocytes	40	16	16
CACTCCAAGGCTCAGA-1_7_D5	4.909533391	10.50969231	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1226	2021	0.017812964	0.019792182	5	oligos	OL-Cntl	40	16	16
CACTCCACAAATCCGT-1_7_D5	23.56420022	-9.373816064	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4105	11790	0.002374894	0.003392706	5	3	EN-L5-6	40	16	16
CACTCCACACAAGTAA-1_7_D5	36.10595045	11.71753972	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	896	1213	0.000824402	0.027205276	5	14	Microglia	40	16	16
CACTCCACAGCCAATT-1_7_D5	20.6297792	-29.51348717	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4065	11322	0.001059883	0.001766472	5	3	EN-L5-6	40	16	16
CACTCCACATGTTGAC-1_7_D5	-35.38086641	3.192244746	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2083	4258	0.003287929	0.005166745	5	9	OPC	40	16	16
CACTCCATCCAGAGGA-1_7_D5	10.17777315	19.71967515	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1065	1893	0.001584786	0.006339144	5	oligos	OL-Cntl	40	16	16
CACTCCATCTCTAGGA-1_7_D5	-3.7464467	23.36713124	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	765	1123	0.009795191	0.005342832	5	oligos	OL-Cntl	40	16	16
CACTCCATCTGAGGGA-1_7_D5	-19.02225798	19.99902824	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1639	2853	0.001051525	0.008762706	5	8	Astrocytes	40	16	16
CAGAATCAGAAAGTGG-1_7_D5	12.1269523	7.838100271	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1585	2623	0.017155928	0.0186809	5	oligos	OL-Cntl	40	16	16
CAGAATCAGAATAGGG-1_7_D5	20.44006761	18.83151587	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1180	1900	0.01	0.005263158	5	oligos	OL-Cntl	40	16	16
CAGAATCAGGATGTAT-1_7_D5	13.85530257	10.35674802	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1525	2475	0.002020202	0.010909091	5	oligos	OL-Cntl	40	16	16
CAGAATCAGTACCGGA-1_7_D5	5.210585607	-18.17586672	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3176	7096	0.005636979	0.018461105	5	L2-3	EN-L2-3-MS	40	16	16
CAGAATCCATTACCTT-1_7_D5	7.713795531	-18.12842101	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3942	9671	0.00806535	0.013235446	5	L2-3	EN-L2-3-MS	40	16	16
CAGAATCGTCTTCTCG-1_7_D5	20.50877812	0.510012876	2	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1567	2716	0.013254786	0.008100147	5	2	EN-L4	40	16	16
CAGAATCGTTCAACCA-1_7_D5	18.81924052	-25.88346983	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4826	14434	0.006928086	0.013440488	5	3	EN-L5-6	40	16	16
CAGAATCTCCAGGGCT-1_7_D5	8.526470976	-17.15167354	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4624	10887	0.004868191	0.017084596	5	L2-3	EN-L2-3-MS	40	16	16
CAGAGAGAGCACGCCT-1_7_D5	-2.846758533	12.9566564	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	963	1404	0.003561254	0.037037037	5	oligos	OL-Cntl	40	16	16
CAGAGAGAGGATATAC-1_7_D5	37.36817185	10.09642063	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	820	1160	0.001724138	0.012931034	5	14	Microglia	40	16	16
CAGAGAGGTCTGCCAG-1_7_D5	30.28236845	15.33897902	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	990	1489	0.001343183	0.146406985	5	14	Microglia	40	16	16
CAGAGAGTCGAATGCT-1_7_D5	-2.700166137	23.1888619	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	759	1127	0.002661934	0.008873114	5	oligos	OL-Cntl	40	16	16
CAGATCAAGACCGGAT-1_7_D5	-33.20300428	5.238880536	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3346	7319	0.006148381	0.003005875	5	9	OPC	40	16	16
CAGATCAAGCAGGTCA-1_7_D5	-33.87656902	2.920544827	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2217	4216	0.007590133	0.00426945	5	9	OPC	40	16	16
CAGATCAAGCTGTCTA-1_7_D5	9.389050647	14.10183782	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1223	2006	0.001994018	0.012961117	5	oligos	OL-Cntl	40	16	16
CAGATCAGTACGCTGC-1_7_D5	29.90448615	14.67744516	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	915	1336	0.001497006	0.185628743	5	14	Microglia	40	16	16
CAGCAGCCATCCGGGT-1_7_D5	-34.15393404	1.50585031	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1801	3165	0.00821485	0.005371248	5	9	OPC	40	16	16
CAGCATAAGAAACCTA-1_7_D5	3.131475467	-24.42539561	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	6085	20866	0.011597815	0.003594364	5	L2-3	EN-L2-3-MS	40	16	16
CAGCATAAGCAGGTCA-1_7_D5	-35.21721483	2.434960404	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1860	3334	0.00209958	0.00629874	5	9	OPC	40	16	16
CAGCATAAGCGCCTCA-1_7_D5	4.200810489	4.052345456	7	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1951	3241	0.005862388	0.086701635	5	7	Phagocytes	40	16	16
CAGCATACAAACGTGG-1_7_D5	30.41762424	15.50022997	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	886	1394	0.005738881	0.128407461	5	14	Microglia	40	16	16
CAGCATACACGGTGTC-1_7_D5	-9.136879174	17.24661194	11	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3247	7189	0.003616637	0.006815969	5	11	Glia-MIX	40	16	16
CAGCATAGTCCAACTA-1_7_D5	-33.07285514	5.30251206	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3037	6085	0.005094495	0.008216927	5	9	OPC	40	16	16
CAGCATATCACAACGT-1_7_D5	-20.87321079	29.18006541	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2207	4284	0.005368814	0.006302521	5	8	Astrocytes	40	16	16
CAGCATATCACTCTTA-1_7_D5	-1.533033687	11.97298427	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	992	1575	0.055238095	0.013333333	5	oligos	OL-Cntl	40	16	16
CAGCCGAAGCGATATA-1_7_D5	3.30915063	10.96900702	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1245	1960	0.025510204	0.020408163	5	oligos	OL-Cntl	40	16	16
CAGCCGAAGCGCTCCA-1_7_D5	38.32153677	13.22745841	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	999	1470	0.001360544	0.018367347	5	14	Microglia	40	16	16
CAGCCGAAGGAGTCTG-1_7_D5	4.970879718	16.17886765	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	975	1418	0.014809591	0.011283498	5	oligos	OL-Cntl	40	16	16
CAGCCGACACACTGCG-1_7_D5	-2.937391961	15.87874324	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	686	1066	0.006566604	0.015947467	5	oligos	OL-Cntl	40	16	16
CAGCCGACATTCACTT-1_7_D5	38.84030781	15.28068967	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1220	1845	0.001626016	0.010840108	5	14	Microglia	40	16	16
CAGCCGACATTGTGCA-1_7_D5	17.3156661	12.83390603	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1256	2134	0.002811621	0.002811621	5	oligos	OL-Cntl	40	16	16
CAGCCGAGTAAATACG-1_7_D5	12.93498242	-7.196324615	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2918	6856	0.013418903	0.001750292	5	3	EN-L5-6	40	16	16
CAGCCGATCAGGATCT-1_7_D5	-32.21641508	2.955057005	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2305	4388	0.003646308	0.004329991	5	9	OPC	40	16	16
CAGCGACAGGTGTTAA-1_7_D5	-19.97941745	25.11053228	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1691	3039	0.01349128	0.01052978	5	8	Astrocytes	40	16	16
CAGCGACCAGTATAAG-1_7_D5	5.930819928	26.47505104	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	857	1225	0.003265306	0.006530612	5	oligos	OL-Cntl	40	16	16
CAGCGACCATTGTGCA-1_7_D5	14.58252335	12.03970393	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1445	2460	0.004471545	0.007723577	5	oligos	OL-Cntl	40	16	16
CAGCGACGTATGAATG-1_7_D5	2.87968579	13.24709914	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	990	1468	0.021798365	0.008855586	5	oligos	OL-Cntl	40	16	16
CAGCGACGTCCGTGAC-1_7_D5	-13.80603151	-0.510571473	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2443	4225	0.005207101	0.013727811	5	13A	IN-VIP	40	16	16
CAGCGACGTGCTCTTC-1_7_D5	-33.26331396	1.990922617	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1900	3256	0.00460688	0.007985258	5	9	OPC	40	16	16
CAGCGACGTTAAGTAG-1_7_D5	-25.82441618	-17.39672572	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	5902	15562	0.033350469	0.015422182	5	13A	IN-VIP	40	16	16
CAGCGACTCATCGCTC-1_7_D5	15.97009189	6.449116064	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2002	4155	0.004091456	0.006738869	5	oligos	OL-Cntl	40	16	16
CAGCGACTCGCAAGCC-1_7_D5	3.158159941	13.66034507	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	968	1507	0.00331785	0.0199071	5	oligos	OL-Cntl	40	16	16
CAGCGACTCGCTGATA-1_7_D5	12.84605277	-6.999617785	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2611	6349	0.020790676	0.007875256	5	3	EN-L5-6	40	16	16
CAGCGACTCGGCCGAT-1_7_D5	-19.60633372	29.00808392	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2040	4337	0.001614019	0.014295596	5	8	Astrocytes	40	16	16
CAGCTAAAGAGCTTCT-1_7_D5	37.83639151	10.41126563	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	944	1255	0.004780876	0.007171315	5	14	Microglia	40	16	16
CAGCTAAAGTGGTCCC-1_7_D5	0.248094496	0.956760276	11	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1431	2284	0.035464098	0.008318739	5	11	Glia-MIX	40	16	16
CAGCTAACAATAGAGT-1_7_D5	7.040385807	13.24515789	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1111	1689	0.009473061	0.014209591	5	oligos	OL-Cntl	40	16	16
CAGCTAACACAGGAGT-1_7_D5	-32.85373037	-10.79770985	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	972	1390	0.002877698	0	5	9	OPC	40	16	16
CAGCTAACAGTAAGAT-1_7_D5	2.782725739	16.18507014	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	944	1337	0.002991773	0.010471204	5	oligos	OL-Cntl	40	16	16
CAGCTAAGTAAAGGAG-1_7_D5	6.030756079	12.16093882	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1309	2099	0.005240591	0.008099095	5	oligos	OL-Cntl	40	16	16
CAGCTAAGTCGAACAG-1_7_D5	6.406964181	-20.03663855	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4313	10400	0.005576923	0.012115385	5	L2-3	EN-L2-3-MS	40	16	16
CAGCTAAGTTCTCATT-1_7_D5	39.85164638	14.11627881	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1176	1662	0.001805054	0.007220217	5	14	Microglia	40	16	16
CAGCTAAGTTGTTTGG-1_7_D5	-18.49327228	28.11149103	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2203	4152	0.008911368	0.006262042	5	8	Astrocytes	40	16	16
CAGCTAATCTGTCCGT-1_7_D5	-14.46250559	-7.207493464	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3711	9756	0.006867569	0.005125051	5	13A	IN-VIP	40	16	16
CAGCTGGAGCACACAG-1_7_D5	6.495159888	12.64243107	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1405	2160	0.005555556	0.0125	5	oligos	OL-Cntl	40	16	16
CAGCTGGAGCACAGGT-1_7_D5	30.96814811	15.48575881	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	894	1286	0.00466563	0.112752722	5	14	Microglia	40	16	16
CAGCTGGAGCCCAGCT-1_7_D5	10.95486811	9.818479628	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1323	2041	0.007349339	0.017148457	5	oligos	OL-Cntl	40	16	16
CAGCTGGAGGTGCAAC-1_7_D5	-37.35677706	-10.09389502	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1004	1753	0.003422704	0.003993155	5	9	OPC	40	16	16
CAGCTGGCAAAGCGGT-1_7_D5	2.329465927	12.13563961	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	971	1484	0.005390836	0.014150943	5	oligos	OL-Cntl	40	16	16
CAGCTGGCATGACATC-1_7_D5	-37.63975734	-9.211698819	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	878	1425	0.002105263	0.002105263	5	9	OPC	40	16	16
CAGCTGGTCAAGGTAA-1_7_D5	2.340104721	13.84752778	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	890	1343	0.011169025	0.014147431	5	oligos	OL-Cntl	40	16	16
CAGCTGGTCCTGTAGA-1_7_D5	12.96429446	-7.228779861	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3936	11988	0.004921588	0.00333667	5	3	EN-L5-6	40	16	16
CAGGTGCAGCACCGCT-1_7_D5	13.28757886	31.52336049	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	720	1018	0.006876228	0.000982318	5	oligos	OL-Cntl	40	16	16
CAGGTGCAGCTGTTCA-1_7_D5	4.817726124	-17.46111571	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2994	6155	0.002274574	0.015434606	5	L2-3	EN-L2-3-MS	40	16	16
CAGGTGCAGTTAGCGG-1_7_D5	-31.25309332	11.3509413	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	718	1093	0.004574565	0.004574565	5	8	Astrocytes	40	16	16
CAGGTGCAGTTCGCAT-1_7_D5	5.211428284	14.46920175	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1053	1553	0.001931745	0.008370895	5	oligos	OL-Cntl	40	16	16
CAGGTGCCATGACGGA-1_7_D5	-20.51931969	26.70085176	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1794	3277	0.0042722	0.0064083	5	8	Astrocytes	40	16	16
CAGGTGCTCCGTCAAA-1_7_D5	-32.9045764	3.651854149	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2444	4889	0.001636326	0.004090816	5	9	OPC	40	16	16
CAGGTGCTCGGAAACG-1_7_D5	-2.505161181	17.53948329	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	695	1062	0.004708098	0.011299435	5	oligos	OL-Cntl	40	16	16
CAGTAACAGATGTGGC-1_7_D5	37.38842703	-9.8743488	2	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4972	13296	0.006242479	0.007972323	5	2	EN-L4	40	16	16
CAGTAACCAGTGGGAT-1_7_D5	10.29253126	-21.87328027	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	8899	36298	0.010386247	0.00807207	5	L2-3	EN-L2-3-MS	40	16	16
CAGTAACCATCGGAAG-1_7_D5	-20.01616385	27.25074036	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1953	3928	0.001782077	0.005346232	5	8	Astrocytes	40	16	16
CAGTAACGTAATCGTC-1_7_D5	-36.09557649	-6.708909837	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1065	1693	0.002953337	0.002953337	5	9	OPC	40	16	16
CAGTAACGTATGCTTG-1_7_D5	32.95343076	14.77378363	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	862	1148	0.005226481	0.047038328	5	14	Microglia	40	16	16
CAGTAACGTTTAGCTG-1_7_D5	0.799423	19.61550188	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	749	1171	0.005977797	0.003415884	5	oligos	OL-Cntl	40	16	16
CAGTCCTAGGACACCA-1_7_D5	15.49963126	6.139780629	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2030	4009	0.00598653	0.010725867	5	oligos	OL-Cntl	40	16	16
CAGTCCTAGTCGTTTG-1_7_D5	18.93739018	-7.901774239	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3081	7742	0.015112374	0.001808318	5	3	EN-L5-6	40	16	16
CAGTCCTCACGTTGGC-1_7_D5	8.668407179	11.95370582	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1226	2012	0.000994036	0.011928429	5	oligos	OL-Cntl	40	16	16
CAGTCCTGTCTCCACT-1_7_D5	13.87494435	10.7699968	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1338	2369	0.0088645	0.007176024	5	oligos	OL-Cntl	40	16	16
CAGTCCTTCACAGTAC-1_7_D5	37.40951511	12.94037567	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1079	1569	0.003186743	0.025493945	5	14	Microglia	40	16	16
CAGTCCTTCCCTCTTT-1_7_D5	25.23173491	4.138364945	15BA	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1396	2799	0.00035727	0.005001786	5	15BA	Stromal cells	40	16	16
CATATGGCAATAGCGG-1_7_D5	12.49510203	-6.503317644	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1970	3674	0.013609145	0.004354927	5	3	EN-L5-6	40	16	16
CATATGGCATGCTAGT-1_7_D5	-31.76761609	0.526286644	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1943	3632	0.004129956	0.003854626	5	9	OPC	40	16	16
CATATGGGTATTACCG-1_7_D5	14.24902755	-33.24021632	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4939	18254	0.013147803	0.002519996	5	3	EN-L5-6	40	16	16
CATATGGGTCGCCATG-1_7_D5	4.666433712	5.72696533	7	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1562	2471	0.00364225	0.044921085	5	7	Phagocytes	40	16	16
CATATGGGTTCCCTTG-1_7_D5	14.20632999	10.83054799	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1357	2345	0.003837953	0.009381663	5	oligos	OL-Cntl	40	16	16
CATATTCAGAAAGTGG-1_7_D5	-19.6339473	25.79402885	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1865	4112	0.004863813	0.008268482	5	8	Astrocytes	40	16	16
CATATTCAGAGTGAGA-1_7_D5	1.257578565	11.54934926	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	863	1336	0.005988024	0.020209581	5	oligos	OL-Cntl	40	16	16
CATATTCAGGCAATTA-1_7_D5	-20.09141697	28.95752306	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2116	4475	0.001340782	0.005139665	5	8	Astrocytes	40	16	16
CATATTCAGGCCGAAT-1_7_D5	13.89913576	8.533713045	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1575	2860	0.011538462	0.011888112	5	oligos	OL-Cntl	40	16	16
CATATTCCAACACCTA-1_7_D5	9.478767266	10.87198278	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1260	2248	0.002224199	0.007562278	5	oligos	OL-Cntl	40	16	16
CATATTCCAAGACGTG-1_7_D5	-25.03457459	25.85967979	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1646	2959	0.001013856	0.003041568	5	8	Astrocytes	40	16	16
CATATTCCATCCGTGG-1_7_D5	-20.46935052	27.75248347	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2443	6097	0.001804166	0.006888634	5	8	Astrocytes	40	16	16
CATATTCTCACGCATA-1_7_D5	-34.19693429	2.539180986	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2088	3962	0.001009591	0.005047956	5	9	OPC	40	16	16
CATCAAGAGCTGCAAG-1_7_D5	-17.42875809	1.403343871	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3773	7927	0.013498171	0.021445692	5	13A	IN-VIP	40	16	16
CATCAAGCAAACCCAT-1_7_D5	-1.646876771	15.83453798	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	738	1147	0.005231037	0.019180471	5	oligos	OL-Cntl	40	16	16
CATCAAGCAGTCTTCC-1_7_D5	-10.18348323	23.40376984	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3157	7415	0.001483479	0.024814565	5	8	Astrocytes	40	16	16
CATCAAGCATCACCCT-1_7_D5	24.63447906	-28.96697395	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4003	11208	0.004282655	0.002587438	5	3	EN-L5-6	40	16	16
CATCAAGGTAAAGGAG-1_7_D5	-1.062877777	15.95996085	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	804	1200	0.015833333	0.016666667	5	oligos	OL-Cntl	40	16	16
CATCAAGTCGGCGGTT-1_7_D5	-15.23110785	1.677034464	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4302	10510	0.003805899	0.009990485	5	13A	IN-VIP	40	16	16
CATCAAGTCTGGTTCC-1_7_D5	0.032346677	16.41275098	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	839	1197	0.01754386	0.011695906	5	oligos	OL-Cntl	40	16	16
CATCAGAAGATGGCGT-1_7_D5	-31.19015593	2.049027447	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1831	3105	0.00547504	0.006763285	5	9	OPC	40	16	16
CATCAGAAGGAGCGTT-1_7_D5	34.42830814	-8.6423036	2	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	5167	13964	0.011816099	0.00973933	5	2	EN-L4	40	16	16
CATCAGACAGAAGCAC-1_7_D5	-21.77752955	28.92044466	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2154	4228	0.003784295	0.004257332	5	8	Astrocytes	40	16	16
CATCAGACAGTAGAGC-1_7_D5	38.52998132	12.17539538	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1036	1473	0.017651052	0.007467753	5	14	Microglia	40	16	16
CATCAGACAGTGAGTG-1_7_D5	-31.23583976	-3.567264618	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1465	2288	0.002185315	0.01048951	5	9	OPC	40	16	16
CATCAGAGTTTCCACC-1_7_D5	12.35267751	12.54731865	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1282	2214	0.005420054	0.008130081	5	oligos	OL-Cntl	40	16	16
CATCAGATCCAAAGTC-1_7_D5	15.45938283	13.9996327	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1333	2439	0.00902009	0.00697007	5	oligos	OL-Cntl	40	16	16
CATCAGATCCATGCTC-1_7_D5	-36.83295618	-4.912455058	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1193	1953	0.007168459	0.003072197	5	9	OPC	40	16	16
CATCCACCAAGGCTCC-1_7_D5	13.09405524	13.37953316	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1216	2082	0.005763689	0.011527378	5	oligos	OL-Cntl	40	16	16
CATCCACCACCACGTG-1_7_D5	33.21731533	-7.230334795	2	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	5554	15798	0.005886821	0.006773009	5	2	EN-L4	40	16	16
CATCCACCATCATCCC-1_7_D5	10.45466022	12.26334615	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1214	2033	0.001967536	0.003443187	5	oligos	OL-Cntl	40	16	16
CATCCACCATCCGCGA-1_7_D5	-19.70683029	30.2992978	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2633	5525	0.002895928	0.006515837	5	8	Astrocytes	40	16	16
CATCCACGTATGGTTC-1_7_D5	2.251452933	12.16193568	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	979	1607	0.008089608	0.016179216	5	oligos	OL-Cntl	40	16	16
CATCGAAAGAAACGAG-1_7_D5	-0.903841726	16.57166632	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	811	1217	0.004930156	0.013147083	5	oligos	OL-Cntl	40	16	16
CATCGAAAGACAAAGG-1_7_D5	17.38181772	-26.42488834	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	5550	16975	0.007010309	0.007481591	5	3	EN-L5-6	40	16	16
CATCGAAAGAGCTGGT-1_7_D5	25.35552901	1.16338213	2	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2237	4209	0.019244476	0.006177239	5	2	EN-L4	40	16	16
CATCGAAAGCTAGTTC-1_7_D5	-32.23996259	2.973664022	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2079	3827	0.001829109	0.004703423	5	9	OPC	40	16	16
CATCGAAAGTGTGAAT-1_7_D5	-35.6593667	-6.914113028	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1058	1681	0.00297442	0.001189768	5	9	OPC	40	16	16
CATCGAAGTGGAAAGA-1_7_D5	15.49998919	-8.041411957	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2444	4671	0.000428174	0.005352173	5	3	EN-L5-6	40	16	16
CATCGAATCATGCAAC-1_7_D5	-27.53326114	4.344137347	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3591	7824	0.002556237	0.005751534	5	9	OPC	40	16	16
CATCGAATCCCATTAT-1_7_D5	12.94403275	-7.200533513	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2852	6711	0.0065564	0.004172255	5	3	EN-L5-6	40	16	16
CATCGGGAGTAACCCT-1_7_D5	32.69342606	15.17920818	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	930	1277	0.003915427	0.05403289	5	14	Microglia	40	16	16
CATCGGGAGTTACGGG-1_7_D5	-33.46359234	-12.73714681	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	856	1252	0.003194888	0.001597444	5	9	OPC	40	16	16
CATCGGGCATGGGAAC-1_7_D5	29.66781897	6.283843308	5	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	739	1002	0.003992016	0.067864271	5	oligos	OL-MS-1	40	16	16
CATCGGGTCCGCGTTT-1_7_D5	14.43839044	-29.45553576	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4422	12910	0.005731991	0.005422153	5	3	EN-L5-6	40	16	16
CATGACACAGTATCTG-1_7_D5	-33.84577227	-2.133659172	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1500	2498	0.001200961	0.005204163	5	9	OPC	40	16	16
CATGACAGTGAAAGAG-1_7_D5	31.77661522	15.50423312	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1013	1403	0.003563792	0.058446187	5	14	Microglia	40	16	16
CATGACAGTGGTAACG-1_7_D5	30.43121488	15.93925332	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1238	1934	0.001034126	0.12254395	5	14	Microglia	40	16	16
CATGACATCAGAGACG-1_7_D5	-0.104790489	18.84645706	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	739	1082	0	0.018484288	5	oligos	OL-Cntl	40	16	16
CATGACATCCAAACTG-1_7_D5	7.830498474	19.00570957	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1187	1949	0.008209338	0.007183171	5	oligos	OL-Cntl	40	16	16
CATGACATCCATGAAC-1_7_D5	14.05195157	7.897559812	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1824	3337	0.008690441	0.012286485	5	oligos	OL-Cntl	40	16	16
CATGACATCCCGACTT-1_7_D5	-20.95710165	29.10271435	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2172	5037	0.001786778	0.007147111	5	8	Astrocytes	40	16	16
CATGACATCCTTGACC-1_7_D5	8.316616011	-18.12602633	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	5584	15935	0.006714779	0.014998431	5	L2-3	EN-L2-3-MS	40	16	16
CATGACATCCTTTCTC-1_7_D5	20.03263164	12.30951545	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1440	2577	0.005432674	0.004268529	5	oligos	OL-Cntl	40	16	16
CATGACATCTGTCAAG-1_7_D5	16.60705986	12.70654678	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1295	2303	0.000868432	0.005210595	5	oligos	OL-Cntl	40	16	16
CATGCCTAGCATCATC-1_7_D5	23.45720329	-1.117485009	2	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2388	4702	0.055082943	0.002552105	5	2	EN-L4	40	16	16
CATGCCTCAAACCTAC-1_7_D5	39.1818315	14.98532792	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1299	1968	0.004065041	0.009146341	5	14	Microglia	40	16	16
CATGCCTGTCCTCTTG-1_7_D5	-7.29629121	-2.271687344	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1790	3286	0.037127206	0.005477785	5	13A	IN-VIP	40	16	16
CATGCCTTCGTCCGTT-1_7_D5	-35.8754601	-0.981676691	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1466	2558	0.003127443	0.006645817	5	9	OPC	40	16	16
CATGGCGAGATGTGGC-1_7_D5	13.4432947	11.36494778	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1382	2334	0.002142245	0.015424165	5	oligos	OL-Cntl	40	16	16
CATGGCGAGGGTTTCT-1_7_D5	-35.18690641	-1.504855562	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1582	2590	0.002702703	0.003088803	5	9	OPC	40	16	16
CATGGCGAGTGTCCAT-1_7_D5	-12.56625444	-18.57118135	6B	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1295	2303	0.059921841	0.001736865	5	6B	IN-SST	40	16	16
CATGGCGCACGAAATA-1_7_D5	36.09642231	12.45018909	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1013	1378	0.004354136	0.02467344	5	14	Microglia	40	16	16
CATGGCGCAGAGCCAA-1_7_D5	34.84202659	-5.712147009	2	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3109	6129	0.003263175	0.008810573	5	2	EN-L4	40	16	16
CATGGCGCATTGAGCT-1_7_D5	-3.035864923	16.1717997	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	808	1202	0.000831947	0.012479201	5	oligos	OL-Cntl	40	16	16
CATGGCGGTGCACCAC-1_7_D5	-31.34856243	2.900131898	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2663	5133	0.003701539	0.008766803	5	9	OPC	40	16	16
CATGGCGGTTGACGTT-1_7_D5	20.06993703	-25.83270508	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	5484	14062	0.011235955	0.006329114	5	3	EN-L5-6	40	16	16
CATTATCAGGATGCGT-1_7_D5	15.07238359	-29.71824073	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	5244	17774	0.002700574	0.004444694	5	3	EN-L5-6	40	16	16
CATTATCAGTTCCACA-1_7_D5	11.42141256	-4.990277926	12	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	923	1568	0.024234694	0.003826531	5	12	EN-MIX	40	16	16
CATTATCCACCGCTAG-1_7_D5	5.195058671	11.10769938	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1252	2010	0.003482587	0.010945274	5	oligos	OL-Cntl	40	16	16
CATTATCCATAGGATA-1_7_D5	40.63171518	14.70930536	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1227	1773	0.012972363	0.00676819	5	14	Microglia	40	16	16
CATTATCTCAAAGACA-1_7_D5	17.05274127	22.34521668	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	938	1466	0.004092769	0.001364256	5	oligos	OL-Cntl	40	16	16
CATTATCTCACTTCAT-1_7_D5	14.55879512	9.248783026	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1581	3039	0.006252057	0.009871668	5	oligos	OL-Cntl	40	16	16
CATTATCTCTTACCTA-1_7_D5	-9.408640678	13.64077973	11	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1340	2125	0.009411765	0.009411765	5	11	Glia-MIX	40	16	16
CATTCGCAGCTTCGCG-1_7_D5	11.22584146	20.92558496	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	945	1538	0.010403121	0.007152146	5	oligos	OL-Cntl	40	16	16
CATTCGCAGGCCGAAT-1_7_D5	4.467830806	29.10531908	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	694	1014	0.00295858	0.00591716	5	oligos	OL-Cntl	40	16	16
CATTCGCAGTCAAGGC-1_7_D5	1.518786123	17.57504799	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	837	1420	0.003521127	0.01056338	5	oligos	OL-Cntl	40	16	16
CATTCGCAGTGGTAAT-1_7_D5	-19.28212351	29.00625199	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2424	5385	0.001114206	0.008727948	5	8	Astrocytes	40	16	16
CATTCGCCAATAGCAA-1_7_D5	2.709308149	13.6105442	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1058	1707	0.028119508	0.010544815	5	oligos	OL-Cntl	40	16	16
CATTCGCCATTGGCGC-1_7_D5	6.534754693	9.19686653	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1333	2281	0.004822446	0.01359053	5	oligos	OL-Cntl	40	16	16
CATTCGCGTACTTAGC-1_7_D5	4.236131132	-26.35024043	10	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3941	11319	0.006272639	0.002562064	5	L2-3	EN-L2-3-Cntl	40	16	16
CATTCGCTCAGTGTTG-1_7_D5	7.585719595	11.45441554	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1243	1978	0.004044489	0.010111223	5	oligos	OL-Cntl	40	16	16
CATTCGCTCGTTACGA-1_7_D5	3.142502333	14.64688734	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1084	1586	0.006935687	0.014501892	5	oligos	OL-Cntl	40	16	16
CATTCGCTCTCAACTT-1_7_D5	-27.79428971	13.42493326	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	844	1499	0	0.002668446	5	8	Astrocytes	40	16	16
CATTCGCTCTCGAGTA-1_7_D5	-31.0399169	13.77693136	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	876	1494	0.002008032	0.00334672	5	8	Astrocytes	40	16	16
CCAATCCAGTCTCAAC-1_7_D5	-15.69120872	-19.14210139	6B	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1798	3787	0.027462371	0.003696858	5	6B	IN-SST	40	16	16
CCAATCCCATTAGCCA-1_7_D5	6.066919251	16.85205639	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	984	1566	0.001915709	0.012771392	5	oligos	OL-Cntl	40	16	16
CCAATCCGTCCTAGCG-1_7_D5	-3.559252611	19.09410341	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	725	1014	0.003944773	0.012820513	5	oligos	OL-Cntl	40	16	16
CCAATCCTCAATCACG-1_7_D5	4.472596067	4.3457158	7	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1755	2750	0.003272727	0.012363636	5	7	Phagocytes	40	16	16
CCAATCCTCTGTCAAG-1_7_D5	12.15571113	9.43129751	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1346	2532	0.007109005	0.010663507	5	oligos	OL-Cntl	40	16	16
CCACCTAAGCAATCTC-1_7_D5	-34.11755118	3.910113049	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2396	4829	0.004348726	0.008490371	5	9	OPC	40	16	16
CCACCTAAGGAGTTGC-1_7_D5	12.92384151	-7.177713991	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2620	5978	0.010036802	0.0025092	5	3	EN-L5-6	40	16	16
CCACCTAAGTTTAGGA-1_7_D5	38.99162833	10.35692346	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	949	1323	0.003023432	0.008314437	5	14	Microglia	40	16	16
CCACCTACAGAAGCAC-1_7_D5	-15.53120612	15.24389215	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2434	4947	0.000404285	0.004851425	5	8	Astrocytes	40	16	16
CCACCTACATCTCGCT-1_7_D5	11.84497095	12.74080776	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1131	2004	0.000499002	0.008483034	5	oligos	OL-Cntl	40	16	16
CCACCTAGTCTTCTCG-1_7_D5	-36.11317041	1.982376899	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1841	3437	0.00407332	0.004364271	5	9	OPC	40	16	16
CCACCTATCCAAGTAC-1_7_D5	-10.908813	-18.33311305	6B	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1043	1657	0.026554013	0.003017502	5	6B	IN-SST	40	16	16
CCACCTATCCTTTACA-1_7_D5	4.439843316	12.34761787	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1087	1723	0.009286129	0.008705746	5	oligos	OL-Cntl	40	16	16
CCACCTATCGTCCGTT-1_7_D5	13.93337	9.466804465	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1550	2802	0.004996431	0.01034975	5	oligos	OL-Cntl	40	16	16
CCACGGAAGATCCCAT-1_7_D5	-15.53040466	1.817523919	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4187	9639	0.003112356	0.016495487	5	13A	IN-VIP	40	16	16
CCACGGAAGATCTGCT-1_7_D5	6.693732698	11.8265264	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1122	1701	0.018224574	0.010582011	5	oligos	OL-Cntl	40	16	16
CCACGGAAGCAGATCG-1_7_D5	-20.2521777	26.22296125	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1992	4546	0.004839419	0.007699076	5	8	Astrocytes	40	16	16
CCACGGACATACTACG-1_7_D5	10.7701571	9.641136456	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1297	2186	0.003202196	0.01189387	5	oligos	OL-Cntl	40	16	16
CCACGGAGTGACTCAT-1_7_D5	-21.04843369	9.980199263	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1130	1897	0.002108593	0.002635741	5	8	Astrocytes	40	16	16
CCACGGAGTTAAGTAG-1_7_D5	13.62733809	9.497602605	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1477	2610	0.002681992	0.008045977	5	oligos	OL-Cntl	40	16	16
CCACGGATCCAAAGTC-1_7_D5	-18.70009414	-18.87998543	6B	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2288	4489	0.010024504	0.005791936	5	6B	IN-SST	40	16	16
CCACTACAGCCCAACC-1_7_D5	32.43268917	15.60055257	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1098	1495	0.008026756	0.051505017	5	14	Microglia	40	16	16
CCACTACCACTTACGA-1_7_D5	12.38283266	9.474616545	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1532	2733	0.007317966	0.008781559	5	oligos	OL-Cntl	40	16	16
CCACTACGTCAAAGCG-1_7_D5	7.587466535	-20.42631166	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4482	12455	0.014612605	0.006904857	5	L2-3	EN-L2-3-MS	40	16	16
CCACTACGTGGCTCCA-1_7_D5	19.68881807	10.90263028	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1668	3193	0.00062637	0.004384591	5	oligos	OL-Cntl	40	16	16
CCACTACTCAAAGACA-1_7_D5	0.560237579	15.97249466	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	892	1322	0.004538578	0.017397882	5	oligos	OL-Cntl	40	16	16
CCAGCGAAGAATTGTG-1_7_D5	11.16916185	6.894759842	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1749	3017	0.009280742	0.014252569	5	oligos	OL-Cntl	40	16	16
CCAGCGAAGAGCCCAA-1_7_D5	37.96065611	14.70629351	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1157	1696	0.003537736	0.018278302	5	14	Microglia	40	16	16
CCAGCGAAGATCCGAG-1_7_D5	-23.4330516	20.68519932	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1459	2496	0.003605769	0.005608974	5	8	Astrocytes	40	16	16
CCAGCGAAGCTGGAAC-1_7_D5	-10.55075101	18.5954426	11	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3218	6738	0.008756308	0.007272188	5	11	Glia-MIX	40	16	16
CCAGCGAAGTCGATAA-1_7_D5	-30.19798585	-1.111407317	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1635	2738	0.013513514	0.009495982	5	9	OPC	40	16	16
CCATGTCAGCGTGTCC-1_7_D5	10.61448907	10.96139034	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1398	2377	0.001682793	0.005889777	5	oligos	OL-Cntl	40	16	16
CCATGTCAGGATGTAT-1_7_D5	12.15086082	20.87540368	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	930	1419	0.019027484	0.002114165	5	oligos	OL-Cntl	40	16	16
CCATGTCAGGCTCAGA-1_7_D5	32.39275679	15.91473759	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1061	1457	0.012354152	0.055593686	5	14	Microglia	40	16	16
CCATGTCAGTGCCAGA-1_7_D5	10.70354111	24.3364347	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	859	1282	0.001560062	0.003900156	5	oligos	OL-Cntl	40	16	16
CCATGTCCAGATAATG-1_7_D5	-18.90141605	25.74002734	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2088	4521	0.00331785	0.01349259	5	8	Astrocytes	40	16	16
CCATGTCCATAGTAAG-1_7_D5	-35.16632898	1.375230507	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1683	2964	0.000674764	0.004385965	5	9	OPC	40	16	16
CCATGTCCATCGATTG-1_7_D5	-20.1164615	25.61776264	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1857	3502	0.00256996	0.011993147	5	8	Astrocytes	40	16	16
CCATGTCGTCTTGTCC-1_7_D5	3.504846741	-17.76105357	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3391	7288	0.003155873	0.004116356	5	L2-3	EN-L2-3-MS	40	16	16
CCATGTCTCATCACCC-1_7_D5	-35.76721068	-3.774772296	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1311	2037	0.001472754	0.003927344	5	9	OPC	40	16	16
CCATTCGAGCAATCTC-1_7_D5	12.87443006	-7.095053746	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3049	8786	0.024470749	0.003414523	5	3	EN-L5-6	40	16	16
CCATTCGAGTACGACG-1_7_D5	6.785867656	15.14167456	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1058	1545	0.001941748	0.009708738	5	oligos	OL-Cntl	40	16	16
CCATTCGGTGGTACAG-1_7_D5	2.745886923	9.134567328	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1368	2230	0.004484305	0.012107623	5	oligos	OL-Cntl	40	16	16
CCATTCGGTTTCGCTC-1_7_D5	3.911760461	9.914303051	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1278	2151	0.014876801	0.040446304	5	oligos	OL-Cntl	40	16	16
CCATTCGTCAAGGTAA-1_7_D5	-34.36255948	1.670516131	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1896	3456	0.008391204	0.005208333	5	9	OPC	40	16	16
CCATTCGTCCACGACG-1_7_D5	-26.16358424	15.0186665	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1029	1621	0.000616903	0.003701419	5	8	Astrocytes	40	16	16
CCATTCGTCCTTTCTC-1_7_D5	20.28700417	-28.82390016	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3732	9678	0.00361645	0.00216987	5	3	EN-L5-6	40	16	16
CCATTCGTCGGCTTGG-1_7_D5	-1.451798088	21.77616285	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	729	1017	0.012782694	0.01179941	5	oligos	OL-Cntl	40	16	16
CCATTCGTCTTGCATT-1_7_D5	33.66329578	-2.189764967	2	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2367	4804	0.01561199	0.005203997	5	2	EN-L4	40	16	16
CCCAATCAGCCGTCGT-1_7_D5	7.142305693	-20.8941368	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	6145	20878	0.011639046	0.007376185	5	L2-3	EN-L2-3-MS	40	16	16
CCCAATCGTAGGGACT-1_7_D5	15.47928765	12.36184367	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1379	2354	0	0.004672897	5	oligos	OL-Cntl	40	16	16
CCCAATCGTGCCTGTG-1_7_D5	8.657522111	18.40803494	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1268	1988	0.001509054	0.011066398	5	oligos	OL-Cntl	40	16	16
CCCAATCTCATGCATG-1_7_D5	0.197270918	16.53949372	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	806	1157	0.000864304	0.007778738	5	oligos	OL-Cntl	40	16	16
CCCAATCTCCGCAGTG-1_7_D5	14.85606969	13.62857894	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1216	2055	0.005352798	0.011192214	5	oligos	OL-Cntl	40	16	16
CCCAATCTCTACTTAC-1_7_D5	8.655258062	8.725851631	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1403	2265	0.008830022	0.014128035	5	oligos	OL-Cntl	40	16	16
CCCAGTTCAACCGCCA-1_7_D5	16.08215758	6.160912658	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2364	4884	0.005118755	0.009418509	5	oligos	OL-Cntl	40	16	16
CCCAGTTCAGACGTAG-1_7_D5	16.07133731	10.4763304	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1440	2353	0.002549936	0.009774756	5	oligos	OL-Cntl	40	16	16
CCCAGTTGTCGTTGTA-1_7_D5	2.124538589	19.55794571	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	870	1327	0.00075358	0.007535795	5	oligos	OL-Cntl	40	16	16
CCCAGTTGTGACCAAG-1_7_D5	-1.814098096	23.80303624	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	726	1016	0.007874016	0.00492126	5	oligos	OL-Cntl	40	16	16
CCCAGTTTCTGTCCGT-1_7_D5	30.70293583	15.66921417	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	980	1459	0.003427005	0.12131597	5	14	Microglia	40	16	16
CCCATACAGGAGTTGC-1_7_D5	-1.855024554	17.43325676	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	724	1042	0.016314779	0.013435701	5	oligos	OL-Cntl	40	16	16
CCCATACAGGAGTTTA-1_7_D5	-14.94102081	1.056749626	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3501	7588	0.006721139	0.014760148	5	13A	IN-VIP	40	16	16
CCCATACAGTGACATA-1_7_D5	13.15612389	-30.35385016	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3871	11030	0.004623753	0.002447869	5	3	EN-L5-6	40	16	16
CCCATACAGTTAGGTA-1_7_D5	4.067835651	18.64845379	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	962	1464	0.00273224	0.012295082	5	oligos	OL-Cntl	40	16	16
CCCTCCTAGCAGCCTC-1_7_D5	11.08660562	7.503012667	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1599	2893	0.003802281	0.016246111	5	oligos	OL-Cntl	40	16	16
CCCTCCTAGGCTAGAC-1_7_D5	-33.99658004	-9.645288015	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1002	1504	0.001329787	0.001994681	5	9	OPC	40	16	16
CCCTCCTCACAACTGT-1_7_D5	19.64287091	10.90356142	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1519	2703	0.000369959	0.007769145	5	oligos	OL-Cntl	40	16	16
CCCTCCTCAGCGATCC-1_7_D5	3.153823194	11.07413164	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1104	1770	0.012429379	0.020903955	5	oligos	OL-Cntl	40	16	16
CCCTCCTCAGCTGCAC-1_7_D5	-1.885833294	12.45726218	5	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	970	1460	0.010273973	0.028767123	5	oligos	OL-MS-1	40	16	16
CCCTCCTGTATGAAAC-1_7_D5	37.38353	10.72965977	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	961	1380	0.005072464	0.012318841	5	14	Microglia	40	16	16
CCCTCCTGTCGACTAT-1_7_D5	16.53007065	5.822524754	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2534	5625	0.005866667	0.012088889	5	oligos	OL-Cntl	40	16	16
CCCTCCTTCCGTAGGC-1_7_D5	38.79463935	14.7497783	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1222	1783	0.003365115	0.007851935	5	14	Microglia	40	16	16
CCCTCCTTCGCCATAA-1_7_D5	1.302630172	18.0956284	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	713	1121	0.001784121	0.007136485	5	oligos	OL-Cntl	40	16	16
CCCTCCTTCTATCCCG-1_7_D5	17.36886606	8.884472484	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1629	3065	0.001631321	0.005546493	5	oligos	OL-Cntl	40	16	16
CCGGGATAGGTGCTAG-1_7_D5	-0.461785868	14.31860322	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	870	1261	0.007137193	0.01665345	5	oligos	OL-Cntl	40	16	16
CCGGGATCACCGCTAG-1_7_D5	18.61969399	17.58276635	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1295	2127	0.000470146	0.004231312	5	oligos	OL-Cntl	40	16	16
CCGGGATGTATCTGCA-1_7_D5	7.860859412	-19.35950846	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	5167	14085	0.012069578	0.013276535	5	L2-3	EN-L2-3-MS	40	16	16
CCGGGATGTCTACCTC-1_7_D5	0.096280252	20.19841501	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	791	1131	0.004420866	0.007073386	5	oligos	OL-Cntl	40	16	16
CCGGGATGTTCCATGA-1_7_D5	-19.67219858	28.40214944	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2322	4708	0.002761257	0.006372133	5	8	Astrocytes	40	16	16
CCGGTAGCATACCATG-1_7_D5	4.001755265	15.99793469	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1073	1662	0	0.012033694	5	oligos	OL-Cntl	40	16	16
CCGGTAGCATCCGCGA-1_7_D5	13.5532922	9.847200894	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1459	2531	0.003951008	0.009087317	5	oligos	OL-Cntl	40	16	16
CCGGTAGCATGAGCGA-1_7_D5	-21.74203183	31.61531981	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3638	9056	0.002429329	0.004858657	5	8	Astrocytes	40	16	16
CCGGTAGGTAGCCTAT-1_7_D5	31.23879622	15.31405821	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	936	1307	0.009181331	0.078041316	5	14	Microglia	40	16	16
CCGGTAGGTGTGGCTC-1_7_D5	18.98579396	-26.71127353	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3507	8690	0.014844649	0.00310702	5	3	EN-L5-6	40	16	16
CCGTACTAGCTACCTA-1_7_D5	16.5929289	5.775163361	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2762	5889	0.001867889	0.00815079	5	oligos	OL-Cntl	40	16	16
CCGTACTAGTCACGCC-1_7_D5	11.41550726	-4.962019476	12	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	928	1442	0.017337032	0.000693481	5	12	EN-MIX	40	16	16
CCGTACTGTAAATACG-1_7_D5	12.44690843	10.86556013	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1226	1918	0.002606882	0.009384776	5	oligos	OL-Cntl	40	16	16
CCGTACTGTGACGCCT-1_7_D5	17.59913015	6.982417907	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2184	4304	0.00116171	0.009758364	5	oligos	OL-Cntl	40	16	16
CCGTACTTCCTTGCCA-1_7_D5	15.51516952	7.215548354	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1740	3415	0.001464129	0.009077599	5	oligos	OL-Cntl	40	16	16
CCGTGGAAGAAACGAG-1_7_D5	1.742681203	14.51081797	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	983	1482	0.007422402	0.021592443	5	oligos	OL-Cntl	40	16	16
CCGTGGACAATCAGAA-1_7_D5	12.71684364	0.886283744	12	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	885	1108	0.009927798	0.012635379	5	12	EN-MIX	40	16	16
CCGTGGAGTGTTTGTG-1_7_D5	9.328897359	13.34448033	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1162	1924	0.001559252	0.006756757	5	oligos	OL-Cntl	40	16	16
CCGTGGAGTTCAGGCC-1_7_D5	-20.49704542	28.34897349	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2206	4365	0.002749141	0.009163803	5	8	Astrocytes	40	16	16
CCGTGGATCCTCAACC-1_7_D5	12.97019543	-7.255547064	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3749	10938	0.00603401	0.002742732	5	3	EN-L5-6	40	16	16
CCGTGGATCTAACTCT-1_7_D5	8.024705955	-18.03198951	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4516	11078	0.009749052	0.013089005	5	L2-3	EN-L2-3-MS	40	16	16
CCGTTCAAGCCCTAAT-1_7_D5	1.100990775	-21.81684119	10	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4570	14618	0.007046108	0.003625667	5	L2-3	EN-L2-3-Cntl	40	16	16
CCGTTCAAGTCCGTAT-1_7_D5	32.5798431	16.10224549	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1296	1891	0.023268112	0.042834479	5	14	Microglia	40	16	16
CCGTTCACACCTCGGA-1_7_D5	2.900766318	11.76018452	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1035	1544	0.007124352	0.024611399	5	oligos	OL-Cntl	40	16	16
CCGTTCAGTGTTTGGT-1_7_D5	7.688298255	14.26887907	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	911	1328	0.005271084	0.015813253	5	oligos	OL-Cntl	40	16	16
CCGTTCATCCCTCAGT-1_7_D5	0.379651981	20.74203353	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	791	1147	0.012205754	0.007846556	5	oligos	OL-Cntl	40	16	16
CCGTTCATCTATCCCG-1_7_D5	38.28362038	15.03477938	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1268	1931	0.003107198	0.01294666	5	14	Microglia	40	16	16
CCGTTCATCTCTGCTG-1_7_D5	23.99333858	-28.90093169	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3124	7086	0.006915044	0.003951454	5	3	EN-L5-6	40	16	16
CCTAAAGAGTAGCCGA-1_7_D5	4.522211599	6.308850761	7	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1475	2226	0.006738544	0.013477089	5	7	Phagocytes	40	16	16
CCTAAAGCAAGCCGTC-1_7_D5	36.29078713	12.53433843	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	883	1226	0.009787928	0.032626427	5	14	Microglia	40	16	16
CCTAAAGCAGGGATTG-1_7_D5	-36.61425787	-0.814552051	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1586	2821	0.004962779	0.005671748	5	9	OPC	40	16	16
CCTAAAGGTATTAGCC-1_7_D5	0.786592924	19.24117998	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	819	1273	0.002356638	0.013354281	5	oligos	OL-Cntl	40	16	16
CCTAAAGGTTAAGAAC-1_7_D5	3.68089383	12.78680187	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1041	1650	0.001818182	0.012727273	5	oligos	OL-Cntl	40	16	16
CCTAAAGGTTGGACCC-1_7_D5	-30.46317825	1.685180149	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1966	3478	0.003450259	0.009488212	5	9	OPC	40	16	16
CCTAAAGTCACGATGT-1_7_D5	-31.29738769	1.548585791	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1926	3487	0.000860338	0.004588471	5	9	OPC	40	16	16
CCTACACAGTGTCTCA-1_7_D5	14.11558418	10.09398624	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1456	2505	0.000798403	0.008782435	5	oligos	OL-Cntl	40	16	16
CCTACACCATAAGACA-1_7_D5	32.80799049	16.78495927	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1469	2430	0.000823045	0.048559671	5	14	Microglia	40	16	16
CCTACACGTACTTGAC-1_7_D5	-19.36190426	29.6307601	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2626	5761	0.001909391	0.007984725	5	8	Astrocytes	40	16	16
CCTACACGTCTCGTTC-1_7_D5	-15.49957245	0.70343748	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3243	6554	0.007323772	0.013274336	5	13A	IN-VIP	40	16	16
CCTACACGTGGTCCGT-1_7_D5	11.40572723	18.15638839	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1063	1797	0.001112966	0.007234279	5	oligos	OL-Cntl	40	16	16
CCTACACTCCAGTATG-1_7_D5	10.1390318	17.67570618	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1002	1533	0.003913894	0.010437052	5	oligos	OL-Cntl	40	16	16
CCTACCACAATGAAAC-1_7_D5	12.87730918	10.81134382	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1422	2458	0.003254679	0.008950366	5	oligos	OL-Cntl	40	16	16
CCTACCACACATGACT-1_7_D5	15.58500237	10.01587888	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1583	2802	0.000356888	0.006423983	5	oligos	OL-Cntl	40	16	16
CCTACCACACTCTGTC-1_7_D5	11.94593787	6.762548435	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1810	3206	0.001871491	0.016531503	5	oligos	OL-Cntl	40	16	16
CCTACCACATCGATGT-1_7_D5	14.45735592	7.517403333	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1866	3554	0.005627462	0.007315701	5	oligos	OL-Cntl	40	16	16
CCTACCAGTACAGTGG-1_7_D5	9.3679293	-28.41968937	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	5664	20484	0.00068346	0.004930678	5	3	EN-L5-6	40	16	16
CCTACCAGTCTAACGT-1_7_D5	-35.81194307	-6.516803053	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1089	1738	0.000575374	0.002301496	5	9	OPC	40	16	16
CCTACCAGTCTCTTTA-1_7_D5	-36.60585235	-4.971180296	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1212	2207	0.004984141	0.004077934	5	9	OPC	40	16	16
CCTACCAGTCTTCTCG-1_7_D5	-6.262619423	14.81369868	5	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	881	1268	0.028391167	0.014195584	5	oligos	OL-MS-1	40	16	16
CCTACCAGTGACGCCT-1_7_D5	4.498510758	10.7732975	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1319	2154	0.006035283	0.018570102	5	oligos	OL-Cntl	40	16	16
CCTACCAGTGCCTGGT-1_7_D5	14.93347181	10.79852343	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1373	2540	0.001574803	0.004724409	5	oligos	OL-Cntl	40	16	16
CCTACCAGTTAAAGAC-1_7_D5	-1.177327923	24.96681366	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	778	1047	0	0.015281757	5	oligos	OL-Cntl	40	16	16
CCTACCAGTTACCAGT-1_7_D5	-19.43523796	29.92187781	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2684	5896	0.004070556	0.008310719	5	8	Astrocytes	40	16	16
CCTACCATCATGTCCC-1_7_D5	-12.59696581	1.006022293	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3519	9157	0.008408868	0.006770776	5	13A	IN-VIP	40	16	16
CCTACCATCCGCGCAA-1_7_D5	37.95395977	14.64572301	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1186	1721	0.004067403	0.015107496	5	14	Microglia	40	16	16
CCTACCATCGACCAGC-1_7_D5	13.05541182	9.888383915	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1484	2689	0.002603198	0.009297136	5	oligos	OL-Cntl	40	16	16
CCTAGCTAGACTGTAA-1_7_D5	8.468351819	31.34482606	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	748	1161	0.007751938	0.003445306	5	oligos	OL-Cntl	40	16	16
CCTAGCTAGATCCTGT-1_7_D5	31.0117559	15.70727651	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	899	1314	0.000761035	0.104261796	5	14	Microglia	40	16	16
CCTAGCTAGTCTCAAC-1_7_D5	12.38871515	-6.338542896	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1642	3209	0.018074166	0.006855718	5	3	EN-L5-6	40	16	16
CCTAGCTCATTACGAC-1_7_D5	9.261513995	13.78837251	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1058	1688	0.000592417	0.012440758	5	oligos	OL-Cntl	40	16	16
CCTAGCTGTGGTGTAG-1_7_D5	9.673487604	-14.39389937	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3847	8122	0.009480424	0.017360256	5	L2-3	EN-L2-3-MS	40	16	16
CCTAGCTGTTAAGATG-1_7_D5	25.64011419	-28.22231119	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4648	13142	0.002206666	0.004108964	5	3	EN-L5-6	40	16	16
CCTAGCTTCTCTGAGA-1_7_D5	16.17145091	5.942985838	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2225	4257	0.007282124	0.014564247	5	oligos	OL-Cntl	40	16	16
CCTAGCTTCTGCTTGC-1_7_D5	-30.95868388	2.372974835	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2345	4566	0.003723171	0.007446343	5	9	OPC	40	16	16
CCTATTAAGCTGCGAA-1_7_D5	38.03241134	12.15502633	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1048	1441	0.010409438	0.018043026	5	14	Microglia	40	16	16
CCTATTACAAGTACCT-1_7_D5	1.731659825	23.87728071	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	708	1045	0.00861244	0.00861244	5	oligos	OL-Cntl	40	16	16
CCTATTACAGCTGGCT-1_7_D5	-28.02616194	23.36363292	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1155	2115	0.001891253	0.008037825	5	8	Astrocytes	40	16	16
CCTATTACATACCATG-1_7_D5	-14.58750411	-6.757892147	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3875	9837	0.010165701	0.004574565	5	13A	IN-VIP	40	16	16
CCTATTAGTTTAGCTG-1_7_D5	9.937695478	21.04489858	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	879	1470	0.01292517	0.004081633	5	oligos	OL-Cntl	40	16	16
CCTCAGTAGCGTAGTG-1_7_D5	-19.30741757	27.77981865	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2117	4083	0.00122459	0.01077639	5	8	Astrocytes	40	16	16
CCTCAGTAGCGTTGCC-1_7_D5	-33.90686344	2.209603127	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1997	3581	0.005026529	0.007539793	5	9	OPC	40	16	16
CCTCAGTAGGGCTTCC-1_7_D5	-12.84034386	1.710431832	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3480	7059	0.003683241	0.007366483	5	13A	IN-VIP	40	16	16
CCTCAGTAGTTGTAGA-1_7_D5	-34.2720016	2.173362873	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1898	3461	0.004045074	0.004911875	5	9	OPC	40	16	16
CCTCAGTCACAGCGTC-1_7_D5	-18.94460345	29.75006808	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2838	6265	0.004628891	0.006384677	5	8	Astrocytes	40	16	16
CCTCAGTGTTCCTCCA-1_7_D5	6.344099942	-21.41988934	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	6665	23601	0.004406593	0.009236897	5	L2-3	EN-L2-3-MS	40	16	16
CCTCAGTGTTCGCTAA-1_7_D5	13.73931057	8.825352435	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1526	2921	0.003423485	0.009585758	5	oligos	OL-Cntl	40	16	16
CCTCAGTTCCCGGATG-1_7_D5	12.87992227	11.45805146	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1528	2630	0.010646388	0.007984791	5	oligos	OL-Cntl	40	16	16
CCTCAGTTCCTGCCAT-1_7_D5	5.028081497	14.41102643	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1019	1524	0.001312336	0.00984252	5	oligos	OL-Cntl	40	16	16
CCTCTGAAGCGTTCCG-1_7_D5	8.713150387	14.74917458	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1068	1648	0.003640777	0.010315534	5	oligos	OL-Cntl	40	16	16
CCTCTGAAGGATCGCA-1_7_D5	-21.61399863	26.08485988	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1781	3457	0.002603413	0.005206827	5	8	Astrocytes	40	16	16
CCTCTGACACCATCCT-1_7_D5	2.40199365	12.38999434	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	960	1502	0.008655126	0.015312916	5	oligos	OL-Cntl	40	16	16
CCTCTGAGTCATTAGC-1_7_D5	12.17165043	10.59472963	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1363	2357	0.002121341	0.012728044	5	oligos	OL-Cntl	40	16	16
CCTTACGAGATCCCGC-1_7_D5	-32.4193516	-12.00318354	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	904	1346	0.002971768	0.001485884	5	9	OPC	40	16	16
CCTTACGAGCCAGAAC-1_7_D5	2.724545867	-22.19165499	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4714	14813	0.004455546	0.002767839	5	L2-3	EN-L2-3-MS	40	16	16
CCTTACGAGCTGTCTA-1_7_D5	-35.09690379	-4.608598616	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1249	2024	0.01284585	0.005434783	5	9	OPC	40	16	16
CCTTACGAGTGGGTTG-1_7_D5	31.999575	-9.43748222	2	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4789	11758	0.016839599	0.007484266	5	2	EN-L4	40	16	16
CCTTACGAGTTGAGTA-1_7_D5	-33.05514266	5.318750766	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3549	7733	0.005043321	0.005431269	5	9	OPC	40	16	16
CCTTACGAGTTGTAGA-1_7_D5	-23.47500393	-18.84839204	6B	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3305	7086	0.022861981	0.014535704	5	6B	IN-SST	40	16	16
CCTTACGCACCAGGCT-1_7_D5	13.39323209	10.47873701	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1266	2070	0.007246377	0.006763285	5	oligos	OL-Cntl	40	16	16
CCTTACGCATTGGGCC-1_7_D5	6.295601755	9.631441965	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1128	1775	0.002253521	0.014084507	5	oligos	OL-Cntl	40	16	16
CCTTACGGTCCTCCAT-1_7_D5	-19.05150025	29.48228193	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2720	5804	0.001206065	0.006374914	5	8	Astrocytes	40	16	16
CCTTACGGTTGGAGGT-1_7_D5	-18.80601935	28.76783846	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2353	4740	0.001687764	0.008227848	5	8	Astrocytes	40	16	16
CCTTACGTCTTACCTA-1_7_D5	-25.32373961	22.49742137	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1307	2418	0.003308519	0.005376344	5	8	Astrocytes	40	16	16
CCTTACGTCTTGGGTA-1_7_D5	13.96679398	7.671722656	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1632	2635	0.001897533	0.012903226	5	oligos	OL-Cntl	40	16	16
CCTTCCCAGACTACAA-1_7_D5	-20.34321574	30.24065191	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2592	5337	0.002810568	0.00637062	5	8	Astrocytes	40	16	16
CCTTCCCAGAGTAATC-1_7_D5	14.88935358	8.808307566	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1707	3064	0.002610966	0.006201044	5	oligos	OL-Cntl	40	16	16
CCTTCCCAGGCAGTCA-1_7_D5	7.061578957	27.52083294	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	807	1245	0	0.002409639	5	oligos	OL-Cntl	40	16	16
CCTTCCCCACGGACAA-1_7_D5	-1.365799722	16.99666717	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	805	1198	0.001669449	0.012520868	5	oligos	OL-Cntl	40	16	16
CCTTCCCCACTTAACG-1_7_D5	38.65899895	13.05318876	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1083	1503	0.000665336	0.011310712	5	14	Microglia	40	16	16
CCTTCCCGTAAATACG-1_7_D5	32.32864603	15.76583176	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1105	1531	0.001306336	0.057478772	5	14	Microglia	40	16	16
CCTTCCCGTACATCCA-1_7_D5	17.11900144	-4.805430063	12	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1223	1920	0.002604167	0.002083333	5	12	EN-MIX	40	16	16
CCTTCCCGTGAGGGTT-1_7_D5	9.698481609	12.52212528	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1230	1946	0.004624872	0.012846865	5	oligos	OL-Cntl	40	16	16
CCTTCCCTCCCATTAT-1_7_D5	-19.56529549	29.03909813	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2380	5361	0.002238388	0.006528633	5	8	Astrocytes	40	16	16
CCTTCCCTCCGGCACA-1_7_D5	-38.39141042	-3.223784097	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1153	2049	0.006344558	0.002928258	5	9	OPC	40	16	16
CCTTCCCTCGCATGGC-1_7_D5	14.13629541	9.277372212	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1776	3195	0.002503912	0.007198748	5	oligos	OL-Cntl	40	16	16
CCTTCGACAATAGCGG-1_7_D5	32.6037456	14.95979576	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	764	1047	0.00191022	0.080229226	5	14	Microglia	40	16	16
CCTTCGACACCAGGTC-1_7_D5	15.33906797	19.44381084	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	974	1521	0.020381328	0.001972387	5	oligos	OL-Cntl	40	16	16
CCTTCGACACGGTGTC-1_7_D5	-25.39951911	11.21542603	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1044	1685	0.001186944	0.008308605	5	8	Astrocytes	40	16	16
CCTTCGAGTTACGCGC-1_7_D5	-3.207760693	17.45487994	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	877	1277	0.008613939	0.014095536	5	oligos	OL-Cntl	40	16	16
CCTTCGAGTTGATTCG-1_7_D5	10.30059225	17.87540084	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1012	1679	0.002977963	0.005955926	5	oligos	OL-Cntl	40	16	16
CCTTTCTCACATGTGT-1_7_D5	6.239226852	12.20344234	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1124	1788	0.001677852	0.010626398	5	oligos	OL-Cntl	40	16	16
CCTTTCTGTCACCTAA-1_7_D5	-10.07427415	23.26196485	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3331	6845	0.003214025	0.003798393	5	8	Astrocytes	40	16	16
CCTTTCTTCCTACAGA-1_7_D5	11.77149317	9.687970588	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1356	2391	0.00250941	0.006691761	5	oligos	OL-Cntl	40	16	16
CGAACATAGCCATCGC-1_7_D5	0.38231588	19.23358888	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	714	1021	0.002938296	0.007835455	5	oligos	OL-Cntl	40	16	16
CGAACATAGTCCATAC-1_7_D5	10.33754711	-27.19356391	10	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	7084	30668	0.003945481	0.00586931	5	L2-3	EN-L2-3-Cntl	40	16	16
CGAACATTCAACACTG-1_7_D5	24.68733465	-29.43684338	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3808	11626	0.005160846	0.001634268	5	3	EN-L5-6	40	16	16
CGAACATTCGCAAGCC-1_7_D5	2.902843606	15.13583009	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1062	1757	0.007398976	0.007968127	5	oligos	OL-Cntl	40	16	16
CGAACATTCGGCCGAT-1_7_D5	13.04255166	9.796782907	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1321	2273	0.002639683	0.012758469	5	oligos	OL-Cntl	40	16	16
CGAACATTCTGTACGA-1_7_D5	12.75709387	14.99205962	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1137	1775	0.007887324	0.015211268	5	oligos	OL-Cntl	40	16	16
CGAATGTAGACTTTCG-1_7_D5	-19.36905574	30.27872756	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2519	5750	0.001391304	0.013043478	5	8	Astrocytes	40	16	16
CGAATGTAGAGTCTGG-1_7_D5	-14.14161427	-21.68875502	6A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1299	2206	0.036718042	0.006799637	5	6A	IN-PV	40	16	16
CGAATGTGTTGTCTTT-1_7_D5	-31.46322908	12.99209526	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	834	1355	0.002214022	0.002214022	5	8	Astrocytes	40	16	16
CGAATGTTCTTATCTG-1_7_D5	0.98618379	-20.45251518	10	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3467	8863	0.004625973	0.005302945	5	L2-3	EN-L2-3-Cntl	40	16	16
CGACCTTAGTGACATA-1_7_D5	22.53464619	-28.64986941	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4834	14741	0.001967302	0.0033919	5	3	EN-L5-6	40	16	16
CGACCTTCAACTGCGC-1_7_D5	12.59938089	12.38020198	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1242	2014	0.000993049	0.008937438	5	oligos	OL-Cntl	40	16	16
CGACCTTGTAAACCTC-1_7_D5	-36.57951945	0.985180236	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1623	2962	0.001688049	0.004388926	5	9	OPC	40	16	16
CGACCTTTCACCTTAT-1_7_D5	32.88347035	16.74930392	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1227	1868	0.002141328	0.052462527	5	14	Microglia	40	16	16
CGACCTTTCAGCAACT-1_7_D5	16.47080999	6.159009672	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2344	4887	0.005524862	0.010640475	5	oligos	OL-Cntl	40	16	16
CGACCTTTCATCGCTC-1_7_D5	-28.09145988	17.34685568	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1022	1864	0.003755365	0.004828326	5	8	Astrocytes	40	16	16
CGACTTCAGTACGACG-1_7_D5	13.45710689	-30.33286247	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4025	12081	0.002566013	0.002979886	5	3	EN-L5-6	40	16	16
CGACTTCCACTTGGAT-1_7_D5	-32.19498683	3.276349571	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2373	4537	0.004849019	0.005730659	5	9	OPC	40	16	16
CGACTTCCATATGCTG-1_7_D5	37.00503193	11.69605435	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	871	1172	0.006825939	0.016211604	5	14	Microglia	40	16	16
CGACTTCGTATTAGCC-1_7_D5	26.60173998	-4.672158213	2	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3392	7979	0.002381251	0.003133225	5	2	EN-L4	40	16	16
CGACTTCGTCGGCACT-1_7_D5	-15.00385477	26.20028646	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3300	7920	0.013888889	0.009090909	5	8	Astrocytes	40	16	16
CGACTTCGTCTCAACA-1_7_D5	39.34145776	9.723113386	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	832	1118	0.007155635	0.008050089	5	14	Microglia	40	16	16
CGAGAAGAGTGCGATG-1_7_D5	8.290662786	-17.60468218	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	6095	19043	0.007351783	0.023263141	5	L2-3	EN-L2-3-MS	40	16	16
CGAGAAGCAAGCGTAG-1_7_D5	-2.415624531	15.11550494	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	736	1077	0.002785515	0.011142061	5	oligos	OL-Cntl	40	16	16
CGAGAAGCATCCCATC-1_7_D5	-30.53536588	-0.052544495	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1575	2515	0.013518887	0.009542744	5	9	OPC	40	16	16
CGAGAAGTCCGGGTGT-1_7_D5	-20.87026506	29.23537555	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2217	4471	0.001341982	0.003578618	5	8	Astrocytes	40	16	16
CGAGCACAGACAGACC-1_7_D5	6.298373776	13.52964822	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1257	1930	0.00880829	0.011398964	5	oligos	OL-Cntl	40	16	16
CGAGCACAGGGCTTCC-1_7_D5	-9.249171496	-1.775345088	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1844	3598	0.006114508	0.006670372	5	13A	IN-VIP	40	16	16
CGAGCACCAAACAACA-1_7_D5	-22.19173833	-17.03951797	6B	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4380	11035	0.0096058	0.006252832	5	6B	IN-SST	40	16	16
CGAGCACCATGCCTAA-1_7_D5	0.391312253	12.5655167	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1052	1618	0.00618047	0.016687268	5	oligos	OL-Cntl	40	16	16
CGAGCACGTTACCGAT-1_7_D5	3.524945596	-21.85278567	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	5198	16481	0.011407075	0.006310297	5	L2-3	EN-L2-3-MS	40	16	16
CGAGCACGTTCGGGCT-1_7_D5	-16.10448621	-4.14306296	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3657	8746	0.01589298	0.006860279	5	13A	IN-VIP	40	16	16
CGAGCACTCACGCATA-1_7_D5	32.33030875	16.73270971	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1327	2151	0.005578801	0.081357508	5	14	Microglia	40	16	16
CGAGCACTCCAAGTAC-1_7_D5	13.40087725	-29.98463541	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3102	7409	0.007828317	0.002294507	5	3	EN-L5-6	40	16	16
CGAGCACTCTCTGCTG-1_7_D5	-33.17498897	5.167061318	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3181	7065	0.002406228	0.004246285	5	9	OPC	40	16	16
CGAGCCAAGATAGGAG-1_7_D5	6.026682267	17.25952962	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1020	1622	0.003082614	0.004932182	5	oligos	OL-Cntl	40	16	16
CGAGCCAAGCCCAACC-1_7_D5	16.65879932	15.09764665	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1141	1843	0.00759631	0.004340749	5	oligos	OL-Cntl	40	16	16
CGAGCCAAGGAGTAGA-1_7_D5	8.0640701	-18.02206175	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	5849	17506	0.00645493	0.016223009	5	L2-3	EN-L2-3-MS	40	16	16
CGAGCCACAAGCGTAG-1_7_D5	-19.43865051	28.77334618	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2296	5059	0.00237201	0.010674046	5	8	Astrocytes	40	16	16
CGAGCCACAGCGTAAG-1_7_D5	-11.79294182	17.48632223	11	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2056	3653	0.001368738	0.011223652	5	11	Glia-MIX	40	16	16
CGAGCCAGTCTTGCGG-1_7_D5	-3.256903793	18.15754512	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	708	1003	0.001994018	0.00997009	5	oligos	OL-Cntl	40	16	16
CGAGCCAGTTGGTGGA-1_7_D5	-27.26219057	13.4767229	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	898	1425	0.003508772	0.003508772	5	8	Astrocytes	40	16	16
CGATCGGCACTTCTGC-1_7_D5	4.603551563	14.60132469	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1054	1473	0.003394433	0.021724372	5	oligos	OL-Cntl	40	16	16
CGATCGGCAGATCGGA-1_7_D5	-26.81735012	10.77428824	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	753	1239	0.004842615	0.005649718	5	8	Astrocytes	40	16	16
CGATCGGGTCAAACTC-1_7_D5	36.27872346	11.26160581	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	770	1019	0.007850834	0.028459274	5	14	Microglia	40	16	16
CGATGGCAGCCAGGAT-1_7_D5	2.906534735	13.35974963	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1031	1607	0.001866833	0.016179216	5	oligos	OL-Cntl	40	16	16
CGATGGCAGTAGCGGT-1_7_D5	35.49711062	-10.57205109	2	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4819	12295	0.013989427	0.009190728	5	2	EN-L4	40	16	16
CGATGGCCAAGGTTTC-1_7_D5	12.01022339	9.435850454	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1421	2481	0.022571544	0.006852076	5	oligos	OL-Cntl	40	16	16
CGATGGCCACTGTGTA-1_7_D5	32.28739771	-7.167240583	2	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4791	13682	0.012205818	0.009282269	5	2	EN-L4	40	16	16
CGATGGCCATCTCCCA-1_7_D5	13.00627755	-7.363345255	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4706	16055	0.003363438	0.002180006	5	3	EN-L5-6	40	16	16
CGATGGCCATGCAATC-1_7_D5	24.19794199	-10.01768167	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	5369	16496	0.016731329	0.003637245	5	3	EN-L5-6	40	16	16
CGATGTACAAGCGAGT-1_7_D5	2.68297368	12.20643164	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1049	1672	0.00777512	0.01076555	5	oligos	OL-Cntl	40	16	16
CGATGTACAATCCGAT-1_7_D5	-15.645645	0.309570727	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2943	5589	0.001073537	0.01735552	5	13A	IN-VIP	40	16	16
CGATGTACAGTAACGG-1_7_D5	-6.067341603	-5.265406933	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1308	2235	0.051901566	0.001789709	5	13A	IN-VIP	40	16	16
CGATGTAGTTCTGGTA-1_7_D5	10.02150278	11.65884811	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1167	1777	0.005064716	0.013505909	5	oligos	OL-Cntl	40	16	16
CGATGTATCAGCTCGG-1_7_D5	-3.128083176	13.00710326	5	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	847	1304	0.011503067	0.025306748	5	oligos	OL-MS-1	40	16	16
CGATGTATCGTCACGG-1_7_D5	2.289484646	23.98209237	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	753	1133	0.000882613	0.002647838	5	oligos	OL-Cntl	40	16	16
CGATTGAAGCAGACTG-1_7_D5	2.662027435	13.08806154	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	941	1398	0.001430615	0.017167382	5	oligos	OL-Cntl	40	16	16
CGATTGAGTGCCTGTG-1_7_D5	37.99806755	13.65679677	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	983	1345	0.000743494	0.019330855	5	14	Microglia	40	16	16
CGATTGAGTTCCACGG-1_7_D5	37.6280134	11.67378779	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	924	1312	0.00152439	0.012195122	5	14	Microglia	40	16	16
CGATTGATCAACGCTA-1_7_D5	-0.323728023	18.08328716	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	833	1116	0.008064516	0.012544803	5	oligos	OL-Cntl	40	16	16
CGATTGATCGTGTAGT-1_7_D5	-0.73194545	19.0240921	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	750	1099	0.006369427	0.005459509	5	oligos	OL-Cntl	40	16	16
CGCCAAGAGCGTAATA-1_7_D5	5.064148787	14.13388671	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1160	1912	0.013075314	0.014644351	5	oligos	OL-Cntl	40	16	16
CGCCAAGCAGGTCTCG-1_7_D5	10.57928629	18.22687998	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1089	1748	0.002860412	0.008581236	5	oligos	OL-Cntl	40	16	16
CGCCAAGCATGCATGT-1_7_D5	-21.73166837	28.87611347	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2019	3679	0.009785268	0.006251699	5	8	Astrocytes	40	16	16
CGCCAAGGTGACTCAT-1_7_D5	18.49383973	-25.00323905	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	7218	25842	0.010332018	0.00878415	5	3	EN-L5-6	40	16	16
CGCCAAGGTGTCTGAT-1_7_D5	-9.595863809	-5.427521207	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1831	3385	0.004726736	0.007090103	5	13A	IN-VIP	40	16	16
CGCCAAGGTTTGTTTC-1_7_D5	29.01385886	-3.482786639	2	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3966	10159	0.004724874	0.00442957	5	2	EN-L4	40	16	16
CGCCAAGTCACATAGC-1_7_D5	9.649604221	27.0781449	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	903	1399	0.015010722	0.00571837	5	oligos	OL-Cntl	40	16	16
CGCGGTACAAGCTGTT-1_7_D5	-28.50529529	-5.331271105	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1242	2020	0.007425743	0.008415842	5	9	OPC	40	16	16
CGCGGTACAAGTCATC-1_7_D5	16.28915079	-9.642506705	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3008	6931	0.009089597	0.006636849	5	3	EN-L5-6	40	16	16
CGCGGTACACTATCTT-1_7_D5	4.740462141	11.43688245	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1220	2006	0.012462612	0.013459621	5	oligos	OL-Cntl	40	16	16
CGCGGTACACTTACGA-1_7_D5	-23.95066121	0.617957905	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2640	5265	0.007977208	0.005128205	5	9	OPC	40	16	16
CGCGGTAGTTAGAACA-1_7_D5	11.90037546	-5.446696331	12	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1332	2270	0.012334802	0.010132159	5	12	EN-MIX	40	16	16
CGCGGTAGTTCAGTAC-1_7_D5	-32.04971975	2.810044636	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2229	4211	0.004749466	0.005224412	5	9	OPC	40	16	16
CGCGGTATCCAGAGGA-1_7_D5	-27.4074089	17.03894154	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1285	2379	0.000420345	0.002522068	5	8	Astrocytes	40	16	16
CGCGGTATCTGCGGCA-1_7_D5	12.22079673	9.061060093	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1440	2463	0.006902152	0.008932197	5	oligos	OL-Cntl	40	16	16
CGCGTTTCACACCGCA-1_7_D5	15.62221906	-26.9279555	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	6364	23416	0.00913905	0.005551759	5	3	EN-L5-6	40	16	16
CGCGTTTCATCTATGG-1_7_D5	10.35456691	12.27066008	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1255	2249	0.003557137	0.005780347	5	oligos	OL-Cntl	40	16	16
CGCGTTTGTCCAGTTA-1_7_D5	-20.35454609	28.27154438	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2077	4048	0.001976285	0.006422925	5	8	Astrocytes	40	16	16
CGCGTTTGTGTTTGTG-1_7_D5	7.063327702	26.66299875	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	832	1301	0.009223674	0.006917756	5	oligos	OL-Cntl	40	16	16
CGCGTTTTCCCATTAT-1_7_D5	7.986576653	3.433689917	12	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1367	1837	0.021774633	0.013609145	5	12	EN-MIX	40	16	16
CGCGTTTTCGCCAGCA-1_7_D5	-0.046868085	16.14467034	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	763	1107	0.021680217	0.018066847	5	oligos	OL-Cntl	40	16	16
CGCGTTTTCTCTGCTG-1_7_D5	12.7279784	-6.847170962	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2230	4671	0.028901734	0.013701563	5	3	EN-L5-6	40	16	16
CGCGTTTTCTGGAGCC-1_7_D5	-15.95328702	-20.86883899	6A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1783	3428	0.029463244	0.006709452	5	6A	IN-PV	40	16	16
CGCTATCAGACTGTAA-1_7_D5	23.45643862	-9.243207416	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4044	11896	0.001008742	0.003026227	5	3	EN-L5-6	40	16	16
CGCTATCAGATCTGAA-1_7_D5	17.34325761	-5.533757683	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1658	2872	0.01183844	0.002089136	5	3	EN-L5-6	40	16	16
CGCTATCAGATGTGGC-1_7_D5	8.299501254	14.46947093	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1050	1649	0.012128563	0.008489994	5	oligos	OL-Cntl	40	16	16
CGCTATCGTCATATCG-1_7_D5	1.955724012	15.51686323	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	841	1253	0.004788508	0.015961692	5	oligos	OL-Cntl	40	16	16
CGCTATCGTGGTCTCG-1_7_D5	1.043044261	16.30046425	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	932	1364	0.00659824	0.015395894	5	oligos	OL-Cntl	40	16	16
CGCTATCGTTCCCTTG-1_7_D5	35.11750261	7.603181743	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	819	1088	0.005514706	0.005514706	5	14	Microglia	40	16	16
CGCTATCTCCACGCAG-1_7_D5	35.02292715	15.26460578	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	934	1276	0.014106583	0.028213166	5	14	Microglia	40	16	16
CGCTATCTCCTCATTA-1_7_D5	-20.30481583	30.72798567	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3247	8151	0.003435161	0.006134217	5	8	Astrocytes	40	16	16
CGCTATCTCGCGTAGC-1_7_D5	-1.337458124	12.04574356	5	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	938	1343	0.002978407	0.017125838	5	oligos	OL-MS-1	40	16	16
CGCTATCTCTGTACGA-1_7_D5	-18.6990378	-21.10177542	6A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2743	5821	0.033327607	0.00292046	5	6A	IN-PV	40	16	16
CGCTATCTCTTTCCTC-1_7_D5	-20.74502374	26.87326602	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1814	4048	0.003952569	0.006916996	5	8	Astrocytes	40	16	16
CGCTGGAAGTCCAGGA-1_7_D5	-20.43732519	28.48993295	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2040	4059	0.00566642	0.009608278	5	8	Astrocytes	40	16	16
CGCTGGAAGTGCAAGC-1_7_D5	11.47301657	9.337702712	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1431	2340	0.018376068	0.013247863	5	oligos	OL-Cntl	40	16	16
CGCTGGACAAGCCCAC-1_7_D5	-14.37485473	-5.226789874	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3178	6694	0.008664476	0.005826113	5	13A	IN-VIP	40	16	16
CGCTGGACATGCAACT-1_7_D5	-15.10463029	1.673584417	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3967	8890	0.001012373	0.013835771	5	13A	IN-VIP	40	16	16
CGCTGGATCAACCAAC-1_7_D5	8.221747572	-17.8024652	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	5444	16338	0.006243114	0.01634227	5	L2-3	EN-L2-3-MS	40	16	16
CGCTGGATCGGGAGTA-1_7_D5	-39.40494071	-1.365967669	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1460	2639	0.000757863	0.003031451	5	9	OPC	40	16	16
CGCTGGATCTTCGAGA-1_7_D5	3.348301394	13.0691523	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	998	1527	0.001964637	0.016371971	5	oligos	OL-Cntl	40	16	16
CGCTTCACAATAACGA-1_7_D5	-32.33024329	2.811397446	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2157	3841	0.003384535	0.005988024	5	9	OPC	40	16	16
CGCTTCAGTACCCAAT-1_7_D5	2.025046961	16.44400393	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	899	1359	0.003679176	0.006622517	5	oligos	OL-Cntl	40	16	16
CGCTTCAGTCCGCTGA-1_7_D5	-15.01080135	-5.989303348	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4859	14390	0.011605281	0.010006949	5	13A	IN-VIP	40	16	16
CGCTTCAGTGCCTGCA-1_7_D5	-31.95042847	3.314946854	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2429	4569	0.00350186	0.004815058	5	9	OPC	40	16	16
CGCTTCATCAACACAC-1_7_D5	10.44114027	19.4008782	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	935	1410	0.003546099	0.007092199	5	oligos	OL-Cntl	40	16	16
CGCTTCATCCCTCAGT-1_7_D5	35.64251494	-7.148280451	2	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4058	10432	0.007285276	0.007285276	5	2	EN-L4	40	16	16
CGCTTCATCCTAGAAC-1_7_D5	17.65423249	8.124579804	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1856	3685	0.003527815	0.008683853	5	oligos	OL-Cntl	40	16	16
CGGACACAGCGTTTAC-1_7_D5	37.43070281	14.58262255	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1143	1633	0.006123699	0.023882425	5	14	Microglia	40	16	16
CGGACACAGTACGTAA-1_7_D5	11.24587435	22.73742747	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	852	1328	0.00376506	0.00753012	5	oligos	OL-Cntl	40	16	16
CGGACACCACCGATAT-1_7_D5	-11.44302805	1.601274881	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2977	6454	0.004338395	0.00464828	5	13A	IN-VIP	40	16	16
CGGACACCAGTTCCCT-1_7_D5	12.91517019	-7.148985742	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2827	7264	0.002340308	0.005506608	5	3	EN-L5-6	40	16	16
CGGACACGTACCGGCT-1_7_D5	30.42043219	16.11940512	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1273	1910	0.006806283	0.096335079	5	14	Microglia	40	16	16
CGGACACTCAGGATCT-1_7_D5	11.0343466	25.5901209	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	856	1336	0.004491018	0.002245509	5	oligos	OL-Cntl	40	16	16
CGGACGTAGGCAAAGA-1_7_D5	-1.831306471	27.00236977	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	815	1091	0.00091659	0.003666361	5	oligos	OL-Cntl	40	16	16
CGGACGTGTCGCCATG-1_7_D5	37.30979669	11.52226496	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	805	1082	0	0.015711645	5	14	Microglia	40	16	16
CGGACGTGTGCGCTTG-1_7_D5	37.11532366	9.151304272	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	857	1193	0.002514669	0.02263202	5	14	Microglia	40	16	16
CGGACGTTCAGCAACT-1_7_D5	0.277297894	19.57846192	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	870	1385	0.002888087	0.007220217	5	oligos	OL-Cntl	40	16	16
CGGACGTTCTTGTTTG-1_7_D5	35.30893196	-7.120243797	2	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4064	9892	0.012333199	0.006975334	5	2	EN-L4	40	16	16
CGGACTGAGAACAATC-1_7_D5	13.14477864	-30.04326955	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4469	13877	0.016790373	0.001801542	5	3	EN-L5-6	40	16	16
CGGACTGAGAATTCCC-1_7_D5	-22.1397918	-16.45424392	6B	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4113	10773	0.028404344	0.005569479	5	6B	IN-SST	40	16	16
CGGACTGAGAGTACAT-1_7_D5	-30.3522041	2.177896041	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2311	4112	0.007538911	0.005836576	5	9	OPC	40	16	16
CGGACTGCAGTTAACC-1_7_D5	19.43817281	-21.92629617	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	7681	31580	0.012571248	0.009183027	5	3	EN-L5-6	40	16	16
CGGACTGGTCAGATAA-1_7_D5	-3.590942318	16.86043151	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	768	1127	0.007985803	0.019520852	5	oligos	OL-Cntl	40	16	16
CGGACTGGTCATATGC-1_7_D5	11.53149249	9.588992176	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1344	2351	0.008507018	0.011909826	5	oligos	OL-Cntl	40	16	16
CGGACTGTCTTGAGAC-1_7_D5	38.39790383	13.67236386	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1131	1667	0.00119976	0.0119976	5	14	Microglia	40	16	16
CGGAGCTAGATTACCC-1_7_D5	11.30028599	1.877390324	12	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	663	1105	0.006334842	0.013574661	5	12	EN-MIX	40	16	16
CGGAGCTAGTAATCCC-1_7_D5	37.65468166	11.86042747	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	875	1190	0.004201681	0.015966387	5	14	Microglia	40	16	16
CGGAGCTCACGGATAG-1_7_D5	4.097915186	14.18708268	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	891	1312	0.016768293	0.016768293	5	oligos	OL-Cntl	40	16	16
CGGAGCTTCAAGCCTA-1_7_D5	12.59454378	-6.654746852	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2090	4805	0.017689906	0.004786681	5	3	EN-L5-6	40	16	16
CGGAGCTTCCCTTGTG-1_7_D5	-6.664148973	-37.05608402	16	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	932	1339	0.075429425	0.023898432	5	16	EN-PYR	40	16	16
CGGAGTCAGATCCTGT-1_7_D5	3.841388079	24.75143441	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	781	1157	0.015557476	0.005185825	5	oligos	OL-Cntl	40	16	16
CGGAGTCCACGGTAGA-1_7_D5	-31.7027911	2.644167132	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2205	4148	0.003857281	0.006750241	5	9	OPC	40	16	16
CGGAGTCGTACTCTCC-1_7_D5	-3.543278658	18.8704257	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	747	1115	0.00896861	0.008071749	5	oligos	OL-Cntl	40	16	16
CGGAGTCGTGTGGTTT-1_7_D5	5.331723251	15.07549956	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1066	1706	0.015826495	0.008792497	5	oligos	OL-Cntl	40	16	16
CGGAGTCTCCGGCACA-1_7_D5	16.35274169	8.212218516	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1849	3303	0.007568877	0.012412958	5	oligos	OL-Cntl	40	16	16
CGGAGTCTCGTGGGAA-1_7_D5	-2.582961474	17.47707788	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	725	1037	0.00096432	0.012536162	5	oligos	OL-Cntl	40	16	16
CGGCTAGAGATCACGG-1_7_D5	-2.771960561	16.1834028	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	840	1274	0.003139717	0.014128728	5	oligos	OL-Cntl	40	16	16
CGGCTAGAGGCTAGAC-1_7_D5	1.537844448	19.13544523	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	872	1363	0.001467351	0.011738811	5	oligos	OL-Cntl	40	16	16
CGGCTAGAGTGTCCCG-1_7_D5	21.29828785	-26.1691015	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3855	9514	0.001997057	0.008408661	5	3	EN-L5-6	40	16	16
CGGCTAGAGTTTGCGT-1_7_D5	23.58991576	-9.49423362	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4207	11018	0.002904338	0.003721184	5	3	EN-L5-6	40	16	16
CGGCTAGCAGTTAACC-1_7_D5	17.11103018	12.36618194	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1539	2760	0.000724638	0.003985507	5	oligos	OL-Cntl	40	16	16
CGGCTAGGTCAAAGCG-1_7_D5	-4.769129598	23.06790415	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	642	1006	0.000994036	0.005964215	5	oligos	OL-Cntl	40	16	16
CGGCTAGGTTAAGATG-1_7_D5	23.00351884	-29.41231224	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3717	10346	0.002223081	0.001256524	5	3	EN-L5-6	40	16	16
CGGCTAGTCATCATTC-1_7_D5	8.281581359	9.847217232	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1439	2469	0.004860267	0.010935601	5	oligos	OL-Cntl	40	16	16
CGGCTAGTCTCGAGTA-1_7_D5	-33.48569261	0.899982814	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1861	3186	0.011927181	0.007219083	5	9	OPC	40	16	16
CGGGTCAAGGACACCA-1_7_D5	-19.80680242	27.42119731	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2117	4355	0.00206659	0.007118255	5	8	Astrocytes	40	16	16
CGGGTCAAGTCTTGCA-1_7_D5	10.58223224	7.171984993	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1660	2803	0.003567606	0.014983946	5	oligos	OL-Cntl	40	16	16
CGGGTCACACGAAAGC-1_7_D5	-6.776492517	10.9245249	5	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	787	1234	0.003241491	0.017017828	5	oligos	OL-MS-1	40	16	16
CGGGTCACAGCCTTTC-1_7_D5	-32.82969487	1.168101594	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1930	3318	0.01416516	0.009041591	5	9	OPC	40	16	16
CGGGTCACATCGATGT-1_7_D5	13.77168058	13.88187519	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1179	2006	0.006979063	0.007477567	5	oligos	OL-Cntl	40	16	16
CGGGTCATCCACGTTC-1_7_D5	31.99888809	15.91167488	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1004	1452	0.00137741	0.074380165	5	14	Microglia	40	16	16
CGGTTAAAGATTACCC-1_7_D5	-21.20356806	26.04080995	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1766	3984	0.001004016	0.006777108	5	8	Astrocytes	40	16	16
CGGTTAAAGTGAAGAG-1_7_D5	-30.99699598	2.258482257	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2107	3831	0.006003654	0.007047768	5	9	OPC	40	16	16
CGGTTAAAGTGTGAAT-1_7_D5	13.59891752	-30.07821041	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3572	9204	0.004563233	0.003150804	5	3	EN-L5-6	40	16	16
CGGTTAACAGGCGATA-1_7_D5	5.549822033	11.48390258	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1096	1577	0.003804692	0.010779962	5	oligos	OL-Cntl	40	16	16
CGGTTAACAGTGACAG-1_7_D5	15.19809967	-2.057394599	12	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	970	1551	0.001934236	0.004513217	5	12	EN-MIX	40	16	16
CGGTTAACATTCTTAC-1_7_D5	38.36936776	9.778456539	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	874	1164	0.000859107	0.006013746	5	14	Microglia	40	16	16
CGGTTAATCAGAGACG-1_7_D5	10.89816656	17.90000265	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1044	1637	0.001832621	0.006719609	5	oligos	OL-Cntl	40	16	16
CGGTTAATCCACGAAT-1_7_D5	2.068729488	12.21716876	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	924	1283	0.009353079	0.028059236	5	oligos	OL-Cntl	40	16	16
CGTAGCGAGGTACTCT-1_7_D5	9.752382916	16.2345748	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1011	1624	0.018472906	0.008004926	5	oligos	OL-Cntl	40	16	16
CGTAGCGAGTATTGGA-1_7_D5	7.331926456	-18.29809505	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4010	9220	0.007266811	0.012906725	5	L2-3	EN-L2-3-MS	40	16	16
CGTAGCGGTTACGACT-1_7_D5	13.33208676	9.164645794	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1452	2464	0.000811688	0.006493506	5	oligos	OL-Cntl	40	16	16
CGTAGCGTCACCCTCA-1_7_D5	-26.33398354	10.83838895	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	901	1366	0.004392387	0.004392387	5	8	Astrocytes	40	16	16
CGTAGCGTCAGAAATG-1_7_D5	11.92591103	-5.593821242	12	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1442	2789	0.048045895	0.004302617	5	12	EN-MIX	40	16	16
CGTAGCGTCAGGCAAG-1_7_D5	17.67204854	16.87576283	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1226	1999	0.005002501	0.003001501	5	oligos	OL-Cntl	40	16	16
CGTAGGCAGACAGGCT-1_7_D5	8.478104027	12.00077511	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1213	2083	0.006721075	0.015362458	5	oligos	OL-Cntl	40	16	16
CGTAGGCAGCACGCCT-1_7_D5	-24.01183153	-25.39571223	6A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	6233	19091	0.003928553	0.009428527	5	6A	IN-PV	40	16	16
CGTAGGCAGCGATGAC-1_7_D5	-24.5676656	23.83648253	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1284	2285	0.007439825	0.004814004	5	8	Astrocytes	40	16	16
CGTAGGCAGGACAGCT-1_7_D5	-19.76997675	28.7846149	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2352	5158	0.003295851	0.005428461	5	8	Astrocytes	40	16	16
CGTAGGCAGGGTCTCC-1_7_D5	-34.78186588	1.096765196	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1787	3265	0.000918836	0.00704441	5	9	OPC	40	16	16
CGTAGGCCAATCACAC-1_7_D5	-35.29997548	1.710331816	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1890	3445	0.006386067	0.003773585	5	9	OPC	40	16	16
CGTAGGCCACCCATGG-1_7_D5	-0.130131325	15.71018332	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	837	1247	0.000801925	0.012830794	5	oligos	OL-Cntl	40	16	16
CGTAGGCCACGACTCG-1_7_D5	-32.93384149	5.347054207	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3660	8225	0.020182371	0.009118541	5	9	OPC	40	16	16
CGTAGGCCAGATGGGT-1_7_D5	-35.96410729	-8.917102655	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	892	1352	0.000739645	0.00591716	5	9	OPC	40	16	16
CGTAGGCGTACAGTTC-1_7_D5	10.64557515	7.320177283	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1532	2507	0.003191065	0.017151974	5	oligos	OL-Cntl	40	16	16
CGTAGGCGTAGCGATG-1_7_D5	-35.79675865	3.647765875	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2075	3872	0.001033058	0.005940083	5	9	OPC	40	16	16
CGTAGGCGTCCCGACA-1_7_D5	11.39276258	8.554214756	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1455	2463	0.009338205	0.017864393	5	oligos	OL-Cntl	40	16	16
CGTAGGCGTTAAGATG-1_7_D5	-34.19874894	1.929831097	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1892	3307	0.004838222	0.007559722	5	9	OPC	40	16	16
CGTAGGCTCTGCGTAA-1_7_D5	-19.38524831	26.24838104	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2133	4172	0.004793864	0.007670182	5	8	Astrocytes	40	16	16
CGTAGGCTCTGGTATG-1_7_D5	14.42252827	-29.65987552	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4271	12644	0.005457134	0.004191711	5	3	EN-L5-6	40	16	16
CGTAGGCTCTGGTTCC-1_7_D5	4.977370211	5.559009106	7	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2009	3454	0.00492183	0.00492183	5	7	Phagocytes	40	16	16
CGTCACTAGATAGCAT-1_7_D5	4.198409839	21.73047917	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	881	1361	0.016164585	0.003673769	5	oligos	OL-Cntl	40	16	16
CGTCACTAGCCACGTC-1_7_D5	-20.67877423	27.25217165	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1807	3160	0.000949367	0.006962025	5	8	Astrocytes	40	16	16
CGTCACTAGTGGAGTC-1_7_D5	4.188967732	11.07675179	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1221	2001	0.011494253	0.014492754	5	oligos	OL-Cntl	40	16	16
CGTCACTGTGCACCAC-1_7_D5	-7.560879475	11.71485095	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	693	1055	0.002843602	0.015165877	5	oligos	OL-Cntl	40	16	16
CGTCACTTCAGCTCGG-1_7_D5	12.51725098	-31.18168383	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2635	6238	0.006732927	0.004809234	5	3	EN-L5-6	40	16	16
CGTCACTTCTGTACGA-1_7_D5	-37.74609118	-0.790503286	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1429	2482	0.002820306	0.003626108	5	9	OPC	40	16	16
CGTCAGGAGAGATGAG-1_7_D5	10.55220112	13.13383905	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1158	1856	0.001077586	0.011314655	5	oligos	OL-Cntl	40	16	16
CGTCAGGAGGATGGAA-1_7_D5	33.0747613	14.43207569	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1031	1414	0.002121641	0.024752475	5	14	Microglia	40	16	16
CGTCAGGAGTGTGGCA-1_7_D5	-27.92600379	-22.77300953	6A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	5912	17579	0.018829285	0.016440071	5	6A	IN-PV	40	16	16
CGTCAGGTCACCACCT-1_7_D5	13.27579745	-29.76897607	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3418	8645	0.019317525	0.002891845	5	3	EN-L5-6	40	16	16
CGTCCATAGATGCCAG-1_7_D5	-19.76867534	28.45498441	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2197	4548	0.001759015	0.007475814	5	8	Astrocytes	40	16	16
CGTCCATAGCGTTTAC-1_7_D5	8.365285092	11.99474799	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1207	1953	0.005120328	0.00921659	5	oligos	OL-Cntl	40	16	16
CGTCCATAGCTCCCAG-1_7_D5	19.19351269	-25.42965832	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4248	11283	0.01462377	0.008242489	5	3	EN-L5-6	40	16	16
CGTCCATAGGTACTCT-1_7_D5	5.232153641	11.57943012	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1303	2054	0.004381694	0.012171373	5	oligos	OL-Cntl	40	16	16
CGTCCATAGTTACCCA-1_7_D5	10.70064829	17.7595976	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1007	1580	0.015189873	0.00443038	5	oligos	OL-Cntl	40	16	16
CGTCCATCACGGTGTC-1_7_D5	0.383467603	18.06946666	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	817	1195	0.005020921	0.006694561	5	oligos	OL-Cntl	40	16	16
CGTCCATCAGCTCCGA-1_7_D5	9.491478178	7.897417464	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1693	2839	0.006340261	0.009510391	5	oligos	OL-Cntl	40	16	16
CGTCCATTCATGTCTT-1_7_D5	9.765057619	12.07046816	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1206	1816	0.003303965	0.007709251	5	oligos	OL-Cntl	40	16	16
CGTCCATTCCCAAGAT-1_7_D5	0.516773016	15.90759324	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1004	1554	0.005148005	0.00965251	5	oligos	OL-Cntl	40	16	16
CGTCCATTCGCCATAA-1_7_D5	-35.63657831	-7.368139927	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1111	1735	0.00518732	0.002881844	5	9	OPC	40	16	16
CGTCTACAGCCACGCT-1_7_D5	6.365733586	-21.38989057	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	6734	25166	0.005642534	0.008900898	5	L2-3	EN-L2-3-MS	40	16	16
CGTCTACAGGCCATAG-1_7_D5	-25.31947652	23.49673178	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1540	3017	0.001988731	0.005634736	5	8	Astrocytes	40	16	16
CGTCTACAGGCCGAAT-1_7_D5	12.0122731	-5.755416152	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1530	2766	0.003615329	0.001446132	5	3	EN-L5-6	40	16	16
CGTCTACCACCAGTTA-1_7_D5	1.576184454	23.49352612	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	749	1083	0.00923361	0.001846722	5	oligos	OL-Cntl	40	16	16
CGTCTACGTTATCCGA-1_7_D5	-1.441771827	17.25059928	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	814	1196	0.007525084	0.013377926	5	oligos	OL-Cntl	40	16	16
CGTCTACTCAAACCAC-1_7_D5	-34.70820896	2.305106754	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1969	3732	0.003215434	0.006698821	5	9	OPC	40	16	16
CGTCTACTCAACTCTT-1_7_D5	-4.681391312	-3.776985404	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1229	2028	0.029092702	0.000986193	5	13A	IN-VIP	40	16	16
CGTCTACTCCTCCTAG-1_7_D5	12.41887252	-6.3667247	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1842	4143	0.01472363	0.003137823	5	3	EN-L5-6	40	16	16
CGTCTACTCTAGAGTC-1_7_D5	19.09221404	10.99743458	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1549	2849	0.006318006	0.002457002	5	oligos	OL-Cntl	40	16	16
CGTGAGCAGGACCACA-1_7_D5	-2.871264233	14.47773983	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	723	1020	0.001960784	0.029411765	5	oligos	OL-Cntl	40	16	16
CGTGAGCAGTCTCGGC-1_7_D5	9.835262402	13.27510235	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1159	1826	0.014238773	0.006571742	5	oligos	OL-Cntl	40	16	16
CGTGAGCCATAGGATA-1_7_D5	-24.34137103	23.77814833	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1397	2301	0.003911343	0.008691873	5	8	Astrocytes	40	16	16
CGTGAGCCATGTAGTC-1_7_D5	11.3084515	-0.252570895	12	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1134	1890	0.016402116	0.007407407	5	12	EN-MIX	40	16	16
CGTGAGCGTATCACCA-1_7_D5	10.75561378	9.829262481	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1314	2044	0.010273973	0.014677104	5	oligos	OL-Cntl	40	16	16
CGTGAGCGTGGTTTCA-1_7_D5	35.42232333	14.77317911	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1164	1612	0.009305211	0.017990074	5	14	Microglia	40	16	16
CGTGAGCTCAAGGCTT-1_7_D5	1.568815988	15.0681452	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	948	1524	0.010498688	0.00656168	5	oligos	OL-Cntl	40	16	16
CGTGAGCTCGGAGGTA-1_7_D5	-1.05100917	17.19145365	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	841	1197	0	0.015037594	5	oligos	OL-Cntl	40	16	16
CGTGAGCTCTCCGGTT-1_7_D5	-15.15214312	-7.599400029	13B	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2865	6231	0.011715615	0.004814636	5	13B	IN-SV2C	40	16	16
CGTGAGCTCTGCGACG-1_7_D5	30.62457765	15.54760252	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	958	1358	0.002945508	0.120765832	5	14	Microglia	40	16	16
CGTGTAAAGAATCTCC-1_7_D5	-16.80787799	0.144631286	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4377	10322	0.009300523	0.013950785	5	13A	IN-VIP	40	16	16
CGTGTAAAGAGGTTGC-1_7_D5	15.38539848	10.39323814	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1472	2542	0.002360346	0.010228167	5	oligos	OL-Cntl	40	16	16
CGTGTAAAGGAACTGC-1_7_D5	29.84094803	9.436582452	15DB	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1338	3735	0.004283802	0.027576975	5	15DB	B cells	40	16	16
CGTGTAAAGGTCGGAT-1_7_D5	-35.68473762	-3.434963535	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1313	2178	0.000459137	0.005050505	5	9	OPC	40	16	16
CGTGTAACAATAGAGT-1_7_D5	8.557604692	13.74686808	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	993	1475	0.010847458	0.008813559	5	oligos	OL-Cntl	40	16	16
CGTGTCTCAGACTCGC-1_7_D5	-25.56123703	23.00980573	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1340	2523	0.004756243	0.007530717	5	8	Astrocytes	40	16	16
CGTGTCTCAGATGGGT-1_7_D5	-17.17847316	-26.305218	6A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2462	5578	0.004840445	0.003047687	5	6A	IN-PV	40	16	16
CGTGTCTGTACTTCTT-1_7_D5	-6.249304116	-2.893754514	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1821	3331	0.012308616	0.008405884	5	13A	IN-VIP	40	16	16
CGTGTCTGTGATAAGT-1_7_D5	31.769517	15.07451864	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	816	1133	0.01059135	0.060017652	5	14	Microglia	40	16	16
CGTGTCTGTGCCTGCA-1_7_D5	9.108337986	-21.42238919	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	6622	21143	0.007520219	0.010216147	5	L2-3	EN-L2-3-MS	40	16	16
CGTGTCTGTGCCTGGT-1_7_D5	19.60197483	-22.08676014	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4418	10918	0.019509068	0.007785309	5	3	EN-L5-6	40	16	16
CGTGTCTGTTAGAACA-1_7_D5	14.76094622	11.87393415	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1586	2707	0.000369413	0.008865903	5	oligos	OL-Cntl	40	16	16
CGTTAGAAGCTAAGAT-1_7_D5	8.157897031	-17.6333299	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4415	10789	0.006580777	0.022986375	5	L2-3	EN-L2-3-MS	40	16	16
CGTTAGACAAGGACTG-1_7_D5	3.721807326	30.94304188	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	814	1165	0.004291845	0.008583691	5	oligos	OL-Cntl	40	16	16
CGTTAGACAATCTGCA-1_7_D5	6.881887217	11.2808201	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1063	1572	0.000636132	0.01653944	5	oligos	OL-Cntl	40	16	16
CGTTAGAGTGCAACTT-1_7_D5	-19.75212663	30.20228431	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2333	4640	0.007543103	0.006465517	5	8	Astrocytes	40	16	16
CGTTAGATCGAATGGG-1_7_D5	36.35876872	11.48880619	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	785	1039	0.00481232	0.02213667	5	14	Microglia	40	16	16
CGTTAGATCGCAAACT-1_7_D5	15.95792579	10.85410634	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1327	2196	0.009562842	0.008196721	5	oligos	OL-Cntl	40	16	16
CGTTAGATCGTCCAGG-1_7_D5	-35.40077029	2.194261545	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1794	3179	0.000629129	0.004403901	5	9	OPC	40	16	16
CGTTCTGAGGAGTAGA-1_7_D5	2.902753163	12.5890645	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1077	1646	0.016403402	0.012758202	5	oligos	OL-Cntl	40	16	16
CGTTCTGCAAAGGAAG-1_7_D5	-37.01009832	-0.874654635	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1480	2584	0.003869969	0.004256966	5	9	OPC	40	16	16
CGTTCTGCACTCGACG-1_7_D5	10.90160967	18.3635979	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1058	1851	0.011345219	0.002701243	5	oligos	OL-Cntl	40	16	16
CGTTCTGGTGGACGAT-1_7_D5	-19.9750846	29.65726068	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2585	5734	0.002441577	0.006975933	5	8	Astrocytes	40	16	16
CGTTCTGTCATCGCTC-1_7_D5	14.60769143	10.83414437	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1292	2234	0.007609669	0.007162041	5	oligos	OL-Cntl	40	16	16
CGTTCTGTCCATGCTC-1_7_D5	-8.284627044	7.637480696	5	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	802	1134	0.00617284	0.043209877	5	oligos	OL-MS-1	40	16	16
CGTTCTGTCCTTTCGG-1_7_D5	11.21344188	10.17366885	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1375	2450	0.002857143	0.006122449	5	oligos	OL-Cntl	40	16	16
CGTTGGGAGACCGGAT-1_7_D5	-31.71149199	0.412505074	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1882	3255	0.002457757	0.004301075	5	9	OPC	40	16	16
CGTTGGGAGCTGCCCA-1_7_D5	-14.20077831	1.858811863	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4661	11661	0.011748564	0.008404082	5	13A	IN-VIP	40	16	16
CGTTGGGCAATGGTCT-1_7_D5	31.73918962	16.30402347	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1056	1482	0.00877193	0.084345479	5	14	Microglia	40	16	16
CGTTGGGCACCGGAAA-1_7_D5	10.38072694	7.303962051	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1532	2656	0.041039157	0.025978916	5	oligos	OL-Cntl	40	16	16
CGTTGGGGTGCATCTA-1_7_D5	13.67084137	7.079498623	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1793	3153	0.004123057	0.010783381	5	oligos	OL-Cntl	40	16	16
CTAACTTAGAACAACT-1_7_D5	18.72850808	23.88855968	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	990	1568	0.007653061	0.004464286	5	oligos	OL-Cntl	40	16	16
CTAACTTAGCGTAGTG-1_7_D5	-32.32022194	-8.490924966	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1055	1471	0.003399048	0.005438477	5	9	OPC	40	16	16
CTAACTTAGGATGGTC-1_7_D5	23.12720123	-6.831262429	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4631	13404	0.002163533	0.005669949	5	3	EN-L5-6	40	16	16
CTAACTTAGTCCGTAT-1_7_D5	-0.986591759	15.54219359	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	791	1182	0.003384095	0.017766497	5	oligos	OL-Cntl	40	16	16
CTAACTTCAAAGCGGT-1_7_D5	-25.62654988	22.41129567	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1180	1868	0.004817987	0.006959315	5	8	Astrocytes	40	16	16
CTAACTTCACGGCTAC-1_7_D5	0.077620085	12.86139062	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	926	1362	0.000734214	0.01835536	5	oligos	OL-Cntl	40	16	16
CTAACTTGTATATCCG-1_7_D5	-13.60967272	-0.509066059	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2688	4922	0.016253555	0.010158472	5	13A	IN-VIP	40	16	16
CTAACTTGTGACGGTA-1_7_D5	-24.21055841	15.48941189	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1165	1954	0.008188332	0.004094166	5	8	Astrocytes	40	16	16
CTAACTTTCAGTGCAT-1_7_D5	-9.788588795	-2.389854738	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2091	4247	0.013421239	0.004473746	5	13A	IN-VIP	40	16	16
CTAAGACAGGTACTCT-1_7_D5	5.69284856	-26.97504424	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	5955	18803	0.005477849	0.006169228	5	L2-3	EN-L2-3-MS	40	16	16
CTAAGACCAATGACCT-1_7_D5	38.27407061	12.59878066	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1036	1521	0.009204471	0.01183432	5	14	Microglia	40	16	16
CTAAGACTCACCACCT-1_7_D5	-0.076151187	13.90663552	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	960	1449	0.004140787	0.010351967	5	oligos	OL-Cntl	40	16	16
CTAAGACTCCGAACGC-1_7_D5	-1.509604858	22.11172902	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	725	1063	0.011288805	0.00752587	5	oligos	OL-Cntl	40	16	16
CTAATGGAGACCCACC-1_7_D5	1.773102477	20.72085187	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	839	1305	0.009961686	0.012260536	5	oligos	OL-Cntl	40	16	16
CTAATGGCACGTCTCT-1_7_D5	11.03581316	8.498480994	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1388	2295	0.003485839	0.010021786	5	oligos	OL-Cntl	40	16	16
CTAATGGCATCGTCGG-1_7_D5	-2.743287271	15.04082186	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	828	1268	0.014195584	0.021293375	5	oligos	OL-Cntl	40	16	16
CTAATGGGTAGCCTAT-1_7_D5	3.081319807	20.41320912	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	862	1195	0.021757322	0.0041841	5	oligos	OL-Cntl	40	16	16
CTAATGGGTATAGTAG-1_7_D5	-18.75773354	6.663706424	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	717	1183	0.000845309	0.00591716	5	8	Astrocytes	40	16	16
CTAATGGGTGTAAGTA-1_7_D5	13.33590356	20.58722916	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	942	1466	0.000682128	0.006821282	5	oligos	OL-Cntl	40	16	16
CTACACCAGGGCTCTC-1_7_D5	8.481232558	29.83989567	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	850	1366	0.002196193	0.003660322	5	oligos	OL-Cntl	40	16	16
CTACACCCAAGCGATG-1_7_D5	-0.512833211	18.11316443	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	744	1128	0.011524823	0.017730496	5	oligos	OL-Cntl	40	16	16
CTACACCGTGACCAAG-1_7_D5	-23.83189951	1.085782629	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3284	6966	0.00717772	0.011340798	5	9	OPC	40	16	16
CTACACCGTTTGTGTG-1_7_D5	31.0607164	15.03069812	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	803	1087	0.003679853	0.079116835	5	14	Microglia	40	16	16
CTACACCTCTTTACAC-1_7_D5	-29.77883123	-13.02517448	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	777	1306	0.011485452	0.006125574	5	9	OPC	40	16	16
CTACATTAGGGCTCTC-1_7_D5	6.99012338	11.37448017	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1141	1920	0.0125	0.016145833	5	oligos	OL-Cntl	40	16	16
CTACATTCAAACGTGG-1_7_D5	10.64467432	14.55048579	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1099	1832	0.007641921	0.007641921	5	oligos	OL-Cntl	40	16	16
CTACATTTCAGCATGT-1_7_D5	12.51770806	14.34527035	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1185	1984	0.006552419	0.005040323	5	oligos	OL-Cntl	40	16	16
CTACATTTCGGAGCAA-1_7_D5	-28.18308984	14.01142392	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1059	1658	0.000603136	0.00482509	5	8	Astrocytes	40	16	16
CTACATTTCTACTTAC-1_7_D5	4.278323215	13.37118134	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1081	1607	0.008089608	0.014312383	5	oligos	OL-Cntl	40	16	16
CTACCCAAGTCGTACT-1_7_D5	9.518785918	26.93949836	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	855	1299	0.001539646	0.006158584	5	oligos	OL-Cntl	40	16	16
CTACCCACATAGAAAC-1_7_D5	-19.63667322	30.41117016	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2798	5944	0.004542396	0.004878869	5	8	Astrocytes	40	16	16
CTACCCACATATACCG-1_7_D5	18.0703752	-10.2789836	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3429	8661	0.005888466	0.007273987	5	3	EN-L5-6	40	16	16
CTACCCAGTCCTAGCG-1_7_D5	-16.36334965	2.334012769	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	5431	14141	0.010253872	0.010395304	5	13A	IN-VIP	40	16	16
CTACCCAGTCGCCATG-1_7_D5	32.90796951	14.99909982	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1016	1443	0.005544006	0.041580042	5	14	Microglia	40	16	16
CTACGTCAGCTGTTCA-1_7_D5	12.13114717	8.540729283	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1431	2375	0.009684211	0.017684211	5	oligos	OL-Cntl	40	16	16
CTACGTCAGTACGCGA-1_7_D5	-33.94571783	2.988423357	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2271	4402	0.00840527	0.006815084	5	9	OPC	40	16	16
CTACGTCGTGTATGGG-1_7_D5	12.92976149	-7.172299086	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3148	8527	0.009851061	0.003283687	5	3	EN-L5-6	40	16	16
CTACGTCGTTAGTGGG-1_7_D5	12.41206537	-6.313326356	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1780	3519	0.018755328	0.006251776	5	3	EN-L5-6	40	16	16
CTACGTCTCAACACAC-1_7_D5	-21.41759033	25.65399607	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1755	3641	0.003570448	0.004943697	5	8	Astrocytes	40	16	16
CTACGTCTCGTCTGAA-1_7_D5	39.521378	12.11019842	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	879	1268	0.003154574	0.010252366	5	14	Microglia	40	16	16
CTAGAGTAGGGCATGT-1_7_D5	10.30531256	13.68425085	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1210	2070	0.010144928	0.013043478	5	oligos	OL-Cntl	40	16	16
CTAGAGTCAATCACAC-1_7_D5	14.69178752	11.654809	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1446	2512	0.002786624	0.011146497	5	oligos	OL-Cntl	40	16	16
CTAGAGTCAGCTTAAC-1_7_D5	12.25808096	11.88055919	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1158	1917	0.001043297	0.011476265	5	oligos	OL-Cntl	40	16	16
CTAGAGTGTGTCTGAT-1_7_D5	-19.57209462	26.15096104	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1979	3765	0.003984064	0.006374502	5	8	Astrocytes	40	16	16
CTAGAGTGTTAGGGTG-1_7_D5	-34.1066911	-0.623741923	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1604	2630	0.005703422	0.007984791	5	9	OPC	40	16	16
CTAGAGTTCTTCCTTC-1_7_D5	14.94536318	8.750532825	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1591	3116	0.00449294	0.005455712	5	oligos	OL-Cntl	40	16	16
CTAGCCTCATAGTAAG-1_7_D5	11.28161228	8.551553461	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1548	2780	0.017266187	0.00971223	5	oligos	OL-Cntl	40	16	16
CTAGCCTGTTCACCTC-1_7_D5	11.1358849	8.316107692	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1394	2274	0.008795075	0.012752858	5	oligos	OL-Cntl	40	16	16
CTAGCCTGTTGATTCG-1_7_D5	-10.80809443	-4.197412198	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2099	3558	0.010961214	0.018830804	5	13A	IN-VIP	40	16	16
CTAGCCTTCCTTTACA-1_7_D5	13.5669128	9.628537797	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1594	2875	0.00626087	0.009043478	5	oligos	OL-Cntl	40	16	16
CTAGTGAAGATCCCGC-1_7_D5	6.338119754	-21.6347233	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	7351	27125	0.000442396	0.010543779	5	L2-3	EN-L2-3-MS	40	16	16
CTAGTGAAGCGACGTA-1_7_D5	-16.1137954	-19.14731867	6B	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1961	3875	0.01883871	0.002064516	5	6B	IN-SST	40	16	16
CTAGTGAAGGCGATAC-1_7_D5	-18.86142767	-17.76737648	6B	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2283	4354	0.001607717	0.003674782	5	6B	IN-SST	40	16	16
CTAGTGAAGTTGTAGA-1_7_D5	-4.034032085	-4.423585912	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1155	1873	0.026695141	0.004805125	5	13A	IN-VIP	40	16	16
CTAGTGAGTACACCGC-1_7_D5	-1.754591342	21.14303919	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	683	1012	0	0.018774704	5	oligos	OL-Cntl	40	16	16
CTAGTGATCAGGTAAA-1_7_D5	13.9287157	-29.59736824	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3713	8555	0.002454705	0.0050263	5	3	EN-L5-6	40	16	16
CTAGTGATCTAACCGA-1_7_D5	30.61097161	15.78810083	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1019	1409	0.008516678	0.102200142	5	14	Microglia	40	16	16
CTCACACAGGTGATAT-1_7_D5	38.9879387	9.633108973	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	819	1108	0.001805054	0.010830325	5	14	Microglia	40	16	16
CTCACACAGTGCTGCC-1_7_D5	14.00348727	9.72997582	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1459	2474	0.001616815	0.008892482	5	oligos	OL-Cntl	40	16	16
CTCACACCACCATCCT-1_7_D5	-10.1445382	23.38043696	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3687	7929	0.00365746	0.013873124	5	8	Astrocytes	40	16	16
CTCACACCACGTCTCT-1_7_D5	12.34685219	12.59001399	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1191	1987	0.001509814	0.005535984	5	oligos	OL-Cntl	40	16	16
CTCACACCAGGGTTAG-1_7_D5	-23.53950949	-18.42701878	6B	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3703	8609	0.017307469	0.012428854	5	6B	IN-SST	40	16	16
CTCACACTCACCCTCA-1_7_D5	10.8850391	13.48657609	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1226	1914	0.001044932	0.013061651	5	oligos	OL-Cntl	40	16	16
CTCACACTCTCACATT-1_7_D5	35.53570275	10.60514952	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	752	1035	0.018357488	0.021256039	5	14	Microglia	40	16	16
CTCAGAAAGAGCTTCT-1_7_D5	10.8119866	12.25687856	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1281	2163	0.007397134	0.010171059	5	oligos	OL-Cntl	40	16	16
CTCAGAACACATCCGG-1_7_D5	-18.62683444	29.46444276	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2722	5822	0.002748196	0.006698729	5	8	Astrocytes	40	16	16
CTCAGAACAGCTGGCT-1_7_D5	-21.79529973	-17.28623559	6B	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3867	9435	0.00572337	0.006677266	5	6B	IN-SST	40	16	16
CTCAGAACATGTCCTC-1_7_D5	-27.49074593	24.65828383	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1317	2266	0.003971756	0.003971756	5	8	Astrocytes	40	16	16
CTCAGAAGTATCACCA-1_7_D5	-16.22328066	-19.06915841	6B	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1996	4340	0.021889401	0.001382488	5	6B	IN-SST	40	16	16
CTCAGAAGTCGGATCC-1_7_D5	-20.37302891	28.00846552	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2093	3689	0.013824885	0.004066143	5	8	Astrocytes	40	16	16
CTCAGAAGTGCTGTAT-1_7_D5	-36.89526137	-10.03925772	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	996	1505	0.007973422	0.005315615	5	9	OPC	40	16	16
CTCAGAATCCACTCCA-1_7_D5	8.384221813	11.03655796	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1255	1968	0.012195122	0.011686992	5	oligos	OL-Cntl	40	16	16
CTCAGAATCTGATTCT-1_7_D5	-36.90124908	2.42130937	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1842	3630	0.002203857	0.002479339	5	9	OPC	40	16	16
CTCATTAAGATCCGAG-1_7_D5	-35.23390787	1.36857602	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1743	3175	0.000944882	0.005984252	5	9	OPC	40	16	16
CTCATTAAGCCTATGT-1_7_D5	35.29742536	15.42911982	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1101	1537	0.008458035	0.022121015	5	14	Microglia	40	16	16
CTCATTAAGTCTCAAC-1_7_D5	-2.249648866	18.75019023	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	630	1021	0.001958864	0.010773751	5	oligos	OL-Cntl	40	16	16
CTCATTAAGTGTTAGA-1_7_D5	11.34107199	-4.884766674	12	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	892	1415	0.062897527	0.004946996	5	12	EN-MIX	40	16	16
CTCATTACAGACAGGT-1_7_D5	2.188775848	16.21308098	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	834	1164	0	0.018041237	5	oligos	OL-Cntl	40	16	16
CTCATTACAGAGTGTG-1_7_D5	-21.13361652	28.62951939	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2144	4169	0.006476373	0.005516911	5	8	Astrocytes	40	16	16
CTCATTACAGGGATTG-1_7_D5	10.05240309	11.44500958	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1332	2284	0.010507881	0.011383538	5	oligos	OL-Cntl	40	16	16
CTCATTAGTAAACCTC-1_7_D5	18.5124732	6.351350469	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2323	4841	0.005990498	0.004544516	5	oligos	OL-Cntl	40	16	16
CTCATTAGTGGTCCGT-1_7_D5	-20.5921111	27.66260672	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2093	4527	0.007952286	0.007731389	5	8	Astrocytes	40	16	16
CTCCTAGAGAAACCTA-1_7_D5	15.44956006	-34.20175902	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	6628	27154	0.001657214	0.002872505	5	3	EN-L5-6	40	16	16
CTCCTAGAGCAGACTG-1_7_D5	1.071603266	17.02215045	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	833	1224	0.006535948	0.014705882	5	oligos	OL-Cntl	40	16	16
CTCCTAGCAATGTAAG-1_7_D5	12.23366611	8.901121893	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1472	2347	0.002982531	0.01022582	5	oligos	OL-Cntl	40	16	16
CTCCTAGCAGCTCCGA-1_7_D5	0.061814816	19.89506583	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	781	1197	0	0.010025063	5	oligos	OL-Cntl	40	16	16
CTCCTAGGTAGGCTGA-1_7_D5	-14.4687288	0.708826629	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3139	6606	0.004087193	0.012110203	5	13A	IN-VIP	40	16	16
CTCCTAGGTGCGAAAC-1_7_D5	-10.18357968	23.30930083	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1987	3567	0.009251472	0.025511634	5	8	Astrocytes	40	16	16
CTCCTAGGTGTGACGA-1_7_D5	3.659831558	16.48591325	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	892	1308	0.00764526	0.013761468	5	oligos	OL-Cntl	40	16	16
CTCCTAGGTTCCTCCA-1_7_D5	-27.48405216	4.397063342	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3656	9628	0.00166182	0.005089323	5	9	OPC	40	16	16
CTCCTAGTCAACGCTA-1_7_D5	-16.57231141	-10.85298885	13B	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3496	9062	0.005738248	0.004303686	5	13B	IN-SV2C	40	16	16
CTCCTAGTCACTTATC-1_7_D5	-16.57535324	15.12439398	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1737	3369	0.000890472	0.00296824	5	8	Astrocytes	40	16	16
CTCCTAGTCCAGGGCT-1_7_D5	-15.66034595	1.507899302	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4728	12790	0.005707584	0.009538702	5	13A	IN-VIP	40	16	16
CTCCTAGTCGGCTTGG-1_7_D5	-22.85901212	24.15501201	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1491	2574	0.003885004	0.005439005	5	8	Astrocytes	40	16	16
CTCGAAAAGAAACGAG-1_7_D5	15.8570597	5.988712148	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2437	4660	0.007296137	0.014592275	5	oligos	OL-Cntl	40	16	16
CTCGAAACACTCTGTC-1_7_D5	-25.06493223	25.36528132	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1667	3519	0.007104291	0.004262575	5	8	Astrocytes	40	16	16
CTCGAAACATATGGTC-1_7_D5	-3.569447993	15.71494682	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	786	1073	0.013979497	0.023299161	5	oligos	OL-Cntl	40	16	16
CTCGAAAGTCCGAAGA-1_7_D5	-34.54310847	5.037917688	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2711	5745	0.002610966	0.002436902	5	9	OPC	40	16	16
CTCGAAAGTGTGTGCC-1_7_D5	16.41748605	-3.80885466	12	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1658	3075	0.012357724	0.007804878	5	12	EN-MIX	40	16	16
CTCGAAAGTTGATTCG-1_7_D5	4.201319981	-22.95966821	10	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3841	10127	0.014021922	0.003258616	5	L2-3	EN-L2-3-Cntl	40	16	16
CTCGAAATCGAGCCCA-1_7_D5	-11.88918292	14.37710822	11	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1111	1650	0.005454545	0.012727273	5	11	Glia-MIX	40	16	16
CTCGAGGAGTACGTAA-1_7_D5	-9.602340757	-2.939469486	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1997	3686	0.024688009	0.01275095	5	13A	IN-VIP	40	16	16
CTCGAGGCAAGGGTCA-1_7_D5	-31.24510022	11.99539782	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	955	1445	0.009688581	0.007612457	5	8	Astrocytes	40	16	16
CTCGAGGGTAAAGTCA-1_7_D5	9.699070563	20.80652991	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	895	1433	0.00418702	0.00837404	5	oligos	OL-Cntl	40	16	16
CTCGAGGGTAAGAGAG-1_7_D5	0.060826024	10.95436664	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1027	1429	0.010496851	0.008397481	5	oligos	OL-Cntl	40	16	16
CTCGAGGGTACGCTGC-1_7_D5	15.99622746	-8.748546469	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2486	6100	0.009508197	0.003770492	5	3	EN-L5-6	40	16	16
CTCGAGGGTCTCTCGT-1_7_D5	-32.0922398	1.804132073	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2294	4539	0.003525006	0.004185944	5	9	OPC	40	16	16
CTCGGAGAGCTGAAAT-1_7_D5	4.985179851	11.36568417	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1155	1792	0.010602679	0.018415179	5	oligos	OL-Cntl	40	16	16
CTCGGAGAGTACGCGA-1_7_D5	4.726646934	18.38314747	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	928	1326	0.005279035	0.010558069	5	oligos	OL-Cntl	40	16	16
CTCGGAGCACCAGATT-1_7_D5	32.88697686	16.65001979	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1275	1858	0.004305705	0.04467169	5	14	Microglia	40	16	16
CTCGGAGCACCCTATC-1_7_D5	-25.40406672	25.51475331	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1561	2815	0.002131439	0.004262877	5	8	Astrocytes	40	16	16
CTCGGAGGTGTATGGG-1_7_D5	-20.28068143	26.80857737	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1794	3398	0.002942908	0.006180106	5	8	Astrocytes	40	16	16
CTCGGAGGTGTGACCC-1_7_D5	8.533090141	1.539417398	12	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	695	1190	0.013445378	0.01092437	5	12	EN-MIX	40	16	16
CTCGGAGTCAGCATGT-1_7_D5	-27.61568344	4.328670881	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3385	7251	0.001517032	0.003999448	5	9	OPC	40	16	16
CTCGGAGTCGTCCGTT-1_7_D5	16.42304314	-4.583523566	12	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1633	3522	0.006246451	0.003407155	5	12	EN-MIX	40	16	16
CTCGGGAAGATCGATA-1_7_D5	12.71821341	-30.71998707	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2761	6637	0.00632816	0.002561398	5	3	EN-L5-6	40	16	16
CTCGGGAAGCAGACTG-1_7_D5	13.4674731	-29.35853031	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2960	6588	0.008500304	0.004250152	5	3	EN-L5-6	40	16	16
CTCGGGAAGCGTTTAC-1_7_D5	2.164192876	12.56889555	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1032	1564	0.007033248	0.008951407	5	oligos	OL-Cntl	40	16	16
CTCGGGAAGTGTGAAT-1_7_D5	4.7066961	16.40932224	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	902	1279	0.001563722	0.008600469	5	oligos	OL-Cntl	40	16	16
CTCGGGACAGCTGTGC-1_7_D5	7.574437964	31.49469755	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	715	1143	0.007874016	0.003499563	5	oligos	OL-Cntl	40	16	16
CTCGGGATCCAAACTG-1_7_D5	35.00828918	15.28578582	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1146	1633	0.002449479	0.033680343	5	14	Microglia	40	16	16
CTCGGGATCTCAAGTG-1_7_D5	4.570820914	-21.99738337	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	5198	14783	0.003517554	0.004735169	5	L2-3	EN-L2-3-MS	40	16	16
CTCGTACCACGGACAA-1_7_D5	-12.99551033	-17.3679572	6B	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1200	1931	0.021750388	0.007250129	5	6B	IN-SST	40	16	16
CTCGTACGTCGTCTTC-1_7_D5	18.49136671	23.87823962	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	991	1624	0.001847291	0.003078818	5	oligos	OL-Cntl	40	16	16
CTCGTACGTCTTGCGG-1_7_D5	-9.503186233	-2.773499627	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2088	4001	0.038490377	0.007498125	5	13A	IN-VIP	40	16	16
CTCGTACGTGATGTCT-1_7_D5	-23.21529963	18.77223233	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1294	2171	0.002763703	0.002303086	5	8	Astrocytes	40	16	16
CTCGTACGTTAAAGAC-1_7_D5	-9.393252554	-3.602625412	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1846	3211	0.017751479	0.006540019	5	13A	IN-VIP	40	16	16
CTCGTACTCCACGTGG-1_7_D5	10.26206672	9.073508492	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1294	1883	0.007434944	0.014338821	5	oligos	OL-Cntl	40	16	16
CTCGTACTCCAGAGGA-1_7_D5	4.742120113	22.105048	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	873	1251	0.005595524	0.010391687	5	oligos	OL-Cntl	40	16	16
CTCGTACTCCATGCTC-1_7_D5	-29.22733968	12.63935459	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	817	1272	0.003930818	0.003144654	5	8	Astrocytes	40	16	16
CTCGTCAAGCAGATCG-1_7_D5	3.174522015	-15.41563062	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3069	7259	0.004132801	0.007025761	5	L2-3	EN-L2-3-MS	40	16	16
CTCGTCAAGGACAGCT-1_7_D5	0.53885296	12.51350653	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1027	1550	0.013548387	0.032903226	5	oligos	OL-Cntl	40	16	16
CTCGTCACAACACCTA-1_7_D5	-19.16543359	28.92912095	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2326	4865	0.00020555	0.008633094	5	8	Astrocytes	40	16	16
CTCGTCACAGCAGTTT-1_7_D5	-34.25545557	2.009343063	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1969	3976	0.002012072	0.006539235	5	9	OPC	40	16	16
CTCGTCACATGTTGAC-1_7_D5	-35.21109608	1.803271496	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1822	3249	0.002462296	0.005847953	5	9	OPC	40	16	16
CTCGTCAGTACAGCAG-1_7_D5	22.51034602	-27.46160279	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	6422	22213	0.012920362	0.006437672	5	3	EN-L5-6	40	16	16
CTCGTCAGTCCGTTAA-1_7_D5	-33.12080167	3.918809806	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2427	4983	0.001404776	0.003210917	5	9	OPC	40	16	16
CTCGTCAGTCGAACAG-1_7_D5	-20.5773258	28.49111598	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2108	4153	0.007705273	0.006260535	5	8	Astrocytes	40	16	16
CTCGTCAGTTAGAACA-1_7_D5	0.660117966	-20.19073187	10	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2992	7389	0.006631479	0.004060089	5	L2-3	EN-L2-3-Cntl	40	16	16
CTCGTCATCTCGTTTA-1_7_D5	8.065421244	-17.85519129	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4563	11656	0.008407687	0.02016129	5	L2-3	EN-L2-3-MS	40	16	16
CTCTAATAGATTACCC-1_7_D5	-19.58873659	27.12392103	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2257	5322	0.000939496	0.006200676	5	8	Astrocytes	40	16	16
CTCTAATAGGTGACCA-1_7_D5	6.49624525	-31.01928255	10	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	7005	28438	0.001934032	0.003270272	5	L2-3	EN-L2-3-Cntl	40	16	16
CTCTAATAGGTGCTAG-1_7_D5	-36.61336814	-6.014587148	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1194	2006	0.006979063	0.004985045	5	9	OPC	40	16	16
CTCTAATCACATCCGG-1_7_D5	18.5571622	15.31195007	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1097	1870	0.004278075	0.002673797	5	oligos	OL-Cntl	40	16	16
CTCTAATCAGCATACT-1_7_D5	35.58500639	13.54435369	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1080	1514	0.00660502	0.017173052	5	14	Microglia	40	16	16
CTCTAATCAGCTGTAT-1_7_D5	15.37468284	15.57174554	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1211	2032	0.015748031	0.005413386	5	oligos	OL-Cntl	40	16	16
CTCTAATGTCCATCCT-1_7_D5	9.218230464	10.24657896	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1115	1739	0.004025302	0.005750431	5	oligos	OL-Cntl	40	16	16
CTCTAATGTCTAACGT-1_7_D5	38.005195	14.07285416	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1065	1487	0.00268998	0.016812374	5	14	Microglia	40	16	16
CTCTAATGTGACCAAG-1_7_D5	-29.00892094	13.62197774	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	899	1422	0.004922644	0.003516174	5	8	Astrocytes	40	16	16
CTCTACGCATCACCCT-1_7_D5	-27.91040781	16.80879469	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1075	1767	0.003395586	0.005093379	5	8	Astrocytes	40	16	16
CTCTACGCATGAAGTA-1_7_D5	3.186000915	-16.46295775	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3167	7117	0.006884923	0.004215259	5	L2-3	EN-L2-3-MS	40	16	16
CTCTACGGTAAATGTG-1_7_D5	11.53976222	9.096465372	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1438	2392	0.017558528	0.013795987	5	oligos	OL-Cntl	40	16	16
CTCTACGGTGCTGTAT-1_7_D5	12.62223346	-6.699553216	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2165	4804	0.003538718	0.003538718	5	3	EN-L5-6	40	16	16
CTCTACGTCAGAGACG-1_7_D5	10.37866658	13.16375026	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1201	1912	0.006799163	0.007322176	5	oligos	OL-Cntl	40	16	16
CTCTACGTCATCGGAT-1_7_D5	10.98837542	18.37688501	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1014	1494	0.005354752	0.010709505	5	oligos	OL-Cntl	40	16	16
CTCTACGTCTACTTAC-1_7_D5	12.91455351	-7.168783512	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3103	8557	0.003505902	0.002804721	5	3	EN-L5-6	40	16	16
CTCTGGTCAATAGCGG-1_7_D5	-14.90722058	1.422229706	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3384	7722	0.002201502	0.024216524	5	13A	IN-VIP	40	16	16
CTCTGGTCACCTGGTG-1_7_D5	9.468850559	13.39136554	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1072	1678	0.007151371	0.010727056	5	oligos	OL-Cntl	40	16	16
CTCTGGTCAGTAAGAT-1_7_D5	-31.92197314	2.830683449	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2235	4190	0.002147971	0.005966587	5	9	OPC	40	16	16
CTCTGGTCATCGGGTC-1_7_D5	-34.99144929	-0.566930997	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1588	2682	0.004101417	0.005965697	5	9	OPC	40	16	16
CTCTGGTCATTCTCAT-1_7_D5	0.928234508	18.07832184	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	798	1177	0.0144435	0.006796941	5	oligos	OL-Cntl	40	16	16
CTCTGGTGTCGACTAT-1_7_D5	-0.079417654	18.44878713	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	873	1318	0	0.006069803	5	oligos	OL-Cntl	40	16	16
CTCTGGTGTTAAGGGC-1_7_D5	31.21088502	16.11219132	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	973	1419	0.005637773	0.114164905	5	14	Microglia	40	16	16
CTCTGGTTCCTCAACC-1_7_D5	-35.09990797	-0.622737011	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1487	2544	0.002358491	0.003930818	5	9	OPC	40	16	16
CTCTGGTTCTGGAGCC-1_7_D5	-35.21329242	-0.428753846	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1527	2745	0.005100182	0.004735883	5	9	OPC	40	16	16
CTGAAACAGAAAGTGG-1_7_D5	5.927740587	-12.23176941	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2364	4174	0.012218495	0.013895544	5	L2-3	EN-L2-3-MS	40	16	16
CTGAAACAGTTCGCGC-1_7_D5	-1.568352627	15.8541901	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	862	1295	0.01003861	0.015444015	5	oligos	OL-Cntl	40	16	16
CTGAAACCAGCGTTCG-1_7_D5	1.992766866	12.88235918	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	999	1500	0.004	0.017333333	5	oligos	OL-Cntl	40	16	16
CTGAAACTCCAGTAGT-1_7_D5	-18.19507037	-6.308979458	13B	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3227	6675	0.034157303	0.008539326	5	13B	IN-SV2C	40	16	16
CTGAAACTCGAATCCA-1_7_D5	-18.97769143	28.68299465	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2715	6336	0.005366162	0.005050505	5	8	Astrocytes	40	16	16
CTGAAACTCTCCAGGG-1_7_D5	-20.01578377	27.24665704	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2111	4194	0.001669051	0.00286123	5	8	Astrocytes	40	16	16
CTGAAACTCTTATCTG-1_7_D5	8.039933262	11.05843978	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1197	1984	0.001008065	0.013104839	5	oligos	OL-Cntl	40	16	16
CTGAAGTAGGACGAAA-1_7_D5	-7.946270091	9.127120141	5	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1014	1652	0.008474576	0.013317191	5	oligos	OL-MS-1	40	16	16
CTGAAGTCACCAGGTC-1_7_D5	12.50808876	-6.520251488	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1838	3596	0.002224694	0.003893215	5	3	EN-L5-6	40	16	16
CTGAAGTGTCATTAGC-1_7_D5	2.643927401	19.54714144	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	935	1360	0.010294118	0.005882353	5	oligos	OL-Cntl	40	16	16
CTGAAGTGTTCGTGAT-1_7_D5	11.04572199	9.923444926	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1343	2326	0.000859845	0.012897678	5	oligos	OL-Cntl	40	16	16
CTGAAGTTCACGCGGT-1_7_D5	9.886641687	10.72863555	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1339	2372	0.01306914	0.008010118	5	oligos	OL-Cntl	40	16	16
CTGAAGTTCGCCTGAG-1_7_D5	9.777968262	-24.09469483	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	7514	28476	0.008147212	0.005618767	5	L2-3	EN-L2-3-MS	40	16	16
CTGAAGTTCGGTTCGG-1_7_D5	34.28659208	14.7710644	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1014	1368	0.014619883	0.024853801	5	14	Microglia	40	16	16
CTGAAGTTCTTAGAGC-1_7_D5	-9.930456894	-18.39738162	6B	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	913	1466	0.002046385	0.002046385	5	6B	IN-SST	40	16	16
CTGATAGGTGATGTGG-1_7_D5	-4.542381798	20.83208787	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	757	1041	0.015369837	0.027857829	5	oligos	OL-Cntl	40	16	16
CTGATAGTCCCTCAGT-1_7_D5	14.74933346	9.806028415	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1421	2538	0.001970055	0.005516154	5	oligos	OL-Cntl	40	16	16
CTGATCCAGCCTCGTG-1_7_D5	-7.017314505	-3.614856333	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1953	3257	0.014737488	0.004298434	5	13A	IN-VIP	40	16	16
CTGATCCAGGCATGGT-1_7_D5	-34.32947757	-2.867789898	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1477	2517	0.01231625	0.003575685	5	9	OPC	40	16	16
CTGATCCAGGGTTCCC-1_7_D5	39.32823543	9.925058243	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	810	1149	0.000870322	0.005221932	5	14	Microglia	40	16	16
CTGATCCCAAGAGGCT-1_7_D5	-33.49390227	-9.177672967	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	979	1496	0.019385027	0.001336898	5	9	OPC	40	16	16
CTGATCCCACATCTTT-1_7_D5	-34.62783125	2.015297349	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1865	3525	0.004255319	0.004539007	5	9	OPC	40	16	16
CTGATCCCACGGTGTC-1_7_D5	37.40590217	10.42522498	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	875	1209	0.009098428	0.015715467	5	14	Microglia	40	16	16
CTGATCCTCCTCCTAG-1_7_D5	-0.426707209	18.03217739	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	931	1429	0.00279916	0.009797061	5	oligos	OL-Cntl	40	16	16
CTGATCCTCTAGCACA-1_7_D5	7.964217653	15.50309239	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	903	1418	0.002820874	0.012693935	5	oligos	OL-Cntl	40	16	16
CTGATCCTCTCGGACG-1_7_D5	6.194233599	-19.83943234	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4195	10546	0.00246539	0.011094254	5	L2-3	EN-L2-3-MS	40	16	16
CTGATCCTCTCGTATT-1_7_D5	12.15774825	9.535980318	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1480	2597	0.001155179	0.010781671	5	oligos	OL-Cntl	40	16	16
CTGCCTACAGATAATG-1_7_D5	-4.943385921	-2.711309935	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1477	2600	0.040769231	0.003846154	5	13A	IN-VIP	40	16	16
CTGCCTACAGCTCCGA-1_7_D5	-34.84082578	1.327624504	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1765	3046	0.001969796	0.003939593	5	9	OPC	40	16	16
CTGCCTACATTACGAC-1_7_D5	-24.61137398	-9.805803189	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	922	1346	0.011144131	0.010401189	5	9	OPC	40	16	16
CTGCCTAGTATTAGCC-1_7_D5	9.482118695	7.825767175	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1658	2831	0.009184034	0.012716355	5	oligos	OL-Cntl	40	16	16
CTGCCTAGTCGACTGC-1_7_D5	-35.8214848	0.937566438	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1651	2942	0.001359619	0.008157716	5	9	OPC	40	16	16
CTGCCTAGTGAACCTT-1_7_D5	36.13057008	11.53165609	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	854	1128	0.002659574	0.018617021	5	14	Microglia	40	16	16
CTGCGGAAGATATGGT-1_7_D5	-20.28090264	28.56176946	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2142	4378	0.004796711	0.003426222	5	8	Astrocytes	40	16	16
CTGCGGAAGCATGGCA-1_7_D5	17.00045678	-5.102963289	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2049	3096	0.01873385	0.005490956	5	3	EN-L5-6	40	16	16
CTGCGGAAGGCTCTTA-1_7_D5	-0.226906145	20.29526332	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	736	1114	0.005385996	0.007181329	5	oligos	OL-Cntl	40	16	16
CTGCGGACATGCGCAC-1_7_D5	38.41902453	15.04771949	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1323	2122	0.004712535	0.011310085	5	14	Microglia	40	16	16
CTGCGGAGTCACCTAA-1_7_D5	-33.6385707	2.496424528	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2008	3872	0.004132231	0.007489669	5	9	OPC	40	16	16
CTGCGGAGTGACGGTA-1_7_D5	23.48011046	-27.38346468	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4211	12061	0.010529807	0.003316475	5	3	EN-L5-6	40	16	16
CTGCGGAGTTCACCTC-1_7_D5	-3.325565732	17.74651251	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	778	1097	0.010027347	0.016408387	5	oligos	OL-Cntl	40	16	16
CTGCGGAGTTCGTCTC-1_7_D5	-20.81870794	9.849256206	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1184	1905	0.005774278	0.003149606	5	8	Astrocytes	40	16	16
CTGCGGAGTTGGTTTG-1_7_D5	-2.081515007	18.02662093	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	700	1091	0.004582951	0.017415215	5	oligos	OL-Cntl	40	16	16
CTGCGGAGTTTACTCT-1_7_D5	14.80976231	11.15878243	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1350	2321	0.010340371	0.004308488	5	oligos	OL-Cntl	40	16	16
CTGCGGATCCGTAGGC-1_7_D5	14.21629315	17.1598946	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1061	1798	0.012235818	0.015572859	5	oligos	OL-Cntl	40	16	16
CTGCTGTAGACCTTTG-1_7_D5	9.828397342	12.40552716	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1249	2133	0.00140647	0.009845288	5	oligos	OL-Cntl	40	16	16
CTGCTGTAGTACTTGC-1_7_D5	4.373174485	10.14872839	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1247	2179	0.00826067	0.017439192	5	oligos	OL-Cntl	40	16	16
CTGCTGTCAACTGCGC-1_7_D5	31.12373968	15.33541729	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	959	1443	0.003465003	0.0997921	5	14	Microglia	40	16	16
CTGCTGTCAATGTTGC-1_7_D5	-27.51110193	24.02970452	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1405	2621	0.002289203	0.004578405	5	8	Astrocytes	40	16	16
CTGCTGTCACGCGAAA-1_7_D5	-15.30774299	1.780265919	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4190	9711	0.005560704	0.012872001	5	13A	IN-VIP	40	16	16
CTGCTGTGTGCCTGTG-1_7_D5	5.150315907	31.86421183	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	770	1102	0.005444646	0.010889292	5	oligos	OL-Cntl	40	16	16
CTGCTGTTCAGAGCTT-1_7_D5	9.80297157	12.70198898	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1198	1965	0.011195929	0.013231552	5	oligos	OL-Cntl	40	16	16
CTGCTGTTCCTATTCA-1_7_D5	15.76052577	10.0945662	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1474	2563	0.009754194	0.009754194	5	oligos	OL-Cntl	40	16	16
CTGGTCTAGGGTTTCT-1_7_D5	-31.64023001	-12.83980051	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	777	1113	0.014375562	0.002695418	5	9	OPC	40	16	16
CTGGTCTCAATCGGTT-1_7_D5	22.31209982	-27.1734313	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	5192	15884	0.006610426	0.006862251	5	3	EN-L5-6	40	16	16
CTGGTCTGTACGCTGC-1_7_D5	13.93689376	14.27706229	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1243	2151	0.0041841	0.006508601	5	oligos	OL-Cntl	40	16	16
CTGGTCTTCAACCATG-1_7_D5	3.26884166	15.77717844	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	974	1508	0.015251989	0.013262599	5	oligos	OL-Cntl	40	16	16
CTGGTCTTCCCAAGAT-1_7_D5	-2.691528041	17.67598409	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	752	1133	0.01059135	0.009708738	5	oligos	OL-Cntl	40	16	16
CTGGTCTTCCGTTGTC-1_7_D5	12.30428375	9.570127071	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1421	2542	0.007867821	0.008654603	5	oligos	OL-Cntl	40	16	16
CTGGTCTTCCTAGGGC-1_7_D5	-20.40943185	26.28273018	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1779	3485	0.00143472	0.006025825	5	8	Astrocytes	40	16	16
CTGTGCTAGGCTAGAC-1_7_D5	4.656515165	12.45166295	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1113	1795	0.005013928	0.008356546	5	oligos	OL-Cntl	40	16	16
CTGTGCTTCACCCGAG-1_7_D5	-25.40927456	-2.172990339	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1244	1827	0.009304871	0.01532567	5	9	OPC	40	16	16
CTGTGCTTCATCGATG-1_7_D5	8.432636328	15.61380222	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1029	1567	0.00319081	0.016592214	5	oligos	OL-Cntl	40	16	16
CTGTGCTTCCTTCAAT-1_7_D5	-34.94396673	-1.587595401	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1498	2515	0.006759443	0.004771372	5	9	OPC	40	16	16
CTGTTTAAGCAATATG-1_7_D5	-31.52726215	12.93359707	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	948	1531	0.000653168	0.002612671	5	8	Astrocytes	40	16	16
CTGTTTAAGCGGCTTC-1_7_D5	-19.88993785	29.37824075	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2212	4365	0.003894616	0.004810997	5	8	Astrocytes	40	16	16
CTGTTTACACATTTCT-1_7_D5	3.956834238	15.56958866	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	958	1464	0.010245902	0.008196721	5	oligos	OL-Cntl	40	16	16
CTGTTTACAGTCAGAG-1_7_D5	37.77322479	12.97347908	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1118	1566	0.003831418	0.010217114	5	14	Microglia	40	16	16
CTGTTTAGTATCTGCA-1_7_D5	-34.24103492	0.255408566	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1760	3157	0.006335128	0.00886918	5	9	OPC	40	16	16
CTGTTTAGTCCCTACT-1_7_D5	2.2381744	14.0631561	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	877	1282	0.008580343	0.016380655	5	oligos	OL-Cntl	40	16	16
CTGTTTATCATAGCAC-1_7_D5	22.35379389	-26.23586624	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2930	6943	0.009794037	0.008497768	5	3	EN-L5-6	40	16	16
CTGTTTATCCGCGTTT-1_7_D5	-20.24242283	28.41275264	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2112	4446	0.005398111	0.00697256	5	8	Astrocytes	40	16	16
CTGTTTATCTTGCCGT-1_7_D5	-18.91170612	29.14542887	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2365	5153	0.001746555	0.007180283	5	8	Astrocytes	40	16	16
CTTAACTAGAAACCAT-1_7_D5	-31.18154956	-1.171108476	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1552	2656	0.000753012	0.005271084	5	9	OPC	40	16	16
CTTAACTAGGCAAAGA-1_7_D5	-31.69424221	2.87851033	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2302	4325	0.002543353	0.002543353	5	9	OPC	40	16	16
CTTAACTCAAAGCAAT-1_7_D5	-9.979537031	0.075757694	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2666	5470	0.008043876	0.004936015	5	13A	IN-VIP	40	16	16
CTTAACTCAATGGATA-1_7_D5	11.84539331	-5.506254268	12	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1239	2201	0.006360745	0.003634711	5	12	EN-MIX	40	16	16
CTTAACTCACCTTGTC-1_7_D5	-38.25319979	-8.055282457	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1107	2024	0.008399209	0.001976285	5	9	OPC	40	16	16
CTTAACTCAGACAGGT-1_7_D5	-9.623945675	-2.88617402	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1980	3401	0.003234343	0.010585122	5	13A	IN-VIP	40	16	16
CTTAACTGTAGCGTAG-1_7_D5	-33.90130753	2.830828251	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2090	3826	0.005227392	0.007579718	5	9	OPC	40	16	16
CTTAACTTCCATGAAC-1_7_D5	-34.20044875	2.010751674	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2005	3657	0.00300793	0.008476894	5	9	OPC	40	16	16
CTTAACTTCTGTGCAA-1_7_D5	10.3543432	18.13541163	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1025	1764	0.00170068	0.008503401	5	oligos	OL-Cntl	40	16	16
CTTACCGAGGATGCGT-1_7_D5	2.853977275	13.30118645	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	975	1534	0.008474576	0.01303781	5	oligos	OL-Cntl	40	16	16
CTTACCGAGGCAAAGA-1_7_D5	31.09942221	15.1441089	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	804	1093	0.015553522	0.119853614	5	14	Microglia	40	16	16
CTTACCGGTTACAGAA-1_7_D5	-16.7348738	-19.20772234	6B	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2267	5000	0.0136	0.0036	5	6B	IN-SST	40	16	16
CTTACCGTCCTAGTGA-1_7_D5	9.491232128	12.08475438	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1143	1917	0.005738132	0.015127804	5	oligos	OL-Cntl	40	16	16
CTTACCGTCCTCCTAG-1_7_D5	12.58051979	13.34689002	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1248	2100	0.001428571	0.005714286	5	oligos	OL-Cntl	40	16	16
CTTAGGAAGTGCCATT-1_7_D5	-33.38415651	-3.112732925	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1378	2166	0.013850416	0.008310249	5	9	OPC	40	16	16
CTTAGGACAATCTACG-1_7_D5	20.41867418	22.72401158	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1085	1874	0.001067236	0.003201708	5	oligos	OL-Cntl	40	16	16
CTTAGGACACCAGGCT-1_7_D5	7.158229939	-20.70368036	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	5742	18738	0.00955278	0.004642972	5	L2-3	EN-L2-3-MS	40	16	16
CTTAGGACAGACAGGT-1_7_D5	11.83461224	-5.480184897	12	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1243	2195	0.04738041	0.005922551	5	12	EN-MIX	40	16	16
CTTAGGACATCTCCCA-1_7_D5	12.17667764	7.593472421	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1762	3243	0.001233426	0.011717545	5	oligos	OL-Cntl	40	16	16
CTTAGGAGTACTCGCG-1_7_D5	11.80386636	8.701045866	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1565	2840	0.007394366	0.00915493	5	oligos	OL-Cntl	40	16	16
CTTAGGAGTAGCGCTC-1_7_D5	-1.116790791	-18.75203463	10	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2562	5733	0.019012733	0.001744287	5	L2-3	EN-L2-3-Cntl	40	16	16
CTTAGGAGTCGCGTGT-1_7_D5	11.44817179	-5.041282921	12	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	904	1560	0.041666667	0.003205128	5	12	EN-MIX	40	16	16
CTTAGGAGTCTTGTCC-1_7_D5	9.400250205	9.943821301	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1350	2396	0.000834725	0.009599332	5	oligos	OL-Cntl	40	16	16
CTTAGGATCACATAGC-1_7_D5	-0.885475081	15.06157464	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	763	1054	0.013282732	0.018975332	5	oligos	OL-Cntl	40	16	16
CTTAGGATCGCCATAA-1_7_D5	6.296247249	18.66417177	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	891	1256	0.000796178	0.012738854	5	oligos	OL-Cntl	40	16	16
CTTAGGATCTGCTTGC-1_7_D5	-13.29636804	4.562174611	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	5324	16846	0.002552535	0.00557996	5	8	Astrocytes	40	16	16
CTTAGGATCTGGCGAC-1_7_D5	-2.571262268	16.17657785	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	812	1146	0.002617801	0.022687609	5	oligos	OL-Cntl	40	16	16
CTTCTCTAGACAATAC-1_7_D5	15.0642658	9.435724529	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1569	2852	0.001753156	0.011220196	5	oligos	OL-Cntl	40	16	16
CTTCTCTCATGGAATA-1_7_D5	-36.51738732	1.390432808	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1585	2865	0.002094241	0.003839442	5	9	OPC	40	16	16
CTTCTCTGTGGTCTCG-1_7_D5	10.2236573	18.2622573	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	976	1518	0.001976285	0.007905138	5	oligos	OL-Cntl	40	16	16
CTTCTCTGTTTGTGTG-1_7_D5	0.114124773	20.89939588	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	729	1126	0.000888099	0.009769094	5	oligos	OL-Cntl	40	16	16
CTTCTCTTCCAAAGTC-1_7_D5	-34.34598136	2.101943735	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1996	3787	0.001320306	0.004753103	5	9	OPC	40	16	16
CTTCTCTTCGTAGGAG-1_7_D5	14.56632943	-7.684845128	10	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1921	4425	0.059661017	0.000903955	5	L2-3	EN-L2-3-Cntl	40	16	16
CTTCTCTTCTGCAGTA-1_7_D5	3.902023778	-31.36384508	10	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4843	17934	0.00144976	0.00178432	5	L2-3	EN-L2-3-Cntl	40	16	16
CTTGGCTCAAGACGTG-1_7_D5	-11.73341394	17.43350998	11	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1861	3479	0.008910606	0.011784996	5	11	Glia-MIX	40	16	16
CTTGGCTCACAACGCC-1_7_D5	8.843848011	26.79381854	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	828	1328	0.004518072	0.002259036	5	oligos	OL-Cntl	40	16	16
CTTGGCTCACCATCCT-1_7_D5	7.703071114	-20.20007119	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	6251	20299	0.00546825	0.01290704	5	L2-3	EN-L2-3-MS	40	16	16
CTTGGCTCATGGGACA-1_7_D5	16.56226032	6.838629363	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2010	3666	0.008183306	0.005455537	5	oligos	OL-Cntl	40	16	16
CTTGGCTGTCGCATCG-1_7_D5	8.388880851	11.91672155	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1251	2024	0.010375494	0.011363636	5	oligos	OL-Cntl	40	16	16
CTTGGCTGTTCGGGCT-1_7_D5	-14.12459381	-1.44727369	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2306	4183	0.011475018	0.016017213	5	13A	IN-VIP	40	16	16
CTTGGCTTCAACTCTT-1_7_D5	32.63563343	16.57600595	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1153	1676	0.006563246	0.066229117	5	14	Microglia	40	16	16
CTTGGCTTCACTCCTG-1_7_D5	9.15743976	10.01810231	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1242	2051	0.006825939	0.016089712	5	oligos	OL-Cntl	40	16	16
CTTTGCGAGACTACAA-1_7_D5	11.81084949	14.52133244	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1256	2024	0.003952569	0.010869565	5	oligos	OL-Cntl	40	16	16
CTTTGCGCACGGCCAT-1_7_D5	15.04819539	11.03045658	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1339	2293	0.002616659	0.008286088	5	oligos	OL-Cntl	40	16	16
CTTTGCGGTAGGCTGA-1_7_D5	2.644996829	18.48867945	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	894	1396	0.003581662	0.008595989	5	oligos	OL-Cntl	40	16	16
CTTTGCGTCAGCACAT-1_7_D5	4.969943215	-23.19815724	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4993	15198	0.005790236	0.003553099	5	L2-3	EN-L2-3-MS	40	16	16
CTTTGCGTCAGGTTCA-1_7_D5	5.616229334	18.97484841	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	895	1258	0.002384738	0.013513514	5	oligos	OL-Cntl	40	16	16
CTTTGCGTCATATCGG-1_7_D5	2.626615262	23.89256725	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	825	1221	0.004095004	0.004914005	5	oligos	OL-Cntl	40	16	16
GAAACTCAGAATGTGT-1_7_D5	38.79309377	12.28596497	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	927	1294	0.003863988	0.013137558	5	14	Microglia	40	16	16
GAAACTCCACAAGTAA-1_7_D5	11.48895168	13.42945419	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1147	1804	0.004988914	0.00886918	5	oligos	OL-Cntl	40	16	16
GAAACTCCACCGGAAA-1_7_D5	-0.410111599	13.3189895	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	960	1420	0.026056338	0.019014085	5	oligos	OL-Cntl	40	16	16
GAAACTCCATTAGCCA-1_7_D5	37.72757063	11.87884443	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	985	1390	0.01294964	0.020143885	5	14	Microglia	40	16	16
GAAACTCCATTCGACA-1_7_D5	-13.4444688	-0.525854058	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2793	5573	0.013457743	0.014175489	5	13A	IN-VIP	40	16	16
GAAACTCTCAACTCTT-1_7_D5	-12.38971251	-38.19943926	16	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1968	3897	0.020015396	0.011034129	5	16	EN-PYR	40	16	16
GAAACTCTCACCGTAA-1_7_D5	-0.356648594	16.2828495	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	772	1137	0.007915567	0.013192612	5	oligos	OL-Cntl	40	16	16
GAAATGAAGGAATCGC-1_7_D5	-21.23674538	27.668637	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1810	3419	0.004094765	0.002339865	5	8	Astrocytes	40	16	16
GAAATGAGTTACCAGT-1_7_D5	18.54358759	-25.0392869	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	5265	15876	0.010456034	0.016187957	5	3	EN-L5-6	40	16	16
GAAATGATCTTGACGA-1_7_D5	15.62257089	-7.740307481	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1986	3725	0.001879195	0.005637584	5	3	EN-L5-6	40	16	16
GAACATCGTGTATGGG-1_7_D5	-19.57108984	28.52817862	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2134	4144	0.00265444	0.00796332	5	8	Astrocytes	40	16	16
GAACATCGTTCCAACA-1_7_D5	11.32297743	-4.877470839	12	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	754	1168	0.019691781	0.004280822	5	12	EN-MIX	40	16	16
GAACATCTCCATGAAC-1_7_D5	31.23301792	15.03301376	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	775	1001	0.006993007	0.088911089	5	14	Microglia	40	16	16
GAACATCTCCCACTTG-1_7_D5	13.55032153	13.3406999	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1161	2024	0.003458498	0.007411067	5	oligos	OL-Cntl	40	16	16
GAACATCTCTGATACG-1_7_D5	1.452188054	20.31838508	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	787	1106	0.005424955	0.01084991	5	oligos	OL-Cntl	40	16	16
GAACCTAAGCCCAACC-1_7_D5	-7.600266389	-3.17900487	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1657	2697	0.002966259	0.006674082	5	13A	IN-VIP	40	16	16
GAACCTACAAGTCTAC-1_7_D5	-14.25383105	0.931215025	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3611	8092	0.005561048	0.011122096	5	13A	IN-VIP	40	16	16
GAACCTAGTGAGGGAG-1_7_D5	13.02557333	-30.72553489	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2974	7495	0.005737158	0.003735824	5	3	EN-L5-6	40	16	16
GAACCTAGTTCCAACA-1_7_D5	-1.17349617	18.39913877	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	709	1047	0.00095511	0.014326648	5	oligos	OL-Cntl	40	16	16
GAACCTATCAAAGTAG-1_7_D5	0.710340259	21.33747043	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	818	1166	0.024871355	0.003430532	5	oligos	OL-Cntl	40	16	16
GAACCTATCCCAACGG-1_7_D5	12.66245021	6.890866997	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1889	3395	0.005301915	0.010014728	5	oligos	OL-Cntl	40	16	16
GAACCTATCTTACCTA-1_7_D5	10.93333928	11.05566754	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1298	2234	0.004923903	0.008504924	5	oligos	OL-Cntl	40	16	16
GAACGGACAAACAACA-1_7_D5	6.784681073	-18.91452068	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4238	9493	0.004740335	0.013272938	5	L2-3	EN-L2-3-MS	40	16	16
GAACGGACAAGCGATG-1_7_D5	-22.65005953	-17.22675755	6B	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3980	9374	0.016215063	0.011521229	5	6B	IN-SST	40	16	16
GAACGGACATAGACTC-1_7_D5	-16.12576119	2.368106399	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4671	11118	0.005216766	0.013671524	5	13A	IN-VIP	40	16	16
GAACGGAGTATATGGA-1_7_D5	1.354748911	13.03463371	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	934	1372	0.027696793	0.014577259	5	oligos	OL-Cntl	40	16	16
GAACGGAGTCCATGAT-1_7_D5	30.30266872	16.14421926	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1221	1918	0.00729927	0.130344108	5	14	Microglia	40	16	16
GAACGGAGTCGAATCT-1_7_D5	31.21287544	15.10977203	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	840	1085	0.005529954	0.101382488	5	14	Microglia	40	16	16
GAACGGATCATTTGGG-1_7_D5	12.67147164	9.501424068	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1516	2720	0.003676471	0.013970588	5	oligos	OL-Cntl	40	16	16
GAAGCAGAGTAACCCT-1_7_D5	10.59466888	12.25885863	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1197	1990	0.011055276	0.003517588	5	oligos	OL-Cntl	40	16	16
GAAGCAGAGTACACCT-1_7_D5	38.84828118	10.24157164	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	788	1095	0	0.010958904	5	14	Microglia	40	16	16
GAAGCAGGTAGAGTGC-1_7_D5	11.4021835	8.554771187	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1496	2568	0.003894081	0.01635514	5	oligos	OL-Cntl	40	16	16
GAAGCAGGTCAGATAA-1_7_D5	-31.7428398	2.803220629	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2157	3922	0.004844467	0.005609383	5	9	OPC	40	16	16
GAAGCAGGTTCACCTC-1_7_D5	5.246222713	29.93450153	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	776	1087	0.011039558	0.00275989	5	oligos	OL-Cntl	40	16	16
GAAGCAGTCAGTCCCT-1_7_D5	12.92831897	-30.54361227	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2670	6697	0.001642527	0.00253845	5	3	EN-L5-6	40	16	16
GAAGCAGTCATCGGAT-1_7_D5	15.93877392	-7.421953846	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2221	4318	0.007410838	0.002547476	5	3	EN-L5-6	40	16	16
GAAGCAGTCTCTAAGG-1_7_D5	34.184453	15.37803242	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	979	1365	0.013186813	0.052747253	5	14	Microglia	40	16	16
GAATAAGCACTTACGA-1_7_D5	31.32624514	16.01512306	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1093	1600	0.004375	0.085625	5	14	Microglia	40	16	16
GAATAAGCATGAACCT-1_7_D5	12.84773142	10.40113412	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1428	2459	0.001626678	0.009353396	5	oligos	OL-Cntl	40	16	16
GAATAAGTCCACGCAG-1_7_D5	-1.549567621	15.46037899	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	873	1306	0.001531394	0.017611026	5	oligos	OL-Cntl	40	16	16
GAATAAGTCTTACCGC-1_7_D5	13.9011556	9.6084585	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1432	2544	0.001572327	0.010220126	5	oligos	OL-Cntl	40	16	16
GAATGAAAGTAGTGCG-1_7_D5	-19.5641072	-27.77625943	6A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3448	9011	0.006769504	0.002885362	5	6A	IN-PV	40	16	16
GAATGAACAACACCCG-1_7_D5	9.150614566	-21.02212504	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	6487	22305	0.006052455	0.006411119	5	L2-3	EN-L2-3-MS	40	16	16
GAATGAACACGGCTAC-1_7_D5	7.428675381	-8.263405511	10	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1830	3283	0.011879379	0.005178191	5	L2-3	EN-L2-3-Cntl	40	16	16
GAATGAACAGTCAGAG-1_7_D5	-8.307833643	0.934449205	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2145	4328	0.006469501	0.003927911	5	13A	IN-VIP	40	16	16
GAATGAAGTAGGCATG-1_7_D5	14.91122102	12.29368335	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1193	1930	0.002072539	0.00880829	5	oligos	OL-Cntl	40	16	16
GAATGAATCAGGCGAA-1_7_D5	-0.267459501	22.34941055	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	743	1047	0.016236867	0.006685769	5	oligos	OL-Cntl	40	16	16
GAATGAATCCTAGGGC-1_7_D5	-5.296080004	-1.754411747	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1846	3691	0.007044161	0.00379301	5	13A	IN-VIP	40	16	16
GACACGCAGCCCAATT-1_7_D5	-17.96096117	1.300988325	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4705	10602	0.012261837	0.03772873	5	13A	IN-VIP	40	16	16
GACACGCCAAAGTCAA-1_7_D5	8.276257935	33.33998148	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1066	1746	0.001718213	0.006300115	5	oligos	OL-Cntl	40	16	16
GACACGCCACATAACC-1_7_D5	-38.74370773	-2.500482221	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1228	2189	0.005025126	0.002284148	5	9	OPC	40	16	16
GACACGCGTAGCGATG-1_7_D5	-19.22168053	30.1241795	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2874	7087	0.002539862	0.008889516	5	8	Astrocytes	40	16	16
GACACGCGTGGTAACG-1_7_D5	-3.89478952	-16.95055826	10	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2491	4779	0.006486713	0.005858966	5	L2-3	EN-L2-3-Cntl	40	16	16
GACACGCTCACTCCTG-1_7_D5	4.629895609	17.40866119	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	984	1542	0.009079118	0.006485084	5	oligos	OL-Cntl	40	16	16
GACACGCTCAGCCTAA-1_7_D5	13.21207384	10.37616237	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1323	2214	0.001806685	0.009936766	5	oligos	OL-Cntl	40	16	16
GACACGCTCCAGATCA-1_7_D5	0.70432107	16.2906218	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	944	1520	0.003947368	0.011184211	5	oligos	OL-Cntl	40	16	16
GACACGCTCCTCATTA-1_7_D5	-16.09082865	15.73557869	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2534	5764	0.002428869	0.004857738	5	8	Astrocytes	40	16	16
GACAGAGCAACCGCCA-1_7_D5	-2.115988081	17.73706581	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	773	1145	0.002620087	0.009606987	5	oligos	OL-Cntl	40	16	16
GACAGAGCATGCCACG-1_7_D5	-1.342200981	18.0993499	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	704	1002	0.003992016	0.008982036	5	oligos	OL-Cntl	40	16	16
GACAGAGGTAAACACA-1_7_D5	-3.857142207	14.31158667	5	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	830	1239	0.008071025	0.016949153	5	oligos	OL-MS-1	40	16	16
GACAGAGTCTCTTATG-1_7_D5	11.818268	8.410510602	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1528	2727	0.00770077	0.011734507	5	oligos	OL-Cntl	40	16	16
GACCAATAGATCCGAG-1_7_D5	4.955834772	-23.11354192	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4526	12586	0.007389163	0.004449388	5	L2-3	EN-L2-3-MS	40	16	16
GACCAATAGTCAAGGC-1_7_D5	-25.14698856	22.44628711	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1293	2296	0.003484321	0.007404181	5	8	Astrocytes	40	16	16
GACCAATCACTGTGTA-1_7_D5	-20.39555489	30.64695491	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2704	5861	0.002900529	0.005459819	5	8	Astrocytes	40	16	16
GACCAATCATACAGCT-1_7_D5	9.68180483	10.65697563	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1298	2134	0.002811621	0.011246485	5	oligos	OL-Cntl	40	16	16
GACCAATGTACATCCA-1_7_D5	-33.14418239	4.540644898	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2563	4970	0.002012072	0.007042254	5	9	OPC	40	16	16
GACCAATGTGTGAAAT-1_7_D5	-18.97546812	-17.75540233	6B	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2711	5653	0.004068636	0.006545197	5	6B	IN-SST	40	16	16
GACCAATGTTCGCGAC-1_7_D5	-0.909622642	22.97852961	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	756	1118	0.012522361	0.007155635	5	oligos	OL-Cntl	40	16	16
GACCAATTCCTCATTA-1_7_D5	-17.56669621	1.172176942	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4987	13141	0.015904421	0.017959059	5	13A	IN-VIP	40	16	16
GACCTGGAGGAACTGC-1_7_D5	-27.78035102	9.620468908	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	809	1224	0.004901961	0.007352941	5	8	Astrocytes	40	16	16
GACCTGGCACAGACAG-1_7_D5	-3.044484253	24.74160156	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	692	1030	0.000970874	0.010679612	5	oligos	OL-Cntl	40	16	16
GACCTGGCACCAGCAC-1_7_D5	-26.60352095	24.88070316	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1361	2602	0.007302075	0.003074558	5	8	Astrocytes	40	16	16
GACCTGGGTAGCGTGA-1_7_D5	12.87293798	-7.084393748	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2438	5550	0.016396396	0.003603604	5	3	EN-L5-6	40	16	16
GACCTGGGTCTCTTTA-1_7_D5	12.84142901	8.214847547	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1613	2807	0.00320627	0.008193801	5	oligos	OL-Cntl	40	16	16
GACCTGGTCGGCGGTT-1_7_D5	-38.96320846	-0.818720633	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1402	2520	0.002380952	0.003968254	5	9	OPC	40	16	16
GACCTGGTCGTTTATC-1_7_D5	-20.38204315	28.85500866	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2014	4002	0.000749625	0.006996502	5	8	Astrocytes	40	16	16
GACCTGGTCTTGTATC-1_7_D5	4.314296718	19.94204328	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	987	1534	0.009778357	0.003911343	5	oligos	OL-Cntl	40	16	16
GACGCGTAGACGACGT-1_7_D5	-34.40750104	0.766273816	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1780	3000	0.006	0.006666667	5	9	OPC	40	16	16
GACGCGTAGACTGGGT-1_7_D5	-2.572161867	17.23427921	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	712	1067	0	0.016869728	5	oligos	OL-Cntl	40	16	16
GACGCGTAGTCCCACG-1_7_D5	-18.71850948	27.78496037	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2066	4077	0.004169733	0.008094187	5	8	Astrocytes	40	16	16
GACGCGTAGTCTCCTC-1_7_D5	-36.25887186	1.42477246	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1698	3088	0.002266839	0.004209845	5	9	OPC	40	16	16
GACGCGTCAATGTAAG-1_7_D5	7.839789664	11.38193	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1239	2131	0.006100422	0.013139371	5	oligos	OL-Cntl	40	16	16
GACGCGTCAGATCTGT-1_7_D5	12.29972923	-6.22007992	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1742	3696	0.024080087	0.00487013	5	3	EN-L5-6	40	16	16
GACGCGTCAGGAACGT-1_7_D5	11.18881382	-18.80433919	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	5742	15670	0.015762604	0.008104659	5	L2-3	EN-L2-3-MS	40	16	16
GACGCGTGTCAGATAA-1_7_D5	4.580793806	27.35593648	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	762	1098	0.004553734	0.010928962	5	oligos	OL-Cntl	40	16	16
GACGCGTGTGTTGGGA-1_7_D5	-24.19062185	24.01776754	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1515	2627	0.002664636	0.003806624	5	8	Astrocytes	40	16	16
GACGCGTTCCCAAGTA-1_7_D5	25.05932691	-26.69280478	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4624	12985	0.009395456	0.00438968	5	3	EN-L5-6	40	16	16
GACGGCTCACAACTGT-1_7_D5	14.14383236	10.52759401	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1534	2495	0.003206413	0.007214429	5	oligos	OL-Cntl	40	16	16
GACGGCTCACTTACGA-1_7_D5	-19.96900206	25.45869662	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1665	3540	0	0.00960452	5	8	Astrocytes	40	16	16
GACGGCTCAGCGTCCA-1_7_D5	-20.07035544	24.86544497	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1556	2824	0.001416431	0.007790368	5	8	Astrocytes	40	16	16
GACGGCTCAGTGAGTG-1_7_D5	-21.08843797	10.25350918	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1208	2005	0.002992519	0.002992519	5	8	Astrocytes	40	16	16
GACGGCTGTGAAGGCT-1_7_D5	-25.39726291	-17.43459374	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	5449	14215	0.015265565	0.010622582	5	13A	IN-VIP	40	16	16
GACGGCTTCACTCTTA-1_7_D5	11.43072953	7.56573929	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1799	3051	0.002949853	0.012782694	5	oligos	OL-Cntl	40	16	16
GACGTGCAGGCTATCT-1_7_D5	6.346412394	-19.79672356	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3847	9339	0.008994539	0.011992719	5	L2-3	EN-L2-3-MS	40	16	16
GACGTGCAGTGACTCT-1_7_D5	-24.85908056	0.161657151	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2568	4872	0.003489327	0.009031199	5	9	OPC	40	16	16
GACGTGCAGTGTGGCA-1_7_D5	3.680126802	14.14374486	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1123	1750	0.010857143	0.016	5	oligos	OL-Cntl	40	16	16
GACGTGCCACAACGCC-1_7_D5	14.94444511	30.92831606	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	886	1434	0.006276151	0.0041841	5	oligos	OL-Cntl	40	16	16
GACGTGCGTAGAAGGA-1_7_D5	-21.83659417	9.941056954	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	983	1656	0.002415459	0.004227053	5	8	Astrocytes	40	16	16
GACGTGCGTTCAGACT-1_7_D5	34.81852356	-8.737549812	2	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	6290	18783	0.006016078	0.011073843	5	2	EN-L4	40	16	16
GACGTGCTCTACTTAC-1_7_D5	34.34327302	15.60841385	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1325	1913	0.007318348	0.042341871	5	14	Microglia	40	16	16
GACGTGCTCTCAACTT-1_7_D5	-9.760212188	-17.79789647	6B	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1011	1765	0.071954674	0.001699717	5	6B	IN-SST	40	16	16
GACGTGCTCTTAGCCC-1_7_D5	32.48979857	16.62284774	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1323	1975	0.009113924	0.064303797	5	14	Microglia	40	16	16
GACGTTAAGCGAAGGG-1_7_D5	12.17267933	6.215042646	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2245	4196	0.013822688	0.015967588	5	oligos	OL-Cntl	40	16	16
GACGTTAAGTAGATGT-1_7_D5	14.66073473	13.80021444	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1219	2089	0.007180469	0.004308281	5	oligos	OL-Cntl	40	16	16
GACGTTAAGTGAAGAG-1_7_D5	12.07651183	15.70267871	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1092	1734	0.010380623	0.008073818	5	oligos	OL-Cntl	40	16	16
GACGTTACATCCCACT-1_7_D5	-32.21406687	-8.323223101	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1121	1584	0.003156566	0.004419192	5	9	OPC	40	16	16
GACGTTATCTTCAACT-1_7_D5	-36.00744886	3.757551414	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2106	4201	0.00499881	0.003570578	5	9	OPC	40	16	16
GACTAACAGAAGCCCA-1_7_D5	4.922321417	10.94617948	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1257	2066	0.002904163	0.01500484	5	oligos	OL-Cntl	40	16	16
GACTAACAGAGACTTA-1_7_D5	-32.42011135	-8.595719149	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	991	1463	0.004784689	0.011619959	5	9	OPC	40	16	16
GACTAACAGGAATGGA-1_7_D5	6.886865129	20.72797663	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1007	1557	0.013487476	0.007064868	5	oligos	OL-Cntl	40	16	16
GACTAACCAAACTGTC-1_7_D5	7.127393897	-20.85824359	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	6823	24393	0.008240069	0.007707129	5	L2-3	EN-L2-3-MS	40	16	16
GACTAACCAAAGTCAA-1_7_D5	-3.958349959	14.54943392	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	834	1180	0.003389831	0.011864407	5	oligos	OL-Cntl	40	16	16
GACTAACCACAGGCCT-1_7_D5	11.63831264	8.196210301	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1640	2906	0.005161734	0.012388162	5	oligos	OL-Cntl	40	16	16
GACTAACGTTCCATGA-1_7_D5	5.433873587	11.25382097	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1293	2059	0.000971345	0.016998543	5	oligos	OL-Cntl	40	16	16
GACTAACTCAGTGCAT-1_7_D5	16.44915745	5.862294822	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2453	5011	0.002793854	0.009978048	5	oligos	OL-Cntl	40	16	16
GACTAACTCCACGCAG-1_7_D5	12.97752367	-7.297291728	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3635	10913	0.008155411	0.002565747	5	3	EN-L5-6	40	16	16
GACTAACTCGCACTCT-1_7_D5	10.48775915	8.199906968	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1591	2813	0.009242801	0.012442232	5	oligos	OL-Cntl	40	16	16
GACTAACTCGTTGCCT-1_7_D5	38.64029631	14.51402449	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1189	1848	0.007034632	0.009199134	5	14	Microglia	40	16	16
GACTACAAGCGAGAAA-1_7_D5	15.08830733	6.082602836	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2440	4775	0.010680628	0.018010471	5	oligos	OL-Cntl	40	16	16
GACTACACACCGAATT-1_7_D5	5.729121887	-27.28783637	10	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	5925	18597	0.000967898	0.005646072	5	L2-3	EN-L2-3-Cntl	40	16	16
GACTACACACTTCGAA-1_7_D5	-35.02486983	5.193915213	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3124	6824	0.002051583	0.003223916	5	9	OPC	40	16	16
GACTACACATGCCCGA-1_7_D5	15.15249094	13.17962336	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1330	2422	0.012386457	0.007018993	5	oligos	OL-Cntl	40	16	16
GACTACATCCAGATCA-1_7_D5	35.32362741	-9.161787943	2	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	5651	15352	0.007751433	0.009705576	5	2	EN-L4	40	16	16
GACTACATCTTCAACT-1_7_D5	19.26335196	12.26069924	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1446	2675	0.00635514	0.004859813	5	oligos	OL-Cntl	40	16	16
GACTGCGAGCGCCTCA-1_7_D5	10.9962568	8.512744555	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1484	2443	0.003683995	0.01023332	5	oligos	OL-Cntl	40	16	16
GACTGCGAGTCCATAC-1_7_D5	32.07920932	16.67897384	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1455	2255	0.007095344	0.073614191	5	14	Microglia	40	16	16
GACTGCGCAAAGAATC-1_7_D5	-4.85394771	9.236616342	5	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	942	1398	0.012160229	0.032904149	5	oligos	OL-MS-1	40	16	16
GACTGCGCAACTTGAC-1_7_D5	12.61859789	15.92629919	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1058	1614	0.003717472	0.010532838	5	oligos	OL-Cntl	40	16	16
GACTGCGCACGAAAGC-1_7_D5	35.80005887	-11.40372544	2	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	6241	18338	0.016359472	0.015432435	5	2	EN-L4	40	16	16
GACTGCGCATACGCTA-1_7_D5	18.41003828	-23.99400298	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	6790	22255	0.010469557	0.021882723	5	3	EN-L5-6	40	16	16
GACTGCGGTCTAGGTT-1_7_D5	-2.973188656	17.16175771	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	725	1046	0.010516252	0.023900574	5	oligos	OL-Cntl	40	16	16
GACTGCGTCCGCATAA-1_7_D5	-3.843245381	24.88206258	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	710	1138	0.004393673	0.006151142	5	oligos	OL-Cntl	40	16	16
GACTGCGTCCTTTCTC-1_7_D5	-31.52550381	2.595973725	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2150	4192	0.007395038	0.009303435	5	9	OPC	40	16	16
GACTGCGTCTGTACGA-1_7_D5	-24.48799213	24.24441968	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1583	3136	0.003188776	0.007015306	5	8	Astrocytes	40	16	16
GACTGCGTCTGTTGAG-1_7_D5	-24.6664421	16.19025935	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1216	2135	0.00234192	0.007494145	5	8	Astrocytes	40	16	16
GAGCAGAAGCGAGAAA-1_7_D5	-20.17295925	-29.23299553	6A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4873	15370	0.001626545	0.004359141	5	6A	IN-PV	40	16	16
GAGCAGAAGGCACATG-1_7_D5	-20.29594536	28.27459822	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2231	4567	0.001313773	0.006568864	5	8	Astrocytes	40	16	16
GAGCAGAAGGGCACTA-1_7_D5	3.229535155	10.95984522	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1033	1582	0.007585335	0.028445006	5	oligos	OL-Cntl	40	16	16
GAGCAGAAGTTAAGTG-1_7_D5	12.84007696	-7.035582128	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2407	5096	0.010007849	0.004120879	5	3	EN-L5-6	40	16	16
GAGCAGACACACAGAG-1_7_D5	15.09599232	11.66436401	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1300	2286	0.001312336	0.005686789	5	oligos	OL-Cntl	40	16	16
GAGCAGACAGATCGGA-1_7_D5	32.77747171	16.54729051	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1297	1893	0.00528262	0.041732699	5	14	Microglia	40	16	16
GAGCAGAGTAAGTAGT-1_7_D5	-18.36821884	0.239821674	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4165	9401	0.010956281	0.020210616	5	13A	IN-VIP	40	16	16
GAGCAGAGTTCAGCGC-1_7_D5	-12.33229811	-19.08484993	6B	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1172	2104	0.050380228	0.002376426	5	6B	IN-SST	40	16	16
GAGCAGAGTTCGCTAA-1_7_D5	14.71860674	10.31328224	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1375	2347	0.012356199	0.008947593	5	oligos	OL-Cntl	40	16	16
GAGCAGATCACAAACC-1_7_D5	-35.48701474	1.648338173	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1715	3074	0.004554327	0.002927781	5	9	OPC	40	16	16
GAGGTGAAGCCCAGCT-1_7_D5	-20.04978725	-18.11693704	6B	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3079	6980	0.013610315	0.004441261	5	6B	IN-SST	40	16	16
GAGGTGAAGCTGAAAT-1_7_D5	-12.99170458	-17.37905674	6B	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1098	1675	0.023880597	0.00358209	5	6B	IN-SST	40	16	16
GAGGTGAAGTCCGGTC-1_7_D5	-19.49850588	29.12181856	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2441	4965	0.003826788	0.006243706	5	8	Astrocytes	40	16	16
GAGGTGAGTAGCCTAT-1_7_D5	-4.791358788	21.34394774	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	719	1060	0.021698113	0.006603774	5	oligos	OL-Cntl	40	16	16
GAGGTGATCAATACCG-1_7_D5	10.16783406	18.12211691	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	878	1387	0.005046864	0.008651766	5	oligos	OL-Cntl	40	16	16
GAGGTGATCACTGGGC-1_7_D5	-34.94940047	0.313713913	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1779	3204	0.005617978	0.004681648	5	9	OPC	40	16	16
GAGGTGATCCAACCAA-1_7_D5	-11.66486188	18.41841881	11	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2183	4180	0.00645933	0.010526316	5	11	Glia-MIX	40	16	16
GAGTCCGAGAGGTACC-1_7_D5	-34.04214704	-12.87373742	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	760	1161	0.009474591	0.003445306	5	9	OPC	40	16	16
GAGTCCGCAAACGTGG-1_7_D5	12.47182053	-6.469220151	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1878	3613	0.002767783	0.001107113	5	3	EN-L5-6	40	16	16
GAGTCCGCACCATCCT-1_7_D5	-12.16270554	-19.43018707	6B	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1085	1894	0.06969377	0.001583949	5	6B	IN-SST	40	16	16
GAGTCCGCAGCGATCC-1_7_D5	37.88685335	11.29387523	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	917	1310	0.019083969	0.014503817	5	14	Microglia	40	16	16
GAGTCCGCAGTCAGAG-1_7_D5	-24.93858544	25.67007482	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2011	4081	0.00612595	0.005390836	5	8	Astrocytes	40	16	16
GAGTCCGCATGAACCT-1_7_D5	2.979225584	16.88782319	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	862	1347	0.003711952	0.012620638	5	oligos	OL-Cntl	40	16	16
GAGTCCGGTAGGACAC-1_7_D5	-38.51558757	-1.006661049	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1318	2301	0.002172968	0.002607562	5	9	OPC	40	16	16
GAGTCCGGTGTGTGCC-1_7_D5	-3.596476104	25.04872005	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	666	1045	0.002870813	0.009569378	5	oligos	OL-Cntl	40	16	16
GAGTCCGGTTATCCGA-1_7_D5	15.98846087	6.071460204	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2145	4232	0.007561437	0.008979206	5	oligos	OL-Cntl	40	16	16
GAGTCCGTCAGTTCGA-1_7_D5	-19.38370439	28.95809237	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2273	4551	0.002197319	0.007031422	5	8	Astrocytes	40	16	16
GATCAGTAGCCAGAAC-1_7_D5	4.734351462	-21.86190177	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4851	14709	0.00523489	0.004419063	5	L2-3	EN-L2-3-MS	40	16	16
GATCAGTAGGACGAAA-1_7_D5	39.68788712	13.11443933	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1079	1582	0.001264223	0.005689001	5	14	Microglia	40	16	16
GATCAGTAGTAGTGCG-1_7_D5	9.486544897	16.56173939	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1084	1643	0.000608643	0.006086427	5	oligos	OL-Cntl	40	16	16
GATCAGTCACGAAACG-1_7_D5	-34.9826759	-12.43614878	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	879	1408	0.024857955	0.002840909	5	9	OPC	40	16	16
GATCAGTGTAAGAGGA-1_7_D5	-35.43457819	2.204971722	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1924	3831	0.002610285	0.007830854	5	9	OPC	40	16	16
GATCAGTGTAGAGGAA-1_7_D5	-17.11887345	1.459555788	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3839	8432	0.013994307	0.014468691	5	13A	IN-VIP	40	16	16
GATCAGTGTTGGACCC-1_7_D5	-20.48453466	-6.457231266	13B	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	5382	14290	0.023862841	0.01196641	5	13B	IN-SV2C	40	16	16
GATCGATAGCTAGTCT-1_7_D5	5.606813047	16.17464386	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	979	1538	0.003250975	0.007802341	5	oligos	OL-Cntl	40	16	16
GATCGATCAGCTGTGC-1_7_D5	-16.68624853	12.17639083	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1226	2361	0.000847099	0.002541296	5	8	Astrocytes	40	16	16
GATCGATCATGCGCAC-1_7_D5	15.69663643	9.929870953	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1597	3012	0.001992032	0.007636122	5	oligos	OL-Cntl	40	16	16
GATCGATCATTACCTT-1_7_D5	35.13759599	-8.637997919	2	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	5510	16123	0.009179433	0.011660361	5	2	EN-L4	40	16	16
GATCGATGTACAAGTA-1_7_D5	12.94800586	-7.225625528	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2657	5600	0.002142857	0.004107143	5	3	EN-L5-6	40	16	16
GATCGATGTAGAGTGC-1_7_D5	10.94215311	14.71794916	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1028	1740	0.02816092	0.006896552	5	oligos	OL-Cntl	40	16	16
GATCGATGTAGTAGTA-1_7_D5	-2.790446864	17.4691371	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	717	1087	0.009199632	0.016559338	5	oligos	OL-Cntl	40	16	16
GATCGATTCGGCCGAT-1_7_D5	9.392281095	-23.27544316	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4843	13477	0.005639237	0.009571863	5	L2-3	EN-L2-3-MS	40	16	16
GATCGATTCTACTATC-1_7_D5	35.39830251	15.72091056	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1317	2083	0.009601536	0.042726836	5	14	Microglia	40	16	16
GATCGATTCTCCGGTT-1_7_D5	11.96534108	16.77563691	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1077	1802	0.002774695	0.01054384	5	oligos	OL-Cntl	40	16	16
GATCGATTCTTAGAGC-1_7_D5	-21.87363175	-18.75900422	6B	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2761	5948	0.019670477	0.007733692	5	6B	IN-SST	40	16	16
GATCGCGCAATCCGAT-1_7_D5	34.12391474	-6.740072982	2	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	5495	16681	0.007793298	0.004975721	5	2	EN-L4	40	16	16
GATCGCGTCCGTTGCT-1_7_D5	9.161725121	14.9749585	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1064	1663	0.001202646	0.011425135	5	oligos	OL-Cntl	40	16	16
GATCGCGTCTTCCTTC-1_7_D5	16.0434441	9.831022523	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1553	2759	0	0.005799203	5	oligos	OL-Cntl	40	16	16
GATCGCGTCTTGAGGT-1_7_D5	-24.52846051	16.83619557	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1231	1911	0.002616431	0.003663004	5	8	Astrocytes	40	16	16
GATCGTAAGGCAGTCA-1_7_D5	37.01089243	11.87573228	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	928	1276	0.014106583	0.019592476	5	14	Microglia	40	16	16
GATCGTAAGTTGAGTA-1_7_D5	-16.17975168	-19.02658533	6B	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1945	3982	0.013309895	0.002260171	5	6B	IN-SST	40	16	16
GATCTAGAGCGTTGCC-1_7_D5	13.45996194	11.00144223	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1395	2384	0.005033557	0.008389262	5	oligos	OL-Cntl	40	16	16
GATCTAGAGTGCAAGC-1_7_D5	-20.94404136	27.94087487	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2047	4171	0.001438504	0.005274515	5	8	Astrocytes	40	16	16
GATCTAGCAAGGGTCA-1_7_D5	-35.04547849	1.200219538	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1589	2838	0.006342495	0.00845666	5	9	OPC	40	16	16
GATCTAGGTATTCGTG-1_7_D5	-15.4993727	-19.04635301	6B	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1590	3197	0.062871442	0.001876759	5	6B	IN-SST	40	16	16
GATCTAGGTTGTGGAG-1_7_D5	-13.0574046	-16.51536966	6B	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1397	2670	0.048689139	0.003745318	5	6B	IN-SST	40	16	16
GATCTAGTCAGAAATG-1_7_D5	-21.77837455	25.41666896	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1752	3343	0.006281783	0.005384385	5	8	Astrocytes	40	16	16
GATCTAGTCTCTGAGA-1_7_D5	-34.01615615	-5.375184239	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1145	1788	0.001118568	0.005033557	5	9	OPC	40	16	16
GATGAAAAGCTCCTCT-1_7_D5	-38.1111704	-5.950657415	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1136	1939	0.00051573	0.003094379	5	9	OPC	40	16	16
GATGAAAAGGCATTGG-1_7_D5	12.47503819	11.78978041	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1258	1898	0.005795574	0.010537408	5	oligos	OL-Cntl	40	16	16
GATGAAAAGGTAGCCA-1_7_D5	4.713952696	5.914758336	7	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1564	2379	0.008827238	0.008827238	5	7	Phagocytes	40	16	16
GATGAAACACTTGGAT-1_7_D5	-28.06856969	23.22188093	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1194	2147	0.001863065	0.003260363	5	8	Astrocytes	40	16	16
GATGAAACATCAGTAC-1_7_D5	-25.91856218	29.9133052	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1907	3641	0.0005493	0.004669047	5	8	Astrocytes	40	16	16
GATGAAAGTGAAATCA-1_7_D5	-34.33908241	2.637207873	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2064	3797	0.00500395	0.006057414	5	9	OPC	40	16	16
GATGAAAGTGCAGTAG-1_7_D5	2.460569898	17.98282444	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	929	1395	0.014336918	0.008602151	5	oligos	OL-Cntl	40	16	16
GATGAAATCCATGAGT-1_7_D5	-0.065951638	14.9386498	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	833	1256	0.001592357	0.012738854	5	oligos	OL-Cntl	40	16	16
GATGAAATCGTGGACC-1_7_D5	-17.84613101	-24.85471373	6A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2496	5600	0	0.002857143	5	6A	IN-PV	40	16	16
GATGAGGAGAAACCTA-1_7_D5	14.49948064	12.66469731	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1206	1856	0.009698276	0.00862069	5	oligos	OL-Cntl	40	16	16
GATGAGGAGAGACTTA-1_7_D5	31.46453206	16.31392603	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1159	1688	0.007109005	0.077606635	5	14	Microglia	40	16	16
GATGAGGCAATCACAC-1_7_D5	39.67924371	11.96801977	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	976	1389	0.006479482	0.003599712	5	14	Microglia	40	16	16
GATGAGGCATACGCCG-1_7_D5	-17.76984988	-19.16516236	6A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2724	6398	0.021256643	0.002969678	5	6A	IN-PV	40	16	16
GATGAGGGTGCCTGCA-1_7_D5	36.30475828	9.16101031	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	806	1098	0.001821494	0.010928962	5	14	Microglia	40	16	16
GATGCTAAGAGCTATA-1_7_D5	34.39833118	15.12369332	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	816	1163	0.008598452	0.03955288	5	14	Microglia	40	16	16
GATGCTAAGGGTTCCC-1_7_D5	9.707553378	10.68588178	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1266	2080	0.014903846	0.015865385	5	oligos	OL-Cntl	40	16	16
GATGCTAAGTCCATAC-1_7_D5	13.66558695	-9.976934754	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4047	9814	0.004687182	0.015895659	5	13A	IN-VIP	40	16	16
GATGCTACACATCTTT-1_7_D5	12.29775825	14.28058752	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1140	1887	0.003709592	0.0063593	5	oligos	OL-Cntl	40	16	16
GATGCTACACGGATAG-1_7_D5	-3.976274173	14.07202594	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	902	1273	0.019638649	0.021995287	5	oligos	OL-Cntl	40	16	16
GATGCTACAGCTCGCA-1_7_D5	-25.97813152	14.97624728	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1012	1583	0.002526848	0.001895136	5	8	Astrocytes	40	16	16
GATGCTATCATCTGTT-1_7_D5	9.790345551	23.60535957	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	816	1195	0.008368201	0.007531381	5	oligos	OL-Cntl	40	16	16
GATGCTATCGAACGGA-1_7_D5	10.38359823	21.9134933	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	914	1444	0.000692521	0.003462604	5	oligos	OL-Cntl	40	16	16
GATTCAGCAGTATCTG-1_7_D5	30.34666236	15.41947843	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	944	1377	0.002904866	0.140885984	5	14	Microglia	40	16	16
GATTCAGCATTCTCAT-1_7_D5	-2.734614394	-0.897485956	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4396	10773	0.007704446	0.008354219	5	13A	IN-VIP	40	16	16
GATTCAGGTCTCACCT-1_7_D5	10.92103139	8.177663314	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1324	2333	0.015002143	0.018431204	5	oligos	OL-Cntl	40	16	16
GATTCAGGTCTCCCTA-1_7_D5	-34.0465498	-9.835962432	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	846	1223	0.004905969	0.004088307	5	9	OPC	40	16	16
GATTCAGTCACAACGT-1_7_D5	-3.647995668	16.77627918	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	700	1043	0.014381592	0.014381592	5	oligos	OL-Cntl	40	16	16
GATTCAGTCGGAGGTA-1_7_D5	2.774998694	11.52610092	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1055	1677	0.01013715	0.019081694	5	oligos	OL-Cntl	40	16	16
GCAAACTAGAAGAAGC-1_7_D5	3.877903564	18.81853346	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	852	1190	0.003361345	0.011764706	5	oligos	OL-Cntl	40	16	16
GCAAACTAGGATGTAT-1_7_D5	2.970215008	19.70849854	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	867	1333	0.0060015	0.004501125	5	oligos	OL-Cntl	40	16	16
GCAAACTGTGACAAAT-1_7_D5	4.228472553	18.45633702	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1040	1608	0.013681592	0.008706468	5	oligos	OL-Cntl	40	16	16
GCAAACTTCTCGTTTA-1_7_D5	9.655236635	10.56300413	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1270	2129	0.005636449	0.015969939	5	oligos	OL-Cntl	40	16	16
GCAATCAGTCCATCCT-1_7_D5	-31.01730469	12.86852098	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	935	1515	0.025742574	0.00330033	5	8	Astrocytes	40	16	16
GCAATCATCCGCTGTT-1_7_D5	7.270089668	-20.38114867	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	5506	15978	0.006133433	0.00888722	5	L2-3	EN-L2-3-MS	40	16	16
GCAATCATCGCACTCT-1_7_D5	35.48363494	-7.412568436	2	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4083	9703	0.008038751	0.007832629	5	2	EN-L4	40	16	16
GCAATCATCGGCCGAT-1_7_D5	37.67978201	15.31158099	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1257	1841	0.002172732	0.017381858	5	14	Microglia	40	16	16
GCACATAAGCACCGCT-1_7_D5	4.588214456	14.41275616	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1041	1616	0.004331683	0.017326733	5	oligos	OL-Cntl	40	16	16
GCACATAAGCGATTCT-1_7_D5	39.00840923	15.06942661	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1296	2068	0.010154739	0.004352031	5	14	Microglia	40	16	16
GCACATACAAATCCGT-1_7_D5	5.464864269	11.38511637	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1217	1963	0.005094244	0.013754457	5	oligos	OL-Cntl	40	16	16
GCACATACATTCTCAT-1_7_D5	32.51807241	15.13043466	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1024	1402	0.007845934	0.04636234	5	14	Microglia	40	16	16
GCACATAGTGTATGGG-1_7_D5	37.27630238	9.568300333	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	782	1052	0.014258555	0.016159696	5	14	Microglia	40	16	16
GCACATAGTTCGTCTC-1_7_D5	10.88660015	7.944680592	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1546	2752	0.006177326	0.015625	5	oligos	OL-Cntl	40	16	16
GCACATATCTCATTCA-1_7_D5	-0.466003553	18.19830952	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	868	1405	0.010676157	0.007829181	5	oligos	OL-Cntl	40	16	16
GCACTCTCACCACCAG-1_7_D5	31.26607776	15.24481949	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	919	1287	0.005439005	0.094017094	5	14	Microglia	40	16	16
GCACTCTGTCTAAAGA-1_7_D5	-13.29594538	0.34326742	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3328	6889	0.006822471	0.012628829	5	13A	IN-VIP	40	16	16
GCACTCTGTGAGGGTT-1_7_D5	-12.77341485	0.964534695	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3834	8746	0.01017608	0.005488223	5	13A	IN-VIP	40	16	16
GCACTCTTCCACGTTC-1_7_D5	-20.57734806	27.06830469	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1669	2924	0.004787962	0.006497948	5	8	Astrocytes	40	16	16
GCACTCTTCGTACGGC-1_7_D5	-0.190843701	17.09127536	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	795	1183	0.006762468	0.009298394	5	oligos	OL-Cntl	40	16	16
GCAGCCAAGAAACCAT-1_7_D5	18.24592758	13.99242763	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1260	2253	0.003550821	0.003106968	5	oligos	OL-Cntl	40	16	16
GCAGCCACATCGGAAG-1_7_D5	0.153350205	23.51338956	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	737	1113	0.004492363	0.007187781	5	oligos	OL-Cntl	40	16	16
GCAGCCAGTCCATCCT-1_7_D5	-26.76584537	15.93308766	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1102	1841	0.000543183	0.004345464	5	8	Astrocytes	40	16	16
GCAGCCAGTCTTGATG-1_7_D5	32.61333336	14.61170185	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	918	1244	0.004823151	0.040192926	5	14	Microglia	40	16	16
GCAGCCATCATTATCC-1_7_D5	0.393875904	18.70500036	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	797	1162	0.011187608	0.004302926	5	oligos	OL-Cntl	40	16	16
GCAGCCATCGGATGGA-1_7_D5	13.02566739	-7.380660606	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3435	8407	0.001903176	0.006661116	5	3	EN-L5-6	40	16	16
GCAGTTAAGCGCCTTG-1_7_D5	12.69107661	10.32724678	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1222	1927	0.004151531	0.010378827	5	oligos	OL-Cntl	40	16	16
GCAGTTACAGACACTT-1_7_D5	-30.72252854	-1.438308051	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1576	2821	0.004962779	0.003544842	5	9	OPC	40	16	16
GCAGTTAGTAGCGCAA-1_7_D5	-21.82887333	25.29396881	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1874	3495	0.005722461	0.005436338	5	8	Astrocytes	40	16	16
GCATACAAGTGTTGAA-1_7_D5	37.79589042	13.71178239	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1183	1655	0.001812689	0.016918429	5	14	Microglia	40	16	16
GCATACACAAGCCGCT-1_7_D5	3.256185041	-24.08554633	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	5597	15121	0.007274651	0.007935983	5	L2-3	EN-L2-3-MS	40	16	16
GCATACAGTGCTAGCC-1_7_D5	10.4942629	20.61570631	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	895	1362	0.000734214	0.012481645	5	oligos	OL-Cntl	40	16	16
GCATACAGTTTGTTGG-1_7_D5	6.098072115	-1.626763054	12	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	961	1479	0.004732928	0.008789723	5	12	EN-MIX	40	16	16
GCATACATCCGCAGTG-1_7_D5	-24.33218366	25.77004908	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1432	2533	0.000789578	0.007895776	5	8	Astrocytes	40	16	16
GCATACATCCTGTAGA-1_7_D5	3.152730817	18.06001424	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	951	1462	0.004787962	0.005471956	5	oligos	OL-Cntl	40	16	16
GCATACATCGAACTGT-1_7_D5	-25.53398767	22.55537467	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1336	2303	0.000434216	0.006079027	5	8	Astrocytes	40	16	16
GCATACATCTCACATT-1_7_D5	11.32883415	7.939060441	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1414	2342	0.006404782	0.018787361	5	oligos	OL-Cntl	40	16	16
GCATGATAGAGGTTGC-1_7_D5	-19.25131776	28.64655043	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2269	4597	0.003915597	0.00957146	5	8	Astrocytes	40	16	16
GCATGATAGTACCGGA-1_7_D5	14.94357408	12.19650697	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1412	2361	0.001694197	0.005929691	5	oligos	OL-Cntl	40	16	16
GCATGATGTCTCCATC-1_7_D5	-21.53039263	17.14143086	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1457	2318	0.007765315	0.005176877	5	8	Astrocytes	40	16	16
GCATGATGTGTGCGTC-1_7_D5	-16.09135917	-0.801993684	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2382	3875	0.017806452	0.020129032	5	13A	IN-VIP	40	16	16
GCATGATTCTTTAGGG-1_7_D5	3.252869497	-18.49362518	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3700	9167	0.015490346	0.004799825	5	L2-3	EN-L2-3-MS	40	16	16
GCATGCGAGCCGATTT-1_7_D5	26.157892	5.147583512	15BA	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1255	1988	0.015090543	0.023641851	5	15BA	Stromal cells	40	16	16
GCATGCGAGGAGCGTT-1_7_D5	-34.84281127	2.619925265	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1784	3169	0.000631114	0.005680025	5	9	OPC	40	16	16
GCATGCGAGTACGATA-1_7_D5	15.31529831	-2.545301089	12	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1150	2017	0.070401587	0.008428359	5	12	EN-MIX	40	16	16
GCATGCGGTCTCTCGT-1_7_D5	-0.514261391	18.08400078	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	759	1094	0.004570384	0.013711152	5	oligos	OL-Cntl	40	16	16
GCATGCGTCACCCGAG-1_7_D5	-34.3827576	2.459693895	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1876	3412	0.003810082	0.006447831	5	9	OPC	40	16	16
GCATGCGTCGTTTAGG-1_7_D5	-20.58511096	26.41674951	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1901	3722	0.00483611	0.007522837	5	8	Astrocytes	40	16	16
GCATGCGTCTCGCATC-1_7_D5	7.176812413	30.01709668	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	736	1060	0.004716981	0.008490566	5	oligos	OL-Cntl	40	16	16
GCATGTAAGTCTTGCA-1_7_D5	7.197979569	-19.2598712	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4628	13173	0.013132923	0.010551886	5	L2-3	EN-L2-3-MS	40	16	16
GCATGTACAGCCTTGG-1_7_D5	11.08268307	11.31184559	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1380	2219	0.004055881	0.012618297	5	oligos	OL-Cntl	40	16	16
GCATGTACAGCGTAAG-1_7_D5	-32.35784932	-13.23635699	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	737	1040	0.011538462	0.001923077	5	9	OPC	40	16	16
GCATGTACAGTCTTCC-1_7_D5	5.900296039	-25.2380675	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	5619	19586	0.013581129	0.003573981	5	L2-3	EN-L2-3-MS	40	16	16
GCATGTACATACGCCG-1_7_D5	9.076036413	12.33220838	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1199	2041	0.00832925	0.011268986	5	oligos	OL-Cntl	40	16	16
GCATGTACATCTACGA-1_7_D5	4.448758552	-18.53060828	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3302	7096	0.012965051	0.007046223	5	L2-3	EN-L2-3-MS	40	16	16
GCATGTAGTAGCTGCC-1_7_D5	4.057722944	15.69148833	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1055	1522	0.013797635	0.010512484	5	oligos	OL-Cntl	40	16	16
GCATGTAGTATCTGCA-1_7_D5	11.85178167	7.880393936	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1487	2507	0.005584364	0.01276426	5	oligos	OL-Cntl	40	16	16
GCATGTAGTCTGATTG-1_7_D5	12.51752068	15.81581862	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1212	1994	0.003009027	0.011534604	5	oligos	OL-Cntl	40	16	16
GCATGTAGTGAAAGAG-1_7_D5	-36.48668108	-2.194761023	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1333	2221	0.000900495	0.005402972	5	9	OPC	40	16	16
GCATGTAGTTTGGCGC-1_7_D5	-31.04198778	2.270082579	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2131	3950	0.013670886	0.005316456	5	9	OPC	40	16	16
GCATGTATCGGAATCT-1_7_D5	-20.06417621	28.60339797	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2207	4406	0.002042669	0.005674081	5	8	Astrocytes	40	16	16
GCATGTATCGGATGTT-1_7_D5	-0.574368443	15.60919309	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	846	1348	0.004451039	0.014094955	5	oligos	OL-Cntl	40	16	16
GCCAAATAGCCAGAAC-1_7_D5	11.68429628	18.84945109	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1059	1720	0.003488372	0.005813953	5	oligos	OL-Cntl	40	16	16
GCCAAATGTAGTAGTA-1_7_D5	12.49223069	7.182412444	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1881	3425	0.010218978	0.017226277	5	oligos	OL-Cntl	40	16	16
GCCAAATGTTGTTTGG-1_7_D5	13.39331433	-29.95852402	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4272	12607	0.001110494	0.005076545	5	3	EN-L5-6	40	16	16
GCCAAATTCGTCTGCT-1_7_D5	6.045280632	12.10893038	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1294	2188	0.003656307	0.010968921	5	oligos	OL-Cntl	40	16	16
GCCAAATTCGTTTAGG-1_7_D5	-29.44996942	13.53801395	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	902	1451	0.006202619	0.004824259	5	8	Astrocytes	40	16	16
GCCTCTAAGGTGCTAG-1_7_D5	-36.33980963	1.28262643	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1702	3145	0.00508744	0.00508744	5	9	OPC	40	16	16
GCCTCTACAAAGTGCG-1_7_D5	-36.52653391	-4.671361092	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1237	2027	0.00197336	0.004933399	5	9	OPC	40	16	16
GCCTCTACACCAGGTC-1_7_D5	-1.620519196	24.03778687	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	727	1110	0.018918919	0.006306306	5	oligos	OL-Cntl	40	16	16
GCCTCTACACTATCTT-1_7_D5	9.838505285	12.61480446	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1177	2049	0.005856515	0.006344558	5	oligos	OL-Cntl	40	16	16
GCCTCTACATCATCCC-1_7_D5	11.25402182	12.06562714	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1233	2202	0.014078111	0.009990917	5	oligos	OL-Cntl	40	16	16
GCCTCTAGTCGAGTTT-1_7_D5	-26.19584588	22.82601481	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1324	2224	0.002697842	0.003597122	5	8	Astrocytes	40	16	16
GCGACCAAGACTGTAA-1_7_D5	13.66699416	2.627183649	12	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	697	1075	0.04744186	0.005581395	5	12	EN-MIX	40	16	16
GCGACCAAGGAGTAGA-1_7_D5	11.20236728	6.183287808	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2116	4108	0.009980526	0.020691334	5	oligos	OL-Cntl	40	16	16
GCGACCACAAGCGTAG-1_7_D5	-31.97930232	2.680445548	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2075	3612	0.005537099	0.007198228	5	9	OPC	40	16	16
GCGACCACAGATTGCT-1_7_D5	37.68401248	14.3991453	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1087	1579	0.003799873	0.014566181	5	14	Microglia	40	16	16
GCGACCAGTTCAGTAC-1_7_D5	15.66768892	11.20906386	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1335	2202	0.01044505	0.005903724	5	oligos	OL-Cntl	40	16	16
GCGAGAAAGATCTGAA-1_7_D5	-18.20755407	28.22505394	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2386	4591	0.004356349	0.00348508	5	8	Astrocytes	40	16	16
GCGAGAACACTCTGTC-1_7_D5	-18.81351943	-27.5696123	6A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2992	7517	0.002527604	0.003325795	5	6A	IN-PV	40	16	16
GCGAGAATCAATCTCT-1_7_D5	8.785672203	-21.54106892	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	6352	20572	0.00811783	0.006416488	5	L2-3	EN-L2-3-MS	40	16	16
GCGAGAATCACAGTAC-1_7_D5	-2.96241706	13.07776013	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	878	1261	0.000793021	0.028548771	5	oligos	OL-Cntl	40	16	16
GCGCAACAGACAGAGA-1_7_D5	-1.359635024	8.584269829	5	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1377	2061	0.033478894	0.011159631	5	oligos	OL-MS-1	40	16	16
GCGCAACAGCCGGTAA-1_7_D5	8.471513758	17.66912082	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	865	1346	0.001485884	0.005943536	5	oligos	OL-Cntl	40	16	16
GCGCAACGTCGGCTCA-1_7_D5	19.36431408	11.0808171	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1574	2806	0.003920171	0.002138275	5	oligos	OL-Cntl	40	16	16
GCGCAACTCAAACCAC-1_7_D5	3.320701409	21.42242969	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	799	1146	0.005235602	0.008726003	5	oligos	OL-Cntl	40	16	16
GCGCAACTCACCGGGT-1_7_D5	32.82933935	16.55077048	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1254	1831	0.009284544	0.044238121	5	14	Microglia	40	16	16
GCGCAACTCACGCATA-1_7_D5	-27.3596876	4.521984623	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2287	3934	0.002796136	0.010930351	5	9	OPC	40	16	16
GCGCAACTCAGCATGT-1_7_D5	12.13630382	8.822263856	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1520	2617	0.010317157	0.011845625	5	oligos	OL-Cntl	40	16	16
GCGCAACTCAGTCAGT-1_7_D5	5.997317443	-22.30198197	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	6044	18473	0.00460131	0.006874899	5	L2-3	EN-L2-3-MS	40	16	16
GCGCAGTAGATGTGGC-1_7_D5	-18.65624418	-17.17150195	6B	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2337	4549	0.028797538	0.003737085	5	6B	IN-SST	40	16	16
GCGCAGTAGGCTAGAC-1_7_D5	-37.59026887	-9.633232577	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1077	1787	0.001678791	0.003357583	5	9	OPC	40	16	16
GCGCAGTGTTGAGGTG-1_7_D5	-31.69614185	0.556180653	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1670	2794	0.005010737	0.006442377	5	9	OPC	40	16	16
GCGCAGTTCCGCTGTT-1_7_D5	-33.9325373	2.251429642	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1910	3465	0.001443001	0.008658009	5	9	OPC	40	16	16
GCGCAGTTCGTTGCCT-1_7_D5	11.69119302	9.150823558	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1364	2353	0.002124947	0.011899703	5	oligos	OL-Cntl	40	16	16
GCGCCAAAGCAGACTG-1_7_D5	-17.22995699	1.54867579	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4851	11384	0.012385805	0.013703443	5	13A	IN-VIP	40	16	16
GCGCCAACAGAGTGTG-1_7_D5	3.809964112	16.99109115	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	882	1390	0.007194245	0.007913669	5	oligos	OL-Cntl	40	16	16
GCGCCAACAGTTCCCT-1_7_D5	10.88607428	7.215303022	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1488	2440	0.006557377	0.018442623	5	oligos	OL-Cntl	40	16	16
GCGCCAACATGGTTGT-1_7_D5	-29.9319323	-13.22255428	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	682	1071	0.001867414	0.012138189	5	9	OPC	40	16	16
GCGCCAAGTACGAAAT-1_7_D5	9.735968201	10.37882989	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1295	2122	0.013666352	0.012723845	5	oligos	OL-Cntl	40	16	16
GCGCCAAGTCATCGGC-1_7_D5	3.504056753	-17.75703363	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2849	5710	0.009982487	0.008406305	5	L2-3	EN-L2-3-MS	40	16	16
GCGCCAAGTGCTTCTC-1_7_D5	-14.04731037	0.509622103	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2688	5060	0.006916996	0.01284585	5	13A	IN-VIP	40	16	16
GCGCCAATCCTCTAGC-1_7_D5	2.519811907	15.03585824	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	986	1596	0.003759398	0.016290727	5	oligos	OL-Cntl	40	16	16
GCGCCAATCTTTCCTC-1_7_D5	4.759623033	5.994900882	7	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1659	2656	0.004141566	0.017695783	5	7	Phagocytes	40	16	16
GCGCGATCACTTACGA-1_7_D5	14.34781426	9.399394515	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1551	2785	0.004308797	0.010771993	5	oligos	OL-Cntl	40	16	16
GCGCGATCATCGATGT-1_7_D5	-37.22108259	-10.24942445	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	948	1594	0.010037641	0.005646173	5	9	OPC	40	16	16
GCGCGATGTAAGAGGA-1_7_D5	-30.77804757	-12.13012671	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	855	1155	0.004329004	0.004329004	5	9	OPC	40	16	16
GCGCGATGTTAAGTAG-1_7_D5	-19.99546854	30.08903418	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2519	5062	0.002370605	0.006124062	5	8	Astrocytes	40	16	16
GCGGGTTAGACCACGA-1_7_D5	-37.50221665	-1.495365601	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1488	2692	0.002971768	0.002600297	5	9	OPC	40	16	16
GCGGGTTCAACAACCT-1_7_D5	-7.323904077	10.66290192	5	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	727	1022	0.011741683	0.02739726	5	oligos	OL-MS-1	40	16	16
GCGGGTTCAGGTGCCT-1_7_D5	13.12231061	13.1252405	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1331	2345	0.001705757	0.008528785	5	oligos	OL-Cntl	40	16	16
GCGGGTTCAGTAACGG-1_7_D5	10.91810402	-27.19205634	10	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	8114	32105	0.003301666	0.003986918	5	L2-3	EN-L2-3-Cntl	40	16	16
GCGGGTTTCATGTAGC-1_7_D5	-23.93659234	0.361126869	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2293	4150	0.002168675	0.005542169	5	9	OPC	40	16	16
GCGGGTTTCGCATGAT-1_7_D5	37.19848784	8.328487348	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	751	1000	0.021	0.005	5	14	Microglia	40	16	16
GCGGGTTTCTTCTGGC-1_7_D5	-20.66171513	27.52863361	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1802	3706	0.005126821	0.008094981	5	8	Astrocytes	40	16	16
GCTCCTAAGATGAGAG-1_7_D5	-18.868481	28.27153786	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2124	4403	0.002952532	0.009766069	5	8	Astrocytes	40	16	16
GCTCCTAAGTCAATAG-1_7_D5	-24.53299218	15.85246754	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1289	2174	0.000459982	0.009199632	5	8	Astrocytes	40	16	16
GCTCCTACAGGCTCAC-1_7_D5	11.76812859	16.99661952	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1075	1715	0.002915452	0.006997085	5	oligos	OL-Cntl	40	16	16
GCTCCTATCTCTTGAT-1_7_D5	-15.77288858	1.614950899	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3934	8601	0.006627136	0.019648878	5	13A	IN-VIP	40	16	16
GCTCTGTAGCCCGAAA-1_7_D5	37.63483317	10.58613459	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	919	1268	0.007886435	0.008675079	5	14	Microglia	40	16	16
GCTCTGTAGTTGTCGT-1_7_D5	-10.22477402	-3.354932342	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2127	3401	0.011173184	0.019406057	5	13A	IN-VIP	40	16	16
GCTCTGTCATATGCTG-1_7_D5	18.85838049	24.01203388	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	938	1516	0.003298153	0.006596306	5	oligos	OL-Cntl	40	16	16
GCTGCAGAGATCCTGT-1_7_D5	6.014079162	-22.25060202	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	5964	18743	0.0041082	0.007949635	5	L2-3	EN-L2-3-MS	40	16	16
GCTGCAGAGGACAGCT-1_7_D5	-4.773652841	23.28081515	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	661	1009	0.014866204	0.005946482	5	oligos	OL-Cntl	40	16	16
GCTGCAGCACAGGTTT-1_7_D5	10.54883789	9.818715953	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1398	2321	0.003015941	0.012494614	5	oligos	OL-Cntl	40	16	16
GCTGCAGCAGGCAGTA-1_7_D5	-28.11044912	4.251930771	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2224	4575	0.001748634	0.003497268	5	9	OPC	40	16	16
GCTGCAGCAGTACACT-1_7_D5	25.88738573	-28.12937682	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	6042	20525	0.002046285	0.004043849	5	3	EN-L5-6	40	16	16
GCTGCAGCATCAGTAC-1_7_D5	38.37266366	15.27377418	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1275	1878	0.001597444	0.013312034	5	14	Microglia	40	16	16
GCTGCAGCATCCAACA-1_7_D5	13.56690687	10.55707251	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1348	2382	0.004617968	0.011335013	5	oligos	OL-Cntl	40	16	16
GCTGCAGGTGGTCTCG-1_7_D5	7.908762692	-18.18702058	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4211	10417	0.007295767	0.01219161	5	L2-3	EN-L2-3-MS	40	16	16
GCTGCAGGTTCCAACA-1_7_D5	3.384312641	-18.45456765	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3418	8314	0.01383209	0.004450325	5	L2-3	EN-L2-3-MS	40	16	16
GCTGCAGGTTCCACTC-1_7_D5	-13.38361818	-1.168778057	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2373	4188	0.010028653	0.014804202	5	13A	IN-VIP	40	16	16
GCTGCAGTCTTGTATC-1_7_D5	16.49442657	8.275187542	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1874	3368	0.002969121	0.008313539	5	oligos	OL-Cntl	40	16	16
GCTGCGAGTCAGATAA-1_7_D5	12.51095268	-6.553050473	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2020	4021	0.006217359	0.002984332	5	3	EN-L5-6	40	16	16
GCTGCGAGTGTTTGTG-1_7_D5	4.408104175	17.14552359	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	912	1287	0.016317016	0.012432012	5	oligos	OL-Cntl	40	16	16
GCTGCGAGTTACGTCA-1_7_D5	-0.092496643	17.69366484	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	808	1293	0.010054138	0.014694509	5	oligos	OL-Cntl	40	16	16
GCTGCGAGTTTGTTGG-1_7_D5	-25.36007893	-2.073019772	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1354	2176	0.009191176	0.013786765	5	9	OPC	40	16	16
GCTGCTTAGACGACGT-1_7_D5	-25.17047223	11.59593763	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1078	1861	0.00483611	0.009672219	5	8	Astrocytes	40	16	16
GCTGCTTAGCTAGCCC-1_7_D5	0.777132776	-21.18885683	10	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3810	9491	0.008007586	0.003160889	5	L2-3	EN-L2-3-Cntl	40	16	16
GCTGCTTCAGATCTGT-1_7_D5	-19.89911998	28.36551787	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2082	4297	0.002792646	0.011170584	5	8	Astrocytes	40	16	16
GCTGCTTGTCCGAATT-1_7_D5	9.558460213	9.081813326	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1277	1920	0.010416667	0.015625	5	oligos	OL-Cntl	40	16	16
GCTGCTTGTGAGCGAT-1_7_D5	14.55260201	-5.078548583	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1654	2862	0.019217331	0.003843466	5	3	EN-L5-6	40	16	16
GCTGGGTAGCGCTCCA-1_7_D5	2.405122438	19.49140748	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	967	1482	0.01754386	0.006747638	5	oligos	OL-Cntl	40	16	16
GCTGGGTCAAGCCGTC-1_7_D5	4.781372687	-22.51195319	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	5698	19479	0.007033215	0.004363674	5	L2-3	EN-L2-3-MS	40	16	16
GCTGGGTGTAAAGGAG-1_7_D5	13.71612578	18.58939331	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1215	2021	0.001484414	0.009896091	5	oligos	OL-Cntl	40	16	16
GCTGGGTGTGGCAAAC-1_7_D5	17.24217727	-4.917680546	12	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1367	2363	0.008887008	0.002962336	5	12	EN-MIX	40	16	16
GCTGGGTTCCACGACG-1_7_D5	10.54038419	8.258067558	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1526	2722	0.006245408	0.015062454	5	oligos	OL-Cntl	40	16	16
GCTGGGTTCTGCAGTA-1_7_D5	-34.46917115	4.788117265	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2409	4624	0.002811419	0.00432526	5	9	OPC	40	16	16
GCTGGGTTCTTGTTTG-1_7_D5	-1.313335165	19.7054748	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	690	1053	0.00379867	0.011396011	5	oligos	OL-Cntl	40	16	16
GCTTCCAAGATCCGAG-1_7_D5	-30.20186622	-9.474056228	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1028	1393	0.000717875	0.012203877	5	9	OPC	40	16	16
GCTTCCAAGCTGCCCA-1_7_D5	7.793691938	12.1605143	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1139	1721	0.009877978	0.008715863	5	oligos	OL-Cntl	40	16	16
GCTTCCACAGGGAGAG-1_7_D5	-30.65839282	10.64199685	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	669	1098	0.035519126	0.004553734	5	8	Astrocytes	40	16	16
GCTTCCACAGGTGGAT-1_7_D5	-18.9430953	28.42712427	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2373	4618	0.006496319	0.006063231	5	8	Astrocytes	40	16	16
GCTTCCAGTAGCCTCG-1_7_D5	-10.12284356	23.25391744	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2946	6020	0.006976744	0.013621262	5	8	Astrocytes	40	16	16
GCTTCCAGTTGATTGC-1_7_D5	-20.03293465	25.19632341	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1964	3632	0.000825991	0.008259912	5	8	Astrocytes	40	16	16
GCTTCCATCCCGGATG-1_7_D5	14.48540088	13.94057724	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1283	2071	0.003862868	0.006760019	5	oligos	OL-Cntl	40	16	16
GCTTCCATCTACTTAC-1_7_D5	9.617016449	13.4850026	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1191	1873	0.00747464	0.008542445	5	oligos	OL-Cntl	40	16	16
GCTTGAAAGCCAGGAT-1_7_D5	-34.7845961	2.807622118	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2062	3811	0.006559958	0.006035161	5	9	OPC	40	16	16
GCTTGAAAGTACGTAA-1_7_D5	7.584990451	-20.80235067	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	7069	23731	0.002739033	0.007542876	5	L2-3	EN-L2-3-MS	40	16	16
GCTTGAAAGTGTACCT-1_7_D5	35.44485469	10.96255416	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	906	1219	0.01804758	0.020508614	5	14	Microglia	40	16	16
GCTTGAACAAGTCATC-1_7_D5	-14.83428839	-6.38452404	13B	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4047	10493	0.019918041	0.004955685	5	13B	IN-SV2C	40	16	16
GCTTGAACACATGTGT-1_7_D5	12.13330426	6.224997018	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2001	3362	0.014277216	0.021713266	5	oligos	OL-Cntl	40	16	16
GCTTGAAGTAGCTAAA-1_7_D5	13.62021859	9.564530582	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1483	2595	0.002312139	0.009633911	5	oligos	OL-Cntl	40	16	16
GCTTGAATCATCACCC-1_7_D5	-24.06838835	0.018411146	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2096	3949	0.00759686	0.006330717	5	9	OPC	40	16	16
GCTTGAATCCCTAATT-1_7_D5	-9.041885949	16.23763481	11	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2579	5081	0.003936233	0.007872466	5	11	Glia-MIX	40	16	16
GCTTGAATCGCATGGC-1_7_D5	11.34574361	-4.887279632	12	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	948	1623	0.070856439	0.006161429	5	12	EN-MIX	40	16	16
GCTTGAATCGGATGTT-1_7_D5	11.3149566	-4.867821273	12	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	816	1188	0.012626263	0.000841751	5	12	EN-MIX	40	16	16
GCTTGAATCTCGTATT-1_7_D5	-34.08258513	2.74106467	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2081	4062	0.002461841	0.005169867	5	9	OPC	40	16	16
GCTTGAATCTGTCTAT-1_7_D5	37.4103787	9.254205047	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	735	1040	0.007692308	0.008653846	5	14	Microglia	40	16	16
GCTTGAATCTTGTCAT-1_7_D5	-26.76513778	1.561693326	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1663	2875	0.004521739	0.017391304	5	9	OPC	40	16	16
GGAAAGCCAGATAATG-1_7_D5	-25.35294468	22.54029202	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1325	2478	0.018563358	0.008071025	5	8	Astrocytes	40	16	16
GGAAAGCCAGTATCTG-1_7_D5	-18.243066	0.488283487	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3555	7181	0.016014483	0.024230609	5	13A	IN-VIP	40	16	16
GGAAAGCCATGCTGGC-1_7_D5	36.96871607	15.6580395	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1259	1762	0.001702611	0.028376844	5	14	Microglia	40	16	16
GGAAAGCGTCTTGTCC-1_7_D5	5.234991947	12.35479471	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1147	1836	0.002723312	0.010348584	5	oligos	OL-Cntl	40	16	16
GGAAAGCGTTTAGGAA-1_7_D5	17.45123988	-8.149228419	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2100	3921	0.017852589	0.011986738	5	3	EN-L5-6	40	16	16
GGAACTTAGTATTGGA-1_7_D5	11.89733153	-5.554087463	12	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1464	2698	0.027427724	0.003706449	5	12	EN-MIX	40	16	16
GGAACTTAGTCGAGTG-1_7_D5	12.54406023	-6.583628332	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2232	4502	0.009551311	0.0037761	5	3	EN-L5-6	40	16	16
GGAACTTCAAGTCTAC-1_7_D5	5.308182668	11.27464411	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1250	2056	0.013618677	0.01459144	5	oligos	OL-Cntl	40	16	16
GGAACTTCATGATCCA-1_7_D5	0.410561879	20.43901452	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	782	1211	0.007431874	0.004128819	5	oligos	OL-Cntl	40	16	16
GGAACTTGTAGGGTAC-1_7_D5	7.623013121	-18.4341147	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4463	11918	0.006544722	0.016697432	5	L2-3	EN-L2-3-MS	40	16	16
GGAACTTGTCATCCCT-1_7_D5	13.57292797	9.118387	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1684	3041	0.005590266	0.007563302	5	oligos	OL-Cntl	40	16	16
GGAATAAAGCCGGTAA-1_7_D5	-23.87653921	18.94462245	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1488	3011	0.001328462	0.003653271	5	8	Astrocytes	40	16	16
GGAATAAAGCGTGAAC-1_7_D5	-32.45673456	-8.645048345	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	994	1399	0.000714796	0.002859185	5	9	OPC	40	16	16
GGAATAAAGGGATACC-1_7_D5	-19.50614989	-17.25084602	6B	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3319	8463	0.016306274	0.005671748	5	6B	IN-SST	40	16	16
GGAATAACACCACGTG-1_7_D5	-18.74153427	28.65814102	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2164	4123	0.001697793	0.011399466	5	8	Astrocytes	40	16	16
GGAATAACACTCGACG-1_7_D5	3.142890488	17.71432314	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	863	1331	0.009015778	0.003756574	5	oligos	OL-Cntl	40	16	16
GGAATAAGTACCTACA-1_7_D5	9.488618158	9.439599268	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1275	2156	0.004638219	0.012059369	5	oligos	OL-Cntl	40	16	16
GGAATAATCGTTTATC-1_7_D5	-35.50067698	2.165541388	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1654	3036	0.001646904	0.003952569	5	9	OPC	40	16	16
GGAATAATCTGGTATG-1_7_D5	-28.20559422	0.860540566	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2566	4818	0.00788709	0.01411374	5	9	OPC	40	16	16
GGACAAGAGACCACGA-1_7_D5	5.416431057	11.30766808	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1263	2045	0.007334963	0.015158924	5	oligos	OL-Cntl	40	16	16
GGACAAGAGATCCCAT-1_7_D5	12.51120557	11.27754859	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1297	2022	0.002472799	0.011374876	5	oligos	OL-Cntl	40	16	16
GGACAAGAGGTGCTAG-1_7_D5	32.83456603	14.95297958	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	778	1027	0.005842259	0.054527751	5	14	Microglia	40	16	16
GGACAAGGTACCGGCT-1_7_D5	12.99538225	-7.293308861	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3641	9846	0.014625229	0.003757871	5	3	EN-L5-6	40	16	16
GGACAAGGTAGGGACT-1_7_D5	-29.29522391	22.21611309	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1222	2072	0.001930502	0.006274131	5	8	Astrocytes	40	16	16
GGACAAGGTATGGTTC-1_7_D5	9.289310969	28.80194142	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	764	1116	0.004480287	0.002688172	5	oligos	OL-Cntl	40	16	16
GGACAAGGTCTGCAAT-1_7_D5	1.45020444	11.89221972	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	962	1453	0.007570544	0.010323469	5	oligos	OL-Cntl	40	16	16
GGACAAGTCGACAGCC-1_7_D5	-32.17577708	-6.565305018	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1175	1706	0.002930832	0.00996483	5	9	OPC	40	16	16
GGACAAGTCTCTGAGA-1_7_D5	18.92069301	23.86526651	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	966	1520	0.005263158	0.005921053	5	oligos	OL-Cntl	40	16	16
GGACAAGTCTGTTGAG-1_7_D5	34.87109467	11.25006523	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	935	1247	0.002405774	0.027265437	5	14	Microglia	40	16	16
GGACAGAAGCCACCTG-1_7_D5	11.30139629	13.48743274	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1072	1538	0.012353706	0.007152146	5	oligos	OL-Cntl	40	16	16
GGACAGAAGCCCAGCT-1_7_D5	8.488154508	-21.27937618	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	7545	26376	0.011563543	0.007506824	5	L2-3	EN-L2-3-MS	40	16	16
GGACAGAAGTGAAGTT-1_7_D5	3.103079352	12.91543447	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	983	1466	0.003410641	0.012278308	5	oligos	OL-Cntl	40	16	16
GGACAGAGTCCGTTAA-1_7_D5	-0.013011199	12.65383152	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1030	1487	0.006052455	0.024882313	5	oligos	OL-Cntl	40	16	16
GGACAGAGTCTAGTGT-1_7_D5	16.19076782	-7.148775968	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2018	3868	0.000517063	0.00336091	5	3	EN-L5-6	40	16	16
GGACAGATCTATGTGG-1_7_D5	17.25607618	-4.441271281	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1906	3800	0.003421053	0.004736842	5	3	EN-L5-6	40	16	16
GGACATTAGACAATAC-1_7_D5	15.46246585	-2.297725508	12	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1006	1566	0.030012771	0.005108557	5	12	EN-MIX	40	16	16
GGACATTAGCGCTTAT-1_7_D5	0.339099056	18.19272273	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	739	1121	0.008028546	0.011596789	5	oligos	OL-Cntl	40	16	16
GGACATTCACGCCAGT-1_7_D5	18.92321135	10.3397973	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1385	2503	0	0.001997603	5	oligos	OL-Cntl	40	16	16
GGACATTGTAGCGCTC-1_7_D5	30.57564369	15.75241309	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1043	1545	0.010355987	0.130097087	5	14	Microglia	40	16	16
GGACATTGTGATGATA-1_7_D5	5.574074452	11.77099297	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1251	2037	0.00490918	0.00981836	5	oligos	OL-Cntl	40	16	16
GGACATTGTTTGGGCC-1_7_D5	-11.31165414	0.367222737	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3089	6723	0.014130596	0.006098468	5	13A	IN-VIP	40	16	16
GGACATTTCAACACAC-1_7_D5	3.927905227	14.44451731	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	939	1349	0.012601927	0.010378058	5	oligos	OL-Cntl	40	16	16
GGACGTCAGTCGTACT-1_7_D5	0.789644319	17.90056181	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	794	1117	0.006266786	0.004476276	5	oligos	OL-Cntl	40	16	16
GGACGTCCAAGGGTCA-1_7_D5	0.478588167	-22.48152054	10	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4737	14779	0.004330469	0.005548413	5	L2-3	EN-L2-3-Cntl	40	16	16
GGACGTCCACCAACCG-1_7_D5	-32.6102156	3.161534735	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2186	4357	0.001147579	0.00481983	5	9	OPC	40	16	16
GGACGTCCAGACAAAT-1_7_D5	-21.01426313	30.58873221	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2647	6451	0.002790265	0.003720353	5	8	Astrocytes	40	16	16
GGAGCAAAGATAGGAG-1_7_D5	-33.70148174	-2.675993808	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1467	2468	0.007293355	0.005672609	5	9	OPC	40	16	16
GGAGCAAAGTTGTAGA-1_7_D5	-34.60709966	-13.09708988	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	690	1010	0.004950495	0.002970297	5	9	OPC	40	16	16
GGAGCAAGTCTTCAAG-1_7_D5	-34.49751604	4.80647098	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2622	5500	0.003636364	0.003818182	5	9	OPC	40	16	16
GGAGCAATCACATGCA-1_7_D5	7.772193337	11.20063583	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1237	1929	0.0155521	0.011404873	5	oligos	OL-Cntl	40	16	16
GGAGCAATCCCTAACC-1_7_D5	39.2110158	10.21645133	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	736	1024	0.002929688	0.01171875	5	14	Microglia	40	16	16
GGAGCAATCGTAGATC-1_7_D5	1.496525324	19.53958558	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	872	1306	0.016079632	0.009188361	5	oligos	OL-Cntl	40	16	16
GGAGCAATCTCATTCA-1_7_D5	37.24343206	10.86637557	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	943	1332	0.002252252	0.02027027	5	14	Microglia	40	16	16
GGATGTTAGAAACCTA-1_7_D5	-24.81913525	15.85839563	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1364	2439	0.001230012	0.004510045	5	8	Astrocytes	40	16	16
GGATGTTAGGAGTACC-1_7_D5	15.64747564	14.2444414	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1256	1962	0.000509684	0.005606524	5	oligos	OL-Cntl	40	16	16
GGATGTTAGTGAAGAG-1_7_D5	7.883834047	-19.91921984	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	5082	14153	0.012435526	0.008196142	5	L2-3	EN-L2-3-MS	40	16	16
GGATGTTCACATCCAA-1_7_D5	12.55062269	-6.587854318	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2039	4322	0.000925497	0.002545118	5	3	EN-L5-6	40	16	16
GGATGTTCAGATCCAT-1_7_D5	-34.65314815	-1.084439756	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1460	2436	0.003284072	0.004515599	5	9	OPC	40	16	16
GGATGTTGTAGCGCAA-1_7_D5	-19.14042458	30.1666441	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2725	6070	0.008401977	0.010543657	5	8	Astrocytes	40	16	16
GGATGTTGTCTTCTCG-1_7_D5	-15.5254983	2.169240217	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3350	7072	0.013291855	0.014705882	5	13A	IN-VIP	40	16	16
GGATGTTTCTACCTGC-1_7_D5	9.573788673	10.65753308	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1317	2206	0.002719855	0.014052584	5	oligos	OL-Cntl	40	16	16
GGATTACAGAATGTTG-1_7_D5	6.867846132	12.16595329	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1346	2150	0.014883721	0.013488372	5	oligos	OL-Cntl	40	16	16
GGATTACAGAGGTTAT-1_7_D5	9.385869609	14.00623952	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1170	1839	0.009787928	0.016313214	5	oligos	OL-Cntl	40	16	16
GGATTACAGCCCGAAA-1_7_D5	-15.79985581	-18.99451368	6B	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1917	4069	0.028999754	0.004177931	5	6B	IN-SST	40	16	16
GGATTACAGGGTCGAT-1_7_D5	22.83194718	-27.71895492	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3775	8889	0.007087411	0.003824952	5	3	EN-L5-6	40	16	16
GGATTACAGTTTGCGT-1_7_D5	2.449802432	12.37679061	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	968	1414	0.012729844	0.015558699	5	oligos	OL-Cntl	40	16	16
GGATTACCAAGCGTAG-1_7_D5	-32.75303663	3.766299508	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2434	4663	0.003002359	0.006433626	5	9	OPC	40	16	16
GGATTACCACGACTCG-1_7_D5	12.87831994	15.02550325	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1131	1775	0.005070423	0.012394366	5	oligos	OL-Cntl	40	16	16
GGATTACCAGTCAGCC-1_7_D5	-37.93586552	2.574978657	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1695	3214	0.001244555	0.001866833	5	9	OPC	40	16	16
GGATTACTCAGTGCAT-1_7_D5	4.430586718	23.81623236	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	835	1260	0.000793651	0.00952381	5	oligos	OL-Cntl	40	16	16
GGATTACTCGGAGGTA-1_7_D5	10.49040173	11.1685524	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1094	1645	0.001215805	0.009726444	5	oligos	OL-Cntl	40	16	16
GGCAATTAGAATGTTG-1_7_D5	-20.3863627	26.34738568	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1856	3687	0.003254679	0.005966911	5	8	Astrocytes	40	16	16
GGCAATTAGTGCCATT-1_7_D5	12.77350984	18.58059636	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1034	1656	0.001207729	0.004227053	5	oligos	OL-Cntl	40	16	16
GGCAATTCACAAGCCC-1_7_D5	-25.46129072	22.52559551	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1332	2123	0.00612341	0.007065473	5	8	Astrocytes	40	16	16
GGCAATTCAGTCGATT-1_7_D5	-3.447077508	15.99586006	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	767	1125	0.006222222	0.014222222	5	oligos	OL-Cntl	40	16	16
GGCAATTCATGCAATC-1_7_D5	-32.37388527	-9.194417765	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	898	1336	0.00748503	0.006736527	5	9	OPC	40	16	16
GGCCGATCAGCATGAG-1_7_D5	5.234684723	-20.85096293	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4339	11822	0.001691761	0.005921164	5	L2-3	EN-L2-3-MS	40	16	16
GGCCGATCAGCGTAAG-1_7_D5	4.819220766	14.39515195	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1116	1753	0.001140901	0.010268112	5	oligos	OL-Cntl	40	16	16
GGCCGATCATGCTGGC-1_7_D5	-1.452545287	13.89202466	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	904	1341	0.001491424	0.012677107	5	oligos	OL-Cntl	40	16	16
GGCCGATCATTCGACA-1_7_D5	4.478911101	6.295605388	7	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1361	2058	0.009718173	0.01068999	5	7	Phagocytes	40	16	16
GGCCGATTCTTCTGGC-1_7_D5	16.08295458	7.404847176	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1740	3374	0.003556609	0.008298755	5	oligos	OL-Cntl	40	16	16
GGCGACTAGAACTGTA-1_7_D5	-2.624349518	14.23706406	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	793	1125	0.005333333	0.017777778	5	oligos	OL-Cntl	40	16	16
GGCGACTTCTGGAGCC-1_7_D5	-3.622541978	7.089541364	5	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1670	2644	0.015506808	0.028366112	5	oligos	OL-MS-1	40	16	16
GGCGTGTAGCCGGTAA-1_7_D5	-13.29495138	-0.56505028	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3021	6082	0.015784281	0.007563302	5	13A	IN-VIP	40	16	16
GGCGTGTCACGACTCG-1_7_D5	10.18487305	13.56739801	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1248	2052	0.004385965	0.0082846	5	oligos	OL-Cntl	40	16	16
GGCGTGTCACTCAGGC-1_7_D5	12.52252479	14.93158076	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1129	1869	0.008025682	0.008560728	5	oligos	OL-Cntl	40	16	16
GGCGTGTCATGCCCGA-1_7_D5	-10.63108285	-0.194759264	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2721	5525	0.01158371	0.006153846	5	13A	IN-VIP	40	16	16
GGCGTGTTCAAACGGG-1_7_D5	9.64991737	13.00464261	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1135	1773	0.006204174	0.012972363	5	oligos	OL-Cntl	40	16	16
GGCGTGTTCCTGCCAT-1_7_D5	11.87598425	31.75141059	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	698	1008	0.018849206	0.001984127	5	oligos	OL-Cntl	40	16	16
GGCGTGTTCGCCTGAG-1_7_D5	24.35626471	-11.4869325	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	5526	14627	0.007315239	0.010049908	5	3	EN-L5-6	40	16	16
GGCTCGAAGCGTCTAT-1_7_D5	-0.903111522	1.022095196	11	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1641	2713	0.006266126	0.004791743	5	11	Glia-MIX	40	16	16
GGCTCGACAAACTGCT-1_7_D5	11.21449976	6.804433728	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1873	3288	0.006082725	0.026459854	5	oligos	OL-Cntl	40	16	16
GGCTCGACACTTCTGC-1_7_D5	-1.465577397	25.4967545	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	805	1179	0.002544529	0.002544529	5	oligos	OL-Cntl	40	16	16
GGCTCGACATCCGTGG-1_7_D5	20.54149806	23.37083202	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1203	2082	0.015369837	0.002881844	5	oligos	OL-Cntl	40	16	16
GGCTCGACATCTATGG-1_7_D5	12.82034835	-25.79376457	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	8325	34731	0.00221704	0.013043103	5	3	EN-L5-6	40	16	16
GGCTCGAGTCCGAGTC-1_7_D5	0.925091978	23.54356088	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	755	1131	0.00530504	0.00795756	5	oligos	OL-Cntl	40	16	16
GGCTCGATCTGCGGCA-1_7_D5	18.37701299	15.68437794	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1118	1798	0.000556174	0.004449388	5	oligos	OL-Cntl	40	16	16
GGCTGGTAGAGTTGGC-1_7_D5	10.75964585	7.552846194	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1489	2640	0.013257576	0.018939394	5	oligos	OL-Cntl	40	16	16
GGCTGGTAGGATCGCA-1_7_D5	34.1245471	-8.399378741	2	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4929	12622	0.012993186	0.009903343	5	2	EN-L4	40	16	16
GGCTGGTGTCATACTG-1_7_D5	-23.19882837	-18.72183244	6B	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3368	7376	0.010439262	0.011388286	5	6B	IN-SST	40	16	16
GGCTGGTGTGGTAACG-1_7_D5	-19.32476941	29.25684655	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2561	5507	0.003994916	0.005084438	5	8	Astrocytes	40	16	16
GGCTGGTTCTCCGGTT-1_7_D5	-12.86380057	1.712178602	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3293	6660	0.001051051	0.006306306	5	13A	IN-VIP	40	16	16
GGGAATGAGAAACCGC-1_7_D5	-1.340435444	17.05221014	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	712	1008	0.004960317	0.018849206	5	oligos	OL-Cntl	40	16	16
GGGAATGAGAAACCTA-1_7_D5	36.23686718	12.50876429	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	833	1151	0.011294526	0.044309296	5	14	Microglia	40	16	16
GGGAATGAGATATGGT-1_7_D5	-17.84054979	13.44496785	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1135	1954	0.000511771	0.003582395	5	8	Astrocytes	40	16	16
GGGAATGAGCTCCCAG-1_7_D5	3.164521844	13.2814432	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1040	1627	0.002458513	0.015365704	5	oligos	OL-Cntl	40	16	16
GGGAATGCATCTCGCT-1_7_D5	-28.64953541	16.29593787	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	990	1607	0.018046049	0.00497822	5	8	Astrocytes	40	16	16
GGGAATGGTAGAAAGG-1_7_D5	-10.39605965	18.52572129	11	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3233	6919	0.00332418	0.005636653	5	11	Glia-MIX	40	16	16
GGGAATGGTAGCTTGT-1_7_D5	1.287996491	14.87746852	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	855	1336	0.002994012	0.011227545	5	oligos	OL-Cntl	40	16	16
GGGAATGGTCTACCTC-1_7_D5	-4.278889796	18.0878911	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	830	1211	0.025598679	0.009083402	5	oligos	OL-Cntl	40	16	16
GGGAATGTCAGCAACT-1_7_D5	32.46612653	15.64891868	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	898	1205	0.004979253	0.065560166	5	14	Microglia	40	16	16
GGGACCTAGGTGATAT-1_7_D5	5.536625884	13.16998663	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1080	1588	0.011335013	0.011964736	5	oligos	OL-Cntl	40	16	16
GGGACCTCATTGGGCC-1_7_D5	9.893375255	10.31574283	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1340	2227	0.01077683	0.007184553	5	oligos	OL-Cntl	40	16	16
GGGACCTGTCTTGCGG-1_7_D5	-4.980357214	-10.16565393	13B	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	773	1097	0.019143118	0.003646308	5	13B	IN-SV2C	40	16	16
GGGACCTGTTACGCGC-1_7_D5	12.68070404	8.940408102	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1544	2696	0.005563798	0.007789318	5	oligos	OL-Cntl	40	16	16
GGGACCTTCATGTAGC-1_7_D5	-18.69003068	29.35537085	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2625	5264	0.003609422	0.006838906	5	8	Astrocytes	40	16	16
GGGACCTTCCACGTGG-1_7_D5	15.87998153	10.29294531	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1458	2697	0.000370782	0.007044865	5	oligos	OL-Cntl	40	16	16
GGGAGATAGCGTCTAT-1_7_D5	32.33170899	15.12356483	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	920	1202	0.00249584	0.060732113	5	14	Microglia	40	16	16
GGGAGATAGCTAGGCA-1_7_D5	-19.19939031	19.77287202	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1526	2494	0.007618284	0.006415397	5	8	Astrocytes	40	16	16
GGGAGATAGTACACCT-1_7_D5	10.69528172	8.484015878	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1384	2324	0.004302926	0.020654045	5	oligos	OL-Cntl	40	16	16
GGGAGATAGTTCGATC-1_7_D5	0.081199102	15.03089497	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	828	1147	0.006102877	0.014821273	5	oligos	OL-Cntl	40	16	16
GGGAGATGTCGAGTTT-1_7_D5	-17.19206001	1.435272727	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4343	10486	0.010776273	0.015830631	5	13A	IN-VIP	40	16	16
GGGAGATTCATTGCCC-1_7_D5	-32.73179131	-8.587811054	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1023	1685	0.005934718	0.008902077	5	9	OPC	40	16	16
GGGATGAAGCTAACTC-1_7_D5	11.066541	9.638432008	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1252	2017	0.016360932	0.010411502	5	oligos	OL-Cntl	40	16	16
GGGATGAAGTCTTGCA-1_7_D5	18.9097751	1.445190038	12	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1325	2331	0.040755041	0.006864007	5	12	EN-MIX	40	16	16
GGGATGACAAATCCGT-1_7_D5	-12.99820833	-19.57446293	6B	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1210	2182	0.021998167	0.004124656	5	6B	IN-SST	40	16	16
GGGATGACAGCGAACA-1_7_D5	-8.182328126	7.848377148	5	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	766	1015	0.004926108	0.048275862	5	oligos	OL-MS-1	40	16	16
GGGATGACAGCTATTG-1_7_D5	20.20788233	22.54109821	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1157	1875	0.0096	0.002666667	5	oligos	OL-Cntl	40	16	16
GGGATGACATAGAAAC-1_7_D5	-22.74697538	-16.85135126	6A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4625	11551	0.013072461	0.008830404	5	6A	IN-PV	40	16	16
GGGATGATCCGATATG-1_7_D5	5.871403331	15.81833106	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	993	1544	0.005181347	0.015544041	5	oligos	OL-Cntl	40	16	16
GGGATGATCCGCAAGC-1_7_D5	8.542095522	15.05116758	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1126	1824	0.012061404	0.014254386	5	oligos	OL-Cntl	40	16	16
GGGATGATCTCCGGTT-1_7_D5	38.08512392	10.64182344	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	908	1235	0.001619433	0.008906883	5	14	Microglia	40	16	16
GGGCACTAGGCTAGCA-1_7_D5	-13.73645368	1.427561364	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4083	9705	0.004945904	0.008037094	5	13A	IN-VIP	40	16	16
GGGCACTCAAAGCAAT-1_7_D5	-17.12717561	1.548190811	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4473	10563	0.010603048	0.017324624	5	13A	IN-VIP	40	16	16
GGGCACTCACATCCAA-1_7_D5	24.77009618	-29.51110505	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3243	9299	0.017098613	0.002688461	5	3	EN-L5-6	40	16	16
GGGCACTCAGCCTATA-1_7_D5	-18.4365752	29.12441712	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2728	5573	0.003947605	0.008612955	5	8	Astrocytes	40	16	16
GGGCACTGTTAGGGTG-1_7_D5	-13.2030489	3.219262551	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2571	5041	0.01606824	0.009323547	5	13A	IN-VIP	40	16	16
GGGCACTGTTATCGGT-1_7_D5	5.260950896	-15.19930611	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2740	6005	0.021981682	0.008825978	5	L2-3	EN-L2-3-MS	40	16	16
GGGCACTTCACTTCAT-1_7_D5	13.33371048	-29.78981115	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3660	10013	0.013682213	0.002197144	5	3	EN-L5-6	40	16	16
GGGCACTTCAGCTCGG-1_7_D5	11.55022929	8.771065818	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1501	2462	0.003249391	0.014622258	5	oligos	OL-Cntl	40	16	16
GGGCATCAGGCAGTCA-1_7_D5	34.43932449	-7.520345522	2	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3319	6181	0.006147873	0.014884323	5	2	EN-L4	40	16	16
GGGCATCCAAGCGATG-1_7_D5	7.243490972	-8.27728959	10	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1733	2925	0.026666667	0.003418803	5	L2-3	EN-L2-3-Cntl	40	16	16
GGGCATCGTAGAAGGA-1_7_D5	-20.97366145	25.91962687	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1782	3261	0.003373198	0.009506286	5	8	Astrocytes	40	16	16
GGGCATCGTAGCACGA-1_7_D5	7.892003426	-18.12248539	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4985	12140	0.004283361	0.01878089	5	L2-3	EN-L2-3-MS	40	16	16
GGGCATCGTATAAACG-1_7_D5	-35.6714865	1.814503969	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1834	3202	0.004059963	0.003747658	5	9	OPC	40	16	16
GGGCATCTCATGTCTT-1_7_D5	12.8606428	7.533251945	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1723	2959	0.002027712	0.012166272	5	oligos	OL-Cntl	40	16	16
GGGCATCTCGTCTGAA-1_7_D5	-22.12122334	-17.15543334	6B	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4065	9949	0.016383556	0.007236908	5	6B	IN-SST	40	16	16
GGGCATCTCTGGTGTA-1_7_D5	26.25111439	3.721873947	15BA	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	782	1412	0.004249292	0.002124646	5	15BA	Stromal cells	40	16	16
GGGTCTGAGGCTAGCA-1_7_D5	40.75966758	14.56795427	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1259	1755	0.01994302	0.017663818	5	14	Microglia	40	16	16
GGGTCTGAGTGGAGTC-1_7_D5	-24.72559065	24.50977182	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1894	4081	0.011026709	0.005635874	5	8	Astrocytes	40	16	16
GGGTCTGCAGCGATCC-1_7_D5	-22.90264296	-18.55198656	6B	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3183	7044	0.020159001	0.006388416	5	6B	IN-SST	40	16	16
GGGTCTGCAGGAATGC-1_7_D5	39.3990675	9.550196464	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	759	1061	0.000942507	0.006597549	5	14	Microglia	40	16	16
GGGTCTGCATACGCTA-1_7_D5	3.915076525	15.78896071	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	910	1303	0.003837299	0.016116654	5	oligos	OL-Cntl	40	16	16
GGGTCTGCATCACGAT-1_7_D5	4.50317479	10.72684551	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1167	1828	0.006564551	0.018052516	5	oligos	OL-Cntl	40	16	16
GGGTCTGCATCTACGA-1_7_D5	13.0897332	11.56365745	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1270	2145	0.009324009	0.009324009	5	oligos	OL-Cntl	40	16	16
GGGTCTGGTGGTAACG-1_7_D5	3.957209103	16.07612578	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	847	1227	0	0.016299919	5	oligos	OL-Cntl	40	16	16
GGGTCTGTCCCTCTTT-1_7_D5	5.470786531	16.24063867	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1075	1797	0.007790762	0.00556483	5	oligos	OL-Cntl	40	16	16
GGGTTGCAGGCTAGAC-1_7_D5	-34.42862886	-11.53894647	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	833	1301	0.004611837	0.002305919	5	9	OPC	40	16	16
GGGTTGCCAGGTGGAT-1_7_D5	0.372152201	18.91741858	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	789	1171	0.010247652	0.005123826	5	oligos	OL-Cntl	40	16	16
GGGTTGCCATGATCCA-1_7_D5	-19.83352392	25.98352622	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1802	3595	0.003894298	0.00945758	5	8	Astrocytes	40	16	16
GGGTTGCGTAGGGTAC-1_7_D5	9.727944855	10.5346863	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1404	2379	0.001681379	0.013030685	5	oligos	OL-Cntl	40	16	16
GGGTTGCTCACCTTAT-1_7_D5	-26.37185528	13.69588878	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1052	1640	0.001219512	0.001829268	5	8	Astrocytes	40	16	16
GGGTTGCTCCTATGTT-1_7_D5	-4.901242099	21.49337401	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	739	1054	0.004743833	0.012333966	5	oligos	OL-Cntl	40	16	16
GGGTTGCTCTAACTGG-1_7_D5	-34.64879021	-5.789608793	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1177	1879	0.005854178	0.003193188	5	9	OPC	40	16	16
GGGTTGCTCTGCAGTA-1_7_D5	9.972929383	16.85240563	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1015	1647	0.003035823	0.008500304	5	oligos	OL-Cntl	40	16	16
GGTATTGAGCAGATCG-1_7_D5	15.9100548	5.987729591	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2472	4782	0.009410289	0.010874111	5	oligos	OL-Cntl	40	16	16
GGTATTGCAGATGGGT-1_7_D5	3.961597948	12.03274821	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1132	1743	0.005163511	0.01491681	5	oligos	OL-Cntl	40	16	16
GGTATTGGTGGTCCGT-1_7_D5	-35.10108353	1.411530669	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1818	3253	0.00430372	0.004918537	5	9	OPC	40	16	16
GGTATTGTCCATTCTA-1_7_D5	7.430696825	11.53703517	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1001	1529	0.0117724	0.024198823	5	oligos	OL-Cntl	40	16	16
GGTATTGTCGAGGTAG-1_7_D5	6.746051029	-21.06557498	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	6545	21974	0.005005916	0.011331574	5	L2-3	EN-L2-3-MS	40	16	16
GGTGAAGAGCCCTAAT-1_7_D5	-34.58746152	-3.391850265	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1344	2215	0.006320542	0.006772009	5	9	OPC	40	16	16
GGTGAAGTCATTGCCC-1_7_D5	18.52294258	11.89383613	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1425	2507	0.001994416	0.002792182	5	oligos	OL-Cntl	40	16	16
GGTGAAGTCCGAACGC-1_7_D5	10.71779071	22.47577253	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	827	1273	0.000785546	0.016496465	5	oligos	OL-Cntl	40	16	16
GGTGAAGTCGTGTAGT-1_7_D5	16.48733825	-5.336585594	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1770	3071	0.00097688	0.014978834	5	3	EN-L5-6	40	16	16
GGTGAAGTCTTCAACT-1_7_D5	-13.79137769	1.661607226	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4653	12299	0.009756891	0.007236361	5	13A	IN-VIP	40	16	16
GGTGCGTAGAGCAATT-1_7_D5	4.19286828	11.23769143	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1080	1590	0.012578616	0.014465409	5	oligos	OL-Cntl	40	16	16
GGTGCGTAGTTAGCGG-1_7_D5	-34.36967288	4.872686409	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2778	5704	0.002629734	0.007713885	5	9	OPC	40	16	16
GGTGCGTCACTTAAGC-1_7_D5	4.404429819	10.89933651	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1246	2020	0.018811881	0.018316832	5	oligos	OL-Cntl	40	16	16
GGTGCGTGTCCGAGTC-1_7_D5	35.63210925	11.86286116	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	910	1225	0.004081633	0.030204082	5	14	Microglia	40	16	16
GGTGCGTGTTAGATGA-1_7_D5	10.7535125	14.63299272	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1239	1871	0.021913415	0.003741315	5	oligos	OL-Cntl	40	16	16
GGTGTTACAAGAAAGG-1_7_D5	1.732393897	17.73091968	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	782	1177	0.005097706	0.016992353	5	oligos	OL-Cntl	40	16	16
GGTGTTACACGCGAAA-1_7_D5	3.572875698	15.78059532	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	950	1452	0.00137741	0.013774105	5	oligos	OL-Cntl	40	16	16
GGTGTTAGTAAATGAC-1_7_D5	-25.75924263	15.91134471	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1106	1828	0.003829322	0.004923414	5	8	Astrocytes	40	16	16
GGTGTTATCGCGATCG-1_7_D5	1.445682444	12.93171634	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1003	1526	0.03604194	0.0163827	5	oligos	OL-Cntl	40	16	16
GTAACGTAGTGCTGCC-1_7_D5	-1.694887517	15.86991854	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	828	1280	0.00546875	0.01484375	5	oligos	OL-Cntl	40	16	16
GTAACGTCAGGTCCAC-1_7_D5	33.99802019	15.41226225	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	980	1371	0.005105762	0.051787017	5	14	Microglia	40	16	16
GTAACGTGTGTGGCTC-1_7_D5	-34.53259701	1.546280577	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1958	3659	0.005465974	0.005739273	5	9	OPC	40	16	16
GTAACGTGTTCACCTC-1_7_D5	5.274432886	15.6620277	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1030	1672	0.005980861	0.011961722	5	oligos	OL-Cntl	40	16	16
GTAACGTTCAACGGCC-1_7_D5	-35.02746103	5.10847421	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2675	5491	0.00145693	0.003642324	5	9	OPC	40	16	16
GTAACGTTCCCGGATG-1_7_D5	-4.481727628	25.38977513	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	703	1043	0.005752637	0.005752637	5	oligos	OL-Cntl	40	16	16
GTAACGTTCGAGAACG-1_7_D5	3.04588866	-19.42638294	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4355	11303	0.005750686	0.004512076	5	L2-3	EN-L2-3-MS	40	16	16
GTAACGTTCTACGAGT-1_7_D5	4.25786163	-23.2346052	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4416	13011	0.032664668	0.00391976	5	L2-3	EN-L2-3-MS	40	16	16
GTAACTGAGACGCACA-1_7_D5	-24.93180244	26.21828448	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1713	3164	0.002844501	0.002212389	5	8	Astrocytes	40	16	16
GTAACTGAGTGTCTCA-1_7_D5	12.74318294	-6.864917997	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2395	5469	0.028707259	0.010056683	5	3	EN-L5-6	40	16	16
GTAACTGTCATGTCCC-1_7_D5	8.272367565	15.17916456	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1050	1761	0.010221465	0.005678592	5	oligos	OL-Cntl	40	16	16
GTACGTAAGATATACG-1_7_D5	-4.892637375	-34.66177104	16	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	755	1014	0.096646943	0.018737673	5	16	EN-PYR	40	16	16
GTACGTACAGGAACGT-1_7_D5	-36.3293905	1.901765201	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1756	3355	0.000894188	0.003576751	5	9	OPC	40	16	16
GTACGTAGTGAGTGAC-1_7_D5	22.51493373	-26.11324269	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2934	5746	0.012530456	0.005743126	5	3	EN-L5-6	40	16	16
GTACGTAGTTACAGAA-1_7_D5	10.81989292	18.16862319	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1020	1633	0.003674219	0.011022658	5	oligos	OL-Cntl	40	16	16
GTACGTATCCCTAACC-1_7_D5	7.926283653	16.69187493	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	975	1695	0.007079646	0.005309735	5	oligos	OL-Cntl	40	16	16
GTACGTATCCTGCTTG-1_7_D5	-3.073602035	16.96634902	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	744	1049	0.007626311	0.021925643	5	oligos	OL-Cntl	40	16	16
GTACTCCAGTGAACAT-1_7_D5	-36.22130097	1.179080176	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1728	2944	0.00611413	0.005434783	5	9	OPC	40	16	16
GTACTCCCAATACGCT-1_7_D5	24.3452654	-26.97088918	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	5025	16206	0.012526225	0.003825744	5	3	EN-L5-6	40	16	16
GTACTCCCACTGTTAG-1_7_D5	33.46229237	-7.098289288	2	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4238	10008	0.005295763	0.008293365	5	2	EN-L4	40	16	16
GTACTCCCAGGATCGA-1_7_D5	-34.72311472	4.696655427	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2393	4575	0.001748634	0.005464481	5	9	OPC	40	16	16
GTACTCCGTAGAAAGG-1_7_D5	12.45917255	8.089860294	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1592	2736	0.004385965	0.011330409	5	oligos	OL-Cntl	40	16	16
GTACTCCGTCTCTTTA-1_7_D5	4.802712078	15.95921657	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	943	1473	0.002715547	0.015614392	5	oligos	OL-Cntl	40	16	16
GTACTCCTCACCGGGT-1_7_D5	3.955931584	11.15215728	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1110	1757	0.012521343	0.014797951	5	oligos	OL-Cntl	40	16	16
GTACTCCTCATTATCC-1_7_D5	1.921064339	18.28600274	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	896	1376	0.002906977	0.00872093	5	oligos	OL-Cntl	40	16	16
GTACTCCTCGCGTAGC-1_7_D5	13.01444768	9.057692458	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1541	2699	0.004075584	0.011485735	5	oligos	OL-Cntl	40	16	16
GTACTCCTCTGCCAGG-1_7_D5	11.69205508	9.915208382	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1305	2130	0.005164319	0.010798122	5	oligos	OL-Cntl	40	16	16
GTACTTTCATTTCAGG-1_7_D5	-3.354955139	-35.98323253	16	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	769	1018	0.032416503	0.025540275	5	16	EN-PYR	40	16	16
GTACTTTGTAATCGTC-1_7_D5	11.91504168	-5.564147269	12	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1426	2617	0.018341613	0.004585403	5	12	EN-MIX	40	16	16
GTACTTTGTATGAATG-1_7_D5	27.1113162	6.183089313	15BA	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1046	1513	0.020489095	0.028420357	5	15BA	Stromal cells	40	16	16
GTACTTTGTCAACTGT-1_7_D5	0.485909915	15.52589885	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	859	1283	0.003897116	0.021044427	5	oligos	OL-Cntl	40	16	16
GTACTTTTCGAACTGT-1_7_D5	1.543556168	18.07651522	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	851	1387	0.005767844	0.009372747	5	oligos	OL-Cntl	40	16	16
GTACTTTTCGTAGGAG-1_7_D5	-35.3469915	0.678292602	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1661	3100	0.003870968	0.004516129	5	9	OPC	40	16	16
GTAGGCCAGCGAAGGG-1_7_D5	9.486971385	18.7380533	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1054	1633	0.015309247	0.006123699	5	oligos	OL-Cntl	40	16	16
GTAGGCCCACCATGTA-1_7_D5	6.829037443	-16.46702654	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2990	6115	0.00784955	0.015044971	5	L2-3	EN-L2-3-MS	40	16	16
GTAGGCCTCTCTGAGA-1_7_D5	8.529656765	8.512196514	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1398	2396	0.015442404	0.019616027	5	oligos	OL-Cntl	40	16	16
GTAGTCAAGCTGAAAT-1_7_D5	11.63116486	-5.204036455	12	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1116	1869	0.009630819	0.004815409	5	12	EN-MIX	40	16	16
GTAGTCAAGGACAGAA-1_7_D5	9.314104676	-23.31583833	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	5487	15890	0.003524229	0.006293266	5	L2-3	EN-L2-3-MS	40	16	16
GTAGTCAAGGGCTTCC-1_7_D5	38.98538326	10.60102025	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	922	1298	0.003081664	0.006933744	5	14	Microglia	40	16	16
GTAGTCAAGTACGCGA-1_7_D5	5.540622091	-22.00245667	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	7165	26815	0.001230654	0.003729256	5	L2-3	EN-L2-3-MS	40	16	16
GTAGTCACATAGAAAC-1_7_D5	-24.43660386	-18.33276745	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3661	7906	0.017202125	0.022641032	5	13A	IN-VIP	40	16	16
GTAGTCACATGCAACT-1_7_D5	10.76338261	7.410839464	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1519	2449	0.005716619	0.018783177	5	oligos	OL-Cntl	40	16	16
GTAGTCAGTTATGCGT-1_7_D5	14.26511251	13.39939187	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1330	2140	0.002803738	0.006542056	5	oligos	OL-Cntl	40	16	16
GTAGTCATCCCATTAT-1_7_D5	13.2251748	8.911137961	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1484	2479	0.001613554	0.017749092	5	oligos	OL-Cntl	40	16	16
GTATCTTCAATCTACG-1_7_D5	-20.70099751	28.47685326	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2222	4556	0.009218613	0.003950834	5	8	Astrocytes	40	16	16
GTATCTTCATCTACGA-1_7_D5	-20.60126098	8.405351334	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	808	1241	0.004029009	0.005640612	5	8	Astrocytes	40	16	16
GTATCTTGTCGGCACT-1_7_D5	13.22087991	9.330492505	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1569	2750	0.007636364	0.010909091	5	oligos	OL-Cntl	40	16	16
GTATCTTGTCTTGATG-1_7_D5	14.78297358	9.854419767	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1545	2735	0	0.006581353	5	oligos	OL-Cntl	40	16	16
GTATCTTGTGGGTCAA-1_7_D5	17.16725769	6.28585846	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2355	5183	0.013312753	0.006752846	5	oligos	OL-Cntl	40	16	16
GTATCTTTCAACACTG-1_7_D5	8.438775407	-17.54633217	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	5435	14175	0.012416226	0.015520282	5	L2-3	EN-L2-3-MS	40	16	16
GTATTCTCACACCGAC-1_7_D5	39.03868355	14.71458854	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1148	1640	0.005487805	0.004878049	5	14	Microglia	40	16	16
GTATTCTCACATAACC-1_7_D5	19.92821765	-29.81509861	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	6946	28253	0.002017485	0.006477188	5	3	EN-L5-6	40	16	16
GTATTCTGTCATCCCT-1_7_D5	7.874606732	-18.84171324	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	6883	27293	0.004470011	0.0090133	5	L2-3	EN-L2-3-MS	40	16	16
GTATTCTGTGTGCCTG-1_7_D5	-33.72596937	1.72860836	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1930	3477	0.004601668	0.007765315	5	9	OPC	40	16	16
GTATTCTTCGATCCCT-1_7_D5	0.920632845	20.43403526	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	748	1139	0.005267779	0.009657594	5	oligos	OL-Cntl	40	16	16
GTATTCTTCGCGATCG-1_7_D5	-0.451298236	22.9861795	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	786	1136	0.004401408	0.007922535	5	oligos	OL-Cntl	40	16	16
GTCAAGTAGACCGGAT-1_7_D5	0.426708972	13.69799948	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	938	1474	0.001356852	0.013568521	5	oligos	OL-Cntl	40	16	16
GTCAAGTCATGTCCTC-1_7_D5	-34.02763118	2.622345856	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2070	3774	0.003974563	0.00609433	5	9	OPC	40	16	16
GTCAAGTGTAAGGGAA-1_7_D5	-5.41930604	12.77492571	5	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	791	1120	0.015178571	0.01875	5	oligos	OL-MS-1	40	16	16
GTCAAGTGTATAGGTA-1_7_D5	4.008323295	15.80872032	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	917	1374	0.005822416	0.013828239	5	oligos	OL-Cntl	40	16	16
GTCAAGTGTCTCCATC-1_7_D5	-33.85504973	2.371232822	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2121	4013	0.003488662	0.005482183	5	9	OPC	40	16	16
GTCAAGTTCACTCCTG-1_7_D5	32.76462424	-1.222414618	2	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3219	6907	0.008542059	0.005646446	5	2	EN-L4	40	16	16
GTCAAGTTCTGCTTGC-1_7_D5	4.470357704	10.71352899	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1225	1941	0.008758372	0.022153529	5	oligos	OL-Cntl	40	16	16
GTCACAAAGCGCCTCA-1_7_D5	4.696856253	-16.4976295	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3704	8438	0.014339891	0.004621948	5	L2-3	EN-L2-3-MS	40	16	16
GTCACAACAACTGGCC-1_7_D5	2.838058748	17.8914279	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1024	1543	0.005832793	0.007777058	5	oligos	OL-Cntl	40	16	16
GTCACAAGTGCCTGCA-1_7_D5	-39.66146311	0.674811305	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1646	3159	0	0.002215891	5	9	OPC	40	16	16
GTCACAAGTGGCCCTA-1_7_D5	15.80160838	6.575919372	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1994	3990	0.004010025	0.009774436	5	oligos	OL-Cntl	40	16	16
GTCACAAGTGTTAAGA-1_7_D5	5.046486496	10.3124364	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1407	2233	0.003134796	0.02060009	5	oligos	OL-Cntl	40	16	16
GTCACAAGTTCCACGG-1_7_D5	31.00563287	15.50281707	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	909	1319	0.00227445	0.105382866	5	14	Microglia	40	16	16
GTCACGGCACCACGTG-1_7_D5	12.23067915	8.821644086	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1561	2569	0.007395874	0.014402491	5	oligos	OL-Cntl	40	16	16
GTCACGGGTATGAATG-1_7_D5	0.232904333	20.16908622	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	735	1095	0.003652968	0.00913242	5	oligos	OL-Cntl	40	16	16
GTCACGGGTCCCGACA-1_7_D5	10.18425035	7.606387874	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1719	2998	0.012008005	0.012341561	5	oligos	OL-Cntl	40	16	16
GTCACGGGTCTTTCAT-1_7_D5	-27.23214526	23.69106898	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1389	2594	0.000385505	0.005782575	5	8	Astrocytes	40	16	16
GTCACGGGTTCGTCTC-1_7_D5	16.9867632	11.93908781	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1367	2336	0.006421233	0.006421233	5	oligos	OL-Cntl	40	16	16
GTCACGGGTTGCCTCT-1_7_D5	8.498111543	10.97924494	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1400	2377	0.002944889	0.009255364	5	oligos	OL-Cntl	40	16	16
GTCACGGTCTGTCTCG-1_7_D5	-19.84497205	-20.58940779	6A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2197	4476	0.035969616	0.010947274	5	6A	IN-PV	40	16	16
GTCATTTAGATCACGG-1_7_D5	13.71357924	11.12432968	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1246	2008	0.001494024	0.011454183	5	oligos	OL-Cntl	40	16	16
GTCATTTAGATCGATA-1_7_D5	4.766404292	-21.63805181	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4971	14359	0.003760708	0.005153562	5	L2-3	EN-L2-3-MS	40	16	16
GTCATTTAGGTGATAT-1_7_D5	-10.38582018	18.47574346	11	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2624	5430	0.002394107	0.005709024	5	11	Glia-MIX	40	16	16
GTCATTTAGGTGCTTT-1_7_D5	11.37169575	16.8696529	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1079	1834	0.00436205	0.005997819	5	oligos	OL-Cntl	40	16	16
GTCATTTAGTGACATA-1_7_D5	-19.00501061	27.53574901	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2220	4595	0.001088139	0.008705114	5	8	Astrocytes	40	16	16
GTCATTTCAAGGACTG-1_7_D5	6.646667456	15.11386442	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1179	1957	0.002043945	0.015329586	5	oligos	OL-Cntl	40	16	16
GTCATTTTCCAAGCCG-1_7_D5	10.44632273	9.319711002	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1342	2245	0.003563474	0.012026726	5	oligos	OL-Cntl	40	16	16
GTCATTTTCCTCAATT-1_7_D5	14.47829257	13.14779162	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1377	2418	0.006203474	0.005789909	5	oligos	OL-Cntl	40	16	16
GTCATTTTCTATCCTA-1_7_D5	37.50233466	14.83884612	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1156	1665	0.003603604	0.02042042	5	14	Microglia	40	16	16
GTCCTCAAGAACTGTA-1_7_D5	5.073352078	10.36725194	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1383	2167	0.004614675	0.015689894	5	oligos	OL-Cntl	40	16	16
GTCCTCAGTAAGCACG-1_7_D5	4.652705153	5.622239624	7	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1628	2515	0.0027833	0.011530815	5	7	Phagocytes	40	16	16
GTCCTCAGTCGATTGT-1_7_D5	-29.04155877	21.47050905	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1159	2150	0	0.006046512	5	8	Astrocytes	40	16	16
GTCCTCATCACGACTA-1_7_D5	-20.99970268	28.4807903	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2650	5577	0.004303389	0.002868926	5	8	Astrocytes	40	16	16
GTCCTCATCAGGCGAA-1_7_D5	2.996528274	12.47867345	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1050	1675	0.012537313	0.015522388	5	oligos	OL-Cntl	40	16	16
GTCCTCATCATCGGAT-1_7_D5	-2.44099379	13.41656253	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	805	1142	0.011383538	0.025394046	5	oligos	OL-Cntl	40	16	16
GTCCTCATCCATTCTA-1_7_D5	-26.69483471	22.23305539	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1154	1959	0.003062787	0.003062787	5	8	Astrocytes	40	16	16
GTCCTCATCCTTTCTC-1_7_D5	31.52349336	15.98042884	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1054	1463	0.004784689	0.088174983	5	14	Microglia	40	16	16
GTCCTCATCGAGGTAG-1_7_D5	39.39507107	9.885694519	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	834	1206	0.004145937	0.009121061	5	14	Microglia	40	16	16
GTCCTCATCTGTCAAG-1_7_D5	0.551197392	19.33494226	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	733	1101	0.004541326	0.009082652	5	oligos	OL-Cntl	40	16	16
GTCGGGTAGCCAGAAC-1_7_D5	2.362473168	-8.578683032	12	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1491	2455	0.005702648	0.00407332	5	12	EN-MIX	40	16	16
GTCGGGTAGGACATTA-1_7_D5	2.10888285	16.60294981	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	902	1488	0.003360215	0.009408602	5	oligos	OL-Cntl	40	16	16
GTCGGGTGTCCGCTGA-1_7_D5	3.378212959	16.53237476	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	987	1475	0.000677966	0.010169492	5	oligos	OL-Cntl	40	16	16
GTCGGGTGTCGACTGC-1_7_D5	-25.35764676	23.55431133	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1552	3012	0.000996016	0.006308101	5	8	Astrocytes	40	16	16
GTCGGGTGTGAGGGTT-1_7_D5	38.8423954	14.8466192	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1198	1733	0.013848817	0.008655511	5	14	Microglia	40	16	16
GTCGGGTGTTCACGGC-1_7_D5	17.18138376	-4.863701551	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2029	4191	0.008112622	0.003579098	5	3	EN-L5-6	40	16	16
GTCGGGTTCACTTATC-1_7_D5	9.413416496	10.88769284	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1322	2296	0.013501742	0.014372822	5	oligos	OL-Cntl	40	16	16
GTCGGGTTCTAACTTC-1_7_D5	36.02660002	-8.57040088	2	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	5587	15601	0.007179027	0.007563618	5	2	EN-L4	40	16	16
GTCGTAAAGACCCACC-1_7_D5	-29.59845039	22.02374694	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1070	2064	0.001937984	0.002422481	5	8	Astrocytes	40	16	16
GTCGTAAGTACAGTTC-1_7_D5	11.71822259	16.0353752	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1173	1950	0.007179487	0.005641026	5	oligos	OL-Cntl	40	16	16
GTCGTAATCGGAATCT-1_7_D5	-30.24585779	-12.73565369	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	679	1037	0.012536162	0.008678881	5	9	OPC	40	16	16
GTCTCGTAGCCACGCT-1_7_D5	-19.62727628	29.4222219	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2526	5711	0.00245141	0.005953423	5	8	Astrocytes	40	16	16
GTCTCGTAGCTGATAA-1_7_D5	-36.62711345	1.280909339	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1771	3337	0.003895715	0.003296374	5	9	OPC	40	16	16
GTCTCGTGTGTCCTCT-1_7_D5	38.06562463	11.44810966	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	921	1267	0.004735596	0.020520916	5	14	Microglia	40	16	16
GTCTCGTGTTAGTGGG-1_7_D5	-28.79745692	16.60171758	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	943	1504	0.010638298	0.00731383	5	8	Astrocytes	40	16	16
GTCTCGTGTTGGTAAA-1_7_D5	-1.340629149	17.74768194	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	727	1007	0.008937438	0.015888779	5	oligos	OL-Cntl	40	16	16
GTCTCGTGTTGTGGAG-1_7_D5	4.372298611	10.98203618	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1129	1711	0.015195792	0.021624781	5	oligos	OL-Cntl	40	16	16
GTCTCGTTCTTGCCGT-1_7_D5	-33.98181832	3.066090029	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2144	4214	0.002610346	0.009492169	5	9	OPC	40	16	16
GTCTTCGAGCGTAGTG-1_7_D5	20.01819596	-29.61713253	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	7808	32314	0.000804605	0.003558829	5	3	EN-L5-6	40	16	16
GTCTTCGAGGCTCATT-1_7_D5	7.790370126	18.54991652	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1062	1711	0.005844535	0.00818235	5	oligos	OL-Cntl	40	16	16
GTCTTCGCAATAGAGT-1_7_D5	9.914230793	10.16810152	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1417	2450	0.008979592	0.012653061	5	oligos	OL-Cntl	40	16	16
GTCTTCGCAGCAGTTT-1_7_D5	0.594124014	18.0113847	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	753	1238	0.003231018	0.013731826	5	oligos	OL-Cntl	40	16	16
GTCTTCGCATAAAGGT-1_7_D5	-12.07700513	-0.659505319	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2781	5925	0.023628692	0.008945148	5	13A	IN-VIP	40	16	16
GTCTTCGGTTAGAACA-1_7_D5	2.345713488	16.88497067	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	913	1435	0.005574913	0.008362369	5	oligos	OL-Cntl	40	16	16
GTCTTCGTCGTTGACA-1_7_D5	10.93308114	13.61366985	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1289	2278	0.021071115	0.010535558	5	oligos	OL-Cntl	40	16	16
GTCTTCGTCTTGGGTA-1_7_D5	7.796847434	-18.48257535	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4702	12936	0.006261596	0.014378479	5	L2-3	EN-L2-3-MS	40	16	16
GTGAAGGCAAGCCTAT-1_7_D5	-20.37050607	28.67657881	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2183	4709	0.001274156	0.007220217	5	8	Astrocytes	40	16	16
GTGAAGGCACACATGT-1_7_D5	8.988535784	11.27680749	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1151	1768	0.010180995	0.016402715	5	oligos	OL-Cntl	40	16	16
GTGAAGGCACCGATAT-1_7_D5	19.68811348	-28.19334013	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2869	5927	0.001518475	0.007423654	5	3	EN-L5-6	40	16	16
GTGAAGGTCAAGGTAA-1_7_D5	11.984187	7.51545419	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1677	2886	0.001386001	0.016285516	5	oligos	OL-Cntl	40	16	16
GTGAAGGTCCCTGACT-1_7_D5	-17.39524381	1.398049411	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4226	9013	0.007655609	0.017752136	5	13A	IN-VIP	40	16	16
GTGAAGGTCCTCTAGC-1_7_D5	12.43295721	7.164109044	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1776	2971	0.010770784	0.014473241	5	oligos	OL-Cntl	40	16	16
GTGCAGCCATTAGCCA-1_7_D5	13.29995979	7.589879308	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1878	3267	0.000306091	0.010713193	5	oligos	OL-Cntl	40	16	16
GTGCAGCGTATCTGCA-1_7_D5	30.66723951	13.59279777	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1464	2270	0.017621145	0.086343612	5	14	Microglia	40	16	16
GTGCAGCGTCTCCATC-1_7_D5	15.11229318	8.768320015	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1712	3263	0.001838799	0.011032792	5	oligos	OL-Cntl	40	16	16
GTGCAGCTCTCCTATA-1_7_D5	-29.68482784	12.84386031	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	722	1211	0.019818332	0.005780347	5	8	Astrocytes	40	16	16
GTGCAGCTCTGTCCGT-1_7_D5	31.40653276	-11.05818026	2	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2621	5816	0.03301238	0.00326685	5	2	EN-L4	40	16	16
GTGCATAAGCAGGTCA-1_7_D5	8.816030761	11.89035503	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1287	2095	0.001431981	0.009069212	5	oligos	OL-Cntl	40	16	16
GTGCATAAGGTGCTTT-1_7_D5	-34.21829459	-0.375381616	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1719	3106	0.002897618	0.00643915	5	9	OPC	40	16	16
GTGCATAAGTACGACG-1_7_D5	7.365070643	-18.25655028	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3879	8993	0.008451017	0.0138997	5	L2-3	EN-L2-3-MS	40	16	16
GTGCATACACATCCGG-1_7_D5	33.67960206	-11.22274062	2	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2740	4870	0.018685832	0.014784394	5	2	EN-L4	40	16	16
GTGCATACACTTACGA-1_7_D5	-24.96401806	11.99799577	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1208	2325	0.00344086	0.006451613	5	8	Astrocytes	40	16	16
GTGCATACAGCTCGCA-1_7_D5	-33.5695032	-4.380409526	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1340	2266	0.003089144	0.009267432	5	9	OPC	40	16	16
GTGCATAGTAAAGGAG-1_7_D5	12.78439429	-6.944577285	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2432	5437	0.009012323	0.002574949	5	3	EN-L5-6	40	16	16
GTGCATAGTAGGACAC-1_7_D5	37.52628878	14.06713549	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1118	1628	0.011670762	0.019041769	5	14	Microglia	40	16	16
GTGCATAGTCATATGC-1_7_D5	13.28490979	13.12288049	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1341	2300	0.006086957	0.003913043	5	oligos	OL-Cntl	40	16	16
GTGCATAGTGTAAGTA-1_7_D5	6.982401184	-20.93407381	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	6175	18283	0.000382869	0.01236121	5	L2-3	EN-L2-3-MS	40	16	16
GTGCGGTAGCGAAGGG-1_7_D5	33.12646853	-4.731514237	2	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3121	7036	0.028425242	0.004263786	5	2	EN-L4	40	16	16
GTGCGGTAGGCATGGT-1_7_D5	11.17563604	8.469301249	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1395	2326	0.006448839	0.012467756	5	oligos	OL-Cntl	40	16	16
GTGCGGTAGGTAGCTG-1_7_D5	-28.46148505	1.017143384	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2196	4104	0.001461988	0.011695906	5	9	OPC	40	16	16
GTGCGGTAGTTGTAGA-1_7_D5	1.752563142	17.29171371	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1012	1623	0.011090573	0.008009858	5	oligos	OL-Cntl	40	16	16
GTGCGGTCAGCGATCC-1_7_D5	-0.018605528	16.46747223	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	844	1286	0.008553655	0.018662519	5	oligos	OL-Cntl	40	16	16
GTGCGGTCATAACCTG-1_7_D5	-25.23706554	15.89445919	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1041	1531	0.008491182	0.005878511	5	8	Astrocytes	40	16	16
GTGCGGTCATTCGACA-1_7_D5	5.326375009	14.77915043	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1105	1779	0.007307476	0.008431703	5	oligos	OL-Cntl	40	16	16
GTGCGGTGTCCATCCT-1_7_D5	9.418753802	15.6284337	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1024	1675	0.008358209	0.011343284	5	oligos	OL-Cntl	40	16	16
GTGCGGTTCCGCTGTT-1_7_D5	14.77769306	8.808517674	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1624	2793	0.001432152	0.008234873	5	oligos	OL-Cntl	40	16	16
GTGCGGTTCTAACGGT-1_7_D5	-16.37450514	2.354741722	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	6800	21698	0.006221772	0.009816573	5	13A	IN-VIP	40	16	16
GTGCTTCAGAGACTAT-1_7_D5	-35.54346001	2.76446444	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1952	3828	0.004179728	0.002873563	5	9	OPC	40	16	16
GTGCTTCAGATGCCAG-1_7_D5	15.81975221	-18.53347013	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	8431	36876	0.030670355	0.005260874	5	L2-3	EN-L2-3-MS	40	16	16
GTGCTTCAGGGTCGAT-1_7_D5	-34.89834674	-0.849380449	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1559	2786	0.008255564	0.005025126	5	9	OPC	40	16	16
GTGCTTCAGTGTGGCA-1_7_D5	-34.35378134	3.267173641	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2325	4642	0.001507971	0.007970702	5	9	OPC	40	16	16
GTGCTTCCAAACGCGA-1_7_D5	8.431227874	-17.35028334	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4520	10545	0.005595069	0.02494073	5	L2-3	EN-L2-3-MS	40	16	16
GTGCTTCCAAGAGGCT-1_7_D5	30.82285306	15.51026596	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	851	1250	0.0056	0.1168	5	14	Microglia	40	16	16
GTGCTTCCACAGCGTC-1_7_D5	10.13630141	14.37311175	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1107	1930	0.001554404	0.008290155	5	oligos	OL-Cntl	40	16	16
GTGCTTCCACTGTGTA-1_7_D5	5.34784296	16.05030768	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	946	1503	0.000665336	0.007318696	5	oligos	OL-Cntl	40	16	16
GTGCTTCCAGTCAGCC-1_7_D5	12.251925	9.176003844	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1552	2666	0.006751688	0.009002251	5	oligos	OL-Cntl	40	16	16
GTGCTTCCATCTCGCT-1_7_D5	10.73178757	7.398316038	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1577	2647	0.010955799	0.018511522	5	oligos	OL-Cntl	40	16	16
GTGCTTCCATGCTAGT-1_7_D5	13.43017674	18.4544293	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1088	1726	0.004634994	0.00811124	5	oligos	OL-Cntl	40	16	16
GTGCTTCGTAGATTAG-1_7_D5	-11.82392398	-2.912753848	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2393	4582	0.025971192	0.011785247	5	13A	IN-VIP	40	16	16
GTGCTTCGTTCACGGC-1_7_D5	-31.6439844	-2.397149585	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1182	1889	0.005293806	0.003176284	5	9	OPC	40	16	16
GTGCTTCTCACTTCAT-1_7_D5	-0.002204538	20.95150214	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	688	1012	0	0.006916996	5	oligos	OL-Cntl	40	16	16
GTGCTTCTCGTCACGG-1_7_D5	3.668953456	-17.47884504	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3210	7284	0.009747392	0.007276222	5	L2-3	EN-L2-3-MS	40	16	16
GTGGGTCAGCAAATCA-1_7_D5	12.68904851	9.93226784	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1364	2234	0.003581021	0.01477171	5	oligos	OL-Cntl	40	16	16
GTGGGTCAGCAATCTC-1_7_D5	5.924152962	18.66846436	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	966	1413	0.004953999	0.012738854	5	oligos	OL-Cntl	40	16	16
GTGGGTCCACCGAAAG-1_7_D5	-10.42662279	-17.85893704	6B	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1030	1645	0.067477204	0.00668693	5	6B	IN-SST	40	16	16
GTGGGTCCAGGTGCCT-1_7_D5	22.36837751	-18.84340724	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	8737	41732	0.040855938	0.007236653	5	3	EN-L5-6	40	16	16
GTGGGTCGTAATAGCA-1_7_D5	32.10462113	15.81053912	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	940	1340	0.001492537	0.065671642	5	14	Microglia	40	16	16
GTGGGTCGTGCTGTAT-1_7_D5	-0.511464077	18.20294296	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	776	1192	0.001677852	0.015100671	5	oligos	OL-Cntl	40	16	16
GTGGGTCTCACGACTA-1_7_D5	23.18109385	-28.81977257	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4723	15759	0.004505362	0.00196713	5	3	EN-L5-6	40	16	16
GTGGGTCTCTCGCATC-1_7_D5	7.14504238	-20.8434043	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	5812	18479	0.009903133	0.009740787	5	L2-3	EN-L2-3-MS	40	16	16
GTGTGCGAGACGCACA-1_7_D5	15.9863954	8.574437273	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1591	2914	0.005490734	0.004461222	5	oligos	OL-Cntl	40	16	16
GTGTGCGAGAGACTAT-1_7_D5	8.512993163	12.14310119	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1206	1887	0.010068892	0.009538951	5	oligos	OL-Cntl	40	16	16
GTGTGCGAGTCCATAC-1_7_D5	8.346755668	-22.62081218	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	7918	31563	0.003960333	0.005576149	5	L2-3	EN-L2-3-MS	40	16	16
GTGTGCGCAAATTGCC-1_7_D5	9.570666516	-24.07139062	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	6166	19488	0.004207718	0.004361658	5	L2-3	EN-L2-3-MS	40	16	16
GTGTGCGCAGATGGGT-1_7_D5	25.74351077	-27.92981606	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	5125	16902	0.003135724	0.003904863	5	3	EN-L5-6	40	16	16
GTGTGCGGTATGAAAC-1_7_D5	1.528503142	12.37013643	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	964	1419	0.010570825	0.015503876	5	oligos	OL-Cntl	40	16	16
GTGTGCGGTCCAGTAT-1_7_D5	4.651180649	14.72674981	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	875	1299	0.003849115	0.016166282	5	oligos	OL-Cntl	40	16	16
GTGTGCGGTCTTCTCG-1_7_D5	13.220757	7.909155952	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1650	2917	0.004799451	0.01508399	5	oligos	OL-Cntl	40	16	16
GTGTGCGTCGCGATCG-1_7_D5	21.15425641	-26.39526453	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3225	7132	0.000420639	0.007431296	5	3	EN-L5-6	40	16	16
GTGTGCGTCGGAAATA-1_7_D5	-33.84335551	1.733862698	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1781	3015	0.0039801	0.007628524	5	9	OPC	40	16	16
GTGTTAGAGATCGATA-1_7_D5	0.627700075	-9.810430177	12	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1686	3227	0.016423923	0.003718624	5	12	EN-MIX	40	16	16
GTGTTAGGTATCACCA-1_7_D5	-3.092116033	15.37819974	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	769	1117	0.008057296	0.019695613	5	oligos	OL-Cntl	40	16	16
GTGTTAGTCGCCAAAT-1_7_D5	-19.70082681	28.14299369	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2204	4320	0.001851852	0.006944444	5	8	Astrocytes	40	16	16
GTGTTAGTCGGAGCAA-1_7_D5	19.36082617	25.75382059	17	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1136	1733	0.032313907	0.006347374	5	oligos	OL-MS-2	40	16	16
GTTAAGCAGTCACGCC-1_7_D5	-33.78370308	1.881255425	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2100	3929	0.004581318	0.005853907	5	9	OPC	40	16	16
GTTAAGCCACATTCGA-1_7_D5	2.338367602	12.82835752	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	953	1464	0.010928962	0.015710383	5	oligos	OL-Cntl	40	16	16
GTTAAGCCATCTCCCA-1_7_D5	-21.26879939	29.31280307	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2058	4247	0.000941841	0.004944667	5	8	Astrocytes	40	16	16
GTTAAGCGTCACAAGG-1_7_D5	10.87259517	7.495281297	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1476	2514	0.001193317	0.009944312	5	oligos	OL-Cntl	40	16	16
GTTAAGCGTCTGATTG-1_7_D5	0.831378232	15.86519926	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	849	1279	0.025019547	0.024237686	5	oligos	OL-Cntl	40	16	16
GTTAAGCGTGCCTGGT-1_7_D5	7.220227273	-20.72974165	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	5000	14098	0.007873457	0.007518797	5	L2-3	EN-L2-3-MS	40	16	16
GTTAAGCGTGGTCCGT-1_7_D5	-34.46563286	1.368104626	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1760	3123	0.003842459	0.002881844	5	9	OPC	40	16	16
GTTAAGCGTTATCACG-1_7_D5	4.835568428	14.73358148	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1067	1863	0.012345679	0.016639828	5	oligos	OL-Cntl	40	16	16
GTTAAGCTCAGGCGAA-1_7_D5	-29.04710776	-3.592287805	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1529	2721	0.006982727	0.008820287	5	9	OPC	40	16	16
GTTAAGCTCTCAAGTG-1_7_D5	12.7298759	-6.863345471	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2256	4893	0.00286123	0.004700593	5	3	EN-L5-6	40	16	16
GTTAAGCTCTGAGGGA-1_7_D5	-0.789085921	-19.14673119	10	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3129	7308	0.00862069	0.002463054	5	L2-3	EN-L2-3-Cntl	40	16	16
GTTAAGCTCTGCAAGT-1_7_D5	5.999300253	-21.95206858	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	6647	23834	0.007678107	0.005370479	5	L2-3	EN-L2-3-MS	40	16	16
GTTACAGAGATGCCAG-1_7_D5	-33.86578339	-5.376066456	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1140	1786	0.002239642	0.006718925	5	9	OPC	40	16	16
GTTACAGAGGCTATCT-1_7_D5	4.85675978	-23.30984491	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	5524	20106	0.007908087	0.003978912	5	L2-3	EN-L2-3-MS	40	16	16
GTTACAGAGTATCTCG-1_7_D5	-23.63551875	-18.71578579	6B	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2961	6144	0.006347656	0.018880208	5	6B	IN-SST	40	16	16
GTTACAGCAAAGGAAG-1_7_D5	-2.700962269	14.59013418	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	771	1072	0.006529851	0.031716418	5	oligos	OL-Cntl	40	16	16
GTTACAGCATATGCTG-1_7_D5	7.148416811	11.37973255	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1131	1764	0.017573696	0.011904762	5	oligos	OL-Cntl	40	16	16
GTTACAGGTACTTCTT-1_7_D5	9.535240698	13.0371699	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1167	1973	0.001013685	0.009123163	5	oligos	OL-Cntl	40	16	16
GTTACAGTCAAGCCTA-1_7_D5	8.391638725	-17.57096412	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	5216	14327	0.010609339	0.01912473	5	L2-3	EN-L2-3-MS	40	16	16
GTTACAGTCCACGTTC-1_7_D5	4.321353987	9.374428586	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1124	1913	0.008886566	0.023523262	5	oligos	OL-Cntl	40	16	16
GTTCATTAGGTTACCT-1_7_D5	10.02572579	19.78215744	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	910	1467	0.003408316	0.006134969	5	oligos	OL-Cntl	40	16	16
GTTCATTCAATCTGCA-1_7_D5	30.84791785	15.45823926	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	893	1218	0.013136289	0.095238095	5	14	Microglia	40	16	16
GTTCATTGTCTTGATG-1_7_D5	32.33120863	15.45678728	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	938	1309	0.011459129	0.064935065	5	14	Microglia	40	16	16
GTTCATTGTTACGGAG-1_7_D5	0.022423846	25.31358695	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	684	1011	0.011869436	0.008902077	5	oligos	OL-Cntl	40	16	16
GTTCATTTCGGCTTGG-1_7_D5	-22.01106611	25.2286596	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1674	2880	0.006597222	0.005902778	5	8	Astrocytes	40	16	16
GTTCGGGAGGCGTACA-1_7_D5	5.666895158	33.80206219	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	926	1598	0.019399249	0.009386733	5	oligos	OL-Cntl	40	16	16
GTTCGGGCAAGTTCTG-1_7_D5	14.29178039	8.339904596	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1668	2894	0.00414651	0.008984105	5	oligos	OL-Cntl	40	16	16
GTTCGGGCATGGTCTA-1_7_D5	-25.25777036	23.50615375	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1544	3062	0.002939255	0.003919007	5	8	Astrocytes	40	16	16
GTTCGGGGTCTCCATC-1_7_D5	11.84134333	12.40649401	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1240	2107	0.007119127	0.006644518	5	oligos	OL-Cntl	40	16	16
GTTCGGGGTTCCGGCA-1_7_D5	-20.21738574	26.36411007	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2012	3981	0.004521477	0.007284602	5	8	Astrocytes	40	16	16
GTTCGGGTCTAGCACA-1_7_D5	-18.94454432	29.11512656	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2593	5731	0.000523469	0.006630605	5	8	Astrocytes	40	16	16
GTTCTCGAGAAAGTGG-1_7_D5	15.62773463	15.58069623	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1134	1930	0.003108808	0.006735751	5	oligos	OL-Cntl	40	16	16
GTTCTCGAGTAGGTGC-1_7_D5	8.338682252	11.77787951	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1231	2086	0.002876318	0.014381592	5	oligos	OL-Cntl	40	16	16
GTTCTCGAGTCGTTTG-1_7_D5	12.51586682	-6.534894383	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1953	3990	0.021303258	0.003258145	5	3	EN-L5-6	40	16	16
GTTCTCGCAACGCACC-1_7_D5	-34.57106748	0.876500704	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1707	2953	0.001354555	0.006772773	5	9	OPC	40	16	16
GTTCTCGTCCTGTAGA-1_7_D5	-34.28226214	0.500785866	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1697	2962	0.005401756	0.005401756	5	9	OPC	40	16	16
GTTTCTACACCCATGG-1_7_D5	-20.54814063	26.50987368	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1871	3988	0.000250752	0.006018054	5	8	Astrocytes	40	16	16
GTTTCTACACGGCGTT-1_7_D5	35.40842088	-7.076918703	2	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4038	9481	0.01002004	0.006539395	5	2	EN-L4	40	16	16
GTTTCTACATTGTGCA-1_7_D5	8.187236613	14.69533379	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1042	1634	0.00244798	0.005507956	5	oligos	OL-Cntl	40	16	16
GTTTCTAGTAAACACA-1_7_D5	19.4158115	-26.25364546	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2927	6512	0.013206388	0.005528256	5	3	EN-L5-6	40	16	16
GTTTCTAGTAATCACC-1_7_D5	-25.00430921	24.83665072	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1533	3092	0.010996119	0.008408797	5	8	Astrocytes	40	16	16
GTTTCTATCTTGTATC-1_7_D5	33.11350211	-7.100033579	2	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4783	13183	0.012136843	0.008268224	5	2	EN-L4	40	16	16
TAAACCGAGAGCCCAA-1_7_D5	-1.924653893	14.08921691	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	764	1115	0.003587444	0.025112108	5	oligos	OL-Cntl	40	16	16
TAAACCGAGGGCTCTC-1_7_D5	18.57877415	20.21159718	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	985	1649	0.009096422	0.003638569	5	oligos	OL-Cntl	40	16	16
TAAACCGCAAGGTTTC-1_7_D5	13.72459714	-27.5567716	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2636	5645	0.014526129	0.004960142	5	3	EN-L5-6	40	16	16
TAAACCGCAATCACAC-1_7_D5	32.18848474	14.65340312	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	916	1311	0.00228833	0.088482075	5	14	Microglia	40	16	16
TAAACCGCATGAACCT-1_7_D5	38.17980212	12.57177632	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	920	1284	0.004672897	0.017912773	5	14	Microglia	40	16	16
TAAACCGGTACCGTAT-1_7_D5	11.63727755	29.56396359	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	720	1077	0.008356546	0.004642526	5	oligos	OL-Cntl	40	16	16
TAAACCGGTCAAAGCG-1_7_D5	10.46893985	22.78121981	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	983	1655	0.004229607	0.004833837	5	oligos	OL-Cntl	40	16	16
TAAACCGGTTTGGCGC-1_7_D5	4.517642795	-22.55737898	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	6120	22518	0.000888178	0.004130029	5	L2-3	EN-L2-3-MS	40	16	16
TAAACCGTCACGCGGT-1_7_D5	30.48922022	14.80241922	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	816	1152	0.005208333	0.118055556	5	14	Microglia	40	16	16
TAAGAGATCTGAGGGA-1_7_D5	6.137871372	19.13123864	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	930	1424	0.005617978	0.013342697	5	oligos	OL-Cntl	40	16	16
TAAGCGTAGAGAACAG-1_7_D5	7.186932785	-19.95690356	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	5268	15105	0.003376365	0.009864283	5	L2-3	EN-L2-3-MS	40	16	16
TAAGCGTGTGTCGCTG-1_7_D5	33.1721622	-5.751449557	2	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3845	9104	0.017904218	0.006480668	5	2	EN-L4	40	16	16
TAAGCGTTCATGTCTT-1_7_D5	-17.87623771	-10.38438755	13B	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4156	11034	0.001993837	0.006706543	5	13B	IN-SV2C	40	16	16
TAAGTGCAGGTGCTTT-1_7_D5	5.067545423	11.29445862	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1220	1966	0.006612411	0.014750763	5	oligos	OL-Cntl	40	16	16
TAAGTGCGTAGGACAC-1_7_D5	-15.57437803	-16.4358254	6B	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1859	3627	0.030328095	0.005514199	5	6B	IN-SST	40	16	16
TAAGTGCTCAATACCG-1_7_D5	-32.62895614	-9.233285859	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	902	1377	0.013071895	0.005083515	5	9	OPC	40	16	16
TAAGTGCTCTTGACGA-1_7_D5	-23.88310262	0.741115671	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2611	5213	0.006330328	0.006522156	5	9	OPC	40	16	16
TACACGAAGCACAGGT-1_7_D5	1.511340078	13.65306275	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	960	1433	0.005582694	0.018841591	5	oligos	OL-Cntl	40	16	16
TACACGAGTCAGAAGC-1_7_D5	-33.55783257	1.466374615	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1846	3326	0.006915213	0.006915213	5	9	OPC	40	16	16
TACAGTGAGCGATAGC-1_7_D5	-19.43752313	28.92218897	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2251	4900	0.003673469	0.011836735	5	8	Astrocytes	40	16	16
TACAGTGAGGTGCAAC-1_7_D5	-36.17165694	-3.061907451	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1307	2062	0.006789525	0.004364694	5	9	OPC	40	16	16
TACAGTGAGTGTACGG-1_7_D5	-1.685234289	21.16920166	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	717	1085	0.015668203	0.010138249	5	oligos	OL-Cntl	40	16	16
TACAGTGAGTGTCCAT-1_7_D5	11.40540986	-13.87859418	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4669	10735	0.010433163	0.021425245	5	L2-3	EN-L2-3-MS	40	16	16
TACAGTGAGTTACGGG-1_7_D5	34.50317897	15.51333526	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1074	1470	0.001360544	0.036734694	5	14	Microglia	40	16	16
TACAGTGCAGGTCGTC-1_7_D5	-30.91466054	2.177114383	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2082	3698	0.005949162	0.006219578	5	9	OPC	40	16	16
TACAGTGCATGATCCA-1_7_D5	11.92076371	-5.538448823	12	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1473	2649	0.035107588	0.003020008	5	12	EN-MIX	40	16	16
TACAGTGGTGATGTGG-1_7_D5	-18.67534027	29.16712217	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2650	5625	0.006933333	0.007466667	5	8	Astrocytes	40	16	16
TACAGTGTCACCTTAT-1_7_D5	-19.55446898	28.6960013	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2226	4444	0.003375338	0.005625563	5	8	Astrocytes	40	16	16
TACAGTGTCCCAAGTA-1_7_D5	1.861452618	18.01266988	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	883	1427	0	0.012613875	5	oligos	OL-Cntl	40	16	16
TACCTATAGAGGTAGA-1_7_D5	36.35733734	11.77552882	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	892	1148	0.004355401	0.015679443	5	14	Microglia	40	16	16
TACCTATCACAACTGT-1_7_D5	38.33615482	9.868322417	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	769	1062	0.007532957	0.005649718	5	14	Microglia	40	16	16
TACCTATCATAGAAAC-1_7_D5	-27.54865321	9.84527691	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	761	1180	0.001694915	0.005084746	5	8	Astrocytes	40	16	16
TACCTATCATTCACTT-1_7_D5	-33.75822342	3.140007441	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2155	4147	0.002411382	0.006269592	5	9	OPC	40	16	16
TACCTATGTCCGTGAC-1_7_D5	11.34398407	7.554901334	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1635	2701	0.002961866	0.017400963	5	oligos	OL-Cntl	40	16	16
TACCTTAAGAAGGTGA-1_7_D5	2.843238123	20.12099624	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	759	1096	0.006386861	0.011861314	5	oligos	OL-Cntl	40	16	16
TACCTTAAGCCGCCTA-1_7_D5	10.28475383	29.70109139	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	713	1088	0	0.006433824	5	oligos	OL-Cntl	40	16	16
TACCTTAAGGTCGGAT-1_7_D5	-18.14590579	29.2938777	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2485	4879	0.004714081	0.017626563	5	8	Astrocytes	40	16	16
TACCTTAAGTGCGTGA-1_7_D5	1.396861334	14.67224375	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	913	1276	0.011755486	0.017241379	5	oligos	OL-Cntl	40	16	16
TACCTTAAGTGGAGTC-1_7_D5	-36.25518933	0.693710117	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1646	3081	0.00227199	0.003894839	5	9	OPC	40	16	16
TACCTTACACTGCCAG-1_7_D5	-36.78631445	1.456088461	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1703	2937	0	0.00102145	5	9	OPC	40	16	16
TACCTTAGTGCACGAA-1_7_D5	-34.32478763	3.222753905	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2177	4466	0.00335871	0.00447828	5	9	OPC	40	16	16
TACCTTATCATCGCTC-1_7_D5	11.89048942	-5.580323608	12	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1310	2393	0.015879649	0.005014626	5	12	EN-MIX	40	16	16
TACCTTATCCACGCAG-1_7_D5	8.990714384	9.993329931	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1280	2378	0.005046257	0.010513036	5	oligos	OL-Cntl	40	16	16
TACCTTATCCCGACTT-1_7_D5	-14.83754414	1.855452805	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4378	10521	0.011500808	0.00902956	5	13A	IN-VIP	40	16	16
TACCTTATCTCCAACC-1_7_D5	-15.0225741	1.631751235	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4254	10111	0.009989121	0.012263871	5	13A	IN-VIP	40	16	16
TACCTTATCTCTTGAT-1_7_D5	8.923780873	9.903942551	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1205	2076	0.010597303	0.01300578	5	oligos	OL-Cntl	40	16	16
TACGGATGTCTGCAAT-1_7_D5	-36.5657769	2.24316936	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1791	3326	0.004509922	0.003307276	5	9	OPC	40	16	16
TACGGATTCGAGAACG-1_7_D5	12.94012073	-7.200989742	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3069	7797	0.004745415	0.005258433	5	3	EN-L5-6	40	16	16
TACGGATTCTTGAGAC-1_7_D5	-17.51681741	-6.312905632	13B	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2935	5767	0.027917461	0.006242414	5	13B	IN-SV2C	40	16	16
TACGGGCAGAAGGGTA-1_7_D5	-31.48690089	2.346081939	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2122	3894	0.005906523	0.005392912	5	9	OPC	40	16	16
TACGGGCAGCCACGCT-1_7_D5	-12.70844887	-19.55084124	6B	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1163	2002	0.048951049	0.001498501	5	6B	IN-SST	40	16	16
TACGGGCGTAGGACAC-1_7_D5	-15.73243879	0.610057229	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3312	6684	0.013913824	0.015559545	5	13A	IN-VIP	40	16	16
TACGGGCGTCTAGCCG-1_7_D5	-3.228393036	19.14273698	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	816	1136	0.007042254	0.01584507	5	oligos	OL-Cntl	40	16	16
TACGGGCGTTATCACG-1_7_D5	35.65627132	13.79873185	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1070	1504	0.001994681	0.01462766	5	14	Microglia	40	16	16
TACGGGCTCACCGGGT-1_7_D5	13.70456821	9.301562455	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1501	2518	0.002382844	0.009928515	5	oligos	OL-Cntl	40	16	16
TACGGGCTCGAGAGCA-1_7_D5	32.9782184	-4.331436589	2	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2812	5736	0.008891213	0.005753138	5	2	EN-L4	40	16	16
TACGGTAAGCTTTGGT-1_7_D5	-3.17467198	17.1626244	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	817	1151	0.002606429	0.015638575	5	oligos	OL-Cntl	40	16	16
TACGGTAAGGCAGTCA-1_7_D5	-33.43139299	1.496680908	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1941	3394	0.000294638	0.007071302	5	9	OPC	40	16	16
TACGGTAAGTTAGCGG-1_7_D5	8.722841099	10.52307092	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1211	2130	0.004225352	0.01314554	5	oligos	OL-Cntl	40	16	16
TACGGTACAAGAAAGG-1_7_D5	5.953866316	-1.729349757	12	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	962	1419	0.00845666	0.011980268	5	12	EN-MIX	40	16	16
TACGGTAGTAGATTAG-1_7_D5	12.45462004	5.870337413	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2688	5457	0.013194063	0.02308961	5	oligos	OL-Cntl	40	16	16
TACGGTAGTGAGGGAG-1_7_D5	-0.185933036	16.08757045	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	816	1214	0.009884679	0.020593081	5	oligos	OL-Cntl	40	16	16
TACTCATAGGGATACC-1_7_D5	11.64708327	-5.199894868	12	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1034	1659	0.022905365	0.004822182	5	12	EN-MIX	40	16	16
TACTCATCACCACGTG-1_7_D5	11.88656133	-5.496375743	12	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1326	2527	0.039968342	0.002374357	5	12	EN-MIX	40	16	16
TACTCATCACCGAAAG-1_7_D5	19.19660373	-25.52501375	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4091	10805	0.007774179	0.006848681	5	3	EN-L5-6	40	16	16
TACTCATCAGCCAATT-1_7_D5	35.36787767	15.50082394	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1082	1573	0.001271456	0.03051494	5	14	Microglia	40	16	16
TACTCATCATGCCTAA-1_7_D5	-4.212924217	14.29692972	5	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	853	1231	0.009748172	0.017059301	5	oligos	OL-MS-1	40	16	16
TACTCATGTACAGACG-1_7_D5	9.326071694	15.74303032	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	976	1460	0.004109589	0.015068493	5	oligos	OL-Cntl	40	16	16
TACTCATGTAGAGGAA-1_7_D5	30.49259934	14.76143907	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	860	1244	0.006430868	0.106109325	5	14	Microglia	40	16	16
TACTCATTCCGTCATC-1_7_D5	12.57083638	-6.622747207	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2050	4417	0.003622368	0.004301562	5	3	EN-L5-6	40	16	16
TACTCATTCTGCTTGC-1_7_D5	0.317653273	20.85560154	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	751	1083	0.014773777	0.008310249	5	oligos	OL-Cntl	40	16	16
TACTCGCAGACTTGAA-1_7_D5	8.068502804	-18.14647509	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4644	12399	0.006694088	0.01645294	5	L2-3	EN-L2-3-MS	40	16	16
TACTCGCCAATCGGTT-1_7_D5	33.1407322	14.74533689	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	808	1053	0.006647673	0.02374169	5	14	Microglia	40	16	16
TACTCGCGTCTGGTCG-1_7_D5	11.55126661	7.462407823	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1489	2483	0.007652034	0.010068466	5	oligos	OL-Cntl	40	16	16
TACTCGCGTTACGTCA-1_7_D5	4.275674231	10.18618901	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1223	1963	0.008660214	0.025980642	5	oligos	OL-Cntl	40	16	16
TACTCGCGTTAGGGTG-1_7_D5	4.723501539	12.09390346	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1022	1612	0.003101737	0.015508685	5	oligos	OL-Cntl	40	16	16
TACTCGCTCTCATTCA-1_7_D5	12.62642129	28.92373955	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	802	1229	0.001627339	0.002441009	5	oligos	OL-Cntl	40	16	16
TACTCGCTCTCTGTCG-1_7_D5	12.57518674	8.721020025	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1652	2981	0.003354579	0.011741027	5	oligos	OL-Cntl	40	16	16
TACTTACAGACTTTCG-1_7_D5	12.26267161	11.88989901	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1218	2010	0.006965174	0.006467662	5	oligos	OL-Cntl	40	16	16
TACTTACAGGATGCGT-1_7_D5	-28.10216743	22.98749939	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1369	2360	0.002542373	0.004661017	5	8	Astrocytes	40	16	16
TACTTACAGTCGATAA-1_7_D5	14.86742498	-20.38419007	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	8428	33648	0.013076557	0.011947218	5	L2-3	EN-L2-3-MS	40	16	16
TACTTACAGTTTAGGA-1_7_D5	12.60677088	-6.672360647	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2108	4368	0.003891941	0.00206044	5	3	EN-L5-6	40	16	16
TACTTACCAAAGCAAT-1_7_D5	24.87292046	-28.97798028	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3922	11909	0.035099505	0.002603073	5	3	EN-L5-6	40	16	16
TACTTACCAAGTCTAC-1_7_D5	20.151554	-29.28166498	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	5423	18004	0.005998667	0.004943346	5	3	EN-L5-6	40	16	16
TACTTACGTACCGTAT-1_7_D5	16.11468516	7.665674321	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1998	3737	0.004013915	0.006957453	5	oligos	OL-Cntl	40	16	16
TACTTACGTACCTACA-1_7_D5	11.71054395	18.71277574	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1041	1753	0	0.009697661	5	oligos	OL-Cntl	40	16	16
TACTTACGTCCAGTAT-1_7_D5	-33.67702618	4.923444029	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2666	5389	0.002597885	0.003525701	5	9	OPC	40	16	16
TACTTACGTTAAGGGC-1_7_D5	6.817509648	-20.26482919	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4138	10436	0.004791108	0.012552702	5	L2-3	EN-L2-3-MS	40	16	16
TACTTACTCGCCATAA-1_7_D5	11.28845754	18.48113599	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1036	1644	0.005474453	0.011557178	5	oligos	OL-Cntl	40	16	16
TACTTGTCAAGGCTCC-1_7_D5	11.16293265	25.44310969	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	717	1077	0	0.004642526	5	oligos	OL-Cntl	40	16	16
TACTTGTGTCTGCGGT-1_7_D5	6.397285723	12.44401854	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1058	1685	0.00652819	0.012462908	5	oligos	OL-Cntl	40	16	16
TACTTGTGTGACCAAG-1_7_D5	-31.65054235	0.891468152	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1941	3479	0.002299511	0.005461339	5	9	OPC	40	16	16
TACTTGTGTTCCCTTG-1_7_D5	18.42940072	14.89970567	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1144	1835	0.005449591	0.004904632	5	oligos	OL-Cntl	40	16	16
TAGACCAAGACTTGAA-1_7_D5	6.127241811	-21.56477063	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	6059	19750	0.00521519	0.005113924	5	L2-3	EN-L2-3-MS	40	16	16
TAGACCAAGATACACA-1_7_D5	12.95711979	8.747300201	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1530	2461	0.014221861	0.012596505	5	oligos	OL-Cntl	40	16	16
TAGACCAAGGCGACAT-1_7_D5	22.96273793	16.32090225	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1357	2154	0.008356546	0.010213556	5	oligos	OL-Cntl	40	16	16
TAGACCAAGTCCTCCT-1_7_D5	-1.214057936	-0.192453611	11	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2126	3896	0.008983573	0.003336756	5	11	Glia-MIX	40	16	16
TAGACCACACCGCTAG-1_7_D5	5.623527066	-27.15278174	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4494	11094	0.007211105	0.008923743	5	L2-3	EN-L2-3-MS	40	16	16
TAGACCATCCATGCTC-1_7_D5	5.471622848	15.18778691	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1099	1847	0.002165674	0.01082837	5	oligos	OL-Cntl	40	16	16
TAGACCATCTGGTGTA-1_7_D5	5.394398853	-11.38045445	12	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1873	3095	0.002584814	0.011954766	5	12	EN-MIX	40	16	16
TAGAGCTAGCGTTCCG-1_7_D5	-29.17337264	12.56150794	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	795	1311	0.000762777	0.003051106	5	8	Astrocytes	40	16	16
TAGAGCTGTGAACCTT-1_7_D5	-3.05253884	14.71592568	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	776	1094	0.000914077	0.018281536	5	oligos	OL-Cntl	40	16	16
TAGAGCTTCACATGCA-1_7_D5	-31.15117796	-11.88698454	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	962	1587	0.003780718	0.005671078	5	9	OPC	40	16	16
TAGAGCTTCTGGTATG-1_7_D5	32.59336024	-7.149007154	2	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	6009	19647	0.008550924	0.006209599	5	2	EN-L4	40	16	16
TAGCCGGAGCTAAGAT-1_7_D5	-36.59704994	-8.791492067	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1009	1675	0.004179104	0.00358209	5	9	OPC	40	16	16
TAGCCGGGTCAGAGGT-1_7_D5	-32.68367914	2.742191766	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1971	3711	0.003503099	0.008353544	5	9	OPC	40	16	16
TAGCCGGGTCTAAACC-1_7_D5	-15.63683396	1.874101365	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4302	10578	0.006522972	0.011344299	5	13A	IN-VIP	40	16	16
TAGGCATAGGCTAGAC-1_7_D5	-16.99951684	-19.31789383	6B	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1944	3792	0.012130802	0.004483122	5	6B	IN-SST	40	16	16
TAGGCATCACCAGTTA-1_7_D5	33.05532603	14.78867535	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	823	1082	0.001848429	0.03142329	5	14	Microglia	40	16	16
TAGGCATCAGGTGGAT-1_7_D5	14.82682564	8.890511118	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1572	2714	0.002210759	0.008843036	5	oligos	OL-Cntl	40	16	16
TAGGCATCAGTCAGCC-1_7_D5	-0.865196414	18.2400622	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	810	1207	0.004142502	0.007456504	5	oligos	OL-Cntl	40	16	16
TAGGCATCATCACCCT-1_7_D5	-35.83353162	4.301959129	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2212	4939	0.003644462	0.002632112	5	9	OPC	40	16	16
TAGGCATGTAACGCGA-1_7_D5	32.00991035	15.36068547	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	916	1252	0.00399361	0.076677316	5	14	Microglia	40	16	16
TAGGCATGTAAGTGGC-1_7_D5	36.11602374	11.04262223	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	821	1129	0.020372011	0.020372011	5	14	Microglia	40	16	16
TAGGCATGTACTTGAC-1_7_D5	-20.12451784	25.91960417	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2228	4364	0.002062328	0.004353804	5	8	Astrocytes	40	16	16
TAGGCATGTGCACTTA-1_7_D5	8.331322258	-17.6161271	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4596	11773	0.007984371	0.020810329	5	L2-3	EN-L2-3-MS	40	16	16
TAGGCATTCCTCGCAT-1_7_D5	8.866724513	13.98910654	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1031	1764	0.004535147	0.010204082	5	oligos	OL-Cntl	40	16	16
TAGGCATTCGTATCAG-1_7_D5	38.86124052	10.56519831	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	847	1179	0	0.006785411	5	14	Microglia	40	16	16
TAGTGGTAGTCGTACT-1_7_D5	10.76069123	26.37949446	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	876	1355	0.011070111	0.004428044	5	oligos	OL-Cntl	40	16	16
TAGTGGTCAGAAGCAC-1_7_D5	1.22669039	19.84730613	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	863	1223	0.003270646	0.014717907	5	oligos	OL-Cntl	40	16	16
TAGTGGTGTCATTAGC-1_7_D5	13.70840531	-29.38975212	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3741	9645	0.006013478	0.003836185	5	3	EN-L5-6	40	16	16
TAGTGGTTCCCTGACT-1_7_D5	-35.85595362	0.073826478	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1519	2684	0.004470939	0.003353204	5	9	OPC	40	16	16
TAGTGGTTCTGTCTAT-1_7_D5	8.20742423	14.33482654	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1011	1710	0.001754386	0.012280702	5	oligos	OL-Cntl	40	16	16
TAGTGGTTCTTGCATT-1_7_D5	-17.63660958	-6.062158718	13B	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3172	6736	0.018705463	0.009946556	5	13B	IN-SV2C	40	16	16
TAGTTGGAGAGACTTA-1_7_D5	-32.60491672	3.25203263	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2248	4186	0.008361204	0.005016722	5	9	OPC	40	16	16
TAGTTGGAGTGATCGG-1_7_D5	38.87565689	10.2592615	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	860	1184	0.001689189	0.017736486	5	14	Microglia	40	16	16
TAGTTGGCAACTTGAC-1_7_D5	37.70346199	12.09574523	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1019	1428	0.003501401	0.022408964	5	14	Microglia	40	16	16
TAGTTGGCAGCCTTTC-1_7_D5	-20.42801787	27.81646055	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1866	3522	0.001987507	0.009369676	5	8	Astrocytes	40	16	16
TAGTTGGGTACCGTAT-1_7_D5	-8.951688136	-17.89177831	6B	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	698	1063	0.028222013	0.005644403	5	6B	IN-SST	40	16	16
TAGTTGGGTCAGTGGA-1_7_D5	-32.95705175	2.899815719	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2122	3940	0.003553299	0.00786802	5	9	OPC	40	16	16
TAGTTGGTCATCACCC-1_7_D5	9.680026533	9.93976023	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1331	2229	0.003140422	0.01345895	5	oligos	OL-Cntl	40	16	16
TAGTTGGTCGAACTGT-1_7_D5	-3.7639858	24.96960596	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	813	1247	0.012830794	0.005613472	5	oligos	OL-Cntl	40	16	16
TAGTTGGTCGTTTATC-1_7_D5	-34.6128017	0.863029912	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1736	3051	0.003277614	0.008194035	5	9	OPC	40	16	16
TAGTTGGTCTCCCTGA-1_7_D5	8.165681886	-20.1782111	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	6163	21337	0.006420771	0.009420256	5	L2-3	EN-L2-3-MS	40	16	16
TATCAGGGTGGTAACG-1_7_D5	25.35250111	-29.2126672	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	5107	18861	0.000742272	0.002120778	5	3	EN-L5-6	40	16	16
TATCTCACAATAGCGG-1_7_D5	32.4096803	15.85912972	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1133	1621	0.008019741	0.05490438	5	14	Microglia	40	16	16
TATCTCACACTTAACG-1_7_D5	14.7081094	13.73572829	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1201	2074	0.006750241	0.0024108	5	oligos	OL-Cntl	40	16	16
TATCTCAGTAGCAAAT-1_7_D5	13.63096709	-29.80795324	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4740	15148	0.001452337	0.004819118	5	3	EN-L5-6	40	16	16
TATCTCAGTAGCTCCG-1_7_D5	9.294715717	21.94083417	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	800	1218	0.000821018	0.010673235	5	oligos	OL-Cntl	40	16	16
TATCTCAGTCTCGTTC-1_7_D5	9.566639292	11.83988381	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1202	2049	0.006344558	0.011713031	5	oligos	OL-Cntl	40	16	16
TATCTCAGTCTTCGTC-1_7_D5	13.43846185	-30.45887484	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3915	11848	0.001603646	0.001856853	5	3	EN-L5-6	40	16	16
TATCTCAGTTCCCGAG-1_7_D5	-6.920441356	-5.516076744	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1381	2338	0.007698888	0.003849444	5	13A	IN-VIP	40	16	16
TATCTCATCCTGCAGG-1_7_D5	2.710626584	13.97959832	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1082	1753	0.006274957	0.015972618	5	oligos	OL-Cntl	40	16	16
TATGCCCCACAACTGT-1_7_D5	14.43038587	-29.78699999	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	5088	16186	0.008278759	0.003768689	5	3	EN-L5-6	40	16	16
TATGCCCCATTAGCCA-1_7_D5	-20.67580032	-24.80770628	6A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3618	9139	0.107998687	0.00284495	5	6A	IN-PV	40	16	16
TATGCCCTCCTAGAAC-1_7_D5	12.05102304	7.946453799	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1657	2931	0.009553054	0.012282497	5	oligos	OL-Cntl	40	16	16
TATTACCAGGGTCTCC-1_7_D5	38.54488239	13.30456536	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1063	1539	0.001299545	0.010396361	5	14	Microglia	40	16	16
TATTACCAGGTTACCT-1_7_D5	10.89012637	25.56124088	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	845	1271	0.009441385	0.005507474	5	oligos	OL-Cntl	40	16	16
TATTACCAGTACGTTC-1_7_D5	9.850322777	8.49150322	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1450	2616	0.002675841	0.01146789	5	oligos	OL-Cntl	40	16	16
TATTACCAGTCAATAG-1_7_D5	35.86045397	-7.828705607	2	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	5374	14915	0.004223936	0.006436473	5	2	EN-L4	40	16	16
TATTACCCAAGCCATT-1_7_D5	12.25219986	9.548356811	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1452	2445	0.007361963	0.012678937	5	oligos	OL-Cntl	40	16	16
TATTACCCATTGCGGC-1_7_D5	-25.53301616	23.2074045	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1480	2810	0.004270463	0.003202847	5	8	Astrocytes	40	16	16
TATTACCGTCATGCAT-1_7_D5	13.93365325	9.045218248	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1524	2770	0.009747292	0.007581227	5	oligos	OL-Cntl	40	16	16
TATTACCTCCAAGCCG-1_7_D5	13.71382208	12.59772229	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1307	2341	0.001708672	0.006834686	5	oligos	OL-Cntl	40	16	16
TATTACCTCCCAACGG-1_7_D5	-17.18352565	1.280768946	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4070	9582	0.009392611	0.01554999	5	13A	IN-VIP	40	16	16
TATTACCTCCTACAGA-1_7_D5	7.168190444	-18.59438168	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4767	13545	0.004429679	0.013362865	5	L2-3	EN-L2-3-MS	40	16	16
TATTACCTCGAGAGCA-1_7_D5	-3.260324431	14.21028773	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	718	1071	0.005602241	0.02334267	5	oligos	OL-Cntl	40	16	16
TATTACCTCGCGTTTC-1_7_D5	35.69868598	11.74314843	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	961	1314	0.00152207	0.014459665	5	14	Microglia	40	16	16
TCAACGAAGGGTCGAT-1_7_D5	4.902744224	10.16487526	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1488	2318	0.004314064	0.016393443	5	oligos	OL-Cntl	40	16	16
TCAACGACACTGCCAG-1_7_D5	10.04691617	13.72946	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1166	1961	0.00254972	0.00917899	5	oligos	OL-Cntl	40	16	16
TCAACGAGTCACCTAA-1_7_D5	-1.578124282	14.91096219	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	734	1072	0.01119403	0.029850746	5	oligos	OL-Cntl	40	16	16
TCAACGATCACAACGT-1_7_D5	-1.371362181	0.815052951	11	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4922	13568	0.015551297	0.008475825	5	11	Glia-MIX	40	16	16
TCAATCTCACGAAACG-1_7_D5	19.33470396	22.05407861	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1028	1626	0.00799508	0.004920049	5	oligos	OL-Cntl	40	16	16
TCAATCTGTGCATCTA-1_7_D5	-35.383112	0.427505308	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1635	2933	0.001363791	0.003750426	5	9	OPC	40	16	16
TCAATCTTCAGCTGGC-1_7_D5	0.876735427	16.11303085	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	896	1309	0.006875477	0.012223071	5	oligos	OL-Cntl	40	16	16
TCAATCTTCAGTTAGC-1_7_D5	5.084150814	-17.44521503	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2806	5447	0.008445016	0.01835873	5	L2-3	EN-L2-3-MS	40	16	16
TCAATCTTCTTAGAGC-1_7_D5	3.270113577	-24.05472696	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4696	12328	0.008598313	0.012086308	5	L2-3	EN-L2-3-MS	40	16	16
TCACAAGAGAGGGATA-1_7_D5	19.81388215	-29.6988816	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	8139	34923	0.007244509	0.002748905	5	3	EN-L5-6	40	16	16
TCACAAGCAGCGATCC-1_7_D5	12.63428285	11.24305551	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1477	2504	0.000798722	0.010782748	5	oligos	OL-Cntl	40	16	16
TCACAAGCATCCCATC-1_7_D5	-31.55398536	2.561974814	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2211	4198	0.003096713	0.004764173	5	9	OPC	40	16	16
TCACAAGCATGGGAAC-1_7_D5	-2.741233767	13.23797923	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	859	1175	0.007659574	0.020425532	5	oligos	OL-Cntl	40	16	16
TCACAAGGTACAGACG-1_7_D5	1.884185754	20.43093152	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	809	1202	0.013311148	0.009983361	5	oligos	OL-Cntl	40	16	16
TCACAAGTCACGAAGG-1_7_D5	-33.93089838	1.84159995	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1816	3320	0.003012048	0.006927711	5	9	OPC	40	16	16
TCACAAGTCGGCCGAT-1_7_D5	37.22715581	11.12905272	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	818	1112	0.000899281	0.020683453	5	14	Microglia	40	16	16
TCACGAAAGAGACGAA-1_7_D5	12.95313385	-7.223969555	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3161	7749	0.016905407	0.002064783	5	3	EN-L5-6	40	16	16
TCACGAAGTCTGGAGA-1_7_D5	-9.714964612	22.72388706	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1458	2151	0.0013947	0.012552301	5	14	Microglia	40	16	16
TCACGAAGTTGAACTC-1_7_D5	-34.65650176	-8.407271064	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1012	1560	0.001923077	0.003846154	5	9	OPC	40	16	16
TCACGAATCCGGCACA-1_7_D5	2.289353048	19.54605514	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	809	1151	0.013900956	0.004344049	5	oligos	OL-Cntl	40	16	16
TCACGAATCGAATCCA-1_7_D5	-0.952846141	-0.378058912	11	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1779	2844	0.03164557	0.005274262	5	11	Glia-MIX	40	16	16
TCACGAATCGCCAGCA-1_7_D5	-2.044774098	13.88441025	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	795	1168	0.017123288	0.025684932	5	oligos	OL-Cntl	40	16	16
TCACGAATCGGCGCAT-1_7_D5	6.045925744	-18.35733382	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3593	7739	0.013309213	0.011758625	5	L2-3	EN-L2-3-MS	40	16	16
TCAGATGAGCGCCTCA-1_7_D5	1.93741366	19.47980728	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	843	1263	0.013460016	0.007917656	5	oligos	OL-Cntl	40	16	16
TCAGATGCAAGACACG-1_7_D5	10.78210224	14.67901849	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1137	1929	0.014515293	0.00777605	5	oligos	OL-Cntl	40	16	16
TCAGATGGTGCAACTT-1_7_D5	12.51361288	11.43813895	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1323	2146	0.002795899	0.009785648	5	oligos	OL-Cntl	40	16	16
TCAGATGTCATGCATG-1_7_D5	14.36620036	8.355975993	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1736	3204	0.00093633	0.013732834	5	oligos	OL-Cntl	40	16	16
TCAGATGTCCACTGGG-1_7_D5	8.320383094	10.15596831	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1148	1921	0.008328995	0.017178553	5	oligos	OL-Cntl	40	16	16
TCAGATGTCGTACCGG-1_7_D5	35.85449142	-10.74611016	2	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	5468	15442	0.012368864	0.009001425	5	2	EN-L4	40	16	16
TCAGATGTCTCCCTGA-1_7_D5	-19.44261888	27.85013759	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2208	4616	0.00194974	0.005415945	5	8	Astrocytes	40	16	16
TCAGCAAAGAGTCTGG-1_7_D5	1.331245888	15.78768938	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	953	1402	0.002853067	0.017118402	5	oligos	OL-Cntl	40	16	16
TCAGCAAAGGTGTTAA-1_7_D5	11.86430951	-5.530599554	12	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1277	2295	0.012200436	0.003050109	5	12	EN-MIX	40	16	16
TCAGCAAAGTTACGGG-1_7_D5	33.27383047	16.73700535	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1335	2042	0.015181195	0.043584721	5	14	Microglia	40	16	16
TCAGCAACATTGTGCA-1_7_D5	13.82544688	9.179388901	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1679	2932	0.002387449	0.01159618	5	oligos	OL-Cntl	40	16	16
TCAGCAAGTCATATGC-1_7_D5	11.4503034	8.318854099	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1651	2846	0.003162333	0.017568517	5	oligos	OL-Cntl	40	16	16
TCAGCAAGTTAGATGA-1_7_D5	-35.09171549	3.322541405	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2217	4307	0.001625261	0.006036684	5	9	OPC	40	16	16
TCAGCAATCATCTGCC-1_7_D5	10.14629805	12.86260797	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1190	1977	0.011127972	0.012139605	5	oligos	OL-Cntl	40	16	16
TCAGCTCAGCCGATTT-1_7_D5	10.82102956	22.65581993	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	862	1318	0.002276176	0.005311077	5	oligos	OL-Cntl	40	16	16
TCAGCTCAGGGCTCTC-1_7_D5	0.815216579	15.76529249	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	869	1273	0.004713276	0.014925373	5	oligos	OL-Cntl	40	16	16
TCAGCTCAGGGTATCG-1_7_D5	13.99531775	-23.88035798	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	5706	18754	0.011464221	0.009704596	5	L2-3	EN-L2-3-MS	40	16	16
TCAGCTCGTCAATACC-1_7_D5	-32.67173642	-8.370163148	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1140	1765	0.004532578	0.009631728	5	9	OPC	40	16	16
TCAGCTCTCACTCCTG-1_7_D5	-16.3743572	-18.97106909	6B	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2025	4167	0.023038157	0.000719942	5	6B	IN-SST	40	16	16
TCAGCTCTCATTCACT-1_7_D5	38.49007454	13.25110985	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1043	1506	0.006640106	0.009296149	5	14	Microglia	40	16	16
TCAGCTCTCATTGCGA-1_7_D5	11.51609551	9.243069356	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1404	2531	0.003160806	0.016594232	5	oligos	OL-Cntl	40	16	16
TCAGCTCTCCAATGGT-1_7_D5	21.22602588	-27.79926806	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3025	7121	0.001966016	0.004072462	5	3	EN-L5-6	40	16	16
TCAGCTCTCCGTACAA-1_7_D5	-20.75871931	30.20287704	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2443	5267	0.001898614	0.006265426	5	8	Astrocytes	40	16	16
TCAGCTCTCGGCATCG-1_7_D5	3.13624863	14.3739211	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1064	1625	0.008	0.012307692	5	oligos	OL-Cntl	40	16	16
TCAGGATAGAGAACAG-1_7_D5	-0.288434763	18.66357787	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	782	1099	0.007279345	0.011828935	5	oligos	OL-Cntl	40	16	16
TCAGGATAGGACGAAA-1_7_D5	2.550329852	4.666594608	7	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	780	1071	0.005602241	0.003734827	5	7	Phagocytes	40	16	16
TCAGGATCATGTTGAC-1_7_D5	26.8806907	4.361108311	15DA	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	812	1087	0.009199632	0.033118675	5	15DA	T cells	40	16	16
TCAGGATGTAGGCATG-1_7_D5	-2.820821754	22.61157442	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	738	1062	0.009416196	0.010357815	5	oligos	OL-Cntl	40	16	16
TCAGGATGTATAGTAG-1_7_D5	10.77763891	8.94762673	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1370	2228	0.002692998	0.013464991	5	oligos	OL-Cntl	40	16	16
TCAGGATGTGTTTGGT-1_7_D5	19.61783544	-25.60703734	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3737	9461	0.002325336	0.006341824	5	3	EN-L5-6	40	16	16
TCAGGTAAGAGTAATC-1_7_D5	35.1154873	-8.930000799	2	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	6873	21306	0.006805595	0.013939735	5	2	EN-L4	40	16	16
TCAGGTACAGTCAGAG-1_7_D5	10.78662678	9.851492916	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1380	2169	0.007376671	0.019824804	5	oligos	OL-Cntl	40	16	16
TCAGGTACATCGGAAG-1_7_D5	-24.2959971	-24.51578904	6A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4489	10603	0.024709988	0.012166368	5	6A	IN-PV	40	16	16
TCAGGTAGTGAACCTT-1_7_D5	3.403314327	30.31720592	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	778	1115	0.020627803	0.004484305	5	oligos	OL-Cntl	40	16	16
TCAGGTAGTGTGGTTT-1_7_D5	2.297050172	20.71343438	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	881	1340	0.014925373	0.009701493	5	oligos	OL-Cntl	40	16	16
TCATTACAGCGTAATA-1_7_D5	9.276071615	11.23423411	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1115	1768	0.006221719	0.013574661	5	oligos	OL-Cntl	40	16	16
TCATTACAGGAGCGAG-1_7_D5	20.95432194	-5.642381702	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2437	5627	0.20170606	0.003732006	5	3	EN-L5-6	40	16	16
TCATTACCACCTTGTC-1_7_D5	0.10352723	16.3744138	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	888	1399	0.012866333	0.013581129	5	oligos	OL-Cntl	40	16	16
TCATTACCATATACCG-1_7_D5	14.08662749	10.24239659	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1611	2796	0.001788269	0.008583691	5	oligos	OL-Cntl	40	16	16
TCATTACGTCTGGAGA-1_7_D5	-20.69559211	9.223970384	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	965	1686	0.002965599	0.003558719	5	8	Astrocytes	40	16	16
TCATTACGTTCCACTC-1_7_D5	24.9244815	-29.04351105	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3716	10778	0.017257376	0.003154574	5	3	EN-L5-6	40	16	16
TCATTACGTTCTGAAC-1_7_D5	-20.61259568	28.43167676	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2151	4203	0.000713776	0.006186058	5	8	Astrocytes	40	16	16
TCATTACTCTTTACGT-1_7_D5	-36.64839662	-1.479261528	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1451	2774	0.004325883	0.001081471	5	9	OPC	40	16	16
TCATTTGAGCAGATCG-1_7_D5	34.01568922	-8.410630203	2	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	5164	13208	0.014990915	0.007495457	5	2	EN-L4	40	16	16
TCATTTGCACTCAGGC-1_7_D5	-2.618131668	17.35404438	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	771	1180	0.005932203	0.011864407	5	oligos	OL-Cntl	40	16	16
TCATTTGGTCGCCATG-1_7_D5	-16.08670192	14.43010352	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1830	3790	0.001055409	0.003430079	5	8	Astrocytes	40	16	16
TCATTTGTCGTAGATC-1_7_D5	37.55252249	15.09791807	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1180	1672	0.003588517	0.016746411	5	14	Microglia	40	16	16
TCCACACCAACACCTA-1_7_D5	-19.96191043	30.57118046	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3128	7774	0.001029071	0.006817597	5	8	Astrocytes	40	16	16
TCCACACCACTACAGT-1_7_D5	36.86683514	12.72017527	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	968	1397	0.002863278	0.024337867	5	14	Microglia	40	16	16
TCCACACGTTTGGGCC-1_7_D5	12.52018034	-6.531279631	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1983	4550	0.00989011	0.003076923	5	3	EN-L5-6	40	16	16
TCCACACTCAAACCAC-1_7_D5	-34.18381379	1.56110157	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1947	3695	0.007307172	0.007577808	5	9	OPC	40	16	16
TCCACACTCAAACCGT-1_7_D5	12.09658872	18.99300631	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	974	1466	0.000682128	0.007503411	5	oligos	OL-Cntl	40	16	16
TCCACACTCGTCTGCT-1_7_D5	4.655344136	9.975619452	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1627	3085	0.14165316	0.016531605	5	oligos	OL-Cntl	40	16	16
TCCCGATAGACGCTTT-1_7_D5	-34.38147801	3.530626951	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2137	4280	0.000934579	0.005373832	5	9	OPC	40	16	16
TCCCGATAGATCGATA-1_7_D5	-6.762802115	-1.031073754	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1704	2951	0.019654354	0.001355473	5	13A	IN-VIP	40	16	16
TCCCGATGTACTTAGC-1_7_D5	0.149459267	13.80953536	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	950	1318	0.005311077	0.016691958	5	oligos	OL-Cntl	40	16	16
TCCCGATGTCTAAAGA-1_7_D5	-32.29248627	2.575481002	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1948	3534	0.001980758	0.005942275	5	9	OPC	40	16	16
TCCCGATTCCGCTGTT-1_7_D5	19.59183754	21.83232821	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1079	1810	0.010497238	0.002762431	5	oligos	OL-Cntl	40	16	16
TCGAGGCAGTGACTCT-1_7_D5	36.78674405	12.68544572	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	926	1207	0.001657001	0.023198012	5	14	Microglia	40	16	16
TCGAGGCCAAAGTGCG-1_7_D5	10.60762772	9.701516676	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1328	2089	0.004786979	0.016754428	5	oligos	OL-Cntl	40	16	16
TCGAGGCCACAAGACG-1_7_D5	24.25564512	-11.50029546	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	5200	15265	0.011595152	0.005633803	5	3	EN-L5-6	40	16	16
TCGAGGCCACGTGAGA-1_7_D5	-10.89975071	0.957740608	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2837	6476	0.006022236	0.00293391	5	13A	IN-VIP	40	16	16
TCGAGGCGTACTTAGC-1_7_D5	6.348886019	10.94529942	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1376	2362	0.010584251	0.020321761	5	oligos	OL-Cntl	40	16	16
TCGAGGCGTCTCTTTA-1_7_D5	8.340031843	-3.019926305	12	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1692	2902	0.003445899	0.025499655	5	12	EN-MIX	40	16	16
TCGAGGCTCACCACCT-1_7_D5	-0.186789009	19.54029053	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	752	1155	0.005194805	0.01038961	5	oligos	OL-Cntl	40	16	16
TCGAGGCTCCTTGACC-1_7_D5	32.7572924	16.69273286	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1332	1998	0.004504505	0.058058058	5	14	Microglia	40	16	16
TCGCGAGAGACTTGAA-1_7_D5	-24.40828204	16.53048779	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1539	2700	0.004444444	0.008888889	5	8	Astrocytes	40	16	16
TCGCGAGAGCACCGTC-1_7_D5	10.17111159	7.68704034	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1445	2295	0.006535948	0.016122004	5	oligos	OL-Cntl	40	16	16
TCGCGAGGTAGCGTGA-1_7_D5	8.469742846	31.94027974	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	757	1127	0.007098492	0.001774623	5	oligos	OL-Cntl	40	16	16
TCGCGAGGTCATATGC-1_7_D5	-1.225261082	14.76809682	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	816	1227	0.008149959	0.024449878	5	oligos	OL-Cntl	40	16	16
TCGCGAGTCAGAAATG-1_7_D5	-3.030999748	15.95922185	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	733	1057	0.011352886	0.015137181	5	oligos	OL-Cntl	40	16	16
TCGCGAGTCCCAGGTG-1_7_D5	8.595243955	-12.65973307	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2613	4587	0.005450185	0.02528886	5	L2-3	EN-L2-3-MS	40	16	16
TCGCGTTAGGCATGTG-1_7_D5	3.970617798	10.81483888	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1111	1709	0.006436513	0.019894675	5	oligos	OL-Cntl	40	16	16
TCGCGTTCACCTGGTG-1_7_D5	13.08635791	7.067950455	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1742	3044	0.008869908	0.012483574	5	oligos	OL-Cntl	40	16	16
TCGCGTTCAGATGGGT-1_7_D5	-19.12038614	25.50763242	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1746	3412	0.002344666	0.007033998	5	8	Astrocytes	40	16	16
TCGCGTTGTCTGCAAT-1_7_D5	11.86068015	6.331860286	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1900	3684	0.007871878	0.022258415	5	oligos	OL-Cntl	40	16	16
TCGCGTTTCCTATTCA-1_7_D5	-1.583157152	16.91999664	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	721	1076	0.002788104	0.018587361	5	oligos	OL-Cntl	40	16	16
TCGCGTTTCGCGATCG-1_7_D5	8.353181531	-17.59116971	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	5321	14350	0.009268293	0.021324042	5	L2-3	EN-L2-3-MS	40	16	16
TCGCGTTTCGGTCCGA-1_7_D5	14.05034854	13.69010425	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1111	1888	0.002648305	0.007944915	5	oligos	OL-Cntl	40	16	16
TCGGGACAGCCATCGC-1_7_D5	-3.091565196	14.0229387	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	790	1080	0.005555556	0.026851852	5	oligos	OL-Cntl	40	16	16
TCGGGACAGCCTTGAT-1_7_D5	-1.130698702	0.874910537	11	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2739	5502	0.021810251	0.010178117	5	11	Glia-MIX	40	16	16
TCGGGACAGTTAACGA-1_7_D5	-25.24311899	11.49575715	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	952	1366	0.008784773	0.002928258	5	8	Astrocytes	40	16	16
TCGGGACCAACACCCG-1_7_D5	5.929526838	15.73295394	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1025	1633	0.014084507	0.006123699	5	oligos	OL-Cntl	40	16	16
TCGGGACCACACTGCG-1_7_D5	20.01580916	8.945311486	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1787	3284	0.002131547	0.005176614	5	oligos	OL-Cntl	40	16	16
TCGGGACCAGGTTTCA-1_7_D5	-34.0824331	-8.056636312	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1137	1759	0.003411029	0.006822058	5	9	OPC	40	16	16
TCGGGACCATTCCTCG-1_7_D5	-34.97061197	-1.062039848	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1466	2418	0.004135649	0.005789909	5	9	OPC	40	16	16
TCGGGACGTAGCCTCG-1_7_D5	-9.647143608	13.5058504	11	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1180	1726	0.002896871	0.013904983	5	11	Glia-MIX	40	16	16
TCGGGACGTTCGGCAC-1_7_D5	12.78403846	-6.947535043	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2356	5220	0.013218391	0.003831418	5	3	EN-L5-6	40	16	16
TCGGTAAAGACTTTCG-1_7_D5	9.552367351	14.39107349	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1076	1736	0.002880184	0.012096774	5	oligos	OL-Cntl	40	16	16
TCGGTAACAACTGGCC-1_7_D5	-32.15008793	3.243038753	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2378	4473	0.001117818	0.004918399	5	9	OPC	40	16	16
TCGGTAACATAGACTC-1_7_D5	1.828059612	18.47623119	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	874	1232	0.012987013	0.010551948	5	oligos	OL-Cntl	40	16	16
TCGGTAAGTTGTCGCG-1_7_D5	9.020103057	12.10259419	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1218	1936	0.015495868	0.005681818	5	oligos	OL-Cntl	40	16	16
TCGGTAATCAGGCAAG-1_7_D5	0.740737578	12.44333802	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1001	1523	0.003282994	0.019697965	5	oligos	OL-Cntl	40	16	16
TCGGTAATCAGTGCAT-1_7_D5	12.29038357	10.97262337	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1411	2422	0.001238646	0.016515277	5	oligos	OL-Cntl	40	16	16
TCGTACCAGCACGCCT-1_7_D5	12.3415542	9.795726365	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1389	2378	0.001682086	0.010092515	5	oligos	OL-Cntl	40	16	16
TCGTACCAGGGATGGG-1_7_D5	-23.17046979	18.7956989	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1502	2994	0	0.004342017	5	8	Astrocytes	40	16	16
TCGTACCTCTCACATT-1_7_D5	-3.376371674	13.22732942	5	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	795	1132	0.003533569	0.024734982	5	oligos	OL-MS-1	40	16	16
TCGTACCTCTTCATGT-1_7_D5	-14.00189452	1.829811161	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3810	8742	0.009151224	0.009265614	5	13A	IN-VIP	40	16	16
TCGTAGAAGACAAAGG-1_7_D5	12.87147591	-30.65426982	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2578	6184	0.017302717	0.003072445	5	3	EN-L5-6	40	16	16
TCGTAGAAGATGTGGC-1_7_D5	4.113053706	16.09867768	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	887	1281	0.003903201	0.008587041	5	oligos	OL-Cntl	40	16	16
TCGTAGAAGCGCCTTG-1_7_D5	32.48633982	-5.198706864	2	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3420	7916	0.021475493	0.007579586	5	2	EN-L4	40	16	16
TCGTAGAAGTCCAGGA-1_7_D5	10.07679264	20.05424322	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	956	1542	0.006485084	0.009079118	5	oligos	OL-Cntl	40	16	16
TCGTAGACAGAAGCAC-1_7_D5	2.566437324	12.85386366	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	963	1467	0.000681663	0.014314928	5	oligos	OL-Cntl	40	16	16
TCGTAGACATATACCG-1_7_D5	24.2510626	-29.2316788	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3340	9265	0.002266595	0.00280626	5	3	EN-L5-6	40	16	16
TCGTAGAGTAGCACGA-1_7_D5	0.319357907	-0.411814862	6B	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	838	1271	0.070023603	0.002360346	5	6B	IN-SST	40	16	16
TCGTAGAGTCTCTTTA-1_7_D5	9.550937352	13.37861322	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1223	1977	0.006069803	0.011127972	5	oligos	OL-Cntl	40	16	16
TCTATTGAGGTCATCT-1_7_D5	-2.794653402	17.17630077	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	724	1018	0.009823183	0.008840864	5	oligos	OL-Cntl	40	16	16
TCTATTGAGGTGCTTT-1_7_D5	-16.16753358	2.190679953	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4730	12048	0.010541169	0.012948207	5	13A	IN-VIP	40	16	16
TCTATTGTCGGCTTGG-1_7_D5	17.28830969	20.2804226	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	948	1506	0.003320053	0.002656042	5	oligos	OL-Cntl	40	16	16
TCTATTGTCTGGTATG-1_7_D5	-2.185050901	14.87770363	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	717	1025	0.011707317	0.011707317	5	oligos	OL-Cntl	40	16	16
TCTCATAGTCAGCTAT-1_7_D5	31.54414801	16.03710942	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1038	1485	0.005387205	0.101010101	5	14	Microglia	40	16	16
TCTCATAGTGTCTGAT-1_7_D5	-21.16563175	9.214335091	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	913	1557	0.003211304	0.003211304	5	8	Astrocytes	40	16	16
TCTCATATCATTGCGA-1_7_D5	2.112628316	12.61766166	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	794	1084	0.014760148	0.014760148	5	oligos	OL-Cntl	40	16	16
TCTCATATCGTACGGC-1_7_D5	9.295791424	28.71104741	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	818	1326	0.012066365	0.002262443	5	oligos	OL-Cntl	40	16	16
TCTCTAAAGAGACTTA-1_7_D5	2.038221345	13.52685369	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	969	1518	0.013175231	0.015151515	5	oligos	OL-Cntl	40	16	16
TCTCTAAAGCTAGCCC-1_7_D5	-35.9296423	-0.709957647	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1481	2659	0.001880406	0.00300865	5	9	OPC	40	16	16
TCTCTAAAGTAACCCT-1_7_D5	8.15296986	10.83471654	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1078	1629	0.000613874	0.025168815	5	oligos	OL-Cntl	40	16	16
TCTCTAAAGTGAACGC-1_7_D5	37.64569163	10.42794538	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	833	1133	0.002647838	0.01059135	5	14	Microglia	40	16	16
TCTCTAACAATCCGAT-1_7_D5	-19.94095592	29.32361936	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2290	5203	0.00057659	0.008841053	5	8	Astrocytes	40	16	16
TCTCTAACACTTAACG-1_7_D5	17.5577265	-6.14586631	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1848	3156	0.00792142	0.006653992	5	3	EN-L5-6	40	16	16
TCTCTAAGTTGATTGC-1_7_D5	-31.80056233	1.163905094	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1792	3062	0.002612671	0.004245591	5	9	OPC	40	16	16
TCTCTAAGTTTGTTTC-1_7_D5	-15.82558663	-19.00934136	6B	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2015	4249	0.044481054	0.002353495	5	6B	IN-SST	40	16	16
TCTGAGAAGGCATGGT-1_7_D5	-1.111478079	14.80365911	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	777	1047	0.005730659	0.022922636	5	oligos	OL-Cntl	40	16	16
TCTGAGAAGTGTGGCA-1_7_D5	-34.27465278	1.544118301	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1751	2830	0.002826855	0.00565371	5	9	OPC	40	16	16
TCTGAGACAAGCGATG-1_7_D5	-0.898677564	15.46696143	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	744	1125	0.013333333	0.016	5	oligos	OL-Cntl	40	16	16
TCTGAGAGTGTTCTTT-1_7_D5	-34.7124824	2.17344751	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1973	3581	0.003071768	0.004188774	5	9	OPC	40	16	16
TCTGAGATCACTTCAT-1_7_D5	8.243314172	13.06413729	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1018	1584	0.009469697	0.015782828	5	oligos	OL-Cntl	40	16	16
TCTGAGATCCTTGGTC-1_7_D5	-33.86603059	4.309607373	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2398	4582	0.003491925	0.005456133	5	9	OPC	40	16	16
TCTGAGATCGCTTAGA-1_7_D5	10.56989068	18.99370752	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	959	1444	0.004847645	0.008310249	5	oligos	OL-Cntl	40	16	16
TCTGAGATCGTGGTCG-1_7_D5	11.90139958	-5.584793267	12	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1414	2591	0.033191818	0.003087611	5	12	EN-MIX	40	16	16
TCTGAGATCTTCCTTC-1_7_D5	-1.783084573	18.19091247	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	826	1234	0.0089141	0.007293355	5	oligos	OL-Cntl	40	16	16
TCTGGAAAGCTGAAAT-1_7_D5	22.31087799	-1.580587586	2	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2100	3647	0.010967919	0.008774335	5	2	EN-L4	40	16	16
TCTGGAAAGGCGACAT-1_7_D5	36.52509687	12.03375409	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	975	1343	0.005212211	0.021593448	5	14	Microglia	40	16	16
TCTGGAAAGTTAGGTA-1_7_D5	-30.40075543	10.69123744	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	790	1189	0.006728343	0.007569386	5	8	Astrocytes	40	16	16
TCTGGAACACGAAGCA-1_7_D5	35.71342477	-11.31982549	2	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	5320	15040	0.013630319	0.01662234	5	2	EN-L4	40	16	16
TCTGGAACAGACAGGT-1_7_D5	13.57908835	-29.72571985	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3618	9432	0.009329941	0.003816794	5	3	EN-L5-6	40	16	16
TCTGGAACAGTCTTCC-1_7_D5	3.438120206	-17.03574819	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2914	6313	0.010454617	0.006019325	5	L2-3	EN-L2-3-MS	40	16	16
TCTGGAAGTAAGGGCT-1_7_D5	38.70195007	13.14995042	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1058	1517	0.007251154	0.007251154	5	14	Microglia	40	16	16
TCTGGAAGTAGCGCTC-1_7_D5	8.687592818	10.99586128	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1286	1960	0.01122449	0.010714286	5	oligos	OL-Cntl	40	16	16
TCTGGAAGTCTTCGTC-1_7_D5	-24.48427154	15.7158387	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1408	2656	0.011671687	0.009036145	5	8	Astrocytes	40	16	16
TCTTCGGAGACTAGGC-1_7_D5	-32.40722219	1.667607712	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1994	3477	0.006327294	0.008052919	5	9	OPC	40	16	16
TCTTCGGAGCAATCTC-1_7_D5	12.11930775	11.83308111	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1369	2311	0.005192557	0.003461705	5	oligos	OL-Cntl	40	16	16
TCTTCGGCAGCCTTGG-1_7_D5	-4.475056148	-8.570131847	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	707	1253	0.171588188	0.003192338	5	13A	IN-VIP	40	16	16
TCTTCGGCATCCTTGC-1_7_D5	-33.8234777	-9.415420633	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	982	1485	0.012794613	0.007407407	5	9	OPC	40	16	16
TCTTTCCCAGCCTTGG-1_7_D5	12.80454867	14.37877808	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1188	2038	0.006378803	0.006378803	5	oligos	OL-Cntl	40	16	16
TCTTTCCCATCTACGA-1_7_D5	5.383742882	11.22630808	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1285	1965	0.010687023	0.01221374	5	oligos	OL-Cntl	40	16	16
TCTTTCCGTAAGTGGC-1_7_D5	-34.39985838	3.425877513	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2186	4473	0.004471272	0.006259781	5	9	OPC	40	16	16
TCTTTCCGTACAGACG-1_7_D5	34.39293354	15.22853851	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	837	1200	0.003333333	0.04	5	14	Microglia	40	16	16
TCTTTCCGTAGTGAAT-1_7_D5	9.45723477	15.9128562	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	951	1567	0.002552648	0.007019783	5	oligos	OL-Cntl	40	16	16
TCTTTCCGTGACTACT-1_7_D5	-35.94002848	3.608460498	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2025	4044	0.00074184	0.002967359	5	9	OPC	40	16	16
TCTTTCCGTGTCCTCT-1_7_D5	34.46837332	15.19410381	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1023	1415	0.000706714	0.03180212	5	14	Microglia	40	16	16
TCTTTCCTCACAATGC-1_7_D5	-14.41703166	-7.163515146	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3451	8400	0.013928571	0.004047619	5	13A	IN-VIP	40	16	16
TGAAAGAAGACACTAA-1_7_D5	15.19428631	12.86063748	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1294	2080	0.004326923	0.011538462	5	oligos	OL-Cntl	40	16	16
TGAAAGAAGACGCAAC-1_7_D5	19.48853113	-27.41132708	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3169	7485	0.004275217	0.004008016	5	3	EN-L5-6	40	16	16
TGAAAGAAGATGAGAG-1_7_D5	10.44378527	12.65123586	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1143	1892	0.007928118	0.013742072	5	oligos	OL-Cntl	40	16	16
TGAAAGAAGTTCCACA-1_7_D5	-34.61018486	1.481048903	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1974	3624	0.002759382	0.00607064	5	9	OPC	40	16	16
TGAAAGACACATGGGA-1_7_D5	20.09456235	8.955495808	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1781	3176	0.006297229	0.003778338	5	oligos	OL-Cntl	40	16	16
TGAAAGACATTAGGCT-1_7_D5	17.52289123	7.099412915	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2294	4780	0.001882845	0.011715481	5	oligos	OL-Cntl	40	16	16
TGAAAGAGTAATTGGA-1_7_D5	30.49769511	16.0111979	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1086	1723	0.000580383	0.137550784	5	14	Microglia	40	16	16
TGAAAGAGTCGAAAGC-1_7_D5	11.40410814	-4.965396106	12	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	942	1422	0.012658228	0.004922644	5	12	EN-MIX	40	16	16
TGAAAGAGTTACCAGT-1_7_D5	-19.20284503	19.48083755	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1712	3349	0.002388773	0.010152284	5	8	Astrocytes	40	16	16
TGAAAGATCGTCTGAA-1_7_D5	-33.68097494	-3.954892458	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1405	2228	0.002244165	0.003590664	5	9	OPC	40	16	16
TGAAAGATCTGCTTGC-1_7_D5	-26.30250131	13.90730076	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	990	1588	0.001889169	0.013224181	5	8	Astrocytes	40	16	16
TGACAACAGTACGACG-1_7_D5	19.67033071	10.48193834	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1780	3342	0.002692998	0.00598444	5	oligos	OL-Cntl	40	16	16
TGACAACCAACACCCG-1_7_D5	30.6523388	15.02414534	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	812	1123	0.006233304	0.119323241	5	14	Microglia	40	16	16
TGACAACCACCGAAAG-1_7_D5	35.5282964	15.37810558	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1110	1524	0.002624672	0.022965879	5	14	Microglia	40	16	16
TGACAACGTTCTCATT-1_7_D5	3.191210348	-24.15494951	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	5444	16915	0.001005025	0.00880875	5	L2-3	EN-L2-3-MS	40	16	16
TGACAACTCACCGGGT-1_7_D5	-34.58599124	2.693587338	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2037	3979	0.003769791	0.004775069	5	9	OPC	40	16	16
TGACAACTCGACGGAA-1_7_D5	-31.11485385	1.611578445	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1862	3169	0.012306721	0.006942253	5	9	OPC	40	16	16
TGACAACTCGGCATCG-1_7_D5	-20.20818124	27.78360207	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2128	4277	0.001636661	0.008183306	5	8	Astrocytes	40	16	16
TGACGGCAGTAGATGT-1_7_D5	-5.240603962	12.96665304	5	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	761	1050	0.022857143	0.027619048	5	oligos	OL-MS-1	40	16	16
TGACGGCCAATCCGAT-1_7_D5	-2.611560827	17.48972902	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	773	1150	0.014782609	0.006956522	5	oligos	OL-Cntl	40	16	16
TGACGGCGTAACGCGA-1_7_D5	1.732317668	14.20205988	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	979	1515	0.009240924	0.018481848	5	oligos	OL-Cntl	40	16	16
TGACGGCGTACCGTAT-1_7_D5	36.02827492	13.45537291	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1105	1550	0.000645161	0.012903226	5	14	Microglia	40	16	16
TGACGGCTCCTTTCTC-1_7_D5	37.79743715	14.74679798	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1161	1718	0.011059371	0.015715949	5	14	Microglia	40	16	16
TGACGGCTCGTCTGCT-1_7_D5	-39.01968619	-1.308469771	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1492	2840	0.001056338	0.002464789	5	9	OPC	40	16	16
TGACGGCTCTTGAGAC-1_7_D5	6.26325856	-1.644686773	12	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	985	1708	0.013466042	0.005269321	5	12	EN-MIX	40	16	16
TGACTAGAGCGTGAGT-1_7_D5	1.990326193	19.30244583	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	928	1237	0.004850445	0.009700889	5	oligos	OL-Cntl	40	16	16
TGACTAGAGTGGACGT-1_7_D5	-0.298040547	22.98462144	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	728	1164	0.00257732	0.017182131	5	oligos	OL-Cntl	40	16	16
TGACTAGCAAGTCTGT-1_7_D5	37.36239958	9.805188185	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	793	1021	0.005876592	0.012732615	5	14	Microglia	40	16	16
TGACTAGGTTCAACCA-1_7_D5	13.51742412	8.063268944	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1572	2600	0.001153846	0.016538462	5	oligos	OL-Cntl	40	16	16
TGACTAGTCACAATGC-1_7_D5	-21.04307087	30.20170624	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2160	4645	0.000861141	0.005166846	5	8	Astrocytes	40	16	16
TGACTAGTCGGTTCGG-1_7_D5	2.624940148	15.19874941	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1018	1638	0.003663004	0.012820513	5	oligos	OL-Cntl	40	16	16
TGACTTTAGGGCTCTC-1_7_D5	9.64723921	-23.22427526	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	5363	15896	0.006731253	0.012959235	5	L2-3	EN-L2-3-MS	40	16	16
TGACTTTCAGGACCCT-1_7_D5	0.056685901	19.21378649	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	781	1137	0.001759015	0.004397537	5	oligos	OL-Cntl	40	16	16
TGACTTTTCTGCGGCA-1_7_D5	-16.20536969	13.29446521	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1335	2452	0.002446982	0.010603589	5	8	Astrocytes	40	16	16
TGAGAGGAGGTGCTTT-1_7_D5	9.299734113	10.87354566	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1302	2208	0.007246377	0.014492754	5	oligos	OL-Cntl	40	16	16
TGAGAGGCACACATGT-1_7_D5	4.655411111	27.41336738	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	817	1210	0.012396694	0.004132231	5	oligos	OL-Cntl	40	16	16
TGAGAGGGTCTCTCTG-1_7_D5	-19.82555419	7.745933307	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	737	1063	0.001881468	0.003762935	5	8	Astrocytes	40	16	16
TGAGAGGGTTCGGGCT-1_7_D5	7.083892907	-18.50439173	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4130	10115	0.004646565	0.014532872	5	L2-3	EN-L2-3-MS	40	16	16
TGAGAGGGTTGGACCC-1_7_D5	-29.49030387	-0.261942425	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1789	2978	0.004365346	0.011417058	5	9	OPC	40	16	16
TGAGAGGTCTCTGCTG-1_7_D5	-26.0808206	19.03320199	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1359	2235	0.000894855	0.003131991	5	8	Astrocytes	40	16	16
TGAGCATAGCCCTAAT-1_7_D5	2.088173502	13.38532715	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1077	1626	0.006765068	0.014760148	5	oligos	OL-Cntl	40	16	16
TGAGCATAGGTCATCT-1_7_D5	-0.025053156	19.08822389	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	824	1215	0.005761317	0.004115226	5	oligos	OL-Cntl	40	16	16
TGAGCATCAACGATGG-1_7_D5	15.83066835	6.154765944	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2020	3663	0.008190008	0.009009009	5	oligos	OL-Cntl	40	16	16
TGAGCATCATACAGCT-1_7_D5	19.15000143	-27.33192343	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3457	8378	0.011219862	0.003580807	5	3	EN-L5-6	40	16	16
TGAGCATCATATACCG-1_7_D5	9.64394227	14.4570372	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1128	1778	0.002249719	0.005624297	5	oligos	OL-Cntl	40	16	16
TGAGCATCATGTTGAC-1_7_D5	-19.29023838	30.29927785	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2789	6225	0.005140562	0.008353414	5	8	Astrocytes	40	16	16
TGAGCATCATTTCACT-1_7_D5	-21.22017598	-16.84665035	6B	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3949	10413	0.011716124	0.005377893	5	6B	IN-SST	40	16	16
TGAGCATGTCTTCTCG-1_7_D5	35.68850911	11.73351181	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	828	1127	0	0.029281278	5	14	Microglia	40	16	16
TGAGCATGTGCCTGCA-1_7_D5	16.33016586	1.762931489	12	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	894	1565	0.166134185	0.001916933	5	12	EN-MIX	40	16	16
TGAGCATTCAGCCTAA-1_7_D5	16.11374706	10.11637974	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1595	2866	0.010118632	0.007676204	5	oligos	OL-Cntl	40	16	16
TGAGCATTCCAAAGTC-1_7_D5	34.35057004	14.80080771	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	914	1250	0.0024	0.0368	5	14	Microglia	40	16	16
TGAGCATTCTCTAAGG-1_7_D5	10.64229045	18.3818122	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	985	1510	0	0.005960265	5	oligos	OL-Cntl	40	16	16
TGAGCCGCACGTCTCT-1_7_D5	-34.61136064	-2.082264003	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1412	2421	0.00165221	0.009913259	5	9	OPC	40	16	16
TGAGCCGCAGTACACT-1_7_D5	3.507203563	9.19602517	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1534	2535	0.003550296	0.029980276	5	oligos	OL-Cntl	40	16	16
TGAGCCGGTACAGACG-1_7_D5	7.12567708	17.2958337	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	923	1426	0.007713885	0.008415147	5	oligos	OL-Cntl	40	16	16
TGAGCCGGTACTCGCG-1_7_D5	0.807372152	15.69676485	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	992	1573	0.004450095	0.013986014	5	oligos	OL-Cntl	40	16	16
TGAGCCGGTCTAGCCG-1_7_D5	5.319918488	14.8978554	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1003	1564	0.00831202	0.007033248	5	oligos	OL-Cntl	40	16	16
TGAGCCGTCAAACCAC-1_7_D5	12.70149717	13.41732253	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1274	2292	0.006544503	0.008726003	5	oligos	OL-Cntl	40	16	16
TGAGCCGTCATAGCAC-1_7_D5	9.44261103	15.94042656	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1027	1690	0.00591716	0.013017751	5	oligos	OL-Cntl	40	16	16
TGAGGGAAGAACAACT-1_7_D5	3.112718758	19.55138567	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	883	1208	0.002483444	0.014072848	5	oligos	OL-Cntl	40	16	16
TGAGGGAAGCCACTAT-1_7_D5	11.1592339	7.887320936	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1528	2460	0.023577236	0.012195122	5	oligos	OL-Cntl	40	16	16
TGAGGGAAGGGTCTCC-1_7_D5	-30.40908119	11.01927631	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	796	1174	0.005110733	0.005962521	5	8	Astrocytes	40	16	16
TGAGGGAGTATGAAAC-1_7_D5	17.36224755	-29.61609413	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	6678	24865	0.003780414	0.004986929	5	3	EN-L5-6	40	16	16
TGAGGGAGTCCGAACC-1_7_D5	-4.717867957	21.27864381	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	721	1115	0.023318386	0.007174888	5	oligos	OL-Cntl	40	16	16
TGAGGGAGTCTGCGGT-1_7_D5	-2.789140582	17.17145638	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	782	1133	0.004413063	0.013239188	5	oligos	OL-Cntl	40	16	16
TGAGGGAGTGAAATCA-1_7_D5	13.95240368	11.63870815	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1365	2194	0.004557885	0.006381039	5	oligos	OL-Cntl	40	16	16
TGAGGGAGTTTAGGAA-1_7_D5	13.55212733	-29.33453462	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2843	6164	0.005191434	0.004542505	5	3	EN-L5-6	40	16	16
TGAGGGATCAGTTCGA-1_7_D5	-20.29246084	28.66007297	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2398	4975	0.00281407	0.005829146	5	8	Astrocytes	40	16	16
TGAGGGATCTTAGAGC-1_7_D5	2.712619312	11.76171345	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1066	1654	0.007255139	0.013905683	5	oligos	OL-Cntl	40	16	16
TGATTTCAGATCACGG-1_7_D5	1.819086235	13.96956121	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	805	1187	0.00336984	0.02358888	5	oligos	OL-Cntl	40	16	16
TGATTTCAGATGTAAC-1_7_D5	34.29057065	14.51496036	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	889	1267	0.006314128	0.030781373	5	14	Microglia	40	16	16
TGATTTCAGCGATCCC-1_7_D5	9.695825545	10.29922997	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1406	2384	0.007550336	0.006711409	5	oligos	OL-Cntl	40	16	16
TGATTTCCAATCTGCA-1_7_D5	-20.18496191	30.30393073	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2396	5059	0.004546353	0.003755683	5	8	Astrocytes	40	16	16
TGATTTCCACATCCAA-1_7_D5	-4.273794595	14.97760346	5	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	812	1182	0.005922166	0.018612521	5	oligos	OL-MS-1	40	16	16
TGATTTCCATACGCCG-1_7_D5	-32.57332925	3.237064846	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2374	4693	0.003409333	0.004687833	5	9	OPC	40	16	16
TGATTTCCATAGACTC-1_7_D5	19.96235469	21.94547364	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1121	1851	0.007563479	0.003241491	5	oligos	OL-Cntl	40	16	16
TGATTTCGTCGGCATC-1_7_D5	7.619879618	14.49864075	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1012	1615	0.001857585	0.009287926	5	oligos	OL-Cntl	40	16	16
TGATTTCTCACGAAGG-1_7_D5	13.72271925	-29.88764477	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3966	11092	0.006040389	0.004958529	5	3	EN-L5-6	40	16	16
TGCACCTAGCCACGCT-1_7_D5	4.870207002	5.472027778	7	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1932	3103	0.006767644	0.022558814	5	7	Phagocytes	40	16	16
TGCACCTAGGCGTACA-1_7_D5	10.32565385	10.99471515	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1343	2210	0.001357466	0.009049774	5	oligos	OL-Cntl	40	16	16
TGCACCTAGTACACCT-1_7_D5	-16.00036134	1.471316779	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4316	9953	0.007033055	0.010951472	5	13A	IN-VIP	40	16	16
TGCACCTCAAGAGGCT-1_7_D5	12.55904702	14.86961948	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1246	2100	0.002857143	0.013333333	5	oligos	OL-Cntl	40	16	16
TGCACCTTCCAGAGGA-1_7_D5	0.168209773	15.52726832	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	870	1333	0.0060015	0.018004501	5	oligos	OL-Cntl	40	16	16
TGCACCTTCTTACCGC-1_7_D5	-29.61480443	13.07230643	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	764	1193	0.001676446	0.003352892	5	8	Astrocytes	40	16	16
TGCCAAACAAACTGCT-1_7_D5	5.076303322	15.67240287	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	991	1495	0.020735786	0.011371237	5	oligos	OL-Cntl	40	16	16
TGCCAAATCTGTGCAA-1_7_D5	36.81619718	12.23876068	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	896	1254	0.004784689	0.023923445	5	14	Microglia	40	16	16
TGCCCATAGATGTCGG-1_7_D5	-19.88592131	-17.93805212	6A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3721	9600	0.02	0.003541667	5	6A	IN-PV	40	16	16
TGCCCATAGCTAGGCA-1_7_D5	-35.00555876	2.201539307	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1959	3693	0.002707826	0.004061738	5	9	OPC	40	16	16
TGCCCATCACCAGGTC-1_7_D5	-19.30527556	30.27437643	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2834	6119	0.000817127	0.009805524	5	8	Astrocytes	40	16	16
TGCCCATTCCTGTACC-1_7_D5	-32.47550955	3.045113537	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2229	4330	0.004157044	0.003926097	5	9	OPC	40	16	16
TGCCCTAAGGGAAACA-1_7_D5	-32.23104451	-8.905225355	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1051	1547	0.004524887	0.010342599	5	9	OPC	40	16	16
TGCCCTAAGGTGCTAG-1_7_D5	10.78317047	8.24684699	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1518	2480	0.005241935	0.015725806	5	oligos	OL-Cntl	40	16	16
TGCCCTACATTGTGCA-1_7_D5	2.660739173	13.31908354	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	918	1340	0.017910448	0.021641791	5	oligos	OL-Cntl	40	16	16
TGCCCTAGTCCAAGTT-1_7_D5	-7.22550619	-11.56807061	12	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	808	1191	0.04534005	0.008396306	5	12	EN-MIX	40	16	16
TGCCCTAGTCTAGCCG-1_7_D5	-3.399554505	12.16407286	5	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	922	1407	0.005685856	0.034115139	5	oligos	OL-MS-1	40	16	16
TGCCCTAGTTGGGACA-1_7_D5	17.24045979	-26.07894106	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	6357	20997	0.004048197	0.010430061	5	3	EN-L5-6	40	16	16
TGCGCAGAGAAACCTA-1_7_D5	-15.03241574	1.243639877	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3139	5893	0.006957407	0.020532836	5	13A	IN-VIP	40	16	16
TGCGCAGAGATCTGAA-1_7_D5	38.78156122	11.18909826	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	923	1334	0.00149925	0.008995502	5	14	Microglia	40	16	16
TGCGCAGAGCAGACTG-1_7_D5	11.87424954	9.714429772	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1535	2531	0.000790202	0.008297116	5	oligos	OL-Cntl	40	16	16
TGCGCAGAGCGTAATA-1_7_D5	32.56420465	15.69337768	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1094	1637	0.003054368	0.053145999	5	14	Microglia	40	16	16
TGCGCAGAGTTCGCGC-1_7_D5	10.3290269	9.668633189	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1417	2344	0.015358362	0.012798635	5	oligos	OL-Cntl	40	16	16
TGCGCAGCAGTAACGG-1_7_D5	4.872947941	14.97018148	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	962	1335	0.005243446	0.014981273	5	oligos	OL-Cntl	40	16	16
TGCGCAGCATATGAGA-1_7_D5	-7.580862274	9.084423041	5	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	934	1279	0.002345582	0.017200938	5	oligos	OL-MS-1	40	16	16
TGCGCAGGTCACCTAA-1_7_D5	9.869922241	17.25118431	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1087	1698	0.001177856	0.010600707	5	oligos	OL-Cntl	40	16	16
TGCGCAGTCAACCAAC-1_7_D5	-18.30066616	28.30338941	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2471	4771	0.003353595	0.004820792	5	8	Astrocytes	40	16	16
TGCGCAGTCAGAGCTT-1_7_D5	10.64282589	18.55286316	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	962	1578	0.004435995	0.010139417	5	oligos	OL-Cntl	40	16	16
TGCGCAGTCGTGGTCG-1_7_D5	9.243830058	10.73780616	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1273	2101	0.008567349	0.012375059	5	oligos	OL-Cntl	40	16	16
TGCGCAGTCTGCCCTA-1_7_D5	13.19051011	-9.55412393	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3792	9483	0.011599705	0.008225245	5	13A	IN-VIP	40	16	16
TGCGGGTAGAGCTGCA-1_7_D5	6.916960656	-18.88602399	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4070	10054	0.001392481	0.013129103	5	L2-3	EN-L2-3-MS	40	16	16
TGCGGGTCAAAGAATC-1_7_D5	14.41433917	-29.88045238	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	5651	20063	0.006928176	0.003189952	5	3	EN-L5-6	40	16	16
TGCGGGTCAAGAAAGG-1_7_D5	9.29427846	-26.56827199	10	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	7531	29009	0.00351615	0.004481368	5	L2-3	EN-L2-3-Cntl	40	16	16
TGCGGGTCAAGAGGCT-1_7_D5	-24.4584536	18.94154277	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1398	2867	0.00418556	0.003487967	5	8	Astrocytes	40	16	16
TGCGGGTGTAGGAGTC-1_7_D5	12.53435954	-6.532827495	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2150	4360	0.055963303	0.004816514	5	3	EN-L5-6	40	16	16
TGCGGGTTCAACGCTA-1_7_D5	16.63375184	9.500746692	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1672	3030	0.009240924	0.004290429	5	oligos	OL-Cntl	40	16	16
TGCGGGTTCCTCATTA-1_7_D5	9.605712828	13.62108531	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1186	1917	0.008868023	0.007824726	5	oligos	OL-Cntl	40	16	16
TGCGGGTTCTCGGACG-1_7_D5	11.06090072	9.10405681	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1415	2335	0.005567452	0.010706638	5	oligos	OL-Cntl	40	16	16
TGCGGGTTCTGTTTGT-1_7_D5	-1.396132744	18.59877797	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	715	1056	0.006628788	0.006628788	5	oligos	OL-Cntl	40	16	16
TGCGTGGCACCAGCAC-1_7_D5	-36.6679147	-10.51611429	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1042	1685	0.007715134	0.002373887	5	9	OPC	40	16	16
TGCGTGGGTGTTCTTT-1_7_D5	5.727844056	-21.94762201	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	5960	18596	0.003602925	0.005646376	5	L2-3	EN-L2-3-MS	40	16	16
TGCGTGGTCAGAAATG-1_7_D5	12.46039232	-6.446740108	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1804	3280	0.00304878	0.007012195	5	3	EN-L5-6	40	16	16
TGCGTGGTCGTTTAGG-1_7_D5	8.842196049	31.51213854	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	706	1071	0.010270775	0.00280112	5	oligos	OL-Cntl	40	16	16
TGCTACCAGCGCCTTG-1_7_D5	13.38180276	17.23212745	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1089	1713	0.007005254	0.004670169	5	oligos	OL-Cntl	40	16	16
TGCTACCAGCTTCGCG-1_7_D5	12.71620691	7.718336923	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1646	2868	0.006276151	0.010460251	5	oligos	OL-Cntl	40	16	16
TGCTACCCAGGGTATG-1_7_D5	16.70661516	15.05969439	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1202	1977	0.003540718	0.007587253	5	oligos	OL-Cntl	40	16	16
TGCTACCGTAGCTGCC-1_7_D5	7.439361489	25.18257399	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	967	1473	0.002715547	0.003394433	5	oligos	OL-Cntl	40	16	16
TGCTACCGTGTGTGCC-1_7_D5	35.53644228	10.31647978	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	778	1046	0.003824092	0.019120459	5	14	Microglia	40	16	16
TGCTACCTCCGAGCCA-1_7_D5	3.103148888	16.1296163	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	885	1297	0.00616808	0.01156515	5	oligos	OL-Cntl	40	16	16
TGCTACCTCCGCGTTT-1_7_D5	35.21218504	15.44782178	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1237	1761	0.007382169	0.026689381	5	14	Microglia	40	16	16
TGCTACCTCCTAGAAC-1_7_D5	38.43707035	8.739802001	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	807	1046	0.006692161	0.008604207	5	14	Microglia	40	16	16
TGCTACCTCGGATGTT-1_7_D5	4.894277621	12.10330927	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1086	1506	0.012616202	0.017928287	5	oligos	OL-Cntl	40	16	16
TGCTACCTCGTTTGCC-1_7_D5	10.1044687	9.639679618	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1452	2449	0.003674969	0.014291548	5	oligos	OL-Cntl	40	16	16
TGCTGCTCAGACGCTC-1_7_D5	-28.43973613	22.30761578	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1210	2084	0.002879079	0.003358925	5	8	Astrocytes	40	16	16
TGCTGCTGTGTGAATA-1_7_D5	22.62367954	-9.066843006	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2489	5158	0.026560682	0.003877472	5	3	EN-L5-6	40	16	16
TGCTGCTTCCGGGTGT-1_7_D5	8.684441126	31.74947852	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	739	1212	0.012376238	0.002475248	5	oligos	OL-Cntl	40	16	16
TGCTGCTTCGTCTGAA-1_7_D5	-28.12146011	9.760131911	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	752	1009	0.006937562	0.006937562	5	8	Astrocytes	40	16	16
TGGACGCAGCTAGGCA-1_7_D5	12.50737837	-6.521541588	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1944	3841	0.006769071	0.004165582	5	3	EN-L5-6	40	16	16
TGGACGCAGGCCCGTT-1_7_D5	-34.2337056	0.396429128	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1725	3014	0.00597213	0.00464499	5	9	OPC	40	16	16
TGGACGCAGGCTAGCA-1_7_D5	13.37053997	-30.144498	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3631	9653	0.004661763	0.003004247	5	3	EN-L5-6	40	16	16
TGGACGCAGGTAGCCA-1_7_D5	13.2849009	16.97549139	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1160	1843	0.014650027	0.00759631	5	oligos	OL-Cntl	40	16	16
TGGACGCAGTCCGGTC-1_7_D5	33.64104873	15.00053737	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	939	1286	0.00777605	0.048211509	5	14	Microglia	40	16	16
TGGACGCAGTTTCCTT-1_7_D5	-27.46716009	12.1546833	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	853	1262	0.004754358	0.005546751	5	8	Astrocytes	40	16	16
TGGACGCGTTACTGAC-1_7_D5	-2.865023105	17.25469313	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	839	1249	0.007205765	0.008006405	5	oligos	OL-Cntl	40	16	16
TGGCCAGAGACGCTTT-1_7_D5	24.51309741	4.868121092	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2291	4222	0.001421127	0.014211274	5	14	Microglia	40	16	16
TGGCCAGCAAGCTGGA-1_7_D5	15.39330673	14.45595947	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1275	2010	0.009452736	0.007960199	5	oligos	OL-Cntl	40	16	16
TGGCCAGCAAGTCTGT-1_7_D5	10.95746508	11.01964809	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1343	2175	0.008275862	0.009195402	5	oligos	OL-Cntl	40	16	16
TGGCCAGGTAAGTGTA-1_7_D5	8.577122146	13.39937488	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1034	1519	0.005266623	0.012508229	5	oligos	OL-Cntl	40	16	16
TGGCGCAAGTGGCACA-1_7_D5	32.33482319	15.82453653	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1090	1543	0.004536617	0.062216461	5	14	Microglia	40	16	16
TGGCGCACACTGAAGG-1_7_D5	15.32459923	9.004459785	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1531	2749	0.012368134	0.007275373	5	oligos	OL-Cntl	40	16	16
TGGCGCATCGGAGCAA-1_7_D5	-30.46215274	1.565847449	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1945	3307	0.003023889	0.011793166	5	9	OPC	40	16	16
TGGCTGGCAGGAACGT-1_7_D5	8.31776274	8.777517544	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1488	2914	0.00377488	0.007892931	5	oligos	OL-Cntl	40	16	16
TGGCTGGGTCTGCAAT-1_7_D5	0.119829358	16.65736479	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	840	1203	0.004987531	0.014131338	5	oligos	OL-Cntl	40	16	16
TGGCTGGGTGCGAAAC-1_7_D5	-16.38640568	1.57676101	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4289	10225	0.00792176	0.014865526	5	13A	IN-VIP	40	16	16
TGGCTGGGTGGTCTCG-1_7_D5	9.130535925	21.40456259	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	828	1308	0.008409786	0.01146789	5	oligos	OL-Cntl	40	16	16
TGGGAAGCAGGCTGAA-1_7_D5	10.09327691	18.17904572	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	991	1550	0.000645161	0.007741935	5	oligos	OL-Cntl	40	16	16
TGGGAAGCATAGAAAC-1_7_D5	17.44856271	16.32950525	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1136	1889	0.004235045	0.002117522	5	oligos	OL-Cntl	40	16	16
TGGGAAGGTGCACTTA-1_7_D5	31.87210628	-7.583777524	2	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	6521	27414	0.005398701	0.004742103	5	2	EN-L4	40	16	16
TGGGAAGGTGTCCTCT-1_7_D5	-2.57312055	13.77078618	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	879	1296	0.012345679	0.019290123	5	oligos	OL-Cntl	40	16	16
TGGGAAGGTTGTTTGG-1_7_D5	-24.66089732	9.462220469	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1092	1827	0.004926108	0.011494253	5	8	Astrocytes	40	16	16
TGGGAAGTCACTTATC-1_7_D5	3.779026138	-17.12951184	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2726	5531	0.00415838	0.011028747	5	L2-3	EN-L2-3-MS	40	16	16
TGGGAAGTCAGCGATT-1_7_D5	12.97774032	-7.290047987	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3423	8821	0.004194536	0.006688584	5	3	EN-L5-6	40	16	16
TGGGAAGTCGTCACGG-1_7_D5	-1.068091998	15.51656587	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	799	1111	0.00720072	0.01260126	5	oligos	OL-Cntl	40	16	16
TGGGAAGTCTACCAGA-1_7_D5	11.50809469	10.10239205	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1325	2246	0.015583259	0.010240427	5	oligos	OL-Cntl	40	16	16
TGGGAAGTCTTACCGC-1_7_D5	-1.915947457	-12.75518355	10	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1951	3578	0.005030743	0.001397429	5	L2-3	EN-L2-3-Cntl	40	16	16
TGGGCGTCAATAACGA-1_7_D5	0.949720838	19.7843864	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	819	1193	0.013411567	0.009220453	5	oligos	OL-Cntl	40	16	16
TGGGCGTGTCCGACGT-1_7_D5	-20.32993745	26.42886263	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1882	3405	0.005580029	0.005286344	5	8	Astrocytes	40	16	16
TGGGCGTGTGTTGGGA-1_7_D5	36.34817806	12.15396333	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	938	1329	0.017306245	0.027840482	5	14	Microglia	40	16	16
TGGTTAGAGCTGAAAT-1_7_D5	-2.938139095	15.15237496	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	708	1025	0.005853659	0.015609756	5	oligos	OL-Cntl	40	16	16
TGGTTAGCAGACAGGT-1_7_D5	-15.89445838	0.170089152	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3500	6414	0.016994075	0.011537262	5	13A	IN-VIP	40	16	16
TGGTTAGCATAGACTC-1_7_D5	-0.289805064	12.8308005	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	971	1449	0.004830918	0.019323671	5	oligos	OL-Cntl	40	16	16
TGGTTAGGTTGTCGCG-1_7_D5	-3.962520299	14.85450894	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	732	1010	0.007920792	0.016831683	5	oligos	OL-Cntl	40	16	16
TGGTTAGTCAGTTTGG-1_7_D5	12.6723541	-6.778631171	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2257	4585	0.00348964	0.003053435	5	3	EN-L5-6	40	16	16
TGGTTCCAGGATGCGT-1_7_D5	-20.92426148	23.86608082	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1685	3563	0.00954252	0.009823183	5	8	Astrocytes	40	16	16
TGGTTCCAGTAGGTGC-1_7_D5	-24.07366334	19.38761055	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1462	2721	0.002940096	0.010657846	5	8	Astrocytes	40	16	16
TGGTTCCAGTTAGCGG-1_7_D5	1.895812681	17.11154325	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	864	1294	0.00927357	0.011591963	5	oligos	OL-Cntl	40	16	16
TGGTTCCCACGGTAAG-1_7_D5	3.383782008	12.35114802	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	985	1361	0.015429831	0.015429831	5	oligos	OL-Cntl	40	16	16
TGGTTCCTCAGTACGT-1_7_D5	0.052526882	16.00611333	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	842	1330	0.005263158	0.021052632	5	oligos	OL-Cntl	40	16	16
TGGTTCCTCCCTAACC-1_7_D5	11.33678441	8.529132781	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1383	2363	0.005924672	0.012695726	5	oligos	OL-Cntl	40	16	16
TGGTTCCTCCCTCAGT-1_7_D5	-20.34089787	29.13471504	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2122	4354	0.000918695	0.005282499	5	8	Astrocytes	40	16	16
TGTATTCAGAGTAATC-1_7_D5	30.26283235	15.47927752	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1014	1501	0.007328448	0.149233844	5	14	Microglia	40	16	16
TGTATTCAGCCACTAT-1_7_D5	5.126456163	5.630559811	7	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2130	3600	0.013055556	0.0175	5	7	Phagocytes	40	16	16
TGTATTCAGTAGCCGA-1_7_D5	1.648051553	20.38135708	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	762	1104	0.014492754	0.009057971	5	oligos	OL-Cntl	40	16	16
TGTATTCCACGACGAA-1_7_D5	-29.39000429	10.0053362	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	922	1362	0.000734214	0.01174743	5	8	Astrocytes	40	16	16
TGTATTCCACGGCCAT-1_7_D5	9.997361871	13.35231185	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1212	1955	0.006649616	0.010741688	5	oligos	OL-Cntl	40	16	16
TGTATTCTCGTTTATC-1_7_D5	7.017168908	-20.75309841	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4952	14170	0.008115737	0.007904023	5	L2-3	EN-L2-3-MS	40	16	16
TGTCCCAAGAAGAAGC-1_7_D5	-1.501908665	14.42284196	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	862	1263	0.006334125	0.016627078	5	oligos	OL-Cntl	40	16	16
TGTCCCAAGAGGGCTT-1_7_D5	-18.61724232	29.2729316	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2819	5800	0.002586207	0.00637931	5	8	Astrocytes	40	16	16
TGTCCCAAGATCTGCT-1_7_D5	31.38757085	15.05583826	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	749	1002	0.00499002	0.075848303	5	14	Microglia	40	16	16
TGTCCCACAAGTCTAC-1_7_D5	-17.79699097	1.398664573	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	5216	12657	0.012404203	0.018092755	5	13A	IN-VIP	40	16	16
TGTCCCACATACCATG-1_7_D5	15.16369393	-1.812726654	12	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1152	1744	0.005733945	0.001720183	5	12	EN-MIX	40	16	16
TGTCCCACATCACCCT-1_7_D5	16.13241602	9.668027141	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1743	3167	0.002210294	0.009156931	5	oligos	OL-Cntl	40	16	16
TGTCCCAGTGCAGACA-1_7_D5	-0.608193154	13.02677979	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	922	1318	0.006069803	0.024279211	5	oligos	OL-Cntl	40	16	16
TGTCCCAGTTCCGTCT-1_7_D5	4.755232292	15.58227811	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	975	1529	0.006540222	0.007194245	5	oligos	OL-Cntl	40	16	16
TGTCCCATCGGAAACG-1_7_D5	-3.461878709	18.27696873	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	856	1228	0.002442997	0.013843648	5	oligos	OL-Cntl	40	16	16
TGTCCCATCGGCCGAT-1_7_D5	0.649461666	14.84948001	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	871	1416	0.003531073	0.014830508	5	oligos	OL-Cntl	40	16	16
TGTCCCATCTAACCGA-1_7_D5	12.53515787	-6.555517769	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1902	3719	0.009948911	0.002688895	5	3	EN-L5-6	40	16	16
TGTGGTAAGGTGCTTT-1_7_D5	4.619060621	17.28249798	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	939	1448	0.008287293	0.015883978	5	oligos	OL-Cntl	40	16	16
TGTGGTACAAGGTGTG-1_7_D5	4.697249804	5.246167795	7	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1912	3008	0.003989362	0.010305851	5	7	Phagocytes	40	16	16
TGTGGTACACAGACTT-1_7_D5	10.79746145	8.391419503	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1450	2481	0.00362757	0.013301088	5	oligos	OL-Cntl	40	16	16
TGTGGTACAGGGTACA-1_7_D5	12.22928401	20.27700571	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	980	1552	0.011597938	0.003865979	5	oligos	OL-Cntl	40	16	16
TGTGGTACAGTATCTG-1_7_D5	-1.637072024	17.44639637	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	721	1068	0.009363296	0.012172285	5	oligos	OL-Cntl	40	16	16
TGTGGTAGTAAACGCG-1_7_D5	-18.73569173	29.42333041	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2391	5101	0.00901784	0.00940992	5	8	Astrocytes	40	16	16
TGTGGTAGTAGCCTCG-1_7_D5	19.37495989	9.191176414	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1670	3196	0.001564456	0.002503129	5	oligos	OL-Cntl	40	16	16
TGTGGTAGTCGCCATG-1_7_D5	-20.91115001	26.23481459	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1744	3538	0.002826456	0.006500848	5	8	Astrocytes	40	16	16
TGTGGTAGTGTCCTCT-1_7_D5	2.983243253	4.854060085	7	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1052	1368	0.014619883	0.024122807	5	7	Phagocytes	40	16	16
TGTGGTATCCTTTCGG-1_7_D5	11.94693615	-5.648380529	12	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1392	2561	0.010933229	0.002733307	5	12	EN-MIX	40	16	16
TGTGGTATCGCCTGAG-1_7_D5	8.323425527	-16.88589422	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3699	7253	0.007169447	0.027988419	5	L2-3	EN-L2-3-MS	40	16	16
TGTGTTTAGACACGAC-1_7_D5	-2.67269551	17.50876264	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	902	1379	0.01595359	0.014503263	5	oligos	OL-Cntl	40	16	16
TGTGTTTAGCAAATCA-1_7_D5	-32.36105322	2.964032509	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2075	3799	0.006580679	0.005264543	5	9	OPC	40	16	16
TGTGTTTCACATCCGG-1_7_D5	10.87977892	7.414972171	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1548	2645	0.005293006	0.011342155	5	oligos	OL-Cntl	40	16	16
TGTGTTTTCATACGGT-1_7_D5	13.64213902	9.575599311	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1413	2615	0.001529637	0.01414914	5	oligos	OL-Cntl	40	16	16
TGTTCCGAGCTAACTC-1_7_D5	-16.18845324	-19.10136505	6B	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2151	4606	0.019322623	0.005861919	5	6B	IN-SST	40	16	16
TGTTCCGGTTCATGGT-1_7_D5	9.65451464	13.46046611	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1096	1798	0.003337041	0.012791991	5	oligos	OL-Cntl	40	16	16
TGTTCCGTCGAGGTAG-1_7_D5	9.206074298	14.95331049	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1042	1520	0.010526316	0.011842105	5	oligos	OL-Cntl	40	16	16
TTAACTCCAAGTCTAC-1_7_D5	37.8244446	15.08702317	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1209	1748	0.00228833	0.017162471	5	14	Microglia	40	16	16
TTAACTCGTCATACTG-1_7_D5	25.28255355	4.091545741	15BA	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1372	2722	0.001102131	0.005143277	5	15BA	Stromal cells	40	16	16
TTAACTCGTCCGACGT-1_7_D5	-27.47442439	21.50213969	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1274	2040	0.012254902	0.003921569	5	8	Astrocytes	40	16	16
TTAACTCTCACCGTAA-1_7_D5	-8.715882105	-18.3813675	6B	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	666	1013	0.051332675	0.001974334	5	6B	IN-SST	40	16	16
TTAACTCTCAGTTTGG-1_7_D5	11.94876071	-22.97486617	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	6806	23122	0.005579102	0.006487328	5	L2-3	EN-L2-3-MS	40	16	16
TTAACTCTCGAACGGA-1_7_D5	10.35579454	21.83791821	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	857	1324	0.001510574	0.006042296	5	oligos	OL-Cntl	40	16	16
TTAACTCTCGCTAGCG-1_7_D5	-29.57879632	20.68859543	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1086	1663	0.00420926	0.00420926	5	8	Astrocytes	40	16	16
TTAGGACAGAAGAAGC-1_7_D5	18.57784945	-25.77994753	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4987	15345	0.019029	0.014206582	5	3	EN-L5-6	40	16	16
TTAGGACAGCTAGCCC-1_7_D5	0.015131155	13.80448917	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	941	1356	0.016961652	0.020648968	5	oligos	OL-Cntl	40	16	16
TTAGGACAGCTGTCTA-1_7_D5	12.08892053	8.977092858	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1477	2373	0.008006743	0.010535188	5	oligos	OL-Cntl	40	16	16
TTAGGACCACACAGAG-1_7_D5	10.51438421	17.59743112	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1022	1518	0.011198946	0.010540184	5	oligos	OL-Cntl	40	16	16
TTAGGACGTAGCAAAT-1_7_D5	10.49366472	14.11764715	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1225	2018	0.014866204	0.010901883	5	oligos	OL-Cntl	40	16	16
TTAGGCAAGAATGTTG-1_7_D5	-26.5881473	13.57313253	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	924	1446	0.004840941	0.002766252	5	8	Astrocytes	40	16	16
TTAGGCACAATGGTCT-1_7_D5	8.594902071	16.00184368	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	917	1519	0.008558262	0.003949967	5	oligos	OL-Cntl	40	16	16
TTAGGCACACGGCTAC-1_7_D5	-7.283845782	10.39951043	5	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	805	1135	0.017621145	0.026431718	5	oligos	OL-MS-1	40	16	16
TTAGGCACATCTCCCA-1_7_D5	4.164589326	-23.00191283	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3975	10735	0.002515137	0.002980904	5	L2-3	EN-L2-3-MS	40	16	16
TTAGGCAGTGAGGGAG-1_7_D5	0.14040662	18.96827057	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	780	1128	0.009751773	0.011524823	5	oligos	OL-Cntl	40	16	16
TTAGGCATCCAAGTAC-1_7_D5	-32.28961029	-3.792950563	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1197	1827	0.005473454	0.016420361	5	9	OPC	40	16	16
TTAGTTCCATTCCTCG-1_7_D5	8.758893398	17.10154215	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	883	1369	0.015339664	0.010956903	5	oligos	OL-Cntl	40	16	16
TTAGTTCGTTATGCGT-1_7_D5	7.243042615	-18.69849408	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	5056	13874	0.000576618	0.018884244	5	L2-3	EN-L2-3-MS	40	16	16
TTAGTTCTCCATGAGT-1_7_D5	-37.79378142	3.448241619	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2078	5246	0.00133435	0.001524971	5	9	OPC	40	16	16
TTAGTTCTCGTATCAG-1_7_D5	6.968410907	11.18579739	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1158	1885	0.005835544	0.014323607	5	oligos	OL-Cntl	40	16	16
TTATGCTAGGATTCGG-1_7_D5	-29.08812285	12.98988444	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	772	1155	0.002597403	0.006926407	5	8	Astrocytes	40	16	16
TTATGCTAGTGAACAT-1_7_D5	-26.10597263	22.98068036	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1353	2343	0.008962868	0.003414426	5	8	Astrocytes	40	16	16
TTATGCTCACGCATCG-1_7_D5	5.511030251	10.66460104	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1546	2759	0.008336354	0.011598405	5	oligos	OL-Cntl	40	16	16
TTATGCTCAGACACTT-1_7_D5	16.74133864	15.37021946	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1158	1976	0.00354251	0.004048583	5	oligos	OL-Cntl	40	16	16
TTATGCTCAGGTGGAT-1_7_D5	37.74091086	13.83573122	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1015	1370	0.003649635	0.023357664	5	14	Microglia	40	16	16
TTATGCTTCAGTCAGT-1_7_D5	35.36085582	10.87422214	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	763	1037	0.012536162	0.027965284	5	14	Microglia	40	16	16
TTATGCTTCGAGGTAG-1_7_D5	8.705699437	8.35313683	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1690	3369	0.010388839	0.0074206	5	oligos	OL-Cntl	40	16	16
TTCCCAGCAGGTCCAC-1_7_D5	7.282264441	9.565958138	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1170	1922	0.006763788	0.01508845	5	oligos	OL-Cntl	40	16	16
TTCCCAGGTACCGCTG-1_7_D5	38.94466089	9.93994151	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	903	1245	0.008032129	0.009638554	5	14	Microglia	40	16	16
TTCCCAGTCATGTGGT-1_7_D5	-35.38877929	-0.018968256	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1525	2730	0.001098901	0.001831502	5	9	OPC	40	16	16
TTCCCAGTCCCAGGTG-1_7_D5	-34.15126696	2.186791858	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1943	3572	0.004479283	0.006718925	5	9	OPC	40	16	16
TTCCCAGTCTGGAGCC-1_7_D5	-31.42796077	12.56188062	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	789	1166	0.004288165	0.000857633	5	8	Astrocytes	40	16	16
TTCGAAGAGGGATCTG-1_7_D5	7.463424507	-19.88573656	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4669	11760	0.002721088	0.010714286	5	L2-3	EN-L2-3-MS	40	16	16
TTCGAAGGTAGCGCTC-1_7_D5	15.55170212	-27.35890327	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3646	9239	0.013313129	0.004545947	5	3	EN-L5-6	40	16	16
TTCGAAGGTCCGTCAG-1_7_D5	-34.55127706	-9.400013035	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	987	1542	0.027237354	0.006485084	5	9	OPC	40	16	16
TTCGAAGTCGGACAAG-1_7_D5	15.0652286	0.289448129	12	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	770	1098	0.003642987	0.005464481	5	12	EN-MIX	40	16	16
TTCGGTCAGCTCCTCT-1_7_D5	-0.122934583	18.79980714	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	722	1075	0.00744186	0.004651163	5	oligos	OL-Cntl	40	16	16
TTCGGTCCACGAGGTA-1_7_D5	11.42495622	18.81279731	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	984	1594	0.005646173	0.003136763	5	oligos	OL-Cntl	40	16	16
TTCGGTCCAGGGTTAG-1_7_D5	1.118352878	-20.66581822	10	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3963	10474	0.016898988	0.004009929	5	L2-3	EN-L2-3-Cntl	40	16	16
TTCGGTCCATAGACTC-1_7_D5	10.37655693	17.80126247	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1001	1596	0.000626566	0.011904762	5	oligos	OL-Cntl	40	16	16
TTCGGTCGTAGCGTAG-1_7_D5	9.276975432	12.89030349	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1194	1947	0.005649718	0.009758603	5	oligos	OL-Cntl	40	16	16
TTCGGTCGTCTTCAAG-1_7_D5	-37.21489122	2.157282638	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1681	3205	0.002808112	0.004368175	5	9	OPC	40	16	16
TTCGGTCGTGGCGAAT-1_7_D5	13.25075565	-9.582889185	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4496	11296	0.002655807	0.004160765	5	3	EN-L5-6	40	16	16
TTCGGTCGTGTTCTTT-1_7_D5	13.05965836	9.995811262	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1395	2351	0.009783071	0.008507018	5	oligos	OL-Cntl	40	16	16
TTCGGTCGTTCGTTGA-1_7_D5	16.29596551	18.28760952	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1077	1817	0.001100715	0.001651073	5	oligos	OL-Cntl	40	16	16
TTCGGTCTCAACACAC-1_7_D5	9.615509868	28.26981311	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	835	1304	0.003067485	0.003067485	5	oligos	OL-Cntl	40	16	16
TTCGGTCTCACGAAGG-1_7_D5	11.87611187	12.12091059	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1239	2038	0.014720314	0.008832188	5	oligos	OL-Cntl	40	16	16
TTCGGTCTCCTATTCA-1_7_D5	-18.46777041	29.43499454	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2979	7022	0.006266021	0.007120478	5	8	Astrocytes	40	16	16
TTCTACATCAAGAAGT-1_7_D5	-0.74596007	17.55379018	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	842	1295	0.003088803	0.014671815	5	oligos	OL-Cntl	40	16	16
TTCTACATCAGAGGTG-1_7_D5	11.32501543	-4.896252312	12	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	749	1169	0.005132592	0.00427716	5	12	EN-MIX	40	16	16
TTCTCAAAGACAATAC-1_7_D5	-17.59460799	14.29222122	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1466	2561	0.000780945	0.007418977	5	8	Astrocytes	40	16	16
TTCTCAACACGAAATA-1_7_D5	4.81509846	14.02169848	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1088	1692	0.004137116	0.011820331	5	oligos	OL-Cntl	40	16	16
TTCTCAACAGGGTATG-1_7_D5	-19.66003977	28.78819466	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2238	4793	0.001043188	0.004798665	5	8	Astrocytes	40	16	16
TTCTCAATCCTCTAGC-1_7_D5	5.331458886	14.92007	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1081	1737	0.006332758	0.009211284	5	oligos	OL-Cntl	40	16	16
TTCTCCTAGGTAGCTG-1_7_D5	-34.90533116	5.131623339	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3020	6900	0.000869565	0.004927536	5	9	OPC	40	16	16
TTCTCCTAGTATCGAA-1_7_D5	0.215415395	17.20726294	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	889	1417	0.004940014	0.015525759	5	oligos	OL-Cntl	40	16	16
TTCTCCTCAGGCTCAC-1_7_D5	9.386934927	11.96840583	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1201	1946	0.00668037	0.014388489	5	oligos	OL-Cntl	40	16	16
TTCTCCTGTCCGTTAA-1_7_D5	33.14144464	-9.376998502	2	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	5495	15963	0.012779553	0.008143833	5	2	EN-L4	40	16	16
TTCTCCTTCACGGTTA-1_7_D5	-35.19033043	-0.338567266	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1610	2920	0.004794521	0.003767123	5	9	OPC	40	16	16
TTCTCCTTCAGCATGT-1_7_D5	-19.27348689	28.43451436	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2042	4020	0.003482587	0.007711443	5	8	Astrocytes	40	16	16
TTCTCCTTCCTCATTA-1_7_D5	-1.090651094	12.87890473	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	950	1490	0.008724832	0.026845638	5	oligos	OL-Cntl	40	16	16
TTCTCCTTCCTGCAGG-1_7_D5	-21.03657926	30.44926842	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2468	5583	0.002686728	0.005015225	5	8	Astrocytes	40	16	16
TTCTCCTTCGGCGCTA-1_7_D5	14.60811011	13.76240321	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1176	2085	0.003357314	0.006714628	5	oligos	OL-Cntl	40	16	16
TTCTTAGAGAAGGTTT-1_7_D5	13.97908828	-29.45561422	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4280	12931	0.007733354	0.005722682	5	3	EN-L5-6	40	16	16
TTCTTAGAGCTGGAAC-1_7_D5	8.066080512	11.99015627	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1223	1975	0.007088608	0.012151899	5	oligos	OL-Cntl	40	16	16
TTCTTAGCACACGCTG-1_7_D5	12.68001109	-6.784451193	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3102	9376	0.007892491	0.002453072	5	3	EN-L5-6	40	16	16
TTCTTAGCAGCGATCC-1_7_D5	-19.46572955	29.54966076	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2533	5513	0.000544168	0.005985852	5	8	Astrocytes	40	16	16
TTCTTAGGTCGAATCT-1_7_D5	1.066962252	20.19843902	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	765	1077	0.002785515	0.006499536	5	oligos	OL-Cntl	40	16	16
TTCTTAGTCCTTCAAT-1_7_D5	-11.14124844	-3.904754282	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2271	4383	0.0134611	0.012548483	5	13A	IN-VIP	40	16	16
TTGAACGAGGTAGCTG-1_7_D5	-20.25442273	25.54624963	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1790	3355	0.002682563	0.005365127	5	8	Astrocytes	40	16	16
TTGAACGCACTTGGAT-1_7_D5	23.36705142	-28.73098686	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	5260	17503	0.003656516	0.003256585	5	3	EN-L5-6	40	16	16
TTGAACGTCCCAAGTA-1_7_D5	-0.825396304	15.43953532	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	741	1037	0.011571842	0.016393443	5	oligos	OL-Cntl	40	16	16
TTGAACGTCGTGGACC-1_7_D5	-1.366340602	16.23252217	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	778	1160	0.000862069	0.013793103	5	oligos	OL-Cntl	40	16	16
TTGACTTAGCAATCTC-1_7_D5	7.319027704	11.0203547	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1091	1693	0.002953337	0.018901359	5	oligos	OL-Cntl	40	16	16
TTGACTTAGTTCGCGC-1_7_D5	15.20508132	-29.09070509	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	6086	21842	0.0010988	0.00709642	5	3	EN-L5-6	40	16	16
TTGACTTCAATCTACG-1_7_D5	30.65555537	15.63456748	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	952	1398	0.005007153	0.116595136	5	14	Microglia	40	16	16
TTGACTTGTAGCTTGT-1_7_D5	10.91771699	-19.04293042	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	5919	17524	0.012839534	0.006733622	5	L2-3	EN-L2-3-MS	40	16	16
TTGACTTGTCAGAGGT-1_7_D5	21.99948934	-29.07484204	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4491	13983	0.003075163	0.002431524	5	3	EN-L5-6	40	16	16
TTGACTTTCGCCCTTA-1_7_D5	5.360711878	-22.10555511	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	7104	29659	0.005596952	0.004113423	5	L2-3	EN-L2-3-MS	40	16	16
TTGCCGTAGTGCAAGC-1_7_D5	5.974837054	-18.174117	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3770	8588	0.009315324	0.014089427	5	L2-3	EN-L2-3-MS	40	16	16
TTGCCGTCAACACCCG-1_7_D5	2.155250782	19.97777146	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	907	1390	0.004316547	0.010071942	5	oligos	OL-Cntl	40	16	16
TTGCCGTCACCGTTGG-1_7_D5	-3.293299032	15.21842072	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	740	1058	0.008506616	0.02173913	5	oligos	OL-Cntl	40	16	16
TTGCCGTCAGGAATCG-1_7_D5	10.79339019	8.684635388	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1368	2293	0.006977758	0.013519407	5	oligos	OL-Cntl	40	16	16
TTGCCGTCAGTAAGAT-1_7_D5	36.39928292	12.37754179	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	957	1347	0.00074239	0.020786934	5	14	Microglia	40	16	16
TTGCCGTTCCTCTAGC-1_7_D5	0.676223581	20.35895951	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	831	1268	0.003154574	0.010252366	5	oligos	OL-Cntl	40	16	16
TTGCCGTTCGTACGGC-1_7_D5	-20.28677849	28.35296121	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1861	3745	0.003471295	0.008277704	5	8	Astrocytes	40	16	16
TTGCGTCAGCTAAGAT-1_7_D5	-0.924282381	15.38485711	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	796	1184	0.001689189	0.019425676	5	oligos	OL-Cntl	40	16	16
TTGCGTCAGTCCAGGA-1_7_D5	7.450584478	-18.50472542	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4621	11852	0.008437395	0.017887276	5	L2-3	EN-L2-3-MS	40	16	16
TTGCGTCCACCGTTGG-1_7_D5	-32.12174452	2.5533925	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1978	3724	0.001879699	0.001879699	5	9	OPC	40	16	16
TTGCGTCCATCACAAC-1_7_D5	-33.93096206	2.487229904	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2098	3703	0.003240616	0.004320821	5	9	OPC	40	16	16
TTGCGTCTCACAATGC-1_7_D5	-33.6079619	-8.603147118	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1128	1672	0.002392344	0.003588517	5	9	OPC	40	16	16
TTGGAACAGACAGACC-1_7_D5	-1.548667522	15.69467844	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	775	1172	0.009385666	0.013651877	5	oligos	OL-Cntl	40	16	16
TTGGAACGTAAACGCG-1_7_D5	-1.560099328	21.50072913	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	718	1082	0.004621072	0.010166359	5	oligos	OL-Cntl	40	16	16
TTGGAACGTACATCCA-1_7_D5	10.38194484	14.05017264	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1156	1911	0.007326007	0.007326007	5	oligos	OL-Cntl	40	16	16
TTGGAACGTGAGGCTA-1_7_D5	9.854312625	7.098570201	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1569	2542	0.011801731	0.020456334	5	oligos	OL-Cntl	40	16	16
TTGGAACGTGCCTGCA-1_7_D5	-18.9321868	19.81372476	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1888	3375	0.000592593	0.010962963	5	8	Astrocytes	40	16	16
TTGGAACGTGGTTTCA-1_7_D5	38.83001823	9.890405407	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	883	1197	0.006683375	0.005847953	5	14	Microglia	40	16	16
TTGGCAAAGAAACGCC-1_7_D5	-0.093731171	18.80238324	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	789	1172	0.019624573	0.006825939	5	oligos	OL-Cntl	40	16	16
TTGGCAAAGAGACTAT-1_7_D5	3.857557483	15.84726138	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	896	1389	0.011519078	0.009359251	5	oligos	OL-Cntl	40	16	16
TTGGCAATCGGCATCG-1_7_D5	9.392288336	12.88798736	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1163	1963	0.003056546	0.011207336	5	oligos	OL-Cntl	40	16	16
TTGGCAATCGTCGTTC-1_7_D5	7.191348258	-20.56214118	4	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	5266	16701	0.008023472	0.007963595	5	L2-3	EN-L2-3-MS	40	16	16
TTGTAGGAGCTTATCG-1_7_D5	-34.07959427	-0.347043645	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1648	2716	0.005154639	0.009204713	5	9	OPC	40	16	16
TTGTAGGCAAAGTCAA-1_7_D5	11.17442888	9.689137019	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1418	2352	0.005527211	0.008928571	5	oligos	OL-Cntl	40	16	16
TTGTAGGCAGACGTAG-1_7_D5	-19.67727629	26.19464378	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1938	3864	0.000776398	0.011645963	5	8	Astrocytes	40	16	16
TTGTAGGGTTGAGGTG-1_7_D5	-8.330845905	-2.53931729	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2022	3644	0.021953897	0.006311745	5	13A	IN-VIP	40	16	16
TTGTAGGTCCTTCAAT-1_7_D5	15.19753702	-27.4066147	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	3695	10261	0.017152324	0.004970276	5	3	EN-L5-6	40	16	16
TTTACTGAGACTTGAA-1_7_D5	-35.21211268	2.003812648	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1909	3849	0.002857885	0.003897116	5	9	OPC	40	16	16
TTTACTGAGAGACGAA-1_7_D5	10.2693895	11.22923241	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1297	2235	0.013870246	0.010738255	5	oligos	OL-Cntl	40	16	16
TTTACTGAGTATCGAA-1_7_D5	0.587484059	18.32592307	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	691	1006	0.017892644	0.009940358	5	oligos	OL-Cntl	40	16	16
TTTACTGCAGTCACTA-1_7_D5	19.10067387	7.634403684	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1879	3663	0.002730003	0.006006006	5	oligos	OL-Cntl	40	16	16
TTTACTGGTAAGTGTA-1_7_D5	1.266845049	20.81943376	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	863	1245	0.002409639	0.01124498	5	oligos	OL-Cntl	40	16	16
TTTACTGGTCGGATCC-1_7_D5	-9.268763574	-1.255847046	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2072	4011	0.006731488	0.005734231	5	13A	IN-VIP	40	16	16
TTTACTGGTTACAGAA-1_7_D5	8.585081458	17.00816163	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	920	1446	0.006224066	0.009681881	5	oligos	OL-Cntl	40	16	16
TTTATGCAGCGTGAGT-1_7_D5	36.64273512	11.9927304	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	802	1098	0.003642987	0.031876138	5	14	Microglia	40	16	16
TTTATGCAGGTGGGTT-1_7_D5	4.663483762	14.61006478	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1010	1597	0.012523482	0.012523482	5	oligos	OL-Cntl	40	16	16
TTTATGCCAAGGCTCC-1_7_D5	-35.2574738	3.090076981	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2099	4241	0.001650554	0.005894836	5	9	OPC	40	16	16
TTTATGCGTCGCATAT-1_7_D5	-6.522955392	-3.263896075	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1526	2706	0.032889874	0.002586844	5	13A	IN-VIP	40	16	16
TTTCCTCAGCAATCTC-1_7_D5	32.26706107	15.93634096	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1011	1367	0.001463058	0.07315289	5	14	Microglia	40	16	16
TTTCCTCCACGGATAG-1_7_D5	0.630645527	11.75414704	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	876	1250	0.0104	0.0128	5	oligos	OL-Cntl	40	16	16
TTTCCTCCATCCTTGC-1_7_D5	13.49979022	9.07279252	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1464	2850	0.000701754	0.00877193	5	oligos	OL-Cntl	40	16	16
TTTCCTCGTTCAGGCC-1_7_D5	-35.51371216	0.0616662	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1557	2997	0.001334668	0.00333667	5	9	OPC	40	16	16
TTTCCTCGTTCCCTTG-1_7_D5	39.50399806	13.9886355	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1107	1688	0.000592417	0.004739336	5	14	Microglia	40	16	16
TTTCCTCTCTTAGAGC-1_7_D5	-17.00540998	1.506891398	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	4267	9943	0.015186563	0.014985417	5	13A	IN-VIP	40	16	16
TTTGCGCAGACTTTCG-1_7_D5	34.44303734	15.60680451	14	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1020	1498	0.000667557	0.046061415	5	14	Microglia	40	16	16
TTTGCGCAGCCCGAAA-1_7_D5	-18.53542436	27.69525733	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2389	5490	0.003096539	0.008925319	5	8	Astrocytes	40	16	16
TTTGCGCAGGATGGTC-1_7_D5	-32.63442503	-12.95429215	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	726	1019	0.016683023	0.00686948	5	9	OPC	40	16	16
TTTGCGCAGGATGTAT-1_7_D5	11.35602992	-4.909438257	12	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	847	1351	0.018504811	0.003700962	5	12	EN-MIX	40	16	16
TTTGCGCAGTGTCTCA-1_7_D5	-37.28193366	-1.768663969	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1349	2267	0.001323335	0.003087781	5	9	OPC	40	16	16
TTTGCGCCAGGCGATA-1_7_D5	14.86650287	7.824002905	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1772	3399	0.00353045	0.012062371	5	oligos	OL-Cntl	40	16	16
TTTGCGCCAGTCAGCC-1_7_D5	-17.09242871	-4.347829948	13A	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2779	5942	0.015819589	0.007236621	5	13A	IN-VIP	40	16	16
TTTGCGCGTGATGTGG-1_7_D5	-20.67638672	26.90738543	8	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1967	3958	0.000252653	0.009095503	5	8	Astrocytes	40	16	16
TTTGCGCGTTAAGATG-1_7_D5	9.17011021	14.69227989	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1219	2073	0.009165461	0.007718283	5	oligos	OL-Cntl	40	16	16
TTTGCGCGTTCTGAAC-1_7_D5	2.238550545	12.50300214	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1034	1648	0.009708738	0.018203883	5	oligos	OL-Cntl	40	16	16
TTTGCGCTCAAAGTAG-1_7_D5	-34.22530144	2.990773943	9	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	2037	3845	0.002340702	0.004681404	5	9	OPC	40	16	16
TTTGGTTGTTCCACTC-1_7_D5	19.6033779	22.09087742	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	965	1707	0.011130639	0.002929115	5	oligos	OL-Cntl	40	16	16
TTTGGTTGTTTGTGTG-1_7_D5	12.53724322	-6.569632458	3	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	1934	4136	0.005802708	0.002901354	5	3	EN-L5-6	40	16	16
TTTGGTTTCTTCTGGC-1_7_D5	36.00420421	-7.794556211	2	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	5141	14867	0.006928096	0.008676935	5	2	EN-L4	40	16	16
TTTGTCAAGGCCGAAT-1_7_D5	8.192159997	15.2123092	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	904	1297	0.01156515	0.01310717	5	oligos	OL-Cntl	40	16	16
TTTGTCAGTTCCACTC-1_7_D5	-2.599014725	17.47166945	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	718	1069	0.004677268	0.014967259	5	oligos	OL-Cntl	40	16	16
TTTGTCATCAGATAAG-1_7_D5	2.560337511	14.77783544	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	950	1469	0.002042206	0.012253233	5	oligos	OL-Cntl	40	16	16
TTTGTCATCAGCTCTC-1_7_D5	-7.030378703	-36.78770508	16	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	921	1328	0.034638554	0.018825301	5	16	EN-PYR	40	16	16
TTTGTCATCCTAGGGC-1_7_D5	4.989011232	14.77078019	1	7_D5	MS	Acute/Chronic active	42	female	temporal	CAP2	SEQ1	8.7	11	973	1422	0.009142053	0.014064698	5	oligos	OL-Cntl	40	16	16
AAACCTGAGAACTCGG-1_7_G10	2.545002528	-16.66201108	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2486	4703	0.005103126	0.0091431	2	L2-3	EN-L2-3-MS	12	6	6
AAACCTGAGCGTGAAC-1_7_G10	-0.541263118	35.20643215	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	765	1037	0.014464802	0.005785921	2	oligos	OL-MS-2	12	6	6
AAACCTGAGGATGGAA-1_7_G10	3.167205244	-14.31609949	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2161	3737	0.006957453	0.014717688	2	L2-3	EN-L2-3-MS	12	6	6
AAACCTGCACAGCCCA-1_7_G10	-3.33649284	34.68726921	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	822	1129	0.009743136	0.004428698	2	oligos	OL-MS-2	12	6	6
AAACCTGGTGATAAAC-1_7_G10	-4.052913856	36.15261546	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	789	1040	0.007692308	0.003846154	2	oligos	OL-MS-2	12	6	6
AAACGGGAGCAATCTC-1_7_G10	0.301534669	-27.57000525	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4769	14996	0.001333689	0.003801014	2	L2-3	EN-L2-3-Cntl	12	6	6
AAACGGGAGGCCCTCA-1_7_G10	-26.80445203	-7.154539837	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1177	1762	0.003405221	0.010215664	2	9	OPC	12	6	6
AAACGGGAGGGCTTCC-1_7_G10	24.63147027	-27.50588867	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2859	5854	0.012128459	0.006832935	2	3	EN-L5-6	12	6	6
AAACGGGAGGGTCGAT-1_7_G10	31.95627195	-8.625300297	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2793	5643	0.015594542	0.005670743	2	2	EN-L4	12	6	6
AAACGGGAGTGTCTCA-1_7_G10	7.812571433	-30.95152831	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3605	8894	0.002023836	0.005621767	2	L2-3	EN-L2-3-Cntl	12	6	6
AAACGGGAGTTGAGTA-1_7_G10	-21.89951222	-21.70931614	6A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2004	3678	0.018760196	0.005709625	2	6A	IN-PV	12	6	6
AAACGGGCACCAGATT-1_7_G10	-8.349051754	-30.71374587	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1050	1582	0.118204804	0.005689001	2	16	EN-PYR	12	6	6
AAACGGGCACGAAAGC-1_7_G10	19.61251256	18.31595712	1	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1105	1672	0.004784689	0.005980861	2	oligos	OL-Cntl	12	6	6
AAACGGGCACGGTAAG-1_7_G10	-0.854167303	33.90047089	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	845	1173	0.00341006	0.005967604	2	oligos	OL-MS-2	12	6	6
AAACGGGGTGAGGCTA-1_7_G10	-13.78420533	-35.9520202	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1917	3196	0.05350438	0.010325407	2	16	EN-PYR	12	6	6
AAACGGGTCGAACTGT-1_7_G10	-1.095815335	-21.62628451	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3278	7772	0.002702007	0.006690685	2	L2-3	EN-L2-3-Cntl	12	6	6
AAACGGGTCGGCTACG-1_7_G10	31.59295137	-8.389604195	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2748	5420	0.021771218	0.006273063	2	2	EN-L4	12	6	6
AAAGATGAGTACGTAA-1_7_G10	24.75735437	8.116479878	15A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2319	3549	0.020569174	0.027895182	2	15A	Endo cells	12	6	6
AAAGATGCACCAGCAC-1_7_G10	-19.51589609	14.65029691	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1405	2156	0.013914657	0.004174397	2	8	Astrocytes	12	6	6
AAAGATGCAGTATAAG-1_7_G10	-25.57786012	-6.754654924	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1130	1610	0.004968944	0.006832298	2	9	OPC	12	6	6
AAAGATGGTAGAAGGA-1_7_G10	25.48612156	6.469406271	15A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1422	1976	0.025303644	0.015688259	2	15A	Endo cells	12	6	6
AAAGATGGTGGCAAAC-1_7_G10	-24.65212805	-0.678252694	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2379	4263	0.031433263	0.007741027	2	9	OPC	12	6	6
AAAGATGGTTACCAGT-1_7_G10	-13.00250169	16.41848786	11	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1354	1994	0.003510532	0.006519559	2	11	Glia-MIX	12	6	6
AAAGCAACAAACCCAT-1_7_G10	-23.20161428	-0.232510563	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1568	2518	0.005559968	0.004765687	2	9	OPC	12	6	6
AAAGCAAGTCAGAAGC-1_7_G10	31.19088278	-10.41546628	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3923	9058	0.022190329	0.00618238	2	2	EN-L4	12	6	6
AAAGCAAGTCTTGTCC-1_7_G10	5.369053064	-16.49014695	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3084	6627	0.009657462	0.009959258	2	L2-3	EN-L2-3-MS	12	6	6
AAAGCAATCTCCTATA-1_7_G10	29.86948658	-8.011594758	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	5160	16001	0.008061996	0.005937129	2	2	EN-L4	12	6	6
AAAGTAGCAAACTGTC-1_7_G10	-11.08404779	-27.81247352	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1700	3143	0.179446389	0.007954184	2	16	EN-PYR	12	6	6
AAAGTAGCAACAACCT-1_7_G10	-5.734048901	35.50906246	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	785	1016	0.01476378	0.00492126	2	oligos	OL-MS-2	12	6	6
AAAGTAGCATCTCCCA-1_7_G10	-14.70357366	8.099332746	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1614	2336	0.008561644	0.007705479	2	8	Astrocytes	12	6	6
AAAGTAGTCTGGTTCC-1_7_G10	32.94073215	-4.597304886	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3194	6971	0.01090231	0.006024961	2	2	EN-L4	12	6	6
AAATGCCGTAAAGTCA-1_7_G10	-7.633286577	-2.452193921	13A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1671	2754	0.01815541	0.002178649	2	13A	IN-VIP	12	6	6
AAATGCCTCCGCGCAA-1_7_G10	-6.138394125	31.74958834	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1070	1460	0.010958904	0.004794521	2	oligos	OL-MS-2	12	6	6
AACACGTAGTGTGAAT-1_7_G10	-31.70864941	-1.802645073	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1340	2028	0.00591716	0.003451677	2	9	OPC	12	6	6
AACACGTCACGTGAGA-1_7_G10	-5.788847013	35.46629351	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	767	1049	0.021925643	0.006673022	2	oligos	OL-MS-2	12	6	6
AACACGTCAGGGTACA-1_7_G10	-6.005429456	34.19487211	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	958	1335	0.018726592	0.008988764	2	oligos	OL-MS-2	12	6	6
AACACGTCAGTATAAG-1_7_G10	21.06910935	27.7110757	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	878	1211	0.002477291	0.004954583	2	oligos	OL-MS-2	12	6	6
AACACGTGTAAACACA-1_7_G10	-20.46061464	11.71417441	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	848	1155	0.012121212	0.005194805	2	8	Astrocytes	12	6	6
AACACGTGTTTGGGCC-1_7_G10	16.31188293	-32.48675608	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	5036	17147	0.005190412	0.005132093	2	3	EN-L5-6	12	6	6
AACACGTTCCGGGTGT-1_7_G10	-0.038597759	33.1326688	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	866	1183	0.00591716	0.002535926	2	oligos	OL-MS-2	12	6	6
AACCATGCAATAGCAA-1_7_G10	-0.85451763	34.3210012	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	864	1230	0.011382114	0.008130081	2	oligos	OL-MS-2	12	6	6
AACCATGCACAACGTT-1_7_G10	29.81380975	-9.287413569	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4451	10958	0.024183245	0.005566709	2	2	EN-L4	12	6	6
AACCATGCACACCGAC-1_7_G10	-20.62903366	17.03953193	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1520	2352	0.004251701	0.003826531	2	8	Astrocytes	12	6	6
AACCATGCAGGATCGA-1_7_G10	-5.587626914	32.23249821	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	977	1335	0.014981273	0.002996255	2	oligos	OL-MS-2	12	6	6
AACCATGCATGCCCGA-1_7_G10	-25.02357293	-6.224658371	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1217	1896	0.007911392	0.004219409	2	9	OPC	12	6	6
AACCATGGTCAGATAA-1_7_G10	23.79429581	27.73462171	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1238	1848	0.004329004	0.002705628	2	oligos	OL-MS-2	12	6	6
AACCATGTCCAAGCCG-1_7_G10	-7.449043447	-32.20361306	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	848	1176	0.022108844	0.009353741	2	16	EN-PYR	12	6	6
AACCGCGAGTTGCAGG-1_7_G10	19.19368694	-17.66544551	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	5447	15271	0.018138956	0.008643835	2	L2-3	EN-L2-3-MS	12	6	6
AACCGCGCAGCTCGCA-1_7_G10	31.66410201	-2.730392571	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3087	6790	0.010603829	0.003681885	2	2	EN-L4	12	6	6
AACCGCGCATGCAACT-1_7_G10	13.63105144	-4.612536654	12	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1988	3765	0.011420983	0.004249668	2	12	EN-MIX	12	6	6
AACCGCGGTCTCTTAT-1_7_G10	1.87121741	-21.2029738	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3426	8120	0.004433498	0.007389163	2	L2-3	EN-L2-3-MS	12	6	6
AACCGCGGTGACAAAT-1_7_G10	-8.803093423	33.92073124	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	810	1083	0.01754386	0.002770083	2	oligos	OL-MS-2	12	6	6
AACCGCGGTTGTTTGG-1_7_G10	19.50069967	26.53942502	1	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	923	1348	0.004451039	0.005192878	2	oligos	OL-Cntl	12	6	6
AACCGCGTCAAACGGG-1_7_G10	-4.198473524	33.39507145	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	933	1332	0.006756757	0.005255255	2	oligos	OL-MS-2	12	6	6
AACGTTGAGCGGATCA-1_7_G10	27.21541495	-6.049724316	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4310	11949	0.003514938	0.00426814	2	2	EN-L4	12	6	6
AACGTTGAGGCGCTCT-1_7_G10	-23.42037382	-23.57385906	6A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3005	6266	0.027768912	0.006224066	2	6A	IN-PV	12	6	6
AACGTTGAGTTACGGG-1_7_G10	29.62349439	-10.93431538	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3667	8311	0.015521598	0.004933221	2	2	EN-L4	12	6	6
AACGTTGCATCGATGT-1_7_G10	-18.75785184	-8.086567405	13B	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4230	10390	0.015399423	0.007314726	2	13B	IN-SV2C	12	6	6
AACGTTGTCACAAACC-1_7_G10	0.563039585	-16.71335667	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2442	4781	0.003555741	0.007111483	2	L2-3	EN-L2-3-Cntl	12	6	6
AACGTTGTCATTATCC-1_7_G10	24.25394688	-6.393702391	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2864	5320	0.012030075	0.003571429	2	2	EN-L4	12	6	6
AACTCAGAGGTGCTTT-1_7_G10	-23.29668964	-0.302566198	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1522	2486	0.005631537	0.002413516	2	9	OPC	12	6	6
AACTCAGCAGGGTTAG-1_7_G10	-13.27394549	-3.154170504	13A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2602	4927	0.025573371	0.014004465	2	13A	IN-VIP	12	6	6
AACTCAGCAGGTCTCG-1_7_G10	-3.058760278	36.00094042	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	844	1134	0.008818342	0.005291005	2	oligos	OL-MS-2	12	6	6
AACTCAGCATCTGGTA-1_7_G10	24.21678132	-6.350586604	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3380	7184	0.005707127	0.004871938	2	2	EN-L4	12	6	6
AACTCAGTCCTGTACC-1_7_G10	-21.2981573	-15.75323404	6B	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2975	6661	0.008857529	0.005554722	2	6B	IN-SST	12	6	6
AACTCAGTCGTACGGC-1_7_G10	21.15120072	20.01504183	1	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1058	1662	0.003610108	0.004211793	2	oligos	OL-Cntl	12	6	6
AACTCCCAGACACTAA-1_7_G10	13.13174021	-22.22991805	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	5294	16237	0.013241362	0.005604484	2	L2-3	EN-L2-3-MS	12	6	6
AACTCCCCACGGTGTC-1_7_G10	-0.68209113	7.400413918	5	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2404	4411	0.08252097	0.038540014	2	oligos	OL-MS-1	12	6	6
AACTCCCGTACAGACG-1_7_G10	30.3976437	-5.646097295	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4612	12112	0.010155218	0.004293263	2	2	EN-L4	12	6	6
AACTCCCGTAGAGCTG-1_7_G10	-6.68920734	-30.81318751	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	865	1321	0.155942468	0.009084027	2	16	EN-PYR	12	6	6
AACTCCCGTCCAGTTA-1_7_G10	23.67194998	14.96928346	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1230	1797	0.005008347	0.002225932	2	oligos	OL-MS-2	12	6	6
AACTCCCGTCCCTTGT-1_7_G10	-3.806693403	34.46032248	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	897	1251	0.008792966	0.004796163	2	oligos	OL-MS-2	12	6	6
AACTCCCTCAATACCG-1_7_G10	28.81344538	-4.398753374	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3807	9462	0.00591841	0.014267597	2	2	EN-L4	12	6	6
AACTCCCTCATGTCCC-1_7_G10	-1.512528002	33.44269206	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	909	1277	0.007047768	0.003915427	2	oligos	OL-MS-2	12	6	6
AACTCCCTCGGAAATA-1_7_G10	-10.74530564	12.04083128	11	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	874	1161	0.009474591	0.004306632	2	11	Glia-MIX	12	6	6
AACTCTTCATACGCTA-1_7_G10	-32.36689369	-2.019415302	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1406	2387	0.004189359	0.001675744	2	9	OPC	12	6	6
AACTCTTCATCCTAGA-1_7_G10	-12.321045	-31.60465164	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1530	2430	0.113580247	0.009053498	2	16	EN-PYR	12	6	6
AACTCTTGTTATCACG-1_7_G10	-8.166006116	-30.08117848	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	843	1183	0.066779374	0.004226543	2	16	EN-PYR	12	6	6
AACTCTTTCTGCCCTA-1_7_G10	-19.52578369	11.80217313	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1083	1561	0.00384369	0.00512492	2	8	Astrocytes	12	6	6
AACTGGTAGTCGAGTG-1_7_G10	-1.960912243	36.17558797	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	757	1073	0.003727866	0.002795899	2	oligos	OL-MS-2	12	6	6
AACTGGTAGTTGAGAT-1_7_G10	-12.10324587	-13.5818376	6A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1382	2304	0.014756944	0.012152778	2	6A	IN-PV	12	6	6
AACTGGTCAGTAACGG-1_7_G10	29.51087125	-8.007140582	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	5420	15020	0.010186418	0.007123835	2	2	EN-L4	12	6	6
AACTGGTCATGCTGGC-1_7_G10	-32.03939846	-2.344540614	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1285	2103	0.003804089	0.004755112	2	9	OPC	12	6	6
AACTGGTTCATCGATG-1_7_G10	-15.5851654	-4.97660896	13A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4038	10301	0.019027279	0.010484419	2	13A	IN-VIP	12	6	6
AACTGGTTCCATGCTC-1_7_G10	-28.05044577	-3.873473607	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1236	1889	0.003705664	0.018528322	2	9	OPC	12	6	6
AACTTTCAGGACGAAA-1_7_G10	-35.06949418	-5.598946277	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1326	2309	0.005630143	0.005197055	2	9	OPC	12	6	6
AACTTTCCAATCACAC-1_7_G10	-11.07425496	32.78229707	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	882	1129	0.018600531	0.003542958	2	oligos	OL-MS-2	12	6	6
AACTTTCCACCCTATC-1_7_G10	25.05501697	5.240718458	15BA	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1487	2204	0.018602541	0.024047187	2	15BA	Stromal cells	12	6	6
AACTTTCCAGGACCCT-1_7_G10	0.322883555	-0.931307744	6B	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	854	1245	0.006425703	0.004016064	2	6B	IN-SST	12	6	6
AACTTTCCATCATCCC-1_7_G10	22.78964357	27.10137989	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1168	1772	0.003950339	0.006772009	2	oligos	OL-MS-2	12	6	6
AACTTTCGTACTTGAC-1_7_G10	19.49684793	-17.37236552	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	9078	52354	0.041945219	0.004221263	2	L2-3	EN-L2-3-MS	12	6	6
AACTTTCGTCCGCTGA-1_7_G10	-25.73577701	-6.127403257	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1203	1815	0.009366391	0.003856749	2	9	OPC	12	6	6
AACTTTCGTCTGGAGA-1_7_G10	17.91849559	-8.109952977	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1875	3505	0.00171184	0.015691869	2	3	EN-L5-6	12	6	6
AACTTTCGTGCCTGTG-1_7_G10	-7.167314389	-29.12602402	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	881	1310	0.140458015	0.006870229	2	16	EN-PYR	12	6	6
AACTTTCGTTCCGGCA-1_7_G10	21.93313296	26.40541427	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1074	1539	0.007147498	0.007797271	2	oligos	OL-MS-2	12	6	6
AACTTTCGTTTGTTTC-1_7_G10	-17.25241028	-16.23149285	6B	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2126	4058	0.046081814	0.009610646	2	6B	IN-SST	12	6	6
AAGACCTAGTACGTAA-1_7_G10	13.84607362	24.77046284	1	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	908	1312	0.007621951	0.005335366	2	oligos	OL-Cntl	12	6	6
AAGACCTCAGCTGTGC-1_7_G10	27.43162076	5.149796816	15A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	898	1138	0.006151142	0.016695958	2	15A	Endo cells	12	6	6
AAGACCTGTGGTAACG-1_7_G10	20.91069178	-1.128180213	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1560	2517	0.023837902	0.005164879	2	2	EN-L4	12	6	6
AAGACCTGTGTATGGG-1_7_G10	16.02150737	-32.65044618	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4134	11641	0.001546259	0.005154196	2	3	EN-L5-6	12	6	6
AAGACCTTCACTCCTG-1_7_G10	-0.210726459	35.24896586	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	784	1122	0.005347594	0.005347594	2	oligos	OL-MS-2	12	6	6
AAGCCGCAGCAATCTC-1_7_G10	-10.41580949	33.29019428	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	813	1010	0.006930693	0.010891089	2	oligos	OL-MS-2	12	6	6
AAGCCGCAGCCAGAAC-1_7_G10	10.24434723	-1.41673896	12	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1523	2608	0.018404908	0.009202454	2	12	EN-MIX	12	6	6
AAGCCGCAGCGGATCA-1_7_G10	-11.24180311	-32.59465529	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1396	2351	0.136962994	0.012760527	2	16	EN-PYR	12	6	6
AAGCCGCCAACAACCT-1_7_G10	-32.03613261	-1.131083547	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1508	2572	0.003499222	0.003499222	2	9	OPC	12	6	6
AAGCCGCCAGTGAGTG-1_7_G10	-22.74725139	13.77797553	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1072	1534	0.007170795	0.01303781	2	8	Astrocytes	12	6	6
AAGCCGCGTAGGCTGA-1_7_G10	0.289445203	31.9728937	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	782	1117	0.002685765	0.006266786	2	oligos	OL-MS-2	12	6	6
AAGCCGCTCGCACTCT-1_7_G10	23.21840208	26.73499122	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1195	1739	0.005750431	0.005750431	2	oligos	OL-MS-2	12	6	6
AAGCCGCTCTAACTCT-1_7_G10	20.78277691	-29.53205093	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	5159	18323	0.002565082	0.003929488	2	3	EN-L5-6	12	6	6
AAGGAGCCACTTACGA-1_7_G10	27.10176431	-15.7709178	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	7701	33377	0.044222069	0.008628696	2	3	EN-L5-6	12	6	6
AAGGAGCCAGCGATCC-1_7_G10	-19.68505602	11.39270053	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	846	1197	0.006683375	0.005012531	2	8	Astrocytes	12	6	6
AAGGCAGAGCAGACTG-1_7_G10	-10.75543772	15.6382239	11	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1628	2545	0.006679764	0.005500982	2	11	Glia-MIX	12	6	6
AAGGCAGAGGAGTTGC-1_7_G10	-2.685084072	32.49122411	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	997	1410	0.007092199	0.002836879	2	oligos	OL-MS-2	12	6	6
AAGGCAGAGTAGATGT-1_7_G10	9.223812493	-29.35196984	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4364	11623	0.007571195	0.006108578	2	L2-3	EN-L2-3-Cntl	12	6	6
AAGGCAGCACATTTCT-1_7_G10	27.57975247	-6.496977499	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	5431	18294	0.010659233	0.003771728	2	2	EN-L4	12	6	6
AAGGCAGCATTCCTCG-1_7_G10	1.218817873	1.12259254	12	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1912	3251	0.077207013	0.013534297	2	12	EN-MIX	12	6	6
AAGGCAGGTAATCGTC-1_7_G10	8.161042965	-26.46799717	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3793	9253	0.00248568	0.004430995	2	L2-3	EN-L2-3-Cntl	12	6	6
AAGGCAGGTGCAACTT-1_7_G10	33.22870704	-4.16958676	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2697	5477	0.003651634	0.007303268	2	2	EN-L4	12	6	6
AAGGCAGGTTGGACCC-1_7_G10	33.06566806	-6.078095519	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3586	7734	0.018748384	0.010861133	2	2	EN-L4	12	6	6
AAGGTTCCAAGAGGCT-1_7_G10	17.22542876	-18.5387822	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4383	10686	0.029852143	0.005146921	2	L2-3	EN-L2-3-MS	12	6	6
AAGGTTCCAGGCTCAC-1_7_G10	-11.3039082	-0.286976214	13A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2593	5161	0.022282503	0.002325131	2	13A	IN-VIP	12	6	6
AAGGTTCCATAGGATA-1_7_G10	-2.025537692	5.917921747	11	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	947	1205	0.005809129	0.003319502	2	11	Glia-MIX	12	6	6
AAGGTTCCATGGTCAT-1_7_G10	-16.86030812	8.826733032	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1114	1516	0.009234828	0.002638522	2	8	Astrocytes	12	6	6
AAGGTTCGTATAGGGC-1_7_G10	32.94892219	-2.400839362	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2345	4020	0.005472637	0.004477612	2	2	EN-L4	12	6	6
AAGGTTCGTCTAACGT-1_7_G10	-11.97452479	-15.60121557	6B	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1201	1841	0.015752309	0.005975014	2	6B	IN-SST	12	6	6
AAGGTTCGTGCAGACA-1_7_G10	0.315777469	33.62104314	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	874	1215	0.006584362	0.003292181	2	oligos	OL-MS-2	12	6	6
AAGGTTCTCTGCCAGG-1_7_G10	2.235202699	-21.9285909	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3356	7303	0.003149391	0.005614131	2	L2-3	EN-L2-3-Cntl	12	6	6
AAGTCTGCAGCATACT-1_7_G10	0.427341448	35.26396488	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	765	1039	0.008662175	0.006737247	2	oligos	OL-MS-2	12	6	6
AAGTCTGTCAACACCA-1_7_G10	-4.817387987	32.79586189	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	930	1262	0.00792393	0.002377179	2	oligos	OL-MS-2	12	6	6
AAGTCTGTCTGCTTGC-1_7_G10	-0.747728304	32.91430668	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	802	1054	0.007590133	0.0028463	2	oligos	OL-MS-2	12	6	6
AATCCAGAGCACACAG-1_7_G10	13.38423975	-22.41469353	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	5723	17538	0.011175733	0.006215076	2	L2-3	EN-L2-3-MS	12	6	6
AATCCAGAGCCTATGT-1_7_G10	-10.90375867	-30.65306822	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1123	1579	0.0569981	0.009499683	2	16	EN-PYR	12	6	6
AATCCAGCAAACCCAT-1_7_G10	-12.07526036	-33.19952496	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1521	2511	0.110712863	0.009159697	2	16	EN-PYR	12	6	6
AATCCAGCATACGCTA-1_7_G10	-11.23124852	-1.696815369	13A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2200	3954	0.007334345	0.009357613	2	13A	IN-VIP	12	6	6
AATCCAGTCAGGATCT-1_7_G10	23.77218256	27.58551388	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1117	1619	0.003705991	0.001852996	2	oligos	OL-MS-2	12	6	6
AATCGGTAGAGTCTGG-1_7_G10	33.05614817	-5.724486552	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2952	5759	0.007813857	0.008855704	2	2	EN-L4	12	6	6
AATCGGTAGCTCCCAG-1_7_G10	-20.82672171	11.91777851	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	860	1242	0.006441224	0.004830918	2	8	Astrocytes	12	6	6
AATCGGTCATGATCCA-1_7_G10	-4.11297732	35.24995818	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	755	1015	0.006896552	0.003940887	2	oligos	OL-MS-2	12	6	6
AATCGGTTCAGCGATT-1_7_G10	3.225873828	-21.4545251	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3559	8313	0.008179959	0.003608805	2	L2-3	EN-L2-3-MS	12	6	6
AATCGGTTCGGAAATA-1_7_G10	-14.89234773	9.709917387	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1264	1814	0.006615215	0.004410143	2	8	Astrocytes	12	6	6
AATCGGTTCGGAGCAA-1_7_G10	-19.05729164	9.552465605	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	810	1087	0.004599816	0.00275989	2	8	Astrocytes	12	6	6
AATCGGTTCGGTTCGG-1_7_G10	31.12708502	-11.14275153	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3396	7555	0.027928524	0.00741231	2	2	EN-L4	12	6	6
AATCGGTTCGTTTGCC-1_7_G10	-33.45925304	-9.563435017	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1072	1560	0.003846154	0.001923077	2	9	OPC	12	6	6
ACACCAAAGGTGCACA-1_7_G10	33.10898548	-1.870657906	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2453	4794	0.002711723	0.007300793	2	2	EN-L4	12	6	6
ACACCAACAAGAGGCT-1_7_G10	33.41691474	6.71973389	14	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	812	1029	0.024295432	0.016520894	2	14	Microglia	12	6	6
ACACCAACATGACATC-1_7_G10	-34.78976824	-6.851133979	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1185	1926	0.001557632	0.001038422	2	9	OPC	12	6	6
ACACCAACATGTCTCC-1_7_G10	-5.15471204	33.70220903	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	908	1192	0.005872483	0.005872483	2	oligos	OL-MS-2	12	6	6
ACACCAAGTCAGAATA-1_7_G10	-17.85808403	-17.58421229	6B	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2007	3858	0.00155521	0.003628823	2	6B	IN-SST	12	6	6
ACACCAATCAACCATG-1_7_G10	-20.44411712	18.1051121	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1955	3288	0.003345499	0.003345499	2	8	Astrocytes	12	6	6
ACACCAATCTCTGAGA-1_7_G10	-19.39233359	16.29839505	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1430	2282	0.006573181	0.004820333	2	8	Astrocytes	12	6	6
ACACCCTAGCGTCAAG-1_7_G10	-5.752714731	-30.59724407	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	793	1055	0.091943128	0.006635071	2	16	EN-PYR	12	6	6
ACACCCTAGCTAACTC-1_7_G10	5.471989915	-16.4022943	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2985	6124	0.015512737	0.006858263	2	L2-3	EN-L2-3-MS	12	6	6
ACACCCTCACCGGAAA-1_7_G10	-26.30933916	-6.39317564	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1114	1687	0.003556609	0.004149378	2	9	OPC	12	6	6
ACACCCTCATGCGCAC-1_7_G10	2.374442459	6.381300617	7	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1304	1806	0.009966777	0.008859358	2	7	Phagocytes	12	6	6
ACACCCTGTCGCATCG-1_7_G10	23.83762132	-11.82546226	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3497	7816	0.015353122	0.004605937	2	3	EN-L5-6	12	6	6
ACACCCTGTTGAGTTC-1_7_G10	-0.973489805	32.75556026	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	819	1086	0.008287293	0.003683241	2	oligos	OL-MS-2	12	6	6
ACACCCTGTTGTGGCC-1_7_G10	-0.528757038	-21.45400544	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3389	8094	0.002470966	0.003088708	2	L2-3	EN-L2-3-Cntl	12	6	6
ACACCCTTCAACGCTA-1_7_G10	4.343490735	-14.85343346	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2391	4306	0.010450534	0.004412448	2	L2-3	EN-L2-3-MS	12	6	6
ACACCCTTCATAAAGG-1_7_G10	23.09065739	27.08901018	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1127	1653	0.002419843	0.004234725	2	oligos	OL-MS-2	12	6	6
ACACCCTTCGTGGTCG-1_7_G10	-1.950533315	10.65557464	5	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1040	1430	0.013286713	0.016083916	2	oligos	OL-MS-1	12	6	6
ACACCGGAGTGGCACA-1_7_G10	3.150511675	-15.07092465	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2310	4203	0.004758506	0.01213419	2	L2-3	EN-L2-3-MS	12	6	6
ACACCGGCAATCTACG-1_7_G10	-12.24620354	-32.95749632	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1326	2138	0.062207671	0.00748363	2	16	EN-PYR	12	6	6
ACACCGGCATACCATG-1_7_G10	22.65883183	27.09958873	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1155	1708	0.0029274	0.005854801	2	oligos	OL-MS-2	12	6	6
ACACCGGGTCTTGCGG-1_7_G10	13.77671515	-22.03674031	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4996	13521	0.011833444	0.005990681	2	L2-3	EN-L2-3-MS	12	6	6
ACACCGGTCATTGCCC-1_7_G10	27.62540219	4.004768858	15BA	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	909	1182	0.018612521	0.010152284	2	15BA	Stromal cells	12	6	6
ACACTGAAGCGTGAAC-1_7_G10	21.82355468	-3.122381498	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2244	3912	0.021728016	0.00408998	2	2	EN-L4	12	6	6
ACACTGAAGCTCCCAG-1_7_G10	-5.746912204	33.75699372	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	967	1394	0.008608321	0.00286944	2	oligos	OL-MS-2	12	6	6
ACACTGAAGTGTCCCG-1_7_G10	12.05475278	-20.91276266	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3460	7982	0.01991982	0.003883738	2	L2-3	EN-L2-3-MS	12	6	6
ACACTGACAATGCCAT-1_7_G10	8.609479888	-28.68503892	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	6294	22726	0.006996392	0.005016281	2	L2-3	EN-L2-3-Cntl	12	6	6
ACACTGATCAACACGT-1_7_G10	-6.12373275	34.22066323	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	898	1206	0.009950249	0.000829187	2	oligos	OL-MS-2	12	6	6
ACACTGATCGGCGCAT-1_7_G10	-21.64739544	13.10305101	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1103	1663	0.002405292	0.007215875	2	8	Astrocytes	12	6	6
ACACTGATCGTACCGG-1_7_G10	31.058102	-10.55794173	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3610	7942	0.014857718	0.005414253	2	2	EN-L4	12	6	6
ACACTGATCTACCAGA-1_7_G10	-1.499682768	1.058167931	11	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2486	4359	0.005964671	0.004588208	2	11	Glia-MIX	12	6	6
ACAGCCGAGCAGATCG-1_7_G10	2.096224051	-16.79595823	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2538	4906	0.006726457	0.004688137	2	L2-3	EN-L2-3-MS	12	6	6
ACAGCCGCAAATCCGT-1_7_G10	-3.763892753	32.98157033	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	990	1394	0.008608321	0.004304161	2	oligos	OL-MS-2	12	6	6
ACAGCCGCAAGCTGGA-1_7_G10	-20.41531906	-17.61607743	6A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2901	5942	0.011275665	0.00622686	2	6A	IN-PV	12	6	6
ACAGCCGCACATTTCT-1_7_G10	-8.61586571	34.46020451	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	841	1072	0.008395522	0.003731343	2	oligos	OL-MS-2	12	6	6
ACAGCCGCATTCCTCG-1_7_G10	-7.407782761	35.29868118	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	799	1060	0.004716981	0.00754717	2	oligos	OL-MS-2	12	6	6
ACAGCCGGTACATCCA-1_7_G10	14.45656044	-4.855719433	12	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1934	3686	0.004340749	0.006239826	2	12	EN-MIX	12	6	6
ACAGCCGGTCTCGTTC-1_7_G10	-19.10946697	-8.092425028	13B	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	5299	14612	0.015261429	0.005064331	2	13B	IN-SV2C	12	6	6
ACAGCCGGTTAGTGGG-1_7_G10	-0.67500383	33.28228796	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	870	1235	0.001619433	0.007287449	2	oligos	OL-MS-2	12	6	6
ACAGCCGTCCGCATCT-1_7_G10	3.114929098	-24.28017224	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4304	10677	0.002341482	0.007024445	2	L2-3	EN-L2-3-MS	12	6	6
ACAGCTACATTACCTT-1_7_G10	1.914338114	-17.35502297	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2738	5746	0.006091194	0.005046989	2	L2-3	EN-L2-3-MS	12	6	6
ACAGCTAGTTCCATGA-1_7_G10	32.77750349	-4.907041292	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3431	7578	0.004750594	0.003958828	2	2	EN-L4	12	6	6
ACAGCTATCCCAAGAT-1_7_G10	33.42692615	-2.385439038	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2268	3958	0.006821627	0.006316321	2	2	EN-L4	12	6	6
ACAGCTATCTTGAGGT-1_7_G10	-23.32644026	30.1308755	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1828	3471	0.005762028	0.00403342	2	8	Astrocytes	12	6	6
ACATACGAGGAATGGA-1_7_G10	-21.23964095	12.44734021	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	922	1270	0.011023622	0.004724409	2	8	Astrocytes	12	6	6
ACATACGCAAAGCAAT-1_7_G10	3.53590357	-24.14032086	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4138	9989	0.010111122	0.006306938	2	L2-3	EN-L2-3-MS	12	6	6
ACATACGCAATGTAAG-1_7_G10	-6.171770106	31.32031721	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1223	1707	0.012302285	0.005272408	2	oligos	OL-MS-2	12	6	6
ACATACGCAGTCGATT-1_7_G10	29.97507195	-6.591735557	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3899	9863	0.008212511	0.005373619	2	2	EN-L4	12	6	6
ACATACGGTACGAAAT-1_7_G10	20.54263314	27.330045	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	925	1282	0.010140406	0.000780031	2	oligos	OL-MS-2	12	6	6
ACATACGGTAGGGACT-1_7_G10	9.378949363	-23.33078661	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	5351	16284	0.003868828	0.017808892	2	L2-3	EN-L2-3-MS	12	6	6
ACATACGTCCTTAATC-1_7_G10	-6.423765175	34.94586984	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	816	1052	0.016159696	0.002851711	2	oligos	OL-MS-2	12	6	6
ACATCAGCATACGCCG-1_7_G10	-2.46606873	31.75012792	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	910	1269	0.009456265	0.005516154	2	oligos	OL-MS-2	12	6	6
ACATCAGCATATGCTG-1_7_G10	-6.57872928	32.20832181	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1090	1520	0.025657895	0.005921053	2	oligos	OL-MS-2	12	6	6
ACATCAGGTCTGATTG-1_7_G10	-17.85743919	8.971121004	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	934	1317	0.002277904	0.012908125	2	8	Astrocytes	12	6	6
ACATCAGTCAATAAGG-1_7_G10	-21.92127817	14.91410642	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1190	1765	0.006232295	0.007365439	2	8	Astrocytes	12	6	6
ACATCAGTCTTCAACT-1_7_G10	-21.11248139	16.31543	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1279	2079	0.006734007	0.002886003	2	8	Astrocytes	12	6	6
ACATGGTAGAGAGCTC-1_7_G10	-1.036608226	35.36048278	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	772	1060	0.006603774	0.004716981	2	oligos	OL-MS-2	12	6	6
ACATGGTCAATAACGA-1_7_G10	16.31180061	-32.17833532	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4784	14697	0.001564945	0.004422671	2	3	EN-L5-6	12	6	6
ACATGGTCAGAGTGTG-1_7_G10	11.40911824	1.212304307	12	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	668	1002	0.010978044	0.006986028	2	12	EN-MIX	12	6	6
ACATGGTCATGCATGT-1_7_G10	1.689633679	-20.32758952	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3168	6963	0.004452104	0.00344679	2	L2-3	EN-L2-3-Cntl	12	6	6
ACATGGTGTGTGAAAT-1_7_G10	-5.762315357	31.73650395	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1180	1673	0.009563658	0.007172744	2	oligos	OL-MS-2	12	6	6
ACATGGTTCCAAATGC-1_7_G10	26.2871049	-26.29855412	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	5252	18088	0.010725343	0.007905794	2	3	EN-L5-6	12	6	6
ACATGGTTCTTTAGTC-1_7_G10	-8.402099362	-0.190447624	13A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2255	4698	0.00617284	0.006811409	2	13A	IN-VIP	12	6	6
ACCAGTACAGCTGTAT-1_7_G10	-5.192930052	31.4806473	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1128	1616	0.017945545	0.004950495	2	oligos	OL-MS-2	12	6	6
ACCAGTAGTCCAGTAT-1_7_G10	3.541088984	-13.6012271	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2029	3449	0.009278052	0.005508843	2	L2-3	EN-L2-3-MS	12	6	6
ACCAGTAGTGTTGGGA-1_7_G10	-22.67523164	15.40942137	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1109	1701	0.005291005	0.006466784	2	8	Astrocytes	12	6	6
ACCAGTAGTTATCCGA-1_7_G10	2.750982447	-24.92032563	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3455	8193	0.002196997	0.001952887	2	L2-3	EN-L2-3-Cntl	12	6	6
ACCAGTAGTTCGTGAT-1_7_G10	-11.17861575	15.96882654	11	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1572	2422	0.002890173	0.006193229	2	11	Glia-MIX	12	6	6
ACCAGTAGTTGGACCC-1_7_G10	-9.951656282	13.91895241	11	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1471	2224	0.001348921	0.005395683	2	11	Glia-MIX	12	6	6
ACCAGTATCAGCTTAG-1_7_G10	-6.125787215	-2.614376024	13A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1594	3028	0.017503303	0.003963012	2	13A	IN-VIP	12	6	6
ACCCACTAGTACCGGA-1_7_G10	0.631227677	31.98012217	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	751	1025	0.00195122	0.00195122	2	oligos	OL-MS-2	12	6	6
ACCCACTCAAGCCGCT-1_7_G10	23.00010058	27.22471923	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1124	1631	0.006744329	0.003678725	2	oligos	OL-MS-2	12	6	6
ACCCACTCAATAAGCA-1_7_G10	16.82109873	-32.80265387	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	5891	21031	0.001426466	0.003423518	2	3	EN-L5-6	12	6	6
ACCCACTCAATGCCAT-1_7_G10	29.27232616	-11.22954106	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4931	13765	0.026153287	0.005230657	2	2	EN-L4	12	6	6
ACCCACTGTGATGCCC-1_7_G10	21.74881234	27.80201098	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1013	1499	0.003335557	0.002668446	2	oligos	OL-MS-2	12	6	6
ACCCACTTCCGAACGC-1_7_G10	-34.54043188	-6.81242957	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1189	1927	0.005189414	0.004670472	2	9	OPC	12	6	6
ACCCACTTCCGCATAA-1_7_G10	-34.38999379	-6.108170857	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1312	2082	0.010086455	0.003842459	2	9	OPC	12	6	6
ACCCACTTCGCACTCT-1_7_G10	-8.90439924	33.3274614	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	932	1208	0.013245033	0.007450331	2	oligos	OL-MS-2	12	6	6
ACCGTAAAGAGCCCAA-1_7_G10	-10.78157418	-1.872279432	13A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1949	3562	0.008422235	0.008702976	2	13A	IN-VIP	12	6	6
ACCGTAAAGTTCCACA-1_7_G10	-9.791066657	-29.3329571	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1156	1691	0.078060319	0.00295683	2	16	EN-PYR	12	6	6
ACCGTAACAATCTACG-1_7_G10	-4.116799281	34.57668202	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	859	1214	0.004118616	0.005766063	2	oligos	OL-MS-2	12	6	6
ACCGTAACATGTCCTC-1_7_G10	-13.10915007	-17.59773976	6B	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1213	1835	0.007629428	0.00599455	2	6B	IN-SST	12	6	6
ACCGTAATCCTAGTGA-1_7_G10	-10.71667521	15.97634594	11	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1707	2655	0.002636535	0.003389831	2	11	Glia-MIX	12	6	6
ACCGTAATCTAACTGG-1_7_G10	29.92540661	-10.86189077	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3805	8760	0.02956621	0.005936073	2	2	EN-L4	12	6	6
ACCTTTAAGCGTCTAT-1_7_G10	-18.02652048	8.716555505	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	997	1366	0.007320644	0.002928258	2	8	Astrocytes	12	6	6
ACCTTTAAGGTAGCTG-1_7_G10	-17.85415455	9.251545259	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	909	1204	0.009966777	0.005813953	2	8	Astrocytes	12	6	6
ACCTTTACAATAGAGT-1_7_G10	-20.01451474	14.18930849	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1187	1716	0.005244755	0.006410256	2	8	Astrocytes	12	6	6
ACCTTTAGTCCGTCAG-1_7_G10	-25.1497725	-23.62329132	6A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4212	11386	0.037765677	0.005620938	2	6A	IN-PV	12	6	6
ACGAGCCAGAGGTACC-1_7_G10	7.535703173	-29.94527282	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3537	8600	0.011627907	0.002209302	2	L2-3	EN-L2-3-Cntl	12	6	6
ACGAGCCAGAGTCTGG-1_7_G10	2.596396126	-14.49190685	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2175	4012	0.006729811	0.002741775	2	L2-3	EN-L2-3-MS	12	6	6
ACGAGCCAGCCGGTAA-1_7_G10	29.69739938	-3.749795625	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3418	8052	0.010059613	0.00360159	2	L2-3	EN-L2-3-Cntl	12	6	6
ACGAGCCAGCGTCAAG-1_7_G10	30.78149223	-0.768046934	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2750	5467	0.009328699	0.004207061	2	2	EN-L4	12	6	6
ACGAGCCAGGATGGTC-1_7_G10	13.71739735	-21.14687103	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4002	9436	0.022573124	0.00805426	2	L2-3	EN-L2-3-MS	12	6	6
ACGAGCCAGTCATCCA-1_7_G10	-26.4844179	-7.690341042	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1044	1433	0.00418702	0.003489184	2	9	OPC	12	6	6
ACGAGCCAGTTCGCGC-1_7_G10	-2.779848348	31.75513907	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	944	1360	0.004411765	0.002941176	2	oligos	OL-MS-2	12	6	6
ACGAGCCCAAACTGCT-1_7_G10	4.151817558	-10.74183775	12	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1888	3442	0.00464846	0.004067403	2	12	EN-MIX	12	6	6
ACGAGCCCACCCAGTG-1_7_G10	-2.320762476	36.46623467	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	762	1030	0.011650485	0.010679612	2	oligos	OL-MS-2	12	6	6
ACGAGCCCACGGCCAT-1_7_G10	1.484290923	-21.45615185	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3802	9508	0.005363904	0.004101809	2	L2-3	EN-L2-3-Cntl	12	6	6
ACGAGCCCACTCTGTC-1_7_G10	1.686733263	-17.47089903	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2605	5195	0.006544755	0.00481232	2	L2-3	EN-L2-3-MS	12	6	6
ACGAGCCCAGTTCCCT-1_7_G10	-2.881401017	-0.897812143	13A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3245	6967	0.00114827	0.00717669	2	13A	IN-VIP	12	6	6
ACGAGCCGTCCTCCAT-1_7_G10	-32.00279109	-1.282257768	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1355	2135	0.007025761	0.005620609	2	9	OPC	12	6	6
ACGAGCCTCATGCAAC-1_7_G10	-22.24278839	-14.9494309	6B	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2854	5628	0.016346837	0.009061834	2	6B	IN-SST	12	6	6
ACGAGCCTCGTTACAG-1_7_G10	20.46684058	-3.386466961	12	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1646	2557	0.04497458	0.006648416	2	12	EN-MIX	12	6	6
ACGAGGAAGATGCCTT-1_7_G10	15.99726046	-32.74321844	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4252	12288	0.001871745	0.003173828	2	3	EN-L5-6	12	6	6
ACGAGGAAGCTAGTCT-1_7_G10	16.60095949	-30.9544061	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3974	9989	0.007308039	0.004705176	2	3	EN-L5-6	12	6	6
ACGAGGAAGGATGGTC-1_7_G10	-0.771857168	34.62198204	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	883	1175	0.002553191	0.009361702	2	oligos	OL-MS-2	12	6	6
ACGAGGAAGTCAATAG-1_7_G10	-14.19965163	-16.05936568	6B	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1392	2317	0.020284851	0.011653	2	6B	IN-SST	12	6	6
ACGAGGAAGTGGCACA-1_7_G10	-21.31120412	11.90723541	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	924	1304	0.036042945	0.004601227	2	8	Astrocytes	12	6	6
ACGAGGACAATGGAAT-1_7_G10	31.30132315	-9.883928844	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3179	6777	0.022871477	0.003098716	2	2	EN-L4	12	6	6
ACGAGGACACCGCTAG-1_7_G10	31.91325633	-3.066598416	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2690	5356	0.010082151	0.003920836	2	2	EN-L4	12	6	6
ACGAGGACACGAGAGT-1_7_G10	-6.208998384	-30.28564614	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	768	1001	0.02997003	0.008991009	2	16	EN-PYR	12	6	6
ACGAGGACAGGTCGTC-1_7_G10	-23.00311896	14.5521241	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1164	1742	0.006314581	0.002870264	2	8	Astrocytes	12	6	6
ACGAGGACATTCTTAC-1_7_G10	-33.85772791	-8.877498449	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	972	1420	0.004225352	0.001408451	2	9	OPC	12	6	6
ACGAGGAGTTCGGGCT-1_7_G10	0.930348835	34.05876406	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	731	1058	0.005671078	0.005671078	2	oligos	OL-MS-2	12	6	6
ACGAGGAGTTGCGTTA-1_7_G10	23.95866392	-27.59580459	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3262	7868	0.00088968	0.004448399	2	3	EN-L5-6	12	6	6
ACGAGGATCCGTTGTC-1_7_G10	5.248861517	-16.30363027	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3125	6598	0.010306153	0.006062443	2	L2-3	EN-L2-3-MS	12	6	6
ACGATACAGATCGATA-1_7_G10	21.85440678	26.2875623	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1014	1438	0.001390821	0.006954103	2	oligos	OL-MS-2	12	6	6
ACGATACAGCGCCTTG-1_7_G10	-6.023217405	-30.62297133	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	797	1071	0.084033613	0.005602241	2	16	EN-PYR	12	6	6
ACGATACAGTGTGGCA-1_7_G10	-17.50977865	6.276125776	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	838	1109	0.035166817	0.016230839	2	8	Astrocytes	12	6	6
ACGATACCAGACTCGC-1_7_G10	27.01600426	-6.430045461	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	5719	19111	0.002825598	0.006017477	2	3	EN-L5-6	12	6	6
ACGATACGTTTGCATG-1_7_G10	2.604152496	6.41271682	7	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1178	1609	0.002486016	0.008701057	2	7	Phagocytes	12	6	6
ACGATGTAGCCAGTTT-1_7_G10	23.88869628	26.62253406	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1356	2061	0.005822416	0.008248423	2	oligos	OL-MS-2	12	6	6
ACGATGTCAAAGAATC-1_7_G10	-21.3227888	-28.1130378	6A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3920	9703	0.003194888	0.004740802	2	6A	IN-PV	12	6	6
ACGATGTTCCATTCTA-1_7_G10	26.37889247	5.528762663	15A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1128	1521	0.021696252	0.018408941	2	15A	Endo cells	12	6	6
ACGATGTTCGGCGGTT-1_7_G10	0.397483099	32.53750647	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	794	1099	0.003639672	0.004549591	2	oligos	OL-MS-2	12	6	6
ACGATGTTCGTCGTTC-1_7_G10	-9.441561099	32.56101553	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	852	1151	0.042571677	0.006081668	2	oligos	OL-MS-2	12	6	6
ACGATGTTCTCGCATC-1_7_G10	-11.87440869	-32.96451276	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1442	2408	0.120431894	0.004568106	2	16	EN-PYR	12	6	6
ACGCAGCAGTACGACG-1_7_G10	-13.20595503	-35.6143101	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1726	3007	0.068506817	0.015962754	2	16	EN-PYR	12	6	6
ACGCAGCCACGCGAAA-1_7_G10	-18.85133647	-16.89099561	6B	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2088	3846	0.009620385	0.008840354	2	6B	IN-SST	12	6	6
ACGCAGCCATTCTTAC-1_7_G10	8.802088934	-20.82810058	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3562	7896	0.005699088	0.010764944	2	L2-3	EN-L2-3-MS	12	6	6
ACGCAGCGTAGCAAAT-1_7_G10	14.0424492	-31.88443075	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3479	8289	0.000361925	0.004705031	2	3	EN-L5-6	12	6	6
ACGCAGCGTAGCTAAA-1_7_G10	-12.3812888	-17.52704032	6B	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1081	1603	0.005614473	0.002495321	2	6B	IN-SST	12	6	6
ACGCAGCGTGTGAATA-1_7_G10	1.50589458	30.28337869	1	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	754	1082	0.00831793	0.006469501	2	oligos	OL-Cntl	12	6	6
ACGCAGCTCTTGAGGT-1_7_G10	-14.73680845	9.904436995	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1300	1846	0.009750813	0.004875406	2	8	Astrocytes	12	6	6
ACGCCAGAGGCAGGTT-1_7_G10	22.41193049	-18.46420952	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	6455	21976	0.013605752	0.009055333	2	3	EN-L5-6	12	6	6
ACGCCAGCAGGCGATA-1_7_G10	0.019064422	33.12303463	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	853	1168	0.005993151	0.009417808	2	oligos	OL-MS-2	12	6	6
ACGCCAGGTAATCACC-1_7_G10	5.659317878	0.362372699	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1202	1734	0.028258362	0.010957324	2	16	EN-PYR	12	6	6
ACGCCAGGTAGCTAAA-1_7_G10	-16.77239626	10.8963878	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1264	1776	0.007882883	0.002252252	2	8	Astrocytes	12	6	6
ACGCCAGGTCGGCTCA-1_7_G10	-9.92494408	-33.04119534	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1121	1618	0.074783684	0.014833127	2	16	EN-PYR	12	6	6
ACGCCAGTCGGCGCAT-1_7_G10	-0.814618196	32.71514856	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	807	1084	0.007380074	0.006457565	2	oligos	OL-MS-2	12	6	6
ACGCCAGTCTACTTAC-1_7_G10	-23.86746796	25.19308448	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1668	2830	0.009540636	0.00459364	2	8	Astrocytes	12	6	6
ACGCCGAAGCACAGGT-1_7_G10	13.48990393	-28.58305709	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2483	5020	0.004780876	0.005577689	2	3	EN-L5-6	12	6	6
ACGCCGAAGTTGCAGG-1_7_G10	-14.22150527	-16.40022592	6B	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1481	2566	0.058456742	0.003897116	2	6B	IN-SST	12	6	6
ACGCCGACAAGGACTG-1_7_G10	10.61869749	-26.24894859	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4287	11395	0.004738921	0.007371654	2	L2-3	EN-L2-3-Cntl	12	6	6
ACGCCGACAATAGAGT-1_7_G10	-7.061255517	31.69635897	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1179	1713	0.026269702	0.006421483	2	oligos	OL-MS-2	12	6	6
ACGCCGACAATCCGAT-1_7_G10	-20.46980747	15.10287919	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1309	1987	0.008555611	0.007045798	2	8	Astrocytes	12	6	6
ACGCCGACAGCCACCA-1_7_G10	31.33486048	-4.647165565	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3515	7594	0.007637609	0.004872268	2	2	EN-L4	12	6	6
ACGCCGAGTCTAGGTT-1_7_G10	33.9958606	7.456820121	14	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1015	1361	0.013225569	0.008082292	2	14	Microglia	12	6	6
ACGCCGAGTTCCACGG-1_7_G10	-13.40956894	-17.25892868	6B	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1331	2101	0.004283674	0.005711566	2	6B	IN-SST	12	6	6
ACGCCGATCGTGACAT-1_7_G10	-22.01868708	14.76093622	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1191	1726	0.00405562	0.003476246	2	8	Astrocytes	12	6	6
ACGCCGATCTGGTATG-1_7_G10	17.63872892	-7.012253506	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1504	2546	0.003142184	0.006284368	2	3	EN-L5-6	12	6	6
ACGGAGAAGTCGTACT-1_7_G10	4.318796635	-15.02685756	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2443	4424	0.00994575	0.011528029	2	L2-3	EN-L2-3-MS	12	6	6
ACGGAGACACGCCAGT-1_7_G10	-8.446771939	-31.66927621	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	913	1215	0.041975309	0.008230453	2	16	EN-PYR	12	6	6
ACGGAGACAGCTCGCA-1_7_G10	31.92053603	-3.392486232	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2976	6114	0.015047432	0.00507033	2	2	EN-L4	12	6	6
ACGGAGAGTCCGAACC-1_7_G10	32.00137614	-8.522237825	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3513	7381	0.017341824	0.006503184	2	2	EN-L4	12	6	6
ACGGAGAGTCGCGTGT-1_7_G10	1.342199876	-21.63518165	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3354	7609	0.005519779	0.006834012	2	L2-3	EN-L2-3-Cntl	12	6	6
ACGGAGATCGTCGTTC-1_7_G10	-20.48683276	-26.6623803	6A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3152	7414	0.017129755	0.004720798	2	6A	IN-PV	12	6	6
ACGGCCAAGACGCTTT-1_7_G10	-14.60984486	-16.95611129	6B	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1416	2490	0.010843373	0.003212851	2	6B	IN-SST	12	6	6
ACGGCCAAGGCGCTCT-1_7_G10	1.525804574	-29.11750842	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4816	14439	0.004709467	0.002493247	2	L2-3	EN-L2-3-Cntl	12	6	6
ACGGCCAAGTACGCGA-1_7_G10	28.49246397	-4.845609203	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4015	10622	0.000847298	0.019487855	2	2	EN-L4	12	6	6
ACGGCCACAGAAGCAC-1_7_G10	19.17330271	-17.36889373	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	7334	29219	0.031931278	0.005749683	2	L2-3	EN-L2-3-MS	12	6	6
ACGGCCAGTACACCGC-1_7_G10	-20.20635664	14.6739568	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1249	1867	0.002142475	0.005356186	2	8	Astrocytes	12	6	6
ACGGCCATCAACACAC-1_7_G10	3.299267767	-14.95704428	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2354	3945	0.007097592	0.015209125	2	L2-3	EN-L2-3-MS	12	6	6
ACGGCCATCAGTTAGC-1_7_G10	24.446122	-25.09173582	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2623	5519	0.001993115	0.004167422	2	3	EN-L5-6	12	6	6
ACGGCCATCCACGACG-1_7_G10	-8.09745065	34.32405861	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	932	1224	0.017156863	0.006535948	2	oligos	OL-MS-2	12	6	6
ACGGCCATCTCGTATT-1_7_G10	22.28622894	27.33249793	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1088	1627	0.00676091	0.004917025	2	oligos	OL-MS-2	12	6	6
ACGGGCTAGCTAAGAT-1_7_G10	16.37864464	-28.92293258	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4653	12788	0.007585236	0.004222709	2	3	EN-L5-6	12	6	6
ACGGGCTAGTGTTTGC-1_7_G10	-25.05512186	-9.776056799	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	912	1196	0.002508361	0.008361204	2	9	OPC	12	6	6
ACGGGCTCAACCGCCA-1_7_G10	-20.41124469	15.35279535	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1306	1934	0.003102378	0.004136505	2	8	Astrocytes	12	6	6
ACGGGCTCAGGGCATA-1_7_G10	25.79848573	3.648293705	15BA	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	924	1204	0.006644518	0.006644518	2	15BA	Stromal cells	12	6	6
ACGGGCTCATTAGGCT-1_7_G10	5.384927167	-21.53282876	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3436	7727	0.019024201	0.005953151	2	L2-3	EN-L2-3-MS	12	6	6
ACGGGCTGTCCAAGTT-1_7_G10	-7.124934757	36.1152337	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	767	1018	0.006876228	0.006876228	2	oligos	OL-MS-2	12	6	6
ACGGGCTGTTCGTGAT-1_7_G10	-17.79678219	8.108892592	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	970	1329	0.017306245	0.0082769	2	8	Astrocytes	12	6	6
ACGGGCTTCAACCATG-1_7_G10	-11.04166473	31.56238201	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	914	1127	0.016858917	0.007098492	2	oligos	OL-MS-2	12	6	6
ACGGGCTTCCGATATG-1_7_G10	21.56817117	27.27156232	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1066	1554	0.003861004	0.003861004	2	oligos	OL-MS-2	12	6	6
ACGGGTCAGCCTATGT-1_7_G10	15.69408638	-32.7979093	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4786	14203	0.000704077	0.007392804	2	3	EN-L5-6	12	6	6
ACGGGTCAGGAGTAGA-1_7_G10	2.64052063	5.778582087	7	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1096	1492	0.004691689	0.00536193	2	7	Phagocytes	12	6	6
ACGGGTCAGTAATCCC-1_7_G10	-17.62240139	-17.44514321	6B	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1930	3824	0.011767782	0.005753138	2	6B	IN-SST	12	6	6
ACGGGTCCATAGAAAC-1_7_G10	25.09272456	8.309318854	15A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1924	2843	0.015124868	0.028842772	2	15A	Endo cells	12	6	6
ACGGGTCGTTTCGCTC-1_7_G10	-31.07927466	-2.375376862	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1341	2165	0.002771363	0.0073903	2	9	OPC	12	6	6
ACGGGTCTCAGAGGTG-1_7_G10	-1.853799459	35.5661082	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	784	1076	0.00464684	0.00464684	2	oligos	OL-MS-2	12	6	6
ACGTCAAAGTAAGTAC-1_7_G10	-11.10278065	15.3361896	11	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1363	1961	0.003059663	0.004079551	2	11	Glia-MIX	12	6	6
ACGTCAAAGTGCTGCC-1_7_G10	27.92035431	-11.32391583	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4554	11691	0.01308699	0.007954837	2	L2-3	EN-L2-3-MS	12	6	6
ACGTCAACACCCATTC-1_7_G10	16.23237923	-28.78556188	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	5029	14999	0.005867058	0.00540036	2	3	EN-L5-6	12	6	6
ACGTCAACATGGATGG-1_7_G10	-23.05104144	14.15338367	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1009	1426	0.00631136	0.004908836	2	8	Astrocytes	12	6	6
ACGTCAACATGGGAAC-1_7_G10	27.69464735	3.863036366	15DA	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	828	1053	0.011396011	0.008547009	2	15DA	T cells	12	6	6
ACGTCAAGTAAATGTG-1_7_G10	3.071838223	-27.86693827	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2866	6534	0.003367003	0.004132231	2	L2-3	EN-L2-3-Cntl	12	6	6
ACGTCAATCGGAAATA-1_7_G10	-4.587699865	34.46307794	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	825	1085	0.005529954	0.001843318	2	oligos	OL-MS-2	12	6	6
ACTATCTAGCCTCGTG-1_7_G10	-14.61430545	-22.40780752	6A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1330	2162	0.030064755	0.002312673	2	6A	IN-PV	12	6	6
ACTATCTAGCTAGTCT-1_7_G10	22.03359614	25.02098509	1	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1064	1652	0.008474576	0.003631961	2	oligos	OL-Cntl	12	6	6
ACTATCTCAAGACACG-1_7_G10	3.469674385	-16.43303956	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2626	4931	0.007909146	0.009328737	2	L2-3	EN-L2-3-MS	12	6	6
ACTATCTCAGCTGCAC-1_7_G10	-14.84514668	8.216441866	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1035	1385	0.015162455	0.003610108	2	8	Astrocytes	12	6	6
ACTATCTCATCCAACA-1_7_G10	21.19575396	27.92938747	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	899	1270	0.006299213	0.003149606	2	oligos	OL-MS-2	12	6	6
ACTATCTGTGAACCTT-1_7_G10	-7.050829889	-29.96662757	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1004	1774	0.22886133	0.002254791	2	16	EN-PYR	12	6	6
ACTATCTGTGCACCAC-1_7_G10	25.33073464	4.652239648	15BA	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1153	1576	0.018401015	0.004441624	2	15BA	Stromal cells	12	6	6
ACTATCTTCCGTACAA-1_7_G10	1.43675642	-22.89058098	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4344	13107	0.002288853	0.004501411	2	L2-3	EN-L2-3-Cntl	12	6	6
ACTATCTTCGACAGCC-1_7_G10	-16.7596844	8.717873668	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1024	1358	0.009572901	0.010309278	2	8	Astrocytes	12	6	6
ACTATCTTCTATCGCC-1_7_G10	25.87109497	-2.736957801	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2967	7098	0.004508312	0.002817695	2	2	EN-L4	12	6	6
ACTATCTTCTTGGGTA-1_7_G10	30.40820185	9.175841412	15DA	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	886	1182	0.010998308	0.042301184	2	15DA	T cells	12	6	6
ACTGAACAGACGACGT-1_7_G10	-9.75806854	22.26815009	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1821	3279	0.164989326	0.016468435	2	8	Astrocytes	12	6	6
ACTGAACAGGTAAACT-1_7_G10	-7.98586407	-38.8005231	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1735	3088	0.195272021	0.018782383	2	16	EN-PYR	12	6	6
ACTGAACCAATGCCAT-1_7_G10	-5.537289844	33.57373259	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	946	1293	0.008507347	0.009280742	2	oligos	OL-MS-2	12	6	6
ACTGAACCACATCTTT-1_7_G10	-5.428699098	-4.543806519	13A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1321	2102	0.01094196	0.000951475	2	13A	IN-VIP	12	6	6
ACTGAACCACGAAATA-1_7_G10	-4.515469974	34.5203621	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	764	1012	0.011857708	0.002964427	2	oligos	OL-MS-2	12	6	6
ACTGAACTCAGGTTCA-1_7_G10	-20.71729221	11.2551324	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	912	1260	0.008730159	0.004761905	2	8	Astrocytes	12	6	6
ACTGAACTCCAGTATG-1_7_G10	2.273694133	-20.10836968	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3152	6730	0.006240713	0.003417533	2	L2-3	EN-L2-3-MS	12	6	6
ACTGAACTCCTCATTA-1_7_G10	-4.367606821	35.60663721	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	875	1152	0.006076389	0.003472222	2	oligos	OL-MS-2	12	6	6
ACTGAGTAGGGTTCCC-1_7_G10	1.831279769	-11.66140053	12	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1723	2868	0.00209205	0.008019526	2	12	EN-MIX	12	6	6
ACTGAGTCAGCTCGAC-1_7_G10	25.59406735	3.650533636	15BA	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	939	1251	0.005595524	0.003197442	2	15BA	Stromal cells	12	6	6
ACTGAGTCAGCTTCGG-1_7_G10	-13.6235547	-18.90875514	6B	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1261	2081	0.00528592	0.000961076	2	6B	IN-SST	12	6	6
ACTGAGTCATGGATGG-1_7_G10	21.58705096	-2.295646688	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2014	3606	0.006655574	0.007764836	2	2	EN-L4	12	6	6
ACTGAGTTCCGCGTTT-1_7_G10	29.40118709	-11.78066309	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4890	13451	0.017322132	0.010110772	2	2	EN-L4	12	6	6
ACTGATGAGATGGGTC-1_7_G10	-21.26308819	15.76210274	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1228	1830	0.007103825	0.004371585	2	8	Astrocytes	12	6	6
ACTGATGAGTGCTGCC-1_7_G10	-9.491829313	15.67973815	11	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2026	3325	0.002105263	0.006616541	2	11	Glia-MIX	12	6	6
ACTGATGCAAGCCATT-1_7_G10	32.38740517	-7.864789462	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2682	4829	0.008490371	0.005798302	2	2	EN-L4	12	6	6
ACTGATGCACACCGCA-1_7_G10	-11.38373217	31.79687718	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	991	1255	0.022310757	0.006374502	2	oligos	OL-MS-2	12	6	6
ACTGATGCACCATCCT-1_7_G10	33.2124895	-4.286126886	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2743	5351	0.013829191	0.004672024	2	2	EN-L4	12	6	6
ACTGATGCAGGGAGAG-1_7_G10	-20.79531268	13.72561861	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1215	1781	0.00729927	0.008983717	2	8	Astrocytes	12	6	6
ACTGATGGTCGTGGCT-1_7_G10	-2.835380012	35.49498805	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	831	1151	0.009556907	0.006081668	2	oligos	OL-MS-2	12	6	6
ACTGATGGTCTGCGGT-1_7_G10	-8.040694613	33.86739812	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	935	1244	0.02170418	0.008842444	2	oligos	OL-MS-2	12	6	6
ACTGATGGTGTGAATA-1_7_G10	25.13426784	-17.71958339	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	5095	14091	0.040735221	0.007238663	2	3	EN-L5-6	12	6	6
ACTGATGTCATTGCCC-1_7_G10	23.66916771	-9.120034862	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3710	9513	0.001997267	0.004204772	2	3	EN-L5-6	12	6	6
ACTGATGTCTTCAACT-1_7_G10	22.95229165	26.89542219	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1102	1562	0.008322663	0.003841229	2	oligos	OL-MS-2	12	6	6
ACTGCTCAGCCACGTC-1_7_G10	26.00495179	-26.57866234	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4520	11812	0.007026752	0.004910261	2	3	EN-L5-6	12	6	6
ACTGCTCAGGGCATGT-1_7_G10	-14.01181232	-35.19513766	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1940	3284	0.03410475	0.007917174	2	16	EN-PYR	12	6	6
ACTGCTCCACAGGAGT-1_7_G10	-18.36552611	-23.41001681	6A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2131	4062	0.002461841	0.003692762	2	6A	IN-PV	12	6	6
ACTGCTCCACTACAGT-1_7_G10	-4.771386504	33.6211678	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1011	1415	0.007067138	0.009187279	2	oligos	OL-MS-2	12	6	6
ACTGCTCGTCACCTAA-1_7_G10	16.40680092	-28.85212185	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4083	10832	0.011170606	0.005354505	2	3	EN-L5-6	12	6	6
ACTGCTCTCATAGCAC-1_7_G10	1.961043833	-17.28439699	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2805	5373	0.006327936	0.007444631	2	L2-3	EN-L2-3-MS	12	6	6
ACTGCTCTCGGATGGA-1_7_G10	21.05813853	-0.861996708	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1616	2536	0.001182965	0.008675079	2	2	EN-L4	12	6	6
ACTGTCCAGAGTGAGA-1_7_G10	-11.29908603	-33.14781745	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1139	1709	0.054417788	0.012287888	2	16	EN-PYR	12	6	6
ACTGTCCAGATGTAAC-1_7_G10	33.70712934	-6.541778201	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3830	8405	0.007495538	0.008685306	2	2	EN-L4	12	6	6
ACTGTCCAGATGTTAG-1_7_G10	-11.99940402	15.95805361	11	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1383	1968	0.003556911	0.00304878	2	11	Glia-MIX	12	6	6
ACTGTCCAGGCGTACA-1_7_G10	-30.92912987	-2.667239923	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1313	2170	0.006451613	0.004147465	2	9	OPC	12	6	6
ACTGTCCAGGGCTCTC-1_7_G10	29.39661904	-11.02634035	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	5208	15708	0.023300229	0.007066463	2	2	EN-L4	12	6	6
ACTGTCCAGTAACCCT-1_7_G10	-1.757065749	33.29940617	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	940	1351	0.00592154	0.004441155	2	oligos	OL-MS-2	12	6	6
ACTGTCCCACTTAAGC-1_7_G10	-9.828991468	-28.18128878	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1256	1732	0.069284065	0.008083141	2	16	EN-PYR	12	6	6
ACTGTCCCAGTATGCT-1_7_G10	-26.43148898	17.39021664	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1255	1992	0.016064257	0.00753012	2	8	Astrocytes	12	6	6
ACTGTCCCATGAACCT-1_7_G10	3.324359429	-19.5789387	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3463	7511	0.001997071	0.007189455	2	L2-3	EN-L2-3-MS	12	6	6
ACTGTCCTCCTATGTT-1_7_G10	22.48987063	26.97510511	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1077	1506	0.007968127	0.003320053	2	oligos	OL-MS-2	12	6	6
ACTGTCCTCGTTTAGG-1_7_G10	-24.84171254	-11.75541523	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	947	1460	0.003424658	0.003424658	2	9	OPC	12	6	6
ACTTACTAGCCAACAG-1_7_G10	15.5815582	-19.01689632	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	6352	22601	0.009070395	0.005221008	2	L2-3	EN-L2-3-MS	12	6	6
ACTTACTAGCGTCTAT-1_7_G10	-17.39582993	-24.14875692	6A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2057	3873	0.001032791	0.003614769	2	6A	IN-PV	12	6	6
ACTTACTCACGTCTCT-1_7_G10	24.32517996	27.1209107	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1426	2213	0.006326254	0.005422503	2	oligos	OL-MS-2	12	6	6
ACTTACTCATATACGC-1_7_G10	0.655013672	35.41899341	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	714	1008	0.006944444	0.003968254	2	oligos	OL-MS-2	12	6	6
ACTTACTGTAAAGTCA-1_7_G10	8.600200877	-29.23781487	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4377	12017	0.004410419	0.005575435	2	L2-3	EN-L2-3-Cntl	12	6	6
ACTTACTTCGCAAGCC-1_7_G10	-9.550571466	0.595277504	13A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2292	4708	0.00382328	0.005734919	2	13A	IN-VIP	12	6	6
ACTTGTTAGAAACCAT-1_7_G10	-15.16453688	-34.23934493	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1636	2545	0.04086444	0.007858546	2	16	EN-PYR	12	6	6
ACTTGTTAGAGCAATT-1_7_G10	5.920901265	-13.73258694	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2340	4120	0.017475728	0.00776699	2	L2-3	EN-L2-3-MS	12	6	6
ACTTGTTCACATCCGG-1_7_G10	0.805366774	33.85389263	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	748	1032	0.013565891	0.001937984	2	oligos	OL-MS-2	12	6	6
ACTTGTTCATGCCTAA-1_7_G10	-22.14318721	14.23130585	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1114	1637	0.012828345	0.006719609	2	8	Astrocytes	12	6	6
ACTTGTTCATGGTTGT-1_7_G10	22.63161795	-17.7306752	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	7588	32525	0.036863951	0.011714066	2	2	EN-L4	12	6	6
ACTTGTTGTAGCGTCC-1_7_G10	-24.06583759	25.36444916	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1494	2506	0.006384677	0.00518755	2	8	Astrocytes	12	6	6
ACTTGTTGTCGGCTCA-1_7_G10	26.53648407	-5.870899323	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4169	11656	0.001115305	0.00377488	2	2	EN-L4	12	6	6
ACTTGTTGTGCGATAG-1_7_G10	27.67834028	6.088848358	15A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1073	1405	0.039857651	0.014234875	2	15A	Endo cells	12	6	6
ACTTGTTGTGCTCTTC-1_7_G10	33.47305082	6.549181113	14	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1002	1239	0.00645682	0.00968523	2	14	Microglia	12	6	6
ACTTGTTGTGTGTGCC-1_7_G10	-15.66784705	-18.05764076	6B	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1533	2621	0.001526135	0.004196871	2	6B	IN-SST	12	6	6
ACTTGTTTCCCATTAT-1_7_G10	6.171824944	1.96449416	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1252	1707	0.029876977	0.004686585	2	16	EN-PYR	12	6	6
ACTTGTTTCCGTCAAA-1_7_G10	29.00295783	-5.652738374	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3744	9263	0.009176293	0.010255857	2	2	EN-L4	12	6	6
ACTTTCAAGGATTCGG-1_7_G10	-5.976260756	35.26575399	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	799	1065	0.015023474	0.00657277	2	oligos	OL-MS-2	12	6	6
ACTTTCAAGTACGACG-1_7_G10	6.769029827	-24.89068131	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	5008	13711	0.008825031	0.004521917	2	L2-3	EN-L2-3-MS	12	6	6
ACTTTCACAAACGCGA-1_7_G10	-16.4935828	-9.165845701	6A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2313	4350	0.024597701	0.004367816	2	6A	IN-PV	12	6	6
ACTTTCACATTCTCAT-1_7_G10	-6.190430834	33.74031924	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	967	1283	0.011691348	0.003117693	2	oligos	OL-MS-2	12	6	6
ACTTTCAGTCTCTCGT-1_7_G10	24.36831387	27.01270562	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1360	2209	0.004074242	0.003621548	2	oligos	OL-MS-2	12	6	6
ACTTTCAGTGAAAGAG-1_7_G10	-21.77899106	13.37060863	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	936	1314	0.01217656	0.00304414	2	8	Astrocytes	12	6	6
ACTTTCATCACCTCGT-1_7_G10	-5.945446428	-2.688708116	13A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1606	2899	0.006898931	0.004484305	2	13A	IN-VIP	12	6	6
AGAATAGAGATAGCAT-1_7_G10	-2.989318558	35.71687997	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	808	1067	0.003748828	0.000937207	2	oligos	OL-MS-2	12	6	6
AGAATAGCAATCAGAA-1_7_G10	-0.076363372	33.27501763	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	765	1038	0.005780347	0.006743738	2	oligos	OL-MS-2	12	6	6
AGAATAGCACTGTGTA-1_7_G10	29.68955946	-12.28837071	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3358	6821	0.020085032	0.007916728	2	2	EN-L4	12	6	6
AGAATAGGTCTAGGTT-1_7_G10	25.27381408	-27.79617478	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3360	8063	0.004588863	0.003100583	2	3	EN-L5-6	12	6	6
AGAATAGGTGTGCGTC-1_7_G10	-5.921583034	34.00066235	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	903	1174	0.007666099	0.001703578	2	oligos	OL-MS-2	12	6	6
AGAATAGTCGAGAACG-1_7_G10	-5.355566631	-30.2684295	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	693	1024	0.17578125	0.01171875	2	16	EN-PYR	12	6	6
AGACGTTAGTGTACTC-1_7_G10	32.6953995	4.928976988	14	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1067	1338	0.018684604	0.00896861	2	14	Microglia	12	6	6
AGACGTTCACCAGGTC-1_7_G10	25.70004051	-1.733266068	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2497	5076	0.001576044	0.004728132	2	2	EN-L4	12	6	6
AGACGTTGTCCCTTGT-1_7_G10	-5.407892182	34.22929147	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	861	1119	0.00714924	0.00714924	2	oligos	OL-MS-2	12	6	6
AGAGCGAAGGCCGAAT-1_7_G10	16.15672183	-32.40277525	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4885	15192	0.003422854	0.005529226	2	3	EN-L5-6	12	6	6
AGAGCGACAATACGCT-1_7_G10	-10.84367607	-32.50375611	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1293	1970	0.124365482	0.007106599	2	16	EN-PYR	12	6	6
AGAGCGACACATGACT-1_7_G10	27.04381541	-6.105441526	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4858	14461	0.001867091	0.005739575	2	2	EN-L4	12	6	6
AGAGCGACATCACGAT-1_7_G10	1.541781153	-20.65168094	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3152	7172	0.007250418	0.006553263	2	L2-3	EN-L2-3-Cntl	12	6	6
AGAGCGAGTCACCCAG-1_7_G10	21.13238944	28.42902885	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	909	1328	0.004518072	0.00376506	2	oligos	OL-MS-2	12	6	6
AGAGCGAGTCTCACCT-1_7_G10	22.12976781	25.75336665	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	997	1421	0.009148487	0.004222379	2	oligos	OL-MS-2	12	6	6
AGAGCGAGTCTGATTG-1_7_G10	-4.10757345	-31.80029128	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	615	1066	0.30956848	0.004690432	2	16	EN-PYR	12	6	6
AGAGCGAGTCTTGATG-1_7_G10	-0.24364502	32.96637424	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	782	1058	0.012287335	0.001890359	2	oligos	OL-MS-2	12	6	6
AGAGCGATCAAACGGG-1_7_G10	-0.48089444	32.01271865	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	890	1234	0.005672609	0.004051864	2	oligos	OL-MS-2	12	6	6
AGAGCTTAGGAGTAGA-1_7_G10	-1.204914576	31.31482219	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	857	1155	0.002597403	0.001731602	2	oligos	OL-MS-2	12	6	6
AGAGCTTCACAACGTT-1_7_G10	21.27341498	27.58161405	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	947	1359	0.005150846	0.008094187	2	oligos	OL-MS-2	12	6	6
AGAGCTTCACAGAGGT-1_7_G10	-5.844048374	-28.23210592	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	954	1237	0.082457559	0.014551334	2	16	EN-PYR	12	6	6
AGAGCTTCAGATTGCT-1_7_G10	-28.08405148	10.57307851	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	767	1044	0	0.005747126	2	8	Astrocytes	12	6	6
AGAGCTTCATGCGCAC-1_7_G10	-16.64793807	-9.602783282	13B	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2795	5822	0.012710409	0.003607008	2	13B	IN-SV2C	12	6	6
AGAGCTTCATTAACCG-1_7_G10	3.28172756	-11.05843209	12	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1636	2696	0.005563798	0.009643917	2	12	EN-MIX	12	6	6
AGAGCTTTCACAATGC-1_7_G10	25.70944475	-28.10356176	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3917	10694	0.001122125	0.003927436	2	3	EN-L5-6	12	6	6
AGAGCTTTCCCATTAT-1_7_G10	8.596966405	-2.464581465	12	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1884	2720	0.025735294	0.010294118	2	12	EN-MIX	12	6	6
AGAGCTTTCTGACCTC-1_7_G10	-8.01901203	-31.60054479	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	913	1292	0.070433437	0.013157895	2	16	EN-PYR	12	6	6
AGAGTGGAGAATGTTG-1_7_G10	-5.006107612	-8.337704594	13A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	795	1073	0.024231128	0.001863933	2	13A	IN-VIP	12	6	6
AGAGTGGCAACCGCCA-1_7_G10	2.72499141	-32.19661831	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	6321	25123	0.002746487	0.002547466	2	L2-3	EN-L2-3-Cntl	12	6	6
AGAGTGGCAGACGCAA-1_7_G10	-13.3640104	-31.99618457	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1870	2934	0.044648943	0.009202454	2	16	EN-PYR	12	6	6
AGAGTGGGTCATATCG-1_7_G10	3.793556516	-19.56947948	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3243	7062	0.009062589	0.01203625	2	L2-3	EN-L2-3-MS	12	6	6
AGAGTGGTCGCCCTTA-1_7_G10	-7.709756133	-33.18460751	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	970	1421	0.108374384	0.011963406	2	16	EN-PYR	12	6	6
AGAGTGGTCGTAGGTT-1_7_G10	-9.702414989	22.30780602	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1231	1740	0.005172414	0.006321839	2	8	Astrocytes	12	6	6
AGATCTGAGAATTGTG-1_7_G10	-21.09484924	-17.00593788	6B	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2984	6745	0.004892513	0.004744255	2	6B	IN-SST	12	6	6
AGATCTGAGCGTTCCG-1_7_G10	-6.11262212	32.76660573	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	981	1295	0.007722008	0.004633205	2	oligos	OL-MS-2	12	6	6
AGATCTGGTCAAGCGA-1_7_G10	-15.87754986	-9.701020177	13B	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2479	5013	0.009176142	0.006383403	2	13B	IN-SV2C	12	6	6
AGATCTGGTCCATCCT-1_7_G10	21.10379115	23.46844107	1	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1041	1664	0.005408654	0.004206731	2	oligos	OL-Cntl	12	6	6
AGATCTGGTTCGGCAC-1_7_G10	-0.619873131	34.58475388	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	870	1242	0.006441224	0.006441224	2	oligos	OL-MS-2	12	6	6
AGATCTGTCACAGGCC-1_7_G10	-31.99579581	-0.663428414	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1532	2440	0.006147541	0.004098361	2	9	OPC	12	6	6
AGATTGCCAAGACGTG-1_7_G10	9.102972999	-30.51403122	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4242	11230	0.006767587	0.006411398	2	L2-3	EN-L2-3-Cntl	12	6	6
AGATTGCGTCTGATTG-1_7_G10	-11.90101429	13.14140819	11	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	897	1207	0.005799503	0.003314002	2	11	Glia-MIX	12	6	6
AGATTGCGTTGTGGAG-1_7_G10	-0.626701615	35.12898798	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	767	1008	0.014880952	0.003968254	2	oligos	OL-MS-2	12	6	6
AGCAGCCCAGTCGTGC-1_7_G10	0.583009764	33.00642754	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	775	1006	0.00695825	0.005964215	2	oligos	OL-MS-2	12	6	6
AGCAGCCGTGAACCTT-1_7_G10	-0.948344166	31.68203724	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	739	1003	0.005982054	0.001994018	2	oligos	OL-MS-2	12	6	6
AGCAGCCTCGCCATAA-1_7_G10	31.07718703	-4.820671467	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3020	6351	0.002676744	0.00771532	2	2	EN-L4	12	6	6
AGCAGCCTCGCCTGAG-1_7_G10	8.482271835	-31.66837743	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3487	8072	0.00123885	0.007680872	2	L2-3	EN-L2-3-Cntl	12	6	6
AGCAGCCTCGGAGGTA-1_7_G10	29.9351985	-11.29607399	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3340	7109	0.017442678	0.011675341	2	2	EN-L4	12	6	6
AGCATACAGCAGCGTA-1_7_G10	-10.37396513	33.06813318	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	890	1132	0.008833922	0.006183746	2	oligos	OL-MS-2	12	6	6
AGCATACCAAGTCATC-1_7_G10	1.437777786	-23.05381381	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4324	11444	0.002970989	0.003670045	2	L2-3	EN-L2-3-MS	12	6	6
AGCATACTCACAAACC-1_7_G10	-32.00519493	-0.55275028	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1626	2691	0.008175399	0.002229654	2	9	OPC	12	6	6
AGCATACTCGTCGTTC-1_7_G10	-1.200129394	31.62947185	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	788	1094	0.000914077	0.00274223	2	oligos	OL-MS-2	12	6	6
AGCCTAAAGATCTGCT-1_7_G10	-7.487656864	35.52694973	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	758	1002	0.008982036	0.006986028	2	oligos	OL-MS-2	12	6	6
AGCCTAACACCGGAAA-1_7_G10	6.684664865	-27.15391061	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3584	7000	0.003857143	0.013428571	2	L2-3	EN-L2-3-MS	12	6	6
AGCCTAACAGCCTTTC-1_7_G10	22.39040019	-0.273472533	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1918	3285	0.009436834	0.003652968	2	2	EN-L4	12	6	6
AGCCTAAGTACCTACA-1_7_G10	-13.84616934	-32.21203636	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2353	4355	0.048220436	0.008725603	2	16	EN-PYR	12	6	6
AGCCTAATCAGGCCCA-1_7_G10	-21.09855562	15.74326725	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1275	1891	0.013749339	0.004230566	2	8	Astrocytes	12	6	6
AGCCTAATCCCTTGCA-1_7_G10	-25.31429474	-23.03351764	6A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3440	7823	0.049469513	0.008564489	2	6A	IN-PV	12	6	6
AGCGGTCCACAAGACG-1_7_G10	-16.89704375	10.77501499	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1064	1521	0.004602235	0.005259698	2	8	Astrocytes	12	6	6
AGCGGTCCACGTGAGA-1_7_G10	-1.00128237	35.06292738	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	785	1112	0.005395683	0.006294964	2	oligos	OL-MS-2	12	6	6
AGCGGTCGTGTGGTTT-1_7_G10	3.351491895	-20.35288292	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3408	8064	0.006076389	0.00483631	2	L2-3	EN-L2-3-MS	12	6	6
AGCGTATAGTACATGA-1_7_G10	33.83603487	7.64162427	14	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	882	1103	0.020852221	0.013599275	2	14	Microglia	12	6	6
AGCGTATTCACTTACT-1_7_G10	15.80088675	-33.13843226	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	5539	19490	0.001385326	0.005130836	2	3	EN-L5-6	12	6	6
AGCGTATTCCTGCAGG-1_7_G10	-2.648632575	-0.944033107	13A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3004	6073	0.008891816	0.010044459	2	13A	IN-VIP	12	6	6
AGCGTATTCTGTCTAT-1_7_G10	0.12945498	35.31803877	1	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	732	1100	0.003636364	0.005454545	2	oligos	OL-Cntl	12	6	6
AGCGTCGCAATGGAGC-1_7_G10	-6.91227159	-1.545043014	13A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1720	2892	0.007261411	0.006915629	2	13A	IN-VIP	12	6	6
AGCTCCTAGAGTACAT-1_7_G10	-21.96013097	13.7255278	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	964	1416	0.006355932	0.002118644	2	8	Astrocytes	12	6	6
AGCTCCTCAAATACAG-1_7_G10	1.230994518	-19.51755435	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2881	5932	0.002865813	0.006405934	2	L2-3	EN-L2-3-Cntl	12	6	6
AGCTCCTCAGCGTAAG-1_7_G10	-9.425190215	2.978842903	13A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3016	6989	0.007440263	0.003290886	2	13A	IN-VIP	12	6	6
AGCTCCTCAGTAACGG-1_7_G10	-18.56699636	8.72097278	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	881	1157	0.011235955	0.005185825	2	8	Astrocytes	12	6	6
AGCTCCTCAGTACACT-1_7_G10	17.76953315	-28.91350534	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4916	14884	0.006987369	0.004971782	2	3	EN-L5-6	12	6	6
AGCTCCTCATTCGACA-1_7_G10	4.628498412	-21.24393507	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3332	7751	0.012385499	0.002967359	2	L2-3	EN-L2-3-MS	12	6	6
AGCTCCTGTGGTGTAG-1_7_G10	-8.037382569	-11.00443874	6B	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	809	1120	0.022321429	0.005357143	2	6B	IN-SST	12	6	6
AGCTCCTGTTTCGCTC-1_7_G10	20.83948791	19.919309	1	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1028	1579	0.005066498	0.007599747	2	oligos	OL-Cntl	12	6	6
AGCTCTCAGAAGAAGC-1_7_G10	-31.46741529	-12.39128851	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	850	1145	0.002620087	0.004366812	2	9	OPC	12	6	6
AGCTCTCAGTCACGCC-1_7_G10	-12.86670056	-0.824526247	13A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2949	6126	0.007345739	0.005550114	2	13A	IN-VIP	12	6	6
AGCTCTCAGTGGTAGC-1_7_G10	-16.89368875	-16.81278345	6B	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1862	3319	0.007833685	0.007231094	2	6B	IN-SST	12	6	6
AGCTCTCCAGCGATCC-1_7_G10	29.55985203	-6.959714531	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	5132	15096	0.003775835	0.009936407	2	2	EN-L4	12	6	6
AGCTCTCTCAGGCAAG-1_7_G10	-4.021820172	36.12231199	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	798	1072	0.010261194	0.013992537	2	oligos	OL-MS-2	12	6	6
AGCTCTCTCATTGCGA-1_7_G10	-6.383684716	34.13570884	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	883	1145	0.008733624	0.006113537	2	oligos	OL-MS-2	12	6	6
AGCTCTCTCGAACTGT-1_7_G10	1.306899459	-28.9010486	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	5232	17248	0.005275974	0.005160019	2	L2-3	EN-L2-3-Cntl	12	6	6
AGCTTGAAGATCCTGT-1_7_G10	-2.055759958	34.6012786	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	795	1059	0.002832861	0.003777148	2	oligos	OL-MS-2	12	6	6
AGCTTGAAGGACTGGT-1_7_G10	-19.46644245	17.7098229	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1516	2372	0.004215852	0.009696459	2	8	Astrocytes	12	6	6
AGCTTGAGTAAAGTCA-1_7_G10	21.40648593	27.54649249	1	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	961	1438	0.004172462	0.004172462	2	oligos	OL-Cntl	12	6	6
AGCTTGAGTATCACCA-1_7_G10	-31.85361314	0.644873041	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1776	3021	0.00264813	0.003310162	2	9	OPC	12	6	6
AGCTTGAGTTAGATGA-1_7_G10	15.59352539	-28.79508446	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3588	8572	0.001399907	0.015865609	2	3	EN-L5-6	12	6	6
AGCTTGAGTTCCCTTG-1_7_G10	-14.74066602	-6.774472922	13A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3350	8122	0.008372322	0.01083477	2	13A	IN-VIP	12	6	6
AGGCCACAGAGTGACC-1_7_G10	27.15418499	-15.60393246	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	8197	39340	0.032562278	0.006329436	2	3	EN-L5-6	12	6	6
AGGCCACAGCTAGCCC-1_7_G10	31.33069508	-7.267051516	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3355	7639	0.002487237	0.012828904	2	2	EN-L4	12	6	6
AGGCCACAGGCCCTCA-1_7_G10	1.684175925	-22.21828801	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3969	9948	0.004322477	0.003216727	2	L2-3	EN-L2-3-MS	12	6	6
AGGCCACCACATGACT-1_7_G10	1.582575545	-20.49550919	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3283	7357	0.005844774	0.005301074	2	L2-3	EN-L2-3-Cntl	12	6	6
AGGCCACCACCCATGG-1_7_G10	31.83455906	-1.641914366	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2630	5104	0.003330721	0.004310345	2	2	EN-L4	12	6	6
AGGCCACGTGCTCTTC-1_7_G10	2.86517874	-19.64409409	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3230	6999	0.005143592	0.008572653	2	L2-3	EN-L2-3-MS	12	6	6
AGGCCACTCAAACGGG-1_7_G10	-6.931130406	-31.322473	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	962	1328	0.09563253	0.012048193	2	16	EN-PYR	12	6	6
AGGCCACTCCTCATTA-1_7_G10	6.234444711	1.813866498	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	870	1111	0.02070207	0.01260126	2	16	EN-PYR	12	6	6
AGGCCACTCTCCTATA-1_7_G10	-3.260632571	35.09893909	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	800	1081	0.005550416	0.004625347	2	oligos	OL-MS-2	12	6	6
AGGCCACTCTGCAGTA-1_7_G10	-15.89217222	-16.80426184	6B	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1613	2689	0.010784678	0.007437709	2	6B	IN-SST	12	6	6
AGGCCGTAGCCACTAT-1_7_G10	-1.268312218	33.52799882	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	791	1032	0.010658915	0.003875969	2	oligos	OL-MS-2	12	6	6
AGGCCGTCACTAAGTC-1_7_G10	0.0003029	31.07856848	1	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	888	1263	0.005542359	0.003958828	2	oligos	OL-Cntl	12	6	6
AGGCCGTCATTGCGGC-1_7_G10	-0.025541073	35.95840318	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	854	1235	0.008906883	0.007287449	2	oligos	OL-MS-2	12	6	6
AGGCCGTGTCATGCAT-1_7_G10	3.017700784	-11.09511096	12	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1614	2670	0.007116105	0.005243446	2	12	EN-MIX	12	6	6
AGGGAGTCAGCGTTCG-1_7_G10	31.84099408	-1.421034326	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2525	4936	0.005470016	0.00445705	2	2	EN-L4	12	6	6
AGGGAGTCATTGGCGC-1_7_G10	-22.68209634	12.37729842	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1032	1443	0.002772003	0.011781012	2	8	Astrocytes	12	6	6
AGGGAGTGTCCGAGTC-1_7_G10	27.73385361	5.921725654	15A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	987	1297	0.024672321	0.023901311	2	15A	Endo cells	12	6	6
AGGGATGAGGTACTCT-1_7_G10	3.814782512	-9.427002511	12	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1522	2716	0.003313697	0.004050074	2	12	EN-MIX	12	6	6
AGGGATGCACGGTAAG-1_7_G10	-24.39257153	-12.35331947	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	874	1153	0.042497832	0.006071119	2	8	Astrocytes	12	6	6
AGGGATGCATTGGGCC-1_7_G10	-9.595855456	-32.98238366	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1132	1626	0.05904059	0.01599016	2	16	EN-PYR	12	6	6
AGGGATGTCGCAAGCC-1_7_G10	-8.469613866	31.79975457	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1069	1456	0.019230769	0.004807692	2	oligos	OL-MS-2	12	6	6
AGGGATGTCTAACTTC-1_7_G10	18.30464814	-30.17919447	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	5731	19314	0.007507508	0.011546029	2	3	EN-L5-6	12	6	6
AGGGTGAAGGCAAAGA-1_7_G10	-15.12694174	-34.41897667	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2123	3633	0.065235343	0.010459675	2	16	EN-PYR	12	6	6
AGGGTGAAGGCATGTG-1_7_G10	19.91844421	-17.1751122	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4558	11158	0.026617673	0.008872558	2	L2-3	EN-L2-3-MS	12	6	6
AGGGTGACAAGCGTAG-1_7_G10	8.509378091	7.861821952	1	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2495	5432	0.009020619	0.004970545	2	oligos	OL-Cntl	12	6	6
AGGGTGACAAGCTGTT-1_7_G10	-22.49938182	12.72205465	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1226	1934	0.026370217	0.007755946	2	8	Astrocytes	12	6	6
AGGGTGACAGCTGTGC-1_7_G10	20.56621965	-29.520887	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	5024	15727	0.001589623	0.006231322	2	3	EN-L5-6	12	6	6
AGGGTGATCAGCCTAA-1_7_G10	21.62818775	26.31969894	1	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	938	1336	0.008982036	0.002994012	2	oligos	OL-Cntl	12	6	6
AGGGTGATCTGCTGCT-1_7_G10	-9.719999422	33.16270145	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	883	1154	0.016464471	0.005199307	2	oligos	OL-MS-2	12	6	6
AGGTCATCAAATTGCC-1_7_G10	-13.83676461	-34.58189847	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2666	6351	0.217446071	0.004881121	2	16	EN-PYR	12	6	6
AGGTCATCAGTCACTA-1_7_G10	-17.69441778	8.634062571	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	860	1139	0.004389816	0.004389816	2	8	Astrocytes	12	6	6
AGGTCATCATACGCTA-1_7_G10	-3.065638717	35.15918999	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	810	1076	0.007434944	0.003717472	2	oligos	OL-MS-2	12	6	6
AGGTCATTCAAGAAGT-1_7_G10	37.35834484	8.269813804	14	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	824	1045	0.002870813	0.007655502	2	14	Microglia	12	6	6
AGGTCATTCCGGGTGT-1_7_G10	-20.66144308	17.29620348	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1484	2351	0.008932369	0.005529562	2	8	Astrocytes	12	6	6
AGGTCATTCGCCGTGA-1_7_G10	-21.82047019	15.57864909	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1144	1745	0.005157593	0.009169054	2	8	Astrocytes	12	6	6
AGGTCCGAGAGGTACC-1_7_G10	-7.315681545	35.90565552	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	920	1192	0.016778523	0.005033557	2	oligos	OL-MS-2	12	6	6
AGGTCCGAGGCCCTCA-1_7_G10	-4.644813371	32.56079249	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	996	1372	0.005830904	0.004373178	2	oligos	OL-MS-2	12	6	6
AGGTCCGAGGTGACCA-1_7_G10	25.40251337	-28.91505249	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3889	10487	0.001716411	0.003146753	2	3	EN-L5-6	12	6	6
AGGTCCGGTGCGATAG-1_7_G10	-21.08814767	16.8096977	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1398	2079	0.005291005	0.00962001	2	8	Astrocytes	12	6	6
AGGTCCGTCAAACCAC-1_7_G10	22.90375006	26.05007771	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1272	1835	0.007629428	0.005449591	2	oligos	OL-MS-2	12	6	6
AGGTCCGTCGAGAACG-1_7_G10	-25.21064946	-23.09172958	6A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3871	9828	0.051587302	0.004884005	2	6A	IN-PV	12	6	6
AGTAGTCAGCGGATCA-1_7_G10	33.22942209	-4.172362609	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2762	5389	0.003896827	0.005752459	2	2	EN-L4	12	6	6
AGTAGTCAGTTTGCGT-1_7_G10	-13.77265339	-17.26307091	6B	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1332	2317	0.051359517	0.002157963	2	6B	IN-SST	12	6	6
AGTAGTCCACAGGAGT-1_7_G10	-14.78023733	-4.293532228	13A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3194	6495	0.014318707	0.004464973	2	13A	IN-VIP	12	6	6
AGTAGTCCATTCCTGC-1_7_G10	-7.877783846	-32.92358462	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	891	1266	0.100315956	0.007898894	2	16	EN-PYR	12	6	6
AGTAGTCGTCCGCTGA-1_7_G10	-27.39905993	16.00249592	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1031	1572	0.005089059	0.00826972	2	8	Astrocytes	12	6	6
AGTAGTCGTCTTCAAG-1_7_G10	-6.364597293	4.339919694	11	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	6352	19125	0.00345098	0.004810458	2	11	Glia-MIX	12	6	6
AGTAGTCGTGAGGGTT-1_7_G10	-13.14465907	-17.7645221	6B	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1185	1886	0.00583245	0.004772004	2	6B	IN-SST	12	6	6
AGTAGTCGTGTAACGG-1_7_G10	8.933796926	-28.81892559	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	5803	19766	0.012243246	0.00419913	2	L2-3	EN-L2-3-Cntl	12	6	6
AGTAGTCGTGTGAAAT-1_7_G10	12.0151003	13.37065786	1	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1684	3248	0.001539409	0.002155172	2	oligos	OL-Cntl	12	6	6
AGTAGTCTCTACCAGA-1_7_G10	29.76969211	-11.26174213	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3881	8882	0.031074082	0.009344742	2	2	EN-L4	12	6	6
AGTCTTTAGAGGTAGA-1_7_G10	-1.970028219	33.01509359	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	898	1226	0.007340946	0.007340946	2	oligos	OL-MS-2	12	6	6
AGTCTTTAGATGCCTT-1_7_G10	-23.73580817	-1.562203536	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1151	1786	0.007838746	0.006718925	2	9	OPC	12	6	6
AGTCTTTCATATGGTC-1_7_G10	-9.235108687	-16.66166427	6B	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	813	1171	0.023057216	0.001707942	2	6B	IN-SST	12	6	6
AGTCTTTTCAGGTTCA-1_7_G10	-1.027361355	-19.2869301	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2773	6058	0.00330142	0.005777484	2	L2-3	EN-L2-3-Cntl	12	6	6
AGTCTTTTCTTGGGTA-1_7_G10	-37.26868145	-8.757491818	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	976	1560	0.001282051	0.002564103	2	9	OPC	12	6	6
AGTGAGGTCTGTGCAA-1_7_G10	5.71888316	-14.81889226	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2736	5406	0.019607843	0.004994451	2	L2-3	EN-L2-3-MS	12	6	6
AGTGGGAAGCGTGTCC-1_7_G10	2.738638982	-10.76674884	12	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1631	2560	0.01015625	0.0078125	2	12	EN-MIX	12	6	6
AGTGGGAAGGAATGGA-1_7_G10	-22.56746752	14.82280888	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1073	1694	0.004132231	0.007083825	2	8	Astrocytes	12	6	6
AGTGGGAGTGTAATGA-1_7_G10	-21.19198935	17.4335644	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1454	2337	0.010697475	0.006418485	2	8	Astrocytes	12	6	6
AGTGGGAGTTTGACTG-1_7_G10	21.36775649	27.40035092	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	959	1401	0.001427552	0.006423983	2	oligos	OL-MS-2	12	6	6
AGTGGGATCCTAGAAC-1_7_G10	-5.853174425	31.63647806	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1147	1584	0.009469697	0.001893939	2	oligos	OL-MS-2	12	6	6
AGTGTCAAGTAGCCGA-1_7_G10	23.59959139	-26.65872109	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2640	5622	0.003735326	0.005158307	2	3	EN-L5-6	12	6	6
AGTGTCACAGCTGTAT-1_7_G10	-35.13200892	-5.664559658	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1242	2046	0.001466276	0.00342131	2	9	OPC	12	6	6
AGTGTCATCCTCCTAG-1_7_G10	-6.77339224	35.32307862	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	771	1007	0.008937438	0.003972195	2	oligos	OL-MS-2	12	6	6
AGTTGGTCAATCTACG-1_7_G10	32.3335398	-5.320376514	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3363	7671	0.01186286	0.006909138	2	2	EN-L4	12	6	6
AGTTGGTCATAGAAAC-1_7_G10	-2.830940043	32.31714117	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	928	1325	0.003018868	0.003018868	2	oligos	OL-MS-2	12	6	6
AGTTGGTCATTGAGCT-1_7_G10	3.259813863	-13.15290556	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1975	3320	0.006325301	0.006325301	2	L2-3	EN-L2-3-MS	12	6	6
AGTTGGTGTGACGGTA-1_7_G10	16.23941817	-31.85123242	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4987	15804	0.002657555	0.009048342	2	3	EN-L5-6	12	6	6
ATAACGCCAAACAACA-1_7_G10	-14.75548007	9.788987139	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1267	1840	0.0125	0.004891304	2	8	Astrocytes	12	6	6
ATAACGCCAGTATCTG-1_7_G10	-17.03192435	-17.44265279	6B	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2014	3852	0.0096054	0.008047767	2	6B	IN-SST	12	6	6
ATAACGCCATGGTTGT-1_7_G10	-4.574701906	34.43616838	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	819	1095	0.008219178	0.006392694	2	oligos	OL-MS-2	12	6	6
ATAACGCGTATAGTAG-1_7_G10	0.244870193	31.91270904	1	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	798	1109	0.008115419	0.004508566	2	oligos	OL-Cntl	12	6	6
ATAACGCGTCATCGGC-1_7_G10	21.09123374	27.8508186	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	909	1273	0.009426551	0.003142184	2	oligos	OL-MS-2	12	6	6
ATAACGCTCACAATGC-1_7_G10	6.06154581	-15.97091874	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2818	5435	0.013063477	0.011223551	2	L2-3	EN-L2-3-MS	12	6	6
ATAACGCTCGTTGACA-1_7_G10	17.06041024	-18.29919782	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4301	10091	0.02318898	0.00772966	2	L2-3	EN-L2-3-MS	12	6	6
ATAAGAGAGCCAACAG-1_7_G10	1.903086551	6.176862186	7	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1270	1627	0.008604794	0.004917025	2	7	Phagocytes	12	6	6
ATAAGAGCATCACGTA-1_7_G10	3.274856875	-21.47989171	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4120	11115	0.011426001	0.005038237	2	L2-3	EN-L2-3-MS	12	6	6
ATAAGAGGTAGTAGTA-1_7_G10	-22.71281826	15.19012687	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1134	1747	0.003434459	0.004006869	2	8	Astrocytes	12	6	6
ATAAGAGGTCGCCATG-1_7_G10	-34.13776295	-8.668048742	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	985	1540	0.001948052	0.005844156	2	9	OPC	12	6	6
ATAGACCAGGACGAAA-1_7_G10	-31.971473	-1.156676713	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1433	2286	0.004811899	0.001749781	2	9	OPC	12	6	6
ATAGACCCAAGCCCAC-1_7_G10	34.09117199	7.951273314	14	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1704	2598	0.00269438	0.004618938	2	14	Microglia	12	6	6
ATAGACCCAATGTAAG-1_7_G10	13.10012623	-31.58665985	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2573	5707	0.00105134	0.003154021	2	3	EN-L5-6	12	6	6
ATAGACCCACACCGAC-1_7_G10	-18.19416426	9.87307647	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	831	1030	0.011650485	0.008737864	2	8	Astrocytes	12	6	6
ATAGACCCACCAGCAC-1_7_G10	-4.17944764	-18.02708054	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2762	6017	0.002659132	0.006647831	2	L2-3	EN-L2-3-Cntl	12	6	6
ATAGACCGTGAGTGAC-1_7_G10	-12.80793922	-19.47184089	6B	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1092	1829	0.002733734	0.003827228	2	6B	IN-SST	12	6	6
ATAGACCGTTAGGGTG-1_7_G10	24.25064779	-6.206360894	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2953	6192	0.002099483	0.004037468	2	2	EN-L4	12	6	6
ATAGACCTCATGCAAC-1_7_G10	32.39363209	-8.120748968	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3672	8247	0.01442949	0.008487935	2	2	EN-L4	12	6	6
ATAGACCTCTAGAGTC-1_7_G10	4.461925343	-15.36743639	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2626	5091	0.006089177	0.009231978	2	L2-3	EN-L2-3-MS	12	6	6
ATCACGAAGAGCCCAA-1_7_G10	13.86534081	19.75487855	1	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1026	1533	0.003913894	0.005218526	2	oligos	OL-Cntl	12	6	6
ATCACGAAGCACACAG-1_7_G10	20.45254602	26.97509232	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	956	1386	0.007936508	0.003607504	2	oligos	OL-MS-2	12	6	6
ATCACGAAGGCGATAC-1_7_G10	-31.64409351	-10.1323194	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	933	1355	0.004428044	0.003690037	2	9	OPC	12	6	6
ATCACGAAGGTACTCT-1_7_G10	-15.20539381	-8.040043379	13A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2614	5556	0.004139669	0.006299496	2	13A	IN-VIP	12	6	6
ATCACGAAGTGTGAAT-1_7_G10	-12.3571733	-1.121849702	13A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2884	5511	0.009254219	0.007621121	2	13A	IN-VIP	12	6	6
ATCACGACAAAGCAAT-1_7_G10	-20.52684445	18.06411228	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1621	2671	0.006364657	0.004492699	2	8	Astrocytes	12	6	6
ATCACGAGTACTTAGC-1_7_G10	2.063895283	-16.78715535	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2513	4684	0.010034159	0.006404782	2	L2-3	EN-L2-3-MS	12	6	6
ATCACGAGTCGCGTGT-1_7_G10	-21.76737082	16.07107289	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1263	2020	0.007425743	0.004455446	2	8	Astrocytes	12	6	6
ATCATCTAGCTAACTC-1_7_G10	-1.486237033	34.29888832	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	858	1207	0.005799503	0.004142502	2	oligos	OL-MS-2	12	6	6
ATCATCTAGTTGCAGG-1_7_G10	25.4674253	7.310495661	15A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1567	2332	0.01329331	0.024013722	2	15A	Endo cells	12	6	6
ATCATCTGTAGGACAC-1_7_G10	24.26467144	26.75214726	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1484	2196	0.008652095	0.006375228	2	oligos	OL-MS-2	12	6	6
ATCATCTGTCGTTGTA-1_7_G10	-14.58419334	-17.55571324	6B	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1425	2374	0.00505476	0.00379107	2	6B	IN-SST	12	6	6
ATCATGGAGGGCACTA-1_7_G10	-3.880773968	34.42561717	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	835	1103	0.007252947	0.00543971	2	oligos	OL-MS-2	12	6	6
ATCATGGAGGGTGTTG-1_7_G10	11.953002	33.30940858	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	819	1191	0.001679261	0	2	oligos	OL-MS-2	12	6	6
ATCATGGAGTGGACGT-1_7_G10	6.102568852	-15.75288746	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2728	4986	0.00762134	0.011231448	2	L2-3	EN-L2-3-MS	12	6	6
ATCATGGCATATACGC-1_7_G10	-21.05642896	15.8313319	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1373	2108	0.0056926	0.00426945	2	8	Astrocytes	12	6	6
ATCATGGGTATATGAG-1_7_G10	7.751452882	-15.45620058	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3647	8915	0.025238362	0.006281548	2	L2-3	EN-L2-3-MS	12	6	6
ATCATGGGTCCATCCT-1_7_G10	33.2365464	6.292656523	14	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	847	1044	0.00862069	0.011494253	2	14	Microglia	12	6	6
ATCATGGGTGTGTGCC-1_7_G10	31.24749489	-9.416482	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3666	8422	0.021610069	0.002968416	2	2	EN-L4	12	6	6
ATCATGGTCAGCACAT-1_7_G10	25.89523938	-27.24766888	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4724	14309	0.005590887	0.006359634	2	3	EN-L5-6	12	6	6
ATCATGGTCAGGCCCA-1_7_G10	1.6379346	-21.20967593	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3329	8105	0.002837754	0.006662554	2	L2-3	EN-L2-3-Cntl	12	6	6
ATCATGGTCCTGTACC-1_7_G10	21.67521855	23.59138929	1	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1132	1775	0.003943662	0.003380282	2	oligos	OL-Cntl	12	6	6
ATCATGGTCTAACTTC-1_7_G10	6.650487077	-27.12547277	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2427	4097	0.008298755	0.005613864	2	L2-3	EN-L2-3-MS	12	6	6
ATCCACCCACGTGAGA-1_7_G10	-2.181735273	32.87495745	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	954	1329	0.009029345	0.003762227	2	oligos	OL-MS-2	12	6	6
ATCCACCCAGTAAGAT-1_7_G10	22.68424464	27.45822522	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1071	1526	0.003931848	0.001965924	2	oligos	OL-MS-2	12	6	6
ATCCACCTCACCACCT-1_7_G10	-7.471316915	35.31799292	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	832	1135	0.010572687	0.002643172	2	oligos	OL-MS-2	12	6	6
ATCCACCTCCCTTGTG-1_7_G10	33.50282672	6.747360597	14	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	866	1086	0.009208103	0.007366483	2	14	Microglia	12	6	6
ATCCACCTCGGAGGTA-1_7_G10	-21.57948118	12.70648964	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1151	1657	0.010863005	0.005431503	2	8	Astrocytes	12	6	6
ATCCGAAAGCCCAATT-1_7_G10	0.320576053	33.26399936	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	810	1109	0.006311993	0.004508566	2	oligos	OL-MS-2	12	6	6
ATCCGAAGTTACCGAT-1_7_G10	-11.17707139	15.95356839	11	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1677	2726	0.001467351	0.004035216	2	11	Glia-MIX	12	6	6
ATCCGAATCAGCTGGC-1_7_G10	4.459595679	-11.14076864	12	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1844	3339	0.007487272	0.007187781	2	12	EN-MIX	12	6	6
ATCCGAATCAGTCCCT-1_7_G10	23.11094735	26.58400129	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1139	1697	0.003535651	0.002946376	2	oligos	OL-MS-2	12	6	6
ATCCGAATCGCCAAAT-1_7_G10	-26.91083166	-8.809155579	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	860	1161	0.001722653	0.002583979	2	9	OPC	12	6	6
ATCGAGTCAAGGGTCA-1_7_G10	33.87364627	-3.370647824	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2305	4074	0.007854688	0.004172803	2	2	EN-L4	12	6	6
ATCGAGTGTAAGTTCC-1_7_G10	32.67205895	-4.384914128	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3140	6758	0.004587156	0.005770938	2	2	EN-L4	12	6	6
ATCGAGTTCGTGACAT-1_7_G10	26.94233839	4.6123035	15A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	886	1143	0.017497813	0.008748906	2	15A	Endo cells	12	6	6
ATCGAGTTCTAACTGG-1_7_G10	3.702354441	-20.94536485	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3702	8833	0.009509793	0.004075625	2	L2-3	EN-L2-3-MS	12	6	6
ATCTACTAGACTTTCG-1_7_G10	-12.1060132	32.15900484	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1039	1539	0.10331384	0.004548408	2	oligos	OL-MS-2	12	6	6
ATCTACTAGTGTTTGC-1_7_G10	23.35058359	19.81656217	1	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	999	1471	0.003399048	0.006798097	2	oligos	OL-Cntl	12	6	6
ATCTACTCAGCCTGTG-1_7_G10	-9.525846848	32.10765735	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	894	1229	0.071602929	0.008136697	2	oligos	OL-MS-2	12	6	6
ATCTACTCATCACAAC-1_7_G10	-11.61101089	-1.182704006	13A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2222	4134	0.011369134	0.004354136	2	13A	IN-VIP	12	6	6
ATCTACTGTCGAATCT-1_7_G10	24.49259411	-24.47416788	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2827	6210	0.003381643	0.004186795	2	3	EN-L5-6	12	6	6
ATCTGCCAGCTGGAAC-1_7_G10	-6.352056675	33.9152529	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	881	1206	0.013266998	0.00331675	2	oligos	OL-MS-2	12	6	6
ATCTGCCCACAGCCCA-1_7_G10	15.87026235	-18.90265766	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4744	11803	0.013301703	0.00542235	2	L2-3	EN-L2-3-MS	12	6	6
ATCTGCCCAGTCTTCC-1_7_G10	21.91882907	26.3919034	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	997	1476	0.007452575	0.002710027	2	oligos	OL-MS-2	12	6	6
ATCTGCCCATTATCTC-1_7_G10	-19.64596717	12.08848337	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1027	1409	0.011355571	0.005677786	2	8	Astrocytes	12	6	6
ATCTGCCGTTATGTGC-1_7_G10	7.847203528	-32.44026517	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3124	7128	0.002665544	0.003367003	2	L2-3	EN-L2-3-Cntl	12	6	6
ATCTGCCGTTCCTCCA-1_7_G10	-0.377711419	34.94740322	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	774	1099	0.021838035	0.004549591	2	oligos	OL-MS-2	12	6	6
ATCTGCCGTTGATTGC-1_7_G10	30.30674028	-8.109901631	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4603	11282	0.007002305	0.009218224	2	2	EN-L4	12	6	6
ATCTGCCGTTTGGCGC-1_7_G10	18.71859993	-25.74799899	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3989	9562	0.00669316	0.016000837	2	3	EN-L5-6	12	6	6
ATCTGCCTCAACGGCC-1_7_G10	-31.94484297	-0.980070659	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1476	2374	0.00631845	0.00379107	2	9	OPC	12	6	6
ATCTGCCTCGGTTAAC-1_7_G10	-1.943169898	32.50487801	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	928	1316	0.003799392	0.008358663	2	oligos	OL-MS-2	12	6	6
ATGAGGGAGGACACCA-1_7_G10	23.02626477	26.79687223	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1085	1563	0.005118362	0.005758157	2	oligos	OL-MS-2	12	6	6
ATGAGGGCAAGGTGTG-1_7_G10	-0.921510513	33.34980484	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	804	1043	0.003835091	0.000958773	2	oligos	OL-MS-2	12	6	6
ATGAGGGGTAAATACG-1_7_G10	31.7748398	-1.46164077	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2598	5140	0.004474708	0.006420233	2	2	EN-L4	12	6	6
ATGAGGGGTCCGAACC-1_7_G10	1.527814386	-16.99706759	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2282	4349	0.006898138	0.006438262	2	L2-3	EN-L2-3-MS	12	6	6
ATGAGGGTCACCTTAT-1_7_G10	-27.36269756	-7.716400863	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1132	1654	0.003022975	0.004232164	2	9	OPC	12	6	6
ATGAGGGTCAGCACAT-1_7_G10	-1.587551647	31.41897463	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	842	1182	0.00676819	0.003384095	2	oligos	OL-MS-2	12	6	6
ATGAGGGTCCTGCCAT-1_7_G10	21.16099191	25.64730098	1	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	957	1420	0.004929577	0.006338028	2	oligos	OL-Cntl	12	6	6
ATGAGGGTCGTAGGTT-1_7_G10	-21.5607941	14.70428056	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1292	1953	0.02406554	0.001024066	2	8	Astrocytes	12	6	6
ATGCGATAGCTGCGAA-1_7_G10	-0.399644908	33.96722015	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	797	1077	0	0.006499536	2	oligos	OL-MS-2	12	6	6
ATGCGATCACATTCGA-1_7_G10	22.74226489	27.40929279	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1082	1555	0.003215434	0.00192926	2	oligos	OL-MS-2	12	6	6
ATGCGATGTGCTAGCC-1_7_G10	12.37201417	-21.71672928	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	5023	14023	0.011481138	0.007915567	2	L2-3	EN-L2-3-MS	12	6	6
ATGCGATGTTACTGAC-1_7_G10	3.372022434	-18.60861507	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2965	5902	0.005591325	0.010335479	2	L2-3	EN-L2-3-MS	12	6	6
ATGGGAGCAGTCCTTC-1_7_G10	-6.191083769	32.93601452	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1008	1500	0.011333333	0.004	2	oligos	OL-MS-2	12	6	6
ATGGGAGGTCCAGTGC-1_7_G10	-1.71116806	35.02460133	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	762	1016	0.00492126	0.005905512	2	oligos	OL-MS-2	12	6	6
ATGGGAGTCCAAAGTC-1_7_G10	22.66653103	18.5625293	1	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1076	1474	0.002713704	0.006105834	2	oligos	OL-Cntl	12	6	6
ATGTGTGAGTTACGGG-1_7_G10	0.138807773	-15.64093727	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2222	4080	0.00245098	0.004411765	2	L2-3	EN-L2-3-Cntl	12	6	6
ATGTGTGCAGATCCAT-1_7_G10	0.132939891	32.65676866	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	848	1162	0.011187608	0.005163511	2	oligos	OL-MS-2	12	6	6
ATGTGTGCAGTAGAGC-1_7_G10	-23.34635096	-2.072175505	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	979	1290	0.011627907	0.001550388	2	9	OPC	12	6	6
ATGTGTGCAGTCTTCC-1_7_G10	23.03180097	26.80650131	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1104	1607	0.00497822	0.003111388	2	oligos	OL-MS-2	12	6	6
ATGTGTGCATACTCTT-1_7_G10	1.069194588	-19.43434715	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2724	5625	0.005688889	0.0032	2	L2-3	EN-L2-3-Cntl	12	6	6
ATGTGTGGTGCAGGTA-1_7_G10	0.775799512	34.28993286	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	868	1233	0.00162206	0.00486618	2	oligos	OL-MS-2	12	6	6
ATGTGTGTCAGCATGT-1_7_G10	-0.609872963	31.78676023	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	893	1299	0.002309469	0.002309469	2	oligos	OL-MS-2	12	6	6
ATGTGTGTCCACGAAT-1_7_G10	-0.598431691	-26.51181916	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4594	13292	0.000902799	0.007673789	2	L2-3	EN-L2-3-Cntl	12	6	6
ATGTGTGTCGGAATCT-1_7_G10	-5.538527829	-30.63732387	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	784	1166	0.1432247	0.010291595	2	16	EN-PYR	12	6	6
ATGTGTGTCGTAGGTT-1_7_G10	32.78167306	-4.790903252	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3339	7428	0.011308562	0.004308024	2	2	EN-L4	12	6	6
ATGTGTGTCTTGTCAT-1_7_G10	-19.27344882	-26.3836187	6A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2490	5508	0.005628177	0.003267974	2	6A	IN-PV	12	6	6
ATTACTCAGCGCCTCA-1_7_G10	21.42826399	0.375980411	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1474	2459	0.002846686	0.002033347	2	2	EN-L4	12	6	6
ATTACTCAGTGGAGAA-1_7_G10	-27.4105722	11.29597119	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	882	1224	0.010620915	0.004084967	2	8	Astrocytes	12	6	6
ATTACTCCAAGTAATG-1_7_G10	-1.278748881	34.86916042	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	777	1066	0.008442777	0.003752345	2	oligos	OL-MS-2	12	6	6
ATTACTCCACGGCTAC-1_7_G10	-2.325933846	36.4803467	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	825	1070	0.012149533	0.007476636	2	oligos	OL-MS-2	12	6	6
ATTACTCCAGGTGGAT-1_7_G10	-6.066960563	31.49136288	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1199	1683	0.017825312	0.006535948	2	oligos	OL-MS-2	12	6	6
ATTACTCGTACAGTTC-1_7_G10	12.5252132	-20.01167398	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4350	11081	0.014078152	0.004873206	2	L2-3	EN-L2-3-MS	12	6	6
ATTACTCGTGGAAAGA-1_7_G10	-21.73981409	14.81765339	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1157	1686	0.007710558	0.007117438	2	8	Astrocytes	12	6	6
ATTACTCTCCTCTAGC-1_7_G10	-14.71132948	-5.310085845	13A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3091	7540	0.024270557	0.005570292	2	13A	IN-VIP	12	6	6
ATTATCCAGACAATAC-1_7_G10	21.16180544	12.68297177	1	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1569	2614	0.008798776	0.008033665	2	oligos	OL-Cntl	12	6	6
ATTATCCAGATGTGGC-1_7_G10	-20.74680871	16.93572028	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1481	2514	0.00477327	0.003977725	2	8	Astrocytes	12	6	6
ATTATCCAGGGCTCTC-1_7_G10	2.620157126	-19.22913173	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2722	5549	0.011894035	0.005586592	2	L2-3	EN-L2-3-MS	12	6	6
ATTATCCCAATGTAAG-1_7_G10	-6.798329437	35.06165171	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	930	1313	0.020563595	0.006092917	2	oligos	OL-MS-2	12	6	6
ATTATCCGTAGCACGA-1_7_G10	32.99329803	6.392456231	14	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	797	1001	0.007992008	0.002997003	2	14	Microglia	12	6	6
ATTATCCTCAGCCTAA-1_7_G10	20.98197305	27.48936408	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	916	1327	0.009042954	0.002260739	2	oligos	OL-MS-2	12	6	6
ATTATCCTCCACTCCA-1_7_G10	29.65586453	-7.010051824	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	5262	16462	0.007593245	0.009051148	2	2	EN-L4	12	6	6
ATTCTACAGCACCGTC-1_7_G10	-0.03687036	34.59576826	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	740	1046	0.009560229	0.006692161	2	oligos	OL-MS-2	12	6	6
ATTCTACCAATTGCTG-1_7_G10	16.3536406	-18.30655657	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	5463	16549	0.024654058	0.00713034	2	L2-3	EN-L2-3-MS	12	6	6
ATTCTACCAGCGAACA-1_7_G10	-9.459842593	33.21007323	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	878	1114	0.02513465	0.008976661	2	oligos	OL-MS-2	12	6	6
ATTCTACCAGCTGTTA-1_7_G10	20.28416696	27.23430476	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	963	1403	0.0085531	0.002138275	2	oligos	OL-MS-2	12	6	6
ATTCTACCATTGGTAC-1_7_G10	21.73846181	-20.43397391	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	5774	19725	0.005424588	0.005576679	2	3	EN-L5-6	12	6	6
ATTCTACGTCCCTTGT-1_7_G10	23.99324628	27.51515934	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1253	1881	0.006379585	0.001594896	2	oligos	OL-MS-2	12	6	6
ATTCTACTCCACGAAT-1_7_G10	-21.83789728	14.98327524	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1184	1801	0.002776235	0.00388673	2	8	Astrocytes	12	6	6
ATTCTACTCGCCTGAG-1_7_G10	-3.23784133	36.9672556	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	815	1165	0.046351931	0.007725322	2	oligos	OL-MS-2	12	6	6
ATTCTACTCTAACCGA-1_7_G10	2.325944081	-16.92451248	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2639	5231	0.003823361	0.004588033	2	L2-3	EN-L2-3-MS	12	6	6
ATTCTACTCTTCCTTC-1_7_G10	-3.494683591	34.54495374	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	766	1047	0.009551098	0.00191022	2	oligos	OL-MS-2	12	6	6
ATTGGACAGCACCGTC-1_7_G10	6.940873207	-14.40526487	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2602	4688	0.018131399	0.00746587	2	L2-3	EN-L2-3-MS	12	6	6
ATTGGACAGGAGTACC-1_7_G10	-23.87944384	25.05258429	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1428	2324	0.007314974	0.005593804	2	8	Astrocytes	12	6	6
ATTGGACCATAGAAAC-1_7_G10	19.37479148	0.199825494	12	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1219	1826	0.026834611	0.004928806	2	12	EN-MIX	12	6	6
ATTGGACCATGAAGTA-1_7_G10	24.30068853	27.0828602	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1295	2031	0.00295421	0.004431315	2	oligos	OL-MS-2	12	6	6
ATTGGACGTCCCTTGT-1_7_G10	29.98502134	-8.529493515	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	5138	15209	0.01939641	0.00729831	2	2	EN-L4	12	6	6
ATTGGACGTCCTCCAT-1_7_G10	3.987481995	1.013861144	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	865	1114	0.061041293	0.005385996	2	16	EN-PYR	12	6	6
ATTGGACGTTAAGACA-1_7_G10	-1.502083514	31.20711756	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	867	1167	0.003427592	0.010282776	2	oligos	OL-MS-2	12	6	6
ATTGGACTCATCATTC-1_7_G10	32.90059158	5.459581772	14	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1143	1449	0.019323671	0.005521049	2	14	Microglia	12	6	6
ATTGGACTCCGTCATC-1_7_G10	-18.29972277	8.539964437	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	772	1011	0.017804154	0.001978239	2	8	Astrocytes	12	6	6
ATTGGACTCTACTATC-1_7_G10	22.7376676	27.14826005	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1079	1591	0.00565682	0.00565682	2	oligos	OL-MS-2	12	6	6
ATTGGACTCTTACCGC-1_7_G10	-5.117503299	29.92779256	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	995	1453	0.007570544	0.002752925	2	oligos	OL-MS-2	12	6	6
ATTGGACTCTTGCAAG-1_7_G10	25.42207749	5.552939232	15A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1283	1756	0.014806378	0.008542141	2	15A	Endo cells	12	6	6
ATTGGTGAGCTCCTTC-1_7_G10	3.390339596	-21.30431438	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3827	9189	0.006529546	0.006311895	2	L2-3	EN-L2-3-MS	12	6	6
ATTGGTGAGTTCGCGC-1_7_G10	-11.35405083	-33.43866861	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1195	1826	0.06736035	0.002738226	2	16	EN-PYR	12	6	6
ATTGGTGCAAGGGTCA-1_7_G10	-21.14371713	-17.55755593	6A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2754	5632	0.012961648	0.004971591	2	6A	IN-PV	12	6	6
ATTGGTGCACGAAAGC-1_7_G10	-20.67720998	15.32001222	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1335	2112	0.004734848	0.004261364	2	8	Astrocytes	12	6	6
ATTGGTGCATGGATGG-1_7_G10	-8.9608623	-31.40439805	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	952	1326	0.059577677	0.008295626	2	16	EN-PYR	12	6	6
ATTGGTGGTCAGTGGA-1_7_G10	21.31878928	28.4114391	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	953	1329	0.004514673	0.003762227	2	oligos	OL-MS-2	12	6	6
ATTGGTGGTTGGTGGA-1_7_G10	31.99507928	-3.109558084	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2636	5193	0.005777008	0.006162141	2	2	EN-L4	12	6	6
ATTGGTGTCCAAATGC-1_7_G10	1.903662261	5.917093429	7	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	986	1227	0.004889976	0.011409943	2	7	Phagocytes	12	6	6
ATTGGTGTCCGATATG-1_7_G10	-21.71798576	-16.24379749	6B	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2836	6056	0.028731836	0.005449141	2	6B	IN-SST	12	6	6
ATTTCTGAGATCTGAA-1_7_G10	17.92699023	-20.40110192	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2941	5882	0.040462428	0.004930296	2	L2-3	EN-L2-3-MS	12	6	6
ATTTCTGAGATGCGAC-1_7_G10	-23.93648117	25.6632685	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1412	2303	0.003907946	0.007815892	2	8	Astrocytes	12	6	6
ATTTCTGAGTCTTGCA-1_7_G10	3.302240108	28.35087635	1	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	730	1040	0.003846154	0.000961538	2	oligos	OL-Cntl	12	6	6
ATTTCTGAGTTGAGTA-1_7_G10	4.128665982	-14.84649161	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2272	4035	0.015613383	0.003717472	2	L2-3	EN-L2-3-MS	12	6	6
ATTTCTGCACGGCTAC-1_7_G10	3.149185629	-32.18432296	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4775	15461	0.003557338	0.003298622	2	L2-3	EN-L2-3-Cntl	12	6	6
ATTTCTGCATAAAGGT-1_7_G10	21.33153984	27.04720739	1	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	974	1388	0.00648415	0.003602305	2	oligos	OL-Cntl	12	6	6
ATTTCTGGTCACTGGC-1_7_G10	2.64070214	-25.54124522	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3439	8228	0.001944579	0.003038405	2	L2-3	EN-L2-3-Cntl	12	6	6
ATTTCTGGTCGCGGTT-1_7_G10	-35.13070661	-9.272977037	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1025	1557	0.012202954	0.004495825	2	9	OPC	12	6	6
ATTTCTGTCCCTAACC-1_7_G10	21.5383853	27.44325613	1	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	983	1425	0.006315789	0.003508772	2	oligos	OL-Cntl	12	6	6
CAACCAAAGACAGAGA-1_7_G10	3.428556205	-20.1888084	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3314	7002	0.006712368	0.007283633	2	L2-3	EN-L2-3-MS	12	6	6
CAACCAACAAGAGGCT-1_7_G10	-0.485455841	35.39478899	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	794	1089	0.008264463	0.005509642	2	oligos	OL-MS-2	12	6	6
CAACCAACACAACTGT-1_7_G10	-6.116844595	31.55777811	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1087	1502	0.013315579	0.001331558	2	oligos	OL-MS-2	12	6	6
CAACCAACAGTCACTA-1_7_G10	-10.51537243	33.75175103	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	963	1244	0.01607717	0.00562701	2	oligos	OL-MS-2	12	6	6
CAACCAAGTGTGACGA-1_7_G10	-0.805328512	34.9551124	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	854	1287	0.012432012	0.006216006	2	oligos	OL-MS-2	12	6	6
CAACCAAGTTGGAGGT-1_7_G10	-0.03875002	34.60993341	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	777	1055	0.003791469	0.004739336	2	oligos	OL-MS-2	12	6	6
CAACCAATCAGTTTGG-1_7_G10	1.388887735	-23.13126209	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4008	10599	0.004811775	0.004811775	2	L2-3	EN-L2-3-Cntl	12	6	6
CAACCAATCTTCTGGC-1_7_G10	14.97382427	-33.42730853	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4591	15222	0.000985416	0.003941663	2	3	EN-L5-6	12	6	6
CAACCTCAGAGACGAA-1_7_G10	-3.415139383	35.61411999	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	861	1185	0.005907173	0.008438819	2	oligos	OL-MS-2	12	6	6
CAACCTCCAATGGTCT-1_7_G10	19.94195307	25.11545459	1	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	945	1439	0.004864489	0.005559416	2	oligos	OL-Cntl	12	6	6
CAACCTCCACACGCTG-1_7_G10	-5.67876203	33.66489461	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	934	1249	0.012810248	0.009607686	2	oligos	OL-MS-2	12	6	6
CAACCTCCACCAGCAC-1_7_G10	-5.66998462	35.48804716	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	773	1040	0.004807692	0.004807692	2	oligos	OL-MS-2	12	6	6
CAACCTCCACCTCGTT-1_7_G10	24.57299058	7.290954615	15A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2612	4411	0.023350714	0.01065518	2	15A	Endo cells	12	6	6
CAACCTCGTAGCGTAG-1_7_G10	7.843713275	-31.53980647	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3689	9420	0.001380042	0.004883227	2	L2-3	EN-L2-3-Cntl	12	6	6
CAACCTCGTTAGGGTG-1_7_G10	3.559943156	-20.62865099	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3498	7526	0.006643635	0.006643635	2	L2-3	EN-L2-3-MS	12	6	6
CAACTAGCACACGCTG-1_7_G10	21.2431256	12.57614527	1	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1609	2613	0.004209721	0.003827019	2	oligos	OL-Cntl	12	6	6
CAACTAGCAGTACACT-1_7_G10	-14.79170531	-3.651650715	13A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4491	11395	0.009741115	0.006318561	2	13A	IN-VIP	12	6	6
CAACTAGCAGTCAGCC-1_7_G10	22.03335581	27.74708005	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1049	1532	0.007832898	0.001958225	2	oligos	OL-MS-2	12	6	6
CAACTAGTCTGGTGTA-1_7_G10	28.92052944	-13.36476945	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4505	10616	0.016861341	0.015542577	2	3	EN-L5-6	12	6	6
CAAGAAAGTCGAGATG-1_7_G10	-16.55908966	-9.15225558	6A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2511	5121	0.02148018	0.005272408	2	6A	IN-PV	12	6	6
CAAGAAATCGGTGTCG-1_7_G10	-12.37851713	0.844114847	13A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3237	7262	0.005783531	0.00619664	2	13A	IN-VIP	12	6	6
CAAGATCAGACCCACC-1_7_G10	32.63958586	5.138172037	14	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	858	1014	0.020710059	0.001972387	2	14	Microglia	12	6	6
CAAGATCGTGAAATCA-1_7_G10	-5.973406245	33.78715055	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	922	1230	0.008130081	0.002439024	2	oligos	OL-MS-2	12	6	6
CAAGATCTCTAACTTC-1_7_G10	-2.737082254	31.93887108	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	974	1380	0.00942029	0.003623188	2	oligos	OL-MS-2	12	6	6
CAAGGCCAGCCACGCT-1_7_G10	9.079199064	-24.20538883	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3515	7647	0.00562312	0.008107755	2	L2-3	EN-L2-3-MS	12	6	6
CAAGGCCAGGCTATCT-1_7_G10	0.01015578	36.07255552	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	781	1059	0.003777148	0.007554297	2	oligos	OL-MS-2	12	6	6
CAAGGCCAGTACGCCC-1_7_G10	-24.63627838	-5.770640736	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1487	2377	0.005889777	0.005469079	2	9	OPC	12	6	6
CAAGGCCCAGCTCGAC-1_7_G10	9.068633431	-27.79731358	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4385	12124	0.002144507	0.008495546	2	L2-3	EN-L2-3-Cntl	12	6	6
CAAGGCCGTCGCATAT-1_7_G10	1.331509469	-21.96062506	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4018	10652	0.002253098	0.00920015	2	L2-3	EN-L2-3-MS	12	6	6
CAAGGCCGTGTGAAAT-1_7_G10	-3.147000018	34.59490194	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	781	1052	0.005703422	0.003802281	2	oligos	OL-MS-2	12	6	6
CAAGGCCGTTCAACCA-1_7_G10	33.51068832	7.140074618	14	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	852	1039	0.008662175	0.006737247	2	14	Microglia	12	6	6
CAAGGCCGTTCCACTC-1_7_G10	31.00718815	-10.91724642	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3978	8705	0.018954624	0.007696726	2	2	EN-L4	12	6	6
CAAGGCCTCAATCTCT-1_7_G10	22.36939386	25.8312401	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1074	1660	0.007228916	0.002409639	2	oligos	OL-MS-2	12	6	6
CAAGTTGAGCTAAACA-1_7_G10	-3.039516533	31.96709853	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	983	1424	0.011938202	0.004213483	2	oligos	OL-MS-2	12	6	6
CAAGTTGCAGCCTTGG-1_7_G10	29.43650015	-11.14838234	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	5241	15173	0.012719963	0.009358729	2	2	EN-L4	12	6	6
CAAGTTGCATCTGGTA-1_7_G10	-23.01369574	30.23032318	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1911	3338	0.002696225	0.006590773	2	8	Astrocytes	12	6	6
CAAGTTGCATTGAGCT-1_7_G10	-8.34150825	34.58000928	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	808	1046	0.010516252	0.001912046	2	oligos	OL-MS-2	12	6	6
CAAGTTGGTCCATCCT-1_7_G10	-7.808643257	-31.40168629	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	898	1284	0.082554517	0.004672897	2	16	EN-PYR	12	6	6
CAAGTTGGTGTGCGTC-1_7_G10	10.24415269	-26.46861695	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	6530	23623	0.012784151	0.003005545	2	L2-3	EN-L2-3-Cntl	12	6	6
CAAGTTGGTTCTGGTA-1_7_G10	-2.1738464	34.35086234	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	879	1201	0.009991674	0.005828476	2	oligos	OL-MS-2	12	6	6
CAAGTTGTCAAACCAC-1_7_G10	25.36002918	-23.78214144	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3883	9827	0.026050677	0.002645772	2	3	EN-L5-6	12	6	6
CAAGTTGTCACCATAG-1_7_G10	22.85970716	20.02515946	1	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1135	1642	0.002436054	0.004263094	2	oligos	OL-Cntl	12	6	6
CAAGTTGTCAGCAACT-1_7_G10	-3.105461134	34.1746756	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	852	1136	0.007042254	0.006161972	2	oligos	OL-MS-2	12	6	6
CAAGTTGTCATACGGT-1_7_G10	27.52563197	-15.21762332	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	6908	23909	0.031117989	0.009159731	2	2	EN-L4	12	6	6
CAAGTTGTCGCAAACT-1_7_G10	-8.756235988	-1.35628115	13A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2092	3817	0.001833901	0.011265392	2	13A	IN-VIP	12	6	6
CACAAACAGCTAGTCT-1_7_G10	-1.056390462	33.18748387	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	927	1368	0.005116959	0.008040936	2	oligos	OL-MS-2	12	6	6
CACAAACAGTTCGCAT-1_7_G10	-5.975764052	31.56056872	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1146	1671	0.010173549	0.003590664	2	oligos	OL-MS-2	12	6	6
CACAAACGTAGCGCTC-1_7_G10	-13.45679324	8.236941974	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1498	2225	0.024269663	0.008089888	2	8	Astrocytes	12	6	6
CACAAACGTTTACTCT-1_7_G10	16.17100795	-32.1547838	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	6040	23169	0.004402434	0.008286935	2	3	EN-L5-6	12	6	6
CACACAACAGGTCCAC-1_7_G10	18.92246193	-27.32797585	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3732	9730	0.00606372	0.011202467	2	3	EN-L5-6	12	6	6
CACACAACATGGGACA-1_7_G10	-10.69630887	-27.75888608	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1300	1893	0.062334918	0.008452192	2	16	EN-PYR	12	6	6
CACACAAGTAGGCTGA-1_7_G10	2.337016871	-21.54922664	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3770	9392	0.003087734	0.009689097	2	L2-3	EN-L2-3-MS	12	6	6
CACACAAGTCCATCCT-1_7_G10	21.65456986	12.36931125	1	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1485	2455	0.005295316	0.002851324	2	oligos	OL-Cntl	12	6	6
CACACAAGTCGGCATC-1_7_G10	-5.047805044	36.21788469	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	799	1084	0.004612546	0.009225092	2	oligos	OL-MS-2	12	6	6
CACACAAGTCTGATCA-1_7_G10	22.24620449	27.15252945	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1107	1593	0.008788449	0.00690521	2	oligos	OL-MS-2	12	6	6
CACACAAGTGCAGTAG-1_7_G10	9.265133612	-2.117311634	12	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1477	2377	0.03323517	0.012200252	2	12	EN-MIX	12	6	6
CACACAAGTTCGAATC-1_7_G10	-2.546537143	34.41023457	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	865	1192	0.003355705	0.006711409	2	oligos	OL-MS-2	12	6	6
CACACAATCAGCTTAG-1_7_G10	-25.03749704	-5.582071081	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1448	2295	0.005228758	0.00043573	2	9	OPC	12	6	6
CACACAATCCCAAGTA-1_7_G10	-5.057676914	32.92539777	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1038	1506	0.008632138	0.002656042	2	oligos	OL-MS-2	12	6	6
CACACAATCCTTAATC-1_7_G10	-10.71663371	-27.41666234	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	988	1322	0.040847201	0.011346445	2	16	EN-PYR	12	6	6
CACACCTAGATGCCAG-1_7_G10	34.0514723	7.375007995	14	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	914	1219	0.018867925	0.007383101	2	14	Microglia	12	6	6
CACACCTAGCCGATTT-1_7_G10	1.155907508	-28.53332351	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	5278	17113	0.006310992	0.004265763	2	L2-3	EN-L2-3-Cntl	12	6	6
CACACCTAGCTGAAAT-1_7_G10	29.41859997	-10.97604917	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	5024	13739	0.018778659	0.006841837	2	2	EN-L4	12	6	6
CACACCTCACTAGTAC-1_7_G10	-6.574962344	32.4302665	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1022	1421	0.016889514	0.002814919	2	oligos	OL-MS-2	12	6	6
CACACCTCATGTCGAT-1_7_G10	20.81944287	-22.80476657	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3986	9095	0.008576141	0.008796042	2	3	EN-L5-6	12	6	6
CACACCTGTACTCGCG-1_7_G10	-28.71843546	-12.60722384	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	858	1226	0.052202284	0.004893964	2	9	OPC	12	6	6
CACACCTTCAACGCTA-1_7_G10	-4.208789735	32.77767041	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1031	1481	0.008102633	0.003376097	2	oligos	OL-MS-2	12	6	6
CACACCTTCGGAAACG-1_7_G10	19.0570963	1.299732381	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1229	1773	0.003384095	0.001128032	2	2	EN-L4	12	6	6
CACACTCAGAAGGACA-1_7_G10	-12.17392653	-15.59276338	6B	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1246	1916	0.049582463	0.004697286	2	6B	IN-SST	12	6	6
CACACTCAGAAGGTTT-1_7_G10	-5.548006149	-30.25707531	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	806	1037	0.075216972	0.008678881	2	16	EN-PYR	12	6	6
CACACTCCACACCGAC-1_7_G10	32.84185523	-4.83581999	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3347	7261	0.010053712	0.00399394	2	2	EN-L4	12	6	6
CACACTCCACCATCCT-1_7_G10	-12.14678286	-30.94190057	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1566	2371	0.068325601	0.006326445	2	16	EN-PYR	12	6	6
CACACTCCACCCATTC-1_7_G10	24.6764723	6.646365415	15A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1832	2762	0.019188993	0.009775525	2	15A	Endo cells	12	6	6
CACACTCCAGGACCCT-1_7_G10	3.175701991	6.155730371	7	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1371	1941	0.007212777	0.007727975	2	7	Phagocytes	12	6	6
CACACTCGTTGAACTC-1_7_G10	-21.8608265	14.64333544	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1145	1682	0.002972652	0.007728894	2	8	Astrocytes	12	6	6
CACACTCTCATCGCTC-1_7_G10	-7.390376811	35.7276968	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	854	1130	0.011504425	0.002654867	2	oligos	OL-MS-2	12	6	6
CACAGGCAGCCCAACC-1_7_G10	-4.099284131	32.42107104	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1025	1419	0.007751938	0.005637773	2	oligos	OL-MS-2	12	6	6
CACAGGCAGCCGGTAA-1_7_G10	-17.07266315	7.204986243	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	837	1102	0.007259528	0.000907441	2	8	Astrocytes	12	6	6
CACAGGCAGCTAACAA-1_7_G10	31.39747417	-6.650492339	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3858	9112	0.010316067	0.006365233	2	2	EN-L4	12	6	6
CACAGGCAGGGATCTG-1_7_G10	24.85751172	-14.61251654	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	5690	16154	0.027361644	0.016961743	2	3	EN-L5-6	12	6	6
CACAGGCAGGTGCACA-1_7_G10	-2.584816945	31.70293734	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	912	1274	0.01177394	0.003924647	2	oligos	OL-MS-2	12	6	6
CACAGGCCAATGTTGC-1_7_G10	1.209935608	-26.60963623	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3610	8944	0.004360465	0.002236136	2	L2-3	EN-L2-3-Cntl	12	6	6
CACAGGCCACCCATTC-1_7_G10	-1.933234101	33.41641631	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	933	1316	0.006838906	0.004559271	2	oligos	OL-MS-2	12	6	6
CACAGGCGTAGCCTAT-1_7_G10	-14.87036123	10.41576386	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1436	2118	0.004249292	0.004249292	2	8	Astrocytes	12	6	6
CACAGGCTCCTATGTT-1_7_G10	25.3639658	6.128733801	15A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1448	2007	0.032884903	0.013452915	2	15A	Endo cells	12	6	6
CACAGGCTCTACCTGC-1_7_G10	-10.03178307	32.28567802	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	838	1046	0.019120459	0.001912046	2	oligos	OL-MS-2	12	6	6
CACAGGCTCTGGAGCC-1_7_G10	-11.58277735	-31.37316819	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1430	2414	0.162800331	0.006213753	2	16	EN-PYR	12	6	6
CACAGTACAGACAAGC-1_7_G10	18.51850097	-7.009163466	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1909	3544	0.008182844	0.003668172	2	3	EN-L5-6	12	6	6
CACAGTACAGGGCATA-1_7_G10	24.39090552	0.577154633	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2410	4942	0.004249292	0.003237556	2	2	EN-L4	12	6	6
CACAGTATCTCCTATA-1_7_G10	-26.24549036	-7.976538031	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1003	1456	0.010302198	0.00206044	2	9	OPC	12	6	6
CACATAGCAATAGCAA-1_7_G10	24.69997148	6.927800175	15A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2096	3211	0.033634382	0.018685768	2	15A	Endo cells	12	6	6
CACATAGGTCTCAACA-1_7_G10	22.63399858	27.46938694	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1063	1602	0.008114856	0.006242197	2	oligos	OL-MS-2	12	6	6
CACATAGTCAGGCGAA-1_7_G10	-5.886422791	-30.21168906	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	818	1110	0.07027027	0.011711712	2	16	EN-PYR	12	6	6
CACATAGTCCTCAATT-1_7_G10	-10.14433548	30.68458049	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1324	1928	0.02593361	0.010373444	2	oligos	OL-MS-2	12	6	6
CACATTTAGCTAGTGG-1_7_G10	17.4099903	-30.85487261	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4617	12272	0.00839309	0.004074316	2	3	EN-L5-6	12	6	6
CACATTTAGTAACCCT-1_7_G10	32.1220883	-1.902406668	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2425	4995	0.005605606	0.003603604	2	2	EN-L4	12	6	6
CACATTTAGTTTGCGT-1_7_G10	-1.03261664	34.29231127	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	819	1140	0.009649123	0.007017544	2	oligos	OL-MS-2	12	6	6
CACATTTCAATGTTGC-1_7_G10	-17.65823858	9.22464314	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	955	1265	0.006324111	0.007114625	2	8	Astrocytes	12	6	6
CACATTTCACAACGTT-1_7_G10	-4.928600789	-10.02229098	13B	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	833	1168	0.010273973	0.002568493	2	13B	IN-SV2C	12	6	6
CACATTTCATACCATG-1_7_G10	-17.53933459	-17.6664361	6B	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1853	3687	0.009221589	0.002441009	2	6B	IN-SST	12	6	6
CACATTTTCCCATTAT-1_7_G10	8.446356933	-2.1137752	12	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1532	2142	0.029411765	0.006535948	2	12	EN-MIX	12	6	6
CACATTTTCCGCAAGC-1_7_G10	-22.51229718	-22.14089666	6A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2669	5236	0.036669213	0.005729565	2	6A	IN-PV	12	6	6
CACATTTTCGTACGGC-1_7_G10	24.23166095	27.1062254	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1428	2189	0.006852444	0.005938785	2	oligos	OL-MS-2	12	6	6
CACCACTAGAGTACCG-1_7_G10	-5.32179189	34.61627736	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	868	1119	0.002680965	0.00536193	2	oligos	OL-MS-2	12	6	6
CACCACTAGATGTTAG-1_7_G10	4.429362691	-11.53253776	12	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1855	2960	0.008783784	0.0125	2	12	EN-MIX	12	6	6
CACCACTAGCCACGCT-1_7_G10	32.56904765	4.896205031	14	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1156	1450	0.022068966	0.009655172	2	14	Microglia	12	6	6
CACCACTAGCGTTTAC-1_7_G10	24.18701167	-6.294059805	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3600	8640	0.003356481	0.004166667	2	2	EN-L4	12	6	6
CACCACTAGGCTATCT-1_7_G10	27.67226408	-5.176020554	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3988	10434	0.003258578	0.007858923	2	2	EN-L4	12	6	6
CACCACTAGTGGGATC-1_7_G10	21.17579199	12.74401855	1	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1435	2387	0.005027231	0.002932551	2	oligos	OL-Cntl	12	6	6
CACCACTCAAACTGTC-1_7_G10	29.77332532	-10.73058389	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4337	10984	0.027676621	0.008011653	2	2	EN-L4	12	6	6
CACCACTCAATAGCAA-1_7_G10	-13.25405946	-32.02868391	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1725	2734	0.06986101	0.011338698	2	16	EN-PYR	12	6	6
CACCACTCATAACCTG-1_7_G10	-16.36204634	7.824783724	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1113	1513	0.003965631	0.005287508	2	8	Astrocytes	12	6	6
CACCACTCATGGGACA-1_7_G10	9.503805492	-23.58749618	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	5223	15272	0.003404924	0.011000524	2	L2-3	EN-L2-3-MS	12	6	6
CACCACTGTGAGGGTT-1_7_G10	8.673181619	-31.43321095	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3288	7432	0.002287406	0.004709365	2	L2-3	EN-L2-3-Cntl	12	6	6
CACCACTTCATCTGCC-1_7_G10	-31.98575623	-1.147001461	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1482	2498	0.004803843	0.003602882	2	9	OPC	12	6	6
CACCACTTCTCCGGTT-1_7_G10	-1.113657185	-25.48073524	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4450	13541	0.000886197	0.006055683	2	L2-3	EN-L2-3-Cntl	12	6	6
CACCACTTCTGCCCTA-1_7_G10	-20.10536969	15.4012629	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1276	1929	0.006739243	0.00155521	2	8	Astrocytes	12	6	6
CACCACTTCTGGTATG-1_7_G10	-26.29161073	-1.999687629	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1491	2439	0.002460025	0.052890529	2	9	OPC	12	6	6
CACCAGGAGAAGGGTA-1_7_G10	3.632823445	-15.01000023	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2452	4393	0.008194855	0.005007967	2	L2-3	EN-L2-3-MS	12	6	6
CACCAGGAGGTGCTTT-1_7_G10	-4.486307165	29.62466865	11	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	924	1479	0.007437458	0.001352265	2	11	Glia-MIX	12	6	6
CACCAGGCAGTGGAGT-1_7_G10	-0.737605629	33.27604942	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	810	1071	0.003734827	0.001867414	2	oligos	OL-MS-2	12	6	6
CACCAGGGTCTACCTC-1_7_G10	-21.47042841	-18.08163228	6B	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2676	5624	0.016180654	0.004800853	2	6B	IN-SST	12	6	6
CACCAGGGTTCAGACT-1_7_G10	31.02946673	-10.40798959	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4035	9867	0.022803284	0.005675484	2	2	EN-L4	12	6	6
CACCAGGTCAGCTCTC-1_7_G10	10.7630851	0.846250319	12	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	941	1225	0.007346939	0.013061224	2	12	EN-MIX	12	6	6
CACCAGGTCCAAACAC-1_7_G10	-14.7975232	-3.596558586	13A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4305	10472	0.028647823	0.006779985	2	13A	IN-VIP	12	6	6
CACCAGGTCTCTAGGA-1_7_G10	29.50318545	-11.30726487	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4620	11249	0.010845408	0.007822918	2	2	EN-L4	12	6	6
CACCAGGTCTGAAAGA-1_7_G10	0.33131334	34.10711599	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	848	1134	0.003527337	0.004409171	2	oligos	OL-MS-2	12	6	6
CACCTTGAGACGACGT-1_7_G10	-0.355371495	31.97900227	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	888	1182	0.000846024	0.004230118	2	oligos	OL-MS-2	12	6	6
CACCTTGAGGAACTGC-1_7_G10	23.22168099	-6.20450827	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2222	3738	0.012841091	0.007758159	2	2	EN-L4	12	6	6
CACCTTGAGGTGCACA-1_7_G10	30.63201213	-8.287281087	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3825	9121	0.018967219	0.008551694	2	2	EN-L4	12	6	6
CACCTTGCAAGTACCT-1_7_G10	2.918987423	-24.67278277	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3333	7113	0.009981724	0.003092928	2	L2-3	EN-L2-3-MS	12	6	6
CACCTTGTCCAGAAGG-1_7_G10	4.631222255	18.98297341	1	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1016	1441	0.009715475	0.013879251	2	oligos	OL-Cntl	12	6	6
CACCTTGTCGCGCCAA-1_7_G10	-21.46940044	15.43308292	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1190	1832	0.006004367	0.004366812	2	8	Astrocytes	12	6	6
CACTCCAAGACAGGCT-1_7_G10	3.163320131	-24.3226381	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3387	7095	0.004087385	0.010007047	2	L2-3	EN-L2-3-MS	12	6	6
CACTCCAAGTGGGATC-1_7_G10	-2.094617668	35.15620273	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	776	1030	0.006796117	0.004854369	2	oligos	OL-MS-2	12	6	6
CACTCCACACAGGTTT-1_7_G10	-7.275097049	35.29230725	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	860	1136	0.006161972	0.007042254	2	oligos	OL-MS-2	12	6	6
CACTCCACACGCTTTC-1_7_G10	34.01087121	7.232810149	14	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1029	1272	0.002358491	0.006289308	2	14	Microglia	12	6	6
CACTCCACAGAGTGTG-1_7_G10	-3.721143053	34.96205934	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	817	1110	0.004504505	0.004504505	2	oligos	OL-MS-2	12	6	6
CACTCCATCTTGTACT-1_7_G10	-5.543852331	34.78008564	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	822	1132	0.009717314	0.004416961	2	oligos	OL-MS-2	12	6	6
CAGAATCAGGACATTA-1_7_G10	-3.700983729	35.48757926	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	794	1030	0.00776699	0	2	oligos	OL-MS-2	12	6	6
CAGAATCCAAGCCGCT-1_7_G10	21.42114661	0.26881422	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1413	2294	0.004359198	0.004795118	2	2	EN-L4	12	6	6
CAGAATCCAGTATGCT-1_7_G10	-12.38545623	-0.038964072	13A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2962	5996	0.011174116	0.010006671	2	13A	IN-VIP	12	6	6
CAGAATCCAGTCGTGC-1_7_G10	1.342810037	-29.00811266	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4603	12903	0.002092537	0.003177556	2	L2-3	EN-L2-3-Cntl	12	6	6
CAGAATCGTAGCCTCG-1_7_G10	22.01545913	28.16035775	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1062	1510	0.005960265	0.002649007	2	oligos	OL-MS-2	12	6	6
CAGAATCGTGTGGCTC-1_7_G10	0.801908524	33.78614076	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	785	1138	0.007908612	0.002636204	2	oligos	OL-MS-2	12	6	6
CAGAATCGTTTGTTTC-1_7_G10	10.03792631	-18.95526947	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3654	8093	0.017546027	0.006795997	2	L2-3	EN-L2-3-MS	12	6	6
CAGAATCTCAGGATCT-1_7_G10	22.13760928	11.26449872	1	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1574	2463	0.002436054	0.002842063	2	oligos	OL-Cntl	12	6	6
CAGAATCTCTGATTCT-1_7_G10	-10.47089436	9.615363258	11	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3402	7553	0.001456375	0.003177545	2	11	Glia-MIX	12	6	6
CAGAGAGCAATCGAAA-1_7_G10	-17.5674764	7.754364044	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	921	1196	0.007525084	0.006688963	2	8	Astrocytes	12	6	6
CAGAGAGCATTAACCG-1_7_G10	-0.053837928	33.56360282	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	809	1150	0.004347826	0.004347826	2	oligos	OL-MS-2	12	6	6
CAGAGAGGTGTGACCC-1_7_G10	30.09316085	-10.95850901	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4599	11146	0.012201687	0.006190562	2	2	EN-L4	12	6	6
CAGAGAGTCTTGTCAT-1_7_G10	-19.75887509	10.27054651	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	889	1213	0.009892828	0.003297609	2	8	Astrocytes	12	6	6
CAGATCAAGGAGTCTG-1_7_G10	1.025917528	32.83223156	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	845	1203	0.004987531	0.004987531	2	oligos	OL-MS-2	12	6	6
CAGATCAAGGTTCCTA-1_7_G10	11.16869734	32.80185869	1	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	861	1257	0.000795545	0.00477327	2	oligos	OL-Cntl	12	6	6
CAGATCACACTTACGA-1_7_G10	-33.86201446	-8.481762183	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1068	1630	0.001840491	0.004294479	2	9	OPC	12	6	6
CAGCAGCAGCCCAACC-1_7_G10	1.349773061	-20.15649573	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3248	7170	0.005160391	0.00264993	2	L2-3	EN-L2-3-Cntl	12	6	6
CAGCAGCAGGGCTTCC-1_7_G10	26.44915382	-25.80631516	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3865	9990	0.008708709	0.004604605	2	3	EN-L5-6	12	6	6
CAGCAGCAGGTCGGAT-1_7_G10	6.299759263	-8.512502257	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2205	3649	0.015072623	0.007399287	2	L2-3	EN-L2-3-MS	12	6	6
CAGCAGCAGTGGGATC-1_7_G10	2.028857826	-20.08711734	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3201	6799	0.002353287	0.011325195	2	L2-3	EN-L2-3-MS	12	6	6
CAGCAGCAGTGTGAAT-1_7_G10	32.57290749	-3.942942544	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2892	5762	0.00399167	0.005727178	2	2	EN-L4	12	6	6
CAGCAGCGTACGCTGC-1_7_G10	-17.36453165	9.392647716	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1012	1356	0.005162242	0.001474926	2	8	Astrocytes	12	6	6
CAGCAGCGTCAATGTC-1_7_G10	31.2395281	-6.492128481	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3588	7966	0.005900075	0.011172483	2	2	EN-L4	12	6	6
CAGCAGCGTCTAGAGG-1_7_G10	17.02774749	-26.54439417	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4664	12540	0.007735247	0.012679426	2	3	EN-L5-6	12	6	6
CAGCAGCTCAAGGTAA-1_7_G10	-2.460516915	35.77574087	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	760	1024	0.021484375	0.005859375	2	oligos	OL-MS-2	12	6	6
CAGCAGCTCCTTGGTC-1_7_G10	3.240085231	-17.00530678	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2687	5366	0.007454342	0.009317928	2	L2-3	EN-L2-3-MS	12	6	6
CAGCAGCTCTCTGAGA-1_7_G10	2.763397497	-11.65394872	12	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1790	2986	0.00435365	0.002679169	2	12	EN-MIX	12	6	6
CAGCATACAGCTGTGC-1_7_G10	-5.446825788	34.30595166	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	871	1174	0.008517888	0.003407155	2	oligos	OL-MS-2	12	6	6
CAGCATACAGTCGTGC-1_7_G10	23.93142927	26.7114275	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1360	1989	0.004524887	0.003519356	2	oligos	OL-MS-2	12	6	6
CAGCATAGTCATGCCG-1_7_G10	22.61680249	25.71706267	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1237	1907	0.008914525	0.00681699	2	oligos	OL-MS-2	12	6	6
CAGCATAGTTAAGACA-1_7_G10	-5.878873834	33.29709263	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	987	1368	0.010233918	0.005847953	2	oligos	OL-MS-2	12	6	6
CAGCATATCAAGGCTT-1_7_G10	-23.89081948	-25.78376508	6A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	5208	16866	0.019388118	0.005454761	2	6A	IN-PV	12	6	6
CAGCCGAAGAGCCCAA-1_7_G10	-35.21228342	-2.717971619	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1191	1786	0.002799552	0.002239642	2	9	OPC	12	6	6
CAGCCGAAGCTCCTCT-1_7_G10	-6.94242718	-30.65570062	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	928	1304	0.094325153	0.007668712	2	16	EN-PYR	12	6	6
CAGCCGAAGGCGATAC-1_7_G10	-7.745686338	-32.64247762	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	918	1296	0.035493827	0.006944444	2	16	EN-PYR	12	6	6
CAGCCGACAATGGATA-1_7_G10	-2.562491319	33.35142199	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	913	1250	0.0064	0.0016	2	oligos	OL-MS-2	12	6	6
CAGCCGAGTCCCGACA-1_7_G10	23.20565564	26.65951878	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1223	1869	0.004280364	0.006420546	2	oligos	OL-MS-2	12	6	6
CAGCCGAGTTCAGACT-1_7_G10	-22.23803227	15.41428934	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1191	1910	0.006282723	0.003141361	2	8	Astrocytes	12	6	6
CAGCCGATCAGTACGT-1_7_G10	2.216716847	-21.83845004	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3890	9690	0.004747162	0.005985552	2	L2-3	EN-L2-3-MS	12	6	6
CAGCCGATCCGTCATC-1_7_G10	32.70533499	-4.242211003	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3271	7212	0.005823627	0.007348863	2	2	EN-L4	12	6	6
CAGCCGATCGTCACGG-1_7_G10	-7.30141444	-31.40614577	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	932	1242	0.02979066	0.012077295	2	16	EN-PYR	12	6	6
CAGCGACCAATACGCT-1_7_G10	-25.54880718	-9.51728387	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1058	1460	0.006849315	0.005479452	2	9	OPC	12	6	6
CAGCGACGTTCGCTAA-1_7_G10	-12.8191022	16.75342105	11	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1449	2150	0.006046512	0.002790698	2	11	Glia-MIX	12	6	6
CAGCGACTCACTATTC-1_7_G10	31.96026287	-1.669427567	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2548	4702	0.002126755	0.005104211	2	2	EN-L4	12	6	6
CAGCGACTCGGCTTGG-1_7_G10	-23.12515076	-23.91970269	6A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2989	6420	0.014485981	0.008411215	2	6A	IN-PV	12	6	6
CAGCTAAAGACCCACC-1_7_G10	-4.67944638	30.11215054	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1285	2169	0.004149378	0.000461042	2	oligos	OL-MS-2	12	6	6
CAGCTAAAGATGTCGG-1_7_G10	1.351833453	30.98235717	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	778	1026	0.007797271	0.002923977	2	oligos	OL-MS-2	12	6	6
CAGCTAACAAATACAG-1_7_G10	1.890444271	-12.24843398	12	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1781	2799	0.003929975	0.003572705	2	12	EN-MIX	12	6	6
CAGCTAACACAAGTAA-1_7_G10	-25.77772607	-6.462973348	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1132	1669	0.002995806	0.002995806	2	9	OPC	12	6	6
CAGCTAACACCCTATC-1_7_G10	-5.27608664	33.56786506	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	965	1317	0.012148823	0.009111617	2	oligos	OL-MS-2	12	6	6
CAGCTAACAGCTGTAT-1_7_G10	2.266006424	-20.846161	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3289	7595	0.009874918	0.004081633	2	L2-3	EN-L2-3-MS	12	6	6
CAGCTAACAGGGATTG-1_7_G10	-1.864488948	31.66805429	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	850	1104	0.003623188	0.005434783	2	oligos	OL-MS-2	12	6	6
CAGCTAACATACAGCT-1_7_G10	-20.63243247	14.90904338	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1274	1865	0.011260054	0.00536193	2	8	Astrocytes	12	6	6
CAGCTAAGTCTCCCTA-1_7_G10	-12.82341873	-0.925101515	13A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3045	6786	0.006189213	0.008694371	2	13A	IN-VIP	12	6	6
CAGCTAAGTGTGCCTG-1_7_G10	1.766729138	-22.73058593	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4173	11504	0.005041725	0.005997914	2	L2-3	EN-L2-3-Cntl	12	6	6
CAGCTAATCGACAGCC-1_7_G10	-2.751332332	34.48463465	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	859	1116	0.008064516	0.003584229	2	oligos	OL-MS-2	12	6	6
CAGCTGGCACTAAGTC-1_7_G10	27.57299549	5.430908359	15A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	995	1260	0.033333333	0.017460317	2	15A	Endo cells	12	6	6
CAGCTGGCATCCCATC-1_7_G10	-21.05801714	12.70869807	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	983	1376	0.005813953	0.00872093	2	8	Astrocytes	12	6	6
CAGCTGGGTAAGTAGT-1_7_G10	8.451905876	-26.48676559	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3974	10519	0.003422379	0.007129955	2	L2-3	EN-L2-3-Cntl	12	6	6
CAGCTGGGTAGCTAAA-1_7_G10	-24.0428993	25.16517123	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1667	2755	0.004718693	0.007622505	2	8	Astrocytes	12	6	6
CAGCTGGGTCAAACTC-1_7_G10	22.10589749	27.17881	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1024	1464	0.009562842	0.006147541	2	oligos	OL-MS-2	12	6	6
CAGCTGGGTCCGAACC-1_7_G10	-10.23425455	-17.19904467	6B	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	940	1422	0.023206751	0.002109705	2	6B	IN-SST	12	6	6
CAGCTGGGTCTAGTGT-1_7_G10	21.40873535	12.74405736	1	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1337	2127	0.004231312	0.00658204	2	oligos	OL-Cntl	12	6	6
CAGCTGGGTTTCGCTC-1_7_G10	-8.481504003	34.30516291	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	867	1120	0.014285714	0.004464286	2	oligos	OL-MS-2	12	6	6
CAGGTGCGTACTTCTT-1_7_G10	1.323307955	-20.28356417	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3009	6542	0.005502904	0.004738612	2	L2-3	EN-L2-3-Cntl	12	6	6
CAGGTGCGTAGGAGTC-1_7_G10	-14.93052106	-7.058881076	13A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3461	8545	0.004564073	0.0046811	2	13A	IN-VIP	12	6	6
CAGGTGCTCGGAAACG-1_7_G10	1.805876835	6.144145137	7	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	898	1121	0.008028546	0.004460303	2	7	Phagocytes	12	6	6
CAGTAACAGATGGGTC-1_7_G10	-18.38575074	-17.41772905	6B	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2252	4596	0.009573542	0.003916449	2	6B	IN-SST	12	6	6
CAGTAACAGGCCCGTT-1_7_G10	2.58606702	-31.86633012	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	6091	24185	0.001364482	0.002770312	2	L2-3	EN-L2-3-Cntl	12	6	6
CAGTAACCAGACTCGC-1_7_G10	32.87721229	-4.603644758	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3135	6693	0.010010459	0.006872852	2	2	EN-L4	12	6	6
CAGTAACCAGCCAATT-1_7_G10	22.34439778	28.76322332	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	902	1226	0.007340946	0.009787928	2	oligos	OL-MS-2	12	6	6
CAGTAACGTCTTTCAT-1_7_G10	-0.792536787	36.05623999	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	850	1150	0.007826087	0.00173913	2	oligos	OL-MS-2	12	6	6
CAGTAACTCCACGAAT-1_7_G10	1.968649659	6.449824747	7	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	865	1107	0.007226739	0.000903342	2	7	Phagocytes	12	6	6
CAGTCCTAGAAACCTA-1_7_G10	-0.068392053	33.35502633	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	862	1207	0.008285004	0.002485501	2	oligos	OL-MS-2	12	6	6
CAGTCCTAGACTTTCG-1_7_G10	-1.077006934	34.38684877	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	804	1072	0.005597015	0.001865672	2	oligos	OL-MS-2	12	6	6
CAGTCCTAGCAGGCTA-1_7_G10	31.20180526	-10.9140807	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2792	5555	0.021062106	0.005760576	2	2	EN-L4	12	6	6
CAGTCCTCAGATTGCT-1_7_G10	2.726719269	-21.87477518	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4376	11711	0.003671762	0.00888054	2	L2-3	EN-L2-3-MS	12	6	6
CAGTCCTCATATACCG-1_7_G10	2.956101114	-14.73156649	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2228	4216	0.004032258	0.008301708	2	L2-3	EN-L2-3-MS	12	6	6
CAGTCCTGTCCTCCAT-1_7_G10	-1.173678209	33.21908128	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	786	1103	0.007252947	0.002719855	2	oligos	OL-MS-2	12	6	6
CAGTCCTGTTAGAACA-1_7_G10	-20.69315313	-24.57647818	6A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2386	4785	0.002089864	0.006687565	2	6A	IN-PV	12	6	6
CAGTCCTTCACAGTAC-1_7_G10	-14.41337883	-6.864464624	13A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2711	5696	0.014044944	0.008602528	2	13A	IN-VIP	12	6	6
CAGTCCTTCACGGTTA-1_7_G10	31.59708413	-6.993180952	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3445	7669	0.011474769	0.009518842	2	2	EN-L4	12	6	6
CATATGGAGATCGATA-1_7_G10	-17.91170763	-21.37553555	6A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1999	3765	0.013811421	0.006108898	2	6A	IN-PV	12	6	6
CATATGGAGATGAGAG-1_7_G10	18.36475689	-5.903681385	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1545	2563	0.004682013	0.004291845	2	3	EN-L5-6	12	6	6
CATATGGAGGGAGTAA-1_7_G10	23.75012322	27.54089758	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1163	1679	0.000595593	0.004169148	2	oligos	OL-MS-2	12	6	6
CATATGGCACGAGAGT-1_7_G10	6.187342671	1.917196719	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1197	1660	0.015060241	0.004216867	2	16	EN-PYR	12	6	6
CATATGGCAGCTGTTA-1_7_G10	21.54534575	27.49345924	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1105	1555	0.002572347	0.003858521	2	oligos	OL-MS-2	12	6	6
CATATGGGTACCAGTT-1_7_G10	-15.70862316	15.27252639	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2078	3396	0.003828033	0.003828033	2	8	Astrocytes	12	6	6
CATATGGGTACCTACA-1_7_G10	23.50934592	26.24323746	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1250	1825	0.004931507	0.002739726	2	oligos	OL-MS-2	12	6	6
CATATGGGTCATACTG-1_7_G10	-4.586640983	30.48744247	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1294	1840	0.011413043	0.005434783	2	oligos	OL-MS-2	12	6	6
CATATGGGTCTGCAAT-1_7_G10	-21.79749475	16.1179817	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1210	1784	0.006165919	0.004484305	2	8	Astrocytes	12	6	6
CATATGGGTGACCAAG-1_7_G10	-17.97335	-7.831557049	13B	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3317	6978	0.021066208	0.00988822	2	13B	IN-SV2C	12	6	6
CATATTCAGTACCGGA-1_7_G10	20.91098613	26.73498803	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	899	1294	0.00618238	0.006955178	2	oligos	OL-MS-2	12	6	6
CATATTCCAATAAGCA-1_7_G10	-3.813814518	34.65512171	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	893	1294	0.00927357	0.005409583	2	oligos	OL-MS-2	12	6	6
CATATTCCACAACTGT-1_7_G10	15.28547504	-33.24275001	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4411	13640	0.001099707	0.005058651	2	3	EN-L5-6	12	6	6
CATATTCGTTACCAGT-1_7_G10	6.389480274	-15.5166097	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2860	5614	0.013003206	0.013537585	2	L2-3	EN-L2-3-MS	12	6	6
CATCAAGCATATGCTG-1_7_G10	21.68308365	25.73233142	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1026	1519	0.004608295	0.003949967	2	oligos	OL-MS-2	12	6	6
CATCAAGGTTCCGTCT-1_7_G10	-19.13489151	-26.67172097	6A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2903	6682	0.003292427	0.007632445	2	6A	IN-PV	12	6	6
CATCAAGTCAACACAC-1_7_G10	-17.77194107	-16.54243777	6B	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2432	4906	0.01691806	0.007541786	2	6B	IN-SST	12	6	6
CATCAAGTCATCGCTC-1_7_G10	-5.28973152	33.62081132	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	936	1261	0.014274385	0.009516257	2	oligos	OL-MS-2	12	6	6
CATCAAGTCCGCGCAA-1_7_G10	-26.31497121	9.020559914	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	789	1075	0.004651163	0.004651163	2	8	Astrocytes	12	6	6
CATCAAGTCCGTACAA-1_7_G10	4.617297602	-4.057265309	12	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1109	1686	0.018386714	0.002372479	2	12	EN-MIX	12	6	6
CATCAAGTCTCCAGGG-1_7_G10	31.56332531	-5.550410034	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3216	6916	0.009832273	0.00838635	2	2	EN-L4	12	6	6
CATCAGAAGCCTCGTG-1_7_G10	-26.83976344	17.93448791	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1165	1720	0.006976744	0.004651163	2	8	Astrocytes	12	6	6
CATCAGAAGGTAGCTG-1_7_G10	23.63469004	26.62632673	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1217	1861	0.00483611	0.003224073	2	oligos	OL-MS-2	12	6	6
CATCAGATCAACGGGA-1_7_G10	-26.30486726	-6.343894615	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1023	1526	0.003931848	0.003931848	2	9	OPC	12	6	6
CATCAGATCGCTGATA-1_7_G10	-2.381770004	33.02552165	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	898	1236	0.012944984	0.004854369	2	oligos	OL-MS-2	12	6	6
CATCCACAGAGGTTAT-1_7_G10	11.58324083	-20.81836609	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4839	13339	0.009820826	0.004947897	2	L2-3	EN-L2-3-MS	12	6	6
CATCCACAGCGTCTAT-1_7_G10	-22.85367882	14.50876977	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1092	1555	0.001286174	0.003215434	2	8	Astrocytes	12	6	6
CATCCACCATGGTAGG-1_7_G10	23.50544113	14.94328936	1	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1295	1968	0.003556911	0.006097561	2	oligos	OL-Cntl	12	6	6
CATCCACGTCTCCATC-1_7_G10	-7.914959498	33.14327491	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	919	1225	0.015510204	0.004081633	2	oligos	OL-MS-2	12	6	6
CATCGAAAGCGTAATA-1_7_G10	1.786316034	-20.15153838	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3396	7503	0.007197121	0.006397441	2	L2-3	EN-L2-3-MS	12	6	6
CATCGAAAGGGTGTTG-1_7_G10	24.9648708	7.205607692	15A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1823	2683	0.027953783	0.018263138	2	15A	Endo cells	12	6	6
CATCGAAGTCCATCCT-1_7_G10	-1.36563602	31.55817922	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	825	1147	0.004359198	0.002615519	2	oligos	OL-MS-2	12	6	6
CATCGAAGTTCCCTTG-1_7_G10	-5.512625736	30.77558373	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1160	1784	0.012892377	0.004484305	2	oligos	OL-MS-2	12	6	6
CATCGGGAGCAAATCA-1_7_G10	-3.335993981	33.76396981	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	884	1263	0.007917656	0.003167063	2	oligos	OL-MS-2	12	6	6
CATCGGGAGCAGCCTC-1_7_G10	7.220205545	-14.67403334	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2920	5724	0.014325646	0.012403913	2	L2-3	EN-L2-3-MS	12	6	6
CATCGGGCATCGACGC-1_7_G10	-8.543054726	-3.360700806	13A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1734	2820	0.005673759	0.008156028	2	13A	IN-VIP	12	6	6
CATCGGGCATGGTAGG-1_7_G10	-26.23259512	-6.054808405	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1117	1725	0.004057971	0.002318841	2	9	OPC	12	6	6
CATCGGGGTGCGCTTG-1_7_G10	-16.26398403	-16.47150863	6B	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1682	2991	0.016716817	0.002674691	2	6B	IN-SST	12	6	6
CATCGGGTCCTGTAGA-1_7_G10	12.86402713	0.602648545	12	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	905	1448	0.007596685	0.006906077	2	12	EN-MIX	12	6	6
CATCGGGTCGATCCCT-1_7_G10	-21.39740072	14.8916447	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1204	1821	0.001098298	0.004942339	2	8	Astrocytes	12	6	6
CATCGGGTCTAACTTC-1_7_G10	-2.683703397	32.13867567	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	885	1219	0.004101723	0.001640689	2	oligos	OL-MS-2	12	6	6
CATGACACAATAACGA-1_7_G10	32.58907841	4.690052788	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1347	1899	0.042127435	0.014218009	2	16	EN-PYR	12	6	6
CATGACACACGGATAG-1_7_G10	16.72308672	-18.25013897	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	5322	15459	0.035707355	0.007827156	2	L2-3	EN-L2-3-MS	12	6	6
CATGACACAGACAAGC-1_7_G10	7.450737356	2.082495285	12	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	903	1191	0.048698573	0.009235936	2	12	EN-MIX	12	6	6
CATGACACATATGGTC-1_7_G10	-2.757223411	34.09195649	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	821	1096	0.000912409	0.005474453	2	oligos	OL-MS-2	12	6	6
CATGACACATGGGAAC-1_7_G10	-19.91416626	12.04872917	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	953	1344	0.009672619	0.006696429	2	8	Astrocytes	12	6	6
CATGACACATGTCTCC-1_7_G10	-14.40682265	-4.840886296	13A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3119	6282	0.019898122	0.009073543	2	13A	IN-VIP	12	6	6
CATGACAGTAGGCTGA-1_7_G10	-10.8510418	0.139940316	13A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2478	4911	0.004683364	0.008348605	2	13A	IN-VIP	12	6	6
CATGACATCGGTGTTA-1_7_G10	-1.454781623	32.98968389	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	912	1265	0.005533597	0.004743083	2	oligos	OL-MS-2	12	6	6
CATGACATCGTAGGAG-1_7_G10	-6.20588951	-30.40414136	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	840	1144	0.100524476	0.012237762	2	16	EN-PYR	12	6	6
CATGCCTAGGAACTGC-1_7_G10	-3.256141314	35.13133284	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	797	1107	0.007226739	0.003613369	2	oligos	OL-MS-2	12	6	6
CATGCCTAGGGTTTCT-1_7_G10	23.84984012	27.83370413	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1105	1609	0.001243008	0.002486016	2	oligos	OL-MS-2	12	6	6
CATGCCTCACATCTTT-1_7_G10	-31.90330049	-0.809136832	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1572	2510	0.003187251	0.005179283	2	9	OPC	12	6	6
CATGCCTGTATTACCG-1_7_G10	3.74695118	-14.79462286	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2247	4144	0.001689189	0.007722008	2	L2-3	EN-L2-3-MS	12	6	6
CATGCCTGTCTGCCAG-1_7_G10	6.785767619	-17.0717365	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3012	6019	0.009636152	0.014786509	2	L2-3	EN-L2-3-MS	12	6	6
CATGCCTGTTACCAGT-1_7_G10	20.42835664	27.26382654	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	933	1380	0.007971014	0.004347826	2	oligos	OL-MS-2	12	6	6
CATGCCTTCAGGTTCA-1_7_G10	-9.550551294	32.0473506	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	919	1243	0.05229284	0.008045052	2	oligos	OL-MS-2	12	6	6
CATGCCTTCTTACCTA-1_7_G10	-7.887103236	-30.52897709	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	832	1184	0.099662162	0.004222973	2	16	EN-PYR	12	6	6
CATGGCGAGATCGATA-1_7_G10	-20.59614814	-27.40366989	6A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3343	7951	0.008300843	0.00352157	2	6A	IN-PV	12	6	6
CATGGCGAGGGAACGG-1_7_G10	-34.29491546	-8.687058724	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1029	1569	0.00446144	0.002549395	2	9	OPC	12	6	6
CATGGCGCAATGCCAT-1_7_G10	-25.30462712	-24.2720118	6A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4515	12762	0.039648958	0.00493653	2	6A	IN-PV	12	6	6
CATGGCGCACACCGAC-1_7_G10	28.97486872	-12.98759419	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	5634	16431	0.019049358	0.006877244	2	3	EN-L5-6	12	6	6
CATGGCGCATATGCTG-1_7_G10	20.94706868	27.95633177	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	925	1384	0.007225434	0.00433526	2	oligos	OL-MS-2	12	6	6
CATGGCGGTAGGACAC-1_7_G10	32.77432829	-5.353724747	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3406	7227	0.00581154	0.00954753	2	2	EN-L4	12	6	6
CATGGCGGTATGAAAC-1_7_G10	-26.19916333	8.653322184	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	814	1045	0.003827751	0.001913876	2	8	Astrocytes	12	6	6
CATGGCGTCCATTCTA-1_7_G10	22.64276836	27.364427	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1018	1503	0.005988024	0.007318696	2	oligos	OL-MS-2	12	6	6
CATTATCAGAACAATC-1_7_G10	3.24858185	-19.38345991	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2673	5523	0.005069708	0.004888647	2	L2-3	EN-L2-3-MS	12	6	6
CATTATCAGGCGCTCT-1_7_G10	-9.806248192	31.3476927	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	961	1341	0.019388516	0.007457122	2	oligos	OL-MS-2	12	6	6
CATTATCAGTAGGCCA-1_7_G10	29.93403222	-9.930519369	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3822	9162	0.018664047	0.004256713	2	2	EN-L4	12	6	6
CATTATCGTAGCGTAG-1_7_G10	33.83469857	7.635832942	14	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	820	1041	0.011527378	0.005763689	2	14	Microglia	12	6	6
CATTATCGTATCACCA-1_7_G10	-25.3384163	-11.52518856	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1256	1831	0.003276898	0.003823048	2	9	OPC	12	6	6
CATTATCTCCTCAATT-1_7_G10	-5.797250704	31.60493144	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1006	1367	0.009509876	0.002926116	2	oligos	OL-MS-2	12	6	6
CATTCGCAGTAACCCT-1_7_G10	1.215873817	-28.54631925	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4653	13732	0.005607341	0.004223711	2	L2-3	EN-L2-3-Cntl	12	6	6
CATTCGCCACCCATGG-1_7_G10	-19.36388551	10.53657714	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	904	1253	0.003192338	0.007980846	2	8	Astrocytes	12	6	6
CATTCGCCACGCCAGT-1_7_G10	7.145419044	-1.876892283	12	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1000	1409	0.012065295	0.010645848	2	12	EN-MIX	12	6	6
CATTCGCGTCGATTGT-1_7_G10	-18.81162511	7.692590211	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	904	1213	0.004122012	0.009068425	2	8	Astrocytes	12	6	6
CATTCGCTCAGGCGAA-1_7_G10	-11.93412552	-9.15130601	13B	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1824	2920	0.017123288	0.005821918	2	13B	IN-SV2C	12	6	6
CATTCGCTCCTTGCCA-1_7_G10	22.05054186	-26.05838517	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3934	10078	0.004564398	0.010716412	2	3	EN-L5-6	12	6	6
CCAATCCCACACAGAG-1_7_G10	-11.6851575	-31.13661103	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1378	2006	0.083748754	0.007976072	2	16	EN-PYR	12	6	6
CCAATCCGTATATGAG-1_7_G10	-17.09065505	8.918729432	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1164	1671	0.002393776	0.010771993	2	8	Astrocytes	12	6	6
CCAATCCTCAAGCCTA-1_7_G10	-22.05596119	-14.60047456	6A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2968	6365	0.007541241	0.004241948	2	6A	IN-PV	12	6	6
CCAATCCTCACTTATC-1_7_G10	33.98306368	7.707573125	14	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1028	1369	0.018991965	0.006574142	2	14	Microglia	12	6	6
CCAATCCTCCTCCTAG-1_7_G10	-20.84154476	17.6466283	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1520	2428	0.002883031	0.009060956	2	8	Astrocytes	12	6	6
CCAATCCTCTGAGGGA-1_7_G10	8.691999556	-29.39440597	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	5053	14745	0.005289929	0.002170227	2	L2-3	EN-L2-3-Cntl	12	6	6
CCAATCCTCTTCATGT-1_7_G10	21.87247689	27.04935862	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1133	1695	0.004129794	0.004129794	2	oligos	OL-MS-2	12	6	6
CCACCTACAATCAGAA-1_7_G10	-2.745419546	-0.919133237	13A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3358	7256	0.008406836	0.005650496	2	13A	IN-VIP	12	6	6
CCACCTAGTCGGCACT-1_7_G10	-27.25934029	9.590938928	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	773	1069	0.00748363	0.004677268	2	8	Astrocytes	12	6	6
CCACCTAGTGACTCAT-1_7_G10	22.60890429	27.14950987	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1013	1532	0.005874674	0.006527415	2	oligos	OL-MS-2	12	6	6
CCACCTATCACCCGAG-1_7_G10	21.80995113	-20.70830221	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	5980	20685	0.036113125	0.005462896	2	3	EN-L5-6	12	6	6
CCACCTATCCATGCTC-1_7_G10	33.12330478	5.968266684	14	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	941	1145	0.010480349	0.0069869	2	14	Microglia	12	6	6
CCACGGAAGCGAAGGG-1_7_G10	5.740655904	-10.11993737	12	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1555	2491	0.004415897	0.014050582	2	12	EN-MIX	12	6	6
CCACGGACACCCATGG-1_7_G10	22.64080624	27.27960001	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1122	1670	0.003592814	0.006586826	2	oligos	OL-MS-2	12	6	6
CCACGGACACCTGGTG-1_7_G10	-2.019444125	32.64924356	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	908	1259	0.007148531	0.009531374	2	oligos	OL-MS-2	12	6	6
CCACGGAGTAATCACC-1_7_G10	-1.296330125	34.12205741	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	804	1109	0.003606853	0.001803427	2	oligos	OL-MS-2	12	6	6
CCACGGAGTATTCTCT-1_7_G10	-1.896649158	34.53268153	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	794	1073	0.007455732	0.007455732	2	oligos	OL-MS-2	12	6	6
CCACGGAGTTCAGGCC-1_7_G10	30.50347213	-5.894720923	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4630	12113	0.008420705	0.006191695	2	2	EN-L4	12	6	6
CCACGGATCTCAACTT-1_7_G10	4.280414359	-11.41442235	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1853	2861	0.007689619	0.009087732	2	L2-3	EN-L2-3-MS	12	6	6
CCACGGATCTCGTTTA-1_7_G10	0.203156325	34.96359345	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	756	1002	0.008982036	0.002994012	2	oligos	OL-MS-2	12	6	6
CCACTACAGAAACCTA-1_7_G10	-31.88843782	-2.26031772	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1353	2201	0.005906406	0.007269423	2	9	OPC	12	6	6
CCACTACAGACGCTTT-1_7_G10	33.58801007	6.656948991	14	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	998	1281	0.014832162	0.007806401	2	14	Microglia	12	6	6
CCACTACAGTAACCCT-1_7_G10	24.16647109	-12.4261568	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	5481	15927	0.01224336	0.006090287	2	3	EN-L5-6	12	6	6
CCACTACAGTCTCAAC-1_7_G10	32.62066879	4.957920733	14	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1069	1328	0.02560241	0.012048193	2	14	Microglia	12	6	6
CCACTACAGTGGCACA-1_7_G10	-19.13602839	15.15177674	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1674	2609	0.016098122	0.008049061	2	8	Astrocytes	12	6	6
CCACTACAGTGTTTGC-1_7_G10	-1.253126477	33.34204294	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	984	1377	0.006535948	0.003631082	2	oligos	OL-MS-2	12	6	6
CCACTACCACATGTGT-1_7_G10	-5.977602376	33.62803174	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1063	1543	0.012961763	0.003888529	2	oligos	OL-MS-2	12	6	6
CCACTACCAGGGTACA-1_7_G10	5.307471004	-16.3057974	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3231	6922	0.011412886	0.008523548	2	L2-3	EN-L2-3-MS	12	6	6
CCACTACCATCAGTCA-1_7_G10	-7.371325946	33.92076672	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	909	1218	0.006568144	0.009031199	2	oligos	OL-MS-2	12	6	6
CCACTACGTAAGTTCC-1_7_G10	-2.763903355	34.48331797	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	834	1104	0.00634058	0.004528986	2	oligos	OL-MS-2	12	6	6
CCACTACGTCGCGGTT-1_7_G10	21.32540185	13.08024661	1	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1394	2225	0.003595506	0.006292135	2	oligos	OL-Cntl	12	6	6
CCACTACGTCTTGCGG-1_7_G10	6.46773575	-22.26931294	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3844	9115	0.010751509	0.005046626	2	L2-3	EN-L2-3-MS	12	6	6
CCACTACGTTGAACTC-1_7_G10	29.56628998	-11.15936434	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4250	10387	0.013382112	0.007701935	2	2	EN-L4	12	6	6
CCACTACTCACCGTAA-1_7_G10	-5.337019711	34.04369918	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	869	1201	0.013322231	0.004163197	2	oligos	OL-MS-2	12	6	6
CCACTACTCCTTTCGG-1_7_G10	-14.53976233	-3.773474939	13A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4278	10799	0.002222428	0.007593296	2	13A	IN-VIP	12	6	6
CCACTACTCGCATGAT-1_7_G10	-4.482093465	30.20808931	11	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1079	1501	0.011325783	0.00532978	2	11	Glia-MIX	12	6	6
CCACTACTCTGCAGTA-1_7_G10	-21.01489941	15.92044219	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1266	1856	0.006465517	0.007543103	2	8	Astrocytes	12	6	6
CCACTACTCTGCTTGC-1_7_G10	-8.589420557	-30.02962566	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	968	1324	0.046072508	0.006797583	2	16	EN-PYR	12	6	6
CCACTACTCTTTAGGG-1_7_G10	-20.96868598	16.9765113	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1348	2080	0.007692308	0.007692308	2	8	Astrocytes	12	6	6
CCAGCGAAGAAACGAG-1_7_G10	-0.051253094	35.12154499	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	839	1170	0.006837607	0.004273504	2	oligos	OL-MS-2	12	6	6
CCAGCGAAGATGTGGC-1_7_G10	2.771134151	-26.87369613	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2832	5615	0.003383793	0.004274265	2	L2-3	EN-L2-3-Cntl	12	6	6
CCAGCGAAGTCGTTTG-1_7_G10	12.66614567	-21.47961108	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4422	11415	0.020674551	0.003328953	2	L2-3	EN-L2-3-MS	12	6	6
CCAGCGACAAAGCAAT-1_7_G10	23.30220937	26.69289829	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1214	1776	0.009009009	0.002815315	2	oligos	OL-MS-2	12	6	6
CCAGCGACAATAGCAA-1_7_G10	13.03632724	-30.486049	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2541	5360	0.003731343	0.005970149	2	3	EN-L5-6	12	6	6
CCAGCGAGTGAGTGAC-1_7_G10	2.739228282	-21.70914118	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3992	9560	0.003451883	0.009205021	2	L2-3	EN-L2-3-MS	12	6	6
CCAGCGATCCCTGACT-1_7_G10	-25.98494274	-7.42711042	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1063	1607	0.003733665	0.004355943	2	9	OPC	12	6	6
CCATGTCCAATCTACG-1_7_G10	-2.688699156	35.22492348	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	799	1051	0.007611798	0.003805899	2	oligos	OL-MS-2	12	6	6
CCATGTCCACAACTGT-1_7_G10	-26.59271814	-6.64234764	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1030	1517	0.011206328	0.005932762	2	9	OPC	12	6	6
CCATGTCCACAGAGGT-1_7_G10	-5.518435843	33.74270334	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	988	1296	0.013888889	0.00308642	2	oligos	OL-MS-2	12	6	6
CCATGTCCACGAGGTA-1_7_G10	-2.645905625	34.2896688	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	817	1067	0.007497657	0.005623243	2	oligos	OL-MS-2	12	6	6
CCATGTCCAGTAAGAT-1_7_G10	-17.40967166	-21.63026582	6A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1905	3266	0.017452541	0.013778322	2	6A	IN-PV	12	6	6
CCATGTCCATAAGACA-1_7_G10	-21.44064144	15.72943858	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1252	1904	0.004201681	0.006302521	2	8	Astrocytes	12	6	6
CCATGTCGTTAAGAAC-1_7_G10	-3.468712237	34.19915446	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	858	1158	0.005181347	0.004317789	2	oligos	OL-MS-2	12	6	6
CCATGTCTCAAACCGT-1_7_G10	-16.37665368	-17.94882528	6A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1738	2885	0.003812825	0.003119584	2	6A	IN-PV	12	6	6
CCATTCGTCAGGCCCA-1_7_G10	-19.16060067	16.51874665	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1804	3044	0.004599212	0.003285151	2	8	Astrocytes	12	6	6
CCCAATCAGCTCCTCT-1_7_G10	23.36697604	27.92825305	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1009	1430	0.006293706	0.004895105	2	oligos	OL-MS-2	12	6	6
CCCAATCAGTCTTGCA-1_7_G10	-27.23441846	-6.062729626	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1182	1776	0.006193694	0.005630631	2	9	OPC	12	6	6
CCCAATCGTAGCGATG-1_7_G10	4.099901358	-14.82806314	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2340	4230	0.007801418	0.007565012	2	L2-3	EN-L2-3-MS	12	6	6
CCCAATCGTCATATGC-1_7_G10	32.2803054	-2.791854454	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2264	4030	0.005707196	0.006203474	2	2	EN-L4	12	6	6
CCCAATCGTCCGACGT-1_7_G10	14.99234153	-33.74969325	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4356	12701	0.000551138	0.005826313	2	3	EN-L5-6	12	6	6
CCCAATCGTGCATCTA-1_7_G10	21.42579127	26.62464031	1	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1017	1518	0.004611331	0.007246377	2	oligos	OL-Cntl	12	6	6
CCCAATCTCACTGGGC-1_7_G10	-21.57305866	-18.27024124	6A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3050	6939	0.012393717	0.007061536	2	6A	IN-PV	12	6	6
CCCAGTTGTTCCTCCA-1_7_G10	23.45623903	26.05266952	1	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1226	1851	0.00378174	0.006482982	2	oligos	OL-Cntl	12	6	6
CCCAGTTTCAAAGTAG-1_7_G10	-19.53236705	11.40403308	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	923	1248	0.012820513	0.004807692	2	8	Astrocytes	12	6	6
CCCAGTTTCATGCAAC-1_7_G10	-1.526333843	35.56060205	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	749	1051	0.008563273	0.007611798	2	oligos	OL-MS-2	12	6	6
CCCAGTTTCCGCGCAA-1_7_G10	20.80675257	-29.29981892	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3921	9905	0.001615346	0.006360424	2	3	EN-L5-6	12	6	6
CCCAGTTTCCGTACAA-1_7_G10	2.972901473	6.099686137	7	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1273	1778	0.006186727	0.005624297	2	7	Phagocytes	12	6	6
CCCAGTTTCTCCAGGG-1_7_G10	-2.153727366	36.09046482	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	757	1016	0.005905512	0.003937008	2	oligos	OL-MS-2	12	6	6
CCCATACCAATGGTCT-1_7_G10	21.94879316	27.24774957	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1011	1396	0.006446991	0.005014327	2	oligos	OL-MS-2	12	6	6
CCCATACCAGACTCGC-1_7_G10	21.2528886	12.65401433	1	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1623	2542	0.004720692	0.004720692	2	oligos	OL-Cntl	12	6	6
CCCATACCATCCGTGG-1_7_G10	-7.739136336	33.13824335	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	968	1279	0.016419077	0.006254887	2	oligos	OL-MS-2	12	6	6
CCCATACGTCAGGACA-1_7_G10	-20.61561487	-27.50709869	6A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3849	10607	0.002828321	0.003393985	2	6A	IN-PV	12	6	6
CCCATACGTTAAGACA-1_7_G10	1.82312899	6.672430495	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	843	1102	0.007259528	0.005444646	2	oligos	OL-MS-2	12	6	6
CCCATACTCACGAAGG-1_7_G10	12.2378481	-21.23040831	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3973	9478	0.016248154	0.006330449	2	L2-3	EN-L2-3-MS	12	6	6
CCCTCCTAGAAACCTA-1_7_G10	-0.883270379	32.47883107	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	962	1379	0.003625816	0.005801305	2	oligos	OL-MS-2	12	6	6
CCCTCCTAGTACCGGA-1_7_G10	1.639735323	32.64708183	1	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	826	1158	0.011226252	0.002590674	2	oligos	OL-Cntl	12	6	6
CCCTCCTAGTCACGCC-1_7_G10	23.20701311	26.1096002	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1223	1845	0.011382114	0.00596206	2	oligos	OL-MS-2	12	6	6
CCCTCCTCAAACAACA-1_7_G10	-11.8189326	32.1380527	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	903	1164	0.026632302	0.008591065	2	oligos	OL-MS-2	12	6	6
CCCTCCTCAATTCCTT-1_7_G10	30.68246668	-3.01651668	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2645	5614	0.004453153	0.004987531	2	2	EN-L4	12	6	6
CCCTCCTCACCTATCC-1_7_G10	23.41231573	26.60139287	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1184	1839	0.003806417	0.00435019	2	oligos	OL-MS-2	12	6	6
CCCTCCTCAGCTGCAC-1_7_G10	-20.80036975	17.42872412	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1553	2569	0.004281822	0.005060335	2	8	Astrocytes	12	6	6
CCCTCCTCATCCCACT-1_7_G10	26.64230793	4.440076247	15A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	935	1244	0.00562701	0.004019293	2	15A	Endo cells	12	6	6
CCCTCCTCATTCACTT-1_7_G10	12.10837839	-21.55938097	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	5651	18589	0.010490075	0.00532573	2	L2-3	EN-L2-3-MS	12	6	6
CCCTCCTGTCGGGTCT-1_7_G10	-37.96806755	-0.346962132	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1492	2574	0.002719503	0.003108003	2	9	OPC	12	6	6
CCCTCCTTCGAATCCA-1_7_G10	22.73491789	28.1538669	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1009	1417	0.007762879	0.003528582	2	oligos	OL-MS-2	12	6	6
CCGGGATAGAGCTGCA-1_7_G10	9.417880004	-25.74163599	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4173	10790	0.008989805	0.006765524	2	L2-3	EN-L2-3-MS	12	6	6
CCGGGATCAGCGATCC-1_7_G10	-22.23243265	13.79110891	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1004	1486	0.006056528	0.004037685	2	8	Astrocytes	12	6	6
CCGGGATCATAGAAAC-1_7_G10	-12.82485901	-17.66145597	6B	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1116	1720	0.018604651	0.002906977	2	6B	IN-SST	12	6	6
CCGGGATTCTGCGGCA-1_7_G10	29.21152417	-17.87790514	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	7287	27486	0.032234592	0.012588227	2	2	EN-L4	12	6	6
CCGGGATTCTGGCGTG-1_7_G10	-14.94880305	-0.626122584	13A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3872	8870	0.015219842	0.010372041	2	13A	IN-VIP	12	6	6
CCGGTAGAGACGCAAC-1_7_G10	29.73076034	-12.80473847	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3230	6409	0.031050086	0.011858324	2	2	EN-L4	12	6	6
CCGGTAGAGCAACGGT-1_7_G10	-22.9242434	14.63961839	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1012	1499	0.010673783	0.004002668	2	8	Astrocytes	12	6	6
CCGGTAGCACAGACAG-1_7_G10	23.23073193	-10.38576571	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3210	7105	0.009429979	0.003940887	2	3	EN-L5-6	12	6	6
CCGGTAGGTCACACGC-1_7_G10	30.17027892	-1.352397278	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3291	6923	0.001300014	0.005055612	2	2	EN-L4	12	6	6
CCGGTAGGTCTTGCGG-1_7_G10	-6.95143611	-31.12403066	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	785	1045	0.051674641	0.009569378	2	16	EN-PYR	12	6	6
CCGGTAGTCATGTCCC-1_7_G10	1.138584994	-23.25726293	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4088	11068	0.000993856	0.004427177	2	L2-3	EN-L2-3-Cntl	12	6	6
CCGGTAGTCGTGGTCG-1_7_G10	26.95953953	-16.43896369	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	8263	38978	0.037585305	0.010390477	2	2	EN-L4	12	6	6
CCGGTAGTCTTAGAGC-1_7_G10	-24.09430758	25.0774743	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1373	2230	0.012107623	0.003139013	2	8	Astrocytes	12	6	6
CCGTACTGTGATAAAC-1_7_G10	-0.14386758	-21.89935211	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3319	8181	0.004155971	0.003055861	2	L2-3	EN-L2-3-Cntl	12	6	6
CCGTACTGTTGACGTT-1_7_G10	-9.319661405	-32.11437083	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1024	1366	0.036603221	0.012445095	2	16	EN-PYR	12	6	6
CCGTACTTCTTGTATC-1_7_G10	-0.195486481	33.02727058	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	800	1116	0.007168459	0.003584229	2	oligos	OL-MS-2	12	6	6
CCGTGGAAGCTGCGAA-1_7_G10	29.05976433	-12.98949378	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4696	11764	0.026011561	0.009095546	2	2	EN-L4	12	6	6
CCGTGGAAGTTAAGTG-1_7_G10	-3.572133646	33.8655486	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	909	1244	0.006430868	0.007234727	2	oligos	OL-MS-2	12	6	6
CCGTGGACACACTGCG-1_7_G10	16.13772986	-18.70973048	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	6649	23978	0.052714989	0.00621403	2	L2-3	EN-L2-3-MS	12	6	6
CCGTGGACATCACAAC-1_7_G10	-22.03592552	14.86067839	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1174	1815	0.004407713	0.009366391	2	8	Astrocytes	12	6	6
CCGTGGACATTCCTCG-1_7_G10	-5.515618607	34.89969332	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	872	1168	0.015410959	0.004280822	2	oligos	OL-MS-2	12	6	6
CCGTGGAGTTATCCGA-1_7_G10	6.351879163	-8.502907045	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2405	4427	0.004517732	0.006098938	2	L2-3	EN-L2-3-MS	12	6	6
CCGTGGATCACAAACC-1_7_G10	-1.475445755	36.32311594	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	802	1137	0.014951627	0.00703606	2	oligos	OL-MS-2	12	6	6
CCGTGGATCATATCGG-1_7_G10	-22.12191565	-16.09461882	6A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3229	6726	0.024234315	0.005947071	2	6A	IN-PV	12	6	6
CCGTTCAAGACAGGCT-1_7_G10	19.04721153	-17.75703853	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	5894	18752	0.023304181	0.010398891	2	L2-3	EN-L2-3-MS	12	6	6
CCGTTCACAGTCAGAG-1_7_G10	-17.80697152	9.264670903	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	943	1381	0.004344678	0.004344678	2	8	Astrocytes	12	6	6
CCGTTCATCACGACTA-1_7_G10	-7.925274325	-7.332888412	13A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1203	1750	0.013714286	0.007428571	2	13A	IN-VIP	12	6	6
CCGTTCATCCACGTGG-1_7_G10	3.811880483	-16.7898096	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2591	4696	0.008943782	0.005536627	2	L2-3	EN-L2-3-MS	12	6	6
CCTAAAGAGGGCATGT-1_7_G10	11.7276321	-22.17501528	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	5553	17634	0.0111716	0.005557446	2	L2-3	EN-L2-3-MS	12	6	6
CCTAAAGAGTCAAGCG-1_7_G10	16.29144718	-28.85224325	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4748	14071	0.00461943	0.006396134	2	3	EN-L5-6	12	6	6
CCTAAAGCACTTAACG-1_7_G10	-7.755898503	-30.64411653	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	917	1328	0.098644578	0.005271084	2	16	EN-PYR	12	6	6
CCTAAAGCAGTTCATG-1_7_G10	-2.492690637	34.58457737	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	762	1079	0.00463392	0.008341057	2	oligos	OL-MS-2	12	6	6
CCTAAAGGTACCGTTA-1_7_G10	15.24030227	-33.24529148	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	6026	26090	0.001226524	0.003871215	2	3	EN-L5-6	12	6	6
CCTAAAGGTACTTAGC-1_7_G10	-17.12028756	8.42529781	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	919	1195	0.005857741	0.007531381	2	8	Astrocytes	12	6	6
CCTAAAGGTCTTTCAT-1_7_G10	24.96978901	-20.56226754	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3037	6385	0.016758027	0.005481597	2	3	EN-L5-6	12	6	6
CCTAAAGGTGGCTCCA-1_7_G10	12.57565504	-21.8930827	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	6389	22729	0.011087157	0.009239298	2	L2-3	EN-L2-3-MS	12	6	6
CCTAAAGTCTGGTATG-1_7_G10	-1.391975689	34.74745252	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	813	1080	0.001851852	0.002777778	2	oligos	OL-MS-2	12	6	6
CCTACACCAGATCGGA-1_7_G10	-1.77606432	31.36661657	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	813	1096	0.004562044	0.003649635	2	oligos	OL-MS-2	12	6	6
CCTACACGTAAGGGAA-1_7_G10	21.32248148	26.84896339	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	940	1382	0.002894356	0.002170767	2	oligos	OL-MS-2	12	6	6
CCTACACGTATATCCG-1_7_G10	7.243565542	-27.87259299	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	5546	18451	0.003956425	0.004281611	2	L2-3	EN-L2-3-Cntl	12	6	6
CCTACACTCAAAGACA-1_7_G10	1.680958398	-20.77342448	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3243	7143	0.004759905	0.002799944	2	L2-3	EN-L2-3-Cntl	12	6	6
CCTACCAAGGTAGCCA-1_7_G10	-1.19813501	34.55470565	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	846	1132	0.009717314	0.005300353	2	oligos	OL-MS-2	12	6	6
CCTACCACAGATAATG-1_7_G10	-19.4756886	-23.2598949	6A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2020	3598	0.023624236	0.005558644	2	6A	IN-PV	12	6	6
CCTACCACATTACGAC-1_7_G10	1.635762364	-21.7097283	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4097	11380	0.006678383	0.007029877	2	L2-3	EN-L2-3-Cntl	12	6	6
CCTACCAGTAGCTCCG-1_7_G10	25.75788527	-8.223674683	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3871	8751	0.004570906	0.003656725	2	2	EN-L4	12	6	6
CCTACCAGTATAGTAG-1_7_G10	-15.61943902	11.47936565	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1408	2079	0.005772006	0.004329004	2	8	Astrocytes	12	6	6
CCTACCAGTCACTGGC-1_7_G10	-23.45900933	-21.57585898	6A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3014	6384	0.013157895	0.005482456	2	6A	IN-PV	12	6	6
CCTACCAGTGATGTCT-1_7_G10	-1.798576298	33.0110281	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1089	1519	0.008558262	0.001974984	2	oligos	OL-MS-2	12	6	6
CCTACCAGTGCAACTT-1_7_G10	22.50580307	-18.25998677	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	7141	27710	0.030783111	0.006892818	2	3	EN-L5-6	12	6	6
CCTACCAGTTGGTTTG-1_7_G10	-10.81690429	-33.48757689	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1053	1492	0.042895442	0.008042895	2	16	EN-PYR	12	6	6
CCTAGCTAGCCCTAAT-1_7_G10	21.27076243	12.48087558	1	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1424	2372	0.003794266	0.003794266	2	oligos	OL-Cntl	12	6	6
CCTAGCTCAGATGGGT-1_7_G10	1.910414959	-18.1539179	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2785	5796	0.012249827	0.004830918	2	L2-3	EN-L2-3-MS	12	6	6
CCTAGCTCAGGATTGG-1_7_G10	21.32291834	12.74687579	1	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1369	2157	0.002781641	0.003708855	2	oligos	OL-Cntl	12	6	6
CCTAGCTCAGGCTGAA-1_7_G10	-1.387269374	35.55628738	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	808	1091	0.002749771	0.002749771	2	oligos	OL-MS-2	12	6	6
CCTAGCTGTCAAGCGA-1_7_G10	7.578213946	-28.30524023	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	6585	24996	0.00556089	0.002640422	2	L2-3	EN-L2-3-Cntl	12	6	6
CCTAGCTGTCTAGTGT-1_7_G10	18.59286054	-17.5866179	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	7854	32725	0.025271199	0.006875477	2	L2-3	EN-L2-3-MS	12	6	6
CCTAGCTTCAGCGACC-1_7_G10	23.35046788	14.82864858	1	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1229	1888	0.003177966	0.003177966	2	oligos	OL-Cntl	12	6	6
CCTATTACAATGCCAT-1_7_G10	-8.58128871	34.07674692	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	891	1153	0.010407632	0.003469211	2	oligos	OL-MS-2	12	6	6
CCTATTACAGCTGCAC-1_7_G10	-24.70388973	-24.78785279	6A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4919	13767	0.023098714	0.005375173	2	6A	IN-PV	12	6	6
CCTATTACATACGCTA-1_7_G10	-11.72430587	17.53365719	11	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1840	2949	0.007121058	0.005764666	2	11	Glia-MIX	12	6	6
CCTATTACATTACGAC-1_7_G10	2.988255247	-20.35765503	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3423	8141	0.005896082	0.004667731	2	L2-3	EN-L2-3-MS	12	6	6
CCTATTATCCGCATCT-1_7_G10	-11.89694652	17.46759384	11	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1640	2724	0.007342144	0.005506608	2	11	Glia-MIX	12	6	6
CCTCAGTCAAACCCAT-1_7_G10	-4.907269189	30.69231187	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	960	1361	0.007347539	0.005143277	2	oligos	OL-MS-2	12	6	6
CCTCAGTCAATCCGAT-1_7_G10	11.90149549	33.28498221	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	778	1065	0.008450704	0.001877934	2	oligos	OL-MS-2	12	6	6
CCTCAGTCAGCTTAAC-1_7_G10	29.4571431	-11.33277323	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	5252	15228	0.016876806	0.011491988	2	2	EN-L4	12	6	6
CCTCAGTGTCCGAATT-1_7_G10	12.14373453	-2.277813925	12	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1176	1922	0.00780437	0.004682622	2	12	EN-MIX	12	6	6
CCTCAGTGTTACAGAA-1_7_G10	-31.26999394	-12.24977409	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	900	1275	0.009411765	0.005490196	2	9	OPC	12	6	6
CCTCTGAAGATGAGAG-1_7_G10	-27.92501889	23.10124377	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1197	1879	0.00266099	0.004789782	2	8	Astrocytes	12	6	6
CCTCTGAAGCTGGAAC-1_7_G10	-2.48630991	35.93094074	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	737	1012	0.009881423	0.006916996	2	oligos	OL-MS-2	12	6	6
CCTCTGACAAACCCAT-1_7_G10	9.770431245	-24.13550029	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	5591	17391	0.005980105	0.010235179	2	L2-3	EN-L2-3-MS	12	6	6
CCTCTGACACACAGAG-1_7_G10	-18.93416192	-8.147160226	13B	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4013	10039	0.021117641	0.004482518	2	13B	IN-SV2C	12	6	6
CCTCTGAGTAAGAGGA-1_7_G10	-9.638645709	31.741541	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	905	1252	0.051916933	0.005591054	2	oligos	OL-MS-2	12	6	6
CCTCTGAGTATCGCAT-1_7_G10	5.797482968	-14.51856421	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2556	4856	0.015856672	0.005766063	2	L2-3	EN-L2-3-MS	12	6	6
CCTTACGTCACATACG-1_7_G10	23.66743488	-27.5118828	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3496	8908	0.003929053	0.008194881	2	3	EN-L5-6	12	6	6
CCTTACGTCGAGGTAG-1_7_G10	24.57600302	8.390607748	15A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3289	5944	0.030955585	0.024394347	2	15A	Endo cells	12	6	6
CCTTCCCAGAGACTAT-1_7_G10	8.31572459	-28.74290209	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	5034	14709	0.003807193	0.004894962	2	L2-3	EN-L2-3-Cntl	12	6	6
CCTTCCCAGGACCACA-1_7_G10	9.030014419	-2.147298544	12	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1810	3483	0.034740167	0.004019523	2	12	EN-MIX	12	6	6
CCTTCCCGTACACCGC-1_7_G10	14.6072406	-30.0175749	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4702	14220	0.005485232	0.00583685	2	3	EN-L5-6	12	6	6
CCTTCCCGTCACACGC-1_7_G10	-7.597407454	34.41344905	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	948	1296	0.010030864	0.00462963	2	oligos	OL-MS-2	12	6	6
CCTTCCCTCACTTATC-1_7_G10	10.39248083	2.565551434	12	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	989	1266	0.003949447	0.001579779	2	12	EN-MIX	12	6	6
CCTTCCCTCATAAAGG-1_7_G10	24.8236687	-20.10791019	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4531	11866	0.012893983	0.007247598	2	3	EN-L5-6	12	6	6
CCTTCCCTCGCGTAGC-1_7_G10	-36.17301086	-5.113687208	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1282	2044	0.005381605	0.005381605	2	9	OPC	12	6	6
CCTTCCCTCTGGCGAC-1_7_G10	22.8300649	27.17220673	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1069	1598	0.003128911	0.002503129	2	oligos	OL-MS-2	12	6	6
CCTTCGAAGAAGGTTT-1_7_G10	2.403134603	-12.38706668	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1869	3349	0.015228426	0.002090176	2	L2-3	EN-L2-3-MS	12	6	6
CCTTCGAAGCATCATC-1_7_G10	22.08653363	25.56786151	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1116	1687	0.007113219	0.008891523	2	oligos	OL-MS-2	12	6	6
CCTTCGAAGGAGTTTA-1_7_G10	3.332301926	-32.61353806	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	5659	20841	0.00143947	0.002399117	2	L2-3	EN-L2-3-Cntl	12	6	6
CCTTCGAAGGGCACTA-1_7_G10	-15.52573546	-9.489739507	13B	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2212	4141	0.003380826	0.005312726	2	13B	IN-SV2C	12	6	6
CCTTCGACACCCATTC-1_7_G10	-31.92576247	-0.724144527	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1694	2937	0.004426285	0.009533538	2	9	OPC	12	6	6
CCTTCGACAGACGCAA-1_7_G10	33.72736062	7.162719729	14	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	799	1091	0.005499542	0.004582951	2	14	Microglia	12	6	6
CCTTCGACAGACGCTC-1_7_G10	-9.98604437	30.8090978	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1080	1491	0.04158283	0.005365526	2	oligos	OL-MS-2	12	6	6
CCTTCGAGTGCGATAG-1_7_G10	0.631735816	31.93213912	1	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	800	1112	0.003597122	0.006294964	2	oligos	OL-Cntl	12	6	6
CCTTCGAGTTAAAGTG-1_7_G10	25.56421856	6.945425616	15A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1585	2289	0.02839668	0.018348624	2	15A	Endo cells	12	6	6
CCTTCGAGTTGTGGCC-1_7_G10	-31.7204212	-12.4233857	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	792	1126	0.004440497	0.003552398	2	9	OPC	12	6	6
CCTTCGATCACAGGCC-1_7_G10	26.62341936	-5.365011109	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4758	14325	0.001465969	0.003699825	2	2	EN-L4	12	6	6
CCTTCGATCCAGATCA-1_7_G10	29.56771815	-10.88195893	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4654	12214	0.02562633	0.004175536	2	2	EN-L4	12	6	6
CCTTCGATCGATAGAA-1_7_G10	2.353271822	30.54174186	1	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	727	1008	0.003968254	0.008928571	2	oligos	OL-Cntl	12	6	6
CCTTCGATCTACTCAT-1_7_G10	-31.95280502	-1.784878889	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1381	2254	0.004880213	0.005323869	2	9	OPC	12	6	6
CCTTCGATCTGCCCTA-1_7_G10	-11.18728319	15.66095076	11	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1783	2778	0.009719222	0.002159827	2	11	Glia-MIX	12	6	6
CCTTTCTCACTTAAGC-1_7_G10	29.49196215	-6.094587319	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4281	11846	0.006162418	0.005065001	2	2	EN-L4	12	6	6
CCTTTCTCAGGATCGA-1_7_G10	9.019345701	-0.543195661	12	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	898	1226	0.063621533	0.003262643	2	12	EN-MIX	12	6	6
CCTTTCTGTAGGGACT-1_7_G10	-21.60314056	15.05395378	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1179	1723	0.004062681	0.002321532	2	8	Astrocytes	12	6	6
CCTTTCTTCTCCCTGA-1_7_G10	20.60915657	27.67959216	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	868	1298	0.006933744	0.006163328	2	oligos	OL-MS-2	12	6	6
CGAACATCAACCGCCA-1_7_G10	1.385310675	-23.01428974	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3920	10615	0.006029204	0.004050871	2	L2-3	EN-L2-3-Cntl	12	6	6
CGAACATCAATCACAC-1_7_G10	-4.44039419	36.11607124	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	776	1013	0.008884501	0.004935834	2	oligos	OL-MS-2	12	6	6
CGAACATGTAAGCACG-1_7_G10	24.22890411	-6.439721918	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3902	8894	0.002136272	0.009107263	2	2	EN-L4	12	6	6
CGAACATGTCTCCATC-1_7_G10	-8.173238188	33.85140412	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	855	1155	0.027705628	0.007792208	2	oligos	OL-MS-2	12	6	6
CGAACATGTTCAGCGC-1_7_G10	-0.142292983	32.89094842	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	786	1101	0.007266122	0.00181653	2	oligos	OL-MS-2	12	6	6
CGAACATGTTCCGTCT-1_7_G10	-21.14571245	14.30325999	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1157	1770	0.003389831	0.002824859	2	8	Astrocytes	12	6	6
CGAACATTCCCAAGTA-1_7_G10	24.447463	26.26303355	1	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1839	3032	0.031002639	0.007255937	2	oligos	OL-Cntl	12	6	6
CGAACATTCTCCAGGG-1_7_G10	-21.89597846	-18.82509613	6B	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2560	4908	0.01405868	0.007334963	2	6B	IN-SST	12	6	6
CGAACATTCTCCTATA-1_7_G10	-25.95329318	-6.327998999	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1167	1760	0.003409091	0.003409091	2	9	OPC	12	6	6
CGAATGTAGGTGGGTT-1_7_G10	-0.204339884	31.30598112	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	803	1169	0.00427716	0.005988024	2	oligos	OL-MS-2	12	6	6
CGAATGTCATGCAACT-1_7_G10	-22.20934426	13.16363782	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1049	1522	0.003285151	0.005913272	2	8	Astrocytes	12	6	6
CGAATGTGTTGGTGGA-1_7_G10	16.07004116	-28.81455841	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4476	12790	0.004065676	0.008444097	2	3	EN-L5-6	12	6	6
CGAATGTTCAGCATGT-1_7_G10	-17.20652086	-8.487438265	13B	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2933	6020	0.00730897	0.007475083	2	13B	IN-SV2C	12	6	6
CGAATGTTCTCTTGAT-1_7_G10	2.893423445	-14.90437194	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2216	3897	0.006415191	0.002566076	2	L2-3	EN-L2-3-MS	12	6	6
CGACCTTAGTGAACAT-1_7_G10	0.052148776	32.54698585	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	843	1246	0.004815409	0.005617978	2	oligos	OL-MS-2	12	6	6
CGACCTTAGTGTTGAA-1_7_G10	-14.22781098	-17.88899783	6B	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1294	2061	0.004852014	0.008248423	2	6B	IN-SST	12	6	6
CGACCTTCACTTAAGC-1_7_G10	-20.80870611	14.8029981	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1194	1812	0.004966887	0.004966887	2	8	Astrocytes	12	6	6
CGACCTTGTCTAGTGT-1_7_G10	18.95603786	-15.11300985	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	6788	23886	0.029640794	0.009210416	2	L2-3	EN-L2-3-MS	12	6	6
CGACCTTTCATAACCG-1_7_G10	-1.390266195	34.19906785	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	827	1134	0.002645503	0.000881834	2	oligos	OL-MS-2	12	6	6
CGACTTCAGAATTCCC-1_7_G10	5.342146967	1.496584949	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	809	1004	0.051792829	0.007968127	2	16	EN-PYR	12	6	6
CGACTTCCACGACTCG-1_7_G10	7.140658411	-3.053169264	12	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1254	1952	0.011270492	0.006659836	2	12	EN-MIX	12	6	6
CGACTTCGTACCGTTA-1_7_G10	-14.3817042	-16.89806918	6B	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1441	2372	0.013490725	0.004637437	2	6B	IN-SST	12	6	6
CGACTTCGTCCATCCT-1_7_G10	14.67207162	-21.81893218	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	6813	25347	0.021383201	0.006825265	2	L2-3	EN-L2-3-MS	12	6	6
CGACTTCTCAACACCA-1_7_G10	22.83781146	-9.103999923	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2622	5410	0.002402957	0.00702403	2	3	EN-L5-6	12	6	6
CGACTTCTCACAGTAC-1_7_G10	-25.57060015	-5.424821709	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1311	2074	0.00289296	0.00192864	2	9	OPC	12	6	6
CGACTTCTCCAGATCA-1_7_G10	23.44821735	13.97967064	1	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1353	2016	0.002480159	0.004464286	2	oligos	OL-Cntl	12	6	6
CGACTTCTCTCCCTGA-1_7_G10	-18.73636091	-22.89340137	6B	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2428	4910	0.001425662	0.004887984	2	6B	IN-SST	12	6	6
CGAGAAGAGAGGTAGA-1_7_G10	21.52018062	26.89894535	1	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1066	1495	0.004013378	0.004013378	2	oligos	OL-Cntl	12	6	6
CGAGAAGAGGCCATAG-1_7_G10	25.01368752	-19.49879135	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	6650	26269	0.1022498	0.00361643	2	3	EN-L5-6	12	6	6
CGAGAAGAGTACGCCC-1_7_G10	-33.85436736	-8.652920773	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1081	1573	0.004450095	0.001907184	2	9	OPC	12	6	6
CGAGAAGGTATAGGGC-1_7_G10	4.440356303	6.947819328	7	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1500	2274	0.010993843	0.008795075	2	7	Phagocytes	12	6	6
CGAGAAGGTGTTGGGA-1_7_G10	-16.20580097	-6.24428645	13A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2889	6009	0.009152937	0.006157431	2	13A	IN-VIP	12	6	6
CGAGAAGTCTATGTGG-1_7_G10	15.87920936	-27.39158387	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3506	7562	0.00886009	0.006347527	2	3	EN-L5-6	12	6	6
CGAGAAGTCTCACATT-1_7_G10	-32.33261233	3.831993	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2176	4248	0.004237288	0.003531073	2	9	OPC	12	6	6
CGAGCACAGATAGCAT-1_7_G10	-14.67474019	9.295857359	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1156	1550	0.019354839	0.003870968	2	8	Astrocytes	12	6	6
CGAGCACAGTACGCCC-1_7_G10	13.15977437	-22.59598536	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4225	11255	0.014215904	0.005775211	2	L2-3	EN-L2-3-MS	12	6	6
CGAGCACCAGCGAACA-1_7_G10	-20.29168784	-26.70523717	6A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2920	6574	0.001673258	0.004715546	2	6A	IN-PV	12	6	6
CGAGCACCAGCTTAAC-1_7_G10	24.92102814	6.638355323	15A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1672	2456	0.029315961	0.015879479	2	15A	Endo cells	12	6	6
CGAGCACCATTGTGCA-1_7_G10	-8.402324633	34.24137013	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	848	1062	0.005649718	0.002824859	2	oligos	OL-MS-2	12	6	6
CGAGCACGTGTGGCTC-1_7_G10	-19.6365937	14.53248453	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1349	1898	0.008429926	0.003688093	2	8	Astrocytes	12	6	6
CGAGCACTCCATTCTA-1_7_G10	-17.1733313	-10.2238108	13B	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3714	8744	0.005832571	0.004460201	2	13B	IN-SV2C	12	6	6
CGAGCACTCCTCATTA-1_7_G10	-13.76666524	-32.14122177	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2601	5279	0.065542716	0.013828377	2	16	EN-PYR	12	6	6
CGAGCACTCGGTTCGG-1_7_G10	-1.344625434	34.88206171	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	796	1070	0.006542056	0.010280374	2	oligos	OL-MS-2	12	6	6
CGAGCCAAGATGTAAC-1_7_G10	-10.94143813	-9.737788927	13B	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1299	2069	0.014499758	0.003383277	2	13B	IN-SV2C	12	6	6
CGAGCCAAGCATCATC-1_7_G10	10.38941219	0.216752112	12	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	912	1258	0.067567568	0.001589825	2	12	EN-MIX	12	6	6
CGAGCCAAGGTGCTTT-1_7_G10	13.40770449	-23.69040527	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3787	9273	0.011754556	0.003558719	2	L2-3	EN-L2-3-Cntl	12	6	6
CGAGCCAGTCTTTCAT-1_7_G10	21.29241106	27.14280337	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	950	1333	0.0060015	0.00300075	2	oligos	OL-MS-2	12	6	6
CGAGCCAGTGAGCGAT-1_7_G10	-4.983352588	-30.52491838	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	721	1013	0.130306022	0.006910168	2	16	EN-PYR	12	6	6
CGAGCCAGTGTTTGTG-1_7_G10	-0.343206429	35.27412504	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	819	1202	0.014143095	0.004991681	2	oligos	OL-MS-2	12	6	6
CGAGCCATCTGCAAGT-1_7_G10	-21.09119769	15.45295605	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1300	2012	0.004970179	0.002485089	2	8	Astrocytes	12	6	6
CGATCGGAGTCGTACT-1_7_G10	20.3480762	26.61986148	1	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	867	1231	0.003249391	0.006498781	2	oligos	OL-Cntl	12	6	6
CGATCGGCAGTCGATT-1_7_G10	0.56620235	-20.35244913	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3054	7020	0.003561254	0.002421652	2	L2-3	EN-L2-3-Cntl	12	6	6
CGATCGGCATTACCTT-1_7_G10	-18.78447956	-8.151130326	13B	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3828	8861	0.009931159	0.005416996	2	13B	IN-SV2C	12	6	6
CGATCGGGTAGGCATG-1_7_G10	-10.99224756	15.84481196	11	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1593	2533	0.003553099	0.004737465	2	11	Glia-MIX	12	6	6
CGATCGGTCTATCGCC-1_7_G10	33.12198981	5.109816282	14	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	970	1206	0.019900498	0.010779436	2	14	Microglia	12	6	6
CGATGGCAGATTACCC-1_7_G10	21.45084384	27.2273591	1	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	977	1393	0.007178751	0.003589375	2	oligos	OL-Cntl	12	6	6
CGATGGCAGCTTATCG-1_7_G10	23.10240633	27.76204699	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1152	1692	0.002955083	0.002364066	2	oligos	OL-MS-2	12	6	6
CGATGGCCAAGTCTGT-1_7_G10	24.7175414	8.274816813	15A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2530	4253	0.052198448	0.024688455	2	15A	Endo cells	12	6	6
CGATGGCCAGTTTACG-1_7_G10	-8.506877058	0.395692544	13A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2138	3948	0.00810537	0.009118541	2	13A	IN-VIP	12	6	6
CGATGGCGTGTGTGCC-1_7_G10	-4.084330221	-4.70127656	13A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1146	1945	0.004627249	0.002056555	2	13A	IN-VIP	12	6	6
CGATGGCTCGAATGCT-1_7_G10	2.399746689	6.354201462	7	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	994	1329	0.006019564	0.005267118	2	7	Phagocytes	12	6	6
CGATGGCTCGCAAGCC-1_7_G10	17.44832069	-19.05840702	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3333	7249	0.038350117	0.003310801	2	L2-3	EN-L2-3-MS	12	6	6
CGATGTAAGCTTATCG-1_7_G10	-34.10824342	-7.501437311	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1033	1621	0.007402838	0.003701419	2	9	OPC	12	6	6
CGATGTAAGTGGCACA-1_7_G10	-1.80054029	35.79100428	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	778	1022	0.019569472	0.005870841	2	oligos	OL-MS-2	12	6	6
CGATGTAAGTTCGCGC-1_7_G10	13.47401045	-30.37296225	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2816	5977	0.006190397	0.005186548	2	3	EN-L5-6	12	6	6
CGATGTACAATGGACG-1_7_G10	24.90494911	-22.63896869	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3394	7803	0.003844675	0.005510701	2	3	EN-L5-6	12	6	6
CGATGTACACATCCGG-1_7_G10	-4.687549166	36.56632593	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	806	1081	0.020351526	0.010175763	2	oligos	OL-MS-2	12	6	6
CGATGTAGTGCTAGCC-1_7_G10	19.32540823	-17.26684898	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	5478	15014	0.02411083	0.008658585	2	L2-3	EN-L2-3-MS	12	6	6
CGATGTAGTGTGACGA-1_7_G10	2.699448358	-19.83923557	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3395	7057	0.008077087	0.004534505	2	L2-3	EN-L2-3-MS	12	6	6
CGATGTAGTTGACGTT-1_7_G10	-1.224270106	34.66728334	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	834	1169	0.013686912	0.009409752	2	oligos	OL-MS-2	12	6	6
CGATGTATCAGCAACT-1_7_G10	-11.89665363	-31.29962248	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1623	3139	0.215036636	0.007327174	2	16	EN-PYR	12	6	6
CGATTGAAGCACCGCT-1_7_G10	13.94164147	-29.69563283	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3340	7598	0.001710977	0.004869703	2	3	EN-L5-6	12	6	6
CGATTGACAAAGTGCG-1_7_G10	-6.88315016	-31.83018167	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	841	1109	0.04418395	0.007213706	2	16	EN-PYR	12	6	6
CGATTGACACGAAACG-1_7_G10	-31.74770738	-1.993739026	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1310	2001	0.004497751	0.005497251	2	9	OPC	12	6	6
CGATTGATCATCTGCC-1_7_G10	-2.502565028	34.99427774	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	835	1184	0.007601351	0.000844595	2	oligos	OL-MS-2	12	6	6
CGATTGATCCCGACTT-1_7_G10	-2.356329661	-22.66248656	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3457	8310	0.00433213	0.004091456	2	L2-3	EN-L2-3-Cntl	12	6	6
CGATTGATCTGGGCCA-1_7_G10	29.65690463	-11.10799178	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4288	10700	0.016448598	0.005140187	2	2	EN-L4	12	6	6
CGCCAAGAGCTAAACA-1_7_G10	-10.85052858	30.37693073	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2015	2970	0.027272727	0.007744108	2	oligos	OL-MS-2	12	6	6
CGCCAAGAGCTGTCTA-1_7_G10	16.12104099	-10.83667757	12	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2651	5506	0.03414457	0.006901562	2	12	EN-MIX	12	6	6
CGCCAAGCAAGGTTCT-1_7_G10	5.171719312	34.88068079	1	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	729	1004	0.014940239	0.006972112	2	oligos	OL-Cntl	12	6	6
CGCCAAGCACCAGCAC-1_7_G10	-1.109132983	32.17374498	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	873	1233	0.02676399	0.00324412	2	oligos	OL-MS-2	12	6	6
CGCCAAGCATACAGCT-1_7_G10	-11.38267325	31.94691939	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	853	1061	0.010367578	0.004712535	2	oligos	OL-MS-2	12	6	6
CGCCAAGCATTCGACA-1_7_G10	32.97364185	-2.33758643	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2494	4553	0.005710521	0.005930156	2	2	EN-L4	12	6	6
CGCCAAGTCTCCGGTT-1_7_G10	-31.92023382	-9.857249862	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1018	1482	0.004048583	0.005398111	2	9	OPC	12	6	6
CGCGGTAAGAGTGACC-1_7_G10	-5.377208757	36.56197559	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	768	1004	0.010956175	0.012948207	2	oligos	OL-MS-2	12	6	6
CGCGGTAAGCAGGCTA-1_7_G10	-13.14667827	-15.96896932	6B	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1297	2109	0.031768611	0.002370792	2	6B	IN-SST	12	6	6
CGCGGTACACGAAGCA-1_7_G10	33.06584666	-4.726827686	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3125	6730	0.006835067	0.006240713	2	2	EN-L4	12	6	6
CGCGGTACATCGATTG-1_7_G10	-6.852507626	-31.16039187	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	981	1424	0.108848315	0.013342697	2	16	EN-PYR	12	6	6
CGCGGTACATGTCGAT-1_7_G10	-0.321111883	31.7596098	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	929	1258	0.003974563	0.003974563	2	oligos	OL-MS-2	12	6	6
CGCGGTAGTACATGTC-1_7_G10	16.37654896	-27.21248755	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3336	7379	0.008266703	0.005827348	2	3	EN-L5-6	12	6	6
CGCGGTATCACCACCT-1_7_G10	-22.33916903	14.7836453	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1092	1653	0.003629764	0.006049607	2	8	Astrocytes	12	6	6
CGCGGTATCATCGATG-1_7_G10	-34.00853059	-8.444011568	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1141	1752	0.003424658	0.003995434	2	9	OPC	12	6	6
CGCGGTATCATCGGAT-1_7_G10	1.819033366	-21.20769597	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3416	7831	0.003064743	0.003447836	2	L2-3	EN-L2-3-Cntl	12	6	6
CGCGGTATCGGTGTTA-1_7_G10	23.35961145	26.32169653	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1178	1782	0.004489338	0.001122334	2	oligos	OL-MS-2	12	6	6
CGCGTTTAGAGCCCAA-1_7_G10	-8.312488505	-5.829780593	13A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1437	2216	0.020306859	0.006768953	2	13A	IN-VIP	12	6	6
CGCGTTTAGCTACCGC-1_7_G10	11.71182589	33.80356426	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	892	1224	0.004901961	0.004901961	2	oligos	OL-MS-2	12	6	6
CGCGTTTAGTCAATAG-1_7_G10	6.549866341	1.276729435	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	818	1193	0.033528919	0.015088013	2	16	EN-PYR	12	6	6
CGCGTTTCACATGACT-1_7_G10	-10.82060679	32.9513067	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1087	1491	0.019450034	0.009389671	2	oligos	OL-MS-2	12	6	6
CGCGTTTCACTGAAGG-1_7_G10	31.30418831	-1.901588407	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2895	6121	0.014540108	0.004411044	2	2	EN-L4	12	6	6
CGCGTTTGTAAATACG-1_7_G10	21.06746654	-3.74468138	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2092	3836	0.050052138	0.0044317	2	2	EN-L4	12	6	6
CGCGTTTGTAGCGTCC-1_7_G10	9.642433473	-18.38125762	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3584	7940	0.022040302	0.009445844	2	L2-3	EN-L2-3-MS	12	6	6
CGCGTTTGTGAAATCA-1_7_G10	-22.27108563	15.0146201	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1114	1791	0.002233389	0.003350084	2	8	Astrocytes	12	6	6
CGCGTTTGTTCAGACT-1_7_G10	-15.99733643	-17.15046837	6B	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1709	2942	0.005438477	0.013256288	2	6B	IN-SST	12	6	6
CGCGTTTTCATACGGT-1_7_G10	-17.38064417	7.442189961	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	796	1033	0.008712488	0.002904163	2	8	Astrocytes	12	6	6
CGCGTTTTCCTATTCA-1_7_G10	-7.13697613	33.83921426	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1005	1373	0.008739985	0.002184996	2	oligos	OL-MS-2	12	6	6
CGCTATCAGAGCTGGT-1_7_G10	3.105622611	-32.58331829	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	5791	20603	0.002572441	0.001941465	2	L2-3	EN-L2-3-Cntl	12	6	6
CGCTATCCAATCTACG-1_7_G10	-1.980902171	34.44293155	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	794	1082	0.018484288	0.004621072	2	oligos	OL-MS-2	12	6	6
CGCTATCCAATGTTGC-1_7_G10	1.157408277	-22.08080388	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3929	10116	0.004052985	0.006128905	2	L2-3	EN-L2-3-Cntl	12	6	6
CGCTATCCAGGGTACA-1_7_G10	26.7097598	4.325607056	15A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	864	1140	0.005263158	0.003508772	2	15A	Endo cells	12	6	6
CGCTATCCATGAGCGA-1_7_G10	-18.61151555	-17.25617948	6B	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2358	4514	0.01617191	0.007310589	2	6B	IN-SST	12	6	6
CGCTATCCATGGTCTA-1_7_G10	-0.700553441	33.85264646	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	794	1108	0.002707581	0.002707581	2	oligos	OL-MS-2	12	6	6
CGCTATCCATTACCTT-1_7_G10	15.44634404	-29.99123125	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3962	10628	0.007433195	0.005833647	2	3	EN-L5-6	12	6	6
CGCTATCGTGACAAAT-1_7_G10	-7.451161328	35.81552145	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	894	1422	0.009845288	0.003516174	2	oligos	OL-MS-2	12	6	6
CGCTGGAAGACTACAA-1_7_G10	27.4874883	-15.05499272	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	5733	17819	0.032942365	0.006341546	2	2	EN-L4	12	6	6
CGCTGGAAGGTGTGGT-1_7_G10	-26.39392772	-7.827613468	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1052	1439	0.004169562	0.004169562	2	9	OPC	12	6	6
CGCTGGACACGGCCAT-1_7_G10	29.80514288	-10.68815477	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3901	8845	0.013906162	0.005992086	2	2	EN-L4	12	6	6
CGCTGGACATACTACG-1_7_G10	24.63190385	7.152832765	15A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2316	3625	0.017931034	0.010758621	2	15A	Endo cells	12	6	6
CGCTGGAGTACTTCTT-1_7_G10	-4.356147833	34.30340674	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	886	1210	0.007438017	0.00661157	2	oligos	OL-MS-2	12	6	6
CGCTGGATCTATGTGG-1_7_G10	12.56720857	-20.95688226	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4481	11320	0.010689046	0.006625442	2	L2-3	EN-L2-3-MS	12	6	6
CGCTTCAAGTGAACGC-1_7_G10	29.3874712	-5.701502259	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3650	8962	0.004240125	0.007252845	2	2	EN-L4	12	6	6
CGCTTCACAGCTGTAT-1_7_G10	-4.109755315	34.9590611	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	763	1075	0.00372093	0.005581395	2	oligos	OL-MS-2	12	6	6
CGCTTCACATGTTCCC-1_7_G10	18.98668334	12.72157415	1	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1361	2223	0.007647323	0.00359874	2	oligos	OL-Cntl	12	6	6
CGCTTCAGTACTTGAC-1_7_G10	-4.478487826	35.65821717	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	791	1066	0.005628518	0.002814259	2	oligos	OL-MS-2	12	6	6
CGCTTCAGTCTGGTCG-1_7_G10	-21.04690933	17.01282244	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1409	2067	0.003870343	0.008708273	2	8	Astrocytes	12	6	6
CGCTTCATCGAATGGG-1_7_G10	0.278578466	33.31994876	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	782	1069	0.005612722	0.006548176	2	oligos	OL-MS-2	12	6	6
CGCTTCATCTTTAGGG-1_7_G10	30.0090237	-0.459607064	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2951	6403	0.009058254	0.005622365	2	2	EN-L4	12	6	6
CGGACACAGGAATGGA-1_7_G10	-3.459652346	34.73562477	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	798	1014	0.007889546	0.004930966	2	oligos	OL-MS-2	12	6	6
CGGACACAGTACACCT-1_7_G10	0.439017965	-20.65096743	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3246	7604	0.003945292	0.001841136	2	L2-3	EN-L2-3-Cntl	12	6	6
CGGACACAGTGGGTTG-1_7_G10	22.8699881	26.92806441	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1146	1686	0.003558719	0.004744958	2	oligos	OL-MS-2	12	6	6
CGGACACCAAGTTGTC-1_7_G10	24.94240736	-28.17933534	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2894	6509	0.002150868	0.004762636	2	3	EN-L5-6	12	6	6
CGGACACCAGACACTT-1_7_G10	-3.770276565	33.39444988	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	908	1184	0.009290541	0.010135135	2	oligos	OL-MS-2	12	6	6
CGGACACGTCAGTGGA-1_7_G10	-35.76661367	-6.19479612	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1198	1845	0.004336043	0.003794038	2	9	OPC	12	6	6
CGGACACTCAGCGATT-1_7_G10	-7.648367572	-31.2237448	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	927	1340	0.107462687	0.003731343	2	16	EN-PYR	12	6	6
CGGACGTCAAGGACTG-1_7_G10	-26.82405998	-7.455147353	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	966	1372	0.005830904	0.002915452	2	9	OPC	12	6	6
CGGACGTGTACATCCA-1_7_G10	-9.338317349	32.59876096	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	809	1033	0.004840271	0.006776379	2	oligos	OL-MS-2	12	6	6
CGGACGTGTCTAGCGC-1_7_G10	32.69199143	-4.781533912	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3314	7222	0.010384935	0.004707837	2	2	EN-L4	12	6	6
CGGACTGAGAAACGCC-1_7_G10	24.64968417	27.00281448	1	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1669	2499	0.010004002	0.006402561	2	oligos	OL-Cntl	12	6	6
CGGACTGAGTTCGCGC-1_7_G10	-1.18806551	34.94255537	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	802	1066	0.009380863	0.000938086	2	oligos	OL-MS-2	12	6	6
CGGACTGGTCGAGTTT-1_7_G10	-22.66488787	15.21006096	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1163	1793	0.003904071	0.003346347	2	8	Astrocytes	12	6	6
CGGACTGTCTGTCCGT-1_7_G10	-16.94084851	7.579166792	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1129	1685	0.004154303	0.003560831	2	8	Astrocytes	12	6	6
CGGAGCTAGCCGTCGT-1_7_G10	-8.63682473	-30.4635421	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	951	1294	0.085007728	0.008500773	2	16	EN-PYR	12	6	6
CGGAGCTAGGGCTTCC-1_7_G10	-2.398507884	34.68443768	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	769	1043	0.004793864	0.004793864	2	oligos	OL-MS-2	12	6	6
CGGAGCTCACACCGAC-1_7_G10	2.48803778	6.261830901	7	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1423	1929	0.010368066	0.003628823	2	7	Phagocytes	12	6	6
CGGAGCTTCAGAGCTT-1_7_G10	-11.95698493	12.40488591	11	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	872	1090	0.00733945	0.003669725	2	11	Glia-MIX	12	6	6
CGGAGCTTCTCTAAGG-1_7_G10	-21.7018114	16.17552923	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1346	2152	0.011152416	0.005576208	2	8	Astrocytes	12	6	6
CGGAGTCAGGAATCGC-1_7_G10	3.357944281	32.30914352	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	781	1033	0.003872217	0.005808325	2	oligos	OL-MS-2	12	6	6
CGGAGTCCAATAAGCA-1_7_G10	4.581639027	-11.02384313	12	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1816	3169	0.021142316	0.006626696	2	12	EN-MIX	12	6	6
CGGAGTCCACGACGAA-1_7_G10	-7.486058869	35.21480891	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	796	1031	0.011639185	0.006789525	2	oligos	OL-MS-2	12	6	6
CGGAGTCCAGGCTCAC-1_7_G10	27.36656762	-14.81997918	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	5051	13525	0.025064695	0.007911275	2	3	EN-L5-6	12	6	6
CGGAGTCGTACAGTTC-1_7_G10	-11.34333666	29.99767718	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	978	1375	0.078545455	0.013090909	2	oligos	OL-MS-2	12	6	6
CGGCTAGGTACGACCC-1_7_G10	-0.486259215	35.32277474	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	803	1129	0.006200177	0.007971656	2	oligos	OL-MS-2	12	6	6
CGGGTCAAGTGCGTGA-1_7_G10	18.80602213	-17.45662695	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	5692	16736	0.016909656	0.006811663	2	L2-3	EN-L2-3-MS	12	6	6
CGGGTCACAGCTCCGA-1_7_G10	33.23694028	-4.179121707	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2803	5395	0.008341057	0.005560704	2	2	EN-L4	12	6	6
CGGGTCACAGTATCTG-1_7_G10	33.37243616	-2.625698347	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2150	4072	0.009823183	0.008104126	2	2	EN-L4	12	6	6
CGGGTCAGTTTAGGAA-1_7_G10	-34.10175514	-8.273759966	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1062	1560	0.005128205	0.002564103	2	9	OPC	12	6	6
CGGGTCATCACATAGC-1_7_G10	16.45456513	-28.7902035	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4161	10674	0.014989695	0.004871651	2	3	EN-L5-6	12	6	6
CGGGTCATCAGGTTCA-1_7_G10	32.78729623	-6.314834037	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3022	6087	0.009528503	0.006242813	2	2	EN-L4	12	6	6
CGGGTCATCCAGGGCT-1_7_G10	-27.30890009	12.71617037	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	871	1257	0.007955449	0.00636436	2	8	Astrocytes	12	6	6
CGGGTCATCCTGTAGA-1_7_G10	16.72082653	-18.30457605	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	5619	16885	0.020313888	0.00852828	2	L2-3	EN-L2-3-MS	12	6	6
CGGGTCATCTGCTGTC-1_7_G10	29.89745823	-10.99220666	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3785	8662	0.019625952	0.01073655	2	2	EN-L4	12	6	6
CGGTTAAAGAACAATC-1_7_G10	-19.89298541	15.06026552	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1402	2034	0.010816126	0.002949853	2	8	Astrocytes	12	6	6
CGGTTAAAGACCTTTG-1_7_G10	21.58343601	26.11025899	1	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1030	1515	0.002640264	0.004620462	2	oligos	OL-Cntl	12	6	6
CGGTTAAAGCTGTCTA-1_7_G10	-0.11790162	35.34496798	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	806	1082	0	0.004621072	2	oligos	OL-MS-2	12	6	6
CGGTTAACATGCAATC-1_7_G10	24.85551769	6.994548065	15A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1907	2822	0.014883062	0.013111269	2	15A	Endo cells	12	6	6
CGGTTAACATTTCAGG-1_7_G10	29.10408907	-3.095118113	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3922	9707	0.004429793	0.006696199	2	2	EN-L4	12	6	6
CGGTTAATCGATCCCT-1_7_G10	32.7971526	5.053037339	14	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	972	1228	0.027687296	0.00732899	2	14	Microglia	12	6	6
CGTAGCGCAATGACCT-1_7_G10	3.195709421	-21.41194145	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3738	8949	0.00257012	0.009610012	2	L2-3	EN-L2-3-MS	12	6	6
CGTAGCGCAGGGTATG-1_7_G10	2.666755467	-12.80121182	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2112	3772	0.006892895	0.007423118	2	L2-3	EN-L2-3-MS	12	6	6
CGTAGCGGTCCGAATT-1_7_G10	-20.21256939	14.9319794	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1249	1889	0.005293806	0.006352567	2	8	Astrocytes	12	6	6
CGTAGCGGTGTTTGTG-1_7_G10	3.263462341	-15.47188751	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2473	4431	0.005642067	0.006093433	2	L2-3	EN-L2-3-MS	12	6	6
CGTAGCGGTTGGTAAA-1_7_G10	13.06836692	-21.53290538	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	6896	24391	0.012504612	0.006026813	2	L2-3	EN-L2-3-MS	12	6	6
CGTAGCGTCAGAGCTT-1_7_G10	32.2101015	-6.255025261	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2924	6086	0.005915215	0.010023004	2	2	EN-L4	12	6	6
CGTAGCGTCGTTACAG-1_7_G10	-12.01622403	-4.094958563	13A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2273	4120	0.026941748	0.011407767	2	13A	IN-VIP	12	6	6
CGTAGCGTCTACCTGC-1_7_G10	-6.263354691	-31.4182706	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	836	1251	0.150279776	0.005595524	2	16	EN-PYR	12	6	6
CGTAGCGTCTATCCCG-1_7_G10	22.45908713	27.22666141	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1009	1479	0.004056795	0.002028398	2	oligos	OL-MS-2	12	6	6
CGTAGGCAGTCATCCA-1_7_G10	-14.88737718	-16.99324109	6B	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1421	2332	0.005574614	0.005145798	2	6B	IN-SST	12	6	6
CGTAGGCCACGGCGTT-1_7_G10	29.70583933	-3.755648249	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3372	7423	0.007005254	0.004715075	2	L2-3	EN-L2-3-Cntl	12	6	6
CGTAGGCCAGCCTTTC-1_7_G10	11.80039521	-21.99553336	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4586	12653	0.01556943	0.004583893	2	L2-3	EN-L2-3-MS	12	6	6
CGTAGGCGTGTCTGAT-1_7_G10	-15.04961281	-18.04035401	6B	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1403	2218	0.002254283	0.006762849	2	6B	IN-SST	12	6	6
CGTAGGCTCTGGTGTA-1_7_G10	-0.476002029	35.33378987	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	810	1103	0.00543971	0.008159565	2	oligos	OL-MS-2	12	6	6
CGTCACTAGAGATGAG-1_7_G10	-5.402894018	31.50089636	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1106	1580	0.010759494	0.005696203	2	oligos	OL-MS-2	12	6	6
CGTCACTCAAGTTAAG-1_7_G10	9.128145117	-25.9469387	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3831	9559	0.006799874	0.004393765	2	L2-3	EN-L2-3-MS	12	6	6
CGTCACTCAATCACAC-1_7_G10	-24.44438384	-12.26914032	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	897	1242	0.006441224	0.008856683	2	9	OPC	12	6	6
CGTCACTCATCAGTAC-1_7_G10	22.51616634	-18.50510624	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	6051	19965	0.022389181	0.006160781	2	3	EN-L5-6	12	6	6
CGTCACTGTCGGCATC-1_7_G10	-1.50291986	33.36253013	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	937	1271	0.006294256	0.003147128	2	oligos	OL-MS-2	12	6	6
CGTCACTTCTTGGGTA-1_7_G10	34.05183436	12.13103551	14	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	981	1257	0.015910899	0.019888624	2	14	Microglia	12	6	6
CGTCAGGCACAGAGGT-1_7_G10	-21.04905327	-25.3513297	6A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2927	6202	0.004998388	0.003063528	2	6A	IN-PV	12	6	6
CGTCAGGTCATTCACT-1_7_G10	-15.34109053	-9.407925549	13B	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2182	4001	0.00499875	0.004498875	2	13B	IN-SV2C	12	6	6
CGTCCATAGGGCTCTC-1_7_G10	-33.95508367	-8.553118258	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1028	1568	0.005739796	0.005102041	2	9	OPC	12	6	6
CGTCCATCAATGGAAT-1_7_G10	21.7847279	27.70240653	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	966	1351	0.003700962	0.005181347	2	oligos	OL-MS-2	12	6	6
CGTCCATTCGGAAATA-1_7_G10	-21.66889437	16.37791844	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1300	1989	0.004022122	0.003016591	2	8	Astrocytes	12	6	6
CGTCTACAGGTTCCTA-1_7_G10	21.76629426	27.3565148	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	977	1411	0.002834869	0.002834869	2	oligos	OL-MS-2	12	6	6
CGTCTACAGTCTTGCA-1_7_G10	-10.92001932	-1.658249128	13A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2302	4393	0.012747553	0.008650125	2	13A	IN-VIP	12	6	6
CGTCTACCAATCTGCA-1_7_G10	-19.85882441	15.40039229	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1396	2175	0.015172414	0.004137931	2	8	Astrocytes	12	6	6
CGTCTACCAATGCCAT-1_7_G10	-1.520515196	31.39726914	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	756	1009	0.003964321	0.005946482	2	oligos	OL-MS-2	12	6	6
CGTCTACCACAGGCCT-1_7_G10	9.190456427	31.92139748	1	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	781	1112	0.004496403	0.002697842	2	oligos	OL-Cntl	12	6	6
CGTCTACCAGTATCTG-1_7_G10	21.0814933	28.1128301	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	837	1183	0.003381234	0.001690617	2	oligos	OL-MS-2	12	6	6
CGTCTACCATAAAGGT-1_7_G10	12.46242548	-20.99060476	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3804	9852	0.036439302	0.004364596	2	L2-3	EN-L2-3-MS	12	6	6
CGTCTACCATCACGAT-1_7_G10	25.76416084	-24.13743444	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3993	9814	0.00387202	0.00621561	2	3	EN-L5-6	12	6	6
CGTCTACCATTTGCCC-1_7_G10	23.56126598	-28.9286996	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4018	10935	0.005761317	0.005578418	2	3	EN-L5-6	12	6	6
CGTCTACGTACTCTCC-1_7_G10	-14.54327209	-5.293512877	13A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2599	4683	0.005551997	0.006192612	2	13A	IN-VIP	12	6	6
CGTCTACGTTTGACAC-1_7_G10	-1.283713072	31.22950957	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	876	1180	0.010169492	0.006779661	2	oligos	OL-MS-2	12	6	6
CGTGAGCAGCCAGTTT-1_7_G10	-22.34933265	14.83917992	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1102	1584	0.003156566	0.005050505	2	8	Astrocytes	12	6	6
CGTGAGCAGTCGCCGT-1_7_G10	16.0723876	-32.18968588	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4922	15243	0.001902513	0.006101161	2	3	EN-L5-6	12	6	6
CGTGAGCCACAAGCCC-1_7_G10	-2.440089361	32.20900224	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	811	1098	0.000910747	0.004553734	2	oligos	OL-MS-2	12	6	6
CGTGAGCCAGATTGCT-1_7_G10	-6.020242708	-30.65726823	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	797	1018	0.057956778	0.00589391	2	16	EN-PYR	12	6	6
CGTGAGCCAGCCACCA-1_7_G10	-22.32533165	16.35507149	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1214	1863	0.004830918	0.009125067	2	8	Astrocytes	12	6	6
CGTGAGCGTACCAGTT-1_7_G10	6.388891695	-1.905624473	12	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	920	1311	0.026697178	0.009916095	2	12	EN-MIX	12	6	6
CGTGAGCGTGGGTATG-1_7_G10	30.94614293	-10.8565185	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4003	9019	0.024171194	0.009868056	2	2	EN-L4	12	6	6
CGTGAGCGTGTGAATA-1_7_G10	-17.13009498	10.30032945	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1047	1423	0.002810963	0.004919185	2	8	Astrocytes	12	6	6
CGTGAGCTCTTCGGTC-1_7_G10	-16.58925206	7.881519334	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1026	1477	0.006093433	0.006770481	2	8	Astrocytes	12	6	6
CGTGTAAAGTTCGCAT-1_7_G10	-15.08314493	-14.77313066	6B	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1506	2335	0.010706638	0.022269807	2	6B	IN-SST	12	6	6
CGTGTAACAGCCACCA-1_7_G10	-19.1732687	8.101395328	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	853	1109	0.001803427	0.007213706	2	8	Astrocytes	12	6	6
CGTGTAAGTCCGAGTC-1_7_G10	-25.8450303	-23.9184567	6A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4046	10200	0.056960784	0.007058824	2	6A	IN-PV	12	6	6
CGTGTAAGTCTAGTGT-1_7_G10	2.027474693	-16.62517593	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2367	4313	0.003941572	0.006955715	2	L2-3	EN-L2-3-MS	12	6	6
CGTGTAATCGAGGTAG-1_7_G10	29.05396006	-10.46196252	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3754	9001	0.046217087	0.001999778	2	2	EN-L4	12	6	6
CGTGTAATCTCTGAGA-1_7_G10	29.48291379	-5.535109684	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3454	7840	0.008163265	0.009438776	2	2	EN-L4	12	6	6
CGTGTAATCTGAGTGT-1_7_G10	-26.20647771	-9.141164696	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1008	1384	0.003612717	0.007947977	2	9	OPC	12	6	6
CGTGTCTAGACTAAGT-1_7_G10	6.404284016	-13.71223209	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2418	4386	0.020747834	0.006839945	2	L2-3	EN-L2-3-MS	12	6	6
CGTTAGAAGAAACCGC-1_7_G10	-5.588665142	-30.76751964	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	789	1170	0.141880342	0.002564103	2	16	EN-PYR	12	6	6
CGTTAGAAGACTAGGC-1_7_G10	3.046481002	-21.76303286	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4282	11291	0.006199628	0.005756797	2	L2-3	EN-L2-3-MS	12	6	6
CGTTAGAAGATCACGG-1_7_G10	-14.94735697	-23.12109782	6A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1545	2766	0.028922632	0.00253073	2	6A	IN-PV	12	6	6
CGTTAGAAGCCATCGC-1_7_G10	-25.51530477	-23.08398196	6A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3880	9268	0.032153647	0.008955546	2	6A	IN-PV	12	6	6
CGTTAGAAGCGTTTAC-1_7_G10	-5.689237412	34.93582958	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	795	1069	0.005612722	0	2	oligos	OL-MS-2	12	6	6
CGTTAGACACCTCGTT-1_7_G10	-24.11762348	24.91933987	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1664	2790	0.007885305	0.007526882	2	8	Astrocytes	12	6	6
CGTTAGACAGCTGCAC-1_7_G10	8.835965329	-30.97836281	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4048	10476	0.002481863	0.005345552	2	L2-3	EN-L2-3-Cntl	12	6	6
CGTTAGACATCCCACT-1_7_G10	-33.39534428	-9.241120534	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1002	1484	0.010107817	0.001347709	2	9	OPC	12	6	6
CGTTAGACATTCCTCG-1_7_G10	-24.37943242	-12.24973715	15DA	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	833	1135	0.020264317	0.003524229	2	15DA	T cells	12	6	6
CGTTAGAGTTCCTCCA-1_7_G10	-11.79824551	13.75131166	11	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1134	1529	0.004578156	0.007848267	2	11	Glia-MIX	12	6	6
CGTTAGATCATCGGAT-1_7_G10	3.042085601	-12.756263	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1938	3255	0.007987711	0.006451613	2	L2-3	EN-L2-3-MS	12	6	6
CGTTCTGAGAAGGACA-1_7_G10	-1.229723741	31.66701083	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	951	1285	0.004669261	0.006225681	2	oligos	OL-MS-2	12	6	6
CGTTCTGAGCGATATA-1_7_G10	-20.25517748	-28.32477886	6A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3443	8988	0.001446373	0.003560303	2	6A	IN-PV	12	6	6
CGTTCTGAGCTGTCTA-1_7_G10	25.05936101	-24.36257726	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3408	7823	0.003834846	0.005752269	2	3	EN-L5-6	12	6	6
CGTTCTGAGGACGAAA-1_7_G10	-0.388711077	32.23295717	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	903	1310	0.001526718	0.00610687	2	oligos	OL-MS-2	12	6	6
CGTTCTGGTCGCGTGT-1_7_G10	-1.005702936	34.22004423	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	792	1114	0.005385996	0.002692998	2	oligos	OL-MS-2	12	6	6
CGTTCTGGTCGCTTCT-1_7_G10	-20.76351548	13.75746287	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1203	1796	0.005567929	0.0077951	2	8	Astrocytes	12	6	6
CGTTCTGTCATTCACT-1_7_G10	-26.98312369	9.790188332	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	746	1051	0.005708849	0.000951475	2	8	Astrocytes	12	6	6
CGTTCTGTCCATGAAC-1_7_G10	7.037712413	1.432191859	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	737	1047	0.085004776	0.004775549	2	16	EN-PYR	12	6	6
CGTTGGGAGGCTAGGT-1_7_G10	11.66858341	33.32847034	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	740	1061	0.004712535	0.001885014	2	oligos	OL-MS-2	12	6	6
CGTTGGGAGTCTCAAC-1_7_G10	-25.41165025	-6.599955153	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1272	1937	0.006711409	0.007227672	2	9	OPC	12	6	6
CGTTGGGAGTTGTCGT-1_7_G10	20.69999952	-29.36726321	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4283	12013	0.002330808	0.008490802	2	3	EN-L5-6	12	6	6
CGTTGGGCACCTCGTT-1_7_G10	23.00777485	26.60850576	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1155	1679	0.004764741	0.004169148	2	oligos	OL-MS-2	12	6	6
CGTTGGGCACTTAACG-1_7_G10	2.521528199	-25.01091353	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4320	11302	0.001681118	0.004423996	2	L2-3	EN-L2-3-Cntl	12	6	6
CGTTGGGCATGGGACA-1_7_G10	-34.54504289	-6.68420192	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1255	1917	0.00312989	0.004694836	2	9	OPC	12	6	6
CGTTGGGGTAAACACA-1_7_G10	-7.715664034	33.45599877	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1038	1392	0.011494253	0.005747126	2	oligos	OL-MS-2	12	6	6
CGTTGGGGTAGGACAC-1_7_G10	27.90157804	6.200180516	15A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1092	1457	0.020590254	0.016472203	2	15A	Endo cells	12	6	6
CGTTGGGGTCTTCTCG-1_7_G10	2.167050233	-22.04701124	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4009	10398	0.003462204	0.006443547	2	L2-3	EN-L2-3-MS	12	6	6
CGTTGGGGTGCAGACA-1_7_G10	-15.84999755	-17.16127562	6B	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1549	2667	0.006749156	0.007874016	2	6B	IN-SST	12	6	6
CGTTGGGTCAGTTGAC-1_7_G10	32.5480758	-8.517689399	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3239	6670	0.006596702	0.010044978	2	2	EN-L4	12	6	6
CTAACTTCAGATTGCT-1_7_G10	3.067156278	-14.09093553	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2109	3830	0.01305483	0.009138381	2	L2-3	EN-L2-3-MS	12	6	6
CTAACTTGTATCTGCA-1_7_G10	32.31933114	-5.213137254	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3457	7896	0.005192503	0.008738602	2	2	EN-L4	12	6	6
CTAACTTGTCACTGGC-1_7_G10	-34.88947567	-5.913479132	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1246	2034	0.008357915	0.003441495	2	9	OPC	12	6	6
CTAAGACAGACAATAC-1_7_G10	-15.45098921	-16.89568097	6B	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1589	2724	0.009544787	0.009544787	2	6B	IN-SST	12	6	6
CTAAGACAGAGTACCG-1_7_G10	-0.218388094	35.21561871	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	757	1078	0.012987013	0.005565863	2	oligos	OL-MS-2	12	6	6
CTAAGACAGGAATGGA-1_7_G10	24.60331156	8.193978714	15A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2890	5147	0.043909073	0.018068778	2	15A	Endo cells	12	6	6
CTAAGACAGGGATGGG-1_7_G10	8.107721479	-15.37009943	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3088	6210	0.01884058	0.006763285	2	L2-3	EN-L2-3-MS	12	6	6
CTAAGACCAAGAAAGG-1_7_G10	13.60494842	-4.448500052	12	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1451	2320	0.017672414	0.002155172	2	12	EN-MIX	12	6	6
CTAAGACCACTGAAGG-1_7_G10	26.55117512	4.563074535	15A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	989	1351	0.010362694	0.004441155	2	15A	Endo cells	12	6	6
CTAAGACGTATCAGTC-1_7_G10	19.00609314	-17.41980576	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4724	12601	0.023966352	0.007539084	2	L2-3	EN-L2-3-MS	12	6	6
CTAAGACTCCGCAAGC-1_7_G10	-17.51089885	-16.52922881	6B	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2189	4056	0.017504931	0.004191321	2	6B	IN-SST	12	6	6
CTAAGACTCGCCTGAG-1_7_G10	-21.58404049	12.72919463	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	941	1359	0.007358352	0.008094187	2	8	Astrocytes	12	6	6
CTAAGACTCGTCACGG-1_7_G10	-19.43666371	-18.11824567	6A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2614	5449	0.002018719	0.003853918	2	6A	IN-PV	12	6	6
CTAAGACTCTCGTTTA-1_7_G10	21.75036963	27.54676429	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1041	1462	0.001367989	0.005471956	2	oligos	OL-MS-2	12	6	6
CTAATGGAGGTAGCTG-1_7_G10	-9.680704482	22.30181935	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1155	1594	0.004391468	0.001254705	2	8	Astrocytes	12	6	6
CTAATGGTCACGAAGG-1_7_G10	-8.168196775	-5.461294788	13A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1352	2094	0.007640879	0.004297994	2	13A	IN-VIP	12	6	6
CTAATGGTCGCGTAGC-1_7_G10	-27.36778199	13.28449124	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	863	1178	0.004244482	0.005093379	2	8	Astrocytes	12	6	6
CTAATGGTCGTTACGA-1_7_G10	-7.0143654	35.41575474	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	806	1069	0.011225444	0.00748363	2	oligos	OL-MS-2	12	6	6
CTACACCAGATATGCA-1_7_G10	22.82242209	26.82752639	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1105	1638	0.005494505	0.009157509	2	oligos	OL-MS-2	12	6	6
CTACACCAGCGATGAC-1_7_G10	-6.323165952	34.66458389	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	814	1077	0.011142061	0	2	oligos	OL-MS-2	12	6	6
CTACACCCAACTGCGC-1_7_G10	22.32871205	-19.10372061	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	7726	32642	0.018932663	0.007505668	2	3	EN-L5-6	12	6	6
CTACACCCACAACTGT-1_7_G10	3.774151685	-19.1711073	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3402	7457	0.009253051	0.007777927	2	L2-3	EN-L2-3-MS	12	6	6
CTACACCCACAAGACG-1_7_G10	22.41635912	25.82701936	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1102	1665	0.003603604	0.003603604	2	oligos	OL-MS-2	12	6	6
CTACACCGTGAGTATA-1_7_G10	23.84940814	27.05462659	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1224	1801	0.004441977	0.006107718	2	oligos	OL-MS-2	12	6	6
CTACACCTCAATAAGG-1_7_G10	2.738602482	-11.97197368	12	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1869	3097	0.009041007	0.011301259	2	12	EN-MIX	12	6	6
CTACACCTCACTTCAT-1_7_G10	-3.479648905	34.40655306	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	888	1201	0.011656953	0.004995837	2	oligos	OL-MS-2	12	6	6
CTACACCTCCTTGGTC-1_7_G10	-25.17591164	18.87915844	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1400	2368	0.001266892	0.002111486	2	8	Astrocytes	12	6	6
CTACATTCAAGGGTCA-1_7_G10	-32.0617579	-0.243767456	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1798	3167	0.007893906	0.004736344	2	9	OPC	12	6	6
CTACATTCACGTCAGC-1_7_G10	10.19931021	-19.02698009	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3829	9067	0.009705526	0.008382045	2	L2-3	EN-L2-3-MS	12	6	6
CTACATTCATGCAACT-1_7_G10	-32.03174432	-0.415830299	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1796	3110	0.008360129	0.004501608	2	9	OPC	12	6	6
CTACATTTCCATGAGT-1_7_G10	-1.035045925	35.34398463	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	774	1058	0.004725898	0.004725898	2	oligos	OL-MS-2	12	6	6
CTACATTTCTTCCTTC-1_7_G10	-22.12601148	14.76904541	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1091	1595	0.001880878	0.003134796	2	8	Astrocytes	12	6	6
CTACCCAAGCCACGTC-1_7_G10	-4.645443503	32.21428305	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1106	1544	0.007124352	0.004533679	2	oligos	OL-MS-2	12	6	6
CTACCCAAGCGTGAAC-1_7_G10	21.54277175	27.55225201	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	973	1328	0.005271084	0.003012048	2	oligos	OL-MS-2	12	6	6
CTACCCAAGCTGGAAC-1_7_G10	7.862776715	-29.76767349	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	5815	20434	0.00200646	0.004306548	2	L2-3	EN-L2-3-Cntl	12	6	6
CTACCCAAGGCCCTCA-1_7_G10	-8.144278842	33.2766748	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	984	1341	0.011185682	0.008202834	2	oligos	OL-MS-2	12	6	6
CTACCCAAGTGTGGCA-1_7_G10	3.210986403	-20.93583883	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3597	8563	0.006539764	0.005722294	2	L2-3	EN-L2-3-MS	12	6	6
CTACCCACAAGCCGCT-1_7_G10	-15.7446042	-17.45191719	6B	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1629	2848	0.026685393	0.001755618	2	6B	IN-SST	12	6	6
CTACCCACACCCTATC-1_7_G10	-4.566978357	34.29250938	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	894	1275	0.005490196	0.00627451	2	oligos	OL-MS-2	12	6	6
CTACCCACAGATAATG-1_7_G10	-7.082235043	35.33720344	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	782	1110	0.014414414	0.003603604	2	oligos	OL-MS-2	12	6	6
CTACCCACATGTCGAT-1_7_G10	2.048934205	6.462284779	7	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1106	1491	0.014084507	0.004024145	2	7	Phagocytes	12	6	6
CTACCCAGTTGGTGGA-1_7_G10	25.49378402	5.592382796	15A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1342	1792	0.029017857	0.009486607	2	15A	Endo cells	12	6	6
CTACCCATCACGCGGT-1_7_G10	21.35604195	-20.77923147	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4536	11703	0.006921302	0.007433991	2	3	EN-L5-6	12	6	6
CTACCCATCGTCCGTT-1_7_G10	-11.63867666	-33.08184352	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1331	2121	0.113625648	0.008958039	2	16	EN-PYR	12	6	6
CTACCCATCTCTAGGA-1_7_G10	-5.736563612	30.59190394	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1255	1987	0.008555611	0.003019628	2	oligos	OL-MS-2	12	6	6
CTACGTCCAATTGCTG-1_7_G10	-9.776944854	-33.37890274	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1010	1447	0.04284727	0.00967519	2	16	EN-PYR	12	6	6
CTACGTCGTAATCACC-1_7_G10	-31.84786544	-2.300842276	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1320	2127	0.005171603	0.002350729	2	9	OPC	12	6	6
CTACGTCGTCTACCTC-1_7_G10	0.002131919	32.34794868	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	792	1076	0.00929368	0.003717472	2	oligos	OL-MS-2	12	6	6
CTACGTCTCATATCGG-1_7_G10	-10.63116439	15.56088738	11	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1705	2695	0.002597403	0.006307978	2	11	Glia-MIX	12	6	6
CTACGTCTCCAAGTAC-1_7_G10	33.65199351	7.1708764	14	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	867	1071	0.003734827	0.012138189	2	14	Microglia	12	6	6
CTAGAGTAGAGAGCTC-1_7_G10	6.336615417	24.87433163	1	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	923	1364	0.001466276	0.002199413	2	oligos	OL-Cntl	12	6	6
CTAGAGTAGGACTGGT-1_7_G10	-4.497646483	32.59323213	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1053	1516	0.013852243	0.003957784	2	oligos	OL-MS-2	12	6	6
CTAGAGTCAAAGGCGT-1_7_G10	23.79417177	15.25285143	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1313	1980	0.004040404	0.004040404	2	oligos	OL-MS-2	12	6	6
CTAGAGTCAAGACACG-1_7_G10	-37.90712231	0.534468071	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1546	2598	0.005003849	0.003464203	2	9	OPC	12	6	6
CTAGAGTCACCTATCC-1_7_G10	-9.459691298	-32.02902519	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1059	1473	0.059063136	0.010183299	2	16	EN-PYR	12	6	6
CTAGAGTGTGACTACT-1_7_G10	-17.73603737	-26.50964655	6A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2410	5275	0.002274882	0.003791469	2	6A	IN-PV	12	6	6
CTAGAGTGTGCCTTGG-1_7_G10	-14.89490521	-22.69008635	6A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1485	2471	0.027923917	0.0072845	2	6A	IN-PV	12	6	6
CTAGAGTTCCTAGGGC-1_7_G10	13.40957417	30.59928748	1	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	861	1217	0.00903862	0.003286771	2	oligos	OL-Cntl	12	6	6
CTAGAGTTCTATCCCG-1_7_G10	25.80223491	-8.309964475	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4456	10522	0.014255845	0.00551226	2	2	EN-L4	12	6	6
CTAGCCTAGGCGACAT-1_7_G10	10.02825445	-1.293965082	12	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1258	1771	0.027103331	0.00621118	2	12	EN-MIX	12	6	6
CTAGCCTCATGGATGG-1_7_G10	-14.36717082	-6.84940796	13A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2692	5580	0.010573477	0.005017921	2	13A	IN-VIP	12	6	6
CTAGCCTGTCTGCGGT-1_7_G10	31.17997778	-9.632010497	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4107	9837	0.023584426	0.005591136	2	2	EN-L4	12	6	6
CTAGCCTGTTCGCGAC-1_7_G10	3.298845215	-19.65285648	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3157	6922	0.005345276	0.005489743	2	L2-3	EN-L2-3-MS	12	6	6
CTAGCCTTCAAAGTAG-1_7_G10	5.763707513	2.400685765	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1016	1405	0.051957295	0.007117438	2	16	EN-PYR	12	6	6
CTAGTGAAGTGAAGAG-1_7_G10	3.46588019	-21.52711733	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4270	10811	0.004717417	0.006474887	2	L2-3	EN-L2-3-MS	12	6	6
CTAGTGATCGGTGTTA-1_7_G10	20.76299754	8.487855666	1	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1723	3025	0.003636364	0.00231405	2	oligos	OL-Cntl	12	6	6
CTCACACAGACTAGAT-1_7_G10	-1.471780125	33.16700433	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	950	1310	0.005343511	0.002290076	2	oligos	OL-MS-2	12	6	6
CTCACACAGGCCCGTT-1_7_G10	1.838909852	-22.74050912	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4253	12158	0.007073532	0.005839776	2	L2-3	EN-L2-3-MS	12	6	6
CTCACACAGGCTAGAC-1_7_G10	23.78375569	27.75958589	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1221	1796	0.010022272	0.002227171	2	oligos	OL-MS-2	12	6	6
CTCACACAGTGGTCCC-1_7_G10	-15.89772531	7.031107872	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1031	1455	0.003436426	0.006185567	2	8	Astrocytes	12	6	6
CTCACACCAACACCTA-1_7_G10	9.69907105	-29.67786527	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	6445	25569	0.005397161	0.003910986	2	L2-3	EN-L2-3-Cntl	12	6	6
CTCACACCAAGCTGTT-1_7_G10	2.201259243	-10.73529872	12	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1657	2822	0.004252303	0.007087172	2	12	EN-MIX	12	6	6
CTCACACCACTTGGAT-1_7_G10	-2.821402599	35.97509033	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	751	1006	0.005964215	0.004970179	2	oligos	OL-MS-2	12	6	6
CTCACACCAGACGCCT-1_7_G10	24.1632326	26.19264386	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1446	2395	0.023382046	0.003340292	2	oligos	OL-MS-2	12	6	6
CTCACACGTCGAGATG-1_7_G10	24.48576374	7.300247816	15A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2888	5143	0.041609955	0.011083025	2	15A	Endo cells	12	6	6
CTCACACGTGCGGTAA-1_7_G10	5.470318553	-16.31061992	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3061	6254	0.023345059	0.0068756	2	L2-3	EN-L2-3-MS	12	6	6
CTCACACTCAAGGTAA-1_7_G10	1.987053661	-21.85240119	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3663	8913	0.005721979	0.004936609	2	L2-3	EN-L2-3-Cntl	12	6	6
CTCACACTCAGGCGAA-1_7_G10	23.8594435	27.55558508	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1190	1795	0.003342618	0.003899721	2	oligos	OL-MS-2	12	6	6
CTCACACTCATGTCCC-1_7_G10	-32.01048853	-0.160763274	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1821	3216	0.0164801	0.002176617	2	9	OPC	12	6	6
CTCACACTCATTCACT-1_7_G10	2.558397378	-18.75298506	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2996	6305	0.005868358	0.004758128	2	L2-3	EN-L2-3-MS	12	6	6
CTCAGAAAGCTATGCT-1_7_G10	33.69743907	7.497483574	14	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	822	1095	0.014611872	0.00913242	2	14	Microglia	12	6	6
CTCAGAACATCGTCGG-1_7_G10	-31.53908407	-9.968384006	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1016	1512	0.009259259	0.001984127	2	9	OPC	12	6	6
CTCAGAACATCTCCCA-1_7_G10	3.802198578	-16.80518506	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2624	4721	0.002965473	0.007201864	2	L2-3	EN-L2-3-MS	12	6	6
CTCAGAAGTGCACGAA-1_7_G10	10.98730531	-25.82133544	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4848	13246	0.009512306	0.007473954	2	L2-3	EN-L2-3-Cntl	12	6	6
CTCAGAATCACAGTAC-1_7_G10	-2.869591921	32.14432982	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	952	1367	0.005852231	0.003657644	2	oligos	OL-MS-2	12	6	6
CTCAGAATCCTAAGTG-1_7_G10	-22.37125896	14.52256135	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1133	1696	0.016509434	0.004127358	2	8	Astrocytes	12	6	6
CTCAGAATCCTCGCAT-1_7_G10	14.53730681	-31.40952669	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2925	6699	0.002686968	0.005075384	2	3	EN-L5-6	12	6	6
CTCAGAATCTTACCTA-1_7_G10	25.52371339	5.547009721	15A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1224	1719	0.009889471	0.006399069	2	15A	Endo cells	12	6	6
CTCATTACACATGTGT-1_7_G10	-10.60174383	33.13834441	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	839	1090	0.016513761	0.00733945	2	oligos	OL-MS-2	12	6	6
CTCATTACATAAAGGT-1_7_G10	2.518966208	-16.78065898	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2506	4687	0.009601024	0.005333902	2	L2-3	EN-L2-3-MS	12	6	6
CTCATTACATGCCCGA-1_7_G10	-21.4087604	14.09143543	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1117	1621	0.006785935	0.008019741	2	8	Astrocytes	12	6	6
CTCATTAGTAAATGAC-1_7_G10	-12.28173796	17.27261136	11	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1530	2548	0.004317111	0.008634223	2	11	Glia-MIX	12	6	6
CTCATTATCACGATGT-1_7_G10	1.024847928	-21.22143075	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3320	7439	0.004301653	0.006318054	2	L2-3	EN-L2-3-Cntl	12	6	6
CTCATTATCATCTGTT-1_7_G10	-5.309644468	31.50720085	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1100	1529	0.003270111	0.0058862	2	oligos	OL-MS-2	12	6	6
CTCATTATCCTGCCAT-1_7_G10	34.37330451	7.441765173	14	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	867	1100	0.004545455	0.004545455	2	14	Microglia	12	6	6
CTCCTAGAGATCCTGT-1_7_G10	-8.745011476	14.69656665	11	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2424	4171	0.003836011	0.004555263	2	11	Glia-MIX	12	6	6
CTCCTAGAGCCACGCT-1_7_G10	-21.59958805	13.78224746	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1117	1591	0.007542426	0.002514142	2	8	Astrocytes	12	6	6
CTCCTAGAGTACGCGA-1_7_G10	18.13564099	-15.25637802	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	6320	20241	0.022676745	0.006966059	2	L2-3	EN-L2-3-MS	12	6	6
CTCCTAGAGTGTGGCA-1_7_G10	22.81963344	26.85454597	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1158	1722	0.012775842	0.009291521	2	oligos	OL-MS-2	12	6	6
CTCCTAGCATACTCTT-1_7_G10	-20.16672467	-24.44922586	6A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3093	7173	0.008225289	0.005018821	2	6A	IN-PV	12	6	6
CTCCTAGGTTACGACT-1_7_G10	26.70722726	-5.714626945	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	5291	17908	0.004132231	0.00636587	2	2	EN-L4	12	6	6
CTCCTAGTCCACGACG-1_7_G10	-0.566044684	35.6404246	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	754	1013	0.006910168	0.005923001	2	oligos	OL-MS-2	12	6	6
CTCCTAGTCGGTCTAA-1_7_G10	-8.234763758	-31.68467629	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1008	1548	0.123385013	0.007751938	2	16	EN-PYR	12	6	6
CTCCTAGTCTGAAAGA-1_7_G10	13.8050183	-28.09559564	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2859	6470	0.001545595	0.003709428	2	3	EN-L5-6	12	6	6
CTCGAAAAGAGCTGGT-1_7_G10	-8.501804514	-30.7462674	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1042	1462	0.075239398	0.009575923	2	16	EN-PYR	12	6	6
CTCGAAAAGCGCTTAT-1_7_G10	2.310900193	-15.77896178	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2309	4175	0.007185629	0.01245509	2	L2-3	EN-L2-3-MS	12	6	6
CTCGAAAAGTAGGTGC-1_7_G10	-25.82616645	-5.99632794	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1140	1733	0.00288517	0.003462204	2	9	OPC	12	6	6
CTCGAAAAGTGCGATG-1_7_G10	-1.078441696	32.77928836	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	966	1407	0.004975124	0.006396588	2	oligos	OL-MS-2	12	6	6
CTCGAAACACACCGCA-1_7_G10	-11.30585673	-31.90065292	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1315	2031	0.103397341	0.013293944	2	16	EN-PYR	12	6	6
CTCGAAACATATGGTC-1_7_G10	0.726927832	-20.34926918	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3072	6722	0.005355549	0.003570366	2	L2-3	EN-L2-3-Cntl	12	6	6
CTCGAAAGTTCAGGCC-1_7_G10	21.4283055	27.42934465	1	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	974	1528	0.003272251	0.006544503	2	oligos	OL-Cntl	12	6	6
CTCGAAATCCGCGCAA-1_7_G10	10.01690319	34.45125556	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	868	1294	0.003863988	0.003863988	2	oligos	OL-MS-2	12	6	6
CTCGAAATCCTTTCGG-1_7_G10	-35.8090648	-6.788717601	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1066	1628	0.001228501	0.004914005	2	9	OPC	12	6	6
CTCGAAATCGCAAACT-1_7_G10	-2.064374529	35.05764884	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	723	1005	0.0039801	0.00199005	2	oligos	OL-MS-2	12	6	6
CTCGAGGAGACCTAGG-1_7_G10	11.49616678	-0.320876185	12	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1108	1709	0.016968988	0.008191925	2	12	EN-MIX	12	6	6
CTCGAGGCACATTTCT-1_7_G10	29.76571019	-8.817164912	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4401	11167	0.022835139	0.006805767	2	2	EN-L4	12	6	6
CTCGAGGCACTAAGTC-1_7_G10	-0.712454926	35.02238608	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	801	1089	0.012855831	0.002754821	2	oligos	OL-MS-2	12	6	6
CTCGAGGGTGGTCCGT-1_7_G10	31.80053022	-3.289668734	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2759	5715	0.00839895	0.008223972	2	2	EN-L4	12	6	6
CTCGAGGGTGTGACCC-1_7_G10	-1.681887101	32.344119	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	776	1015	0.006896552	0.003940887	2	oligos	OL-MS-2	12	6	6
CTCGAGGGTTAAGATG-1_7_G10	24.50131146	26.9761698	1	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1334	2043	0.008810573	0.004894763	2	oligos	OL-Cntl	12	6	6
CTCGGAGAGACAGGCT-1_7_G10	-12.198785	-3.312444071	13A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2483	4637	0.017683847	0.006254044	2	13A	IN-VIP	12	6	6
CTCGGAGGTCTTCGTC-1_7_G10	16.87213312	-9.295709713	12	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1590	2572	0.055598756	0.005054432	2	12	EN-MIX	12	6	6
CTCGGAGTCCGTAGTA-1_7_G10	30.79074973	-10.66660841	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3696	7901	0.017339577	0.005822048	2	2	EN-L4	12	6	6
CTCGGAGTCGGAGCAA-1_7_G10	32.63487831	-5.351571655	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3324	7083	0.008188621	0.006635606	2	2	EN-L4	12	6	6
CTCGGGAAGCATGGCA-1_7_G10	-17.56884272	-14.72779471	6B	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1968	3370	0.018991098	0.011869436	2	6B	IN-SST	12	6	6
CTCGGGACATATGAGA-1_7_G10	-1.25474916	33.60877074	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	834	1167	0.00428449	0.007712082	2	oligos	OL-MS-2	12	6	6
CTCGGGAGTCGACTGC-1_7_G10	-26.7107802	-8.666748645	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	936	1324	0.010574018	0.002265861	2	9	OPC	12	6	6
CTCGGGAGTGATAAAC-1_7_G10	-21.39418515	12.85519294	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1043	1511	0.003309067	0.00595632	2	8	Astrocytes	12	6	6
CTCGTACAGAATCTCC-1_7_G10	-7.688609292	35.14409858	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	803	1069	0.010289991	0.006548176	2	oligos	OL-MS-2	12	6	6
CTCGTACAGGACAGAA-1_7_G10	2.625906248	-16.42503034	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2485	4547	0.006597757	0.006377832	2	L2-3	EN-L2-3-MS	12	6	6
CTCGTACGTCCAACTA-1_7_G10	-2.843754101	35.97088928	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	769	1021	0.008814887	0.000979432	2	oligos	OL-MS-2	12	6	6
CTCGTACGTCGGCTCA-1_7_G10	10.17772969	34.36396822	1	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	846	1143	0.002624672	0.004374453	2	oligos	OL-Cntl	12	6	6
CTCGTCAAGAAACGCC-1_7_G10	12.21826158	-21.12948378	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	5044	14971	0.018302051	0.004475319	2	L2-3	EN-L2-3-MS	12	6	6
CTCGTCACACTGTTAG-1_7_G10	7.503810364	-15.31144038	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3222	6729	0.0240749	0.008470798	2	L2-3	EN-L2-3-MS	12	6	6
CTCGTCAGTTGTGGCC-1_7_G10	-16.53480097	-22.03946749	6A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1774	3206	0.010605115	0.002495321	2	6A	IN-PV	12	6	6
CTCGTCATCTCCTATA-1_7_G10	-3.039352483	34.8954081	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	884	1197	0.010025063	0.004177109	2	oligos	OL-MS-2	12	6	6
CTCGTCATCTTCCTTC-1_7_G10	21.81206478	-20.03960741	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	7679	35380	0.017580554	0.00732052	2	3	EN-L5-6	12	6	6
CTCTAATAGCAGCCTC-1_7_G10	30.81214084	-1.175824025	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2947	6345	0.003309693	0.004728132	2	2	EN-L4	12	6	6
CTCTAATAGCTAAACA-1_7_G10	33.08284039	5.854385646	14	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1037	1293	0.011600928	0.007733952	2	14	Microglia	12	6	6
CTCTAATAGCTGCCCA-1_7_G10	-19.3998909	16.00963235	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1641	2671	0.005615874	0.005615874	2	8	Astrocytes	12	6	6
CTCTAATAGTGGGTTG-1_7_G10	-7.461875461	-32.83066227	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	812	1085	0.065437788	0.010138249	2	16	EN-PYR	12	6	6
CTCTAATCAGGTCCAC-1_7_G10	-2.128151587	32.42802712	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	973	1376	0.003633721	0.004360465	2	oligos	OL-MS-2	12	6	6
CTCTAATGTCGAATCT-1_7_G10	21.15410025	22.87068705	1	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1176	1868	0.004282655	0.005888651	2	oligos	OL-Cntl	12	6	6
CTCTAATTCACTCTTA-1_7_G10	-9.134994078	31.54213913	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1020	1413	0.016985138	0.002123142	2	oligos	OL-MS-2	12	6	6
CTCTACGAGCCACGCT-1_7_G10	-5.848495028	-31.1342404	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	779	1045	0.096650718	0.00861244	2	16	EN-PYR	12	6	6
CTCTACGCAAGCTGGA-1_7_G10	10.88103191	-19.41020311	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4015	9412	0.016468338	0.008499788	2	L2-3	EN-L2-3-MS	12	6	6
CTCTACGCAGTCCTTC-1_7_G10	-17.07153111	-10.19407907	13B	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3501	8467	0.008267391	0.004251801	2	13B	IN-SV2C	12	6	6
CTCTACGGTCTGGTCG-1_7_G10	27.02778249	-6.520351102	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	5035	14790	0.001893171	0.007437458	2	2	EN-L4	12	6	6
CTCTGGTCAACAACCT-1_7_G10	-26.42101264	16.35036595	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1064	1717	0.002912056	0.008153757	2	8	Astrocytes	12	6	6
CTCTGGTCATCCAACA-1_7_G10	-17.32578946	-14.30515977	6B	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2060	3673	0.024503131	0.009256738	2	6B	IN-SST	12	6	6
CTCTGGTCATGCAACT-1_7_G10	-34.99937145	-5.812933116	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1272	2055	0.001946472	0.00243309	2	9	OPC	12	6	6
CTCTGGTGTCTTGATG-1_7_G10	-0.775217657	34.52480632	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	753	1063	0.004703669	0.001881468	2	oligos	OL-MS-2	12	6	6
CTCTGGTGTGATGTCT-1_7_G10	-11.07851385	15.30500806	11	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1394	2120	0.005188679	0.002358491	2	11	Glia-MIX	12	6	6
CTCTGGTGTTTGTTGG-1_7_G10	-21.18404277	16.08394375	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1226	1905	0.004199475	0.007874016	2	8	Astrocytes	12	6	6
CTCTGGTTCAACGCTA-1_7_G10	5.012505238	-12.65976012	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1991	3450	0.008985507	0.010434783	2	L2-3	EN-L2-3-MS	12	6	6
CTCTGGTTCATCGCTC-1_7_G10	7.715676117	-24.56977198	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	5172	16694	0.011081826	0.009644184	2	L2-3	EN-L2-3-MS	12	6	6
CTCTGGTTCGCCGTGA-1_7_G10	3.794936536	-11.18183772	12	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1678	2647	0.003777862	0.006044579	2	12	EN-MIX	12	6	6
CTGAAACCAGGACGTA-1_7_G10	7.276908892	-29.81466658	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3369	7923	0.001893222	0.002398082	2	3	EN-L5-6	12	6	6
CTGAAACTCATTGCCC-1_7_G10	30.5422619	-5.835203365	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4502	12618	0.016246632	0.00681566	2	2	EN-L4	12	6	6
CTGAAACTCCAAATGC-1_7_G10	-10.15017423	-31.77611945	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1155	1765	0.104815864	0.006232295	2	16	EN-PYR	12	6	6
CTGAAACTCGACGGAA-1_7_G10	24.02869525	-27.83314691	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3225	7426	0.00201993	0.00538648	2	3	EN-L5-6	12	6	6
CTGAAACTCGCATGGC-1_7_G10	-21.43573511	15.53939818	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1243	1828	0.006564551	0.003282276	2	8	Astrocytes	12	6	6
CTGAAACTCTACCAGA-1_7_G10	17.8490717	-31.29374432	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4246	11553	0.002250498	0.003721977	2	3	EN-L5-6	12	6	6
CTGAAGTAGATGTAAC-1_7_G10	2.375305984	30.19732502	1	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	734	1002	0.003992016	0.010978044	2	oligos	OL-Cntl	12	6	6
CTGAAGTCATCCCACT-1_7_G10	-0.73520888	32.46154336	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	936	1318	0.005311077	0.006069803	2	oligos	OL-MS-2	12	6	6
CTGAAGTCATTTCACT-1_7_G10	-19.89011013	14.4304838	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1170	1712	0.010514019	0.005257009	2	8	Astrocytes	12	6	6
CTGAAGTGTACAAGTA-1_7_G10	30.65527972	-5.756057663	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3847	8867	0.005300553	0.004623886	2	2	EN-L4	12	6	6
CTGAAGTTCAGAGCTT-1_7_G10	1.934104383	-30.89629594	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4740	15392	0.001364345	0.003898129	2	L2-3	EN-L2-3-Cntl	12	6	6
CTGATAGAGATCTGCT-1_7_G10	32.18079516	-8.788114155	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3316	7319	0.014209591	0.015712529	2	2	EN-L4	12	6	6
CTGATAGAGGCTCTTA-1_7_G10	-17.6126909	-6.912904857	13B	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2697	5735	0.03766347	0.003661726	2	13B	IN-SV2C	12	6	6
CTGATAGCACGGACAA-1_7_G10	24.04923267	26.73154143	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1329	2140	0.004672897	0.005140187	2	oligos	OL-MS-2	12	6	6
CTGATAGGTTCGAATC-1_7_G10	0.310281129	-20.772636	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2963	6168	0.00616083	0.004053178	2	L2-3	EN-L2-3-Cntl	12	6	6
CTGATAGTCCGCATAA-1_7_G10	-0.613165491	31.76703659	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	920	1223	0.012264922	0.004088307	2	oligos	OL-MS-2	12	6	6
CTGATAGTCGAATGGG-1_7_G10	16.80637916	-26.81262598	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4481	12329	0.019952956	0.009327602	2	3	EN-L5-6	12	6	6
CTGATAGTCGGAAACG-1_7_G10	-26.30416511	-23.81575052	6A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	5378	15832	0.045351187	0.007769075	2	6A	IN-PV	12	6	6
CTGATCCGTAAACCTC-1_7_G10	29.4793509	-11.23962873	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4626	11731	0.020629102	0.010058819	2	2	EN-L4	12	6	6
CTGATCCGTAAAGTCA-1_7_G10	3.810118381	0.726153931	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	838	1077	0.061281337	0.010213556	2	16	EN-PYR	12	6	6
CTGATCCGTCACTGGC-1_7_G10	26.52893189	-25.67313575	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4329	11995	0.005335556	0.008253439	2	3	EN-L5-6	12	6	6
CTGATCCGTGAAAGAG-1_7_G10	-1.325860282	31.33869945	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	840	1141	0.005258545	0.002629273	2	oligos	OL-MS-2	12	6	6
CTGATCCGTGACAAAT-1_7_G10	-21.9057427	12.84891503	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1009	1414	0.021923621	0.007072136	2	8	Astrocytes	12	6	6
CTGATCCTCGCTTAGA-1_7_G10	0.455541384	-28.115552	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4664	14024	0.002709641	0.004563605	2	L2-3	EN-L2-3-Cntl	12	6	6
CTGCCTAAGGCAGTCA-1_7_G10	-16.86261999	10.78621107	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1201	1647	0.004250152	0.003035823	2	8	Astrocytes	12	6	6
CTGCCTAAGGCTCATT-1_7_G10	-31.71434626	0.20138055	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1832	2907	0.008255934	0.002407981	2	9	OPC	12	6	6
CTGCCTAAGGGTGTTG-1_7_G10	-0.844330293	33.65752129	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	786	1073	0.002795899	0.008387698	2	oligos	OL-MS-2	12	6	6
CTGCCTAAGTACGACG-1_7_G10	5.297270892	-15.99989635	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2976	6086	0.012487677	0.005750904	2	L2-3	EN-L2-3-MS	12	6	6
CTGCCTAAGTCTCAAC-1_7_G10	-8.042992622	-27.36500109	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	896	1160	0.03362069	0.007758621	2	16	EN-PYR	12	6	6
CTGCCTACAGGGCATA-1_7_G10	-22.02496021	14.81736169	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1082	1614	0.006195787	0.004956629	2	8	Astrocytes	12	6	6
CTGCCTAGTAAGTGTA-1_7_G10	0.988372547	32.7501213	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	803	1135	0.005286344	0.002643172	2	oligos	OL-MS-2	12	6	6
CTGCCTAGTATAATGG-1_7_G10	1.135789702	-23.09355786	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4673	13226	0.002495085	0.005292605	2	L2-3	EN-L2-3-Cntl	12	6	6
CTGCCTAGTCACCCAG-1_7_G10	23.64210261	-25.74875224	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3338	9061	0.002317625	0.014347202	2	3	EN-L5-6	12	6	6
CTGCCTATCACGATGT-1_7_G10	-37.25241382	3.833655999	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1983	3673	0.007623196	0.001633542	2	9	OPC	12	6	6
CTGCCTATCAGTTTGG-1_7_G10	22.14757527	25.11193227	1	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1069	1609	0.004350528	0.00621504	2	oligos	OL-Cntl	12	6	6
CTGCCTATCATGTCCC-1_7_G10	-9.553999765	34.23376726	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	788	1005	0.008955224	0.004975124	2	oligos	OL-MS-2	12	6	6
CTGCCTATCTCTGTCG-1_7_G10	21.74958562	28.5352039	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	923	1306	0.001531394	0.004594181	2	oligos	OL-MS-2	12	6	6
CTGCGGAAGACAGACC-1_7_G10	21.66214048	27.55598131	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	985	1394	0.005021521	0.00286944	2	oligos	OL-MS-2	12	6	6
CTGCGGACAGTGGGAT-1_7_G10	25.22970672	-24.35272429	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3743	8519	0.016433854	0.004812771	2	3	EN-L5-6	12	6	6
CTGCGGATCGGATGTT-1_7_G10	-4.409589532	31.6462554	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1092	1545	0.011003236	0.003883495	2	oligos	OL-MS-2	12	6	6
CTGCTGTAGCGTGAAC-1_7_G10	1.205345601	34.69305404	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	794	1089	0.001836547	0.001836547	2	oligos	OL-MS-2	12	6	6
CTGCTGTCAAGACGTG-1_7_G10	32.45780162	-5.552823536	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3472	7317	0.009156758	0.00697007	2	2	EN-L4	12	6	6
CTGCTGTCACGAAAGC-1_7_G10	11.65677814	-0.682480505	12	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1143	1665	0.009009009	0.004204204	2	12	EN-MIX	12	6	6
CTGCTGTCATGTCGAT-1_7_G10	-31.44658581	-10.31350796	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	880	1242	0.002415459	0.002415459	2	9	OPC	12	6	6
CTGCTGTCATTCTTAC-1_7_G10	-6.668904198	30.70198763	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2138	3589	0.015045974	0.005015325	2	oligos	OL-MS-2	12	6	6
CTGCTGTGTCCCTTGT-1_7_G10	-5.04780859	33.56167212	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1003	1335	0.019475655	0.008988764	2	oligos	OL-MS-2	12	6	6
CTGCTGTGTGGCAAAC-1_7_G10	3.084689103	-21.30931794	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4081	10449	0.007751938	0.007943344	2	L2-3	EN-L2-3-MS	12	6	6
CTGCTGTGTTAGATGA-1_7_G10	20.51490087	26.98207763	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	897	1323	0.003023432	0.005291005	2	oligos	OL-MS-2	12	6	6
CTGGTCTAGTCAAGGC-1_7_G10	32.14558351	-2.825456632	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2901	6117	0.004904365	0.00555828	2	2	EN-L4	12	6	6
CTGGTCTAGTGAACAT-1_7_G10	31.68035068	-7.420945884	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2954	6090	0.004926108	0.00771757	2	2	EN-L4	12	6	6
CTGGTCTCAAATCCGT-1_7_G10	-12.153122	-0.360793765	13A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2738	5405	0.007400555	0.0066605	2	13A	IN-VIP	12	6	6
CTGGTCTTCGGTTCGG-1_7_G10	-24.33836375	19.11224355	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1112	1757	0.00284576	0.006260672	2	8	Astrocytes	12	6	6
CTGGTCTTCTGTACGA-1_7_G10	-5.11966155	32.43431091	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	984	1396	0.013610315	0.008595989	2	oligos	OL-MS-2	12	6	6
CTGTGCTAGACTTGAA-1_7_G10	31.3015611	-5.599774937	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3528	7799	0.001410437	0.01230927	2	2	EN-L4	12	6	6
CTGTGCTAGTACATGA-1_7_G10	-16.45824627	-18.30814672	6B	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1915	3683	0.005430356	0.004615802	2	6B	IN-SST	12	6	6
CTGTGCTCAGTAAGCG-1_7_G10	1.588753712	-18.30334234	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2491	5188	0.006553585	0.001927525	2	L2-3	EN-L2-3-MS	12	6	6
CTGTGCTCATCTACGA-1_7_G10	-32.23199521	-9.957055589	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	945	1379	0.011602611	0.003625816	2	9	OPC	12	6	6
CTGTGCTGTTCCGTCT-1_7_G10	29.56624642	-0.684910095	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3177	6916	0.00448236	0.004337767	2	2	EN-L4	12	6	6
CTGTGCTGTTTGTGTG-1_7_G10	-11.90925861	16.38354932	11	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1678	2675	0.004859813	0.002616822	2	11	Glia-MIX	12	6	6
CTGTGCTTCCTAGGGC-1_7_G10	-16.62896943	12.70634374	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1247	1874	0.001600854	0.003201708	2	8	Astrocytes	12	6	6
CTGTGCTTCGATAGAA-1_7_G10	2.229328049	5.288964658	7	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	902	1132	0.005300353	0.002650177	2	7	Phagocytes	12	6	6
CTGTTTAAGACTCGGA-1_7_G10	7.163483441	-24.83124445	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	6255	21235	0.016105486	0.005180127	2	L2-3	EN-L2-3-MS	12	6	6
CTGTTTAAGTGCGTGA-1_7_G10	24.81815585	-21.75309089	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3410	7872	0.015879065	0.004700203	2	3	EN-L5-6	12	6	6
CTGTTTACACCACCAG-1_7_G10	-22.81316329	-1.135406995	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1119	1543	0.005184705	0.003240441	2	9	OPC	12	6	6
CTGTTTAGTATGAAAC-1_7_G10	6.830300166	-22.45374749	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4306	11085	0.018132612	0.004691024	2	L2-3	EN-L2-3-MS	12	6	6
CTGTTTAGTCTTGTCC-1_7_G10	-11.91356844	-0.411926247	13A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2731	5907	0.019468427	0.00507872	2	13A	IN-VIP	12	6	6
CTGTTTAGTGAGGGAG-1_7_G10	-1.414762958	32.88019935	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	935	1277	0.001566171	0.007830854	2	oligos	OL-MS-2	12	6	6
CTGTTTATCAGCGATT-1_7_G10	20.31557297	24.12804976	1	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1006	1458	0.001371742	0.004115226	2	oligos	OL-Cntl	12	6	6
CTGTTTATCAGTTCGA-1_7_G10	-21.20415537	12.89029841	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	982	1378	0.002902758	0.001451379	2	8	Astrocytes	12	6	6
CTGTTTATCCCTTGTG-1_7_G10	23.46636217	13.67221934	1	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1394	2229	0.004037685	0.00538358	2	oligos	OL-Cntl	12	6	6
CTGTTTATCGAACGGA-1_7_G10	-6.204905773	-30.9470373	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	884	1339	0.142643764	0.006721434	2	16	EN-PYR	12	6	6
CTTAACTAGGGAAACA-1_7_G10	-0.145913163	31.16755471	1	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	874	1237	0.007275667	0.004850445	2	oligos	OL-Cntl	12	6	6
CTTAACTCAGATCGGA-1_7_G10	-31.12649576	-10.62442987	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	989	1403	0.003563792	0.011404134	2	9	OPC	12	6	6
CTTAACTCATGATCCA-1_7_G10	-7.287849455	33.21701651	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1023	1356	0.017699115	0.005162242	2	oligos	OL-MS-2	12	6	6
CTTAACTCATGTCTCC-1_7_G10	8.433664318	-27.88383426	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	6442	23537	0.006245486	0.004206144	2	L2-3	EN-L2-3-Cntl	12	6	6
CTTAACTGTGGCGAAT-1_7_G10	4.585046215	-8.594236431	12	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1375	1920	0.016145833	0.010416667	2	12	EN-MIX	12	6	6
CTTAACTGTGTGGCTC-1_7_G10	30.98386096	-1.655590666	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3047	6769	0.003693308	0.004727434	2	2	EN-L4	12	6	6
CTTACCGAGTTATCGC-1_7_G10	3.252943583	-16.25943431	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2538	5014	0.009373753	0.010769844	2	L2-3	EN-L2-3-MS	12	6	6
CTTACCGCAACGATGG-1_7_G10	-22.07613362	15.47420551	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1230	1947	0.00719055	0.004622496	2	8	Astrocytes	12	6	6
CTTACCGCATCGGAAG-1_7_G10	32.10467131	-7.153684699	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3267	6665	0.008102026	0.005851463	2	2	EN-L4	12	6	6
CTTACCGGTCGCATAT-1_7_G10	-11.13857833	-32.56332131	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1322	2031	0.102412605	0.010339734	2	16	EN-PYR	12	6	6
CTTACCGGTGGGTATG-1_7_G10	5.933502719	-15.76928582	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2894	5734	0.010638298	0.012382281	2	L2-3	EN-L2-3-MS	12	6	6
CTTACCGGTTAGTGGG-1_7_G10	8.761272243	-11.80841823	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2751	5337	0.068390482	0.010867529	2	L2-3	EN-L2-3-MS	12	6	6
CTTACCGGTTGCGCAC-1_7_G10	8.086901223	-31.85604065	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4090	10946	0.002740727	0.003928376	2	L2-3	EN-L2-3-Cntl	12	6	6
CTTACCGTCACAACGT-1_7_G10	-6.30507546	32.97389343	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	975	1413	0.012031139	0.004246285	2	oligos	OL-MS-2	12	6	6
CTTACCGTCCCAAGTA-1_7_G10	-10.59675945	33.57561301	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	884	1162	0.017211704	0.005163511	2	oligos	OL-MS-2	12	6	6
CTTACCGTCCCTCTTT-1_7_G10	22.3905465	13.71702285	1	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1265	2035	0.003439803	0.002948403	2	oligos	OL-Cntl	12	6	6
CTTAGGAAGCGTTGCC-1_7_G10	-26.24415551	-6.284916841	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1042	1631	0	0.006744329	2	9	OPC	12	6	6
CTTAGGACAGATAATG-1_7_G10	28.58266913	0.732178623	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2571	5092	0.001767478	0.006480754	2	2	EN-L4	12	6	6
CTTAGGACAGCCTTTC-1_7_G10	1.090157238	-22.05161205	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3981	10850	0.003410138	0.004884793	2	L2-3	EN-L2-3-Cntl	12	6	6
CTTAGGAGTAAATGTG-1_7_G10	-6.997866081	35.08420431	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	830	1130	0.009734513	0.001769912	2	oligos	OL-MS-2	12	6	6
CTTAGGAGTCGGGTCT-1_7_G10	-25.06688006	9.33996604	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	936	1329	0.004514673	0.003009782	2	8	Astrocytes	12	6	6
CTTAGGATCCGTCAAA-1_7_G10	-34.34780298	-7.136594432	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1110	1748	0.010869565	0.00228833	2	9	OPC	12	6	6
CTTCTCTAGAGGTTAT-1_7_G10	-22.14112779	14.88552608	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1232	1871	0.013361839	0.003741315	2	8	Astrocytes	12	6	6
CTTCTCTGTAAGTTCC-1_7_G10	3.375754286	-31.59547213	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	6241	26580	0.001956358	0.002558315	2	L2-3	EN-L2-3-Cntl	12	6	6
CTTCTCTGTACCATCA-1_7_G10	21.39419914	27.1793606	1	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	960	1456	0.004120879	0.000686813	2	oligos	OL-Cntl	12	6	6
CTTCTCTGTCTGATTG-1_7_G10	10.78091748	-19.34241381	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3495	7484	0.014965259	0.008417958	2	L2-3	EN-L2-3-MS	12	6	6
CTTGGCTCAGACGCAA-1_7_G10	-25.28788694	10.07722957	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	845	1165	0.006866953	0.011158798	2	8	Astrocytes	12	6	6
CTTGGCTCATGACATC-1_7_G10	3.091346096	-20.08796619	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3456	7581	0.003693444	0.009629336	2	L2-3	EN-L2-3-MS	12	6	6
CTTGGCTGTCGAGTTT-1_7_G10	2.387672986	-12.00186195	12	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1911	3292	0.006379101	0.006986634	2	12	EN-MIX	12	6	6
CTTGGCTGTCGCATAT-1_7_G10	11.27501926	-21.92293682	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4027	10530	0.013580247	0.00351377	2	L2-3	EN-L2-3-MS	12	6	6
CTTGGCTGTCTCTTAT-1_7_G10	17.56565228	25.52536725	1	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	865	1270	0.002362205	0.005511811	2	oligos	OL-Cntl	12	6	6
CTTGGCTTCTTAGAGC-1_7_G10	8.087218782	-29.17082829	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	6006	22442	0.009268336	0.004188575	2	L2-3	EN-L2-3-Cntl	12	6	6
CTTGGCTTCTTTACGT-1_7_G10	26.31467032	5.188248233	15BA	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1228	1842	0.121064061	0.015743757	2	15BA	Stromal cells	12	6	6
CTTTGCGAGTTCGCGC-1_7_G10	-18.88054144	-8.078924569	13B	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4115	10099	0.018219626	0.008020596	2	13B	IN-SV2C	12	6	6
CTTTGCGCACGCTTTC-1_7_G10	-0.931685663	33.98022857	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	791	1066	0.004690432	0.000938086	2	oligos	OL-MS-2	12	6	6
CTTTGCGCACGTAAGG-1_7_G10	-15.53965961	-24.0418947	6A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1816	3469	0.017296051	0.001729605	2	6A	IN-PV	12	6	6
CTTTGCGCACTTCGAA-1_7_G10	-10.14024931	-31.66281051	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1187	1742	0.071756602	0.011481056	2	16	EN-PYR	12	6	6
CTTTGCGGTAAAGTCA-1_7_G10	-2.591132026	31.46147697	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	956	1273	0.003142184	0.002356638	2	oligos	OL-MS-2	12	6	6
CTTTGCGGTCATTAGC-1_7_G10	-0.203600154	33.67847934	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	811	1158	0.009499136	0.002590674	2	oligos	OL-MS-2	12	6	6
CTTTGCGGTCTAAACC-1_7_G10	-13.01373787	14.75739688	11	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	937	1299	0.004618938	0.008468052	2	11	Glia-MIX	12	6	6
CTTTGCGGTGATGTCT-1_7_G10	0.588915522	33.10116863	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	784	1076	0.005576208	0.005576208	2	oligos	OL-MS-2	12	6	6
CTTTGCGGTTCGGGCT-1_7_G10	32.49966543	-6.056471357	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3708	8428	0.004271476	0.0084243	2	2	EN-L4	12	6	6
CTTTGCGTCTGTCTCG-1_7_G10	18.05426334	28.71340958	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	848	1178	0.004244482	0.002546689	2	oligos	OL-MS-2	12	6	6
GAAACTCAGATAGCAT-1_7_G10	-2.783546456	34.99910742	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	773	1005	0.0039801	0.008955224	2	oligos	OL-MS-2	12	6	6
GAAACTCCAATAAGCA-1_7_G10	-3.568376125	35.53189412	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	768	1058	0.003780718	0.006616257	2	oligos	OL-MS-2	12	6	6
GAAACTCCAATCACAC-1_7_G10	-15.30294931	11.19422039	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1496	2224	0.006744604	0.006744604	2	8	Astrocytes	12	6	6
GAAACTCCACGGATAG-1_7_G10	-14.58095876	-3.585486129	13A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3356	7071	0.009758167	0.009192476	2	13A	IN-VIP	12	6	6
GAAACTCTCAACGGCC-1_7_G10	29.45610879	-10.73015704	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	5175	15123	0.010513787	0.007538187	2	2	EN-L4	12	6	6
GAAACTCTCCAGATCA-1_7_G10	-5.03720754	34.25599985	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	876	1160	0.006034483	0.005172414	2	oligos	OL-MS-2	12	6	6
GAAACTCTCCTGTACC-1_7_G10	23.5205999	27.47497001	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1104	1621	0.006169031	0.005552128	2	oligos	OL-MS-2	12	6	6
GAAATGAAGCTAACAA-1_7_G10	-14.32735372	-16.91090747	6B	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1424	2331	0.03045903	0.004290004	2	6B	IN-SST	12	6	6
GAAATGAAGGAGTTGC-1_7_G10	-27.959421	10.18651154	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	850	1174	0.015332198	0.00681431	2	8	Astrocytes	12	6	6
GAAATGAAGGTGATAT-1_7_G10	-8.026052458	35.04709216	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	775	1042	0.022072937	0.010556622	2	oligos	OL-MS-2	12	6	6
GAAATGAAGTACATGA-1_7_G10	-23.71730061	-23.99592098	6A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3798	9394	0.048860975	0.005003194	2	6A	IN-PV	12	6	6
GAAATGAGTCCATCCT-1_7_G10	23.07792133	-6.802086322	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3742	8995	0.000889383	0.004113396	2	3	EN-L5-6	12	6	6
GAACATCAGTAGCCGA-1_7_G10	-26.69760476	-21.97105658	6A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3688	8563	0.048113979	0.009809646	2	6A	IN-PV	12	6	6
GAACATCCAACTTGAC-1_7_G10	-3.887923193	30.94978467	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1085	1504	0.003324468	0.007978723	2	oligos	OL-MS-2	12	6	6
GAACATCCAAGGGTCA-1_7_G10	5.830013464	-16.16667268	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2874	5451	0.010456797	0.011007155	2	L2-3	EN-L2-3-MS	12	6	6
GAACATCCACTTAACG-1_7_G10	1.90715611	-16.66029761	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2427	4558	0.006143045	0.003290917	2	L2-3	EN-L2-3-MS	12	6	6
GAACATCCAGATGGGT-1_7_G10	5.515666985	0.204664199	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1259	1719	0.057009889	0.018615474	2	16	EN-PYR	12	6	6
GAACATCCAGCTCGCA-1_7_G10	12.88595787	-22.58885333	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	5181	15307	0.00320115	0.005944992	2	L2-3	EN-L2-3-MS	12	6	6
GAACATCCATCAGTAC-1_7_G10	-2.292469978	36.20280828	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	819	1131	0.007073386	0.003536693	2	oligos	OL-MS-2	12	6	6
GAACATCGTTTGGGCC-1_7_G10	-17.01706118	9.078024337	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1069	1449	0.009661836	0.004830918	2	8	Astrocytes	12	6	6
GAACCTAAGGTGATTA-1_7_G10	6.122484365	5.978094512	11	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3133	5769	0.005893569	0.005720229	2	11	Glia-MIX	12	6	6
GAACCTACAAGAAAGG-1_7_G10	-20.54427874	12.17882813	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	916	1273	0.004713276	0.003142184	2	8	Astrocytes	12	6	6
GAACCTACAAGTTAAG-1_7_G10	-8.667629611	33.54090985	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	904	1217	0.04601479	0.004930156	2	oligos	OL-MS-2	12	6	6
GAACCTAGTAAATACG-1_7_G10	32.98276112	5.77736753	14	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	864	1053	0.02374169	0.00379867	2	14	Microglia	12	6	6
GAACCTATCCAATGGT-1_7_G10	20.12269235	-0.22431451	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1368	2132	0.012664165	0.002345216	2	2	EN-L4	12	6	6
GAACCTATCCTTTACA-1_7_G10	23.79724632	7.437523665	15A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3147	5722	0.01031108	0.012408249	2	15A	Endo cells	12	6	6
GAACCTATCCTTTCTC-1_7_G10	-20.46897208	13.33511827	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	978	1357	0.011790715	0.003684598	2	8	Astrocytes	12	6	6
GAACGGAAGACGCACA-1_7_G10	-2.10719501	35.06284051	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	833	1097	0.005469462	0.005469462	2	oligos	OL-MS-2	12	6	6
GAACGGAAGATCCTGT-1_7_G10	-1.628223757	-18.13961148	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2948	6812	0.003376395	0.003229595	2	L2-3	EN-L2-3-Cntl	12	6	6
GAACGGAAGCGTAGTG-1_7_G10	-15.60560363	-17.32000496	6B	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1727	3158	0.000949968	0.01139962	2	6B	IN-SST	12	6	6
GAACGGAGTCCGAAGA-1_7_G10	33.94497271	-4.781059513	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2688	5215	0.009395973	0.004602109	2	2	EN-L4	12	6	6
GAACGGAGTGATGTCT-1_7_G10	-5.543097026	31.06631974	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1101	1591	0.01257071	0.004399749	2	oligos	OL-MS-2	12	6	6
GAAGCAGAGTTGAGAT-1_7_G10	33.18342745	-5.210292375	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2906	5929	0.019733513	0.004216563	2	2	EN-L4	12	6	6
GAAGCAGCAAGCGATG-1_7_G10	22.44568814	27.23722979	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1042	1559	0.003848621	0.003207184	2	oligos	OL-MS-2	12	6	6
GAAGCAGCAGTTCCCT-1_7_G10	-2.4080286	31.21661521	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	966	1300	0.008461538	0.001538462	2	oligos	OL-MS-2	12	6	6
GAAGCAGGTTAAAGAC-1_7_G10	-27.98405287	12.02845775	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	943	1347	0.013363029	0.005196733	2	8	Astrocytes	12	6	6
GAAGCAGTCCAAATGC-1_7_G10	-21.46366638	-18.64350359	6A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2656	5548	0.031182408	0.005046864	2	6A	IN-PV	12	6	6
GAAGCAGTCCCTGACT-1_7_G10	3.088634124	-24.35725035	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2938	5631	0.010300124	0.008346652	2	L2-3	EN-L2-3-MS	12	6	6
GAAGCAGTCTGGAGCC-1_7_G10	-31.58192429	-9.738155411	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1057	1502	0.004660453	0.005326232	2	9	OPC	12	6	6
GAATAAGAGGTGGGTT-1_7_G10	6.139436677	-15.95128172	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2676	4946	0.0135463	0.014759402	2	L2-3	EN-L2-3-MS	12	6	6
GAATAAGAGTCGCCGT-1_7_G10	-11.35744182	-0.860138228	13A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2583	5060	0.014426877	0.004743083	2	13A	IN-VIP	12	6	6
GAATAAGCAACTGCGC-1_7_G10	9.990407984	34.63957036	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	828	1201	0.004995837	0.005828476	2	oligos	OL-MS-2	12	6	6
GAATAAGCAAGTAGTA-1_7_G10	8.976282733	-26.10309666	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4423	11442	0.005069044	0.008827128	2	L2-3	EN-L2-3-Cntl	12	6	6
GAATAAGCATCAGTCA-1_7_G10	-17.629078	9.457666466	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1005	1407	0.008528785	0.009950249	2	8	Astrocytes	12	6	6
GAATAAGGTAGCCTCG-1_7_G10	-26.41378484	-6.427985301	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1070	1586	0.006935687	0.004413619	2	9	OPC	12	6	6
GAATAAGGTCATCCCT-1_7_G10	18.70329768	-17.51779626	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	7412	30197	0.020366262	0.005530351	2	L2-3	EN-L2-3-MS	12	6	6
GAATAAGGTCCATGAT-1_7_G10	-7.925084433	-30.49811246	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	855	1142	0.034150613	0.011383538	2	16	EN-PYR	12	6	6
GAATAAGGTCTGGTCG-1_7_G10	-21.95181756	15.17950379	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1196	1851	0.005402485	0.004862237	2	8	Astrocytes	12	6	6
GAATAAGTCTGAAAGA-1_7_G10	-22.07728731	13.14836797	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1069	1523	0.004596192	0.006565988	2	8	Astrocytes	12	6	6
GAATGAAAGTGGAGTC-1_7_G10	-3.693286865	32.8059648	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	853	1152	0.0078125	0.002604167	2	oligos	OL-MS-2	12	6	6
GAATGAACAAGCTGGA-1_7_G10	-19.42263979	15.74179445	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1542	2340	0.005982906	0.006410256	2	8	Astrocytes	12	6	6
GAATGAACATCCTTGC-1_7_G10	-21.08205527	-27.50359553	6A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3306	8007	0.023354565	0.004246285	2	6A	IN-PV	12	6	6
GAATGAACATTCTCAT-1_7_G10	-16.92528339	8.758078298	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1061	1426	0.007713885	0.004207574	2	8	Astrocytes	12	6	6
GAATGAAGTACGACCC-1_7_G10	2.007605045	-16.72530474	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2440	4782	0.009828524	0.010037641	2	L2-3	EN-L2-3-MS	12	6	6
GAATGAAGTAGAAAGG-1_7_G10	28.23437861	0.619237384	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2717	5907	0.001354325	0.004062976	2	2	EN-L4	12	6	6
GAATGAATCACAACGT-1_7_G10	2.239414584	-22.43764684	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4484	12011	0.00557822	0.006494047	2	L2-3	EN-L2-3-MS	12	6	6
GAATGAATCTCTGCTG-1_7_G10	21.474925	26.98351548	1	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	981	1388	0.005763689	0.007204611	2	oligos	OL-Cntl	12	6	6
GAATGAATCTGTCTAT-1_7_G10	-35.10801087	-5.773786057	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1322	2273	0.004839419	0.004399472	2	9	OPC	12	6	6
GACACGCAGGCGTACA-1_7_G10	23.84114351	-27.62935148	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3237	7578	0.00567432	0.00699393	2	3	EN-L5-6	12	6	6
GACACGCAGGTTCCTA-1_7_G10	14.88083294	-33.5551457	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4455	13985	0.001358598	0.003146228	2	3	EN-L5-6	12	6	6
GACACGCAGTGCAAGC-1_7_G10	27.43335835	-18.75767273	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3594	8156	0.059465424	0.007111329	2	2	EN-L4	12	6	6
GACACGCCAAGTCATC-1_7_G10	-0.541077777	34.23655706	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	815	1113	0.015274034	0.005390836	2	oligos	OL-MS-2	12	6	6
GACACGCCACGACTCG-1_7_G10	20.17574712	-0.335221376	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1298	2051	0.022428084	0.005850804	2	2	EN-L4	12	6	6
GACACGCCATGTCCTC-1_7_G10	5.979916882	-1.289303623	12	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	706	1021	0.012732615	0.007835455	2	12	EN-MIX	12	6	6
GACACGCTCCTTCAAT-1_7_G10	23.01668339	26.61366208	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1156	1819	0.003298516	0.003298516	2	oligos	OL-MS-2	12	6	6
GACAGAGCACTTAACG-1_7_G10	16.61140096	13.22382394	1	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1206	1942	0.005664264	0.004119464	2	oligos	OL-Cntl	12	6	6
GACAGAGGTACTTGAC-1_7_G10	25.96493077	5.318603848	15A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1248	1685	0.007121662	0.007715134	2	15A	Endo cells	12	6	6
GACAGAGGTCTCAACA-1_7_G10	10.24212453	-18.83198382	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3789	8735	0.013050944	0.009502003	2	L2-3	EN-L2-3-MS	12	6	6
GACCAATCACGAGGTA-1_7_G10	21.39264556	25.745761	1	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1065	1536	0.00390625	0.004557292	2	oligos	OL-Cntl	12	6	6
GACCAATGTGCAGGTA-1_7_G10	21.39990141	16.60203492	1	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1226	1925	0.003636364	0.006233766	2	oligos	OL-Cntl	12	6	6
GACCAATGTGGGTCAA-1_7_G10	19.86810658	8.307779465	1	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1854	3305	0.00332829	0.003025719	2	oligos	OL-Cntl	12	6	6
GACCAATGTTCCTCCA-1_7_G10	22.15647072	26.0507703	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1028	1538	0.00390117	0.00520156	2	oligos	OL-MS-2	12	6	6
GACCAATTCACAGGCC-1_7_G10	-1.733957371	33.42450464	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	984	1395	0.006451613	0.003584229	2	oligos	OL-MS-2	12	6	6
GACCAATTCCTCATTA-1_7_G10	21.82360376	-20.23963914	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	5808	20039	0.024801637	0.004241729	2	3	EN-L5-6	12	6	6
GACCAATTCCTGCAGG-1_7_G10	-14.22791938	-5.028305203	13A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3076	6839	0.006433689	0.015791782	2	13A	IN-VIP	12	6	6
GACCAATTCGTCTGCT-1_7_G10	11.91460943	-22.03468562	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4483	11825	0.008794926	0.005919662	2	L2-3	EN-L2-3-MS	12	6	6
GACCAATTCTTCCTTC-1_7_G10	21.05926706	27.59688343	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	863	1236	0.004854369	0.000809061	2	oligos	OL-MS-2	12	6	6
GACCTGGAGTACCGGA-1_7_G10	1.999081221	-16.93909502	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2536	4933	0.006284208	0.00506791	2	L2-3	EN-L2-3-MS	12	6	6
GACCTGGGTCTTCAAG-1_7_G10	-31.50135795	-10.26860596	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	945	1278	0.001564945	0.006259781	2	9	OPC	12	6	6
GACGCGTCACATGGGA-1_7_G10	25.12420414	5.743295635	15A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1437	2170	0.007834101	0.007373272	2	15A	Endo cells	12	6	6
GACGCGTCAGCTGCTG-1_7_G10	-15.73573363	11.36426814	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1386	2061	0.008248423	0.003881611	2	8	Astrocytes	12	6	6
GACGCGTCAGCTGTTA-1_7_G10	-14.68954656	-3.60177974	13A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4050	10109	0.014640419	0.00791374	2	13A	IN-VIP	12	6	6
GACGCGTCATGGTAGG-1_7_G10	-22.96250951	13.54866534	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	968	1357	0.011053795	0.003684598	2	8	Astrocytes	12	6	6
GACGCGTGTTCGCGAC-1_7_G10	31.55370843	-9.268187674	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3539	7473	0.006958384	0.006155493	2	2	EN-L4	12	6	6
GACGCGTTCCGGCACA-1_7_G10	-19.49749611	-28.01000516	6A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2836	6653	0.004358936	0.003156471	2	6A	IN-PV	12	6	6
GACGGCTAGAGTCGGT-1_7_G10	19.52353735	-17.26486575	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	6073	18597	0.021078669	0.008926171	2	L2-3	EN-L2-3-MS	12	6	6
GACGGCTAGCCTCGTG-1_7_G10	-28.55940401	10.15323803	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	742	1010	0.01980198	0.005940594	2	8	Astrocytes	12	6	6
GACGGCTGTCACACGC-1_7_G10	20.99940274	28.32602047	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	887	1256	0.003184713	0.003980892	2	oligos	OL-MS-2	12	6	6
GACGGCTGTTATCACG-1_7_G10	-2.488525806	32.28221344	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	897	1225	0.008163265	0.004897959	2	oligos	OL-MS-2	12	6	6
GACGGCTGTTCCACTC-1_7_G10	-10.92551205	-0.253907308	13A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2323	4394	0.00887574	0.01115157	2	13A	IN-VIP	12	6	6
GACGGCTTCACCATAG-1_7_G10	-12.38683004	-2.190776468	13A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2581	4901	0.00999796	0.0091818	2	13A	IN-VIP	12	6	6
GACGGCTTCGCCAGCA-1_7_G10	20.92906607	-19.62079771	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	6104	19400	0.012680412	0.009226804	2	3	EN-L5-6	12	6	6
GACGGCTTCGTAGGTT-1_7_G10	-15.84157919	11.34845466	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1363	2026	0.006910168	0.002467917	2	8	Astrocytes	12	6	6
GACGTGCAGCAGGCTA-1_7_G10	-22.27262621	-24.79509791	6A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2874	6133	0.021359857	0.006195989	2	6A	IN-PV	12	6	6
GACGTGCCATGCGCAC-1_7_G10	31.87255468	-4.512256953	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2893	6062	0.008578027	0.004124051	2	2	EN-L4	12	6	6
GACGTGCGTAGGGTAC-1_7_G10	-26.63709867	9.669855394	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	845	1130	0.002654867	0.007964602	2	8	Astrocytes	12	6	6
GACGTGCGTTACGGAG-1_7_G10	-5.725219636	33.9281078	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	925	1246	0.005617978	0.006420546	2	oligos	OL-MS-2	12	6	6
GACGTGCTCGGCGCTA-1_7_G10	-24.05059164	25.07032345	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1417	2354	0.008920986	0.005947324	2	8	Astrocytes	12	6	6
GACGTGCTCTGCAGTA-1_7_G10	20.39211751	-15.39707823	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	10185	65931	0.06659993	0.005111404	2	2	EN-L4	12	6	6
GACGTTACACAGCCCA-1_7_G10	-8.783635357	35.04242982	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	957	1265	0.012648221	0.003952569	2	oligos	OL-MS-2	12	6	6
GACGTTACAGCGTCCA-1_7_G10	16.80554387	-32.8606552	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	5673	19683	0.000762079	0.005334553	2	3	EN-L5-6	12	6	6
GACGTTACATTCTTAC-1_7_G10	25.51671722	5.481933414	15A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1265	1786	0.019036954	0.010078387	2	15A	Endo cells	12	6	6
GACGTTATCGGTCTAA-1_7_G10	2.051576689	5.982149083	7	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	880	1121	0.015165031	0.005352364	2	7	Phagocytes	12	6	6
GACGTTATCTCGTTTA-1_7_G10	2.00874685	-26.24661253	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2957	6431	0.008863318	0.003576427	2	L2-3	EN-L2-3-Cntl	12	6	6
GACTAACAGAAACCGC-1_7_G10	-19.99021321	-26.92742436	6A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2990	6587	0.008197966	0.002277213	2	6A	IN-PV	12	6	6
GACTAACAGCGATAGC-1_7_G10	-1.710673638	31.15299086	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	773	1029	0.008746356	0.004859086	2	oligos	OL-MS-2	12	6	6
GACTAACAGCGCTCCA-1_7_G10	12.62593259	-20.6612963	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	5235	15791	0.014375277	0.004749541	2	L2-3	EN-L2-3-MS	12	6	6
GACTAACAGTAATCCC-1_7_G10	-3.141575046	34.0796512	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	863	1152	0.006076389	0.002604167	2	oligos	OL-MS-2	12	6	6
GACTAACCACATGTGT-1_7_G10	20.40921831	-1.015166292	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1538	2466	0.037712895	0.005271695	2	2	EN-L4	12	6	6
GACTAACCACCGCTAG-1_7_G10	-3.618684473	32.62306784	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	957	1312	0.006097561	0.003810976	2	oligos	OL-MS-2	12	6	6
GACTAACGTTGCCTCT-1_7_G10	-21.38272033	12.53229357	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	924	1363	0.00513573	0.005869406	2	8	Astrocytes	12	6	6
GACTACAAGATGTGTA-1_7_G10	-21.67388981	16.24540418	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1306	2075	0.003373494	0.003855422	2	8	Astrocytes	12	6	6
GACTACACACCCAGTG-1_7_G10	-25.69914118	-5.666401631	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1260	1998	0.00950951	0.001501502	2	9	OPC	12	6	6
GACTACACATCCCACT-1_7_G10	23.99628156	-10.38129825	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4923	14518	0.006199201	0.005648161	2	3	EN-L5-6	12	6	6
GACTACAGTAAGTGGC-1_7_G10	-20.90725673	-16.60045516	6B	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3114	7009	0.008560422	0.007276359	2	6B	IN-SST	12	6	6
GACTACAGTCTTGATG-1_7_G10	21.50337881	-0.90544361	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1815	3584	0.005301339	0.006138393	2	2	EN-L4	12	6	6
GACTACATCACTTATC-1_7_G10	-22.55598461	14.41020189	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	987	1421	0.009852217	0.002814919	2	8	Astrocytes	12	6	6
GACTGCGAGCTGAAAT-1_7_G10	-5.709008285	31.21903558	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1192	1656	0.010869565	0.003019324	2	oligos	OL-MS-2	12	6	6
GACTGCGCACTGCCAG-1_7_G10	-14.36277945	-3.60730718	13A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3687	8370	0.01827957	0.004540024	2	13A	IN-VIP	12	6	6
GACTGCGCAGCCAGAA-1_7_G10	3.314490013	-9.449648858	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1689	3277	0.001830943	0.007018615	2	L2-3	EN-L2-3-Cntl	12	6	6
GACTGCGGTACTCGCG-1_7_G10	6.470601073	2.226179088	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1178	1506	0.026560425	0.009960159	2	16	EN-PYR	12	6	6
GACTGCGGTTATCGGT-1_7_G10	1.980894486	-20.97130007	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3543	8477	0.005308482	0.004836617	2	L2-3	EN-L2-3-Cntl	12	6	6
GACTGCGTCTGGTTCC-1_7_G10	18.36801019	-30.27457589	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	5832	20162	0.010366035	0.006398175	2	3	EN-L5-6	12	6	6
GAGCAGAGTCGTGGCT-1_7_G10	18.72230957	13.23785753	1	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1179	1864	0.003755365	0.001072961	2	oligos	OL-Cntl	12	6	6
GAGGTGAAGAGTTGGC-1_7_G10	16.12760739	-32.67731559	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4325	11899	0.000756366	0.004454156	2	3	EN-L5-6	12	6	6
GAGGTGAAGTGGTAAT-1_7_G10	29.38576147	-5.224575443	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3557	8993	0.001556766	0.005893473	2	2	EN-L4	12	6	6
GAGGTGACATAGAAAC-1_7_G10	-4.630045609	34.99358693	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	881	1251	0.021582734	0.003197442	2	oligos	OL-MS-2	12	6	6
GAGGTGACATGCCACG-1_7_G10	-19.75973916	13.24245235	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1138	1553	0.00772698	0.005795235	2	8	Astrocytes	12	6	6
GAGGTGATCCTACAGA-1_7_G10	-5.905554113	33.82699067	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	990	1310	0.016030534	0.007633588	2	oligos	OL-MS-2	12	6	6
GAGGTGATCTACTATC-1_7_G10	-18.29447101	-15.93983069	6B	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2154	4032	0.013640873	0.013888889	2	6B	IN-SST	12	6	6
GAGGTGATCTGTTGAG-1_7_G10	16.84393536	-18.1392717	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	5122	13741	0.029546612	0.007423041	2	L2-3	EN-L2-3-MS	12	6	6
GAGGTGATCTTACCGC-1_7_G10	23.97499951	26.34234294	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1395	2129	0.007515265	0.005166745	2	oligos	OL-MS-2	12	6	6
GAGTCCGAGTGGAGTC-1_7_G10	1.543155395	30.54372935	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	771	1042	0.008637236	0.004798464	2	oligos	OL-MS-2	12	6	6
GAGTCCGCATGCCCGA-1_7_G10	-0.444619742	33.64221442	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	773	1064	0.006578947	0.009398496	2	oligos	OL-MS-2	12	6	6
GAGTCCGGTTACAGAA-1_7_G10	24.41647857	-24.83408022	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2473	5313	0.011857708	0.006399398	2	3	EN-L5-6	12	6	6
GAGTCCGTCACCTCGT-1_7_G10	12.16782521	-21.57397689	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	5746	18025	0.013925104	0.006546463	2	L2-3	EN-L2-3-MS	12	6	6
GAGTCCGTCCAACCAA-1_7_G10	32.61929663	-3.859170649	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2854	5853	0.007517512	0.007517512	2	2	EN-L4	12	6	6
GATCAGTAGCCTTGAT-1_7_G10	-0.584964776	31.89200718	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	813	1156	0.002595156	0.005190311	2	oligos	OL-MS-2	12	6	6
GATCAGTCACTAGTAC-1_7_G10	-5.801266504	34.59649197	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	831	1220	0.009836066	0.006557377	2	oligos	OL-MS-2	12	6	6
GATCAGTGTTACTGAC-1_7_G10	2.842187309	-24.83497911	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3972	9954	0.002210167	0.004822182	2	L2-3	EN-L2-3-MS	12	6	6
GATCGATCACATGGGA-1_7_G10	32.76840426	-4.824325792	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3285	7209	0.008461645	0.006380913	2	2	EN-L4	12	6	6
GATCGATCATATGCTG-1_7_G10	7.919354393	32.02411285	1	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	714	1034	0.002901354	0.003868472	2	oligos	OL-Cntl	12	6	6
GATCGATGTGCGCTTG-1_7_G10	-13.14620773	-18.30093211	6B	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1190	2032	0.013779528	0.001968504	2	6B	IN-SST	12	6	6
GATCGCGAGTAACCCT-1_7_G10	15.97799262	-25.216513	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	5277	16121	0.008808387	0.003721853	2	3	EN-L5-6	12	6	6
GATCGCGGTAGCTCCG-1_7_G10	9.213323602	-25.89833841	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4492	12838	0.003661006	0.00560835	2	L2-3	EN-L2-3-Cntl	12	6	6
GATCGCGGTCGAGTTT-1_7_G10	9.330858111	29.57343371	1	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	885	1318	0.003793627	0.001517451	2	oligos	OL-Cntl	12	6	6
GATCGCGGTCGCATCG-1_7_G10	1.338343953	-28.68223494	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4527	13438	0.004092871	0.00446495	2	L2-3	EN-L2-3-Cntl	12	6	6
GATCGCGGTGTGTGCC-1_7_G10	23.79220932	26.69416906	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1317	2030	0.013300493	0.004433498	2	oligos	OL-MS-2	12	6	6
GATCGCGTCAGCGATT-1_7_G10	3.891002177	-11.44632946	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1848	2996	0.008344459	0.012016021	2	L2-3	EN-L2-3-MS	12	6	6
GATCGCGTCGCGATCG-1_7_G10	8.766226554	-29.05257116	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	5886	21260	0.011994356	0.002398871	2	L2-3	EN-L2-3-Cntl	12	6	6
GATCGTAAGCTGCAAG-1_7_G10	-11.12355886	16.17278658	11	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1630	2574	0.003885004	0.002331002	2	11	Glia-MIX	12	6	6
GATCGTAAGGACTGGT-1_7_G10	1.351004124	-20.17493703	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3142	7529	0.005976889	0.003054855	2	L2-3	EN-L2-3-Cntl	12	6	6
GATCGTAAGGTAGCTG-1_7_G10	0.010456083	32.12813894	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	787	1090	0.006422018	0.001834862	2	oligos	OL-MS-2	12	6	6
GATCGTAAGTATCGAA-1_7_G10	-9.126613168	-31.04827231	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	965	1397	0.068718683	0.002863278	2	16	EN-PYR	12	6	6
GATCGTACAAGCCGCT-1_7_G10	-18.05504946	-15.83205389	6B	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2224	4353	0.025269929	0.006432346	2	6B	IN-SST	12	6	6
GATCGTACAGGTCGTC-1_7_G10	-26.49619477	-5.982790206	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1170	1739	0.002300173	0.004600345	2	9	OPC	12	6	6
GATCGTACAGGTGCCT-1_7_G10	-1.405515231	35.84060972	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	745	1015	0.008866995	0.010837438	2	oligos	OL-MS-2	12	6	6
GATCGTACATAAAGGT-1_7_G10	-23.4733549	-6.800974555	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1787	2991	0.010364427	0.004680709	2	9	OPC	12	6	6
GATCGTACATGCCTTC-1_7_G10	27.17587657	-14.56770055	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	7028	27000	0.026518519	0.009037037	2	2	EN-L4	12	6	6
GATCGTAGTGCTAGCC-1_7_G10	-3.258656321	36.16707089	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	765	1022	0.009784736	0.007827789	2	oligos	OL-MS-2	12	6	6
GATCGTATCCCAAGAT-1_7_G10	-16.80653054	10.6718411	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1225	1838	0.005984766	0.002720348	2	8	Astrocytes	12	6	6
GATCTAGAGAGAACAG-1_7_G10	-9.615118557	22.15520302	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1176	1552	0.005798969	0.005798969	2	8	Astrocytes	12	6	6
GATCTAGAGATATACG-1_7_G10	-9.003563828	-29.82062095	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1121	1784	0.134529148	0.002242152	2	16	EN-PYR	12	6	6
GATCTAGAGCCTTGAT-1_7_G10	8.0116346	-11.82135004	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2369	4675	0.018395722	0.005989305	2	L2-3	EN-L2-3-MS	12	6	6
GATCTAGCACGCCAGT-1_7_G10	3.311524998	-18.63172047	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3014	6006	0.007659008	0.007326007	2	L2-3	EN-L2-3-MS	12	6	6
GATCTAGCATATGCTG-1_7_G10	23.45076082	26.27009824	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1161	1744	0.003440367	0.006307339	2	oligos	OL-MS-2	12	6	6
GATCTAGGTAAGAGGA-1_7_G10	-23.21001476	15.07606725	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	997	1496	0.002673797	0.007352941	2	8	Astrocytes	12	6	6
GATCTAGGTCGGCTCA-1_7_G10	0.142000045	31.97766628	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	778	1024	0.005859375	0.005859375	2	oligos	OL-MS-2	12	6	6
GATCTAGGTGAGGCTA-1_7_G10	4.336413127	-14.84763602	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2301	4244	0.014137606	0.004712535	2	L2-3	EN-L2-3-MS	12	6	6
GATCTAGTCACAATGC-1_7_G10	-1.423566613	33.49178053	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	861	1177	0.005097706	0.004248088	2	oligos	OL-MS-2	12	6	6
GATCTAGTCATGTGGT-1_7_G10	-1.918674357	31.44192684	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	833	1152	0.004340278	0.005208333	2	oligos	OL-MS-2	12	6	6
GATGAAAAGCGTTCCG-1_7_G10	30.86836404	-10.69388887	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3764	8064	0.023189484	0.009672619	2	2	EN-L4	12	6	6
GATGAAAAGTGCCATT-1_7_G10	-32.53046296	-9.651012662	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1060	1675	0.014328358	0.006567164	2	9	OPC	12	6	6
GATGAAAAGTGGTCCC-1_7_G10	-0.922644471	34.71819432	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	848	1136	0.007922535	0.004401408	2	oligos	OL-MS-2	12	6	6
GATGAAACAAAGTCAA-1_7_G10	-9.81732796	-12.98886716	6B	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	994	1488	0.047043011	0.008736559	2	6B	IN-SST	12	6	6
GATGAAAGTAAGGGAA-1_7_G10	-12.0652753	-3.296226144	13A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2356	4159	0.05578264	0.006732388	2	13A	IN-VIP	12	6	6
GATGAAATCGCCGTGA-1_7_G10	20.81034767	27.95753393	1	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	838	1149	0.00435161	0.001740644	2	oligos	OL-Cntl	12	6	6
GATGAGGAGTGCTGCC-1_7_G10	18.87864469	-20.07109551	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3382	7651	0.019082473	0.006927199	2	3	EN-L5-6	12	6	6
GATGAGGAGTTCGCAT-1_7_G10	-3.431860718	35.69795987	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	769	1084	0.010147601	0.002767528	2	oligos	OL-MS-2	12	6	6
GATGAGGCAAAGGTGC-1_7_G10	-10.376628	11.90591943	11	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	769	1018	0.002946955	0.006876228	2	11	Glia-MIX	12	6	6
GATGAGGCAGGGATTG-1_7_G10	-5.670080225	-30.4643117	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	780	1044	0.081417625	0.012452107	2	16	EN-PYR	12	6	6
GATGAGGGTAAGTTCC-1_7_G10	-34.83208101	-6.708046277	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1141	1801	0.006107718	0.002220988	2	9	OPC	12	6	6
GATGAGGGTGCTAGCC-1_7_G10	-23.95983223	24.99817508	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1484	2396	0.007512521	0.005008347	2	8	Astrocytes	12	6	6
GATGAGGTCAAACCGT-1_7_G10	1.798565327	-22.6431251	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3903	10151	0.004630086	0.004531573	2	L2-3	EN-L2-3-Cntl	12	6	6
GATGAGGTCCACTCCA-1_7_G10	24.66142029	-24.02162157	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4064	11015	0.007444394	0.003722197	2	3	EN-L5-6	12	6	6
GATGAGGTCCTCGCAT-1_7_G10	28.75109158	-4.889609226	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3681	8885	0.001012943	0.008778841	2	2	EN-L4	12	6	6
GATGCTAAGGCGTACA-1_7_G10	-16.54289552	-22.16745162	6A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1501	2546	0.019638649	0.005106049	2	6A	IN-PV	12	6	6
GATGCTAAGGGTGTGT-1_7_G10	19.15777617	-20.60828885	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3617	8875	0.044507042	0.00428169	2	3	EN-L5-6	12	6	6
GATGCTAAGTTTGCGT-1_7_G10	4.117695596	-15.01702051	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2425	4564	0.00942156	0.007449606	2	L2-3	EN-L2-3-MS	12	6	6
GATGCTACAAGCCATT-1_7_G10	-16.1789165	-5.403370155	13A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4545	11736	0.017126789	0.007668712	2	13A	IN-VIP	12	6	6
GATGCTACAAGCGATG-1_7_G10	2.337778275	-16.90226341	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2683	5352	0.007100149	0.008781764	2	L2-3	EN-L2-3-MS	12	6	6
GATGCTAGTCGGCTCA-1_7_G10	-12.88771024	-17.42786883	6B	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1098	1622	0.016029593	0.001849568	2	6B	IN-SST	12	6	6
GATGCTAGTTGGTGGA-1_7_G10	-1.157710434	35.30030309	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	802	1148	0.019163763	0.006097561	2	oligos	OL-MS-2	12	6	6
GATGCTATCAGCTGGC-1_7_G10	16.48019133	-30.41112335	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3276	7226	0.004428453	0.004705231	2	3	EN-L5-6	12	6	6
GATTCAGAGATGGGTC-1_7_G10	32.17237057	-9.296425884	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3115	6349	0.023153252	0.008032761	2	2	EN-L4	12	6	6
GATTCAGCAAGTTAAG-1_7_G10	6.675966829	-27.24729156	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2696	5050	0.007128713	0.003762376	2	L2-3	EN-L2-3-MS	12	6	6
GATTCAGCACAGGCCT-1_7_G10	2.186778129	-13.71912452	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2014	3551	0.00337933	0.008166714	2	L2-3	EN-L2-3-MS	12	6	6
GATTCAGCAGCCTTGG-1_7_G10	-2.461630449	31.68073785	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	851	1142	0.001751313	0.006129597	2	oligos	OL-MS-2	12	6	6
GATTCAGTCCCTAATT-1_7_G10	-1.08546256	-22.07019449	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3404	8765	0.002852253	0.003422704	2	L2-3	EN-L2-3-Cntl	12	6	6
GATTCAGTCGCAGGCT-1_7_G10	13.55453468	-21.19306163	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3775	8648	0.021160962	0.006359852	2	L2-3	EN-L2-3-MS	12	6	6
GATTCAGTCGGCGGTT-1_7_G10	-29.38820266	-12.90025202	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	823	1124	0.007117438	0.007117438	2	9	OPC	12	6	6
GCAAACTAGAGCTGGT-1_7_G10	29.78161776	-9.394126154	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4329	9811	0.022831516	0.006930996	2	2	EN-L4	12	6	6
GCAAACTAGATCTGCT-1_7_G10	2.403957741	-15.25466489	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2222	3946	0.009123163	0.00430816	2	L2-3	EN-L2-3-MS	12	6	6
GCAAACTAGCCGATTT-1_7_G10	-32.41738573	3.823306434	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2191	4056	0.004191321	0.002465483	2	9	OPC	12	6	6
GCAAACTGTCTTTCAT-1_7_G10	-0.869433403	34.23404447	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	959	1348	0.005934718	0.007418398	2	oligos	OL-MS-2	12	6	6
GCAAACTGTGTGGCTC-1_7_G10	24.14991911	-10.21629227	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4226	10544	0.006828528	0.00853566	2	3	EN-L5-6	12	6	6
GCAAACTTCAGTTAGC-1_7_G10	-14.0598568	-5.6970258	13A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2395	4487	0.006908848	0.007577446	2	13A	IN-VIP	12	6	6
GCAATCAAGAGGTTAT-1_7_G10	-19.98122015	16.22774744	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1452	2266	0.008826125	0.008384819	2	8	Astrocytes	12	6	6
GCAATCAAGATACACA-1_7_G10	13.4524095	-22.27506452	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4726	12675	0.011676529	0.006153846	2	L2-3	EN-L2-3-MS	12	6	6
GCAATCAAGTGGTAGC-1_7_G10	-15.74522138	-18.77366933	6B	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1708	3226	0.005269684	0.004649721	2	6B	IN-SST	12	6	6
GCAATCACACAGCCCA-1_7_G10	-11.35462188	32.57756165	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1035	1361	0.016164585	0.012490816	2	oligos	OL-MS-2	12	6	6
GCAATCAGTGATAAGT-1_7_G10	-21.76530049	-16.2733406	6B	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2848	6004	0.028814124	0.007161892	2	6B	IN-SST	12	6	6
GCAATCATCAATCACG-1_7_G10	32.91139366	-4.660793838	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3308	7118	0.009272267	0.01025569	2	2	EN-L4	12	6	6
GCACATAAGAATAGGG-1_7_G10	-17.61989505	9.127856555	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	990	1331	0.016528926	0.000751315	2	8	Astrocytes	12	6	6
GCACATAAGAGGGATA-1_7_G10	1.775466755	-16.85080401	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2481	4741	0.004007593	0.004429445	2	L2-3	EN-L2-3-MS	12	6	6
GCACATAAGCAGGTCA-1_7_G10	-2.104788151	32.53069603	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	890	1180	0.012711864	0.004237288	2	oligos	OL-MS-2	12	6	6
GCACATAAGCGTGTCC-1_7_G10	23.72430213	-10.140445	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3624	8302	0.001324982	0.008552156	2	3	EN-L5-6	12	6	6
GCACATAAGGGAGTAA-1_7_G10	29.20628004	-5.619558011	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3411	7987	0.002879679	0.005133342	2	2	EN-L4	12	6	6
GCACATACACGGTGTC-1_7_G10	-2.895124357	32.16083295	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1009	1462	0.006839945	0.004787962	2	oligos	OL-MS-2	12	6	6
GCACATACATTGGGCC-1_7_G10	-23.55329	-7.217531689	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1479	2168	0.011070111	0.00599631	2	9	OPC	12	6	6
GCACATACATTTCACT-1_7_G10	-20.86682566	12.23800203	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	871	1194	0.010887772	0.003350084	2	8	Astrocytes	12	6	6
GCACATAGTCAGGACA-1_7_G10	13.54807175	-21.96901144	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4588	11507	0.020596159	0.004432085	2	L2-3	EN-L2-3-MS	12	6	6
GCACATATCCGGCACA-1_7_G10	21.108288	28.41492755	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1000	1432	0.004888268	0.002094972	2	oligos	OL-MS-2	12	6	6
GCACATATCCTCTAGC-1_7_G10	31.22239577	-9.712728759	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4016	9683	0.021894041	0.005370236	2	2	EN-L4	12	6	6
GCACTCTAGTACCGGA-1_7_G10	23.29661633	-25.94158081	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2753	6028	0.007133378	0.017086928	2	3	EN-L5-6	12	6	6
GCACTCTGTTAAGACA-1_7_G10	1.82120174	-12.8449419	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2041	3846	0.005460218	0.003120125	2	L2-3	EN-L2-3-Cntl	12	6	6
GCACTCTGTTGTCTTT-1_7_G10	1.561198971	-21.14307352	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3353	8201	0.005487136	0.003414218	2	L2-3	EN-L2-3-Cntl	12	6	6
GCACTCTGTTGTTTGG-1_7_G10	9.570073433	1.396505476	12	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	747	1048	0.022900763	0.006679389	2	12	EN-MIX	12	6	6
GCACTCTTCGCGTTTC-1_7_G10	23.45268837	27.96744841	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1142	1668	0.008992806	0.002398082	2	oligos	OL-MS-2	12	6	6
GCAGCCAAGAAACCGC-1_7_G10	22.72075022	-19.03854084	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	5928	19075	0.025530799	0.005242464	2	3	EN-L5-6	12	6	6
GCAGCCATCAGAGACG-1_7_G10	22.23798052	27.07841033	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1134	1642	0.005481121	0.009135201	2	oligos	OL-MS-2	12	6	6
GCAGCCATCCTCAACC-1_7_G10	32.13453661	-1.748283198	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2457	5005	0.005794206	0.004995005	2	2	EN-L4	12	6	6
GCAGCCATCTGCAAGT-1_7_G10	8.14178845	-29.60781539	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4481	12604	0.004681054	0.004363694	2	L2-3	EN-L2-3-Cntl	12	6	6
GCAGTTAAGCCACGCT-1_7_G10	19.18316931	-17.48788318	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	6619	23724	0.036460968	0.004552352	2	L2-3	EN-L2-3-MS	12	6	6
GCAGTTAAGGCCCTTG-1_7_G10	-17.84556926	-16.33028681	6B	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2393	4713	0.019732654	0.005941014	2	6B	IN-SST	12	6	6
GCAGTTACAGCGTCCA-1_7_G10	1.793348547	-10.51782664	12	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1633	2645	0.005671078	0.007561437	2	12	EN-MIX	12	6	6
GCAGTTACATACCATG-1_7_G10	-4.367027564	33.73853949	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	913	1259	0.010325655	0.002382844	2	oligos	OL-MS-2	12	6	6
GCAGTTAGTCTCCACT-1_7_G10	-11.12935739	-27.35486791	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	974	1493	0.192230409	0.012056263	2	16	EN-PYR	12	6	6
GCATACAAGACTAGGC-1_7_G10	31.22160849	-10.5120222	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3730	7881	0.018525568	0.008628347	2	2	EN-L4	12	6	6
GCATACACAATAGCGG-1_7_G10	31.67415431	-9.274134325	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3677	7871	0.011688477	0.008258163	2	2	EN-L4	12	6	6
GCATACACACCACGTG-1_7_G10	10.61225747	-18.87506032	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4369	11089	0.01487961	0.006222383	2	L2-3	EN-L2-3-MS	12	6	6
GCATACACAGCCTTTC-1_7_G10	-11.16916823	32.70644982	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1004	1317	0.011389522	0.008352316	2	oligos	OL-MS-2	12	6	6
GCATACAGTAACGACG-1_7_G10	23.7733301	7.248762898	15A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3045	5898	0.007460156	0.007460156	2	15A	Endo cells	12	6	6
GCATACAGTAGAGGAA-1_7_G10	-1.445956751	33.12781333	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	960	1378	0.001451379	0.006531205	2	oligos	OL-MS-2	12	6	6
GCATACAGTCCGACGT-1_7_G10	-25.63460316	-9.016392821	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1049	1459	0.012337217	0.003427005	2	9	OPC	12	6	6
GCATACAGTCCGTGAC-1_7_G10	25.08841439	-24.50787375	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3439	8057	0.00546109	0.005585205	2	3	EN-L5-6	12	6	6
GCATACAGTCTTGTCC-1_7_G10	-5.871016448	36.27333164	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	765	1013	0.019743337	0.009871668	2	oligos	OL-MS-2	12	6	6
GCATACATCAAAGACA-1_7_G10	-7.129985414	31.45305771	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1175	1634	0.010403917	0.006731946	2	oligos	OL-MS-2	12	6	6
GCATACATCATCGATG-1_7_G10	-15.47055133	-18.03075632	6B	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1499	2523	0.00554895	0.005945303	2	6B	IN-SST	12	6	6
GCATGATGTCCTCCAT-1_7_G10	30.76367106	-8.84554015	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4203	10225	0.012224939	0.003227384	2	2	EN-L4	12	6	6
GCATGATGTCTCTCGT-1_7_G10	-8.750643406	-30.61786694	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	992	1455	0.081099656	0.003436426	2	16	EN-PYR	12	6	6
GCATGATTCAACTCTT-1_7_G10	-1.564312463	36.5070285	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	864	1170	0.017094017	0.005982906	2	oligos	OL-MS-2	12	6	6
GCATGATTCTCTAAGG-1_7_G10	32.69461624	-4.940282397	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3155	6383	0.009243303	0.004699984	2	2	EN-L4	12	6	6
GCATGATTCTTCGAGA-1_7_G10	11.87589412	13.37784645	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1517	2838	0.011980268	0.003171247	2	oligos	OL-MS-2	12	6	6
GCATGCGCATTGGGCC-1_7_G10	-20.40295601	19.3809207	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1666	2813	0.001777462	0.00604337	2	8	Astrocytes	12	6	6
GCATGCGGTATGAATG-1_7_G10	-24.6619655	-1.38543022	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1848	3581	0.005864284	0.002234013	2	9	OPC	12	6	6
GCATGCGGTATGGTTC-1_7_G10	19.01040636	-17.39895217	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	8613	42753	0.028419058	0.007625196	2	L2-3	EN-L2-3-MS	12	6	6
GCATGCGGTCGCCATG-1_7_G10	33.22841567	-12.22609511	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3261	6642	0.02152966	0.011141223	2	2	EN-L4	12	6	6
GCATGCGGTGACGCCT-1_7_G10	2.105047494	-20.52364291	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3175	7183	0.007796185	0.003619658	2	L2-3	EN-L2-3-MS	12	6	6
GCATGCGGTTTAGCTG-1_7_G10	2.026476695	31.0020948	1	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	783	1086	0.002762431	0.003683241	2	oligos	OL-Cntl	12	6	6
GCATGTAAGAGCAATT-1_7_G10	-26.17635065	-9.231150518	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	949	1386	0.002164502	0.01010101	2	9	OPC	12	6	6
GCATGTAAGCGTAATA-1_7_G10	-18.23830915	-26.57825939	6A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2542	5523	0.003802281	0.00362122	2	6A	IN-PV	12	6	6
GCATGTACACTTCGAA-1_7_G10	25.29439595	-22.77231159	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3734	8824	0.016999093	0.006572983	2	3	EN-L5-6	12	6	6
GCATGTACATGCAACT-1_7_G10	-5.792024114	31.59156519	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1068	1493	0.010046885	0.004018754	2	oligos	OL-MS-2	12	6	6
GCATGTAGTAATCGTC-1_7_G10	-26.31593615	-20.33654173	6A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2521	5122	0.033580633	0.008199922	2	6A	IN-PV	12	6	6
GCATGTAGTCGCGAAA-1_7_G10	5.082015209	-15.1477771	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2745	5535	0.009575429	0.006684734	2	L2-3	EN-L2-3-MS	12	6	6
GCATGTAGTGATGATA-1_7_G10	16.40623899	-32.40766414	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	5018	15196	0.001776783	0.004738089	2	3	EN-L5-6	12	6	6
GCATGTAGTTACGACT-1_7_G10	3.832454519	7.198823442	7	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1183	1692	0.004137116	0.007092199	2	7	Phagocytes	12	6	6
GCATGTATCAAGATCC-1_7_G10	-2.51617869	31.57799538	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1017	1376	0.006540698	0.005813953	2	oligos	OL-MS-2	12	6	6
GCATGTATCCGCGGTA-1_7_G10	-10.20814671	-31.31491109	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1106	1550	0.09483871	0.007096774	2	16	EN-PYR	12	6	6
GCATGTATCTTATCTG-1_7_G10	27.49124633	-5.993200801	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4353	12109	0.003881411	0.005945991	2	2	EN-L4	12	6	6
GCCAAATAGCTGCGAA-1_7_G10	6.361968239	-8.400243234	12	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1943	3292	0.0027339	0.005164034	2	12	EN-MIX	12	6	6
GCCAAATAGCTTATCG-1_7_G10	-20.52098141	13.40968069	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1060	1498	0.008678238	0.006675567	2	8	Astrocytes	12	6	6
GCCAAATAGGCCCTTG-1_7_G10	0.519847728	33.43676214	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	837	1176	0.008503401	0.00255102	2	oligos	OL-MS-2	12	6	6
GCCAAATCAGAGTGTG-1_7_G10	-17.82689023	8.980124734	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	907	1184	0.015202703	0.006756757	2	8	Astrocytes	12	6	6
GCCAAATCAGATCTGT-1_7_G10	-24.00968773	-11.99177588	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1076	1452	0.023415978	0.010330579	2	16	EN-PYR	12	6	6
GCCAAATCATCTACGA-1_7_G10	28.04715392	-11.20899248	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4279	10916	0.009802125	0.008519604	2	2	EN-L4	12	6	6
GCCAAATGTCTGGAGA-1_7_G10	29.61359463	-3.40446105	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3995	10295	0.001359883	0.004371054	2	L2-3	EN-L2-3-Cntl	12	6	6
GCCAAATGTGCAGACA-1_7_G10	-12.22332974	16.21282122	11	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1514	2238	0.004915103	0.006702413	2	11	Glia-MIX	12	6	6
GCCAAATTCGCCCTTA-1_7_G10	2.924847023	-24.63941044	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4296	11676	0.00445358	0.004539226	2	L2-3	EN-L2-3-MS	12	6	6
GCCTCTAAGTCCGGTC-1_7_G10	-13.56737955	-19.14795857	6B	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1227	2080	0.011538462	0.002884615	2	6B	IN-SST	12	6	6
GCCTCTACACGTAAGG-1_7_G10	-7.918991264	-32.88434252	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1037	1556	0.091902314	0.007712082	2	16	EN-PYR	12	6	6
GCCTCTACATCGATTG-1_7_G10	-25.18936761	-11.57804425	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	931	1182	0.016920474	0.007614213	2	9	OPC	12	6	6
GCCTCTACATGCCTAA-1_7_G10	21.24942035	12.92936729	1	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1383	2214	0.007226739	0.003161698	2	oligos	OL-Cntl	12	6	6
GCCTCTACATGCTAGT-1_7_G10	-29.45063746	-13.03743454	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	779	1036	0.005791506	0.005791506	2	9	OPC	12	6	6
GCCTCTATCAAGATCC-1_7_G10	-15.29218336	-17.3158228	6B	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1498	2572	0.012052877	0.008553655	2	6B	IN-SST	12	6	6
GCCTCTATCACGATGT-1_7_G10	-1.219522913	34.74255417	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	860	1156	0.008650519	0.006055363	2	oligos	OL-MS-2	12	6	6
GCCTCTATCTTGGGTA-1_7_G10	-11.19447463	29.38810535	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1033	1410	0.056028369	0.004255319	2	oligos	OL-MS-2	12	6	6
GCGACCAAGGTGGGTT-1_7_G10	21.72832375	27.2729541	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1058	1538	0.00520156	0.00390117	2	oligos	OL-MS-2	12	6	6
GCGACCAAGGTTCCTA-1_7_G10	-11.84234194	13.51469446	11	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	874	1157	0.009507347	0.002592913	2	11	Glia-MIX	12	6	6
GCGACCACAACAACCT-1_7_G10	9.063491084	-30.2575173	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	5227	17132	0.008113472	0.005486808	2	L2-3	EN-L2-3-Cntl	12	6	6
GCGACCAGTGGGTATG-1_7_G10	-22.64071602	-22.52018458	6A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2833	6023	0.027893077	0.004980907	2	6A	IN-PV	12	6	6
GCGACCAGTGGTCCGT-1_7_G10	20.8619517	-2.420068588	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1781	2944	0.012567935	0.00611413	2	2	EN-L4	12	6	6
GCGACCATCAACCAAC-1_7_G10	22.50801774	-0.739537284	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1721	2790	0.016129032	0.006451613	2	2	EN-L4	12	6	6
GCGACCATCAGCCTAA-1_7_G10	27.80141549	4.387783945	15BA	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	871	1191	0.037783375	0.021830395	2	15BA	Stromal cells	12	6	6
GCGACCATCGTGGTCG-1_7_G10	-17.69190904	-21.3172477	6A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2008	3940	0.033248731	0.003553299	2	6A	IN-PV	12	6	6
GCGAGAAAGCAGATCG-1_7_G10	3.183250878	-14.79454804	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2419	4465	0.004927212	0.009630459	2	L2-3	EN-L2-3-MS	12	6	6
GCGAGAAAGCTCAACT-1_7_G10	13.837643	-27.38750097	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2293	4579	0.005678096	0.005459707	2	3	EN-L5-6	12	6	6
GCGAGAAAGGACATTA-1_7_G10	-5.767010177	-30.46260992	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	854	1166	0.102058319	0.013722127	2	16	EN-PYR	12	6	6
GCGAGAAAGGTCATCT-1_7_G10	-5.716423064	-29.13965926	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1111	1631	0.108522379	0.012875536	2	16	EN-PYR	12	6	6
GCGAGAAGTAGTAGTA-1_7_G10	19.23252251	0.056996467	12	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1305	1951	0.005638134	0.00871348	2	12	EN-MIX	12	6	6
GCGAGAATCGCCCTTA-1_7_G10	-2.437098434	33.76850186	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	836	1166	0.006003431	0.005145798	2	oligos	OL-MS-2	12	6	6
GCGAGAATCGTTTGCC-1_7_G10	-0.149491541	32.06702067	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	790	1063	0.006585136	0.003762935	2	oligos	OL-MS-2	12	6	6
GCGAGAATCTATCCCG-1_7_G10	-0.595635346	4.900248938	11	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	844	1329	0.006019564	0.002257336	2	11	Glia-MIX	12	6	6
GCGCAACAGAGTAATC-1_7_G10	-3.439259405	36.64726227	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	872	1183	0.008453085	0.005071851	2	oligos	OL-MS-2	12	6	6
GCGCAACCAATGGATA-1_7_G10	21.86528386	27.35764842	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1015	1440	0.005555556	0.005555556	2	oligos	OL-MS-2	12	6	6
GCGCAACCATGTTCCC-1_7_G10	-20.88216756	15.76940696	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1399	2085	0.002398082	0.007194245	2	8	Astrocytes	12	6	6
GCGCAACGTAACGCGA-1_7_G10	-9.627400576	34.03169928	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	856	1080	0.024074074	0.00462963	2	oligos	OL-MS-2	12	6	6
GCGCAACGTAGCCTCG-1_7_G10	-7.320160521	-6.88341306	13A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1177	1719	0.010471204	0.00814427	2	13A	IN-VIP	12	6	6
GCGCAGTAGAGCCTAG-1_7_G10	-17.21158329	8.057958809	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1077	1660	0.002409639	0.003012048	2	8	Astrocytes	12	6	6
GCGCAGTAGTGCTGCC-1_7_G10	5.629691543	-15.27305049	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2651	4956	0.01291364	0.008071025	2	L2-3	EN-L2-3-MS	12	6	6
GCGCAGTCATGGTAGG-1_7_G10	-12.31451676	17.23117501	11	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1481	2316	0.004317789	0.002590674	2	11	Glia-MIX	12	6	6
GCGCAGTTCAACGGCC-1_7_G10	-11.3130036	-35.43743395	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1405	2172	0.067679558	0.010589319	2	16	EN-PYR	12	6	6
GCGCAGTTCAGTCCCT-1_7_G10	-9.632404145	17.77603259	11	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2277	4137	0.002175489	0.002900653	2	11	Glia-MIX	12	6	6
GCGCCAACAGCCAATT-1_7_G10	32.34192925	-4.870511387	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3768	8498	0.006354436	0.005295364	2	2	EN-L4	12	6	6
GCGCCAACATTATCTC-1_7_G10	2.913346509	-21.81400586	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4097	10459	0.006501578	0.006979635	2	L2-3	EN-L2-3-MS	12	6	6
GCGCCAATCAACCAAC-1_7_G10	8.960112905	-28.14222788	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	5024	14999	0.002733516	0.009867324	2	L2-3	EN-L2-3-Cntl	12	6	6
GCGCGATAGACTAGAT-1_7_G10	32.74082746	-4.912940476	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3153	6538	0.011471398	0.006118079	2	2	EN-L4	12	6	6
GCGCGATAGAGCTGGT-1_7_G10	25.7493201	6.79555105	15A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1448	1994	0.018555667	0.009027081	2	15A	Endo cells	12	6	6
GCGCGATGTATATGGA-1_7_G10	3.957283815	-13.16393953	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1932	3211	0.01183432	0.004671442	2	L2-3	EN-L2-3-MS	12	6	6
GCGCGATTCAACACTG-1_7_G10	27.53279608	4.922929554	15A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	866	1068	0.024344569	0.014981273	2	15A	Endo cells	12	6	6
GCGCGATTCACAACGT-1_7_G10	-8.241614013	-5.425599702	13A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1453	2316	0.012521589	0.00388601	2	13A	IN-VIP	12	6	6
GCGGGTTAGTACACCT-1_7_G10	30.46880637	-1.331129488	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3118	6834	0.004097161	0.002194908	2	2	EN-L4	12	6	6
GCGGGTTAGTGGGCTA-1_7_G10	-2.870887501	35.76565789	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	781	1056	0.005681818	0.002840909	2	oligos	OL-MS-2	12	6	6
GCGGGTTCAGGTGCCT-1_7_G10	5.945188847	0.636246043	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	877	1120	0.015178571	0.021428571	2	16	EN-PYR	12	6	6
GCGGGTTGTAACGTTC-1_7_G10	-4.41166727	32.83973473	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	935	1275	0.010980392	0.001568627	2	oligos	OL-MS-2	12	6	6
GCGGGTTTCAAAGTAG-1_7_G10	16.90986451	-18.18870534	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4283	10375	0.028819277	0.006746988	2	L2-3	EN-L2-3-MS	12	6	6
GCGGGTTTCCCAAGTA-1_7_G10	6.693283893	2.290047913	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	906	1135	0.027312775	0.011453744	2	16	EN-PYR	12	6	6
GCGGGTTTCCCATTAT-1_7_G10	8.538045084	-2.215554907	12	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1554	2142	0.02334267	0.005602241	2	12	EN-MIX	12	6	6
GCGGGTTTCTGCGACG-1_7_G10	26.63910102	-17.42761197	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4349	10822	0.026520052	0.010349288	2	2	EN-L4	12	6	6
GCGGGTTTCTTTAGGG-1_7_G10	-9.943210199	-1.123724407	13A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2184	4355	0.012858783	0.003903559	2	13A	IN-VIP	12	6	6
GCTCCTAAGATGGCGT-1_7_G10	3.882138066	-16.26490926	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2659	5117	0.010748485	0.008989642	2	L2-3	EN-L2-3-MS	12	6	6
GCTCCTAAGCCCGAAA-1_7_G10	-0.25019765	33.33289889	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	805	1161	0.005167959	0.006890612	2	oligos	OL-MS-2	12	6	6
GCTCCTAAGTTGTAGA-1_7_G10	-16.81074574	-16.03865619	6B	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1911	3433	0.025050976	0.006408389	2	6B	IN-SST	12	6	6
GCTCCTACACCTTGTC-1_7_G10	-23.91066901	-22.47309316	6A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3123	7077	0.044369083	0.004097782	2	6A	IN-PV	12	6	6
GCTCCTACACTTAACG-1_7_G10	-0.298134553	35.08984742	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	791	1025	0.006829268	0.005853659	2	oligos	OL-MS-2	12	6	6
GCTCCTAGTGCAACTT-1_7_G10	21.74207834	27.86572879	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	914	1279	0.003127443	0.003909304	2	oligos	OL-MS-2	12	6	6
GCTCCTATCAACACAC-1_7_G10	-18.29130004	9.989253675	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	812	1078	0.008348794	0.005565863	2	8	Astrocytes	12	6	6
GCTCCTATCCTGCTTG-1_7_G10	-7.423951918	35.68660748	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	844	1091	0.009165903	0.010999083	2	oligos	OL-MS-2	12	6	6
GCTCCTATCTGCCCTA-1_7_G10	20.61728874	26.80696191	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	915	1236	0.008899676	0.004854369	2	oligos	OL-MS-2	12	6	6
GCTCTGTAGAATTGTG-1_7_G10	0.014071894	31.4740672	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	833	1148	0.005226481	0.00174216	2	oligos	OL-MS-2	12	6	6
GCTCTGTCACTAAGTC-1_7_G10	-24.04308036	-21.12092462	6A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4366	11239	0.009253492	0.010321203	2	6A	IN-PV	12	6	6
GCTCTGTCACTTCTGC-1_7_G10	-14.15861837	-16.57164772	6B	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1388	2301	0.011734029	0.003476749	2	6B	IN-SST	12	6	6
GCTCTGTGTACCATCA-1_7_G10	18.48262797	-27.92410695	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3484	7136	0.005044843	0.009108744	2	3	EN-L5-6	12	6	6
GCTCTGTGTAGCGATG-1_7_G10	-0.974766258	32.22160314	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	864	1199	0.003336113	0.005838198	2	oligos	OL-MS-2	12	6	6
GCTGCAGAGGTCGGAT-1_7_G10	-0.612905317	30.32822116	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	760	1043	0.003835091	0	2	oligos	OL-MS-2	12	6	6
GCTGCAGCAAGCGTAG-1_7_G10	23.05050366	-20.45423899	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	5029	14838	0.009165656	0.007009031	2	3	EN-L5-6	12	6	6
GCTGCAGCAATAGCGG-1_7_G10	22.25378403	26.30902387	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1098	1573	0.008900191	0.001907184	2	oligos	OL-MS-2	12	6	6
GCTGCAGGTTACGACT-1_7_G10	16.20382029	-32.06855203	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	5052	16015	0.007243209	0.004932875	2	3	EN-L5-6	12	6	6
GCTGCAGTCACTGGGC-1_7_G10	31.52899745	-2.182539205	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2917	5880	0.005612245	0.005272109	2	2	EN-L4	12	6	6
GCTGCAGTCAGGTTCA-1_7_G10	28.96993226	-10.91754221	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4129	9994	0.02791675	0.004802882	2	2	EN-L4	12	6	6
GCTGCAGTCAGTTTGG-1_7_G10	-25.591586	-5.982922448	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1222	1877	0.00426212	0.005860416	2	9	OPC	12	6	6
GCTGCAGTCGCATGAT-1_7_G10	5.014747889	-7.493568316	12	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1171	2047	0.006839277	0.009770396	2	12	EN-MIX	12	6	6
GCTGCAGTCGCGATCG-1_7_G10	15.21961095	-33.28494932	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4818	15743	0.003112494	0.004128819	2	3	EN-L5-6	12	6	6
GCTGCGAAGGCGCTCT-1_7_G10	25.81601029	5.996819487	15A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1267	1761	0.030664395	0.017035775	2	15A	Endo cells	12	6	6
GCTGCGACATGGTAGG-1_7_G10	20.46661992	-27.49500126	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3207	7164	0.002512563	0.008654383	2	2	EN-L4	12	6	6
GCTGCGAGTTTGCATG-1_7_G10	20.90228764	26.03826385	1	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	954	1452	0.007575758	0.006198347	2	oligos	OL-Cntl	12	6	6
GCTGCGATCCAAACTG-1_7_G10	-26.07513799	-7.775459186	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1067	1568	0.004464286	0.012117347	2	9	OPC	12	6	6
GCTGCTTAGAATAGGG-1_7_G10	33.49089236	6.894728369	14	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	828	1046	0.008604207	0.007648184	2	14	Microglia	12	6	6
GCTGCTTAGCATGGCA-1_7_G10	16.48980533	-10.04943152	12	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1797	2924	0.024623803	0.005129959	2	12	EN-MIX	12	6	6
GCTGCTTAGCTACCGC-1_7_G10	2.976127643	-26.17256952	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3985	10829	0.005448333	0.003232062	2	L2-3	EN-L2-3-Cntl	12	6	6
GCTGCTTAGCTCTCGG-1_7_G10	-5.3084997	34.69220601	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	748	1005	0.007960199	0.0039801	2	oligos	OL-MS-2	12	6	6
GCTGCTTAGTGCCATT-1_7_G10	-10.04613444	-8.742808505	13B	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1209	1952	0.03125	0.00307377	2	13B	IN-SV2C	12	6	6
GCTGCTTAGTTACGGG-1_7_G10	-24.94056387	-24.47076789	6A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4352	12020	0.031198003	0.006572379	2	6A	IN-PV	12	6	6
GCTGCTTCAACACCTA-1_7_G10	-8.154080198	33.91708171	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	949	1237	0.015359741	0.004850445	2	oligos	OL-MS-2	12	6	6
GCTGCTTCAGCCAATT-1_7_G10	27.00042618	-16.55937182	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	8981	44390	0.040662311	0.011939626	2	2	EN-L4	12	6	6
GCTGCTTCAGTTTACG-1_7_G10	-25.80827178	-7.573773531	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1041	1457	0.008236102	0.004804393	2	9	OPC	12	6	6
GCTGCTTTCCTACAGA-1_7_G10	29.48536975	-11.31718694	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4359	10967	0.017415884	0.010212456	2	2	EN-L4	12	6	6
GCTGCTTTCTCGAGTA-1_7_G10	-7.929378647	35.02259078	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	840	1072	0.012126866	0.009328358	2	oligos	OL-MS-2	12	6	6
GCTGGGTCATCCGTGG-1_7_G10	-26.15068	8.920119875	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	857	1181	0.00254022	0.00592718	2	8	Astrocytes	12	6	6
GCTGGGTCATGTCGAT-1_7_G10	19.76501107	-0.545712714	12	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1277	1897	0.015814444	0.002635741	2	12	EN-MIX	12	6	6
GCTGGGTGTATCGCAT-1_7_G10	31.75445264	-8.862245296	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3509	7625	0.015606557	0.006163934	2	2	EN-L4	12	6	6
GCTGGGTGTATGGTTC-1_7_G10	-5.774096329	18.60009835	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	762	1056	0.016098485	0.005681818	2	oligos	OL-MS-2	12	6	6
GCTGGGTGTCTGATTG-1_7_G10	-1.172361601	35.36521099	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	775	1008	0.007936508	0.003968254	2	oligos	OL-MS-2	12	6	6
GCTGGGTTCTGCGACG-1_7_G10	-14.1671882	-17.41262884	6B	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1410	2362	0.016088061	0.00635055	2	6B	IN-SST	12	6	6
GCTGGGTTCTTGTCAT-1_7_G10	-17.07081205	9.16038293	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1099	1497	0.008684035	0.004008016	2	8	Astrocytes	12	6	6
GCTTCCAAGACATAAC-1_7_G10	-5.621576418	34.07039516	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	885	1174	0.004258944	0.002555366	2	oligos	OL-MS-2	12	6	6
GCTTCCAAGAGACTAT-1_7_G10	12.05991855	-21.96795986	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	7111	26660	0.011702926	0.005626407	2	L2-3	EN-L2-3-MS	12	6	6
GCTTCCACATGTCTCC-1_7_G10	-16.02827555	-21.89951873	6B	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1591	2661	0.003382187	0.004133784	2	6B	IN-SST	12	6	6
GCTTCCATCAACTCTT-1_7_G10	-20.44312945	18.9201617	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1852	3064	0.001958225	0.006527415	2	8	Astrocytes	12	6	6
GCTTCCATCCATGAAC-1_7_G10	-3.701648896	34.67414967	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	850	1135	0.010572687	0.006167401	2	oligos	OL-MS-2	12	6	6
GCTTCCATCCGTTGTC-1_7_G10	-14.99877965	9.855876708	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1340	1846	0.007583965	0.007583965	2	8	Astrocytes	12	6	6
GCTTGAACAGAAGCAC-1_7_G10	-11.54987701	15.52341671	11	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1448	2149	0.011167985	0.005583993	2	11	Glia-MIX	12	6	6
GCTTGAAGTGTAAGTA-1_7_G10	-3.381612925	33.71808497	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	884	1210	0.009917355	0.003305785	2	oligos	OL-MS-2	12	6	6
GCTTGAATCAAGAAGT-1_7_G10	29.24516044	-12.94863619	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4593	11433	0.015394035	0.012770052	2	2	EN-L4	12	6	6
GGAAAGCAGACAAGCC-1_7_G10	29.41563634	-12.94035563	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3693	7761	0.019198557	0.013529184	2	2	EN-L4	12	6	6
GGAAAGCAGGAATGGA-1_7_G10	-8.53218659	31.56389578	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1238	1700	0.007058824	0.007647059	2	oligos	OL-MS-2	12	6	6
GGAAAGCCAAACGCGA-1_7_G10	1.739104568	-17.2332845	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2601	5028	0.003778839	0.007756563	2	L2-3	EN-L2-3-MS	12	6	6
GGAAAGCGTCCAACTA-1_7_G10	1.002097378	-23.39893999	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3405	8516	0.006223579	0.003522781	2	L2-3	EN-L2-3-Cntl	12	6	6
GGAAAGCGTGTGGTTT-1_7_G10	2.232517777	6.326048706	7	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1075	1455	0.006872852	0.005498282	2	7	Phagocytes	12	6	6
GGAAAGCTCCCATTTA-1_7_G10	-2.410990193	35.73018647	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	789	1028	0.007782101	0.004863813	2	oligos	OL-MS-2	12	6	6
GGAACTTAGCTCCTTC-1_7_G10	16.65474208	11.51029252	1	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1358	2166	0.001846722	0.006925208	2	oligos	OL-Cntl	12	6	6
GGAACTTAGGAGTCTG-1_7_G10	8.32334451	-29.00278414	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	5644	19021	0.002944114	0.004100731	2	L2-3	EN-L2-3-Cntl	12	6	6
GGAACTTCAATCCGAT-1_7_G10	1.990914732	6.046622928	7	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1018	1327	0.008289375	0.004521477	2	7	Phagocytes	12	6	6
GGAACTTCACCAGCAC-1_7_G10	32.64563047	4.931506964	14	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1420	2003	0.012481278	0.006989516	2	14	Microglia	12	6	6
GGAACTTGTAGAGCTG-1_7_G10	-14.03083054	-16.34210143	6B	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1223	1779	0.018549747	0.006745363	2	6B	IN-SST	12	6	6
GGAACTTGTAGCGTGA-1_7_G10	-20.35364071	-18.70735717	6A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3438	7951	0.001006163	0.004024651	2	6A	IN-PV	12	6	6
GGAACTTTCACCAGGC-1_7_G10	-21.83458836	14.20301717	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1104	1626	0.009840098	0.009225092	2	8	Astrocytes	12	6	6
GGAACTTTCCTATGTT-1_7_G10	15.19754589	-21.51830347	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	5362	15927	0.013122371	0.006906511	2	L2-3	EN-L2-3-MS	12	6	6
GGAATAACACGGATAG-1_7_G10	22.47533222	27.0176846	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1047	1485	0.004040404	0.008080808	2	oligos	OL-MS-2	12	6	6
GGAATAACAGGAATCG-1_7_G10	6.299753085	-8.503906577	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2117	3597	0.003892132	0.008618293	2	L2-3	EN-L2-3-MS	12	6	6
GGAATAATCTAAGCCA-1_7_G10	31.97180061	-8.173893197	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3261	6799	0.016031769	0.010736873	2	2	EN-L4	12	6	6
GGACAAGAGATACACA-1_7_G10	-22.98079078	-23.97087653	6A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2955	6416	0.005766833	0.006078554	2	6A	IN-PV	12	6	6
GGACAAGCAGTACACT-1_7_G10	10.0948889	-0.097179873	12	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	957	1272	0.050314465	0.003930818	2	12	EN-MIX	12	6	6
GGACAAGCAGTTCCCT-1_7_G10	-3.59058474	32.81524978	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	906	1252	0.00798722	0.003194888	2	oligos	OL-MS-2	12	6	6
GGACAAGTCAAGATCC-1_7_G10	-18.70573595	-17.2521757	6B	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2420	4760	0.003781513	0.009663866	2	6B	IN-SST	12	6	6
GGACAAGTCACTGGGC-1_7_G10	-4.576529075	32.48347733	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	947	1329	0.006019564	0.002257336	2	oligos	OL-MS-2	12	6	6
GGACAGAAGCAAATCA-1_7_G10	-1.597386631	32.93791479	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1009	1422	0.007735584	0.004219409	2	oligos	OL-MS-2	12	6	6
GGACAGAAGCGTAGTG-1_7_G10	28.97121833	0.663477471	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2648	5396	0.000555967	0.010748703	2	2	EN-L4	12	6	6
GGACAGAAGGACAGCT-1_7_G10	-0.148351279	33.04267436	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	821	1109	0.00270514	0.004508566	2	oligos	OL-MS-2	12	6	6
GGACAGAAGGAGTTTA-1_7_G10	-9.692589402	-7.981255627	13A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1632	2795	0.022898032	0.007155635	2	13A	IN-VIP	12	6	6
GGACAGATCAGAGACG-1_7_G10	-10.79125033	-32.83750535	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1088	1553	0.062459755	0.0128783	2	16	EN-PYR	12	6	6
GGACAGATCATGCTCC-1_7_G10	2.403311332	5.601393596	7	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1070	1477	0.012186865	0.004739336	2	7	Phagocytes	12	6	6
GGACAGATCCGTTGTC-1_7_G10	-24.86564336	-1.703893291	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1572	2708	0.009970458	0.00295421	2	9	OPC	12	6	6
GGACATTCAACTGCGC-1_7_G10	-18.81437505	10.55243023	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	824	1076	0.019516729	0.00464684	2	8	Astrocytes	12	6	6
GGACATTGTAAGTGGC-1_7_G10	-6.523363834	35.3016805	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	809	1042	0.010556622	0.002879079	2	oligos	OL-MS-2	12	6	6
GGACATTGTAGAAGGA-1_7_G10	-10.77813578	-7.790536019	13A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1519	2170	0.011059908	0.00921659	2	13A	IN-VIP	12	6	6
GGACATTGTGGGTCAA-1_7_G10	-34.17290868	-7.141988746	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1195	1903	0.012611666	0.005254861	2	9	OPC	12	6	6
GGACATTTCAACGCTA-1_7_G10	-3.028846504	34.64067226	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	838	1155	0.005194805	0.007792208	2	oligos	OL-MS-2	12	6	6
GGACATTTCAAGAAGT-1_7_G10	19.55177031	-17.1927203	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	5835	17059	0.030247963	0.008499912	2	L2-3	EN-L2-3-MS	12	6	6
GGACATTTCCGCTGTT-1_7_G10	3.436578163	-21.65281447	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4313	11021	0.008529172	0.007531077	2	L2-3	EN-L2-3-MS	12	6	6
GGACATTTCGGTGTTA-1_7_G10	-8.735658617	-16.87827766	6B	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	767	1104	0.038043478	0.004528986	2	6B	IN-SST	12	6	6
GGACGTCAGCTAGTGG-1_7_G10	29.46081582	-10.98275452	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4281	10460	0.015296367	0.005162524	2	2	EN-L4	12	6	6
GGACGTCAGGACTGGT-1_7_G10	-2.601819266	36.20463299	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	805	1087	0.007359706	0.012879485	2	oligos	OL-MS-2	12	6	6
GGACGTCCAAGCGTAG-1_7_G10	-17.61125065	9.293191527	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	976	1284	0.003115265	0.007788162	2	8	Astrocytes	12	6	6
GGACGTCCAGTAAGAT-1_7_G10	-1.702042144	-17.69371369	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2779	6458	0.004026014	0.003871168	2	L2-3	EN-L2-3-Cntl	12	6	6
GGACGTCCATGGGAAC-1_7_G10	6.323814908	2.195514482	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1000	1251	0.020783373	0.007194245	2	16	EN-PYR	12	6	6
GGACGTCCATTGGTAC-1_7_G10	23.25422346	13.85220067	1	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1335	2190	0.003196347	0.003196347	2	oligos	OL-Cntl	12	6	6
GGACGTCTCGCCGTGA-1_7_G10	4.106202248	-14.91044425	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2399	4330	0.01039261	0.004618938	2	L2-3	EN-L2-3-MS	12	6	6
GGACGTCTCGTTTAGG-1_7_G10	-12.8518707	-0.981331208	13A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3182	6722	0.018000595	0.010264802	2	13A	IN-VIP	12	6	6
GGAGCAAAGACTGTAA-1_7_G10	-9.900564884	31.19422151	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	911	1174	0.017887564	0.004258944	2	oligos	OL-MS-2	12	6	6
GGAGCAAAGCAAATCA-1_7_G10	-7.191929188	34.66635223	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	828	1059	0.011331445	0.003777148	2	oligos	OL-MS-2	12	6	6
GGAGCAATCACGAAGG-1_7_G10	2.311276434	-15.62561831	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2287	4120	0.00461165	0.006553398	2	L2-3	EN-L2-3-MS	12	6	6
GGAGCAATCATGTCTT-1_7_G10	23.8951354	-12.33063923	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3454	8212	0.045299562	0.004018509	2	3	EN-L5-6	12	6	6
GGAGCAATCCTATTCA-1_7_G10	-0.0843405	35.04834883	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	742	1027	0.006815969	0.003894839	2	oligos	OL-MS-2	12	6	6
GGAGCAATCGCAGGCT-1_7_G10	-21.44468083	16.89776112	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1335	2068	0.006769826	0.005802708	2	8	Astrocytes	12	6	6
GGATGTTAGCACCGCT-1_7_G10	-6.81631248	-31.24887439	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	954	1279	0.068021892	0.010164191	2	16	EN-PYR	12	6	6
GGATGTTCACAACGCC-1_7_G10	-11.21406267	15.59664951	11	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1946	3184	0.005653266	0.006595477	2	11	Glia-MIX	12	6	6
GGATGTTCACAAGTAA-1_7_G10	-6.139424099	34.33430371	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	903	1187	0.00589722	0.00505476	2	oligos	OL-MS-2	12	6	6
GGATGTTCATGGTAGG-1_7_G10	24.70004455	0.948169143	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2275	4368	0.001831502	0.005723443	2	2	EN-L4	12	6	6
GGATGTTCATGGTCTA-1_7_G10	1.022172169	31.96499639	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	755	1024	0.006835938	0.000976563	2	oligos	OL-MS-2	12	6	6
GGATGTTGTGTAAGTA-1_7_G10	33.21920101	-5.260961467	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2875	5562	0.003955412	0.0062927	2	2	EN-L4	12	6	6
GGATGTTGTTATCACG-1_7_G10	3.503532473	-20.55983822	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3405	7427	0.010232934	0.00592433	2	L2-3	EN-L2-3-MS	12	6	6
GGATGTTTCAGGATCT-1_7_G10	31.14585757	-3.516043706	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3298	7591	0.011065736	0.003425109	2	2	EN-L4	12	6	6
GGATGTTTCCGTTGCT-1_7_G10	-0.801291043	34.85241671	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	874	1209	0.005789909	0.014061208	2	oligos	OL-MS-2	12	6	6
GGATTACAGCCACGTC-1_7_G10	12.00685708	33.51157771	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	802	1103	0.006346328	0.003626473	2	oligos	OL-MS-2	12	6	6
GGATTACCAAAGAATC-1_7_G10	-6.188654798	-30.61951621	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	803	1065	0.049765258	0.009389671	2	16	EN-PYR	12	6	6
GGATTACCAATAAGCA-1_7_G10	-16.91199435	-9.792715575	13B	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3226	7228	0.007609297	0.005949087	2	13B	IN-SV2C	12	6	6
GGATTACCACTGTGTA-1_7_G10	-7.152964567	35.1382388	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	887	1156	0.011245675	0.00432526	2	oligos	OL-MS-2	12	6	6
GGATTACGTCATCCCT-1_7_G10	2.039830643	-12.45740213	12	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1972	3539	0.009324668	0.003673354	2	12	EN-MIX	12	6	6
GGATTACGTCGAACAG-1_7_G10	33.28610796	-4.923530906	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2777	5587	0.008591373	0.006264543	2	2	EN-L4	12	6	6
GGATTACGTCTCTCTG-1_7_G10	-13.62381942	-19.12951062	6B	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1278	2156	0.012523191	0.003246753	2	6B	IN-SST	12	6	6
GGATTACGTTGTACAC-1_7_G10	1.901219687	-21.60888928	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3725	8976	0.006016043	0.006127451	2	L2-3	EN-L2-3-Cntl	12	6	6
GGCAATTAGAGCTATA-1_7_G10	31.46181373	-6.956188247	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3128	6549	0.012673691	0.007634753	2	2	EN-L4	12	6	6
GGCAATTAGCCAGTAG-1_7_G10	30.99334697	-10.80606828	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3719	8147	0.013992881	0.008469375	2	2	EN-L4	12	6	6
GGCAATTCAATGGATA-1_7_G10	-31.5510994	-11.88109075	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	845	1157	0.005185825	0.003457217	2	9	OPC	12	6	6
GGCAATTCACGACTCG-1_7_G10	-6.854975137	34.36271331	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	796	1058	0.026465028	0.003780718	2	oligos	OL-MS-2	12	6	6
GGCAATTCATATACCG-1_7_G10	25.71771886	-22.17903775	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	5818	18895	0.020693305	0.005451178	2	3	EN-L5-6	12	6	6
GGCAATTCATCCTTGC-1_7_G10	23.6940759	15.24722474	1	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1215	1857	0.006462036	0.002154012	2	oligos	OL-Cntl	12	6	6
GGCAATTGTCGACTAT-1_7_G10	-19.61325533	16.31007534	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1458	2208	0.00317029	0.00317029	2	8	Astrocytes	12	6	6
GGCAATTGTCGCTTTC-1_7_G10	8.241556249	-29.98775485	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4902	16240	0.001847291	0.00523399	2	L2-3	EN-L2-3-Cntl	12	6	6
GGCAATTTCCAAGTAC-1_7_G10	-31.86013499	-1.181770624	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1449	2282	0.003505697	0.004820333	2	9	OPC	12	6	6
GGCAATTTCGGATGTT-1_7_G10	-2.291561988	34.83210187	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	750	1002	0.007984032	0.001996008	2	oligos	OL-MS-2	12	6	6
GGCCGATAGAGCTGCA-1_7_G10	3.293958405	-21.03017474	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3449	7849	0.009555357	0.010064976	2	L2-3	EN-L2-3-MS	12	6	6
GGCCGATAGCAGACTG-1_7_G10	0.216442003	31.74943197	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	854	1182	0.00676819	0.002538071	2	oligos	OL-MS-2	12	6	6
GGCCGATCACGAAACG-1_7_G10	-0.289235807	-26.07771308	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	5322	17492	0.001200549	0.004116167	2	L2-3	EN-L2-3-Cntl	12	6	6
GGCCGATGTCCATGAT-1_7_G10	27.59602383	-13.19393887	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	6244	21523	0.051247503	0.004692654	2	2	EN-L4	12	6	6
GGCCGATTCACCGTAA-1_7_G10	-1.526977327	35.00260451	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	739	1004	0.009960159	0.003984064	2	oligos	OL-MS-2	12	6	6
GGCGACTAGTGCCAGA-1_7_G10	20.62653427	1.261403313	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1703	2918	0.018163125	0.005140507	2	2	EN-L4	12	6	6
GGCGACTCAAGGGTCA-1_7_G10	6.596375372	-14.89103877	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2581	4714	0.014637251	0.01145524	2	L2-3	EN-L2-3-MS	12	6	6
GGCGACTCAATCTACG-1_7_G10	-14.06863043	-3.907466684	13A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2912	6036	0.007289596	0.003644798	2	13A	IN-VIP	12	6	6
GGCGACTCACGCTTTC-1_7_G10	31.9482439	-10.16966053	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4407	10788	0.017334075	0.007971821	2	2	EN-L4	12	6	6
GGCGACTCAGATCCAT-1_7_G10	-11.29508177	15.19667241	11	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1710	2622	0.005720824	0.004195271	2	11	Glia-MIX	12	6	6
GGCGACTCAGGAATGC-1_7_G10	-12.90914743	7.392580938	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2129	3623	0.093292851	0.004692244	2	8	Astrocytes	12	6	6
GGCGACTCAGTACACT-1_7_G10	-2.675549695	-0.988306796	13A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2711	5780	0.012110727	0.005017301	2	13A	IN-VIP	12	6	6
GGCGACTGTTGAACTC-1_7_G10	-2.683574822	32.45186824	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	949	1287	0.010878011	0.005439005	2	oligos	OL-MS-2	12	6	6
GGCGTGTCAATGAATG-1_7_G10	31.25521928	-11.01438348	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3142	6195	0.018563358	0.008071025	2	2	EN-L4	12	6	6
GGCGTGTGTAACGTTC-1_7_G10	-17.4435152	9.37034148	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1069	1473	0.006788866	0.003394433	2	8	Astrocytes	12	6	6
GGCGTGTGTGTCAATC-1_7_G10	-8.546909437	-31.67502918	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	904	1248	0.048076923	0.007211538	2	16	EN-PYR	12	6	6
GGCGTGTTCTTGTCAT-1_7_G10	9.385738733	-7.835512335	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2170	4392	0.004098361	0.004326047	2	L2-3	EN-L2-3-Cntl	12	6	6
GGCTCGACACATGGGA-1_7_G10	-5.589010759	34.43758999	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	906	1233	0.00892133	0.00486618	2	oligos	OL-MS-2	12	6	6
GGCTCGAGTCAAAGCG-1_7_G10	7.621129572	-29.86915346	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4283	12415	0.003221909	0.002255336	2	L2-3	EN-L2-3-Cntl	12	6	6
GGCTCGAGTCGTTGTA-1_7_G10	-1.181354932	35.42868065	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	763	1013	0.005923001	0.003948667	2	oligos	OL-MS-2	12	6	6
GGCTCGATCCCAAGTA-1_7_G10	-9.411013662	-15.9323814	6B	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	909	1354	0.011816839	0.015509601	2	6B	IN-SST	12	6	6
GGCTCGATCTCCAGGG-1_7_G10	-17.09680299	9.02399922	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1084	1468	0.003405995	0.004768392	2	8	Astrocytes	12	6	6
GGCTGGTCAAGGTTTC-1_7_G10	1.127084045	-22.81412621	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4293	11647	0.002232335	0.00437881	2	L2-3	EN-L2-3-MS	12	6	6
GGCTGGTCACGGCGTT-1_7_G10	-14.32401881	18.32812056	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2200	3671	0.004903296	0.009534187	2	8	Astrocytes	12	6	6
GGCTGGTGTAAACGCG-1_7_G10	-16.42441145	-17.30468487	6B	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1737	3169	0.018302304	0.002524456	2	6B	IN-SST	12	6	6
GGCTGGTGTCTAGTCA-1_7_G10	-10.43835053	-32.73213369	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1122	1771	0.107848673	0.006775833	2	16	EN-PYR	12	6	6
GGCTGGTGTCTCATCC-1_7_G10	-19.81841322	10.40327264	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	879	1172	0.010238908	0.004266212	2	8	Astrocytes	12	6	6
GGCTGGTTCACGATGT-1_7_G10	23.45281382	1.050910094	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1947	3622	0.002208724	0.002208724	2	2	EN-L4	12	6	6
GGCTGGTTCAGCGACC-1_7_G10	-9.156198891	-12.63851331	6B	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1067	1720	0.072093023	0.002906977	2	6B	IN-SST	12	6	6
GGGAATGAGAAACCAT-1_7_G10	-9.180845741	33.97036586	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	790	1030	0.019417476	0.006796117	2	oligos	OL-MS-2	12	6	6
GGGAATGCAAACAACA-1_7_G10	-0.869746073	33.34072569	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	762	1034	0.006769826	0.003868472	2	oligos	OL-MS-2	12	6	6
GGGAATGCAGAGCCAA-1_7_G10	21.07000613	-2.492392425	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1970	3139	0.018158649	0.005097165	2	2	EN-L4	12	6	6
GGGAATGCAGCTGGCT-1_7_G10	-5.618968633	33.24073378	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1091	1559	0.05837075	0.005772931	2	oligos	OL-MS-2	12	6	6
GGGAATGGTCAATACC-1_7_G10	17.21879091	-16.85976571	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	6383	21569	0.018220594	0.008391673	2	L2-3	EN-L2-3-MS	12	6	6
GGGAATGTCCACTCCA-1_7_G10	-1.305788643	32.9103319	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	844	1170	0.003418803	0.002564103	2	oligos	OL-MS-2	12	6	6
GGGAATGTCCAGATCA-1_7_G10	-1.065033269	33.17835389	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	871	1213	0.008244023	0.004122012	2	oligos	OL-MS-2	12	6	6
GGGACCTCAAGCGATG-1_7_G10	-11.91867342	16.21097269	11	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1458	2217	0.00270636	0.0022553	2	11	Glia-MIX	12	6	6
GGGACCTCACTTCGAA-1_7_G10	21.64379112	12.62599326	1	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1332	2121	0.002357379	0.003771806	2	oligos	OL-Cntl	12	6	6
GGGACCTCATATACGC-1_7_G10	34.02406898	7.275356209	14	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	883	1081	0.004625347	0.008325624	2	14	Microglia	12	6	6
GGGACCTGTTCCAACA-1_7_G10	-11.01900621	15.14493984	11	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1304	1877	0.005860416	0.004794885	2	11	Glia-MIX	12	6	6
GGGAGATAGATCCCGC-1_7_G10	-3.898573496	33.58855905	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	868	1180	0.008474576	0.002542373	2	oligos	OL-MS-2	12	6	6
GGGAGATAGGCTCTTA-1_7_G10	3.474076012	-11.34653202	12	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1833	3050	0.013114754	0.004262295	2	12	EN-MIX	12	6	6
GGGAGATCAACTGGCC-1_7_G10	-0.54119619	35.56974942	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	865	1245	0.004819277	0.008032129	2	oligos	OL-MS-2	12	6	6
GGGAGATCAAGTTGTC-1_7_G10	-0.151165563	32.25426337	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	805	1123	0.00445236	0.003561888	2	oligos	OL-MS-2	12	6	6
GGGAGATCACCGAATT-1_7_G10	-6.07975263	-1.792418506	13A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1488	2483	0.007652034	0.005235602	2	13A	IN-VIP	12	6	6
GGGAGATCATTACCTT-1_7_G10	19.05051013	-17.43604452	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	5765	17752	0.024673276	0.004450203	2	L2-3	EN-L2-3-MS	12	6	6
GGGAGATGTCCAGTTA-1_7_G10	2.339471288	-10.62329554	12	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1493	2370	0.001687764	0.00464135	2	12	EN-MIX	12	6	6
GGGAGATTCTACTATC-1_7_G10	15.23621892	-27.41929236	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3170	7110	0.009423347	0.00323488	2	3	EN-L5-6	12	6	6
GGGATGAAGCTCTCGG-1_7_G10	-0.97203405	35.49150963	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	757	1008	0.006944444	0.008928571	2	oligos	OL-MS-2	12	6	6
GGGATGAAGGTGATAT-1_7_G10	17.97760479	-27.39005796	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4355	10932	0.008141237	0.006494694	2	3	EN-L5-6	12	6	6
GGGATGACAAACAACA-1_7_G10	20.52293779	27.29233104	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	877	1229	0.008136697	0.001627339	2	oligos	OL-MS-2	12	6	6
GGGATGACACAAGCCC-1_7_G10	-19.89379786	-26.85016524	6A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3087	6945	0.004031677	0.002591793	2	6A	IN-PV	12	6	6
GGGATGACATGGATGG-1_7_G10	-3.34240925	34.72270449	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	801	1055	0.013270142	0.002843602	2	oligos	OL-MS-2	12	6	6
GGGATGAGTCTAGCGC-1_7_G10	26.43055592	-24.87717931	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	5004	15642	0.026786856	0.003196522	2	3	EN-L5-6	12	6	6
GGGATGAGTGCAACTT-1_7_G10	-9.625955419	31.79833338	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	858	1145	0.027947598	0.005240175	2	oligos	OL-MS-2	12	6	6
GGGATGAGTGCAGACA-1_7_G10	27.40238363	-15.4913484	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	5838	17459	0.02543101	0.009164328	2	2	EN-L4	12	6	6
GGGATGATCAGCATGT-1_7_G10	11.2558858	-2.679821862	12	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1348	1945	0.027763496	0.011311054	2	12	EN-MIX	12	6	6
GGGATGATCGAACGGA-1_7_G10	-22.06435004	15.98395326	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1290	1975	0.012658228	0.00556962	2	8	Astrocytes	12	6	6
GGGATGATCTCTTGAT-1_7_G10	28.76550062	4.85817459	15DA	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	903	1161	0.05081826	0.021533161	2	15DA	T cells	12	6	6
GGGATGATCTTCATGT-1_7_G10	1.295760726	-25.85342617	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3246	7509	0.003728859	0.002130776	2	L2-3	EN-L2-3-Cntl	12	6	6
GGGCACTAGCTAAACA-1_7_G10	3.119581251	-14.13231383	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2153	3770	0.00795756	0.006366048	2	L2-3	EN-L2-3-MS	12	6	6
GGGCACTCACAGACTT-1_7_G10	-7.766359408	-29.65855581	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	929	1351	0.094744634	0.007401925	2	16	EN-PYR	12	6	6
GGGCACTCATCACAAC-1_7_G10	24.88652397	-20.89990342	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4128	11211	0.026224244	0.004370707	2	3	EN-L5-6	12	6	6
GGGCACTCATCATCCC-1_7_G10	-3.231688512	35.27961151	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	751	1015	0.009852217	0.00591133	2	oligos	OL-MS-2	12	6	6
GGGCACTGTCGCATAT-1_7_G10	-21.75922399	14.65415031	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1178	1832	0.003820961	0.003275109	2	8	Astrocytes	12	6	6
GGGCATCGTAAGTTCC-1_7_G10	21.6585055	-3.299409148	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2219	3723	0.015578834	0.005103411	2	2	EN-L4	12	6	6
GGGCATCGTCATGCAT-1_7_G10	3.626010179	-23.63025644	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3806	8772	0.008207934	0.008549932	2	L2-3	EN-L2-3-MS	12	6	6
GGGCATCGTGCACGAA-1_7_G10	8.328368608	-11.51764579	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2103	3597	0.003892132	0.014178482	2	L2-3	EN-L2-3-MS	12	6	6
GGGTCTGAGATGCCAG-1_7_G10	-21.56115395	15.66158235	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1256	2038	0.00686948	0.00686948	2	8	Astrocytes	12	6	6
GGGTCTGAGGAATCGC-1_7_G10	20.9751516	26.35636664	1	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	971	1355	0.00295203	0.00295203	2	oligos	OL-Cntl	12	6	6
GGGTCTGAGGGATCTG-1_7_G10	13.69330248	-31.06064718	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3597	9081	0.004514921	0.003744081	2	3	EN-L5-6	12	6	6
GGGTCTGAGTGCGTGA-1_7_G10	6.410127145	-13.69927137	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2320	4113	0.013372234	0.004619499	2	L2-3	EN-L2-3-MS	12	6	6
GGGTCTGAGTTTGCGT-1_7_G10	-20.03186772	-25.81516274	6A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2449	4971	0.003017502	0.005230336	2	6A	IN-PV	12	6	6
GGGTCTGCATGATCCA-1_7_G10	14.61569643	-29.85196766	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4487	12267	0.004320535	0.006277003	2	3	EN-L5-6	12	6	6
GGGTCTGGTAAGTTCC-1_7_G10	23.89278906	26.8864897	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1319	1971	0.005073567	0.00608828	2	oligos	OL-MS-2	12	6	6
GGGTCTGGTTACGACT-1_7_G10	23.4117916	26.14572035	1	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1103	1599	0.002501563	0.0068793	2	oligos	OL-Cntl	12	6	6
GGGTCTGGTTCGGGCT-1_7_G10	-3.68703196	34.37251443	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	833	1119	0.006255585	0.002680965	2	oligos	OL-MS-2	12	6	6
GGGTCTGTCCGAACGC-1_7_G10	-4.596973587	35.44585026	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	904	1176	0.011904762	0.004251701	2	oligos	OL-MS-2	12	6	6
GGGTTGCAGCCCAACC-1_7_G10	21.68253463	27.29746623	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	966	1388	0.003602305	0.003602305	2	oligos	OL-MS-2	12	6	6
GGGTTGCAGTACTTGC-1_7_G10	-0.506214692	34.6537935	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	802	1094	0.006398537	0.007312614	2	oligos	OL-MS-2	12	6	6
GGGTTGCAGTGGTAGC-1_7_G10	31.73044573	-3.836358971	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2989	6272	0.004623724	0.00908801	2	2	EN-L4	12	6	6
GGGTTGCCAAGCGTAG-1_7_G10	2.084645382	-19.19800251	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2814	5581	0.004658663	0.006092098	2	L2-3	EN-L2-3-MS	12	6	6
GGGTTGCCACTACAGT-1_7_G10	0.480640727	35.02496073	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	846	1225	0.006530612	0.003265306	2	oligos	OL-MS-2	12	6	6
GGGTTGCCAGGACGTA-1_7_G10	0.621413242	33.63305836	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	728	1028	0.006809339	0.010700389	2	oligos	OL-MS-2	12	6	6
GGGTTGCCAGGCTGAA-1_7_G10	-1.442323349	34.25725983	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	816	1126	0.005328597	0.006216696	2	oligos	OL-MS-2	12	6	6
GGGTTGCCATCAGTAC-1_7_G10	-21.80129222	15.23180093	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1160	1747	0.004579279	0.004006869	2	8	Astrocytes	12	6	6
GGGTTGCGTCAATACC-1_7_G10	2.226526139	-16.64792371	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2544	4971	0.005632669	0.005431503	2	L2-3	EN-L2-3-MS	12	6	6
GGGTTGCGTCAATGTC-1_7_G10	-15.51502993	-18.57181832	6A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1576	2802	0.007137759	0.003211991	2	6A	IN-PV	12	6	6
GGGTTGCGTTCCCGAG-1_7_G10	-0.733555649	31.8935801	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	950	1346	0.004457652	0.007429421	2	oligos	OL-MS-2	12	6	6
GGTATTGAGCGCCTTG-1_7_G10	22.620191	13.32525917	1	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1258	1963	0.001528273	0.002037697	2	oligos	OL-Cntl	12	6	6
GGTATTGAGCTGTCTA-1_7_G10	30.53805835	-0.978248792	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3016	6186	0.00242483	0.004364694	2	2	EN-L4	12	6	6
GGTATTGCACCAGGCT-1_7_G10	-17.91431062	8.78035978	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1085	1488	0.005376344	0.004704301	2	8	Astrocytes	12	6	6
GGTATTGCAGCCTGTG-1_7_G10	-15.11754487	-9.463117335	13B	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2045	3698	0.006489995	0.003515414	2	13B	IN-SV2C	12	6	6
GGTATTGGTCGCGTGT-1_7_G10	0.650681956	-22.16290753	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3316	7710	0.003372244	0.006225681	2	L2-3	EN-L2-3-Cntl	12	6	6
GGTATTGGTGCTGTAT-1_7_G10	-9.645786406	-17.23797306	6B	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	877	1295	0.022393822	0.005405405	2	6B	IN-SST	12	6	6
GGTATTGTCCCAAGTA-1_7_G10	-3.83969877	35.52603354	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	753	1012	0.010869565	0.005928854	2	oligos	OL-MS-2	12	6	6
GGTATTGTCCTAGGGC-1_7_G10	-2.756657462	31.83844365	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	984	1392	0.005747126	0.003591954	2	oligos	OL-MS-2	12	6	6
GGTGAAGAGACATAAC-1_7_G10	-9.157036561	34.08639943	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	802	1011	0.016815035	0.004945598	2	oligos	OL-MS-2	12	6	6
GGTGAAGAGCAGACTG-1_7_G10	24.83557935	-28.02700546	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3117	7112	0.007452193	0.005905512	2	3	EN-L5-6	12	6	6
GGTGAAGAGGACCACA-1_7_G10	12.19624516	-21.81517291	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	5059	14112	0.011550454	0.006094104	2	L2-3	EN-L2-3-MS	12	6	6
GGTGAAGGTTCCGGCA-1_7_G10	29.63654871	-5.897623242	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3649	8284	0.005311444	0.007605022	2	2	EN-L4	12	6	6
GGTGCGTAGAGGTTGC-1_7_G10	30.62977044	-0.961352857	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2838	5934	0.003033367	0.005392653	2	2	EN-L4	12	6	6
GGTGCGTAGAGTCGGT-1_7_G10	-4.170890089	35.78340226	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	794	1061	0.020735156	0.009425071	2	oligos	OL-MS-2	12	6	6
GGTGCGTAGCAAATCA-1_7_G10	-0.370345125	34.187358	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	753	1044	0.007662835	0.004789272	2	oligos	OL-MS-2	12	6	6
GGTGCGTAGCACCGTC-1_7_G10	-18.62412437	8.852342218	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	787	1003	0.017946162	0.004985045	2	8	Astrocytes	12	6	6
GGTGCGTAGCTAACAA-1_7_G10	-22.54049736	15.42702467	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1180	1841	0.001629549	0.004888647	2	8	Astrocytes	12	6	6
GGTGCGTAGCTAGTCT-1_7_G10	2.567939984	5.265858577	7	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1184	1586	0.005044136	0.007566204	2	7	Phagocytes	12	6	6
GGTGCGTAGTGACATA-1_7_G10	-0.693739878	34.7801738	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	814	1065	0.00657277	0.004694836	2	oligos	OL-MS-2	12	6	6
GGTGCGTCACGGTGTC-1_7_G10	19.92209426	24.63997302	1	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1057	1507	0.00464499	0.01260783	2	oligos	OL-Cntl	12	6	6
GGTGCGTGTGGCAAAC-1_7_G10	22.36856123	25.65192169	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1057	1647	0.007893139	0.013964784	2	oligos	OL-MS-2	12	6	6
GGTGCGTGTGTTGAGG-1_7_G10	31.30695454	-10.07528855	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3315	6813	0.030529869	0.007338911	2	2	EN-L4	12	6	6
GGTGCGTGTTCCGGCA-1_7_G10	-18.75064863	-16.93402015	6B	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2217	4292	0.012348555	0.009319664	2	6B	IN-SST	12	6	6
GGTGCGTTCCAACCAA-1_7_G10	-26.20243255	-7.39512595	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1005	1465	0.004778157	0.004095563	2	9	OPC	12	6	6
GGTGCGTTCTACGAGT-1_7_G10	-2.584426785	32.59090008	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	964	1355	0.006642066	0.00295203	2	oligos	OL-MS-2	12	6	6
GGTGCGTTCTTAACCT-1_7_G10	-6.291421305	-30.67103861	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	775	1041	0.033621518	0.007684918	2	16	EN-PYR	12	6	6
GGTGTTACAAACCTAC-1_7_G10	31.46994138	-1.756085381	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2798	5678	0.002994012	0.003522367	2	2	EN-L4	12	6	6
GGTGTTACATGCTGGC-1_7_G10	-24.22818508	-12.02115018	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1048	1239	0.00968523	0.008878128	2	9	OPC	12	6	6
GGTGTTAGTAATTGGA-1_7_G10	-3.891738744	35.84681515	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	769	1032	0.010658915	0.007751938	2	oligos	OL-MS-2	12	6	6
GGTGTTAGTATGAAAC-1_7_G10	-23.80754202	-0.668568158	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1585	2547	0.007852375	0.006674519	2	9	OPC	12	6	6
GGTGTTATCACATAGC-1_7_G10	15.96990417	-29.82149969	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4824	14073	0.006253109	0.011085056	2	3	EN-L5-6	12	6	6
GTAACGTCAAGCGCTC-1_7_G10	-20.22698466	11.21979019	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	963	1317	0.004555809	0.000759301	2	8	Astrocytes	12	6	6
GTAACGTCAATCTACG-1_7_G10	-14.98303528	11.49374116	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1502	2296	0.00174216	0.007404181	2	8	Astrocytes	12	6	6
GTAACGTCAGCGTTCG-1_7_G10	22.37173673	26.95885585	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1105	1555	0.01221865	0.003215434	2	oligos	OL-MS-2	12	6	6
GTAACGTCAGCTGCAC-1_7_G10	-20.1100259	14.75928626	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1314	1943	0.007205353	0.009264025	2	8	Astrocytes	12	6	6
GTAACGTGTATAGTAG-1_7_G10	27.34449901	4.440367643	15BA	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	824	1038	0.022157996	0.01734104	2	15BA	Stromal cells	12	6	6
GTAACGTGTCCGAATT-1_7_G10	-22.93311209	27.1127431	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1687	2832	0.002824859	0.004237288	2	8	Astrocytes	12	6	6
GTAACGTGTGCAACGA-1_7_G10	30.30974939	-7.655929928	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4367	11324	0.006181561	0.008124338	2	2	EN-L4	12	6	6
GTAACGTTCCATGCTC-1_7_G10	1.798883957	-22.63289527	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3843	9927	0.004835298	0.004533092	2	L2-3	EN-L2-3-Cntl	12	6	6
GTAACTGAGAGCCTAG-1_7_G10	3.278869697	-21.26122783	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3801	9238	0.008659883	0.002706213	2	L2-3	EN-L2-3-MS	12	6	6
GTAACTGAGGAATGGA-1_7_G10	-17.10894037	7.252093685	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	809	1094	0.004570384	0.003656307	2	8	Astrocytes	12	6	6
GTAACTGCACCTGGTG-1_7_G10	0.371242992	33.91417725	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	731	1012	0.005928854	0.004940711	2	oligos	OL-MS-2	12	6	6
GTAACTGGTTGAGTTC-1_7_G10	17.73645521	-5.527918651	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1373	2352	0.006377551	0.003401361	2	3	EN-L5-6	12	6	6
GTAACTGGTTTCGCTC-1_7_G10	11.35784099	-28.92437853	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	6882	29132	0.00748318	0.003089386	2	3	EN-L5-6	12	6	6
GTAACTGTCATATCGG-1_7_G10	3.202008429	-21.02036478	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3828	9390	0.020021299	0.007348243	2	L2-3	EN-L2-3-MS	12	6	6
GTAACTGTCTAACTTC-1_7_G10	-21.43263904	16.59474832	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1295	2147	0.022356777	0.003260363	2	8	Astrocytes	12	6	6
GTACGTACACAGAGGT-1_7_G10	-5.741170795	35.43556693	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	746	1006	0.00695825	0.004970179	2	oligos	OL-MS-2	12	6	6
GTACGTACATGGTTGT-1_7_G10	-0.553063202	32.39904791	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	945	1325	0.00754717	0.009056604	2	oligos	OL-MS-2	12	6	6
GTACGTAGTACGCACC-1_7_G10	23.46446333	26.77916474	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1127	1655	0.006042296	0.006646526	2	oligos	OL-MS-2	12	6	6
GTACGTATCAGTGCAT-1_7_G10	-6.179329894	-29.97938461	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	749	1011	0.083086053	0.013847676	2	16	EN-PYR	12	6	6
GTACGTATCAGTTTGG-1_7_G10	-12.0363636	16.21413744	11	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1337	1976	0.003036437	0.002024291	2	11	Glia-MIX	12	6	6
GTACGTATCCCTAACC-1_7_G10	-6.10791599	33.80939508	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	958	1290	0.012403101	0.005426357	2	oligos	OL-MS-2	12	6	6
GTACGTATCGGTGTCG-1_7_G10	-7.903818945	0.575724251	13A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2048	4005	0.005243446	0.009238452	2	13A	IN-VIP	12	6	6
GTACTCCCAACTGGCC-1_7_G10	-1.496804715	35.61372057	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	709	1009	0.006937562	0.002973241	2	oligos	OL-MS-2	12	6	6
GTACTCCCACATGGGA-1_7_G10	-5.791327372	33.74119483	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	993	1347	0.009651076	0.005196733	2	oligos	OL-MS-2	12	6	6
GTACTCCCACGTTGGC-1_7_G10	25.66228631	-27.21241585	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4132	10953	0.004564959	0.00337807	2	3	EN-L5-6	12	6	6
GTACTCCGTACCGTTA-1_7_G10	-9.140763759	34.12356751	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	793	1027	0.017526777	0.005842259	2	oligos	OL-MS-2	12	6	6
GTACTCCGTAGCTCCG-1_7_G10	2.090793618	5.211263714	7	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	990	1237	0.014551334	0.009700889	2	7	Phagocytes	12	6	6
GTACTCCGTCATGCAT-1_7_G10	-31.96031876	-1.22111187	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1495	2306	0.009106678	0.004770165	2	9	OPC	12	6	6
GTACTCCTCAACGGCC-1_7_G10	-17.83921233	8.938060338	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	889	1150	0.007826087	0.007826087	2	8	Astrocytes	12	6	6
GTACTCCTCACCATAG-1_7_G10	33.87839971	7.295833585	14	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	895	1167	0.032562125	0.006855184	2	14	Microglia	12	6	6
GTACTCCTCCAGGGCT-1_7_G10	-0.960515476	33.73841656	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	824	1093	0.007319305	0.005489478	2	oligos	OL-MS-2	12	6	6
GTACTCCTCTGCGTAA-1_7_G10	-26.22493341	-8.083702736	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1040	1387	0.012256669	0.008651766	2	9	OPC	12	6	6
GTACTTTAGTTGAGAT-1_7_G10	32.90308351	-5.923602839	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3123	6478	0.01914171	0.005248533	2	2	EN-L4	12	6	6
GTACTTTCAACTGGCC-1_7_G10	-7.47003185	35.65271384	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	804	1037	0.015429122	0.012536162	2	oligos	OL-MS-2	12	6	6
GTACTTTCAAGCCCAC-1_7_G10	-22.65554104	12.34577883	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1008	1462	0.017783858	0.003419973	2	8	Astrocytes	12	6	6
GTACTTTCAGATGGCA-1_7_G10	-14.47828179	-10.15897803	13B	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1816	3201	0.015620119	0.004373633	2	13B	IN-SV2C	12	6	6
GTACTTTGTACCGTAT-1_7_G10	-25.09015074	-6.338969527	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1269	1868	0.008029979	0.004282655	2	9	OPC	12	6	6
GTACTTTGTGGTCCGT-1_7_G10	30.42283907	-5.509414716	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3195	6765	0.00443459	0.007982262	2	2	EN-L4	12	6	6
GTACTTTTCCCAGGTG-1_7_G10	-11.23712155	32.47740717	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1077	1419	0.011275546	0.00845666	2	oligos	OL-MS-2	12	6	6
GTAGGCCAGGAACTGC-1_7_G10	-13.24206828	-3.410773868	13A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2563	4522	0.021008403	0.013931889	2	13A	IN-VIP	12	6	6
GTAGGCCAGGACAGCT-1_7_G10	-9.453376905	-3.257686753	13A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1902	3180	0.009748428	0.008490566	2	13A	IN-VIP	12	6	6
GTAGGCCAGTATGACA-1_7_G10	-9.254215087	31.69155118	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1064	1578	0.06590621	0.006337136	2	oligos	OL-MS-2	12	6	6
GTAGGCCAGTTCGCAT-1_7_G10	-9.660598069	22.24207029	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1270	1734	0.012110727	0.006343714	2	8	Astrocytes	12	6	6
GTAGGCCCAATGACCT-1_7_G10	-10.29015245	30.47103175	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	849	1064	0.010338346	0.007518797	2	oligos	OL-MS-2	12	6	6
GTAGGCCCATTGGTAC-1_7_G10	24.09939861	-12.60974875	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3883	8659	0.022519921	0.008084074	2	3	EN-L5-6	12	6	6
GTAGGCCGTGCACCAC-1_7_G10	-20.39817993	-26.88610171	6A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3037	6918	0.00318011	0.005059266	2	6A	IN-PV	12	6	6
GTAGTCAAGACCACGA-1_7_G10	1.548717613	-21.32317995	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3858	9649	0.004560058	0.003212768	2	L2-3	EN-L2-3-MS	12	6	6
GTAGTCAAGACGCACA-1_7_G10	-9.725656524	34.50256389	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	833	1223	0.141455437	0.009811938	2	oligos	OL-MS-2	12	6	6
GTAGTCAAGATGTGGC-1_7_G10	-6.394763821	-29.54464151	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	837	1130	0.072566372	0.008849558	2	16	EN-PYR	12	6	6
GTAGTCAAGATGTTAG-1_7_G10	-9.475604321	-20.2607017	6A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	865	1326	0.012820513	0.001508296	2	6A	IN-PV	12	6	6
GTAGTCAAGCAGCGTA-1_7_G10	-9.318740889	-32.49287671	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1017	1402	0.05278174	0.013552068	2	16	EN-PYR	12	6	6
GTAGTCAAGCCAGTAG-1_7_G10	-14.79712633	-3.777522514	13A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4227	9899	0.011415294	0.008283665	2	13A	IN-VIP	12	6	6
GTAGTCAAGCTGAAAT-1_7_G10	-6.443402343	34.84426183	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	850	1137	0.006156552	0.006156552	2	oligos	OL-MS-2	12	6	6
GTAGTCAAGGAATTAC-1_7_G10	29.30829469	-6.028458769	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4571	12043	0.004151789	0.007805364	2	2	EN-L4	12	6	6
GTAGTCACAAAGTCAA-1_7_G10	-25.50805599	-22.93133004	6A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3786	9230	0.049837486	0.007042254	2	6A	IN-PV	12	6	6
GTAGTCACATCGTCGG-1_7_G10	1.10566805	32.8301959	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	866	1227	0.002444988	0.00407498	2	oligos	OL-MS-2	12	6	6
GTAGTCAGTCGGCACT-1_7_G10	33.21374612	6.11377158	14	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	879	1094	0.010054845	0.012797075	2	14	Microglia	12	6	6
GTAGTCAGTGCCTGTG-1_7_G10	-12.96264418	-17.61101775	6B	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1083	1686	0.002965599	0.002372479	2	6B	IN-SST	12	6	6
GTAGTCAGTGCTAGCC-1_7_G10	4.151199951	-11.23841209	12	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1767	2917	0.006856359	0.002399726	2	12	EN-MIX	12	6	6
GTAGTCATCGAACGGA-1_7_G10	-22.56508744	15.08789932	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1022	1528	0.005235602	0.005235602	2	8	Astrocytes	12	6	6
GTAGTCATCTCCTATA-1_7_G10	-9.965512216	-12.99287036	6B	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	865	1175	0.018723404	0.006808511	2	6B	IN-SST	12	6	6
GTATCTTAGAGCTTCT-1_7_G10	24.76817918	-17.79125893	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4167	10674	0.02295297	0.008244332	2	3	EN-L5-6	12	6	6
GTATCTTCACGGTAGA-1_7_G10	2.810676298	-28.0996171	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3105	7170	0.00195258	0.00376569	2	L2-3	EN-L2-3-Cntl	12	6	6
GTATCTTCAGTCCTTC-1_7_G10	31.17545351	-7.869478165	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3660	8860	0.014559819	0.008126411	2	2	EN-L4	12	6	6
GTATCTTCATTAGCCA-1_7_G10	13.54772849	-21.94814075	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	5780	18558	0.015357258	0.005065201	2	L2-3	EN-L2-3-MS	12	6	6
GTATCTTGTCCGTTAA-1_7_G10	-31.8695473	-2.211129068	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1226	1952	0.00307377	0.001536885	2	9	OPC	12	6	6
GTATCTTTCCCATTAT-1_7_G10	3.849510675	0.731051997	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	984	1301	0.055342045	0.007686395	2	16	EN-PYR	12	6	6
GTATTCTAGAGCTATA-1_7_G10	-9.854671116	-0.025516507	13A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2379	4967	0.010871754	0.003825247	2	13A	IN-VIP	12	6	6
GTATTCTAGCCACGTC-1_7_G10	-0.694195143	34.73239537	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	873	1220	0.007377049	0.013114754	2	oligos	OL-MS-2	12	6	6
GTATTCTAGTCGTACT-1_7_G10	22.30912529	27.91073132	1	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	986	1452	0.004132231	0.002754821	2	oligos	OL-Cntl	12	6	6
GTATTCTCATCCGCGA-1_7_G10	29.85503185	-0.400047789	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3225	7822	0.003451803	0.003579647	2	2	EN-L4	12	6	6
GTATTCTGTATTCTCT-1_7_G10	31.01585467	-7.073862281	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3319	7327	0.007370001	0.006414631	2	2	EN-L4	12	6	6
GTATTCTGTCACTGGC-1_7_G10	-5.922623999	31.0641186	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1310	1924	0.00987526	0.007796258	2	oligos	OL-MS-2	12	6	6
GTATTCTGTGCTTCTC-1_7_G10	33.21475652	6.227137513	14	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	863	1067	0.008434864	0.004686036	2	14	Microglia	12	6	6
GTATTCTGTGGTTTCA-1_7_G10	-31.90404476	-1.660508462	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1364	2215	0.00496614	0.001805869	2	9	OPC	12	6	6
GTATTCTTCCCGACTT-1_7_G10	-1.667730701	32.70643741	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	854	1251	0.019184652	0.003197442	2	oligos	OL-MS-2	12	6	6
GTATTCTTCGCCTGAG-1_7_G10	-26.39034923	-7.929425874	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1170	1738	0.006904488	0.004602992	2	9	OPC	12	6	6
GTCAAGTAGCAGCGTA-1_7_G10	-6.037023819	-31.22136744	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	813	1230	0.149593496	0.012195122	2	16	EN-PYR	12	6	6
GTCAAGTCACGTTGGC-1_7_G10	-0.658174053	32.44627466	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	849	1124	0.002669039	0.010676157	2	oligos	OL-MS-2	12	6	6
GTCAAGTCAGACAAGC-1_7_G10	-11.95358636	-0.269206588	13A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2783	6009	0.00282909	0.006989516	2	13A	IN-VIP	12	6	6
GTCAAGTGTATAGGTA-1_7_G10	31.15592799	-10.14263049	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3643	7781	0.021076982	0.008867755	2	2	EN-L4	12	6	6
GTCAAGTGTCCCTTGT-1_7_G10	-34.96446066	-6.157857428	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1213	2018	0.003468781	0.00099108	2	9	OPC	12	6	6
GTCAAGTTCGAGGTAG-1_7_G10	5.71903274	-15.45844616	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2724	4958	0.009277935	0.005849133	2	L2-3	EN-L2-3-MS	12	6	6
GTCACAACACAACGCC-1_7_G10	22.54841756	26.92352676	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1071	1532	0.005874674	0.004569191	2	oligos	OL-MS-2	12	6	6
GTCACAACACCAGATT-1_7_G10	16.7113752	13.12049722	1	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1406	2348	0.003407155	0.005962521	2	oligos	OL-Cntl	12	6	6
GTCACAACACGAGGTA-1_7_G10	-21.35847926	16.90286701	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1406	2160	0.002777778	0.00462963	2	8	Astrocytes	12	6	6
GTCACAATCACGGTTA-1_7_G10	21.59551967	-20.81195474	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4780	12947	0.018228161	0.007801035	2	3	EN-L5-6	12	6	6
GTCACAATCCTGCCAT-1_7_G10	22.53705013	27.20110104	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1011	1473	0.004752206	0.00610998	2	oligos	OL-MS-2	12	6	6
GTCACGGAGAAGGGTA-1_7_G10	9.246564322	-7.376489293	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2088	4350	0.004827586	0.002988506	2	L2-3	EN-L2-3-Cntl	12	6	6
GTCACGGAGAGATGAG-1_7_G10	-25.85972538	-5.634060375	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1283	1886	0.004241782	0.002120891	2	9	OPC	12	6	6
GTCACGGAGATGTCGG-1_7_G10	-0.973555386	34.32854541	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	844	1201	0.004995837	0.001665279	2	oligos	OL-MS-2	12	6	6
GTCACGGCAAGTACCT-1_7_G10	-25.53638215	-6.145433591	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1246	1856	0.00700431	0.002155172	2	9	OPC	12	6	6
GTCACGGCACAGGAGT-1_7_G10	-3.038986174	35.24083224	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	780	1065	0.007511737	0.004694836	2	oligos	OL-MS-2	12	6	6
GTCACGGGTTATGTGC-1_7_G10	1.704241557	32.90818683	1	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	791	1161	0.002583979	0.003445306	2	oligos	OL-Cntl	12	6	6
GTCACGGGTTGCGCAC-1_7_G10	-8.03583002	-0.544337767	13A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2025	3948	0.002786221	0.004812563	2	13A	IN-VIP	12	6	6
GTCATTTAGACTAGAT-1_7_G10	-0.263147034	0.990308806	11	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1788	2593	0.003856537	0.016197455	2	11	Glia-MIX	12	6	6
GTCATTTAGGCGCTCT-1_7_G10	6.734636196	-24.94588315	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	5632	18202	0.009394572	0.005274146	2	L2-3	EN-L2-3-MS	12	6	6
GTCATTTCAAGGTTCT-1_7_G10	10.64711172	-19.56080407	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4395	11346	0.014366296	0.007667901	2	L2-3	EN-L2-3-MS	12	6	6
GTCATTTCAAGTCTAC-1_7_G10	23.71150486	14.87188722	1	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1308	2050	0.00097561	0.00195122	2	oligos	OL-Cntl	12	6	6
GTCATTTCATTCGACA-1_7_G10	-12.90969146	3.211656078	13A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2528	4911	0.00855223	0.005090613	2	13A	IN-VIP	12	6	6
GTCATTTGTCCAGTTA-1_7_G10	10.72031416	-34.13737414	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	6554	28351	0.004726465	0.002962858	2	3	EN-L5-6	12	6	6
GTCATTTTCAGCGATT-1_7_G10	26.90736969	-2.683350151	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2836	6196	0.002098128	0.0029051	2	2	EN-L4	12	6	6
GTCCTCACACGCGAAA-1_7_G10	-14.684151	-3.62804231	13A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4003	9339	0.010493629	0.008137916	2	13A	IN-VIP	12	6	6
GTCCTCACACGCTTTC-1_7_G10	16.03790239	-29.1268475	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4864	14478	0.008426578	0.007874016	2	3	EN-L5-6	12	6	6
GTCCTCACATTCGACA-1_7_G10	-34.09186341	-8.67858151	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1036	1533	0.008480104	0.003913894	2	9	OPC	12	6	6
GTCGGGTAGGCGACAT-1_7_G10	-7.810423114	-6.146527856	13A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1392	2215	0.013544018	0.006320542	2	13A	IN-VIP	12	6	6
GTCGGGTCATGTAAGA-1_7_G10	-16.40260098	-16.79712631	6B	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1871	3321	0.014754592	0.009334538	2	6B	IN-SST	12	6	6
GTCGGGTGTGAAATCA-1_7_G10	25.80406793	6.740763308	15A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1375	1874	0.044823906	0.022945571	2	15A	Endo cells	12	6	6
GTCGGGTGTTCCACGG-1_7_G10	25.76941614	3.733258226	15BA	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	869	1108	0.001805054	0.012635379	2	15BA	Stromal cells	12	6	6
GTCGGGTTCGTACCGG-1_7_G10	30.77552275	-10.59749776	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3706	7917	0.018188708	0.005810282	2	2	EN-L4	12	6	6
GTCGTAAAGTGGTAGC-1_7_G10	33.62224622	-5.257096004	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2809	5400	0.010555556	0.011111111	2	2	EN-L4	12	6	6
GTCGTAACAATACGCT-1_7_G10	-5.783024625	11.4190451	5	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	793	1039	0.013474495	0.018286814	2	oligos	OL-MS-1	12	6	6
GTCGTAACACAGTCGC-1_7_G10	-14.24321539	-3.383100123	13A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2957	5921	0.010808985	0.006755616	2	13A	IN-VIP	12	6	6
GTCGTAACATACGCTA-1_7_G10	3.540514715	-13.57503099	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2064	3603	0.006106023	0.006383569	2	L2-3	EN-L2-3-MS	12	6	6
GTCGTAAGTCTCTTAT-1_7_G10	-2.760214757	31.09490231	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1076	1475	0.004745763	0.007457627	2	oligos	OL-MS-2	12	6	6
GTCGTAATCGCCATAA-1_7_G10	-17.01773762	-2.74256905	13A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3187	6157	0.014779925	0.010719506	2	13A	IN-VIP	12	6	6
GTCGTAATCTTATCTG-1_7_G10	-3.579735923	35.54493627	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	831	1088	0.010110294	0.003676471	2	oligos	OL-MS-2	12	6	6
GTCTCGTCACAGGAGT-1_7_G10	25.78104909	3.600611354	15BA	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	795	1036	0.001930502	0.005791506	2	15BA	Stromal cells	12	6	6
GTCTCGTGTAAGGGCT-1_7_G10	12.12109921	-21.19094749	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4744	13123	0.018898118	0.005867561	2	L2-3	EN-L2-3-MS	12	6	6
GTCTCGTGTTGTGGAG-1_7_G10	10.99510199	-22.50759483	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3873	9653	0.012431368	0.007562416	2	L2-3	EN-L2-3-MS	12	6	6
GTCTCGTTCAAACCGT-1_7_G10	1.337951878	-17.26024148	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2522	5166	0.003484321	0.006387921	2	L2-3	EN-L2-3-MS	12	6	6
GTCTCGTTCCACTGGG-1_7_G10	30.8817452	-11.48849401	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3496	8313	0.017683147	0.005894382	2	2	EN-L4	12	6	6
GTCTTCGCAGTCGATT-1_7_G10	7.459135055	-29.37592644	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3944	9912	0.001715093	0.003631961	2	L2-3	EN-L2-3-Cntl	12	6	6
GTCTTCGGTTACGCGC-1_7_G10	31.24029371	-10.04567792	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3858	9011	0.017090223	0.005215847	2	2	EN-L4	12	6	6
GTCTTCGTCAACCAAC-1_7_G10	-18.98524094	7.678266696	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	763	1022	0.006849315	0.001956947	2	8	Astrocytes	12	6	6
GTCTTCGTCAGAGCTT-1_7_G10	29.87482198	-11.42239877	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3879	8849	0.021019324	0.010848683	2	2	EN-L4	12	6	6
GTCTTCGTCCATTCTA-1_7_G10	-9.300533316	-32.33978359	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	961	1297	0.063993832	0.00925212	2	16	EN-PYR	12	6	6
GTCTTCGTCTCCCTGA-1_7_G10	0.544834083	-27.25859496	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4021	11420	0.00525394	0.003765324	2	L2-3	EN-L2-3-Cntl	12	6	6
GTCTTCGTCTGTCTAT-1_7_G10	-17.57317163	9.246577205	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1079	1561	0.003203075	0.005765535	2	8	Astrocytes	12	6	6
GTGAAGGAGACAAGCC-1_7_G10	-34.05451229	-8.37936228	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1086	1643	0.001825928	0.002434571	2	9	OPC	12	6	6
GTGAAGGAGTGCTGCC-1_7_G10	0.057463696	35.00755908	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	774	1082	0.006469501	0.003696858	2	oligos	OL-MS-2	12	6	6
GTGAAGGCAATCGAAA-1_7_G10	12.35061994	-20.25071982	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4602	11477	0.016990503	0.006099155	2	L2-3	EN-L2-3-MS	12	6	6
GTGAAGGCACCACGTG-1_7_G10	-26.44393848	-7.337059193	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1081	1493	0.003348962	0.003348962	2	9	OPC	12	6	6
GTGAAGGCAGCCTGTG-1_7_G10	6.581806953	-2.514495822	12	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1046	1498	0.074766355	0.015353805	2	12	EN-MIX	12	6	6
GTGAAGGGTCGGATCC-1_7_G10	9.893877285	34.48039242	1	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	808	1118	0.003577818	0.006261181	2	oligos	OL-Cntl	12	6	6
GTGAAGGGTGCTTCTC-1_7_G10	-6.89073602	-29.5002277	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	807	1084	0.0599631	0.006457565	2	16	EN-PYR	12	6	6
GTGAAGGGTGGTCTCG-1_7_G10	-28.70434687	-20.57829535	6A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3919	9093	0.04300011	0.009457825	2	6A	IN-PV	12	6	6
GTGAAGGGTTTGTGTG-1_7_G10	16.28713656	-18.43413395	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4843	12522	0.013895544	0.007586648	2	L2-3	EN-L2-3-MS	12	6	6
GTGCAGCCAACACCTA-1_7_G10	-2.691089686	34.19230276	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	825	1109	0.00541028	0.00270514	2	oligos	OL-MS-2	12	6	6
GTGCAGCGTCTCCATC-1_7_G10	3.444223754	-32.68354128	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	5354	18845	0.001644999	0.002334837	2	L2-3	EN-L2-3-Cntl	12	6	6
GTGCAGCGTGACCAAG-1_7_G10	-10.76495133	-32.54991653	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1172	2016	0.16468254	0.007936508	2	16	EN-PYR	12	6	6
GTGCATAAGCGATTCT-1_7_G10	7.389180628	-1.560812181	12	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	994	1453	0.0220234	0.008947006	2	12	EN-MIX	12	6	6
GTGCATAAGGCGATAC-1_7_G10	3.6953788	-29.17482522	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3275	7723	0.003237084	0.001424317	2	L2-3	EN-L2-3-Cntl	12	6	6
GTGCATAAGTGCGTGA-1_7_G10	32.4251541	-4.199700293	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3401	7910	0.007711757	0.005562579	2	2	EN-L4	12	6	6
GTGCATACAATGACCT-1_7_G10	-21.02480179	17.07128108	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1346	2106	0.004273504	0.004273504	2	8	Astrocytes	12	6	6
GTGCATAGTAATCGTC-1_7_G10	-13.55041163	-9.325788276	13B	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1953	3366	0.018716578	0.005050505	2	13B	IN-SV2C	12	6	6
GTGCATAGTGAGTATA-1_7_G10	2.877335813	-21.76119762	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4058	11737	0.004941638	0.008775667	2	L2-3	EN-L2-3-MS	12	6	6
GTGCATAGTGATAAGT-1_7_G10	-20.48127985	-23.78819513	6A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2327	4354	0.003674782	0.009646302	2	6A	IN-PV	12	6	6
GTGCATAGTTCGTCTC-1_7_G10	11.20614401	-29.40712095	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	5463	17505	0.006798058	0.004912882	2	3	EN-L5-6	12	6	6
GTGCATATCCGTTGCT-1_7_G10	30.08661579	-1.014739644	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3210	7328	0.002319869	0.003411572	2	2	EN-L4	12	6	6
GTGCGGTCACTAAGTC-1_7_G10	-33.99581413	-10.02358129	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	907	1314	0.002283105	0.00304414	2	9	OPC	12	6	6
GTGCGGTGTGCTAGCC-1_7_G10	13.98580409	-22.30589752	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4329	10710	0.013912232	0.00550887	2	L2-3	EN-L2-3-MS	12	6	6
GTGCGGTTCTGTTTGT-1_7_G10	-0.036292854	-22.69037248	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4882	15927	0.005336849	0.005211276	2	L2-3	EN-L2-3-Cntl	12	6	6
GTGCGGTTCTTGCCGT-1_7_G10	7.83457101	-29.99876521	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4826	14273	0.002802494	0.004624115	2	L2-3	EN-L2-3-Cntl	12	6	6
GTGCTTCAGAGTAATC-1_7_G10	-9.515737965	31.99744539	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	870	1085	0.016589862	0.007373272	2	oligos	OL-MS-2	12	6	6
GTGCTTCCACGTAAGG-1_7_G10	-5.982512989	-30.80984017	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	734	1007	0.088381331	0.004965243	2	16	EN-PYR	12	6	6
GTGCTTCGTAACGTTC-1_7_G10	22.97973768	15.0780586	1	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1283	1928	0.003112033	0.003630705	2	oligos	OL-Cntl	12	6	6
GTGCTTCGTAGCGTAG-1_7_G10	3.238838541	-20.80740871	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3553	8214	0.008887266	0.005965425	2	L2-3	EN-L2-3-MS	12	6	6
GTGGGTCAGACAATAC-1_7_G10	27.57846348	-5.796359239	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4241	10862	0.005155588	0.003222243	2	2	EN-L4	12	6	6
GTGGGTCAGAGTGAGA-1_7_G10	-13.51233644	8.35619543	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1430	2084	0.028790787	0.00815739	2	8	Astrocytes	12	6	6
GTGGGTCCAGCCACCA-1_7_G10	-22.00622379	13.93156452	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1107	1663	0.004810583	0.00420926	2	8	Astrocytes	12	6	6
GTGGGTCCATCGGAAG-1_7_G10	-0.191791186	30.46597967	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	772	1005	0.007960199	0.004975124	2	oligos	OL-MS-2	12	6	6
GTGGGTCCATGGGACA-1_7_G10	-0.981612329	32.02609317	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	858	1171	0.006831768	0.001707942	2	oligos	OL-MS-2	12	6	6
GTGGGTCGTGCGGTAA-1_7_G10	-21.37151734	16.61115288	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1376	2280	0.009210526	0.003508772	2	8	Astrocytes	12	6	6
GTGGGTCGTTGTACAC-1_7_G10	0.053644643	32.69211461	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	931	1301	0.005380477	0.009992314	2	oligos	OL-MS-2	12	6	6
GTGGGTCTCACGACTA-1_7_G10	21.2027271	-20.79460408	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	5208	16134	0.016982769	0.007809595	2	3	EN-L5-6	12	6	6
GTGGGTCTCAGAAATG-1_7_G10	3.516315963	-16.12921202	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2503	4508	0.007763975	0.010647737	2	L2-3	EN-L2-3-MS	12	6	6
GTGGGTCTCAGGTAAA-1_7_G10	-11.54515953	13.21072491	11	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1172	1563	0.004478567	0.006397953	2	11	Glia-MIX	12	6	6
GTGTGCGAGTCTCCTC-1_7_G10	-12.9925177	-17.49945773	6B	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1050	1523	0.010505581	0.007222587	2	6B	IN-SST	12	6	6
GTGTGCGCACTCGACG-1_7_G10	-16.90068932	-22.08989755	6A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1787	3149	0.010797078	0.003810734	2	6A	IN-PV	12	6	6
GTGTGCGCAGTCAGAG-1_7_G10	-23.03387619	13.58080258	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	917	1288	0.002329193	0.00310559	2	8	Astrocytes	12	6	6
GTGTGCGCATGGAATA-1_7_G10	1.236016844	33.48461056	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	803	1216	0.002467105	0.009046053	2	oligos	OL-MS-2	12	6	6
GTGTGCGGTCGGCATC-1_7_G10	1.592044111	-16.966397	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2438	4537	0.011461318	0.00286533	2	L2-3	EN-L2-3-MS	12	6	6
GTGTGCGGTCTTCGTC-1_7_G10	-11.64611786	-32.43527239	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1145	1737	0.082901554	0.004029937	2	16	EN-PYR	12	6	6
GTGTGCGGTGCACCAC-1_7_G10	-32.43283093	-1.758206919	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1451	2483	0.004832863	0.006041079	2	9	OPC	12	6	6
GTGTGCGGTTCGTGAT-1_7_G10	-12.06239413	16.63955934	11	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1627	2501	0.006397441	0.004398241	2	11	Glia-MIX	12	6	6
GTGTGCGGTTGGACCC-1_7_G10	29.63353401	-10.77328673	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4077	9746	0.021547301	0.00728504	2	2	EN-L4	12	6	6
GTGTGCGTCACCGGGT-1_7_G10	4.462959424	-8.922107157	12	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1419	2070	0.010628019	0.007246377	2	12	EN-MIX	12	6	6
GTGTGCGTCTTACCGC-1_7_G10	38.92432989	14.15634908	14	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1122	1486	0.00538358	0.01345895	2	14	Microglia	12	6	6
GTGTTAGAGGGTTTCT-1_7_G10	6.118779948	21.76096678	1	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	823	1192	0.005033557	0.009228188	2	oligos	OL-Cntl	12	6	6
GTGTTAGCAACTGCTA-1_7_G10	4.887995932	-13.11965141	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2116	3631	0.01019003	0.008812999	2	L2-3	EN-L2-3-MS	12	6	6
GTGTTAGGTAAGTAGT-1_7_G10	-0.423399091	35.16998215	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	761	1022	0.005870841	0.005870841	2	oligos	OL-MS-2	12	6	6
GTGTTAGTCCGTCATC-1_7_G10	24.7970588	-19.80725547	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4229	10548	0.029105044	0.008722033	2	3	EN-L5-6	12	6	6
GTGTTAGTCTTTACGT-1_7_G10	-10.17245251	-33.06569925	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1180	1834	0.099781897	0.005997819	2	16	EN-PYR	12	6	6
GTTAAGCAGCGTGAAC-1_7_G10	-9.05304403	31.44782103	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1069	1431	0.032145353	0.009084556	2	oligos	OL-MS-2	12	6	6
GTTAAGCCAATAGCAA-1_7_G10	2.701097584	-6.894399707	12	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1196	1813	0.001654716	0.00827358	2	12	EN-MIX	12	6	6
GTTAAGCCAGACACTT-1_7_G10	-4.618398294	32.69308835	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	954	1327	0.003767898	0.003014318	2	oligos	OL-MS-2	12	6	6
GTTAAGCCATATACCG-1_7_G10	19.15591845	-17.56281845	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	6140	20610	0.014847162	0.006598738	2	L2-3	EN-L2-3-MS	12	6	6
GTTAAGCCATCGGAAG-1_7_G10	24.19208487	-26.06391004	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3105	6965	0.022254128	0.006030151	2	3	EN-L5-6	12	6	6
GTTAAGCGTTATCCGA-1_7_G10	-21.69892421	15.39680271	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1239	2009	0.003484321	0.004479841	2	8	Astrocytes	12	6	6
GTTAAGCTCCGCATCT-1_7_G10	23.98303744	-12.15445939	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4253	10659	0.024204897	0.004878506	2	3	EN-L5-6	12	6	6
GTTAAGCTCCTACAGA-1_7_G10	-3.791692026	35.04126088	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	788	1024	0.010742188	0.001953125	2	oligos	OL-MS-2	12	6	6
GTTAAGCTCTTACCTA-1_7_G10	-0.590504774	35.0952722	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	848	1127	0.002661934	0.00621118	2	oligos	OL-MS-2	12	6	6
GTTACAGAGCCCAATT-1_7_G10	24.4049551	-27.21907531	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3269	7813	0.011775246	0.003711762	2	3	EN-L5-6	12	6	6
GTTACAGAGTATCTCG-1_7_G10	18.67655422	0.90383445	12	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1105	1689	0.019538188	0.003552398	2	12	EN-MIX	12	6	6
GTTACAGAGTGCGATG-1_7_G10	30.06203474	-5.383214997	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3502	8141	0.004299226	0.008107112	2	2	EN-L4	12	6	6
GTTACAGCAAGCGATG-1_7_G10	30.65010604	-7.974234342	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4307	10834	0.020675651	0.006368839	2	2	EN-L4	12	6	6
GTTACAGCAGTGAGTG-1_7_G10	16.34302324	-18.27365136	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3665	8458	0.021872783	0.006148026	2	L2-3	EN-L2-3-MS	12	6	6
GTTACAGCATAGACTC-1_7_G10	-2.906848294	34.53598613	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	852	1172	0.006825939	0.008532423	2	oligos	OL-MS-2	12	6	6
GTTACAGCATGACATC-1_7_G10	-26.88137132	-18.3750353	6A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3883	9604	0.042065806	0.005726781	2	6A	IN-PV	12	6	6
GTTACAGTCACAACGT-1_7_G10	27.00074405	4.602956808	15A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	831	1091	0.006416132	0.004582951	2	15A	Endo cells	12	6	6
GTTCATTAGAAGATTC-1_7_G10	15.22948352	-32.5660293	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4732	13883	0.00136858	0.004105741	2	3	EN-L5-6	12	6	6
GTTCATTAGAATGTGT-1_7_G10	10.30812915	34.27362437	1	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	846	1280	0.00234375	0.00390625	2	oligos	OL-Cntl	12	6	6
GTTCATTAGTTCGCGC-1_7_G10	25.122301	-23.97614816	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3971	10040	0.008864542	0.0062749	2	3	EN-L5-6	12	6	6
GTTCATTGTATCAGTC-1_7_G10	6.992638754	-3.410942533	12	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1174	1598	0.026282854	0.00563204	2	12	EN-MIX	12	6	6
GTTCATTGTTGAACTC-1_7_G10	31.2180314	-5.20380317	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3315	7268	0.005503577	0.004678041	2	2	EN-L4	12	6	6
GTTCATTTCCGGCACA-1_7_G10	-17.46206143	-8.55017547	13B	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2997	6687	0.020038881	0.005533124	2	13B	IN-SV2C	12	6	6
GTTCGGGAGAGCTTCT-1_7_G10	-13.67330789	-5.398323526	13A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2457	4662	0.016302016	0.007078507	2	13A	IN-VIP	12	6	6
GTTCGGGCAAACGCGA-1_7_G10	1.432737143	-22.06602022	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3933	9793	0.009394465	0.005105688	2	L2-3	EN-L2-3-Cntl	12	6	6
GTTCGGGCAAGTACCT-1_7_G10	16.14358085	-32.71283978	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4614	14048	0.005908314	0.003915148	2	3	EN-L5-6	12	6	6
GTTCGGGCACAGGCCT-1_7_G10	3.617473179	-14.84911013	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2397	4474	0.012069736	0.009164059	2	L2-3	EN-L2-3-MS	12	6	6
GTTCGGGGTGACGGTA-1_7_G10	-25.88545824	-7.827729763	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1073	1573	0.003814367	0.006357279	2	9	OPC	12	6	6
GTTCGGGTCAGTCCCT-1_7_G10	21.32933563	-1.810774525	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1856	3057	0.014720314	0.005888126	2	2	EN-L4	12	6	6
GTTCGGGTCATGCATG-1_7_G10	1.472846968	33.09801525	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	764	1083	0.004616805	0.003693444	2	oligos	OL-MS-2	12	6	6
GTTCGGGTCTACTTAC-1_7_G10	-21.49897668	16.58426718	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1289	2008	0.006474104	0.005478088	2	8	Astrocytes	12	6	6
GTTCGGGTCTTGCATT-1_7_G10	2.935304184	-32.11459646	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	5727	22860	0.001006124	0.002143482	2	L2-3	EN-L2-3-Cntl	12	6	6
GTTCTCGAGCCACGCT-1_7_G10	21.37302072	-20.70718011	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	5003	14763	0.011786222	0.006096322	2	3	EN-L5-6	12	6	6
GTTCTCGCAATAGAGT-1_7_G10	-21.42484803	-28.51971191	6A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4745	14358	0.011073966	0.003412732	2	6A	IN-PV	12	6	6
GTTCTCGGTGCACTTA-1_7_G10	21.77832865	28.34647328	1	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	957	1355	0.005166052	0.006642066	2	oligos	OL-Cntl	12	6	6
GTTCTCGTCAGTACGT-1_7_G10	15.8000119	-18.84183362	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	5428	15539	0.017375635	0.006628483	2	L2-3	EN-L2-3-MS	12	6	6
GTTTCTAAGATGAGAG-1_7_G10	11.10083978	24.37418014	1	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	827	1219	0.005742412	0.006562756	2	oligos	OL-Cntl	12	6	6
GTTTCTAGTAGCTAAA-1_7_G10	4.42524008	34.02542174	1	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	752	1086	0.004604052	0.002762431	2	oligos	OL-Cntl	12	6	6
GTTTCTATCGGATGGA-1_7_G10	-25.77469307	-6.185818102	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1130	1683	0.008912656	0.004159239	2	9	OPC	12	6	6
GTTTCTATCGTTGCCT-1_7_G10	-21.81095946	15.76876403	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1194	1838	0.008705114	0.005440696	2	8	Astrocytes	12	6	6
GTTTCTATCTATGTGG-1_7_G10	-0.851125221	35.16144953	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	756	1053	0.007597341	0.006647673	2	oligos	OL-MS-2	12	6	6
TAAACCGAGGCGATAC-1_7_G10	8.066487873	24.83047605	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	932	1319	0.006065201	0.005307051	2	oligos	OL-MS-2	12	6	6
TAAACCGCATCAGTAC-1_7_G10	-2.953720008	34.72799047	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	762	1067	0.008434864	0.009372071	2	oligos	OL-MS-2	12	6	6
TAAACCGGTATTCGTG-1_7_G10	21.70286219	-1.906862273	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2035	3260	0.013190184	0.008895706	2	2	EN-L4	12	6	6
TAAACCGGTCGCCATG-1_7_G10	26.25733829	-28.07962453	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4674	14114	0.001629588	0.001629588	2	3	EN-L5-6	12	6	6
TAAACCGGTCTTGTCC-1_7_G10	1.827529763	6.487776307	7	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1137	1492	0.013404826	0.004691689	2	7	Phagocytes	12	6	6
TAAACCGTCGGCTTGG-1_7_G10	21.08458678	-27.5635565	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2484	5052	0.005740301	0.002969121	2	3	EN-L5-6	12	6	6
TAAGAGAAGTCGCCGT-1_7_G10	29.45006503	-16.80808905	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4687	11740	0.047444634	0.0120954	2	2	EN-L4	12	6	6
TAAGAGAAGTGGGTTG-1_7_G10	-9.675119147	31.5879134	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	888	1169	0.019674936	0.002566296	2	oligos	OL-MS-2	12	6	6
TAAGAGACATTCCTCG-1_7_G10	21.81976723	28.0044575	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	922	1325	0.004528302	0.003773585	2	oligos	OL-MS-2	12	6	6
TAAGAGAGTCTTCTCG-1_7_G10	-0.803083007	34.45702837	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	962	1398	0.008583691	0.007153076	2	oligos	OL-MS-2	12	6	6
TAAGCGTAGTACATGA-1_7_G10	-4.930428174	35.98466479	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	811	1109	0.008115419	0.009017133	2	oligos	OL-MS-2	12	6	6
TAAGCGTCACGAAATA-1_7_G10	-8.069268586	33.2813393	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	982	1300	0.004615385	0.01	2	oligos	OL-MS-2	12	6	6
TAAGCGTGTATAGGTA-1_7_G10	-23.75724924	12.01003037	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1058	1491	0.005365526	0.007377599	2	8	Astrocytes	12	6	6
TAAGTGCAGAGCAATT-1_7_G10	-17.09142675	7.151410085	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	844	1120	0.00625	0.007142857	2	8	Astrocytes	12	6	6
TAAGTGCAGTAGTGCG-1_7_G10	18.53199311	-8.961347009	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2237	4275	0.007251462	0.007251462	2	3	EN-L5-6	12	6	6
TAAGTGCCACCCTATC-1_7_G10	-0.669958995	34.04153106	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	805	1067	0.00656045	0.004686036	2	oligos	OL-MS-2	12	6	6
TAAGTGCCATGGTAGG-1_7_G10	-5.47728306	34.09369319	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	875	1180	0.005084746	0.005932203	2	oligos	OL-MS-2	12	6	6
TAAGTGCGTAAGGGAA-1_7_G10	21.75666696	27.24439153	1	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1078	1566	0.001915709	0.006385696	2	oligos	OL-Cntl	12	6	6
TAAGTGCGTCCGACGT-1_7_G10	-0.901444418	33.87378716	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	801	1124	0.005338078	0.008896797	2	oligos	OL-MS-2	12	6	6
TAAGTGCGTGGGTATG-1_7_G10	-0.332228162	35.21764151	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	785	1163	0.007738607	0.006018917	2	oligos	OL-MS-2	12	6	6
TAAGTGCGTTATGTGC-1_7_G10	2.969674228	-24.65579979	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3468	7734	0.002198086	0.005689165	2	L2-3	EN-L2-3-MS	12	6	6
TAAGTGCTCAATCACG-1_7_G10	-27.01641023	12.30443381	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	844	1191	0.01427372	0.005877414	2	8	Astrocytes	12	6	6
TACACGACAAAGTCAA-1_7_G10	-21.11410203	15.49999851	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1254	1885	0.008488064	0.009549072	2	8	Astrocytes	12	6	6
TACACGACAATACGCT-1_7_G10	2.086996709	-20.44122469	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3194	7043	0.007525202	0.002129774	2	L2-3	EN-L2-3-Cntl	12	6	6
TACACGACATGGTTGT-1_7_G10	-2.801346663	31.83427179	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	958	1351	0.004441155	0.003700962	2	oligos	OL-MS-2	12	6	6
TACACGAGTCAGATAA-1_7_G10	-17.36573008	-8.238790625	13B	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2863	5765	0.010928014	0.004856895	2	13B	IN-SV2C	12	6	6
TACACGAGTCCCTTGT-1_7_G10	0.171205013	35.06363642	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	796	1096	0.010948905	0.001824818	2	oligos	OL-MS-2	12	6	6
TACACGATCGGATGTT-1_7_G10	5.49498408	30.00714416	1	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	726	1004	0.005976096	0.006972112	2	oligos	OL-Cntl	12	6	6
TACAGTGAGCCGTCGT-1_7_G10	-1.507915109	33.36478271	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	826	1106	0.006329114	0.009041591	2	oligos	OL-MS-2	12	6	6
TACAGTGCATGCAACT-1_7_G10	-20.36339549	15.13819379	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1281	1861	0.011284256	0.00483611	2	8	Astrocytes	12	6	6
TACAGTGGTCTGCGGT-1_7_G10	32.598272	-2.868713087	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2339	4471	0.006709908	0.007828226	2	2	EN-L4	12	6	6
TACAGTGGTGCACCAC-1_7_G10	-34.90745928	-5.873826788	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1326	2185	0.004576659	0.003661327	2	9	OPC	12	6	6
TACAGTGTCCAGAGGA-1_7_G10	-14.30710498	-16.51801684	6B	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1410	2201	0.008178101	0.00408905	2	6B	IN-SST	12	6	6
TACAGTGTCCTTGACC-1_7_G10	-1.136732972	34.78823277	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	804	1074	0.004655493	0.003724395	2	oligos	OL-MS-2	12	6	6
TACAGTGTCTAACGGT-1_7_G10	0.515527333	-22.36527317	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3466	8220	0.001581509	0.010462287	2	L2-3	EN-L2-3-Cntl	12	6	6
TACAGTGTCTACTATC-1_7_G10	-14.57756496	-17.06308053	6B	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1395	2337	0.015404365	0.002139495	2	6B	IN-SST	12	6	6
TACAGTGTCTATCGCC-1_7_G10	-22.40139861	13.22913402	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1024	1538	0.004551365	0.012353706	2	8	Astrocytes	12	6	6
TACCTATCAAACGTGG-1_7_G10	-19.11168486	-23.29459958	6A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2157	4170	0.013429257	0.004556355	2	6A	IN-PV	12	6	6
TACCTATCAAGCCTAT-1_7_G10	-18.35619821	9.842926722	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	798	1088	0.003676471	0.011029412	2	8	Astrocytes	12	6	6
TACCTATGTGCACGAA-1_7_G10	32.77116811	5.173377024	14	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	887	1070	0.011214953	0.009345794	2	14	Microglia	12	6	6
TACCTATGTTAGATGA-1_7_G10	-9.320669956	-15.17198852	6B	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	829	1134	0.012345679	0.005291005	2	6B	IN-SST	12	6	6
TACCTATTCAAACCAC-1_7_G10	10.23316021	-20.28692631	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4127	11070	0.011924119	0.005510388	2	L2-3	EN-L2-3-MS	12	6	6
TACCTATTCAGGTTCA-1_7_G10	18.77305176	-17.51389847	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	6861	25203	0.02670317	0.006467484	2	L2-3	EN-L2-3-MS	12	6	6
TACCTATTCGCTGATA-1_7_G10	-0.963640625	34.84868929	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	908	1318	0.006828528	0.003793627	2	oligos	OL-MS-2	12	6	6
TACCTATTCTAACTTC-1_7_G10	-15.2313777	7.623499492	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1025	1376	0.011627907	0.005813953	2	8	Astrocytes	12	6	6
TACCTATTCTGCGGCA-1_7_G10	-1.041824837	33.98949991	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	838	1129	0.008857396	0.006200177	2	oligos	OL-MS-2	12	6	6
TACCTTAAGCCAGTTT-1_7_G10	-2.364152649	32.02883716	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	894	1237	0.00323363	0.004042037	2	oligos	OL-MS-2	12	6	6
TACCTTAAGGTAGCCA-1_7_G10	-2.952964186	35.91136686	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	825	1122	0.007130125	0.003565062	2	oligos	OL-MS-2	12	6	6
TACCTTACAAGACGTG-1_7_G10	12.51625475	-20.08843508	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4498	11306	0.012294357	0.008048824	2	L2-3	EN-L2-3-MS	12	6	6
TACCTTACACACAGAG-1_7_G10	-9.80391594	34.08601894	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	812	1028	0.012645914	0.015564202	2	oligos	OL-MS-2	12	6	6
TACCTTAGTCCAAGTT-1_7_G10	23.24946716	27.28303783	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1173	1763	0.007373795	0.00567215	2	oligos	OL-MS-2	12	6	6
TACCTTAGTGAAAGAG-1_7_G10	18.09089724	-20.94071501	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3492	7040	0.020028409	0.008664773	2	L2-3	EN-L2-3-MS	12	6	6
TACCTTATCGAGAACG-1_7_G10	4.605893119	-13.42701032	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2076	3471	0.007778738	0.011812158	2	L2-3	EN-L2-3-MS	12	6	6
TACCTTATCGTAGATC-1_7_G10	33.43721428	-3.665358971	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2805	6121	0.009638948	0.007024996	2	2	EN-L4	12	6	6
TACCTTATCTTCGGTC-1_7_G10	28.58951456	6.880204076	15BA	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	897	1145	0.052401747	0.052401747	2	15BA	Stromal cells	12	6	6
TACGGATAGCCCAACC-1_7_G10	1.909912326	-21.58863785	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3836	9619	0.002183179	0.009044599	2	L2-3	EN-L2-3-MS	12	6	6
TACGGATAGCTGAAAT-1_7_G10	3.916714744	-18.53982656	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2981	6034	0.00812065	0.011435201	2	L2-3	EN-L2-3-MS	12	6	6
TACGGATAGTTCGCGC-1_7_G10	14.58408001	-29.77785047	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4118	11263	0.001243008	0.009588919	2	3	EN-L5-6	12	6	6
TACGGATCATGCATGT-1_7_G10	0.019074666	36.08706193	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	820	1091	0.008249313	0.002749771	2	oligos	OL-MS-2	12	6	6
TACGGATGTACAGCAG-1_7_G10	-12.83516263	-10.70576802	13B	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1680	2855	0.004553415	0.004553415	2	13B	IN-SV2C	12	6	6
TACGGATGTCTCCCTA-1_7_G10	-1.369258716	34.17171374	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	799	1082	0.007393715	0.004621072	2	oligos	OL-MS-2	12	6	6
TACGGATTCGTAGATC-1_7_G10	-3.214343291	34.69205775	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	748	1026	0.011695906	0.001949318	2	oligos	OL-MS-2	12	6	6
TACGGATTCGTGGACC-1_7_G10	33.81724083	-6.430401273	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3601	7957	0.015835114	0.007917557	2	2	EN-L4	12	6	6
TACGGGCAGCTAGGCA-1_7_G10	-16.92417861	-16.3928634	6B	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2144	3752	0.038379531	0.006663113	2	6B	IN-SST	12	6	6
TACGGGCAGGTGCTTT-1_7_G10	-17.85751026	-16.13121119	6B	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2304	4385	0.015735462	0.008665906	2	6B	IN-SST	12	6	6
TACGGGCGTCTTCTCG-1_7_G10	33.58290342	8.308594379	14	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1260	1846	0.024377031	0.018418202	2	14	Microglia	12	6	6
TACGGGCGTTAGTGGG-1_7_G10	23.45326311	-10.02743689	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3124	6533	0.002908312	0.00474514	2	3	EN-L5-6	12	6	6
TACGGGCTCCGCATCT-1_7_G10	32.57488104	-4.190430139	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3261	7154	0.007548225	0.004752586	2	2	EN-L4	12	6	6
TACGGGCTCGCAAGCC-1_7_G10	-22.30172043	13.29619432	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	967	1338	0.003736921	0.002989537	2	8	Astrocytes	12	6	6
TACGGTAAGACAGGCT-1_7_G10	13.32110036	-22.26605918	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	5148	14171	0.009808764	0.007974031	2	L2-3	EN-L2-3-MS	12	6	6
TACGGTAAGACTAGGC-1_7_G10	16.34189441	-32.06401711	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4647	13847	0.007655088	0.005849643	2	3	EN-L5-6	12	6	6
TACGGTAAGCCATCGC-1_7_G10	29.67422163	-11.30568063	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3926	8705	0.014933946	0.014014934	2	2	EN-L4	12	6	6
TACGGTAAGGATGCGT-1_7_G10	22.00454015	-1.549463189	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2002	3558	0.00786959	0.005621135	2	2	EN-L4	12	6	6
TACGGTACACCGAATT-1_7_G10	23.87591644	-10.61958131	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3799	9025	0.008642659	0.008642659	2	3	EN-L5-6	12	6	6
TACGGTACACGCATCG-1_7_G10	6.424088176	-15.41886561	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2556	4736	0.005489865	0.009712838	2	L2-3	EN-L2-3-MS	12	6	6
TACGGTACATCCGTGG-1_7_G10	10.37767078	-28.73718039	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	5102	14754	0.013691202	0.006032262	2	L2-3	EN-L2-3-MS	12	6	6
TACGGTACATGCAACT-1_7_G10	-3.558162182	35.77983083	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	770	1036	0.008687259	0.005791506	2	oligos	OL-MS-2	12	6	6
TACGGTAGTCCAGTAT-1_7_G10	21.7142807	26.98703021	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	976	1475	0.006779661	0.007457627	2	oligos	OL-MS-2	12	6	6
TACGGTAGTGATGATA-1_7_G10	-12.92607519	14.97374375	11	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1066	1537	0.009759271	0.000650618	2	11	Glia-MIX	12	6	6
TACGGTAGTGTGAAAT-1_7_G10	24.89554721	-22.01654195	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3837	9290	0.021959096	0.003875135	2	3	EN-L5-6	12	6	6
TACGGTATCCCAGGTG-1_7_G10	9.280110438	-25.68383582	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4751	14020	0.006704708	0.004850214	2	L2-3	EN-L2-3-MS	12	6	6
TACGGTATCTACTATC-1_7_G10	9.236496338	-29.16813431	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4800	14003	0.005070342	0.005855888	2	L2-3	EN-L2-3-Cntl	12	6	6
TACTCATAGAGTCGGT-1_7_G10	23.80949256	27.39131519	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1163	1663	0.008418521	0.004810583	2	oligos	OL-MS-2	12	6	6
TACTCATCAAGCCGCT-1_7_G10	14.90418238	-33.33263833	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4279	12843	0.001167951	0.003192401	2	3	EN-L5-6	12	6	6
TACTCATCATCTCGCT-1_7_G10	-20.1603251	15.26799738	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1447	2185	0.004118993	0.004576659	2	8	Astrocytes	12	6	6
TACTCATGTACATCCA-1_7_G10	-2.766992686	33.57550601	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	937	1265	0.008695652	0.007905138	2	oligos	OL-MS-2	12	6	6
TACTCATGTCAAGCGA-1_7_G10	19.30329717	-17.4187481	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	5660	17400	0.033045977	0.00591954	2	L2-3	EN-L2-3-MS	12	6	6
TACTCATTCCTGCCAT-1_7_G10	-9.922105762	-32.20938985	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1082	1552	0.056701031	0.007731959	2	16	EN-PYR	12	6	6
TACTCGCAGATATGCA-1_7_G10	-24.52485281	-12.23487147	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1018	1506	0.018592297	0.005312085	2	9	OPC	12	6	6
TACTCGCAGCCTTGAT-1_7_G10	18.33462833	12.39056062	1	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1258	2004	0.006487026	0.005988024	2	oligos	OL-Cntl	12	6	6
TACTCGCAGTTAACGA-1_7_G10	23.84808642	27.58152776	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1148	1554	0.008365508	0.001930502	2	oligos	OL-MS-2	12	6	6
TACTCGCCAAACCTAC-1_7_G10	-18.13238419	9.040007964	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	910	1224	0.003267974	0.005718954	2	8	Astrocytes	12	6	6
TACTCGCCAAGGTTTC-1_7_G10	1.64430862	30.49952791	1	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	770	1083	0.005540166	0.003693444	2	oligos	OL-Cntl	12	6	6
TACTCGCGTCCATGAT-1_7_G10	-31.44114108	-10.41729876	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	865	1180	0.006779661	0.011016949	2	9	OPC	12	6	6
TACTCGCGTCGAACAG-1_7_G10	-26.68288154	-8.129203697	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1028	1436	0.002089136	0.004874652	2	9	OPC	12	6	6
TACTTACAGGCACATG-1_7_G10	-33.29984006	-9.583143753	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	881	1300	0.003846154	0.003076923	2	9	OPC	12	6	6
TACTTACCACTTAAGC-1_7_G10	-16.10483809	-17.90848328	6B	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1741	3209	0.005920848	0.001869741	2	6B	IN-SST	12	6	6
TACTTACGTACCGAGA-1_7_G10	0.986917445	-22.99665296	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3819	9644	0.007569473	0.004666114	2	L2-3	EN-L2-3-Cntl	12	6	6
TACTTACTCTTGAGAC-1_7_G10	29.35751299	-12.00806003	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4486	11172	0.012352309	0.011725743	2	2	EN-L4	12	6	6
TACTTGTAGAGCAATT-1_7_G10	-2.690898583	34.66586396	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	774	1056	0.009469697	0.002840909	2	oligos	OL-MS-2	12	6	6
TACTTGTCAAGGTGTG-1_7_G10	-3.797040022	34.22020941	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	885	1188	0.002525253	0.004208754	2	oligos	OL-MS-2	12	6	6
TACTTGTCAATCAGAA-1_7_G10	1.697204522	-22.77916841	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4296	11100	0.004504505	0.007117117	2	L2-3	EN-L2-3-MS	12	6	6
TACTTGTGTAGCGTGA-1_7_G10	3.219336283	-18.57146564	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2987	6043	0.006288267	0.009432401	2	L2-3	EN-L2-3-MS	12	6	6
TACTTGTGTGAAGGCT-1_7_G10	16.56761814	1.817645508	12	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	881	1219	0.014766202	0.004101723	2	12	EN-MIX	12	6	6
TACTTGTGTGAGTATA-1_7_G10	-32.03293081	-0.353034707	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1878	3212	0.00622665	0.002801993	2	9	OPC	12	6	6
TACTTGTGTGCTTCTC-1_7_G10	0.84502628	32.78885038	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	944	1332	0.005255255	0.006006006	2	oligos	OL-MS-2	12	6	6
TACTTGTGTTGGTGGA-1_7_G10	28.1895152	-5.211619661	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3413	7947	0.001132503	0.006920851	2	2	EN-L4	12	6	6
TAGACCAAGAAGAAGC-1_7_G10	0.257935299	-19.99178111	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3085	6915	0.004049168	0.003326103	2	L2-3	EN-L2-3-Cntl	12	6	6
TAGACCAAGGAGTACC-1_7_G10	14.8423575	-30.47614862	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3034	6453	0.011622501	0.0027894	2	3	EN-L5-6	12	6	6
TAGACCACACGGACAA-1_7_G10	-4.602860623	35.16251777	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	819	1054	0.009487666	0.0028463	2	oligos	OL-MS-2	12	6	6
TAGACCACATTCACTT-1_7_G10	32.63033908	-2.206417681	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2378	4458	0.007626738	0.009869897	2	2	EN-L4	12	6	6
TAGACCAGTCGAACAG-1_7_G10	-2.827991104	35.25766862	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	821	1086	0.002762431	0.003683241	2	oligos	OL-MS-2	12	6	6
TAGACCAGTCGAATCT-1_7_G10	27.42012733	0.238048687	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3518	9090	0.002420242	0.002860286	2	L2-3	EN-L2-3-Cntl	12	6	6
TAGACCATCAGAGGTG-1_7_G10	19.03634485	-17.51803501	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	6046	19315	0.020295107	0.007403572	2	L2-3	EN-L2-3-MS	12	6	6
TAGAGCTAGTGTCTCA-1_7_G10	24.37456445	-13.46337088	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4249	10002	0.024995001	0.00729854	2	3	EN-L5-6	12	6	6
TAGAGCTCAATCTACG-1_7_G10	-25.68140138	-9.641950073	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	967	1314	0.014459665	0.006849315	2	9	OPC	12	6	6
TAGAGCTCACAACTGT-1_7_G10	0.894146826	34.87182046	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	916	1268	0.007097792	0.001577287	2	oligos	OL-MS-2	12	6	6
TAGAGCTCAGTCGATT-1_7_G10	-33.56561448	-8.929154478	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1100	1680	0.010119048	0.005357143	2	9	OPC	12	6	6
TAGAGCTGTTTACTCT-1_7_G10	-0.152430168	32.39402676	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	894	1257	0.00477327	0.00636436	2	oligos	OL-MS-2	12	6	6
TAGAGCTTCCCTGACT-1_7_G10	3.148613083	-24.30087301	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3443	6925	0.012129964	0.007509025	2	L2-3	EN-L2-3-MS	12	6	6
TAGAGCTTCCGTCATC-1_7_G10	31.23500548	-6.532145424	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3451	7710	0.008690013	0.007003891	2	2	EN-L4	12	6	6
TAGCCGGAGCTACCGC-1_7_G10	4.771720712	-14.66002493	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2472	4945	0.020020222	0.003842265	2	L2-3	EN-L2-3-MS	12	6	6
TAGCCGGAGTACGTTC-1_7_G10	31.70002873	-1.180673203	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2510	4898	0.00285831	0.006124949	2	2	EN-L4	12	6	6
TAGCCGGCATCGATGT-1_7_G10	-19.64573682	11.16891284	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	764	1003	0.015952144	0.000997009	2	8	Astrocytes	12	6	6
TAGCCGGCATTAGCCA-1_7_G10	20.61702942	13.40681996	1	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1312	2135	0.004683841	0.007962529	2	oligos	OL-Cntl	12	6	6
TAGCCGGGTCCTAGCG-1_7_G10	-16.20837506	-17.11487601	6B	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1722	3066	0.00456621	0.007501631	2	6B	IN-SST	12	6	6
TAGCCGGTCAGGTTCA-1_7_G10	-17.6132834	9.364999631	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1035	1463	0.002050581	0.004784689	2	8	Astrocytes	12	6	6
TAGCCGGTCGCCCTTA-1_7_G10	-16.61493786	-17.27607762	6B	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1956	3678	0.02800435	0.007340946	2	6B	IN-SST	12	6	6
TAGGCATAGGGCACTA-1_7_G10	29.92121838	-9.362682596	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3715	8622	0.022848527	0.004987242	2	2	EN-L4	12	6	6
TAGGCATAGGTCATCT-1_7_G10	7.383102266	-30.50514695	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4536	13652	0.002710226	0.002124231	2	L2-3	EN-L2-3-Cntl	12	6	6
TAGGCATCAAACAACA-1_7_G10	23.39329874	26.86757694	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1278	1906	0.007869885	0.006295908	2	oligos	OL-MS-2	12	6	6
TAGGCATCAACGCACC-1_7_G10	6.264473565	-9.540804504	12	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1545	2547	0.023164507	0.007459757	2	12	EN-MIX	12	6	6
TAGGCATCAGCCTTTC-1_7_G10	8.695627095	-29.56321754	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4553	13177	0.007133642	0.003642711	2	L2-3	EN-L2-3-Cntl	12	6	6
TAGGCATCAGCGATCC-1_7_G10	-3.26538868	34.65488207	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	796	1064	0.012218045	0.002819549	2	oligos	OL-MS-2	12	6	6
TAGGCATCATCACGAT-1_7_G10	24.17874419	26.90890654	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1421	2233	0.010747873	0.00447828	2	oligos	OL-MS-2	12	6	6
TAGGCATTCGATAGAA-1_7_G10	14.50567681	29.14247449	1	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	830	1202	0.007487521	0.004159734	2	oligos	OL-Cntl	12	6	6
TAGGCATTCTCTAAGG-1_7_G10	-20.83879951	13.60620682	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1140	1655	0.009063444	0.006042296	2	8	Astrocytes	12	6	6
TAGTGGTAGCTGTCTA-1_7_G10	2.365283833	5.147920465	7	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	790	1015	0.003940887	0.00591133	2	7	Phagocytes	12	6	6
TAGTGGTAGGACGAAA-1_7_G10	1.538578947	-20.87056988	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3294	7412	0.003103076	0.007150567	2	L2-3	EN-L2-3-Cntl	12	6	6
TAGTGGTGTATATCCG-1_7_G10	-0.163002309	35.13118828	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	776	1081	0.001850139	0.000925069	2	oligos	OL-MS-2	12	6	6
TAGTGGTTCAATCTCT-1_7_G10	32.47994476	-5.90596062	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3039	6049	0.009257729	0.005455447	2	2	EN-L4	12	6	6
TAGTGGTTCCGTCATC-1_7_G10	-23.28792589	24.7164857	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1506	2479	0.002420331	0.00524405	2	8	Astrocytes	12	6	6
TAGTTGGAGATATGGT-1_7_G10	-11.49283027	-2.587946496	13A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2019	3747	0.014144649	0.012009608	2	13A	IN-VIP	12	6	6
TAGTTGGAGTTTCCTT-1_7_G10	-25.35945063	-6.035312949	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1229	1878	0.004259851	0.005324814	2	9	OPC	12	6	6
TAGTTGGGTAAGGATT-1_7_G10	3.22124552	-18.17700006	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3019	6445	0.006051202	0.010240497	2	L2-3	EN-L2-3-MS	12	6	6
TAGTTGGGTCGGGTCT-1_7_G10	7.954382946	-32.12891559	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3679	9227	0.004009971	0.001625664	2	L2-3	EN-L2-3-Cntl	12	6	6
TAGTTGGGTTAAGACA-1_7_G10	16.90393467	-32.06899506	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4868	14473	0.00331652	0.004491121	2	3	EN-L5-6	12	6	6
TAGTTGGTCGAGAGCA-1_7_G10	-38.26849323	0.109873176	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1400	2218	0.00270514	0.00270514	2	9	OPC	12	6	6
TAGTTGGTCGGGAGTA-1_7_G10	12.31821015	-21.29208812	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4356	10721	0.013431583	0.006809066	2	L2-3	EN-L2-3-MS	12	6	6
TAGTTGGTCTGTGCAA-1_7_G10	-34.24299039	-8.046149655	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1076	1642	0.002436054	0.004263094	2	9	OPC	12	6	6
TATCAGGAGCAGGCTA-1_7_G10	-15.02501603	10.39941515	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1356	2037	0.008836524	0.007854688	2	8	Astrocytes	12	6	6
TATCAGGAGTAGGCCA-1_7_G10	-0.081663468	33.09511471	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	831	1195	0.009205021	0.006694561	2	oligos	OL-MS-2	12	6	6
TATCAGGCACTGTGTA-1_7_G10	-23.05932397	13.76062039	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	965	1364	0.004398827	0.005865103	2	8	Astrocytes	12	6	6
TATCAGGCAGCGTAAG-1_7_G10	3.787975588	-11.09593854	12	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1729	2666	0.007501875	0.014253563	2	12	EN-MIX	12	6	6
TATCAGGCAGCTCGCA-1_7_G10	31.67843896	-1.587584285	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2568	5022	0.004978096	0.005973716	2	2	EN-L4	12	6	6
TATCAGGGTCATACTG-1_7_G10	31.14047009	-10.7271052	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3106	6535	0.02310635	0.005661821	2	2	EN-L4	12	6	6
TATCAGGGTCATATGC-1_7_G10	1.382871519	-18.08103347	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2881	6515	0.004144282	0.007521105	2	L2-3	EN-L2-3-MS	12	6	6
TATCTCAAGCTAGCCC-1_7_G10	22.41418924	-19.00784655	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	6505	23612	0.019439268	0.011858377	2	3	EN-L5-6	12	6	6
TATCTCAAGGTCATCT-1_7_G10	0.514824331	35.04500639	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	858	1241	0.005640612	0.007252216	2	oligos	OL-MS-2	12	6	6
TATCTCACATGGTCAT-1_7_G10	26.07037787	-27.76274877	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	5189	16815	0.002319358	0.005709188	2	3	EN-L5-6	12	6	6
TATCTCAGTACTTAGC-1_7_G10	21.74821179	-19.62673911	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	7216	28464	0.023152052	0.006991287	2	3	EN-L5-6	12	6	6
TATCTCATCACCCGAG-1_7_G10	21.27818195	12.93778891	1	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1377	2189	0.005481955	0.004111466	2	oligos	OL-Cntl	12	6	6
TATCTCATCAGGCCCA-1_7_G10	1.678786151	-27.98304973	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3828	10412	0.006819055	0.003937764	2	L2-3	EN-L2-3-Cntl	12	6	6
TATGCCCAGCGGATCA-1_7_G10	27.58875529	-13.12011613	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	5435	15548	0.018201698	0.00675328	2	2	EN-L4	12	6	6
TATGCCCAGTGTCCCG-1_7_G10	0.81224404	-19.03897613	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2759	5721	0.004719455	0.005243838	2	L2-3	EN-L2-3-Cntl	12	6	6
TATGCCCCAAACTGCT-1_7_G10	-6.486221399	-29.49604999	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	831	1168	0.094178082	0.012842466	2	16	EN-PYR	12	6	6
TATGCCCGTACCGTTA-1_7_G10	-38.40457052	-1.796638221	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1311	2239	0.00223314	0.00223314	2	9	OPC	12	6	6
TATGCCCGTGTTGGGA-1_7_G10	-11.90273348	-2.146739284	13A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2585	5500	0.024	0.011272727	2	13A	IN-VIP	12	6	6
TATGCCCGTTGGTAAA-1_7_G10	23.91815222	-30.19547002	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3253	7806	0.009095568	0.002177812	2	3	EN-L5-6	12	6	6
TATGCCCGTTTCGCTC-1_7_G10	-26.21427319	-8.792826408	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	964	1379	0.008701958	0.005801305	2	9	OPC	12	6	6
TATGCCCTCACCAGGC-1_7_G10	-9.019312755	34.03595402	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	817	1022	0.011741683	0.009784736	2	oligos	OL-MS-2	12	6	6
TATGCCCTCCGTTGCT-1_7_G10	5.758418524	-15.69835903	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2459	4833	0.008276433	0.015311401	2	L2-3	EN-L2-3-MS	12	6	6
TATGCCCTCCTAAGTG-1_7_G10	22.23306152	27.9925812	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1021	1455	0.003436426	0.005498282	2	oligos	OL-MS-2	12	6	6
TATTACCAGTCCGGTC-1_7_G10	-16.07866915	11.230528	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1188	1679	0.004169148	0.004169148	2	8	Astrocytes	12	6	6
TATTACCAGTGCTGCC-1_7_G10	31.16192501	-10.2043703	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3293	7186	0.023657111	0.00542722	2	2	EN-L4	12	6	6
TATTACCCACTTAAGC-1_7_G10	-11.71636264	-30.49746281	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1514	2500	0.1452	0.0056	2	16	EN-PYR	12	6	6
TATTACCCAGGGAGAG-1_7_G10	20.32891257	-15.38117787	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	7697	32562	0.043025613	0.006756342	2	L2-3	EN-L2-3-MS	12	6	6
TATTACCTCACGGTTA-1_7_G10	-19.69632093	10.47352232	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	910	1255	0.004780876	0.007171315	2	8	Astrocytes	12	6	6
TATTACCTCTCGGACG-1_7_G10	-1.188437906	-20.91790218	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3097	7089	0.000846382	0.006912117	2	L2-3	EN-L2-3-Cntl	12	6	6
TCAACGAAGACAAGCC-1_7_G10	-14.19818419	-3.885929287	13A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3428	7471	0.005621737	0.006826395	2	13A	IN-VIP	12	6	6
TCAACGAAGTTCGATC-1_7_G10	4.684745712	33.64824733	1	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	751	1092	0.002747253	0.005494505	2	oligos	OL-Cntl	12	6	6
TCAACGAGTACCTACA-1_7_G10	31.78263772	-1.436373002	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2582	5133	0.0054549	0.006428989	2	2	EN-L4	12	6	6
TCAACGAGTTGTCTTT-1_7_G10	1.315550985	33.57848253	1	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	775	1092	0.004578755	0.008241758	2	oligos	OL-Cntl	12	6	6
TCAACGAGTTGTGGAG-1_7_G10	-15.66324334	11.69026314	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1273	2004	0.00249501	0.000998004	2	8	Astrocytes	12	6	6
TCAACGATCATTTGGG-1_7_G10	30.25119739	-6.486057821	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3992	9883	0.012749165	0.004755641	2	2	EN-L4	12	6	6
TCAACGATCCTAGTGA-1_7_G10	-7.208650957	-2.222251775	13A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1898	3343	0.009572241	0.006580915	2	13A	IN-VIP	12	6	6
TCAACGATCGTATCAG-1_7_G10	-23.16434201	14.10458299	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1052	1500	0.009333333	0.001333333	2	8	Astrocytes	12	6	6
TCAATCTAGAAGAAGC-1_7_G10	12.58051362	-19.96598073	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3987	9285	0.022509424	0.004846527	2	L2-3	EN-L2-3-MS	12	6	6
TCAATCTAGATGCCTT-1_7_G10	-1.546373774	31.22330555	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	953	1330	0.004511278	0.008270677	2	oligos	OL-MS-2	12	6	6
TCAATCTAGCAGCGTA-1_7_G10	-5.086783109	-30.69501292	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	715	1019	0.132482826	0.009813543	2	16	EN-PYR	12	6	6
TCAATCTAGTGAATTG-1_7_G10	-0.939074379	-15.21926799	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2113	4010	0.003491272	0.005735661	2	L2-3	EN-L2-3-Cntl	12	6	6
TCAATCTGTACTTGAC-1_7_G10	-0.540991958	34.81373633	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	775	1084	0.010147601	0.006457565	2	oligos	OL-MS-2	12	6	6
TCAATCTGTCCGCTGA-1_7_G10	-22.5908594	13.26334269	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1012	1427	0.009810792	0.002803083	2	8	Astrocytes	12	6	6
TCAATCTGTGCCTGGT-1_7_G10	23.43803058	27.79702353	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1065	1549	0.006455778	0.003227889	2	oligos	OL-MS-2	12	6	6
TCAATCTTCCTTTCGG-1_7_G10	-22.71514036	12.70809162	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1012	1533	0.005870841	0.003913894	2	8	Astrocytes	12	6	6
TCACAAGAGAACAATC-1_7_G10	26.06656505	-24.43959643	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4565	12083	0.005131176	0.00455185	2	3	EN-L5-6	12	6	6
TCACAAGCAAGCGATG-1_7_G10	-0.848427871	34.29071903	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	886	1237	0.004042037	0.004042037	2	oligos	OL-MS-2	12	6	6
TCACAAGCAATGGACG-1_7_G10	-3.06999322	35.3368476	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	778	1031	0.012609117	0.003879728	2	oligos	OL-MS-2	12	6	6
TCACAAGTCCGAACGC-1_7_G10	-6.665340492	34.02177761	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	895	1189	0.013456686	0.005046257	2	oligos	OL-MS-2	12	6	6
TCACAAGTCTTACCGC-1_7_G10	24.84685661	4.546643121	15BA	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1513	2236	0.007602862	0.009838998	2	15BA	Stromal cells	12	6	6
TCACGAAAGAGGTTGC-1_7_G10	1.185396858	32.80435009	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	982	1465	0.007508532	0.006143345	2	oligos	OL-MS-2	12	6	6
TCACGAAAGCGATATA-1_7_G10	-31.73532867	-2.113418943	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1263	2016	0.003472222	0.001984127	2	9	OPC	12	6	6
TCACGAACAAGGTGTG-1_7_G10	-20.38712154	13.85455736	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1173	1647	0.007893139	0.002428658	2	8	Astrocytes	12	6	6
TCACGAACAATCGAAA-1_7_G10	21.9532161	27.92533191	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	969	1391	0.002156722	0.005032351	2	oligos	OL-MS-2	12	6	6
TCACGAACATGCAACT-1_7_G10	-7.746260709	35.24604621	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	759	1001	0.007992008	0.002997003	2	oligos	OL-MS-2	12	6	6
TCACGAAGTCGAGATG-1_7_G10	-21.27326464	11.89086429	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	865	1159	0.002588438	0.006902502	2	8	Astrocytes	12	6	6
TCACGAAGTGAGGGTT-1_7_G10	-25.93296566	-5.184852068	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1327	2116	0.004725898	0.008034026	2	9	OPC	12	6	6
TCAGATGAGAGAGCTC-1_7_G10	23.37762682	-4.336212959	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2332	4629	0.00691294	0.003672499	2	L2-3	EN-L2-3-Cntl	12	6	6
TCAGATGCAAACGCGA-1_7_G10	-20.96451226	13.77712227	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1160	1698	0.010011779	0.004711425	2	8	Astrocytes	12	6	6
TCAGATGCACGCCAGT-1_7_G10	10.70304513	-34.06872122	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	5517	18730	0.001761879	0.002509343	2	3	EN-L5-6	12	6	6
TCAGATGCACTCAGGC-1_7_G10	-17.53067827	8.726230117	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	944	1300	0.004615385	0.003076923	2	8	Astrocytes	12	6	6
TCAGATGCAGTATAAG-1_7_G10	18.99425411	-17.52149776	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	5223	14449	0.015641221	0.008097446	2	L2-3	EN-L2-3-MS	12	6	6
TCAGATGGTCAGAAGC-1_7_G10	2.511309057	-13.21127257	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2177	4432	0.007445848	0.004061372	2	L2-3	EN-L2-3-MS	12	6	6
TCAGATGGTCAGCTAT-1_7_G10	-15.21513642	-36.51275683	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3066	6314	0.069528033	0.00617675	2	16	EN-PYR	12	6	6
TCAGATGTCAAGCCTA-1_7_G10	-17.45621701	8.486612579	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	952	1275	0.002352941	0.008627451	2	8	Astrocytes	12	6	6
TCAGATGTCACAGGCC-1_7_G10	-31.5137944	-1.113230683	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1580	2639	0.007578628	0.013641531	2	9	OPC	12	6	6
TCAGCAACACTTAACG-1_7_G10	-8.455912252	-30.59942549	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1007	1439	0.078526755	0.006254343	2	16	EN-PYR	12	6	6
TCAGCAACATCGATTG-1_7_G10	-3.507371851	35.08227322	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	763	1013	0.011846002	0.006910168	2	oligos	OL-MS-2	12	6	6
TCAGCAACATCGGGTC-1_7_G10	-2.872198668	35.2190849	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	782	1007	0.003972195	0.007944389	2	oligos	OL-MS-2	12	6	6
TCAGCAAGTAGCGTCC-1_7_G10	32.86430513	-2.748779419	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2718	5382	0.008175399	0.004273504	2	2	EN-L4	12	6	6
TCAGCAAGTCCCTTGT-1_7_G10	2.015465788	6.83901305	7	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	880	1170	0.005128205	0.005128205	2	7	Phagocytes	12	6	6
TCAGCAATCACCCTCA-1_7_G10	-0.888268507	33.03236144	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	878	1213	0.002473207	0.006595218	2	oligos	OL-MS-2	12	6	6
TCAGCAATCCGAATGT-1_7_G10	-8.561238257	-28.22357372	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1076	1534	0.097131682	0.003911343	2	16	EN-PYR	12	6	6
TCAGCTCCAATCAGAA-1_7_G10	-21.01622819	11.9727715	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	808	1124	0.005338078	0.003558719	2	8	Astrocytes	12	6	6
TCAGCTCCACCTGGTG-1_7_G10	2.170672159	4.999867654	14	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	962	1228	0.009771987	0.008957655	2	14	Microglia	12	6	6
TCAGCTCCACGAAAGC-1_7_G10	29.82111924	-7.294181732	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	6647	25083	0.013993541	0.010843998	2	2	EN-L4	12	6	6
TCAGCTCGTACAGTGG-1_7_G10	-0.859897213	29.81090413	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	746	1022	0.002935421	0.006849315	2	oligos	OL-MS-2	12	6	6
TCAGCTCGTCTAGGTT-1_7_G10	-6.912488832	31.9691143	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1071	1469	0.014976174	0.007488087	2	oligos	OL-MS-2	12	6	6
TCAGCTCGTCTTCAAG-1_7_G10	3.000005303	-18.72095109	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2924	6027	0.00215696	0.010784802	2	L2-3	EN-L2-3-MS	12	6	6
TCAGCTCGTTACGCGC-1_7_G10	2.774333022	-15.35898994	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2351	4134	0.003628447	0.010159652	2	L2-3	EN-L2-3-MS	12	6	6
TCAGGATCAGCCAATT-1_7_G10	22.41698809	25.64917315	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1105	1624	0.006773399	0.009236453	2	oligos	OL-MS-2	12	6	6
TCAGGATGTCAGGACA-1_7_G10	-5.769519007	34.6149579	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	833	1064	0.012218045	0.00093985	2	oligos	OL-MS-2	12	6	6
TCAGGATGTGAAATCA-1_7_G10	-14.30715911	-6.366691883	13A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2470	4821	0.016386642	0.005807924	2	13A	IN-VIP	12	6	6
TCAGGTAAGCACGCCT-1_7_G10	27.338728	5.658847865	15A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	916	1169	0.015397776	0.0213858	2	15A	Endo cells	12	6	6
TCAGGTAAGTATCTCG-1_7_G10	29.30280376	-5.79218206	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4143	12763	0.002899005	0.004857792	2	2	EN-L4	12	6	6
TCAGGTACAGCCTGTG-1_7_G10	-13.63768923	-11.13155383	13B	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1968	3666	0.002454992	0.005728314	2	13B	IN-SV2C	12	6	6
TCAGGTACATAAAGGT-1_7_G10	3.100633543	-14.94671132	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2279	4009	0.003741581	0.010725867	2	L2-3	EN-L2-3-MS	12	6	6
TCAGGTAGTAACGCGA-1_7_G10	31.64199169	-1.771132288	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2817	5884	0.004418763	0.00917743	2	2	EN-L4	12	6	6
TCAGGTATCAACGCTA-1_7_G10	6.083887486	-15.01109413	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2657	5082	0.017119244	0.008264463	2	L2-3	EN-L2-3-MS	12	6	6
TCAGGTATCTGCTTGC-1_7_G10	22.89049103	27.24006779	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1135	1747	0.004006869	0.005151689	2	oligos	OL-MS-2	12	6	6
TCAGGTATCTTGTTTG-1_7_G10	3.207194596	32.06126303	1	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	810	1137	0.00351803	0.002638522	2	oligos	OL-Cntl	12	6	6
TCATTACAGGCAGTCA-1_7_G10	-21.19689915	-22.92546861	6A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2223	4091	0.009288682	0.009533121	2	6A	IN-PV	12	6	6
TCATTACAGTTCGCAT-1_7_G10	4.632737677	1.492463162	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	846	1055	0.034123223	0.006635071	2	16	EN-PYR	12	6	6
TCATTACGTCAACATC-1_7_G10	7.706848184	-29.62092869	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	5347	17714	0.00536299	0.003387151	2	L2-3	EN-L2-3-Cntl	12	6	6
TCATTACGTGCTTCTC-1_7_G10	-12.29364877	-17.48855214	6B	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1171	1884	0.008492569	0.001061571	2	6B	IN-SST	12	6	6
TCATTACTCCACGACG-1_7_G10	21.33701189	25.66271223	1	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	926	1325	0.005283019	0.008301887	2	oligos	OL-Cntl	12	6	6
TCATTACTCCCATTAT-1_7_G10	-11.67496152	-30.6685116	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1372	2060	0.072330097	0.00776699	2	16	EN-PYR	12	6	6
TCATTACTCCCTAATT-1_7_G10	-19.3390514	10.90657151	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	733	1021	0.005876592	0.00489716	2	8	Astrocytes	12	6	6
TCATTACTCTAGCACA-1_7_G10	-6.149799258	33.45098888	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	960	1311	0.006102212	0.007627765	2	oligos	OL-MS-2	12	6	6
TCATTTGAGGATGGTC-1_7_G10	5.504061036	-14.12961896	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2278	3974	0.009562154	0.006542526	2	L2-3	EN-L2-3-MS	12	6	6
TCATTTGCAATTGCTG-1_7_G10	29.59827663	-0.593195573	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3026	7033	0.00312811	0.004692166	2	2	EN-L4	12	6	6
TCATTTGGTAGCTGCC-1_7_G10	21.74223777	-19.87756785	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	5793	19489	0.017907538	0.009441223	2	3	EN-L5-6	12	6	6
TCATTTGGTCTCGTTC-1_7_G10	-14.51045616	-3.70434785	13A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3718	8897	0.013375295	0.008205013	2	13A	IN-VIP	12	6	6
TCATTTGTCGTCTGCT-1_7_G10	25.00258131	7.268385994	15A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1758	2599	0.032320123	0.016929588	2	15A	Endo cells	12	6	6
TCATTTGTCTACTTAC-1_7_G10	-15.55736385	11.4747106	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1429	2116	0.004725898	0.002362949	2	8	Astrocytes	12	6	6
TCATTTGTCTGGTGTA-1_7_G10	25.71536774	3.685820634	15BA	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1000	1418	0.003526093	0.002820874	2	15BA	Stromal cells	12	6	6
TCCACACCAATGGAAT-1_7_G10	12.92235331	-1.509737527	12	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1062	1513	0.005287508	0.006609385	2	12	EN-MIX	12	6	6
TCCACACCAATGGATA-1_7_G10	-25.68797876	-9.025647496	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	876	1206	0.005804312	0.001658375	2	9	OPC	12	6	6
TCCACACCACAGCGTC-1_7_G10	31.35891568	-9.356604659	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4122	9779	0.01810001	0.005010737	2	2	EN-L4	12	6	6
TCCACACCATTGGTAC-1_7_G10	25.50926017	5.160850752	15A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1183	1574	0.01905972	0.006988564	2	15A	Endo cells	12	6	6
TCCACACGTAAATACG-1_7_G10	-7.82978718	30.83601681	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1642	2401	0.010412328	0.004581424	2	oligos	OL-MS-2	12	6	6
TCCACACGTAGCACGA-1_7_G10	-7.25502844	35.21845644	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	825	1092	0.006410256	0.003663004	2	oligos	OL-MS-2	12	6	6
TCCACACGTTGCCTCT-1_7_G10	13.62264156	-33.46544305	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4418	15526	0.001803427	0.00302718	2	3	EN-L5-6	12	6	6
TCCACACTCTTGAGGT-1_7_G10	30.34338514	-2.715506255	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3655	8308	0.004694271	0.005657198	2	2	EN-L4	12	6	6
TCCCGATAGAACTGTA-1_7_G10	23.59574236	26.61635393	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1264	1865	0.010723861	0.001608579	2	oligos	OL-MS-2	12	6	6
TCCCGATAGAGCTGCA-1_7_G10	0.637982028	-23.06594792	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4062	10294	0.003302895	0.002720031	2	L2-3	EN-L2-3-Cntl	12	6	6
TCCCGATAGCAAATCA-1_7_G10	-34.19070728	-7.198944277	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1202	1844	0.003253796	0.004338395	2	9	OPC	12	6	6
TCCCGATAGCCGTCGT-1_7_G10	3.52269589	-20.45302106	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3330	6983	0.004868967	0.004868967	2	L2-3	EN-L2-3-MS	12	6	6
TCCCGATAGCGTTTAC-1_7_G10	2.096296703	6.157997134	7	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1154	1508	0.012599469	0.00530504	2	7	Phagocytes	12	6	6
TCCCGATCACAGGCCT-1_7_G10	28.42677314	-5.315987219	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3789	9634	0.002075981	0.00871912	2	2	EN-L4	12	6	6
TCCCGATCAGCCTTTC-1_7_G10	0.662237356	33.69112362	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	843	1215	0.006584362	0.008230453	2	oligos	OL-MS-2	12	6	6
TCCCGATCATAGGATA-1_7_G10	15.36781084	-25.39711421	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3126	6468	0.01144094	0.005411255	2	L2-3	EN-L2-3-MS	12	6	6
TCCCGATCATTACCTT-1_7_G10	-15.72910161	15.34722353	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2099	3513	0.011101623	0.003985198	2	8	Astrocytes	12	6	6
TCCCGATGTAGCACGA-1_7_G10	-20.66263103	13.19025369	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1102	1578	0.004435995	0.007604563	2	8	Astrocytes	12	6	6
TCCCGATGTCATGCCG-1_7_G10	-25.22303572	-5.467098317	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1379	2255	0.002660754	0.003104213	2	9	OPC	12	6	6
TCCCGATGTTCAGCGC-1_7_G10	20.99672201	28.53773829	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	891	1257	0.003977725	0.003977725	2	oligos	OL-MS-2	12	6	6
TCCCGATTCTCACATT-1_7_G10	1.533144404	-20.36284609	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3261	7339	0.006404142	0.008175501	2	L2-3	EN-L2-3-Cntl	12	6	6
TCCCGATTCTGGTTCC-1_7_G10	28.17160256	0.828640509	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2564	5867	0.002727118	0.003068007	2	2	EN-L4	12	6	6
TCGAGGCCACCCATGG-1_7_G10	10.64120868	2.243733548	12	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	850	1065	0.021596244	0.005633803	2	12	EN-MIX	12	6	6
TCGAGGCGTATCGCAT-1_7_G10	-7.17901552	33.67168175	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	927	1252	0.009584665	0.006389776	2	oligos	OL-MS-2	12	6	6
TCGAGGCGTCTCCACT-1_7_G10	20.04711868	-16.6971903	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	8613	44418	0.075509928	0.00603359	2	L2-3	EN-L2-3-MS	12	6	6
TCGAGGCGTGTTGGGA-1_7_G10	-0.177890413	34.91187331	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	892	1246	0.009630819	0.005617978	2	oligos	OL-MS-2	12	6	6
TCGAGGCTCGATCCCT-1_7_G10	2.712604078	5.269880931	7	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1102	1498	0.00200267	0.006675567	2	7	Phagocytes	12	6	6
TCGAGGCTCGCTAGCG-1_7_G10	-14.45529985	-3.633267201	13A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3557	7871	0.013848304	0.005844238	2	13A	IN-VIP	12	6	6
TCGAGGCTCGTACGGC-1_7_G10	-0.086831115	-26.42535929	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	5319	16973	0.006009545	0.005597125	2	L2-3	EN-L2-3-Cntl	12	6	6
TCGCGAGAGCGGCTTC-1_7_G10	31.74523207	-1.084791343	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2590	5071	0.003352396	0.007099191	2	2	EN-L4	12	6	6
TCGCGAGAGGCACATG-1_7_G10	-16.91232553	-15.70828182	6B	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2021	3570	0.019327731	0.008123249	2	6B	IN-SST	12	6	6
TCGCGAGAGTGACTCT-1_7_G10	25.49450462	6.309775888	15A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1511	2100	0.038571429	0.017619048	2	15A	Endo cells	12	6	6
TCGCGAGGTTGCTCCT-1_7_G10	20.82211277	27.66396326	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	912	1289	0.003103181	0.006206362	2	oligos	OL-MS-2	12	6	6
TCGCGTTAGATCGGGT-1_7_G10	6.334142159	-15.4294959	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2907	5678	0.01179993	0.008805918	2	L2-3	EN-L2-3-MS	12	6	6
TCGCGTTAGGATGTAT-1_7_G10	20.97789633	-11.78527978	12	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2317	3805	0.035479632	0.009461235	2	12	EN-MIX	12	6	6
TCGCGTTCACAGGCCT-1_7_G10	31.33690085	-10.23538369	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3049	6085	0.018077239	0.006080526	2	2	EN-L4	12	6	6
TCGCGTTGTCTCTTAT-1_7_G10	2.03451234	6.54502538	7	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	812	1074	0.006517691	0.006517691	2	7	Phagocytes	12	6	6
TCGCGTTTCACGACTA-1_7_G10	1.712384436	-22.48460434	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3652	8778	0.003303714	0.00683527	2	L2-3	EN-L2-3-Cntl	12	6	6
TCGCGTTTCCTTGACC-1_7_G10	-13.17831813	-17.12888917	6B	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1231	2026	0.027147088	0.014313919	2	6B	IN-SST	12	6	6
TCGGGACAGCGTAATA-1_7_G10	-15.82236202	-9.338936892	13B	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2359	4520	0.012831858	0.002654867	2	13B	IN-SV2C	12	6	6
TCGGGACAGGTGCAAC-1_7_G10	16.39208852	-28.26338172	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4704	12360	0.009061489	0.008090615	2	3	EN-L5-6	12	6	6
TCGGGACCATCTACGA-1_7_G10	23.88121321	-11.95912273	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3741	8620	0.014153132	0.006148492	2	3	EN-L5-6	12	6	6
TCGGGACGTTAAGGGC-1_7_G10	-3.464225744	32.16465539	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1048	1426	0.00911641	0.004908836	2	oligos	OL-MS-2	12	6	6
TCGGTAACAGTCACTA-1_7_G10	-26.08563706	-6.212771059	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1161	1860	0.006451613	0.003225806	2	9	OPC	12	6	6
TCGGTAACATTAGCCA-1_7_G10	32.73128114	-4.397129274	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3270	6869	0.008443733	0.005532101	2	2	EN-L4	12	6	6
TCGGTAACATTCCTGC-1_7_G10	3.712426103	-26.98727405	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3459	9495	0.003580832	0.002106372	2	L2-3	EN-L2-3-Cntl	12	6	6
TCGGTAATCCCAGGTG-1_7_G10	29.66051323	-11.38878849	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3741	8347	0.025038936	0.00850605	2	2	EN-L4	12	6	6
TCGGTAATCCCTAACC-1_7_G10	-11.54149616	29.02002699	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1762	2661	0.051860203	0.007515971	2	oligos	OL-MS-2	12	6	6
TCGTACCCAAGGCTCC-1_7_G10	-25.00916856	-22.24335839	6A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3303	7572	0.029714739	0.00528262	2	6A	IN-PV	12	6	6
TCGTACCCATAACCTG-1_7_G10	10.01323676	-29.0820949	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	7140	28510	0.011785338	0.006068046	2	3	EN-L5-6	12	6	6
TCGTACCTCAATACCG-1_7_G10	-9.773768382	-32.00483567	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1177	1890	0.128042328	0.006349206	2	16	EN-PYR	12	6	6
TCGTAGAAGTGAACGC-1_7_G10	-11.57587652	28.95531028	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1716	2548	0.054945055	0.009419152	2	oligos	OL-MS-2	12	6	6
TCGTAGACACACTGCG-1_7_G10	-14.52158232	-6.851662115	13A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2820	5819	0.013060663	0.003952569	2	13A	IN-VIP	12	6	6
TCGTAGACACATAACC-1_7_G10	-1.043458676	34.74489419	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	756	1017	0.007866273	0.007866273	2	oligos	OL-MS-2	12	6	6
TCGTAGACAGATGAGC-1_7_G10	-0.367885367	33.76187414	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	861	1224	0.005718954	0.006535948	2	oligos	OL-MS-2	12	6	6
TCGTAGAGTAGGAGTC-1_7_G10	3.457876927	-20.4718596	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3376	7361	0.011275642	0.010732237	2	L2-3	EN-L2-3-MS	12	6	6
TCGTAGAGTCAACATC-1_7_G10	5.869516332	-16.46518789	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2890	5540	0.005234657	0.012635379	2	L2-3	EN-L2-3-MS	12	6	6
TCGTAGAGTTAAGAAC-1_7_G10	-26.4214654	-7.701148225	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1159	1663	0.00420926	0.008418521	2	9	OPC	12	6	6
TCGTAGATCGAATGCT-1_7_G10	31.21612195	-1.43854273	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2902	5980	0.005016722	0.009364548	2	2	EN-L4	12	6	6
TCGTAGATCTTGCCGT-1_7_G10	-8.732804881	33.73471714	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	837	1150	0.026956522	0.005217391	2	oligos	OL-MS-2	12	6	6
TCTATTGAGAATTCCC-1_7_G10	-12.98637732	3.254610482	13A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2464	4688	0.007892491	0.002773038	2	13A	IN-VIP	12	6	6
TCTATTGAGGAACTGC-1_7_G10	7.048799488	-29.15379148	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4058	10461	0.0069783	0.003536947	2	L2-3	EN-L2-3-Cntl	12	6	6
TCTATTGCAAGAAGAG-1_7_G10	-18.83063268	-23.33519222	6A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2177	4384	0.022582117	0.003649635	2	6A	IN-PV	12	6	6
TCTATTGGTTAAGACA-1_7_G10	-2.278486388	-1.118741758	11	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1872	3107	0.01158674	0.003540393	2	11	Glia-MIX	12	6	6
TCTCATAAGGCAGTCA-1_7_G10	5.925362405	-15.55649621	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2555	4788	0.006265664	0.016499582	2	L2-3	EN-L2-3-MS	12	6	6
TCTCATAAGGGTTCCC-1_7_G10	8.117776614	-26.52624259	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3822	9961	0.009336412	0.003112137	2	L2-3	EN-L2-3-Cntl	12	6	6
TCTCATAAGTTTAGGA-1_7_G10	-12.09330063	-1.246987996	13A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2461	4994	0.031437725	0.004405286	2	13A	IN-VIP	12	6	6
TCTCATAGTAAACCTC-1_7_G10	22.458757	-17.99272475	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	7775	34996	0.043662133	0.008515259	2	3	EN-L5-6	12	6	6
TCTCATAGTCAAACTC-1_7_G10	-4.534287405	30.04652713	11	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	994	1364	0.007331378	0.01026393	2	11	Glia-MIX	12	6	6
TCTCATATCAACCAAC-1_7_G10	29.39869761	-11.57810683	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4655	12027	0.014633741	0.009811258	2	2	EN-L4	12	6	6
TCTCATATCGCACTCT-1_7_G10	-0.210434363	32.79469229	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	840	1160	0.009482759	0.003448276	2	oligos	OL-MS-2	12	6	6
TCTCATATCGGAAATA-1_7_G10	8.543386633	-29.29448249	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	5203	15785	0.008615774	0.004181185	2	L2-3	EN-L2-3-Cntl	12	6	6
TCTCATATCTGGGCCA-1_7_G10	-14.22839897	-4.335048228	13A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3075	6925	0.007509025	0.007797834	2	13A	IN-VIP	12	6	6
TCTCTAAAGTTGTAGA-1_7_G10	26.23807353	-24.12828913	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	5090	14482	0.003659716	0.004281177	2	3	EN-L5-6	12	6	6
TCTCTAACACTTCGAA-1_7_G10	12.83617436	-1.306700513	12	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1111	1755	0.004558405	0.01025641	2	12	EN-MIX	12	6	6
TCTCTAACATCCTTGC-1_7_G10	-20.40520889	11.82909641	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	907	1283	0.010132502	0.003117693	2	8	Astrocytes	12	6	6
TCTCTAACATTGGGCC-1_7_G10	-20.61231625	-27.39613785	6A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3523	8883	0.005628729	0.005291005	2	6A	IN-PV	12	6	6
TCTCTAAGTACAAGTA-1_7_G10	7.810828337	-32.25654187	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3443	8597	0.002559032	0.004071188	2	L2-3	EN-L2-3-Cntl	12	6	6
TCTCTAATCGTAGGTT-1_7_G10	19.1262538	-7.274967423	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1961	3984	0.001757028	0.003263052	2	3	EN-L5-6	12	6	6
TCTGAGAAGACGCTTT-1_7_G10	22.53933378	28.35678611	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	974	1404	0.004273504	0.008547009	2	oligos	OL-MS-2	12	6	6
TCTGAGAAGTATCGAA-1_7_G10	31.52757756	-7.440878515	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2670	5136	0.007788162	0.004478193	2	2	EN-L4	12	6	6
TCTGAGACAACGATGG-1_7_G10	15.11638256	29.46131424	1	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	827	1182	0.007614213	0.001692047	2	oligos	OL-Cntl	12	6	6
TCTGAGACACATTTCT-1_7_G10	-25.96135765	-8.274400492	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1141	1626	0.010455105	0.007380074	2	9	OPC	12	6	6
TCTGAGACATTGCGGC-1_7_G10	-2.509438277	31.39340465	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	964	1363	0.006603081	0.005869406	2	oligos	OL-MS-2	12	6	6
TCTGAGACATTGTGCA-1_7_G10	6.359405078	-8.468329972	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2353	4254	0.003526093	0.003761166	2	L2-3	EN-L2-3-MS	12	6	6
TCTGAGAGTCACCCAG-1_7_G10	-9.807727592	-13.6005014	6B	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1171	1690	0.016568047	0.004142012	2	6B	IN-SST	12	6	6
TCTGAGAGTCTGATCA-1_7_G10	30.99033099	-10.90361806	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3731	7996	0.022261131	0.010505253	2	2	EN-L4	12	6	6
TCTGAGAGTGAAAGAG-1_7_G10	2.712243879	-12.06019047	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1980	3306	0.005444646	0.007259528	2	L2-3	EN-L2-3-MS	12	6	6
TCTGAGAGTTACGCGC-1_7_G10	27.80633726	-4.622694553	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3389	7959	0.001256439	0.006784772	2	2	EN-L4	12	6	6
TCTGAGAGTTCCATGA-1_7_G10	-1.449892921	34.38556368	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	826	1125	0.008	0.003555556	2	oligos	OL-MS-2	12	6	6
TCTGAGATCAGAGCTT-1_7_G10	1.035258899	30.6999506	1	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	781	1044	0.005747126	0.001915709	2	oligos	OL-Cntl	12	6	6
TCTGAGATCGAATGCT-1_7_G10	20.48312912	26.66804972	1	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	919	1334	0.002998501	0.002248876	2	oligos	OL-Cntl	12	6	6
TCTGAGATCGGTGTTA-1_7_G10	32.73600058	-4.685532132	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3107	6472	0.007725587	0.004017305	2	2	EN-L4	12	6	6
TCTGAGATCTGTGCAA-1_7_G10	24.32143368	-11.16812786	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4678	11849	0.007342392	0.007173601	2	3	EN-L5-6	12	6	6
TCTGGAAAGGCTCTTA-1_7_G10	27.77176661	5.324208328	15A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	823	1050	0.032380952	0.016190476	2	15A	Endo cells	12	6	6
TCTGGAACACGCTTTC-1_7_G10	-20.40273888	-27.77243981	6A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3093	6979	0.004871758	0.002722453	2	6A	IN-PV	12	6	6
TCTGGAAGTTCCACGG-1_7_G10	-5.40372055	-28.0617055	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	788	1123	0.138023152	0.00890472	2	16	EN-PYR	12	6	6
TCTGGAATCGTGGGAA-1_7_G10	2.864824906	-27.07046191	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2816	6163	0.007301639	0.005030018	2	L2-3	EN-L2-3-Cntl	12	6	6
TCTTCGGAGCGCCTTG-1_7_G10	0.802116215	-23.52263628	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3628	9301	0.003332975	0.002365337	2	L2-3	EN-L2-3-Cntl	12	6	6
TCTTCGGAGCTCAACT-1_7_G10	-24.15738501	-7.579555445	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1376	2097	0.007629948	0.003814974	2	9	OPC	12	6	6
TCTTCGGAGCTGCAAG-1_7_G10	7.547641483	23.96625784	1	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	974	1332	0.000750751	0.004504505	2	oligos	OL-Cntl	12	6	6
TCTTCGGAGTCGTACT-1_7_G10	-0.049288007	31.4091151	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	744	1055	0.001895735	0.004739336	2	oligos	OL-MS-2	12	6	6
TCTTCGGGTATTCGTG-1_7_G10	-26.42757604	-6.154534361	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1027	1536	0.00390625	0.002604167	2	9	OPC	12	6	6
TCTTCGGGTCTGCAAT-1_7_G10	-11.42481853	-33.07318006	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1395	2249	0.115606936	0.009337483	2	16	EN-PYR	12	6	6
TCTTCGGTCACTATTC-1_7_G10	-4.243427901	33.54442766	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	911	1252	0.012779553	0.005591054	2	oligos	OL-MS-2	12	6	6
TCTTTCCAGATGAGAG-1_7_G10	22.90859198	17.29876022	1	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1215	1795	0.003342618	0.005013928	2	oligos	OL-Cntl	12	6	6
TCTTTCCAGCACACAG-1_7_G10	-10.89861536	-32.21543457	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1265	1974	0.079533941	0.010638298	2	16	EN-PYR	12	6	6
TCTTTCCAGGATGGAA-1_7_G10	-14.30278611	8.985872081	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1398	2024	0.019762846	0.005434783	2	8	Astrocytes	12	6	6
TCTTTCCAGGTCATCT-1_7_G10	7.083011778	32.92281811	1	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	853	1231	0.004061738	0.008123477	2	oligos	OL-Cntl	12	6	6
TCTTTCCCACCACCAG-1_7_G10	-22.03260381	-19.58490308	6A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2697	5623	0.019740352	0.003023297	2	6A	IN-PV	12	6	6
TCTTTCCCACGACTCG-1_7_G10	6.790442792	2.351754674	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	830	1028	0.029182879	0.006809339	2	16	EN-PYR	12	6	6
TCTTTCCCAGCCTTTC-1_7_G10	16.29617099	-32.72808577	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4733	16210	0.0038248	0.003516348	2	3	EN-L5-6	12	6	6
TCTTTCCGTAGTACCT-1_7_G10	-20.0638578	15.02316488	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1240	1777	0.010129432	0.005627462	2	8	Astrocytes	12	6	6
TCTTTCCGTTAGGGTG-1_7_G10	16.03560465	-29.3478889	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4032	10862	0.010311177	0.005155588	2	3	EN-L5-6	12	6	6
TCTTTCCTCGTATCAG-1_7_G10	-21.64639453	13.02943247	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1073	1645	0.003039514	0.004255319	2	8	Astrocytes	12	6	6
TCTTTCCTCTCGAGTA-1_7_G10	-14.19931755	-5.076462313	13A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2678	5238	0.009163803	0.008400153	2	13A	IN-VIP	12	6	6
TGAAAGAGTAAAGTCA-1_7_G10	-1.160900389	34.77794932	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	768	1060	0.001886792	0.005660377	2	oligos	OL-MS-2	12	6	6
TGAAAGAGTATCGCAT-1_7_G10	-15.93601778	11.84156221	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1210	1699	0.005297234	0.003531489	2	8	Astrocytes	12	6	6
TGAAAGAGTCCAGTGC-1_7_G10	33.54049958	-3.936707547	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2559	4743	0.004849252	0.006535948	2	2	EN-L4	12	6	6
TGAAAGAGTGTAATGA-1_7_G10	-17.46454194	-16.22743477	6B	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2301	4355	0.022732491	0.01423651	2	6B	IN-SST	12	6	6
TGAAAGATCAAGGCTT-1_7_G10	0.036141708	-27.29355565	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4448	13570	0.001473839	0.003537214	2	L2-3	EN-L2-3-Cntl	12	6	6
TGACAACCAAGACACG-1_7_G10	-19.71831939	15.30951192	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1371	2057	0.004861449	0.007292173	2	8	Astrocytes	12	6	6
TGACAACCACTCTGTC-1_7_G10	28.56022465	-13.40070123	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	5965	19023	0.027387899	0.008883983	2	2	EN-L4	12	6	6
TGACAACGTAAATGAC-1_7_G10	33.05513588	-5.266129656	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3089	6363	0.017758919	0.003143171	2	2	EN-L4	12	6	6
TGACAACTCACATAGC-1_7_G10	19.18082077	-28.09951303	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4099	10983	0.001092598	0.011745425	2	3	EN-L5-6	12	6	6
TGACAACTCACTCCTG-1_7_G10	-32.00772911	-0.379699406	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1691	2857	0.003150158	0.003850193	2	9	OPC	12	6	6
TGACGGCAGCACCGCT-1_7_G10	33.76971938	-3.520272086	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2664	5413	0.018658784	0.00424903	2	2	EN-L4	12	6	6
TGACGGCAGCTAGCCC-1_7_G10	-21.49660753	-26.43463809	6A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3401	8168	0.002571009	0.005142018	2	6A	IN-PV	12	6	6
TGACTAGCAGCAGTTT-1_7_G10	-19.33200624	-9.44592398	6A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4936	14710	0.015907546	0.005914344	2	6A	IN-PV	12	6	6
TGACTAGCATACTACG-1_7_G10	-0.751114443	32.42774165	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	883	1285	0.004669261	0.003891051	2	oligos	OL-MS-2	12	6	6
TGACTAGCATGAACCT-1_7_G10	8.330080541	-29.46155922	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	5777	20066	0.006976976	0.005182896	2	L2-3	EN-L2-3-Cntl	12	6	6
TGACTAGGTTCGGGCT-1_7_G10	-34.33123937	-6.992590009	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1169	1789	0.005030743	0.0039128	2	9	OPC	12	6	6
TGACTAGTCTGGAGCC-1_7_G10	-0.198830137	33.45244113	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	751	1106	0.004520796	0.002712477	2	oligos	OL-MS-2	12	6	6
TGACTTTAGCACAGGT-1_7_G10	-21.93491246	16.36332555	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1261	1947	0.002568053	0.004622496	2	8	Astrocytes	12	6	6
TGACTTTAGTAGATGT-1_7_G10	-10.72004898	15.59168631	11	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1553	2394	0.015455305	0.00459482	2	11	Glia-MIX	12	6	6
TGACTTTGTAGCGTGA-1_7_G10	-24.42048847	-12.34650297	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	740	1015	0.008866995	0.00591133	2	9	OPC	12	6	6
TGACTTTTCACGATGT-1_7_G10	20.6818654	-27.78508352	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2947	6871	0.002037549	0.005093873	2	3	EN-L5-6	12	6	6
TGACTTTTCACTTACT-1_7_G10	24.82571253	-29.41307988	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3038	7749	0.001806685	0.00477481	2	3	EN-L5-6	12	6	6
TGACTTTTCCCATTAT-1_7_G10	6.716169732	2.358784756	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	973	1246	0.036918138	0.004815409	2	16	EN-PYR	12	6	6
TGACTTTTCCGGGTGT-1_7_G10	31.54661612	-9.517740226	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3860	8903	0.008873413	0.009547344	2	2	EN-L4	12	6	6
TGACTTTTCCTGTACC-1_7_G10	-10.94982246	1.013044092	13A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2764	6411	0.004679457	0.006083294	2	13A	IN-VIP	12	6	6
TGACTTTTCGACCAGC-1_7_G10	22.43971983	28.09076366	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1022	1491	0.003353454	0.001341382	2	oligos	OL-MS-2	12	6	6
TGAGAGGAGTCGTACT-1_7_G10	-14.86697151	-20.81559339	6A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1450	2431	0.007815714	0.004524887	2	6A	IN-PV	12	6	6
TGAGAGGGTATTCTCT-1_7_G10	9.655366769	34.3501377	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	863	1231	0.004061738	0.001624695	2	oligos	OL-MS-2	12	6	6
TGAGAGGGTGGTCTCG-1_7_G10	16.02530901	-32.32939571	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4996	14763	0.001287001	0.007654271	2	3	EN-L5-6	12	6	6
TGAGAGGGTTTCCACC-1_7_G10	-3.088862019	32.28981664	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	934	1287	0.001554002	0.005439005	2	oligos	OL-MS-2	12	6	6
TGAGCATAGTTTAGGA-1_7_G10	8.692803424	-21.13906169	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4049	9740	0.005338809	0.014373717	2	L2-3	EN-L2-3-MS	12	6	6
TGAGCATCATTCCTGC-1_7_G10	-9.1696065	-31.47277215	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1179	1830	0.145901639	0.006557377	2	16	EN-PYR	12	6	6
TGAGCATGTCATACTG-1_7_G10	-5.541746649	34.7285363	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	872	1123	0.011576135	0.007123776	2	oligos	OL-MS-2	12	6	6
TGAGCATGTGTGTGCC-1_7_G10	5.231591797	-12.72537774	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2092	3555	0.009845288	0.009845288	2	L2-3	EN-L2-3-MS	12	6	6
TGAGCATTCACAGTAC-1_7_G10	-2.563177026	31.87356985	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	921	1238	0.008077544	0.004846527	2	oligos	OL-MS-2	12	6	6
TGAGCATTCCACGTTC-1_7_G10	26.26964583	-29.89484177	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3714	9086	0.001650891	0.003631961	2	3	EN-L5-6	12	6	6
TGAGCCGAGCGATGAC-1_7_G10	-4.114299925	36.10878766	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	773	1002	0.00998004	0.003992016	2	oligos	OL-MS-2	12	6	6
TGAGCCGAGCGTCTAT-1_7_G10	-5.265704855	-33.67123984	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	939	1300	0.073076923	0.006923077	2	16	EN-PYR	12	6	6
TGAGCCGAGTGTACGG-1_7_G10	18.72226374	-34.62758544	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3744	9848	0.001523152	0.004264825	2	3	EN-L5-6	12	6	6
TGAGCCGCACAGTCGC-1_7_G10	-14.02833913	-16.10988472	6B	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1425	2216	0.006768953	0.007220217	2	6B	IN-SST	12	6	6
TGAGCCGCAGGCAGTA-1_7_G10	1.911621161	30.8977187	1	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	691	1000	0.003	0	2	oligos	OL-Cntl	12	6	6
TGAGGGACAAAGGTGC-1_7_G10	-1.196562324	31.47964193	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	803	1110	0.002702703	0.003603604	2	oligos	OL-MS-2	12	6	6
TGAGGGACAGATCTGT-1_7_G10	22.02655578	13.47919628	1	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1337	2275	0.006153846	0.007032967	2	oligos	OL-Cntl	12	6	6
TGAGGGACAGGTCGTC-1_7_G10	22.65724464	-18.08955197	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	7576	30487	0.020598944	0.009610654	2	3	EN-L5-6	12	6	6
TGAGGGAGTAAGTGGC-1_7_G10	-9.545043381	17.79393166	11	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2338	4211	0.003087153	0.005461886	2	11	Glia-MIX	12	6	6
TGATTTCAGAGACTAT-1_7_G10	3.971825993	-18.99754109	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3387	7629	0.007209333	0.012059248	2	L2-3	EN-L2-3-MS	12	6	6
TGATTTCAGAGTCGGT-1_7_G10	20.10827108	-22.55897862	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3989	8501	0.011057523	0.012586754	2	3	EN-L5-6	12	6	6
TGATTTCCAGACAGGT-1_7_G10	2.436905233	-16.56405012	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2660	5343	0.004304698	0.005053341	2	L2-3	EN-L2-3-MS	12	6	6
TGATTTCGTAAGTTCC-1_7_G10	2.325940052	-25.00181381	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2561	5179	0.0015447	0.003861749	2	L2-3	EN-L2-3-Cntl	12	6	6
TGATTTCGTACATCCA-1_7_G10	12.24885623	-21.32697988	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4570	11989	0.008841438	0.00408708	2	L2-3	EN-L2-3-MS	12	6	6
TGATTTCGTCAGAATA-1_7_G10	-2.987555883	34.86907686	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	833	1158	0.007772021	0.004317789	2	oligos	OL-MS-2	12	6	6
TGATTTCGTGACGGTA-1_7_G10	-14.34321608	-10.40479977	13B	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1765	3025	0.001652893	0.005950413	2	13B	IN-SV2C	12	6	6
TGATTTCGTTCCACGG-1_7_G10	1.262916716	-19.00639911	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2981	6529	0.006432838	0.002144279	2	L2-3	EN-L2-3-MS	12	6	6
TGATTTCGTTTAGGAA-1_7_G10	17.01157696	-32.32894141	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4411	12211	0.003357628	0.005732536	2	3	EN-L5-6	12	6	6
TGCACCTAGTCGCCGT-1_7_G10	1.800965077	-22.10278308	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3760	9335	0.003320836	0.00460632	2	L2-3	EN-L2-3-Cntl	12	6	6
TGCACCTAGTGGTAGC-1_7_G10	-3.521713465	32.54295713	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1088	1493	0.017414601	0.006028131	2	oligos	OL-MS-2	12	6	6
TGCACCTGTTTGGGCC-1_7_G10	-0.349899085	35.14337662	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	830	1176	0.008503401	0.005952381	2	oligos	OL-MS-2	12	6	6
TGCACCTTCAAGGTAA-1_7_G10	0.655307196	-16.8888372	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2496	4958	0.004437273	0.00524405	2	L2-3	EN-L2-3-Cntl	12	6	6
TGCACCTTCAGCTGGC-1_7_G10	24.82954929	-28.72866691	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2952	7090	0.004795487	0.004090268	2	3	EN-L5-6	12	6	6
TGCCAAAAGCAGGTCA-1_7_G10	32.77276743	-4.625757693	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3220	7031	0.0046935	0.007680273	2	2	EN-L4	12	6	6
TGCCAAAAGTACGATA-1_7_G10	1.204695797	-19.14801772	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2894	7226	0.007334625	0.003044561	2	L2-3	EN-L2-3-MS	12	6	6
TGCCAAAAGTGGAGTC-1_7_G10	-22.78893458	13.87409371	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1039	1412	0.006373938	0.002832861	2	8	Astrocytes	12	6	6
TGCCAAACAAGGACAC-1_7_G10	27.30726225	4.765865285	15A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	851	1054	0.004743833	0.006641366	2	15A	Endo cells	12	6	6
TGCCAAACAAGTAGTA-1_7_G10	-15.61839554	-10.68864679	13B	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2625	5450	0.002752294	0.002018349	2	13B	IN-SV2C	12	6	6
TGCCAAACACTGTCGG-1_7_G10	22.83026364	-6.903609456	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3196	7405	0.001350439	0.005536799	2	3	EN-L5-6	12	6	6
TGCCAAACAGCCACCA-1_7_G10	26.35792247	-5.329002232	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4488	13340	0.001574213	0.004722639	2	2	EN-L4	12	6	6
TGCCAAACAGTACACT-1_7_G10	-11.1531337	0.296317028	13A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2544	4989	0.012627781	0.004610142	2	13A	IN-VIP	12	6	6
TGCCAAAGTAAGAGAG-1_7_G10	-18.32021197	8.942519854	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	921	1316	0.005319149	0.010638298	2	8	Astrocytes	12	6	6
TGCCAAAGTGTTGGGA-1_7_G10	-8.316193599	-30.01022946	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	883	1235	0.072064777	0.007287449	2	16	EN-PYR	12	6	6
TGCCAAATCAATAAGG-1_7_G10	-14.0302813	-16.41503262	6B	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1261	1964	0.017311609	0.005600815	2	6B	IN-SST	12	6	6
TGCCAAATCATTGCGA-1_7_G10	-14.47701348	-3.551565814	13A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3262	6937	0.017586853	0.0047571	2	13A	IN-VIP	12	6	6
TGCCAAATCTGCAGTA-1_7_G10	-19.12307903	-25.87226197	6A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2485	5366	0.01546776	0.004845322	2	6A	IN-PV	12	6	6
TGCCAAATCTGCCCTA-1_7_G10	-17.22249075	8.061215059	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	980	1349	0.010378058	0.005930319	2	8	Astrocytes	12	6	6
TGCCCATAGACTTTCG-1_7_G10	-23.41287981	-0.217754697	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1717	2731	0.005492494	0.003295496	2	9	OPC	12	6	6
TGCCCATAGCTAGGCA-1_7_G10	22.4163096	25.65909274	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1159	1756	0.003416856	0.003986333	2	oligos	OL-MS-2	12	6	6
TGCCCATAGTGGGATC-1_7_G10	-33.80788496	-4.44568118	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1193	1804	0.006097561	0.004988914	2	9	OPC	12	6	6
TGCCCATCATAAGACA-1_7_G10	-13.75004375	-5.46070598	13A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2150	3713	0.011580932	0.004309184	2	13A	IN-VIP	12	6	6
TGCCCATTCAGCTTAG-1_7_G10	1.122963874	30.83861886	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	821	1085	0.003686636	0.003686636	2	oligos	OL-MS-2	12	6	6
TGCCCATTCGGTCTAA-1_7_G10	33.0877046	-4.956613522	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3066	6410	0.014196568	0.004836193	2	2	EN-L4	12	6	6
TGCCCTAAGGACAGCT-1_7_G10	-0.889393606	32.11077026	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	885	1237	0.002425222	0.005658852	2	oligos	OL-MS-2	12	6	6
TGCCCTAAGTTACGGG-1_7_G10	-31.93354509	-1.924227919	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1350	2128	0.006109023	0.002349624	2	9	OPC	12	6	6
TGCCCTACAACACCTA-1_7_G10	1.29391716	-22.35862609	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4412	13182	0.00371719	0.004248217	2	L2-3	EN-L2-3-Cntl	12	6	6
TGCCCTACATGTCTCC-1_7_G10	26.60400009	-5.447382558	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4611	13776	0.00159698	0.005444251	2	2	EN-L4	12	6	6
TGCCCTAGTAGTAGTA-1_7_G10	25.99529115	-27.71788578	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4468	12860	0.00163297	0.007231726	2	3	EN-L5-6	12	6	6
TGCCCTAGTGGCCCTA-1_7_G10	-14.40446152	-7.270131053	13A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3081	6836	0.008045641	0.005997659	2	13A	IN-VIP	12	6	6
TGCCCTATCAACTCTT-1_7_G10	24.71703742	7.003904083	15A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2282	3803	0.023928478	0.009729161	2	15A	Endo cells	12	6	6
TGCCCTATCACCGGGT-1_7_G10	10.69140816	-26.20064038	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	5062	14584	0.005416895	0.007473944	2	L2-3	EN-L2-3-Cntl	12	6	6
TGCCCTATCACGCATA-1_7_G10	-37.22740687	3.899577381	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2039	3769	0.002653224	0.003183868	2	9	OPC	12	6	6
TGCGCAGAGAAGGACA-1_7_G10	-1.283808384	32.41991246	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1006	1440	0.006944444	0.004166667	2	oligos	OL-MS-2	12	6	6
TGCGCAGAGTACACCT-1_7_G10	-21.35744545	-28.16940097	6A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4227	11160	0.020878136	0.003584229	2	6A	IN-PV	12	6	6
TGCGCAGGTAATCACC-1_7_G10	-15.58604322	11.62107845	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1430	2219	0.004055881	0.003605228	2	8	Astrocytes	12	6	6
TGCGCAGGTCCGAAGA-1_7_G10	21.14239447	28.02011529	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	904	1260	0.002380952	0.008730159	2	oligos	OL-MS-2	12	6	6
TGCGCAGGTCTCCATC-1_7_G10	7.119714728	-26.67285839	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	5321	14869	0.004035241	0.004169749	2	L2-3	EN-L2-3-Cntl	12	6	6
TGCGCAGGTCTGGAGA-1_7_G10	-6.137812565	-31.61626324	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	758	1082	0.125693161	0.006469501	2	16	EN-PYR	12	6	6
TGCGCAGTCAAACGGG-1_7_G10	1.953900857	-10.79428631	12	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1708	2814	0.006041222	0.007462687	2	12	EN-MIX	12	6	6
TGCGCAGTCAACGCTA-1_7_G10	-11.1804244	1.526463293	13A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2778	6021	0.003155622	0.003986049	2	13A	IN-VIP	12	6	6
TGCGCAGTCATCATTC-1_7_G10	29.38619975	-5.672313965	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3905	9799	0.002347178	0.007041535	2	2	EN-L4	12	6	6
TGCGGGTAGACGACGT-1_7_G10	0.600419954	30.77264901	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	791	1092	0.007326007	0.006410256	2	oligos	OL-MS-2	12	6	6
TGCGGGTAGGGATGGG-1_7_G10	8.727152119	-30.63290558	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3089	6500	0.007230769	0.003846154	2	L2-3	EN-L2-3-Cntl	12	6	6
TGCGGGTAGTCCTCCT-1_7_G10	7.358555936	-1.635267364	12	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	952	1447	0.0276434	0.00552868	2	12	EN-MIX	12	6	6
TGCGGGTCAGACTCGC-1_7_G10	29.60548926	-5.803763549	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3841	9437	0.005298294	0.007841475	2	2	EN-L4	12	6	6
TGCGGGTCAGCCTGTG-1_7_G10	23.26168621	19.69087841	1	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1010	1410	0.003546099	0.004964539	2	oligos	OL-Cntl	12	6	6
TGCGGGTGTCCGTTAA-1_7_G10	-22.79859383	-24.04709842	6A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3024	6509	0.014748809	0.007220771	2	6A	IN-PV	12	6	6
TGCGTGGAGACGCACA-1_7_G10	30.6815524	-10.68594901	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2963	5381	0.018769745	0.00984947	2	2	EN-L4	12	6	6
TGCGTGGAGAGGTTGC-1_7_G10	-36.31319138	-5.500092088	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1230	1847	0.001624256	0.001082837	2	9	OPC	12	6	6
TGCGTGGAGTAACCCT-1_7_G10	-22.94565482	21.35327372	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1262	1904	0.003676471	0.006827731	2	8	Astrocytes	12	6	6
TGCGTGGCAAAGGCGT-1_7_G10	6.407594002	33.03703143	1	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	931	1284	0.003894081	0.003894081	2	oligos	OL-Cntl	12	6	6
TGCGTGGGTAGGGACT-1_7_G10	8.979101686	-31.69176248	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2747	5794	0.001553331	0.003451847	2	2	EN-L4	12	6	6
TGCGTGGGTATGAATG-1_7_G10	-13.0673894	-17.9751986	6B	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1133	1747	0.005724098	0.003434459	2	6B	IN-SST	12	6	6
TGCGTGGGTCGTGGCT-1_7_G10	6.408036179	-7.805382219	12	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1678	2607	0.026467204	0.010356732	2	12	EN-MIX	12	6	6
TGCGTGGTCAACGGCC-1_7_G10	-22.09304746	15.07575191	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1126	1693	0.001181335	0.00472534	2	8	Astrocytes	12	6	6
TGCGTGGTCGAGCCCA-1_7_G10	26.76246206	4.373696271	15A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	771	1034	0.00967118	0.01934236	2	15A	Endo cells	12	6	6
TGCTACCCAAGAGTCG-1_7_G10	-19.22648024	10.93085523	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	790	1026	0.012670565	0.003898635	2	8	Astrocytes	12	6	6
TGCTACCGTCCTAGCG-1_7_G10	2.040814151	5.990971267	7	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1045	1357	0.019896831	0.011053795	2	7	Phagocytes	12	6	6
TGCTACCTCGCTGATA-1_7_G10	-9.757626131	-31.42367724	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1040	1574	0.089580686	0.005082592	2	16	EN-PYR	12	6	6
TGCTACCTCTCACATT-1_7_G10	24.72909617	6.861221922	15A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1917	3009	0.022266534	0.016949153	2	15A	Endo cells	12	6	6
TGCTGCTAGATTACCC-1_7_G10	19.24476541	-7.334560035	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2199	4345	0.001611047	0.003682394	2	3	EN-L5-6	12	6	6
TGCTGCTGTCGCTTCT-1_7_G10	-21.10323202	11.94973843	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	907	1260	0.005555556	0.004761905	2	8	Astrocytes	12	6	6
TGCTGCTGTGCGATAG-1_7_G10	21.17925641	12.92216991	1	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1375	2119	0.004247286	0.005191128	2	oligos	OL-Cntl	12	6	6
TGCTGCTTCATCTGTT-1_7_G10	-2.282494621	35.04079975	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	756	1001	0.006993007	0.001998002	2	oligos	OL-MS-2	12	6	6
TGCTGCTTCTCAAGTG-1_7_G10	23.88384947	27.05215506	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1199	1754	0.003420753	0.002850627	2	oligos	OL-MS-2	12	6	6
TGGACGCAGCTTCGCG-1_7_G10	30.53616389	-11.16611686	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4070	8909	0.021887978	0.007295993	2	2	EN-L4	12	6	6
TGGACGCAGGCATGTG-1_7_G10	-22.77755811	-8.512690365	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1764	2707	0.024381234	0.00554119	2	9	OPC	12	6	6
TGGACGCAGGTTCCTA-1_7_G10	-23.0963169	-24.10399712	6A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2865	5936	0.011623989	0.007749326	2	6A	IN-PV	12	6	6
TGGACGCAGTGCCATT-1_7_G10	22.09419739	26.36403041	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1098	1569	0.006373486	0.003186743	2	oligos	OL-MS-2	12	6	6
TGGACGCAGTGTACCT-1_7_G10	32.86772142	-4.922494928	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2940	5686	0.015476609	0.007738305	2	2	EN-L4	12	6	6
TGGACGCCAATGCCAT-1_7_G10	3.022304658	-20.29220388	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3118	6711	0.011175682	0.005662345	2	L2-3	EN-L2-3-MS	12	6	6
TGGACGCCACATGGGA-1_7_G10	-9.5692258	31.72934081	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	992	1293	0.023201856	0.003866976	2	oligos	OL-MS-2	12	6	6
TGGACGCCACTTAACG-1_7_G10	-20.50416672	11.9040701	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	891	1242	0.002415459	0.005636071	2	8	Astrocytes	12	6	6
TGGACGCCAGCGTTCG-1_7_G10	23.78069804	-27.20480226	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3162	7074	0.003675431	0.005230421	2	3	EN-L5-6	12	6	6
TGGACGCGTCTAGCCG-1_7_G10	-10.59177302	-33.54548766	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1018	1514	0.054161162	0.007265522	2	16	EN-PYR	12	6	6
TGGACGCGTGCACGAA-1_7_G10	-6.751741077	-28.78469814	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	762	1012	0.088932806	0.003952569	2	16	EN-PYR	12	6	6
TGGACGCGTTGTTTGG-1_7_G10	-24.4289133	-12.26768562	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	791	1078	0.013914657	0.005565863	2	9	OPC	12	6	6
TGGACGCTCAAAGACA-1_7_G10	18.42133551	-6.771154445	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1665	2894	0.004837595	0.004837595	2	3	EN-L5-6	12	6	6
TGGACGCTCATTATCC-1_7_G10	-17.21965589	8.008040619	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1079	1542	0.013618677	0.001945525	2	8	Astrocytes	12	6	6
TGGCCAGAGTGCTGCC-1_7_G10	5.484494909	-16.27331395	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2732	5282	0.012684589	0.012495267	2	L2-3	EN-L2-3-MS	12	6	6
TGGCCAGGTTTCCACC-1_7_G10	-16.3427856	-18.71417094	6B	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1968	3910	0.002046036	0.003069054	2	6B	IN-SST	12	6	6
TGGCCAGTCTTGTTTG-1_7_G10	2.518693171	-31.91660663	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	5709	20902	0.001530954	0.003970912	2	L2-3	EN-L2-3-Cntl	12	6	6
TGGCGCAAGAGAGCTC-1_7_G10	-14.30189794	-2.945550194	13A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3218	6508	0.011370621	0.011063307	2	13A	IN-VIP	12	6	6
TGGCGCAAGCGATATA-1_7_G10	-9.805193403	-0.462140629	13A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2156	4071	0.007369197	0.007860477	2	13A	IN-VIP	12	6	6
TGGCGCACAGTCTTCC-1_7_G10	-1.759319316	34.8804823	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	786	1036	0.006756757	0.005791506	2	oligos	OL-MS-2	12	6	6
TGGCGCACATGCTAGT-1_7_G10	21.5687356	27.4689165	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	965	1334	0.003748126	0.002998501	2	oligos	OL-MS-2	12	6	6
TGGCGCAGTATTAGCC-1_7_G10	-0.475604208	32.39470875	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	939	1298	0.006163328	0.004622496	2	oligos	OL-MS-2	12	6	6
TGGCGCAGTTACGCGC-1_7_G10	2.462049993	6.536381243	7	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1124	1539	0.007797271	0.003898635	2	7	Phagocytes	12	6	6
TGGCTGGAGCAGACTG-1_7_G10	19.68143656	-27.18394085	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3595	7965	0.006779661	0.009039548	2	3	EN-L5-6	12	6	6
TGGCTGGAGCTAAGAT-1_7_G10	16.30281543	-4.759117593	12	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1146	1704	0.008802817	0.003521127	2	12	EN-MIX	12	6	6
TGGCTGGCAACGATCT-1_7_G10	27.22200463	-5.966214775	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4287	11796	0.001186843	0.012207528	2	2	EN-L4	12	6	6
TGGCTGGCAATCGAAA-1_7_G10	5.35511938	-10.62771715	12	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1655	2585	0.015860735	0.006189555	2	12	EN-MIX	12	6	6
TGGGAAGAGGTGGGTT-1_7_G10	7.867891614	-15.47961407	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3187	6528	0.021752451	0.006280637	2	L2-3	EN-L2-3-MS	12	6	6
TGGGAAGGTAAACACA-1_7_G10	-8.66576405	33.73642961	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	923	1190	0.015966387	0.007563025	2	oligos	OL-MS-2	12	6	6
TGGGAAGTCACCTCGT-1_7_G10	15.2953574	-31.65250036	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3871	9663	0.013349891	0.005381352	2	3	EN-L5-6	12	6	6
TGGGAAGTCACTTCAT-1_7_G10	24.39395109	27.01228561	1	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1264	1844	0.002169197	0.004880694	2	oligos	OL-Cntl	12	6	6
TGGGAAGTCGGTCTAA-1_7_G10	-1.393313668	30.90621417	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	879	1189	0.004205214	0.001682086	2	oligos	OL-MS-2	12	6	6
TGGGAAGTCTCCAGGG-1_7_G10	2.820811412	-20.23804515	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3026	6310	0.003011094	0.00570523	2	L2-3	EN-L2-3-MS	12	6	6
TGGGCGTCAGGTCTCG-1_7_G10	27.28127754	-15.6473506	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	7473	30022	0.032742655	0.009493038	2	2	EN-L4	12	6	6
TGGGCGTCATCCAACA-1_7_G10	-1.384465193	34.13714415	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	847	1142	0.006129597	0.003502627	2	oligos	OL-MS-2	12	6	6
TGGTTAGCAATCTACG-1_7_G10	29.45824184	-11.21618011	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4469	11025	0.00952381	0.012063492	2	2	EN-L4	12	6	6
TGGTTAGGTACTCAAC-1_7_G10	22.70602634	27.42706099	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1064	1506	0.005976096	0.004648074	2	oligos	OL-MS-2	12	6	6
TGGTTAGGTGCAACTT-1_7_G10	-21.66101349	17.56157208	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1418	2354	0.008071368	0.004248088	2	8	Astrocytes	12	6	6
TGGTTAGGTTGGTAAA-1_7_G10	33.35415701	-3.718911591	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2592	5151	0.008542031	0.004271015	2	2	EN-L4	12	6	6
TGGTTCCAGGCTATCT-1_7_G10	1.444440068	-20.26273776	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2938	6146	0.007159128	0.004718516	2	L2-3	EN-L2-3-Cntl	12	6	6
TGGTTCCAGTCAATAG-1_7_G10	-20.61388036	-15.58270929	6A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3368	7159	0.015085906	0.008241374	2	6A	IN-PV	12	6	6
TGGTTCCAGTCATGCT-1_7_G10	23.96215933	-12.31553526	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4240	11746	0.016771667	0.002979738	2	3	EN-L5-6	12	6	6
TGGTTCCTCGGTTAAC-1_7_G10	-17.97995146	-8.69703862	13B	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3734	9230	0.009100758	0.004225352	2	13B	IN-SV2C	12	6	6
TGGTTCCTCTATCGCC-1_7_G10	22.99385562	27.26506707	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1106	1621	0.003084516	0.004935225	2	oligos	OL-MS-2	12	6	6
TGTATTCCAAAGCGGT-1_7_G10	-31.63353133	-10.6962967	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	907	1233	0.00324412	0.01216545	2	9	OPC	12	6	6
TGTATTCCAACTGGCC-1_7_G10	-7.110421708	-29.20214492	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	801	1089	0.052341598	0.005509642	2	16	EN-PYR	12	6	6
TGTATTCCACCCATGG-1_7_G10	30.10215789	-10.13171148	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3784	7979	0.022684547	0.006517107	2	2	EN-L4	12	6	6
TGTATTCGTCCTAGCG-1_7_G10	21.73768837	-3.059125219	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2280	3974	0.031957725	0.004781077	2	2	EN-L4	12	6	6
TGTATTCTCCGTAGGC-1_7_G10	33.60863871	-4.586100725	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2714	5264	0.01424772	0.006838906	2	2	EN-L4	12	6	6
TGTCCCAAGGACATTA-1_7_G10	-1.585691862	33.04450043	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	942	1358	0.00736377	0.005891016	2	oligos	OL-MS-2	12	6	6
TGTCCCAGTAGGACAC-1_7_G10	2.732504389	0.009862464	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2042	3671	0.146281667	0.015254699	2	16	EN-PYR	12	6	6
TGTCCCAGTCTGCCAG-1_7_G10	25.36354476	8.471353924	15A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1991	3085	0.047649919	0.027228525	2	15A	Endo cells	12	6	6
TGTCCCAGTTACGCGC-1_7_G10	-1.80325847	2.895200527	11	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1797	3709	0.009166891	0.001887301	2	11	Glia-MIX	12	6	6
TGTGGTAAGGAGTCTG-1_7_G10	-37.38163072	3.543526147	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1785	3196	0.001877347	0.003754693	2	9	OPC	12	6	6
TGTGGTACACTGTGTA-1_7_G10	30.03377958	-11.06646884	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3148	6163	0.027583969	0.006652604	2	2	EN-L4	12	6	6
TGTGGTAGTACCGTTA-1_7_G10	-26.10904667	-5.974100899	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1167	1802	0.004994451	0.002219756	2	9	OPC	12	6	6
TGTGGTATCATCGGAT-1_7_G10	4.721949222	-31.32052684	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3386	8416	0.001188213	0.002138783	2	L2-3	EN-L2-3-Cntl	12	6	6
TGTGGTATCTTAGCCC-1_7_G10	29.38597231	-11.16450916	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4430	10639	0.017200865	0.012407181	2	2	EN-L4	12	6	6
TGTGTTTAGGAGTTTA-1_7_G10	-11.28274153	-1.009905508	13A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2525	4970	0.009859155	0.007042254	2	13A	IN-VIP	12	6	6
TGTGTTTAGGCATGGT-1_7_G10	17.10754181	-32.31018888	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4981	15192	0.001908899	0.005200105	2	3	EN-L5-6	12	6	6
TGTGTTTGTGAACCTT-1_7_G10	-1.392204957	35.08921066	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	796	1064	0.005639098	0.007518797	2	oligos	OL-MS-2	12	6	6
TGTGTTTGTGTTGAGG-1_7_G10	-20.63665892	13.23235415	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1109	1685	0.007715134	0.003560831	2	8	Astrocytes	12	6	6
TGTGTTTGTTCGTTGA-1_7_G10	7.844662157	24.79218591	1	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	874	1228	0.008143322	0.003257329	2	oligos	OL-Cntl	12	6	6
TGTGTTTTCAACGCTA-1_7_G10	2.703108883	-21.31537348	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3693	9097	0.005276465	0.005496317	2	L2-3	EN-L2-3-MS	12	6	6
TGTGTTTTCCCATTAT-1_7_G10	22.40953308	-13.96572497	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3875	7332	0.035597381	0.008456083	2	3	EN-L5-6	12	6	6
TGTGTTTTCCCTTGCA-1_7_G10	6.386419846	2.017870041	12	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1386	1827	0.024630542	0.008210181	2	12	EN-MIX	12	6	6
TGTGTTTTCCTATGTT-1_7_G10	6.347389516	2.063253573	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1266	1630	0.027607362	0.006748466	2	16	EN-PYR	12	6	6
TGTGTTTTCGTAGGAG-1_7_G10	3.226542701	-12.0174401	12	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1757	2708	0.006277696	0.006277696	2	12	EN-MIX	12	6	6
TGTGTTTTCTGCAAGT-1_7_G10	2.857926805	-15.03996227	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2239	4184	0.005975143	0.011950287	2	L2-3	EN-L2-3-MS	12	6	6
TGTTCCGCACAGATTC-1_7_G10	30.94203125	-1.394354194	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2986	6164	0.002595717	0.005840363	2	2	EN-L4	12	6	6
TGTTCCGCAGCCTATA-1_7_G10	33.3203508	-5.055814952	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2975	6224	0.00996144	0.005462725	2	2	EN-L4	12	6	6
TGTTCCGCATCGATTG-1_7_G10	21.07907926	28.68494878	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	971	1330	0.003007519	0.002255639	2	oligos	OL-MS-2	12	6	6
TGTTCCGGTGCCTGTG-1_7_G10	34.06112401	7.542453737	14	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	984	1271	0.041699449	0.003147128	2	14	Microglia	12	6	6
TGTTCCGTCCCATTTA-1_7_G10	-0.271742862	32.72410401	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	924	1280	0.0046875	0.0046875	2	oligos	OL-MS-2	12	6	6
TGTTCCGTCCGCAAGC-1_7_G10	27.43140771	-13.37574911	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4715	12322	0.021830872	0.006817075	2	L2-3	EN-L2-3-MS	12	6	6
TGTTCCGTCGAGCCCA-1_7_G10	1.709830055	-16.95430947	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2752	5866	0.006478009	0.008523696	2	L2-3	EN-L2-3-MS	12	6	6
TTAACTCAGAACAATC-1_7_G10	-7.243174934	34.13579066	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	928	1190	0.016806723	0.004201681	2	oligos	OL-MS-2	12	6	6
TTAACTCCAAAGGCGT-1_7_G10	19.17021646	-7.181311728	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2046	3893	0.001541228	0.006935525	2	3	EN-L5-6	12	6	6
TTAACTCCACACTGCG-1_7_G10	26.92199942	-5.67253362	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4422	13093	0.004429848	0.004047965	2	2	EN-L4	12	6	6
TTAACTCCACGGACAA-1_7_G10	-8.789918892	-28.10297048	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	977	1354	0.0605613	0.008862629	2	16	EN-PYR	12	6	6
TTAACTCCACGTTGGC-1_7_G10	-11.08307023	-27.9921933	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1569	2456	0.061482085	0.011400651	2	16	EN-PYR	12	6	6
TTAACTCCAGGTGGAT-1_7_G10	-19.05128563	-8.529452672	13B	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4516	10847	0.023324421	0.006453397	2	13B	IN-SV2C	12	6	6
TTAACTCGTAACGACG-1_7_G10	22.48880722	-22.02544523	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4122	10474	0.016421615	0.008019859	2	2	EN-L4	12	6	6
TTAACTCGTGTGACCC-1_7_G10	14.81289988	14.54791595	1	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1215	1830	0.004371585	0.002185792	2	oligos	OL-Cntl	12	6	6
TTAACTCGTTGATTCG-1_7_G10	23.28642769	-24.08522378	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2933	6031	0.017907478	0.005471729	2	3	EN-L5-6	12	6	6
TTAACTCTCGATCCCT-1_7_G10	32.73627547	-3.878702349	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2837	5718	0.004721931	0.004896817	2	2	EN-L4	12	6	6
TTAACTCTCGGATGTT-1_7_G10	-1.872524588	-21.34311042	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2995	7111	0.002109408	0.003937562	2	L2-3	EN-L2-3-Cntl	12	6	6
TTAGGACAGGCGTACA-1_7_G10	23.70730554	26.5633286	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1272	1957	0.005109862	0.005620848	2	oligos	OL-MS-2	12	6	6
TTAGGACAGTCATGCT-1_7_G10	2.923003641	-12.12990551	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1939	3248	0.005849754	0.011083744	2	L2-3	EN-L2-3-MS	12	6	6
TTAGGCAAGCGATATA-1_7_G10	-1.19169359	31.63817609	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	866	1191	0.002518892	0.004198153	2	oligos	OL-MS-2	12	6	6
TTAGGCAAGCTGCAAG-1_7_G10	29.98217639	-0.32370359	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3828	9992	0.001200961	0.003002402	2	L2-3	EN-L2-3-Cntl	12	6	6
TTAGGCACACATTCGA-1_7_G10	1.161840641	-28.44167516	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3996	10447	0.002871638	0.00382885	2	L2-3	EN-L2-3-Cntl	12	6	6
TTAGGCACACTAGTAC-1_7_G10	3.428886418	-21.9475479	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	5486	17464	0.010765002	0.003607421	2	L2-3	EN-L2-3-MS	12	6	6
TTAGGCAGTCTCCCTA-1_7_G10	-35.26118403	-5.602766422	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1223	2020	0.002970297	0.003465347	2	9	OPC	12	6	6
TTAGGCAGTTATGCGT-1_7_G10	-22.88490655	15.16730927	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1044	1628	0.004914005	0.004299754	2	8	Astrocytes	12	6	6
TTAGGCAGTTCGAATC-1_7_G10	-25.29384566	18.15490139	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1176	1859	0.003765465	0.002689618	2	8	Astrocytes	12	6	6
TTAGGCATCAGGCAAG-1_7_G10	-7.828073672	-32.00534241	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	796	1090	0.065137615	0.006422018	2	16	EN-PYR	12	6	6
TTAGGCATCATCGGAT-1_7_G10	17.72789087	-20.79640314	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3239	7112	0.012232846	0.008436445	2	L2-3	EN-L2-3-MS	12	6	6
TTAGGCATCCTTAATC-1_7_G10	-23.84480047	-9.798047759	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	938	1251	0.023980815	0.008792966	2	9	OPC	12	6	6
TTAGGCATCTGCTGTC-1_7_G10	22.57781022	26.08970824	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1170	1800	0.003888889	0.006111111	2	oligos	OL-MS-2	12	6	6
TTAGTTCAGAGGTAGA-1_7_G10	18.31716613	-6.830747226	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1610	2864	0.013268156	0.005586592	2	3	EN-L5-6	12	6	6
TTAGTTCAGCAATATG-1_7_G10	-0.318730707	31.9202879	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	870	1204	0.003322259	0.004983389	2	oligos	OL-MS-2	12	6	6
TTAGTTCAGCTGATAA-1_7_G10	31.68918592	-3.545856097	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3241	7373	0.0081378	0.0027126	2	2	EN-L4	12	6	6
TTAGTTCCAGTATCTG-1_7_G10	-7.147854166	-30.49688188	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	944	1283	0.067809821	0.014809041	2	16	EN-PYR	12	6	6
TTAGTTCGTCACTTCC-1_7_G10	25.57761813	6.062917471	15A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1249	1786	0.012318029	0.018477044	2	15A	Endo cells	12	6	6
TTAGTTCGTCGCTTCT-1_7_G10	-13.89543529	-18.04756961	6B	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1244	1809	0.013266998	0.00331675	2	6B	IN-SST	12	6	6
TTAGTTCGTCTAGCGC-1_7_G10	2.999994772	-7.953881649	12	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1317	1971	0.005580923	0.00456621	2	12	EN-MIX	12	6	6
TTAGTTCGTTCACCTC-1_7_G10	21.99587855	27.21628103	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1016	1475	0.004067797	0.002711864	2	oligos	OL-MS-2	12	6	6
TTAGTTCGTTCCAACA-1_7_G10	-18.20285919	8.476442963	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	788	1033	0.004840271	0.006776379	2	8	Astrocytes	12	6	6
TTAGTTCTCCCATTAT-1_7_G10	34.15143752	7.606468408	14	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1230	1687	0.024896266	0.004149378	2	14	Microglia	12	6	6
TTAGTTCTCGCGTAGC-1_7_G10	1.015235519	34.31707912	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	924	1315	0.00608365	0.004562738	2	oligos	OL-MS-2	12	6	6
TTAGTTCTCTGATACG-1_7_G10	-11.20037134	-2.317606873	13A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2218	3930	0.013994911	0.00610687	2	13A	IN-VIP	12	6	6
TTATGCTAGAGTACCG-1_7_G10	-23.69557263	-22.79379731	6A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3152	6634	0.048990051	0.006029545	2	6A	IN-PV	12	6	6
TTATGCTAGCGTGTCC-1_7_G10	8.061017945	-32.04158434	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4036	10514	0.002092448	0.004660453	2	L2-3	EN-L2-3-Cntl	12	6	6
TTATGCTAGGCCGAAT-1_7_G10	3.647608948	-14.74328649	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2275	4134	0.006773101	0.01161103	2	L2-3	EN-L2-3-MS	12	6	6
TTATGCTCAATGGACG-1_7_G10	-16.47278126	8.629166682	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1055	1381	0.013034033	0.002896452	2	8	Astrocytes	12	6	6
TTATGCTCACATGGGA-1_7_G10	2.060844554	-16.76448088	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2532	5021	0.005377415	0.006373232	2	L2-3	EN-L2-3-MS	12	6	6
TTATGCTCATGCATGT-1_7_G10	32.69438058	-4.799520654	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3224	7074	0.013288097	0.003534068	2	2	EN-L4	12	6	6
TTATGCTTCAGATAAG-1_7_G10	-2.570718145	32.07681069	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	832	1151	0.009556907	0.003475239	2	oligos	OL-MS-2	12	6	6
TTATGCTTCGCTAGCG-1_7_G10	20.63172621	-29.07101192	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3552	8516	0.00176139	0.0085721	2	3	EN-L5-6	12	6	6
TTCCCAGAGACTACAA-1_7_G10	0.276413321	33.87779766	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	842	1163	0.004299226	0.002579536	2	oligos	OL-MS-2	12	6	6
TTCCCAGAGCCAGGAT-1_7_G10	-8.158582197	-31.64533079	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	833	1101	0.060853769	0.009082652	2	16	EN-PYR	12	6	6
TTCCCAGAGCGATAGC-1_7_G10	29.80000922	-7.165673361	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4905	14313	0.013903444	0.007056522	2	2	EN-L4	12	6	6
TTCCCAGCAATTCCTT-1_7_G10	23.94930007	-0.836571812	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2066	3912	0.00408998	0.00408998	2	2	EN-L4	12	6	6
TTCCCAGGTCCGTTAA-1_7_G10	-13.10214692	7.044570909	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1248	1715	0.068221574	0.006997085	2	16	EN-PYR	12	6	6
TTCGAAGAGGAGTAGA-1_7_G10	27.70465595	-14.67135035	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4866	12702	0.025822705	0.006849315	2	2	EN-L4	12	6	6
TTCGAAGCAATGAATG-1_7_G10	-14.12240191	-4.024791642	13A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2837	5519	0.010327958	0.009784381	2	13A	IN-VIP	12	6	6
TTCGAAGCACCTCGTT-1_7_G10	3.677979046	-12.64621392	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1926	3368	0.013064133	0.005047506	2	L2-3	EN-L2-3-MS	12	6	6
TTCGAAGCAGTCAGCC-1_7_G10	-0.955908701	30.14081814	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	801	1053	0.004748338	0.007597341	2	oligos	OL-MS-2	12	6	6
TTCGAAGTCAACACAC-1_7_G10	-7.926284034	30.918675	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1618	2443	0.040523946	0.006139992	2	oligos	OL-MS-2	12	6	6
TTCGAAGTCTCGATGA-1_7_G10	22.22340858	27.54995489	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1056	1517	0.005273566	0.00461437	2	oligos	OL-MS-2	12	6	6
TTCGGTCCAAAGGCGT-1_7_G10	-0.598861703	-15.9104726	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2087	3935	0.002287166	0.002541296	2	L2-3	EN-L2-3-Cntl	12	6	6
TTCGGTCTCTTAGAGC-1_7_G10	-20.20024602	-16.62140097	6B	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2788	5826	0.00394782	0.005835908	2	6B	IN-SST	12	6	6
TTCTACAAGATAGTCA-1_7_G10	-32.01273446	-1.292252808	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1467	2406	0.005403159	0.004156276	2	9	OPC	12	6	6
TTCTACAAGGAATCGC-1_7_G10	32.97635906	-4.392497138	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2914	5875	0.004085106	0.003404255	2	2	EN-L4	12	6	6
TTCTACACACACCGCA-1_7_G10	31.67873176	-9.611298583	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4403	11431	0.016096579	0.008398215	2	2	EN-L4	12	6	6
TTCTACACATTCTCAT-1_7_G10	2.662619254	-32.11479229	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4790	15069	0.001459951	0.002986263	2	L2-3	EN-L2-3-Cntl	12	6	6
TTCTACAGTAAACGCG-1_7_G10	31.89037984	-8.920727234	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3902	9370	0.016862327	0.00715048	2	2	EN-L4	12	6	6
TTCTACAGTAAGGGCT-1_7_G10	-8.246995373	-3.606463949	13A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1626	2779	0.037063692	0.007196833	2	13A	IN-VIP	12	6	6
TTCTACATCCGCATCT-1_7_G10	30.97685817	-7.73146575	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3570	8129	0.013285767	0.00811908	2	2	EN-L4	12	6	6
TTCTACATCTACGAGT-1_7_G10	24.2820342	26.96561044	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1426	2219	0.002253267	0.002253267	2	oligos	OL-MS-2	12	6	6
TTCTACATCTCGAGTA-1_7_G10	0.76944348	-23.66886347	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3227	7498	0.009202454	0.002934116	2	L2-3	EN-L2-3-Cntl	12	6	6
TTCTCAAAGAATTCCC-1_7_G10	3.256867228	-24.31658923	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4293	11060	0.010940325	0.006509946	2	L2-3	EN-L2-3-MS	12	6	6
TTCTCAAAGTGCCATT-1_7_G10	2.303524885	4.678761972	14	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	959	1252	0.007188498	0.009584665	2	14	Microglia	12	6	6
TTCTCAACAGGTTTCA-1_7_G10	12.20307677	-22.01436996	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4662	13175	0.014421252	0.00341556	2	L2-3	EN-L2-3-MS	12	6	6
TTCTCAAGTGTTTGTG-1_7_G10	-3.149441814	33.89396607	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	871	1219	0.004922067	0.002461034	2	oligos	OL-MS-2	12	6	6
TTCTCAATCTACCTGC-1_7_G10	3.258060736	-14.76005956	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2110	3737	0.00990099	0.006422264	2	L2-3	EN-L2-3-MS	12	6	6
TTCTCCTCACAAGCCC-1_7_G10	-37.13202438	-4.919340685	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1140	1809	0.002763958	0.004422333	2	9	OPC	12	6	6
TTCTCCTCACAGGTTT-1_7_G10	24.03936618	-28.78783001	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3028	7514	0.004791057	0.00785201	2	3	EN-L5-6	12	6	6
TTCTCCTCATCCCACT-1_7_G10	2.280817134	-20.28222023	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3531	8318	0.005409954	0.0079346	2	L2-3	EN-L2-3-MS	12	6	6
TTCTCCTGTCAATACC-1_7_G10	-1.123350282	31.89806673	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	805	1114	0.007181329	0.003590664	2	oligos	OL-MS-2	12	6	6
TTCTCCTGTGTCGCTG-1_7_G10	-2.772436497	36.01996346	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	776	1035	0.008695652	0.002898551	2	oligos	OL-MS-2	12	6	6
TTCTCCTGTTAAGAAC-1_7_G10	-34.33532334	-7.806573662	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1050	1654	0.00362757	0.003022975	2	9	OPC	12	6	6
TTCTCCTTCTAACTCT-1_7_G10	12.0840419	33.437209	1	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	752	1058	0.006616257	0.002835539	2	oligos	OL-Cntl	12	6	6
TTCTTAGCACCGAATT-1_7_G10	-1.760094231	36.55753276	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	942	1349	0.031875463	0.005930319	2	oligos	OL-MS-2	12	6	6
TTCTTAGCAGCTGTTA-1_7_G10	-3.688938175	33.35151319	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	903	1265	0.008695652	0.005533597	2	oligos	OL-MS-2	12	6	6
TTCTTAGGTAGGGACT-1_7_G10	-6.636731956	-29.81849042	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	872	1153	0.054640069	0.008673027	2	16	EN-PYR	12	6	6
TTCTTAGGTCTAAAGA-1_7_G10	30.25695065	-11.32259887	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4353	10278	0.019653629	0.007783615	2	2	EN-L4	12	6	6
TTCTTAGTCAAGGCTT-1_7_G10	-24.75561567	-11.59760983	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1825	3132	0.01596424	0.001596424	2	9	OPC	12	6	6
TTCTTAGTCATCGGAT-1_7_G10	2.774473532	-11.43776218	12	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1665	2627	0.007232585	0.008755234	2	12	EN-MIX	12	6	6
TTCTTAGTCGCGGATC-1_7_G10	5.106201301	-13.95192111	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2391	4655	0.040601504	0.00386681	2	L2-3	EN-L2-3-MS	12	6	6
TTGAACGAGACTTTCG-1_7_G10	11.69066084	33.69121834	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	779	1094	0.004570384	0	2	oligos	OL-MS-2	12	6	6
TTGAACGCAGCCTGTG-1_7_G10	1.71201397	-30.0263504	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4594	13107	0.000534066	0.005951019	2	L2-3	EN-L2-3-Cntl	12	6	6
TTGAACGCAGTCCTTC-1_7_G10	24.88064071	-20.97355244	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4034	10599	0.015661855	0.005000472	2	3	EN-L5-6	12	6	6
TTGAACGCATGCCTTC-1_7_G10	-8.112062849	34.9111533	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	805	1062	0.016007533	0.006591337	2	oligos	OL-MS-2	12	6	6
TTGAACGGTATAGGTA-1_7_G10	32.42181989	-2.814417685	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2835	5506	0.005630222	0.009262623	2	2	EN-L4	12	6	6
TTGAACGTCCAGATCA-1_7_G10	-2.616801494	34.46124222	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	845	1231	0.004874086	0.012185215	2	oligos	OL-MS-2	12	6	6
TTGAACGTCGGCCGAT-1_7_G10	1.841338695	31.32108752	1	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	739	1070	0.004672897	0.006542056	2	oligos	OL-Cntl	12	6	6
TTGAACGTCTAACTCT-1_7_G10	-32.35286581	3.78759257	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2035	3862	0.005437597	0.003107198	2	9	OPC	12	6	6
TTGACTTAGATGTGGC-1_7_G10	16.54513747	-29.20825405	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	5126	16892	0.013556713	0.006689557	2	3	EN-L5-6	12	6	6
TTGACTTTCCCATTAT-1_7_G10	-20.61704714	-17.60721316	6A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2712	5712	0.023109244	0.003676471	2	6A	IN-PV	12	6	6
TTGACTTTCGTTTAGG-1_7_G10	0.205795434	-20.56162045	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2919	6686	0.005234819	0.00358959	2	L2-3	EN-L2-3-Cntl	12	6	6
TTGACTTTCGTTTGCC-1_7_G10	-36.63792854	-6.191440209	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1203	1943	0.001544004	0.003088008	2	9	OPC	12	6	6
TTGACTTTCTAACTGG-1_7_G10	-24.31849694	24.99178603	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1477	2409	0.00498132	0.00456621	2	8	Astrocytes	12	6	6
TTGACTTTCTGCTGCT-1_7_G10	-3.335628945	36.13789207	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	755	1001	0.00999001	0.003996004	2	oligos	OL-MS-2	12	6	6
TTGCCGTAGACGCACA-1_7_G10	-33.75746464	-9.263683747	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	978	1544	0.00388601	0.00388601	2	9	OPC	12	6	6
TTGCCGTAGATCCTGT-1_7_G10	3.285303213	-16.61571232	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2641	4979	0.004217714	0.009037959	2	L2-3	EN-L2-3-MS	12	6	6
TTGCCGTAGGCGCTCT-1_7_G10	21.69127144	27.50440883	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1031	1535	0.003908795	0.003257329	2	oligos	OL-MS-2	12	6	6
TTGCCGTCAAGGCTCC-1_7_G10	-6.435940082	35.48744094	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	834	1097	0.012762078	0.006381039	2	oligos	OL-MS-2	12	6	6
TTGCCGTGTGTGACCC-1_7_G10	-0.292734592	-21.99077444	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3702	9303	0.000644953	0.006664517	2	L2-3	EN-L2-3-Cntl	12	6	6
TTGCCGTGTTCCATGA-1_7_G10	23.76213779	-6.046224743	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2545	5246	0.007243614	0.00400305	2	2	EN-L4	12	6	6
TTGCCGTTCGCCCTTA-1_7_G10	16.08177108	-32.95649666	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4990	16667	0.00101998	0.003299934	2	3	EN-L5-6	12	6	6
TTGCCGTTCTGACCTC-1_7_G10	-0.481334397	35.53945489	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	702	1018	0.011787819	0.006876228	2	oligos	OL-MS-2	12	6	6
TTGCGTCAGTGGGCTA-1_7_G10	22.30331924	25.71889126	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1132	1729	0.004626952	0.004048583	2	oligos	OL-MS-2	12	6	6
TTGCGTCCAGGACCCT-1_7_G10	1.621117046	-21.03448861	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3368	7542	0.004640679	0.005701405	2	L2-3	EN-L2-3-Cntl	12	6	6
TTGCGTCGTGATGATA-1_7_G10	25.16920456	-9.234361931	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3752	9292	0.01000861	0.005596212	2	2	EN-L4	12	6	6
TTGCGTCTCACCACCT-1_7_G10	-26.27633192	-6.127019504	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1149	1716	0.004079254	0.003496503	2	9	OPC	12	6	6
TTGCGTCTCGATCCCT-1_7_G10	-25.66724105	15.36161031	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1044	1530	0.003921569	0.002614379	2	8	Astrocytes	12	6	6
TTGCGTCTCGTGACAT-1_7_G10	0.555441843	29.71276193	1	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	797	1118	0.002683363	0.002683363	2	oligos	OL-Cntl	12	6	6
TTGGAACAGAAGAAGC-1_7_G10	11.1689436	-19.55712333	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4360	11187	0.014302315	0.009654063	2	L2-3	EN-L2-3-MS	12	6	6
TTGGAACAGAGACGAA-1_7_G10	-25.97555315	-5.968363054	9	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1188	1836	0.004357298	0.004357298	2	9	OPC	12	6	6
TTGGAACAGCCTCGTG-1_7_G10	-17.8206833	7.861602033	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	911	1175	0.025531915	0.005106383	2	8	Astrocytes	12	6	6
TTGGAACCAAGCGCTC-1_7_G10	-21.92196988	13.65448712	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1070	1537	0.002602472	0.003903709	2	8	Astrocytes	12	6	6
TTGGAACGTACAGTTC-1_7_G10	20.91624445	27.65924171	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	861	1214	0.00247117	0.004942339	2	oligos	OL-MS-2	12	6	6
TTGGAACGTCTCCCTA-1_7_G10	24.39484272	-24.30711799	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2788	5953	0.005543423	0.006551319	2	3	EN-L5-6	12	6	6
TTGGAACGTGTCAATC-1_7_G10	31.73736051	-12.38235097	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3869	8419	0.022924338	0.008670864	2	2	EN-L4	12	6	6
TTGGAACTCCTTGCCA-1_7_G10	33.2525785	6.199294081	14	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	966	1225	0.017959184	0.004897959	2	14	Microglia	12	6	6
TTGGCAAAGAATAGGG-1_7_G10	16.29697297	-28.53725769	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4783	13482	0.007194778	0.007788162	2	3	EN-L5-6	12	6	6
TTGGCAAAGGCATGTG-1_7_G10	-1.410869137	31.69183706	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	843	1146	0.0008726	0.004363002	2	oligos	OL-MS-2	12	6	6
TTGGCAAAGGGTCGAT-1_7_G10	-17.10611174	-21.76049201	6B	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1822	3111	0.004500161	0.008357441	2	6B	IN-SST	12	6	6
TTGGCAAAGTCTCGGC-1_7_G10	-5.710915868	36.30836285	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	789	1090	0.00733945	0.004587156	2	oligos	OL-MS-2	12	6	6
TTGGCAAGTCTGCCAG-1_7_G10	26.51310769	-24.7655628	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	5877	19361	0.006094727	0.004906771	2	3	EN-L5-6	12	6	6
TTGGCAAGTGCCTGCA-1_7_G10	22.7026056	27.2430428	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1038	1505	0.00730897	0.002657807	2	oligos	OL-MS-2	12	6	6
TTGGCAAGTTGAGGTG-1_7_G10	-22.25744027	-21.8023649	6A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2347	4588	0.048169137	0.005231037	2	6A	IN-PV	12	6	6
TTGGCAATCAGATAAG-1_7_G10	2.637530759	-11.70031571	12	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1685	2639	0.007199697	0.004926108	2	12	EN-MIX	12	6	6
TTGGCAATCCGTAGGC-1_7_G10	-6.201529302	-30.11248681	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	739	1015	0.082758621	0.008866995	2	16	EN-PYR	12	6	6
TTGTAGGAGCTAGTTC-1_7_G10	1.630737538	31.16085537	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	754	1057	0.004730369	0.003784295	2	oligos	OL-MS-2	12	6	6
TTGTAGGCAAGCGAGT-1_7_G10	-13.54921685	-32.01336186	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1976	3460	0.052890173	0.016184971	2	16	EN-PYR	12	6	6
TTGTAGGGTTCCCTTG-1_7_G10	-0.71340456	-19.91405825	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2775	5660	0.002826855	0.005477032	2	L2-3	EN-L2-3-Cntl	12	6	6
TTGTAGGTCAACACGT-1_7_G10	-21.50081738	16.4172909	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1313	2026	0.0029615	0.001974334	2	8	Astrocytes	12	6	6
TTGTAGGTCATTGCGA-1_7_G10	18.76645893	-30.84243455	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	6088	20920	0.01625239	0.004875717	2	3	EN-L5-6	12	6	6
TTGTAGGTCGGCGCAT-1_7_G10	0.854382107	-18.03813343	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2551	5183	0.005788154	0.0050164	2	L2-3	EN-L2-3-MS	12	6	6
TTTACTGAGCTTATCG-1_7_G10	12.77927946	-21.69922323	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4785	13589	0.012878063	0.004709692	2	L2-3	EN-L2-3-MS	12	6	6
TTTACTGTCAGCTCGG-1_7_G10	26.89475134	-15.96158863	3	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	8348	42503	0.059595793	0.005905465	2	3	EN-L5-6	12	6	6
TTTATGCAGACGCTTT-1_7_G10	22.42469845	17.41400516	1	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1208	1804	0.011086475	0.008314856	2	oligos	OL-Cntl	12	6	6
TTTATGCAGTCAAGGC-1_7_G10	17.87428539	-18.43461994	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3776	8732	0.023362345	0.004924416	2	L2-3	EN-L2-3-MS	12	6	6
TTTATGCCAGGTCGTC-1_7_G10	-17.23228321	7.207924641	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	798	1030	0.010679612	0.005825243	2	8	Astrocytes	12	6	6
TTTATGCCAGTCGTGC-1_7_G10	-15.06241045	-3.428328492	13A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3751	8381	0.01479537	0.009664718	2	13A	IN-VIP	12	6	6
TTTATGCGTACGCTGC-1_7_G10	-19.85834003	-27.17182544	6A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2870	6421	0.004827908	0.002491824	2	6A	IN-PV	12	6	6
TTTATGCTCCTACAGA-1_7_G10	24.24167525	27.21315897	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1249	1831	0.003276898	0.004915347	2	oligos	OL-MS-2	12	6	6
TTTCCTCAGGGCACTA-1_7_G10	13.1995142	-22.47640572	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	5353	17689	0.02962293	0.003505003	2	L2-3	EN-L2-3-MS	12	6	6
TTTCCTCAGTAGCGGT-1_7_G10	-7.711099595	-1.923766632	13A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1627	2730	0.01025641	0.003296703	2	13A	IN-VIP	12	6	6
TTTCCTCGTCATCGGC-1_7_G10	27.01802231	-16.01050976	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	7455	31762	0.029500661	0.007587683	2	2	EN-L4	12	6	6
TTTCCTCGTCTCACCT-1_7_G10	-5.228090644	35.32327559	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	762	1025	0.009756098	0.007804878	2	oligos	OL-MS-2	12	6	6
TTTCCTCTCGTAGGAG-1_7_G10	-10.30861006	-32.95817206	16	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1301	2263	0.206805126	0.0101635	2	16	EN-PYR	12	6	6
TTTCCTCTCTCGATGA-1_7_G10	-11.00561647	1.960381574	13A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2740	5730	0.004886562	0.003839442	2	13A	IN-VIP	12	6	6
TTTGCGCAGGTGCAAC-1_7_G10	11.30900587	-8.382534394	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2352	4832	0.002897351	0.002483444	2	L2-3	EN-L2-3-Cntl	12	6	6
TTTGCGCAGTGGACGT-1_7_G10	-18.40290871	-17.41297365	6B	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2038	3547	0.010149422	0.007330138	2	6B	IN-SST	12	6	6
TTTGCGCGTACCGGCT-1_7_G10	-20.46990822	12.23233567	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1018	1414	0.003536068	0.005657709	2	8	Astrocytes	12	6	6
TTTGCGCGTGAAATCA-1_7_G10	-25.11119966	-23.97712587	6A	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	3920	9784	0.039043336	0.005825838	2	6A	IN-PV	12	6	6
TTTGCGCTCACCGGGT-1_7_G10	-2.206915605	33.23140993	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	883	1175	0.005957447	0.003404255	2	oligos	OL-MS-2	12	6	6
TTTGCGCTCATTTGGG-1_7_G10	-10.74569394	15.78390541	11	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1571	2495	0.00761523	0.00240481	2	11	Glia-MIX	12	6	6
TTTGCGCTCCCGACTT-1_7_G10	8.44693958	28.578273	1	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	906	1258	0.004769475	0.003974563	2	oligos	OL-Cntl	12	6	6
TTTGCGCTCGCATGAT-1_7_G10	1.323931253	-19.46948484	10	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2977	6701	0.008804656	0.003432324	2	L2-3	EN-L2-3-Cntl	12	6	6
TTTGGTTGTAAAGTCA-1_7_G10	27.10888255	4.29380734	15BA	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	869	1169	0.035928144	0.017964072	2	15BA	Stromal cells	12	6	6
TTTGGTTGTCGGGTCT-1_7_G10	29.96346967	-8.040256077	2	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4615	12773	0.012291552	0.004697409	2	2	EN-L4	12	6	6
TTTGGTTTCACGGTTA-1_7_G10	4.193784006	-11.992267	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	2301	5018	0.008369868	0.005579912	2	L2-3	EN-L2-3-MS	12	6	6
TTTGTCAAGGGCACTA-1_7_G10	-9.568968209	31.80965493	17	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	789	1013	0.015794669	0.001974334	2	oligos	OL-MS-2	12	6	6
TTTGTCACAAGGACAC-1_7_G10	1.354383286	-22.09608015	4	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	4027	10485	0.003814974	0.004291845	2	L2-3	EN-L2-3-MS	12	6	6
TTTGTCATCTGCCCTA-1_7_G10	-21.09970948	16.11686244	8	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1354	2127	0.00329102	0.005641749	2	8	Astrocytes	12	6	6
TTTGTCATCTTTAGTC-1_7_G10	5.203714684	5.988344638	7	7_G10	MS	Acute/Chronic active	34	female	parietal	CAP4	SEQ2	8.9	12	1863	2981	0.00805099	0.006038242	2	7	Phagocytes	12	6	6
AAACCTGAGACTACAA-1_8_E5	19.87025663	18.02642324	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1157	1871	0.010154997	0.004810262	0	oligos	OL-Cntl	NA	NA	NA
AAACCTGAGTGTACGG-1_8_E5	5.924168114	33.9745915	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	878	1292	0.01625387	0.00619195	0	oligos	OL-Cntl	NA	NA	NA
AAACCTGGTGCACTTA-1_8_E5	25.77524557	-29.45019037	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5888	25233	0.002853406	0.002932668	0	3	EN-L5-6	NA	NA	NA
AAACGGGAGAAGGTGA-1_8_E5	-22.69093222	27.02593429	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1771	3277	0.003661886	0.0021361	0	8	Astrocytes	NA	NA	NA
AAACGGGAGTGCTGCC-1_8_E5	-24.40898842	29.22685789	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1728	3103	0.002255881	0.003544956	0	8	Astrocytes	NA	NA	NA
AAACGGGGTAGGCTGA-1_8_E5	7.506050865	-32.73193753	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4269	12869	0.004118424	0.003341363	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AAACGGGTCAACTCTT-1_8_E5	-37.44704616	2.558084228	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1858	3668	0.005997819	0.003271538	0	9	OPC	NA	NA	NA
AAACGGGTCGAGAACG-1_8_E5	-19.7942754	-28.502125	6A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3873	10529	0.00607845	0.003514104	0	6A	IN-PV	NA	NA	NA
AAACGGGTCTCGATGA-1_8_E5	-0.067250134	-17.02497164	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2887	7400	0.003918919	0.001891892	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AAAGATGAGATAGGAG-1_8_E5	1.457179733	-30.5927768	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4912	16252	0.003937977	0.003753384	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AAAGATGCAGCTGTAT-1_8_E5	20.37271722	21.65290405	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1150	2046	0.005865103	0.003910068	0	oligos	OL-Cntl	NA	NA	NA
AAAGATGTCCAAGCCG-1_8_E5	9.697390393	31.02518383	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	773	1255	0.004780876	0.006374502	0	oligos	OL-Cntl	NA	NA	NA
AAAGCAAAGCCATCGC-1_8_E5	1.831933005	-30.97434719	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5667	22198	0.006622218	0.003423732	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AAAGCAACAAAGGTGC-1_8_E5	-8.686529271	1.71835172	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2502	5492	0.00782957	0.005462491	0	13A	IN-VIP	NA	NA	NA
AAAGCAACAGCCAATT-1_8_E5	-17.1358675	-10.79403668	13B	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4854	15266	0.01467313	0.003406262	0	13B	IN-SV2C	NA	NA	NA
AAAGCAAGTTAAAGAC-1_8_E5	29.70268131	-2.124600403	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4466	11931	0.009974017	0.004945101	0	2	EN-L4	NA	NA	NA
AAAGCAATCACATAGC-1_8_E5	-26.32909822	17.82971662	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1355	2494	0.002405774	0.003207698	0	8	Astrocytes	NA	NA	NA
AAAGTAGAGCCGATTT-1_8_E5	-8.560671891	-18.03502391	6B	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	755	1112	0.059352518	0.000899281	0	6B	IN-SST	NA	NA	NA
AAAGTAGAGTGACATA-1_8_E5	17.68938613	-4.951295313	12	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1567	3503	0.000856409	0.002283757	0	12	EN-MIX	NA	NA	NA
AAAGTAGCAACCGCCA-1_8_E5	23.5217017	-0.689075522	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2638	6422	0.003892868	0.003425724	0	2	EN-L4	NA	NA	NA
AAAGTAGCAGGTCTCG-1_8_E5	21.67921516	20.76634966	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1183	1885	0.00265252	0.003713528	0	oligos	OL-Cntl	NA	NA	NA
AAAGTAGCATCTGGTA-1_8_E5	-15.91225869	-19.11790748	6B	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2048	4427	0.007906031	0.003840072	0	6B	IN-SST	NA	NA	NA
AAAGTAGTCCTCCTAG-1_8_E5	6.203921584	-6.140656839	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1640	3661	0.000546299	0.001912046	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AAATGCCAGTACGTTC-1_8_E5	0.765684876	-28.64422307	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4830	15797	0.002215611	0.002658733	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AAATGCCCAAGAAAGG-1_8_E5	-11.79988932	15.97289024	11	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1498	2480	0.00483871	0.002822581	0	11	Glia-MIX	NA	NA	NA
AAATGCCCAAGTTGTC-1_8_E5	7.241671177	-30.88702312	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5988	24012	0.005955356	0.002998501	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AAATGCCCAGACAAGC-1_8_E5	-1.643147304	-20.39152015	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3195	7779	0.005784805	0.003599434	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AAATGCCCAGGATTGG-1_8_E5	9.817106412	33.06091738	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	775	1181	0.009314141	0.00169348	0	oligos	OL-Cntl	NA	NA	NA
AAATGCCGTCCGAACC-1_8_E5	26.44414813	-5.509856132	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5526	18703	0.006629952	0.003421911	0	2	EN-L4	NA	NA	NA
AAATGCCGTCCGTTAA-1_8_E5	1.121486614	-30.45546026	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5519	20416	0.006906348	0.001910266	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AAATGCCGTTGAACTC-1_8_E5	24.88223635	-0.166974791	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2432	5221	0.009385175	0.003447615	0	2	EN-L4	NA	NA	NA
AAATGCCTCCTTTACA-1_8_E5	-35.95484843	4.894499408	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2154	4577	0.001529386	0.003058772	0	9	OPC	NA	NA	NA
AACACGTCACTTCGAA-1_8_E5	4.608035959	31.1006552	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	747	1113	0.004492363	0.002695418	0	oligos	OL-Cntl	NA	NA	NA
AACACGTGTCGGCACT-1_8_E5	1.26487959	-22.96024002	4	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4611	13442	0.008108912	0.002454992	0	L2-3	EN-L2-3-MS	NA	NA	NA
AACACGTGTTATTCTC-1_8_E5	14.75667826	-33.71225378	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5058	18365	0.002232507	0.004356112	0	3	EN-L5-6	NA	NA	NA
AACCATGCAGCCACCA-1_8_E5	6.594933327	30.38046275	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	844	1294	0.008500773	0.002318393	0	oligos	OL-Cntl	NA	NA	NA
AACCATGCAGCTGGCT-1_8_E5	-39.4035007	-1.039575543	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1337	2274	0.004837291	0.003957784	0	9	OPC	NA	NA	NA
AACCATGGTACCGTAT-1_8_E5	-4.871648906	-2.499138515	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1529	2897	0.022782188	0.002071108	0	13A	IN-VIP	NA	NA	NA
AACCATGGTTAGGGTG-1_8_E5	28.75449442	-3.818640028	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4575	13036	0.006520405	0.004602639	0	2	EN-L4	NA	NA	NA
AACCATGTCCCACTTG-1_8_E5	-9.244608144	1.293829293	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2626	5590	0.01019678	0.005545617	0	13A	IN-VIP	NA	NA	NA
AACCGCGAGGAACTGC-1_8_E5	-19.8207011	-18.24994012	6B	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3296	8505	0.014697237	0.001763668	0	6B	IN-SST	NA	NA	NA
AACCGCGCACGCTTTC-1_8_E5	21.12371209	22.75137558	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1203	2019	0.005448242	0.001981179	0	oligos	OL-Cntl	NA	NA	NA
AACCGCGGTTCCAACA-1_8_E5	2.759726888	-31.90595827	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5612	20668	0.011128314	0.001886975	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AACGTTGCACCTCGGA-1_8_E5	-25.8749592	30.06468068	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2223	4707	0.001062248	0.002761844	0	8	Astrocytes	NA	NA	NA
AACGTTGCATCGGAAG-1_8_E5	-19.97758435	-27.0465421	6A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3459	9288	0.016580534	0.002153316	0	6A	IN-PV	NA	NA	NA
AACGTTGGTCTGGAGA-1_8_E5	-1.379182934	-19.66665701	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2890	6758	0.006510802	0.003847292	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AACGTTGGTGCAGTAG-1_8_E5	3.82214677	-31.48802203	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5111	17617	0.002951694	0.001475847	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AACGTTGTCGGTCCGA-1_8_E5	-20.30002309	-29.04583711	6A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5091	17423	0.007059634	0.003156747	0	6A	IN-PV	NA	NA	NA
AACTCAGAGGCTATCT-1_8_E5	9.650401767	27.86953047	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	958	1521	0.010519395	0.004602235	0	oligos	OL-Cntl	NA	NA	NA
AACTCAGCAGGTGGAT-1_8_E5	8.137751835	-31.84797813	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4787	14014	0.008848295	0.004210076	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AACTCAGCAGTAAGAT-1_8_E5	-20.03297641	-29.04383706	6A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3656	9657	0.001242622	0.003210107	0	6A	IN-PV	NA	NA	NA
AACTCAGCAGTCGATT-1_8_E5	-26.71352741	15.69348862	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1167	1998	0.002002002	0.006506507	0	8	Astrocytes	NA	NA	NA
AACTCAGGTGATAAGT-1_8_E5	-0.703001011	-14.28409384	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2270	4543	0.006603566	0.002421308	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AACTCAGTCATGGTCA-1_8_E5	0.176095983	-21.1789329	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3768	9666	0.001034554	0.003310573	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AACTCAGTCTACTTAC-1_8_E5	19.38185887	12.47108937	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1503	2797	0.002860207	0.003932785	0	oligos	OL-Cntl	NA	NA	NA
AACTCAGTCTGGCGTG-1_8_E5	-33.74255953	-10.62880349	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	988	1574	0.002541296	0	0	9	OPC	NA	NA	NA
AACTCCCAGCCCGAAA-1_8_E5	23.91250449	-9.659751867	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5298	16634	0.006252254	0.004088013	0	3	EN-L5-6	NA	NA	NA
AACTCCCAGCTTATCG-1_8_E5	26.27916633	-3.131127709	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3538	9196	0.007503262	0.002283602	0	2	EN-L4	NA	NA	NA
AACTCCCCAATGAATG-1_8_E5	-1.052194358	-19.31082388	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2976	6920	0.004768786	0.003179191	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AACTCCCGTACGCACC-1_8_E5	-38.04889097	3.010174167	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1913	4132	0.003630203	0.000968054	0	9	OPC	NA	NA	NA
AACTCCCGTCGGCTCA-1_8_E5	-0.426671811	-21.86780708	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4329	12456	0.003853565	0.002890173	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AACTCCCGTTAAAGAC-1_8_E5	8.971647285	32.89909671	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	825	1261	0.000793021	0.006344171	0	oligos	OL-Cntl	NA	NA	NA
AACTCCCGTTCTGAAC-1_8_E5	-1.120274511	-22.71467746	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4272	12560	0.000636943	0.003423567	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AACTCTTAGCGTTGCC-1_8_E5	-11.89953098	1.973083828	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3795	9769	0.011055379	0.007063159	0	13A	IN-VIP	NA	NA	NA
AACTCTTAGTATGACA-1_8_E5	26.21954503	-4.419311634	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4633	14708	0.003943432	0.00333152	0	2	EN-L4	NA	NA	NA
AACTCTTGTAGCGCAA-1_8_E5	-36.45507102	-3.027412025	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1510	2626	0.002284844	0.005331302	0	9	OPC	NA	NA	NA
AACTCTTGTAGTGAAT-1_8_E5	-0.015507853	-28.1397857	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5123	15944	0.004892122	0.003010537	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AACTCTTGTCGGATCC-1_8_E5	-5.07011919	-2.79902545	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1471	2483	0.006041079	0.003624648	0	13A	IN-VIP	NA	NA	NA
AACTCTTTCTGTCCGT-1_8_E5	10.09720196	-29.10935092	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	6743	28399	0.017676679	0.003380401	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AACTGGTAGCAATCTC-1_8_E5	27.72123542	-5.082745594	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4851	13912	0.00546291	0.005319149	0	2	EN-L4	NA	NA	NA
AACTGGTGTCATGCCG-1_8_E5	29.1482867	-3.85714186	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4292	11244	0.004802561	0.00604767	0	2	EN-L4	NA	NA	NA
AACTTTCAGTGTCCCG-1_8_E5	7.104339601	31.58731458	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	705	1024	0.004882813	0.002929688	0	oligos	OL-Cntl	NA	NA	NA
AACTTTCCACACGCTG-1_8_E5	-5.044419292	-1.25401652	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1554	2941	0.006460388	0.003060184	0	13A	IN-VIP	NA	NA	NA
AACTTTCCAGACGCTC-1_8_E5	-23.73467689	30.62568814	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2134	4182	0.00191296	0.003825921	0	8	Astrocytes	NA	NA	NA
AACTTTCGTCTCCATC-1_8_E5	20.73613544	22.68314642	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1076	1720	0.003488372	0.002325581	0	oligos	OL-Cntl	NA	NA	NA
AACTTTCTCTGTCAAG-1_8_E5	-26.41072465	17.25790487	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1267	2258	0.002657219	0.003100089	0	8	Astrocytes	NA	NA	NA
AAGACCTAGCTAACAA-1_8_E5	20.05178422	22.85218905	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1029	1659	0.003616637	0.004219409	0	oligos	OL-Cntl	NA	NA	NA
AAGACCTAGTCGATAA-1_8_E5	-38.20381039	2.859204247	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1782	3193	0.002192296	0.002818666	0	9	OPC	NA	NA	NA
AAGACCTGTCTTGTCC-1_8_E5	-25.85427382	19.53309518	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1386	2360	0.002542373	0.002542373	0	8	Astrocytes	NA	NA	NA
AAGACCTGTTGGTTTG-1_8_E5	-27.30122746	9.623104035	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	781	1252	0.000798722	0.004792332	0	8	Astrocytes	NA	NA	NA
AAGACCTTCATTATCC-1_8_E5	10.12261844	32.38972339	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	824	1247	0	0.004009623	0	oligos	OL-Cntl	NA	NA	NA
AAGACCTTCGATCCCT-1_8_E5	-11.64104955	-22.14496182	6A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1078	1800	0.042777778	0.001111111	0	6A	IN-PV	NA	NA	NA
AAGCCGCAGACAGAGA-1_8_E5	-38.19100385	1.706916496	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1533	2635	0.001897533	0.00227704	0	9	OPC	NA	NA	NA
AAGCCGCAGCAATCTC-1_8_E5	-37.16366529	-6.426037583	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1150	1801	0.004441977	0.000555247	0	9	OPC	NA	NA	NA
AAGCCGCCAACTTGAC-1_8_E5	-19.99147239	-29.25176833	6A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4369	13637	0.003666496	0.001539928	0	6A	IN-PV	NA	NA	NA
AAGCCGCCAGTCCTTC-1_8_E5	-38.42063388	1.90855315	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1627	3082	0.000973394	0.002920182	0	9	OPC	NA	NA	NA
AAGCCGCCATGACGGA-1_8_E5	19.20871185	24.36447341	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	902	1350	0.000740741	0.005925926	0	oligos	OL-Cntl	NA	NA	NA
AAGCCGCGTAGTAGTA-1_8_E5	18.27818953	10.12556657	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1501	2606	0.009209517	0.005372218	0	oligos	OL-Cntl	NA	NA	NA
AAGCCGCGTCGCGAAA-1_8_E5	10.37019162	16.55923184	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1067	1707	0.005272408	0.005272408	0	oligos	OL-Cntl	NA	NA	NA
AAGCCGCTCCCAGGTG-1_8_E5	28.85898885	-2.106183032	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4497	12442	0.003938274	0.003857901	0	2	EN-L4	NA	NA	NA
AAGGAGCAGCAGGCTA-1_8_E5	10.60968532	27.71870051	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	973	1510	0.003311258	0.002649007	0	oligos	OL-Cntl	NA	NA	NA
AAGGAGCCAGATAATG-1_8_E5	-1.011510311	-19.15900492	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2911	6893	0.006818512	0.003626868	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AAGGAGCGTAAGAGAG-1_8_E5	-15.6952359	-11.20157797	13B	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2851	6719	0.001637148	0.002232475	0	13B	IN-SV2C	NA	NA	NA
AAGGAGCGTAAGGATT-1_8_E5	8.008507376	-29.57449777	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5902	20752	0.01387818	0.002746723	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AAGGAGCGTGCAGGTA-1_8_E5	0.712173924	35.26308553	17	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	785	1141	0.000876424	0.007887818	0	oligos	OL-MS-2	NA	NA	NA
AAGGAGCGTTCGGGCT-1_8_E5	3.354387089	-27.8957406	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2877	7132	0.000981492	0.001822771	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AAGGAGCTCATTATCC-1_8_E5	24.22993988	-6.346064222	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4264	11184	0.006258941	0.004470672	0	2	EN-L4	NA	NA	NA
AAGGCAGAGATATGGT-1_8_E5	-10.94259193	2.406097118	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3292	8068	0.016732771	0.00557759	0	13A	IN-VIP	NA	NA	NA
AAGGCAGCAGAGTGTG-1_8_E5	5.139190941	-32.25035009	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	6614	31520	0.002284264	0.00215736	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AAGGCAGCAGCCACCA-1_8_E5	-23.77364731	-1.656089474	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1104	1651	0.005451242	0.002422774	0	9	OPC	NA	NA	NA
AAGGCAGCAGCTTCGG-1_8_E5	-26.02670724	16.01186328	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1134	1827	0.002189381	0.004378763	0	8	Astrocytes	NA	NA	NA
AAGGCAGTCCTCGCAT-1_8_E5	7.761108295	32.50473108	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	803	1302	0.005376344	0.004608295	0	oligos	OL-Cntl	NA	NA	NA
AAGGTTCCAGGCGATA-1_8_E5	15.65249855	-33.14772035	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5998	24588	0.004758419	0.002968928	0	3	EN-L5-6	NA	NA	NA
AAGGTTCTCGACCAGC-1_8_E5	-9.226677249	-2.267467561	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2085	4204	0.004757374	0.007136061	0	13A	IN-VIP	NA	NA	NA
AAGTCTGAGTACTTGC-1_8_E5	-30.77459848	-13.28364386	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	628	1031	0.001939864	0.004849661	0	9	OPC	NA	NA	NA
AAGTCTGCAATGTAAG-1_8_E5	1.687337438	-30.99180889	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5298	17816	0.000898069	0.002301302	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AAGTCTGGTATTCTCT-1_8_E5	8.422480915	31.53746159	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	708	1035	0.01352657	0.005797101	0	oligos	OL-Cntl	NA	NA	NA
AAGTCTGGTCCGAACC-1_8_E5	-12.56482008	-17.77184032	6B	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1201	2149	0.01023732	0.002791996	0	6B	IN-SST	NA	NA	NA
AAGTCTGTCAAGGTAA-1_8_E5	20.42065353	23.26729428	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1024	1527	0.007203667	0.00589391	0	oligos	OL-Cntl	NA	NA	NA
AAGTCTGTCCACGACG-1_8_E5	2.013211168	-30.93894265	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5168	16875	0.003733333	0.002785185	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AAGTCTGTCTGTACGA-1_8_E5	0.566495827	-29.12713298	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4354	13569	0.00368487	0.004127054	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AATCCAGAGCTGCGAA-1_8_E5	-5.31584232	-4.104081264	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1365	2298	0.026979983	0.003046127	0	13A	IN-VIP	NA	NA	NA
AATCCAGAGGTGCTAG-1_8_E5	-0.756887877	-11.19179578	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1785	3531	0.0048145	0.002265647	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AATCCAGCACCATGTA-1_8_E5	-2.407724528	-23.23271857	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3781	10080	0.006349206	0.002777778	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AATCCAGGTACTTCTT-1_8_E5	25.62637037	0.430910597	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2301	4881	0.009219422	0.003073141	0	2	EN-L4	NA	NA	NA
AATCCAGGTCGTTGTA-1_8_E5	-0.360828007	-13.95131088	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2228	4404	0.016121708	0.005222525	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AATCCAGGTGTTTGTG-1_8_E5	-2.443830197	-21.81699215	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3278	8517	0.004344253	0.003404955	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AATCCAGTCGATGAGG-1_8_E5	10.16047666	27.19507847	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	884	1332	0.003003003	0.003003003	0	oligos	OL-Cntl	NA	NA	NA
AATCCAGTCTGGTATG-1_8_E5	-9.499282657	1.333872406	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2842	6960	0.009913793	0.005890805	0	13A	IN-VIP	NA	NA	NA
AATCGGTAGCGTCTAT-1_8_E5	20.79489516	22.49118843	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1074	1804	0.001662971	0.004988914	0	oligos	OL-Cntl	NA	NA	NA
AATCGGTAGTCGTTTG-1_8_E5	7.357743236	32.44974189	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	723	1040	0.007692308	0.006730769	0	oligos	OL-Cntl	NA	NA	NA
AATCGGTCAAGTAGTA-1_8_E5	-25.54068488	20.40804282	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1552	2785	0	0.003590664	0	8	Astrocytes	NA	NA	NA
AATCGGTCATATGGTC-1_8_E5	-16.23464668	-9.461501231	13B	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3148	7526	0.005049163	0.0029232	0	13B	IN-SV2C	NA	NA	NA
AATCGGTCATGCCACG-1_8_E5	7.80548983	-32.73116249	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3468	8676	0.009797142	0.00230521	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AATCGGTGTGAGGGTT-1_8_E5	10.75345201	26.07782774	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	877	1340	0.005223881	0.002238806	0	oligos	OL-Cntl	NA	NA	NA
AATCGGTGTGATGCCC-1_8_E5	26.43398579	-4.068673951	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3723	9540	0.002096436	0.002830189	0	2	EN-L4	NA	NA	NA
AATCGGTTCAGTTCGA-1_8_E5	10.54216395	-34.16867659	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	6273	24566	0.005169747	0.003337947	0	3	EN-L5-6	NA	NA	NA
ACACCAAAGGGCTCTC-1_8_E5	-7.296238936	-2.434915227	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1683	3105	0.009983897	0.003864734	0	13A	IN-VIP	NA	NA	NA
ACACCAATCCACGTGG-1_8_E5	-36.17621695	3.89753276	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2047	4286	0.003033131	0.002566496	0	9	OPC	NA	NA	NA
ACACCAATCTCTTGAT-1_8_E5	-4.706518244	-23.30720941	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3344	8820	0.002267574	0.002494331	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACACCCTAGATGCGAC-1_8_E5	4.139179041	32.93639155	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	783	1188	0.003367003	0.007575758	0	oligos	OL-Cntl	NA	NA	NA
ACACCCTAGCTACCGC-1_8_E5	9.963429926	32.73347622	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	766	1151	0.00086881	0.002606429	0	oligos	OL-Cntl	NA	NA	NA
ACACCCTCACGAAGCA-1_8_E5	-25.80539062	18.92708244	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1392	2517	0.001589193	0.001986492	0	8	Astrocytes	NA	NA	NA
ACACCCTCATAGTAAG-1_8_E5	0.861462511	-30.00695657	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5423	20000	0.00385	0.0029	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACACCCTCATTCTTAC-1_8_E5	9.582259693	31.44881191	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	703	1050	0.001904762	0.002857143	0	oligos	OL-Cntl	NA	NA	NA
ACACCCTTCATCTGCC-1_8_E5	8.582386732	33.75095323	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	778	1202	0.005823627	0.001663894	0	oligos	OL-Cntl	NA	NA	NA
ACACCCTTCGCCTGTT-1_8_E5	28.50068536	-3.792324668	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4633	14185	0.005357772	0.004370814	0	2	EN-L4	NA	NA	NA
ACACCGGAGCACCGTC-1_8_E5	-2.390975892	-28.33897017	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2907	6877	0.001163298	0.002908245	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACACCGGAGCCACGTC-1_8_E5	5.245795446	32.84222129	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	784	1108	0.01534296	0	0	oligos	OL-Cntl	NA	NA	NA
ACACCGGAGTCGAGTG-1_8_E5	10.6799613	-34.11942692	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	7078	31570	0.002090592	0.002248971	0	3	EN-L5-6	NA	NA	NA
ACACCGGGTAACGCGA-1_8_E5	-16.9670653	-10.9241258	13B	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4104	11090	0.005320108	0.00342651	0	13B	IN-SV2C	NA	NA	NA
ACACCGGTCAGCATGT-1_8_E5	-6.562951983	-0.644136778	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1731	3257	0.007368744	0.003377341	0	13A	IN-VIP	NA	NA	NA
ACACTGAAGGGTTTCT-1_8_E5	-10.25179657	1.815629133	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3279	8443	0.005685183	0.005211418	0	13A	IN-VIP	NA	NA	NA
ACACTGAGTAATCGTC-1_8_E5	3.430297661	28.98572215	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	703	1040	0.003846154	0.011538462	0	oligos	OL-Cntl	NA	NA	NA
ACACTGAGTCGACTAT-1_8_E5	19.80661194	25.780618	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1018	1580	0.001898734	0.003164557	0	oligos	OL-Cntl	NA	NA	NA
ACACTGATCCAGGGCT-1_8_E5	11.63991057	31.97363148	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	707	1023	0.003910068	0.007820137	0	oligos	OL-Cntl	NA	NA	NA
ACAGCCGCATTGTGCA-1_8_E5	18.93279399	24.46415382	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	878	1350	0.004444444	0.002962963	0	oligos	OL-Cntl	NA	NA	NA
ACAGCCGCATTTGCTT-1_8_E5	-37.84162015	2.790731468	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1726	3267	0.001530456	0.001530456	0	9	OPC	NA	NA	NA
ACAGCCGTCCAAACTG-1_8_E5	24.74979093	-28.47802762	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3065	7760	0.002963918	0.002963918	0	3	EN-L5-6	NA	NA	NA
ACAGCCGTCCCTCTTT-1_8_E5	-1.207178695	-20.06863175	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3332	8299	0.003855886	0.002409929	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACAGCTAAGACCTAGG-1_8_E5	-38.70284689	0.707632591	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1444	2553	0.00195848	0.002741872	0	9	OPC	NA	NA	NA
ACAGCTAAGTCATCCA-1_8_E5	8.551408008	-29.2280075	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5537	18486	0.009899383	0.004652169	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACAGCTAGTAAGTGTA-1_8_E5	14.78538706	-1.221036754	12	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1022	1454	0.010316369	0.007565337	0	12	EN-MIX	NA	NA	NA
ACAGCTAGTATGGTTC-1_8_E5	-10.21012063	1.94933976	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3043	7024	0.011531891	0.00441344	0	13A	IN-VIP	NA	NA	NA
ACAGCTATCGCCGTGA-1_8_E5	10.04298026	31.27898864	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	755	1065	0.004694836	0.000938967	0	oligos	OL-Cntl	NA	NA	NA
ACAGCTATCTCTTATG-1_8_E5	2.977386137	-3.158006571	12	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	774	1110	0.003603604	0.007207207	0	12	EN-MIX	NA	NA	NA
ACAGCTATCTTGCAAG-1_8_E5	8.063492221	-31.59706807	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4125	13061	0.004670393	0.002679734	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACATACGGTTATGTGC-1_8_E5	-34.11749871	-8.93774003	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	986	1522	0.002628121	0.00131406	0	9	OPC	NA	NA	NA
ACATACGTCCGTCATC-1_8_E5	-16.70695099	-10.97761793	13B	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3316	7772	0.006562017	0.00386001	0	13B	IN-SV2C	NA	NA	NA
ACATCAGAGGAGCGTT-1_8_E5	-28.95738246	12.98865332	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	831	1127	0.000887311	0.007985803	0	8	Astrocytes	NA	NA	NA
ACATCAGCAGCCTTGG-1_8_E5	-25.52463173	27.96808315	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1567	2844	0.000703235	0.002109705	0	8	Astrocytes	NA	NA	NA
ACATCAGGTCGTCTTC-1_8_E5	-8.691686287	1.281656309	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2346	4729	0.01057306	0.004863608	0	13A	IN-VIP	NA	NA	NA
ACATCAGGTGGTACAG-1_8_E5	6.475693741	-5.634216289	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1213	1896	0.014240506	0.001582278	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACATCAGTCACGATGT-1_8_E5	-17.13994091	-10.934545	13B	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4683	14112	0.009495465	0.004322562	0	13B	IN-SV2C	NA	NA	NA
ACATCAGTCCAGATCA-1_8_E5	-9.689368382	-27.84435203	16	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1145	1644	0.090632603	0.005474453	0	16	EN-PYR	NA	NA	NA
ACATCAGTCTCCAACC-1_8_E5	1.516376192	-6.704547516	12	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1137	1857	0.00538503	0.002692515	0	12	EN-MIX	NA	NA	NA
ACATGGTAGAAGGTGA-1_8_E5	9.225812049	20.50321935	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	915	1473	0.00203666	0.005431093	0	oligos	OL-Cntl	NA	NA	NA
ACATGGTCAGGTGCCT-1_8_E5	28.58312939	-1.064576459	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3496	8038	0.006718089	0.004229908	0	2	EN-L4	NA	NA	NA
ACATGGTTCCTGTAGA-1_8_E5	-26.34115143	17.75937963	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1331	2282	0.007011394	0.003943909	0	8	Astrocytes	NA	NA	NA
ACATGGTTCTCGATGA-1_8_E5	5.819399999	32.16954178	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	769	1144	0.003496503	0.004370629	0	oligos	OL-Cntl	NA	NA	NA
ACATGGTTCTGGCGTG-1_8_E5	21.11010058	-29.41384363	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5265	18409	0.001629638	0.004019773	0	3	EN-L5-6	NA	NA	NA
ACCAGTAAGAAGGTTT-1_8_E5	19.42027663	24.74462634	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	904	1420	0.000704225	0.002816901	0	oligos	OL-Cntl	NA	NA	NA
ACCAGTAAGCTCTCGG-1_8_E5	-1.361732412	-14.98191283	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2544	5613	0.008017103	0.003206841	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACCAGTACACATCCGG-1_8_E5	10.45852714	26.8392424	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	909	1413	0.005661713	0.002830856	0	oligos	OL-Cntl	NA	NA	NA
ACCAGTATCCGAATGT-1_8_E5	-20.438665	-29.07709709	6A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5310	18372	0.015893751	0.002993686	0	6A	IN-PV	NA	NA	NA
ACCCACTAGACTACAA-1_8_E5	22.99532962	13.61313647	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1354	2202	0.009082652	0.004541326	0	oligos	OL-Cntl	NA	NA	NA
ACCCACTAGGCTAGGT-1_8_E5	-14.3550196	-7.503266544	13B	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4035	11535	0.014130906	0.004941482	0	13B	IN-SV2C	NA	NA	NA
ACCCACTCATACGCTA-1_8_E5	-0.188074763	-11.30405159	12	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1818	3441	0.010171462	0.004359198	0	12	EN-MIX	NA	NA	NA
ACCCACTTCGCAAGCC-1_8_E5	-20.0731139	-18.05090918	6B	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3987	11215	0.007579135	0.004369148	0	6B	IN-SST	NA	NA	NA
ACCGTAACACGTCTCT-1_8_E5	-23.17467511	30.63655338	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2246	4738	0.001477417	0.003588012	0	8	Astrocytes	NA	NA	NA
ACCGTAACAGCTTAAC-1_8_E5	-0.489328683	-22.98190774	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4258	11866	0.005477836	0.003539525	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACCGTAACAGTGGGAT-1_8_E5	19.85701068	27.04981702	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	943	1407	0.002132196	0.00355366	0	oligos	OL-Cntl	NA	NA	NA
ACCGTAACATGGTCTA-1_8_E5	6.975766528	31.94395707	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	749	1096	0.004562044	0.005474453	0	oligos	OL-Cntl	NA	NA	NA
ACCGTAAGTAATCACC-1_8_E5	-13.69146539	-21.26504681	6A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1236	2120	0.006132075	0.004245283	0	6A	IN-PV	NA	NA	NA
ACCGTAAGTCGTGGCT-1_8_E5	-26.95092614	17.11438542	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1217	1952	0.000512295	0.004610656	0	8	Astrocytes	NA	NA	NA
ACCGTAATCAGCAACT-1_8_E5	7.68803091	-30.24880763	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5192	17028	0.01562133	0.002583979	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACCGTAATCAGGCAAG-1_8_E5	10.74016915	32.71076657	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	878	1322	0.003025719	0.003782148	0	oligos	OL-Cntl	NA	NA	NA
ACCTTTACACTAAGTC-1_8_E5	-2.548345181	-20.37443825	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2810	6416	0.001246883	0.003584788	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACCTTTAGTATGGTTC-1_8_E5	9.632056512	31.49267521	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	827	1254	0.002392344	0.001594896	0	oligos	OL-Cntl	NA	NA	NA
ACGAGCCAGTCTTGCA-1_8_E5	20.788517	23.32944021	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1131	1733	0.006924409	0.004039238	0	oligos	OL-Cntl	NA	NA	NA
ACGAGCCAGTGTGGCA-1_8_E5	2.374800007	-31.52433896	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	6183	24449	0.004049245	0.003435723	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACGAGCCAGTTAGCGG-1_8_E5	4.107909314	-31.51785788	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4606	14411	0.003608355	0.002498092	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACGAGCCCAAAGGAAG-1_8_E5	-4.21624342	-5.272024751	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1208	1991	0.034153692	0.001506781	0	13A	IN-VIP	NA	NA	NA
ACGAGCCCAATGAAAC-1_8_E5	19.66736825	-0.497752171	12	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1332	2046	0.022482893	0.008308895	0	12	EN-MIX	NA	NA	NA
ACGAGCCTCAAACCAC-1_8_E5	-21.27324912	-28.20952194	6A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5167	17597	0.018696369	0.004091607	0	6A	IN-PV	NA	NA	NA
ACGAGCCTCTGTTTGT-1_8_E5	5.053664002	-32.00059118	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4856	16393	0.001647044	0.002135058	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACGAGCCTCTTACCGC-1_8_E5	25.61320469	-0.002858452	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2659	5700	0.004736842	0.003333333	0	2	EN-L4	NA	NA	NA
ACGAGGACACGGCGTT-1_8_E5	-2.198560093	-24.91940452	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4295	12471	0.002646139	0.003608371	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACGAGGACAGGACGTA-1_8_E5	29.33810278	-1.61156597	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3639	8949	0.007151637	0.006145938	0	2	EN-L4	NA	NA	NA
ACGAGGACATTCCTGC-1_8_E5	-34.92729099	-12.60203322	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	770	1070	0.003738318	0.001869159	0	9	OPC	NA	NA	NA
ACGAGGAGTATCTGCA-1_8_E5	26.52067837	-5.523781184	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	6075	22615	0.010833518	0.004466062	0	2	EN-L4	NA	NA	NA
ACGAGGATCGTTGACA-1_8_E5	-18.85048658	-18.55907546	6A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2687	6193	0.006458905	0.002260617	0	6A	IN-PV	NA	NA	NA
ACGAGGATCTCGTATT-1_8_E5	20.40544604	23.75327801	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1111	1818	0.000550055	0.00330033	0	oligos	OL-Cntl	NA	NA	NA
ACGAGGATCTTGACGA-1_8_E5	6.389086039	-5.722764914	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1203	1924	0.025987526	0.003118503	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACGATGTAGACAAAGG-1_8_E5	10.25089287	30.97542207	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	817	1259	0.005559968	0	0	oligos	OL-Cntl	NA	NA	NA
ACGATGTAGCGGCTTC-1_8_E5	-25.13923002	20.13134103	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1441	2529	0.003558719	0.004349545	0	8	Astrocytes	NA	NA	NA
ACGATGTCAATCCAAC-1_8_E5	8.670698808	34.11663396	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	958	1536	0.005859375	0.005859375	0	oligos	OL-Cntl	NA	NA	NA
ACGATGTCAATCTACG-1_8_E5	3.006524757	-29.10911025	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4163	12096	0.003720238	0.002480159	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACGATGTCAGATGGCA-1_8_E5	4.006370237	-31.59508234	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4857	16298	0.001656645	0.002454289	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACGATGTCATCCTTGC-1_8_E5	16.26685509	-31.78591649	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	6449	30058	0.006986493	0.00336017	0	3	EN-L5-6	NA	NA	NA
ACGATGTGTAAACACA-1_8_E5	26.82339436	-5.263808095	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4733	13851	0.007003104	0.003970832	0	2	EN-L4	NA	NA	NA
ACGATGTGTCAATGTC-1_8_E5	-25.55366227	20.5339879	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1582	2840	0.000352113	0.004225352	0	8	Astrocytes	NA	NA	NA
ACGATGTTCTGAAAGA-1_8_E5	4.127376134	-31.95787745	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5398	19599	0.00153069	0.001734782	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACGCAGCAGAGCTGCA-1_8_E5	-1.002562622	-25.512016	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5110	17825	0.006115007	0.002187938	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACGCAGCAGGCTAGCA-1_8_E5	9.791931513	27.73598643	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	850	1321	0.004542014	0.001514005	0	oligos	OL-Cntl	NA	NA	NA
ACGCAGCCACAACTGT-1_8_E5	-4.698611164	-2.947707377	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1381	2496	0.01161859	0.002003205	0	13A	IN-VIP	NA	NA	NA
ACGCAGCCAGCATACT-1_8_E5	-22.85514454	31.33818805	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2318	4702	0.002977456	0.002552105	0	8	Astrocytes	NA	NA	NA
ACGCAGCCAGGAATCG-1_8_E5	3.958864572	-32.63013966	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	7693	39355	0.003735231	0.002896709	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACGCAGCCATTTCAGG-1_8_E5	19.63208059	23.96058379	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1007	1570	0	0.007643312	0	oligos	OL-Cntl	NA	NA	NA
ACGCAGCGTAGCACGA-1_8_E5	20.830497	22.83855146	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1078	1879	0.007450772	0.003725386	0	oligos	OL-Cntl	NA	NA	NA
ACGCAGCTCGAATGCT-1_8_E5	-38.55446228	2.139347921	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1636	2943	0.010873259	0.000339789	0	9	OPC	NA	NA	NA
ACGCCAGAGTTACCCA-1_8_E5	-20.09347369	-18.024183	6B	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3459	8725	0.009054441	0.004469914	0	6B	IN-SST	NA	NA	NA
ACGCCAGGTTCCACGG-1_8_E5	-24.45639288	30.40127072	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2002	3867	0.000775795	0.00155159	0	8	Astrocytes	NA	NA	NA
ACGCCGAAGAGCAATT-1_8_E5	-11.10810052	2.636155057	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4194	10960	0.009854015	0.004288321	0	13A	IN-VIP	NA	NA	NA
ACGCCGAAGCGAAGGG-1_8_E5	5.60159629	33.20201435	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	687	1077	0.00185701	0.006499536	0	oligos	OL-Cntl	NA	NA	NA
ACGCCGAAGGAGTTTA-1_8_E5	4.375327016	-32.80925425	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	7328	37688	0.001990023	0.002388028	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACGCCGACAACGCACC-1_8_E5	12.92626897	-27.05729118	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3228	8729	0.009508535	0.002634895	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACGCCGATCTGAAAGA-1_8_E5	2.048151502	-30.93347692	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5497	18818	0.008236795	0.00260389	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACGCCGATCTTCGAGA-1_8_E5	-37.74452435	-6.206555442	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1159	1895	0.002110818	0.001583113	0	9	OPC	NA	NA	NA
ACGGAGAAGGCCCTTG-1_8_E5	21.00044248	23.66496947	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1076	1702	0.001175088	0.007638073	0	oligos	OL-Cntl	NA	NA	NA
ACGGAGAAGTCGAGTG-1_8_E5	18.9339694	24.30819353	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	973	1509	0.001325381	0.003313453	0	oligos	OL-Cntl	NA	NA	NA
ACGGAGACATGCTGGC-1_8_E5	-7.161088926	-2.896217756	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1603	2690	0.023791822	0.008550186	0	13A	IN-VIP	NA	NA	NA
ACGGAGATCACGATGT-1_8_E5	-1.518200614	-19.77831081	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3251	8640	0.002314815	0.002430556	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACGGAGATCGTCTGAA-1_8_E5	-16.62448306	-10.77676637	13B	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3537	8847	0.006894993	0.003504013	0	13B	IN-SV2C	NA	NA	NA
ACGGAGATCTCTAGGA-1_8_E5	-23.02619479	31.31136611	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2396	4981	0.001806866	0.002810681	0	8	Astrocytes	NA	NA	NA
ACGGCCATCAGCACAT-1_8_E5	-34.28765777	-11.14247897	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	850	1230	0.007317073	0.000813008	0	9	OPC	NA	NA	NA
ACGGGCTAGCCCAACC-1_8_E5	-20.90231468	-28.13936724	6A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4627	15860	0.01223203	0.004413619	0	6A	IN-PV	NA	NA	NA
ACGGGCTAGGGAAACA-1_8_E5	9.697472767	-8.757778297	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2828	6575	0.001673004	0.001825095	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACGGGCTAGGTGCTTT-1_8_E5	9.923030927	31.82047107	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	833	1311	0.003813883	0.00228833	0	oligos	OL-Cntl	NA	NA	NA
ACGGGCTCATTACGAC-1_8_E5	-0.725944759	-20.11903458	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3225	7701	0.007531489	0.002337359	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACGGGCTGTCGAGTTT-1_8_E5	23.83074182	-9.424153004	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5955	20464	0.002003518	0.00620602	0	3	EN-L5-6	NA	NA	NA
ACGGGCTGTCTAGCGC-1_8_E5	9.432915456	32.12760048	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	919	1391	0.005032351	0.007189073	0	oligos	OL-Cntl	NA	NA	NA
ACGGGCTTCCCAGGTG-1_8_E5	1.062764508	-10.24718133	12	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1654	2695	0.00593692	0.004081633	0	12	EN-MIX	NA	NA	NA
ACGGGTCAGCCAGTAG-1_8_E5	0.393910508	-28.15329492	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4786	14681	0.004495607	0.002111573	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACGGGTCAGCCTTGAT-1_8_E5	10.6972206	27.3352445	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	993	1611	0.001862197	0.001862197	0	oligos	OL-Cntl	NA	NA	NA
ACGGGTCAGGACATTA-1_8_E5	-1.326340691	-26.54140352	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4543	13664	0.004830211	0.004171546	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACGGGTCAGGGTGTTG-1_8_E5	-0.520921209	-25.35914413	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4923	15994	0.00725272	0.002500938	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACGGGTCCAGGATTGG-1_8_E5	-38.87133417	-4.430691445	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1317	2191	0.007759014	0.004107713	0	9	OPC	NA	NA	NA
ACGGGTCCATGCGCAC-1_8_E5	-10.98463445	-20.42065023	6B	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	914	1411	0.019844082	0.003543586	0	6B	IN-SST	NA	NA	NA
ACGGGTCGTACTCTCC-1_8_E5	-24.18156741	30.30928398	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1906	3583	0.002511862	0.004186436	0	8	Astrocytes	NA	NA	NA
ACGGGTCGTCGCATCG-1_8_E5	7.958400437	-32.9377427	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3317	8222	0.006324495	0.003162248	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACGGGTCGTGTCTGAT-1_8_E5	6.237549412	-32.17981032	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5431	19125	0.000679739	0.003607843	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACGGGTCTCTTATCTG-1_8_E5	19.59182065	23.12674212	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	986	1609	0.005593536	0.001864512	0	oligos	OL-Cntl	NA	NA	NA
ACGTCAAAGGTAGCCA-1_8_E5	7.009937649	31.27119977	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	874	1356	0.010324484	0.006637168	0	oligos	OL-Cntl	NA	NA	NA
ACGTCAACAAGCTGGA-1_8_E5	-10.70652464	0.887196341	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2585	5254	0.008755234	0.004948611	0	13A	IN-VIP	NA	NA	NA
ACGTCAACACTTAACG-1_8_E5	19.13038558	12.69777977	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1302	2246	0.000445236	0.006233304	0	oligos	OL-Cntl	NA	NA	NA
ACGTCAAGTCCTGCTT-1_8_E5	0.500698506	-13.60788609	4	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2708	6540	0.008256881	0.002140673	0	L2-3	EN-L2-3-MS	NA	NA	NA
ACGTCAATCCGAAGAG-1_8_E5	4.486846946	32.47923147	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	762	1113	0.001796945	0.004492363	0	oligos	OL-Cntl	NA	NA	NA
ACGTCAATCGCATGGC-1_8_E5	-38.75328419	-2.396802397	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1339	2534	0.001973165	0.002367798	0	9	OPC	NA	NA	NA
ACTATCTAGAGTAATC-1_8_E5	9.247088135	31.5099936	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	724	1054	0	0.001897533	0	oligos	OL-Cntl	NA	NA	NA
ACTATCTAGGGAAACA-1_8_E5	17.22985624	-32.39380807	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5626	19206	0.004269499	0.003748828	0	3	EN-L5-6	NA	NA	NA
ACTATCTAGGGTTTCT-1_8_E5	-28.20336965	12.89889065	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	925	1501	0.000666223	0.001998668	0	8	Astrocytes	NA	NA	NA
ACTATCTAGGTTACCT-1_8_E5	0.103059922	0.130874868	11	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	850	1175	0.02212766	0.001702128	0	11	Glia-MIX	NA	NA	NA
ACTATCTCAAGCCCAC-1_8_E5	10.92645943	32.6935768	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	904	1361	0.000734754	0.002204262	0	oligos	OL-Cntl	NA	NA	NA
ACTATCTCACGAGGTA-1_8_E5	6.138517163	31.55965637	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	864	1268	0.012618297	0.003943218	0	oligos	OL-Cntl	NA	NA	NA
ACTATCTCACGTAAGG-1_8_E5	-23.54022331	30.88700438	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2241	4377	0.002970071	0.002513137	0	8	Astrocytes	NA	NA	NA
ACTATCTCATCCCACT-1_8_E5	1.989392783	-31.03779762	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4743	16080	0.001803483	0.002736318	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACTATCTGTGGTAACG-1_8_E5	-1.912394725	-19.46202178	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2704	6565	0.003351104	0.002741813	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACTATCTGTTAAGATG-1_8_E5	4.785562952	30.14404523	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	724	1065	0.009389671	0.00657277	0	oligos	OL-Cntl	NA	NA	NA
ACTATCTTCTCGATGA-1_8_E5	0.465688257	-29.63780775	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4877	17101	0.002397521	0.002046664	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACTATCTTCTCTTGAT-1_8_E5	8.000127511	-32.95526722	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3868	12136	0.001235992	0.001895188	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACTGAACCACCAACCG-1_8_E5	15.46298292	-33.31204403	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	6528	28102	0.002917942	0.00466159	0	3	EN-L5-6	NA	NA	NA
ACTGAACCATAACCTG-1_8_E5	5.621114073	32.83243608	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	743	1099	0.001819836	0.003639672	0	oligos	OL-Cntl	NA	NA	NA
ACTGAACGTACCGAGA-1_8_E5	11.13176345	32.78014193	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	764	1136	0.003521127	0.001760563	0	oligos	OL-Cntl	NA	NA	NA
ACTGAACTCATCGCTC-1_8_E5	5.457896462	33.39476504	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	758	1056	0.005681818	0.004734848	0	oligos	OL-Cntl	NA	NA	NA
ACTGAGTAGACTAGAT-1_8_E5	-34.09343981	-10.40043917	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	862	1258	0.000794913	0.002384738	0	9	OPC	NA	NA	NA
ACTGAGTAGACTAGGC-1_8_E5	4.61162781	32.47406191	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	708	1012	0.000988142	0.006916996	0	oligos	OL-Cntl	NA	NA	NA
ACTGAGTAGCGAAGGG-1_8_E5	-1.29817496	-19.73143401	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3168	7577	0.010162333	0.005015178	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACTGAGTAGTGAATTG-1_8_E5	28.24716973	-1.777301926	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4945	15222	0.006569439	0.003481803	0	2	EN-L4	NA	NA	NA
ACTGAGTAGTGGTAAT-1_8_E5	7.161185282	-6.926762767	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1360	2206	0.002266546	0.003173164	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACTGAGTGTGACGGTA-1_8_E5	-4.707087513	-3.781681151	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1292	2309	0.022087484	0.004330879	0	13A	IN-VIP	NA	NA	NA
ACTGAGTGTTACAGAA-1_8_E5	16.71959397	16.37556794	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1169	1878	0.008519702	0.005324814	0	oligos	OL-Cntl	NA	NA	NA
ACTGAGTTCAAAGTAG-1_8_E5	-8.910784696	0.975751203	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2330	4729	0.007612603	0.002326073	0	13A	IN-VIP	NA	NA	NA
ACTGAGTTCCTCTAGC-1_8_E5	17.54471643	16.84082254	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1156	1999	0.009004502	0.006503252	0	oligos	OL-Cntl	NA	NA	NA
ACTGAGTTCGCCTGAG-1_8_E5	-2.696978338	-24.02181777	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4267	12851	0.004902342	0.003423858	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACTGATGAGGGAACGG-1_8_E5	28.91072078	-1.249697652	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3784	9735	0.003081664	0.004725218	0	2	EN-L4	NA	NA	NA
ACTGATGCATCTCGCT-1_8_E5	-0.31234513	-14.2920649	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2445	4959	0.004638032	0.004033071	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACTGATGGTCCGAAGA-1_8_E5	-9.716572891	-16.10340591	6B	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1037	1827	0.003284072	0.002189381	0	6B	IN-SST	NA	NA	NA
ACTGCTCAGAACTGTA-1_8_E5	-10.28181738	-0.189644737	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2483	5194	0.015402387	0.008086253	0	13A	IN-VIP	NA	NA	NA
ACTGCTCAGACCTAGG-1_8_E5	-11.01990038	2.349126767	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3369	7695	0.010006498	0.005847953	0	13A	IN-VIP	NA	NA	NA
ACTGCTCAGCTACCGC-1_8_E5	16.33728151	-31.97927299	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	6323	24750	0.007191919	0.004888889	0	3	EN-L5-6	NA	NA	NA
ACTGCTCAGCTAGCCC-1_8_E5	4.351061011	-29.83994007	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3450	9448	0.001587638	0.001905165	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACTGCTCGTACCGTTA-1_8_E5	14.36656148	-8.368463573	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2371	5242	0.005150706	0.00305227	0	3	EN-L5-6	NA	NA	NA
ACTGCTCGTTTCCACC-1_8_E5	-37.69111657	0.384769685	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1455	2507	0.006781013	0.001595533	0	9	OPC	NA	NA	NA
ACTGCTCTCAAACAAG-1_8_E5	7.543315536	33.32611915	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	876	1268	0.003943218	0.007097792	0	oligos	OL-Cntl	NA	NA	NA
ACTGCTCTCCTGCTTG-1_8_E5	1.258534043	-30.4860146	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5315	17814	0.005164477	0.003087459	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACTGTCCAGCCGGTAA-1_8_E5	-25.42743735	20.34788914	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1559	2849	0.002457002	0.001404001	0	8	Astrocytes	NA	NA	NA
ACTGTCCAGGCACATG-1_8_E5	18.54127752	8.906893301	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1795	3412	0.003223916	0.002637749	0	oligos	OL-Cntl	NA	NA	NA
ACTGTCCAGGCTAGAC-1_8_E5	27.51871298	-3.722388726	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4060	10923	0.007690195	0.003204248	0	2	EN-L4	NA	NA	NA
ACTGTCCGTTTGGCGC-1_8_E5	-18.910872	-18.2743323	6B	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2475	5209	0.003263582	0.004031484	0	6B	IN-SST	NA	NA	NA
ACTGTCCTCCCAAGAT-1_8_E5	-1.067890407	-21.1076615	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3708	10172	0.002359418	0.004915454	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACTGTCCTCTATCGCC-1_8_E5	26.43998637	-1.914103827	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3258	8966	0.001226857	0.002676779	0	2	EN-L4	NA	NA	NA
ACTTACTAGGAATGGA-1_8_E5	-38.16841754	2.765339096	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1715	3177	0.006924772	0.004406673	0	9	OPC	NA	NA	NA
ACTTACTAGGGAAACA-1_8_E5	1.606283216	-30.41566742	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4984	16046	0.004923345	0.002804437	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACTTACTAGGGTCTCC-1_8_E5	4.055414973	30.557114	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	759	1113	0.005390836	0.00359389	0	oligos	OL-Cntl	NA	NA	NA
ACTTACTCACCAGCAC-1_8_E5	27.46552847	-1.419986047	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3903	10454	0.003443658	0.003156686	0	2	EN-L4	NA	NA	NA
ACTTACTCACGGTAGA-1_8_E5	14.67270738	-0.41986471	12	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	713	1052	0.00095057	0.002851711	0	12	EN-MIX	NA	NA	NA
ACTTACTCATTAGGCT-1_8_E5	-25.8433929	29.92754733	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1850	3567	0.001962433	0.002803476	0	8	Astrocytes	NA	NA	NA
ACTTACTTCCTCAATT-1_8_E5	3.640918266	-31.55898172	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5435	22110	0.001537766	0.002487562	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACTTGTTAGACAAAGG-1_8_E5	-22.92053815	30.10013258	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2052	3994	0.001752629	0.001752629	0	8	Astrocytes	NA	NA	NA
ACTTGTTCACGTCTCT-1_8_E5	-24.48895423	29.95010439	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1745	3410	0.00058651	0.004692082	0	8	Astrocytes	NA	NA	NA
ACTTGTTCATGAACCT-1_8_E5	-22.97460097	31.35805153	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2334	5327	0.001689506	0.00131406	0	8	Astrocytes	NA	NA	NA
ACTTGTTGTGAAAGAG-1_8_E5	-28.23290853	16.70100946	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1096	1759	0.002842524	0.002274019	0	8	Astrocytes	NA	NA	NA
ACTTGTTGTTAAGATG-1_8_E5	-38.96157767	-0.551406788	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1333	2238	0.002234138	0.002234138	0	9	OPC	NA	NA	NA
ACTTGTTGTTTAAGCC-1_8_E5	-1.559703033	-23.20484963	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4296	12367	0.0136654	0.003396135	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACTTGTTTCAGCTCGG-1_8_E5	-8.35839616	-0.484239267	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2196	4280	0.012383178	0.002803738	0	13A	IN-VIP	NA	NA	NA
ACTTTCAAGAGGTTAT-1_8_E5	1.913878296	-31.16366448	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4457	13675	0.001389397	0.002340037	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACTTTCAAGCACCGCT-1_8_E5	22.64837851	14.98445018	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1342	2145	0.002331002	0.001398601	0	oligos	OL-Cntl	NA	NA	NA
ACTTTCAAGCGTCAAG-1_8_E5	7.021169558	-32.29044531	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5426	20548	0.009149309	0.001654662	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACTTTCAAGGGATCTG-1_8_E5	-1.73382719	-18.28265002	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2903	6339	0.001893043	0.002524057	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACTTTCAAGTGTACCT-1_8_E5	-19.19324472	-28.14898548	6A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3230	8143	0.007122682	0.003192926	0	6A	IN-PV	NA	NA	NA
ACTTTCAGTCCCGACA-1_8_E5	4.092933079	31.68744065	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	753	1087	0.005519779	0.001839926	0	oligos	OL-Cntl	NA	NA	NA
ACTTTCATCAAACCGT-1_8_E5	-0.753603709	-25.36527056	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4270	13232	0.003551995	0.001813785	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ACTTTCATCGCTGATA-1_8_E5	1.647715041	-30.87506244	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5653	20107	0.007808226	0.002238027	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AGAATAGAGCTGAAAT-1_8_E5	0.945960174	-27.75821292	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3564	8909	0.001571445	0.003030643	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AGAATAGCAAACTGTC-1_8_E5	-14.79731372	-19.26064519	6B	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1523	2968	0.027291105	0.001010782	0	6B	IN-SST	NA	NA	NA
AGAATAGTCACAGTAC-1_8_E5	-14.54962898	-3.54677974	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4911	13603	0.010365361	0.004851871	0	13A	IN-VIP	NA	NA	NA
AGAATAGTCCATGAGT-1_8_E5	-38.70637307	-1.328128293	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1346	2491	0.004817342	0.001605781	0	9	OPC	NA	NA	NA
AGAATAGTCTACTATC-1_8_E5	25.39333576	-29.51645524	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4075	13540	0.003692762	0.002141802	0	3	EN-L5-6	NA	NA	NA
AGACGTTAGCGCTCCA-1_8_E5	-14.47004816	-7.31999006	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3078	7126	0.015717092	0.004490598	0	13A	IN-VIP	NA	NA	NA
AGACGTTCACATTTCT-1_8_E5	29.148201	-1.37952992	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3476	8540	0.006791569	0.004215457	0	2	EN-L4	NA	NA	NA
AGACGTTGTGTCAATC-1_8_E5	-1.055867134	-21.19313843	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3459	8832	0.002604167	0.003962862	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AGACGTTTCCTTTACA-1_8_E5	27.30982719	0.282904489	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3853	11164	0.007345038	0.002239341	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AGACGTTTCGACAGCC-1_8_E5	7.661545445	32.90947418	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	721	1066	0.006566604	0.000938086	0	oligos	OL-Cntl	NA	NA	NA
AGAGCGAAGGCTCATT-1_8_E5	10.48674622	32.17841041	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	789	1196	0.00083612	0.003344482	0	oligos	OL-Cntl	NA	NA	NA
AGAGCGAAGTTACCCA-1_8_E5	-25.83533291	18.80396903	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1320	2199	0.004092769	0.006821282	0	8	Astrocytes	NA	NA	NA
AGAGCGACAACGATGG-1_8_E5	9.978931582	27.41635605	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	910	1412	0.002124646	0.007790368	0	oligos	OL-Cntl	NA	NA	NA
AGAGCGATCGTCGTTC-1_8_E5	1.359379746	-30.46858555	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5437	19280	0.007365145	0.002904564	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AGAGCGATCTTGACGA-1_8_E5	-7.184163647	-0.496576002	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1993	3697	0.017311334	0.005409792	0	13A	IN-VIP	NA	NA	NA
AGAGCTTAGATGAGAG-1_8_E5	16.35472977	18.22707036	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1017	1578	0.002534854	0.005069708	0	oligos	OL-Cntl	NA	NA	NA
AGAGCTTCAATAAGCA-1_8_E5	-30.11916615	-12.82224554	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	860	1318	0.003034901	0.003034901	0	9	OPC	NA	NA	NA
AGAGCTTCAGGTCCAC-1_8_E5	5.265545778	-32.00923154	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4941	16988	0.004238286	0.002119143	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AGAGCTTCATAGAAAC-1_8_E5	21.66867139	-28.9988472	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4177	11743	0.014221238	0.00323597	0	3	EN-L5-6	NA	NA	NA
AGAGCTTGTCGCTTCT-1_8_E5	-1.274237123	-26.46642052	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4576	15097	0.003908061	0.003378155	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AGAGCTTGTCGGCACT-1_8_E5	14.87649674	-33.67324324	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5317	20835	0.002399808	0.00537557	0	3	EN-L5-6	NA	NA	NA
AGAGCTTGTGACGGTA-1_8_E5	30.22668273	-4.560914729	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4025	9973	0.013135466	0.005414619	0	2	EN-L4	NA	NA	NA
AGAGCTTTCGGAGGTA-1_8_E5	-13.73329017	-3.136722661	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3738	9122	0.011401009	0.00624863	0	13A	IN-VIP	NA	NA	NA
AGAGCTTTCTGGTATG-1_8_E5	-38.15981975	1.356087903	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1533	2723	0.000734484	0.001468968	0	9	OPC	NA	NA	NA
AGAGTGGAGCTAAACA-1_8_E5	8.71014163	31.09553345	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	700	1072	0.008395522	0.004664179	0	oligos	OL-Cntl	NA	NA	NA
AGAGTGGAGGCATTGG-1_8_E5	14.84318881	-33.56302273	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4086	11878	0.001767974	0.005809059	0	3	EN-L5-6	NA	NA	NA
AGAGTGGAGGTAAACT-1_8_E5	-1.301147755	-20.41350262	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3591	9161	0.004584652	0.003056435	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AGAGTGGAGGTTACCT-1_8_E5	27.01082907	-1.168044916	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2954	7100	0.013521127	0.002535211	0	2	EN-L4	NA	NA	NA
AGAGTGGAGTAGATGT-1_8_E5	7.696126647	31.67143284	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	765	1125	0.007111111	0.005333333	0	oligos	OL-Cntl	NA	NA	NA
AGAGTGGCACTAAGTC-1_8_E5	-26.34711741	28.19157174	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1778	3601	0.000277701	0.003332408	0	8	Astrocytes	NA	NA	NA
AGAGTGGGTCACCCAG-1_8_E5	29.54820346	-3.932390544	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3795	9210	0.01422367	0.004017372	0	2	EN-L4	NA	NA	NA
AGAGTGGGTGTGTGCC-1_8_E5	-1.93425455	-19.31474431	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2727	5977	0.003178852	0.002342312	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AGAGTGGTCAGCTTAG-1_8_E5	-4.31409111	-4.44225394	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1187	1909	0.013095862	0.001571503	0	13A	IN-VIP	NA	NA	NA
AGATCTGAGATGGGTC-1_8_E5	0.789268235	-29.45120753	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5139	18121	0.008277689	0.002207384	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AGATCTGAGGTCGGAT-1_8_E5	-1.176726344	-19.44256606	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2888	6529	0.00597335	0.003063256	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AGATCTGCAGCGTCCA-1_8_E5	-35.91481298	-4.660508179	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1339	2276	0.003514938	0.002196837	0	9	OPC	NA	NA	NA
AGATCTGCAGCTGTTA-1_8_E5	-0.603328707	-14.63621383	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2547	5840	0.003767123	0.004280822	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AGATCTGCAGTCGTGC-1_8_E5	-0.86179481	-14.26241956	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2278	4594	0.003265128	0.004135829	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AGATCTGGTTGGTTTG-1_8_E5	2.743603546	-4.592324219	12	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	903	1368	0.05628655	0.002923977	0	12	EN-MIX	NA	NA	NA
AGATCTGTCCGAACGC-1_8_E5	9.755987544	31.2816233	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	753	1105	0.004524887	0.004524887	0	oligos	OL-Cntl	NA	NA	NA
AGATCTGTCGAACTGT-1_8_E5	9.883315867	27.36425043	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	793	1189	0.001682086	0.005046257	0	oligos	OL-Cntl	NA	NA	NA
AGATTGCAGACAATAC-1_8_E5	26.33494896	-27.99074786	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	6265	27293	0.012640604	0.002344924	0	3	EN-L5-6	NA	NA	NA
AGATTGCAGAGTACAT-1_8_E5	14.07717078	-33.23575809	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4638	15959	0.001002569	0.003696973	0	3	EN-L5-6	NA	NA	NA
AGATTGCCAGGGATTG-1_8_E5	1.347287982	-30.64710991	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5371	18076	0.004425758	0.002710777	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AGATTGCCAGTTAACC-1_8_E5	-35.78523299	4.964971279	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2272	4740	0.008438819	0.002320675	0	9	OPC	NA	NA	NA
AGATTGCGTATCTGCA-1_8_E5	-11.07993087	2.87618525	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3926	10503	0.007236028	0.004855755	0	13A	IN-VIP	NA	NA	NA
AGATTGCGTTCCACAA-1_8_E5	-37.47330042	2.791648006	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1774	3295	0.00030349	0.003034901	0	9	OPC	NA	NA	NA
AGATTGCTCACCCTCA-1_8_E5	-26.00639266	29.88736022	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1821	3498	0.000285878	0.004002287	0	8	Astrocytes	NA	NA	NA
AGATTGCTCAGGCCCA-1_8_E5	-23.36375486	0.834762884	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2376	4664	0.001286449	0.00364494	0	9	OPC	NA	NA	NA
AGATTGCTCCAACCAA-1_8_E5	10.12737042	31.16328954	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	776	1192	0.001677852	0.005033557	0	oligos	OL-Cntl	NA	NA	NA
AGATTGCTCGCCATAA-1_8_E5	26.21640504	-5.504918382	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	6101	23174	0.002287046	0.002675412	0	2	EN-L4	NA	NA	NA
AGCAGCCAGGAATCGC-1_8_E5	7.032003026	-5.905982161	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1364	2448	0.003267974	0.003267974	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AGCAGCCAGGCCATAG-1_8_E5	-24.28473119	30.11466726	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1814	3374	0.001185536	0.001778305	0	8	Astrocytes	NA	NA	NA
AGCAGCCCAATCTACG-1_8_E5	-15.62138986	-25.31013367	6A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1890	3668	0.010087241	0.003271538	0	6A	IN-PV	NA	NA	NA
AGCAGCCCAGTCACTA-1_8_E5	-36.86550254	3.625750548	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2028	4076	0.000981354	0.002698724	0	9	OPC	NA	NA	NA
AGCAGCCTCAATAAGG-1_8_E5	-11.445441	-0.15733797	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2999	6535	0.008110176	0.006579954	0	13A	IN-VIP	NA	NA	NA
AGCAGCCTCTAACTTC-1_8_E5	-33.76299142	4.666577056	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2304	4537	0.006832709	0.003746969	0	9	OPC	NA	NA	NA
AGCATACCAACGATGG-1_8_E5	-21.99209475	31.66080245	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3371	8033	0.000995892	0.004357027	0	8	Astrocytes	NA	NA	NA
AGCATACTCAGTTCGA-1_8_E5	-14.24440814	-7.557726579	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2930	6473	0.01235903	0.007724394	0	13A	IN-VIP	NA	NA	NA
AGCATACTCCGCGTTT-1_8_E5	-35.98431793	-8.873459917	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	952	1462	0.002735978	0.002735978	0	9	OPC	NA	NA	NA
AGCATACTCTGTCTCG-1_8_E5	-20.15557421	-17.97603507	6B	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4393	13182	0.013654984	0.003868912	0	6B	IN-SST	NA	NA	NA
AGCCTAAAGCGTCTAT-1_8_E5	-0.618610843	-14.38783999	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2219	4504	0.015319716	0.003108348	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AGCCTAACAATGTTGC-1_8_E5	-1.1240354	-19.28361181	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3000	7174	0.00125453	0.002787845	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AGCCTAACACTTAACG-1_8_E5	7.96102082	-32.13695893	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5630	19741	0.002380832	0.003951168	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AGCCTAACATTATCTC-1_8_E5	19.58377778	15.62838271	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1186	1928	0.004149378	0.007780083	0	oligos	OL-Cntl	NA	NA	NA
AGCCTAAGTGTCTGAT-1_8_E5	-18.67384148	-27.72371976	6A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2763	6018	0.007477567	0.003157195	0	6A	IN-PV	NA	NA	NA
AGCGGTCAGACCTAGG-1_8_E5	-19.04596732	-18.52764421	6B	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2634	5699	0.008948938	0.003509388	0	6B	IN-SST	NA	NA	NA
AGCGGTCAGGCGCTCT-1_8_E5	-3.031032608	-24.54373714	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3866	10729	0.005033088	0.003262187	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AGCGGTCAGTAGTGCG-1_8_E5	5.382868411	-31.05672587	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4048	11114	0.000809789	0.004138924	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AGCGGTCAGTGCCAGA-1_8_E5	-27.49840374	12.55319273	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	975	1577	0.001268231	0.001268231	0	8	Astrocytes	NA	NA	NA
AGCGGTCCACGTTGGC-1_8_E5	22.67991481	-0.587944424	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2268	4807	0.004160599	0.003952569	0	2	EN-L4	NA	NA	NA
AGCGGTCCAGCCTTTC-1_8_E5	28.45934019	-1.635358052	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4514	13483	0.001780019	0.004079211	0	2	EN-L4	NA	NA	NA
AGCGGTCTCGGTCTAA-1_8_E5	17.30102867	1.735245215	12	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	944	1366	0.017569546	0.002928258	0	12	EN-MIX	NA	NA	NA
AGCGTATAGCACACAG-1_8_E5	-38.63239439	-1.370853459	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1424	2533	0.001184366	0.004342677	0	9	OPC	NA	NA	NA
AGCGTATAGCCCGAAA-1_8_E5	-25.90722293	29.38149502	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1826	3624	0.001103753	0.00303532	0	8	Astrocytes	NA	NA	NA
AGCGTATCACAGGCCT-1_8_E5	28.70339116	-1.453895293	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3857	9715	0.005867216	0.004117344	0	2	EN-L4	NA	NA	NA
AGCGTATGTCCGAAGA-1_8_E5	9.121274807	34.26059264	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	848	1199	0.011676397	0.005838198	0	oligos	OL-Cntl	NA	NA	NA
AGCGTCGAGACAGAGA-1_8_E5	28.99698739	-1.807616988	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4006	10220	0.006555773	0.004207436	0	2	EN-L4	NA	NA	NA
AGCGTCGAGAGACGAA-1_8_E5	-37.39064737	0.145688865	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1515	2681	0.009697874	0.003356956	0	9	OPC	NA	NA	NA
AGCGTCGAGTACGATA-1_8_E5	-29.11549804	14.23298905	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	945	1581	0.002530044	0.003162555	0	8	Astrocytes	NA	NA	NA
AGCGTCGCAAGCCATT-1_8_E5	29.1670677	-1.500221923	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4050	10796	0.008892182	0.002964061	0	2	EN-L4	NA	NA	NA
AGCGTCGCAGACAAAT-1_8_E5	20.58892965	22.2321402	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1082	1700	0.009411765	0.004705882	0	oligos	OL-Cntl	NA	NA	NA
AGCGTCGGTTGTTTGG-1_8_E5	9.734477858	32.53081175	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	783	1228	0.008957655	0.004885993	0	oligos	OL-Cntl	NA	NA	NA
AGCGTCGTCCGTAGGC-1_8_E5	-33.42153883	-8.62044489	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1003	1527	0.003274394	0.003274394	0	9	OPC	NA	NA	NA
AGCTCCTTCTACTCAT-1_8_E5	-9.694682503	22.26462824	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	907	1267	0.003157064	0.00394633	0	8	Astrocytes	NA	NA	NA
AGCTCTCAGACAGGCT-1_8_E5	-36.76752194	-0.077616835	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1543	2586	0.010440835	0.002706883	0	9	OPC	NA	NA	NA
AGCTCTCAGATCACGG-1_8_E5	9.394051602	28.31840765	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	899	1337	0.009723261	0.006731488	0	oligos	OL-Cntl	NA	NA	NA
AGCTCTCCACTTCTGC-1_8_E5	7.566328751	32.98914779	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	740	1028	0.002918288	0.001945525	0	oligos	OL-Cntl	NA	NA	NA
AGCTCTCGTCGCGGTT-1_8_E5	-26.02393869	29.89481045	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1941	3504	0.001141553	0.003710046	0	8	Astrocytes	NA	NA	NA
AGCTCTCGTCTCGTTC-1_8_E5	7.021789548	-27.8710976	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	7777	35450	0.001692525	0.003751763	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AGCTCTCGTTGCGTTA-1_8_E5	-1.370511798	-21.49121393	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3351	8543	0.00526747	0.003277537	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AGCTCTCTCAGTTTGG-1_8_E5	-16.69387227	-10.98838287	13B	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3798	10589	0.010199263	0.004344131	0	13B	IN-SV2C	NA	NA	NA
AGCTCTCTCCAGAAGG-1_8_E5	-1.130690259	-21.86015389	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3866	10306	0.008538715	0.003978265	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AGCTCTCTCCGAGCCA-1_8_E5	-24.28807817	30.20045035	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1830	3512	0.000854214	0.001708428	0	8	Astrocytes	NA	NA	NA
AGCTTGAAGATCTGAA-1_8_E5	-27.75361429	14.8350673	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	952	1421	0.00070373	0.002111189	0	8	Astrocytes	NA	NA	NA
AGCTTGACAGTTCATG-1_8_E5	-1.218966423	-19.75266881	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3100	7545	0.005301524	0.005699139	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AGCTTGAGTAGCAAAT-1_8_E5	27.811022	-5.284629934	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4794	14777	0.012248765	0.003925019	0	2	EN-L4	NA	NA	NA
AGCTTGATCAGGCGAA-1_8_E5	11.04680973	1.697223058	12	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	695	1173	0.009377664	0.005967604	0	12	EN-MIX	NA	NA	NA
AGGCCACAGGGCTTCC-1_8_E5	-8.75048074	33.64272595	17	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	833	1117	0.040286482	0.007162041	0	oligos	OL-MS-2	NA	NA	NA
AGGCCACGTAGGGACT-1_8_E5	-14.69908734	-7.183515383	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3102	6871	0.014553922	0.004366177	0	13A	IN-VIP	NA	NA	NA
AGGCCACTCTATGTGG-1_8_E5	3.599001138	-31.69278735	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5854	21770	0.003353238	0.002939825	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AGGCCGTAGATCGGGT-1_8_E5	13.21027277	-9.557470758	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3027	6454	0.003873567	0.004493337	0	8	Astrocytes	NA	NA	NA
AGGCCGTAGCCACGCT-1_8_E5	-9.493664597	0.784077484	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2640	5273	0.017637019	0.003982553	0	13A	IN-VIP	NA	NA	NA
AGGCCGTCATCCCACT-1_8_E5	-0.952725495	-21.36593403	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3761	10325	0.004164649	0.006198547	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AGGCCGTGTGCACTTA-1_8_E5	4.879556041	5.893676953	7	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1857	3087	0.003239391	0.006154843	0	7	Phagocytes	NA	NA	NA
AGGCCGTGTGCTGTAT-1_8_E5	-32.0256533	-0.170845171	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1692	2896	0.003107735	0.005179558	0	9	OPC	NA	NA	NA
AGGCCGTGTTCACGGC-1_8_E5	10.98732926	26.51959914	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	810	1142	0.000875657	0.001751313	0	oligos	OL-Cntl	NA	NA	NA
AGGCCGTTCGGCATCG-1_8_E5	-25.41642866	19.72886882	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1497	2514	0.001193317	0.001193317	0	8	Astrocytes	NA	NA	NA
AGGCCGTTCTGTTTGT-1_8_E5	4.362116456	6.916270461	7	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1414	2275	0.003516484	0.002637363	0	7	Phagocytes	NA	NA	NA
AGGGAGTAGAAGGGTA-1_8_E5	10.822068	27.63621383	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	967	1562	0.003841229	0.001920615	0	oligos	OL-Cntl	NA	NA	NA
AGGGAGTAGCACAGGT-1_8_E5	7.018833241	-31.47406935	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	7025	30774	0.002567102	0.003184506	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AGGGAGTCAAGGCTCC-1_8_E5	-4.882001874	-2.20721628	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1304	2154	0.008820799	0.002321263	0	13A	IN-VIP	NA	NA	NA
AGGGAGTCATCCTTGC-1_8_E5	19.9756491	24.49561385	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	970	1544	0.001943005	0.005181347	0	oligos	OL-Cntl	NA	NA	NA
AGGGAGTGTACACCGC-1_8_E5	21.34448883	-29.16705466	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3957	10475	0.003818616	0.0049642	0	3	EN-L5-6	NA	NA	NA
AGGGAGTGTCGGATCC-1_8_E5	-25.57903344	20.23488146	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1456	2470	0.000809717	0.001214575	0	8	Astrocytes	NA	NA	NA
AGGGAGTGTCTAGGTT-1_8_E5	-38.31626686	-1.300129673	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1333	2156	0.006029685	0.001391466	0	9	OPC	NA	NA	NA
AGGGAGTTCACCTTAT-1_8_E5	3.334163346	-31.61403821	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5919	23114	0.005018603	0.003763953	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AGGGAGTTCCGCGCAA-1_8_E5	-0.449540339	-22.68866965	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4060	10873	0.004046721	0.003494896	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AGGGATGAGCGGATCA-1_8_E5	20.90380456	-29.32079465	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5034	15353	0.00709959	0.004689637	0	3	EN-L5-6	NA	NA	NA
AGGGATGCACATAACC-1_8_E5	24.23481802	-6.269607235	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3926	10137	0.002564861	0.003551347	0	2	EN-L4	NA	NA	NA
AGGGATGGTGGGTATG-1_8_E5	17.650697	-5.702917075	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1569	2960	0.002702703	0.002364865	0	3	EN-L5-6	NA	NA	NA
AGGGATGGTTAGGGTG-1_8_E5	2.13808728	-9.990470114	12	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1807	3647	0.003290376	0.003838772	0	12	EN-MIX	NA	NA	NA
AGGGTGACAGTCAGCC-1_8_E5	0.206288819	18.9503599	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	775	1171	0.002561913	0.014517506	0	oligos	OL-Cntl	NA	NA	NA
AGGGTGACATACGCTA-1_8_E5	-16.17009818	-11.03434694	13B	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2988	6932	0.011829198	0.002452395	0	13B	IN-SV2C	NA	NA	NA
AGGGTGAGTGCGATAG-1_8_E5	-38.75348232	0.181505344	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1636	3164	0.001264223	0.004740834	0	9	OPC	NA	NA	NA
AGGTCATCAAGTTCTG-1_8_E5	13.18024826	-30.11121435	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4246	13414	0.000521843	0.004622037	0	3	EN-L5-6	NA	NA	NA
AGGTCATCATTTCAGG-1_8_E5	-1.28182177	-25.84072964	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4468	13607	0.00183729	0.003380613	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AGGTCATGTCGCATAT-1_8_E5	5.707731098	26.82687446	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	838	1198	0.004173623	0.005008347	0	oligos	OL-Cntl	NA	NA	NA
AGGTCATGTTGAACTC-1_8_E5	-1.822103721	-20.623818	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3205	7858	0.009289896	0.004072283	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AGGTCATTCACTTACT-1_8_E5	-8.212230939	1.139001453	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2372	4957	0.007060722	0.004639903	0	13A	IN-VIP	NA	NA	NA
AGGTCCGAGGAGTTTA-1_8_E5	1.794530988	6.773153372	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	759	1042	0.005758157	0.002879079	0	oligos	OL-Cntl	NA	NA	NA
AGGTCCGAGGGTTCCC-1_8_E5	-11.76609073	1.493488164	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2951	6055	0.020809249	0.007101569	0	13A	IN-VIP	NA	NA	NA
AGGTCCGCAAAGAATC-1_8_E5	24.0669462	-10.53946349	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4467	11823	0.011672164	0.006512729	0	3	EN-L5-6	NA	NA	NA
AGGTCCGCAATCGAAA-1_8_E5	5.067250857	33.42359982	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	714	1019	0.005888126	0.00686948	0	oligos	OL-Cntl	NA	NA	NA
AGGTCCGCAATGGTCT-1_8_E5	-0.846355091	-21.17850677	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3507	9108	0.008893281	0.00274484	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AGGTCCGCACCACGTG-1_8_E5	1.395229681	-30.76381971	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5387	18973	0.000790597	0.002319085	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AGGTCCGGTAGGAGTC-1_8_E5	-0.530466311	-25.22375243	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4840	14444	0.003530878	0.003738577	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AGGTCCGTCAGAGCTT-1_8_E5	-26.05253207	27.26356552	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1570	2945	0.004414261	0.001018676	0	8	Astrocytes	NA	NA	NA
AGGTCCGTCTGGCGAC-1_8_E5	7.398699111	34.13188704	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	942	1443	0.007623008	0.004851005	0	oligos	OL-Cntl	NA	NA	NA
AGTAGTCCACCAGGTC-1_8_E5	-27.58620495	11.61613879	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	895	1349	0.00148258	0.005930319	0	8	Astrocytes	NA	NA	NA
AGTAGTCCAGCCAGAA-1_8_E5	5.9952034	32.57897132	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	835	1290	0.012403101	0.006976744	0	oligos	OL-Cntl	NA	NA	NA
AGTAGTCGTCCGAATT-1_8_E5	-20.84416289	-28.11526568	6A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4034	11391	0.010885787	0.003335967	0	6A	IN-PV	NA	NA	NA
AGTAGTCGTTATGCGT-1_8_E5	-35.87935625	-8.575975728	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1030	1539	0.005198181	0.001949318	0	9	OPC	NA	NA	NA
AGTCTTTAGATCTGCT-1_8_E5	-39.51455094	0.368628062	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1529	2900	0.007586207	0.003103448	0	9	OPC	NA	NA	NA
AGTCTTTAGTGAACAT-1_8_E5	-17.35134263	-23.41987395	6A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2255	5079	0.003740894	0.004331561	0	6A	IN-PV	NA	NA	NA
AGTCTTTCAAATCCGT-1_8_E5	-3.137151507	-21.06301429	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3456	8770	0.002736602	0.004104903	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AGTCTTTCACCGAAAG-1_8_E5	-25.97627642	19.33799562	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1321	2292	0	0.004799302	0	8	Astrocytes	NA	NA	NA
AGTCTTTGTCTGATTG-1_8_E5	7.6147288	-32.78076967	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3884	10857	0.006447453	0.002671088	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AGTGAGGCACCAGCAC-1_8_E5	24.93449441	-28.32123224	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3928	10725	0.004848485	0.003916084	0	3	EN-L5-6	NA	NA	NA
AGTGAGGGTCCCTACT-1_8_E5	-15.35271417	-25.07956648	6A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1774	3611	0.049570756	0.004984769	0	6A	IN-PV	NA	NA	NA
AGTGAGGGTTGCGTTA-1_8_E5	20.87981598	22.79462104	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1063	1730	0.004046243	0.003468208	0	oligos	OL-Cntl	NA	NA	NA
AGTGAGGTCTTTAGGG-1_8_E5	-18.48321279	-23.12413911	6A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2214	4348	0.00574977	0.006669733	0	6A	IN-PV	NA	NA	NA
AGTGGGAAGGCTCTTA-1_8_E5	-23.80111841	29.43818456	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1938	3803	0.003155404	0.002629503	0	8	Astrocytes	NA	NA	NA
AGTGGGAAGGTGATAT-1_8_E5	-19.84431111	-27.18586717	6A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3051	7210	0.006102635	0.004160888	0	6A	IN-PV	NA	NA	NA
AGTGGGAAGGTGTGGT-1_8_E5	9.700942228	27.74923378	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	931	1346	0.004457652	0.002971768	0	oligos	OL-Cntl	NA	NA	NA
AGTGGGAAGTCACGCC-1_8_E5	-9.87597888	1.888318681	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2861	6502	0.012765303	0.004613965	0	13A	IN-VIP	NA	NA	NA
AGTGGGAAGTGGACGT-1_8_E5	-10.52472024	1.978194327	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2939	6383	0.005169983	0.003133323	0	13A	IN-VIP	NA	NA	NA
AGTGGGACATCTCGCT-1_8_E5	6.655998942	-31.85973742	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5784	20546	0.002725591	0.003212304	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AGTGGGATCGAGCCCA-1_8_E5	18.67779474	8.956395924	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1683	3183	0.00314169	0.004084197	0	oligos	OL-Cntl	NA	NA	NA
AGTGGGATCTGTGCAA-1_8_E5	25.9253519	-4.089376311	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3557	9032	0.000996457	0.003432241	0	2	EN-L4	NA	NA	NA
AGTGTCAAGAATAGGG-1_8_E5	1.0034277	34.91307331	17	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	746	1028	0.010700389	0.004863813	0	oligos	OL-MS-2	NA	NA	NA
AGTGTCAAGAGCTGCA-1_8_E5	-17.27769819	14.34709996	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1450	2798	0.000714796	0.002501787	0	8	Astrocytes	NA	NA	NA
AGTGTCAAGTTAACGA-1_8_E5	28.91687436	-1.762848516	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4096	10490	0.004003813	0.004575786	0	2	EN-L4	NA	NA	NA
AGTGTCACAGGGTACA-1_8_E5	-4.739916168	-3.272939	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1254	2168	0.028136531	0.001383764	0	13A	IN-VIP	NA	NA	NA
AGTGTCAGTAAGAGGA-1_8_E5	19.88856981	1.453977699	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1513	2509	0.001195695	0.001195695	0	2	EN-L4	NA	NA	NA
AGTGTCAGTGAGGGTT-1_8_E5	-1.290807617	-23.00033165	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4411	13548	0.005019191	0.003395335	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
AGTGTCATCACTATTC-1_8_E5	-37.86360502	1.156485975	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1612	2831	0.003532321	0.003179089	0	9	OPC	NA	NA	NA
AGTTGGTAGTACGTAA-1_8_E5	-16.77011395	-10.93520009	13B	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3807	10060	0.012524851	0.002683897	0	13B	IN-SV2C	NA	NA	NA
AGTTGGTCAATACGCT-1_8_E5	-1.453962791	-24.13847841	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3816	10367	0.004919456	0.003086717	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ATAACGCCAAACCTAC-1_8_E5	9.715735072	27.44336846	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	889	1416	0.011299435	0.004237288	0	oligos	OL-Cntl	NA	NA	NA
ATAACGCCATGTCTCC-1_8_E5	8.986756717	29.65918974	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	834	1251	0.004796163	0.003197442	0	oligos	OL-Cntl	NA	NA	NA
ATAACGCGTACCAGTT-1_8_E5	9.841072347	27.24499152	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	897	1360	0.002941176	0.005882353	0	oligos	OL-Cntl	NA	NA	NA
ATAACGCGTCGGGTCT-1_8_E5	17.83038442	1.552627971	12	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	925	1402	0.004992867	0.0021398	0	12	EN-MIX	NA	NA	NA
ATAACGCGTGACTACT-1_8_E5	-8.358847116	1.895363696	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2592	5535	0.010478771	0.003071364	0	13A	IN-VIP	NA	NA	NA
ATAACGCGTTCCCGAG-1_8_E5	-15.53095926	-19.02185416	6B	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1579	3109	0.000321647	0.001929881	0	6B	IN-SST	NA	NA	NA
ATAAGAGCAAACCCAT-1_8_E5	23.34945139	-0.891742971	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2147	3793	0.015291326	0.005536515	0	2	EN-L4	NA	NA	NA
ATAAGAGTCCCTGACT-1_8_E5	-24.26229925	30.20243635	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1870	3457	0.001157073	0.00462829	0	8	Astrocytes	NA	NA	NA
ATAAGAGTCTGCTGTC-1_8_E5	7.100783574	-32.73669635	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4341	13381	0.000373664	0.003811374	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ATAGACCAGGGTGTTG-1_8_E5	24.87391695	-29.54334023	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3059	7424	0.000673491	0.002559267	0	3	EN-L5-6	NA	NA	NA
ATAGACCCAAGGTTTC-1_8_E5	4.135587893	-31.61221749	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	6522	27198	0.007206412	0.002904625	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ATAGACCCAAGTCTAC-1_8_E5	-25.19110271	29.65292655	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1830	3565	0.007012623	0.003366059	0	8	Astrocytes	NA	NA	NA
ATAGACCCAGACAAAT-1_8_E5	20.1903163	24.864631	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1068	1655	0.009063444	0.004229607	0	oligos	OL-Cntl	NA	NA	NA
ATAGACCCAGGACCCT-1_8_E5	3.638238651	-30.79351185	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4455	14551	0.004604495	0.002130438	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ATAGACCGTAGCTAAA-1_8_E5	1.036402332	-22.34037434	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4922	15259	0.010813291	0.006160299	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ATAGACCGTCAGCTAT-1_8_E5	2.326545208	-29.34014171	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4942	16980	0.002767962	0.004416961	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ATAGACCTCACAGTAC-1_8_E5	20.58711325	22.23701614	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1063	1803	0.001109262	0.002773156	0	oligos	OL-Cntl	NA	NA	NA
ATAGACCTCCACTGGG-1_8_E5	-1.574381415	-19.9631031	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3439	9133	0.003284791	0.003394284	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ATCACGAAGACTTTCG-1_8_E5	0.118600905	-27.70281051	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4861	15755	0.001777214	0.002856236	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ATCACGAAGCTAAACA-1_8_E5	-2.38700287	-25.75095237	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5263	18638	0.00182423	0.003541152	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ATCACGACAGGCGATA-1_8_E5	4.989644783	31.44871031	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	767	1098	0.011839709	0.004553734	0	oligos	OL-Cntl	NA	NA	NA
ATCACGATCGCATGGC-1_8_E5	0.454093135	-29.21807636	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4385	14172	0.001834603	0.001622918	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ATCACGATCTGAGTGT-1_8_E5	23.49699381	-9.363870108	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3780	9501	0.008209662	0.004946848	0	3	EN-L5-6	NA	NA	NA
ATCATCTAGAAACCAT-1_8_E5	1.800254839	-31.11474719	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5530	20102	0.001691374	0.00174112	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ATCATCTAGAGTCTGG-1_8_E5	-23.9726813	30.37402164	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1887	3680	0.000543478	0.001902174	0	8	Astrocytes	NA	NA	NA
ATCATCTCAAGTACCT-1_8_E5	7.305049386	-31.84595604	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5333	18712	0.004970073	0.003794357	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ATCATCTCAGCAGTTT-1_8_E5	20.21481563	24.59574657	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1043	1567	0.010210593	0.005105297	0	oligos	OL-Cntl	NA	NA	NA
ATCATCTGTTACGGAG-1_8_E5	21.53238347	-28.95111295	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4457	12224	0.004335733	0.008262435	0	3	EN-L5-6	NA	NA	NA
ATCATCTGTTCTGAAC-1_8_E5	19.96925101	12.00578374	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1411	2592	0.005401235	0.005787037	0	oligos	OL-Cntl	NA	NA	NA
ATCATCTTCAGTGTTG-1_8_E5	-14.33098475	-7.610940662	13B	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3570	9351	0.016575767	0.004384558	0	13B	IN-SV2C	NA	NA	NA
ATCATCTTCCCGGATG-1_8_E5	9.675486462	31.42760106	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	692	1053	0.007597341	0	0	oligos	OL-Cntl	NA	NA	NA
ATCATCTTCGTCCGTT-1_8_E5	6.618852541	31.65261921	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	803	1171	0.00853971	0.006831768	0	oligos	OL-Cntl	NA	NA	NA
ATCATGGAGCTGCAAG-1_8_E5	-0.811103661	-18.97901789	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2692	5812	0.003269098	0.00154852	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ATCATGGAGCTGTCTA-1_8_E5	-32.33805262	-12.37965019	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	796	1235	0.00242915	0.001619433	0	9	OPC	NA	NA	NA
ATCATGGAGGCCGAAT-1_8_E5	-8.605308401	1.12698956	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2425	5139	0.00992411	0.002529675	0	13A	IN-VIP	NA	NA	NA
ATCATGGAGGCGCTCT-1_8_E5	11.04382734	32.87655543	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	846	1290	0.003100775	0.002325581	0	oligos	OL-Cntl	NA	NA	NA
ATCATGGAGGGAAACA-1_8_E5	4.570281962	32.88443335	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	823	1188	0.001683502	0.002525253	0	oligos	OL-Cntl	NA	NA	NA
ATCATGGAGGGATCTG-1_8_E5	-2.030860451	-20.9792579	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3389	8444	0.0026054	0.003552819	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ATCATGGAGGGTTTCT-1_8_E5	9.63514822	31.10044934	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	807	1187	0.01010952	0.0042123	0	oligos	OL-Cntl	NA	NA	NA
ATCATGGAGTAGGTGC-1_8_E5	-37.78716378	0.040315978	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1626	2965	0.004384486	0.003035413	0	9	OPC	NA	NA	NA
ATCATGGGTAAATGAC-1_8_E5	29.55314244	-1.790648999	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4110	10823	0.012935415	0.004065416	0	2	EN-L4	NA	NA	NA
ATCATGGGTCCAGTTA-1_8_E5	11.33465466	32.23048283	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	744	1027	0.00097371	0.005842259	0	oligos	OL-Cntl	NA	NA	NA
ATCATGGTCCCAACGG-1_8_E5	19.39701322	25.07777565	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	980	1445	0	0.002076125	0	oligos	OL-Cntl	NA	NA	NA
ATCATGGTCGAATGCT-1_8_E5	-5.849418702	-2.3449263	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1661	3027	0.018169805	0.003964321	0	13A	IN-VIP	NA	NA	NA
ATCATGGTCGGTGTCG-1_8_E5	25.49797717	-2.57013074	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3220	8351	0.000239492	0.002754161	0	2	EN-L4	NA	NA	NA
ATCCACCAGAAGGGTA-1_8_E5	25.55020556	-28.88401524	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4186	12704	0.009130982	0.002991184	0	3	EN-L5-6	NA	NA	NA
ATCCACCAGCGTCAAG-1_8_E5	15.64187241	-2.420335235	12	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	991	1578	0.005069708	0.001267427	0	12	EN-MIX	NA	NA	NA
ATCCACCAGGCAATTA-1_8_E5	-8.550388485	-18.08867339	6B	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	757	1185	0.026160338	0.001687764	0	6B	IN-SST	NA	NA	NA
ATCCACCAGTGGAGTC-1_8_E5	2.836049156	-31.91589328	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	7086	31731	0.003246037	0.002584224	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ATCCGAAAGCCCAACC-1_8_E5	20.86787169	22.79295019	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1126	1888	0.001059322	0.003177966	0	oligos	OL-Cntl	NA	NA	NA
ATCCGAAAGGCGACAT-1_8_E5	28.32013375	-1.512623868	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4095	10646	0.001502912	0.004320872	0	2	EN-L4	NA	NA	NA
ATCCGAAGTCGAGATG-1_8_E5	10.78406124	27.47426292	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1024	1576	0.005076142	0.003807107	0	oligos	OL-Cntl	NA	NA	NA
ATCCGAAGTGTCAATC-1_8_E5	9.867411522	31.55649549	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	799	1168	0.001712329	0.002568493	0	oligos	OL-Cntl	NA	NA	NA
ATCCGAATCACGCGGT-1_8_E5	-36.35657115	-6.468732993	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1111	1760	0.003409091	0.005113636	0	9	OPC	NA	NA	NA
ATCCGAATCCAACCAA-1_8_E5	-1.049274297	-22.04201798	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4298	13173	0.002429211	0.003795643	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ATCCGAATCTAGAGTC-1_8_E5	4.530830915	29.51463759	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	723	1045	0.010526316	0.005741627	0	oligos	OL-Cntl	NA	NA	NA
ATCGAGTAGGATCGCA-1_8_E5	-22.91815058	31.26627948	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2309	4886	0.001432665	0.00225133	0	8	Astrocytes	NA	NA	NA
ATCGAGTCACAACTGT-1_8_E5	2.74165292	-9.661599952	12	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1458	2115	0.013711584	0.003782506	0	12	EN-MIX	NA	NA	NA
ATCGAGTGTACTTCTT-1_8_E5	-0.705246728	-14.3904682	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2328	4990	0.005611222	0.003406814	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ATCGAGTGTGAAAGAG-1_8_E5	16.46324195	13.19079788	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1320	2133	0.012189405	0.007032349	0	oligos	OL-Cntl	NA	NA	NA
ATCTACTTCATGTCCC-1_8_E5	5.397516393	-32.69464721	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	6241	27543	0.001887957	0.002105798	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ATCTACTTCATTGCGA-1_8_E5	5.466387634	-27.33015876	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2816	6106	0.007697347	0.002620373	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ATCTACTTCGCGCCAA-1_8_E5	-1.181920795	-25.0991458	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4830	16495	0.003758715	0.003031222	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ATCTGCCAGGCATGTG-1_8_E5	7.001847753	34.56032085	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	817	1179	0.005089059	0.004240882	0	oligos	OL-Cntl	NA	NA	NA
ATCTGCCCACGGCCAT-1_8_E5	-0.864933982	-14.30413348	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2377	5131	0.009354902	0.001948938	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ATCTGCCGTAGCTGCC-1_8_E5	-8.481591789	1.147334765	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2265	4871	0.016013139	0.001437077	0	13A	IN-VIP	NA	NA	NA
ATCTGCCTCCTTGCCA-1_8_E5	-23.40094194	0.533816444	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2108	4046	0.006920415	0.000988631	0	9	OPC	NA	NA	NA
ATGAGGGCAATGGTCT-1_8_E5	22.0245542	20.20908571	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1150	1790	0.003351955	0.002234637	0	oligos	OL-Cntl	NA	NA	NA
ATGAGGGCACCAGTTA-1_8_E5	27.93167663	-2.376334086	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4346	13280	0.010843373	0.003388554	0	2	EN-L4	NA	NA	NA
ATGAGGGCACCTCGGA-1_8_E5	-27.05678577	25.77808436	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1441	2755	0.001451906	0.001088929	0	8	Astrocytes	NA	NA	NA
ATGAGGGCAGGTCGTC-1_8_E5	-0.270271523	-26.92990524	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5179	17219	0.001858412	0.002032638	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ATGAGGGCAGTCAGCC-1_8_E5	-3.245831246	-24.77733467	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3897	11089	0.00171341	0.003607178	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ATGAGGGGTTAGAACA-1_8_E5	-25.79056331	14.98842762	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	944	1382	0.001447178	0.005065123	0	8	Astrocytes	NA	NA	NA
ATGAGGGGTTTAGGAA-1_8_E5	-38.71014601	0.007271075	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1471	2625	0.003047619	0.003428571	0	9	OPC	NA	NA	NA
ATGCGATAGAGCCCAA-1_8_E5	14.76590423	1.782490821	12	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	899	1231	0.014622258	0.005686434	0	12	EN-MIX	NA	NA	NA
ATGCGATGTCTCAACA-1_8_E5	-30.01504799	-12.82777196	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	812	1284	0.008566978	0.007009346	0	9	OPC	NA	NA	NA
ATGCGATGTTGTGGCC-1_8_E5	-23.55666444	0.201329179	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2189	4174	0.001677048	0.00143747	0	9	OPC	NA	NA	NA
ATGCGATTCACGATGT-1_8_E5	-38.21803875	-0.939621482	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1412	2380	0.001680672	0.002941176	0	9	OPC	NA	NA	NA
ATGGGAGAGTCCGGTC-1_8_E5	-37.84946184	2.744098618	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1679	3024	0.001322751	0.002314815	0	9	OPC	NA	NA	NA
ATGGGAGGTCTAAACC-1_8_E5	15.52476418	-33.15060082	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5700	22025	0.003586833	0.005221339	0	3	EN-L5-6	NA	NA	NA
ATGGGAGTCTAGAGTC-1_8_E5	-1.375035117	-22.45273333	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4562	13781	0.006022785	0.002467165	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ATGGGAGTCTGTCCGT-1_8_E5	-0.480634005	-14.11268905	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2148	4075	0.005644172	0.002699387	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ATGGGAGTCTTGTTTG-1_8_E5	11.8201134	31.84779829	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	801	1154	0.009532062	0.002599653	0	oligos	OL-Cntl	NA	NA	NA
ATGTGTGCACCTCGTT-1_8_E5	-25.78224172	29.73922293	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1762	3313	0.001207365	0.005433142	0	8	Astrocytes	NA	NA	NA
ATGTGTGCATCGGTTA-1_8_E5	10.05223212	32.38374444	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	832	1238	0.000807754	0.004846527	0	oligos	OL-Cntl	NA	NA	NA
ATGTGTGGTAAGGGCT-1_8_E5	19.04072797	-7.204310358	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2604	6546	0.00152765	0.004430186	0	3	EN-L5-6	NA	NA	NA
ATGTGTGGTCAAAGCG-1_8_E5	5.049654677	34.01156683	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	762	1106	0.006329114	0.002712477	0	oligos	OL-Cntl	NA	NA	NA
ATGTGTGGTGGCGAAT-1_8_E5	-9.541589475	1.841921954	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2966	7153	0.003914441	0.006011464	0	13A	IN-VIP	NA	NA	NA
ATGTGTGTCAACACCA-1_8_E5	-24.40561237	30.24435683	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1759	3309	0.001208824	0.004230885	0	8	Astrocytes	NA	NA	NA
ATGTGTGTCTTGCAAG-1_8_E5	-28.36957048	17.78985567	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1105	1806	0.003875969	0.00110742	0	8	Astrocytes	NA	NA	NA
ATGTGTGTCTTGTTTG-1_8_E5	-9.774532664	1.909700597	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2887	7314	0.013398961	0.004101723	0	13A	IN-VIP	NA	NA	NA
ATTACTCAGGTACTCT-1_8_E5	2.256711261	-30.23389435	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4518	14213	0.004362204	0.002462534	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ATTACTCCAATGTTGC-1_8_E5	23.36221371	-9.240214329	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3873	10807	0.001017859	0.003053576	0	3	EN-L5-6	NA	NA	NA
ATTACTCCATGAACCT-1_8_E5	-8.480753001	0.142260201	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2147	3931	0.013991351	0.003561435	0	13A	IN-VIP	NA	NA	NA
ATTACTCTCCCGACTT-1_8_E5	19.05543274	1.581860848	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1247	1907	0.037231253	0.001573152	0	2	EN-L4	NA	NA	NA
ATTACTCTCTTATCTG-1_8_E5	-39.1021135	0.087714141	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1558	2894	0.00138217	0.002073255	0	9	OPC	NA	NA	NA
ATTATCCAGCAGGTCA-1_8_E5	28.52022032	-1.668553558	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4252	11671	0.010281895	0.003427298	0	2	EN-L4	NA	NA	NA
ATTATCCAGCTAGTGG-1_8_E5	-37.91460925	0.580734644	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1443	2469	0.009720535	0.002025111	0	9	OPC	NA	NA	NA
ATTATCCAGGACAGAA-1_8_E5	-27.98518292	12.45760877	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	843	1238	0.004038772	0.003231018	0	8	Astrocytes	NA	NA	NA
ATTATCCCACAGTCGC-1_8_E5	25.34406862	-28.96461033	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3384	9099	0.004176283	0.003077261	0	3	EN-L5-6	NA	NA	NA
ATTATCCCACTCAGGC-1_8_E5	-1.246635358	-19.61580739	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2838	6664	0.004801921	0.003751501	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ATTATCCCACTTGGAT-1_8_E5	-9.544551176	1.909875547	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2885	6593	0.01562263	0.005763689	0	13A	IN-VIP	NA	NA	NA
ATTATCCGTTAAGGGC-1_8_E5	27.18472921	-3.173165806	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3229	8114	0.005422726	0.003943801	0	2	EN-L4	NA	NA	NA
ATTATCCTCAGCACAT-1_8_E5	19.39639731	12.18026831	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1428	2559	0.001563111	0.003907776	0	oligos	OL-Cntl	NA	NA	NA
ATTATCCTCGCCTGTT-1_8_E5	-9.580159797	-15.77558	6B	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1014	1714	0.012252042	0.007001167	0	6B	IN-SST	NA	NA	NA
ATTATCCTCGTTTGCC-1_8_E5	26.93095365	-4.297959215	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4866	16630	0.001984366	0.002826218	0	2	EN-L4	NA	NA	NA
ATTCTACAGAACTCGG-1_8_E5	-29.3821171	13.77729575	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	816	1317	0.007593014	0.003037206	0	8	Astrocytes	NA	NA	NA
ATTCTACCAAAGTGCG-1_8_E5	0.62692767	-29.08766129	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4782	15839	0.00953343	0.001957194	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ATTCTACCACCAGGTC-1_8_E5	-37.74591946	0.512247847	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1474	2636	0.001138088	0.002655539	0	9	OPC	NA	NA	NA
ATTCTACCATGACATC-1_8_E5	9.273577519	33.35392586	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	827	1247	0.007217322	0.004009623	0	oligos	OL-Cntl	NA	NA	NA
ATTCTACGTCATATCG-1_8_E5	29.33268065	-3.941033045	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4084	11475	0.014901961	0.002265795	0	2	EN-L4	NA	NA	NA
ATTCTACGTCCGAGTC-1_8_E5	-20.59536851	11.62766612	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1047	1554	0.023166023	0.002574003	0	8	Astrocytes	NA	NA	NA
ATTCTACGTCTTGCGG-1_8_E5	21.0025394	-29.37340305	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4998	17400	0.009310345	0.003793103	0	3	EN-L5-6	NA	NA	NA
ATTGGACAGGAGCGTT-1_8_E5	-25.18078877	20.62380044	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1622	2950	0.003050847	0.002372881	0	8	Astrocytes	NA	NA	NA
ATTGGACAGGCACATG-1_8_E5	25.57262394	-2.565076081	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2739	6127	0.001142484	0.0040803	0	2	EN-L4	NA	NA	NA
ATTGGACCACATTAGC-1_8_E5	8.115625876	34.3074757	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	921	1318	0.003793627	0.006828528	0	oligos	OL-Cntl	NA	NA	NA
ATTGGACCACGGCCAT-1_8_E5	20.80091989	22.41713696	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1118	1741	0.001723148	0.00459506	0	oligos	OL-Cntl	NA	NA	NA
ATTGGACCAGGAATGC-1_8_E5	10.66955931	25.92926271	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	951	1482	0.004048583	0.005398111	0	oligos	OL-Cntl	NA	NA	NA
ATTGGACGTCCGTTAA-1_8_E5	1.120038756	-30.21928756	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5864	21597	0.005371116	0.002778164	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ATTGGTGAGCGTTCCG-1_8_E5	7.904955833	-32.1255702	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4495	13033	0.005908079	0.003452774	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ATTGGTGAGCTAGTCT-1_8_E5	-0.711954664	-22.88553855	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4466	12420	0.003542673	0.003542673	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ATTGGTGAGGACGAAA-1_8_E5	9.985963759	29.57386235	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	820	1162	0.007745267	0.006884682	0	oligos	OL-Cntl	NA	NA	NA
ATTGGTGAGGCTACGA-1_8_E5	3.293386413	-28.99144381	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3671	10286	0.006902586	0.001263854	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ATTGGTGCAATAAGCA-1_8_E5	-37.9185066	2.558042292	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1836	3489	0.004299226	0.002866151	0	9	OPC	NA	NA	NA
ATTGGTGCATGTTGAC-1_8_E5	24.8155073	-9.528643343	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	6436	22349	0.008009307	0.005190389	0	3	EN-L5-6	NA	NA	NA
ATTGGTGGTAGCGTCC-1_8_E5	2.404304464	-6.168193106	12	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1086	1616	0.012376238	0.005569307	0	12	EN-MIX	NA	NA	NA
ATTGGTGGTCAGAAGC-1_8_E5	2.75455333	-30.4249498	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4608	14947	0.002140898	0.001873286	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
ATTGGTGGTTACCGAT-1_8_E5	10.51954488	32.32381387	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	740	1125	0.002666667	0	0	oligos	OL-Cntl	NA	NA	NA
ATTGGTGTCGTAGGTT-1_8_E5	25.43320271	-29.40797455	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3923	11737	0.002726421	0.002811621	0	3	EN-L5-6	NA	NA	NA
ATTGGTGTCTCAAACG-1_8_E5	25.91181509	-2.876128636	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3290	7965	0.003013183	0.003640929	0	2	EN-L4	NA	NA	NA
ATTGGTGTCTCTGAGA-1_8_E5	29.6230417	-3.681775792	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4357	12790	0.010946052	0.004534793	0	2	EN-L4	NA	NA	NA
ATTTCTGAGTAGCGGT-1_8_E5	2.239018758	-13.60662256	4	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2275	4407	0.010211028	0.006126617	0	L2-3	EN-L2-3-MS	NA	NA	NA
ATTTCTGCAAACAACA-1_8_E5	-0.816959062	28.42711259	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	837	1153	0.016478751	0.002601908	0	oligos	OL-Cntl	NA	NA	NA
ATTTCTGTCAACACCA-1_8_E5	20.60989939	23.59697109	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1051	1638	0.004273504	0.005494505	0	oligos	OL-Cntl	NA	NA	NA
ATTTCTGTCACGCGGT-1_8_E5	20.73309019	22.97580095	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1039	1680	0	0.004166667	0	oligos	OL-Cntl	NA	NA	NA
ATTTCTGTCACGGTTA-1_8_E5	-1.145463361	-14.15677077	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2381	5529	0.016096943	0.002170374	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CAACCAAAGACTAGAT-1_8_E5	-1.10652691	-21.91653773	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3882	10574	0.00472858	0.003120862	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CAACCAACAGGCGATA-1_8_E5	12.95960432	-31.41660343	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2924	7105	0.009852217	0.004926108	0	3	EN-L5-6	NA	NA	NA
CAACCAACATCACGTA-1_8_E5	10.65630073	32.09867698	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	892	1374	0.004366812	0.00363901	0	oligos	OL-Cntl	NA	NA	NA
CAACCAAGTTGCGCAC-1_8_E5	0.438206375	-29.42289551	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4488	14738	0.002171258	0.002646221	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CAACCAATCAGGTTCA-1_8_E5	-1.368415103	1.045830728	11	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2135	3847	0.02495451	0.004419028	0	11	Glia-MIX	NA	NA	NA
CAACCAATCATGTCTT-1_8_E5	-17.20138088	-10.82426771	13B	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4790	14392	0.012367982	0.003613118	0	13B	IN-SV2C	NA	NA	NA
CAACCAATCGCCCTTA-1_8_E5	9.024290052	28.87618822	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	857	1308	0.003058104	0.009938838	0	oligos	OL-Cntl	NA	NA	NA
CAACCTCAGAACAACT-1_8_E5	-38.65702896	1.531105218	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1555	2783	0.001796622	0.002155947	0	9	OPC	NA	NA	NA
CAACCTCAGAGCTATA-1_8_E5	17.26938833	7.611482292	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1941	3525	0.011347518	0.006808511	0	oligos	OL-Cntl	NA	NA	NA
CAACCTCAGCCACCTG-1_8_E5	20.45983312	24.44876205	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1160	1842	0.001628664	0.005428882	0	oligos	OL-Cntl	NA	NA	NA
CAACCTCAGCTGCCCA-1_8_E5	-37.88179678	3.241112072	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1942	3741	0.001871157	0.002138466	0	9	OPC	NA	NA	NA
CAACCTCCACGAGGTA-1_8_E5	4.861835319	33.15333268	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	760	1115	0.031390135	0.003587444	0	oligos	OL-Cntl	NA	NA	NA
CAACTAGAGGCGATAC-1_8_E5	4.471639406	-32.45385792	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	6133	25439	0.000511026	0.002515822	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CAACTAGCAAGCTGAG-1_8_E5	0.992972475	-29.17982711	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5396	18350	0.013623978	0.002724796	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CAACTAGCAAGGTTTC-1_8_E5	-26.38819904	19.373065	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1270	2081	0.000480538	0.003363767	0	8	Astrocytes	NA	NA	NA
CAACTAGCACCGATAT-1_8_E5	-5.871484471	-0.676046996	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1620	2908	0.030261348	0.002751032	0	13A	IN-VIP	NA	NA	NA
CAACTAGCAGCCTTGG-1_8_E5	-12.64079876	1.033158322	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3527	7832	0.025153218	0.006001021	0	13A	IN-VIP	NA	NA	NA
CAACTAGGTCAGCTAT-1_8_E5	24.86364818	-29.15997911	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3627	9881	0.002732517	0.003339743	0	3	EN-L5-6	NA	NA	NA
CAACTAGGTGTTTGTG-1_8_E5	4.689424841	33.17016368	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	704	1011	0.007912957	0.002967359	0	oligos	OL-Cntl	NA	NA	NA
CAACTAGGTTGGACCC-1_8_E5	-18.50536653	-17.87688811	6B	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2299	4956	0.003430186	0.002421308	0	6B	IN-SST	NA	NA	NA
CAACTAGTCCTCAACC-1_8_E5	26.26893624	-29.93102109	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4491	13882	0.001656822	0.002737358	0	3	EN-L5-6	NA	NA	NA
CAACTAGTCTAAGCCA-1_8_E5	15.70543188	30.20112234	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	771	1079	0.00463392	0.002780352	0	oligos	OL-Cntl	NA	NA	NA
CAAGAAAAGGACACCA-1_8_E5	-19.53860225	-28.52425075	6A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3881	10988	0.002275209	0.002730251	0	6A	IN-PV	NA	NA	NA
CAAGAAAAGTCGTACT-1_8_E5	13.46470334	-30.98154201	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3164	7919	0.00441975	0.00441975	0	3	EN-L5-6	NA	NA	NA
CAAGAAACAACCGCCA-1_8_E5	1.177805247	-30.17270358	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	6233	24794	0.006654836	0.003024925	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CAAGAAACACAGGTTT-1_8_E5	8.954675402	32.43557343	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	771	1124	0.003558719	0.002669039	0	oligos	OL-Cntl	NA	NA	NA
CAAGAAACACAGTCGC-1_8_E5	-25.33449177	29.86594692	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1704	3243	0.000308356	0.003083565	0	8	Astrocytes	NA	NA	NA
CAAGAAACACCTGGTG-1_8_E5	-25.51580234	20.15374526	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1435	2485	0.002816901	0.002816901	0	8	Astrocytes	NA	NA	NA
CAAGAAAGTAATTGGA-1_8_E5	28.06889473	-26.42193192	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5762	21409	0.003222944	0.003783456	0	3	EN-L5-6	NA	NA	NA
CAAGAAATCACGAAGG-1_8_E5	11.43021718	25.76555496	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	835	1246	0.000802568	0.006420546	0	oligos	OL-Cntl	NA	NA	NA
CAAGATCAGACTTTCG-1_8_E5	-13.20886597	-19.71648834	6B	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1295	2225	0.013483146	0.003146067	0	6B	IN-SST	NA	NA	NA
CAAGATCAGCCAGGAT-1_8_E5	-34.94215169	-12.73665278	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	782	1211	0.002477291	0.002477291	0	9	OPC	NA	NA	NA
CAAGATCAGCCGCCTA-1_8_E5	21.30878087	25.65874096	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1083	1588	0.00440806	0.003148615	0	oligos	OL-Cntl	NA	NA	NA
CAAGATCAGCTACCGC-1_8_E5	8.667915645	31.9093689	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	784	1144	0.006118881	0.000874126	0	oligos	OL-Cntl	NA	NA	NA
CAAGATCAGTGTCTCA-1_8_E5	4.710416603	32.89999084	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	755	1080	0.005555556	0.00462963	0	oligos	OL-Cntl	NA	NA	NA
CAAGATCCACCGTTGG-1_8_E5	29.73323594	-4.852676205	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4860	16404	0.012618873	0.002560351	0	2	EN-L4	NA	NA	NA
CAAGATCGTAGGCATG-1_8_E5	-20.06253624	-18.25830599	6A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3635	9547	0.00974128	0.005132502	0	6A	IN-PV	NA	NA	NA
CAAGATCTCTTCATGT-1_8_E5	-16.49323734	-19.51783157	6B	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1986	3995	0.003754693	0.002002503	0	6B	IN-SST	NA	NA	NA
CAAGGCCAGTGGTAGC-1_8_E5	0.758829135	-28.32825428	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	6168	23002	0.008173202	0.004477871	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CAAGGCCAGTTGTCGT-1_8_E5	7.021447985	-31.65246758	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5036	15216	0.004731861	0.003877497	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CAAGGCCCAATCCAAC-1_8_E5	4.698182066	33.14835231	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	730	1077	0.007428041	0.005571031	0	oligos	OL-Cntl	NA	NA	NA
CAAGGCCGTGACTACT-1_8_E5	-37.40785217	2.618295507	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1769	3418	0.002633119	0.004095963	0	9	OPC	NA	NA	NA
CAAGGCCGTTCATGGT-1_8_E5	-38.34678301	2.17206553	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1688	3259	0.003682111	0.001534213	0	9	OPC	NA	NA	NA
CAAGGCCTCACAGGCC-1_8_E5	5.831072671	33.98035448	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	846	1275	0.007843137	0.004705882	0	oligos	OL-Cntl	NA	NA	NA
CAAGGCCTCTTGAGAC-1_8_E5	-35.94278815	4.833222201	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2239	4528	0.009717314	0.002871025	0	9	OPC	NA	NA	NA
CAAGTTGAGGAGTACC-1_8_E5	-26.53110536	18.10012515	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1175	1977	0.002023268	0.005058169	0	8	Astrocytes	NA	NA	NA
CAAGTTGAGGCGACAT-1_8_E5	18.75783279	9.184436827	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1579	3060	0.004901961	0.002941176	0	oligos	OL-Cntl	NA	NA	NA
CAAGTTGCATGGATGG-1_8_E5	-19.38062675	-25.57154673	6A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3049	6568	0.003806334	0.005633374	0	6A	IN-PV	NA	NA	NA
CAAGTTGGTATAGGTA-1_8_E5	27.1525972	-4.819985108	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4160	12008	0.004830113	0.00341439	0	2	EN-L4	NA	NA	NA
CAAGTTGGTCTTGCGG-1_8_E5	-0.812245393	-21.83955299	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4221	12224	0.004499346	0.00417212	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CAAGTTGGTGATGATA-1_8_E5	-24.60487219	30.41073349	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1826	3419	0.002632349	0.003509798	0	8	Astrocytes	NA	NA	NA
CAAGTTGTCCGCAGTG-1_8_E5	33.08552355	-3.425036766	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2879	5830	0.012864494	0.005831904	0	2	EN-L4	NA	NA	NA
CAAGTTGTCGGTGTCG-1_8_E5	1.646693195	-31.06109026	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5443	18598	0.000914077	0.001881923	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CACAAACCATACTCTT-1_8_E5	-17.03892246	-10.80859055	13B	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3648	9731	0.011715137	0.005138218	0	13B	IN-SV2C	NA	NA	NA
CACAAACGTGTGCCTG-1_8_E5	21.99012367	11.60762654	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1776	3211	0.005294301	0.004360012	0	oligos	OL-Cntl	NA	NA	NA
CACAAACGTTAAGACA-1_8_E5	-1.458391675	-22.0408158	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3664	9866	0.010439895	0.00283803	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CACACAAAGGACACCA-1_8_E5	9.157986177	33.41075378	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	955	1447	0.004837595	0.00276434	0	oligos	OL-Cntl	NA	NA	NA
CACACAACAATCGAAA-1_8_E5	9.503738962	-0.405788625	12	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1130	2146	0.034016775	0.005125815	0	12	EN-MIX	NA	NA	NA
CACACAACAATGGATA-1_8_E5	7.203210284	31.33229939	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	846	1286	0.00622084	0.00311042	0	oligos	OL-Cntl	NA	NA	NA
CACACAACACTGTGTA-1_8_E5	26.79895778	-5.181131747	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5533	19338	0.00656738	0.003206123	0	2	EN-L4	NA	NA	NA
CACACAACATGCCACG-1_8_E5	20.57662922	24.14175984	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	996	1627	0.001843884	0.001843884	0	oligos	OL-Cntl	NA	NA	NA
CACACAAGTGGGTATG-1_8_E5	-26.64555824	15.92945584	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1229	1991	0.001506781	0.002009041	0	8	Astrocytes	NA	NA	NA
CACACAATCAGCATGT-1_8_E5	-38.05035986	2.833247914	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1759	3311	0.008154636	0.001812141	0	9	OPC	NA	NA	NA
CACACAATCTCACATT-1_8_E5	-24.07302549	30.34808242	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1942	3664	0.001637555	0.003275109	0	8	Astrocytes	NA	NA	NA
CACACCTAGAAGGACA-1_8_E5	27.00229869	-4.748130419	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4147	12137	0.008404054	0.004119634	0	2	EN-L4	NA	NA	NA
CACACCTGTTGTGGCC-1_8_E5	-11.26913632	-21.69642937	6A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	971	1673	0.019725045	0.001195457	0	6A	IN-PV	NA	NA	NA
CACACTCAGACAGACC-1_8_E5	14.94883532	-33.69686461	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5702	22818	0.001884477	0.004557805	0	3	EN-L5-6	NA	NA	NA
CACACTCAGCAATATG-1_8_E5	4.19141148	31.73836362	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	705	1081	0.002775208	0.003700278	0	oligos	OL-Cntl	NA	NA	NA
CACACTCAGCTAGTCT-1_8_E5	-23.94176499	30.32769325	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2120	4477	0.001116819	0.003573822	0	8	Astrocytes	NA	NA	NA
CACACTCGTCCGACGT-1_8_E5	-11.23178233	2.489261691	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3817	9504	0.015361953	0.003893098	0	13A	IN-VIP	NA	NA	NA
CACACTCGTGTGAATA-1_8_E5	-11.81854279	-19.46425061	6B	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1088	1807	0.023242944	0.005534034	0	6B	IN-SST	NA	NA	NA
CACACTCGTTACAGAA-1_8_E5	-38.11016984	0.68385719	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1584	2915	0.001372213	0.002058319	0	9	OPC	NA	NA	NA
CACACTCTCAGTTGAC-1_8_E5	-1.584894678	-22.72838336	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3800	11413	0.007798125	0.002716201	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CACACTCTCCCTCAGT-1_8_E5	2.696979985	-31.64599415	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	6434	27009	0.003110074	0.002776852	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CACACTCTCTCCCTGA-1_8_E5	7.961210655	32.58079785	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	704	1045	0.005741627	0.007655502	0	oligos	OL-Cntl	NA	NA	NA
CACAGGCCACCGAAAG-1_8_E5	10.04771082	27.73101188	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	922	1425	0.002807018	0.003508772	0	oligos	OL-Cntl	NA	NA	NA
CACAGGCCAGACACTT-1_8_E5	-19.96752482	-18.40184757	6B	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3803	10789	0.001946427	0.004448976	0	6B	IN-SST	NA	NA	NA
CACAGGCGTAAGCACG-1_8_E5	28.30981694	-1.469869597	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4399	13014	0.006377747	0.003073613	0	2	EN-L4	NA	NA	NA
CACAGGCGTCACCTAA-1_8_E5	-17.19789286	-10.85175449	13B	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4749	13840	0.007153179	0.005202312	0	13B	IN-SV2C	NA	NA	NA
CACAGGCTCAGATAAG-1_8_E5	-17.05712888	-10.68661412	13B	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4053	11208	0.010706638	0.002855103	0	13B	IN-SV2C	NA	NA	NA
CACAGGCTCCACTCCA-1_8_E5	2.9855886	-29.46781931	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	6178	26327	0.003304592	0.002734835	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CACAGGCTCGTAGGAG-1_8_E5	12.71355567	20.30754126	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1022	1553	0.01416613	0.00515132	0	oligos	OL-Cntl	NA	NA	NA
CACAGTAAGCTGATAA-1_8_E5	-24.18766377	30.23349224	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1994	3731	0.005360493	0.002948271	0	8	Astrocytes	NA	NA	NA
CACAGTAAGTAGGCCA-1_8_E5	-0.229372432	-23.10755142	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4285	12830	0.010444271	0.00233827	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CACAGTACAAGAAGAG-1_8_E5	5.410835765	-27.2819205	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3523	8734	0.005381269	0.002289902	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CACAGTAGTATCGCAT-1_8_E5	19.73594784	21.37192373	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	989	1538	0.00390117	0.00390117	0	oligos	OL-Cntl	NA	NA	NA
CACAGTAGTTTGCATG-1_8_E5	-38.09428268	1.592955813	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1564	2895	0.001036269	0.000690846	0	9	OPC	NA	NA	NA
CACAGTATCACTTACT-1_8_E5	-37.16964928	2.659761586	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1823	3379	0.005622965	0.005031074	0	9	OPC	NA	NA	NA
CACATAGAGCCGCCTA-1_8_E5	-0.702407409	-13.30474665	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1868	3425	0.004671533	0.001751825	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CACATAGAGGGTCGAT-1_8_E5	6.433033468	34.76469737	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	759	1056	0.001893939	0.008522727	0	oligos	OL-Cntl	NA	NA	NA
CACATAGCAAAGGAAG-1_8_E5	28.11681278	-2.374385686	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4034	10525	0.009976247	0.004085511	0	2	EN-L4	NA	NA	NA
CACATAGCAACCGCCA-1_8_E5	-8.758101667	2.333482978	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2498	5519	0.014132995	0.002899076	0	13A	IN-VIP	NA	NA	NA
CACATAGCAGATAATG-1_8_E5	19.60691128	12.52355508	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1330	2276	0.000878735	0.005711775	0	oligos	OL-Cntl	NA	NA	NA
CACATAGGTGTGAATA-1_8_E5	-0.846328626	-13.89852223	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2285	4933	0.009527671	0.001824448	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CACATAGGTTCCATGA-1_8_E5	20.3413719	13.31914659	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1401	2277	0.005709267	0.005709267	0	oligos	OL-Cntl	NA	NA	NA
CACATTTCAGGATCGA-1_8_E5	20.79795623	-28.79875394	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3552	9056	0.002539753	0.006404594	0	3	EN-L5-6	NA	NA	NA
CACATTTGTGCTGTAT-1_8_E5	-10.12142321	-15.95456706	6A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1243	2536	0.00670347	0.002760252	0	6A	IN-PV	NA	NA	NA
CACATTTTCAAACCAC-1_8_E5	-11.4762102	2.323704294	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3701	8871	0.008679968	0.006763612	0	13A	IN-VIP	NA	NA	NA
CACATTTTCCCATTAT-1_8_E5	12.03722608	-0.586731	12	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1107	1521	0.017751479	0.004602235	0	12	EN-MIX	NA	NA	NA
CACATTTTCTGCGGCA-1_8_E5	28.28098661	-1.645425766	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4544	12632	0.00451235	0.003720709	0	2	EN-L4	NA	NA	NA
CACCACTAGTGGACGT-1_8_E5	-38.33569493	0.990997552	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1539	2730	0.006959707	0.005128205	0	9	OPC	NA	NA	NA
CACCACTAGTGTGAAT-1_8_E5	-0.360060323	35.34409067	17	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	762	1093	0.002744739	0.005489478	0	oligos	OL-MS-2	NA	NA	NA
CACCACTCACAGATTC-1_8_E5	-38.60296963	-0.03114677	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1492	2613	0.001913509	0.001913509	0	9	OPC	NA	NA	NA
CACCACTGTAGAGTGC-1_8_E5	10.36293868	27.14138972	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	891	1464	0.00068306	0.00204918	0	oligos	OL-Cntl	NA	NA	NA
CACCAGGAGAAGATTC-1_8_E5	-20.21624046	-28.86907441	6A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3871	10353	0.010528349	0.003960205	0	6A	IN-PV	NA	NA	NA
CACCAGGAGGAGTTTA-1_8_E5	9.925186113	32.4541216	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	867	1278	0.002347418	0.007042254	0	oligos	OL-Cntl	NA	NA	NA
CACCAGGCATCCCATC-1_8_E5	-23.96359176	29.81893705	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1945	3991	0.000751691	0.003758457	0	8	Astrocytes	NA	NA	NA
CACCAGGCATGAAGTA-1_8_E5	26.16554834	-5.593769021	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	6044	22766	0.007906527	0.002152332	0	2	EN-L4	NA	NA	NA
CACCAGGGTTCTGTTT-1_8_E5	6.058646775	33.75817937	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	734	1080	0.010185185	0.005555556	0	oligos	OL-Cntl	NA	NA	NA
CACCAGGTCAGCTCTC-1_8_E5	6.67604643	-30.09639183	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4178	12996	0.002231456	0.002693136	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CACCTTGAGTCATGCT-1_8_E5	-0.79396705	-21.43340308	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4068	11610	0.002153316	0.00620155	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CACCTTGCAAAGGCGT-1_8_E5	20.7141724	23.39812817	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1060	1692	0.002364066	0.003546099	0	oligos	OL-Cntl	NA	NA	NA
CACCTTGCAATCAGAA-1_8_E5	20.1894393	23.88956136	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1001	1589	0.001258653	0.002517306	0	oligos	OL-Cntl	NA	NA	NA
CACCTTGCACGACTCG-1_8_E5	-28.74650962	12.3892805	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	785	1114	0.001795332	0.001795332	0	8	Astrocytes	NA	NA	NA
CACCTTGGTAAATGTG-1_8_E5	-1.79729902	-24.66904521	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4105	11923	0.004529061	0.00335486	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CACCTTGGTGATAAGT-1_8_E5	8.923778582	32.52581862	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	822	1268	0.008675079	0.003154574	0	oligos	OL-Cntl	NA	NA	NA
CACTCCAAGCTGGAAC-1_8_E5	4.065798629	-31.72704304	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5525	21058	0.002279419	0.002421882	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CACTCCAAGGAGCGAG-1_8_E5	-2.014432595	-25.95776753	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4289	12365	0.004933279	0.003396684	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CACTCCACACAGTCGC-1_8_E5	25.60459867	-4.141434205	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4522	15331	0.000391364	0.002543865	0	2	EN-L4	NA	NA	NA
CACTCCACAGTTTACG-1_8_E5	-37.21448981	-0.641201719	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1376	2322	0.004306632	0.002153316	0	9	OPC	NA	NA	NA
CACTCCACATACTACG-1_8_E5	19.01526525	13.2606401	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1253	2157	0.003245248	0.002781641	0	oligos	OL-Cntl	NA	NA	NA
CACTCCAGTCGCGGTT-1_8_E5	-37.03569387	3.099832846	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1898	3652	0.003833516	0.003012048	0	9	OPC	NA	NA	NA
CACTCCATCAACACTG-1_8_E5	1.697622948	-8.236008331	12	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1365	2210	0.009954751	0.002714932	0	12	EN-MIX	NA	NA	NA
CACTCCATCGTTGACA-1_8_E5	2.804996777	-31.73101357	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	6308	25276	0.003956322	0.002413357	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CACTCCATCTCCCTGA-1_8_E5	24.75818055	-29.94635946	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2712	6663	0.003752064	0.003001651	0	3	EN-L5-6	NA	NA	NA
CAGAATCAGTGCCATT-1_8_E5	11.94330414	32.61087286	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	797	1136	0.006161972	0	0	oligos	OL-Cntl	NA	NA	NA
CAGAATCCAAGTTGTC-1_8_E5	-38.55142478	0.310976725	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1514	2681	0.004102947	0.002610966	0	9	OPC	NA	NA	NA
CAGAATCGTATGAATG-1_8_E5	-0.42865574	-22.31299482	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4743	14461	0.002558606	0.005117212	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CAGAATCGTCTCACCT-1_8_E5	-1.224771697	-25.3436836	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5352	18272	0.006512697	0.002900613	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CAGAATCGTTCGTCTC-1_8_E5	-38.92218826	0.487305781	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1474	2791	0.001433178	0.001074884	0	9	OPC	NA	NA	NA
CAGAATCTCAATAAGG-1_8_E5	-36.5734029	-7.917148662	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1093	1754	0.003420753	0.003420753	0	9	OPC	NA	NA	NA
CAGAGAGAGCTAGCCC-1_8_E5	11.2140926	28.88150049	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	895	1316	0.008358663	0.003799392	0	oligos	OL-Cntl	NA	NA	NA
CAGAGAGAGGCAGGTT-1_8_E5	25.44245987	-29.33261495	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4017	11776	0.002377717	0.004925272	0	3	EN-L5-6	NA	NA	NA
CAGAGAGAGTGAACGC-1_8_E5	28.10361767	-1.446806692	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3728	9235	0.006172171	0.002815376	0	2	EN-L4	NA	NA	NA
CAGAGAGCACGGTAAG-1_8_E5	-0.528851972	-21.80904153	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4515	13889	0.006047952	0.004895961	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CAGAGAGGTCCGAGTC-1_8_E5	-0.812640034	-20.51976778	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3201	7134	0.006588169	0.005606953	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CAGAGAGGTGATAAAC-1_8_E5	2.841357974	-24.74120323	4	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3299	7464	0.002679528	0.005091104	0	L2-3	EN-L2-3-MS	NA	NA	NA
CAGAGAGTCACCGGGT-1_8_E5	-6.41672118	-0.10094263	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1939	3881	0.01855192	0.002576656	0	13A	IN-VIP	NA	NA	NA
CAGAGAGTCGGAGCAA-1_8_E5	-29.15851608	13.29193414	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	797	1212	0.002475248	0.004125413	0	8	Astrocytes	NA	NA	NA
CAGAGAGTCTAACCGA-1_8_E5	-7.121682081	-0.50817262	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2013	4105	0.03727162	0.002923264	0	13A	IN-VIP	NA	NA	NA
CAGATCAAGAGGGATA-1_8_E5	9.579904368	32.30555501	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	878	1320	0.003030303	0.001515152	0	oligos	OL-Cntl	NA	NA	NA
CAGATCAAGTGACTCT-1_8_E5	18.97030963	13.46239595	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1192	2012	0.000994036	0.007455268	0	oligos	OL-Cntl	NA	NA	NA
CAGATCACAAGCGAGT-1_8_E5	7.842211074	-31.4789354	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4866	15455	0.011452604	0.002394047	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CAGATCACACGCATCG-1_8_E5	-20.28341392	-18.84897054	6A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5533	18240	0.013157895	0.003399123	0	6A	IN-PV	NA	NA	NA
CAGATCAGTAGTAGTA-1_8_E5	-25.88508207	19.51770406	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1431	2479	0.001613554	0.002420331	0	8	Astrocytes	NA	NA	NA
CAGATCATCACTGGGC-1_8_E5	-2.695366243	-24.04467261	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4072	11734	0.003749787	0.003835009	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CAGATCATCCTCCTAG-1_8_E5	25.86800555	-29.37431287	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	6082	26773	0.002539872	0.002278415	0	3	EN-L5-6	NA	NA	NA
CAGCAGCAGAAGAAGC-1_8_E5	-1.344872515	-19.43873925	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2739	6159	0.004870921	0.002760188	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CAGCAGCCAGACAGGT-1_8_E5	21.05395125	-29.40576588	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5457	18174	0.005612413	0.006052603	0	3	EN-L5-6	NA	NA	NA
CAGCAGCGTGACTACT-1_8_E5	-26.95774823	15.70353589	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1023	1643	0.003043214	0.001825928	0	8	Astrocytes	NA	NA	NA
CAGCATAAGCCGATTT-1_8_E5	16.21885533	-31.9630181	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	6195	23706	0.006369695	0.005019826	0	3	EN-L5-6	NA	NA	NA
CAGCATAAGGTTCCTA-1_8_E5	-36.89970343	-8.098342866	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1009	1674	0.001792115	0.002389486	0	9	OPC	NA	NA	NA
CAGCATACAAGACACG-1_8_E5	26.02547623	-5.166929637	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4731	15298	0.012616028	0.002418617	0	2	EN-L4	NA	NA	NA
CAGCATACACCGCTAG-1_8_E5	10.24855072	28.12246584	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	874	1398	0.001430615	0.005007153	0	oligos	OL-Cntl	NA	NA	NA
CAGCATAGTACCGTAT-1_8_E5	-25.88116093	18.73942287	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1341	2331	0.002574003	0.002574003	0	8	Astrocytes	NA	NA	NA
CAGCATAGTACGCTGC-1_8_E5	5.718013223	31.37176155	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	760	1113	0.001796945	0.004492363	0	oligos	OL-Cntl	NA	NA	NA
CAGCATAGTGGTCCGT-1_8_E5	-23.75027731	30.22869408	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1967	3689	0.001355381	0.001897533	0	8	Astrocytes	NA	NA	NA
CAGCCGAAGGCTACGA-1_8_E5	0.842842232	-28.64127939	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4374	13388	0.004929788	0.002913056	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CAGCCGAGTAAGGGCT-1_8_E5	-8.306542967	0.513531408	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2300	4757	0.010090393	0.003363464	0	13A	IN-VIP	NA	NA	NA
CAGCCGAGTCATCCCT-1_8_E5	-10.91332368	1.349990252	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2811	6450	0.006046512	0.002325581	0	13A	IN-VIP	NA	NA	NA
CAGCCGATCATGCATG-1_8_E5	11.771339	13.31904549	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1529	3093	0.004849661	0.003556418	0	oligos	OL-Cntl	NA	NA	NA
CAGCCGATCGTCCAGG-1_8_E5	-28.85453041	12.69038014	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	781	1169	0.001710864	0.002566296	0	8	Astrocytes	NA	NA	NA
CAGCCGATCTGCGGCA-1_8_E5	-1.390775061	-19.60664991	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2823	6420	0.013862928	0.004205607	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CAGCGACAGCGACGTA-1_8_E5	3.942106346	-31.66917766	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5252	18004	0.003499222	0.002110642	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CAGCGACAGGTAGCTG-1_8_E5	8.825726896	28.07087784	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	893	1330	0.001503759	0.005263158	0	oligos	OL-Cntl	NA	NA	NA
CAGCGACCAAGAGTCG-1_8_E5	3.141146466	-28.68617787	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3874	10831	0.001200259	0.002215862	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CAGCGACCAGTCAGAG-1_8_E5	8.952968099	33.59105535	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1010	1562	0.001920615	0.005761844	0	oligos	OL-Cntl	NA	NA	NA
CAGCGACGTGCGATAG-1_8_E5	10.99947332	33.02244278	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	911	1342	0.008941878	0.002980626	0	oligos	OL-Cntl	NA	NA	NA
CAGCGACGTGGGTCAA-1_8_E5	0.969893892	-29.6446007	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5596	20268	0.00473653	0.00217091	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CAGCGACTCCCTCTTT-1_8_E5	15.23395711	-34.02360067	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	6216	26075	0.001418984	0.004448706	0	3	EN-L5-6	NA	NA	NA
CAGCGACTCCCTTGCA-1_8_E5	-11.38264042	2.29160308	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3877	9486	0.005587181	0.006430529	0	13A	IN-VIP	NA	NA	NA
CAGCGACTCTATGTGG-1_8_E5	4.605428222	28.93723216	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	762	1118	0.004472272	0.006261181	0	oligos	OL-Cntl	NA	NA	NA
CAGCGACTCTTACCTA-1_8_E5	-1.510469592	-13.48081934	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2214	4084	0.003183154	0.005631734	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CAGCTAAAGAAGGGTA-1_8_E5	-26.9344701	10.55974997	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	804	1131	0.001768347	0.004420866	0	8	Astrocytes	NA	NA	NA
CAGCTAAAGGTCATCT-1_8_E5	17.6494842	9.399741569	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1526	2703	0.003699593	0.002959674	0	oligos	OL-Cntl	NA	NA	NA
CAGCTAACATCCCACT-1_8_E5	28.49597308	-1.789833094	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4328	11246	0.005513071	0.004268184	0	2	EN-L4	NA	NA	NA
CAGCTAAGTCAAACTC-1_8_E5	13.14749862	31.92678747	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	875	1383	0.002892263	0.003615329	0	oligos	OL-Cntl	NA	NA	NA
CAGCTGGCATGTCGAT-1_8_E5	20.8401659	22.40185005	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1088	1776	0.000563063	0.004504505	0	oligos	OL-Cntl	NA	NA	NA
CAGCTGGGTTAAGACA-1_8_E5	8.355994556	34.08868593	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	960	1433	0.007676204	0.003489184	0	oligos	OL-Cntl	NA	NA	NA
CAGCTGGGTTTGGGCC-1_8_E5	4.487210818	-25.70017527	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5027	18048	0.007480053	0.003601507	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CAGCTGGTCACTTACT-1_8_E5	28.51365124	-1.993462019	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4309	11390	0.006584723	0.003511853	0	2	EN-L4	NA	NA	NA
CAGGTGCAGCTTCGCG-1_8_E5	13.60136372	25.84209939	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	890	1364	0.003665689	0.00659824	0	oligos	OL-Cntl	NA	NA	NA
CAGGTGCGTTGGGACA-1_8_E5	-0.735976302	-20.67416341	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3160	7692	0.009880395	0.002860114	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CAGGTGCTCCGTACAA-1_8_E5	7.873931105	-32.4298127	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3719	9848	0.022948822	0.002437043	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CAGTAACAGAGTCTGG-1_8_E5	9.331548362	32.10340113	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	862	1413	0.005661713	0.004246285	0	oligos	OL-Cntl	NA	NA	NA
CAGTAACAGATGGGTC-1_8_E5	-18.94311857	-17.07036435	6B	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2395	5050	0.003960396	0.005148515	0	6B	IN-SST	NA	NA	NA
CAGTAACCAATTGCTG-1_8_E5	-35.78457431	5.051506477	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2461	5526	0.000904814	0.002171553	0	9	OPC	NA	NA	NA
CAGTAACCAGCGAACA-1_8_E5	17.98929445	25.38440409	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	961	1545	0.001941748	0.005177994	0	oligos	OL-Cntl	NA	NA	NA
CAGTAACCAGTCACTA-1_8_E5	-37.99779662	2.399285139	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1720	3243	0.002775208	0.003391921	0	9	OPC	NA	NA	NA
CAGTAACTCCAAACAC-1_8_E5	3.657815682	-28.26288223	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2667	5399	0.004445268	0.00351917	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CAGTAACTCTCTGAGA-1_8_E5	-19.8910156	-18.06287887	6B	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3122	7571	0.019548276	0.005547484	0	6B	IN-SST	NA	NA	NA
CAGTAACTCTCTGTCG-1_8_E5	-0.915237401	-19.68788217	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3190	7374	0.006509357	0.003932737	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CAGTCCTAGTTAGGTA-1_8_E5	27.07179215	0.13783565	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3719	10723	0.004569617	0.001771892	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CAGTCCTCACGGTGTC-1_8_E5	-37.24249904	-9.733788879	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1002	1570	0.001273885	0.001910828	0	9	OPC	NA	NA	NA
CAGTCCTTCCTGCTTG-1_8_E5	-1.781799875	-21.52190455	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3710	10898	0.003211598	0.002202239	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CAGTCCTTCTGTCTCG-1_8_E5	-36.71629958	-1.98527538	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1419	2632	0.007598784	0.002659574	0	9	OPC	NA	NA	NA
CAGTCCTTCTTACCTA-1_8_E5	-4.087896006	-4.450070792	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1220	2018	0.022299306	0.003964321	0	13A	IN-VIP	NA	NA	NA
CATATGGAGTTTAGGA-1_8_E5	2.814462185	-26.01974315	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5887	22995	0.00665362	0.002652751	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CATATGGTCCTCGCAT-1_8_E5	-18.20475009	-23.22879836	6B	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2268	4755	0.022712934	0.003995794	0	6B	IN-SST	NA	NA	NA
CATATTCAGATAGTCA-1_8_E5	9.208998964	31.92427405	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	776	1209	0.00082713	0.009098428	0	oligos	OL-Cntl	NA	NA	NA
CATATTCCAAATACAG-1_8_E5	-2.469806768	-19.705853	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3132	7820	0.002429668	0.002173913	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CATATTCCATCACGTA-1_8_E5	-26.66033869	9.855541724	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	788	1334	0.004497751	0.00149925	0	8	Astrocytes	NA	NA	NA
CATATTCGTACCATCA-1_8_E5	-6.757717472	-0.963621133	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1982	3997	0.012259194	0.002251689	0	13A	IN-VIP	NA	NA	NA
CATATTCTCCACGCAG-1_8_E5	13.94317191	30.1523708	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	741	1053	0.006647673	0.009496676	0	oligos	OL-Cntl	NA	NA	NA
CATATTCTCTGAGGGA-1_8_E5	-0.738817103	-13.932531	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2218	4553	0.010322864	0.004612344	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CATCAAGAGGCTAGCA-1_8_E5	-11.73475037	19.37756063	11	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2158	4158	0.001202501	0.004569505	0	11	Glia-MIX	NA	NA	NA
CATCAAGAGTCGAGTG-1_8_E5	28.46280873	-1.470818812	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3981	10575	0.001607565	0.00321513	0	2	EN-L4	NA	NA	NA
CATCAAGAGTTCGCGC-1_8_E5	-33.87796194	-10.5332992	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	910	1299	0.005388761	0.002309469	0	9	OPC	NA	NA	NA
CATCAAGAGTTGTAGA-1_8_E5	-36.69911426	1.3664414	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1639	2955	0.003384095	0.004737733	0	9	OPC	NA	NA	NA
CATCAAGGTCTAGTCA-1_8_E5	-24.32038045	30.23164163	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1888	3726	0.001341922	0.002147075	0	8	Astrocytes	NA	NA	NA
CATCAAGTCCACTGGG-1_8_E5	-10.59130086	1.850102961	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2878	6048	0.006779101	0.003141534	0	13A	IN-VIP	NA	NA	NA
CATCAAGTCCCAGGTG-1_8_E5	-1.394237931	-18.80739259	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2720	5849	0.001880663	0.003590357	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CATCAAGTCGCTAGCG-1_8_E5	25.94984348	-29.31451018	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	6325	26224	0.001830384	0.003203173	0	3	EN-L5-6	NA	NA	NA
CATCAAGTCTCGAGTA-1_8_E5	22.25374283	21.17794971	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1064	1636	0.000611247	0.003056235	0	oligos	OL-Cntl	NA	NA	NA
CATCAGAAGGACATTA-1_8_E5	-26.02512	19.84258799	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1478	2730	0.002564103	0.002930403	0	8	Astrocytes	NA	NA	NA
CATCAGACATCGGAAG-1_8_E5	-23.69630106	-0.393399975	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1700	3006	0.00166334	0.00166334	0	9	OPC	NA	NA	NA
CATCAGAGTAATTGGA-1_8_E5	-25.13883213	19.65609417	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1487	2636	0.001138088	0.000379363	0	8	Astrocytes	NA	NA	NA
CATCAGAGTGCAGACA-1_8_E5	8.59947767	28.11492397	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	867	1359	0.003679176	0.003679176	0	oligos	OL-Cntl	NA	NA	NA
CATCAGATCCAAATGC-1_8_E5	25.62624857	3.640460553	15DA	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	924	1405	0.007117438	0.007117438	0	15DA	T cells	NA	NA	NA
CATCAGATCCAGTAGT-1_8_E5	20.49684341	-28.52417836	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3960	11608	0.008270159	0.005341144	0	3	EN-L5-6	NA	NA	NA
CATCCACAGCGCCTCA-1_8_E5	28.61152553	-1.537711488	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3793	9702	0.006802721	0.003607504	0	2	EN-L4	NA	NA	NA
CATCCACAGTATCGAA-1_8_E5	-20.17999037	-28.5075522	6A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3654	9708	0.014936135	0.00236918	0	6A	IN-PV	NA	NA	NA
CATCCACGTCGAAAGC-1_8_E5	15.27510374	-33.42655951	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5799	22728	0.000835973	0.003167899	0	3	EN-L5-6	NA	NA	NA
CATCCACGTTTAAGCC-1_8_E5	23.57274329	0.290215269	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2266	5044	0.005154639	0.004361618	0	2	EN-L4	NA	NA	NA
CATCCACTCATAGCAC-1_8_E5	-11.15397531	2.859119935	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4736	14268	0.011424166	0.004485562	0	13A	IN-VIP	NA	NA	NA
CATCCACTCTCATTCA-1_8_E5	-23.34782431	31.03740855	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2217	4746	0.000421408	0.001896334	0	8	Astrocytes	NA	NA	NA
CATCGAAAGAACAATC-1_8_E5	-15.7213707	-11.18253168	13B	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2967	6912	0.004195602	0.002459491	0	13B	IN-SV2C	NA	NA	NA
CATCGAACAGATCTGT-1_8_E5	-11.05159697	2.632696142	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4450	12967	0.004241536	0.005398319	0	13A	IN-VIP	NA	NA	NA
CATCGAATCCGAAGAG-1_8_E5	-0.999889456	-20.6597831	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3345	8024	0.00772682	0.004112662	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CATCGAATCGAGAACG-1_8_E5	-35.41187419	5.094480139	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2452	4977	0.008840667	0.003013864	0	9	OPC	NA	NA	NA
CATCGAATCTACTCAT-1_8_E5	4.602696201	32.91344594	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	736	1052	0.008555133	0.002851711	0	oligos	OL-Cntl	NA	NA	NA
CATCGGGAGAAGAAGC-1_8_E5	25.62535312	-2.624820109	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3245	8025	0.004859813	0.002741433	0	2	EN-L4	NA	NA	NA
CATCGGGAGGTAGCTG-1_8_E5	2.709841544	-5.915290668	12	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1170	1801	0.005552471	0.004997224	0	12	EN-MIX	NA	NA	NA
CATCGGGAGTGACTCT-1_8_E5	-20.14644564	-17.55030749	6A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3358	7864	0.010045778	0.00508647	0	6A	IN-PV	NA	NA	NA
CATCGGGCATGCCACG-1_8_E5	10.3434015	19.52214381	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1012	1723	0.00754498	0.005223447	0	oligos	OL-Cntl	NA	NA	NA
CATCGGGGTACCATCA-1_8_E5	0.889952943	-30.04597846	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5572	19715	0.002130358	0.00253614	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CATCGGGGTAGGACAC-1_8_E5	10.11978657	27.10198337	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	849	1359	0.005150846	0.008094187	0	oligos	OL-Cntl	NA	NA	NA
CATCGGGGTCCATCCT-1_8_E5	-11.78781979	19.33020847	11	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2392	4668	0.003427592	0.00428449	0	11	Glia-MIX	NA	NA	NA
CATCGGGGTCGGGTCT-1_8_E5	-10.26595894	2.088827942	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3090	7192	0.012652948	0.004727475	0	13A	IN-VIP	NA	NA	NA
CATCGGGGTTCCACGG-1_8_E5	13.59030519	0.001919417	12	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	882	1534	0.004563233	0.003259452	0	12	EN-MIX	NA	NA	NA
CATCGGGGTTTGTGTG-1_8_E5	9.31483242	-30.97524937	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3207	8253	0.005089059	0.001938689	0	3	EN-L5-6	NA	NA	NA
CATCGGGTCTTGCAAG-1_8_E5	18.32913716	12.60870983	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1240	2013	0.006954794	0.005464481	0	oligos	OL-Cntl	NA	NA	NA
CATGACAAGAGGACGG-1_8_E5	-4.217700599	-8.411166922	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	815	1191	0.042821159	0.004198153	0	13A	IN-VIP	NA	NA	NA
CATGACAAGTAACCCT-1_8_E5	5.00212001	-32.3003156	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	6413	28608	0.001747763	0.002796421	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CATGACAGTCCGTCAG-1_8_E5	-0.895272913	-21.42035967	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3820	9880	0.003340081	0.004251012	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CATGACAGTTACCGAT-1_8_E5	28.92785675	-1.536276444	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4591	13387	0.009785613	0.004407261	0	2	EN-L4	NA	NA	NA
CATGACATCACTTCAT-1_8_E5	-1.116891267	-20.89919615	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3595	9642	0.003007675	0.00497822	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CATGCCTAGATGTCGG-1_8_E5	23.0334719	1.234684605	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1669	2941	0.003740224	0.004420265	0	2	EN-L4	NA	NA	NA
CATGCCTCAGCTGTTA-1_8_E5	6.383068145	34.08973601	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	899	1280	0.0046875	0.0015625	0	oligos	OL-Cntl	NA	NA	NA
CATGCCTGTACCAGTT-1_8_E5	18.83083283	1.525642653	12	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1179	1875	0.014933333	0.002666667	0	12	EN-MIX	NA	NA	NA
CATGCCTGTCTAGCGC-1_8_E5	-37.46010776	1.225121257	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1532	2708	0.000369276	0.004431315	0	9	OPC	NA	NA	NA
CATGCCTTCAAACCAC-1_8_E5	20.51661179	24.04982547	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1035	1612	0.000620347	0.003722084	0	oligos	OL-Cntl	NA	NA	NA
CATGCCTTCCCAACGG-1_8_E5	25.61461681	-3.788619736	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3813	10939	0.005210714	0.001554073	0	2	EN-L4	NA	NA	NA
CATGCCTTCGTCCGTT-1_8_E5	-17.09251306	-11.10328974	13B	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4983	15932	0.004519207	0.00483304	0	13B	IN-SV2C	NA	NA	NA
CATGGCGAGCGGCTTC-1_8_E5	8.553235175	34.21045404	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	999	1510	0.002649007	0	0	oligos	OL-Cntl	NA	NA	NA
CATGGCGCACGTCTCT-1_8_E5	24.35325147	-6.512456333	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5375	15738	0.006163426	0.00273224	0	2	EN-L4	NA	NA	NA
CATGGCGGTCCGAAGA-1_8_E5	9.410742914	26.85312984	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	969	1478	0.00338295	0.00541272	0	oligos	OL-Cntl	NA	NA	NA
CATGGCGTCATTTGGG-1_8_E5	-37.34239354	2.9541027	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1830	3352	0.002088305	0.002386635	0	9	OPC	NA	NA	NA
CATGGCGTCCACGTTC-1_8_E5	6.812441796	34.17081922	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	775	1103	0.008159565	0.002719855	0	oligos	OL-Cntl	NA	NA	NA
CATGGCGTCGAGGTAG-1_8_E5	13.88262491	30.89954047	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	844	1312	0.003810976	0.005335366	0	oligos	OL-Cntl	NA	NA	NA
CATGGCGTCTTGTCAT-1_8_E5	18.38562608	15.3680359	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1217	2043	0.006363191	0.009789525	0	oligos	OL-Cntl	NA	NA	NA
CATTATCCAAAGCGGT-1_8_E5	-28.69038811	13.99748878	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	815	1161	0.000861326	0.000861326	0	8	Astrocytes	NA	NA	NA
CATTATCCAGTCGATT-1_8_E5	0.760538859	-29.16091687	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5318	19116	0.011613308	0.002981795	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CATTATCGTATCTGCA-1_8_E5	-27.42163643	17.20789733	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1193	1868	0.000535332	0.001605996	0	8	Astrocytes	NA	NA	NA
CATTATCGTGTTGGGA-1_8_E5	-37.93036379	-4.356912744	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1309	2333	0.007286755	0.005143592	0	9	OPC	NA	NA	NA
CATTATCTCTGGTTCC-1_8_E5	31.41593449	-1.159862205	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2940	6270	0.004944179	0.004944179	0	2	EN-L4	NA	NA	NA
CATTATCTCTTGCAAG-1_8_E5	18.67746176	24.48453371	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	920	1419	0.00422833	0.002114165	0	oligos	OL-Cntl	NA	NA	NA
CATTCGCAGAGTCTGG-1_8_E5	-25.63684276	30.05725849	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1843	3546	0.003666103	0.003666103	0	8	Astrocytes	NA	NA	NA
CATTCGCAGTACTTGC-1_8_E5	-11.2145081	-19.86971876	6B	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	920	1414	0.025459689	0.004950495	0	6B	IN-SST	NA	NA	NA
CATTCGCCAAGAAGAG-1_8_E5	-18.81081252	-17.84028189	6B	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2315	4609	0.006075071	0.009546539	0	6B	IN-SST	NA	NA	NA
CATTCGCCACGAAATA-1_8_E5	4.395905727	32.92402675	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	772	1062	0.013182674	0.001883239	0	oligos	OL-Cntl	NA	NA	NA
CATTCGCCATCATCCC-1_8_E5	9.096798135	32.56702612	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	809	1202	0.004991681	0.005823627	0	oligos	OL-Cntl	NA	NA	NA
CATTCGCCATGCAACT-1_8_E5	-36.39199926	-4.045874665	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1411	2385	0	0.001677149	0	9	OPC	NA	NA	NA
CATTCGCCATTCTTAC-1_8_E5	10.82987746	27.96201874	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	848	1255	0.004780876	0.004780876	0	oligos	OL-Cntl	NA	NA	NA
CATTCGCGTTTGGCGC-1_8_E5	-22.82787729	31.3908877	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2420	5411	0.001293661	0.002587322	0	8	Astrocytes	NA	NA	NA
CATTCGCTCAACACCA-1_8_E5	-11.24423194	17.74553855	11	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2136	4125	0.010909091	0.003151515	0	11	Glia-MIX	NA	NA	NA
CCAATCCAGTGCGTGA-1_8_E5	28.53914236	-1.684305879	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4160	10619	0.006968641	0.003955175	0	2	EN-L4	NA	NA	NA
CCAATCCGTGCACGAA-1_8_E5	1.054459024	-30.46583103	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	6171	24595	0.002968083	0.002398862	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CCAATCCGTTGATTGC-1_8_E5	27.72830096	-2.686032303	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4883	15927	0.006592579	0.002260313	0	2	EN-L4	NA	NA	NA
CCACCTAAGCTGGAAC-1_8_E5	-20.06124422	-18.12730571	6B	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3255	7627	0.017831388	0.006424544	0	6B	IN-SST	NA	NA	NA
CCACCTACACAGCGTC-1_8_E5	-1.894885527	-20.46625011	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3538	9507	0.005680025	0.002840013	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CCACCTAGTACAGCAG-1_8_E5	20.11291082	-0.434833008	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1584	3013	0.009624959	0.002655161	0	2	EN-L4	NA	NA	NA
CCACCTAGTCACTTCC-1_8_E5	16.86505743	16.50603346	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1072	1700	0.006470588	0.005294118	0	oligos	OL-Cntl	NA	NA	NA
CCACGGAGTAGCACGA-1_8_E5	27.86451855	-3.492850939	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3861	9374	0.002453595	0.00384041	0	2	EN-L4	NA	NA	NA
CCACGGAGTGGACGAT-1_8_E5	23.17428091	0.619862846	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1832	3360	0.001488095	0.001488095	0	2	EN-L4	NA	NA	NA
CCACTACAGAAACCAT-1_8_E5	-0.415826313	-19.74122017	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3431	8385	0.006678593	0.004293381	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CCACTACAGGCCATAG-1_8_E5	-8.843202093	-17.89974491	6B	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	845	1270	0.011811024	0.002362205	0	6B	IN-SST	NA	NA	NA
CCACTACAGTATCTCG-1_8_E5	26.6389523	-0.1068561	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2777	6026	0.00614006	0.002489213	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CCACTACCACTGTTAG-1_8_E5	-28.75207056	13.91437484	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	802	1144	0.012237762	0.000874126	0	8	Astrocytes	NA	NA	NA
CCACTACCATCACAAC-1_8_E5	27.841169	-1.373927492	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3923	11073	0.005508896	0.002889912	0	2	EN-L4	NA	NA	NA
CCACTACGTATAAACG-1_8_E5	-33.93546426	-10.94219962	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	877	1280	0.00546875	0.00078125	0	9	OPC	NA	NA	NA
CCACTACGTCTGGAGA-1_8_E5	19.48255144	24.95482421	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	990	1547	0.003232062	0.003878474	0	oligos	OL-Cntl	NA	NA	NA
CCACTACTCGCTTAGA-1_8_E5	24.29741896	-6.472214191	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5524	16104	0.004595132	0.004470939	0	2	EN-L4	NA	NA	NA
CCAGCGAAGCGTTGCC-1_8_E5	-14.62094941	-18.70572198	6B	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1544	2813	0.008176324	0.003199431	0	6B	IN-SST	NA	NA	NA
CCAGCGAAGGCCATAG-1_8_E5	-0.386745692	-25.75785642	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5733	20409	0.008623646	0.002988877	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CCAGCGACAAGAAAGG-1_8_E5	3.210925611	-32.02296769	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	6579	26755	0.001719305	0.002205195	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CCAGCGACAGGGTACA-1_8_E5	0.667264098	-19.44040234	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3200	7947	0.007172518	0.004026677	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CCAGCGACATCGACGC-1_8_E5	9.934724136	27.67479944	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	884	1379	0.002175489	0.005076142	0	oligos	OL-Cntl	NA	NA	NA
CCAGCGAGTGCACGAA-1_8_E5	5.655230257	32.6637653	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	718	1048	0.001908397	0.003816794	0	oligos	OL-Cntl	NA	NA	NA
CCAGCGATCAGCATGT-1_8_E5	-23.01984208	31.2161273	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2364	4827	0.001450176	0.004972032	0	8	Astrocytes	NA	NA	NA
CCAGCGATCTCTTGAT-1_8_E5	29.77006127	-2.165251716	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4160	10928	0.016288433	0.005032943	0	2	EN-L4	NA	NA	NA
CCATGTCAGCTGTCTA-1_8_E5	-2.343987717	-0.951470538	11	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2817	6012	0.012641384	0.003160346	0	11	Glia-MIX	NA	NA	NA
CCATGTCAGGTAGCCA-1_8_E5	-8.171711892	-0.239411041	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2194	4437	0.009465855	0.004732928	0	13A	IN-VIP	NA	NA	NA
CCATGTCCAACGATCT-1_8_E5	-9.687396054	1.866137058	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3200	7990	0.010012516	0.004255319	0	13A	IN-VIP	NA	NA	NA
CCATGTCCATCTGGTA-1_8_E5	-25.53595795	20.42202676	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1671	2990	0.003010033	0.00367893	0	8	Astrocytes	NA	NA	NA
CCATGTCGTTAAAGAC-1_8_E5	-18.66893336	-24.84576304	6A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2800	5897	0.000678311	0.004409022	0	6A	IN-PV	NA	NA	NA
CCATGTCTCATCGGAT-1_8_E5	4.549470037	32.40944027	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	744	1011	0.004945598	0.004945598	0	oligos	OL-Cntl	NA	NA	NA
CCATTCGAGATCCCGC-1_8_E5	-1.015024641	-0.265149887	11	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1729	2967	0.014492754	0.001685204	0	11	Glia-MIX	NA	NA	NA
CCATTCGCAATCACAC-1_8_E5	-5.632760742	-1.089865117	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1471	2731	0.019406811	0.000732332	0	13A	IN-VIP	NA	NA	NA
CCATTCGCACAGTCGC-1_8_E5	-0.988011081	-19.60956363	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3101	7201	0.004027218	0.003888349	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CCATTCGTCACCAGGC-1_8_E5	22.40358666	-6.405363207	11	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2216	4846	0.001857202	0.003095336	0	11	Glia-MIX	NA	NA	NA
CCATTCGTCATAGCAC-1_8_E5	4.212817329	-31.39129093	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4809	15379	0.005657065	0.003511282	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CCATTCGTCCAGGGCT-1_8_E5	2.949276341	-5.544624041	12	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1132	2009	0.010950722	0.00149328	0	12	EN-MIX	NA	NA	NA
CCATTCGTCTTGTACT-1_8_E5	0.895011085	-29.90535626	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5477	19441	0.005915334	0.002520446	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CCCAATCAGGCCCTCA-1_8_E5	24.21494842	-6.381088948	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4522	12791	0.006098038	0.003439919	0	2	EN-L4	NA	NA	NA
CCCAATCGTAGCGCAA-1_8_E5	-37.79321423	2.327116639	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1692	2928	0.003415301	0.004098361	0	9	OPC	NA	NA	NA
CCCAATCGTCCAGTGC-1_8_E5	-37.76514103	2.234290775	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1739	3273	0.003360831	0.006110602	0	9	OPC	NA	NA	NA
CCCAATCGTCCCGACA-1_8_E5	22.48918227	20.30057101	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1202	1902	0.003154574	0.003680336	0	oligos	OL-Cntl	NA	NA	NA
CCCAATCGTGCGAAAC-1_8_E5	37.35762801	8.224632431	14	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	775	1043	0.004793864	0.001917546	0	14	Microglia	NA	NA	NA
CCCAATCGTTTGCATG-1_8_E5	6.702366408	30.40226579	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	820	1195	0.007531381	0.0041841	0	oligos	OL-Cntl	NA	NA	NA
CCCAATCTCCCTTGCA-1_8_E5	19.63809574	12.68658389	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1379	2276	0.00483304	0.003514938	0	oligos	OL-Cntl	NA	NA	NA
CCCAATCTCCGGGTGT-1_8_E5	-9.43157418	1.60139099	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2468	5329	0.023081254	0.004316007	0	13A	IN-VIP	NA	NA	NA
CCCAGTTAGAGTCTGG-1_8_E5	-8.830965464	0.748991024	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2272	4539	0.010354704	0.004846883	0	13A	IN-VIP	NA	NA	NA
CCCAGTTAGGATGTAT-1_8_E5	-0.903152599	-19.41590409	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2834	6180	0.00420712	0.004368932	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CCCAGTTAGTTTCCTT-1_8_E5	19.00545125	13.26904286	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1279	2220	0.002252252	0.003603604	0	oligos	OL-Cntl	NA	NA	NA
CCCAGTTCAGACGCCT-1_8_E5	14.90851769	-33.65000441	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5928	23822	0.00167912	0.004701536	0	3	EN-L5-6	NA	NA	NA
CCCAGTTGTCCCTTGT-1_8_E5	7.141643848	33.91254065	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	842	1222	0.005728314	0.002454992	0	oligos	OL-Cntl	NA	NA	NA
CCCAGTTTCAACGCTA-1_8_E5	-1.148734143	-21.16754481	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3634	10489	0.006196968	0.003336829	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CCCATACAGTACTTGC-1_8_E5	-10.54222364	0.187489368	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3065	6523	0.013030814	0.004292503	0	13A	IN-VIP	NA	NA	NA
CCCATACCACACATGT-1_8_E5	-25.95389384	29.97458436	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1872	3369	0.006233304	0.003561888	0	8	Astrocytes	NA	NA	NA
CCCATACCACCACCAG-1_8_E5	-8.899429828	1.770130766	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2578	5742	0.006095437	0.003308952	0	13A	IN-VIP	NA	NA	NA
CCCATACCACCTGGTG-1_8_E5	16.44974068	-1.000546425	12	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	930	1345	0.042379182	0.000743494	0	12	EN-MIX	NA	NA	NA
CCCATACCAGTAGAGC-1_8_E5	-17.01133289	-10.78524197	13B	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3622	9014	0.006434435	0.00377191	0	13B	IN-SV2C	NA	NA	NA
CCCATACGTCGGCATC-1_8_E5	-18.52667274	-23.23274155	6A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2315	4499	0.008668593	0.003334074	0	6A	IN-PV	NA	NA	NA
CCCATACGTGACTACT-1_8_E5	22.26540454	-27.97191266	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5333	16909	0.013306523	0.005086049	0	3	EN-L5-6	NA	NA	NA
CCCATACGTGTGTGCC-1_8_E5	-11.08215041	2.243957251	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3324	7268	0.010044029	0.003990094	0	13A	IN-VIP	NA	NA	NA
CCCATACTCAACACAC-1_8_E5	3.2486858	18.06511682	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	910	1320	0.006818182	0.006818182	0	oligos	OL-Cntl	NA	NA	NA
CCCATACTCCCATTTA-1_8_E5	6.910476482	-31.34569601	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	6888	28452	0.005131449	0.002741459	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CCCATACTCCCTCTTT-1_8_E5	-23.16042272	31.18942526	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2427	5372	0.001489203	0.003164557	0	8	Astrocytes	NA	NA	NA
CCCATACTCGCCAAAT-1_8_E5	18.50804447	12.03793498	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1573	2758	0.004713561	0.006163887	0	oligos	OL-Cntl	NA	NA	NA
CCCTCCTAGCTAGTGG-1_8_E5	27.94801196	-1.193170231	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3753	9786	0.002656857	0.003985285	0	2	EN-L4	NA	NA	NA
CCCTCCTAGTTCGATC-1_8_E5	0.008759149	-22.72288655	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5186	16844	0.006946094	0.003562099	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CCCTCCTCATCCCACT-1_8_E5	-16.5393717	-17.39471538	6B	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2316	5556	0.009539237	0.003599712	0	6B	IN-SST	NA	NA	NA
CCCTCCTCATCTCCCA-1_8_E5	28.31757543	-3.661940873	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4463	12674	0.006785545	0.002840461	0	2	EN-L4	NA	NA	NA
CCGGGATCAACTGCGC-1_8_E5	9.193452383	-31.13669346	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3523	9579	0.004906566	0.002609876	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CCGGGATCACACATGT-1_8_E5	5.372668013	-32.3272228	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	6086	24676	0.003728319	0.001985735	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CCGGGATCACAGGCCT-1_8_E5	9.766349628	26.85202716	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1037	1612	0.00248139	0.005583127	0	oligos	OL-Cntl	NA	NA	NA
CCGGGATCACGGTGTC-1_8_E5	-38.98401469	0.166828368	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1451	2645	0.001134216	0.002268431	0	9	OPC	NA	NA	NA
CCGGGATCAGCTGCAC-1_8_E5	-21.42382784	-28.39329607	6A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5603	19223	0.012693128	0.005254123	0	6A	IN-PV	NA	NA	NA
CCGGGATCATGTCTCC-1_8_E5	26.28732967	-5.468864917	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5969	22280	0.002962298	0.003635548	0	2	EN-L4	NA	NA	NA
CCGGGATGTCCTCCAT-1_8_E5	1.034050901	-30.2495488	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	6008	24261	0.004204278	0.002184576	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CCGGGATTCCGTCAAA-1_8_E5	-20.03769429	-18.06053046	6B	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3424	8559	0.007711181	0.007243837	0	6B	IN-SST	NA	NA	NA
CCGGTAGAGAGGTTAT-1_8_E5	0.855965466	33.9585059	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	789	1145	0.0069869	0.007860262	0	oligos	OL-Cntl	NA	NA	NA
CCGGTAGAGAGTACCG-1_8_E5	-1.216772379	-25.03179995	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4828	15432	0.005572836	0.00311042	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CCGGTAGAGTTGTAGA-1_8_E5	29.51030913	-2.35816138	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4282	11132	0.008174632	0.00485088	0	2	EN-L4	NA	NA	NA
CCGGTAGCACTGAAGG-1_8_E5	-6.784148401	-3.047097978	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1492	2554	0.03797964	0.002740799	0	13A	IN-VIP	NA	NA	NA
CCGGTAGTCACCACCT-1_8_E5	-27.56712674	13.15276223	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	890	1328	0.001506024	0.000753012	0	8	Astrocytes	NA	NA	NA
CCGTACTAGTCGTTTG-1_8_E5	11.97622319	32.4260312	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	862	1303	0.001534919	0.001534919	0	oligos	OL-Cntl	NA	NA	NA
CCGTACTGTATAAACG-1_8_E5	-0.846811162	-25.29551266	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5378	20296	0.003448955	0.002414269	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CCGTACTGTCTCAACA-1_8_E5	11.27672605	-4.902484567	6B	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	848	1165	0.036051502	0.008583691	0	6B	IN-SST	NA	NA	NA
CCGTACTTCCGGCACA-1_8_E5	-20.90163172	-28.065764	6A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3899	10288	0.006998445	0.003790824	0	6A	IN-PV	NA	NA	NA
CCGTACTTCGCCCTTA-1_8_E5	10.73146005	32.11604725	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	826	1323	0.005291005	0.005291005	0	oligos	OL-Cntl	NA	NA	NA
CCGTACTTCTCAACTT-1_8_E5	-24.16027168	30.20009282	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1943	4079	0.001225791	0.002451581	0	8	Astrocytes	NA	NA	NA
CCGTGGAAGCCCAATT-1_8_E5	-27.29669465	15.06663015	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	972	1477	0.00338524	0.004062288	0	8	Astrocytes	NA	NA	NA
CCGTGGAAGTACGATA-1_8_E5	8.770207834	33.61353438	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	804	1145	0.002620087	0.002620087	0	oligos	OL-Cntl	NA	NA	NA
CCGTGGAGTCACCTAA-1_8_E5	-0.501522942	-14.77994414	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2694	6097	0.006396588	0.006068558	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CCGTTCAAGACTACAA-1_8_E5	15.86195938	-33.18068148	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	7539	38546	0.004358429	0.003554195	0	3	EN-L5-6	NA	NA	NA
CCGTTCAAGATCCTGT-1_8_E5	8.942129953	33.62712093	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	854	1255	0.001593625	0.003187251	0	oligos	OL-Cntl	NA	NA	NA
CCGTTCAAGGAGTAGA-1_8_E5	-35.40069036	5.202948761	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2849	6365	0.001413983	0.004399057	0	9	OPC	NA	NA	NA
CCGTTCACATGTCGAT-1_8_E5	-12.93386064	-18.0030845	6B	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1234	2211	0.013568521	0.005879692	0	6B	IN-SST	NA	NA	NA
CCGTTCAGTATTCGTG-1_8_E5	10.57051857	27.6549138	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	885	1400	0.003571429	0.001428571	0	oligos	OL-Cntl	NA	NA	NA
CCGTTCAGTCGAACAG-1_8_E5	7.55349271	-29.83184855	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5640	19221	0.008324229	0.00364185	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CCGTTCAGTCTAGCCG-1_8_E5	-14.34128718	-7.551719783	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3976	11103	0.012519139	0.00297217	0	13A	IN-VIP	NA	NA	NA
CCGTTCATCACTTATC-1_8_E5	-9.090426763	1.824528501	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2757	6270	0.003827751	0.003668262	0	13A	IN-VIP	NA	NA	NA
CCTAAAGAGCGTGTCC-1_8_E5	-23.91391483	30.35323193	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2130	4485	0.001560758	0.002229654	0	8	Astrocytes	NA	NA	NA
CCTAAAGAGTGTTTGC-1_8_E5	-1.194569973	-18.98349136	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2749	6037	0.008282259	0.003644194	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CCTAAAGCAGTGGGAT-1_8_E5	1.188052749	-30.34267818	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5914	21215	0.005844921	0.003299552	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CCTAAAGGTACAGCAG-1_8_E5	20.96529327	22.32414212	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1091	1665	0.005405405	0.004804805	0	oligos	OL-Cntl	NA	NA	NA
CCTAAAGGTCTTGCGG-1_8_E5	-33.67602916	-13.2807621	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	685	1040	0.001923077	0.002884615	0	9	OPC	NA	NA	NA
CCTAAAGGTTCAGGCC-1_8_E5	-13.28744237	-19.43683797	6B	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1221	2157	0.021789522	0.001390821	0	6B	IN-SST	NA	NA	NA
CCTAAAGGTTTAGGAA-1_8_E5	-37.77443721	-6.144896935	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1231	2082	0.006724304	0.003362152	0	9	OPC	NA	NA	NA
CCTAAAGTCTTTAGTC-1_8_E5	-10.61022963	0.441136347	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2707	5832	0.032921811	0.007030178	0	13A	IN-VIP	NA	NA	NA
CCTACACCAAACCTAC-1_8_E5	-25.88964482	29.93897009	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1822	3473	0.000575871	0.004606968	0	8	Astrocytes	NA	NA	NA
CCTACACCAAGTTCTG-1_8_E5	-25.32520951	20.33076486	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1500	2618	0.002291826	0.004965623	0	8	Astrocytes	NA	NA	NA
CCTACACGTCTCATCC-1_8_E5	-7.992008117	1.439701139	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2242	4729	0.002537534	0.002748996	0	13A	IN-VIP	NA	NA	NA
CCTACACTCCGATATG-1_8_E5	27.5999324	-4.11406312	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3815	9857	0.009130567	0.00405803	0	2	EN-L4	NA	NA	NA
CCTACACTCGTTTGCC-1_8_E5	5.934852024	35.10402858	11	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	926	1411	0.013465627	0.004961021	0	11	Glia-MIX	NA	NA	NA
CCTACACTCTCGGACG-1_8_E5	1.287089307	-30.66552637	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	6420	24572	0.00423246	0.003499919	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CCTACCAAGATCCCAT-1_8_E5	20.27654066	22.93807283	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1072	1965	0.004071247	0.004071247	0	oligos	OL-Cntl	NA	NA	NA
CCTACCAAGTGTGGCA-1_8_E5	28.78360504	-0.863971518	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3558	8725	0.006876791	0.002292264	0	2	EN-L4	NA	NA	NA
CCTACCAGTCTTGATG-1_8_E5	8.534855146	34.1165474	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	981	1524	0.005905512	0.002624672	0	oligos	OL-Cntl	NA	NA	NA
CCTACCATCCTTCAAT-1_8_E5	27.11861439	-3.24028782	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3663	10164	0.001869343	0.003738686	0	2	EN-L4	NA	NA	NA
CCTAGCTCAATGGAAT-1_8_E5	9.00043114	28.33859622	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	924	1439	0.007644197	0.001389854	0	oligos	OL-Cntl	NA	NA	NA
CCTAGCTGTAAGAGAG-1_8_E5	-14.28911092	-8.606669439	13B	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2849	6649	0.014137464	0.002406377	0	13B	IN-SV2C	NA	NA	NA
CCTAGCTTCAAGCCTA-1_8_E5	-6.703041707	-0.762939576	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1866	3864	0.013975155	0.004140787	0	13A	IN-VIP	NA	NA	NA
CCTAGCTTCACCGGGT-1_8_E5	25.91164114	-5.268187201	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5303	19136	0.009615385	0.002038043	0	2	EN-L4	NA	NA	NA
CCTATTAGTGGACGAT-1_8_E5	2.199103795	-31.37560562	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	6468	28321	0.001518308	0.00204795	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CCTCAGTAGCAGGCTA-1_8_E5	25.09872266	-29.31031506	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3601	10005	0.004597701	0.002098951	0	3	EN-L5-6	NA	NA	NA
CCTCAGTCAGCTGTGC-1_8_E5	10.64681425	33.44374235	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	828	1214	0.023887974	0.00247117	0	oligos	OL-Cntl	NA	NA	NA
CCTCAGTCAGCTTCGG-1_8_E5	-0.877863339	-22.1221952	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4225	12250	0.006612245	0.003836735	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CCTCAGTCAGGGTATG-1_8_E5	-1.094798914	-21.33235415	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3373	8615	0.004062681	0.003134068	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CCTCAGTCATTTCAGG-1_8_E5	21.70364445	-8.425930481	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1870	3699	0.00567721	0.002703433	0	3	EN-L5-6	NA	NA	NA
CCTCAGTGTACCATCA-1_8_E5	11.19420353	32.26748799	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	831	1224	0.005718954	0.004084967	0	oligos	OL-Cntl	NA	NA	NA
CCTCAGTTCAACGGGA-1_8_E5	-23.14468871	31.09546313	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2222	4696	0.000212947	0.004684838	0	8	Astrocytes	NA	NA	NA
CCTCAGTTCACTTATC-1_8_E5	-1.241160338	-19.80803144	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3057	7204	0.00388673	0.004025541	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CCTCTGAAGTTCCACA-1_8_E5	-0.430682313	-0.206595933	11	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1286	2027	0.063640849	0.005920079	0	11	Glia-MIX	NA	NA	NA
CCTCTGACAAATACAG-1_8_E5	11.36473368	-0.572883254	12	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1179	1997	0.007010516	0.010515774	0	12	EN-MIX	NA	NA	NA
CCTCTGACACCGAAAG-1_8_E5	14.90950229	-33.6864331	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5470	19862	0.000453127	0.004380224	0	3	EN-L5-6	NA	NA	NA
CCTCTGAGTTCTCATT-1_8_E5	20.57341176	22.75706876	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1092	1813	0.002206288	0.003861004	0	oligos	OL-Cntl	NA	NA	NA
CCTTACGAGAGTCTGG-1_8_E5	16.31618386	-32.65707088	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	6407	28212	0.004218063	0.002658443	0	3	EN-L5-6	NA	NA	NA
CCTTACGAGGAACTGC-1_8_E5	-20.34176305	-29.14545769	6A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5250	17357	0.001325114	0.0038025	0	6A	IN-PV	NA	NA	NA
CCTTACGAGTACGACG-1_8_E5	9.075052077	33.35769961	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	804	1170	0.009401709	0.002564103	0	oligos	OL-Cntl	NA	NA	NA
CCTTACGCAAAGGCGT-1_8_E5	-1.99860156	-19.01817865	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3197	8085	0.012739641	0.004205318	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CCTTACGTCACATGCA-1_8_E5	25.57840064	-4.626532669	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4686	15723	0.000445208	0.001908033	0	2	EN-L4	NA	NA	NA
CCTTACGTCTGCTGCT-1_8_E5	20.7601721	24.64721508	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1014	1610	0.001863354	0.003726708	0	oligos	OL-Cntl	NA	NA	NA
CCTTCCCAGTGTACGG-1_8_E5	19.79358974	8.717170375	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1694	3184	0.001884422	0.005967337	0	oligos	OL-Cntl	NA	NA	NA
CCTTCCCCAAGGTGTG-1_8_E5	-0.801892705	-19.09234766	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2740	5948	0.004371217	0.005716207	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CCTTCCCCAGACGTAG-1_8_E5	-10.32469593	2.065535082	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3107	6851	0.003065246	0.007006276	0	13A	IN-VIP	NA	NA	NA
CCTTCCCGTTCTGTTT-1_8_E5	-7.456370478	-13.65903731	6B	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1242	1843	0.024416712	0.003798155	0	6B	IN-SST	NA	NA	NA
CCTTCCCTCAAACCGT-1_8_E5	20.8201569	22.93952462	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1202	2086	0.001438159	0.002396932	0	oligos	OL-Cntl	NA	NA	NA
CCTTCCCTCAAGCCTA-1_8_E5	19.22226306	13.24899603	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1309	2179	0.005048187	0.004130335	0	oligos	OL-Cntl	NA	NA	NA
CCTTCCCTCTGCAAGT-1_8_E5	20.70848883	23.52076397	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1160	1980	0.004545455	0.005555556	0	oligos	OL-Cntl	NA	NA	NA
CCTTCGAAGCATGGCA-1_8_E5	5.888287273	26.99380314	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	953	1492	0.000670241	0.007372654	0	oligos	OL-Cntl	NA	NA	NA
CCTTCGAAGCTATGCT-1_8_E5	-4.414310732	-30.87184039	16	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	697	1290	0.343410853	0.004651163	0	16	EN-PYR	NA	NA	NA
CCTTCGACACAGAGGT-1_8_E5	10.35264222	27.28109557	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	850	1346	0.002228826	0.008915305	0	oligos	OL-Cntl	NA	NA	NA
CCTTCGACACGAAGCA-1_8_E5	-1.095497304	-23.78367116	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4404	13047	0.000306584	0.003219131	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CCTTCGACAGCATGAG-1_8_E5	-2.526206398	-26.16601728	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3730	10382	0.000192641	0.003660181	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CCTTCGAGTCAAAGAT-1_8_E5	27.43972374	-5.137027558	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5119	15861	0.010087636	0.003972007	0	2	EN-L4	NA	NA	NA
CCTTCGAGTCTCCATC-1_8_E5	8.887835286	33.60641654	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	893	1411	0.013465627	0.002834869	0	oligos	OL-Cntl	NA	NA	NA
CCTTCGATCGCGTAGC-1_8_E5	14.96645056	-33.52677287	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4976	16831	0.004515477	0.005287862	0	3	EN-L5-6	NA	NA	NA
CCTTCGATCTTGCAAG-1_8_E5	-36.60582513	3.925343822	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2091	4516	0.003321523	0.003985828	0	9	OPC	NA	NA	NA
CCTTTCTAGACGACGT-1_8_E5	-2.105433824	-19.26407187	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3020	7152	0.004753915	0.002097315	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CCTTTCTAGAGTTGGC-1_8_E5	-27.53941712	4.396605964	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2472	4785	0.002716823	0.003761755	0	9	OPC	NA	NA	NA
CCTTTCTAGGCAGTCA-1_8_E5	-35.02620715	5.399326709	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4494	13122	0.002133821	0.002819692	0	9	OPC	NA	NA	NA
CCTTTCTAGTGCGTGA-1_8_E5	1.740898911	-30.45109774	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5125	16331	0.009246219	0.002694262	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CCTTTCTAGTGTGAAT-1_8_E5	11.6171982	27.18373745	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	846	1341	0.008202834	0.002982849	0	oligos	OL-Cntl	NA	NA	NA
CCTTTCTGTACCATCA-1_8_E5	-10.76427631	2.362691634	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3622	9303	0.011931635	0.003762227	0	13A	IN-VIP	NA	NA	NA
CCTTTCTGTCCAGTGC-1_8_E5	25.7535109	-29.46467803	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5413	21444	0.001678791	0.003497482	0	3	EN-L5-6	NA	NA	NA
CGAACATAGACTTGAA-1_8_E5	7.592618066	33.61809912	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	796	1174	0	0.003407155	0	oligos	OL-Cntl	NA	NA	NA
CGAACATAGCAGATCG-1_8_E5	9.745702396	32.08426558	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	808	1159	0.005176877	0.001725626	0	oligos	OL-Cntl	NA	NA	NA
CGAACATCAGATTGCT-1_8_E5	12.063571	1.89621279	12	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	674	1118	0.005366726	0.003577818	0	12	EN-MIX	NA	NA	NA
CGAACATGTATCGCAT-1_8_E5	-0.709147904	-14.0945724	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2119	4252	0.008936971	0.002587018	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGAACATGTCTAGCCG-1_8_E5	18.48048292	23.9099267	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	971	1439	0.009034051	0.008339124	0	oligos	OL-Cntl	NA	NA	NA
CGAACATTCATGGTCA-1_8_E5	3.002487747	-32.11179395	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	8109	44248	0.003209185	0.002983186	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGAACATTCGGATGGA-1_8_E5	-2.514420565	-17.23532542	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2782	5959	0.003691895	0.006712536	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGAACATTCGGTGTCG-1_8_E5	6.806205188	28.00186452	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	815	1219	0.003281378	0.008203445	0	oligos	OL-Cntl	NA	NA	NA
CGAATGTGTCCGACGT-1_8_E5	-23.69326095	30.53848399	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2150	4524	0.000221043	0.002431477	0	8	Astrocytes	NA	NA	NA
CGAATGTGTGGCGAAT-1_8_E5	-20.77857192	-17.03285692	6A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3580	8692	0.008283479	0.003681546	0	6A	IN-PV	NA	NA	NA
CGAATGTGTTCACGGC-1_8_E5	-37.99602506	3.02226779	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1915	3814	0.003146303	0.004195071	0	9	OPC	NA	NA	NA
CGAATGTTCACGGTTA-1_8_E5	25.08405254	-2.561083471	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2877	7433	0.009821068	0.00363245	0	2	EN-L4	NA	NA	NA
CGACCTTAGCCACCTG-1_8_E5	17.54024265	18.87200309	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1082	1665	0.006606607	0.005405405	0	oligos	OL-Cntl	NA	NA	NA
CGACCTTAGGAGTCTG-1_8_E5	28.4741438	-1.332861211	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3769	9486	0.011174362	0.004005903	0	2	EN-L4	NA	NA	NA
CGACCTTCACGCGAAA-1_8_E5	15.02288468	-33.60926147	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4613	15007	0.005197574	0.004597854	0	3	EN-L5-6	NA	NA	NA
CGACCTTCAGTGGGAT-1_8_E5	-18.29390628	-24.4939454	6A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3084	7796	0.009748589	0.003976398	0	6A	IN-PV	NA	NA	NA
CGACCTTCATCGGACC-1_8_E5	7.212552988	-32.41712233	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5080	18080	0.003152655	0.003042035	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGACCTTGTCGCATCG-1_8_E5	-0.53049053	-21.99857621	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4357	13193	0.00545744	0.003562495	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGACTTCCACAACGCC-1_8_E5	9.414069774	26.74071377	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	863	1343	0.002978407	0.002233805	0	oligos	OL-Cntl	NA	NA	NA
CGACTTCCAGGCTGAA-1_8_E5	-36.67657932	-3.101743563	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1377	2302	0.004778454	0.002606429	0	9	OPC	NA	NA	NA
CGACTTCGTCATGCCG-1_8_E5	-0.659057828	-22.62740702	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4544	14230	0.006535488	0.002529866	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGACTTCGTGTTGGGA-1_8_E5	6.651578375	29.50233664	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	772	1111	0.00180018	0.00360036	0	oligos	OL-Cntl	NA	NA	NA
CGACTTCTCGATCCCT-1_8_E5	-36.59772859	3.270961368	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1931	3584	0.002511161	0.003069196	0	9	OPC	NA	NA	NA
CGACTTCTCTAACCGA-1_8_E5	-9.006457311	1.553470466	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2804	6414	0.009510446	0.003741815	0	13A	IN-VIP	NA	NA	NA
CGAGAAGAGAGACTAT-1_8_E5	-1.671164103	-22.64533214	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4155	12386	0.007185532	0.002341353	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGAGAAGAGGATGTAT-1_8_E5	-0.911500862	-20.22050879	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3159	7036	0.003837408	0.006395679	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGAGAAGAGGTGGGTT-1_8_E5	9.982225938	27.31523589	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	922	1471	0.004758668	0.002719239	0	oligos	OL-Cntl	NA	NA	NA
CGAGAAGAGTACACCT-1_8_E5	23.15896677	11.66594329	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1842	3455	0.001736614	0.004052098	0	oligos	OL-Cntl	NA	NA	NA
CGAGAAGAGTGATCGG-1_8_E5	25.25873904	-29.33075324	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3232	8004	0.004997501	0.003123438	0	3	EN-L5-6	NA	NA	NA
CGAGAAGGTACTTGAC-1_8_E5	11.59881	1.028807529	12	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	753	1130	0.019469027	0.014159292	0	12	EN-MIX	NA	NA	NA
CGAGAAGTCAAACCGT-1_8_E5	21.38898975	-29.23223697	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5183	17232	0.008820799	0.004004178	0	3	EN-L5-6	NA	NA	NA
CGAGAAGTCTAACTCT-1_8_E5	-27.19329408	10.58339848	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	824	1271	0.002360346	0.002360346	0	8	Astrocytes	NA	NA	NA
CGAGCACAGACCCACC-1_8_E5	3.051719327	-32.30434853	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	7158	31466	0.004703489	0.00282845	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGAGCACAGCTAACAA-1_8_E5	-23.5321968	30.37364157	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2087	4111	0.000729749	0.002189248	0	8	Astrocytes	NA	NA	NA
CGAGCACAGGTAGCTG-1_8_E5	0.462046078	-28.65394328	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5493	18907	0.002009838	0.00338499	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGAGCACAGTCAAGCG-1_8_E5	-16.7268986	-10.8458044	13B	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3831	10402	0.007498558	0.004518362	0	13B	IN-SV2C	NA	NA	NA
CGAGCACAGTCAATAG-1_8_E5	-22.04298105	31.68699908	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3182	7554	0.004765687	0.002912364	0	8	Astrocytes	NA	NA	NA
CGAGCACCAGACGCCT-1_8_E5	-22.00630978	31.66763183	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2900	6309	0.00126803	0.004755112	0	8	Astrocytes	NA	NA	NA
CGAGCACCAGTGAGTG-1_8_E5	6.953624924	32.29940708	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	751	1110	0.004504505	0.006306306	0	oligos	OL-Cntl	NA	NA	NA
CGAGCACTCCGCAGTG-1_8_E5	27.02614679	-5.426338726	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	6118	22257	0.010783124	0.004672687	0	2	EN-L4	NA	NA	NA
CGAGCCACAGTCGATT-1_8_E5	18.3530485	15.15355322	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1168	1914	0.002089864	0.00522466	0	oligos	OL-Cntl	NA	NA	NA
CGAGCCACATGGTTGT-1_8_E5	-19.23038605	8.678049772	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	849	1251	0.002398082	0.003996803	0	8	Astrocytes	NA	NA	NA
CGAGCCAGTTGCGCAC-1_8_E5	19.72150757	-6.959595603	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2227	4771	0.019492769	0.003563194	0	3	EN-L5-6	NA	NA	NA
CGAGCCATCTTACCGC-1_8_E5	39.30086078	9.31038859	14	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	832	1156	0.006920415	0.006055363	0	14	Microglia	NA	NA	NA
CGATCGGAGTCATCCA-1_8_E5	26.96459426	-3.196572075	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3110	6710	0.001937407	0.00461997	0	2	EN-L4	NA	NA	NA
CGATCGGCAAGTCTGT-1_8_E5	-0.596914531	-14.87253377	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2532	5499	0.013456992	0.003273322	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGATCGGGTCCATGAT-1_8_E5	-5.618348697	-5.381913591	13B	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1134	1860	0.016129032	0.001075269	0	13B	IN-SV2C	NA	NA	NA
CGATCGGTCTCCAGGG-1_8_E5	-24.92959541	18.66620182	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1441	2473	0.001213101	0.002426203	0	8	Astrocytes	NA	NA	NA
CGATGGCAGATGCCAG-1_8_E5	20.03653984	24.01475151	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1035	1735	0.002305476	0.002305476	0	oligos	OL-Cntl	NA	NA	NA
CGATGTAAGCGATTCT-1_8_E5	-23.48540381	0.831423832	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2666	5518	0.003443277	0.005255527	0	9	OPC	NA	NA	NA
CGATGTACAAAGAATC-1_8_E5	-16.79679756	-10.89973612	13B	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3641	9180	0.016122004	0.004901961	0	13B	IN-SV2C	NA	NA	NA
CGATGTACATGCATGT-1_8_E5	-17.12345224	-10.91470968	13B	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4926	15941	0.01091525	0.00426573	0	13B	IN-SV2C	NA	NA	NA
CGATGTAGTAACGTTC-1_8_E5	13.35128826	17.38700335	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1065	1685	0.002967359	0.005934718	0	oligos	OL-Cntl	NA	NA	NA
CGATGTAGTCCGAAGA-1_8_E5	5.248063775	33.20920676	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	756	1090	0.010091743	0.001834862	0	oligos	OL-Cntl	NA	NA	NA
CGATTGACAATGAATG-1_8_E5	5.927920627	28.01143138	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	837	1224	0.009803922	0.003267974	0	oligos	OL-Cntl	NA	NA	NA
CGATTGAGTCGCATCG-1_8_E5	-5.090477248	-2.64723749	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1410	2357	0.01145524	0.003818413	0	13A	IN-VIP	NA	NA	NA
CGATTGATCAGGCCCA-1_8_E5	-9.565202481	2.801981425	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3432	8773	0.014476234	0.00205175	0	13A	IN-VIP	NA	NA	NA
CGCCAAGAGGAACTGC-1_8_E5	-10.60897825	1.927882138	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3055	7671	0.014600443	0.00351975	0	13A	IN-VIP	NA	NA	NA
CGCCAAGCAAAGGCGT-1_8_E5	-24.60277087	30.2213414	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1759	3237	0.00154464	0.003398208	0	8	Astrocytes	NA	NA	NA
CGCCAAGGTAAAGTCA-1_8_E5	14.61897319	-33.73812943	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4759	16160	6.19E-05	0.004269802	0	3	EN-L5-6	NA	NA	NA
CGCCAAGGTGAAATCA-1_8_E5	16.47716414	-32.88787729	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	6276	24215	0.005822837	0.003551518	0	3	EN-L5-6	NA	NA	NA
CGCCAAGGTTTAAGCC-1_8_E5	20.83663267	22.65644867	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1117	1811	0.011043622	0.00496963	0	oligos	OL-Cntl	NA	NA	NA
CGCCAAGTCTTGACGA-1_8_E5	10.55451603	26.92074014	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	918	1479	0.001352265	0.003380663	0	oligos	OL-Cntl	NA	NA	NA
CGCGGTAAGTCGATAA-1_8_E5	15.12105953	-33.91196856	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4940	15806	0.002973554	0.005504239	0	3	EN-L5-6	NA	NA	NA
CGCGGTATCATTGCCC-1_8_E5	20.96238575	-29.43480396	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5098	16737	0.00280815	0.005616299	0	3	EN-L5-6	NA	NA	NA
CGCGTTTCATGTAGTC-1_8_E5	4.980584518	32.30325292	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	773	1123	0.009795191	0.009795191	0	oligos	OL-Cntl	NA	NA	NA
CGCGTTTGTACCTACA-1_8_E5	-4.443630744	-9.611790422	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	695	1020	0.064705882	0.000980392	0	13A	IN-VIP	NA	NA	NA
CGCGTTTTCAGTGTTG-1_8_E5	-1.530411467	-20.77567708	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3405	9165	0.003382433	0.004255319	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGCGTTTTCCACTCCA-1_8_E5	19.33480055	8.935482092	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1661	3097	0.001291572	0.003551824	0	oligos	OL-Cntl	NA	NA	NA
CGCGTTTTCTAACGGT-1_8_E5	2.644676745	-31.7425974	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	6437	24962	0.004887429	0.001882862	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGCTATCCAATCGAAA-1_8_E5	-37.97751273	-0.859357816	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1370	2381	0.006719866	0.002099958	0	9	OPC	NA	NA	NA
CGCTATCCACAAGCCC-1_8_E5	10.0921942	-7.804258311	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1885	3646	0.005485464	0.001371366	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGCTATCGTAGCTAAA-1_8_E5	-38.31680252	0.342621138	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1460	2429	0.002470152	0.002470152	0	9	OPC	NA	NA	NA
CGCTATCGTCTAAACC-1_8_E5	-0.766921243	-14.62892151	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2457	5338	0.002435369	0.001498689	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGCTGGAAGACTAGGC-1_8_E5	-0.948181808	-15.94343743	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2616	5913	0.007948588	0.002875021	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGCTGGAAGATATACG-1_8_E5	29.49244759	-5.263856774	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4418	12157	0.016862713	0.0051822	0	2	EN-L4	NA	NA	NA
CGCTGGAAGCGTGAAC-1_8_E5	23.49328136	0.577618856	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2019	4132	0.009196515	0.001210068	0	2	EN-L4	NA	NA	NA
CGCTGGACACAGACAG-1_8_E5	-38.97615872	-0.686089783	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1472	2607	0.004602992	0.002301496	0	9	OPC	NA	NA	NA
CGCTGGAGTTGTGGCC-1_8_E5	-2.059319395	-19.69405077	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2967	6946	0.002303484	0.002447452	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGCTGGATCAGCAACT-1_8_E5	17.91008609	13.27178126	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1228	1980	0.00959596	0.006060606	0	oligos	OL-Cntl	NA	NA	NA
CGCTGGATCGTGGTCG-1_8_E5	28.92271477	-2.098992211	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4498	12774	0.005401597	0.005949585	0	2	EN-L4	NA	NA	NA
CGCTGGATCTGCTTGC-1_8_E5	-8.610835525	-31.15780506	16	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	978	1342	0.078241431	0.003725782	0	16	EN-PYR	NA	NA	NA
CGCTTCAAGACAGGCT-1_8_E5	-4.862379803	-2.296783226	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1457	2603	0.01459854	0.002305033	0	13A	IN-VIP	NA	NA	NA
CGCTTCACAAGTCATC-1_8_E5	27.40783578	0.169305651	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5853	23140	0.009593777	0.002765774	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGCTTCAGTACTTCTT-1_8_E5	25.52014159	-29.46262716	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4048	12611	0.004678455	0.0019031	0	3	EN-L5-6	NA	NA	NA
CGCTTCAGTGCAACGA-1_8_E5	-17.61396585	-19.24998056	6A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2267	4845	0.027038184	0.003302374	0	6A	IN-PV	NA	NA	NA
CGGACACCACCAGCAC-1_8_E5	-38.84455418	-0.867380525	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1432	2568	0.002336449	0.002725857	0	9	OPC	NA	NA	NA
CGGACACCAGCTGCTG-1_8_E5	7.616764809	-32.26046736	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5127	18054	0.005871275	0.003267974	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGGACACCAGCTGTAT-1_8_E5	21.4184437	-29.23476197	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4393	12611	0.003092538	0.003409722	0	3	EN-L5-6	NA	NA	NA
CGGACACGTACAGACG-1_8_E5	-1.154133676	-22.53082463	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4045	11311	0.000795686	0.002740695	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGGACACGTGGTCTCG-1_8_E5	1.885550324	-31.15775894	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	6062	22702	0.005506123	0.001761959	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGGACACGTGTGGTTT-1_8_E5	-23.90273485	30.47190464	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1963	3926	0.000509424	0.00356597	0	8	Astrocytes	NA	NA	NA
CGGACACTCCGATATG-1_8_E5	24.44201327	-29.22469749	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3106	7733	0.002327687	0.002974266	0	3	EN-L5-6	NA	NA	NA
CGGACACTCGTCACGG-1_8_E5	-9.047705338	1.392236559	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2574	5717	0.006297009	0.001749169	0	13A	IN-VIP	NA	NA	NA
CGGACGTGTTAGAACA-1_8_E5	0.487259053	-29.69294284	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5355	20516	0.003265744	0.00199844	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGGACGTTCACTGGGC-1_8_E5	-7.897797953	1.280003853	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2204	4659	0.016956428	0.004292767	0	13A	IN-VIP	NA	NA	NA
CGGACGTTCATGTCTT-1_8_E5	-3.500340385	35.93435005	17	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	760	1089	0.005509642	0.004591368	0	oligos	OL-MS-2	NA	NA	NA
CGGACGTTCGAGAGCA-1_8_E5	4.038353306	-31.56388787	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	6412	26677	0.007047269	0.00273644	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGGACTGAGATCCCGC-1_8_E5	-38.67882107	-0.258357333	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1390	2329	0.007728639	0.002146844	0	9	OPC	NA	NA	NA
CGGACTGCAATGGATA-1_8_E5	20.4763299	22.62772963	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1065	1826	0.00109529	0.003833516	0	oligos	OL-Cntl	NA	NA	NA
CGGACTGCACCGGAAA-1_8_E5	5.264573717	32.43975069	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	845	1249	0.003202562	0.000800641	0	oligos	OL-Cntl	NA	NA	NA
CGGACTGCAGCTGGCT-1_8_E5	26.85707594	-27.4739829	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	6374	25887	0.010932128	0.003090354	0	3	EN-L5-6	NA	NA	NA
CGGACTGGTCGGCATC-1_8_E5	9.7436791	32.01169642	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	896	1400	0.002142857	0.006428571	0	oligos	OL-Cntl	NA	NA	NA
CGGACTGTCGGACAAG-1_8_E5	29.14950005	-1.500369774	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3514	7926	0.011859702	0.00428968	0	2	EN-L4	NA	NA	NA
CGGAGCTCAGGACGTA-1_8_E5	27.44496094	-1.062430893	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4059	11345	0.009431468	0.002556192	0	2	EN-L4	NA	NA	NA
CGGAGCTGTTGCGTTA-1_8_E5	18.1824232	8.282710394	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1811	3478	0.002875216	0.004312823	0	oligos	OL-Cntl	NA	NA	NA
CGGAGCTTCGCACTCT-1_8_E5	14.65291364	-33.65990962	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4837	16008	0.002186407	0.003810595	0	3	EN-L5-6	NA	NA	NA
CGGAGTCCAAGCGATG-1_8_E5	-10.9094858	2.184010123	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3318	8060	0.009181141	0.005459057	0	13A	IN-VIP	NA	NA	NA
CGGAGTCCACAGGCCT-1_8_E5	20.66158101	-29.74585251	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	6701	25566	0.005828053	0.004654619	0	3	EN-L5-6	NA	NA	NA
CGGAGTCGTAAACACA-1_8_E5	-19.63546742	-28.52087541	6A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3768	10435	0.000479157	0.003354097	0	6A	IN-PV	NA	NA	NA
CGGAGTCGTCGTCTTC-1_8_E5	1.384157331	-30.6032006	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	6092	23482	0.005323226	0.002512563	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGGAGTCGTGCGAAAC-1_8_E5	-20.73063084	-28.29334232	6A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4735	15516	0.01282547	0.003480278	0	6A	IN-PV	NA	NA	NA
CGGAGTCGTTACTGAC-1_8_E5	25.5974587	-2.698578076	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3101	7339	0.00081755	0.002588909	0	2	EN-L4	NA	NA	NA
CGGCTAGAGCAATCTC-1_8_E5	27.84420123	-3.999850041	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4354	11653	0.009268	0.004548185	0	2	EN-L4	NA	NA	NA
CGGCTAGAGTGAAGTT-1_8_E5	-11.4164469	-22.04311679	6A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	968	1488	0.02688172	0.004032258	0	6A	IN-PV	NA	NA	NA
CGGCTAGGTACCGCTG-1_8_E5	-9.591839031	1.588806679	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2423	5276	0.014025777	0.003980288	0	13A	IN-VIP	NA	NA	NA
CGGCTAGGTCCAACTA-1_8_E5	18.11430651	17.590315	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1129	1715	0.001749271	0.006997085	0	oligos	OL-Cntl	NA	NA	NA
CGGCTAGGTGGTCTCG-1_8_E5	-38.08504904	-1.263886098	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1325	2388	0.002512563	0.005025126	0	9	OPC	NA	NA	NA
CGGGTCAAGCTAACAA-1_8_E5	-19.99536713	8.404430309	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	915	1404	0.004273504	0.002136752	0	8	Astrocytes	NA	NA	NA
CGGGTCACACTATCTT-1_8_E5	2.029731818	-31.04535045	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5300	18267	0.005145891	0.002244485	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGGGTCACAGATGGCA-1_8_E5	10.91184255	27.51798386	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	918	1398	0.00286123	0.007153076	0	oligos	OL-Cntl	NA	NA	NA
CGGGTCAGTCAGTGGA-1_8_E5	1.796828108	-31.42524059	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	8862	48957	0.002880078	0.004330331	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGGGTCAGTTGGAGGT-1_8_E5	-10.36268336	1.513211607	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2295	4686	0.006402049	0.004481434	0	13A	IN-VIP	NA	NA	NA
CGGGTCATCAAACGGG-1_8_E5	25.62698583	-26.0612731	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4543	13047	0.012033418	0.003985591	0	3	EN-L5-6	NA	NA	NA
CGGGTCATCCTACAGA-1_8_E5	-9.469210873	2.672163255	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2913	6365	0.014454046	0.004556167	0	13A	IN-VIP	NA	NA	NA
CGGTTAACAGCATGAG-1_8_E5	30.14313562	-3.987814046	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3786	9451	0.011744789	0.003491694	0	2	EN-L4	NA	NA	NA
CGGTTAACATTACGAC-1_8_E5	1.39134082	-7.625232183	12	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1408	2287	0.005247049	0.003060778	0	12	EN-MIX	NA	NA	NA
CGGTTAAGTGTTCGAT-1_8_E5	-37.91543068	2.549256245	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1730	3205	0.0024961	0.002184087	0	9	OPC	NA	NA	NA
CGGTTAATCAGTCAGT-1_8_E5	21.64510768	0.828323849	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1535	2513	0.010744131	0.001591723	0	2	EN-L4	NA	NA	NA
CGGTTAATCCAAAGTC-1_8_E5	6.723656384	-31.91244775	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4874	15656	0.005301482	0.002938171	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGTAGCGAGAGCTGGT-1_8_E5	4.177711659	34.2320517	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	753	1077	0.007428041	0.00185701	0	oligos	OL-Cntl	NA	NA	NA
CGTAGCGTCATTGCGA-1_8_E5	-0.638103354	-14.47111755	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2472	5132	0.000584567	0.003897116	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGTAGGCAGCTCCTCT-1_8_E5	26.26147043	-27.08899269	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4884	15043	0.004121518	0.003589709	0	3	EN-L5-6	NA	NA	NA
CGTAGGCAGGTGATAT-1_8_E5	25.79860756	-2.832802109	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3392	8424	0.012345679	0.002136752	0	2	EN-L4	NA	NA	NA
CGTAGGCGTATATGGA-1_8_E5	-24.919156	20.38610539	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1818	3132	0.009578544	0.005747126	0	8	Astrocytes	NA	NA	NA
CGTAGGCGTGACCAAG-1_8_E5	-0.735082063	-19.49244801	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3377	8307	0.011315758	0.004454075	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGTAGGCGTGCTGTAT-1_8_E5	17.23432487	-4.813706511	12	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1226	1900	0.006315789	0.003684211	0	12	EN-MIX	NA	NA	NA
CGTAGGCTCCTGTAGA-1_8_E5	8.740448229	30.17363291	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	758	1108	0.003610108	0.005415162	0	oligos	OL-Cntl	NA	NA	NA
CGTCACTAGGGTCTCC-1_8_E5	-11.76511906	2.40591693	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4289	11226	0.008996971	0.006502761	0	13A	IN-VIP	NA	NA	NA
CGTCACTCATCACGTA-1_8_E5	19.31229252	24.11673802	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	968	1522	0.002628121	0.006570302	0	oligos	OL-Cntl	NA	NA	NA
CGTCACTGTCCAACTA-1_8_E5	-21.21482622	-28.19069279	6A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4608	14281	0.007142357	0.005671872	0	6A	IN-PV	NA	NA	NA
CGTCACTTCAAGGCTT-1_8_E5	20.00489835	12.47246794	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1386	2450	0	0.003265306	0	oligos	OL-Cntl	NA	NA	NA
CGTCAGGAGCCCAATT-1_8_E5	-0.367351709	-21.89184752	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4282	12111	0.005201883	0.004954174	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGTCAGGGTCAAGCGA-1_8_E5	28.87957469	-1.504340118	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3577	8522	0.004811077	0.004693734	0	2	EN-L4	NA	NA	NA
CGTCAGGGTGTTGGGA-1_8_E5	5.31872286	33.29138581	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	751	1080	0.009259259	0.006481481	0	oligos	OL-Cntl	NA	NA	NA
CGTCCATAGCATCATC-1_8_E5	9.71241673	32.67568152	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	786	1152	0.000868056	0.004340278	0	oligos	OL-Cntl	NA	NA	NA
CGTCCATCAAGCTGAG-1_8_E5	29.34293693	-0.529159028	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3186	7429	0.007807242	0.004172836	0	2	EN-L4	NA	NA	NA
CGTCCATGTCGGGTCT-1_8_E5	-0.505018793	-14.48096189	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2415	4830	0.004968944	0.004140787	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGTCCATGTCTGCCAG-1_8_E5	25.43823254	-2.595631966	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2926	6653	0.005711709	0.003306779	0	2	EN-L4	NA	NA	NA
CGTCCATGTTACGGAG-1_8_E5	4.794253922	27.51393429	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	799	1149	0.005221932	0.002610966	0	oligos	OL-Cntl	NA	NA	NA
CGTCCATGTTCCGGCA-1_8_E5	9.946609957	26.83208181	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	896	1365	0.002197802	0.004395604	0	oligos	OL-Cntl	NA	NA	NA
CGTCCATTCATCGCTC-1_8_E5	-26.25920337	18.87925176	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1273	2132	0.000938086	0.003752345	0	8	Astrocytes	NA	NA	NA
CGTCTACAGAAGGTTT-1_8_E5	8.22451852	-29.38233944	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5950	21362	0.008519802	0.004166277	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGTCTACGTGGTTTCA-1_8_E5	10.50630123	25.20661237	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	876	1403	0.003563792	0.011404134	0	oligos	OL-Cntl	NA	NA	NA
CGTCTACTCACCCTCA-1_8_E5	8.659973951	34.06873101	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	950	1419	0.003523608	0.000704722	0	oligos	OL-Cntl	NA	NA	NA
CGTGAGCAGGACAGCT-1_8_E5	4.445619352	-32.09656062	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5762	23230	0.000990099	0.002281533	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGTGAGCCAATGACCT-1_8_E5	-24.24884062	28.9109617	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1720	3056	0.00065445	0.002617801	0	8	Astrocytes	NA	NA	NA
CGTGAGCGTACTTAGC-1_8_E5	-38.50708067	-1.126861224	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1523	2679	0.007838746	0.003359462	0	9	OPC	NA	NA	NA
CGTGAGCGTCCGAAGA-1_8_E5	9.203400632	26.91501578	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	808	1130	0.001769912	0.005309735	0	oligos	OL-Cntl	NA	NA	NA
CGTGAGCTCAGTTTGG-1_8_E5	-25.85470038	27.09922067	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1519	2839	0.001761184	0.00317013	0	8	Astrocytes	NA	NA	NA
CGTGAGCTCCTTCAAT-1_8_E5	23.22801205	12.17360759	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1485	2569	0.00116777	0.003114052	0	oligos	OL-Cntl	NA	NA	NA
CGTGAGCTCGCTGATA-1_8_E5	-0.548796001	-14.46734082	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2334	4807	0.007697108	0.004992719	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGTGAGCTCTGCAAGT-1_8_E5	1.306236788	-30.18700673	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5686	19490	0.004617753	0.003181119	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGTGAGCTCTTCATGT-1_8_E5	-26.74132959	16.10963263	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1173	1894	0.001583949	0.003167899	0	8	Astrocytes	NA	NA	NA
CGTGTAAAGGAACTGC-1_8_E5	-31.82029833	0.451403768	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1872	3332	0.00210084	0.00240096	0	9	OPC	NA	NA	NA
CGTGTAAAGGGAACGG-1_8_E5	-35.43532489	-7.522299575	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1088	1662	0	0.002406739	0	9	OPC	NA	NA	NA
CGTGTAAAGTATTGGA-1_8_E5	-5.378670654	-1.636535016	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1588	2783	0.006827165	0.004311894	0	13A	IN-VIP	NA	NA	NA
CGTGTAACAATCACAC-1_8_E5	16.01045377	-33.15694327	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5398	18066	0.001826636	0.006310196	0	3	EN-L5-6	NA	NA	NA
CGTGTAACAATGGAGC-1_8_E5	-9.267243583	-18.5391837	6B	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	770	1218	0.000821018	0.001642036	0	6B	IN-SST	NA	NA	NA
CGTGTAATCTTATCTG-1_8_E5	3.750913938	-31.8759944	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5744	22525	0.005238624	0.002619312	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGTGTCTCAATGACCT-1_8_E5	27.3207587	-3.951780844	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3821	10449	0.013972629	0.002009762	0	2	EN-L4	NA	NA	NA
CGTGTCTCAGTGGGAT-1_8_E5	2.901493885	32.16015173	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	816	1135	0.007048458	0.004405286	0	oligos	OL-Cntl	NA	NA	NA
CGTGTCTGTAAGAGGA-1_8_E5	9.207670693	29.29902722	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	760	1142	0.00262697	0.007005254	0	oligos	OL-Cntl	NA	NA	NA
CGTGTCTGTCCGTCAG-1_8_E5	-1.508163426	-20.22274899	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3425	8821	0.002267317	0.002834146	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGTTAGAAGACTAAGT-1_8_E5	19.68956046	24.76232808	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1027	1623	0.002464572	0.001848429	0	oligos	OL-Cntl	NA	NA	NA
CGTTAGACAAACAACA-1_8_E5	-16.56173584	-10.87409333	13B	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3308	7515	0.012907518	0.004391218	0	13B	IN-SV2C	NA	NA	NA
CGTTAGACAGGATCGA-1_8_E5	9.132001599	21.59253916	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	826	1238	0.009693053	0.004846527	0	oligos	OL-Cntl	NA	NA	NA
CGTTAGAGTAGCGCTC-1_8_E5	8.352196508	33.27144405	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	919	1475	0.001355932	0.006779661	0	oligos	OL-Cntl	NA	NA	NA
CGTTAGATCACTCTTA-1_8_E5	19.98956947	24.37926478	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	999	1575	0.003174603	0.002539683	0	oligos	OL-Cntl	NA	NA	NA
CGTTCTGCATGAAGTA-1_8_E5	3.572956057	-30.57683451	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4265	12535	0.006461907	0.00095732	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CGTTCTGGTACAGACG-1_8_E5	-26.19366176	25.87358249	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1588	2791	0.005016123	0.007524185	0	8	Astrocytes	NA	NA	NA
CGTTCTGGTGAAAGAG-1_8_E5	-20.33798882	-26.33797777	6A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3442	8406	0.009992862	0.002974066	0	6A	IN-PV	NA	NA	NA
CGTTCTGTCCAAGCCG-1_8_E5	11.2453912	28.26323942	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	836	1322	0.005295008	0.003782148	0	oligos	OL-Cntl	NA	NA	NA
CGTTCTGTCGGAGGTA-1_8_E5	5.63212005	30.24458794	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	701	1007	0.001986097	0.003972195	0	oligos	OL-Cntl	NA	NA	NA
CGTTGGGAGACTCGGA-1_8_E5	29.35582162	-2.017725018	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4953	13999	0.009072077	0.004714622	0	2	EN-L4	NA	NA	NA
CGTTGGGAGAGCAATT-1_8_E5	-26.69766546	15.8938105	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1161	1916	0.001043841	0.002609603	0	8	Astrocytes	NA	NA	NA
CGTTGGGAGCTGCAAG-1_8_E5	-23.79487822	-0.794624987	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1462	2476	0.001615509	0.002827141	0	9	OPC	NA	NA	NA
CGTTGGGAGTTGTCGT-1_8_E5	19.61395319	1.785733416	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1334	2206	0.003626473	0.001359927	0	2	EN-L4	NA	NA	NA
CGTTGGGCAGCTGTTA-1_8_E5	-21.14518891	-27.96778437	6A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4618	14176	0.01601298	0.00239842	0	6A	IN-PV	NA	NA	NA
CGTTGGGTCTACTATC-1_8_E5	-0.454031317	-22.62009186	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4484	12948	0.006024096	0.00424776	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTAACTTAGACACTAA-1_8_E5	-26.05043233	18.93100374	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1350	2449	0.00204165	0.00204165	0	8	Astrocytes	NA	NA	NA
CTAACTTAGCCACCTG-1_8_E5	7.235215809	-33.34495261	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4570	15581	0.001797061	0.001540338	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTAACTTCACATCTTT-1_8_E5	19.1523279	25.31867257	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1045	1665	0.003603604	0.004204204	0	oligos	OL-Cntl	NA	NA	NA
CTAACTTCATACTACG-1_8_E5	0.725288862	-29.86750807	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4765	16218	0.000986558	0.002096436	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTAACTTGTCGCGGTT-1_8_E5	11.00508541	-8.9435565	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3045	7773	0.002187058	0.002058407	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTAACTTTCCTGCCAT-1_8_E5	8.903388994	33.23239477	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	936	1430	0.003496503	0.000699301	0	oligos	OL-Cntl	NA	NA	NA
CTAAGACAGATCACGG-1_8_E5	23.04838333	-0.593932506	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2337	4660	0.006652361	0.003862661	0	2	EN-L4	NA	NA	NA
CTAAGACGTTATCCGA-1_8_E5	5.237896231	-32.41854926	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5535	21714	0.001980289	0.001888183	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTAAGACTCCTACAGA-1_8_E5	20.56004761	24.91024691	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	992	1528	0.003926702	0.001963351	0	oligos	OL-Cntl	NA	NA	NA
CTAATGGAGAGTACAT-1_8_E5	12.46588162	1.549992436	12	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	711	1080	0.030555556	0.00462963	0	12	EN-MIX	NA	NA	NA
CTAATGGCACGTTGGC-1_8_E5	-26.64444325	15.77822272	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1244	2102	0.001427212	0.00190295	0	8	Astrocytes	NA	NA	NA
CTAATGGGTCACTGGC-1_8_E5	-25.48736258	30.15239451	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1789	3289	0	0.00243235	0	8	Astrocytes	NA	NA	NA
CTAATGGGTGTTAAGA-1_8_E5	-1.16772033	-19.80989498	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2896	6664	0.003451381	0.003451381	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTAATGGTCTTAACCT-1_8_E5	26.51055592	-5.457673499	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	6142	23475	0.004600639	0.003280085	0	2	EN-L4	NA	NA	NA
CTACACCAGTCCATAC-1_8_E5	7.515317416	30.24293203	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	723	1104	0.004528986	0.004528986	0	oligos	OL-Cntl	NA	NA	NA
CTACACCAGTTACGGG-1_8_E5	7.87806403	30.48822925	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	691	1027	0.00194742	0.00097371	0	oligos	OL-Cntl	NA	NA	NA
CTACACCCAAAGCGGT-1_8_E5	7.622775907	33.26155763	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	808	1129	0.006200177	0.006200177	0	oligos	OL-Cntl	NA	NA	NA
CTACACCCAGATAATG-1_8_E5	10.59903071	33.06402076	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	854	1218	0.007389163	0.003284072	0	oligos	OL-Cntl	NA	NA	NA
CTACACCGTAGGCATG-1_8_E5	5.656969099	32.90327176	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	783	1121	0.002676182	0.004460303	0	oligos	OL-Cntl	NA	NA	NA
CTACACCGTTGAGGTG-1_8_E5	10.20471784	33.49191429	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	826	1162	0.005163511	0.002581756	0	oligos	OL-Cntl	NA	NA	NA
CTACACCTCTTGCAAG-1_8_E5	-13.1293941	19.40298789	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1995	3787	0.005281225	0.00422498	0	8	Astrocytes	NA	NA	NA
CTACATTAGGCTATCT-1_8_E5	-12.11664468	-19.44330975	6B	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1049	1739	0.012075906	0.002300173	0	6B	IN-SST	NA	NA	NA
CTACATTAGTCCCACG-1_8_E5	4.666080767	-32.72324477	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5459	21911	0.000182557	0.002418876	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTACATTGTAAATGTG-1_8_E5	2.96568417	-24.56532025	4	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4956	14900	0.00442953	0.002348993	0	L2-3	EN-L2-3-MS	NA	NA	NA
CTACATTTCACGCATA-1_8_E5	16.45859807	-32.85653035	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	7015	39153	0.003958828	0.003524634	0	3	EN-L5-6	NA	NA	NA
CTACATTTCTGCTGTC-1_8_E5	10.73871847	27.59187785	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	854	1377	0.001452433	0.004357298	0	oligos	OL-Cntl	NA	NA	NA
CTACCCAAGTCCAGGA-1_8_E5	25.51440478	-2.730989138	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3149	8046	0.006711409	0.002237136	0	2	EN-L4	NA	NA	NA
CTACCCACAAAGGTGC-1_8_E5	1.421037195	-27.51006612	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3670	10077	0.001190831	0.003274784	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTACCCACACTTCTGC-1_8_E5	-23.7690644	29.64208931	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2049	4097	0.000488162	0.002928972	0	8	Astrocytes	NA	NA	NA
CTACCCAGTCGATTGT-1_8_E5	21.10813786	-29.37526835	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5260	17033	0.009980626	0.004227089	0	3	EN-L5-6	NA	NA	NA
CTACCCAGTGCACTTA-1_8_E5	25.28638374	-27.67520404	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3211	7457	0.007777927	0.004559474	0	3	EN-L5-6	NA	NA	NA
CTACCCAGTGTATGGG-1_8_E5	-26.68860676	15.33637156	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1209	2001	0.00149925	0.002498751	0	8	Astrocytes	NA	NA	NA
CTACCCATCAGTACGT-1_8_E5	-37.27184135	2.982610612	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2056	4108	0.003894839	0.004868549	0	9	OPC	NA	NA	NA
CTACCCATCTTACCTA-1_8_E5	28.46082666	-1.639540418	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4277	11973	0.005930009	0.004092542	0	2	EN-L4	NA	NA	NA
CTACGTCCATGGTCTA-1_8_E5	23.47523627	-9.259619763	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4351	13233	0.005818786	0.00392957	0	3	EN-L5-6	NA	NA	NA
CTACGTCGTTGCGCAC-1_8_E5	-37.48835629	0.816437728	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1697	3134	0.003828973	0.001914486	0	9	OPC	NA	NA	NA
CTAGAGTAGTGATCGG-1_8_E5	7.194659184	-30.94406661	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4678	14243	0.006178474	0.002878607	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTAGAGTCAAAGGCGT-1_8_E5	8.554834906	32.32320762	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	751	1138	0.001757469	0.001757469	0	oligos	OL-Cntl	NA	NA	NA
CTAGAGTGTGAGTATA-1_8_E5	-1.008721075	-13.49062277	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2136	4449	0.010339402	0.004045853	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTAGAGTGTGCCTGGT-1_8_E5	-36.53972925	-7.788836656	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1103	1785	0.007282913	0.001120448	0	9	OPC	NA	NA	NA
CTAGAGTGTTGGACCC-1_8_E5	-9.707313079	22.33493185	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1154	1668	0.011990408	0.001798561	0	8	Astrocytes	NA	NA	NA
CTAGAGTTCTGGAGCC-1_8_E5	-37.7770307	1.370791229	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1584	2770	0.002888087	0.002888087	0	9	OPC	NA	NA	NA
CTAGCCTAGGACCACA-1_8_E5	1.866181233	-30.9473272	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5669	20492	0.004538356	0.002244778	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTAGCCTAGGCCGAAT-1_8_E5	-17.49227304	-26.85039728	6A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2538	6322	0.012970579	0.002214489	0	6A	IN-PV	NA	NA	NA
CTAGCCTGTCACACGC-1_8_E5	9.680130496	27.38160973	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	966	1443	0.006930007	0.004158004	0	oligos	OL-Cntl	NA	NA	NA
CTAGCCTGTGACTCAT-1_8_E5	17.1233145	17.61264552	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1063	1801	0.001110494	0.004441977	0	oligos	OL-Cntl	NA	NA	NA
CTAGCCTGTGGACGAT-1_8_E5	7.913617246	-31.43987435	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	6431	25521	0.008267701	0.002507739	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTAGCCTTCGCAAGCC-1_8_E5	23.06648806	-0.84064746	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2688	5958	0.002349782	0.003356831	0	2	EN-L4	NA	NA	NA
CTAGTGACAACGCACC-1_8_E5	25.7309456	-5.070838877	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	6672	31108	0.003182461	0.003053877	0	2	EN-L4	NA	NA	NA
CTAGTGACAAGGCTCC-1_8_E5	-10.41268853	18.14744148	11	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2250	4365	0.002290951	0.002061856	0	11	Glia-MIX	NA	NA	NA
CTAGTGACAGACGCCT-1_8_E5	3.95729056	31.04849113	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	743	1082	0.001848429	0.009242144	0	oligos	OL-Cntl	NA	NA	NA
CTAGTGACAGATCCAT-1_8_E5	4.931069681	-5.380285225	12	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1109	1819	0.096206707	0.001099505	0	12	EN-MIX	NA	NA	NA
CTAGTGAGTCCAACTA-1_8_E5	16.21527794	1.832060484	12	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	776	1179	0.065309584	0.003392706	0	12	EN-MIX	NA	NA	NA
CTAGTGAGTTAAGTAG-1_8_E5	6.114219063	34.38855496	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	748	1074	0.001862197	0.000931099	0	oligos	OL-Cntl	NA	NA	NA
CTAGTGATCCCTTGCA-1_8_E5	-5.325162015	-11.03427654	6B	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	780	1321	0.011355034	0.001514005	0	6B	IN-SST	NA	NA	NA
CTCACACAGAACAATC-1_8_E5	-27.06176796	15.79124863	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1116	1891	0.002644104	0.003172924	0	8	Astrocytes	NA	NA	NA
CTCACACCACAGGCCT-1_8_E5	-14.44347796	-7.353669197	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2912	6735	0.005345212	0.003860431	0	13A	IN-VIP	NA	NA	NA
CTCACACCACATGACT-1_8_E5	28.17341443	-5.687250346	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5752	19140	0.009456635	0.005433647	0	2	EN-L4	NA	NA	NA
CTCACACCAGGGCATA-1_8_E5	-38.54817271	1.919450069	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1583	3083	0.001621797	0.000973078	0	9	OPC	NA	NA	NA
CTCACACCAGTCGATT-1_8_E5	-1.240731219	-19.34662045	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2706	5988	0.011022044	0.002672011	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTCACACGTCACTGGC-1_8_E5	8.123576566	32.75380316	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	840	1231	0.005686434	0.006498781	0	oligos	OL-Cntl	NA	NA	NA
CTCACACTCATGTCTT-1_8_E5	8.007241802	34.06544966	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	775	1158	0.002590674	0.005181347	0	oligos	OL-Cntl	NA	NA	NA
CTCACACTCCTGTACC-1_8_E5	20.68070174	21.90997328	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1108	1794	0.002229654	0.002787068	0	oligos	OL-Cntl	NA	NA	NA
CTCACACTCGCTGATA-1_8_E5	-23.14104974	26.07925737	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1862	3377	0.002072846	0.004737933	0	8	Astrocytes	NA	NA	NA
CTCAGAAAGACTGTAA-1_8_E5	28.45758056	-2.575276761	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4164	10769	0.003064351	0.003435788	0	2	EN-L4	NA	NA	NA
CTCAGAACAGGGTTAG-1_8_E5	-25.83190773	19.42168191	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1358	2412	0.002072968	0.002902156	0	8	Astrocytes	NA	NA	NA
CTCAGAAGTCCGCTGA-1_8_E5	11.36877435	32.48542436	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	855	1282	0.012480499	0.001560062	0	oligos	OL-Cntl	NA	NA	NA
CTCAGAATCATCTGCC-1_8_E5	-17.13589016	-11.10348008	13B	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5270	17764	0.008106282	0.003546499	0	13B	IN-SV2C	NA	NA	NA
CTCAGAATCGTGGGAA-1_8_E5	25.97445346	-27.97679488	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4866	15972	0.00870273	0.005447032	0	3	EN-L5-6	NA	NA	NA
CTCATTAAGGAGCGAG-1_8_E5	26.02551891	-2.611660345	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3396	8759	0.001940861	0.003425049	0	2	EN-L4	NA	NA	NA
CTCATTATCAACCAAC-1_8_E5	-37.77006508	2.437572917	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1722	3243	0.002158495	0.001850139	0	9	OPC	NA	NA	NA
CTCATTATCGCAAGCC-1_8_E5	18.16015471	23.15663614	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	865	1340	0.008208955	0.003731343	0	oligos	OL-Cntl	NA	NA	NA
CTCCTAGAGCTCCTCT-1_8_E5	-39.32575973	-0.761924253	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1481	2691	0.000743218	0.004830918	0	9	OPC	NA	NA	NA
CTCCTAGCAAGAAGAG-1_8_E5	-1.104192445	-22.00543354	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3967	10883	0.002664706	0.004686208	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTCCTAGCATAACCTG-1_8_E5	19.00274235	25.0817675	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	945	1506	0.005976096	0.002656042	0	oligos	OL-Cntl	NA	NA	NA
CTCCTAGTCACAACGT-1_8_E5	-24.21895063	31.05809082	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2060	3967	0.001260398	0.004537434	0	8	Astrocytes	NA	NA	NA
CTCCTAGTCAGTTTGG-1_8_E5	-26.14659208	29.8010769	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1867	3480	0.000574713	0.002586207	0	8	Astrocytes	NA	NA	NA
CTCCTAGTCCATGAAC-1_8_E5	1.026145869	-11.49167909	12	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2195	5011	0.007383756	0.004589902	0	12	EN-MIX	NA	NA	NA
CTCCTAGTCCATGCTC-1_8_E5	-23.49202222	30.2143555	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1938	3874	0.008260196	0.003097574	0	8	Astrocytes	NA	NA	NA
CTCGAAAAGGGAAACA-1_8_E5	-6.070494648	33.66752257	17	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	929	1269	0.019700552	0.00394011	0	oligos	OL-MS-2	NA	NA	NA
CTCGAAAAGTGGAGTC-1_8_E5	8.978664734	31.8764595	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	767	1181	0.00338696	0.00592718	0	oligos	OL-Cntl	NA	NA	NA
CTCGAAATCGTTACAG-1_8_E5	0.401955883	-27.43103956	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4456	13263	0.004523863	0.002111136	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTCGAAATCTCTAGGA-1_8_E5	16.81797946	-30.67985682	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	6440	26323	0.006078335	0.003457053	0	3	EN-L5-6	NA	NA	NA
CTCGAGGCACACCGAC-1_8_E5	0.232686593	-27.90511461	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	6383	26899	0.010037548	0.002119038	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTCGAGGCATGATCCA-1_8_E5	-0.494109827	-18.91357709	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2758	5746	0.005221023	0.004350853	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTCGAGGTCGAACGGA-1_8_E5	-39.06474577	-3.596769901	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1280	2149	0.001861331	0.002326664	0	9	OPC	NA	NA	NA
CTCGAGGTCGGCTACG-1_8_E5	27.14016477	-0.889909513	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3876	10597	0.004152119	0.002359158	0	2	EN-L4	NA	NA	NA
CTCGGAGAGGCAAAGA-1_8_E5	-31.73826014	-0.549689667	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1625	2733	0.006586169	0.002927186	0	9	OPC	NA	NA	NA
CTCGGAGGTCCAGTGC-1_8_E5	-35.43338035	5.154848914	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2679	5787	0.004147227	0.002246414	0	9	OPC	NA	NA	NA
CTCGGAGGTCGACTGC-1_8_E5	-19.81628024	-18.32064194	6B	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2941	6834	0.01038923	0.005999415	0	6B	IN-SST	NA	NA	NA
CTCGGAGTCAAGGTAA-1_8_E5	-38.85754512	-0.516853513	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1440	2497	0.000800961	0.003604325	0	9	OPC	NA	NA	NA
CTCGGAGTCACTTATC-1_8_E5	-37.6306491	2.496413179	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1777	3340	0.007185629	0.00239521	0	9	OPC	NA	NA	NA
CTCGGAGTCCTCATTA-1_8_E5	-1.398244937	-22.22616586	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3779	10395	0.003078403	0.002693603	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTCGGAGTCGTTTGCC-1_8_E5	-26.85608534	14.54018489	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1005	1550	0.004516129	0.010322581	0	8	Astrocytes	NA	NA	NA
CTCGGGAAGTTCGCGC-1_8_E5	4.904894415	-30.31243377	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3172	6850	0.002481752	0.004233577	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTCGGGACAGTCGTGC-1_8_E5	-24.4506008	30.39768466	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1799	3394	0.00117855	0.003535651	0	8	Astrocytes	NA	NA	NA
CTCGGGATCGTGGTCG-1_8_E5	-18.17731905	-21.93863857	6A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2325	5158	0.01240791	0.00213261	0	6A	IN-PV	NA	NA	NA
CTCGGGATCTGCTTGC-1_8_E5	-12.85817802	-19.34696315	6B	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1086	1803	0.031613977	0.003882418	0	6B	IN-SST	NA	NA	NA
CTCGTACAGAACTCGG-1_8_E5	26.92590909	-0.806798308	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3180	7488	0.003739316	0.003472222	0	2	EN-L4	NA	NA	NA
CTCGTACAGTGGCACA-1_8_E5	10.76348593	32.97725093	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	924	1365	0.002930403	0.003663004	0	oligos	OL-Cntl	NA	NA	NA
CTCGTACCAATCCAAC-1_8_E5	-0.292109675	-19.26076809	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2959	6666	0.008850885	0.003750375	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTCGTACCACCCAGTG-1_8_E5	-16.75369159	-10.9724264	13B	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3787	10415	0.005760922	0.004704753	0	13B	IN-SV2C	NA	NA	NA
CTCGTACCAGCTGGCT-1_8_E5	-15.55331752	-19.28706166	6B	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1586	3147	0.017159199	0.002542104	0	6B	IN-SST	NA	NA	NA
CTCGTACGTAGAAGGA-1_8_E5	-23.00965707	-25.60406816	6A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3979	10624	0.0234375	0.005835843	0	6A	IN-PV	NA	NA	NA
CTCGTACGTATTCGTG-1_8_E5	24.18722685	-6.505976655	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5610	16392	0.016654466	0.004819424	0	2	EN-L4	NA	NA	NA
CTCGTACGTCAAAGCG-1_8_E5	-35.27619851	-3.838444681	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1396	2250	0.004	0.002666667	0	9	OPC	NA	NA	NA
CTCGTACGTTGAGTTC-1_8_E5	-7.921046921	-1.378070861	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2157	4160	0.035096154	0.004807692	0	13A	IN-VIP	NA	NA	NA
CTCGTACGTTTGACAC-1_8_E5	1.230761358	-12.44609869	12	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2112	4070	0.007371007	0.005651106	0	12	EN-MIX	NA	NA	NA
CTCGTACTCAATAAGG-1_8_E5	19.1819301	0.259049965	12	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1475	2855	0.00385289	0.00385289	0	12	EN-MIX	NA	NA	NA
CTCGTACTCTCTGTCG-1_8_E5	23.66737681	-9.382370119	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4147	11389	0.003073141	0.005619457	0	3	EN-L5-6	NA	NA	NA
CTCGTACTCTTGACGA-1_8_E5	-22.37057029	31.5666581	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2910	6571	0.001065287	0.002130574	0	8	Astrocytes	NA	NA	NA
CTCGTCATCACGACTA-1_8_E5	22.26453979	13.68837149	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1320	2362	0.00084674	0.00084674	0	oligos	OL-Cntl	NA	NA	NA
CTCGTCATCACTATTC-1_8_E5	16.09133513	11.74779318	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1336	2308	0.006499133	0.004332756	0	oligos	OL-Cntl	NA	NA	NA
CTCGTCATCAGGATCT-1_8_E5	31.79974943	-1.612244138	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2900	6278	0.004300733	0.005575024	0	2	EN-L4	NA	NA	NA
CTCGTCATCCACGTTC-1_8_E5	18.57158267	13.05779954	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1297	2238	0.00178731	0.002234138	0	oligos	OL-Cntl	NA	NA	NA
CTCTAATAGGCGCTCT-1_8_E5	5.359991375	-32.27161104	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5570	20391	0.004462753	0.002893433	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTCTAATAGTGTCTCA-1_8_E5	10.2408556	26.2656694	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	898	1340	0.000746269	0.004477612	0	oligos	OL-Cntl	NA	NA	NA
CTCTAATCACCACGTG-1_8_E5	27.74947797	-5.143185766	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4727	15007	0.010195242	0.003598321	0	2	EN-L4	NA	NA	NA
CTCTAATCAGTTTACG-1_8_E5	-1.921177626	-21.58092625	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3147	7987	0.004507324	0.00325529	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTCTAATCATGACATC-1_8_E5	-18.91011906	9.187412977	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	706	1003	0.005982054	0.003988036	0	8	Astrocytes	NA	NA	NA
CTCTAATGTCTCTCTG-1_8_E5	11.55931098	26.83639861	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	883	1403	0.024233785	0.000712758	0	oligos	OL-Cntl	NA	NA	NA
CTCTAATGTGGAAAGA-1_8_E5	-28.41383786	22.79807976	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1177	2045	0.00195599	0.002444988	0	8	Astrocytes	NA	NA	NA
CTCTAATGTTCCACAA-1_8_E5	9.793154089	27.20615026	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	900	1387	0.005046864	0.005046864	0	oligos	OL-Cntl	NA	NA	NA
CTCTAATGTTGCGCAC-1_8_E5	-12.0333183	-21.06126902	6A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1232	2399	0.010837849	0.001667361	0	6A	IN-PV	NA	NA	NA
CTCTAATGTTGGTTTG-1_8_E5	28.41951723	-1.547295712	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4245	11494	0.003567078	0.003045067	0	2	EN-L4	NA	NA	NA
CTCTAATTCACCCGAG-1_8_E5	-19.02547953	-25.04081479	6A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3095	7202	0.00430436	0.005276312	0	6A	IN-PV	NA	NA	NA
CTCTAATTCGGATGTT-1_8_E5	10.73406494	26.26368706	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	818	1220	0.002459016	0.002459016	0	oligos	OL-Cntl	NA	NA	NA
CTCTAATTCTGCGGCA-1_8_E5	29.44945129	-5.003372829	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3660	9145	0.013340623	0.003280481	0	2	EN-L4	NA	NA	NA
CTCTACGAGTAGCGGT-1_8_E5	-23.3151463	-24.95108994	6A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4552	13551	0.053280201	0.00376356	0	6A	IN-PV	NA	NA	NA
CTCTACGCAAGCGAGT-1_8_E5	5.792357635	30.97482037	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	851	1196	0.008361204	0.006688963	0	oligos	OL-Cntl	NA	NA	NA
CTCTACGTCATTGCGA-1_8_E5	-25.98953027	19.20797053	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1479	2561	0.00468567	0.005857087	0	8	Astrocytes	NA	NA	NA
CTCTACGTCTTAACCT-1_8_E5	-20.26875028	-29.10251462	6A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4405	13197	0.004394938	0.003258316	0	6A	IN-PV	NA	NA	NA
CTCTGGTCAAGTTGTC-1_8_E5	-35.90347537	-3.495775941	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1305	2117	0.008974965	0.001889466	0	9	OPC	NA	NA	NA
CTCTGGTCATTAACCG-1_8_E5	8.535220707	31.72343175	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	773	1254	0.003987241	0.003987241	0	oligos	OL-Cntl	NA	NA	NA
CTCTGGTGTATAGTAG-1_8_E5	-1.824772239	-19.98942652	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2980	7251	0.003034064	0.002206592	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTCTGGTGTATGAAAC-1_8_E5	-16.74769178	-10.98711133	13B	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3734	10086	0.011104501	0.002280389	0	13B	IN-SV2C	NA	NA	NA
CTCTGGTGTCCTCTTG-1_8_E5	-1.013435939	-22.11693089	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4102	11535	0.005635024	0.003467707	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTCTGGTTCGGATGGA-1_8_E5	25.39477681	-28.15693276	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4285	13182	0.002275831	0.003110302	0	3	EN-L5-6	NA	NA	NA
CTGAAACAGGGTCGAT-1_8_E5	-35.77682704	-3.971051008	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1310	2158	0.009267841	0.001853568	0	9	OPC	NA	NA	NA
CTGAAACAGTTTGCGT-1_8_E5	1.803096426	-30.59075302	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5399	19836	0.005041339	0.002419843	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTGAAACCATCCCATC-1_8_E5	22.29419119	20.86142421	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1145	1849	0.011357491	0.003244997	0	oligos	OL-Cntl	NA	NA	NA
CTGAAACGTAGCGCTC-1_8_E5	-23.14136435	31.10035904	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2434	5050	0.001782178	0.001782178	0	8	Astrocytes	NA	NA	NA
CTGAAGTAGGTTCCTA-1_8_E5	-38.01864113	2.764556337	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1852	3608	0.001385809	0.001662971	0	9	OPC	NA	NA	NA
CTGAAGTCAGGGTATG-1_8_E5	-1.503528235	-21.31351304	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3396	8472	0.007790368	0.003659112	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTGAAGTGTAAATGTG-1_8_E5	28.93319304	-1.097247638	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3146	7237	0.005388973	0.006079867	0	2	EN-L4	NA	NA	NA
CTGAAGTGTATAATGG-1_8_E5	14.86210517	1.707346506	12	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	950	1601	0.003747658	0.010618364	0	12	EN-MIX	NA	NA	NA
CTGAAGTGTCAAGCGA-1_8_E5	30.69759337	-7.732573408	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4602	12066	0.016907011	0.006630201	0	2	EN-L4	NA	NA	NA
CTGAAGTTCCGAGCCA-1_8_E5	-0.964483649	-21.01445878	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3374	8188	0.005740107	0.004152418	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTGAAGTTCGCATGAT-1_8_E5	18.97775804	13.58564105	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1203	2138	0.007015903	0.005612722	0	oligos	OL-Cntl	NA	NA	NA
CTGATAGAGCTGATAA-1_8_E5	-26.2293839	-5.909318011	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1197	1859	0.004841313	0.003227542	0	9	OPC	NA	NA	NA
CTGATAGAGTGTACGG-1_8_E5	4.189431661	32.68520904	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	753	1018	0.014734774	0.006876228	0	oligos	OL-Cntl	NA	NA	NA
CTGATAGCAGCTCGAC-1_8_E5	-37.89433878	-0.285222254	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1385	2340	0.009401709	0.000854701	0	9	OPC	NA	NA	NA
CTGATAGCAGTAACGG-1_8_E5	-19.35937861	-24.37307042	6A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3196	8298	0.01120752	0.005784526	0	6A	IN-PV	NA	NA	NA
CTGATAGTCACGAAGG-1_8_E5	-23.95717667	30.35535713	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1936	3732	0.000535906	0.002947481	0	8	Astrocytes	NA	NA	NA
CTGATAGTCCACGACG-1_8_E5	7.842492196	-32.18142268	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5237	17348	0.002593959	0.004035047	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTGATAGTCCCTTGTG-1_8_E5	-29.73415054	-13.30190173	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	717	1106	0.004520796	0.002712477	0	9	OPC	NA	NA	NA
CTGATCCAGAGATGAG-1_8_E5	-37.27817751	0.46214584	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1613	2867	0.001743983	0.004883153	0	9	OPC	NA	NA	NA
CTGATCCAGTCCAGGA-1_8_E5	4.188817629	21.89883068	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	877	1308	0.006880734	0.008409786	0	oligos	OL-Cntl	NA	NA	NA
CTGATCCCACTTCGAA-1_8_E5	14.72790154	-33.70232592	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4785	15528	0.001416795	0.004829985	0	3	EN-L5-6	NA	NA	NA
CTGATCCCAGTATCTG-1_8_E5	11.71346658	28.54280946	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	865	1384	0.005057803	0.00216763	0	oligos	OL-Cntl	NA	NA	NA
CTGATCCGTACACCGC-1_8_E5	14.84716915	-33.67242501	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4878	17609	0.005622125	0.002328355	0	3	EN-L5-6	NA	NA	NA
CTGATCCGTGGGTATG-1_8_E5	-13.68060099	-19.35775145	6B	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1325	2351	0.030199915	0.005529562	0	6B	IN-SST	NA	NA	NA
CTGATCCGTTGTCGCG-1_8_E5	18.92644589	12.617585	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1306	2160	0.001388889	0.005555556	0	oligos	OL-Cntl	NA	NA	NA
CTGCCTAAGCAGCGTA-1_8_E5	-1.729601165	-19.86188149	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3050	7375	0.007728814	0.003118644	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTGCCTAAGTACATGA-1_8_E5	-17.13581371	-23.61719228	6A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1937	4272	0.001872659	0.001170412	0	6A	IN-PV	NA	NA	NA
CTGCCTAAGTGCCATT-1_8_E5	1.659822596	-17.11310974	4	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2650	5674	0.014628128	0.003877335	0	L2-3	EN-L2-3-MS	NA	NA	NA
CTGCCTACAGGCAGTA-1_8_E5	1.950296292	-30.99635695	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5573	20351	0.002948258	0.002555157	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTGCCTAGTAAGCACG-1_8_E5	25.96434832	-4.352625771	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4156	11945	0.002009209	0.003264964	0	2	EN-L4	NA	NA	NA
CTGCCTAGTCATGCCG-1_8_E5	2.426017347	-27.7167962	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4170	12318	0.000893002	0.003734372	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTGCCTAGTTAAAGTG-1_8_E5	1.004773613	-10.50112572	12	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1904	4274	0.001169864	0.002807674	0	12	EN-MIX	NA	NA	NA
CTGCCTATCGCCTGTT-1_8_E5	-6.78222453	-0.555678553	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2104	4591	0.00348508	0.002395992	0	13A	IN-VIP	NA	NA	NA
CTGCGGAAGAAGGGTA-1_8_E5	-1.058589766	-20.75652689	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3431	8409	0.003686526	0.002854085	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTGCGGAAGGAGTTTA-1_8_E5	-0.611957953	-14.11557471	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2236	4527	0.010823945	0.003534349	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTGCGGAAGTTCGATC-1_8_E5	-24.68439151	28.88925665	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1719	3261	0.002146581	0.00275989	0	8	Astrocytes	NA	NA	NA
CTGCGGACAGCTTAAC-1_8_E5	-25.73964213	20.43219504	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1528	2717	0.002576371	0.004048583	0	8	Astrocytes	NA	NA	NA
CTGCGGACAGTTCCCT-1_8_E5	-3.557605776	-7.513175395	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	781	1105	0.019909502	0.004524887	0	13A	IN-VIP	NA	NA	NA
CTGCGGACAGTTTACG-1_8_E5	-10.16651418	1.758728177	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2685	5795	0.014150129	0.004831752	0	13A	IN-VIP	NA	NA	NA
CTGCGGACATATGAGA-1_8_E5	-1.561740264	-19.72348601	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2977	6867	0.005388088	0.004223096	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTGCGGAGTAACGTTC-1_8_E5	6.555022115	31.56261671	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	812	1186	0.005059022	0.011804384	0	oligos	OL-Cntl	NA	NA	NA
CTGCGGAGTACGCACC-1_8_E5	21.37220709	-29.2429463	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4502	13104	0.003357753	0.005876068	0	3	EN-L5-6	NA	NA	NA
CTGCGGAGTCGTCTTC-1_8_E5	27.05876741	-4.137169608	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4092	11336	0.002470007	0.004410727	0	2	EN-L4	NA	NA	NA
CTGCGGAGTTAAGAAC-1_8_E5	18.9294701	9.004232677	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1635	3152	0.006662437	0.004124365	0	oligos	OL-Cntl	NA	NA	NA
CTGCGGATCCGCATAA-1_8_E5	-25.94426397	30.02286877	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1786	3326	0.003006615	0.001503307	0	8	Astrocytes	NA	NA	NA
CTGCGGATCTGTGCAA-1_8_E5	28.85276115	-1.179462729	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3085	6777	0.011066844	0.003688948	0	2	EN-L4	NA	NA	NA
CTGCTGTCACTTCTGC-1_8_E5	-38.67322623	1.463083614	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1523	2717	0.001472212	0.003312477	0	9	OPC	NA	NA	NA
CTGCTGTCAGACGCAA-1_8_E5	-8.827583647	-18.53566017	6B	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	741	1148	0.052264808	0.00087108	0	6B	IN-SST	NA	NA	NA
CTGCTGTCATTTGCTT-1_8_E5	26.15398915	-4.281476031	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4304	13076	0.005123891	0.002753136	0	2	EN-L4	NA	NA	NA
CTGCTGTGTAAAGGAG-1_8_E5	8.266851902	-32.02326076	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3857	9729	0.008839552	0.003083565	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTGCTGTGTATAATGG-1_8_E5	-16.24650718	-18.52188112	6B	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1710	3103	0.016435707	0.002255881	0	6B	IN-SST	NA	NA	NA
CTGCTGTGTGCAGTAG-1_8_E5	-35.49166742	-7.48516781	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1164	1815	0.004407713	0.003856749	0	9	OPC	NA	NA	NA
CTGCTGTTCCAAGTAC-1_8_E5	9.945044967	32.50902351	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	922	1435	0.008362369	0.003484321	0	oligos	OL-Cntl	NA	NA	NA
CTGCTGTTCCGAACGC-1_8_E5	-13.94192136	-10.12236578	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2371	5325	0.021784038	0.002253521	0	13A	IN-VIP	NA	NA	NA
CTGGTCTCAATAGCAA-1_8_E5	29.45432919	-1.874850126	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4529	12659	0.007425547	0.00639861	0	2	EN-L4	NA	NA	NA
CTGGTCTCACACGCTG-1_8_E5	-1.803579856	-16.91305639	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2514	5299	0.004717871	0.002075863	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTGGTCTCACATAACC-1_8_E5	1.073068576	35.34274096	17	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	718	1003	0.007976072	0.004985045	0	oligos	OL-MS-2	NA	NA	NA
CTGGTCTCACATTAGC-1_8_E5	19.94463089	20.78685543	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	990	1635	0.001223242	0.003058104	0	oligos	OL-Cntl	NA	NA	NA
CTGGTCTCAGCTGGCT-1_8_E5	-23.43645283	30.94553543	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2085	4314	0.00069541	0.002781641	0	8	Astrocytes	NA	NA	NA
CTGGTCTCATCGGTTA-1_8_E5	-1.452373864	-22.23506173	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4041	12125	0.005113402	0.003463918	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTGGTCTCATTCCTCG-1_8_E5	-38.24051421	2.834951282	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1702	3213	0.006847183	0.000933707	0	9	OPC	NA	NA	NA
CTGGTCTCATTCGACA-1_8_E5	9.575471729	31.60513605	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	804	1201	0.003330558	0.003330558	0	oligos	OL-Cntl	NA	NA	NA
CTGGTCTGTCTGATTG-1_8_E5	9.833972842	27.61446356	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	864	1361	0.003673769	0.005143277	0	oligos	OL-Cntl	NA	NA	NA
CTGGTCTGTTCCGGCA-1_8_E5	-38.50275036	-0.896553763	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1452	2530	0.002766798	0.001976285	0	9	OPC	NA	NA	NA
CTGGTCTTCCTACAGA-1_8_E5	9.820341853	29.08565116	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	833	1286	0.003888025	0.00311042	0	oligos	OL-Cntl	NA	NA	NA
CTGTGCTCAACTTGAC-1_8_E5	27.23353227	-3.341247911	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3663	9195	0.006525285	0.002175095	0	2	EN-L4	NA	NA	NA
CTGTGCTCAATGTTGC-1_8_E5	15.59590876	-7.799507394	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2067	4164	0.005763689	0.003362152	0	3	EN-L5-6	NA	NA	NA
CTGTGCTCAGCGAACA-1_8_E5	14.23382777	-1.148655673	12	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1064	2232	0.002240143	0.002240143	0	12	EN-MIX	NA	NA	NA
CTGTGCTGTATTCGTG-1_8_E5	7.847992329	30.79983895	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	783	1139	0.000877963	0.003511853	0	oligos	OL-Cntl	NA	NA	NA
CTGTTTAAGCCTTGAT-1_8_E5	-1.611275196	-25.7701832	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4995	17810	0.001066816	0.001403706	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTGTTTAAGTCAATAG-1_8_E5	-18.15254836	-18.01453784	6B	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2303	4936	0.007293355	0.002228525	0	6B	IN-SST	NA	NA	NA
CTGTTTACAGTTCATG-1_8_E5	-6.497626567	-0.981499571	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1826	3397	0.012952605	0.001471887	0	13A	IN-VIP	NA	NA	NA
CTGTTTACATAAAGGT-1_8_E5	4.200141972	32.95427112	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	777	1095	0.005479452	0.00456621	0	oligos	OL-Cntl	NA	NA	NA
CTGTTTACATTAGCCA-1_8_E5	18.9158684	21.44716615	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	990	1642	0.002436054	0.000609013	0	oligos	OL-Cntl	NA	NA	NA
CTGTTTAGTCCTCCAT-1_8_E5	27.63192676	-1.900177056	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3684	9314	0.008481855	0.002791497	0	2	EN-L4	NA	NA	NA
CTGTTTATCGTCACGG-1_8_E5	-18.46542262	-29.05468199	6A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4644	14620	0.003009576	0.003351573	0	6A	IN-PV	NA	NA	NA
CTTAACTAGAGACGAA-1_8_E5	-5.247054421	-1.966627279	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1722	3252	0.005842558	0.002152522	0	13A	IN-VIP	NA	NA	NA
CTTAACTCAATCCGAT-1_8_E5	-20.04620279	-29.21665873	6A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4530	15545	0.000514635	0.002187198	0	6A	IN-PV	NA	NA	NA
CTTAACTCAGGGTACA-1_8_E5	20.85974945	11.93686327	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1604	3001	0.002999	0.004331889	0	oligos	OL-Cntl	NA	NA	NA
CTTAACTCATATACCG-1_8_E5	-37.86890545	-5.424400696	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1110	1770	0.002824859	0	0	9	OPC	NA	NA	NA
CTTAACTGTACAGACG-1_8_E5	3.397525889	-31.07083649	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5133	19482	0.004414331	0.001539883	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTTAACTTCAGAGGTG-1_8_E5	20.82302081	-29.44075863	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4734	14965	0.006815904	0.005078517	0	3	EN-L5-6	NA	NA	NA
CTTAACTTCAGCTCTC-1_8_E5	21.1767428	-29.34803473	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4941	16109	0.010118567	0.00428332	0	3	EN-L5-6	NA	NA	NA
CTTAACTTCCTAGAAC-1_8_E5	11.6397951	30.40178145	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	692	1008	0.011904762	0.00297619	0	oligos	OL-Cntl	NA	NA	NA
CTTAACTTCCTCATTA-1_8_E5	-3.324694809	-6.968123267	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	898	1402	0.040656205	0.001426534	0	13A	IN-VIP	NA	NA	NA
CTTAACTTCTAAGCCA-1_8_E5	10.65622175	32.1446394	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	770	1191	0.000839631	0.004198153	0	oligos	OL-Cntl	NA	NA	NA
CTTACCGAGTACGCGA-1_8_E5	-0.954203588	-15.36960935	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2597	5879	0.007484266	0.002551454	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTTACCGCACCGATAT-1_8_E5	-1.600747467	-19.93291431	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3590	10306	0.003687173	0.002813895	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTTACCGCATCACAAC-1_8_E5	-26.65161651	9.871753576	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	748	1207	0	0.001657001	0	8	Astrocytes	NA	NA	NA
CTTACCGGTCGCATCG-1_8_E5	-38.80210342	0.172292504	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1493	2707	0.002216476	0.001108238	0	9	OPC	NA	NA	NA
CTTACCGTCCAATGGT-1_8_E5	-16.81310153	-10.98673625	13B	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4223	12544	0.009964923	0.003029337	0	13B	IN-SV2C	NA	NA	NA
CTTAGGACAATCTGCA-1_8_E5	-26.85453947	15.54446773	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1060	1678	0.001787843	0.001787843	0	8	Astrocytes	NA	NA	NA
CTTAGGACAGTTCCCT-1_8_E5	25.81718574	-29.42109451	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5251	20444	0.002201135	0.003375073	0	3	EN-L5-6	NA	NA	NA
CTTAGGACATCGTCGG-1_8_E5	10.2830695	32.16109212	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	879	1327	0.003014318	0.006782216	0	oligos	OL-Cntl	NA	NA	NA
CTTAGGATCAGGCGAA-1_8_E5	-23.78676624	-0.598544588	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1615	2920	0.003424658	0.002739726	0	9	OPC	NA	NA	NA
CTTAGGATCATATCGG-1_8_E5	-26.07095796	18.84290652	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1351	2352	0.00170068	0.00042517	0	8	Astrocytes	NA	NA	NA
CTTCTCTAGATGCGAC-1_8_E5	27.81157632	-4.943581629	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5039	16938	0.011335459	0.003010981	0	2	EN-L4	NA	NA	NA
CTTCTCTCAACACCCG-1_8_E5	25.43926898	-29.21124466	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4527	15734	0.007309012	0.003050718	0	3	EN-L5-6	NA	NA	NA
CTTCTCTCAATGGAGC-1_8_E5	-11.40030092	-20.05191142	6B	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	950	1625	0.016615385	0.004307692	0	6B	IN-SST	NA	NA	NA
CTTCTCTCACTTCGAA-1_8_E5	7.967564643	34.81633908	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1144	2024	0.010375494	0.008893281	0	oligos	OL-Cntl	NA	NA	NA
CTTCTCTCATCGGGTC-1_8_E5	28.56368351	-1.282483644	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3731	9460	0.0102537	0.003699789	0	2	EN-L4	NA	NA	NA
CTTCTCTCATTTGCTT-1_8_E5	0.264213271	-29.55668063	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4506	14870	0.00268998	0.002353732	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
CTTCTCTGTCTCTTTA-1_8_E5	10.25668391	27.59846124	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	926	1457	0.003431709	0.005490734	0	oligos	OL-Cntl	NA	NA	NA
CTTCTCTTCAACACAC-1_8_E5	-12.3297719	-32.35476306	16	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1518	2471	0.114528531	0.008498584	0	16	EN-PYR	NA	NA	NA
CTTCTCTTCCAAGCCG-1_8_E5	26.07910979	-5.635361411	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5804	20865	0.002923556	0.002875629	0	2	EN-L4	NA	NA	NA
CTTCTCTTCTGACCTC-1_8_E5	-19.29612626	-18.4481049	6A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2968	7360	0.017934783	0.002309783	0	6A	IN-PV	NA	NA	NA
CTTGGCTAGGTGGGTT-1_8_E5	25.81862339	0.553256423	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2595	5544	0.002705628	0.00450938	0	2	EN-L4	NA	NA	NA
CTTGGCTGTTTAGGAA-1_8_E5	-19.77133969	-28.98777442	6A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3745	11087	0.006403896	0.001984306	0	6A	IN-PV	NA	NA	NA
CTTTGCGAGCCTCGTG-1_8_E5	6.092648141	31.96367714	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	714	1026	0.003898635	0.000974659	0	oligos	OL-Cntl	NA	NA	NA
CTTTGCGCAGGGTTAG-1_8_E5	29.27369627	-1.298661319	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3524	8399	0.014287415	0.002976545	0	2	EN-L4	NA	NA	NA
CTTTGCGGTAGAGCTG-1_8_E5	8.986615668	33.54911089	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	867	1270	0.005511811	0.005511811	0	oligos	OL-Cntl	NA	NA	NA
CTTTGCGGTCAGGACA-1_8_E5	-26.14245904	26.54713039	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1552	2768	0.00216763	0.001445087	0	8	Astrocytes	NA	NA	NA
CTTTGCGGTCGCGTGT-1_8_E5	4.92914242	30.20710891	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	743	1086	0.001841621	0.003683241	0	oligos	OL-Cntl	NA	NA	NA
CTTTGCGTCCAAAGTC-1_8_E5	4.590998404	33.74721486	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	727	1250	0.1888	0.004	0	oligos	OL-Cntl	NA	NA	NA
CTTTGCGTCCAGAGGA-1_8_E5	26.6358928	-5.310632638	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4445	12488	0.007206919	0.003042921	0	2	EN-L4	NA	NA	NA
CTTTGCGTCCTATGTT-1_8_E5	25.63477365	-5.154434907	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5811	23452	0.001151288	0.002856899	0	2	EN-L4	NA	NA	NA
CTTTGCGTCTCGATGA-1_8_E5	-25.84619743	20.54820876	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1667	3005	0.00765391	0.001331115	0	8	Astrocytes	NA	NA	NA
CTTTGCGTCTTAGCCC-1_8_E5	-34.52454335	-8.588699208	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1085	1710	0.002339181	0.003508772	0	9	OPC	NA	NA	NA
GAAACTCAGCATCATC-1_8_E5	-1.961760414	-19.57580693	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2943	7286	0.006038979	0.00274499	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GAAACTCAGGGAACGG-1_8_E5	30.65131157	-1.417647916	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3319	7665	0.008871494	0.004827136	0	2	EN-L4	NA	NA	NA
GAAACTCGTCCATGAT-1_8_E5	-0.162441488	-22.83225028	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5750	20063	0.005881473	0.004037283	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GAAACTCGTCGGCACT-1_8_E5	19.31081204	22.18972467	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1018	1663	0.001202646	0.003607937	0	oligos	OL-Cntl	NA	NA	NA
GAAACTCGTTTAGCTG-1_8_E5	5.834844825	33.42956783	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	825	1225	0.017142857	0.004897959	0	oligos	OL-Cntl	NA	NA	NA
GAAATGAAGCAGCCTC-1_8_E5	-24.83120105	29.77572204	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1767	3235	0.000618238	0.00309119	0	8	Astrocytes	NA	NA	NA
GAAATGAAGTCAAGCG-1_8_E5	-10.33623126	1.081270859	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2741	5769	0.007973652	0.002600104	0	13A	IN-VIP	NA	NA	NA
GAAATGACAAGCTGAG-1_8_E5	-16.83080375	-10.99514831	13B	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3912	10214	0.011846485	0.003622479	0	13B	IN-SV2C	NA	NA	NA
GAAATGATCAATCTCT-1_8_E5	-34.81749292	-12.59007218	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	781	1178	0.002546689	0.004244482	0	9	OPC	NA	NA	NA
GAACATCGTGAGGCTA-1_8_E5	28.50432096	-2.239947771	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3583	8727	0.008594019	0.003437607	0	2	EN-L4	NA	NA	NA
GAACATCGTTGTACAC-1_8_E5	14.88017159	-33.63367539	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5109	17405	0.002010916	0.005458202	0	3	EN-L5-6	NA	NA	NA
GAACATCTCAGTCCCT-1_8_E5	15.16732902	-33.51112044	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	6944	34874	0.003469634	0.003096863	0	3	EN-L5-6	NA	NA	NA
GAACATCTCTGGCGAC-1_8_E5	23.75177009	-9.388961358	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5391	18066	0.000719584	0.004704971	0	3	EN-L5-6	NA	NA	NA
GAACCTAAGAAACGCC-1_8_E5	-18.65162645	-29.04047923	6A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3772	10403	0.006632702	0.002787657	0	6A	IN-PV	NA	NA	NA
GAACCTACAGCAGTTT-1_8_E5	-0.766198924	-14.34041531	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2263	4646	0.001721911	0.002152389	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GAACCTACAGCCACCA-1_8_E5	4.405745238	32.55054691	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	726	1020	0.015686275	0.002941176	0	oligos	OL-Cntl	NA	NA	NA
GAACCTAGTCAACTGT-1_8_E5	-10.54720168	18.26873517	11	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2535	5225	0.003253589	0.002870813	0	11	Glia-MIX	NA	NA	NA
GAACCTAGTCTAACGT-1_8_E5	4.322214641	-32.36615001	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	6193	28784	0.001980267	0.002362424	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GAACCTAGTGCGAAAC-1_8_E5	8.614183966	33.98704837	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	918	1377	0.003631082	0.005083515	0	oligos	OL-Cntl	NA	NA	NA
GAACCTATCACAACGT-1_8_E5	4.667813323	29.57543736	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	724	1075	0.001860465	0.00372093	0	oligos	OL-Cntl	NA	NA	NA
GAACGGAAGTGAACGC-1_8_E5	18.24384595	1.537866317	12	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1036	1507	0.00995355	0.00265428	0	12	EN-MIX	NA	NA	NA
GAACGGACATAGACTC-1_8_E5	-0.991729233	-20.94778849	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3049	7190	0.003894298	0.00403338	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GAACGGAGTAGCCTAT-1_8_E5	-26.67756145	17.60478343	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1236	2062	0.001939864	0.006304559	0	8	Astrocytes	NA	NA	NA
GAAGCAGAGGCATTGG-1_8_E5	-1.481723943	-22.12415494	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3884	11803	0.00542235	0.003558417	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GAAGCAGCAAAGGAAG-1_8_E5	-11.6459079	-19.37721805	6B	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1050	1649	0.007277138	0.003032141	0	6B	IN-SST	NA	NA	NA
GAAGCAGGTCGGCATC-1_8_E5	-3.084939063	-20.91028085	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3389	8553	0.004442886	0.003507541	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GAAGCAGGTTACCGAT-1_8_E5	21.11167006	-29.46462489	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5660	20017	0.002148174	0.006394565	0	3	EN-L5-6	NA	NA	NA
GAAGCAGTCCTCTAGC-1_8_E5	25.17151062	-0.894963476	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2689	5932	0.005057316	0.003877276	0	2	EN-L4	NA	NA	NA
GAATAAGAGGGCATGT-1_8_E5	-23.13270325	18.80660102	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1423	2588	0.001545595	0.003477589	0	8	Astrocytes	NA	NA	NA
GAATAAGCAAACCTAC-1_8_E5	-26.53247013	15.65791784	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1118	1673	0.011356844	0.0041841	0	8	Astrocytes	NA	NA	NA
GAATAAGCACCCTATC-1_8_E5	-0.528540879	-14.31954039	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2265	4349	0.005058634	0.002759255	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GAATAAGCAGGGATTG-1_8_E5	31.22521892	-3.218742829	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3101	6800	0.012205882	0.004852941	0	2	EN-L4	NA	NA	NA
GAATAAGTCCACTCCA-1_8_E5	-11.08422939	2.997442634	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4937	15203	0.012760639	0.004275472	0	13A	IN-VIP	NA	NA	NA
GAATAAGTCCAGAAGG-1_8_E5	-29.03142456	16.26464482	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	953	1506	0.001328021	0.002656042	0	8	Astrocytes	NA	NA	NA
GAATGAAAGGCAGTCA-1_8_E5	-27.18280224	25.37637323	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1364	2336	0.014982877	0.001712329	0	8	Astrocytes	NA	NA	NA
GAATGAACATCCGTGG-1_8_E5	-4.487826084	-3.157128535	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1346	2304	0.006944444	0.00390625	0	13A	IN-VIP	NA	NA	NA
GAATGAATCTCACATT-1_8_E5	-19.75345173	-28.65859616	6A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3377	8327	0.003122373	0.003242464	0	6A	IN-PV	NA	NA	NA
GACACGCAGACTTGAA-1_8_E5	-2.729621094	-0.919043953	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3615	8534	0.006796344	0.007499414	0	13A	IN-VIP	NA	NA	NA
GACACGCCAAGGTTCT-1_8_E5	-14.35478156	-7.457758092	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3647	9383	0.005328786	0.00298412	0	13A	IN-VIP	NA	NA	NA
GACACGCCAGATCGGA-1_8_E5	9.382363759	32.4598024	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	869	1317	0.003037206	0.004555809	0	oligos	OL-Cntl	NA	NA	NA
GACACGCCATAGTAAG-1_8_E5	-0.661976864	-14.47198225	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2212	4416	0.00611413	0.004076087	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GACACGCTCATCTGCC-1_8_E5	6.880365747	34.58123814	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	750	1098	0.003642987	0.00273224	0	oligos	OL-Cntl	NA	NA	NA
GACACGCTCTCCAGGG-1_8_E5	-37.86610504	-5.552939227	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1133	1879	0.012772751	0.00532198	0	9	OPC	NA	NA	NA
GACAGAGCACCAGCAC-1_8_E5	25.81379344	-29.34782984	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5172	18315	0.003166803	0.003767404	0	3	EN-L5-6	NA	NA	NA
GACAGAGCACTCGACG-1_8_E5	-25.93733095	29.89954414	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1834	3567	0.000560695	0.003364172	0	8	Astrocytes	NA	NA	NA
GACAGAGTCAAAGTAG-1_8_E5	7.807134649	-32.20760741	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5091	17144	0.008924405	0.003674755	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GACAGAGTCGGCCGAT-1_8_E5	-20.35950611	-29.13073215	6A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5177	17263	0.006082373	0.003533569	0	6A	IN-PV	NA	NA	NA
GACCAATAGATGTGGC-1_8_E5	-25.90746207	29.95251554	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1900	3561	0.00252738	0.00393148	0	8	Astrocytes	NA	NA	NA
GACCAATAGCAATCTC-1_8_E5	28.89964619	-0.517936227	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3395	8349	0.007545814	0.002275722	0	2	EN-L4	NA	NA	NA
GACCAATAGCTGATAA-1_8_E5	1.734347229	-29.97061075	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4293	12301	0.007479067	0.002845297	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GACCAATAGCTGCCCA-1_8_E5	4.255355212	-32.84117785	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	7400	36275	0.000854583	0.003004824	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GACCAATAGGAATCGC-1_8_E5	-19.34574211	-28.40261747	6A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3452	8998	0.001111358	0.003222938	0	6A	IN-PV	NA	NA	NA
GACCAATAGGTAGCTG-1_8_E5	-5.904937287	-30.63230895	16	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	795	1120	0.140178571	0.008035714	0	16	EN-PYR	NA	NA	NA
GACCAATCAAAGGAAG-1_8_E5	2.794307374	-29.53411994	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4466	12905	0.00116234	0.004106935	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GACCAATCATGCAACT-1_8_E5	25.92209246	-5.243097963	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5834	22632	0.001811594	0.002651113	0	2	EN-L4	NA	NA	NA
GACCAATGTAGCGCTC-1_8_E5	25.80099133	-8.116139261	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5073	14573	0.003362382	0.004940644	0	2	EN-L4	NA	NA	NA
GACCAATGTTATCACG-1_8_E5	-0.947571787	-21.29082248	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3630	9163	0.003164902	0.003383171	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GACCAATTCTTGTACT-1_8_E5	-25.49608699	29.00057283	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1758	3321	0.004817826	0.003011141	0	8	Astrocytes	NA	NA	NA
GACCTGGAGGGCTTCC-1_8_E5	-24.50565068	30.38901309	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2059	4140	0.001932367	0.003623188	0	8	Astrocytes	NA	NA	NA
GACCTGGAGTGAAGAG-1_8_E5	-37.85119929	0.057359465	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1454	2637	0.004171407	0.004171407	0	9	OPC	NA	NA	NA
GACCTGGCAATAAGCA-1_8_E5	-0.597123088	-25.4558086	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5826	22270	0.003861697	0.002379883	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GACCTGGGTCATATGC-1_8_E5	-24.02715964	28.71531808	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1627	2839	0.002465657	0.001761184	0	8	Astrocytes	NA	NA	NA
GACCTGGGTGTGACGA-1_8_E5	17.89988694	15.51341035	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1094	1716	0.002331002	0.006993007	0	oligos	OL-Cntl	NA	NA	NA
GACCTGGTCGCGGATC-1_8_E5	6.016816171	-5.604903203	12	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1059	1643	0.010955569	0.003651856	0	12	EN-MIX	NA	NA	NA
GACGCGTAGGAATTAC-1_8_E5	4.898782966	32.54334818	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	756	1039	0.01732435	0.003849856	0	oligos	OL-Cntl	NA	NA	NA
GACGCGTCAAGCGAGT-1_8_E5	12.12085564	33.03101617	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	709	1052	0.008555133	0.001901141	0	oligos	OL-Cntl	NA	NA	NA
GACGCGTGTAGCTTGT-1_8_E5	-2.039395149	-19.60315604	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2952	6928	0.002742494	0.002742494	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GACGCGTGTATAGGGC-1_8_E5	-10.57738989	2.359033	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3553	8839	0.005204209	0.004072859	0	13A	IN-VIP	NA	NA	NA
GACGCGTGTGTCTGAT-1_8_E5	-36.01212855	-8.367221612	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1086	1740	0.001149425	0.001149425	0	9	OPC	NA	NA	NA
GACGCGTTCCGAAGAG-1_8_E5	11.14007516	31.70843205	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	727	1065	0.003755869	0.000938967	0	oligos	OL-Cntl	NA	NA	NA
GACGGCTGTTCCACAA-1_8_E5	-32.2141917	-12.43290892	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	759	1133	0.0070609	0.00353045	0	9	OPC	NA	NA	NA
GACGGCTGTTCCACTC-1_8_E5	0.121584857	-27.4525216	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5308	18972	0.00421674	0.002371917	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GACGGCTGTTCTGTTT-1_8_E5	25.9128557	-2.001273623	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3435	9147	0.009948617	0.003061113	0	2	EN-L4	NA	NA	NA
GACGGCTTCAAACCAC-1_8_E5	-8.673269674	2.210024712	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2570	5638	0.014012061	0.002660518	0	13A	IN-VIP	NA	NA	NA
GACGGCTTCCTTGCCA-1_8_E5	-7.248896841	-13.58073681	6B	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1126	1623	0.01047443	0.003080715	0	6B	IN-SST	NA	NA	NA
GACGTGCAGGCCGAAT-1_8_E5	17.45657967	-5.421983772	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1796	4029	0.003474808	0.00471581	0	3	EN-L5-6	NA	NA	NA
GACGTGCCACATGGGA-1_8_E5	28.95095773	-3.58395242	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3896	10040	0.006673307	0.005478088	0	2	EN-L4	NA	NA	NA
GACGTGCCAGCTGTGC-1_8_E5	7.626177081	-32.44669427	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5497	19364	0.003924809	0.002685396	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GACGTGCGTCGGCTCA-1_8_E5	19.06501247	0.292579468	12	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1197	1738	0.007479862	0.006904488	0	12	EN-MIX	NA	NA	NA
GACGTTACACCCTATC-1_8_E5	-10.93859878	2.499132139	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3552	8669	0.008190103	0.003691314	0	13A	IN-VIP	NA	NA	NA
GACGTTAGTGCTTCTC-1_8_E5	28.51452071	-1.27499108	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3558	8833	0.004754896	0.005094532	0	2	EN-L4	NA	NA	NA
GACGTTATCCACGAAT-1_8_E5	-37.29993048	-2.262077305	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1430	2363	0.002962336	0.007617435	0	9	OPC	NA	NA	NA
GACGTTATCGTTTATC-1_8_E5	28.52736435	-1.70042218	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3832	9307	0.009132911	0.004190394	0	2	EN-L4	NA	NA	NA
GACTAACAGAACAATC-1_8_E5	-27.28882358	15.69507013	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1086	1807	0.003873824	0.002213614	0	8	Astrocytes	NA	NA	NA
GACTAACAGCCAGTAG-1_8_E5	9.939687264	27.90555461	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	901	1429	0.00279916	0.00279916	0	oligos	OL-Cntl	NA	NA	NA
GACTAACCACTTCTGC-1_8_E5	26.68815046	-0.324400507	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2905	6777	0.002951158	0.00354139	0	2	EN-L4	NA	NA	NA
GACTAACCAGCTCGAC-1_8_E5	-23.81311993	30.29416833	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2203	4616	0.001083189	0.003249567	0	8	Astrocytes	NA	NA	NA
GACTAACGTCAGTGGA-1_8_E5	-1.918148728	-19.76819959	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3078	7208	0.001526082	0.00263596	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GACTAACGTGGCTCCA-1_8_E5	-8.227866359	0.957546004	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2215	4613	0.010838933	0.003034901	0	13A	IN-VIP	NA	NA	NA
GACTAACTCAACCAAC-1_8_E5	-20.11659358	-29.01537455	6A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4203	12585	0.0049265	0.003098927	0	6A	IN-PV	NA	NA	NA
GACTACAAGACCTAGG-1_8_E5	20.06874333	24.8209208	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1041	1625	0.001846154	0.002461538	0	oligos	OL-Cntl	NA	NA	NA
GACTACAAGTATCTCG-1_8_E5	9.838700403	32.76356935	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	854	1313	0.000761615	0.003808073	0	oligos	OL-Cntl	NA	NA	NA
GACTACACAAGTCATC-1_8_E5	-24.4961815	30.53210433	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2167	4437	0.00090151	0.00360604	0	8	Astrocytes	NA	NA	NA
GACTACACAGTACACT-1_8_E5	-20.25688078	-17.71705158	6A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3791	10099	0.005347064	0.004059808	0	6A	IN-PV	NA	NA	NA
GACTACAGTTTGACAC-1_8_E5	-17.53421598	-17.61093002	6B	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2202	4568	0.015761821	0.004378284	0	6B	IN-SST	NA	NA	NA
GACTACATCACGATGT-1_8_E5	10.17956897	32.74676671	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	872	1327	0.002260739	0.006782216	0	oligos	OL-Cntl	NA	NA	NA
GACTGCGAGACTACAA-1_8_E5	10.20974614	-26.42857742	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	8155	38622	0.018719901	0.003495417	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GACTGCGAGAGGGATA-1_8_E5	-25.9455703	29.09448792	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1708	3185	0.001569859	0.001569859	0	8	Astrocytes	NA	NA	NA
GACTGCGAGCTAGGCA-1_8_E5	3.71727904	-32.08802041	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	6025	25542	0.005050505	0.002035863	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GACTGCGCAAAGCGGT-1_8_E5	28.60852165	-1.29443995	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3986	10374	0.011085406	0.003470214	0	2	EN-L4	NA	NA	NA
GACTGCGCACGGTAGA-1_8_E5	7.545069029	-32.74124381	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4517	13872	0.008362168	0.003027682	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GACTGCGCAGCTATTG-1_8_E5	27.0636818	-4.546292755	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3940	10444	0.004308694	0.003542704	0	2	EN-L4	NA	NA	NA
GACTGCGCATCGGTTA-1_8_E5	26.77282992	-5.246242614	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	6220	25978	0.005697128	0.004272846	0	2	EN-L4	NA	NA	NA
GACTGCGCATGGTAGG-1_8_E5	20.4807766	23.06439371	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1104	1863	0.001073537	0.003757381	0	oligos	OL-Cntl	NA	NA	NA
GACTGCGGTGTGACGA-1_8_E5	10.64468548	30.81529752	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	801	1180	0.008474576	0.007627119	0	oligos	OL-Cntl	NA	NA	NA
GAGCAGAAGCTCCTTC-1_8_E5	-20.08400028	-29.03939505	6A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4110	12110	0.004459125	0.002559868	0	6A	IN-PV	NA	NA	NA
GAGCAGAAGGTGATTA-1_8_E5	-21.28659898	-16.84065434	6A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4207	11563	0.008734757	0.004151172	0	6A	IN-PV	NA	NA	NA
GAGCAGAAGTGTGGCA-1_8_E5	-1.193095773	-21.27749148	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3350	8274	0.006647329	0.004471839	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GAGCAGAGTACAAGTA-1_8_E5	10.58371888	-33.94942393	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	7765	34608	0.004594313	0.003958622	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GAGCAGAGTAGATTAG-1_8_E5	-0.671993729	-14.3425504	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2302	5000	0.0088	0.0038	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GAGCAGAGTAGTACCT-1_8_E5	-24.06886915	30.49163389	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2017	4031	0.004465393	0.004465393	0	8	Astrocytes	NA	NA	NA
GAGCAGAGTATAATGG-1_8_E5	-38.55727744	0.26670775	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1629	2969	0.004041765	0.004378579	0	9	OPC	NA	NA	NA
GAGCAGATCCTTTCTC-1_8_E5	21.28901628	-29.31772219	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4688	14889	0.006716368	0.005910404	0	3	EN-L5-6	NA	NA	NA
GAGGTGAAGCACACAG-1_8_E5	20.19699574	24.39454187	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1018	1567	0.001914486	0.002552648	0	oligos	OL-Cntl	NA	NA	NA
GAGGTGACAAGAGTCG-1_8_E5	5.557125006	32.64505897	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	818	1158	0.014680484	0.003454231	0	oligos	OL-Cntl	NA	NA	NA
GAGGTGACACTTACGA-1_8_E5	-38.92059612	0.595864859	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1585	2958	0.011494253	0.003380663	0	9	OPC	NA	NA	NA
GAGGTGACATTTGCTT-1_8_E5	-17.94490754	-18.99888259	6B	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2395	5241	0.003052853	0.004960885	0	6B	IN-SST	NA	NA	NA
GAGGTGAGTACTCTCC-1_8_E5	20.44998338	8.361132558	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1954	3661	0.004370391	0.006828735	0	oligos	OL-Cntl	NA	NA	NA
GAGGTGAGTAGGCATG-1_8_E5	-39.09038533	-3.547094987	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1313	2088	0.006226054	0.003831418	0	9	OPC	NA	NA	NA
GAGGTGAGTGCATCTA-1_8_E5	-0.921678096	-25.19650431	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4664	14554	0.002129999	0.002610966	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GAGGTGAGTTGATTCG-1_8_E5	-16.42473986	-10.79133654	13B	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3404	8214	0.004504505	0.003895788	0	13B	IN-SV2C	NA	NA	NA
GAGTCCGAGTACGCCC-1_8_E5	6.963977216	31.5713248	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	708	1045	0.007655502	0.006698565	0	oligos	OL-Cntl	NA	NA	NA
GAGTCCGCACACATGT-1_8_E5	18.85047588	24.1051401	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	943	1528	0.009162304	0.003272251	0	oligos	OL-Cntl	NA	NA	NA
GAGTCCGCAGGCTGAA-1_8_E5	21.37500067	-29.27553717	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4855	14975	0.008146912	0.006143573	0	3	EN-L5-6	NA	NA	NA
GAGTCCGGTACTTAGC-1_8_E5	26.02570637	-5.337641109	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5927	23152	0.003585003	0.002937111	0	2	EN-L4	NA	NA	NA
GAGTCCGTCCGAGCCA-1_8_E5	27.80538191	-0.922689449	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3857	10146	0.001576976	0.004435245	0	2	EN-L4	NA	NA	NA
GATCAGTAGCTGTCTA-1_8_E5	-0.926070221	-24.48240929	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4903	16837	0.00831502	0.002197541	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GATCAGTAGGCCCGTT-1_8_E5	20.1431891	22.42030178	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1019	1689	0.001184133	0.003552398	0	oligos	OL-Cntl	NA	NA	NA
GATCAGTCAGTTCATG-1_8_E5	25.4807515	-29.60866531	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3816	11074	0.003431461	0.001715731	0	3	EN-L5-6	NA	NA	NA
GATCAGTCATAGAAAC-1_8_E5	-38.86086833	-0.10694088	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1514	2798	0.000357398	0.003216583	0	9	OPC	NA	NA	NA
GATCAGTGTACCATCA-1_8_E5	0.158938293	-27.58652969	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5718	21211	0.005421715	0.003960209	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GATCAGTGTCACCCAG-1_8_E5	23.46288522	-9.420288114	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3660	9235	0.004656199	0.004764483	0	3	EN-L5-6	NA	NA	NA
GATCAGTGTCTGATTG-1_8_E5	-15.30673139	-10.98870198	13B	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2602	5495	0.02511374	0.002729754	0	13B	IN-SV2C	NA	NA	NA
GATCAGTGTGAACCTT-1_8_E5	15.00039709	-33.62630127	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5428	20502	0.003950834	0.003219198	0	3	EN-L5-6	NA	NA	NA
GATCAGTTCCTTGACC-1_8_E5	-17.10198917	-10.97968681	13B	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4519	13601	0.009116977	0.003455628	0	13B	IN-SV2C	NA	NA	NA
GATCAGTTCTGCAGTA-1_8_E5	-8.866952179	-18.37436872	6B	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	772	1210	0.009090909	0.004132231	0	6B	IN-SST	NA	NA	NA
GATCAGTTCTGTCTCG-1_8_E5	-35.44756929	5.139111238	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2746	6226	0.003854802	0.002248635	0	9	OPC	NA	NA	NA
GATCGATAGACTCGGA-1_8_E5	6.551424707	34.99005105	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	824	1213	0.006595218	0.007419621	0	oligos	OL-Cntl	NA	NA	NA
GATCGATAGATATACG-1_8_E5	-3.142814859	-5.868858086	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	931	1422	0.022503516	0.004219409	0	13A	IN-VIP	NA	NA	NA
GATCGATCATCACGAT-1_8_E5	-23.2476452	31.08167825	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2162	4441	0.000900698	0.00247692	0	8	Astrocytes	NA	NA	NA
GATCGATGTACCGGCT-1_8_E5	-25.66827911	29.86283526	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1720	3274	0.001221747	0.002748931	0	8	Astrocytes	NA	NA	NA
GATCGATTCACCTTAT-1_8_E5	18.71676451	25.95686955	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	935	1436	0.002785515	0.004178273	0	oligos	OL-Cntl	NA	NA	NA
GATCGATTCAGAGGTG-1_8_E5	-24.41642585	30.34538972	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1919	3606	0.004159734	0.001941209	0	8	Astrocytes	NA	NA	NA
GATCGATTCTGAGGGA-1_8_E5	-9.662118718	0.858797451	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2721	6029	0.011444684	0.006137004	0	13A	IN-VIP	NA	NA	NA
GATCGATTCTTCTGGC-1_8_E5	7.712091927	32.45360488	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	746	1082	0.013863216	0.009242144	0	oligos	OL-Cntl	NA	NA	NA
GATCGCGGTTAAGAAC-1_8_E5	9.502287629	32.16000682	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	840	1248	0.002403846	0.003205128	0	oligos	OL-Cntl	NA	NA	NA
GATCGCGTCAATCTCT-1_8_E5	-2.124076014	-22.33086861	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3789	10649	0.004225749	0.003380599	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GATCGCGTCTAACGGT-1_8_E5	-26.48528794	19.8407507	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1365	2369	0.000844238	0.001266357	0	8	Astrocytes	NA	NA	NA
GATCGTAAGGCCCTCA-1_8_E5	-10.93242095	2.474867659	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3567	8418	0.005464481	0.006296032	0	13A	IN-VIP	NA	NA	NA
GATCGTAAGTTAGCGG-1_8_E5	-1.021195171	-21.67710565	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3914	11091	0.001622938	0.003967181	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GATCGTAGTACTTAGC-1_8_E5	-39.38867158	-2.348839593	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1233	2242	0.001784121	0.004014273	0	9	OPC	NA	NA	NA
GATCTAGAGAGGTTGC-1_8_E5	26.34061348	-8.14555686	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	6117	21222	0.009047215	0.003722552	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GATCTAGAGTGCGTGA-1_8_E5	29.1057252	-1.721424302	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3957	10090	0.004757185	0.004162537	0	2	EN-L4	NA	NA	NA
GATCTAGCAAAGGCGT-1_8_E5	-37.33010432	-0.407805707	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1508	2660	0.00112782	0.004511278	0	9	OPC	NA	NA	NA
GATCTAGCACTTAAGC-1_8_E5	5.037270038	32.39028699	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	710	1044	0.002873563	0.005747126	0	oligos	OL-Cntl	NA	NA	NA
GATCTAGGTAGCTCCG-1_8_E5	19.45211633	24.43307232	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1055	1679	0.008933889	0.005955926	0	oligos	OL-Cntl	NA	NA	NA
GATCTAGTCATCATTC-1_8_E5	25.42812406	-5.262347028	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	6758	31705	0.001766283	0.002302476	0	2	EN-L4	NA	NA	NA
GATCTAGTCCTCAATT-1_8_E5	-34.19523171	-9.759905123	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	935	1379	0.005076142	0.003625816	0	9	OPC	NA	NA	NA
GATCTAGTCGTAGATC-1_8_E5	-26.26558974	25.47079503	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1448	2532	0.001184834	0.003554502	0	8	Astrocytes	NA	NA	NA
GATGAAACACTGTTAG-1_8_E5	-27.17042165	9.418979043	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	730	1030	0.004854369	0.003883495	0	8	Astrocytes	NA	NA	NA
GATGAAAGTTCCCTTG-1_8_E5	28.37379644	-1.197587102	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4093	10598	0.001415361	0.003585582	0	2	EN-L4	NA	NA	NA
GATGAAATCAACCAAC-1_8_E5	25.03477419	-28.91873994	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4591	14657	0.008869482	0.004980555	0	3	EN-L5-6	NA	NA	NA
GATGAAATCCGCGTTT-1_8_E5	-21.22610309	-17.03678949	6A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3938	9885	0.005867476	0.004653515	0	6A	IN-PV	NA	NA	NA
GATGAGGAGCGTCAAG-1_8_E5	-0.819594883	-21.27723466	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3426	8566	0.004436143	0.004903105	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GATGAGGAGTAACCCT-1_8_E5	8.981588259	33.53771232	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	945	1385	0.005054152	0.003610108	0	oligos	OL-Cntl	NA	NA	NA
GATGAGGGTGATAAAC-1_8_E5	-0.405035548	-22.02917899	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4545	13527	0.004139868	0.004435573	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GATGAGGGTTCAGACT-1_8_E5	-38.44819354	-0.923242863	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1366	2413	0.002900953	0.001243266	0	9	OPC	NA	NA	NA
GATGAGGTCCCTTGTG-1_8_E5	-2.001423239	-25.11741524	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5267	18340	0.005997819	0.004089422	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GATGAGGTCCGCATCT-1_8_E5	-34.12625731	-10.39991438	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1009	1644	0.003041363	0.001216545	0	9	OPC	NA	NA	NA
GATGCTAAGAGTAATC-1_8_E5	10.09959304	30.47209346	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	719	1038	0.013487476	0.002890173	0	oligos	OL-Cntl	NA	NA	NA
GATGCTAAGCGAGAAA-1_8_E5	-36.17635772	-6.51275678	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1187	1960	0.003571429	0.005102041	0	9	OPC	NA	NA	NA
GATGCTAGTGGTAACG-1_8_E5	24.52560635	-28.97175143	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3225	8174	0.00134573	0.004281869	0	3	EN-L5-6	NA	NA	NA
GATGCTAGTTTAGCTG-1_8_E5	9.390836989	26.96750687	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	870	1297	0.01233616	0.00539707	0	oligos	OL-Cntl	NA	NA	NA
GATGCTATCACCGTAA-1_8_E5	19.74528907	12.31697629	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1369	2337	0.003423192	0.003423192	0	oligos	OL-Cntl	NA	NA	NA
GATGCTATCAGGCAAG-1_8_E5	-14.31579204	-7.055863378	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3049	6783	0.00737137	0.004717677	0	13A	IN-VIP	NA	NA	NA
GATGCTATCATAACCG-1_8_E5	-1.799046995	-19.57147475	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2881	6518	0.010125805	0.002915005	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GATTCAGCAATGAATG-1_8_E5	16.25245256	-31.55848553	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	6317	24446	0.005726908	0.006258693	0	3	EN-L5-6	NA	NA	NA
GATTCAGCAGGCAGTA-1_8_E5	29.6409851	-3.708929796	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3780	9970	0.016349047	0.003510532	0	2	EN-L4	NA	NA	NA
GATTCAGCATATGCTG-1_8_E5	0.459724898	-11.02080719	12	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1900	3400	0.006470588	0.005294118	0	12	EN-MIX	NA	NA	NA
GATTCAGGTACACCGC-1_8_E5	-1.33242204	-23.88708978	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4536	13267	0.008668124	0.004220999	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GATTCAGGTGCACGAA-1_8_E5	-37.59545579	3.134028726	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2024	4310	0.005104408	0.00324826	0	9	OPC	NA	NA	NA
GATTCAGGTTAAGTAG-1_8_E5	10.98525884	28.62291528	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	811	1212	0.00330033	0.004125413	0	oligos	OL-Cntl	NA	NA	NA
GATTCAGTCACTGGGC-1_8_E5	15.56954471	-7.980408617	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2607	6092	0.004596192	0.003939593	0	3	EN-L5-6	NA	NA	NA
GCAAACTAGATCCGAG-1_8_E5	6.084890993	31.87631907	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	795	1113	0.006289308	0.001796945	0	oligos	OL-Cntl	NA	NA	NA
GCAAACTAGTGTACTC-1_8_E5	24.10283424	-10.04190073	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5122	14511	0.009234374	0.003238922	0	3	EN-L5-6	NA	NA	NA
GCAAACTAGTGTCCCG-1_8_E5	6.459469572	26.39613415	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	862	1263	0.000791766	0.004750594	0	oligos	OL-Cntl	NA	NA	NA
GCAAACTCAATAAGCA-1_8_E5	17.09263895	-5.407669035	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1417	2293	0.009594418	0.005233319	0	3	EN-L5-6	NA	NA	NA
GCAAACTCAATCACAC-1_8_E5	-5.894435235	-4.638082922	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1326	2298	0.01305483	0.001740644	0	13A	IN-VIP	NA	NA	NA
GCAAACTGTAGCGCTC-1_8_E5	21.22201675	22.93458904	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1145	1811	0.006626173	0.006073992	0	oligos	OL-Cntl	NA	NA	NA
GCAAACTGTGGGTCAA-1_8_E5	9.913580296	32.46259293	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	843	1229	0.005695688	0.007323027	0	oligos	OL-Cntl	NA	NA	NA
GCAAACTGTTCCCTTG-1_8_E5	0.164929895	-27.3193954	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4312	12277	0.003339578	0.002525047	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCAAACTGTTGATTCG-1_8_E5	4.643060627	-7.096131796	12	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1384	2571	0.005056398	0.004667445	0	12	EN-MIX	NA	NA	NA
GCAATCAAGAGGACGG-1_8_E5	3.964165633	32.02009558	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	766	1067	0.003748828	0.004686036	0	oligos	OL-Cntl	NA	NA	NA
GCAATCACAAGTACCT-1_8_E5	16.86377098	-32.55952818	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5766	21691	0.007284127	0.003688166	0	3	EN-L5-6	NA	NA	NA
GCAATCAGTAAGTTCC-1_8_E5	20.33447602	24.20052134	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1033	1620	0.004320988	0.006790123	0	oligos	OL-Cntl	NA	NA	NA
GCAATCAGTAGCTAAA-1_8_E5	-16.14306371	-10.96017478	13B	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2915	6302	0.020469692	0.002697556	0	13B	IN-SV2C	NA	NA	NA
GCAATCAGTGACGGTA-1_8_E5	-14.71047523	-19.2282719	6B	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1429	2553	0.01684293	0.005875441	0	6B	IN-SST	NA	NA	NA
GCAATCAGTGATAAAC-1_8_E5	5.635076029	-32.3075579	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	6343	25718	0.00213858	0.002838479	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCACATAAGACTAGGC-1_8_E5	28.30977748	-1.693570713	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4323	11716	0.006913622	0.003926255	0	2	EN-L4	NA	NA	NA
GCACATAAGATCCTGT-1_8_E5	19.73673209	24.37450987	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	987	1503	0.003992016	0.005322688	0	oligos	OL-Cntl	NA	NA	NA
GCACATACAAAGCGGT-1_8_E5	-19.42451379	-28.28999463	6A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3621	9804	0.003671971	0.003161975	0	6A	IN-PV	NA	NA	NA
GCACATATCCCATTAT-1_8_E5	19.5554441	8.359188571	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1993	3998	0.004002001	0.004752376	0	oligos	OL-Cntl	NA	NA	NA
GCACATATCCCATTTA-1_8_E5	1.001407758	-30.51696155	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5841	21668	0.00369208	0.004061289	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCACATATCCGTCAAA-1_8_E5	26.84063871	-4.66190317	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5041	15067	0.007632575	0.005375987	0	2	EN-L4	NA	NA	NA
GCACATATCCTAGTGA-1_8_E5	14.90019285	-33.57939382	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5239	19798	0.004192343	0.004141833	0	3	EN-L5-6	NA	NA	NA
GCACTCTAGACTGGGT-1_8_E5	9.739825319	30.76557389	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	877	1351	0.006661732	0.002220577	0	oligos	OL-Cntl	NA	NA	NA
GCACTCTAGATGCCTT-1_8_E5	18.78395864	25.41633987	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1022	1543	0.003240441	0.001296176	0	oligos	OL-Cntl	NA	NA	NA
GCACTCTAGTAACCCT-1_8_E5	2.379058859	-31.47623095	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	6557	27949	0.007191671	0.001753193	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCACTCTCAAGCTGTT-1_8_E5	-2.15558581	-21.06599131	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3538	8897	0.004495897	0.003484321	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCACTCTCAGTACACT-1_8_E5	-1.930752489	-19.52112929	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3009	7266	0.003853565	0.003715937	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCACTCTCATAAGACA-1_8_E5	-38.19210965	2.383911172	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1728	3260	0.003374233	0.002147239	0	9	OPC	NA	NA	NA
GCACTCTCATCGGAAG-1_8_E5	-33.55270186	-11.81982615	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	870	1369	0.003652301	0.002921841	0	9	OPC	NA	NA	NA
GCACTCTCATCGGACC-1_8_E5	20.07018491	22.28914509	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1045	1798	0.001112347	0.003337041	0	oligos	OL-Cntl	NA	NA	NA
GCACTCTCATGCGCAC-1_8_E5	18.4302904	12.54509972	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1354	2310	0.001298701	0.003463203	0	oligos	OL-Cntl	NA	NA	NA
GCACTCTCATGCTAGT-1_8_E5	-4.407718253	-4.280398254	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1164	1971	0.018772197	0.002029427	0	13A	IN-VIP	NA	NA	NA
GCAGCCACAGATGAGC-1_8_E5	25.3486076	-2.788794914	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3038	6990	0.010586552	0.002718169	0	2	EN-L4	NA	NA	NA
GCAGCCACATACAGCT-1_8_E5	1.425965755	-7.319621028	12	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1337	2114	0.007095553	0.003311258	0	12	EN-MIX	NA	NA	NA
GCAGCCATCAAGCCTA-1_8_E5	28.73739643	-1.472936427	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4054	11088	0.005050505	0.003336941	0	2	EN-L4	NA	NA	NA
GCAGCCATCGGCGCAT-1_8_E5	1.172282488	-9.730600701	12	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1541	2719	0.00478117	0.002206694	0	12	EN-MIX	NA	NA	NA
GCAGCCATCTGCCCTA-1_8_E5	-37.07388519	-6.597054682	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1203	1985	0.001511335	0.002518892	0	9	OPC	NA	NA	NA
GCAGTTAAGGCGCTCT-1_8_E5	-0.920542399	-19.25275276	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2862	6550	0.005343511	0.00519084	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCAGTTAGTTTGGCGC-1_8_E5	20.33489522	22.84446584	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	977	1574	0.001905972	0.001905972	0	oligos	OL-Cntl	NA	NA	NA
GCAGTTATCAAACCAC-1_8_E5	-23.65203675	30.72200388	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2048	3986	0.001505268	0.003512293	0	8	Astrocytes	NA	NA	NA
GCAGTTATCGTATCAG-1_8_E5	7.613678008	30.5809996	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	740	1084	0.002767528	0.005535055	0	oligos	OL-Cntl	NA	NA	NA
GCATACAAGGCCGAAT-1_8_E5	27.12163371	-5.260741575	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5240	17024	0.005580357	0.003524436	0	2	EN-L4	NA	NA	NA
GCATACACATCACAAC-1_8_E5	1.961114324	-31.23472922	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5879	23239	0.00271096	0.002495804	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCATACAGTACCCAAT-1_8_E5	10.40923489	27.67487819	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	902	1463	0.001367054	0.003417635	0	oligos	OL-Cntl	NA	NA	NA
GCATACATCTCGCATC-1_8_E5	-38.54806157	0.594393885	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1517	2695	0.001855288	0.002226345	0	9	OPC	NA	NA	NA
GCATGATAGACGCTTT-1_8_E5	-8.6373086	1.451504779	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2330	4915	0.002644964	0.0034588	0	13A	IN-VIP	NA	NA	NA
GCATGATAGGAGTACC-1_8_E5	-29.07813249	13.76267465	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	881	1358	0.002209131	0.000736377	0	8	Astrocytes	NA	NA	NA
GCATGATCAAGTTCTG-1_8_E5	-17.12465311	-10.83277524	13B	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4386	12130	0.009975268	0.004699093	0	13B	IN-SV2C	NA	NA	NA
GCATGATGTAAGTAGT-1_8_E5	-37.17817811	3.108747059	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1946	3746	0.017618793	0.003470368	0	9	OPC	NA	NA	NA
GCATGATGTCACCTAA-1_8_E5	8.711836589	31.47902315	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	752	1141	0.007011394	0.005258545	0	oligos	OL-Cntl	NA	NA	NA
GCATGATGTCTGCCAG-1_8_E5	6.425112962	33.97096024	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	788	1099	0.000909918	0.001819836	0	oligos	OL-Cntl	NA	NA	NA
GCATGATTCAGCTCTC-1_8_E5	5.280957998	33.84403926	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	694	1002	0.002994012	0.003992016	0	oligos	OL-Cntl	NA	NA	NA
GCATGCGAGCTAGTGG-1_8_E5	23.35676739	-6.606985143	11	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3999	9510	0.005362776	0.003680336	0	11	Glia-MIX	NA	NA	NA
GCATGCGAGGGATCTG-1_8_E5	-23.97991539	30.25001279	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1778	3227	0.000619771	0.004028509	0	8	Astrocytes	NA	NA	NA
GCATGCGAGGTGATTA-1_8_E5	-1.620932945	-16.08915126	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2601	5732	0.002791347	0.002442428	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCATGCGCATTGGGCC-1_8_E5	-1.360153558	-20.34743055	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3294	7962	0.003893494	0.003014318	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCATGCGGTAAGGGAA-1_8_E5	27.56538616	-1.047924635	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3521	8355	0.002393776	0.002393776	0	2	EN-L4	NA	NA	NA
GCATGCGGTCGTTGTA-1_8_E5	25.65314497	-4.127574488	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4056	11966	0.002590674	0.002089253	0	2	EN-L4	NA	NA	NA
GCATGCGGTCTTGCGG-1_8_E5	-27.0131642	15.28131939	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1127	1721	0.001162115	0.004067403	0	8	Astrocytes	NA	NA	NA
GCATGCGTCAGAGCTT-1_8_E5	-34.74736842	-12.6633717	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	766	1138	0.005272408	0.004393673	0	9	OPC	NA	NA	NA
GCATGTAAGGCCCTCA-1_8_E5	-19.22379133	-24.19544953	6A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3016	7342	0.007218741	0.004494688	0	6A	IN-PV	NA	NA	NA
GCATGTAAGGGCATGT-1_8_E5	20.48540403	1.400154384	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2104	5618	0.003559986	0.001779993	0	2	EN-L4	NA	NA	NA
GCATGTACAAGCGTAG-1_8_E5	4.495398431	32.06955943	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	803	1138	0.009666081	0.003514938	0	oligos	OL-Cntl	NA	NA	NA
GCATGTACAATGGTCT-1_8_E5	5.363142892	33.62638663	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	705	1021	0.003917728	0.001958864	0	oligos	OL-Cntl	NA	NA	NA
GCATGTAGTGCAACTT-1_8_E5	10.56329295	31.791252	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	944	1499	0.002668446	0.004002668	0	oligos	OL-Cntl	NA	NA	NA
GCCAAATAGAGCTGCA-1_8_E5	-25.74554955	20.50981735	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1513	2743	0.00255195	0.00255195	0	8	Astrocytes	NA	NA	NA
GCCAAATAGCTTTGGT-1_8_E5	-25.58706257	20.45331506	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1609	3021	0.000662032	0.00264813	0	8	Astrocytes	NA	NA	NA
GCCAAATGTGTTTGGT-1_8_E5	27.64515728	-2.577921301	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4112	11293	0.005401576	0.003276366	0	2	EN-L4	NA	NA	NA
GCCAAATGTTCACCTC-1_8_E5	15.90551028	-33.03458218	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5511	20362	0.004321776	0.003192221	0	3	EN-L5-6	NA	NA	NA
GCCAAATTCGGTTCGG-1_8_E5	25.68222782	3.86980918	15BA	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	934	1434	0.009065551	0.006276151	0	15BA	Stromal cells	NA	NA	NA
GCCTCTACATCCGTGG-1_8_E5	29.63752888	-1.947684749	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4102	10137	0.008878366	0.006313505	0	2	EN-L4	NA	NA	NA
GCCTCTAGTATATGAG-1_8_E5	-0.36075431	-15.56933921	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2636	6315	0.004908947	0.004433888	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCCTCTAGTGGCCCTA-1_8_E5	27.11638647	-4.783172971	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4924	15834	0.014652015	0.003157762	0	2	EN-L4	NA	NA	NA
GCCTCTATCAAAGTAG-1_8_E5	-38.07503603	-5.351472838	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1196	2092	0.004780115	0.001434034	0	9	OPC	NA	NA	NA
GCCTCTATCTGCAAGT-1_8_E5	27.56260258	-0.95275797	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3338	8276	0.002054132	0.003504108	0	2	EN-L4	NA	NA	NA
GCGACCATCCCATTAT-1_8_E5	28.6574502	-1.867688586	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4628	13004	0.002230083	0.00392187	0	2	EN-L4	NA	NA	NA
GCGACCATCGAGGTAG-1_8_E5	8.606620576	33.99257183	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	875	1363	0.005869406	0.004402054	0	oligos	OL-Cntl	NA	NA	NA
GCGAGAACAGGCTGAA-1_8_E5	-0.968426809	-20.86929058	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3273	7948	0.006039255	0.004529441	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCGAGAAGTCTCTCTG-1_8_E5	-37.75097948	2.563860346	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1785	3273	0.003055301	0.004582951	0	9	OPC	NA	NA	NA
GCGAGAATCCAAACTG-1_8_E5	23.15004819	-6.893915479	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3500	8384	0.002266221	0.005844466	0	3	EN-L5-6	NA	NA	NA
GCGAGAATCTAACTCT-1_8_E5	6.670728517	-31.52415258	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	6489	25595	0.005274468	0.003399101	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCGCAACCAAACCTAC-1_8_E5	19.49185308	12.46925462	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1468	2677	0.010085917	0.003735525	0	oligos	OL-Cntl	NA	NA	NA
GCGCAACTCAGCACAT-1_8_E5	26.24749167	-5.554200819	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	7927	38115	0.004512659	0.002859766	0	2	EN-L4	NA	NA	NA
GCGCAGTAGATCTGCT-1_8_E5	-27.21290787	16.87752451	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1065	1740	0	0.005747126	0	8	Astrocytes	NA	NA	NA
GCGCAGTAGCTGAACG-1_8_E5	-9.018886349	-18.60425743	6B	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	801	1223	0.117743254	0.00572363	0	6B	IN-SST	NA	NA	NA
GCGCAGTCAAGCGATG-1_8_E5	-37.92497328	3.016944172	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1965	3966	0.003025719	0.003277862	0	9	OPC	NA	NA	NA
GCGCAGTCAAGTAGTA-1_8_E5	6.686050198	-32.11363327	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5144	17673	0.005884683	0.001414587	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCGCAGTGTCGCTTTC-1_8_E5	10.44205047	31.65020515	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	840	1266	0.02685624	0.004739336	0	oligos	OL-Cntl	NA	NA	NA
GCGCAGTTCACCGTAA-1_8_E5	25.98093509	0.157766517	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2654	5472	0.005847953	0.004203216	0	2	EN-L4	NA	NA	NA
GCGCAGTTCGCCAAAT-1_8_E5	-22.98695642	31.34188201	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2464	5568	0.002155172	0.001975575	0	8	Astrocytes	NA	NA	NA
GCGCCAAAGTACGACG-1_8_E5	2.905656531	-29.59019925	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5166	17224	0.003599628	0.002090107	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCGCCAACATTCACTT-1_8_E5	-25.11952396	28.88593402	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1681	3070	0.001302932	0.002931596	0	8	Astrocytes	NA	NA	NA
GCGCCAAGTTAAGTAG-1_8_E5	5.733857371	35.11813189	17	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	812	1086	0.007366483	0.005524862	0	oligos	OL-MS-2	NA	NA	NA
GCGCCAAGTTGTGGCC-1_8_E5	7.434543448	34.445199	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	932	1361	0.006612785	0.002204262	0	oligos	OL-Cntl	NA	NA	NA
GCGCCAATCGTTACGA-1_8_E5	-17.79777637	-19.22230998	6B	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2297	5193	0.001925669	0.003466205	0	6B	IN-SST	NA	NA	NA
GCGCGATAGAGACTTA-1_8_E5	7.263492151	-33.25028467	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5086	16636	0.002043761	0.002284203	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCGCGATAGCTACCTA-1_8_E5	15.75085112	-7.605335731	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2894	7745	0.001549387	0.00232408	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCGCGATAGTACGATA-1_8_E5	22.43135046	13.44868976	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1361	2268	0.004850088	0.004409171	0	oligos	OL-Cntl	NA	NA	NA
GCGCGATCACCATCCT-1_8_E5	-0.852603766	-20.25602546	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2954	6704	0.007458234	0.002684964	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCGCGATGTAAAGTCA-1_8_E5	2.746260746	-28.25195657	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3256	7583	0.0030331	0.002769352	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCGCGATGTACCCAAT-1_8_E5	-0.028290636	-17.22665169	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2849	7078	0.006499011	0.003673354	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCGCGATGTCATCCCT-1_8_E5	-26.2618942	18.20535418	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1362	2252	0.001776199	0.003108348	0	8	Astrocytes	NA	NA	NA
GCGCGATTCACCGTAA-1_8_E5	-28.88456932	14.10849879	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	861	1307	0.005355777	0.001530222	0	8	Astrocytes	NA	NA	NA
GCGCGATTCTTGAGGT-1_8_E5	29.65917217	-2.257207308	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4021	9948	0.009147567	0.006332931	0	2	EN-L4	NA	NA	NA
GCGGGTTCACAGAGGT-1_8_E5	-6.266514704	-1.199170483	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1621	2903	0.017568033	0.005167069	0	13A	IN-VIP	NA	NA	NA
GCGGGTTGTAGAAGGA-1_8_E5	-6.156915684	-0.811093463	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1738	3176	0.01070529	0.004093199	0	13A	IN-VIP	NA	NA	NA
GCGGGTTTCCACGTTC-1_8_E5	20.74825634	23.54239722	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1095	1768	0.002262443	0.003393665	0	oligos	OL-Cntl	NA	NA	NA
GCGGGTTTCCGCAGTG-1_8_E5	13.97037813	-33.12377863	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4061	12613	0.001268532	0.00507413	0	3	EN-L5-6	NA	NA	NA
GCTCCTACAGAGTGTG-1_8_E5	-20.06532583	-27.45221093	6A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3386	8786	0.009219212	0.001821079	0	6A	IN-PV	NA	NA	NA
GCTCCTACAGGTGGAT-1_8_E5	4.933761602	29.97077786	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	791	1187	0.00589722	0.00758214	0	oligos	OL-Cntl	NA	NA	NA
GCTCCTACATGCCACG-1_8_E5	10.92209059	32.64221919	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	896	1428	0.00210084	0.007703081	0	oligos	OL-Cntl	NA	NA	NA
GCTCCTATCCGGGTGT-1_8_E5	-4.696628808	-9.814986223	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	869	1316	0.035714286	0.001519757	0	13A	IN-VIP	NA	NA	NA
GCTCCTATCGAATGCT-1_8_E5	19.18892466	15.71243582	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1083	1710	0.001754386	0.004093567	0	oligos	OL-Cntl	NA	NA	NA
GCTCCTATCTACCAGA-1_8_E5	19.39569992	8.522568691	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1800	3480	0.002011494	0.006034483	0	oligos	OL-Cntl	NA	NA	NA
GCTCTGTCAAAGTCAA-1_8_E5	25.87951576	-0.246049838	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2869	6777	0.012247307	0.002951158	0	2	EN-L4	NA	NA	NA
GCTCTGTCAAGGTGTG-1_8_E5	-1.539249993	-19.78670367	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2874	6540	0.00764526	0.002293578	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCTCTGTCAAGTCATC-1_8_E5	21.06665736	-29.52307832	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5955	21951	0.005147829	0.005375609	0	3	EN-L5-6	NA	NA	NA
GCTCTGTGTATAGTAG-1_8_E5	19.92096662	22.46990729	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1025	1616	0	0.006188119	0	oligos	OL-Cntl	NA	NA	NA
GCTCTGTGTCTAGCGC-1_8_E5	-8.673191181	0.555985769	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2342	4708	0.010195412	0.005097706	0	13A	IN-VIP	NA	NA	NA
GCTCTGTGTGACGGTA-1_8_E5	-7.101077081	-2.184649199	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1890	3477	0.025596779	0.004601668	0	13A	IN-VIP	NA	NA	NA
GCTCTGTTCGACAGCC-1_8_E5	-8.647764114	1.195301522	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2366	4751	0.015996632	0.002315302	0	13A	IN-VIP	NA	NA	NA
GCTGCAGCACCCAGTG-1_8_E5	-23.83062128	30.66650492	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2221	4790	0.00125261	0.003966597	0	8	Astrocytes	NA	NA	NA
GCTGCAGGTAGCGATG-1_8_E5	9.89808804	33.38304375	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	815	1217	0.00903862	0.004108463	0	oligos	OL-Cntl	NA	NA	NA
GCTGCAGTCCTGCAGG-1_8_E5	-24.75524036	29.98745894	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1827	3497	0.002287675	0.002001716	0	8	Astrocytes	NA	NA	NA
GCTGCGATCAGCCTAA-1_8_E5	-21.29337262	-27.99420265	6A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4775	14065	0.008745112	0.004692499	0	6A	IN-PV	NA	NA	NA
GCTGCGATCCAGAGGA-1_8_E5	-18.96116981	-17.86479618	6B	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2776	6350	0.012913386	0.003779528	0	6B	IN-SST	NA	NA	NA
GCTGCTTAGCGTAATA-1_8_E5	-38.9460212	0.754588118	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1448	2719	0.002574476	0.001471129	0	9	OPC	NA	NA	NA
GCTGCTTAGTCATCCA-1_8_E5	-26.72959195	15.92305948	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1170	1896	0.000527426	0.002109705	0	8	Astrocytes	NA	NA	NA
GCTGCTTCACCCATGG-1_8_E5	4.704867979	32.84320458	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	742	1037	0.004821601	0.00096432	0	oligos	OL-Cntl	NA	NA	NA
GCTGCTTCACTTAAGC-1_8_E5	10.37069986	32.75464744	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	878	1361	0.007347539	0.001469508	0	oligos	OL-Cntl	NA	NA	NA
GCTGGGTGTACCGAGA-1_8_E5	28.79026345	-1.730203071	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4212	11472	0.0027894	0.004358438	0	2	EN-L4	NA	NA	NA
GCTGGGTGTCATGCAT-1_8_E5	25.76402092	-5.020517334	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5433	18892	0.001164514	0.003334745	0	2	EN-L4	NA	NA	NA
GCTGGGTTCATATCGG-1_8_E5	2.034089825	-31.15478517	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5887	22794	0.003772923	0.001974204	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCTTCCACATCGGACC-1_8_E5	18.33240288	-0.007378645	12	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1503	3377	0.002072846	0.002072846	0	12	EN-MIX	NA	NA	NA
GCTTCCATCGCTTGTC-1_8_E5	28.79417701	-1.626326466	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5375	17964	0.005622356	0.004230684	0	2	EN-L4	NA	NA	NA
GCTTCCATCGTTACGA-1_8_E5	26.70379802	-5.217066174	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4534	13568	0.006264741	0.002948113	0	2	EN-L4	NA	NA	NA
GCTTCCATCTTTACAC-1_8_E5	0.738808775	-29.65807926	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4466	14038	0.004131643	0.001709645	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCTTGAAAGGATTCGG-1_8_E5	21.39861243	-0.028267325	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1621	3006	0.006320692	0.00332668	0	2	EN-L4	NA	NA	NA
GCTTGAAAGGGATGGG-1_8_E5	27.02522763	-4.957354959	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4186	11085	0.004330176	0.005051872	0	2	EN-L4	NA	NA	NA
GCTTGAACAACTTGAC-1_8_E5	18.11687999	-34.1394309	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4710	15399	0.003961296	0.003896357	0	3	EN-L5-6	NA	NA	NA
GCTTGAACATGGTCTA-1_8_E5	0.713620053	-26.22017089	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5644	21945	0.001594896	0.001731602	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCTTGAAGTACAGACG-1_8_E5	8.969887244	-8.475995932	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2144	4055	0.010850801	0.003205919	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GCTTGAAGTATCTGCA-1_8_E5	-9.438757097	2.159855155	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2884	6402	0.003748828	0.00531084	0	13A	IN-VIP	NA	NA	NA
GCTTGAAGTCGGCATC-1_8_E5	9.141589786	29.4452988	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	926	1459	0.007539411	0.006168609	0	oligos	OL-Cntl	NA	NA	NA
GCTTGAAGTGCTTCTC-1_8_E5	15.32222418	-33.91259451	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	7210	32290	0.004180861	0.004056984	0	3	EN-L5-6	NA	NA	NA
GGAAAGCAGGCGTACA-1_8_E5	15.73559014	-33.21180455	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5868	23608	0.00144019	0.003388682	0	3	EN-L5-6	NA	NA	NA
GGAAAGCCAGATCGGA-1_8_E5	-37.28454987	-6.610148622	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1145	1958	0.00102145	0.004085802	0	9	OPC	NA	NA	NA
GGAAAGCCAGCAGTTT-1_8_E5	-1.000178319	-20.83388228	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3791	10466	0.007548251	0.00305752	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GGAAAGCGTATAGGGC-1_8_E5	-7.026719134	-0.434057869	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2000	4255	0.015746181	0.003760282	0	13A	IN-VIP	NA	NA	NA
GGAAAGCGTTCACCTC-1_8_E5	18.9103614	8.012333976	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1952	4063	0.001968988	0.004676348	0	oligos	OL-Cntl	NA	NA	NA
GGAAAGCTCTTTCCTC-1_8_E5	17.5113078	13.21419515	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1221	2112	0.003314394	0.003787879	0	oligos	OL-Cntl	NA	NA	NA
GGAACTTCAAAGTCAA-1_8_E5	-22.41380148	-4.549818625	13B	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4087	10773	0.013181101	0.003156038	0	13B	IN-SV2C	NA	NA	NA
GGAACTTCAGATGGGT-1_8_E5	-0.980056447	-20.09498017	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3057	6523	0.010884562	0.00582554	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GGAACTTCAGTTTACG-1_8_E5	9.47547885	27.06059423	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	909	1366	0.002928258	0.005856515	0	oligos	OL-Cntl	NA	NA	NA
GGAACTTGTTTGTGTG-1_8_E5	4.189043724	-32.51222083	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	6333	27027	0.001406001	0.002516003	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GGAACTTTCATCACCC-1_8_E5	-2.149920521	-22.25741756	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3473	9532	0.004196391	0.003147293	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GGAACTTTCGTCCGTT-1_8_E5	4.321413004	-31.17165109	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3949	11942	0.000753643	0.002428404	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GGAATAAAGAAACCAT-1_8_E5	-3.087871459	-6.019673035	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	814	1230	0.000813008	0.003252033	0	13A	IN-VIP	NA	NA	NA
GGAATAACATCGGAAG-1_8_E5	31.24450269	-6.063290577	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3907	9367	0.012383901	0.005551404	0	2	EN-L4	NA	NA	NA
GGAATAAGTCCGAAGA-1_8_E5	-1.163491054	-19.73834269	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2828	6150	0.005528455	0.004390244	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GGAATAATCGATGAGG-1_8_E5	-25.13062454	20.12422286	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1565	2876	0.00069541	0.002781641	0	8	Astrocytes	NA	NA	NA
GGAATAATCTACTTAC-1_8_E5	-13.05356123	-19.41534352	6B	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1216	2136	0.020131086	0.002340824	0	6B	IN-SST	NA	NA	NA
GGACAAGAGAAGGCCT-1_8_E5	-4.104751324	-5.110035614	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1029	1609	0.013051585	0.003729024	0	13A	IN-VIP	NA	NA	NA
GGACAAGAGATACACA-1_8_E5	18.72952819	13.07495511	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1386	2308	0.009098787	0.005199307	0	oligos	OL-Cntl	NA	NA	NA
GGACAAGAGATAGGAG-1_8_E5	2.586052994	-24.87072893	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3687	9421	0.005731876	0.003715105	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GGACAAGAGATATACG-1_8_E5	-17.9554707	-27.30651223	6A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2799	6923	0.013000144	0.001300014	0	6A	IN-PV	NA	NA	NA
GGACAAGAGCCACCTG-1_8_E5	5.80012138	32.87679844	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	799	1158	0.001727116	0.004317789	0	oligos	OL-Cntl	NA	NA	NA
GGACAAGAGGCTAGAC-1_8_E5	-0.95111616	-21.00255098	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3669	9371	0.009604098	0.00341479	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GGACAAGAGGTAGCTG-1_8_E5	4.9012994	32.33339716	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	787	1185	0.005063291	0.007594937	0	oligos	OL-Cntl	NA	NA	NA
GGACAAGCACACGCTG-1_8_E5	8.606128319	33.81123426	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1005	1482	0.001349528	0.005398111	0	oligos	OL-Cntl	NA	NA	NA
GGACAAGCAGATGGCA-1_8_E5	11.04551471	31.66784104	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	762	1077	0.004642526	0.00185701	0	oligos	OL-Cntl	NA	NA	NA
GGACAAGGTATTAGCC-1_8_E5	15.52242355	-34.27356244	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5812	21891	0.004979215	0.005024896	0	3	EN-L5-6	NA	NA	NA
GGACAAGTCAGGATCT-1_8_E5	-31.89218027	-1.105978318	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1507	2698	0.009266123	0.004077094	0	9	OPC	NA	NA	NA
GGACAAGTCCACGACG-1_8_E5	-3.098858203	-6.49239856	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	832	1270	0.005511811	0.002362205	0	13A	IN-VIP	NA	NA	NA
GGACAAGTCGTCTGAA-1_8_E5	-1.599500224	-19.59742598	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3062	7775	0.008102894	0.001800643	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GGACAGACAACGCACC-1_8_E5	5.156105872	33.00128284	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	719	1039	0.006737247	0.006737247	0	oligos	OL-Cntl	NA	NA	NA
GGACAGACACGTGAGA-1_8_E5	25.94679252	-5.012870099	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4769	15011	0.001998534	0.003797215	0	2	EN-L4	NA	NA	NA
GGACAGACAGTCAGAG-1_8_E5	-25.86809667	19.64498917	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1352	2282	0.001314636	0.00219106	0	8	Astrocytes	NA	NA	NA
GGACATTAGATCTGCT-1_8_E5	18.51612026	1.593171594	12	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1135	1752	0.017123288	0.002283105	0	12	EN-MIX	NA	NA	NA
GGACATTAGTGACTCT-1_8_E5	23.10421833	12.23188458	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1509	2568	0.004283489	0.005841121	0	oligos	OL-Cntl	NA	NA	NA
GGACATTGTAGCCTCG-1_8_E5	-20.84121027	-27.4624888	6A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3930	10172	0.002457727	0.005996854	0	6A	IN-PV	NA	NA	NA
GGACATTGTTGAACTC-1_8_E5	13.02610747	29.99298036	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	852	1329	0.003009782	0.003009782	0	oligos	OL-Cntl	NA	NA	NA
GGACATTTCGCCATAA-1_8_E5	-0.66789996	-14.8543199	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2415	5347	0.004301477	0.002992332	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GGACGTCCACTACAGT-1_8_E5	1.860005773	30.4395289	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	798	1169	0.005988024	0.006843456	0	oligos	OL-Cntl	NA	NA	NA
GGACGTCGTCTGATTG-1_8_E5	-23.99364821	29.69398389	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1982	4007	0.004492139	0.003244322	0	8	Astrocytes	NA	NA	NA
GGACGTCTCCTGTAGA-1_8_E5	-36.84145349	2.163359414	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1753	3261	0.00766636	0.006133088	0	9	OPC	NA	NA	NA
GGACGTCTCCTTCAAT-1_8_E5	-9.441392715	2.732859718	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3636	10019	0.006088432	0.004691087	0	13A	IN-VIP	NA	NA	NA
GGAGCAAAGGTAAACT-1_8_E5	-25.7868959	20.520242	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1586	2775	0.002882883	0.003603604	0	8	Astrocytes	NA	NA	NA
GGAGCAACAAGTCTAC-1_8_E5	-0.742659269	-21.77981662	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4184	12344	0.005508749	0.003807518	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GGAGCAACACAGACAG-1_8_E5	29.13017371	-1.217867736	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3211	7442	0.008465466	0.002553077	0	2	EN-L4	NA	NA	NA
GGAGCAACATTCCTGC-1_8_E5	23.8915773	-9.554150086	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5305	16610	0.005779651	0.004033715	0	3	EN-L5-6	NA	NA	NA
GGAGCAACATTTCAGG-1_8_E5	-25.74140336	20.59529809	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1616	2953	0.000338639	0.002031832	0	8	Astrocytes	NA	NA	NA
GGATGTTCACATGGGA-1_8_E5	-12.46644442	-19.61550736	6B	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1140	1927	0.015049299	0.00363259	0	6B	IN-SST	NA	NA	NA
GGATGTTGTCGAACAG-1_8_E5	-1.183806139	-21.75753052	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3810	11227	0.008372673	0.002493988	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GGATGTTTCAAACCAC-1_8_E5	8.343828774	34.20791003	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	931	1450	0.006206897	0.004137931	0	oligos	OL-Cntl	NA	NA	NA
GGATGTTTCGTGGGAA-1_8_E5	11.42831698	30.64725741	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	706	1012	0.002964427	0.004940711	0	oligos	OL-Cntl	NA	NA	NA
GGATGTTTCGTTGACA-1_8_E5	-10.98926422	2.958262459	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3795	10380	0.014450867	0.003949904	0	13A	IN-VIP	NA	NA	NA
GGATTACAGAAGGCCT-1_8_E5	-4.349297476	23.96469744	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	644	1004	0.00498008	0.005976096	0	oligos	OL-Cntl	NA	NA	NA
GGATTACGTGATAAAC-1_8_E5	-25.57789342	20.54658732	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1576	3014	0.001658925	0.00199071	0	8	Astrocytes	NA	NA	NA
GGATTACTCAGTTCGA-1_8_E5	26.75427389	-0.131628857	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3005	7338	0.002861815	0.002316708	0	2	EN-L4	NA	NA	NA
GGCAATTAGTGCGTGA-1_8_E5	11.2165079	28.2148202	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	768	1171	0.002561913	0.003415884	0	oligos	OL-Cntl	NA	NA	NA
GGCAATTAGTTCGATC-1_8_E5	5.907924021	32.02056756	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	723	1060	0.003773585	0.005660377	0	oligos	OL-Cntl	NA	NA	NA
GGCAATTCAACACCTA-1_8_E5	27.44911021	-1.322571964	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3228	7779	0.0052706	0.002828127	0	2	EN-L4	NA	NA	NA
GGCAATTCATGAACCT-1_8_E5	-25.32998622	20.22472484	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1600	2979	0.000671366	0.003021148	0	8	Astrocytes	NA	NA	NA
GGCAATTGTTAAAGTG-1_8_E5	20.8645919	1.059006754	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2202	5131	0.001754044	0.003118301	0	2	EN-L4	NA	NA	NA
GGCCGATCAATACGCT-1_8_E5	-25.84835638	19.6212349	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1398	2495	0.000801603	0.003607214	0	8	Astrocytes	NA	NA	NA
GGCCGATCACATCCGG-1_8_E5	28.40225893	-1.705046435	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4613	13539	0.005170249	0.002954428	0	2	EN-L4	NA	NA	NA
GGCCGATGTGCAGGTA-1_8_E5	17.31526678	11.69836446	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1424	2649	0.003397508	0.006417516	0	oligos	OL-Cntl	NA	NA	NA
GGCGACTAGATGTGGC-1_8_E5	-3.921571269	35.7467599	17	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	819	1105	0.00361991	0.007239819	0	oligos	OL-MS-2	NA	NA	NA
GGCGACTCACAAGACG-1_8_E5	-38.2487956	0.595716239	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1513	2602	0.012298232	0.001537279	0	9	OPC	NA	NA	NA
GGCGACTGTTTGGCGC-1_8_E5	18.58153733	8.841870339	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1608	2989	0.00200736	0.005018401	0	oligos	OL-Cntl	NA	NA	NA
GGCGACTTCAACCAAC-1_8_E5	9.668580745	28.53290964	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	754	1090	0.002752294	0.001834862	0	oligos	OL-Cntl	NA	NA	NA
GGCGACTTCTCACATT-1_8_E5	9.242800871	33.2673352	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	928	1375	0.008	0.004363636	0	oligos	OL-Cntl	NA	NA	NA
GGCGACTTCTCGTTTA-1_8_E5	10.09549377	-7.160149671	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1725	3308	0.021765417	0.001813785	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GGCGTGTAGCGTCTAT-1_8_E5	18.17316929	1.578835471	12	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1106	1703	0.024075161	0.004110393	0	12	EN-MIX	NA	NA	NA
GGCTCGATCACAATGC-1_8_E5	-1.581376687	-19.81665501	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2987	6981	0.002578427	0.003437903	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GGCTGGTAGCGTGTCC-1_8_E5	28.70480626	-0.884910562	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3737	9644	0.007154708	0.003110742	0	2	EN-L4	NA	NA	NA
GGCTGGTAGCTCCTCT-1_8_E5	8.172065077	32.35873885	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	805	1210	0.009917355	0.012396694	0	oligos	OL-Cntl	NA	NA	NA
GGCTGGTCAGTGGGAT-1_8_E5	19.66608699	25.75515064	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	966	1485	0	0.006060606	0	oligos	OL-Cntl	NA	NA	NA
GGCTGGTTCCCAACGG-1_8_E5	1.685246622	-30.8563613	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	6351	25107	0.006253236	0.002907556	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GGCTGGTTCCCTAACC-1_8_E5	17.49278415	1.006640555	12	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1002	1488	0.036962366	0.000672043	0	12	EN-MIX	NA	NA	NA
GGCTGGTTCTGGCGTG-1_8_E5	26.3052375	-5.20891773	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4916	14937	0.001740644	0.003213497	0	2	EN-L4	NA	NA	NA
GGGAATGAGCCAGAAC-1_8_E5	-8.948451544	2.361749757	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2995	7690	0.004421326	0.004681404	0	13A	IN-VIP	NA	NA	NA
GGGAATGAGCCAGTAG-1_8_E5	5.971110867	34.52775826	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	752	1022	0.008806262	0.006849315	0	oligos	OL-Cntl	NA	NA	NA
GGGAATGCAATAGAGT-1_8_E5	24.79795417	-28.14810236	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3268	8162	0.002817937	0.002940456	0	3	EN-L5-6	NA	NA	NA
GGGAATGCATCCGGGT-1_8_E5	-10.9991248	2.667839365	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3291	7698	0.01208106	0.004806443	0	13A	IN-VIP	NA	NA	NA
GGGAATGCATCTACGA-1_8_E5	28.38519167	-26.15695536	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5297	19587	0.003114311	0.00347169	0	3	EN-L5-6	NA	NA	NA
GGGAATGGTTTCGCTC-1_8_E5	-24.07613982	15.67144739	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1379	2351	0.027222459	0.003402807	0	8	Astrocytes	NA	NA	NA
GGGACCTAGAAACCGC-1_8_E5	-25.64672613	29.98671629	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1926	3760	0.001861702	0.00212766	0	8	Astrocytes	NA	NA	NA
GGGACCTAGACAGAGA-1_8_E5	3.500672928	-29.02713061	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3290	7724	0.003495598	0.003107198	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GGGACCTAGCCATCGC-1_8_E5	10.21240367	31.53244715	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	829	1192	0.000838926	0.000838926	0	oligos	OL-Cntl	NA	NA	NA
GGGACCTAGTCACGCC-1_8_E5	7.421531107	33.32385778	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	795	1156	0.002595156	0.001730104	0	oligos	OL-Cntl	NA	NA	NA
GGGACCTAGTCTTGCA-1_8_E5	10.12068026	-8.92501231	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2558	5837	0.001199246	0.002227171	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GGGACCTCAAGTACCT-1_8_E5	20.99833195	-29.34401453	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4727	14397	0.005973467	0.006112385	0	3	EN-L5-6	NA	NA	NA
GGGACCTGTAGGGACT-1_8_E5	-31.79462833	-12.35159687	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	820	1194	0.001675042	0.002512563	0	9	OPC	NA	NA	NA
GGGACCTGTCACCCAG-1_8_E5	8.35086777	34.29090025	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	946	1460	0.00890411	0.003424658	0	oligos	OL-Cntl	NA	NA	NA
GGGACCTGTCCATCCT-1_8_E5	-1.636095614	-24.39658374	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4615	14577	0.006105509	0.003292859	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GGGACCTTCTGCGGCA-1_8_E5	-8.851984387	1.312958609	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2163	4433	0.010602301	0.004962779	0	13A	IN-VIP	NA	NA	NA
GGGAGATGTCACCTAA-1_8_E5	-26.31995816	16.3075344	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1225	1896	0.002637131	0.005801688	0	8	Astrocytes	NA	NA	NA
GGGAGATGTCCAGTTA-1_8_E5	-0.839772314	-13.57172881	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1984	3826	0.004443283	0.003920544	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GGGAGATGTGAGGCTA-1_8_E5	5.752166669	32.69879956	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	714	1020	0.003921569	0.006862745	0	oligos	OL-Cntl	NA	NA	NA
GGGAGATGTTAGAACA-1_8_E5	29.3980084	-2.143762856	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4364	11483	0.004441348	0.003657581	0	2	EN-L4	NA	NA	NA
GGGAGATGTTTGTGTG-1_8_E5	-24.56984095	29.7867159	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1706	3071	0.002279388	0.002279388	0	8	Astrocytes	NA	NA	NA
GGGAGATTCATTGCGA-1_8_E5	-17.50982362	-23.60980714	6A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2217	5115	0.037536657	0.002541544	0	6A	IN-PV	NA	NA	NA
GGGAGATTCGCGGATC-1_8_E5	-35.34187941	-8.114663947	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1073	1651	0.004239855	0.003028468	0	9	OPC	NA	NA	NA
GGGAGATTCTAGAGTC-1_8_E5	-36.02007411	-8.805469449	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1066	1642	0.00182704	0.005481121	0	9	OPC	NA	NA	NA
GGGATGACAGGGTATG-1_8_E5	9.430365181	26.15535331	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1005	1541	0.002595717	0.007138222	0	oligos	OL-Cntl	NA	NA	NA
GGGATGATCAACCATG-1_8_E5	-38.50430059	0.564226961	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1542	2728	0.002565982	0.002199413	0	9	OPC	NA	NA	NA
GGGATGATCATGCAAC-1_8_E5	5.373060168	33.12482306	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	714	1036	0.004826255	0.003861004	0	oligos	OL-Cntl	NA	NA	NA
GGGCACTAGCAACGGT-1_8_E5	-4.142352124	-4.506359706	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1232	2145	0.037296037	0.002331002	0	13A	IN-VIP	NA	NA	NA
GGGCACTAGCCGTCGT-1_8_E5	20.25434161	22.69323047	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1243	2133	0.004219409	0.005157056	0	oligos	OL-Cntl	NA	NA	NA
GGGCACTAGTCAAGGC-1_8_E5	-0.783558603	-24.63094258	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4690	14306	0.003145533	0.004194044	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GGGCACTAGTCTTGCA-1_8_E5	-35.86526523	4.940352919	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2413	4870	0.002053388	0.00164271	0	9	OPC	NA	NA	NA
GGGCACTGTAGATTAG-1_8_E5	-22.11814846	31.68615991	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3232	7904	0.000506073	0.003795547	0	8	Astrocytes	NA	NA	NA
GGGCACTTCTACTTAC-1_8_E5	10.84072536	15.81408462	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1145	1870	0.002673797	0.006417112	0	oligos	OL-Cntl	NA	NA	NA
GGGCACTTCTTTACAC-1_8_E5	5.338076294	31.56171673	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	687	1055	0.003791469	0.005687204	0	oligos	OL-Cntl	NA	NA	NA
GGGCATCAGTTGTAGA-1_8_E5	18.38846146	14.9728672	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1216	2105	0.004275534	0.003325416	0	oligos	OL-Cntl	NA	NA	NA
GGGCATCGTGGTCCGT-1_8_E5	17.31849578	16.13757864	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1095	1840	0.005434783	0.003804348	0	oligos	OL-Cntl	NA	NA	NA
GGGCATCTCCGTCAAA-1_8_E5	10.80904901	27.11204857	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	877	1358	0.008836524	0.001472754	0	oligos	OL-Cntl	NA	NA	NA
GGGCATCTCTGCGACG-1_8_E5	0.823721206	33.14926448	17	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	834	1102	0.007259528	0.006352087	0	oligos	OL-MS-2	NA	NA	NA
GGGTCTGAGCCAACAG-1_8_E5	7.993332931	32.1964794	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	752	1036	0.000965251	0.002895753	0	oligos	OL-Cntl	NA	NA	NA
GGGTCTGAGTACCGGA-1_8_E5	0.308079351	-27.35329079	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4208	12108	0.002147341	0.0016518	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GGGTCTGAGTGTCTCA-1_8_E5	-5.48802071	-5.402868958	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1209	2018	0.03518335	0.003468781	0	13A	IN-VIP	NA	NA	NA
GGGTCTGCAGACGCCT-1_8_E5	21.2412642	23.10016708	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1068	1664	0.006610577	0.004206731	0	oligos	OL-Cntl	NA	NA	NA
GGGTCTGCATTCACTT-1_8_E5	1.888132009	-30.72774083	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	6028	24117	0.005058672	0.003400091	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GGGTCTGTCACAGTAC-1_8_E5	-26.20309373	19.2046172	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1326	2215	0.001805869	0.003160271	0	8	Astrocytes	NA	NA	NA
GGGTCTGTCCACTCCA-1_8_E5	-20.09425235	-29.15168386	6A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4041	11303	0.003892772	0.003273467	0	6A	IN-PV	NA	NA	NA
GGGTTGCAGAACTGTA-1_8_E5	-19.27534711	-18.36180348	6B	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2884	6331	0.003948823	0.005528353	0	6B	IN-SST	NA	NA	NA
GGGTTGCAGATGTCGG-1_8_E5	29.1064435	-1.300620992	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3656	8789	0.002844465	0.004778701	0	2	EN-L4	NA	NA	NA
GGGTTGCAGGACGAAA-1_8_E5	-31.73242564	-2.31539486	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1272	2025	0.003950617	0.002469136	0	9	OPC	NA	NA	NA
GGGTTGCAGTTGTCGT-1_8_E5	1.071865395	-27.84333051	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4442	13265	0.007312476	0.001809273	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GGGTTGCCAAGGTTTC-1_8_E5	-36.71172476	1.585126631	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1707	3084	0.002918288	0.004215305	0	9	OPC	NA	NA	NA
GGGTTGCGTCATTAGC-1_8_E5	-20.32474127	-26.34185962	6A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3645	9623	0.008625169	0.004780214	0	6A	IN-PV	NA	NA	NA
GGGTTGCGTCTCAACA-1_8_E5	17.5686301	15.47726647	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1185	1988	0.004024145	0.002515091	0	oligos	OL-Cntl	NA	NA	NA
GGGTTGCTCCACGTGG-1_8_E5	26.26700212	-5.339382875	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4213	12050	0.007551867	0.002489627	0	2	EN-L4	NA	NA	NA
GGTATTGCAAACCCAT-1_8_E5	3.58974658	33.32143101	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	731	1060	0.002830189	0.009433962	0	oligos	OL-Cntl	NA	NA	NA
GGTATTGCACGCCAGT-1_8_E5	0.129965479	2.142332766	11	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	977	1411	0.004961021	0.002834869	0	11	Glia-MIX	NA	NA	NA
GGTATTGCAGTATAAG-1_8_E5	17.76289857	-5.352558102	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1203	2079	0.007215007	0.001443001	0	3	EN-L5-6	NA	NA	NA
GGTATTGGTAAGCACG-1_8_E5	30.40305125	-7.028310652	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3730	8575	0.0096793	0.004664723	0	2	EN-L4	NA	NA	NA
GGTATTGGTCTCTCTG-1_8_E5	9.085068722	33.22258962	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	930	1446	0.004840941	0.003457815	0	oligos	OL-Cntl	NA	NA	NA
GGTATTGGTTGAGTTC-1_8_E5	10.31606498	30.32692823	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	752	1099	0.005459509	0.003639672	0	oligos	OL-Cntl	NA	NA	NA
GGTATTGTCCCTTGCA-1_8_E5	9.100051657	28.6034471	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	966	1565	0.01086262	0.004472843	0	oligos	OL-Cntl	NA	NA	NA
GGTATTGTCCTTAATC-1_8_E5	-4.578287262	-21.0145839	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2933	6821	0.006304061	0.002785515	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GGTATTGTCGAGAGCA-1_8_E5	-2.307769306	-18.42790007	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3342	9122	0.002959877	0.002411752	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GGTATTGTCTGCTGTC-1_8_E5	-10.46881646	2.269611019	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2998	7291	0.008092168	0.004251817	0	13A	IN-VIP	NA	NA	NA
GGTGAAGAGCTCCTCT-1_8_E5	-0.800163316	-21.92686548	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4188	11326	0.003884867	0.00291365	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GGTGAAGGTCAGAGGT-1_8_E5	26.30038442	-27.61020004	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5625	18798	0.001915097	0.004202575	0	3	EN-L5-6	NA	NA	NA
GGTGAAGGTTGCGTTA-1_8_E5	-24.20620508	30.0297165	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1842	3725	0.003221477	0.002684564	0	8	Astrocytes	NA	NA	NA
GGTGAAGTCGGCGGTT-1_8_E5	-14.12128985	-23.81983201	6A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1471	2516	0.003577107	0.005961844	0	6A	IN-PV	NA	NA	NA
GGTGCGTAGTGTTTGC-1_8_E5	-19.47140601	-25.35995752	6A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3010	6489	0.007397134	0.003390353	0	6A	IN-PV	NA	NA	NA
GGTGCGTCAGGCTGAA-1_8_E5	-7.411557555	-2.382982204	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1660	2868	0.038354254	0.0027894	0	13A	IN-VIP	NA	NA	NA
GGTGCGTCATTCACTT-1_8_E5	-22.94781907	26.5813635	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1863	3418	0.008484494	0.004388531	0	8	Astrocytes	NA	NA	NA
GGTGCGTGTCAAACTC-1_8_E5	-4.315634679	-31.12734397	16	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	630	1214	0.382207578	0.010708402	0	16	EN-PYR	NA	NA	NA
GGTGCGTTCAGTTGAC-1_8_E5	10.96719788	32.21879668	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	867	1294	0.004636785	0.001545595	0	oligos	OL-Cntl	NA	NA	NA
GGTGCGTTCATAGCAC-1_8_E5	22.75050035	1.03058138	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1703	2861	0.005242922	0.00559245	0	2	EN-L4	NA	NA	NA
GGTGCGTTCCGAGCCA-1_8_E5	13.30381608	-30.05928573	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3535	9200	0.001630435	0.00673913	0	3	EN-L5-6	NA	NA	NA
GGTGCGTTCGCTTGTC-1_8_E5	-0.211425722	-0.081153114	11	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1038	1571	0.021005729	0.002546149	0	11	Glia-MIX	NA	NA	NA
GGTGTTAAGAGGTAGA-1_8_E5	-35.66093646	4.992553781	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2561	5715	0.001574803	0.004024497	0	9	OPC	NA	NA	NA
GGTGTTAAGCGCCTTG-1_8_E5	-27.5720249	18.6300972	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1225	2129	0.001878816	0.003757633	0	8	Astrocytes	NA	NA	NA
GGTGTTAAGGGATCTG-1_8_E5	-26.66154994	10.07161178	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	868	1376	0.003633721	0.004360465	0	8	Astrocytes	NA	NA	NA
GGTGTTACAAATCCGT-1_8_E5	18.9724948	23.81733764	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	949	1483	0.002022927	0.009440324	0	oligos	OL-Cntl	NA	NA	NA
GGTGTTACACTACAGT-1_8_E5	-25.46452247	20.32401134	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1548	2923	0.003079028	0.003421143	0	8	Astrocytes	NA	NA	NA
GGTGTTACATCGGGTC-1_8_E5	-26.405906	18.71919491	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1246	2086	0.001438159	0.001917546	0	8	Astrocytes	NA	NA	NA
GGTGTTAGTCTACCTC-1_8_E5	-4.593705912	-2.266439721	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1407	2688	0.015252976	0.001860119	0	13A	IN-VIP	NA	NA	NA
GGTGTTAGTTGGTTTG-1_8_E5	-3.528552505	-4.926935743	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1176	2068	0.01450677	0.003868472	0	13A	IN-VIP	NA	NA	NA
GTAACGTAGCCAACAG-1_8_E5	4.44773177	32.36150037	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	740	1046	0.000956023	0.004780115	0	oligos	OL-Cntl	NA	NA	NA
GTAACGTGTACAAGTA-1_8_E5	9.838940553	32.54636286	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	806	1190	0.005042017	0.001680672	0	oligos	OL-Cntl	NA	NA	NA
GTAACTGAGATGCCAG-1_8_E5	30.68486013	-1.091217158	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3311	8065	0.006819591	0.003967762	0	2	EN-L4	NA	NA	NA
GTAACTGAGGGATCTG-1_8_E5	-10.52421718	2.074039394	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3292	7983	0.01478141	0.005636979	0	13A	IN-VIP	NA	NA	NA
GTAACTGCAATGGATA-1_8_E5	14.74250073	-33.72896149	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4263	13269	0.000678273	0.004521818	0	3	EN-L5-6	NA	NA	NA
GTAACTGGTTAGTGGG-1_8_E5	9.989434094	30.4899834	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	749	1146	0.003490401	0.002617801	0	oligos	OL-Cntl	NA	NA	NA
GTAACTGTCTTATCTG-1_8_E5	25.43106134	-2.611384366	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2834	6786	0.006336575	0.003094607	0	2	EN-L4	NA	NA	NA
GTACGTAAGATCGATA-1_8_E5	-34.12660269	-8.741849384	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1148	1881	0.03774588	0.002658161	0	9	OPC	NA	NA	NA
GTACGTACATAGAAAC-1_8_E5	26.17464877	-5.392324238	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5977	22313	0.009277103	0.002957917	0	2	EN-L4	NA	NA	NA
GTACGTACATCGGGTC-1_8_E5	-38.52940803	-1.19748936	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1334	2353	0.003399915	0.002974926	0	9	OPC	NA	NA	NA
GTACGTAGTGCCTTGG-1_8_E5	-38.07747951	2.343161945	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1651	3138	0.00446144	0.002549395	0	9	OPC	NA	NA	NA
GTACGTATCAAACGGG-1_8_E5	6.538204631	31.62296659	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	726	1098	0.007285974	0.005464481	0	oligos	OL-Cntl	NA	NA	NA
GTACGTATCGCTTAGA-1_8_E5	10.49521341	-29.05491149	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	6689	25356	0.010608929	0.002445181	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GTACTCCAGATGTAAC-1_8_E5	-15.7634391	-11.18496667	13B	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3179	7146	0.01959138	0.003638399	0	13B	IN-SV2C	NA	NA	NA
GTACTCCCATCACAAC-1_8_E5	-25.83654143	29.6152684	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1637	2925	0.000683761	0.002735043	0	8	Astrocytes	NA	NA	NA
GTACTCCTCAATAAGG-1_8_E5	-25.96234907	29.96220124	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1966	3623	0.002208115	0.006072316	0	8	Astrocytes	NA	NA	NA
GTACTTTAGATGAGAG-1_8_E5	-9.647182113	2.714165193	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3255	7405	0.010938555	0.005131668	0	13A	IN-VIP	NA	NA	NA
GTACTTTAGGTGCACA-1_8_E5	7.009922494	30.71926129	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	919	1373	0.002913328	0.002913328	0	oligos	OL-Cntl	NA	NA	NA
GTACTTTCACGGACAA-1_8_E5	-16.94461496	-10.7959145	13B	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3766	10213	0.010476843	0.003622834	0	13B	IN-SV2C	NA	NA	NA
GTACTTTCATCAGTCA-1_8_E5	1.095069176	-30.24045389	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	6005	23421	0.005465181	0.002860681	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GTACTTTGTAAGTGTA-1_8_E5	7.288615867	-32.59761307	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5036	17121	0.003095614	0.002219497	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GTACTTTTCCTAGAAC-1_8_E5	19.61660642	12.10543932	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1436	2692	0.006686478	0.002600297	0	oligos	OL-Cntl	NA	NA	NA
GTAGGCCAGAGCTATA-1_8_E5	-26.71873597	16.00358509	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1163	1843	0.000542594	0.003798155	0	8	Astrocytes	NA	NA	NA
GTAGGCCAGTTAGGTA-1_8_E5	-1.961682341	-20.24914623	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3144	7970	0.004140527	0.003387704	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GTAGGCCCAAGCCCAC-1_8_E5	-1.351371376	-19.82700587	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3359	7998	0.003625906	0.002500625	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GTAGGCCCAGGGCATA-1_8_E5	15.04916063	-33.69874127	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	6152	25552	0.00446149	0.00399186	0	3	EN-L5-6	NA	NA	NA
GTAGGCCGTCACTGGC-1_8_E5	-0.393301065	-22.22346298	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4589	13784	0.003627394	0.004280325	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GTAGGCCGTGGGTCAA-1_8_E5	5.788272912	31.02991804	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	880	1338	0.005231689	0.008221226	0	oligos	OL-Cntl	NA	NA	NA
GTAGGCCGTTAGATGA-1_8_E5	16.49637431	1.422143669	12	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	742	1050	0.018095238	0.001904762	0	12	EN-MIX	NA	NA	NA
GTAGGCCTCATACGGT-1_8_E5	-6.695703612	-1.320130567	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1803	3281	0.017067967	0.003657422	0	13A	IN-VIP	NA	NA	NA
GTAGGCCTCGCATGAT-1_8_E5	-14.85813972	-19.27457017	6B	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1525	3063	0.025138753	0.00359125	0	6B	IN-SST	NA	NA	NA
GTAGGCCTCTCGAGTA-1_8_E5	19.01424419	25.09709329	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	928	1372	0.008746356	0.002915452	0	oligos	OL-Cntl	NA	NA	NA
GTAGTCAAGAGGACGG-1_8_E5	-1.636122649	-22.12665006	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3754	9834	0.008440106	0.003355705	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GTAGTCAAGATTACCC-1_8_E5	13.06670576	23.86078955	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1049	1646	0.005467801	0.005467801	0	oligos	OL-Cntl	NA	NA	NA
GTAGTCAAGCGGATCA-1_8_E5	-19.94136517	-28.82487421	6A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4132	12000	0.002416667	0.00325	0	6A	IN-PV	NA	NA	NA
GTAGTCAAGGGCTTGA-1_8_E5	-2.680051702	-0.933775458	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3190	7340	0.004495913	0.003814714	0	13A	IN-VIP	NA	NA	NA
GTAGTCAGTGACGCCT-1_8_E5	-3.440594763	-4.659260189	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1175	1944	0.018004115	0.000514403	0	13A	IN-VIP	NA	NA	NA
GTAGTCATCCAATGGT-1_8_E5	18.46621355	24.29672391	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	946	1450	0.000689655	0.004137931	0	oligos	OL-Cntl	NA	NA	NA
GTAGTCATCCAGATCA-1_8_E5	10.07298785	31.74893882	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	902	1403	0.002851033	0.006414825	0	oligos	OL-Cntl	NA	NA	NA
GTAGTCATCCCAAGAT-1_8_E5	-1.878630281	-15.78243495	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2562	5467	0.002560819	0.004938723	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GTAGTCATCTTGTCAT-1_8_E5	25.40884579	-2.501144004	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2388	4873	0.008824133	0.004719885	0	2	EN-L4	NA	NA	NA
GTATCTTCAGGGTACA-1_8_E5	5.58305883	-32.16640003	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4031	12659	0.002606841	0.002053875	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GTATCTTCATCTACGA-1_8_E5	-38.61414915	-0.592224476	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1517	2810	0.001779359	0.003914591	0	9	OPC	NA	NA	NA
GTATCTTGTAGTACCT-1_8_E5	-1.9698176	-19.13893316	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3118	7725	0.003754045	0.002847896	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GTATCTTGTCGGCATC-1_8_E5	23.53329249	-9.178230874	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3997	11290	0.001860053	0.003454384	0	3	EN-L5-6	NA	NA	NA
GTATCTTGTGGCGAAT-1_8_E5	-25.5395848	19.71146562	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1353	2178	0.00137741	0.004132231	0	8	Astrocytes	NA	NA	NA
GTATTCTCACGCGAAA-1_8_E5	-9.028785896	0.799280197	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2340	5167	0.009676795	0.005999613	0	13A	IN-VIP	NA	NA	NA
GTATTCTTCCTCAACC-1_8_E5	6.175975704	34.78468085	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	772	1118	0.006261181	0.001788909	0	oligos	OL-Cntl	NA	NA	NA
GTATTCTTCTCGCATC-1_8_E5	-9.039040511	1.283935845	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2717	6395	0.008600469	0.002814699	0	13A	IN-VIP	NA	NA	NA
GTCAAGTAGACTCGGA-1_8_E5	8.458853517	31.95450621	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	784	1135	0.005286344	0.007048458	0	oligos	OL-Cntl	NA	NA	NA
GTCAAGTCAGGTCCAC-1_8_E5	-1.225666346	-19.79449429	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3143	7561	0.000925803	0.005951594	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GTCAAGTGTAATCGTC-1_8_E5	2.258958366	-28.20954247	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3299	8538	0.006910283	0.002693839	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GTCAAGTGTACAGTGG-1_8_E5	-0.840885692	-25.21359208	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4788	14924	0.002948271	0.002881265	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GTCAAGTGTCATCGGC-1_8_E5	18.40280211	7.480347092	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1959	3577	0.002795639	0.005591278	0	oligos	OL-Cntl	NA	NA	NA
GTCAAGTGTCTCTTAT-1_8_E5	15.61447278	-33.14875301	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	6140	23684	0.002955582	0.005193379	0	3	EN-L5-6	NA	NA	NA
GTCAAGTGTTACAGAA-1_8_E5	-7.645818511	-0.895562008	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2087	4009	0.016462958	0.003741581	0	13A	IN-VIP	NA	NA	NA
GTCAAGTTCAAGATCC-1_8_E5	-3.213067365	-5.674311642	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1025	1669	0.011983223	0.002995806	0	13A	IN-VIP	NA	NA	NA
GTCAAGTTCCATGCTC-1_8_E5	20.00143958	23.28569507	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1035	1684	0	0.004750594	0	oligos	OL-Cntl	NA	NA	NA
GTCACAAAGACTACAA-1_8_E5	5.775076889	34.94868298	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	832	1165	0.01888412	0.006866953	0	oligos	OL-Cntl	NA	NA	NA
GTCACAAAGTGGAGTC-1_8_E5	-17.6933696	-26.73845	6A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2407	5126	0.008973859	0.004291845	0	6A	IN-PV	NA	NA	NA
GTCACAACACAGCCCA-1_8_E5	-12.89309841	-19.55455032	6B	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1143	1917	0.010432968	0.004694836	0	6B	IN-SST	NA	NA	NA
GTCACAACACGGACAA-1_8_E5	22.3476126	-29.43015436	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4591	14451	0.002629576	0.004636357	0	3	EN-L5-6	NA	NA	NA
GTCACAACAGCTTAAC-1_8_E5	-0.543607042	-14.88736533	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2680	6129	0.004078969	0.001794746	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GTCACAACATGGGAAC-1_8_E5	-38.3493603	2.061284027	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1609	2724	0.003303965	0.001835536	0	9	OPC	NA	NA	NA
GTCACAAGTGCCTGCA-1_8_E5	-0.415143663	-19.4991413	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3217	8007	0.009366804	0.005744973	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GTCACAAGTTTCGCTC-1_8_E5	-10.81592686	2.43309722	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3431	8854	0.009374294	0.005985995	0	13A	IN-VIP	NA	NA	NA
GTCACAATCAGTGTTG-1_8_E5	-28.17103899	14.35562048	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	889	1443	0.002079002	0.001386001	0	8	Astrocytes	NA	NA	NA
GTCACAATCAGTTTGG-1_8_E5	6.401916108	31.47702736	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	829	1194	0.006700168	0.004187605	0	oligos	OL-Cntl	NA	NA	NA
GTCACAATCTACTTAC-1_8_E5	19.09790234	13.9474862	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1150	1866	0.002143623	0.005359057	0	oligos	OL-Cntl	NA	NA	NA
GTCACGGAGCAATCTC-1_8_E5	-26.017395	18.89830618	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1362	2322	0.000430663	0.003445306	0	8	Astrocytes	NA	NA	NA
GTCACGGAGTACTTGC-1_8_E5	-37.2263982	-0.962984278	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1430	2441	0.001638673	0.00450635	0	9	OPC	NA	NA	NA
GTCACGGCATTACGAC-1_8_E5	-0.351904939	1.017822824	11	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1355	2115	0.009456265	0.003309693	0	11	Glia-MIX	NA	NA	NA
GTCACGGCATTCACTT-1_8_E5	-38.12202214	2.940771543	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1702	3194	0.001565435	0.002817783	0	9	OPC	NA	NA	NA
GTCACGGGTAAGTTCC-1_8_E5	-23.08945875	29.71597708	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1986	3878	0.00051573	0.003610108	0	8	Astrocytes	NA	NA	NA
GTCACGGGTCCATCCT-1_8_E5	-20.293149	-17.84695867	6B	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3449	9111	0.014158709	0.005158599	0	6B	IN-SST	NA	NA	NA
GTCACGGGTCGAATCT-1_8_E5	33.37330396	6.57415928	14	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	872	1150	0.03826087	0.007826087	0	14	Microglia	NA	NA	NA
GTCACGGTCGGCCGAT-1_8_E5	29.48218049	-2.315642981	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4783	13147	0.009583935	0.004791968	0	2	EN-L4	NA	NA	NA
GTCATTTAGTTTCCTT-1_8_E5	1.099213164	-26.3813742	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4898	16145	0.007370703	0.003468566	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GTCATTTCAATGGACG-1_8_E5	-0.642330106	-14.51764214	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2215	4357	0.008262566	0.003901767	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GTCATTTCACGCCAGT-1_8_E5	6.021894859	-31.97989091	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5369	18546	0.00140192	0.003396959	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GTCCTCAAGTTTCCTT-1_8_E5	15.31200405	-34.06600895	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5602	20202	0.002970003	0.006237006	0	3	EN-L5-6	NA	NA	NA
GTCCTCAGTAAGGGAA-1_8_E5	-27.18298007	24.99301603	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1357	2359	0.000423908	0.003815176	0	8	Astrocytes	NA	NA	NA
GTCCTCAGTATCTGCA-1_8_E5	13.02638884	0.776654648	12	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	835	1403	0.003563792	0.002138275	0	12	EN-MIX	NA	NA	NA
GTCCTCAGTGATGTGG-1_8_E5	-12.82568951	-19.50847686	6B	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1128	1842	0.02062975	0.003257329	0	6B	IN-SST	NA	NA	NA
GTCCTCATCGTTACGA-1_8_E5	-20.25973509	-29.12503594	6A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4783	15230	0.006040709	0.003348654	0	6A	IN-PV	NA	NA	NA
GTCGGGTAGACAGACC-1_8_E5	-26.68518324	27.53123516	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1631	3191	0.001880288	0.001880288	0	8	Astrocytes	NA	NA	NA
GTCGGGTAGGCCCTTG-1_8_E5	-14.05784325	-24.81166569	6A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1470	2581	0.003099574	0.003874467	0	6A	IN-PV	NA	NA	NA
GTCGGGTCACTGCCAG-1_8_E5	-19.98343561	9.429783831	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	935	1338	0.001494768	0.003736921	0	8	Astrocytes	NA	NA	NA
GTCGGGTGTCTAACGT-1_8_E5	-15.95753755	-11.21693267	13B	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3217	7828	0.004471129	0.002043945	0	13B	IN-SV2C	NA	NA	NA
GTCGGGTGTCTGCCAG-1_8_E5	20.56073352	23.20233485	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1176	1919	0.006774362	0.003126628	0	oligos	OL-Cntl	NA	NA	NA
GTCGGGTGTTAAGAAC-1_8_E5	10.45201151	25.90610967	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	963	1552	0.00257732	0.009664948	0	oligos	OL-Cntl	NA	NA	NA
GTCGGGTTCCTCAATT-1_8_E5	27.12999249	-3.533767947	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3549	8930	0.008174692	0.002799552	0	2	EN-L4	NA	NA	NA
GTCGGGTTCGGCGCAT-1_8_E5	10.61898007	26.49515216	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	813	1235	0.004048583	0.006477733	0	oligos	OL-Cntl	NA	NA	NA
GTCGGGTTCTATCCTA-1_8_E5	-17.73466978	-24.95918003	6A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2362	4780	0.001464435	0.004393305	0	6A	IN-PV	NA	NA	NA
GTCGTAAAGGCCCTCA-1_8_E5	2.983601447	18.33423309	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	806	1246	0.004815409	0.017656501	0	oligos	OL-Cntl	NA	NA	NA
GTCGTAAAGTTCGATC-1_8_E5	-25.96608096	29.90698755	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1895	3578	0.003074343	0.002235886	0	8	Astrocytes	NA	NA	NA
GTCGTAAGTACCGTAT-1_8_E5	9.135198216	32.89560299	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	859	1313	0.004569688	0.005331302	0	oligos	OL-Cntl	NA	NA	NA
GTCGTAAGTGTGACCC-1_8_E5	-27.62426517	13.04960302	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	971	1463	0.002734108	0.005468216	0	8	Astrocytes	NA	NA	NA
GTCGTAATCATATCGG-1_8_E5	23.5030268	-9.299493035	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4102	11581	0.00362663	0.004058371	0	3	EN-L5-6	NA	NA	NA
GTCGTAATCCACGCAG-1_8_E5	11.86852261	31.72792214	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	772	1081	0.001850139	0.004625347	0	oligos	OL-Cntl	NA	NA	NA
GTCGTAATCGTCACGG-1_8_E5	-6.098988842	-1.138144344	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1544	2814	0.007107321	0.004619758	0	13A	IN-VIP	NA	NA	NA
GTCTCGTAGGCTCTTA-1_8_E5	-36.38036975	-3.026374739	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1397	2384	0.007969799	0.003355705	0	9	OPC	NA	NA	NA
GTCTCGTAGGTTACCT-1_8_E5	-25.74393697	29.9143421	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1746	3428	0.001458576	0.002042007	0	8	Astrocytes	NA	NA	NA
GTCTCGTCACAACTGT-1_8_E5	-0.78032539	-14.18056958	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2245	4824	0.005389718	0.002487562	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GTCTCGTGTATCTGCA-1_8_E5	-37.91637544	3.144138483	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1929	3764	0.001859724	0.001328374	0	9	OPC	NA	NA	NA
GTCTTCGAGATAGCAT-1_8_E5	-27.87927624	14.84519719	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	936	1423	0.003513703	0.003513703	0	8	Astrocytes	NA	NA	NA
GTCTTCGAGATAGTCA-1_8_E5	-25.50947501	20.2943977	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1458	2462	0.000812348	0.003249391	0	8	Astrocytes	NA	NA	NA
GTCTTCGAGATGTAAC-1_8_E5	26.78220885	-3.944061257	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3818	10075	0.002382134	0.00337469	0	2	EN-L4	NA	NA	NA
GTCTTCGAGGACAGCT-1_8_E5	28.33033281	-1.173931522	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3574	9325	0.004289544	0.004075067	0	2	EN-L4	NA	NA	NA
GTCTTCGCACGGTGTC-1_8_E5	7.776766382	-7.107364687	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1447	2363	0.007617435	0.001692763	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GTCTTCGTCAGCGACC-1_8_E5	9.524078776	29.70362877	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	869	1271	0.002360346	0.001573564	0	oligos	OL-Cntl	NA	NA	NA
GTCTTCGTCCGATATG-1_8_E5	9.830043264	27.17981349	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	976	1495	0.00735786	0.004013378	0	oligos	OL-Cntl	NA	NA	NA
GTGAAGGCATGTCTCC-1_8_E5	28.38091078	-3.721190568	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4001	10275	0.002335766	0.003309002	0	2	EN-L4	NA	NA	NA
GTGAAGGGTCATTAGC-1_8_E5	-35.12452819	5.170780127	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3047	6998	0.005287225	0.003286653	0	9	OPC	NA	NA	NA
GTGAAGGGTCTAGAGG-1_8_E5	-0.599838269	-22.0192885	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4214	12349	0.003563042	0.00453478	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GTGAAGGTCCAAGCCG-1_8_E5	-26.0906544	18.18263197	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1437	2591	0.001543805	0.003473562	0	8	Astrocytes	NA	NA	NA
GTGAAGGTCTGGAGCC-1_8_E5	23.29982199	12.08559177	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1556	2650	0.001886792	0.003773585	0	oligos	OL-Cntl	NA	NA	NA
GTGCAGCAGAGCTGGT-1_8_E5	-0.835596244	-20.81012697	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3471	8444	0.005802937	0.004263382	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GTGCAGCAGGCCATAG-1_8_E5	14.81793702	-33.77925957	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4975	16903	0.001538188	0.004259599	0	3	EN-L5-6	NA	NA	NA
GTGCAGCTCTTGTCAT-1_8_E5	8.181783785	33.1142645	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	888	1360	0.005147059	0.009558824	0	oligos	OL-Cntl	NA	NA	NA
GTGCATAAGAAGGACA-1_8_E5	6.021976904	31.98312899	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	842	1270	0.003937008	0.003937008	0	oligos	OL-Cntl	NA	NA	NA
GTGCATAAGAGGTACC-1_8_E5	19.33917776	13.27370647	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1252	2151	0.0018596	0.006508601	0	oligos	OL-Cntl	NA	NA	NA
GTGCATAAGGGCTCTC-1_8_E5	-1.138324173	-21.30303341	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3454	8847	0.006103764	0.004408274	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GTGCATAAGTGGGATC-1_8_E5	-25.43118407	20.03424961	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1441	2451	0.000407997	0.002039984	0	8	Astrocytes	NA	NA	NA
GTGCATAGTCATCCCT-1_8_E5	-7.313717326	-13.65218737	6B	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	791	1020	0.016666667	0.005882353	0	6B	IN-SST	NA	NA	NA
GTGCATAGTTGGTAAA-1_8_E5	-22.6750035	31.40194508	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2254	4685	0.001280683	0.003628602	0	8	Astrocytes	NA	NA	NA
GTGCATATCAACACCA-1_8_E5	18.66189617	19.60405659	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1098	1927	0.00778412	0.004151531	0	oligos	OL-Cntl	NA	NA	NA
GTGCATATCGTAGATC-1_8_E5	-37.88370247	3.028352534	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1907	3609	0.006095871	0.00110834	0	9	OPC	NA	NA	NA
GTGCGGTAGAAGGTGA-1_8_E5	-28.20194226	23.56848134	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1274	2193	0.001823985	0.001367989	0	8	Astrocytes	NA	NA	NA
GTGCGGTAGACCGGAT-1_8_E5	5.076277991	31.26172372	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	758	1065	0.001877934	0.001877934	0	oligos	OL-Cntl	NA	NA	NA
GTGCGGTAGGGTGTTG-1_8_E5	1.273039369	-30.45474781	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5263	17746	0.003437394	0.003550096	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GTGCGGTCAAATCCGT-1_8_E5	17.69452558	1.5537517	12	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	999	1482	0.018893387	0.002024291	0	12	EN-MIX	NA	NA	NA
GTGCGGTCAATGGATA-1_8_E5	6.592096432	31.38656974	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	862	1232	0.00487013	0.00487013	0	oligos	OL-Cntl	NA	NA	NA
GTGCGGTCACAACGTT-1_8_E5	-10.84337269	2.71582432	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3658	9208	0.011511729	0.004778454	0	13A	IN-VIP	NA	NA	NA
GTGCGGTCATACAGCT-1_8_E5	-11.92560653	-19.07341327	6B	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1207	2034	0.029990167	0.002949853	0	6B	IN-SST	NA	NA	NA
GTGCGGTCATCGGTTA-1_8_E5	4.440615502	-32.64977509	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	6919	33009	0.00063619	0.002787119	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GTGCGGTGTTGCTCCT-1_8_E5	27.00674651	-4.118763787	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4299	11976	0.005594522	0.004175017	0	2	EN-L4	NA	NA	NA
GTGCGGTTCCGCAGTG-1_8_E5	5.888191923	-32.34134165	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5089	17585	0.000909866	0.002274666	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GTGCTTCAGAACAATC-1_8_E5	10.64644796	32.87244084	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	868	1275	0.001568627	0.003137255	0	oligos	OL-Cntl	NA	NA	NA
GTGCTTCAGTACTTGC-1_8_E5	-39.2108891	-1.592496671	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1314	2370	0.002531646	0.001687764	0	9	OPC	NA	NA	NA
GTGCTTCCAATGGATA-1_8_E5	-1.916000693	-22.92772369	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4008	10940	0.004204753	0.004296161	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GTGCTTCTCAAGGCTT-1_8_E5	19.77989368	22.41174087	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	986	1544	0.00388601	0.006476684	0	oligos	OL-Cntl	NA	NA	NA
GTGCTTCTCGGCGCTA-1_8_E5	-37.7141149	-5.837924888	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1185	2001	0	0.002998501	0	9	OPC	NA	NA	NA
GTGGGTCAGCTAGTCT-1_8_E5	-14.63445439	-6.784815855	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4039	10622	0.015533798	0.008190548	0	13A	IN-VIP	NA	NA	NA
GTGGGTCAGTGCGATG-1_8_E5	13.29953968	-1.201145832	12	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1009	1777	0.001688239	0.006190208	0	12	EN-MIX	NA	NA	NA
GTGGGTCCACAGCGTC-1_8_E5	26.63388024	-4.450121123	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4516	13647	0.008719865	0.003077599	0	2	EN-L4	NA	NA	NA
GTGGGTCCAGCATGAG-1_8_E5	-1.58834827	-19.51393438	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3024	7081	0.010168055	0.00423669	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GTGGGTCCAGTATGCT-1_8_E5	-9.264860428	1.305365972	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2776	6163	0.008761967	0.005841311	0	13A	IN-VIP	NA	NA	NA
GTGGGTCCATGGTCAT-1_8_E5	-23.57517866	0.084001359	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2055	3872	0.002840909	0.002840909	0	9	OPC	NA	NA	NA
GTGGGTCGTGAGTGAC-1_8_E5	4.894605234	30.86826344	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	800	1213	0.003297609	0.008244023	0	oligos	OL-Cntl	NA	NA	NA
GTGGGTCTCCAGGGCT-1_8_E5	-23.28442594	16.58542997	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1333	2097	0.001430615	0.008106819	0	8	Astrocytes	NA	NA	NA
GTGGGTCTCTCGTTTA-1_8_E5	-38.21784517	2.205536543	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1612	2985	0.001005025	0.003350084	0	9	OPC	NA	NA	NA
GTGGGTCTCTGTTTGT-1_8_E5	7.382060552	34.93068184	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	940	1370	0.005839416	0.00729927	0	oligos	OL-Cntl	NA	NA	NA
GTGTGCGAGTAGATGT-1_8_E5	-25.35009924	27.48390281	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1536	2634	0.003796507	0.004935459	0	8	Astrocytes	NA	NA	NA
GTGTGCGAGTGGTAAT-1_8_E5	-33.80922214	-10.2194247	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	995	1532	0.001958225	0.002610966	0	9	OPC	NA	NA	NA
GTGTGCGCACAACGCC-1_8_E5	-3.338100629	-6.266989444	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	949	1465	0.03003413	0.002047782	0	13A	IN-VIP	NA	NA	NA
GTGTGCGGTACCAGTT-1_8_E5	-25.94986962	29.94942217	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1837	3477	0.001150417	0.003451251	0	8	Astrocytes	NA	NA	NA
GTGTGCGGTGAGGGAG-1_8_E5	6.853225251	33.92701706	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	969	1410	0.006382979	0.004255319	0	oligos	OL-Cntl	NA	NA	NA
GTGTGCGGTGCGATAG-1_8_E5	-24.91427198	30.04042134	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1798	3502	0.001998858	0.004283267	0	8	Astrocytes	NA	NA	NA
GTGTGCGGTTCCACGG-1_8_E5	19.91158834	24.25214014	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1081	1711	0.006428989	0.006428989	0	oligos	OL-Cntl	NA	NA	NA
GTGTTAGAGAAACCGC-1_8_E5	-0.600277877	-23.04273057	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4479	12319	0.005276402	0.004383473	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GTGTTAGAGACTGTAA-1_8_E5	4.939128774	32.52000231	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	749	1083	0.003693444	0.004616805	0	oligos	OL-Cntl	NA	NA	NA
GTGTTAGCAAAGCAAT-1_8_E5	-0.270838641	-15.07859862	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2539	5516	0.006526468	0.003263234	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GTGTTAGCAGGTCCAC-1_8_E5	9.887878171	-29.01849569	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	8171	40565	0.011783557	0.003500555	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GTTAAGCAGGCTCAGA-1_8_E5	26.28490931	-28.01842019	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5643	21352	0.004870738	0.004823904	0	3	EN-L5-6	NA	NA	NA
GTTAAGCCAGCCTGTG-1_8_E5	28.41052504	-1.652517101	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4703	13412	0.004697286	0.004175365	0	2	EN-L4	NA	NA	NA
GTTAAGCGTAGGAGTC-1_8_E5	1.231111959	-30.45775089	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5271	17990	0.006614786	0.002723735	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GTTAAGCGTAGGCATG-1_8_E5	-1.257827426	-19.2807389	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3019	7128	0.007996633	0.003367003	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GTTAAGCGTTTGGCGC-1_8_E5	12.00921758	17.11291463	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1057	1735	0.002881844	0.006340058	0	oligos	OL-Cntl	NA	NA	NA
GTTAAGCTCCCAACGG-1_8_E5	6.623114574	-31.75912837	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5521	19790	0.002324406	0.003688732	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GTTACAGAGGATGGAA-1_8_E5	5.648902443	32.79495188	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	767	1099	0.002729754	0.003639672	0	oligos	OL-Cntl	NA	NA	NA
GTTACAGGTCTGCGGT-1_8_E5	14.75460872	-1.498816602	12	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	940	1419	0.021846371	0.003523608	0	12	EN-MIX	NA	NA	NA
GTTACAGGTGTGCCTG-1_8_E5	26.39093075	-5.299429773	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5458	18296	0.005793616	0.003989943	0	2	EN-L4	NA	NA	NA
GTTACAGGTTGGACCC-1_8_E5	8.787033151	33.56280935	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	874	1380	0.002173913	0.003623188	0	oligos	OL-Cntl	NA	NA	NA
GTTACAGTCAGAGCTT-1_8_E5	-35.35312924	-8.157025583	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1064	1634	0.00122399	0.003059976	0	9	OPC	NA	NA	NA
GTTCATTCAAGTTCTG-1_8_E5	20.11951284	22.46692845	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1049	1750	0.000571429	0.006285714	0	oligos	OL-Cntl	NA	NA	NA
GTTCATTCATGCTGGC-1_8_E5	5.148239781	32.12005807	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	704	1029	0.002915452	0.002915452	0	oligos	OL-Cntl	NA	NA	NA
GTTCATTTCTGTCCGT-1_8_E5	27.46422068	0.232423725	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4943	17469	0.011563341	0.002633236	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GTTCGGGAGAAGCCCA-1_8_E5	-24.42233473	29.69308613	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1954	3882	0.000772798	0.002833591	0	8	Astrocytes	NA	NA	NA
GTTCGGGCACGTCAGC-1_8_E5	25.95266986	-28.40151024	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5065	17708	0.002880054	0.004122431	0	3	EN-L5-6	NA	NA	NA
GTTCGGGCATGCTGGC-1_8_E5	20.5881276	22.00929869	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1074	1769	0.002261164	0.001130582	0	oligos	OL-Cntl	NA	NA	NA
GTTCGGGGTAGGAGTC-1_8_E5	-23.9534731	30.11418001	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1934	3634	0.000550358	0.004402862	0	8	Astrocytes	NA	NA	NA
GTTCGGGGTCGCTTCT-1_8_E5	24.24448695	-6.326342165	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5273	16408	0.006338372	0.003473915	0	2	EN-L4	NA	NA	NA
GTTCTCGAGGCATGTG-1_8_E5	-23.82622893	30.28999518	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2002	3796	0.010010537	0.002370917	0	8	Astrocytes	NA	NA	NA
GTTCTCGAGTGTCCCG-1_8_E5	-23.28298166	27.9293446	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1802	3358	0.00565813	0.002084574	0	8	Astrocytes	NA	NA	NA
GTTCTCGCAGATTGCT-1_8_E5	8.74313373	33.80620419	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	962	1456	0.00206044	0.006868132	0	oligos	OL-Cntl	NA	NA	NA
GTTCTCGCAGTCCTTC-1_8_E5	-23.06708243	29.96724563	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1960	3920	0.000765306	0.002806122	0	8	Astrocytes	NA	NA	NA
GTTCTCGGTCGTGGCT-1_8_E5	27.11642449	-4.263483502	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3879	10825	0.00369515	0.003879908	0	2	EN-L4	NA	NA	NA
GTTCTCGGTTCCTCCA-1_8_E5	0.730599098	-29.99883205	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5367	21132	0.003217869	0.002176793	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
GTTTCTAAGGGCTTGA-1_8_E5	-27.47704514	18.59050057	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1138	1920	0.003125	0.002604167	0	8	Astrocytes	NA	NA	NA
GTTTCTAGTCCGACGT-1_8_E5	9.412968131	29.09205841	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	771	1212	0.001650165	0.004950495	0	oligos	OL-Cntl	NA	NA	NA
GTTTCTATCAAAGTAG-1_8_E5	14.58849773	-33.61589017	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4709	16369	0.001466186	0.003726556	0	3	EN-L5-6	NA	NA	NA
TAAACCGAGGCTCATT-1_8_E5	-12.72713921	-19.35510361	6B	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1147	1979	0.013643254	0.003031834	0	6B	IN-SST	NA	NA	NA
TAAACCGGTCTCACCT-1_8_E5	-0.913836143	-22.02274539	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3995	11467	0.006540508	0.003052237	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TAAACCGGTGCGGTAA-1_8_E5	-0.584685444	-21.75579575	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3997	10791	0.007969604	0.003521453	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TAAACCGTCCGCATCT-1_8_E5	20.76665699	22.59172466	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1118	1771	0.002258611	0.002258611	0	oligos	OL-Cntl	NA	NA	NA
TAAACCGTCTGGTTCC-1_8_E5	-2.362261225	-17.20428743	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2576	5866	0.006137061	0.002216161	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TAAGAGAAGAAGGGTA-1_8_E5	8.144171672	34.63429295	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1039	1520	0.009210526	0.002631579	0	oligos	OL-Cntl	NA	NA	NA
TAAGAGACACTATCTT-1_8_E5	8.823840555	31.24982875	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	737	1080	0.003703704	0.002777778	0	oligos	OL-Cntl	NA	NA	NA
TAAGAGAGTCCAGTTA-1_8_E5	14.95064918	-33.57370855	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5488	20561	0.002626331	0.003842226	0	3	EN-L5-6	NA	NA	NA
TAAGAGAGTCCTAGCG-1_8_E5	-19.03399006	19.7864449	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1432	2287	0.008307827	0.017927416	0	8	Astrocytes	NA	NA	NA
TAAGCGTAGACTACAA-1_8_E5	-1.138702482	24.22687258	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	755	1035	0.003864734	0.005797101	0	oligos	OL-Cntl	NA	NA	NA
TAAGCGTAGCATCATC-1_8_E5	-4.717857484	-2.955879659	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1389	2446	0.006132461	0.0053148	0	13A	IN-VIP	NA	NA	NA
TAAGCGTAGCTATGCT-1_8_E5	26.70458185	-5.19025445	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5190	18487	0.006977876	0.004273273	0	2	EN-L4	NA	NA	NA
TAAGCGTGTTAAGACA-1_8_E5	4.913885926	32.73528645	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	714	1075	0.004651163	0.009302326	0	oligos	OL-Cntl	NA	NA	NA
TAAGTGCCAAGCGATG-1_8_E5	3.868080444	-31.3978882	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4630	13625	0.009688073	0.004110092	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TAAGTGCCAATCTGCA-1_8_E5	7.758484415	32.42273248	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	677	1027	0.00292113	0.003894839	0	oligos	OL-Cntl	NA	NA	NA
TAAGTGCCATCTGGTA-1_8_E5	20.834129	22.20779837	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1153	1910	0.010994764	0.005235602	0	oligos	OL-Cntl	NA	NA	NA
TAAGTGCGTTGTCGCG-1_8_E5	1.539584049	-30.85537322	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	6518	26154	0.006538197	0.002217634	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TAAGTGCTCAACACGT-1_8_E5	-37.88881566	-1.308484662	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1354	2447	0.001225991	0.001225991	0	9	OPC	NA	NA	NA
TAAGTGCTCATGCATG-1_8_E5	2.401674127	29.87320952	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	750	1079	0.00463392	0.006487488	0	oligos	OL-Cntl	NA	NA	NA
TACACGAGTAAATGAC-1_8_E5	29.87082286	-1.913963253	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4122	11799	0.007882024	0.003898635	0	2	EN-L4	NA	NA	NA
TACACGAGTAGCGCAA-1_8_E5	10.13941442	31.3327898	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	815	1172	0.011945392	0.004266212	0	oligos	OL-Cntl	NA	NA	NA
TACACGAGTAGCGTCC-1_8_E5	18.81311529	13.95422276	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1190	1985	0.003526448	0.005037783	0	oligos	OL-Cntl	NA	NA	NA
TACAGTGAGCGTGAAC-1_8_E5	8.421668787	-7.096467172	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1814	3649	0.00356262	0.002466429	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TACAGTGCACATGACT-1_8_E5	26.20037735	-2.095913287	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2997	7081	0.002118345	0.004801582	0	2	EN-L4	NA	NA	NA
TACAGTGCAGGTTTCA-1_8_E5	-33.51736176	-8.712050635	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1029	1642	0.002436054	0.005481121	0	9	OPC	NA	NA	NA
TACAGTGGTCTCTCTG-1_8_E5	6.35625575	34.80940619	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	809	1190	0.007563025	0.004201681	0	oligos	OL-Cntl	NA	NA	NA
TACAGTGTCACCAGGC-1_8_E5	18.56371428	9.104262926	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1553	2942	0.002719239	0.006798097	0	oligos	OL-Cntl	NA	NA	NA
TACCTATAGGGATGGG-1_8_E5	-5.597962594	-0.871836595	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1929	3932	0.000508647	0.003560529	0	13A	IN-VIP	NA	NA	NA
TACCTATAGTGAAGAG-1_8_E5	-19.14027727	-24.94181183	6A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2718	5524	0.00724113	0.003801593	0	6A	IN-PV	NA	NA	NA
TACCTATCAAACAACA-1_8_E5	-38.30807218	1.558342735	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1740	3565	0.007573633	0.002244039	0	9	OPC	NA	NA	NA
TACCTATCAAATTGCC-1_8_E5	29.13965973	-1.062549335	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3320	8333	0.013800552	0.003120125	0	2	EN-L4	NA	NA	NA
TACCTATGTGAGGCTA-1_8_E5	28.52359797	-2.050988152	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4204	11347	0.006962193	0.005199612	0	2	EN-L4	NA	NA	NA
TACCTATTCACCTCGT-1_8_E5	-25.27817245	27.78597731	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1588	2810	0.000355872	0.003914591	0	8	Astrocytes	NA	NA	NA
TACCTTAAGAGCAATT-1_8_E5	9.911731434	32.24873363	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	804	1207	0.001657001	0.003314002	0	oligos	OL-Cntl	NA	NA	NA
TACCTTACAACACCCG-1_8_E5	-8.64542343	1.1514742	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2263	4595	0.011316649	0.005658324	0	13A	IN-VIP	NA	NA	NA
TACCTTACATGATCCA-1_8_E5	-11.03963072	2.705374609	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3944	10678	0.008428545	0.005338078	0	13A	IN-VIP	NA	NA	NA
TACCTTAGTATAATGG-1_8_E5	-26.36772139	17.77241219	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1211	1935	0.000516796	0.002067183	0	8	Astrocytes	NA	NA	NA
TACCTTAGTGATGCCC-1_8_E5	13.06610703	17.47562313	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1115	1864	0.009120172	0.005364807	0	oligos	OL-Cntl	NA	NA	NA
TACCTTATCAGAAATG-1_8_E5	-6.954925676	-1.160190001	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1677	3056	0.016688482	0.002617801	0	13A	IN-VIP	NA	NA	NA
TACGGATAGAAACGAG-1_8_E5	29.76576345	-2.467906947	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4052	10119	0.009981223	0.00444708	0	2	EN-L4	NA	NA	NA
TACGGATAGACACTAA-1_8_E5	-2.420457891	-21.66963586	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3294	7708	0.009340944	0.001556824	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TACGGATAGCGATATA-1_8_E5	17.35075275	-5.200378686	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1784	3559	0.021354313	0.002247822	0	3	EN-L5-6	NA	NA	NA
TACGGATAGGAATTAC-1_8_E5	27.05226525	-4.325638981	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3902	10426	0.012948398	0.002685594	0	2	EN-L4	NA	NA	NA
TACGGATAGGCACATG-1_8_E5	-21.25765078	-27.70005177	6A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4092	10883	0.00900487	0.006523936	0	6A	IN-PV	NA	NA	NA
TACGGATCACAAGTAA-1_8_E5	27.93677105	-4.294312841	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3645	9175	0.013297003	0.003051771	0	2	EN-L4	NA	NA	NA
TACGGATCAGTCAGAG-1_8_E5	-19.50485665	-18.8315205	6A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3767	9567	0.001463364	0.002926727	0	6A	IN-PV	NA	NA	NA
TACGGATCATAGACTC-1_8_E5	-22.23976889	31.66092424	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2941	6813	0.002348451	0.003082343	0	8	Astrocytes	NA	NA	NA
TACGGATGTCCGTGAC-1_8_E5	8.865367082	27.64976467	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	896	1358	0.001472754	0.008100147	0	oligos	OL-Cntl	NA	NA	NA
TACGGATGTGGGTCAA-1_8_E5	-7.688113475	-0.375655356	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1947	3695	0.008930988	0.003518268	0	13A	IN-VIP	NA	NA	NA
TACGGATGTTCACGGC-1_8_E5	-3.687889382	-4.168796569	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1291	2305	0.006507592	0.006073753	0	13A	IN-VIP	NA	NA	NA
TACGGATTCACCTCGT-1_8_E5	-7.977089364	-0.633399528	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2144	4446	0.021817364	0.003148898	0	13A	IN-VIP	NA	NA	NA
TACGGGCAGATCCGAG-1_8_E5	9.041875663	33.08470126	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	953	1453	0.021335169	0.00550585	0	oligos	OL-Cntl	NA	NA	NA
TACGGGCCAACACCTA-1_8_E5	11.6663965	32.03030747	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	722	1055	0.007582938	0.002843602	0	oligos	OL-Cntl	NA	NA	NA
TACGGGCCATTCACTT-1_8_E5	-0.581630197	-14.2405311	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2172	4275	0.001169591	0.003040936	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TACGGGCGTACCCAAT-1_8_E5	-37.62548264	-6.438167024	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1136	1775	0.002816901	0.005070423	0	9	OPC	NA	NA	NA
TACGGGCGTTGCCTCT-1_8_E5	23.64032265	-9.285785967	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	6510	27685	0.002131118	0.00281741	0	3	EN-L5-6	NA	NA	NA
TACGGTAAGGGTCTCC-1_8_E5	5.80457086	34.90540694	11	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	780	1066	0.006566604	0.003752345	0	11	Glia-MIX	NA	NA	NA
TACGGTAAGTGTACGG-1_8_E5	-27.64275093	4.461009366	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1546	2546	0.002356638	0.001571092	0	9	OPC	NA	NA	NA
TACGGTACACATGACT-1_8_E5	-11.66786952	-19.20304482	6B	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	890	1322	0.012102874	0.003025719	0	6B	IN-SST	NA	NA	NA
TACGGTAGTACCGGCT-1_8_E5	-26.84382663	10.12752851	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	861	1288	0.004658385	0.00310559	0	8	Astrocytes	NA	NA	NA
TACTCATAGTAGCGGT-1_8_E5	7.367197598	-31.72800894	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5227	16532	0.003205904	0.004052746	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TACTCATAGTCTCCTC-1_8_E5	-19.4414477	-28.86759428	6A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4056	13213	0.001589344	0.002421857	0	6A	IN-PV	NA	NA	NA
TACTCATCAGTGGGAT-1_8_E5	-2.111106693	-18.47117169	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2759	6463	0.007426892	0.003094538	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TACTCATGTAACGACG-1_8_E5	8.550473099	33.62829069	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	847	1298	0.00385208	0.00385208	0	oligos	OL-Cntl	NA	NA	NA
TACTCATGTCTAGTCA-1_8_E5	-19.91190119	-28.97983082	6A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3331	8268	0.007861635	0.002418965	0	6A	IN-PV	NA	NA	NA
TACTCATGTTCAGCGC-1_8_E5	-26.5753298	15.44172996	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1109	1810	0.001104972	0.00441989	0	8	Astrocytes	NA	NA	NA
TACTCATTCCACGTTC-1_8_E5	-25.57732716	20.43374938	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1475	2552	0.000783699	0.004702194	0	8	Astrocytes	NA	NA	NA
TACTCGCAGACTAAGT-1_8_E5	-9.517281103	2.440654189	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3068	7135	0.009250175	0.004204625	0	13A	IN-VIP	NA	NA	NA
TACTCGCCAGCGAACA-1_8_E5	15.53262966	-33.82426245	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	6173	23889	0.005609276	0.005232534	0	3	EN-L5-6	NA	NA	NA
TACTCGCCAGTAAGCG-1_8_E5	-20.34317318	-18.66673989	6A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3863	10223	0.005282207	0.003814927	0	6A	IN-PV	NA	NA	NA
TACTCGCGTAAACCTC-1_8_E5	4.532041997	-5.121023749	12	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	828	1198	0.00918197	0.001669449	0	12	EN-MIX	NA	NA	NA
TACTCGCGTGAAAGAG-1_8_E5	21.35661554	23.24236642	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1159	1748	0.006292906	0.002860412	0	oligos	OL-Cntl	NA	NA	NA
TACTCGCTCAGTGCAT-1_8_E5	24.99338142	-3.216236744	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3682	11313	0.003889331	0.002033059	0	2	EN-L4	NA	NA	NA
TACTCGCTCCATGCTC-1_8_E5	9.481273592	27.92717525	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	921	1561	0.003203075	0.00128123	0	oligos	OL-Cntl	NA	NA	NA
TACTTACAGAGGTACC-1_8_E5	16.86463221	-6.570507237	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2196	5200	0.000192308	0.003076923	0	3	EN-L5-6	NA	NA	NA
TACTTACTCAAGCCTA-1_8_E5	-15.50579662	-11.3126214	13B	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2623	6199	0.002742378	0.002258429	0	13B	IN-SV2C	NA	NA	NA
TACTTACTCATGTAGC-1_8_E5	26.35679291	-4.213050462	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3856	10220	0.001663405	0.003033268	0	2	EN-L4	NA	NA	NA
TACTTACTCCTGTAGA-1_8_E5	8.572224417	33.76053128	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	889	1361	0.002939015	0.004408523	0	oligos	OL-Cntl	NA	NA	NA
TACTTACTCGTTTGCC-1_8_E5	-39.20311868	-0.169318781	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1470	2776	0.001080692	0.001080692	0	9	OPC	NA	NA	NA
TACTTGTAGAACAACT-1_8_E5	15.15191131	-33.16757103	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4762	15660	0.004214559	0.003767561	0	3	EN-L5-6	NA	NA	NA
TACTTGTAGGTGGGTT-1_8_E5	6.41907213	32.5687645	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	713	1046	0.002868069	0.002868069	0	oligos	OL-Cntl	NA	NA	NA
TACTTGTAGTGTTAGA-1_8_E5	4.173787933	32.57805094	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	760	1075	0.006511628	0.004651163	0	oligos	OL-Cntl	NA	NA	NA
TACTTGTCAATACGCT-1_8_E5	-0.90421537	-14.54893639	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2388	5414	0.004802364	0.00350942	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TACTTGTCACCACGTG-1_8_E5	10.29562086	25.92199784	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	856	1388	0.004322767	0.004322767	0	oligos	OL-Cntl	NA	NA	NA
TACTTGTGTTAGAACA-1_8_E5	-18.29293814	-17.76342269	6B	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2177	4331	0.01362272	0.002770723	0	6B	IN-SST	NA	NA	NA
TACTTGTTCAACGAAA-1_8_E5	-5.629011821	-2.266017421	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1681	3233	0.048871018	0.002165172	0	13A	IN-VIP	NA	NA	NA
TACTTGTTCCGTCAAA-1_8_E5	10.92391397	32.42453552	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	890	1377	0.002178649	0.005083515	0	oligos	OL-Cntl	NA	NA	NA
TAGACCAAGCACCGCT-1_8_E5	1.056556843	-10.03704815	12	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1483	2485	0.042655936	0.002816901	0	12	EN-MIX	NA	NA	NA
TAGACCAAGGTCATCT-1_8_E5	-1.012382525	-14.66705484	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2600	6205	0.002256245	0.003223207	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TAGACCACAAAGCAAT-1_8_E5	-27.20209182	9.435475193	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	807	1269	0.003152088	0.002364066	0	8	Astrocytes	NA	NA	NA
TAGACCACAATCACAC-1_8_E5	26.23615227	-0.079803822	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2751	6325	0.002529644	0.002371542	0	2	EN-L4	NA	NA	NA
TAGACCACATGCCTTC-1_8_E5	-38.50335719	-0.21676761	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1638	3033	0.001978239	0.002967359	0	9	OPC	NA	NA	NA
TAGAGCTCACGAAATA-1_8_E5	3.979248403	-28.73954924	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3662	10661	0.000281399	0.002063596	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TAGAGCTCATGCCTTC-1_8_E5	27.80012047	-1.10826596	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3342	8261	0.009926159	0.002057862	0	2	EN-L4	NA	NA	NA
TAGAGCTGTAAAGTCA-1_8_E5	0.763265681	-29.288474	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5531	21291	0.004790757	0.002818092	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TAGAGCTGTACGCACC-1_8_E5	-0.4417631	-22.27518627	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4195	11402	0.003858972	0.004472899	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TAGAGCTGTCTGCGGT-1_8_E5	15.24012832	-7.729737118	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2356	5158	0.00271423	0.003683598	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TAGCCGGAGCGTTGCC-1_8_E5	-38.8301974	-0.078660581	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1423	2428	0.005354201	0.00247117	0	9	OPC	NA	NA	NA
TAGCCGGAGCTGTTCA-1_8_E5	1.358787371	-30.4979988	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5562	19326	0.006623202	0.002535444	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TAGCCGGCAATCAGAA-1_8_E5	26.38814472	-5.436356852	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	6236	23617	0.002032434	0.004911716	0	2	EN-L4	NA	NA	NA
TAGCCGGCACAAGCCC-1_8_E5	-25.70541251	30.02577065	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1927	3738	0.001605136	0.003210273	0	8	Astrocytes	NA	NA	NA
TAGCCGGCACTGTCGG-1_8_E5	-20.55791076	-27.92462644	6A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4029	12175	0.030554415	0.002710472	0	6A	IN-PV	NA	NA	NA
TAGCCGGGTCGGATCC-1_8_E5	-1.157380014	-20.13799837	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3084	6816	0.004694836	0.006748826	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TAGCCGGGTGTGAATA-1_8_E5	5.769106705	-32.18648094	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4344	13340	0.001874063	0.002248876	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TAGCCGGTCACCCGAG-1_8_E5	-20.47874589	-17.71691362	6B	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3801	9928	0.017224013	0.006043513	0	6B	IN-SST	NA	NA	NA
TAGCCGGTCTGTCTAT-1_8_E5	-24.46471239	30.3396145	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1855	3489	0.001433075	0.00171969	0	8	Astrocytes	NA	NA	NA
TAGGCATGTGGAAAGA-1_8_E5	4.154235804	31.88474646	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	716	1056	0.00094697	0.005681818	0	oligos	OL-Cntl	NA	NA	NA
TAGGCATGTTTGTTTC-1_8_E5	-36.20188882	1.918659203	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1624	2935	0.001703578	0.003407155	0	9	OPC	NA	NA	NA
TAGGCATTCAAAGACA-1_8_E5	15.55159363	-6.223479992	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1488	2567	0.005843397	0.004674718	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TAGTGGTAGTACGCGA-1_8_E5	-19.56307631	-17.14615583	6B	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3111	7343	0.087294022	0.00626447	0	6B	IN-SST	NA	NA	NA
TAGTGGTGTCGACTGC-1_8_E5	15.60954757	-33.09978664	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5125	19520	0.001844262	0.002920082	0	3	EN-L5-6	NA	NA	NA
TAGTGGTGTCTGCCAG-1_8_E5	-10.00943028	1.866913029	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2851	6517	0.019947829	0.005830904	0	13A	IN-VIP	NA	NA	NA
TAGTGGTTCATTGCCC-1_8_E5	-9.423187667	2.832916932	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3034	7456	0.002414163	0.002682403	0	13A	IN-VIP	NA	NA	NA
TAGTGGTTCCGTAGGC-1_8_E5	12.6377828	19.2084783	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1027	1587	0.001890359	0.004410838	0	oligos	OL-Cntl	NA	NA	NA
TAGTGGTTCCTGCCAT-1_8_E5	19.64645504	18.12142943	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1105	1720	0.004651163	0.004651163	0	oligos	OL-Cntl	NA	NA	NA
TAGTGGTTCGAACGGA-1_8_E5	5.930340381	32.43138178	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	723	1078	0.008348794	0.002782931	0	oligos	OL-Cntl	NA	NA	NA
TAGTGGTTCGAATGCT-1_8_E5	10.67729572	26.21871526	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	884	1263	0.007917656	0.007125891	0	oligos	OL-Cntl	NA	NA	NA
TAGTGGTTCGCTTAGA-1_8_E5	4.096954948	-32.13804438	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5203	18834	0.000690241	0.0023362	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TAGTGGTTCGGTGTTA-1_8_E5	8.541577053	32.42441963	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	713	1029	0.003887269	0.002915452	0	oligos	OL-Cntl	NA	NA	NA
TAGTTGGCAGGTTTCA-1_8_E5	0.390997617	-12.68413858	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1984	3516	0.010807736	0.002844141	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TAGTTGGGTCACTTCC-1_8_E5	-12.08901272	-21.05308177	6A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1196	2119	0.012741859	0.002359604	0	6A	IN-PV	NA	NA	NA
TATCAGGAGCTCAACT-1_8_E5	6.082060542	34.03546261	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	826	1229	0.004882018	0.005695688	0	oligos	OL-Cntl	NA	NA	NA
TATCAGGAGGACAGCT-1_8_E5	-0.139916349	-21.42879049	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3760	10119	0.006225912	0.003854136	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TATCAGGCAATGGATA-1_8_E5	-32.82737867	3.673714734	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2219	4387	0.001595623	0.003191247	0	9	OPC	NA	NA	NA
TATCAGGCACATAACC-1_8_E5	-22.04492053	31.70044874	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3538	9429	0.000318167	0.002545339	0	8	Astrocytes	NA	NA	NA
TATCTCAAGCACACAG-1_8_E5	0.573476876	34.10781224	17	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	796	1195	0.014225941	0.005020921	0	oligos	OL-MS-2	NA	NA	NA
TATCTCAAGGGTATCG-1_8_E5	29.16543648	-1.779780976	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3927	10174	0.009239237	0.00412817	0	2	EN-L4	NA	NA	NA
TATCTCACAGCCAATT-1_8_E5	7.925904967	32.6996905	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	822	1232	0.00487013	0.008928571	0	oligos	OL-Cntl	NA	NA	NA
TATCTCAGTTCGAATC-1_8_E5	7.521031477	32.10601491	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	712	1006	0.008946322	0.002982107	0	oligos	OL-Cntl	NA	NA	NA
TATCTCATCGTGGTCG-1_8_E5	18.1492789	23.0887044	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	918	1437	0.008350731	0.002783577	0	oligos	OL-Cntl	NA	NA	NA
TATGCCCAGTCAAGCG-1_8_E5	-25.90097588	29.87054766	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1771	3295	0.002124431	0.002427921	0	8	Astrocytes	NA	NA	NA
TATGCCCCACACGCTG-1_8_E5	21.17718327	22.61112363	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1175	1925	0.001558442	0.003116883	0	oligos	OL-Cntl	NA	NA	NA
TATGCCCCATGCTGGC-1_8_E5	6.842205861	-31.6080223	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	6285	23071	0.005288024	0.003337523	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TATGCCCGTAAATGAC-1_8_E5	-25.95928297	29.94529983	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2004	3933	0.001017035	0.002542588	0	8	Astrocytes	NA	NA	NA
TATGCCCTCCATGCTC-1_8_E5	26.03913056	-5.240065674	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5266	17575	0.004153627	0.002162162	0	2	EN-L4	NA	NA	NA
TATTACCAGCTTATCG-1_8_E5	14.25062721	22.51092878	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	933	1438	0.001390821	0.006258693	0	oligos	OL-Cntl	NA	NA	NA
TATTACCAGGAGTAGA-1_8_E5	1.290311923	-10.00806141	12	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1489	2458	0.007729862	0.003661513	0	12	EN-MIX	NA	NA	NA
TATTACCAGTAGGCCA-1_8_E5	8.696583854	31.27728599	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	765	1162	0	0.004302926	0	oligos	OL-Cntl	NA	NA	NA
TATTACCCATAAAGGT-1_8_E5	28.53618215	-1.446457412	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3832	10122	0.003260225	0.005631298	0	2	EN-L4	NA	NA	NA
TATTACCGTAAGGATT-1_8_E5	-11.54320343	1.293119371	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2786	6036	0.017229954	0.007289596	0	13A	IN-VIP	NA	NA	NA
TATTACCGTCATGCAT-1_8_E5	-23.20755313	31.22490008	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2158	4554	0.000439174	0.002195872	0	8	Astrocytes	NA	NA	NA
TATTACCGTCTAGTCA-1_8_E5	-7.275855323	-8.039580507	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1299	2443	0.011870651	0.004093328	0	13A	IN-VIP	NA	NA	NA
TATTACCGTTCAGACT-1_8_E5	20.67624452	22.18368018	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1058	1780	0.001123596	0.003370787	0	oligos	OL-Cntl	NA	NA	NA
TATTACCTCGGGAGTA-1_8_E5	30.17179702	-3.938434784	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3501	8153	0.009199068	0.006132712	0	2	EN-L4	NA	NA	NA
TATTACCTCGTCACGG-1_8_E5	-26.73327563	16.93792292	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1179	2032	0.000984252	0.004429134	0	8	Astrocytes	NA	NA	NA
TCAACGAAGTCCGTAT-1_8_E5	25.59456739	-28.40678612	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4037	12227	0.004171097	0.003516807	0	3	EN-L5-6	NA	NA	NA
TCAACGACACCAGATT-1_8_E5	5.58377534	33.27356067	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	752	1095	0.005479452	0.003652968	0	oligos	OL-Cntl	NA	NA	NA
TCAACGACAGTAAGAT-1_8_E5	-25.22238255	19.84473885	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1487	2426	0.001648805	0.00370981	0	8	Astrocytes	NA	NA	NA
TCAACGACATGGTTGT-1_8_E5	20.43327731	22.72128382	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1041	1616	0.010519802	0.004331683	0	oligos	OL-Cntl	NA	NA	NA
TCAACGACATTACCTT-1_8_E5	7.908779802	28.72653528	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	862	1242	0.008856683	0.006441224	0	oligos	OL-Cntl	NA	NA	NA
TCAACGAGTACTTAGC-1_8_E5	-28.88713703	14.24302015	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	953	1536	0.002604167	0.001302083	0	8	Astrocytes	NA	NA	NA
TCAACGATCTCATTCA-1_8_E5	19.23840127	23.94787001	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	949	1577	0.002536462	0.002536462	0	oligos	OL-Cntl	NA	NA	NA
TCAATCTAGAACAACT-1_8_E5	26.38651533	-5.446312208	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5368	17247	0.004116658	0.004000696	0	2	EN-L4	NA	NA	NA
TCAATCTAGGCTCATT-1_8_E5	7.461372834	-32.26085837	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5420	19599	0.00744936	0.002296036	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TCAATCTCAATACGCT-1_8_E5	-16.94409088	-11.1152625	13B	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4592	13842	0.006646438	0.00390117	0	13B	IN-SV2C	NA	NA	NA
TCAATCTCATAAGACA-1_8_E5	-38.89945423	0.682021479	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1590	2907	0.00378397	0.002063983	0	9	OPC	NA	NA	NA
TCAATCTGTCGCATAT-1_8_E5	7.530178652	32.34897788	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	715	1057	0.001892148	0.002838221	0	oligos	OL-Cntl	NA	NA	NA
TCACAAGAGACTAGGC-1_8_E5	31.33642549	-4.443038009	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4503	12346	0.012878665	0.005264863	0	2	EN-L4	NA	NA	NA
TCACAAGAGTCAAGGC-1_8_E5	25.68470964	-2.547267464	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2895	6658	0.0031541	0.004956443	0	2	EN-L4	NA	NA	NA
TCACAAGAGTGTCCAT-1_8_E5	-25.95627183	29.82584934	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1764	3244	0.00215783	0.001849568	0	8	Astrocytes	NA	NA	NA
TCACAAGCACCACGTG-1_8_E5	-19.16498322	-28.377882	6A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3469	9710	0.001132853	0.003398558	0	6A	IN-PV	NA	NA	NA
TCACAAGCAGCTTCGG-1_8_E5	21.06029552	-0.275958031	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1572	2911	0.019924425	0.00377877	0	2	EN-L4	NA	NA	NA
TCACAAGGTTCAGACT-1_8_E5	21.45969345	-29.1335909	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3879	10630	0.012135466	0.005174036	0	3	EN-L5-6	NA	NA	NA
TCACAAGGTTCCACTC-1_8_E5	5.652519083	-32.39062284	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	6115	25318	0.001856387	0.001856387	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TCACAAGTCATGTCCC-1_8_E5	19.4211885	25.73064801	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1021	1572	0.013358779	0.001272265	0	oligos	OL-Cntl	NA	NA	NA
TCACGAACAAAGTCAA-1_8_E5	9.62078159	32.25194266	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	879	1301	0.007686395	0.003074558	0	oligos	OL-Cntl	NA	NA	NA
TCACGAACACAGAGGT-1_8_E5	10.832238	28.08210393	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	896	1401	0.007851535	0.002855103	0	oligos	OL-Cntl	NA	NA	NA
TCACGAATCCACGTTC-1_8_E5	-37.89727313	2.837537225	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1859	3698	0.003515414	0.001892915	0	9	OPC	NA	NA	NA
TCACGAATCCACTCCA-1_8_E5	26.05338161	-2.844987075	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3851	11667	0.001028542	0.003342762	0	2	EN-L4	NA	NA	NA
TCAGATGCACAGGTTT-1_8_E5	-8.989437243	-1.289668826	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2126	4145	0.010373945	0.005066345	0	13A	IN-VIP	NA	NA	NA
TCAGATGCATCATCCC-1_8_E5	-0.841270019	-14.59638835	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2452	5507	0.004539677	0.002723806	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TCAGATGCATTTGCCC-1_8_E5	-7.546781178	1.047214601	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2087	4566	0.02847131	0.003066141	0	13A	IN-VIP	NA	NA	NA
TCAGATGGTATCACCA-1_8_E5	4.712711936	30.12127771	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	754	1077	0.00185701	0.00185701	0	oligos	OL-Cntl	NA	NA	NA
TCAGATGGTCTAGAGG-1_8_E5	28.80675619	-1.658705313	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3940	9580	0.009394572	0.005323591	0	2	EN-L4	NA	NA	NA
TCAGATGTCGCATGAT-1_8_E5	28.7269303	-1.369204782	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3953	10586	0.013697336	0.003211789	0	2	EN-L4	NA	NA	NA
TCAGATGTCTCCCTGA-1_8_E5	-23.15065596	0.27139473	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1802	3083	0.003243594	0.003243594	0	9	OPC	NA	NA	NA
TCAGCAAAGCCCAATT-1_8_E5	-8.3503318	1.310157513	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2316	4701	0.004679855	0.004679855	0	13A	IN-VIP	NA	NA	NA
TCAGCAAAGTGTACGG-1_8_E5	-14.60708851	-6.492539767	13B	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2945	6569	0.01796316	0.004414675	0	13B	IN-SV2C	NA	NA	NA
TCAGCAACAAGCCCAC-1_8_E5	27.481512	-5.043193647	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4662	13488	0.007117438	0.003855279	0	2	EN-L4	NA	NA	NA
TCAGCAACATAAGACA-1_8_E5	-0.709664826	-29.36026771	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4152	12153	0.001974821	0.003373653	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TCAGCAATCACCTCGT-1_8_E5	9.371622435	32.91147218	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	810	1167	0.006855184	0.011139674	0	oligos	OL-Cntl	NA	NA	NA
TCAGCAATCTCGTATT-1_8_E5	28.65912834	-1.526984272	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4193	11817	0.005077431	0.00440044	0	2	EN-L4	NA	NA	NA
TCAGCTCCATTAACCG-1_8_E5	9.455971739	33.46601412	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	902	1345	0.003717472	0.00669145	0	oligos	OL-Cntl	NA	NA	NA
TCAGCTCGTTCACCTC-1_8_E5	5.702761687	33.65232517	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	668	1026	0.007797271	0.003898635	0	oligos	OL-Cntl	NA	NA	NA
TCAGGATAGAATGTGT-1_8_E5	-25.50961018	20.50229022	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1559	2767	0.000722804	0.00325262	0	8	Astrocytes	NA	NA	NA
TCAGGATGTCATATCG-1_8_E5	2.00504127	-31.60971615	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	6898	30267	0.00138765	0.002510986	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TCAGGATTCCAGTATG-1_8_E5	12.61456109	-31.36523375	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2785	6681	0.003741955	0.001796138	0	3	EN-L5-6	NA	NA	NA
TCAGGTAAGTGCCAGA-1_8_E5	8.579558995	27.4761314	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	872	1364	0.001466276	0.002932551	0	oligos	OL-Cntl	NA	NA	NA
TCAGGTAGTCTCTTTA-1_8_E5	5.520814782	-27.34746769	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2690	5614	0.011221945	0.004275027	0	3	EN-L5-6	NA	NA	NA
TCAGGTAGTTTGTTGG-1_8_E5	-1.321033826	-21.79009605	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3652	9433	0.006678681	0.004240433	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TCAGGTATCGAATGGG-1_8_E5	-37.70864377	-0.054999692	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1410	2295	0.001742919	0.002178649	0	9	OPC	NA	NA	NA
TCATTACCAACAACCT-1_8_E5	3.741345136	-31.69300003	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5299	19396	0.005310373	0.001804496	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TCATTACCAAGCCATT-1_8_E5	-25.86936628	29.99224223	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2008	3763	0.004783417	0.002391709	0	8	Astrocytes	NA	NA	NA
TCATTACCAGTGGGAT-1_8_E5	-1.714407475	-20.05200863	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3469	9519	0.002521273	0.00378191	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TCATTACCAGTTCATG-1_8_E5	20.0720825	22.62148262	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1008	1651	0.001817081	0.002422774	0	oligos	OL-Cntl	NA	NA	NA
TCATTTGGTAGCGCTC-1_8_E5	-3.251905259	-7.513165463	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	723	1111	0.0270027	0.00180018	0	13A	IN-VIP	NA	NA	NA
TCATTTGGTGTGAATA-1_8_E5	13.20156764	1.888250152	12	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	640	1123	0.000890472	0.00445236	0	12	EN-MIX	NA	NA	NA
TCCACACAGCTAACTC-1_8_E5	20.37484865	24.11262066	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1045	1617	0.003710575	0.006184292	0	oligos	OL-Cntl	NA	NA	NA
TCCCGATAGAAGGACA-1_8_E5	-23.82372604	30.45049271	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2025	4139	0.000724813	0.00338246	0	8	Astrocytes	NA	NA	NA
TCCCGATAGATATGCA-1_8_E5	12.3621309	1.375175276	12	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	697	1315	0.012927757	0.00608365	0	12	EN-MIX	NA	NA	NA
TCCCGATAGGTTCCTA-1_8_E5	15.02010366	-33.81050495	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5456	20097	0.001741553	0.006468627	0	3	EN-L5-6	NA	NA	NA
TCCCGATCACCGTTGG-1_8_E5	14.35207233	-33.52716042	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4729	15970	0.000751409	0.00338134	0	3	EN-L5-6	NA	NA	NA
TCCCGATGTATGGTTC-1_8_E5	24.20172893	-6.510343742	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	8417	46639	0.001994039	0.002765926	0	2	EN-L4	NA	NA	NA
TCCCGATTCCGCAGTG-1_8_E5	23.93281743	-10.11198369	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4126	10705	0.006912658	0.003643157	0	3	EN-L5-6	NA	NA	NA
TCGAGGCAGAGCTATA-1_8_E5	-25.64572417	26.93023818	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1665	3131	0.001277547	0.002874481	0	8	Astrocytes	NA	NA	NA
TCGAGGCAGGTGTGGT-1_8_E5	11.51252868	-20.52757987	4	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5717	18289	0.013122642	0.005959867	0	L2-3	EN-L2-3-MS	NA	NA	NA
TCGAGGCAGTGGTAAT-1_8_E5	-24.05904468	30.12865965	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1817	3371	0.004449718	0.005339662	0	8	Astrocytes	NA	NA	NA
TCGAGGCGTGTAATGA-1_8_E5	-37.81984861	1.482608004	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1649	3090	0.005825243	0.00420712	0	9	OPC	NA	NA	NA
TCGAGGCTCCAGGGCT-1_8_E5	29.03063863	-1.679348968	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4382	12421	0.005635617	0.003783914	0	2	EN-L4	NA	NA	NA
TCGCGAGAGAACAACT-1_8_E5	-11.37616832	2.778773542	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4322	11710	0.01588386	0.005465414	0	13A	IN-VIP	NA	NA	NA
TCGCGAGAGGAGTTGC-1_8_E5	5.868519227	-31.93088823	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5971	21383	0.00313333	0.003320395	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TCGCGAGCAAGGACAC-1_8_E5	-32.14359572	-0.644577579	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1585	2669	0.002248033	0.002997377	0	9	OPC	NA	NA	NA
TCGCGAGCAATAGCGG-1_8_E5	11.17992071	32.34521589	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	841	1224	0.008169935	0.004084967	0	oligos	OL-Cntl	NA	NA	NA
TCGCGAGCACCACGTG-1_8_E5	25.52572737	-28.5070279	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4101	12236	0.009970579	0.003432494	0	3	EN-L5-6	NA	NA	NA
TCGCGAGCATCCTAGA-1_8_E5	-37.5738964	2.785268568	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1717	3289	0.000912131	0.004256613	0	9	OPC	NA	NA	NA
TCGCGAGGTTCGTGAT-1_8_E5	-37.39506474	-6.284312651	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1312	2287	0	0.000874508	0	9	OPC	NA	NA	NA
TCGCGAGTCATCGGAT-1_8_E5	-20.330815	-26.8377688	6A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3794	10582	0.015592516	0.003969004	0	6A	IN-PV	NA	NA	NA
TCGCGAGTCGTCCAGG-1_8_E5	3.125689857	-32.11512436	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	6207	24033	0.005950152	0.002122082	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TCGCGTTAGAGCTATA-1_8_E5	-1.159737378	-19.66386948	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3034	7078	0.011161345	0.00296694	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TCGCGTTAGTAGGCCA-1_8_E5	-26.36016258	17.6861287	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1312	2156	0.000927644	0.002782931	0	8	Astrocytes	NA	NA	NA
TCGCGTTCAGTCAGAG-1_8_E5	9.995789012	31.18778435	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	761	1157	0.007778738	0.007778738	0	oligos	OL-Cntl	NA	NA	NA
TCGCGTTCATTGAGCT-1_8_E5	6.521364998	-30.66410656	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	6490	28132	0.006078487	0.002950377	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TCGCGTTGTATTAGCC-1_8_E5	29.36693694	-2.49060499	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4046	10442	0.009672477	0.004884122	0	2	EN-L4	NA	NA	NA
TCGCGTTGTGTAATGA-1_8_E5	-14.11116753	-21.16720336	6A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1386	2664	0.041666667	0.001501502	0	6A	IN-PV	NA	NA	NA
TCGGGACAGTGCCATT-1_8_E5	-4.44798894	29.98986511	17	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1220	2009	0.005973121	0.004977601	0	oligos	OL-MS-2	NA	NA	NA
TCGGGACCATGGGAAC-1_8_E5	-0.243660334	-15.87466446	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2818	6190	0.012600969	0.002907916	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TCGGGACGTATAAACG-1_8_E5	13.77429962	-2.883692436	12	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1263	2416	0.001241722	0.006622517	0	12	EN-MIX	NA	NA	NA
TCGGGACGTTCCCTTG-1_8_E5	-1.08651394	-20.61158299	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3312	7859	0.003053824	0.003435552	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TCGGGACTCCTGTAGA-1_8_E5	7.335243841	-33.10838576	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4243	13055	0.006970509	0.001761777	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TCGGTAAAGCCCTAAT-1_8_E5	-20.16796721	-27.26815405	6A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2918	6623	0.042125925	0.004529669	0	6A	IN-PV	NA	NA	NA
TCGGTAAGTGGGTATG-1_8_E5	-3.66339171	-7.35074167	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	836	1303	0.02686109	0.003837299	0	13A	IN-VIP	NA	NA	NA
TCGTACCAGCTACCGC-1_8_E5	29.24099282	-1.717652475	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4509	12755	0.00744806	0.005174441	0	2	EN-L4	NA	NA	NA
TCGTACCAGTGCTGCC-1_8_E5	8.073099264	32.59734562	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	834	1254	0.001594896	0.005582137	0	oligos	OL-Cntl	NA	NA	NA
TCGTACCTCTTACCGC-1_8_E5	-36.30909322	4.477740304	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2113	4102	0.003412969	0.003169186	0	9	OPC	NA	NA	NA
TCGTAGAAGAAGGACA-1_8_E5	25.96441554	-3.993964608	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3931	10755	0.00158066	0.00260344	0	2	EN-L4	NA	NA	NA
TCGTAGATCCTTGACC-1_8_E5	5.604909658	33.20375839	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	732	1087	0.006439742	0.003679853	0	oligos	OL-Cntl	NA	NA	NA
TCTATTGAGACTAAGT-1_8_E5	27.46469025	-6.318538136	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	7638	36921	0.020367812	0.003141843	0	2	EN-L4	NA	NA	NA
TCTATTGAGACTAGGC-1_8_E5	-17.197483	-26.35273638	6A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2360	5310	0.023352166	0.002824859	0	6A	IN-PV	NA	NA	NA
TCTATTGCACATTAGC-1_8_E5	-12.19593076	-19.40461046	6B	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1130	1911	0.015175301	0.009419152	0	6B	IN-SST	NA	NA	NA
TCTATTGCAGGTCCAC-1_8_E5	26.98591681	-1.749172571	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3233	8038	0.006469271	0.00261259	0	2	EN-L4	NA	NA	NA
TCTATTGGTATAAACG-1_8_E5	-38.64682854	0.658724092	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1531	2775	0.003243243	0.002522523	0	9	OPC	NA	NA	NA
TCTATTGGTCGCATCG-1_8_E5	25.61968408	-2.954746813	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3317	8744	0.004117109	0.002630375	0	2	EN-L4	NA	NA	NA
TCTATTGTCATGTCTT-1_8_E5	-13.66568234	-24.3245666	6A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1309	2416	0.041804636	0.002897351	0	6A	IN-PV	NA	NA	NA
TCTCATAAGGACATTA-1_8_E5	4.904619906	-31.11248851	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3754	10616	0.001224567	0.002543331	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TCTCATAAGGTCATCT-1_8_E5	-18.07232855	-24.27022838	6A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2724	6810	0.011894273	0.003524229	0	6A	IN-PV	NA	NA	NA
TCTCATATCACAATGC-1_8_E5	28.38749123	-1.165770714	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3951	10758	0.003904071	0.003067485	0	2	EN-L4	NA	NA	NA
TCTCATATCAGAGACG-1_8_E5	28.55986447	-1.472019581	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4106	10847	0.005070526	0.002765742	0	2	EN-L4	NA	NA	NA
TCTCATATCCGTCAAA-1_8_E5	-26.52386195	9.776270595	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	766	1122	0	0.005347594	0	8	Astrocytes	NA	NA	NA
TCTCTAAAGAGTCGGT-1_8_E5	28.806243	-1.395489384	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3859	9969	0.010933895	0.002808707	0	2	EN-L4	NA	NA	NA
TCTCTAAAGCTAGGCA-1_8_E5	28.98815824	-4.004442181	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4172	11486	0.012885252	0.006007313	0	2	EN-L4	NA	NA	NA
TCTCTAACACGTCAGC-1_8_E5	1.572207274	-10.49467258	12	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2051	4347	0.003680699	0.00621118	0	12	EN-MIX	NA	NA	NA
TCTCTAATCCGCGTTT-1_8_E5	-1.149815526	-19.10410265	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2753	6323	0.002530444	0.005219042	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TCTCTAATCTACTCAT-1_8_E5	21.21172498	1.540628796	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1485	2713	0.013269443	0.00258017	0	2	EN-L4	NA	NA	NA
TCTCTAATCTTTAGGG-1_8_E5	-1.301916297	-14.58653081	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2465	5615	0.003205699	0.003918077	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TCTGAGAAGACTCGGA-1_8_E5	-1.063275133	-14.2804764	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2260	4499	0.007557235	0.003556346	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TCTGAGACACGAAATA-1_8_E5	-11.42363489	2.453758544	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4279	10645	0.009394082	0.003851574	0	13A	IN-VIP	NA	NA	NA
TCTGAGACACGTGAGA-1_8_E5	27.09963464	-5.140947486	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5185	17450	0.003782235	0.003667622	0	2	EN-L4	NA	NA	NA
TCTGAGAGTTCCCGAG-1_8_E5	7.783665217	32.46710797	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	698	1104	0.002717391	0.005434783	0	oligos	OL-Cntl	NA	NA	NA
TCTGGAAAGAGAACAG-1_8_E5	-17.14359457	-11.09551059	13B	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4703	13561	0.002064744	0.005235602	0	13B	IN-SV2C	NA	NA	NA
TCTGGAACATCAGTAC-1_8_E5	-38.13137888	2.948219436	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1803	3419	0.002339865	0.001462416	0	9	OPC	NA	NA	NA
TCTGGAAGTAAGTGTA-1_8_E5	21.12858452	-1.343134891	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1827	3053	0.018015067	0.0049132	0	2	EN-L4	NA	NA	NA
TCTGGAAGTGAGTGAC-1_8_E5	17.00150017	10.317923	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1479	2562	0.005854801	0.003903201	0	oligos	OL-Cntl	NA	NA	NA
TCTGGAATCGCCATAA-1_8_E5	23.40910529	0.897904237	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2017	3750	0.0104	0.003466667	0	2	EN-L4	NA	NA	NA
TCTGGAATCTCACATT-1_8_E5	19.96605242	25.07886738	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1072	1655	0.008459215	0.004833837	0	oligos	OL-Cntl	NA	NA	NA
TCTTCGGCAATGTAAG-1_8_E5	5.826872606	32.53756759	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	708	1045	0.005741627	0.003827751	0	oligos	OL-Cntl	NA	NA	NA
TCTTCGGCACCGAATT-1_8_E5	18.75078165	13.0562525	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1357	2446	0.002452984	0.003679477	0	oligos	OL-Cntl	NA	NA	NA
TCTTCGGCACTGCCAG-1_8_E5	-9.50127359	13.20884311	11	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1042	1540	0.007142857	0.002597403	0	11	Glia-MIX	NA	NA	NA
TCTTCGGCATCGGAAG-1_8_E5	15.08455758	-33.64979549	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5323	18099	0.005469915	0.006409194	0	3	EN-L5-6	NA	NA	NA
TCTTCGGTCACTCTTA-1_8_E5	1.696582603	-31.05221597	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4913	16658	0.003001561	0.003241686	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TCTTCGGTCTTGTTTG-1_8_E5	19.93078155	22.88815903	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1065	1787	0.003357583	0.002238388	0	oligos	OL-Cntl	NA	NA	NA
TCTTTCCCAGGGATTG-1_8_E5	17.7707389	13.1582348	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1237	2120	0.001415094	0.002358491	0	oligos	OL-Cntl	NA	NA	NA
TCTTTCCGTCTCCCTA-1_8_E5	11.42824836	-4.99471311	12	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	857	1265	0.002371542	0.001581028	0	12	EN-MIX	NA	NA	NA
TGAAAGACAAGTTGTC-1_8_E5	-0.796192835	-24.81139018	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4407	13001	0.012922083	0.003153604	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TGAAAGACAATCTACG-1_8_E5	8.193068215	34.29739879	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	967	1480	0.006081081	0.002027027	0	oligos	OL-Cntl	NA	NA	NA
TGAAAGACACACGCTG-1_8_E5	-2.772020433	-0.920481684	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3081	6474	0.016836577	0.006487488	0	13A	IN-VIP	NA	NA	NA
TGAAAGACAGTATGCT-1_8_E5	-11.54355428	17.25183367	11	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1701	2982	0.001341382	0.004694836	0	11	Glia-MIX	NA	NA	NA
TGAAAGACATCACGTA-1_8_E5	18.67629448	26.09567066	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	963	1530	0.003267974	0.009803922	0	oligos	OL-Cntl	NA	NA	NA
TGAAAGAGTCTGGTCG-1_8_E5	8.263287822	26.78213158	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	922	1367	0.004389173	0.00658376	0	oligos	OL-Cntl	NA	NA	NA
TGAAAGAGTTATTCTC-1_8_E5	-37.00936284	-6.575254559	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1051	1677	0.006559332	0.003577818	0	9	OPC	NA	NA	NA
TGACAACAGACAATAC-1_8_E5	-2.196604572	-22.45553009	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3526	9071	0.002756036	0.003307243	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TGACAACCAAGCTGAG-1_8_E5	-0.697582061	-21.55706383	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3889	10320	0.002616279	0.002616279	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TGACAACGTCGCGTGT-1_8_E5	19.41459685	24.40211244	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1008	1605	0.006853583	0.003738318	0	oligos	OL-Cntl	NA	NA	NA
TGACAACGTCTCGTTC-1_8_E5	-1.56447837	-19.88403984	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3052	6950	0.001726619	0.004028777	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TGACAACTCATCTGCC-1_8_E5	-3.455192442	34.28857432	17	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	890	1221	0.012285012	0.005733006	0	oligos	OL-MS-2	NA	NA	NA
TGACGGCAGACCACGA-1_8_E5	20.78107779	-29.252637	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4752	14376	0.012520868	0.004660545	0	3	EN-L5-6	NA	NA	NA
TGACGGCAGCAGCGTA-1_8_E5	-38.87679233	-1.0208255	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1404	2354	0.002124044	0.00382328	0	9	OPC	NA	NA	NA
TGACGGCAGGCAATTA-1_8_E5	15.69556573	-33.28748375	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	6127	23178	0.003020105	0.003753559	0	3	EN-L5-6	NA	NA	NA
TGACGGCCAGCCTTTC-1_8_E5	0.556492423	-27.4534008	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4100	11367	0.003958828	0.002727193	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TGACGGCGTAATCACC-1_8_E5	-18.96061841	-24.20118283	6A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2849	6153	0.000812612	0.004388103	0	6A	IN-PV	NA	NA	NA
TGACGGCGTCAATGTC-1_8_E5	4.022970388	-32.28889076	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	6347	28416	0.00098536	0.001653998	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TGACGGCTCCTCATTA-1_8_E5	4.797622735	32.74506166	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	750	1096	0.001824818	0.002737226	0	oligos	OL-Cntl	NA	NA	NA
TGACGGCTCGTCGTTC-1_8_E5	-14.19509739	-9.896155623	13B	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2590	5846	0.006671228	0.003934314	0	13B	IN-SV2C	NA	NA	NA
TGACTAGAGAAGGGTA-1_8_E5	5.728172968	33.81731109	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	824	1196	0.003344482	0.010033445	0	oligos	OL-Cntl	NA	NA	NA
TGACTAGAGATCCGAG-1_8_E5	-18.39929215	-17.89496226	6B	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2415	5171	0.021272481	0.003094179	0	6B	IN-SST	NA	NA	NA
TGACTAGAGGCCATAG-1_8_E5	28.5764498	-1.995445106	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4116	10156	0.005415518	0.005907838	0	2	EN-L4	NA	NA	NA
TGACTAGAGGGAACGG-1_8_E5	-11.17348432	2.50202155	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3421	8037	0.018414831	0.003359462	0	13A	IN-VIP	NA	NA	NA
TGACTAGAGTGGACGT-1_8_E5	14.80545117	-33.68658643	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5493	20771	0.001011025	0.003899668	0	3	EN-L5-6	NA	NA	NA
TGACTAGAGTGGAGTC-1_8_E5	-10.42536769	1.396766581	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2617	5809	0.003270787	0.006025133	0	13A	IN-VIP	NA	NA	NA
TGACTAGCAGTATCTG-1_8_E5	18.34876355	-34.12024655	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4963	15824	0.003538928	0.0065091	0	3	EN-L5-6	NA	NA	NA
TGACTAGCAGTTAACC-1_8_E5	7.819924058	34.40660515	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	901	1362	0.004405286	0.002202643	0	oligos	OL-Cntl	NA	NA	NA
TGACTAGGTTCAGCGC-1_8_E5	-21.13946206	-28.37625029	6A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4430	12727	0.012257406	0.003692936	0	6A	IN-PV	NA	NA	NA
TGACTAGTCCGCATAA-1_8_E5	28.32018746	-1.936451431	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4822	14137	0.004880809	0.003819764	0	2	EN-L4	NA	NA	NA
TGACTAGTCGTTGACA-1_8_E5	-8.84283898	-18.18493918	6B	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	708	1059	0.067988669	0.001888574	0	6B	IN-SST	NA	NA	NA
TGACTTTAGCTAGGCA-1_8_E5	-19.84785678	-27.0558511	6A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3290	8670	0.010149942	0.005190311	0	6A	IN-PV	NA	NA	NA
TGACTTTAGGAATCGC-1_8_E5	-25.68972622	20.49997514	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1458	2472	0.002022654	0.001618123	0	8	Astrocytes	NA	NA	NA
TGACTTTGTAAGTTCC-1_8_E5	15.35568684	-4.125725178	12	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1234	1971	0.008625063	0.005580923	0	12	EN-MIX	NA	NA	NA
TGACTTTGTCATATGC-1_8_E5	-1.94525341	-25.68347985	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4414	12946	0.003012514	0.003167001	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TGACTTTGTGACCAAG-1_8_E5	-37.52959822	0.936676809	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1632	3022	0.007279947	0.004301787	0	9	OPC	NA	NA	NA
TGACTTTTCCGAATGT-1_8_E5	3.812887783	-30.41133754	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3888	11556	0.004499827	0.001903773	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TGAGAGGAGGCATTGG-1_8_E5	-38.82017007	-0.472281584	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1413	2419	0.007027697	0.003720546	0	9	OPC	NA	NA	NA
TGAGAGGCAAGCCCAC-1_8_E5	0.298283194	-27.94889752	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5938	21078	0.006784325	0.002799127	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TGAGAGGGTTACTGAC-1_8_E5	3.910406391	-32.52606714	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	6630	29853	0.001004924	0.00251231	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TGAGAGGTCATGTCTT-1_8_E5	9.165729703	33.28970098	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	964	1460	0.003424658	0.005479452	0	oligos	OL-Cntl	NA	NA	NA
TGAGAGGTCTTATCTG-1_8_E5	8.146749082	-7.368508164	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1723	3063	0.014691479	0.002938296	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TGAGCATAGATCTGAA-1_8_E5	10.68419068	26.60392493	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	969	1541	0.001946788	0.002595717	0	oligos	OL-Cntl	NA	NA	NA
TGAGCATAGCATCATC-1_8_E5	18.58449022	13.53902776	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1232	2050	0.002439024	0.005853659	0	oligos	OL-Cntl	NA	NA	NA
TGAGCATAGCGTTCCG-1_8_E5	-25.90300424	29.81524066	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1678	3210	0.000311526	0.004361371	0	8	Astrocytes	NA	NA	NA
TGAGCATCAAGGTGTG-1_8_E5	10.68213619	26.64800351	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	965	1562	0.005121639	0.007682458	0	oligos	OL-Cntl	NA	NA	NA
TGAGCATGTAGCTCCG-1_8_E5	-23.51846363	29.63158278	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1832	3495	0.001716738	0.001716738	0	8	Astrocytes	NA	NA	NA
TGAGCATGTTCGGGCT-1_8_E5	-38.42775695	-2.419446636	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1385	2484	0.006441224	0.004025765	0	9	OPC	NA	NA	NA
TGAGCATTCGCGATCG-1_8_E5	25.52049685	-2.601737084	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2856	6468	0.001082251	0.002473717	0	2	EN-L4	NA	NA	NA
TGAGCCGAGGCGTACA-1_8_E5	-38.49897393	1.980676231	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1569	2789	0.001075654	0.002151309	0	9	OPC	NA	NA	NA
TGAGCCGAGTCCTCCT-1_8_E5	0.698859819	-29.66152266	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4679	14032	0.005986317	0.002280502	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TGAGCCGGTATCACCA-1_8_E5	26.22055792	-2.752375157	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3625	9594	0.003022723	0.003231186	0	2	EN-L4	NA	NA	NA
TGAGCCGGTATGAAAC-1_8_E5	29.36776962	-1.925083279	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4115	10152	0.012115839	0.004728132	0	2	EN-L4	NA	NA	NA
TGAGCCGGTCTTCTCG-1_8_E5	-10.64487498	2.665832349	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3543	9025	0.007534626	0.004099723	0	13A	IN-VIP	NA	NA	NA
TGAGCCGGTTTGTTGG-1_8_E5	-24.29754116	29.17486125	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1837	3460	0.003757225	0.003757225	0	8	Astrocytes	NA	NA	NA
TGAGCCGTCCCTTGTG-1_8_E5	9.967672842	32.57992746	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	863	1284	0.004672897	0.002336449	0	oligos	OL-Cntl	NA	NA	NA
TGAGGGAAGCGAAGGG-1_8_E5	-4.564390528	-8.157352457	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	764	1159	0.012079379	0.006039689	0	13A	IN-VIP	NA	NA	NA
TGAGGGAAGGCAGGTT-1_8_E5	-0.44171442	-22.5951932	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4827	15377	0.003056513	0.003966964	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TGAGGGAAGTCGCCGT-1_8_E5	15.19857334	-33.51616335	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5625	19802	0.005554994	0.004544995	0	3	EN-L5-6	NA	NA	NA
TGAGGGACACATAACC-1_8_E5	-4.998845284	-2.405750525	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1507	2809	0.012815949	0.001423994	0	13A	IN-VIP	NA	NA	NA
TGAGGGAGTCTAACGT-1_8_E5	-24.05902411	30.47312432	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1917	3767	0.001327316	0.003716485	0	8	Astrocytes	NA	NA	NA
TGAGGGAGTGTTCGAT-1_8_E5	23.19827291	-9.120504861	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3266	8134	0.000614704	0.003565282	0	3	EN-L5-6	NA	NA	NA
TGAGGGATCCTAGAAC-1_8_E5	10.02888005	31.10362874	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	795	1172	0	0.005119454	0	oligos	OL-Cntl	NA	NA	NA
TGATTTCAGGCATTGG-1_8_E5	-37.47181998	-0.856660457	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1460	2617	0.001910585	0.003439052	0	9	OPC	NA	NA	NA
TGATTTCCAGGTGCCT-1_8_E5	-1.062982891	-23.21998654	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4403	12930	0.003402939	0.002938902	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TGATTTCCATGGAATA-1_8_E5	16.88645481	-33.2429773	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	7496	35856	0.003988175	0.00421129	0	3	EN-L5-6	NA	NA	NA
TGATTTCTCCATGAAC-1_8_E5	-37.80717323	3.016511991	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1922	3788	0.001583949	0.002111932	0	9	OPC	NA	NA	NA
TGATTTCTCCCTTGTG-1_8_E5	18.75543158	25.9818577	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	911	1388	0.003602305	0.002161383	0	oligos	OL-Cntl	NA	NA	NA
TGATTTCTCCGATATG-1_8_E5	28.31666404	-1.48945041	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4202	12188	0.003856252	0.003774204	0	2	EN-L4	NA	NA	NA
TGATTTCTCTTCGGTC-1_8_E5	7.808406583	30.7072694	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	778	1140	0.007017544	0.001754386	0	oligos	OL-Cntl	NA	NA	NA
TGCACCTAGAGAACAG-1_8_E5	8.22646999	33.18161202	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1024	1639	0.009151922	0.003660769	0	oligos	OL-Cntl	NA	NA	NA
TGCACCTCATTACGAC-1_8_E5	-0.224270318	35.38741865	17	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	839	1229	0.005695688	0.004882018	0	oligos	OL-MS-2	NA	NA	NA
TGCACCTGTAAGTGGC-1_8_E5	7.917790816	32.1880154	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	773	1138	0.004393673	0.000878735	0	oligos	OL-Cntl	NA	NA	NA
TGCACCTTCAACACCA-1_8_E5	22.22720859	14.55411212	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1309	2129	0.000939408	0.006106153	0	oligos	OL-Cntl	NA	NA	NA
TGCCAAAAGTCGCCGT-1_8_E5	-1.657059683	-15.87042307	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2315	4834	0.005585436	0.002896152	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TGCCAAACACCAGTTA-1_8_E5	25.01558832	-29.65300051	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3166	8161	0.001102806	0.003553486	0	3	EN-L5-6	NA	NA	NA
TGCCAAACAGATCCAT-1_8_E5	-14.23891922	-7.564197593	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3626	9685	0.007537429	0.002581311	0	13A	IN-VIP	NA	NA	NA
TGCCAAACATGGTCTA-1_8_E5	27.11816994	-1.909085842	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3520	8659	0.004965931	0.00323363	0	2	EN-L4	NA	NA	NA
TGCCAAAGTGTGACGA-1_8_E5	24.73120549	0.064871747	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2421	5130	0.006432749	0.001169591	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TGCCAAATCGGTCCGA-1_8_E5	-25.95077051	29.89811091	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1694	2982	0.001341382	0.002347418	0	8	Astrocytes	NA	NA	NA
TGCCAAATCTCAACTT-1_8_E5	-1.415411399	-21.58313657	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3622	9777	0.00235246	0.001841056	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TGCCCATAGGCTCTTA-1_8_E5	0.794266769	-30.30326145	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5712	21412	0.005230712	0.002054922	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TGCCCATAGGTGTTAA-1_8_E5	20.73616758	23.41736869	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1071	1726	0.001158749	0.00405562	0	oligos	OL-Cntl	NA	NA	NA
TGCCCATAGTTACCCA-1_8_E5	9.586161841	32.44496515	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	876	1326	0.004524887	0.003016591	0	oligos	OL-Cntl	NA	NA	NA
TGCCCATCAAGCTGGA-1_8_E5	-25.11745018	19.77398794	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1561	2866	0.001046755	0.00418702	0	8	Astrocytes	NA	NA	NA
TGCCCATCACGGATAG-1_8_E5	-14.2810724	-19.16963958	6B	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1381	2334	0.006426735	0.001285347	0	6B	IN-SST	NA	NA	NA
TGCCCATGTCATATCG-1_8_E5	-20.06353604	-18.35196244	6A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4241	11353	0.031797763	0.002730556	0	6A	IN-PV	NA	NA	NA
TGCCCATGTGGTTTCA-1_8_E5	18.63034681	25.60487637	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1037	1537	0.005855563	0.001951854	0	oligos	OL-Cntl	NA	NA	NA
TGCCCATGTTGATTCG-1_8_E5	-10.87407701	-17.37923478	6B	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1012	1612	0.039702233	0.001861042	0	6B	IN-SST	NA	NA	NA
TGCCCATTCACCTCGT-1_8_E5	27.71396268	-2.481979481	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4585	13347	0.000974002	0.003446467	0	2	EN-L4	NA	NA	NA
TGCCCATTCGTGGTCG-1_8_E5	14.74599714	-33.68059076	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4520	13963	0.001145886	0.004297071	0	3	EN-L5-6	NA	NA	NA
TGCCCATTCTTGGGTA-1_8_E5	-27.61023708	14.43987625	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	921	1348	0.002967359	0.002225519	0	8	Astrocytes	NA	NA	NA
TGCCCTAAGGAATGGA-1_8_E5	8.928147027	33.71053189	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	986	1463	0.004101162	0.006151743	0	oligos	OL-Cntl	NA	NA	NA
TGCCCTACATCCGGGT-1_8_E5	20.28768051	25.06061532	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1040	1590	0.011949686	0.00754717	0	oligos	OL-Cntl	NA	NA	NA
TGCCCTAGTAACGACG-1_8_E5	4.217705774	30.75747286	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	710	1013	0.007897335	0.004935834	0	oligos	OL-Cntl	NA	NA	NA
TGCCCTAGTTCACCTC-1_8_E5	8.08322444	31.99082638	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	774	1176	0.005952381	0.003401361	0	oligos	OL-Cntl	NA	NA	NA
TGCCCTATCGAATCCA-1_8_E5	0.612179802	-30.14834553	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4898	16528	0.001210068	0.001996612	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TGCCCTATCGACAGCC-1_8_E5	20.72551554	22.67719407	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1131	1972	0.002028398	0.002028398	0	oligos	OL-Cntl	NA	NA	NA
TGCGCAGAGACTACAA-1_8_E5	0.12639086	-28.01246751	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	6275	23190	0.008106943	0.002587322	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TGCGCAGAGGATGGAA-1_8_E5	26.05947606	-2.783090536	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3256	7307	0.006158478	0.003831942	0	2	EN-L4	NA	NA	NA
TGCGCAGAGGGATACC-1_8_E5	-1.164132432	-22.6249584	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3833	10122	0.002371073	0.002963841	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TGCGCAGCATAGTAAG-1_8_E5	-24.45648952	29.97746576	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1848	3653	0	0.001368738	0	8	Astrocytes	NA	NA	NA
TGCGCAGGTTAGATGA-1_8_E5	1.785107385	-30.98735495	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5851	21472	0.002468331	0.003772355	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TGCGGGTGTAACGTTC-1_8_E5	0.262529945	-28.02085272	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	6327	25497	0.004235792	0.002941523	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TGCGGGTGTTACGTCA-1_8_E5	20.95948001	25.65032293	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	926	1451	0.00137836	0.005513439	0	oligos	OL-Cntl	NA	NA	NA
TGCGGGTTCAAGCCTA-1_8_E5	-10.75315642	1.413332865	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2987	6706	0.005964808	0.004324486	0	13A	IN-VIP	NA	NA	NA
TGCGGGTTCCTAGGGC-1_8_E5	2.340018315	-28.22844599	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3867	10572	0.006242906	0.003216042	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TGCGTGGAGCCATCGC-1_8_E5	22.75248273	-9.190476431	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2938	6810	0.004845815	0.005726872	0	3	EN-L5-6	NA	NA	NA
TGCGTGGAGCCTTGAT-1_8_E5	8.054289171	-31.93820114	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5189	15844	0.005995961	0.003786922	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TGCGTGGAGTGGTCCC-1_8_E5	15.01727677	-33.92185119	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5329	18640	0.001555794	0.005257511	0	3	EN-L5-6	NA	NA	NA
TGCGTGGCAAGCGAGT-1_8_E5	10.11811193	27.66127939	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	888	1381	0.001448226	0.007965243	0	oligos	OL-Cntl	NA	NA	NA
TGCGTGGGTTAAAGAC-1_8_E5	28.72779627	-4.88994205	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3737	8749	0.012572865	0.00468625	0	2	EN-L4	NA	NA	NA
TGCGTGGTCATCACCC-1_8_E5	-0.651594369	-20.20036488	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3450	8601	0.006743402	0.005115684	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TGCTACCAGCCTATGT-1_8_E5	-23.95610959	30.48218274	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1804	3316	0.001507841	0.002714113	0	8	Astrocytes	NA	NA	NA
TGCTACCAGTGAAGAG-1_8_E5	-3.561599976	-5.254496097	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1161	1733	0.009232545	0.003462204	0	13A	IN-VIP	NA	NA	NA
TGCTACCCAGCGTAAG-1_8_E5	10.91246451	32.96088314	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	930	1379	0.004350979	0.005801305	0	oligos	OL-Cntl	NA	NA	NA
TGCTACCCAGTAACGG-1_8_E5	-1.043078252	-20.98627961	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3508	8759	0.011530997	0.003653385	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TGCTACCCATTTCAGG-1_8_E5	29.06971283	-1.699045188	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4287	11378	0.006679557	0.005097557	0	2	EN-L4	NA	NA	NA
TGCTACCGTAGCAAAT-1_8_E5	9.417015778	33.28303533	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	774	1100	0.014545455	0.006363636	0	oligos	OL-Cntl	NA	NA	NA
TGCTACCTCCGCGGTA-1_8_E5	4.529540946	32.29850198	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	728	1010	0.005940594	0.002970297	0	oligos	OL-Cntl	NA	NA	NA
TGCTGCTAGCCCAGCT-1_8_E5	-37.77856137	3.101576425	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1764	3195	0.00312989	0.005633803	0	9	OPC	NA	NA	NA
TGCTGCTAGCTTTGGT-1_8_E5	-0.834595418	-21.29072964	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3844	10446	0.002106069	0.004882252	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TGCTGCTCAGAGCCAA-1_8_E5	-18.21100044	-24.4388985	6A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3002	7078	0.02232269	0.002825657	0	6A	IN-PV	NA	NA	NA
TGCTGCTGTCGTGGCT-1_8_E5	-1.319837162	-20.97829614	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3814	11075	0.005056433	0.002799097	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TGCTGCTGTGGTCCGT-1_8_E5	-0.636281189	-14.51513197	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2276	4515	0.013953488	0.003986711	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TGCTGCTTCAACCAAC-1_8_E5	-38.62092581	-0.610199917	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1417	2484	0.000402576	0.002818035	0	9	OPC	NA	NA	NA
TGCTGCTTCACCGGGT-1_8_E5	6.049332491	34.91049252	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	825	1186	0.013490725	0.005902192	0	oligos	OL-Cntl	NA	NA	NA
TGCTGCTTCATGGTCA-1_8_E5	20.89097878	23.62649428	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	984	1600	0.0075	0.00375	0	oligos	OL-Cntl	NA	NA	NA
TGGACGCAGCAGGTCA-1_8_E5	2.469769105	6.188655949	7	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	990	1323	0.015117158	0.004535147	0	7	Phagocytes	NA	NA	NA
TGGACGCCACATGACT-1_8_E5	6.987800419	35.05693569	11	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	916	1396	0.000716332	0.002148997	0	11	Glia-MIX	NA	NA	NA
TGGACGCGTCTGCAAT-1_8_E5	-18.41651225	-22.5019691	6A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2296	4673	0.02182752	0.006847849	0	6A	IN-PV	NA	NA	NA
TGGACGCGTGCACCAC-1_8_E5	26.42195359	-2.547231273	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3243	7447	0.023230831	0.003491339	0	2	EN-L4	NA	NA	NA
TGGACGCTCATGGTCA-1_8_E5	-17.96809556	-23.76705606	6A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2673	6300	0.021269841	0.005238095	0	6A	IN-PV	NA	NA	NA
TGGACGCTCCTAGTGA-1_8_E5	-38.49047917	-0.900954887	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1452	2625	0.001904762	0.001904762	0	9	OPC	NA	NA	NA
TGGCCAGAGAGGGATA-1_8_E5	6.50282503	31.89866474	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	716	1082	0.012939002	0.005545287	0	oligos	OL-Cntl	NA	NA	NA
TGGCCAGCAAGCCGCT-1_8_E5	-12.23864412	1.959240543	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3289	7504	0.016924307	0.009594883	0	13A	IN-VIP	NA	NA	NA
TGGCCAGCATATACCG-1_8_E5	20.84997635	23.45044433	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1068	1665	0.001201201	0.004804805	0	oligos	OL-Cntl	NA	NA	NA
TGGCCAGGTACCAGTT-1_8_E5	25.33672065	4.04979106	15BA	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1120	1708	0.00234192	0.008196721	0	15BA	Stromal cells	NA	NA	NA
TGGCGCAAGCGTCTAT-1_8_E5	4.831404601	-1.604238975	12	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	640	1022	0.006849315	0.002935421	0	12	EN-MIX	NA	NA	NA
TGGCGCAAGGCTCAGA-1_8_E5	5.536768651	-27.28689544	4	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4570	12786	0.00437979	0.002502737	0	L2-3	EN-L2-3-MS	NA	NA	NA
TGGCGCAGTACAGCAG-1_8_E5	-1.537319124	-21.71025764	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3802	9840	0.007215447	0.003353659	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TGGCGCATCACTATTC-1_8_E5	23.67895056	-9.317758454	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4862	15057	0.0013947	0.004051272	0	3	EN-L5-6	NA	NA	NA
TGGCGCATCGTCTGCT-1_8_E5	-19.92924017	-18.02395781	6A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3948	10857	0.009302754	0.004881643	0	6A	IN-PV	NA	NA	NA
TGGCGCATCTAGCACA-1_8_E5	-0.432408528	-13.08965985	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1953	3694	0.015159718	0.002977802	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TGGCTGGAGCACAGGT-1_8_E5	17.45835949	-4.865403217	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1387	2675	0.002990654	0.003738318	0	3	EN-L5-6	NA	NA	NA
TGGCTGGCATCCCATC-1_8_E5	-26.87483949	10.43285063	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	880	1291	0.001549187	0.00464756	0	8	Astrocytes	NA	NA	NA
TGGCTGGGTAGCGTAG-1_8_E5	22.10980014	-19.68149945	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	8470	41986	0.04027533	0.004763493	0	3	EN-L5-6	NA	NA	NA
TGGCTGGGTATATGAG-1_8_E5	-38.1281615	2.815843565	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1838	3400	0.004411765	0.003235294	0	9	OPC	NA	NA	NA
TGGCTGGTCCCACTTG-1_8_E5	-27.55875314	16.30519804	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1140	1858	0.003229279	0.002691066	0	8	Astrocytes	NA	NA	NA
TGGGAAGAGAATCTCC-1_8_E5	6.129707268	34.72805717	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	746	1061	0.005655042	0.002827521	0	oligos	OL-Cntl	NA	NA	NA
TGGGAAGAGCGTGTCC-1_8_E5	-1.061735089	-21.26024212	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3663	10147	0.002857988	0.004237706	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TGGGAAGAGGGCTCTC-1_8_E5	-31.36701084	-1.503369836	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1425	2375	0.001263158	0.004210526	0	9	OPC	NA	NA	NA
TGGGAAGAGGTAGCTG-1_8_E5	-0.90632243	-20.73324833	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3304	7898	0.006963788	0.003038744	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TGGGAAGGTGCTGTAT-1_8_E5	9.80529357	27.37818668	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	894	1316	0.000759878	0.006838906	0	oligos	OL-Cntl	NA	NA	NA
TGGGAAGTCTTACCGC-1_8_E5	-26.72549581	15.15823554	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1173	2056	0.000486381	0.001459144	0	8	Astrocytes	NA	NA	NA
TGGGCGTGTGCGAAAC-1_8_E5	-36.71140322	-1.022864983	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1455	2589	0.003089996	0.005021244	0	9	OPC	NA	NA	NA
TGGGCGTTCAACACCA-1_8_E5	18.12680283	9.181862834	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1596	2851	0.007015082	0.006313574	0	oligos	OL-Cntl	NA	NA	NA
TGGGCGTTCCTTCAAT-1_8_E5	-6.729651811	-0.322911281	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1983	3878	0.012893244	0.003610108	0	13A	IN-VIP	NA	NA	NA
TGGGCGTTCGTGGGAA-1_8_E5	-37.98636959	-4.624699151	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1287	2153	0.003251277	0.003715745	0	9	OPC	NA	NA	NA
TGGTTAGAGCTAAGAT-1_8_E5	0.919734945	-29.71732492	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5340	17072	0.005506092	0.002987348	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TGGTTAGGTACCGTAT-1_8_E5	-1.338640559	-24.01416928	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3415	9160	0.003056769	0.001965066	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TGGTTAGGTATTACCG-1_8_E5	-24.05921412	30.30891323	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1983	3891	0.000514007	0.002570033	0	8	Astrocytes	NA	NA	NA
TGGTTAGGTGGCAAAC-1_8_E5	-31.57268245	-1.315345995	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1593	2710	0.005904059	0.001845018	0	9	OPC	NA	NA	NA
TGGTTAGGTGTGAATA-1_8_E5	-26.12015645	25.71949601	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1464	2529	0.005931198	0.002372479	0	8	Astrocytes	NA	NA	NA
TGGTTAGGTTGAGTTC-1_8_E5	27.68398407	-3.485313036	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3342	7943	0.003651013	0.00377691	0	2	EN-L4	NA	NA	NA
TGGTTAGTCAACTCTT-1_8_E5	-18.50567825	-17.93574055	6B	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2393	5200	0.013461538	0.005384615	0	6B	IN-SST	NA	NA	NA
TGGTTAGTCCATTCTA-1_8_E5	24.14764246	-1.185205856	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2547	5371	0.006144107	0.006330292	0	2	EN-L4	NA	NA	NA
TGGTTAGTCCGCATCT-1_8_E5	2.743169857	-24.79731931	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3428	8435	0.002963841	0.004505039	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TGGTTCCAGAGCCTAG-1_8_E5	-14.5286292	-7.294641472	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4840	14900	0.01261745	0.004496644	0	13A	IN-VIP	NA	NA	NA
TGGTTCCAGAGTACAT-1_8_E5	19.8542217	24.29466046	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	986	1483	0.00606878	0.003371544	0	oligos	OL-Cntl	NA	NA	NA
TGGTTCCAGTAAGTAC-1_8_E5	-31.83300548	0.36507288	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1942	3537	0.002544529	0.005089059	0	9	OPC	NA	NA	NA
TGGTTCCAGTGGTAAT-1_8_E5	-27.16529759	15.16592148	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1017	1562	0.002560819	0.003201024	0	8	Astrocytes	NA	NA	NA
TGGTTCCAGTTGCAGG-1_8_E5	-31.63952874	-0.734702526	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1614	2644	0.0102118	0.001891074	0	9	OPC	NA	NA	NA
TGGTTCCTCATAAAGG-1_8_E5	-13.28763946	-18.9776047	6B	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1255	2120	0.033962264	0.001886792	0	6B	IN-SST	NA	NA	NA
TGGTTCCTCATAACCG-1_8_E5	-38.12322119	2.010249565	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1610	3004	0.003661784	0.001997337	0	9	OPC	NA	NA	NA
TGTATTCCAATGGTCT-1_8_E5	-13.3153247	17.67084687	11	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1384	2214	0.001806685	0.003613369	0	11	Glia-MIX	NA	NA	NA
TGTATTCCATGCCTTC-1_8_E5	28.8393709	-2.23164008	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4061	10565	0.005111216	0.003880738	0	2	EN-L4	NA	NA	NA
TGTATTCGTTCCCTTG-1_8_E5	-1.04672716	-25.42463507	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5034	18554	0.001024038	0.002910424	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TGTCCCAAGAGGTAGA-1_8_E5	31.81522975	-2.992824243	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3251	6970	0.01205165	0.005308465	0	2	EN-L4	NA	NA	NA
TGTCCCAAGCCACTAT-1_8_E5	-25.39273417	20.33950949	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1535	2594	0.00308404	0.00308404	0	8	Astrocytes	NA	NA	NA
TGTCCCAAGCTAGCCC-1_8_E5	25.81294999	-26.66576664	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4894	14873	0.00578229	0.003092853	0	3	EN-L5-6	NA	NA	NA
TGTCCCACAGTGGGAT-1_8_E5	8.625641654	31.51837907	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	764	1116	0.007168459	0.005376344	0	oligos	OL-Cntl	NA	NA	NA
TGTCCCAGTACTCAAC-1_8_E5	-0.649030284	-22.02602938	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4022	10997	0.00654724	0.004092025	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TGTCCCAGTTACCGAT-1_8_E5	-38.68158504	-0.330489245	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1481	2680	0.001492537	0.002985075	0	9	OPC	NA	NA	NA
TGTCCCAGTTCACCTC-1_8_E5	-15.02721644	-25.64436126	6A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1737	3329	0.008711325	0.002403124	0	6A	IN-PV	NA	NA	NA
TGTCCCAGTTGCTCCT-1_8_E5	10.59141618	27.72079712	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	946	1367	0.002194587	0.003657644	0	oligos	OL-Cntl	NA	NA	NA
TGTCCCATCAGGCAAG-1_8_E5	1.903086552	-31.23569647	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	7436	36429	0.002058799	0.00208625	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TGTCCCATCTAGAGTC-1_8_E5	14.5013818	-33.41352261	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4370	13238	0.003550385	0.003852546	0	3	EN-L5-6	NA	NA	NA
TGTCCCATCTCGTTTA-1_8_E5	24.21420705	-6.343946656	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4154	10543	0.011571659	0.003035189	0	2	EN-L4	NA	NA	NA
TGTGGTAAGCCGGTAA-1_8_E5	27.17701162	-3.865955779	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3334	8025	0.00211838	0.004984424	0	2	EN-L4	NA	NA	NA
TGTGGTAAGTACGCCC-1_8_E5	7.226306119	33.92548362	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	799	1197	0.001670844	0.005847953	0	oligos	OL-Cntl	NA	NA	NA
TGTGGTACACATTTCT-1_8_E5	-8.95968314	1.182318292	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2483	5511	0.014516422	0.004173471	0	13A	IN-VIP	NA	NA	NA
TGTGGTACATTCGACA-1_8_E5	-1.001611482	-20.74869183	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3373	8033	0.004232541	0.002240757	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TGTGGTATCCGGCACA-1_8_E5	-0.795514142	-21.85571743	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4402	12610	0.002775575	0.004599524	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TGTGTTTAGTGTACTC-1_8_E5	5.341044213	34.86655148	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	697	1010	0.001980198	0.005940594	0	oligos	OL-Cntl	NA	NA	NA
TGTGTTTTCGGCATCG-1_8_E5	6.861077973	-32.97536381	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4913	16450	0.000425532	0.002006079	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TGTTCCGAGCTAGGCA-1_8_E5	29.03051085	-0.93496442	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2943	6687	0.006280843	0.002392702	0	2	EN-L4	NA	NA	NA
TGTTCCGAGCTGTTCA-1_8_E5	-4.970787931	-2.422115581	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1520	2699	0.010374213	0.002593553	0	13A	IN-VIP	NA	NA	NA
TGTTCCGCAAAGGAAG-1_8_E5	25.16456529	-27.74042628	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3676	9358	0.008548835	0.003633255	0	3	EN-L5-6	NA	NA	NA
TGTTCCGCAATGCCAT-1_8_E5	4.307475797	31.22285493	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	728	1002	0.001996008	0.001996008	0	oligos	OL-Cntl	NA	NA	NA
TGTTCCGTCGGAATCT-1_8_E5	27.97616164	-5.299377765	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4293	12058	0.007878587	0.004063692	0	2	EN-L4	NA	NA	NA
TTAACTCAGACCTAGG-1_8_E5	21.20227954	1.538922306	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1705	3478	0.01840138	0.002012651	0	2	EN-L4	NA	NA	NA
TTAACTCAGCTAGTCT-1_8_E5	-29.09133049	12.36469199	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	759	1234	0.002431118	0.002431118	0	8	Astrocytes	NA	NA	NA
TTAACTCAGGCGACAT-1_8_E5	25.95701964	-5.312478425	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4871	14802	0.008107013	0.002364545	0	2	EN-L4	NA	NA	NA
TTAACTCAGTAAGTAC-1_8_E5	24.250684	-28.78346853	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3184	8367	0.009202821	0.002868412	0	3	EN-L5-6	NA	NA	NA
TTAACTCAGTGGGCTA-1_8_E5	-18.67037837	-25.16080288	6A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2556	5524	0.01230992	0.004525706	0	6A	IN-PV	NA	NA	NA
TTAACTCCATATACCG-1_8_E5	-25.64695191	20.16511392	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1387	2450	0.002040816	0.002040816	0	8	Astrocytes	NA	NA	NA
TTAACTCTCGAACGGA-1_8_E5	22.59436869	-0.842159112	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2346	5012	0.005985634	0.005387071	0	2	EN-L4	NA	NA	NA
TTAACTCTCTTCGGTC-1_8_E5	7.152230236	-33.15221137	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5162	19576	0.006896199	0.001787904	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TTAGGACAGATGAGAG-1_8_E5	2.148428382	-29.1191121	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4159	11807	0.001863301	0.002879648	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TTAGGACAGTACGCCC-1_8_E5	13.26119943	24.54784673	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	959	1570	0.001273885	0.004458599	0	oligos	OL-Cntl	NA	NA	NA
TTAGGACAGTCGTACT-1_8_E5	-26.6331597	15.73627849	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1113	1727	0.00463231	0.002316155	0	8	Astrocytes	NA	NA	NA
TTAGGACAGTTGAGTA-1_8_E5	-36.69543426	-7.02441909	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1118	1774	0	0.001691094	0	9	OPC	NA	NA	NA
TTAGGACCATGGAATA-1_8_E5	1.70228083	-31.02586465	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	6059	24638	0.004667587	0.003125254	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TTAGGACGTCTTCTCG-1_8_E5	-3.087753453	-5.987362091	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	900	1441	0.011797363	0.002081888	0	13A	IN-VIP	NA	NA	NA
TTAGGACGTGGTACAG-1_8_E5	4.491301942	-32.16182991	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	6504	26960	0.005563798	0.002707715	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TTAGGACTCTACCAGA-1_8_E5	30.39380742	-7.302007324	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5250	17820	0.021885522	0.00342312	0	2	EN-L4	NA	NA	NA
TTAGGCAAGCCCAATT-1_8_E5	25.81610483	-8.21133686	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5426	16633	0.003907894	0.003487044	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TTAGGCAAGGCTAGAC-1_8_E5	20.81731061	22.83342922	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1079	1771	0.001129305	0.002258611	0	oligos	OL-Cntl	NA	NA	NA
TTAGGCAAGGTGCTAG-1_8_E5	7.643317845	32.17361649	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	653	1029	0.004859086	0.002915452	0	oligos	OL-Cntl	NA	NA	NA
TTAGTTCCACACATGT-1_8_E5	13.04837365	-0.077314178	12	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	977	1960	0.004081633	0.006122449	0	12	EN-MIX	NA	NA	NA
TTAGTTCCAGATGGCA-1_8_E5	-6.389498218	-1.099678534	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1645	3027	0.007928642	0.003633961	0	13A	IN-VIP	NA	NA	NA
TTAGTTCCAGCGTTCG-1_8_E5	-23.44937928	0.162056878	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1954	3709	0.00485306	0.002965759	0	9	OPC	NA	NA	NA
TTAGTTCGTAGCGATG-1_8_E5	-37.11865058	-6.715437035	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1118	1762	0.005675369	0.003405221	0	9	OPC	NA	NA	NA
TTAGTTCGTGATGATA-1_8_E5	-2.219718455	-23.34676941	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3811	10247	0.003122865	0.003513223	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TTAGTTCTCCCGACTT-1_8_E5	9.702849615	18.9355292	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	951	1467	0.001363327	0.006134969	0	oligos	OL-Cntl	NA	NA	NA
TTATGCTAGTACCGGA-1_8_E5	-25.31180095	28.13525651	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1563	2831	0.001059696	0.002472625	0	8	Astrocytes	NA	NA	NA
TTATGCTGTACATCCA-1_8_E5	-39.35974376	-1.449825916	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1234	2165	0.002309469	0.002771363	0	9	OPC	NA	NA	NA
TTATGCTTCAGAGACG-1_8_E5	3.890010604	-30.08340889	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4023	12274	0.001792407	0.001955353	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TTATGCTTCCCATTTA-1_8_E5	-15.10569834	-6.033257886	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4270	11313	0.010607266	0.005480421	0	13A	IN-VIP	NA	NA	NA
TTCCCAGAGCTGAAAT-1_8_E5	-15.10734903	-18.18097312	6B	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1668	3112	0.021208226	0.008033419	0	6B	IN-SST	NA	NA	NA
TTCCCAGCAGTTCATG-1_8_E5	-24.50071169	29.78687114	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1862	3539	0.001412828	0.003390788	0	8	Astrocytes	NA	NA	NA
TTCCCAGGTCGCGAAA-1_8_E5	27.9083464	-0.967804709	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3570	8959	0.005134502	0.002455631	0	2	EN-L4	NA	NA	NA
TTCCCAGTCACCGGGT-1_8_E5	-6.332116507	-1.452823184	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1591	2837	0.014804371	0.00422982	0	13A	IN-VIP	NA	NA	NA
TTCCCAGTCAGGTAAA-1_8_E5	8.273358038	34.18801086	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	850	1261	0.000793021	0.00555115	0	oligos	OL-Cntl	NA	NA	NA
TTCCCAGTCCGTCAAA-1_8_E5	-0.189881127	-10.07132262	12	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1607	2970	0.006734007	0.003030303	0	12	EN-MIX	NA	NA	NA
TTCCCAGTCCTCAACC-1_8_E5	12.87721946	1.398448332	12	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	564	1133	0.002647838	0.002647838	0	12	EN-MIX	NA	NA	NA
TTCGAAGAGCGATCCC-1_8_E5	-7.442078418	1.014647766	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2331	5052	0.008907363	0.00138559	0	13A	IN-VIP	NA	NA	NA
TTCGAAGAGCTAGCCC-1_8_E5	-35.63887086	-8.631282764	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	992	1540	0.002597403	0.003896104	0	9	OPC	NA	NA	NA
TTCGAAGAGTTCGCGC-1_8_E5	-1.163258615	-19.66452785	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3028	6989	0.005294033	0.003863214	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TTCGAAGCAGGCTGAA-1_8_E5	8.11949193	32.12031572	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	706	1025	0.002926829	0.002926829	0	oligos	OL-Cntl	NA	NA	NA
TTCGGTCAGACTGGGT-1_8_E5	-24.17598274	30.51171828	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2111	4225	0.001420118	0.002130178	0	8	Astrocytes	NA	NA	NA
TTCGGTCAGAGCTATA-1_8_E5	20.18592506	24.26457145	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1051	1619	0.003705991	0.001852996	0	oligos	OL-Cntl	NA	NA	NA
TTCGGTCGTGTGTGCC-1_8_E5	-18.44169113	-27.56810555	6A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3091	7834	0.023997958	0.003574164	0	6A	IN-PV	NA	NA	NA
TTCGGTCGTTAGATGA-1_8_E5	18.10150138	-6.891591053	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2316	5658	0.001237186	0.002120891	0	3	EN-L5-6	NA	NA	NA
TTCGGTCTCTTCTGGC-1_8_E5	20.75277478	21.50581011	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1090	1669	0.001198322	0.004793289	0	oligos	OL-Cntl	NA	NA	NA
TTCTACAAGCCACGCT-1_8_E5	-9.257299758	-20.32569725	6B	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	724	1063	0.039510818	0.002822201	0	6B	IN-SST	NA	NA	NA
TTCTACAAGCTACCGC-1_8_E5	-9.435477343	2.964525607	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3197	8614	0.020083585	0.002670072	0	13A	IN-VIP	NA	NA	NA
TTCTACAAGGCTACGA-1_8_E5	-28.75843469	14.39342537	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	959	1482	0.003373819	0.003373819	0	8	Astrocytes	NA	NA	NA
TTCTACAAGTTAACGA-1_8_E5	26.5187722	-5.326394289	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5538	20556	0.005010702	0.002821561	0	2	EN-L4	NA	NA	NA
TTCTACACACCTGGTG-1_8_E5	22.9220429	0.499012816	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2044	4001	0.007998	0.002249438	0	2	EN-L4	NA	NA	NA
TTCTACAGTCAGAATA-1_8_E5	6.668097992	29.98221921	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	645	1044	0.014367816	0.002873563	0	oligos	OL-Cntl	NA	NA	NA
TTCTACATCGAGCCCA-1_8_E5	15.70303367	-33.1992103	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	6184	28044	0.000356583	0.003316217	0	3	EN-L5-6	NA	NA	NA
TTCTCAAAGACACTAA-1_8_E5	8.109700569	32.19758389	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	716	1057	0.004730369	0.004730369	0	oligos	OL-Cntl	NA	NA	NA
TTCTCAACACTGAAGG-1_8_E5	3.463788498	-31.84773316	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	6577	30036	0.006092689	0.003062991	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TTCTCAACAGCAGTTT-1_8_E5	-36.97543199	-7.875484631	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1045	1689	0.001776199	0.001776199	0	9	OPC	NA	NA	NA
TTCTCAATCCATTCTA-1_8_E5	18.07065103	13.78977139	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1164	1946	0.003083248	0.003597122	0	oligos	OL-Cntl	NA	NA	NA
TTCTCCTAGACCTAGG-1_8_E5	7.914463308	32.20052898	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	686	1037	0.00096432	0.00192864	0	oligos	OL-Cntl	NA	NA	NA
TTCTCCTAGGCTCATT-1_8_E5	19.00669749	24.08818728	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	932	1454	0.007565337	0.006189821	0	oligos	OL-Cntl	NA	NA	NA
TTCTCCTAGTGGAGAA-1_8_E5	-4.409709041	-9.606835452	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	736	1099	0.054595086	0.000909918	0	13A	IN-VIP	NA	NA	NA
TTCTCCTGTCGAGTTT-1_8_E5	25.04934501	-27.6612329	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4116	11746	0.007066235	0.003916227	0	3	EN-L5-6	NA	NA	NA
TTCTCCTTCGACCAGC-1_8_E5	-10.63138741	2.401220406	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3074	7906	0.002276752	0.003162155	0	13A	IN-VIP	NA	NA	NA
TTCTCCTTCGGCCGAT-1_8_E5	7.67798159	-32.27886523	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5863	22727	0.013244159	0.002068025	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TTCTTAGAGAGACTAT-1_8_E5	28.76985754	-0.911670077	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3402	8184	0.00342131	0.005376344	0	2	EN-L4	NA	NA	NA
TTCTTAGAGGACATTA-1_8_E5	6.835191418	33.46027309	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	738	1122	0.004456328	0.004456328	0	oligos	OL-Cntl	NA	NA	NA
TTCTTAGAGTCCAGGA-1_8_E5	30.24532258	-4.030760287	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3650	9273	0.008519357	0.007225278	0	2	EN-L4	NA	NA	NA
TTCTTAGCATGGATGG-1_8_E5	-3.339139663	-6.138189306	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	953	1493	0.046885466	0.003348962	0	13A	IN-VIP	NA	NA	NA
TTCTTAGGTCAAGCGA-1_8_E5	9.393680593	32.32383782	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	838	1208	0.015728477	0.001655629	0	oligos	OL-Cntl	NA	NA	NA
TTCTTAGGTTCAACCA-1_8_E5	-0.552756924	-14.01268348	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1985	3652	0.002464403	0.004107338	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TTCTTAGTCCGCATCT-1_8_E5	-35.47500546	-3.727949751	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1428	2633	0.00151918	0.006456513	0	9	OPC	NA	NA	NA
TTCTTAGTCGAACGGA-1_8_E5	-20.03177886	-27.18175488	6A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3328	8380	0.02052506	0.003937947	0	6A	IN-PV	NA	NA	NA
TTCTTAGTCGCCCTTA-1_8_E5	-0.472904624	-14.26361731	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2197	4447	0.002923319	0.002248707	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TTGAACGAGAGACTTA-1_8_E5	26.25414554	-5.538465409	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5906	21294	0.006058045	0.002864657	0	2	EN-L4	NA	NA	NA
TTGAACGAGAGCAATT-1_8_E5	5.714829464	34.05417013	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	770	1059	0.005665722	0.005665722	0	oligos	OL-Cntl	NA	NA	NA
TTGAACGAGAGGTTAT-1_8_E5	-0.391636587	-15.51388732	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2537	5521	0.004890418	0.003803659	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TTGAACGAGCCATCGC-1_8_E5	28.85026214	-1.267781543	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3280	7807	0.003714615	0.002305623	0	2	EN-L4	NA	NA	NA
TTGAACGAGGCCCTTG-1_8_E5	27.82545022	-1.134007646	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3471	8919	0.002242404	0.001793923	0	2	EN-L4	NA	NA	NA
TTGAACGCAAGTCTAC-1_8_E5	19.54312669	23.13432872	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1037	1646	0.001215067	0.0018226	0	oligos	OL-Cntl	NA	NA	NA
TTGAACGCAGTGGAGT-1_8_E5	-11.05858581	2.398131081	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3347	8016	0.004241517	0.007734531	0	13A	IN-VIP	NA	NA	NA
TTGAACGCATGCAATC-1_8_E5	-0.431497233	-14.85892604	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2360	4456	0.00448833	0.007405745	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TTGAACGGTGCCTGCA-1_8_E5	-1.779695485	-19.25324831	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2671	5948	0.007733692	0.003026227	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TTGAACGTCGTAGGAG-1_8_E5	-0.715929113	-20.15918422	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3069	6659	0.006307253	0.004204836	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TTGAACGTCGTAGGTT-1_8_E5	11.08216871	33.41422616	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	749	1051	0.008563273	0.000951475	0	oligos	OL-Cntl	NA	NA	NA
TTGAACGTCTAACTGG-1_8_E5	27.9648966	-1.226780863	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4079	11165	0.004657412	0.004120018	0	2	EN-L4	NA	NA	NA
TTGACTTTCTATCCCG-1_8_E5	26.19732216	-2.405161558	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2584	5551	0.00630517	0.002702216	0	2	EN-L4	NA	NA	NA
TTGCCGTAGCCCTAAT-1_8_E5	13.34177841	29.62790569	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	932	1444	0.00900277	0.002770083	0	oligos	OL-Cntl	NA	NA	NA
TTGCCGTAGGATGGAA-1_8_E5	-26.97756088	15.89086265	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1119	1839	0.001631321	0.002175095	0	8	Astrocytes	NA	NA	NA
TTGCCGTAGGTGCTTT-1_8_E5	-38.38523456	-0.229032916	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1316	2381	0.002939941	0.003359933	0	9	OPC	NA	NA	NA
TTGCCGTCACGACTCG-1_8_E5	-0.59387628	-16.73704342	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2490	5418	0.009228498	0.002030269	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TTGCCGTCATTCGACA-1_8_E5	4.163336232	30.15447397	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	722	1058	0.00094518	0.002835539	0	oligos	OL-Cntl	NA	NA	NA
TTGCCGTGTGGCAAAC-1_8_E5	5.998252482	33.92800542	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	799	1089	0.003673095	0.005509642	0	oligos	OL-Cntl	NA	NA	NA
TTGCCGTTCCACTCCA-1_8_E5	29.14526301	-2.292896899	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4097	10372	0.002313922	0.004820671	0	2	EN-L4	NA	NA	NA
TTGCGTCAGGCTCTTA-1_8_E5	18.71332822	-4.495393653	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1970	3703	0.030515798	0.005130975	0	3	EN-L5-6	NA	NA	NA
TTGCGTCAGTACGTTC-1_8_E5	4.267498098	-32.40280425	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	6830	31968	0.001157407	0.002095846	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TTGCGTCCACGACGAA-1_8_E5	25.37674706	-2.653987176	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2829	6438	0.00621311	0.002485244	0	2	EN-L4	NA	NA	NA
TTGCGTCGTACACCGC-1_8_E5	-27.02481133	26.3006707	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1467	2652	0.002639517	0.003770739	0	8	Astrocytes	NA	NA	NA
TTGCGTCTCATTTGGG-1_8_E5	28.22100686	-1.505899155	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4053	11298	0.006284298	0.004868118	0	2	EN-L4	NA	NA	NA
TTGCGTCTCCCTTGCA-1_8_E5	-38.02835239	2.719837769	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1897	3713	0.00403986	0.001885268	0	9	OPC	NA	NA	NA
TTGCGTCTCTATGTGG-1_8_E5	18.89596825	24.28551349	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	881	1320	0.003787879	0.00530303	0	oligos	OL-Cntl	NA	NA	NA
TTGGAACAGATGGGTC-1_8_E5	5.261535886	33.32558593	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	760	1083	0.005540166	0.005540166	0	oligos	OL-Cntl	NA	NA	NA
TTGGAACAGCATGGCA-1_8_E5	20.51107052	23.83469466	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1129	1824	0.00877193	0.002741228	0	oligos	OL-Cntl	NA	NA	NA
TTGGAACAGGGATCTG-1_8_E5	-27.59379672	14.55311153	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	973	1467	0.004771643	0.000681663	0	8	Astrocytes	NA	NA	NA
TTGGAACAGTCCTCCT-1_8_E5	-37.117047	3.155047488	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1823	3485	0.000573888	0.003443329	0	9	OPC	NA	NA	NA
TTGGAACCACCGATAT-1_8_E5	21.09737843	22.59474882	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1095	1770	0.005084746	0.001694915	0	oligos	OL-Cntl	NA	NA	NA
TTGGAACCATGCGCAC-1_8_E5	13.26036878	-1.376938287	12	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1211	2413	0.006216328	0.004973063	0	12	EN-MIX	NA	NA	NA
TTGGAACGTTGTCTTT-1_8_E5	28.76296656	-2.178456861	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3964	10471	0.005825614	0.003533569	0	2	EN-L4	NA	NA	NA
TTGGAACTCAATACCG-1_8_E5	-26.85920375	16.44350995	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1149	2086	0.001917546	0.004314477	0	8	Astrocytes	NA	NA	NA
TTGGCAAAGATGTCGG-1_8_E5	28.57991733	-1.065310051	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3473	8505	0.003997648	0.002586714	0	2	EN-L4	NA	NA	NA
TTGGCAAAGCTAGGCA-1_8_E5	1.042503889	-30.23538221	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4970	15642	0.004602992	0.0029408	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TTGGCAAAGGAATTAC-1_8_E5	0.798942725	-28.73491045	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5936	20946	0.00711353	0.003532894	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TTGGCAAAGTACGCGA-1_8_E5	0.427775685	-8.444776819	12	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1465	2516	0.015500795	0.006756757	0	12	EN-MIX	NA	NA	NA
TTGGCAACAACTTGAC-1_8_E5	-0.133123066	-21.95107367	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4438	12713	0.008337922	0.003932982	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TTGGCAACACCAGCAC-1_8_E5	-10.23113803	2.327261271	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3937	11360	0.005809859	0.005457746	0	13A	IN-VIP	NA	NA	NA
TTGGCAATCGGTCCGA-1_8_E5	26.59564832	-4.301838621	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4163	11634	0.002234829	0.002492694	0	2	EN-L4	NA	NA	NA
TTGTAGGGTCGTTGTA-1_8_E5	-0.687972574	-14.4126115	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2345	5098	0.004903884	0.002157709	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TTGTAGGGTTTACTCT-1_8_E5	-25.16793088	27.23604794	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1554	2900	0.001034483	0.002413793	0	8	Astrocytes	NA	NA	NA
TTGTAGGTCACCGTAA-1_8_E5	11.50159335	33.07581476	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	717	1038	0.013487476	0.001926782	0	oligos	OL-Cntl	NA	NA	NA
TTTACTGCAGGTGCCT-1_8_E5	5.621095005	30.061517	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	720	1018	0.002946955	0.006876228	0	oligos	OL-Cntl	NA	NA	NA
TTTACTGCATGCCCGA-1_8_E5	9.956786061	27.47685239	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	826	1278	0.004694836	0.007042254	0	oligos	OL-Cntl	NA	NA	NA
TTTACTGGTTCACGGC-1_8_E5	9.271380237	27.9984792	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	804	1303	0.003069839	0.003837299	0	oligos	OL-Cntl	NA	NA	NA
TTTACTGTCATTATCC-1_8_E5	-1.755724706	-14.85364185	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2573	5835	0.004970009	0.004970009	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TTTATGCAGGCGATAC-1_8_E5	-25.88154711	20.2981002	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1458	2452	0.003670473	0.002039152	0	8	Astrocytes	NA	NA	NA
TTTATGCGTCCGTGAC-1_8_E5	-1.102382283	-20.2823997	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3151	7682	0.001952617	0.006248373	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TTTATGCTCACCCGAG-1_8_E5	15.98086645	-32.98170511	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5788	22792	0.001579502	0.003992629	0	3	EN-L5-6	NA	NA	NA
TTTCCTCAGCACAGGT-1_8_E5	-38.337556	0.419346735	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1446	2561	0.001952362	0.001952362	0	9	OPC	NA	NA	NA
TTTCCTCAGCCACTAT-1_8_E5	1.311270664	-29.82515394	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5111	18610	0.006179473	0.002310586	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TTTCCTCAGCGATAGC-1_8_E5	9.363831929	28.11725091	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	892	1434	0	0.0041841	0	oligos	OL-Cntl	NA	NA	NA
TTTCCTCCACGCTTTC-1_8_E5	12.51796285	0.988169292	12	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	744	1427	0.007708479	0.004204625	0	12	EN-MIX	NA	NA	NA
TTTCCTCGTCTCAACA-1_8_E5	14.16754665	-33.4424183	3	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4782	19564	0.000153343	0.002811286	0	3	EN-L5-6	NA	NA	NA
TTTCCTCTCATCACCC-1_8_E5	-6.665225516	-0.44035962	13A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1788	3515	0.013940256	0.00341394	0	13A	IN-VIP	NA	NA	NA
TTTGCGCAGGAATTAC-1_8_E5	20.23215471	1.722628695	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1535	2732	0.002196193	0.001098097	0	2	EN-L4	NA	NA	NA
TTTGCGCCACACAGAG-1_8_E5	-23.58413782	30.80012926	8	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2078	4422	0.001809136	0.002713704	0	8	Astrocytes	NA	NA	NA
TTTGCGCGTATTCTCT-1_8_E5	16.89244104	19.8116155	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	966	1506	0.007304117	0.005976096	0	oligos	OL-Cntl	NA	NA	NA
TTTGCGCGTCTCCACT-1_8_E5	28.58063425	-1.561771789	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3863	10215	0.00372002	0.004992658	0	2	EN-L4	NA	NA	NA
TTTGCGCTCCACGACG-1_8_E5	6.528970029	-30.92094145	10	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	6540	26397	0.00685684	0.003409478	0	L2-3	EN-L2-3-Cntl	NA	NA	NA
TTTGCGCTCCAGAGGA-1_8_E5	26.86643382	-4.113281093	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4543	14269	0.00630738	0.002733198	0	2	EN-L4	NA	NA	NA
TTTGCGCTCGATCCCT-1_8_E5	3.291386443	32.81343741	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	799	1205	0.002489627	0.00746888	0	oligos	OL-Cntl	NA	NA	NA
TTTGCGCTCGCCCTTA-1_8_E5	21.60240876	24.23003766	1	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1261	2044	0.014187867	0.004403131	0	oligos	OL-Cntl	NA	NA	NA
TTTGCGCTCGTCTGAA-1_8_E5	-20.03253651	-28.98659873	6A	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	4026	12154	0.005348034	0.003620207	0	6A	IN-PV	NA	NA	NA
TTTGCGCTCTCGATGA-1_8_E5	-39.24801102	0.347564874	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1410	2411	0.007465782	0.004977188	0	9	OPC	NA	NA	NA
TTTGGTTCACGCATCG-1_8_E5	22.5006992	-6.334884083	11	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	2135	3846	0.012220489	0.002860114	0	11	Glia-MIX	NA	NA	NA
TTTGTCAAGGGTGTTG-1_8_E5	-35.38441977	-3.715280771	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1340	2229	0.013010319	0.001794527	0	9	OPC	NA	NA	NA
TTTGTCACATGCAATC-1_8_E5	-37.93154779	2.72968905	9	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	1846	3456	0.0078125	0.002604167	0	9	OPC	NA	NA	NA
TTTGTCATCACTCCTG-1_8_E5	28.32505859	-1.733126715	2	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	5070	16114	0.00775723	0.003102892	0	2	EN-L4	NA	NA	NA
TTTGTCATCGAATGCT-1_8_E5	-19.56596805	-18.08278879	6B	8_E5	Control	Control	68	male	prefrontal	CAP2	SEQ1	8.5	30	3446	9134	0.00416028	0.003284432	0	6B	IN-SST	NA	NA	NA
AAACCTGCACTGCCAG-1_8_H10	18.27868855	-24.59197537	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	7116	26311	0.0060431	0.011250048	8	3	EN-L5-6	49	33	33
AAACCTGTCCAATGGT-1_8_H10	-17.63974317	24.29897399	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1469	2301	0.007388092	0.007822686	8	8	Astrocytes	49	33	33
AAACCTGTCCCATTAT-1_8_H10	-4.081766977	7.876896959	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1194	1767	0.021505376	0.020939445	8	oligos	OL-MS-1	49	33	33
AAACGGGAGATCGGGT-1_8_H10	-17.27067675	-14.93665353	6B	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1959	3467	0.007787713	0.010960485	8	6B	IN-SST	49	33	33
AAACGGGAGGTCATCT-1_8_H10	-5.833455426	7.48086433	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	919	1158	0.020725389	0.033678756	8	oligos	OL-MS-1	49	33	33
AAACGGGCAACTGGCC-1_8_H10	13.14122462	-23.99366566	4	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5446	15180	0.008827404	0.010144928	8	L2-3	EN-L2-3-MS	49	33	33
AAACGGGGTCATTAGC-1_8_H10	-9.452295604	-16.37012707	6B	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	934	1424	0.024578652	0.007022472	8	6B	IN-SST	49	33	33
AAACGGGTCCACGTGG-1_8_H10	-3.815595486	10.08603521	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	922	1394	0.004304161	0.019368723	8	oligos	OL-MS-1	49	33	33
AAAGATGAGATCTGAA-1_8_H10	31.36559546	12.44536241	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	871	1243	0.024135157	0.05390185	8	14	Microglia	49	33	33
AAAGATGAGTCTCCTC-1_8_H10	19.54960545	-21.23897386	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5434	16877	0.025241453	0.006043728	8	3	EN-L5-6	49	33	33
AAAGATGCAATAGAGT-1_8_H10	26.93303342	9.94950499	15A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1588	2482	0.01813054	0.056003223	8	15A	Endo cells	49	33	33
AAAGATGCAGGGAGAG-1_8_H10	-4.225411161	10.25624072	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	846	1161	0.007751938	0.023255814	8	oligos	OL-MS-1	49	33	33
AAAGATGGTAGGACAC-1_8_H10	17.40737128	-10.14181519	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2507	4761	0.050409578	0.006511237	8	3	EN-L5-6	49	33	33
AAAGATGGTGAAAGAG-1_8_H10	27.26119048	4.742884991	15DA	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	887	1168	0.020547945	0.031678082	8	15DA	T cells	49	33	33
AAAGATGGTGATAAGT-1_8_H10	-5.152980386	10.24874697	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	849	1170	0.013675214	0.022222222	8	oligos	OL-MS-1	49	33	33
AAAGCAAGTACAGTTC-1_8_H10	28.52517908	5.792553349	15DA	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	821	1247	0.093023256	0.032076985	8	15DA	T cells	49	33	33
AAAGCAATCTGTCCGT-1_8_H10	-5.813149516	10.4249253	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	810	1156	0.011245675	0.024221453	8	oligos	OL-MS-1	49	33	33
AAAGTAGAGCAGACTG-1_8_H10	24.875738	-14.88330038	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5120	12333	0.025541231	0.010459742	8	3	EN-L5-6	49	33	33
AAAGTAGAGCGTTTAC-1_8_H10	-8.893173522	-14.56647878	6B	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	738	1055	0.038862559	0.007582938	8	6B	IN-SST	49	33	33
AAAGTAGAGGGTATCG-1_8_H10	-16.50015495	6.720801479	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1029	1392	0.037356322	0.010057471	8	8	Astrocytes	49	33	33
AAAGTAGCAGTATGCT-1_8_H10	-5.013883266	10.06089013	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	834	1141	0.008764242	0.015775635	8	oligos	OL-MS-1	49	33	33
AAAGTAGTCAATCTCT-1_8_H10	-1.304345105	7.990325341	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1318	2052	0.007797271	0.022904483	8	oligos	OL-MS-1	49	33	33
AAAGTAGTCTGTCTAT-1_8_H10	-3.321278058	-35.66080249	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	794	1018	0.046168959	0.026522593	8	16	EN-PYR	49	33	33
AAATGCCCAACTTGAC-1_8_H10	-6.535171358	9.442246237	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	796	1048	0.016221374	0.025763359	8	oligos	OL-MS-1	49	33	33
AAATGCCCATCGGAAG-1_8_H10	-5.52826895	9.232560587	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	839	1178	0.011035654	0.018675722	8	oligos	OL-MS-1	49	33	33
AAATGCCGTCGCATAT-1_8_H10	28.84596371	7.058565328	15DA	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	851	1136	0.071302817	0.069542254	8	15DA	T cells	49	33	33
AAATGCCTCCGAATGT-1_8_H10	-4.118043265	7.139154319	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1236	1867	0.00803428	0.028923407	8	oligos	OL-MS-1	49	33	33
AAATGCCTCCGCATAA-1_8_H10	7.861740336	-17.53070427	4	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3749	8198	0.005489144	0.019760917	8	L2-3	EN-L2-3-MS	49	33	33
AAATGCCTCTCAAGTG-1_8_H10	-33.19167182	4.828974141	9	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2489	4772	0.003981559	0.006915339	8	9	OPC	49	33	33
AAATGCCTCTGCCAGG-1_8_H10	8.210809203	-17.44891787	4	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3882	8800	0.005795455	0.031818182	8	L2-3	EN-L2-3-MS	49	33	33
AACACGTAGTAGCGGT-1_8_H10	-3.895614464	10.54748081	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	832	1116	0.010752688	0.024193548	8	oligos	OL-MS-1	49	33	33
AACACGTCAAGCCCAC-1_8_H10	-3.499876689	-35.83277171	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	862	1184	0.086148649	0.026182432	8	16	EN-PYR	49	33	33
AACACGTCAGCTCGCA-1_8_H10	-5.263760375	10.45322321	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	870	1219	0.010664479	0.014766202	8	oligos	OL-MS-1	49	33	33
AACACGTGTTCGAATC-1_8_H10	-18.31946504	0.343096247	13A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3659	7764	0.015069552	0.020221535	8	13A	IN-VIP	49	33	33
AACACGTTCAGGCCCA-1_8_H10	-11.25957221	28.51089203	17	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1623	2405	0.037422037	0.016216216	8	oligos	OL-MS-2	49	33	33
AACCATGAGGGTTTCT-1_8_H10	-21.3777791	5.91227626	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1189	1675	0.030447761	0.021492537	8	8	Astrocytes	49	33	33
AACCATGAGTACGACG-1_8_H10	14.15949645	12.88007825	1	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1306	2085	0.014388489	0.010551559	8	oligos	OL-Cntl	49	33	33
AACCATGCAAGTCTGT-1_8_H10	24.42204887	-20.02427659	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	6351	20443	0.044514015	0.006799393	8	3	EN-L5-6	49	33	33
AACCGCGAGTGCTGCC-1_8_H10	-1.853269044	9.976226004	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1042	1468	0.01226158	0.018392371	8	oligos	OL-MS-1	49	33	33
AACCGCGAGTGGAGAA-1_8_H10	19.67342283	-21.70534718	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5735	16911	0.017739933	0.015197209	8	3	EN-L5-6	49	33	33
AACCGCGCATAAGACA-1_8_H10	22.63168504	-24.15709396	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4222	10684	0.010482965	0.007207039	8	3	EN-L5-6	49	33	33
AACCGCGCATGCTAGT-1_8_H10	-10.199813	27.53370244	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1284	1836	0.051742919	0.026143791	8	oligos	OL-MS-1	49	33	33
AACCGCGGTGGACGAT-1_8_H10	-1.800939586	10.68593522	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	934	1324	0.00755287	0.014350453	8	oligos	OL-MS-1	49	33	33
AACCGCGTCAAAGTAG-1_8_H10	32.00655924	9.804297463	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	783	1170	0.012820513	0.034188034	8	14	Microglia	49	33	33
AACGTTGAGCAATATG-1_8_H10	30.37160627	-7.751420889	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5785	16577	0.009410629	0.008023165	8	2	EN-L4	49	33	33
AACGTTGAGCACAGGT-1_8_H10	-7.226987555	9.772787013	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	771	1029	0.005830904	0.021379981	8	oligos	OL-MS-1	49	33	33
AACGTTGAGCTTATCG-1_8_H10	29.68742945	14.72238894	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1206	1742	0.013777268	0.094144661	8	14	Microglia	49	33	33
AACGTTGGTAGAAAGG-1_8_H10	29.86484943	9.400715293	15DA	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	994	1378	0.059506531	0.041364296	8	15DA	T cells	49	33	33
AACGTTGGTCTGGTCG-1_8_H10	25.65707941	10.5523648	15A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4094	9603	0.012808497	0.081120483	8	15A	Endo cells	49	33	33
AACGTTGGTTGCGTTA-1_8_H10	24.85613603	-15.15257023	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4681	11748	0.0195778	0.014896153	8	3	EN-L5-6	49	33	33
AACGTTGTCATGTGGT-1_8_H10	-5.126054599	9.096232138	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	912	1270	0.004724409	0.039370079	8	oligos	OL-MS-1	49	33	33
AACTCAGCATCAGTCA-1_8_H10	-21.03731315	-25.53175453	6A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2995	6966	0.008326156	0.005598622	8	6A	IN-PV	49	33	33
AACTCAGGTGGCTCCA-1_8_H10	29.98974455	14.2930318	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1124	1738	0.019562716	0.117951669	8	14	Microglia	49	33	33
AACTCAGGTTAAGAAC-1_8_H10	1.501866722	10.49253029	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1106	1620	0.014814815	0.012345679	8	oligos	OL-MS-1	49	33	33
AACTCAGTCACAGGCC-1_8_H10	-2.736565539	9.902439296	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	993	1466	0.015006821	0.026603001	8	oligos	OL-MS-1	49	33	33
AACTCCCAGATCGGGT-1_8_H10	-3.323695417	8.25914964	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1052	1479	0.015551048	0.025693036	8	oligos	OL-MS-1	49	33	33
AACTCCCAGCACGCCT-1_8_H10	8.952666446	-21.73585423	4	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5721	19979	0.004554783	0.007658041	8	L2-3	EN-L2-3-MS	49	33	33
AACTCCCAGGGATACC-1_8_H10	5.751989624	11.67776838	1	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1315	2171	0.009672962	0.013818517	8	oligos	OL-Cntl	49	33	33
AACTCCCAGGTGCTAG-1_8_H10	-14.23601112	-16.56333547	6B	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1408	2279	0.036419482	0.006581834	8	6B	IN-SST	49	33	33
AACTCCCAGGTTCCTA-1_8_H10	-15.06970732	13.83092846	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1954	3287	0.006693033	0.004563432	8	8	Astrocytes	49	33	33
AACTCCCCAATGGTCT-1_8_H10	-6.165968424	11.88381288	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	860	1172	0.017918089	0.014505119	8	oligos	OL-MS-1	49	33	33
AACTCCCCACCAGCAC-1_8_H10	-16.33473803	-17.21567787	6B	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1975	3790	0.00817942	0.007915567	8	6B	IN-SST	49	33	33
AACTCCCGTAAATGAC-1_8_H10	-4.776523593	8.540904635	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	970	1296	0.013888889	0.023919753	8	oligos	OL-MS-1	49	33	33
AACTCCCGTAACGTTC-1_8_H10	-3.607685692	8.632461037	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1016	1464	0.015027322	0.023224044	8	oligos	OL-MS-1	49	33	33
AACTCCCGTCTCTCTG-1_8_H10	-15.47412582	12.93347311	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1751	2989	0.007694881	0.007360321	8	8	Astrocytes	49	33	33
AACTCCCGTTACGTCA-1_8_H10	-28.25450043	-0.50408459	9	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1771	2779	0.0043181	0.020151134	8	9	OPC	49	33	33
AACTCCCGTTCCAACA-1_8_H10	23.64738094	7.471737646	15DA	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2335	3940	0.019543147	0.025634518	8	15DA	T cells	49	33	33
AACTCTTAGTGTTAGA-1_8_H10	7.462360885	-19.16990184	4	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4108	9634	0.005086153	0.010483704	8	L2-3	EN-L2-3-MS	49	33	33
AACTCTTCAGCTGGCT-1_8_H10	-2.672472338	11.80850388	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	851	1232	0.015422078	0.018668831	8	oligos	OL-MS-1	49	33	33
AACTGGTAGGTGCAAC-1_8_H10	-22.71493116	-8.254568459	9	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2294	3828	0.02246604	0.015673981	8	9	OPC	49	33	33
AACTGGTCAACGCACC-1_8_H10	-29.43049606	-1.246406835	9	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1715	2803	0.006421691	0.009632537	8	9	OPC	49	33	33
AACTGGTGTCGGCTCA-1_8_H10	8.027405726	-16.55005843	4	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3217	6248	0.008162612	0.025928297	8	L2-3	EN-L2-3-MS	49	33	33
AACTGGTGTCTGCCAG-1_8_H10	-5.658149111	10.93216462	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	824	1164	0.024054983	0.020618557	8	oligos	OL-MS-1	49	33	33
AACTGGTTCCGGCACA-1_8_H10	16.42991997	-27.18351298	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3998	10004	0.009196321	0.008996401	8	3	EN-L5-6	49	33	33
AACTGGTTCTTGAGAC-1_8_H10	-5.415379281	10.01101127	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	788	1047	0.008595989	0.028653295	8	oligos	OL-MS-1	49	33	33
AACTTTCAGAGTAAGG-1_8_H10	-8.628514389	-15.62536386	6B	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	713	1051	0.050428164	0.007611798	8	6B	IN-SST	49	33	33
AACTTTCAGTTTGCGT-1_8_H10	-31.18501016	1.7567798	9	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2113	3862	0.004401864	0.007767996	8	9	OPC	49	33	33
AACTTTCCAGACGTAG-1_8_H10	-15.91539951	11.78424894	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1223	1740	0.005747126	0.009770115	8	8	Astrocytes	49	33	33
AACTTTCCAGTATCTG-1_8_H10	-6.418636045	9.25144028	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	789	1121	0.020517395	0.02676182	8	oligos	OL-MS-1	49	33	33
AACTTTCCATAAAGGT-1_8_H10	8.988101792	1.505464306	12	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	983	1647	0.25136612	0.018822101	8	12	EN-MIX	49	33	33
AACTTTCCATGTAAGA-1_8_H10	-5.097151297	8.046374926	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	964	1311	0.018306636	0.039664378	8	oligos	OL-MS-1	49	33	33
AACTTTCGTATTCGTG-1_8_H10	-6.614469813	10.71484028	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	744	1048	0.020038168	0.022900763	8	oligos	OL-MS-1	49	33	33
AACTTTCTCGCCTGTT-1_8_H10	-3.318703017	8.024618339	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1078	1547	0.010342599	0.02133161	8	oligos	OL-MS-1	49	33	33
AACTTTCTCTTGTCAT-1_8_H10	4.957351599	-19.06550797	4	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3350	7308	0.003968254	0.009168035	8	L2-3	EN-L2-3-MS	49	33	33
AAGACCTCATTCACTT-1_8_H10	-16.1907229	10.17886719	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1211	1746	0.01489118	0.005154639	8	8	Astrocytes	49	33	33
AAGACCTGTGTGGCTC-1_8_H10	13.60407465	-24.19731361	4	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5003	13314	0.005708277	0.012468079	8	L2-3	EN-L2-3-MS	49	33	33
AAGACCTTCACAGTAC-1_8_H10	-3.232620116	8.370561289	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1057	1647	0.014571949	0.021250759	8	oligos	OL-MS-1	49	33	33
AAGACCTTCGGAAATA-1_8_H10	27.41963556	7.056604579	15BA	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1140	1610	0.011180124	0.040372671	8	15BA	Stromal cells	49	33	33
AAGCCGCCACGCGAAA-1_8_H10	-20.59368411	-6.436443586	13B	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4201	9469	0.006019643	0.018164537	8	13B	IN-SV2C	49	33	33
AAGCCGCTCAGCTGGC-1_8_H10	-4.154832449	9.358424848	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	997	1411	0.016300496	0.021970234	8	oligos	OL-MS-1	49	33	33
AAGCCGCTCCTTTCGG-1_8_H10	-7.067066775	6.812978527	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	960	1313	0.018278751	0.042650419	8	oligos	OL-MS-1	49	33	33
AAGCCGCTCTTGACGA-1_8_H10	18.5046627	-25.83069594	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5532	16759	0.003520496	0.00835372	8	3	EN-L5-6	49	33	33
AAGGAGCAGCCCAGCT-1_8_H10	-4.07917014	9.475280157	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	974	1441	0.018043026	0.033310201	8	oligos	OL-MS-1	49	33	33
AAGGAGCAGGTGTGGT-1_8_H10	8.328079246	-16.95920504	4	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3782	7695	0.008576998	0.028979857	8	L2-3	EN-L2-3-MS	49	33	33
AAGGAGCCATCCAACA-1_8_H10	33.27205326	10.86117547	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1017	1362	0.031571219	0.020558003	8	14	Microglia	49	33	33
AAGGAGCTCGTGACAT-1_8_H10	-26.31405808	-22.44264941	6A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3652	8085	0.026839827	0.013852814	8	6A	IN-PV	49	33	33
AAGGAGCTCTCTTATG-1_8_H10	32.62231363	13.62792821	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1623	2476	0.021405493	0.037156704	8	14	Microglia	49	33	33
AAGGAGCTCTTACCGC-1_8_H10	14.02121927	-4.33498618	12	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1874	3765	0.014342629	0.012749004	8	12	EN-MIX	49	33	33
AAGGCAGAGAATTCCC-1_8_H10	-0.773305087	7.765067503	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1424	2001	0.012493753	0.029485257	8	oligos	OL-MS-1	49	33	33
AAGGCAGTCCCTAATT-1_8_H10	-4.099382087	12.08415919	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	825	1154	0.005199307	0.028596187	8	oligos	OL-MS-1	49	33	33
AAGGCAGTCTTGTCAT-1_8_H10	31.6506537	-9.978182558	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2757	5386	0.033791311	0.006869662	8	2	EN-L4	49	33	33
AAGGTTCAGCAATATG-1_8_H10	-17.82338558	24.98856692	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1688	2699	0.011485735	0.008892182	8	8	Astrocytes	49	33	33
AAGGTTCCATAGACTC-1_8_H10	-5.327097876	8.854651089	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	869	1173	0.023017903	0.023870418	8	oligos	OL-MS-1	49	33	33
AAGGTTCGTAAACCTC-1_8_H10	-15.48829024	14.91782771	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2124	4067	0.00491763	0.009097615	8	8	Astrocytes	49	33	33
AAGGTTCGTACCGGCT-1_8_H10	15.94269022	-26.48489767	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4131	10919	0.009066764	0.007784596	8	3	EN-L5-6	49	33	33
AAGTCTGCAAACCTAC-1_8_H10	-17.43976892	-6.450410855	13B	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2606	5094	0.014919513	0.012171182	8	13B	IN-SV2C	49	33	33
AAGTCTGCACACTGCG-1_8_H10	16.98340319	-26.64125833	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5655	18413	0.011350676	0.005050779	8	3	EN-L5-6	49	33	33
AAGTCTGCATATGGTC-1_8_H10	28.18799379	6.389457117	15BA	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	746	1047	0.026743075	0.027698185	8	15BA	Stromal cells	49	33	33
AAGTCTGGTTTGTGTG-1_8_H10	9.850784088	-0.868841681	12	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1436	2516	0.019872814	0.014705882	8	12	EN-MIX	49	33	33
AAGTCTGTCGTTGACA-1_8_H10	25.64249114	4.38798761	15BA	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1217	1850	0.005945946	0.011891892	8	15BA	Stromal cells	49	33	33
AATCCAGCAAACTGCT-1_8_H10	27.64884325	8.82138199	15A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1056	1428	0.013305322	0.046218487	8	15A	Endo cells	49	33	33
AATCCAGCATTTCACT-1_8_H10	-2.63416727	10.71328661	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	899	1293	0.011600928	0.025522042	8	oligos	OL-MS-1	49	33	33
AATCCAGGTGTCGCTG-1_8_H10	29.52542189	15.22274182	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1841	3129	0.026206456	0.070949185	8	14	Microglia	49	33	33
AATCCAGTCGCCGTGA-1_8_H10	16.27020627	-16.20259037	4	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	6688	21510	0.014690841	0.014690841	8	L2-3	EN-L2-3-MS	49	33	33
AATCCAGTCTTGTCAT-1_8_H10	-15.67317905	-17.78939757	6B	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1684	2947	0.040380048	0.005089922	8	6B	IN-SST	49	33	33
AATCGGTGTAATCGTC-1_8_H10	25.74287737	10.56920259	15A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2987	5978	0.024757444	0.093174975	8	15A	Endo cells	49	33	33
AATCGGTGTAGCGTCC-1_8_H10	-5.402581228	8.717127195	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	906	1264	0.008702532	0.029272152	8	oligos	OL-MS-1	49	33	33
ACACCAACATCGATGT-1_8_H10	24.80915206	-14.71434015	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4219	9777	0.023933722	0.01421704	8	3	EN-L5-6	49	33	33
ACACCAAGTGCCTGCA-1_8_H10	8.437488953	-17.44305294	4	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5508	14595	0.004727646	0.030215827	8	L2-3	EN-L2-3-MS	49	33	33
ACACCAAGTGTCTGAT-1_8_H10	33.67957216	10.71616557	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	876	1203	0.028262677	0.025768911	8	14	Microglia	49	33	33
ACACCAATCAACACAC-1_8_H10	33.65298279	-9.117356724	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4546	11316	0.008483563	0.013432308	8	2	EN-L4	49	33	33
ACACCAATCACCTTAT-1_8_H10	-1.507661466	9.215811231	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1112	1623	0.01663586	0.014171288	8	oligos	OL-MS-1	49	33	33
ACACCAATCAGTCCCT-1_8_H10	34.36604871	12.85091979	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1297	1879	0.013304949	0.012240553	8	14	Microglia	49	33	33
ACACCAATCCCATTTA-1_8_H10	7.622183317	-19.01577785	4	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3965	9054	0.010382152	0.013474707	8	L2-3	EN-L2-3-MS	49	33	33
ACACCAATCTGGTTCC-1_8_H10	24.65646093	-22.76221614	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3633	8194	0.013180376	0.005735904	8	3	EN-L5-6	49	33	33
ACACCCTGTAGCTAAA-1_8_H10	-25.08257643	-17.57016318	6A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4207	9355	0.031747728	0.011758418	8	6A	IN-PV	49	33	33
ACACCCTGTCTAGCGC-1_8_H10	-6.253430953	10.19440092	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	749	1009	0.016848365	0.021803766	8	oligos	OL-MS-1	49	33	33
ACACCCTGTCTCTCGT-1_8_H10	-6.909254207	7.349891598	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	785	1015	0.024630542	0.030541872	8	oligos	OL-MS-1	49	33	33
ACACCCTTCATCTGTT-1_8_H10	-2.577157575	10.2386408	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	891	1381	0.015206372	0.028964518	8	oligos	OL-MS-1	49	33	33
ACACCCTTCGAGGTAG-1_8_H10	-4.211791643	11.18868038	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	763	1063	0.014111007	0.031044214	8	oligos	OL-MS-1	49	33	33
ACACCCTTCTCGGACG-1_8_H10	-9.844764681	-4.819085714	13A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1886	3203	0.025288792	0.011239463	8	13A	IN-VIP	49	33	33
ACACCGGAGGTGCTAG-1_8_H10	-28.35992652	-22.42838894	6A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4384	10021	0.025745934	0.013970662	8	6A	IN-PV	49	33	33
ACACCGGCATGTTCCC-1_8_H10	-7.463268147	7.52310508	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	971	1563	0.017274472	0.018554063	8	oligos	OL-MS-1	49	33	33
ACACCGGGTCACAAGG-1_8_H10	21.59637092	-13.80828132	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2917	5900	0.026101695	0.014237288	8	2	EN-L4	49	33	33
ACACCGGGTCATGCCG-1_8_H10	29.00290506	11.72771801	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1318	1908	0.01048218	0.071802935	8	14	Microglia	49	33	33
ACACCGGGTGTGGCTC-1_8_H10	-7.457589716	7.717559256	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	836	1091	0.013748854	0.028414299	8	oligos	OL-MS-1	49	33	33
ACACCGGGTGTGTGCC-1_8_H10	8.712691711	0.960390242	12	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	951	1507	0.03583278	0.01459854	8	12	EN-MIX	49	33	33
ACACCGGGTTATCCGA-1_8_H10	-6.02114409	11.87268506	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	763	1031	0.010669253	0.009699321	8	oligos	OL-MS-1	49	33	33
ACACTGAAGAGGGATA-1_8_H10	20.28464428	-20.78448718	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5447	15512	0.027913873	0.010443528	8	3	EN-L5-6	49	33	33
ACACTGAAGCCCGAAA-1_8_H10	-4.24911099	11.57900682	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	818	1100	0.010909091	0.012727273	8	oligos	OL-MS-1	49	33	33
ACACTGAAGGATGTAT-1_8_H10	4.906858662	-15.71506469	4	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2677	5093	0.005890438	0.009228353	8	L2-3	EN-L2-3-MS	49	33	33
ACACTGAAGGTGTGGT-1_8_H10	34.85935969	11.13142416	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	853	1133	0.009708738	0.01059135	8	14	Microglia	49	33	33
ACACTGAAGTACTTGC-1_8_H10	-29.21016485	19.53931298	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1075	1677	0.020274299	0.005963029	8	8	Astrocytes	49	33	33
ACACTGACAATCCGAT-1_8_H10	29.71881758	9.640140557	15DA	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1230	1625	0.035076923	0.044307692	8	15DA	T cells	49	33	33
ACACTGACAGCCTTGG-1_8_H10	19.73172605	-21.79204955	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	6524	22776	0.020152792	0.008825079	8	3	EN-L5-6	49	33	33
ACACTGACATATACCG-1_8_H10	-16.30114979	11.53652374	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1345	1943	0.016984045	0.006176016	8	8	Astrocytes	49	33	33
ACACTGACATGCCACG-1_8_H10	20.78612234	-11.17598659	12	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2142	3580	0.041899441	0.009217877	8	12	EN-MIX	49	33	33
ACACTGAGTCCGTGAC-1_8_H10	28.84941151	-14.69414838	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4642	12227	0.027561953	0.010632207	8	2	EN-L4	49	33	33
ACACTGAGTGTTGAGG-1_8_H10	27.67575703	9.760706638	15A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	911	1264	0.067246835	0.107594937	8	15A	Endo cells	49	33	33
ACACTGAGTTGATTCG-1_8_H10	20.74676241	-21.01485629	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4988	12739	0.039249549	0.010047884	8	3	EN-L5-6	49	33	33
ACACTGATCAGCGATT-1_8_H10	9.748290776	-21.70398823	4	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5270	13402	0.0066408	0.011863901	8	L2-3	EN-L2-3-MS	49	33	33
ACAGCCGCACGAGAGT-1_8_H10	25.31759079	10.13799331	15A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4288	9666	0.025553486	0.031657356	8	15A	Endo cells	49	33	33
ACAGCCGCATATGCTG-1_8_H10	-4.925481327	10.7789223	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	797	1082	0.019408503	0.038817006	8	oligos	OL-MS-1	49	33	33
ACAGCCGGTAGCCTAT-1_8_H10	9.519300257	1.492567046	12	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	774	1198	0.047579299	0.006677796	8	12	EN-MIX	49	33	33
ACAGCCGTCTTAGCCC-1_8_H10	-17.27542649	7.033366258	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1040	1707	0.008201523	0.006444054	8	8	Astrocytes	49	33	33
ACAGCTAAGAGTGAGA-1_8_H10	9.610759303	-3.825994109	12	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2242	3914	0.031681145	0.013285641	8	12	EN-MIX	49	33	33
ACAGCTAAGGAGTAGA-1_8_H10	-15.63920117	11.73666096	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1281	1926	0.009345794	0.009345794	8	8	Astrocytes	49	33	33
ACAGCTAAGTTAACGA-1_8_H10	-6.181389678	9.926683789	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	774	1058	0.014177694	0.017958412	8	oligos	OL-MS-1	49	33	33
ACAGCTACACAGACTT-1_8_H10	-13.55993335	-38.26960267	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1982	3459	0.020237063	0.017635155	8	16	EN-PYR	49	33	33
ACAGCTACACGAAAGC-1_8_H10	-3.923245498	10.17873801	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	917	1305	0.013793103	0.026819923	8	oligos	OL-MS-1	49	33	33
ACAGCTACATTGGTAC-1_8_H10	32.8557455	-11.87929086	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4067	9397	0.027774822	0.009896776	8	2	EN-L4	49	33	33
ACAGCTAGTAGCCTCG-1_8_H10	-3.035150413	-34.19649213	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	746	1046	0.143403442	0.017208413	8	16	EN-PYR	49	33	33
ACATACGAGAACAATC-1_8_H10	-24.0265907	-24.73252281	6A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4052	10425	0.012757794	0.005179856	8	6A	IN-PV	49	33	33
ACATACGAGTTAACGA-1_8_H10	29.86473483	9.374147282	15DA	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	907	1162	0.030120482	0.055938038	8	15DA	T cells	49	33	33
ACATACGCAAGAAGAG-1_8_H10	31.87598081	-18.49184238	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5560	13727	0.013185692	0.022656079	8	2	EN-L4	49	33	33
ACATACGGTCAGATAA-1_8_H10	-6.08797759	11.71941613	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	771	1013	0.020730503	0.019743337	8	oligos	OL-MS-1	49	33	33
ACATCAGAGCCTTGAT-1_8_H10	23.49248056	-25.84653	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2796	5901	0.025588883	0.00542281	8	3	EN-L5-6	49	33	33
ACATCAGCAAGCCATT-1_8_H10	33.92314944	-9.690084474	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4801	11601	0.011809327	0.013533316	8	2	EN-L4	49	33	33
ACATCAGGTAGCCTCG-1_8_H10	-27.88291284	-12.6671494	9	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	781	1096	0.010036496	0.023722628	8	9	OPC	49	33	33
ACATCAGGTCCAGTTA-1_8_H10	-6.621801596	8.01406137	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	870	1169	0.01283148	0.030795552	8	oligos	OL-MS-1	49	33	33
ACATCAGTCAGTTTGG-1_8_H10	29.63496595	9.611812864	15DA	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	840	1067	0.017806935	0.056232427	8	15DA	T cells	49	33	33
ACATCAGTCTAACCGA-1_8_H10	24.75765898	-16.82597744	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	8656	40577	0.05204919	0.011262538	8	2	EN-L4	49	33	33
ACATGGTCAGGACCCT-1_8_H10	0.657495673	8.812661464	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1215	1843	0.013022246	0.022788931	8	oligos	OL-MS-1	49	33	33
ACATGGTGTAGCTTGT-1_8_H10	34.3337753	13.37823265	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1138	1566	0.014048531	0.023627075	8	14	Microglia	49	33	33
ACATGGTGTCGGGTCT-1_8_H10	24.80403289	25.90494683	17	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1727	2888	0.034279778	0.010734072	8	oligos	OL-MS-2	49	33	33
ACATGGTGTTCTGAAC-1_8_H10	-0.791528269	9.13911578	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1153	1655	0.018731118	0.024169184	8	oligos	OL-MS-1	49	33	33
ACCAGTAAGCTACCTA-1_8_H10	10.53766651	-22.31458454	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	7460	26659	0.008177351	0.006489366	8	3	EN-L5-6	49	33	33
ACCAGTAAGCTCCTCT-1_8_H10	0.025540626	9.072830368	17	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1290	1985	0.020654912	0.015617128	8	oligos	OL-MS-2	49	33	33
ACCAGTAAGTGGCACA-1_8_H10	-7.77817587	-37.78565511	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1086	1605	0.075389408	0.033021807	8	16	EN-PYR	49	33	33
ACCAGTAGTGATGCCC-1_8_H10	8.524247656	-17.11238564	4	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4730	11509	0.010687288	0.025371448	8	L2-3	EN-L2-3-MS	49	33	33
ACCAGTAGTTCCACAA-1_8_H10	-11.90091217	-38.39280779	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1659	2706	0.046932742	0.021433851	8	16	EN-PYR	49	33	33
ACCAGTATCGGACAAG-1_8_H10	26.62345296	8.529360588	15A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1570	2420	0.044628099	0.031404959	8	15A	Endo cells	49	33	33
ACCCACTAGTTAGCGG-1_8_H10	-5.205814221	15.10245506	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	769	1113	0.009883199	0.02066487	8	oligos	OL-MS-1	49	33	33
ACCCACTCACAGACTT-1_8_H10	11.21078985	6.50362371	1	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1672	2771	0.011909058	0.022013713	8	oligos	OL-Cntl	49	33	33
ACCCACTCACCAGGTC-1_8_H10	-27.74655403	4.319082427	9	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2401	4238	0.004719207	0.004955168	8	9	OPC	49	33	33
ACCCACTTCACGGTTA-1_8_H10	-6.894811042	9.242255673	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	751	1014	0.021696252	0.019723866	8	oligos	OL-MS-1	49	33	33
ACCGTAACACGGTGTC-1_8_H10	28.0814037	4.358899684	15DA	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	842	1104	0.043478261	0.032608696	8	15DA	T cells	49	33	33
ACCGTAACATGAACCT-1_8_H10	31.11465301	4.508557865	15DA	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	994	1208	0.027317881	0.024006623	8	15DA	T cells	49	33	33
ACCGTAACATTCGACA-1_8_H10	-7.625764309	7.482070037	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	793	1006	0.013916501	0.050695825	8	oligos	OL-MS-1	49	33	33
ACCGTAAGTAAATACG-1_8_H10	-6.854501237	9.116950148	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	912	1234	0.025931929	0.017017828	8	oligos	OL-MS-1	49	33	33
ACCGTAAGTGCAGGTA-1_8_H10	-2.357654692	10.85627856	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	899	1199	0.014178482	0.014178482	8	oligos	OL-MS-1	49	33	33
ACCGTAATCATTCACT-1_8_H10	8.626799527	-28.25143969	10	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5582	19156	0.007987054	0.004332846	8	L2-3	EN-L2-3-Cntl	49	33	33
ACCGTAATCTTTAGTC-1_8_H10	15.55368117	-8.601093107	12	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1940	3841	0.011976048	0.00468628	8	12	EN-MIX	49	33	33
ACCTTTATCACGCGGT-1_8_H10	32.79414606	9.343583442	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	916	1242	0.017713366	0.02979066	8	14	Microglia	49	33	33
ACCTTTATCGGAAATA-1_8_H10	-15.05057945	12.07356583	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1575	2387	0.013824885	0.008378718	8	8	Astrocytes	49	33	33
ACCTTTATCGGTCCGA-1_8_H10	-10.45466339	-38.93792442	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1392	2088	0.067049808	0.022509579	8	16	EN-PYR	49	33	33
ACCTTTATCTGTACGA-1_8_H10	-8.250700618	7.769297429	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	788	1102	0.019056261	0.022686025	8	oligos	OL-MS-1	49	33	33
ACGAGCCAGTAGGCCA-1_8_H10	29.8544733	14.19731929	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	996	1586	0.006935687	0.138083228	8	14	Microglia	49	33	33
ACGAGCCAGTCATCCA-1_8_H10	22.7194406	-23.99631496	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3910	9707	0.026681776	0.006284125	8	3	EN-L5-6	49	33	33
ACGAGCCCAAGACACG-1_8_H10	-0.956516707	7.600937383	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1508	2369	0.013929928	0.038834951	8	oligos	OL-MS-1	49	33	33
ACGAGCCGTAACGCGA-1_8_H10	0.396838499	8.570794552	1	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1305	1952	0.010758197	0.025102459	8	oligos	OL-Cntl	49	33	33
ACGAGCCGTAACGTTC-1_8_H10	0.033904501	9.035455545	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1297	2034	0.04719764	0.020648968	8	oligos	OL-MS-1	49	33	33
ACGAGGAAGCTCCTCT-1_8_H10	-5.514303914	-3.38394024	13A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1445	2431	0.026326615	0.009461127	8	13A	IN-VIP	49	33	33
ACGAGGAAGCTGAAAT-1_8_H10	-1.647054663	11.38238591	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	913	1346	0.007429421	0.026745914	8	oligos	OL-MS-1	49	33	33
ACGAGGAAGTCAATAG-1_8_H10	-17.92212946	25.12583995	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1818	2873	0.005569092	0.009397842	8	8	Astrocytes	49	33	33
ACGAGGAGTACCGCTG-1_8_H10	-16.64228273	24.7338473	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1948	3177	0.014793831	0.010072395	8	8	Astrocytes	49	33	33
ACGATACCAAACAACA-1_8_H10	-15.84133207	12.05306602	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1212	1839	0.022838499	0.008700381	8	8	Astrocytes	49	33	33
ACGATACCAGTAAGAT-1_8_H10	-0.916902574	7.805740883	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1307	1787	0.010632345	0.027420257	8	oligos	OL-MS-1	49	33	33
ACGATACCATCACGTA-1_8_H10	18.4269473	-25.04995755	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5265	14164	0.00741316	0.007342559	8	3	EN-L5-6	49	33	33
ACGATACCATGTCCTC-1_8_H10	-5.808450045	11.86286394	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	868	1203	0.023275145	0.02244389	8	oligos	OL-MS-1	49	33	33
ACGATACGTAAATACG-1_8_H10	23.34150737	-25.52650558	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2963	6165	0.023844282	0.006974858	8	3	EN-L5-6	49	33	33
ACGATACGTCTGCAAT-1_8_H10	-13.42835461	-38.45456268	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1906	3302	0.026953362	0.025741975	8	16	EN-PYR	49	33	33
ACGATGTAGCGTTGCC-1_8_H10	-5.939125843	10.33834034	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	865	1146	0.013089005	0.022687609	8	oligos	OL-MS-1	49	33	33
ACGATGTCAAGCCGTC-1_8_H10	15.23227093	-22.04010864	4	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5210	14146	0.018591828	0.007139828	8	L2-3	EN-L2-3-MS	49	33	33
ACGATGTGTGCTGTAT-1_8_H10	24.90561106	-20.64521977	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3798	8831	0.063073265	0.005322161	8	3	EN-L5-6	49	33	33
ACGCAGCGTACAGTTC-1_8_H10	9.125775947	-23.62121902	4	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5616	20187	0.002476842	0.006885619	8	L2-3	EN-L2-3-MS	49	33	33
ACGCAGCGTTGAGTTC-1_8_H10	31.46664537	12.10394412	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	989	1307	0.027543994	0.041315991	8	14	Microglia	49	33	33
ACGCAGCTCGCAAACT-1_8_H10	10.25220283	-29.27210208	10	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5031	13333	0.007500188	0.006375159	8	L2-3	EN-L2-3-Cntl	49	33	33
ACGCAGCTCGTCTGCT-1_8_H10	-3.806500821	-36.69747134	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	799	1041	0.039385207	0.030739673	8	16	EN-PYR	49	33	33
ACGCCAGAGCGATATA-1_8_H10	-6.543461959	-37.65993123	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1002	1312	0.060213415	0.017530488	8	16	EN-PYR	49	33	33
ACGCCAGGTCCATCCT-1_8_H10	23.74242633	-18.84802908	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5345	14500	0.034275862	0.01	8	3	EN-L5-6	49	33	33
ACGCCAGTCTCGCATC-1_8_H10	17.88763558	-14.05352355	4	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	7594	27806	0.021793857	0.013018773	8	L2-3	EN-L2-3-MS	49	33	33
ACGCCGAAGTGTACCT-1_8_H10	-15.76495746	15.0540722	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1922	3549	0.009861933	0.004226543	8	8	Astrocytes	49	33	33
ACGCCGATCCGCGTTT-1_8_H10	24.75406267	-19.64603329	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5233	14176	0.042254515	0.007265801	8	3	EN-L5-6	49	33	33
ACGCCGATCGGCATCG-1_8_H10	19.82199568	-17.7563497	4	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	6446	17932	0.009257194	0.010874414	8	L2-3	EN-L2-3-MS	49	33	33
ACGGAGAAGGTGCACA-1_8_H10	28.24651483	6.626182934	15A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	895	1237	0.024252223	0.020210186	8	15A	Endo cells	49	33	33
ACGGAGACAAAGGCGT-1_8_H10	30.06508576	-11.460346	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4066	8962	0.032693595	0.010823477	8	2	EN-L4	49	33	33
ACGGAGACAAGCGTAG-1_8_H10	28.74754437	7.408153156	15DA	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1624	2821	0.209854661	0.052109181	8	15DA	T cells	49	33	33
ACGGAGACAGCGTCCA-1_8_H10	34.08341014	13.77024649	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1090	1499	0.012675117	0.020013342	8	14	Microglia	49	33	33
ACGGAGACAGGCAGTA-1_8_H10	18.29037697	-25.14588454	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5088	14436	0.010113605	0.00983652	8	3	EN-L5-6	49	33	33
ACGGAGACATTCGACA-1_8_H10	-5.27725439	8.594201577	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	886	1143	0.021872266	0.032370954	8	oligos	OL-MS-1	49	33	33
ACGGAGAGTGATAAAC-1_8_H10	-26.57901466	-11.3648412	9	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1292	1812	0.012693157	0.03807947	8	9	OPC	49	33	33
ACGGAGATCATCTGTT-1_8_H10	3.872169877	3.837891605	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1419	1995	0.011528822	0.040601504	8	14	Microglia	49	33	33
ACGGAGATCCTCGCAT-1_8_H10	-9.169475341	-37.67424544	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1279	1861	0.080601827	0.016657711	8	16	EN-PYR	49	33	33
ACGGCCAAGTTCGCAT-1_8_H10	-5.896963903	11.48389967	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	804	1093	0.029277219	0.017383349	8	oligos	OL-MS-1	49	33	33
ACGGCCACAGATTGCT-1_8_H10	6.67627333	-27.02751669	4	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4176	9893	0.013544931	0.008591934	8	L2-3	EN-L2-3-MS	49	33	33
ACGGCCAGTCACCCAG-1_8_H10	-2.989385585	9.781905562	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1019	1487	0.020174849	0.018157364	8	oligos	OL-MS-1	49	33	33
ACGGCCAGTCTTGCGG-1_8_H10	-18.85560169	8.2566518	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1020	1563	0.015994882	0.008317338	8	8	Astrocytes	49	33	33
ACGGCCAGTTTGTTTC-1_8_H10	29.76246294	9.501242345	15DA	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	817	1149	0.031331593	0.062663185	8	15DA	T cells	49	33	33
ACGGGCTCACAGTCGC-1_8_H10	-4.767118278	13.1880476	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	811	1112	0.01528777	0.017985612	8	oligos	OL-MS-1	49	33	33
ACGGGCTCATACTACG-1_8_H10	-23.22342196	-22.82109209	6A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3177	7017	0.055579307	0.007125552	8	6A	IN-PV	49	33	33
ACGGGCTCATCACGAT-1_8_H10	10.49833492	1.457814996	12	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	746	1097	0.03372835	0.007292616	8	12	EN-MIX	49	33	33
ACGGGCTTCATCTGTT-1_8_H10	33.99807796	14.04464533	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1041	1540	0.015584416	0.033116883	8	14	Microglia	49	33	33
ACGGGCTTCCCACTTG-1_8_H10	7.327139801	1.818431269	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1031	1351	0.088082902	0.032568468	8	16	EN-PYR	49	33	33
ACGGGCTTCCGAATGT-1_8_H10	34.17015821	-8.382256282	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4273	10067	0.011522797	0.010827456	8	2	EN-L4	49	33	33
ACGGGCTTCTTGAGGT-1_8_H10	-29.08958287	-0.060012476	9	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1853	3019	0.006293475	0.010599536	8	9	OPC	49	33	33
ACGGGTCGTACTCTCC-1_8_H10	-23.03347316	10.71214133	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1172	1711	0.019286967	0.011104617	8	8	Astrocytes	49	33	33
ACGGGTCGTCGTTGTA-1_8_H10	25.24915065	9.794597438	15A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2888	5203	0.037862771	0.037862771	8	15A	Endo cells	49	33	33
ACGGGTCGTGGTAACG-1_8_H10	-5.209091281	10.05702435	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	781	1028	0.010700389	0.021400778	8	oligos	OL-MS-1	49	33	33
ACGGGTCTCGGCGCAT-1_8_H10	-18.97982933	4.92750418	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	822	1029	0.020408163	0.020408163	8	8	Astrocytes	49	33	33
ACGGGTCTCTAACTGG-1_8_H10	-19.56781326	-1.603156293	13A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4944	12577	0.021706289	0.012960165	8	13A	IN-VIP	49	33	33
ACGTCAAAGTGTGAAT-1_8_H10	2.458313452	12.03801121	1	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	955	1411	0.010630758	0.015591779	8	oligos	OL-Cntl	49	33	33
ACGTCAACAAAGCAAT-1_8_H10	-10.71304323	28.19575011	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1017	1356	0.029498525	0.037610619	8	oligos	OL-MS-1	49	33	33
ACGTCAACACACCGCA-1_8_H10	7.199648719	-21.74571514	4	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4963	13379	0.005007848	0.006502728	8	L2-3	EN-L2-3-MS	49	33	33
ACGTCAACATGAGCGA-1_8_H10	-3.723378704	-36.36785234	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	785	1008	0.026785714	0.023809524	8	16	EN-PYR	49	33	33
ACGTCAACATGTAGTC-1_8_H10	34.64257086	-15.26238622	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4204	8886	0.016880486	0.018343462	8	2	EN-L4	49	33	33
ACGTCAAGTCAGCTAT-1_8_H10	5.655071766	0.678020473	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1136	1646	0.025516403	0.02308627	8	16	EN-PYR	49	33	33
ACGTCAAGTCTCTTAT-1_8_H10	-23.80579136	11.2382451	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1045	1532	0.042428198	0.007832898	8	8	Astrocytes	49	33	33
ACGTCAATCTGCAGTA-1_8_H10	10.09605598	-24.2214193	4	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	6437	20702	0.002415226	0.007873635	8	L2-3	EN-L2-3-MS	49	33	33
ACTATCTAGTCATCCA-1_8_H10	18.75098209	-9.370790354	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2107	3956	0.052072801	0.005813953	8	3	EN-L5-6	49	33	33
ACTATCTAGTGCAAGC-1_8_H10	24.35031276	-23.91300914	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3402	7337	0.018945073	0.005724411	8	3	EN-L5-6	49	33	33
ACTATCTAGTGGTAGC-1_8_H10	-3.715224304	11.28427046	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	915	1254	0.005582137	0.033492823	8	oligos	OL-MS-1	49	33	33
ACTATCTCAGCTCGAC-1_8_H10	-4.565362451	10.96112727	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	859	1155	0.019047619	0.018181818	8	oligos	OL-MS-1	49	33	33
ACTATCTTCTGTCAAG-1_8_H10	-3.494330613	11.75585769	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	842	1172	0.012798635	0.023037543	8	oligos	OL-MS-1	49	33	33
ACTGAACAGGGATACC-1_8_H10	6.323088715	-1.339995114	12	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	973	1558	0.046854942	0.017971759	8	12	EN-MIX	49	33	33
ACTGAACAGTTAGCGG-1_8_H10	-10.63454182	-33.030158	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1853	4637	0.351736036	0.00711667	8	16	EN-PYR	49	33	33
ACTGAACCAATGGTCT-1_8_H10	32.78671118	-2.410420467	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2535	5087	0.043247494	0.006487124	8	2	EN-L4	49	33	33
ACTGAACCAGGTTTCA-1_8_H10	-16.90559356	5.922766812	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	863	1149	0.020017406	0.030461271	8	8	Astrocytes	49	33	33
ACTGAACCATGGTTGT-1_8_H10	-14.58906812	-1.868687922	13A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2589	4892	0.006132461	0.014922322	8	13A	IN-VIP	49	33	33
ACTGAACTCAACGAAA-1_8_H10	24.44957721	-22.24982435	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5820	17876	0.019019915	0.007552025	8	3	EN-L5-6	49	33	33
ACTGAACTCATGCAAC-1_8_H10	-17.35428961	5.844739848	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	717	1052	0.017110266	0.011406844	8	8	Astrocytes	49	33	33
ACTGAACTCGCTTGTC-1_8_H10	21.7898862	-25.17895734	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3870	9231	0.009099773	0.006174846	8	3	EN-L5-6	49	33	33
ACTGAGTAGAAACGAG-1_8_H10	28.54848967	7.230170382	15DA	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	984	1309	0.043544691	0.039724981	8	15DA	T cells	49	33	33
ACTGAGTAGGACAGCT-1_8_H10	25.35927866	10.13593012	15A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3266	6406	0.0128005	0.050889791	8	15A	Endo cells	49	33	33
ACTGAGTAGTCCCACG-1_8_H10	23.42661636	7.4056698	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2192	3953	0.002529724	0.056159879	8	oligos	OL-MS-1	49	33	33
ACTGAGTCACTCGACG-1_8_H10	-17.25001825	6.38374698	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	934	1232	0.019480519	0.010551948	8	8	Astrocytes	49	33	33
ACTGAGTGTACTCAAC-1_8_H10	21.52695116	-21.69121904	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4749	11536	0.022364771	0.015516644	8	3	EN-L5-6	49	33	33
ACTGAGTGTCATGCAT-1_8_H10	-4.230292459	-37.24709002	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	960	1284	0.036604361	0.028037383	8	16	EN-PYR	49	33	33
ACTGAGTTCGAACTGT-1_8_H10	-17.2684233	25.71588455	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2097	3599	0.017504862	0.008891359	8	8	Astrocytes	49	33	33
ACTGATGCATCGATTG-1_8_H10	17.62584007	-31.9570064	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4663	13583	0.002429507	0.003754693	8	3	EN-L5-6	49	33	33
ACTGATGTCTTGAGGT-1_8_H10	6.625831987	-1.188815804	12	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	926	1432	0.025139665	0.01396648	8	12	EN-MIX	49	33	33
ACTGCTCAGTGCAAGC-1_8_H10	-2.92380246	-35.28804845	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	792	1139	0.139596137	0.016681299	8	16	EN-PYR	49	33	33
ACTGCTCCATCTCGCT-1_8_H10	-7.47069281	8.555574808	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	830	1062	0.014124294	0.031073446	8	oligos	OL-MS-1	49	33	33
ACTGCTCTCCGTACAA-1_8_H10	20.25455743	-26.69337697	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4691	13831	0.010628299	0.004482684	8	3	EN-L5-6	49	33	33
ACTGTCCAGTTTCCTT-1_8_H10	18.69084994	-25.72533462	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	7335	29232	0.017686097	0.005507663	8	3	EN-L5-6	49	33	33
ACTGTCCCACGGCTAC-1_8_H10	31.41516163	10.18035406	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	958	1217	0.041906327	0.050123254	8	14	Microglia	49	33	33
ACTGTCCGTCGAACAG-1_8_H10	-0.575276508	9.780508685	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1099	1561	0.005765535	0.0256246	8	oligos	OL-MS-1	49	33	33
ACTGTCCGTCTGGAGA-1_8_H10	-18.7774595	-4.066824304	13B	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2704	4865	0.006372045	0.02672148	8	13B	IN-SV2C	49	33	33
ACTGTCCGTTCTGAAC-1_8_H10	-19.55128341	-5.303254924	13B	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3387	7050	0.024539007	0.013617021	8	13B	IN-SV2C	49	33	33
ACTGTCCTCAATAAGG-1_8_H10	9.007465183	-27.43666786	10	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4523	12536	0.002871729	0.004786216	8	L2-3	EN-L2-3-Cntl	49	33	33
ACTGTCCTCGATCCCT-1_8_H10	25.45744703	10.1855491	15A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2803	4996	0.012409928	0.044635709	8	15A	Endo cells	49	33	33
ACTTACTAGCGACGTA-1_8_H10	-4.331016804	12.46310344	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	733	1003	0.011964108	0.027916251	8	oligos	OL-MS-1	49	33	33
ACTTACTAGGAGTAGA-1_8_H10	28.63095982	-13.82014802	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5586	15127	0.04720037	0.007932835	8	2	EN-L4	49	33	33
ACTTACTGTCAAAGCG-1_8_H10	0.21421037	10.16160244	1	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1076	1575	0.010793651	0.018412698	8	oligos	OL-Cntl	49	33	33
ACTTACTGTCTACCTC-1_8_H10	4.308168639	10.05616549	1	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1221	1952	0.011270492	0.012807377	8	oligos	OL-Cntl	49	33	33
ACTTACTGTCTCTTTA-1_8_H10	31.43826301	12.29256763	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1152	1518	0.0256917	0.044137022	8	14	Microglia	49	33	33
ACTTACTTCACCATAG-1_8_H10	-3.375894066	-36.66218679	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1100	1546	0.091203105	0.032341527	8	16	EN-PYR	49	33	33
ACTTACTTCCGTCATC-1_8_H10	13.17456594	-20.66103777	4	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	6701	23711	0.007886635	0.007549239	8	L2-3	EN-L2-3-MS	49	33	33
ACTTGTTAGATCCCGC-1_8_H10	-6.403065799	9.699150272	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	767	1008	0.009920635	0.033730159	8	oligos	OL-MS-1	49	33	33
ACTTGTTAGCACCGCT-1_8_H10	37.35826149	9.667405529	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	823	1198	0.016694491	0.013355593	8	14	Microglia	49	33	33
ACTTGTTAGGGTGTTG-1_8_H10	25.01122662	-22.81063354	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4103	10238	0.033307287	0.005176792	8	3	EN-L5-6	49	33	33
ACTTGTTGTAATCACC-1_8_H10	-21.03519129	-24.28389295	6A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2473	4662	0.013728014	0.006435006	8	6A	IN-PV	49	33	33
ACTTGTTGTACAGTTC-1_8_H10	34.16329286	8.272450239	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1055	1449	0.011042098	0.00621118	8	14	Microglia	49	33	33
ACTTGTTTCAGATAAG-1_8_H10	33.95125873	12.87312172	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1113	1645	0.009726444	0.017021277	8	14	Microglia	49	33	33
ACTTGTTTCGCGTTTC-1_8_H10	-17.97859208	24.83093364	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1657	2626	0.006854532	0.007616146	8	8	Astrocytes	49	33	33
ACTTGTTTCTCTAGGA-1_8_H10	33.23595991	13.39023449	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1445	2040	0.013235294	0.019607843	8	14	Microglia	49	33	33
ACTTGTTTCTGCTGCT-1_8_H10	26.19895889	7.423012944	15BA	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1391	2135	0.02529274	0.031850117	8	15BA	Stromal cells	49	33	33
ACTTTCAAGACAGACC-1_8_H10	27.97066396	5.166124473	15DA	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1164	1638	0.032356532	0.029304029	8	15DA	T cells	49	33	33
ACTTTCAAGAGGGCTT-1_8_H10	-3.937936732	10.82713687	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	872	1194	0.024288107	0.022613065	8	oligos	OL-MS-1	49	33	33
ACTTTCACAACGATCT-1_8_H10	-5.668932121	7.905772823	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	906	1292	0.017027864	0.03250774	8	oligos	OL-MS-1	49	33	33
ACTTTCACAATCAGAA-1_8_H10	-22.46524605	-16.95066972	6A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5969	17707	0.004630937	0.005026261	8	6A	IN-PV	49	33	33
ACTTTCACACCATGTA-1_8_H10	16.90451474	-20.72809942	4	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5387	14918	0.012669259	0.009920901	8	L2-3	EN-L2-3-MS	49	33	33
ACTTTCACACCCTATC-1_8_H10	8.838044696	1.860899105	12	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	850	1181	0.036409822	0.019475021	8	12	EN-MIX	49	33	33
ACTTTCAGTCACTGGC-1_8_H10	-17.85349213	25.11101616	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1689	2708	0.003323486	0.007754801	8	8	Astrocytes	49	33	33
ACTTTCATCATGGTCA-1_8_H10	-16.44209202	-22.56703633	6A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1771	3185	0.014128728	0.00533752	8	6A	IN-PV	49	33	33
ACTTTCATCCTAGTGA-1_8_H10	11.49923467	0.61862859	12	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	830	1402	0.024964337	0.007845934	8	12	EN-MIX	49	33	33
ACTTTCATCTCCAACC-1_8_H10	-1.261472314	8.788361179	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1110	1618	0.009270705	0.017305315	8	oligos	OL-MS-1	49	33	33
AGAATAGAGTGAACAT-1_8_H10	32.39769702	13.47316617	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1343	1932	0.025362319	0.037267081	8	14	Microglia	49	33	33
AGACGTTAGACGCACA-1_8_H10	29.61411857	14.80816765	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1355	2093	0.025322504	0.098901099	8	14	Microglia	49	33	33
AGACGTTAGATCCCGC-1_8_H10	-26.77146691	-12.05185167	9	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1041	1443	0.026334026	0.031185031	8	9	OPC	49	33	33
AGACGTTGTATAATGG-1_8_H10	-4.281561309	-37.37766986	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	897	1180	0.039830508	0.041525424	8	16	EN-PYR	49	33	33
AGACGTTTCCTATGTT-1_8_H10	5.967067689	0.604903022	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1118	1419	0.050035236	0.016913319	8	16	EN-PYR	49	33	33
AGAGCGAGTCCGTCAG-1_8_H10	-5.065257069	10.58010194	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	788	1050	0.007619048	0.038095238	8	oligos	OL-MS-1	49	33	33
AGAGCGAGTCTCCCTA-1_8_H10	-16.81374871	-1.055003761	13A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3038	5820	0.011683849	0.017697595	8	13A	IN-VIP	49	33	33
AGAGCGAGTTTGGCGC-1_8_H10	24.84324808	-14.68985301	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5362	14935	0.034817543	0.010579176	8	3	EN-L5-6	49	33	33
AGAGCGATCACCGTAA-1_8_H10	-5.984446529	10.92586357	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	836	1159	0.010353753	0.02502157	8	oligos	OL-MS-1	49	33	33
AGAGCGATCTGGTATG-1_8_H10	-6.703673959	10.93012897	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	780	1049	0.012392755	0.017159199	8	oligos	OL-MS-1	49	33	33
AGAGCTTAGAATGTGT-1_8_H10	-0.33762632	9.596877533	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1117	1666	0.013205282	0.017406963	8	oligos	OL-MS-1	49	33	33
AGAGCTTAGAGCCTAG-1_8_H10	19.42577689	-18.38510711	4	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4833	12442	0.030461341	0.008760649	8	L2-3	EN-L2-3-MS	49	33	33
AGAGCTTAGATCGGGT-1_8_H10	29.74838	14.23488874	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	818	1288	0.010869565	0.125	8	14	Microglia	49	33	33
AGAGCTTAGCCCAATT-1_8_H10	-5.565822246	14.15058758	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	747	1009	0.004955401	0.012884044	8	oligos	OL-MS-1	49	33	33
AGAGCTTAGGAGTAGA-1_8_H10	-32.82980314	5.130205779	9	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2916	5798	0.005346671	0.007243877	8	9	OPC	49	33	33
AGAGCTTAGTGTACGG-1_8_H10	4.800768402	-22.84438535	4	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4861	13468	0.002673003	0.006905257	8	L2-3	EN-L2-3-MS	49	33	33
AGAGCTTCAATGAAAC-1_8_H10	-5.86813566	7.556339665	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	972	1293	0.043310131	0.030935808	8	oligos	OL-MS-1	49	33	33
AGAGCTTCAGCGTCCA-1_8_H10	-15.72035215	15.0572887	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1889	3373	0.00592944	0.003557664	8	8	Astrocytes	49	33	33
AGAGCTTCATTAACCG-1_8_H10	-5.680549264	12.0604623	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	750	1037	0.015429122	0.021215043	8	oligos	OL-MS-1	49	33	33
AGAGCTTTCCCATTAT-1_8_H10	6.095954359	0.607053622	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1500	2085	0.063788969	0.025899281	8	16	EN-PYR	49	33	33
AGAGTGGAGAGAGCTC-1_8_H10	-19.72149026	-4.877903293	13B	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3937	8403	0.012376532	0.011186481	8	13B	IN-SV2C	49	33	33
AGAGTGGAGCTTTGGT-1_8_H10	14.02650335	-31.21364029	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2857	6177	0.004209163	0.005180508	8	3	EN-L5-6	49	33	33
AGAGTGGAGGACTGGT-1_8_H10	26.49545408	10.0532991	15A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2004	3661	0.018027861	0.04206501	8	15A	Endo cells	49	33	33
AGAGTGGGTGTGAATA-1_8_H10	26.24342059	-24.5623056	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5807	18807	0.017706173	0.004200564	8	3	EN-L5-6	49	33	33
AGAGTGGGTTGGACCC-1_8_H10	-2.840005643	-35.04531581	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	688	1134	0.052910053	0.020282187	8	16	EN-PYR	49	33	33
AGAGTGGGTTGGTTTG-1_8_H10	34.07596453	10.74158284	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	835	1085	0.038709677	0.014746544	8	14	Microglia	49	33	33
AGAGTGGTCACAGTAC-1_8_H10	-6.018994697	8.740079937	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	930	1307	0.022953328	0.019892884	8	oligos	OL-MS-1	49	33	33
AGATCTGCAAGCGATG-1_8_H10	26.00679371	3.504318972	15DA	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	737	1016	0.022637795	0.00984252	8	15DA	T cells	49	33	33
AGATCTGCATCAGTAC-1_8_H10	29.4670855	13.91129538	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1183	1695	0.021238938	0.098525074	8	14	Microglia	49	33	33
AGATCTGCATTCACTT-1_8_H10	-1.199076682	8.92071741	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1185	1769	0.009609949	0.014132278	8	oligos	OL-MS-1	49	33	33
AGATCTGGTAGCCTAT-1_8_H10	-2.941312442	8.964452619	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1047	1484	0.007412399	0.016172507	8	oligos	OL-MS-1	49	33	33
AGATCTGTCATTTGGG-1_8_H10	28.93226868	10.04135799	15DB	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1034	1710	0.012865497	0.095906433	8	15DB	B cells	49	33	33
AGATCTGTCCCTCAGT-1_8_H10	5.12411873	9.701759684	1	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1395	2174	0.009199632	0.022079117	8	oligos	OL-Cntl	49	33	33
AGATCTGTCCTAGAAC-1_8_H10	-4.665959318	17.58760043	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	807	1103	0.014505893	0.026291931	8	oligos	OL-MS-1	49	33	33
AGATCTGTCCTTAATC-1_8_H10	28.25017857	5.823807133	15BA	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	730	1102	0.017241379	0.029038113	8	15BA	Stromal cells	49	33	33
AGATCTGTCTTTAGGG-1_8_H10	1.415081237	20.71229831	1	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	795	1194	0.015912898	0.018425461	8	oligos	OL-Cntl	49	33	33
AGATTGCAGCGACGTA-1_8_H10	18.80958722	-23.55228146	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5603	16167	0.010082266	0.010391538	8	3	EN-L5-6	49	33	33
AGATTGCAGGACATTA-1_8_H10	33.58637339	12.76658799	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1013	1427	0.023826209	0.027330063	8	14	Microglia	49	33	33
AGATTGCAGGATGCGT-1_8_H10	-3.839108285	15.08385461	1	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	747	1073	0.01584343	0.016775396	8	oligos	OL-Cntl	49	33	33
AGATTGCAGTTGTAGA-1_8_H10	1.756403106	13.634093	1	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	991	1477	0.022342586	0.010832769	8	oligos	OL-Cntl	49	33	33
AGATTGCCACGGTGTC-1_8_H10	-31.96094745	-5.614021495	9	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1300	2209	0.01539158	0.009959258	8	9	OPC	49	33	33
AGATTGCCATCACGAT-1_8_H10	25.45752788	10.3910983	15A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4876	12171	0.015035741	0.055295374	8	15A	Endo cells	49	33	33
AGATTGCGTCTAGCGC-1_8_H10	13.00759148	-27.02720881	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2924	6164	0.019792343	0.003893576	8	3	EN-L5-6	49	33	33
AGATTGCGTGCTTCTC-1_8_H10	-1.604649991	9.196572583	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1029	1526	0.011140236	0.020969856	8	oligos	OL-MS-1	49	33	33
AGATTGCTCATATCGG-1_8_H10	34.58723689	-4.388734233	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2989	6314	0.039119417	0.006335128	8	2	EN-L4	49	33	33
AGATTGCTCTTCATGT-1_8_H10	32.77524679	11.06130049	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	823	1068	0.026217228	0.030898876	8	14	Microglia	49	33	33
AGCAGCCAGATGAGAG-1_8_H10	-29.8260056	-1.210572371	9	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1702	2726	0.006969919	0.005502568	8	9	OPC	49	33	33
AGCAGCCCATAGACTC-1_8_H10	-14.92697504	13.5241667	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2142	3715	0.011843876	0.01076716	8	8	Astrocytes	49	33	33
AGCAGCCGTACGCACC-1_8_H10	13.56594727	-24.0594607	4	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5005	14891	0.013565241	0.00678262	8	L2-3	EN-L2-3-MS	49	33	33
AGCAGCCGTACTCGCG-1_8_H10	-5.577797511	9.295184084	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	834	1133	0.019417476	0.024713151	8	oligos	OL-MS-1	49	33	33
AGCAGCCGTCATCCCT-1_8_H10	-7.340371776	7.121876563	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	781	1001	0.032967033	0.038961039	8	oligos	OL-MS-1	49	33	33
AGCAGCCTCCGCATCT-1_8_H10	-4.710731675	10.41049434	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	814	1122	0.005347594	0.035650624	8	oligos	OL-MS-1	49	33	33
AGCAGCCTCGCGTAGC-1_8_H10	-24.17169678	21.99970721	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1317	2092	0.006214149	0.007170172	8	8	Astrocytes	49	33	33
AGCATACAGCGACGTA-1_8_H10	-7.493310456	7.45988658	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	866	1165	0.015450644	0.056652361	8	oligos	OL-MS-1	49	33	33
AGCATACCAACACCCG-1_8_H10	31.22950696	11.95575596	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1452	2073	0.014954173	0.05065123	8	14	Microglia	49	33	33
AGCATACCAGATCCAT-1_8_H10	-2.636239931	-34.91120406	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	803	1048	0.084923664	0.041030534	8	16	EN-PYR	49	33	33
AGCATACCAGATGAGC-1_8_H10	34.09614112	12.3405928	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	999	1348	0.016320475	0.020771513	8	14	Microglia	49	33	33
AGCATACCATCCTAGA-1_8_H10	-3.338571876	7.729507609	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1248	2029	0.011335633	0.02316412	8	oligos	OL-MS-1	49	33	33
AGCATACGTCCTCCAT-1_8_H10	21.60788727	-21.86199754	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4861	12354	0.018698397	0.009713453	8	3	EN-L5-6	49	33	33
AGCATACTCATGTAGC-1_8_H10	-6.847435828	6.594743225	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1299	1782	0.027497194	0.038159371	8	oligos	OL-MS-1	49	33	33
AGCATACTCCAAACTG-1_8_H10	-6.371171014	13.82297471	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	807	1120	0.016964286	0.013392857	8	oligos	OL-MS-1	49	33	33
AGCATACTCCACTGGG-1_8_H10	32.8239441	-7.572745005	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3499	7841	0.011860732	0.009947711	8	2	EN-L4	49	33	33
AGCATACTCCCAACGG-1_8_H10	28.55202097	6.290369279	15DA	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1103	1591	0.040226273	0.037712131	8	15DA	T cells	49	33	33
AGCATACTCTCTAGGA-1_8_H10	-10.71369008	-39.12063694	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1670	2707	0.10934614	0.039527152	8	16	EN-PYR	49	33	33
AGCCTAATCGTTTATC-1_8_H10	-2.185584059	10.98342862	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	928	1296	0.016975309	0.024691358	8	oligos	OL-MS-1	49	33	33
AGCCTAATCTTTAGGG-1_8_H10	26.97615585	9.949019889	15A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1392	2094	0.032473734	0.065902579	8	15A	Endo cells	49	33	33
AGCGGTCAGAGTAATC-1_8_H10	-2.836657581	10.66362716	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	911	1243	0.010458568	0.027353178	8	oligos	OL-MS-1	49	33	33
AGCGGTCAGCGGCTTC-1_8_H10	-16.42778149	-1.330742014	13A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2575	4644	0.008397933	0.021963824	8	13A	IN-VIP	49	33	33
AGCGGTCCAAGACGTG-1_8_H10	-10.95598003	-8.657206939	13A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1898	3452	0.069524913	0.004634994	8	13A	IN-VIP	49	33	33
AGCGGTCCAATCCGAT-1_8_H10	28.67310229	-13.86903695	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	6119	19270	0.033886871	0.008666321	8	2	EN-L4	49	33	33
AGCGGTCCACGTCTCT-1_8_H10	30.46342908	-18.72495173	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	7680	28150	0.038223801	0.012611012	8	2	EN-L4	49	33	33
AGCGGTCGTCACTTCC-1_8_H10	33.30388038	8.808917561	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1060	1408	0.012784091	0.009943182	8	14	Microglia	49	33	33
AGCGGTCGTCTGGAGA-1_8_H10	-28.1078578	-1.007323453	9	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1835	2932	0.008867667	0.008867667	8	9	OPC	49	33	33
AGCGGTCTCCTTTCGG-1_8_H10	-29.41709445	-1.364160301	9	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1458	2437	0.008206812	0.00738613	8	9	OPC	49	33	33
AGCGGTCTCTCGTATT-1_8_H10	-22.19484681	7.754412164	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1291	1922	0.014047867	0.013527575	8	8	Astrocytes	49	33	33
AGCGTATAGCGATATA-1_8_H10	29.22418733	5.505613837	15DA	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	880	1147	0.042720139	0.036617262	8	15DA	T cells	49	33	33
AGCGTATAGGCCATAG-1_8_H10	-6.377499597	11.08974425	1	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	916	1264	0.018987342	0.012658228	8	oligos	OL-Cntl	49	33	33
AGCGTATCAAGTCTAC-1_8_H10	-15.70379788	10.9538031	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1315	2001	0.006996502	0.009495252	8	8	Astrocytes	49	33	33
AGCGTATCAATGTAAG-1_8_H10	8.846742974	-23.18301501	4	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5868	16730	0.003227735	0.005977286	8	L2-3	EN-L2-3-MS	49	33	33
AGCGTATGTAGCGTAG-1_8_H10	10.15378056	6.382917997	1	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1722	2910	0.003780069	0.012714777	8	oligos	OL-Cntl	49	33	33
AGCGTATGTGCAACGA-1_8_H10	-5.714936453	7.943892211	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	912	1218	0.009852217	0.019704433	8	oligos	OL-MS-1	49	33	33
AGCGTATGTTAGTGGG-1_8_H10	4.500085201	9.938770692	1	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1359	2135	0.007025761	0.008899297	8	oligos	OL-Cntl	49	33	33
AGCGTATTCCCATTAT-1_8_H10	6.323437412	1.028088613	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	814	1034	0.075435203	0.022243714	8	16	EN-PYR	49	33	33
AGCGTCGAGGCATGGT-1_8_H10	5.952782733	-19.60014679	4	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3722	8996	0.006669631	0.007558915	8	L2-3	EN-L2-3-MS	49	33	33
AGCGTCGGTGGTCCGT-1_8_H10	29.65729585	15.02239063	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1102	1686	0.005338078	0.127520759	8	14	Microglia	49	33	33
AGCGTCGGTGTTGGGA-1_8_H10	20.35729144	-21.86579881	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4638	11695	0.029841813	0.009491236	8	3	EN-L5-6	49	33	33
AGCGTCGTCATCGATG-1_8_H10	-25.10608323	11.80490591	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1059	1500	0.013333333	0.012666667	8	8	Astrocytes	49	33	33
AGCGTCGTCGTGGGAA-1_8_H10	19.03842067	-10.2427914	12	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1918	3457	0.108186289	0.006653167	8	12	EN-MIX	49	33	33
AGCTCCTAGATGGCGT-1_8_H10	-9.706284047	-38.97018469	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1151	1722	0.066782811	0.036004646	8	16	EN-PYR	49	33	33
AGCTCCTAGCGTTGCC-1_8_H10	32.15985861	14.13697954	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1575	2414	0.017812759	0.038111019	8	14	Microglia	49	33	33
AGCTCCTGTCAGTGGA-1_8_H10	14.84133609	-27.28973883	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2971	6730	0.03922734	0.005497771	8	3	EN-L5-6	49	33	33
AGCTCCTGTTCAGTAC-1_8_H10	-5.173055575	-37.81280633	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1214	1734	0.087658593	0.027681661	8	16	EN-PYR	49	33	33
AGCTCCTTCCCTAATT-1_8_H10	-5.684269646	9.492961688	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	768	1035	0.014492754	0.025120773	8	oligos	OL-MS-1	49	33	33
AGCTCCTTCGTTACAG-1_8_H10	-11.57748743	-38.44496161	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1530	2460	0.078455285	0.029268293	8	16	EN-PYR	49	33	33
AGCTCTCAGACCACGA-1_8_H10	8.31745012	-17.55692729	4	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4494	10412	0.004898194	0.021225509	8	L2-3	EN-L2-3-MS	49	33	33
AGCTCTCAGTATCGAA-1_8_H10	36.57437016	13.83964607	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1122	1577	0.0082435	0.010779962	8	14	Microglia	49	33	33
AGCTCTCCACACCGCA-1_8_H10	-17.20492286	25.72562321	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2572	5277	0.01061209	0.006632556	8	8	Astrocytes	49	33	33
AGCTCTCCACGTTGGC-1_8_H10	-6.939447753	7.951205398	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	881	1137	0.025505717	0.013192612	8	oligos	OL-MS-1	49	33	33
AGCTCTCCATGTTGAC-1_8_H10	-5.444886777	9.437224174	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	851	1174	0.014480409	0.018739353	8	oligos	OL-MS-1	49	33	33
AGCTTGAAGCTAGCCC-1_8_H10	-7.696851764	7.701960152	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	759	1014	0.00887574	0.024654832	8	oligos	OL-MS-1	49	33	33
AGCTTGACACTATCTT-1_8_H10	-3.834970705	8.893881177	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1023	1459	0.023303633	0.017820425	8	oligos	OL-MS-1	49	33	33
AGCTTGACATTGGGCC-1_8_H10	-2.483010557	11.42108294	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	918	1336	0.013473054	0.021706587	8	oligos	OL-MS-1	49	33	33
AGCTTGATCCACGACG-1_8_H10	-24.65239234	-24.64610174	6A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5045	13938	0.028411537	0.006744153	8	6A	IN-PV	49	33	33
AGGCCACAGCCGCCTA-1_8_H10	-27.20889298	-22.95089916	6A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4950	13473	0.02946634	0.011430268	8	6A	IN-PV	49	33	33
AGGCCACCAAGGTGTG-1_8_H10	-3.84277506	10.62289953	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	951	1356	0.01179941	0.014749263	8	oligos	OL-MS-1	49	33	33
AGGCCACCATGTCCTC-1_8_H10	-3.460925943	9.702584539	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	960	1365	0.017582418	0.027106227	8	oligos	OL-MS-1	49	33	33
AGGCCACGTTAGTGGG-1_8_H10	34.25852423	13.9150599	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1079	1531	0.007184847	0.02743305	8	14	Microglia	49	33	33
AGGCCACTCAGGTTCA-1_8_H10	-29.07981053	-2.434663127	9	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1499	2326	0.012467756	0.012037833	8	9	OPC	49	33	33
AGGCCGTAGGCTACGA-1_8_H10	32.46780949	9.527977804	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	890	1178	0.016129032	0.037351443	8	14	Microglia	49	33	33
AGGCCGTCAAACTGTC-1_8_H10	-3.669636003	17.04530153	1	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	906	1311	0.009916095	0.019069413	8	oligos	OL-Cntl	49	33	33
AGGCCGTCATGCCTAA-1_8_H10	-20.24666804	-17.33758687	6A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3861	9952	0.002713023	0.006832797	8	6A	IN-PV	49	33	33
AGGCCGTGTGCAGGTA-1_8_H10	-8.862264585	-7.581917349	13A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1372	2110	0.03507109	0.009952607	8	13A	IN-VIP	49	33	33
AGGCCGTGTGGTTTCA-1_8_H10	-1.67250014	10.9454328	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	918	1298	0.016949153	0.019260401	8	oligos	OL-MS-1	49	33	33
AGGCCGTTCAAACGGG-1_8_H10	29.6006735	14.56785014	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1074	1617	0.014223871	0.139764997	8	14	Microglia	49	33	33
AGGCCGTTCTGCCAGG-1_8_H10	-25.67090425	-19.33053264	6A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3219	6123	0.044585987	0.024497795	8	6A	IN-PV	49	33	33
AGGGAGTAGGAGTTTA-1_8_H10	24.72779148	-16.66721202	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	7196	23427	0.029794681	0.013659453	8	3	EN-L5-6	49	33	33
AGGGAGTAGGGCTCTC-1_8_H10	-6.765269696	10.79342763	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	763	1041	0.004803074	0.016330451	8	oligos	OL-MS-1	49	33	33
AGGGAGTCAATAGCGG-1_8_H10	-28.75387594	-10.90463664	9	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1029	1454	0.044704264	0.022008253	8	9	OPC	49	33	33
AGGGAGTCACGGTAGA-1_8_H10	0.352853112	8.424474612	1	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1353	2039	0.010789603	0.023050515	8	oligos	OL-Cntl	49	33	33
AGGGAGTTCTTCAACT-1_8_H10	0.585580404	8.595786113	1	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1226	1861	0.01074691	0.034390113	8	oligos	OL-Cntl	49	33	33
AGGGATGAGGTGGGTT-1_8_H10	-3.349186356	9.551261146	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1008	1431	0.008385744	0.021663173	8	oligos	OL-MS-1	49	33	33
AGGGATGCAGGCGATA-1_8_H10	23.37695357	-0.799507252	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2144	3890	0.024421594	0.003856041	8	2	EN-L4	49	33	33
AGGGATGGTAGGCATG-1_8_H10	-4.133442905	8.394297381	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	962	1268	0.029968454	0.020504732	8	oligos	OL-MS-1	49	33	33
AGGGATGGTCGTTGTA-1_8_H10	31.71537983	11.6155118	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	974	1266	0.02764613	0.049763033	8	14	Microglia	49	33	33
AGGGATGTCTTCTGGC-1_8_H10	-27.59256089	-21.25057835	6A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3434	7205	0.019569743	0.010825815	8	6A	IN-PV	49	33	33
AGGGTGAAGAAACGAG-1_8_H10	-15.11679556	12.21569844	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1695	2676	0.007100149	0.007100149	8	8	Astrocytes	49	33	33
AGGGTGACAGGACCCT-1_8_H10	-29.29084487	-1.339394732	9	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1565	2562	0.005854801	0.012490242	8	9	OPC	49	33	33
AGGGTGATCCGTAGTA-1_8_H10	-15.45237339	13.33407733	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1626	2580	0.006589147	0.011627907	8	8	Astrocytes	49	33	33
AGGTCATCAAGCTGGA-1_8_H10	-4.10827102	6.887450975	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1257	1717	0.006406523	0.030867793	8	oligos	OL-MS-1	49	33	33
AGGTCATGTCGAATCT-1_8_H10	-23.42262242	-24.06224513	6A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3154	7317	0.021730217	0.004510045	8	6A	IN-PV	49	33	33
AGGTCATGTTTGGGCC-1_8_H10	-19.64460978	-3.586362309	13A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5987	18111	0.012368174	0.011429518	8	13A	IN-VIP	49	33	33
AGGTCATTCGGAGGTA-1_8_H10	-1.736458497	10.38145045	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	953	1349	0.008895478	0.022979985	8	oligos	OL-MS-1	49	33	33
AGGTCCGAGCGATATA-1_8_H10	-5.646043594	-32.24045136	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	837	1244	0.176848875	0.012057878	8	16	EN-PYR	49	33	33
AGGTCCGAGCGTGAGT-1_8_H10	-17.67184148	0.21590264	13A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3428	7032	0.010238908	0.01976678	8	13A	IN-VIP	49	33	33
AGGTCCGAGTAACCCT-1_8_H10	-3.283680996	12.71639896	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	883	1244	0.008038585	0.036173633	8	oligos	OL-MS-1	49	33	33
AGGTCCGCAGGAATGC-1_8_H10	24.50112402	-22.23713651	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5892	16805	0.011663195	0.006010116	8	3	EN-L5-6	49	33	33
AGGTCCGTCTGCTGCT-1_8_H10	9.779968048	6.739391003	1	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1364	2187	0.007773205	0.015089163	8	oligos	OL-Cntl	49	33	33
AGTAGTCAGAAGGGTA-1_8_H10	-2.950311109	10.85233566	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	922	1219	0.015586546	0.014766202	8	oligos	OL-MS-1	49	33	33
AGTAGTCAGGCTAGGT-1_8_H10	-29.06520083	-1.536844868	9	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1462	2367	0.007182087	0.009716941	8	9	OPC	49	33	33
AGTAGTCGTAGGACAC-1_8_H10	-14.78848611	11.20506956	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1861	3000	0.010333333	0.009333333	8	8	Astrocytes	49	33	33
AGTAGTCGTCCCGACA-1_8_H10	18.49445547	-24.76452964	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5220	14777	0.016850511	0.005481492	8	3	EN-L5-6	49	33	33
AGTAGTCTCCGGGTGT-1_8_H10	-3.760054869	17.67185844	1	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	783	1086	0.018416206	0.009208103	8	oligos	OL-Cntl	49	33	33
AGTAGTCTCGAGAGCA-1_8_H10	17.59315827	-26.55056144	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4526	11942	0.012309496	0.006112879	8	3	EN-L5-6	49	33	33
AGTCTTTAGGCCCTCA-1_8_H10	1.38833197	10.8019932	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1004	1417	0.016231475	0.012702893	8	oligos	OL-MS-1	49	33	33
AGTCTTTCAGACGCCT-1_8_H10	4.093447743	-18.61647027	4	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3243	7073	0.004524247	0.007917432	8	L2-3	EN-L2-3-MS	49	33	33
AGTCTTTGTTACGGAG-1_8_H10	20.06914043	-11.16178659	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2965	6167	0.040862656	0.005188909	8	3	EN-L5-6	49	33	33
AGTCTTTTCAAACAAG-1_8_H10	14.41586137	-22.62125297	4	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5035	13845	0.018779343	0.006139401	8	L2-3	EN-L2-3-MS	49	33	33
AGTCTTTTCCGAACGC-1_8_H10	-5.441337673	11.32016348	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	812	1093	0.017383349	0.019213175	8	oligos	OL-MS-1	49	33	33
AGTGAGGAGACAATAC-1_8_H10	31.75007818	10.58529226	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1283	1830	0.030054645	0.024043716	8	14	Microglia	49	33	33
AGTGAGGAGCTTTGGT-1_8_H10	-11.44131186	28.25333635	17	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1599	2421	0.063610078	0.024370095	8	oligos	OL-MS-2	49	33	33
AGTGAGGCAGCCTGTG-1_8_H10	-17.82393891	25.044336	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1752	2893	0.009678534	0.010369858	8	8	Astrocytes	49	33	33
AGTGAGGCATCGGACC-1_8_H10	-29.55450592	-0.185553193	9	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1851	3086	0.005832793	0.015878159	8	9	OPC	49	33	33
AGTGAGGGTCCCGACA-1_8_H10	0.883952456	16.69826032	1	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	859	1283	0.007794232	0.017147311	8	oligos	OL-Cntl	49	33	33
AGTGAGGGTCGATTGT-1_8_H10	17.95216593	-25.00405634	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	6800	22855	0.007744476	0.013695034	8	3	EN-L5-6	49	33	33
AGTGAGGGTTTAGCTG-1_8_H10	-2.891118051	10.31480041	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	905	1233	0.00567721	0.02108678	8	oligos	OL-MS-1	49	33	33
AGTGGGAAGTCCAGGA-1_8_H10	31.32165898	-7.219547585	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5466	15646	0.010417998	0.005177042	8	2	EN-L4	49	33	33
AGTGGGACAGTTCCCT-1_8_H10	-2.899280422	21.76222089	1	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	894	1260	0.012698413	0.01031746	8	oligos	OL-Cntl	49	33	33
AGTGGGAGTAAGAGGA-1_8_H10	27.91014687	-12.78197784	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4830	12384	0.050226098	0.009124677	8	2	EN-L4	49	33	33
AGTGGGAGTCATTAGC-1_8_H10	-11.70381057	28.23653729	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1533	2261	0.067226891	0.022114109	8	16	EN-PYR	49	33	33
AGTGGGAGTGTGAATA-1_8_H10	-6.440973611	-28.08695284	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1024	1522	0.124178712	0.019053876	8	16	EN-PYR	49	33	33
AGTGGGATCAATCACG-1_8_H10	-5.317132988	10.19331179	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	747	1012	0.018774704	0.020750988	8	oligos	OL-MS-1	49	33	33
AGTGGGATCATGTCCC-1_8_H10	22.50947309	-1.252501787	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2237	4197	0.035501549	0.011436741	8	2	EN-L4	49	33	33
AGTGGGATCTGTCTAT-1_8_H10	-2.292783062	11.62782181	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	916	1308	0.013761468	0.014525994	8	oligos	OL-MS-1	49	33	33
AGTGTCAAGTTCGCAT-1_8_H10	-28.14301213	-2.646484375	9	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1469	2305	0.003904555	0.013882863	8	9	OPC	49	33	33
AGTGTCAGTGGAAAGA-1_8_H10	7.484551795	1.177985728	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	868	1394	0.068866571	0.018651363	8	16	EN-PYR	49	33	33
AGTGTCAGTTGATTGC-1_8_H10	-4.595492556	7.57672677	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	982	1357	0.009579956	0.042741341	8	oligos	OL-MS-1	49	33	33
AGTGTCAGTTTGTGTG-1_8_H10	-20.78565341	-25.64864896	6A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2883	6140	0.01742671	0.005863192	8	6A	IN-PV	49	33	33
AGTGTCATCTTCCTTC-1_8_H10	-30.11571944	-0.960279032	9	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1558	2651	0.006035458	0.0116937	8	9	OPC	49	33	33
AGTTGGTGTCAACTGT-1_8_H10	4.145977443	4.775377518	7	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1624	2396	0.009599332	0.014607679	8	7	Phagocytes	49	33	33
AGTTGGTTCTGCAAGT-1_8_H10	-10.95116061	27.92498632	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1323	1920	0.03125	0.034375	8	oligos	OL-MS-1	49	33	33
ATAACGCAGTGGAGTC-1_8_H10	23.4133945	-25.77595458	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2980	6307	0.016331061	0.00634216	8	3	EN-L5-6	49	33	33
ATAACGCCAACACCTA-1_8_H10	-7.753921028	8.033490572	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	798	1033	0.019361084	0.026137464	8	oligos	OL-MS-1	49	33	33
ATAACGCCAATAACGA-1_8_H10	-6.977746016	9.416370904	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	743	1027	0.016553067	0.018500487	8	oligos	OL-MS-1	49	33	33
ATAACGCCAATGGAGC-1_8_H10	8.149583018	-21.81488003	4	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5042	13039	0.005138431	0.008896388	8	L2-3	EN-L2-3-MS	49	33	33
ATAACGCCATGCATGT-1_8_H10	9.575637331	-22.17953089	4	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	6516	19502	0.00415342	0.015280484	8	L2-3	EN-L2-3-MS	49	33	33
ATAACGCGTATTAGCC-1_8_H10	3.848721737	3.911646156	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1503	2168	0.01199262	0.037361624	8	14	Microglia	49	33	33
ATAAGAGAGCCCGAAA-1_8_H10	23.364194	-25.59868623	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3249	7112	0.011248594	0.006889764	8	3	EN-L5-6	49	33	33
ATAAGAGAGTAGGCCA-1_8_H10	19.63711246	-25.3501938	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4226	10182	0.009919466	0.007071302	8	3	EN-L5-6	49	33	33
ATAAGAGAGTGCCAGA-1_8_H10	27.32159065	7.865660862	15A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1026	1533	0.053489889	0.030006523	8	15A	Endo cells	49	33	33
ATAAGAGAGTGTTAGA-1_8_H10	33.89628554	-15.10663601	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3783	7463	0.021573094	0.013667426	8	2	EN-L4	49	33	33
ATAAGAGCACTGTGTA-1_8_H10	4.381306531	-14.76073778	4	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2742	6048	0.040509259	0.004298942	8	L2-3	EN-L2-3-MS	49	33	33
ATAAGAGCATGAGCGA-1_8_H10	-5.118999788	10.27061358	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	800	1083	0.011080332	0.020313943	8	oligos	OL-MS-1	49	33	33
ATAAGAGGTAGCCTCG-1_8_H10	-3.990595673	10.95661431	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	856	1209	0.015715467	0.019023987	8	oligos	OL-MS-1	49	33	33
ATAAGAGTCAGCACAT-1_8_H10	32.60967187	-8.344611104	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3605	7824	0.013675869	0.010224949	8	2	EN-L4	49	33	33
ATAAGAGTCAGTTTGG-1_8_H10	-4.464283879	17.1985881	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	784	1122	0.018716578	0.012477718	8	oligos	OL-MS-1	49	33	33
ATAAGAGTCTGCTGTC-1_8_H10	-4.655897363	16.55775257	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	778	1052	0.011406844	0.022813688	8	oligos	OL-MS-1	49	33	33
ATAGACCAGGACTGGT-1_8_H10	-15.25847276	-37.39644158	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2937	6052	0.050727032	0.014375413	8	16	EN-PYR	49	33	33
ATAGACCCAATGCCAT-1_8_H10	-0.236173464	9.111110977	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1291	1998	0.008508509	0.02002002	8	oligos	OL-MS-1	49	33	33
ATAGACCCACATTAGC-1_8_H10	-6.086756673	9.772474025	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	859	1239	0.015334948	0.023405973	8	oligos	OL-MS-1	49	33	33
ATAGACCCAGGATCGA-1_8_H10	35.52450798	-12.56237132	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3846	7835	0.01212508	0.018123803	8	2	EN-L4	49	33	33
ATAGACCGTACAGACG-1_8_H10	-4.68787237	11.48831451	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	773	1053	0.014245014	0.01994302	8	oligos	OL-MS-1	49	33	33
ATAGACCGTAGCCTAT-1_8_H10	34.27405375	11.45369659	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	930	1307	0.016832441	0.013006886	8	14	Microglia	49	33	33
ATAGACCGTCATATGC-1_8_H10	-17.42344501	-6.281965663	13B	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2473	4591	0.013069048	0.012851231	8	13B	IN-SV2C	49	33	33
ATCACGAAGATCGATA-1_8_H10	10.0732746	-21.74991342	4	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	6291	18411	0.008962034	0.006735104	8	L2-3	EN-L2-3-MS	49	33	33
ATCACGAAGCCACTAT-1_8_H10	-10.67203849	-33.51032845	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1327	2291	0.175905718	0.010039284	8	16	EN-PYR	49	33	33
ATCACGACACCCATGG-1_8_H10	-4.257050201	9.47674556	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	924	1268	0.019716088	0.023659306	8	oligos	OL-MS-1	49	33	33
ATCATCTCAGCTCCGA-1_8_H10	-19.40505955	-0.558012868	13A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4511	9911	0.006861063	0.01957421	8	13A	IN-VIP	49	33	33
ATCATCTCAGTTTACG-1_8_H10	-3.338005179	21.55314932	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	760	1065	0.015962441	0.021596244	8	oligos	OL-MS-1	49	33	33
ATCATCTTCAGCTCTC-1_8_H10	23.60811082	7.41516948	15A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1437	2099	0.020009528	0.025250119	8	15A	Endo cells	49	33	33
ATCATCTTCGACAGCC-1_8_H10	-0.449305875	10.25795425	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1039	1546	0.01164295	0.026520052	8	oligos	OL-MS-1	49	33	33
ATCATGGAGAGCTGCA-1_8_H10	-5.100371402	10.05164463	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	832	1097	0.023701003	0.019143118	8	oligos	OL-MS-1	49	33	33
ATCATGGAGTGTGGCA-1_8_H10	-0.735255722	7.764338172	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1545	2344	0.015358362	0.023890785	8	oligos	OL-MS-1	49	33	33
ATCATGGCATCGGGTC-1_8_H10	-2.343075043	9.989984383	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	980	1352	0.017011834	0.014792899	8	oligos	OL-MS-1	49	33	33
ATCATGGGTTATCACG-1_8_H10	-17.71304378	24.48472613	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1651	2618	0.008785332	0.005729565	8	8	Astrocytes	49	33	33
ATCATGGTCTTTAGGG-1_8_H10	-3.962837844	14.6849839	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	786	1058	0.016068053	0.025519849	8	oligos	OL-MS-1	49	33	33
ATCCACCAGGGTTCCC-1_8_H10	-6.821837531	7.254282668	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	954	1268	0.033123028	0.028391167	8	oligos	OL-MS-1	49	33	33
ATCCACCAGGTCATCT-1_8_H10	-0.202462296	8.430407559	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1227	1799	0.00889383	0.025013897	8	oligos	OL-MS-1	49	33	33
ATCCACCCAAGTTAAG-1_8_H10	16.91726934	-3.923125827	12	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1345	2097	0.062947067	0.006676204	8	12	EN-MIX	49	33	33
ATCCACCCACACTGCG-1_8_H10	-20.64182006	-20.27475136	6A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2228	4064	0.017470472	0.008612205	8	6A	IN-PV	49	33	33
ATCCACCCACCAGCAC-1_8_H10	-3.657105984	8.382747204	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1110	1548	0.013565891	0.012919897	8	oligos	OL-MS-1	49	33	33
ATCCACCGTAGGGTAC-1_8_H10	34.01260593	12.56957743	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1065	1435	0.033449477	0.018118467	8	14	Microglia	49	33	33
ATCCACCGTTATCACG-1_8_H10	19.55399925	-24.79696048	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	7597	29859	0.002042935	0.009645333	8	3	EN-L5-6	49	33	33
ATCCACCGTTGACGTT-1_8_H10	27.0393476	9.625452347	15A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1486	2432	0.017680921	0.046463816	8	15A	Endo cells	49	33	33
ATCCGAACACATGGGA-1_8_H10	-11.88065377	-8.883270288	13B	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1825	3046	0.018384767	0.005252791	8	13B	IN-SV2C	49	33	33
ATCCGAACACGAGAGT-1_8_H10	-18.68505295	0.170385738	13A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4029	8216	0.010467381	0.01959591	8	13A	IN-VIP	49	33	33
ATCCGAACATAGACTC-1_8_H10	30.787026	9.342371895	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1247	1738	0.031070196	0.027617952	8	14	Microglia	49	33	33
ATCCGAATCCGAATGT-1_8_H10	21.668753	-13.70437424	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2958	6004	0.016155896	0.016822119	8	2	EN-L4	49	33	33
ATCGAGTCACCACCAG-1_8_H10	29.05235769	10.016458	15DB	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	738	1048	0.010496183	0.133587786	8	15DB	B cells	49	33	33
ATCGAGTGTCTAGGTT-1_8_H10	32.79957163	-3.150917083	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2918	6103	0.003768638	0.009175815	8	2	EN-L4	49	33	33
ATCGAGTGTCTTGCGG-1_8_H10	28.77632567	-13.94936685	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5780	16926	0.033794163	0.012997755	8	2	EN-L4	49	33	33
ATCGAGTGTTTGTGTG-1_8_H10	21.36949872	-21.45582478	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5102	13598	0.01963524	0.014046183	8	3	EN-L5-6	49	33	33
ATCTACTAGGGAAACA-1_8_H10	26.79191144	10.02451059	15A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1621	2592	0.023919753	0.069444444	8	15A	Endo cells	49	33	33
ATCTACTCATGTCGAT-1_8_H10	-5.184529836	13.02340929	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	736	1004	0.014940239	0.019920319	8	oligos	OL-MS-1	49	33	33
ATCTACTTCTGACCTC-1_8_H10	-2.649740365	10.19464762	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1007	1562	0.101152369	0.02240717	8	oligos	OL-MS-1	49	33	33
ATCTGCCAGTATTGGA-1_8_H10	-0.191171914	8.558278112	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1218	1798	0.014460512	0.025027809	8	oligos	OL-MS-1	49	33	33
ATCTGCCCAAAGGTGC-1_8_H10	-17.85108681	6.596407061	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	881	1196	0.014214047	0.011705686	8	8	Astrocytes	49	33	33
ATCTGCCCAGTTCATG-1_8_H10	-5.821113634	7.573387729	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	977	1303	0.013046815	0.021488872	8	oligos	OL-MS-1	49	33	33
ATCTGCCGTACTTCTT-1_8_H10	-1.464855793	8.804073174	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1117	1659	0.012658228	0.013261001	8	oligos	OL-MS-1	49	33	33
ATCTGCCGTAGCTAAA-1_8_H10	31.296725	12.31373791	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1041	1401	0.022840828	0.042826552	8	14	Microglia	49	33	33
ATCTGCCTCGTCCAGG-1_8_H10	4.032100463	4.018074529	7	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1858	2922	0.014715948	0.023271732	8	7	Phagocytes	49	33	33
ATGAGGGTCACCAGGC-1_8_H10	3.802518837	4.109116735	7	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1441	1950	0.015897436	0.034871795	8	7	Phagocytes	49	33	33
ATGCGATAGTAGGTGC-1_8_H10	-5.074623759	-36.22008697	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	861	1199	0.089241034	0.022518766	8	16	EN-PYR	49	33	33
ATGCGATCATCTGGTA-1_8_H10	24.89617892	-14.72343048	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5342	13628	0.033020252	0.007924861	8	3	EN-L5-6	49	33	33
ATGCGATCATGCTAGT-1_8_H10	25.75653001	-23.10064706	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5615	17371	0.020551494	0.004144839	8	3	EN-L5-6	49	33	33
ATGCGATGTAACGTTC-1_8_H10	3.861333215	-19.33110853	4	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3377	7483	0.007884538	0.005479086	8	L2-3	EN-L2-3-MS	49	33	33
ATGCGATGTGACTACT-1_8_H10	-18.03442485	25.40385371	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1828	3071	0.005535656	0.011396939	8	8	Astrocytes	49	33	33
ATGCGATTCAGAGGTG-1_8_H10	-4.111217126	12.11272094	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	878	1223	0.012264922	0.022894522	8	oligos	OL-MS-1	49	33	33
ATGGGAGAGTCGAGTG-1_8_H10	5.70660931	0.584092802	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1107	1689	0.059798697	0.018354056	8	16	EN-PYR	49	33	33
ATGGGAGGTAGCGATG-1_8_H10	34.68071333	-8.840894181	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4692	10897	0.005873176	0.012205194	8	2	EN-L4	49	33	33
ATGGGAGTCATAAAGG-1_8_H10	7.750335927	0.062114982	12	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	910	1310	0.030534351	0.016793893	8	12	EN-MIX	49	33	33
ATGGGAGTCTTGACGA-1_8_H10	-9.845366904	-37.7886267	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1272	1928	0.062240664	0.023858921	8	16	EN-PYR	49	33	33
ATGTGTGGTAAGTGGC-1_8_H10	-8.238729234	8.042388741	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	782	1010	0.035643564	0.041584158	8	oligos	OL-MS-1	49	33	33
ATGTGTGGTCTAAAGA-1_8_H10	29.87081772	14.49463546	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1281	1877	0.020245072	0.077250932	8	14	Microglia	49	33	33
ATGTGTGGTCTCATCC-1_8_H10	24.66639086	-20.14754045	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5845	18346	0.037719394	0.006540935	8	3	EN-L5-6	49	33	33
ATGTGTGGTGCAGGTA-1_8_H10	-10.34790419	-2.078154541	13A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2073	3650	0.007671233	0.007671233	8	13A	IN-VIP	49	33	33
ATGTGTGGTGCGCTTG-1_8_H10	-1.657619303	11.24278751	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	975	1376	0.009447674	0.020348837	8	oligos	OL-MS-1	49	33	33
ATGTGTGGTTGAGGTG-1_8_H10	-5.70779493	8.139284164	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	894	1171	0.006831768	0.045260461	8	oligos	OL-MS-1	49	33	33
ATTACTCAGGAATGGA-1_8_H10	-20.61693764	-5.052831305	13B	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5197	13041	0.020857296	0.018480178	8	13B	IN-SV2C	49	33	33
ATTACTCCAAACAACA-1_8_H10	-15.13256825	-7.346168411	13A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3809	10180	0.014440079	0.005009823	8	13A	IN-VIP	49	33	33
ATTACTCCACCTCGGA-1_8_H10	-18.06781574	26.09809088	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1910	3167	0.006315125	0.007893906	8	8	Astrocytes	49	33	33
ATTACTCCACTGTGTA-1_8_H10	24.45933484	-19.32634113	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5664	15946	0.02771855	0.009971153	8	3	EN-L5-6	49	33	33
ATTACTCCAGTCGTGC-1_8_H10	23.75094808	-10.17632016	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3738	9204	0.009126467	0.003802694	8	3	EN-L5-6	49	33	33
ATTACTCGTGATGCCC-1_8_H10	-4.047090964	11.81375164	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	765	1141	0.01051709	0.01051709	8	oligos	OL-MS-1	49	33	33
ATTATCCAGATTACCC-1_8_H10	-7.0660614	-37.54288192	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	995	1310	0.035114504	0.020610687	8	16	EN-PYR	49	33	33
ATTATCCAGTCACGCC-1_8_H10	-2.844081015	9.945612012	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	964	1401	0.017130621	0.022127052	8	oligos	OL-MS-1	49	33	33
ATTATCCAGTTGAGTA-1_8_H10	11.78295397	-18.84356475	4	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5593	16641	0.012919897	0.006129439	8	L2-3	EN-L2-3-MS	49	33	33
ATTATCCGTCGACTGC-1_8_H10	17.82545766	-13.98479547	4	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	7403	25783	0.020594966	0.013419695	8	L2-3	EN-L2-3-MS	49	33	33
ATTATCCTCGTTACGA-1_8_H10	-15.13844498	14.81981061	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1920	3299	0.004849955	0.012731131	8	8	Astrocytes	49	33	33
ATTCTACAGCATGGCA-1_8_H10	7.738236554	1.448994334	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	826	1257	0.038981702	0.010342084	8	16	EN-PYR	49	33	33
ATTCTACAGTACGATA-1_8_H10	34.10382395	-9.940429629	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5500	14301	0.013845186	0.015803091	8	2	EN-L4	49	33	33
ATTCTACCAGTTAACC-1_8_H10	-17.77255665	6.687506918	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	847	1145	0.015720524	0.015720524	8	8	Astrocytes	49	33	33
ATTCTACGTCGAATCT-1_8_H10	9.939908594	-3.816747864	12	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2526	4745	0.055216017	0.011801897	8	12	EN-MIX	49	33	33
ATTCTACGTCTCATCC-1_8_H10	34.12587715	-9.861185812	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4706	12227	0.022818353	0.01316758	8	2	EN-L4	49	33	33
ATTCTACGTGACGGTA-1_8_H10	-27.81255782	-3.430889388	9	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1519	2500	0.012	0.0084	8	9	OPC	49	33	33
ATTCTACGTTTACTCT-1_8_H10	-5.696159694	10.93303244	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	792	1050	0.017142857	0.020952381	8	oligos	OL-MS-1	49	33	33
ATTGGACCAGCTCGAC-1_8_H10	9.261411069	-4.077576643	12	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2357	3975	0.011069182	0.017861635	8	12	EN-MIX	49	33	33
ATTGGTGTCACAATGC-1_8_H10	5.455084368	13.369732	1	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	945	1373	0.018208303	0.011653314	8	oligos	OL-Cntl	49	33	33
ATTGGTGTCGGAATCT-1_8_H10	27.81156868	10.45380025	15DB	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1868	3988	0.006770311	0.207121364	8	15DB	B cells	49	33	33
ATTTCTGAGAGCCTAG-1_8_H10	2.258584955	11.76971272	1	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	879	1216	0.012335526	0.022203947	8	oligos	OL-Cntl	49	33	33
ATTTCTGAGTTAGGTA-1_8_H10	5.782017261	-17.42563999	4	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2940	5817	0.008939316	0.012721334	8	L2-3	EN-L2-3-MS	49	33	33
ATTTCTGCACTAAGTC-1_8_H10	-34.6113173	-0.340388066	9	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1625	2854	0.004555011	0.005606167	8	9	OPC	49	33	33
ATTTCTGCATGCCTTC-1_8_H10	14.19588813	-0.729072612	12	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	903	1479	0.064908722	0.004056795	8	12	EN-MIX	49	33	33
ATTTCTGTCTGCCAGG-1_8_H10	12.39608261	-23.75509951	4	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5423	16685	0.007731495	0.008870243	8	L2-3	EN-L2-3-MS	49	33	33
CAACCAACAACTTGAC-1_8_H10	-6.495566053	11.04053952	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	879	1253	0.015163607	0.011971269	8	oligos	OL-MS-1	49	33	33
CAACCAACATAGGATA-1_8_H10	0.022546771	10.23801809	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1058	1560	0.024358974	0.020512821	8	oligos	OL-MS-1	49	33	33
CAACCAAGTAAATGAC-1_8_H10	6.90688798	12.78414276	1	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1332	2106	0.009496676	0.009496676	8	oligos	OL-Cntl	49	33	33
CAACCAAGTAATCACC-1_8_H10	-10.32837399	27.71077266	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	964	1311	0.07856598	0.020594966	8	oligos	OL-MS-1	49	33	33
CAACCAAGTTTCCACC-1_8_H10	27.00462981	4.356380471	15BA	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	888	1121	0.011596789	0.022301517	8	15BA	Stromal cells	49	33	33
CAACCAATCATACGGT-1_8_H10	15.65820134	-29.38585024	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5558	19494	0.006207038	0.004873294	8	3	EN-L5-6	49	33	33
CAACCAATCTTCAACT-1_8_H10	-17.55534775	27.17368456	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2200	3786	0.009772847	0.006339144	8	8	Astrocytes	49	33	33
CAACCTCAGACCTAGG-1_8_H10	17.9681427	-27.76954236	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4735	12615	0.015933413	0.007451447	8	3	EN-L5-6	49	33	33
CAACCTCAGCGGCTTC-1_8_H10	-10.30985535	27.68640225	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	754	1005	0.028855721	0.034825871	8	oligos	OL-MS-1	49	33	33
CAACCTCCACAGAGGT-1_8_H10	29.70275619	9.480966825	15DA	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	823	1108	0.013537906	0.055956679	8	15DA	T cells	49	33	33
CAACCTCCAGTGACAG-1_8_H10	16.87494737	-9.769046457	12	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2279	4694	0.021090754	0.006391138	8	12	EN-MIX	49	33	33
CAACCTCCATTTCACT-1_8_H10	17.58387474	-25.51470702	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4360	12070	0.030323115	0.008202154	8	3	EN-L5-6	49	33	33
CAACCTCGTGACAAAT-1_8_H10	32.04907786	10.78020284	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	808	1040	0.035576923	0.044230769	8	14	Microglia	49	33	33
CAACCTCTCAGGCCCA-1_8_H10	-16.90970015	17.86083687	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1706	2762	0.013758146	0.015206372	8	8	Astrocytes	49	33	33
CAACTAGAGCGCCTCA-1_8_H10	-31.20032075	2.814079632	9	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2365	4393	0.007739586	0.007511951	8	9	OPC	49	33	33
CAACTAGAGCGTGAGT-1_8_H10	-7.935059231	7.061746255	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	849	1156	0.03200692	0.089965398	8	oligos	OL-MS-1	49	33	33
CAACTAGAGGTGATAT-1_8_H10	25.13164015	6.829692227	15A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1792	3271	0.00397432	0.013145827	8	15A	Endo cells	49	33	33
CAACTAGCATTCACTT-1_8_H10	-24.08428703	-11.84685844	9	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1352	1886	0.025450689	0.024390244	8	9	OPC	49	33	33
CAACTAGTCCGTAGTA-1_8_H10	-19.65066542	-17.35057997	6A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3053	6732	0.011437908	0.004604872	8	6A	IN-PV	49	33	33
CAACTAGTCTGCTGTC-1_8_H10	-27.47860318	-22.44761651	6A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4301	9587	0.028163138	0.011473871	8	6A	IN-PV	49	33	33
CAAGAAAAGTACGATA-1_8_H10	31.32191952	4.691470698	15DA	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1032	1503	0.077844311	0.035262808	8	15DA	T cells	49	33	33
CAAGAAACACAAGCCC-1_8_H10	-6.303785528	11.60142154	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	813	1144	0.013111888	0.022727273	8	oligos	OL-MS-1	49	33	33
CAAGAAATCACTATTC-1_8_H10	-5.07067357	8.143566429	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	974	1366	0.013909224	0.02489019	8	oligos	OL-MS-1	49	33	33
CAAGAAATCATCTGCC-1_8_H10	-0.551168212	10.00500451	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1064	1550	0.02	0.028387097	8	oligos	OL-MS-1	49	33	33
CAAGAAATCCACGACG-1_8_H10	-5.009477076	7.55222788	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1016	1401	0.029978587	0.035688794	8	oligos	OL-MS-1	49	33	33
CAAGAAATCTTCATGT-1_8_H10	18.75637853	-27.31280409	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4971	14452	0.012316634	0.004151675	8	3	EN-L5-6	49	33	33
CAAGATCAGAGTTGGC-1_8_H10	-7.684987786	8.20996973	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	783	1067	0.007497657	0.029053421	8	oligos	OL-MS-1	49	33	33
CAAGATCCAGTAGAGC-1_8_H10	-19.12038653	-4.792355936	13B	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3739	8136	0.008603736	0.013397247	8	13B	IN-SV2C	49	33	33
CAAGATCGTAATCACC-1_8_H10	-0.494695325	7.611804998	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2036	3360	0.016369048	0.016964286	8	oligos	OL-MS-1	49	33	33
CAAGATCGTCCGTCAG-1_8_H10	-20.69664738	-23.49568294	6A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2309	4254	0.039962388	0.010343206	8	6A	IN-PV	49	33	33
CAAGATCGTGTTGAGG-1_8_H10	-15.93942835	11.84152741	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1288	1866	0.013933548	0.008574491	8	8	Astrocytes	49	33	33
CAAGGCCAGGCATGGT-1_8_H10	-32.1843803	-5.413671374	9	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1154	1810	0.004972376	0.010497238	8	9	OPC	49	33	33
CAAGGCCAGTCCCACG-1_8_H10	-7.180075945	7.886928942	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	766	1019	0.01373896	0.033366045	8	oligos	OL-MS-1	49	33	33
CAAGGCCCAAGAAGAG-1_8_H10	-6.91859785	10.69582392	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	748	1057	0.009460738	0.017975402	8	oligos	OL-MS-1	49	33	33
CAAGGCCCAGAGTGTG-1_8_H10	27.40902455	7.979547321	15A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1195	1775	0.031549296	0.034366197	8	15A	Endo cells	49	33	33
CAAGGCCGTCTCCCTA-1_8_H10	25.21803885	-22.867169	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5867	18926	0.013790553	0.005336574	8	3	EN-L5-6	49	33	33
CAAGTTGAGCTAAACA-1_8_H10	32.21908933	9.624702952	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	802	1095	0.021004566	0.017351598	8	14	Microglia	49	33	33
CAAGTTGCACTCTGTC-1_8_H10	-23.1114528	10.3410634	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1146	1720	0.044186047	0.00872093	8	8	Astrocytes	49	33	33
CAAGTTGCAGGACCCT-1_8_H10	-1.022006025	8.280421982	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1386	2097	0.01382928	0.020982356	8	oligos	OL-MS-1	49	33	33
CAAGTTGGTGGAAAGA-1_8_H10	-27.70118722	-3.257059685	9	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1419	2196	0.006375228	0.021857923	8	9	OPC	49	33	33
CAAGTTGTCACAACGT-1_8_H10	16.08936606	-27.6283179	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4445	12186	0.019776793	0.005744297	8	3	EN-L5-6	49	33	33
CAAGTTGTCGTTACAG-1_8_H10	-27.37506567	-22.27081144	6A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3769	7866	0.022501907	0.011568777	8	6A	IN-PV	49	33	33
CAAGTTGTCTCCAGGG-1_8_H10	-17.69462217	24.68201186	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1509	2397	0.030871923	0.009178139	8	8	Astrocytes	49	33	33
CACAAACAGAGTAATC-1_8_H10	-7.428315583	7.595873084	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	880	1145	0.023580786	0.031441048	8	oligos	OL-MS-1	49	33	33
CACAAACAGTGAATTG-1_8_H10	25.25693184	-22.54697683	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4602	12140	0.024794069	0.005766063	8	3	EN-L5-6	49	33	33
CACAAACAGTGCTGCC-1_8_H10	-5.782193771	8.559968798	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	933	1255	0.007968127	0.035059761	8	oligos	OL-MS-1	49	33	33
CACAAACAGTGGGCTA-1_8_H10	-4.30067949	9.634903366	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	902	1237	0.022635408	0.023443816	8	oligos	OL-MS-1	49	33	33
CACAAACGTGCCTGCA-1_8_H10	-26.29490811	4.798618964	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2033	3338	0.025164769	0.036848412	8	8	Astrocytes	49	33	33
CACACAACAAGGGTCA-1_8_H10	25.26782831	9.669800515	15A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2713	4830	0.024637681	0.038302277	8	15A	Endo cells	49	33	33
CACACAACACCATCCT-1_8_H10	-15.68791739	8.623265965	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1423	2165	0.027713626	0.017551963	8	8	Astrocytes	49	33	33
CACACAACACGACTCG-1_8_H10	-23.52307788	-11.22459522	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	813	1075	0.035348837	0.022325581	8	16	EN-PYR	49	33	33
CACACAAGTACTCTCC-1_8_H10	-26.66142911	-11.58277107	9	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1035	1359	0.033848418	0.024282561	8	9	OPC	49	33	33
CACACAAGTCCGCTGA-1_8_H10	25.62684172	10.41002341	15A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3055	5881	0.022105084	0.063764666	8	15A	Endo cells	49	33	33
CACACAAGTCCGTCAG-1_8_H10	-32.7546582	4.896673365	9	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2600	5001	0.00519896	0.01019796	8	9	OPC	49	33	33
CACACCTCAATCCAAC-1_8_H10	-5.918003079	10.32577712	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	850	1198	0.012520868	0.034223706	8	oligos	OL-MS-1	49	33	33
CACACCTCAGGCTCAC-1_8_H10	25.0612532	-22.52497967	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5536	16260	0.030627306	0.004735547	8	3	EN-L5-6	49	33	33
CACACCTCAGTGAGTG-1_8_H10	-28.64558065	-0.0467487	9	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1957	3312	0.007850242	0.020833333	8	9	OPC	49	33	33
CACACCTTCATTTGGG-1_8_H10	34.01489718	-3.867692838	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3553	8531	0.0419646	0.006095417	8	2	EN-L4	49	33	33
CACACTCCACTGAAGG-1_8_H10	-2.766605657	10.33995406	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	994	1418	0.007757405	0.009167842	8	oligos	OL-MS-1	49	33	33
CACACTCGTCGTGGCT-1_8_H10	-26.54023177	-1.578349239	9	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1882	3065	0.013050571	0.017618271	8	9	OPC	49	33	33
CACACTCTCTCTTATG-1_8_H10	-30.5091883	1.465070223	9	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2054	3756	0.007188498	0.012513312	8	9	OPC	49	33	33
CACAGGCAGAAGAAGC-1_8_H10	-1.190333259	8.751164421	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1153	1678	0.010727056	0.026221692	8	oligos	OL-MS-1	49	33	33
CACAGGCAGCCCAACC-1_8_H10	5.122343456	-22.40161112	4	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4937	14262	0.004557566	0.005679428	8	L2-3	EN-L2-3-MS	49	33	33
CACAGGCAGTGGTAAT-1_8_H10	-5.615509481	9.153783161	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	855	1156	0.022491349	0.051038062	8	oligos	OL-MS-1	49	33	33
CACAGGCCATGCGCAC-1_8_H10	32.5959011	8.858584998	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	793	1021	0.028403526	0.016650343	8	14	Microglia	49	33	33
CACAGGCGTAATTGGA-1_8_H10	33.01434812	10.73179185	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	803	1055	0.016113744	0.036966825	8	14	Microglia	49	33	33
CACAGGCGTACACCGC-1_8_H10	-26.55743344	-1.973003362	9	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1624	2455	0.03503055	0.031771894	8	9	OPC	49	33	33
CACAGGCGTGTGTGCC-1_8_H10	32.32550027	12.42973003	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1250	1772	0.024266366	0.033860045	8	14	Microglia	49	33	33
CACAGGCGTTACGACT-1_8_H10	17.6378268	-14.22966751	4	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	6874	22237	0.022305167	0.015244862	8	L2-3	EN-L2-3-MS	49	33	33
CACAGGCTCCACGAAT-1_8_H10	-8.251678654	7.336545009	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	751	1008	0.018849206	0.024801587	8	oligos	OL-MS-1	49	33	33
CACAGTAAGAATGTTG-1_8_H10	-3.531841792	9.77244019	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	937	1295	0.016216216	0.023938224	8	oligos	OL-MS-1	49	33	33
CACAGTACATCGATGT-1_8_H10	-17.64476844	24.12868883	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1491	2498	0.004803843	0.007606085	8	8	Astrocytes	49	33	33
CACAGTAGTAGTACCT-1_8_H10	-6.271376466	11.52842806	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	781	1109	0.027051398	0.034265104	8	oligos	OL-MS-1	49	33	33
CACAGTAGTCGCTTTC-1_8_H10	32.01943413	14.30133236	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1461	2219	0.013519603	0.047769265	8	14	Microglia	49	33	33
CACAGTAGTTACCAGT-1_8_H10	-15.00541641	14.27448697	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1944	3079	0.013316012	0.01266645	8	8	Astrocytes	49	33	33
CACAGTATCAGATAAG-1_8_H10	18.0800302	-24.92478886	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5070	13733	0.010267239	0.008665259	8	3	EN-L5-6	49	33	33
CACAGTATCCCTTGCA-1_8_H10	-17.93318828	-7.440101771	13B	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3264	6851	0.018683404	0.009487666	8	13B	IN-SV2C	49	33	33
CACAGTATCGTCGTTC-1_8_H10	33.78506115	9.13317982	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	974	1357	0.017686072	0.020633751	8	14	Microglia	49	33	33
CACATAGCATCGGTTA-1_8_H10	19.71750972	-26.38355724	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2400	4211	0.011636191	0.006174305	8	3	EN-L5-6	49	33	33
CACATTTCATCTACGA-1_8_H10	29.16832985	-13.49184689	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	6273	21684	0.037631433	0.006871426	8	2	EN-L4	49	33	33
CACATTTGTAAGTGTA-1_8_H10	-6.255499379	9.685073376	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	806	1075	0.014883721	0.021395349	8	oligos	OL-MS-1	49	33	33
CACATTTGTACCTACA-1_8_H10	8.15663188	2.125487712	12	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	930	1186	0.063237774	0.018549747	8	12	EN-MIX	49	33	33
CACATTTGTAGAGTGC-1_8_H10	-19.37630464	-3.515562858	13A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3932	8859	0.027542612	0.010836438	8	13A	IN-VIP	49	33	33
CACATTTGTGCCTGCA-1_8_H10	29.51173348	13.99645574	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1217	1926	0.053478712	0.112668744	8	14	Microglia	49	33	33
CACATTTTCCCAACGG-1_8_H10	21.76545358	-21.87400273	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4301	10648	0.042449286	0.005728775	8	2	EN-L4	49	33	33
CACCACTAGCCTATGT-1_8_H10	-16.02177075	8.780740583	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1147	1593	0.023226616	0.011927181	8	8	Astrocytes	49	33	33
CACCACTAGCGTCAAG-1_8_H10	19.5079686	-24.62384061	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	7008	23259	0.003482523	0.010748527	8	3	EN-L5-6	49	33	33
CACCACTCAAACGTGG-1_8_H10	-17.14101127	6.080481966	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	752	1076	0.00929368	0.00929368	8	8	Astrocytes	49	33	33
CACCACTCAATGAATG-1_8_H10	18.85564346	-30.70561133	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	6364	21743	0.008784436	0.006806788	8	3	EN-L5-6	49	33	33
CACCACTCATTTGCCC-1_8_H10	23.59036755	-25.85464934	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3285	7659	0.024154589	0.00391696	8	3	EN-L5-6	49	33	33
CACCACTTCACAATGC-1_8_H10	-3.492163547	-36.75965926	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1073	1474	0.083446404	0.031886024	8	16	EN-PYR	49	33	33
CACCACTTCATCACCC-1_8_H10	-3.065518141	-36.07920836	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1036	1390	0.035251799	0.032374101	8	16	EN-PYR	49	33	33
CACCACTTCCTCAATT-1_8_H10	-0.954890183	9.230697903	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1144	1725	0.019130435	0.017391304	8	oligos	OL-MS-1	49	33	33
CACCACTTCCTGCTTG-1_8_H10	-7.325236346	7.633866945	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	803	1047	0.021012416	0.028653295	8	oligos	OL-MS-1	49	33	33
CACCACTTCCTTAATC-1_8_H10	-4.037112359	7.917163689	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1021	1399	0.038598999	0.020729092	8	oligos	OL-MS-1	49	33	33
CACCACTTCGGCATCG-1_8_H10	-3.002932	10.73831537	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	871	1192	0.015100671	0.021812081	8	oligos	OL-MS-1	49	33	33
CACCAGGAGCTCCCAG-1_8_H10	29.63343146	9.648545029	15DB	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1160	1575	0.033015873	0.062222222	8	15DB	B cells	49	33	33
CACCAGGAGCTTATCG-1_8_H10	-9.316824344	-27.43407435	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1179	1791	0.061976549	0.021217197	8	16	EN-PYR	49	33	33
CACCAGGAGGCATTGG-1_8_H10	-4.974353577	8.671067115	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	910	1290	0.020155039	0.037209302	8	oligos	OL-MS-1	49	33	33
CACCAGGCACCAACCG-1_8_H10	30.45110816	-5.228011048	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3720	8900	0.00494382	0.006292135	8	2	EN-L4	49	33	33
CACCAGGCAGTCTTCC-1_8_H10	7.618456888	18.8013453	1	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1070	1617	0.011131725	0.013605442	8	oligos	OL-Cntl	49	33	33
CACCAGGGTCCTCTTG-1_8_H10	-6.929816111	9.282865864	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	806	1076	0.012081784	0.021375465	8	oligos	OL-MS-1	49	33	33
CACCAGGGTGACAAAT-1_8_H10	20.60298921	-11.97600716	12	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2025	3802	0.065228827	0.006575487	8	12	EN-MIX	49	33	33
CACCAGGGTGCGCTTG-1_8_H10	-7.092051505	9.13145972	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	851	1143	0.009623797	0.033245844	8	oligos	OL-MS-1	49	33	33
CACCAGGGTGTTCTTT-1_8_H10	-4.333126453	8.567210167	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	955	1366	0.016837482	0.019765739	8	oligos	OL-MS-1	49	33	33
CACCTTGAGCCACGTC-1_8_H10	-26.63858139	-4.548176153	9	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1490	2441	0.009422368	0.00450635	8	9	OPC	49	33	33
CACCTTGAGTCCGTAT-1_8_H10	24.38056562	-24.08265462	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2988	6595	0.049431387	0.005761941	8	3	EN-L5-6	49	33	33
CACCTTGAGTTGAGAT-1_8_H10	33.60682995	4.804150751	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1385	2099	0.06622201	0.032396379	8	14	Microglia	49	33	33
CACCTTGCAGCTGGCT-1_8_H10	26.41638196	10.25550666	15A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2028	3499	0.021434696	0.074306945	8	15A	Endo cells	49	33	33
CACCTTGCAGTCGTGC-1_8_H10	-0.803782778	-1.200566317	13B	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1957	3048	0.024278215	0.019028871	8	13B	IN-SV2C	49	33	33
CACCTTGCATATGGTC-1_8_H10	9.926633142	-20.95513795	4	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	6183	18717	0.009189507	0.00609072	8	L2-3	EN-L2-3-MS	49	33	33
CACCTTGTCATTCACT-1_8_H10	31.43119186	-7.145923178	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4782	13309	0.009317004	0.011045157	8	2	EN-L4	49	33	33
CACCTTGTCGTCTGAA-1_8_H10	34.53529501	10.71172972	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	912	1177	0.031435854	0.011894647	8	14	Microglia	49	33	33
CACCTTGTCTTGCCGT-1_8_H10	14.84061794	-4.978943845	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1495	2475	0.029090909	0.010505051	8	3	EN-L5-6	49	33	33
CACTCCAAGACCTTTG-1_8_H10	30.31458712	-7.996562238	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4882	14519	0.015634686	0.005510021	8	2	EN-L4	49	33	33
CACTCCACACACCGAC-1_8_H10	-3.390154875	7.376960223	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1253	1750	0.013714286	0.029142857	8	oligos	OL-MS-1	49	33	33
CACTCCACAGCATGAG-1_8_H10	-10.11783955	27.98427996	17	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	880	1208	0.024834437	0.016556291	8	oligos	OL-MS-2	49	33	33
CACTCCACATACGCTA-1_8_H10	33.57522662	13.39522993	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1188	1655	0.013897281	0.040483384	8	14	Microglia	49	33	33
CACTCCAGTTATGCGT-1_8_H10	-3.83101729	11.78054195	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	862	1166	0.009433962	0.02915952	8	oligos	OL-MS-1	49	33	33
CACTCCATCCCTAACC-1_8_H10	-2.345722844	8.053051597	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1107	1622	0.016646116	0.030826141	8	oligos	OL-MS-1	49	33	33
CACTCCATCGCAAGCC-1_8_H10	-5.304297779	8.77626607	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	849	1198	0.030884808	0.030884808	8	oligos	OL-MS-1	49	33	33
CACTCCATCTGCGACG-1_8_H10	-26.82382023	-1.674875522	9	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1830	3208	0.012157107	0.014027431	8	9	OPC	49	33	33
CAGAATCAGGACAGCT-1_8_H10	-16.9053139	25.33038861	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2103	3514	0.006545248	0.009106431	8	8	Astrocytes	49	33	33
CAGAATCCAGCATACT-1_8_H10	-5.935380922	11.53946906	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	836	1157	0.01642178	0.015557476	8	oligos	OL-MS-1	49	33	33
CAGAATCCATGCAATC-1_8_H10	-3.901681339	10.81192388	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	877	1196	0.011705686	0.025919732	8	oligos	OL-MS-1	49	33	33
CAGAATCGTAAACGCG-1_8_H10	34.08073736	14.46588986	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1161	1632	0.014093137	0.02879902	8	14	Microglia	49	33	33
CAGAATCGTGCACTTA-1_8_H10	17.07608703	-27.27903885	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5347	16819	0.011058921	0.007907723	8	3	EN-L5-6	49	33	33
CAGAATCTCAGGTAAA-1_8_H10	-29.63180172	-0.349101163	9	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2000	3552	0.006193694	0.010698198	8	9	OPC	49	33	33
CAGAATCTCAGTTAGC-1_8_H10	33.64943046	11.54742366	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	995	1341	0.020134228	0.012677107	8	14	Microglia	49	33	33
CAGAGAGAGACTGTAA-1_8_H10	-28.85288782	-11.76485145	9	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	806	1076	0.018587361	0.015799257	8	9	OPC	49	33	33
CAGAGAGCACAAGTAA-1_8_H10	-2.926677802	7.772058067	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1266	1747	0.015455066	0.032054951	8	oligos	OL-MS-1	49	33	33
CAGAGAGCATGCAACT-1_8_H10	8.78594892	1.869046459	12	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	716	1083	0.0710988	0.006463527	8	12	EN-MIX	49	33	33
CAGAGAGGTTCGTGAT-1_8_H10	-7.5574147	7.54512099	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	763	1002	0.0249501	0.066866267	8	oligos	OL-MS-1	49	33	33
CAGAGAGTCAACACGT-1_8_H10	13.27381868	-24.22823311	4	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5130	14586	0.009324009	0.00740436	8	L2-3	EN-L2-3-MS	49	33	33
CAGATCAGTGCCTGGT-1_8_H10	-10.59290135	27.82442498	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1158	1513	0.026437541	0.031064111	8	oligos	OL-MS-1	49	33	33
CAGATCATCGAGAACG-1_8_H10	-3.596092267	-35.37254203	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1053	1460	0.050684932	0.019178082	8	16	EN-PYR	49	33	33
CAGCAGCAGATGGGTC-1_8_H10	-7.439437298	9.106125789	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	787	1028	0.011673152	0.01848249	8	oligos	OL-MS-1	49	33	33
CAGCAGCAGTCCAGGA-1_8_H10	-4.308757401	10.77666848	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	813	1124	0.010676157	0.022241993	8	oligos	OL-MS-1	49	33	33
CAGCAGCCAATGTTGC-1_8_H10	-4.21153258	10.71079896	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	850	1190	0.014285714	0.035294118	8	oligos	OL-MS-1	49	33	33
CAGCAGCCATTGGCGC-1_8_H10	-6.92359557	11.02798597	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	798	1114	0.017953321	0.018850987	8	oligos	OL-MS-1	49	33	33
CAGCAGCGTTACGCGC-1_8_H10	29.45876592	15.45389838	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2373	4372	0.005718207	0.088517841	8	14	Microglia	49	33	33
CAGCAGCTCGGCGGTT-1_8_H10	33.16879292	8.472658769	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1456	2049	0.032210835	0.025378233	8	14	Microglia	49	33	33
CAGCAGCTCGTTACGA-1_8_H10	34.25546886	14.15484852	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1039	1417	0.018348624	0.019760056	8	14	Microglia	49	33	33
CAGCATACACATCCAA-1_8_H10	-7.502623106	9.143992031	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	790	1107	0.014453478	0.016260163	8	oligos	OL-MS-1	49	33	33
CAGCATACACCACGTG-1_8_H10	32.97877507	9.094699646	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	882	1183	0.013524937	0.014370245	8	14	Microglia	49	33	33
CAGCATACACCCTATC-1_8_H10	-21.65359335	-16.18722749	6B	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3162	7250	0.017517241	0.008	8	6B	IN-SST	49	33	33
CAGCATACATCACGTA-1_8_H10	17.30051559	-26.20934242	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5989	19959	0.01072198	0.008818077	8	3	EN-L5-6	49	33	33
CAGCATAGTAAGTGTA-1_8_H10	28.45935379	-19.17381973	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	6947	21907	0.042543479	0.018213356	8	2	EN-L4	49	33	33
CAGCATAGTAGCTAAA-1_8_H10	-3.278411913	-34.67858848	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	736	1020	0.130392157	0.017647059	8	16	EN-PYR	49	33	33
CAGCATAGTCCGAATT-1_8_H10	27.93371507	10.39857738	15DB	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1387	2545	0.011001965	0.195284872	8	15DB	B cells	49	33	33
CAGCATAGTCGGCACT-1_8_H10	-3.246466008	-35.70048405	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1001	1354	0.098966027	0.025849335	8	16	EN-PYR	49	33	33
CAGCATAGTTCGCTAA-1_8_H10	10.09504787	-21.71249455	4	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	6274	19075	0.007653997	0.013735256	8	L2-3	EN-L2-3-MS	49	33	33
CAGCATATCACTGGGC-1_8_H10	-25.40241546	6.978149898	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	790	1072	0.019589552	0.005597015	8	8	Astrocytes	49	33	33
CAGCATATCCCTAATT-1_8_H10	-5.049841354	10.12918006	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	776	1047	0.019102197	0.023877746	8	oligos	OL-MS-1	49	33	33
CAGCATATCCGCGCAA-1_8_H10	-17.94376737	-14.93065695	6B	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2202	3734	0.054097483	0.005891805	8	6B	IN-SST	49	33	33
CAGCATATCCTAGAAC-1_8_H10	-2.880212575	7.897239355	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1159	1719	0.018033741	0.019197208	8	oligos	OL-MS-1	49	33	33
CAGCATATCTCGCATC-1_8_H10	-4.412128796	8.866593736	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	914	1229	0.014646054	0.040683483	8	oligos	OL-MS-1	49	33	33
CAGCCGACACAGCCCA-1_8_H10	34.18693966	-8.690648724	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4716	11942	0.008206331	0.012728186	8	2	EN-L4	49	33	33
CAGCCGACACCGATAT-1_8_H10	-1.935662732	8.655080923	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1136	1702	0.019976498	0.012338425	8	oligos	OL-MS-1	49	33	33
CAGCCGACAGTAAGAT-1_8_H10	-7.211651345	6.847501925	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	916	1184	0.024493243	0.043918919	8	oligos	OL-MS-1	49	33	33
CAGCCGAGTCTTCAAG-1_8_H10	-3.239977607	10.48675668	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	905	1256	0.042197452	0.021496815	8	oligos	OL-MS-1	49	33	33
CAGCCGATCGCAGGCT-1_8_H10	10.86552383	-2.253720251	12	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1466	2510	0.060159363	0.009163347	8	12	EN-MIX	49	33	33
CAGCCGATCGTCTGAA-1_8_H10	-5.894737949	15.67625096	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	804	1118	0.017889088	0.009838998	8	oligos	OL-MS-1	49	33	33
CAGCCGATCTATGTGG-1_8_H10	24.44080903	-18.99208767	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5561	16278	0.043555719	0.010566409	8	3	EN-L5-6	49	33	33
CAGCCGATCTGTCAAG-1_8_H10	-0.04710263	10.83228257	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1087	1661	0.008428657	0.018663456	8	oligos	OL-MS-1	49	33	33
CAGCGACAGACAAGCC-1_8_H10	25.4738863	10.2095984	15A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3132	6053	0.020320502	0.044440773	8	15A	Endo cells	49	33	33
CAGCGACCACCGCTAG-1_8_H10	-1.941821293	9.189384576	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1160	1665	0.019219219	0.013813814	8	oligos	OL-MS-1	49	33	33
CAGCGACCACTTCTGC-1_8_H10	32.02831691	14.62016064	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1377	2095	0.012887828	0.050119332	8	14	Microglia	49	33	33
CAGCGACGTCGCATAT-1_8_H10	-7.188419631	7.760717326	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	808	1036	0.027027027	0.053088803	8	oligos	OL-MS-1	49	33	33
CAGCGACGTGTGAAAT-1_8_H10	-0.524087973	9.997215458	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1096	1572	0.007633588	0.017811705	8	oligos	OL-MS-1	49	33	33
CAGCGACTCACAGTAC-1_8_H10	31.2193764	12.83650401	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1057	1417	0.033168666	0.050105857	8	14	Microglia	49	33	33
CAGCGACTCATAAAGG-1_8_H10	-4.355030933	-37.58613579	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1094	1664	0.103966346	0.045072115	8	16	EN-PYR	49	33	33
CAGCGACTCGTCTGCT-1_8_H10	24.72034681	-16.73235356	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	7641	27418	0.03417463	0.012035889	8	3	EN-L5-6	49	33	33
CAGCTAAAGTGTACCT-1_8_H10	18.23421708	-24.64246848	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	6661	20961	0.010829636	0.007680931	8	3	EN-L5-6	49	33	33
CAGCTAACAAGTCTAC-1_8_H10	17.05586818	-28.80605515	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5845	19091	0.010109476	0.006757111	8	3	EN-L5-6	49	33	33
CAGCTAACAGCATACT-1_8_H10	-3.001730152	-34.69065127	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	867	1093	0.048490393	0.022872827	8	16	EN-PYR	49	33	33
CAGCTAACAGGACGTA-1_8_H10	-0.424209191	7.654237884	1	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1962	3586	0.008087005	0.016731735	8	oligos	OL-Cntl	49	33	33
CAGCTAAGTACAGCAG-1_8_H10	24.50729107	-19.91135753	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5702	16218	0.024293994	0.008694044	8	3	EN-L5-6	49	33	33
CAGCTAAGTAGCCTCG-1_8_H10	34.43862255	-13.00370614	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3985	8334	0.019438445	0.011399088	8	2	EN-L4	49	33	33
CAGCTAATCACTCTTA-1_8_H10	33.90956511	-14.60489513	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3565	7547	0.019080429	0.013912813	8	2	EN-L4	49	33	33
CAGCTAATCTTGTCAT-1_8_H10	18.24236798	-24.67092098	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	6800	22661	0.009840695	0.006486916	8	3	EN-L5-6	49	33	33
CAGCTGGAGGCTAGCA-1_8_H10	20.86544342	-17.67198906	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5804	16897	0.024915666	0.012309877	8	3	EN-L5-6	49	33	33
CAGCTGGCATCGATGT-1_8_H10	35.13707237	-9.630793723	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5448	14400	0.010069444	0.013402778	8	2	EN-L4	49	33	33
CAGCTGGCATGCAACT-1_8_H10	36.84958063	14.62615875	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1393	2102	0.008563273	0.011893435	8	14	Microglia	49	33	33
CAGCTGGGTAGCACGA-1_8_H10	-5.647218754	9.984706794	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	883	1189	0.03195963	0.020185029	8	oligos	OL-MS-1	49	33	33
CAGCTGGGTAGTACCT-1_8_H10	31.82222675	-17.0262857	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5318	13770	0.033333333	0.015831518	8	2	EN-L4	49	33	33
CAGGTGCAGATGCCAG-1_8_H10	21.50154857	-22.87438906	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4255	9995	0.011005503	0.012606303	8	3	EN-L5-6	49	33	33
CAGGTGCCAATCACAC-1_8_H10	-7.554954186	7.843486323	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	816	1065	0.016901408	0.023474178	8	oligos	OL-MS-1	49	33	33
CAGGTGCCAGTCTTCC-1_8_H10	29.87059916	9.256894782	15DA	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	823	1113	0.014375562	0.023360288	8	15DA	T cells	49	33	33
CAGGTGCGTCATCGGC-1_8_H10	25.68333337	10.53921291	15A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3452	7429	0.024767802	0.071611253	8	15A	Endo cells	49	33	33
CAGGTGCTCACAACGT-1_8_H10	-5.687694471	-33.69445913	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	926	1353	0.129342203	0.017738359	8	16	EN-PYR	49	33	33
CAGTCCTCAACTGCTA-1_8_H10	-5.31601631	8.020275518	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	941	1278	0.024256651	0.042253521	8	oligos	OL-MS-1	49	33	33
CAGTCCTCAATAGCGG-1_8_H10	-5.583119224	9.697491512	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	765	1062	0.019774011	0.016007533	8	oligos	OL-MS-1	49	33	33
CAGTCCTCAGAGCCAA-1_8_H10	-4.685190017	10.57049961	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	766	1037	0.004821601	0.027000964	8	oligos	OL-MS-1	49	33	33
CATATGGAGGAATTAC-1_8_H10	-6.683386335	9.042032666	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	795	1034	0.006769826	0.025145068	8	oligos	OL-MS-1	49	33	33
CATATGGCAAACCTAC-1_8_H10	11.71492203	-0.888293759	12	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1219	1934	0.014477766	0.008273009	8	12	EN-MIX	49	33	33
CATATGGGTCCAAGTT-1_8_H10	24.13276478	-10.56412698	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5129	14170	0.00910374	0.005222301	8	3	EN-L5-6	49	33	33
CATATGGGTGGCCCTA-1_8_H10	29.7500742	9.411337428	15DA	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	829	1095	0.029223744	0.042009132	8	15DA	T cells	49	33	33
CATATGGTCGGAGGTA-1_8_H10	-17.5134077	24.47874746	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1677	2834	0.010585745	0.011997177	8	8	Astrocytes	49	33	33
CATATTCAGATCGGGT-1_8_H10	31.88174832	13.36949045	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1124	1479	0.017579446	0.039215686	8	14	Microglia	49	33	33
CATATTCAGGATGCGT-1_8_H10	23.03982484	-16.1461022	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	6027	18067	0.029944097	0.016660209	8	3	EN-L5-6	49	33	33
CATATTCAGTGGTAGC-1_8_H10	12.77606826	-24.44783993	4	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5042	13046	0.006285451	0.01119117	8	L2-3	EN-L2-3-MS	49	33	33
CATATTCGTATATCCG-1_8_H10	-1.581252618	9.177868945	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	978	1450	0.008965517	0.015862069	8	oligos	OL-MS-1	49	33	33
CATATTCGTCTCCCTA-1_8_H10	26.0758986	7.380722117	15A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1426	2368	0.006756757	0.02027027	8	15A	Endo cells	49	33	33
CATATTCGTGCTCTTC-1_8_H10	-5.610307857	-37.70089378	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1122	1545	0.066019417	0.026537217	8	16	EN-PYR	49	33	33
CATATTCTCGCACTCT-1_8_H10	24.84852758	-22.56262701	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5472	16279	0.032925855	0.006020026	8	3	EN-L5-6	49	33	33
CATCAAGAGGGTTCCC-1_8_H10	-8.357462395	7.187561178	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1026	1558	0.010911425	0.026315789	8	oligos	OL-MS-1	49	33	33
CATCAAGCATCTGGTA-1_8_H10	19.5982567	-22.5230739	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	6213	18954	0.021578559	0.014350533	8	3	EN-L5-6	49	33	33
CATCAAGCATGGAATA-1_8_H10	1.563240624	-23.03706588	4	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4317	12221	0.013746829	0.004173145	8	L2-3	EN-L2-3-MS	49	33	33
CATCAAGCATTAGGCT-1_8_H10	-19.12081585	-7.408616243	13B	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3836	8507	0.04196544	0.00940402	8	13B	IN-SV2C	49	33	33
CATCAAGTCCACGAAT-1_8_H10	25.76322083	10.6029237	15A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3335	7401	0.016754493	0.119443318	8	15A	Endo cells	49	33	33
CATCAAGTCTCCTATA-1_8_H10	-0.864160829	7.750791732	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1417	2238	0.008042895	0.021447721	8	oligos	OL-MS-1	49	33	33
CATCAGACACCAGCAC-1_8_H10	25.68496897	10.32536399	15A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2596	4519	0.020137198	0.048683337	8	15A	Endo cells	49	33	33
CATCAGACACGACGAA-1_8_H10	-26.44092987	-2.221528985	9	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1379	1939	0.02062919	0.04228984	8	9	OPC	49	33	33
CATCAGACACTTCGAA-1_8_H10	0.810206154	10.80487217	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1126	1687	0.014226437	0.013040901	8	oligos	OL-MS-1	49	33	33
CATCAGACAGTCGATT-1_8_H10	35.18424567	-9.495100067	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5988	16741	0.009617108	0.020548354	8	2	EN-L4	49	33	33
CATCAGAGTAAGAGAG-1_8_H10	28.65095179	10.20394251	15DB	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	996	1427	0.007708479	0.144358795	8	15DB	B cells	49	33	33
CATCAGAGTGGTCTCG-1_8_H10	-7.474201179	7.838097717	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	806	1047	0.011461318	0.042024833	8	oligos	OL-MS-1	49	33	33
CATCAGAGTTCTGGTA-1_8_H10	-17.84017243	23.7399167	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1471	2517	0.010329758	0.009932459	8	8	Astrocytes	49	33	33
CATCCACAGGCTAGAC-1_8_H10	30.97328743	-7.055720025	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4129	11161	0.012006093	0.006899023	8	2	EN-L4	49	33	33
CATCCACAGGCTCTTA-1_8_H10	27.72527334	-5.80294765	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4316	12252	0.004978779	0.003917728	8	2	EN-L4	49	33	33
CATCCACCAGTAAGAT-1_8_H10	-2.436253278	10.11060286	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	961	1337	0.012715034	0.024682124	8	oligos	OL-MS-1	49	33	33
CATCCACTCCTCAATT-1_8_H10	-3.776106951	10.24435181	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	892	1224	0.016339869	0.02124183	8	oligos	OL-MS-1	49	33	33
CATCGAACAACAACCT-1_8_H10	-17.0868637	7.371723076	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	965	1309	0.012223071	0.016806723	8	8	Astrocytes	49	33	33
CATCGAACACGACTCG-1_8_H10	-24.92130736	10.4242024	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	946	1336	0.013473054	0.014221557	8	8	Astrocytes	49	33	33
CATCGAACATGAAGTA-1_8_H10	18.08311014	-25.03545267	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5414	15425	0.0073906	0.01089141	8	3	EN-L5-6	49	33	33
CATCGGGCACAGGTTT-1_8_H10	-12.19999889	-3.414200718	13A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2251	3940	0.015482234	0.006345178	8	13A	IN-VIP	49	33	33
CATCGGGCACCTGGTG-1_8_H10	-1.506297455	10.56349004	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	879	1266	0.011058452	0.017377567	8	oligos	OL-MS-1	49	33	33
CATCGGGGTCCGTTAA-1_8_H10	34.03238207	10.84350618	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	928	1406	0.019203414	0.014935989	8	14	Microglia	49	33	33
CATCGGGGTCGGATCC-1_8_H10	9.267244392	1.815087196	12	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	780	1142	0.021891419	0.008756567	8	12	EN-MIX	49	33	33
CATCGGGTCTTCAACT-1_8_H10	28.88846587	-12.18222685	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	6556	21695	0.018760083	0.010094492	8	3	EN-L5-6	49	33	33
CATGACAAGAATAGGG-1_8_H10	25.962386	10.33490145	15A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2304	3918	0.012761613	0.058448188	8	15A	Endo cells	49	33	33
CATGACAAGACTAGGC-1_8_H10	-17.31701233	16.09595909	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1304	1962	0.009174312	0.011722732	8	8	Astrocytes	49	33	33
CATGACAAGGAGTTGC-1_8_H10	-24.9287642	-0.33185381	9	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1693	2709	0.008859358	0.021410114	8	9	OPC	49	33	33
CATGACAAGGATATAC-1_8_H10	32.75655334	8.862423277	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	919	1231	0.018683997	0.014622258	8	14	Microglia	49	33	33
CATGACAAGTACTTGC-1_8_H10	-3.213862267	12.13988346	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	887	1285	0.010116732	0.031128405	8	oligos	OL-MS-1	49	33	33
CATGACAGTGCACCAC-1_8_H10	10.60611452	-0.957788403	12	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1379	2156	0.034786642	0.013914657	8	12	EN-MIX	49	33	33
CATGCCTAGTTGTAGA-1_8_H10	-4.213570005	17.15668375	1	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	771	1070	0.009345794	0.01588785	8	oligos	OL-Cntl	49	33	33
CATGCCTCAAGAAGAG-1_8_H10	-5.86021202	9.613452873	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	771	1044	0.018199234	0.031609195	8	oligos	OL-MS-1	49	33	33
CATGCCTCATGCTAGT-1_8_H10	-6.850710939	7.336458057	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	839	1095	0.033789954	0.034703196	8	oligos	OL-MS-1	49	33	33
CATGCCTGTAGGAGTC-1_8_H10	-4.801838517	8.865031417	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	843	1154	0.028596187	0.045060659	8	oligos	OL-MS-1	49	33	33
CATGCCTGTCTACCTC-1_8_H10	-15.62322942	14.74942408	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1860	3146	0.007946599	0.006039415	8	8	Astrocytes	49	33	33
CATGGCGAGATGTGTA-1_8_H10	-7.335024898	7.566253366	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	877	1206	0.009121061	0.035655058	8	oligos	OL-MS-1	49	33	33
CATGGCGAGCCACGTC-1_8_H10	12.31077292	-24.69125473	4	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	6446	21461	0.003541307	0.005964307	8	L2-3	EN-L2-3-MS	49	33	33
CATGGCGCAAACAACA-1_8_H10	-6.762869807	9.679595068	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	858	1179	0.025445293	0.021204411	8	oligos	OL-MS-1	49	33	33
CATGGCGCAAGCCTAT-1_8_H10	-2.717336659	11.04667874	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	962	1372	0.008017493	0.014577259	8	oligos	OL-MS-1	49	33	33
CATGGCGCATAGACTC-1_8_H10	34.50573338	12.69595689	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1115	1546	0.014877102	0.014230272	8	14	Microglia	49	33	33
CATGGCGTCAGCTCGG-1_8_H10	24.86433459	-20.70291422	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4231	11114	0.058484794	0.005668526	8	3	EN-L5-6	49	33	33
CATGGCGTCATCTGTT-1_8_H10	-5.277509855	9.604260546	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	883	1228	0.005700326	0.021172638	8	oligos	OL-MS-1	49	33	33
CATGGCGTCGAATGGG-1_8_H10	-28.09430513	-22.41269292	6A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4438	10164	0.026564345	0.012298308	8	6A	IN-PV	49	33	33
CATTATCAGAGTCTGG-1_8_H10	-18.31046765	-0.410798745	13A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3503	6981	0.01203266	0.025927518	8	13A	IN-VIP	49	33	33
CATTATCCAAAGTCAA-1_8_H10	-0.891571837	9.103593819	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1276	2070	0.012560386	0.01352657	8	oligos	OL-MS-1	49	33	33
CATTATCGTACAGACG-1_8_H10	-0.8845387	7.327146194	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2097	3425	0.03620438	0.034452555	8	oligos	OL-MS-1	49	33	33
CATTATCGTGATAAGT-1_8_H10	24.81898613	-20.64723105	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4361	10500	0.045142857	0.005047619	8	3	EN-L5-6	49	33	33
CATTATCTCCAAACTG-1_8_H10	-23.46092081	-25.17214061	6A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3655	8469	0.005431574	0.010036604	8	6A	IN-PV	49	33	33
CATTCGCAGTCTCAAC-1_8_H10	28.55538114	10.36418546	15DB	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1395	2152	0.017193309	0.097583643	8	15DB	B cells	49	33	33
CATTCGCGTCATATGC-1_8_H10	20.97112965	-22.80319549	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4256	9628	0.015891151	0.009347736	8	3	EN-L5-6	49	33	33
CATTCGCGTTTGACTG-1_8_H10	15.37567484	-22.18147089	4	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5616	16042	0.009537464	0.008851764	8	L2-3	EN-L2-3-MS	49	33	33
CCAATCCAGGTGATTA-1_8_H10	-3.978426736	9.333574199	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	954	1391	0.01581596	0.019410496	8	oligos	OL-MS-1	49	33	33
CCAATCCCAAAGTCAA-1_8_H10	-1.182306963	9.099588262	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1149	1683	0.011883541	0.013666072	8	oligos	OL-MS-1	49	33	33
CCAATCCCACTGTTAG-1_8_H10	32.17561305	13.86168697	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2066	3277	0.017088801	0.037839487	8	14	Microglia	49	33	33
CCAATCCCATGTAAGA-1_8_H10	24.28829745	-26.15255293	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3148	6726	0.01382694	0.00416295	8	3	EN-L5-6	49	33	33
CCAATCCTCACCGGGT-1_8_H10	-0.146590008	8.229221401	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1394	2216	0.009476534	0.028429603	8	oligos	OL-MS-1	49	33	33
CCAATCCTCAGCTCGG-1_8_H10	-20.54688087	8.930538095	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	959	1413	0.013446568	0.004953999	8	8	Astrocytes	49	33	33
CCAATCCTCGATAGAA-1_8_H10	19.13715738	-23.98754991	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	7383	24549	0.00562141	0.012138987	8	3	EN-L5-6	49	33	33
CCACCTAAGACTGGGT-1_8_H10	22.1794709	-22.69274147	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4096	10911	0.030153057	0.006598845	8	3	EN-L5-6	49	33	33
CCACCTAAGGCTCATT-1_8_H10	-14.51102581	-38.20235532	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3110	6214	0.042645639	0.034599292	8	16	EN-PYR	49	33	33
CCACCTATCACAGTAC-1_8_H10	-0.341914152	9.460798928	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1214	1811	0.00993926	0.016565433	8	oligos	OL-MS-1	49	33	33
CCACCTATCGTAGGTT-1_8_H10	-6.105007189	16.48877995	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	770	1077	0.018570102	0.015784587	8	oligos	OL-MS-1	49	33	33
CCACGGACATTCTTAC-1_8_H10	-7.606645318	8.008187615	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	810	1083	0.024007387	0.020313943	8	oligos	OL-MS-1	49	33	33
CCACGGACATTGGGCC-1_8_H10	25.67992244	10.61472449	15A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5452	15063	0.022040762	0.138086703	8	15A	Endo cells	49	33	33
CCACGGACATTTCACT-1_8_H10	26.20230035	8.6995715	15A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1613	2287	0.028858767	0.038478356	8	15A	Endo cells	49	33	33
CCACTACCAGTCCTTC-1_8_H10	32.67440169	13.35631342	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1310	1915	0.013577023	0.036553525	8	14	Microglia	49	33	33
CCACTACGTATAGGGC-1_8_H10	27.42583415	9.113381955	15A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1262	1825	0.018630137	0.052054795	8	15A	Endo cells	49	33	33
CCACTACGTCTTGATG-1_8_H10	29.51956282	15.26384721	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1888	3151	0.013963821	0.104411298	8	14	Microglia	49	33	33
CCACTACGTTAGGGTG-1_8_H10	18.44857258	-10.44912763	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2159	3689	0.024396856	0.015180266	8	3	EN-L5-6	49	33	33
CCACTACTCTCATTCA-1_8_H10	31.29676605	12.53524697	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1391	2032	0.027066929	0.034940945	8	14	Microglia	49	33	33
CCAGCGAAGCATCATC-1_8_H10	29.67195274	-7.051696357	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5968	19280	0.008039419	0.007209544	8	2	EN-L4	49	33	33
CCAGCGAAGTGAAGTT-1_8_H10	30.71900391	-7.623898666	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	6378	19383	0.005520301	0.012175618	8	2	EN-L4	49	33	33
CCAGCGACACTTACGA-1_8_H10	29.85000021	13.83487995	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1141	1647	0.024286582	0.074074074	8	14	Microglia	49	33	33
CCAGCGACAGATAATG-1_8_H10	-30.25327179	2.764449531	9	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3046	5774	0.006234846	0.009698649	8	9	OPC	49	33	33
CCAGCGAGTCAAAGAT-1_8_H10	7.906639476	1.341161809	12	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	913	1414	0.02970297	0.024045262	8	12	EN-MIX	49	33	33
CCAGCGAGTGAAATCA-1_8_H10	-25.07505445	-0.501662494	9	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1605	2482	0.005237712	0.01813054	8	9	OPC	49	33	33
CCAGCGAGTGTGCGTC-1_8_H10	-27.56278957	-5.150385892	9	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1237	1888	0.010063559	0.015360169	8	9	OPC	49	33	33
CCAGCGATCGAGGTAG-1_8_H10	29.61075383	6.31742753	15DA	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	772	1074	0.008379888	0.079143389	8	15DA	T cells	49	33	33
CCATGTCAGGGTCTCC-1_8_H10	3.697361063	11.8536122	1	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1057	1541	0.005840363	0.013627515	8	oligos	OL-Cntl	49	33	33
CCATGTCAGTCTCAAC-1_8_H10	29.91384794	14.13322411	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1193	1729	0.022556391	0.083285136	8	14	Microglia	49	33	33
CCATGTCAGTGTGAAT-1_8_H10	-11.64360035	-38.40520236	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1573	2493	0.074608905	0.023265142	8	16	EN-PYR	49	33	33
CCATGTCCACCCATGG-1_8_H10	36.76801779	13.94835008	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1120	1568	0.008290816	0.010841837	8	14	Microglia	49	33	33
CCATGTCCAGGGATTG-1_8_H10	34.99980749	-8.938490264	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4395	9874	0.006076565	0.011545473	8	2	EN-L4	49	33	33
CCATGTCTCCTTTCGG-1_8_H10	28.8108995	9.998796141	15DB	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	902	1276	0.067398119	0.105799373	8	15DB	B cells	49	33	33
CCATTCGCACCAGCAC-1_8_H10	-11.23221819	17.43605761	11	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2330	3909	0.004348938	0.009976976	8	11	Glia-MIX	49	33	33
CCATTCGGTACTCTCC-1_8_H10	-6.079401064	11.26724399	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	877	1208	0.040562914	0.019039735	8	oligos	OL-MS-1	49	33	33
CCATTCGGTTCTGTTT-1_8_H10	25.29607506	-27.32617878	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4911	14101	0.004467768	0.004042267	8	3	EN-L5-6	49	33	33
CCATTCGTCACCGTAA-1_8_H10	-5.22211366	8.679928112	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	914	1325	0.009811321	0.035471698	8	oligos	OL-MS-1	49	33	33
CCATTCGTCCGAAGAG-1_8_H10	5.359190755	11.5643777	1	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1186	1709	0.008191925	0.013458163	8	oligos	OL-Cntl	49	33	33
CCCAATCAGATCCTGT-1_8_H10	-28.25368142	-1.731962581	9	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1674	2777	0.014404033	0.010803025	8	9	OPC	49	33	33
CCCAATCAGCCATCGC-1_8_H10	28.91938545	7.212685919	15DA	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	991	1408	0.153409091	0.050426136	8	15DA	T cells	49	33	33
CCCAATCAGTAGTGCG-1_8_H10	-21.83359837	8.290435555	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	799	1096	0.020072993	0.010948905	8	8	Astrocytes	49	33	33
CCCAATCCAGAGTGTG-1_8_H10	-3.432186952	10.25330112	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	923	1355	0.010332103	0.023616236	8	oligos	OL-MS-1	49	33	33
CCCAATCTCCGTAGTA-1_8_H10	-1.594554073	9.335533495	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1128	1596	0.011904762	0.016917293	8	oligos	OL-MS-1	49	33	33
CCCAATCTCCTTTCTC-1_8_H10	-3.255634415	10.16322569	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	949	1374	0.012372635	0.018195051	8	oligos	OL-MS-1	49	33	33
CCCAGTTAGGATATAC-1_8_H10	-5.781870464	9.821125152	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	825	1140	0.012280702	0.026315789	8	oligos	OL-MS-1	49	33	33
CCCAGTTCATCGGACC-1_8_H10	18.08199925	-24.8640415	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	6173	20225	0.009295426	0.011223733	8	3	EN-L5-6	49	33	33
CCCAGTTTCCGCGCAA-1_8_H10	-10.29381888	-32.88857975	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1266	1919	0.113079729	0.013027619	8	16	EN-PYR	49	33	33
CCCAGTTTCCGTCATC-1_8_H10	28.57492753	11.33991965	15DB	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1998	3532	0.010475651	0.098244621	8	15DB	B cells	49	33	33
CCCAGTTTCTAACTGG-1_8_H10	-30.19427891	-22.1139692	6A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	6069	16373	0.013375679	0.01447505	8	6A	IN-PV	49	33	33
CCCAGTTTCTGCTGCT-1_8_H10	-7.163509824	7.411278841	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	931	1218	0.026272578	0.040229885	8	oligos	OL-MS-1	49	33	33
CCCATACTCGCGTTTC-1_8_H10	31.67037567	-18.66623545	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5762	13936	0.01880023	0.019302526	8	2	EN-L4	49	33	33
CCCTCCTAGGGTTCCC-1_8_H10	34.74723303	-7.676063902	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5205	15112	0.008337745	0.005227634	8	2	EN-L4	49	33	33
CCCTCCTCAAGCCATT-1_8_H10	15.30618041	-22.20049618	4	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5843	17714	0.021508411	0.008242068	8	L2-3	EN-L2-3-MS	49	33	33
CCCTCCTGTACGACCC-1_8_H10	-3.609666009	8.505587985	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1055	1503	0.008649368	0.017964072	8	oligos	OL-MS-1	49	33	33
CCCTCCTTCAAAGACA-1_8_H10	7.718827309	-1.262898036	12	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	959	1358	0.024300442	0.013254786	8	12	EN-MIX	49	33	33
CCCTCCTTCCAGTAGT-1_8_H10	-17.51682457	1.429033031	13A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4029	9315	0.007085346	0.023188406	8	13A	IN-VIP	49	33	33
CCGGGATAGGAGCGTT-1_8_H10	34.50654314	13.41385005	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	999	1418	0.014104372	0.014104372	8	14	Microglia	49	33	33
CCGGGATAGGAGTTGC-1_8_H10	-1.55891855	8.743271358	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1137	1632	0.021446078	0.015318627	8	oligos	OL-MS-1	49	33	33
CCGGGATAGGTGGGTT-1_8_H10	25.29826809	10.01025869	15DB	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3989	9934	0.028991343	0.095631166	8	15DB	B cells	49	33	33
CCGGGATCAAACCCAT-1_8_H10	25.73725342	3.585956039	15DA	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	851	1188	0.005892256	0.008417508	8	15DA	T cells	49	33	33
CCGGGATCAATAGCGG-1_8_H10	-18.10265679	25.19058652	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1662	2682	0.004847129	0.010812826	8	8	Astrocytes	49	33	33
CCGGGATCACCAGTTA-1_8_H10	-22.71517248	8.889959328	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1324	1998	0.030530531	0.005505506	8	8	Astrocytes	49	33	33
CCGGGATGTAAGAGGA-1_8_H10	19.83483271	-3.846104645	12	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1843	3145	0.068044515	0.009856916	8	12	EN-MIX	49	33	33
CCGGGATGTATTCGTG-1_8_H10	-15.88849775	13.50026368	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1537	2537	0.006700828	0.010248325	8	8	Astrocytes	49	33	33
CCGGGATGTGTGGTTT-1_8_H10	23.30679849	-17.31191724	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5866	17374	0.057211926	0.008691148	8	3	EN-L5-6	49	33	33
CCGGGATTCCCTAATT-1_8_H10	-3.290891958	-36.30506909	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	788	1076	0.098513011	0.026022305	8	16	EN-PYR	49	33	33
CCGGGATTCCGCGTTT-1_8_H10	-6.069612403	6.903772221	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1111	1692	0.013593381	0.01713948	8	oligos	OL-MS-1	49	33	33
CCGGGATTCCGTCAAA-1_8_H10	-1.644908811	9.911231116	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1071	1644	0.018856448	0.022506083	8	oligos	OL-MS-1	49	33	33
CCGGTAGAGATGTAAC-1_8_H10	-25.82840862	-7.725934897	9	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1072	1553	0.016097875	0.00515132	8	9	OPC	49	33	33
CCGGTAGAGTCAAGCG-1_8_H10	-15.84103293	0.448756849	13A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2965	5732	0.00645499	0.02110956	8	13A	IN-VIP	49	33	33
CCGGTAGGTCTCCACT-1_8_H10	-4.464010645	17.38636888	1	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	858	1244	0.009646302	0.010450161	8	oligos	OL-Cntl	49	33	33
CCGGTAGGTGGTCTCG-1_8_H10	30.54958718	-18.95632141	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	8727	35743	0.033628962	0.018688974	8	2	EN-L4	49	33	33
CCGGTAGTCACAAACC-1_8_H10	19.34265673	-23.65400904	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	8299	33005	0.026268747	0.010816543	8	3	EN-L5-6	49	33	33
CCGGTAGTCCTTGACC-1_8_H10	-4.070810956	7.256402703	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1183	1704	0.01056338	0.056338028	8	oligos	OL-MS-1	49	33	33
CCGGTAGTCTGCGACG-1_8_H10	23.83930189	7.699579719	15A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1986	3129	0.015020773	0.033876638	8	15A	Endo cells	49	33	33
CCGTACTAGTCTTGCA-1_8_H10	7.214660892	-29.13981153	10	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5043	15411	0.009343975	0.004736876	8	L2-3	EN-L2-3-Cntl	49	33	33
CCGTACTGTAGGCTGA-1_8_H10	-11.95115523	17.71762507	11	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1874	3078	0.009096816	0.009746589	8	11	Glia-MIX	49	33	33
CCGTACTTCTCTGAGA-1_8_H10	-2.094406534	10.56678223	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1011	1410	0.009219858	0.010638298	8	oligos	OL-MS-1	49	33	33
CCGTGGAAGATCGATA-1_8_H10	-9.925181457	12.66425908	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1336	1850	0.004324324	0.016216216	8	oligos	OL-MS-1	49	33	33
CCGTGGAAGCTAGTCT-1_8_H10	-17.27866024	6.193167285	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1107	1699	0.01177163	0.005297234	8	8	Astrocytes	49	33	33
CCGTGGAAGTACTTGC-1_8_H10	-9.486128082	-5.482383552	13A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1664	2954	0.023358158	0.005754909	8	13A	IN-VIP	49	33	33
CCGTGGAAGTCTCAAC-1_8_H10	10.03152894	-21.68606502	4	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5844	17016	0.007639868	0.012987776	8	L2-3	EN-L2-3-MS	49	33	33
CCGTGGACACAGACTT-1_8_H10	31.90003848	13.31827481	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1189	1706	0.016998828	0.038686987	8	14	Microglia	49	33	33
CCGTGGACACCAACCG-1_8_H10	9.888288211	-22.02261731	4	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	6718	21433	0.004852331	0.01255074	8	L2-3	EN-L2-3-MS	49	33	33
CCGTGGACAGATAATG-1_8_H10	25.64339179	10.23828643	15A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2402	4026	0.012916046	0.044461003	8	15A	Endo cells	49	33	33
CCGTGGACAGCAGTTT-1_8_H10	-9.63606624	-15.19535909	6B	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1018	1587	0.080655325	0.011972275	8	6B	IN-SST	49	33	33
CCGTGGACATGGATGG-1_8_H10	32.00267429	13.62546312	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1456	2363	0.025391452	0.036394414	8	14	Microglia	49	33	33
CCGTGGAGTAGAGCTG-1_8_H10	33.84341593	13.69359398	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1002	1368	0.010233918	0.02119883	8	14	Microglia	49	33	33
CCGTGGATCCCGACTT-1_8_H10	-3.8682007	17.27689567	1	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	816	1132	0.008833922	0.015017668	8	oligos	OL-Cntl	49	33	33
CCGTGGATCTTATCTG-1_8_H10	-17.48422465	7.516002775	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	873	1142	0.019264448	0.010507881	8	8	Astrocytes	49	33	33
CCGTTCAAGGATTCGG-1_8_H10	-28.45636106	-1.539455429	9	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1717	2776	0.017651297	0.009005764	8	9	OPC	49	33	33
CCGTTCAAGTCCGTAT-1_8_H10	-11.38429167	-38.52821427	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1685	2887	0.09560097	0.029442328	8	16	EN-PYR	49	33	33
CCGTTCAAGTGAACAT-1_8_H10	7.805453282	9.958735185	1	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1231	1925	0.012467532	0.01038961	8	oligos	OL-Cntl	49	33	33
CCGTTCAAGTGATCGG-1_8_H10	-29.5207555	-1.790524981	9	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1357	2103	0.00808369	0.005706134	8	9	OPC	49	33	33
CCGTTCACAACACGCC-1_8_H10	25.23035525	9.861799127	15A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3089	5619	0.017262858	0.042890194	8	15A	Endo cells	49	33	33
CCGTTCACATCTCGCT-1_8_H10	-27.70811178	-21.18385894	6A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3313	6862	0.024919848	0.011804139	8	6A	IN-PV	49	33	33
CCGTTCACATGGTAGG-1_8_H10	-28.6510144	-5.750341568	9	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1205	1860	0.03655914	0.010752688	8	9	OPC	49	33	33
CCGTTCAGTGCTGTAT-1_8_H10	27.61565124	-12.18870232	4	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5653	17084	0.035471786	0.007199719	8	L2-3	EN-L2-3-MS	49	33	33
CCGTTCAGTTTGTGTG-1_8_H10	-7.437714961	9.069231926	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	850	1145	0.016593886	0.013973799	8	oligos	OL-MS-1	49	33	33
CCGTTCATCCGCTGTT-1_8_H10	-5.537779594	11.00817366	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	754	1000	0.02	0.013	8	oligos	OL-MS-1	49	33	33
CCGTTCATCCTCATTA-1_8_H10	31.80738915	-7.743702791	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4940	13624	0.005798591	0.00645919	8	2	EN-L4	49	33	33
CCTAAAGCAAAGAATC-1_8_H10	-7.059150916	6.910834362	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	984	1311	0.01754386	0.043478261	8	oligos	OL-MS-1	49	33	33
CCTAAAGCACACATGT-1_8_H10	-6.806751671	6.59817383	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1330	1828	0.024617068	0.030634573	8	oligos	OL-MS-1	49	33	33
CCTAAAGCATGGGACA-1_8_H10	-19.61808144	-1.021764558	13A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5566	13066	0.010102556	0.015230369	8	13A	IN-VIP	49	33	33
CCTAAAGGTAGGGACT-1_8_H10	32.2967815	14.01715452	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1477	2097	0.018121125	0.036242251	8	14	Microglia	49	33	33
CCTAAAGGTGCGAAAC-1_8_H10	2.353528385	-19.34905252	4	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3231	7185	0.010160056	0.007654836	8	L2-3	EN-L2-3-MS	49	33	33
CCTACACAGATAGCAT-1_8_H10	-4.546795477	7.740272795	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1114	1581	0.030360531	0.02340291	8	oligos	OL-MS-1	49	33	33
CCTACACCACCGAATT-1_8_H10	-5.276507178	-36.45627482	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	941	1294	0.044049459	0.018547141	8	16	EN-PYR	49	33	33
CCTACACCAGCTGTAT-1_8_H10	5.435633517	-22.53696892	4	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4748	13021	0.004531142	0.007526304	8	L2-3	EN-L2-3-MS	49	33	33
CCTACACCATCTACGA-1_8_H10	-4.407709175	9.180590481	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1002	1472	0.048913043	0.02173913	8	oligos	OL-MS-1	49	33	33
CCTACACTCCGTTGTC-1_8_H10	29.94062831	8.989019839	15DB	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	823	1143	0.026246719	0.020997375	8	15DB	B cells	49	33	33
CCTACCAAGCTGCGAA-1_8_H10	-28.31696811	0.623856733	9	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2099	3475	0.002877698	0.017266187	8	9	OPC	49	33	33
CCTACCAAGTGGTAAT-1_8_H10	-5.663562532	6.444096122	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1355	1939	0.010314595	0.044352759	8	oligos	OL-MS-1	49	33	33
CCTACCACAATCACAC-1_8_H10	29.89763462	9.275977668	15DA	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	886	1171	0.027327071	0.032450897	8	15DA	T cells	49	33	33
CCTACCACATGGTCAT-1_8_H10	25.37220805	5.536707226	15A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1459	2631	0.006081338	0.006461422	8	15A	Endo cells	49	33	33
CCTACCAGTCTCTCTG-1_8_H10	6.832649562	-20.76196537	4	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5353	15383	0.003380355	0.012481311	8	L2-3	EN-L2-3-MS	49	33	33
CCTACCAGTGAGGGAG-1_8_H10	-6.517534455	8.278091111	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	802	1019	0.016683023	0.026496565	8	oligos	OL-MS-1	49	33	33
CCTACCATCCGCAAGC-1_8_H10	-18.28739564	9.859188576	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	857	1109	0.030658251	0.020739405	8	8	Astrocytes	49	33	33
CCTACCATCGGTCCGA-1_8_H10	-31.93497979	-8.325642767	9	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1064	1563	0.013435701	0.004478567	8	9	OPC	49	33	33
CCTACCATCTGCGTAA-1_8_H10	32.13490119	13.42238046	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1444	2201	0.019082235	0.038164471	8	14	Microglia	49	33	33
CCTAGCTAGAAACCTA-1_8_H10	16.54585882	-4.355786174	12	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1608	2494	0.024859663	0.008420209	8	12	EN-MIX	49	33	33
CCTAGCTAGAGGACGG-1_8_H10	36.65329601	15.60015986	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1358	2039	0.010789603	0.027464443	8	14	Microglia	49	33	33
CCTAGCTAGTCATCCA-1_8_H10	33.27284762	10.7241462	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	789	1004	0.020916335	0.018924303	8	14	Microglia	49	33	33
CCTAGCTAGTCGCCGT-1_8_H10	33.07734712	13.49003972	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1150	1722	0.027874564	0.024390244	8	14	Microglia	49	33	33
CCTAGCTCAAGTTCTG-1_8_H10	-28.54023362	-2.391802017	9	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1421	2251	0.003553976	0.015992892	8	9	OPC	49	33	33
CCTAGCTCACACCGCA-1_8_H10	-1.468862429	8.271361739	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1223	1779	0.01742552	0.018549747	8	oligos	OL-MS-1	49	33	33
CCTAGCTGTACAGTTC-1_8_H10	19.56517169	-23.33637667	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	6712	22973	0.005658817	0.009924694	8	3	EN-L5-6	49	33	33
CCTAGCTGTGTGTGCC-1_8_H10	-15.26247051	11.80693738	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1578	2497	0.007609131	0.005206247	8	8	Astrocytes	49	33	33
CCTAGCTGTTACGGAG-1_8_H10	-4.193502447	8.521184889	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1007	1413	0.021939137	0.025477707	8	oligos	OL-MS-1	49	33	33
CCTAGCTTCAGCTGGC-1_8_H10	15.33313219	-29.10857039	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5399	17531	0.003536592	0.007757686	8	3	EN-L5-6	49	33	33
CCTAGCTTCGCCCTTA-1_8_H10	1.695347842	13.34387512	1	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	941	1418	0.008462623	0.016925247	8	oligos	OL-Cntl	49	33	33
CCTATTAAGCAGGTCA-1_8_H10	18.90355796	-10.34620548	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2206	4272	0.033473783	0.007724719	8	3	EN-L5-6	49	33	33
CCTATTAAGCCTATGT-1_8_H10	-1.877718432	8.701267256	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1171	1660	0.01686747	0.013855422	8	oligos	OL-MS-1	49	33	33
CCTATTAAGGACATTA-1_8_H10	-29.86701908	-1.238557223	9	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1514	2405	0.007484407	0.010810811	8	9	OPC	49	33	33
CCTATTACAAGTTCTG-1_8_H10	-5.930297343	8.349645363	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	877	1217	0.008216927	0.031224322	8	oligos	OL-MS-1	49	33	33
CCTATTACAGTATCTG-1_8_H10	-19.11777149	27.59915028	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2203	4647	0.010544437	0.004088659	8	8	Astrocytes	49	33	33
CCTATTAGTCATGCCG-1_8_H10	-3.71009061	8.879016993	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1020	1381	0.02679218	0.023895728	8	oligos	OL-MS-1	49	33	33
CCTATTATCTGTGCAA-1_8_H10	10.56606933	-1.404282196	12	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1608	2680	0.010074627	0.011940299	8	12	EN-MIX	49	33	33
CCTCAGTAGCTGTTCA-1_8_H10	-1.585927427	8.083713636	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1203	1771	0.007905138	0.033879164	8	oligos	OL-MS-1	49	33	33
CCTCAGTAGTACGACG-1_8_H10	31.69423019	13.67556049	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1270	1856	0.027478448	0.038793103	8	14	Microglia	49	33	33
CCTCAGTAGTCGCCGT-1_8_H10	-24.15717348	-19.4149334	6A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2569	4966	0.019935562	0.010068466	8	6A	IN-PV	49	33	33
CCTCAGTCACAGGCCT-1_8_H10	-0.914278578	8.649619328	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1334	2094	0.021489971	0.016714422	8	oligos	OL-MS-1	49	33	33
CCTCAGTCAGGTTTCA-1_8_H10	18.97599754	-14.55378182	4	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	7183	23622	0.014774363	0.010922022	8	L2-3	EN-L2-3-MS	49	33	33
CCTCAGTGTGGACGAT-1_8_H10	-18.89901189	-17.92971952	6A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2746	6106	0.017359974	0.004585653	8	6A	IN-PV	49	33	33
CCTCAGTTCAACCATG-1_8_H10	11.09287361	-25.91124186	10	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5585	17009	0.007349051	0.005820448	8	L2-3	EN-L2-3-Cntl	49	33	33
CCTCAGTTCCTTTACA-1_8_H10	-3.337770121	10.76584622	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	906	1333	0.031507877	0.019504876	8	oligos	OL-MS-1	49	33	33
CCTCAGTTCTGTCCGT-1_8_H10	-7.479490964	10.3564492	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	866	1150	0.034782609	0.02	8	oligos	OL-MS-1	49	33	33
CCTCTGAAGAAGGTGA-1_8_H10	-5.442838598	8.48038967	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	924	1239	0.034705408	0.031476998	8	oligos	OL-MS-1	49	33	33
CCTCTGAAGCGTGAAC-1_8_H10	-10.97875023	-39.08241995	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1719	2719	0.074659801	0.038617139	8	16	EN-PYR	49	33	33
CCTCTGAAGCTAGGCA-1_8_H10	28.67049473	-14.41886553	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5079	13005	0.022991157	0.018685121	8	2	EN-L4	49	33	33
CCTCTGAAGTGTGGCA-1_8_H10	-5.006026669	13.01502645	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	756	1007	0.017874876	0.023833168	8	oligos	OL-MS-1	49	33	33
CCTCTGACACAGACAG-1_8_H10	35.67422099	-11.40362807	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5760	15751	0.00838042	0.019427338	8	2	EN-L4	49	33	33
CCTCTGACAGTTCCCT-1_8_H10	-1.674764493	10.02253699	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1013	1489	0.013431833	0.02014775	8	oligos	OL-MS-1	49	33	33
CCTCTGAGTAGCGTGA-1_8_H10	-11.19568829	28.20728432	17	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1268	1726	0.035341831	0.027809965	8	oligos	OL-MS-2	49	33	33
CCTCTGAGTCACACGC-1_8_H10	-7.020630739	7.352490757	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	892	1165	0.025751073	0.027467811	8	oligos	OL-MS-1	49	33	33
CCTCTGAGTTCAGACT-1_8_H10	3.854059151	19.18293288	1	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	881	1308	0.013761468	0.009938838	8	oligos	OL-Cntl	49	33	33
CCTCTGAGTTTCCACC-1_8_H10	25.7861834	10.63876492	15A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3425	7410	0.022132254	0.123481781	8	15A	Endo cells	49	33	33
CCTCTGATCCATGAGT-1_8_H10	-14.59390905	14.06574793	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2690	4507	0.009762592	0.035056579	8	8	Astrocytes	49	33	33
CCTCTGATCCGCAAGC-1_8_H10	-5.833160162	9.478227032	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	830	1126	0.013321492	0.022202487	8	oligos	OL-MS-1	49	33	33
CCTCTGATCTCGTATT-1_8_H10	5.973047667	9.926348409	1	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1346	2160	0.008333333	0.025925926	8	oligos	OL-Cntl	49	33	33
CCTCTGATCTTCAACT-1_8_H10	-6.797748501	8.456469755	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	774	1040	0.025	0.013461538	8	oligos	OL-MS-1	49	33	33
CCTTACGAGAGGTTGC-1_8_H10	34.20210628	10.66424384	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	857	1202	0.022462562	0.017470882	8	14	Microglia	49	33	33
CCTTACGAGCCAGGAT-1_8_H10	19.4584004	-22.18554529	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5738	17620	0.013961407	0.008910329	8	3	EN-L5-6	49	33	33
CCTTACGAGGTGACCA-1_8_H10	-16.54070449	25.16478984	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1997	3300	0.018181818	0.008181818	8	8	Astrocytes	49	33	33
CCTTACGAGGTGCTAG-1_8_H10	-3.767101188	11.78163648	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	786	1121	0.010704728	0.035682426	8	oligos	OL-MS-1	49	33	33
CCTTACGTCAATACCG-1_8_H10	10.62573372	-25.27746633	4	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	6310	20842	0.005853565	0.009356108	8	L2-3	EN-L2-3-MS	49	33	33
CCTTCCCAGGGTATCG-1_8_H10	0.501560291	9.012184803	1	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1210	1823	0.007679649	0.020296215	8	oligos	OL-Cntl	49	33	33
CCTTCCCCAGATAATG-1_8_H10	-2.929993921	9.749074092	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	970	1325	0.010566038	0.022641509	8	oligos	OL-MS-1	49	33	33
CCTTCCCGTAATTGGA-1_8_H10	29.34432576	13.44428117	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1850	2808	0.042378917	0.043803419	8	14	Microglia	49	33	33
CCTTCCCGTATCTGCA-1_8_H10	37.37693079	14.98168577	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1476	2341	0.025630073	0.010679197	8	14	Microglia	49	33	33
CCTTCCCGTCACAAGG-1_8_H10	8.737446188	-28.05601087	10	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	7090	28710	0.003134796	0.003378614	8	L2-3	EN-L2-3-Cntl	49	33	33
CCTTCCCGTGCGAAAC-1_8_H10	32.72356825	8.986882314	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	785	1033	0.01839303	0.01839303	8	14	Microglia	49	33	33
CCTTCCCGTTCGCGAC-1_8_H10	10.70197525	6.439448817	1	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1590	2519	0.008733624	0.027391822	8	oligos	OL-Cntl	49	33	33
CCTTCCCTCAAGATCC-1_8_H10	-31.80361717	-1.003255845	9	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1560	2630	0.006463878	0.005703422	8	9	OPC	49	33	33
CCTTCCCTCTACCTGC-1_8_H10	-5.63742393	10.00010532	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	808	1099	0.015468608	0.01910828	8	oligos	OL-MS-1	49	33	33
CCTTCGAAGCGCCTCA-1_8_H10	23.51598202	-25.80824808	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3086	6825	0.024468864	0.004981685	8	3	EN-L5-6	49	33	33
CCTTCGACATTCTCAT-1_8_H10	23.29920768	-23.98860278	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3355	7791	0.051469644	0.005519189	8	3	EN-L5-6	49	33	33
CCTTCGAGTCGAATCT-1_8_H10	17.25447655	-27.53903759	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5958	19736	0.00952574	0.006384272	8	3	EN-L5-6	49	33	33
CCTTCGATCGGACAAG-1_8_H10	-5.760097318	-35.94395357	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	751	1096	0.064781022	0.01459854	8	16	EN-PYR	49	33	33
CCTTTCTCAAAGGTGC-1_8_H10	-7.491326684	7.230937488	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	954	1273	0.031421838	0.028279654	8	oligos	OL-MS-1	49	33	33
CCTTTCTGTACAGTGG-1_8_H10	32.94325129	13.45555073	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1380	2043	0.018600098	0.025452766	8	14	Microglia	49	33	33
CCTTTCTGTATAGGTA-1_8_H10	29.56002514	14.84899322	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1274	2286	0.005686789	0.150918635	8	14	Microglia	49	33	33
CCTTTCTGTCGAAAGC-1_8_H10	-17.27558273	24.27349243	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1479	2232	0.021505376	0.012992832	8	8	Astrocytes	49	33	33
CCTTTCTTCGTGGGAA-1_8_H10	-7.704390455	-2.160625154	13A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1812	3143	0.01686287	0.007317849	8	13A	IN-VIP	49	33	33
CGAACATAGCTCCTCT-1_8_H10	-0.532819609	7.866182735	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1588	2728	0.01356305	0.017228739	8	oligos	OL-MS-1	49	33	33
CGAACATCAGGGCATA-1_8_H10	23.84701511	-16.55413453	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5783	15990	0.018761726	0.017323327	8	3	EN-L5-6	49	33	33
CGAACATCATCTACGA-1_8_H10	-6.702403155	10.95308481	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	779	1053	0.024691358	0.012345679	8	oligos	OL-MS-1	49	33	33
CGAACATCATGACATC-1_8_H10	25.64476262	-26.38113751	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4354	12238	0.002778232	0.003105083	8	3	EN-L5-6	49	33	33
CGAACATTCACCGGGT-1_8_H10	-3.697186752	8.281034982	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1012	1365	0.016849817	0.030769231	8	oligos	OL-MS-1	49	33	33
CGAACATTCCTTAATC-1_8_H10	-4.428265349	17.23269241	1	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	824	1138	0.016695958	0.0228471	8	oligos	OL-Cntl	49	33	33
CGAATGTCATCATCCC-1_8_H10	-3.171429022	10.13248743	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	940	1322	0.026475038	0.037821483	8	oligos	OL-MS-1	49	33	33
CGAATGTGTACCATCA-1_8_H10	-5.610134545	9.676985609	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	813	1105	0.022624434	0.032579186	8	oligos	OL-MS-1	49	33	33
CGAATGTGTTATCGGT-1_8_H10	15.16002894	-4.472165133	12	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1892	3266	0.013472137	0.008879363	8	12	EN-MIX	49	33	33
CGACCTTCAGTACACT-1_8_H10	19.53736006	-22.06320804	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	6611	24711	0.026344543	0.006596253	8	3	EN-L5-6	49	33	33
CGACTTCAGAATTCCC-1_8_H10	-15.99418732	10.88193561	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1288	1972	0.017748479	0.005578093	8	8	Astrocytes	49	33	33
CGACTTCCAAATTGCC-1_8_H10	7.478977277	1.34894352	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	687	1084	0.078413284	0.011070111	8	16	EN-PYR	49	33	33
CGACTTCTCCGCGGTA-1_8_H10	10.08956237	7.772265762	1	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1414	2236	0.008497317	0.014758497	8	oligos	OL-Cntl	49	33	33
CGAGAAGAGACACTAA-1_8_H10	-4.340222375	7.69508689	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1130	1543	0.025923526	0.02786779	8	oligos	OL-MS-1	49	33	33
CGAGAAGAGACTGGGT-1_8_H10	-3.569498714	9.782901284	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	922	1381	0.010861694	0.018102824	8	oligos	OL-MS-1	49	33	33
CGAGAAGCACACCGAC-1_8_H10	-20.44095017	-15.58522069	6B	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3584	8533	0.096097504	0.00621118	8	6B	IN-SST	49	33	33
CGAGCACAGGCAGGTT-1_8_H10	-5.628249611	11.1893321	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	797	1155	0.016450216	0.017316017	8	oligos	OL-MS-1	49	33	33
CGAGCACAGGGAGTAA-1_8_H10	29.27648028	10.55735679	15DA	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1690	2650	0.025660377	0.034716981	8	15DA	T cells	49	33	33
CGAGCACCAGCGATCC-1_8_H10	-4.373224782	12.07583637	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	743	1017	0.007866273	0.02359882	8	oligos	OL-MS-1	49	33	33
CGAGCACGTACATCCA-1_8_H10	9.533414487	-11.99578258	4	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2636	5133	0.016754335	0.033703487	8	L2-3	EN-L2-3-MS	49	33	33
CGAGCACTCTCGTTTA-1_8_H10	-5.865707713	10.3382427	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	730	1000	0.009	0.025	8	oligos	OL-MS-1	49	33	33
CGAGCACTCTTTAGTC-1_8_H10	-20.13098791	-20.54019824	6A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2450	4836	0.116211745	0.008271299	8	6A	IN-PV	49	33	33
CGAGCCAAGTGATCGG-1_8_H10	-5.63704721	11.33463335	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	803	1124	0.012455516	0.027580071	8	oligos	OL-MS-1	49	33	33
CGAGCCACAATCTACG-1_8_H10	31.8204664	9.191421004	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	842	1168	0.016267123	0.016267123	8	14	Microglia	49	33	33
CGAGCCACACGTAAGG-1_8_H10	32.25270556	10.69407245	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	854	1285	0.058365759	0.023346304	8	14	Microglia	49	33	33
CGAGCCATCACTGGGC-1_8_H10	25.09746841	-22.38757418	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5913	19938	0.051660146	0.006018658	8	3	EN-L5-6	49	33	33
CGATCGGAGTACGATA-1_8_H10	-5.36569616	12.31231033	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	739	1005	0.017910448	0.024875622	8	oligos	OL-MS-1	49	33	33
CGATCGGAGTTTAGGA-1_8_H10	-2.134853556	10.51192431	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	936	1316	0.012917933	0.018237082	8	oligos	OL-MS-1	49	33	33
CGATCGGGTCTTTCAT-1_8_H10	23.81135646	-26.30618056	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2958	6759	0.021600829	0.004586477	8	3	EN-L5-6	49	33	33
CGATCGGTCGGAGGTA-1_8_H10	-15.73938626	15.44747175	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2081	3670	0.009536785	0.007901907	8	8	Astrocytes	49	33	33
CGATGGCAGAATAGGG-1_8_H10	-17.9683816	6.150571784	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	789	1014	0.025641026	0.016765286	8	8	Astrocytes	49	33	33
CGATGGCCATGGGACA-1_8_H10	33.30927463	8.752727419	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	968	1298	0.017719569	0.022342065	8	14	Microglia	49	33	33
CGATGGCGTCCAGTAT-1_8_H10	10.23849821	-3.601113786	12	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2056	3421	0.031569716	0.0119848	8	12	EN-MIX	49	33	33
CGATGGCGTCGCGGTT-1_8_H10	20.91755775	-21.43813155	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4820	11515	0.023708207	0.012158055	8	3	EN-L5-6	49	33	33
CGATGGCGTGTCCTCT-1_8_H10	23.46857168	-25.9799896	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3642	8485	0.01661756	0.005067767	8	3	EN-L5-6	49	33	33
CGATGGCGTTCAGGCC-1_8_H10	-4.379792115	8.665129002	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	933	1279	0.017982799	0.01876466	8	oligos	OL-MS-1	49	33	33
CGATGGCTCACATAGC-1_8_H10	27.67293689	6.734649251	15BA	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	995	1332	0.023273273	0.038288288	8	15BA	Stromal cells	49	33	33
CGATGTAGTCGCTTTC-1_8_H10	36.59491321	14.54597564	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1346	1957	0.008175779	0.01073071	8	14	Microglia	49	33	33
CGATTGAAGGACGAAA-1_8_H10	-4.668366813	10.87830692	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	754	1034	0.008704062	0.028046422	8	oligos	OL-MS-1	49	33	33
CGATTGAGTCTCTCGT-1_8_H10	22.25270393	-22.04978311	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4156	10610	0.035249764	0.008765316	8	3	EN-L5-6	49	33	33
CGATTGAGTGGGTCAA-1_8_H10	-7.142057532	6.913813659	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	869	1166	0.02915952	0.036878216	8	oligos	OL-MS-1	49	33	33
CGATTGAGTTAAAGTG-1_8_H10	28.66361953	11.72278515	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2127	3672	0.008986928	0.08251634	8	14	Microglia	49	33	33
CGCCAAGAGACCCACC-1_8_H10	-3.308938888	9.785151397	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	949	1285	0.018677043	0.028793774	8	oligos	OL-MS-1	49	33	33
CGCCAAGCAGCCTTTC-1_8_H10	-33.40325553	4.911793081	9	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2772	6008	0.005159787	0.007656458	8	9	OPC	49	33	33
CGCGGTAAGATGTGTA-1_8_H10	23.46501577	-16.0215978	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	6181	19341	0.039139652	0.017734347	8	2	EN-L4	49	33	33
CGCGGTAAGTTCGATC-1_8_H10	-15.6987356	14.96686397	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1837	3310	0.006042296	0.003021148	8	8	Astrocytes	49	33	33
CGCGGTACATTGAGCT-1_8_H10	-4.007143909	10.63748242	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	906	1213	0.009892828	0.027205276	8	oligos	OL-MS-1	49	33	33
CGCGGTAGTGCCTGCA-1_8_H10	-6.486980634	7.715339585	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	899	1159	0.036238136	0.01553063	8	oligos	OL-MS-1	49	33	33
CGCGGTATCAAGGTAA-1_8_H10	24.18683744	-26.23361723	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2713	5620	0.016192171	0.005516014	8	3	EN-L5-6	49	33	33
CGCGTTTAGCAGGTCA-1_8_H10	-27.35044612	-12.5483998	9	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	758	1014	0.024654832	0.018737673	8	9	OPC	49	33	33
CGCGTTTCAAGGTTTC-1_8_H10	10.60530266	-11.46399754	4	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3082	6584	0.015188335	0.017162819	8	L2-3	EN-L2-3-MS	49	33	33
CGCGTTTCAGTCCTTC-1_8_H10	-7.683727047	7.466850118	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	868	1239	0.01937046	0.05165456	8	oligos	OL-MS-1	49	33	33
CGCGTTTCATGTCTCC-1_8_H10	-13.21213357	-14.35660667	6B	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1401	2308	0.018630849	0.023830156	8	6B	IN-SST	49	33	33
CGCGTTTGTCAGAATA-1_8_H10	28.82281063	-14.00713703	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5253	13496	0.018449911	0.014671014	8	3	EN-L5-6	49	33	33
CGCGTTTGTCCGTCAG-1_8_H10	-17.66841997	7.479211621	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	945	1303	0.018419033	0.014581734	8	8	Astrocytes	49	33	33
CGCGTTTGTCGAAAGC-1_8_H10	-22.54092584	-15.9381589	6A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3441	6659	0.017870551	0.009160535	8	6A	IN-PV	49	33	33
CGCGTTTGTTCTGTTT-1_8_H10	19.44001573	-9.952324755	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2345	4478	0.040643144	0.004019652	8	3	EN-L5-6	49	33	33
CGCTATCAGCAACGGT-1_8_H10	-16.91577242	6.186038279	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	953	1494	0.008701473	0.010040161	8	8	Astrocytes	49	33	33
CGCTATCCATTACCTT-1_8_H10	22.32314948	-24.10838667	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4009	9757	0.017320898	0.006764374	8	3	EN-L5-6	49	33	33
CGCTATCTCCATGAGT-1_8_H10	-10.23958869	-9.141870412	13B	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1172	1700	0.009411765	0.01	8	13B	IN-SV2C	49	33	33
CGCTGGAAGAATGTTG-1_8_H10	34.13467921	7.981701298	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1814	2780	0.03057554	0.01618705	8	14	Microglia	49	33	33
CGCTGGAAGCGGCTTC-1_8_H10	-5.471034034	8.198038593	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	874	1220	0.010655738	0.032786885	8	oligos	OL-MS-1	49	33	33
CGCTGGAAGGCTAGAC-1_8_H10	28.5258706	11.03435743	15DB	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1761	2931	0.033435687	0.141589901	8	15DB	B cells	49	33	33
CGCTGGACAAGTAATG-1_8_H10	-9.371953114	-36.53034409	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1206	1883	0.139670738	0.011152416	8	16	EN-PYR	49	33	33
CGCTGGACAGCTCCGA-1_8_H10	18.53164656	-24.60222907	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5580	15401	0.011233037	0.00844101	8	3	EN-L5-6	49	33	33
CGCTGGAGTTCTGTTT-1_8_H10	33.28878347	9.004349002	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	830	1055	0.011374408	0.011374408	8	14	Microglia	49	33	33
CGCTTCAAGAACAATC-1_8_H10	-7.407465228	7.743461602	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	810	1069	0.008419083	0.033676333	8	oligos	OL-MS-1	49	33	33
CGCTTCAAGAGACTTA-1_8_H10	-4.037680966	9.180119335	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	882	1226	0.026101142	0.043230016	8	oligos	OL-MS-1	49	33	33
CGCTTCAGTATTCGTG-1_8_H10	-1.627026914	11.09452938	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	947	1326	0.012066365	0.030165913	8	oligos	OL-MS-1	49	33	33
CGCTTCAGTTATGTGC-1_8_H10	24.91822	4.398469366	15BA	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1728	2966	0.004383007	0.00606878	8	15BA	Stromal cells	49	33	33
CGCTTCATCAGCTCGG-1_8_H10	29.6381724	-6.426126026	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3992	9915	0.008270298	0.005143722	8	2	EN-L4	49	33	33
CGCTTCATCTGCTTGC-1_8_H10	-6.809124218	9.090797793	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	796	1084	0.013837638	0.024907749	8	oligos	OL-MS-1	49	33	33
CGCTTCATCTGTTGAG-1_8_H10	-27.97593436	-5.253128936	9	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1293	1937	0.021166753	0.005678885	8	9	OPC	49	33	33
CGGACACAGAGATGAG-1_8_H10	27.37090984	10.13808117	15A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1328	2187	0.029263832	0.102423411	8	15A	Endo cells	49	33	33
CGGACACAGTGGAGAA-1_8_H10	-0.366979671	9.816609212	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1115	1625	0.009846154	0.024615385	8	oligos	OL-MS-1	49	33	33
CGGACACCACTGCCAG-1_8_H10	14.46108067	-4.39632428	12	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2026	3983	0.013808687	0.011549084	8	12	EN-MIX	49	33	33
CGGACACTCCGATATG-1_8_H10	-0.981807368	7.64040821	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1558	2446	0.017170891	0.039656582	8	oligos	OL-MS-1	49	33	33
CGGACGTCAAGTAGTA-1_8_H10	-15.06430271	-6.495756789	13A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3378	7627	0.028844893	0.005375639	8	13A	IN-VIP	49	33	33
CGGACGTGTTCACGGC-1_8_H10	-3.473359948	16.25325145	1	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	750	1050	0.012380952	0.018095238	8	oligos	OL-Cntl	49	33	33
CGGACGTGTTGTGGAG-1_8_H10	9.955363926	-0.621167147	12	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1404	2430	0.020987654	0.013168724	8	12	EN-MIX	49	33	33
CGGACGTGTTTAAGCC-1_8_H10	30.26720763	14.42103441	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	739	1032	0.015503876	0.148255814	8	14	Microglia	49	33	33
CGGACGTTCATCTGTT-1_8_H10	33.41815706	14.37964834	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1081	1573	0.010807374	0.034329307	8	14	Microglia	49	33	33
CGGACTGCAGCCTTGG-1_8_H10	-2.577995077	11.35274658	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	893	1266	0.011058452	0.023696682	8	oligos	OL-MS-1	49	33	33
CGGACTGCAGGGAGAG-1_8_H10	-7.36970895	7.494096589	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	788	1075	0.012093023	0.035348837	8	oligos	OL-MS-1	49	33	33
CGGACTGGTAGGAGTC-1_8_H10	33.65095087	11.79055755	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1074	1450	0.026896552	0.01862069	8	14	Microglia	49	33	33
CGGACTGGTATAAACG-1_8_H10	7.86891972	-16.97242558	4	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3218	6584	0.006075334	0.02354192	8	L2-3	EN-L2-3-MS	49	33	33
CGGACTGTCACAGTAC-1_8_H10	-5.214285321	-36.27388459	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	849	1186	0.08010118	0.016020236	8	16	EN-PYR	49	33	33
CGGAGCTCAACTGGCC-1_8_H10	-18.79479117	-17.42415238	6A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2494	4833	0.027932961	0.006207325	8	6A	IN-PV	49	33	33
CGGAGCTCAATAGAGT-1_8_H10	-2.244489097	11.03683202	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	947	1330	0.015037594	0.02481203	8	oligos	OL-MS-1	49	33	33
CGGAGCTCATCGGTTA-1_8_H10	-29.51539538	-1.053178892	9	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1755	3031	0.009567799	0.003629165	8	9	OPC	49	33	33
CGGAGCTCATGGATGG-1_8_H10	31.67211791	11.45269982	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1182	1577	0.031071655	0.031071655	8	14	Microglia	49	33	33
CGGAGCTGTACTCGCG-1_8_H10	35.69697823	-11.24185632	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5348	13172	0.012222897	0.01647434	8	2	EN-L4	49	33	33
CGGAGCTTCTAACTGG-1_8_H10	-5.45013583	11.72165426	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	747	1017	0.01179941	0.028515241	8	oligos	OL-MS-1	49	33	33
CGGAGTCAGCACCGCT-1_8_H10	23.51535101	-16.22160424	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	7307	27053	0.036483939	0.013492034	8	2	EN-L4	49	33	33
CGGAGTCAGTCATCCA-1_8_H10	31.55075857	13.58664837	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1297	2050	0.021463415	0.04	8	14	Microglia	49	33	33
CGGAGTCCAGCTGTGC-1_8_H10	-3.099014855	-35.25521285	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1069	1632	0.121323529	0.026960784	8	16	EN-PYR	49	33	33
CGGAGTCGTCGGCACT-1_8_H10	-14.14833896	-35.89104403	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2262	4162	0.070158578	0.017059106	8	16	EN-PYR	49	33	33
CGGAGTCTCCGGCACA-1_8_H10	-18.82663878	-8.24029625	13B	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3781	8723	0.03175513	0.005502694	8	13B	IN-SV2C	49	33	33
CGGCTAGAGGCGATAC-1_8_H10	18.46005082	-9.23403471	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2309	4446	0.043409807	0.005173189	8	3	EN-L5-6	49	33	33
CGGCTAGAGTGTGAAT-1_8_H10	26.5488197	10.10097543	15A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1788	3010	0.011295681	0.054817276	8	15A	Endo cells	49	33	33
CGGCTAGGTCATATCG-1_8_H10	-3.083402421	-35.38291373	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	788	1017	0.078662734	0.018682399	8	16	EN-PYR	49	33	33
CGGCTAGTCAACACGT-1_8_H10	8.232094396	-17.59983468	4	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4731	11487	0.004613911	0.030643336	8	L2-3	EN-L2-3-MS	49	33	33
CGGCTAGTCTGGGCCA-1_8_H10	-16.05669528	11.67201896	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1137	1596	0.009398496	0.013784461	8	8	Astrocytes	49	33	33
CGGGTCACAAGGCTCC-1_8_H10	32.00255108	14.05090119	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1139	1700	0.008823529	0.05	8	14	Microglia	49	33	33
CGGGTCAGTAAACCTC-1_8_H10	18.38439644	-25.66957596	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5081	14395	0.008683571	0.010837096	8	3	EN-L5-6	49	33	33
CGGGTCAGTAGGAGTC-1_8_H10	30.86727488	-18.78438698	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	7024	23140	0.037640449	0.02048401	8	2	EN-L4	49	33	33
CGGGTCATCAAACCAC-1_8_H10	13.83818072	-10.20538612	13A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4694	11972	0.005846976	0.015703308	8	13A	IN-VIP	49	33	33
CGGGTCATCCCGGATG-1_8_H10	-21.76009996	4.502033034	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	898	1347	0.058648849	0.008166295	8	8	Astrocytes	49	33	33
CGGGTCATCTCCTATA-1_8_H10	32.49552937	-7.115615016	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4471	11287	0.00531585	0.009479933	8	2	EN-L4	49	33	33
CGGTTAAAGAAGGTTT-1_8_H10	-4.126434996	9.438688248	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	973	1387	0.007930786	0.015140591	8	oligos	OL-MS-1	49	33	33
CGGTTAAAGTGTGAAT-1_8_H10	-18.19755018	-2.632414757	13A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3204	6133	0.024947008	0.013044187	8	13A	IN-VIP	49	33	33
CGGTTAACATGGAATA-1_8_H10	24.42798639	-20.29050144	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5819	17241	0.023838524	0.006670147	8	3	EN-L5-6	49	33	33
CGGTTAAGTCAAAGAT-1_8_H10	-17.94624408	-14.24765159	6A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2042	3412	0.032825322	0.01084408	8	6A	IN-PV	49	33	33
CGGTTAAGTGCCTGCA-1_8_H10	-7.657243243	7.880858095	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	779	1048	0.016221374	0.03721374	8	oligos	OL-MS-1	49	33	33
CGGTTAAGTGTTGAGG-1_8_H10	-3.094501781	10.71542753	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	928	1305	0.020689655	0.016858238	8	oligos	OL-MS-1	49	33	33
CGGTTAATCAACGCTA-1_8_H10	24.60190466	-17.02124335	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	7712	29141	0.035276758	0.01166741	8	3	EN-L5-6	49	33	33
CGGTTAATCAATCTCT-1_8_H10	-19.28809602	24.11613507	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1467	2518	0.008737093	0.007545671	8	8	Astrocytes	49	33	33
CGTAGCGAGGAATGGA-1_8_H10	-3.827832458	9.663091834	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	883	1177	0.015293118	0.03653356	8	oligos	OL-MS-1	49	33	33
CGTAGCGTCTAACTGG-1_8_H10	-20.513421	-15.13043095	6B	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2460	4799	0.043342363	0.006042926	8	6B	IN-SST	49	33	33
CGTAGCGTCTGCAAGT-1_8_H10	-3.491002327	-35.29150777	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	688	1021	0.126346719	0.017629775	8	16	EN-PYR	49	33	33
CGTAGGCAGCTGCCCA-1_8_H10	-3.215662335	7.407268271	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1293	1936	0.02427686	0.040805785	8	oligos	OL-MS-1	49	33	33
CGTAGGCAGTGACATA-1_8_H10	11.39112413	-25.40763877	4	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4408	10606	0.008485763	0.008391477	8	L2-3	EN-L2-3-MS	49	33	33
CGTAGGCCAGACGCCT-1_8_H10	26.40433011	9.586059488	15A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1662	2499	0.018407363	0.049219688	8	15A	Endo cells	49	33	33
CGTAGGCTCGGATGGA-1_8_H10	32.78806246	9.768195801	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	874	1137	0.014951627	0.030782762	8	14	Microglia	49	33	33
CGTAGGCTCTGCAGTA-1_8_H10	-5.639796122	8.097937493	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	937	1230	0.012195122	0.036585366	8	oligos	OL-MS-1	49	33	33
CGTCACTAGACAGAGA-1_8_H10	10.42041286	0.5092326	12	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1068	1700	0.012941176	0.01	8	12	EN-MIX	49	33	33
CGTCACTAGGATGGTC-1_8_H10	-15.61371203	-23.34178375	6A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1679	2888	0.041551247	0.004847645	8	6A	IN-PV	49	33	33
CGTCACTAGTGCCAGA-1_8_H10	-2.28367712	8.156521328	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1087	1609	0.010565569	0.021752641	8	oligos	OL-MS-1	49	33	33
CGTCACTCATCGATGT-1_8_H10	-15.72068672	11.93526276	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1271	1957	0.013285641	0.007153807	8	8	Astrocytes	49	33	33
CGTCACTGTATTCGTG-1_8_H10	-6.702608184	7.933873792	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	814	1124	0.089857651	0.023131673	8	oligos	OL-MS-1	49	33	33
CGTCAGGAGAGCTTCT-1_8_H10	-3.296341238	15.60086235	1	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	823	1192	0.01090604	0.012583893	8	oligos	OL-Cntl	49	33	33
CGTCAGGCACCGTTGG-1_8_H10	11.61672051	-2.8433202	12	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1616	2902	0.028945555	0.006547209	8	12	EN-MIX	49	33	33
CGTCAGGGTCACACGC-1_8_H10	32.66648599	8.624324662	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1139	1665	0.021621622	0.012012012	8	14	Microglia	49	33	33
CGTCAGGTCATCATTC-1_8_H10	-2.421660471	11.20946228	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	884	1255	0.010358566	0.018326693	8	oligos	OL-MS-1	49	33	33
CGTCCATCAGTATAAG-1_8_H10	-17.37772519	8.21689253	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1088	1489	0.014775017	0.006715917	8	8	Astrocytes	49	33	33
CGTCCATTCACTCCTG-1_8_H10	31.77879257	-7.812021862	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3434	7289	0.013444917	0.007820003	8	2	EN-L4	49	33	33
CGTCTACAGAATAGGG-1_8_H10	-4.837386543	9.868750951	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	829	1056	0.013257576	0.029356061	8	oligos	OL-MS-1	49	33	33
CGTCTACAGATGTGTA-1_8_H10	11.52603807	6.495752672	1	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1772	2947	0.011876485	0.023413641	8	oligos	OL-Cntl	49	33	33
CGTCTACCAACTTGAC-1_8_H10	-3.868412824	-37.03264175	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	993	1351	0.065877128	0.034048853	8	16	EN-PYR	49	33	33
CGTCTACCAAGCTGGA-1_8_H10	-24.03618391	12.81660795	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1192	1846	0.008667389	0.012459372	8	8	Astrocytes	49	33	33
CGTCTACCAGACACTT-1_8_H10	-26.62252141	1.645152856	9	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2755	5245	0.012392755	0.015061964	8	9	OPC	49	33	33
CGTCTACCAGCTCCGA-1_8_H10	10.07132916	-21.83663862	4	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	6178	18290	0.010169492	0.011372335	8	L2-3	EN-L2-3-MS	49	33	33
CGTGAGCAGTGTTGAA-1_8_H10	-5.850905816	11.27106115	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	747	1018	0.017681729	0.02259332	8	oligos	OL-MS-1	49	33	33
CGTGAGCCAGTGGAGT-1_8_H10	33.16546987	10.49841288	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	953	1300	0.023076923	0.016923077	8	14	Microglia	49	33	33
CGTGAGCCATCTCGCT-1_8_H10	22.07601258	-23.63584422	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4251	10905	0.017331499	0.010087116	8	3	EN-L5-6	49	33	33
CGTGAGCCATGAGCGA-1_8_H10	-2.402338433	7.948224638	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1187	1624	0.02955665	0.022783251	8	oligos	OL-MS-1	49	33	33
CGTGAGCGTCGGCTCA-1_8_H10	15.09241749	-28.9087334	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4088	11232	0.000712251	0.009170228	8	3	EN-L5-6	49	33	33
CGTGAGCGTGATAAGT-1_8_H10	-6.090545911	6.606565381	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1122	1506	0.005976096	0.043824701	8	oligos	OL-MS-1	49	33	33
CGTGTAACAAGGACTG-1_8_H10	29.97087596	15.648668	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1465	2204	0.022232305	0.067604356	8	14	Microglia	49	33	33
CGTGTCTAGAAACCAT-1_8_H10	18.51921057	-9.118858387	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2178	4129	0.088883507	0.003632841	8	3	EN-L5-6	49	33	33
CGTGTCTAGGACACCA-1_8_H10	15.37685542	-28.23217068	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3600	9207	0.013793853	0.004127294	8	3	EN-L5-6	49	33	33
CGTGTCTCAAGAGGCT-1_8_H10	-28.59399767	-22.49775048	6A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4567	10781	0.053612837	0.012058251	8	6A	IN-PV	49	33	33
CGTGTCTCACAAGCCC-1_8_H10	-3.207717963	8.282861431	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1025	1459	0.031528444	0.017135024	8	oligos	OL-MS-1	49	33	33
CGTGTCTGTACTTCTT-1_8_H10	3.378023915	4.818586599	7	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1361	1823	0.021393308	0.016456391	8	7	Phagocytes	49	33	33
CGTGTCTGTCTGGAGA-1_8_H10	31.50377657	12.02839359	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	845	1089	0.015610652	0.04775023	8	14	Microglia	49	33	33
CGTGTCTTCATTGCGA-1_8_H10	29.63700393	9.54036416	15DB	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	769	1035	0.020289855	0.060869565	8	15DB	B cells	49	33	33
CGTGTCTTCGGTTCGG-1_8_H10	-3.560115978	11.48913458	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	848	1118	0.012522361	0.02236136	8	oligos	OL-MS-1	49	33	33
CGTTAGAAGGGTTTCT-1_8_H10	-22.03465691	-17.89124011	6A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3770	8875	0.015211268	0.008	8	6A	IN-PV	49	33	33
CGTTAGACAAGCTGGA-1_8_H10	11.12956351	-1.422251327	12	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1324	2346	0.013640239	0.007246377	8	12	EN-MIX	49	33	33
CGTTAGACACAGGCCT-1_8_H10	-3.821146143	7.524788154	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1192	1690	0.017159763	0.024260355	8	oligos	OL-MS-1	49	33	33
CGTTAGAGTCTAACGT-1_8_H10	-3.631229517	16.37471164	1	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	832	1237	0.012934519	0.025869038	8	oligos	OL-Cntl	49	33	33
CGTTCTGAGAGTACAT-1_8_H10	-5.443153834	-37.50922848	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1161	2000	0.1655	0.0185	8	16	EN-PYR	49	33	33
CGTTCTGGTACAAGTA-1_8_H10	25.96926349	10.26372471	15A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2290	3974	0.034222446	0.05359839	8	15A	Endo cells	49	33	33
CGTTCTGGTCTACCTC-1_8_H10	12.10051758	-1.066903745	12	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1312	2659	0.015419331	0.005265137	8	12	EN-MIX	49	33	33
CGTTCTGTCTTATCTG-1_8_H10	-1.98766972	10.20667479	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1008	1423	0.002810963	0.016163036	8	oligos	OL-MS-1	49	33	33
CGTTGGGAGCGGCTTC-1_8_H10	8.237341963	-18.1498207	4	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5262	13600	0.005588235	0.013455882	8	L2-3	EN-L2-3-MS	49	33	33
CGTTGGGAGCTTTGGT-1_8_H10	-1.518926723	9.226918873	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1086	1561	0.026265215	0.021140295	8	oligos	OL-MS-1	49	33	33
CGTTGGGCATTGGGCC-1_8_H10	33.25533349	10.827183	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	930	1298	0.028505393	0.023112481	8	14	Microglia	49	33	33
CGTTGGGGTCCATGAT-1_8_H10	7.571550007	-17.91512852	4	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4129	9800	0.005612245	0.026530612	8	L2-3	EN-L2-3-MS	49	33	33
CGTTGGGGTCGAACAG-1_8_H10	-5.512032149	10.57298573	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	759	1006	0.011928429	0.033797217	8	oligos	OL-MS-1	49	33	33
CGTTGGGGTGAGGGAG-1_8_H10	0.009627946	8.252223702	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1346	2080	0.008653846	0.020192308	8	oligos	OL-MS-1	49	33	33
CGTTGGGGTGATAAAC-1_8_H10	-7.412887863	9.519283769	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	826	1230	0.016260163	0.025203252	8	oligos	OL-MS-1	49	33	33
CTAACTTAGATGTGGC-1_8_H10	8.907902682	-3.845977127	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1574	2474	0.035569927	0.019805982	8	16	EN-PYR	49	33	33
CTAACTTCATATACCG-1_8_H10	32.86417591	10.47007432	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	975	1363	0.026412326	0.017608217	8	14	Microglia	49	33	33
CTAACTTGTACCGCTG-1_8_H10	21.87672932	-14.12470308	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2765	4978	0.023503415	0.021293692	8	3	EN-L5-6	49	33	33
CTAAGACAGAGCCTAG-1_8_H10	22.36937402	-18.78644169	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	7133	24614	0.031242382	0.007841066	8	3	EN-L5-6	49	33	33
CTAAGACAGAGGACGG-1_8_H10	-0.804945804	7.354378083	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2152	3345	0.007473842	0.030493274	8	oligos	OL-MS-1	49	33	33
CTAAGACCAATAGCAA-1_8_H10	-6.999151504	6.837171198	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	976	1319	0.025777104	0.041698256	8	oligos	OL-MS-1	49	33	33
CTAAGACCACGTTGGC-1_8_H10	27.8285466	10.42992166	15DB	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1798	3553	0.005910498	0.189135941	8	15DB	B cells	49	33	33
CTAAGACTCGGTGTTA-1_8_H10	-4.438166479	10.39759191	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	830	1135	0.00969163	0.040528634	8	oligos	OL-MS-1	49	33	33
CTAAGACTCTACCTGC-1_8_H10	-15.11707955	14.6235516	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1941	3515	0.0056899	0.009388336	8	8	Astrocytes	49	33	33
CTAAGACTCTTCGGTC-1_8_H10	13.38517482	-24.32133362	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	6533	21538	0.007103724	0.00965735	8	3	EN-L5-6	49	33	33
CTAATGGAGTCCATAC-1_8_H10	34.08340017	12.19749223	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1053	1443	0.011781012	0.021483021	8	14	Microglia	49	33	33
CTAATGGAGTGGGCTA-1_8_H10	-6.256160729	11.06450111	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	827	1154	0.017331023	0.014731369	8	oligos	OL-MS-1	49	33	33
CTAATGGGTCGAATCT-1_8_H10	17.09286292	-4.954862854	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1355	2459	0.017893453	0.004880033	8	3	EN-L5-6	49	33	33
CTAATGGTCAACACGT-1_8_H10	-9.654776318	-15.74720778	6B	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	979	1388	0.03314121	0.008645533	8	6B	IN-SST	49	33	33
CTACACCAGGACATTA-1_8_H10	31.71631169	10.80320419	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1039	1512	0.009920635	0.029761905	8	14	Microglia	49	33	33
CTACACCAGTTTAGGA-1_8_H10	33.81964877	-9.548843867	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5419	14568	0.025192202	0.010777046	8	2	EN-L4	49	33	33
CTACACCCAATGAATG-1_8_H10	-7.532634357	7.820529075	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	804	1007	0.022840119	0.027805362	8	oligos	OL-MS-1	49	33	33
CTACACCGTCCGTCAG-1_8_H10	23.56843599	-25.9123129	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3085	7292	0.040318157	0.005348327	8	3	EN-L5-6	49	33	33
CTACACCTCCAGATCA-1_8_H10	-3.60863557	-33.79902034	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	749	1052	0.127376426	0.020912548	8	16	EN-PYR	49	33	33
CTACATTAGCAGCGTA-1_8_H10	23.24353985	-10.20604536	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2956	6235	0.007377706	0.005613472	8	3	EN-L5-6	49	33	33
CTACATTCACACCGCA-1_8_H10	29.49196584	14.99087365	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1444	2509	0.009166999	0.165803109	8	14	Microglia	49	33	33
CTACATTCATGCCTAA-1_8_H10	26.58093005	7.267611216	15A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1175	1693	0.007088009	0.017129356	8	15A	Endo cells	49	33	33
CTACATTCATTACCTT-1_8_H10	-2.651219395	10.56063094	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	905	1284	0.014018692	0.023364486	8	oligos	OL-MS-1	49	33	33
CTACATTGTGTTGGGA-1_8_H10	-20.505941	-6.483605249	13B	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4634	11066	0.008494488	0.015723839	8	13B	IN-SV2C	49	33	33
CTACATTTCTACTCAT-1_8_H10	9.8227512	-24.11017151	4	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	6940	25688	0.006968234	0.007591093	8	L2-3	EN-L2-3-MS	49	33	33
CTACATTTCTGGCGTG-1_8_H10	-23.63391932	-8.866396082	9	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1292	2070	0.028019324	0.01352657	8	9	OPC	49	33	33
CTACCCAAGAGGGATA-1_8_H10	-3.553838276	11.89571492	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	847	1196	0.014214047	0.038461538	8	oligos	OL-MS-1	49	33	33
CTACCCAAGTGGTAGC-1_8_H10	31.30474133	14.96042401	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1102	1855	0.00916442	0.067924528	8	14	Microglia	49	33	33
CTACCCACAACTGCTA-1_8_H10	-5.719737968	7.755747168	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	941	1319	0.031842305	0.034116755	8	oligos	OL-MS-1	49	33	33
CTACCCACACGAAACG-1_8_H10	31.76885456	10.18620999	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	931	1249	0.025620496	0.045636509	8	14	Microglia	49	33	33
CTACCCAGTATGAATG-1_8_H10	-20.79064283	-16.33904913	6A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2966	6055	0.038150289	0.004128819	8	6A	IN-PV	49	33	33
CTACCCAGTCTTCTCG-1_8_H10	-31.7774891	-0.944430773	9	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1607	2701	0.006664198	0.007034432	8	9	OPC	49	33	33
CTACCCATCAACACAC-1_8_H10	-4.643626053	-37.80370949	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1147	1707	0.090802578	0.035149385	8	16	EN-PYR	49	33	33
CTACCCATCTTAGCCC-1_8_H10	-17.60951569	7.742569683	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1018	1436	0.036908078	0.010445682	8	8	Astrocytes	49	33	33
CTACGTCAGATCCCGC-1_8_H10	10.39324298	6.558405819	1	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1550	2414	0.011184756	0.018227009	8	oligos	OL-Cntl	49	33	33
CTACGTCTCGCTAGCG-1_8_H10	-1.540673812	10.82271561	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	915	1312	0.009908537	0.019054878	8	oligos	OL-MS-1	49	33	33
CTACGTCTCTCGATGA-1_8_H10	-1.141138846	7.293152299	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1847	3046	0.041365726	0.057780696	8	oligos	OL-MS-1	49	33	33
CTAGAGTAGGTGTGGT-1_8_H10	-24.04499006	6.15426212	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	785	1081	0.038852914	0.008325624	8	8	Astrocytes	49	33	33
CTAGAGTTCATGCTCC-1_8_H10	-6.610894407	-37.12918873	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1162	1964	0.209775967	0.014256619	8	16	EN-PYR	49	33	33
CTAGCCTAGAGGGCTT-1_8_H10	32.18999109	10.46207788	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	861	1130	0.016814159	0.02920354	8	14	Microglia	49	33	33
CTAGCCTAGATACACA-1_8_H10	-18.32878015	6.492731431	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	739	1007	0.019860973	0.009930487	8	8	Astrocytes	49	33	33
CTAGCCTAGGCAAAGA-1_8_H10	13.29980133	-14.94867765	4	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3869	8391	0.02538434	0.008461447	8	L2-3	EN-L2-3-MS	49	33	33
CTAGCCTAGGTGCACA-1_8_H10	33.32476738	11.19480815	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1196	1641	0.021937843	0.01889092	8	14	Microglia	49	33	33
CTAGCCTCAATCTGCA-1_8_H10	-27.08521645	-11.28415923	9	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	993	1402	0.014265335	0.018544936	8	9	OPC	49	33	33
CTAGCCTCACTTAACG-1_8_H10	-5.29065764	8.461453082	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	955	1312	0.016006098	0.02820122	8	oligos	OL-MS-1	49	33	33
CTAGCCTCAGCCTTGG-1_8_H10	9.434074861	-22.59646918	4	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	7374	26588	0.008725741	0.007635023	8	L2-3	EN-L2-3-MS	49	33	33
CTAGCCTCATCGGACC-1_8_H10	29.81485313	9.397952309	15DA	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	831	1097	0.013673655	0.060164084	8	15DA	T cells	49	33	33
CTAGCCTGTACAGTTC-1_8_H10	-3.800083646	8.77810089	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1080	1542	0.010376135	0.02464332	8	oligos	OL-MS-1	49	33	33
CTAGCCTGTAGATTAG-1_8_H10	22.71621456	-10.36764896	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2670	5492	0.03605244	0.004552076	8	3	EN-L5-6	49	33	33
CTAGCCTGTCGCGAAA-1_8_H10	-15.22730998	6.614494771	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	899	1234	0.048622366	0.021880065	8	8	Astrocytes	49	33	33
CTAGCCTGTTGCTCCT-1_8_H10	29.72490313	-6.385500987	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4828	14042	0.007477567	0.008901866	8	2	EN-L4	49	33	33
CTAGCCTTCCCATTAT-1_8_H10	-3.079837773	-35.11339238	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	967	1292	0.057275542	0.030959752	8	16	EN-PYR	49	33	33
CTAGTGAAGGAGTTGC-1_8_H10	-6.613861666	9.26573584	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	796	1066	0.036585366	0.030956848	8	oligos	OL-MS-1	49	33	33
CTAGTGAAGTGCCAGA-1_8_H10	25.62305825	10.49817761	15A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3945	8085	0.059245516	0.057884972	8	15A	Endo cells	49	33	33
CTAGTGACACAGTCGC-1_8_H10	-17.84874497	24.45386255	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1434	2314	0.007778738	0.00821089	8	8	Astrocytes	49	33	33
CTAGTGACATCACCCT-1_8_H10	-2.192620534	9.806916965	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1025	1472	0.013586957	0.022418478	8	oligos	OL-MS-1	49	33	33
CTCACACCAAGGTGTG-1_8_H10	15.13581577	-22.21680707	4	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5712	17058	0.017411185	0.007034822	8	L2-3	EN-L2-3-MS	49	33	33
CTCACACCATCTGGTA-1_8_H10	-7.804939795	-37.68132428	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1017	1478	0.01556157	0.027063599	8	16	EN-PYR	49	33	33
CTCACACGTAGTAGTA-1_8_H10	22.1022981	-21.98358111	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	6615	21444	0.024715538	0.006435367	8	3	EN-L5-6	49	33	33
CTCACACGTTACGCGC-1_8_H10	-1.472213665	8.80214746	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1080	1628	0.015970516	0.019041769	8	oligos	OL-MS-1	49	33	33
CTCACACTCACCCGAG-1_8_H10	-7.583697696	7.704954447	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	787	1029	0.015549077	0.053449951	8	oligos	OL-MS-1	49	33	33
CTCACACTCCCACTTG-1_8_H10	-11.63205833	-27.38622885	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	810	1074	0.106145251	0.010242086	8	16	EN-PYR	49	33	33
CTCACACTCTCTTATG-1_8_H10	-1.676920552	9.881928168	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1016	1469	0.014295439	0.015656909	8	oligos	OL-MS-1	49	33	33
CTCAGAACAACTGCGC-1_8_H10	18.34536316	-25.48271249	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4492	11470	0.013687881	0.009590235	8	3	EN-L5-6	49	33	33
CTCAGAACACCACCAG-1_8_H10	-2.760582487	9.984109621	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	957	1391	0.01581596	0.017253774	8	oligos	OL-MS-1	49	33	33
CTCAGAAGTACCTACA-1_8_H10	5.123269449	9.525259244	1	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1539	2383	0.013428452	0.019723038	8	oligos	OL-Cntl	49	33	33
CTCATTACAAGGGTCA-1_8_H10	-7.483393957	7.940619946	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	957	1359	0.012509198	0.02281089	8	oligos	OL-MS-1	49	33	33
CTCATTACATTACGAC-1_8_H10	29.39294827	5.699202353	15DA	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	937	1220	0.037704918	0.047540984	8	15DA	T cells	49	33	33
CTCATTAGTCCAGTTA-1_8_H10	31.03480351	-7.827336887	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5723	16660	0.007563025	0.014465786	8	2	EN-L4	49	33	33
CTCCTAGAGGAGCGTT-1_8_H10	-3.229907704	11.58759282	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	889	1214	0.014003295	0.021416804	8	oligos	OL-MS-1	49	33	33
CTCCTAGAGTATGACA-1_8_H10	-29.65931224	-0.777584393	9	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1799	2994	0.005678023	0.006680027	8	9	OPC	49	33	33
CTCCTAGCACCAACCG-1_8_H10	-16.72176551	5.069485348	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	788	1098	0.172131148	0.028233151	8	8	Astrocytes	49	33	33
CTCCTAGCACTGAAGG-1_8_H10	33.38034063	13.67229172	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1146	1728	0.012731481	0.021990741	8	14	Microglia	49	33	33
CTCCTAGCAGCATGAG-1_8_H10	36.94379297	14.67374499	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1298	1964	0.00712831	0.016802444	8	14	Microglia	49	33	33
CTCCTAGGTACTTGAC-1_8_H10	34.00452539	-6.561632412	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3825	8448	0.014796402	0.005326705	8	2	EN-L4	49	33	33
CTCCTAGGTGCAACGA-1_8_H10	-1.304317952	8.856244901	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1185	1723	0.012768427	0.013929193	8	oligos	OL-MS-1	49	33	33
CTCCTAGTCCTGTAGA-1_8_H10	-1.957985961	11.32491451	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	838	1190	0.007563025	0.015966387	8	oligos	OL-MS-1	49	33	33
CTCGAAACACAGCGTC-1_8_H10	-6.38172774	9.649063789	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	741	1031	0.010669253	0.025218235	8	oligos	OL-MS-1	49	33	33
CTCGAAACAGGTGGAT-1_8_H10	-7.024593585	6.719719234	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1088	1568	0.067602041	0.054209184	8	oligos	OL-MS-1	49	33	33
CTCGAAAGTAGCCTCG-1_8_H10	-10.92931908	-2.053733117	13A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2334	4300	0.012093023	0.009302326	8	13A	IN-VIP	49	33	33
CTCGAAAGTCCCTTGT-1_8_H10	18.99054793	-23.96525188	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	6339	18101	0.004806364	0.012982708	8	3	EN-L5-6	49	33	33
CTCGAAAGTTCACCTC-1_8_H10	-2.268058953	11.64294881	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	921	1315	0.0121673	0.013688213	8	oligos	OL-MS-1	49	33	33
CTCGAAATCAAGAAGT-1_8_H10	-5.623428021	9.531833513	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	770	1017	0.020648968	0.029498525	8	oligos	OL-MS-1	49	33	33
CTCGAGGGTCAGAAGC-1_8_H10	33.97915403	13.86722655	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1117	1565	0.008306709	0.020447284	8	14	Microglia	49	33	33
CTCGAGGGTCCGTCAG-1_8_H10	-3.219586833	7.88790725	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1167	1647	0.009714633	0.027322404	8	oligos	OL-MS-1	49	33	33
CTCGAGGGTTACGGAG-1_8_H10	22.503923	-26.79186667	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4950	13179	0.003490401	0.008194855	8	3	EN-L5-6	49	33	33
CTCGAGGTCAGAGACG-1_8_H10	-19.59753173	25.38069041	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1738	3068	0.011734029	0.007822686	8	8	Astrocytes	49	33	33
CTCGAGGTCATTGCCC-1_8_H10	9.014688279	-23.28308651	4	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5706	15940	0.003387704	0.009598494	8	L2-3	EN-L2-3-MS	49	33	33
CTCGAGGTCGGCGCAT-1_8_H10	-29.10643122	-1.244346706	9	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1474	2343	0.004268032	0.025608195	8	9	OPC	49	33	33
CTCGGAGAGGCAAAGA-1_8_H10	-30.34337557	-21.29267819	6A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5052	11644	0.043455857	0.016746822	8	6A	IN-PV	49	33	33
CTCGGAGCAAACTGCT-1_8_H10	13.87407471	13.11698299	1	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1292	1944	0.008744856	0.011316872	8	oligos	OL-Cntl	49	33	33
CTCGGAGCAACTGCTA-1_8_H10	-15.05901473	14.2546862	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1999	3462	0.009243212	0.00779896	8	8	Astrocytes	49	33	33
CTCGGAGCAGCCTTGG-1_8_H10	-4.209903387	-37.54085767	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1168	1641	0.017062767	0.031078611	8	16	EN-PYR	49	33	33
CTCGGAGGTCTCACCT-1_8_H10	7.054253715	-21.42971559	4	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4058	9711	0.013798785	0.006590464	8	L2-3	EN-L2-3-MS	49	33	33
CTCGGAGGTTCCACTC-1_8_H10	-17.77649953	-2.784362747	13A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2915	5696	0.017205056	0.018082865	8	13A	IN-VIP	49	33	33
CTCGGAGGTTGCGTTA-1_8_H10	32.93995285	-16.75236898	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4578	10542	0.0169797	0.022955796	8	2	EN-L4	49	33	33
CTCGGAGTCATTCACT-1_8_H10	16.18575543	-9.223236035	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2389	5046	0.020412208	0.008323424	8	3	EN-L5-6	49	33	33
CTCGGAGTCGAGCCCA-1_8_H10	24.32105635	-12.10266609	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4133	9235	0.01082837	0.010070384	8	3	EN-L5-6	49	33	33
CTCGGGAAGAACTCGG-1_8_H10	-1.980065412	11.18454485	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1005	1386	0.008658009	0.022366522	8	oligos	OL-MS-1	49	33	33
CTCGGGAAGCTAAACA-1_8_H10	-0.371712551	9.627229118	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1222	1783	0.007291082	0.019629837	8	oligos	OL-MS-1	49	33	33
CTCGGGAAGCTACCGC-1_8_H10	28.44783932	-14.96373584	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5470	13874	0.036326942	0.012108981	8	2	EN-L4	49	33	33
CTCGGGAAGGTGCTTT-1_8_H10	-6.578948605	10.22839969	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	830	1206	0.010779436	0.029021559	8	oligos	OL-MS-1	49	33	33
CTCGGGACAAACGTGG-1_8_H10	-23.62373153	5.781592405	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	782	1071	0.02054155	0.013071895	8	8	Astrocytes	49	33	33
CTCGGGACATAGACTC-1_8_H10	29.07059142	10.0583294	15DB	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1103	1473	0.012219959	0.097759674	8	15DB	B cells	49	33	33
CTCGGGAGTCTGGTCG-1_8_H10	30.0474258	-13.04673381	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3973	9132	0.038874288	0.009745948	8	2	EN-L4	49	33	33
CTCGGGAGTTAAGATG-1_8_H10	21.68858965	-22.33710636	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4411	10785	0.021325916	0.011775614	8	3	EN-L5-6	49	33	33
CTCGGGATCCTATTCA-1_8_H10	-4.797018503	16.04304681	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	737	1032	0.015503876	0.022286822	8	oligos	OL-MS-1	49	33	33
CTCGTACAGTATGACA-1_8_H10	20.01044786	-33.91861242	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5092	14973	0.010752688	0.006344754	8	3	EN-L5-6	49	33	33
CTCGTACCACCAGTTA-1_8_H10	-4.354002721	8.13146998	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	967	1341	0.01715138	0.036539896	8	oligos	OL-MS-1	49	33	33
CTCGTACGTAAGTGGC-1_8_H10	-3.223120758	8.502813821	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	979	1343	0.012658228	0.020848846	8	oligos	OL-MS-1	49	33	33
CTCGTACGTAGTAGTA-1_8_H10	32.84183898	10.1025737	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	862	1146	0.012216405	0.035776614	8	14	Microglia	49	33	33
CTCGTACGTCAGTGGA-1_8_H10	-0.310028883	10.36378477	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1005	1538	0.022106632	0.016905072	8	oligos	OL-MS-1	49	33	33
CTCGTACGTCTAGGTT-1_8_H10	16.29363933	-20.57194623	4	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5722	19327	0.018626792	0.009572101	8	L2-3	EN-L2-3-MS	49	33	33
CTCGTACGTCTGCGGT-1_8_H10	-28.25742885	-0.701289376	9	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1896	3066	0.010763209	0.021852577	8	9	OPC	49	33	33
CTCGTACGTGGTACAG-1_8_H10	19.34092126	-30.19077904	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	7307	27243	0.002826414	0.007671695	8	3	EN-L5-6	49	33	33
CTCGTCAAGCTAAACA-1_8_H10	25.51174002	10.26172337	15A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3181	6040	0.012748344	0.039900662	8	15A	Endo cells	49	33	33
CTCGTCACAAACAACA-1_8_H10	-4.142336958	-36.62604121	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	792	1082	0.020332717	0.029574861	8	16	EN-PYR	49	33	33
CTCGTCACACCAGATT-1_8_H10	-26.66299286	-2.675375127	9	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1322	1981	0.009591116	0.042907622	8	9	OPC	49	33	33
CTCGTCAGTAAATGTG-1_8_H10	-18.08851649	-9.520043747	13B	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4045	9713	0.008236384	0.009162977	8	13B	IN-SV2C	49	33	33
CTCGTCAGTGAGTGAC-1_8_H10	9.975478817	-21.72805407	4	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5310	13821	0.007163013	0.011576586	8	L2-3	EN-L2-3-MS	49	33	33
CTCGTCAGTGGTAACG-1_8_H10	24.38084151	-22.32076199	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3880	8724	0.034961027	0.00997249	8	3	EN-L5-6	49	33	33
CTCGTCATCGGAGCAA-1_8_H10	24.35953355	-23.97939453	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3431	7981	0.037965167	0.005262498	8	3	EN-L5-6	49	33	33
CTCTAATCAACTGCTA-1_8_H10	-1.130182349	9.017455856	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1177	1835	0.010899183	0.019073569	8	oligos	OL-MS-1	49	33	33
CTCTAATGTCCGAAGA-1_8_H10	-5.979327015	-37.4002101	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1023	1428	0.051820728	0.016806723	8	16	EN-PYR	49	33	33
CTCTAATGTCTCCACT-1_8_H10	-6.378939683	10.47745157	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	873	1196	0.014214047	0.024247492	8	oligos	OL-MS-1	49	33	33
CTCTAATGTCTGCGGT-1_8_H10	-0.305859706	-26.30942554	10	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5681	19867	0.00372477	0.005989832	8	L2-3	EN-L2-3-Cntl	49	33	33
CTCTACGAGGATTCGG-1_8_H10	9.503091396	-21.7415768	4	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5516	14999	0.005600373	0.012867525	8	L2-3	EN-L2-3-MS	49	33	33
CTCTACGCAGTCGTGC-1_8_H10	29.8046676	9.540470864	15DA	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	892	1191	0.010075567	0.057934509	8	15DA	T cells	49	33	33
CTCTACGCATGCATGT-1_8_H10	-6.805110787	6.62754927	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1244	1803	0.021075984	0.021075984	8	oligos	OL-MS-1	49	33	33
CTCTACGGTGTGCGTC-1_8_H10	-2.14667353	10.8435529	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	944	1299	0.013856813	0.021555042	8	oligos	OL-MS-1	49	33	33
CTCTACGGTTCTGTTT-1_8_H10	16.27722288	-22.51206021	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	8308	34620	0.007192374	0.006990179	8	3	EN-L5-6	49	33	33
CTCTACGGTTTACTCT-1_8_H10	-23.63905273	-25.67212217	6A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5136	15125	0.004826446	0.007008264	8	6A	IN-PV	49	33	33
CTCTGGTAGGCCCTCA-1_8_H10	-11.55409547	-27.3640175	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	879	1286	0.126749611	0.014774495	8	16	EN-PYR	49	33	33
CTCTGGTGTATTCTCT-1_8_H10	-24.11980062	-19.45546662	6A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2887	5872	0.00613079	0.011410082	8	6A	IN-PV	49	33	33
CTGAAACAGGCTCAGA-1_8_H10	30.1440313	13.4739186	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	874	1160	0.01637931	0.086206897	8	14	Microglia	49	33	33
CTGAAACAGTTAAGTG-1_8_H10	18.54028998	-8.635095303	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2039	3623	0.018216947	0.005244273	8	3	EN-L5-6	49	33	33
CTGAAACCACGACTCG-1_8_H10	39.02878581	14.7148872	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1317	1933	0.008277289	0.011381273	8	14	Microglia	49	33	33
CTGAAACCAGTTTACG-1_8_H10	-6.107028286	9.392373094	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	851	1112	0.010791367	0.027877698	8	oligos	OL-MS-1	49	33	33
CTGAAACCATGCTAGT-1_8_H10	6.797059177	1.519961321	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	785	1307	0.273909717	0.020657995	8	16	EN-PYR	49	33	33
CTGAAACGTGCCTGCA-1_8_H10	-1.090359104	8.547138759	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1308	2001	0.009495252	0.020489755	8	oligos	OL-MS-1	49	33	33
CTGAAGTGTATTCTCT-1_8_H10	33.19254523	9.200087061	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	900	1309	0.025210084	0.009167303	8	14	Microglia	49	33	33
CTGAAGTGTGAAGGCT-1_8_H10	22.66433058	-23.93485923	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5034	13628	0.019518638	0.005650132	8	3	EN-L5-6	49	33	33
CTGAAGTTCCAAACAC-1_8_H10	-31.32351522	0.604257606	9	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1800	3077	0.008449789	0.006174846	8	9	OPC	49	33	33
CTGATAGAGGACAGCT-1_8_H10	10.07160954	-21.85306006	4	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	6577	21031	0.007750464	0.010365651	8	L2-3	EN-L2-3-MS	49	33	33
CTGATAGCATACTACG-1_8_H10	-3.207913197	8.17122638	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1078	1536	0.021484375	0.02734375	8	oligos	OL-MS-1	49	33	33
CTGATAGGTTCCGTCT-1_8_H10	-17.35267575	5.753025117	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	732	1054	0.012333966	0.015180266	8	8	Astrocytes	49	33	33
CTGATAGGTTGGTAAA-1_8_H10	3.805153859	4.154815244	7	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1610	2418	0.020264682	0.017369727	8	7	Phagocytes	49	33	33
CTGATAGTCAACGGGA-1_8_H10	-32.14508713	-10.99721445	9	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	891	1198	0.004173623	0.002504174	8	9	OPC	49	33	33
CTGATAGTCCACGACG-1_8_H10	-5.946270972	-37.66315038	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1067	1605	0.102180685	0.026168224	8	16	EN-PYR	49	33	33
CTGATAGTCTTTAGGG-1_8_H10	-3.580188883	-36.45167557	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	939	1220	0.049180328	0.023770492	8	16	EN-PYR	49	33	33
CTGATCCAGACTAAGT-1_8_H10	16.00427621	-22.34640418	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5863	16356	0.008926388	0.014184397	8	3	EN-L5-6	49	33	33
CTGATCCAGTCTTGCA-1_8_H10	-22.05121285	9.625635633	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1152	1919	0.007816571	0.003647733	8	8	Astrocytes	49	33	33
CTGATCCCAATCCGAT-1_8_H10	33.32669933	13.37234282	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1104	1553	0.01802962	0.026400515	8	14	Microglia	49	33	33
CTGATCCGTGACGCCT-1_8_H10	31.14135456	13.36647655	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1334	1943	0.02110139	0.040658775	8	14	Microglia	49	33	33
CTGATCCTCCGCGGTA-1_8_H10	27.40370228	9.989713341	15A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1188	1855	0.046361186	0.083557951	8	15A	Endo cells	49	33	33
CTGATCCTCTGGCGAC-1_8_H10	-4.463345128	10.40771075	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	748	1020	0.018627451	0.016666667	8	oligos	OL-MS-1	49	33	33
CTGCCTAAGTGAAGTT-1_8_H10	-17.37759257	25.38241931	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1926	3113	0.003854802	0.009637006	8	8	Astrocytes	49	33	33
CTGCCTACACCGGAAA-1_8_H10	-15.36963005	12.04391393	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1499	2338	0.009837468	0.005560308	8	8	Astrocytes	49	33	33
CTGCCTACACCTATCC-1_8_H10	33.06671509	8.773392783	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	928	1256	0.027070064	0.016719745	8	14	Microglia	49	33	33
CTGCCTACATCACGAT-1_8_H10	-6.81951536	8.626043888	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	823	1091	0.047662695	0.018331806	8	oligos	OL-MS-1	49	33	33
CTGCCTATCATGTGGT-1_8_H10	-1.116410948	-19.17369132	10	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2711	5878	0.002551888	0.008676421	8	L2-3	EN-L2-3-Cntl	49	33	33
CTGCCTATCGACCAGC-1_8_H10	-5.440459692	-37.38073079	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1019	1420	0.044366197	0.028873239	8	16	EN-PYR	49	33	33
CTGCCTATCTCCGGTT-1_8_H10	29.43705821	-11.35928371	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5664	17171	0.030283618	0.007337954	8	2	EN-L4	49	33	33
CTGCGGAAGGCGTACA-1_8_H10	-18.95422743	8.633136896	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1180	1827	0.014778325	0.003831418	8	8	Astrocytes	49	33	33
CTGCGGACAGTAAGCG-1_8_H10	-30.10164561	-1.660984739	9	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1527	2433	0.01027538	0.007398274	8	9	OPC	49	33	33
CTGCGGACATCCCACT-1_8_H10	-4.104417968	10.40456096	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	859	1201	0.019150708	0.034138218	8	oligos	OL-MS-1	49	33	33
CTGCGGAGTCGAATCT-1_8_H10	18.47020674	-24.65205276	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	6826	23468	0.017683654	0.010269303	8	3	EN-L5-6	49	33	33
CTGCGGAGTGGTGTAG-1_8_H10	-5.011907621	8.66306866	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	817	1094	0.007312614	0.026508227	8	oligos	OL-MS-1	49	33	33
CTGCGGAGTTCCAACA-1_8_H10	32.34203226	11.95013144	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1098	1453	0.018582244	0.0330351	8	14	Microglia	49	33	33
CTGCGGATCATCACCC-1_8_H10	-5.868884475	11.4965809	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	761	1063	0.017873942	0.011288805	8	oligos	OL-MS-1	49	33	33
CTGCGGATCTTGTACT-1_8_H10	-17.20029959	16.42796247	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1531	2524	0.009508716	0.005150555	8	8	Astrocytes	49	33	33
CTGCTGTAGCCAGTTT-1_8_H10	-2.616631048	11.60650905	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	898	1253	0.011971269	0.015961692	8	oligos	OL-MS-1	49	33	33
CTGCTGTAGGAGTACC-1_8_H10	17.8067963	-25.54617908	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5677	16565	0.006640507	0.011590703	8	3	EN-L5-6	49	33	33
CTGGTCTCAATGTTGC-1_8_H10	29.3764157	15.41340272	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2439	4180	0.026555024	0.044976077	8	14	Microglia	49	33	33
CTGGTCTTCTTGAGGT-1_8_H10	-3.084429685	10.01195114	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	957	1352	0.020710059	0.025147929	8	oligos	OL-MS-1	49	33	33
CTGTGCTCACGTCTCT-1_8_H10	-5.59665873	11.87455709	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	741	1004	0.016932271	0.022908367	8	oligos	OL-MS-1	49	33	33
CTGTGCTGTACAGCAG-1_8_H10	8.621726008	-21.29751035	4	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5943	15846	0.004543733	0.0119273	8	L2-3	EN-L2-3-MS	49	33	33
CTGTGCTGTATCTGCA-1_8_H10	26.88459378	8.598043151	15A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1308	1975	0.01164557	0.041518987	8	15A	Endo cells	49	33	33
CTGTTTAGTGACTCAT-1_8_H10	20.00538246	-4.228572358	12	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2493	5202	0.099000384	0.006728181	8	12	EN-MIX	49	33	33
CTGTTTAGTGTAAGTA-1_8_H10	-27.66057862	-10.92559148	9	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1055	1463	0.014354067	0.017088175	8	9	OPC	49	33	33
CTTAACTAGGCAGGTT-1_8_H10	33.22681224	9.239891362	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1010	1479	0.045977011	0.021636241	8	14	Microglia	49	33	33
CTTAACTAGGCGACAT-1_8_H10	-4.421002849	8.45528394	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1040	1426	0.01542777	0.021037868	8	oligos	OL-MS-1	49	33	33
CTTAACTAGGTAGCTG-1_8_H10	-17.27998344	6.370689455	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	776	1027	0.023369036	0.016553067	8	8	Astrocytes	49	33	33
CTTAACTAGTACGTAA-1_8_H10	-11.03805387	-9.003206363	13B	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1553	2510	0.028286853	0.005976096	8	13B	IN-SV2C	49	33	33
CTTAACTGTCCGTGAC-1_8_H10	-28.60546221	-1.031139498	9	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1524	2419	0.011575031	0.021083092	8	9	OPC	49	33	33
CTTAACTGTGCATCTA-1_8_H10	-23.19117212	-15.53677552	6A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5586	16381	0.043342897	0.006104633	8	6A	IN-PV	49	33	33
CTTAACTTCCGAGCCA-1_8_H10	-3.130670027	-35.69180316	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	917	1269	0.115839243	0.033096927	8	16	EN-PYR	49	33	33
CTTACCGAGATACACA-1_8_H10	-16.24798268	6.400962163	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	834	1023	0.048875855	0.015640274	8	8	Astrocytes	49	33	33
CTTACCGAGCACACAG-1_8_H10	20.31066237	-20.95991774	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	6685	23105	0.026790738	0.013719974	8	3	EN-L5-6	49	33	33
CTTACCGCAACAACCT-1_8_H10	-17.48914938	6.297744708	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	807	1062	0.035781544	0.009416196	8	8	Astrocytes	49	33	33
CTTACCGCAGGCGATA-1_8_H10	4.046061897	3.885296856	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2761	4993	0.026837573	0.05087122	8	14	Microglia	49	33	33
CTTACCGCATACAGCT-1_8_H10	-16.52144896	8.096533409	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1220	1707	0.033977739	0.008787346	8	8	Astrocytes	49	33	33
CTTACCGGTGTGAATA-1_8_H10	33.06770281	13.50951991	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1400	1983	0.009581442	0.026727181	8	14	Microglia	49	33	33
CTTACCGGTGTTGGGA-1_8_H10	29.90559919	9.627272235	15DA	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1176	1710	0.016959064	0.05497076	8	15DA	T cells	49	33	33
CTTACCGTCGAGGTAG-1_8_H10	-1.963516536	11.50889026	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	966	1415	0.007067138	0.009893993	8	oligos	OL-MS-1	49	33	33
CTTACCGTCGATCCCT-1_8_H10	-17.54967994	8.144404203	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1099	1544	0.011010363	0.010362694	8	8	Astrocytes	49	33	33
CTTACCGTCGGAAACG-1_8_H10	25.50592433	-26.33867956	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4401	10992	0.009552402	0.006004367	8	3	EN-L5-6	49	33	33
CTTAGGAAGACTAGAT-1_8_H10	37.87063067	11.07308721	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	931	1274	0.01255887	0.009419152	8	14	Microglia	49	33	33
CTTAGGAAGCGCTCCA-1_8_H10	24.38171603	-24.12129445	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3062	7073	0.05867383	0.003393185	8	3	EN-L5-6	49	33	33
CTTAGGAAGGGATCTG-1_8_H10	33.17397225	13.76123883	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1048	1508	0.00729443	0.043103448	8	14	Microglia	49	33	33
CTTAGGAAGGGCATGT-1_8_H10	-5.040732587	9.912835323	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	888	1223	0.017170891	0.017170891	8	oligos	OL-MS-1	49	33	33
CTTAGGACACGCGAAA-1_8_H10	-12.24108331	-1.777284722	13A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2400	4345	0.012428078	0.009896433	8	13A	IN-VIP	49	33	33
CTTAGGAGTCCAACTA-1_8_H10	-21.76316712	5.508730061	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	990	1368	0.024122807	0.016812865	8	8	Astrocytes	49	33	33
CTTAGGATCAGCGATT-1_8_H10	25.77523705	10.57141859	15A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2916	5985	0.023224728	0.077025898	8	15A	Endo cells	49	33	33
CTTAGGATCTCTTGAT-1_8_H10	-30.01931216	-1.142171803	9	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1630	3016	0.00862069	0.006962865	8	9	OPC	49	33	33
CTTAGGATCTTGTACT-1_8_H10	-6.014661201	10.69121069	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	936	1269	0.010244287	0.02679275	8	oligos	OL-MS-1	49	33	33
CTTCTCTAGAAACCGC-1_8_H10	-29.90238841	0.358660993	9	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2035	3567	0.007289038	0.010933558	8	9	OPC	49	33	33
CTTCTCTAGGATGGTC-1_8_H10	-4.717496556	11.58092354	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	890	1215	0.011522634	0.027160494	8	oligos	OL-MS-1	49	33	33
CTTCTCTAGTGCGTGA-1_8_H10	29.466681	6.343838812	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1331	1981	0.04997476	0.058556285	8	oligos	OL-MS-1	49	33	33
CTTCTCTAGTGTACTC-1_8_H10	29.06007731	7.478119461	15DA	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	704	1018	0.148330059	0.062868369	8	15DA	T cells	49	33	33
CTTCTCTCAACTGGCC-1_8_H10	-1.772035494	11.311418	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	942	1394	0.010760402	0.015064562	8	oligos	OL-MS-1	49	33	33
CTTCTCTCATGTTCCC-1_8_H10	27.08310429	4.645730161	15BA	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	949	1267	0.041831097	0.014996054	8	15BA	Stromal cells	49	33	33
CTTCTCTGTAGCTAAA-1_8_H10	-5.023163624	9.849468578	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	908	1267	0.01183899	0.028413575	8	oligos	OL-MS-1	49	33	33
CTTCTCTGTAGGGACT-1_8_H10	-4.329478257	-37.42593816	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1006	1286	0.037325039	0.029548989	8	16	EN-PYR	49	33	33
CTTCTCTTCACATGCA-1_8_H10	-7.967234377	-38.41709486	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1251	1714	0.055425904	0.021003501	8	16	EN-PYR	49	33	33
CTTCTCTTCCACGTTC-1_8_H10	-1.690968855	9.912176995	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1055	1511	0.020516214	0.016545334	8	oligos	OL-MS-1	49	33	33
CTTCTCTTCTTGAGGT-1_8_H10	2.583942214	19.20416104	1	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	923	1347	0.006681514	0.01484781	8	oligos	OL-Cntl	49	33	33
CTTGGCTAGATGTGGC-1_8_H10	-4.768325697	8.513729884	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	860	1189	0.012615643	0.042893188	8	oligos	OL-MS-1	49	33	33
CTTGGCTAGCTAGTGG-1_8_H10	-4.055505503	10.81405278	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	799	1083	0.004616805	0.019390582	8	oligos	OL-MS-1	49	33	33
CTTGGCTAGGGAAACA-1_8_H10	33.07974889	10.17988418	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	852	1243	0.010458568	0.016090105	8	14	Microglia	49	33	33
CTTGGCTAGGGAGTAA-1_8_H10	-10.44435406	27.3285932	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	996	1292	0.025541796	0.034055728	8	oligos	OL-MS-1	49	33	33
CTTGGCTCAAGGTTTC-1_8_H10	19.56375687	-21.89996612	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	6484	20048	0.015213488	0.016510375	8	3	EN-L5-6	49	33	33
CTTGGCTCATAAAGGT-1_8_H10	-3.581146287	-35.37834721	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	784	1096	0.140510949	0.027372263	8	16	EN-PYR	49	33	33
CTTGGCTGTGATGTCT-1_8_H10	-17.02836284	25.48012063	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2070	3756	0.018636848	0.008519702	8	8	Astrocytes	49	33	33
CTTTGCGAGTCTCAAC-1_8_H10	-6.288733654	11.22248025	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	804	1089	0.009182736	0.015610652	8	oligos	OL-MS-1	49	33	33
CTTTGCGCACGAGGTA-1_8_H10	17.27558043	-27.07686508	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5990	20046	0.015863514	0.005287838	8	3	EN-L5-6	49	33	33
CTTTGCGGTCATATGC-1_8_H10	23.62155798	7.524302027	15DA	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2855	4908	0.029339853	0.04604727	8	15DA	T cells	49	33	33
GAAACTCAGCTAGTCT-1_8_H10	5.608364043	11.30633381	1	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1306	2005	0.008977556	0.016957606	8	oligos	OL-Cntl	49	33	33
GAAACTCCACAGGTTT-1_8_H10	-1.488836947	7.995963783	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1328	1936	0.011363636	0.02427686	8	oligos	OL-MS-1	49	33	33
GAAACTCGTAGCGCAA-1_8_H10	29.35600388	9.755894759	15DA	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	882	1152	0.024305556	0.071180556	8	15DA	T cells	49	33	33
GAAACTCTCCAGAGGA-1_8_H10	19.90774593	-23.13729248	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	6758	22852	0.006782776	0.006388938	8	3	EN-L5-6	49	33	33
GAAATGAAGTCACGCC-1_8_H10	-4.170808859	6.229270616	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1764	3183	0.003770028	0.038956959	8	oligos	OL-MS-1	49	33	33
GAAATGACAAGCTGTT-1_8_H10	30.18324691	-7.072729811	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5073	14792	0.010208221	0.007030827	8	2	EN-L4	49	33	33
GAAATGACAATCTGCA-1_8_H10	-6.837904176	10.09917147	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	829	1076	0.01394052	0.035315985	8	oligos	OL-MS-1	49	33	33
GAAATGACAGCTCCGA-1_8_H10	31.63767432	12.10403805	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1381	1864	0.017703863	0.022532189	8	14	Microglia	49	33	33
GAAATGACATCGATGT-1_8_H10	-23.63109733	-25.00486898	6A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3745	9192	0.039708442	0.007288947	8	6A	IN-PV	49	33	33
GAAATGAGTATATGAG-1_8_H10	19.57900513	-21.79822327	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5603	15819	0.024084961	0.012643024	8	3	EN-L5-6	49	33	33
GAAATGAGTTGTGGCC-1_8_H10	-16.10014914	15.08145694	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1741	3292	0.007897934	0.003341434	8	8	Astrocytes	49	33	33
GAAATGATCCGCGGTA-1_8_H10	8.121105156	1.519495262	12	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	758	1015	0.05320197	0.027586207	8	12	EN-MIX	49	33	33
GAAATGATCTCCAGGG-1_8_H10	-28.87970898	-22.3880539	6A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4943	12016	0.020805593	0.012816245	8	6A	IN-PV	49	33	33
GAACATCAGATATACG-1_8_H10	8.973258464	-21.65268133	4	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5320	14399	0.0094451	0.007708869	8	L2-3	EN-L2-3-MS	49	33	33
GAACATCAGTGTCTCA-1_8_H10	-6.382128219	7.18736754	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	982	1316	0.022036474	0.032674772	8	oligos	OL-MS-1	49	33	33
GAACATCCATCAGTAC-1_8_H10	-25.21295445	0.932427836	11	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1968	3345	0.00328849	0.015246637	8	11	Glia-MIX	49	33	33
GAACATCCATCTACGA-1_8_H10	18.29238306	-25.13379173	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	7447	28297	0.007810015	0.009647666	8	3	EN-L5-6	49	33	33
GAACATCGTTTGGCGC-1_8_H10	1.257381663	13.84742536	1	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	916	1362	0.00660793	0.013950073	8	oligos	OL-Cntl	49	33	33
GAACATCTCAAACCGT-1_8_H10	-3.619520613	10.19596539	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	889	1232	0.01461039	0.024350649	8	oligos	OL-MS-1	49	33	33
GAACATCTCCTCGCAT-1_8_H10	-3.082690256	-35.33929712	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	884	1258	0.095389507	0.022257552	8	16	EN-PYR	49	33	33
GAACCTAAGGACAGCT-1_8_H10	-7.603443621	9.344814914	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	795	1161	0.022394488	0.021533161	8	oligos	OL-MS-1	49	33	33
GAACCTAAGTCCGTAT-1_8_H10	5.395372375	5.323010167	7	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3229	7298	0.007262264	0.013017265	8	7	Phagocytes	49	33	33
GAACCTAAGTGGTCCC-1_8_H10	-4.482821181	8.330557714	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	938	1321	0.022710068	0.042392127	8	oligos	OL-MS-1	49	33	33
GAACCTAGTCCGAGTC-1_8_H10	-6.738057481	10.30796614	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	840	1102	0.021778584	0.0353902	8	oligos	OL-MS-1	49	33	33
GAACCTAGTTAAGGGC-1_8_H10	29.99178981	15.55825234	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1590	2473	0.017387788	0.086938941	8	14	Microglia	49	33	33
GAACCTAGTTCGTGAT-1_8_H10	8.809577655	-21.03428099	4	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5556	16691	0.008867054	0.007608891	8	L2-3	EN-L2-3-MS	49	33	33
GAACCTATCACAGTAC-1_8_H10	-14.19195549	-22.0573793	6A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1413	2407	0.069796427	0.007893644	8	6A	IN-PV	49	33	33
GAACCTATCAGCGATT-1_8_H10	-3.884535617	9.188638871	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1023	1432	0.009078212	0.026536313	8	oligos	OL-MS-1	49	33	33
GAACCTATCCGAAGAG-1_8_H10	-27.7832101	-5.105062087	9	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1234	1776	0.013513514	0.015202703	8	9	OPC	49	33	33
GAACGGAAGGGCTCTC-1_8_H10	-9.107174634	-11.14602768	6B	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1094	1529	0.058207979	0.0117724	8	6B	IN-SST	49	33	33
GAACGGAAGTGTACTC-1_8_H10	14.68965449	-22.49662153	4	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4381	10894	0.024141729	0.006609143	8	L2-3	EN-L2-3-MS	49	33	33
GAACGGAGTTGTACAC-1_8_H10	-12.57704075	-3.20313945	13A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2378	4282	0.018682858	0.010275572	8	13A	IN-VIP	49	33	33
GAACGGATCACATACG-1_8_H10	-3.923317402	-37.16558977	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1033	1425	0.046315789	0.042807018	8	16	EN-PYR	49	33	33
GAAGCAGAGACGCACA-1_8_H10	-17.03435923	-14.56615535	6B	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1960	3404	0.022620447	0.009106933	8	6B	IN-SST	49	33	33
GAAGCAGAGCTAACAA-1_8_H10	-17.50713082	24.50656869	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1641	2528	0.009493671	0.006724684	8	8	Astrocytes	49	33	33
GAAGCAGAGCTGAAAT-1_8_H10	-12.19560927	-13.44178625	6A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1827	3326	0.066746843	0.009921828	8	6A	IN-PV	49	33	33
GAAGCAGAGTCCTCCT-1_8_H10	-7.889676714	7.906367838	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	735	1078	0.020408163	0.018552876	8	oligos	OL-MS-1	49	33	33
GAAGCAGCAAGCTGGA-1_8_H10	28.82125787	10.10471207	15DB	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	906	1261	0.036478985	0.113402062	8	15DB	B cells	49	33	33
GAAGCAGCACCGGAAA-1_8_H10	-4.511682182	16.62936478	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	825	1157	0.008643042	0.021607606	8	oligos	OL-MS-1	49	33	33
GAAGCAGGTCTTCTCG-1_8_H10	30.04113016	-11.12620978	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4158	10371	0.03085527	0.010317231	8	2	EN-L4	49	33	33
GAAGCAGGTGTGAAAT-1_8_H10	-20.36495039	3.940530431	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1023	1339	0.039581777	0.02240478	8	8	Astrocytes	49	33	33
GAATAAGAGATCGGGT-1_8_H10	-24.63625201	-18.46152826	6A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3361	6673	0.023227933	0.014835906	8	6A	IN-PV	49	33	33
GAATAAGCAACCGCCA-1_8_H10	-2.857678728	18.98537056	1	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	887	1250	0.0088	0.008	8	oligos	OL-Cntl	49	33	33
GAATAAGGTATAGGGC-1_8_H10	24.86317276	-14.75159899	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4969	11970	0.057560568	0.010025063	8	3	EN-L5-6	49	33	33
GAATAAGGTCGCTTCT-1_8_H10	35.68212597	-8.679331188	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5952	16927	0.007502806	0.014946535	8	2	EN-L4	49	33	33
GAATAAGTCCCTCAGT-1_8_H10	31.70209532	9.641773878	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	855	1179	0.026293469	0.048346056	8	14	Microglia	49	33	33
GAATAAGTCCTAGTGA-1_8_H10	32.14556836	14.14212754	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1660	2499	0.011604642	0.039615846	8	14	Microglia	49	33	33
GAATAAGTCGAATGGG-1_8_H10	24.17477134	-17.40865117	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4499	10610	0.025541942	0.015268615	8	3	EN-L5-6	49	33	33
GAATGAAAGATCCTGT-1_8_H10	-8.664337603	-37.70973763	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1122	1643	0.04686549	0.017650639	8	16	EN-PYR	49	33	33
GAATGAAAGGGAAACA-1_8_H10	-17.60536027	25.16035874	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1888	2994	0.008350033	0.006012024	8	8	Astrocytes	49	33	33
GAATGAACAAGCGAGT-1_8_H10	-3.898805925	11.26355444	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	793	1087	0.011959522	0.021159154	8	oligos	OL-MS-1	49	33	33
GAATGAACAGCCTTTC-1_8_H10	0.456419807	9.054451995	1	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1220	1817	0.014309301	0.022564667	8	oligos	OL-Cntl	49	33	33
GAATGAACAGGTTTCA-1_8_H10	18.69746314	-28.02949306	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5597	17603	0.003351701	0.007839573	8	3	EN-L5-6	49	33	33
GAATGAACATCTCGCT-1_8_H10	-15.49473803	12.56271272	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1489	2341	0.00811619	0.005126015	8	8	Astrocytes	49	33	33
GAATGAAGTGTGCCTG-1_8_H10	30.22879799	15.77041637	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1453	2214	0.012646793	0.063233966	8	14	Microglia	49	33	33
GAATGAATCCTTGGTC-1_8_H10	-8.437368774	8.092597031	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1000	1386	0.051948052	0.038239538	8	oligos	OL-MS-1	49	33	33
GACACGCAGCCAACAG-1_8_H10	-7.018813326	8.807655443	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	767	1021	0.019588639	0.024485798	8	oligos	OL-MS-1	49	33	33
GACACGCAGCCAGTTT-1_8_H10	-6.911846111	8.801543981	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	817	1112	0.013489209	0.018884892	8	oligos	OL-MS-1	49	33	33
GACACGCCAAGTTGTC-1_8_H10	-1.774419703	9.916274745	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1027	1451	0.017229497	0.013783598	8	oligos	OL-MS-1	49	33	33
GACACGCCAATCTACG-1_8_H10	24.4625731	-17.00272313	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	7752	28603	0.021536202	0.01304059	8	3	EN-L5-6	49	33	33
GACACGCCACATTTCT-1_8_H10	17.1579853	-26.44010397	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	6421	21906	0.011640646	0.005797498	8	3	EN-L5-6	49	33	33
GACACGCGTGTGAAAT-1_8_H10	32.08538229	13.28931468	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1114	1518	0.022397892	0.03886693	8	14	Microglia	49	33	33
GACACGCGTTCCGGCA-1_8_H10	19.44278715	-22.67364145	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	8288	31014	0.010640356	0.012574966	8	3	EN-L5-6	49	33	33
GACACGCTCTCTGAGA-1_8_H10	-0.807067285	10.26627801	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1034	1587	0.016383113	0.010712035	8	oligos	OL-MS-1	49	33	33
GACAGAGCAACGATCT-1_8_H10	-10.83073995	-39.06270758	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1494	2387	0.072056975	0.035190616	8	16	EN-PYR	49	33	33
GACAGAGCAAGTCTGT-1_8_H10	-22.57879942	-19.18453648	6A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2333	4372	0.030192132	0.020585544	8	6A	IN-PV	49	33	33
GACAGAGCACCAGCAC-1_8_H10	22.51082465	-6.956694823	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2941	5952	0.003696237	0.007056452	8	3	EN-L5-6	49	33	33
GACAGAGGTACCTACA-1_8_H10	-4.137318196	9.322160334	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	961	1354	0.020679468	0.03323486	8	oligos	OL-MS-1	49	33	33
GACAGAGGTGCGATAG-1_8_H10	-4.218220608	10.4050959	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	878	1256	0.016719745	0.015127389	8	oligos	OL-MS-1	49	33	33
GACAGAGTCAATCTCT-1_8_H10	-4.225840508	11.5594164	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	867	1194	0.016750419	0.024288107	8	oligos	OL-MS-1	49	33	33
GACCAATAGTCGAGTG-1_8_H10	-12.79292218	-4.607254687	13A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2166	3748	0.01280683	0.007203842	8	13A	IN-VIP	49	33	33
GACCAATCAGAAGCAC-1_8_H10	7.42983854	-21.72776135	4	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4971	13351	0.006741068	0.007639877	8	L2-3	EN-L2-3-MS	49	33	33
GACCAATGTTTGACAC-1_8_H10	-17.10383789	7.806947873	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1106	1564	0.008951407	0.014705882	8	8	Astrocytes	49	33	33
GACCAATTCACGCGGT-1_8_H10	-6.780144324	10.5870983	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	763	1021	0.012732615	0.024485798	8	oligos	OL-MS-1	49	33	33
GACCAATTCAGCACAT-1_8_H10	-29.40776877	0.029220686	9	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1941	3327	0.003005711	0.008115419	8	9	OPC	49	33	33
GACCAATTCTTAGAGC-1_8_H10	-1.040540012	9.204985963	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1143	1772	0.031602709	0.020880361	8	oligos	OL-MS-1	49	33	33
GACCTGGAGACATAAC-1_8_H10	-16.23128391	13.13057193	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1438	2366	0.009721048	0.007185123	8	8	Astrocytes	49	33	33
GACCTGGAGCGTCAAG-1_8_H10	-10.01916976	-37.7805437	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1338	2130	0.12629108	0.021596244	8	16	EN-PYR	49	33	33
GACCTGGAGGAATTAC-1_8_H10	27.54177694	9.511872305	15A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1005	1429	0.016794962	0.072778167	8	15A	Endo cells	49	33	33
GACCTGGCACTTCTGC-1_8_H10	-15.56328218	6.946701548	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1087	1519	0.015799868	0.016458196	8	8	Astrocytes	49	33	33
GACCTGGCATATACGC-1_8_H10	17.17494457	-10.09156598	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2516	4831	0.046781205	0.00765887	8	3	EN-L5-6	49	33	33
GACCTGGGTTCCAACA-1_8_H10	-4.975409503	9.851142972	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	787	1109	0.008115419	0.026149684	8	oligos	OL-MS-1	49	33	33
GACCTGGTCATGTCTT-1_8_H10	-5.462993907	8.765977432	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	809	1101	0.006357856	0.029064487	8	oligos	OL-MS-1	49	33	33
GACCTGGTCCACTGGG-1_8_H10	9.090392075	-30.31120929	10	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4791	13816	0.012232195	0.002822814	8	L2-3	EN-L2-3-Cntl	49	33	33
GACCTGGTCCTGCAGG-1_8_H10	23.02808233	-22.30952925	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5911	18440	0.019143167	0.006995662	8	3	EN-L5-6	49	33	33
GACGCGTCAGGTCCAC-1_8_H10	28.97798888	-11.71523575	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	6164	19776	0.021794094	0.008444579	8	2	EN-L4	49	33	33
GACGCGTGTTTAGGAA-1_8_H10	4.280057178	1.444266898	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	790	1123	0.029385574	0.012466607	8	16	EN-PYR	49	33	33
GACGCGTTCCTAAGTG-1_8_H10	24.23441064	-18.82226804	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4542	11327	0.033989582	0.012536417	8	3	EN-L5-6	49	33	33
GACGCGTTCTTGAGGT-1_8_H10	29.10098547	-13.66477413	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	6860	21152	0.017303328	0.012906581	8	2	EN-L4	49	33	33
GACGGCTAGCTACCGC-1_8_H10	-17.57331983	-1.576710447	13A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3492	7225	0.010657439	0.014256055	8	13A	IN-VIP	49	33	33
GACGGCTCATGGATGG-1_8_H10	-3.101770897	-36.31677342	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	784	1037	0.077145612	0.035679846	8	16	EN-PYR	49	33	33
GACGGCTGTCACCTAA-1_8_H10	22.80141002	-17.26891332	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	6890	23959	0.032847782	0.012187487	8	3	EN-L5-6	49	33	33
GACGGCTTCAAGAAGT-1_8_H10	-28.291766	-2.32976437	9	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1532	2493	0.004813478	0.009626955	8	9	OPC	49	33	33
GACGGCTTCTAACTCT-1_8_H10	24.31037807	-11.75273306	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5117	14058	0.0088206	0.008607199	8	3	EN-L5-6	49	33	33
GACGGCTTCTGGGCCA-1_8_H10	25.57466403	10.36471163	15A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3075	5693	0.019848937	0.054804145	8	15A	Endo cells	49	33	33
GACGTGCCACACTGCG-1_8_H10	-5.271433679	10.08742367	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	759	1027	0.019474197	0.021421616	8	oligos	OL-MS-1	49	33	33
GACGTGCCATCACGTA-1_8_H10	29.66595512	9.570408329	15DB	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	913	1320	0.008333333	0.074242424	8	15DB	B cells	49	33	33
GACGTGCGTAAATACG-1_8_H10	24.60259376	-16.93673434	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	8000	28467	0.016967014	0.013454175	8	3	EN-L5-6	49	33	33
GACGTGCTCATGGTCA-1_8_H10	-4.849928757	-37.59480805	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1006	1436	0.087047354	0.027855153	8	16	EN-PYR	49	33	33
GACGTTAAGAAAGTGG-1_8_H10	-22.63767035	5.194153698	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	932	1276	0.020376176	0.007836991	8	8	Astrocytes	49	33	33
GACGTTAAGCTCCTCT-1_8_H10	-17.29800449	26.05196584	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2268	4008	0.005988024	0.00998004	8	8	Astrocytes	49	33	33
GACTAACAGACTCGGA-1_8_H10	-29.93716042	0.299190761	9	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1800	3066	0.007827789	0.010110894	8	9	OPC	49	33	33
GACTAACCATCTCGCT-1_8_H10	17.09572091	-24.98050632	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4049	10031	0.03329678	0.009670023	8	3	EN-L5-6	49	33	33
GACTAACGTCTTGATG-1_8_H10	-4.875839616	9.867162067	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	875	1202	0.015806988	0.026622296	8	oligos	OL-MS-1	49	33	33
GACTAACGTGAGTGAC-1_8_H10	33.00590027	9.15457523	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	853	1105	0.011764706	0.008144796	8	14	Microglia	49	33	33
GACTAACTCGATAGAA-1_8_H10	-4.284113903	8.461028241	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1040	1440	0.020138889	0.027777778	8	oligos	OL-MS-1	49	33	33
GACTAACTCGTGACAT-1_8_H10	-1.067488365	9.693258061	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1058	1577	0.01521877	0.027901078	8	oligos	OL-MS-1	49	33	33
GACTAACTCTTTAGGG-1_8_H10	24.31035727	-25.78884528	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3128	6984	0.015893471	0.003293242	8	3	EN-L5-6	49	33	33
GACTACACAATGGTCT-1_8_H10	28.41797578	10.45250034	15DB	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1428	2243	0.016941596	0.123049487	8	15DB	B cells	49	33	33
GACTACACACGGTTTA-1_8_H10	-18.01508254	-6.024971679	13B	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3257	6283	0.026897979	0.00875378	8	13B	IN-SV2C	49	33	33
GACTACAGTACTTGAC-1_8_H10	32.96395654	9.028599155	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	903	1186	0.022765599	0.021922428	8	14	Microglia	49	33	33
GACTACAGTGATGCCC-1_8_H10	20.86138827	-12.34295783	12	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2417	4304	0.036245353	0.01045539	8	12	EN-MIX	49	33	33
GACTACAGTGTAACGG-1_8_H10	-2.609166805	11.44166385	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	861	1255	0.01752988	0.014342629	8	oligos	OL-MS-1	49	33	33
GACTGCGAGAGGTAGA-1_8_H10	15.65325226	-27.40838369	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3609	8361	0.023800981	0.006936969	8	3	EN-L5-6	49	33	33
GACTGCGCAAGTACCT-1_8_H10	-2.486275239	10.5421522	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	961	1307	0.012241775	0.019892884	8	oligos	OL-MS-1	49	33	33
GACTGCGCAATAGAGT-1_8_H10	35.94977746	-9.390817797	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4474	10171	0.007668862	0.019860387	8	2	EN-L4	49	33	33
GACTGCGGTAAACCTC-1_8_H10	-17.95548377	25.98173281	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1984	3477	0.014092609	0.008340523	8	8	Astrocytes	49	33	33
GACTGCGGTACGCACC-1_8_H10	-15.24368021	-1.868083632	13A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2874	5723	0.016599685	0.013629215	8	13A	IN-VIP	49	33	33
GACTGCGTCAATAAGG-1_8_H10	-17.35545827	24.50150767	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1649	2529	0.013839462	0.010280743	8	8	Astrocytes	49	33	33
GACTGCGTCCACGTTC-1_8_H10	-10.29946015	-15.85918022	6B	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	998	1421	0.007741027	0.012667136	8	6B	IN-SST	49	33	33
GAGCAGAAGCTCTCGG-1_8_H10	-4.631363817	18.08969443	1	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	745	1042	0.013435701	0.016314779	8	oligos	OL-Cntl	49	33	33
GAGCAGAAGGTTCCTA-1_8_H10	-5.090107233	10.43729776	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	816	1070	0.020560748	0.022429907	8	oligos	OL-MS-1	49	33	33
GAGCAGAAGTGGTAAT-1_8_H10	-4.81295885	-36.75906198	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1039	1572	0.105597964	0.017175573	8	16	EN-PYR	49	33	33
GAGCAGACAAACGTGG-1_8_H10	-1.567515951	11.67073163	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1084	1528	0.022905759	0.020287958	8	oligos	OL-MS-1	49	33	33
GAGCAGACACCACGTG-1_8_H10	-27.27366137	-0.024452709	9	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2703	4619	0.015154795	0.022515696	8	9	OPC	49	33	33
GAGCAGACAGGATTGG-1_8_H10	9.455088273	-21.4495654	4	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5339	13703	0.007808509	0.011822229	8	L2-3	EN-L2-3-MS	49	33	33
GAGCAGATCTTACCGC-1_8_H10	-5.837080572	8.839292902	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	891	1207	0.007456504	0.024855012	8	oligos	OL-MS-1	49	33	33
GAGGTGACAAGCGATG-1_8_H10	-3.632308158	11.13772885	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	831	1163	0.006878762	0.022355976	8	oligos	OL-MS-1	49	33	33
GAGGTGACACCACCAG-1_8_H10	-0.334766105	9.406964578	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1221	1819	0.0104453	0.016492578	8	oligos	OL-MS-1	49	33	33
GAGGTGACATTGAGCT-1_8_H10	-22.40324482	-19.44889929	6A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3509	8336	0.018354127	0.004198656	8	6A	IN-PV	49	33	33
GAGGTGAGTCGAATCT-1_8_H10	32.98860113	9.717210585	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	843	1163	0.021496131	0.027515047	8	14	Microglia	49	33	33
GAGGTGAGTCTGATCA-1_8_H10	-7.62709716	6.866464817	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	901	1213	0.019785655	0.019785655	8	oligos	OL-MS-1	49	33	33
GAGGTGAGTTGGACCC-1_8_H10	-3.524417422	-36.14213622	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	858	1255	0.165737052	0.027091633	8	16	EN-PYR	49	33	33
GAGGTGATCCAATGGT-1_8_H10	32.78619179	13.2972319	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1097	1576	0.013324873	0.038071066	8	14	Microglia	49	33	33
GAGGTGATCTCTGCTG-1_8_H10	11.32311733	6.990447479	1	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1447	2317	0.006905481	0.011221407	8	oligos	OL-Cntl	49	33	33
GAGTCCGGTTTGACTG-1_8_H10	35.33174221	-11.18323063	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4416	10117	0.016902244	0.011367006	8	2	EN-L4	49	33	33
GATCAGTAGCAATCTC-1_8_H10	33.2276142	8.556196576	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1123	1466	0.018417462	0.01568895	8	14	Microglia	49	33	33
GATCAGTAGGGTTCCC-1_8_H10	2.109549121	11.39209662	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	980	1491	0.010731053	0.018779343	8	oligos	OL-MS-1	49	33	33
GATCAGTAGTGGGCTA-1_8_H10	-1.118187952	15.50865621	1	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	841	1245	0.021686747	0.017670683	8	oligos	OL-Cntl	49	33	33
GATCAGTGTCGCGTGT-1_8_H10	-16.91033947	-0.65107192	13A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3671	8058	0.007073716	0.013030529	8	13A	IN-VIP	49	33	33
GATCGATAGAATTGTG-1_8_H10	-11.1313392	-8.173271754	13B	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1577	2440	0.020491803	0.017213115	8	13B	IN-SV2C	49	33	33
GATCGATAGGGTTTCT-1_8_H10	5.266409725	10.12683026	1	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1292	2128	0.006109023	0.023496241	8	oligos	OL-Cntl	49	33	33
GATCGATCAAGGTTCT-1_8_H10	-4.729214201	-37.16725398	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	853	1168	0.02739726	0.02140411	8	16	EN-PYR	49	33	33
GATCGATGTAGCGTGA-1_8_H10	31.27577298	-17.85869891	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	7457	23727	0.011674464	0.017027016	8	2	EN-L4	49	33	33
GATCGCGAGCTCTCGG-1_8_H10	16.63914112	-28.74773319	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5454	18256	0.012708151	0.005751534	8	3	EN-L5-6	49	33	33
GATCGCGAGTCGATAA-1_8_H10	24.65035336	-22.08655389	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4208	10862	0.056343215	0.003682563	8	3	EN-L5-6	49	33	33
GATCGCGCAGGACGTA-1_8_H10	-15.9904154	14.79467894	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1788	3204	0.004993758	0.006866417	8	8	Astrocytes	49	33	33
GATCGCGGTAGGCATG-1_8_H10	-17.63935402	7.7886431	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1058	1472	0.014945652	0.005434783	8	8	Astrocytes	49	33	33
GATCGCGGTCTCTTAT-1_8_H10	-5.725335528	10.30064142	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	848	1244	0.013665595	0.020096463	8	oligos	OL-MS-1	49	33	33
GATCGCGTCAAGATCC-1_8_H10	-3.420497891	-35.20014836	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	725	1037	0.111861138	0.017357763	8	16	EN-PYR	49	33	33
GATCGCGTCCCGGATG-1_8_H10	33.43287401	10.93672836	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	998	1296	0.022376543	0.014660494	8	14	Microglia	49	33	33
GATCGCGTCTCCAACC-1_8_H10	-29.19583956	-1.333922598	9	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1537	2490	0.00562249	0.010040161	8	9	OPC	49	33	33
GATCGTAAGCGATAGC-1_8_H10	-24.85724295	-19.27708914	6A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2609	4888	0.019230769	0.009615385	8	6A	IN-PV	49	33	33
GATCGTACACAACTGT-1_8_H10	-4.216595651	10.57193915	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	839	1181	0.015241321	0.020321761	8	oligos	OL-MS-1	49	33	33
GATCGTACAGACAGGT-1_8_H10	18.23461695	-27.0718849	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5075	15315	0.014952661	0.00633366	8	3	EN-L5-6	49	33	33
GATCGTAGTTCTCATT-1_8_H10	24.43204595	-19.14898186	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	6588	21595	0.030377402	0.008937254	8	3	EN-L5-6	49	33	33
GATCTAGAGTAGGCCA-1_8_H10	21.72850783	-13.86136362	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3076	5863	0.012621525	0.013815453	8	2	EN-L4	49	33	33
GATCTAGCATGCAATC-1_8_H10	-5.148699193	11.24310918	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	816	1153	0.003469211	0.019080659	8	oligos	OL-MS-1	49	33	33
GATCTAGTCTCGTATT-1_8_H10	-5.959216349	9.857066491	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	788	1023	0.028347996	0.032258065	8	oligos	OL-MS-1	49	33	33
GATCTAGTCTGCGACG-1_8_H10	32.52296297	13.46639702	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1270	1807	0.015495296	0.040951854	8	14	Microglia	49	33	33
GATGAAAAGTGCCAGA-1_8_H10	9.989970959	-21.73750682	4	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	6080	18012	0.012047524	0.008327781	8	L2-3	EN-L2-3-MS	49	33	33
GATGAAACACCCTATC-1_8_H10	32.47604448	9.033446357	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	854	1100	0.014545455	0.02	8	14	Microglia	49	33	33
GATGAAAGTCAATACC-1_8_H10	-4.249960743	8.412290435	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	973	1302	0.020737327	0.02688172	8	oligos	OL-MS-1	49	33	33
GATGAAAGTCGTTGTA-1_8_H10	-4.778834068	11.03814325	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	793	1046	0.02581262	0.026768642	8	oligos	OL-MS-1	49	33	33
GATGAAATCACTGGGC-1_8_H10	-9.230252824	-37.63618357	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1104	1643	0.057821059	0.022519781	8	16	EN-PYR	49	33	33
GATGAAATCCAAACTG-1_8_H10	31.16715599	13.08607244	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1101	1497	0.018036072	0.056780227	8	14	Microglia	49	33	33
GATGAAATCCTCATTA-1_8_H10	-18.67356914	-0.001620791	13A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3532	7122	0.01713002	0.02302724	8	13A	IN-VIP	49	33	33
GATGAAATCGGCGCTA-1_8_H10	6.778298321	-19.08599286	4	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4018	9365	0.007688201	0.015589963	8	L2-3	EN-L2-3-MS	49	33	33
GATGAAATCTAGAGTC-1_8_H10	34.50678635	12.33448028	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1088	1562	0.019846351	0.018565941	8	14	Microglia	49	33	33
GATGAAATCTTCGAGA-1_8_H10	3.022353173	7.071021586	7	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1315	1931	0.008285862	0.020714656	8	7	Phagocytes	49	33	33
GATGAGGAGACACTAA-1_8_H10	-7.109467603	7.737665118	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	777	1018	0.025540275	0.032416503	8	oligos	OL-MS-1	49	33	33
GATGAGGAGTGCCAGA-1_8_H10	-4.659671271	7.795900483	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1097	1594	0.04391468	0.033877039	8	oligos	OL-MS-1	49	33	33
GATGAGGCAAACAACA-1_8_H10	29.85960775	9.127450201	15DB	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	878	1222	0.022913257	0.028641571	8	15DB	B cells	49	33	33
GATGAGGCATGCTGGC-1_8_H10	29.62392191	6.286203993	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	836	1221	0.007371007	0.063063063	8	oligos	OL-MS-1	49	33	33
GATGAGGTCGTAGGAG-1_8_H10	7.189434633	-21.50835586	4	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4033	9379	0.005757543	0.006930376	8	L2-3	EN-L2-3-MS	49	33	33
GATGCTAAGTAACCCT-1_8_H10	31.28561425	12.66970466	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	978	1347	0.017817372	0.05939124	8	14	Microglia	49	33	33
GATGCTACACGACTCG-1_8_H10	15.17237116	-4.521895973	12	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1949	3261	0.033118675	0.015026066	8	12	EN-MIX	49	33	33
GATGCTACACTGTTAG-1_8_H10	-2.145623077	10.61050266	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1006	1390	0.017266187	0.011510791	8	oligos	OL-MS-1	49	33	33
GATGCTACAGACAAAT-1_8_H10	14.99426796	-21.70156544	4	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5941	18341	0.013303528	0.009105283	8	L2-3	EN-L2-3-MS	49	33	33
GATGCTATCTTGCCGT-1_8_H10	-7.905199462	7.668442495	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	760	1030	0.015533981	0.055339806	8	oligos	OL-MS-1	49	33	33
GATTCAGAGGCTCAGA-1_8_H10	27.18439363	8.755219712	15A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1242	1765	0.015864023	0.034560907	8	15A	Endo cells	49	33	33
GATTCAGCACTTAAGC-1_8_H10	-24.44015063	-1.034317847	9	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1365	2030	0.008374384	0.007881773	8	9	OPC	49	33	33
GATTCAGCAGTTCATG-1_8_H10	25.71397945	10.46161374	15A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3099	6250	0.03024	0.04944	8	15A	Endo cells	49	33	33
GATTCAGTCCCAGGTG-1_8_H10	-7.140700259	8.694814378	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	813	1098	0.012750455	0.020947177	8	oligos	OL-MS-1	49	33	33
GCAAACTAGACCTAGG-1_8_H10	-0.849181784	7.46547466	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1966	3426	0.00992411	0.025394046	8	oligos	OL-MS-1	49	33	33
GCAAACTCACAGGCCT-1_8_H10	22.47362892	-22.76918941	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3684	8725	0.033581662	0.005272206	8	3	EN-L5-6	49	33	33
GCAAACTTCAAGAAGT-1_8_H10	21.37402336	-25.00532897	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4581	11534	0.003901509	0.008670019	8	3	EN-L5-6	49	33	33
GCAAACTTCTGATTCT-1_8_H10	3.863661752	4.143159206	7	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1650	2448	0.024918301	0.024509804	8	7	Phagocytes	49	33	33
GCAATCAAGAGTGACC-1_8_H10	32.15656506	9.762923487	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	826	1024	0.014648438	0.030273438	8	14	Microglia	49	33	33
GCAATCAAGCCCAATT-1_8_H10	-0.25570408	9.886384975	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1106	1733	0.010386613	0.019042123	8	oligos	OL-MS-1	49	33	33
GCAATCAAGGCAGGTT-1_8_H10	-6.903408646	8.091790242	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	854	1147	0.027027027	0.036617262	8	oligos	OL-MS-1	49	33	33
GCAATCACAAGCTGTT-1_8_H10	29.74720628	8.66061893	15DA	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	849	1088	0.035845588	0.026654412	8	15DA	T cells	49	33	33
GCAATCACAGCCAGAA-1_8_H10	-4.362388114	9.474094489	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	930	1266	0.018167457	0.021327014	8	oligos	OL-MS-1	49	33	33
GCAATCAGTCTGATTG-1_8_H10	-7.016640676	6.804443432	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1007	1399	0.054324518	0.034310222	8	oligos	OL-MS-1	49	33	33
GCACATAAGCCACCTG-1_8_H10	26.52943572	10.11320478	15A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2082	3480	0.029310345	0.05	8	15A	Endo cells	49	33	33
GCACATACACGAAATA-1_8_H10	-4.451397095	8.18289666	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1055	1387	0.017303533	0.022350397	8	oligos	OL-MS-1	49	33	33
GCACATAGTCAGCTAT-1_8_H10	31.74448574	9.414452642	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	752	1051	0.033301618	0.025689819	8	14	Microglia	49	33	33
GCACATATCGAGCCCA-1_8_H10	-15.05821267	12.33945781	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1800	3162	0.0028463	0.007273877	8	8	Astrocytes	49	33	33
GCACTCTAGAAGGGTA-1_8_H10	34.24259649	-11.31010662	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4007	8635	0.020266358	0.010770122	8	2	EN-L4	49	33	33
GCACTCTCAAACAACA-1_8_H10	-2.657342509	9.845747448	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	969	1368	0.016812865	0.020467836	8	oligos	OL-MS-1	49	33	33
GCAGCCAAGAGTAAGG-1_8_H10	-0.825675962	7.821766849	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1356	2068	0.012572534	0.037717602	8	oligos	OL-MS-1	49	33	33
GCAGCCAAGTGTTTGC-1_8_H10	32.65610251	14.45091725	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1231	1816	0.009911894	0.042951542	8	14	Microglia	49	33	33
GCAGCCATCCAGTATG-1_8_H10	-6.791343667	8.051385039	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	765	1034	0.034816248	0.01934236	8	oligos	OL-MS-1	49	33	33
GCAGTTAAGGAATTAC-1_8_H10	-7.48364988	7.714627324	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	923	1377	0.01016703	0.024691358	8	oligos	OL-MS-1	49	33	33
GCAGTTAAGTACCGGA-1_8_H10	-7.098558997	9.813894768	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	724	1024	0.010742188	0.040039063	8	oligos	OL-MS-1	49	33	33
GCATACAAGCGCTCCA-1_8_H10	-4.787590308	7.497687501	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1108	1484	0.012803235	0.041105121	8	oligos	OL-MS-1	49	33	33
GCATACAAGCGTGTCC-1_8_H10	21.67434074	-13.99477121	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3032	5715	0.015048119	0.014173228	8	2	EN-L4	49	33	33
GCATACACAAGTAATG-1_8_H10	19.6093552	-10.73075794	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2544	4805	0.013943809	0.007284079	8	3	EN-L5-6	49	33	33
GCATACACAATACGCT-1_8_H10	14.33837487	-4.525612145	12	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1895	3363	0.01338091	0.011299435	8	12	EN-MIX	49	33	33
GCATACACAATTGCTG-1_8_H10	-3.325316489	-35.7305928	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	818	1141	0.084136722	0.028921998	8	16	EN-PYR	49	33	33
GCATACACAGATGAGC-1_8_H10	20.41489031	-21.45590379	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4883	12904	0.034020459	0.007904526	8	3	EN-L5-6	49	33	33
GCATACAGTACAGTGG-1_8_H10	-29.55407003	-22.4472345	6A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5113	12350	0.019838057	0.021133603	8	6A	IN-PV	49	33	33
GCATACAGTAGCGATG-1_8_H10	26.8237407	9.937429517	15A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1555	2301	0.026510213	0.063450674	8	15A	Endo cells	49	33	33
GCATACATCCAGATCA-1_8_H10	-7.243135338	6.885325104	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	880	1131	0.026525199	0.031830239	8	oligos	OL-MS-1	49	33	33
GCATACATCCCTCTTT-1_8_H10	-10.82408974	-27.17291834	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	804	1217	0.161051767	0.013968776	8	16	EN-PYR	49	33	33
GCATACATCTGGTTCC-1_8_H10	33.85628301	7.607839635	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	940	1434	0.006973501	0.006276151	8	14	Microglia	49	33	33
GCATGATAGAGCTTCT-1_8_H10	-6.381917284	9.478075435	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	865	1168	0.012842466	0.025684932	8	oligos	OL-MS-1	49	33	33
GCATGATAGATACACA-1_8_H10	17.74666953	-25.33425477	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4045	9305	0.016657711	0.008812466	8	3	EN-L5-6	49	33	33
GCATGATAGGCTCAGA-1_8_H10	17.13982462	-26.85183525	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4659	12003	0.012663501	0.005915188	8	3	EN-L5-6	49	33	33
GCATGATCAATAACGA-1_8_H10	15.74010053	-21.75289479	4	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5238	13198	0.014244583	0.013941506	8	L2-3	EN-L2-3-MS	49	33	33
GCATGATCAGCTCCGA-1_8_H10	21.24683752	-22.72284397	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4170	9273	0.028038391	0.011323196	8	3	EN-L5-6	49	33	33
GCATGATTCCCAACGG-1_8_H10	-15.75302601	9.317628743	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1328	1999	0.009504752	0.015507754	8	8	Astrocytes	49	33	33
GCATGCGAGACAGAGA-1_8_H10	-2.677313153	8.520091417	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1125	1578	0.015842839	0.020278834	8	oligos	OL-MS-1	49	33	33
GCATGCGGTACCCAAT-1_8_H10	-10.72393879	-38.6652813	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1292	1921	0.028630921	0.022384175	8	16	EN-PYR	49	33	33
GCATGCGGTCGCGGTT-1_8_H10	-4.580969482	10.6618914	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	794	1139	0.021949078	0.02809482	8	oligos	OL-MS-1	49	33	33
GCATGCGGTGTTTGGT-1_8_H10	1.144193775	16.70498055	1	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	946	1419	0.010570825	0.009866103	8	oligos	OL-Cntl	49	33	33
GCATGCGGTTCGGCAC-1_8_H10	31.20478201	-10.24941244	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4159	10379	0.045765488	0.008093265	8	2	EN-L4	49	33	33
GCATGCGTCCGAGCCA-1_8_H10	31.84436798	10.01808417	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	965	1243	0.017699115	0.029766693	8	14	Microglia	49	33	33
GCATGCGTCGTCTGCT-1_8_H10	-25.36210721	10.72553513	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	864	1270	0.020472441	0.008661417	8	8	Astrocytes	49	33	33
GCATGTAAGCAGATCG-1_8_H10	27.46890578	8.679726995	15BA	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1128	1619	0.024088944	0.05558987	8	15BA	Stromal cells	49	33	33
GCATGTACACCAACCG-1_8_H10	-5.026560967	8.523366361	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	915	1247	0.019246191	0.03127506	8	oligos	OL-MS-1	49	33	33
GCATGTAGTCGAGTTT-1_8_H10	29.38489224	5.386825969	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	853	1183	0.087912088	0.032121724	8	oligos	OL-MS-1	49	33	33
GCATGTAGTTCGGGCT-1_8_H10	28.5074276	11.77598909	15DB	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2902	5235	0.016045845	0.06895893	8	15DB	B cells	49	33	33
GCATGTATCGCGGATC-1_8_H10	17.12102689	-30.55516088	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3971	9483	0.004323526	0.003796267	8	3	EN-L5-6	49	33	33
GCATGTATCTCATTCA-1_8_H10	-18.18599496	26.19928655	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1810	3228	0.008054523	0.008674102	8	8	Astrocytes	49	33	33
GCCAAATAGTTTCCTT-1_8_H10	32.28785536	13.91975178	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1849	3107	0.023173479	0.033794657	8	14	Microglia	49	33	33
GCCAAATCAGCCTATA-1_8_H10	-4.28647828	-37.68379301	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1105	1656	0.070652174	0.035024155	8	16	EN-PYR	49	33	33
GCCAAATGTGGCAAAC-1_8_H10	18.56813276	-9.094572547	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2212	4511	0.037907338	0.004876967	8	3	EN-L5-6	49	33	33
GCCAAATGTGTGGTTT-1_8_H10	31.84135629	11.58948224	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	867	1185	0.018565401	0.044725738	8	14	Microglia	49	33	33
GCCAAATGTTGCTCCT-1_8_H10	25.71069923	10.50090763	15A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2804	5331	0.022885012	0.062277246	8	15A	Endo cells	49	33	33
GCCAAATTCAAGGCTT-1_8_H10	32.1028751	13.73849569	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1484	2216	0.016245487	0.052797834	8	14	Microglia	49	33	33
GCCAAATTCCTCCTAG-1_8_H10	18.38501399	-25.58226697	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4931	14174	0.009242275	0.009665585	8	3	EN-L5-6	49	33	33
GCCAAATTCGACGGAA-1_8_H10	28.97569104	-14.36390558	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5954	15872	0.02249244	0.013986895	8	2	EN-L4	49	33	33
GCCAAATTCGCACTCT-1_8_H10	20.18183747	-21.51468293	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5181	15465	0.02748141	0.011057226	8	3	EN-L5-6	49	33	33
GCCAAATTCTTCGGTC-1_8_H10	-10.37883073	27.71291286	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	841	1053	0.02374169	0.026590693	8	oligos	OL-MS-1	49	33	33
GCCTCTAAGTTGAGAT-1_8_H10	18.00149895	-29.27747715	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	6430	21385	0.003507131	0.004863222	8	3	EN-L5-6	49	33	33
GCCTCTACAGTAGAGC-1_8_H10	-20.26668277	12.70325865	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1251	1799	0.03557532	0.009449694	8	8	Astrocytes	49	33	33
GCCTCTATCTTCGGTC-1_8_H10	34.21972788	13.50287647	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1189	1786	0.015117581	0.018477044	8	14	Microglia	49	33	33
GCGACCAAGACGCACA-1_8_H10	27.8273532	10.4103678	15DB	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1692	3491	0.009452879	0.176167287	8	15DB	B cells	49	33	33
GCGACCAAGGCTATCT-1_8_H10	25.13094555	-22.39154969	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5660	16700	0.02508982	0.00491018	8	3	EN-L5-6	49	33	33
GCGACCACAGTAGAGC-1_8_H10	35.25044419	-10.82306293	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5790	15242	0.017320562	0.013449679	8	2	EN-L4	49	33	33
GCGACCACATTGGTAC-1_8_H10	28.73553671	11.52935365	15DA	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2376	3893	0.022604675	0.041356281	8	15DA	T cells	49	33	33
GCGACCAGTCTTCTCG-1_8_H10	31.82973609	10.23977899	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	951	1283	0.028838659	0.034294622	8	14	Microglia	49	33	33
GCGACCAGTGATGATA-1_8_H10	-5.341348125	9.141251023	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	898	1285	0.017120623	0.031906615	8	oligos	OL-MS-1	49	33	33
GCGACCATCTTCCTTC-1_8_H10	-5.951685887	8.401211548	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	962	1347	0.018559762	0.023756496	8	oligos	OL-MS-1	49	33	33
GCGAGAAAGGAACTGC-1_8_H10	-18.71307728	-0.025627759	13A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3306	6322	0.018032268	0.026415691	8	13A	IN-VIP	49	33	33
GCGAGAACAGACTCGC-1_8_H10	-2.71176291	9.913626188	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1022	1444	0.014542936	0.032548476	8	oligos	OL-MS-1	49	33	33
GCGAGAACAGTCGATT-1_8_H10	-3.601082705	11.38077838	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	890	1257	0.012728719	0.035799523	8	oligos	OL-MS-1	49	33	33
GCGAGAAGTCGAAAGC-1_8_H10	-4.983774824	8.466479418	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	920	1259	0.023828435	0.022239873	8	oligos	OL-MS-1	49	33	33
GCGAGAATCAATCTCT-1_8_H10	33.55234254	10.26989075	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	814	1111	0.02880288	0.01620162	8	14	Microglia	49	33	33
GCGAGAATCCACGAAT-1_8_H10	-26.34909101	-11.80685869	9	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1082	1704	0.161384977	0.021126761	8	9	OPC	49	33	33
GCGAGAATCTCAAGTG-1_8_H10	-15.8130023	15.45697461	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2129	4104	0.006335283	0.005604288	8	8	Astrocytes	49	33	33
GCGCAACCATATGCTG-1_8_H10	-7.180275759	-37.48102408	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1069	1557	0.074502248	0.014771997	8	16	EN-PYR	49	33	33
GCGCAACGTAGCGCTC-1_8_H10	-3.459604221	-34.54320302	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	855	1210	0.129752066	0.025619835	8	16	EN-PYR	49	33	33
GCGCAACGTCATATGC-1_8_H10	26.10218663	4.392974235	15BA	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1037	1558	0.007060334	0.012195122	8	15BA	Stromal cells	49	33	33
GCGCAACGTGGAAAGA-1_8_H10	-3.873962974	15.29549745	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	733	1021	0.008814887	0.022526934	8	oligos	OL-MS-1	49	33	33
GCGCAGTAGTACGCCC-1_8_H10	-8.076355428	7.18148226	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	903	1241	0.011281225	0.047542305	8	oligos	OL-MS-1	49	33	33
GCGCAGTCAATCACAC-1_8_H10	-27.97841557	-12.41657318	9	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	827	1210	0.014876033	0.015702479	8	9	OPC	49	33	33
GCGCAGTTCGGAATCT-1_8_H10	16.25928619	-30.23333177	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4363	12735	0.006046329	0.004083235	8	3	EN-L5-6	49	33	33
GCGCCAAAGAACAATC-1_8_H10	-3.093458732	-36.34523227	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	822	1057	0.052034059	0.033112583	8	16	EN-PYR	49	33	33
GCGCCAAAGCTGGAAC-1_8_H10	16.33890235	-25.58929763	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3688	8327	0.027260718	0.007445659	8	3	EN-L5-6	49	33	33
GCGCCAACATCGTCGG-1_8_H10	-18.16561487	0.085221643	13A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3450	6582	0.013521726	0.017927682	8	13A	IN-VIP	49	33	33
GCGCCAACATGCATGT-1_8_H10	-7.579632033	9.015098666	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	819	1084	0.017527675	0.015682657	8	oligos	OL-MS-1	49	33	33
GCGCCAACATTCACTT-1_8_H10	-14.76415268	7.649310739	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	976	1291	0.031758327	0.020139427	8	8	Astrocytes	49	33	33
GCGCCAACATTTCAGG-1_8_H10	11.11677716	6.204681517	1	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2063	3516	0.008816837	0.02559727	8	oligos	OL-Cntl	49	33	33
GCGCCAAGTACGCTGC-1_8_H10	-9.148704801	-37.51635503	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1292	2207	0.125056638	0.018577254	8	16	EN-PYR	49	33	33
GCGCCAAGTCCATCCT-1_8_H10	-1.163236476	10.53372785	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1049	1459	0.00685401	0.010281014	8	oligos	OL-MS-1	49	33	33
GCGCCAAGTCCGTCAG-1_8_H10	-5.69071172	10.03545406	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	812	1122	0.028520499	0.03030303	8	oligos	OL-MS-1	49	33	33
GCGCCAAGTCGATTGT-1_8_H10	-29.87281129	-20.56039854	6B	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5318	13770	0.037327524	0.015904139	8	6B	IN-SST	49	33	33
GCGCCAAGTCGCGTGT-1_8_H10	33.36696887	-9.6142301	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4206	8704	0.013901654	0.008731618	8	2	EN-L4	49	33	33
GCGCCAAGTGCCTGGT-1_8_H10	18.12534461	-9.911536177	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2486	4666	0.010072868	0.006643806	8	3	EN-L5-6	49	33	33
GCGCCAATCAACACGT-1_8_H10	-10.79024152	-39.00654549	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1561	2445	0.082208589	0.024948875	8	16	EN-PYR	49	33	33
GCGCCAATCACATACG-1_8_H10	-0.452660422	9.754671314	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1146	1698	0.016489988	0.021790342	8	oligos	OL-MS-1	49	33	33
GCGCCAATCAGAGGTG-1_8_H10	-4.546826382	8.597494619	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	896	1220	0.026229508	0.025409836	8	oligos	OL-MS-1	49	33	33
GCGCCAATCAGTCCCT-1_8_H10	-25.01973976	-11.59141234	9	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	922	1321	0.024224073	0.00681302	8	9	OPC	49	33	33
GCGCCAATCTTCCTTC-1_8_H10	-11.64944614	18.41573893	11	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2530	4379	0.005023978	0.009591231	8	11	Glia-MIX	49	33	33
GCGCGATCAAGGACAC-1_8_H10	25.72731498	7.426164753	15A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1511	2454	0.011002445	0.02404238	8	15A	Endo cells	49	33	33
GCGCGATCAGTAACGG-1_8_H10	-9.379949572	-15.88738921	6B	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	879	1256	0.027866242	0.011146497	8	6B	IN-SST	49	33	33
GCGCGATGTCACCCAG-1_8_H10	26.59146369	9.724724843	15DA	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2317	4713	0.015913431	0.071716529	8	15DA	T cells	49	33	33
GCGCGATGTTGCTCCT-1_8_H10	-6.92103549	7.926187501	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	839	1057	0.032166509	0.034058657	8	oligos	OL-MS-1	49	33	33
GCGCGATTCAAACAAG-1_8_H10	-6.385001729	10.96461571	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	766	1033	0.015488867	0.025169409	8	oligos	OL-MS-1	49	33	33
GCGCGATTCTTTAGGG-1_8_H10	-7.946762525	7.12882359	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	778	1096	0.010948905	0.028284672	8	oligos	OL-MS-1	49	33	33
GCGGGTTAGCTTTGGT-1_8_H10	15.66125231	-22.19085829	4	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	6020	16965	0.007309166	0.008370174	8	L2-3	EN-L2-3-MS	49	33	33
GCGGGTTCAGCCTGTG-1_8_H10	24.74507934	-16.47579082	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	6512	20053	0.062384681	0.014012866	8	3	EN-L5-6	49	33	33
GCGGGTTGTACAGTGG-1_8_H10	16.18228052	-26.93687565	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4300	11279	0.010816562	0.006738186	8	3	EN-L5-6	49	33	33
GCGGGTTGTCAATGTC-1_8_H10	37.20425524	8.958049834	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	748	1017	0.018682399	0.003933137	8	14	Microglia	49	33	33
GCGGGTTGTCGACTGC-1_8_H10	23.86060241	7.711664294	15DA	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3391	6272	0.030452806	0.02997449	8	15DA	T cells	49	33	33
GCGGGTTTCACATACG-1_8_H10	30.03240298	8.765193583	15DA	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	754	1005	0.018905473	0.017910448	8	15DA	T cells	49	33	33
GCGGGTTTCACCTCGT-1_8_H10	-6.238891666	8.581404144	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	910	1264	0.013449367	0.024525316	8	oligos	OL-MS-1	49	33	33
GCGGGTTTCGTCCGTT-1_8_H10	25.17252268	-22.27544286	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4944	15190	0.044568795	0.004410797	8	3	EN-L5-6	49	33	33
GCTCCTAAGTCCAGGA-1_8_H10	-13.16293598	-13.78104862	6A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1844	2948	0.077001357	0.018317503	8	6A	IN-PV	49	33	33
GCTCCTAAGTGAATTG-1_8_H10	-17.00013355	6.96928732	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1065	1415	0.0204947	0.016961131	8	8	Astrocytes	49	33	33
GCTCCTAGTCTCCCTA-1_8_H10	-4.208695447	10.77862331	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	902	1228	0.016286645	0.010586319	8	oligos	OL-MS-1	49	33	33
GCTCCTATCGCGATCG-1_8_H10	26.81258985	8.443300333	15A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1298	1907	0.016255899	0.047194546	8	15A	Endo cells	49	33	33
GCTCCTATCTAACTTC-1_8_H10	31.10513785	-7.395360594	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3620	7924	0.014008077	0.006309944	8	2	EN-L4	49	33	33
GCTCCTATCTAGCACA-1_8_H10	-4.046451218	7.913549708	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1103	1516	0.029683377	0.023087071	8	oligos	OL-MS-1	49	33	33
GCTCCTATCTGCCCTA-1_8_H10	-0.522799887	10.62259189	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	992	1495	0.009364548	0.018729097	8	oligos	OL-MS-1	49	33	33
GCTCTGTAGAACAACT-1_8_H10	-0.929457626	10.18034485	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1050	1429	0.006298111	0.021693492	8	oligos	OL-MS-1	49	33	33
GCTCTGTAGAGCCTAG-1_8_H10	17.09515591	-25.06530518	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4151	10753	0.006974798	0.009113736	8	3	EN-L5-6	49	33	33
GCTCTGTAGTCCTCCT-1_8_H10	-7.116167672	9.359664394	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	823	1098	0.023679417	0.027322404	8	oligos	OL-MS-1	49	33	33
GCTCTGTCAGGTTTCA-1_8_H10	-3.017502046	24.17913686	1	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	696	1021	0.014691479	0.011753183	8	oligos	OL-Cntl	49	33	33
GCTCTGTTCAGTGTTG-1_8_H10	-5.632008155	9.888551345	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	806	1060	0.012264151	0.023584906	8	oligos	OL-MS-1	49	33	33
GCTGCAGAGCACGCCT-1_8_H10	5.868304763	12.23622673	1	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1057	1506	0.011288181	0.007968127	8	oligos	OL-Cntl	49	33	33
GCTGCAGAGCAGATCG-1_8_H10	-4.896859655	11.07379372	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	884	1244	0.008038585	0.020900322	8	oligos	OL-MS-1	49	33	33
GCTGCAGCACAGGAGT-1_8_H10	-7.251315936	7.485107766	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	826	1134	0.022045855	0.030864198	8	oligos	OL-MS-1	49	33	33
GCTGCAGCAGTGACAG-1_8_H10	29.80878717	-12.62602931	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3897	8284	0.020642202	0.014485756	8	2	EN-L4	49	33	33
GCTGCAGGTCACCCAG-1_8_H10	18.34326805	-23.53124527	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	6315	18032	0.006433008	0.031887755	8	3	EN-L5-6	49	33	33
GCTGCAGTCCTCAACC-1_8_H10	33.12091144	8.098949517	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	834	1120	0.013392857	0.0125	8	14	Microglia	49	33	33
GCTGCAGTCGCGGATC-1_8_H10	-1.191275378	10.45423461	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1040	1540	0.011688312	0.015584416	8	oligos	OL-MS-1	49	33	33
GCTGCGACAGGGTTAG-1_8_H10	19.92417739	-23.19879858	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	6093	18077	0.005365935	0.008740388	8	3	EN-L5-6	49	33	33
GCTGCGACAGTAAGCG-1_8_H10	-27.95040424	-5.159900571	9	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1294	1904	0.007352941	0.006827731	8	9	OPC	49	33	33
GCTGCGATCGCGGATC-1_8_H10	21.92263959	-14.42370408	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4032	9133	0.020584693	0.008211979	8	3	EN-L5-6	49	33	33
GCTGCTTAGAGCCCAA-1_8_H10	16.73560385	-26.07768409	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4129	10236	0.027159047	0.006545526	8	3	EN-L5-6	49	33	33
GCTGCTTAGATATACG-1_8_H10	25.01550975	-22.42687669	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4874	13939	0.029055169	0.007532822	8	3	EN-L5-6	49	33	33
GCTGCTTAGTCTCGGC-1_8_H10	-6.567860236	9.511859829	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	770	1062	0.016949153	0.017890772	8	oligos	OL-MS-1	49	33	33
GCTGCTTCAATACGCT-1_8_H10	-2.344072994	10.04371904	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	942	1305	0.024521073	0.019157088	8	oligos	OL-MS-1	49	33	33
GCTGCTTGTGTTTGTG-1_8_H10	-4.180665322	8.084319334	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1135	1582	0.021491783	0.02022756	8	oligos	OL-MS-1	49	33	33
GCTGCTTTCGTCGTTC-1_8_H10	33.12633466	8.859653405	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	959	1254	0.015151515	0.018341308	8	14	Microglia	49	33	33
GCTGCTTTCTGAGGGA-1_8_H10	-4.035629206	8.491321172	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	963	1313	0.025133283	0.016755522	8	oligos	OL-MS-1	49	33	33
GCTGCTTTCTGCAGTA-1_8_H10	34.33316249	12.49882201	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1028	1419	0.019027484	0.018322763	8	14	Microglia	49	33	33
GCTGGGTAGACCTTTG-1_8_H10	-4.274504367	14.57419717	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	858	1214	0.009884679	0.019769357	8	oligos	OL-MS-1	49	33	33
GCTGGGTAGTACGTAA-1_8_H10	-5.78987536	8.007989212	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	841	1154	0.019930676	0.035528596	8	oligos	OL-MS-1	49	33	33
GCTGGGTCAGCCAATT-1_8_H10	-6.36193327	9.528054743	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	761	1013	0.01875617	0.027640671	8	oligos	OL-MS-1	49	33	33
GCTGGGTCATCTGGTA-1_8_H10	-3.426703168	-35.05982488	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	815	1112	0.098920863	0.019784173	8	16	EN-PYR	49	33	33
GCTGGGTGTGAGGCTA-1_8_H10	-17.73899923	7.51712294	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	939	1321	0.011355034	0.012869039	8	8	Astrocytes	49	33	33
GCTGGGTTCGTACGGC-1_8_H10	-17.77172952	25.26021441	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1783	3034	0.008899143	0.00626236	8	8	Astrocytes	49	33	33
GCTTCCAAGACAGACC-1_8_H10	-8.058478815	7.233983039	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	833	1095	0.012785388	0.034703196	8	oligos	OL-MS-1	49	33	33
GCTTCCACAAGAAGAG-1_8_H10	-7.183866096	7.839301572	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	757	1011	0.018793274	0.026706231	8	oligos	OL-MS-1	49	33	33
GCTTCCACAGGTGCCT-1_8_H10	33.05378044	8.783559851	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1096	1446	0.015214385	0.017980636	8	14	Microglia	49	33	33
GCTTCCAGTCGACTAT-1_8_H10	-5.861178018	7.541445623	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	945	1287	0.024087024	0.011655012	8	oligos	OL-MS-1	49	33	33
GCTTCCAGTTTAAGCC-1_8_H10	-15.15394916	14.44293499	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1868	3153	0.010466223	0.008563273	8	8	Astrocytes	49	33	33
GCTTCCAGTTTAGCTG-1_8_H10	-7.370377996	7.635651722	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	801	1081	0.024976873	0.024051804	8	oligos	OL-MS-1	49	33	33
GCTTCCATCGGAAATA-1_8_H10	-5.817933478	8.900218106	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	764	1023	0.018572825	0.026392962	8	oligos	OL-MS-1	49	33	33
GCTTGAAAGAGCTGCA-1_8_H10	-6.09864936	7.657513087	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	839	1089	0.028466483	0.02020202	8	oligos	OL-MS-1	49	33	33
GCTTGAAAGCGATTCT-1_8_H10	-17.83978048	23.66629773	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1391	2196	0.010928962	0.007741348	8	8	Astrocytes	49	33	33
GCTTGAAGTGCTCTTC-1_8_H10	18.11680787	-13.95694111	4	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	8329	29744	0.010556751	0.015465304	8	L2-3	EN-L2-3-MS	49	33	33
GCTTGAAGTTACAGAA-1_8_H10	-11.2890612	17.91291794	11	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2809	5357	0.008213552	0.004853463	8	11	Glia-MIX	49	33	33
GCTTGAATCGTCACGG-1_8_H10	16.74152325	-28.26521135	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4203	10843	0.028036521	0.004703495	8	3	EN-L5-6	49	33	33
GCTTGAATCTTTACAC-1_8_H10	35.16053457	10.67769204	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	958	1294	0.020092736	0.010046368	8	14	Microglia	49	33	33
GGAAAGCCAGACGCAA-1_8_H10	31.50698769	9.909801923	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	922	1291	0.026336174	0.024012393	8	14	Microglia	49	33	33
GGAAAGCCAGCCAGAA-1_8_H10	8.068081197	2.611249294	15DA	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1021	1287	0.04972805	0.034188034	8	15DA	T cells	49	33	33
GGAACTTAGATCCTGT-1_8_H10	8.15125428	-17.92579603	4	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4823	12376	0.003797673	0.023109244	8	L2-3	EN-L2-3-MS	49	33	33
GGAACTTCAGCCACCA-1_8_H10	35.05516488	11.11320418	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	897	1280	0.01171875	0.01171875	8	14	Microglia	49	33	33
GGAACTTGTCGAGATG-1_8_H10	-2.885063837	9.148075896	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1050	1488	0.014784946	0.030913978	8	oligos	OL-MS-1	49	33	33
GGAACTTGTTCAGTAC-1_8_H10	-4.611515256	11.5970234	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	799	1080	0.018518519	0.025925926	8	oligos	OL-MS-1	49	33	33
GGAATAAAGCCAACAG-1_8_H10	24.12516783	-11.54705104	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3441	7183	0.009466797	0.008492273	8	3	EN-L5-6	49	33	33
GGAATAAAGTTCGATC-1_8_H10	32.56232576	10.06147164	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	798	1041	0.010566763	0.026897214	8	14	Microglia	49	33	33
GGAATAAGTCCGAGTC-1_8_H10	31.86167643	10.99299719	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	836	1114	0.024236984	0.045780969	8	14	Microglia	49	33	33
GGAATAATCCAGATCA-1_8_H10	-17.23433699	16.8131382	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1310	1959	0.012761613	0.011230219	8	8	Astrocytes	49	33	33
GGAATAATCGCCAGCA-1_8_H10	9.253810132	-24.98069226	4	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5679	18120	0.005077263	0.00584989	8	L2-3	EN-L2-3-MS	49	33	33
GGAATAATCTATCGCC-1_8_H10	-15.9706149	-17.87252071	6B	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1750	3296	0.016080097	0.005764563	8	6B	IN-SST	49	33	33
GGACAAGAGGGAAACA-1_8_H10	24.74055964	-20.82455873	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3839	8636	0.054654933	0.007063455	8	3	EN-L5-6	49	33	33
GGACAAGCACGCTTTC-1_8_H10	-16.13052191	13.05379543	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1397	2207	0.006796556	0.007702764	8	8	Astrocytes	49	33	33
GGACAAGGTGCAGACA-1_8_H10	-17.71572075	16.48653581	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1328	2010	0.010447761	0.005970149	8	8	Astrocytes	49	33	33
GGACAAGGTGTTCGAT-1_8_H10	34.93653805	-10.42375654	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5094	13242	0.010119317	0.013291044	8	2	EN-L4	49	33	33
GGACAAGTCCTTGGTC-1_8_H10	-29.97983018	0.190368362	9	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1826	3008	0.004986702	0.00731383	8	9	OPC	49	33	33
GGACAAGTCGGAGGTA-1_8_H10	-17.18618096	-4.105597898	13A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2697	5047	0.064790965	0.01188825	8	13A	IN-VIP	49	33	33
GGACAGAAGGTGTGGT-1_8_H10	-1.60913235	16.75220958	1	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	738	1037	0.021215043	0.014464802	8	oligos	OL-Cntl	49	33	33
GGACAGATCCCTCAGT-1_8_H10	13.38043379	-24.24306564	4	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5437	14865	0.004641776	0.022872519	8	L2-3	EN-L2-3-MS	49	33	33
GGACAGATCGAATGGG-1_8_H10	-27.72266227	-3.404189334	9	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1324	1930	0.006217617	0.01865285	8	9	OPC	49	33	33
GGACAGATCGTTTATC-1_8_H10	34.02361533	14.63824227	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1141	1619	0.015441631	0.037059914	8	14	Microglia	49	33	33
GGACATTAGTGAACAT-1_8_H10	-22.9831084	-7.119156058	9	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2007	3366	0.017825312	0.008318479	8	9	OPC	49	33	33
GGACATTCACATGACT-1_8_H10	20.26956422	-26.74443335	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2640	5406	0.022197558	0.004624491	8	3	EN-L5-6	49	33	33
GGACATTCATAAGACA-1_8_H10	7.005105708	1.239747395	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1276	2020	0.048019802	0.011881188	8	16	EN-PYR	49	33	33
GGACATTGTACTCAAC-1_8_H10	-30.11119797	1.11642513	9	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2041	3505	0.006847361	0.009415121	8	9	OPC	49	33	33
GGACATTGTCAGAGGT-1_8_H10	33.87333678	-9.388386588	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	6077	17999	0.01311184	0.01311184	8	2	EN-L4	49	33	33
GGACATTGTCTCTCTG-1_8_H10	21.48941871	-13.87959789	12	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2809	6003	0.025320673	0.018657338	8	12	EN-MIX	49	33	33
GGACATTGTTAGGGTG-1_8_H10	-18.25098298	0.043169525	13A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2997	5369	0.010616502	0.03240827	8	13A	IN-VIP	49	33	33
GGACATTTCAGCATGT-1_8_H10	26.16915948	10.15979214	15A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2299	4204	0.049000951	0.059705043	8	15A	Endo cells	49	33	33
GGACATTTCGGAAACG-1_8_H10	19.57262274	-22.01233111	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5510	15837	0.021279283	0.007892909	8	3	EN-L5-6	49	33	33
GGACGTCAGACCGGAT-1_8_H10	-17.01154359	6.935008796	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1049	1625	0.016615385	0.008615385	8	8	Astrocytes	49	33	33
GGACGTCAGCGAAGGG-1_8_H10	-4.143579952	7.504569389	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1100	1728	0.045138889	0.028356481	8	oligos	OL-MS-1	49	33	33
GGACGTCCAAGTAATG-1_8_H10	27.19636061	9.829171618	15A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1309	1953	0.026113671	0.074244752	8	15A	Endo cells	49	33	33
GGACGTCGTACTTGAC-1_8_H10	26.75167045	-2.486428395	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2636	5308	0.002637528	0.003767898	8	2	EN-L4	49	33	33
GGACGTCTCGAATGCT-1_8_H10	-6.885105558	6.751105706	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1068	1463	0.056049214	0.056049214	8	oligos	OL-MS-1	49	33	33
GGAGCAAAGGTGATAT-1_8_H10	-13.17602262	-16.88071459	6B	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1296	2170	0.021198157	0.00921659	8	6B	IN-SST	49	33	33
GGAGCAACAAGAAGAG-1_8_H10	-7.323942637	7.751145505	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	814	1112	0.008093525	0.026978417	8	oligos	OL-MS-1	49	33	33
GGAGCAACAAGTCTAC-1_8_H10	-17.24048699	16.24310756	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1442	2406	0.006650042	0.007065669	8	8	Astrocytes	49	33	33
GGAGCAACACCATGTA-1_8_H10	-7.794686287	-37.55231013	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1035	1431	0.059399022	0.025157233	8	16	EN-PYR	49	33	33
GGAGCAACACCCATTC-1_8_H10	23.23346641	-25.6956052	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2758	5688	0.024437412	0.005801688	8	3	EN-L5-6	49	33	33
GGAGCAACAGAGTGTG-1_8_H10	-14.61346272	-16.46009681	6B	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1522	2567	0.013634593	0.010128555	8	6B	IN-SST	49	33	33
GGAGCAACAGTAGAGC-1_8_H10	20.42618601	-22.40252941	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2847	5097	0.013144987	0.014125956	8	3	EN-L5-6	49	33	33
GGAGCAAGTCAAAGAT-1_8_H10	31.76659261	-18.54463571	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4753	11225	0.02325167	0.016926503	8	2	EN-L4	49	33	33
GGAGCAAGTGTCTGAT-1_8_H10	-2.858764755	-34.41438921	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	863	1221	0.064701065	0.024570025	8	16	EN-PYR	49	33	33
GGAGCAATCGCGTAGC-1_8_H10	-28.30818138	-12.65995838	9	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	765	1087	0.060717571	0.012879485	8	9	OPC	49	33	33
GGATGTTAGATAGGAG-1_8_H10	31.17370428	-19.18683112	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	6007	16114	0.026995159	0.022775227	8	2	EN-L4	49	33	33
GGATGTTCAACCGCCA-1_8_H10	16.0356164	-22.37129782	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	8976	40587	0.013304753	0.011111932	8	3	EN-L5-6	49	33	33
GGATGTTCAATAGCGG-1_8_H10	-4.13259761	5.747650249	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1718	2820	0.004255319	0.019503546	8	oligos	OL-MS-1	49	33	33
GGATGTTGTAAATACG-1_8_H10	16.85104067	-27.54793364	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	6123	18349	0.004141915	0.008447327	8	3	EN-L5-6	49	33	33
GGATGTTGTCTGATTG-1_8_H10	4.110123297	4.272391627	7	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2200	3650	0.015616438	0.032328767	8	7	Phagocytes	49	33	33
GGATGTTTCTACCTGC-1_8_H10	-0.553854622	7.864829241	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1502	2326	0.009028375	0.025795357	8	oligos	OL-MS-1	49	33	33
GGATTACAGGTGCAAC-1_8_H10	-23.43212824	-25.18377903	6A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4138	10445	0.02316898	0.004786979	8	6A	IN-PV	49	33	33
GGATTACCACGCCAGT-1_8_H10	9.886365772	-21.81753418	4	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	6345	19596	0.007144315	0.006429884	8	L2-3	EN-L2-3-MS	49	33	33
GGATTACCACTACAGT-1_8_H10	-2.806769954	7.849593556	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1189	1625	0.016	0.037538462	8	oligos	OL-MS-1	49	33	33
GGATTACCATGAAGTA-1_8_H10	15.41266255	-21.68132728	4	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	6013	18310	0.007755325	0.012889132	8	L2-3	EN-L2-3-MS	49	33	33
GGATTACTCTCGCTTG-1_8_H10	29.35421151	6.655265112	15DA	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1442	2444	0.180851064	0.066693944	8	15DA	T cells	49	33	33
GGCAATTAGAGGGCTT-1_8_H10	27.14950853	10.13600549	15A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1431	2463	0.024766545	0.111246447	8	15A	Endo cells	49	33	33
GGCAATTAGATATGGT-1_8_H10	28.72105207	-19.14562517	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	11286	77853	0.025265565	0.020024919	8	2	EN-L4	49	33	33
GGCAATTAGCGGATCA-1_8_H10	-2.602989341	-35.45293991	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	722	1144	0.231643357	0.058566434	8	16	EN-PYR	49	33	33
GGCCGATGTAAGGGCT-1_8_H10	-5.837021094	8.081474265	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	932	1364	0.012463343	0.0271261	8	oligos	OL-MS-1	49	33	33
GGCCGATGTCATACTG-1_8_H10	-4.73201481	-30.62995584	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	771	1241	0.195004029	0.010475423	8	16	EN-PYR	49	33	33
GGCCGATTCCTTTCTC-1_8_H10	-3.947000518	-37.45717642	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1057	1489	0.057085292	0.0402955	8	16	EN-PYR	49	33	33
GGCGACTAGCCAGTTT-1_8_H10	-17.4162595	25.36946043	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1823	2959	0.009462656	0.008786752	8	8	Astrocytes	49	33	33
GGCGACTCAAACAACA-1_8_H10	28.78963945	10.23413478	15DB	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1195	1859	0.01183432	0.103819258	8	15DB	B cells	49	33	33
GGCGACTCATGATCCA-1_8_H10	-3.947427722	-37.00058399	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	845	1155	0.03982684	0.031168831	8	16	EN-PYR	49	33	33
GGCGACTGTCGCTTCT-1_8_H10	-3.058209015	9.247050155	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	961	1382	0.013748191	0.035455861	8	oligos	OL-MS-1	49	33	33
GGCGACTGTGACAAAT-1_8_H10	-5.128315511	-36.40334333	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	830	1143	0.048993876	0.026246719	8	16	EN-PYR	49	33	33
GGCGACTGTTATGTGC-1_8_H10	-6.808602366	9.78255092	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	801	1141	0.007887818	0.017528484	8	oligos	OL-MS-1	49	33	33
GGCGACTGTTTGACTG-1_8_H10	-4.49019158	14.33451208	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	858	1232	0.025974026	0.022727273	8	oligos	OL-MS-1	49	33	33
GGCGACTTCACTCTTA-1_8_H10	16.88182448	-29.31616501	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5710	18547	0.004636868	0.0066318	8	3	EN-L5-6	49	33	33
GGCGACTTCCCTTGCA-1_8_H10	17.2593131	-26.79931044	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	7249	27685	0.01011378	0.008235507	8	3	EN-L5-6	49	33	33
GGCGTGTAGATCCCAT-1_8_H10	-30.27993178	-11.46628411	9	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	911	1314	0.00608828	0.005327245	8	9	OPC	49	33	33
GGCGTGTCACCAGATT-1_8_H10	-1.350401339	-1.136947385	11	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1970	3088	0.014248705	0.015867876	8	11	Glia-MIX	49	33	33
GGCGTGTCACGAAGCA-1_8_H10	-4.379475329	11.77877483	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	843	1144	0.008741259	0.024475524	8	oligos	OL-MS-1	49	33	33
GGCGTGTGTTCCGTCT-1_8_H10	-15.96769552	13.73206949	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1728	3273	0.004582951	0.004277421	8	8	Astrocytes	49	33	33
GGCGTGTTCGACGGAA-1_8_H10	18.51755488	-9.283681595	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2370	4481	0.020754296	0.006025441	8	3	EN-L5-6	49	33	33
GGCTCGAAGATACACA-1_8_H10	31.94214646	9.617248571	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	783	1079	0.025949954	0.030583874	8	14	Microglia	49	33	33
GGCTCGAGTTGTGGCC-1_8_H10	30.72240783	-7.302416037	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5742	17226	0.01271334	0.006966214	8	2	EN-L4	49	33	33
GGCTCGATCATGTCCC-1_8_H10	23.31829346	-21.74247211	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	7162	25249	0.012911402	0.008475583	8	3	EN-L5-6	49	33	33
GGCTCGATCCGTACAA-1_8_H10	25.69298039	3.644869835	15DA	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	985	1465	0.014334471	0.005460751	8	15DA	T cells	49	33	33
GGCTGGTAGTTGTAGA-1_8_H10	38.26206736	11.82520216	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	959	1347	0.005196733	0.013363029	8	14	Microglia	49	33	33
GGCTGGTCACCCTATC-1_8_H10	-26.91410325	-9.888381818	9	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1339	1843	0.011937059	0.014107434	8	9	OPC	49	33	33
GGCTGGTCATGACATC-1_8_H10	24.142558	-25.04784184	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3002	7097	0.047907567	0.004649852	8	3	EN-L5-6	49	33	33
GGCTGGTGTACGCTGC-1_8_H10	7.320498195	1.955039546	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	856	1054	0.093927894	0.028462998	8	16	EN-PYR	49	33	33
GGCTGGTGTCAAACTC-1_8_H10	34.34100261	12.56829798	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1021	1399	0.007862759	0.015725518	8	14	Microglia	49	33	33
GGCTGGTTCGGAAATA-1_8_H10	-29.13684553	-0.484512892	9	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1771	2896	0.008977901	0.018301105	8	9	OPC	49	33	33
GGCTGGTTCTTTACGT-1_8_H10	7.366752121	-18.1813183	4	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4090	9023	0.005208911	0.016624183	8	L2-3	EN-L2-3-MS	49	33	33
GGGAATGAGTCCCACG-1_8_H10	-3.703818692	7.290642692	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1232	1819	0.022539857	0.024189115	8	oligos	OL-MS-1	49	33	33
GGGAATGAGTGCGTGA-1_8_H10	-3.96234429	9.084903707	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	949	1311	0.028222731	0.020594966	8	oligos	OL-MS-1	49	33	33
GGGAATGCATTGTGCA-1_8_H10	34.16762613	10.77141681	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	789	1020	0.029411765	0.025490196	8	14	Microglia	49	33	33
GGGAATGGTAAGTTCC-1_8_H10	-4.380351418	7.325689203	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1082	1532	0.024151436	0.044386423	8	oligos	OL-MS-1	49	33	33
GGGAATGGTGCAGGTA-1_8_H10	-1.047728773	7.507562422	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1516	2337	0.013692769	0.037227214	8	oligos	OL-MS-1	49	33	33
GGGAATGGTTCGGCAC-1_8_H10	-4.009920183	11.04448514	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	823	1107	0.016260163	0.01897019	8	oligos	OL-MS-1	49	33	33
GGGAATGTCAGCTTAG-1_8_H10	34.73504533	-7.081888216	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2952	5746	0.005395057	0.012878524	8	2	EN-L4	49	33	33
GGGAATGTCATAACCG-1_8_H10	-15.09729994	15.01010462	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2625	4887	0.006138735	0.006138735	8	8	Astrocytes	49	33	33
GGGAATGTCTGCCCTA-1_8_H10	-17.85023052	24.75101882	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1629	2548	0.004317111	0.008634223	8	8	Astrocytes	49	33	33
GGGACCTAGGTGCTTT-1_8_H10	-1.756127827	8.866925547	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1027	1530	0.007843137	0.013071895	8	oligos	OL-MS-1	49	33	33
GGGACCTCACGAAAGC-1_8_H10	18.00600693	-25.15487729	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	6697	22777	0.002590332	0.01281995	8	3	EN-L5-6	49	33	33
GGGACCTGTCGAACAG-1_8_H10	-3.348406547	21.37022241	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	809	1138	0.010544815	0.020210896	8	oligos	OL-MS-1	49	33	33
GGGACCTTCAGCTCGG-1_8_H10	-27.42511309	-10.9340174	9	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1014	1550	0.003225806	0.005806452	8	9	OPC	49	33	33
GGGAGATAGCGATATA-1_8_H10	-6.462983762	9.611494779	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	821	1125	0.015111111	0.027555556	8	oligos	OL-MS-1	49	33	33
GGGAGATCAAACAACA-1_8_H10	-26.62303181	-1.634518163	9	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1708	3152	0.00571066	0.034581218	8	9	OPC	49	33	33
GGGAGATCACCAGGCT-1_8_H10	-17.59913074	25.71744713	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1908	3182	0.007856694	0.009428033	8	8	Astrocytes	49	33	33
GGGAGATGTAGAAGGA-1_8_H10	8.193970891	-21.55240011	4	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5268	14250	0.003438596	0.010245614	8	L2-3	EN-L2-3-MS	49	33	33
GGGAGATGTTTGGGCC-1_8_H10	-2.031113791	11.42798659	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	970	1325	0.006037736	0.01509434	8	oligos	OL-MS-1	49	33	33
GGGAGATTCCCATTAT-1_8_H10	-21.73401342	-16.17247642	6B	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3663	8479	0.012737351	0.010260644	8	6B	IN-SST	49	33	33
GGGAGATTCTTATCTG-1_8_H10	-4.133979214	17.28211982	1	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	832	1185	0.010126582	0.014345992	8	oligos	OL-Cntl	49	33	33
GGGATGAAGAGGTTAT-1_8_H10	-27.41832801	-2.857640083	9	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1373	2085	0.010551559	0.036930456	8	9	OPC	49	33	33
GGGATGAAGCCAACAG-1_8_H10	26.07086518	7.037759792	15DA	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1471	2311	0.013414106	0.037646041	8	15DA	T cells	49	33	33
GGGATGAAGTGACTCT-1_8_H10	30.18692943	13.30366436	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1030	1413	0.021231423	0.059447983	8	14	Microglia	49	33	33
GGGATGAGTCAACTGT-1_8_H10	26.32451593	10.17442289	15A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2108	3458	0.019375361	0.060150376	8	15A	Endo cells	49	33	33
GGGATGAGTCCGAACC-1_8_H10	-5.175800713	12.87316528	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	818	1095	0.019178082	0.021917808	8	oligos	OL-MS-1	49	33	33
GGGCACTAGGTTACCT-1_8_H10	23.29556132	-16.21297194	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	7283	25329	0.018279443	0.018674247	8	2	EN-L4	49	33	33
GGGCACTCACTGTCGG-1_8_H10	9.17526518	-21.99472828	4	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5336	14885	0.008330534	0.016795432	8	L2-3	EN-L2-3-MS	49	33	33
GGGCACTCATCGGTTA-1_8_H10	20.29021017	-21.13135836	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	6859	23470	0.020536856	0.010268428	8	3	EN-L5-6	49	33	33
GGGCACTGTATATGAG-1_8_H10	33.8643765	12.41158737	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1097	1539	0.016894087	0.012995452	8	14	Microglia	49	33	33
GGGCACTGTCTGCCAG-1_8_H10	5.153669788	0.797790441	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1149	1853	0.104155424	0.008634647	8	16	EN-PYR	49	33	33
GGGCACTGTGTTTGTG-1_8_H10	-5.310188128	8.642715471	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	972	1359	0.009565857	0.024282561	8	oligos	OL-MS-1	49	33	33
GGGCATCAGGGCTTCC-1_8_H10	-15.40224335	-5.100624055	13A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4238	10647	0.025734949	0.009204471	8	13A	IN-VIP	49	33	33
GGGCATCCACGTGAGA-1_8_H10	29.88823463	9.506175981	15DA	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	882	1156	0.024221453	0.044117647	8	15DA	T cells	49	33	33
GGGCATCGTCGAAAGC-1_8_H10	6.905509112	-20.94999718	4	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4615	11789	0.006192213	0.006446688	8	L2-3	EN-L2-3-MS	49	33	33
GGGCATCTCGTGGTCG-1_8_H10	-24.65702106	-19.07585317	6A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3391	6853	0.010506348	0.01167372	8	6A	IN-PV	49	33	33
GGGCATCTCTCGCTTG-1_8_H10	-3.50296909	11.241493	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	862	1180	0.016949153	0.024576271	8	oligos	OL-MS-1	49	33	33
GGGTCTGAGACCACGA-1_8_H10	24.17956585	-17.3283516	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4584	11127	0.049339445	0.01393008	8	3	EN-L5-6	49	33	33
GGGTCTGAGCGTTTAC-1_8_H10	33.00264741	13.81511692	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1026	1343	0.011913626	0.035740879	8	14	Microglia	49	33	33
GGGTCTGAGGAGCGAG-1_8_H10	35.12525118	10.70367494	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	939	1227	0.018744906	0.013854931	8	14	Microglia	49	33	33
GGGTCTGAGGCTCATT-1_8_H10	-1.93419923	11.3774849	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	916	1334	0.007496252	0.020989505	8	oligos	OL-MS-1	49	33	33
GGGTCTGAGTCAAGCG-1_8_H10	15.2786282	-27.45293215	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2911	5845	0.012660393	0.00615911	8	3	EN-L5-6	49	33	33
GGGTCTGCAAAGGCGT-1_8_H10	-19.80521299	-3.428838725	13A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4711	10950	0.009863014	0.016894977	8	13A	IN-VIP	49	33	33
GGGTCTGCACGGCTAC-1_8_H10	-22.30788089	7.773749766	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1219	1798	0.022803115	0.014460512	8	8	Astrocytes	49	33	33
GGGTCTGCATCCTTGC-1_8_H10	-3.225241692	-36.61211828	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	809	1037	0.069431051	0.035679846	8	16	EN-PYR	49	33	33
GGGTCTGGTATAGGTA-1_8_H10	28.87045196	10.11810267	15DB	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	977	1397	0.015748031	0.119541875	8	15DB	B cells	49	33	33
GGGTCTGGTATATGAG-1_8_H10	-11.09731291	-38.97623814	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1436	2388	0.037269682	0.033919598	8	16	EN-PYR	49	33	33
GGGTCTGGTGATAAAC-1_8_H10	-6.386405109	10.79653241	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	791	1060	0.013207547	0.017924528	8	oligos	OL-MS-1	49	33	33
GGGTCTGTCAAACAAG-1_8_H10	13.90307512	-10.25632292	13A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5514	14705	0.008772526	0.025297518	8	13A	IN-VIP	49	33	33
GGGTCTGTCTGGCGTG-1_8_H10	-10.90988304	-39.06725039	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1505	2317	0.069054812	0.029348295	8	16	EN-PYR	49	33	33
GGGTTGCCATATGGTC-1_8_H10	25.24010493	9.609944553	15A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2837	5281	0.017610301	0.022722969	8	15A	Endo cells	49	33	33
GGGTTGCCATTACCTT-1_8_H10	-26.59435869	-11.44355645	9	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1060	1410	0.022695035	0.021276596	8	9	OPC	49	33	33
GGGTTGCGTCATATGC-1_8_H10	8.916705252	8.462952144	1	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1339	2212	0.014014467	0.014918626	8	oligos	OL-Cntl	49	33	33
GGGTTGCGTGTGCCTG-1_8_H10	-7.768570506	7.601380694	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	844	1171	0.017079419	0.023911187	8	oligos	OL-MS-1	49	33	33
GGGTTGCTCACATAGC-1_8_H10	-5.252840781	10.4875873	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	936	1277	0.015661707	0.025841817	8	oligos	OL-MS-1	49	33	33
GGGTTGCTCAGATAAG-1_8_H10	8.504557977	-24.57281431	4	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3599	7969	0.011168277	0.006776258	8	L2-3	EN-L2-3-MS	49	33	33
GGGTTGCTCAGTCCCT-1_8_H10	-3.173114815	21.33534907	1	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	809	1135	0.011453744	0.016740088	8	oligos	OL-Cntl	49	33	33
GGTATTGAGACCGGAT-1_8_H10	-4.941051727	18.50581961	1	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	737	1025	0.012682927	0.013658537	8	oligos	OL-Cntl	49	33	33
GGTATTGAGTACTTGC-1_8_H10	2.951703759	-20.78343741	4	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3740	9740	0.021355236	0.004312115	8	L2-3	EN-L2-3-MS	49	33	33
GGTATTGGTACTTGAC-1_8_H10	24.85206625	-20.65127283	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4936	13532	0.036949453	0.005246822	8	3	EN-L5-6	49	33	33
GGTATTGGTAGAGGAA-1_8_H10	23.56095855	7.177375083	11	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2959	5050	0.022772277	0.031683168	8	11	Glia-MIX	49	33	33
GGTATTGGTAGGAGTC-1_8_H10	34.10241002	12.58377584	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1218	1790	0.013407821	0.020111732	8	14	Microglia	49	33	33
GGTATTGGTCGGATCC-1_8_H10	-5.465538099	7.901567713	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1007	1393	0.010768126	0.029432879	8	oligos	OL-MS-1	49	33	33
GGTATTGTCACAAACC-1_8_H10	-7.547610248	8.581166721	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	774	1059	0.033994334	0.014164306	8	oligos	OL-MS-1	49	33	33
GGTATTGTCGCGATCG-1_8_H10	-3.241201256	11.51586912	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	863	1129	0.011514615	0.023029229	8	oligos	OL-MS-1	49	33	33
GGTGAAGCAAAGAATC-1_8_H10	-4.945253704	8.585257732	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	851	1143	0.012248469	0.035870516	8	oligos	OL-MS-1	49	33	33
GGTGAAGCATCGGTTA-1_8_H10	-4.914276022	8.237397618	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	925	1231	0.017871649	0.038992689	8	oligos	OL-MS-1	49	33	33
GGTGAAGGTACAGTGG-1_8_H10	23.1921083	-24.02914483	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3051	6392	0.035356696	0.006414268	8	3	EN-L5-6	49	33	33
GGTGAAGGTAGTGAAT-1_8_H10	9.130048861	-3.854845795	12	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2435	4329	0.067221067	0.018480018	8	12	EN-MIX	49	33	33
GGTGAAGGTCCTCTTG-1_8_H10	-6.563227255	10.45078849	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	869	1158	0.011226252	0.022452504	8	oligos	OL-MS-1	49	33	33
GGTGAAGGTGCACGAA-1_8_H10	34.3533346	12.17749401	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1063	1463	0.010936432	0.018455229	8	14	Microglia	49	33	33
GGTGAAGGTGTTCTTT-1_8_H10	9.206375017	-30.47088724	10	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4440	12497	0.006641594	0.005201248	8	L2-3	EN-L2-3-Cntl	49	33	33
GGTGAAGGTTACGGAG-1_8_H10	-9.366263037	-8.053427107	13A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1716	2815	0.015630551	0.022735346	8	13A	IN-VIP	49	33	33
GGTGAAGTCTGCTGTC-1_8_H10	-5.842625267	10.48223133	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	821	1104	0.02173913	0.029891304	8	oligos	OL-MS-1	49	33	33
GGTGCGTAGCATCATC-1_8_H10	-3.569932241	8.642014382	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	964	1297	0.023901311	0.040092521	8	oligos	OL-MS-1	49	33	33
GGTGCGTAGTGGTAAT-1_8_H10	-4.398523439	9.400418676	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	892	1188	0.015993266	0.031986532	8	oligos	OL-MS-1	49	33	33
GGTGCGTCACTTAACG-1_8_H10	-16.82114443	-6.908831586	13B	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2315	4242	0.019094767	0.006129184	8	13B	IN-SV2C	49	33	33
GGTGCGTTCGCAAACT-1_8_H10	-1.324292618	8.042820642	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1366	1940	0.010824742	0.02371134	8	oligos	OL-MS-1	49	33	33
GGTGCGTTCGCGATCG-1_8_H10	12.03983857	-2.225773679	12	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1251	2099	0.068604097	0.006669843	8	12	EN-MIX	49	33	33
GGTGCGTTCTATCCCG-1_8_H10	6.2214453	-12.37695015	4	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2637	5639	0.012945558	0.010285512	8	L2-3	EN-L2-3-MS	49	33	33
GGTGTTAAGTAAGTAC-1_8_H10	18.0945832	-25.25090955	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4356	10736	0.013971684	0.012947094	8	3	EN-L5-6	49	33	33
GGTGTTAGTTATGTGC-1_8_H10	-7.640803739	7.041109388	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	764	1035	0.019323671	0.023188406	8	oligos	OL-MS-1	49	33	33
GGTGTTATCGCGGATC-1_8_H10	24.39704273	-19.92770474	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4998	13429	0.037456251	0.006850845	8	3	EN-L5-6	49	33	33
GTAACGTAGACAAGCC-1_8_H10	17.86492812	-7.840632941	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1804	3109	0.04567385	0.006432937	8	3	EN-L5-6	49	33	33
GTAACGTAGGCACATG-1_8_H10	-3.169087718	7.808312675	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1195	1662	0.009626955	0.027075812	8	oligos	OL-MS-1	49	33	33
GTAACGTCAATCGGTT-1_8_H10	13.52745637	-24.10417625	4	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4920	12730	0.004241948	0.009190888	8	L2-3	EN-L2-3-MS	49	33	33
GTAACGTCACTGAAGG-1_8_H10	7.465443775	-17.32591016	4	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3093	6148	0.006180872	0.024072869	8	L2-3	EN-L2-3-MS	49	33	33
GTAACGTGTATGGTTC-1_8_H10	29.8727382	9.147161308	15DA	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	774	1009	0.018830525	0.037661051	8	15DA	T cells	49	33	33
GTAACGTTCTTAGCCC-1_8_H10	-4.915537129	11.55093585	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	792	1080	0.014814815	0.02037037	8	oligos	OL-MS-1	49	33	33
GTAACTGGTTGATTGC-1_8_H10	30.67728223	-18.72108629	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	6498	19936	0.02538122	0.014897673	8	2	EN-L4	49	33	33
GTAACTGTCTGTCAAG-1_8_H10	-20.03119238	9.051360296	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1004	1396	0.012893983	0.004297994	8	8	Astrocytes	49	33	33
GTAACTGTCTTTACGT-1_8_H10	-7.038625202	-37.52004471	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1046	1425	0.034385965	0.019649123	8	16	EN-PYR	49	33	33
GTACGTACAAATCCGT-1_8_H10	32.62986719	13.60695396	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1359	2045	0.011735941	0.027872861	8	14	Microglia	49	33	33
GTACGTACAAGCGCTC-1_8_H10	-10.22519175	-2.730586442	13A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2155	3867	0.01448151	0.009050944	8	13A	IN-VIP	49	33	33
GTACGTACACTTACGA-1_8_H10	35.87179585	-9.31880509	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3754	8391	0.006077941	0.013109284	8	2	EN-L4	49	33	33
GTACGTACAGATCCAT-1_8_H10	-4.890823886	8.064077868	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	978	1386	0.007936508	0.044733045	8	oligos	OL-MS-1	49	33	33
GTACGTAGTATGAATG-1_8_H10	-3.806156133	-37.0373344	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1001	1369	0.044558072	0.034331629	8	16	EN-PYR	49	33	33
GTACTCCAGACTAGGC-1_8_H10	-10.1052563	-5.592960498	13A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1918	3303	0.025128671	0.012715713	8	13A	IN-VIP	49	33	33
GTACTCCAGCTCTCGG-1_8_H10	-1.732901056	11.15568252	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	931	1319	0.020470053	0.016679303	8	oligos	OL-MS-1	49	33	33
GTACTCCAGGTCATCT-1_8_H10	15.97492619	-27.19127932	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4458	11635	0.005844435	0.007305544	8	3	EN-L5-6	49	33	33
GTACTCCCAGCGATCC-1_8_H10	22.72526007	-16.15787459	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	6305	19564	0.035626661	0.014669802	8	3	EN-L5-6	49	33	33
GTACTCCCATCACGAT-1_8_H10	-16.53313584	25.16674455	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2127	3465	0.011255411	0.011832612	8	8	Astrocytes	49	33	33
GTACTCCCATTGCGGC-1_8_H10	25.09455275	-22.44195481	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5971	18237	0.0075122	0.005812359	8	3	EN-L5-6	49	33	33
GTACTCCGTGTTGGGA-1_8_H10	-3.941281094	7.325728808	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1164	1745	0.00974212	0.036103152	8	oligos	OL-MS-1	49	33	33
GTACTCCTCAAACCGT-1_8_H10	-3.725592972	-35.78480518	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	854	1198	0.094323873	0.012520868	8	16	EN-PYR	49	33	33
GTACTCCTCACGACTA-1_8_H10	-5.509932089	9.779146575	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	771	1005	0.014925373	0.024875622	8	oligos	OL-MS-1	49	33	33
GTACTCCTCATTTGGG-1_8_H10	-29.6056741	-1.170871467	9	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1620	2547	0.004711425	0.009815469	8	9	OPC	49	33	33
GTACTCCTCGTAGGTT-1_8_H10	-6.457627724	9.395496292	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	818	1098	0.010018215	0.02276867	8	oligos	OL-MS-1	49	33	33
GTACTTTAGAATTCCC-1_8_H10	28.68357649	-14.04100035	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	6855	23424	0.02172985	0.011185109	8	3	EN-L5-6	49	33	33
GTACTTTAGCTAACAA-1_8_H10	24.36327752	-11.59484319	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	6317	19607	0.006834294	0.008619371	8	3	EN-L5-6	49	33	33
GTACTTTCAAGCCCAC-1_8_H10	-30.00382272	-1.299362988	9	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1419	2304	0.005208333	0.008680556	8	9	OPC	49	33	33
GTACTTTCAATCCAAC-1_8_H10	25.50950683	10.06287757	15A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2481	4247	0.022604191	0.044266541	8	15A	Endo cells	49	33	33
GTACTTTCACTTGGAT-1_8_H10	-3.941308097	9.373756511	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1005	1461	0.020533881	0.019164956	8	oligos	OL-MS-1	49	33	33
GTACTTTGTACCGGCT-1_8_H10	-7.094372324	8.570994675	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	846	1108	0.010830325	0.038808664	8	oligos	OL-MS-1	49	33	33
GTACTTTGTACTCGCG-1_8_H10	-10.59042968	-38.97068583	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1445	2172	0.098987109	0.025782689	8	16	EN-PYR	49	33	33
GTACTTTGTTGACGTT-1_8_H10	18.7124326	-9.294438798	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2377	5003	0.026384169	0.005796522	8	3	EN-L5-6	49	33	33
GTAGGCCAGGATGGAA-1_8_H10	-22.6842207	-20.49702873	6A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2835	5257	0.02377782	0.007228457	8	6A	IN-PV	49	33	33
GTAGGCCCAAGGTTTC-1_8_H10	-6.611154096	10.93466308	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	847	1184	0.007601351	0.014358108	8	oligos	OL-MS-1	49	33	33
GTAGGCCCAATGTAAG-1_8_H10	28.26485718	7.733962346	15DA	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1062	1618	0.145859085	0.072929543	8	15DA	T cells	49	33	33
GTAGGCCCAGCCTTGG-1_8_H10	34.18023642	10.68800716	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	837	1141	0.036809816	0.013146363	8	14	Microglia	49	33	33
GTAGGCCGTCTGATTG-1_8_H10	-5.64200756	11.12847247	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	769	1081	0.01480111	0.019426457	8	oligos	OL-MS-1	49	33	33
GTAGGCCTCGTCTGAA-1_8_H10	-5.714081038	6.405668209	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1393	2138	0.018241347	0.043498597	8	oligos	OL-MS-1	49	33	33
GTAGTCAAGCCACTAT-1_8_H10	29.59735953	14.2933303	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1384	1988	0.017605634	0.092555332	8	14	Microglia	49	33	33
GTAGTCACACCCAGTG-1_8_H10	-17.3037149	6.580237726	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	802	1100	0.021818182	0.01	8	8	Astrocytes	49	33	33
GTAGTCACAGGGATTG-1_8_H10	33.84045848	-8.374876836	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4474	10493	0.013056323	0.010673783	8	2	EN-L4	49	33	33
GTAGTCACATGCAACT-1_8_H10	20.23765303	-22.91522382	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4028	9653	0.025691495	0.0078732	8	3	EN-L5-6	49	33	33
GTAGTCAGTAAGCACG-1_8_H10	-22.12752748	8.381546228	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	991	1442	0.049930652	0.009015257	8	8	Astrocytes	49	33	33
GTAGTCAGTAGGGTAC-1_8_H10	-24.02184611	6.267044311	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	784	1025	0.015609756	0.013658537	8	8	Astrocytes	49	33	33
GTAGTCAGTATTAGCC-1_8_H10	-6.204791282	9.585405063	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	906	1216	0.018914474	0.019736842	8	oligos	OL-MS-1	49	33	33
GTAGTCAGTCACCTAA-1_8_H10	-12.95113894	-2.092312453	13A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2681	5029	0.007755021	0.009942334	8	13A	IN-VIP	49	33	33
GTAGTCAGTCATGCCG-1_8_H10	-16.52218445	24.89522716	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1847	2895	0.015544041	0.016580311	8	8	Astrocytes	49	33	33
GTAGTCAGTCGGCTCA-1_8_H10	-6.544644031	10.21998472	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	824	1097	0.015496809	0.026435734	8	oligos	OL-MS-1	49	33	33
GTATCTTAGGGCATGT-1_8_H10	24.87740698	-16.50805004	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	8136	31019	0.032592927	0.013862471	8	2	EN-L4	49	33	33
GTATCTTAGGTGCACA-1_8_H10	-6.884657436	10.5489032	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	990	1499	0.01400934	0.011340894	8	oligos	OL-MS-1	49	33	33
GTATCTTTCGTGGTCG-1_8_H10	29.85577758	9.169285158	15DA	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	908	1215	0.038683128	0.044444444	8	15DA	T cells	49	33	33
GTATTCTGTCAAAGAT-1_8_H10	5.867230847	0.443515004	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1099	1656	0.10326087	0.025362319	8	16	EN-PYR	49	33	33
GTATTCTGTCAGAGGT-1_8_H10	39.90703039	12.65149317	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1062	1486	0.01345895	0.004710633	8	14	Microglia	49	33	33
GTCAAGTAGATGCGAC-1_8_H10	-4.051681396	-37.06549217	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	828	1135	0.062555066	0.040528634	8	16	EN-PYR	49	33	33
GTCAAGTCATTGGGCC-1_8_H10	35.62393364	-11.11524775	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5048	12553	0.012666295	0.017366367	8	2	EN-L4	49	33	33
GTCAAGTCATTTGCCC-1_8_H10	8.460996727	-2.973541344	12	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2098	3490	0.014899713	0.026647564	8	12	EN-MIX	49	33	33
GTCAAGTGTATATGAG-1_8_H10	30.63560355	-7.8986723	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4694	12230	0.014963205	0.008340147	8	2	EN-L4	49	33	33
GTCAAGTGTCAAAGCG-1_8_H10	-17.50838544	24.01569271	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1676	2676	0.012331839	0.004857997	8	8	Astrocytes	49	33	33
GTCAAGTTCGTATCAG-1_8_H10	-7.295915058	7.197810694	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	885	1261	0.00555115	0.028548771	8	oligos	OL-MS-1	49	33	33
GTCACAAAGGTCATCT-1_8_H10	-3.661967857	-36.89505246	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	889	1287	0.128982129	0.034188034	8	16	EN-PYR	49	33	33
GTCACAACACCGTTGG-1_8_H10	-6.368975905	10.87278054	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	841	1180	0.01440678	0.018644068	8	oligos	OL-MS-1	49	33	33
GTCACAAGTGCGAAAC-1_8_H10	22.12345234	-21.01657927	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5068	13360	0.021706587	0.007784431	8	3	EN-L5-6	49	33	33
GTCACAATCGGCGCAT-1_8_H10	-24.29034762	21.7352938	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1314	2163	0.012482663	0.008321775	8	8	Astrocytes	49	33	33
GTCACGGAGCTAACTC-1_8_H10	-16.18300233	-22.18782739	6A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1717	3198	0.085991245	0.005628518	8	6A	IN-PV	49	33	33
GTCACGGTCAGCTGGC-1_8_H10	33.49294196	-16.77046753	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5025	12132	0.021760633	0.017392021	8	2	EN-L4	49	33	33
GTCACGGTCCAATGGT-1_8_H10	-4.126192061	11.03209696	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	858	1201	0.016652789	0.019983347	8	oligos	OL-MS-1	49	33	33
GTCACGGTCGAACGGA-1_8_H10	-6.412415279	7.561510591	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	920	1254	0.041467305	0.01754386	8	oligos	OL-MS-1	49	33	33
GTCACGGTCTGGCGTG-1_8_H10	-3.491879211	-36.13307991	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	917	1309	0.137509549	0.025974026	8	16	EN-PYR	49	33	33
GTCATTTAGCCTCGTG-1_8_H10	28.13546231	-11.73421101	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4840	12394	0.036307891	0.00806842	8	2	EN-L4	49	33	33
GTCATTTCAATTGCTG-1_8_H10	24.76257324	4.806624427	15BA	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1790	2926	0.006493506	0.009569378	8	15BA	Stromal cells	49	33	33
GTCATTTCACGACGAA-1_8_H10	-18.21061217	25.24871549	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1731	2873	0.006613296	0.013574661	8	8	Astrocytes	49	33	33
GTCCTCAAGGTACTCT-1_8_H10	-23.9884112	-22.05770085	6A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3750	8750	0.131885714	0.008228571	8	6A	IN-PV	49	33	33
GTCCTCACACCCATTC-1_8_H10	-7.759422288	7.328472768	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	754	1024	0.014648438	0.032226563	8	oligos	OL-MS-1	49	33	33
GTCCTCACATCACCCT-1_8_H10	-3.617194769	7.973318446	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1002	1427	0.009810792	0.028030834	8	oligos	OL-MS-1	49	33	33
GTCCTCACATTGCGGC-1_8_H10	24.64396949	-19.96264306	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	6094	20826	0.032747527	0.005906079	8	3	EN-L5-6	49	33	33
GTCCTCATCCGCATAA-1_8_H10	24.46003035	-28.35607093	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3130	7198	0.005001389	0.006112809	8	3	EN-L5-6	49	33	33
GTCCTCATCCTAGGGC-1_8_H10	-4.191148792	18.73548132	1	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	872	1236	0.021035599	0.024271845	8	oligos	OL-Cntl	49	33	33
GTCGGGTAGAATTGTG-1_8_H10	6.053432002	10.24069124	1	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1301	2067	0.004837929	0.020319303	8	oligos	OL-Cntl	49	33	33
GTCGGGTCACCATCCT-1_8_H10	32.89067936	9.171720057	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	754	1002	0.008982036	0.015968064	8	14	Microglia	49	33	33
GTCGGGTCACGTCAGC-1_8_H10	18.57445917	-9.28178858	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2386	4764	0.077036104	0.005037783	8	3	EN-L5-6	49	33	33
GTCGGGTCATGTCGAT-1_8_H10	-15.99578777	11.91972158	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1300	2164	0.012014787	0.006007394	8	8	Astrocytes	49	33	33
GTCGGGTGTATAGTAG-1_8_H10	-4.932304158	10.18247606	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	774	1054	0.015180266	0.041745731	8	oligos	OL-MS-1	49	33	33
GTCGGGTGTATTACCG-1_8_H10	-17.7145801	26.11955815	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2103	3750	0.0072	0.008266667	8	8	Astrocytes	49	33	33
GTCGGGTTCACAACGT-1_8_H10	-3.037282136	10.44842032	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	871	1307	0.010711553	0.01606733	8	oligos	OL-MS-1	49	33	33
GTCGGGTTCTGAGGGA-1_8_H10	-17.60384032	7.62262502	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1079	1611	0.00744879	0.008690255	8	8	Astrocytes	49	33	33
GTCGTAAAGCAATCTC-1_8_H10	8.347267267	-17.61443898	4	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5171	14419	0.007351411	0.024065469	8	L2-3	EN-L2-3-MS	49	33	33
GTCGTAACACACTGCG-1_8_H10	-6.754862269	9.084087892	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	825	1100	0.016363636	0.02	8	oligos	OL-MS-1	49	33	33
GTCGTAAGTGCAACTT-1_8_H10	-2.139968275	11.52449384	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	877	1220	0.020491803	0.028688525	8	oligos	OL-MS-1	49	33	33
GTCGTAAGTGCACTTA-1_8_H10	18.32165267	-25.00258248	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	6216	21206	0.008205225	0.010563048	8	3	EN-L5-6	49	33	33
GTCGTAATCGGAATCT-1_8_H10	26.80621187	9.931341788	15A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1651	2606	0.033000767	0.049117421	8	15A	Endo cells	49	33	33
GTCTCGTAGCTTATCG-1_8_H10	21.42362324	-22.75299591	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3872	8750	0.017485714	0.020342857	8	3	EN-L5-6	49	33	33
GTCTCGTCACCACGTG-1_8_H10	33.36477091	5.325644958	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1234	1683	0.046939988	0.010695187	8	14	Microglia	49	33	33
GTCTCGTCAGGTCTCG-1_8_H10	18.80381058	-23.98147672	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	6312	19421	0.007157201	0.011739869	8	3	EN-L5-6	49	33	33
GTCTCGTTCAAACGGG-1_8_H10	-18.57337421	25.4324725	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1760	2955	0.007783418	0.008121827	8	8	Astrocytes	49	33	33
GTCTCGTTCCACTGGG-1_8_H10	24.45048118	-19.48335923	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	6291	20122	0.042292019	0.009044827	8	3	EN-L5-6	49	33	33
GTCTCGTTCTACTATC-1_8_H10	24.67159466	-19.97455827	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	6079	20373	0.029597997	0.005546557	8	3	EN-L5-6	49	33	33
GTCTTCGAGAAGAAGC-1_8_H10	-17.76566147	24.0659474	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1744	2834	0.00564573	0.004940014	8	8	Astrocytes	49	33	33
GTCTTCGAGCAATCTC-1_8_H10	-2.530371605	11.90404008	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	814	1120	0.016964286	0.021428571	8	oligos	OL-MS-1	49	33	33
GTCTTCGAGCTCTCGG-1_8_H10	14.52703819	-27.0659712	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3297	7516	0.062533262	0.004789782	8	3	EN-L5-6	49	33	33
GTCTTCGAGTATGACA-1_8_H10	-6.845659698	10.72967786	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	815	1079	0.016682113	0.02502317	8	oligos	OL-MS-1	49	33	33
GTCTTCGTCAAAGTAG-1_8_H10	-17.61025582	24.5420099	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1620	2591	0.003473562	0.009262833	8	8	Astrocytes	49	33	33
GTCTTCGTCTGACCTC-1_8_H10	-5.21408181	8.507345768	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	928	1333	0.017254314	0.035258815	8	oligos	OL-MS-1	49	33	33
GTGAAGGAGAATTGTG-1_8_H10	-19.60771901	-0.446979243	13A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4140	8297	0.007954682	0.038809208	8	13A	IN-VIP	49	33	33
GTGAAGGCATGCCTTC-1_8_H10	-22.68659675	-17.0565977	6A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3681	8528	0.037406191	0.01184334	8	6A	IN-PV	49	33	33
GTGAAGGGTACGAAAT-1_8_H10	-22.22062135	-17.18169255	6A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4653	13310	0.01472577	0.007438017	8	6A	IN-PV	49	33	33
GTGAAGGTCAGTGTTG-1_8_H10	-4.405639409	16.55926338	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	743	1025	0.010731707	0.009756098	8	oligos	OL-MS-1	49	33	33
GTGCAGCAGATAGTCA-1_8_H10	-5.669325314	10.7129772	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	818	1110	0.018918919	0.02972973	8	oligos	OL-MS-1	49	33	33
GTGCAGCAGCTATGCT-1_8_H10	-4.325039761	15.53695692	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	749	1011	0.005934718	0.016815035	8	oligos	OL-MS-1	49	33	33
GTGCAGCCACCTCGGA-1_8_H10	24.0921323	-20.22471092	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	6311	19291	0.026955575	0.007205433	8	3	EN-L5-6	49	33	33
GTGCAGCCACTGTTAG-1_8_H10	-4.14053153	-36.3077313	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	946	1351	0.084381939	0.0392302	8	16	EN-PYR	49	33	33
GTGCAGCGTACAGTTC-1_8_H10	-10.58509115	27.52588765	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1091	1563	0.062699936	0.033909149	8	oligos	OL-MS-1	49	33	33
GTGCAGCGTGTGAAAT-1_8_H10	-0.350925919	7.3848546	1	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2415	4362	0.007336084	0.022237506	8	oligos	OL-Cntl	49	33	33
GTGCAGCTCAGAGACG-1_8_H10	31.94244506	10.70059508	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	927	1295	0.017760618	0.033204633	8	14	Microglia	49	33	33
GTGCAGCTCATTATCC-1_8_H10	-4.282082379	12.45505636	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	848	1194	0.016750419	0.020938023	8	oligos	OL-MS-1	49	33	33
GTGCAGCTCGTGACAT-1_8_H10	-29.62526294	-1.440746777	9	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1540	2599	0.005771451	0.008080031	8	9	OPC	49	33	33
GTGCAGCTCGTGGACC-1_8_H10	33.96479373	14.18992089	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	977	1397	0.006442377	0.027201145	8	14	Microglia	49	33	33
GTGCATAAGACCCACC-1_8_H10	33.21510431	9.068267224	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	965	1244	0.007234727	0.022508039	8	14	Microglia	49	33	33
GTGCATAAGAGGACGG-1_8_H10	2.155954436	19.12591578	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	932	1309	0.011459129	0.019098549	8	oligos	OL-MS-1	49	33	33
GTGCATAAGAGTAAGG-1_8_H10	-18.33772266	6.359498808	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	909	1205	0.015767635	0.009958506	8	8	Astrocytes	49	33	33
GTGCATAAGATCCTGT-1_8_H10	20.4220198	-17.7711311	4	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5548	15373	0.025239055	0.012749626	8	L2-3	EN-L2-3-MS	49	33	33
GTGCATACACAAGACG-1_8_H10	24.36011466	-12.84679329	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4241	9805	0.032024477	0.007445181	8	3	EN-L5-6	49	33	33
GTGCATACACTTGGAT-1_8_H10	13.36634548	7.303651109	1	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1570	2644	0.007564297	0.010590015	8	oligos	OL-Cntl	49	33	33
GTGCATAGTGTGGTTT-1_8_H10	-18.65421207	17.7441549	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1812	3021	0.004303211	0.003641178	8	8	Astrocytes	49	33	33
GTGCATAGTTCCCTTG-1_8_H10	-4.241423441	9.349729241	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	953	1335	0.007490637	0.016479401	8	oligos	OL-MS-1	49	33	33
GTGCATATCCAGTAGT-1_8_H10	10.62922899	-1.83039052	12	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1358	2013	0.025832091	0.018380527	8	12	EN-MIX	49	33	33
GTGCGGTCAGCTTAAC-1_8_H10	22.43586056	-23.63376888	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4142	10446	0.024411258	0.007754164	8	3	EN-L5-6	49	33	33
GTGCTTCAGCCGGTAA-1_8_H10	9.01262882	-3.793339775	12	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2098	3646	0.050740538	0.021119035	8	12	EN-MIX	49	33	33
GTGCTTCAGCTAGTTC-1_8_H10	18.60865432	-25.73658632	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4432	11519	0.013456029	0.007552739	8	3	EN-L5-6	49	33	33
GTGCTTCAGGACAGCT-1_8_H10	34.29889523	12.57918162	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1006	1415	0.006360424	0.021201413	8	14	Microglia	49	33	33
GTGCTTCAGGCATGGT-1_8_H10	24.99588043	-15.86546239	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4323	10502	0.018377452	0.012283375	8	3	EN-L5-6	49	33	33
GTGCTTCCACAACGCC-1_8_H10	-3.730169076	9.589925576	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	969	1347	0.021529324	0.017074981	8	oligos	OL-MS-1	49	33	33
GTGCTTCCACACTGCG-1_8_H10	-5.602698834	8.292927457	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	899	1260	0.014285714	0.051587302	8	oligos	OL-MS-1	49	33	33
GTGCTTCGTAATTGGA-1_8_H10	-3.152507929	7.72282011	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1151	1669	0.019173158	0.023367286	8	oligos	OL-MS-1	49	33	33
GTGGGTCAGCGTTTAC-1_8_H10	-0.700434544	8.136918485	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1277	1848	0.027056277	0.031385281	8	oligos	OL-MS-1	49	33	33
GTGGGTCAGGCACATG-1_8_H10	18.32775687	-24.78823211	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4856	13004	0.016148877	0.011458013	8	3	EN-L5-6	49	33	33
GTGGGTCCAAAGCGGT-1_8_H10	33.04602638	10.29951985	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	870	1212	0.018976898	0.025577558	8	14	Microglia	49	33	33
GTGGGTCCATTGGCGC-1_8_H10	-17.39682833	-0.268933674	13A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3430	6817	0.008214757	0.020536893	8	13A	IN-VIP	49	33	33
GTGGGTCGTATGCTTG-1_8_H10	-29.52981584	-1.297619237	9	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1657	2736	0.013157895	0.008406433	8	9	OPC	49	33	33
GTGGGTCTCCGTAGGC-1_8_H10	-11.67383672	28.32406917	17	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1732	2740	0.066423358	0.018978102	8	oligos	OL-MS-2	49	33	33
GTGGGTCTCGGCTACG-1_8_H10	-3.939450256	6.897025819	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1320	1944	0.011316872	0.058641975	8	oligos	OL-MS-1	49	33	33
GTGTGCGAGGGATCTG-1_8_H10	-2.670788625	7.892266939	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1175	1697	0.01473188	0.040070713	8	oligos	OL-MS-1	49	33	33
GTGTGCGAGTTGTCGT-1_8_H10	29.59016663	9.547725657	15DB	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	910	1402	0.014265335	0.051355207	8	15DB	B cells	49	33	33
GTGTGCGCAATCCGAT-1_8_H10	-17.18624533	25.54456846	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2020	3454	0.00463231	0.012159815	8	8	Astrocytes	49	33	33
GTGTGCGCACCGAAAG-1_8_H10	31.73354554	-7.058383307	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4975	12857	0.007933421	0.007700086	8	2	EN-L4	49	33	33
GTGTGCGCACTAGTAC-1_8_H10	-1.796668386	8.648506272	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1082	1544	0.017487047	0.02007772	8	oligos	OL-MS-1	49	33	33
GTGTGCGCATGCGCAC-1_8_H10	29.71033943	-6.606799603	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4842	13947	0.008460601	0.0042303	8	2	EN-L4	49	33	33
GTGTGCGGTAGCTAAA-1_8_H10	-16.12674273	14.95596362	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1843	3101	0.007739439	0.004837149	8	8	Astrocytes	49	33	33
GTGTGCGGTGGCCCTA-1_8_H10	-5.661800966	6.374790964	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1544	2447	0.012668574	0.065794851	8	oligos	OL-MS-1	49	33	33
GTGTGCGGTTCCGTCT-1_8_H10	0.113298397	10.46629316	1	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1083	1588	0.009445844	0.013853904	8	oligos	OL-Cntl	49	33	33
GTGTGCGTCATACGGT-1_8_H10	31.6263177	15.34484383	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1180	1723	0.016250725	0.044689495	8	14	Microglia	49	33	33
GTGTGCGTCGTATCAG-1_8_H10	-17.70759233	24.91823983	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1643	2711	0.008852822	0.006270749	8	8	Astrocytes	49	33	33
GTGTGCGTCTGAGTGT-1_8_H10	22.07001825	-24.55308348	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3775	8880	0.007545045	0.009459459	8	3	EN-L5-6	49	33	33
GTGTTAGAGCCAACAG-1_8_H10	-4.731076023	10.26694818	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	802	1087	0.011039558	0.027598896	8	oligos	OL-MS-1	49	33	33
GTGTTAGTCTCCAACC-1_8_H10	-4.60402701	10.03212549	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	851	1165	0.019742489	0.024892704	8	oligos	OL-MS-1	49	33	33
GTTAAGCCACGAAGCA-1_8_H10	25.81891125	3.662286329	15DA	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	966	1405	0.009964413	0.007829181	8	15DA	T cells	49	33	33
GTTAAGCCAGCATGAG-1_8_H10	-5.623336913	9.049719042	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	758	1012	0.015810277	0.022727273	8	oligos	OL-MS-1	49	33	33
GTTAAGCTCACCAGGC-1_8_H10	-26.71309511	-23.27024033	6A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5525	15580	0.014313222	0.009050064	8	6A	IN-PV	49	33	33
GTTAAGCTCACTCCTG-1_8_H10	33.62659364	-16.77331469	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5136	12060	0.014759536	0.016749585	8	2	EN-L4	49	33	33
GTTAAGCTCCTATTCA-1_8_H10	19.59796411	-19.65106808	4	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	6004	18602	0.019675304	0.006719708	8	L2-3	EN-L2-3-MS	49	33	33
GTTAAGCTCGTTTAGG-1_8_H10	10.04957972	-21.83956928	4	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	6569	20925	0.003632019	0.008936679	8	L2-3	EN-L2-3-MS	49	33	33
GTTACAGGTATGAAAC-1_8_H10	-7.84068924	9.169038105	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	753	1127	0.01863354	0.014196983	8	oligos	OL-MS-1	49	33	33
GTTACAGGTCCTAGCG-1_8_H10	33.84494504	13.30302876	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1128	1680	0.048214286	0.025	8	14	Microglia	49	33	33
GTTACAGGTGGTCTCG-1_8_H10	-3.472326804	11.93799767	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	865	1176	0.012755102	0.043367347	8	oligos	OL-MS-1	49	33	33
GTTACAGGTGGTTTCA-1_8_H10	-2.727599064	10.08946845	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	949	1384	0.009393064	0.025289017	8	oligos	OL-MS-1	49	33	33
GTTCATTAGACCGGAT-1_8_H10	34.59491899	-8.966724595	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5044	12796	0.013597999	0.014613942	8	2	EN-L4	49	33	33
GTTCATTCAACTGCGC-1_8_H10	-6.484561824	7.117650496	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	972	1304	0.030674847	0.029907975	8	oligos	OL-MS-1	49	33	33
GTTCATTCAAGCGATG-1_8_H10	-18.20415243	-13.99761952	6B	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2218	3688	0.015997831	0.020065076	8	6B	IN-SST	49	33	33
GTTCATTGTTCGCGAC-1_8_H10	-4.232187187	-36.66563246	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	750	1040	0.039423077	0.028846154	8	16	EN-PYR	49	33	33
GTTCATTTCCTCCTAG-1_8_H10	-2.940803159	18.7629421	1	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	899	1381	0.01230992	0.011585807	8	oligos	OL-Cntl	49	33	33
GTTCGGGAGAAACCTA-1_8_H10	-24.34792586	-19.2578364	6A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3468	7870	0.052096569	0.007878018	8	6A	IN-PV	49	33	33
GTTCGGGAGGCTCTTA-1_8_H10	-17.50568855	24.13659329	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1424	2032	0.00738189	0.011318898	8	8	Astrocytes	49	33	33
GTTCGGGGTAATCGTC-1_8_H10	24.34314663	-11.59122174	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4395	10008	0.005295763	0.010991207	8	3	EN-L5-6	49	33	33
GTTCGGGGTGAGTGAC-1_8_H10	-4.442060899	9.79244598	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	932	1281	0.007806401	0.021857923	8	oligos	OL-MS-1	49	33	33
GTTCGGGGTTCGCTAA-1_8_H10	31.89989431	-7.259705397	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3831	8779	0.009910013	0.011390819	8	2	EN-L4	49	33	33
GTTCGGGGTTCGGGCT-1_8_H10	-5.513468913	12.09116847	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	764	1065	0.008450704	0.022535211	8	oligos	OL-MS-1	49	33	33
GTTCGGGGTTGCCTCT-1_8_H10	24.99238991	-22.46500141	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5169	14930	0.014199598	0.005827194	8	3	EN-L5-6	49	33	33
GTTCGGGTCACGACTA-1_8_H10	-4.355331843	-37.30741021	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	922	1238	0.059773829	0.02180937	8	16	EN-PYR	49	33	33
GTTCGGGTCATAGCAC-1_8_H10	33.35068359	10.57014926	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	849	1068	0.016853933	0.017790262	8	14	Microglia	49	33	33
GTTCTCGAGCAATATG-1_8_H10	31.61477892	9.399465448	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	891	1192	0.022651007	0.021812081	8	14	Microglia	49	33	33
GTTCTCGCACTGCCAG-1_8_H10	29.7399654	14.17864567	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1197	1888	0.106991525	0.09904661	8	14	Microglia	49	33	33
GTTCTCGGTCTCCATC-1_8_H10	34.12858852	11.58119897	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	889	1201	0.013322231	0.01498751	8	14	Microglia	49	33	33
GTTCTCGGTCTTTCAT-1_8_H10	-17.88907554	-6.575970074	13B	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2626	4971	0.030979682	0.00683967	8	13B	IN-SV2C	49	33	33
GTTCTCGTCCGATATG-1_8_H10	31.64691316	11.47360115	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1107	1514	0.030383091	0.040951123	8	14	Microglia	49	33	33
GTTTCTAAGAACTGTA-1_8_H10	19.74150242	-18.61793825	4	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5665	15862	0.033665364	0.007628294	8	L2-3	EN-L2-3-MS	49	33	33
GTTTCTAAGTAGATGT-1_8_H10	-1.695459242	7.983744804	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1202	1690	0.009467456	0.030177515	8	oligos	OL-MS-1	49	33	33
GTTTCTACAGTCTTCC-1_8_H10	35.56991764	-8.473423401	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5530	15460	0.011901682	0.010672704	8	2	EN-L4	49	33	33
GTTTCTAGTCATGCCG-1_8_H10	27.54417317	9.147333215	15A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1047	1471	0.025832767	0.065941536	8	15A	Endo cells	49	33	33
GTTTCTAGTTAGATGA-1_8_H10	-10.86032437	14.46858683	11	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1603	2471	0.019425334	0.011736139	8	11	Glia-MIX	49	33	33
GTTTCTAGTTCCGGCA-1_8_H10	26.0701384	10.24895583	15A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2207	3932	0.02110885	0.066632757	8	15A	Endo cells	49	33	33
GTTTCTATCAGCCTAA-1_8_H10	-3.037821785	-35.51709892	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	811	1113	0.085354897	0.029649596	8	16	EN-PYR	49	33	33
GTTTCTATCGATCCCT-1_8_H10	32.2216176	11.19145261	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	850	1138	0.019332162	0.033391916	8	14	Microglia	49	33	33
TAAACCGCACGGTTTA-1_8_H10	-29.27827817	-11.10828002	9	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	966	1379	0.025380711	0.011602611	8	9	OPC	49	33	33
TAAACCGGTACCGAGA-1_8_H10	17.47172415	-29.55407488	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5487	17136	0.005018674	0.006185808	8	3	EN-L5-6	49	33	33
TAAACCGGTCGCTTCT-1_8_H10	-26.44234776	-23.69259925	6A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5163	14460	0.058852006	0.006984786	8	6A	IN-PV	49	33	33
TAAACCGGTCTCTTAT-1_8_H10	14.59289891	-22.04388975	4	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	6024	19240	0.025051975	0.00504158	8	L2-3	EN-L2-3-MS	49	33	33
TAAACCGGTCTTCGTC-1_8_H10	-1.626545649	9.16073233	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1048	1410	0.021985816	0.015602837	8	oligos	OL-MS-1	49	33	33
TAAACCGTCCACTCCA-1_8_H10	34.8036646	-9.179707837	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5696	16055	0.014201183	0.012644036	8	2	EN-L4	49	33	33
TAAGAGAAGAAACGAG-1_8_H10	33.37597394	10.78511271	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	925	1217	0.015612161	0.025472473	8	14	Microglia	49	33	33
TAAGAGAAGAATGTGT-1_8_H10	33.27708548	10.97337958	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	869	1251	0.059952038	0.027977618	8	14	Microglia	49	33	33
TAAGAGAAGAGTACAT-1_8_H10	-6.57566329	8.009601685	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	857	1146	0.020069808	0.021815009	8	oligos	OL-MS-1	49	33	33
TAAGAGACAGTAAGAT-1_8_H10	-15.44564832	-14.20870162	6B	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2161	4008	0.088323353	0.01247505	8	6B	IN-SST	49	33	33
TAAGAGAGTGATGCCC-1_8_H10	-18.99364986	-16.14437977	6B	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2365	4435	0.013979707	0.006087937	8	6B	IN-SST	49	33	33
TAAGAGAGTTCGTCTC-1_8_H10	8.849391886	-30.60505735	10	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3870	9939	0.018110474	0.003823322	8	L2-3	EN-L2-3-Cntl	49	33	33
TAAGAGATCAGGCCCA-1_8_H10	-3.035041437	-35.36222799	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	789	1087	0.119595216	0.032198712	8	16	EN-PYR	49	33	33
TAAGCGTAGCGTTTAC-1_8_H10	-17.9629788	16.91804961	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1233	1821	0.015925316	0.006589786	8	8	Astrocytes	49	33	33
TAAGCGTAGGCTCATT-1_8_H10	-18.68681689	-16.42723073	6B	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2387	4615	0.008884074	0.005417118	8	6B	IN-SST	49	33	33
TAAGCGTCAAATCCGT-1_8_H10	-9.025751351	-10.21448408	6B	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1037	1450	0.046206897	0.012413793	8	6B	IN-SST	49	33	33
TAAGCGTCAATCCGAT-1_8_H10	30.04265576	9.413515263	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1091	1509	0.040424122	0.03843605	8	14	Microglia	49	33	33
TAAGCGTGTCTTGTCC-1_8_H10	-2.965404371	8.280924505	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1065	1560	0.005128205	0.020512821	8	oligos	OL-MS-1	49	33	33
TAAGCGTGTGCTCTTC-1_8_H10	-3.141912201	-36.247923	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	785	1053	0.088319088	0.035137702	8	16	EN-PYR	49	33	33
TAAGCGTGTTCAGTAC-1_8_H10	-3.812490824	15.26905189	1	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	742	1002	0.022954092	0.017964072	8	oligos	OL-Cntl	49	33	33
TAAGCGTGTTCGTTGA-1_8_H10	-14.57890546	21.38511686	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1295	1896	0.042194093	0.015822785	8	8	Astrocytes	49	33	33
TAAGCGTGTTGCGTTA-1_8_H10	29.68194253	-11.58532109	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4279	10409	0.02305697	0.009222788	8	2	EN-L4	49	33	33
TAAGTGCAGATCCGAG-1_8_H10	13.54878805	-23.95662291	4	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	6179	18991	0.020799326	0.008214417	8	L2-3	EN-L2-3-MS	49	33	33
TAAGTGCAGTGCGATG-1_8_H10	31.44478536	9.808249549	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	768	1002	0.013972056	0.05489022	8	14	Microglia	49	33	33
TAAGTGCCATCAGTCA-1_8_H10	-6.546146342	9.61774468	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	821	1119	0.017873101	0.018766756	8	oligos	OL-MS-1	49	33	33
TAAGTGCGTACCCAAT-1_8_H10	33.44416288	-16.89106906	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5534	13939	0.016643949	0.01980056	8	2	EN-L4	49	33	33
TAAGTGCGTACTCAAC-1_8_H10	-7.128197126	6.756539398	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1116	1562	0.016645327	0.030089629	8	oligos	OL-MS-1	49	33	33
TAAGTGCTCAAGGTAA-1_8_H10	25.1852468	-15.56608701	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	6828	20633	0.01177725	0.012795037	8	3	EN-L5-6	49	33	33
TAAGTGCTCACCGTAA-1_8_H10	10.57131403	-2.732361263	12	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1770	3293	0.045247495	0.009413908	8	12	EN-MIX	49	33	33
TACACGACAATACGCT-1_8_H10	34.57297039	-9.083949587	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	6288	20714	0.009075987	0.010524283	8	2	EN-L4	49	33	33
TACACGAGTACAAGTA-1_8_H10	-9.183139262	-15.26013591	6B	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	818	1116	0.028673835	0.011648746	8	6B	IN-SST	49	33	33
TACACGATCGCCGTGA-1_8_H10	-5.329874431	8.39146898	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	783	1086	0.015653775	0.039594843	8	oligos	OL-MS-1	49	33	33
TACAGTGAGGACATTA-1_8_H10	16.82626653	-9.910779866	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2352	4260	0.041549296	0.006338028	8	3	EN-L5-6	49	33	33
TACAGTGGTACAGTGG-1_8_H10	9.660737345	-23.87718009	4	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	6706	24393	0.003648588	0.005247407	8	L2-3	EN-L2-3-MS	49	33	33
TACAGTGGTTCCAACA-1_8_H10	-7.026962788	8.907721271	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	768	1012	0.016798419	0.020750988	8	oligos	OL-MS-1	49	33	33
TACAGTGTCAGCGACC-1_8_H10	15.65121089	-27.61509859	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4205	11735	0.016105667	0.006135492	8	3	EN-L5-6	49	33	33
TACAGTGTCTGGCGTG-1_8_H10	26.33447779	4.426640471	15BA	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1011	1505	0.008637874	0.013953488	8	15BA	Stromal cells	49	33	33
TACCTATCAAGGACAC-1_8_H10	12.72076181	-4.212827487	12	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2081	3928	0.038441955	0.009419552	8	12	EN-MIX	49	33	33
TACCTATCACCGCTAG-1_8_H10	34.5651207	13.52872252	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1330	1946	0.010277492	0.024665982	8	14	Microglia	49	33	33
TACCTATCATGCATGT-1_8_H10	28.95213805	-13.64020854	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	6170	18721	0.024464505	0.009401207	8	2	EN-L4	49	33	33
TACCTATGTGCACGAA-1_8_H10	-5.011942296	8.999194451	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	883	1263	0.028503563	0.028503563	8	oligos	OL-MS-1	49	33	33
TACCTATGTGGTCTCG-1_8_H10	24.90895321	-27.23195043	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3041	6904	0.003186559	0.003765933	8	3	EN-L5-6	49	33	33
TACCTATGTGTGAATA-1_8_H10	27.13455016	9.745353581	15DA	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1501	2320	0.033189655	0.092241379	8	15DA	T cells	49	33	33
TACCTATGTTAGATGA-1_8_H10	-14.66647737	-16.80540296	6B	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1542	2661	0.035325066	0.00526118	8	6B	IN-SST	49	33	33
TACCTATGTTTAGCTG-1_8_H10	3.282012399	-19.45082646	4	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3775	9800	0.032040816	0.005816327	8	L2-3	EN-L2-3-MS	49	33	33
TACCTATTCCACGTTC-1_8_H10	-1.089403804	9.092317546	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1175	1827	0.038861522	0.017515052	8	oligos	OL-MS-1	49	33	33
TACCTTAAGAGGGATA-1_8_H10	-6.513684691	7.25553723	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	829	1112	0.034172662	0.035071942	8	oligos	OL-MS-1	49	33	33
TACCTTAAGATCTGCT-1_8_H10	-12.22690065	-5.715042164	13A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2250	3838	0.012245961	0.027097447	8	13A	IN-VIP	49	33	33
TACCTTAAGCGTCTAT-1_8_H10	-9.539232012	-15.59881754	6B	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	961	1452	0.032369146	0.020661157	8	6B	IN-SST	49	33	33
TACCTTAAGTCCGTAT-1_8_H10	-8.840203492	-12.39476694	6B	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1167	1821	0.164195497	0.01867106	8	6B	IN-SST	49	33	33
TACCTTAAGTTGTCGT-1_8_H10	33.5689043	-9.477572907	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4287	10244	0.029675908	0.010933229	8	2	EN-L4	49	33	33
TACCTTACAGTATAAG-1_8_H10	24.30197483	-12.13079221	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4693	11430	0.028171479	0.008486439	8	3	EN-L5-6	49	33	33
TACCTTACATGGATGG-1_8_H10	-28.21920148	-1.624943168	9	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1638	2537	0.014978321	0.018525818	8	9	OPC	49	33	33
TACCTTATCATTGCCC-1_8_H10	29.85083724	9.488293174	15DA	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	784	1069	0.015902713	0.055191768	8	15DA	T cells	49	33	33
TACCTTATCTAGCACA-1_8_H10	27.7850566	5.024530465	15DA	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1216	1643	0.038344492	0.023128424	8	15DA	T cells	49	33	33
TACGGATAGTGCTGCC-1_8_H10	-3.600671705	-36.41450002	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	870	1155	0.062337662	0.029437229	8	16	EN-PYR	49	33	33
TACGGATCAGACGCCT-1_8_H10	-0.908602566	8.495782615	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1222	1820	0.009340659	0.025824176	8	oligos	OL-MS-1	49	33	33
TACGGATCATCACGAT-1_8_H10	3.037835659	7.189137792	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1666	2593	0.016968762	0.025067489	8	oligos	OL-MS-1	49	33	33
TACGGATGTGCGGTAA-1_8_H10	-6.396355224	8.951353828	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	904	1207	0.01905551	0.032311516	8	oligos	OL-MS-1	49	33	33
TACGGATGTTCACCTC-1_8_H10	-6.94311904	7.05141107	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1026	1557	0.00834939	0.023121387	8	oligos	OL-MS-1	49	33	33
TACGGATTCACCACCT-1_8_H10	-3.659471074	8.5369484	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1089	1555	0.014790997	0.021221865	8	oligos	OL-MS-1	49	33	33
TACGGATTCTCTTGAT-1_8_H10	-7.334216849	8.738484819	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	781	1018	0.018664047	0.02259332	8	oligos	OL-MS-1	49	33	33
TACGGATTCTGCAGTA-1_8_H10	-10.52140172	-15.73819611	6B	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1098	1679	0.019654556	0.007147111	8	6B	IN-SST	49	33	33
TACGGGCAGGAATTAC-1_8_H10	-5.576168803	9.859699687	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	915	1259	0.010325655	0.020651311	8	oligos	OL-MS-1	49	33	33
TACGGGCAGTCCAGGA-1_8_H10	-30.67378931	0.126603832	9	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1752	3144	0.006361323	0.006997455	8	9	OPC	49	33	33
TACGGGCGTACAGCAG-1_8_H10	-2.540673573	10.65394563	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	913	1280	0.009375	0.0234375	8	oligos	OL-MS-1	49	33	33
TACGGGCGTTATCACG-1_8_H10	9.66707928	0.855309342	12	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	973	1592	0.015703518	0.010678392	8	12	EN-MIX	49	33	33
TACGGGCGTTCCTCCA-1_8_H10	25.4499782	10.19985329	15A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3001	5690	0.019859402	0.052724077	8	15A	Endo cells	49	33	33
TACGGGCTCCTTAATC-1_8_H10	13.13386965	7.039956946	1	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1642	2816	0.004616477	0.01171875	8	oligos	OL-Cntl	49	33	33
TACGGTAAGGTGGGTT-1_8_H10	27.13208607	9.452179802	15A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1348	2028	0.039447732	0.07790927	8	15A	Endo cells	49	33	33
TACGGTACAAACGCGA-1_8_H10	15.21845114	-27.23867846	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3671	9556	0.024696526	0.007325241	8	3	EN-L5-6	49	33	33
TACGGTACAATGGAAT-1_8_H10	-12.25800338	-8.004712536	13B	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1850	3057	0.0307491	0.012103369	8	13B	IN-SV2C	49	33	33
TACGGTACACTTCTGC-1_8_H10	25.44957115	10.32118295	15A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4073	8962	0.023767016	0.05288998	8	15A	Endo cells	49	33	33
TACGGTACATTGGGCC-1_8_H10	-17.09112582	-21.86672168	6A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2240	4953	0.17383404	0.00747022	8	6A	IN-PV	49	33	33
TACGGTAGTAAGGGAA-1_8_H10	9.271072751	-26.60863262	10	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5896	19116	0.002301737	0.005335844	8	L2-3	EN-L2-3-Cntl	49	33	33
TACGGTAGTCGCCATG-1_8_H10	29.51185711	14.83502713	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1532	2864	0.014664804	0.154678771	8	14	Microglia	49	33	33
TACGGTATCCGTAGTA-1_8_H10	-22.77003683	-7.931563204	9	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1684	2661	0.025930101	0.012401353	8	9	OPC	49	33	33
TACTCATCATCCCACT-1_8_H10	-5.298349526	9.63592957	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	891	1198	0.012520868	0.023372287	8	oligos	OL-MS-1	49	33	33
TACTCATGTATATCCG-1_8_H10	-14.14496668	8.578990841	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1289	1941	0.054611025	0.011334364	8	8	Astrocytes	49	33	33
TACTCATGTGGCGAAT-1_8_H10	9.618778673	-0.961540256	12	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1583	2998	0.099733155	0.00933956	8	12	EN-MIX	49	33	33
TACTCATTCATTCACT-1_8_H10	-13.02810807	-16.31672991	6B	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1295	2128	0.036654135	0.010338346	8	6B	IN-SST	49	33	33
TACTCATTCCCTAATT-1_8_H10	19.93629845	-11.07470475	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3279	8119	0.015272817	0.009730262	8	3	EN-L5-6	49	33	33
TACTCGCCACGGCTAC-1_8_H10	-10.941396	-38.97475756	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1395	2184	0.06959707	0.028388278	8	16	EN-PYR	49	33	33
TACTCGCGTTCGCTAA-1_8_H10	29.45670772	6.33931288	15DA	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	978	1503	0.069194943	0.059214904	8	15DA	T cells	49	33	33
TACTCGCTCAGAGACG-1_8_H10	-17.60030909	24.17737004	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1398	2062	0.003879728	0.008729389	8	8	Astrocytes	49	33	33
TACTCGCTCATGTCTT-1_8_H10	-17.57280171	24.96230492	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2040	3641	0.011809942	0.008239495	8	8	Astrocytes	49	33	33
TACTTACAGAGACTTA-1_8_H10	18.55314261	-28.87227283	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	7192	29649	0.010017201	0.004654457	8	3	EN-L5-6	49	33	33
TACTTACAGCTCCTCT-1_8_H10	-0.936258267	10.14117486	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1047	1568	0.015943878	0.019132653	8	oligos	OL-MS-1	49	33	33
TACTTACCACCGAATT-1_8_H10	7.980640859	0.741236495	12	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	762	1184	0.030405405	0.021959459	8	12	EN-MIX	49	33	33
TACTTACGTCGCGGTT-1_8_H10	-6.996362951	-37.46172784	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1066	1541	0.096690461	0.015574302	8	16	EN-PYR	49	33	33
TACTTACTCAAACGGG-1_8_H10	-2.385193557	11.6275214	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	836	1157	0.010371651	0.020743302	8	oligos	OL-MS-1	49	33	33
TACTTACTCAGCGACC-1_8_H10	-28.73957474	-0.767606119	9	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1740	2908	0.004814305	0.015130674	8	9	OPC	49	33	33
TACTTACTCATTCACT-1_8_H10	-4.419529979	17.41867623	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	814	1140	0.019298246	0.011403509	8	oligos	OL-MS-1	49	33	33
TACTTACTCCATGAGT-1_8_H10	9.043799385	1.76360381	12	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	708	1101	0.023614896	0.007266122	8	12	EN-MIX	49	33	33
TACTTGTAGCAGGTCA-1_8_H10	-7.786573389	7.595139234	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	751	1018	0.025540275	0.036345776	8	oligos	OL-MS-1	49	33	33
TACTTGTCAACTGCGC-1_8_H10	-5.360646975	16.06799818	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	771	1075	0.018604651	0.013023256	8	oligos	OL-MS-1	49	33	33
TACTTGTCAACTTGAC-1_8_H10	-26.06495188	-23.0941878	6A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4267	10170	0.014060964	0.016715831	8	6A	IN-PV	49	33	33
TACTTGTCAATACGCT-1_8_H10	27.82253162	-6.603514827	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4939	14833	0.020360008	0.003033776	8	2	EN-L4	49	33	33
TACTTGTCAGGAATGC-1_8_H10	-8.9548018	-12.94766982	6B	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	817	1189	0.118587048	0.016820858	8	6B	IN-SST	49	33	33
TACTTGTGTTCGCTAA-1_8_H10	-18.06653299	0.747057227	13A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3777	7711	0.008948256	0.016859033	8	13A	IN-VIP	49	33	33
TACTTGTTCAGCGATT-1_8_H10	26.94993299	5.042617498	15BA	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1008	1408	0.007102273	0.014204545	8	15BA	Stromal cells	49	33	33
TAGACCAAGACGCTTT-1_8_H10	-32.8094678	-7.84546124	9	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1084	1676	0.008949881	0.007159905	8	9	OPC	49	33	33
TAGACCAAGTGGGATC-1_8_H10	0.145980271	-17.40079521	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2366	4661	0.004290925	0.00343274	8	3	EN-L5-6	49	33	33
TAGACCACAATTCCTT-1_8_H10	29.25148746	7.142260145	15DA	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	747	1038	0.015414258	0.043352601	8	15DA	T cells	49	33	33
TAGACCAGTCAACTGT-1_8_H10	12.48329885	10.97978981	1	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1387	2262	0.012378426	0.018125553	8	oligos	OL-Cntl	49	33	33
TAGACCAGTCACACGC-1_8_H10	-8.051012867	-38.34731772	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1193	1677	0.055456172	0.019081694	8	16	EN-PYR	49	33	33
TAGAGCTCAGTGACAG-1_8_H10	-18.43632383	26.84269192	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1975	3423	0.004674262	0.007011394	8	8	Astrocytes	49	33	33
TAGAGCTCATAGACTC-1_8_H10	-3.295604537	-36.01150632	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	815	1130	0.087610619	0.031858407	8	16	EN-PYR	49	33	33
TAGAGCTGTTAAGTAG-1_8_H10	17.03611798	-26.56483871	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5113	15322	0.015141626	0.006852891	8	3	EN-L5-6	49	33	33
TAGAGCTTCGAATGCT-1_8_H10	-15.63052412	15.23282585	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1858	3031	0.005938634	0.006598482	8	8	Astrocytes	49	33	33
TAGCCGGGTATCTGCA-1_8_H10	18.67652618	-31.51635877	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	6495	22412	0.009013029	0.005265037	8	3	EN-L5-6	49	33	33
TAGCCGGTCCCAGGTG-1_8_H10	25.56015878	10.46478996	15A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3806	8356	0.028243179	0.064863571	8	15A	Endo cells	49	33	33
TAGCCGGTCGGCTACG-1_8_H10	19.39039244	-22.26925753	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5014	14104	0.026942711	0.010706183	8	3	EN-L5-6	49	33	33
TAGGCATAGACGACGT-1_8_H10	-9.570828886	-38.59893014	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1183	1780	0.073595506	0.035393258	8	16	EN-PYR	49	33	33
TAGGCATCATCCGGGT-1_8_H10	-26.59080079	-2.073246478	9	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1657	2543	0.007078254	0.025953598	8	9	OPC	49	33	33
TAGGCATGTCCTCTTG-1_8_H10	15.58479626	-21.75323387	4	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5815	17276	0.022864089	0.010245427	8	L2-3	EN-L2-3-MS	49	33	33
TAGGCATGTTTGTTGG-1_8_H10	-18.0420818	8.592139188	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	975	1309	0.018334607	0.004583652	8	8	Astrocytes	49	33	33
TAGGCATTCAGTTCGA-1_8_H10	29.55171652	-13.26385159	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5052	12905	0.044556373	0.009608679	8	2	EN-L4	49	33	33
TAGTGGTAGGGATGGG-1_8_H10	-6.90160579	-37.78343887	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1120	1707	0.095489162	0.021089631	8	16	EN-PYR	49	33	33
TAGTGGTAGTGAAGTT-1_8_H10	5.574089591	11.55442137	1	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1225	1888	0.009533898	0.020127119	8	oligos	OL-Cntl	49	33	33
TAGTGGTCACAGATTC-1_8_H10	-21.3867853	8.504112447	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	895	1267	0.012628256	0.008681926	8	8	Astrocytes	49	33	33
TAGTGGTCAGGTCTCG-1_8_H10	24.1766128	-11.184	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4084	9664	0.013969371	0.009002483	8	3	EN-L5-6	49	33	33
TAGTGGTCAGTTCATG-1_8_H10	-18.54945349	0.172533491	13A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3898	8172	0.012236907	0.027655409	8	13A	IN-VIP	49	33	33
TAGTGGTGTAGCGTGA-1_8_H10	-0.590411732	10.65915482	1	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	936	1322	0.009077156	0.017397882	8	oligos	OL-Cntl	49	33	33
TAGTGGTGTCCAGTTA-1_8_H10	-4.92579972	10.46731886	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	856	1224	0.017973856	0.02369281	8	oligos	OL-MS-1	49	33	33
TAGTGGTGTCTGATCA-1_8_H10	0.124983617	8.291491615	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1449	2313	0.013402508	0.016861219	8	oligos	OL-MS-1	49	33	33
TAGTGGTGTGCAACTT-1_8_H10	-5.134924107	11.07982224	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	850	1256	0.031847134	0.023089172	8	oligos	OL-MS-1	49	33	33
TAGTGGTTCCATTCTA-1_8_H10	-19.58743107	5.148210545	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	784	1079	0.016682113	0.00463392	8	8	Astrocytes	49	33	33
TAGTGGTTCCTCGCAT-1_8_H10	-3.07810421	11.6500038	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	914	1314	0.017503805	0.011415525	8	oligos	OL-MS-1	49	33	33
TAGTGGTTCTTGTCAT-1_8_H10	-6.878035195	6.869837142	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	970	1354	0.018463811	0.03323486	8	oligos	OL-MS-1	49	33	33
TAGTTGGGTCTTGCGG-1_8_H10	32.07173833	-17.61491942	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	6680	20129	0.023200358	0.01723881	8	2	EN-L4	49	33	33
TAGTTGGTCTTAGCCC-1_8_H10	30.52508675	-3.207990209	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3204	7222	0.011631127	0.0052617	8	2	EN-L4	49	33	33
TATCAGGAGCCAGTAG-1_8_H10	33.32359834	-16.86265145	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4781	10847	0.01060201	0.023693187	8	2	EN-L4	49	33	33
TATCAGGAGCGTGAGT-1_8_H10	-4.250799225	-36.49216792	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	791	1049	0.052430887	0.025738799	8	16	EN-PYR	49	33	33
TATCAGGAGGTCGGAT-1_8_H10	-16.980511	-1.105385637	13A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3302	6274	0.008766337	0.017213899	8	13A	IN-VIP	49	33	33
TATCAGGAGTGGCACA-1_8_H10	-0.727471374	9.943644841	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1052	1507	0.01658925	0.02322495	8	oligos	OL-MS-1	49	33	33
TATCAGGGTACAGACG-1_8_H10	28.93050458	10.15142025	15DB	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1118	1683	0.017825312	0.093285799	8	15DB	B cells	49	33	33
TATCAGGGTGAGCGAT-1_8_H10	-5.091375212	11.88580716	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	801	1096	0.049270073	0.022810219	8	oligos	OL-MS-1	49	33	33
TATCAGGTCCAAAGTC-1_8_H10	-3.596715035	-35.27900042	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	755	1128	0.166666667	0.022163121	8	16	EN-PYR	49	33	33
TATCTCAAGGATGGTC-1_8_H10	-15.08470857	14.66441352	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2289	4432	0.008574007	0.006092058	8	8	Astrocytes	49	33	33
TATCTCAGTCTAAAGA-1_8_H10	-16.6905102	13.46359983	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1303	2005	0.004987531	0.005985037	8	8	Astrocytes	49	33	33
TATCTCAGTGTGCCTG-1_8_H10	32.70410121	11.53449857	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	923	1256	0.023089172	0.029458599	8	14	Microglia	49	33	33
TATCTCATCACGAAGG-1_8_H10	-10.17101493	27.40728043	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1520	2264	0.034452297	0.02385159	8	oligos	OL-MS-1	49	33	33
TATCTCATCCGCAGTG-1_8_H10	19.9897536	-22.41348044	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	6852	22596	0.017525226	0.007921756	8	3	EN-L5-6	49	33	33
TATCTCATCTAGCACA-1_8_H10	-1.526068414	8.211349432	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1181	1873	0.009610251	0.014415376	8	oligos	OL-MS-1	49	33	33
TATGCCCAGAGTGACC-1_8_H10	24.38289758	-24.30407042	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3676	9174	0.087093961	0.004578156	8	3	EN-L5-6	49	33	33
TATGCCCGTCCTCCAT-1_8_H10	-5.917987261	10.31337685	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	829	1136	0.020246479	0.031690141	8	oligos	OL-MS-1	49	33	33
TATGCCCGTCGAAAGC-1_8_H10	-3.682492958	10.91111255	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	904	1321	0.012869039	0.014383043	8	oligos	OL-MS-1	49	33	33
TATGCCCGTTATCACG-1_8_H10	-4.300101132	9.784170584	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	870	1293	0.007733952	0.032482599	8	oligos	OL-MS-1	49	33	33
TATGCCCTCAACCATG-1_8_H10	-23.85986484	-25.04175774	6A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4003	9841	0.016868204	0.010263185	8	6A	IN-PV	49	33	33
TATGCCCTCACTCTTA-1_8_H10	-3.740673432	-36.40634007	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	842	1146	0.063699825	0.027050611	8	16	EN-PYR	49	33	33
TATGCCCTCCTCAACC-1_8_H10	-15.78033169	17.89204807	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1346	2067	0.029995162	0.017416546	8	8	Astrocytes	49	33	33
TATTACCAGCTGAAAT-1_8_H10	17.14986051	-26.17118584	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	6105	21004	0.020757951	0.006094077	8	3	EN-L5-6	49	33	33
TATTACCCAAAGGTGC-1_8_H10	-26.68354796	-22.48657002	6A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4158	9818	0.042676716	0.010389081	8	6A	IN-PV	49	33	33
TATTACCGTCCCTACT-1_8_H10	-2.749867639	10.95677846	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	959	1339	0.019417476	0.014189694	8	oligos	OL-MS-1	49	33	33
TATTACCGTCTGATTG-1_8_H10	-28.32653451	-1.0510497	9	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1721	2738	0.011322133	0.014609204	8	9	OPC	49	33	33
TATTACCGTGACGCCT-1_8_H10	25.53386578	10.44394691	15A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4397	10761	0.02583403	0.05473469	8	15A	Endo cells	49	33	33
TATTACCTCCGCGTTT-1_8_H10	-6.619616636	10.64125255	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	874	1196	0.010869565	0.019230769	8	oligos	OL-MS-1	49	33	33
TCAACGACACCCAGTG-1_8_H10	-2.93571588	7.932799315	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1135	1701	0.026455026	0.024103469	8	oligos	OL-MS-1	49	33	33
TCAACGACACTGTCGG-1_8_H10	-4.583947178	11.06661095	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	868	1193	0.016764459	0.029337804	8	oligos	OL-MS-1	49	33	33
TCAACGACAGCTTCGG-1_8_H10	-24.78244021	-17.29748053	6A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3979	8958	0.022661308	0.010493414	8	6A	IN-PV	49	33	33
TCAACGAGTCGAACAG-1_8_H10	-3.833661554	11.52639835	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	837	1150	0.011304348	0.026086957	8	oligos	OL-MS-1	49	33	33
TCAACGAGTGTTGGGA-1_8_H10	-1.75505934	11.81564463	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	890	1297	0.020046261	0.01310717	8	oligos	OL-MS-1	49	33	33
TCAACGAGTTCAGACT-1_8_H10	8.151137258	-17.65158559	4	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4553	11217	0.003209414	0.027993225	8	L2-3	EN-L2-3-MS	49	33	33
TCAATCTAGACCTTTG-1_8_H10	36.48104286	14.63618998	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1385	2131	0.006569686	0.016424214	8	14	Microglia	49	33	33
TCAATCTAGTTACGGG-1_8_H10	-7.149994838	-37.79402389	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1196	1714	0.08168028	0.015752625	8	16	EN-PYR	49	33	33
TCAATCTAGTTGCAGG-1_8_H10	-17.8459931	7.556935171	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1022	1539	0.043534763	0.013645224	8	8	Astrocytes	49	33	33
TCAATCTCAACTGGCC-1_8_H10	-28.13308039	-19.321072	6A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2733	5110	0.024853229	0.014872798	8	6A	IN-PV	49	33	33
TCAATCTCATGAAGTA-1_8_H10	-5.606608049	8.464844984	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	877	1193	0.019279128	0.025984912	8	oligos	OL-MS-1	49	33	33
TCAATCTGTCAAGCGA-1_8_H10	30.23256055	15.56088276	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1274	2140	0.009345794	0.105607477	8	14	Microglia	49	33	33
TCAATCTTCATGGTCA-1_8_H10	-27.13084096	-22.78260726	6A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5484	15136	0.016847252	0.012090381	8	6A	IN-PV	49	33	33
TCAATCTTCCTGCTTG-1_8_H10	23.03473863	-22.3678613	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	7829	31340	0.012252712	0.007147415	8	3	EN-L5-6	49	33	33
TCAATCTTCTCGCATC-1_8_H10	-22.58696939	6.187002149	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	898	1217	0.015612161	0.004930156	8	8	Astrocytes	49	33	33
TCAATCTTCTGATACG-1_8_H10	31.99704656	14.06150973	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1786	2828	0.01874116	0.044200849	8	14	Microglia	49	33	33
TCACAAGAGATCCGAG-1_8_H10	-3.636927035	11.05468553	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	829	1100	0.007272727	0.024545455	8	oligos	OL-MS-1	49	33	33
TCACAAGGTTATGCGT-1_8_H10	12.49635543	-18.05585166	4	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5494	16094	0.011619237	0.008263949	8	L2-3	EN-L2-3-MS	49	33	33
TCACAAGTCTGTCTAT-1_8_H10	-10.10212943	-39.05908655	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1438	2177	0.075792375	0.038125861	8	16	EN-PYR	49	33	33
TCACGAAAGTACGACG-1_8_H10	-24.46780165	-18.24193947	6A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3583	7015	0.011261582	0.018246614	8	6A	IN-PV	49	33	33
TCACGAACACAACTGT-1_8_H10	-5.093379933	7.938888971	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1026	1417	0.039520113	0.026111503	8	oligos	OL-MS-1	49	33	33
TCACGAAGTAGGAGTC-1_8_H10	-14.77670641	-22.94066403	6A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1504	2464	0.042207792	0.003652597	8	6A	IN-PV	49	33	33
TCACGAAGTTCGGGCT-1_8_H10	-16.83669342	7.876106407	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1127	1582	0.022123894	0.013274336	8	8	Astrocytes	49	33	33
TCAGATGCAAATCCGT-1_8_H10	21.72180237	-15.15097273	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3448	6917	0.009975423	0.025589128	8	2	EN-L4	49	33	33
TCAGATGCAGGACCCT-1_8_H10	-16.27666001	13.83294982	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1476	2329	0.009875483	0.007728639	8	8	Astrocytes	49	33	33
TCAGATGCAGTAAGAT-1_8_H10	-2.717558181	11.65350717	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	873	1192	0.009228188	0.019295302	8	oligos	OL-MS-1	49	33	33
TCAGATGCATCTACGA-1_8_H10	11.88407921	-1.033843997	12	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1145	1955	0.065984655	0.00511509	8	12	EN-MIX	49	33	33
TCAGATGGTAGTAGTA-1_8_H10	22.97716736	-15.93178768	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	7001	21318	0.017215499	0.015432967	8	2	EN-L4	49	33	33
TCAGATGTCACTCCTG-1_8_H10	18.28852607	-8.308891141	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1948	3587	0.045720658	0.004739336	8	3	EN-L5-6	49	33	33
TCAGATGTCTCGCATC-1_8_H10	34.751025	12.82354526	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1155	1627	0.017209588	0.017824216	8	14	Microglia	49	33	33
TCAGCAAAGAGGTACC-1_8_H10	-4.874338923	10.19862454	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	851	1142	0.009632224	0.036777583	8	oligos	OL-MS-1	49	33	33
TCAGCAAAGGCCGAAT-1_8_H10	22.97132625	-22.54270754	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5150	12945	0.017767478	0.009733488	8	3	EN-L5-6	49	33	33
TCAGCTCAGTGAATTG-1_8_H10	16.05605891	-25.87903519	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3756	9244	0.028342709	0.007572479	8	3	EN-L5-6	49	33	33
TCAGCTCCACACCGCA-1_8_H10	-26.87361084	-22.75269179	6A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4743	12001	0.010332472	0.011999	8	6A	IN-PV	49	33	33
TCAGCTCCAGATGAGC-1_8_H10	-18.6408144	-3.454067418	13A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3466	7452	0.015834675	0.017713366	8	13A	IN-VIP	49	33	33
TCAGCTCCATCCAACA-1_8_H10	18.37135446	-7.191935695	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1995	3900	0.061794872	0.005128205	8	3	EN-L5-6	49	33	33
TCAGCTCGTTCGAATC-1_8_H10	-17.92445985	24.96115669	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1806	3032	0.006266491	0.007255937	8	8	Astrocytes	49	33	33
TCAGCTCTCCTAGTGA-1_8_H10	-17.75405475	0.578845967	13A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3582	7402	0.014590651	0.018508511	8	13A	IN-VIP	49	33	33
TCAGCTCTCCTCATTA-1_8_H10	-4.472396701	9.386989877	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	928	1304	0.028374233	0.021472393	8	oligos	OL-MS-1	49	33	33
TCAGCTCTCGAGCCCA-1_8_H10	6.112825283	0.714958201	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	883	1286	0.136080871	0.024883359	8	16	EN-PYR	49	33	33
TCAGGATAGATCCCAT-1_8_H10	26.51796045	8.896970815	15A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1744	2796	0.023247496	0.060443491	8	15A	Endo cells	49	33	33
TCAGGATAGCACCGTC-1_8_H10	-25.06594027	10.9630871	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1020	1589	0.015103839	0.004405286	8	8	Astrocytes	49	33	33
TCAGGATGTCAACTGT-1_8_H10	-4.199543354	9.734117304	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	895	1289	0.052754073	0.025601241	8	oligos	OL-MS-1	49	33	33
TCAGGATGTGACTACT-1_8_H10	-7.491613259	7.743637021	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	824	1089	0.018365473	0.036730946	8	oligos	OL-MS-1	49	33	33
TCAGGATTCTGTCTCG-1_8_H10	-24.99845176	-17.80194377	6B	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3847	7903	0.014298368	0.016575984	8	6B	IN-SST	49	33	33
TCAGGTAAGGCTATCT-1_8_H10	30.02812903	9.277543713	15DA	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	896	1215	0.018106996	0.028806584	8	15DA	T cells	49	33	33
TCAGGTAGTAATCGTC-1_8_H10	22.58758034	-6.700554877	11	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2619	4895	0.017977528	0.012053115	8	11	Glia-MIX	49	33	33
TCAGGTAGTCCTCTTG-1_8_H10	30.85648068	13.68226728	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1069	1490	0.02147651	0.083221477	8	14	Microglia	49	33	33
TCAGGTAGTGTTAAGA-1_8_H10	28.09528201	6.596034391	15BA	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	772	1039	0.020211742	0.03946102	8	15BA	Stromal cells	49	33	33
TCAGGTATCCCTGACT-1_8_H10	22.41018018	-2.251796608	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2322	4501	0.020217729	0.007998223	8	2	EN-L4	49	33	33
TCATTACCAAGGTTTC-1_8_H10	-5.938007735	11.28476352	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	752	1007	0.011916584	0.017874876	8	oligos	OL-MS-1	49	33	33
TCATTACCACGAAGCA-1_8_H10	-1.096855422	7.86126839	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1376	2152	0.011152416	0.032527881	8	oligos	OL-MS-1	49	33	33
TCATTACCACGGACAA-1_8_H10	-20.79693984	-25.11490665	6A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2526	4959	0.007864489	0.008066142	8	6A	IN-PV	49	33	33
TCATTACCACTATCTT-1_8_H10	-7.52679278	7.207138591	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	920	1266	0.032385466	0.028436019	8	oligos	OL-MS-1	49	33	33
TCATTACCAGCCTGTG-1_8_H10	37.17800583	10.29401563	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	953	1485	0.01010101	0.008080808	8	14	Microglia	49	33	33
TCATTACCATATGGTC-1_8_H10	21.30520705	1.497897752	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1678	3140	0.032165605	0.00477707	8	2	EN-L4	49	33	33
TCATTACCATTCCTGC-1_8_H10	18.36645803	-8.700410917	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2086	3931	0.035359959	0.005087764	8	3	EN-L5-6	49	33	33
TCATTACGTAGCGCAA-1_8_H10	8.481428161	-17.4347725	4	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5690	15936	0.012048193	0.019954819	8	L2-3	EN-L2-3-MS	49	33	33
TCATTACGTCGCCATG-1_8_H10	26.87735099	10.24258559	15A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2325	4399	0.08797454	0.063878154	8	15A	Endo cells	49	33	33
TCATTACTCCACGCAG-1_8_H10	11.58329685	-1.29146553	12	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1468	2743	0.023696682	0.010207802	8	12	EN-MIX	49	33	33
TCATTTGAGCCGGTAA-1_8_H10	5.29660678	12.04106167	1	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1166	1873	0.005339028	0.013881474	8	oligos	OL-Cntl	49	33	33
TCATTTGAGGCTAGCA-1_8_H10	-4.262844193	12.40441865	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	811	1123	0.010685663	0.021371327	8	oligos	OL-MS-1	49	33	33
TCATTTGCAGTATGCT-1_8_H10	30.08866	-10.95793593	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4000	9554	0.029202428	0.007222106	8	2	EN-L4	49	33	33
TCATTTGGTAGCCTCG-1_8_H10	-18.75792051	24.47701758	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1807	3052	0.004587156	0.006225426	8	8	Astrocytes	49	33	33
TCATTTGGTGGAAAGA-1_8_H10	31.703811	13.47339999	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1154	1640	0.017073171	0.065853659	8	14	Microglia	49	33	33
TCATTTGTCCTGTAGA-1_8_H10	-2.519880761	10.46807596	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	831	1133	0.014121801	0.017652251	8	oligos	OL-MS-1	49	33	33
TCATTTGTCGTCTGCT-1_8_H10	3.675102949	4.024216983	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1165	1596	0.029448622	0.036967419	8	14	Microglia	49	33	33
TCATTTGTCTGTCTAT-1_8_H10	-3.648898054	7.995272541	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1073	1549	0.0116204	0.036152356	8	oligos	OL-MS-1	49	33	33
TCCACACAGACCCACC-1_8_H10	-2.78284711	10.64351577	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1003	1414	0.010608204	0.018387553	8	oligos	OL-MS-1	49	33	33
TCCACACAGAGTGACC-1_8_H10	32.6840612	13.60396933	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1825	2873	0.014966934	0.024712844	8	14	Microglia	49	33	33
TCCACACCATCGATTG-1_8_H10	17.29761127	-26.78126847	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	6000	20225	0.009789864	0.007911001	8	3	EN-L5-6	49	33	33
TCCACACGTGAGGCTA-1_8_H10	-25.90709131	-4.852206058	9	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1592	2697	0.012235818	0.009269559	8	9	OPC	49	33	33
TCCACACGTGTTGAGG-1_8_H10	-3.190630243	8.197397919	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1061	1426	0.013323983	0.037868163	8	oligos	OL-MS-1	49	33	33
TCCACACTCATAAAGG-1_8_H10	-3.200383739	9.621905716	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1005	1534	0.008474576	0.024119948	8	oligos	OL-MS-1	49	33	33
TCCCGATAGAGCCTAG-1_8_H10	-18.02734266	-16.23762271	6B	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2002	3595	0.010292072	0.005006954	8	6B	IN-SST	49	33	33
TCCCGATCATCAGTAC-1_8_H10	34.27189498	10.60774023	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	765	1023	0.021505376	0.015640274	8	14	Microglia	49	33	33
TCCCGATGTTCCTCCA-1_8_H10	-6.441140977	7.920120567	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	799	1073	0.017707363	0.012115564	8	oligos	OL-MS-1	49	33	33
TCGAGGCAGGCGTACA-1_8_H10	-5.399534451	11.86944181	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	807	1090	0.011926606	0.020183486	8	oligos	OL-MS-1	49	33	33
TCGAGGCCACGACTCG-1_8_H10	25.78242995	10.61114238	15A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4083	11037	0.034701459	0.107003715	8	15A	Endo cells	49	33	33
TCGAGGCCACTCGACG-1_8_H10	-27.744004	-21.87871757	6A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5289	15331	0.054725719	0.007696823	8	6A	IN-PV	49	33	33
TCGCGAGGTCGATTGT-1_8_H10	31.28596603	-17.43739109	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	6963	21833	0.022763706	0.01048871	8	2	EN-L4	49	33	33
TCGCGTTAGGTGCTAG-1_8_H10	4.943573497	18.8535269	1	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	936	1312	0.013719512	0.009908537	8	oligos	OL-Cntl	49	33	33
TCGCGTTAGTTCGCGC-1_8_H10	15.86223228	-26.91557886	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3689	8943	0.017667449	0.007044616	8	3	EN-L5-6	49	33	33
TCGCGTTCACCCTATC-1_8_H10	29.78286934	15.76485855	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2023	3534	0.005093379	0.101018676	8	14	Microglia	49	33	33
TCGCGTTCATGCAACT-1_8_H10	-9.731563201	-38.86424866	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1125	1672	0.005382775	0.019138756	8	16	EN-PYR	49	33	33
TCGCGTTGTCGCGTGT-1_8_H10	-7.146518565	6.841096391	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	885	1136	0.020246479	0.063380282	8	oligos	OL-MS-1	49	33	33
TCGCGTTTCCGTAGGC-1_8_H10	-11.34839203	-38.22141095	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1656	2753	0.10642935	0.015256084	8	16	EN-PYR	49	33	33
TCGGGACAGGATGTAT-1_8_H10	-3.726459207	-36.3989042	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	776	1012	0.040513834	0.029644269	8	16	EN-PYR	49	33	33
TCGGGACCAAGCCGCT-1_8_H10	-17.57532083	-0.418757814	13A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3073	5621	0.01120797	0.023305462	8	13A	IN-VIP	49	33	33
TCGGGACCACACATGT-1_8_H10	28.59508285	-6.048604539	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4264	10873	0.014347466	0.00294307	8	2	EN-L4	49	33	33
TCGGGACCAGACGCCT-1_8_H10	31.65614904	-18.70581648	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	6370	18025	0.017309293	0.025076283	8	2	EN-L4	49	33	33
TCGGGACCAGCCTATA-1_8_H10	-15.25121604	13.24216286	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1720	2676	0.007473842	0.007847534	8	8	Astrocytes	49	33	33
TCGGGACCAGGAATCG-1_8_H10	17.68197802	-25.12967437	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5129	13981	0.017166154	0.006794936	8	3	EN-L5-6	49	33	33
TCGGGACCATCTCGCT-1_8_H10	-12.68018779	-17.31221234	6B	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1166	1910	0.020418848	0.007329843	8	6B	IN-SST	49	33	33
TCGGGACGTACCTACA-1_8_H10	33.13138495	-8.149720257	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4164	9513	0.011563124	0.00914538	8	2	EN-L4	49	33	33
TCGGGACGTGTATGGG-1_8_H10	-4.357546804	8.004701869	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1107	1481	0.033760972	0.027008778	8	oligos	OL-MS-1	49	33	33
TCGGTAAAGAAACGCC-1_8_H10	34.50319796	10.69683831	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	791	1019	0.014720314	0.012757605	8	14	Microglia	49	33	33
TCGGTAAAGGGTTTCT-1_8_H10	21.76278761	-13.80845805	12	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2921	5611	0.051684192	0.014435929	8	12	EN-MIX	49	33	33
TCGGTAAAGTCAATAG-1_8_H10	-23.73512747	-24.16772459	6A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3997	10056	0.047434368	0.004176611	8	6A	IN-PV	49	33	33
TCGGTAATCACCCTCA-1_8_H10	-6.181439215	9.718366024	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	817	1100	0.014545455	0.02	8	oligos	OL-MS-1	49	33	33
TCGTACCGTACATCCA-1_8_H10	26.42506778	8.725923341	15A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1600	2491	0.00923324	0.036531513	8	15A	Endo cells	49	33	33
TCGTACCGTACCTACA-1_8_H10	-5.357702721	10.80972283	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	747	1037	0.032786885	0.036644166	8	oligos	OL-MS-1	49	33	33
TCGTACCGTTTAGGAA-1_8_H10	18.94203037	-26.97703555	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4689	13675	0.007531993	0.006142596	8	3	EN-L5-6	49	33	33
TCGTAGAAGTCATGCT-1_8_H10	-3.716999539	8.472521301	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	955	1282	0.010140406	0.02574103	8	oligos	OL-MS-1	49	33	33
TCGTAGACAAGGACAC-1_8_H10	-5.849436303	11.46515132	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	761	1047	0.018147087	0.025787966	8	oligos	OL-MS-1	49	33	33
TCGTAGAGTTCGTCTC-1_8_H10	-6.245950859	8.27522499	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	777	1017	0.010816126	0.026548673	8	oligos	OL-MS-1	49	33	33
TCTATTGAGATCCTGT-1_8_H10	32.94119173	-16.68951861	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	6021	17189	0.020652743	0.01570772	8	2	EN-L4	49	33	33
TCTATTGCAACTGCGC-1_8_H10	24.94941543	-24.49323575	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4127	11565	0.051448335	0.005274535	8	3	EN-L5-6	49	33	33
TCTATTGCATATGGTC-1_8_H10	-4.296287091	8.662405232	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	994	1382	0.026772793	0.027496382	8	oligos	OL-MS-1	49	33	33
TCTATTGGTACAAGTA-1_8_H10	-6.780753387	7.326034888	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	944	1274	0.045525903	0.03610675	8	oligos	OL-MS-1	49	33	33
TCTCATAAGCTTATCG-1_8_H10	-2.354311244	11.66669663	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	839	1225	0.009795918	0.01877551	8	oligos	OL-MS-1	49	33	33
TCTCATAAGGACAGCT-1_8_H10	18.87438075	-23.90531067	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4692	11613	0.018858176	0.013433221	8	3	EN-L5-6	49	33	33
TCTCATAAGTCGAGTG-1_8_H10	-23.0744886	-25.08646582	6A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3221	7127	0.01318928	0.006454329	8	6A	IN-PV	49	33	33
TCTCATAGTAAACGCG-1_8_H10	-26.26105978	-23.01177614	6A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4459	10703	0.014575353	0.010090629	8	6A	IN-PV	49	33	33
TCTCATAGTAGGCATG-1_8_H10	-10.85505432	-28.10794135	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1707	2745	0.044808743	0.010564663	8	16	EN-PYR	49	33	33
TCTCATATCTGAGTGT-1_8_H10	-27.44780985	-4.118705254	9	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1348	2029	0.026121242	0.012814194	8	9	OPC	49	33	33
TCTCATATCTGCTTGC-1_8_H10	-15.14930058	11.81597185	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1592	2678	0.004854369	0.002613891	8	8	Astrocytes	49	33	33
TCTCTAAAGGACGAAA-1_8_H10	32.32264002	11.08863035	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	907	1211	0.014863749	0.034682081	8	14	Microglia	49	33	33
TCTCTAAAGGCCATAG-1_8_H10	-7.645683531	7.549689326	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	932	1456	0.023351648	0.013736264	8	oligos	OL-MS-1	49	33	33
TCTCTAAAGGGAAACA-1_8_H10	-6.775145829	10.77268622	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	784	1129	0.024800709	0.019486271	8	oligos	OL-MS-1	49	33	33
TCTCTAAGTTCCAACA-1_8_H10	-4.039782638	10.36895061	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	906	1247	0.013632719	0.02085004	8	oligos	OL-MS-1	49	33	33
TCTGAGAAGAATCTCC-1_8_H10	-24.48447469	-17.37079101	6A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5205	14564	0.021354024	0.009406756	8	6A	IN-PV	49	33	33
TCTGAGAAGTAGGCCA-1_8_H10	19.03031505	-24.12763507	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5593	14810	0.006549629	0.01181634	8	3	EN-L5-6	49	33	33
TCTGAGAGTCAGAAGC-1_8_H10	22.33754769	-19.88227239	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	6143	18749	0.019201024	0.007733746	8	3	EN-L5-6	49	33	33
TCTGAGAGTCGTGGCT-1_8_H10	30.30684127	15.88968898	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1167	1788	0.006711409	0.119686801	8	14	Microglia	49	33	33
TCTGAGATCACCCGAG-1_8_H10	24.57989688	-17.02637581	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	7127	23808	0.026167675	0.012978831	8	3	EN-L5-6	49	33	33
TCTGAGATCCGCAAGC-1_8_H10	33.41300209	13.4862005	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1137	1581	0.010752688	0.026565465	8	14	Microglia	49	33	33
TCTGAGATCTGGTTCC-1_8_H10	-28.82275515	-1.309135182	9	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1362	2166	0.010618652	0.010618652	8	9	OPC	49	33	33
TCTGGAAAGCTCCCAG-1_8_H10	3.831757028	4.030237948	7	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1499	2118	0.008970727	0.049102927	8	7	Phagocytes	49	33	33
TCTGGAACAATGAATG-1_8_H10	-18.75858971	-21.07702098	6A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2446	4867	0.023012122	0.003287446	8	6A	IN-PV	49	33	33
TCTGGAAGTAGCTGCC-1_8_H10	-5.384087276	8.386839104	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	834	1123	0.020480855	0.032947462	8	oligos	OL-MS-1	49	33	33
TCTGGAAGTGGTAACG-1_8_H10	19.32685781	-10.38571782	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2049	3435	0.02852984	0.013100437	8	3	EN-L5-6	49	33	33
TCTGGAATCAACGGGA-1_8_H10	-16.7527052	6.278384453	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1115	1661	0.036122818	0.011438892	8	8	Astrocytes	49	33	33
TCTGGAATCACATAGC-1_8_H10	-3.621618548	12.23051218	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	868	1212	0.012376238	0.044554455	8	oligos	OL-MS-1	49	33	33
TCTGGAATCCGCGCAA-1_8_H10	-14.35936794	-5.909461745	13A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3059	6311	0.010933291	0.005545872	8	13A	IN-VIP	49	33	33
TCTGGAATCGGATGGA-1_8_H10	-15.76933762	12.43136697	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1537	2582	0.0116189	0.00580945	8	8	Astrocytes	49	33	33
TCTGGAATCGTCTGAA-1_8_H10	27.9574981	10.48193634	15DB	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1829	3548	0.029312289	0.183483653	8	15DB	B cells	49	33	33
TCTTCGGCAACACCTA-1_8_H10	34.57724979	13.06501634	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1121	1562	0.008962868	0.016645327	8	14	Microglia	49	33	33
TCTTTCCAGAGACTAT-1_8_H10	-3.711098405	15.88068948	1	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	737	1007	0.012909633	0.015888779	8	oligos	OL-Cntl	49	33	33
TCTTTCCAGTGTACCT-1_8_H10	-13.4941366	-16.84949617	6B	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1364	2149	0.028850628	0.008375989	8	6B	IN-SST	49	33	33
TCTTTCCCAGCGTTCG-1_8_H10	26.43256171	7.561839814	15A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1327	1978	0.004550051	0.018200202	8	15A	Endo cells	49	33	33
TCTTTCCCAGTATCTG-1_8_H10	23.5289958	7.434252001	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1593	2281	0.010521701	0.025427444	8	oligos	OL-MS-1	49	33	33
TCTTTCCGTACGCACC-1_8_H10	-3.086681656	11.19819483	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	883	1260	0.012698413	0.018253968	8	oligos	OL-MS-1	49	33	33
TCTTTCCGTCGACTGC-1_8_H10	-17.28215735	7.990317008	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1317	2230	0.007174888	0.008071749	8	8	Astrocytes	49	33	33
TCTTTCCGTGAGGGTT-1_8_H10	-3.147960351	10.26052332	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	955	1396	0.006446991	0.018624642	8	oligos	OL-MS-1	49	33	33
TCTTTCCGTTCCCTTG-1_8_H10	-1.740645185	8.749291429	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1163	1772	0.016365688	0.018058691	8	oligos	OL-MS-1	49	33	33
TCTTTCCGTTTAGGAA-1_8_H10	-3.698876279	-35.44964507	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	728	1102	0.164246824	0.034482759	8	16	EN-PYR	49	33	33
TGAAAGAAGACAAAGG-1_8_H10	-15.74020106	1.671385782	13A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3728	7796	0.006670087	0.013468445	8	13A	IN-VIP	49	33	33
TGAAAGAAGATACACA-1_8_H10	31.58040851	9.480870986	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	837	1073	0.027027027	0.042870457	8	14	Microglia	49	33	33
TGAAAGAAGATAGCAT-1_8_H10	-7.018605893	8.958400676	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	769	1026	0.01754386	0.022417154	8	oligos	OL-MS-1	49	33	33
TGAAAGAAGCCTATGT-1_8_H10	19.6866073	-23.07491902	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5568	15732	0.014365624	0.00769133	8	3	EN-L5-6	49	33	33
TGAAAGACAGGGTATG-1_8_H10	-1.644150288	8.839087949	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1093	1529	0.0117724	0.020274689	8	oligos	OL-MS-1	49	33	33
TGAAAGAGTAAGAGAG-1_8_H10	-15.61070637	11.70781151	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1413	2316	0.004749568	0.007772021	8	8	Astrocytes	49	33	33
TGAAAGAGTCCGACGT-1_8_H10	10.12480414	-21.85255557	4	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	6511	20236	0.008104368	0.009142123	8	L2-3	EN-L2-3-MS	49	33	33
TGAAAGAGTTGACGTT-1_8_H10	-6.334997763	7.091145541	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1058	1536	0.015625	0.03125	8	oligos	OL-MS-1	49	33	33
TGAAAGATCCCACTTG-1_8_H10	25.60712869	-24.1862207	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4603	13432	0.030226325	0.003350208	8	3	EN-L5-6	49	33	33
TGAAAGATCCTGTACC-1_8_H10	-11.07907505	-38.89078142	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1408	2152	0.039033457	0.038104089	8	16	EN-PYR	49	33	33
TGACAACAGCCCTAAT-1_8_H10	19.9540508	-10.96454127	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2976	6681	0.104176022	0.003741955	8	3	EN-L5-6	49	33	33
TGACAACGTACGCACC-1_8_H10	17.78202266	-10.63104207	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2679	5444	0.014144012	0.010653931	8	3	EN-L5-6	49	33	33
TGACAACGTCTCACCT-1_8_H10	-1.030229034	8.328915885	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1226	1846	0.006500542	0.021126761	8	oligos	OL-MS-1	49	33	33
TGACAACTCACTCTTA-1_8_H10	25.57802374	10.28784488	15A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2949	5305	0.019415646	0.04938737	8	15A	Endo cells	49	33	33
TGACAACTCTAACTTC-1_8_H10	-7.747964408	7.568116456	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1053	1384	0.029624277	0.026734104	8	oligos	OL-MS-1	49	33	33
TGACGGCCAAACGCGA-1_8_H10	30.909273	-7.088167135	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4658	11784	0.017651052	0.004837067	8	2	EN-L4	49	33	33
TGACGGCCATTTGCCC-1_8_H10	-12.10087275	-13.63561027	6B	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1465	2708	0.103028065	0.008124077	8	6B	IN-SST	49	33	33
TGACGGCTCGAGAGCA-1_8_H10	16.77205443	-25.60303869	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4165	10430	0.024065197	0.006615532	8	3	EN-L5-6	49	33	33
TGACGGCTCGCATGAT-1_8_H10	20.51850378	-21.17433963	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5258	15100	0.03218543	0.007350993	8	3	EN-L5-6	49	33	33
TGACGGCTCGGTCTAA-1_8_H10	-3.353467264	11.36532468	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	890	1241	0.016921837	0.01369863	8	oligos	OL-MS-1	49	33	33
TGACTAGAGAATTCCC-1_8_H10	-17.48570402	7.297207276	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	902	1223	0.008994276	0.010629599	8	8	Astrocytes	49	33	33
TGACTAGAGGTGCTTT-1_8_H10	-5.107400274	13.2544407	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	693	1010	0.014851485	0.022772277	8	oligos	OL-MS-1	49	33	33
TGACTAGTCAACACTG-1_8_H10	15.50765837	7.783574022	1	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1876	3601	0.006664815	0.009441822	8	oligos	OL-Cntl	49	33	33
TGACTAGTCATTCACT-1_8_H10	-15.0767442	13.28981083	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1932	3357	0.009532321	0.011021746	8	8	Astrocytes	49	33	33
TGACTTTAGACAGGCT-1_8_H10	-5.150378958	8.411423906	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	946	1298	0.00770416	0.028505393	8	oligos	OL-MS-1	49	33	33
TGACTTTAGATGTGTA-1_8_H10	-3.457104874	7.537925894	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1279	1865	0.034852547	0.032707775	8	oligos	OL-MS-1	49	33	33
TGACTTTCACTTAAGC-1_8_H10	27.41953626	-15.48359216	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	7681	29868	0.031773135	0.011282978	8	2	EN-L4	49	33	33
TGACTTTCAGATCCAT-1_8_H10	-10.80549946	-4.18371995	13A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2149	4108	0.01436222	0.0124148	8	13A	IN-VIP	49	33	33
TGACTTTCATGACATC-1_8_H10	9.828777444	-21.83175833	4	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5921	17829	0.007123226	0.006898873	8	L2-3	EN-L2-3-MS	49	33	33
TGACTTTGTAAGGGCT-1_8_H10	-3.824045982	7.793100241	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1062	1495	0.009364548	0.039464883	8	oligos	OL-MS-1	49	33	33
TGACTTTGTCTTGCGG-1_8_H10	7.71576917	18.92142881	1	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1028	1587	0.012602394	0.013862634	8	oligos	OL-Cntl	49	33	33
TGACTTTGTTTGTTTC-1_8_H10	-2.458662936	10.92131732	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	843	1227	0.010594947	0.019559902	8	oligos	OL-MS-1	49	33	33
TGACTTTTCACTTACT-1_8_H10	-13.16941485	-2.740695136	13A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2987	6232	0.03915276	0.008023107	8	13A	IN-VIP	49	33	33
TGACTTTTCGGCATCG-1_8_H10	-11.91216964	-0.26024282	13A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2849	5450	0.006055046	0.007155963	8	13A	IN-VIP	49	33	33
TGACTTTTCTTCATGT-1_8_H10	-15.58968601	14.39614106	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1893	3367	0.007425007	0.005940006	8	8	Astrocytes	49	33	33
TGAGAGGCAACAACCT-1_8_H10	-23.09909463	6.261653977	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	881	1190	0.022689076	0.022689076	8	8	Astrocytes	49	33	33
TGAGAGGCATAGTAAG-1_8_H10	16.31935021	-26.86564194	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5178	15143	0.024631843	0.005811266	8	3	EN-L5-6	49	33	33
TGAGAGGGTGAGCGAT-1_8_H10	32.073449	9.942996091	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	724	1179	0.022900763	0.029686175	8	14	Microglia	49	33	33
TGAGAGGGTGTCAATC-1_8_H10	-17.55534592	6.307948379	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	822	1056	0.013257576	0.013257576	8	8	Astrocytes	49	33	33
TGAGAGGTCAGCTGGC-1_8_H10	27.1981417	7.455677626	15A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1017	1443	0.011781012	0.021483021	8	15A	Endo cells	49	33	33
TGAGAGGTCAGGCCCA-1_8_H10	32.92533009	13.25164765	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1204	1638	0.027472527	0.029304029	8	14	Microglia	49	33	33
TGAGAGGTCCTTGCCA-1_8_H10	13.69216483	-4.288616796	12	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1888	3504	0.018550228	0.017979452	8	12	EN-MIX	49	33	33
TGAGCATCACAACGCC-1_8_H10	-29.97764536	-22.23999519	6A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5341	13323	0.018239135	0.020415822	8	6A	IN-PV	49	33	33
TGAGCATCAGGATCGA-1_8_H10	-24.0033069	12.84057412	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1218	1845	0.003794038	0.008672087	8	8	Astrocytes	49	33	33
TGAGCATCAGGTTTCA-1_8_H10	21.85449664	-21.7077587	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3881	8999	0.035448383	0.007556395	8	3	EN-L5-6	49	33	33
TGAGCATCATCACGTA-1_8_H10	-27.31960357	-4.721051041	9	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1323	1976	0.008097166	0.011133603	8	9	OPC	49	33	33
TGAGCATGTCGGCACT-1_8_H10	-24.53905457	-21.6774237	6A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3968	10216	0.104737666	0.005090055	8	6A	IN-PV	49	33	33
TGAGCATGTGGCTCCA-1_8_H10	-6.734474073	8.962099043	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	817	1090	0.016513761	0.029357798	8	oligos	OL-MS-1	49	33	33
TGAGCCGCAATCCAAC-1_8_H10	31.52337879	4.598642452	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1310	1795	0.041225627	0.026740947	8	16	EN-PYR	49	33	33
TGAGCCGCATCCTTGC-1_8_H10	-25.43029032	-7.979565784	9	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1103	1609	0.011808577	0.005593536	8	9	OPC	49	33	33
TGAGCCGGTACCGTTA-1_8_H10	17.19709786	-13.81395106	4	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	7636	27199	0.014853487	0.013640207	8	L2-3	EN-L2-3-MS	49	33	33
TGAGCCGGTAGGGACT-1_8_H10	-3.404677926	11.44871149	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	854	1173	0.002557545	0.009377664	8	oligos	OL-MS-1	49	33	33
TGAGCCGGTCTAGTCA-1_8_H10	27.68531818	8.731398192	15A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	931	1260	0.013492063	0.061111111	8	15A	Endo cells	49	33	33
TGAGCCGGTCTCAACA-1_8_H10	34.29063045	-9.039369398	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	6196	19236	0.006498232	0.01632356	8	2	EN-L4	49	33	33
TGAGGGAAGCGTTTAC-1_8_H10	26.96787083	10.01682846	15A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1473	2395	0.055949896	0.070981211	8	15A	Endo cells	49	33	33
TGAGGGACACTTAACG-1_8_H10	27.89878761	5.363461471	15A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	742	1014	0.042406312	0.019723866	8	15A	Endo cells	49	33	33
TGAGGGACAGGGTACA-1_8_H10	-2.062807263	11.87923814	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	895	1213	0.005770816	0.007419621	8	oligos	OL-MS-1	49	33	33
TGAGGGAGTCAGTGGA-1_8_H10	19.29202099	-22.44043352	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5756	16574	0.009653674	0.008929649	8	3	EN-L5-6	49	33	33
TGAGGGAGTCGAGATG-1_8_H10	3.964990462	3.910005324	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1892	3160	0.006329114	0.09335443	8	14	Microglia	49	33	33
TGAGGGAGTCTCTCGT-1_8_H10	-20.58308118	-20.99762732	6A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2112	4068	0.039331367	0.007374631	8	6A	IN-PV	49	33	33
TGAGGGATCCGTTGTC-1_8_H10	33.33256155	-16.68665518	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4198	8923	0.020508797	0.014793231	8	2	EN-L4	49	33	33
TGAGGGATCGTAGATC-1_8_H10	31.78807808	-17.12174783	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5729	15510	0.035654417	0.014635719	8	2	EN-L4	49	33	33
TGAGGGATCGTCTGCT-1_8_H10	31.59481024	15.16908393	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1182	1730	0.019075145	0.061271676	8	14	Microglia	49	33	33
TGATTTCAGAACAATC-1_8_H10	-6.582966798	7.905930529	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	813	1071	0.030812325	0.02334267	8	oligos	OL-MS-1	49	33	33
TGATTTCAGAGACGAA-1_8_H10	3.84283221	3.939935589	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1703	2549	0.01647705	0.028246371	8	14	Microglia	49	33	33
TGATTTCAGCACGCCT-1_8_H10	-21.07137097	-17.04187302	6A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3404	8226	0.043885242	0.003525407	8	6A	IN-PV	49	33	33
TGATTTCCAGGTTTCA-1_8_H10	33.78127311	13.36008063	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1493	2224	0.03057554	0.020683453	8	14	Microglia	49	33	33
TGATTTCTCGGCTTGG-1_8_H10	20.25997507	-21.0451393	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3955	9046	0.043223524	0.009617511	8	3	EN-L5-6	49	33	33
TGATTTCTCTCCGGTT-1_8_H10	9.612680858	-29.07549755	10	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	6274	23852	0.018489016	0.004569847	8	L2-3	EN-L2-3-Cntl	49	33	33
TGCACCTAGAGCCTAG-1_8_H10	27.62192743	8.376794044	15BA	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1133	1580	0.021518987	0.039240506	8	15BA	Stromal cells	49	33	33
TGCACCTAGTGTACCT-1_8_H10	-4.276485501	11.43710034	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	771	1082	0.011090573	0.046210721	8	oligos	OL-MS-1	49	33	33
TGCACCTCACCGGAAA-1_8_H10	-4.865869014	7.332124135	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1130	1543	0.016202203	0.041477641	8	oligos	OL-MS-1	49	33	33
TGCACCTGTTCGTGAT-1_8_H10	34.09501041	14.19991792	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1103	1520	0.009210526	0.027631579	8	14	Microglia	49	33	33
TGCCAAAAGACATAAC-1_8_H10	29.59016496	-6.982037848	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5522	16499	0.003757804	0.008182314	8	2	EN-L4	49	33	33
TGCCAAAAGCCGATTT-1_8_H10	18.87152926	-25.29775408	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	6483	21843	0.00947672	0.009293595	8	3	EN-L5-6	49	33	33
TGCCAAAAGGATATAC-1_8_H10	-10.45495108	27.52114507	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	943	1222	0.051554828	0.036006547	8	oligos	OL-MS-1	49	33	33
TGCCAAACAATCCGAT-1_8_H10	31.86267464	-16.62342769	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5956	17115	0.020508326	0.013964359	8	2	EN-L4	49	33	33
TGCCAAACAGCGAACA-1_8_H10	-4.937707029	10.17888399	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	879	1200	0.0125	0.015	8	oligos	OL-MS-1	49	33	33
TGCCAAACAGGATTGG-1_8_H10	-0.847050737	7.193139287	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2393	4107	0.029705381	0.043584125	8	oligos	OL-MS-1	49	33	33
TGCCAAACATAGACTC-1_8_H10	29.3221698	9.901274633	15DB	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1328	1978	0.012133468	0.069261881	8	15DB	B cells	49	33	33
TGCCCATAGCTCTCGG-1_8_H10	33.07698653	-17.67232175	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4368	9348	0.036692341	0.01529739	8	2	EN-L4	49	33	33
TGCCCATAGGACAGAA-1_8_H10	-14.14381735	-36.62853839	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2234	4422	0.096110357	0.016734509	8	16	EN-PYR	49	33	33
TGCCCATAGGCTAGCA-1_8_H10	21.1183466	-21.97605438	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	6201	19991	0.027062178	0.008853984	8	3	EN-L5-6	49	33	33
TGCCCATCACAGATTC-1_8_H10	13.75451844	-29.80368323	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3979	11169	0.008147551	0.004834811	8	3	EN-L5-6	49	33	33
TGCCCATCAGACGCAA-1_8_H10	-2.874797943	-35.10884104	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	915	1272	0.087264151	0.030660377	8	16	EN-PYR	49	33	33
TGCCCATCAGTGGAGT-1_8_H10	25.75152365	10.49695721	15A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2699	5018	0.024910323	0.070346752	8	15A	Endo cells	49	33	33
TGCCCATCATGCGCAC-1_8_H10	-11.83239661	-27.40977017	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	957	1285	0.073151751	0.030350195	8	16	EN-PYR	49	33	33
TGCCCATGTGTGACCC-1_8_H10	-10.70260753	-38.69272796	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1814	3337	0.180401558	0.015283188	8	16	EN-PYR	49	33	33
TGCCCATTCCGTTGTC-1_8_H10	-6.121874587	-36.61607037	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1006	1461	0.095140315	0.02532512	8	16	EN-PYR	49	33	33
TGCCCATTCTACTATC-1_8_H10	-29.92408096	-6.643314606	9	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1158	1760	0.006818182	0.009090909	8	9	OPC	49	33	33
TGCCCATTCTCGCATC-1_8_H10	26.49879419	6.565651398	15DA	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1594	2339	0.044463446	0.045746045	8	15DA	T cells	49	33	33
TGCCCATTCTTGTTTG-1_8_H10	33.59852527	9.548152508	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	780	1061	0.020735156	0.017907634	8	14	Microglia	49	33	33
TGCCCTAAGCGAAGGG-1_8_H10	9.457322035	-2.540262434	12	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1642	2787	0.096160746	0.009329028	8	12	EN-MIX	49	33	33
TGCCCTAAGCGGCTTC-1_8_H10	-3.502133082	10.73918252	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	908	1232	0.011363636	0.017857143	8	oligos	OL-MS-1	49	33	33
TGCCCTAAGTAGCCGA-1_8_H10	-10.29493307	27.40653601	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1217	1711	0.016949153	0.035067212	8	oligos	OL-MS-1	49	33	33
TGCCCTACAGATGGCA-1_8_H10	-3.901629829	7.723463107	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1151	1640	0.011585366	0.018292683	8	oligos	OL-MS-1	49	33	33
TGCCCTAGTCATTAGC-1_8_H10	-1.042946539	10.0883701	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1136	1667	0.00959808	0.017396521	8	oligos	OL-MS-1	49	33	33
TGCCCTAGTTTAGCTG-1_8_H10	-4.445400752	17.55795127	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	916	1288	0.01242236	0.010869565	8	oligos	OL-MS-1	49	33	33
TGCCCTATCTGAGGGA-1_8_H10	30.04471351	9.460373615	15DB	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	803	1107	0.008130081	0.040650407	8	15DB	B cells	49	33	33
TGCGCAGAGAATAGGG-1_8_H10	-4.296150832	12.11046676	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	787	1045	0.015311005	0.024880383	8	oligos	OL-MS-1	49	33	33
TGCGCAGAGCTCTCGG-1_8_H10	-7.576965397	8.252593202	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	767	1077	0.014856082	0.03992572	8	oligos	OL-MS-1	49	33	33
TGCGCAGAGGGTATCG-1_8_H10	18.15474506	-14.16836891	4	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	7124	23004	0.01551904	0.014041036	8	L2-3	EN-L2-3-MS	49	33	33
TGCGCAGCATACGCCG-1_8_H10	28.71875024	-14.09992578	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	6638	20304	0.020390071	0.015267928	8	3	EN-L5-6	49	33	33
TGCGCAGCATGAAGTA-1_8_H10	-17.86947353	24.53841862	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1675	2601	0.005382545	0.006920415	8	8	Astrocytes	49	33	33
TGCGCAGGTCGCTTTC-1_8_H10	26.9090618	10.01293082	15A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1559	2523	0.030915577	0.072532699	8	15A	Endo cells	49	33	33
TGCGCAGGTCGTTGTA-1_8_H10	14.10000948	-11.81646626	4	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3076	5756	0.0404795	0.019457957	8	L2-3	EN-L2-3-MS	49	33	33
TGCGCAGTCGGTTAAC-1_8_H10	17.33874443	-26.38269933	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4945	13934	0.010119133	0.009401464	8	3	EN-L5-6	49	33	33
TGCGCAGTCTGTTGAG-1_8_H10	-15.93442042	11.98265343	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1190	1775	0.014647887	0.016901408	8	8	Astrocytes	49	33	33
TGCGGGTAGAAGGGTA-1_8_H10	21.59240103	-22.22541595	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3699	8001	0.036245469	0.008623922	8	3	EN-L5-6	49	33	33
TGCGGGTAGGGCTTGA-1_8_H10	-17.69309762	25.38961737	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1930	3194	0.008140263	0.007514089	8	8	Astrocytes	49	33	33
TGCGGGTGTGCGATAG-1_8_H10	23.93510992	-23.94860454	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3248	7074	0.054283291	0.007350862	8	3	EN-L5-6	49	33	33
TGCGGGTTCGGACAAG-1_8_H10	-3.563381589	-35.96064551	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	866	1213	0.122835944	0.032976092	8	16	EN-PYR	49	33	33
TGCGTGGCAGGCTCAC-1_8_H10	-4.368139338	11.87435186	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	765	1033	0.014520813	0.029041626	8	oligos	OL-MS-1	49	33	33
TGCTACCAGAAAGTGG-1_8_H10	-3.914331315	6.859211727	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1383	1996	0.022044088	0.022044088	8	oligos	OL-MS-1	49	33	33
TGCTACCAGACTTTCG-1_8_H10	-27.51921335	-3.728983501	9	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1426	2129	0.008454674	0.016439643	8	9	OPC	49	33	33
TGCTACCAGAGCTGGT-1_8_H10	-18.25036962	0.449732116	13A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3507	7173	0.01408058	0.022724104	8	13A	IN-VIP	49	33	33
TGCTACCAGGGATGGG-1_8_H10	-4.017253921	11.27716763	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	798	1054	0.012333966	0.016129032	8	oligos	OL-MS-1	49	33	33
TGCTACCCAAATTGCC-1_8_H10	-2.738578748	10.54338208	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1000	1415	0.014840989	0.013427562	8	oligos	OL-MS-1	49	33	33
TGCTACCGTGTTAAGA-1_8_H10	32.84936778	13.72232014	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1148	1643	0.009738284	0.032866707	8	14	Microglia	49	33	33
TGCTGCTAGATATACG-1_8_H10	10.26914482	6.645484387	1	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1394	2136	0.005149813	0.021535581	8	oligos	OL-Cntl	49	33	33
TGCTGCTAGCTAAACA-1_8_H10	6.617194824	2.924224869	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	710	1079	0.169601483	0.02965709	8	16	EN-PYR	49	33	33
TGCTGCTCATCGTCGG-1_8_H10	28.06878202	9.903018907	15DB	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	666	1040	0.035576923	0.249038462	8	15DB	B cells	49	33	33
TGCTGCTGTAGCCTCG-1_8_H10	-1.570444135	9.259157122	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1029	1406	0.009957326	0.019203414	8	oligos	OL-MS-1	49	33	33
TGCTGCTGTCATCGGC-1_8_H10	-17.8905606	16.94691173	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1362	2049	0.012201074	0.008784773	8	8	Astrocytes	49	33	33
TGCTGCTGTGAGGGAG-1_8_H10	-17.37944342	0.024336621	13A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3310	6535	0.007804132	0.017903596	8	13A	IN-VIP	49	33	33
TGCTGCTGTTATCACG-1_8_H10	-27.20848124	-4.98185448	9	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1323	1990	0.006532663	0.007537688	8	9	OPC	49	33	33
TGCTGCTGTTCACGGC-1_8_H10	-24.67274199	-24.59543705	6A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4984	13833	0.014747343	0.007518253	8	6A	IN-PV	49	33	33
TGCTGCTTCAGAGGTG-1_8_H10	-2.12004956	10.35280064	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	962	1353	0.012564671	0.014042868	8	oligos	OL-MS-1	49	33	33
TGCTGCTTCCTCAACC-1_8_H10	-18.22086861	-6.277364928	13B	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3220	6386	0.021453179	0.011118071	8	13B	IN-SV2C	49	33	33
TGGACGCAGTAGCGGT-1_8_H10	6.037546166	-11.3941099	12	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1883	3151	0.016185338	0.022849889	8	12	EN-MIX	49	33	33
TGGACGCAGTCTCAAC-1_8_H10	-3.941597231	8.468711112	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1031	1531	0.060091444	0.025473547	8	oligos	OL-MS-1	49	33	33
TGGACGCCAGCGTAAG-1_8_H10	-33.20994117	5.135076272	9	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2940	5865	0.002898551	0.005797101	8	9	OPC	49	33	33
TGGACGCCATCTATGG-1_8_H10	29.08030923	-13.73603104	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5705	15588	0.02450603	0.015075699	8	2	EN-L4	49	33	33
TGGACGCCATTGAGCT-1_8_H10	26.79930382	7.524017782	15A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1209	1726	0.00405562	0.02838934	8	15A	Endo cells	49	33	33
TGGACGCGTCCGCTGA-1_8_H10	-1.360312482	15.72634157	1	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	827	1172	0.009385666	0.018771331	8	oligos	OL-Cntl	49	33	33
TGGACGCGTCTACCTC-1_8_H10	-5.126808155	8.641667946	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	776	1113	0.008086253	0.037735849	8	oligos	OL-MS-1	49	33	33
TGGACGCGTTCACCTC-1_8_H10	-17.60242757	7.201380591	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	988	1314	0.009893455	0.006849315	8	8	Astrocytes	49	33	33
TGGACGCTCGATAGAA-1_8_H10	-2.916815117	7.992655945	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1125	1626	0.006765068	0.028905289	8	oligos	OL-MS-1	49	33	33
TGGCCAGCACCGAAAG-1_8_H10	2.259771579	5.902423356	7	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1118	1625	0.006153846	0.011076923	8	7	Phagocytes	49	33	33
TGGCCAGCAGTCACTA-1_8_H10	-3.877352288	15.05228078	1	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	851	1196	0.012541806	0.014214047	8	oligos	OL-Cntl	49	33	33
TGGCCAGGTCAGAAGC-1_8_H10	0.657728173	8.584400716	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1314	1944	0.005144033	0.021090535	8	oligos	OL-MS-1	49	33	33
TGGCCAGTCAGTTGAC-1_8_H10	-7.051169176	9.413723399	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	807	1093	0.018298262	0.019213175	8	oligos	OL-MS-1	49	33	33
TGGCGCAAGCTCTCGG-1_8_H10	-5.822483395	10.00837048	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	877	1233	0.01865369	0.01297648	8	oligos	OL-MS-1	49	33	33
TGGCGCAAGTAGGCCA-1_8_H10	-28.03010706	-2.498134641	9	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1504	2389	0.008371704	0.013813311	8	9	OPC	49	33	33
TGGCGCACACCGCTAG-1_8_H10	-5.855491465	11.11244943	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	804	1078	0.018552876	0.015769944	8	oligos	OL-MS-1	49	33	33
TGGCTGGAGGAGTCTG-1_8_H10	-9.481051861	-16.17862413	6B	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	917	1367	0.025603511	0.009509876	8	6B	IN-SST	49	33	33
TGGCTGGCACACATGT-1_8_H10	28.59361288	10.74826916	15DB	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1370	1995	0.040601504	0.111779449	8	15DB	B cells	49	33	33
TGGCTGGCATCGGAAG-1_8_H10	25.09378508	-26.55426377	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4871	13514	0.003921859	0.005105816	8	3	EN-L5-6	49	33	33
TGGCTGGGTCTGATTG-1_8_H10	10.89582977	6.560380711	1	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1665	2673	0.014590348	0.020576132	8	oligos	OL-Cntl	49	33	33
TGGCTGGGTCTGGTCG-1_8_H10	-10.80664017	-38.94004262	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1593	2391	0.079464659	0.031785864	8	16	EN-PYR	49	33	33
TGGGAAGAGAATAGGG-1_8_H10	-15.02866322	-22.23184569	6A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1754	3447	0.154046997	0.006962576	8	6A	IN-PV	49	33	33
TGGGAAGAGCCAGGAT-1_8_H10	26.97123152	9.978379696	15A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1460	2300	0.02826087	0.066956522	8	15A	Endo cells	49	33	33
TGGGAAGAGCTGCCCA-1_8_H10	-2.679136554	7.993461861	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1110	1526	0.007208388	0.028833552	8	oligos	OL-MS-1	49	33	33
TGGGAAGAGGCTAGCA-1_8_H10	26.87222572	9.532377363	15A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1410	2118	0.024551464	0.048630784	8	15A	Endo cells	49	33	33
TGGGAAGAGTAGGCCA-1_8_H10	31.61520428	-18.69875019	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	6053	15135	0.017443013	0.018698381	8	2	EN-L4	49	33	33
TGGGAAGAGTGAAGAG-1_8_H10	-5.720319446	7.602529722	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1105	1655	0.087613293	0.033836858	8	oligos	OL-MS-1	49	33	33
TGGGAAGCACAAGTAA-1_8_H10	-5.026587509	8.887077202	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	917	1197	0.01336675	0.031746032	8	oligos	OL-MS-1	49	33	33
TGGGAAGCACTTGGAT-1_8_H10	-29.80285723	-9.435161793	9	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1103	1541	0.007138222	0.018170019	8	9	OPC	49	33	33
TGGGAAGCAGATGAGC-1_8_H10	24.8156069	-19.43644902	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	7512	28947	0.066742668	0.005596435	8	3	EN-L5-6	49	33	33
TGGGAAGTCCGGGTGT-1_8_H10	-4.980237433	9.410042909	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	951	1339	0.00746826	0.017176998	8	oligos	OL-MS-1	49	33	33
TGGGCGTAGTTCGCGC-1_8_H10	25.62421982	10.52301861	15A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3598	7722	0.013338513	0.074721575	8	15A	Endo cells	49	33	33
TGGGCGTCAATGTTGC-1_8_H10	-5.338009882	9.599117876	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	761	1014	0.025641026	0.037475345	8	oligos	OL-MS-1	49	33	33
TGGGCGTTCCTTGCCA-1_8_H10	-9.613946531	-38.12798748	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1168	1743	0.063683305	0.022375215	8	16	EN-PYR	49	33	33
TGGGCGTTCGGACAAG-1_8_H10	-17.68106048	25.15717334	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1812	2769	0.013362225	0.009750813	8	8	Astrocytes	49	33	33
TGGTTAGCAAACTGCT-1_8_H10	-0.459067746	10.11112868	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1082	1539	0.008447044	0.012995452	8	oligos	OL-MS-1	49	33	33
TGGTTAGGTTACGTCA-1_8_H10	-5.058528524	12.8212492	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	810	1119	0.010723861	0.015192136	8	oligos	OL-MS-1	49	33	33
TGGTTAGTCCGCAGTG-1_8_H10	-14.7642347	-37.71749214	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2546	4551	0.038453087	0.020654801	8	16	EN-PYR	49	33	33
TGGTTCCAGTGGAGAA-1_8_H10	17.37604201	-26.5735589	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5046	13252	0.006338666	0.009432538	8	3	EN-L5-6	49	33	33
TGGTTCCGTCTAGGTT-1_8_H10	-4.199697426	-34.8470342	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	831	1059	0.062322946	0.016997167	8	16	EN-PYR	49	33	33
TGGTTCCGTGCTGTAT-1_8_H10	-3.14475538	11.09942635	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	930	1315	0.019771863	0.0121673	8	oligos	OL-MS-1	49	33	33
TGTATTCCAATGGAGC-1_8_H10	32.32212932	13.88631695	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1424	2116	0.026937618	0.040170132	8	14	Microglia	49	33	33
TGTATTCCACAGCCCA-1_8_H10	31.94017527	9.462411187	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	834	1089	0.022956841	0.025711662	8	14	Microglia	49	33	33
TGTATTCTCCTCTAGC-1_8_H10	-6.927228022	10.5486781	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	791	1041	0.014409222	0.005763689	8	oligos	OL-MS-1	49	33	33
TGTCCCAAGGAATGGA-1_8_H10	8.981915974	-4.011082024	12	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1837	3012	0.067397078	0.023572377	8	12	EN-MIX	49	33	33
TGTCCCAAGGCTAGCA-1_8_H10	-17.77726761	25.09721306	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1716	2835	0.010229277	0.009171076	8	8	Astrocytes	49	33	33
TGTCCCACAGCGTAAG-1_8_H10	24.36933981	-16.95482463	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4837	12073	0.038101549	0.012424418	8	3	EN-L5-6	49	33	33
TGTCCCAGTACGCACC-1_8_H10	-28.93455738	-1.019814439	9	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1704	2776	0.011527378	0.012247839	8	9	OPC	49	33	33
TGTCCCATCGTACCGG-1_8_H10	23.51307898	-16.25743118	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	6368	20167	0.041999306	0.012991521	8	2	EN-L4	49	33	33
TGTGGTAAGAACAACT-1_8_H10	-4.155634207	10.20159259	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	879	1199	0.009174312	0.026688907	8	oligos	OL-MS-1	49	33	33
TGTGGTAAGCTAAACA-1_8_H10	24.69131873	-16.13024339	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4673	11238	0.035059619	0.013080619	8	3	EN-L5-6	49	33	33
TGTGGTACAATGACCT-1_8_H10	33.74028682	14.3863319	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1038	1632	0.026348039	0.024509804	8	14	Microglia	49	33	33
TGTGGTAGTATATGAG-1_8_H10	27.23378314	10.23013119	15DB	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1846	3274	0.013439218	0.156994502	8	15DB	B cells	49	33	33
TGTGTTTAGACTTGAA-1_8_H10	-12.89574636	-2.21596322	13A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2788	5437	0.02041567	0.010851573	8	13A	IN-VIP	49	33	33
TGTGTTTAGAGCTATA-1_8_H10	-1.650031052	7.853243988	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1213	1773	0.007332205	0.02820079	8	oligos	OL-MS-1	49	33	33
TGTGTTTAGCCACGTC-1_8_H10	29.70436299	7.887558162	15DA	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	601	1018	0.026522593	0.02848723	8	15DA	T cells	49	33	33
TGTGTTTAGGTCGGAT-1_8_H10	3.29146485	13.42661765	1	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	948	1415	0.009893993	0.016961131	8	oligos	OL-Cntl	49	33	33
TGTGTTTCACCAGTTA-1_8_H10	18.4888122	-24.62798543	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5792	17358	0.013884088	0.009793755	8	3	EN-L5-6	49	33	33
TGTGTTTCACGCTTTC-1_8_H10	-4.281075072	12.21525377	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	782	1044	0.003831418	0.027777778	8	oligos	OL-MS-1	49	33	33
TGTGTTTCAGCTTCGG-1_8_H10	33.26931945	-9.943769736	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4943	12379	0.030535584	0.010016964	8	2	EN-L4	49	33	33
TGTGTTTGTCAAAGAT-1_8_H10	24.32138165	-21.57633587	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	6276	19297	0.028968233	0.004819402	8	3	EN-L5-6	49	33	33
TGTGTTTTCATAAAGG-1_8_H10	9.790133519	-24.03586602	4	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4447	11288	0.004163714	0.010719348	8	L2-3	EN-L2-3-MS	49	33	33
TGTGTTTTCCGTAGGC-1_8_H10	11.3849124	6.898085666	1	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1517	2459	0.007320049	0.013826759	8	oligos	OL-Cntl	49	33	33
TGTTCCGAGTCTTGCA-1_8_H10	28.05168757	10.39109997	15DB	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1291	2129	0.008924378	0.132926256	8	15DB	B cells	49	33	33
TGTTCCGCACGGCGTT-1_8_H10	-0.447351628	9.616183606	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1073	1496	0.006684492	0.018716578	8	oligos	OL-MS-1	49	33	33
TGTTCCGGTACAGTGG-1_8_H10	26.85663781	9.962786224	15A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1503	2298	0.014795474	0.063533507	8	15A	Endo cells	49	33	33
TGTTCCGGTATGGTTC-1_8_H10	7.162501746	-18.42348348	4	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3788	8899	0.00618047	0.02011462	8	L2-3	EN-L2-3-MS	49	33	33
TGTTCCGGTATTCGTG-1_8_H10	23.83053026	-20.48693842	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5369	14127	0.013024704	0.013803355	8	3	EN-L5-6	49	33	33
TGTTCCGGTCATACTG-1_8_H10	-4.264966139	10.5420827	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	795	1057	0.010406812	0.023651845	8	oligos	OL-MS-1	49	33	33
TGTTCCGGTGTGACGA-1_8_H10	-6.780065587	9.554950208	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	758	1007	0.018867925	0.02979146	8	oligos	OL-MS-1	49	33	33
TGTTCCGTCCTGCCAT-1_8_H10	-18.04682758	24.26318016	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1464	2408	0.005398671	0.005813953	8	8	Astrocytes	49	33	33
TGTTCCGTCGATAGAA-1_8_H10	28.01133984	10.46780826	15DB	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1785	3448	0.008990719	0.153422274	8	15DB	B cells	49	33	33
TTAACTCAGGTAGCCA-1_8_H10	33.00006816	6.563761692	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	714	1004	0.119521912	0.011952191	8	14	Microglia	49	33	33
TTAACTCCACCGCTAG-1_8_H10	9.516662877	-26.41751239	10	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	7703	34399	0.005785052	0.003604756	8	L2-3	EN-L2-3-Cntl	49	33	33
TTAACTCCAGATGAGC-1_8_H10	28.39805845	10.38289481	15DB	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1346	2047	0.012212995	0.11333659	8	15DB	B cells	49	33	33
TTAACTCTCTCTTGAT-1_8_H10	23.84523108	-10.62247513	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4274	11701	0.008802666	0.005042304	8	3	EN-L5-6	49	33	33
TTAGGACCACAAGCCC-1_8_H10	-17.53354564	7.757090001	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1042	1503	0.015302728	0.005322688	8	8	Astrocytes	49	33	33
TTAGGACCAGTAAGAT-1_8_H10	-28.88443736	0.228412363	9	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1759	2842	0.012315271	0.016889514	8	9	OPC	49	33	33
TTAGGACGTAGCGCAA-1_8_H10	-6.868472928	7.072913305	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	893	1198	0.033388982	0.043405676	8	oligos	OL-MS-1	49	33	33
TTAGGCAAGTAATCCC-1_8_H10	33.91348261	13.30253258	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1256	1846	0.016251354	0.021126761	8	14	Microglia	49	33	33
TTAGGCACACCTCGTT-1_8_H10	27.45992385	10.28455458	15A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1477	2489	0.033346726	0.122137405	8	15A	Endo cells	49	33	33
TTAGGCACAGTCAGAG-1_8_H10	24.21897381	-10.84604629	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4072	9436	0.002543451	0.011127596	8	3	EN-L5-6	49	33	33
TTAGGCACATAAGACA-1_8_H10	34.15320207	12.95941262	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1234	1766	0.016987542	0.020951302	8	14	Microglia	49	33	33
TTAGGCAGTACGCACC-1_8_H10	-35.74011815	-1.552126011	9	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1497	2578	0.010473235	0.005818464	8	9	OPC	49	33	33
TTAGGCAGTCTCTTTA-1_8_H10	28.20118525	11.7247252	15DB	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4360	10828	0.018747691	0.124584411	8	15DB	B cells	49	33	33
TTAGGCATCAAAGTAG-1_8_H10	-18.00167868	25.79550148	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1800	2870	0.004529617	0.008013937	8	8	Astrocytes	49	33	33
TTAGGCATCTGGTATG-1_8_H10	0.124914049	8.875089849	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1299	1909	0.00471451	0.022524882	8	oligos	OL-MS-1	49	33	33
TTAGTTCCATTAGCCA-1_8_H10	6.743094241	-21.40311023	4	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	6133	19417	0.003914096	0.011124273	8	L2-3	EN-L2-3-MS	49	33	33
TTAGTTCGTTTACTCT-1_8_H10	24.76486588	-20.55777895	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5231	16249	0.055941904	0.004984922	8	3	EN-L5-6	49	33	33
TTAGTTCTCGCCATAA-1_8_H10	-4.342438356	10.74156497	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	843	1164	0.012027491	0.025773196	8	oligos	OL-MS-1	49	33	33
TTAGTTCTCGGTCTAA-1_8_H10	31.38369433	12.30647124	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1012	1499	0.016677785	0.040693796	8	14	Microglia	49	33	33
TTAGTTCTCTCAAACG-1_8_H10	11.35361396	6.517823222	1	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1721	2825	0.008495575	0.022300885	8	oligos	OL-Cntl	49	33	33
TTATGCTCACTCTGTC-1_8_H10	-0.168105985	9.50599676	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1156	1707	0.011716462	0.024018746	8	oligos	OL-MS-1	49	33	33
TTATGCTGTGTGAAAT-1_8_H10	-17.53749613	24.93019059	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1733	2708	0.009231905	0.008493353	8	8	Astrocytes	49	33	33
TTATGCTGTTCACCTC-1_8_H10	4.031566566	-18.80332531	4	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4238	11331	0.005206954	0.005648222	8	L2-3	EN-L2-3-MS	49	33	33
TTATGCTTCATGTGGT-1_8_H10	27.09894426	9.098952694	15A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1247	1853	0.037236913	0.063140853	8	15A	Endo cells	49	33	33
TTATGCTTCGCATGAT-1_8_H10	0.337670123	9.235699183	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1161	1749	0.013150372	0.022298456	8	oligos	OL-MS-1	49	33	33
TTATGCTTCGTAGGTT-1_8_H10	-4.61636194	11.63565723	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	769	1051	0.015223597	0.018078021	8	oligos	OL-MS-1	49	33	33
TTATGCTTCGTTTGCC-1_8_H10	5.600270963	-27.28145675	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4022	9413	0.00807394	0.004355678	8	3	EN-L5-6	49	33	33
TTATGCTTCTTCATGT-1_8_H10	27.80924728	-10.87771288	4	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4609	11999	0.041586799	0.004333694	8	L2-3	EN-L2-3-MS	49	33	33
TTCCCAGCAAATACAG-1_8_H10	-18.16409109	-2.235786036	13A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3525	7155	0.016631726	0.012997904	8	13A	IN-VIP	49	33	33
TTCCCAGCACAGAGGT-1_8_H10	-3.360636722	-36.01475587	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	914	1201	0.071606994	0.022481266	8	16	EN-PYR	49	33	33
TTCCCAGCACCAGTTA-1_8_H10	10.92108469	6.365022425	1	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1826	2859	0.007345226	0.016089542	8	oligos	OL-Cntl	49	33	33
TTCCCAGCACTCAGGC-1_8_H10	6.35144124	0.859928525	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1107	1376	0.050145349	0.030523256	8	16	EN-PYR	49	33	33
TTCCCAGGTCAGAATA-1_8_H10	38.66184441	12.47462864	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1066	1484	0.016846361	0.003369272	8	14	Microglia	49	33	33
TTCCCAGTCTGATACG-1_8_H10	25.95117967	-23.96748915	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4849	13522	0.010575359	0.004585121	8	3	EN-L5-6	49	33	33
TTCGAAGAGGCATGTG-1_8_H10	-4.625589121	9.09826281	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	887	1175	0.022978723	0.020425532	8	oligos	OL-MS-1	49	33	33
TTCGAAGCATGAGCGA-1_8_H10	31.69082505	-18.64272082	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	6497	18621	0.021695935	0.024005155	8	2	EN-L4	49	33	33
TTCGAAGGTAAGCACG-1_8_H10	30.17909565	13.45822441	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	995	1389	0.100071994	0.078473722	8	14	Microglia	49	33	33
TTCGAAGTCAGCAACT-1_8_H10	-12.57644924	-13.29201182	6A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1770	2887	0.012469692	0.026671285	8	6A	IN-PV	49	33	33
TTCGAAGTCCGTTGCT-1_8_H10	12.09157328	-24.36219365	4	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5244	14602	0.008491987	0.010341049	8	L2-3	EN-L2-3-MS	49	33	33
TTCGAAGTCTCAACTT-1_8_H10	23.24594314	-27.47792978	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4004	10754	0.008554956	0.004370467	8	3	EN-L5-6	49	33	33
TTCGGTCAGTCATGCT-1_8_H10	32.05540578	13.93585579	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1083	1557	0.012845215	0.060372511	8	14	Microglia	49	33	33
TTCGGTCCAGCTCGAC-1_8_H10	20.13247091	-20.96559447	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	6304	21636	0.021723054	0.01002958	8	3	EN-L5-6	49	33	33
TTCGGTCTCATAACCG-1_8_H10	29.84699497	8.969390033	15DA	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	939	1265	0.045849802	0.026086957	8	15DA	T cells	49	33	33
TTCGGTCTCGGCTACG-1_8_H10	-3.475110759	9.83884963	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	998	1459	0.010966415	0.025359836	8	oligos	OL-MS-1	49	33	33
TTCTACAAGGAATGGA-1_8_H10	-19.46793724	-0.783285822	13A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4280	8941	0.014316072	0.019572755	8	13A	IN-VIP	49	33	33
TTCTACACACAAGTAA-1_8_H10	-2.032819564	9.47603371	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	879	1260	0.019047619	0.030952381	8	oligos	OL-MS-1	49	33	33
TTCTACACACACCGCA-1_8_H10	0.12166442	10.59305382	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1076	1585	0.020820189	0.0170347	8	oligos	OL-MS-1	49	33	33
TTCTACAGTGTCTGAT-1_8_H10	-20.61056808	-5.295858516	13B	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5373	13475	0.01432282	0.013654917	8	13B	IN-SV2C	49	33	33
TTCTACAGTTGGTGGA-1_8_H10	30.09196338	13.65212671	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1086	1526	0.02293578	0.0491481	8	14	Microglia	49	33	33
TTCTACATCACTTACT-1_8_H10	-2.433647524	8.058343764	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1135	1723	0.01334881	0.024956471	8	oligos	OL-MS-1	49	33	33
TTCTACATCACTTATC-1_8_H10	-6.062888196	11.69237009	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	784	1073	0.013979497	0.017707363	8	oligos	OL-MS-1	49	33	33
TTCTCAAGTACGCTGC-1_8_H10	-27.96540109	-2.111603167	9	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1559	2257	0.00886132	0.025254763	8	9	OPC	49	33	33
TTCTCAAGTCGACTGC-1_8_H10	-26.39532925	-23.44109301	6A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4582	11358	0.034337031	0.008188061	8	6A	IN-PV	49	33	33
TTCTCCTAGTGTTAGA-1_8_H10	33.32389582	8.873764792	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	872	1192	0.01761745	0.014261745	8	14	Microglia	49	33	33
TTCTCCTCACCTCGGA-1_8_H10	-3.128115256	-35.33843949	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	799	1078	0.079777365	0.030612245	8	16	EN-PYR	49	33	33
TTCTCCTCACCTGGTG-1_8_H10	-2.596732688	8.318404651	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1110	1623	0.011090573	0.025261861	8	oligos	OL-MS-1	49	33	33
TTCTCCTCAGATGAGC-1_8_H10	9.041687336	-30.86686453	10	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3465	8143	0.018666339	0.00429817	8	L2-3	EN-L2-3-Cntl	49	33	33
TTCTCCTGTGATAAAC-1_8_H10	20.53281795	-16.76809421	4	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	8043	35064	0.085073009	0.007357974	8	L2-3	EN-L2-3-MS	49	33	33
TTCTTAGAGAACTGTA-1_8_H10	-15.81497086	13.4180755	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1700	2849	0.007371007	0.005265005	8	8	Astrocytes	49	33	33
TTCTTAGAGAAGAAGC-1_8_H10	-23.6806248	-25.22209835	6A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4182	9916	0.011294877	0.006353368	8	6A	IN-PV	49	33	33
TTCTTAGAGATGTAAC-1_8_H10	-3.717358398	17.16165523	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	757	1037	0.004821601	0.017357763	8	oligos	OL-MS-1	49	33	33
TTCTTAGCAATACGCT-1_8_H10	-3.389755506	-35.43589486	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	915	1363	0.167278063	0.024944974	8	16	EN-PYR	49	33	33
TTCTTAGGTATAATGG-1_8_H10	29.57853766	9.644918847	15DB	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	907	1252	0.009584665	0.082268371	8	15DB	B cells	49	33	33
TTCTTAGTCTTAGCCC-1_8_H10	32.92338943	13.41650393	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1274	1887	0.034446211	0.027556969	8	14	Microglia	49	33	33
TTGAACGAGTGTACTC-1_8_H10	23.37699383	-16.19535147	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	7107	23044	0.019397674	0.013192154	8	2	EN-L4	49	33	33
TTGAACGTCACGCGGT-1_8_H10	-3.947749461	-36.61916518	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	805	1127	0.080745342	0.040816327	8	16	EN-PYR	49	33	33
TTGACTTAGAAGGGTA-1_8_H10	10.39670813	-25.64930089	4	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	6105	18281	0.004047919	0.007330015	8	L2-3	EN-L2-3-MS	49	33	33
TTGACTTAGAGCCCAA-1_8_H10	-15.95418982	15.57788912	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1994	3774	0.01245363	0.007684155	8	8	Astrocytes	49	33	33
TTGACTTAGGGCTTGA-1_8_H10	-15.83101615	-8.920128788	13A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2594	5601	0.037671844	0.0076772	8	13A	IN-VIP	49	33	33
TTGACTTCAAACAACA-1_8_H10	27.85659558	10.46211658	15DB	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2001	4352	0.010110294	0.215073529	8	15DB	B cells	49	33	33
TTGACTTCACACATGT-1_8_H10	-6.805861612	8.297096344	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	877	1173	0.025575448	0.019607843	8	oligos	OL-MS-1	49	33	33
TTGACTTGTAGGCATG-1_8_H10	20.21037304	-28.62559894	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3572	8998	0.002000445	0.00477884	8	3	EN-L5-6	49	33	33
TTGACTTTCCTCAATT-1_8_H10	17.61208354	-10.59124044	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2944	6793	0.008390991	0.011335198	8	3	EN-L5-6	49	33	33
TTGCCGTAGAGCTGCA-1_8_H10	-3.335449297	21.03890326	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	830	1230	0.015447154	0.017886179	8	oligos	OL-MS-1	49	33	33
TTGCCGTAGCCGCCTA-1_8_H10	-20.18401152	-16.6315123	6B	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3297	7328	0.011053493	0.005867904	8	6B	IN-SST	49	33	33
TTGCCGTCACGGACAA-1_8_H10	33.08854253	10.90222736	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	893	1219	0.023789992	0.027891715	8	14	Microglia	49	33	33
TTGCCGTGTACTCTCC-1_8_H10	-29.2529446	-3.319144824	9	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1296	1984	0.007056452	0.013608871	8	9	OPC	49	33	33
TTGCCGTGTGACAAAT-1_8_H10	30.69272316	9.448432764	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1110	1474	0.005427408	0.033921303	8	14	Microglia	49	33	33
TTGCGTCAGAAGCCCA-1_8_H10	30.07368761	15.94456306	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1492	2273	0.018037835	0.0866696	8	14	Microglia	49	33	33
TTGCGTCAGACCGGAT-1_8_H10	-17.59741001	-6.033902906	13B	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2319	4031	0.043413545	0.007690399	8	13B	IN-SV2C	49	33	33
TTGCGTCAGCCCAATT-1_8_H10	-3.96348862	11.1096075	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	824	1166	0.013722127	0.036878216	8	oligos	OL-MS-1	49	33	33
TTGCGTCCAGTTTACG-1_8_H10	18.14705091	-8.056106048	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1953	3828	0.004963427	0.004963427	8	3	EN-L5-6	49	33	33
TTGCGTCTCAGGCAAG-1_8_H10	-0.741826916	7.760581649	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1642	2695	0.013358071	0.021892393	8	oligos	OL-MS-1	49	33	33
TTGCGTCTCGAACGGA-1_8_H10	17.40551784	-26.30772882	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5030	14705	0.009928596	0.011696702	8	3	EN-L5-6	49	33	33
TTGCGTCTCTTTCCTC-1_8_H10	29.86324365	14.2026242	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	939	1328	0.02936747	0.105421687	8	14	Microglia	49	33	33
TTGGAACAGGGTCGAT-1_8_H10	-6.337501014	-37.45995838	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1054	1548	0.09496124	0.020671835	8	16	EN-PYR	49	33	33
TTGGAACCACCGAATT-1_8_H10	8.101391775	2.624985632	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1082	1356	0.028761062	0.039085546	8	16	EN-PYR	49	33	33
TTGGAACGTTATGTGC-1_8_H10	-24.48697832	0.802130803	9	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2067	3395	0.00736377	0.020324006	8	9	OPC	49	33	33
TTGGAACTCAACGGGA-1_8_H10	-1.018205091	8.296758549	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1283	1796	0.018374165	0.025055679	8	oligos	OL-MS-1	49	33	33
TTGGAACTCGGTGTTA-1_8_H10	31.86277047	-18.56943958	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5799	14825	0.024620573	0.016661046	8	2	EN-L4	49	33	33
TTGGAACTCTCCGGTT-1_8_H10	25.04248954	-26.44204224	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3978	10378	0.005781461	0.003950665	8	3	EN-L5-6	49	33	33
TTGGCAAAGATGTTAG-1_8_H10	19.69338281	-23.23214635	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	6102	19543	0.012996981	0.010387351	8	3	EN-L5-6	49	33	33
TTGGCAACATAAGACA-1_8_H10	25.67802399	10.13248972	15A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2474	4282	0.02078468	0.054880897	8	15A	Endo cells	49	33	33
TTGGCAATCCTAGAAC-1_8_H10	-17.68468628	24.55375821	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1582	2442	0.006552007	0.006552007	8	8	Astrocytes	49	33	33
TTGTAGGAGGAGTTTA-1_8_H10	-10.09316014	-39.02381753	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1385	2097	0.070100143	0.039103481	8	16	EN-PYR	49	33	33
TTGTAGGCAAGTCTAC-1_8_H10	5.986754376	-19.39432087	4	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3870	8949	0.001899654	0.01575595	8	L2-3	EN-L2-3-MS	49	33	33
TTGTAGGGTGTGACGA-1_8_H10	33.67231171	14.04923774	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1226	1751	0.013135351	0.032552827	8	14	Microglia	49	33	33
TTGTAGGTCTGATTCT-1_8_H10	20.72508371	-12.11694754	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2630	5402	0.081451314	0.009070715	8	3	EN-L5-6	49	33	33
TTTACTGCAATCAGAA-1_8_H10	-5.792598793	11.53893841	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	760	1081	0.019426457	0.023126735	8	oligos	OL-MS-1	49	33	33
TTTACTGCACAACGTT-1_8_H10	-18.51882533	17.43520757	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1443	2262	0.00795756	0.007515473	8	8	Astrocytes	49	33	33
TTTACTGCATGCCTAA-1_8_H10	9.846759637	-21.90729023	4	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5277	14692	0.00639804	0.012728015	8	L2-3	EN-L2-3-MS	49	33	33
TTTACTGCATGTAAGA-1_8_H10	25.03070607	4.1978926	15BA	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1471	2390	0.005439331	0.00209205	8	15BA	Stromal cells	49	33	33
TTTACTGGTCTGCGGT-1_8_H10	-17.61424876	25.36704716	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1918	3369	0.00890472	0.006826952	8	8	Astrocytes	49	33	33
TTTACTGGTGCTGTAT-1_8_H10	-22.04177439	-24.52722275	6A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2723	5592	0.039878398	0.005901288	8	6A	IN-PV	49	33	33
TTTACTGTCCAAAGTC-1_8_H10	-3.540970113	-35.23921028	16	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	781	1018	0.061886051	0.026522593	8	16	EN-PYR	49	33	33
TTTACTGTCGCATGGC-1_8_H10	23.3993899	-16.28058738	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	8869	42050	0.044019025	0.011414982	8	2	EN-L4	49	33	33
TTTACTGTCGCTGATA-1_8_H10	-2.580330687	10.38692339	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	991	1382	0.013748191	0.015918958	8	oligos	OL-MS-1	49	33	33
TTTATGCAGCCAGGAT-1_8_H10	-8.359247237	-15.4953078	6B	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	796	1203	0.078137988	0.009975062	8	6B	IN-SST	49	33	33
TTTATGCGTCAATGTC-1_8_H10	27.68248617	8.359175936	15A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1123	1590	0.024528302	0.036477987	8	15A	Endo cells	49	33	33
TTTATGCGTCACTGGC-1_8_H10	-6.878959755	10.9259392	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	749	1047	0.013371538	0.021012416	8	oligos	OL-MS-1	49	33	33
TTTATGCTCATGTAGC-1_8_H10	9.127613662	-3.672923175	12	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2135	3754	0.022642515	0.014384656	8	12	EN-MIX	49	33	33
TTTATGCTCGAGAACG-1_8_H10	18.33979709	-24.68449764	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	6494	20057	0.008027123	0.011467318	8	3	EN-L5-6	49	33	33
TTTATGCTCTTCGAGA-1_8_H10	26.81780329	8.884719581	15BA	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1323	1966	0.053407935	0.055442523	8	15BA	Stromal cells	49	33	33
TTTCCTCGTTGTACAC-1_8_H10	28.27554147	6.064124754	15BA	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	998	1315	0.035741445	0.018250951	8	15BA	Stromal cells	49	33	33
TTTCCTCTCAGTACGT-1_8_H10	29.06502339	-13.84737593	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	7104	25145	0.028156691	0.01682243	8	2	EN-L4	49	33	33
TTTCCTCTCTCGCTTG-1_8_H10	-1.896655488	11.31653679	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	907	1370	0.00729927	0.023357664	8	oligos	OL-MS-1	49	33	33
TTTCCTCTCTGGTTCC-1_8_H10	31.15400571	4.478977552	15DA	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1024	1290	0.014728682	0.028682171	8	15DA	T cells	49	33	33
TTTGCGCCACATGACT-1_8_H10	-5.917901432	9.962440117	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	895	1212	0.018151815	0.018976898	8	oligos	OL-MS-1	49	33	33
TTTGCGCCATAGTAAG-1_8_H10	-16.08863032	12.0650762	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1530	2522	0.016256939	0.005947661	8	8	Astrocytes	49	33	33
TTTGCGCGTAAGCACG-1_8_H10	-7.623260911	7.603143882	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	789	1097	0.016408387	0.030082042	8	oligos	OL-MS-1	49	33	33
TTTGCGCGTTAAGTAG-1_8_H10	-5.746718951	-3.397003678	13A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1425	2330	0.030042918	0.003862661	8	13A	IN-VIP	49	33	33
TTTGCGCTCGGAGCAA-1_8_H10	-2.486338589	9.846603403	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1009	1431	0.009783368	0.021663173	8	oligos	OL-MS-1	49	33	33
TTTGGTTAGGTCGGAT-1_8_H10	33.52002506	4.775177691	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1321	1890	0.084656085	0.022222222	8	14	Microglia	49	33	33
TTTGGTTCACGGCCAT-1_8_H10	25.04256734	-22.87217332	3	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	4436	12280	0.070032573	0.005537459	8	3	EN-L5-6	49	33	33
TTTGGTTGTGCAACGA-1_8_H10	-15.91068484	11.89513866	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1291	1978	0.01314459	0.011122346	8	8	Astrocytes	49	33	33
TTTGGTTGTTACGACT-1_8_H10	33.11588481	-6.85789708	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	3622	7917	0.008589112	0.011115321	8	2	EN-L4	49	33	33
TTTGGTTTCGAGAACG-1_8_H10	-17.41570118	25.13030813	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1848	3058	0.005559189	0.012426422	8	8	Astrocytes	49	33	33
TTTGTCAAGCAACGGT-1_8_H10	13.44245275	13.967035	1	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1215	1943	0.009264025	0.011322697	8	oligos	OL-Cntl	49	33	33
TTTGTCAAGGATGCGT-1_8_H10	26.25711853	10.07867475	15A	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2085	3412	0.016119578	0.077960141	8	15A	Endo cells	49	33	33
TTTGTCAAGGTGCTTT-1_8_H10	-28.89818934	-12.58609282	9	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	757	1123	0.019590383	0.012466607	8	9	OPC	49	33	33
TTTGTCACAAATCCGT-1_8_H10	14.3266645	-5.066656561	12	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	2090	4533	0.008382969	0.008162365	8	12	EN-MIX	49	33	33
TTTGTCACAAGTCATC-1_8_H10	36.36286125	14.28489051	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1380	2071	0.012071463	0.011105746	8	14	Microglia	49	33	33
TTTGTCACACGCATCG-1_8_H10	-3.628468773	11.90418209	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	864	1199	0.010842369	0.032527106	8	oligos	OL-MS-1	49	33	33
TTTGTCACAGTCAGCC-1_8_H10	35.81314563	-11.14310557	2	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	5822	16614	0.010473095	0.013061274	8	2	EN-L4	49	33	33
TTTGTCAGTCGAGATG-1_8_H10	-18.02045385	25.73320555	8	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	1780	2758	0.005801305	0.007976795	8	8	Astrocytes	49	33	33
TTTGTCATCCGCAAGC-1_8_H10	-10.49143675	27.70024668	5	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	818	1049	0.046711153	0.027645377	8	oligos	OL-MS-1	49	33	33
TTTGTCATCCTGCTTG-1_8_H10	31.80124081	10.09466306	14	8_H10	MS	Acute/Chronic active	40	male	prefrontal	CAP4	SEQ2	7.6	27	843	1164	0.053264605	0.034364261	8	14	Microglia	49	33	33
AAACCTGAGTACGACG-1_MS377_A2D2	-1.849425679	17.26436765	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	708	1061	0.004712535	0.024505184	7	oligos	OL-Cntl	32	7	7
AAACCTGAGTGGTAGC-1_MS377_A2D2	27.94324105	-9.800452676	2	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	3028	6368	0.028109296	0.00423995	7	2	EN-L4	32	7	7
AAACCTGCAGATGGCA-1_MS377_A2D2	-16.60284062	-1.68501888	13A	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	3048	5799	0.019313675	0.017244352	7	13A	IN-VIP	32	7	7
AAACCTGGTTACTGAC-1_MS377_A2D2	2.071139202	23.12007702	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	794	1200	0.000833333	0.004166667	7	oligos	OL-Cntl	32	7	7
AAACCTGTCGGCGCAT-1_MS377_A2D2	17.80695992	-8.032902018	3	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	2131	4141	0.011591403	0.004829751	7	3	EN-L5-6	32	7	7
AAACGGGTCCAAACTG-1_MS377_A2D2	0.461352366	26.20581664	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	807	1152	0.003472222	0.004340278	7	oligos	OL-Cntl	32	7	7
AAAGATGGTTATCCGA-1_MS377_A2D2	6.654066157	13.81018077	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1210	1904	0.00210084	0.016281513	7	oligos	OL-Cntl	32	7	7
AAAGCAAAGTGGGCTA-1_MS377_A2D2	-8.141608372	30.79904658	17	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1669	2442	0.017199017	0.013513514	7	oligos	OL-MS-2	32	7	7
AAAGCAACACCCAGTG-1_MS377_A2D2	20.50354494	-22.66486915	3	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	4492	10974	0.025332604	0.004920722	7	3	EN-L5-6	32	7	7
AAAGTAGCATTGTGCA-1_MS377_A2D2	-30.24129955	-10.39002855	9	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1103	1558	0.001925546	0.005134788	7	9	OPC	32	7	7
AAAGTAGGTTCAGACT-1_MS377_A2D2	21.56849959	-3.160946116	2	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	2286	4151	0.016140689	0.005781739	7	2	EN-L4	32	7	7
AAATGCCAGCTGATAA-1_MS377_A2D2	27.67951009	5.041710198	15BA	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	784	1027	0.007789679	0.031158715	7	15BA	Stromal cells	32	7	7
AAATGCCAGTCATGCT-1_MS377_A2D2	16.43230695	-16.73308086	4	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	5009	13672	0.022015799	0.005924517	7	L2-3	EN-L2-3-MS	32	7	7
AAATGCCCACTGTGTA-1_MS377_A2D2	9.822895952	-16.52420254	4	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	3675	7882	0.009769094	0.007612281	7	L2-3	EN-L2-3-MS	32	7	7
AAATGCCCAGCCAGAA-1_MS377_A2D2	32.12620328	-10.11647209	2	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	3407	7957	0.012693226	0.007289179	7	2	EN-L4	32	7	7
AAATGCCCAGCTGCAC-1_MS377_A2D2	15.34226675	-17.88196634	4	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	6193	17907	0.012397386	0.007092199	7	L2-3	EN-L2-3-MS	32	7	7
AAATGCCTCACCTTAT-1_MS377_A2D2	7.241411184	22.66281112	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1051	1606	0.001867995	0.01120797	7	oligos	OL-Cntl	32	7	7
AACACGTAGAAACCTA-1_MS377_A2D2	-24.91090843	-19.30510654	6A	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	2712	5188	0.025057826	0.009059368	7	6A	IN-PV	32	7	7
AACACGTGTGTTTGGT-1_MS377_A2D2	5.982901028	26.55920785	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	871	1267	0.006314128	0.009471192	7	oligos	OL-Cntl	32	7	7
AACCATGGTCATGCCG-1_MS377_A2D2	-28.50543533	-2.011125098	9	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1526	2823	0.001416932	0.005313496	7	9	OPC	32	7	7
AACCATGTCTGCCAGG-1_MS377_A2D2	-13.5546102	-3.159881694	13A	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	3341	7209	0.004161465	0.008461645	7	13A	IN-VIP	32	7	7
AACCGCGAGACAAAGG-1_MS377_A2D2	2.685282888	6.221946689	7	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1096	1492	0.004021448	0.007372654	7	7	Phagocytes	32	7	7
AACCGCGCACACGCTG-1_MS377_A2D2	8.946013123	-3.231827929	12	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1431	2217	0.0112765	0.01262968	7	12	EN-MIX	32	7	7
AACCGCGCACGAGAGT-1_MS377_A2D2	-12.54521112	-10.39465382	13B	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1851	3477	0.010353753	0.003451251	7	13B	IN-SV2C	32	7	7
AACCGCGCAGACAGGT-1_MS377_A2D2	14.859888	-28.06346273	3	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	3628	8640	0.004282407	0.005787037	7	3	EN-L5-6	32	7	7
AACCGCGGTCCCTTGT-1_MS377_A2D2	15.72257832	-25.12275606	4	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	4509	12888	0.018544382	0.005431409	7	L2-3	EN-L2-3-MS	32	7	7
AACGTTGAGCTCCCAG-1_MS377_A2D2	-31.80251725	-7.013106654	9	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1250	1893	0.001584786	0.005810882	7	9	OPC	32	7	7
AACTCAGAGTCATGCT-1_MS377_A2D2	-21.16757462	8.382292765	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	924	1320	0.001515152	0.006818182	7	8	Astrocytes	32	7	7
AACTCAGTCGAATGCT-1_MS377_A2D2	-32.7950656	-9.065873924	9	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1063	1718	0.001746217	0.00523865	7	9	OPC	32	7	7
AACTCAGTCTGCGGCA-1_MS377_A2D2	-17.14778962	19.71833775	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1351	2228	0.003590664	0.008527828	7	8	Astrocytes	32	7	7
AACTCCCAGAGATGAG-1_MS377_A2D2	-29.28882739	-6.864045117	9	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1194	1749	0.002287021	0.007432819	7	9	OPC	32	7	7
AACTCCCCAAGGACTG-1_MS377_A2D2	-0.126491198	29.03612923	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	931	1269	0.002364066	0.007092199	7	oligos	OL-Cntl	32	7	7
AACTCCCCACGCCAGT-1_MS377_A2D2	-9.096559122	27.21603321	17	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1033	1486	0.032974428	0.01345895	7	oligos	OL-MS-2	32	7	7
AACTCTTAGAAACCTA-1_MS377_A2D2	12.51555865	-23.32659161	4	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	4921	13618	0.007563519	0.004993391	7	L2-3	EN-L2-3-MS	32	7	7
AACTCTTCAATCCGAT-1_MS377_A2D2	-6.721367069	-36.06182058	16	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	914	1200	0.0425	0.023333333	7	16	EN-PYR	32	7	7
AACTCTTGTGCACTTA-1_MS377_A2D2	-14.89562223	-6.194150966	13A	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	4025	9727	0.005243138	0.003701038	7	13A	IN-VIP	32	7	7
AACTGGTGTTGGTTTG-1_MS377_A2D2	-20.51429804	-4.674580263	13A	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	5363	14094	0.021214701	0.016389953	7	13A	IN-VIP	32	7	7
AACTTTCTCTGGTATG-1_MS377_A2D2	-0.876359436	18.05190038	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	799	1237	0.000808407	0.012934519	7	oligos	OL-Cntl	32	7	7
AACTTTCTCTTAACCT-1_MS377_A2D2	5.643366927	19.50218815	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	820	1215	0.000823045	0.011522634	7	oligos	OL-Cntl	32	7	7
AAGACCTAGGCATGGT-1_MS377_A2D2	5.915300443	22.77903383	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	913	1419	0.005637773	0.012684989	7	oligos	OL-Cntl	32	7	7
AAGACCTCACGGCTAC-1_MS377_A2D2	-11.51015529	-21.4843086	6B	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	996	1822	0.093852909	0.003841932	7	6B	IN-SST	32	7	7
AAGACCTCAGGCTCAC-1_MS377_A2D2	21.90595235	12.18458128	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1482	2630	0.001140684	0.001520913	7	oligos	OL-Cntl	32	7	7
AAGCCGCCAAGCCATT-1_MS377_A2D2	-7.213552243	-5.730726306	13A	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1303	2124	0.020244821	0.008003766	7	13A	IN-VIP	32	7	7
AAGCCGCGTCAACTGT-1_MS377_A2D2	-2.282888625	22.1989178	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	821	1155	0	0.006926407	7	oligos	OL-Cntl	32	7	7
AAGCCGCGTCTTCAAG-1_MS377_A2D2	-33.46965688	-9.427537763	9	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	998	1510	0.003311258	0.002649007	7	9	OPC	32	7	7
AAGGCAGAGATGCCTT-1_MS377_A2D2	-5.530454903	15.63155061	5	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	714	1017	0.002949853	0.014749263	7	oligos	OL-MS-1	32	7	7
AAGGCAGCAAGTACCT-1_MS377_A2D2	10.71332956	-0.495354389	12	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1117	1737	0.059873345	0.004605642	7	12	EN-MIX	32	7	7
AAGGCAGCACAGGTTT-1_MS377_A2D2	-2.918790183	23.49825983	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	734	1045	0.002870813	0.010526316	7	oligos	OL-Cntl	32	7	7
AAGGCAGGTTCATGGT-1_MS377_A2D2	-15.75395447	-1.872511825	13A	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	2316	4026	0.016890214	0.013164431	7	13A	IN-VIP	32	7	7
AAGGCAGTCCAAACAC-1_MS377_A2D2	-0.540053961	22.32546839	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	734	1021	0.002938296	0.005876592	7	oligos	OL-Cntl	32	7	7
AAGGTTCCACCGAATT-1_MS377_A2D2	2.564730244	19.09438046	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1036	1562	0.003201024	0.016005122	7	oligos	OL-Cntl	32	7	7
AAGGTTCCATGGGAAC-1_MS377_A2D2	-20.53511523	9.003293332	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1142	1921	0.000520562	0.005205622	7	8	Astrocytes	32	7	7
AAGGTTCGTACCTACA-1_MS377_A2D2	6.907787993	13.61218957	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1220	1936	0.002582645	0.012913223	7	oligos	OL-Cntl	32	7	7
AAGGTTCGTATGCTTG-1_MS377_A2D2	-2.067754076	28.06047182	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	735	1008	0.00297619	0.006944444	7	oligos	OL-Cntl	32	7	7
AAGTCTGAGGCCGAAT-1_MS377_A2D2	5.977974224	0.481197979	16	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	787	1074	0.02886406	0.023277467	7	16	EN-PYR	32	7	7
AAGTCTGTCCTGTACC-1_MS377_A2D2	7.455394647	-12.82461169	4	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	2469	4448	0.014838129	0.004946043	7	L2-3	EN-L2-3-MS	32	7	7
AATCCAGCACTACAGT-1_MS377_A2D2	22.48235029	16.22039768	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1321	2081	0.002883229	0.007208073	7	oligos	OL-Cntl	32	7	7
AATCCAGCAGCTGGCT-1_MS377_A2D2	-11.72539001	17.73745832	11	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	2152	3764	0.006907545	0.00664187	7	11	Glia-MIX	32	7	7
AATCGGTCATCCTTGC-1_MS377_A2D2	-12.14536149	-1.551482173	13A	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	2760	5577	0.010399857	0.00591716	7	13A	IN-VIP	32	7	7
ACACCAACAGTTAACC-1_MS377_A2D2	-8.619509104	-10.68020286	6B	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1130	1909	0.016238869	0.005762179	7	6B	IN-SST	32	7	7
ACACCAATCCTACAGA-1_MS377_A2D2	33.57174429	-12.32953298	2	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	4631	12017	0.016060581	0.005575435	7	2	EN-L4	32	7	7
ACACCAATCGCGGATC-1_MS377_A2D2	-2.79997444	21.76259978	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	817	1100	0.001818182	0.018181818	7	oligos	OL-Cntl	32	7	7
ACACCCTAGACTCGGA-1_MS377_A2D2	-17.80349621	-14.45564698	6B	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	2207	3858	0.009590461	0.013737688	7	6B	IN-SST	32	7	7
ACACCCTAGCGTCAAG-1_MS377_A2D2	-18.50612867	19.43098319	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1688	2943	0.003737683	0.006795787	7	8	Astrocytes	32	7	7
ACACCGGAGTTCCACA-1_MS377_A2D2	5.054403169	-10.11012781	12	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1757	2891	0.008301626	0.003459011	7	12	EN-MIX	32	7	7
ACACCGGGTATATGAG-1_MS377_A2D2	3.591299879	-13.89542009	4	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	2505	4597	0.003698064	0.007613661	7	L2-3	EN-L2-3-MS	32	7	7
ACACCGGGTCACAAGG-1_MS377_A2D2	-24.04159038	10.04197487	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1077	1581	0.008222644	0.011385199	7	8	Astrocytes	32	7	7
ACACTGAGTAGCGCTC-1_MS377_A2D2	6.193834708	20.72698127	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	997	1472	0.001358696	0.005434783	7	oligos	OL-Cntl	32	7	7
ACACTGATCCGCGTTT-1_MS377_A2D2	30.77841006	-14.82746042	2	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	3394	7600	0.056842105	0.005394737	7	2	EN-L4	32	7	7
ACAGCCGTCAGTACGT-1_MS377_A2D2	23.79186006	-12.42315892	3	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	2914	5261	0.010264208	0.006082494	7	3	EN-L5-6	32	7	7
ACAGCTAGTAGCCTCG-1_MS377_A2D2	-33.86359335	-10.24239902	9	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	950	1411	0.000708717	0.003543586	7	9	OPC	32	7	7
ACAGCTATCAAGCCTA-1_MS377_A2D2	-22.87719017	8.462781555	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	977	1417	0.004234298	0.016937191	7	8	Astrocytes	32	7	7
ACAGCTATCACGACTA-1_MS377_A2D2	-30.11049833	-2.521469559	9	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1569	2595	0.006936416	0.007321773	7	9	OPC	32	7	7
ACATACGAGGATGGAA-1_MS377_A2D2	-18.39849642	-5.924948429	13B	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	3734	7587	0.006853829	0.012389614	7	13B	IN-SV2C	32	7	7
ACATACGCAGCTCGAC-1_MS377_A2D2	-27.97381162	9.279036126	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	773	1100	0.002727273	0.004545455	7	8	Astrocytes	32	7	7
ACATACGTCCGGCACA-1_MS377_A2D2	0.573724925	22.57205152	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	876	1308	0.003058104	0.008409786	7	oligos	OL-Cntl	32	7	7
ACATACGTCCTGTACC-1_MS377_A2D2	14.39234433	-21.64476475	4	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	6707	21372	0.009311248	0.010340633	7	L2-3	EN-L2-3-MS	32	7	7
ACATACGTCGAATCCA-1_MS377_A2D2	0.199077376	24.19382817	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	789	1083	0.006463527	0.004616805	7	oligos	OL-Cntl	32	7	7
ACATCAGAGATAGTCA-1_MS377_A2D2	19.34700211	-18.02272931	4	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	4812	11050	0.019638009	0.010859729	7	L2-3	EN-L2-3-MS	32	7	7
ACATGGTCAGGCGATA-1_MS377_A2D2	-2.438673088	22.97367372	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	735	1043	0.005752637	0.005752637	7	oligos	OL-Cntl	32	7	7
ACATGGTGTAGGCTGA-1_MS377_A2D2	32.42842779	14.72328526	14	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	879	1166	0.000857633	0.063464837	7	14	Microglia	32	7	7
ACATGGTTCGGCGCTA-1_MS377_A2D2	-5.198175174	-10.14984367	13B	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1016	1618	0.01421508	0.002472188	7	13B	IN-SV2C	32	7	7
ACCAGTAAGATGTGGC-1_MS377_A2D2	0.833650124	26.58902248	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	879	1277	0.001566171	0.005481597	7	oligos	OL-Cntl	32	7	7
ACCAGTAAGGGATGGG-1_MS377_A2D2	-25.17530693	9.945867679	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	935	1370	0.002919708	0.008029197	7	8	Astrocytes	32	7	7
ACCAGTACATCACAAC-1_MS377_A2D2	-0.101456676	24.09736403	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	700	1017	0.000983284	0.007866273	7	oligos	OL-Cntl	32	7	7
ACCAGTACATTGAGCT-1_MS377_A2D2	-3.912177978	20.38839487	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	780	1110	0.008108108	0.012612613	7	oligos	OL-Cntl	32	7	7
ACCAGTAGTCATACTG-1_MS377_A2D2	9.308918366	-13.94505527	4	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	3286	6499	0.008001231	0.015694722	7	L2-3	EN-L2-3-MS	32	7	7
ACCAGTATCCTTCAAT-1_MS377_A2D2	-20.08237934	17.99932514	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1436	2477	0.005248284	0.002422285	7	8	Astrocytes	32	7	7
ACCCACTTCTACTTAC-1_MS377_A2D2	-11.72139363	-17.39635081	6B	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1134	1849	0.02433748	0.004867496	7	6B	IN-SST	32	7	7
ACCGTAAAGTCTCAAC-1_MS377_A2D2	6.15414997	25.41266215	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	939	1348	0.002967359	0.005934718	7	oligos	OL-Cntl	32	7	7
ACCGTAAGTACACCGC-1_MS377_A2D2	-25.62709523	-17.90083556	6B	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	2931	6256	0.033407928	0.004795396	7	6B	IN-SST	32	7	7
ACCGTAAGTAGCCTCG-1_MS377_A2D2	21.83121114	-16.95952103	3	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	5833	16131	0.018225776	0.010414729	7	3	EN-L5-6	32	7	7
ACCGTAAGTATATGAG-1_MS377_A2D2	14.03743562	-15.84442974	4	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	6136	15299	0.0104582	0.013726387	7	L2-3	EN-L2-3-MS	32	7	7
ACCTTTAAGACGACGT-1_MS377_A2D2	-19.07594637	-23.09737014	6A	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	2179	4034	0.009419931	0.003470501	7	6A	IN-PV	32	7	7
ACCTTTAAGATGCCTT-1_MS377_A2D2	18.05008198	-17.92954972	4	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	4546	11737	0.021640964	0.004345233	7	L2-3	EN-L2-3-MS	32	7	7
ACCTTTAAGCGTTCCG-1_MS377_A2D2	-31.39502698	12.26493926	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	891	1253	0.004788508	0.011971269	7	8	Astrocytes	32	7	7
ACCTTTATCAGCGACC-1_MS377_A2D2	-28.59979004	11.10028942	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	976	1465	0.00887372	0.000682594	7	8	Astrocytes	32	7	7
ACCTTTATCTCACATT-1_MS377_A2D2	18.38651186	16.50478989	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1123	1856	0.001077586	0.003771552	7	oligos	OL-Cntl	32	7	7
ACGAGCCAGCAGCCTC-1_MS377_A2D2	7.203275782	-13.44924638	4	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	2734	5093	0.011780876	0.01040644	7	L2-3	EN-L2-3-MS	32	7	7
ACGATGTCACCTCGTT-1_MS377_A2D2	-3.172395523	23.26315321	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	729	1032	0.000968992	0.009689922	7	oligos	OL-Cntl	32	7	7
ACGCAGCTCACCCGAG-1_MS377_A2D2	7.366241423	-14.473472	4	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	2823	5469	0.009873834	0.00603401	7	L2-3	EN-L2-3-MS	32	7	7
ACGCAGCTCAGAGGTG-1_MS377_A2D2	-26.14800597	-9.7918839	9	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1003	1353	0.005912786	0.007390983	7	9	OPC	32	7	7
ACGCAGCTCTCCAGGG-1_MS377_A2D2	10.93409768	-20.16451727	4	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	3931	9967	0.010534765	0.004514899	7	L2-3	EN-L2-3-MS	32	7	7
ACGCCAGCATGCCCGA-1_MS377_A2D2	30.71568034	-11.01234544	2	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	3610	8950	0.036536313	0.003240223	7	2	EN-L4	32	7	7
ACGCCAGGTGAAAGAG-1_MS377_A2D2	32.66771332	-12.12233067	2	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	3367	6610	0.01225416	0.006656581	7	2	EN-L4	32	7	7
ACGCCGACAGTACACT-1_MS377_A2D2	-6.595522161	-32.69834752	16	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	776	1107	0.08401084	0.005420054	7	16	EN-PYR	32	7	7
ACGCCGATCAACACCA-1_MS377_A2D2	16.72753165	-9.887983696	3	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	2673	5387	0.022090217	0.004083906	7	3	EN-L5-6	32	7	7
ACGGAGAAGAAACCGC-1_MS377_A2D2	18.54920033	-20.28007786	4	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	3526	7747	0.01045566	0.006325029	7	L2-3	EN-L2-3-MS	32	7	7
ACGGAGAGTGACGCCT-1_MS377_A2D2	33.49025136	-10.88596816	2	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	3011	6099	0.0050828	0.006558452	7	2	EN-L4	32	7	7
ACGGCCAAGCTACCGC-1_MS377_A2D2	12.72894162	-14.7541886	4	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	4193	9708	0.022867738	0.007622579	7	L2-3	EN-L2-3-MS	32	7	7
ACGGCCAAGGACAGAA-1_MS377_A2D2	-5.816794673	14.82251518	5	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	980	1372	0.009475219	0.011661808	7	oligos	OL-MS-1	32	7	7
ACGGGCTGTGCATCTA-1_MS377_A2D2	19.09582291	-17.18215596	4	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	4964	12813	0.01646765	0.006087567	7	L2-3	EN-L2-3-MS	32	7	7
ACGGGCTTCAACGCTA-1_MS377_A2D2	7.690909446	19.09145656	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1157	1703	0.001174398	0.008807986	7	oligos	OL-Cntl	32	7	7
ACGGGCTTCAGTACGT-1_MS377_A2D2	34.50112455	-3.449094559	2	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	3260	7109	0.003376002	0.004642003	7	2	EN-L4	32	7	7
ACGGGCTTCTAGAGTC-1_MS377_A2D2	6.926473476	25.4674427	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	952	1356	0.002212389	0.005899705	7	oligos	OL-Cntl	32	7	7
ACGTCAAAGCGATAGC-1_MS377_A2D2	-3.474310392	20.38432892	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	743	1080	0.006481481	0.009259259	7	oligos	OL-Cntl	32	7	7
ACGTCAAAGGAATCGC-1_MS377_A2D2	19.18813148	-16.30458087	4	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	4202	9527	0.029495119	0.00671775	7	L2-3	EN-L2-3-MS	32	7	7
ACGTCAACAATCAGAA-1_MS377_A2D2	-30.18427258	-2.756329547	9	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1395	2210	0.003167421	0.005882353	7	9	OPC	32	7	7
ACGTCAACAGTGGGAT-1_MS377_A2D2	-13.21298278	16.79911618	11	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1737	2733	0.001463593	0.011342847	7	11	Glia-MIX	32	7	7
ACGTCAAGTTTACTCT-1_MS377_A2D2	-12.83648989	-15.73240985	6B	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1383	2206	0.025838622	0.014505893	7	6B	IN-SST	32	7	7
ACGTCAATCTACGAGT-1_MS377_A2D2	-29.19266449	20.12702116	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1129	1675	0.001791045	0.006567164	7	8	Astrocytes	32	7	7
ACTATCTGTGCACGAA-1_MS377_A2D2	32.6107095	10.7240244	14	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	730	1064	0.015977444	0.030075188	7	14	Microglia	32	7	7
ACTATCTTCAGCTGGC-1_MS377_A2D2	6.614561906	22.3288427	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	887	1296	0.000771605	0.00617284	7	oligos	OL-Cntl	32	7	7
ACTGAACAGGCCCTCA-1_MS377_A2D2	13.41309637	-15.82427901	4	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	5411	13435	0.009973949	0.01153703	7	L2-3	EN-L2-3-MS	32	7	7
ACTGAACAGTGGGATC-1_MS377_A2D2	23.55767183	-6.101609384	2	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	3126	6247	0.002561229	0.006883304	7	2	EN-L4	32	7	7
ACTGAACCATTGGTAC-1_MS377_A2D2	-16.06382023	13.91833454	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1659	2896	0.001035912	0.006906077	7	8	Astrocytes	32	7	7
ACTGAACTCCTCGCAT-1_MS377_A2D2	21.95497425	18.37703895	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1137	1745	0.001146132	0.002292264	7	oligos	OL-Cntl	32	7	7
ACTGAGTAGGCCCGTT-1_MS377_A2D2	-2.971791502	20.38593255	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	693	1020	0.001960784	0.006862745	7	oligos	OL-Cntl	32	7	7
ACTGAGTCATGGTCAT-1_MS377_A2D2	7.964519449	25.00278504	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1135	1693	0.00472534	0.007088009	7	oligos	OL-Cntl	32	7	7
ACTGATGCAGTCGATT-1_MS377_A2D2	-11.77828385	-7.650310362	13B	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1941	3002	0.018654231	0.011325783	7	13B	IN-SV2C	32	7	7
ACTGATGCATCGACGC-1_MS377_A2D2	11.80068218	-24.93394044	4	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	3051	6374	0.006432382	0.004235959	7	L2-3	EN-L2-3-MS	32	7	7
ACTGATGGTTCTCATT-1_MS377_A2D2	-23.25072107	10.25496764	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1228	1729	0.007518797	0.009832273	7	8	Astrocytes	32	7	7
ACTGATGTCACATAGC-1_MS377_A2D2	10.48656923	-16.3414017	4	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	4060	9553	0.010677274	0.00617607	7	L2-3	EN-L2-3-MS	32	7	7
ACTGATGTCCGAACGC-1_MS377_A2D2	19.72393208	-19.92889514	3	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	5279	15891	0.049902461	0.002265433	7	3	EN-L5-6	32	7	7
ACTGCTCGTTCGTCTC-1_MS377_A2D2	10.75923409	-17.15182763	4	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	4520	10867	0.010766541	0.013159106	7	L2-3	EN-L2-3-MS	32	7	7
ACTGCTCTCCACTCCA-1_MS377_A2D2	27.67661329	6.984647806	15BA	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1160	1722	0.029616725	0.042392567	7	15BA	Stromal cells	32	7	7
ACTGCTCTCTCGATGA-1_MS377_A2D2	-18.89138202	-6.454875497	13B	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	3171	6570	0.03500761	0.005631659	7	13B	IN-SV2C	32	7	7
ACTGTCCGTAAACCTC-1_MS377_A2D2	37.57965647	10.37963961	14	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	894	1167	0.00428449	0.013710368	7	14	Microglia	32	7	7
ACTTGTTAGTAATCCC-1_MS377_A2D2	-18.86736896	7.444337674	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	977	1435	0.005574913	0.003484321	7	8	Astrocytes	32	7	7
ACTTGTTCAAGGTGTG-1_MS377_A2D2	21.42244597	-3.392939721	2	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	2615	5204	0.050153728	0.004419677	7	2	EN-L4	32	7	7
ACTTGTTCACTCTGTC-1_MS377_A2D2	-4.873549633	-34.85688898	16	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	815	1099	0.041856233	0.023657871	7	16	EN-PYR	32	7	7
ACTTGTTGTAAGTGGC-1_MS377_A2D2	-23.5141876	10.1244916	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1148	1709	0.0046811	0.006436513	7	8	Astrocytes	32	7	7
ACTTGTTTCCAGGGCT-1_MS377_A2D2	-23.8818658	16.03946953	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1346	2116	0.00094518	0.008506616	7	8	Astrocytes	32	7	7
ACTTGTTTCTGGTGTA-1_MS377_A2D2	11.50128356	18.68113663	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1017	1591	0.000628536	0.006285355	7	oligos	OL-Cntl	32	7	7
ACTTTCAGTCGCATCG-1_MS377_A2D2	14.0666966	18.87011357	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	988	1470	0.005442177	0.008163265	7	oligos	OL-Cntl	32	7	7
AGAATAGCATCCAACA-1_MS377_A2D2	-3.720413978	18.15123316	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	912	1292	0.002321981	0.021671827	7	oligos	OL-Cntl	32	7	7
AGAATAGTCAGTCCCT-1_MS377_A2D2	-17.37240757	-2.934884847	13A	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	3168	6224	0.019440874	0.012050129	7	13A	IN-VIP	32	7	7
AGACGTTCATGATCCA-1_MS377_A2D2	3.647332583	21.58511841	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	806	1213	0.002473207	0.014014839	7	oligos	OL-Cntl	32	7	7
AGACGTTTCATTCACT-1_MS377_A2D2	9.444575589	20.35541575	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	932	1414	0.004950495	0.005657709	7	oligos	OL-Cntl	32	7	7
AGAGCGATCGCATGGC-1_MS377_A2D2	33.34014505	-18.63127238	2	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	4019	8715	0.025243832	0.011474469	7	2	EN-L4	32	7	7
AGAGCGATCTTACCTA-1_MS377_A2D2	-29.88957249	-11.77032764	9	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	881	1271	0.004720692	0.008654603	7	9	OPC	32	7	7
AGAGCTTCAGAGCCAA-1_MS377_A2D2	-1.310532727	26.05351244	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	731	1009	0.001982161	0.006937562	7	oligos	OL-Cntl	32	7	7
AGAGTGGAGCTGATAA-1_MS377_A2D2	-24.70704896	7.057525284	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	847	1133	0.001765225	0.015887026	7	8	Astrocytes	32	7	7
AGAGTGGAGGCACATG-1_MS377_A2D2	6.369450764	-16.71282647	4	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	3488	7226	0.004151675	0.014807639	7	L2-3	EN-L2-3-MS	32	7	7
AGAGTGGTCCCAAGTA-1_MS377_A2D2	-2.648509342	21.67082697	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	788	1038	0.005780347	0.009633911	7	oligos	OL-Cntl	32	7	7
AGAGTGGTCGGTGTTA-1_MS377_A2D2	-32.08198181	-11.4873078	9	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1013	1510	0.001986755	0.003311258	7	9	OPC	32	7	7
AGATCTGAGACCTAGG-1_MS377_A2D2	3.662738448	23.97346595	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	799	1179	0.004240882	0.010178117	7	oligos	OL-Cntl	32	7	7
AGATCTGAGACTACAA-1_MS377_A2D2	11.84653236	24.35287607	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	812	1253	0.000798085	0.005586592	7	oligos	OL-Cntl	32	7	7
AGATCTGAGTGTACTC-1_MS377_A2D2	30.76090207	-5.862414436	2	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	3576	8752	0.009483547	0.005484461	7	2	EN-L4	32	7	7
AGATCTGTCAGCTCTC-1_MS377_A2D2	13.96023866	20.53596198	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	973	1548	0.002583979	0.010981912	7	oligos	OL-Cntl	32	7	7
AGATCTGTCATCATTC-1_MS377_A2D2	27.55080639	4.795664486	15BA	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1019	1423	0.027406887	0.014054814	7	15BA	Stromal cells	32	7	7
AGATTGCTCCAGGGCT-1_MS377_A2D2	15.51646757	-17.80494337	4	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	4492	11771	0.017670546	0.005691955	7	L2-3	EN-L2-3-MS	32	7	7
AGCAGCCAGATCCCAT-1_MS377_A2D2	6.391077998	-14.5827592	4	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	2717	5552	0.007564841	0.009726225	7	L2-3	EN-L2-3-MS	32	7	7
AGCAGCCCACGGTAGA-1_MS377_A2D2	5.242351491	16.70784479	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1010	1443	0.002079002	0.009009009	7	oligos	OL-Cntl	32	7	7
AGCAGCCCAGGTCTCG-1_MS377_A2D2	5.751708752	0.31748738	16	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1149	1715	0.055976676	0.011661808	7	16	EN-PYR	32	7	7
AGCAGCCGTAGAGGAA-1_MS377_A2D2	16.63300475	10.92930878	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1634	2636	0.008345979	0.010622155	7	oligos	OL-Cntl	32	7	7
AGCATACCACAGATTC-1_MS377_A2D2	-22.64891637	-24.19097475	6A	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	3414	7866	0.021612001	0.006229341	7	6A	IN-PV	32	7	7
AGCATACCATAGACTC-1_MS377_A2D2	22.70034792	16.85158645	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1336	2059	0.002914036	0.009713453	7	oligos	OL-Cntl	32	7	7
AGCCTAAAGTTAACGA-1_MS377_A2D2	33.44530781	10.62113339	14	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	840	1150	0.004347826	0.015652174	7	14	Microglia	32	7	7
AGCCTAACATTGGGCC-1_MS377_A2D2	9.935763907	-4.092865049	2	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	3119	6153	0.012514221	0.011214042	7	2	EN-L4	32	7	7
AGCGGTCCAGACAAAT-1_MS377_A2D2	-25.52896587	11.83650983	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1108	1597	0.00313087	0.007514089	7	8	Astrocytes	32	7	7
AGCGGTCGTACCGGCT-1_MS377_A2D2	-0.522439812	22.12760753	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	758	1045	0.002870813	0.012440191	7	oligos	OL-Cntl	32	7	7
AGCGTATAGAAGGTGA-1_MS377_A2D2	-2.75449802	23.29244843	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	786	1045	0.009569378	0.003827751	7	oligos	OL-Cntl	32	7	7
AGCTCCTCAGTCCTTC-1_MS377_A2D2	5.486719687	20.22022903	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	906	1332	0	0.00975976	7	oligos	OL-Cntl	32	7	7
AGCTCCTGTGGGTATG-1_MS377_A2D2	29.58811029	9.148217571	15DB	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	586	1126	0.004440497	0.086145648	7	15DB	B cells	32	7	7
AGCTCTCAGGCTCTTA-1_MS377_A2D2	20.95752848	-3.501078811	2	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	2145	3762	0.034556087	0.002126528	7	2	EN-L4	32	7	7
AGCTCTCAGGTAAACT-1_MS377_A2D2	-4.778486744	-34.78878841	16	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	733	1054	0.093927894	0.014231499	7	16	EN-PYR	32	7	7
AGCTCTCGTACCGTTA-1_MS377_A2D2	-23.51215702	14.78879166	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1245	1916	0.004697286	0.003131524	7	8	Astrocytes	32	7	7
AGCTCTCTCGTGACAT-1_MS377_A2D2	8.300827242	19.26909217	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1257	1973	0.01064369	0.004054739	7	oligos	OL-Cntl	32	7	7
AGCTTGACAAGCTGGA-1_MS377_A2D2	-14.87993412	-18.42575057	6B	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1556	2897	0.002416293	0.006213324	7	6B	IN-SST	32	7	7
AGCTTGACAGATGGGT-1_MS377_A2D2	-18.80314658	7.495166841	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1016	1461	0.003422313	0.009582478	7	8	Astrocytes	32	7	7
AGGCCACCAACTGCTA-1_MS377_A2D2	4.604591346	22.26114496	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	865	1279	0.002345582	0.011727912	7	oligos	OL-Cntl	32	7	7
AGGCCACGTAACGACG-1_MS377_A2D2	-16.18146596	17.70490433	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1834	2909	0.017875559	0.012375387	7	8	Astrocytes	32	7	7
AGGCCGTGTATAGGGC-1_MS377_A2D2	-30.12693241	9.412279595	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	896	1305	0.033716475	0.011494253	7	8	Astrocytes	32	7	7
AGGCCGTGTGTTGAGG-1_MS377_A2D2	-17.50990059	20.38040912	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1671	2657	0.003763643	0.008656379	7	8	Astrocytes	32	7	7
AGGGATGAGATCTGCT-1_MS377_A2D2	18.40361434	-9.553860658	3	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	2518	4944	0.001011327	0.004854369	7	3	EN-L5-6	32	7	7
AGGGATGTCGCTGATA-1_MS377_A2D2	-28.19654049	-6.008182568	9	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1167	1739	0.012650949	0.016101208	7	9	OPC	32	7	7
AGGGTGACACGTAAGG-1_MS377_A2D2	28.63694418	-13.41408214	2	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	4936	12588	0.028995869	0.009135685	7	2	EN-L4	32	7	7
AGGTCATAGAGGTTGC-1_MS377_A2D2	-20.79689091	23.79601463	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1750	3199	0.00406377	0.003438575	7	8	Astrocytes	32	7	7
AGGTCCGAGGCCCGTT-1_MS377_A2D2	32.68331712	-14.03848356	2	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	3275	6715	0.020997766	0.006701415	7	2	EN-L4	32	7	7
AGGTCCGCAGACTCGC-1_MS377_A2D2	-11.19012149	-38.01971414	16	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1585	2658	0.098570354	0.024078254	7	16	EN-PYR	32	7	7
AGGTCCGTCTACTCAT-1_MS377_A2D2	-17.76865337	19.37564606	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1322	2342	0.000853971	0.014090521	7	8	Astrocytes	32	7	7
AGTAGTCAGTGTCTCA-1_MS377_A2D2	-3.902134894	18.31477589	5	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	988	1432	0.002094972	0.011173184	7	oligos	OL-MS-1	32	7	7
AGTAGTCGTATAGTAG-1_MS377_A2D2	8.973638886	-4.004779216	12	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1994	3383	0.036949453	0.022465268	7	12	EN-MIX	32	7	7
AGTAGTCGTCATTAGC-1_MS377_A2D2	32.48806224	-13.22136556	2	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	2912	5762	0.020305449	0.006942034	7	2	EN-L4	32	7	7
AGTGAGGAGTCCGTAT-1_MS377_A2D2	8.439999007	-16.9833489	4	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	4220	8883	0.007542497	0.024653833	7	L2-3	EN-L2-3-MS	32	7	7
AGTGAGGCACAGAGGT-1_MS377_A2D2	9.791476576	9.427542852	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1284	2088	0.007662835	0.019157088	7	oligos	OL-Cntl	32	7	7
AGTGGGAAGCACCGTC-1_MS377_A2D2	21.71586561	-14.00386151	3	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	2959	5509	0.043383554	0.012161917	7	3	EN-L5-6	32	7	7
AGTGGGAAGTCGAGTG-1_MS377_A2D2	-18.15079556	6.490370063	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	797	1062	0.001883239	0.001883239	7	8	Astrocytes	32	7	7
AGTGGGATCATCTGTT-1_MS377_A2D2	-33.37814566	-6.774590161	9	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1135	1765	0.002832861	0.003399433	7	9	OPC	32	7	7
AGTGTCAAGGATATAC-1_MS377_A2D2	-9.577534863	15.44317614	11	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1990	3021	0.00264813	0.010923535	7	11	Glia-MIX	32	7	7
AGTGTCACAAGTTGTC-1_MS377_A2D2	14.24348925	-15.88821989	4	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	5754	14201	0.013449757	0.010985142	7	L2-3	EN-L2-3-MS	32	7	7
AGTGTCACATCACAAC-1_MS377_A2D2	-21.07444458	8.93004239	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1071	1532	0.003916449	0.005874674	7	8	Astrocytes	32	7	7
AGTGTCAGTCTCTCTG-1_MS377_A2D2	-24.14122232	10.91803069	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1198	1819	0.004947774	0.001649258	7	8	Astrocytes	32	7	7
AGTTGGTAGACGCTTT-1_MS377_A2D2	-10.0913331	22.49059827	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1552	2234	0.002685765	0.009400179	7	8	Astrocytes	32	7	7
AGTTGGTCAAGCGCTC-1_MS377_A2D2	4.318279309	22.36520412	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	859	1269	0.001576044	0.009456265	7	oligos	OL-Cntl	32	7	7
AGTTGGTTCAACTCTT-1_MS377_A2D2	15.99422087	-7.314124468	3	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	2039	3820	0.004973822	0.007329843	7	3	EN-L5-6	32	7	7
AGTTGGTTCGTAGATC-1_MS377_A2D2	2.270521032	19.62435233	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	843	1282	0.00624025	0.017160686	7	oligos	OL-Cntl	32	7	7
ATAACGCAGGATTCGG-1_MS377_A2D2	-17.28989745	-4.487066476	13A	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	3940	8581	0.015732432	0.007924484	7	13A	IN-VIP	32	7	7
ATAACGCAGTTTCCTT-1_MS377_A2D2	-33.07530619	-9.908138801	9	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	991	1602	0.001248439	0.004369538	7	9	OPC	32	7	7
ATAACGCGTTGGTGGA-1_MS377_A2D2	17.66471663	-8.416631278	3	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	2146	3899	0.006668377	0.006924853	7	3	EN-L5-6	32	7	7
ATAAGAGCATGCAACT-1_MS377_A2D2	-26.11103525	-21.67884934	6A	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	3468	7743	0.038486375	0.007361488	7	6A	IN-PV	32	7	7
ATAAGAGTCGGCGCTA-1_MS377_A2D2	6.36991423	-9.604095386	12	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1625	2667	0.016122985	0.004124484	7	12	EN-MIX	32	7	7
ATAAGAGTCTCTTGAT-1_MS377_A2D2	-32.62503942	-8.20684171	9	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1049	1553	0.00128783	0.00901481	7	9	OPC	32	7	7
ATAGACCAGAGTCTGG-1_MS377_A2D2	16.12192659	17.53495902	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1183	1852	0.002159827	0.005399568	7	oligos	OL-Cntl	32	7	7
ATAGACCGTTGCGCAC-1_MS377_A2D2	25.32942616	9.087778957	15A	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	2434	4041	0.012868102	0.034149963	7	15A	Endo cells	32	7	7
ATCACGACAATTGCTG-1_MS377_A2D2	19.58379396	-21.78490486	3	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	4703	11485	0.010361341	0.008532869	7	3	EN-L5-6	32	7	7
ATCACGACAGGAATCG-1_MS377_A2D2	4.926886127	25.20766342	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	807	1197	0.000835422	0.005012531	7	oligos	OL-Cntl	32	7	7
ATCACGACAGGACGTA-1_MS377_A2D2	-11.5119891	-29.37729994	16	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1278	1828	0.024070022	0.019146608	7	16	EN-PYR	32	7	7
ATCATCTAGCTCTCGG-1_MS377_A2D2	23.09865205	14.13142598	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1455	2460	0.004065041	0.003252033	7	oligos	OL-Cntl	32	7	7
ATCATCTAGGATGCGT-1_MS377_A2D2	-9.802619119	-9.38897562	13B	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1321	2031	0.037912358	0.006400788	7	13B	IN-SV2C	32	7	7
ATCATCTCACCGCTAG-1_MS377_A2D2	-2.65709361	21.46293806	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	725	1028	0.006809339	0.016536965	7	oligos	OL-Cntl	32	7	7
ATCATCTGTCTAGTCA-1_MS377_A2D2	32.24231954	-16.84759219	2	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	4724	11095	0.021090581	0.012978819	7	2	EN-L4	32	7	7
ATCATGGAGTTATCGC-1_MS377_A2D2	6.826457861	-13.71486792	4	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	2762	5192	0.008474576	0.006163328	7	L2-3	EN-L2-3-MS	32	7	7
ATCATGGTCGCGCCAA-1_MS377_A2D2	-23.77314926	10.20759436	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1159	1737	0.004029937	0.004605642	7	8	Astrocytes	32	7	7
ATCATGGTCGTCACGG-1_MS377_A2D2	27.83894096	6.307444861	15BA	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1025	1492	0.019436997	0.02613941	7	15BA	Stromal cells	32	7	7
ATCCACCTCCTCAACC-1_MS377_A2D2	-19.80675842	20.59013404	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1951	3638	0.004398021	0.004947774	7	8	Astrocytes	32	7	7
ATCCGAAAGACGCAAC-1_MS377_A2D2	-32.14638343	-12.70396495	9	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	806	1130	0.004424779	0.001769912	7	9	OPC	32	7	7
ATCCGAAAGCTAACAA-1_MS377_A2D2	-19.08974481	7.891958192	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	918	1347	0	0.008166295	7	8	Astrocytes	32	7	7
ATCCGAAGTCATGCAT-1_MS377_A2D2	5.657751365	30.13388104	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	743	1162	0.00172117	0.014629948	7	oligos	OL-Cntl	32	7	7
ATCGAGTAGGAGCGAG-1_MS377_A2D2	16.77415188	-14.16563506	4	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	5215	12719	0.015410017	0.014309301	7	L2-3	EN-L2-3-MS	32	7	7
ATCGAGTCATCGATGT-1_MS377_A2D2	10.97959894	-15.40164913	4	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	3439	7314	0.015996719	0.00669948	7	L2-3	EN-L2-3-MS	32	7	7
ATCGAGTGTGGTACAG-1_MS377_A2D2	4.945023451	-11.76344899	4	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	2110	3638	0.00522265	0.009895547	7	L2-3	EN-L2-3-MS	32	7	7
ATCGAGTGTTCCATGA-1_MS377_A2D2	-24.15334814	10.1770261	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1104	1637	0.003054368	0.012217471	7	8	Astrocytes	32	7	7
ATCTACTAGCGTAATA-1_MS377_A2D2	22.69054784	10.59473452	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1740	2824	0.000708215	0.008144476	7	oligos	OL-Cntl	32	7	7
ATCTACTTCGTGTAGT-1_MS377_A2D2	9.278144632	-1.464230558	12	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1201	1704	0.082159624	0.007042254	7	12	EN-MIX	32	7	7
ATCTGCCCAATCGGTT-1_MS377_A2D2	14.00241802	-27.04946105	3	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	2534	5053	0.010884623	0.004749654	7	3	EN-L5-6	32	7	7
ATCTGCCGTTGGTGGA-1_MS377_A2D2	33.04608624	11.02174913	14	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	879	1221	0.029484029	0.027027027	7	14	Microglia	32	7	7
ATCTGCCTCTAACTTC-1_MS377_A2D2	-17.80260057	19.09590372	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1538	2503	0.000799041	0.013184179	7	8	Astrocytes	32	7	7
ATGCGATAGTGCGTGA-1_MS377_A2D2	21.91384016	-1.873966187	2	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	2269	4113	0.019450523	0.002431315	7	2	EN-L4	32	7	7
ATGCGATAGTGTACCT-1_MS377_A2D2	-2.820306721	22.74803752	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	788	1121	0.002676182	0.017841213	7	oligos	OL-Cntl	32	7	7
ATGCGATGTGGCGAAT-1_MS377_A2D2	-5.579561161	17.69060213	5	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	899	1339	0.002987304	0.016430172	7	oligos	OL-MS-1	32	7	7
ATGCGATTCATAGCAC-1_MS377_A2D2	13.28104222	2.008955443	12	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	819	1111	0.053105311	0.00180018	7	12	EN-MIX	32	7	7
ATGCGATTCTCCGGTT-1_MS377_A2D2	-0.858906956	21.86795822	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	753	1042	0.002879079	0.012476008	7	oligos	OL-Cntl	32	7	7
ATGGGAGAGATGCCTT-1_MS377_A2D2	-12.94462298	7.239630446	16	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1803	2697	0.03003337	0.020022247	7	16	EN-PYR	32	7	7
ATGGGAGAGTGTACCT-1_MS377_A2D2	-7.365385385	-35.66627987	16	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1005	1387	0.055515501	0.020908435	7	16	EN-PYR	32	7	7
ATGGGAGAGTTAACGA-1_MS377_A2D2	9.42010473	-3.05740771	12	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	2350	4196	0.021925643	0.009532888	7	12	EN-MIX	32	7	7
ATGGGAGCAATCCAAC-1_MS377_A2D2	19.9727127	-3.731011525	12	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1638	2554	0.029757244	0.007830854	7	12	EN-MIX	32	7	7
ATGGGAGCATGATCCA-1_MS377_A2D2	-2.897988244	21.77019083	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	867	1311	0.00228833	0.016018307	7	oligos	OL-Cntl	32	7	7
ATGTGTGCATGCCTTC-1_MS377_A2D2	5.645966174	20.23421456	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1063	1602	0.003121099	0.006242197	7	oligos	OL-Cntl	32	7	7
ATGTGTGGTGATGATA-1_MS377_A2D2	23.45831164	18.07944745	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1439	2207	0.001359311	0.00362483	7	oligos	OL-Cntl	32	7	7
ATTATCCGTTCTGGTA-1_MS377_A2D2	-31.56191852	12.79136711	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	938	1366	0.003660322	0.002196193	7	8	Astrocytes	32	7	7
ATTATCCTCGAACTGT-1_MS377_A2D2	5.838311583	21.62477882	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	840	1208	0.003311258	0.006622517	7	oligos	OL-Cntl	32	7	7
ATTCTACCACTGTTAG-1_MS377_A2D2	18.99997919	-16.46300724	4	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	4799	12191	0.022803708	0.007628578	7	L2-3	EN-L2-3-MS	32	7	7
ATTCTACTCTGGTGTA-1_MS377_A2D2	-28.53648885	8.361390585	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	714	1039	0.010587103	0.009624639	7	8	Astrocytes	32	7	7
ATTGGACAGTACGTAA-1_MS377_A2D2	-11.84095061	-27.39251214	16	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	843	1065	0.030046948	0.03943662	7	16	EN-PYR	32	7	7
ATTGGACGTCTACCTC-1_MS377_A2D2	-17.53863007	-1.554553918	13A	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	3032	5620	0.009430605	0.021174377	7	13A	IN-VIP	32	7	7
ATTGGTGCAAAGCGGT-1_MS377_A2D2	-3.080265556	21.54133149	5	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	921	1295	0.004633205	0.019305019	7	oligos	OL-MS-1	32	7	7
ATTGGTGGTAATCACC-1_MS377_A2D2	-33.18780416	-4.302056115	9	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1309	2009	0.004977601	0.003982081	7	9	OPC	32	7	7
ATTGGTGTCTGAGTGT-1_MS377_A2D2	-1.818564011	20.43538341	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	757	1127	0.002661934	0.01242236	7	oligos	OL-Cntl	32	7	7
ATTTCTGGTGAAAGAG-1_MS377_A2D2	8.808918627	1.563047868	16	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	869	1323	0.076341648	0.008314437	7	16	EN-PYR	32	7	7
ATTTCTGGTGGTTTCA-1_MS377_A2D2	15.77948145	14.885011	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1087	1681	0.001784652	0.008328376	7	oligos	OL-Cntl	32	7	7
ATTTCTGGTGTGGCTC-1_MS377_A2D2	19.29808388	-19.65670401	3	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	3045	7192	0.020995551	0.006256952	7	3	EN-L5-6	32	7	7
ATTTCTGTCTAGAGTC-1_MS377_A2D2	11.64644434	21.8579263	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	907	1383	0.001446132	0.009399855	7	oligos	OL-Cntl	32	7	7
CAACCAAAGGACTGGT-1_MS377_A2D2	14.05601074	15.08531193	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1253	1939	0.00051573	0.006704487	7	oligos	OL-Cntl	32	7	7
CAACCAACAGGCTCAC-1_MS377_A2D2	-22.53865532	23.16034923	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1440	2234	0.004028648	0.005819158	7	8	Astrocytes	32	7	7
CAACCAACATCTATGG-1_MS377_A2D2	4.898704168	21.93627133	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	965	1495	0.002675585	0.008026756	7	oligos	OL-Cntl	32	7	7
CAACCAAGTCGAAAGC-1_MS377_A2D2	20.78435996	-3.764421448	2	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	2288	3913	0.023255814	0.005366726	7	2	EN-L4	32	7	7
CAACCAAGTTAGGGTG-1_MS377_A2D2	21.92626749	17.25403309	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1208	1854	0.000539374	0.006472492	7	oligos	OL-Cntl	32	7	7
CAACCAATCGATAGAA-1_MS377_A2D2	-4.906693966	18.89472974	5	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	842	1188	0.009259259	0.015151515	7	oligos	OL-MS-1	32	7	7
CAACCTCAGTACCGGA-1_MS377_A2D2	-3.908342319	-7.967619691	13A	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	717	1015	0.025615764	0.001970443	7	13A	IN-VIP	32	7	7
CAACCTCTCGCGATCG-1_MS377_A2D2	-18.52296652	8.420044739	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1034	1467	0.000681663	0.004771643	7	8	Astrocytes	32	7	7
CAACTAGAGGGCTTGA-1_MS377_A2D2	33.39005591	-7.461980275	2	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	5575	13818	0.001447387	0.007815892	7	2	EN-L4	32	7	7
CAACTAGGTTCAGACT-1_MS377_A2D2	19.05638436	-9.889301283	3	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	2156	4067	0.030243423	0.002704696	7	3	EN-L5-6	32	7	7
CAAGATCAGGCAGTCA-1_MS377_A2D2	31.30785316	-18.15437274	2	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	4615	10185	0.020618557	0.01443299	7	2	EN-L4	32	7	7
CAAGATCAGGTGTGGT-1_MS377_A2D2	6.639327731	20.20033717	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1032	1471	0.008157716	0.011556764	7	oligos	OL-Cntl	32	7	7
CAAGATCTCACCCGAG-1_MS377_A2D2	-16.73984514	-6.968764254	13B	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	2625	5072	0.01557571	0.004337539	7	13B	IN-SV2C	32	7	7
CAAGGCCGTAGGAGTC-1_MS377_A2D2	-17.50547215	19.95076939	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1546	2466	0.001216545	0.015004055	7	8	Astrocytes	32	7	7
CAAGGCCTCTGACCTC-1_MS377_A2D2	-10.29687008	-5.894192074	13A	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1850	3105	0.013848631	0.010305958	7	13A	IN-VIP	32	7	7
CAAGTTGCATGCTGGC-1_MS377_A2D2	2.53011504	-12.9998067	4	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	2302	4765	0.027911857	0.002728227	7	L2-3	EN-L2-3-MS	32	7	7
CAAGTTGGTGATGCCC-1_MS377_A2D2	27.47433313	-18.90381829	2	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	5084	13585	0.036510858	0.008686051	7	2	EN-L4	32	7	7
CACAAACAGAGCCTAG-1_MS377_A2D2	-24.90337021	15.42380247	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1193	1931	0.003625065	0.008285862	7	8	Astrocytes	32	7	7
CACAAACGTGCAGACA-1_MS377_A2D2	-3.256910696	22.41343329	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	725	1024	0.005859375	0.013671875	7	oligos	OL-Cntl	32	7	7
CACAAACTCACCATAG-1_MS377_A2D2	15.56944005	12.99900149	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1545	2363	0.004655099	0.007617435	7	oligos	OL-Cntl	32	7	7
CACACAAGTGGCCCTA-1_MS377_A2D2	19.83396518	-25.62409512	3	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	3451	7649	0.000915152	0.010066675	7	3	EN-L5-6	32	7	7
CACACAAGTGTGGCTC-1_MS377_A2D2	2.428776613	27.24069186	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	783	1101	0.000908265	0.003633061	7	oligos	OL-Cntl	32	7	7
CACACAATCGTATCAG-1_MS377_A2D2	-1.859865581	23.72428997	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	744	1029	0.005830904	0.006802721	7	oligos	OL-Cntl	32	7	7
CACACCTGTAAGAGAG-1_MS377_A2D2	-5.005693055	13.89238652	5	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	895	1273	0.009426551	0.033778476	7	oligos	OL-MS-1	32	7	7
CACACCTGTGAGTGAC-1_MS377_A2D2	-3.652891872	24.74939992	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	770	1052	0.00095057	0.010456274	7	oligos	OL-Cntl	32	7	7
CACACCTGTTGATTCG-1_MS377_A2D2	27.75582095	9.272006662	15A	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	989	1429	0.039888034	0.077676697	7	15A	Endo cells	32	7	7
CACACTCAGTACGCGA-1_MS377_A2D2	-26.8249002	-22.6930975	6A	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	4724	11813	0.032421908	0.008719208	7	6A	IN-PV	32	7	7
CACACTCGTTCTGTTT-1_MS377_A2D2	37.33599545	10.0652855	14	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	897	1263	0	0.014251781	7	14	Microglia	32	7	7
CACAGGCCAGGATCGA-1_MS377_A2D2	24.78283702	-14.13891845	3	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	4822	11675	0.028179872	0.008650964	7	3	EN-L5-6	32	7	7
CACAGGCTCCGTAGTA-1_MS377_A2D2	-5.038934971	13.13339443	5	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	816	1145	0.017467249	0.007860262	7	oligos	OL-MS-1	32	7	7
CACATAGAGCGTAGTG-1_MS377_A2D2	28.09777976	-12.91776396	2	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	3919	8340	0.016546763	0.007553957	7	2	EN-L4	32	7	7
CACATAGCACGTCAGC-1_MS377_A2D2	23.94362732	-20.28304251	3	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	4895	12233	0.005722227	0.009809532	7	3	EN-L5-6	32	7	7
CACATTTCATTCTTAC-1_MS377_A2D2	29.75467295	-11.78464395	2	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	4504	11982	0.025037556	0.005424804	7	2	EN-L4	32	7	7
CACATTTGTGTGGCTC-1_MS377_A2D2	-5.57715386	13.46222013	5	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	801	1156	0.010380623	0.021626298	7	oligos	OL-MS-1	32	7	7
CACATTTTCACCCTCA-1_MS377_A2D2	10.80801355	0.609973496	12	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	802	1201	0.012489592	0.008326395	7	12	EN-MIX	32	7	7
CACATTTTCTCACATT-1_MS377_A2D2	-13.94980844	-9.113135518	13B	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	2072	3840	0.011197917	0.003645833	7	13B	IN-SV2C	32	7	7
CACATTTTCTGTCTCG-1_MS377_A2D2	-22.76746195	12.39681767	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1149	1674	0.002986858	0.004181601	7	8	Astrocytes	32	7	7
CACCACTAGACGCTTT-1_MS377_A2D2	1.323129235	10.50240652	5	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1181	1890	0.011640212	0.01005291	7	oligos	OL-MS-1	32	7	7
CACCACTAGATATGGT-1_MS377_A2D2	4.481445282	-10.80099838	12	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1700	2921	0.015748031	0.00684697	7	12	EN-MIX	32	7	7
CACCACTAGCTAGTGG-1_MS377_A2D2	-15.80634246	-1.921116618	13A	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	2658	5044	0.022006344	0.01704996	7	13A	IN-VIP	32	7	7
CACCACTAGCTTCGCG-1_MS377_A2D2	23.29835322	-3.10555179	2	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	2391	4819	0.000415024	0.003112679	7	2	EN-L4	32	7	7
CACCACTTCTACTATC-1_MS377_A2D2	-6.453042388	-36.66417887	16	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	944	1343	0.052866716	0.018615041	7	16	EN-PYR	32	7	7
CACCAGGGTGTGAATA-1_MS377_A2D2	2.563951235	20.67226648	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	842	1253	0.001596169	0.0103751	7	oligos	OL-Cntl	32	7	7
CACCTTGAGTTGTCGT-1_MS377_A2D2	-13.6054334	17.65872635	11	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1316	2017	0.002478929	0.011403074	7	11	Glia-MIX	32	7	7
CACCTTGGTGCAGGTA-1_MS377_A2D2	-1.083705507	21.26036775	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	758	1057	0.003784295	0.009460738	7	oligos	OL-Cntl	32	7	7
CACCTTGTCAACTCTT-1_MS377_A2D2	-8.07355454	-5.639465553	13A	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1442	2639	0.022356953	0.003031451	7	13A	IN-VIP	32	7	7
CACTCCAAGACGCTTT-1_MS377_A2D2	-19.06091623	6.808882628	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	741	1078	0.004638219	0.003710575	7	8	Astrocytes	32	7	7
CACTCCATCAGCATGT-1_MS377_A2D2	-15.63693511	13.09568173	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1623	2701	0.002591633	0.007404665	7	8	Astrocytes	32	7	7
CACTCCATCCGAATGT-1_MS377_A2D2	11.26262444	24.91105275	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	818	1238	0.003231018	0.009693053	7	oligos	OL-Cntl	32	7	7
CAGAATCAGGCAAAGA-1_MS377_A2D2	6.846090131	-13.36887882	4	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	2797	5205	0.009798271	0.014024976	7	L2-3	EN-L2-3-MS	32	7	7
CAGAATCCACGCATCG-1_MS377_A2D2	8.244682242	-13.39784377	4	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	2675	4833	0.006000414	0.014069936	7	L2-3	EN-L2-3-MS	32	7	7
CAGAATCGTAAGAGAG-1_MS377_A2D2	-28.13737316	10.66812457	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	901	1222	0.017184943	0.005728314	7	8	Astrocytes	32	7	7
CAGAATCGTACCATCA-1_MS377_A2D2	15.05868176	-21.34192518	4	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	5769	17137	0.014763377	0.005718621	7	L2-3	EN-L2-3-MS	32	7	7
CAGAATCGTGTGACGA-1_MS377_A2D2	19.14868123	-17.96055389	4	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	5295	14047	0.023136613	0.007902043	7	L2-3	EN-L2-3-MS	32	7	7
CAGAGAGGTCGCATCG-1_MS377_A2D2	27.11158237	4.686251667	15BA	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	719	1011	0.004945598	0.012858556	7	15BA	Stromal cells	32	7	7
CAGAGAGTCGAATGGG-1_MS377_A2D2	32.58829431	-13.03081148	2	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	2734	5081	0.016138555	0.006691596	7	2	EN-L4	32	7	7
CAGATCAAGCCAGTTT-1_MS377_A2D2	-18.44209435	-5.797068114	13B	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	2715	5255	0.033111323	0.006470029	7	13B	IN-SV2C	32	7	7
CAGATCACAGACTCGC-1_MS377_A2D2	-0.334375126	22.6105761	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	748	1116	0.003584229	0.004480287	7	oligos	OL-Cntl	32	7	7
CAGATCAGTTCGAATC-1_MS377_A2D2	24.16081466	-17.44241858	3	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	6197	17942	0.020231858	0.011147029	7	3	EN-L5-6	32	7	7
CAGATCATCGCCCTTA-1_MS377_A2D2	4.898163465	16.3989016	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1045	1586	0.00630517	0.016393443	7	oligos	OL-Cntl	32	7	7
CAGATCATCGCCTGTT-1_MS377_A2D2	17.66170183	-18.83751972	4	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	3796	9284	0.026389487	0.005062473	7	L2-3	EN-L2-3-MS	32	7	7
CAGCAGCAGCGATCCC-1_MS377_A2D2	-31.75139562	2.913808056	9	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	2456	4529	0.003974387	0.004857584	7	9	OPC	32	7	7
CAGCAGCCATGCCCGA-1_MS377_A2D2	34.71781825	11.17475179	14	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	927	1145	0.012227074	0.018340611	7	14	Microglia	32	7	7
CAGCAGCGTTCGCGAC-1_MS377_A2D2	18.48223377	-20.22658133	3	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	2707	5481	0.026637475	0.004013866	7	3	EN-L5-6	32	7	7
CAGCAGCTCGGTTAAC-1_MS377_A2D2	12.65879461	15.54934038	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1151	1764	0.003401361	0.007936508	7	oligos	OL-Cntl	32	7	7
CAGCATAAGCTGCCCA-1_MS377_A2D2	22.69770691	15.71015842	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1373	2226	0.001347709	0.003144654	7	oligos	OL-Cntl	32	7	7
CAGCATAAGGTGATTA-1_MS377_A2D2	-15.5378763	10.82997142	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1372	2165	0.005542725	0.006928406	7	8	Astrocytes	32	7	7
CAGCATACAAGTAGTA-1_MS377_A2D2	16.09903494	6.117809876	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	2283	4314	0.006026889	0.010431154	7	oligos	OL-Cntl	32	7	7
CAGCATAGTAAACCTC-1_MS377_A2D2	27.26361561	-13.21684071	4	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	6080	18494	0.021898994	0.006488591	7	L2-3	EN-L2-3-MS	32	7	7
CAGCCGACACTGTCGG-1_MS377_A2D2	3.922012012	21.59682948	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	930	1374	0.000727802	0.009461426	7	oligos	OL-Cntl	32	7	7
CAGCCGACATGCAACT-1_MS377_A2D2	30.55954922	-12.14078323	2	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	3763	8593	0.028278832	0.007913418	7	2	EN-L4	32	7	7
CAGCGACAGAATGTGT-1_MS377_A2D2	-3.423888881	11.9060802	5	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	863	1254	0.015948963	0.015948963	7	oligos	OL-MS-1	32	7	7
CAGCGACCAGTCGTGC-1_MS377_A2D2	-1.79690448	22.03290347	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	804	1107	0.000903342	0.018066847	7	oligos	OL-Cntl	32	7	7
CAGCTAAAGCATGGCA-1_MS377_A2D2	-32.95156904	-3.834490351	9	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1517	2498	0.004803843	0.004803843	7	9	OPC	32	7	7
CAGCTAAAGTGAAGTT-1_MS377_A2D2	28.03712784	-13.016625	2	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	4438	10063	0.016893571	0.008546159	7	2	EN-L4	32	7	7
CAGCTAAGTTCGTGAT-1_MS377_A2D2	3.581283233	22.26834566	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	909	1307	0.006885998	0.003825555	7	oligos	OL-Cntl	32	7	7
CAGCTAATCCGTCATC-1_MS377_A2D2	-22.54927433	12.47290105	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1108	1589	0.006293266	0.011957206	7	8	Astrocytes	32	7	7
CAGCTGGCAGGGTATG-1_MS377_A2D2	-23.44238193	16.11037909	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1500	2447	0.002043318	0.011442583	7	8	Astrocytes	32	7	7
CAGGTGCAGAAGGTTT-1_MS377_A2D2	-23.65007622	10.42556788	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1066	1660	0.004216867	0.004819277	7	8	Astrocytes	32	7	7
CAGGTGCAGACCACGA-1_MS377_A2D2	-33.32866776	-8.965804114	9	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1047	1638	0.003663004	0.004884005	7	9	OPC	32	7	7
CAGGTGCAGCTCCTCT-1_MS377_A2D2	29.27309586	-16.25142031	2	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	5478	16533	0.039315309	0.006471905	7	2	EN-L4	32	7	7
CAGGTGCCAGCTCGCA-1_MS377_A2D2	16.76397556	-14.02116213	4	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	5509	14134	0.010612707	0.020234895	7	L2-3	EN-L2-3-MS	32	7	7
CAGTAACCACAACGTT-1_MS377_A2D2	-1.787809854	36.36783206	17	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	798	1149	0.00435161	0.006092254	7	oligos	OL-MS-2	32	7	7
CAGTAACGTAGAAGGA-1_MS377_A2D2	-22.52365172	-24.17288639	6A	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	3291	6751	0.016886387	0.00429566	7	6A	IN-PV	32	7	7
CAGTAACTCAACGGCC-1_MS377_A2D2	34.99543579	10.74670145	14	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	849	1086	0.004604052	0.015653775	7	14	Microglia	32	7	7
CAGTAACTCGAGCCCA-1_MS377_A2D2	-18.99160272	-23.49735582	6A	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	2319	4836	0.028949545	0.003722084	7	6A	IN-PV	32	7	7
CAGTCCTCACTGTTAG-1_MS377_A2D2	-12.58292369	15.09402183	11	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1174	1667	0.00359928	0.00539892	7	11	Glia-MIX	32	7	7
CAGTCCTGTTTCGCTC-1_MS377_A2D2	-25.10816343	9.106045025	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	924	1386	0.008658009	0.012265512	7	8	Astrocytes	32	7	7
CATATGGCACCAACCG-1_MS377_A2D2	11.98645678	-20.14343503	4	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	3462	7564	0.01454257	0.004627181	7	L2-3	EN-L2-3-MS	32	7	7
CATATGGGTTAGTGGG-1_MS377_A2D2	-20.63862184	-25.05349084	6A	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	3722	8658	0.003465003	0.002656503	7	6A	IN-PV	32	7	7
CATATTCGTACAGTTC-1_MS377_A2D2	-20.61805445	27.38667466	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	2135	3755	0.00159787	0.009054594	7	8	Astrocytes	32	7	7
CATCAAGCACTCGACG-1_MS377_A2D2	28.18253515	-10.15456798	2	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	3251	7466	0.026654166	0.004286097	7	2	EN-L4	32	7	7
CATCAAGTCAGTTGAC-1_MS377_A2D2	10.77524743	-14.36565111	4	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	3755	7796	0.014879425	0.018599282	7	L2-3	EN-L2-3-MS	32	7	7
CATCAAGTCATTTGGG-1_MS377_A2D2	-25.24006155	10.90766787	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	875	1328	0.003012048	0.012801205	7	8	Astrocytes	32	7	7
CATCAGACAGATCTGT-1_MS377_A2D2	13.66278406	20.28178059	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	993	1498	0.00400534	0.008678238	7	oligos	OL-Cntl	32	7	7
CATCAGACATCGTCGG-1_MS377_A2D2	-18.59482304	-0.2501394	13A	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	3389	6449	0.006047449	0.027446116	7	13A	IN-VIP	32	7	7
CATCAGACATTAGCCA-1_MS377_A2D2	18.74006518	-16.472085	4	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	5688	16363	0.018700727	0.006844711	7	L2-3	EN-L2-3-MS	32	7	7
CATCAGATCCAGAGGA-1_MS377_A2D2	-16.82319837	-2.159470541	13A	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	3059	5681	0.010737546	0.010737546	7	13A	IN-VIP	32	7	7
CATCCACAGCCACTAT-1_MS377_A2D2	-23.81577206	12.15201742	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1131	1745	0.006303725	0.006303725	7	8	Astrocytes	32	7	7
CATCCACAGCTGCAAG-1_MS377_A2D2	-7.156522376	-4.996248493	13A	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1546	2605	0.011516315	0.003838772	7	13A	IN-VIP	32	7	7
CATCCACAGGACGAAA-1_MS377_A2D2	-1.224352845	0.94074566	11	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	3961	7711	0.010374789	0.016340293	7	11	Glia-MIX	32	7	7
CATCCACCACACAGAG-1_MS377_A2D2	10.55475182	-19.99592022	4	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	4993	13809	0.011731479	0.004634659	7	L2-3	EN-L2-3-MS	32	7	7
CATCCACGTCTCTTAT-1_MS377_A2D2	7.04543772	-14.02117377	4	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	2622	5153	0.003493111	0.008732777	7	L2-3	EN-L2-3-MS	32	7	7
CATCGAAGTGAAATCA-1_MS377_A2D2	30.37803383	-11.0218791	2	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	3967	9201	0.024562548	0.005760243	7	2	EN-L4	32	7	7
CATCGAATCTACTATC-1_MS377_A2D2	-13.28166948	-23.86903789	6A	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1220	2172	0.025322284	0.001841621	7	6A	IN-PV	32	7	7
CATCGAATCTTCCTTC-1_MS377_A2D2	22.5093749	17.24714225	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1346	2113	0.003312825	0.005679129	7	oligos	OL-Cntl	32	7	7
CATCGGGGTCGAGTTT-1_MS377_A2D2	-26.96188238	-18.3502289	6B	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	3012	5861	0.023033612	0.015867599	7	6B	IN-SST	32	7	7
CATCGGGGTTTGGCGC-1_MS377_A2D2	-33.35135804	-8.348690176	9	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1193	1773	0.004512126	0.003948111	7	9	OPC	32	7	7
CATGACACATGACATC-1_MS377_A2D2	33.79833663	-16.73420743	2	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	6225	17208	0.013656439	0.015632264	7	2	EN-L4	32	7	7
CATGGCGCAGGATTGG-1_MS377_A2D2	-17.80330605	-5.89314813	13B	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	2568	4688	0.019197952	0.008959044	7	13B	IN-SV2C	32	7	7
CATGGCGGTCAGTGGA-1_MS377_A2D2	2.447512754	19.67587303	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	887	1277	0.003132341	0.013312451	7	oligos	OL-Cntl	32	7	7
CATGGCGTCCGTTGCT-1_MS377_A2D2	22.67269868	17.05222623	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1311	2045	0.002933985	0.006356968	7	oligos	OL-Cntl	32	7	7
CATTATCTCTTCAACT-1_MS377_A2D2	37.25618966	10.08502783	14	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	806	1058	0.010396975	0.017013233	7	14	Microglia	32	7	7
CATTCGCCAGCTCGCA-1_MS377_A2D2	-29.83994984	-21.962508	6A	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	5055	11941	0.022443681	0.016246546	7	6A	IN-PV	32	7	7
CATTCGCTCTCTAGGA-1_MS377_A2D2	11.60025678	-14.56145259	4	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	4250	9872	0.006482982	0.015295786	7	L2-3	EN-L2-3-MS	32	7	7
CCAATCCTCACATAGC-1_MS377_A2D2	16.46052707	14.98312943	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1223	1955	0.002046036	0.008695652	7	oligos	OL-Cntl	32	7	7
CCAATCCTCTGGGCCA-1_MS377_A2D2	31.16076666	-12.41810701	2	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	3569	7616	0.038602941	0.003151261	7	2	EN-L4	32	7	7
CCACGGACATGCAACT-1_MS377_A2D2	5.219170616	19.77912745	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1005	1476	0.004065041	0.01897019	7	oligos	OL-Cntl	32	7	7
CCACGGACATGGTCTA-1_MS377_A2D2	18.31365162	-16.63524554	4	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	5781	16191	0.025384473	0.004755728	7	L2-3	EN-L2-3-MS	32	7	7
CCACTACAGCAATATG-1_MS377_A2D2	13.32881611	-23.92304464	4	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	3739	9338	0.004926108	0.003748126	7	L2-3	EN-L2-3-MS	32	7	7
CCACTACAGGACTGGT-1_MS377_A2D2	-24.48576876	11.27500842	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1119	1631	0.001839362	0.008583691	7	8	Astrocytes	32	7	7
CCACTACCACCTCGGA-1_MS377_A2D2	1.898064681	22.06421498	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	895	1303	0.001534919	0.011511896	7	oligos	OL-Cntl	32	7	7
CCAGCGAAGCTGGAAC-1_MS377_A2D2	-3.394351856	17.69652003	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	869	1265	0.002371542	0.01027668	7	oligos	OL-Cntl	32	7	7
CCAGCGACACAACGCC-1_MS377_A2D2	0.900031576	22.21504587	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	905	1311	0.003051106	0.004576659	7	oligos	OL-Cntl	32	7	7
CCAGCGACACAGGTTT-1_MS377_A2D2	-19.0710317	19.8586579	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1652	2713	0.001105787	0.009952083	7	8	Astrocytes	32	7	7
CCATGTCAGTCGAGTG-1_MS377_A2D2	28.09839195	6.788950254	15BA	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	991	1439	0.003474635	0.031966644	7	15BA	Stromal cells	32	7	7
CCATTCGCATGAAGTA-1_MS377_A2D2	2.742337434	19.4554778	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	893	1343	0.009679821	0.006701415	7	oligos	OL-Cntl	32	7	7
CCATTCGGTCACTTCC-1_MS377_A2D2	33.34579407	-13.78793161	2	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	4312	10209	0.01195024	0.008521892	7	2	EN-L4	32	7	7
CCATTCGTCTTTACGT-1_MS377_A2D2	13.95781624	16.93570345	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1123	1681	0.001189768	0.017251636	7	oligos	OL-Cntl	32	7	7
CCCAATCGTCGATTGT-1_MS377_A2D2	22.15435851	-25.86680818	3	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	4682	12484	0.005527075	0.007369433	7	3	EN-L5-6	32	7	7
CCCAATCGTTGCGTTA-1_MS377_A2D2	-5.372259505	-34.70935464	16	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1003	1354	0.065731167	0.019940916	7	16	EN-PYR	32	7	7
CCCAATCTCAGTCAGT-1_MS377_A2D2	15.16605477	2.827862957	12	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	924	1427	0.004905396	0.003503854	7	12	EN-MIX	32	7	7
CCCAATCTCTCAAGTG-1_MS377_A2D2	-13.36271639	-37.46921241	16	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	2012	3425	0.088759124	0.013138686	7	16	EN-PYR	32	7	7
CCCAGTTAGGCAAAGA-1_MS377_A2D2	35.1574283	10.17412136	14	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	889	1119	0.000893655	0.014298481	7	14	Microglia	32	7	7
CCCAGTTGTAGCGTGA-1_MS377_A2D2	-18.86578367	6.757793691	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	714	1042	0.003838772	0.004798464	7	8	Astrocytes	32	7	7
CCCATACCACCTTGTC-1_MS377_A2D2	14.29220754	13.41178406	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1307	2160	0.005555556	0.011574074	7	oligos	OL-Cntl	32	7	7
CCCATACCAGGGCATA-1_MS377_A2D2	34.10310387	13.69317906	14	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1123	1560	0.01025641	0.026282051	7	14	Microglia	32	7	7
CCCATACGTGAGTATA-1_MS377_A2D2	4.40877946	21.64687535	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	907	1337	0.011219147	0.005235602	7	oligos	OL-Cntl	32	7	7
CCCATACGTTCTGTTT-1_MS377_A2D2	35.50334163	8.010270614	14	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	995	1384	0.002890173	0.036127168	7	14	Microglia	32	7	7
CCCATACGTTTGTTGG-1_MS377_A2D2	31.13918894	-18.38053159	2	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	5313	13587	0.020975933	0.015971149	7	2	EN-L4	32	7	7
CCCATACTCATGTCCC-1_MS377_A2D2	-18.76185258	19.81964032	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1687	2935	0.006473595	0.004770017	7	8	Astrocytes	32	7	7
CCCTCCTCAATCTGCA-1_MS377_A2D2	-16.98032	12.36755957	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1205	1955	0.005626598	0.004603581	7	8	Astrocytes	32	7	7
CCCTCCTCATATGGTC-1_MS377_A2D2	18.84021537	-14.82706471	4	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	7449	27109	0.022169759	0.009554023	7	L2-3	EN-L2-3-MS	32	7	7
CCCTCCTGTATAATGG-1_MS377_A2D2	10.76940148	-17.25437751	4	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	5032	12281	0.005781288	0.011888283	7	L2-3	EN-L2-3-MS	32	7	7
CCCTCCTGTCGTCTTC-1_MS377_A2D2	-19.39683447	-7.276307824	13B	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	4729	11614	0.010762872	0.01214052	7	13B	IN-SV2C	32	7	7
CCCTCCTTCGCCATAA-1_MS377_A2D2	13.98427858	-15.91629042	4	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	6645	20082	0.014689772	0.009511005	7	L2-3	EN-L2-3-MS	32	7	7
CCGGGATGTCGAAAGC-1_MS377_A2D2	18.91769526	-10.57314892	3	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	2281	4306	0.026242452	0.005805852	7	3	EN-L5-6	32	7	7
CCGGGATGTTGAACTC-1_MS377_A2D2	-25.13619763	9.334602812	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	982	1371	0.002917578	0.004376368	7	8	Astrocytes	32	7	7
CCGGGATGTTTGGGCC-1_MS377_A2D2	-16.78110998	-8.306224039	13B	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	3173	6893	0.006238213	0.003771943	7	13B	IN-SV2C	32	7	7
CCGGTAGGTCTCCATC-1_MS377_A2D2	28.27281711	5.832649152	15DA	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	747	1101	0.000908265	0.024523161	7	15DA	T cells	32	7	7
CCGGTAGTCTGTCTAT-1_MS377_A2D2	13.37644827	18.43075697	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1114	1732	0.001732102	0.006351039	7	oligos	OL-Cntl	32	7	7
CCGTACTAGTGTCCAT-1_MS377_A2D2	14.36645966	6.323929171	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	2076	3693	0.008935825	0.01272678	7	oligos	OL-Cntl	32	7	7
CCGTGGAAGCAGCGTA-1_MS377_A2D2	-12.30295611	-13.44383992	6B	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1759	2641	0.011737978	0.022340023	7	6B	IN-SST	32	7	7
CCGTGGAAGGAGCGAG-1_MS377_A2D2	-1.011541998	20.6332121	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	874	1236	0.00566343	0.019417476	7	oligos	OL-Cntl	32	7	7
CCGTGGATCCTAGGGC-1_MS377_A2D2	6.524785357	20.88736637	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	922	1348	0.008160237	0.006676558	7	oligos	OL-Cntl	32	7	7
CCGTTCAAGAAGGGTA-1_MS377_A2D2	18.58120955	-9.780713161	3	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	2848	5607	0.011771001	0.003210273	7	3	EN-L5-6	32	7	7
CCGTTCACACACAGAG-1_MS377_A2D2	12.8222188	-3.630940948	12	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1263	1855	0.003234501	0.007008086	7	12	EN-MIX	32	7	7
CCGTTCAGTCATGCAT-1_MS377_A2D2	6.127993483	17.95508251	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1071	1626	0.002460025	0.015375154	7	oligos	OL-Cntl	32	7	7
CCGTTCAGTCGGATCC-1_MS377_A2D2	3.397036986	20.38375371	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	899	1372	0.013119534	0.005830904	7	oligos	OL-Cntl	32	7	7
CCTAAAGCATGGTCAT-1_MS377_A2D2	7.778162977	-12.4390169	4	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	2306	3960	0.013888889	0.011111111	7	L2-3	EN-L2-3-MS	32	7	7
CCTACACAGGGTTTCT-1_MS377_A2D2	6.906572871	-17.13419306	4	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	4299	9945	0.005329311	0.01256913	7	L2-3	EN-L2-3-MS	32	7	7
CCTACACGTGACGCCT-1_MS377_A2D2	13.74423571	-27.6442523	3	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	3187	7271	0.00618897	0.002750653	7	3	EN-L5-6	32	7	7
CCTACACGTGATGTCT-1_MS377_A2D2	13.4705051	15.4516514	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1250	1917	0.004173187	0.010954617	7	oligos	OL-Cntl	32	7	7
CCTACACTCGTTGCCT-1_MS377_A2D2	22.56729304	17.36554175	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1271	2000	0.001	0.0085	7	oligos	OL-Cntl	32	7	7
CCTACCAAGTGCCAGA-1_MS377_A2D2	-32.75133887	-7.008749396	9	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1164	1717	0.002912056	0.007571345	7	9	OPC	32	7	7
CCTACCACACTATCTT-1_MS377_A2D2	29.33433203	-12.7649706	2	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	6145	22163	0.034020665	0.004782746	7	2	EN-L4	32	7	7
CCTACCACAGTATCTG-1_MS377_A2D2	33.14634077	10.92793065	14	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	765	1005	0.00199005	0.04079602	7	14	Microglia	32	7	7
CCTACCACATCCAACA-1_MS377_A2D2	18.14662772	-19.04852966	4	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	4364	11528	0.022553782	0.003643303	7	L2-3	EN-L2-3-MS	32	7	7
CCTAGCTAGAGCTTCT-1_MS377_A2D2	-28.60570564	10.15449107	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	904	1379	0.002175489	0.009427121	7	8	Astrocytes	32	7	7
CCTAGCTAGCCTATGT-1_MS377_A2D2	25.97347167	9.359674875	15A	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1984	3184	0.017273869	0.055590452	7	15A	Endo cells	32	7	7
CCTAGCTTCGCCATAA-1_MS377_A2D2	-28.32002499	9.297250853	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	813	1058	0.001890359	0.003780718	7	8	Astrocytes	32	7	7
CCTAGCTTCGTCGTTC-1_MS377_A2D2	17.53423929	-18.97653545	4	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	3281	7203	0.018742191	0.006108566	7	L2-3	EN-L2-3-MS	32	7	7
CCTATTAAGCCACTAT-1_MS377_A2D2	-9.262643856	-0.142198634	13A	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	2289	4544	0.006161972	0.007702465	7	13A	IN-VIP	32	7	7
CCTATTACAACACCTA-1_MS377_A2D2	-18.05451026	20.07732391	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1414	2369	0.002532714	0.004643309	7	8	Astrocytes	32	7	7
CCTATTAGTTAGAACA-1_MS377_A2D2	17.33547502	-14.76934301	4	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	10428	55269	0.02344895	0.00870289	7	L2-3	EN-L2-3-MS	32	7	7
CCTCAGTAGGCATGGT-1_MS377_A2D2	-34.73234189	-5.849517408	9	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1368	2349	0.001277139	0.005108557	7	9	OPC	32	7	7
CCTCAGTCATTTGCTT-1_MS377_A2D2	29.86553778	8.576128794	15DA	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	847	1912	0.001569038	0.026150628	7	15DA	T cells	32	7	7
CCTCAGTGTAGAAGGA-1_MS377_A2D2	-33.25075329	-5.227397455	9	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1345	2028	0.003451677	0.007889546	7	9	OPC	32	7	7
CCTCAGTGTAGTACCT-1_MS377_A2D2	-11.78713853	13.66986048	11	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1089	1518	0.004611331	0.007246377	7	11	Glia-MIX	32	7	7
CCTCTGACAGATCTGT-1_MS377_A2D2	-2.381356113	23.33437105	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	833	1181	0.00254022	0.010160881	7	oligos	OL-Cntl	32	7	7
CCTCTGACATCATCCC-1_MS377_A2D2	-31.58982738	0.552059339	9	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	2019	3363	0.00416295	0.004757657	7	9	OPC	32	7	7
CCTCTGACATGGTCAT-1_MS377_A2D2	-11.9193946	-37.87018049	16	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1489	2433	0.050143855	0.021783806	7	16	EN-PYR	32	7	7
CCTCTGATCTGGTTCC-1_MS377_A2D2	-24.49804425	-19.61355513	6A	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	3526	7428	0.012520194	0.006731287	7	6A	IN-PV	32	7	7
CCTTACGAGATAGGAG-1_MS377_A2D2	-2.764259	21.88945358	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	914	1234	0.001620746	0.009724473	7	oligos	OL-Cntl	32	7	7
CCTTACGCAGCCACCA-1_MS377_A2D2	25.23077482	9.967489203	15A	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	4008	8376	0.0169532	0.042860554	7	15A	Endo cells	32	7	7
CCTTACGTCATTGCCC-1_MS377_A2D2	11.14863101	21.67949531	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	942	1477	0.001354096	0.010832769	7	oligos	OL-Cntl	32	7	7
CCTTCCCAGTGGTAAT-1_MS377_A2D2	-18.07438545	20.09459714	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1542	2401	0.002915452	0.007080383	7	8	Astrocytes	32	7	7
CCTTCCCGTTGTCGCG-1_MS377_A2D2	22.7313547	13.87139415	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1472	2522	0.002379064	0.003965107	7	oligos	OL-Cntl	32	7	7
CCTTTCTCACAGATTC-1_MS377_A2D2	15.91291996	-17.02319891	4	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	5334	14725	0.017453311	0.007741935	7	L2-3	EN-L2-3-MS	32	7	7
CGAACATAGTACCGGA-1_MS377_A2D2	-11.95012257	18.09065119	11	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	2242	3800	0.002631579	0.006842105	7	11	Glia-MIX	32	7	7
CGAACATGTCGATTGT-1_MS377_A2D2	-20.43161839	25.56688817	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1881	3323	0.008426121	0.007824255	7	8	Astrocytes	32	7	7
CGAATGTAGACACGAC-1_MS377_A2D2	-8.77134398	-15.50606169	6B	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	776	1175	0.060425532	0.001702128	7	6B	IN-SST	32	7	7
CGAATGTAGCCAGTTT-1_MS377_A2D2	33.01116135	-18.95377987	2	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	3305	6272	0.021843112	0.018016582	7	2	EN-L4	32	7	7
CGAATGTTCCAGGGCT-1_MS377_A2D2	22.94512879	-25.73112184	3	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	4108	10255	0.004095563	0.002827889	7	3	EN-L5-6	32	7	7
CGAATGTTCCTTGCCA-1_MS377_A2D2	8.170718688	-17.17751788	4	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	3864	8300	0.005301205	0.022168675	7	L2-3	EN-L2-3-MS	32	7	7
CGACCTTCAAACCTAC-1_MS377_A2D2	4.99590522	-11.90016747	4	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	2213	4107	0.016557098	0.007061115	7	L2-3	EN-L2-3-MS	32	7	7
CGACCTTCAACTGGCC-1_MS377_A2D2	11.76548708	-23.89627804	4	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	5929	18182	0.005059949	0.006654933	7	L2-3	EN-L2-3-MS	32	7	7
CGACCTTTCTAACTCT-1_MS377_A2D2	-2.073699136	18.15467028	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	748	1122	0.005347594	0.012477718	7	oligos	OL-Cntl	32	7	7
CGACTTCCATTGAGCT-1_MS377_A2D2	-29.41364736	-2.948375451	9	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1598	2561	0.00624756	0.013666537	7	9	OPC	32	7	7
CGACTTCGTGGACGAT-1_MS377_A2D2	22.5266081	17.40698165	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1231	1850	0.003783784	0.01027027	7	oligos	OL-Cntl	32	7	7
CGAGAAGAGTCAAGGC-1_MS377_A2D2	-17.46836311	-21.13079929	6A	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1980	3641	0.004943697	0.004943697	7	6A	IN-PV	32	7	7
CGAGAAGGTAGTACCT-1_MS377_A2D2	9.537662832	-2.823884523	12	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1823	3028	0.019815059	0.008916777	7	12	EN-MIX	32	7	7
CGAGCACAGAGCTTCT-1_MS377_A2D2	6.79142777	-9.885060646	4	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1567	2423	0.026000825	0.008666942	7	L2-3	EN-L2-3-MS	32	7	7
CGAGCACCACAAGCCC-1_MS377_A2D2	33.29477278	-11.3801015	2	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	3338	7054	0.013042246	0.005103487	7	2	EN-L4	32	7	7
CGAGCCACACGTGAGA-1_MS377_A2D2	6.470453023	17.53460952	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1027	1473	0.000678887	0.016293279	7	oligos	OL-Cntl	32	7	7
CGAGCCAGTGCACTTA-1_MS377_A2D2	-0.376896538	21.70279912	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	723	1041	0.004803074	0.007684918	7	oligos	OL-Cntl	32	7	7
CGAGCCATCTCCAACC-1_MS377_A2D2	17.0725243	-17.78729844	4	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	2872	5986	0.026060809	0.003508186	7	L2-3	EN-L2-3-MS	32	7	7
CGATCGGCAGTCAGCC-1_MS377_A2D2	4.538235167	9.288541481	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1640	2740	0.010583942	0.027372263	7	oligos	OL-Cntl	32	7	7
CGATCGGTCACCTCGT-1_MS377_A2D2	-23.86878207	15.65110984	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1437	2151	0.0027894	0.008368201	7	8	Astrocytes	32	7	7
CGATCGGTCGGTCTAA-1_MS377_A2D2	33.79873996	-17.59354344	2	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	4790	11807	0.034725163	0.013635979	7	2	EN-L4	32	7	7
CGATCGGTCTGTACGA-1_MS377_A2D2	5.576975968	20.67919097	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	900	1308	0.001529052	0.00764526	7	oligos	OL-Cntl	32	7	7
CGATGGCAGGGAACGG-1_MS377_A2D2	-15.74677799	-23.70777673	6A	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1838	3251	0.028298985	0.002460781	7	6A	IN-PV	32	7	7
CGATGTACACCATCCT-1_MS377_A2D2	5.219265224	-14.75593555	4	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	3338	8037	0.038571606	0.003235038	7	L2-3	EN-L2-3-MS	32	7	7
CGATGTAGTATGGTTC-1_MS377_A2D2	-12.3446272	-14.03362412	6A	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1527	2265	0.023399558	0.003090508	7	6A	IN-PV	32	7	7
CGATTGACATCTCGCT-1_MS377_A2D2	20.00684969	-4.177078408	12	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	2054	3579	0.059793238	0.00838223	7	12	EN-MIX	32	7	7
CGATTGAGTATCTGCA-1_MS377_A2D2	25.93317103	3.704907727	15BA	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	776	1004	0.008964143	0.005976096	7	15BA	Stromal cells	32	7	7
CGATTGAGTCTTGTCC-1_MS377_A2D2	-18.47683965	6.746967808	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1032	1520	0.0125	0.009868421	7	8	Astrocytes	32	7	7
CGCCAAGAGTGAACGC-1_MS377_A2D2	-12.22790969	-36.69562577	16	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1751	3123	0.112071726	0.006404099	7	16	EN-PYR	32	7	7
CGCCAAGAGTGTACTC-1_MS377_A2D2	19.02955517	-17.15304664	4	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	6019	16987	0.020427386	0.011302761	7	L2-3	EN-L2-3-MS	32	7	7
CGCCAAGGTCCGAATT-1_MS377_A2D2	-20.28827086	-4.686643056	13B	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	3620	6941	0.009220573	0.01483936	7	13B	IN-SV2C	32	7	7
CGCGGTACAGTCCTTC-1_MS377_A2D2	6.833921773	24.578637	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	856	1309	0.005347594	0.007639419	7	oligos	OL-Cntl	32	7	7
CGCGTTTGTTATGCGT-1_MS377_A2D2	-19.38653232	7.695118762	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	891	1177	0.004248088	0.004248088	7	8	Astrocytes	32	7	7
CGCTATCCACCTATCC-1_MS377_A2D2	14.88287836	17.01789565	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1057	1604	0.002493766	0.008104738	7	oligos	OL-Cntl	32	7	7
CGCTATCGTCTCTTTA-1_MS377_A2D2	1.753053625	19.65598398	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	875	1242	0.008856683	0.012077295	7	oligos	OL-Cntl	32	7	7
CGCTATCGTTTGTTTC-1_MS377_A2D2	16.47271564	23.80466192	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	926	1409	0.001419446	0.005677786	7	oligos	OL-Cntl	32	7	7
CGCTGGACACATTCGA-1_MS377_A2D2	-19.50735068	7.657824257	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	882	1184	0.001689189	0.01097973	7	8	Astrocytes	32	7	7
CGCTGGAGTTACGGAG-1_MS377_A2D2	-33.23639206	-7.660535805	9	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1115	1786	0.004479283	0.006718925	7	9	OPC	32	7	7
CGCTGGATCAGCTTAG-1_MS377_A2D2	-19.16349261	8.530772364	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1150	1773	0.000564016	0.007896221	7	8	Astrocytes	32	7	7
CGCTTCACATATACGC-1_MS377_A2D2	6.832925653	-14.8895072	4	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	3092	6670	0.006446777	0.008545727	7	L2-3	EN-L2-3-MS	32	7	7
CGGACACAGATGTCGG-1_MS377_A2D2	-21.21035056	7.834499238	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	900	1261	0.002379064	0.0111023	7	8	Astrocytes	32	7	7
CGGACACGTACCTACA-1_MS377_A2D2	6.746485818	13.24722612	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1216	1835	0.013079019	0.020163488	7	oligos	OL-Cntl	32	7	7
CGGACTGAGGATGCGT-1_MS377_A2D2	-4.303455771	-36.05437879	16	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	996	1465	0.126279863	0.046416382	7	16	EN-PYR	32	7	7
CGGACTGTCGTTTATC-1_MS377_A2D2	32.04119737	-6.431002275	2	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	3501	7838	0.022965042	0.005103343	7	2	EN-L4	32	7	7
CGGACTGTCTCCCTGA-1_MS377_A2D2	15.32284592	1.73370594	12	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1076	1846	0.088299025	0.003250271	7	12	EN-MIX	32	7	7
CGGAGCTAGCTCAACT-1_MS377_A2D2	27.67337252	-12.4249445	2	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	5180	14195	0.024727017	0.005706235	7	2	EN-L4	32	7	7
CGGAGCTGTCATATGC-1_MS377_A2D2	18.61595225	-10.94571894	3	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	2917	5884	0.011046907	0.007477906	7	3	EN-L5-6	32	7	7
CGGAGCTTCCAAAGTC-1_MS377_A2D2	-30.38870677	9.690506081	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	831	1156	0.003460208	0.007785467	7	8	Astrocytes	32	7	7
CGGAGCTTCTGTCAAG-1_MS377_A2D2	-23.48847284	11.75463278	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1240	1827	0.002189381	0.008210181	7	8	Astrocytes	32	7	7
CGGAGTCGTGAGTGAC-1_MS377_A2D2	29.52343841	-15.99037296	2	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	5852	16842	0.058187864	0.004690654	7	2	EN-L4	32	7	7
CGGAGTCTCAGTGTTG-1_MS377_A2D2	-23.72915279	11.11660965	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1203	1845	0.006504065	0.007588076	7	8	Astrocytes	32	7	7
CGGCTAGTCTACCAGA-1_MS377_A2D2	24.61356573	-18.51404682	3	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	4782	12726	0.030410184	0.006050605	7	3	EN-L5-6	32	7	7
CGGCTAGTCTGTGCAA-1_MS377_A2D2	-2.039793821	22.71818569	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	808	1136	0.00528169	0.013204225	7	oligos	OL-Cntl	32	7	7
CGGGTCAGTCAGAGGT-1_MS377_A2D2	19.04304228	-16.47763255	4	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	4747	12156	0.030684436	0.004935834	7	L2-3	EN-L2-3-MS	32	7	7
CGGTTAAGTCCATCCT-1_MS377_A2D2	-23.26142788	-25.22751065	6A	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	4098	9745	0.006054387	0.003488969	7	6A	IN-PV	32	7	7
CGGTTAATCAACTCTT-1_MS377_A2D2	-22.01096825	24.10207895	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1657	2829	0.000706964	0.010604454	7	8	Astrocytes	32	7	7
CGTAGCGCACAGAGGT-1_MS377_A2D2	-8.783606112	-15.12776921	6B	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	773	1123	0.045414069	0.007123776	7	6B	IN-SST	32	7	7
CGTAGCGCATCCAACA-1_MS377_A2D2	-12.22632042	17.13638113	11	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1675	2613	0.005740528	0.013394566	7	11	Glia-MIX	32	7	7
CGTAGCGTCAACCATG-1_MS377_A2D2	-28.57264705	9.403786651	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	922	1309	0.00381971	0.009931245	7	8	Astrocytes	32	7	7
CGTAGGCTCGCAAACT-1_MS377_A2D2	26.75427256	4.547593232	15BA	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	937	1318	0.003034901	0.034901366	7	15BA	Stromal cells	32	7	7
CGTAGGCTCTACCTGC-1_MS377_A2D2	-0.607466964	24.29109185	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	718	1030	0.002912621	0.002912621	7	oligos	OL-Cntl	32	7	7
CGTCACTCAAACCTAC-1_MS377_A2D2	11.45438837	-16.99609445	4	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	5385	14546	0.007424722	0.007562216	7	L2-3	EN-L2-3-MS	32	7	7
CGTCACTCACGTCTCT-1_MS377_A2D2	-33.55185088	4.855450478	9	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	2900	6158	0.005358883	0.00438454	7	9	OPC	32	7	7
CGTCAGGTCCTAGAAC-1_MS377_A2D2	18.58544292	-20.30837233	3	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	3182	7251	0.044683492	0.003309888	7	3	EN-L5-6	32	7	7
CGTCCATAGCGAGAAA-1_MS377_A2D2	7.024661819	24.07659626	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1000	1499	0	0.008005337	7	oligos	OL-Cntl	32	7	7
CGTCTACAGCTGATAA-1_MS377_A2D2	-29.18499757	-11.53788362	9	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1114	1704	0.033450704	0.007042254	7	9	OPC	32	7	7
CGTCTACCAAGTAGTA-1_MS377_A2D2	-13.31410223	1.672946662	13A	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	4237	9121	0.003179476	0.008770968	7	13A	IN-VIP	32	7	7
CGTCTACCAATCCAAC-1_MS377_A2D2	-15.39408702	-3.792957215	13A	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	4314	10013	0.009887147	0.007889743	7	13A	IN-VIP	32	7	7
CGTCTACGTCCGAGTC-1_MS377_A2D2	26.94920757	7.789946758	15A	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1257	1788	0.021252796	0.032438479	7	15A	Endo cells	32	7	7
CGTGAGCAGCCGGTAA-1_MS377_A2D2	9.34354728	-13.37042592	4	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	3071	5439	0.010663725	0.014892443	7	L2-3	EN-L2-3-MS	32	7	7
CGTGAGCGTACTTAGC-1_MS377_A2D2	23.38641062	-15.93929773	2	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	6085	16191	0.017849423	0.023531592	7	2	EN-L4	32	7	7
CGTGAGCTCCAAGTAC-1_MS377_A2D2	-2.748503966	22.72973673	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	826	1175	0.006808511	0.013617021	7	oligos	OL-Cntl	32	7	7
CGTGTCTAGAGTCGGT-1_MS377_A2D2	-10.07271871	-6.45684152	13B	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1742	2906	0.00550585	0.006194081	7	13B	IN-SV2C	32	7	7
CGTGTCTCAAGGCTCC-1_MS377_A2D2	-16.15987601	0.485707885	13A	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	3142	5822	0.004637582	0.018550326	7	13A	IN-VIP	32	7	7
CGTGTCTTCTCAACTT-1_MS377_A2D2	31.52768764	-15.32620862	2	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	3990	9384	0.047208014	0.006393862	7	2	EN-L4	32	7	7
CGTTAGAAGCGGCTTC-1_MS377_A2D2	33.28264833	-15.57182957	2	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	3666	7184	0.020879733	0.015729399	7	2	EN-L4	32	7	7
CGTTGGGGTATATGAG-1_MS377_A2D2	-5.86676693	-32.52585727	16	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	784	1152	0.119791667	0.012152778	7	16	EN-PYR	32	7	7
CGTTGGGTCGAACGGA-1_MS377_A2D2	0.592508448	26.33439131	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	876	1223	0.001635323	0.004905969	7	oligos	OL-Cntl	32	7	7
CTAACTTCACTGTGTA-1_MS377_A2D2	-18.08872602	-14.22536837	6B	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	2079	3407	0.010859994	0.023774582	7	6B	IN-SST	32	7	7
CTAATGGCAAGTCTGT-1_MS377_A2D2	15.7828897	-16.54750852	4	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	5359	13953	0.013402136	0.009460331	7	L2-3	EN-L2-3-MS	32	7	7
CTAATGGCAGCCAGAA-1_MS377_A2D2	36.86823444	9.825157388	14	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	916	1225	0.006530612	0.011428571	7	14	Microglia	32	7	7
CTACACCCAATCAGAA-1_MS377_A2D2	-1.58538939	22.58909431	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	730	1043	0.000958773	0.0105465	7	oligos	OL-Cntl	32	7	7
CTACACCCATAAAGGT-1_MS377_A2D2	9.057551098	-13.338374	4	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	2809	5363	0.013238859	0.011560694	7	L2-3	EN-L2-3-MS	32	7	7
CTACATTAGGGTATCG-1_MS377_A2D2	-23.9983369	11.53769135	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1271	1978	0.00859454	0.01314459	7	8	Astrocytes	32	7	7
CTACATTAGGTCGGAT-1_MS377_A2D2	-3.385129429	21.6611631	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	828	1129	0.003542958	0.011514615	7	oligos	OL-Cntl	32	7	7
CTACATTGTATATCCG-1_MS377_A2D2	8.047718484	19.82280239	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1152	1694	0.001770956	0.015348288	7	oligos	OL-Cntl	32	7	7
CTACATTTCTGCCAGG-1_MS377_A2D2	-19.34418276	7.99865161	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1260	2029	0.005914243	0.007885658	7	8	Astrocytes	32	7	7
CTACCCAGTACAAGTA-1_MS377_A2D2	-9.452803243	-17.99989036	6B	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	835	1279	0.024237686	0.000781861	7	6B	IN-SST	32	7	7
CTACCCAGTGCCTTGG-1_MS377_A2D2	-30.52138356	-1.844464222	9	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1474	2232	0.001344086	0.005376344	7	9	OPC	32	7	7
CTACCCATCAACACAC-1_MS377_A2D2	-30.06048404	-2.173444335	9	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1813	3172	0.001891551	0.009457755	7	9	OPC	32	7	7
CTACGTCCACCGCTAG-1_MS377_A2D2	-21.33158138	19.45431727	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1335	2206	0.002266546	0.01087942	7	8	Astrocytes	32	7	7
CTAGAGTAGGATGCGT-1_MS377_A2D2	21.05108398	-12.90791192	3	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	2932	5461	0.018677898	0.012635049	7	3	EN-L5-6	32	7	7
CTAGAGTCATGGTCTA-1_MS377_A2D2	-12.75272625	-2.813077157	13A	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	2580	5141	0.013810543	0.011476366	7	13A	IN-VIP	32	7	7
CTAGAGTGTGATAAGT-1_MS377_A2D2	-15.86923065	11.88777031	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1487	2273	0.000879894	0.01099868	7	8	Astrocytes	32	7	7
CTAGAGTTCCCATTAT-1_MS377_A2D2	-33.6476944	-9.615131993	9	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1093	1677	0.00417412	0.006559332	7	9	OPC	32	7	7
CTAGAGTTCGGAATCT-1_MS377_A2D2	-28.48910068	9.741423938	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	807	1071	0.001867414	0.007469655	7	8	Astrocytes	32	7	7
CTAGAGTTCGGTCTAA-1_MS377_A2D2	-16.91699483	12.86045668	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1297	2135	0.004215457	0.005152225	7	8	Astrocytes	32	7	7
CTAGCCTCAACCGCCA-1_MS377_A2D2	7.346291034	-20.54155903	4	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	4525	11604	0.000775595	0.009134781	7	L2-3	EN-L2-3-MS	32	7	7
CTAGCCTCACACATGT-1_MS377_A2D2	-16.03985857	-24.82043548	6A	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1889	3621	0.00690417	0.003314002	7	6A	IN-PV	32	7	7
CTAGCCTCATCGATTG-1_MS377_A2D2	4.131752817	22.10576396	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	837	1246	0.006420546	0.004012841	7	oligos	OL-Cntl	32	7	7
CTAGCCTGTAGCGATG-1_MS377_A2D2	-2.530335295	-1.005866822	13A	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	2201	3874	0.003871967	0.003097574	7	13A	IN-VIP	32	7	7
CTAGTGACAGACGCCT-1_MS377_A2D2	-5.847690011	-35.77321748	16	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1041	1532	0.095300261	0.012402089	7	16	EN-PYR	32	7	7
CTAGTGAGTATTACCG-1_MS377_A2D2	34.92452004	-15.59617026	2	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	4755	11006	0.016627294	0.007904779	7	2	EN-L4	32	7	7
CTCACACAGACTTTCG-1_MS377_A2D2	34.38260219	9.598784128	14	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	898	1249	0.018414732	0.016813451	7	14	Microglia	32	7	7
CTCACACCACGAGGTA-1_MS377_A2D2	-18.34634204	19.37051981	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1675	2836	0.002115656	0.013751763	7	8	Astrocytes	32	7	7
CTCACACGTCTCCACT-1_MS377_A2D2	21.63529733	-26.52920971	3	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	4037	10379	0.001637923	0.009827536	7	3	EN-L5-6	32	7	7
CTCACACGTTACAGAA-1_MS377_A2D2	-18.23671785	6.372819276	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	818	1203	0.00166251	0.008312552	7	8	Astrocytes	32	7	7
CTCAGAAAGCCCAGCT-1_MS377_A2D2	6.697358073	25.50286019	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	914	1324	0.000755287	0.008308157	7	oligos	OL-Cntl	32	7	7
CTCAGAACAACTGCTA-1_MS377_A2D2	-2.036738524	22.00911427	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	771	1096	0.00729927	0.015510949	7	oligos	OL-Cntl	32	7	7
CTCAGAACAATTCCTT-1_MS377_A2D2	25.84580322	3.697954363	15BA	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	910	1409	0.001419446	0.003548616	7	15BA	Stromal cells	32	7	7
CTCAGAAGTTCGCTAA-1_MS377_A2D2	33.22632941	-2.428003524	2	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	2451	4904	0.007544861	0.002854812	7	2	EN-L4	32	7	7
CTCATTACAGACGCTC-1_MS377_A2D2	-0.038335217	28.58500796	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	770	1067	0.004686036	0.003748828	7	oligos	OL-Cntl	32	7	7
CTCATTAGTATGGTTC-1_MS377_A2D2	-16.50676125	14.61670489	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1700	3051	0.001311046	0.005244182	7	8	Astrocytes	32	7	7
CTCATTAGTTCACCTC-1_MS377_A2D2	10.77852455	-20.99053582	4	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	3431	8396	0.008218199	0.002977608	7	L2-3	EN-L2-3-MS	32	7	7
CTCCTAGAGCGTGTCC-1_MS377_A2D2	11.04721931	-15.32136306	4	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	4312	9523	0.009345794	0.011235955	7	L2-3	EN-L2-3-MS	32	7	7
CTCCTAGAGGACATTA-1_MS377_A2D2	6.373810335	26.10364251	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	959	1391	0.001437815	0.003594536	7	oligos	OL-Cntl	32	7	7
CTCCTAGCAGGAATGC-1_MS377_A2D2	-17.32539598	-3.721662907	13A	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	3127	5953	0.028389048	0.010750882	7	13A	IN-VIP	32	7	7
CTCGAAAAGAGCCTAG-1_MS377_A2D2	13.02810676	-22.69500531	4	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	5171	12806	0.00679369	0.006559425	7	L2-3	EN-L2-3-MS	32	7	7
CTCGAAACAATAGCAA-1_MS377_A2D2	29.89485442	-16.23323635	2	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	4466	10590	0.047403211	0.006232295	7	2	EN-L4	32	7	7
CTCGAGGAGGTGCTTT-1_MS377_A2D2	-5.2549943	12.94887149	5	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	777	1111	0.00270027	0.01440144	7	oligos	OL-MS-1	32	7	7
CTCGAGGAGTTACCCA-1_MS377_A2D2	10.29537312	-2.842057487	12	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1814	3166	0.029374605	0.006632975	7	12	EN-MIX	32	7	7
CTCGAGGCATACGCCG-1_MS377_A2D2	1.093000114	26.05284712	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	756	1042	0.004798464	0.003838772	7	oligos	OL-Cntl	32	7	7
CTCGGAGGTTTGTGTG-1_MS377_A2D2	20.04677256	-0.839411465	12	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1501	2343	0.024754588	0.005121639	7	12	EN-MIX	32	7	7
CTCGTACCATGGGACA-1_MS377_A2D2	-11.7576782	-37.64564844	16	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1539	2683	0.091315691	0.024226612	7	16	EN-PYR	32	7	7
CTCGTCAAGAACAATC-1_MS377_A2D2	-7.005642638	-34.14082521	16	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	744	1015	0.045320197	0.018719212	7	16	EN-PYR	32	7	7
CTCGTCAAGTAATCCC-1_MS377_A2D2	22.87288799	-25.20080643	3	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	4312	10667	0.004031124	0.004031124	7	3	EN-L5-6	32	7	7
CTCGTCAGTTATCGGT-1_MS377_A2D2	-10.02346429	-36.19135691	16	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1246	1838	0.073993471	0.008705114	7	16	EN-PYR	32	7	7
CTCTAATAGATGGGTC-1_MS377_A2D2	-18.70428982	19.72259126	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1625	2631	0.00418092	0.007221589	7	8	Astrocytes	32	7	7
CTCTAATAGTGCGATG-1_MS377_A2D2	-24.19360412	11.06151873	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1078	1596	0.003759398	0.00877193	7	8	Astrocytes	32	7	7
CTCTAATCACATAACC-1_MS377_A2D2	-14.53558505	-21.78981888	6A	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1500	2613	0.013777268	0.001530808	7	6A	IN-PV	32	7	7
CTCTACGGTAAGGGAA-1_MS377_A2D2	-23.67291315	6.74337689	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	930	1262	0	0.012678288	7	8	Astrocytes	32	7	7
CTCTGGTAGGTGACCA-1_MS377_A2D2	1.940326504	20.82872946	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	870	1285	0.00311284	0.007782101	7	oligos	OL-Cntl	32	7	7
CTCTGGTGTTAAGAAC-1_MS377_A2D2	-26.66363042	5.321413496	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1003	1378	0.006531205	0.009433962	7	8	Astrocytes	32	7	7
CTGAAACAGGTGATTA-1_MS377_A2D2	-20.89416029	-24.84622105	6A	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	2657	4902	0.006731946	0.004691962	7	6A	IN-PV	32	7	7
CTGAAACCAAACGTGG-1_MS377_A2D2	32.41995421	-13.19291327	2	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	3584	7543	0.015378497	0.006230943	7	2	EN-L4	32	7	7
CTGAAGTAGCGTTGCC-1_MS377_A2D2	-4.195623188	18.81071172	5	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	962	1383	0.003615329	0.012292119	7	oligos	OL-MS-1	32	7	7
CTGATAGAGCAAATCA-1_MS377_A2D2	-28.55044842	-4.575103073	9	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1232	1855	0.007008086	0.006469003	7	9	OPC	32	7	7
CTGATAGCATTCCTGC-1_MS377_A2D2	-28.89344539	-3.831910561	9	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1452	2140	0.000934579	0.007476636	7	9	OPC	32	7	7
CTGATCCAGAGTCTGG-1_MS377_A2D2	27.94161594	-9.82538712	2	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	2746	5156	0.016291699	0.005624515	7	2	EN-L4	32	7	7
CTGATCCGTAGGCTGA-1_MS377_A2D2	0.423541303	22.40640103	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	835	1151	0.001737619	0.004344049	7	oligos	OL-Cntl	32	7	7
CTGATCCTCACATGCA-1_MS377_A2D2	9.784893009	-15.89263276	4	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	3612	8101	0.015306752	0.007036168	7	L2-3	EN-L2-3-MS	32	7	7
CTGCCTACAATGGATA-1_MS377_A2D2	-8.820530128	-36.6869042	16	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1039	1464	0.027322404	0.019125683	7	16	EN-PYR	32	7	7
CTGCCTACAATGGTCT-1_MS377_A2D2	13.9280511	-2.920014884	12	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1269	2220	0.017117117	0.004504505	7	12	EN-MIX	32	7	7
CTGCCTAGTCGGATCC-1_MS377_A2D2	17.61503975	-21.96273024	3	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	3965	9027	0.006757505	0.010634762	7	3	EN-L5-6	32	7	7
CTGCGGACAGGCGATA-1_MS377_A2D2	19.27769162	-16.05122567	4	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	5666	15669	0.039760036	0.007275512	7	L2-3	EN-L2-3-MS	32	7	7
CTGCGGAGTCCGAACC-1_MS377_A2D2	8.340173689	19.47459818	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1201	1783	0.001682557	0.006169377	7	oligos	OL-Cntl	32	7	7
CTGCGGATCTTTAGTC-1_MS377_A2D2	-6.011847533	-36.97182723	16	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	984	1550	0.125806452	0.02	7	16	EN-PYR	32	7	7
CTGCTGTAGCACCGTC-1_MS377_A2D2	-11.11153216	-36.90017108	16	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1426	2100	0.046666667	0.016190476	7	16	EN-PYR	32	7	7
CTGCTGTGTCGGCATC-1_MS377_A2D2	-2.39081627	11.70618348	5	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1076	1530	0.003267974	0.011111111	7	oligos	OL-MS-1	32	7	7
CTGGTCTAGACTCGGA-1_MS377_A2D2	-23.69182261	-24.95090858	6A	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	3857	7949	0.006038495	0.010315763	7	6A	IN-PV	32	7	7
CTGGTCTGTAAATACG-1_MS377_A2D2	8.39877196	20.63312848	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	990	1484	0.004716981	0.006738544	7	oligos	OL-Cntl	32	7	7
CTGTGCTAGCGTTCCG-1_MS377_A2D2	-6.35371435	-7.610370398	13A	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	960	1434	0.027196653	0.00069735	7	13A	IN-VIP	32	7	7
CTGTGCTCACCAGGTC-1_MS377_A2D2	0.715105818	23.98217753	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	814	1152	0.002604167	0.004340278	7	oligos	OL-Cntl	32	7	7
CTGTGCTGTCACACGC-1_MS377_A2D2	1.966988059	22.36343973	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	869	1262	0.003169572	0.011885895	7	oligos	OL-Cntl	32	7	7
CTGTGCTTCGATAGAA-1_MS377_A2D2	16.64102385	-13.86239516	4	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	6001	17076	0.028051066	0.010248302	7	L2-3	EN-L2-3-MS	32	7	7
CTGTTTAAGACAGAGA-1_MS377_A2D2	-32.67025916	-8.482936761	9	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1111	1701	0.002351558	0.004115226	7	9	OPC	32	7	7
CTGTTTAGTCGGCTCA-1_MS377_A2D2	-32.44536354	-8.169582701	9	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1133	1774	0.003945885	0.003382187	7	9	OPC	32	7	7
CTGTTTAGTTGACGTT-1_MS377_A2D2	8.64668111	-13.7429132	4	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	2992	5895	0.010687023	0.01509754	7	L2-3	EN-L2-3-MS	32	7	7
CTTAACTAGCGGATCA-1_MS377_A2D2	-16.52924602	-14.93691046	6B	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1653	2702	0.038119911	0.007031828	7	6B	IN-SST	32	7	7
CTTAACTAGCTAAGAT-1_MS377_A2D2	-10.0951778	28.31368823	17	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	791	1026	0.01754386	0.007797271	7	oligos	OL-MS-2	32	7	7
CTTAACTCACGGCGTT-1_MS377_A2D2	17.20500911	-9.735975085	12	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	2548	5373	0.110366648	0.003722315	7	12	EN-MIX	32	7	7
CTTAACTTCCGCGTTT-1_MS377_A2D2	21.60110286	11.32009273	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1597	2855	0.001050788	0.00385289	7	oligos	OL-Cntl	32	7	7
CTTACCGTCGTTTGCC-1_MS377_A2D2	-10.85021043	16.23536085	11	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1941	3216	0.003109453	0.006840796	7	11	Glia-MIX	32	7	7
CTTAGGAAGATCCCAT-1_MS377_A2D2	-16.17308267	12.60914122	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1436	2307	0.002167317	0.011270048	7	8	Astrocytes	32	7	7
CTTAGGAAGCACCGTC-1_MS377_A2D2	5.069981954	-9.314869291	12	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1514	2439	0.03403034	0.008610086	7	12	EN-MIX	32	7	7
CTTAGGATCTCTGCTG-1_MS377_A2D2	22.40523834	15.53843447	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1579	2539	0.007483261	0.012997243	7	oligos	OL-Cntl	32	7	7
CTTCTCTAGGTTCCTA-1_MS377_A2D2	-21.76312203	9.973591573	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1160	1831	0.002184599	0.003276898	7	8	Astrocytes	32	7	7
CTTGGCTGTACGAAAT-1_MS377_A2D2	15.66590209	-17.23411347	4	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	5519	15357	0.012697793	0.008139611	7	L2-3	EN-L2-3-MS	32	7	7
CTTGGCTGTCGCTTTC-1_MS377_A2D2	-26.69710098	-20.8596569	6A	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	3448	7705	0.052303699	0.008176509	7	6A	IN-PV	32	7	7
CTTGGCTTCAACACAC-1_MS377_A2D2	-25.59287172	22.78748985	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1408	2379	0.002101723	0.004623792	7	8	Astrocytes	32	7	7
CTTGGCTTCAGATAAG-1_MS377_A2D2	2.074967128	22.27971364	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	983	1395	0.003584229	0.005017921	7	oligos	OL-Cntl	32	7	7
CTTGGCTTCTCGTTTA-1_MS377_A2D2	16.15556936	14.39357849	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1350	2143	0.001399907	0.009799347	7	oligos	OL-Cntl	32	7	7
CTTGGCTTCTGCTGCT-1_MS377_A2D2	3.615779664	-12.57686391	4	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	2102	3794	0.009488666	0.003953611	7	L2-3	EN-L2-3-MS	32	7	7
CTTTGCGCAGGGAGAG-1_MS377_A2D2	32.95118777	-18.42013244	2	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	3174	5825	0.030901288	0.017854077	7	2	EN-L4	32	7	7
CTTTGCGGTCTTCGTC-1_MS377_A2D2	-24.3325631	15.72246644	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1182	1938	0.004127967	0.010319917	7	8	Astrocytes	32	7	7
CTTTGCGGTGAAATCA-1_MS377_A2D2	-19.86057687	8.279557867	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1080	1557	0.002569043	0.017983301	7	8	Astrocytes	32	7	7
GAAACTCCATTGAGCT-1_MS377_A2D2	22.19891998	-1.495195207	2	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	2380	4506	0.002885042	0.009542832	7	2	EN-L4	32	7	7
GAAACTCGTCCATCCT-1_MS377_A2D2	-17.43371265	17.85204216	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1701	3040	0.008223684	0.005263158	7	8	Astrocytes	32	7	7
GAAATGACACATTAGC-1_MS377_A2D2	7.610706568	21.29095851	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	976	1449	0.004140787	0.002760524	7	oligos	OL-Cntl	32	7	7
GAAATGAGTAAGCACG-1_MS377_A2D2	35.1776643	10.69514407	14	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	810	1015	0.006896552	0.015763547	7	14	Microglia	32	7	7
GAACCTAGTGAAGGCT-1_MS377_A2D2	-28.41852135	9.717499199	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	853	1197	0.001670844	0.001670844	7	8	Astrocytes	32	7	7
GAACGGAAGTGCAAGC-1_MS377_A2D2	6.844813974	-10.41431326	4	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1987	3203	0.013424914	0.013737121	7	L2-3	EN-L2-3-MS	32	7	7
GAACGGACACAAGCCC-1_MS377_A2D2	-2.098071117	23.80821602	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	755	1084	0.001845018	0.008302583	7	oligos	OL-Cntl	32	7	7
GAAGCAGCATTTGCTT-1_MS377_A2D2	-17.35968407	-14.85553745	6A	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1988	3727	0.011000805	0.006439496	7	6A	IN-PV	32	7	7
GAAGCAGTCTGGAGCC-1_MS377_A2D2	19.96985087	-20.01179312	3	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	3627	7534	0.017520573	0.007300239	7	3	EN-L5-6	32	7	7
GAATAAGTCGCAGGCT-1_MS377_A2D2	33.41642983	-15.86828348	2	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	3681	7790	0.024005135	0.011681643	7	2	EN-L4	32	7	7
GAATGAAAGTACCGGA-1_MS377_A2D2	2.264506338	-7.36321806	12	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1394	2308	0.002599653	0.004766031	7	12	EN-MIX	32	7	7
GAATGAATCGTGGTCG-1_MS377_A2D2	-19.35194079	-5.270285318	13B	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	3492	7165	0.014235869	0.008792742	7	13B	IN-SV2C	32	7	7
GACACGCAGAAACGCC-1_MS377_A2D2	14.0387163	-29.52933013	3	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	4942	14724	0.00258082	0.004957892	7	3	EN-L5-6	32	7	7
GACACGCAGTGGCACA-1_MS377_A2D2	31.35126248	-18.23928243	2	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	5288	12692	0.017964072	0.013394264	7	2	EN-L4	32	7	7
GACACGCCAGCATGAG-1_MS377_A2D2	-2.669575346	21.43835334	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	799	1119	0.004468275	0.010723861	7	oligos	OL-Cntl	32	7	7
GACAGAGAGATCGATA-1_MS377_A2D2	20.68054428	-0.979890649	2	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1736	2851	0.007015082	0.004559804	7	2	EN-L4	32	7	7
GACAGAGAGCACCGTC-1_MS377_A2D2	14.93795687	-19.90823849	4	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	5074	11718	0.004864311	0.012886158	7	L2-3	EN-L2-3-MS	32	7	7
GACAGAGAGGCCCGTT-1_MS377_A2D2	-3.573602417	19.95073905	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	796	1104	0.003623188	0.013586957	7	oligos	OL-Cntl	32	7	7
GACAGAGCAAAGTCAA-1_MS377_A2D2	-25.97596333	21.97992809	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1240	1874	0.012273212	0.008004269	7	8	Astrocytes	32	7	7
GACAGAGCAATTGCTG-1_MS377_A2D2	-0.455126384	29.06910575	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	950	1329	0.003009782	0.004514673	7	oligos	OL-Cntl	32	7	7
GACAGAGCATCCAACA-1_MS377_A2D2	18.37647014	-14.99862894	4	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	6146	17013	0.024804561	0.010580145	7	L2-3	EN-L2-3-MS	32	7	7
GACAGAGGTAGCACGA-1_MS377_A2D2	-16.11395502	-3.909261674	13A	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	2948	5767	0.008843419	0.013005029	7	13A	IN-VIP	32	7	7
GACAGAGGTGCACGAA-1_MS377_A2D2	6.745546233	22.96385827	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	837	1199	0.002502085	0.008340284	7	oligos	OL-Cntl	32	7	7
GACAGAGGTTAGAACA-1_MS377_A2D2	32.49186173	-14.90933742	2	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	3602	7844	0.028429373	0.007649159	7	2	EN-L4	32	7	7
GACAGAGTCCCATTAT-1_MS377_A2D2	-17.80962918	-24.22408336	6A	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	2573	5646	0.001416932	0.00460503	7	6A	IN-PV	32	7	7
GACAGAGTCGAACTGT-1_MS377_A2D2	-3.76635542	18.84057627	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	932	1345	0.001486989	0.017100372	7	oligos	OL-Cntl	32	7	7
GACCAATAGAGGTTAT-1_MS377_A2D2	-34.33357246	-10.18292879	9	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	896	1396	0.004297994	0.003581662	7	9	OPC	32	7	7
GACCTGGAGATATACG-1_MS377_A2D2	20.53486494	-3.869727225	2	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	2245	3988	0.030090271	0.008274824	7	2	EN-L4	32	7	7
GACCTGGAGGCCCTCA-1_MS377_A2D2	1.852837412	25.19349648	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	714	1039	0.001924928	0.003849856	7	oligos	OL-Cntl	32	7	7
GACCTGGCAGTCTTCC-1_MS377_A2D2	9.2386035	18.26190478	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1068	1652	0.007263923	0.011501211	7	oligos	OL-Cntl	32	7	7
GACGCGTAGTCCATAC-1_MS377_A2D2	12.53298072	-12.32113297	4	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	3966	8025	0.010716511	0.021308411	7	L2-3	EN-L2-3-MS	32	7	7
GACGCGTCATCAGTCA-1_MS377_A2D2	-24.17740626	10.91133327	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1127	1585	0.008832808	0.002523659	7	8	Astrocytes	32	7	7
GACGCGTGTGAGGCTA-1_MS377_A2D2	-0.817516162	21.22072323	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	831	1158	0.002590674	0.011226252	7	oligos	OL-Cntl	32	7	7
GACGGCTAGAGCCCAA-1_MS377_A2D2	20.2346908	-1.316260165	12	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1720	2620	0.014122137	0.005725191	7	12	EN-MIX	32	7	7
GACGGCTCAAACTGCT-1_MS377_A2D2	13.94889234	-27.25835059	3	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	3318	7589	0.005666096	0.00395309	7	3	EN-L5-6	32	7	7
GACGGCTGTATGCTTG-1_MS377_A2D2	7.656610905	1.326400435	16	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	695	1014	0.044378698	0.013806706	7	16	EN-PYR	32	7	7
GACGGCTGTGTGACGA-1_MS377_A2D2	-19.06215695	-4.57970878	13A	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	3644	8761	0.072594453	0.005821253	7	13A	IN-VIP	32	7	7
GACGGCTTCATGTCCC-1_MS377_A2D2	-1.753169804	18.62233374	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	680	1010	0.007920792	0.01980198	7	oligos	OL-Cntl	32	7	7
GACGTGCCAAGTTAAG-1_MS377_A2D2	31.31552287	-16.4526974	2	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	4274	9433	0.036785752	0.008480865	7	2	EN-L4	32	7	7
GACGTGCCAGGACCCT-1_MS377_A2D2	7.875318417	23.79188692	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	959	1496	0.006684492	0.004679144	7	oligos	OL-Cntl	32	7	7
GACGTTACACTGTCGG-1_MS377_A2D2	-2.814731204	23.15598171	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	775	1069	0.005612722	0.008419083	7	oligos	OL-Cntl	32	7	7
GACGTTACATTCGACA-1_MS377_A2D2	9.831382377	-16.2020698	4	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	3938	8840	0.012104072	0.009502262	7	L2-3	EN-L2-3-MS	32	7	7
GACGTTAGTCTCTTTA-1_MS377_A2D2	32.37533183	-10.34066137	2	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	3052	6343	0.016553681	0.004414315	7	2	EN-L4	32	7	7
GACGTTAGTCTGATTG-1_MS377_A2D2	23.21968546	15.5721346	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1495	2369	0.001688476	0.002110595	7	oligos	OL-Cntl	32	7	7
GACGTTATCATCGATG-1_MS377_A2D2	-11.7203553	28.2811844	17	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1506	2305	0.056399132	0.015184382	7	oligos	OL-MS-2	32	7	7
GACGTTATCCGCGGTA-1_MS377_A2D2	-18.86366106	0.02641978	13A	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	4452	9724	0.007301522	0.023035788	7	13A	IN-VIP	32	7	7
GACGTTATCCTTGCCA-1_MS377_A2D2	13.73664336	-27.62307467	3	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	2520	5143	0.016721758	0.004860976	7	3	EN-L5-6	32	7	7
GACTAACAGAGGTAGA-1_MS377_A2D2	-15.55046734	-23.08267827	6A	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1947	3621	0.035073184	0.005523336	7	6A	IN-PV	32	7	7
GACTAACGTTTGACAC-1_MS377_A2D2	-10.69078637	-9.360338724	13B	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1285	2148	0.043296089	0.003258845	7	13B	IN-SV2C	32	7	7
GACTAACTCACAAACC-1_MS377_A2D2	6.703928864	-14.53345898	4	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	2689	5051	0.004553554	0.007523263	7	L2-3	EN-L2-3-MS	32	7	7
GACTAACTCTAACTTC-1_MS377_A2D2	-25.42462399	18.18394314	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1277	2175	0.00137931	0.002298851	7	8	Astrocytes	32	7	7
GACTGCGAGGATATAC-1_MS377_A2D2	-2.48172464	21.87845086	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	819	1120	0.004464286	0.009821429	7	oligos	OL-Cntl	32	7	7
GACTGCGAGTTCCACA-1_MS377_A2D2	-17.4376432	-5.709635665	13B	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	2140	3651	0.019172829	0.015064366	7	13B	IN-SV2C	32	7	7
GACTGCGGTCATATCG-1_MS377_A2D2	21.54298506	-1.318024721	2	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	2006	3508	0.003420753	0.00313569	7	2	EN-L4	32	7	7
GACTGCGTCGCCAGCA-1_MS377_A2D2	-3.922388326	18.38166799	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	838	1192	0.006711409	0.012583893	7	oligos	OL-Cntl	32	7	7
GACTGCGTCTCTGAGA-1_MS377_A2D2	13.52153685	18.42291804	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1112	1649	0.000606428	0.003638569	7	oligos	OL-Cntl	32	7	7
GAGCAGAAGCATGGCA-1_MS377_A2D2	-7.91299153	-36.64746014	16	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1132	1731	0.074523397	0.01502022	7	16	EN-PYR	32	7	7
GAGCAGAGTAACGACG-1_MS377_A2D2	-31.479102	-12.64348256	9	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	878	1205	0	0.004979253	7	9	OPC	32	7	7
GAGTCCGAGTTCGCGC-1_MS377_A2D2	-18.42722276	19.75591257	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1476	2346	0.004262575	0.009377664	7	8	Astrocytes	32	7	7
GAGTCCGCAGCTTCGG-1_MS377_A2D2	-1.42018637	23.82772198	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	784	1089	0.004591368	0.008264463	7	oligos	OL-Cntl	32	7	7
GATCAGTCACATGTGT-1_MS377_A2D2	12.52729542	-17.70581786	4	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	4412	11053	0.01510902	0.0037094	7	L2-3	EN-L2-3-MS	32	7	7
GATCGATAGGCATGGT-1_MS377_A2D2	-0.285666081	22.21860251	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	789	1163	0.00171969	0.012897678	7	oligos	OL-Cntl	32	7	7
GATCGATCACAACTGT-1_MS377_A2D2	-32.469887	-3.558440004	9	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1277	2086	0.002396932	0.012464046	7	9	OPC	32	7	7
GATCGATGTCGATTGT-1_MS377_A2D2	2.313956296	19.26948532	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	935	1385	0.002166065	0.015162455	7	oligos	OL-Cntl	32	7	7
GATCGATTCAGATAAG-1_MS377_A2D2	6.313285761	-13.85992491	4	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	2795	5362	0.008392391	0.007832898	7	L2-3	EN-L2-3-MS	32	7	7
GATCGATTCGATAGAA-1_MS377_A2D2	-4.137341412	18.52401097	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	809	1108	0.00631769	0.016245487	7	oligos	OL-Cntl	32	7	7
GATCGCGCAATGTTGC-1_MS377_A2D2	4.815988818	17.76606461	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	914	1404	0.003561254	0.016381766	7	oligos	OL-Cntl	32	7	7
GATCGCGCATACTCTT-1_MS377_A2D2	-17.80699917	0.419447383	13A	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	3767	8037	0.010202812	0.019161379	7	13A	IN-VIP	32	7	7
GATCGTAGTGTGAATA-1_MS377_A2D2	-26.33774004	-20.41710288	6A	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	2598	5135	0.044790652	0.010710808	7	6A	IN-PV	32	7	7
GATGAAAAGTACTTGC-1_MS377_A2D2	25.04215967	4.231429192	15BA	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1476	2325	0	0.004731183	7	15BA	Stromal cells	32	7	7
GATGAAAGTCAGAATA-1_MS377_A2D2	31.53541047	-14.32245105	2	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	3610	7898	0.025449481	0.005824259	7	2	EN-L4	32	7	7
GATGAAATCAGCCTAA-1_MS377_A2D2	32.07886398	-8.120618548	2	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	4245	10448	0.012346861	0.007656968	7	2	EN-L4	32	7	7
GATGAGGGTAAGTTCC-1_MS377_A2D2	-17.6630278	-6.710693743	13B	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	2923	5612	0.013542409	0.006771205	7	13B	IN-SV2C	32	7	7
GATGAGGGTCTCTTAT-1_MS377_A2D2	2.978608197	24.76717342	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	799	1190	0.002521008	0.009243697	7	oligos	OL-Cntl	32	7	7
GATGCTAAGTCCAGGA-1_MS377_A2D2	-5.914824867	-32.97421613	16	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	752	1050	0.111428571	0.00952381	7	16	EN-PYR	32	7	7
GATGCTAGTGGCAAAC-1_MS377_A2D2	-2.369921804	22.54401344	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	777	1083	0.007386888	0.015697138	7	oligos	OL-Cntl	32	7	7
GATGCTATCCTGTACC-1_MS377_A2D2	15.97762657	-9.228388008	3	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	2150	4352	0.018612132	0.003446691	7	3	EN-L5-6	32	7	7
GATTCAGCAACTGCTA-1_MS377_A2D2	8.064698257	18.82828254	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1264	1894	0.001583949	0.007919747	7	oligos	OL-Cntl	32	7	7
GATTCAGCACAAGCCC-1_MS377_A2D2	-19.93158489	8.854101456	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1026	1662	0.002406739	0.009025271	7	8	Astrocytes	32	7	7
GCAAACTCATCACAAC-1_MS377_A2D2	9.339212753	0.207368647	12	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	930	1340	0.047761194	0.007462687	7	12	EN-MIX	32	7	7
GCAAACTGTTTCCACC-1_MS377_A2D2	8.457466954	19.14110418	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1067	1551	0.001934236	0.00967118	7	oligos	OL-Cntl	32	7	7
GCAAACTTCAGCACAT-1_MS377_A2D2	34.56634606	10.06570519	14	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1010	1292	0.001547988	0.008513932	7	14	Microglia	32	7	7
GCAAACTTCTGGTATG-1_MS377_A2D2	-24.56247064	9.806793449	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1117	1603	0.006238303	0.006862133	7	8	Astrocytes	32	7	7
GCAATCAAGATCTGAA-1_MS377_A2D2	29.86415459	-13.22328949	2	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	4381	10900	0.065137615	0.006055046	7	2	EN-L4	32	7	7
GCAATCAAGTGGTCCC-1_MS377_A2D2	-28.46193341	9.477053682	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	824	1190	0.006722689	0.004201681	7	8	Astrocytes	32	7	7
GCACATAAGAAACGCC-1_MS377_A2D2	-5.105324703	-35.00511411	16	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	922	1336	0.10254491	0.017215569	7	16	EN-PYR	32	7	7
GCACATAAGTGGTAGC-1_MS377_A2D2	20.79874892	-3.965752042	2	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	2456	4330	0.021247113	0.006928406	7	2	EN-L4	32	7	7
GCACATACACCTATCC-1_MS377_A2D2	-18.43900093	0.18746193	13A	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	3720	7621	0.012071907	0.024012597	7	13A	IN-VIP	32	7	7
GCACATATCGAGCCCA-1_MS377_A2D2	-22.20009239	-21.68677797	6A	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	2591	5200	0.067884615	0.003846154	7	6A	IN-PV	32	7	7
GCACTCTAGTACGTTC-1_MS377_A2D2	16.12775148	-10.52964058	12	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	2342	4708	0.113211555	0.004248088	7	12	EN-MIX	32	7	7
GCACTCTGTAGCGCTC-1_MS377_A2D2	-16.49708456	-1.585644086	13A	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	2755	5159	0.017832913	0.021321962	7	13A	IN-VIP	32	7	7
GCAGCCAAGTAAGTAC-1_MS377_A2D2	13.84318975	14.86591383	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1238	2000	0.004	0.0105	7	oligos	OL-Cntl	32	7	7
GCAGCCAAGTCCATAC-1_MS377_A2D2	27.11126495	-13.62280606	4	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	7005	24416	0.0327654	0.005856815	7	L2-3	EN-L2-3-MS	32	7	7
GCAGCCATCGTTACAG-1_MS377_A2D2	33.62149377	14.30664818	14	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	955	1298	0.003081664	0.026194145	7	14	Microglia	32	7	7
GCAGTTACACCACCAG-1_MS377_A2D2	7.134237166	18.6812873	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1052	1529	0.001308044	0.018966645	7	oligos	OL-Cntl	32	7	7
GCAGTTAGTGCGGTAA-1_MS377_A2D2	-23.55703643	-18.30404908	6B	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	2749	5122	0.007223741	0.016985553	7	6B	IN-SST	32	7	7
GCATACACAGCGTCCA-1_MS377_A2D2	4.900950628	-14.51744668	4	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	2746	5812	0.015313145	0.003785272	7	L2-3	EN-L2-3-MS	32	7	7
GCATACATCGTATCAG-1_MS377_A2D2	13.23068317	-2.229675889	12	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1261	2047	0.006350757	0.005862237	7	12	EN-MIX	32	7	7
GCATACATCTTCATGT-1_MS377_A2D2	-12.79551795	17.38844087	11	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1599	2452	0.01223491	0.013458401	7	11	Glia-MIX	32	7	7
GCATGATAGCGGCTTC-1_MS377_A2D2	5.012455949	-9.280988374	12	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1441	2260	0.02300885	0.001327434	7	12	EN-MIX	32	7	7
GCATGATAGGAATTAC-1_MS377_A2D2	-14.64403422	-4.889471808	13A	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	3209	6246	0.006884406	0.008965738	7	13A	IN-VIP	32	7	7
GCATGATCACATGACT-1_MS377_A2D2	9.339904654	1.238559107	12	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	844	1382	0.028219971	0.00723589	7	12	EN-MIX	32	7	7
GCATGCGCAAGGACAC-1_MS377_A2D2	14.73773268	20.39529554	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1072	1585	0	0.007570978	7	oligos	OL-Cntl	32	7	7
GCATGCGCAGTATCTG-1_MS377_A2D2	-2.525159363	21.75029901	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	789	1088	0.003676471	0.017463235	7	oligos	OL-Cntl	32	7	7
GCATGCGGTACTCAAC-1_MS377_A2D2	16.79087435	-25.59570779	3	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	4164	10165	0.004820462	0.008165273	7	3	EN-L5-6	32	7	7
GCATGTACAACCGCCA-1_MS377_A2D2	-28.51345327	20.53024268	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1201	1983	0.001512859	0.005042864	7	8	Astrocytes	32	7	7
GCCAAATAGGATTCGG-1_MS377_A2D2	17.50703307	-4.007267417	3	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1607	2584	0.020510836	0.003869969	7	3	EN-L5-6	32	7	7
GCCAAATTCCGCAAGC-1_MS377_A2D2	7.168243246	-14.87435075	4	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	3102	6435	0.016161616	0.004817405	7	L2-3	EN-L2-3-MS	32	7	7
GCCTCTAAGACACGAC-1_MS377_A2D2	22.80953061	27.01207692	17	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1282	2041	0.003429691	0.004899559	7	oligos	OL-MS-2	32	7	7
GCCTCTAAGCTACCGC-1_MS377_A2D2	-25.02842986	-21.93191863	6A	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	3298	7308	0.037903667	0.005199781	7	6A	IN-PV	32	7	7
GCCTCTAGTGGCGAAT-1_MS377_A2D2	23.34614834	-21.75905012	3	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	4161	10660	0.020919325	0.00478424	7	3	EN-L5-6	32	7	7
GCCTCTAGTGTGTGCC-1_MS377_A2D2	-2.993642399	20.07439336	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	717	1072	0.002798507	0.013992537	7	oligos	OL-Cntl	32	7	7
GCCTCTATCGCAGGCT-1_MS377_A2D2	-18.48964956	-1.10151034	13A	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	3790	7863	0.013099326	0.022764848	7	13A	IN-VIP	32	7	7
GCCTCTATCGCCCTTA-1_MS377_A2D2	14.02771482	-17.43939619	4	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	7340	23453	0.007291178	0.017993434	7	L2-3	EN-L2-3-MS	32	7	7
GCGACCAAGATCCTGT-1_MS377_A2D2	7.313054792	-15.01733398	4	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	3416	7572	0.011357633	0.0038299	7	L2-3	EN-L2-3-MS	32	7	7
GCGACCAAGCTAGTTC-1_MS377_A2D2	25.58195632	10.45014726	15A	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	3894	8360	0.024043062	0.075358852	7	15A	Endo cells	32	7	7
GCGACCAGTGGTGTAG-1_MS377_A2D2	-26.77356005	-22.03506093	6A	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	4389	10212	0.037700744	0.012534273	7	6A	IN-PV	32	7	7
GCGAGAACAATCAGAA-1_MS377_A2D2	-5.572123093	-35.22430473	16	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	854	1194	0.049413735	0.00921273	7	16	EN-PYR	32	7	7
GCGAGAATCACTATTC-1_MS377_A2D2	11.27299139	20.04060087	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	985	1506	0.000664011	0.011288181	7	oligos	OL-Cntl	32	7	7
GCGCAACCACGAAATA-1_MS377_A2D2	-17.2327923	-2.045745078	13A	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	3451	6973	0.010755772	0.012763516	7	13A	IN-VIP	32	7	7
GCGCAGTCAGCATGAG-1_MS377_A2D2	13.47121708	13.28339447	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1165	1813	0.002206288	0.008825152	7	oligos	OL-Cntl	32	7	7
GCGCAGTTCCAAACTG-1_MS377_A2D2	5.907669805	-14.35302719	4	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	2680	5481	0.004378763	0.006933041	7	L2-3	EN-L2-3-MS	32	7	7
GCGCCAAGTGGAAAGA-1_MS377_A2D2	-31.01014418	0.763762476	9	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1918	3209	0.003116236	0.00436273	7	9	OPC	32	7	7
GCGCGATAGTCAAGCG-1_MS377_A2D2	-24.89946808	11.10193813	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	949	1415	0.002826855	0.009187279	7	8	Astrocytes	32	7	7
GCGCGATGTATAGGGC-1_MS377_A2D2	18.03122677	-19.24698436	4	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	3912	9470	0.033896515	0.004751848	7	L2-3	EN-L2-3-MS	32	7	7
GCGCGATGTGCACGAA-1_MS377_A2D2	7.363514445	-10.67644454	4	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1804	2891	0.014181944	0.017640955	7	L2-3	EN-L2-3-MS	32	7	7
GCGGGTTAGATCCCAT-1_MS377_A2D2	4.858862532	11.23840361	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1224	1922	0.003121748	0.020811655	7	oligos	OL-Cntl	32	7	7
GCGGGTTCACCTGGTG-1_MS377_A2D2	15.17032826	2.926498054	12	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1016	1568	0.009566327	0.003188776	7	12	EN-MIX	32	7	7
GCTCCTAAGCGTGAGT-1_MS377_A2D2	-30.42963575	9.456808955	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	801	1112	0.009892086	0.01618705	7	8	Astrocytes	32	7	7
GCTCCTACACCATGTA-1_MS377_A2D2	-13.01633066	-17.59352168	6B	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1250	2084	0.020633397	0.002879079	7	6B	IN-SST	32	7	7
GCTCTGTAGCGTAATA-1_MS377_A2D2	-31.89501305	-11.28228941	9	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	888	1281	0.00156128	0.00312256	7	9	OPC	32	7	7
GCTCTGTCAGGCTGAA-1_MS377_A2D2	36.53179957	-13.35201411	2	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	5553	13212	0.011353315	0.012867091	7	2	EN-L4	32	7	7
GCTGCAGGTAGAGCTG-1_MS377_A2D2	-23.99796961	9.645245097	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1069	1513	0.001982816	0.010575017	7	8	Astrocytes	32	7	7
GCTGCAGGTGCGAAAC-1_MS377_A2D2	-29.88695124	-9.295316431	9	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1148	1731	0.002310803	0.020219526	7	9	OPC	32	7	7
GCTGCAGTCTGGTGTA-1_MS377_A2D2	17.01480758	26.14310249	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1008	1575	0.001904762	0.004444444	7	oligos	OL-Cntl	32	7	7
GCTGCGATCTTAGCCC-1_MS377_A2D2	18.5226454	-20.32979996	4	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	3819	8758	0.016556291	0.00776433	7	L2-3	EN-L2-3-MS	32	7	7
GCTGCGATCTTCTGGC-1_MS377_A2D2	-0.324989052	27.39846765	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	736	1007	0.000993049	0.003972195	7	oligos	OL-Cntl	32	7	7
GCTGGGTTCCCAAGAT-1_MS377_A2D2	33.62993983	10.59680703	14	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	924	1257	0.002386635	0.032617343	7	14	Microglia	32	7	7
GCTTCCACATCCTAGA-1_MS377_A2D2	33.56281366	-10.90951583	2	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	3398	6887	0.006679251	0.006679251	7	2	EN-L4	32	7	7
GCTTCCACATGTTGAC-1_MS377_A2D2	22.5535661	-25.65451461	3	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	3544	7872	0.001651423	0.007113821	7	3	EN-L5-6	32	7	7
GGAAAGCCACACATGT-1_MS377_A2D2	-16.55376482	13.62688751	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1447	2219	0.003605228	0.018026138	7	8	Astrocytes	32	7	7
GGAAAGCTCAAAGACA-1_MS377_A2D2	19.992334	-1.14010118	12	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1541	2521	0.020230067	0.004363348	7	12	EN-MIX	32	7	7
GGAACTTCACTGTGTA-1_MS377_A2D2	-23.7116177	11.4199224	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1183	1693	0.004134672	0.013585351	7	8	Astrocytes	32	7	7
GGAACTTTCATGCAAC-1_MS377_A2D2	13.8158009	-4.635091137	12	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1698	2965	0.028667791	0.002698145	7	12	EN-MIX	32	7	7
GGAATAACATTCCTCG-1_MS377_A2D2	12.30391547	-15.60556705	4	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	4791	11318	0.010072451	0.012016257	7	L2-3	EN-L2-3-MS	32	7	7
GGACAGAAGGCAGTCA-1_MS377_A2D2	-30.45747995	9.626419927	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	747	1005	0.007960199	0.0039801	7	8	Astrocytes	32	7	7
GGACAGATCACCAGGC-1_MS377_A2D2	-28.844063	-21.33167789	6A	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	3825	8380	0.025536993	0.019689737	7	6A	IN-PV	32	7	7
GGACAGATCACCCGAG-1_MS377_A2D2	18.27101806	-22.69691465	3	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	5127	12959	0.007948144	0.030249248	7	3	EN-L5-6	32	7	7
GGACAGATCAGCACAT-1_MS377_A2D2	-9.356207892	-34.60783529	16	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1010	1528	0.082460733	0.007198953	7	16	EN-PYR	32	7	7
GGACAGATCTAACCGA-1_MS377_A2D2	22.47772529	16.15639988	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1360	2132	0.005628518	0.00891182	7	oligos	OL-Cntl	32	7	7
GGACATTAGTACGATA-1_MS377_A2D2	22.00480215	14.74922231	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1332	2118	0.001888574	0.006610009	7	oligos	OL-Cntl	32	7	7
GGACATTTCACCGTAA-1_MS377_A2D2	-5.421581387	-35.84608519	16	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	884	1234	0.064829822	0.021069692	7	16	EN-PYR	32	7	7
GGACATTTCGTAGGTT-1_MS377_A2D2	-19.13677905	-5.935860877	13B	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	3787	8042	0.008455608	0.009947774	7	13B	IN-SV2C	32	7	7
GGACATTTCTACTCAT-1_MS377_A2D2	5.537867451	18.21870284	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	971	1429	0.00489853	0.017494752	7	oligos	OL-Cntl	32	7	7
GGACGTCCAATCGGTT-1_MS377_A2D2	7.353665242	34.00934399	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	923	1389	0.007199424	0.006479482	7	oligos	OL-Cntl	32	7	7
GGAGCAAGTCTCTTAT-1_MS377_A2D2	30.43367739	-17.61580746	2	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	6339	19639	0.031518916	0.008656245	7	2	EN-L4	32	7	7
GGATGTTAGTGGAGTC-1_MS377_A2D2	19.8349803	-1.022418074	12	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1478	2367	0.024503591	0.004647233	7	12	EN-MIX	32	7	7
GGATGTTCACGTCAGC-1_MS377_A2D2	-3.145951324	21.492745	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	882	1240	0.013709677	0.016935484	7	oligos	OL-Cntl	32	7	7
GGATGTTCAGTATCTG-1_MS377_A2D2	22.3430221	16.71755873	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1347	2038	0.001962709	0.009322866	7	oligos	OL-Cntl	32	7	7
GGATGTTGTCTCGTTC-1_MS377_A2D2	-17.88497035	-21.45737868	6A	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1923	3413	0.014356871	0.004980955	7	6A	IN-PV	32	7	7
GGATGTTTCACCCTCA-1_MS377_A2D2	22.78056935	11.01500868	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1736	2923	0.003421143	0.005473828	7	oligos	OL-Cntl	32	7	7
GGATGTTTCCTTTCGG-1_MS377_A2D2	-19.75483428	-5.032690261	13B	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	3545	7083	0.008188621	0.012282931	7	13B	IN-SV2C	32	7	7
GGATGTTTCTACGAGT-1_MS377_A2D2	-2.67890089	23.05395611	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	802	1094	0.000914077	0.010968921	7	oligos	OL-Cntl	32	7	7
GGATTACAGGTGATAT-1_MS377_A2D2	-14.87572088	-16.04278438	6B	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1795	3373	0.011858879	0.0074118	7	6B	IN-SST	32	7	7
GGATTACTCGCTTAGA-1_MS377_A2D2	7.375755242	-16.69496106	4	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	3601	6924	0.004621606	0.013142692	7	L2-3	EN-L2-3-MS	32	7	7
GGCAATTAGTCCAGGA-1_MS377_A2D2	16.69129849	-4.592879949	12	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1252	1985	0.004030227	0.004534005	7	12	EN-MIX	32	7	7
GGCAATTCACCGCTAG-1_MS377_A2D2	-31.79813939	-6.422927362	9	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1182	1893	0.004754358	0.005810882	7	9	OPC	32	7	7
GGCAATTCACGGCCAT-1_MS377_A2D2	-3.631341677	19.51952715	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	801	1242	0.004830918	0.012077295	7	oligos	OL-Cntl	32	7	7
GGCAATTCATTAGGCT-1_MS377_A2D2	9.1305106	0.282821789	12	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1116	1726	0.00405562	0.016801854	7	12	EN-MIX	32	7	7
GGCAATTGTCAAACTC-1_MS377_A2D2	10.62568369	26.42662065	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	829	1203	0.004156276	0.002493766	7	oligos	OL-Cntl	32	7	7
GGCAATTGTGGTGTAG-1_MS377_A2D2	20.77736637	-4.527326608	2	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	2814	5461	0.016663615	0.015015565	7	2	EN-L4	32	7	7
GGCCGATAGGTACTCT-1_MS377_A2D2	-19.77413069	-6.130853029	13B	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	4311	9826	0.00875229	0.009769998	7	13B	IN-SV2C	32	7	7
GGCCGATCATGTAAGA-1_MS377_A2D2	-19.74749678	5.013602073	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	778	1058	0.006616257	0.011342155	7	8	Astrocytes	32	7	7
GGCCGATGTGAGGCTA-1_MS377_A2D2	-33.62827333	-6.016459044	9	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1308	2041	0.003429691	0.004899559	7	9	OPC	32	7	7
GGCCGATGTTCAGGCC-1_MS377_A2D2	27.84990929	7.115262978	15A	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	946	1353	0.013303769	0.040650407	7	15A	Endo cells	32	7	7
GGCGACTCACGAAATA-1_MS377_A2D2	-15.46989735	-4.941745384	13A	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	3818	8419	0.008670864	0.010927664	7	13A	IN-VIP	32	7	7
GGCGACTCATGGGAAC-1_MS377_A2D2	8.634588941	-15.41627049	4	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	3015	5776	0.011772853	0.007271468	7	L2-3	EN-L2-3-MS	32	7	7
GGCGACTCATGTTGAC-1_MS377_A2D2	21.66285464	-14.10117565	3	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	4393	12902	0.022244613	0.005813052	7	3	EN-L5-6	32	7	7
GGCGACTTCTACGAGT-1_MS377_A2D2	-14.60850023	-1.462836436	13A	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	2426	4277	0.010521394	0.020808978	7	13A	IN-VIP	32	7	7
GGCGTGTTCTAACTGG-1_MS377_A2D2	13.97511503	28.86826055	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	840	1225	0.001632653	0.000816327	7	oligos	OL-Cntl	32	7	7
GGCTCGACATTAGGCT-1_MS377_A2D2	-6.37636785	-7.200895516	13A	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1049	1524	0.021653543	0.00656168	7	13A	IN-VIP	32	7	7
GGCTCGATCCAAGCCG-1_MS377_A2D2	-11.56163314	-9.80925152	13B	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1616	2793	0.002864304	0.002864304	7	13B	IN-SV2C	32	7	7
GGCTGGTAGTGAACGC-1_MS377_A2D2	3.623009212	21.6278808	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	994	1456	0.004807692	0.005494505	7	oligos	OL-Cntl	32	7	7
GGCTGGTCATACAGCT-1_MS377_A2D2	6.605482898	30.49785785	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	830	1259	0.002382844	0.004765687	7	oligos	OL-Cntl	32	7	7
GGCTGGTCATGACGGA-1_MS377_A2D2	-2.04618794	23.25786976	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	813	1111	0.00270027	0.01440144	7	oligos	OL-Cntl	32	7	7
GGGAATGCACTACAGT-1_MS377_A2D2	19.14932026	-19.56141778	3	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	4026	9848	0.031275386	0.005686434	7	3	EN-L5-6	32	7	7
GGGACCTAGACGCACA-1_MS377_A2D2	2.383162977	4.743793694	7	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	982	1276	0.007053292	0.011755486	7	7	Phagocytes	32	7	7
GGGACCTAGCGATCCC-1_MS377_A2D2	-15.46962772	-22.04280454	6A	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1989	4186	0.007644529	0.004538939	7	6A	IN-PV	32	7	7
GGGACCTGTCGTGGCT-1_MS377_A2D2	24.73844382	8.291029158	15A	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	2745	4770	0.011740042	0.026205451	7	15A	Endo cells	32	7	7
GGGAGATAGGGATACC-1_MS377_A2D2	-24.67356219	-19.26861163	6A	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	4193	9052	0.012704375	0.007512152	7	6A	IN-PV	32	7	7
GGGAGATGTGCTGTAT-1_MS377_A2D2	31.10997377	-10.90898606	2	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	3126	6422	0.016972906	0.006072874	7	2	EN-L4	32	7	7
GGGAGATTCACAGGCC-1_MS377_A2D2	-7.434672883	-5.066176968	13A	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1652	2947	0.00542925	0.005768578	7	13A	IN-VIP	32	7	7
GGGATGATCATCATTC-1_MS377_A2D2	29.81506998	-11.37827294	2	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	5697	15859	0.009899741	0.00832335	7	2	EN-L4	32	7	7
GGGTCTGCAGGGTACA-1_MS377_A2D2	33.47744621	8.506774476	14	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	772	1001	0.010989011	0.017982018	7	14	Microglia	32	7	7
GGGTCTGTCTCCGGTT-1_MS377_A2D2	3.781779893	29.37747101	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	778	1080	0.002777778	0.013888889	7	oligos	OL-Cntl	32	7	7
GGGTTGCAGAAGCCCA-1_MS377_A2D2	13.73678603	1.897655824	12	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	791	1162	0.006884682	0.005163511	7	12	EN-MIX	32	7	7
GGGTTGCAGAGCTGGT-1_MS377_A2D2	15.62965368	-26.72219593	3	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	3575	7505	0.004796802	0.006928714	7	3	EN-L5-6	32	7	7
GGGTTGCAGCGCCTTG-1_MS377_A2D2	-10.11443541	-6.140974964	13A	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1707	2638	0.011372252	0.006444276	7	13A	IN-VIP	32	7	7
GGGTTGCAGCGTTGCC-1_MS377_A2D2	1.454811233	22.15500745	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	972	1350	0.002962963	0.008888889	7	oligos	OL-Cntl	32	7	7
GGGTTGCAGGATCGCA-1_MS377_A2D2	19.07772666	-19.5116037	3	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	2846	6232	0.027599487	0.00529525	7	3	EN-L5-6	32	7	7
GGGTTGCAGTGTCCAT-1_MS377_A2D2	-32.02473209	-5.57145748	9	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1452	2316	0.003022453	0.003454231	7	9	OPC	32	7	7
GGGTTGCGTGAACCTT-1_MS377_A2D2	-15.83456932	10.02759315	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1379	2225	0.00494382	0.003595506	7	8	Astrocytes	32	7	7
GGGTTGCTCTGGCGAC-1_MS377_A2D2	-2.66183464	-0.922276432	13A	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	2708	4848	0.001650165	0.014851485	7	13A	IN-VIP	32	7	7
GGTATTGGTTTGGCGC-1_MS377_A2D2	-5.500014605	-32.54040619	16	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	817	1096	0.079379562	0.008211679	7	16	EN-PYR	32	7	7
GGTATTGTCAAGGTAA-1_MS377_A2D2	23.16558123	18.4551686	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1227	1852	0.001079914	0.003239741	7	oligos	OL-Cntl	32	7	7
GGTATTGTCCCTCTTT-1_MS377_A2D2	12.43317618	-17.40250094	4	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	5651	17188	0.016174075	0.006807075	7	L2-3	EN-L2-3-MS	32	7	7
GGTGAAGAGTGTCTCA-1_MS377_A2D2	-3.269944795	17.89369286	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	879	1196	0.001672241	0.022575251	7	oligos	OL-Cntl	32	7	7
GGTGAAGCACAAGTAA-1_MS377_A2D2	20.85342028	-1.580343789	2	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1639	2732	0.03147877	0.002196193	7	2	EN-L4	32	7	7
GGTGAAGGTATAAACG-1_MS377_A2D2	34.32769181	-15.91905832	2	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	4299	9030	0.014839424	0.018272425	7	2	EN-L4	32	7	7
GGTGAAGGTGGAAAGA-1_MS377_A2D2	2.109513334	22.09432502	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	890	1238	0.001615509	0.005654281	7	oligos	OL-Cntl	32	7	7
GGTGAAGTCATCGCTC-1_MS377_A2D2	-0.228088713	23.5488175	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	754	1044	0	0.009578544	7	oligos	OL-Cntl	32	7	7
GGTGCGTCAAGTTAAG-1_MS377_A2D2	-23.99916021	13.66855238	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1415	2111	0.001421127	0.010421601	7	8	Astrocytes	32	7	7
GGTGCGTTCAGATAAG-1_MS377_A2D2	5.502651734	16.9741645	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1094	1638	0.004884005	0.01037851	7	oligos	OL-Cntl	32	7	7
GGTGTTATCGCTAGCG-1_MS377_A2D2	-2.516361338	22.13824627	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	864	1274	0.004709576	0.01255887	7	oligos	OL-Cntl	32	7	7
GTAACGTAGATCTGCT-1_MS377_A2D2	-32.37681565	2.108311372	9	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1904	3257	0.003684372	0.003377341	7	9	OPC	32	7	7
GTAACGTAGGAGTCTG-1_MS377_A2D2	-30.77673588	2.503215628	9	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	2406	4238	0.001887683	0.00660689	7	9	OPC	32	7	7
GTAACGTAGGATGGAA-1_MS377_A2D2	14.1868083	-27.07314361	3	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	3103	6404	0.006402249	0.005465334	7	3	EN-L5-6	32	7	7
GTAACGTCATCCCACT-1_MS377_A2D2	33.3741922	-11.09843621	2	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	2941	6192	0.008397933	0.004521964	7	2	EN-L4	32	7	7
GTAACTGCACAGACTT-1_MS377_A2D2	-26.8998376	-5.58469518	9	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1348	2162	0.000925069	0.001850139	7	9	OPC	32	7	7
GTAACTGTCCTAGGGC-1_MS377_A2D2	28.92312005	-13.48304493	2	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	5839	16987	0.013186554	0.009360099	7	2	EN-L4	32	7	7
GTAACTGTCTAACGGT-1_MS377_A2D2	30.55035517	-16.9177311	2	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	5542	15488	0.041322314	0.007877066	7	2	EN-L4	32	7	7
GTACTCCCAGACACTT-1_MS377_A2D2	12.73470357	-0.475607661	12	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	995	1565	0.044089457	0.003194888	7	12	EN-MIX	32	7	7
GTACTCCGTAGGACAC-1_MS377_A2D2	19.67839781	-10.32807015	3	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	2375	4521	0.03030303	0.00619332	7	3	EN-L5-6	32	7	7
GTACTTTCATTATCTC-1_MS377_A2D2	2.846839874	28.78785138	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	765	1068	0.00093633	0.012172285	7	oligos	OL-Cntl	32	7	7
GTAGGCCCACTGTCGG-1_MS377_A2D2	20.46190161	-22.64089914	3	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	7814	27861	0.017407846	0.004701913	7	3	EN-L5-6	32	7	7
GTAGGCCGTTTGACAC-1_MS377_A2D2	-23.92624285	10.40759607	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	999	1484	0.002695418	0.008086253	7	8	Astrocytes	32	7	7
GTAGGCCTCTTGTTTG-1_MS377_A2D2	-31.58987088	-11.57383523	9	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	919	1408	0.004261364	0.005681818	7	9	OPC	32	7	7
GTAGTCAAGAGCTGGT-1_MS377_A2D2	3.720840624	4.089127177	7	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1292	1937	0.001548787	0.074858028	7	7	Phagocytes	32	7	7
GTAGTCACATGACATC-1_MS377_A2D2	15.08998973	1.672844885	12	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1157	1817	0.035773253	0.006053935	7	12	EN-MIX	32	7	7
GTAGTCAGTAACGTTC-1_MS377_A2D2	0.576471659	22.27436408	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	840	1194	0.006700168	0.010050251	7	oligos	OL-Cntl	32	7	7
GTATCTTAGCCACGCT-1_MS377_A2D2	8.015697413	-10.7848537	4	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1896	2978	0.014439221	0.005708529	7	L2-3	EN-L2-3-MS	32	7	7
GTATCTTCAGCTTCGG-1_MS377_A2D2	17.69935595	18.06161729	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1162	1803	0.000554631	0.012756517	7	oligos	OL-Cntl	32	7	7
GTATCTTGTCGCCATG-1_MS377_A2D2	-14.76015736	-1.730179298	13A	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	2413	4364	0.015811182	0.021310724	7	13A	IN-VIP	32	7	7
GTATCTTGTTCAGCGC-1_MS377_A2D2	-32.61923808	-8.287207489	9	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1124	1642	0.002436054	0.004872107	7	9	OPC	32	7	7
GTATTCTTCCAGTATG-1_MS377_A2D2	-30.27786037	-1.988615855	9	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1428	2307	0.000433463	0.009969658	7	9	OPC	32	7	7
GTCAAGTCAATAAGCA-1_MS377_A2D2	-31.75985209	-12.94465933	9	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	735	1037	0.006750241	0.00289296	7	9	OPC	32	7	7
GTCACAAAGACAGACC-1_MS377_A2D2	-29.01003938	-5.32236341	9	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1222	1923	0.002080083	0.009880395	7	9	OPC	32	7	7
GTCACAAAGCTAAACA-1_MS377_A2D2	-18.07480689	-21.56739466	6A	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	2157	3838	0.008858781	0.00442939	7	6A	IN-PV	32	7	7
GTCACAAGTCCGCTGA-1_MS377_A2D2	5.720170441	13.27562407	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1188	1812	0.002759382	0.00607064	7	oligos	OL-Cntl	32	7	7
GTCACGGAGCCACCTG-1_MS377_A2D2	-4.825118986	-35.95122011	16	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	753	1083	0.082179132	0.006463527	7	16	EN-PYR	32	7	7
GTCACGGAGTTGTAGA-1_MS377_A2D2	-1.767831223	19.11556757	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	800	1159	0.008628128	0.010353753	7	oligos	OL-Cntl	32	7	7
GTCACGGTCGGATGGA-1_MS377_A2D2	-20.70245363	-20.74297198	6A	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	2043	3729	0.06409225	0.0050952	7	6A	IN-PV	32	7	7
GTCACGGTCTGTGCAA-1_MS377_A2D2	-23.79520727	18.99035297	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1485	2265	0.001324503	0.003090508	7	8	Astrocytes	32	7	7
GTCATTTAGCGTCTAT-1_MS377_A2D2	-3.579545132	17.09693708	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	809	1118	0.005366726	0.01431127	7	oligos	OL-Cntl	32	7	7
GTCATTTGTAAACCTC-1_MS377_A2D2	-16.75816197	11.98356085	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1198	1787	0.001119194	0.005595971	7	8	Astrocytes	32	7	7
GTCATTTGTCAAGCGA-1_MS377_A2D2	17.95063046	-21.5650086	3	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	4235	10166	0.011410584	0.008951407	7	3	EN-L5-6	32	7	7
GTCATTTTCACTGGGC-1_MS377_A2D2	-18.70042764	8.360798665	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	940	1323	0.004535147	0.009070295	7	8	Astrocytes	32	7	7
GTCATTTTCTTTACAC-1_MS377_A2D2	11.90376778	-14.49792757	4	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	4466	10282	0.015172145	0.010698308	7	L2-3	EN-L2-3-MS	32	7	7
GTCCTCAAGTGCAAGC-1_MS377_A2D2	-23.73414352	16.04462628	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1310	2095	0.001431981	0.007637232	7	8	Astrocytes	32	7	7
GTCCTCACAGTATAAG-1_MS377_A2D2	15.08122479	-21.56071641	4	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	7052	23407	0.01567907	0.005724783	7	L2-3	EN-L2-3-MS	32	7	7
GTCCTCAGTTAAGAAC-1_MS377_A2D2	-27.5467537	4.330344333	9	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	3537	7242	0.001380834	0.004694836	7	9	OPC	32	7	7
GTCGGGTAGTGCGTGA-1_MS377_A2D2	-23.33495904	9.131059762	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1130	1682	0.027348395	0.008323424	7	8	Astrocytes	32	7	7
GTCGGGTGTATAAACG-1_MS377_A2D2	27.23926173	4.830463002	15BA	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	776	1040	0.005769231	0.016346154	7	15BA	Stromal cells	32	7	7
GTCGTAAAGTGGAGAA-1_MS377_A2D2	-19.14442546	7.618546014	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	972	1385	0.002888087	0.00866426	7	8	Astrocytes	32	7	7
GTCGTAACAAGTAATG-1_MS377_A2D2	-17.83536129	-1.302642887	13A	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	3470	6420	0.011993769	0.016510903	7	13A	IN-VIP	32	7	7
GTCGTAACACGACTCG-1_MS377_A2D2	-32.27507229	-7.248962405	9	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1199	1858	0.004843918	0.003229279	7	9	OPC	32	7	7
GTCGTAACATATACGC-1_MS377_A2D2	-3.036038575	18.96601471	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	836	1243	0.009654063	0.012872084	7	oligos	OL-Cntl	32	7	7
GTCGTAATCACTTCAT-1_MS377_A2D2	-15.56726656	23.75716616	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1661	2675	0.002990654	0.009345794	7	8	Astrocytes	32	7	7
GTCTCGTTCCCATTAT-1_MS377_A2D2	25.11983835	8.873548218	15A	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	2533	4556	0.019973661	0.03358209	7	15A	Endo cells	32	7	7
GTCTTCGAGCACCGCT-1_MS377_A2D2	4.698233893	-8.944088411	12	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1492	2328	0.011168385	0.010309278	7	12	EN-MIX	32	7	7
GTCTTCGAGGGTCGAT-1_MS377_A2D2	-1.311611194	1.002976161	11	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	2628	4578	0.015727392	0.004805592	7	11	Glia-MIX	32	7	7
GTCTTCGGTCTAGAGG-1_MS377_A2D2	-0.342489552	23.75167649	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	779	1134	0	0.003527337	7	oligos	OL-Cntl	32	7	7
GTGAAGGCAGCTGTTA-1_MS377_A2D2	11.74900217	13.42116623	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1548	2659	0.001880406	0.005265137	7	oligos	OL-Cntl	32	7	7
GTGCAGCCACCCTATC-1_MS377_A2D2	-16.92634857	-2.157623604	13A	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	3008	5927	0.01164164	0.014847309	7	13A	IN-VIP	32	7	7
GTGCAGCGTATCTGCA-1_MS377_A2D2	27.03080652	4.752396643	15BA	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	896	1319	0.005307051	0.012888552	7	15BA	Stromal cells	32	7	7
GTGCAGCGTCTCTTTA-1_MS377_A2D2	-3.821684492	22.16704868	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	784	1063	0.004703669	0.020696143	7	oligos	OL-Cntl	32	7	7
GTGCAGCTCCTTGGTC-1_MS377_A2D2	2.209818885	22.7809112	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	869	1284	0	0.010124611	7	oligos	OL-Cntl	32	7	7
GTGCATACATGAACCT-1_MS377_A2D2	32.01024628	-11.32538529	2	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	2798	5344	0.023203593	0.011227545	7	2	EN-L4	32	7	7
GTGCATAGTCTTGATG-1_MS377_A2D2	-18.90340805	6.91846587	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	765	1087	0.00275989	0.007359706	7	8	Astrocytes	32	7	7
GTGCATATCCTAAGTG-1_MS377_A2D2	0.270595014	24.16966424	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	779	1073	0.002795899	0.014911463	7	oligos	OL-Cntl	32	7	7
GTGCGGTAGACTACAA-1_MS377_A2D2	6.279017806	34.26445104	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	942	1519	0.001316656	0.005266623	7	oligos	OL-Cntl	32	7	7
GTGCGGTCATCTCCCA-1_MS377_A2D2	4.953800476	0.312488393	16	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	968	1413	0.063694268	0.013446568	7	16	EN-PYR	32	7	7
GTGCGGTGTGGTCCGT-1_MS377_A2D2	22.16676019	-6.845028235	3	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	2403	4532	0.002868491	0.005957635	7	3	EN-L5-6	32	7	7
GTGGGTCCAAGTAATG-1_MS377_A2D2	8.507562688	-17.29444139	4	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	4872	11161	0.007347012	0.020517875	7	L2-3	EN-L2-3-MS	32	7	7
GTGGGTCCACCATGTA-1_MS377_A2D2	3.812769355	-11.23258822	12	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1894	3174	0.009136736	0.005356018	7	12	EN-MIX	32	7	7
GTGGGTCCAGAGTGTG-1_MS377_A2D2	-17.02858186	12.23172093	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1443	2122	0.001885014	0.004712535	7	8	Astrocytes	32	7	7
GTGGGTCGTTCGTTGA-1_MS377_A2D2	-14.15804418	-15.27406535	6B	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1474	2425	0.029278351	0.006597938	7	6B	IN-SST	32	7	7
GTGTTAGAGACAAAGG-1_MS377_A2D2	22.13424977	-17.23317444	3	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	5961	14999	0.012267484	0.014600973	7	3	EN-L5-6	32	7	7
GTGTTAGAGCCAGGAT-1_MS377_A2D2	17.10060944	-17.32993306	4	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	5651	15448	0.017024858	0.006602796	7	L2-3	EN-L2-3-MS	32	7	7
GTGTTAGCACTGAAGG-1_MS377_A2D2	-7.38830931	-33.54918384	16	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	948	1580	0.162658228	0.011392405	7	16	EN-PYR	32	7	7
GTGTTAGCATCCAACA-1_MS377_A2D2	-10.39402696	-15.99627275	6B	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1066	1668	0.068944844	0.002398082	7	6B	IN-SST	32	7	7
GTGTTAGGTTGATTCG-1_MS377_A2D2	-29.65965328	-5.933117661	9	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1154	1708	0.003512881	0.005269321	7	9	OPC	32	7	7
GTTAAGCAGGCACATG-1_MS377_A2D2	32.27124975	-16.41196288	2	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	4251	9540	0.018658281	0.010272537	7	2	EN-L4	32	7	7
GTTACAGAGTGAAGTT-1_MS377_A2D2	5.327692426	-16.54849138	4	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	3541	7317	0.004510045	0.006560066	7	L2-3	EN-L2-3-MS	32	7	7
GTTACAGGTTACAGAA-1_MS377_A2D2	20.21815206	-3.625953436	2	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1729	2711	0.029878274	0.004795278	7	2	EN-L4	32	7	7
GTTCATTAGCGATAGC-1_MS377_A2D2	-16.58927669	-1.805405318	13A	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	3228	6179	0.007120893	0.01068134	7	13A	IN-VIP	32	7	7
GTTCATTGTGGCCCTA-1_MS377_A2D2	-10.43278678	9.488188253	11	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	5444	15243	0.005313915	0.007544447	7	11	Glia-MIX	32	7	7
GTTCGGGGTCCGAGTC-1_MS377_A2D2	-16.76286799	22.88178197	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1556	2529	0.00118624	0.007512851	7	8	Astrocytes	32	7	7
GTTCGGGTCGATGAGG-1_MS377_A2D2	-31.42484133	0.599067507	9	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1858	3021	0.004634227	0.007613373	7	9	OPC	32	7	7
GTTCTCGTCTTGTACT-1_MS377_A2D2	29.64150129	9.47166348	15DB	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	800	1498	0.007343124	0.072763685	7	15DB	B cells	32	7	7
GTTTCTAAGAAACGCC-1_MS377_A2D2	14.62596004	18.87904934	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1061	1625	0.002461538	0.003692308	7	oligos	OL-Cntl	32	7	7
GTTTCTAAGATGTTAG-1_MS377_A2D2	12.89030594	-18.03833865	4	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	5329	14280	0.010714286	0.004901961	7	L2-3	EN-L2-3-MS	32	7	7
GTTTCTACACGAAACG-1_MS377_A2D2	22.56918236	16.42196816	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1333	2025	0.002962963	0.00691358	7	oligos	OL-Cntl	32	7	7
GTTTCTACACTTAACG-1_MS377_A2D2	11.22636996	-2.520928992	12	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1443	2171	0.035006909	0.005066789	7	12	EN-MIX	32	7	7
GTTTCTACAGTAAGCG-1_MS377_A2D2	-4.164801042	19.8663717	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	761	1054	0	0.015180266	7	oligos	OL-Cntl	32	7	7
TAAACCGAGCGTGAAC-1_MS377_A2D2	-12.45821331	-21.71136146	6B	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1192	2241	0.135207497	0.003123606	7	6B	IN-SST	32	7	7
TAAGAGACATCCGGGT-1_MS377_A2D2	-24.86938199	-7.803637943	9	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1371	2180	0.044036697	0.003211009	7	9	OPC	32	7	7
TAAGCGTCACGAGAGT-1_MS377_A2D2	-32.45029271	-10.92810719	9	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	978	1497	0.004008016	0.004008016	7	9	OPC	32	7	7
TAAGCGTGTGTTTGGT-1_MS377_A2D2	-18.27121452	-1.209966535	13A	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	3636	7200	0.007222222	0.02	7	13A	IN-VIP	32	7	7
TAAGTGCAGGAGTTGC-1_MS377_A2D2	-13.42264827	16.92842987	11	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1428	2083	0.005280845	0.009121459	7	11	Glia-MIX	32	7	7
TAAGTGCGTCCTCTTG-1_MS377_A2D2	2.812436964	19.98723001	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	795	1178	0.006791171	0.005942275	7	oligos	OL-Cntl	32	7	7
TACACGAAGCAATCTC-1_MS377_A2D2	3.850660711	19.79494041	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	946	1407	0.002842928	0.008528785	7	oligos	OL-Cntl	32	7	7
TACACGAGTTCGAATC-1_MS377_A2D2	12.70893797	11.57394866	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1427	2210	0.001809955	0.017647059	7	oligos	OL-Cntl	32	7	7
TACACGATCGGGAGTA-1_MS377_A2D2	5.470902387	18.10696088	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1095	1578	0.000633714	0.01774398	7	oligos	OL-Cntl	32	7	7
TACCTATGTCAGAATA-1_MS377_A2D2	-18.16591049	6.352214514	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	887	1200	0.0075	0.009166667	7	8	Astrocytes	32	7	7
TACCTTAAGCAGGTCA-1_MS377_A2D2	5.568757821	26.29351308	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	862	1309	0.004583652	0.005347594	7	oligos	OL-Cntl	32	7	7
TACCTTAGTCACTTCC-1_MS377_A2D2	-15.33362276	10.52162053	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1743	3036	0.001976285	0.012187088	7	8	Astrocytes	32	7	7
TACGGATCAGCTTCGG-1_MS377_A2D2	7.110248982	-0.823274699	12	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1117	1769	0.041266252	0.011871114	7	12	EN-MIX	32	7	7
TACGGATTCGAGAGCA-1_MS377_A2D2	-1.889039383	16.0052857	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	795	1126	0.005328597	0.020426288	7	oligos	OL-Cntl	32	7	7
TACGGGCAGCGGATCA-1_MS377_A2D2	-6.581095709	-33.67427517	16	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	661	1013	0.109575518	0.008884501	7	16	EN-PYR	32	7	7
TACGGGCGTTGAGTTC-1_MS377_A2D2	-2.831464114	21.92901385	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	802	1152	0.000868056	0.011284722	7	oligos	OL-Cntl	32	7	7
TACGGGCTCAATCTCT-1_MS377_A2D2	14.46672209	-17.4667878	4	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	6621	19399	0.008196299	0.008763338	7	L2-3	EN-L2-3-MS	32	7	7
TACGGGCTCTGCTTGC-1_MS377_A2D2	26.42403288	3.791731019	15BA	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	740	1326	0	0.007541478	7	15BA	Stromal cells	32	7	7
TACGGTAAGTGTTGAA-1_MS377_A2D2	-19.00449623	8.064627663	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1168	1709	0.003510825	0.004095963	7	8	Astrocytes	32	7	7
TACGGTAGTGGCTCCA-1_MS377_A2D2	23.13000243	16.90104778	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1432	2175	0.002298851	0.004597701	7	oligos	OL-Cntl	32	7	7
TACGGTAGTTGCGCAC-1_MS377_A2D2	7.503610203	19.5288525	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1138	1694	0.004132231	0.006493506	7	oligos	OL-Cntl	32	7	7
TACGGTAGTTTCGCTC-1_MS377_A2D2	-2.352517255	23.27620845	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	800	1123	0.001780944	0.010685663	7	oligos	OL-Cntl	32	7	7
TACTCATTCAAACGGG-1_MS377_A2D2	10.01204132	0.804391992	12	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	880	1509	0.157057654	0.003976143	7	12	EN-MIX	32	7	7
TACTCATTCTTGGGTA-1_MS377_A2D2	-17.2527072	-14.72252059	6B	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1985	3341	0.039509129	0.003891051	7	6B	IN-SST	32	7	7
TACTCGCAGAGTACCG-1_MS377_A2D2	5.948601793	13.08039844	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1284	1931	0.012428793	0.015535992	7	oligos	OL-Cntl	32	7	7
TACTCGCAGCCTATGT-1_MS377_A2D2	-3.48851108	19.99788486	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	759	1049	0.000953289	0.012392755	7	oligos	OL-Cntl	32	7	7
TACTCGCAGCGCCTTG-1_MS377_A2D2	-6.370614224	-35.82859383	16	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	822	1142	0.050788091	0.015761821	7	16	EN-PYR	32	7	7
TACTTGTAGGGTGTGT-1_MS377_A2D2	15.13274252	1.72217728	12	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	985	1497	0.017368069	0.001336005	7	12	EN-MIX	32	7	7
TACTTGTCAGTAGAGC-1_MS377_A2D2	12.70940926	16.96451052	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1344	1975	0	0.006075949	7	oligos	OL-Cntl	32	7	7
TACTTGTGTCCGAATT-1_MS377_A2D2	-1.77171789	24.03564042	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	762	1116	0.000896057	0.005376344	7	oligos	OL-Cntl	32	7	7
TACTTGTGTTCAGCGC-1_MS377_A2D2	3.517006969	4.865930095	7	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1240	1756	0.004555809	0.018792711	7	7	Phagocytes	32	7	7
TACTTGTTCTGATTCT-1_MS377_A2D2	21.30170616	-21.62887309	3	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	3987	10060	0.014612326	0.00695825	7	3	EN-L5-6	32	7	7
TAGACCAAGCTCCCAG-1_MS377_A2D2	10.82567674	-20.42497571	4	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	4103	10240	0.006054688	0.003027344	7	L2-3	EN-L2-3-MS	32	7	7
TAGAGCTCAATGCCAT-1_MS377_A2D2	-33.89462921	-8.596207322	9	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	984	1503	0.000665336	0.002661344	7	9	OPC	32	7	7
TAGCCGGAGATATGGT-1_MS377_A2D2	-2.013738861	19.95363711	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	818	1135	0.001762115	0.013215859	7	oligos	OL-Cntl	32	7	7
TAGCCGGAGCTCCTTC-1_MS377_A2D2	-15.01514432	-0.340125286	13A	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	2638	4840	0.004338843	0.01838843	7	13A	IN-VIP	32	7	7
TAGCCGGCACATTTCT-1_MS377_A2D2	8.970015805	21.49761255	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	806	1211	0.003303055	0.005780347	7	oligos	OL-Cntl	32	7	7
TAGCCGGCATTCCTCG-1_MS377_A2D2	-18.70810873	-19.92029713	6A	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	2171	4040	0.006435644	0.007178218	7	6A	IN-PV	32	7	7
TAGGCATCAAGGCTCC-1_MS377_A2D2	32.59032134	9.445376716	14	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	910	1270	0.033070866	0.034645669	7	14	Microglia	32	7	7
TAGGCATGTTCCCGAG-1_MS377_A2D2	-6.545691304	-35.34338515	16	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	940	1311	0.080091533	0.022120519	7	16	EN-PYR	32	7	7
TAGTGGTCAAGTACCT-1_MS377_A2D2	-19.70453264	4.727397868	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1044	1635	0.017737003	0.017737003	7	8	Astrocytes	32	7	7
TAGTGGTCATTGCGGC-1_MS377_A2D2	-31.85236335	-8.051598984	9	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1087	1629	0.004910988	0.004910988	7	9	OPC	32	7	7
TAGTTGGTCTTGACGA-1_MS377_A2D2	1.22258561	22.47859475	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	828	1178	0.005093379	0.007640068	7	oligos	OL-Cntl	32	7	7
TATCAGGTCGGACAAG-1_MS377_A2D2	33.68787919	-18.3785403	2	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	4390	9233	0.017112531	0.016679303	7	2	EN-L4	32	7	7
TATCTCATCCTCAATT-1_MS377_A2D2	37.0649116	9.314372008	14	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	764	1044	0.002873563	0.006704981	7	14	Microglia	32	7	7
TATGCCCTCGCCCTTA-1_MS377_A2D2	-0.589226324	18.90484199	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	756	1108	0.005415162	0.013537906	7	oligos	OL-Cntl	32	7	7
TATTACCCATAGACTC-1_MS377_A2D2	-1.918712058	23.22877404	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	783	1099	0.005459509	0.005459509	7	oligos	OL-Cntl	32	7	7
TCAACGAAGGGAGTAA-1_MS377_A2D2	5.776134863	13.95628134	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1177	1764	0.005102041	0.017573696	7	oligos	OL-Cntl	32	7	7
TCAACGACAATGGTCT-1_MS377_A2D2	35.85675879	9.701753079	14	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	864	1164	0.013745704	0.012886598	7	14	Microglia	32	7	7
TCAACGAGTACCGCTG-1_MS377_A2D2	7.142531758	-14.24000844	4	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	2474	4528	0.010159011	0.0170053	7	L2-3	EN-L2-3-MS	32	7	7
TCAACGAGTATAATGG-1_MS377_A2D2	6.019992869	13.12651059	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1212	1820	0.005494505	0.025274725	7	oligos	OL-Cntl	32	7	7
TCAACGAGTCACCTAA-1_MS377_A2D2	14.53367692	-17.37557867	4	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	5788	15236	0.010304542	0.01174849	7	L2-3	EN-L2-3-MS	32	7	7
TCAACGATCACTCCTG-1_MS377_A2D2	-13.11524318	-37.19850253	16	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1821	3430	0.083090379	0.011370262	7	16	EN-PYR	32	7	7
TCAATCTAGCTTTGGT-1_MS377_A2D2	16.84037792	11.80139148	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1351	2370	0.001265823	0.006329114	7	oligos	OL-Cntl	32	7	7
TCAATCTGTATAAACG-1_MS377_A2D2	-3.935789818	19.34195089	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	837	1188	0.01010101	0.011784512	7	oligos	OL-Cntl	32	7	7
TCAATCTGTGAGTATA-1_MS377_A2D2	-26.66514401	-2.055369905	9	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1600	2637	0.004929845	0.019719378	7	9	OPC	32	7	7
TCAATCTGTTCAACCA-1_MS377_A2D2	4.576300013	-12.2133432	4	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	2152	4067	0.008605852	0.006884682	7	L2-3	EN-L2-3-MS	32	7	7
TCACAAGAGAAGAAGC-1_MS377_A2D2	6.537425376	13.25942044	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1561	2426	0.008244023	0.017312448	7	oligos	OL-Cntl	32	7	7
TCACAAGAGCCCGAAA-1_MS377_A2D2	27.09456909	8.902330562	15A	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1259	1820	0.012087912	0.045604396	7	15A	Endo cells	32	7	7
TCACAAGCATGGTAGG-1_MS377_A2D2	9.060402253	-3.028530041	12	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1783	2929	0.069989758	0.004096961	7	12	EN-MIX	32	7	7
TCACAAGTCTTGTCAT-1_MS377_A2D2	18.71157167	-19.92262438	4	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	3261	7331	0.030282363	0.004910653	7	L2-3	EN-L2-3-MS	32	7	7
TCACGAAAGAGTAAGG-1_MS377_A2D2	20.83715836	-21.13707336	3	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	5552	14411	0.018805079	0.008604538	7	3	EN-L5-6	32	7	7
TCACGAAAGTTAGGTA-1_MS377_A2D2	-10.39967523	9.595124532	11	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	3942	8075	0.008421053	0.01003096	7	11	Glia-MIX	32	7	7
TCACGAACATCTACGA-1_MS377_A2D2	22.99754593	-22.58859287	3	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	3853	9633	0.024706737	0.003529534	7	3	EN-L5-6	32	7	7
TCACGAAGTGGCTCCA-1_MS377_A2D2	-24.50752474	-19.43855503	6A	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	3884	8358	0.013639627	0.009452022	7	6A	IN-PV	32	7	7
TCACGAATCAAACCGT-1_MS377_A2D2	-32.40294554	-8.42100708	9	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1080	1582	0.001896334	0.003160556	7	9	OPC	32	7	7
TCACGAATCAGTGCAT-1_MS377_A2D2	-4.697941116	-3.250859155	13A	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1397	2523	0.00673801	0.001189061	7	13A	IN-VIP	32	7	7
TCACGAATCGGTCTAA-1_MS377_A2D2	-2.35304084	18.36619658	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	806	1181	0.00254022	0.00762066	7	oligos	OL-Cntl	32	7	7
TCAGATGGTCGCGGTT-1_MS377_A2D2	0.698000058	26.75681598	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1009	1444	0.001385042	0.005540166	7	oligos	OL-Cntl	32	7	7
TCAGATGGTCTAGCCG-1_MS377_A2D2	-19.24951811	-20.80024627	6A	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	2820	5970	0.023785595	0.005025126	7	6A	IN-PV	32	7	7
TCAGATGGTGATAAGT-1_MS377_A2D2	-11.73544299	-14.43530212	6B	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1242	1846	0.020043337	0.009209101	7	6B	IN-SST	32	7	7
TCAGCAATCACCTCGT-1_MS377_A2D2	-9.139061919	-16.52288303	6B	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	836	1309	0.095492743	0.005347594	7	6B	IN-SST	32	7	7
TCAGCAATCTGACCTC-1_MS377_A2D2	17.45150154	-17.94270348	4	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	5183	16155	0.031445373	0.003404519	7	L2-3	EN-L2-3-MS	32	7	7
TCAGCTCAGGGTTCCC-1_MS377_A2D2	3.252722577	18.04958526	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	977	1515	0.005280528	0.007260726	7	oligos	OL-Cntl	32	7	7
TCAGCTCCACGGTGTC-1_MS377_A2D2	18.10177216	-10.60542764	3	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	2952	5974	0.003850017	0.008871778	7	3	EN-L5-6	32	7	7
TCAGCTCCAGATGGCA-1_MS377_A2D2	-16.50430264	16.32911936	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1957	3308	0.001511487	0.015114873	7	8	Astrocytes	32	7	7
TCAGCTCTCTATCGCC-1_MS377_A2D2	13.76692418	-27.38869267	3	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	2840	6559	0.02286934	0.002591859	7	3	EN-L5-6	32	7	7
TCAGGATAGCCTTGAT-1_MS377_A2D2	33.37934465	-15.75733851	2	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	4016	8964	0.015171798	0.009036145	7	2	EN-L4	32	7	7
TCAGGATCACTGTGTA-1_MS377_A2D2	-10.81466292	29.00300991	17	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	884	1156	0.033737024	0.009515571	7	oligos	OL-MS-2	32	7	7
TCAGGATCAGTTCATG-1_MS377_A2D2	-26.49724221	11.41421452	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	981	1408	0.000710227	0.009232955	7	8	Astrocytes	32	7	7
TCAGGATGTCTAAACC-1_MS377_A2D2	-28.10933808	11.26329228	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	889	1251	0.003996803	0.007194245	7	8	Astrocytes	32	7	7
TCAGGATGTGACCAAG-1_MS377_A2D2	2.647004715	20.17423499	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	941	1350	0.006666667	0.016296296	7	oligos	OL-Cntl	32	7	7
TCAGGTACACAGACAG-1_MS377_A2D2	-9.312075332	19.3699547	11	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	3036	5477	0.003103889	0.013693628	7	11	Glia-MIX	32	7	7
TCAGGTACATCATCCC-1_MS377_A2D2	1.70386625	25.9713998	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	659	1013	0.000987167	0.014807502	7	oligos	OL-Cntl	32	7	7
TCAGGTAGTTTAGCTG-1_MS377_A2D2	10.12504853	26.0624847	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	956	1486	0.00269179	0.007402423	7	oligos	OL-Cntl	32	7	7
TCAGGTAGTTTGTTTC-1_MS377_A2D2	0.516323041	21.45082087	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	774	1045	0.001913876	0.010526316	7	oligos	OL-Cntl	32	7	7
TCAGGTATCCCTCAGT-1_MS377_A2D2	-28.12751233	-1.873909267	9	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1618	2611	0.003446955	0.019149751	7	9	OPC	32	7	7
TCAGGTATCGATAGAA-1_MS377_A2D2	22.4630016	-16.74741676	3	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	5017	11505	0.011734029	0.008431117	7	3	EN-L5-6	32	7	7
TCATTACCAAATTGCC-1_MS377_A2D2	32.1946485	13.95973247	14	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1241	1925	0.006753247	0.048831169	7	14	Microglia	32	7	7
TCATTACCATGGAATA-1_MS377_A2D2	-16.73691091	-2.169903482	13A	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	2552	4711	0.02780726	0.017406071	7	13A	IN-VIP	32	7	7
TCATTACTCCTCCTAG-1_MS377_A2D2	16.46751459	17.64572908	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1065	1735	0.001152738	0.005763689	7	oligos	OL-Cntl	32	7	7
TCATTTGGTACTTCTT-1_MS377_A2D2	9.765034908	17.6777512	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	971	1591	0.001257071	0.006285355	7	oligos	OL-Cntl	32	7	7
TCCACACAGTCCAGGA-1_MS377_A2D2	12.42353685	-17.1428804	4	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	5357	14139	0.010962586	0.009477332	7	L2-3	EN-L2-3-MS	32	7	7
TCCACACCACATAACC-1_MS377_A2D2	-32.91646472	-8.84812924	9	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1073	1752	0.000570776	0.000570776	7	9	OPC	32	7	7
TCCACACGTATTCGTG-1_MS377_A2D2	-2.839693205	23.14305704	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	712	1033	0.010648596	0.010648596	7	oligos	OL-Cntl	32	7	7
TCCACACTCAGCAACT-1_MS377_A2D2	4.557075121	-13.59866623	4	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	2466	5296	0.011518127	0.007175227	7	L2-3	EN-L2-3-MS	32	7	7
TCCACACTCGGAAATA-1_MS377_A2D2	8.117066533	-10.76158683	4	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	2032	3562	0.013756317	0.004211117	7	L2-3	EN-L2-3-MS	32	7	7
TCCACACTCTACCAGA-1_MS377_A2D2	1.787633584	25.95327741	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	865	1278	0.008607199	0.003912363	7	oligos	OL-Cntl	32	7	7
TCCCGATAGTCAAGCG-1_MS377_A2D2	-20.43244113	-4.797037764	13B	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	4173	8573	0.01656363	0.014230724	7	13B	IN-SV2C	32	7	7
TCCCGATGTATAGGTA-1_MS377_A2D2	10.34282377	28.93006537	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	803	1177	0.004248088	0.004248088	7	oligos	OL-Cntl	32	7	7
TCCCGATTCAACGGCC-1_MS377_A2D2	25.467037	8.361896541	15A	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1863	2935	0.009540034	0.029982964	7	15A	Endo cells	32	7	7
TCCCGATTCCGAATGT-1_MS377_A2D2	4.582848215	-8.654513142	12	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1410	2379	0.026481715	0.008406894	7	12	EN-MIX	32	7	7
TCGAGGCAGGGTTTCT-1_MS377_A2D2	1.172464366	20.96428143	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	826	1148	0.00087108	0.015679443	7	oligos	OL-Cntl	32	7	7
TCGAGGCCACACTGCG-1_MS377_A2D2	-24.84361966	12.58708056	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1083	1505	0.002657807	0.002657807	7	8	Astrocytes	32	7	7
TCGAGGCCATTCCTGC-1_MS377_A2D2	-16.34177991	12.61640794	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1302	2060	0.005825243	0.010194175	7	8	Astrocytes	32	7	7
TCGCGAGGTAAATGTG-1_MS377_A2D2	6.452963438	13.62527663	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1420	2158	0.007877665	0.009731233	7	oligos	OL-Cntl	32	7	7
TCGCGTTAGAGCTATA-1_MS377_A2D2	-24.53441241	11.09383629	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	949	1360	0	0.005882353	7	8	Astrocytes	32	7	7
TCGCGTTAGCTAAGAT-1_MS377_A2D2	10.68521061	-16.50374853	4	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	4041	8686	0.009440479	0.007943818	7	L2-3	EN-L2-3-MS	32	7	7
TCGCGTTGTACCAGTT-1_MS377_A2D2	-31.04158914	10.76139776	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	893	1253	0.003192338	0.007980846	7	8	Astrocytes	32	7	7
TCGCGTTGTGGTTTCA-1_MS377_A2D2	-31.26543926	-10.26197118	9	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1060	1619	0.003705991	0.010500309	7	9	OPC	32	7	7
TCGGTAAGTCGTGGCT-1_MS377_A2D2	18.96780506	-16.57928629	4	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	5276	14780	0.032611637	0.006156969	7	L2-3	EN-L2-3-MS	32	7	7
TCGGTAATCTATCCCG-1_MS377_A2D2	23.44643332	-24.58867925	3	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	3217	7065	0.015852795	0.004812456	7	3	EN-L5-6	32	7	7
TCGTACCAGCCGGTAA-1_MS377_A2D2	5.194600686	19.84623227	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1071	1559	0.002565747	0.01411161	7	oligos	OL-Cntl	32	7	7
TCGTACCGTAAGTGGC-1_MS377_A2D2	-32.2787602	-7.544348431	9	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1143	1653	0.001814882	0.007259528	7	9	OPC	32	7	7
TCGTAGATCGCCATAA-1_MS377_A2D2	-17.44466792	-6.218713541	13B	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	2644	5141	0.005251897	0.008558646	7	13B	IN-SV2C	32	7	7
TCTATTGGTCGGATCC-1_MS377_A2D2	-10.70172764	-13.52277652	6B	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1227	1959	0.064828994	0.01020929	7	6B	IN-SST	32	7	7
TCTATTGGTGATGTCT-1_MS377_A2D2	-31.14498627	11.23121818	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	806	1132	0.010600707	0.006183746	7	8	Astrocytes	32	7	7
TCTATTGTCCAACCAA-1_MS377_A2D2	21.46281853	16.65937106	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1280	2103	0.000475511	0.009510223	7	oligos	OL-Cntl	32	7	7
TCTCTAACAATGGAAT-1_MS377_A2D2	18.77048143	16.41459288	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1126	1744	0.010894495	0.005733945	7	oligos	OL-Cntl	32	7	7
TCTCTAACAGTAACGG-1_MS377_A2D2	-3.555389637	19.33263434	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	869	1224	0.004901961	0.012254902	7	oligos	OL-Cntl	32	7	7
TCTCTAAGTGTAAGTA-1_MS377_A2D2	3.733741818	25.85331272	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	800	1151	0	0.004344049	7	oligos	OL-Cntl	32	7	7
TCTGAGAGTCGAACAG-1_MS377_A2D2	21.42680084	-2.0239597	2	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	2127	3718	0.007261969	0.005648198	7	2	EN-L4	32	7	7
TCTGAGATCCCAAGAT-1_MS377_A2D2	-33.8532968	-3.505336875	9	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1469	2301	0.00478053	0.007388092	7	9	OPC	32	7	7
TCTGAGATCTGAGGGA-1_MS377_A2D2	7.869690712	-2.807054893	12	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1339	2096	0.023854962	0.016698473	7	12	EN-MIX	32	7	7
TCTTCGGAGCGTTTAC-1_MS377_A2D2	33.13418495	-4.529409262	2	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	3210	6911	0.005498481	0.005787874	7	2	EN-L4	32	7	7
TCTTCGGAGGATGGAA-1_MS377_A2D2	-9.644188857	-17.60166446	6B	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	880	1389	0.037437005	0	7	6B	IN-SST	32	7	7
TCTTCGGCATGTAGTC-1_MS377_A2D2	25.80702123	3.6348016	15BA	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	800	1119	0.00178731	0.002680965	7	15BA	Stromal cells	32	7	7
TCTTTCCAGGGTATCG-1_MS377_A2D2	20.79987492	-4.184647855	2	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	2206	3846	0.018980759	0.014560582	7	2	EN-L4	32	7	7
TCTTTCCCAAGAGGCT-1_MS377_A2D2	-14.3791638	-2.069757489	13A	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	2471	4613	0.006936917	0.018426187	7	13A	IN-VIP	32	7	7
TCTTTCCTCACGCATA-1_MS377_A2D2	19.35850018	1.509758757	2	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1313	2337	0.004706889	0.001711596	7	2	EN-L4	32	7	7
TGAAAGAAGCTAGTGG-1_MS377_A2D2	-8.61776901	-5.507529443	13A	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1602	2581	0.005424254	0.007361488	7	13A	IN-VIP	32	7	7
TGAAAGACAAATTGCC-1_MS377_A2D2	0.080235457	23.88362735	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	737	1059	0.002832861	0.008498584	7	oligos	OL-Cntl	32	7	7
TGAAAGACAAGCCGCT-1_MS377_A2D2	7.579836903	-12.38645163	4	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	2093	3634	0.010456797	0.007429829	7	L2-3	EN-L2-3-MS	32	7	7
TGAAAGACATGTAAGA-1_MS377_A2D2	28.13900097	6.73930999	15BA	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	778	1064	0.026315789	0.047932331	7	15BA	Stromal cells	32	7	7
TGAAAGATCTTGCAAG-1_MS377_A2D2	23.09808433	11.90271248	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1597	2713	0.001474383	0.002948765	7	oligos	OL-Cntl	32	7	7
TGACAACCACTGTGTA-1_MS377_A2D2	-15.33950851	-21.46751547	6A	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1970	3751	0.005331911	0.006398294	7	6A	IN-PV	32	7	7
TGACGGCTCTCGTTTA-1_MS377_A2D2	34.08052559	-4.794960002	2	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	3109	6267	0.001436094	0.007978299	7	2	EN-L4	32	7	7
TGACTTTCAAGTCTAC-1_MS377_A2D2	6.605385047	19.90260253	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1010	1485	0.005387205	0.012794613	7	oligos	OL-Cntl	32	7	7
TGACTTTGTATAATGG-1_MS377_A2D2	-2.026286308	22.7611929	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	795	1093	0.005489478	0.016468435	7	oligos	OL-Cntl	32	7	7
TGACTTTTCGTTGCCT-1_MS377_A2D2	1.619440598	10.31669454	5	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1167	1887	0.056173821	0.013248543	7	oligos	OL-MS-1	32	7	7
TGAGCATAGACTGGGT-1_MS377_A2D2	14.00499358	0.33830433	12	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	688	1017	0.006882989	0.004916421	7	12	EN-MIX	32	7	7
TGAGCATAGGCTATCT-1_MS377_A2D2	0.279644889	26.68250658	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	932	1323	0.008314437	0.009070295	7	oligos	OL-Cntl	32	7	7
TGAGCATCAGACAGGT-1_MS377_A2D2	-31.9696952	-8.198027589	9	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1073	1624	0	0.008004926	7	9	OPC	32	7	7
TGAGCATGTGCAGGTA-1_MS377_A2D2	-1.995907787	23.95723268	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	763	1057	0.000946074	0.008514664	7	oligos	OL-Cntl	32	7	7
TGAGCATTCCTGCTTG-1_MS377_A2D2	3.259139061	20.96534217	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	848	1232	0.019480519	0.005681818	7	oligos	OL-Cntl	32	7	7
TGAGCCGAGTGCAAGC-1_MS377_A2D2	5.721745607	26.9035795	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	987	1460	0.002054795	0.010958904	7	oligos	OL-Cntl	32	7	7
TGAGCCGGTTAAAGTG-1_MS377_A2D2	-1.102825642	29.35172715	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	807	1068	0.002808989	0.005617978	7	oligos	OL-Cntl	32	7	7
TGAGCCGGTTCAGACT-1_MS377_A2D2	13.72566892	-27.33931053	3	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	3324	8295	0.0092827	0.003254973	7	3	EN-L5-6	32	7	7
TGAGGGACAGTAAGCG-1_MS377_A2D2	-29.87724208	-13.18714647	9	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	783	1108	0.003610108	0.004512635	7	9	OPC	32	7	7
TGAGGGACATCGGTTA-1_MS377_A2D2	-27.49599056	8.800505302	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	755	1078	0.001855288	0.003710575	7	8	Astrocytes	32	7	7
TGATTTCCACGTCAGC-1_MS377_A2D2	18.28736843	-13.65727538	4	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	8273	31287	0.017611148	0.013583917	7	L2-3	EN-L2-3-MS	32	7	7
TGATTTCGTCTCGTTC-1_MS377_A2D2	11.62084185	22.11634271	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	986	1443	0.004158004	0.009009009	7	oligos	OL-Cntl	32	7	7
TGATTTCGTGGCAAAC-1_MS377_A2D2	33.87989289	-3.567759351	2	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	3238	7789	0.005648992	0.00436513	7	2	EN-L4	32	7	7
TGATTTCTCGGAAATA-1_MS377_A2D2	18.51902903	-9.742573712	3	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	2805	5723	0.005067272	0.005591473	7	3	EN-L5-6	32	7	7
TGCACCTAGTTACCCA-1_MS377_A2D2	13.11494263	-21.11216653	4	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	5267	15931	0.018454585	0.00445672	7	L2-3	EN-L2-3-MS	32	7	7
TGCACCTCACACGCTG-1_MS377_A2D2	25.47299194	6.289665927	15BA	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1665	2618	0.018716578	0.016042781	7	15BA	Stromal cells	32	7	7
TGCACCTGTTGACGTT-1_MS377_A2D2	-10.11737371	28.07929093	17	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	801	1166	0.104631218	0.02058319	7	oligos	OL-MS-2	32	7	7
TGCACCTTCCATGAGT-1_MS377_A2D2	-3.16243885	21.34317499	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1014	1499	0.002001334	0.019346231	7	oligos	OL-Cntl	32	7	7
TGCACCTTCTCGAGTA-1_MS377_A2D2	20.01944446	-17.32887626	4	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	9179	41062	0.022648678	0.012249769	7	L2-3	EN-L2-3-MS	32	7	7
TGCCAAACACAGTCGC-1_MS377_A2D2	27.77148987	6.898659036	15BA	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1242	2020	0.025742574	0.024752475	7	15BA	Stromal cells	32	7	7
TGCCAAATCATCTGTT-1_MS377_A2D2	-4.070795164	-34.86490728	16	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	766	1109	0.119927863	0.021641118	7	16	EN-PYR	32	7	7
TGCCAAATCCTTTACA-1_MS377_A2D2	-19.36800451	7.517094346	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	819	1181	0	0.00677392	7	8	Astrocytes	32	7	7
TGCCCATTCCCACTTG-1_MS377_A2D2	-1.780931287	22.13458198	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	758	1043	0	0.005752637	7	oligos	OL-Cntl	32	7	7
TGCCCTACATAGACTC-1_MS377_A2D2	-24.98380836	22.49818785	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1337	2058	0.002429543	0.006316812	7	8	Astrocytes	32	7	7
TGCCCTAGTGGCGAAT-1_MS377_A2D2	-30.2377848	0.647443045	9	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1855	3254	0.002151199	0.004609711	7	9	OPC	32	7	7
TGCCCTAGTGTGCGTC-1_MS377_A2D2	32.60193227	-12.35976264	2	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	3346	6992	0.00715103	0.008867277	7	2	EN-L4	32	7	7
TGCCCTAGTTTGTGTG-1_MS377_A2D2	22.74855978	15.13907586	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1364	2125	0.003294118	0.004235294	7	oligos	OL-Cntl	32	7	7
TGCCCTATCAACACTG-1_MS377_A2D2	-0.723237424	22.98363985	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	773	1096	0.000912409	0.002737226	7	oligos	OL-Cntl	32	7	7
TGCGCAGAGGTGATTA-1_MS377_A2D2	-31.35743455	-10.49977213	9	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1016	1454	0.002063274	0.000687758	7	9	OPC	32	7	7
TGCGCAGCAGTCAGAG-1_MS377_A2D2	7.917504929	18.93858533	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1206	1800	0.005	0.01	7	oligos	OL-Cntl	32	7	7
TGCGGGTCAAGTAGTA-1_MS377_A2D2	-22.20145529	-26.44151401	6A	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	3786	8121	0.023888684	0.005171777	7	6A	IN-PV	32	7	7
TGCGGGTCAGATTGCT-1_MS377_A2D2	1.559354591	20.35436656	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	824	1164	0.001718213	0.021477663	7	oligos	OL-Cntl	32	7	7
TGCGGGTTCCATGCTC-1_MS377_A2D2	6.982194746	18.76742559	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1069	1597	0.008140263	0.008766437	7	oligos	OL-Cntl	32	7	7
TGCGTGGAGCAGCCTC-1_MS377_A2D2	-1.509260797	8.953476906	5	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1172	1776	0.003378378	0.016891892	7	oligos	OL-MS-1	32	7	7
TGCGTGGAGCGCTCCA-1_MS377_A2D2	-34.10723213	-3.195880198	9	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1556	2720	0.004779412	0.006617647	7	9	OPC	32	7	7
TGCGTGGCAAGTCTGT-1_MS377_A2D2	-24.74846607	-19.49031302	6A	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	3135	6210	0.027536232	0.007246377	7	6A	IN-PV	32	7	7
TGCGTGGCAGCCTGTG-1_MS377_A2D2	-6.920683747	14.60376899	5	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	867	1198	0.031719533	0.005843072	7	oligos	OL-MS-1	32	7	7
TGCGTGGGTCAAGCGA-1_MS377_A2D2	-4.818493036	-34.55853065	16	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	734	1070	0.110280374	0.01588785	7	16	EN-PYR	32	7	7
TGCGTGGTCAGTTTGG-1_MS377_A2D2	-5.00110803	17.95849565	5	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	749	1081	0.009250694	0.012025902	7	oligos	OL-MS-1	32	7	7
TGCTACCAGACTAGGC-1_MS377_A2D2	-11.38142323	-2.171169655	13A	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	2238	3979	0.01306861	0.010555416	7	13A	IN-VIP	32	7	7
TGCTACCGTACCGAGA-1_MS377_A2D2	-29.6544962	-2.755593223	9	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1477	2328	0.003436426	0.005154639	7	9	OPC	32	7	7
TGCTACCTCAAGGCTT-1_MS377_A2D2	-32.35244342	3.546817982	9	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	2603	5362	0.003356956	0.005594927	7	9	OPC	32	7	7
TGCTGCTCAATGCCAT-1_MS377_A2D2	-5.567998285	18.68332627	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	728	1010	0.00990099	0.003960396	7	oligos	OL-Cntl	32	7	7
TGCTGCTGTACCGTAT-1_MS377_A2D2	35.67915475	10.8133424	14	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	890	1216	0.004934211	0.014802632	7	14	Microglia	32	7	7
TGGACGCAGTGTGAAT-1_MS377_A2D2	-0.276520402	28.90927208	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	882	1248	0.010416667	0.003205128	7	oligos	OL-Cntl	32	7	7
TGGACGCGTTACGCGC-1_MS377_A2D2	-15.85442291	-3.323817459	13A	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	3070	6532	0.021279853	0.005970606	7	13A	IN-VIP	32	7	7
TGGCCAGCAGACACTT-1_MS377_A2D2	32.98846818	-6.788943336	2	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	4056	10360	0.001544402	0.009169884	7	2	EN-L4	32	7	7
TGGCGCAAGGATCGCA-1_MS377_A2D2	5.78745432	17.48549305	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1027	1533	0.003913894	0.014350946	7	oligos	OL-Cntl	32	7	7
TGGCGCATCTAACGGT-1_MS377_A2D2	-24.13758119	7.893898488	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	906	1313	0.003808073	0.006854532	7	8	Astrocytes	32	7	7
TGGCTGGAGGACGAAA-1_MS377_A2D2	-18.9093413	19.91611782	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1635	2680	0.002238806	0.01119403	7	8	Astrocytes	32	7	7
TGGGAAGCACAACGTT-1_MS377_A2D2	20.21910124	-25.74115883	3	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	3498	7483	0.002271816	0.012829079	7	3	EN-L5-6	32	7	7
TGGGAAGGTCTAGCCG-1_MS377_A2D2	-19.38357791	-4.970026117	13A	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	3926	8122	0.005417385	0.012065994	7	13A	IN-VIP	32	7	7
TGGGAAGTCCCATTTA-1_MS377_A2D2	-16.36935024	11.8742811	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1324	2208	0.00317029	0.005887681	7	8	Astrocytes	32	7	7
TGGGCGTGTCCGACGT-1_MS377_A2D2	-24.92660981	15.80638754	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1188	1860	0.002150538	0.004301075	7	8	Astrocytes	32	7	7
TGGGCGTGTTTAGCTG-1_MS377_A2D2	-12.4732473	-16.45400292	6B	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1165	1830	0.015300546	0.003825137	7	6B	IN-SST	32	7	7
TGGGCGTTCCTTCAAT-1_MS377_A2D2	25.34881909	9.103444798	15A	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	2073	3311	0.021443673	0.046813651	7	15A	Endo cells	32	7	7
TGGTTAGGTACCGGCT-1_MS377_A2D2	-12.63665433	-16.48920849	6B	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1330	2120	0.040566038	0.001415094	7	6B	IN-SST	32	7	7
TGGTTAGGTATGCTTG-1_MS377_A2D2	13.82199343	-14.79164978	4	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	4582	10683	0.012730506	0.007769353	7	L2-3	EN-L2-3-MS	32	7	7
TGGTTAGTCACTCTTA-1_MS377_A2D2	-19.3518135	20.37633168	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	2003	3681	0.001358327	0.005433306	7	8	Astrocytes	32	7	7
TGGTTAGTCACTGGGC-1_MS377_A2D2	-19.20870041	-6.176036109	13B	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	3347	6895	0.010587382	0.009137056	7	13B	IN-SV2C	32	7	7
TGGTTAGTCTATGTGG-1_MS377_A2D2	-30.80571241	-8.655887136	9	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1076	1562	0.008962868	0.004481434	7	9	OPC	32	7	7
TGGTTCCCATTTGCCC-1_MS377_A2D2	7.622837871	-15.01348161	4	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	3192	7114	0.017711555	0.005903852	7	L2-3	EN-L2-3-MS	32	7	7
TGGTTCCGTGGCCCTA-1_MS377_A2D2	4.835254093	-11.73515927	4	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	2185	4005	0.025218477	0.007990012	7	L2-3	EN-L2-3-MS	32	7	7
TGTATTCTCTTTAGTC-1_MS377_A2D2	-18.63034776	-5.549426067	13B	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	3042	5690	0.010193322	0.011775044	7	13B	IN-SV2C	32	7	7
TGTGTTTAGCACGCCT-1_MS377_A2D2	12.65048372	0.716751472	12	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	746	1109	0.055906222	0.00541028	7	12	EN-MIX	32	7	7
TGTGTTTCAATGTAAG-1_MS377_A2D2	-24.64398181	11.68713422	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1114	1670	0.004790419	0.008383234	7	8	Astrocytes	32	7	7
TGTGTTTTCCCAAGTA-1_MS377_A2D2	-23.91177098	-0.453967745	9	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1718	2639	0.009094354	0.006441834	7	9	OPC	32	7	7
TGTGTTTTCCTGTACC-1_MS377_A2D2	34.19671723	-13.90010247	2	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	4245	10122	0.019660146	0.009780676	7	2	EN-L4	32	7	7
TGTTCCGAGTCAATAG-1_MS377_A2D2	-18.8360702	19.84695563	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1690	2813	0.004621401	0.011375755	7	8	Astrocytes	32	7	7
TGTTCCGGTAAGAGGA-1_MS377_A2D2	-17.23634291	20.18711145	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1638	2846	0.002459592	0.00983837	7	8	Astrocytes	32	7	7
TTAACTCAGTGCCAGA-1_MS377_A2D2	-18.60963661	-0.014938292	13A	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	3507	6986	0.008302319	0.018036072	7	13A	IN-VIP	32	7	7
TTAACTCCAATAGAGT-1_MS377_A2D2	-8.020981822	-8.722037014	13A	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1216	1819	0.001649258	0.02528862	7	13A	IN-VIP	32	7	7
TTAACTCCATGGTTGT-1_MS377_A2D2	-12.12588084	14.57530204	11	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1007	1451	0.00137836	0.007580979	7	11	Glia-MIX	32	7	7
TTAACTCTCCGCGTTT-1_MS377_A2D2	-16.42340897	-5.395354851	13B	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	3990	9611	0.010404745	0.009156175	7	13B	IN-SV2C	32	7	7
TTAACTCTCGAGCCCA-1_MS377_A2D2	14.30054292	13.17042277	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1397	2175	0.002758621	0.009655172	7	oligos	OL-Cntl	32	7	7
TTAGGACAGCCCTAAT-1_MS377_A2D2	-8.301361376	-36.73121067	16	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1025	1543	0.059624109	0.018794556	7	16	EN-PYR	32	7	7
TTAGGACTCGTGTAGT-1_MS377_A2D2	8.390124225	-1.74136227	12	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1323	1841	0.052145573	0.005431831	7	12	EN-MIX	32	7	7
TTAGGCAAGCCTATGT-1_MS377_A2D2	-27.50937812	-10.11769501	9	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1107	1683	0.002376708	0.002970885	7	9	OPC	32	7	7
TTAGGCAGTCCATGAT-1_MS377_A2D2	-12.07758948	-13.34511177	6A	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1673	2973	0.072317524	0.007399933	7	6A	IN-PV	32	7	7
TTAGTTCAGGGTATCG-1_MS377_A2D2	10.91979062	24.97239105	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	802	1216	0.003289474	0.007401316	7	oligos	OL-Cntl	32	7	7
TTAGTTCGTCCAACTA-1_MS377_A2D2	3.521856259	-11.21885915	12	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1737	2982	0.005700872	0.006036217	7	12	EN-MIX	32	7	7
TTATGCTAGAATCTCC-1_MS377_A2D2	-20.99702763	9.436667338	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1074	1761	0	0.004542873	7	8	Astrocytes	32	7	7
TTATGCTAGCCTATGT-1_MS377_A2D2	2.95494039	21.01864729	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	815	1207	0.002485501	0.008285004	7	oligos	OL-Cntl	32	7	7
TTATGCTCAAGCGCTC-1_MS377_A2D2	-14.22881751	-36.57606151	16	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	2869	6544	0.156020782	0.009932763	7	16	EN-PYR	32	7	7
TTATGCTCACCTGGTG-1_MS377_A2D2	4.69003569	32.25574479	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	725	1112	0.000899281	0.010791367	7	oligos	OL-Cntl	32	7	7
TTATGCTTCATCTGCC-1_MS377_A2D2	-29.84289193	17.53944452	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1188	1900	0.001578947	0.004736842	7	8	Astrocytes	32	7	7
TTCCCAGCAAATTGCC-1_MS377_A2D2	5.471021637	17.52475275	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	935	1418	0.001410437	0.014809591	7	oligos	OL-Cntl	32	7	7
TTCCCAGCATTTCAGG-1_MS377_A2D2	3.869526842	18.77362398	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	876	1304	0	0.009969325	7	oligos	OL-Cntl	32	7	7
TTCGAAGGTCCAGTAT-1_MS377_A2D2	-9.464931717	-16.65876931	6B	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	872	1351	0.058475204	0.004441155	7	6B	IN-SST	32	7	7
TTCGGTCAGTACGACG-1_MS377_A2D2	12.0188165	23.06214826	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	903	1368	0.005116959	0.006578947	7	oligos	OL-Cntl	32	7	7
TTCTACACAGACGTAG-1_MS377_A2D2	15.62640355	-16.78639648	4	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	6164	18179	0.008691347	0.008031245	7	L2-3	EN-L2-3-MS	32	7	7
TTCTCAAGTCCGCTGA-1_MS377_A2D2	-19.48172457	20.37454602	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1631	2560	0.003125	0.007421875	7	8	Astrocytes	32	7	7
TTCTCCTTCACCAGGC-1_MS377_A2D2	-25.71136424	22.51154477	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1517	2556	0.002347418	0.005868545	7	8	Astrocytes	32	7	7
TTCTTAGCAGCTCGCA-1_MS377_A2D2	-8.660645917	-16.12722354	6B	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	743	1133	0.036187114	0.004413063	7	6B	IN-SST	32	7	7
TTCTTAGTCTGATTCT-1_MS377_A2D2	4.071171042	17.91848154	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	987	1657	0.006035003	0.012070006	7	oligos	OL-Cntl	32	7	7
TTGAACGAGAACTGTA-1_MS377_A2D2	1.536392875	28.84468536	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	779	1055	0.002843602	0.003791469	7	oligos	OL-Cntl	32	7	7
TTGAACGCAGACAAAT-1_MS377_A2D2	27.80593386	7.197733302	15A	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	863	1140	0.007894737	0.04122807	7	15A	Endo cells	32	7	7
TTGAACGTCAAACCAC-1_MS377_A2D2	19.44834242	-16.26348239	4	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	4669	11560	0.023183391	0.01366782	7	L2-3	EN-L2-3-MS	32	7	7
TTGAACGTCCCTAACC-1_MS377_A2D2	-33.75414584	-9.872096464	9	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	993	1445	0.002768166	0.002076125	7	9	OPC	32	7	7
TTGACTTAGTTGCAGG-1_MS377_A2D2	-26.56386033	12.97492776	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1158	1740	0.002298851	0.006321839	7	8	Astrocytes	32	7	7
TTGACTTCAGCCAATT-1_MS377_A2D2	31.19972828	15.26985787	14	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	949	1304	0.001533742	0.073619632	7	14	Microglia	32	7	7
TTGACTTCAGCTGCAC-1_MS377_A2D2	10.0225889	-3.175514652	12	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1829	3096	0.033268734	0.007428941	7	12	EN-MIX	32	7	7
TTGACTTGTCTGCGGT-1_MS377_A2D2	15.64947446	-26.45054505	4	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	4295	11265	0.009409676	0.008699512	7	L2-3	EN-L2-3-MS	32	7	7
TTGACTTTCATCATTC-1_MS377_A2D2	19.71911114	-10.76418718	3	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	2134	4138	0.048090865	0.00459159	7	3	EN-L5-6	32	7	7
TTGCCGTAGCCGGTAA-1_MS377_A2D2	-11.53846687	-13.29073405	6B	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1318	1998	0.025025025	0.007007007	7	6B	IN-SST	32	7	7
TTGCCGTAGGCGATAC-1_MS377_A2D2	-12.91611827	-21.72501298	6B	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1326	2621	0.216329645	0.003433804	7	6B	IN-SST	32	7	7
TTGCCGTGTAATCACC-1_MS377_A2D2	-21.68555218	16.99292692	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1407	2294	0.005231037	0.004795118	7	8	Astrocytes	32	7	7
TTGCCGTGTACCTACA-1_MS377_A2D2	-16.9875735	-22.16425427	6A	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1929	3587	0.018957346	0.006412043	7	6A	IN-PV	32	7	7
TTGGCAAAGTGTTGAA-1_MS377_A2D2	-11.46281682	-0.872563086	13A	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	2717	5311	0.007531538	0.005648654	7	13A	IN-VIP	32	7	7
TTGGCAACAAATTGCC-1_MS377_A2D2	12.02126279	-14.01003446	4	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	4278	9539	0.009434951	0.014886256	7	L2-3	EN-L2-3-MS	32	7	7
TTGGCAACATCGGTTA-1_MS377_A2D2	-23.50468591	-24.85456927	6A	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	4024	8857	0.008580784	0.008129163	7	6A	IN-PV	32	7	7
TTGGCAAGTGGTTTCA-1_MS377_A2D2	30.85477844	-11.28980438	2	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	3267	7321	0.019942631	0.003551427	7	2	EN-L4	32	7	7
TTGTAGGCAAGCCGCT-1_MS377_A2D2	-2.506186425	23.83108977	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	746	1017	0.003933137	0.01179941	7	oligos	OL-Cntl	32	7	7
TTGTAGGGTTTACTCT-1_MS377_A2D2	-0.189049129	19.15879909	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	728	1021	0	0.011753183	7	oligos	OL-Cntl	32	7	7
TTTACTGCATCCTTGC-1_MS377_A2D2	-21.58804388	24.14567562	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1668	2994	0.003006012	0.005344021	7	8	Astrocytes	32	7	7
TTTATGCCACCGAAAG-1_MS377_A2D2	5.166165187	-10.36586515	12	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1759	3120	0.025641026	0.004487179	7	12	EN-MIX	32	7	7
TTTATGCGTAGTGAAT-1_MS377_A2D2	-2.602325791	21.64688465	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	738	1019	0.008832188	0.009813543	7	oligos	OL-Cntl	32	7	7
TTTATGCGTCAGAGGT-1_MS377_A2D2	-17.64532161	20.53048216	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1699	2715	0.02946593	0.008471455	7	8	Astrocytes	32	7	7
TTTCCTCAGAGCCCAA-1_MS377_A2D2	6.373967349	20.31328649	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1020	1506	0.001328021	0.007968127	7	oligos	OL-Cntl	32	7	7
TTTCCTCTCGCGTTTC-1_MS377_A2D2	-3.877797748	19.77439745	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	715	1177	0.011894647	0.007646559	7	oligos	OL-Cntl	32	7	7
TTTGCGCTCCATTCTA-1_MS377_A2D2	0.399894276	18.37152873	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	777	1171	0.001707942	0.010247652	7	oligos	OL-Cntl	32	7	7
TTTGGTTCAAACCCAT-1_MS377_A2D2	17.06472267	-20.37714663	4	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	3520	7750	0.016258065	0.006193548	7	L2-3	EN-L2-3-MS	32	7	7
TTTGGTTCACCGAATT-1_MS377_A2D2	14.53210562	11.14050143	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1518	2383	0.004196391	0.01426773	7	oligos	OL-Cntl	32	7	7
TTTGGTTGTCTGCGGT-1_MS377_A2D2	5.705980787	17.25831074	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	951	1448	0.002071823	0.013812155	7	oligos	OL-Cntl	32	7	7
TTTGTCACAGCGAACA-1_MS377_A2D2	-18.26666224	19.98663577	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1445	2353	0.00679983	0.005524862	7	8	Astrocytes	32	7	7
TTTGTCAGTCGCCATG-1_MS377_A2D2	-16.81029456	12.49174446	8	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	1450	2707	0.002585888	0.004802364	7	8	Astrocytes	32	7	7
TTTGTCATCCAGATCA-1_MS377_A2D2	15.58458928	28.58541443	1	MS377_A2D2	MS	Acute/Chronic active	50	female	prefrontal	CAP6	SEQ4	8.9	22	763	1150	0.002608696	0.00173913	7	oligos	OL-Cntl	32	7	7
AAACCTGAGAGTAATC-1_MS200_A303	2.670517512	-8.073380063	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1495	2473	0.05135463	0.006874242	10	12	EN-MIX	41	6	6
AAACCTGAGCGTTTAC-1_MS200_A303	-5.528890558	15.91662868	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	887	1323	0.006802721	0.012849584	10	oligos	OL-MS-1	41	6	6
AAACCTGAGTCGAGTG-1_MS200_A303	-28.84208836	-12.58821881	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	764	1067	0.015932521	0.007497657	10	9	OPC	41	6	6
AAACCTGAGTGTCCCG-1_MS200_A303	-17.38187051	20.58601383	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1696	2895	0.002417962	0.008635579	10	8	Astrocytes	41	6	6
AAACCTGCAGACTCGC-1_MS200_A303	15.38340935	-25.87022654	3	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3666	9464	0.017540152	0.004860524	10	3	EN-L5-6	41	6	6
AAACCTGCAGGCGATA-1_MS200_A303	-36.58544921	-10.21421339	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1076	1631	0.008583691	0.004291845	10	9	OPC	41	6	6
AAACCTGGTCCAGTAT-1_MS200_A303	20.67557113	-22.85456788	3	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4963	14615	0.004173794	0.006021211	10	3	EN-L5-6	41	6	6
AAACCTGGTCCGAAGA-1_MS200_A303	-32.35431432	-6.120507874	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1093	1673	0.0041841	0.002988643	10	9	OPC	41	6	6
AAACCTGGTTCTCATT-1_MS200_A303	-32.01485272	-12.8533526	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	755	1073	0.004659832	0.003727866	10	9	OPC	41	6	6
AAACCTGGTTGGTGGA-1_MS200_A303	27.68342322	7.45929519	15A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	940	1316	0.004559271	0.051671733	10	15A	Endo cells	41	6	6
AAACCTGTCAATCACG-1_MS200_A303	-10.89053864	-15.58446096	6B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1043	1683	0.02020202	0.006535948	10	6B	IN-SST	41	6	6
AAACGGGAGAGCCCAA-1_MS200_A303	9.115242362	-1.404384898	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1214	1958	0.127170582	0.01174668	10	12	EN-MIX	41	6	6
AAACGGGAGATAGCAT-1_MS200_A303	-19.77863502	-1.932211934	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4550	10410	0.021517771	0.009990394	10	13A	IN-VIP	41	6	6
AAACGGGAGCCAGGAT-1_MS200_A303	20.09034458	-15.11600039	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5805	17251	0.043475741	0.00765173	10	L2-3	EN-L2-3-MS	41	6	6
AAACGGGAGCTCAACT-1_MS200_A303	-29.0410448	-6.112740677	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	990	1414	0.002828854	0.006364922	10	9	OPC	41	6	6
AAACGGGCACTTCGAA-1_MS200_A303	34.53208908	-14.77870329	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3768	7772	0.006819352	0.021230057	10	2	EN-L4	41	6	6
AAACGGGGTTCACCTC-1_MS200_A303	-6.166214708	15.04906908	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	775	1158	0.015544041	0.010362694	10	oligos	OL-MS-1	41	6	6
AAAGATGAGCGTGAAC-1_MS200_A303	-5.735909989	15.34199977	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	756	1055	0.004739336	0.011374408	10	oligos	OL-MS-1	41	6	6
AAAGATGAGTCACGCC-1_MS200_A303	-31.54089234	-6.322786711	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1089	1664	0.004807692	0.005408654	10	9	OPC	41	6	6
AAAGATGCAATCAGAA-1_MS200_A303	-15.94820966	-2.535754618	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2906	5687	0.00949534	0.007736944	10	13A	IN-VIP	41	6	6
AAAGATGCACAACTGT-1_MS200_A303	-12.12853423	-3.526598666	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2253	4246	0.013659915	0.008007537	10	13A	IN-VIP	41	6	6
AAAGATGCAGCGAACA-1_MS200_A303	-13.79576897	23.00363645	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1549	2332	0.002144082	0.021440823	10	8	Astrocytes	41	6	6
AAAGATGCAGGACCCT-1_MS200_A303	5.021029444	-10.3634178	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1823	3380	0.065680473	0.007100592	10	12	EN-MIX	41	6	6
AAAGATGGTCGTGGCT-1_MS200_A303	-15.08973181	22.30644141	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1476	2328	0.007731959	0.009450172	10	8	Astrocytes	41	6	6
AAAGATGTCCAGATCA-1_MS200_A303	-5.463036356	-37.20634862	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	951	1320	0.075757576	0.024242424	10	16	EN-PYR	41	6	6
AAAGATGTCTCAAGTG-1_MS200_A303	-16.08637284	20.53142249	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1399	2152	0.004182156	0.012546468	10	8	Astrocytes	41	6	6
AAAGCAAAGCACGCCT-1_MS200_A303	-20.22754508	7.299523228	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	921	1321	0.00681302	0.012112036	10	8	Astrocytes	41	6	6
AAAGCAAAGTGCCATT-1_MS200_A303	-17.22559771	20.45098768	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1473	2480	0.001209677	0.008870968	10	8	Astrocytes	41	6	6
AAAGCAACACCGAAAG-1_MS200_A303	-20.06385568	-2.247566619	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5608	15491	0.038280292	0.011425989	10	13A	IN-VIP	41	6	6
AAAGCAACACGGCGTT-1_MS200_A303	-30.18414255	-9.235527465	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	989	1421	0.009852217	0.010555947	10	9	OPC	41	6	6
AAAGCAACAGGTTTCA-1_MS200_A303	9.824223533	-2.096614023	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1370	2026	0.022211254	0.005923001	10	12	EN-MIX	41	6	6
AAAGCAAGTCAGAAGC-1_MS200_A303	23.93275149	-12.59631739	3	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3184	6487	0.030830893	0.005241252	10	3	EN-L5-6	41	6	6
AAAGCAAGTCTAAACC-1_MS200_A303	-15.51949091	23.47686088	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1707	3034	0.014172709	0.007580751	10	8	Astrocytes	41	6	6
AAAGCAAGTGATGTCT-1_MS200_A303	16.11616609	-14.16698815	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	7156	24082	0.012623536	0.008346483	10	L2-3	EN-L2-3-MS	41	6	6
AAAGCAATCACTCTTA-1_MS200_A303	-16.60744998	20.57869657	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1483	2234	0.004476276	0.006714414	10	8	Astrocytes	41	6	6
AAAGCAATCCTTGCCA-1_MS200_A303	3.021302565	6.834558407	7	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1094	1634	0.009791922	0.017747858	10	7	Phagocytes	41	6	6
AAAGCAATCGAATGGG-1_MS200_A303	-18.14345946	6.431517098	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	918	1408	0.000710227	0.010653409	10	8	Astrocytes	41	6	6
AAAGTAGAGACATAAC-1_MS200_A303	18.04583409	-13.66550834	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	6796	22993	0.033184013	0.010829383	10	L2-3	EN-L2-3-MS	41	6	6
AAAGTAGAGTATGACA-1_MS200_A303	-29.37628883	-10.22508045	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	973	1340	0.003731343	0.006716418	10	9	OPC	41	6	6
AAAGTAGAGTGGAGTC-1_MS200_A303	-6.290022109	14.66735014	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	770	1049	0.011439466	0.018112488	10	oligos	OL-MS-1	41	6	6
AAAGTAGCACAGTCGC-1_MS200_A303	7.463767076	-11.15073417	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2046	3102	0.015473888	0.012250161	10	L2-3	EN-L2-3-MS	41	6	6
AAAGTAGCAGGGTACA-1_MS200_A303	-31.53529339	-6.193385237	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1093	1615	0.003095975	0.009907121	10	9	OPC	41	6	6
AAAGTAGCATCTCGCT-1_MS200_A303	14.15745995	-5.251414506	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2222	3651	0.005477951	0.006847439	10	12	EN-MIX	41	6	6
AAAGTAGGTAATCGTC-1_MS200_A303	-29.81882989	-20.56819994	6B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4629	11143	0.017320291	0.018127973	10	6B	IN-SST	41	6	6
AAAGTAGGTCCGACGT-1_MS200_A303	11.15533903	-0.210350768	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1122	1737	0.073114565	0.011514105	10	12	EN-MIX	41	6	6
AAAGTAGGTCTCGTTC-1_MS200_A303	-8.62363923	-37.44675828	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1101	1536	0.048828125	0.020833333	10	16	EN-PYR	41	6	6
AAAGTAGGTTACGTCA-1_MS200_A303	-24.8489541	8.57046168	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	932	1374	0.002911208	0.008733624	10	8	Astrocytes	41	6	6
AAAGTAGGTTGGAGGT-1_MS200_A303	-10.36889241	-4.717328051	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1683	2648	0.018126888	0.010574018	10	13A	IN-VIP	41	6	6
AAAGTAGTCCGCAAGC-1_MS200_A303	18.16976245	-22.25592291	3	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4650	12257	0.014359142	0.007669087	10	3	EN-L5-6	41	6	6
AAAGTAGTCGGCTACG-1_MS200_A303	-11.31975299	22.59806468	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1609	2554	0.005481597	0.009005482	10	8	Astrocytes	41	6	6
AAAGTAGTCTGAGGGA-1_MS200_A303	-15.65642614	20.72161943	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1593	2435	0.007392197	0.012731006	10	8	Astrocytes	41	6	6
AAAGTAGTCTGCGTAA-1_MS200_A303	-8.057188293	-38.71470902	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1270	1737	0.051237766	0.017271157	10	16	EN-PYR	41	6	6
AAATGCCAGAATTGTG-1_MS200_A303	-16.34165426	-0.280822527	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3057	6045	0.011414392	0.011579818	10	13A	IN-VIP	41	6	6
AAATGCCAGCGATATA-1_MS200_A303	11.28836542	-1.24505294	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1270	1927	0.081992735	0.009859886	10	12	EN-MIX	41	6	6
AAATGCCAGTCGTACT-1_MS200_A303	-24.03145764	-24.93032327	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5526	17661	0.006851254	0.006001925	10	6A	IN-PV	41	6	6
AAATGCCAGTGTCCCG-1_MS200_A303	6.252582048	-2.750286582	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1046	1603	0.121646912	0.003119152	10	12	EN-MIX	41	6	6
AAATGCCAGTTCCACA-1_MS200_A303	-15.89648684	-1.931861554	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2646	4827	0.00621504	0.008701057	10	13A	IN-VIP	41	6	6
AAATGCCCACATAACC-1_MS200_A303	-15.5844938	-16.42865782	6B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1761	3159	0.033238367	0.004115226	10	6B	IN-SST	41	6	6
AAATGCCGTACAAGTA-1_MS200_A303	5.733010076	-9.028019085	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1419	2356	0.076400679	0.005517827	10	12	EN-MIX	41	6	6
AAATGCCGTCTTCTCG-1_MS200_A303	33.40319314	-16.71887278	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5192	13183	0.01828112	0.012212698	10	2	EN-L4	41	6	6
AAATGCCGTGCAGACA-1_MS200_A303	33.61999474	-18.60001155	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3549	6940	0.010086455	0.01815562	10	2	EN-L4	41	6	6
AAATGCCTCGAATCCA-1_MS200_A303	11.10048443	-0.471000153	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1116	1522	0.025624179	0.013797635	10	12	EN-MIX	41	6	6
AACACGTAGGATGGTC-1_MS200_A303	14.05917437	-15.1470187	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5348	14474	0.012228824	0.008497996	10	L2-3	EN-L2-3-MS	41	6	6
AACACGTAGGGCTTGA-1_MS200_A303	-16.72928713	20.51552037	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1411	2266	0.004413063	0.008826125	10	8	Astrocytes	41	6	6
AACACGTAGTCCATAC-1_MS200_A303	-22.73478658	-8.381643189	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2038	3383	0.043156961	0.007389891	10	9	OPC	41	6	6
AACACGTAGTCCTCCT-1_MS200_A303	25.58727127	5.490604284	15A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1141	1560	0.015384615	0.019871795	10	15A	Endo cells	41	6	6
AACACGTCACTGTGTA-1_MS200_A303	-10.31402921	9.92630239	11	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2736	5277	0.006822058	0.010043585	10	11	Glia-MIX	41	6	6
AACACGTGTCGCTTCT-1_MS200_A303	-5.932277201	15.32229038	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	947	1392	0.007183908	0.010775862	10	oligos	OL-MS-1	41	6	6
AACACGTGTGAGTGAC-1_MS200_A303	-16.9530926	20.31022076	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1583	2646	0.003401361	0.019652305	10	8	Astrocytes	41	6	6
AACACGTTCCCTAACC-1_MS200_A303	2.437467969	4.548619857	14	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	967	1303	0.007674597	0.006139678	10	14	Microglia	41	6	6
AACCATGCAACTGCTA-1_MS200_A303	-11.90637813	-4.775329254	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2007	3631	0.018452217	0.0044065	10	13A	IN-VIP	41	6	6
AACCATGCAAGTAATG-1_MS200_A303	27.31502422	10.29090283	15A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1832	3939	0.005077431	0.160954557	10	15A	Endo cells	41	6	6
AACCATGGTCTGCAAT-1_MS200_A303	-29.65539179	-1.136809113	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1583	2548	0.0066719	0.0066719	10	9	OPC	41	6	6
AACCATGTCACAAACC-1_MS200_A303	9.838034365	-1.929987318	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1398	2172	0.011970534	0.005524862	10	12	EN-MIX	41	6	6
AACCATGTCTTACCGC-1_MS200_A303	-27.60063829	-22.43658524	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4625	12449	0.029399952	0.00674753	10	6A	IN-PV	41	6	6
AACCGCGAGAGGGCTT-1_MS200_A303	-6.069722292	13.25428876	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	926	1290	0.012403101	0.01627907	10	oligos	OL-MS-1	41	6	6
AACCGCGAGCTATGCT-1_MS200_A303	-17.34250835	20.33644762	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1281	2065	0.001937046	0.00968523	10	8	Astrocytes	41	6	6
AACCGCGCACAGATTC-1_MS200_A303	-30.03055538	-21.77529698	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4439	10178	0.028984083	0.015523679	10	6A	IN-PV	41	6	6
AACCGCGGTATAATGG-1_MS200_A303	4.604855703	5.236509578	7	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1885	2961	0.008780817	0.011820331	10	7	Phagocytes	41	6	6
AACCGCGGTTGTTTGG-1_MS200_A303	-9.28656121	-37.93227806	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1183	1627	0.051014136	0.020897357	10	16	EN-PYR	41	6	6
AACCGCGTCACAATGC-1_MS200_A303	-14.38567701	22.13333132	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1478	2514	0.022673031	0.013524264	10	8	Astrocytes	41	6	6
AACCGCGTCATGCATG-1_MS200_A303	-4.119562381	19.93258256	1	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	743	1027	0.00292113	0.007789679	10	oligos	OL-Cntl	41	6	6
AACGTTGAGATCCCAT-1_MS200_A303	-16.98567041	-3.961320938	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2849	5880	0.026360544	0.005782313	10	13A	IN-VIP	41	6	6
AACGTTGAGGCCCTTG-1_MS200_A303	-29.86740585	-4.902581761	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1225	1943	0.003088008	0.007205353	10	9	OPC	41	6	6
AACGTTGCAAGCGAGT-1_MS200_A303	33.09974465	10.99707217	14	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	812	1014	0.00591716	0.035502959	10	14	Microglia	41	6	6
AACGTTGCAATGAAAC-1_MS200_A303	10.7366363	-17.42288758	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5693	15435	0.011402656	0.012827988	10	L2-3	EN-L2-3-MS	41	6	6
AACGTTGCACAAGACG-1_MS200_A303	-4.420657392	19.03501878	1	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	805	1128	0.006205674	0.018617021	10	oligos	OL-Cntl	41	6	6
AACGTTGCATTAACCG-1_MS200_A303	-10.60430346	-3.700184966	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2016	3699	0.04136253	0.007028927	10	13A	IN-VIP	41	6	6
AACGTTGGTCTGGAGA-1_MS200_A303	-14.06163095	23.85455207	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1648	2719	0.015079073	0.01618242	10	8	Astrocytes	41	6	6
AACGTTGGTCTTGATG-1_MS200_A303	-19.6119402	-5.296189486	13B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3597	7640	0.021465969	0.009554974	10	13B	IN-SV2C	41	6	6
AACGTTGTCCTTTCTC-1_MS200_A303	9.897713357	-15.8950547	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3986	9222	0.007373672	0.010626762	10	L2-3	EN-L2-3-MS	41	6	6
AACGTTGTCGCATGGC-1_MS200_A303	-8.671592727	-13.35878034	6B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	710	1132	0.230565371	0.00795053	10	6B	IN-SST	41	6	6
AACTCAGAGAGGTTAT-1_MS200_A303	-4.380942271	17.80008981	1	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	848	1154	0.009532062	0.012998267	10	oligos	OL-Cntl	41	6	6
AACTCAGAGTCAATAG-1_MS200_A303	-19.34206335	-1.727263603	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3564	7021	0.018515881	0.013530836	10	13A	IN-VIP	41	6	6
AACTCAGAGTCCTCCT-1_MS200_A303	-23.56753906	7.423803723	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1041	1388	0.005043228	0.013688761	10	8	Astrocytes	41	6	6
AACTCAGAGTTACCCA-1_MS200_A303	9.957582517	-20.20669751	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4092	11035	0.006252832	0.003534209	10	L2-3	EN-L2-3-MS	41	6	6
AACTCAGCAATGGACG-1_MS200_A303	-14.06948688	3.444023697	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4178	8954	0.006700916	0.011726603	10	13A	IN-VIP	41	6	6
AACTCAGGTTAGAACA-1_MS200_A303	-26.10028848	7.781049919	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	854	1212	0.018976898	0.005775578	10	8	Astrocytes	41	6	6
AACTCAGGTTCCCTTG-1_MS200_A303	-7.684682606	-10.42163374	6B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	722	1044	0.132183908	0.00862069	10	6B	IN-SST	41	6	6
AACTCAGTCTCCAGGG-1_MS200_A303	-23.08908267	-19.72638638	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3832	9571	0.019433706	0.003970327	10	6A	IN-PV	41	6	6
AACTCCCAGACCTTTG-1_MS200_A303	32.5640689	-5.480963462	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3150	6799	0.006912781	0.005441977	10	2	EN-L4	41	6	6
AACTCCCCATCAGTCA-1_MS200_A303	9.538039037	-1.935697278	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1770	3676	0.251360174	0.005712731	10	12	EN-MIX	41	6	6
AACTCCCGTGTTAAGA-1_MS200_A303	-17.76348572	-1.633745412	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3129	5911	0.009981391	0.017086787	10	13A	IN-VIP	41	6	6
AACTCCCTCTTGTATC-1_MS200_A303	-32.46031481	-5.329062173	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1334	2263	0.004860804	0.003977022	10	9	OPC	41	6	6
AACTCTTAGCTGATAA-1_MS200_A303	16.6413203	-14.00881767	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	6774	21670	0.014536225	0.008998616	10	L2-3	EN-L2-3-MS	41	6	6
AACTCTTAGGTCATCT-1_MS200_A303	10.78758771	1.507826225	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	832	1275	0.188235294	0.009411765	10	12	EN-MIX	41	6	6
AACTCTTCAATCACAC-1_MS200_A303	9.713750542	-2.453096691	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1786	3131	0.104439476	0.007665283	10	12	EN-MIX	41	6	6
AACTCTTCAATTCCTT-1_MS200_A303	-4.4214628	17.95240198	1	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	803	1133	0.00353045	0.006178288	10	oligos	OL-Cntl	41	6	6
AACTCTTCACATGACT-1_MS200_A303	-24.30022923	10.87039047	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	994	1558	0.002567394	0.005134788	10	8	Astrocytes	41	6	6
AACTCTTCAGCTTCGG-1_MS200_A303	33.93975696	-18.49254322	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4873	11886	0.017247182	0.015227999	10	2	EN-L4	41	6	6
AACTCTTCAGGAATGC-1_MS200_A303	-13.833561	22.91677724	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1512	2464	0.003652597	0.013798701	10	8	Astrocytes	41	6	6
AACTCTTGTATCTGCA-1_MS200_A303	-26.05060302	-17.67832549	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4847	12513	0.021018141	0.013825621	10	6A	IN-PV	41	6	6
AACTCTTTCATCGCTC-1_MS200_A303	-2.80397388	27.79026797	1	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	761	1073	0.012115564	0.008387698	10	oligos	OL-Cntl	41	6	6
AACTCTTTCCCTGACT-1_MS200_A303	-22.6753234	-1.457506936	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1039	1621	0.011104257	0.008636644	10	9	OPC	41	6	6
AACTCTTTCGCGATCG-1_MS200_A303	22.84010836	-5.985774565	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1960	3492	0.002004582	0.004295533	10	2	EN-L4	41	6	6
AACTGGTAGCCTATGT-1_MS200_A303	8.498746678	-19.80061421	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5452	15272	0.002946569	0.00753012	10	L2-3	EN-L2-3-MS	41	6	6
AACTGGTAGGATCGCA-1_MS200_A303	-19.64685798	-5.177532218	13B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3421	6900	0.014347826	0.008550725	10	13B	IN-SV2C	41	6	6
AACTGGTAGGCATGGT-1_MS200_A303	29.63776697	9.568209347	15DB	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1022	1666	0.003601441	0.043217287	10	15DB	B cells	41	6	6
AACTGGTAGTGACATA-1_MS200_A303	-30.84320797	-11.46779828	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	889	1281	0.007806401	0.003903201	10	9	OPC	41	6	6
AACTGGTCAAAGCGGT-1_MS200_A303	0.736879611	11.39373265	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	908	1347	0.005939124	0.0155902	10	oligos	OL-MS-1	41	6	6
AACTGGTCACCCATTC-1_MS200_A303	-4.904753455	18.60096699	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	872	1228	0.004885993	0.006514658	10	oligos	OL-MS-1	41	6	6
AACTGGTCATCAGTCA-1_MS200_A303	-5.515166717	15.95639621	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	670	1005	0.009950249	0.014925373	10	oligos	OL-MS-1	41	6	6
AACTGGTTCCACGACG-1_MS200_A303	-12.74665778	17.8172048	11	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1855	3033	0.006923838	0.014836795	10	11	Glia-MIX	41	6	6
AACTGGTTCGCAGGCT-1_MS200_A303	-24.33138356	9.975917133	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1038	1565	0.003833866	0.008306709	10	8	Astrocytes	41	6	6
AACTGGTTCTTTACGT-1_MS200_A303	33.77111104	-16.30927703	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4482	10490	0.024976168	0.011534795	10	2	EN-L4	41	6	6
AACTTTCAGATCTGCT-1_MS200_A303	8.8525802	-15.22134145	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3288	7734	0.007887251	0.009568141	10	L2-3	EN-L2-3-MS	41	6	6
AACTTTCAGATGCCTT-1_MS200_A303	-10.66876853	-17.98203129	6B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	857	1284	0.02258567	0.001557632	10	6B	IN-SST	41	6	6
AACTTTCAGATGTGGC-1_MS200_A303	14.82376877	1.666755265	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1121	1719	0.084933101	0.005817336	10	12	EN-MIX	41	6	6
AACTTTCAGTTCGATC-1_MS200_A303	13.98068357	-16.41482935	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5088	14108	0.010632265	0.008151403	10	L2-3	EN-L2-3-MS	41	6	6
AACTTTCAGTTTGCGT-1_MS200_A303	-22.42969409	-23.4727912	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2561	5437	0.047820489	0.004414199	10	6A	IN-PV	41	6	6
AACTTTCCAGCTGGCT-1_MS200_A303	-18.0096652	8.183111019	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	791	1160	0.001724138	0.007758621	10	8	Astrocytes	41	6	6
AACTTTCCATGGTTGT-1_MS200_A303	15.96786435	-13.68958873	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5428	15128	0.016129032	0.00918826	10	L2-3	EN-L2-3-MS	41	6	6
AACTTTCTCCGAAGAG-1_MS200_A303	-9.516413162	22.13061169	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	994	1318	0.044764795	0.012898331	10	8	Astrocytes	41	6	6
AACTTTCTCGGTTAAC-1_MS200_A303	-12.7980717	17.66395362	11	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1713	2821	0.00921659	0.014179369	10	11	Glia-MIX	41	6	6
AAGACCTCAGACAAAT-1_MS200_A303	16.82095398	-15.2372587	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	6496	20821	0.016137553	0.006195668	10	L2-3	EN-L2-3-MS	41	6	6
AAGACCTGTCGACTAT-1_MS200_A303	-15.95330903	20.91662039	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1119	1734	0.014994233	0.014417532	10	8	Astrocytes	41	6	6
AAGACCTTCCAAACAC-1_MS200_A303	-5.150619407	-7.886976139	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	897	1253	0.02952913	0.013567438	10	13A	IN-VIP	41	6	6
AAGACCTTCCGCATCT-1_MS200_A303	-37.2208414	-9.743930352	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1018	1677	0.007155635	0.005963029	10	9	OPC	41	6	6
AAGACCTTCCTCTAGC-1_MS200_A303	-11.74067157	28.26341588	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1636	2345	0.036247335	0.023027719	10	16	EN-PYR	41	6	6
AAGACCTTCGCCTGTT-1_MS200_A303	-24.49940398	-24.30110623	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4689	13874	0.03639902	0.004396713	10	6A	IN-PV	41	6	6
AAGCCGCAGCCACGCT-1_MS200_A303	-5.732234202	14.49033892	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	796	1143	0.01399825	0.014873141	10	oligos	OL-MS-1	41	6	6
AAGCCGCAGTCTCAAC-1_MS200_A303	-30.90356269	-8.422717649	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	896	1383	0.007230658	0.004338395	10	9	OPC	41	6	6
AAGCCGCCAATAACGA-1_MS200_A303	-23.93422735	10.15678748	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1190	1860	0.002150538	0.009677419	10	8	Astrocytes	41	6	6
AAGCCGCCAATCCGAT-1_MS200_A303	19.23114404	-24.53891305	3	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3279	7459	0.009116504	0.009116504	10	3	EN-L5-6	41	6	6
AAGCCGCCAATTGCTG-1_MS200_A303	-15.91300849	-1.798138946	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2662	5020	0.01374502	0.013346614	10	13A	IN-VIP	41	6	6
AAGCCGCCAGCAGTTT-1_MS200_A303	-29.39474204	-21.95423713	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4457	11486	0.033519067	0.012101689	10	6A	IN-PV	41	6	6
AAGCCGCCATACGCCG-1_MS200_A303	-5.711678263	13.26728153	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	716	1013	0.005923001	0.01875617	10	oligos	OL-MS-1	41	6	6
AAGCCGCGTCTTCGTC-1_MS200_A303	-29.53091217	-10.21780982	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1044	1562	0.003201024	0.015364917	10	9	OPC	41	6	6
AAGCCGCTCAGTTAGC-1_MS200_A303	-24.34531928	6.501538522	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	752	1058	0.006616257	0.012287335	10	8	Astrocytes	41	6	6
AAGCCGCTCTGCGACG-1_MS200_A303	-13.78420229	22.47878435	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1493	2343	0.011523688	0.01579172	10	8	Astrocytes	41	6	6
AAGCCGCTCTGTACGA-1_MS200_A303	10.54493252	-15.33166694	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3292	6755	0.012435233	0.006809771	10	L2-3	EN-L2-3-MS	41	6	6
AAGGAGCAGGATGTAT-1_MS200_A303	-5.012452726	14.99998253	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	879	1290	0.013178295	0.010852713	10	oligos	OL-MS-1	41	6	6
AAGGAGCAGGTGATAT-1_MS200_A303	10.25072573	-0.625455222	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1155	1690	0.082248521	0.004733728	10	12	EN-MIX	41	6	6
AAGGAGCCAAGACACG-1_MS200_A303	-14.72184046	25.29929961	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2118	3583	0.002790957	0.00781468	10	8	Astrocytes	41	6	6
AAGGAGCCAATAACGA-1_MS200_A303	29.56379504	-17.97649973	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	6156	18072	0.025287738	0.009738822	10	2	EN-L4	41	6	6
AAGGAGCCACACATGT-1_MS200_A303	-14.29782555	23.68434996	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1878	3053	0.0049132	0.009171307	10	8	Astrocytes	41	6	6
AAGGAGCGTCTGGAGA-1_MS200_A303	9.063382486	-21.73326316	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4162	10506	0.00513992	0.008852085	10	L2-3	EN-L2-3-MS	41	6	6
AAGGAGCGTTTGTGTG-1_MS200_A303	14.78549559	-13.73050486	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4435	11300	0.024778761	0.005221239	10	L2-3	EN-L2-3-MS	41	6	6
AAGGAGCTCGCGTAGC-1_MS200_A303	33.79590713	-18.48002718	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3173	5906	0.021842194	0.020995598	10	2	EN-L4	41	6	6
AAGGAGCTCGCTGATA-1_MS200_A303	22.70120514	-10.68026061	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2712	5756	0.042043085	0.005559416	10	2	EN-L4	41	6	6
AAGGAGCTCGGCGCAT-1_MS200_A303	9.28708243	0.140287766	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1005	1342	0.017138599	0.01490313	10	12	EN-MIX	41	6	6
AAGGCAGAGCACAGGT-1_MS200_A303	-28.79119852	-5.828722333	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1131	1650	0.001818182	0.006666667	10	9	OPC	41	6	6
AAGGCAGAGCTATGCT-1_MS200_A303	33.5810572	10.64326855	14	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	752	1046	0.002868069	0.013384321	10	14	Microglia	41	6	6
AAGGCAGCACTTAAGC-1_MS200_A303	25.17274304	-14.89851336	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4705	11395	0.016059675	0.012637122	10	2	EN-L4	41	6	6
AAGGCAGCAGCTGTAT-1_MS200_A303	-12.0287095	28.94405665	17	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1623	2472	0.003236246	0.017799353	10	oligos	OL-MS-2	41	6	6
AAGGCAGCAGGTCCAC-1_MS200_A303	17.43333915	-18.86436789	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3362	6972	0.062248996	0.004876649	10	L2-3	EN-L2-3-MS	41	6	6
AAGGCAGGTCTTCGTC-1_MS200_A303	-23.66813122	9.696274155	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1031	1645	0.006079027	0.015197568	10	8	Astrocytes	41	6	6
AAGGCAGGTTAGTGGG-1_MS200_A303	-24.29113726	6.295475178	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	797	1043	0.008628955	0.007670182	10	8	Astrocytes	41	6	6
AAGGCAGGTTCAACCA-1_MS200_A303	-18.03990575	-6.179251895	13B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2484	4856	0.028418451	0.008443163	10	13B	IN-SV2C	41	6	6
AAGGCAGGTTCACCTC-1_MS200_A303	-23.63721156	9.553390295	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1010	1537	0.011060507	0.011060507	10	8	Astrocytes	41	6	6
AAGGCAGGTTGGTGGA-1_MS200_A303	4.569122577	-2.451003223	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	840	1148	0.027874564	0.006968641	10	12	EN-MIX	41	6	6
AAGGCAGTCGAGGTAG-1_MS200_A303	-5.248947364	16.23452235	1	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	760	1109	0.003606853	0.017132552	10	oligos	OL-Cntl	41	6	6
AAGGCAGTCGTCTGAA-1_MS200_A303	-15.10835463	21.64960386	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1191	1784	0.006165919	0.016255605	10	8	Astrocytes	41	6	6
AAGGCAGTCGTTTGCC-1_MS200_A303	-23.89843246	10.78535109	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1127	1654	0.010882709	0.006650544	10	8	Astrocytes	41	6	6
AAGGTTCCAGGGCATA-1_MS200_A303	-29.76336355	-5.154617485	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1227	1858	0.005382131	0.009149623	10	9	OPC	41	6	6
AAGGTTCCAGTATCTG-1_MS200_A303	-16.12083317	23.18674054	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1380	2353	0.002549936	0.009349766	10	8	Astrocytes	41	6	6
AAGGTTCCATGGGAAC-1_MS200_A303	-6.309712709	15.49692936	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	746	1087	0.019319227	0.004599816	10	oligos	OL-MS-1	41	6	6
AAGGTTCGTACCGGCT-1_MS200_A303	-13.98036626	-36.90764447	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2130	3944	0.107758621	0.011916836	10	16	EN-PYR	41	6	6
AAGGTTCTCAATCACG-1_MS200_A303	-14.0634951	-8.967229012	13B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2088	3811	0.020729467	0.005772763	10	13B	IN-SV2C	41	6	6
AAGGTTCTCGATAGAA-1_MS200_A303	-19.49998138	-0.943834829	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4206	8970	0.022630992	0.019509476	10	13A	IN-VIP	41	6	6
AAGGTTCTCTTTAGTC-1_MS200_A303	-20.54816095	23.64223756	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1391	2314	0.003457217	0.010803803	10	8	Astrocytes	41	6	6
AAGTCTGAGAGCAATT-1_MS200_A303	11.58396007	-13.00948528	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3422	7176	0.012681159	0.009754738	10	L2-3	EN-L2-3-MS	41	6	6
AAGTCTGAGCCCAATT-1_MS200_A303	-11.80674321	-27.3919734	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	843	1096	0.03649635	0.023722628	10	16	EN-PYR	41	6	6
AAGTCTGAGGGTTTCT-1_MS200_A303	18.62272043	-7.191414185	3	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2156	4413	0.016315432	0.003172445	10	3	EN-L5-6	41	6	6
AAGTCTGAGTCTTGCA-1_MS200_A303	10.08283343	-2.607527387	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1479	2381	0.048719026	0.01049979	10	12	EN-MIX	41	6	6
AAGTCTGGTTACGGAG-1_MS200_A303	-18.75159027	-24.17343165	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2389	4459	0.004709576	0.003139717	10	6A	IN-PV	41	6	6
AAGTCTGTCACCTCGT-1_MS200_A303	-24.15057029	6.8309405	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	865	1280	0.00703125	0.00859375	10	8	Astrocytes	41	6	6
AAGTCTGTCCTGTAGA-1_MS200_A303	16.90642164	-14.30955526	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	6135	18119	0.014459959	0.008664937	10	L2-3	EN-L2-3-MS	41	6	6
AATCCAGAGAAACCGC-1_MS200_A303	33.93318595	-18.17575602	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4906	11951	0.018492176	0.015647226	10	2	EN-L4	41	6	6
AATCCAGCAGCTGGCT-1_MS200_A303	-4.87466607	-36.92814418	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	902	1181	0.038950042	0.027095682	10	16	EN-PYR	41	6	6
AATCCAGGTCATATGC-1_MS200_A303	-12.92755888	16.96603971	11	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1491	2470	0.005668016	0.009311741	10	11	Glia-MIX	41	6	6
AATCCAGGTTAAAGAC-1_MS200_A303	-23.68160829	9.423026478	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1117	1630	0.006134969	0.009815951	10	8	Astrocytes	41	6	6
AATCCAGGTTCCATGA-1_MS200_A303	-14.63992157	24.97233324	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1941	3620	0.008287293	0.011049724	10	8	Astrocytes	41	6	6
AATCCAGTCACGCATA-1_MS200_A303	30.64894588	-12.87550984	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2687	5583	0.091527852	0.004298764	10	2	EN-L4	41	6	6
AATCCAGTCAGAGGTG-1_MS200_A303	-19.57391054	5.241597718	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	891	1298	0.002311248	0.020801233	10	8	Astrocytes	41	6	6
AATCGGTAGTCTCAAC-1_MS200_A303	18.91350531	-14.0432787	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	8348	35644	0.031730446	0.011755134	10	L2-3	EN-L2-3-MS	41	6	6
AATCGGTCACTGTCGG-1_MS200_A303	-32.25274955	-8.342414915	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1011	1430	0.002097902	0.006293706	10	9	OPC	41	6	6
AATCGGTCAGGACCCT-1_MS200_A303	14.50494702	-17.35877762	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	6312	20116	0.010290316	0.008252138	10	L2-3	EN-L2-3-MS	41	6	6
AATCGGTCAGGGATTG-1_MS200_A303	-7.877050846	-36.97340153	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	909	1285	0.023346304	0.015564202	10	16	EN-PYR	41	6	6
AATCGGTCATCATCCC-1_MS200_A303	34.23586566	10.73575522	14	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	794	1086	0.003683241	0.02854512	10	14	Microglia	41	6	6
AATCGGTGTCCGTTAA-1_MS200_A303	-18.9569137	-0.917974045	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3750	7830	0.019029374	0.018390805	10	13A	IN-VIP	41	6	6
AATCGGTGTCGTGGCT-1_MS200_A303	-5.297779795	-35.67759524	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	833	1143	0.111111111	0.016622922	10	16	EN-PYR	41	6	6
AATCGGTGTTGGACCC-1_MS200_A303	19.51855775	-0.444086519	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1444	2225	0.002247191	0.002696629	10	12	EN-MIX	41	6	6
AATCGGTTCTGCTTGC-1_MS200_A303	-23.83999607	9.160874874	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	943	1319	0.006065201	0.006065201	10	8	Astrocytes	41	6	6
ACACCAAAGAGTACCG-1_MS200_A303	12.78072181	-16.88932247	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5791	17005	0.010349897	0.005116142	10	L2-3	EN-L2-3-MS	41	6	6
ACACCAAAGTACTTGC-1_MS200_A303	34.99232378	10.63082321	14	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	805	1017	0.003933137	0.015732547	10	14	Microglia	41	6	6
ACACCAACAAGCGTAG-1_MS200_A303	10.67925865	1.216263706	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	798	1152	0.115451389	0.008680556	10	12	EN-MIX	41	6	6
ACACCAAGTAACGTTC-1_MS200_A303	4.777145444	-14.25030651	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2687	5872	0.035081744	0.004938692	10	L2-3	EN-L2-3-MS	41	6	6
ACACCAAGTAAGGATT-1_MS200_A303	34.67618289	-15.46925244	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	6161	17265	0.011699971	0.011410368	10	2	EN-L4	41	6	6
ACACCAATCATCGATG-1_MS200_A303	-27.55553719	-22.66416604	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4905	13351	0.025016853	0.008538686	10	6A	IN-PV	41	6	6
ACACCCTCAGTTTACG-1_MS200_A303	-30.92292999	-7.993027586	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1060	1664	0.005408654	0.006009615	10	9	OPC	41	6	6
ACACCCTGTAGGCTGA-1_MS200_A303	0.739278408	10.46042713	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	953	1331	0.009767092	0.01728024	10	oligos	OL-MS-1	41	6	6
ACACCCTGTCGAGTTT-1_MS200_A303	-15.35986205	23.44410933	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1568	2438	0.002871206	0.011074651	10	8	Astrocytes	41	6	6
ACACCCTGTGCACTTA-1_MS200_A303	-30.54409487	-21.38775424	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5628	16178	0.029731734	0.01242428	10	6A	IN-PV	41	6	6
ACACCCTGTGGTGTAG-1_MS200_A303	-12.53078624	-14.29887233	6B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1392	2229	0.026469269	0.014356214	10	6B	IN-SST	41	6	6
ACACCGGAGACTAGGC-1_MS200_A303	30.81402777	-18.87682891	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	6571	19436	0.019911504	0.017544762	10	2	EN-L4	41	6	6
ACACCGGAGTGCCAGA-1_MS200_A303	-14.20886329	17.61375444	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1151	1778	0.010123735	0.016872891	10	8	Astrocytes	41	6	6
ACACCGGCACAACTGT-1_MS200_A303	33.98994407	-17.4377392	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5059	12561	0.015285407	0.011941724	10	2	EN-L4	41	6	6
ACACCGGCACACTGCG-1_MS200_A303	28.64822272	-19.09036338	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	10651	74461	0.063294879	0.011885417	10	2	EN-L4	41	6	6
ACACCGGCACTCGACG-1_MS200_A303	19.38909487	-0.823565801	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1303	1934	0.041365047	0.005170631	10	12	EN-MIX	41	6	6
ACACCGGCATTTGCCC-1_MS200_A303	-9.192661701	-15.71013858	6B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	809	1188	0.029461279	0.011784512	10	6B	IN-SST	41	6	6
ACACCGGGTAGAGTGC-1_MS200_A303	0.855947891	8.925162666	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1240	1892	0.002114165	0.021141649	10	oligos	OL-MS-1	41	6	6
ACACCGGGTCAAACTC-1_MS200_A303	-17.40175044	-2.003544738	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3805	9468	0.00686523	0.012568652	10	13A	IN-VIP	41	6	6
ACACCGGTCGGCGCAT-1_MS200_A303	-29.3550814	-10.28409547	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	978	1366	0.011713031	0.008784773	10	9	OPC	41	6	6
ACACCGGTCGTTTGCC-1_MS200_A303	-5.744925815	14.71845723	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	900	1320	0.00530303	0.016666667	10	oligos	OL-MS-1	41	6	6
ACACCGGTCTCGTATT-1_MS200_A303	8.865442215	-4.022887118	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1608	2680	0.058208955	0.009701493	10	16	EN-PYR	41	6	6
ACACTGAAGAGACTTA-1_MS200_A303	-15.70175214	23.41175561	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1467	2440	0.002459016	0.00942623	10	8	Astrocytes	41	6	6
ACACTGAAGCTGCGAA-1_MS200_A303	30.8150952	-18.92628002	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4739	11155	0.016225908	0.01792918	10	2	EN-L4	41	6	6
ACACTGAAGGGTATCG-1_MS200_A303	2.07959841	10.38202806	1	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1071	1578	0.019011407	0.010139417	10	oligos	OL-Cntl	41	6	6
ACACTGAAGGTGATTA-1_MS200_A303	14.57546519	-20.46067671	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	7281	24457	0.006051437	0.009158932	10	L2-3	EN-L2-3-MS	41	6	6
ACACTGACAAACGTGG-1_MS200_A303	-19.3035399	5.240860386	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	742	1003	0.004985045	0.013958126	10	8	Astrocytes	41	6	6
ACACTGACAATAACGA-1_MS200_A303	-6.216539184	14.79190972	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	894	1288	0.013198758	0.01242236	10	oligos	OL-MS-1	41	6	6
ACACTGATCAACACCA-1_MS200_A303	32.83485505	-16.6562855	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4610	10949	0.009315919	0.013973879	10	2	EN-L4	41	6	6
ACACTGATCGTCGTTC-1_MS200_A303	18.32274873	-9.464494983	3	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2328	4586	0.019843	0.002180549	10	3	EN-L5-6	41	6	6
ACAGCCGAGGGATCTG-1_MS200_A303	-4.232868042	13.99167611	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	825	1157	0.001728608	0.015557476	10	oligos	OL-MS-1	41	6	6
ACAGCCGAGTTAAGTG-1_MS200_A303	-25.84404416	-1.408111614	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1306	1874	0.005336179	0.011205977	10	9	OPC	41	6	6
ACAGCCGCATCGGACC-1_MS200_A303	-11.86018088	-27.38781167	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	882	1168	0.038527397	0.025684932	10	16	EN-PYR	41	6	6
ACAGCCGCATTATCTC-1_MS200_A303	-24.22761043	-21.30959013	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2844	6198	0.041303646	0.00613101	10	6A	IN-PV	41	6	6
ACAGCTAAGATCCCGC-1_MS200_A303	24.66765671	-13.21924466	3	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4585	11752	0.013955071	0.005445882	10	3	EN-L5-6	41	6	6
ACAGCTAAGATGCCAG-1_MS200_A303	-13.40987733	22.87999165	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2024	3644	0.003841932	0.015642151	10	8	Astrocytes	41	6	6
ACAGCTACAAACAACA-1_MS200_A303	10.4626765	0.822012402	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	917	1412	0.059490085	0.005665722	10	12	EN-MIX	41	6	6
ACAGCTACACATCTTT-1_MS200_A303	11.07083991	-18.35664859	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5820	18741	0.005869484	0.005816125	10	L2-3	EN-L2-3-MS	41	6	6
ACAGCTACACATTCGA-1_MS200_A303	-16.17759217	22.93981422	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1465	2400	0.0025	0.011666667	10	8	Astrocytes	41	6	6
ACAGCTAGTCTTGATG-1_MS200_A303	13.34750451	-14.88930639	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3991	8590	0.01757858	0.008731083	10	L2-3	EN-L2-3-MS	41	6	6
ACATACGCAAATACAG-1_MS200_A303	-30.54674847	-21.66604914	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	6288	18257	0.032316372	0.011502437	10	6A	IN-PV	41	6	6
ACATACGCAAGGTTTC-1_MS200_A303	-14.67127548	25.13974653	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1977	3439	0.004652515	0.012794417	10	8	Astrocytes	41	6	6
ACATACGGTGGTAACG-1_MS200_A303	-20.96563404	5.642220114	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1245	1796	0.023385301	0.012806236	10	8	Astrocytes	41	6	6
ACATACGGTGTAACGG-1_MS200_A303	15.93665487	-16.27751324	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	7268	23577	0.010985282	0.017517072	10	L2-3	EN-L2-3-MS	41	6	6
ACATACGGTTCAACCA-1_MS200_A303	-17.06094818	20.05311419	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1331	2127	0.002350729	0.012223789	10	8	Astrocytes	41	6	6
ACATACGGTTCTGAAC-1_MS200_A303	-5.922769435	-36.04502519	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	816	1034	0.046421663	0.020309478	10	16	EN-PYR	41	6	6
ACATCAGCACGAAATA-1_MS200_A303	30.71271469	-12.59746838	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3012	6726	0.107790663	0.003419566	10	2	EN-L4	41	6	6
ACATCAGCACGGTTTA-1_MS200_A303	-15.15155469	20.84739632	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1207	1838	0.006528836	0.021218716	10	8	Astrocytes	41	6	6
ACATCAGCACTAGTAC-1_MS200_A303	-17.63388278	-0.981140824	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3639	7876	0.010411376	0.011681056	10	13A	IN-VIP	41	6	6
ACATCAGGTAAGTTCC-1_MS200_A303	-17.57637784	-0.966587952	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3765	8454	0.00804353	0.013839603	10	13A	IN-VIP	41	6	6
ACATCAGGTATGAATG-1_MS200_A303	-8.487547087	-10.0197308	13B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1127	1540	0.008441558	0.017532468	10	13B	IN-SV2C	41	6	6
ACATCAGGTCCGAATT-1_MS200_A303	-29.78014291	-3.780496222	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1429	2324	0.003872633	0.006024096	10	9	OPC	41	6	6
ACATCAGGTGTGGCTC-1_MS200_A303	-30.67036616	-21.58984973	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5794	16471	0.031934916	0.013296096	10	6A	IN-PV	41	6	6
ACATCAGTCACCACCT-1_MS200_A303	29.78327745	-17.66344368	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	7872	34695	0.040092232	0.006917423	10	2	EN-L4	41	6	6
ACATCAGTCTACTATC-1_MS200_A303	2.335637532	19.30164707	1	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	931	1418	0.005641749	0.013399154	10	oligos	OL-Cntl	41	6	6
ACATGGTAGAAGGGTA-1_MS200_A303	-11.12581786	-6.503503021	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1786	2947	0.015269766	0.006786563	10	13A	IN-VIP	41	6	6
ACATGGTCAAGTACCT-1_MS200_A303	12.96022706	-15.64888001	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4962	13832	0.01026605	0.0093262	10	L2-3	EN-L2-3-MS	41	6	6
ACATGGTGTACCGTTA-1_MS200_A303	-9.756020725	-2.978838256	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1929	3299	0.003334344	0.012428008	10	13A	IN-VIP	41	6	6
ACATGGTGTAGCGTCC-1_MS200_A303	13.88564252	-13.9768998	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3900	8362	0.020090887	0.008132026	10	L2-3	EN-L2-3-MS	41	6	6
ACATGGTGTCCGACGT-1_MS200_A303	18.21561566	-20.4445744	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3381	7591	0.008562772	0.006981952	10	L2-3	EN-L2-3-MS	41	6	6
ACATGGTTCAATCTCT-1_MS200_A303	11.91646389	0.644385233	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	835	1301	0.153727902	0.003843198	10	12	EN-MIX	41	6	6
ACATGGTTCCCGGATG-1_MS200_A303	10.79616009	-17.67912695	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4556	11764	0.006715403	0.005695342	10	L2-3	EN-L2-3-MS	41	6	6
ACATGGTTCGCACTCT-1_MS200_A303	26.77702909	8.093980052	15A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1244	1876	0.010660981	0.033049041	10	15A	Endo cells	41	6	6
ACATGGTTCTATCGCC-1_MS200_A303	-19.59820013	-0.919334155	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4214	9557	0.027623731	0.016950926	10	13A	IN-VIP	41	6	6
ACATGGTTCTGCTTGC-1_MS200_A303	10.40299933	1.334083832	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	789	1076	0.095724907	0.007434944	10	12	EN-MIX	41	6	6
ACCAGTAAGCCCAGCT-1_MS200_A303	35.13665368	10.35590404	14	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	744	1005	0.012935323	0.011940299	10	14	Microglia	41	6	6
ACCAGTAAGCGTGAAC-1_MS200_A303	-23.74458548	7.875545673	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1112	1588	0.00440806	0.025188917	10	8	Astrocytes	41	6	6
ACCAGTAAGTTGTAGA-1_MS200_A303	-15.42155333	22.22643356	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1486	2252	0.007104796	0.007548845	10	8	Astrocytes	41	6	6
ACCAGTACAACGCACC-1_MS200_A303	-16.68110095	-3.450107265	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3293	7085	0.007904023	0.005928017	10	13A	IN-VIP	41	6	6
ACCAGTACAGCTGCTG-1_MS200_A303	32.8476404	-8.488916569	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3781	9182	0.003920714	0.010019604	10	2	EN-L4	41	6	6
ACCAGTAGTGACCAAG-1_MS200_A303	25.02347841	-14.86137569	3	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5005	12499	0.020641651	0.007920634	10	3	EN-L5-6	41	6	6
ACCAGTATCTGACCTC-1_MS200_A303	-32.4600908	-5.600315014	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1261	2053	0.000974184	0.011690209	10	9	OPC	41	6	6
ACCAGTATCTGATACG-1_MS200_A303	-14.33948102	22.75549027	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1540	2426	0.004534213	0.008656224	10	8	Astrocytes	41	6	6
ACCCACTAGACCCACC-1_MS200_A303	-30.00523803	-12.21115228	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	815	1213	0.001648805	0.003297609	10	9	OPC	41	6	6
ACCCACTAGAGCCCAA-1_MS200_A303	11.4148931	-3.609935889	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2060	3489	0.049871023	0.004872456	10	12	EN-MIX	41	6	6
ACCCACTAGCTAGGCA-1_MS200_A303	21.9658033	-15.7801886	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4019	8906	0.016393443	0.017403997	10	2	EN-L4	41	6	6
ACCCACTAGGGTATCG-1_MS200_A303	-33.31567368	-4.582969331	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1224	1941	0.001030397	0.004121587	10	9	OPC	41	6	6
ACCCACTAGTCTCAAC-1_MS200_A303	-15.21098243	24.51256536	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1661	3055	0.005237316	0.008837971	10	8	Astrocytes	41	6	6
ACCCACTCACCAACCG-1_MS200_A303	-16.00074266	23.43297504	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1607	2939	0.001020755	0.007825791	10	8	Astrocytes	41	6	6
ACCCACTCATGGTAGG-1_MS200_A303	14.36249087	-12.83465128	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4273	10047	0.012640589	0.014133572	10	L2-3	EN-L2-3-MS	41	6	6
ACCCACTGTCCAGTGC-1_MS200_A303	19.80430485	-0.95204839	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1443	2276	0.014499121	0.005711775	10	12	EN-MIX	41	6	6
ACCCACTTCCGAATGT-1_MS200_A303	-16.74410088	-0.129006678	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3345	6898	0.00985793	0.012612351	10	13A	IN-VIP	41	6	6
ACCGTAAAGACTGGGT-1_MS200_A303	-21.82615134	5.182179996	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1060	1646	0.002430134	0.019441069	10	8	Astrocytes	41	6	6
ACCGTAAGTCTCCATC-1_MS200_A303	-4.029239811	15.84128929	1	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	741	1069	0.006548176	0.016838167	10	oligos	OL-Cntl	41	6	6
ACCGTAAGTGGTACAG-1_MS200_A303	10.44031889	1.441682263	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	744	1023	0.115347019	0.003910068	10	12	EN-MIX	41	6	6
ACCGTAAGTTACCAGT-1_MS200_A303	-27.44377986	4.507054167	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2128	3880	0.007216495	0.008247423	10	9	OPC	41	6	6
ACCGTAATCCTTGCCA-1_MS200_A303	16.4821666	-16.80766808	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	6322	22506	0.030969519	0.00462099	10	L2-3	EN-L2-3-MS	41	6	6
ACCGTAATCTGATTCT-1_MS200_A303	5.324742662	-2.243402794	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	840	1172	0.048634812	0.005119454	10	12	EN-MIX	41	6	6
ACCTTTAAGAAACGCC-1_MS200_A303	-33.30785091	-4.522526339	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1314	2130	0.002816901	0.005164319	10	9	OPC	41	6	6
ACCTTTAAGGAATCGC-1_MS200_A303	-18.58261085	-1.22681909	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2793	4963	0.017126738	0.020552085	10	13A	IN-VIP	41	6	6
ACCTTTACAAACGTGG-1_MS200_A303	-15.45355921	21.65525556	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1134	1852	0.00161987	0.010259179	10	8	Astrocytes	41	6	6
ACCTTTACACCGTTGG-1_MS200_A303	-29.47966432	-10.09789745	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	993	1383	0.005061461	0.009399855	10	9	OPC	41	6	6
ACCTTTACACGTCTCT-1_MS200_A303	5.491163602	20.20503666	1	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	901	1347	0.002227171	0.01484781	10	oligos	OL-Cntl	41	6	6
ACCTTTACATGACATC-1_MS200_A303	9.875236992	-11.87086174	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2328	3903	0.007686395	0.014860364	10	L2-3	EN-L2-3-MS	41	6	6
ACCTTTACATGTTGAC-1_MS200_A303	22.19406291	-17.17068761	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4721	12415	0.047039871	0.005718888	10	L2-3	EN-L2-3-MS	41	6	6
ACCTTTAGTGGTTTCA-1_MS200_A303	-31.43147296	-6.355655267	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1125	1807	0.003320421	0.006640841	10	9	OPC	41	6	6
ACCTTTATCAGCAACT-1_MS200_A303	34.41182025	-17.8610131	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5175	13467	0.017524319	0.019306453	10	2	EN-L4	41	6	6
ACCTTTATCTAACGGT-1_MS200_A303	-14.13431004	-15.99292188	6B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1511	2726	0.023110785	0.00513573	10	6B	IN-SST	41	6	6
ACGAGCCAGCTGATAA-1_MS200_A303	-26.98607002	4.960332557	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1383	2117	0.008030231	0.008502598	10	8	Astrocytes	41	6	6
ACGAGCCCAGTTAACC-1_MS200_A303	-30.34914051	-21.72493547	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5058	13483	0.040643774	0.012979307	10	6A	IN-PV	41	6	6
ACGAGCCTCGAGGTAG-1_MS200_A303	-6.784341129	-35.65519655	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	821	1105	0.076923077	0.018099548	10	16	EN-PYR	41	6	6
ACGAGCCTCGTTACGA-1_MS200_A303	-23.56413877	9.477442701	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1043	1504	0.003989362	0.013962766	10	8	Astrocytes	41	6	6
ACGAGGAAGAAGGTGA-1_MS200_A303	-15.786343	22.54094705	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1329	2048	0.005371094	0.0078125	10	8	Astrocytes	41	6	6
ACGAGGACAACACGCC-1_MS200_A303	14.33981916	-15.94295232	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	7179	24339	0.015160853	0.008422696	10	L2-3	EN-L2-3-MS	41	6	6
ACGAGGACATGAACCT-1_MS200_A303	-13.56277407	17.87723865	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1579	2419	0.00413394	0.011575031	10	8	Astrocytes	41	6	6
ACGAGGAGTGCCTGTG-1_MS200_A303	-16.11955821	22.5091807	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1327	2038	0.002944063	0.008832188	10	8	Astrocytes	41	6	6
ACGAGGATCATCATTC-1_MS200_A303	23.21818369	-24.98230424	3	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3946	10775	0.021809745	0.002412993	10	3	EN-L5-6	41	6	6
ACGAGGATCGGAAACG-1_MS200_A303	9.923317153	-11.56017472	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2096	3340	0.019760479	0.017964072	10	L2-3	EN-L2-3-MS	41	6	6
ACGAGGATCGTCGTTC-1_MS200_A303	-24.04202175	9.67994171	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1008	1472	0.012228261	0.006793478	10	8	Astrocytes	41	6	6
ACGAGGATCTATGTGG-1_MS200_A303	15.89426604	-13.19622046	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5131	12676	0.017355633	0.011596718	10	L2-3	EN-L2-3-MS	41	6	6
ACGAGGATCTGTTTGT-1_MS200_A303	7.038828433	-10.61514636	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1866	3098	0.006132989	0.010652034	10	L2-3	EN-L2-3-MS	41	6	6
ACGATACAGACTGTAA-1_MS200_A303	-5.843162711	16.30565572	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	757	1088	0.003676471	0.008272059	10	oligos	OL-MS-1	41	6	6
ACGATACAGAGACTAT-1_MS200_A303	15.50010962	-14.8503928	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	7095	24377	0.016326865	0.00721992	10	L2-3	EN-L2-3-MS	41	6	6
ACGATACAGTGGGCTA-1_MS200_A303	33.27587218	-15.62245363	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3940	8640	0.022916667	0.009259259	10	2	EN-L4	41	6	6
ACGATACCAAATACAG-1_MS200_A303	14.29286642	-15.13356025	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4886	13282	0.024695076	0.006625508	10	L2-3	EN-L2-3-MS	41	6	6
ACGATACCACATTTCT-1_MS200_A303	-24.49439371	-12.40490496	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	820	1221	0.010647011	0.004914005	10	9	OPC	41	6	6
ACGATACCACCATGTA-1_MS200_A303	-30.56607298	-8.743898943	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1038	1537	0.00325309	0.007156799	10	9	OPC	41	6	6
ACGATACCATCGGAAG-1_MS200_A303	-7.600443512	9.762985892	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1407	2497	0.040849019	0.010012014	10	oligos	OL-MS-1	41	6	6
ACGATACCATGAGCGA-1_MS200_A303	-5.346812406	13.5559118	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	732	1003	0.005982054	0.017946162	10	oligos	OL-MS-1	41	6	6
ACGATACGTAGGCATG-1_MS200_A303	-29.93775894	1.135166086	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1985	3238	0.006794317	0.006794317	10	9	OPC	41	6	6
ACGATACGTGTGAATA-1_MS200_A303	-14.52988202	21.59121091	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1316	1906	0.011542497	0.011017838	10	8	Astrocytes	41	6	6
ACGATACTCATACGGT-1_MS200_A303	-9.836234938	-33.45552451	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1135	1584	0.083333333	0.013888889	10	16	EN-PYR	41	6	6
ACGATACTCATCATTC-1_MS200_A303	11.98340623	-18.28778081	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	6679	22703	0.010042726	0.00550588	10	L2-3	EN-L2-3-MS	41	6	6
ACGATGTAGGCGCTCT-1_MS200_A303	-16.19090835	20.52760289	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1330	2184	0.002289377	0.010531136	10	8	Astrocytes	41	6	6
ACGATGTGTCAAGCGA-1_MS200_A303	-23.13046616	9.005634909	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1145	1758	0.004550626	0.013083049	10	8	Astrocytes	41	6	6
ACGATGTGTGCTAGCC-1_MS200_A303	10.97469314	11.2301965	1	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1302	2114	0.005676443	0.012298959	10	oligos	OL-Cntl	41	6	6
ACGATGTGTGGCTCCA-1_MS200_A303	-6.415935945	15.69605975	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	798	1092	0.010989011	0.009157509	10	oligos	OL-MS-1	41	6	6
ACGATGTTCAGAGACG-1_MS200_A303	-23.64331608	9.5925237	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	915	1422	0.004219409	0.016174402	10	8	Astrocytes	41	6	6
ACGATGTTCCACGTGG-1_MS200_A303	-9.701195941	27.72661727	17	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	993	1392	0.00933908	0.010775862	10	oligos	OL-MS-2	41	6	6
ACGATGTTCTTTCCTC-1_MS200_A303	-24.45799557	-23.89449982	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3670	8801	0.013975685	0.008976253	10	6A	IN-PV	41	6	6
ACGCAGCAGGATGTAT-1_MS200_A303	-20.23832631	-4.666483831	13B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3678	7592	0.012513172	0.011064278	10	13B	IN-SV2C	41	6	6
ACGCAGCAGGTGTTAA-1_MS200_A303	-12.09025428	-13.41268986	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1485	2283	0.116075339	0.005256242	10	6A	IN-PV	41	6	6
ACGCAGCCAGAGTGTG-1_MS200_A303	14.99514374	-12.60130113	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4093	9186	0.025364685	0.018397562	10	L2-3	EN-L2-3-MS	41	6	6
ACGCAGCGTACTCGCG-1_MS200_A303	-4.121109776	12.0083275	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	836	1166	0.003430532	0.022298456	10	oligos	OL-MS-1	41	6	6
ACGCAGCGTTCACGGC-1_MS200_A303	33.43107227	-11.25422431	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2547	4461	0.00313831	0.008069939	10	2	EN-L4	41	6	6
ACGCAGCTCGGTGTCG-1_MS200_A303	30.59836647	-6.385798435	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3515	8003	0.043983506	0.003873547	10	2	EN-L4	41	6	6
ACGCCAGAGACTGTAA-1_MS200_A303	-30.12474882	-21.7959168	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4127	9304	0.023538263	0.016229579	10	6A	IN-PV	41	6	6
ACGCCAGAGTATCGAA-1_MS200_A303	11.01577959	-16.720977	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4172	10440	0.016666667	0.004885057	10	L2-3	EN-L2-3-MS	41	6	6
ACGCCAGCAAGCCATT-1_MS200_A303	-23.01761834	8.944771257	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1104	1664	0.018629808	0.009014423	10	8	Astrocytes	41	6	6
ACGCCAGGTCATCGGC-1_MS200_A303	-15.99718517	20.3573645	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1259	1867	0.004284949	0.007498661	10	8	Astrocytes	41	6	6
ACGCCAGGTCTAGCGC-1_MS200_A303	4.632702142	-14.26140391	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2401	4616	0.048743501	0.003032929	10	L2-3	EN-L2-3-MS	41	6	6
ACGCCAGGTCTTCTCG-1_MS200_A303	18.19923636	-23.54159041	3	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3392	8092	0.00111221	0.034107761	10	3	EN-L5-6	41	6	6
ACGCCAGTCAGTTAGC-1_MS200_A303	-15.50256657	20.78107322	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1379	2006	0.006480558	0.012462612	10	8	Astrocytes	41	6	6
ACGCCAGTCCGTACAA-1_MS200_A303	-24.17591941	8.669306397	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	955	1370	0.002189781	0.010218978	10	8	Astrocytes	41	6	6
ACGCCAGTCCGTAGTA-1_MS200_A303	-24.85088984	-18.21919484	6B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2654	5252	0.00990099	0.006283321	10	6B	IN-SST	41	6	6
ACGCCGAAGAGGTACC-1_MS200_A303	-23.0225578	-24.34735953	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3379	7631	0.007207443	0.004979688	10	6A	IN-PV	41	6	6
ACGCCGACACGGCTAC-1_MS200_A303	-30.8745844	-5.172203053	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1235	2005	0.00798005	0.004488778	10	9	OPC	41	6	6
ACGCCGACATAGGATA-1_MS200_A303	5.639569016	12.5645723	1	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1089	1717	0.000582411	0.012813046	10	oligos	OL-Cntl	41	6	6
ACGCCGAGTTCAGTAC-1_MS200_A303	-32.28659033	-5.927025223	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1142	1845	0.007588076	0.005420054	10	9	OPC	41	6	6
ACGGAGAAGTCATGCT-1_MS200_A303	-5.586746903	-36.27170496	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	788	1009	0.052527255	0.007928642	10	16	EN-PYR	41	6	6
ACGGAGACATCGGGTC-1_MS200_A303	9.217734929	0.514721833	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	996	1533	0.006523157	0.016307893	10	12	EN-MIX	41	6	6
ACGGAGAGTCTCCCTA-1_MS200_A303	-10.61688136	-8.2254	13B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1584	2688	0.026785714	0.00483631	10	13B	IN-SV2C	41	6	6
ACGGAGATCAGCTGGC-1_MS200_A303	-23.04893115	6.950504918	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	976	1433	0.001395673	0.009769714	10	8	Astrocytes	41	6	6
ACGGAGATCATGCAAC-1_MS200_A303	-5.535190304	15.69081527	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	759	1123	0.020480855	0.016918967	10	oligos	OL-MS-1	41	6	6
ACGGAGATCATGCTCC-1_MS200_A303	34.14511171	-12.9018875	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3779	8075	0.002972136	0.01498452	10	2	EN-L4	41	6	6
ACGGAGATCCTCTAGC-1_MS200_A303	-30.33935737	-2.358336485	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1541	2588	0.008887172	0.008887172	10	9	OPC	41	6	6
ACGGAGATCTACCAGA-1_MS200_A303	-5.601183575	17.57751252	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	814	1223	0.002452984	0.010629599	10	oligos	OL-MS-1	41	6	6
ACGGAGATCTCACATT-1_MS200_A303	33.36838672	-11.48451105	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2687	5197	0.013661728	0.007504329	10	2	EN-L4	41	6	6
ACGGAGATCTCGATGA-1_MS200_A303	11.86988707	-3.113243076	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1391	2142	0.046685341	0.012605042	10	12	EN-MIX	41	6	6
ACGGCCAAGAGGTACC-1_MS200_A303	15.14618152	-13.38603393	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5447	14796	0.010002703	0.012368208	10	L2-3	EN-L2-3-MS	41	6	6
ACGGCCAAGGGATGGG-1_MS200_A303	16.93085399	-9.52160953	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1814	3227	0.071273629	0.005577936	10	12	EN-MIX	41	6	6
ACGGCCAAGTTTCCTT-1_MS200_A303	-15.1403727	25.46157329	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2167	4040	0.007920792	0.013861386	10	8	Astrocytes	41	6	6
ACGGCCACAGTTCATG-1_MS200_A303	-22.490436	-24.40683851	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3091	7419	0.013209327	0.006604664	10	6A	IN-PV	41	6	6
ACGGCCAGTACCTACA-1_MS200_A303	-14.04199918	-38.0935034	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1937	3165	0.036966825	0.020537125	10	16	EN-PYR	41	6	6
ACGGCCAGTATATGAG-1_MS200_A303	-29.78869448	-5.240134985	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1160	1888	0.010063559	0.008474576	10	9	OPC	41	6	6
ACGGCCAGTCCGAAGA-1_MS200_A303	34.02871964	-18.27329819	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4199	9129	0.022346369	0.015992989	10	2	EN-L4	41	6	6
ACGGCCAGTCCGAATT-1_MS200_A303	12.04916485	-14.98252288	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3829	9025	0.011191136	0.011080332	10	L2-3	EN-L2-3-MS	41	6	6
ACGGCCAGTTGCTCCT-1_MS200_A303	26.92475084	4.116370271	15BA	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	786	1100	0.066363636	0.011818182	10	15BA	Stromal cells	41	6	6
ACGGCCAGTTTAGCTG-1_MS200_A303	-29.67143846	-2.773792136	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1357	2193	0.001823985	0.006383949	10	9	OPC	41	6	6
ACGGCCATCAGTACGT-1_MS200_A303	11.68294327	-3.399637307	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1773	3120	0.136538462	0.008653846	10	12	EN-MIX	41	6	6
ACGGCCATCGAATCCA-1_MS200_A303	33.22055382	-15.88229676	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4283	10012	0.016779864	0.009688374	10	2	EN-L4	41	6	6
ACGGGCTCACGCATCG-1_MS200_A303	3.714397395	4.802238462	7	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1346	1837	0.007076756	0.016330974	10	7	Phagocytes	41	6	6
ACGGGCTGTAAACGCG-1_MS200_A303	16.7461436	-13.70028041	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	6142	18183	0.019193752	0.00830446	10	L2-3	EN-L2-3-MS	41	6	6
ACGGGCTTCACGATGT-1_MS200_A303	-30.27964551	-21.72882472	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5803	16757	0.034373695	0.012711106	10	6A	IN-PV	41	6	6
ACGGGCTTCTCTTGAT-1_MS200_A303	8.811668672	1.483499611	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	707	1138	0.228471002	0.004393673	10	12	EN-MIX	41	6	6
ACGGGCTTCTGCGACG-1_MS200_A303	-4.18676195	-32.14010539	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	693	1406	0.379800853	0.0056899	10	16	EN-PYR	41	6	6
ACGGGTCAGAACTCGG-1_MS200_A303	10.57306818	-15.38784109	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4267	10784	0.004451039	0.019287834	10	L2-3	EN-L2-3-MS	41	6	6
ACGGGTCAGACTCGGA-1_MS200_A303	11.89059909	-13.3063939	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3871	8637	0.004283895	0.01354637	10	L2-3	EN-L2-3-MS	41	6	6
ACGGGTCAGTGTGGCA-1_MS200_A303	-24.07639072	9.808102857	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1112	1624	0.006157635	0.007389163	10	8	Astrocytes	41	6	6
ACGGGTCGTAAAGGAG-1_MS200_A303	15.99858299	-16.83999354	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5161	12850	0.018365759	0.00770428	10	L2-3	EN-L2-3-MS	41	6	6
ACGGGTCGTAGAAAGG-1_MS200_A303	-12.02356244	-3.052751594	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2477	4682	0.015805211	0.008543358	10	13A	IN-VIP	41	6	6
ACGGGTCGTCACTGGC-1_MS200_A303	9.832008494	-0.633793559	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1185	1951	0.168631471	0.009738596	10	12	EN-MIX	41	6	6
ACGGGTCGTGTGCGTC-1_MS200_A303	5.512196404	12.82050076	1	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1138	1692	0.007683215	0.020094563	10	oligos	OL-Cntl	41	6	6
ACGGGTCTCAACACTG-1_MS200_A303	13.47027081	-2.477861539	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1167	1868	0.017130621	0.00267666	10	12	EN-MIX	41	6	6
ACGGGTCTCTCTGCTG-1_MS200_A303	14.41080942	1.749532113	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1022	1731	0.180242634	0.005199307	10	12	EN-MIX	41	6	6
ACGTCAACACAGATTC-1_MS200_A303	-27.20224251	-4.172939199	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1367	2071	0.012071463	0.007242878	10	9	OPC	41	6	6
ACGTCAACATGGTTGT-1_MS200_A303	33.59921289	-13.97222822	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4216	9518	0.011136793	0.007774743	10	2	EN-L4	41	6	6
ACGTCAATCAGCATGT-1_MS200_A303	4.357571715	9.702788649	1	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1387	2201	0.007723762	0.019990913	10	oligos	OL-Cntl	41	6	6
ACGTCAATCCCTAACC-1_MS200_A303	-29.84127169	-8.60430649	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1077	1559	0.005772931	0.012828736	10	9	OPC	41	6	6
ACTATCTAGACTAAGT-1_MS200_A303	-8.066425032	-37.82522606	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1044	1506	0.081009296	0.020584329	10	16	EN-PYR	41	6	6
ACTATCTAGATCCTGT-1_MS200_A303	-7.531199501	-6.411008192	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1220	1867	0.003213712	0.009641136	10	13A	IN-VIP	41	6	6
ACTATCTAGCCGTCGT-1_MS200_A303	-30.21701885	9.467785896	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	799	1128	0.011524823	0.006205674	10	8	Astrocytes	41	6	6
ACTATCTCAGCTGCAC-1_MS200_A303	11.08030304	-13.03305953	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2896	5558	0.012414538	0.009895646	10	L2-3	EN-L2-3-MS	41	6	6
ACTATCTCAGTCACTA-1_MS200_A303	-9.801281622	22.380424	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1371	1964	0.00407332	0.016802444	10	8	Astrocytes	41	6	6
ACTATCTGTAAGTGGC-1_MS200_A303	-5.59589782	14.09466961	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	805	1109	0.00541028	0.023444545	10	oligos	OL-MS-1	41	6	6
ACTATCTGTTCCACAA-1_MS200_A303	-30.328797	-8.776602866	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1114	1776	0.00731982	0.005630631	10	9	OPC	41	6	6
ACTATCTTCACTTCAT-1_MS200_A303	-15.89556892	-0.150165221	13B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3400	7373	0.02346399	0.00623898	10	13B	IN-SV2C	41	6	6
ACTATCTTCGCCAAAT-1_MS200_A303	-5.553555932	-35.49282935	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	912	1185	0.078481013	0.016877637	10	16	EN-PYR	41	6	6
ACTGAACAGTAGGCCA-1_MS200_A303	33.75154469	-15.71340941	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4156	9703	0.010512213	0.01247037	10	2	EN-L4	41	6	6
ACTGAACCACAACGTT-1_MS200_A303	-30.4242104	9.64137964	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	760	1183	0.008453085	0.008453085	10	8	Astrocytes	41	6	6
ACTGAACCATAGAAAC-1_MS200_A303	34.45059347	-15.8014825	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5554	14128	0.009201586	0.012457531	10	2	EN-L4	41	6	6
ACTGAACCATGTCTCC-1_MS200_A303	-0.92536799	8.051520392	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1718	2892	0.020401107	0.008644537	10	oligos	OL-MS-1	41	6	6
ACTGAACGTAACGTTC-1_MS200_A303	-29.90406379	-21.78777843	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4412	10372	0.0366371	0.013979946	10	6A	IN-PV	41	6	6
ACTGAACGTAGCCTAT-1_MS200_A303	13.68455642	-27.7064088	3	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2793	6134	0.010107597	0.003097489	10	3	EN-L5-6	41	6	6
ACTGAACGTCTCCCTA-1_MS200_A303	-22.18144062	-20.39659139	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2415	4574	0.036947967	0.004809794	10	6A	IN-PV	41	6	6
ACTGAACGTTCCTCCA-1_MS200_A303	-24.62576404	-19.50029924	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4929	13980	0.018955651	0.006723891	10	6A	IN-PV	41	6	6
ACTGAACGTTGATTCG-1_MS200_A303	2.471817035	11.53103399	1	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1060	1638	0.005494505	0.009157509	10	oligos	OL-Cntl	41	6	6
ACTGAACGTTTGGGCC-1_MS200_A303	-14.16725612	17.04685242	11	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1665	3061	0.001960144	0.00522705	10	11	Glia-MIX	41	6	6
ACTGAACTCGCGCCAA-1_MS200_A303	-9.958302782	22.82133183	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2380	3737	0.007760235	0.023280706	10	8	Astrocytes	41	6	6
ACTGAACTCGTTGACA-1_MS200_A303	-11.80233898	-27.38937276	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	880	1230	0.056097561	0.021138211	10	16	EN-PYR	41	6	6
ACTGAGTAGGTGCACA-1_MS200_A303	-14.17949376	-21.95010308	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1284	2116	0.062854442	0.003780718	10	6A	IN-PV	41	6	6
ACTGAGTAGTCACGCC-1_MS200_A303	-18.69352153	-0.905973696	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3451	6854	0.009191713	0.021009629	10	13A	IN-VIP	41	6	6
ACTGAGTCAACACCTA-1_MS200_A303	10.66985973	-13.25728766	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3266	6725	0.007286245	0.023197026	10	L2-3	EN-L2-3-MS	41	6	6
ACTGAGTCAGTCACTA-1_MS200_A303	-15.60218733	22.77133081	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1450	2312	0.014273356	0.009083045	10	8	Astrocytes	41	6	6
ACTGAGTCATTAACCG-1_MS200_A303	-29.37429733	-4.418792578	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1348	2175	0.006896552	0.006436782	10	9	OPC	41	6	6
ACTGAGTGTTACGCGC-1_MS200_A303	-27.20241378	4.695396383	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1842	2989	0.007360321	0.009367681	10	8	Astrocytes	41	6	6
ACTGAGTGTTCAACCA-1_MS200_A303	17.78419867	-20.80580106	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3108	6544	0.012224939	0.009932763	10	L2-3	EN-L2-3-MS	41	6	6
ACTGAGTTCCACGTGG-1_MS200_A303	-22.72409459	-8.4832463	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1568	2332	0.015008576	0.011578045	10	9	OPC	41	6	6
ACTGAGTTCCAGAAGG-1_MS200_A303	10.09956354	-2.444012161	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1473	2140	0.037850467	0.01682243	10	12	EN-MIX	41	6	6
ACTGAGTTCCCAACGG-1_MS200_A303	4.192329469	-3.580905409	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1062	1751	0.114791548	0.007424329	10	12	EN-MIX	41	6	6
ACTGAGTTCTGATACG-1_MS200_A303	-23.40770162	9.611352315	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1226	1772	0.003950339	0.006772009	10	8	Astrocytes	41	6	6
ACTGATGAGCATGGCA-1_MS200_A303	-27.24472574	-4.092031944	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1427	2149	0.016286645	0.016751978	10	9	OPC	41	6	6
ACTGATGAGCCAACAG-1_MS200_A303	25.3267802	-15.22580307	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	6222	16960	0.01928066	0.012087264	10	2	EN-L4	41	6	6
ACTGATGAGGGTCTCC-1_MS200_A303	-32.83382857	-4.29267417	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1315	2073	0.004823927	0.009647853	10	9	OPC	41	6	6
ACTGATGAGTCCTCCT-1_MS200_A303	-16.27532786	20.04739893	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1580	2562	0.006245121	0.008196721	10	8	Astrocytes	41	6	6
ACTGATGAGTGGTCCC-1_MS200_A303	12.91191417	-14.95953885	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4020	9379	0.015566692	0.009915769	10	L2-3	EN-L2-3-MS	41	6	6
ACTGATGCACGGCTAC-1_MS200_A303	-5.143279711	16.36225853	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	788	1143	0.007874016	0.016622922	10	oligos	OL-MS-1	41	6	6
ACTGATGCACTTAAGC-1_MS200_A303	-27.16309305	4.724029867	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2252	4007	0.005490392	0.011729473	10	8	Astrocytes	41	6	6
ACTGATGCATGCAATC-1_MS200_A303	33.40635623	10.78527863	14	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	885	1151	0.003475239	0.024326672	10	14	Microglia	41	6	6
ACTGATGGTCGCCATG-1_MS200_A303	25.36747887	-15.21276314	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5091	12156	0.011763738	0.011434682	10	2	EN-L4	41	6	6
ACTGATGGTGGGTCAA-1_MS200_A303	-5.954839468	15.46778499	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	756	1032	0.004844961	0.011627907	10	oligos	OL-MS-1	41	6	6
ACTGATGGTGTCCTCT-1_MS200_A303	7.505533032	0.06822265	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	857	1344	0.078869048	0.008928571	10	12	EN-MIX	41	6	6
ACTGATGTCCGTCATC-1_MS200_A303	1.946943971	10.40895393	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	984	1448	0.002762431	0.020718232	10	oligos	OL-MS-1	41	6	6
ACTGCTCAGCCAGGAT-1_MS200_A303	-24.1136206	7.759171874	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	943	1344	0.002232143	0.008184524	10	8	Astrocytes	41	6	6
ACTGCTCAGGATGGAA-1_MS200_A303	-30.51437413	-21.61308864	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5132	12828	0.050982226	0.012082944	10	6A	IN-PV	41	6	6
ACTGCTCAGGTGACCA-1_MS200_A303	-16.47937693	25.36294166	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1833	2917	0.004456634	0.008570449	10	8	Astrocytes	41	6	6
ACTGCTCCAGGCTCAC-1_MS200_A303	34.26010209	-18.09604434	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5347	14054	0.015938523	0.020421232	10	2	EN-L4	41	6	6
ACTGCTCCAGGTGGAT-1_MS200_A303	32.37922026	-14.76911396	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3371	7064	0.029303511	0.007078143	10	2	EN-L4	41	6	6
ACTGCTCGTGCTTCTC-1_MS200_A303	-14.03074659	-15.13983553	6B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1462	2373	0.024441635	0.006321113	10	6B	IN-SST	41	6	6
ACTGCTCGTTATCCGA-1_MS200_A303	10.37347829	-17.63010846	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4865	12603	0.005236848	0.007061811	10	L2-3	EN-L2-3-MS	41	6	6
ACTGCTCGTTGCGCAC-1_MS200_A303	-11.71882825	-21.81715036	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1043	1568	0.054846939	0.007653061	10	6A	IN-PV	41	6	6
ACTGTCCAGTCGTTTG-1_MS200_A303	14.88189133	-30.78232676	3	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3636	9572	0.001567071	0.003760969	10	3	EN-L5-6	41	6	6
ACTGTCCCAAGCGTAG-1_MS200_A303	-6.261172984	-35.65538526	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	831	1085	0.044239631	0.019354839	10	16	EN-PYR	41	6	6
ACTGTCCCAAGCTGTT-1_MS200_A303	14.90083294	-14.03749189	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	6735	22011	0.013811276	0.007768843	10	L2-3	EN-L2-3-MS	41	6	6
ACTGTCCCATTAACCG-1_MS200_A303	-24.62959397	8.867820775	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	889	1242	0.005636071	0.008856683	10	8	Astrocytes	41	6	6
ACTGTCCGTGAGGGAG-1_MS200_A303	-18.83112045	-1.069189904	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3251	5983	0.012201237	0.02206251	10	13A	IN-VIP	41	6	6
ACTGTCCGTGTGGTTT-1_MS200_A303	-20.14465351	-5.460305028	13B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4653	12132	0.029508737	0.007171118	10	13B	IN-SV2C	41	6	6
ACTGTCCTCACCCTCA-1_MS200_A303	-1.676465668	10.62351688	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	951	1395	0.007168459	0.02437276	10	oligos	OL-MS-1	41	6	6
ACTGTCCTCCACGTGG-1_MS200_A303	29.22488242	-18.8905745	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	9498	49541	0.026039038	0.013907672	10	2	EN-L4	41	6	6
ACTGTCCTCGCATGAT-1_MS200_A303	22.84122803	-21.76741214	3	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4529	12449	0.046268777	0.003775404	10	3	EN-L5-6	41	6	6
ACTGTCCTCGTATCAG-1_MS200_A303	-5.486523185	16.88611268	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	933	1370	0.005839416	0.01459854	10	oligos	OL-MS-1	41	6	6
ACTGTCCTCTGACCTC-1_MS200_A303	-15.32278657	21.84495301	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1238	1956	0.001533742	0.017382413	10	8	Astrocytes	41	6	6
ACTGTCCTCTGTTTGT-1_MS200_A303	-13.55663364	-38.21024694	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1917	3198	0.091932458	0.023139462	10	16	EN-PYR	41	6	6
ACTTACTAGGAATGGA-1_MS200_A303	-9.176165625	-36.80262821	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1070	1493	0.041527127	0.014735432	10	16	EN-PYR	41	6	6
ACTTACTCAATAAGCA-1_MS200_A303	-24.24831581	11.01019473	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1041	1471	0.001359619	0.008157716	10	8	Astrocytes	41	6	6
ACTTACTCACAGGCCT-1_MS200_A303	3.72067896	4.172958509	7	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1168	1672	0.002392344	0.059210526	10	7	Phagocytes	41	6	6
ACTTGTTAGTCTCGGC-1_MS200_A303	33.62692676	10.91442074	14	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	831	1078	0.006493506	0.029684601	10	14	Microglia	41	6	6
ACTTGTTCACAGAGGT-1_MS200_A303	-6.620856269	13.5887545	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	770	1052	0.009505703	0.016159696	10	oligos	OL-MS-1	41	6	6
ACTTGTTCACGACGAA-1_MS200_A303	-10.8189501	-38.97597413	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1357	1949	0.032324269	0.026680349	10	16	EN-PYR	41	6	6
ACTTGTTCATCTACGA-1_MS200_A303	2.11346554	10.41065098	1	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	990	1496	0.006016043	0.010026738	10	oligos	OL-Cntl	41	6	6
ACTTGTTCATGCAATC-1_MS200_A303	-30.07415281	-9.500278535	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	910	1309	0.001527884	0.009167303	10	9	OPC	41	6	6
ACTTGTTGTCAAACTC-1_MS200_A303	14.4938535	-17.68688012	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	6853	24936	0.010105871	0.005534167	10	L2-3	EN-L2-3-MS	41	6	6
ACTTGTTTCAGTCAGT-1_MS200_A303	7.293881409	0.812758975	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	666	1028	0.245136187	0.005836576	10	16	EN-PYR	41	6	6
ACTTGTTTCTCGGACG-1_MS200_A303	-19.88066039	-1.339796659	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4330	9190	0.014798694	0.016866159	10	13A	IN-VIP	41	6	6
ACTTTCAAGAAACGAG-1_MS200_A303	28.82668068	-18.94199806	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	9962	53270	0.037826169	0.013178149	10	2	EN-L4	41	6	6
ACTTTCAAGTACGTAA-1_MS200_A303	-24.30013932	6.411064677	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	788	1076	0.003717472	0.011152416	10	8	Astrocytes	41	6	6
ACTTTCACACTAAGTC-1_MS200_A303	26.71742214	4.298538938	15BA	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	909	1447	0.000691085	0.008984105	10	15BA	Stromal cells	41	6	6
ACTTTCAGTATCGCAT-1_MS200_A303	-12.92251505	-8.627965538	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1817	3207	0.014967259	0.003741815	10	6A	IN-PV	41	6	6
ACTTTCATCAGCTCGG-1_MS200_A303	9.768178548	-3.662350061	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1858	3038	0.025016458	0.012837393	10	12	EN-MIX	41	6	6
AGAATAGAGCGATCCC-1_MS200_A303	-29.15057514	-1.398639538	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1518	2474	0.004850445	0.010509297	10	9	OPC	41	6	6
AGAATAGAGCTCCCAG-1_MS200_A303	-10.11878117	-5.876116621	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1683	2442	0.004095004	0.016380016	10	13A	IN-VIP	41	6	6
AGAATAGAGGCGCTCT-1_MS200_A303	-15.44780555	21.86216002	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1208	1974	0.005572442	0.011651469	10	8	Astrocytes	41	6	6
AGAATAGGTTCGTCTC-1_MS200_A303	-29.02397843	-21.72972039	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3850	9098	0.029237195	0.012640141	10	6A	IN-PV	41	6	6
AGAATAGGTTTAGCTG-1_MS200_A303	-9.698395361	22.3655429	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1307	1827	0.009304871	0.016420361	10	8	Astrocytes	41	6	6
AGAATAGTCGCCATAA-1_MS200_A303	-15.56820849	23.65236228	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1464	2369	0.002954833	0.009286619	10	8	Astrocytes	41	6	6
AGAATAGTCTAACTTC-1_MS200_A303	34.11404433	-13.40884019	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3562	7892	0.008236189	0.013177902	10	2	EN-L4	41	6	6
AGACGTTAGCCAGGAT-1_MS200_A303	30.71935019	-19.02872516	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	6427	19084	0.021064766	0.01854957	10	2	EN-L4	41	6	6
AGACGTTAGCGCCTTG-1_MS200_A303	17.15064911	-14.6623779	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	6003	18323	0.029471156	0.006767451	10	L2-3	EN-L2-3-MS	41	6	6
AGACGTTAGGAGCGAG-1_MS200_A303	-19.06758561	0.74345746	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3925	7533	0.012345679	0.025089606	10	13A	IN-VIP	41	6	6
AGACGTTCACGAGAGT-1_MS200_A303	-27.75152551	4.320695868	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1824	2897	0.004142216	0.014152572	10	9	OPC	41	6	6
AGACGTTGTACCTACA-1_MS200_A303	-30.68573833	-11.36248051	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	881	1232	0.006493506	0.00974026	10	9	OPC	41	6	6
AGACGTTGTAGCCTCG-1_MS200_A303	-12.73665147	18.02163842	11	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2041	3409	0.005866823	0.012907011	10	11	Glia-MIX	41	6	6
AGACGTTGTCAAAGCG-1_MS200_A303	14.4105741	-12.57692442	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3432	6703	0.013426824	0.015366254	10	L2-3	EN-L2-3-MS	41	6	6
AGACGTTGTCCATCCT-1_MS200_A303	-25.17512969	-19.45877626	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3337	7363	0.033002852	0.008827923	10	6A	IN-PV	41	6	6
AGACGTTGTGCTTCTC-1_MS200_A303	-4.590634621	-32.84098018	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	663	1060	0.236792453	0.012264151	10	16	EN-PYR	41	6	6
AGACGTTGTGTGAAAT-1_MS200_A303	9.946579129	-15.9638799	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3595	7865	0.01322314	0.005085823	10	L2-3	EN-L2-3-MS	41	6	6
AGACGTTTCACCCTCA-1_MS200_A303	-16.34031854	20.00548306	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1350	2315	0.001727862	0.012958963	10	8	Astrocytes	41	6	6
AGACGTTTCGTGGTCG-1_MS200_A303	18.46759927	-21.33099474	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4429	11154	0.016675632	0.01138605	10	L2-3	EN-L2-3-MS	41	6	6
AGAGCGAAGAAACCAT-1_MS200_A303	4.000226034	4.207207748	7	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2482	4192	0.003101145	0.035066794	10	7	Phagocytes	41	6	6
AGAGCGAAGTTTCCTT-1_MS200_A303	13.41498879	-20.53049296	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4724	13002	0.008306414	0.006614367	10	L2-3	EN-L2-3-MS	41	6	6
AGAGCGACAAGTCTGT-1_MS200_A303	-31.97181267	-6.258446836	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1206	1918	0.005735141	0.006256517	10	9	OPC	41	6	6
AGAGCGACAATGCCAT-1_MS200_A303	12.04149496	-19.5292949	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5263	15436	0.002267427	0.010494947	10	L2-3	EN-L2-3-MS	41	6	6
AGAGCGACACAGACTT-1_MS200_A303	10.70679465	-19.7040435	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4937	14733	0.011335098	0.005022738	10	L2-3	EN-L2-3-MS	41	6	6
AGAGCGAGTATCGCAT-1_MS200_A303	-7.222260612	-34.13257254	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	769	1036	0.060810811	0.005791506	10	16	EN-PYR	41	6	6
AGAGCGAGTGCCTGGT-1_MS200_A303	-16.72074723	-1.789817813	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2935	5697	0.024574337	0.010005266	10	13A	IN-VIP	41	6	6
AGAGCGATCCAGATCA-1_MS200_A303	-29.98907127	-21.47597441	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5422	15527	0.04868938	0.006955626	10	6A	IN-PV	41	6	6
AGAGCTTAGCCACCTG-1_MS200_A303	-9.112716475	15.7384198	11	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2957	5524	0.003982621	0.016111513	10	11	Glia-MIX	41	6	6
AGAGCTTAGCGCCTTG-1_MS200_A303	-15.37725211	23.90438671	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1595	2649	0.004907512	0.014722537	10	8	Astrocytes	41	6	6
AGAGCTTAGGCTCATT-1_MS200_A303	-24.03097439	9.296424827	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1182	1857	0.002692515	0.011847065	10	8	Astrocytes	41	6	6
AGAGCTTGTACCCAAT-1_MS200_A303	19.3194515	-10.53936791	3	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2184	3868	0.043174767	0.002843847	10	3	EN-L5-6	41	6	6
AGAGCTTGTGAAGGCT-1_MS200_A303	-31.9800598	-5.551242995	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1253	1960	0.007653061	0.004081633	10	9	OPC	41	6	6
AGAGCTTGTGCGCTTG-1_MS200_A303	-15.1863477	21.80862976	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1216	2001	0.008495752	0.013993003	10	8	Astrocytes	41	6	6
AGAGCTTTCAACACAC-1_MS200_A303	-9.228881491	27.31337304	17	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1096	1583	0.007580543	0.013265951	10	oligos	OL-MS-2	41	6	6
AGAGCTTTCAAGAAGT-1_MS200_A303	-24.07754587	8.719470871	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1214	1870	0.003208556	0.013903743	10	8	Astrocytes	41	6	6
AGAGCTTTCACTGGGC-1_MS200_A303	25.61469318	10.56496183	15A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5607	18215	0.005984079	0.115015097	10	15A	Endo cells	41	6	6
AGAGCTTTCCCGGATG-1_MS200_A303	-15.01241218	23.78836027	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1569	2523	0.005152596	0.01228696	10	8	Astrocytes	41	6	6
AGAGTGGCAACGATGG-1_MS200_A303	18.79551356	-20.45349337	3	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3345	7493	0.006005605	0.002402242	10	3	EN-L5-6	41	6	6
AGAGTGGCAACTTGAC-1_MS200_A303	-13.0867084	7.820142433	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2114	3427	0.028012839	0.015465422	10	8	Astrocytes	41	6	6
AGAGTGGCAATAGCAA-1_MS200_A303	29.34880775	-16.28122158	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5078	13867	0.041970145	0.005624865	10	2	EN-L4	41	6	6
AGAGTGGCAATGTTGC-1_MS200_A303	-15.2884305	-2.083213115	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2458	4357	0.011016755	0.010098692	10	13A	IN-VIP	41	6	6
AGAGTGGCACCGAATT-1_MS200_A303	8.946245925	1.537370398	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	828	1171	0.060631939	0.009393681	10	12	EN-MIX	41	6	6
AGAGTGGCACGGCCAT-1_MS200_A303	-5.558423615	17.00241987	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	729	1036	0.003861004	0.00965251	10	oligos	OL-MS-1	41	6	6
AGAGTGGCAGGGTTAG-1_MS200_A303	-4.796292574	13.1413937	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	769	1042	0.00671785	0.028790787	10	oligos	OL-MS-1	41	6	6
AGAGTGGGTAGCGTAG-1_MS200_A303	-30.43932009	-8.980447995	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1032	1497	0.008016032	0.004676019	10	9	OPC	41	6	6
AGAGTGGTCGTAGATC-1_MS200_A303	12.3769087	-18.6712898	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5313	14286	0.005739885	0.0100098	10	L2-3	EN-L2-3-MS	41	6	6
AGAGTGGTCGTCGTTC-1_MS200_A303	-12.11170395	18.52956588	11	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2560	4783	0.005017771	0.01045369	10	11	Glia-MIX	41	6	6
AGATCTGAGAAGATTC-1_MS200_A303	24.59711269	-13.68933798	3	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3818	8601	0.01906755	0.006510871	10	3	EN-L5-6	41	6	6
AGATCTGAGATGCGAC-1_MS200_A303	-12.62600345	17.66778333	11	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2092	3137	0.012113484	0.010838381	10	11	Glia-MIX	41	6	6
AGATCTGAGGCATGGT-1_MS200_A303	-4.36670833	19.27894285	1	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	751	1099	0.001819836	0.020018198	10	oligos	OL-Cntl	41	6	6
AGATCTGCACATCTTT-1_MS200_A303	-5.807863381	16.71643867	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	808	1199	0.004170142	0.011676397	10	oligos	OL-MS-1	41	6	6
AGATCTGCATCCAACA-1_MS200_A303	32.40051889	-12.54570936	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4144	10031	0.010766623	0.009869405	10	2	EN-L4	41	6	6
AGATCTGGTCGCTTTC-1_MS200_A303	34.28277023	-14.62270914	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4228	10004	0.008396641	0.010395842	10	2	EN-L4	41	6	6
AGATCTGGTTAGGGTG-1_MS200_A303	13.30478931	-17.18135401	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5105	13942	0.010471955	0.009109167	10	L2-3	EN-L2-3-MS	41	6	6
AGATCTGGTTCAGACT-1_MS200_A303	34.91011738	-15.56226801	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4556	10965	0.020611035	0.008116735	10	2	EN-L4	41	6	6
AGATTGCAGGCTAGGT-1_MS200_A303	26.79293317	4.248160759	15BA	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	746	1025	0.00195122	0.030243902	10	15BA	Stromal cells	41	6	6
AGATTGCCAACTGGCC-1_MS200_A303	-5.559194021	15.69456006	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	689	1023	0.002932551	0.013685239	10	oligos	OL-MS-1	41	6	6
AGATTGCCAATCTACG-1_MS200_A303	-17.31822472	-1.395976055	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3359	7043	0.010506886	0.011926736	10	13A	IN-VIP	41	6	6
AGATTGCCACCGGAAA-1_MS200_A303	-30.12920417	-2.846336874	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1493	2499	0.00280112	0.008003201	10	9	OPC	41	6	6
AGATTGCCAGGAACGT-1_MS200_A303	-15.87444034	-3.016967567	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2347	4205	0.014744352	0.007372176	10	13A	IN-VIP	41	6	6
AGATTGCCAGGACCCT-1_MS200_A303	-16.89274735	-0.802244428	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3321	7008	0.006849315	0.012557078	10	13A	IN-VIP	41	6	6
AGATTGCGTCCGCTGA-1_MS200_A303	-24.02802334	9.898730491	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1047	1465	0.007508532	0.018430034	10	8	Astrocytes	41	6	6
AGCAGCCAGAGCCTAG-1_MS200_A303	33.95455413	-17.99634144	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4439	9995	0.014707354	0.014007004	10	2	EN-L4	41	6	6
AGCAGCCAGGTGACCA-1_MS200_A303	12.79182132	0.600043328	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	813	1226	0.102773246	0.01223491	10	12	EN-MIX	41	6	6
AGCAGCCCAATCGAAA-1_MS200_A303	10.97615305	-12.10890752	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2743	5110	0.017808219	0.017808219	10	L2-3	EN-L2-3-MS	41	6	6
AGCAGCCGTGCTAGCC-1_MS200_A303	-2.776330001	21.33226	1	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	731	1031	0.002909796	0.006789525	10	oligos	OL-Cntl	41	6	6
AGCAGCCGTGTCTGAT-1_MS200_A303	-4.884621158	11.628009	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	797	1120	0.00625	0.026785714	10	oligos	OL-MS-1	41	6	6
AGCAGCCTCCGTTGCT-1_MS200_A303	-3.716833508	-36.04598985	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	841	1174	0.115843271	0.029812606	10	16	EN-PYR	41	6	6
AGCAGCCTCTACTATC-1_MS200_A303	-13.85738216	22.21440732	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1498	2254	0.003992902	0.014196983	10	8	Astrocytes	41	6	6
AGCAGCCTCTTACCTA-1_MS200_A303	-29.15438907	-22.12937532	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4555	11369	0.034919518	0.011698478	10	6A	IN-PV	41	6	6
AGCATACAGATCTGAA-1_MS200_A303	-3.056910589	11.67225625	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	885	1214	0.003294893	0.020593081	10	oligos	OL-MS-1	41	6	6
AGCATACAGTTTGCGT-1_MS200_A303	-16.31156637	20.52866465	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1422	2257	0.009747452	0.009747452	10	8	Astrocytes	41	6	6
AGCATACTCCCAAGAT-1_MS200_A303	-15.05011978	23.53628008	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1548	2392	0.001254181	0.007525084	10	8	Astrocytes	41	6	6
AGCATACTCCCTGACT-1_MS200_A303	-24.03897883	9.606588651	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1108	1805	0.005540166	0.014958449	10	8	Astrocytes	41	6	6
AGCCTAACAGGAATCG-1_MS200_A303	-25.99859161	-18.21304767	6B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3272	6483	0.015270708	0.008792226	10	6B	IN-SST	41	6	6
AGCCTAAGTGCACCAC-1_MS200_A303	-5.069885313	-36.54756247	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	943	1290	0.092248062	0.027131783	10	16	EN-PYR	41	6	6
AGCGGTCAGCTAGTCT-1_MS200_A303	19.88004851	-11.44452082	3	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3013	6081	0.051800691	0.005097846	10	3	EN-L5-6	41	6	6
AGCGGTCAGGTGACCA-1_MS200_A303	28.76482161	-18.73485724	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	9367	49583	0.050662525	0.010588306	10	2	EN-L4	41	6	6
AGCGGTCGTCACAAGG-1_MS200_A303	-19.02000203	-13.39906134	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2588	4978	0.01446364	0.007432704	10	6A	IN-PV	41	6	6
AGCGTATAGGACATTA-1_MS200_A303	-6.223755921	-35.89339743	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	808	1105	0.0760181	0.015384615	10	16	EN-PYR	41	6	6
AGCGTATAGGCTAGCA-1_MS200_A303	32.2618086	-19.26527956	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4163	8834	0.011999094	0.019243831	10	2	EN-L4	41	6	6
AGCGTATAGTCGTACT-1_MS200_A303	5.167139393	-1.764584891	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	695	1165	0.214592275	0.006866953	10	12	EN-MIX	41	6	6
AGCGTATAGTCTCAAC-1_MS200_A303	7.398128595	-0.998421629	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	918	1555	0.245659164	0.003858521	10	12	EN-MIX	41	6	6
AGCGTATCAGCCTTTC-1_MS200_A303	-19.76062895	-0.875637596	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4222	9211	0.009879492	0.021387472	10	13A	IN-VIP	41	6	6
AGCGTATCAGGACGTA-1_MS200_A303	7.325363224	0.091810051	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	742	1121	0.179304193	0.007136485	10	12	EN-MIX	41	6	6
AGCGTATCATGACATC-1_MS200_A303	-29.48304851	-2.398084531	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1582	2548	0.0066719	0.007064364	10	9	OPC	41	6	6
AGCGTATGTATAGTAG-1_MS200_A303	3.805744889	4.490837621	7	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1409	2133	0.005625879	0.026722925	10	7	Phagocytes	41	6	6
AGCGTATGTCCCGACA-1_MS200_A303	-29.05997796	-20.92147264	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4126	10074	0.044669446	0.010522136	10	6A	IN-PV	41	6	6
AGCGTATGTGGTCTCG-1_MS200_A303	11.40295497	1.381504891	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	694	1005	0.119402985	0.008955224	10	12	EN-MIX	41	6	6
AGCGTCGAGACAGGCT-1_MS200_A303	34.0117882	-18.3051889	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4211	9343	0.01819544	0.015198544	10	2	EN-L4	41	6	6
AGCGTCGAGTCACGCC-1_MS200_A303	12.8188388	-15.67190692	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4571	12575	0.012803181	0.005407555	10	L2-3	EN-L2-3-MS	41	6	6
AGCGTCGAGTTGTCGT-1_MS200_A303	13.14684236	-24.30767453	10	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3973	10822	0.007761966	0.00360377	10	L2-3	EN-L2-3-Cntl	41	6	6
AGCGTCGCAAGTTGTC-1_MS200_A303	-27.35241528	-3.815041401	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1500	2330	0.00472103	0.012446352	10	9	OPC	41	6	6
AGCGTCGCACCTATCC-1_MS200_A303	9.564898326	-2.342527583	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2427	6166	0.301005514	0.004541031	10	12	EN-MIX	41	6	6
AGCGTCGGTAGCGCTC-1_MS200_A303	-23.42826855	9.548943529	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1044	1508	0.00198939	0.00994695	10	8	Astrocytes	41	6	6
AGCGTCGGTCAGCTAT-1_MS200_A303	-17.20649865	-3.616577587	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2535	4941	0.014571949	0.011333738	10	13A	IN-VIP	41	6	6
AGCGTCGTCGGCTACG-1_MS200_A303	-24.38974569	8.377274573	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	869	1299	0.000769823	0.018475751	10	8	Astrocytes	41	6	6
AGCTCCTAGCTAGTGG-1_MS200_A303	-6.631177522	14.97643996	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	933	1319	0.031084155	0.010614102	10	oligos	OL-MS-1	41	6	6
AGCTCCTAGGACAGCT-1_MS200_A303	-14.75726094	-0.383998282	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3388	7207	0.005966422	0.005827668	10	13A	IN-VIP	41	6	6
AGCTCCTAGGGAACGG-1_MS200_A303	-28.93212195	-5.484191032	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1126	1605	0.001246106	0.00623053	10	9	OPC	41	6	6
AGCTCCTCAAGTCTGT-1_MS200_A303	-16.84736677	-14.47203016	6B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1990	3600	0.062777778	0.006944444	10	6B	IN-SST	41	6	6
AGCTCCTCACACAGAG-1_MS200_A303	33.97983323	-8.517237332	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4206	10058	0.003479817	0.012229071	10	2	EN-L4	41	6	6
AGCTCCTGTCACTGGC-1_MS200_A303	24.90522452	-14.62938051	3	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3903	8424	0.016025641	0.008190883	10	3	EN-L5-6	41	6	6
AGCTCTCAGCTACCGC-1_MS200_A303	-29.41130738	-3.688920672	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1411	2263	0.007070261	0.007512152	10	9	OPC	41	6	6
AGCTCTCAGTACTTGC-1_MS200_A303	15.0187217	-13.39085926	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5423	14777	0.021925966	0.011233674	10	L2-3	EN-L2-3-MS	41	6	6
AGCTCTCCACCGAAAG-1_MS200_A303	-23.93283513	9.164999324	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	975	1409	0.007806955	0.009936125	10	8	Astrocytes	41	6	6
AGCTCTCCAGTATGCT-1_MS200_A303	17.05212726	-13.66196243	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	6615	21081	0.018215455	0.01076799	10	L2-3	EN-L2-3-MS	41	6	6
AGCTCTCGTAGAAAGG-1_MS200_A303	-31.7179675	-6.331473029	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1156	1733	0.00288517	0.006924409	10	9	OPC	41	6	6
AGCTCTCGTTGATTGC-1_MS200_A303	8.334130955	-11.04602695	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2287	3992	0.076152305	0.006513026	10	L2-3	EN-L2-3-MS	41	6	6
AGCTCTCTCCTGCCAT-1_MS200_A303	34.38306942	10.73041222	14	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	804	1235	0.003238866	0.011336032	10	14	Microglia	41	6	6
AGCTCTCTCTCATTCA-1_MS200_A303	10.27255469	-15.75704962	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3768	8498	0.00717816	0.010473052	10	L2-3	EN-L2-3-MS	41	6	6
AGCTCTCTCTCCTATA-1_MS200_A303	12.26925556	-17.01488803	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5480	15733	0.008898494	0.005974703	10	L2-3	EN-L2-3-MS	41	6	6
AGCTTGAAGACAAAGG-1_MS200_A303	-24.51806044	8.255710517	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	949	1353	0.003695492	0.009608278	10	8	Astrocytes	41	6	6
AGCTTGAAGCTAGGCA-1_MS200_A303	14.56625098	-20.11299133	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5908	17488	0.004803294	0.011665142	10	L2-3	EN-L2-3-MS	41	6	6
AGCTTGAAGGCAGGTT-1_MS200_A303	16.01584396	-20.55608819	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3776	8099	0.011112483	0.013211508	10	L2-3	EN-L2-3-MS	41	6	6
AGCTTGAAGTACGATA-1_MS200_A303	-27.33393805	-22.04363796	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3971	9779	0.051232232	0.007260456	10	6A	IN-PV	41	6	6
AGCTTGAGTTAGATGA-1_MS200_A303	-10.11055384	-37.22283766	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1194	1716	0.0495338	0.02039627	10	16	EN-PYR	41	6	6
AGCTTGATCTCCAGGG-1_MS200_A303	-14.84431141	24.66061078	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1816	3197	0.004691899	0.011260557	10	8	Astrocytes	41	6	6
AGGCCACGTACTTAGC-1_MS200_A303	-28.81071833	-5.175361129	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1290	1916	0.007306889	0.010438413	10	9	OPC	41	6	6
AGGCCACTCAAGATCC-1_MS200_A303	33.19173539	-16.94924305	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4764	11522	0.01058844	0.023780594	10	2	EN-L4	41	6	6
AGGCCACTCACCTCGT-1_MS200_A303	13.17041586	-12.83620062	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4646	10983	0.008103433	0.019120459	10	L2-3	EN-L2-3-MS	41	6	6
AGGCCACTCCGCGGTA-1_MS200_A303	-28.88201358	-21.17052075	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4610	11723	0.021837414	0.009297961	10	6A	IN-PV	41	6	6
AGGCCACTCGGAGCAA-1_MS200_A303	-17.16723721	20.44901034	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1506	2722	0.001836885	0.008449669	10	8	Astrocytes	41	6	6
AGGCCGTCACTTACGA-1_MS200_A303	-5.419761129	-35.49586536	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	830	1058	0.053875236	0.018903592	10	16	EN-PYR	41	6	6
AGGCCGTGTGTAAGTA-1_MS200_A303	13.96676868	-4.791364763	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1843	3105	0.040257649	0.020289855	10	12	EN-MIX	41	6	6
AGGCCGTTCATGCATG-1_MS200_A303	-15.02203427	-36.8927388	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2109	3760	0.039893617	0.009042553	10	16	EN-PYR	41	6	6
AGGCCGTTCTAACGGT-1_MS200_A303	5.843951535	0.291167911	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	903	1221	0.014742015	0.016380016	10	16	EN-PYR	41	6	6
AGGGAGTAGCCATCGC-1_MS200_A303	18.29390602	-7.131569105	3	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1920	3696	0.005140693	0.00297619	10	3	EN-L5-6	41	6	6
AGGGAGTAGGACACCA-1_MS200_A303	-11.33613767	-3.384056814	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2046	3681	0.019016572	0.007334963	10	13A	IN-VIP	41	6	6
AGGGAGTCATCAGTAC-1_MS200_A303	-15.83473227	-1.896334225	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2790	5330	0.009193246	0.010881801	10	13A	IN-VIP	41	6	6
AGGGAGTGTATGGTTC-1_MS200_A303	12.46748897	-18.62272738	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5758	17375	0.009438849	0.004374101	10	L2-3	EN-L2-3-MS	41	6	6
AGGGAGTGTCGCTTCT-1_MS200_A303	-19.82874573	-4.136031326	13B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3439	6906	0.015783377	0.012742543	10	13B	IN-SV2C	41	6	6
AGGGAGTGTTCAACCA-1_MS200_A303	-5.518416595	17.22309131	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	736	1038	0.002890173	0.007707129	10	oligos	OL-MS-1	41	6	6
AGGGAGTTCTATCCTA-1_MS200_A303	-26.36612078	-20.491483	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2671	5382	0.066518023	0.004645113	10	6A	IN-PV	41	6	6
AGGGATGAGAACAACT-1_MS200_A303	-6.208067567	-35.79181108	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	752	1013	0.068114511	0.011846002	10	16	EN-PYR	41	6	6
AGGGATGAGAGCCCAA-1_MS200_A303	-29.13856464	-4.814175743	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1226	1758	0.005688282	0.009101251	10	9	OPC	41	6	6
AGGGATGAGAGTACCG-1_MS200_A303	-23.50805181	9.56607634	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1099	1622	0.002466091	0.016646116	10	8	Astrocytes	41	6	6
AGGGATGCAAGTTCTG-1_MS200_A303	-6.760520348	13.41982249	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	892	1202	0.004991681	0.011647255	10	oligos	OL-MS-1	41	6	6
AGGGATGCACATCCGG-1_MS200_A303	17.23701619	-14.80213912	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	6956	25761	0.03497535	0.005318117	10	L2-3	EN-L2-3-MS	41	6	6
AGGGATGCACGGATAG-1_MS200_A303	-23.46640759	9.502673051	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1119	1668	0.003597122	0.022182254	10	8	Astrocytes	41	6	6
AGGGATGCAGGTCCAC-1_MS200_A303	10.67930927	1.447044507	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	815	1104	0.048913043	0.010869565	10	12	EN-MIX	41	6	6
AGGGATGCATCTCCCA-1_MS200_A303	-16.07631101	20.84870483	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1523	2398	0.004170142	0.013761468	10	8	Astrocytes	41	6	6
AGGGATGTCAACACTG-1_MS200_A303	28.1043446	10.58496523	15DB	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1538	2897	0.01104591	0.141870901	10	15DB	B cells	41	6	6
AGGGATGTCGCAGGCT-1_MS200_A303	15.81949618	-10.47069326	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2385	4609	0.050770232	0.005641137	10	L2-3	EN-L2-3-MS	41	6	6
AGGGTGAAGAAGATTC-1_MS200_A303	9.017005029	-12.72659311	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2903	5716	0.013470959	0.005948216	10	L2-3	EN-L2-3-MS	41	6	6
AGGGTGAAGAAGGCCT-1_MS200_A303	17.22758901	-14.47777511	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	6774	20976	0.019832189	0.008676583	10	L2-3	EN-L2-3-MS	41	6	6
AGGGTGAGTAGCGTAG-1_MS200_A303	-15.77524694	20.83015311	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1480	2242	0.003122212	0.006690455	10	8	Astrocytes	41	6	6
AGGGTGAGTCATTAGC-1_MS200_A303	-16.37242206	20.86688808	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1366	2141	0.005137786	0.013078001	10	8	Astrocytes	41	6	6
AGGGTGAGTTCCGTCT-1_MS200_A303	-15.80080873	8.647408268	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1244	2014	0.002979146	0.010923535	10	8	Astrocytes	41	6	6
AGGTCATCAACTTGAC-1_MS200_A303	22.96695127	-16.15323003	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	6989	24633	0.020988105	0.010189583	10	L2-3	EN-L2-3-MS	41	6	6
AGGTCATCATGCCCGA-1_MS200_A303	-13.36636536	17.11301782	11	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1146	1806	0.006090808	0.013842746	10	11	Glia-MIX	41	6	6
AGGTCATCATGGAATA-1_MS200_A303	-31.4729279	-5.665708555	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1332	2074	0.004339441	0.005785921	10	9	OPC	41	6	6
AGGTCATGTATAGTAG-1_MS200_A303	-5.377527974	-33.64273001	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	827	1098	0.068306011	0.013661202	10	16	EN-PYR	41	6	6
AGGTCATGTCGAAAGC-1_MS200_A303	-9.881231329	-36.3217332	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1113	1715	0.06180758	0.006997085	10	16	EN-PYR	41	6	6
AGGTCATTCAGATAAG-1_MS200_A303	16.22177902	-14.734692	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	6163	19358	0.020508317	0.009505114	10	L2-3	EN-L2-3-MS	41	6	6
AGGTCCGAGTGTTGAA-1_MS200_A303	-16.2036214	20.25714112	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1274	1910	0.001570681	0.013089005	10	8	Astrocytes	41	6	6
AGGTCCGCAAGTAATG-1_MS200_A303	-12.77887518	17.74772693	11	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1659	2657	0.004140008	0.010538201	10	11	Glia-MIX	41	6	6
AGGTCCGCATCATCCC-1_MS200_A303	-24.61591026	-19.49923519	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2972	6825	0.03003663	0.003809524	10	6A	IN-PV	41	6	6
AGGTCCGGTCTTCGTC-1_MS200_A303	-30.43225474	-21.67931825	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5413	14586	0.02289867	0.011586453	10	6A	IN-PV	41	6	6
AGGTCCGTCAACGCTA-1_MS200_A303	-14.57445672	21.38325603	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1318	2031	0.007385524	0.011324471	10	8	Astrocytes	41	6	6
AGTAGTCAGCGCTCCA-1_MS200_A303	-14.63078201	22.16762416	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1463	2377	0.008413967	0.010938157	10	8	Astrocytes	41	6	6
AGTAGTCAGGAGTTTA-1_MS200_A303	-14.39786075	22.9223445	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1575	2638	0.011372252	0.015542077	10	8	Astrocytes	41	6	6
AGTAGTCCACTGAAGG-1_MS200_A303	-11.68306493	-3.286575341	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2303	4417	0.020828617	0.00679194	10	13A	IN-VIP	41	6	6
AGTAGTCCATCATCCC-1_MS200_A303	33.54531041	-16.65805139	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5158	13347	0.028620664	0.009889863	10	2	EN-L4	41	6	6
AGTAGTCTCAGTCCCT-1_MS200_A303	9.684793241	-16.08353681	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3552	8220	0.009854015	0.006934307	10	L2-3	EN-L2-3-MS	41	6	6
AGTAGTCTCCAGAAGG-1_MS200_A303	-31.42537106	-6.402581836	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1111	1593	0.005021971	0.005021971	10	9	OPC	41	6	6
AGTAGTCTCGCAAGCC-1_MS200_A303	-30.20715266	-21.74232992	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4594	11063	0.028925246	0.011208533	10	6A	IN-PV	41	6	6
AGTCTTTAGTGATCGG-1_MS200_A303	-31.10203687	-7.908821286	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1096	1565	0.015335463	0.008945687	10	9	OPC	41	6	6
AGTCTTTCACGAAGCA-1_MS200_A303	12.70822863	-14.65531434	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4463	11153	0.016139155	0.009055859	10	L2-3	EN-L2-3-MS	41	6	6
AGTGAGGAGAAACCAT-1_MS200_A303	10.21338419	-29.51982822	10	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5575	16689	0.001497993	0.005093175	10	L2-3	EN-L2-3-Cntl	41	6	6
AGTGAGGAGTGGACGT-1_MS200_A303	-14.19594314	22.70252241	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1537	2512	0.017914013	0.010350318	10	8	Astrocytes	41	6	6
AGTGAGGCAAGTAATG-1_MS200_A303	-26.75075519	-10.28485374	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	890	1187	0.01010952	0.00758214	10	9	OPC	41	6	6
AGTGAGGCACAGATTC-1_MS200_A303	-14.53108	21.9031941	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1423	2218	0.00135257	0.013525699	10	8	Astrocytes	41	6	6
AGTGAGGCAGAGCCAA-1_MS200_A303	-14.31583847	-38.13442155	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2215	4116	0.063896987	0.02696793	10	16	EN-PYR	41	6	6
AGTGAGGCAGCGAACA-1_MS200_A303	-27.92927455	-2.926075175	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1776	2833	0.025767737	0.011648429	10	9	OPC	41	6	6
AGTGAGGCAGTCACTA-1_MS200_A303	9.814032184	-2.067869611	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1645	2929	0.150904746	0.005462615	10	12	EN-MIX	41	6	6
AGTGAGGCATCCGGGT-1_MS200_A303	-16.5638753	20.41721176	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1392	2150	0.00372093	0.014418605	10	8	Astrocytes	41	6	6
AGTGAGGGTATAGTAG-1_MS200_A303	-6.218428397	13.19487951	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	797	1040	0.000961538	0.027884615	10	oligos	OL-MS-1	41	6	6
AGTGAGGGTTAGGGTG-1_MS200_A303	-30.8173065	-8.838401779	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	894	1286	0.003888025	0.005443235	10	9	OPC	41	6	6
AGTGAGGTCTGAAAGA-1_MS200_A303	-16.12601221	20.29605397	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1338	2000	0.0105	0.0075	10	8	Astrocytes	41	6	6
AGTGGGAAGTGGCACA-1_MS200_A303	-10.55008704	-8.228238943	13B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1445	2258	0.039415412	0.004871568	10	13B	IN-SV2C	41	6	6
AGTGGGACACATAACC-1_MS200_A303	18.2271685	-22.63556032	3	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2709	5335	0.003373946	0.01968135	10	3	EN-L5-6	41	6	6
AGTGGGACATGCGCAC-1_MS200_A303	-15.48147637	23.04323139	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1565	2499	0.007202881	0.007202881	10	8	Astrocytes	41	6	6
AGTGGGACATGTCGAT-1_MS200_A303	-29.2296989	-5.223041481	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1172	1752	0.005707763	0.005707763	10	9	OPC	41	6	6
AGTGGGAGTCGTCTTC-1_MS200_A303	12.01535993	-13.23611876	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3816	8206	0.006702413	0.016695101	10	L2-3	EN-L2-3-MS	41	6	6
AGTGGGAGTCTTCGTC-1_MS200_A303	10.32090508	-17.21652679	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4047	9093	0.009787749	0.009457825	10	L2-3	EN-L2-3-MS	41	6	6
AGTGGGAGTTCAGACT-1_MS200_A303	-29.94210465	-9.439978925	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1076	1513	0.005948447	0.005287508	10	9	OPC	41	6	6
AGTGGGATCCTATTCA-1_MS200_A303	-14.17006401	17.61690258	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1256	1865	0.022520107	0.016621984	10	8	Astrocytes	41	6	6
AGTGGGATCTCCAGGG-1_MS200_A303	-15.36253599	-37.43822358	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4106	11215	0.097280428	0.011056621	10	16	EN-PYR	41	6	6
AGTGTCAAGCGTGAGT-1_MS200_A303	-6.161741637	13.71543354	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	886	1169	0.011976048	0.019674936	10	oligos	OL-MS-1	41	6	6
AGTGTCAGTGACTACT-1_MS200_A303	11.60250611	-16.54268433	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4187	9909	0.009889999	0.007568877	10	L2-3	EN-L2-3-MS	41	6	6
AGTGTCAGTGTCAATC-1_MS200_A303	14.65631139	-12.57854485	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3846	8341	0.011629301	0.018343124	10	L2-3	EN-L2-3-MS	41	6	6
AGTGTCATCCCAACGG-1_MS200_A303	-20.72894323	-20.76535654	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2003	3639	0.132453971	0.007419621	10	6A	IN-PV	41	6	6
AGTGTCATCCCTCTTT-1_MS200_A303	-14.14776072	3.466694726	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5958	15431	0.009461474	0.011988854	10	13A	IN-VIP	41	6	6
AGTTGGTCACACAGAG-1_MS200_A303	1.728541412	10.33389512	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1059	1559	0.001282874	0.015394484	10	oligos	OL-MS-1	41	6	6
AGTTGGTGTGAGGGAG-1_MS200_A303	-13.93699957	22.33701114	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1480	2202	0.010899183	0.012715713	10	8	Astrocytes	41	6	6
AGTTGGTGTTGACGTT-1_MS200_A303	-24.39193607	6.70036849	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	784	1060	0.011320755	0.011320755	10	8	Astrocytes	41	6	6
AGTTGGTTCGTTTATC-1_MS200_A303	34.18018978	-14.73891852	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4637	11605	0.005084016	0.012322275	10	2	EN-L4	41	6	6
ATAACGCAGTGTGAAT-1_MS200_A303	8.814696361	-12.86591199	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2182	4043	0.012861736	0.022508039	10	L2-3	EN-L2-3-MS	41	6	6
ATAACGCCACAGACTT-1_MS200_A303	-18.07733031	-9.327655473	13B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3498	8054	0.021728334	0.0052148	10	13B	IN-SV2C	41	6	6
ATAACGCCACTATCTT-1_MS200_A303	19.0268607	-15.03353404	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5710	16832	0.022813688	0.008079848	10	2	EN-L4	41	6	6
ATAACGCCAGCGATCC-1_MS200_A303	-10.8149592	-5.780373278	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2157	4543	0.013427251	0.004182258	10	13A	IN-VIP	41	6	6
ATAACGCCATGTCCTC-1_MS200_A303	14.83687127	-14.34157201	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5861	16417	0.014679905	0.009075958	10	L2-3	EN-L2-3-MS	41	6	6
ATAACGCGTAGAGCTG-1_MS200_A303	18.89835599	-14.81367764	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5620	15182	0.01850876	0.009419049	10	L2-3	EN-L2-3-MS	41	6	6
ATAACGCGTTAAAGAC-1_MS200_A303	-7.649142369	-33.50010401	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	919	1275	0.07372549	0.014117647	10	16	EN-PYR	41	6	6
ATAACGCTCAACACGT-1_MS200_A303	-3.299001766	24.54831765	1	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	905	1293	0.003866976	0.003866976	10	oligos	OL-Cntl	41	6	6
ATAACGCTCACTTATC-1_MS200_A303	-19.4706283	-6.208405445	13B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4030	9198	0.012393999	0.009241139	10	13B	IN-SV2C	41	6	6
ATAACGCTCATAGCAC-1_MS200_A303	-31.24740596	-6.553346961	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1044	1519	0.007241606	0.013824885	10	9	OPC	41	6	6
ATAACGCTCCTCAATT-1_MS200_A303	0.639932501	10.41910817	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1059	1621	0.005552128	0.024059223	10	oligos	OL-MS-1	41	6	6
ATAACGCTCTCGTATT-1_MS200_A303	-17.1856007	5.80468277	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	853	1730	0.002890173	0.009248555	10	8	Astrocytes	41	6	6
ATAAGAGAGAATTGTG-1_MS200_A303	34.21065601	-17.64585324	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3679	7514	0.016103274	0.020228906	10	2	EN-L4	41	6	6
ATAAGAGAGGAGCGTT-1_MS200_A303	-29.58994228	-10.51103959	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	914	1277	0.003132341	0.007830854	10	9	OPC	41	6	6
ATAAGAGGTAGCTTGT-1_MS200_A303	-30.38702758	-8.969303339	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	968	1412	0.007790368	0.004249292	10	9	OPC	41	6	6
ATAAGAGGTCTCTTTA-1_MS200_A303	12.58252097	-15.29937572	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3788	8773	0.012310498	0.006269235	10	L2-3	EN-L2-3-MS	41	6	6
ATAAGAGTCAATCACG-1_MS200_A303	-16.85715207	-1.168394085	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3226	6768	0.005762411	0.015218676	10	13A	IN-VIP	41	6	6
ATAAGAGTCATGGTCA-1_MS200_A303	-7.379482803	-35.47704449	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	910	1193	0.056160939	0.018440905	10	16	EN-PYR	41	6	6
ATAAGAGTCTGGGCCA-1_MS200_A303	22.59133674	-22.15571369	3	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4354	12725	0.012102161	0.005343811	10	3	EN-L5-6	41	6	6
ATAGACCAGGATGCGT-1_MS200_A303	-15.17512379	22.21584546	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1438	2349	0.002128565	0.013622818	10	8	Astrocytes	41	6	6
ATAGACCCACAAGTAA-1_MS200_A303	-16.99341709	-4.273933807	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3777	8906	0.012688075	0.007410734	10	13A	IN-VIP	41	6	6
ATAGACCCAGGGTACA-1_MS200_A303	-13.51184066	22.70453544	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1667	2892	0.004495159	0.007607192	10	8	Astrocytes	41	6	6
ATAGACCCATGACGGA-1_MS200_A303	-18.24145057	-6.38336384	13B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3221	6802	0.010144075	0.008820935	10	13B	IN-SV2C	41	6	6
ATAGACCGTATATGGA-1_MS200_A303	12.98238564	-12.84873929	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3982	8822	0.012242122	0.019950125	10	L2-3	EN-L2-3-MS	41	6	6
ATAGACCGTGCAGTAG-1_MS200_A303	-20.12332484	5.675271444	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	976	1490	0.004026846	0.005369128	10	8	Astrocytes	41	6	6
ATAGACCGTGGTCCGT-1_MS200_A303	12.6552466	-23.81220116	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4602	12341	0.012721822	0.004942873	10	L2-3	EN-L2-3-MS	41	6	6
ATCACGACAAGCGTAG-1_MS200_A303	9.381757697	-30.79486297	10	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4304	11081	0.00216587	0.004873206	10	L2-3	EN-L2-3-Cntl	41	6	6
ATCACGACACTATCTT-1_MS200_A303	17.46059379	-18.66055769	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3806	9195	0.044154432	0.002936378	10	L2-3	EN-L2-3-MS	41	6	6
ATCACGACAGCAGTTT-1_MS200_A303	9.907932384	-19.59496213	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5626	17487	0.005775719	0.004403271	10	L2-3	EN-L2-3-MS	41	6	6
ATCACGACATGGTCTA-1_MS200_A303	-23.78209619	10.30166026	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1063	1626	0.004920049	0.008610086	10	8	Astrocytes	41	6	6
ATCACGAGTCTCCACT-1_MS200_A303	-15.91486086	21.96582695	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1257	2087	0.00287494	0.00574988	10	8	Astrocytes	41	6	6
ATCACGAGTGGCCCTA-1_MS200_A303	-13.93164077	23.19679867	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1635	2681	0.013427825	0.014546811	10	8	Astrocytes	41	6	6
ATCACGATCACTCCTG-1_MS200_A303	-27.46952257	-2.357575474	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1538	2564	0.004680187	0.007410296	10	9	OPC	41	6	6
ATCACGATCGCGGATC-1_MS200_A303	-6.200220774	14.80468393	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	776	1135	0.001762115	0.007929515	10	oligos	OL-MS-1	41	6	6
ATCACGATCTCGATGA-1_MS200_A303	3.098936106	-10.13137155	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1592	2844	0.003867792	0.004922644	10	12	EN-MIX	41	6	6
ATCATCTAGACACGAC-1_MS200_A303	3.755597522	-3.626469557	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	968	1482	0.081646424	0.007422402	10	12	EN-MIX	41	6	6
ATCATCTAGTGAATTG-1_MS200_A303	12.90678575	-15.84984291	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4490	11636	0.012461327	0.005414232	10	L2-3	EN-L2-3-MS	41	6	6
ATCATCTAGTGCAAGC-1_MS200_A303	14.3943634	-5.33979382	3	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2159	4229	0.023646252	0.016788839	10	3	EN-L5-6	41	6	6
ATCATCTAGTGCGTGA-1_MS200_A303	21.76909646	-17.74630537	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5420	15972	0.022852492	0.006824443	10	L2-3	EN-L2-3-MS	41	6	6
ATCATCTCAGTTTACG-1_MS200_A303	14.08541203	-16.09832347	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	7027	24826	0.009828406	0.010190929	10	L2-3	EN-L2-3-MS	41	6	6
ATCATCTGTCTAGCCG-1_MS200_A303	-27.85759645	8.292086845	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	733	1099	0.001819836	0.010009099	10	8	Astrocytes	41	6	6
ATCATCTGTGCGAAAC-1_MS200_A303	19.28158248	-10.32925648	3	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2466	4940	0.016194332	0.003441296	10	3	EN-L5-6	41	6	6
ATCATCTTCCAAAGTC-1_MS200_A303	9.123488641	-13.61223669	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2933	6101	0.012293067	0.007867563	10	L2-3	EN-L2-3-MS	41	6	6
ATCATCTTCTCCAACC-1_MS200_A303	11.94852534	-18.22920066	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5976	19445	0.005554127	0.008588326	10	L2-3	EN-L2-3-MS	41	6	6
ATCATGGAGTGGTCCC-1_MS200_A303	13.55086467	-13.01017463	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4253	9558	0.00952082	0.011822557	10	L2-3	EN-L2-3-MS	41	6	6
ATCATGGCAAGTCTGT-1_MS200_A303	27.83840329	-17.92177389	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	7069	26512	0.045262523	0.00765691	10	2	EN-L4	41	6	6
ATCATGGCACCAGTTA-1_MS200_A303	-29.22684854	-4.923876169	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1326	1991	0.010547464	0.005524862	10	9	OPC	41	6	6
ATCATGGGTAAGTAGT-1_MS200_A303	-16.56589659	20.8837438	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1433	2191	0.000912825	0.006389776	10	8	Astrocytes	41	6	6
ATCATGGTCAGCGACC-1_MS200_A303	-15.79573975	23.17003577	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1401	2155	0.001856148	0.006960557	10	8	Astrocytes	41	6	6
ATCATGGTCTGCGTAA-1_MS200_A303	-33.04051662	-4.630089011	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1323	2074	0.006268081	0.008678881	10	9	OPC	41	6	6
ATCCACCAGTTTCCTT-1_MS200_A303	-19.73040644	-2.071581336	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4508	10986	0.00737302	0.008738394	10	13A	IN-VIP	41	6	6
ATCCACCGTAGAAGGA-1_MS200_A303	-24.11384819	9.705368538	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1084	1622	0.00431566	0.010480888	10	8	Astrocytes	41	6	6
ATCCACCTCTCTGAGA-1_MS200_A303	-24.38203424	6.810947906	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	880	1230	0.008130081	0.011382114	10	8	Astrocytes	41	6	6
ATCCGAAAGAAGGTTT-1_MS200_A303	-19.81633037	-1.561531923	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4948	11794	0.015685942	0.013057487	10	13A	IN-VIP	41	6	6
ATCCGAAAGATCCCGC-1_MS200_A303	-14.69107253	24.01488266	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1935	3584	0.000837054	0.008370536	10	8	Astrocytes	41	6	6
ATCCGAAAGTACGCGA-1_MS200_A303	9.197909475	-1.815326253	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1401	2354	0.155055225	0.006796941	10	12	EN-MIX	41	6	6
ATCCGAACAATCACAC-1_MS200_A303	-6.523530456	-38.19952816	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	936	1210	0.038016529	0.029752066	10	16	EN-PYR	41	6	6
ATCCGAACACCTCGGA-1_MS200_A303	-14.57581011	24.15157511	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1655	2866	0.005233775	0.011514306	10	8	Astrocytes	41	6	6
ATCCGAAGTAATCACC-1_MS200_A303	-15.25536682	-4.454594911	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3758	8972	0.050156041	0.005795809	10	13A	IN-VIP	41	6	6
ATCCGAAGTCAACTGT-1_MS200_A303	-5.758017213	14.84051614	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	822	1112	0.002697842	0.018884892	10	oligos	OL-MS-1	41	6	6
ATCCGAAGTCACTGGC-1_MS200_A303	-5.727601911	13.26764423	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	733	1072	0.009328358	0.021455224	10	oligos	OL-MS-1	41	6	6
ATCCGAATCACCACCT-1_MS200_A303	-15.77195302	23.38863138	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1515	2429	0.000823384	0.007410457	10	8	Astrocytes	41	6	6
ATCCGAATCACTTATC-1_MS200_A303	-0.318931539	0.027278159	17	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1188	1775	0.034366197	0.009014085	10	oligos	OL-MS-2	41	6	6
ATCCGAATCTCAACTT-1_MS200_A303	-30.0025065	-1.755150543	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1631	2824	0.003186969	0.009915014	10	9	OPC	41	6	6
ATCCGAATCTTTAGTC-1_MS200_A303	17.09015843	-14.97016325	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	6918	23737	0.013775962	0.00779374	10	L2-3	EN-L2-3-MS	41	6	6
ATCGAGTAGAATTCCC-1_MS200_A303	-16.8198762	19.50405338	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1410	2386	0.00293378	0.007124895	10	8	Astrocytes	41	6	6
ATCGAGTAGTGACTCT-1_MS200_A303	-16.46408903	6.426090015	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	740	1106	0.17721519	0.01084991	10	8	Astrocytes	41	6	6
ATCGAGTCAGCTGTGC-1_MS200_A303	-8.054424233	-37.83551238	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1177	1645	0.047416413	0.021276596	10	16	EN-PYR	41	6	6
ATCGAGTCAGGTGGAT-1_MS200_A303	18.68691649	-13.72845748	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	6655	20401	0.02333219	0.016028626	10	L2-3	EN-L2-3-MS	41	6	6
ATCGAGTGTCTGATCA-1_MS200_A303	32.92262222	10.41104442	14	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1020	1292	0.020123839	0.020123839	10	14	Microglia	41	6	6
ATCGAGTGTTCGTCTC-1_MS200_A303	11.16405698	-12.51911371	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3159	6482	0.007250849	0.01373033	10	L2-3	EN-L2-3-MS	41	6	6
ATCGAGTTCACCGGGT-1_MS200_A303	-18.15998488	-1.159734507	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3801	8107	0.014431972	0.015048723	10	13A	IN-VIP	41	6	6
ATCGAGTTCCGGGTGT-1_MS200_A303	26.24283733	3.620921767	15DA	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	909	1403	0.005702067	0.007127584	10	15DA	T cells	41	6	6
ATCGAGTTCCGTCAAA-1_MS200_A303	-30.45464339	-21.60626535	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4985	12121	0.025905453	0.014932761	10	6A	IN-PV	41	6	6
ATCGAGTTCTAGCACA-1_MS200_A303	-19.19809684	-5.133618888	13B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3005	5919	0.025511066	0.00794053	10	13B	IN-SV2C	41	6	6
ATCTACTAGTGCGTGA-1_MS200_A303	14.37467939	-13.77632607	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4658	11270	0.012333629	0.006832298	10	L2-3	EN-L2-3-MS	41	6	6
ATCTACTCACGTCTCT-1_MS200_A303	15.70624434	-13.91381859	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	6513	21918	0.008851173	0.01090428	10	L2-3	EN-L2-3-MS	41	6	6
ATCTACTGTAACGCGA-1_MS200_A303	7.142670403	-0.233172409	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	728	1130	0.177876106	0.005309735	10	12	EN-MIX	41	6	6
ATCTACTGTAGCCTCG-1_MS200_A303	-23.52503946	9.899672415	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	997	1585	0.005047319	0.010725552	10	8	Astrocytes	41	6	6
ATCTACTGTCCAAGTT-1_MS200_A303	-15.03975314	24.36063759	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1733	2975	0.007394958	0.010420168	10	8	Astrocytes	41	6	6
ATCTACTGTCCCTTGT-1_MS200_A303	-26.88902046	-22.50404274	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4449	12302	0.0321086	0.007559746	10	6A	IN-PV	41	6	6
ATCTACTGTCCGCTGA-1_MS200_A303	-15.8422991	21.95571601	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1347	2115	0.007565012	0.006619385	10	8	Astrocytes	41	6	6
ATCTACTTCGAGAGCA-1_MS200_A303	12.212359	0.564068462	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	782	1048	0.020038168	0.007633588	10	12	EN-MIX	41	6	6
ATCTACTTCTTAACCT-1_MS200_A303	15.29930559	-7.22228056	3	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1626	2790	0.02437276	0.004659498	10	3	EN-L5-6	41	6	6
ATCTGCCAGACCACGA-1_MS200_A303	9.273058644	1.487955562	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	766	1115	0.144394619	0.003587444	10	12	EN-MIX	41	6	6
ATCTGCCAGGGCATGT-1_MS200_A303	-23.93031341	9.025157125	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1172	1835	0.003814714	0.007629428	10	8	Astrocytes	41	6	6
ATCTGCCCAGCCTATA-1_MS200_A303	-22.01816841	-21.88183047	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2600	5960	0.09647651	0.003355705	10	6A	IN-PV	41	6	6
ATCTGCCCATAGAAAC-1_MS200_A303	10.61590554	-19.77025429	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4321	10803	0.008331019	0.005554013	10	L2-3	EN-L2-3-MS	41	6	6
ATCTGCCCATATACGC-1_MS200_A303	-13.93802524	24.61669706	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2052	3850	0.003116883	0.012467532	10	8	Astrocytes	41	6	6
ATCTGCCGTAGAGGAA-1_MS200_A303	-23.54422232	8.712236314	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1264	1819	0.004947774	0.004947774	10	8	Astrocytes	41	6	6
ATCTGCCGTTACGCGC-1_MS200_A303	-16.28665724	10.69148897	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1208	1953	0.005120328	0.007680492	10	8	Astrocytes	41	6	6
ATCTGCCTCACGAAGG-1_MS200_A303	-4.215238981	19.24817643	1	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	777	1090	0.004587156	0.018348624	10	oligos	OL-Cntl	41	6	6
ATCTGCCTCATCATTC-1_MS200_A303	1.951440155	10.42543464	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1068	1624	0.015394089	0.011083744	10	oligos	OL-MS-1	41	6	6
ATCTGCCTCCCAAGTA-1_MS200_A303	-25.41768667	-18.56273342	6B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2580	5208	0.023425499	0.009408602	10	6B	IN-SST	41	6	6
ATCTGCCTCTGTCAAG-1_MS200_A303	-24.85974873	-23.5948329	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4230	10585	0.020311762	0.005290505	10	6A	IN-PV	41	6	6
ATGAGGGAGCGCCTCA-1_MS200_A303	10.22727009	-16.61226018	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3591	7669	0.010301213	0.00717173	10	L2-3	EN-L2-3-MS	41	6	6
ATGAGGGAGTTGAGTA-1_MS200_A303	32.23542879	-16.35537007	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4096	9367	0.030852995	0.011423081	10	2	EN-L4	41	6	6
ATGAGGGGTCCGTTAA-1_MS200_A303	-7.154813921	-35.42579715	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	828	1083	0.034164358	0.021237304	10	16	EN-PYR	41	6	6
ATGAGGGGTCTCCATC-1_MS200_A303	-32.7320758	-5.268779693	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1190	1930	0.004145078	0.006735751	10	9	OPC	41	6	6
ATGAGGGGTGCATCTA-1_MS200_A303	-13.88455679	-15.41742488	6B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1430	2301	0.026075619	0.008257279	10	6B	IN-SST	41	6	6
ATGAGGGGTGTGAATA-1_MS200_A303	-11.33897349	28.42662086	17	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1321	1861	0.029554003	0.017732402	10	oligos	OL-MS-2	41	6	6
ATGAGGGTCATGCTCC-1_MS200_A303	-26.95539657	-10.55043697	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1290	1966	0.005595117	0.013733469	10	9	OPC	41	6	6
ATGCGATAGCCACCTG-1_MS200_A303	-16.92914629	-7.42826535	13B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2679	5373	0.020472734	0.004466778	10	13B	IN-SV2C	41	6	6
ATGCGATAGCTAGTGG-1_MS200_A303	-29.04082225	-10.59871566	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	951	1281	0.00312256	0.008587041	10	9	OPC	41	6	6
ATGCGATAGGCGACAT-1_MS200_A303	-5.368796701	14.71817546	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	919	1322	0.006051437	0.027987897	10	oligos	OL-MS-1	41	6	6
ATGCGATCATACTACG-1_MS200_A303	-7.534513204	-6.023310992	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1359	2084	0.021113244	0.00671785	10	13A	IN-VIP	41	6	6
ATGCGATCATTCCTGC-1_MS200_A303	12.51735715	-13.75588835	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4106	9506	0.011887229	0.010098885	10	L2-3	EN-L2-3-MS	41	6	6
ATGCGATGTAAGGGCT-1_MS200_A303	6.648642483	-2.013022114	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	984	1463	0.136021873	0.004101162	10	12	EN-MIX	41	6	6
ATGCGATGTGCGATAG-1_MS200_A303	-14.73347349	25.48868135	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2497	4699	0.010427751	0.007448393	10	8	Astrocytes	41	6	6
ATGCGATGTGGTAACG-1_MS200_A303	-17.74501797	-2.593172567	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3069	5777	0.022676129	0.012809417	10	13A	IN-VIP	41	6	6
ATGCGATTCCCTCTTT-1_MS200_A303	-15.26586846	24.17210965	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1605	2847	0.002107482	0.007727432	10	8	Astrocytes	41	6	6
ATGCGATTCGAGGTAG-1_MS200_A303	-30.46312548	-21.6592862	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5141	13029	0.033080052	0.012971065	10	6A	IN-PV	41	6	6
ATGCGATTCGGTCTAA-1_MS200_A303	-17.27387976	20.68501996	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1592	2456	0.003257329	0.011400651	10	8	Astrocytes	41	6	6
ATGGGAGCAGCTCGAC-1_MS200_A303	-24.16728496	7.179270875	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	943	1380	0.006521739	0.008695652	10	8	Astrocytes	41	6	6
ATGGGAGGTATGGTTC-1_MS200_A303	-13.93918886	17.44947041	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1240	1839	0.005981512	0.010875476	10	8	Astrocytes	41	6	6
ATGGGAGTCATGTCCC-1_MS200_A303	13.35800108	-20.10609126	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	6001	19125	0.005803922	0.005699346	10	L2-3	EN-L2-3-MS	41	6	6
ATGGGAGTCGAATCCA-1_MS200_A303	-15.85959316	23.60098517	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1520	2659	0.003384731	0.00902595	10	8	Astrocytes	41	6	6
ATGGGAGTCGCCAAAT-1_MS200_A303	22.65551476	-15.7864826	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4357	9179	0.020699423	0.020263645	10	L2-3	EN-L2-3-MS	41	6	6
ATGTGTGAGATAGTCA-1_MS200_A303	-0.566058566	-0.701120328	11	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1561	2438	0.03076292	0.012305168	10	11	Glia-MIX	41	6	6
ATGTGTGCAGATCTGT-1_MS200_A303	13.75433472	-27.60247109	3	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3107	6994	0.010723477	0.003288533	10	3	EN-L5-6	41	6	6
ATGTGTGCATCCTAGA-1_MS200_A303	-13.34829326	-37.03635422	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1904	3276	0.073870574	0.008241758	10	16	EN-PYR	41	6	6
ATGTGTGGTAGCGCTC-1_MS200_A303	-14.31598106	-16.01157994	6B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1516	2500	0.0168	0.0068	10	6B	IN-SST	41	6	6
ATGTGTGGTCCAGTGC-1_MS200_A303	9.406767352	1.033483438	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	895	1253	0.007182761	0.007980846	10	12	EN-MIX	41	6	6
ATGTGTGGTCCATCCT-1_MS200_A303	28.38369186	-13.84688474	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	6264	20226	0.02862652	0.006872343	10	2	EN-L4	41	6	6
ATGTGTGGTCGCATAT-1_MS200_A303	24.72973609	-13.8925595	3	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3924	8698	0.008737641	0.011381927	10	3	EN-L5-6	41	6	6
ATGTGTGTCGTCGTTC-1_MS200_A303	33.81091738	-18.53670471	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5174	12619	0.015373643	0.020128378	10	2	EN-L4	41	6	6
ATTACTCAGATACACA-1_MS200_A303	14.64690504	-20.75051338	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5828	16938	0.009859488	0.010272759	10	L2-3	EN-L2-3-MS	41	6	6
ATTACTCAGGACTGGT-1_MS200_A303	-16.32763186	-4.133611866	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3024	6681	0.014518785	0.003143242	10	13A	IN-VIP	41	6	6
ATTACTCAGTATTGGA-1_MS200_A303	-31.97481675	-5.973412324	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1131	1748	0.006292906	0.004004577	10	9	OPC	41	6	6
ATTACTCCACGAAAGC-1_MS200_A303	-19.81322053	-5.585521752	13B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3801	8508	0.022802069	0.009520451	10	13B	IN-SV2C	41	6	6
ATTACTCGTCGAAAGC-1_MS200_A303	-15.28769105	12.88408023	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1741	3143	0.001909004	0.004136176	10	8	Astrocytes	41	6	6
ATTACTCGTCTCTCGT-1_MS200_A303	7.862937404	-11.81807497	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2693	5735	0.093635571	0.004707934	10	L2-3	EN-L2-3-MS	41	6	6
ATTACTCTCTCCAACC-1_MS200_A303	4.303604918	11.66015804	1	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1104	1771	0.007340486	0.011857708	10	oligos	OL-Cntl	41	6	6
ATTACTCTCTGTCCGT-1_MS200_A303	-22.72274653	-8.401040924	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2071	3463	0.021946289	0.008951776	10	9	OPC	41	6	6
ATTATCCAGATTACCC-1_MS200_A303	9.319288833	1.933144233	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	728	1162	0.002581756	0.007745267	10	12	EN-MIX	41	6	6
ATTATCCAGGGTGTGT-1_MS200_A303	-14.01573052	22.34867245	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1599	2468	0.008508914	0.008103728	10	8	Astrocytes	41	6	6
ATTATCCAGTACGACG-1_MS200_A303	-15.74106587	19.9949742	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1460	2236	0.006261181	0.021019678	10	8	Astrocytes	41	6	6
ATTATCCAGTCAATAG-1_MS200_A303	-23.54384916	-20.478179	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4843	12615	0.011256441	0.004597701	10	6A	IN-PV	41	6	6
ATTATCCAGTTCGCAT-1_MS200_A303	-9.175502638	27.23693981	17	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1092	1615	0.012383901	0.014241486	10	oligos	OL-MS-2	41	6	6
ATTATCCCAAACGTGG-1_MS200_A303	-32.35804637	-5.319817488	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1341	2231	0.008068131	0.004482295	10	9	OPC	41	6	6
ATTATCCCACACCGCA-1_MS200_A303	18.59192006	-25.6872567	3	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4910	14540	0.005295736	0.00866575	10	3	EN-L5-6	41	6	6
ATTATCCGTAAGCACG-1_MS200_A303	17.04363576	-14.59283828	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	6375	19958	0.018939774	0.01142399	10	L2-3	EN-L2-3-MS	41	6	6
ATTATCCTCCTCATTA-1_MS200_A303	10.25152397	11.17774758	1	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1329	2251	0.006663705	0.012883163	10	oligos	OL-Cntl	41	6	6
ATTATCCTCTTGTACT-1_MS200_A303	14.99571417	-16.99946638	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5204	14504	0.011445119	0.006067292	10	L2-3	EN-L2-3-MS	41	6	6
ATTCTACCAGGCTCAC-1_MS200_A303	-16.78403646	-1.422466951	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2938	6065	0.011706513	0.015169002	10	13A	IN-VIP	41	6	6
ATTCTACGTAGCCTAT-1_MS200_A303	-14.50710086	24.73044804	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1866	3220	0.001242236	0.010559006	10	8	Astrocytes	41	6	6
ATTCTACGTCTCATCC-1_MS200_A303	5.59826011	0.176060165	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1000	1393	0.022972003	0.015075377	10	16	EN-PYR	41	6	6
ATTCTACGTGGGTCAA-1_MS200_A303	-17.76617533	-1.261307858	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3323	6802	0.012055278	0.013378418	10	13A	IN-VIP	41	6	6
ATTCTACTCAGCTTAG-1_MS200_A303	-31.48483474	-6.213918813	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1207	1836	0.004357298	0.008714597	10	9	OPC	41	6	6
ATTCTACTCATGCTCC-1_MS200_A303	16.32730574	-18.24752297	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4858	14473	0.020106405	0.005182063	10	L2-3	EN-L2-3-MS	41	6	6
ATTCTACTCTCGGACG-1_MS200_A303	-26.74194098	-1.938082643	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1523	2395	0.005427975	0.014196242	10	9	OPC	41	6	6
ATTGGACAGCTGTCTA-1_MS200_A303	-11.36094067	28.61543873	17	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1397	2013	0.072031793	0.011922504	10	oligos	OL-MS-2	41	6	6
ATTGGACCAAATTGCC-1_MS200_A303	11.95606051	-24.10956307	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	6338	21483	0.001908486	0.009309687	10	L2-3	EN-L2-3-MS	41	6	6
ATTGGACCACCGAAAG-1_MS200_A303	5.190006961	-2.945104469	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	986	1525	0.100983607	0.006557377	10	12	EN-MIX	41	6	6
ATTGGACCAGACAGGT-1_MS200_A303	-11.70041961	17.36139697	11	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1757	2736	0.004751462	0.00877193	10	11	Glia-MIX	41	6	6
ATTGGACTCGTCACGG-1_MS200_A303	23.26591131	-27.71872782	3	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3521	8967	0.010594402	0.003680161	10	3	EN-L5-6	41	6	6
ATTGGACTCTGGCGTG-1_MS200_A303	9.968387784	-11.69777361	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2370	4128	0.017199612	0.011870155	10	L2-3	EN-L2-3-MS	41	6	6
ATTGGTGAGAGTGAGA-1_MS200_A303	-19.10827941	5.388058748	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	801	1088	0.004595588	0.021139706	10	8	Astrocytes	41	6	6
ATTGGTGAGGTTACCT-1_MS200_A303	-15.09948656	23.93815758	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1626	2822	0.00248051	0.010630758	10	8	Astrocytes	41	6	6
ATTGGTGCACAGACTT-1_MS200_A303	7.274021513	13.79083707	1	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1133	1752	0.005136986	0.009703196	10	oligos	OL-Cntl	41	6	6
ATTGGTGCACCGGAAA-1_MS200_A303	-32.84036019	-5.315697731	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1210	2001	0.001999	0.006996502	10	9	OPC	41	6	6
ATTGGTGGTCGTGGCT-1_MS200_A303	-15.60562468	23.23261549	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1565	2682	0.002982849	0.005592841	10	8	Astrocytes	41	6	6
ATTGGTGTCCTGCCAT-1_MS200_A303	-17.97019624	-0.757433297	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4072	9079	0.008040533	0.013547748	10	13A	IN-VIP	41	6	6
ATTGGTGTCGGAAATA-1_MS200_A303	-24.59137888	9.459107513	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	913	1352	0.00147929	0.015532544	10	8	Astrocytes	41	6	6
ATTTCTGAGATAGTCA-1_MS200_A303	29.96953215	15.98376881	14	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1507	2353	0.00679983	0.105397365	10	14	Microglia	41	6	6
ATTTCTGAGCAATATG-1_MS200_A303	-17.34035661	-1.739859749	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2921	5750	0.008	0.014956522	10	13A	IN-VIP	41	6	6
ATTTCTGAGCACAGGT-1_MS200_A303	20.93443446	-21.50950037	3	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3854	8857	0.007677543	0.008806594	10	3	EN-L5-6	41	6	6
ATTTCTGAGTACACCT-1_MS200_A303	29.10982137	9.919222844	15DB	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	980	1590	0.016352201	0.088050314	10	15DB	B cells	41	6	6
ATTTCTGCAACACCTA-1_MS200_A303	13.20234277	-2.315044468	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	977	1482	0.004048583	0.005398111	10	12	EN-MIX	41	6	6
ATTTCTGCACACTGCG-1_MS200_A303	-15.08547738	22.16460892	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1274	2122	0.019321395	0.009425071	10	8	Astrocytes	41	6	6
ATTTCTGCAGGATTGG-1_MS200_A303	-10.95654	22.69364157	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1906	3133	0.005106926	0.009575487	10	8	Astrocytes	41	6	6
ATTTCTGGTAAACACA-1_MS200_A303	15.03210192	-15.91283551	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	6653	24016	0.015031646	0.006287475	10	L2-3	EN-L2-3-MS	41	6	6
ATTTCTGGTGCAACTT-1_MS200_A303	-32.92081142	-12.35997749	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	791	1221	0.000819001	0.001638002	10	9	OPC	41	6	6
ATTTCTGGTTCGTGAT-1_MS200_A303	-16.63304766	-1.555666313	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2685	4915	0.02889115	0.01363174	10	13A	IN-VIP	41	6	6
ATTTCTGTCTGTTGAG-1_MS200_A303	19.64677758	-19.62861134	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5178	17210	0.031841952	0.006624056	10	L2-3	EN-L2-3-MS	41	6	6
CAACCAAAGAAGGCCT-1_MS200_A303	4.064045214	-2.592464041	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	880	1224	0.044934641	0.008169935	10	12	EN-MIX	41	6	6
CAACCAAAGACAGGCT-1_MS200_A303	-28.21445235	-4.909161799	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1292	1896	0.001582278	0.010021097	10	9	OPC	41	6	6
CAACCAAAGCTGATAA-1_MS200_A303	-14.88704878	16.90648511	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1900	3631	0.003029468	0.007160562	10	8	Astrocytes	41	6	6
CAACCAACAAATCCGT-1_MS200_A303	1.024878026	-13.18446424	10	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2227	4520	0.023672566	0.005088496	10	L2-3	EN-L2-3-Cntl	41	6	6
CAACCAACAAGGTGTG-1_MS200_A303	29.04160132	10.00236665	15DB	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1555	2996	0.003337784	0.070761015	10	15DB	B cells	41	6	6
CAACCAACATACAGCT-1_MS200_A303	34.08609595	-17.26987024	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5557	15251	0.011409088	0.013966297	10	2	EN-L4	41	6	6
CAACCAAGTAGAGGAA-1_MS200_A303	-24.1400569	8.8430356	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1153	1625	0.003692308	0.008	10	8	Astrocytes	41	6	6
CAACCAATCCAGAAGG-1_MS200_A303	-12.75962755	18.04117612	11	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1730	2860	0.003496503	0.012587413	10	11	Glia-MIX	41	6	6
CAACCTCAGGTGCACA-1_MS200_A303	-11.10077493	-6.879251891	13B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1796	3214	0.023957685	0.003422526	10	13B	IN-SV2C	41	6	6
CAACCTCAGTCCATAC-1_MS200_A303	-15.7806327	-0.570721123	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3793	9161	0.015500491	0.009060146	10	13A	IN-VIP	41	6	6
CAACCTCCAAACAACA-1_MS200_A303	-32.3763148	-5.264831236	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1246	2044	0.004403131	0.002935421	10	9	OPC	41	6	6
CAACCTCGTCCAAGTT-1_MS200_A303	-12.87554395	7.370713328	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2705	4646	0.023245803	0.013560052	10	16	EN-PYR	41	6	6
CAACCTCGTTCCACGG-1_MS200_A303	-5.750844145	15.3958186	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	778	1148	0.013066202	0.012195122	10	oligos	OL-MS-1	41	6	6
CAACCTCGTTGTTTGG-1_MS200_A303	-19.50617828	-22.91455048	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2018	3710	0.026145553	0.00458221	10	6A	IN-PV	41	6	6
CAACCTCGTTTGGGCC-1_MS200_A303	33.24451461	-10.99526363	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2592	4883	0.012901905	0.00573418	10	2	EN-L4	41	6	6
CAACCTCTCATGGTCA-1_MS200_A303	-2.801790432	23.08627721	1	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	734	1121	0.008028546	0.014272971	10	oligos	OL-Cntl	41	6	6
CAACCTCTCCGCAAGC-1_MS200_A303	10.49957944	-25.27292625	10	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4875	15621	0.004929262	0.00691377	10	L2-3	EN-L2-3-Cntl	41	6	6
CAACCTCTCTCTGAGA-1_MS200_A303	13.62017536	6.655154085	1	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1692	2873	0.005569092	0.008353637	10	oligos	OL-Cntl	41	6	6
CAACCTCTCTGACCTC-1_MS200_A303	-17.74864983	5.585963353	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	823	1159	0.004314064	0.008628128	10	8	Astrocytes	41	6	6
CAACTAGAGAAGGTGA-1_MS200_A303	18.67479517	-19.14534972	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2940	5418	0.020487265	0.006644518	10	L2-3	EN-L2-3-MS	41	6	6
CAACTAGCATCGGGTC-1_MS200_A303	-8.845065933	-12.35220702	6B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1267	1986	0.042296073	0.024672709	10	6B	IN-SST	41	6	6
CAACTAGGTGGTCTCG-1_MS200_A303	-5.57715186	-35.30337783	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	819	1112	0.077338129	0.017086331	10	16	EN-PYR	41	6	6
CAACTAGGTTACTGAC-1_MS200_A303	-3.337822772	18.86092923	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	817	1217	0.003286771	0.013968776	10	oligos	OL-MS-1	41	6	6
CAACTAGTCCTTTACA-1_MS200_A303	8.566708293	-18.39090454	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4320	11216	0.005171184	0.011144793	10	L2-3	EN-L2-3-MS	41	6	6
CAACTAGTCTATCGCC-1_MS200_A303	16.03346254	-14.03850843	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	6588	21416	0.014521853	0.00770452	10	L2-3	EN-L2-3-MS	41	6	6
CAACTAGTCTGAAAGA-1_MS200_A303	-16.57683159	-1.684112061	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2734	5004	0.019584333	0.014388489	10	13A	IN-VIP	41	6	6
CAAGAAAAGCGTAATA-1_MS200_A303	10.70377099	2.325974434	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	863	1289	0.144297905	0.006982157	10	12	EN-MIX	41	6	6
CAAGAAAAGGAGTACC-1_MS200_A303	-5.914670928	15.66630177	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	774	1001	0.000999001	0.006993007	10	oligos	OL-MS-1	41	6	6
CAAGAAAGTATATGAG-1_MS200_A303	-15.43849491	25.40225706	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2070	3575	0.001118881	0.011468531	10	8	Astrocytes	41	6	6
CAAGAAAGTCGAAAGC-1_MS200_A303	-12.78720109	-8.518346073	13B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1832	3167	0.027470793	0.007893906	10	13B	IN-SV2C	41	6	6
CAAGAAATCTACCAGA-1_MS200_A303	15.89723549	-28.97070416	3	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5307	18587	0.006240921	0.003120461	10	3	EN-L5-6	41	6	6
CAAGATCAGAAACGAG-1_MS200_A303	-9.82955811	-9.860759174	6B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1251	1995	0.045614035	0.004010025	10	6B	IN-SST	41	6	6
CAAGATCCACATTTCT-1_MS200_A303	1.183066777	12.15384095	1	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	913	1349	0.005189029	0.024462565	10	oligos	OL-Cntl	41	6	6
CAAGATCCACGAGAGT-1_MS200_A303	-29.05415412	-21.48685928	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3735	7951	0.038359955	0.013960508	10	6A	IN-PV	41	6	6
CAAGATCGTCATATGC-1_MS200_A303	-14.77063275	22.21424115	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1433	2400	0.01	0.012916667	10	8	Astrocytes	41	6	6
CAAGATCGTGTAATGA-1_MS200_A303	29.79846892	-15.99226134	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3550	7631	0.052810903	0.007600577	10	2	EN-L4	41	6	6
CAAGATCGTTCCACTC-1_MS200_A303	-5.460741334	14.96661111	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	772	1091	0.003666361	0.019248396	10	oligos	OL-MS-1	41	6	6
CAAGATCTCGAATCCA-1_MS200_A303	-14.55438068	24.40788312	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1793	3237	0.004324992	0.011739265	10	8	Astrocytes	41	6	6
CAAGGCCAGCATCATC-1_MS200_A303	-14.20623515	22.63057864	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1570	2775	0.00972973	0.007927928	10	8	Astrocytes	41	6	6
CAAGGCCAGGCAGTCA-1_MS200_A303	15.07316998	-13.59822107	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5849	16350	0.012110092	0.00795107	10	L2-3	EN-L2-3-MS	41	6	6
CAAGGCCGTCCGACGT-1_MS200_A303	-21.08314602	-21.58157915	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2209	4280	0.10817757	0.005841121	10	6A	IN-PV	41	6	6
CAAGGCCGTGGCCCTA-1_MS200_A303	-7.116586953	-35.40858942	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	877	1223	0.071136549	0.017170891	10	16	EN-PYR	41	6	6
CAAGGCCGTGGGTCAA-1_MS200_A303	33.39086228	-16.67523626	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4528	10524	0.017008742	0.011687571	10	2	EN-L4	41	6	6
CAAGGCCGTTAAGTAG-1_MS200_A303	33.99699345	-18.07044295	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4306	9979	0.017737248	0.016735144	10	2	EN-L4	41	6	6
CAAGGCCTCAGGTTCA-1_MS200_A303	-9.888960755	27.80186088	17	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	885	1167	0.020565553	0.00856898	10	oligos	OL-MS-2	41	6	6
CAAGGCCTCATCTGCC-1_MS200_A303	9.313599496	-1.918243417	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1642	3360	0.260416667	0.004464286	10	12	EN-MIX	41	6	6
CAAGGCCTCTAACTCT-1_MS200_A303	-5.774393684	16.23130079	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	825	1189	0.020185029	0.014297729	10	oligos	OL-MS-1	41	6	6
CAAGTTGAGAACAACT-1_MS200_A303	19.9124929	-3.111244763	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1604	2589	0.083816145	0.007338741	10	12	EN-MIX	41	6	6
CAAGTTGAGACGCACA-1_MS200_A303	13.70339785	-17.55725507	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5208	14476	0.00939486	0.008704062	10	L2-3	EN-L2-3-MS	41	6	6
CAAGTTGAGCTAAGAT-1_MS200_A303	-21.17909979	4.25896497	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	766	1110	0.020720721	0.021621622	10	8	Astrocytes	41	6	6
CAAGTTGAGGCGATAC-1_MS200_A303	-24.46490291	6.407764271	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	739	1046	0.006692161	0.008604207	10	8	Astrocytes	41	6	6
CAAGTTGCAACACCTA-1_MS200_A303	-24.32746627	-19.34225086	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2884	5796	0.010006901	0.007591442	10	6A	IN-PV	41	6	6
CAAGTTGCATGCCTTC-1_MS200_A303	32.7954696	-9.70413621	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4485	10793	0.00806078	0.011118317	10	2	EN-L4	41	6	6
CAAGTTGGTAGCGCTC-1_MS200_A303	-24.92260265	-19.29455399	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3334	6976	0.024512615	0.011181193	10	6A	IN-PV	41	6	6
CAAGTTGGTATAATGG-1_MS200_A303	-14.70345104	23.50253324	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1555	2538	0.005516154	0.012608353	10	8	Astrocytes	41	6	6
CAAGTTGGTCTCCCTA-1_MS200_A303	19.15996504	-19.70752865	3	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3464	8160	0.092647059	0.00379902	10	3	EN-L5-6	41	6	6
CAAGTTGGTTCACCTC-1_MS200_A303	13.93777232	-16.27847783	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5456	15398	0.020392259	0.006299519	10	L2-3	EN-L2-3-MS	41	6	6
CAAGTTGTCAGGCCCA-1_MS200_A303	-13.64046106	22.68700073	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1517	2331	0.008151008	0.015015015	10	8	Astrocytes	41	6	6
CACAAACAGCAAATCA-1_MS200_A303	14.42178144	-16.39249833	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5884	18618	0.012246213	0.007143624	10	L2-3	EN-L2-3-MS	41	6	6
CACAAACAGGCTAGAC-1_MS200_A303	13.5861856	-23.1063544	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4756	13364	0.01848249	0.004564502	10	L2-3	EN-L2-3-MS	41	6	6
CACAAACGTAGCTCCG-1_MS200_A303	-5.097881682	-8.193889608	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	810	1136	0.063380282	0.007042254	10	13A	IN-VIP	41	6	6
CACAAACGTCTCCACT-1_MS200_A303	-16.91833622	20.28473813	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1421	2363	0.007617435	0.011426153	10	8	Astrocytes	41	6	6
CACACAAAGAATTGTG-1_MS200_A303	-11.14676217	19.12143195	11	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3032	5802	0.002930024	0.022750776	10	11	Glia-MIX	41	6	6
CACACAAAGTACCGGA-1_MS200_A303	-13.38133474	22.09579249	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1561	2594	0.00925212	0.011950655	10	8	Astrocytes	41	6	6
CACACAAAGTCATGCT-1_MS200_A303	-27.72841045	0.535788139	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2606	5269	0.001708104	0.036059973	10	9	OPC	41	6	6
CACACAACACAGACAG-1_MS200_A303	-29.26803276	-1.928741874	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1971	3327	0.018334836	0.011722272	10	9	OPC	41	6	6
CACACAACACCGTTGG-1_MS200_A303	34.27314395	10.83336546	14	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	834	1066	0.008442777	0.024390244	10	14	Microglia	41	6	6
CACACAAGTGCCTGTG-1_MS200_A303	-24.63161683	8.212139572	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	874	1237	0.004042037	0.008892482	10	8	Astrocytes	41	6	6
CACACAAGTGTAATGA-1_MS200_A303	-11.86558869	-5.625212495	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1749	2418	0.010339123	0.035153019	10	13A	IN-VIP	41	6	6
CACACCTCATGGAATA-1_MS200_A303	10.31671763	1.303382055	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	805	1302	0.19969278	0.003840246	10	12	EN-MIX	41	6	6
CACACCTCATTGGTAC-1_MS200_A303	-22.53534436	-17.06462488	6B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2968	6238	0.007053543	0.009939083	10	6B	IN-SST	41	6	6
CACACCTGTAAATGTG-1_MS200_A303	9.267505873	-18.46035045	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5303	15604	0.003845168	0.009997437	10	L2-3	EN-L2-3-MS	41	6	6
CACACCTGTAGAGTGC-1_MS200_A303	-12.89322133	-16.46257969	6B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1226	2033	0.02508608	0.005410723	10	6B	IN-SST	41	6	6
CACACCTGTTACCAGT-1_MS200_A303	-17.65608072	18.44372098	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1929	3435	0.004075691	0.006404658	10	8	Astrocytes	41	6	6
CACACCTTCTCGCATC-1_MS200_A303	6.852191847	-1.047814548	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	778	1156	0.131487889	0.012110727	10	12	EN-MIX	41	6	6
CACACTCAGTTAACGA-1_MS200_A303	15.3245503	-5.972296192	3	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1439	2460	0.003252033	0.003252033	10	3	EN-L5-6	41	6	6
CACACTCCACCCATGG-1_MS200_A303	5.43923599	-2.232299163	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	925	1357	0.108327192	0.005158438	10	12	EN-MIX	41	6	6
CACACTCCACTACAGT-1_MS200_A303	7.681099397	1.401636602	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	635	1091	0.302474794	0.007332722	10	16	EN-PYR	41	6	6
CACACTCCATTTCAGG-1_MS200_A303	13.63334901	-3.562429358	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1511	2476	0.012116317	0.004846527	10	12	EN-MIX	41	6	6
CACACTCGTAATCACC-1_MS200_A303	18.52716197	-21.74849878	3	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2796	5467	0.017194074	0.010974941	10	3	EN-L5-6	41	6	6
CACACTCGTACAGACG-1_MS200_A303	9.028279105	-11.39782102	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2009	3254	0.018438844	0.013214505	10	L2-3	EN-L2-3-MS	41	6	6
CACACTCGTGATAAAC-1_MS200_A303	32.42940795	16.45214018	14	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1354	1980	0.004545455	0.052020202	10	14	Microglia	41	6	6
CACACTCGTTAGGGTG-1_MS200_A303	-5.815308161	13.22618257	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	736	1009	0.008919722	0.026759167	10	oligos	OL-MS-1	41	6	6
CACACTCTCGAGAACG-1_MS200_A303	-15.01834638	-2.38142551	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2078	3604	0.012486127	0.014983352	10	13A	IN-VIP	41	6	6
CACACTCTCTGGCGAC-1_MS200_A303	-26.2805764	-23.10360621	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4119	9736	0.015406738	0.010682005	10	6A	IN-PV	41	6	6
CACAGGCAGGTGACCA-1_MS200_A303	17.65278349	-21.89243939	3	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5341	15742	0.005526617	0.011434379	10	3	EN-L5-6	41	6	6
CACAGGCAGTCCCACG-1_MS200_A303	-16.30717109	-2.593115413	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2971	6068	0.012689519	0.009723138	10	13A	IN-VIP	41	6	6
CACAGGCCAGACTCGC-1_MS200_A303	-6.765457855	13.52746176	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	827	1166	0.01457976	0.026586621	10	oligos	OL-MS-1	41	6	6
CACAGGCCAGTACACT-1_MS200_A303	9.707877443	-2.217081925	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1712	3196	0.181789737	0.005944931	10	12	EN-MIX	41	6	6
CACAGGCGTAAGGATT-1_MS200_A303	33.92641181	-12.5522851	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3577	7467	0.015936789	0.010579885	10	2	EN-L4	41	6	6
CACAGGCGTCTCAACA-1_MS200_A303	15.03636558	-17.48025943	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	7025	25870	0.015384615	0.008078856	10	L2-3	EN-L2-3-MS	41	6	6
CACAGGCGTTCACGGC-1_MS200_A303	-29.08116917	-5.591265327	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1080	1662	0.006016847	0.003610108	10	9	OPC	41	6	6
CACAGGCTCAGGCCCA-1_MS200_A303	34.02235401	-15.87931287	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4408	10515	0.009510223	0.014740846	10	2	EN-L4	41	6	6
CACAGGCTCAGGCGAA-1_MS200_A303	28.80380517	-19.07032144	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	10737	63176	0.0252311	0.013232873	10	2	EN-L4	41	6	6
CACAGTAAGTCAAGCG-1_MS200_A303	-28.15913854	-22.03340914	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4768	12861	0.052250991	0.006686883	10	6A	IN-PV	41	6	6
CACAGTACACACTGCG-1_MS200_A303	32.68660664	-13.50059662	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3308	6819	0.016278047	0.007479103	10	2	EN-L4	41	6	6
CACAGTACACTCTGTC-1_MS200_A303	-16.69188129	-3.870226451	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3078	6477	0.006638876	0.007410838	10	13A	IN-VIP	41	6	6
CACAGTAGTCCGAGTC-1_MS200_A303	-5.051220318	9.117788083	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	788	1040	0.003846154	0.033653846	10	oligos	OL-MS-1	41	6	6
CACAGTAGTTCACCTC-1_MS200_A303	-11.65901811	-36.6775888	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1223	1850	0.030810811	0.012972973	10	16	EN-PYR	41	6	6
CACAGTATCGAGGTAG-1_MS200_A303	-6.030627967	14.09183253	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	803	1096	0.005474453	0.023722628	10	oligos	OL-MS-1	41	6	6
CACATAGAGAAGGCCT-1_MS200_A303	-18.15905089	-1.167062791	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3137	6029	0.016752364	0.019737933	10	13A	IN-VIP	41	6	6
CACATAGAGACTGTAA-1_MS200_A303	-12.94952779	15.48596653	11	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1179	1667	0.0059988	0.01139772	10	11	Glia-MIX	41	6	6
CACATAGAGCTAGTTC-1_MS200_A303	-15.82192602	20.68510498	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1311	2018	0.010901883	0.010901883	10	8	Astrocytes	41	6	6
CACATAGAGGATCGCA-1_MS200_A303	-5.608375267	18.13870358	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	777	1022	0.003913894	0.018590998	10	oligos	OL-MS-1	41	6	6
CACATAGAGGTGATAT-1_MS200_A303	-14.66389565	24.26921945	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1797	3092	0.004527814	0.009379043	10	8	Astrocytes	41	6	6
CACATAGAGTCAAGCG-1_MS200_A303	24.74721626	-13.86569276	3	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4354	9956	0.027219767	0.008738449	10	3	EN-L5-6	41	6	6
CACATAGAGTTTGCGT-1_MS200_A303	14.16941445	-14.27293864	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4969	13155	0.021056632	0.005625238	10	L2-3	EN-L2-3-MS	41	6	6
CACATAGCACCTTGTC-1_MS200_A303	19.15274426	-26.79606514	3	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3063	7270	0.018569464	0.004401651	10	3	EN-L5-6	41	6	6
CACATAGCATTGCGGC-1_MS200_A303	21.7395937	-3.771310699	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2223	4238	0.080934403	0.004483247	10	2	EN-L4	41	6	6
CACATAGGTAGCGCAA-1_MS200_A303	-23.79369312	9.089670526	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1028	1547	0.003878474	0.011635423	10	8	Astrocytes	41	6	6
CACATAGGTCTCACCT-1_MS200_A303	14.26783632	-17.07950255	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	6084	18644	0.011960953	0.009279125	10	L2-3	EN-L2-3-MS	41	6	6
CACATAGTCAAAGACA-1_MS200_A303	-17.58296283	29.44471304	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3047	6074	0.003786632	0.011195258	10	8	Astrocytes	41	6	6
CACATAGTCATCGATG-1_MS200_A303	11.42928344	-1.732480337	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1100	1544	0.011010363	0.007124352	10	12	EN-MIX	41	6	6
CACATAGTCCTTAATC-1_MS200_A303	-1.824730271	10.55967354	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	952	1374	0.002911208	0.023289665	10	oligos	OL-MS-1	41	6	6
CACATAGTCGAACGGA-1_MS200_A303	15.56087159	-13.39959944	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4385	10082	0.018349534	0.017060107	10	L2-3	EN-L2-3-MS	41	6	6
CACATAGTCGAATCCA-1_MS200_A303	-16.77525246	-0.124302101	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3501	7206	0.013044685	0.010963086	10	13A	IN-VIP	41	6	6
CACATTTCAACAACCT-1_MS200_A303	-35.6595567	-9.48569287	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1081	1971	0.004058853	0.002029427	10	9	OPC	41	6	6
CACATTTCAATGCCAT-1_MS200_A303	-10.4209999	-16.25099399	6B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	996	1465	0.03003413	0.003412969	10	6B	IN-SST	41	6	6
CACATTTCATGATCCA-1_MS200_A303	1.70640997	10.66505063	1	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	916	1379	0.004350979	0.015228426	10	oligos	OL-Cntl	41	6	6
CACATTTGTCACCTAA-1_MS200_A303	6.534383744	13.76512698	1	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1249	2033	0.007378259	0.008362027	10	oligos	OL-Cntl	41	6	6
CACATTTGTTACGTCA-1_MS200_A303	-17.36373793	-1.660197169	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3097	6192	0.013242894	0.013242894	10	13A	IN-VIP	41	6	6
CACATTTTCGCCAAAT-1_MS200_A303	34.32270599	-15.31871145	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5034	13015	0.009373799	0.011064157	10	2	EN-L4	41	6	6
CACATTTTCGGCTTGG-1_MS200_A303	33.59166558	-11.71385891	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3202	6751	0.006665679	0.006665679	10	2	EN-L4	41	6	6
CACATTTTCTTTAGGG-1_MS200_A303	1.073104483	11.49251222	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	771	1106	0.001808318	0.014466546	10	oligos	OL-MS-1	41	6	6
CACCACTAGATGCCTT-1_MS200_A303	-26.82233801	-9.252404089	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	910	1247	0.008019246	0.003207698	10	9	OPC	41	6	6
CACCACTAGTTACCCA-1_MS200_A303	-20.64725178	6.484322657	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1412	2290	0.00349345	0.010480349	10	8	Astrocytes	41	6	6
CACCACTCACGCGAAA-1_MS200_A303	16.61014717	-14.05034687	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	6615	21081	0.024619325	0.006925668	10	L2-3	EN-L2-3-MS	41	6	6
CACCACTCACGTCAGC-1_MS200_A303	-14.60485926	-1.921184401	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2124	3790	0.006332454	0.013456464	10	13A	IN-VIP	41	6	6
CACCACTGTTTGACTG-1_MS200_A303	33.7757242	-14.08325038	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3365	6750	0.010518519	0.01037037	10	2	EN-L4	41	6	6
CACCACTTCGCCAGCA-1_MS200_A303	-5.750271287	-36.96987504	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	873	1180	0.05	0.023728814	10	16	EN-PYR	41	6	6
CACCAGGAGCTCAACT-1_MS200_A303	14.55936012	-12.53307023	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3514	7041	0.019599489	0.014202528	10	L2-3	EN-L2-3-MS	41	6	6
CACCAGGCAGACACTT-1_MS200_A303	-15.72191242	-2.019770754	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2986	6109	0.012113275	0.006875102	10	13A	IN-VIP	41	6	6
CACCAGGGTAAATGTG-1_MS200_A303	0.663675637	12.14657407	1	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	930	1388	0.005763689	0.011527378	10	oligos	OL-Cntl	41	6	6
CACCAGGGTTGATTGC-1_MS200_A303	4.728182928	-2.114502501	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	766	1052	0.05513308	0.007604563	10	12	EN-MIX	41	6	6
CACCTTGAGAAACGCC-1_MS200_A303	-22.77279775	6.527769563	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	970	1460	0.015753425	0.01369863	10	8	Astrocytes	41	6	6
CACCTTGAGCATGGCA-1_MS200_A303	34.04425678	-13.80352924	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3141	6085	0.009202958	0.013640099	10	2	EN-L4	41	6	6
CACCTTGAGTTAGGTA-1_MS200_A303	-32.31268795	-7.619650837	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1084	1569	0.003186743	0.007648184	10	9	OPC	41	6	6
CACCTTGTCAAAGTAG-1_MS200_A303	-30.08383113	-2.115381921	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1486	2340	0.002136752	0.008547009	10	9	OPC	41	6	6
CACCTTGTCCGTCATC-1_MS200_A303	-8.99718139	-36.31298831	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1092	1572	0.078244275	0.013358779	10	16	EN-PYR	41	6	6
CACCTTGTCGTTACAG-1_MS200_A303	-25.04037547	-23.20182664	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4367	12082	0.091541136	0.002896871	10	6A	IN-PV	41	6	6
CACCTTGTCGTTGCCT-1_MS200_A303	21.84636376	-15.78611995	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4070	9072	0.014770723	0.032407407	10	2	EN-L4	41	6	6
CACCTTGTCTTGGGTA-1_MS200_A303	-0.388444301	-0.498532815	11	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1529	2728	0.131231672	0.010997067	10	11	Glia-MIX	41	6	6
CACTCCAAGAGCAATT-1_MS200_A303	-26.22543048	-18.21984421	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3425	7178	0.034550014	0.009334076	10	6A	IN-PV	41	6	6
CACTCCAAGGAACTGC-1_MS200_A303	-14.70361271	24.6451567	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1878	3351	0.002387347	0.008654133	10	8	Astrocytes	41	6	6
CACTCCACAAATCCGT-1_MS200_A303	-17.45660847	-5.900517629	13B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2148	3533	0.010472686	0.009623549	10	13B	IN-SV2C	41	6	6
CACTCCACAATGGACG-1_MS200_A303	-30.05216625	-11.43621796	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	861	1188	0.01010101	0.007575758	10	9	OPC	41	6	6
CACTCCAGTCCGACGT-1_MS200_A303	-23.75249019	9.351442018	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	890	1302	0.002304147	0.009984639	10	8	Astrocytes	41	6	6
CACTCCATCACGGTTA-1_MS200_A303	-30.46702194	-2.284619317	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1539	2632	0.004179331	0.002279635	10	9	OPC	41	6	6
CACTCCATCAGTACGT-1_MS200_A303	-12.55525909	0.699028652	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3399	7773	0.003087611	0.005917921	10	13A	IN-VIP	41	6	6
CACTCCATCTTGGGTA-1_MS200_A303	-15.89578848	20.25349793	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1226	1915	0.002610966	0.007832898	10	8	Astrocytes	41	6	6
CAGAATCCACCTATCC-1_MS200_A303	13.74924615	-20.57112455	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	8050	31828	0.010211135	0.006912153	10	L2-3	EN-L2-3-MS	41	6	6
CAGAATCGTACCGGCT-1_MS200_A303	10.96393846	-13.30218484	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3296	7257	0.012126223	0.015433375	10	L2-3	EN-L2-3-MS	41	6	6
CAGAATCGTGCACCAC-1_MS200_A303	21.84863086	-15.88069612	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5145	13071	0.01285288	0.031367149	10	2	EN-L4	41	6	6
CAGAGAGAGCGTAATA-1_MS200_A303	-14.04589323	22.39289323	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1433	2301	0.00956106	0.014341591	10	8	Astrocytes	41	6	6
CAGAGAGAGGTGATTA-1_MS200_A303	-8.523682706	-37.58709808	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1070	1456	0.048076923	0.019230769	10	16	EN-PYR	41	6	6
CAGAGAGCAAACGTGG-1_MS200_A303	11.03883781	-22.41479609	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4526	11831	0.007860705	0.004817851	10	L2-3	EN-L2-3-MS	41	6	6
CAGAGAGCAAGCCGTC-1_MS200_A303	-9.912593406	-6.214891221	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1606	2241	0.008032129	0.016064257	10	13A	IN-VIP	41	6	6
CAGAGAGCAAGTTCTG-1_MS200_A303	-5.512278651	14.84408937	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	763	1092	0.006410256	0.026556777	10	oligos	OL-MS-1	41	6	6
CAGAGAGCACATTAGC-1_MS200_A303	-5.599017536	13.80809521	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	834	1166	0.004288165	0.023156089	10	oligos	OL-MS-1	41	6	6
CAGAGAGCACCGATAT-1_MS200_A303	16.27275279	-14.35172889	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	6531	21623	0.028441937	0.007908246	10	L2-3	EN-L2-3-MS	41	6	6
CAGAGAGCACTGCCAG-1_MS200_A303	34.32487386	13.27775139	14	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1348	1801	0.005552471	0.02276513	10	14	Microglia	41	6	6
CAGAGAGCAGTGGAGT-1_MS200_A303	11.37630584	-2.710631401	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1706	3095	0.150242326	0.002261712	10	12	EN-MIX	41	6	6
CAGAGAGCATAAAGGT-1_MS200_A303	-30.60235723	-21.63393684	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5602	14502	0.031995587	0.016549441	10	6A	IN-PV	41	6	6
CAGAGAGGTCTCATCC-1_MS200_A303	15.68316508	-17.73287958	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	6354	21780	0.016115702	0.003673095	10	L2-3	EN-L2-3-MS	41	6	6
CAGAGAGTCAGTGCAT-1_MS200_A303	-28.67039564	-6.860571329	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	942	1343	0.005956813	0.005212211	10	9	OPC	41	6	6
CAGAGAGTCGCATGAT-1_MS200_A303	10.91869466	-15.36266887	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2994	5957	0.020144368	0.007386268	10	L2-3	EN-L2-3-MS	41	6	6
CAGATCACAAACGCGA-1_MS200_A303	-31.63545554	-6.097567651	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1220	1885	0.00530504	0.006366048	10	9	OPC	41	6	6
CAGATCACAGGGAGAG-1_MS200_A303	31.92124148	-16.46205046	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3967	8859	0.032960831	0.014900102	10	2	EN-L4	41	6	6
CAGATCACATACGCCG-1_MS200_A303	2.320354464	10.53770725	1	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1106	1738	0.009781358	0.009781358	10	oligos	OL-Cntl	41	6	6
CAGATCAGTAATCGTC-1_MS200_A303	28.42792588	-18.22589486	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5483	16670	0.068866227	0.007858428	10	2	EN-L4	41	6	6
CAGATCATCAGCTTAG-1_MS200_A303	15.19357312	-14.84463558	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	6946	23394	0.010771993	0.008164487	10	L2-3	EN-L2-3-MS	41	6	6
CAGATCATCATGTCCC-1_MS200_A303	-22.64624387	-17.27970192	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3871	10019	0.002595069	0.007785208	10	6A	IN-PV	41	6	6
CAGATCATCCCTTGTG-1_MS200_A303	-31.37736571	-6.613898764	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1071	1570	0.003184713	0.005095541	10	9	OPC	41	6	6
CAGATCATCTCAAGTG-1_MS200_A303	8.51061218	-11.85039411	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2707	5250	0.01447619	0.007428571	10	L2-3	EN-L2-3-MS	41	6	6
CAGCAGCAGACTAGAT-1_MS200_A303	-17.58422976	-20.57302809	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1950	3765	0.041168659	0.004780876	10	6A	IN-PV	41	6	6
CAGCAGCAGATGTTAG-1_MS200_A303	-14.92009133	22.16463395	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1452	2360	0.002966102	0.013559322	10	8	Astrocytes	41	6	6
CAGCAGCCACAGACAG-1_MS200_A303	-30.11679566	-3.66612209	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1312	2216	0.00767148	0.007220217	10	9	OPC	41	6	6
CAGCAGCCAGGACGTA-1_MS200_A303	-28.37614071	-4.790817074	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1285	1941	0.007727975	0.011849562	10	9	OPC	41	6	6
CAGCAGCCAGTCTTCC-1_MS200_A303	-32.66553227	-8.132753362	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1161	1752	0.001141553	0.002283105	10	9	OPC	41	6	6
CAGCAGCCATGCATGT-1_MS200_A303	-10.12018637	-36.7328062	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1152	1654	0.048367594	0.016928658	10	16	EN-PYR	41	6	6
CAGCAGCGTGAGTGAC-1_MS200_A303	-15.26515813	-37.39972221	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3221	7765	0.119381842	0.012234385	10	16	EN-PYR	41	6	6
CAGCAGCGTTCCTCCA-1_MS200_A303	-12.37839644	17.43913358	11	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1823	2839	0.003874604	0.012680521	10	11	Glia-MIX	41	6	6
CAGCAGCTCACAGTAC-1_MS200_A303	10.97368512	-18.72121774	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5383	15531	0.00534415	0.005215376	10	L2-3	EN-L2-3-MS	41	6	6
CAGCAGCTCCTAGTGA-1_MS200_A303	-14.47057609	24.3670947	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1775	2915	0.002744425	0.013379074	10	8	Astrocytes	41	6	6
CAGCAGCTCCTCAACC-1_MS200_A303	1.392505923	10.67235485	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	988	1427	0.010511563	0.005606167	10	oligos	OL-MS-1	41	6	6
CAGCATAAGGCATGGT-1_MS200_A303	3.623330613	-2.708436796	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	732	1021	0.05582762	0.008814887	10	12	EN-MIX	41	6	6
CAGCATACACAGCCCA-1_MS200_A303	32.64289266	12.13846177	14	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1010	1371	0.005835157	0.023340627	10	14	Microglia	41	6	6
CAGCATAGTCTAGCGC-1_MS200_A303	15.24256647	-13.27126235	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5057	12540	0.021132376	0.014673046	10	L2-3	EN-L2-3-MS	41	6	6
CAGCATAGTCTTGATG-1_MS200_A303	-16.92999573	-10.09869274	13B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3326	7672	0.002085506	0.003649635	10	13B	IN-SV2C	41	6	6
CAGCATATCTCCAGGG-1_MS200_A303	4.698600214	-14.21554998	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2587	5598	0.031975706	0.005001786	10	L2-3	EN-L2-3-MS	41	6	6
CAGCCGAAGCGCCTTG-1_MS200_A303	-17.41322496	-1.644986872	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2942	5428	0.009948416	0.010132646	10	13A	IN-VIP	41	6	6
CAGCCGAAGTGCTGCC-1_MS200_A303	-5.964607173	-36.21087507	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	980	1310	0.070992366	0.019847328	10	16	EN-PYR	41	6	6
CAGCCGACACCACCAG-1_MS200_A303	33.95592469	10.91007883	14	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	864	1212	0.018976898	0.024752475	10	14	Microglia	41	6	6
CAGCCGAGTACTTGAC-1_MS200_A303	9.550684603	-1.500346099	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1458	2399	0.010837849	0.010421009	10	12	EN-MIX	41	6	6
CAGCCGAGTAGGCATG-1_MS200_A303	-15.52648447	21.84773619	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1585	2496	0.005208333	0.006810897	10	8	Astrocytes	41	6	6
CAGCCGAGTTTAGGAA-1_MS200_A303	21.0750011	-12.64797503	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2449	4485	0.024749164	0.009364548	10	12	EN-MIX	41	6	6
CAGCCGATCAACTCTT-1_MS200_A303	-23.44453579	9.29323584	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1110	1635	0.015902141	0.012232416	10	8	Astrocytes	41	6	6
CAGCCGATCCCTTGTG-1_MS200_A303	24.82556242	-16.57741863	3	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	6110	19284	0.021261149	0.009126737	10	3	EN-L5-6	41	6	6
CAGCGACAGAAGGACA-1_MS200_A303	12.8023569	-15.47318428	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4563	11436	0.015739769	0.007082896	10	L2-3	EN-L2-3-MS	41	6	6
CAGCGACAGAGTACCG-1_MS200_A303	-29.61324915	-7.952577789	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1188	1672	0.007177033	0.01076555	10	9	OPC	41	6	6
CAGCGACAGCCACCTG-1_MS200_A303	28.96238011	-17.88695111	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	7041	25611	0.047401507	0.006950139	10	2	EN-L4	41	6	6
CAGCGACAGTATCTCG-1_MS200_A303	21.41627633	-2.828516155	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2093	3448	0.011890951	0.011310905	10	2	EN-L4	41	6	6
CAGCGACCAAGCTGTT-1_MS200_A303	-14.17391697	23.40302324	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1647	2851	0.002806033	0.016485444	10	8	Astrocytes	41	6	6
CAGCGACCAAGGTTTC-1_MS200_A303	-20.34818805	-4.880151259	13B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3776	8020	0.008354115	0.013591022	10	13B	IN-SV2C	41	6	6
CAGCGACCAATAGCGG-1_MS200_A303	33.66247793	-18.39195076	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4365	9466	0.015529263	0.017219523	10	2	EN-L4	41	6	6
CAGCGACGTAGCCTCG-1_MS200_A303	-20.55785841	-4.272412737	13B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4208	9209	0.024866978	0.011619068	10	13B	IN-SV2C	41	6	6
CAGCGACGTGCCTGGT-1_MS200_A303	-19.48846865	-2.098652375	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3658	7506	0.019717559	0.008926192	10	13A	IN-VIP	41	6	6
CAGCGACGTTGCTCCT-1_MS200_A303	-26.09371325	-21.66828345	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3480	7395	0.007707911	0.013793103	10	6A	IN-PV	41	6	6
CAGCGACTCCCTAACC-1_MS200_A303	-11.59976806	12.31733104	17	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	950	1252	0.007188498	0.023162939	10	oligos	OL-MS-2	41	6	6
CAGCTAAAGATGGGTC-1_MS200_A303	11.88349714	-12.25790486	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3012	5541	0.018047284	0.022378632	10	L2-3	EN-L2-3-MS	41	6	6
CAGCTAAAGTATCTCG-1_MS200_A303	-6.80413732	-10.3527832	13B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1211	1861	0.001074691	0.003761419	10	13B	IN-SV2C	41	6	6
CAGCTAACAATAAGCA-1_MS200_A303	-0.109925228	29.20908261	1	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	905	1359	0.002207506	0.010301692	10	oligos	OL-Cntl	41	6	6
CAGCTAACAATTGCTG-1_MS200_A303	-5.399484606	14.4300953	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	715	1002	0.00499002	0.020958084	10	oligos	OL-MS-1	41	6	6
CAGCTAACACTTCTGC-1_MS200_A303	-9.311096899	-15.75993099	6B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	834	1183	0.015215554	0.012679628	10	6B	IN-SST	41	6	6
CAGCTAACAGTGGGAT-1_MS200_A303	-23.97743332	9.983103216	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1145	1800	0.006666667	0.01	10	8	Astrocytes	41	6	6
CAGCTAACATCCGCGA-1_MS200_A303	-15.31790347	25.05196228	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1917	3398	0.003531489	0.012360212	10	8	Astrocytes	41	6	6
CAGCTAAGTGTGAAAT-1_MS200_A303	-4.650894509	-32.9983149	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	747	1046	0.130975143	0.009560229	10	16	EN-PYR	41	6	6
CAGCTAATCATGTCTT-1_MS200_A303	34.19213477	-17.71382449	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5372	13575	0.011049724	0.014290976	10	2	EN-L4	41	6	6
CAGCTAATCCAGGGCT-1_MS200_A303	-14.17847412	-9.180277264	13B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1984	3409	0.005280141	0.004106776	10	13B	IN-SV2C	41	6	6
CAGCTGGAGTCTCAAC-1_MS200_A303	-14.57376541	24.4320152	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1724	2884	0.003814147	0.013869626	10	8	Astrocytes	41	6	6
CAGCTGGAGTGACTCT-1_MS200_A303	6.710705265	-27.07587672	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5213	13562	0.00339183	0.006414983	10	L2-3	EN-L2-3-MS	41	6	6
CAGCTGGCAATCAGAA-1_MS200_A303	-16.9154969	-1.139314195	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3179	6596	0.00667071	0.021831413	10	13A	IN-VIP	41	6	6
CAGCTGGCAATGGAGC-1_MS200_A303	-5.849295489	-37.27783898	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	911	1206	0.058043118	0.018242123	10	16	EN-PYR	41	6	6
CAGCTGGCACGGCCAT-1_MS200_A303	-26.6113587	-21.09522637	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3247	6991	0.032899442	0.004577314	10	6A	IN-PV	41	6	6
CAGCTGGCAGATTGCT-1_MS200_A303	10.19953924	-16.73527887	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4332	10830	0.007202216	0.00757156	10	L2-3	EN-L2-3-MS	41	6	6
CAGCTGGCATCACGAT-1_MS200_A303	-17.53607658	-0.443610688	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3295	6778	0.008557096	0.018589554	10	13A	IN-VIP	41	6	6
CAGCTGGCATCGATTG-1_MS200_A303	-29.64177467	-4.41024922	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1346	2144	0.00233209	0.007929104	10	9	OPC	41	6	6
CAGCTGGGTCCAACTA-1_MS200_A303	-5.561052588	15.02734162	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	848	1208	0.005794702	0.025662252	10	oligos	OL-MS-1	41	6	6
CAGCTGGTCCCATTAT-1_MS200_A303	-27.88618808	-3.884566224	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1464	2434	0.005751849	0.005341002	10	9	OPC	41	6	6
CAGCTGGTCGTCTGCT-1_MS200_A303	-9.186067034	27.33274135	17	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1177	1720	0.034883721	0.009302326	10	oligos	OL-MS-2	41	6	6
CAGGTGCAGAACTCGG-1_MS200_A303	10.26548652	1.119930232	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	879	1234	0.088330632	0.009724473	10	12	EN-MIX	41	6	6
CAGGTGCAGGACATTA-1_MS200_A303	-15.2467625	20.90586767	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1353	2288	0.013986014	0.012674825	10	8	Astrocytes	41	6	6
CAGGTGCAGGGCTCTC-1_MS200_A303	-8.66747182	-15.16997465	6B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	722	1014	0.071005917	0.00591716	10	6B	IN-SST	41	6	6
CAGGTGCCATTGGGCC-1_MS200_A303	33.9391388	-12.55154166	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4133	9286	0.006030584	0.007107474	10	2	EN-L4	41	6	6
CAGGTGCTCGAATCCA-1_MS200_A303	13.13456366	-14.15889959	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4585	10743	0.01275249	0.009122219	10	L2-3	EN-L2-3-MS	41	6	6
CAGTAACAGAACAATC-1_MS200_A303	-12.97621686	-36.83878075	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1617	2638	0.094389689	0.014783927	10	16	EN-PYR	41	6	6
CAGTAACAGACTTTCG-1_MS200_A303	20.62041064	-3.981428817	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2116	3489	0.023502436	0.010604758	10	2	EN-L4	41	6	6
CAGTAACAGTTTGCGT-1_MS200_A303	-14.48823067	23.6658338	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1783	2896	0.008977901	0.011395028	10	8	Astrocytes	41	6	6
CAGTAACCAATTCCTT-1_MS200_A303	-19.78650921	-1.830339661	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5034	12450	0.014859438	0.009477912	10	13A	IN-VIP	41	6	6
CAGTAACCACTGAAGG-1_MS200_A303	-26.7470143	-22.66561623	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4755	12697	0.051823265	0.005198078	10	6A	IN-PV	41	6	6
CAGTAACTCAATCACG-1_MS200_A303	34.63759374	10.90054413	14	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	834	1083	0.002770083	0.012003693	10	14	Microglia	41	6	6
CAGTAACTCCAAAGTC-1_MS200_A303	-5.760508327	13.88613784	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	733	1020	0.010784314	0.014705882	10	oligos	OL-MS-1	41	6	6
CAGTCCTCACCGCTAG-1_MS200_A303	29.0477605	-18.68199739	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	9254	47756	0.035011307	0.01130748	10	2	EN-L4	41	6	6
CAGTCCTCATTCACTT-1_MS200_A303	-23.00361729	-24.09589573	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3410	8549	0.036495497	0.002807346	10	6A	IN-PV	41	6	6
CATATGGCAGACTCGC-1_MS200_A303	-12.97357442	-36.92637665	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1751	2977	0.113537118	0.013100437	10	16	EN-PYR	41	6	6
CATATGGCAGTTTACG-1_MS200_A303	21.90698649	-15.78246148	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4611	11221	0.015506639	0.017289012	10	2	EN-L4	41	6	6
CATATGGGTACCAGTT-1_MS200_A303	-20.40291111	-5.358244482	13B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4514	10950	0.012876712	0.012968037	10	13B	IN-SV2C	41	6	6
CATATGGTCATCTGCC-1_MS200_A303	-12.1311729	-2.814696264	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2613	5330	0.015009381	0.010506567	10	13A	IN-VIP	41	6	6
CATATGGTCATGTAGC-1_MS200_A303	25.35847804	-15.23176402	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5767	14848	0.020810884	0.009294181	10	2	EN-L4	41	6	6
CATATGGTCGTGGGAA-1_MS200_A303	31.85797221	-15.21531417	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2463	4039	0.017826195	0.014855162	10	2	EN-L4	41	6	6
CATATTCCAATCAGAA-1_MS200_A303	-15.47864304	23.55930772	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1501	2556	0.005086072	0.009389671	10	8	Astrocytes	41	6	6
CATATTCCAATGGTCT-1_MS200_A303	5.031281508	-9.044451154	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1261	1919	0.040125065	0.007816571	10	12	EN-MIX	41	6	6
CATATTCCAGGTTTCA-1_MS200_A303	13.25885892	-2.4227725	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1056	1608	0.016169154	0.004353234	10	12	EN-MIX	41	6	6
CATATTCCATGTTCCC-1_MS200_A303	16.33290866	-18.06227473	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	6488	23434	0.015106256	0.006187591	10	L2-3	EN-L2-3-MS	41	6	6
CATATTCGTAAGTGGC-1_MS200_A303	-19.92399627	-3.593308468	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3530	7353	0.018903849	0.014143887	10	13A	IN-VIP	41	6	6
CATATTCGTCTTTCAT-1_MS200_A303	9.680401579	-2.436778236	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1330	1967	0.057956279	0.01270971	10	12	EN-MIX	41	6	6
CATATTCTCAAACAAG-1_MS200_A303	-19.55303318	-5.525842371	13B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3844	8479	0.006722491	0.011204151	10	13B	IN-SV2C	41	6	6
CATATTCTCCGCTGTT-1_MS200_A303	-26.80432913	3.946246695	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3343	6654	0.005560565	0.006462278	10	9	OPC	41	6	6
CATCAAGAGTTAAGTG-1_MS200_A303	-11.36707328	-15.297091	6B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1185	1855	0.079245283	0.006469003	10	6B	IN-SST	41	6	6
CATCAAGCACAGACTT-1_MS200_A303	-24.30509251	7.16540651	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	896	1399	0.012866333	0.010721944	10	8	Astrocytes	41	6	6
CATCAAGTCCACGAAT-1_MS200_A303	18.68325238	-19.1352729	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3502	8530	0.050644783	0.006799531	10	L2-3	EN-L2-3-MS	41	6	6
CATCAAGTCTCTAGGA-1_MS200_A303	14.63354407	-20.99656806	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	6685	21915	0.005110655	0.011179557	10	L2-3	EN-L2-3-MS	41	6	6
CATCAGAAGAGGTTGC-1_MS200_A303	-18.1299698	-1.173690414	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3083	5975	0.009874477	0.017238494	10	13A	IN-VIP	41	6	6
CATCAGAAGGACACCA-1_MS200_A303	13.960505	-17.07825415	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	6074	17587	0.008017285	0.010746574	10	L2-3	EN-L2-3-MS	41	6	6
CATCAGAAGGAGTACC-1_MS200_A303	-9.867223604	-38.67430295	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1203	1696	0.051886792	0.017099057	10	16	EN-PYR	41	6	6
CATCAGAAGGTGCTAG-1_MS200_A303	-14.65284201	21.43372114	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1174	1718	0.003492433	0.011641444	10	8	Astrocytes	41	6	6
CATCAGAAGTCGTACT-1_MS200_A303	-16.01114012	12.64726444	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1513	2642	0.001514005	0.007191522	10	8	Astrocytes	41	6	6
CATCAGACAGTACACT-1_MS200_A303	-30.54234642	-21.6743406	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5962	16829	0.023887337	0.016043734	10	6A	IN-PV	41	6	6
CATCAGACATCGGTTA-1_MS200_A303	-29.50900689	-4.633183762	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1400	2218	0.006311993	0.008566276	10	9	OPC	41	6	6
CATCAGACATTACCTT-1_MS200_A303	-8.791783285	-13.80358691	6B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	786	1004	0.028884462	0.005976096	10	6B	IN-SST	41	6	6
CATCAGATCTGCTGTC-1_MS200_A303	-14.02447776	24.08924758	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1798	2972	0.006393001	0.019515478	10	8	Astrocytes	41	6	6
CATCCACAGTTCGCAT-1_MS200_A303	-20.13649889	-5.3270559	13B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4266	10049	0.012140511	0.01084685	10	13B	IN-SV2C	41	6	6
CATCCACGTACCATCA-1_MS200_A303	5.886051842	0.960994573	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	997	1428	0.099439776	0.006302521	10	16	EN-PYR	41	6	6
CATCCACGTCAAGCGA-1_MS200_A303	-2.914935505	18.76772381	1	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	843	1239	0.008878128	0.007263923	10	oligos	OL-Cntl	41	6	6
CATCCACGTGGTAACG-1_MS200_A303	-17.795197	-0.635554498	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3389	7035	0.017768301	0.017768301	10	13A	IN-VIP	41	6	6
CATCCACTCAGAGCTT-1_MS200_A303	-10.90929654	-8.397505758	13B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1600	2607	0.008438819	0.004986575	10	13B	IN-SV2C	41	6	6
CATCCACTCGCCAAAT-1_MS200_A303	13.57640371	-15.04591663	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5024	14216	0.023283624	0.005135059	10	L2-3	EN-L2-3-MS	41	6	6
CATCGAAAGCGATGAC-1_MS200_A303	33.79570179	-16.38174668	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4011	8984	0.022707035	0.012689225	10	2	EN-L4	41	6	6
CATCGAACATGTCTCC-1_MS200_A303	-25.26342234	8.440690153	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	824	1139	0.006145742	0.007901668	10	8	Astrocytes	41	6	6
CATCGAAGTAGCCTAT-1_MS200_A303	9.822804663	-2.156426566	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1796	3311	0.180610088	0.006040471	10	12	EN-MIX	41	6	6
CATCGGGAGCGATATA-1_MS200_A303	-24.83157996	-19.6421813	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3446	6714	0.019064641	0.00893655	10	6A	IN-PV	41	6	6
CATCGGGCAAACGTGG-1_MS200_A303	-14.18534602	22.00702705	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1405	2159	0.005558129	0.022232515	10	8	Astrocytes	41	6	6
CATCGGGCACTTAACG-1_MS200_A303	19.11277314	-20.56279252	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4983	14256	0.019430415	0.00701459	10	L2-3	EN-L2-3-MS	41	6	6
CATCGGGGTGCGATAG-1_MS200_A303	29.23931382	6.315043024	15A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1107	1443	0.022176022	0.028413028	10	15A	Endo cells	41	6	6
CATCGGGTCAACCATG-1_MS200_A303	7.655722877	-13.71236293	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2355	4300	0.01627907	0.006046512	10	L2-3	EN-L2-3-MS	41	6	6
CATCGGGTCTTAACCT-1_MS200_A303	24.51117402	-13.18255863	3	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4066	9399	0.007660389	0.009575487	10	3	EN-L5-6	41	6	6
CATCGGGTCTTCTGGC-1_MS200_A303	32.67333203	-6.896810952	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4996	14432	0.00152439	0.004711752	10	2	EN-L4	41	6	6
CATGACAAGAGGGATA-1_MS200_A303	-17.0414696	20.21098885	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1581	2476	0.002423263	0.011308562	10	8	Astrocytes	41	6	6
CATGACAGTAGGCTGA-1_MS200_A303	-29.37117772	-5.308777436	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1172	1799	0.007226237	0.004446915	10	9	OPC	41	6	6
CATGACAGTCAGATAA-1_MS200_A303	-5.349315348	14.35746301	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	748	1036	0.001930502	0.027027027	10	oligos	OL-MS-1	41	6	6
CATGACAGTCGGCACT-1_MS200_A303	-19.0600263	-1.02866193	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3920	8046	0.013547104	0.018891375	10	13A	IN-VIP	41	6	6
CATGACAGTGACGGTA-1_MS200_A303	-26.26692447	-10.87765655	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1386	1930	0.006217617	0.015025907	10	9	OPC	41	6	6
CATGACATCTCGATGA-1_MS200_A303	34.10030342	-8.692292399	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5125	13862	0.0041841	0.012263743	10	2	EN-L4	41	6	6
CATGCCTAGTGCTGCC-1_MS200_A303	-6.681133192	-35.88295747	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1025	1346	0.049777117	0.014115899	10	16	EN-PYR	41	6	6
CATGCCTCAAACTGTC-1_MS200_A303	-32.10601794	-5.197035282	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1490	2435	0.005749487	0.008213552	10	9	OPC	41	6	6
CATGCCTCAGCTGGCT-1_MS200_A303	-11.89804797	-27.40334667	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1082	1466	0.055252387	0.023874488	10	16	EN-PYR	41	6	6
CATGCCTGTTAGTGGG-1_MS200_A303	-31.0436517	-8.122695452	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	984	1472	0.007472826	0.007472826	10	9	OPC	41	6	6
CATGCCTTCTCCGGTT-1_MS200_A303	-18.37927799	-2.147061519	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3747	8012	0.013729406	0.010109835	10	13A	IN-VIP	41	6	6
CATGGCGAGTGTGAAT-1_MS200_A303	13.02174332	-15.07761567	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4358	10210	0.011851126	0.008521058	10	L2-3	EN-L2-3-MS	41	6	6
CATGGCGCACTTAACG-1_MS200_A303	-14.03832013	-0.482148703	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3122	6789	0.006186478	0.011047282	10	13A	IN-VIP	41	6	6
CATGGCGCAGACACTT-1_MS200_A303	20.76065827	-2.21879387	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1802	3030	0.012541254	0.003630363	10	2	EN-L4	41	6	6
CATGGCGCAGACGCCT-1_MS200_A303	-22.83473042	-24.40145848	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3100	6848	0.010075935	0.008031542	10	6A	IN-PV	41	6	6
CATGGCGCATGACGGA-1_MS200_A303	-14.54465444	24.22232066	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1691	2824	0.002832861	0.012747875	10	8	Astrocytes	41	6	6
CATGGCGGTCCATCCT-1_MS200_A303	-30.83778185	-5.612418338	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1283	2003	0.00449326	0.007488767	10	9	OPC	41	6	6
CATGGCGGTTCGTTGA-1_MS200_A303	-8.319795625	-5.886135277	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1547	2474	0.019805982	0.008084074	10	13A	IN-VIP	41	6	6
CATGGCGGTTGAGTTC-1_MS200_A303	8.389915502	-1.618287985	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1255	2103	0.164051355	0.004279601	10	12	EN-MIX	41	6	6
CATGGCGTCGTCACGG-1_MS200_A303	14.31257107	1.745223487	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	941	1378	0.103047896	0.005079826	10	12	EN-MIX	41	6	6
CATTATCAGCGTGAAC-1_MS200_A303	-15.76262721	20.19961497	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1415	2199	0.004092769	0.013187813	10	8	Astrocytes	41	6	6
CATTATCAGGAACTGC-1_MS200_A303	34.69322405	10.68416915	14	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	830	1085	0.003686636	0.023041475	10	14	Microglia	41	6	6
CATTATCAGGTGTGGT-1_MS200_A303	-13.99045207	23.99640442	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1834	3087	0.005506965	0.013929381	10	8	Astrocytes	41	6	6
CATTATCAGTCTCCTC-1_MS200_A303	-6.946921583	-34.91386503	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	859	1167	0.067694944	0.011996572	10	16	EN-PYR	41	6	6
CATTATCCAGCGAACA-1_MS200_A303	-22.17674795	7.0280584	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1400	2030	0.007389163	0.014778325	10	8	Astrocytes	41	6	6
CATTATCCAGTACACT-1_MS200_A303	-18.24743397	-6.25252288	13B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3392	7179	0.014625992	0.006128987	10	13B	IN-SV2C	41	6	6
CATTATCTCCGTCAAA-1_MS200_A303	-27.49541528	-22.73891845	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5762	17916	0.027573119	0.006251395	10	6A	IN-PV	41	6	6
CATTCGCAGTGACATA-1_MS200_A303	14.13717481	-4.783840674	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1914	3488	0.047305046	0.010034404	10	12	EN-MIX	41	6	6
CATTCGCCAACACCCG-1_MS200_A303	-15.51869348	23.40444661	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1466	2316	0.002158895	0.009067358	10	8	Astrocytes	41	6	6
CATTCGCCAAGCGCTC-1_MS200_A303	-28.9523973	-6.688357388	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1057	1552	0.003865979	0.003221649	10	9	OPC	41	6	6
CATTCGCCACATCCAA-1_MS200_A303	-31.2379982	-8.23361206	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	960	1501	0.00266489	0.007328448	10	9	OPC	41	6	6
CATTCGCCATATGCTG-1_MS200_A303	-29.69349553	-22.04460814	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4745	11777	0.01944468	0.016982254	10	6A	IN-PV	41	6	6
CATTCGCGTGCACTTA-1_MS200_A303	-16.21458188	22.28485171	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1175	1865	0.014477212	0.010723861	10	8	Astrocytes	41	6	6
CATTCGCTCAAACCGT-1_MS200_A303	-5.754471466	15.60147682	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	877	1280	0.00859375	0.01640625	10	oligos	OL-MS-1	41	6	6
CATTCGCTCACGCATA-1_MS200_A303	-15.32522712	20.57634456	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1140	1637	0.003054368	0.010995724	10	8	Astrocytes	41	6	6
CATTCGCTCTCTGCTG-1_MS200_A303	33.68152897	-14.525466	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3639	7679	0.013803881	0.005990363	10	2	EN-L4	41	6	6
CCAATCCCAGCCTGTG-1_MS200_A303	23.0255774	-15.93315802	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5636	16485	0.017167122	0.030755232	10	2	EN-L4	41	6	6
CCAATCCCATGCCACG-1_MS200_A303	-8.014306837	-10.68621884	6B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	829	1207	0.118475559	0.009942005	10	6B	IN-SST	41	6	6
CCAATCCGTAAGCACG-1_MS200_A303	-29.12998748	-4.874380566	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1396	2131	0.007038949	0.005161896	10	9	OPC	41	6	6
CCAATCCGTAGGGTAC-1_MS200_A303	-20.54904686	6.586683418	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1039	1682	0.007134364	0.008323424	10	8	Astrocytes	41	6	6
CCAATCCGTGTAACGG-1_MS200_A303	18.36257603	-20.4225639	3	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2836	6445	0.058184639	0.004189294	10	3	EN-L5-6	41	6	6
CCAATCCTCAACGGGA-1_MS200_A303	16.51774418	-16.80427992	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	8128	33719	0.016311279	0.006554168	10	L2-3	EN-L2-3-MS	41	6	6
CCAATCCTCCGTAGGC-1_MS200_A303	-16.90762344	20.39474842	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1196	1954	0.003582395	0.012794268	10	8	Astrocytes	41	6	6
CCAATCCTCCTTCAAT-1_MS200_A303	-30.26131274	-2.362361941	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1673	3007	0.002660459	0.004655803	10	9	OPC	41	6	6
CCAATCCTCTGGTATG-1_MS200_A303	-27.53705691	-12.46603886	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	834	1162	0.006024096	0.020654045	10	9	OPC	41	6	6
CCACCTAAGAACAACT-1_MS200_A303	10.81222968	-19.75170975	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4952	14918	0.007373643	0.006569245	10	L2-3	EN-L2-3-MS	41	6	6
CCACCTAAGAAGGTTT-1_MS200_A303	-11.25223572	22.69400118	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1927	3296	0.002427184	0.010315534	10	8	Astrocytes	41	6	6
CCACCTAGTAGCGCTC-1_MS200_A303	15.33307105	-13.71191401	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5982	18088	0.016640867	0.00818222	10	L2-3	EN-L2-3-MS	41	6	6
CCACCTAGTGTTAAGA-1_MS200_A303	-30.75004231	-21.61394649	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	8052	33193	0.047600398	0.012683397	10	6A	IN-PV	41	6	6
CCACCTATCAGTCAGT-1_MS200_A303	-7.378971007	-6.866580645	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1369	2150	0.018604651	0.007906977	10	13A	IN-VIP	41	6	6
CCACCTATCGCCCTTA-1_MS200_A303	-14.32597598	10.63275661	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2285	4386	0.004787962	0.009575923	10	8	Astrocytes	41	6	6
CCACGGAAGCCCAACC-1_MS200_A303	-31.88814079	-5.117007584	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1418	2253	0.006213937	0.007545495	10	9	OPC	41	6	6
CCACGGAAGTAATCCC-1_MS200_A303	-24.48402269	8.866135414	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	998	1419	0.002818887	0.009866103	10	8	Astrocytes	41	6	6
CCACGGACAAGGACTG-1_MS200_A303	-14.44611503	21.03569213	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1226	1835	0.015258856	0.016893733	10	8	Astrocytes	41	6	6
CCACGGACACAGGTTT-1_MS200_A303	-14.57995903	0.310758635	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3150	6709	0.010284692	0.007452676	10	13A	IN-VIP	41	6	6
CCACGGACAGGTTTCA-1_MS200_A303	-6.923568187	12.79407571	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	753	1009	0.010901883	0.012884044	10	oligos	OL-MS-1	41	6	6
CCACGGAGTAAGGATT-1_MS200_A303	12.67012317	-23.7886484	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4753	12602	0.006030789	0.005078559	10	L2-3	EN-L2-3-MS	41	6	6
CCACTACAGAAGGTTT-1_MS200_A303	-14.21493039	23.28788526	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1705	2630	0.003422053	0.011787072	10	8	Astrocytes	41	6	6
CCACTACAGTCAATAG-1_MS200_A303	19.94051688	-19.25211445	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	7538	29109	0.012229895	0.007695215	10	L2-3	EN-L2-3-MS	41	6	6
CCACTACCAAGTCTGT-1_MS200_A303	-12.96193734	-37.28791625	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1421	2218	0.03336339	0.015779982	10	16	EN-PYR	41	6	6
CCACTACCACGGTAAG-1_MS200_A303	15.60150146	-25.25358942	3	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2988	6497	0.044020317	0.003694013	10	3	EN-L5-6	41	6	6
CCACTACCACTTAAGC-1_MS200_A303	-24.25379387	10.46150484	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1057	1649	0.004244997	0.012128563	10	8	Astrocytes	41	6	6
CCACTACCAGATCGGA-1_MS200_A303	18.81030743	-13.49020232	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	7604	27926	0.031834133	0.011602091	10	2	EN-L4	41	6	6
CCACTACCATCGGAAG-1_MS200_A303	9.390081783	0.15723242	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1097	1362	0.013215859	0.012481645	10	12	EN-MIX	41	6	6
CCACTACGTAGCTTGT-1_MS200_A303	-27.4813466	-4.007426403	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1410	2131	0.007038949	0.012200845	10	9	OPC	41	6	6
CCACTACGTTATGTGC-1_MS200_A303	34.56475005	-8.53583973	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4883	13985	0.002645692	0.011154809	10	2	EN-L4	41	6	6
CCACTACTCACAACGT-1_MS200_A303	34.11077425	-15.67691112	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4400	10004	0.010395842	0.014494202	10	2	EN-L4	41	6	6
CCACTACTCATCTGTT-1_MS200_A303	3.956773952	4.770851317	7	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1416	2079	0.008177008	0.019240019	10	7	Phagocytes	41	6	6
CCACTACTCCCGACTT-1_MS200_A303	-27.78225113	-22.04095084	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4574	12350	0.038461538	0.005263158	10	6A	IN-PV	41	6	6
CCACTACTCGCCTGTT-1_MS200_A303	-4.112462031	14.73344749	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	741	1028	0.004863813	0.015564202	10	oligos	OL-MS-1	41	6	6
CCACTACTCGGCATCG-1_MS200_A303	-22.8966724	8.411100198	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1209	1944	0.00154321	0.005144033	10	8	Astrocytes	41	6	6
CCACTACTCTGTACGA-1_MS200_A303	18.65253008	-13.97545329	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	7119	23093	0.020179275	0.008357511	10	L2-3	EN-L2-3-MS	41	6	6
CCAGCGAAGAGATGAG-1_MS200_A303	32.99229506	6.077251013	14	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	880	1229	0.112286412	0.016273393	10	14	Microglia	41	6	6
CCAGCGAAGAGTGAGA-1_MS200_A303	11.40919578	-12.44305442	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2942	5538	0.008125677	0.028169014	10	L2-3	EN-L2-3-MS	41	6	6
CCAGCGAAGTTCGCGC-1_MS200_A303	-29.29363283	-21.54738106	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4411	10320	0.03129845	0.012015504	10	6A	IN-PV	41	6	6
CCAGCGACACATAACC-1_MS200_A303	11.45421361	-1.575443509	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1191	1695	0.007669617	0.010619469	10	12	EN-MIX	41	6	6
CCAGCGACAGTATCTG-1_MS200_A303	-11.65152969	-37.99368291	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1462	2222	0.058505851	0.016651665	10	16	EN-PYR	41	6	6
CCATGTCAGCCAGAAC-1_MS200_A303	14.87251661	-20.20112356	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	6986	22084	0.007788444	0.010505343	10	L2-3	EN-L2-3-MS	41	6	6
CCATGTCAGCTGCAAG-1_MS200_A303	-30.01995823	-21.80284726	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4551	10541	0.031970401	0.013660943	10	6A	IN-PV	41	6	6
CCATGTCAGGCCCTTG-1_MS200_A303	17.93937101	-8.240543856	3	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1954	3960	0.00959596	0.003282828	10	3	EN-L5-6	41	6	6
CCATGTCGTTCACCTC-1_MS200_A303	-9.704289391	-36.94731088	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1208	1774	0.068207441	0.016910936	10	16	EN-PYR	41	6	6
CCATGTCTCAAGATCC-1_MS200_A303	9.262467729	-12.16154856	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2503	4052	0.011352419	0.005676209	10	L2-3	EN-L2-3-MS	41	6	6
CCATGTCTCACGCGGT-1_MS200_A303	-9.679675806	22.39574369	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1213	1658	0.001206273	0.007237636	10	8	Astrocytes	41	6	6
CCATTCGAGAAACGAG-1_MS200_A303	34.64905918	10.54368991	14	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	815	1019	0.002944063	0.025515211	10	14	Microglia	41	6	6
CCATTCGAGACCGGAT-1_MS200_A303	16.29029468	-10.26245548	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1926	3384	0.090425532	0.00679669	10	12	EN-MIX	41	6	6
CCATTCGAGGTGTTAA-1_MS200_A303	-5.353941728	15.48619345	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	742	1027	0.004868549	0.016553067	10	oligos	OL-MS-1	41	6	6
CCATTCGAGTAGATGT-1_MS200_A303	9.525534941	-12.63475604	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2905	5776	0.007790859	0.014196676	10	L2-3	EN-L2-3-MS	41	6	6
CCATTCGAGTTCGATC-1_MS200_A303	-23.57964382	-20.24849833	6B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2664	5099	0.012159247	0.009805844	10	6B	IN-SST	41	6	6
CCATTCGCAAGAGGCT-1_MS200_A303	-8.41096742	-36.92815278	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1025	1345	0.053531599	0.018587361	10	16	EN-PYR	41	6	6
CCATTCGCAAGCGAGT-1_MS200_A303	12.60000126	-17.024462	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5100	13094	0.012983046	0.008629907	10	L2-3	EN-L2-3-MS	41	6	6
CCATTCGCAGCCAGAA-1_MS200_A303	12.81337398	-13.18157158	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4787	12897	0.011165387	0.010157401	10	L2-3	EN-L2-3-MS	41	6	6
CCATTCGCAGGGTATG-1_MS200_A303	-16.03652058	-1.949644349	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3184	6748	0.006372258	0.009928868	10	13A	IN-VIP	41	6	6
CCATTCGCATCACGTA-1_MS200_A303	6.5330677	14.02403742	1	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1168	1840	0.004891304	0.014130435	10	oligos	OL-Cntl	41	6	6
CCATTCGGTACGACCC-1_MS200_A303	-23.61172721	0.928027958	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1908	3280	0.010060976	0.0125	10	9	OPC	41	6	6
CCATTCGGTCTTCGTC-1_MS200_A303	15.70774218	-10.9203696	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2620	5208	0.050883257	0.006912442	10	L2-3	EN-L2-3-MS	41	6	6
CCATTCGTCACCTCGT-1_MS200_A303	-19.83835903	-0.984517348	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5105	12458	0.017017178	0.019585808	10	13A	IN-VIP	41	6	6
CCATTCGTCACGAAGG-1_MS200_A303	12.76467289	1.252577039	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	735	1088	0.083639706	0.003676471	10	12	EN-MIX	41	6	6
CCCAATCAGACCCACC-1_MS200_A303	35.71099974	11.84080574	14	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	967	1353	0.001478197	0.011825573	10	14	Microglia	41	6	6
CCCAATCAGCCAGAAC-1_MS200_A303	-5.35480244	14.43959726	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	976	1407	0.006396588	0.015636105	10	oligos	OL-MS-1	41	6	6
CCCAATCCAGTGACAG-1_MS200_A303	12.76234608	-3.600163196	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1138	1665	0.01021021	0.009009009	10	12	EN-MIX	41	6	6
CCCAATCCAGTGGGAT-1_MS200_A303	12.14135104	-16.90709289	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4668	11848	0.008102633	0.008440243	10	L2-3	EN-L2-3-MS	41	6	6
CCCAATCGTACCGAGA-1_MS200_A303	4.035254456	-8.380080069	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1451	2380	0.040756303	0.009663866	10	12	EN-MIX	41	6	6
CCCAATCGTCTGATTG-1_MS200_A303	22.39865514	-17.51715378	3	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	6423	23865	0.087031217	0.003729311	10	3	EN-L5-6	41	6	6
CCCAATCGTTGTCTTT-1_MS200_A303	10.85224936	-18.19191687	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4805	13233	0.008765964	0.005818786	10	L2-3	EN-L2-3-MS	41	6	6
CCCAATCTCATATCGG-1_MS200_A303	-24.38006435	10.56876771	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1000	1546	0.001940492	0.007115136	10	8	Astrocytes	41	6	6
CCCAATCTCGTTGCCT-1_MS200_A303	-15.51833428	24.51483688	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1672	3055	0.007855974	0.009165303	10	8	Astrocytes	41	6	6
CCCAATCTCTGCTTGC-1_MS200_A303	4.147284881	-2.696434219	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	951	1426	0.086956522	0.007012623	10	12	EN-MIX	41	6	6
CCCAGTTAGAATTCCC-1_MS200_A303	29.9287543	14.84960651	14	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1101	1851	0.005942734	0.097784981	10	14	Microglia	41	6	6
CCCAGTTAGATCCGAG-1_MS200_A303	17.61269615	-16.05294911	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	7911	27360	0.009027778	0.011769006	10	L2-3	EN-L2-3-MS	41	6	6
CCCAGTTAGGCTAGGT-1_MS200_A303	18.46798629	-13.79237084	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	6844	21640	0.013770795	0.011645102	10	L2-3	EN-L2-3-MS	41	6	6
CCCAGTTAGGTGTGGT-1_MS200_A303	-26.55114318	-10.89686601	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	964	1272	0.01336478	0.008647799	10	9	OPC	41	6	6
CCCAGTTCAATCGAAA-1_MS200_A303	-19.62703107	-0.867382548	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4450	9903	0.009593053	0.016560638	10	13A	IN-VIP	41	6	6
CCCAGTTCAGTCAGAG-1_MS200_A303	13.09917233	0.548105099	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	773	1044	0.026819923	0.007662835	10	12	EN-MIX	41	6	6
CCCATACAGCGCCTTG-1_MS200_A303	28.15727571	6.44740473	15BA	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	858	1247	0.011226945	0.017642342	10	15BA	Stromal cells	41	6	6
CCCATACCACCGATAT-1_MS200_A303	10.1439636	-19.5463472	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5529	17527	0.005762538	0.003993838	10	L2-3	EN-L2-3-MS	41	6	6
CCCATACCACCTGGTG-1_MS200_A303	33.08146455	10.67472663	14	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1010	1333	0.014253563	0.025506377	10	14	Microglia	41	6	6
CCCATACCAGTCCTTC-1_MS200_A303	-13.46953917	22.1049871	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1748	2869	0.016033461	0.008713838	10	8	Astrocytes	41	6	6
CCCATACCAGTTTACG-1_MS200_A303	16.96468283	-14.5463051	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	8154	30793	0.013639464	0.007696554	10	L2-3	EN-L2-3-MS	41	6	6
CCCATACCATCCAACA-1_MS200_A303	11.58997408	-13.55231803	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3976	9218	0.009655023	0.013777392	10	L2-3	EN-L2-3-MS	41	6	6
CCCATACCATGGAATA-1_MS200_A303	-20.01865037	-5.7285499	13B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4959	13089	0.033463213	0.005577202	10	13B	IN-SV2C	41	6	6
CCCATACTCAAACCGT-1_MS200_A303	16.67745832	-5.234079627	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1358	2206	0.024932004	0.001813237	10	12	EN-MIX	41	6	6
CCCATACTCAACACAC-1_MS200_A303	-29.06877358	-10.29528621	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	939	1307	0.003825555	0.019127774	10	9	OPC	41	6	6
CCCATACTCCCGGATG-1_MS200_A303	-5.953458354	16.32289291	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	842	1203	0.004987531	0.009143807	10	oligos	OL-MS-1	41	6	6
CCCATACTCTGCAAGT-1_MS200_A303	23.52468811	-16.12608414	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	6528	18597	0.014679787	0.012851535	10	2	EN-L4	41	6	6
CCCTCCTAGGCCCTCA-1_MS200_A303	-24.15533128	10.06246346	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1080	1651	0.006662629	0.005451242	10	8	Astrocytes	41	6	6
CCCTCCTAGTATCTCG-1_MS200_A303	-12.19612532	17.99749103	11	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2189	4004	0.007492507	0.00999001	10	11	Glia-MIX	41	6	6
CCCTCCTCAGCTGTAT-1_MS200_A303	14.65036894	-21.05078074	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	6873	23431	0.00512142	0.007554095	10	L2-3	EN-L2-3-MS	41	6	6
CCCTCCTGTAGCTTGT-1_MS200_A303	-14.41028463	-0.075056369	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2652	5270	0.008538899	0.009867173	10	13A	IN-VIP	41	6	6
CCCTCCTGTGGACGAT-1_MS200_A303	16.5891976	-9.783131989	3	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2437	4838	0.036585366	0.003100455	10	3	EN-L5-6	41	6	6
CCCTCCTGTGGGTATG-1_MS200_A303	8.953817905	-3.824317657	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1685	2789	0.026174256	0.010756544	10	12	EN-MIX	41	6	6
CCCTCCTGTTTAGCTG-1_MS200_A303	4.96779953	-14.16838553	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2532	5366	0.043235184	0.002236303	10	L2-3	EN-L2-3-MS	41	6	6
CCCTCCTTCAAACCGT-1_MS200_A303	-26.827192	-23.07460426	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4845	13241	0.017068197	0.00981799	10	6A	IN-PV	41	6	6
CCCTCCTTCAGCTTAG-1_MS200_A303	-28.72276552	-21.77582815	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3787	8483	0.015089002	0.013202876	10	6A	IN-PV	41	6	6
CCCTCCTTCTGCAGTA-1_MS200_A303	10.19173213	-19.47232707	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5254	16240	0.005357143	0.004433498	10	L2-3	EN-L2-3-MS	41	6	6
CCGGGATAGTATGACA-1_MS200_A303	24.64402018	-13.35540792	3	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4181	9456	0.012267343	0.006450931	10	3	EN-L5-6	41	6	6
CCGGGATAGTCTCGGC-1_MS200_A303	14.48395565	-5.065513702	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1497	2332	0.021440823	0.005145798	10	12	EN-MIX	41	6	6
CCGGGATCACAACGCC-1_MS200_A303	31.277748	-17.66764877	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	7042	23686	0.013678966	0.010343663	10	2	EN-L4	41	6	6
CCGGGATCAGCCAGAA-1_MS200_A303	-14.2174641	22.49656763	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1437	2478	0.002824859	0.013317191	10	8	Astrocytes	41	6	6
CCGGGATGTAGATTAG-1_MS200_A303	32.77399316	-17.05723575	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4909	12058	0.008376182	0.014264389	10	2	EN-L4	41	6	6
CCGGGATGTATTCGTG-1_MS200_A303	-26.64633334	-20.68129452	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2926	6090	0.052873563	0.00591133	10	6A	IN-PV	41	6	6
CCGGGATGTGTGAAAT-1_MS200_A303	12.03032117	-22.71983722	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3646	8423	0.004867624	0.005936127	10	L2-3	EN-L2-3-MS	41	6	6
CCGGGATTCCTTCAAT-1_MS200_A303	-24.42293862	6.743507879	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	755	1073	0.003727866	0.01584343	10	8	Astrocytes	41	6	6
CCGGGATTCTGAGGGA-1_MS200_A303	-10.81532931	-4.27183039	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1866	3230	0.03003096	0.008668731	10	13A	IN-VIP	41	6	6
CCGGTAGAGAAGATTC-1_MS200_A303	24.1906443	-18.37317907	3	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3697	8202	0.02962692	0.005120702	10	3	EN-L5-6	41	6	6
CCGGTAGAGCCAGTTT-1_MS200_A303	31.11549061	-17.80000563	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	6343	19100	0.016596859	0.016544503	10	2	EN-L4	41	6	6
CCGGTAGAGTCAATAG-1_MS200_A303	33.94361688	-18.45559887	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5221	12733	0.01445064	0.017513547	10	2	EN-L4	41	6	6
CCGGTAGAGTTGAGTA-1_MS200_A303	-27.10063894	-2.156317221	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1509	2252	0.003996448	0.009325044	10	9	OPC	41	6	6
CCGGTAGCAAGCCCAC-1_MS200_A303	-30.29608481	-21.51995182	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5821	18133	0.054265703	0.007996471	10	6A	IN-PV	41	6	6
CCGGTAGGTAGATTAG-1_MS200_A303	-15.36890269	20.3915436	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1162	1711	0.001753361	0.013442431	10	8	Astrocytes	41	6	6
CCGGTAGGTAGGACAC-1_MS200_A303	-31.08699054	-7.977542608	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1056	1663	0.005411906	0.006614552	10	9	OPC	41	6	6
CCGGTAGGTTACGCGC-1_MS200_A303	-18.10389914	-1.529323901	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3655	7365	0.010047522	0.010590631	10	13A	IN-VIP	41	6	6
CCGTACTAGGAACTGC-1_MS200_A303	17.67846152	-13.46079917	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	7909	27756	0.011204785	0.011637124	10	L2-3	EN-L2-3-MS	41	6	6
CCGTACTAGTAACCCT-1_MS200_A303	-24.40435791	10.19895446	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1089	1600	0.01375	0.01125	10	8	Astrocytes	41	6	6
CCGTACTCAGATCTGT-1_MS200_A303	-5.885156969	15.3101194	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	943	1385	0.006498195	0.02166065	10	oligos	OL-MS-1	41	6	6
CCGTACTCAGCCTATA-1_MS200_A303	5.096311134	-9.50825526	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1613	2825	0.055575221	0.003893805	10	12	EN-MIX	41	6	6
CCGTACTCATAGGATA-1_MS200_A303	-6.241125074	-5.126120542	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1297	2089	0.03255146	0.004786979	10	13A	IN-VIP	41	6	6
CCGTACTGTGTGCCTG-1_MS200_A303	-8.414718118	-6.833476825	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1422	2087	0.009583134	0.01149976	10	13A	IN-VIP	41	6	6
CCGTACTTCCAAGCCG-1_MS200_A303	-24.33722714	6.671964115	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	850	1204	0.002491694	0.007475083	10	8	Astrocytes	41	6	6
CCGTACTTCTAACTTC-1_MS200_A303	-17.31576709	20.57087076	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1363	2259	0.003098716	0.008853475	10	8	Astrocytes	41	6	6
CCGTACTTCTTGAGAC-1_MS200_A303	11.59955768	-1.873214821	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1262	1934	0.007238883	0.005170631	10	12	EN-MIX	41	6	6
CCGTGGAAGACAGACC-1_MS200_A303	-30.40277952	-8.59876762	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	996	1425	0.003508772	0.004912281	10	9	OPC	41	6	6
CCGTGGAAGTGCTGCC-1_MS200_A303	13.23965537	0.152406105	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	825	1161	0.01464255	0.006029285	10	12	EN-MIX	41	6	6
CCGTGGACAAGTCATC-1_MS200_A303	5.064516308	-9.696520717	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1650	2729	0.050934408	0.007695126	10	12	EN-MIX	41	6	6
CCGTGGACAGTAACGG-1_MS200_A303	-28.9019221	-4.970172808	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1348	1998	0.003503504	0.011511512	10	9	OPC	41	6	6
CCGTGGACATCCGGGT-1_MS200_A303	-23.69797831	9.552217657	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	890	1311	0.00228833	0.016018307	10	8	Astrocytes	41	6	6
CCGTGGACATCTCCCA-1_MS200_A303	-13.46163778	22.92780021	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1692	2877	0.001737921	0.018074383	10	8	Astrocytes	41	6	6
CCGTGGACATTCACTT-1_MS200_A303	-15.58384051	18.58588765	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1671	2647	0.002644503	0.015489233	10	8	Astrocytes	41	6	6
CCGTGGAGTATAAACG-1_MS200_A303	-16.37080638	20.13219488	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1296	2111	0.003315964	0.011842729	10	8	Astrocytes	41	6	6
CCGTGGAGTCGGATCC-1_MS200_A303	-20.43618906	-4.831238822	13B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4080	9138	0.025497921	0.011052747	10	13B	IN-SV2C	41	6	6
CCGTGGAGTGCAGACA-1_MS200_A303	10.96854422	-17.48473648	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4980	12875	0.008621359	0.006291262	10	L2-3	EN-L2-3-MS	41	6	6
CCGTGGATCTTGTTTG-1_MS200_A303	1.686252991	10.21520769	1	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1019	1502	0.013981358	0.011984021	10	oligos	OL-Cntl	41	6	6
CCGTTCAAGATGCCTT-1_MS200_A303	-17.01396191	-1.936769584	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2835	5510	0.008892922	0.009618875	10	13A	IN-VIP	41	6	6
CCGTTCAAGCTTTGGT-1_MS200_A303	30.53830198	14.50491003	14	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	794	1024	0.00390625	0.09765625	10	14	Microglia	41	6	6
CCGTTCACACAGACAG-1_MS200_A303	28.31011936	5.592874164	15BA	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	684	1091	0.007332722	0.021081577	10	15BA	Stromal cells	41	6	6
CCGTTCAGTCACACGC-1_MS200_A303	-9.149034754	-36.62586312	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1060	1496	0.048128342	0.011363636	10	16	EN-PYR	41	6	6
CCGTTCAGTCCAAGTT-1_MS200_A303	-18.10815132	19.79742881	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1937	3556	0.002249719	0.008998875	10	8	Astrocytes	41	6	6
CCGTTCAGTCCGCTGA-1_MS200_A303	-5.122046021	13.35672467	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	733	1037	0.008678881	0.028929605	10	oligos	OL-MS-1	41	6	6
CCGTTCAGTGAGTATA-1_MS200_A303	15.80940364	-25.19584457	3	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3814	9609	0.022374857	0.003746488	10	3	EN-L5-6	41	6	6
CCGTTCATCGATGAGG-1_MS200_A303	16.06985024	-9.474152412	3	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2175	4036	0.031714569	0.005698712	10	3	EN-L5-6	41	6	6
CCTAAAGAGAATTGTG-1_MS200_A303	-14.99587281	22.90121221	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1391	2091	0.006217121	0.007651841	10	8	Astrocytes	41	6	6
CCTAAAGAGATGTAAC-1_MS200_A303	20.59066638	-27.06186831	3	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3011	6927	0.001154901	0.005052692	10	3	EN-L5-6	41	6	6
CCTAAAGCACGAAAGC-1_MS200_A303	-1.662247381	-35.63746744	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1221	1823	0.114097641	0.014810752	10	16	EN-PYR	41	6	6
CCTAAAGCACGCATCG-1_MS200_A303	-10.15985712	28.46086291	17	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	753	1003	0.049850449	0.007976072	10	oligos	OL-MS-2	41	6	6
CCTAAAGCATCAGTCA-1_MS200_A303	-11.54714902	-38.47181864	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1395	2050	0.047804878	0.021463415	10	16	EN-PYR	41	6	6
CCTAAAGGTACATGTC-1_MS200_A303	-24.44705487	-0.376174324	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1767	2881	0.003123915	0.006942034	10	9	OPC	41	6	6
CCTAAAGGTATGAAAC-1_MS200_A303	11.38685637	-12.55624429	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2922	5766	0.011966701	0.020117933	10	L2-3	EN-L2-3-MS	41	6	6
CCTAAAGGTTCGGGCT-1_MS200_A303	-4.37891703	18.50081768	1	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	879	1214	0.004942339	0.018945634	10	oligos	OL-Cntl	41	6	6
CCTACACAGATATGGT-1_MS200_A303	-24.62087827	-18.3505516	6B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3588	7597	0.010925365	0.010267211	10	6B	IN-SST	41	6	6
CCTACACAGCATGGCA-1_MS200_A303	-8.734673565	-37.64494001	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1152	1622	0.053020962	0.022811344	10	16	EN-PYR	41	6	6
CCTACACCAAGTCTAC-1_MS200_A303	12.17558775	-18.04745212	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5848	18304	0.009888549	0.006392045	10	L2-3	EN-L2-3-MS	41	6	6
CCTACACCACCAGGCT-1_MS200_A303	-8.772227449	-13.74397775	6B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	756	1082	0.114602588	0.002772643	10	6B	IN-SST	41	6	6
CCTACACGTGTCAATC-1_MS200_A303	-6.608860642	13.49807619	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	831	1134	0.026455026	0.020282187	10	oligos	OL-MS-1	41	6	6
CCTACACTCCTCCTAG-1_MS200_A303	-12.13085341	-36.96864641	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1402	2123	0.046632124	0.019312294	10	16	EN-PYR	41	6	6
CCTACACTCCTCTAGC-1_MS200_A303	-18.88497833	-5.744202846	13B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3044	5992	0.011849132	0.011849132	10	13B	IN-SV2C	41	6	6
CCTACACTCTCGCATC-1_MS200_A303	34.06351266	-14.86645943	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4697	12079	0.013825648	0.008858349	10	2	EN-L4	41	6	6
CCTACCAAGGCGATAC-1_MS200_A303	-14.17320335	-15.36393802	6B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1535	2636	0.031866464	0.003793627	10	6B	IN-SST	41	6	6
CCTACCAAGTACGACG-1_MS200_A303	1.406824999	10.17287308	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1245	1915	0.01618799	0.01462141	10	oligos	OL-MS-1	41	6	6
CCTACCAAGTGGGTTG-1_MS200_A303	-21.78812198	-21.40456866	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2335	4730	0.06384778	0.005496829	10	6A	IN-PV	41	6	6
CCTACCACAAACGTGG-1_MS200_A303	-19.61965277	-6.248495103	13B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4636	11807	0.004997036	0.012026764	10	13B	IN-SV2C	41	6	6
CCTACCACACAACTGT-1_MS200_A303	-14.99562368	25.05919915	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1947	3815	0.006815203	0.010222805	10	8	Astrocytes	41	6	6
CCTACCACAGTACACT-1_MS200_A303	-13.67283227	17.1072527	11	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1225	2058	0.002429543	0.004859086	10	11	Glia-MIX	41	6	6
CCTACCACATCATCCC-1_MS200_A303	7.159986237	1.113750783	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	812	1487	0.293880296	0.006052455	10	16	EN-PYR	41	6	6
CCTACCACATGAACCT-1_MS200_A303	-16.41690925	-4.209733942	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3466	8087	0.012983801	0.006059107	10	13A	IN-VIP	41	6	6
CCTACCAGTTACGGAG-1_MS200_A303	-14.79390275	24.18808847	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1552	2473	0.007682976	0.009704812	10	8	Astrocytes	41	6	6
CCTACCAGTTCGGGCT-1_MS200_A303	14.96028559	-17.38992312	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	6340	19664	0.011238812	0.009052075	10	L2-3	EN-L2-3-MS	41	6	6
CCTACCATCACCAGGC-1_MS200_A303	-3.76873363	-36.69042053	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	948	1266	0.046603476	0.032385466	10	16	EN-PYR	41	6	6
CCTACCATCAGGCCCA-1_MS200_A303	9.990613744	-16.47550879	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4041	9953	0.0054255	0.005224555	10	L2-3	EN-L2-3-MS	41	6	6
CCTAGCTAGGCGCTCT-1_MS200_A303	-19.17600319	-26.46205476	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2847	7046	0.00127732	0.006386602	10	6A	IN-PV	41	6	6
CCTAGCTCATTAACCG-1_MS200_A303	-5.089959805	14.97656564	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	684	1011	0.001978239	0.018793274	10	oligos	OL-MS-1	41	6	6
CCTAGCTGTCAATACC-1_MS200_A303	-34.53105786	-3.747674079	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1357	2274	0.002638522	0.004837291	10	9	OPC	41	6	6
CCTAGCTGTGACTACT-1_MS200_A303	-4.700915089	18.25453747	1	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	766	1203	0.00166251	0.011637573	10	oligos	OL-Cntl	41	6	6
CCTAGCTGTGGGTATG-1_MS200_A303	15.75166895	-10.99316465	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2933	6231	0.011555128	0.008024394	10	L2-3	EN-L2-3-MS	41	6	6
CCTAGCTGTGTGCCTG-1_MS200_A303	-29.75102421	-4.231157516	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1337	2080	0.003846154	0.010576923	10	9	OPC	41	6	6
CCTAGCTGTTAAGAAC-1_MS200_A303	-5.615649507	13.61580518	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	755	1041	0.018251681	0.025936599	10	oligos	OL-MS-1	41	6	6
CCTAGCTTCGCTTAGA-1_MS200_A303	1.879342808	6.367667788	7	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1344	1935	0.043410853	0.010852713	10	7	Phagocytes	41	6	6
CCTAGCTTCTTCAACT-1_MS200_A303	12.36324401	-17.97729096	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	7636	31172	0.009463621	0.005261132	10	L2-3	EN-L2-3-MS	41	6	6
CCTATTAAGAACTGTA-1_MS200_A303	-5.444640379	14.14640467	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	737	1058	0.011342155	0.013232514	10	oligos	OL-MS-1	41	6	6
CCTATTAAGCCTCGTG-1_MS200_A303	-30.54919384	-12.4703698	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	740	1037	0.011571842	0.006750241	10	9	OPC	41	6	6
CCTATTAAGCGTCAAG-1_MS200_A303	18.15044592	-18.20337477	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3972	9719	0.02068114	0.008539973	10	L2-3	EN-L2-3-MS	41	6	6
CCTATTAAGCTAGTTC-1_MS200_A303	-8.195440114	-9.606802113	13B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1000	1465	0.030716724	0.010921502	10	13B	IN-SV2C	41	6	6
CCTATTAGTGTGGTTT-1_MS200_A303	12.97933671	-17.36370979	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5981	17550	0.005925926	0.010883191	10	L2-3	EN-L2-3-MS	41	6	6
CCTATTATCATGTCCC-1_MS200_A303	-18.29718752	27.73543429	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2000	3736	0.003747323	0.007226981	10	8	Astrocytes	41	6	6
CCTATTATCCTTTCTC-1_MS200_A303	10.0455562	-19.74040061	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5645	18254	0.008217377	0.006299989	10	L2-3	EN-L2-3-MS	41	6	6
CCTCAGTCATGATCCA-1_MS200_A303	-17.08158523	-22.17454801	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1908	3692	0.030065005	0.003791983	10	6A	IN-PV	41	6	6
CCTCAGTTCAGGCGAA-1_MS200_A303	37.3325231	-10.09657623	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3804	8341	0.013187867	0.012588419	10	2	EN-L4	41	6	6
CCTCTGAAGGATTCGG-1_MS200_A303	-15.20439437	-37.57436928	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3325	7454	0.104373491	0.02200161	10	16	EN-PYR	41	6	6
CCTCTGACACTAGTAC-1_MS200_A303	-24.74497319	0.125241301	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2429	4414	0.005890349	0.008155868	10	9	OPC	41	6	6
CCTCTGACAGCTGTGC-1_MS200_A303	-19.29947721	-0.713836461	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4316	10659	0.026737968	0.015855146	10	13A	IN-VIP	41	6	6
CCTCTGACATGAAGTA-1_MS200_A303	4.759727756	19.05878344	1	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	961	1430	0.008391608	0.013986014	10	oligos	OL-Cntl	41	6	6
CCTCTGACATTATCTC-1_MS200_A303	-14.8399305	24.02267269	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1686	2880	0.00625	0.008333333	10	8	Astrocytes	41	6	6
CCTCTGATCAAAGTAG-1_MS200_A303	28.36191144	5.786847152	15BA	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	723	1084	0.011070111	0.018450185	10	15BA	Stromal cells	41	6	6
CCTCTGATCATAAAGG-1_MS200_A303	-12.23586593	-38.5984661	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1666	2626	0.067402894	0.0312262	10	16	EN-PYR	41	6	6
CCTCTGATCCTTTCTC-1_MS200_A303	-15.23418931	-34.73355002	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3316	7750	0.14283871	0.008516129	10	16	EN-PYR	41	6	6
CCTCTGATCTCAAACG-1_MS200_A303	8.467008462	-14.94800178	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3209	6814	0.011887291	0.010272967	10	L2-3	EN-L2-3-MS	41	6	6
CCTCTGATCTCCCTGA-1_MS200_A303	33.89432083	-17.32868245	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4992	12529	0.01388778	0.010216298	10	2	EN-L4	41	6	6
CCTTACGAGAGGTACC-1_MS200_A303	-27.33087595	-2.244433417	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1575	2710	0.005166052	0.011070111	10	9	OPC	41	6	6
CCTTACGAGCCAGGAT-1_MS200_A303	-9.382632748	-36.6894314	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1038	1535	0.071661238	0.014332248	10	16	EN-PYR	41	6	6
CCTTACGAGGATGTAT-1_MS200_A303	-20.63088115	23.60922982	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1530	2706	0.001847746	0.007390983	10	8	Astrocytes	41	6	6
CCTTACGCACGGACAA-1_MS200_A303	12.39184929	-3.584284169	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1496	2587	0.108620023	0.003092385	10	12	EN-MIX	41	6	6
CCTTACGCAGCTGGCT-1_MS200_A303	-10.2897412	-4.051843987	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1903	3533	0.007076139	0.005377866	10	13A	IN-VIP	41	6	6
CCTTACGGTTCCACAA-1_MS200_A303	-31.60624322	-6.241749477	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1190	1853	0.003777658	0.004856989	10	9	OPC	41	6	6
CCTTCCCAGAGACTAT-1_MS200_A303	-15.75773691	-0.443773799	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2009	3408	0.012323944	0.014377934	10	13A	IN-VIP	41	6	6
CCTTCCCAGCCCAGCT-1_MS200_A303	1.810185213	10.39450493	1	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1047	1565	0.011501597	0.008306709	10	oligos	OL-Cntl	41	6	6
CCTTCCCCACGGCTAC-1_MS200_A303	-18.96811307	-2.934791974	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5300	14501	0.039445555	0.00910282	10	13A	IN-VIP	41	6	6
CCTTCCCCATTAACCG-1_MS200_A303	-16.90842645	23.92531467	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1507	2594	0.005782575	0.01387818	10	8	Astrocytes	41	6	6
CCTTCCCGTAGGGACT-1_MS200_A303	8.871392198	-12.60977803	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2599	4762	0.016589668	0.005669887	10	L2-3	EN-L2-3-MS	41	6	6
CCTTCCCGTCTGATTG-1_MS200_A303	-23.33362023	-24.83649479	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3569	8923	0.01669842	0.004146587	10	6A	IN-PV	41	6	6
CCTTCCCGTGGGTCAA-1_MS200_A303	33.38210289	4.746145061	14	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1494	2046	0.02688172	0.018084066	10	14	Microglia	41	6	6
CCTTCCCTCACTATTC-1_MS200_A303	-18.45781073	29.32229913	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2443	4870	0.001026694	0.010472279	10	8	Astrocytes	41	6	6
CCTTCCCTCAGCATGT-1_MS200_A303	-2.644532172	21.51635582	1	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	716	1061	0.008482564	0.016965127	10	oligos	OL-Cntl	41	6	6
CCTTCCCTCCGCTGTT-1_MS200_A303	-21.33637559	-16.02588021	6B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3066	6937	0.067752631	0.003892172	10	6B	IN-SST	41	6	6
CCTTCCCTCGGCCGAT-1_MS200_A303	-14.75435366	25.09556574	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1996	3776	0.006620763	0.009798729	10	8	Astrocytes	41	6	6
CCTTCGAAGAACAACT-1_MS200_A303	33.88831548	-17.88731212	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4897	12308	0.019418265	0.011455964	10	2	EN-L4	41	6	6
CCTTCGAAGCCTCGTG-1_MS200_A303	34.18529318	-4.966797844	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2766	5700	0.004736842	0.006842105	10	2	EN-L4	41	6	6
CCTTCGACATTATCTC-1_MS200_A303	-16.93859255	-1.915385699	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2854	5715	0.015573053	0.012773403	10	13A	IN-VIP	41	6	6
CCTTCGAGTCAACATC-1_MS200_A303	-24.17294954	7.462824982	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1119	1879	0.016498137	0.005854178	10	8	Astrocytes	41	6	6
CCTTTCTCAAATCCGT-1_MS200_A303	17.25875306	-14.51213292	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	7601	27582	0.012363135	0.015336089	10	L2-3	EN-L2-3-MS	41	6	6
CCTTTCTCACTGTCGG-1_MS200_A303	-14.85335628	24.67272854	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1765	3206	0.004366812	0.012476606	10	8	Astrocytes	41	6	6
CCTTTCTCAGACTCGC-1_MS200_A303	-5.445775558	15.91959016	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	740	1077	0.004642526	0.016713092	10	oligos	OL-MS-1	41	6	6
CCTTTCTCAGTACACT-1_MS200_A303	3.060454607	-7.174245175	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1222	1972	0.042089249	0.002535497	10	12	EN-MIX	41	6	6
CCTTTCTGTACATGTC-1_MS200_A303	6.966822947	-9.786330729	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1229	1900	0.012631579	0.013157895	10	12	EN-MIX	41	6	6
CCTTTCTTCACTTATC-1_MS200_A303	-33.95663652	-1.164163115	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1513	2623	0.004574914	0.004956157	10	9	OPC	41	6	6
CCTTTCTTCAGCACAT-1_MS200_A303	13.65932947	-3.259073932	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1352	2382	0.005877414	0.004617968	10	12	EN-MIX	41	6	6
CCTTTCTTCCGCGGTA-1_MS200_A303	29.98560048	-10.5362499	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4049	10427	0.030689556	0.004507529	10	2	EN-L4	41	6	6
CCTTTCTTCGGATGTT-1_MS200_A303	-17.77294752	-1.10032162	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3431	7079	0.009323351	0.014267552	10	13A	IN-VIP	41	6	6
CGAACATAGAGCTGCA-1_MS200_A303	-14.88170454	21.48496739	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1279	2012	0.006461233	0.012425447	10	8	Astrocytes	41	6	6
CGAACATAGAGTTGGC-1_MS200_A303	9.543285308	0.348586623	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	873	1163	0.063628547	0.009458298	10	12	EN-MIX	41	6	6
CGAACATAGCACCGCT-1_MS200_A303	-11.05272448	31.75299053	17	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1167	1658	0.010253317	0.017490953	10	oligos	OL-MS-2	41	6	6
CGAACATAGCCGTCGT-1_MS200_A303	-29.03061923	-5.586879822	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1191	1808	0.014380531	0.006084071	10	9	OPC	41	6	6
CGAACATAGGGTCGAT-1_MS200_A303	-14.01270827	23.057869	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1638	2556	0.00743349	0.014475743	10	8	Astrocytes	41	6	6
CGAACATAGTCGCCGT-1_MS200_A303	14.4436399	-15.66848639	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5641	15549	0.0100328	0.007395974	10	L2-3	EN-L2-3-MS	41	6	6
CGAACATGTACCGTAT-1_MS200_A303	-6.629194506	14.21433241	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	909	1361	0.021307862	0.0191036	10	oligos	OL-MS-1	41	6	6
CGAACATGTAGGAGTC-1_MS200_A303	-23.6106984	9.538297021	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	878	1257	0.00477327	0.018297534	10	8	Astrocytes	41	6	6
CGAACATGTGGGTCAA-1_MS200_A303	-5.706480855	13.45938742	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	765	1041	0.00192123	0.018251681	10	oligos	OL-MS-1	41	6	6
CGAACATGTGTGCCTG-1_MS200_A303	-30.10993428	-21.72744206	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5117	13096	0.031459988	0.017944411	10	6A	IN-PV	41	6	6
CGAACATTCAGCATGT-1_MS200_A303	28.01625682	7.543152605	15A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	779	1047	0.00286533	0.041069723	10	15A	Endo cells	41	6	6
CGAACATTCGCCTGAG-1_MS200_A303	36.37528388	-10.72736603	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5019	12933	0.007500193	0.019794325	10	2	EN-L4	41	6	6
CGAATGTAGCGTGTCC-1_MS200_A303	-11.57214941	-6.401382501	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2088	3688	0.014099783	0.004880694	10	13A	IN-VIP	41	6	6
CGAATGTCAAAGGTGC-1_MS200_A303	29.6704183	14.42802395	14	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	731	1071	0.010270775	0.145658263	10	14	Microglia	41	6	6
CGAATGTCATACTCTT-1_MS200_A303	-16.68483712	-3.397952079	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3297	6845	0.013732652	0.007742878	10	13A	IN-VIP	41	6	6
CGAATGTTCTAGAGTC-1_MS200_A303	1.620543836	10.88802302	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1041	1566	0.019795658	0.009578544	10	oligos	OL-MS-1	41	6	6
CGAATGTTCTTGCCGT-1_MS200_A303	-28.43679401	-5.969091543	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1145	1667	0.00239952	0.00539892	10	9	OPC	41	6	6
CGACCTTAGCGTTCCG-1_MS200_A303	15.26778779	-21.42304166	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5834	17667	0.008207392	0.00815079	10	L2-3	EN-L2-3-MS	41	6	6
CGACCTTGTCCCTTGT-1_MS200_A303	-12.63157542	-8.057216134	13B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1940	3328	0.011418269	0.007512019	10	13B	IN-SV2C	41	6	6
CGACCTTGTCTAAAGA-1_MS200_A303	-5.480279636	14.97319021	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	956	1382	0.002894356	0.010853835	10	oligos	OL-MS-1	41	6	6
CGACCTTTCAAAGTAG-1_MS200_A303	-29.42117461	-5.010293047	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1310	2064	0.004844961	0.006782946	10	9	OPC	41	6	6
CGACCTTTCAGCGATT-1_MS200_A303	18.9846662	-19.56086276	3	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3641	8749	0.07292262	0.004000457	10	3	EN-L5-6	41	6	6
CGACCTTTCGGTGTCG-1_MS200_A303	-17.42321935	12.50347756	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1287	2207	0.003171726	0.009515179	10	8	Astrocytes	41	6	6
CGACTTCAGGTAAACT-1_MS200_A303	-15.12278159	24.39759891	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1644	2831	0.002472625	0.008830802	10	8	Astrocytes	41	6	6
CGACTTCAGTGCGATG-1_MS200_A303	-24.46396818	6.989391298	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	894	1396	0.002148997	0.007879656	10	8	Astrocytes	41	6	6
CGACTTCAGTTGCAGG-1_MS200_A303	-24.09718379	8.991902597	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1082	1579	0.001266624	0.008866371	10	8	Astrocytes	41	6	6
CGACTTCCAAGCGTAG-1_MS200_A303	17.19189246	-13.22728249	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	6534	18836	0.016510937	0.016192398	10	L2-3	EN-L2-3-MS	41	6	6
CGACTTCCAGGGTATG-1_MS200_A303	15.71453524	-13.81866726	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	6268	20300	0.01862069	0.008374384	10	L2-3	EN-L2-3-MS	41	6	6
CGACTTCCATAGGATA-1_MS200_A303	-29.29552203	-5.580060978	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1172	1855	0.038814016	0.003234501	10	9	OPC	41	6	6
CGACTTCTCACCACCT-1_MS200_A303	2.110287484	5.716620355	7	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	737	1007	0.006951341	0.011916584	10	7	Phagocytes	41	6	6
CGACTTCTCGTGGTCG-1_MS200_A303	10.89611489	1.459658014	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	795	1030	0.045631068	0.008737864	10	12	EN-MIX	41	6	6
CGACTTCTCTGTCTCG-1_MS200_A303	-9.442179519	-9.785229172	6B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1173	1932	0.069875776	0.010351967	10	6B	IN-SST	41	6	6
CGAGAAGAGCAAATCA-1_MS200_A303	-30.55017126	-2.305775856	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1533	2459	0.002033347	0.007726718	10	9	OPC	41	6	6
CGAGAAGCAAGGCTCC-1_MS200_A303	19.80306434	-17.98580143	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5486	16039	0.016896315	0.011035601	10	L2-3	EN-L2-3-MS	41	6	6
CGAGAAGCATGGGAAC-1_MS200_A303	-19.26110418	-0.797446695	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3895	8392	0.012511916	0.017397521	10	13A	IN-VIP	41	6	6
CGAGAAGTCAGTACGT-1_MS200_A303	-3.822388527	-7.043216746	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	975	1410	0.038297872	0.004964539	10	13A	IN-VIP	41	6	6
CGAGAAGTCCAGGGCT-1_MS200_A303	-28.87211173	-5.659681052	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1102	1594	0.001882058	0.010664994	10	9	OPC	41	6	6
CGAGAAGTCTCGTTTA-1_MS200_A303	15.70255032	-10.69569618	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2612	5358	0.038820455	0.005599104	10	L2-3	EN-L2-3-MS	41	6	6
CGAGCACAGAAGGTTT-1_MS200_A303	-10.69021819	17.61784834	11	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2721	4941	0.012548067	0.013155232	10	11	Glia-MIX	41	6	6
CGAGCACAGCTAGGCA-1_MS200_A303	-9.679519124	-14.65118368	6B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	855	1196	0.026755853	0.010869565	10	6B	IN-SST	41	6	6
CGAGCACCAGATCGGA-1_MS200_A303	9.065783569	-4.381439627	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2215	3780	0.043650794	0.009259259	10	12	EN-MIX	41	6	6
CGAGCACCAGTATCTG-1_MS200_A303	-10.85697208	-8.231298906	13B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1561	2554	0.007830854	0.00587314	10	13B	IN-SV2C	41	6	6
CGAGCACGTTCGGGCT-1_MS200_A303	-14.64144159	24.17492633	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1781	2825	0.004955752	0.011327434	10	8	Astrocytes	41	6	6
CGAGCACTCCGAATGT-1_MS200_A303	-4.425047381	19.264603	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	780	1135	0.007929515	0.014096916	10	oligos	OL-MS-1	41	6	6
CGAGCACTCGCAGGCT-1_MS200_A303	11.11338419	-0.963956705	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1259	1950	0.073333333	0.005641026	10	12	EN-MIX	41	6	6
CGAGCACTCGTGGTCG-1_MS200_A303	-19.64893717	-6.23618523	13B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3461	7108	0.018570625	0.005908835	10	13B	IN-SV2C	41	6	6
CGAGCACTCTGCTGTC-1_MS200_A303	-26.35129105	-18.39629202	6B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2009	3377	0.017175007	0.009771987	10	6B	IN-SST	41	6	6
CGAGCACTCTGGTGTA-1_MS200_A303	14.49557991	-12.44415933	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2843	5106	0.019193106	0.010379945	10	L2-3	EN-L2-3-MS	41	6	6
CGAGCCAAGAGGTACC-1_MS200_A303	-19.03261494	-6.116957819	13B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3333	6679	0.024255128	0.008534212	10	13B	IN-SV2C	41	6	6
CGAGCCAAGCTTATCG-1_MS200_A303	-13.05353025	-14.78145166	6B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1471	2413	0.025694157	0.005387484	10	6B	IN-SST	41	6	6
CGAGCCAAGGTGATTA-1_MS200_A303	13.80492506	-15.70133223	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4830	12825	0.016374269	0.009044834	10	L2-3	EN-L2-3-MS	41	6	6
CGAGCCAAGTCCAGGA-1_MS200_A303	-31.47543952	-6.468411069	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1111	1643	0.004260499	0.003043214	10	9	OPC	41	6	6
CGAGCCAAGTTATCGC-1_MS200_A303	-9.35942987	-15.39895253	6B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	885	1295	0.058687259	0.01003861	10	6B	IN-SST	41	6	6
CGAGCCACACCCAGTG-1_MS200_A303	0.693970099	1.131236439	17	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1301	1984	0.058467742	0.008568548	10	oligos	OL-MS-2	41	6	6
CGAGCCAGTCTCCATC-1_MS200_A303	7.182090855	-0.818257531	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	694	1067	0.177132146	0.003748828	10	12	EN-MIX	41	6	6
CGAGCCAGTGCAACGA-1_MS200_A303	-11.53003109	-38.60774896	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1398	2016	0.031746032	0.021329365	10	16	EN-PYR	41	6	6
CGAGCCATCAACACAC-1_MS200_A303	-16.21537239	11.80227605	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1305	2197	0.001820665	0.00591716	10	8	Astrocytes	41	6	6
CGATCGGCAGGGAGAG-1_MS200_A303	-13.93550947	22.34078912	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1480	2308	0.00389948	0.011265165	10	8	Astrocytes	41	6	6
CGATCGGGTCTTTCAT-1_MS200_A303	-16.39604951	-3.733581053	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2706	5540	0.012274368	0.00631769	10	13A	IN-VIP	41	6	6
CGATCGGGTGACTACT-1_MS200_A303	11.38018971	-12.77466021	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3191	6606	0.028458977	0.00983954	10	L2-3	EN-L2-3-MS	41	6	6
CGATCGGTCCGCATCT-1_MS200_A303	5.848634509	-2.92997259	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1062	1477	0.043331077	0.008801625	10	12	EN-MIX	41	6	6
CGATCGGTCGCCCTTA-1_MS200_A303	-12.86681159	-17.47622102	6B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1193	1987	0.063412179	0.005535984	10	6B	IN-SST	41	6	6
CGATGGCAGCCACGTC-1_MS200_A303	18.41310068	-13.62365221	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	7302	25490	0.020047077	0.017732444	10	L2-3	EN-L2-3-MS	41	6	6
CGATGGCAGGTGCAAC-1_MS200_A303	7.559809075	-13.86584669	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2682	5668	0.048341567	0.010938603	10	L2-3	EN-L2-3-MS	41	6	6
CGATGGCAGTAACCCT-1_MS200_A303	12.39544618	-1.023887828	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1080	1582	0.071428571	0.011378003	10	12	EN-MIX	41	6	6
CGATGGCGTTATCCGA-1_MS200_A303	-12.05842619	-5.899162261	13B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2173	4014	0.021923269	0.006726457	10	13B	IN-SV2C	41	6	6
CGATGTAAGTGAAGAG-1_MS200_A303	6.869880232	-1.102787081	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	891	1129	0.008857396	0.008857396	10	12	EN-MIX	41	6	6
CGATGTACACCAGGCT-1_MS200_A303	-16.16162813	-2.271692884	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2833	5529	0.017362995	0.006872852	10	13A	IN-VIP	41	6	6
CGATGTACAGGATTGG-1_MS200_A303	-16.36190174	-1.84682344	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2378	4138	0.015224746	0.013533108	10	13A	IN-VIP	41	6	6
CGATGTACATAGTAAG-1_MS200_A303	-24.9299647	-0.244248164	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1817	3015	0.008623549	0.009286899	10	9	OPC	41	6	6
CGATGTACATCGATGT-1_MS200_A303	12.45644319	-13.35769002	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4276	9672	0.011166253	0.015301902	10	L2-3	EN-L2-3-MS	41	6	6
CGATGTAGTATAGTAG-1_MS200_A303	-30.83584009	-1.798321668	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1763	3008	0.002659574	0.003656915	10	9	OPC	41	6	6
CGATGTAGTTATCGGT-1_MS200_A303	-5.872698105	14.55127967	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	915	1350	0.01037037	0.022222222	10	oligos	OL-MS-1	41	6	6
CGATGTAGTTCCACTC-1_MS200_A303	-15.04055463	-2.206243606	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2069	3354	0.012522361	0.013118664	10	13A	IN-VIP	41	6	6
CGATTGAAGATACACA-1_MS200_A303	30.42427361	-18.67629676	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	7614	26622	0.026970175	0.011644505	10	2	EN-L4	41	6	6
CGATTGAAGGAATTAC-1_MS200_A303	-29.916705	-10.95827631	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	900	1330	0.009022556	0.006015038	10	9	OPC	41	6	6
CGATTGACAAGCCGTC-1_MS200_A303	-24.8203296	8.961452965	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	977	1390	0.002877698	0.007913669	10	8	Astrocytes	41	6	6
CGATTGAGTCAGCTAT-1_MS200_A303	-5.927992466	16.99592452	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	910	1295	0.003861004	0.003861004	10	oligos	OL-MS-1	41	6	6
CGATTGAGTGAACCTT-1_MS200_A303	-16.49660765	-3.216585984	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2572	4927	0.012786686	0.005885935	10	13A	IN-VIP	41	6	6
CGATTGATCATGTCCC-1_MS200_A303	-9.316637697	-36.32644074	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1010	1414	0.054455446	0.010608204	10	16	EN-PYR	41	6	6
CGATTGATCATTATCC-1_MS200_A303	33.88829265	10.84257708	14	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	790	1045	0.006698565	0.022009569	10	14	Microglia	41	6	6
CGATTGATCCGCAGTG-1_MS200_A303	-16.37814777	20.50216615	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1403	2241	0.002231147	0.009370817	10	8	Astrocytes	41	6	6
CGCCAAGAGGCTAGAC-1_MS200_A303	9.897399649	-1.508071796	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1309	2066	0.100677638	0.004840271	10	12	EN-MIX	41	6	6
CGCCAAGAGGGCTCTC-1_MS200_A303	7.373665116	0.590040782	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	676	1121	0.265834077	0.006244425	10	12	EN-MIX	41	6	6
CGCCAAGAGTGGTAGC-1_MS200_A303	-9.325725183	19.53634113	11	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2649	4643	0.002369158	0.033814344	10	11	Glia-MIX	41	6	6
CGCCAAGCAATGTTGC-1_MS200_A303	33.72215488	-15.37719801	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4430	10636	0.010436254	0.011658518	10	2	EN-L4	41	6	6
CGCCAAGCAGGAACGT-1_MS200_A303	-5.976302587	12.68050665	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	737	1011	0.007912957	0.024727992	10	oligos	OL-MS-1	41	6	6
CGCCAAGGTACCGTTA-1_MS200_A303	-14.10400971	-15.49345164	6B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1484	2516	0.016693164	0.004372019	10	6B	IN-SST	41	6	6
CGCCAAGGTCGCATAT-1_MS200_A303	31.08539649	14.78135696	14	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	847	1131	0.006189213	0.038019452	10	14	Microglia	41	6	6
CGCCAAGTCGCCATAA-1_MS200_A303	-33.00072659	5.31159337	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3243	6584	0.00318955	0.006530984	10	9	OPC	41	6	6
CGCGGTAAGACTTTCG-1_MS200_A303	23.64890863	7.359271049	15A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2301	4008	0.008732535	0.013473054	10	15A	Endo cells	41	6	6
CGCGGTAAGCAACGGT-1_MS200_A303	-28.11135104	-5.131231504	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1154	1594	0.005018821	0.017565872	10	9	OPC	41	6	6
CGCGGTAAGCTAACTC-1_MS200_A303	-15.92327206	-1.776924341	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2814	5376	0.011346726	0.012834821	10	13A	IN-VIP	41	6	6
CGCGGTAAGCTCAACT-1_MS200_A303	-19.52081572	-4.979142439	13B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3101	5924	0.013841999	0.008271438	10	13B	IN-SV2C	41	6	6
CGCGGTAAGGCTCTTA-1_MS200_A303	7.307171652	-9.941313491	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1773	3061	0.010127409	0.007513884	10	L2-3	EN-L2-3-MS	41	6	6
CGCGGTAAGTTGCAGG-1_MS200_A303	29.57238717	14.2019749	14	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	807	1191	0.006717045	0.184718724	10	14	Microglia	41	6	6
CGCGGTAGTGGTAACG-1_MS200_A303	-4.199228172	18.75322717	1	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	771	1074	0.002793296	0.015828678	10	oligos	OL-Cntl	41	6	6
CGCGGTATCAGGCCCA-1_MS200_A303	9.808661661	-2.162567546	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1547	2852	0.201963534	0.005259467	10	12	EN-MIX	41	6	6
CGCGTTTGTCTCAACA-1_MS200_A303	11.63068259	1.299104232	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	777	1349	0.243884359	0.002965159	10	12	EN-MIX	41	6	6
CGCGTTTTCATTTGGG-1_MS200_A303	-14.84994132	25.75890624	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2645	4827	0.008493889	0.007872385	10	8	Astrocytes	41	6	6
CGCGTTTTCCCACTTG-1_MS200_A303	1.707330457	-8.585753254	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1624	2819	0.043277758	0.003547357	10	12	EN-MIX	41	6	6
CGCGTTTTCCGAAGAG-1_MS200_A303	12.11838919	-13.30661112	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3813	8009	0.00799101	0.01872893	10	L2-3	EN-L2-3-MS	41	6	6
CGCGTTTTCCTGTACC-1_MS200_A303	-27.41756302	-22.3848225	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4367	10947	0.040010962	0.004658811	10	6A	IN-PV	41	6	6
CGCTATCAGCGATATA-1_MS200_A303	-5.567340443	15.47413588	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	741	1063	0.005644403	0.012229539	10	oligos	OL-MS-1	41	6	6
CGCTATCAGCTAGTGG-1_MS200_A303	18.77728918	-25.0897801	3	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5452	14979	0.002470125	0.004272648	10	3	EN-L5-6	41	6	6
CGCTATCAGGCTAGGT-1_MS200_A303	33.45891088	-15.87870192	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4317	9773	0.011664791	0.008288141	10	2	EN-L4	41	6	6
CGCTATCAGTGTCTCA-1_MS200_A303	18.57272379	-13.72471658	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	7267	24410	0.018107333	0.015157722	10	L2-3	EN-L2-3-MS	41	6	6
CGCTATCCAAGGTGTG-1_MS200_A303	33.92934323	-18.33928435	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4939	11544	0.015852391	0.014899515	10	2	EN-L4	41	6	6
CGCTATCCAATCGGTT-1_MS200_A303	-19.12186018	-1.069229791	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3385	6407	0.015139691	0.01982207	10	13A	IN-VIP	41	6	6
CGCTATCCAGCCTTGG-1_MS200_A303	-17.21391594	-2.478382809	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2935	5572	0.006819813	0.011306533	10	13A	IN-VIP	41	6	6
CGCTATCGTAAGGATT-1_MS200_A303	10.18747273	-12.16485559	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3240	6941	0.010373145	0.014119003	10	L2-3	EN-L2-3-MS	41	6	6
CGCTATCGTATGAAAC-1_MS200_A303	34.14215306	-14.67802328	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4709	11640	0.008419244	0.010395189	10	2	EN-L4	41	6	6
CGCTATCGTCGCCATG-1_MS200_A303	-8.921698424	-15.67675974	6B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	806	1224	0.105392157	0.010620915	10	6B	IN-SST	41	6	6
CGCTATCGTGTTCGAT-1_MS200_A303	-5.931283259	-36.67990275	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	900	1216	0.069901316	0.017269737	10	16	EN-PYR	41	6	6
CGCTGGAAGGAATCGC-1_MS200_A303	-13.59493148	23.00066462	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1603	2564	0.001950078	0.024960998	10	8	Astrocytes	41	6	6
CGCTGGACAGGGATTG-1_MS200_A303	14.76974153	-13.42531132	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4158	9021	0.013634852	0.010530983	10	L2-3	EN-L2-3-MS	41	6	6
CGCTGGAGTAGCCTAT-1_MS200_A303	-20.13166435	-1.658042881	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5598	14735	0.036104513	0.016559213	10	13A	IN-VIP	41	6	6
CGCTGGAGTTCCACGG-1_MS200_A303	-29.43313836	-10.94071253	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	872	1164	0.004295533	0.009450172	10	9	OPC	41	6	6
CGCTTCAAGACTACAA-1_MS200_A303	33.27016187	-15.55918071	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3684	7966	0.01820236	0.008661813	10	2	EN-L4	41	6	6
CGCTTCACAACTGGCC-1_MS200_A303	32.70775482	9.80262314	14	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	816	1061	0.001885014	0.019792648	10	14	Microglia	41	6	6
CGCTTCACAAGTAGTA-1_MS200_A303	12.0745067	-12.73174991	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3482	7286	0.012352457	0.015646445	10	L2-3	EN-L2-3-MS	41	6	6
CGCTTCACACCACGTG-1_MS200_A303	-14.70089361	21.65137457	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1294	2057	0.011667477	0.013125912	10	8	Astrocytes	41	6	6
CGCTTCACATACGCCG-1_MS200_A303	-7.304101449	-6.622450391	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1221	1787	0.024062675	0.006155568	10	13A	IN-VIP	41	6	6
CGCTTCAGTCGAGATG-1_MS200_A303	9.391011389	-13.46489342	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2884	5288	0.004727685	0.005295008	10	L2-3	EN-L2-3-MS	41	6	6
CGCTTCAGTCTCTCGT-1_MS200_A303	34.01644275	-17.32155581	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5316	13768	0.013800116	0.015398024	10	2	EN-L4	41	6	6
CGCTTCAGTGACCAAG-1_MS200_A303	13.41766892	-16.97299228	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5046	13821	0.007090659	0.007163013	10	L2-3	EN-L2-3-MS	41	6	6
CGCTTCAGTTCTGTTT-1_MS200_A303	-17.06340293	20.4777257	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1288	2025	0.00345679	0.010864198	10	8	Astrocytes	41	6	6
CGCTTCATCACGATGT-1_MS200_A303	-27.14974253	4.751977968	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2273	4168	0.004318618	0.013675624	10	8	Astrocytes	41	6	6
CGCTTCATCATATCGG-1_MS200_A303	10.30589634	-19.19803019	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4645	12235	0.005557826	0.005803024	10	L2-3	EN-L2-3-MS	41	6	6
CGCTTCATCATCTGCC-1_MS200_A303	-26.81371375	-22.86780799	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4760	12628	0.015125119	0.011878366	10	6A	IN-PV	41	6	6
CGCTTCATCGATGAGG-1_MS200_A303	13.34493391	-17.25796946	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4888	12851	0.012216948	0.014784842	10	L2-3	EN-L2-3-MS	41	6	6
CGGACACAGACAAGCC-1_MS200_A303	34.08873362	-17.86504755	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4789	10809	0.013507262	0.019428254	10	2	EN-L4	41	6	6
CGGACACAGACCCACC-1_MS200_A303	-24.00133822	10.63636044	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1071	1661	0.003010235	0.009030704	10	8	Astrocytes	41	6	6
CGGACACAGCCACGCT-1_MS200_A303	13.12372721	-14.93685291	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3815	8442	0.013503909	0.013148543	10	L2-3	EN-L2-3-MS	41	6	6
CGGACACCATAACCTG-1_MS200_A303	-29.83145086	-9.795719134	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1049	1488	0.003360215	0.00672043	10	9	OPC	41	6	6
CGGACACGTATGCTTG-1_MS200_A303	-23.79273619	9.999872047	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1010	1506	0.005976096	0.007968127	10	8	Astrocytes	41	6	6
CGGACACGTCGGATCC-1_MS200_A303	-17.77968865	-6.592034273	13B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2839	5702	0.019642231	0.005261312	10	13B	IN-SV2C	41	6	6
CGGACGTAGCTAGTCT-1_MS200_A303	5.99533416	9.940551591	1	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1385	2124	0.003766478	0.013653484	10	oligos	OL-Cntl	41	6	6
CGGACGTAGGGTATCG-1_MS200_A303	-11.05733003	-4.250044908	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2267	4083	0.00832721	0.011511144	10	13A	IN-VIP	41	6	6
CGGACTGAGCTAGTTC-1_MS200_A303	33.78817462	10.87498793	14	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	807	1030	0.002912621	0.021359223	10	14	Microglia	41	6	6
CGGACTGGTAACGCGA-1_MS200_A303	-10.63667919	12.81704134	11	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1168	1639	0.007931666	0.014643075	10	11	Glia-MIX	41	6	6
CGGACTGTCACAATGC-1_MS200_A303	20.26568329	-11.45119238	3	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2633	5154	0.010089251	0.005044626	10	3	EN-L5-6	41	6	6
CGGACTGTCGCCCTTA-1_MS200_A303	-23.69536647	9.317601276	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	925	1316	0.003799392	0.011398176	10	8	Astrocytes	41	6	6
CGGACTGTCGCCGTGA-1_MS200_A303	-30.58994261	-21.44949157	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4082	8066	0.018100669	0.019960327	10	6A	IN-PV	41	6	6
CGGACTGTCTGCGTAA-1_MS200_A303	29.92048281	-18.83062545	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	6528	20187	0.033635508	0.01406846	10	2	EN-L4	41	6	6
CGGACTGTCTTTCCTC-1_MS200_A303	23.02365781	-16.0800083	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	7325	27167	0.01623293	0.009754482	10	2	EN-L4	41	6	6
CGGAGCTAGGGTGTGT-1_MS200_A303	-15.67484692	22.49335922	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1371	2142	0.007002801	0.009803922	10	8	Astrocytes	41	6	6
CGGAGCTAGTGCGTGA-1_MS200_A303	-17.68944388	-2.105048862	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3161	6108	0.015225933	0.008840864	10	13A	IN-VIP	41	6	6
CGGAGCTTCCTGTACC-1_MS200_A303	21.34115936	-3.430213433	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2041	3370	0.038575668	0.006824926	10	2	EN-L4	41	6	6
CGGAGCTTCGCTTAGA-1_MS200_A303	-5.597053686	15.52771404	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	767	1116	0.002688172	0.015232975	10	oligos	OL-MS-1	41	6	6
CGGAGTCCAACACCTA-1_MS200_A303	4.701569848	11.66005893	1	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1103	1701	0.005291005	0.024103469	10	oligos	OL-Cntl	41	6	6
CGGAGTCCAGTAAGAT-1_MS200_A303	-29.88275967	-20.8492542	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5228	14186	0.046172283	0.009939377	10	6A	IN-PV	41	6	6
CGGAGTCCAGTTTACG-1_MS200_A303	-26.33987257	-20.43809651	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2573	5123	0.057193051	0.005465548	10	6A	IN-PV	41	6	6
CGGAGTCGTAACGTTC-1_MS200_A303	-19.88832973	6.618989149	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1145	1871	0.001603421	0.008551577	10	8	Astrocytes	41	6	6
CGGAGTCGTCACTGGC-1_MS200_A303	-5.824987887	-35.37968665	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	902	1258	0.116057234	0.014308426	10	16	EN-PYR	41	6	6
CGGAGTCGTCATGCCG-1_MS200_A303	12.33474109	-3.654062625	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1681	3009	0.103356597	0.004985045	10	12	EN-MIX	41	6	6
CGGAGTCGTCTCCACT-1_MS200_A303	9.501037734	-17.78246016	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5359	15050	0.00538206	0.013488372	10	L2-3	EN-L2-3-MS	41	6	6
CGGAGTCGTGGACGAT-1_MS200_A303	15.74617835	-25.2211034	3	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3395	8025	0.013707165	0.00635514	10	3	EN-L5-6	41	6	6
CGGAGTCGTTCCACGG-1_MS200_A303	-17.4518584	-6.897192452	13B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2899	5885	0.009345794	0.005437553	10	13B	IN-SV2C	41	6	6
CGGAGTCTCATATCGG-1_MS200_A303	-15.17236234	22.30177932	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1450	2315	0.001295896	0.014686825	10	8	Astrocytes	41	6	6
CGGAGTCTCCGCAGTG-1_MS200_A303	-8.921030989	-15.25589788	6B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	750	1044	0.040229885	0.00862069	10	6B	IN-SST	41	6	6
CGGAGTCTCGTTTAGG-1_MS200_A303	-18.91915422	5.48335638	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	923	1138	0.006151142	0.020210896	10	8	Astrocytes	41	6	6
CGGAGTCTCTTGACGA-1_MS200_A303	-17.84389148	-6.044382632	13B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2561	4518	0.013501549	0.006197432	10	13B	IN-SV2C	41	6	6
CGGCTAGAGCGTAGTG-1_MS200_A303	-28.98486592	-7.459893699	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	976	1405	0.002846975	0.007829181	10	9	OPC	41	6	6
CGGCTAGAGGAGTTTA-1_MS200_A303	27.80434809	-18.0370421	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	6980	25242	0.061722526	0.008834482	10	2	EN-L4	41	6	6
CGGCTAGAGGGTATCG-1_MS200_A303	-11.44049359	-38.44155928	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1474	2279	0.090390522	0.024133392	10	16	EN-PYR	41	6	6
CGGCTAGAGTGAACGC-1_MS200_A303	-30.60602696	-21.57071977	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5082	12537	0.04091888	0.00941214	10	6A	IN-PV	41	6	6
CGGCTAGCACCAACCG-1_MS200_A303	20.29894221	-26.80393809	3	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3743	9293	0.000968471	0.003766276	10	3	EN-L5-6	41	6	6
CGGCTAGGTGCACTTA-1_MS200_A303	-16.83794826	20.46715587	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1555	2580	0.002713178	0.010465116	10	8	Astrocytes	41	6	6
CGGCTAGGTGGAAAGA-1_MS200_A303	30.84954915	-15.04300657	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2557	4548	0.022427441	0.01121372	10	2	EN-L4	41	6	6
CGGCTAGGTTGGTTTG-1_MS200_A303	-24.48729745	-23.51894046	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3465	8313	0.034403946	0.004330567	10	6A	IN-PV	41	6	6
CGGCTAGTCTGGTTCC-1_MS200_A303	-5.446758024	17.03072094	1	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	945	1380	0.004347826	0.00942029	10	oligos	OL-Cntl	41	6	6
CGGGTCAAGATGGCGT-1_MS200_A303	-11.29751964	-1.989781574	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2211	4040	0.003217822	0.006930693	10	13A	IN-VIP	41	6	6
CGGGTCACAAGCCTAT-1_MS200_A303	-18.47606033	-0.932581972	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3118	5861	0.011772735	0.02081556	10	13A	IN-VIP	41	6	6
CGGGTCACAATGACCT-1_MS200_A303	23.58708495	7.47244395	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1587	2360	0.013983051	0.024152542	10	oligos	OL-MS-1	41	6	6
CGGGTCAGTAAAGTCA-1_MS200_A303	-28.99295016	-10.91530428	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	951	1313	0.015232292	0.014470678	10	9	OPC	41	6	6
CGGGTCAGTCTCACCT-1_MS200_A303	-15.37556134	24.93892138	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1878	3470	0.005763689	0.008933718	10	8	Astrocytes	41	6	6
CGGGTCAGTGAGGCTA-1_MS200_A303	-13.98736323	22.0749076	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1462	2268	0.011022928	0.015432099	10	8	Astrocytes	41	6	6
CGGGTCAGTTCATGGT-1_MS200_A303	-6.443681032	-34.72401316	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	866	1249	0.116092874	0.013610889	10	16	EN-PYR	41	6	6
CGGGTCAGTTGATTCG-1_MS200_A303	-13.93769681	-37.40620137	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1972	3059	0.042170644	0.019614253	10	16	EN-PYR	41	6	6
CGGGTCATCTTGTCAT-1_MS200_A303	18.28214304	-23.29008986	3	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4818	12908	0.008057019	0.021769445	10	3	EN-L5-6	41	6	6
CGGTTAAAGACCTTTG-1_MS200_A303	-10.91947103	-15.58741949	6B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1029	1597	0.083907326	0.008140263	10	6B	IN-SST	41	6	6
CGGTTAAAGCCATCGC-1_MS200_A303	28.487194	-19.03983432	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	6324	19149	0.021724372	0.014674396	10	2	EN-L4	41	6	6
CGGTTAAAGTTCGCGC-1_MS200_A303	-10.83754388	-4.373210643	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2158	3680	0.049184783	0.011413043	10	13A	IN-VIP	41	6	6
CGGTTAAAGTTTGCGT-1_MS200_A303	8.74475473	-11.19313982	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2038	3367	0.019305019	0.00980101	10	L2-3	EN-L2-3-MS	41	6	6
CGGTTAAGTAGATTAG-1_MS200_A303	-14.74966939	21.76326666	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1278	1961	0.00254972	0.015298317	10	8	Astrocytes	41	6	6
CGGTTAAGTTCAGGCC-1_MS200_A303	-15.28812429	23.94288674	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1685	3142	0.00700191	0.007956715	10	8	Astrocytes	41	6	6
CGGTTAAGTTGTCGCG-1_MS200_A303	-28.11747417	-5.128611848	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1152	1576	0.006345178	0.01142132	10	9	OPC	41	6	6
CGGTTAATCGGTGTCG-1_MS200_A303	8.676401132	1.489591876	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	734	1105	0.175565611	0.010859729	10	12	EN-MIX	41	6	6
CGTAGCGCAATTCCTT-1_MS200_A303	3.61563762	4.76025582	7	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1366	1909	0.013095862	0.015715034	10	7	Phagocytes	41	6	6
CGTAGCGTCAGCTGGC-1_MS200_A303	12.44906023	-18.54232555	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5833	18086	0.00757492	0.008238416	10	L2-3	EN-L2-3-MS	41	6	6
CGTAGCGTCGCCCTTA-1_MS200_A303	-11.3657776	28.55351265	17	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1168	1598	0.048811014	0.010638298	10	oligos	OL-MS-2	41	6	6
CGTAGGCAGGGATGGG-1_MS200_A303	10.60204022	1.155134314	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	871	1331	0.141998497	0.004507889	10	12	EN-MIX	41	6	6
CGTAGGCCATGGTAGG-1_MS200_A303	-14.54416972	22.81151768	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1543	2526	0.006334125	0.011876485	10	8	Astrocytes	41	6	6
CGTAGGCGTACAGCAG-1_MS200_A303	-10.29353082	16.9451467	11	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2454	4440	0.006981982	0.013513514	10	11	Glia-MIX	41	6	6
CGTAGGCGTCTCTTAT-1_MS200_A303	-15.35421903	21.94742594	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1250	1932	0.008799172	0.015010352	10	8	Astrocytes	41	6	6
CGTAGGCGTGTGAAAT-1_MS200_A303	-29.74657601	-3.763462731	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1332	1961	0.005609383	0.005099439	10	9	OPC	41	6	6
CGTAGGCGTTTCCACC-1_MS200_A303	34.21440625	-17.92767441	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4307	9588	0.01126408	0.018251982	10	2	EN-L4	41	6	6
CGTAGGCTCACGAAGG-1_MS200_A303	34.23584123	-18.13153123	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3805	7767	0.011072486	0.020986224	10	2	EN-L4	41	6	6
CGTAGGCTCGCAAGCC-1_MS200_A303	9.848578191	-19.35938868	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4068	9480	0.007067511	0.010443038	10	L2-3	EN-L2-3-MS	41	6	6
CGTCACTAGGCTCAGA-1_MS200_A303	0.726214397	1.097603812	11	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1559	2345	0.052452026	0.012366738	10	11	Glia-MIX	41	6	6
CGTCACTAGGGCTTCC-1_MS200_A303	-24.5334406	9.288978462	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1021	1465	0.013651877	0.00887372	10	8	Astrocytes	41	6	6
CGTCACTCAACACCCG-1_MS200_A303	18.409207	-20.55064536	3	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3295	7553	0.030848669	0.003971932	10	3	EN-L5-6	41	6	6
CGTCACTCATCCGGGT-1_MS200_A303	12.83731457	0.357099229	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	982	1635	0.179816514	0.005504587	10	12	EN-MIX	41	6	6
CGTCACTGTGTTTGGT-1_MS200_A303	6.547866792	-13.87108317	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2763	5807	0.029963837	0.008438092	10	L2-3	EN-L2-3-MS	41	6	6
CGTCAGGAGCTACCTA-1_MS200_A303	13.52703417	-20.37137407	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4897	13317	0.009236314	0.007659383	10	L2-3	EN-L2-3-MS	41	6	6
CGTCAGGAGCTTTGGT-1_MS200_A303	11.84431394	-12.96325653	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3355	6715	0.011764706	0.014147431	10	L2-3	EN-L2-3-MS	41	6	6
CGTCAGGCATATGAGA-1_MS200_A303	-11.96133546	19.26969737	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2851	5316	0.005643341	0.006019564	10	8	Astrocytes	41	6	6
CGTCAGGTCAACACCA-1_MS200_A303	-29.57857337	-3.96436249	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1276	1966	0.003560529	0.01525941	10	9	OPC	41	6	6
CGTCAGGTCACATAGC-1_MS200_A303	34.19566134	-15.97066768	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4272	9576	0.011173768	0.01566416	10	2	EN-L4	41	6	6
CGTCAGGTCCCACTTG-1_MS200_A303	-12.21274909	17.66940234	11	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2167	3855	0.010376135	0.010894942	10	11	Glia-MIX	41	6	6
CGTCCATAGAAACCGC-1_MS200_A303	33.40172694	10.88026592	14	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	798	1048	0.005725191	0.027671756	10	14	Microglia	41	6	6
CGTCCATAGAGGTAGA-1_MS200_A303	-28.73547455	-5.317376839	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1275	1833	0.003273322	0.012002182	10	9	OPC	41	6	6
CGTCCATGTGTTCGAT-1_MS200_A303	-4.978415552	17.7237169	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	808	1175	0.001702128	0.01106383	10	oligos	OL-MS-1	41	6	6
CGTCCATTCCAGAAGG-1_MS200_A303	15.96669932	-16.14094156	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	6537	20425	0.007735618	0.023108935	10	L2-3	EN-L2-3-MS	41	6	6
CGTCCATTCCCATTTA-1_MS200_A303	-24.79744076	7.381434705	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	835	1219	0.003281378	0.007383101	10	8	Astrocytes	41	6	6
CGTCCATTCCTAGTGA-1_MS200_A303	-22.0741738	-16.43987164	6B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3352	7653	0.015549458	0.003658696	10	6B	IN-SST	41	6	6
CGTCCATTCGCCCTTA-1_MS200_A303	-5.61886246	-36.39947925	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	884	1124	0.044483986	0.023131673	10	16	EN-PYR	41	6	6
CGTCCATTCTGCCCTA-1_MS200_A303	-26.22376521	-20.29908937	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2473	4646	0.027120103	0.00796384	10	6A	IN-PV	41	6	6
CGTCTACAGAGTACAT-1_MS200_A303	27.79750609	-11.05407493	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4434	11254	0.019904034	0.005420295	10	L2-3	EN-L2-3-MS	41	6	6
CGTCTACGTTCCAACA-1_MS200_A303	-31.08918357	2.638346323	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2049	3782	0.006345849	0.009254363	10	9	OPC	41	6	6
CGTCTACGTTCGGGCT-1_MS200_A303	18.6264761	-16.65593275	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4564	11814	0.030641612	0.006094464	10	L2-3	EN-L2-3-MS	41	6	6
CGTCTACGTTGTGGAG-1_MS200_A303	-5.170167948	-35.30950885	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	808	1165	0.13304721	0.022317597	10	16	EN-PYR	41	6	6
CGTCTACTCGAGAACG-1_MS200_A303	-26.72204429	-21.7382064	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3481	7738	0.026234169	0.00710778	10	6A	IN-PV	41	6	6
CGTCTACTCTCAAACG-1_MS200_A303	-24.25806852	-19.46941925	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3688	8306	0.014086203	0.009390802	10	6A	IN-PV	41	6	6
CGTGAGCAGAATGTTG-1_MS200_A303	16.42744581	-14.10242477	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	6625	21003	0.018949674	0.007475123	10	L2-3	EN-L2-3-MS	41	6	6
CGTGAGCAGTCAAGCG-1_MS200_A303	-9.319086013	-13.16773221	6B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	912	1266	0.017377567	0.004739336	10	6B	IN-SST	41	6	6
CGTGAGCCAATGACCT-1_MS200_A303	-33.27167051	-11.90263748	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	886	1242	0.003220612	0.008856683	10	9	OPC	41	6	6
CGTGAGCCATACTCTT-1_MS200_A303	16.29599856	-16.11057958	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	6691	21649	0.018984711	0.016028454	10	L2-3	EN-L2-3-MS	41	6	6
CGTGAGCCATAGACTC-1_MS200_A303	33.76729034	-18.20519405	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3806	7632	0.012578616	0.016771488	10	2	EN-L4	41	6	6
CGTGAGCCATGTCGAT-1_MS200_A303	-5.289961191	12.14740198	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	790	1160	0.018103448	0.025862069	10	oligos	OL-MS-1	41	6	6
CGTGTAAAGACAGACC-1_MS200_A303	-24.73029264	-19.47901508	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2656	5334	0.028683915	0.010311211	10	6A	IN-PV	41	6	6
CGTGTAACAACAACCT-1_MS200_A303	11.8867932	-12.38409611	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3192	6585	0.028549734	0.015186029	10	L2-3	EN-L2-3-MS	41	6	6
CGTGTAACACAGAGGT-1_MS200_A303	-14.28226378	21.78433737	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1442	2295	0.005664488	0.013507625	10	8	Astrocytes	41	6	6
CGTGTAACACATTAGC-1_MS200_A303	-15.42653996	-2.229916455	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2388	4437	0.022086996	0.011043498	10	13A	IN-VIP	41	6	6
CGTGTAAGTATAATGG-1_MS200_A303	34.11682246	-12.36574798	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3017	5616	0.006766382	0.011930199	10	2	EN-L4	41	6	6
CGTGTAAGTGTGCCTG-1_MS200_A303	-29.13027929	-21.36228895	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4482	10692	0.02590722	0.010194538	10	6A	IN-PV	41	6	6
CGTGTAAGTTCAGCGC-1_MS200_A303	10.99317462	-0.18114998	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1072	1563	0.075495841	0.005118362	10	12	EN-MIX	41	6	6
CGTGTAAGTTCGGCAC-1_MS200_A303	15.15826225	-13.70299006	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5471	15034	0.014167886	0.00891313	10	L2-3	EN-L2-3-MS	41	6	6
CGTGTAATCAGCTCTC-1_MS200_A303	10.88585715	1.5382351	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	791	1126	0.130550622	0.006216696	10	12	EN-MIX	41	6	6
CGTGTCTAGAATCTCC-1_MS200_A303	10.65672839	1.043505656	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	885	1289	0.065166796	0.004654771	10	12	EN-MIX	41	6	6
CGTGTCTCACATCCGG-1_MS200_A303	-29.75682	-21.69628037	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4530	11045	0.037211408	0.011317338	10	6A	IN-PV	41	6	6
CGTGTCTCACCCTATC-1_MS200_A303	12.64380087	1.725304353	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	823	1147	0.054925894	0.003487358	10	12	EN-MIX	41	6	6
CGTGTCTCACGCATCG-1_MS200_A303	33.21163047	-15.67222254	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3376	6516	0.015346839	0.015500307	10	2	EN-L4	41	6	6
CGTGTCTCAGCCTTTC-1_MS200_A303	-16.39924569	20.56471965	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1458	2295	0.006100218	0.010021786	10	8	Astrocytes	41	6	6
CGTGTCTGTCGAGTTT-1_MS200_A303	14.3964482	-15.79780424	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	6607	20206	0.017668019	0.008512323	10	L2-3	EN-L2-3-MS	41	6	6
CGTGTCTGTGAGCGAT-1_MS200_A303	33.41088964	-17.9344395	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4423	9693	0.022180955	0.019808109	10	2	EN-L4	41	6	6
CGTGTCTTCTCGCATC-1_MS200_A303	6.312736712	-5.961726269	10	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1361	2193	0.001823985	0.004559964	10	L2-3	EN-L2-3-Cntl	41	6	6
CGTTAGAAGAGCTGCA-1_MS200_A303	14.73720841	-13.75231015	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5013	12463	0.023188638	0.0121961	10	L2-3	EN-L2-3-MS	41	6	6
CGTTAGACAAATCCGT-1_MS200_A303	-28.99452289	-5.102202488	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1264	1849	0.008112493	0.006489995	10	9	OPC	41	6	6
CGTTAGAGTGAACCTT-1_MS200_A303	-4.564247568	18.48944678	1	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	696	1008	0.00297619	0.008928571	10	oligos	OL-Cntl	41	6	6
CGTTAGAGTTAGATGA-1_MS200_A303	-19.33009928	-0.362007211	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3934	7763	0.010820559	0.011979905	10	13A	IN-VIP	41	6	6
CGTTAGATCAGGCAAG-1_MS200_A303	5.153260841	-9.477929974	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1657	2745	0.084153005	0.003642987	10	12	EN-MIX	41	6	6
CGTTCTGAGAGGGATA-1_MS200_A303	29.73396572	14.38843484	14	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	850	1278	0.002347418	0.103286385	10	14	Microglia	41	6	6
CGTTCTGAGGCAGGTT-1_MS200_A303	11.83644422	-14.88396761	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3795	8427	0.010323959	0.011866619	10	L2-3	EN-L2-3-MS	41	6	6
CGTTCTGCAAACCCAT-1_MS200_A303	-25.0605912	0.087070176	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2352	4193	0.008108753	0.012401622	10	9	OPC	41	6	6
CGTTCTGCACGGCTAC-1_MS200_A303	-30.36378661	-2.356553667	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1379	2170	0.000460829	0.004608295	10	9	OPC	41	6	6
CGTTCTGCACGTGAGA-1_MS200_A303	-16.32549167	12.74653899	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1492	2578	0.000387898	0.006206362	10	8	Astrocytes	41	6	6
CGTTCTGCACTCTGTC-1_MS200_A303	-15.41893694	23.27398642	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1539	2388	0.011306533	0.008375209	10	8	Astrocytes	41	6	6
CGTTCTGGTAAAGGAG-1_MS200_A303	-14.1412792	10.02354052	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1865	2949	0.009155646	0.011190234	10	8	Astrocytes	41	6	6
CGTTCTGGTTCCGTCT-1_MS200_A303	-17.02704374	20.32762346	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1299	1980	0.001515152	0.015151515	10	8	Astrocytes	41	6	6
CGTTCTGTCGCATGGC-1_MS200_A303	-17.57489883	-4.017752934	13B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2637	4959	0.013712442	0.008872757	10	13B	IN-SV2C	41	6	6
CGTTCTGTCGTCGTTC-1_MS200_A303	28.27922369	-14.30885213	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	6156	19307	0.020821464	0.009789196	10	2	EN-L4	41	6	6
CGTTCTGTCTGTTTGT-1_MS200_A303	-16.17156079	23.40307455	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1366	2403	0.004161465	0.010403662	10	8	Astrocytes	41	6	6
CGTTGGGAGGGTTCCC-1_MS200_A303	18.85017158	-10.72897683	3	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2427	4556	0.031606673	0.004609306	10	3	EN-L5-6	41	6	6
CGTTGGGCAAGGTTTC-1_MS200_A303	-5.643637623	14.95707489	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	747	1032	0.004844961	0.01744186	10	oligos	OL-MS-1	41	6	6
CGTTGGGGTATTACCG-1_MS200_A303	-11.01178033	-15.20133736	6B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1021	1566	0.029374202	0.012132822	10	6B	IN-SST	41	6	6
CGTTGGGGTCATATGC-1_MS200_A303	-29.26772029	-21.89623045	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4552	11110	0.039243924	0.007290729	10	6A	IN-PV	41	6	6
CGTTGGGTCGAATCCA-1_MS200_A303	-10.98796511	-38.09831538	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1307	1905	0.061942257	0.014698163	10	16	EN-PYR	41	6	6
CGTTGGGTCGTGGGAA-1_MS200_A303	17.10751508	-14.49056151	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	6980	22013	0.01621769	0.007813565	10	L2-3	EN-L2-3-MS	41	6	6
CTAACTTAGACCTTTG-1_MS200_A303	12.14257	-13.23321376	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4180	10023	0.018158236	0.010974758	10	L2-3	EN-L2-3-MS	41	6	6
CTAACTTAGAGGTAGA-1_MS200_A303	12.39337027	-15.3655675	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4286	10256	0.005850234	0.010335413	10	L2-3	EN-L2-3-MS	41	6	6
CTAACTTCACAAGTAA-1_MS200_A303	-32.66566915	4.644961611	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2582	5147	0.003885759	0.006217214	10	9	OPC	41	6	6
CTAACTTGTGTATGGG-1_MS200_A303	-15.77988901	21.87341677	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1225	2013	0.006458023	0.00993542	10	8	Astrocytes	41	6	6
CTAACTTTCATGCATG-1_MS200_A303	-30.26837645	-11.85944027	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	774	1159	0.003451251	0.005176877	10	9	OPC	41	6	6
CTAACTTTCCATGCTC-1_MS200_A303	3.882958454	-4.715752035	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1085	1690	0.09408284	0.00591716	10	12	EN-MIX	41	6	6
CTAAGACAGAGGTACC-1_MS200_A303	-14.75184951	25.63718059	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2580	4670	0.00235546	0.011777302	10	8	Astrocytes	41	6	6
CTAAGACGTCCATGAT-1_MS200_A303	12.22903826	-16.59082961	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4821	12435	0.007318054	0.011499799	10	L2-3	EN-L2-3-MS	41	6	6
CTAAGACGTGCGAAAC-1_MS200_A303	-24.71424225	7.845792086	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1007	1368	0.005847953	0.005116959	10	8	Astrocytes	41	6	6
CTAAGACGTTCTGTTT-1_MS200_A303	-18.43485372	-1.084589301	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3480	6946	0.009645839	0.013245033	10	13A	IN-VIP	41	6	6
CTAAGACTCTTCCTTC-1_MS200_A303	29.52641069	-3.29026929	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3823	10401	0.000769157	0.003941929	10	2	EN-L4	41	6	6
CTAATGGAGGTGACCA-1_MS200_A303	-23.7996768	-9.663947836	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	968	1329	0.021068473	0.005267118	10	9	OPC	41	6	6
CTAATGGCACAACGCC-1_MS200_A303	-24.5691928	-0.318783687	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1778	2983	0.004358029	0.004693262	10	9	OPC	41	6	6
CTACACCAGCGATCCC-1_MS200_A303	32.50788045	-14.08797854	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3535	7769	0.028446389	0.007208135	10	2	EN-L4	41	6	6
CTACACCAGTACACCT-1_MS200_A303	-17.69978475	-1.676640634	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3877	8342	0.034524095	0.010069528	10	13A	IN-VIP	41	6	6
CTACACCCACGCGAAA-1_MS200_A303	-5.678646229	15.36659971	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	763	1100	0.010909091	0.013636364	10	oligos	OL-MS-1	41	6	6
CTACACCCATACTCTT-1_MS200_A303	-24.03769033	9.351816782	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1120	1726	0.017381228	0.011008111	10	8	Astrocytes	41	6	6
CTACACCCATCCGTGG-1_MS200_A303	33.8878321	-14.74496921	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4576	11250	0.015555556	0.007022222	10	2	EN-L4	41	6	6
CTACACCCATCTCCCA-1_MS200_A303	-15.32441455	25.12906533	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1874	3391	0.004128576	0.00678266	10	8	Astrocytes	41	6	6
CTACACCGTAAGCACG-1_MS200_A303	16.7095261	-15.18663946	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	7471	26573	0.014036804	0.014262597	10	L2-3	EN-L2-3-MS	41	6	6
CTACACCGTCTGCGGT-1_MS200_A303	-9.279636815	-20.26257281	6B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	798	1150	0.046086957	0.004347826	10	6B	IN-SST	41	6	6
CTACACCGTGGCAAAC-1_MS200_A303	17.9477035	-15.73684561	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	6976	24167	0.018330782	0.008896429	10	L2-3	EN-L2-3-MS	41	6	6
CTACACCTCTTACCTA-1_MS200_A303	10.94363516	0.089011896	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	995	1503	0.111111111	0.00665336	10	12	EN-MIX	41	6	6
CTACATTAGACTTTCG-1_MS200_A303	-22.42534156	-24.36694865	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2704	5739	0.016727653	0.006098623	10	6A	IN-PV	41	6	6
CTACATTAGTACACCT-1_MS200_A303	3.858006613	4.278567777	7	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1576	2370	0.008438819	0.033755274	10	7	Phagocytes	41	6	6
CTACATTCACGAGGTA-1_MS200_A303	9.365676473	-19.135434	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5282	15305	0.003593597	0.009996733	10	L2-3	EN-L2-3-MS	41	6	6
CTACATTCAGGGATTG-1_MS200_A303	5.944958541	-2.483459412	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	960	1497	0.144288577	0.006680027	10	12	EN-MIX	41	6	6
CTACATTGTCCGAACC-1_MS200_A303	-30.06021012	-2.341622327	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1515	2417	0.00413736	0.004551096	10	9	OPC	41	6	6
CTACATTGTCTCCACT-1_MS200_A303	-19.40932662	-0.503511771	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5418	13865	0.007789398	0.015146051	10	13A	IN-VIP	41	6	6
CTACATTGTGTGCGTC-1_MS200_A303	-28.92718575	-10.24686651	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1016	1395	0.009318996	0.013620072	10	9	OPC	41	6	6
CTACATTGTGTGGCTC-1_MS200_A303	24.75100823	-13.37123645	3	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5256	14425	0.008665511	0.009012132	10	3	EN-L5-6	41	6	6
CTACATTTCTACTTAC-1_MS200_A303	-28.26326434	-6.774101344	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1004	1494	0.004685408	0.00669344	10	9	OPC	41	6	6
CTACCCAAGCCGTCGT-1_MS200_A303	25.08048828	-14.9143176	3	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5324	13530	0.015373245	0.007982262	10	3	EN-L5-6	41	6	6
CTACCCAAGCGCCTCA-1_MS200_A303	25.13336258	-15.00761084	3	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	8443	35564	0.024322348	0.009785176	10	3	EN-L5-6	41	6	6
CTACCCAAGCGTTTAC-1_MS200_A303	-9.425551022	-9.283333005	13B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1234	1846	0.009209101	0.008125677	10	13B	IN-SV2C	41	6	6
CTACCCAAGCTAACAA-1_MS200_A303	-16.68199982	20.16247187	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1248	1842	0.00597177	0.00597177	10	8	Astrocytes	41	6	6
CTACCCAAGCTCTCGG-1_MS200_A303	28.66726891	-19.03617721	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	9195	47240	0.039839119	0.011812024	10	2	EN-L4	41	6	6
CTACCCACAGTACACT-1_MS200_A303	11.30728665	-18.20061214	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5678	17559	0.007289709	0.004726921	10	L2-3	EN-L2-3-MS	41	6	6
CTACCCAGTCTCATCC-1_MS200_A303	-27.87460451	-22.15384408	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4485	12117	0.044400429	0.010151027	10	6A	IN-PV	41	6	6
CTACCCATCATTCACT-1_MS200_A303	25.40387617	9.592942331	15A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3109	7001	0.018140266	0.031424082	10	15A	Endo cells	41	6	6
CTACCCATCGTTGACA-1_MS200_A303	29.59974344	-18.84443439	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	7376	26513	0.03198431	0.014445744	10	2	EN-L4	41	6	6
CTACGTCAGCACGCCT-1_MS200_A303	-24.62653092	-23.87876676	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4466	11879	0.027780116	0.006818756	10	6A	IN-PV	41	6	6
CTACGTCAGGACACCA-1_MS200_A303	-4.716709085	20.18224065	1	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	752	1146	0.004363002	0.013089005	10	oligos	OL-Cntl	41	6	6
CTACGTCAGTCGATAA-1_MS200_A303	-24.47504177	10.83246565	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1035	1580	0.005063291	0.009493671	10	8	Astrocytes	41	6	6
CTACGTCCACAACGTT-1_MS200_A303	6.907280818	-1.173375372	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	780	1005	0.023880597	0.010945274	10	12	EN-MIX	41	6	6
CTACGTCCACATCTTT-1_MS200_A303	-30.30380742	-21.85677858	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5616	16114	0.021347896	0.016259154	10	6A	IN-PV	41	6	6
CTACGTCGTCCAGTGC-1_MS200_A303	-30.35915529	-21.70197761	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5841	17416	0.048805696	0.007694074	10	6A	IN-PV	41	6	6
CTACGTCGTCGTTGTA-1_MS200_A303	24.09695702	-17.69680117	3	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4892	12814	0.025128765	0.009286718	10	3	EN-L5-6	41	6	6
CTACGTCGTGTGGTTT-1_MS200_A303	17.18122805	-13.47224772	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	6290	19051	0.01233531	0.010603118	10	L2-3	EN-L2-3-MS	41	6	6
CTACGTCGTTTGTGTG-1_MS200_A303	-15.3125575	21.89635996	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1239	2092	0.00334608	0.012428298	10	8	Astrocytes	41	6	6
CTACGTCTCCTAGTGA-1_MS200_A303	-24.45115988	-12.34553695	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	857	1096	0.020985401	0.017335766	10	9	OPC	41	6	6
CTAGAGTCAATGAATG-1_MS200_A303	-7.242981715	-34.04543459	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	980	1484	0.150943396	0.011455526	10	16	EN-PYR	41	6	6
CTAGAGTCACACATGT-1_MS200_A303	-5.384162803	14.08083001	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	820	1225	0.008979592	0.019591837	10	oligos	OL-MS-1	41	6	6
CTAGAGTCAGGACCCT-1_MS200_A303	4.188037015	-2.680565312	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	844	1279	0.082877248	0.008600469	10	12	EN-MIX	41	6	6
CTAGAGTCATGGTAGG-1_MS200_A303	16.82833067	-9.431457719	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1828	3339	0.087151842	0.00359389	10	12	EN-MIX	41	6	6
CTAGAGTGTAGCGTAG-1_MS200_A303	-5.92761199	14.63470268	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	802	1082	0.006469501	0.014787431	10	oligos	OL-MS-1	41	6	6
CTAGAGTTCCTTTCTC-1_MS200_A303	-4.62754699	15.7792316	1	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	750	1080	0.009259259	0.016666667	10	oligos	OL-Cntl	41	6	6
CTAGAGTTCTGATACG-1_MS200_A303	-29.28679516	-3.150635829	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1533	2360	0.009322034	0.006779661	10	9	OPC	41	6	6
CTAGCCTAGCGGCTTC-1_MS200_A303	19.28001875	-24.94388079	3	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3749	9210	0.002171553	0.010206298	10	3	EN-L5-6	41	6	6
CTAGCCTCAATGAATG-1_MS200_A303	-29.90504265	-10.98242462	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	831	1178	0.004244482	0.006791171	10	9	OPC	41	6	6
CTAGCCTCAGATCCAT-1_MS200_A303	10.78657231	-13.45462127	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3327	7277	0.008107737	0.01690257	10	L2-3	EN-L2-3-MS	41	6	6
CTAGCCTCATATGGTC-1_MS200_A303	-15.76743549	23.58138855	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1730	3342	0.002692998	0.007480551	10	8	Astrocytes	41	6	6
CTAGCCTGTTTCGCTC-1_MS200_A303	17.76777923	-21.66215309	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3946	9826	0.016893955	0.010991248	10	L2-3	EN-L2-3-MS	41	6	6
CTAGCCTTCAGAAATG-1_MS200_A303	-33.18706008	-4.933574204	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1243	1987	0.003019628	0.005535984	10	9	OPC	41	6	6
CTAGCCTTCATACGGT-1_MS200_A303	-7.900966738	-32.97188601	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1046	1423	0.082923401	0.01054111	10	16	EN-PYR	41	6	6
CTAGCCTTCGCTTGTC-1_MS200_A303	-14.2726125	22.68871891	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1466	2529	0.005140372	0.013444049	10	8	Astrocytes	41	6	6
CTAGTGAAGAGACTTA-1_MS200_A303	29.08978058	7.107101134	15DA	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	846	1104	0.097826087	0.052536232	10	15DA	T cells	41	6	6
CTAGTGAAGCCAGTAG-1_MS200_A303	15.56323813	-26.58574569	3	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3746	8607	0.005112118	0.006622517	10	3	EN-L5-6	41	6	6
CTAGTGAAGCTACCTA-1_MS200_A303	10.27910907	-2.595185918	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1676	2490	0.028915663	0.008032129	10	12	EN-MIX	41	6	6
CTAGTGAAGTCGCCGT-1_MS200_A303	-26.80411013	-18.33704692	6B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2303	4047	0.034840623	0.008648382	10	6B	IN-SST	41	6	6
CTAGTGAAGTTACCCA-1_MS200_A303	-4.016145066	14.90962858	1	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	807	1110	0.005405405	0.014414414	10	oligos	OL-Cntl	41	6	6
CTAGTGACACGTTGGC-1_MS200_A303	14.47082245	-13.15338505	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4632	11240	0.012900356	0.014145907	10	L2-3	EN-L2-3-MS	41	6	6
CTAGTGACATGGTTGT-1_MS200_A303	34.25708558	-17.25336766	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5203	13412	0.009320012	0.014762899	10	2	EN-L4	41	6	6
CTAGTGACATTTCACT-1_MS200_A303	-8.265436509	-37.62546992	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1109	1568	0.045280612	0.020408163	10	16	EN-PYR	41	6	6
CTAGTGAGTACCATCA-1_MS200_A303	-22.08560861	-21.77294362	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2469	4637	0.056717705	0.00388182	10	6A	IN-PV	41	6	6
CTAGTGAGTGGCTCCA-1_MS200_A303	-0.873592287	-0.937819576	11	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1782	2853	0.042762005	0.013669821	10	11	Glia-MIX	41	6	6
CTAGTGAGTTCAGGCC-1_MS200_A303	-24.47469669	9.039407485	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1025	1609	0.012430081	0.00621504	10	8	Astrocytes	41	6	6
CTAGTGAGTTGCCTCT-1_MS200_A303	-13.96273652	3.392864616	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2981	5815	0.020120378	0.006190886	10	13A	IN-VIP	41	6	6
CTAGTGATCCATGAGT-1_MS200_A303	33.3172912	-16.88097682	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5109	12857	0.011900132	0.021000233	10	2	EN-L4	41	6	6
CTAGTGATCTCTAGGA-1_MS200_A303	-9.394464102	-9.175636629	13B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1337	1969	0.008125952	0.009649568	10	13B	IN-SV2C	41	6	6
CTCACACAGAATAGGG-1_MS200_A303	27.84189951	-18.10188927	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	8832	47440	0.078161889	0.005417369	10	2	EN-L4	41	6	6
CTCACACAGCTAGCCC-1_MS200_A303	-7.493377533	-33.80856791	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	872	1173	0.051150895	0.007672634	10	16	EN-PYR	41	6	6
CTCACACAGCTGGAAC-1_MS200_A303	34.67411435	10.52533489	14	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	781	1003	0.003988036	0.014955135	10	14	Microglia	41	6	6
CTCACACCAAAGGTGC-1_MS200_A303	-2.249155817	19.58999129	1	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	735	1053	0.005698006	0.012345679	10	oligos	OL-Cntl	41	6	6
CTCACACCAGCCACCA-1_MS200_A303	-17.50848734	-0.923495641	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3956	8889	0.008324896	0.010574868	10	13A	IN-VIP	41	6	6
CTCACACTCACCATAG-1_MS200_A303	-10.8428357	-38.47988781	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1343	1876	0.042643923	0.026119403	10	16	EN-PYR	41	6	6
CTCACACTCCAAACAC-1_MS200_A303	-27.46577838	-22.63056168	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4247	10684	0.02096593	0.010670161	10	6A	IN-PV	41	6	6
CTCACACTCTAACTCT-1_MS200_A303	-23.94472712	-20.70023288	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3127	6704	0.021479714	0.005220764	10	6A	IN-PV	41	6	6
CTCACACTCTACTATC-1_MS200_A303	23.15503202	-16.30755235	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	7766	32646	0.027966673	0.008056117	10	2	EN-L4	41	6	6
CTCAGAAAGCCCAACC-1_MS200_A303	-14.66425796	-37.69587917	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2115	3491	0.042108278	0.021770266	10	16	EN-PYR	41	6	6
CTCAGAAAGTACGCGA-1_MS200_A303	-19.49572723	-1.946483383	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3672	7380	0.022628726	0.014498645	10	13A	IN-VIP	41	6	6
CTCAGAAAGTCCCACG-1_MS200_A303	35.3845076	11.149952	14	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	880	1240	0.008870968	0.02016129	10	14	Microglia	41	6	6
CTCAGAAAGTGAAGAG-1_MS200_A303	-13.64601001	-38.02610532	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1734	2841	0.050686378	0.017951426	10	16	EN-PYR	41	6	6
CTCAGAACAAGAGGCT-1_MS200_A303	15.9757086	-10.40822085	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1995	3690	0.033875339	0.005420054	10	12	EN-MIX	41	6	6
CTCAGAACATCAGTCA-1_MS200_A303	-14.0953813	23.1323997	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1867	3234	0.004329004	0.009276438	10	8	Astrocytes	41	6	6
CTCAGAAGTAATAGCA-1_MS200_A303	9.876162885	-3.894849335	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2181	3425	0.011970803	0.012554745	10	12	EN-MIX	41	6	6
CTCAGAAGTAGTAGTA-1_MS200_A303	-28.14159293	-6.063169908	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1066	1443	0.009009009	0.01039501	10	9	OPC	41	6	6
CTCAGAAGTATGGTTC-1_MS200_A303	25.1476228	-17.97051018	3	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4886	13722	0.078632852	0.004081038	10	3	EN-L5-6	41	6	6
CTCAGAAGTTGAGGTG-1_MS200_A303	22.35802383	-4.712213985	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2374	4023	0.063385533	0.00347999	10	2	EN-L4	41	6	6
CTCAGAATCGTGGACC-1_MS200_A303	-27.03259025	-21.12574799	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3080	5954	0.023177696	0.00974135	10	6A	IN-PV	41	6	6
CTCAGAATCGTGGGAA-1_MS200_A303	-14.49070851	22.01747994	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1294	1974	0.010131712	0.01621074	10	8	Astrocytes	41	6	6
CTCATTAAGCACACAG-1_MS200_A303	-31.60604183	-6.070546341	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1200	1935	0.004134367	0.008268734	10	9	OPC	41	6	6
CTCATTAAGCGATTCT-1_MS200_A303	-14.45456404	-3.221937339	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3403	8008	0.009240759	0.005244755	10	13A	IN-VIP	41	6	6
CTCATTAAGTGAATTG-1_MS200_A303	-22.66556153	-20.32756551	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2711	5301	0.017166572	0.003772873	10	6A	IN-PV	41	6	6
CTCATTACACGGTAGA-1_MS200_A303	-29.0263383	-5.491723079	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1219	1778	0.006749156	0.007874016	10	9	OPC	41	6	6
CTCATTACAGCTTAAC-1_MS200_A303	-35.47434385	-3.5384149	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1403	2254	0.004880213	0.004880213	10	9	OPC	41	6	6
CTCATTACATGTTCCC-1_MS200_A303	4.956871181	-17.35836946	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2939	6790	0.006774669	0.008247423	10	L2-3	EN-L2-3-MS	41	6	6
CTCATTAGTAGTACCT-1_MS200_A303	-32.84444823	-4.564097783	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1264	2081	0.000480538	0.004805382	10	9	OPC	41	6	6
CTCATTAGTATCTGCA-1_MS200_A303	-12.03132835	32.22613971	17	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	957	1429	0.1126662	0.009097271	10	oligos	OL-MS-2	41	6	6
CTCATTAGTCTTCTCG-1_MS200_A303	-18.3143269	-6.323370862	13B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3642	8307	0.008306248	0.009630432	10	13B	IN-SV2C	41	6	6
CTCATTAGTGCCTGTG-1_MS200_A303	-9.357193323	-16.26486164	6B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	836	1258	0.076311606	0.00317965	10	6B	IN-SST	41	6	6
CTCATTAGTTAGAACA-1_MS200_A303	34.11636511	-14.47138805	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4369	10436	0.007761594	0.00843235	10	2	EN-L4	41	6	6
CTCATTAGTTCCGTCT-1_MS200_A303	-27.15087697	-22.98913484	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4470	10575	0.0243026	0.010307329	10	6A	IN-PV	41	6	6
CTCATTATCAATCACG-1_MS200_A303	-31.68992746	-6.216399546	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1127	1787	0.001678791	0.004476777	10	9	OPC	41	6	6
CTCATTATCACAGGCC-1_MS200_A303	-14.96040321	24.65021702	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1732	3178	0.003146633	0.012586532	10	8	Astrocytes	41	6	6
CTCATTATCTTCAACT-1_MS200_A303	25.38715286	7.068765751	15A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1639	3200	0.00125	0.01625	10	15A	Endo cells	41	6	6
CTCCTAGAGCAGATCG-1_MS200_A303	-14.09982949	22.71751032	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1631	2581	0.00232468	0.013948082	10	8	Astrocytes	41	6	6
CTCCTAGAGCTCAACT-1_MS200_A303	34.16614936	-17.54292598	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3755	7778	0.011956801	0.017356647	10	2	EN-L4	41	6	6
CTCCTAGAGCTCTCGG-1_MS200_A303	-29.07882214	-4.040486772	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1342	2182	0.003208066	0.009165903	10	9	OPC	41	6	6
CTCCTAGAGGGAAACA-1_MS200_A303	-11.99679011	-5.154540016	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2164	3708	0.017799353	0.013754045	10	13A	IN-VIP	41	6	6
CTCCTAGCAACAACCT-1_MS200_A303	25.40949881	8.959865806	15A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2125	3546	0.014946418	0.034968979	10	15A	Endo cells	41	6	6
CTCCTAGCACTTAACG-1_MS200_A303	13.6494187	-14.71811648	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4118	9729	0.012642615	0.005961558	10	L2-3	EN-L2-3-MS	41	6	6
CTCCTAGCAGCGTAAG-1_MS200_A303	-29.80163985	-11.65339776	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	799	1130	0.017699115	0.011504425	10	9	OPC	41	6	6
CTCCTAGGTCCCTACT-1_MS200_A303	-18.17466636	27.76968716	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2039	3879	0.003093581	0.008507347	10	8	Astrocytes	41	6	6
CTCGAAACACGTGAGA-1_MS200_A303	-16.05284682	20.14774607	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1609	2365	0.003382664	0.013107822	10	8	Astrocytes	41	6	6
CTCGAAACACTGCCAG-1_MS200_A303	4.334395414	-3.112083768	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	982	1541	0.098637249	0.003893576	10	12	EN-MIX	41	6	6
CTCGAAACAGTCTTCC-1_MS200_A303	33.96111582	-16.89431878	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5074	13569	0.016803007	0.012233768	10	2	EN-L4	41	6	6
CTCGAAACATGGATGG-1_MS200_A303	-1.610944436	-35.63125305	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1603	2202	0.036330609	0.021344233	10	16	EN-PYR	41	6	6
CTCGAAAGTAGTAGTA-1_MS200_A303	-23.7808254	9.329625583	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1116	1613	0.004959702	0.014879107	10	8	Astrocytes	41	6	6
CTCGAAAGTCCGAGTC-1_MS200_A303	-13.65390733	22.82092241	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1683	2782	0.005751258	0.016894321	10	8	Astrocytes	41	6	6
CTCGAAAGTGTGTGCC-1_MS200_A303	-31.64060428	-5.470432089	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1337	2102	0.002854424	0.004281637	10	9	OPC	41	6	6
CTCGAAATCTGGTATG-1_MS200_A303	-16.42146997	20.58819964	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1483	2310	0.003463203	0.011255411	10	8	Astrocytes	41	6	6
CTCGAGGAGAACAACT-1_MS200_A303	33.62106949	-11.23423055	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2469	4549	0.005056056	0.010771598	10	2	EN-L4	41	6	6
CTCGAGGAGGCATGGT-1_MS200_A303	11.35393807	-3.239396315	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2017	3551	0.147000845	0.006477049	10	12	EN-MIX	41	6	6
CTCGAGGAGGCCCTTG-1_MS200_A303	13.80083805	-14.70615175	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4362	10530	0.010731244	0.008452042	10	L2-3	EN-L2-3-MS	41	6	6
CTCGAGGAGTGGAGAA-1_MS200_A303	-28.28938404	-10.01825474	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	985	1325	0.009056604	0.012075472	10	9	OPC	41	6	6
CTCGAGGGTATCAGTC-1_MS200_A303	-22.3562185	7.065856611	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1236	1916	0.008872651	0.012526096	10	8	Astrocytes	41	6	6
CTCGAGGGTGCCTGCA-1_MS200_A303	-18.72977301	-1.046157984	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3170	5941	0.009089379	0.019525332	10	13A	IN-VIP	41	6	6
CTCGAGGTCAGGTAAA-1_MS200_A303	-25.18577398	-19.38895133	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2698	4861	0.0162518	0.012343139	10	6A	IN-PV	41	6	6
CTCGAGGTCTGTTTGT-1_MS200_A303	33.53061435	-15.62767363	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3866	8643	0.014462571	0.01214856	10	2	EN-L4	41	6	6
CTCGGAGAGAAGATTC-1_MS200_A303	32.37033094	-7.999969032	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3871	9518	0.007039294	0.00693423	10	2	EN-L4	41	6	6
CTCGGAGCACCATCCT-1_MS200_A303	26.05115554	4.503525133	15DA	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1085	1500	0.007333333	0.027333333	10	15DA	T cells	41	6	6
CTCGGAGGTAATTGGA-1_MS200_A303	-12.05516114	-5.600956557	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2091	3229	0.027872406	0.030349954	10	13A	IN-VIP	41	6	6
CTCGGAGTCACAGGCC-1_MS200_A303	-30.12010545	-2.35840344	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1455	2286	0.005249344	0.00743657	10	9	OPC	41	6	6
CTCGGGAAGTCTTGCA-1_MS200_A303	12.05967844	-12.57407125	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3270	6448	0.0117866	0.02310794	10	L2-3	EN-L2-3-MS	41	6	6
CTCGGGAGTACCGAGA-1_MS200_A303	28.02323302	6.16360134	15A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	847	1166	0.041166381	0.02058319	10	15A	Endo cells	41	6	6
CTCGGGAGTCTCTCGT-1_MS200_A303	-18.07267473	-1.430506169	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3004	5814	0.011007912	0.015995872	10	13A	IN-VIP	41	6	6
CTCGGGATCCAAGTAC-1_MS200_A303	11.14129703	-0.95428449	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1156	1747	0.11276474	0.010875787	10	12	EN-MIX	41	6	6
CTCGGGATCCATGCTC-1_MS200_A303	-16.24913161	-2.334005891	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2864	5621	0.007827789	0.009784736	10	13A	IN-VIP	41	6	6
CTCGTACAGACCACGA-1_MS200_A303	17.68823792	-20.76717841	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3164	6976	0.02078555	0.007884174	10	L2-3	EN-L2-3-MS	41	6	6
CTCGTACAGCTAGGCA-1_MS200_A303	0.818568712	10.80787883	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	977	1413	0.004246285	0.026893135	10	oligos	OL-MS-1	41	6	6
CTCGTACAGGATGCGT-1_MS200_A303	32.06093727	11.13179544	14	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	764	1129	0.020372011	0.02214349	10	14	Microglia	41	6	6
CTCGTACCATTACGAC-1_MS200_A303	2.73589298	0.099488996	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1548	2090	0.054066986	0.015311005	10	16	EN-PYR	41	6	6
CTCGTCAAGAGCTATA-1_MS200_A303	-19.47053656	-0.647461949	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4081	8848	0.009493671	0.025090416	10	13A	IN-VIP	41	6	6
CTCGTCAAGGCTAGGT-1_MS200_A303	14.4412771	-13.01449451	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3833	8026	0.020931971	0.015200598	10	L2-3	EN-L2-3-MS	41	6	6
CTCGTCACAAACCTAC-1_MS200_A303	-29.9100637	-20.57924242	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2929	5735	0.032083697	0.015344377	10	6A	IN-PV	41	6	6
CTCGTCACAGTAACGG-1_MS200_A303	-11.82644874	-38.2519231	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1380	2071	0.043457267	0.019314341	10	16	EN-PYR	41	6	6
CTCGTCAGTACTCTCC-1_MS200_A303	-21.48186294	-20.44522261	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2432	5233	0.042040894	0.00305752	10	6A	IN-PV	41	6	6
CTCGTCAGTGCAGGTA-1_MS200_A303	0.809902102	10.20245461	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1151	1751	0.004568818	0.018275271	10	oligos	OL-MS-1	41	6	6
CTCGTCAGTGCTCTTC-1_MS200_A303	-31.63506683	-7.006573815	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1100	1516	0.006596306	0.004617414	10	9	OPC	41	6	6
CTCGTCATCGAGAACG-1_MS200_A303	34.07561133	-17.18349434	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5247	12985	0.007316134	0.015710435	10	2	EN-L4	41	6	6
CTCGTCATCGAGCCCA-1_MS200_A303	-31.55808626	-5.983832655	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1158	1786	0.003359462	0.007278835	10	9	OPC	41	6	6
CTCGTCATCGCCTGTT-1_MS200_A303	27.21693565	5.734932614	15BA	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1116	1777	0.003939223	0.024198087	10	15BA	Stromal cells	41	6	6
CTCGTCATCGGTCTAA-1_MS200_A303	9.861664731	-1.026024804	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1234	1950	0.140512821	0.003076923	10	12	EN-MIX	41	6	6
CTCTAATAGCACCGCT-1_MS200_A303	0.222846402	20.4214742	1	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	790	1216	0.002467105	0.011513158	10	oligos	OL-Cntl	41	6	6
CTCTAATCAAACGTGG-1_MS200_A303	18.48205074	-24.59323733	3	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5825	19062	0.009547791	0.007029693	10	3	EN-L5-6	41	6	6
CTCTAATGTGCAGGTA-1_MS200_A303	0.059355667	24.02070428	1	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	763	1161	0.009474591	0.006029285	10	oligos	OL-Cntl	41	6	6
CTCTAATGTTCAGTAC-1_MS200_A303	8.076873977	1.448669384	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	671	1229	0.364524003	0.005695688	10	16	EN-PYR	41	6	6
CTCTAATTCTGCTGCT-1_MS200_A303	-29.37286128	-4.248607651	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1335	2134	0.002343018	0.008903468	10	9	OPC	41	6	6
CTCTACGAGCTGCAAG-1_MS200_A303	-26.55387798	-3.180813837	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1255	1754	0.005131129	0.029076397	10	9	OPC	41	6	6
CTCTACGAGTGGGTTG-1_MS200_A303	17.08560427	-4.988296826	3	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1306	2149	0.01535598	0.003257329	10	3	EN-L5-6	41	6	6
CTCTACGCAAGTCATC-1_MS200_A303	16.4046933	-13.04933962	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5222	14222	0.018984672	0.016242441	10	L2-3	EN-L2-3-MS	41	6	6
CTCTACGCATCGATGT-1_MS200_A303	-24.91517842	15.80076005	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1128	1924	0.005197505	0.011434511	10	8	Astrocytes	41	6	6
CTCTACGCATTGTGCA-1_MS200_A303	6.480538418	14.87313064	1	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1050	1558	0.002567394	0.010269576	10	oligos	OL-Cntl	41	6	6
CTCTACGTCACCGTAA-1_MS200_A303	-9.302838372	27.33989316	17	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1148	1575	0.017142857	0.014603175	10	oligos	OL-MS-2	41	6	6
CTCTACGTCGGTGTTA-1_MS200_A303	11.63362589	-12.62121272	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3301	6412	0.020430443	0.009513412	10	L2-3	EN-L2-3-MS	41	6	6
CTCTGGTAGGTTACCT-1_MS200_A303	-11.51564121	29.87260495	17	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2148	3612	0.131782946	0.009136213	10	oligos	OL-MS-2	41	6	6
CTCTGGTCATCTGGTA-1_MS200_A303	-29.91552269	-21.357125	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4446	10072	0.028693407	0.014495631	10	6A	IN-PV	41	6	6
CTCTGGTTCCCAACGG-1_MS200_A303	-8.948698537	-14.56863431	6B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	885	1239	0.100887813	0.008071025	10	6B	IN-SST	41	6	6
CTCTGGTTCTCAAGTG-1_MS200_A303	16.51872266	-16.26550885	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	6712	21435	0.021273618	0.016655003	10	L2-3	EN-L2-3-MS	41	6	6
CTGAAACAGCGTCAAG-1_MS200_A303	-14.84156796	21.74614776	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1252	1993	0.002508781	0.01304566	10	8	Astrocytes	41	6	6
CTGAAACAGGAACTGC-1_MS200_A303	-31.46974462	-4.584730896	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1315	1926	0.009345794	0.007268951	10	9	OPC	41	6	6
CTGAAACAGTTGCAGG-1_MS200_A303	-0.06628741	-0.447346555	11	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1001	1399	0.010721944	0.013581129	10	11	Glia-MIX	41	6	6
CTGAAACCAAGTACCT-1_MS200_A303	6.746780107	-1.046589586	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	703	1105	0.209954751	0.005429864	10	12	EN-MIX	41	6	6
CTGAAACCATGGGACA-1_MS200_A303	17.21522959	-14.13741298	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5929	18332	0.018546803	0.009655248	10	L2-3	EN-L2-3-MS	41	6	6
CTGAAACGTAATTGGA-1_MS200_A303	16.56545244	-13.43710913	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4508	10121	0.039324177	0.00731153	10	L2-3	EN-L2-3-MS	41	6	6
CTGAAACGTATTCTCT-1_MS200_A303	-10.21216006	-36.426755	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1171	1668	0.060551559	0.008393285	10	16	EN-PYR	41	6	6
CTGAAACGTCCGACGT-1_MS200_A303	32.79136275	-16.92841836	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4511	10952	0.018991965	0.01807889	10	2	EN-L4	41	6	6
CTGAAACTCGGTCCGA-1_MS200_A303	-15.90145546	20.25028789	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1248	1820	0.009340659	0.008791209	10	8	Astrocytes	41	6	6
CTGAAACTCTGATACG-1_MS200_A303	-7.78294162	-36.69895587	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	963	1237	0.021827001	0.018593371	10	16	EN-PYR	41	6	6
CTGAAGTCAAGACACG-1_MS200_A303	10.36991052	-18.43132232	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4768	12649	0.008538224	0.004190055	10	L2-3	EN-L2-3-MS	41	6	6
CTGAAGTCAAGTCATC-1_MS200_A303	-17.61658627	17.13636208	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1508	2445	0.008179959	0.008179959	10	8	Astrocytes	41	6	6
CTGAAGTGTCGGATCC-1_MS200_A303	-14.36122567	22.52613836	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1395	2225	0.002696629	0.013033708	10	8	Astrocytes	41	6	6
CTGAAGTGTTGGTGGA-1_MS200_A303	-10.54968276	-36.75289323	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1260	1845	0.068292683	0.014092141	10	16	EN-PYR	41	6	6
CTGAAGTTCAATCACG-1_MS200_A303	-16.77814723	-3.293884824	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2784	5508	0.01325345	0.011982571	10	13A	IN-VIP	41	6	6
CTGAAGTTCATGCTCC-1_MS200_A303	35.62944604	-9.897758858	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	7352	24771	0.010334666	0.010657624	10	2	EN-L4	41	6	6
CTGAAGTTCTCACATT-1_MS200_A303	23.24557915	-29.37901842	3	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2728	6561	0.003353147	0.0057918	10	3	EN-L5-6	41	6	6
CTGATAGAGCCCGAAA-1_MS200_A303	-10.59147927	-4.958897361	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1816	2875	0.012173913	0.012869565	10	13A	IN-VIP	41	6	6
CTGATAGAGCGTAATA-1_MS200_A303	7.785607263	1.438910267	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	723	1205	0.285477178	0.010788382	10	16	EN-PYR	41	6	6
CTGATAGAGCTCCTTC-1_MS200_A303	34.0463904	-14.51289647	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4010	9024	0.010527482	0.012300532	10	2	EN-L4	41	6	6
CTGATAGCACAAGTAA-1_MS200_A303	-7.627046071	-37.31446905	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1069	1544	0.090673575	0.017487047	10	16	EN-PYR	41	6	6
CTGATAGCATGGTCTA-1_MS200_A303	-18.20321495	-1.237531868	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3384	6433	0.008705114	0.015389398	10	13A	IN-VIP	41	6	6
CTGATAGGTTTGTTTC-1_MS200_A303	15.43421008	-13.43899032	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5956	16825	0.012124814	0.017533432	10	L2-3	EN-L2-3-MS	41	6	6
CTGATCCAGATCTGAA-1_MS200_A303	-14.58342928	21.81056616	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1309	2084	0.003358925	0.018714012	10	8	Astrocytes	41	6	6
CTGATCCAGCCCAGCT-1_MS200_A303	18.26236902	-13.76289027	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	8197	31784	0.009470174	0.017084067	10	L2-3	EN-L2-3-MS	41	6	6
CTGATCCCACATTAGC-1_MS200_A303	-4.391006316	-8.779467402	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	941	1542	0.108949416	0.005188067	10	13A	IN-VIP	41	6	6
CTGATCCCATCCCACT-1_MS200_A303	9.82118152	-17.92482547	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5465	16129	0.006882014	0.008804018	10	L2-3	EN-L2-3-MS	41	6	6
CTGATCCGTACCCAAT-1_MS200_A303	-5.487816387	15.48616284	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	724	1036	0.003861004	0.013513514	10	oligos	OL-MS-1	41	6	6
CTGATCCGTGATGATA-1_MS200_A303	-18.97378909	8.285200631	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	910	1380	0.002173913	0.010144928	10	8	Astrocytes	41	6	6
CTGATCCGTTCGGCAC-1_MS200_A303	-5.36841595	15.71094496	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	736	1071	0.003734827	0.014005602	10	oligos	OL-MS-1	41	6	6
CTGATCCTCGCCTGAG-1_MS200_A303	-11.75134004	18.97493085	11	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3027	5929	0.00337325	0.006915163	10	11	Glia-MIX	41	6	6
CTGATCCTCGCTGATA-1_MS200_A303	-29.02936259	-5.640041282	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1160	1740	0.005747126	0.004022989	10	9	OPC	41	6	6
CTGATCCTCGGCTTGG-1_MS200_A303	-8.335556305	-6.887228717	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1374	2006	0.01894317	0.011964108	10	13A	IN-VIP	41	6	6
CTGATCCTCTAAGCCA-1_MS200_A303	-6.439281616	14.99644972	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	789	1090	0.044954128	0.011926606	10	oligos	OL-MS-1	41	6	6
CTGCCTAAGACTGGGT-1_MS200_A303	28.62490248	-13.65321377	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	6007	18677	0.020292338	0.005407721	10	2	EN-L4	41	6	6
CTGCCTAAGATCGGGT-1_MS200_A303	12.74160145	-17.28106794	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5789	16630	0.009079976	0.007817198	10	L2-3	EN-L2-3-MS	41	6	6
CTGCCTACAAGGCTCC-1_MS200_A303	24.72661874	-13.63283621	3	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4906	12669	0.014760439	0.007735417	10	3	EN-L5-6	41	6	6
CTGCCTATCCAACCAA-1_MS200_A303	-7.481290428	-13.65080688	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1463	2297	0.074009578	0.010013061	10	6A	IN-PV	41	6	6
CTGCGGAAGGCTAGGT-1_MS200_A303	22.33363143	-13.82776516	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3437	7238	0.095882841	0.008842222	10	2	EN-L4	41	6	6
CTGCGGACAACGATCT-1_MS200_A303	28.42694707	-14.03595322	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	6699	21207	0.022398265	0.00778045	10	2	EN-L4	41	6	6
CTGCGGACACATCCGG-1_MS200_A303	7.353660882	12.55923878	1	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1182	1881	0.005316321	0.013822435	10	oligos	OL-Cntl	41	6	6
CTGCGGACACTCAGGC-1_MS200_A303	10.91826926	-2.308797081	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1311	1840	0.011956522	0.004891304	10	12	EN-MIX	41	6	6
CTGCGGACACTCGACG-1_MS200_A303	-24.06751627	8.092478628	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	991	1542	0.001297017	0.009079118	10	8	Astrocytes	41	6	6
CTGCGGAGTACACCGC-1_MS200_A303	-26.89007369	-22.01660117	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3949	8846	0.028713543	0.009156681	10	6A	IN-PV	41	6	6
CTGCGGAGTATAGTAG-1_MS200_A303	-4.747658857	19.8288233	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	751	1014	0.014792899	0.00887574	10	oligos	OL-MS-1	41	6	6
CTGCGGAGTCACCCAG-1_MS200_A303	1.104887875	10.75307258	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1012	1507	0.00597213	0.01924353	10	oligos	OL-MS-1	41	6	6
CTGCGGAGTCGAGATG-1_MS200_A303	32.56940858	4.831826992	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1464	2157	0.041724618	0.006026889	10	12	EN-MIX	41	6	6
CTGCGGAGTCTGCGGT-1_MS200_A303	-19.53814308	-5.298688554	13B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3684	7643	0.007719482	0.011644642	10	13B	IN-SV2C	41	6	6
CTGCGGAGTGGACGAT-1_MS200_A303	4.605459774	-14.59268445	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2780	6006	0.026806527	0.002664003	10	L2-3	EN-L2-3-MS	41	6	6
CTGCGGATCAGAGGTG-1_MS200_A303	8.385293588	-15.25668851	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3246	6380	0.007210031	0.011598746	10	L2-3	EN-L2-3-MS	41	6	6
CTGCGGATCAGTTTGG-1_MS200_A303	-18.68701134	-2.328660596	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2712	4557	0.021944262	0.016238754	10	13A	IN-VIP	41	6	6
CTGCTGTAGTACGATA-1_MS200_A303	17.25838278	-13.58654302	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	7209	23950	0.019039666	0.007891441	10	L2-3	EN-L2-3-MS	41	6	6
CTGCTGTTCGAGAGCA-1_MS200_A303	-15.40197294	21.84406816	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1396	2153	0.006038086	0.006502555	10	8	Astrocytes	41	6	6
CTGCTGTTCTGTCCGT-1_MS200_A303	14.17256986	-13.74472272	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4386	10667	0.016499484	0.010124684	10	L2-3	EN-L2-3-MS	41	6	6
CTGGTCTAGCTTATCG-1_MS200_A303	-12.37668574	-0.096776326	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2941	6340	0.002523659	0.006466877	10	13A	IN-VIP	41	6	6
CTGGTCTAGTAGCGGT-1_MS200_A303	-28.60446913	-5.384659808	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1151	1612	0.012406948	0.0117866	10	9	OPC	41	6	6
CTGGTCTCAATGTTGC-1_MS200_A303	-14.52293021	-37.89705051	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2176	4118	0.070908208	0.018698397	10	16	EN-PYR	41	6	6
CTGGTCTGTCACACGC-1_MS200_A303	31.72614558	-15.27046633	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2731	5291	0.014931015	0.011907012	10	2	EN-L4	41	6	6
CTGGTCTGTCCAGTTA-1_MS200_A303	33.92406677	10.79558441	14	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	906	1175	0.009361702	0.014468085	10	14	Microglia	41	6	6
CTGGTCTGTCGCTTCT-1_MS200_A303	-9.160747827	27.08565694	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	989	1360	0.008823529	0.016176471	10	oligos	OL-MS-1	41	6	6
CTGGTCTGTCTCCACT-1_MS200_A303	-18.20584441	-1.376046798	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3860	8273	0.012329264	0.00894476	10	13A	IN-VIP	41	6	6
CTGGTCTGTTACGACT-1_MS200_A303	-28.00807316	-22.52261965	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4834	12603	0.020312624	0.009838927	10	6A	IN-PV	41	6	6
CTGGTCTGTTCGTCTC-1_MS200_A303	-13.54908622	-37.0244951	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1691	2692	0.049777117	0.012258544	10	16	EN-PYR	41	6	6
CTGGTCTTCGAATGGG-1_MS200_A303	9.160200517	-13.07151058	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2782	5266	0.014622104	0.006456513	10	L2-3	EN-L2-3-MS	41	6	6
CTGTGCTCAAGCGATG-1_MS200_A303	32.83739089	-13.86395989	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2798	5098	0.016869361	0.00804237	10	2	EN-L4	41	6	6
CTGTGCTCAATTGCTG-1_MS200_A303	-30.08069141	-13.03633642	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	770	1158	0.003454231	0.007772021	10	9	OPC	41	6	6
CTGTGCTCACCTTGTC-1_MS200_A303	9.036441166	1.470363518	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	766	1308	0.256116208	0.009938838	10	12	EN-MIX	41	6	6
CTGTGCTCATCGGTTA-1_MS200_A303	-15.04942161	23.19128276	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1452	2210	0.003167421	0.011764706	10	8	Astrocytes	41	6	6
CTGTGCTGTCATTAGC-1_MS200_A303	13.77466154	-16.98863924	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5491	15329	0.010437732	0.009002544	10	L2-3	EN-L2-3-MS	41	6	6
CTGTTTAAGCGTGTCC-1_MS200_A303	-28.94302178	-5.853273681	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1123	1617	0.005565863	0.00742115	10	9	OPC	41	6	6
CTGTTTAAGCTCCTTC-1_MS200_A303	9.030806623	-12.4913409	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2493	4718	0.011657482	0.006358627	10	L2-3	EN-L2-3-MS	41	6	6
CTGTTTACATAGTAAG-1_MS200_A303	-4.419095134	17.69034539	1	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	763	1038	0.002890173	0.009633911	10	oligos	OL-Cntl	41	6	6
CTGTTTACATTACCTT-1_MS200_A303	24.0040369	-19.7778198	3	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	6987	25548	0.01229059	0.005910443	10	3	EN-L5-6	41	6	6
CTGTTTAGTGTGGCTC-1_MS200_A303	-5.318512231	16.99970982	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	845	1175	0.008510638	0.015319149	10	oligos	OL-MS-1	41	6	6
CTGTTTATCATGCAAC-1_MS200_A303	-14.13115905	24.16381877	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1803	3014	0.000995355	0.016257465	10	8	Astrocytes	41	6	6
CTGTTTATCTCCCTGA-1_MS200_A303	-22.8820022	-4.658791943	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1794	2661	0.019917324	0.006012777	10	9	OPC	41	6	6
CTTAACTAGATCGGGT-1_MS200_A303	-18.77665187	-0.924050497	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3172	6324	0.013124605	0.022770398	10	13A	IN-VIP	41	6	6
CTTAACTAGGCGCTCT-1_MS200_A303	4.403171271	-2.132766276	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	725	1101	0.123524069	0.009990917	10	12	EN-MIX	41	6	6
CTTAACTAGTGCAAGC-1_MS200_A303	-14.99020914	24.71738354	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1996	3432	0.003787879	0.005244755	10	8	Astrocytes	41	6	6
CTTAACTAGTTCGCAT-1_MS200_A303	-29.00653439	-6.063951039	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1094	1696	0.012382075	0.007665094	10	9	OPC	41	6	6
CTTAACTGTACCGCTG-1_MS200_A303	-16.8250305	20.60568927	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1460	2427	0.004120313	0.016893284	10	8	Astrocytes	41	6	6
CTTAACTGTCAGAATA-1_MS200_A303	-1.414681981	11.48883933	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	935	1337	0.005983545	0.023934181	10	oligos	OL-MS-1	41	6	6
CTTAACTGTTGTACAC-1_MS200_A303	8.513052214	7.920564344	1	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2428	5916	0.015551048	0.006254226	10	oligos	OL-Cntl	41	6	6
CTTAACTTCGTCCGTT-1_MS200_A303	-12.9893942	-17.35058967	6B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1215	1896	0.012130802	0.002637131	10	6B	IN-SST	41	6	6
CTTACCGAGAGCCCAA-1_MS200_A303	29.89229911	15.17825527	14	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1239	1907	0.005768222	0.087047719	10	14	Microglia	41	6	6
CTTACCGCACGCTTTC-1_MS200_A303	-16.13464918	22.99770496	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1457	2358	0.0072095	0.007633588	10	8	Astrocytes	41	6	6
CTTACCGCACGGCCAT-1_MS200_A303	2.323950906	11.88672019	1	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	902	1365	0.006593407	0.016849817	10	oligos	OL-Cntl	41	6	6
CTTACCGCAGCTGTAT-1_MS200_A303	33.42854757	10.94670454	14	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	842	1076	0.000929368	0.026022305	10	14	Microglia	41	6	6
CTTACCGCATGGTAGG-1_MS200_A303	12.71490501	-13.50911128	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4484	10753	0.012368641	0.012554636	10	L2-3	EN-L2-3-MS	41	6	6
CTTACCGTCCAGAAGG-1_MS200_A303	-16.85567426	20.24699841	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1651	2747	0.005096469	0.01565344	10	8	Astrocytes	41	6	6
CTTACCGTCTGTCTAT-1_MS200_A303	2.993767955	-2.648347972	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	762	1123	0	0.007123776	10	12	EN-MIX	41	6	6
CTTACCGTCTTATCTG-1_MS200_A303	4.651526659	-3.746099244	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1026	1607	0.067828251	0.00497822	10	12	EN-MIX	41	6	6
CTTAGGAAGGAGTTTA-1_MS200_A303	27.43079825	5.327437898	15A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	790	1074	0.051210428	0.025139665	10	15A	Endo cells	41	6	6
CTTAGGACAATTCCTT-1_MS200_A303	-26.42549005	-1.401818751	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2136	4088	0.006604697	0.01834638	10	9	OPC	41	6	6
CTTAGGACATTTGCCC-1_MS200_A303	31.2436051	-17.58799079	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	6110	19504	0.013638228	0.01235644	10	2	EN-L4	41	6	6
CTTAGGAGTAGCGTAG-1_MS200_A303	-15.66772466	20.6970059	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1357	2031	0.011816839	0.012801576	10	8	Astrocytes	41	6	6
CTTAGGATCTTCTGGC-1_MS200_A303	-16.89563505	20.25101636	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1317	2039	0.003923492	0.003433055	10	8	Astrocytes	41	6	6
CTTCTCTAGACAGGCT-1_MS200_A303	3.760942689	19.49481184	1	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	876	1364	0.002932551	0.009530792	10	oligos	OL-Cntl	41	6	6
CTTCTCTCACGGATAG-1_MS200_A303	12.90502696	-13.66242433	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5027	13250	0.011245283	0.012679245	10	L2-3	EN-L2-3-MS	41	6	6
CTTCTCTCACGGTTTA-1_MS200_A303	9.565302716	-18.88258909	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3891	9568	0.006166388	0.004285117	10	L2-3	EN-L2-3-MS	41	6	6
CTTCTCTGTAAACCTC-1_MS200_A303	13.74760036	-3.994340707	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1561	2728	0.004398827	0.002565982	10	12	EN-MIX	41	6	6
CTTCTCTTCCGTCATC-1_MS200_A303	-16.84757897	-6.766850297	13B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2549	5417	0.016245154	0.004061289	10	13B	IN-SV2C	41	6	6
CTTCTCTTCCTTTCGG-1_MS200_A303	-26.48208895	-18.11929272	6B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4507	12706	0.018495199	0.008342515	10	6B	IN-SST	41	6	6
CTTCTCTTCGTTTATC-1_MS200_A303	-14.07853218	22.60888787	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1639	2939	0.01326982	0.010888057	10	8	Astrocytes	41	6	6
CTTGGCTAGTTAAGTG-1_MS200_A303	-26.19141138	-18.51498576	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3079	6447	0.025283077	0.006514658	10	6A	IN-PV	41	6	6
CTTGGCTCAAAGGTGC-1_MS200_A303	-16.30513463	-1.729173582	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2746	5323	0.012211159	0.012023295	10	13A	IN-VIP	41	6	6
CTTGGCTCACAGGTTT-1_MS200_A303	-24.94691298	10.67985011	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	970	1449	0.003450656	0.00621118	10	8	Astrocytes	41	6	6
CTTGGCTGTCTAGGTT-1_MS200_A303	3.88295158	21.51852913	1	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	863	1323	0.016628874	0.006802721	10	oligos	OL-Cntl	41	6	6
CTTGGCTGTCTCCATC-1_MS200_A303	-19.67540043	-5.235506857	13B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4124	10055	0.024763799	0.010044754	10	13B	IN-SV2C	41	6	6
CTTGGCTTCCCTTGCA-1_MS200_A303	-24.16634983	15.72440427	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1276	2072	0.000482625	0.004343629	10	8	Astrocytes	41	6	6
CTTTGCGAGATAGCAT-1_MS200_A303	10.17052623	-14.31607034	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3505	7525	0.006511628	0.016478405	10	L2-3	EN-L2-3-MS	41	6	6
CTTTGCGAGTTCGCAT-1_MS200_A303	-4.230379617	19.30467864	1	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	811	1207	0.003314002	0.010770505	10	oligos	OL-Cntl	41	6	6
CTTTGCGCAATCTACG-1_MS200_A303	18.30365597	-24.44818146	3	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5804	18609	0.008490515	0.009242839	10	3	EN-L5-6	41	6	6
CTTTGCGCACTACAGT-1_MS200_A303	-30.26195536	9.526145432	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	911	1339	0.00373413	0.005974608	10	8	Astrocytes	41	6	6
CTTTGCGGTGCCTTGG-1_MS200_A303	1.878271463	10.95012752	1	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	975	1434	0.0027894	0.016736402	10	oligos	OL-Cntl	41	6	6
CTTTGCGTCAGCGACC-1_MS200_A303	16.93964649	-14.49934917	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	6900	23814	0.019022424	0.010665995	10	L2-3	EN-L2-3-MS	41	6	6
CTTTGCGTCATCGATG-1_MS200_A303	-19.1915073	-1.858121083	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3629	7640	0.018586387	0.012827225	10	13A	IN-VIP	41	6	6
CTTTGCGTCCGCAGTG-1_MS200_A303	6.720508794	-1.88966733	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	887	1233	0.0162206	0.00567721	10	12	EN-MIX	41	6	6
GAAACTCAGATCCGAG-1_MS200_A303	11.40357438	-12.46826138	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3209	6314	0.014570795	0.012987013	10	L2-3	EN-L2-3-MS	41	6	6
GAAACTCAGCTGCAAG-1_MS200_A303	32.26685852	-19.29719706	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3751	8343	0.020616085	0.017020257	10	2	EN-L4	41	6	6
GAAACTCCAAGCGAGT-1_MS200_A303	11.5999299	-12.12655215	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3094	6162	0.017039922	0.015092502	10	L2-3	EN-L2-3-MS	41	6	6
GAAACTCCACCCTATC-1_MS200_A303	-29.78992206	-5.159934327	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1158	1918	0.006256517	0.005213764	10	9	OPC	41	6	6
GAAACTCGTACAGCAG-1_MS200_A303	27.61300996	-12.54594736	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4367	11271	0.012155088	0.007009138	10	2	EN-L4	41	6	6
GAAACTCGTCAAGCGA-1_MS200_A303	-5.917948166	18.9638008	1	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	737	1012	0.029644269	0.006916996	10	oligos	OL-Cntl	41	6	6
GAAACTCGTCGTCTTC-1_MS200_A303	12.47557243	-13.5082737	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4094	9838	0.011486074	0.016161822	10	L2-3	EN-L2-3-MS	41	6	6
GAAACTCTCATTTGGG-1_MS200_A303	-26.75413209	-18.1856088	6B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3964	9404	0.039557635	0.007656316	10	6B	IN-SST	41	6	6
GAAACTCTCGTTTATC-1_MS200_A303	-4.925731762	15.01497961	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	744	1022	0.008806262	0.015655577	10	oligos	OL-MS-1	41	6	6
GAAATGAAGAAGGACA-1_MS200_A303	-27.723883	-2.790937134	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1452	2259	0.002213369	0.011509517	10	9	OPC	41	6	6
GAAATGACAGACAAAT-1_MS200_A303	21.42690385	-1.750887044	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1745	2914	0.020590254	0.008922443	10	2	EN-L4	41	6	6
GAAATGACAGCTGTTA-1_MS200_A303	11.51079859	-19.38375926	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5569	17848	0.003249664	0.006331242	10	L2-3	EN-L2-3-MS	41	6	6
GAAATGAGTTATCGGT-1_MS200_A303	-12.81950269	17.81078165	11	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1722	2939	0.006124532	0.008846546	10	11	Glia-MIX	41	6	6
GAAATGATCAGTTCGA-1_MS200_A303	-11.78617189	-27.37967835	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	763	1056	0.053977273	0.023674242	10	16	EN-PYR	41	6	6
GAAATGATCCGATATG-1_MS200_A303	-28.39014093	-6.261174513	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1125	1638	0.014041514	0.007936508	10	9	OPC	41	6	6
GAAATGATCTCACATT-1_MS200_A303	-19.11564182	-18.07309141	6B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2691	5829	0.00514668	0.00171556	10	6B	IN-SST	41	6	6
GAAATGATCTTAGCCC-1_MS200_A303	10.45436442	-28.9173651	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	7013	26541	0.005124148	0.005048792	10	L2-3	EN-L2-3-MS	41	6	6
GAACATCAGACAGAGA-1_MS200_A303	-14.17894804	-21.14847307	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1449	2600	0.051153846	0.003846154	10	6A	IN-PV	41	6	6
GAACATCAGACCTAGG-1_MS200_A303	-14.81307789	22.00279073	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1434	2244	0.004010695	0.012477718	10	8	Astrocytes	41	6	6
GAACATCAGTTCGCAT-1_MS200_A303	26.38109907	8.198777933	15A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1530	2235	0.007158837	0.033557047	10	15A	Endo cells	41	6	6
GAACATCCAATAGAGT-1_MS200_A303	-24.3299083	6.336228255	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	771	1123	0.032947462	0.017809439	10	8	Astrocytes	41	6	6
GAACATCCATAACCTG-1_MS200_A303	29.96456432	14.31044533	14	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	962	1358	0.006627393	0.095729013	10	14	Microglia	41	6	6
GAACATCGTAAACACA-1_MS200_A303	-26.59258237	8.176852072	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	827	1143	0.006999125	0.004374453	10	8	Astrocytes	41	6	6
GAACATCGTTATCGGT-1_MS200_A303	-7.120395438	-34.05765537	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	908	1294	0.108964451	0.013137558	10	16	EN-PYR	41	6	6
GAACATCTCGTTACAG-1_MS200_A303	14.22236843	-13.20848876	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4315	9879	0.008502885	0.014778824	10	L2-3	EN-L2-3-MS	41	6	6
GAACCTAAGACAGAGA-1_MS200_A303	-6.297373366	13.43136593	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	781	1034	0.022243714	0.022243714	10	oligos	OL-MS-1	41	6	6
GAACCTAAGGCACATG-1_MS200_A303	20.71637376	-19.38251923	3	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5048	14421	0.116704805	0.005408779	10	3	EN-L5-6	41	6	6
GAACCTAAGTGAACGC-1_MS200_A303	-28.17073148	-2.771850627	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1423	2211	0.004070556	0.02125735	10	9	OPC	41	6	6
GAACCTACACTTCTGC-1_MS200_A303	-7.522416221	-34.13166661	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	742	1047	0.028653295	0.008595989	10	16	EN-PYR	41	6	6
GAACCTACAGTATGCT-1_MS200_A303	-12.11365254	-13.38910129	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1623	2862	0.054157932	0.00698812	10	6A	IN-PV	41	6	6
GAACCTAGTGGCCCTA-1_MS200_A303	-15.58830114	23.43522663	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1581	2671	0.004867091	0.008611007	10	8	Astrocytes	41	6	6
GAACCTAGTTGGTGGA-1_MS200_A303	-24.33812387	7.651790852	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1025	1533	0.006523157	0.005870841	10	8	Astrocytes	41	6	6
GAACCTATCAATAAGG-1_MS200_A303	-8.01004912	7.036837575	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	812	1044	0.007662835	0.064176245	10	oligos	OL-MS-1	41	6	6
GAACCTATCACGGTTA-1_MS200_A303	-18.12553179	-14.24897784	6B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2034	3498	0.013150372	0.012864494	10	6B	IN-SST	41	6	6
GAACCTATCGGCGCTA-1_MS200_A303	-9.364535426	27.37477747	17	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1204	1889	0.129168872	0.011646374	10	oligos	OL-MS-2	41	6	6
GAACCTATCGGGAGTA-1_MS200_A303	12.40721307	-23.81876585	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5529	15449	0.004401579	0.008091139	10	L2-3	EN-L2-3-MS	41	6	6
GAACCTATCTGTGCAA-1_MS200_A303	-24.51312283	11.23114026	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1053	1562	0.004481434	0.008962868	10	8	Astrocytes	41	6	6
GAACGGACACTCTGTC-1_MS200_A303	9.266423796	-16.12935903	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3177	6727	0.015162777	0.004162331	10	L2-3	EN-L2-3-MS	41	6	6
GAACGGACAGATCTGT-1_MS200_A303	-15.51114484	21.54775001	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1165	1713	0.002335085	0.009340339	10	8	Astrocytes	41	6	6
GAACGGAGTTGGTTTG-1_MS200_A303	15.73749064	-10.83349716	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2140	4027	0.020362553	0.008939657	10	L2-3	EN-L2-3-MS	41	6	6
GAACGGATCTCTTATG-1_MS200_A303	-27.39586292	-3.914703723	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1512	2421	0.009087154	0.013217679	10	9	OPC	41	6	6
GAAGCAGAGAGGGATA-1_MS200_A303	3.300262916	-7.218918688	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1275	2039	0.053948014	0.004413928	10	12	EN-MIX	41	6	6
GAAGCAGCAATAGCGG-1_MS200_A303	33.76955464	-12.58038023	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3760	8003	0.008621767	0.008371861	10	2	EN-L4	41	6	6
GAAGCAGGTATATGGA-1_MS200_A303	-14.88350455	23.8039211	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1621	2672	0.003742515	0.013098802	10	8	Astrocytes	41	6	6
GAAGCAGGTCTCCACT-1_MS200_A303	16.94402686	-14.81295739	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	6652	22609	0.014419037	0.010969083	10	L2-3	EN-L2-3-MS	41	6	6
GAAGCAGGTGCTCTTC-1_MS200_A303	34.64416078	-8.021763989	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	6449	21978	0.002957503	0.008190008	10	2	EN-L4	41	6	6
GAAGCAGGTGGTCCGT-1_MS200_A303	2.68614617	10.68593915	1	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1078	1646	0.004860267	0.012150668	10	oligos	OL-Cntl	41	6	6
GAAGCAGGTTAAGGGC-1_MS200_A303	-9.517034297	-6.961001189	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1643	2970	0.07003367	0.004713805	10	13A	IN-VIP	41	6	6
GAAGCAGGTTATCGGT-1_MS200_A303	33.28096136	-11.10768043	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2583	4739	0.033973412	0.006541464	10	2	EN-L4	41	6	6
GAAGCAGGTTGATTCG-1_MS200_A303	-15.97393425	-0.075132864	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2928	5369	0.007077668	0.012665301	10	13A	IN-VIP	41	6	6
GAAGCAGTCCACGCAG-1_MS200_A303	11.59364981	-14.65980914	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4270	10252	0.005559891	0.015314085	10	L2-3	EN-L2-3-MS	41	6	6
GAAGCAGTCCAGATCA-1_MS200_A303	33.71572053	-16.0490831	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3978	8954	0.015970516	0.014853697	10	2	EN-L4	41	6	6
GAATAAGAGTCTCCTC-1_MS200_A303	3.991859261	4.491382316	7	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1655	2349	0.006811409	0.019157088	10	7	Phagocytes	41	6	6
GAATAAGCACACCGAC-1_MS200_A303	2.201427165	10.61828184	1	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1075	1644	0.003649635	0.012773723	10	oligos	OL-Cntl	41	6	6
GAATAAGCATGCATGT-1_MS200_A303	13.62739479	-3.053073283	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1377	2403	0.088223055	0.004577611	10	12	EN-MIX	41	6	6
GAATAAGGTACTCTCC-1_MS200_A303	-31.73559382	-6.852615898	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1181	1796	0.004454343	0.002783964	10	9	OPC	41	6	6
GAATAAGTCTGAAAGA-1_MS200_A303	33.18241192	-15.72271229	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3888	8244	0.018437652	0.008733624	10	2	EN-L4	41	6	6
GAATGAAAGAGCCCAA-1_MS200_A303	13.9508741	-4.78359126	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1528	2699	0.044090404	0.006669137	10	12	EN-MIX	41	6	6
GAATGAAAGGGTCGAT-1_MS200_A303	33.9016729	-18.43529922	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4305	9181	0.013179392	0.018080819	10	2	EN-L4	41	6	6
GAATGAACAGGACGTA-1_MS200_A303	23.96840628	-18.34953241	3	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5566	16308	0.029617366	0.005886681	10	3	EN-L5-6	41	6	6
GAATGAACATCATCCC-1_MS200_A303	-25.01880992	-18.89330411	6B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2733	5292	0.019085412	0.009070295	10	6B	IN-SST	41	6	6
GAATGAAGTACAGTGG-1_MS200_A303	7.490938554	-7.269143969	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1572	2777	0.01728484	0.003601008	10	12	EN-MIX	41	6	6
GAATGAAGTCGGATCC-1_MS200_A303	-16.67102166	-1.677222156	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2734	4991	0.015628131	0.015628131	10	13A	IN-VIP	41	6	6
GAATGAATCACAAACC-1_MS200_A303	25.18528266	9.849474923	15A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3270	6389	0.015338864	0.042729692	10	15A	Endo cells	41	6	6
GAATGAATCCGTACAA-1_MS200_A303	-23.965812	9.204203184	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1068	1686	0.004151839	0.011862396	10	8	Astrocytes	41	6	6
GAATGAATCGAATCCA-1_MS200_A303	10.06840635	-15.81692692	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3550	7743	0.011494253	0.009557019	10	L2-3	EN-L2-3-MS	41	6	6
GACACGCGTAGCGTCC-1_MS200_A303	-27.22059332	-20.73540701	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3033	5977	0.0438347	0.00585578	10	6A	IN-PV	41	6	6
GACACGCGTTGTTTGG-1_MS200_A303	30.79432586	-18.16470125	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5128	13458	0.023331847	0.012111755	10	2	EN-L4	41	6	6
GACACGCTCCAAACAC-1_MS200_A303	6.927958664	-9.858523761	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1353	2110	0.042654028	0.00521327	10	L2-3	EN-L2-3-MS	41	6	6
GACACGCTCCGCGGTA-1_MS200_A303	10.00756241	-3.907609263	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2304	4159	0.012503006	0.012022121	10	12	EN-MIX	41	6	6
GACACGCTCCTTGGTC-1_MS200_A303	20.02134786	-19.56770539	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	6369	21873	0.010743839	0.00745211	10	L2-3	EN-L2-3-MS	41	6	6
GACACGCTCGGTTAAC-1_MS200_A303	-7.516516849	-10.60743759	6B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	674	1082	0.231977819	0.006469501	10	6B	IN-SST	41	6	6
GACACGCTCTTACCTA-1_MS200_A303	-14.26853179	24.2479729	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1739	2963	0.002024975	0.016537293	10	8	Astrocytes	41	6	6
GACAGAGAGGCTAGAC-1_MS200_A303	-15.63487937	23.47051499	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1438	2341	0.009397693	0.012815036	10	8	Astrocytes	41	6	6
GACAGAGAGTACGCCC-1_MS200_A303	-19.69167583	-6.209996097	13B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4239	9707	0.035850417	0.005150922	10	13B	IN-SV2C	41	6	6
GACAGAGCAAACTGCT-1_MS200_A303	-19.92132987	-2.216523393	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5455	15215	0.015642458	0.008149852	10	13A	IN-VIP	41	6	6
GACAGAGCACCATCCT-1_MS200_A303	28.43052645	-14.37192104	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	6105	20048	0.018206305	0.007831205	10	2	EN-L4	41	6	6
GACAGAGCATGAGCGA-1_MS200_A303	-24.8394347	-23.55393445	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3754	8473	0.011094063	0.008025493	10	6A	IN-PV	41	6	6
GACAGAGGTCAGATAA-1_MS200_A303	-30.32518587	-21.78228768	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5332	14452	0.02691669	0.014184888	10	6A	IN-PV	41	6	6
GACAGAGTCCAAATGC-1_MS200_A303	-29.1035516	-2.332390679	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1826	3014	0.034173855	0.002986065	10	9	OPC	41	6	6
GACCAATAGACAAAGG-1_MS200_A303	33.89773166	-16.93464895	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4891	11601	0.008878545	0.012757521	10	2	EN-L4	41	6	6
GACCAATAGCACCGCT-1_MS200_A303	-24.81931698	9.276093948	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	985	1441	0.009021513	0.006245663	10	8	Astrocytes	41	6	6
GACCAATAGGAATCGC-1_MS200_A303	13.08461069	-23.90156041	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3964	9634	0.016504048	0.004774756	10	L2-3	EN-L2-3-MS	41	6	6
GACCAATAGTATCGAA-1_MS200_A303	-16.21467663	-1.525836315	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2179	3575	0.008671329	0.016783217	10	13A	IN-VIP	41	6	6
GACCAATCAGTGGAGT-1_MS200_A303	16.3907653	-14.01682972	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	6481	20387	0.031098249	0.007700986	10	L2-3	EN-L2-3-MS	41	6	6
GACCAATGTAAGTGTA-1_MS200_A303	21.74467221	-16.43821471	3	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4924	12544	0.010124362	0.019371811	10	3	EN-L5-6	41	6	6
GACCAATGTGTGACGA-1_MS200_A303	-13.50657362	23.07195969	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1690	2875	0.003826087	0.020173913	10	8	Astrocytes	41	6	6
GACCAATGTTTGTTGG-1_MS200_A303	25.66933876	4.171106664	15BA	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1117	1655	0.005438066	0.009063444	10	15BA	Stromal cells	41	6	6
GACCAATTCGCACTCT-1_MS200_A303	0.697761791	8.552198888	1	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1255	1961	0.006119327	0.022437532	10	oligos	OL-Cntl	41	6	6
GACCAATTCGGCTTGG-1_MS200_A303	-21.81400553	6.808962463	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1137	1840	0.002717391	0.0125	10	8	Astrocytes	41	6	6
GACCAATTCTTGTACT-1_MS200_A303	11.11707308	-24.58387682	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4074	10192	0.002747253	0.006573783	10	L2-3	EN-L2-3-MS	41	6	6
GACCAATTCTTTACAC-1_MS200_A303	26.07209135	6.957827246	15BA	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1739	2974	0.003362475	0.025554808	10	15BA	Stromal cells	41	6	6
GACCTGGAGACAGACC-1_MS200_A303	-19.25822072	-0.735397382	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4013	8808	0.011807448	0.023274296	10	13A	IN-VIP	41	6	6
GACCTGGAGTACCGGA-1_MS200_A303	33.10113212	-15.60924332	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3102	5539	0.014984654	0.012096046	10	2	EN-L4	41	6	6
GACCTGGAGTCCGGTC-1_MS200_A303	1.351334093	10.67086664	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	991	1465	0.017064846	0.01774744	10	oligos	OL-MS-1	41	6	6
GACCTGGAGTGGACGT-1_MS200_A303	-15.82839698	22.84227165	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1341	2026	0.00148075	0.008884501	10	8	Astrocytes	41	6	6
GACCTGGCACCCTATC-1_MS200_A303	7.059569637	-0.735161851	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	907	1386	0.016594517	0.011544012	10	12	EN-MIX	41	6	6
GACCTGGGTCATGCAT-1_MS200_A303	-14.50131242	24.47504928	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1850	3344	0.006578947	0.016447368	10	8	Astrocytes	41	6	6
GACCTGGTCTCGGACG-1_MS200_A303	17.79747453	-7.693016085	3	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1788	3302	0.033918837	0.003937008	10	3	EN-L5-6	41	6	6
GACGCGTAGGACTGGT-1_MS200_A303	14.28187096	1.761976001	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	900	1215	0.050205761	0.004938272	10	12	EN-MIX	41	6	6
GACGCGTCAGCTGTTA-1_MS200_A303	8.258941049	-11.44527877	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2252	4206	0.032572515	0.00594389	10	L2-3	EN-L2-3-MS	41	6	6
GACGCGTCAGTCAGCC-1_MS200_A303	-9.466602143	19.64649553	11	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2166	3549	0.001690617	0.01183432	10	11	Glia-MIX	41	6	6
GACGCGTTCATTGCGA-1_MS200_A303	12.61823961	-1.509239918	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1167	1836	0.053921569	0.005446623	10	12	EN-MIX	41	6	6
GACGCGTTCGTTGCCT-1_MS200_A303	-26.77046668	-1.711256547	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1673	2606	0.003069839	0.015349194	10	9	OPC	41	6	6
GACGGCTCACCAACCG-1_MS200_A303	-9.256862444	27.09993315	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	998	1382	0.025325615	0.02170767	10	oligos	OL-MS-1	41	6	6
GACGGCTCACCTATCC-1_MS200_A303	-29.19109162	-21.87565167	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4241	9941	0.018710391	0.010562318	10	6A	IN-PV	41	6	6
GACGGCTCAGCTATTG-1_MS200_A303	-28.03551509	-4.717554663	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1423	2058	0.003887269	0.009718173	10	9	OPC	41	6	6
GACGGCTCAGGATTGG-1_MS200_A303	-14.86486798	23.89662051	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1717	3074	0.008132726	0.011711126	10	8	Astrocytes	41	6	6
GACGGCTCATGGAATA-1_MS200_A303	-28.2907413	8.773945172	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	802	1092	0.006410256	0.011904762	10	8	Astrocytes	41	6	6
GACGGCTTCATAGCAC-1_MS200_A303	12.06301231	-1.058635861	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1075	1547	0.023917259	0.011635423	10	12	EN-MIX	41	6	6
GACGTGCAGCCCTAAT-1_MS200_A303	17.25746806	-13.44142219	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5682	16102	0.035461433	0.009626133	10	L2-3	EN-L2-3-MS	41	6	6
GACGTGCAGTACGTTC-1_MS200_A303	26.28133863	3.617840492	15BA	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	724	1042	0.003838772	0.015355086	10	15BA	Stromal cells	41	6	6
GACGTGCAGTGGACGT-1_MS200_A303	-14.36752975	-32.13352031	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4218	9881	0.037344398	0.019734845	10	16	EN-PYR	41	6	6
GACGTGCGTCGATTGT-1_MS200_A303	-18.94645794	-3.572146235	13B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2726	4541	0.035895177	0.020259855	10	13B	IN-SV2C	41	6	6
GACGTGCTCACTTACT-1_MS200_A303	-29.01387562	-21.61425647	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3816	8151	0.021715127	0.016807754	10	6A	IN-PV	41	6	6
GACGTGCTCGCATGGC-1_MS200_A303	-30.49045887	-5.90974296	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1290	1996	0.004509018	0.006513026	10	9	OPC	41	6	6
GACGTGCTCGTTACAG-1_MS200_A303	-5.782505887	13.9490629	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	793	1099	0.007279345	0.011828935	10	oligos	OL-MS-1	41	6	6
GACGTGCTCTCAACTT-1_MS200_A303	-7.633955698	-35.02905155	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	956	1322	0.08774584	0.02269289	10	16	EN-PYR	41	6	6
GACGTTAAGTGGAGTC-1_MS200_A303	23.92632127	-12.92722911	3	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2671	4799	0.005626172	0.00770994	10	3	EN-L5-6	41	6	6
GACGTTAAGTGTACTC-1_MS200_A303	-18.48747039	-1.032906844	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3473	6897	0.013484124	0.016383935	10	13A	IN-VIP	41	6	6
GACGTTACACAAGCCC-1_MS200_A303	3.952175556	-3.155784772	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	944	1487	0.098184264	0.008742434	10	12	EN-MIX	41	6	6
GACGTTAGTAAACGCG-1_MS200_A303	19.28858146	-10.61592218	3	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2729	5374	0.047078526	0.004093785	10	3	EN-L5-6	41	6	6
GACGTTAGTACAGCAG-1_MS200_A303	-31.08664719	2.596996103	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2065	3763	0.00345469	0.006112145	10	9	OPC	41	6	6
GACGTTAGTCCGACGT-1_MS200_A303	33.8739589	-18.37533931	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3864	8570	0.009334889	0.017152859	10	2	EN-L4	41	6	6
GACGTTATCCTATGTT-1_MS200_A303	13.08086575	-13.3160175	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5035	12813	0.013111683	0.012799501	10	L2-3	EN-L2-3-MS	41	6	6
GACGTTATCTGGTGTA-1_MS200_A303	12.99247968	-19.19462114	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5252	14711	0.010536333	0.008225138	10	L2-3	EN-L2-3-MS	41	6	6
GACGTTATCTTACCTA-1_MS200_A303	6.714331581	-27.04513231	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4781	11537	0.008234376	0.011441449	10	L2-3	EN-L2-3-MS	41	6	6
GACTAACAGCTGCCCA-1_MS200_A303	-1.598778095	10.66068443	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1033	1586	0.022698613	0.020807062	10	oligos	OL-MS-1	41	6	6
GACTAACAGTTCGCGC-1_MS200_A303	13.9321331	-16.30763404	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	6910	21936	0.006291028	0.01622903	10	L2-3	EN-L2-3-MS	41	6	6
GACTAACGTCGGATCC-1_MS200_A303	13.4707671	-17.93727426	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	6210	18818	0.008449357	0.006270592	10	L2-3	EN-L2-3-MS	41	6	6
GACTAACGTTATCGGT-1_MS200_A303	-19.47960715	-5.515529939	13B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3516	7533	0.011150936	0.008363202	10	13B	IN-SV2C	41	6	6
GACTAACTCCAAACAC-1_MS200_A303	-15.00729437	24.41157977	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1880	3155	0.006339144	0.008874802	10	8	Astrocytes	41	6	6
GACTAACTCCGCGTTT-1_MS200_A303	-15.20982649	-23.27337128	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1594	3162	0.047122075	0.003478811	10	6A	IN-PV	41	6	6
GACTAACTCGAATCCA-1_MS200_A303	2.38543324	4.582315939	14	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	917	1192	0.006711409	0.012583893	10	14	Microglia	41	6	6
GACTAACTCTCTGAGA-1_MS200_A303	9.318895555	1.526011193	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	835	1526	0.262778506	0.00655308	10	12	EN-MIX	41	6	6
GACTAACTCTGCAGTA-1_MS200_A303	-22.70604506	-4.538533656	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2572	4726	0.013753703	0.006559458	10	13A	IN-VIP	41	6	6
GACTACAAGAATGTGT-1_MS200_A303	34.03536861	-17.11261861	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	6037	16301	0.010490154	0.016624747	10	2	EN-L4	41	6	6
GACTACAAGACTACAA-1_MS200_A303	15.06549489	-13.55520744	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5665	15287	0.015568784	0.014129653	10	L2-3	EN-L2-3-MS	41	6	6
GACTACACACCAGCAC-1_MS200_A303	-14.19921676	24.67249041	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2036	3442	0.004067403	0.013654852	10	8	Astrocytes	41	6	6
GACTACACACTCGACG-1_MS200_A303	10.34427869	-15.40305832	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3531	8189	0.006838442	0.006227867	10	L2-3	EN-L2-3-MS	41	6	6
GACTACACAGATCCAT-1_MS200_A303	8.784143193	-11.46859073	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2013	3562	0.029477821	0.008983717	10	L2-3	EN-L2-3-MS	41	6	6
GACTACAGTCTAGGTT-1_MS200_A303	-17.05427654	20.54081135	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1605	2548	0.001962323	0.013343799	10	8	Astrocytes	41	6	6
GACTACAGTGAGGCTA-1_MS200_A303	-15.38197103	-37.59695857	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4751	13719	0.042714484	0.027553029	10	16	EN-PYR	41	6	6
GACTGCGAGAACAACT-1_MS200_A303	12.9695543	-14.99044302	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3749	8513	0.027487372	0.003993892	10	L2-3	EN-L2-3-MS	41	6	6
GACTGCGAGAGACGAA-1_MS200_A303	3.801268444	10.60016163	1	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1222	1800	0.004444444	0.017777778	10	oligos	OL-Cntl	41	6	6
GACTGCGAGAGATGAG-1_MS200_A303	15.45051452	-13.56245851	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5629	15076	0.01797559	0.017312284	10	L2-3	EN-L2-3-MS	41	6	6
GACTGCGAGGGATACC-1_MS200_A303	31.21152241	-19.20612298	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4975	11892	0.016818029	0.026236125	10	2	EN-L4	41	6	6
GACTGCGAGTGCGTGA-1_MS200_A303	13.72981136	-15.25915307	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4445	10703	0.015322807	0.009156311	10	L2-3	EN-L2-3-MS	41	6	6
GACTGCGGTAGATTAG-1_MS200_A303	0.700321328	-6.708830907	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1306	2061	0.017467249	0.003881611	10	12	EN-MIX	41	6	6
GACTGCGTCAATCACG-1_MS200_A303	-5.810622899	14.84567272	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	738	1032	0.005813953	0.016472868	10	oligos	OL-MS-1	41	6	6
GACTGCGTCCAACCAA-1_MS200_A303	-3.889518069	-37.08144605	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	877	1173	0.065643649	0.039215686	10	16	EN-PYR	41	6	6
GACTGCGTCGTAGGAG-1_MS200_A303	14.75932306	-13.70345389	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4898	12125	0.014350515	0.014762887	10	L2-3	EN-L2-3-MS	41	6	6
GACTGCGTCTAACCGA-1_MS200_A303	-19.780662	-5.82009524	13B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4103	9073	0.013005621	0.007164113	10	13B	IN-SV2C	41	6	6
GAGCAGAAGATGCCTT-1_MS200_A303	33.49039546	-15.62340491	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4245	9566	0.017562199	0.011708133	10	2	EN-L4	41	6	6
GAGCAGAAGCCACGCT-1_MS200_A303	29.6364895	14.41831012	14	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1018	1583	0.007580543	0.097283639	10	14	Microglia	41	6	6
GAGCAGAAGGAGTCTG-1_MS200_A303	-13.94188601	23.9971513	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1719	3017	0.004640371	0.012263838	10	8	Astrocytes	41	6	6
GAGCAGAAGGTTCCTA-1_MS200_A303	-23.45284064	-15.45997419	13B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5594	14426	0.025717455	0.008595591	10	13B	IN-SV2C	41	6	6
GAGCAGAAGTCCCACG-1_MS200_A303	-4.775728016	17.97299269	1	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	859	1272	0.002358491	0.020440252	10	oligos	OL-Cntl	41	6	6
GAGCAGACAAGCCATT-1_MS200_A303	19.2148177	-0.798787416	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1187	1767	0.05319751	0.003961517	10	12	EN-MIX	41	6	6
GAGCAGACACGAAGCA-1_MS200_A303	-16.84356662	-2.694238063	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2248	3754	0.015982952	0.020245072	10	13A	IN-VIP	41	6	6
GAGCAGACATGCTGGC-1_MS200_A303	-11.53094074	-3.307981709	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2210	3950	0.011139241	0.005822785	10	13A	IN-VIP	41	6	6
GAGCAGACATTCCTCG-1_MS200_A303	4.601464432	-8.555624014	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1473	2506	0.085395052	0.001596169	10	12	EN-MIX	41	6	6
GAGCAGAGTAAACCTC-1_MS200_A303	-29.57610086	-3.966714146	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1424	2251	0.002665482	0.005330964	10	9	OPC	41	6	6
GAGCAGAGTACTTGAC-1_MS200_A303	17.11347989	-21.57591794	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4000	10370	0.017743491	0.007521697	10	L2-3	EN-L2-3-MS	41	6	6
GAGCAGAGTAGGACAC-1_MS200_A303	-8.894960078	-10.83571069	6B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1274	1743	0.033275961	0.006884682	10	6B	IN-SST	41	6	6
GAGCAGAGTCACCCAG-1_MS200_A303	-13.93990669	23.6041286	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1723	3067	0.004564721	0.016302576	10	8	Astrocytes	41	6	6
GAGGTGAAGAGACGAA-1_MS200_A303	-29.28864184	-10.33654066	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	979	1310	0.005343511	0.006870229	10	9	OPC	41	6	6
GAGGTGAAGGAACTGC-1_MS200_A303	-15.24203497	-37.42060143	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3125	7155	0.11222921	0.015234102	10	16	EN-PYR	41	6	6
GAGGTGAAGGCTCAGA-1_MS200_A303	14.58024589	-12.70761023	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4437	10186	0.014137051	0.013646181	10	L2-3	EN-L2-3-MS	41	6	6
GAGGTGACAAATCCGT-1_MS200_A303	8.975327592	-3.877387303	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2297	4216	0.029411765	0.013282732	10	12	EN-MIX	41	6	6
GAGGTGATCCTAAGTG-1_MS200_A303	-31.77109973	-7.353856583	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1032	1537	0.002602472	0.011060507	10	9	OPC	41	6	6
GAGGTGATCTCTTATG-1_MS200_A303	10.81137658	-17.14817491	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4910	13327	0.013956629	0.009079313	10	L2-3	EN-L2-3-MS	41	6	6
GAGGTGATCTGCAGTA-1_MS200_A303	7.829523162	-1.563089362	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1170	1852	0.1587473	0.005399568	10	12	EN-MIX	41	6	6
GAGTCCGAGAGCCTAG-1_MS200_A303	2.778753633	-7.15022085	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1383	2326	0.038693035	0.003439381	10	12	EN-MIX	41	6	6
GAGTCCGAGCACACAG-1_MS200_A303	1.163982066	10.64665276	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	905	1304	0.006134969	0.018404908	10	oligos	OL-MS-1	41	6	6
GAGTCCGAGCTAACAA-1_MS200_A303	-29.00963412	-3.213676533	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1588	2461	0.005282406	0.0073141	10	9	OPC	41	6	6
GAGTCCGCACGGTTTA-1_MS200_A303	-18.17344793	-6.163564673	13B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2857	5497	0.011096962	0.006912862	10	13B	IN-SV2C	41	6	6
GAGTCCGCATGCAACT-1_MS200_A303	-31.05279446	-8.294160276	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	856	1290	0.002325581	0.003875969	10	9	OPC	41	6	6
GAGTCCGGTGATAAGT-1_MS200_A303	15.71513732	-24.65581305	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3514	8281	0.017509963	0.006400193	10	L2-3	EN-L2-3-MS	41	6	6
GAGTCCGGTTCCAACA-1_MS200_A303	25.99053425	4.445690178	15BA	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1126	1542	0.016212711	0.007782101	10	15BA	Stromal cells	41	6	6
GAGTCCGTCTCTGAGA-1_MS200_A303	14.27395721	-16.27641103	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	6869	23339	0.009726209	0.00826942	10	L2-3	EN-L2-3-MS	41	6	6
GATCAGTAGCCAGAAC-1_MS200_A303	10.63545893	-18.14979896	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4557	11902	0.007897832	0.00655352	10	L2-3	EN-L2-3-MS	41	6	6
GATCAGTAGCCATCGC-1_MS200_A303	13.7601995	-15.84593181	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	6127	19097	0.014400168	0.011258313	10	L2-3	EN-L2-3-MS	41	6	6
GATCAGTAGCTGATAA-1_MS200_A303	19.18796549	-26.80692387	3	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3355	7870	0.001397713	0.00317662	10	3	EN-L5-6	41	6	6
GATCAGTGTACGACCC-1_MS200_A303	-27.60442139	-21.52028068	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3568	7969	0.028234408	0.009285983	10	6A	IN-PV	41	6	6
GATCAGTGTTCCATGA-1_MS200_A303	10.82410093	-2.14227718	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1566	2658	0.144469526	0.006772009	10	12	EN-MIX	41	6	6
GATCAGTTCACCGTAA-1_MS200_A303	-17.04420687	20.66781731	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1518	2555	0.003913894	0.010176125	10	8	Astrocytes	41	6	6
GATCAGTTCACGATGT-1_MS200_A303	-20.46956195	-5.356031197	13B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5791	17018	0.021682924	0.007932777	10	13B	IN-SV2C	41	6	6
GATCAGTTCACTGGGC-1_MS200_A303	-14.43038004	24.12595087	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1680	2871	0.008359457	0.012190874	10	8	Astrocytes	41	6	6
GATCAGTTCGGAGCAA-1_MS200_A303	-14.72615168	22.09258478	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1383	2264	0.005300353	0.019434629	10	8	Astrocytes	41	6	6
GATCAGTTCGGTCTAA-1_MS200_A303	-17.5905524	20.75926438	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1523	2636	0.001517451	0.011001517	10	8	Astrocytes	41	6	6
GATCGATAGTGTCCCG-1_MS200_A303	-22.70668805	-24.35256243	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2898	5975	0.005523013	0.006861925	10	6A	IN-PV	41	6	6
GATCGATCAGATAATG-1_MS200_A303	2.257939697	5.449269903	7	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	802	1141	0.006134969	0.01665206	10	7	Phagocytes	41	6	6
GATCGATCATTCTTAC-1_MS200_A303	-4.276696768	19.95031118	1	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	743	1056	0.002840909	0.011363636	10	oligos	OL-Cntl	41	6	6
GATCGATGTACTCTCC-1_MS200_A303	27.45245236	-13.90453768	3	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	6515	22516	0.034642032	0.005063066	10	3	EN-L5-6	41	6	6
GATCGATTCCTGTAGA-1_MS200_A303	-12.49013769	-16.31069531	6B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1273	2211	0.029398462	0.004070556	10	6B	IN-SST	41	6	6
GATCGATTCGGCGGTT-1_MS200_A303	-9.051838716	-17.71871443	6B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	737	1081	0.000925069	0.004625347	10	6B	IN-SST	41	6	6
GATCGATTCTGCTTGC-1_MS200_A303	4.641234892	5.239972001	7	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1762	2773	0.001081861	0.018031013	10	7	Phagocytes	41	6	6
GATCGCGAGGTCATCT-1_MS200_A303	-14.001896	-16.19411631	6B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1391	2275	0.021538462	0.004395604	10	6B	IN-SST	41	6	6
GATCGCGAGTAGCGGT-1_MS200_A303	18.27698169	-22.49538958	3	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4089	10201	0.008528576	0.019409862	10	3	EN-L5-6	41	6	6
GATCGCGAGTCGAGTG-1_MS200_A303	-23.69474183	9.333425349	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1187	1722	0.003484321	0.011614402	10	8	Astrocytes	41	6	6
GATCGCGCACCAGCAC-1_MS200_A303	-14.07871394	-0.338391677	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3101	6794	0.013394171	0.009272888	10	13A	IN-VIP	41	6	6
GATCGCGCAGATAATG-1_MS200_A303	21.40738137	-2.486076198	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1971	3425	0.006423358	0.008175182	10	2	EN-L4	41	6	6
GATCGCGGTCACAAGG-1_MS200_A303	-25.49101425	9.298902711	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1025	1555	0.002572347	0.005787781	10	8	Astrocytes	41	6	6
GATCGCGGTGGGTATG-1_MS200_A303	19.15322877	-16.40014483	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4941	12862	0.062742964	0.005986627	10	L2-3	EN-L2-3-MS	41	6	6
GATCGCGTCACCGTAA-1_MS200_A303	21.23681972	-12.832933	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2952	6104	0.048165138	0.008355177	10	12	EN-MIX	41	6	6
GATCGCGTCGGATGTT-1_MS200_A303	-19.51267423	-0.765197948	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3679	7679	0.008725094	0.022008074	10	13A	IN-VIP	41	6	6
GATCGTAAGCCAACAG-1_MS200_A303	-18.10686668	-15.70948251	6B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2258	4306	0.018810961	0.007199257	10	6B	IN-SST	41	6	6
GATCGTACAACTGCTA-1_MS200_A303	-19.36499132	-6.061623464	13B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3723	8970	0.028316611	0.00613155	10	13B	IN-SV2C	41	6	6
GATCGTACAGATAATG-1_MS200_A303	2.715897897	10.2797273	1	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1234	1830	0.007103825	0.023497268	10	oligos	OL-Cntl	41	6	6
GATCGTAGTCATCGGC-1_MS200_A303	-20.48911505	-4.755855822	13B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3901	8024	0.016450648	0.017572283	10	13B	IN-SV2C	41	6	6
GATCGTAGTCGAACAG-1_MS200_A303	30.97409075	-18.25528252	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5374	13935	0.016505203	0.012199498	10	2	EN-L4	41	6	6
GATCGTAGTTCCGTCT-1_MS200_A303	-36.12983927	-12.05121573	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	747	1111	0.00540054	0.00540054	10	9	OPC	41	6	6
GATCGTATCCTAGTGA-1_MS200_A303	-14.50268874	21.26759426	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1362	2064	0.00872093	0.015988372	10	8	Astrocytes	41	6	6
GATCGTATCCTTTCTC-1_MS200_A303	-29.55382823	-3.526241063	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1380	2210	0.002714932	0.01040724	10	9	OPC	41	6	6
GATCGTATCTAAGCCA-1_MS200_A303	-6.288282435	15.34314799	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	849	1211	0.012386457	0.014037985	10	oligos	OL-MS-1	41	6	6
GATCGTATCTTTCCTC-1_MS200_A303	-14.55481844	23.04338335	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1592	2617	0.006495988	0.015284677	10	8	Astrocytes	41	6	6
GATCTAGAGCCGTCGT-1_MS200_A303	32.52838111	9.8044431	14	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	816	1003	0.022931206	0.012961117	10	14	Microglia	41	6	6
GATCTAGAGTCGAGTG-1_MS200_A303	10.32035329	-0.609490239	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1179	1722	0.087108014	0.007549361	10	12	EN-MIX	41	6	6
GATCTAGAGTGGGATC-1_MS200_A303	34.20043786	-14.60479496	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4069	9404	0.011271799	0.01403658	10	2	EN-L4	41	6	6
GATCTAGCAACGCACC-1_MS200_A303	26.42522433	3.819992514	15DA	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	877	1211	0.003303055	0.01734104	10	15DA	T cells	41	6	6
GATCTAGCACTTAAGC-1_MS200_A303	6.497614596	-28.6418829	10	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3519	9217	0.044374525	0.003688836	10	L2-3	EN-L2-3-Cntl	41	6	6
GATCTAGGTCGGATCC-1_MS200_A303	-11.17900099	-8.011392984	13B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1659	2550	0.027058824	0.004705882	10	13B	IN-SV2C	41	6	6
GATCTAGGTGCTAGCC-1_MS200_A303	-9.527856737	-15.44659633	6B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	879	1337	0.029169783	0.012715034	10	6B	IN-SST	41	6	6
GATCTAGTCCGAACGC-1_MS200_A303	-9.186999545	27.12696471	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	884	1199	0.016680567	0.012510425	10	oligos	OL-MS-1	41	6	6
GATGAAAAGATGTGTA-1_MS200_A303	-16.64104692	20.402161	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1529	2521	0.007140024	0.00793336	10	8	Astrocytes	41	6	6
GATGAAAAGCATCATC-1_MS200_A303	28.65080023	-19.05250227	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	9484	47978	0.048105382	0.01242236	10	2	EN-L4	41	6	6
GATGAAAAGTTACGGG-1_MS200_A303	-20.77530933	6.398943362	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1122	1919	0.003126628	0.006774362	10	8	Astrocytes	41	6	6
GATGAAACACTATCTT-1_MS200_A303	12.31336219	-18.26876458	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5158	15055	0.00617735	0.005048157	10	L2-3	EN-L2-3-MS	41	6	6
GATGAAAGTATCGCAT-1_MS200_A303	23.59641654	-24.51449422	3	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3136	7260	0.019146006	0.003856749	10	3	EN-L5-6	41	6	6
GATGAAAGTATTCTCT-1_MS200_A303	33.5327952	-15.74167441	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3728	7986	0.010267969	0.010768845	10	2	EN-L4	41	6	6
GATGAAAGTTCTCATT-1_MS200_A303	-14.79467824	-37.6363813	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2336	4183	0.063112599	0.02079847	10	16	EN-PYR	41	6	6
GATGAAATCCCTTGTG-1_MS200_A303	-5.405702896	15.99365093	1	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	685	1048	0.003816794	0.009541985	10	oligos	OL-Cntl	41	6	6
GATGAAATCTTGTTTG-1_MS200_A303	-13.96150752	23.27717469	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1729	3085	0.002917342	0.018800648	10	8	Astrocytes	41	6	6
GATGAGGCAAGCGAGT-1_MS200_A303	-24.37309463	-19.50368653	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2822	5646	0.017003188	0.007970244	10	6A	IN-PV	41	6	6
GATGAGGCAGCTGTTA-1_MS200_A303	33.5275413	10.6749914	14	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	862	1226	0.017128874	0.016313214	10	14	Microglia	41	6	6
GATGAGGGTAAGGGAA-1_MS200_A303	-4.828656309	-37.0307112	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	798	1027	0.035053554	0.021421616	10	16	EN-PYR	41	6	6
GATGAGGGTGATAAAC-1_MS200_A303	-23.57578979	-24.86792469	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3867	9824	0.013232899	0.004784202	10	6A	IN-PV	41	6	6
GATGAGGTCAGGTTCA-1_MS200_A303	15.08430793	-21.33028447	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	6652	22373	0.016269611	0.004693157	10	L2-3	EN-L2-3-MS	41	6	6
GATGAGGTCTCTAGGA-1_MS200_A303	33.88706504	-17.17992057	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4673	10927	0.012446234	0.017479638	10	2	EN-L4	41	6	6
GATGCTAAGACTGTAA-1_MS200_A303	14.1439721	-15.87605959	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5425	14674	0.019149516	0.012811776	10	L2-3	EN-L2-3-MS	41	6	6
GATGCTAAGACTTTCG-1_MS200_A303	17.58180269	-15.78162019	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	7102	22596	0.011904762	0.011196672	10	L2-3	EN-L2-3-MS	41	6	6
GATGCTAAGGACCACA-1_MS200_A303	-17.54247863	-1.160838592	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3082	6027	0.011116642	0.016923843	10	13A	IN-VIP	41	6	6
GATGCTAAGGCGTACA-1_MS200_A303	-0.51213686	-0.437509601	11	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1640	2523	0.021799445	0.013476021	10	11	Glia-MIX	41	6	6
GATGCTACACTGTCGG-1_MS200_A303	-31.12538006	-8.010561719	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	949	1385	0.010830325	0.007942238	10	9	OPC	41	6	6
GATGCTACAGGTGGAT-1_MS200_A303	18.27609924	-22.39938962	3	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3928	8704	0.020335478	0.00792739	10	3	EN-L5-6	41	6	6
GATGCTACATACTCTT-1_MS200_A303	-3.17164286	-34.50107331	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	807	1002	0.046906188	0.0249501	10	16	EN-PYR	41	6	6
GATGCTAGTATCTGCA-1_MS200_A303	11.19120095	1.386382661	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	738	1029	0.08649174	0.004859086	10	12	EN-MIX	41	6	6
GATGCTAGTCAATGTC-1_MS200_A303	22.93390535	-22.57290827	3	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5232	15342	0.00358493	0.005214444	10	3	EN-L5-6	41	6	6
GATTCAGAGATGTTAG-1_MS200_A303	-15.98679379	-1.86985278	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2351	4021	0.006217359	0.014424273	10	13A	IN-VIP	41	6	6
GATTCAGCAGCTCGAC-1_MS200_A303	-3.713731115	-36.1264166	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	749	1019	0.064769382	0.023552502	10	16	EN-PYR	41	6	6
GATTCAGCATATGGTC-1_MS200_A303	-16.19573302	23.0339748	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1249	2068	0.003384913	0.00967118	10	8	Astrocytes	41	6	6
GATTCAGGTATGCTTG-1_MS200_A303	-7.580819838	-6.195310296	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1403	2257	0.008418254	0.006202924	10	13A	IN-VIP	41	6	6
GATTCAGGTTAGAACA-1_MS200_A303	-13.41606956	-37.56766444	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1829	3091	0.096085409	0.022322873	10	16	EN-PYR	41	6	6
GATTCAGGTTGGACCC-1_MS200_A303	-30.56011214	-21.53170569	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4422	10462	0.038615943	0.017778627	10	6A	IN-PV	41	6	6
GATTCAGGTTTGGGCC-1_MS200_A303	6.607922592	-2.495112421	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	991	1435	0.075261324	0.008362369	10	12	EN-MIX	41	6	6
GATTCAGTCCAAACAC-1_MS200_A303	-5.932668377	-35.63300469	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	894	1167	0.034275921	0.014567266	10	16	EN-PYR	41	6	6
GCAAACTAGCTAACAA-1_MS200_A303	-13.48752549	-38.12532984	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1928	3158	0.061431286	0.024382521	10	16	EN-PYR	41	6	6
GCAAACTAGGTACTCT-1_MS200_A303	6.774233206	-2.862947058	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1232	1767	0.003961517	0.010752688	10	12	EN-MIX	41	6	6
GCAAACTCACTTAACG-1_MS200_A303	-31.84965445	-5.832085101	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1185	1872	0.003739316	0.006944444	10	9	OPC	41	6	6
GCAAACTCATGTCGAT-1_MS200_A303	-15.88141157	10.03682359	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1365	2198	0.001364877	0.00955414	10	8	Astrocytes	41	6	6
GCAAACTGTCATTAGC-1_MS200_A303	1.19787571	10.99607871	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	905	1387	0.001441961	0.016582552	10	oligos	OL-MS-1	41	6	6
GCAAACTGTTCACCTC-1_MS200_A303	34.22540624	-18.09182064	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5638	15506	0.012253321	0.022184961	10	2	EN-L4	41	6	6
GCAAACTGTTCTGTTT-1_MS200_A303	12.38713731	-13.94076494	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4483	11588	0.011391094	0.014152572	10	L2-3	EN-L2-3-MS	41	6	6
GCAAACTTCAATAAGG-1_MS200_A303	-27.97259373	-22.7859591	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5868	16048	0.015453639	0.010157029	10	6A	IN-PV	41	6	6
GCAATCAAGCCCTAAT-1_MS200_A303	22.42848945	-16.88640377	3	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5142	14815	0.020384745	0.008167398	10	3	EN-L5-6	41	6	6
GCAATCAAGGTGATTA-1_MS200_A303	19.10806817	-19.81111481	3	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3365	7588	0.084343701	0.004085398	10	3	EN-L5-6	41	6	6
GCAATCACAAGTACCT-1_MS200_A303	34.35869828	-17.61152532	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5045	13164	0.010559101	0.01694014	10	2	EN-L4	41	6	6
GCAATCACACTTAAGC-1_MS200_A303	6.1053782	-16.58321232	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3237	7658	0.007051449	0.010054845	10	L2-3	EN-L2-3-MS	41	6	6
GCAATCACATTGAGCT-1_MS200_A303	-30.11507425	-11.06574581	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	867	1229	0.005695688	0.010577705	10	9	OPC	41	6	6
GCAATCAGTATCTGCA-1_MS200_A303	13.82021943	-16.19189901	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5633	16126	0.011844227	0.006759271	10	L2-3	EN-L2-3-MS	41	6	6
GCAATCAGTCACTGGC-1_MS200_A303	8.197609881	-10.95232905	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2148	3919	0.102832355	0.004337841	10	L2-3	EN-L2-3-MS	41	6	6
GCAATCATCCTCTAGC-1_MS200_A303	-24.45610539	11.11764508	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	989	1494	0.004016064	0.005354752	10	8	Astrocytes	41	6	6
GCACATAAGAAACCTA-1_MS200_A303	8.348994228	1.576404577	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	670	1367	0.399414777	0.008778347	10	16	EN-PYR	41	6	6
GCACATAAGACCACGA-1_MS200_A303	13.09793587	-12.88574718	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4527	10525	0.015771971	0.014726841	10	L2-3	EN-L2-3-MS	41	6	6
GCACATAAGAGGGCTT-1_MS200_A303	-9.654736502	21.78476168	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1509	2128	0.015507519	0.01174812	10	8	Astrocytes	41	6	6
GCACATAAGCGTGAAC-1_MS200_A303	-4.988917856	19.59366414	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	756	1058	0.005671078	0.019848771	10	oligos	OL-MS-1	41	6	6
GCACATAAGCTTTGGT-1_MS200_A303	-6.112749212	-36.1449057	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	827	1139	0.093942054	0.014925373	10	16	EN-PYR	41	6	6
GCACATACACTTAAGC-1_MS200_A303	-17.46331428	-1.372527306	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3636	7800	0.006794872	0.012179487	10	13A	IN-VIP	41	6	6
GCACATACAGACGCAA-1_MS200_A303	-13.53772881	-14.91982747	6B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1396	2274	0.017150396	0.009234828	10	6B	IN-SST	41	6	6
GCACATACATATACCG-1_MS200_A303	2.712866789	10.48085004	1	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1169	1823	0.007679649	0.013165112	10	oligos	OL-Cntl	41	6	6
GCACATACATATGCTG-1_MS200_A303	35.13230591	-15.10673815	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5087	12130	0.011459192	0.015581204	10	2	EN-L4	41	6	6
GCACATACATCAGTAC-1_MS200_A303	13.59900397	-14.92118277	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3956	9031	0.019377699	0.008526188	10	L2-3	EN-L2-3-MS	41	6	6
GCACATACATCCGGGT-1_MS200_A303	9.389432609	-19.03895473	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5264	15842	0.003598031	0.010857215	10	L2-3	EN-L2-3-MS	41	6	6
GCACATAGTACAGCAG-1_MS200_A303	-16.18366287	20.39355916	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1526	2638	0.004927976	0.015163002	10	8	Astrocytes	41	6	6
GCACATATCCGCGGTA-1_MS200_A303	-15.79467004	23.32415337	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1471	2545	0.005108055	0.009430255	10	8	Astrocytes	41	6	6
GCACTCTAGGCGTACA-1_MS200_A303	-4.66536833	12.7115236	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	732	1041	0.002881844	0.028818444	10	oligos	OL-MS-1	41	6	6
GCACTCTCAACGCACC-1_MS200_A303	-0.384903142	35.37510178	17	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	820	1198	0.005008347	0.012520868	10	oligos	OL-MS-2	41	6	6
GCACTCTCAAGGTGTG-1_MS200_A303	-13.22403735	-8.56388955	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2239	4149	0.026994456	0.005543504	10	6A	IN-PV	41	6	6
GCACTCTCACACGCTG-1_MS200_A303	15.28486804	-20.84306365	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4499	10738	0.011082138	0.008753958	10	L2-3	EN-L2-3-MS	41	6	6
GCACTCTCATCCTAGA-1_MS200_A303	-29.73292198	-21.90340062	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5152	13045	0.02154082	0.012495209	10	6A	IN-PV	41	6	6
GCACTCTGTTCCCTTG-1_MS200_A303	16.01692517	-18.35288814	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5493	17431	0.020136538	0.004646893	10	L2-3	EN-L2-3-MS	41	6	6
GCACTCTTCCTATGTT-1_MS200_A303	-5.160055852	18.30632183	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	842	1182	0.005922166	0.013536379	10	oligos	OL-MS-1	41	6	6
GCACTCTTCCTCATTA-1_MS200_A303	9.009608913	-14.69961286	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3174	6735	0.005196733	0.014253898	10	L2-3	EN-L2-3-MS	41	6	6
GCACTCTTCTATGTGG-1_MS200_A303	-30.53631853	-1.958691766	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1743	2957	0.002705445	0.006763612	10	9	OPC	41	6	6
GCAGCCAAGAGCTTCT-1_MS200_A303	-25.77116942	-18.97726322	6B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2180	3831	0.038371182	0.008874967	10	6B	IN-SST	41	6	6
GCAGCCACAAAGAATC-1_MS200_A303	-5.236215232	13.47795483	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	767	1093	0.003659652	0.015553522	10	oligos	OL-MS-1	41	6	6
GCAGCCACACTTGGAT-1_MS200_A303	-14.78463262	23.74404405	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1677	2884	0.008668516	0.010402219	10	8	Astrocytes	41	6	6
GCAGCCATCGTTGACA-1_MS200_A303	11.02776993	-2.09990106	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1389	2482	0.181305399	0.007252216	10	12	EN-MIX	41	6	6
GCAGTTAAGGCTAGCA-1_MS200_A303	-30.09079602	-3.220217649	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1434	2252	0.007104796	0.003552398	10	9	OPC	41	6	6
GCAGTTAAGGCTCTTA-1_MS200_A303	-14.96638828	24.56586833	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1767	3093	0.002909796	0.008082768	10	8	Astrocytes	41	6	6
GCAGTTACAATGGAAT-1_MS200_A303	4.321325445	11.40037991	1	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1058	1626	0.00799508	0.011685117	10	oligos	OL-Cntl	41	6	6
GCAGTTACACGTCTCT-1_MS200_A303	-5.489997608	17.3550542	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	724	1075	0.018604651	0.005581395	10	oligos	OL-MS-1	41	6	6
GCAGTTACAGTGAGTG-1_MS200_A303	-30.64089505	9.773288044	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	841	1208	0.014900662	0.006622517	10	8	Astrocytes	41	6	6
GCAGTTACATGCAACT-1_MS200_A303	-16.28224351	20.09085829	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1479	2412	0.002902156	0.014510779	10	8	Astrocytes	41	6	6
GCAGTTAGTGAGTATA-1_MS200_A303	-27.8032649	-22.59908931	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4702	11913	0.015781079	0.010324855	10	6A	IN-PV	41	6	6
GCAGTTAGTGTAAGTA-1_MS200_A303	18.90622574	-19.59753155	3	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4045	10008	0.090427658	0.003397282	10	3	EN-L5-6	41	6	6
GCAGTTAGTTGAGTTC-1_MS200_A303	-3.973962066	8.962458244	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	991	1398	0.00286123	0.030758226	10	oligos	OL-MS-1	41	6	6
GCAGTTATCAGATAAG-1_MS200_A303	-16.41706395	18.12070011	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1619	2417	0.012412081	0.009102193	10	8	Astrocytes	41	6	6
GCAGTTATCGTTTGCC-1_MS200_A303	8.641956271	-13.29300839	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2547	4954	0.008881712	0.006459427	10	L2-3	EN-L2-3-MS	41	6	6
GCATACAAGACCGGAT-1_MS200_A303	-14.29523071	22.67185832	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1625	2810	0.00747331	0.011743772	10	8	Astrocytes	41	6	6
GCATACAAGAGGGATA-1_MS200_A303	-14.84175064	-37.69272529	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2406	4341	0.065192352	0.02211472	10	16	EN-PYR	41	6	6
GCATACAAGATCTGCT-1_MS200_A303	-9.06497545	-16.59753683	6B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	779	1135	0.003524229	0.00969163	10	6B	IN-SST	41	6	6
GCATACAAGCGCTTAT-1_MS200_A303	28.71402695	-19.00104465	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	10108	58408	0.044771264	0.011402548	10	2	EN-L4	41	6	6
GCATACAAGGCGATAC-1_MS200_A303	-15.07573722	22.44135733	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1450	2333	0.003000429	0.014144878	10	8	Astrocytes	41	6	6
GCATACAAGTGCTGCC-1_MS200_A303	-5.607575898	16.02268331	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	853	1185	0.006751055	0.016033755	10	oligos	OL-MS-1	41	6	6
GCATACACATTGTGCA-1_MS200_A303	0.873629519	10.26249923	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1122	1748	0.004004577	0.019450801	10	oligos	OL-MS-1	41	6	6
GCATACAGTACTCAAC-1_MS200_A303	-32.8318457	-4.293162163	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1518	2594	0.00925212	0.005011565	10	9	OPC	41	6	6
GCATACAGTAGCTAAA-1_MS200_A303	28.76358678	-17.83027515	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	8772	41927	0.026116822	0.008586352	10	2	EN-L4	41	6	6
GCATACAGTCTTGCGG-1_MS200_A303	-29.1813597	-10.53297674	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	873	1227	0.004889976	0.02607987	10	9	OPC	41	6	6
GCATACATCACTCCTG-1_MS200_A303	18.09715257	-22.81912123	3	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3797	8906	0.01223894	0.018526836	10	3	EN-L5-6	41	6	6
GCATACATCAGTACGT-1_MS200_A303	-2.47098693	-35.30866931	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	803	1010	0.072277228	0.037623762	10	16	EN-PYR	41	6	6
GCATACATCCCTAACC-1_MS200_A303	29.26641376	9.857492266	15DB	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1401	2633	0.003797949	0.069502469	10	15DB	B cells	41	6	6
GCATGATAGGACACCA-1_MS200_A303	-8.670205782	-15.53310545	6B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	766	1080	0.046296296	0.007407407	10	6B	IN-SST	41	6	6
GCATGATCAAGACGTG-1_MS200_A303	-12.97283638	-38.55326893	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1810	2918	0.059287183	0.029472241	10	16	EN-PYR	41	6	6
GCATGATCATCGTCGG-1_MS200_A303	12.87502834	-13.14375177	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4446	10506	0.009423187	0.018941557	10	L2-3	EN-L2-3-MS	41	6	6
GCATGATCATGTAGTC-1_MS200_A303	28.73771251	-17.85988743	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	7732	30788	0.034234117	0.007795245	10	2	EN-L4	41	6	6
GCATGATGTACCGTAT-1_MS200_A303	33.70310382	-12.17225441	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3279	6826	0.010401406	0.006592441	10	2	EN-L4	41	6	6
GCATGATGTTACGTCA-1_MS200_A303	5.594422523	-3.792255067	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1121	1603	0.029943855	0.006238303	10	12	EN-MIX	41	6	6
GCATGATTCTGAAAGA-1_MS200_A303	14.53518215	-20.15994892	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	6952	22091	0.005069938	0.010864153	10	L2-3	EN-L2-3-MS	41	6	6
GCATGATTCTGCGTAA-1_MS200_A303	-22.816972	7.365268397	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1120	1619	0.004323657	0.010500309	10	8	Astrocytes	41	6	6
GCATGCGAGCTGAAAT-1_MS200_A303	-15.80151498	-0.187161945	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2705	5092	0.005891595	0.010408484	10	13A	IN-VIP	41	6	6
GCATGCGAGTTATCGC-1_MS200_A303	-2.701569711	18.6279593	1	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	778	1069	0.006548176	0.004677268	10	oligos	OL-Cntl	41	6	6
GCATGCGCAAGAGTCG-1_MS200_A303	-19.61105381	-5.272922253	13B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3556	7460	0.019168901	0.010857909	10	13B	IN-SV2C	41	6	6
GCATGCGCATCGGACC-1_MS200_A303	31.24639045	-18.39180691	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	6040	17328	0.013215605	0.015408587	10	2	EN-L4	41	6	6
GCATGCGGTGAAAGAG-1_MS200_A303	-18.18677154	-1.207382351	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3300	6439	0.013356111	0.016928094	10	13A	IN-VIP	41	6	6
GCATGCGTCAACCATG-1_MS200_A303	-32.04584745	-6.048194969	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1235	1932	0.007246377	0.005693582	10	9	OPC	41	6	6
GCATGCGTCGGGAGTA-1_MS200_A303	15.71589661	-10.96434843	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2353	4314	0.017385257	0.012749189	10	L2-3	EN-L2-3-MS	41	6	6
GCATGTAAGACTTTCG-1_MS200_A303	-16.45230924	20.51631173	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1457	2130	0.005633803	0.012206573	10	8	Astrocytes	41	6	6
GCATGTAAGGTGCACA-1_MS200_A303	-31.36577315	-6.443794391	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1074	1623	0.003696858	0.006161429	10	9	OPC	41	6	6
GCATGTAAGTTACGGG-1_MS200_A303	-13.58246582	22.29296686	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1505	2456	0.002035831	0.020358306	10	8	Astrocytes	41	6	6
GCATGTACACATCCAA-1_MS200_A303	3.304248252	-8.208195913	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1535	2713	0.093991891	0.005528935	10	12	EN-MIX	41	6	6
GCATGTACATGCAATC-1_MS200_A303	-15.79065135	20.7625013	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1235	1742	0.001722158	0.006314581	10	8	Astrocytes	41	6	6
GCATGTACATTTGCCC-1_MS200_A303	-30.89919011	-11.480836	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	849	1174	0.008517888	0.00681431	10	9	OPC	41	6	6
GCATGTATCCGTCAAA-1_MS200_A303	-26.9506078	-23.04018699	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5253	14272	0.012331839	0.008478139	10	6A	IN-PV	41	6	6
GCCAAATAGCAATCTC-1_MS200_A303	24.87032502	-15.19773958	3	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4880	12808	0.029512804	0.007026858	10	3	EN-L5-6	41	6	6
GCCAAATAGTATGACA-1_MS200_A303	-16.42359364	-2.174186005	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3111	6184	0.016009056	0.006468305	10	13A	IN-VIP	41	6	6
GCCAAATCAAAGGAAG-1_MS200_A303	-18.82850798	-1.184318018	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3119	5600	0.010178571	0.018571429	10	13A	IN-VIP	41	6	6
GCCAAATCAATAACGA-1_MS200_A303	-17.33254948	-1.662867153	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3180	6204	0.007253385	0.01273372	10	13A	IN-VIP	41	6	6
GCCAAATGTCGAATCT-1_MS200_A303	-9.324638988	-15.49414072	6B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	882	1265	0.03083004	0.007114625	10	6B	IN-SST	41	6	6
GCCAAATGTTACCGAT-1_MS200_A303	-10.68343807	28.6323226	17	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	807	1007	0.030784508	0.011916584	10	oligos	OL-MS-2	41	6	6
GCCAAATTCCCTTGTG-1_MS200_A303	2.706944413	-6.504266983	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1166	1717	0.01980198	0.006988934	10	12	EN-MIX	41	6	6
GCCAAATTCCTCTAGC-1_MS200_A303	-19.88690443	5.1142829	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	903	1283	0.004676539	0.007794232	10	8	Astrocytes	41	6	6
GCCAAATTCGTCTGAA-1_MS200_A303	36.52472036	-13.31239605	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4866	11543	0.005111323	0.014294378	10	2	EN-L4	41	6	6
GCCTCTACACCTCGGA-1_MS200_A303	15.75321226	-16.97859728	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	6245	20246	0.014274425	0.005433172	10	L2-3	EN-L2-3-MS	41	6	6
GCCTCTACACTTCGAA-1_MS200_A303	-5.95136011	16.47492222	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	721	1057	0.011352886	0.00756859	10	oligos	OL-MS-1	41	6	6
GCCTCTACAGGTGGAT-1_MS200_A303	-5.552676071	14.3659181	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	762	1062	0.004708098	0.019774011	10	oligos	OL-MS-1	41	6	6
GCCTCTACATGGAATA-1_MS200_A303	17.32637999	-4.933906412	3	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1396	2131	0.004692633	0.004223369	10	3	EN-L5-6	41	6	6
GCCTCTAGTTGTGGAG-1_MS200_A303	-30.71851828	-21.58505171	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5710	15584	0.034330082	0.019571355	10	6A	IN-PV	41	6	6
GCCTCTATCAGGCCCA-1_MS200_A303	29.00278649	-16.54051405	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	6224	21376	0.038126871	0.007110778	10	2	EN-L4	41	6	6
GCGACCAAGATGTAAC-1_MS200_A303	-19.06184277	-1.269797835	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3342	6341	0.016401199	0.012300899	10	13A	IN-VIP	41	6	6
GCGACCAAGCTAGCCC-1_MS200_A303	8.405658287	-11.23044595	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2847	6291	0.139564457	0.003338102	10	L2-3	EN-L2-3-MS	41	6	6
GCGACCAAGGACCACA-1_MS200_A303	-5.8108069	9.816851858	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	771	1049	0.007626311	0.023832221	10	oligos	OL-MS-1	41	6	6
GCGACCAGTCCTGCTT-1_MS200_A303	-11.51477033	-7.193612375	13B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1827	2917	0.009598903	0.012684265	10	13B	IN-SV2C	41	6	6
GCGACCAGTGTTGGGA-1_MS200_A303	-13.16196979	-8.552334184	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2187	4096	0.017822266	0.005615234	10	6A	IN-PV	41	6	6
GCGACCAGTTCCGTCT-1_MS200_A303	-29.03412216	-1.358129528	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1632	2583	0.003871467	0.009678668	10	9	OPC	41	6	6
GCGACCATCCTCATTA-1_MS200_A303	-30.3283869	-8.826080846	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1003	1449	0.003450656	0.005521049	10	9	OPC	41	6	6
GCGAGAAAGTACATGA-1_MS200_A303	-0.189826912	12.194918	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	955	1336	0.002994012	0.019461078	10	oligos	OL-MS-1	41	6	6
GCGAGAACACGTAAGG-1_MS200_A303	-28.81852756	-21.59975317	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3495	7354	0.030323633	0.012374218	10	6A	IN-PV	41	6	6
GCGAGAACAGGTTTCA-1_MS200_A303	34.09963505	10.31021874	14	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	901	1133	0	0.027360989	10	14	Microglia	41	6	6
GCGAGAACATCATCCC-1_MS200_A303	-10.35511742	27.4510203	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	871	1183	0.025359256	0.027895182	10	oligos	OL-MS-1	41	6	6
GCGAGAATCAAACAAG-1_MS200_A303	-31.68688401	-5.30209063	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1251	1898	0.005268704	0.01369863	10	9	OPC	41	6	6
GCGAGAATCCGAACGC-1_MS200_A303	-12.17953293	-36.79945244	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1439	2203	0.05265547	0.01407172	10	16	EN-PYR	41	6	6
GCGAGAATCCTCAATT-1_MS200_A303	-31.9379483	-5.735211059	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1271	1996	0.005511022	0.006012024	10	9	OPC	41	6	6
GCGAGAATCCTTAATC-1_MS200_A303	-24.57640538	9.679369973	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	953	1443	0.004158004	0.013860014	10	8	Astrocytes	41	6	6
GCGAGAATCGAATGCT-1_MS200_A303	-14.04287167	22.42356488	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1596	2551	0.002352019	0.010976088	10	8	Astrocytes	41	6	6
GCGAGAATCGACGGAA-1_MS200_A303	-14.86141268	-37.65055319	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2330	4221	0.073205402	0.021085051	10	16	EN-PYR	41	6	6
GCGAGAATCGTTACGA-1_MS200_A303	14.50420902	-12.70836982	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3557	7456	0.020654506	0.009790773	10	L2-3	EN-L2-3-MS	41	6	6
GCGAGAATCTGTACGA-1_MS200_A303	25.25223008	8.742886063	15A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2265	3701	0.021075385	0.0294515	10	15A	Endo cells	41	6	6
GCGAGAATCTTCCTTC-1_MS200_A303	-24.96619654	-19.44624039	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3167	6973	0.015775133	0.011616234	10	6A	IN-PV	41	6	6
GCGCAACAGCCGTCGT-1_MS200_A303	-14.68066602	23.59746814	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1729	2924	0.010943912	0.007181943	10	8	Astrocytes	41	6	6
GCGCAACCACTAGTAC-1_MS200_A303	-22.76051297	8.319761482	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1176	1806	0.021040975	0.008859358	10	8	Astrocytes	41	6	6
GCGCAACCATAAAGGT-1_MS200_A303	-25.8930472	-1.656289448	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1678	3093	0.005172971	0.014872292	10	9	OPC	41	6	6
GCGCAACTCACGATGT-1_MS200_A303	-14.15128429	22.28612616	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1536	2455	0.005702648	0.006517312	10	8	Astrocytes	41	6	6
GCGCAACTCCACGTGG-1_MS200_A303	14.8651975	-17.42187447	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	6365	20348	0.010025555	0.008649499	10	L2-3	EN-L2-3-MS	41	6	6
GCGCAGTAGATCCTGT-1_MS200_A303	36.57376652	-13.27214067	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4983	11749	0.017022725	0.010383862	10	2	EN-L4	41	6	6
GCGCAGTAGCGCTCCA-1_MS200_A303	-27.17066095	-3.813039764	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1658	2618	0.004583652	0.010313216	10	9	OPC	41	6	6
GCGCAGTAGGGTTTCT-1_MS200_A303	13.96292653	8.984395258	1	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1512	2742	0.004376368	0.011670314	10	oligos	OL-Cntl	41	6	6
GCGCAGTAGTTCGCGC-1_MS200_A303	-29.97629754	-21.49807037	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4372	11035	0.059900317	0.007159039	10	6A	IN-PV	41	6	6
GCGCAGTCAAGTTCTG-1_MS200_A303	7.012166981	0.615746043	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	950	1382	0.015195369	0.01447178	10	16	EN-PYR	41	6	6
GCGCAGTCAGATCGGA-1_MS200_A303	15.97494766	-22.24532605	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	6289	19087	0.008749411	0.008173102	10	L2-3	EN-L2-3-MS	41	6	6
GCGCAGTCAGATGGGT-1_MS200_A303	-4.541497241	17.59064046	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	940	1352	0.00443787	0.011094675	10	oligos	OL-MS-1	41	6	6
GCGCAGTGTAGAGGAA-1_MS200_A303	5.143733779	-3.053625464	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	946	1344	0.004464286	0.006696429	10	12	EN-MIX	41	6	6
GCGCAGTTCTACCAGA-1_MS200_A303	-29.06215002	-6.060003081	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1006	1532	0.004569191	0.006527415	10	9	OPC	41	6	6
GCGCAGTTCTCCAACC-1_MS200_A303	0.340105782	22.17560725	1	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	788	1099	0.004549591	0.013648772	10	oligos	OL-Cntl	41	6	6
GCGCCAAAGAAGCCCA-1_MS200_A303	-31.86922488	-5.73377765	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1257	1937	0.008260196	0.004130098	10	9	OPC	41	6	6
GCGCCAAAGAGACGAA-1_MS200_A303	-15.67819217	9.329228129	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1571	2686	0.006701415	0.014519732	10	8	Astrocytes	41	6	6
GCGCCAAAGCCAGAAC-1_MS200_A303	22.50106972	-16.80280352	3	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4670	11759	0.036057488	0.008929331	10	3	EN-L5-6	41	6	6
GCGCCAACACATGGGA-1_MS200_A303	-6.402352906	12.16287998	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	737	1011	0.010880317	0.018793274	10	oligos	OL-MS-1	41	6	6
GCGCCAACAGTATAAG-1_MS200_A303	-13.53341606	22.89894102	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1667	2743	0.004010208	0.019686475	10	8	Astrocytes	41	6	6
GCGCCAACATGAGCGA-1_MS200_A303	-15.77442079	21.8717529	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1331	1940	0.005670103	0.010824742	10	8	Astrocytes	41	6	6
GCGCCAAGTATTCTCT-1_MS200_A303	-11.39395225	-37.71859524	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1339	1972	0.063387424	0.019269777	10	16	EN-PYR	41	6	6
GCGCCAATCATCTGTT-1_MS200_A303	-30.27986293	-4.364202109	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1307	2104	0.002376426	0.004277567	10	9	OPC	41	6	6
GCGCGATAGAATGTGT-1_MS200_A303	8.9324271	1.525952384	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	744	1342	0.295081967	0.004470939	10	12	EN-MIX	41	6	6
GCGCGATAGCAATCTC-1_MS200_A303	25.06099291	-15.77930288	3	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4760	12151	0.030120978	0.008970455	10	3	EN-L5-6	41	6	6
GCGCGATCACAACGCC-1_MS200_A303	-12.22285541	-37.15793274	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1465	2188	0.062157221	0.014625229	10	16	EN-PYR	41	6	6
GCGCGATCAGGTCGTC-1_MS200_A303	-4.020639814	6.037572224	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2165	3887	0.007975302	0.012091587	10	oligos	OL-MS-1	41	6	6
GCGCGATTCCGTTGCT-1_MS200_A303	-13.65611874	22.86912212	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1604	2610	0.003448276	0.016091954	10	8	Astrocytes	41	6	6
GCGGGTTAGACAGGCT-1_MS200_A303	16.6640275	-14.01185827	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5584	15389	0.018324777	0.007797778	10	L2-3	EN-L2-3-MS	41	6	6
GCGGGTTAGCTAACAA-1_MS200_A303	-12.95734663	16.35734019	11	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1420	2212	0.005424955	0.004972875	10	11	Glia-MIX	41	6	6
GCGGGTTAGTACGTTC-1_MS200_A303	32.2731839	-10.67400486	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2782	5587	0.00698049	0.009307321	10	2	EN-L4	41	6	6
GCGGGTTAGTGACTCT-1_MS200_A303	-9.614314675	27.45538908	17	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1287	1831	0.016384489	0.016384489	10	oligos	OL-MS-2	41	6	6
GCGGGTTCAGCGTTCG-1_MS200_A303	-29.38205985	-10.17298473	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1003	1359	0.002207506	0.007358352	10	9	OPC	41	6	6
GCGGGTTGTACAGTGG-1_MS200_A303	-18.69661278	7.339987578	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	983	1561	0.000640615	0.00768738	10	8	Astrocytes	41	6	6
GCGGGTTGTCTTGTCC-1_MS200_A303	2.109126936	5.177562054	7	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	848	1075	0.005581395	0.026976744	10	7	Phagocytes	41	6	6
GCGGGTTTCACGCATA-1_MS200_A303	23.04967051	-16.15524945	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5665	16120	0.028287841	0.010297767	10	L2-3	EN-L2-3-MS	41	6	6
GCTCCTAAGTAGCCGA-1_MS200_A303	-3.784245814	14.79314803	1	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	775	1141	0	0.021034181	10	oligos	OL-Cntl	41	6	6
GCTCCTAAGTGTGAAT-1_MS200_A303	-21.80700872	-21.76594056	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2390	4975	0.034974874	0.00241206	10	6A	IN-PV	41	6	6
GCTCCTACAATGCCAT-1_MS200_A303	-23.54718697	-19.58972983	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3598	9151	0.013768987	0.004808218	10	6A	IN-PV	41	6	6
GCTCCTACACATAACC-1_MS200_A303	-16.03160044	21.64434463	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1391	2187	0.006858711	0.009144947	10	8	Astrocytes	41	6	6
GCTCCTACATACTACG-1_MS200_A303	19.1640041	-14.08384091	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	8142	32562	0.03049567	0.010441619	10	2	EN-L4	41	6	6
GCTCCTACATGCAACT-1_MS200_A303	6.935789064	-0.968711753	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	725	1008	0.120039683	0.009920635	10	12	EN-MIX	41	6	6
GCTCCTAGTAGAGCTG-1_MS200_A303	-5.645561522	14.74994738	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	801	1117	0.005371531	0.012533572	10	oligos	OL-MS-1	41	6	6
GCTCCTAGTAGGACAC-1_MS200_A303	12.77523498	-18.9494399	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	6403	22691	0.012780398	0.005156229	10	L2-3	EN-L2-3-MS	41	6	6
GCTCCTAGTTACGTCA-1_MS200_A303	-8.825060997	-5.036083169	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1681	2969	0.012462108	0.006399461	10	13A	IN-VIP	41	6	6
GCTCCTATCGAGGTAG-1_MS200_A303	11.54762278	-12.4682752	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3041	5898	0.018989488	0.018989488	10	L2-3	EN-L2-3-MS	41	6	6
GCTCCTATCTGATACG-1_MS200_A303	-16.03216117	23.33331955	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1670	2986	0.003014066	0.006363027	10	8	Astrocytes	41	6	6
GCTCTGTAGAAACGCC-1_MS200_A303	-25.19924322	-19.39715531	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2896	5880	0.026190476	0.008333333	10	6A	IN-PV	41	6	6
GCTCTGTAGGACAGAA-1_MS200_A303	-21.59312678	-21.94229498	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2359	4681	0.032898953	0.002990814	10	6A	IN-PV	41	6	6
GCTCTGTAGTTACCCA-1_MS200_A303	-13.4526313	22.85228252	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1804	2637	0.006067501	0.014410315	10	8	Astrocytes	41	6	6
GCTCTGTCACAAGCCC-1_MS200_A303	-12.8664991	17.11178726	11	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1515	2463	0.002030045	0.009338205	10	11	Glia-MIX	41	6	6
GCTCTGTCAGTCAGCC-1_MS200_A303	31.75782789	-15.60851673	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3243	6830	0.030307467	0.013909224	10	2	EN-L4	41	6	6
GCTCTGTCATCGGACC-1_MS200_A303	9.275374256	1.456551179	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	726	1131	0.014146773	0.00795756	10	12	EN-MIX	41	6	6
GCTCTGTCATGGTAGG-1_MS200_A303	8.220226343	-10.84532452	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2120	3876	0.07997936	0.004385965	10	L2-3	EN-L2-3-MS	41	6	6
GCTCTGTTCGTCCGTT-1_MS200_A303	-15.68998606	21.8351404	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1152	1721	0.00232423	0.008715863	10	8	Astrocytes	41	6	6
GCTGCAGCAATGACCT-1_MS200_A303	2.762338465	10.18287219	1	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1261	1927	0.013492475	0.014011417	10	oligos	OL-Cntl	41	6	6
GCTGCAGCATGCAACT-1_MS200_A303	-17.22996676	20.48164217	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1657	2858	0.006997901	0.010146956	10	8	Astrocytes	41	6	6
GCTGCAGCATGGAATA-1_MS200_A303	8.866782191	-18.9354498	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4842	12772	0.003053555	0.00986533	10	L2-3	EN-L2-3-MS	41	6	6
GCTGCAGGTCGCGGTT-1_MS200_A303	36.75782139	12.68275786	14	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	945	1307	0.00841622	0.017597552	10	14	Microglia	41	6	6
GCTGCAGGTTCTCATT-1_MS200_A303	-5.504699797	15.19507998	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	853	1222	0.022094926	0.014729951	10	oligos	OL-MS-1	41	6	6
GCTGCAGGTTGTGGCC-1_MS200_A303	22.67713364	-16.61172431	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4760	11192	0.022069335	0.0095604	10	2	EN-L4	41	6	6
GCTGCAGTCATACGGT-1_MS200_A303	-19.45060822	-2.322383451	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3783	7926	0.021953066	0.009967197	10	13A	IN-VIP	41	6	6
GCTGCAGTCCTGTACC-1_MS200_A303	-6.000731157	-36.48555478	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	987	1406	0.100284495	0.025604552	10	16	EN-PYR	41	6	6
GCTGCAGTCGCTTGTC-1_MS200_A303	-9.084871095	-15.90379739	6B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	829	1183	0.032967033	0.002535926	10	6B	IN-SST	41	6	6
GCTGCAGTCTTTACGT-1_MS200_A303	34.88862147	-15.54090642	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5422	14474	0.009119801	0.009948874	10	2	EN-L4	41	6	6
GCTGCGAAGAAAGTGG-1_MS200_A303	-26.36854982	-18.30617544	6B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2019	3426	0.038820782	0.008756567	10	6B	IN-SST	41	6	6
GCTGCGAAGTGGCACA-1_MS200_A303	34.02278769	-18.34263742	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4579	10429	0.01793077	0.016876019	10	2	EN-L4	41	6	6
GCTGCGACAATCGAAA-1_MS200_A303	33.67398379	-17.08491473	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4092	8469	0.012398158	0.018538198	10	2	EN-L4	41	6	6
GCTGCGACAGTATCTG-1_MS200_A303	-28.66467486	-5.007312262	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1338	1995	0.007518797	0.007017544	10	9	OPC	41	6	6
GCTGCGACATCCGTGG-1_MS200_A303	-24.52859765	10.05074577	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	953	1441	0.004857738	0.007633588	10	8	Astrocytes	41	6	6
GCTGCGATCTGGTTCC-1_MS200_A303	2.484204651	-6.46177062	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1204	1966	0.070193286	0.004577823	10	12	EN-MIX	41	6	6
GCTGCTTAGCCGTCGT-1_MS200_A303	-15.64979749	23.26171795	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1399	2346	0.00170503	0.013213981	10	8	Astrocytes	41	6	6
GCTGCTTCACGGTTTA-1_MS200_A303	10.95553277	-20.39333346	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3748	9522	0.031505986	0.003885738	10	L2-3	EN-L2-3-MS	41	6	6
GCTGCTTGTCAACTGT-1_MS200_A303	-24.03465077	9.732903952	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1177	1814	0.001653804	0.008269019	10	8	Astrocytes	41	6	6
GCTGCTTTCACAAACC-1_MS200_A303	5.130891966	-1.948758812	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	799	1128	0.011524823	0.015070922	10	12	EN-MIX	41	6	6
GCTGCTTTCACGCGGT-1_MS200_A303	-18.38426386	-2.09493072	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3353	6841	0.012278907	0.011986552	10	13A	IN-VIP	41	6	6
GCTGCTTTCTGCGTAA-1_MS200_A303	-26.59506848	8.402902574	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	829	1154	0.003466205	0.012131716	10	8	Astrocytes	41	6	6
GCTGGGTAGCGCTCCA-1_MS200_A303	3.315954718	10.46243332	1	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1182	1828	0.008752735	0.020787746	10	oligos	OL-Cntl	41	6	6
GCTGGGTAGGGCTTCC-1_MS200_A303	14.20219838	-16.10529591	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	7222	24639	0.014570397	0.005600877	10	L2-3	EN-L2-3-MS	41	6	6
GCTGGGTCAGGTGGAT-1_MS200_A303	12.28482556	-14.95402885	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3489	7833	0.060768543	0.00561726	10	L2-3	EN-L2-3-MS	41	6	6
GCTGGGTTCTACTCAT-1_MS200_A303	-6.380291535	15.09146057	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	862	1246	0.021669342	0.01364366	10	oligos	OL-MS-1	41	6	6
GCTTCCAAGCATGGCA-1_MS200_A303	-30.51560083	-21.51584953	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	6535	20715	0.02645426	0.01230992	10	6A	IN-PV	41	6	6
GCTTCCAAGGGAGTAA-1_MS200_A303	11.90696692	-16.44497762	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4422	10866	0.009571139	0.006442113	10	L2-3	EN-L2-3-MS	41	6	6
GCTTCCAAGTGCTGCC-1_MS200_A303	18.59352758	-18.98694818	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3670	8769	0.053369826	0.004219409	10	L2-3	EN-L2-3-MS	41	6	6
GCTTCCACACAGACTT-1_MS200_A303	-13.9985211	-36.89019944	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2059	3527	0.046781968	0.012758718	10	16	EN-PYR	41	6	6
GCTTCCACATCTATGG-1_MS200_A303	24.92034295	-14.65996289	3	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5391	14890	0.028341169	0.007521827	10	3	EN-L5-6	41	6	6
GCTTCCATCTGCTGCT-1_MS200_A303	-18.1215112	-9.514314554	13B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4293	10708	0.006630557	0.004856182	10	13B	IN-SV2C	41	6	6
GCTTGAAAGCCCAATT-1_MS200_A303	-23.92685123	5.915303498	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	717	1024	0.008789063	0.008789063	10	8	Astrocytes	41	6	6
GCTTGAAAGGATGCGT-1_MS200_A303	18.81037904	-14.7764616	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	6559	20635	0.02437606	0.009886116	10	L2-3	EN-L2-3-MS	41	6	6
GCTTGAACACACTGCG-1_MS200_A303	-29.77825089	-1.301398936	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1679	2675	0.007850467	0.008598131	10	9	OPC	41	6	6
GCTTGAAGTCACAAGG-1_MS200_A303	-16.98449497	20.14277228	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1211	1947	0.005136107	0.008731382	10	8	Astrocytes	41	6	6
GCTTGAAGTCTCTCTG-1_MS200_A303	33.270092	10.54833428	14	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	871	1128	0.015070922	0.016843972	10	14	Microglia	41	6	6
GCTTGAATCTATGTGG-1_MS200_A303	-17.58333375	-25.7058146	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2419	4909	0.029333877	0.002648197	10	6A	IN-PV	41	6	6
GCTTGAATCTGGTTCC-1_MS200_A303	-5.532193148	15.64635463	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	737	1045	0.013397129	0.015311005	10	oligos	OL-MS-1	41	6	6
GGAAAGCAGAAAGTGG-1_MS200_A303	12.50419833	-0.525185153	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	907	1312	0.057926829	0.008384146	10	12	EN-MIX	41	6	6
GGAAAGCAGATAGCAT-1_MS200_A303	-15.92470997	8.680967621	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1147	1710	0.005847953	0.014619883	10	8	Astrocytes	41	6	6
GGAAAGCCAGTCAGAG-1_MS200_A303	15.9203509	-12.8994293	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5406	13211	0.011959731	0.011808342	10	L2-3	EN-L2-3-MS	41	6	6
GGAAAGCTCCACGTGG-1_MS200_A303	12.08519925	-12.79569157	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3399	6944	0.0109447	0.015552995	10	L2-3	EN-L2-3-MS	41	6	6
GGAAAGCTCTTCGGTC-1_MS200_A303	-18.44751341	-0.600304467	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3391	6745	0.008450704	0.022090437	10	13A	IN-VIP	41	6	6
GGAACTTAGAAGGCCT-1_MS200_A303	34.13074992	-18.39565387	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5318	13087	0.010544815	0.020249102	10	2	EN-L4	41	6	6
GGAACTTAGACTGTAA-1_MS200_A303	33.38884054	10.94434575	14	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	908	1147	0.009590235	0.023539669	10	14	Microglia	41	6	6
GGAACTTAGCGCTTAT-1_MS200_A303	-33.16098037	-9.129642868	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	976	1492	0.006032172	0.009383378	10	9	OPC	41	6	6
GGAACTTAGTGACTCT-1_MS200_A303	22.05896404	-21.75705839	3	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4339	11694	0.022832222	0.005985976	10	3	EN-L5-6	41	6	6
GGAACTTCAATGGAAT-1_MS200_A303	-15.04612314	22.32813234	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1497	2382	0.006717045	0.012174643	10	8	Astrocytes	41	6	6
GGAACTTCAGTCCTTC-1_MS200_A303	-31.92371767	-5.641455904	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1301	2087	0.00718735	0.007666507	10	9	OPC	41	6	6
GGAACTTTCCGAATGT-1_MS200_A303	-16.93695628	-1.884674702	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2615	4730	0.007188161	0.014799154	10	13A	IN-VIP	41	6	6
GGAACTTTCTATCCCG-1_MS200_A303	-24.4677716	8.346913019	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	947	1382	0.011577424	0.011577424	10	8	Astrocytes	41	6	6
GGAATAAAGAGGGATA-1_MS200_A303	-5.98706393	14.83100113	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	820	1131	0.00265252	0.020335986	10	oligos	OL-MS-1	41	6	6
GGAATAAAGTTAAGTG-1_MS200_A303	9.902511012	1.519722458	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	699	1008	0.139880952	0.007936508	10	12	EN-MIX	41	6	6
GGAATAACACACGCTG-1_MS200_A303	-24.36991607	8.133428967	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	973	1370	0.00729927	0.012408759	10	8	Astrocytes	41	6	6
GGAATAACATCGGTTA-1_MS200_A303	-14.67692682	21.95017461	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1328	2140	0.001401869	0.01635514	10	8	Astrocytes	41	6	6
GGAATAAGTCCGTGAC-1_MS200_A303	-24.73225286	-19.42994631	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2419	4618	0.009961022	0.015374621	10	6A	IN-PV	41	6	6
GGAATAAGTCCTCCAT-1_MS200_A303	22.35032287	-21.66437376	3	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4511	12388	0.018969971	0.006538586	10	3	EN-L5-6	41	6	6
GGAATAAGTCTCACCT-1_MS200_A303	-17.10177833	-0.400775258	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2689	4867	0.007191288	0.025272242	10	13A	IN-VIP	41	6	6
GGAATAAGTGTGACGA-1_MS200_A303	18.45834587	-19.05377883	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3415	7839	0.032274525	0.004847557	10	L2-3	EN-L2-3-MS	41	6	6
GGAATAAGTTATGTGC-1_MS200_A303	-5.488360334	15.08367539	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	760	1110	0.004504505	0.013513514	10	oligos	OL-MS-1	41	6	6
GGAATAATCCCATTAT-1_MS200_A303	11.4543462	-14.73019903	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4622	12183	0.00517114	0.014692604	10	L2-3	EN-L2-3-MS	41	6	6
GGACAAGAGCGATAGC-1_MS200_A303	-28.99855126	-21.32925394	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3701	7454	0.033673196	0.015427958	10	6A	IN-PV	41	6	6
GGACAAGAGTACATGA-1_MS200_A303	-24.84932012	-19.23331448	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3827	8954	0.022448068	0.00692428	10	6A	IN-PV	41	6	6
GGACAAGCAAGCGTAG-1_MS200_A303	-16.65531966	19.35457685	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1452	2387	0.003770423	0.005865103	10	8	Astrocytes	41	6	6
GGACAGAAGAGCTTCT-1_MS200_A303	11.32640054	1.062629905	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	789	1046	0.078393881	0.013384321	10	12	EN-MIX	41	6	6
GGACAGAAGCGCTTAT-1_MS200_A303	-14.17117819	22.9320061	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1704	2613	0.01224646	0.009950249	10	8	Astrocytes	41	6	6
GGACAGACAAGCGAGT-1_MS200_A303	-14.80751904	22.00967066	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1293	2032	0.00492126	0.016240157	10	8	Astrocytes	41	6	6
GGACAGACAGGAATGC-1_MS200_A303	12.78994801	-13.00642134	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4162	9502	0.013786571	0.017049042	10	L2-3	EN-L2-3-MS	41	6	6
GGACAGACATGTAAGA-1_MS200_A303	-15.77303154	21.95486008	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1232	1898	0.003161222	0.010537408	10	8	Astrocytes	41	6	6
GGACAGAGTGCTTCTC-1_MS200_A303	-6.077388161	12.99885654	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	816	1101	0.010899183	0.014532243	10	oligos	OL-MS-1	41	6	6
GGACAGAGTTCCGTCT-1_MS200_A303	-19.1186587	-0.934066392	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3277	6278	0.01369863	0.018158649	10	13A	IN-VIP	41	6	6
GGACAGAGTTTAGCTG-1_MS200_A303	14.88222806	-12.63143208	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4329	9722	0.021291915	0.015531784	10	L2-3	EN-L2-3-MS	41	6	6
GGACATTAGATGGGTC-1_MS200_A303	26.49613219	-17.4103715	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5815	19157	0.046562614	0.005428825	10	2	EN-L4	41	6	6
GGACATTAGGAGTTGC-1_MS200_A303	-8.502372227	-37.57157017	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1135	1594	0.070890841	0.023839398	10	16	EN-PYR	41	6	6
GGACATTCAAAGGAAG-1_MS200_A303	-17.68506228	-3.729730499	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2753	4928	0.037540584	0.007102273	10	13A	IN-VIP	41	6	6
GGACATTCACATTCGA-1_MS200_A303	-29.95370242	-4.505254417	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1383	2226	0.005390836	0.003144654	10	9	OPC	41	6	6
GGACATTGTACCATCA-1_MS200_A303	14.14469352	-15.51085786	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5139	14542	0.018154312	0.007151699	10	L2-3	EN-L2-3-MS	41	6	6
GGACATTTCCAGATCA-1_MS200_A303	-14.57343367	21.99452475	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1317	2177	0.001837391	0.012861736	10	8	Astrocytes	41	6	6
GGACATTTCCGGCACA-1_MS200_A303	31.49287457	-16.79847605	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5234	14609	0.010267643	0.009925388	10	2	EN-L4	41	6	6
GGACGTCCACAGCCCA-1_MS200_A303	14.73487168	-13.66360287	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5043	13168	0.019213244	0.007290401	10	L2-3	EN-L2-3-MS	41	6	6
GGACGTCCATAAAGGT-1_MS200_A303	-17.94184526	-0.705669409	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3373	7153	0.011184119	0.026562282	10	13A	IN-VIP	41	6	6
GGACGTCTCCGCAGTG-1_MS200_A303	34.42710532	10.70529654	14	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	883	1351	0.00296077	0.009622502	10	14	Microglia	41	6	6
GGACGTCTCCTACAGA-1_MS200_A303	-23.76436943	-24.77930476	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3688	8166	0.011878521	0.006367867	10	6A	IN-PV	41	6	6
GGAGCAAAGCAGCCTC-1_MS200_A303	-23.96207813	8.016273826	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	999	1433	0.003489184	0.013258897	10	8	Astrocytes	41	6	6
GGAGCAACACGAAACG-1_MS200_A303	-30.0258729	9.32937333	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	759	1048	0.003816794	0.006679389	10	8	Astrocytes	41	6	6
GGAGCAACAGATAATG-1_MS200_A303	-20.4849988	-4.851259878	13B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4580	9945	0.012870789	0.013474108	10	13B	IN-SV2C	41	6	6
GGAGCAACAGGGTACA-1_MS200_A303	0.940863317	8.809134871	1	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1191	1867	0.006427424	0.023031601	10	oligos	OL-Cntl	41	6	6
GGAGCAACATGACATC-1_MS200_A303	12.30289102	-12.79025836	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4333	9683	0.00547351	0.023856243	10	L2-3	EN-L2-3-MS	41	6	6
GGAGCAAGTACTCTCC-1_MS200_A303	32.81887961	10.9966692	14	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	768	1025	0.004878049	0.022439024	10	14	Microglia	41	6	6
GGAGCAAGTCCCGACA-1_MS200_A303	9.547917802	1.402094838	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	768	1055	0.069194313	0.01042654	10	12	EN-MIX	41	6	6
GGATGTTAGTGGCACA-1_MS200_A303	29.64208882	14.3626212	14	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	920	1321	0.001514005	0.159727479	10	14	Microglia	41	6	6
GGATGTTCACTGAAGG-1_MS200_A303	-15.81603179	20.10221969	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1525	2390	0.012133891	0.014225941	10	8	Astrocytes	41	6	6
GGATGTTCATGATCCA-1_MS200_A303	16.17533542	-16.21097996	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5540	15276	0.006284368	0.025988479	10	L2-3	EN-L2-3-MS	41	6	6
GGATGTTGTTAAGGGC-1_MS200_A303	29.78436952	14.45380464	14	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	817	1172	0.002559727	0.122013652	10	14	Microglia	41	6	6
GGATGTTTCCTATGTT-1_MS200_A303	-6.024410304	14.94513775	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	855	1178	0.005093379	0.015280136	10	oligos	OL-MS-1	41	6	6
GGATTACAGGTCGGAT-1_MS200_A303	-28.42154354	-21.94654803	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3895	8487	0.031106398	0.011075763	10	6A	IN-PV	41	6	6
GGATTACCACACCGCA-1_MS200_A303	-5.698638795	-35.46293302	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	813	1162	0.115318417	0.016351119	10	16	EN-PYR	41	6	6
GGATTACCAGCAGTTT-1_MS200_A303	14.65127404	-13.90105282	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5164	14188	0.009867494	0.016351847	10	L2-3	EN-L2-3-MS	41	6	6
GGATTACCAGGACGTA-1_MS200_A303	-11.87225875	-5.675525155	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1928	3148	0.012071156	0.009847522	10	13A	IN-VIP	41	6	6
GGATTACCAGGGCATA-1_MS200_A303	-20.12102604	5.129840089	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	925	1326	0.000754148	0.009803922	10	8	Astrocytes	41	6	6
GGATTACGTGCGATAG-1_MS200_A303	-16.91209497	-17.79682455	6B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2059	3943	0.00634035	0.003550596	10	6B	IN-SST	41	6	6
GGATTACTCAAGATCC-1_MS200_A303	7.803702133	1.070692056	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1192	1592	0.05339196	0.009422111	10	12	EN-MIX	41	6	6
GGATTACTCCGCATCT-1_MS200_A303	34.62289649	10.63761783	14	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	839	1159	0.008628128	0.018119068	10	14	Microglia	41	6	6
GGATTACTCTGTACGA-1_MS200_A303	33.68796397	-16.11332357	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3873	8344	0.014860978	0.012703739	10	2	EN-L4	41	6	6
GGCAATTAGCCACGTC-1_MS200_A303	33.30573959	-15.71112212	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4104	9603	0.024054983	0.009788608	10	2	EN-L4	41	6	6
GGCAATTAGGCGACAT-1_MS200_A303	2.332878253	5.3635313	7	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	897	1202	0.004159734	0.009151414	10	7	Phagocytes	41	6	6
GGCAATTAGGCGCTCT-1_MS200_A303	-28.89875609	-5.28841178	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1194	1831	0.004369197	0.007646095	10	9	OPC	41	6	6
GGCAATTAGGGTTCCC-1_MS200_A303	17.39571195	-17.72045914	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4977	14192	0.025789177	0.004932356	10	L2-3	EN-L2-3-MS	41	6	6
GGCAATTCACGCTTTC-1_MS200_A303	-9.628760764	-16.62444986	6B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	908	1408	0.03125	0.004261364	10	6B	IN-SST	41	6	6
GGCAATTCAGGCTGAA-1_MS200_A303	-18.26606847	0.425960529	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3906	8269	0.007256016	0.016930705	10	13A	IN-VIP	41	6	6
GGCAATTCAGTTCCCT-1_MS200_A303	-30.43859912	-4.169814192	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1264	2112	0.001420455	0.007575758	10	9	OPC	41	6	6
GGCAATTGTAGCACGA-1_MS200_A303	7.702276183	-10.49086146	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1597	2690	0.069516729	0.005947955	10	L2-3	EN-L2-3-MS	41	6	6
GGCAATTGTCTTGCGG-1_MS200_A303	-12.7393904	-17.39504277	6B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1320	2338	0.096663815	0.00427716	10	6B	IN-SST	41	6	6
GGCAATTGTGCAGGTA-1_MS200_A303	9.243333317	1.653341649	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	686	1263	0.314330958	0.004750594	10	12	EN-MIX	41	6	6
GGCAATTTCGACAGCC-1_MS200_A303	5.50117404	-9.106658896	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1391	2393	0.128708734	0.003760969	10	12	EN-MIX	41	6	6
GGCAATTTCGCCTGTT-1_MS200_A303	29.78689385	-17.86758364	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	7354	26881	0.02202299	0.008705033	10	2	EN-L4	41	6	6
GGCCGATAGTACGACG-1_MS200_A303	9.06573471	-3.404910335	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1840	3164	0.036662453	0.013274336	10	12	EN-MIX	41	6	6
GGCCGATCACCAACCG-1_MS200_A303	-29.62874121	-3.744469206	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1419	2368	0.002111486	0.015625	10	9	OPC	41	6	6
GGCCGATCACCCTATC-1_MS200_A303	-28.85824139	9.763048537	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	727	1108	0.000902527	0.005415162	10	8	Astrocytes	41	6	6
GGCCGATGTAGAAGGA-1_MS200_A303	-13.56773212	22.55496881	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1614	2495	0.004809619	0.015230461	10	8	Astrocytes	41	6	6
GGCCGATGTCTGATTG-1_MS200_A303	15.3842506	-13.65035401	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4513	10858	0.023945478	0.008473015	10	L2-3	EN-L2-3-MS	41	6	6
GGCCGATTCCGGGTGT-1_MS200_A303	-17.18881817	-0.602242591	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3721	8097	0.010127208	0.013091268	10	13A	IN-VIP	41	6	6
GGCGACTCAGAAGCAC-1_MS200_A303	15.22684641	-21.35580964	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	6344	20566	0.013420208	0.007293591	10	L2-3	EN-L2-3-MS	41	6	6
GGCGACTGTAAATGAC-1_MS200_A303	14.31085347	-4.934256715	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1411	2183	0.003664682	0.003664682	10	12	EN-MIX	41	6	6
GGCGACTGTAAGGGCT-1_MS200_A303	27.2952443	7.680692452	15A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1053	1537	0.011711126	0.041639558	10	15A	Endo cells	41	6	6
GGCGACTGTACGCACC-1_MS200_A303	-12.25131668	-37.56276001	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1533	2320	0.067241379	0.016810345	10	16	EN-PYR	41	6	6
GGCGACTGTCAGTGGA-1_MS200_A303	-9.155547705	-15.68963565	6B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	838	1184	0.029560811	0.005067568	10	6B	IN-SST	41	6	6
GGCGACTTCTTACCTA-1_MS200_A303	-25.3415452	-17.94628888	6B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3433	7034	0.012652829	0.009809497	10	6B	IN-SST	41	6	6
GGCGTGTAGACTACAA-1_MS200_A303	-19.55103145	-4.76346254	13B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2588	4391	0.02049647	0.011614666	10	13B	IN-SV2C	41	6	6
GGCGTGTAGACTTGAA-1_MS200_A303	-11.03189814	-7.674310874	13B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1650	2750	0.031636364	0.004	10	13B	IN-SV2C	41	6	6
GGCGTGTCAGCCAATT-1_MS200_A303	-17.11659877	-6.384063776	13B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2245	3848	0.008316008	0.005717256	10	13B	IN-SV2C	41	6	6
GGCGTGTGTTCAACCA-1_MS200_A303	15.45234928	-13.75976286	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5331	14668	0.017043905	0.007976548	10	L2-3	EN-L2-3-MS	41	6	6
GGCGTGTTCAGCGACC-1_MS200_A303	-28.82329449	-22.17299758	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4675	11780	0.027674024	0.011460102	10	6A	IN-PV	41	6	6
GGCGTGTTCCAAATGC-1_MS200_A303	16.06816391	-10.5574663	3	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2654	5649	0.111170119	0.004071517	10	3	EN-L5-6	41	6	6
GGCGTGTTCTGCCCTA-1_MS200_A303	-26.57881664	-2.190855303	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1301	2060	0.007281553	0.013592233	10	9	OPC	41	6	6
GGCTCGACACTTGGAT-1_MS200_A303	-29.23480391	-4.665986895	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1299	1923	0.007280291	0.010920437	10	9	OPC	41	6	6
GGCTCGACAGCTGTTA-1_MS200_A303	11.17137921	-1.434832345	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1365	2072	0.069015444	0.00530888	10	12	EN-MIX	41	6	6
GGCTCGACATTTGCCC-1_MS200_A303	9.124136782	-16.10613923	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3605	8327	0.010087667	0.005163925	10	L2-3	EN-L2-3-MS	41	6	6
GGCTCGAGTAAATACG-1_MS200_A303	14.5550783	-12.86243178	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4132	9706	0.021533072	0.012981661	10	L2-3	EN-L2-3-MS	41	6	6
GGCTCGAGTATTAGCC-1_MS200_A303	14.61591383	-13.31407238	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4919	12527	0.018519997	0.016364652	10	L2-3	EN-L2-3-MS	41	6	6
GGCTCGAGTCAAACTC-1_MS200_A303	-14.5280839	24.90708237	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2135	3910	0.004092072	0.008184143	10	8	Astrocytes	41	6	6
GGCTCGAGTGCAGACA-1_MS200_A303	-16.6614663	20.52116096	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1465	2362	0.00296359	0.008890771	10	8	Astrocytes	41	6	6
GGCTCGAGTTGATTCG-1_MS200_A303	-11.14322199	-4.371851776	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2038	3446	0.009866512	0.016540917	10	13A	IN-VIP	41	6	6
GGCTGGTAGAAGGGTA-1_MS200_A303	-14.60884966	25.23931762	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2197	3958	0.018948964	0.017433047	10	8	Astrocytes	41	6	6
GGCTGGTAGGTAAACT-1_MS200_A303	-30.71246336	-8.058470521	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1029	1511	0.006618134	0.005294507	10	9	OPC	41	6	6
GGCTGGTCACTCGACG-1_MS200_A303	-16.73892425	19.26583759	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1542	2612	0.002679939	0.011485452	10	8	Astrocytes	41	6	6
GGCTGGTGTAAATGAC-1_MS200_A303	-15.46922924	21.87950664	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1163	1803	0.006655574	0.012201886	10	8	Astrocytes	41	6	6
GGGAATGAGAATGTGT-1_MS200_A303	-20.63565884	-20.97447354	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1692	2903	0.048914916	0.005167069	10	6A	IN-PV	41	6	6
GGGAATGCAGCTGTTA-1_MS200_A303	-29.36667703	-11.5613124	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	827	1102	0.005444646	0.007259528	10	9	OPC	41	6	6
GGGAATGCATTGGCGC-1_MS200_A303	-5.6682182	14.96127071	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	745	1042	0.022072937	0.022072937	10	oligos	OL-MS-1	41	6	6
GGGAATGGTATGAAAC-1_MS200_A303	18.57756058	-13.8022192	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	8276	32917	0.018561837	0.010511286	10	L2-3	EN-L2-3-MS	41	6	6
GGGAATGGTTACCGAT-1_MS200_A303	-24.32612927	7.489274219	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	903	1286	0.020217729	0.00777605	10	8	Astrocytes	41	6	6
GGGAATGTCAGCCTAA-1_MS200_A303	4.837081285	-2.03151953	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	736	1082	0.122920518	0.012014787	10	12	EN-MIX	41	6	6
GGGAATGTCGTATCAG-1_MS200_A303	-10.76814573	-4.253409042	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1871	3026	0.009914078	0.015532056	10	13A	IN-VIP	41	6	6
GGGACCTAGGCTACGA-1_MS200_A303	-32.64107015	-5.287004738	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1223	1888	0.003707627	0.006885593	10	9	OPC	41	6	6
GGGACCTAGTAGGCCA-1_MS200_A303	28.49973892	-19.18718434	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	6996	24999	0.02900116	0.019680787	10	2	EN-L4	41	6	6
GGGACCTAGTCCGGTC-1_MS200_A303	34.25891155	-3.094110345	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2868	6133	0.007826512	0.002608837	10	2	EN-L4	41	6	6
GGGACCTCATACGCCG-1_MS200_A303	-16.8133627	-3.945335929	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3113	6666	0.02880288	0.006750675	10	13A	IN-VIP	41	6	6
GGGACCTGTATATCCG-1_MS200_A303	15.60987792	-16.99245665	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5058	13653	0.009228741	0.006738446	10	L2-3	EN-L2-3-MS	41	6	6
GGGACCTGTTGGAGGT-1_MS200_A303	17.0218997	-14.57920717	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	7182	24197	0.011860975	0.01177832	10	L2-3	EN-L2-3-MS	41	6	6
GGGACCTTCAAGAAGT-1_MS200_A303	16.02067567	-25.13119317	3	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3690	9036	0.025564409	0.004869411	10	3	EN-L5-6	41	6	6
GGGACCTTCTCCTATA-1_MS200_A303	-30.67027241	-2.991820605	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1307	2137	0.001871783	0.004211511	10	9	OPC	41	6	6
GGGACCTTCTGCTTGC-1_MS200_A303	-16.94641905	-1.967323125	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2788	5431	0.007733382	0.015466765	10	13A	IN-VIP	41	6	6
GGGACCTTCTTGAGGT-1_MS200_A303	19.52674571	-19.75793148	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4523	12150	0.012839506	0.00872428	10	L2-3	EN-L2-3-MS	41	6	6
GGGACCTTCTTTAGTC-1_MS200_A303	-19.57519755	-0.781171589	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4166	8955	0.007146845	0.023562256	10	13A	IN-VIP	41	6	6
GGGAGATAGCCGCCTA-1_MS200_A303	16.90235627	-14.43087376	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	6507	20195	0.011933647	0.009556821	10	L2-3	EN-L2-3-MS	41	6	6
GGGAGATCAAGAGTCG-1_MS200_A303	-15.63441933	23.6357644	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1654	2806	0.004632929	0.009265859	10	8	Astrocytes	41	6	6
GGGAGATCAAGGTTCT-1_MS200_A303	-6.240577162	15.20652487	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	818	1117	0.017905103	0.017009848	10	oligos	OL-MS-1	41	6	6
GGGAGATCACCCAGTG-1_MS200_A303	33.68485093	-10.96422291	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3415	7248	0.005794702	0.006208609	10	2	EN-L4	41	6	6
GGGAGATCAGCATACT-1_MS200_A303	3.586730372	-16.49290861	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2803	6276	0.000637349	0.006373486	10	L2-3	EN-L2-3-MS	41	6	6
GGGAGATCAGTTCATG-1_MS200_A303	29.50432576	-11.47261544	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5224	14278	0.012676845	0.009385068	10	2	EN-L4	41	6	6
GGGAGATCATGGTCTA-1_MS200_A303	-24.33738633	6.418990431	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	836	1192	0.023489933	0.013422819	10	8	Astrocytes	41	6	6
GGGAGATGTATGGTTC-1_MS200_A303	30.32471106	14.41345329	14	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	795	1083	0.003693444	0.081255771	10	14	Microglia	41	6	6
GGGAGATGTCAATACC-1_MS200_A303	-24.52742185	8.334708598	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	942	1324	0.003776435	0.012084592	10	8	Astrocytes	41	6	6
GGGATGAAGAAACGCC-1_MS200_A303	10.30859921	0.581825582	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	960	1547	0.193923723	0.003232062	10	12	EN-MIX	41	6	6
GGGATGAAGGAATTAC-1_MS200_A303	-29.57447036	-21.02903082	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4879	11785	0.048536275	0.012897751	10	6A	IN-PV	41	6	6
GGGATGAGTACACCGC-1_MS200_A303	15.90977977	-13.66165254	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4756	11912	0.018049026	0.009738079	10	L2-3	EN-L2-3-MS	41	6	6
GGGATGAGTCTAGGTT-1_MS200_A303	-31.24210393	-7.002695085	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1076	1613	0.003719777	0.006199628	10	9	OPC	41	6	6
GGGATGATCGGATGGA-1_MS200_A303	-28.80415024	-10.68031196	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1074	1572	0.006361323	0.00826972	10	9	OPC	41	6	6
GGGCACTAGGCAGGTT-1_MS200_A303	-6.241290296	12.57522228	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	764	1045	0.019138756	0.023923445	10	oligos	OL-MS-1	41	6	6
GGGCACTCAATCTGCA-1_MS200_A303	10.88940384	1.587985859	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	768	1059	0.087818697	0.009442871	10	12	EN-MIX	41	6	6
GGGCACTCATACTCTT-1_MS200_A303	-13.96297949	-15.99146962	6B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1412	2290	0.013537118	0.003930131	10	6B	IN-SST	41	6	6
GGGCACTGTAGGAGTC-1_MS200_A303	-14.01277248	8.293096153	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1522	2253	0.025299601	0.008877053	10	8	Astrocytes	41	6	6
GGGCACTGTCATATGC-1_MS200_A303	-6.115809394	15.3128954	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	815	1076	0.01394052	0.024163569	10	oligos	OL-MS-1	41	6	6
GGGCACTTCACAATGC-1_MS200_A303	31.54554318	9.792559874	14	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	883	1147	0.014821273	0.0418483	10	14	Microglia	41	6	6
GGGCACTTCACCCGAG-1_MS200_A303	-18.97062331	0.87336628	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4606	9743	0.012419173	0.01857744	10	13A	IN-VIP	41	6	6
GGGCATCCAGCGTCCA-1_MS200_A303	-21.09353566	5.915943707	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1370	2038	0.008832188	0.018645731	10	8	Astrocytes	41	6	6
GGGCATCTCGTAGGTT-1_MS200_A303	29.88433087	-18.70880069	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	6828	22794	0.028165307	0.011625866	10	2	EN-L4	41	6	6
GGGTCTGAGTTGTAGA-1_MS200_A303	17.46432414	-15.20252445	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	7139	24401	0.024630138	0.008524241	10	L2-3	EN-L2-3-MS	41	6	6
GGGTCTGCAAAGAATC-1_MS200_A303	-24.56249063	-23.82518571	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4598	11960	0.015384615	0.006270903	10	6A	IN-PV	41	6	6
GGGTCTGCAGGGAGAG-1_MS200_A303	21.28647991	-12.85069694	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3541	8623	0.154470602	0.004174881	10	2	EN-L4	41	6	6
GGGTCTGGTTTGACTG-1_MS200_A303	21.14692321	-12.94197639	3	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3367	7747	0.102362205	0.004001549	10	3	EN-L5-6	41	6	6
GGGTCTGTCACTGGGC-1_MS200_A303	12.08497791	-16.424919	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4343	10648	0.010518407	0.007794891	10	L2-3	EN-L2-3-MS	41	6	6
GGGTTGCAGCGTGTCC-1_MS200_A303	15.73077862	-16.41741962	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5968	18098	0.009559067	0.01298486	10	L2-3	EN-L2-3-MS	41	6	6
GGGTTGCCATGTCCTC-1_MS200_A303	-24.96458684	-0.745329524	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1438	2172	0.003222836	0.011510129	10	9	OPC	41	6	6
GGGTTGCCATTCGACA-1_MS200_A303	-5.629748331	-36.84211654	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	870	1132	0.058303887	0.016784452	10	16	EN-PYR	41	6	6
GGGTTGCGTCAAACTC-1_MS200_A303	6.469548665	0.517912319	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	839	1108	0.009927798	0.010830325	10	16	EN-PYR	41	6	6
GGTATTGAGTCCATAC-1_MS200_A303	-14.55151611	22.16587959	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1548	2392	0.009615385	0.006688963	10	8	Astrocytes	41	6	6
GGTATTGCACGAAGCA-1_MS200_A303	-12.87100436	-37.26258153	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1527	2446	0.084219133	0.015535568	10	16	EN-PYR	41	6	6
GGTATTGCAGGACGTA-1_MS200_A303	33.60972286	10.87429668	14	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	845	1079	0.002780352	0.032437442	10	14	Microglia	41	6	6
GGTATTGGTGTAACGG-1_MS200_A303	-26.31036658	-1.517850779	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2074	3362	0.027364664	0.011600238	10	9	OPC	41	6	6
GGTGAAGAGATGGCGT-1_MS200_A303	-5.84745481	17.45283922	1	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	740	1035	0.011594203	0.009661836	10	oligos	OL-Cntl	41	6	6
GGTGAAGAGTCAAGCG-1_MS200_A303	-14.99198185	-37.58423412	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2346	4112	0.037937743	0.016293774	10	16	EN-PYR	41	6	6
GGTGAAGCAAGGCTCC-1_MS200_A303	-17.75974832	30.2807286	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4491	9746	0.003488611	0.010773651	10	8	Astrocytes	41	6	6
GGTGAAGCAAGGTTTC-1_MS200_A303	18.20883261	-22.50638799	3	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3620	7660	0.010443864	0.019582245	10	3	EN-L5-6	41	6	6
GGTGAAGCAGCTTCGG-1_MS200_A303	-15.06298887	21.06067212	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1271	1913	0.004181913	0.008886566	10	8	Astrocytes	41	6	6
GGTGAAGGTACGCTGC-1_MS200_A303	15.46793954	-26.808508	3	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3745	9130	0.003066813	0.006243154	10	3	EN-L5-6	41	6	6
GGTGCGTAGCTACCTA-1_MS200_A303	-19.67998555	-4.949511642	13B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3180	6178	0.016024603	0.012949174	10	13B	IN-SV2C	41	6	6
GGTGCGTAGCTGATAA-1_MS200_A303	-9.817216932	-36.76874805	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1062	1539	0.026640676	0.015594542	10	16	EN-PYR	41	6	6
GGTGCGTAGTCTCCTC-1_MS200_A303	-27.94779037	-6.663614726	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1026	1620	0.003703704	0.004938272	10	9	OPC	41	6	6
GGTGCGTAGTGGGATC-1_MS200_A303	-10.82361149	-3.297501355	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2023	3746	0.014148425	0.004538174	10	13A	IN-VIP	41	6	6
GGTGCGTCATAGGATA-1_MS200_A303	-27.77482767	-2.625739922	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1310	1905	0.005249344	0.01312336	10	9	OPC	41	6	6
GGTGCGTCATTACGAC-1_MS200_A303	-7.434315348	-6.088570263	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1318	2011	0.010939831	0.00497265	10	13A	IN-VIP	41	6	6
GGTGCGTGTAGCACGA-1_MS200_A303	-13.66183836	17.80929986	11	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1647	2507	0.005185481	0.003988831	10	11	Glia-MIX	41	6	6
GGTGCGTGTGCATCTA-1_MS200_A303	-27.75372295	-21.89058932	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4329	11269	0.048007809	0.007010382	10	6A	IN-PV	41	6	6
GGTGTTAAGCTGAACG-1_MS200_A303	8.109069501	-3.479061774	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2757	5078	0.019102009	0.013981883	10	12	EN-MIX	41	6	6
GGTGTTAAGTAATCCC-1_MS200_A303	-28.54924823	-7.705350766	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	923	1420	0.011267606	0.006338028	10	9	OPC	41	6	6
GGTGTTACACCATCCT-1_MS200_A303	2.25671392	5.376887768	7	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	895	1226	0.004078303	0.008156607	10	7	Phagocytes	41	6	6
GGTGTTACAGCCAGAA-1_MS200_A303	-9.940724591	-15.56536036	6B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	930	1428	0.074929972	0.004201681	10	6B	IN-SST	41	6	6
GGTGTTACAGCGTCCA-1_MS200_A303	-20.44298176	-20.80587504	6B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1551	2541	0.033057851	0.0094451	10	6B	IN-SST	41	6	6
GGTGTTACATGAAGTA-1_MS200_A303	-5.6779353	15.4809539	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	752	1039	0.005774783	0.014436959	10	oligos	OL-MS-1	41	6	6
GGTGTTAGTCGGCATC-1_MS200_A303	9.760369304	-17.65190331	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4890	13006	0.005920344	0.011379363	10	L2-3	EN-L2-3-MS	41	6	6
GGTGTTAGTGGCTCCA-1_MS200_A303	-13.39028121	-37.02000897	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1907	3304	0.101089588	0.014225182	10	16	EN-PYR	41	6	6
GGTGTTATCGTACCGG-1_MS200_A303	-12.31253015	31.77386429	17	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	981	1363	0.01540719	0.01027146	10	oligos	OL-MS-2	41	6	6
GGTGTTATCTGCCCTA-1_MS200_A303	-13.07204423	7.81399729	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2191	3598	0.034463591	0.018621456	10	8	Astrocytes	41	6	6
GTAACGTAGATGTTAG-1_MS200_A303	-29.155284	-4.887482464	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1312	1951	0.007175807	0.00871348	10	9	OPC	41	6	6
GTAACGTAGCTTATCG-1_MS200_A303	9.041034948	-10.76333499	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2213	4179	0.020818378	0.007418043	10	L2-3	EN-L2-3-MS	41	6	6
GTAACGTGTACGACCC-1_MS200_A303	22.29039817	-16.07780534	3	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5095	12446	0.013176924	0.020970593	10	3	EN-L5-6	41	6	6
GTAACGTGTTACGCGC-1_MS200_A303	-23.45317809	9.699507589	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1175	1711	0.017533606	0.011104617	10	8	Astrocytes	41	6	6
GTAACGTGTTGAGGTG-1_MS200_A303	25.13700973	9.92665991	15A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4359	9483	0.014236001	0.093430349	10	15A	Endo cells	41	6	6
GTAACGTTCAGTTTGG-1_MS200_A303	4.714409562	-13.73110279	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2402	4823	0.022600041	0.004354136	10	L2-3	EN-L2-3-MS	41	6	6
GTAACGTTCTCTTATG-1_MS200_A303	2.705081169	-6.791563084	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1247	2170	0.086635945	0.002764977	10	12	EN-MIX	41	6	6
GTAACTGAGGTAAACT-1_MS200_A303	14.42129163	-15.9257343	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	6190	19061	0.013063323	0.007397303	10	L2-3	EN-L2-3-MS	41	6	6
GTAACTGCAAGTTGTC-1_MS200_A303	33.95256172	-17.84272626	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4320	9912	0.014830508	0.014023406	10	2	EN-L4	41	6	6
GTAACTGCAGAAGCAC-1_MS200_A303	-14.65880495	22.40924285	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1584	2598	0.003464203	0.012317167	10	8	Astrocytes	41	6	6
GTAACTGCAGCCAGAA-1_MS200_A303	-5.701790165	15.0167647	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	794	1157	0.008643042	0.018150389	10	oligos	OL-MS-1	41	6	6
GTAACTGCATGATCCA-1_MS200_A303	-23.90869961	9.601989443	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	950	1487	0.00403497	0.015467384	10	8	Astrocytes	41	6	6
GTAACTGGTCGAGTTT-1_MS200_A303	-11.81073059	-38.44047377	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1444	2168	0.041512915	0.019833948	10	16	EN-PYR	41	6	6
GTAACTGGTCTTCTCG-1_MS200_A303	-36.14536644	-12.01673658	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	799	1248	0.000801282	0.00400641	10	9	OPC	41	6	6
GTAACTGGTGCTGTAT-1_MS200_A303	-17.88664093	20.29343726	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1737	2915	0.003430532	0.008919383	10	8	Astrocytes	41	6	6
GTAACTGGTGTGAATA-1_MS200_A303	-12.55231137	-14.1413093	6B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1474	2376	0.008838384	0.015151515	10	6B	IN-SST	41	6	6
GTAACTGTCGTCGTTC-1_MS200_A303	11.97654297	-16.97778951	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5654	16909	0.007865634	0.00603229	10	L2-3	EN-L2-3-MS	41	6	6
GTACGTAAGGCATGGT-1_MS200_A303	-20.65396626	-20.86041665	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1589	2944	0.132133152	0.005095109	10	6A	IN-PV	41	6	6
GTACGTAGTCAAGCGA-1_MS200_A303	-31.43084268	-5.845270186	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1266	1931	0.005178664	0.010875194	10	9	OPC	41	6	6
GTACGTAGTGGTCTCG-1_MS200_A303	-5.680648262	13.49235231	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	845	1181	0.00169348	0.025402202	10	oligos	OL-MS-1	41	6	6
GTACGTATCACAGTAC-1_MS200_A303	-13.15235261	-17.2833909	6B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1287	2158	0.011121409	0.003707136	10	6B	IN-SST	41	6	6
GTACTCCAGAATGTGT-1_MS200_A303	-24.25009553	-0.983194938	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1517	2474	0.007275667	0.003637833	10	9	OPC	41	6	6
GTACTCCGTACGCTGC-1_MS200_A303	10.25054743	-16.72762209	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4569	11291	0.006996723	0.008768045	10	L2-3	EN-L2-3-MS	41	6	6
GTACTCCGTAGCACGA-1_MS200_A303	-17.9255993	-14.75024804	6B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2355	4243	0.024039595	0.007777516	10	6B	IN-SST	41	6	6
GTACTCCGTTAAGAAC-1_MS200_A303	-29.43047183	-7.669568475	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1184	1672	0.003588517	0.01854067	10	9	OPC	41	6	6
GTACTCCTCACAAACC-1_MS200_A303	-13.55612396	-36.76467398	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1797	2984	0.077412869	0.010723861	10	16	EN-PYR	41	6	6
GTACTCCTCGAATGCT-1_MS200_A303	-31.55125497	-10.90563232	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	952	1346	0.002971768	0.004457652	10	9	OPC	41	6	6
GTACTCCTCGGAATCT-1_MS200_A303	-29.98992084	-2.236322145	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1482	2351	0.002552105	0.005104211	10	9	OPC	41	6	6
GTACTTTAGGTTCCTA-1_MS200_A303	18.88870059	-14.29468401	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5560	15728	0.017230417	0.012207528	10	L2-3	EN-L2-3-MS	41	6	6
GTACTTTCACGTCAGC-1_MS200_A303	-5.894567593	-37.67974145	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1023	1409	0.036905607	0.033356991	10	16	EN-PYR	41	6	6
GTACTTTGTCACCCAG-1_MS200_A303	12.6827613	-13.52632717	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4786	12489	0.010969653	0.008967892	10	L2-3	EN-L2-3-MS	41	6	6
GTACTTTGTTATGCGT-1_MS200_A303	33.95034351	-16.63512059	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4590	10963	0.012587795	0.01404725	10	2	EN-L4	41	6	6
GTACTTTTCAGGTTCA-1_MS200_A303	-36.40995948	-10.35682537	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	981	1568	0.003188776	0.005102041	10	9	OPC	41	6	6
GTACTTTTCCCAAGAT-1_MS200_A303	10.85790513	-0.878518011	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1250	1744	0.006880734	0.006307339	10	12	EN-MIX	41	6	6
GTACTTTTCCGTTGCT-1_MS200_A303	-28.38140115	-3.264536191	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1420	2262	0.00397878	0.007073386	10	9	OPC	41	6	6
GTAGGCCAGCAGACTG-1_MS200_A303	-29.41607971	-10.54799752	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	848	1170	0.004273504	0.017094017	10	9	OPC	41	6	6
GTAGGCCCAATGCCAT-1_MS200_A303	10.94703966	0.614345433	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1169	2004	0.188123752	0.00998004	10	12	EN-MIX	41	6	6
GTAGGCCCACAAGTAA-1_MS200_A303	-28.8419886	-5.412968893	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1240	1777	0.007878447	0.005627462	10	9	OPC	41	6	6
GTAGGCCCACTCGACG-1_MS200_A303	-29.26255392	-5.449305552	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1226	1830	0.003825137	0.009289617	10	9	OPC	41	6	6
GTAGGCCCAGCATGAG-1_MS200_A303	-16.16919552	10.50865141	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1264	2065	0.000968523	0.005811138	10	8	Astrocytes	41	6	6
GTAGGCCCATTGCGGC-1_MS200_A303	-13.67280326	-15.90159231	6B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1281	1958	0.012257406	0.002553626	10	6B	IN-SST	41	6	6
GTAGGCCGTGTAAGTA-1_MS200_A303	22.66819758	-25.87022026	3	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3435	8449	0.016688365	0.003550716	10	3	EN-L5-6	41	6	6
GTAGGCCGTGTGAAAT-1_MS200_A303	-22.7298313	-24.10590189	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2919	6061	0.012044217	0.003959743	10	6A	IN-PV	41	6	6
GTAGGCCTCCGTTGCT-1_MS200_A303	-11.26867386	-15.29850655	6B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1146	1815	0.034710744	0.003305785	10	6B	IN-SST	41	6	6
GTAGGCCTCTTGGGTA-1_MS200_A303	-15.08909192	13.08374623	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1425	2090	0.007177033	0.009090909	10	8	Astrocytes	41	6	6
GTAGTCAAGGCTATCT-1_MS200_A303	-29.38046505	-4.694565282	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1321	2048	0.005371094	0.008300781	10	9	OPC	41	6	6
GTAGTCAAGGGCTTCC-1_MS200_A303	9.959406931	1.246272506	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	854	1270	0.156692913	0.006299213	10	12	EN-MIX	41	6	6
GTAGTCACAGATAATG-1_MS200_A303	-14.73532801	21.51388587	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1302	2067	0.000967586	0.010643445	10	8	Astrocytes	41	6	6
GTAGTCAGTACCGTTA-1_MS200_A303	9.136087122	-13.19456365	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2632	4749	0.009265108	0.011791956	10	L2-3	EN-L2-3-MS	41	6	6
GTAGTCAGTAGCTAAA-1_MS200_A303	33.45076305	-15.63741879	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4018	9105	0.028665568	0.009884679	10	2	EN-L4	41	6	6
GTAGTCAGTCGAATCT-1_MS200_A303	-15.8453393	23.01464657	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1544	2610	0.008429119	0.004980843	10	8	Astrocytes	41	6	6
GTAGTCAGTTCCTCCA-1_MS200_A303	-24.2061431	6.331368447	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	780	1069	0.011225444	0.014967259	10	8	Astrocytes	41	6	6
GTAGTCATCAGTTGAC-1_MS200_A303	-18.68728162	-1.64350193	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4347	9974	0.020553439	0.010828153	10	13A	IN-VIP	41	6	6
GTAGTCATCTCTGTCG-1_MS200_A303	-28.8680792	-22.15143023	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5201	14207	0.037305554	0.009995073	10	6A	IN-PV	41	6	6
GTATCTTAGAGCTATA-1_MS200_A303	20.24635896	-3.559680759	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1793	2880	0.051736111	0.004166667	10	2	EN-L4	41	6	6
GTATCTTAGGCGACAT-1_MS200_A303	2.445775943	10.44283294	1	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1057	1583	0.004421984	0.006948831	10	oligos	OL-Cntl	41	6	6
GTATCTTGTATCGCAT-1_MS200_A303	10.55118384	-14.566085	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3993	9495	0.004949974	0.015481833	10	L2-3	EN-L2-3-MS	41	6	6
GTATCTTGTCACTGGC-1_MS200_A303	-26.57570002	1.751633827	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1688	2644	0.001891074	0.007564297	10	9	OPC	41	6	6
GTATCTTGTCAGAAGC-1_MS200_A303	11.21015143	-13.19906124	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3723	8437	0.010311722	0.006400379	10	L2-3	EN-L2-3-MS	41	6	6
GTATCTTGTTATTCTC-1_MS200_A303	-28.92440623	-11.28502192	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	980	1505	0.077740864	0.008637874	10	9	OPC	41	6	6
GTATCTTTCACGATGT-1_MS200_A303	22.68681293	-16.69908599	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	6667	22156	0.022657519	0.009072035	10	2	EN-L4	41	6	6
GTATCTTTCATGTGGT-1_MS200_A303	-24.82118395	-19.04856013	6B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2635	4933	0.009730387	0.010338536	10	6B	IN-SST	41	6	6
GTATCTTTCGGAAATA-1_MS200_A303	-5.681878604	13.02562625	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	738	1031	0.010669253	0.023278371	10	oligos	OL-MS-1	41	6	6
GTATTCTAGAAGGGTA-1_MS200_A303	24.00476342	-19.78051557	3	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	6752	22221	0.017550965	0.007065389	10	3	EN-L5-6	41	6	6
GTATTCTAGACAGGCT-1_MS200_A303	32.2347139	-17.08979983	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4911	12042	0.022255439	0.012705531	10	2	EN-L4	41	6	6
GTATTCTAGTCCGTAT-1_MS200_A303	-17.77158769	-0.473755535	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3596	7702	0.011425604	0.016748896	10	13A	IN-VIP	41	6	6
GTATTCTCACACATGT-1_MS200_A303	-15.83660739	20.23464344	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1243	1817	0.007705008	0.011557512	10	8	Astrocytes	41	6	6
GTATTCTCACTTACGA-1_MS200_A303	-4.363613438	21.31243932	1	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	713	1036	0.027992278	0.015444015	10	oligos	OL-Cntl	41	6	6
GTATTCTCATCACGTA-1_MS200_A303	-30.31731007	-10.57447933	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	913	1300	0.001538462	0.006923077	10	9	OPC	41	6	6
GTATTCTCATCTGGTA-1_MS200_A303	-4.283317627	19.99005168	1	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	740	1127	0.003549246	0.013309672	10	oligos	OL-Cntl	41	6	6
GTATTCTGTGCGATAG-1_MS200_A303	-16.27344815	20.11287012	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1232	1949	0.002052335	0.015392509	10	8	Astrocytes	41	6	6
GTATTCTGTGTAATGA-1_MS200_A303	16.94639684	-14.55932929	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5873	16599	0.0178324	0.011325983	10	L2-3	EN-L2-3-MS	41	6	6
GTATTCTGTTGACGTT-1_MS200_A303	-17.77389807	-6.170559719	13B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2620	5031	0.02524349	0.00755317	10	13B	IN-SV2C	41	6	6
GTATTCTTCAGCTCGG-1_MS200_A303	12.22346527	-12.58406667	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3559	7574	0.010298389	0.022181146	10	L2-3	EN-L2-3-MS	41	6	6
GTCAAGTAGCCTATGT-1_MS200_A303	-28.92328955	-5.493645521	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1107	1559	0.006414368	0.008980115	10	9	OPC	41	6	6
GTCAAGTAGTCTCCTC-1_MS200_A303	13.97276225	-16.89962999	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	6502	20367	0.005155398	0.010458094	10	L2-3	EN-L2-3-MS	41	6	6
GTCAAGTGTAAAGTCA-1_MS200_A303	-16.51383447	20.55493376	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1494	2273	0.00307963	0.012758469	10	8	Astrocytes	41	6	6
GTCAAGTGTTGCCTCT-1_MS200_A303	21.61787375	-14.78280056	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2175	3708	0.01429342	0.037486516	10	12	EN-MIX	41	6	6
GTCAAGTTCACAAACC-1_MS200_A303	-6.833526517	-37.36946564	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	967	1363	0.108584006	0.013939839	10	16	EN-PYR	41	6	6
GTCAAGTTCTATCCCG-1_MS200_A303	-29.49478785	-21.76765854	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5593	16577	0.042830428	0.008566086	10	6A	IN-PV	41	6	6
GTCACAAAGCGTCAAG-1_MS200_A303	17.98351351	-13.5024891	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	6620	20261	0.020828192	0.015497754	10	L2-3	EN-L2-3-MS	41	6	6
GTCACAAAGGCCCGTT-1_MS200_A303	2.69798114	10.69144151	1	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1077	1674	0.005973716	0.012544803	10	oligos	OL-Cntl	41	6	6
GTCACAAAGGCCGAAT-1_MS200_A303	-8.29349405	-37.09735599	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1079	1457	0.030199039	0.01509952	10	16	EN-PYR	41	6	6
GTCACAACAAAGTCAA-1_MS200_A303	-28.0003103	8.390953565	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	805	1116	0.002688172	0.008064516	10	8	Astrocytes	41	6	6
GTCACAAGTTCTCATT-1_MS200_A303	10.27859919	-25.27753117	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4478	12889	0.002249981	0.006284429	10	L2-3	EN-L2-3-MS	41	6	6
GTCACAAGTTGATTGC-1_MS200_A303	17.33172514	-22.11942214	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4668	12638	0.006409242	0.006488368	10	L2-3	EN-L2-3-MS	41	6	6
GTCACAAGTTGCGTTA-1_MS200_A303	13.40727058	-14.27710747	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3938	8724	0.013411279	0.0108895	10	L2-3	EN-L2-3-MS	41	6	6
GTCACAATCACTCCTG-1_MS200_A303	-29.52586786	-3.986781698	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1347	2193	0.014135887	0.005927953	10	9	OPC	41	6	6
GTCACAATCGTGGGAA-1_MS200_A303	14.5017596	-13.66640076	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4592	11150	0.0167713	0.010313901	10	L2-3	EN-L2-3-MS	41	6	6
GTCACGGAGAGATGAG-1_MS200_A303	-14.56597228	21.86656672	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1420	2257	0.004873726	0.012405848	10	8	Astrocytes	41	6	6
GTCACGGCAATGGAGC-1_MS200_A303	-13.96136158	22.55938468	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1537	2312	0.003892734	0.019463668	10	8	Astrocytes	41	6	6
GTCACGGCACATTTCT-1_MS200_A303	5.522737984	16.80799904	1	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	939	1412	0.002832861	0.016997167	10	oligos	OL-Cntl	41	6	6
GTCACGGCATAAGACA-1_MS200_A303	16.51784607	-14.36606465	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5003	13540	0.033161004	0.006720827	10	L2-3	EN-L2-3-MS	41	6	6
GTCACGGCATATGGTC-1_MS200_A303	21.71482425	-15.39777118	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3284	6373	0.008943982	0.032951514	10	L2-3	EN-L2-3-MS	41	6	6
GTCACGGGTAAGGGCT-1_MS200_A303	9.668908442	1.445292479	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	798	1283	0.198752923	0.003897116	10	12	EN-MIX	41	6	6
GTCACGGGTCGCCATG-1_MS200_A303	-31.36731408	-7.797831005	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	996	1436	0.003481894	0.003481894	10	9	OPC	41	6	6
GTCATTTAGCGAGAAA-1_MS200_A303	30.52896593	-18.74138568	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5223	13316	0.023280264	0.016746771	10	2	EN-L4	41	6	6
GTCATTTAGTTGAGAT-1_MS200_A303	-13.2949413	-15.87604819	6B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1268	2077	0.073182475	0.006740491	10	6B	IN-SST	41	6	6
GTCATTTCATGAAGTA-1_MS200_A303	-11.67165616	-36.99350478	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1368	1977	0.040971168	0.01466869	10	16	EN-PYR	41	6	6
GTCATTTGTGCAGGTA-1_MS200_A303	7.256681714	0.414764901	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	732	1059	0.141643059	0.012275732	10	16	EN-PYR	41	6	6
GTCATTTTCCAAAGTC-1_MS200_A303	33.32813002	6.559635364	14	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	805	1030	0.034951456	0.008737864	10	14	Microglia	41	6	6
GTCATTTTCCGATATG-1_MS200_A303	-17.94630292	0.261880402	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3798	8185	0.005009163	0.022846671	10	13A	IN-VIP	41	6	6
GTCATTTTCCTAGTGA-1_MS200_A303	15.39917748	-16.65266669	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5893	17898	0.009721757	0.005810705	10	L2-3	EN-L2-3-MS	41	6	6
GTCATTTTCCTTGCCA-1_MS200_A303	-1.801472604	21.74027928	1	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	831	1305	0.003065134	0.01302682	10	oligos	OL-Cntl	41	6	6
GTCATTTTCTTGTTTG-1_MS200_A303	-14.61633391	1.053530072	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3748	8557	0.005609443	0.008647891	10	13A	IN-VIP	41	6	6
GTCCTCACACGCGAAA-1_MS200_A303	28.42209608	7.280940767	15A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	905	1190	0.031932773	0.03697479	10	15A	Endo cells	41	6	6
GTCCTCACAGTTAACC-1_MS200_A303	19.91108121	-19.72401372	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5731	18476	0.019755358	0.009417623	10	L2-3	EN-L2-3-MS	41	6	6
GTCCTCAGTATCTGCA-1_MS200_A303	33.87466862	-18.66161308	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4711	10957	0.019257096	0.020534818	10	2	EN-L4	41	6	6
GTCCTCAGTTCCGTCT-1_MS200_A303	20.36768041	-12.613989	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3179	7712	0.180757261	0.004927386	10	12	EN-MIX	41	6	6
GTCCTCAGTTGAGTTC-1_MS200_A303	-8.841273941	-17.67134086	6B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	738	1105	0.016289593	0.006334842	10	6B	IN-SST	41	6	6
GTCCTCATCAAACAAG-1_MS200_A303	-5.455284817	15.42524256	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	824	1194	0.012562814	0.015075377	10	oligos	OL-MS-1	41	6	6
GTCCTCATCAGATAAG-1_MS200_A303	-30.0657388	-9.218910364	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1078	1541	0.006489293	0.00908501	10	9	OPC	41	6	6
GTCCTCATCCTCAACC-1_MS200_A303	-16.71818945	-1.501189045	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2708	5012	0.006584198	0.018954509	10	13A	IN-VIP	41	6	6
GTCCTCATCTAACCGA-1_MS200_A303	-15.7917147	-22.91211479	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1884	3873	0.045184611	0.003614769	10	6A	IN-PV	41	6	6
GTCGGGTAGCGCTTAT-1_MS200_A303	-24.45809201	-12.58928965	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	818	1352	0.014792899	0.00443787	10	9	OPC	41	6	6
GTCGGGTAGGGTCGAT-1_MS200_A303	15.32663428	-21.58035666	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4235	10750	0.004930233	0.008744186	10	L2-3	EN-L2-3-MS	41	6	6
GTCGGGTAGTGGAGTC-1_MS200_A303	-23.80288154	10.26975083	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1018	1554	0.002574003	0.00965251	10	8	Astrocytes	41	6	6
GTCGGGTCATATACGC-1_MS200_A303	33.76621522	-17.49850225	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4472	10343	0.014985981	0.015952818	10	2	EN-L4	41	6	6
GTCGGGTGTACCATCA-1_MS200_A303	-28.79786793	-5.11490704	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1249	1811	0.003865268	0.005521811	10	9	OPC	41	6	6
GTCGGGTTCAAGAAGT-1_MS200_A303	-29.58700725	-11.4594389	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	831	1114	0.003590664	0.009874327	10	9	OPC	41	6	6
GTCGGGTTCACCATAG-1_MS200_A303	-16.97255507	-1.995994978	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2403	4117	0.025018217	0.011173184	10	13A	IN-VIP	41	6	6
GTCGGGTTCGAATGCT-1_MS200_A303	15.54001125	-13.71322045	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	7568	26045	0.022230754	0.010942599	10	L2-3	EN-L2-3-MS	41	6	6
GTCGGGTTCGTATCAG-1_MS200_A303	13.4576678	-14.99776315	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4160	9992	0.026020817	0.007205765	10	L2-3	EN-L2-3-MS	41	6	6
GTCGTAAAGCTAGGCA-1_MS200_A303	15.00942007	-19.67325361	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	7007	22299	0.013632898	0.015740616	10	L2-3	EN-L2-3-MS	41	6	6
GTCGTAAAGGACCACA-1_MS200_A303	15.07654607	-21.31808173	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5058	13017	0.008066375	0.007528616	10	L2-3	EN-L2-3-MS	41	6	6
GTCGTAAAGGGTCGAT-1_MS200_A303	18.23850155	-13.57918945	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	6296	17799	0.023653014	0.016405416	10	L2-3	EN-L2-3-MS	41	6	6
GTCGTAACAAAGGCGT-1_MS200_A303	-24.06436463	9.366889041	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1155	1800	0.002777778	0.015555556	10	8	Astrocytes	41	6	6
GTCGTAACAAGCGAGT-1_MS200_A303	-21.78029335	-21.16862588	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2121	4012	0.035393819	0.010219342	10	6A	IN-PV	41	6	6
GTCGTAACAAGGACAC-1_MS200_A303	-19.06238209	-1.283214417	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3216	6003	0.024321173	0.016491754	10	13A	IN-VIP	41	6	6
GTCGTAACATGTCTCC-1_MS200_A303	12.40693854	-1.122552099	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1125	1768	0.100678733	0.003393665	10	12	EN-MIX	41	6	6
GTCGTAAGTACTCAAC-1_MS200_A303	11.16479726	-12.61673569	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3159	6338	0.024771221	0.009466709	10	L2-3	EN-L2-3-MS	41	6	6
GTCGTAAGTCCGCTGA-1_MS200_A303	7.884154206	-1.579727411	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1187	1875	0.147733333	0.008533333	10	12	EN-MIX	41	6	6
GTCGTAATCTTGTTTG-1_MS200_A303	-6.246041549	14.37463074	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	866	1179	0.008481764	0.019508058	10	oligos	OL-MS-1	41	6	6
GTCTCGTAGAACAACT-1_MS200_A303	-14.24734857	21.97844598	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1436	2243	0.004458315	0.015604102	10	8	Astrocytes	41	6	6
GTCTCGTAGGGTATCG-1_MS200_A303	18.31343925	-19.01755501	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3171	7113	0.052439196	0.01082525	10	L2-3	EN-L2-3-MS	41	6	6
GTCTCGTCACAGCCCA-1_MS200_A303	-16.6023309	-2.219560801	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3196	6591	0.007130936	0.006524048	10	13A	IN-VIP	41	6	6
GTCTCGTCAGCGAACA-1_MS200_A303	-29.34821566	-11.44255909	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	916	1372	0.032069971	0.00728863	10	9	OPC	41	6	6
GTCTCGTGTACGCACC-1_MS200_A303	32.02266434	-16.70053956	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3856	8486	0.022743342	0.012019797	10	2	EN-L4	41	6	6
GTCTCGTGTCGGATCC-1_MS200_A303	5.787500109	0.498680974	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	957	1492	0.184316354	0.012064343	10	16	EN-PYR	41	6	6
GTCTCGTTCCTTCAAT-1_MS200_A303	5.021695321	-1.67929524	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	628	1008	0.239087302	0.003968254	10	12	EN-MIX	41	6	6
GTCTCGTTCGGCATCG-1_MS200_A303	-5.520261217	16.10149474	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	682	1012	0.004940711	0.016798419	10	oligos	OL-MS-1	41	6	6
GTCTCGTTCTCGCTTG-1_MS200_A303	14.55173115	10.43017041	1	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1460	2476	0.004846527	0.010500808	10	oligos	OL-Cntl	41	6	6
GTCTTCGAGCGTCAAG-1_MS200_A303	-14.09578925	23.65088405	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1703	3086	0.002592353	0.011989631	10	8	Astrocytes	41	6	6
GTCTTCGAGGCAATTA-1_MS200_A303	-19.88531985	-4.926959632	13B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3472	7160	0.008798883	0.014385475	10	13B	IN-SV2C	41	6	6
GTCTTCGAGTTAACGA-1_MS200_A303	-19.83071151	-2.626526343	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4459	10651	0.022908647	0.007698808	10	13A	IN-VIP	41	6	6
GTCTTCGCAAGGTTTC-1_MS200_A303	9.72337473	-1.656363605	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1444	2430	0.163374486	0.004115226	10	12	EN-MIX	41	6	6
GTCTTCGCACCATGTA-1_MS200_A303	-18.46752192	-1.693181279	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3863	8471	0.013575729	0.009089836	10	13A	IN-VIP	41	6	6
GTCTTCGCAGGTTTCA-1_MS200_A303	11.83448394	-2.999782415	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1443	2367	0.087452471	0.006759611	10	12	EN-MIX	41	6	6
GTCTTCGGTCATCGGC-1_MS200_A303	-29.32350928	-21.10894592	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3334	6975	0.023225806	0.012616487	10	6A	IN-PV	41	6	6
GTCTTCGGTTACTGAC-1_MS200_A303	-19.62608145	-0.759052245	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4744	11465	0.011774967	0.018839948	10	13A	IN-VIP	41	6	6
GTCTTCGGTTGGAGGT-1_MS200_A303	-23.42937068	7.930155444	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1217	1711	0.009351257	0.016949153	10	8	Astrocytes	41	6	6
GTCTTCGTCGGAATCT-1_MS200_A303	-14.10464464	23.28671721	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1734	3149	0.005080978	0.012384884	10	8	Astrocytes	41	6	6
GTCTTCGTCTCTGTCG-1_MS200_A303	-18.14598368	-21.74554715	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2376	5521	0.061583047	0.002354646	10	6A	IN-PV	41	6	6
GTGAAGGAGAAGGGTA-1_MS200_A303	15.17863754	-13.75218036	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5568	14482	0.022234498	0.01008148	10	L2-3	EN-L2-3-MS	41	6	6
GTGAAGGAGACAGGCT-1_MS200_A303	-31.14874926	-8.146291429	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1063	1614	0.002478315	0.005576208	10	9	OPC	41	6	6
GTGAAGGAGAGGACGG-1_MS200_A303	12.27155865	-13.04341979	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3769	7722	0.012043512	0.013727014	10	L2-3	EN-L2-3-MS	41	6	6
GTGAAGGTCCGCTGTT-1_MS200_A303	-5.684855504	13.28730079	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	799	1079	0.001853568	0.011121409	10	oligos	OL-MS-1	41	6	6
GTGAAGGTCTTAGAGC-1_MS200_A303	17.63675033	-7.385275076	3	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1848	3552	0.034346847	0.002533784	10	3	EN-L5-6	41	6	6
GTGCAGCAGCGTCTAT-1_MS200_A303	31.71140842	-17.60368355	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5515	14025	0.021461676	0.010481283	10	2	EN-L4	41	6	6
GTGCAGCCACCGGAAA-1_MS200_A303	30.13464671	-9.765314561	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3185	6470	0.028902628	0.006491499	10	2	EN-L4	41	6	6
GTGCAGCGTTCATGGT-1_MS200_A303	-19.48829328	-5.204074627	13B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3261	6788	0.017383618	0.009281084	10	13B	IN-SV2C	41	6	6
GTGCAGCGTTGGGACA-1_MS200_A303	14.52513061	-16.59393972	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	6104	18113	0.01065533	0.007121957	10	L2-3	EN-L2-3-MS	41	6	6
GTGCAGCTCATCATTC-1_MS200_A303	-22.65358037	-1.728317915	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	958	1357	0.002947679	0.017686072	10	9	OPC	41	6	6
GTGCAGCTCGCAGGCT-1_MS200_A303	15.71996744	-16.17671481	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	6488	20980	0.016110582	0.007769304	10	L2-3	EN-L2-3-MS	41	6	6
GTGCATAAGCCAGGAT-1_MS200_A303	29.585517	14.47263998	14	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1063	1613	0.003719777	0.133292002	10	14	Microglia	41	6	6
GTGCATAAGGCGACAT-1_MS200_A303	-21.35353892	-20.60780086	6B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2022	3710	0.023719677	0.005121294	10	6B	IN-SST	41	6	6
GTGCATAAGTTGAGAT-1_MS200_A303	20.43180835	-22.53450629	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	6947	24592	0.007563435	0.004107027	10	L2-3	EN-L2-3-MS	41	6	6
GTGCATACAACTGCGC-1_MS200_A303	18.23018802	-22.58602975	3	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4498	11181	0.013505053	0.016009301	10	3	EN-L5-6	41	6	6
GTGCATACAAGTCTAC-1_MS200_A303	-15.11149374	-8.957498106	13B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2659	5291	0.006804007	0.005670006	10	13B	IN-SV2C	41	6	6
GTGCATACAATGGAAT-1_MS200_A303	-11.95526484	-5.31021254	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2089	3424	0.015478972	0.009053738	10	13A	IN-VIP	41	6	6
GTGCATACACTTCGAA-1_MS200_A303	31.04174504	-18.55809591	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4942	11837	0.014953113	0.015544479	10	2	EN-L4	41	6	6
GTGCATAGTGCGATAG-1_MS200_A303	34.61126734	10.74376384	14	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	823	1050	0.008571429	0.023809524	10	14	Microglia	41	6	6
GTGCATATCACGCATA-1_MS200_A303	-19.70563564	-1.226654035	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4130	9168	0.013852531	0.015488656	10	13A	IN-VIP	41	6	6
GTGCATATCCAGTAGT-1_MS200_A303	-22.31683235	-16.45922607	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3603	8435	0.025844695	0.005453468	10	6A	IN-PV	41	6	6
GTGCGGTCAACGCACC-1_MS200_A303	13.33860939	-4.949659958	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2287	4531	0.119841095	0.003751931	10	12	EN-MIX	41	6	6
GTGCGGTGTGACGGTA-1_MS200_A303	-28.68374782	-22.10368339	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4331	9572	0.020476389	0.010133723	10	6A	IN-PV	41	6	6
GTGCGGTTCAACCAAC-1_MS200_A303	27.42649047	-18.97376952	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2927	5465	0.025617566	0.013723696	10	2	EN-L4	41	6	6
GTGCGGTTCAGTACGT-1_MS200_A303	-11.79988447	-27.3899552	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	922	1232	0.030844156	0.019480519	10	16	EN-PYR	41	6	6
GTGCGGTTCATGTGGT-1_MS200_A303	15.41566126	-25.37102382	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3064	6559	0.018600396	0.004421406	10	L2-3	EN-L2-3-MS	41	6	6
GTGCGGTTCGCAAACT-1_MS200_A303	19.35126312	-0.177076538	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1222	1841	0.037479631	0.003802281	10	12	EN-MIX	41	6	6
GTGCGGTTCGTCTGAA-1_MS200_A303	-26.26518302	-10.66239591	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1254	1815	0.016528926	0.015426997	10	9	OPC	41	6	6
GTGCTTCAGACATAAC-1_MS200_A303	20.68971838	-3.382711755	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1931	3372	0.06405694	0.005634638	10	2	EN-L4	41	6	6
GTGCTTCAGGTAGCCA-1_MS200_A303	16.87462235	-9.33349294	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1791	2929	0.058723114	0.004096961	10	12	EN-MIX	41	6	6
GTGCTTCAGTCGTACT-1_MS200_A303	-33.2396031	-4.493434697	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1245	1957	0.002554931	0.006642821	10	9	OPC	41	6	6
GTGCTTCAGTGTGGCA-1_MS200_A303	14.83033679	-12.68541596	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4903	11990	0.014762302	0.01292744	10	L2-3	EN-L2-3-MS	41	6	6
GTGCTTCGTAACGTTC-1_MS200_A303	-10.97865145	-15.31272978	6B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1135	1702	0.022326675	0.005875441	10	6B	IN-SST	41	6	6
GTGCTTCGTCCCTTGT-1_MS200_A303	-16.07258736	11.1682003	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1346	2209	0.001358081	0.005432322	10	8	Astrocytes	41	6	6
GTGCTTCGTTACCAGT-1_MS200_A303	4.101237231	-2.673961341	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	879	1314	0.081430746	0.00761035	10	12	EN-MIX	41	6	6
GTGCTTCGTTGGACCC-1_MS200_A303	-27.18095477	4.35921464	11	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2023	3360	0.011904762	0.007738095	10	11	Glia-MIX	41	6	6
GTGCTTCGTTTGGGCC-1_MS200_A303	-11.88521131	-27.40312244	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1040	1482	0.056005398	0.023616734	10	16	EN-PYR	41	6	6
GTGCTTCTCAACGGCC-1_MS200_A303	14.38127439	-3.22821386	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1160	1778	0.013498313	0.007311586	10	12	EN-MIX	41	6	6
GTGCTTCTCTCTGCTG-1_MS200_A303	-24.3895766	-24.30331644	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3912	9341	0.009527888	0.008029119	10	6A	IN-PV	41	6	6
GTGCTTCTCTGGTATG-1_MS200_A303	14.50762419	12.29160165	1	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1534	2492	0.003210273	0.008025682	10	oligos	OL-Cntl	41	6	6
GTGGGTCAGTTAAGTG-1_MS200_A303	32.916837	4.906923608	14	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1174	1689	0.132030787	0.005920663	10	14	Microglia	41	6	6
GTGGGTCAGTTGAGAT-1_MS200_A303	20.51487296	-22.67164091	3	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4177	9652	0.052631579	0.007148777	10	3	EN-L5-6	41	6	6
GTGGGTCCACCAGTTA-1_MS200_A303	-30.28020202	-12.76045426	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	748	1102	0.011796733	0.016333938	10	9	OPC	41	6	6
GTGGGTCGTTGTCGCG-1_MS200_A303	21.33826076	-3.661254086	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2274	4239	0.014861996	0.011087521	10	2	EN-L4	41	6	6
GTGGGTCTCACCGGGT-1_MS200_A303	-12.29629211	-38.82158435	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1999	3156	0.033903676	0.024714829	10	16	EN-PYR	41	6	6
GTGGGTCTCACCGTAA-1_MS200_A303	-19.19953666	-1.088221466	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3627	7178	0.008637503	0.015463918	10	13A	IN-VIP	41	6	6
GTGTGCGAGCTCTCGG-1_MS200_A303	-18.80939008	-0.807691075	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3460	6917	0.008818852	0.027757698	10	13A	IN-VIP	41	6	6
GTGTGCGAGGCGATAC-1_MS200_A303	-29.79161098	-11.26654347	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	911	1263	0.007125891	0.003958828	10	9	OPC	41	6	6
GTGTGCGGTAAAGTCA-1_MS200_A303	33.40874251	-15.78747675	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3663	7821	0.029408004	0.013169671	10	2	EN-L4	41	6	6
GTGTGCGGTTTAAGCC-1_MS200_A303	-8.827948589	-15.1182178	6B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	801	1099	0.038216561	0.007279345	10	6B	IN-SST	41	6	6
GTGTTAGAGTTAACGA-1_MS200_A303	10.41513514	-16.79104944	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4601	12316	0.006658006	0.009499838	10	L2-3	EN-L2-3-MS	41	6	6
GTGTTAGCAGTTCATG-1_MS200_A303	-11.39767506	-5.750877693	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1584	2492	0.018860353	0.019261637	10	13A	IN-VIP	41	6	6
GTGTTAGCATTAGCCA-1_MS200_A303	-26.48796776	-22.11440281	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3972	9900	0.043333333	0.005353535	10	6A	IN-PV	41	6	6
GTGTTAGGTCGGGTCT-1_MS200_A303	15.56451657	-11.0141477	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2442	4303	0.019521264	0.014640948	10	L2-3	EN-L2-3-MS	41	6	6
GTGTTAGGTGGACGAT-1_MS200_A303	-11.9690196	-36.97825561	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1400	2122	0.073044298	0.011781338	10	16	EN-PYR	41	6	6
GTTAAGCCAGCTGGCT-1_MS200_A303	-9.854877552	-38.8042217	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1121	1603	0.066126014	0.029943855	10	16	EN-PYR	41	6	6
GTTAAGCCAGCTTAAC-1_MS200_A303	9.318703229	11.51661967	1	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1244	1978	0.008088979	0.00859454	10	oligos	OL-Cntl	41	6	6
GTTAAGCGTTGAACTC-1_MS200_A303	-17.20100101	20.59272161	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1588	2652	0.00188537	0.013951735	10	8	Astrocytes	41	6	6
GTTAAGCTCAGTGTTG-1_MS200_A303	-23.47899927	9.368631794	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1023	1501	0.005996003	0.01332445	10	8	Astrocytes	41	6	6
GTTAAGCTCTATCCTA-1_MS200_A303	20.407269	-14.10325837	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3233	6907	0.013898943	0.007094252	10	L2-3	EN-L2-3-MS	41	6	6
GTTACAGAGGCTCTTA-1_MS200_A303	-5.451452999	15.97217265	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	762	1036	0.008687259	0.008687259	10	oligos	OL-MS-1	41	6	6
GTTACAGGTAAGCACG-1_MS200_A303	-5.154709792	15.20286557	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	969	1391	0.005751258	0.014378145	10	oligos	OL-MS-1	41	6	6
GTTACAGGTATTCTCT-1_MS200_A303	-22.41068052	6.927166133	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1217	1887	0.0063593	0.006889242	10	8	Astrocytes	41	6	6
GTTCATTAGAGTACAT-1_MS200_A303	-7.133676933	-38.06327593	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1039	1444	0.05401662	0.025623269	10	16	EN-PYR	41	6	6
GTTCATTCACGGCTAC-1_MS200_A303	13.01266371	-18.72917718	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	6451	22228	0.007917941	0.008277848	10	L2-3	EN-L2-3-MS	41	6	6
GTTCATTCATAAGACA-1_MS200_A303	14.25846842	-15.43133491	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	6191	18160	0.011288546	0.01530837	10	L2-3	EN-L2-3-MS	41	6	6
GTTCATTGTAGCTCCG-1_MS200_A303	-24.05225706	10.60184669	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1142	1803	0.005546312	0.007210205	10	8	Astrocytes	41	6	6
GTTCATTGTCACAAGG-1_MS200_A303	-13.90333682	3.442483132	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3400	6980	0.005587393	0.008739255	10	13A	IN-VIP	41	6	6
GTTCATTGTCGTTGTA-1_MS200_A303	-17.42352897	-6.212311076	13B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2639	5188	0.005011565	0.00925212	10	13B	IN-SV2C	41	6	6
GTTCATTTCCAGAAGG-1_MS200_A303	-30.02013298	1.206519206	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2082	3663	0.013650014	0.009282009	10	9	OPC	41	6	6
GTTCGGGAGCGCTCCA-1_MS200_A303	21.50846463	-3.461559618	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2327	4267	0.018748535	0.006093274	10	2	EN-L4	41	6	6
GTTCGGGAGGAGTACC-1_MS200_A303	-6.322251928	15.30114065	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	948	1287	0.003108003	0.017871018	10	oligos	OL-MS-1	41	6	6
GTTCGGGGTACATCCA-1_MS200_A303	17.33628453	-21.67551956	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	6363	20667	0.004935404	0.00551604	10	L2-3	EN-L2-3-MS	41	6	6
GTTCGGGGTACGACCC-1_MS200_A303	-6.142426582	-35.2115317	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	838	1080	0.034259259	0.013888889	10	16	EN-PYR	41	6	6
GTTCGGGGTCAGAATA-1_MS200_A303	18.45230106	-22.58641248	3	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3653	7810	0.009987196	0.008578745	10	3	EN-L5-6	41	6	6
GTTCGGGGTCCGAACC-1_MS200_A303	19.59914129	-19.88370864	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5070	14670	0.01261077	0.009747785	10	L2-3	EN-L2-3-MS	41	6	6
GTTCGGGGTCTGATTG-1_MS200_A303	-16.09520153	20.30771728	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1296	1993	0.012042148	0.008529854	10	8	Astrocytes	41	6	6
GTTCGGGTCACCGGGT-1_MS200_A303	3.208465593	-9.633694586	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1633	2723	0.053617334	0.00550863	10	12	EN-MIX	41	6	6
GTTCGGGTCGCCCTTA-1_MS200_A303	-23.85389123	-19.59748595	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3164	7386	0.015163823	0.005821825	10	6A	IN-PV	41	6	6
GTTCGGGTCGTAGGTT-1_MS200_A303	-14.69397628	22.16190621	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1332	2174	0.011959522	0.013339466	10	8	Astrocytes	41	6	6
GTTCGGGTCTCCAACC-1_MS200_A303	31.14320955	-18.45598337	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5582	14955	0.007689736	0.014577065	10	2	EN-L4	41	6	6
GTTCGGGTCTCCTATA-1_MS200_A303	-31.30516385	-7.322314435	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	986	1588	0.002518892	0.008186398	10	9	OPC	41	6	6
GTTCGGGTCTGCCAGG-1_MS200_A303	21.42074629	-11.23901979	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2018	3373	0.030240142	0.00592944	10	2	EN-L4	41	6	6
GTTCTCGAGAATAGGG-1_MS200_A303	-27.37694783	-22.92336783	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	6411	21523	0.030014403	0.007294522	10	6A	IN-PV	41	6	6
GTTCTCGAGACCTAGG-1_MS200_A303	-30.58685618	-2.708169442	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1445	2406	0.002078138	0.007065669	10	9	OPC	41	6	6
GTTCTCGAGCCTTGAT-1_MS200_A303	-13.38092618	-36.88568563	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1675	2735	0.07202925	0.014259598	10	16	EN-PYR	41	6	6
GTTCTCGCAGGGTATG-1_MS200_A303	-30.40345445	-8.944890173	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1044	1688	0.001777251	0.007109005	10	9	OPC	41	6	6
GTTCTCGCATCAGTCA-1_MS200_A303	-18.17688982	30.0319866	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3738	8777	0.005240971	0.008431127	10	8	Astrocytes	41	6	6
GTTCTCGCATCGGACC-1_MS200_A303	-12.94115763	-37.76056323	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1471	2314	0.039757995	0.021607606	10	16	EN-PYR	41	6	6
GTTCTCGCATCGGGTC-1_MS200_A303	9.143869581	-12.29386725	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2253	3929	0.00330873	0.017816238	10	L2-3	EN-L2-3-MS	41	6	6
GTTCTCGGTCCGCTGA-1_MS200_A303	36.58010546	-10.78679619	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5055	12962	0.010029316	0.017744175	10	2	EN-L4	41	6	6
GTTCTCGGTCTCGTTC-1_MS200_A303	12.92666355	-13.29266673	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4548	11040	0.015217391	0.0125	10	L2-3	EN-L2-3-MS	41	6	6
GTTCTCGGTGCCTGGT-1_MS200_A303	-5.103603967	-36.50863636	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	933	1291	0.068164214	0.0232378	10	16	EN-PYR	41	6	6
GTTTCTAAGATGTGGC-1_MS200_A303	12.72695298	-18.92973767	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5205	15156	0.020124043	0.004882555	10	L2-3	EN-L2-3-MS	41	6	6
GTTTCTACAGTGACAG-1_MS200_A303	15.75679707	-16.41469694	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4156	9498	0.01642451	0.01642451	10	L2-3	EN-L2-3-MS	41	6	6
GTTTCTAGTAAACACA-1_MS200_A303	-30.91596738	-4.13006303	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1234	1999	0.006503252	0.009004502	10	9	OPC	41	6	6
GTTTCTAGTAAGTAGT-1_MS200_A303	-23.65846811	9.625094361	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	875	1277	0.009397024	0.01018011	10	8	Astrocytes	41	6	6
GTTTCTAGTATTAGCC-1_MS200_A303	-13.20008825	7.98057814	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2020	3031	0.031342791	0.011547344	10	8	Astrocytes	41	6	6
GTTTCTAGTCGAAAGC-1_MS200_A303	-1.658204769	20.8300963	1	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	706	1006	0.005964215	0.013916501	10	oligos	OL-Cntl	41	6	6
GTTTCTAGTGACGCCT-1_MS200_A303	8.700105604	1.560215326	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	718	1358	0.34167894	0.008836524	10	12	EN-MIX	41	6	6
GTTTCTAGTTACGCGC-1_MS200_A303	12.03934134	-16.71133566	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4621	13131	0.012184906	0.007463255	10	L2-3	EN-L2-3-MS	41	6	6
GTTTCTATCAGTTAGC-1_MS200_A303	-6.555544669	13.27250551	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	819	1213	0.022258862	0.014014839	10	oligos	OL-MS-1	41	6	6
TAAACCGAGAGTCGGT-1_MS200_A303	-6.53099654	12.17087869	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	761	1037	0.052073288	0.014464802	10	oligos	OL-MS-1	41	6	6
TAAACCGGTCTCTCTG-1_MS200_A303	-25.70224355	1.233889603	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1453	2090	0.006698565	0.012440191	10	9	OPC	41	6	6
TAAACCGTCCTAGGGC-1_MS200_A303	1.927779531	10.98596253	1	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	990	1519	0.00921659	0.023041475	10	oligos	OL-Cntl	41	6	6
TAAACCGTCGAGCCCA-1_MS200_A303	24.58456103	-17.05647232	3	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	6876	22683	0.016135432	0.01005158	10	3	EN-L5-6	41	6	6
TAAGAGAAGCAATCTC-1_MS200_A303	6.92650509	13.07309526	1	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1084	1657	0.004224502	0.013277007	10	oligos	OL-Cntl	41	6	6
TAAGAGAAGGCAGTCA-1_MS200_A303	-29.42409451	-11.12479462	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	893	1257	0.00636436	0.00477327	10	9	OPC	41	6	6
TAAGAGACAAAGCGGT-1_MS200_A303	22.33782797	-16.85466253	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	7316	27761	0.052375635	0.005187133	10	L2-3	EN-L2-3-MS	41	6	6
TAAGAGACAACACCCG-1_MS200_A303	-30.08632604	-2.183465473	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1801	3144	0.006361323	0.006043257	10	9	OPC	41	6	6
TAAGAGACATATGAGA-1_MS200_A303	-24.35312134	7.138446898	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	976	1446	0.007607192	0.01175657	10	8	Astrocytes	41	6	6
TAAGAGAGTAACGTTC-1_MS200_A303	13.95960943	-4.843983182	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1747	3127	0.070354973	0.007355293	10	12	EN-MIX	41	6	6
TAAGAGAGTAGCGTAG-1_MS200_A303	7.299023832	-0.967551226	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	850	1382	0.199710564	0.003617945	10	12	EN-MIX	41	6	6
TAAGCGTAGATAGCAT-1_MS200_A303	-14.04102838	-15.7690404	6B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1504	2754	0.047567175	0.004357298	10	6B	IN-SST	41	6	6
TAAGCGTCAGAGTGTG-1_MS200_A303	-6.198478035	12.1564614	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	773	1118	0.051878354	0.019677996	10	oligos	OL-MS-1	41	6	6
TAAGCGTGTCGCGTGT-1_MS200_A303	-24.49975279	8.294931637	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	909	1245	0.004016064	0.012851406	10	8	Astrocytes	41	6	6
TAAGCGTGTCTTCGTC-1_MS200_A303	13.70515141	-23.47582475	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4556	12026	0.005654415	0.008481623	10	L2-3	EN-L2-3-MS	41	6	6
TAAGCGTGTGACCAAG-1_MS200_A303	-28.22448828	-20.90026015	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3629	7901	0.054043792	0.006454879	10	6A	IN-PV	41	6	6
TAAGCGTGTGCATCTA-1_MS200_A303	32.70226988	-11.07944936	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2766	5303	0.024137281	0.012257213	10	2	EN-L4	41	6	6
TAAGCGTTCTAGCACA-1_MS200_A303	2.974004816	10.50191641	1	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1260	1960	0.003571429	0.015816327	10	oligos	OL-Cntl	41	6	6
TAAGCGTTCTCGATGA-1_MS200_A303	34.08071452	-17.67811139	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5216	12981	0.014713812	0.013635313	10	2	EN-L4	41	6	6
TAAGTGCCAAGTTGTC-1_MS200_A303	33.90882251	-17.93668022	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4511	10684	0.015443654	0.012448521	10	2	EN-L4	41	6	6
TAAGTGCCAGGAATCG-1_MS200_A303	17.08010008	-16.19051807	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	8228	32289	0.013255288	0.010158258	10	L2-3	EN-L2-3-MS	41	6	6
TAAGTGCGTGCTTCTC-1_MS200_A303	-24.50740504	-19.4983928	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3203	7471	0.014188194	0.007227948	10	6A	IN-PV	41	6	6
TAAGTGCGTTACGTCA-1_MS200_A303	-26.97362697	-18.61368598	6B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2447	4282	0.013311537	0.024988323	10	6B	IN-SST	41	6	6
TAAGTGCTCATCGGAT-1_MS200_A303	-22.95545209	-23.57304632	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3127	6875	0.016727273	0.005818182	10	6A	IN-PV	41	6	6
TAAGTGCTCCTCATTA-1_MS200_A303	-14.02966743	23.88593118	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1831	3417	0.011706175	0.01404741	10	8	Astrocytes	41	6	6
TACACGAAGGAATTAC-1_MS200_A303	16.33365837	-10.27932934	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2225	4162	0.086737146	0.003844306	10	12	EN-MIX	41	6	6
TACACGAAGGCTCAGA-1_MS200_A303	-13.08382644	7.298270205	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1302	1819	0.031885651	0.019791094	10	8	Astrocytes	41	6	6
TACACGAAGGGATGGG-1_MS200_A303	23.28449212	-21.91455889	3	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3253	7024	0.011104784	0.00441344	10	3	EN-L5-6	41	6	6
TACACGAAGTGGTCCC-1_MS200_A303	-27.56804291	-4.007117473	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1373	2087	0.00287494	0.006708194	10	9	OPC	41	6	6
TACACGATCTCGATGA-1_MS200_A303	14.52039447	-13.24993723	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4838	11622	0.009378764	0.014197212	10	L2-3	EN-L2-3-MS	41	6	6
TACACGATCTCGCTTG-1_MS200_A303	3.349596324	-6.656004117	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1345	2304	0.059027778	0.004340278	10	12	EN-MIX	41	6	6
TACAGTGAGCTGCGAA-1_MS200_A303	-5.503640217	15.60054091	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	734	1073	0.002795899	0.013979497	10	oligos	OL-MS-1	41	6	6
TACAGTGAGGTTACCT-1_MS200_A303	-3.483958283	-34.91874678	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	730	1018	0.113948919	0.024557957	10	16	EN-PYR	41	6	6
TACAGTGCACATCTTT-1_MS200_A303	-25.07839257	0.109735889	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2602	4736	0.01097973	0.005701014	10	9	OPC	41	6	6
TACAGTGCAGGCTGAA-1_MS200_A303	-8.520271672	-6.751474086	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1457	2258	0.003100089	0.016386182	10	13A	IN-VIP	41	6	6
TACAGTGCATCTCGCT-1_MS200_A303	-31.20933096	-7.416857747	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1039	1746	0.001145475	0.004009164	10	9	OPC	41	6	6
TACAGTGGTAGGGACT-1_MS200_A303	34.33434618	-5.188371232	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3347	7646	0.004708344	0.008893539	10	2	EN-L4	41	6	6
TACAGTGGTCTCACCT-1_MS200_A303	-17.31754077	5.879846959	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	811	1148	0.006968641	0.020034843	10	8	Astrocytes	41	6	6
TACAGTGGTTCAGACT-1_MS200_A303	20.5083229	-12.79524933	3	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3599	9236	0.153204851	0.003572975	10	3	EN-L5-6	41	6	6
TACAGTGTCTTTACGT-1_MS200_A303	-31.93064755	-5.815316187	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1197	1869	0.004280364	0.008025682	10	9	OPC	41	6	6
TACCTATAGACAAAGG-1_MS200_A303	15.86072724	-15.32505287	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4532	11118	0.025724051	0.005576543	10	L2-3	EN-L2-3-MS	41	6	6
TACCTATAGACAGACC-1_MS200_A303	-26.78371918	-22.49313379	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4313	11639	0.043732279	0.006787525	10	6A	IN-PV	41	6	6
TACCTATCAATAAGCA-1_MS200_A303	-16.89590085	-1.815822816	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2682	4897	0.009393506	0.017153359	10	13A	IN-VIP	41	6	6
TACCTATCACATGACT-1_MS200_A303	10.47399225	-20.14611385	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3406	8497	0.04107332	0.004001412	10	L2-3	EN-L2-3-MS	41	6	6
TACCTATCAGGCTCAC-1_MS200_A303	-34.42423575	-4.523516238	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1303	2192	0.005018248	0.004562044	10	9	OPC	41	6	6
TACCTATCATGCCCGA-1_MS200_A303	9.829268068	-2.635794065	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1934	3668	0.10387132	0.003271538	10	12	EN-MIX	41	6	6
TACCTATGTGCAACGA-1_MS200_A303	-15.1276599	22.90835187	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1503	2355	0.001273885	0.008917197	10	8	Astrocytes	41	6	6
TACCTATGTGTGCCTG-1_MS200_A303	-17.9713455	-10.40520277	13B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3311	7661	0.002349563	0.010050907	10	13B	IN-SV2C	41	6	6
TACCTATGTTTGTTGG-1_MS200_A303	-28.82651377	0.904201372	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2061	3582	0.023171413	0.01228364	10	9	OPC	41	6	6
TACCTATTCCAAGTAC-1_MS200_A303	-6.406544132	14.71278025	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	969	1397	0.008589835	0.017179671	10	oligos	OL-MS-1	41	6	6
TACCTATTCCACTCCA-1_MS200_A303	13.17010031	-2.175393385	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	942	1477	0.004739336	0.004739336	10	12	EN-MIX	41	6	6
TACCTATTCGGAAATA-1_MS200_A303	-8.673505035	-15.69111338	6B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	709	1070	0.088785047	0.002803738	10	6B	IN-SST	41	6	6
TACCTTAAGCCAGAAC-1_MS200_A303	-31.27900939	-5.877574805	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1264	1959	0.004083716	0.008677897	10	9	OPC	41	6	6
TACCTTACACACCGAC-1_MS200_A303	-17.29168168	20.61988925	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1894	3303	0.003633061	0.009082652	10	8	Astrocytes	41	6	6
TACCTTACATGCCCGA-1_MS200_A303	27.48191239	-12.79090841	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5530	16920	0.016134752	0.006264775	10	L2-3	EN-L2-3-MS	41	6	6
TACCTTAGTAGTGAAT-1_MS200_A303	8.741286085	-13.36413503	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2637	5273	0.014223402	0.005689361	10	L2-3	EN-L2-3-MS	41	6	6
TACCTTAGTCCGCTGA-1_MS200_A303	34.94470328	-13.329738	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4063	9527	0.004198593	0.01584969	10	2	EN-L4	41	6	6
TACCTTAGTCTCACCT-1_MS200_A303	33.87335022	-15.01080151	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4918	13610	0.016091109	0.007788391	10	2	EN-L4	41	6	6
TACGGATAGACTAGGC-1_MS200_A303	-23.09796583	6.628816378	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	919	1210	0.008264463	0.012396694	10	8	Astrocytes	41	6	6
TACGGATAGCTTCGCG-1_MS200_A303	-6.181395183	15.42055635	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	901	1284	0.007009346	0.012461059	10	oligos	OL-MS-1	41	6	6
TACGGATAGGACTGGT-1_MS200_A303	-13.93507815	22.22252924	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1635	2559	0.007815553	0.011723329	10	8	Astrocytes	41	6	6
TACGGATCAGCCTTGG-1_MS200_A303	-16.45165174	20.64159883	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1463	2200	0.001363636	0.010909091	10	8	Astrocytes	41	6	6
TACGGATGTCGGCTCA-1_MS200_A303	-17.75493922	-2.852786307	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3092	6172	0.024141283	0.007453014	10	13A	IN-VIP	41	6	6
TACGGATTCCAGGGCT-1_MS200_A303	-30.71795398	-21.62531986	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	7552	27389	0.039541422	0.015188579	10	6A	IN-PV	41	6	6
TACGGATTCGCAAGCC-1_MS200_A303	-17.78419229	-3.828556359	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3007	5789	0.025565728	0.006909656	10	13A	IN-VIP	41	6	6
TACGGATTCTGCGGCA-1_MS200_A303	27.42214973	-18.49731141	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3543	7873	0.059189635	0.007875016	10	2	EN-L4	41	6	6
TACGGGCAGACTTGAA-1_MS200_A303	34.4281938	-14.24024436	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4303	9685	0.003510583	0.010841507	10	2	EN-L4	41	6	6
TACGGGCGTACCGTAT-1_MS200_A303	-33.42385127	0.152029744	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1675	2820	0.008865248	0.004255319	10	9	OPC	41	6	6
TACGGGCGTGAACCTT-1_MS200_A303	7.351100737	12.36159661	1	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1252	2066	0.004840271	0.009680542	10	oligos	OL-Cntl	41	6	6
TACGGGCTCGCCTGAG-1_MS200_A303	-28.16293881	-5.141604239	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1234	1754	0.004561003	0.00627138	10	9	OPC	41	6	6
TACGGTAAGCCCTAAT-1_MS200_A303	-16.43517277	20.42008482	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1266	2062	0.008729389	0.012124151	10	8	Astrocytes	41	6	6
TACGGTAAGGGCTTGA-1_MS200_A303	6.442574077	-2.153963464	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	986	1396	0.010744986	0.005730659	10	12	EN-MIX	41	6	6
TACGGTAAGGGTATCG-1_MS200_A303	-11.79904083	-15.38176658	6B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1130	1696	0.027122642	0.005896226	10	6B	IN-SST	41	6	6
TACGGTACAATCCGAT-1_MS200_A303	-16.2285506	23.31179167	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1535	2634	0.001138952	0.004935459	10	8	Astrocytes	41	6	6
TACGGTACAGGGAGAG-1_MS200_A303	-4.854979797	10.54430939	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	799	1085	0.004608295	0.037788018	10	oligos	OL-MS-1	41	6	6
TACGGTACAGTCAGCC-1_MS200_A303	18.22190634	-22.64896957	3	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3284	6537	0.01024935	0.018357045	10	3	EN-L5-6	41	6	6
TACGGTATCACGAAGG-1_MS200_A303	-4.416131095	-37.49168699	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1036	1407	0.095238095	0.03127221	10	16	EN-PYR	41	6	6
TACGGTATCCACGAAT-1_MS200_A303	25.48730933	8.903821681	15A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2243	3908	0.027891505	0.036079836	10	15A	Endo cells	41	6	6
TACGGTATCGGAAACG-1_MS200_A303	-28.80454113	-21.69196881	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3736	7855	0.021642266	0.011330363	10	6A	IN-PV	41	6	6
TACGGTATCGGCGGTT-1_MS200_A303	14.29113358	-13.02786093	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3670	8017	0.018211301	0.006985157	10	L2-3	EN-L2-3-MS	41	6	6
TACGGTATCTGGTTCC-1_MS200_A303	-29.05745393	-22.20501522	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4769	12884	0.026466936	0.009701956	10	6A	IN-PV	41	6	6
TACTCATCACACCGCA-1_MS200_A303	-15.53121359	-2.797268312	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2643	5419	0.018638125	0.009595866	10	13A	IN-VIP	41	6	6
TACTCATCACAGAGGT-1_MS200_A303	11.65450669	-18.51505075	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5311	15024	0.003061768	0.005125133	10	L2-3	EN-L2-3-MS	41	6	6
TACTCATCAGATCTGT-1_MS200_A303	-15.82435984	0.189128668	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3393	7022	0.011962404	0.007120478	10	13A	IN-VIP	41	6	6
TACTCATCATTAACCG-1_MS200_A303	23.14869968	-15.9836657	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	6967	25022	0.028414995	0.014747023	10	2	EN-L4	41	6	6
TACTCATGTCGAGATG-1_MS200_A303	-24.63988366	-19.43614746	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3308	7302	0.016981649	0.009449466	10	6A	IN-PV	41	6	6
TACTCATGTCTTTCAT-1_MS200_A303	2.298198256	6.325038589	7	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	836	1210	0.012396694	0.001652893	10	7	Phagocytes	41	6	6
TACTCATGTGGCCCTA-1_MS200_A303	-19.81646111	-1.577263279	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4023	8986	0.02003116	0.012686401	10	13A	IN-VIP	41	6	6
TACTCATGTGGGTCAA-1_MS200_A303	17.13496862	-4.819190022	3	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1336	2210	0.046606335	0.00361991	10	3	EN-L5-6	41	6	6
TACTCATGTTAAAGTG-1_MS200_A303	-19.76039806	-1.066496629	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3911	7926	0.007317689	0.017158718	10	13A	IN-VIP	41	6	6
TACTCATGTTCGCTAA-1_MS200_A303	21.35296826	-1.677466432	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1790	3063	0.022200457	0.009467842	10	2	EN-L4	41	6	6
TACTCATTCATACGGT-1_MS200_A303	23.58150369	-27.67833539	3	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2937	6740	0.002967359	0.004451039	10	3	EN-L5-6	41	6	6
TACTCATTCGCGTTTC-1_MS200_A303	9.235007353	-15.98385306	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3412	7504	0.005463753	0.007862473	10	L2-3	EN-L2-3-MS	41	6	6
TACTCATTCTATGTGG-1_MS200_A303	-15.81068743	23.20513781	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1444	2266	0.007502207	0.011032657	10	8	Astrocytes	41	6	6
TACTCATTCTTGACGA-1_MS200_A303	-14.46426954	-38.09319917	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2433	4430	0.072460497	0.025959368	10	16	EN-PYR	41	6	6
TACTCGCCAAACTGCT-1_MS200_A303	-14.73553962	22.19205406	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1469	2469	0.001620089	0.010125557	10	8	Astrocytes	41	6	6
TACTCGCCAATAGCAA-1_MS200_A303	-5.433046066	13.51827778	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	758	1044	0.005747126	0.029693487	10	oligos	OL-MS-1	41	6	6
TACTCGCCAGGTCTCG-1_MS200_A303	-5.573117916	13.63841641	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	808	1135	0.005286344	0.014977974	10	oligos	OL-MS-1	41	6	6
TACTCGCGTAGAGTGC-1_MS200_A303	-6.76644056	-35.6867251	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	873	1160	0.053448276	0.017241379	10	16	EN-PYR	41	6	6
TACTCGCGTCATTAGC-1_MS200_A303	-6.167999349	12.4519313	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	836	1093	0.021043001	0.022872827	10	oligos	OL-MS-1	41	6	6
TACTCGCGTTTGTGTG-1_MS200_A303	9.422577067	-0.857659245	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1055	1655	0.088821752	0.004229607	10	12	EN-MIX	41	6	6
TACTCGCTCGCCAGCA-1_MS200_A303	-29.31038844	-2.105590157	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1761	2899	0.010003449	0.005864091	10	9	OPC	41	6	6
TACTTACAGGACGAAA-1_MS200_A303	-10.56513065	22.60061792	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1484	2306	0.004336513	0.009106678	10	8	Astrocytes	41	6	6
TACTTACAGGATTCGG-1_MS200_A303	17.85647643	-19.23265919	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3618	8122	0.016498399	0.004924895	10	L2-3	EN-L2-3-MS	41	6	6
TACTTACCACAAGCCC-1_MS200_A303	3.618643627	21.24609954	1	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	924	1400	0.011428571	0.009285714	10	oligos	OL-Cntl	41	6	6
TACTTACCACTGTGTA-1_MS200_A303	7.33316031	1.286751875	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	723	1592	0.444723618	0.005653266	10	16	EN-PYR	41	6	6
TACTTACCAGTCCTTC-1_MS200_A303	21.43739635	-2.430830247	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1960	3640	0.059340659	0.007417582	10	2	EN-L4	41	6	6
TACTTACCATCCCATC-1_MS200_A303	-18.16382327	29.91937746	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3213	7322	0.003960666	0.008467632	10	8	Astrocytes	41	6	6
TACTTACGTAGCACGA-1_MS200_A303	10.75353067	-18.0530699	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5275	15246	0.007608553	0.005968779	10	L2-3	EN-L2-3-MS	41	6	6
TACTTACGTCATATGC-1_MS200_A303	-14.46686483	22.07451004	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1424	2357	0.00678829	0.017819262	10	8	Astrocytes	41	6	6
TACTTACGTCTAGGTT-1_MS200_A303	9.829504041	-19.2083743	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4918	14842	0.006872389	0.00518798	10	L2-3	EN-L2-3-MS	41	6	6
TACTTGTAGACTAAGT-1_MS200_A303	-21.80863113	-25.85293343	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3363	7422	0.005524117	0.007140932	10	6A	IN-PV	41	6	6
TACTTGTAGAGTCGGT-1_MS200_A303	-9.114267575	-37.40890321	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1185	1642	0.052984166	0.012180268	10	16	EN-PYR	41	6	6
TACTTGTAGGCTCAGA-1_MS200_A303	-19.8258959	-2.360604321	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4705	12259	0.031894934	0.008483563	10	13A	IN-VIP	41	6	6
TACTTGTCACGACTCG-1_MS200_A303	9.691415383	-19.43642391	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4734	13304	0.009771497	0.003607937	10	L2-3	EN-L2-3-MS	41	6	6
TACTTGTCAGCGAACA-1_MS200_A303	30.3729233	14.53090804	14	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	778	1125	0.004444444	0.094222222	10	14	Microglia	41	6	6
TACTTGTTCACTTCAT-1_MS200_A303	34.1047019	-14.69808108	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4991	13398	0.013658755	0.009031199	10	2	EN-L4	41	6	6
TACTTGTTCATAACCG-1_MS200_A303	-0.162453502	12.47731129	1	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	858	1302	0.013824885	0.026113671	10	oligos	OL-Cntl	41	6	6
TACTTGTTCCTATGTT-1_MS200_A303	-14.95302205	25.37339211	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2134	4064	0.001968504	0.007874016	10	8	Astrocytes	41	6	6
TAGACCAAGAGATGAG-1_MS200_A303	-11.34280726	-4.685349214	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2061	3427	0.023052232	0.006711409	10	13A	IN-VIP	41	6	6
TAGACCAAGGTGCTTT-1_MS200_A303	-10.44722213	13.24233813	11	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1309	2080	0.004807692	0.011538462	10	11	Glia-MIX	41	6	6
TAGACCAAGGTTCCTA-1_MS200_A303	3.558572169	20.82870754	1	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	821	1232	0.00974026	0.011363636	10	oligos	OL-Cntl	41	6	6
TAGACCACAGCCTGTG-1_MS200_A303	-16.89326469	20.28040857	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1499	2549	0.001569243	0.011769321	10	8	Astrocytes	41	6	6
TAGACCAGTAACGTTC-1_MS200_A303	-16.62030972	18.12669848	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1703	3073	0.006508298	0.010087862	10	8	Astrocytes	41	6	6
TAGACCAGTTTAAGCC-1_MS200_A303	-3.856754136	8.910230485	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1066	1521	0.02695595	0.015779093	10	oligos	OL-MS-1	41	6	6
TAGACCATCAACTCTT-1_MS200_A303	11.63361529	-17.97169659	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5656	17440	0.006364679	0.010607798	10	L2-3	EN-L2-3-MS	41	6	6
TAGACCATCCACGAAT-1_MS200_A303	-4.955955733	15.22763053	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	728	1008	0.007936508	0.014880952	10	oligos	OL-MS-1	41	6	6
TAGACCATCCTCAACC-1_MS200_A303	-14.44513787	-22.17369334	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1478	2559	0.085971082	0.003907776	10	6A	IN-PV	41	6	6
TAGAGCTAGCAATCTC-1_MS200_A303	-15.64067129	23.54840361	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1539	2548	0.007064364	0.011381476	10	8	Astrocytes	41	6	6
TAGAGCTAGGATGGAA-1_MS200_A303	30.86390962	-14.90288526	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2887	5505	0.032334242	0.00599455	10	2	EN-L4	41	6	6
TAGAGCTGTCACTTCC-1_MS200_A303	-13.74630225	22.859306	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1436	2264	0.003533569	0.018109541	10	8	Astrocytes	41	6	6
TAGAGCTGTGCGCTTG-1_MS200_A303	-4.142872485	14.08945696	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	816	1197	0.003341688	0.025062657	10	oligos	OL-MS-1	41	6	6
TAGAGCTGTTCACGGC-1_MS200_A303	11.20928441	-18.37705015	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5592	16873	0.008534345	0.004326439	10	L2-3	EN-L2-3-MS	41	6	6
TAGAGCTTCCTACAGA-1_MS200_A303	10.71571102	1.46558795	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	784	1097	0.099361896	0.010027347	10	12	EN-MIX	41	6	6
TAGAGCTTCTTACCGC-1_MS200_A303	-19.28794628	-2.051415203	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3626	7317	0.00765341	0.013666803	10	13A	IN-VIP	41	6	6
TAGCCGGAGAGCTGGT-1_MS200_A303	29.2037057	-16.98903155	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4664	11603	0.03516332	0.007067138	10	2	EN-L4	41	6	6
TAGCCGGAGAGTACAT-1_MS200_A303	9.651942614	-16.07863454	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3554	7624	0.005902413	0.011542497	10	L2-3	EN-L2-3-MS	41	6	6
TAGCCGGCAATCTGCA-1_MS200_A303	-31.49842436	-6.324410029	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1060	1587	0.005040958	0.006931317	10	9	OPC	41	6	6
TAGCCGGCAGCCAGAA-1_MS200_A303	-14.32587283	24.59660157	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1978	3621	0.001657001	0.012427506	10	8	Astrocytes	41	6	6
TAGCCGGCAGGCTGAA-1_MS200_A303	-32.15475164	-13.49116786	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	736	1075	0.00744186	0.008372093	10	9	OPC	41	6	6
TAGCCGGCATCTGGTA-1_MS200_A303	15.45590309	-14.53102643	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5585	15642	0.024421429	0.009269914	10	L2-3	EN-L2-3-MS	41	6	6
TAGCCGGGTTATGTGC-1_MS200_A303	1.647312672	5.449422627	7	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	829	1020	0.009803922	0.011764706	10	7	Phagocytes	41	6	6
TAGCCGGTCCAAGTAC-1_MS200_A303	12.26686408	-13.41047708	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4100	9344	0.006956336	0.016053082	10	L2-3	EN-L2-3-MS	41	6	6
TAGCCGGTCTGGAGCC-1_MS200_A303	12.60718929	-15.26369042	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3722	8145	0.011663597	0.008717004	10	L2-3	EN-L2-3-MS	41	6	6
TAGCCGGTCTGGGCCA-1_MS200_A303	3.653683495	-3.282548622	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	920	1311	0.039664378	0.005339436	10	12	EN-MIX	41	6	6
TAGGCATAGGACACCA-1_MS200_A303	-10.52512572	-36.46432911	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1246	1924	0.111226611	0.016632017	10	16	EN-PYR	41	6	6
TAGGCATCACCGTTGG-1_MS200_A303	1.103159556	10.59423874	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	927	1338	0.011210762	0.013452915	10	oligos	OL-MS-1	41	6	6
TAGGCATGTACTTAGC-1_MS200_A303	-11.13534092	-4.476865923	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2335	4333	0.013385645	0.005077314	10	13A	IN-VIP	41	6	6
TAGGCATGTAGCGATG-1_MS200_A303	14.87041592	-15.39700373	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5724	15820	0.011441214	0.005562579	10	L2-3	EN-L2-3-MS	41	6	6
TAGGCATGTATTAGCC-1_MS200_A303	-24.13120918	7.782585866	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1001	1489	0.0080591	0.008730692	10	8	Astrocytes	41	6	6
TAGGCATTCCTTAATC-1_MS200_A303	-12.62178376	-8.263467052	13B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1714	2962	0.014517218	0.007765024	10	13B	IN-SV2C	41	6	6
TAGTGGTAGTCTTGCA-1_MS200_A303	-13.32587135	17.27869745	11	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1356	1975	0.007594937	0.01164557	10	11	Glia-MIX	41	6	6
TAGTGGTGTTGGTTTG-1_MS200_A303	-19.57659576	-5.022258812	13B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3215	6606	0.023917651	0.009536785	10	13B	IN-SV2C	41	6	6
TAGTGGTTCCGAATGT-1_MS200_A303	34.04829233	-17.96568537	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4743	11776	0.019955842	0.013841712	10	2	EN-L4	41	6	6
TAGTGGTTCGTAGGTT-1_MS200_A303	9.402429248	-1.479497714	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1652	3591	0.316624896	0.004734057	10	12	EN-MIX	41	6	6
TAGTGGTTCTTACCTA-1_MS200_A303	13.61940771	-2.318203154	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1150	1795	0.074651811	0.003342618	10	12	EN-MIX	41	6	6
TAGTTGGAGCGTTGCC-1_MS200_A303	-19.68671053	-0.841816657	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4314	9643	0.011614643	0.02582184	10	13A	IN-VIP	41	6	6
TAGTTGGCAGCGTAAG-1_MS200_A303	-14.03956849	22.62325462	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1671	2684	0.002980626	0.013040238	10	8	Astrocytes	41	6	6
TAGTTGGCAGGGTATG-1_MS200_A303	14.69575281	-17.52067101	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4915	13039	0.00843623	0.008512923	10	L2-3	EN-L2-3-MS	41	6	6
TAGTTGGGTCTTGTCC-1_MS200_A303	-30.14495098	-10.75729179	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	920	1331	0.003005259	0.011269722	10	9	OPC	41	6	6
TAGTTGGGTTGGTTTG-1_MS200_A303	10.55896029	-13.40721343	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3351	7123	0.009125369	0.014179419	10	L2-3	EN-L2-3-MS	41	6	6
TAGTTGGTCCAAACAC-1_MS200_A303	14.57574552	1.773702316	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	970	1500	0.106666667	0.006	10	12	EN-MIX	41	6	6
TAGTTGGTCCCAACGG-1_MS200_A303	29.67390015	-13.24743061	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5367	14602	0.010204082	0.010135598	10	2	EN-L4	41	6	6
TAGTTGGTCTCACATT-1_MS200_A303	32.86313367	8.643605047	14	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	951	1267	0.004735596	0.013417522	10	14	Microglia	41	6	6
TATCAGGAGAGGTTGC-1_MS200_A303	-11.20882747	-6.17313174	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2189	4117	0.009715812	0.005343697	10	13A	IN-VIP	41	6	6
TATCAGGAGGAGCGTT-1_MS200_A303	-19.84669188	-0.981897457	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4249	9245	0.010275825	0.024661979	10	13A	IN-VIP	41	6	6
TATCAGGAGGCGCTCT-1_MS200_A303	16.08898122	-10.66794359	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2504	4892	0.118152085	0.004905969	10	12	EN-MIX	41	6	6
TATCAGGAGTGTTTGC-1_MS200_A303	18.73951961	-13.73695681	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	7426	24815	0.015232722	0.012371549	10	2	EN-L4	41	6	6
TATCAGGCAGTGGAGT-1_MS200_A303	-27.59988182	-20.09082224	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2524	4584	0.041230366	0.007635253	10	6A	IN-PV	41	6	6
TATCAGGGTATTACCG-1_MS200_A303	-15.18858587	23.1425325	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1480	2315	0.003887689	0.00475162	10	8	Astrocytes	41	6	6
TATCAGGGTTTAAGCC-1_MS200_A303	-6.444448557	-35.00110188	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	802	1046	0.053537285	0.013384321	10	16	EN-PYR	41	6	6
TATCTCACACTGTGTA-1_MS200_A303	1.936559741	10.3185625	1	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	999	1588	0.002518892	0.012594458	10	oligos	OL-Cntl	41	6	6
TATCTCAGTAGCAAAT-1_MS200_A303	15.45702668	-13.68678297	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	6212	18366	0.00871175	0.011924208	10	L2-3	EN-L2-3-MS	41	6	6
TATCTCAGTGCTGTAT-1_MS200_A303	9.054724001	-18.34074954	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5187	14713	0.005845171	0.010534901	10	L2-3	EN-L2-3-MS	41	6	6
TATCTCATCGGCATCG-1_MS200_A303	-31.92610281	-5.766827488	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1222	1972	0.005578093	0.006592292	10	9	OPC	41	6	6
TATCTCATCGGTCCGA-1_MS200_A303	-14.47667567	23.40997366	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1644	2998	0.002001334	0.008005337	10	8	Astrocytes	41	6	6
TATCTCATCTCGTATT-1_MS200_A303	-11.296024	18.5611735	11	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3158	6587	0.003491726	0.005920753	10	11	Glia-MIX	41	6	6
TATCTCATCTGAGTGT-1_MS200_A303	-26.46040887	5.49495107	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1012	1496	0.001336898	0.007352941	10	8	Astrocytes	41	6	6
TATGCCCAGGGCATGT-1_MS200_A303	-9.611740046	27.45061801	17	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1044	1455	0.022680412	0.019243986	10	oligos	OL-MS-2	41	6	6
TATGCCCCATTAGCCA-1_MS200_A303	10.5259741	-18.44358961	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4606	12167	0.008465521	0.007890195	10	L2-3	EN-L2-3-MS	41	6	6
TATGCCCGTGCTCTTC-1_MS200_A303	-30.1764629	-21.74157776	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4641	11092	0.032455824	0.015326361	10	6A	IN-PV	41	6	6
TATGCCCGTGTTCTTT-1_MS200_A303	-31.54876655	-9.689397635	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	991	1438	0.005563282	0.009040334	10	9	OPC	41	6	6
TATGCCCTCAAGAAGT-1_MS200_A303	34.10216743	-17.96304231	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5211	13119	0.019589908	0.016540895	10	2	EN-L4	41	6	6
TATGCCCTCACCAGGC-1_MS200_A303	15.55009798	-13.78352989	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	7723	28324	0.009532552	0.016876147	10	L2-3	EN-L2-3-MS	41	6	6
TATGCCCTCCGGCACA-1_MS200_A303	-30.44158597	-4.499132895	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1273	2069	0.003383277	0.00918318	10	9	OPC	41	6	6
TATGCCCTCTTACCTA-1_MS200_A303	2.952443096	10.1588849	1	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1379	2336	0.005136986	0.011130137	10	oligos	OL-Cntl	41	6	6
TATTACCAGCGTAATA-1_MS200_A303	1.363950769	10.78853661	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	942	1431	0.002096436	0.0174703	10	oligos	OL-MS-1	41	6	6
TATTACCAGCTGCGAA-1_MS200_A303	-15.20812517	12.85883892	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1606	2679	0.004852557	0.008212019	10	8	Astrocytes	41	6	6
TATTACCAGGCACATG-1_MS200_A303	-18.40551147	-1.737586244	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3519	7404	0.01647758	0.01269584	10	13A	IN-VIP	41	6	6
TATTACCAGTCGCCGT-1_MS200_A303	18.5628667	-4.437372933	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1613	2760	0.00615942	0.002898551	10	2	EN-L4	41	6	6
TATTACCAGTGGGCTA-1_MS200_A303	-29.41955403	-12.09150603	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	872	1193	0.012573345	0.005029338	10	9	OPC	41	6	6
TATTACCAGTGGGTTG-1_MS200_A303	-8.835198568	-13.50062341	6B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	760	1067	0.072164948	0.012183693	10	6B	IN-SST	41	6	6
TATTACCGTCATGCAT-1_MS200_A303	-14.77133909	-16.20421447	6B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1619	2967	0.028985507	0.003707449	10	6B	IN-SST	41	6	6
TATTACCGTTCCAACA-1_MS200_A303	-17.55217104	20.55752708	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1607	2935	0.001703578	0.008858603	10	8	Astrocytes	41	6	6
TATTACCGTTGATTGC-1_MS200_A303	-10.558699	28.45017658	17	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	866	1168	0.067636986	0.007705479	10	oligos	OL-MS-2	41	6	6
TATTACCTCTGTCTCG-1_MS200_A303	34.53115081	-14.79135207	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4346	10209	0.008032129	0.01439906	10	2	EN-L4	41	6	6
TCAACGAAGTACACCT-1_MS200_A303	13.16558389	-19.81965844	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5243	15941	0.01329904	0.006398595	10	L2-3	EN-L2-3-MS	41	6	6
TCAACGACAACCGCCA-1_MS200_A303	21.29601264	-3.556858356	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2244	4210	0.065320665	0.005700713	10	2	EN-L4	41	6	6
TCAACGAGTCACCTAA-1_MS200_A303	1.771412649	10.33459535	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1004	1442	0.004160888	0.009708738	10	oligos	OL-MS-1	41	6	6
TCAACGAGTGGGTATG-1_MS200_A303	-16.22160771	20.11468275	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1228	1966	0.002034588	0.011190234	10	8	Astrocytes	41	6	6
TCAATCTAGGTAGCTG-1_MS200_A303	14.34804069	-12.71985511	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3419	6637	0.014916378	0.009642911	10	L2-3	EN-L2-3-MS	41	6	6
TCAATCTAGTCTTGCA-1_MS200_A303	-29.17662612	-3.516202134	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1438	2336	0.006421233	0.00984589	10	9	OPC	41	6	6
TCAATCTCACCGCTAG-1_MS200_A303	33.40713669	-16.79890775	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5179	13656	0.010471588	0.015011716	10	2	EN-L4	41	6	6
TCAATCTGTGGTGTAG-1_MS200_A303	-11.16483886	-37.3219853	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1346	1926	0.048805815	0.021806854	10	16	EN-PYR	41	6	6
TCAATCTGTTGTCGCG-1_MS200_A303	-8.730051592	-10.82400368	6B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1568	3872	0.345557851	0.003357438	10	6B	IN-SST	41	6	6
TCAATCTTCAAACAAG-1_MS200_A303	13.23347409	-9.559717046	3	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3162	6179	0.005178832	0.006149862	10	3	EN-L5-6	41	6	6
TCAATCTTCAAACCGT-1_MS200_A303	-30.50707811	-21.67257379	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5520	14793	0.021023457	0.017913878	10	6A	IN-PV	41	6	6
TCAATCTTCAGGCAAG-1_MS200_A303	-16.55297585	20.33430019	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1659	2640	0.001893939	0.009090909	10	8	Astrocytes	41	6	6
TCAATCTTCCGTAGTA-1_MS200_A303	-4.944331681	-7.699845793	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	910	1304	0.056748466	0.008435583	10	13A	IN-VIP	41	6	6
TCAATCTTCCTTGACC-1_MS200_A303	-32.64012169	-3.99577213	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1566	2625	0.00647619	0.006857143	10	9	OPC	41	6	6
TCAATCTTCGAACGGA-1_MS200_A303	-26.36337534	-22.8959882	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4163	9922	0.019048579	0.007055029	10	6A	IN-PV	41	6	6
TCAATCTTCGGGAGTA-1_MS200_A303	-29.25010471	-22.15634066	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5303	13931	0.041203072	0.011126265	10	6A	IN-PV	41	6	6
TCAATCTTCTCGAGTA-1_MS200_A303	-23.62043777	9.507348524	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	939	1449	0.010351967	0.015873016	10	8	Astrocytes	41	6	6
TCACAAGAGCGTGAAC-1_MS200_A303	5.081776234	-9.499652188	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1587	2533	0.028424793	0.005921832	10	12	EN-MIX	41	6	6
TCACAAGAGCGTTCCG-1_MS200_A303	1.092203103	11.44203924	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	825	1182	0.004230118	0.014382403	10	oligos	OL-MS-1	41	6	6
TCACAAGAGTACGACG-1_MS200_A303	15.67938622	-13.61481876	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5806	15728	0.016213123	0.010045778	10	L2-3	EN-L2-3-MS	41	6	6
TCACAAGCACCTATCC-1_MS200_A303	-15.91664301	13.17548382	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1523	2595	0.004624277	0.006165703	10	8	Astrocytes	41	6	6
TCACAAGCATGCCTAA-1_MS200_A303	-15.57397556	23.64601948	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1687	3088	0.005829016	0.007124352	10	8	Astrocytes	41	6	6
TCACAAGGTATATCCG-1_MS200_A303	-31.9084108	-5.302089677	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1310	2134	0.004217432	0.007966261	10	9	OPC	41	6	6
TCACAAGGTCGCCATG-1_MS200_A303	-6.489339978	13.97661486	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	807	1116	0.007168459	0.008960573	10	oligos	OL-MS-1	41	6	6
TCACAAGTCTTTACAC-1_MS200_A303	-29.6004499	-4.809114806	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1294	2063	0.006786234	0.01017935	10	9	OPC	41	6	6
TCACAAGTCTTTCCTC-1_MS200_A303	-15.65660381	23.47898917	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1587	2834	0.002822865	0.006351447	10	8	Astrocytes	41	6	6
TCACGAAAGGACATTA-1_MS200_A303	-24.33023068	7.316965045	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	959	1460	0.020547945	0.009589041	10	8	Astrocytes	41	6	6
TCACGAAAGTATCGAA-1_MS200_A303	-10.81203201	-15.18243766	6B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1053	1522	0.036793693	0.007227332	10	6B	IN-SST	41	6	6
TCACGAACAGTATAAG-1_MS200_A303	-30.81543533	-8.210836278	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	951	1444	0.001385042	0.015235457	10	9	OPC	41	6	6
TCACGAAGTAGCGCAA-1_MS200_A303	-9.002799105	-13.57315001	6B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	886	1419	0.183932347	0.009161381	10	6B	IN-SST	41	6	6
TCACGAAGTCGAGTTT-1_MS200_A303	-16.82762688	-3.681752623	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2577	4755	0.022502629	0.011356467	10	13A	IN-VIP	41	6	6
TCACGAATCCTTGCCA-1_MS200_A303	-13.19604206	-36.78023244	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1766	2791	0.073092082	0.014690075	10	16	EN-PYR	41	6	6
TCAGATGAGACACGAC-1_MS200_A303	-24.29624441	7.638622943	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	997	1440	0.004166667	0.004166667	10	8	Astrocytes	41	6	6
TCAGATGAGATGTAAC-1_MS200_A303	21.89475742	-16.45198987	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5172	13075	0.016596558	0.01667304	10	2	EN-L4	41	6	6
TCAGATGAGGCCCGTT-1_MS200_A303	-15.3471296	-37.55678155	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3555	8144	0.043099214	0.020260314	10	16	EN-PYR	41	6	6
TCAGATGCACAAGCCC-1_MS200_A303	-5.959833773	15.31026839	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	920	1353	0.008130081	0.018477458	10	oligos	OL-MS-1	41	6	6
TCAGATGCAGTCCTTC-1_MS200_A303	12.41900517	-17.33103055	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	6570	22779	0.009570218	0.007375214	10	L2-3	EN-L2-3-MS	41	6	6
TCAGATGCATCCTTGC-1_MS200_A303	-24.57108389	-19.36415847	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4087	10732	0.023387999	0.004099888	10	6A	IN-PV	41	6	6
TCAGATGTCGGCGCAT-1_MS200_A303	-29.08222768	-5.611184085	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1134	1737	0.005181347	0.004605642	10	9	OPC	41	6	6
TCAGATGTCTTGTATC-1_MS200_A303	-28.89530995	-21.7602192	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3961	8781	0.025965152	0.011843754	10	6A	IN-PV	41	6	6
TCAGCAAAGAAGCCCA-1_MS200_A303	-17.11887418	-14.8578915	6B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1753	2885	0.0152513	0.006585789	10	6B	IN-SST	41	6	6
TCAGCAAAGCTAACAA-1_MS200_A303	-9.305356661	-37.59789808	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1119	1566	0.038952746	0.018518519	10	16	EN-PYR	41	6	6
TCAGCAAAGGAGCGTT-1_MS200_A303	13.11008387	-15.34541537	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4984	11983	0.010097638	0.00909622	10	L2-3	EN-L2-3-MS	41	6	6
TCAGCAAAGGCCATAG-1_MS200_A303	-5.493572964	16.0369823	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	747	1069	0.005612722	0.012160898	10	oligos	OL-MS-1	41	6	6
TCAGCAACAACTGCGC-1_MS200_A303	8.475375485	-19.90498572	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4546	11914	0.007302333	0.005120027	10	L2-3	EN-L2-3-MS	41	6	6
TCAGCAACAATCCGAT-1_MS200_A303	-32.13281504	-4.42895715	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1469	2432	0.007401316	0.009868421	10	9	OPC	41	6	6
TCAGCAACATAGAAAC-1_MS200_A303	2.863333936	10.78456934	1	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1039	1551	0.003868472	0.012250161	10	oligos	OL-Cntl	41	6	6
TCAGCAATCCGCATAA-1_MS200_A303	-14.4821574	24.73209999	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1944	3539	0.004521051	0.010737496	10	8	Astrocytes	41	6	6
TCAGCTCAGAGTGAGA-1_MS200_A303	-13.59646336	22.25634067	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1612	2585	0.016247582	0.011218569	10	8	Astrocytes	41	6	6
TCAGCTCCACATTCGA-1_MS200_A303	7.814019803	12.42635141	1	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1229	2056	0.008754864	0.015077821	10	oligos	OL-Cntl	41	6	6
TCAGCTCCACTACAGT-1_MS200_A303	-12.75212208	-17.280271	6B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1154	1817	0.033021464	0.008805724	10	6B	IN-SST	41	6	6
TCAGCTCCACTTACGA-1_MS200_A303	-27.07640826	-22.6988497	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4907	13631	0.027437459	0.006749321	10	6A	IN-PV	41	6	6
TCAGCTCCATGAGCGA-1_MS200_A303	-30.15885621	-21.75157395	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5787	17102	0.051748334	0.008186177	10	6A	IN-PV	41	6	6
TCAGCTCGTCGCGGTT-1_MS200_A303	-29.604003	-4.214615505	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1339	2082	0.006243996	0.003842459	10	9	OPC	41	6	6
TCAGCTCGTCTCTCTG-1_MS200_A303	19.07479826	-14.98770745	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4542	11531	0.021073628	0.013702194	10	L2-3	EN-L2-3-MS	41	6	6
TCAGCTCGTTAGATGA-1_MS200_A303	-11.72708567	28.28201781	17	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1898	2834	0.032110092	0.014114326	10	oligos	OL-MS-2	41	6	6
TCAGCTCTCTTCATGT-1_MS200_A303	-15.19261131	24.79173071	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1750	3205	0.002184087	0.011856474	10	8	Astrocytes	41	6	6
TCAGCTCTCTTGCATT-1_MS200_A303	-33.25922649	-3.231372067	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1303	2127	0.005641749	0.005641749	10	9	OPC	41	6	6
TCAGGATAGCGTCAAG-1_MS200_A303	-6.490189631	-35.26059831	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	904	1239	0.086359968	0.014527845	10	16	EN-PYR	41	6	6
TCAGGATCAATACGCT-1_MS200_A303	20.04371313	-3.91770136	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1953	3440	0.07877907	0.00494186	10	12	EN-MIX	41	6	6
TCAGGATCATCGGACC-1_MS200_A303	-5.529874589	17.21116678	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	762	1105	0.004524887	0.010859729	10	oligos	OL-MS-1	41	6	6
TCAGGATTCACAACGT-1_MS200_A303	-20.01257146	7.700561443	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	869	1376	0.003633721	0.004360465	10	8	Astrocytes	41	6	6
TCAGGATTCACCATAG-1_MS200_A303	20.87310966	-12.38318015	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2320	4287	0.009563798	0.009097271	10	12	EN-MIX	41	6	6
TCAGGATTCTGCGTAA-1_MS200_A303	32.07444161	11.57113592	14	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1007	1287	0.017094017	0.027972028	10	14	Microglia	41	6	6
TCAGGTAAGACTGTAA-1_MS200_A303	17.81236275	-21.45377522	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3924	9803	0.023870244	0.005712537	10	L2-3	EN-L2-3-MS	41	6	6
TCAGGTAAGGACATTA-1_MS200_A303	32.86686607	10.34572368	14	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	939	1170	0.013675214	0.01965812	10	14	Microglia	41	6	6
TCAGGTACATGCCTAA-1_MS200_A303	-9.406719616	-7.114985573	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1688	3155	0.032329635	0.002535658	10	13A	IN-VIP	41	6	6
TCAGGTAGTGCACCAC-1_MS200_A303	19.90523174	-17.90559429	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5407	16283	0.013511024	0.014555057	10	L2-3	EN-L2-3-MS	41	6	6
TCAGGTATCGCGATCG-1_MS200_A303	-19.7085005	-0.79007207	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4092	8387	0.008823179	0.028258018	10	13A	IN-VIP	41	6	6
TCATTACAGCTACCGC-1_MS200_A303	-27.97731982	-22.40891226	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5269	16024	0.039503245	0.00673989	10	6A	IN-PV	41	6	6
TCATTACAGGCCCTCA-1_MS200_A303	-23.67129872	10.10127336	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1038	1519	0.007899934	0.007899934	10	8	Astrocytes	41	6	6
TCATTACAGTAACCCT-1_MS200_A303	36.53110874	-13.3849168	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	6140	17771	0.007146475	0.010972933	10	2	EN-L4	41	6	6
TCATTACAGTACATGA-1_MS200_A303	-24.83447726	-0.009181457	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2068	3630	0.007438017	0.009641873	10	9	OPC	41	6	6
TCATTACGTATAGTAG-1_MS200_A303	-33.22930779	-4.320545235	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1428	2382	0.002938707	0.006717045	10	9	OPC	41	6	6
TCATTACGTGCTGTAT-1_MS200_A303	-14.62178336	23.76174613	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1636	2704	0.007766272	0.00887574	10	8	Astrocytes	41	6	6
TCATTACGTGGAAAGA-1_MS200_A303	-29.49062638	-4.983793665	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1175	1783	0.003365115	0.00448682	10	9	OPC	41	6	6
TCATTTGAGCACGCCT-1_MS200_A303	-10.02321704	-36.63584072	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1075	1516	0.052110818	0.017810026	10	16	EN-PYR	41	6	6
TCATTTGCAGTTTACG-1_MS200_A303	-24.59634509	-19.43702346	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3556	8429	0.019338	0.007118282	10	6A	IN-PV	41	6	6
TCATTTGGTACGACCC-1_MS200_A303	-19.56073713	-5.970636667	13B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3957	9246	0.019359723	0.007246377	10	13B	IN-SV2C	41	6	6
TCCACACAGGCCGAAT-1_MS200_A303	34.93618995	10.38429842	14	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	760	1056	0.00094697	0.011363636	10	14	Microglia	41	6	6
TCCACACAGGTGCTTT-1_MS200_A303	-6.585852238	-35.17284057	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	787	1033	0.028073572	0.013552759	10	16	EN-PYR	41	6	6
TCCACACCAGTACACT-1_MS200_A303	-19.75402527	-0.877563746	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4869	11722	0.015099812	0.019877154	10	13A	IN-VIP	41	6	6
TCCACACCATCTCGCT-1_MS200_A303	-31.67615676	2.731951113	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1991	3727	0.002951435	0.005097934	10	9	OPC	41	6	6
TCCACACGTACAGTTC-1_MS200_A303	15.49972541	-25.31341646	3	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2842	6388	0.02222918	0.003757044	10	3	EN-L5-6	41	6	6
TCCACACGTTACGACT-1_MS200_A303	9.441712802	-19.57503881	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5150	15636	0.003325659	0.006267588	10	L2-3	EN-L2-3-MS	41	6	6
TCCACACTCTTCTGGC-1_MS200_A303	-13.05761793	17.28557061	11	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1411	2209	0.004074242	0.009959258	10	11	Glia-MIX	41	6	6
TCCCGATAGACAAGCC-1_MS200_A303	-8.986846542	-36.9083095	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1112	1526	0.064875491	0.018348624	10	16	EN-PYR	41	6	6
TCCCGATAGACACTAA-1_MS200_A303	-14.67316298	24.29818812	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1903	3070	0.000651466	0.006840391	10	8	Astrocytes	41	6	6
TCCCGATAGTGTGAAT-1_MS200_A303	-14.66375857	-3.769390266	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2983	6180	0.023462783	0.002912621	10	13A	IN-VIP	41	6	6
TCCCGATCAGACGTAG-1_MS200_A303	-5.020280303	7.702651849	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	974	1356	0.012536873	0.028023599	10	oligos	OL-MS-1	41	6	6
TCCCGATCATTACCTT-1_MS200_A303	-31.23759993	-2.365977968	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1602	2825	0.006371681	0.006371681	10	9	OPC	41	6	6
TCCCGATGTAAGTAGT-1_MS200_A303	-30.52980001	-21.57355117	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	6189	20194	0.053431712	0.00866594	10	6A	IN-PV	41	6	6
TCCCGATGTAGGGACT-1_MS200_A303	-24.93961936	-18.65743577	6B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3402	7325	0.023754266	0.015017065	10	6B	IN-SST	41	6	6
TCCCGATGTCGGATCC-1_MS200_A303	-22.92199749	7.830117711	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1108	1690	0.001775148	0.010650888	10	8	Astrocytes	41	6	6
TCGAGGCAGCTAGCCC-1_MS200_A303	33.98901665	-18.07292188	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4676	11072	0.016437861	0.018695809	10	2	EN-L4	41	6	6
TCGAGGCCACTTCGAA-1_MS200_A303	-17.71950828	-4.751445063	13B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2799	5712	0.027310924	0.004376751	10	13B	IN-SV2C	41	6	6
TCGAGGCCATGACGGA-1_MS200_A303	-13.86517645	23.685161	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1813	3118	0.015715202	0.015394484	10	8	Astrocytes	41	6	6
TCGAGGCGTAAGCACG-1_MS200_A303	-24.87215212	-19.81815002	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3457	7206	0.033721898	0.00513461	10	6A	IN-PV	41	6	6
TCGAGGCGTAGCACGA-1_MS200_A303	11.77147723	-23.02589217	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4029	10252	0.004096762	0.007315646	10	L2-3	EN-L2-3-MS	41	6	6
TCGAGGCGTCCTCCAT-1_MS200_A303	-12.53983232	17.89395572	11	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2270	3863	0.007765985	0.020450427	10	11	Glia-MIX	41	6	6
TCGAGGCGTGAGTATA-1_MS200_A303	-11.31887739	-7.477273068	13B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1829	3049	0.042964907	0.004919646	10	13B	IN-SV2C	41	6	6
TCGAGGCTCAACACGT-1_MS200_A303	-17.98916718	-14.32123812	6B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2187	3939	0.017009393	0.015232292	10	6B	IN-SST	41	6	6
TCGAGGCTCCAAGTAC-1_MS200_A303	-11.53805321	28.32979728	17	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1166	1609	0.042883779	0.021131137	10	oligos	OL-MS-2	41	6	6
TCGAGGCTCTGGCGTG-1_MS200_A303	32.72661097	-19.14976394	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3051	5398	0.022971471	0.023341979	10	2	EN-L4	41	6	6
TCGCGAGGTACATCCA-1_MS200_A303	9.397557072	-12.45686157	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2435	4597	0.013487057	0.022405917	10	L2-3	EN-L2-3-MS	41	6	6
TCGCGAGTCACATAGC-1_MS200_A303	-8.756032934	-15.07956552	6B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	742	1080	0.118518519	0.012962963	10	6B	IN-SST	41	6	6
TCGCGAGTCCTTTACA-1_MS200_A303	14.53648088	-13.17237148	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4825	11869	0.012048193	0.015755329	10	L2-3	EN-L2-3-MS	41	6	6
TCGCGAGTCGGGAGTA-1_MS200_A303	14.77658461	-21.25956988	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5887	17386	0.006959623	0.007649833	10	L2-3	EN-L2-3-MS	41	6	6
TCGCGAGTCTCTGCTG-1_MS200_A303	-30.6426912	-11.48907364	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	869	1314	0.00456621	0.005327245	10	9	OPC	41	6	6
TCGCGTTAGTGAACAT-1_MS200_A303	-24.43695633	6.526465813	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	764	1121	0.008920607	0.009812667	10	8	Astrocytes	41	6	6
TCGCGTTCACACCGAC-1_MS200_A303	-24.13553569	8.505804437	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1042	1591	0.001257071	0.021370207	10	8	Astrocytes	41	6	6
TCGCGTTCATTATCTC-1_MS200_A303	27.51876846	0.562971015	10	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4700	13827	0.00224199	0.001952701	10	L2-3	EN-L2-3-Cntl	41	6	6
TCGCGTTCATTCGACA-1_MS200_A303	-10.20216143	23.21011381	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2663	4745	0.004214963	0.013277134	10	8	Astrocytes	41	6	6
TCGCGTTGTGCGATAG-1_MS200_A303	-28.9456716	-4.608986324	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1201	1731	0.005199307	0.020797227	10	9	OPC	41	6	6
TCGCGTTTCAGTGCAT-1_MS200_A303	16.50026892	-10.22311025	3	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2658	5321	0.066340913	0.003946627	10	3	EN-L5-6	41	6	6
TCGCGTTTCAGTTGAC-1_MS200_A303	-26.48251125	-1.543507464	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1830	3022	0.006618134	0.018861681	10	9	OPC	41	6	6
TCGCGTTTCATCGGAT-1_MS200_A303	10.40008742	-19.17772068	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4962	14191	0.006835318	0.005355507	10	L2-3	EN-L2-3-MS	41	6	6
TCGCGTTTCTTCATGT-1_MS200_A303	-5.743700696	15.02259953	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	844	1232	0.00974026	0.012175325	10	oligos	OL-MS-1	41	6	6
TCGGGACAGCTAGTGG-1_MS200_A303	-15.2714375	21.95188108	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1460	2373	0.000421408	0.007163928	10	8	Astrocytes	41	6	6
TCGGGACCAGTCCTTC-1_MS200_A303	34.76402983	11.4586638	14	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	907	1209	0.009098428	0.023159636	10	14	Microglia	41	6	6
TCGGGACGTCCGAAGA-1_MS200_A303	-5.369699582	15.42116222	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	902	1299	0.004618938	0.014626636	10	oligos	OL-MS-1	41	6	6
TCGGGACTCACCTCGT-1_MS200_A303	18.38120446	-13.78862386	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	6312	18911	0.025699328	0.012056475	10	L2-3	EN-L2-3-MS	41	6	6
TCGGGACTCTGGCGAC-1_MS200_A303	-11.66930664	-4.954352222	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1962	3171	0.010406812	0.007253232	10	13A	IN-VIP	41	6	6
TCGGTAACAAGCCGCT-1_MS200_A303	28.51211528	-14.10818955	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5695	15958	0.012031583	0.009963655	10	2	EN-L4	41	6	6
TCGGTAACACTCAGGC-1_MS200_A303	-4.243337892	-33.13679997	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	758	1089	0.17630854	0.019283747	10	16	EN-PYR	41	6	6
TCGGTAACATTCACTT-1_MS200_A303	-14.48773468	23.66164125	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1808	3141	0.004775549	0.009551098	10	8	Astrocytes	41	6	6
TCGGTAAGTCCAGTAT-1_MS200_A303	9.463455052	-1.917395528	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1445	2420	0.155785124	0.006198347	10	12	EN-MIX	41	6	6
TCGGTAAGTGCTGTAT-1_MS200_A303	-16.7284801	-3.914885007	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2625	4972	0.031777957	0.006637168	10	13A	IN-VIP	41	6	6
TCGGTAATCCCTAACC-1_MS200_A303	-6.735959981	-33.60858752	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	807	1040	0.077884615	0.011538462	10	16	EN-PYR	41	6	6
TCGGTAATCTCATTCA-1_MS200_A303	12.27099454	11.63705095	1	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1297	2097	0.007629948	0.003814974	10	oligos	OL-Cntl	41	6	6
TCGTACCTCACGCATA-1_MS200_A303	-14.45716673	22.25256663	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1569	2531	0.003555907	0.01066772	10	8	Astrocytes	41	6	6
TCGTACCTCGTCACGG-1_MS200_A303	-24.46223226	6.361779485	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	743	1039	0.006737247	0.00481232	10	8	Astrocytes	41	6	6
TCGTAGACAGGTTTCA-1_MS200_A303	-26.93206315	-11.00538147	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	864	1190	0.005882353	0.01512605	10	9	OPC	41	6	6
TCGTAGAGTGCTCTTC-1_MS200_A303	-2.526935201	21.54927903	1	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	752	1043	0.005752637	0.015340364	10	oligos	OL-Cntl	41	6	6
TCGTAGAGTTTGGGCC-1_MS200_A303	-9.597122024	27.75800774	17	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	865	1134	0.007054674	0.014109347	10	oligos	OL-MS-2	41	6	6
TCTATTGCAAGTTCTG-1_MS200_A303	-11.4000621	28.71198837	17	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1366	1889	0.022233986	0.013234516	10	oligos	OL-MS-2	41	6	6
TCTATTGCACACTGCG-1_MS200_A303	-4.056676161	19.7209191	1	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	737	1096	0.000912409	0.005474453	10	oligos	OL-Cntl	41	6	6
TCTATTGTCAGCAACT-1_MS200_A303	29.58219135	14.75212905	14	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1137	1902	0.000525762	0.095688749	10	14	Microglia	41	6	6
TCTATTGTCCGAATGT-1_MS200_A303	7.29131042	12.65494839	1	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1150	1872	0.005876068	0.010149573	10	oligos	OL-Cntl	41	6	6
TCTATTGTCCTAGTGA-1_MS200_A303	-30.94484816	-11.71558495	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	768	1093	0.004574565	0.010978957	10	9	OPC	41	6	6
TCTCATAAGTCGATAA-1_MS200_A303	-24.32069482	-19.65897779	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2947	6053	0.011564513	0.009416818	10	6A	IN-PV	41	6	6
TCTCATAGTTCCGTCT-1_MS200_A303	-11.59759409	-29.31045646	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1268	1831	0.036045877	0.021845986	10	16	EN-PYR	41	6	6
TCTCATATCACCGTAA-1_MS200_A303	-4.366124228	-36.65621706	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	893	1194	0.079564489	0.025963149	10	16	EN-PYR	41	6	6
TCTCATATCGCCAGCA-1_MS200_A303	-19.71735694	-5.835030363	13B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3994	9730	0.029290853	0.006166495	10	13B	IN-SV2C	41	6	6
TCTCATATCGGCCGAT-1_MS200_A303	-19.66355289	-1.626555326	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5025	13231	0.007558008	0.012773033	10	13A	IN-VIP	41	6	6
TCTCTAAAGGGCATGT-1_MS200_A303	16.30907229	-14.63085323	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	6211	19402	0.019688692	0.005772601	10	L2-3	EN-L2-3-MS	41	6	6
TCTCTAACACCCAGTG-1_MS200_A303	-29.2988939	-9.495092059	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1091	1648	0.007281553	0.031553398	10	9	OPC	41	6	6
TCTCTAACAGTGGAGT-1_MS200_A303	2.293234627	4.538631768	14	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	895	1104	0.011775362	0.008152174	10	14	Microglia	41	6	6
TCTCTAAGTGACGGTA-1_MS200_A303	-17.54123255	20.50466008	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1212	1955	0.003580563	0.006138107	10	8	Astrocytes	41	6	6
TCTCTAAGTTCCACAA-1_MS200_A303	29.73199119	-18.5537935	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5902	17816	0.029748541	0.011169735	10	2	EN-L4	41	6	6
TCTCTAATCATGTCCC-1_MS200_A303	-20.59602858	23.60896027	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1532	2726	0.007336757	0.008437271	10	8	Astrocytes	41	6	6
TCTCTAATCGAATCCA-1_MS200_A303	16.84373053	-9.805401848	3	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2225	4211	0.010686298	0.004511992	10	3	EN-L5-6	41	6	6
TCTCTAATCGTAGGAG-1_MS200_A303	-5.053549429	-36.27414888	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	808	1056	0.041666667	0.016098485	10	16	EN-PYR	41	6	6
TCTCTAATCTAACTTC-1_MS200_A303	-6.99121365	-36.02155292	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	985	1320	0.059848485	0.018939394	10	16	EN-PYR	41	6	6
TCTGAGAAGCCACCTG-1_MS200_A303	-5.298263685	13.28850148	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	809	1094	0.009140768	0.031078611	10	oligos	OL-MS-1	41	6	6
TCTGAGAAGTGGTAGC-1_MS200_A303	-24.16414308	10.20574737	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	995	1493	0.004018754	0.01138647	10	8	Astrocytes	41	6	6
TCTGAGACACTAGTAC-1_MS200_A303	-27.19367253	4.698882432	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2462	4670	0.004925054	0.005353319	10	8	Astrocytes	41	6	6
TCTGAGAGTAAATGTG-1_MS200_A303	2.777110969	10.59696678	1	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1091	1635	0.006727829	0.014067278	10	oligos	OL-Cntl	41	6	6
TCTGAGAGTAAGTAGT-1_MS200_A303	-24.32862832	6.413586169	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	785	1091	0.006416132	0.016498625	10	8	Astrocytes	41	6	6
TCTGAGAGTACTCTCC-1_MS200_A303	-34.79857629	-1.529322194	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1563	2946	0.00407332	0.003733876	10	9	OPC	41	6	6
TCTGAGATCCTCCTAG-1_MS200_A303	-13.53116965	22.33683347	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1559	2628	0.001141553	0.017884323	10	8	Astrocytes	41	6	6
TCTGGAACACAGACTT-1_MS200_A303	-6.869796368	14.39338228	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	957	1353	0.00443459	0.013303769	10	oligos	OL-MS-1	41	6	6
TCTGGAAGTACCGCTG-1_MS200_A303	-6.491404299	12.71208017	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	795	1041	0.011527378	0.029779059	10	oligos	OL-MS-1	41	6	6
TCTGGAAGTCTGATTG-1_MS200_A303	-11.58519801	-29.52123386	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1340	2012	0.108846918	0.011928429	10	16	EN-PYR	41	6	6
TCTGGAAGTTTGTTTC-1_MS200_A303	-13.69253005	22.47755145	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1357	2139	0.007947639	0.024310425	10	8	Astrocytes	41	6	6
TCTGGAATCAACCATG-1_MS200_A303	-23.77177391	9.598671111	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1064	1619	0.009264978	0.011735639	10	8	Astrocytes	41	6	6
TCTGGAATCTGTCTAT-1_MS200_A303	-16.80626302	-2.612203923	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2590	4554	0.01163812	0.007685551	10	13A	IN-VIP	41	6	6
TCTTCGGAGAAAGTGG-1_MS200_A303	-18.25522279	6.342725167	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1148	2197	0.003641329	0.003186163	10	8	Astrocytes	41	6	6
TCTTCGGAGACAAAGG-1_MS200_A303	10.46768174	-0.02600123	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1188	1869	0.147672552	0.009630819	10	12	EN-MIX	41	6	6
TCTTCGGCAACTTGAC-1_MS200_A303	13.20123274	-9.529725731	3	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2697	5093	0.012958963	0.007461221	10	3	EN-L5-6	41	6	6
TCTTCGGCAGATGGGT-1_MS200_A303	35.88645858	-11.58934564	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5134	12368	0.013745149	0.014472833	10	2	EN-L4	41	6	6
TCTTCGGGTCGAATCT-1_MS200_A303	-6.883053137	13.5138203	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	804	1136	0.017605634	0.014084507	10	oligos	OL-MS-1	41	6	6
TCTTCGGGTCTCTCGT-1_MS200_A303	9.673127069	-11.67962235	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2771	5566	0.011318721	0.005928854	10	L2-3	EN-L2-3-MS	41	6	6
TCTTCGGGTGTGCGTC-1_MS200_A303	14.30613186	-11.92669627	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3664	8175	0.031926606	0.016024465	10	L2-3	EN-L2-3-MS	41	6	6
TCTTCGGTCACCGTAA-1_MS200_A303	-16.07815994	-1.795136111	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2951	5728	0.016759777	0.015363128	10	13A	IN-VIP	41	6	6
TCTTTCCCACACCGAC-1_MS200_A303	9.261209447	-11.57877238	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2547	5108	0.059514487	0.007439311	10	L2-3	EN-L2-3-MS	41	6	6
TCTTTCCCACATCTTT-1_MS200_A303	-27.68157752	-22.86321137	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5624	15737	0.016267395	0.011056745	10	6A	IN-PV	41	6	6
TCTTTCCCACTTACGA-1_MS200_A303	-13.50185193	-37.0884273	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1745	2872	0.079387187	0.012534819	10	16	EN-PYR	41	6	6
TCTTTCCCATGCCTAA-1_MS200_A303	-14.54907715	25.10816369	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2030	3895	0.007188703	0.01309371	10	8	Astrocytes	41	6	6
TCTTTCCGTACCGGCT-1_MS200_A303	-16.74988254	20.61186112	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1439	2525	0.004356436	0.00950495	10	8	Astrocytes	41	6	6
TCTTTCCGTACGCACC-1_MS200_A303	-15.54310936	24.97911241	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1905	3687	0.003525902	0.005424464	10	8	Astrocytes	41	6	6
TCTTTCCGTTATTCTC-1_MS200_A303	-4.483828932	-7.054145782	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	898	1428	0.011204482	0.00280112	10	13A	IN-VIP	41	6	6
TCTTTCCTCAACGGCC-1_MS200_A303	21.37991789	-12.87574811	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2842	5957	0.061776062	0.004364613	10	2	EN-L4	41	6	6
TCTTTCCTCAGTTCGA-1_MS200_A303	-6.221483193	-1.500718405	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1675	3149	0.00285805	0.004445856	10	13A	IN-VIP	41	6	6
TCTTTCCTCGCAAACT-1_MS200_A303	9.529830422	-20.12494138	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4642	13519	0.004512168	0.004660108	10	L2-3	EN-L2-3-MS	41	6	6
TGAAAGAAGACAAAGG-1_MS200_A303	13.88947693	-16.14488528	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	6028	18749	0.010347219	0.006186997	10	L2-3	EN-L2-3-MS	41	6	6
TGAAAGAAGTGCGTGA-1_MS200_A303	18.23707785	-22.60800424	3	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3926	8415	0.007843137	0.019370172	10	3	EN-L5-6	41	6	6
TGAAAGACAACTGCGC-1_MS200_A303	15.96639103	-9.777402467	3	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2200	4423	0.077096993	0.003391363	10	3	EN-L5-6	41	6	6
TGAAAGACAGACACTT-1_MS200_A303	17.10645093	-4.824930498	3	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1438	2684	0.085320417	0.003353204	10	3	EN-L5-6	41	6	6
TGAAAGACAGGATTGG-1_MS200_A303	-15.12191001	25.21613295	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2246	3942	0.00608828	0.004058853	10	8	Astrocytes	41	6	6
TGAAAGAGTCCGTTAA-1_MS200_A303	-26.5644965	1.711825231	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1731	2613	0.005357826	0.010715653	10	9	OPC	41	6	6
TGAAAGAGTTACCGAT-1_MS200_A303	-11.84698451	-38.11309045	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1558	2353	0.050573736	0.021249469	10	16	EN-PYR	41	6	6
TGAAAGATCCTAGTGA-1_MS200_A303	5.918263807	0.400452275	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1028	1604	0.020573566	0.013092269	10	16	EN-PYR	41	6	6
TGAAAGATCGCCAGCA-1_MS200_A303	-5.336529699	13.47985852	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	789	1143	0.01399825	0.0279965	10	oligos	OL-MS-1	41	6	6
TGAAAGATCTCGCATC-1_MS200_A303	30.36295541	-18.45686749	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	6453	20952	0.026011837	0.010404735	10	2	EN-L4	41	6	6
TGACAACAGAATCTCC-1_MS200_A303	16.60213613	-9.846815757	3	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2620	5338	0.013488198	0.005994755	10	3	EN-L5-6	41	6	6
TGACAACAGCCTATGT-1_MS200_A303	-10.04635675	-15.18823011	6B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	914	1346	0.049777117	0.008915305	10	6B	IN-SST	41	6	6
TGACAACCACCACCAG-1_MS200_A303	-3.887176473	-33.16158757	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	809	1084	0.098708487	0.015682657	10	16	EN-PYR	41	6	6
TGACAACTCACGATGT-1_MS200_A303	17.61425681	-13.48338632	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	6322	19856	0.027044722	0.0115834	10	L2-3	EN-L2-3-MS	41	6	6
TGACAACTCTCGGACG-1_MS200_A303	-14.19551376	22.57087514	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1513	2479	0.012101654	0.014118596	10	8	Astrocytes	41	6	6
TGACGGCAGACTAGAT-1_MS200_A303	11.93385629	-12.79812625	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3405	6838	0.011406844	0.024129863	10	L2-3	EN-L2-3-MS	41	6	6
TGACGGCAGGGTTCCC-1_MS200_A303	-5.204899407	14.03408312	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	837	1198	0.008347245	0.013355593	10	oligos	OL-MS-1	41	6	6
TGACGGCCAAAGTCAA-1_MS200_A303	4.215045166	-2.613499484	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	910	1514	0.167767503	0.005944518	10	12	EN-MIX	41	6	6
TGACGGCCAACTTGAC-1_MS200_A303	-1.318433164	-0.961121801	11	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2375	4123	0.011642008	0.007518797	10	11	Glia-MIX	41	6	6
TGACGGCGTAAGTAGT-1_MS200_A303	29.72487954	13.90490618	14	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1126	1638	0.017094017	0.123321123	10	14	Microglia	41	6	6
TGACGGCGTCAACATC-1_MS200_A303	-16.52335296	19.70789902	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1183	1910	0.002094241	0.009424084	10	8	Astrocytes	41	6	6
TGACGGCGTCATGCCG-1_MS200_A303	-24.00366621	5.997062568	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	752	1035	0.008695652	0.010628019	10	8	Astrocytes	41	6	6
TGACGGCGTGCGAAAC-1_MS200_A303	32.7772201	8.355852746	14	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	789	1001	0.051948052	0.015984016	10	14	Microglia	41	6	6
TGACGGCTCGGAGCAA-1_MS200_A303	-12.90612628	-14.38743342	6B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1500	2348	0.006388416	0.010647359	10	6B	IN-SST	41	6	6
TGACTAGAGGATGGTC-1_MS200_A303	15.00787242	-17.82379525	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5782	15481	0.010206059	0.007040889	10	L2-3	EN-L2-3-MS	41	6	6
TGACTAGAGGCATGGT-1_MS200_A303	-18.90681688	-5.260738654	13B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2713	5174	0.031117124	0.005604948	10	13B	IN-SV2C	41	6	6
TGACTAGAGTGTGGCA-1_MS200_A303	-22.57021063	7.05067787	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1189	1804	0.006651885	0.029933481	10	8	Astrocytes	41	6	6
TGACTAGCAGCGATCC-1_MS200_A303	14.01051558	-16.2787028	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	7280	24983	0.010407077	0.007925389	10	L2-3	EN-L2-3-MS	41	6	6
TGACTAGGTAGTACCT-1_MS200_A303	-9.510431541	-4.82631754	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1680	2931	0.0139884	0.00682361	10	13A	IN-VIP	41	6	6
TGACTAGTCCGCTGTT-1_MS200_A303	-17.45977416	20.18847456	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1282	2116	0.002362949	0.009924386	10	8	Astrocytes	41	6	6
TGACTAGTCGCCTGAG-1_MS200_A303	33.87816878	-18.08277691	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5010	12481	0.014742408	0.012418877	10	2	EN-L4	41	6	6
TGACTAGTCTACCTGC-1_MS200_A303	13.99430219	-16.90322366	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	6869	23781	0.008536226	0.006601909	10	L2-3	EN-L2-3-MS	41	6	6
TGACTTTAGCTTTGGT-1_MS200_A303	-14.29269025	22.96835405	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1693	2788	0.006097561	0.014705882	10	8	Astrocytes	41	6	6
TGACTTTCACCAACCG-1_MS200_A303	23.53360528	-10.74734	3	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3649	9092	0.007479103	0.003519578	10	3	EN-L5-6	41	6	6
TGACTTTCACCTATCC-1_MS200_A303	-34.45821183	-4.508402607	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1251	2098	0.003336511	0.009056244	10	9	OPC	41	6	6
TGACTTTGTCTAGCGC-1_MS200_A303	-10.89254539	-4.171744263	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2023	3412	0.009671747	0.01084408	10	13A	IN-VIP	41	6	6
TGACTTTTCAACACTG-1_MS200_A303	-28.39103227	-6.525720357	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	991	1489	0.006715917	0.001343183	10	9	OPC	41	6	6
TGACTTTTCGGAGCAA-1_MS200_A303	3.748212785	-2.517013067	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	771	1067	0.025304592	0.009372071	10	12	EN-MIX	41	6	6
TGACTTTTCTTGAGAC-1_MS200_A303	-6.98414163	12.2644155	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	795	1096	0.020985401	0.017335766	10	oligos	OL-MS-1	41	6	6
TGAGAGGAGACAAGCC-1_MS200_A303	-9.05424651	-37.59100268	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1209	1709	0.053247513	0.016968988	10	16	EN-PYR	41	6	6
TGAGAGGAGTCATCCA-1_MS200_A303	10.46151021	-0.623623645	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1126	1776	0.113175676	0.011261261	10	12	EN-MIX	41	6	6
TGAGAGGAGTCCCACG-1_MS200_A303	8.19927578	-3.482635126	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2598	4573	0.005248196	0.017056637	10	2	EN-L4	41	6	6
TGAGAGGAGTGTACCT-1_MS200_A303	4.522386354	-14.7197351	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2740	5593	0.026819238	0.005006258	10	L2-3	EN-L2-3-MS	41	6	6
TGAGAGGCATTGGGCC-1_MS200_A303	6.943685154	-0.913678355	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	729	1169	0.21043627	0.009409752	10	12	EN-MIX	41	6	6
TGAGAGGGTGGTCCGT-1_MS200_A303	10.60814279	-11.53057724	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3167	6563	0.022550663	0.017065366	10	L2-3	EN-L2-3-MS	41	6	6
TGAGAGGGTTTGTTTC-1_MS200_A303	-15.95776856	23.2250288	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1283	2047	0.004396678	0.007327797	10	8	Astrocytes	41	6	6
TGAGAGGTCCGTACAA-1_MS200_A303	-4.151075225	-7.259010001	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	959	1573	0.034329307	0.003814367	10	13A	IN-VIP	41	6	6
TGAGCATAGTAGGCCA-1_MS200_A303	-21.49069803	-21.33149653	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2049	3824	0.00915272	0.007060669	10	6A	IN-PV	41	6	6
TGAGCATCAAATCCGT-1_MS200_A303	-29.02920315	-22.22639092	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5034	13426	0.037613586	0.009608223	10	6A	IN-PV	41	6	6
TGAGCATCAATAGCAA-1_MS200_A303	30.57558442	-18.80452404	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	7553	26727	0.018034198	0.015714446	10	2	EN-L4	41	6	6
TGAGCATCATTACCTT-1_MS200_A303	-13.63240341	-9.635934844	13B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2328	4701	0.001489045	0.004254414	10	13B	IN-SV2C	41	6	6
TGAGCATCATTGCGGC-1_MS200_A303	14.69726718	-13.73868393	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5006	12844	0.017284335	0.01035503	10	L2-3	EN-L2-3-MS	41	6	6
TGAGCATGTCTAGTCA-1_MS200_A303	-30.07384158	-21.70788577	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4234	9755	0.039671963	0.015889288	10	6A	IN-PV	41	6	6
TGAGCATGTGCACTTA-1_MS200_A303	-8.813203801	-15.07815127	6B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	751	1122	0.061497326	0.005347594	10	6B	IN-SST	41	6	6
TGAGCATTCATTATCC-1_MS200_A303	7.55016648	-10.09782628	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1829	3152	0.015545685	0.014911168	10	L2-3	EN-L2-3-MS	41	6	6
TGAGCATTCCTCAACC-1_MS200_A303	21.6622416	-14.41217793	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3212	7679	0.013934106	0.019143118	10	2	EN-L4	41	6	6
TGAGCATTCGCCTGTT-1_MS200_A303	-18.96778978	-5.646551577	13B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2949	5866	0.013296966	0.010057961	10	13B	IN-SV2C	41	6	6
TGAGCATTCTGACCTC-1_MS200_A303	9.530406436	1.494172584	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	748	1100	0.165454545	0.003636364	10	12	EN-MIX	41	6	6
TGAGCCGAGAGCCTAG-1_MS200_A303	-11.78505035	-27.37806414	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	794	1017	0.031465093	0.029498525	10	16	EN-PYR	41	6	6
TGAGCCGAGGTGCTTT-1_MS200_A303	-29.62414729	-12.01298955	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	741	1051	0.004757374	0.005708849	10	9	OPC	41	6	6
TGAGCCGAGTGACTCT-1_MS200_A303	-27.19185321	4.668856264	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2342	3887	0.005659892	0.009261641	10	8	Astrocytes	41	6	6
TGAGCCGCAACACCCG-1_MS200_A303	-14.20419772	24.24222673	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1861	3314	0.015691008	0.013880507	10	8	Astrocytes	41	6	6
TGAGCCGCAATAGCAA-1_MS200_A303	13.48488241	-16.06387221	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5908	16510	0.009812235	0.006480921	10	L2-3	EN-L2-3-MS	41	6	6
TGAGCCGGTCACTGGC-1_MS200_A303	16.46830434	-14.01261955	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5738	16805	0.020351086	0.007140732	10	L2-3	EN-L2-3-MS	41	6	6
TGAGCCGTCTACTTAC-1_MS200_A303	-6.741758022	13.70827348	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	740	1030	0.015533981	0.012621359	10	oligos	OL-MS-1	41	6	6
TGAGGGAAGGCACATG-1_MS200_A303	-23.94816722	8.183956042	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1091	1497	0.013360053	0.015364061	10	8	Astrocytes	41	6	6
TGAGGGAAGTCTCGGC-1_MS200_A303	-29.06529938	-1.590309929	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1624	2595	0.002312139	0.008477842	10	9	OPC	41	6	6
TGAGGGAAGTTAACGA-1_MS200_A303	-28.89883425	-5.751570581	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1138	1744	0.043004587	0.006307339	10	9	OPC	41	6	6
TGAGGGACAATGTAAG-1_MS200_A303	-7.93518122	-10.50394664	6B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1135	1666	0.019207683	0.018007203	10	6B	IN-SST	41	6	6
TGAGGGACATCAGTAC-1_MS200_A303	-24.86191555	-0.05747278	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1749	2673	0.003367003	0.01271979	10	9	OPC	41	6	6
TGAGGGAGTACTCGCG-1_MS200_A303	27.58634702	10.15192308	15A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1113	1784	0.014573991	0.112107623	10	15A	Endo cells	41	6	6
TGAGGGAGTGCAGGTA-1_MS200_A303	23.04745568	-16.37619459	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3952	7952	0.035211268	0.014964789	10	2	EN-L4	41	6	6
TGAGGGAGTTCCAACA-1_MS200_A303	-13.01684143	7.163716675	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	915	1130	0.015929204	0.016814159	10	16	EN-PYR	41	6	6
TGAGGGATCTATCCCG-1_MS200_A303	-19.55543143	-1.860583396	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3857	8137	0.025562247	0.014132973	10	13A	IN-VIP	41	6	6
TGAGGGATCTGAAAGA-1_MS200_A303	-19.09582301	-1.366709815	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3155	5578	0.021871639	0.019899606	10	13A	IN-VIP	41	6	6
TGATTTCAGACACGAC-1_MS200_A303	8.190281268	-12.25949926	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2477	5417	0.007384161	0.007753369	10	L2-3	EN-L2-3-MS	41	6	6
TGATTTCAGTCCCACG-1_MS200_A303	15.80455722	-7.340748852	3	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2000	3913	0.050089445	0.004088934	10	3	EN-L5-6	41	6	6
TGATTTCAGTGGGTTG-1_MS200_A303	-23.6238805	7.618410506	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	983	1431	0.004891684	0.01397624	10	8	Astrocytes	41	6	6
TGATTTCCAAAGCGGT-1_MS200_A303	12.29015585	-12.75574609	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3861	8914	0.024455912	0.017388378	10	L2-3	EN-L2-3-MS	41	6	6
TGATTTCCAAAGGAAG-1_MS200_A303	-1.211638621	19.27168158	1	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	808	1123	0.011576135	0.016918967	10	oligos	OL-Cntl	41	6	6
TGATTTCCAATGGAAT-1_MS200_A303	-19.80247231	5.838942795	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1018	1557	0.003853565	0.007064868	10	8	Astrocytes	41	6	6
TGATTTCCAGCTCGCA-1_MS200_A303	-13.45564114	22.21907389	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1686	2701	0.019252129	0.01369863	10	8	Astrocytes	41	6	6
TGATTTCGTGTAAGTA-1_MS200_A303	37.43098604	-9.64807151	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3773	8377	0.004297481	0.005013728	10	2	EN-L4	41	6	6
TGATTTCTCATCACCC-1_MS200_A303	-31.2990198	-8.63887172	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	871	1315	0.002281369	0.00608365	10	9	OPC	41	6	6
TGCACCTAGACCGGAT-1_MS200_A303	-23.64960247	9.267827199	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	923	1224	0.009803922	0.013071895	10	8	Astrocytes	41	6	6
TGCACCTAGAGGTAGA-1_MS200_A303	-20.75698414	4.328221788	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	964	1259	0.008737093	0.011914218	10	8	Astrocytes	41	6	6
TGCACCTAGGAACTGC-1_MS200_A303	34.16900393	-14.90511768	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4302	9866	0.011858909	0.009933104	10	2	EN-L4	41	6	6
TGCACCTAGGACAGCT-1_MS200_A303	-12.27654291	-14.12353425	6B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1347	2161	0.018972698	0.009717723	10	6B	IN-SST	41	6	6
TGCACCTCAACACCCG-1_MS200_A303	11.88404711	-18.47634047	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5174	14866	0.009619265	0.012982645	10	L2-3	EN-L2-3-MS	41	6	6
TGCACCTCAAGCGAGT-1_MS200_A303	-24.52533825	9.113001753	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1091	1702	0.007050529	0.009988249	10	8	Astrocytes	41	6	6
TGCACCTCAGCGATCC-1_MS200_A303	-4.590715964	19.97303965	1	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	755	1049	0.001906578	0.003813155	10	oligos	OL-Cntl	41	6	6
TGCACCTGTATATGGA-1_MS200_A303	21.19036607	-2.646149129	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1968	3528	0.05952381	0.004251701	10	2	EN-L4	41	6	6
TGCACCTGTCGCATCG-1_MS200_A303	-32.15647755	-5.571695018	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1214	1876	0.009594883	0.004797441	10	9	OPC	41	6	6
TGCACCTGTCGCTTTC-1_MS200_A303	17.31799405	-18.02580821	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4489	12058	0.037568419	0.005473545	10	L2-3	EN-L2-3-MS	41	6	6
TGCACCTTCCGCAGTG-1_MS200_A303	5.451771817	-2.829994018	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	968	1548	0.129198966	0.003875969	10	12	EN-MIX	41	6	6
TGCACCTTCTCCAACC-1_MS200_A303	12.05046712	-13.58292352	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3656	8154	0.0090753	0.01226392	10	L2-3	EN-L2-3-MS	41	6	6
TGCACCTTCTCCGGTT-1_MS200_A303	-10.87909822	-38.11882623	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1171	1632	0.022058824	0.020220588	10	16	EN-PYR	41	6	6
TGCCAAAAGACACGAC-1_MS200_A303	-19.54934944	-0.714803236	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5077	12377	0.014462309	0.017936495	10	13A	IN-VIP	41	6	6
TGCCAAAAGAGCTTCT-1_MS200_A303	30.38276188	-18.51218572	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	7133	24621	0.024897445	0.014256123	10	2	EN-L4	41	6	6
TGCCAAAAGGCCCGTT-1_MS200_A303	-15.94380737	23.34976324	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1474	2468	0.001620746	0.011750405	10	8	Astrocytes	41	6	6
TGCCAAAAGGGTATCG-1_MS200_A303	-30.51225991	-21.34507052	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3761	7414	0.024683032	0.026301592	10	6A	IN-PV	41	6	6
TGCCAAAAGGGTGTGT-1_MS200_A303	4.5152384	0.509370254	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1326	2213	0.209218256	0.00858563	10	16	EN-PYR	41	6	6
TGCCAAACACCACCAG-1_MS200_A303	12.3259906	-17.42260538	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5946	17741	0.009018657	0.00682036	10	L2-3	EN-L2-3-MS	41	6	6
TGCCAAACAGCAGTTT-1_MS200_A303	14.05622117	-4.78910494	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1761	3412	0.082942556	0.005861665	10	12	EN-MIX	41	6	6
TGCCAAAGTTGAGTTC-1_MS200_A303	15.0529495	-14.97625381	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5666	16788	0.013998094	0.00702883	10	L2-3	EN-L2-3-MS	41	6	6
TGCCAAATCTTTACGT-1_MS200_A303	12.77674454	-19.28286787	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5878	20169	0.009271655	0.00669344	10	L2-3	EN-L2-3-MS	41	6	6
TGCCCATAGAGCTTCT-1_MS200_A303	-16.24890004	-1.763005252	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2585	4799	0.019795791	0.011252344	10	13A	IN-VIP	41	6	6
TGCCCATAGCCCAGCT-1_MS200_A303	-5.080887417	14.68014209	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	826	1162	0.006024096	0.01979346	10	oligos	OL-MS-1	41	6	6
TGCCCATCATATGCTG-1_MS200_A303	-11.77760801	-3.239872143	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2423	4514	0.01838724	0.009525919	10	13A	IN-VIP	41	6	6
TGCCCATCATGCATGT-1_MS200_A303	8.086062592	0.330574619	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1044	1433	0.011863224	0.028611305	10	16	EN-PYR	41	6	6
TGCCCATGTCCAGTGC-1_MS200_A303	3.511763453	-16.78142573	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2727	5439	0.010112153	0.004228719	10	L2-3	EN-L2-3-MS	41	6	6
TGCCCATTCATCGGAT-1_MS200_A303	-24.16783943	9.045706613	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1179	1878	0.00372737	0.009052183	10	8	Astrocytes	41	6	6
TGCCCATTCCTAGAAC-1_MS200_A303	30.15121411	-18.62257092	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	9274	45084	0.017877739	0.010890782	10	2	EN-L4	41	6	6
TGCCCATTCTAACCGA-1_MS200_A303	-6.472764527	15.11328057	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	983	1352	0.017751479	0.015532544	10	oligos	OL-MS-1	41	6	6
TGCCCTACAGCAGTTT-1_MS200_A303	-14.46605155	24.65288009	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1968	3685	0.004070556	0.011126187	10	8	Astrocytes	41	6	6
TGCCCTACATATACGC-1_MS200_A303	-13.96543296	-0.302516577	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3449	7529	0.007570727	0.007703546	10	13A	IN-VIP	41	6	6
TGCCCTACATTAGCCA-1_MS200_A303	2.602596907	10.31869013	1	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1133	1800	0.002222222	0.014444444	10	oligos	OL-Cntl	41	6	6
TGCCCTACATTGCGGC-1_MS200_A303	-11.88097025	-27.40654378	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	975	1284	0.028037383	0.037383178	10	16	EN-PYR	41	6	6
TGCCCTAGTACAGCAG-1_MS200_A303	-29.42394005	-4.800281908	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1303	1982	0.007063572	0.008577195	10	9	OPC	41	6	6
TGCCCTAGTAGAGGAA-1_MS200_A303	12.57900939	-14.92554816	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4464	11869	0.021147527	0.007582779	10	L2-3	EN-L2-3-MS	41	6	6
TGCCCTATCGGAGCAA-1_MS200_A303	-18.77472616	-1.794970747	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3138	6102	0.016879712	0.015896427	10	13A	IN-VIP	41	6	6
TGCGCAGAGGTGACCA-1_MS200_A303	-17.59683281	-1.371244954	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3108	6107	0.008351073	0.01457344	10	13A	IN-VIP	41	6	6
TGCGCAGAGTGTGAAT-1_MS200_A303	33.93824243	-3.057199834	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2577	5320	0.003195489	0.005827068	10	2	EN-L4	41	6	6
TGCGCAGAGTTGCAGG-1_MS200_A303	33.73630394	-17.30242205	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4449	10308	0.011253395	0.023379899	10	2	EN-L4	41	6	6
TGCGCAGGTGTGACCC-1_MS200_A303	-23.42776877	8.845999342	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1031	1437	0.011134308	0.020180932	10	8	Astrocytes	41	6	6
TGCGCAGGTTGCCTCT-1_MS200_A303	-8.856546322	-36.6003057	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1087	1493	0.038178165	0.016075017	10	16	EN-PYR	41	6	6
TGCGCAGTCCTTTACA-1_MS200_A303	13.62902503	-27.37334971	3	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2773	6381	0.04090268	0.004858173	10	3	EN-L5-6	41	6	6
TGCGGGTAGACATAAC-1_MS200_A303	-21.55483103	6.512027881	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1237	1881	0.005316321	0.013822435	10	8	Astrocytes	41	6	6
TGCGGGTAGAGGTTGC-1_MS200_A303	-8.578730479	-37.55698455	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1062	1437	0.054279749	0.022964509	10	16	EN-PYR	41	6	6
TGCGGGTAGTCTTGCA-1_MS200_A303	-31.06626764	-6.228923928	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1159	1694	0.002361275	0.011806375	10	9	OPC	41	6	6
TGCGGGTCAACACCCG-1_MS200_A303	-9.597523973	-37.33040849	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1285	1835	0.038692098	0.011989101	10	16	EN-PYR	41	6	6
TGCGGGTTCGCCGTGA-1_MS200_A303	-24.12241323	7.853643816	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	948	1340	0.007462687	0.009701493	10	8	Astrocytes	41	6	6
TGCGGGTTCTTGCAAG-1_MS200_A303	8.528287058	-19.8461771	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	6276	18255	0.004382361	0.020980553	10	L2-3	EN-L2-3-MS	41	6	6
TGCGTGGCAGTATGCT-1_MS200_A303	-30.97291867	-8.304518542	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	945	1445	0.003460208	0.009688581	10	9	OPC	41	6	6
TGCGTGGTCATCACCC-1_MS200_A303	-5.917718477	13.32447595	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	808	1099	0.004549591	0.027297543	10	oligos	OL-MS-1	41	6	6
TGCGTGGTCTCCCTGA-1_MS200_A303	-5.611560367	13.02688044	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	787	1087	0.005519779	0.022079117	10	oligos	OL-MS-1	41	6	6
TGCGTGGTCTGCCCTA-1_MS200_A303	-5.536089049	14.2217441	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	762	1111	0.01980198	0.01350135	10	oligos	OL-MS-1	41	6	6
TGCTACCAGACTTGAA-1_MS200_A303	35.60059698	-7.213463192	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3748	8505	0.003527337	0.008230453	10	2	EN-L4	41	6	6
TGCTACCAGCAGGTCA-1_MS200_A303	14.06084668	-13.09125844	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4733	11785	0.010267289	0.015697921	10	L2-3	EN-L2-3-MS	41	6	6
TGCTACCAGTCGTACT-1_MS200_A303	-29.10274097	-3.277017426	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1383	2162	0.005087882	0.008788159	10	9	OPC	41	6	6
TGCTACCCAAGCCATT-1_MS200_A303	1.360954445	10.60116799	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1007	1436	0.012534819	0.016016713	10	oligos	OL-MS-1	41	6	6
TGCTACCCAAGGTTCT-1_MS200_A303	3.96279878	-16.20776757	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3128	7399	0.008379511	0.005270983	10	L2-3	EN-L2-3-MS	41	6	6
TGCTACCCAATGGATA-1_MS200_A303	-4.887422274	-3.139825998	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1577	2725	0.011743119	0.004036697	10	13A	IN-VIP	41	6	6
TGCTACCCACACAGAG-1_MS200_A303	1.697999535	10.58219232	1	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1022	1539	0.006497726	0.013645224	10	oligos	OL-Cntl	41	6	6
TGCTACCGTATAATGG-1_MS200_A303	33.69788276	-16.88381019	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5233	13401	0.012312514	0.014998881	10	2	EN-L4	41	6	6
TGCTACCGTATATGAG-1_MS200_A303	11.85451875	-24.13331364	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	6365	21650	0.00591224	0.005681293	10	L2-3	EN-L2-3-MS	41	6	6
TGCTACCGTCTCTCGT-1_MS200_A303	18.64956781	-13.76463961	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	8268	33887	0.025850621	0.013131879	10	L2-3	EN-L2-3-MS	41	6	6
TGCTACCGTCTTCGTC-1_MS200_A303	-16.2945969	23.18043244	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1319	2335	0.002997859	0.00385439	10	8	Astrocytes	41	6	6
TGCTACCGTTTGGGCC-1_MS200_A303	-32.21949219	-10.8972524	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	873	1317	0.003037206	0.003796507	10	9	OPC	41	6	6
TGCTACCTCCAAATGC-1_MS200_A303	-14.38709112	22.88639707	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1633	2971	0.007068327	0.011780545	10	8	Astrocytes	41	6	6
TGCTGCTCATTATCTC-1_MS200_A303	-32.23535728	-5.357355726	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1253	1979	0.00707428	0.010106114	10	9	OPC	41	6	6
TGCTGCTCATTCTCAT-1_MS200_A303	-18.56194735	0.146474443	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4573	10696	0.014771877	0.017950636	10	13A	IN-VIP	41	6	6
TGCTGCTGTCAAAGCG-1_MS200_A303	-5.031295751	-34.92671445	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	765	1016	0.107283465	0.011811024	10	16	EN-PYR	41	6	6
TGCTGCTGTCGGGTCT-1_MS200_A303	-11.65362886	28.33512841	17	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1595	2399	0.033764068	0.020842018	10	oligos	OL-MS-2	41	6	6
TGCTGCTGTGCAGTAG-1_MS200_A303	-15.08690077	24.01605722	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1745	2962	0.001350439	0.010465901	10	8	Astrocytes	41	6	6
TGCTGCTGTGGAAAGA-1_MS200_A303	-24.45833603	8.697583393	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1070	1625	0.008615385	0.012923077	10	8	Astrocytes	41	6	6
TGCTGCTGTTACCGAT-1_MS200_A303	-6.308967021	10.61850326	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	723	1010	0.028712871	0.032673267	10	oligos	OL-MS-1	41	6	6
TGCTGCTTCAGTCCCT-1_MS200_A303	23.31680291	-24.87129782	3	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3535	8537	0.011830854	0.004334075	10	3	EN-L5-6	41	6	6
TGGACGCAGAAGAAGC-1_MS200_A303	33.71456979	-18.43240801	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3604	7139	0.023252556	0.013587337	10	2	EN-L4	41	6	6
TGGACGCAGAATAGGG-1_MS200_A303	-6.085838964	-36.28262827	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	906	1219	0.066447908	0.014766202	10	16	EN-PYR	41	6	6
TGGACGCAGGCATGTG-1_MS200_A303	-29.02461254	-20.98807915	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3266	6709	0.031450291	0.011924281	10	6A	IN-PV	41	6	6
TGGACGCAGGTCGGAT-1_MS200_A303	-6.334441838	12.74905485	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	815	1071	0.005602241	0.025210084	10	oligos	OL-MS-1	41	6	6
TGGACGCCAATAGAGT-1_MS200_A303	16.69202084	-14.33807776	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4593	11178	0.015208445	0.00867776	10	L2-3	EN-L2-3-MS	41	6	6
TGGACGCCATCACGTA-1_MS200_A303	28.31297333	-18.00412303	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	6445	20947	0.033799589	0.009404688	10	2	EN-L4	41	6	6
TGGACGCGTTATCGGT-1_MS200_A303	-10.88588789	-3.380523642	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1964	3451	0.022602144	0.008693132	10	13A	IN-VIP	41	6	6
TGGACGCTCAGGCAAG-1_MS200_A303	-17.48715391	-2.133825132	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3085	5792	0.017783149	0.009150552	10	13A	IN-VIP	41	6	6
TGGACGCTCGAGAACG-1_MS200_A303	-15.11294152	21.58500049	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1143	1826	0.003833516	0.013691128	10	8	Astrocytes	41	6	6
TGGACGCTCGATCCCT-1_MS200_A303	-14.2533936	22.00186604	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1422	2202	0.002724796	0.015894641	10	8	Astrocytes	41	6	6
TGGACGCTCTAACTGG-1_MS200_A303	28.90849707	-18.64878051	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	7390	27785	0.037898146	0.010437286	10	2	EN-L4	41	6	6
TGGCCAGAGGACGAAA-1_MS200_A303	20.88926894	-2.345203293	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1673	2853	0.046267087	0.003855591	10	2	EN-L4	41	6	6
TGGCCAGCAAGAGTCG-1_MS200_A303	-10.43793007	-7.533344799	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1837	2813	0.011375755	0.008887309	10	13A	IN-VIP	41	6	6
TGGCCAGCAATAGCAA-1_MS200_A303	-14.77138644	24.09814599	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1665	2684	0.006706408	0.013412817	10	8	Astrocytes	41	6	6
TGGCCAGCACAGACAG-1_MS200_A303	-30.24975146	-21.43288395	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	6566	23558	0.058196791	0.006961542	10	6A	IN-PV	41	6	6
TGGCCAGGTAGCGTAG-1_MS200_A303	-16.70240742	-1.713853453	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2564	4484	0.009589652	0.018287244	10	13A	IN-VIP	41	6	6
TGGCCAGGTCCATGAT-1_MS200_A303	-28.84959571	-20.61444475	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3437	7339	0.024799019	0.011990734	10	6A	IN-PV	41	6	6
TGGCCAGGTTCTGGTA-1_MS200_A303	28.14435416	-13.69220054	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5810	18238	0.025002742	0.007402127	10	2	EN-L4	41	6	6
TGGCCAGTCATTCACT-1_MS200_A303	11.131891	-18.17047111	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5783	18989	0.009637158	0.006898731	10	L2-3	EN-L2-3-MS	41	6	6
TGGCGCAAGACTAGAT-1_MS200_A303	11.71532586	-11.54580044	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3087	6063	0.009071417	0.014514267	10	L2-3	EN-L2-3-MS	41	6	6
TGGCGCAAGCCAGGAT-1_MS200_A303	33.36788151	-11.72882542	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2549	4714	0.012940178	0.008061095	10	2	EN-L4	41	6	6
TGGCGCAAGGATGTAT-1_MS200_A303	-5.362112092	14.47794013	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	880	1209	0.004962779	0.023986766	10	oligos	OL-MS-1	41	6	6
TGGCGCAAGTGACATA-1_MS200_A303	4.692559059	11.71968843	1	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1103	1676	0.006563246	0.017303103	10	oligos	OL-Cntl	41	6	6
TGGCGCACAACGATCT-1_MS200_A303	-5.878756415	14.09205414	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	841	1231	0.004061738	0.021933387	10	oligos	OL-MS-1	41	6	6
TGGCGCACAGTCGTGC-1_MS200_A303	-4.344144681	19.33440708	1	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	772	1019	0.009813543	0.007850834	10	oligos	OL-Cntl	41	6	6
TGGCGCAGTTGAGGTG-1_MS200_A303	-14.32672589	23.76611538	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1642	2952	0.003726287	0.014566396	10	8	Astrocytes	41	6	6
TGGCGCATCAGTCAGT-1_MS200_A303	-14.27933474	23.4099665	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1645	2845	0.005623902	0.009841828	10	8	Astrocytes	41	6	6
TGGCGCATCCTGCCAT-1_MS200_A303	19.70294348	-0.88233138	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1356	2271	0.043152796	0.012769705	10	12	EN-MIX	41	6	6
TGGCGCATCGTTTATC-1_MS200_A303	-30.21039664	-21.95651011	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	7107	23054	0.023423267	0.012579162	10	6A	IN-PV	41	6	6
TGGCTGGAGCTGCCCA-1_MS200_A303	-16.3086058	20.32330166	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1766	2779	0.005757467	0.016192875	10	8	Astrocytes	41	6	6
TGGCTGGAGTTCGATC-1_MS200_A303	13.00899396	0.490541877	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	911	1325	0.088301887	0.009811321	10	12	EN-MIX	41	6	6
TGGCTGGCACAGACTT-1_MS200_A303	13.04536301	0.791459158	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	791	1159	0.074201898	0.003451251	10	12	EN-MIX	41	6	6
TGGCTGGGTAAGTGTA-1_MS200_A303	21.01850711	-12.56493264	3	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2875	6038	0.125207022	0.00662471	10	3	EN-L5-6	41	6	6
TGGCTGGGTAGTGAAT-1_MS200_A303	-14.82700488	21.75921441	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1454	2301	0.006518905	0.007388092	10	8	Astrocytes	41	6	6
TGGCTGGGTCAGGACA-1_MS200_A303	-17.12053928	-4.197415852	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3709	8497	0.022831588	0.005766741	10	13A	IN-VIP	41	6	6
TGGCTGGTCAGCACAT-1_MS200_A303	-5.383141603	14.94679396	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	852	1195	0.005020921	0.021757322	10	oligos	OL-MS-1	41	6	6
TGGCTGGTCGTCTGCT-1_MS200_A303	-5.143657251	14.50668419	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	839	1240	0.005645161	0.019354839	10	oligos	OL-MS-1	41	6	6
TGGGAAGAGTGAAGAG-1_MS200_A303	-28.61502868	-5.535621353	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1146	1669	0.001198322	0.01018574	10	9	OPC	41	6	6
TGGGAAGCAATGTAAG-1_MS200_A303	-20.02188013	-2.607907769	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5846	17690	0.052176371	0.00638779	10	13A	IN-VIP	41	6	6
TGGGAAGGTTCCAACA-1_MS200_A303	-26.84700309	-23.00906283	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5257	13781	0.018431173	0.008054568	10	6A	IN-PV	41	6	6
TGGGAAGTCATTTGGG-1_MS200_A303	31.83490162	11.24672272	14	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	874	1378	0.054426705	0.029753266	10	14	Microglia	41	6	6
TGGGAAGTCGTCGTTC-1_MS200_A303	-30.41393856	-7.95204516	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1020	1518	0.002635046	0.004611331	10	9	OPC	41	6	6
TGGGAAGTCTAACTTC-1_MS200_A303	22.44750629	-4.798481208	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3246	6600	0.04469697	0.004545455	10	2	EN-L4	41	6	6
TGGGCGTAGACACGAC-1_MS200_A303	33.03758971	-8.696504035	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4837	13111	0.00457631	0.007398368	10	2	EN-L4	41	6	6
TGGGCGTAGCGCCTCA-1_MS200_A303	-14.68004101	25.39241876	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2250	4278	0.014960262	0.01028518	10	8	Astrocytes	41	6	6
TGGGCGTAGCGTGAGT-1_MS200_A303	-28.62844783	-6.423768945	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1049	1593	0.008160703	0.00690521	10	9	OPC	41	6	6
TGGGCGTAGGGCACTA-1_MS200_A303	-15.61427878	-1.073595771	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3491	7279	0.024179145	0.010440995	10	13A	IN-VIP	41	6	6
TGGTTAGAGACACGAC-1_MS200_A303	-16.58901526	-1.666746599	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2901	5458	0.009710517	0.014657384	10	13A	IN-VIP	41	6	6
TGGTTAGAGAGTCTGG-1_MS200_A303	22.89704638	-15.84699746	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5741	15224	0.017209669	0.019640042	10	2	EN-L4	41	6	6
TGGTTAGCAGCTCGAC-1_MS200_A303	23.45885049	-24.88575623	3	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3359	8169	0.002203452	0.00367242	10	3	EN-L5-6	41	6	6
TGGTTAGCATGTAAGA-1_MS200_A303	27.6024599	4.876508034	15BA	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	894	1260	0	0.017460317	10	15BA	Stromal cells	41	6	6
TGGTTAGGTACATCCA-1_MS200_A303	-15.97846541	23.53856555	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1605	2915	0.017838765	0.009262436	10	8	Astrocytes	41	6	6
TGGTTAGTCCCTGACT-1_MS200_A303	34.87746326	10.37656083	14	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	858	1125	0.005333333	0.010666667	10	14	Microglia	41	6	6
TGGTTAGTCGCACTCT-1_MS200_A303	5.050073911	-12.27391986	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2200	4507	0.059463057	0.003328156	10	L2-3	EN-L2-3-MS	41	6	6
TGGTTAGTCTTGAGAC-1_MS200_A303	-6.262717138	15.32817168	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	950	1421	0.017593244	0.011963406	10	oligos	OL-MS-1	41	6	6
TGGTTCCAGAGTTGGC-1_MS200_A303	-27.08312404	-22.71313423	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5142	14901	0.035635192	0.004697671	10	6A	IN-PV	41	6	6
TGGTTCCCACGACTCG-1_MS200_A303	-14.70380794	-37.50793041	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2032	3502	0.0513992	0.018560822	10	16	EN-PYR	41	6	6
TGGTTCCCAGTCGTGC-1_MS200_A303	13.97559009	-4.511763408	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1519	2384	0.021812081	0.007550336	10	12	EN-MIX	41	6	6
TGGTTCCGTTGTACAC-1_MS200_A303	11.96735165	1.415761766	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	957	1586	0.201765448	0.009457755	10	12	EN-MIX	41	6	6
TGTATTCAGAGACTTA-1_MS200_A303	2.746468367	10.65837747	1	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1177	1782	0.007856341	0.01627385	10	oligos	OL-Cntl	41	6	6
TGTATTCAGAGTAATC-1_MS200_A303	-17.28099391	28.92668635	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2341	3953	0.002782697	0.014166456	10	8	Astrocytes	41	6	6
TGTATTCGTGCCTGGT-1_MS200_A303	32.12057805	-8.177955523	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5100	14825	0.010118044	0.005935919	10	2	EN-L4	41	6	6
TGTATTCTCTGTACGA-1_MS200_A303	2.077526342	5.203429858	7	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	859	1073	0.004659832	0.01584343	10	7	Phagocytes	41	6	6
TGTCCCAAGCTTCGCG-1_MS200_A303	-12.65592005	17.67667976	11	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1985	3302	0.008479709	0.01120533	10	11	Glia-MIX	41	6	6
TGTCCCAAGGCGATAC-1_MS200_A303	10.16588773	-2.608192731	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1691	2359	0.019499788	0.00551081	10	12	EN-MIX	41	6	6
TGTCCCACAACACCTA-1_MS200_A303	34.54395773	-3.327824493	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2860	6219	0.035053867	0.003055154	10	2	EN-L4	41	6	6
TGTCCCACACCGGAAA-1_MS200_A303	-10.73593557	-1.068278718	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2263	3946	0.002027369	0.00861632	10	13A	IN-VIP	41	6	6
TGTCCCACATACTCTT-1_MS200_A303	-24.23354516	7.556977477	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1054	1606	0.003113325	0.015566625	10	8	Astrocytes	41	6	6
TGTCCCACATGTCGAT-1_MS200_A303	-14.30438232	22.12332975	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1286	1975	0.005063291	0.014683544	10	8	Astrocytes	41	6	6
TGTGGTAAGAGTGAGA-1_MS200_A303	-6.65431007	14.1574307	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	741	1004	0.011952191	0.014940239	10	oligos	OL-MS-1	41	6	6
TGTGGTAAGCGTTCCG-1_MS200_A303	-30.44434777	-21.42115464	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4229	9038	0.029763222	0.015379509	10	6A	IN-PV	41	6	6
TGTGGTACATTCGACA-1_MS200_A303	-16.10784641	-4.175782892	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2782	5377	0.013762321	0.006137251	10	13A	IN-VIP	41	6	6
TGTGGTAGTCTTCGTC-1_MS200_A303	13.41783538	-21.43349654	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4670	13419	0.053580744	0.005514569	10	L2-3	EN-L2-3-MS	41	6	6
TGTGGTAGTTACGACT-1_MS200_A303	-31.11167165	-5.529052763	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1265	1925	0.004155844	0.010909091	10	9	OPC	41	6	6
TGTGTTTCAGACTCGC-1_MS200_A303	-8.299311778	-37.62565999	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1067	1499	0.044029353	0.017344897	10	16	EN-PYR	41	6	6
TGTGTTTGTACCATCA-1_MS200_A303	14.76865004	-13.27979711	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5016	12798	0.012814502	0.011642444	10	L2-3	EN-L2-3-MS	41	6	6
TGTGTTTGTGCACGAA-1_MS200_A303	-10.44850353	28.14545529	17	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	802	1003	0.012961117	0.021934197	10	oligos	OL-MS-2	41	6	6
TGTGTTTGTTAGAACA-1_MS200_A303	-24.85522369	-19.02127938	6B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2934	6046	0.008435329	0.014058882	10	6B	IN-SST	41	6	6
TGTGTTTTCCCACTTG-1_MS200_A303	20.11108069	-22.63553918	3	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2942	6166	0.012163477	0.005676289	10	3	EN-L5-6	41	6	6
TGTGTTTTCGGCCGAT-1_MS200_A303	-15.71798775	22.2876882	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1314	2125	0.003764706	0.008470588	10	8	Astrocytes	41	6	6
TGTTCCGAGATCCTGT-1_MS200_A303	7.865896996	-14.83806523	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2854	5815	0.001547721	0.00533104	10	L2-3	EN-L2-3-MS	41	6	6
TGTTCCGAGTAAGTAC-1_MS200_A303	7.18545563	-2.028168655	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1029	1587	0.128544423	0.010712035	10	12	EN-MIX	41	6	6
TGTTCCGAGTCTCCTC-1_MS200_A303	-32.20937024	-6.075053119	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1126	1849	0.002163332	0.005408329	10	9	OPC	41	6	6
TGTTCCGCAAGCCATT-1_MS200_A303	12.50069285	-3.788010149	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1899	4124	0.223084384	0.003637245	10	12	EN-MIX	41	6	6
TGTTCCGGTCTTCGTC-1_MS200_A303	17.92004407	-21.53083155	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5940	19727	0.013686825	0.008060019	10	L2-3	EN-L2-3-MS	41	6	6
TGTTCCGGTGGTCCGT-1_MS200_A303	-31.88498048	-6.04824755	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1237	1901	0.011572856	0.006838506	10	9	OPC	41	6	6
TGTTCCGTCTTTAGTC-1_MS200_A303	9.832544185	1.099227914	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	955	1527	0.179436804	0.007203667	10	12	EN-MIX	41	6	6
TTAACTCCAGGAACGT-1_MS200_A303	-15.85907096	-1.888702007	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2695	5252	0.01199543	0.012566641	10	13A	IN-VIP	41	6	6
TTAACTCCAGTAGAGC-1_MS200_A303	-19.88735594	-1.123691762	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4333	9318	0.021141876	0.020712599	10	13A	IN-VIP	41	6	6
TTAACTCGTGGTTTCA-1_MS200_A303	-14.61632975	23.2354288	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1522	2598	0.010007698	0.011932256	10	8	Astrocytes	41	6	6
TTAACTCGTTATGTGC-1_MS200_A303	33.57314106	-16.26971958	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4177	9709	0.016273561	0.014110619	10	2	EN-L4	41	6	6
TTAGGACAGCTGGAAC-1_MS200_A303	-28.76677817	-21.61629652	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3679	7847	0.032878807	0.009302918	10	6A	IN-PV	41	6	6
TTAGGACCACCAGGCT-1_MS200_A303	-13.99796311	22.05510122	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1389	2289	0.00655308	0.018348624	10	8	Astrocytes	41	6	6
TTAGGACCAGCTGTTA-1_MS200_A303	-14.62372637	-38.10788767	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2704	5139	0.062463514	0.029383148	10	16	EN-PYR	41	6	6
TTAGGACTCAAACCGT-1_MS200_A303	-23.90306473	10.08161265	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1024	1565	0.003833866	0.007667732	10	8	Astrocytes	41	6	6
TTAGGACTCGCTTGTC-1_MS200_A303	-7.470892895	-35.19727721	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	836	1107	0.042457091	0.009033424	10	16	EN-PYR	41	6	6
TTAGGCAAGACCGGAT-1_MS200_A303	-29.23108675	-4.08626549	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1293	1926	0.003115265	0.00623053	10	9	OPC	41	6	6
TTAGGCAAGTTATCGC-1_MS200_A303	-5.273064086	17.39141995	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	850	1263	0.009501188	0.014251781	10	oligos	OL-MS-1	41	6	6
TTAGGCAGTGCTGTAT-1_MS200_A303	-19.89440594	-1.017035977	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4981	11571	0.017371014	0.016506784	10	13A	IN-VIP	41	6	6
TTAGGCATCATGTCCC-1_MS200_A303	-16.71020145	-3.962949605	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2924	6572	0.01795496	0.004260499	10	13A	IN-VIP	41	6	6
TTAGGCATCCTCAACC-1_MS200_A303	-9.72486327	-19.92446133	6B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	842	1237	0.062247373	0.004042037	10	6B	IN-SST	41	6	6
TTAGGCATCTTATCTG-1_MS200_A303	13.48303481	-2.675648714	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1194	1823	0.01206802	0.003839824	10	12	EN-MIX	41	6	6
TTAGTTCAGCCTTGAT-1_MS200_A303	-15.20731885	23.97309736	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1736	3399	0.006472492	0.010297146	10	8	Astrocytes	41	6	6
TTAGTTCAGCTGTTCA-1_MS200_A303	-4.645642674	-36.03362651	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	930	1167	0.05655527	0.023993145	10	16	EN-PYR	41	6	6
TTAGTTCAGTACGTAA-1_MS200_A303	-17.8482804	-3.18781723	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2877	5307	0.018277746	0.011682683	10	13A	IN-VIP	41	6	6
TTAGTTCCACCCTATC-1_MS200_A303	-9.587690808	-3.068441996	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1881	3377	0.002665087	0.006218537	10	13A	IN-VIP	41	6	6
TTAGTTCCATTAGCCA-1_MS200_A303	-15.52105537	23.45137614	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1461	2417	0.001654944	0.009102193	10	8	Astrocytes	41	6	6
TTAGTTCGTACATGTC-1_MS200_A303	-30.57714152	-12.4326273	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	732	1064	0.008458647	0.007518797	10	9	OPC	41	6	6
TTAGTTCTCGGTTCGG-1_MS200_A303	-17.19020808	-14.69272105	6B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1945	3435	0.01077147	0.011935953	10	6B	IN-SST	41	6	6
TTATGCTAGATTACCC-1_MS200_A303	8.923016426	1.527251075	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	757	1281	0.279469165	0.00312256	10	12	EN-MIX	41	6	6
TTATGCTAGTCGAGTG-1_MS200_A303	-14.4771358	23.04653021	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1611	2588	0.005795981	0.008500773	10	8	Astrocytes	41	6	6
TTATGCTCAATGTTGC-1_MS200_A303	-30.0631302	-3.602226028	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1330	2163	0.006472492	0.006472492	10	9	OPC	41	6	6
TTATGCTCAGTCACTA-1_MS200_A303	-30.02396452	-2.01239665	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1580	2686	0.005956813	0.006701415	10	9	OPC	41	6	6
TTATGCTCATACCATG-1_MS200_A303	-26.54085979	-21.79269652	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3910	9860	0.045131846	0.004868154	10	6A	IN-PV	41	6	6
TTATGCTCATTCCTCG-1_MS200_A303	-14.60719668	22.05173284	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1420	2188	0.005941499	0.013711152	10	8	Astrocytes	41	6	6
TTATGCTGTAAGGGAA-1_MS200_A303	-5.554322843	13.78112556	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	716	1026	0.002923977	0.020467836	10	oligos	OL-MS-1	41	6	6
TTATGCTGTCTACCTC-1_MS200_A303	-31.21922201	2.934404787	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2210	4292	0.003727866	0.006756757	10	9	OPC	41	6	6
TTATGCTGTTAAGACA-1_MS200_A303	12.72525937	-18.8576692	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	6251	20445	0.011592076	0.004108584	10	L2-3	EN-L2-3-MS	41	6	6
TTATGCTTCAGCACAT-1_MS200_A303	14.73473962	-17.72521779	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	6948	25923	0.012652857	0.006365004	10	L2-3	EN-L2-3-MS	41	6	6
TTATGCTTCAGCTGGC-1_MS200_A303	30.70426083	-11.79861524	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3243	6980	0.009169054	0.007020057	10	2	EN-L4	41	6	6
TTATGCTTCCGTACAA-1_MS200_A303	6.937974696	-1.565627364	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	891	1463	0.192071087	0.00683527	10	12	EN-MIX	41	6	6
TTCCCAGAGAGTAATC-1_MS200_A303	31.64345437	-11.47886037	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3196	6763	0.018335058	0.009167529	10	2	EN-L4	41	6	6
TTCCCAGAGCGATATA-1_MS200_A303	-14.32828589	22.73221258	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1533	2532	0.003554502	0.013823065	10	8	Astrocytes	41	6	6
TTCCCAGCAAGTCATC-1_MS200_A303	-30.58354854	-21.6218093	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5196	12925	0.027775629	0.020270793	10	6A	IN-PV	41	6	6
TTCCCAGCATAAAGGT-1_MS200_A303	-24.27979977	-0.777850801	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1433	2255	0.010643016	0.009312639	10	9	OPC	41	6	6
TTCCCAGCATCGGGTC-1_MS200_A303	-31.49948278	-6.320773605	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1132	1725	0.006376812	0.009855072	10	9	OPC	41	6	6
TTCCCAGTCATACGGT-1_MS200_A303	-6.640886326	-35.61242869	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	809	1047	0.033428844	0.011461318	10	16	EN-PYR	41	6	6
TTCCCAGTCCCACTTG-1_MS200_A303	34.34329187	-14.08596619	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4018	9130	0.005914567	0.013143483	10	2	EN-L4	41	6	6
TTCCCAGTCTTTAGGG-1_MS200_A303	-7.866582665	-10.53405362	6B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	869	1182	0.023688663	0.012690355	10	6B	IN-SST	41	6	6
TTCGAAGAGCAGGTCA-1_MS200_A303	-31.91525677	-8.002888551	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1049	1506	0.003320053	0.003320053	10	9	OPC	41	6	6
TTCGAAGCAACTGCGC-1_MS200_A303	-16.50375404	18.51747129	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1913	3147	0.01080394	0.010168414	10	8	Astrocytes	41	6	6
TTCGAAGGTGTGGCTC-1_MS200_A303	-12.284821	-37.52879853	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1426	2181	0.057313159	0.015130674	10	16	EN-PYR	41	6	6
TTCGAAGGTGTTGGGA-1_MS200_A303	-12.2857224	-15.14700185	6B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1337	2161	0.020823693	0.005552985	10	6B	IN-SST	41	6	6
TTCGAAGTCATCGGAT-1_MS200_A303	-20.55488422	-4.852521732	13B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4351	9550	0.021884817	0.014031414	10	13B	IN-SV2C	41	6	6
TTCGAAGTCTTATCTG-1_MS200_A303	4.83842066	-13.51425228	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2472	4824	0.005182421	0.004145937	10	L2-3	EN-L2-3-MS	41	6	6
TTCGGTCAGATGCGAC-1_MS200_A303	-11.01221125	-15.40705677	6B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1009	1500	0.045333333	0.005333333	10	6B	IN-SST	41	6	6
TTCGGTCAGTAGGTGC-1_MS200_A303	22.86164775	-25.44788773	3	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4351	11910	0.001763224	0.004198153	10	3	EN-L5-6	41	6	6
TTCGGTCAGTCAATAG-1_MS200_A303	-26.54842525	-20.75368649	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3068	6827	0.052585323	0.006298521	10	6A	IN-PV	41	6	6
TTCGGTCGTTGGAGGT-1_MS200_A303	-14.66388905	25.27510073	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2003	3569	0.008125525	0.010086859	10	8	Astrocytes	41	6	6
TTCGGTCTCTGACCTC-1_MS200_A303	-4.539500032	18.6295505	1	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	933	1366	0.009516837	0.013909224	10	oligos	OL-Cntl	41	6	6
TTCGGTCTCTGCGTAA-1_MS200_A303	-30.16151986	-8.324533904	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1186	1935	0.005684755	0.008268734	10	9	OPC	41	6	6
TTCTACACAATAACGA-1_MS200_A303	-5.824478115	17.17133612	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	841	1210	0.003305785	0.004958678	10	oligos	OL-MS-1	41	6	6
TTCTACACACGACTCG-1_MS200_A303	-14.80740685	23.73543846	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1544	2532	0.012638231	0.011058452	10	8	Astrocytes	41	6	6
TTCTACACAGGTGCCT-1_MS200_A303	11.97279098	-16.5604182	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4688	12807	0.016865777	0.004294526	10	L2-3	EN-L2-3-MS	41	6	6
TTCTACACATTTGCTT-1_MS200_A303	-8.974744247	-38.15637461	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1238	1781	0.067377878	0.020774846	10	16	EN-PYR	41	6	6
TTCTACATCGCGATCG-1_MS200_A303	12.78167158	-15.0621398	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3935	8567	0.012256332	0.008754523	10	L2-3	EN-L2-3-MS	41	6	6
TTCTCAAAGGACATTA-1_MS200_A303	7.013282048	-0.927426906	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	757	1111	0.147614761	0.00720072	10	12	EN-MIX	41	6	6
TTCTCAAAGGACCACA-1_MS200_A303	19.26953626	-20.71022345	3	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4396	11906	0.020829834	0.006383336	10	3	EN-L5-6	41	6	6
TTCTCAACAAGTAATG-1_MS200_A303	-9.182208006	27.12477424	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1066	1604	0.014962594	0.014339152	10	oligos	OL-MS-1	41	6	6
TTCTCAACATGCTAGT-1_MS200_A303	-15.53575585	-2.514559323	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2519	4654	0.01009884	0.007090675	10	13A	IN-VIP	41	6	6
TTCTCAAGTCGAGTTT-1_MS200_A303	-15.11028436	23.2009103	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1474	2518	0.001191422	0.010325655	10	8	Astrocytes	41	6	6
TTCTCAAGTTATGTGC-1_MS200_A303	33.40027714	5.367287562	14	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	949	1185	0.017721519	0.012658228	10	14	Microglia	41	6	6
TTCTCAATCAGATAAG-1_MS200_A303	9.849637806	-16.07862069	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3845	9041	0.006747041	0.005087933	10	L2-3	EN-L2-3-MS	41	6	6
TTCTCAATCAGGCGAA-1_MS200_A303	12.07893465	-15.32712181	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4122	9220	0.00813449	0.007483731	10	L2-3	EN-L2-3-MS	41	6	6
TTCTCAATCGAATGCT-1_MS200_A303	1.443484029	13.24459635	1	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1008	1540	0.011038961	0.012987013	10	oligos	OL-Cntl	41	6	6
TTCTCCTAGAATGTTG-1_MS200_A303	-15.26284275	21.84663145	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1200	1821	0.004393191	0.010433828	10	8	Astrocytes	41	6	6
TTCTCCTAGTCATCCA-1_MS200_A303	-5.157908693	-4.558805302	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1221	1955	0.027109974	0.003580563	10	13A	IN-VIP	41	6	6
TTCTCCTCAATGGATA-1_MS200_A303	-13.5326403	-37.12420607	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1842	2961	0.080715974	0.014184397	10	16	EN-PYR	41	6	6
TTCTCCTCAGGGTACA-1_MS200_A303	-32.50241289	-5.768464501	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1108	1811	0.002208724	0.002760906	10	9	OPC	41	6	6
TTCTCCTGTGGAAAGA-1_MS200_A303	33.12158175	-8.716977199	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3871	8576	0.005013993	0.008978545	10	2	EN-L4	41	6	6
TTCTCCTGTTACGCGC-1_MS200_A303	-20.29956462	-5.496903109	13B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4546	11445	0.014591525	0.009261686	10	13B	IN-SV2C	41	6	6
TTCTCCTTCCATGCTC-1_MS200_A303	-30.61226618	-2.444459456	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1455	2535	0.004733728	0.005128205	10	9	OPC	41	6	6
TTCTCCTTCGAACGGA-1_MS200_A303	33.93863943	-18.57783879	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5606	14583	0.014126037	0.022971954	10	2	EN-L4	41	6	6
TTCTTAGAGATCCTGT-1_MS200_A303	-14.3810461	22.2271005	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1526	2508	0.013556619	0.006778309	10	8	Astrocytes	41	6	6
TTCTTAGAGGCATGTG-1_MS200_A303	-26.89863189	-21.58733236	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3470	7559	0.03571901	0.006879217	10	6A	IN-PV	41	6	6
TTCTTAGCACACGCTG-1_MS200_A303	9.561545501	-23.69776437	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4566	13645	0.002491755	0.012238915	10	L2-3	EN-L2-3-MS	41	6	6
TTCTTAGCACATCCAA-1_MS200_A303	33.9126658	-18.37080799	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5241	13278	0.014761259	0.014309384	10	2	EN-L4	41	6	6
TTCTTAGCACGGTTTA-1_MS200_A303	9.927726853	-16.04378959	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3496	8094	0.010625154	0.012849024	10	L2-3	EN-L2-3-MS	41	6	6
TTCTTAGCATCACAAC-1_MS200_A303	-5.206954426	19.55578973	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	713	1012	0.004940711	0.018774704	10	oligos	OL-MS-1	41	6	6
TTCTTAGGTAAATGAC-1_MS200_A303	0.880128561	11.85587522	1	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	857	1291	0.00697134	0.017815647	10	oligos	OL-Cntl	41	6	6
TTCTTAGGTGTGAAAT-1_MS200_A303	-18.46025082	-5.728494382	13B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2881	5613	0.020488153	0.005344735	10	13B	IN-SV2C	41	6	6
TTCTTAGTCAACCATG-1_MS200_A303	-24.07401019	6.400636263	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	823	1208	0.01986755	0.01986755	10	8	Astrocytes	41	6	6
TTCTTAGTCCTTGACC-1_MS200_A303	-32.60458542	-4.443527043	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1418	2406	0.004156276	0.0120532	10	9	OPC	41	6	6
TTCTTAGTCGACGGAA-1_MS200_A303	-14.97873106	22.4377481	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1658	2901	0.005170631	0.008962427	10	8	Astrocytes	41	6	6
TTGAACGAGGCTCAGA-1_MS200_A303	-29.33375705	-5.927826593	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1104	1627	0.007375538	0.004302397	10	9	OPC	41	6	6
TTGAACGAGTGCTGCC-1_MS200_A303	21.67605147	-16.35176715	3	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5293	15116	0.006284731	0.021963482	10	3	EN-L5-6	41	6	6
TTGAACGCAAACTGTC-1_MS200_A303	-22.51084326	-1.721234705	11	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	868	1172	0.008532423	0.010238908	10	11	Glia-MIX	41	6	6
TTGAACGCAAGACGTG-1_MS200_A303	15.94535749	-10.77826924	3	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2798	5845	0.073567151	0.005816938	10	3	EN-L5-6	41	6	6
TTGAACGCAAGTCATC-1_MS200_A303	10.19877227	-16.46865074	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4097	9944	0.006838294	0.009050684	10	L2-3	EN-L2-3-MS	41	6	6
TTGAACGCAGATAATG-1_MS200_A303	17.2600229	-13.40557674	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4588	10656	0.028059309	0.010416667	10	L2-3	EN-L2-3-MS	41	6	6
TTGAACGCAGGGCATA-1_MS200_A303	-16.13216448	-1.796339308	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2537	4604	0.014335361	0.012814944	10	13A	IN-VIP	41	6	6
TTGAACGGTAAACACA-1_MS200_A303	6.404140162	-7.937975952	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1937	3207	0.066417212	0.00592454	10	12	EN-MIX	41	6	6
TTGAACGGTACAGACG-1_MS200_A303	-10.27095477	-33.37715891	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1028	1400	0.059285714	0.014285714	10	16	EN-PYR	41	6	6
TTGAACGGTATCAGTC-1_MS200_A303	13.00067824	-13.36911421	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4949	12216	0.01146038	0.015798952	10	L2-3	EN-L2-3-MS	41	6	6
TTGAACGGTCCTAGCG-1_MS200_A303	-11.61357266	-6.292506176	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2034	3456	0.017650463	0.006076389	10	13A	IN-VIP	41	6	6
TTGAACGGTCTAGAGG-1_MS200_A303	-12.66715184	17.78520345	11	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1997	3328	0.015925481	0.008112981	10	11	Glia-MIX	41	6	6
TTGAACGGTGACTCAT-1_MS200_A303	-12.07530559	-13.97185442	6B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1308	1985	0.042821159	0.007052897	10	6B	IN-SST	41	6	6
TTGAACGGTGTCCTCT-1_MS200_A303	29.70622876	-12.50024922	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3930	8923	0.023310546	0.006051776	10	2	EN-L4	41	6	6
TTGAACGTCCAGTAGT-1_MS200_A303	-23.66711497	10.27959296	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1201	1721	0.004067403	0.00929692	10	8	Astrocytes	41	6	6
TTGAACGTCCATGCTC-1_MS200_A303	12.13546009	-12.61905214	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3697	7890	0.010392902	0.024207858	10	L2-3	EN-L2-3-MS	41	6	6
TTGAACGTCCGCTGTT-1_MS200_A303	-18.62392944	5.889565632	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	882	1185	0.004219409	0.010970464	10	8	Astrocytes	41	6	6
TTGAACGTCCTGCAGG-1_MS200_A303	-5.975469997	-30.50779237	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	808	1236	0.200647249	0.015372168	10	16	EN-PYR	41	6	6
TTGAACGTCGTACGGC-1_MS200_A303	-15.45221174	20.23839981	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1539	2539	0.005907838	0.012209531	10	8	Astrocytes	41	6	6
TTGAACGTCTTGAGAC-1_MS200_A303	-6.148592141	-35.75045042	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	909	1162	0.031841652	0.015490534	10	16	EN-PYR	41	6	6
TTGACTTAGGGATGGG-1_MS200_A303	-29.13389105	-11.63660241	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	905	1255	0.009561753	0.007968127	10	9	OPC	41	6	6
TTGACTTAGTGCAAGC-1_MS200_A303	-9.386864834	27.3784887	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	812	1047	0.012416428	0.014326648	10	oligos	OL-MS-1	41	6	6
TTGACTTCACTCTGTC-1_MS200_A303	-28.47394512	9.117032405	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	769	1075	0.005581395	0.009302326	10	8	Astrocytes	41	6	6
TTGACTTCAGTTCATG-1_MS200_A303	15.24085936	-13.52457802	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5806	17262	0.011006836	0.009616499	10	L2-3	EN-L2-3-MS	41	6	6
TTGACTTCATTCACTT-1_MS200_A303	-14.60039606	-16.53100319	6B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1505	2671	0.029202546	0.008611007	10	6B	IN-SST	41	6	6
TTGACTTTCGCAAGCC-1_MS200_A303	9.647795798	-16.11763215	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3755	9299	0.007097537	0.007527691	10	L2-3	EN-L2-3-MS	41	6	6
TTGCCGTAGGATATAC-1_MS200_A303	-18.17926908	29.74491548	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2644	5328	0.003003003	0.011073574	10	8	Astrocytes	41	6	6
TTGCCGTCAGACTCGC-1_MS200_A303	14.09561338	-17.19897409	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	6482	21896	0.010549872	0.00511509	10	L2-3	EN-L2-3-MS	41	6	6
TTGCCGTCATCGACGC-1_MS200_A303	-27.00173063	-23.15749322	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5083	13477	0.018401721	0.007197448	10	6A	IN-PV	41	6	6
TTGCCGTGTATATGGA-1_MS200_A303	22.66732503	-16.75634909	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5052	13377	0.032443747	0.010017194	10	2	EN-L4	41	6	6
TTGCCGTGTCCGCTGA-1_MS200_A303	-5.683318582	-35.30173959	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	780	1016	0.068897638	0.018700787	10	16	EN-PYR	41	6	6
TTGCCGTGTTGCGCAC-1_MS200_A303	-13.0584071	21.98179385	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2042	3747	0.014144649	0.011208967	10	8	Astrocytes	41	6	6
TTGCGTCAGAAACCAT-1_MS200_A303	-4.732503618	15.13884283	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	755	1047	0.003820439	0.016236867	10	oligos	OL-MS-1	41	6	6
TTGCGTCGTAGCGCTC-1_MS200_A303	34.224525	-14.13816662	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3874	8390	0.009415971	0.011680572	10	2	EN-L4	41	6	6
TTGCGTCTCGCTTAGA-1_MS200_A303	-16.47500409	-1.787456002	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2299	4043	0.021766015	0.014098442	10	13A	IN-VIP	41	6	6
TTGCGTCTCTGAGGGA-1_MS200_A303	9.514901395	-2.090939358	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1466	2565	0.166471735	0.004678363	10	12	EN-MIX	41	6	6
TTGGAACAGATGTAAC-1_MS200_A303	12.75502193	-13.12331743	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4281	10268	0.011686794	0.013342423	10	L2-3	EN-L2-3-MS	41	6	6
TTGGAACAGCCAACAG-1_MS200_A303	-6.388708371	15.74517806	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	730	1037	0.008678881	0.008678881	10	oligos	OL-MS-1	41	6	6
TTGGAACCAAAGAATC-1_MS200_A303	-28.88643108	-20.78788577	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2939	5273	0.03641191	0.011947658	10	6A	IN-PV	41	6	6
TTGGAACCACCCATTC-1_MS200_A303	-14.60430027	24.62060953	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1718	2922	0.002395619	0.010609172	10	8	Astrocytes	41	6	6
TTGGAACGTGAAAGAG-1_MS200_A303	-17.21804421	-1.305886899	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2723	4899	0.013880384	0.014492754	10	13A	IN-VIP	41	6	6
TTGGAACTCATAAAGG-1_MS200_A303	-12.44860784	18.26174208	11	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2199	3892	0.006937307	0.013617677	10	11	Glia-MIX	41	6	6
TTGGAACTCGCCAAAT-1_MS200_A303	6.862300162	1.368120054	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	719	1011	0.085064293	0.010880317	10	16	EN-PYR	41	6	6
TTGGCAACATGCATGT-1_MS200_A303	15.03804415	-20.47739968	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	6110	19141	0.006164777	0.007366386	10	L2-3	EN-L2-3-MS	41	6	6
TTGGCAAGTAACGTTC-1_MS200_A303	-16.55537574	20.41889133	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1557	2403	0.004161465	0.011235955	10	8	Astrocytes	41	6	6
TTGGCAATCCTCAACC-1_MS200_A303	-30.03979147	-1.446932999	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1624	2790	0.002150538	0.005734767	10	9	OPC	41	6	6
TTGTAGGAGAACTCGG-1_MS200_A303	0.411542922	11.26748897	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	984	1361	0.004408523	0.020573108	10	oligos	OL-MS-1	41	6	6
TTGTAGGAGTTGAGTA-1_MS200_A303	28.90182108	-18.85663405	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	8864	39069	0.035450101	0.013079424	10	2	EN-L4	41	6	6
TTGTAGGCAAGGGTCA-1_MS200_A303	12.07278812	1.389116436	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	936	1260	0.04047619	0.01031746	10	12	EN-MIX	41	6	6
TTGTAGGCAGTTCCCT-1_MS200_A303	9.631343153	-16.09092724	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3588	7806	0.003586984	0.011273379	10	L2-3	EN-L2-3-MS	41	6	6
TTGTAGGCATCTCCCA-1_MS200_A303	-32.23707404	-11.27053855	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	899	1393	0.0028715	0.005025126	10	9	OPC	41	6	6
TTGTAGGGTAGAAAGG-1_MS200_A303	15.45827921	-13.67529801	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5376	14168	0.015033879	0.011293055	10	L2-3	EN-L2-3-MS	41	6	6
TTGTAGGGTCGTGGCT-1_MS200_A303	-12.85685751	-17.26597661	6B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1169	1855	0.035040431	0.004851752	10	6B	IN-SST	41	6	6
TTGTAGGGTCTCATCC-1_MS200_A303	15.2719077	-21.01392631	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4335	10355	0.01641719	0.009367455	10	L2-3	EN-L2-3-MS	41	6	6
TTGTAGGTCCCAAGAT-1_MS200_A303	-23.35569469	9.715116958	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1190	1849	0.008653326	0.010275825	10	8	Astrocytes	41	6	6
TTTACTGAGATGCCAG-1_MS200_A303	-12.19921699	17.94751402	11	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2369	4303	0.004880316	0.018359284	10	11	Glia-MIX	41	6	6
TTTACTGAGGAATTAC-1_MS200_A303	18.30996051	-9.342718957	3	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2494	5274	0.025976488	0.002275313	10	3	EN-L5-6	41	6	6
TTTACTGAGGCAAAGA-1_MS200_A303	33.71909112	-18.270124	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5130	13105	0.022205265	0.01457459	10	2	EN-L4	41	6	6
TTTACTGAGTTCGATC-1_MS200_A303	13.2732212	-20.33826633	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	6045	20372	0.00569409	0.005497742	10	L2-3	EN-L2-3-MS	41	6	6
TTTACTGCAGTCACTA-1_MS200_A303	-11.16930212	-2.242354779	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2108	4089	0.022743947	0.004646613	10	13A	IN-VIP	41	6	6
TTTACTGCATAGAAAC-1_MS200_A303	-6.454922663	-10.38330854	13B	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1011	1478	0.01623816	0.00338295	10	13B	IN-SV2C	41	6	6
TTTACTGGTAATCGTC-1_MS200_A303	11.4981424	1.154845953	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	770	1207	0.168185584	0.004142502	10	12	EN-MIX	41	6	6
TTTATGCAGAAGCCCA-1_MS200_A303	33.03300955	-18.64420549	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3157	6578	0.02173913	0.016722408	10	2	EN-L4	41	6	6
TTTATGCAGTTAGCGG-1_MS200_A303	30.88269976	-18.91926675	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5433	14553	0.020133306	0.020064591	10	2	EN-L4	41	6	6
TTTATGCCACATGTGT-1_MS200_A303	1.012797006	10.36398839	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1030	1627	0.005531653	0.012907191	10	oligos	OL-MS-1	41	6	6
TTTATGCCATTACGAC-1_MS200_A303	-10.26118184	-36.43465283	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1212	1913	0.111866179	0.014636696	10	16	EN-PYR	41	6	6
TTTATGCCATTCTTAC-1_MS200_A303	-15.53225398	-4.501333155	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3466	8637	0.009609818	0.007525761	10	13A	IN-VIP	41	6	6
TTTATGCGTCTAAAGA-1_MS200_A303	-29.5150045	-4.420296027	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1343	2073	0.006753497	0.006271105	10	9	OPC	41	6	6
TTTATGCGTGTCGCTG-1_MS200_A303	-31.67621221	-7.850609295	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1131	1718	0.001164144	0.002910361	10	9	OPC	41	6	6
TTTATGCTCACATACG-1_MS200_A303	-31.37034436	2.775216177	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2386	4581	0.005239031	0.005020738	10	9	OPC	41	6	6
TTTATGCTCACCTTAT-1_MS200_A303	-16.46847177	11.39842901	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1214	2035	0.006879607	0.001965602	10	8	Astrocytes	41	6	6
TTTATGCTCTGCCAGG-1_MS200_A303	14.26445131	-2.321721249	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	962	1428	0.00280112	0.004901961	10	12	EN-MIX	41	6	6
TTTCCTCAGCAGGCTA-1_MS200_A303	-19.73970884	-3.342368287	13A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3344	6952	0.029631761	0.00618527	10	13A	IN-VIP	41	6	6
TTTCCTCCATCGATTG-1_MS200_A303	-30.84909471	-3.053521814	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1328	2269	0.003085059	0.004407228	10	9	OPC	41	6	6
TTTCCTCCATGGATGG-1_MS200_A303	-5.31703579	13.61451513	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	881	1216	0.008223684	0.018092105	10	oligos	OL-MS-1	41	6	6
TTTCCTCCATTCCTCG-1_MS200_A303	-23.79263526	-19.59891543	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3551	9215	0.015843733	0.004340749	10	6A	IN-PV	41	6	6
TTTCCTCTCAACGCTA-1_MS200_A303	10.38974124	-8.470904825	10	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2377	5219	0.003832152	0.003257329	10	L2-3	EN-L2-3-Cntl	41	6	6
TTTCCTCTCACTCTTA-1_MS200_A303	21.77594351	-16.77837474	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5069	15490	0.018657198	0.01103938	10	L2-3	EN-L2-3-MS	41	6	6
TTTGCGCAGAATAGGG-1_MS200_A303	-23.85655583	-21.07962794	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2839	5904	0.052676152	0.005420054	10	6A	IN-PV	41	6	6
TTTGCGCCAACACGCC-1_MS200_A303	-15.17984081	25.7298767	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2104	3764	0.002391073	0.011955367	10	8	Astrocytes	41	6	6
TTTGCGCCACATGACT-1_MS200_A303	21.28770122	-3.067988379	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2146	3982	0.041185334	0.004520342	10	2	EN-L4	41	6	6
TTTGCGCGTCCGCTGA-1_MS200_A303	-16.51845978	20.86526729	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1619	2465	0.002028398	0.010141988	10	8	Astrocytes	41	6	6
TTTGCGCGTGAAATCA-1_MS200_A303	14.18518199	-16.23616083	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	6126	18252	0.009478413	0.006519833	10	L2-3	EN-L2-3-MS	41	6	6
TTTGCGCGTGATGCCC-1_MS200_A303	21.38828136	-12.85446791	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3348	7757	0.134588114	0.006445791	10	2	EN-L4	41	6	6
TTTGCGCTCCAAATGC-1_MS200_A303	12.20759031	-16.80026451	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5255	14459	0.008645135	0.009336745	10	L2-3	EN-L2-3-MS	41	6	6
TTTGCGCTCCTCAACC-1_MS200_A303	12.47363125	0.572332334	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	845	1256	0.054936306	0.006369427	10	12	EN-MIX	41	6	6
TTTGCGCTCTTGTATC-1_MS200_A303	-31.12667605	-7.945328807	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1025	1514	0.004623514	0.010568032	10	9	OPC	41	6	6
TTTGGTTAGAGCAATT-1_MS200_A303	-11.07118908	22.70511052	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1846	2923	0.0071844	0.009237085	10	8	Astrocytes	41	6	6
TTTGGTTAGCTAGTCT-1_MS200_A303	-21.51263525	-21.24021932	6A	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	2148	4008	0.039670659	0.005489022	10	6A	IN-PV	41	6	6
TTTGGTTCAGCTCCGA-1_MS200_A303	22.69446069	-22.22064698	3	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5100	15242	0.011087784	0.004198924	10	3	EN-L5-6	41	6	6
TTTGGTTCATCACGAT-1_MS200_A303	-9.205042477	27.25971362	17	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	919	1345	0.016356877	0.015613383	10	oligos	OL-MS-2	41	6	6
TTTGGTTGTACCAGTT-1_MS200_A303	-24.410105	-0.849275904	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1370	2150	0.002325581	0.011162791	10	9	OPC	41	6	6
TTTGGTTGTATAGGTA-1_MS200_A303	21.93344343	-17.04691715	3	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	4455	10615	0.040226095	0.010174282	10	3	EN-L5-6	41	6	6
TTTGGTTGTATTAGCC-1_MS200_A303	-16.11817179	20.40367677	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1379	2177	0.004593477	0.013321084	10	8	Astrocytes	41	6	6
TTTGGTTTCACAATGC-1_MS200_A303	-4.325208186	13.00264688	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	936	1270	0.000787402	0.015748031	10	oligos	OL-MS-1	41	6	6
TTTGGTTTCCCTAATT-1_MS200_A303	11.58217544	-0.429770624	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1029	1542	0.071984436	0.003891051	10	12	EN-MIX	41	6	6
TTTGTCAAGGGCTCTC-1_MS200_A303	11.14847736	-13.20901017	4	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	3610	7681	0.008592631	0.013670095	10	L2-3	EN-L2-3-MS	41	6	6
TTTGTCACACACCGCA-1_MS200_A303	-18.00804181	20.14335396	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1659	2896	0.005524862	0.00621547	10	8	Astrocytes	41	6	6
TTTGTCACACCAGGTC-1_MS200_A303	-27.23805457	-2.213359255	9	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1562	2467	0.003242805	0.011755168	10	9	OPC	41	6	6
TTTGTCACATGAGCGA-1_MS200_A303	-5.657797685	12.5711075	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	817	1165	0.003433476	0.012017167	10	oligos	OL-MS-1	41	6	6
TTTGTCACATTAACCG-1_MS200_A303	7.127555703	-1.724696595	12	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1073	1730	0.139884393	0.003468208	10	12	EN-MIX	41	6	6
TTTGTCAGTGTTAAGA-1_MS200_A303	-5.428650913	17.10755728	5	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	857	1227	0.003259984	0.011409943	10	oligos	OL-MS-1	41	6	6
TTTGTCAGTTCGCGAC-1_MS200_A303	34.01123515	-18.50911805	2	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	5463	14703	0.01061008	0.018159559	10	2	EN-L4	41	6	6
TTTGTCAGTTCTGGTA-1_MS200_A303	-16.62254703	20.91056055	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1560	2548	0.018838305	0.003924647	10	8	Astrocytes	41	6	6
TTTGTCATCCAAATGC-1_MS200_A303	-5.947137363	-35.59468619	16	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	814	1066	0.051594747	0.019699812	10	16	EN-PYR	41	6	6
TTTGTCATCTAACGGT-1_MS200_A303	-15.90668813	23.3220709	8	MS200_A303	MS	Chronic inactive	44	female	prefrontal	CAP6	SEQ4	9	20	1497	2520	0.002777778	0.010714286	10	8	Astrocytes	41	6	6
